Citrus Sinensis ID: 002673
Local Sequence Feature Prediction
| Prediction and (Method) | Result |
|---|
|
|
Close Homologs for Annotation Transfer
Close Homologs in SWISS-PROT Database Detected by BLAST 
Original result of BLAST against SWISS-PROT Database
| ID | Alignment graph | Length |
Definition |
RBH(Q2H) |
RBH(H2Q) |
Q cover |
H cover |
Identity |
E-value |
| Query | 894 | 2.2.26 [Sep-21-2011] | |||||||
| Q9C7S5 | 1095 | Tyrosine-sulfated glycope | yes | no | 0.642 | 0.524 | 0.655 | 0.0 | |
| Q8LPB4 | 1021 | Phytosulfokine receptor 1 | N/A | no | 0.591 | 0.518 | 0.541 | 1e-163 | |
| Q9FN37 | 1036 | Phytosulfokine receptor 2 | no | no | 0.598 | 0.516 | 0.523 | 1e-158 | |
| Q9ZVR7 | 1008 | Phytosulfokine receptor 1 | no | no | 0.598 | 0.530 | 0.535 | 1e-158 | |
| Q9LYN8 | 1192 | Leucine-rich repeat recep | no | no | 0.600 | 0.450 | 0.385 | 1e-95 | |
| Q9LJF3 | 1164 | Receptor-like protein kin | no | no | 0.536 | 0.412 | 0.412 | 2e-95 | |
| Q9ZWC8 | 1166 | Serine/threonine-protein | no | no | 0.548 | 0.420 | 0.398 | 3e-95 | |
| Q8L899 | 1207 | Systemin receptor SR160 O | N/A | no | 0.546 | 0.405 | 0.399 | 3e-93 | |
| Q8GUQ5 | 1207 | Brassinosteroid LRR recep | N/A | no | 0.546 | 0.405 | 0.399 | 5e-93 | |
| O22476 | 1196 | Protein BRASSINOSTEROID I | no | no | 0.542 | 0.405 | 0.392 | 1e-92 |
| >sp|Q9C7S5|PSYR1_ARATH Tyrosine-sulfated glycopeptide receptor 1 OS=Arabidopsis thaliana GN=PSYR1 PE=2 SV=1 | Back alignment and function desciption |
|---|
Score = 733 bits (1891), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 380/580 (65%), Positives = 456/580 (78%), Gaps = 6/580 (1%)
Query: 317 GEVEGKSDEGPSLFS---QANLLSGEFPKELTALPALVSEAANDEVDRSYLELPVFVMPS 373
G + G P LF N L+GE PKEL L AL+S+ A D +R+YLELPVFV P+
Sbjct: 509 GTIPGWLGTLPDLFYLDLSDNFLTGELPKELFQLRALMSQKAYDATERNYLELPVFVNPN 568
Query: 374 NAT-NQQYNQLSNLPPAIYLANNSLSGNIPVEIGQLKSLHVLDLSNNNFSGTIPDELSDL 432
N T NQQYNQLS+LPP IY+ N+L+G IPVE+GQLK LH+L+L NNFSG+IPDELS+L
Sbjct: 569 NVTTNQQYNQLSSLPPTIYIKRNNLTGTIPVEVGQLKVLHILELLGNNFSGSIPDELSNL 628
Query: 433 SNLEKLDLSGNHLVGEIPISLKGLHFLSSFSVAHNNLQGAVPSGGQFDTFPSFSFEGNPE 492
+NLE+LDLS N+L G IP SL GLHFLS F+VA+N L G +P+G QFDTFP +FEGNP
Sbjct: 629 TNLERLDLSNNNLSGRIPWSLTGLHFLSYFNVANNTLSGPIPTGTQFDTFPKANFEGNPL 688
Query: 493 LCGSVVQRPCAISPGATHPTAPHKRTNTKLVIGLVLGICFGTGLIISMLALWILSKRRII 552
LCG V+ C + +T K N LV+GLVLG+ FG LI+ +LAL +LSKRR+
Sbjct: 689 LCGGVLLTSCDPTQHSTTKMGKGK-VNRTLVLGLVLGLFFGVSLILVLLALLVLSKRRVN 747
Query: 553 PGGDPDKIELDTISSTSNFGVSPEADKDASLVMLFPNNTNEIKDLTIYELLKATDNFSQA 612
PG D + EL+ S+ S V P +DKD SLV+LF N+ E+KDLTI+ELLKATDNFSQA
Sbjct: 748 PG-DSENAELEINSNGSYSEVPPGSDKDISLVLLFGNSRYEVKDLTIFELLKATDNFSQA 806
Query: 613 NIIGCGGFGLVYKATLANGTTLAIKKLSGDLGLMEREFKAEVEALSTAQHKNLVSLQGYC 672
NIIGCGGFGLVYKATL NGT LA+KKL+GD G+ME+EFKAEVE LS A+H+NLV+LQGYC
Sbjct: 807 NIIGCGGFGLVYKATLDNGTKLAVKKLTGDYGMMEKEFKAEVEVLSRAKHENLVALQGYC 866
Query: 673 VHQGFRLLIYSYMENGSLDYWLHEKADGASQLDWLTRLKIARGTSCGLAYMHQICEPHIV 732
VH R+LIYS+MENGSLDYWLHE +G +QLDW RL I RG S GLAYMHQICEPHIV
Sbjct: 867 VHDSARILIYSFMENGSLDYWLHENPEGPAQLDWPKRLNIMRGASSGLAYMHQICEPHIV 926
Query: 733 HRDIKSSNILLDDQFEAHLADFGLSRLILPYQTHVTTELVGTLGYIPPEYGQAWVATLRG 792
HRDIKSSNILLD F+A++ADFGLSRLILPY+THVTTELVGTLGYIPPEYGQAWVATLRG
Sbjct: 927 HRDIKSSNILLDGNFKAYVADFGLSRLILPYRTHVTTELVGTLGYIPPEYGQAWVATLRG 986
Query: 793 DMYSFGVVMLELLTGKRPVDVLKPKMSRELVGWVLKMRSEGKQDQVFDPILRGKGFDEEM 852
D+YSFGVVMLELLTGKRP++V +PKMSRELV WV M+ +GK ++VFD +LR G +E M
Sbjct: 987 DVYSFGVVMLELLTGKRPMEVFRPKMSRELVAWVHTMKRDGKPEEVFDTLLRESGNEEAM 1046
Query: 853 LQVLDVACMCVSQNPFKRPTVKEVVEWLNNVGANRRNENK 892
L+VLD+ACMCV+QNP KRP +++VV+WL N+ A + N+
Sbjct: 1047 LRVLDIACMCVNQNPMKRPNIQQVVDWLKNIEAEKNQNNR 1086
|
Tyrosine-sulfated glycopeptide receptor with a serine/threonine-protein kinase activity. Regulates, in response to tyrosine-sulfated glycopeptide binding, a signaling cascade involved in cellular proliferation and plant growth. Not involved in PSK perception. Arabidopsis thaliana (taxid: 3702) EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: 1 |
| >sp|Q8LPB4|PSKR1_DAUCA Phytosulfokine receptor 1 OS=Daucus carota GN=PSKR PE=1 SV=1 | Back alignment and function description |
|---|
Score = 576 bits (1485), Expect = e-163, Method: Compositional matrix adjust.
Identities = 301/556 (54%), Positives = 390/556 (70%), Gaps = 27/556 (4%)
Query: 334 NLLSGEFPKELTALPALVSEAANDEVDRSYLELPVFVMP-SNATNQQYNQLSNLPPAIYL 392
N GE P LT+L +LVS+ + V+ + P F +NA QYNQ S+ PP I L
Sbjct: 483 NTFIGEIPHSLTSLQSLVSKE--NAVEEPSPDFPFFKKKNTNAGGLQYNQPSSFPPMIDL 540
Query: 393 ANNSLSGNIPVEIGQLKSLHVLDLSNNNFSGTIPDELSDLSNLEKLDLSGNHLVGEIPIS 452
+ NSL+G+I E G L+ LHVL+L NNN SG IP LS +++LE LDLS N+L G IP S
Sbjct: 541 SYNSLNGSIWPEFGDLRQLHVLNLKNNNLSGNIPANLSGMTSLEVLDLSHNNLSGNIPPS 600
Query: 453 LKGLHFLSSFSVAHNNLQGAVPSGGQFDTFPSFSFEGNPELCGSVVQRPCAISPGATHPT 512
L L FLS+FSVA+N L G +P+G QF TFP+ SFEGN LCG PC I+ + H +
Sbjct: 601 LVKLSFLSTFSVAYNKLSGPIPTGVQFQTFPNSSFEGNQGLCGEHAS-PCHITDQSPHGS 659
Query: 513 APHKRTNTKLVIGLVLGICFGTGLIISMLALW---ILSKRRIIP--GGDPDKIELDTISS 567
A + N + ++ + +G GT ++++ L S+ + P D D+IEL + S
Sbjct: 660 AVKSKKNIRKIVAVAVGTGLGTVFLLTVTLLIILRTTSRGEVDPEKKADADEIELGSRS- 718
Query: 568 TSNFGVSPEADKDASLVMLFPNNTNEIKDLTIYELLKATDNFSQANIIGCGGFGLVYKAT 627
V+LF +N + +L++ ++LK+T +F+QANIIGCGGFGLVYKAT
Sbjct: 719 ----------------VVLF-HNKDSNNELSLDDILKSTSSFNQANIIGCGGFGLVYKAT 761
Query: 628 LANGTTLAIKKLSGDLGLMEREFKAEVEALSTAQHKNLVSLQGYCVHQGFRLLIYSYMEN 687
L +GT +AIK+LSGD G M+REF+AEVE LS AQH NLV L GYC ++ +LLIYSYM+N
Sbjct: 762 LPDGTKVAIKRLSGDTGQMDREFQAEVETLSRAQHPNLVHLLGYCNYKNDKLLIYSYMDN 821
Query: 688 GSLDYWLHEKADGASQLDWLTRLKIARGTSCGLAYMHQICEPHIVHRDIKSSNILLDDQF 747
GSLDYWLHEK DG LDW TRL+IARG + GLAY+HQ CEPHI+HRDIKSSNILL D F
Sbjct: 822 GSLDYWLHEKVDGPPSLDWKTRLRIARGAAEGLAYLHQSCEPHILHRDIKSSNILLSDTF 881
Query: 748 EAHLADFGLSRLILPYQTHVTTELVGTLGYIPPEYGQAWVATLRGDMYSFGVVMLELLTG 807
AHLADFGL+RLILPY THVTT+LVGTLGYIPPEYGQA VAT +GD+YSFGVV+LELLTG
Sbjct: 882 VAHLADFGLARLILPYDTHVTTDLVGTLGYIPPEYGQASVATYKGDVYSFGVVLLELLTG 941
Query: 808 KRPVDVLKPKMSRELVGWVLKMRSEGKQDQVFDPILRGKGFDEEMLQVLDVACMCVSQNP 867
+RP+DV KP+ SR+L+ WVL+M++E ++ ++FDP + K EEML VL++AC C+ +NP
Sbjct: 942 RRPMDVCKPRGSRDLISWVLQMKTEKRESEIFDPFIYDKDHAEEMLLVLEIACRCLGENP 1001
Query: 868 FKRPTVKEVVEWLNNV 883
RPT +++V WL N+
Sbjct: 1002 KTRPTTQQLVSWLENI 1017
|
Phytosulfokine receptor with a serine/threonine-protein kinase activity. Regulates, in response to phytosulfokine binding, a signaling cascade involved in plant cell differentiation, organogenesis and somatic embryogenesis. Daucus carota (taxid: 4039) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9FN37|PSKR2_ARATH Phytosulfokine receptor 2 OS=Arabidopsis thaliana GN=PSKR2 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 561 bits (1445), Expect = e-158, Method: Compositional matrix adjust.
Identities = 293/560 (52%), Positives = 389/560 (69%), Gaps = 25/560 (4%)
Query: 334 NLLSGEFPKELTALPALV--SEAANDEVDRSYLELPVFVMPSNATNQ-QYNQLSNLPPAI 390
N L+G P +T L L+ + A+ D S +P++V + ++N YNQ+S PP+I
Sbjct: 484 NTLTGAIPVAITELKNLIRLNGTASQMTDSS--GIPLYVKRNKSSNGLPYNQVSRFPPSI 541
Query: 391 YLANNSLSGNIPVEIGQLKSLHVLDLSNNNFSGTIPDELSDLSNLEKLDLSGNHLVGEIP 450
YL NN L+G I EIG+LK LH+LDLS NNF+GTIPD +S L NLE LDLS NHL G IP
Sbjct: 542 YLNNNRLNGTILPEIGRLKELHMLDLSRNNFTGTIPDSISGLDNLEVLDLSYNHLYGSIP 601
Query: 451 ISLKGLHFLSSFSVAHNNLQGAVPSGGQFDTFPSFSFEGNPELCGSVVQRPC-AISPGAT 509
+S + L FLS FSVA+N L GA+PSGGQF +FP SFEGN LC + PC +
Sbjct: 602 LSFQSLTFLSRFSVAYNRLTGAIPSGGQFYSFPHSSFEGNLGLC-RAIDSPCDVLMSNML 660
Query: 510 HPTAPHKRTNT------KLVIGLVLGICFGTGLIISMLALWILSKRRIIPGGDPDKIELD 563
+P +R N ++ L + + G L++S++ L I K D D+ +
Sbjct: 661 NPKGSSRRNNNGGKFGRSSIVVLTISLAIGITLLLSVILLRISRKDVDDRINDVDE---E 717
Query: 564 TISSTSNFGVSPEADKDASLVMLFPNNTNEIKDLTIYELLKATDNFSQANIIGCGGFGLV 623
TIS S + P S ++LF ++ KDL++ ELLK+T+NFSQANIIGCGGFGLV
Sbjct: 718 TISGVSK-ALGP------SKIVLF--HSCGCKDLSVEELLKSTNNFSQANIIGCGGFGLV 768
Query: 624 YKATLANGTTLAIKKLSGDLGLMEREFKAEVEALSTAQHKNLVSLQGYCVHQGFRLLIYS 683
YKA +G+ A+K+LSGD G MEREF+AEVEALS A+HKNLVSLQGYC H RLLIYS
Sbjct: 769 YKANFPDGSKAAVKRLSGDCGQMEREFQAEVEALSRAEHKNLVSLQGYCKHGNDRLLIYS 828
Query: 684 YMENGSLDYWLHEKADGASQLDWLTRLKIARGTSCGLAYMHQICEPHIVHRDIKSSNILL 743
+MENGSLDYWLHE+ DG L W RLKIA+G + GLAY+H++CEP+++HRD+KSSNILL
Sbjct: 829 FMENGSLDYWLHERVDGNMTLIWDVRLKIAQGAARGLAYLHKVCEPNVIHRDVKSSNILL 888
Query: 744 DDQFEAHLADFGLSRLILPYQTHVTTELVGTLGYIPPEYGQAWVATLRGDMYSFGVVMLE 803
D++FEAHLADFGL+RL+ PY THVTT+LVGTLGYIPPEY Q+ +AT RGD+YSFGVV+LE
Sbjct: 889 DEKFEAHLADFGLARLLRPYDTHVTTDLVGTLGYIPPEYSQSLIATCRGDVYSFGVVLLE 948
Query: 804 LLTGKRPVDVLKPKMSRELVGWVLKMRSEGKQDQVFDPILRGKGFDEEMLQVLDVACMCV 863
L+TG+RPV+V K K R+LV V +M++E ++ ++ D +R + +L++L++AC C+
Sbjct: 949 LVTGRRPVEVCKGKSCRDLVSRVFQMKAEKREAELIDTTIRENVNERTVLEMLEIACKCI 1008
Query: 864 SQNPFKRPTVKEVVEWLNNV 883
P +RP ++EVV WL ++
Sbjct: 1009 DHEPRRRPLIEEVVTWLEDL 1028
|
Phytosulfokine receptor with a serine/threonine-protein kinase activity. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9ZVR7|PSKR1_ARATH Phytosulfokine receptor 1 OS=Arabidopsis thaliana GN=PSKR1 PE=2 SV=4 | Back alignment and function description |
|---|
Score = 560 bits (1443), Expect = e-158, Method: Compositional matrix adjust.
Identities = 295/551 (53%), Positives = 388/551 (70%), Gaps = 16/551 (2%)
Query: 334 NLLSGEFPKELTALPALVSEAANDEVDRSYLELPVFVMPS-NATNQQYNQLSNLPPAIYL 392
N +GE PK LT L +L S N V+ + P F+ + +A QYNQ+ PP I L
Sbjct: 473 NSFTGEIPKSLTKLESLTSR--NISVNEPSPDFPFFMKRNESARALQYNQIFGFPPTIEL 530
Query: 393 ANNSLSGNIPVEIGQLKSLHVLDLSNNNFSGTIPDELSDLSNLEKLDLSGNHLVGEIPIS 452
+N+LSG I E G LK LHV DL N SG+IP LS +++LE LDLS N L G IP+S
Sbjct: 531 GHNNLSGPIWEEFGNLKKLHVFDLKWNALSGSIPSSLSGMTSLEALDLSNNRLSGSIPVS 590
Query: 453 LKGLHFLSSFSVAHNNLQGAVPSGGQFDTFPSFSFEGNPELCGSVVQRPCAISPGATHPT 512
L+ L FLS FSVA+NNL G +PSGGQF TFP+ SFE N LCG + PC S G
Sbjct: 591 LQQLSFLSKFSVAYNNLSGVIPSGGQFQTFPNSSFESN-HLCGEH-RFPC--SEGTESAL 646
Query: 513 APHKRTNTKLVIGLVLGICFGTGLIISMLALWILSKRRIIPGGDPDKIELDTISSTSNFG 572
R + IG+ +GI FG+ ++++L+L +L RR DP+ I + +
Sbjct: 647 IKRSRRSRGGDIGMAIGIAFGSVFLLTLLSLIVLRARRRSGEVDPE------IEESESMN 700
Query: 573 VSPEADKDASLVMLFPNNTNEIKDLTIYELLKATDNFSQANIIGCGGFGLVYKATLANGT 632
+ + LV+LF +N K+L+ +LL +T++F QANIIGCGGFG+VYKATL +G
Sbjct: 701 RKELGEIGSKLVVLFQSND---KELSYDDLLDSTNSFDQANIIGCGGFGMVYKATLPDGK 757
Query: 633 TLAIKKLSGDLGLMEREFKAEVEALSTAQHKNLVSLQGYCVHQGFRLLIYSYMENGSLDY 692
+AIKKLSGD G +EREF+AEVE LS AQH NLV L+G+C ++ RLLIYSYMENGSLDY
Sbjct: 758 KVAIKKLSGDCGQIEREFEAEVETLSRAQHPNLVLLRGFCFYKNDRLLIYSYMENGSLDY 817
Query: 693 WLHEKADGASQLDWLTRLKIARGTSCGLAYMHQICEPHIVHRDIKSSNILLDDQFEAHLA 752
WLHE+ DG + L W TRL+IA+G + GL Y+H+ C+PHI+HRDIKSSNILLD+ F +HLA
Sbjct: 818 WLHERNDGPALLKWKTRLRIAQGAAKGLLYLHEGCDPHILHRDIKSSNILLDENFNSHLA 877
Query: 753 DFGLSRLILPYQTHVTTELVGTLGYIPPEYGQAWVATLRGDMYSFGVVMLELLTGKRPVD 812
DFGL+RL+ PY+THV+T+LVGTLGYIPPEYGQA VAT +GD+YSFGVV+LELLT KRPVD
Sbjct: 878 DFGLARLMSPYETHVSTDLVGTLGYIPPEYGQASVATYKGDVYSFGVVLLELLTDKRPVD 937
Query: 813 VLKPKMSRELVGWVLKMRSEGKQDQVFDPILRGKGFDEEMLQVLDVACMCVSQNPFKRPT 872
+ KPK R+L+ WV+KM+ E + +VFDP++ K D+EM +VL++AC+C+S+NP +RPT
Sbjct: 938 MCKPKGCRDLISWVVKMKHESRASEVFDPLIYSKENDKEMFRVLEIACLCLSENPKQRPT 997
Query: 873 VKEVVEWLNNV 883
+++V WL++V
Sbjct: 998 TQQLVSWLDDV 1008
|
Phytosulfokine receptor with a serine/threonine-protein kinase activity. Regulates, in response to phytosulfokine binding, a signaling cascade involved in plant cell differentiation, organogenesis, somatic embryogenesis, cellular proliferation and plant growth. Not involved in PSY perception. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9LYN8|EXS_ARATH Leucine-rich repeat receptor protein kinase EXS OS=Arabidopsis thaliana GN=EXS PE=1 SV=1 | Back alignment and function description |
|---|
Score = 352 bits (902), Expect = 1e-95, Method: Compositional matrix adjust.
Identities = 220/570 (38%), Positives = 309/570 (54%), Gaps = 33/570 (5%)
Query: 333 ANLLSGEFPKEL-TALPALVSEAANDEVDRSYLELPVFVMPSNATNQQYNQLSNLPPA-- 389
N L+G PKE+ +L AN++++ E + N N+L PA
Sbjct: 637 GNALTGSIPKEMGNSLKLQGLNLANNQLNGHIPESFGLLGSLVKLNLTKNKLDGPVPASL 696
Query: 390 --------IYLANNSLSGNIPVEIGQLKSLHVLDLSNNNFSGTIPDELSDLSNLEKLDLS 441
+ L+ N+LSG + E+ ++ L L + N F+G IP EL +L+ LE LD+S
Sbjct: 697 GNLKELTHMDLSFNNLSGELSSELSTMEKLVGLYIEQNKFTGEIPSELGNLTQLEYLDVS 756
Query: 442 GNHLVGEIPISLKGLHFLSSFSVAHNNLQGAVPSGGQFDTFPSFSFEGNPELCGSVVQRP 501
N L GEIP + GL L ++A NNL+G VPS G GN ELCG VV
Sbjct: 757 ENLLSGEIPTKICGLPNLEFLNLAKNNLRGEVPSDGVCQDPSKALLSGNKELCGRVVGSD 816
Query: 502 CAISPGATHPTAPHKRTNTKL-----VIGLVLGICFGTGLIISMLALWILSKRRIIPGGD 556
C I TKL + GL+LG + + L W ++KR + D
Sbjct: 817 CKIE-------------GTKLRSAWGIAGLMLGFTIIVFVFVFSLRRWAMTKR-VKQRDD 862
Query: 557 PDKIELDTISS--TSNFGVSPEADKDASLVMLFPNNTNEIKDLTIYELLKATDNFSQANI 614
P+++E + N + L + + + + ++++ATD+FS+ NI
Sbjct: 863 PERMEESRLKGFVDQNLYFLSGSRSREPLSINIAMFEQPLLKVRLGDIVEATDHFSKKNI 922
Query: 615 IGCGGFGLVYKATLANGTTLAIKKLSGDLGLMEREFKAEVEALSTAQHKNLVSLQGYCVH 674
IG GGFG VYKA L T+A+KKLS REF AE+E L +H NLVSL GYC
Sbjct: 923 IGDGGFGTVYKACLPGEKTVAVKKLSEAKTQGNREFMAEMETLGKVKHPNLVSLLGYCSF 982
Query: 675 QGFRLLIYSYMENGSLDYWLHEKADGASQLDWLTRLKIARGTSCGLAYMHQICEPHIVHR 734
+LL+Y YM NGSLD+WL + LDW RLKIA G + GLA++H PHI+HR
Sbjct: 983 SEEKLLVYEYMVNGSLDHWLRNQTGMLEVLDWSKRLKIAVGAARGLAFLHHGFIPHIIHR 1042
Query: 735 DIKSSNILLDDQFEAHLADFGLSRLILPYQTHVTTELVGTLGYIPPEYGQAWVATLRGDM 794
DIK+SNILLD FE +ADFGL+RLI ++HV+T + GT GYIPPEYGQ+ AT +GD+
Sbjct: 1043 DIKASNILLDGDFEPKVADFGLARLISACESHVSTVIAGTFGYIPPEYGQSARATTKGDV 1102
Query: 795 YSFGVVMLELLTGKRPVDV-LKPKMSRELVGWVLKMRSEGKQDQVFDPILRGKGFDEEML 853
YSFGV++LEL+TGK P K LVGW ++ ++GK V DP+L L
Sbjct: 1103 YSFGVILLELVTGKEPTGPDFKESEGGNLVGWAIQKINQGKAVDVIDPLLVSVALKNSQL 1162
Query: 854 QVLDVACMCVSQNPFKRPTVKEVVEWLNNV 883
++L +A +C+++ P KRP + +V++ L +
Sbjct: 1163 RLLQIAMLCLAETPAKRPNMLDVLKALKEI 1192
|
Receptor with a serine/threonine-protein kinase activity required for the specification of the correct number of male archesporial initials and for the subsequent specification of tapetal and middle cell layer identities. In seeds, required for enhancing cell size and the rate of embryonic development. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9LJF3|BRL3_ARATH Receptor-like protein kinase BRI1-like 3 OS=Arabidopsis thaliana GN=BRL3 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 351 bits (900), Expect = 2e-95, Method: Compositional matrix adjust.
Identities = 202/490 (41%), Positives = 291/490 (59%), Gaps = 10/490 (2%)
Query: 392 LANNSLSGNIPVEIGQLKSLHVLDLSNNNFSGTIPDELSDLSNLEKLDLSGNHLVGEIPI 451
L+ N++SG+IP+ G + L VL+L +N +GTIPD L + LDLS N L G +P
Sbjct: 646 LSYNAVSGSIPLGYGAMGYLQVLNLGHNLLTGTIPDSFGGLKAIGVLDLSHNDLQGFLPG 705
Query: 452 SLKGLHFLSSFSVAHNNLQGAVPSGGQFDTFPSFSFEGNPELCGSVVQRPCAISPGATHP 511
SL GL FLS V++NNL G +P GGQ TFP + N LCG V PC+ + P
Sbjct: 706 SLGGLSFLSDLDVSNNNLTGPIPFGGQLTTFPLTRYANNSGLCG-VPLPPCS---SGSRP 761
Query: 512 TAPHKRTNTK-LVIGLVLGICFGTGLIISMLALWILSKRRIIPGGDPDKIELDTISSTSN 570
T H + + G+ GI F + + I ML + + R++ + ++++ TS
Sbjct: 762 TRSHAHPKKQSIATGMSAGIVF-SFMCIVMLIMALYRARKVQKKEKQREKYIESLP-TSG 819
Query: 571 FGVSPEADKDASLVMLFPNNTNEIKDLTIYELLKATDNFSQANIIGCGGFGLVYKATLAN 630
+ L + ++ LT LL+AT+ FS ++IG GGFG VYKA LA+
Sbjct: 820 SSSWKLSSVHEPLSINVATFEKPLRKLTFAHLLEATNGFSADSMIGSGGFGDVYKAKLAD 879
Query: 631 GTTLAIKKLSGDLGLMEREFKAEVEALSTAQHKNLVSLQGYCVHQGFRLLIYSYMENGSL 690
G+ +AIKKL G +REF AE+E + +H+NLV L GYC RLL+Y YM+ GSL
Sbjct: 880 GSVVAIKKLIQVTGQGDREFMAEMETIGKIKHRNLVPLLGYCKIGEERLLVYEYMKYGSL 939
Query: 691 DYWLHEKA-DGASQLDWLTRLKIARGTSCGLAYMHQICEPHIVHRDIKSSNILLDDQFEA 749
+ LHEK G LDW R KIA G + GLA++H C PHI+HRD+KSSN+LLD F A
Sbjct: 940 ETVLHEKTKKGGIFLDWSARKKIAIGAARGLAFLHHSCIPHIIHRDMKSSNVLLDQDFVA 999
Query: 750 HLADFGLSRLILPYQTHVT-TELVGTLGYIPPEYGQAWVATLRGDMYSFGVVMLELLTGK 808
++DFG++RL+ TH++ + L GT GY+PPEY Q++ T +GD+YS+GV++LELL+GK
Sbjct: 1000 RVSDFGMARLVSALDTHLSVSTLAGTPGYVPPEYYQSFRCTAKGDVYSYGVILLELLSGK 1059
Query: 809 RPVDVLKPKMSRELVGWVLKMRSEGKQDQVFDP-ILRGKGFDEEMLQVLDVACMCVSQNP 867
+P+D + LVGW ++ E + ++ DP ++ K D E+L L +A C+ P
Sbjct: 1060 KPIDPEEFGEDNNLVGWAKQLYREKRGAEILDPELVTDKSGDVELLHYLKIASQCLDDRP 1119
Query: 868 FKRPTVKEVV 877
FKRPT+ +V+
Sbjct: 1120 FKRPTMIQVM 1129
|
Receptor with a dual specificity kinase activity acting on both serine/threonine- and tyrosine-containing substrates. Binds brassinolide. Regulates, in response to brassinosteroid binding, a signaling cascade involved in plant development. May be involved in cell growth and vascular differentiation. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9ZWC8|BRL1_ARATH Serine/threonine-protein kinase BRI1-like 1 OS=Arabidopsis thaliana GN=BRL1 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 350 bits (898), Expect = 3e-95, Method: Compositional matrix adjust.
Identities = 199/500 (39%), Positives = 295/500 (59%), Gaps = 10/500 (2%)
Query: 392 LANNSLSGNIPVEIGQLKSLHVLDLSNNNFSGTIPDELSDLSNLEKLDLSGNHLVGEIPI 451
++ N++SG IP G + L VL+L +N +GTIPD L + LDLS N+L G +P
Sbjct: 646 ISYNAVSGFIPPGYGNMGYLQVLNLGHNRITGTIPDSFGGLKAIGVLDLSHNNLQGYLPG 705
Query: 452 SLKGLHFLSSFSVAHNNLQGAVPSGGQFDTFPSFSFEGNPELCGSVVQRPCAISPGATHP 511
SL L FLS V++NNL G +P GGQ TFP + N LCG V RPC +P
Sbjct: 706 SLGSLSFLSDLDVSNNNLTGPIPFGGQLTTFPVSRYANNSGLCG-VPLRPCGSAPRRPIT 764
Query: 512 TAPHKRTNTKLVIGLVLGICFG-TGLIISMLALWILSKRRIIPGGDPDKIELDTISSTSN 570
+ H + T + ++ GI F ++ ++AL+ + K + IE S + +
Sbjct: 765 SRIHAKKQT-VATAVIAGIAFSFMCFVMLVMALYRVRKVQKKEQKREKYIESLPTSGSCS 823
Query: 571 FGVSPEADKDASLVMLFPNNTNEIKDLTIYELLKATDNFSQANIIGCGGFGLVYKATLAN 630
+ +S + + V F ++ LT LL+AT+ FS ++G GGFG VYKA L +
Sbjct: 824 WKLSSVPEPLSINVATF---EKPLRKLTFAHLLEATNGFSAETMVGSGGFGEVYKAQLRD 880
Query: 631 GTTLAIKKLSGDLGLMEREFKAEVEALSTAQHKNLVSLQGYCVHQGFRLLIYSYMENGSL 690
G+ +AIKKL G +REF AE+E + +H+NLV L GYC RLL+Y YM+ GSL
Sbjct: 881 GSVVAIKKLIRITGQGDREFMAEMETIGKIKHRNLVPLLGYCKVGEERLLVYEYMKWGSL 940
Query: 691 DYWLHEKAD--GASQLDWLTRLKIARGTSCGLAYMHQICEPHIVHRDIKSSNILLDDQFE 748
+ LHEK+ G L+W R KIA G + GLA++H C PHI+HRD+KSSN+LLD+ FE
Sbjct: 941 ETVLHEKSSKKGGIYLNWAARKKIAIGAARGLAFLHHSCIPHIIHRDMKSSNVLLDEDFE 1000
Query: 749 AHLADFGLSRLILPYQTHVT-TELVGTLGYIPPEYGQAWVATLRGDMYSFGVVMLELLTG 807
A ++DFG++RL+ TH++ + L GT GY+PPEY Q++ T +GD+YS+GV++LELL+G
Sbjct: 1001 ARVSDFGMARLVSALDTHLSVSTLAGTPGYVPPEYYQSFRCTAKGDVYSYGVILLELLSG 1060
Query: 808 KRPVDVLKPKMSRELVGWVLKMRSEGKQDQVFDP-ILRGKGFDEEMLQVLDVACMCVSQN 866
K+P+D + LVGW ++ E + ++ DP ++ K D E+ L +A C+
Sbjct: 1061 KKPIDPGEFGEDNNLVGWAKQLYREKRGAEILDPELVTDKSGDVELFHYLKIASQCLDDR 1120
Query: 867 PFKRPTVKEVVEWLNNVGAN 886
PFKRPT+ +++ + A+
Sbjct: 1121 PFKRPTMIQLMAMFKEMKAD 1140
|
Receptor with a serine/threonine-protein kinase activity. Regulates, in response to brassinosteroid binding, a signaling cascade involved in plant development. Binds brassinolide. May be involved in cell growth and vascular differentiation. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q8L899|BRI1_SOLPE Systemin receptor SR160 OS=Solanum peruvianum PE=1 SV=1 | Back alignment and function description |
|---|
Score = 343 bits (881), Expect = 3e-93, Method: Compositional matrix adjust.
Identities = 200/501 (39%), Positives = 293/501 (58%), Gaps = 12/501 (2%)
Query: 392 LANNSLSGNIPVEIGQLKSLHVLDLSNNNFSGTIPDELSDLSNLEKLDLSGNHLVGEIPI 451
L+ N L G+IP E+G + L +L+L +N+ SG IP +L L N+ LDLS N G IP
Sbjct: 670 LSYNKLEGSIPKELGAMYYLSILNLGHNDLSGMIPQQLGGLKNVAILDLSYNRFNGTIPN 729
Query: 452 SLKGLHFLSSFSVAHNNLQGAVPSGGQFDTFPSFSFEGNPELCGSVVQRPCAISPG--AT 509
SL L L +++NNL G +P FDTFP + F N LCG + PC+ P A
Sbjct: 730 SLTSLTLLGEIDLSNNNLSGMIPESAPFDTFPDYRFANN-SLCGYPLPLPCSSGPKSDAN 788
Query: 510 HPTAPHKRTNTKLVIGLVLGICFGTGLIISMLALWILSKRRIIPGGDPDKIELD--TISS 567
H+R L + +G+ F I ++ + I +K+R + +D + S+
Sbjct: 789 QHQKSHRR-QASLAGSVAMGLLFSLFCIFGLIIVAIETKKRRRKKEAALEAYMDGHSHSA 847
Query: 568 TSNFGVSPEADKDASLVMLFPNNTNEIKDLTIYELLKATDNFSQANIIGCGGFGLVYKAT 627
T+N + ++A L + ++ LT +LL+AT+ F +++G GGFG VYKA
Sbjct: 848 TANSAWKFTSAREA-LSINLAAFEKPLRKLTFADLLEATNGFHNDSLVGSGGFGDVYKAQ 906
Query: 628 LANGTTLAIKKLSGDLGLMEREFKAEVEALSTAQHKNLVSLQGYCVHQGFRLLIYSYMEN 687
L +G+ +AIKKL G +REF AE+E + +H+NLV L GYC RLL+Y YM+
Sbjct: 907 LKDGSVVAIKKLIHVSGQGDREFTAEMETIGKIKHRNLVPLLGYCKVGEERLLVYEYMKY 966
Query: 688 GSLDYWLHEKADGASQLDWLTRLKIARGTSCGLAYMHQICEPHIVHRDIKSSNILLDDQF 747
GSL+ LH++ +L+W R KIA G + GLA++H C PHI+HRD+KSSN+LLD+
Sbjct: 967 GSLEDVLHDRKKTGIKLNWPARRKIAIGAARGLAFLHHNCIPHIIHRDMKSSNVLLDENL 1026
Query: 748 EAHLADFGLSRLILPYQTHVT-TELVGTLGYIPPEYGQAWVATLRGDMYSFGVVMLELLT 806
EA ++DFG++RL+ TH++ + L GT GY+PPEY Q++ + +GD+YS+GVV+LELLT
Sbjct: 1027 EARVSDFGMARLMSAMDTHLSVSTLAGTPGYVPPEYYQSFRCSTKGDVYSYGVVLLELLT 1086
Query: 807 GKRPVDVLKPKMSRELVGWVLKMRSEGKQDQVFDPIL--RGKGFDEEMLQVLDVACMCVS 864
GK+P D LVGWV K+ ++GK VFD L + E+LQ L VAC C+
Sbjct: 1087 GKQPTDSADFG-DNNLVGWV-KLHAKGKITDVFDRELLKEDASIEIELLQHLKVACACLD 1144
Query: 865 QNPFKRPTVKEVVEWLNNVGA 885
+KRPT+ +V+ + A
Sbjct: 1145 DRHWKRPTMIQVMAMFKEIQA 1165
|
Receptor with a serine/threonine-protein kinase activity. Involved in the perception of systemin, a peptide hormone responsible for the systemic activation of defense genes in leaves of wounded plants. May also regulate, in response to brassinosteroid binding, a signaling cascade involved in plant development. Solanum peruvianum (taxid: 4082) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q8GUQ5|BRI1_SOLLC Brassinosteroid LRR receptor kinase OS=Solanum lycopersicum GN=CURL3 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 342 bits (878), Expect = 5e-93, Method: Compositional matrix adjust.
Identities = 200/501 (39%), Positives = 293/501 (58%), Gaps = 12/501 (2%)
Query: 392 LANNSLSGNIPVEIGQLKSLHVLDLSNNNFSGTIPDELSDLSNLEKLDLSGNHLVGEIPI 451
L+ N L G+IP E+G + L +L+L +N+ SG IP +L L N+ LDLS N G IP
Sbjct: 670 LSYNKLEGSIPKELGAMYYLSILNLGHNDLSGMIPQQLGGLKNVAILDLSYNRFNGTIPN 729
Query: 452 SLKGLHFLSSFSVAHNNLQGAVPSGGQFDTFPSFSFEGNPELCGSVVQRPCAISPG--AT 509
SL L L +++NNL G +P FDTFP + F N LCG + PC+ P A
Sbjct: 730 SLTSLTLLGEIDLSNNNLSGMIPESAPFDTFPDYRFANN-SLCGYPLPIPCSSGPKSDAN 788
Query: 510 HPTAPHKRTNTKLVIGLVLGICFGTGLIISMLALWILSKRRIIPGGDPDKIELD--TISS 567
H+R L + +G+ F I ++ + I +K+R + +D + S+
Sbjct: 789 QHQKSHRR-QASLAGSVAMGLLFSLFCIFGLIIVAIETKKRRRKKEAALEAYMDGHSHSA 847
Query: 568 TSNFGVSPEADKDASLVMLFPNNTNEIKDLTIYELLKATDNFSQANIIGCGGFGLVYKAT 627
T+N + ++A L + ++ LT +LL+AT+ F +++G GGFG VYKA
Sbjct: 848 TANSAWKFTSAREA-LSINLAAFEKPLRKLTFADLLEATNGFHNDSLVGSGGFGDVYKAQ 906
Query: 628 LANGTTLAIKKLSGDLGLMEREFKAEVEALSTAQHKNLVSLQGYCVHQGFRLLIYSYMEN 687
L +G+ +AIKKL G +REF AE+E + +H+NLV L GYC RLL+Y YM+
Sbjct: 907 LKDGSVVAIKKLIHVSGQGDREFTAEMETIGKIKHRNLVPLLGYCKVGEERLLVYEYMKY 966
Query: 688 GSLDYWLHEKADGASQLDWLTRLKIARGTSCGLAYMHQICEPHIVHRDIKSSNILLDDQF 747
GSL+ LH++ +L+W R KIA G + GLA++H C PHI+HRD+KSSN+LLD+
Sbjct: 967 GSLEDVLHDRKKIGIKLNWPARRKIAIGAARGLAFLHHNCIPHIIHRDMKSSNVLLDENL 1026
Query: 748 EAHLADFGLSRLILPYQTHVT-TELVGTLGYIPPEYGQAWVATLRGDMYSFGVVMLELLT 806
EA ++DFG++RL+ TH++ + L GT GY+PPEY Q++ + +GD+YS+GVV+LELLT
Sbjct: 1027 EARVSDFGMARLMSAMDTHLSVSTLAGTPGYVPPEYYQSFRCSTKGDVYSYGVVLLELLT 1086
Query: 807 GKRPVDVLKPKMSRELVGWVLKMRSEGKQDQVFDPIL--RGKGFDEEMLQVLDVACMCVS 864
GK+P D LVGWV K+ ++GK VFD L + E+LQ L VAC C+
Sbjct: 1087 GKQPTDSADFG-DNNLVGWV-KLHAKGKITDVFDRELLKEDASIEIELLQHLKVACACLD 1144
Query: 865 QNPFKRPTVKEVVEWLNNVGA 885
+KRPT+ +V+ + A
Sbjct: 1145 DRHWKRPTMIQVMAMFKEIQA 1165
|
Receptor with a serine/threonine-protein kinase activity. Regulates, in response to brassinosteroid binding, a signaling cascade involved in plant development, including expression of light- and stress-regulated genes, promotion of cell elongation, normal leaf and chloroplast senescence, and flowering. May be involved in a feedback regulation of brassinosteroid biosynthesis. May be also involved in the perception of systemin, a peptide hormone responsible for the systemic activation of defense genes in leaves of wounded plants. Solanum lycopersicum (taxid: 4081) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|O22476|BRI1_ARATH Protein BRASSINOSTEROID INSENSITIVE 1 OS=Arabidopsis thaliana GN=BRI1 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 341 bits (875), Expect = 1e-92, Method: Compositional matrix adjust.
Identities = 200/509 (39%), Positives = 299/509 (58%), Gaps = 24/509 (4%)
Query: 392 LANNSLSGNIPVEIGQLKSLHVLDLSNNNFSGTIPDELSDLSNLEKLDLSGNHLVGEIPI 451
++ N LSG IP EIG + L +L+L +N+ SG+IPDE+ DL L LDLS N L G IP
Sbjct: 661 MSYNMLSGYIPKEIGSMPYLFILNLGHNDISGSIPDEVGDLRGLNILDLSSNKLDGRIPQ 720
Query: 452 SLKGLHFLSSFSVAHNNLQGAVPSGGQFDTFPSFSFEGNPELCGSVVQRPC--AISPGAT 509
++ L L+ +++NNL G +P GQF+TFP F NP LCG + R C + + G
Sbjct: 721 AMSALTMLTEIDLSNNNLSGPIPEMGQFETFPPAKFLNNPGLCGYPLPR-CDPSNADGYA 779
Query: 510 HPTAPHKRTNTKLVIGLVLGICFGTGLIISMLALWILSKRRIIPGGDPDKIEL------- 562
H H R L + +G+ F I ++ + ++R ++E+
Sbjct: 780 HHQRSHGRRPASLAGSVAMGLLFSFVCIFGLILVGREMRKRRRK--KEAELEMYAEGHGN 837
Query: 563 --DTISSTSNFGVSPEADKDASLVMLFPNNTNEIKDLTIYELLKATDNFSQANIIGCGGF 620
D ++ +N+ ++ + + + F ++ LT +LL+AT+ F ++IG GGF
Sbjct: 838 SGDRTANNTNWKLTGVKEALSINLAAF---EKPLRKLTFADLLQATNGFHNDSLIGSGGF 894
Query: 621 GLVYKATLANGTTLAIKKLSGDLGLMEREFKAEVEALSTAQHKNLVSLQGYCVHQGFRLL 680
G VYKA L +G+ +AIKKL G +REF AE+E + +H+NLV L GYC RLL
Sbjct: 895 GDVYKAILKDGSAVAIKKLIHVSGQGDREFMAEMETIGKIKHRNLVPLLGYCKVGDERLL 954
Query: 681 IYSYMENGSLDYWLHEKADGASQLDWLTRLKIARGTSCGLAYMHQICEPHIVHRDIKSSN 740
+Y +M+ GSL+ LH+ +L+W TR KIA G++ GLA++H C PHI+HRD+KSSN
Sbjct: 955 VYEFMKYGSLEDVLHDPKKAGVKLNWSTRRKIAIGSARGLAFLHHNCSPHIIHRDMKSSN 1014
Query: 741 ILLDDQFEAHLADFGLSRLILPYQTHVT-TELVGTLGYIPPEYGQAWVATLRGDMYSFGV 799
+LLD+ EA ++DFG++RL+ TH++ + L GT GY+PPEY Q++ + +GD+YS+GV
Sbjct: 1015 VLLDENLEARVSDFGMARLMSAMDTHLSVSTLAGTPGYVPPEYYQSFRCSTKGDVYSYGV 1074
Query: 800 VMLELLTGKRPVDVLKPKMS-RELVGWVLKMRSEGKQDQVFDPILRGK--GFDEEMLQVL 856
V+LELLTGKRP D P LVGWV K ++ + VFDP L + + E+LQ L
Sbjct: 1075 VLLELLTGKRPTD--SPDFGDNNLVGWV-KQHAKLRISDVFDPELMKEDPALEIELLQHL 1131
Query: 857 DVACMCVSQNPFKRPTVKEVVEWLNNVGA 885
VA C+ ++RPT+ +V+ + A
Sbjct: 1132 KVAVACLDDRAWRRPTMVQVMAMFKEIQA 1160
|
Receptor with a dual specificity kinase activity acting on both serine/threonine- and tyrosine-containing substrates. Regulates, in response to brassinosteroid binding, a signaling cascade involved in plant development, including expression of light- and stress-regulated genes, promotion of cell elongation, normal leaf and chloroplast senescence, and flowering. Binds brassinolide, and less effectively castasterone, but not 2,3,22,23-O-tetramethylbrassinolide or ecdysone. May be involved in a feedback regulation of brassinosteroid biosynthesis. Phosphorylates BRI1-associated receptor kinase 1 (BAK1), Transthyretin-Like protein (TTL) and SERK1 on 'Ser-299' and 'Thr-462' in vitro. May have a guanylyl cyclase activity. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
Close Homologs in the Non-Redundant Database Detected by BLAST
Original result of BLAST against Nonredundant Database
| GI | Alignment Graph | Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 894 | ||||||
| 224138536 | 1092 | predicted protein [Populus trichocarpa] | 0.644 | 0.527 | 0.797 | 0.0 | |
| 255537393 | 1087 | Leucine-rich repeat receptor protein kin | 0.630 | 0.518 | 0.8 | 0.0 | |
| 219718185 | 1085 | receptor kinase [Gossypium barbadense] | 0.625 | 0.515 | 0.802 | 0.0 | |
| 224074123 | 1050 | predicted protein [Populus trichocarpa] | 0.623 | 0.530 | 0.803 | 0.0 | |
| 359482434 | 1280 | PREDICTED: tyrosine-sulfated glycopeptid | 0.642 | 0.448 | 0.769 | 0.0 | |
| 147832546 | 1188 | hypothetical protein VITISV_009907 [Viti | 0.636 | 0.478 | 0.771 | 0.0 | |
| 356504209 | 1076 | PREDICTED: tyrosine-sulfated glycopeptid | 0.621 | 0.516 | 0.769 | 0.0 | |
| 358248614 | 1065 | tyrosine-sulfated glycopeptide receptor | 0.625 | 0.524 | 0.737 | 0.0 | |
| 356520190 | 1103 | PREDICTED: tyrosine-sulfated glycopeptid | 0.658 | 0.533 | 0.703 | 0.0 | |
| 449436222 | 1095 | PREDICTED: tyrosine-sulfated glycopeptid | 0.628 | 0.513 | 0.742 | 0.0 |
| >gi|224138536|ref|XP_002326627.1| predicted protein [Populus trichocarpa] gi|222833949|gb|EEE72426.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 958 bits (2476), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 464/582 (79%), Positives = 513/582 (88%), Gaps = 6/582 (1%)
Query: 315 IFGEVEGKSDEGPSLFS---QANLLSGEFPKELTALPALVSEAANDEVDRSYLELPVFVM 371
I G + G D SLF NLLSGEFP +LT L L S+ ++DRSYLELPVFVM
Sbjct: 514 IRGSIPGWLDNLSSLFYLDLSNNLLSGEFPLKLTGLRTLTSQEVIKQLDRSYLELPVFVM 573
Query: 372 PSNATNQQYNQLSNLPPAIYLANNSLSGNIPVEIGQLKSLHVLDLSNNNFSGTIPDELSD 431
P+NATN QYNQLSNLPPAIYL NN+LSGNIPV+IGQL LHVLDLS+N FSG IPDELS+
Sbjct: 574 PTNATNLQYNQLSNLPPAIYLGNNNLSGNIPVQIGQLNFLHVLDLSDNRFSGNIPDELSN 633
Query: 432 LSNLEKLDLSGNHLVGEIPISLKGLHFLSSFSVAHNNLQGAVPSGGQFDTFPSFSFEGNP 491
L+NLEKLDLSGN L GEIP SLKGLHFLSSFSVA+N+LQG +PSGGQFDTFPS SF GN
Sbjct: 634 LANLEKLDLSGNLLSGEIPTSLKGLHFLSSFSVANNDLQGPIPSGGQFDTFPSSSFTGNQ 693
Query: 492 ELCGSVVQRPCAISPGATHPTAPHKRTNTKLVIGLVLGICFGTGLIISMLALWILSKRRI 551
LCG V+QR C+ SPG H +APHK TN KLVIGLV+GICFGTGL I++LALWILSKRRI
Sbjct: 694 WLCGQVLQRSCSSSPGTNHTSAPHKSTNIKLVIGLVIGICFGTGLFIAVLALWILSKRRI 753
Query: 552 IPGGDPDKIELDTISSTSNFGVSPEADKDASLVMLFPNNTNEIKDLTIYELLKATDNFSQ 611
IPGGD D ELDTIS S F PE DKDASLV+LFP+NTNEIKDLTI ELLKATDNF+Q
Sbjct: 754 IPGGDTDNTELDTISINSGF--PPEGDKDASLVVLFPSNTNEIKDLTISELLKATDNFNQ 811
Query: 612 ANIIGCGGFGLVYKATLANGTTLAIKKLSGDLGLMEREFKAEVEALSTAQHKNLVSLQGY 671
ANI+GCGGFGLVYKATL +G+ LA+KKLSGDLGLMEREF+AEVEALSTAQH+NLVSLQGY
Sbjct: 812 ANIVGCGGFGLVYKATLGDGSKLAVKKLSGDLGLMEREFRAEVEALSTAQHENLVSLQGY 871
Query: 672 CVHQGFRLLIYSYMENGSLDYWLHEKADGASQLDWLTRLKIARGTSCGLAYMHQICEPHI 731
CVH+G RLLIYS+M+NGSLDYWLHEK DGASQLDW TRLKIARG CGLAYMHQICEPHI
Sbjct: 872 CVHEGCRLLIYSFMDNGSLDYWLHEKTDGASQLDWPTRLKIARGVGCGLAYMHQICEPHI 931
Query: 732 VHRDIKSSNILLDDQFEAHLADFGLSRLILPYQTHVTTELVGTLGYIPPEYGQAWVATLR 791
VHRDIKSSNILLD++FEAH+ADFGLSRLILPYQTHVTTELVGTLGYIPPEYGQAWVATLR
Sbjct: 932 VHRDIKSSNILLDEKFEAHVADFGLSRLILPYQTHVTTELVGTLGYIPPEYGQAWVATLR 991
Query: 792 GDMYSFGVVMLELLTGKRPVDVLKPKMSRELVGWVLKMRSEGKQDQVFDPILRGKGFDEE 851
GD+YSFGVVMLELLTGKRP++V KPKMSRELVGWV +MR+EGKQ+++FDP+LRGKGFD+E
Sbjct: 992 GDIYSFGVVMLELLTGKRPMEVFKPKMSRELVGWVQQMRNEGKQEEIFDPLLRGKGFDDE 1051
Query: 852 MLQVLDVACMCVSQNPFKRPTVKEVVEWLNNVGANRRNENKG 893
MLQ+LDVACMCVSQNPFKRPT+KEVV+WL NVG+ RNENKG
Sbjct: 1052 MLQILDVACMCVSQNPFKRPTIKEVVDWLKNVGS-HRNENKG 1092
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|255537393|ref|XP_002509763.1| Leucine-rich repeat receptor protein kinase EXS precursor, putative [Ricinus communis] gi|223549662|gb|EEF51150.1| Leucine-rich repeat receptor protein kinase EXS precursor, putative [Ricinus communis] | Back alignment and taxonomy information |
|---|
Score = 949 bits (2454), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 456/570 (80%), Positives = 504/570 (88%), Gaps = 6/570 (1%)
Query: 327 PSLFS---QANLLSGEFPKELTALPALVSEAANDEVDRSYLELPVFVMPSNATNQQYNQL 383
PSLF N LSGEFPKEL LP L + A + +DRSYL LPVF P+NAT QQYNQL
Sbjct: 521 PSLFYVDLSRNFLSGEFPKELAGLPTLAFQGAKELIDRSYLPLPVFAQPNNATYQQYNQL 580
Query: 384 SNLPPAIYLANNSLSGNIPVEIGQLKSLHVLDLSNNNFSGTIPDELSDLSNLEKLDLSGN 443
SNLPPAIYL NN LSG+IP+EIGQLK LHVLDLSNNNFSG IPD+LS+L+NLEKLDLSGN
Sbjct: 581 SNLPPAIYLGNNHLSGDIPIEIGQLKFLHVLDLSNNNFSGNIPDQLSNLTNLEKLDLSGN 640
Query: 444 HLVGEIPISLKGLHFLSSFSVAHNNLQGAVPSGGQFDTFPSFSFEGNPELCGSVVQRPCA 503
L GEIP SL+GLHFLSSFSV NNLQG +PSGGQFDTFP SF GNP LCG ++QR C+
Sbjct: 641 QLSGEIPASLRGLHFLSSFSVRDNNLQGPIPSGGQFDTFPISSFVGNPGLCGPILQRSCS 700
Query: 504 ISPGATHPTAPHKRTNTKLVIGLVLGICFGTGLIISMLALWILSKRRIIPGGDPDKIELD 563
G+ HPT PHK TNTKLV+GLVLG CF GL+I+ +ALWILSKRRIIP GD D E+D
Sbjct: 701 NPSGSVHPTNPHKSTNTKLVVGLVLGSCFLIGLVIAAVALWILSKRRIIPRGDSDNTEMD 760
Query: 564 TISSTSNFGVSPEADKDASLVMLFPNNTNEIKDLTIYELLKATDNFSQANIIGCGGFGLV 623
T+SS S G+ EADKD SLV+LFPNNTNE+KDLTI ELLKATDNF+QANI+GCGGFGLV
Sbjct: 761 TLSSNS--GLPLEADKDTSLVILFPNNTNELKDLTISELLKATDNFNQANIVGCGGFGLV 818
Query: 624 YKATLANGTTLAIKKLSGDLGLMEREFKAEVEALSTAQHKNLVSLQGYCVHQGFRLLIYS 683
YKATLANG LAIKKLSG++GLMEREFKAEVEALSTAQH+NLVSLQGYCV++GFRLLIYS
Sbjct: 819 YKATLANGIMLAIKKLSGEMGLMEREFKAEVEALSTAQHENLVSLQGYCVYEGFRLLIYS 878
Query: 684 YMENGSLDYWLHEKADGASQLDWLTRLKIARGTSCGLAYMHQICEPHIVHRDIKSSNILL 743
YMENGSLDYWLHEK DGASQLDW TRLKIARG SCGLAYMHQICEPHIVHRDIKSSNILL
Sbjct: 879 YMENGSLDYWLHEKVDGASQLDWPTRLKIARGASCGLAYMHQICEPHIVHRDIKSSNILL 938
Query: 744 DDQFEAHLADFGLSRLILPYQTHVTTELVGTLGYIPPEYGQAWVATLRGDMYSFGVVMLE 803
D++FEAH+ADFGLSRLILPYQTHVTTELVGTLGYIPPEYGQAWVATLRGDMYSFGVVMLE
Sbjct: 939 DEKFEAHVADFGLSRLILPYQTHVTTELVGTLGYIPPEYGQAWVATLRGDMYSFGVVMLE 998
Query: 804 LLTGKRPVDVLKPKMSRELVGWVLKMRSEGKQDQVFDPILRGKGFDEEMLQVLDVACMCV 863
LLTGKRPV+V KPKMSRELVGWV++MR +GKQDQ+FDP+LRGKGFD+EMLQVLDVAC+CV
Sbjct: 999 LLTGKRPVEVFKPKMSRELVGWVMQMRKDGKQDQIFDPLLRGKGFDDEMLQVLDVACLCV 1058
Query: 864 SQNPFKRPTVKEVVEWLNNVGANRRNENKG 893
+QNPFKRPT+ EVV+WL NVG+ +RN+NKG
Sbjct: 1059 NQNPFKRPTINEVVDWLKNVGS-QRNQNKG 1087
|
Source: Ricinus communis Species: Ricinus communis Genus: Ricinus Family: Euphorbiaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|219718185|gb|ACL35341.1| receptor kinase [Gossypium barbadense] | Back alignment and taxonomy information |
|---|
Score = 937 bits (2423), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 451/562 (80%), Positives = 507/562 (90%), Gaps = 3/562 (0%)
Query: 333 ANLLSGEFPKELTALPALVSEAANDEVDRSYLELPVFVMPSNATNQQ-YNQLSNLPPAIY 391
ANL+SGEFPKELT+L AL ++ +N++VDRSYLELPVFVMP+NAT+QQ YNQLS+LPPAIY
Sbjct: 523 ANLISGEFPKELTSLWALATQESNNQVDRSYLELPVFVMPNNATSQQLYNQLSSLPPAIY 582
Query: 392 LANNSLSGNIPVEIGQLKSLHVLDLSNNNFSGTIPDELSDLSNLEKLDLSGNHLVGEIPI 451
L NN+LSGNIP IGQL+ LHVLDLS N+FSG+IP+ELS+L+NLEKLDLSGN L G+IP
Sbjct: 583 LRNNNLSGNIPEAIGQLRFLHVLDLSQNDFSGSIPEELSNLTNLEKLDLSGNRLSGQIPE 642
Query: 452 SLKGLHFLSSFSVAHNNLQGAVPSGGQFDTFPSFSFEGNPELCGSVVQRPCAISPGATH- 510
SL+GL+FLSSFSVA+NNLQG +PSGGQFDTF S SFEGNP LCGS+VQR C + GA H
Sbjct: 643 SLRGLYFLSSFSVAYNNLQGPIPSGGQFDTFTSSSFEGNPGLCGSIVQRICPNARGAAHS 702
Query: 511 PTAPHKRTNTKLVIGLVLGICFGTGLIISMLALWILSKRRIIPGGDPDKIELDTISSTSN 570
PT P+ R NTKL+IGLVLGIC GTGL+I++LALWILSKRRIIPGGD DKIELDT+S S
Sbjct: 703 PTLPN-RLNTKLIIGLVLGICSGTGLVITVLALWILSKRRIIPGGDTDKIELDTLSCNSY 761
Query: 571 FGVSPEADKDASLVMLFPNNTNEIKDLTIYELLKATDNFSQANIIGCGGFGLVYKATLAN 630
GV P+ DKDASLVMLFPN TNE+KDLTI+ELLKATDNF+Q NIIGCGGFGLVYKA LA+
Sbjct: 762 SGVHPQTDKDASLVMLFPNKTNEVKDLTIFELLKATDNFNQENIIGCGGFGLVYKAILAD 821
Query: 631 GTTLAIKKLSGDLGLMEREFKAEVEALSTAQHKNLVSLQGYCVHQGFRLLIYSYMENGSL 690
GT LA+KKLSGD GLMEREFKAEVE LSTAQH+NLVSLQGYCVH+GFRLLIYSYMENGSL
Sbjct: 822 GTKLAVKKLSGDFGLMEREFKAEVEVLSTAQHENLVSLQGYCVHEGFRLLIYSYMENGSL 881
Query: 691 DYWLHEKADGASQLDWLTRLKIARGTSCGLAYMHQICEPHIVHRDIKSSNILLDDQFEAH 750
DYWLHEK +G SQLDW TRLKIARG S GLAYMHQICEPHIVHRDIKSSNILLDD+FEAH
Sbjct: 882 DYWLHEKENGPSQLDWQTRLKIARGASNGLAYMHQICEPHIVHRDIKSSNILLDDKFEAH 941
Query: 751 LADFGLSRLILPYQTHVTTELVGTLGYIPPEYGQAWVATLRGDMYSFGVVMLELLTGKRP 810
+ADFGLSRLILPY THVTTELVGTLGYIPPEYGQAWVATLRGD+YSFGVVMLELLTGKRP
Sbjct: 942 VADFGLSRLILPYHTHVTTELVGTLGYIPPEYGQAWVATLRGDVYSFGVVMLELLTGKRP 1001
Query: 811 VDVLKPKMSRELVGWVLKMRSEGKQDQVFDPILRGKGFDEEMLQVLDVACMCVSQNPFKR 870
VD+ +PK SRELV WV ++RSEGKQD+VFDP+L+GKG DEEML+VLDVAC+C++QNPFKR
Sbjct: 1002 VDMSRPKTSRELVSWVQRLRSEGKQDEVFDPLLKGKGSDEEMLRVLDVACLCINQNPFKR 1061
Query: 871 PTVKEVVEWLNNVGANRRNENK 892
PT++EVVEWL VG RN+NK
Sbjct: 1062 PTIQEVVEWLKGVGTINRNQNK 1083
|
Source: Gossypium barbadense Species: Gossypium barbadense Genus: Gossypium Family: Malvaceae Order: Malvales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224074123|ref|XP_002304261.1| predicted protein [Populus trichocarpa] gi|222841693|gb|EEE79240.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 929 bits (2402), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 450/560 (80%), Positives = 497/560 (88%), Gaps = 3/560 (0%)
Query: 334 NLLSGEFPKELTALPALVSEAANDEVDRSYLELPVFVMPSNATNQQYNQLSNLPPAIYLA 393
NLLSG FP EL L AL S+ A V+RSYLELPVFV P+NATN QYNQLS+LPPAIYL
Sbjct: 494 NLLSGGFPLELAGLRALTSQEAVKRVERSYLELPVFVKPTNATNLQYNQLSSLPPAIYLK 553
Query: 394 NNSLSGNIPVEIGQLKSLHVLDLSNNNFSGTIPDELSDLSNLEKLDLSGNHLVGEIPISL 453
NN+LSGNIPV+IGQLK LHVLDLS+N F G IPD+LS+L+NLEKLDLSGN L GEIP SL
Sbjct: 554 NNNLSGNIPVQIGQLKFLHVLDLSDNRFFGNIPDQLSNLTNLEKLDLSGNDLSGEIPTSL 613
Query: 454 KGLHFLSSFSVAHNNLQGAVPSGGQFDTFPSFSFEGNPELCGSVVQRPCAISPGATHPTA 513
GLHFLS F+VA+N LQG +PSGGQFDTFPS SF GNP LCG V+QR C+ SPG H +A
Sbjct: 614 SGLHFLSLFNVANNELQGPIPSGGQFDTFPSSSFVGNPGLCGQVLQRSCSSSPGTNHSSA 673
Query: 514 PHKRTNTKLVIGLVLGICFGTGLIISMLALWILSKRRIIPGGDPDKIELDTISSTSNFGV 573
PHK N KLVIGLV+GICFGTGL I++LALWILSKRRIIPGGD D ELDTIS S F +
Sbjct: 674 PHKSANIKLVIGLVVGICFGTGLFIAVLALWILSKRRIIPGGDTDNTELDTISINSGFPL 733
Query: 574 SPEADKDASLVMLFPNNTNEIKDLTIYELLKATDNFSQANIIGCGGFGLVYKATLANGTT 633
E DKDASLV+LFP+NT EIKDLTI ELLK+TDNF+QANI+GCGGFGLVYKATL +G+
Sbjct: 734 --EGDKDASLVVLFPSNTYEIKDLTISELLKSTDNFNQANIVGCGGFGLVYKATLGDGSK 791
Query: 634 LAIKKLSGDLGLMEREFKAEVEALSTAQHKNLVSLQGYCVHQGFRLLIYSYMENGSLDYW 693
LA+KKLSGDLGLMEREF+AEVEALSTAQH+NLVSLQGYCVH+G RLLIYS+MENGSLDYW
Sbjct: 792 LAVKKLSGDLGLMEREFRAEVEALSTAQHENLVSLQGYCVHEGCRLLIYSFMENGSLDYW 851
Query: 694 LHEKADGASQLDWLTRLKIARGTSCGLAYMHQICEPHIVHRDIKSSNILLDDQFEAHLAD 753
LHEK DGAS LDW TRLKIARG GLAYMHQICEPHIVHRDIKSSNILLD++FEAH+AD
Sbjct: 852 LHEKTDGASNLDWPTRLKIARGAGSGLAYMHQICEPHIVHRDIKSSNILLDEKFEAHVAD 911
Query: 754 FGLSRLILPYQTHVTTELVGTLGYIPPEYGQAWVATLRGDMYSFGVVMLELLTGKRPVDV 813
FGLSRLILPYQTHVTTELVGTLGYIPPEYGQAWVATLRGD+YSFGVVMLELLTGKRPV+V
Sbjct: 912 FGLSRLILPYQTHVTTELVGTLGYIPPEYGQAWVATLRGDIYSFGVVMLELLTGKRPVEV 971
Query: 814 LKPKMSRELVGWVLKMRSEGKQDQVFDPILRGKGFDEEMLQVLDVACMCVSQNPFKRPTV 873
KPKMSRELVGWV +MR+EGKQ++VFDP+LRGKGFD+EMLQVLDVACMCVSQNPFKRPT+
Sbjct: 972 SKPKMSRELVGWVQQMRNEGKQNEVFDPLLRGKGFDDEMLQVLDVACMCVSQNPFKRPTI 1031
Query: 874 KEVVEWLNNVGANRRNENKG 893
KEVV+WL NVG+ R+ENKG
Sbjct: 1032 KEVVDWLKNVGS-HRDENKG 1050
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|359482434|ref|XP_002270860.2| PREDICTED: tyrosine-sulfated glycopeptide receptor 1-like [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 921 bits (2381), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 445/578 (76%), Positives = 497/578 (85%), Gaps = 4/578 (0%)
Query: 312 LEIIFGEVEGKSDEGPSLFS---QANLLSGEFPKELTALPALVSEAANDEVDRSYLELPV 368
L I G + G PSLF +NL+SGEFPKE+ LP L SE A EVD+SYLELPV
Sbjct: 699 LNQITGSIPGWLGTLPSLFYIDLSSNLISGEFPKEIIRLPRLTSEEAATEVDQSYLELPV 758
Query: 369 FVMPSNATNQQYNQLSNLPPAIYLANNSLSGNIPVEIGQLKSLHVLDLSNNNFSGTIPDE 428
FVMP+NATN QY QLSNLPPAIYL NNSLSGNIP EIGQLK +H+LDLS NNFSG+IPD+
Sbjct: 759 FVMPNNATNLQYKQLSNLPPAIYLRNNSLSGNIPTEIGQLKFIHILDLSYNNFSGSIPDQ 818
Query: 429 LSDLSNLEKLDLSGNHLVGEIPISLKGLHFLSSFSVAHNNLQGAVPSGGQFDTFPSFSFE 488
+S+L+NLEKLDLSGNHL GEIP SL+ LHFLSSF+VA+N+L+GA+PSGGQFDTFP+ SFE
Sbjct: 819 ISNLTNLEKLDLSGNHLSGEIPGSLRSLHFLSSFNVANNSLEGAIPSGGQFDTFPNSSFE 878
Query: 489 GNPELCGSVVQRPCAISPGATHPTAPHKRTNTKLVIGLVLGICFGTGLIISMLALWILSK 548
GNP LCG +QR C+ PG TH + K N KL++GL++GICF TGLI+++L LWI K
Sbjct: 879 GNPGLCGPPLQRSCSNQPGTTHSSTLGKSLNKKLIVGLIVGICFVTGLILALLTLWI-CK 937
Query: 549 RRIIPGGDPDKIELDTISSTSNFGVSPEADKDASLVMLFPNNTNEIKDLTIYELLKATDN 608
RRI+P G+ +K LDTIS TSN E DKD S+V++FP+NTN IKDLTI E+ KATDN
Sbjct: 938 RRILPRGESEKSNLDTISCTSNTDFHSEVDKDTSMVIVFPSNTNGIKDLTISEIFKATDN 997
Query: 609 FSQANIIGCGGFGLVYKATLANGTTLAIKKLSGDLGLMEREFKAEVEALSTAQHKNLVSL 668
F+Q NIIGCGGFGLVYKA L NGT LAIKKLSGDLGL+EREFKAEVEALSTAQHKNLVSL
Sbjct: 998 FNQENIIGCGGFGLVYKAILENGTKLAIKKLSGDLGLIEREFKAEVEALSTAQHKNLVSL 1057
Query: 669 QGYCVHQGFRLLIYSYMENGSLDYWLHEKADGASQLDWLTRLKIARGTSCGLAYMHQICE 728
QGYCVH G RLLIYSYMENGSLDYWLHEK DG+ QLDW +RLKIA+G SCGLAYMHQICE
Sbjct: 1058 QGYCVHDGIRLLIYSYMENGSLDYWLHEKTDGSPQLDWRSRLKIAQGASCGLAYMHQICE 1117
Query: 729 PHIVHRDIKSSNILLDDQFEAHLADFGLSRLILPYQTHVTTELVGTLGYIPPEYGQAWVA 788
PHIVHRDIKSSNILL+D+FEAH+ADFGLSRLILPY THVTTELVGTLGYIPPEYGQAWVA
Sbjct: 1118 PHIVHRDIKSSNILLNDKFEAHVADFGLSRLILPYHTHVTTELVGTLGYIPPEYGQAWVA 1177
Query: 789 TLRGDMYSFGVVMLELLTGKRPVDVLKPKMSRELVGWVLKMRSEGKQDQVFDPILRGKGF 848
TLRGD+YSFGVVMLELLTGKRPV+V KPKMSRELVGWV +MRSEGKQDQVFDP+LRGKGF
Sbjct: 1178 TLRGDVYSFGVVMLELLTGKRPVEVFKPKMSRELVGWVQQMRSEGKQDQVFDPLLRGKGF 1237
Query: 849 DEEMLQVLDVACMCVSQNPFKRPTVKEVVEWLNNVGAN 886
+EEMLQVLDVACMCVSQNPFKRPT+KEVV WL NVG N
Sbjct: 1238 EEEMLQVLDVACMCVSQNPFKRPTIKEVVNWLENVGNN 1275
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|147832546|emb|CAN68301.1| hypothetical protein VITISV_009907 [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 918 bits (2372), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 442/573 (77%), Positives = 494/573 (86%), Gaps = 4/573 (0%)
Query: 317 GEVEGKSDEGPSLFS---QANLLSGEFPKELTALPALVSEAANDEVDRSYLELPVFVMPS 373
G + G PSLF +NL+SGEFPKE+ LP L SE A EVD+SYLELPVFVMP+
Sbjct: 478 GSIPGWLGTLPSLFYIDLSSNLISGEFPKEIIRLPRLTSEEAATEVDQSYLELPVFVMPN 537
Query: 374 NATNQQYNQLSNLPPAIYLANNSLSGNIPVEIGQLKSLHVLDLSNNNFSGTIPDELSDLS 433
NATN QY QLSNLPPAIYL NNSLSGNIP EIGQLK +H+LDLS NNFSG+IPD++S+L+
Sbjct: 538 NATNLQYKQLSNLPPAIYLRNNSLSGNIPTEIGQLKFIHILDLSYNNFSGSIPDQISNLT 597
Query: 434 NLEKLDLSGNHLVGEIPISLKGLHFLSSFSVAHNNLQGAVPSGGQFDTFPSFSFEGNPEL 493
NLEKLDLSGNHL GEIP SL+ LHFLSSF+VA+N+L+GA+PSGGQFDTFP+ SFEGNP L
Sbjct: 598 NLEKLDLSGNHLSGEIPGSLRSLHFLSSFNVANNSLEGAIPSGGQFDTFPNSSFEGNPGL 657
Query: 494 CGSVVQRPCAISPGATHPTAPHKRTNTKLVIGLVLGICFGTGLIISMLALWILSKRRIIP 553
CG +QR C+ P TH + K N KL++GL++GICF TGLI+++L LWI KRRI+P
Sbjct: 658 CGPPLQRSCSNQPATTHSSTLGKSLNKKLIVGLIVGICFVTGLILALLTLWI-CKRRILP 716
Query: 554 GGDPDKIELDTISSTSNFGVSPEADKDASLVMLFPNNTNEIKDLTIYELLKATDNFSQAN 613
G+ +K LDTIS TSN E DKD S+V++FP+NTN IKDLTI E+ KATDNF+Q N
Sbjct: 717 RGESEKSNLDTISCTSNTDFHSEVDKDTSMVIVFPSNTNGIKDLTISEIFKATDNFNQEN 776
Query: 614 IIGCGGFGLVYKATLANGTTLAIKKLSGDLGLMEREFKAEVEALSTAQHKNLVSLQGYCV 673
IIGCGGFGLVYKA L NGT LAIKKLSGDLGL+EREFKAEVEALSTAQHKNLVSLQGYCV
Sbjct: 777 IIGCGGFGLVYKAILENGTKLAIKKLSGDLGLIEREFKAEVEALSTAQHKNLVSLQGYCV 836
Query: 674 HQGFRLLIYSYMENGSLDYWLHEKADGASQLDWLTRLKIARGTSCGLAYMHQICEPHIVH 733
H G RLLIYSYMENGSLDYWLHEK DG+ QLDW +RLKIA+G SCGLAYMHQICEPHIVH
Sbjct: 837 HDGIRLLIYSYMENGSLDYWLHEKTDGSPQLDWRSRLKIAQGASCGLAYMHQICEPHIVH 896
Query: 734 RDIKSSNILLDDQFEAHLADFGLSRLILPYQTHVTTELVGTLGYIPPEYGQAWVATLRGD 793
RDIKSSNILL+D+FEAH+ADFGLSRLILPY THVTTELVGTLGYIPPEYGQAWVATLRGD
Sbjct: 897 RDIKSSNILLNDKFEAHVADFGLSRLILPYHTHVTTELVGTLGYIPPEYGQAWVATLRGD 956
Query: 794 MYSFGVVMLELLTGKRPVDVLKPKMSRELVGWVLKMRSEGKQDQVFDPILRGKGFDEEML 853
+YSFGVVMLELLTGKRPV+V KPKMSRELVGWV +MRSEGKQDQVFDP+LRGKGF+EEML
Sbjct: 957 VYSFGVVMLELLTGKRPVEVFKPKMSRELVGWVQQMRSEGKQDQVFDPLLRGKGFEEEML 1016
Query: 854 QVLDVACMCVSQNPFKRPTVKEVVEWLNNVGAN 886
QVLDVACMCVSQNPFKRPT+KEVV WL NVG N
Sbjct: 1017 QVLDVACMCVSQNPFKRPTIKEVVNWLENVGNN 1049
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356504209|ref|XP_003520891.1| PREDICTED: tyrosine-sulfated glycopeptide receptor 1-like [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 899 bits (2322), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 430/559 (76%), Positives = 488/559 (87%), Gaps = 3/559 (0%)
Query: 334 NLLSGEFPKELTALPALVSEAANDEVDRSYLELPVFVMPSNATNQQYNQLSNLPPAIYLA 393
N L+G FP ELT LPAL S+ A DEV+R+YLELP+F +N + QYNQ+SNLPPAIYL
Sbjct: 520 NRLTGIFPTELTRLPALTSQQAYDEVERTYLELPLFANANNVSQMQYNQISNLPPAIYLG 579
Query: 394 NNSLSGNIPVEIGQLKSLHVLDLSNNNFSGTIPDELSDLSNLEKLDLSGNHLVGEIPISL 453
NNSL+G+IP+EIG+LK LH LDLSNN FSG IP E+S+L NLEKL LSGN L GEIP+SL
Sbjct: 580 NNSLNGSIPIEIGKLKVLHQLDLSNNKFSGNIPAEISNLINLEKLYLSGNQLSGEIPVSL 639
Query: 454 KGLHFLSSFSVAHNNLQGAVPSGGQFDTFPSFSFEGNPELCGSVVQRPCAISPGATHPTA 513
K LHFLS+FSVA+NNLQG +P+GGQFDTF S SFEGN +LCGSVVQR C G T A
Sbjct: 640 KSLHFLSAFSVAYNNLQGPIPTGGQFDTFSSSSFEGNLQLCGSVVQRSCLPQQGTT---A 696
Query: 514 PHKRTNTKLVIGLVLGICFGTGLIISMLALWILSKRRIIPGGDPDKIELDTISSTSNFGV 573
R+N KL+IG + CFGT IS+L +WI+SKRRI PGGD DK+EL++IS +S GV
Sbjct: 697 RGHRSNKKLIIGFSIAACFGTVSFISVLIVWIISKRRINPGGDTDKVELESISVSSYSGV 756
Query: 574 SPEADKDASLVMLFPNNTNEIKDLTIYELLKATDNFSQANIIGCGGFGLVYKATLANGTT 633
PE DK+ASLV+LFPN TNEIKDLTI+E+LKAT+NFSQANIIGCGGFGLVYKATL NGTT
Sbjct: 757 HPEVDKEASLVVLFPNKTNEIKDLTIFEILKATENFSQANIIGCGGFGLVYKATLPNGTT 816
Query: 634 LAIKKLSGDLGLMEREFKAEVEALSTAQHKNLVSLQGYCVHQGFRLLIYSYMENGSLDYW 693
+AIKKLSGDLGLMEREFKAEVEALSTAQH+NLV+LQGYCVH+G RLLIY+YMENGSLDYW
Sbjct: 817 VAIKKLSGDLGLMEREFKAEVEALSTAQHENLVALQGYCVHEGVRLLIYTYMENGSLDYW 876
Query: 694 LHEKADGASQLDWLTRLKIARGTSCGLAYMHQICEPHIVHRDIKSSNILLDDQFEAHLAD 753
LHEKADG SQLDW TRLKIA+G SCGLAYMHQICEPHIVHRDIKSSNILLD++FEAH+AD
Sbjct: 877 LHEKADGPSQLDWPTRLKIAQGASCGLAYMHQICEPHIVHRDIKSSNILLDEKFEAHVAD 936
Query: 754 FGLSRLILPYQTHVTTELVGTLGYIPPEYGQAWVATLRGDMYSFGVVMLELLTGKRPVDV 813
FGL+RLILPYQTHVTTELVGTLGYIPPEYGQAWVATLRGD+YSFGVVMLELL+G+RPVDV
Sbjct: 937 FGLARLILPYQTHVTTELVGTLGYIPPEYGQAWVATLRGDVYSFGVVMLELLSGRRPVDV 996
Query: 814 LKPKMSRELVGWVLKMRSEGKQDQVFDPILRGKGFDEEMLQVLDVACMCVSQNPFKRPTV 873
KPKMSRELV WV +MRSEGKQDQVFDP+LRGKGF+EEM QVLD ACMCV+QNPFKRP++
Sbjct: 997 SKPKMSRELVAWVQQMRSEGKQDQVFDPLLRGKGFEEEMQQVLDAACMCVNQNPFKRPSI 1056
Query: 874 KEVVEWLNNVGANRRNENK 892
+EVVEWL NVG+++ NK
Sbjct: 1057 REVVEWLKNVGSSKPQMNK 1075
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|358248614|ref|NP_001239911.1| tyrosine-sulfated glycopeptide receptor 1-like precursor [Glycine max] gi|223452476|gb|ACM89565.1| leucine-rich repeat receptor-like kinase [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 866 bits (2238), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 413/560 (73%), Positives = 481/560 (85%), Gaps = 1/560 (0%)
Query: 333 ANLLSGEFPKELTALPALVSEAANDEVDRSYLELPVFVMPSNATNQQYNQLSNLPPAIYL 392
NLL+G FP ELT LPAL S+ AND+V+R+Y ELPVF +N + QYNQLS LPPAIYL
Sbjct: 507 VNLLTGVFPVELTELPALASQQANDKVERTYFELPVFANANNVSLLQYNQLSGLPPAIYL 566
Query: 393 ANNSLSGNIPVEIGQLKSLHVLDLSNNNFSGTIPDELSDLSNLEKLDLSGNHLVGEIPIS 452
+N L+G+IP+EIG+LK LH LDL NNFSG+IP + S+L+NLEKLDLSGN L GEIP S
Sbjct: 567 GSNHLNGSIPIEIGKLKVLHQLDLKKNNFSGSIPVQFSNLTNLEKLDLSGNQLSGEIPDS 626
Query: 453 LKGLHFLSSFSVAHNNLQGAVPSGGQFDTFPSFSFEGNPELCGSVVQRPCAISPGATHPT 512
L+ LHFLS FSVA NNLQG +P+GGQFDTF + SFEGN +LCG V+QR C S T+ T
Sbjct: 627 LRRLHFLSFFSVAFNNLQGQIPTGGQFDTFSNSSFEGNVQLCGLVIQRSCP-SQQNTNTT 685
Query: 513 APHKRTNTKLVIGLVLGICFGTGLIISMLALWILSKRRIIPGGDPDKIELDTISSTSNFG 572
A + +N K+++ L++G+ FG +I +L LWILSKRR+ PGG DKIE+++IS+ SN G
Sbjct: 686 AASRSSNKKVLLVLIIGVSFGFASLIGVLTLWILSKRRVNPGGVSDKIEMESISAYSNNG 745
Query: 573 VSPEADKDASLVMLFPNNTNEIKDLTIYELLKATDNFSQANIIGCGGFGLVYKATLANGT 632
V PE DK+ASLV+LFPN NE KDLTI+E+LK+T+NFSQ NIIGCGGFGLVYKATL NGT
Sbjct: 746 VHPEVDKEASLVVLFPNKNNETKDLTIFEILKSTENFSQENIIGCGGFGLVYKATLPNGT 805
Query: 633 TLAIKKLSGDLGLMEREFKAEVEALSTAQHKNLVSLQGYCVHQGFRLLIYSYMENGSLDY 692
TLAIKKLSGDLGLMEREFKAEVEALSTAQH+NLV+LQGYCVH GFRLL+Y+YMENGSLDY
Sbjct: 806 TLAIKKLSGDLGLMEREFKAEVEALSTAQHENLVALQGYCVHDGFRLLMYNYMENGSLDY 865
Query: 693 WLHEKADGASQLDWLTRLKIARGTSCGLAYMHQICEPHIVHRDIKSSNILLDDQFEAHLA 752
WLHEK DGASQLDW TRLKIA+G SCGLAY+HQICEPHIVHRDIKSSNILL+++FEAH+A
Sbjct: 866 WLHEKPDGASQLDWPTRLKIAQGASCGLAYLHQICEPHIVHRDIKSSNILLNEKFEAHVA 925
Query: 753 DFGLSRLILPYQTHVTTELVGTLGYIPPEYGQAWVATLRGDMYSFGVVMLELLTGKRPVD 812
DFGLSRLILPY THVTTELVGTLGYIPPEYGQAWVATLRGD+YSFGVVMLEL+TG+RPVD
Sbjct: 926 DFGLSRLILPYHTHVTTELVGTLGYIPPEYGQAWVATLRGDVYSFGVVMLELITGRRPVD 985
Query: 813 VLKPKMSRELVGWVLKMRSEGKQDQVFDPILRGKGFDEEMLQVLDVACMCVSQNPFKRPT 872
V KPKMSRELVGWV +MR EGKQDQVFDP+LRGKGF+ +ML+VLDV CMCVS NPFKRP+
Sbjct: 986 VCKPKMSRELVGWVQQMRIEGKQDQVFDPLLRGKGFEVQMLKVLDVTCMCVSHNPFKRPS 1045
Query: 873 VKEVVEWLNNVGANRRNENK 892
++EVVEWL NVG++ + K
Sbjct: 1046 IREVVEWLKNVGSDNQPTQK 1065
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356520190|ref|XP_003528747.1| PREDICTED: tyrosine-sulfated glycopeptide receptor 1-like [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 860 bits (2221), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 420/597 (70%), Positives = 492/597 (82%), Gaps = 8/597 (1%)
Query: 303 LVSRPNADDLEIIFGEVEGKS----DEGPSLFSQ---ANLLSGEFPKELTALPALVSEAA 355
LV + L++ F ++ G P LF NLL+G FP ELT LPAL S+ A
Sbjct: 508 LVKLKKLEALDLSFNQISGPIPLWLGTLPQLFYMDLSVNLLTGVFPVELTELPALASQQA 567
Query: 356 NDEVDRSYLELPVFVMPSNATNQQYNQLSNLPPAIYLANNSLSGNIPVEIGQLKSLHVLD 415
ND+V+R+Y ELPVF +N + QYNQLS LPPAIYL +N L+G+IP+EIG+LK LH LD
Sbjct: 568 NDKVERTYFELPVFANANNVSLLQYNQLSGLPPAIYLGSNHLNGSIPIEIGKLKVLHQLD 627
Query: 416 LSNNNFSGTIPDELSDLSNLEKLDLSGNHLVGEIPISLKGLHFLSSFSVAHNNLQGAVPS 475
L NNFSG IP + S+L+NLEKLDLSGN L GEIP SL+ LHFLS FSVA NNLQG +P+
Sbjct: 628 LKKNNFSGNIPVQFSNLTNLEKLDLSGNQLSGEIPDSLRRLHFLSFFSVAFNNLQGQIPT 687
Query: 476 GGQFDTFPSFSFEGNPELCGSVVQRPCAISPGATHPTAPHKRTNTKLVIGLVLGICFGTG 535
GGQFDTF + SFEGN +LCG V+QR C S T+ TA + +N K+++ L++G+ FG
Sbjct: 688 GGQFDTFSNSSFEGNVQLCGLVIQRSCP-SQQNTNTTAASRSSNKKVLLVLIIGVSFGFA 746
Query: 536 LIISMLALWILSKRRIIPGGDPDKIELDTISSTSNFGVSPEADKDASLVMLFPNNTNEIK 595
+I +L LWILSKRR+ PGG DKIE+++IS+ SN GV PE DK+ASLV+LFPN NE K
Sbjct: 747 FLIGVLTLWILSKRRVNPGGVSDKIEMESISAYSNSGVHPEVDKEASLVVLFPNKNNETK 806
Query: 596 DLTIYELLKATDNFSQANIIGCGGFGLVYKATLANGTTLAIKKLSGDLGLMEREFKAEVE 655
DLTI+E+LK+T+NFSQANIIGCGGFGLVYKATL NGTTLAIKKLSGDLGLMEREFKAEVE
Sbjct: 807 DLTIFEILKSTENFSQANIIGCGGFGLVYKATLPNGTTLAIKKLSGDLGLMEREFKAEVE 866
Query: 656 ALSTAQHKNLVSLQGYCVHQGFRLLIYSYMENGSLDYWLHEKADGASQLDWLTRLKIARG 715
ALSTAQH+NLV+LQGY VH GFRLL+Y+YMENGSLDYWLHEK DGASQLDW TRLKIA+G
Sbjct: 867 ALSTAQHENLVALQGYGVHDGFRLLMYNYMENGSLDYWLHEKPDGASQLDWPTRLKIAQG 926
Query: 716 TSCGLAYMHQICEPHIVHRDIKSSNILLDDQFEAHLADFGLSRLILPYQTHVTTELVGTL 775
SCGLAY+HQICEPHIVHRDIKSSNILL+++FEAH+ADFGLSRLILPY THVTTELVGTL
Sbjct: 927 ASCGLAYLHQICEPHIVHRDIKSSNILLNEKFEAHVADFGLSRLILPYHTHVTTELVGTL 986
Query: 776 GYIPPEYGQAWVATLRGDMYSFGVVMLELLTGKRPVDVLKPKMSRELVGWVLKMRSEGKQ 835
GYIPPEYGQAWVATLRGD+YSFGVVMLELLTG+RPVDV KPKMSRELV WV +MR EGKQ
Sbjct: 987 GYIPPEYGQAWVATLRGDVYSFGVVMLELLTGRRPVDVCKPKMSRELVSWVQQMRIEGKQ 1046
Query: 836 DQVFDPILRGKGFDEEMLQVLDVACMCVSQNPFKRPTVKEVVEWLNNVGANRRNENK 892
DQVFDP+LRGKGF+ +ML+VLDVA +CVS NPFKRP+++EVVEWL NVG++ + K
Sbjct: 1047 DQVFDPLLRGKGFEGQMLKVLDVASVCVSHNPFKRPSIREVVEWLKNVGSDNQPTQK 1103
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|449436222|ref|XP_004135892.1| PREDICTED: tyrosine-sulfated glycopeptide receptor 1-like [Cucumis sativus] gi|449491098|ref|XP_004158799.1| PREDICTED: tyrosine-sulfated glycopeptide receptor 1-like [Cucumis sativus] | Back alignment and taxonomy information |
|---|
Score = 859 bits (2220), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 423/570 (74%), Positives = 488/570 (85%), Gaps = 8/570 (1%)
Query: 327 PSLFS---QANLLSGEFPKELTALPALVSEAANDEVDRSYLELPVFVMPSNATNQQYNQL 383
PSLF N +SG+FP +L L AL+S+ D +S+L LPVFV PSNATNQQYNQL
Sbjct: 528 PSLFYIDLSNNRISGKFPTQLCRLQALMSQQILDPAKQSFLALPVFVAPSNATNQQYNQL 587
Query: 384 SNLPPAIYLANNSLSGNIPVEIGQLKSLHVLDLSNNNFSGTIPDELSDLSNLEKLDLSGN 443
S+LPPAIYL NN++SG IP+EIGQLK +H+LDLSNN+FSG+IPD +S+LSNLE+LDLS N
Sbjct: 588 SSLPPAIYLGNNTISGPIPLEIGQLKFIHILDLSNNSFSGSIPDTISNLSNLERLDLSHN 647
Query: 444 HLVGEIPISLKGLHFLSSFSVAHNNLQGAVPSGGQFDTFPSFSFEGNPELCGS-VVQRPC 502
HL GEIP SLKGLHFLS FSVA N LQG +PSGGQFDTFPS S+EGN LCG +VQR C
Sbjct: 648 HLTGEIPHSLKGLHFLSWFSVAFNELQGPIPSGGQFDTFPSSSYEGNSGLCGPPIVQRSC 707
Query: 503 AISPGATHPTAPHKRTNTKLVIGLVLGICFGTGLIISMLALWILSKRRIIPGGDPDKIEL 562
+ TH TA +K ++ KL IGLV+G C GLII++LALWILSKRRI P GD D I+L
Sbjct: 708 SSQTRITHSTAQNKSSSKKLAIGLVVGTCLSIGLIITLLALWILSKRRIDPRGDTDIIDL 767
Query: 563 DTISSTSNFGVSPEADKDASLVMLFPNNTNEIKDLTIYELLKATDNFSQANIIGCGGFGL 622
D IS +SN+ AD + S+V+LFPNN N IK+LTI ++LKATD+F+Q NIIGCGGFGL
Sbjct: 768 DIISISSNY----NADNNTSIVILFPNNANNIKELTISDILKATDDFNQENIIGCGGFGL 823
Query: 623 VYKATLANGTTLAIKKLSGDLGLMEREFKAEVEALSTAQHKNLVSLQGYCVHQGFRLLIY 682
VYKATLANGT LA+KKLSGDLGLMEREFKAEVEALS A+HKNLV+LQGYCVH+G RLL+Y
Sbjct: 824 VYKATLANGTRLAVKKLSGDLGLMEREFKAEVEALSAAKHKNLVTLQGYCVHEGSRLLMY 883
Query: 683 SYMENGSLDYWLHEKADGASQLDWLTRLKIARGTSCGLAYMHQICEPHIVHRDIKSSNIL 742
SYMENGSLDYWLHEK DGASQLDW TRLKI RG+SCGLAYMHQICEPHIVHRDIKSSNIL
Sbjct: 884 SYMENGSLDYWLHEKVDGASQLDWPTRLKIIRGSSCGLAYMHQICEPHIVHRDIKSSNIL 943
Query: 743 LDDQFEAHLADFGLSRLILPYQTHVTTELVGTLGYIPPEYGQAWVATLRGDMYSFGVVML 802
LD++FEAH+ADFGLSRLI PYQTHVTTELVGTLGYIPPEYGQAWVATLRGDMYSFGVV+L
Sbjct: 944 LDEKFEAHVADFGLSRLINPYQTHVTTELVGTLGYIPPEYGQAWVATLRGDMYSFGVVVL 1003
Query: 803 ELLTGKRPVDVLKPKMSRELVGWVLKMRSEGKQDQVFDPILRGKGFDEEMLQVLDVACMC 862
ELLTGKRPV++ KPK SRELVGWV ++R+EGKQD+VFDPIL+GKGF+EEM+QVLD+ACMC
Sbjct: 1004 ELLTGKRPVEISKPKASRELVGWVQQLRNEGKQDEVFDPILKGKGFEEEMIQVLDIACMC 1063
Query: 863 VSQNPFKRPTVKEVVEWLNNVGANRRNENK 892
VSQNPFKRPT+KEVV+WL +VG + ++K
Sbjct: 1064 VSQNPFKRPTIKEVVDWLKDVGETKVPQSK 1093
|
Source: Cucumis sativus Species: Cucumis sativus Genus: Cucumis Family: Cucurbitaceae Order: Cucurbitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
Prediction of Gene Ontology (GO) Terms
Close Homologs with Gene Ontology terms Detected by BLAST
Original result of BLAST against Gene Ontology (AMIGO)
| ID |
Alignment graph |
Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 894 | ||||||
| TAIR|locus:2207056 | 1095 | PSY1R "PSY1 receptor" [Arabido | 0.642 | 0.524 | 0.655 | 3.1e-202 | |
| TAIR|locus:2051628 | 1008 | PSKR1 "phytosulfokin receptor | 0.598 | 0.530 | 0.537 | 6.9e-150 | |
| TAIR|locus:2154709 | 1036 | PSKR2 "phytosylfokine-alpha re | 0.601 | 0.519 | 0.521 | 6.4e-147 | |
| TAIR|locus:2143626 | 341 | AT5G27560 "AT5G27560" [Arabido | 0.356 | 0.935 | 0.671 | 2.1e-109 | |
| TAIR|locus:2092810 | 1164 | BRL3 "BRI1-like 3" [Arabidopsi | 0.534 | 0.410 | 0.418 | 3.6e-103 | |
| TAIR|locus:2182870 | 1192 | EMS1 "EXCESS MICROSPOROCYTES1" | 0.604 | 0.453 | 0.391 | 4.8e-95 | |
| UNIPROTKB|Q942F3 | 1121 | P0480C01.18-1 "cDNA clone:J033 | 0.554 | 0.442 | 0.392 | 1.3e-94 | |
| TAIR|locus:2020457 | 1166 | BRL1 "BRI1 like" [Arabidopsis | 0.552 | 0.423 | 0.394 | 9.3e-91 | |
| TAIR|locus:2005498 | 1196 | BRI1 "BRASSINOSTEROID INSENSIT | 0.544 | 0.407 | 0.402 | 1.7e-89 | |
| UNIPROTKB|Q8RZV7 | 1294 | P0413C03.22 "Putative extra sp | 0.572 | 0.395 | 0.400 | 4.5e-86 |
| TAIR|locus:2207056 PSY1R "PSY1 receptor" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1957 (694.0 bits), Expect = 3.1e-202, P = 3.1e-202
Identities = 380/580 (65%), Positives = 456/580 (78%)
Query: 317 GEVEGKSDEGPSLFS---QANLLSGEFPKELTALPALVSEAANDEVDRSYLELPVFVMPS 373
G + G P LF N L+GE PKEL L AL+S+ A D +R+YLELPVFV P+
Sbjct: 509 GTIPGWLGTLPDLFYLDLSDNFLTGELPKELFQLRALMSQKAYDATERNYLELPVFVNPN 568
Query: 374 NAT-NQQYNQLSNLPPAIYLANNSLSGNIPVEIGQLKSLHVLDLSNNNFSGTIPDELSDL 432
N T NQQYNQLS+LPP IY+ N+L+G IPVE+GQLK LH+L+L NNFSG+IPDELS+L
Sbjct: 569 NVTTNQQYNQLSSLPPTIYIKRNNLTGTIPVEVGQLKVLHILELLGNNFSGSIPDELSNL 628
Query: 433 SNLEKLDLSGNHLVGEIPISLKGLHFLSSFSVAHNNLQGAVPSGGQFDTFPSFSFEGNPE 492
+NLE+LDLS N+L G IP SL GLHFLS F+VA+N L G +P+G QFDTFP +FEGNP
Sbjct: 629 TNLERLDLSNNNLSGRIPWSLTGLHFLSYFNVANNTLSGPIPTGTQFDTFPKANFEGNPL 688
Query: 493 LCGSVVQRPCAISPGATHPTAPHKRTNTKLVIGLVLGICFGTGLIISMLALWILSKRRII 552
LCG V+ C + +T K N LV+GLVLG+ FG LI+ +LAL +LSKRR+
Sbjct: 689 LCGGVLLTSCDPTQHSTTKMGKGK-VNRTLVLGLVLGLFFGVSLILVLLALLVLSKRRVN 747
Query: 553 PGGDPDKIELDTISSTSNFGVSPEADKDASLVMLFPNNTNEIKDLTIYELLKATDNFSQA 612
PG D + EL+ S+ S V P +DKD SLV+LF N+ E+KDLTI+ELLKATDNFSQA
Sbjct: 748 PG-DSENAELEINSNGSYSEVPPGSDKDISLVLLFGNSRYEVKDLTIFELLKATDNFSQA 806
Query: 613 NIIGCGGFGLVYKATLANGTTLAIKKLSGDLGLMEREFKAEVEALSTAQHKNLVSLQGYC 672
NIIGCGGFGLVYKATL NGT LA+KKL+GD G+ME+EFKAEVE LS A+H+NLV+LQGYC
Sbjct: 807 NIIGCGGFGLVYKATLDNGTKLAVKKLTGDYGMMEKEFKAEVEVLSRAKHENLVALQGYC 866
Query: 673 VHQGFRLLIYSYMENGSLDYWLHEKADGASQLDWLTRLKIARGTSCGLAYMHQICEPHIV 732
VH R+LIYS+MENGSLDYWLHE +G +QLDW RL I RG S GLAYMHQICEPHIV
Sbjct: 867 VHDSARILIYSFMENGSLDYWLHENPEGPAQLDWPKRLNIMRGASSGLAYMHQICEPHIV 926
Query: 733 HRDIKSSNILLDDQFEAHLADFGLSRLILPYQTHVTTELVGTLGYIPPEYGQAWVATLRG 792
HRDIKSSNILLD F+A++ADFGLSRLILPY+THVTTELVGTLGYIPPEYGQAWVATLRG
Sbjct: 927 HRDIKSSNILLDGNFKAYVADFGLSRLILPYRTHVTTELVGTLGYIPPEYGQAWVATLRG 986
Query: 793 DMYSFGVVMLELLTGKRPVDVLKPKMSRELVGWVLKMRSEGKQDQVFDPILRGKGFDEEM 852
D+YSFGVVMLELLTGKRP++V +PKMSRELV WV M+ +GK ++VFD +LR G +E M
Sbjct: 987 DVYSFGVVMLELLTGKRPMEVFRPKMSRELVAWVHTMKRDGKPEEVFDTLLRESGNEEAM 1046
Query: 853 LQVLDVACMCVSQNPFKRPTVKEVVEWLNNVGANRRNENK 892
L+VLD+ACMCV+QNP KRP +++VV+WL N+ A + N+
Sbjct: 1047 LRVLDIACMCVNQNPMKRPNIQQVVDWLKNIEAEKNQNNR 1086
|
|
| TAIR|locus:2051628 PSKR1 "phytosulfokin receptor 1" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1463 (520.1 bits), Expect = 6.9e-150, P = 6.9e-150
Identities = 296/551 (53%), Positives = 388/551 (70%)
Query: 334 NLLSGEFPKELTALPALVSEAANDEVDRSYLELPVFVMPSNATNQ-QYNQLSNLPPAIYL 392
N +GE PK LT L +L S N V+ + P F+ + + QYNQ+ PP I L
Sbjct: 473 NSFTGEIPKSLTKLESLTSR--NISVNEPSPDFPFFMKRNESARALQYNQIFGFPPTIEL 530
Query: 393 ANNSLSGNIPVEIGQLKSLHVLDLSNNNFSGTIPDELSDLSNLEKLDLSGNHLVGEIPIS 452
+N+LSG I E G LK LHV DL N SG+IP LS +++LE LDLS N L G IP+S
Sbjct: 531 GHNNLSGPIWEEFGNLKKLHVFDLKWNALSGSIPSSLSGMTSLEALDLSNNRLSGSIPVS 590
Query: 453 LKGLHFLSSFSVAHNNLQGAVPSGGQFDTFPSFSFEGNPELCGSVVQRPCAISPGATHPT 512
L+ L FLS FSVA+NNL G +PSGGQF TFP+ SFE N LCG + PC S G
Sbjct: 591 LQQLSFLSKFSVAYNNLSGVIPSGGQFQTFPNSSFESN-HLCGEH-RFPC--SEGTESAL 646
Query: 513 APHKRTNTKLVIGLVLGICFGTGLIISMLALWILSKRRIIPGGDPDKIELDTISSTSNFG 572
R + IG+ +GI FG+ ++++L+L +L RR DP+ IE + G
Sbjct: 647 IKRSRRSRGGDIGMAIGIAFGSVFLLTLLSLIVLRARRRSGEVDPE-IEESESMNRKELG 705
Query: 573 VSPEADKDASLVMLFPNNTNEIKDLTIYELLKATDNFSQANIIGCGGFGLVYKATLANGT 632
+ + LV+LF +N K+L+ +LL +T++F QANIIGCGGFG+VYKATL +G
Sbjct: 706 -----EIGSKLVVLFQSND---KELSYDDLLDSTNSFDQANIIGCGGFGMVYKATLPDGK 757
Query: 633 TLAIKKLSGDLGLMEREFKAEVEALSTAQHKNLVSLQGYCVHQGFRLLIYSYMENGSLDY 692
+AIKKLSGD G +EREF+AEVE LS AQH NLV L+G+C ++ RLLIYSYMENGSLDY
Sbjct: 758 KVAIKKLSGDCGQIEREFEAEVETLSRAQHPNLVLLRGFCFYKNDRLLIYSYMENGSLDY 817
Query: 693 WLHEKADGASQLDWLTRLKIARGTSCGLAYMHQICEPHIVHRDIKSSNILLDDQFEAHLA 752
WLHE+ DG + L W TRL+IA+G + GL Y+H+ C+PHI+HRDIKSSNILLD+ F +HLA
Sbjct: 818 WLHERNDGPALLKWKTRLRIAQGAAKGLLYLHEGCDPHILHRDIKSSNILLDENFNSHLA 877
Query: 753 DFGLSRLILPYQTHVTTELVGTLGYIPPEYGQAWVATLRGDMYSFGVVMLELLTGKRPVD 812
DFGL+RL+ PY+THV+T+LVGTLGYIPPEYGQA VAT +GD+YSFGVV+LELLT KRPVD
Sbjct: 878 DFGLARLMSPYETHVSTDLVGTLGYIPPEYGQASVATYKGDVYSFGVVLLELLTDKRPVD 937
Query: 813 VLKPKMSRELVGWVLKMRSEGKQDQVFDPILRGKGFDEEMLQVLDVACMCVSQNPFKRPT 872
+ KPK R+L+ WV+KM+ E + +VFDP++ K D+EM +VL++AC+C+S+NP +RPT
Sbjct: 938 MCKPKGCRDLISWVVKMKHESRASEVFDPLIYSKENDKEMFRVLEIACLCLSENPKQRPT 997
Query: 873 VKEVVEWLNNV 883
+++V WL++V
Sbjct: 998 TQQLVSWLDDV 1008
|
|
| TAIR|locus:2154709 PSKR2 "phytosylfokine-alpha receptor 2" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1435 (510.2 bits), Expect = 6.4e-147, P = 6.4e-147
Identities = 294/564 (52%), Positives = 394/564 (69%)
Query: 330 FSQANLLSGEFPKELTALPALV--SEAANDEVDRSYLELPVFVMPSNATNQ-QYNQLSNL 386
FS N L+G P +T L L+ + A+ D S +P++V + ++N YNQ+S
Sbjct: 481 FSN-NTLTGAIPVAITELKNLIRLNGTASQMTDSS--GIPLYVKRNKSSNGLPYNQVSRF 537
Query: 387 PPAIYLANNSLSGNIPVEIGQLKSLHVLDLSNNNFSGTIPDELSDLSNLEKLDLSGNHLV 446
PP+IYL NN L+G I EIG+LK LH+LDLS NNF+GTIPD +S L NLE LDLS NHL
Sbjct: 538 PPSIYLNNNRLNGTILPEIGRLKELHMLDLSRNNFTGTIPDSISGLDNLEVLDLSYNHLY 597
Query: 447 GEIPISLKGLHFLSSFSVAHNNLQGAVPSGGQFDTFPSFSFEGNPELCGSVVQRPC-AIS 505
G IP+S + L FLS FSVA+N L GA+PSGGQF +FP SFEGN LC ++ PC +
Sbjct: 598 GSIPLSFQSLTFLSRFSVAYNRLTGAIPSGGQFYSFPHSSFEGNLGLCRAI-DSPCDVLM 656
Query: 506 PGATHPTAPHKRTNT------KLVIGLVLGICFGTGLIISMLALWILSKRRIIPGGDPDK 559
+P +R N ++ L + + G L++S++ L I R+ + D
Sbjct: 657 SNMLNPKGSSRRNNNGGKFGRSSIVVLTISLAIGITLLLSVILLRI--SRKDVDDRIND- 713
Query: 560 IELDTISSTSNFGVSPEADKDASLVMLFPNNTNEIKDLTIYELLKATDNFSQANIIGCGG 619
++ +TIS S + P S ++LF ++ KDL++ ELLK+T+NFSQANIIGCGG
Sbjct: 714 VDEETISGVSK-ALGP------SKIVLF--HSCGCKDLSVEELLKSTNNFSQANIIGCGG 764
Query: 620 FGLVYKATLANGTTLAIKKLSGDLGLMEREFKAEVEALSTAQHKNLVSLQGYCVHQGFRL 679
FGLVYKA +G+ A+K+LSGD G MEREF+AEVEALS A+HKNLVSLQGYC H RL
Sbjct: 765 FGLVYKANFPDGSKAAVKRLSGDCGQMEREFQAEVEALSRAEHKNLVSLQGYCKHGNDRL 824
Query: 680 LIYSYMENGSLDYWLHEKADGASQLDWLTRLKIARGTSCGLAYMHQICEPHIVHRDIKSS 739
LIYS+MENGSLDYWLHE+ DG L W RLKIA+G + GLAY+H++CEP+++HRD+KSS
Sbjct: 825 LIYSFMENGSLDYWLHERVDGNMTLIWDVRLKIAQGAARGLAYLHKVCEPNVIHRDVKSS 884
Query: 740 NILLDDQFEAHLADFGLSRLILPYQTHVTTELVGTLGYIPPEYGQAWVATLRGDMYSFGV 799
NILLD++FEAHLADFGL+RL+ PY THVTT+LVGTLGYIPPEY Q+ +AT RGD+YSFGV
Sbjct: 885 NILLDEKFEAHLADFGLARLLRPYDTHVTTDLVGTLGYIPPEYSQSLIATCRGDVYSFGV 944
Query: 800 VMLELLTGKRPVDVLKPKMSRELVGWVLKMRSEGKQDQVFDPILRGKGFDEEMLQVLDVA 859
V+LEL+TG+RPV+V K K R+LV V +M++E ++ ++ D +R + +L++L++A
Sbjct: 945 VLLELVTGRRPVEVCKGKSCRDLVSRVFQMKAEKREAELIDTTIRENVNERTVLEMLEIA 1004
Query: 860 CMCVSQNPFKRPTVKEVVEWLNNV 883
C C+ P +RP ++EVV WL ++
Sbjct: 1005 CKCIDHEPRRRPLIEEVVTWLEDL 1028
|
|
| TAIR|locus:2143626 AT5G27560 "AT5G27560" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1081 (385.6 bits), Expect = 2.1e-109, P = 2.1e-109
Identities = 229/341 (67%), Positives = 260/341 (76%)
Query: 1 MASSSIASCCFYSNSPLTPSNSASTSTAHFALSFSHTIFDGSTNISSLKKAPWSSSRTYA 60
MA SS+ SC F+ L S ST T F+ S S F STN S RT
Sbjct: 1 MAYSSVPSC-FHGY--LLHRCSFST-TQFFSGSLSCG-FSASTN---------SRLRTCV 46
Query: 61 KFDKFQGDN-LEETPNTSPVXXXX-------XXXXXXXXXGDDSCLPSDLEGAVRQSSQA 112
KF+KFQGD+ LE+ + S DD CLP+DLEGAVRQS +A
Sbjct: 47 KFEKFQGDSPLEQNTSVSSSSSVSQELPLEEAQDQLEEEEDDDDCLPNDLEGAVRQSGEA 106
Query: 113 SSLFVSAGGMRAIVELLIPQLQFLDDEGAQAELWELSRLFVDTLIEETGSQRVKAIFPDA 172
+ FV++GG RAIVELLIPQLQFLDDEGAQAELW+LSR+F++TLI+ETG +RVKA+FPDA
Sbjct: 107 GAAFVNSGGNRAIVELLIPQLQFLDDEGAQAELWDLSRVFLETLIKETGCERVKAVFPDA 166
Query: 173 GAAALLKYRWKDAAFGFSSLSDRKPVEKEDEIIVMVVPDYQMLGYVEKIASDLSDDPPRP 232
GAAALLKYRWKDA FGF+SLSDRKPVEKEDEIIVMVVPDYQML YVEKIA+ L+DDPPRP
Sbjct: 167 GAAALLKYRWKDATFGFASLSDRKPVEKEDEIIVMVVPDYQMLEYVEKIANGLADDPPRP 226
Query: 233 LIMWNPRLISEDVGVGINVRNLRRYFLSTFTPVYSMRPLPSGAVFRCYPGLWKVFYDDKD 292
LIMWNPRLISE+VGVG NVR LRRYFLS+FT VYSMRPL +GAVFRCYPG WKVFYD+KD
Sbjct: 227 LIMWNPRLISEEVGVGFNVRKLRRYFLSSFTTVYSMRPLAAGAVFRCYPGKWKVFYDNKD 286
Query: 293 RPNRYLLAKELVSRPNADDLEIIFGEVEGKSDEGPSLFSQA 333
RP RYLLAKEL+ RP+A+DLEII+G VE KS+EGPSL SQA
Sbjct: 287 RPGRYLLAKELIGRPDAEDLEIIYGGVEEKSEEGPSLMSQA 327
|
|
| TAIR|locus:2092810 BRL3 "BRI1-like 3" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 917 (327.9 bits), Expect = 3.6e-103, Sum P(2) = 3.6e-103
Identities = 206/492 (41%), Positives = 296/492 (60%)
Query: 392 LANNSLSGNIPVEIGQLKSLHVLDLSNNNFSGTIPDELSDLSNLEKLDLSGNHLVGEIPI 451
L+ N++SG+IP+ G + L VL+L +N +GTIPD L + LDLS N L G +P
Sbjct: 646 LSYNAVSGSIPLGYGAMGYLQVLNLGHNLLTGTIPDSFGGLKAIGVLDLSHNDLQGFLPG 705
Query: 452 SLKGLHFLSSFSVAHNNLQGAVPSGGQFDTFPSFSFEGNPELCGSVVQRPCAISPGATHP 511
SL GL FLS V++NNL G +P GGQ TFP + N LCG V PC S G+ P
Sbjct: 706 SLGGLSFLSDLDVSNNNLTGPIPFGGQLTTFPLTRYANNSGLCG-VPLPPC--SSGS-RP 761
Query: 512 TAPHKRTNTK-LVIGLVLGICFGTGLIISMLALWILSKRRIIPGGDPDKIELDTI--SST 568
T H + + G+ GI F I+ ML + + R++ + ++++ S +
Sbjct: 762 TRSHAHPKKQSIATGMSAGIVFSFMCIV-MLIMALYRARKVQKKEKQREKYIESLPTSGS 820
Query: 569 SNFGVSPEADKDASLVMLFPNNTNEIKDLTIYELLKATDNFSQANIIGCGGFGLVYKATL 628
S++ +S + + V F ++ LT LL+AT+ FS ++IG GGFG VYKA L
Sbjct: 821 SSWKLSSVHEPLSINVATFEK---PLRKLTFAHLLEATNGFSADSMIGSGGFGDVYKAKL 877
Query: 629 ANGTTLAIKKLSGDLGLMEREFKAEVEALSTAQHKNLVSLQGYCVHQGFRLLIYSYMENG 688
A+G+ +AIKKL G +REF AE+E + +H+NLV L GYC RLL+Y YM+ G
Sbjct: 878 ADGSVVAIKKLIQVTGQGDREFMAEMETIGKIKHRNLVPLLGYCKIGEERLLVYEYMKYG 937
Query: 689 SLDYWLHEKAD-GASQLDWLTRLKIARGTSCGLAYMHQICEPHIVHRDIKSSNILLDDQF 747
SL+ LHEK G LDW R KIA G + GLA++H C PHI+HRD+KSSN+LLD F
Sbjct: 938 SLETVLHEKTKKGGIFLDWSARKKIAIGAARGLAFLHHSCIPHIIHRDMKSSNVLLDQDF 997
Query: 748 EAHLADFGLSRLILPYQTHVTTE-LVGTLGYIPPEYGQAWVATLRGDMYSFGVVMLELLT 806
A ++DFG++RL+ TH++ L GT GY+PPEY Q++ T +GD+YS+GV++LELL+
Sbjct: 998 VARVSDFGMARLVSALDTHLSVSTLAGTPGYVPPEYYQSFRCTAKGDVYSYGVILLELLS 1057
Query: 807 GKRPVDVLKPKMSRELVGWVLKMRSEGKQDQVFDP-ILRGKGFDEEMLQVLDVACMCVSQ 865
GK+P+D + LVGW ++ E + ++ DP ++ K D E+L L +A C+
Sbjct: 1058 GKKPIDPEEFGEDNNLVGWAKQLYREKRGAEILDPELVTDKSGDVELLHYLKIASQCLDD 1117
Query: 866 NPFKRPTVKEVV 877
PFKRPT+ +V+
Sbjct: 1118 RPFKRPTMIQVM 1129
|
|
| TAIR|locus:2182870 EMS1 "EXCESS MICROSPOROCYTES1" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 924 (330.3 bits), Expect = 4.8e-95, Sum P(2) = 4.8e-95
Identities = 221/565 (39%), Positives = 317/565 (56%)
Query: 334 NLLSGEFPKEL-TALPALVSEAANDEVDRSYLE---LPVFVMPSNATNQQYN-----QLS 384
N L+G PKE+ +L AN++++ E L ++ N T + + L
Sbjct: 638 NALTGSIPKEMGNSLKLQGLNLANNQLNGHIPESFGLLGSLVKLNLTKNKLDGPVPASLG 697
Query: 385 NLPPAIY--LANNSLSGNIPVEIGQLKSLHVLDLSNNNFSGTIPDELSDLSNLEKLDLSG 442
NL + L+ N+LSG + E+ ++ L L + N F+G IP EL +L+ LE LD+S
Sbjct: 698 NLKELTHMDLSFNNLSGELSSELSTMEKLVGLYIEQNKFTGEIPSELGNLTQLEYLDVSE 757
Query: 443 NHLVGEIPISLKGLHFLSSFSVAHNNLQGAVPSGGQFDTFPSFSFEGNPELCGSVVQRPC 502
N L GEIP + GL L ++A NNL+G VPS G GN ELCG VV C
Sbjct: 758 NLLSGEIPTKICGLPNLEFLNLAKNNLRGEVPSDGVCQDPSKALLSGNKELCGRVVGSDC 817
Query: 503 AISPGATHPTAPHKRTNTKLVIGLVLGICFGTGLIISMLALWILSKRRIIPGGDPDKIEL 562
I G K + + GL+LG + + L W ++KR + DP+++E
Sbjct: 818 KIE-GT-------KLRSAWGIAGLMLGFTIIVFVFVFSLRRWAMTKR-VKQRDDPERMEE 868
Query: 563 DTISS--TSN-FGVSPEADKDASLVMLFPNNTNEIKDLTIYELLKATDNFSQANIIGCGG 619
+ N + +S ++ + + +K + + ++++ATD+FS+ NIIG GG
Sbjct: 869 SRLKGFVDQNLYFLSGSRSREPLSINIAMFEQPLLK-VRLGDIVEATDHFSKKNIIGDGG 927
Query: 620 FGLVYKATLANGTTLAIKKLSGDLGLMEREFKAEVEALSTAQHKNLVSLQGYCVHQGFRL 679
FG VYKA L T+A+KKLS REF AE+E L +H NLVSL GYC +L
Sbjct: 928 FGTVYKACLPGEKTVAVKKLSEAKTQGNREFMAEMETLGKVKHPNLVSLLGYCSFSEEKL 987
Query: 680 LIYSYMENGSLDYWLHEKADGASQLDWLTRLKIARGTSCGLAYMHQICEPHIVHRDIKSS 739
L+Y YM NGSLD+WL + LDW RLKIA G + GLA++H PHI+HRDIK+S
Sbjct: 988 LVYEYMVNGSLDHWLRNQTGMLEVLDWSKRLKIAVGAARGLAFLHHGFIPHIIHRDIKAS 1047
Query: 740 NILLDDQFEAHLADFGLSRLILPYQTHVTTELVGTLGYIPPEYGQAWVATLRGDMYSFGV 799
NILLD FE +ADFGL+RLI ++HV+T + GT GYIPPEYGQ+ AT +GD+YSFGV
Sbjct: 1048 NILLDGDFEPKVADFGLARLISACESHVSTVIAGTFGYIPPEYGQSARATTKGDVYSFGV 1107
Query: 800 VMLELLTGKRPVDV-LKPKMSRELVGWVLKMRSEGKQDQVFDPILRGKGFDEEMLQVLDV 858
++LEL+TGK P K LVGW ++ ++GK V DP+L L++L +
Sbjct: 1108 ILLELVTGKEPTGPDFKESEGGNLVGWAIQKINQGKAVDVIDPLLVSVALKNSQLRLLQI 1167
Query: 859 ACMCVSQNPFKRPTVKEVVEWLNNV 883
A +C+++ P KRP + +V++ L +
Sbjct: 1168 AMLCLAETPAKRPNMLDVLKALKEI 1192
|
|
| UNIPROTKB|Q942F3 P0480C01.18-1 "cDNA clone:J033069J12, full insert sequence" [Oryza sativa Japonica Group (taxid:39947)] | Back alignment and assigned GO terms |
|---|
Score = 856 (306.4 bits), Expect = 1.3e-94, Sum P(2) = 1.3e-94
Identities = 200/510 (39%), Positives = 293/510 (57%)
Query: 392 LANNSLSGNIPVEIGQLKSLHVLDLSNNNFSGTIPDELSDLSNLEKLDLSGNHLVGEIPI 451
L+ N L IP E+G + L +++L +N SGTIP L++ L LDLS N L G IP
Sbjct: 588 LSYNQLDSAIPGELGDMFYLMIMNLGHNLLSGTIPSRLAEAKKLAVLDLSYNQLEGPIPN 647
Query: 452 SLKGLHFLSSFSVAHNNLQGAVPSGGQFDTFPSFSFEGNPELCGSVVQRPCA-ISPGATH 510
S L LS ++++N L G +P G TFP +E N LCG + PC SP +++
Sbjct: 648 SFSALS-LSEINLSNNQLNGTIPELGSLATFPKSQYENNTGLCGFPLP-PCDHSSPRSSN 705
Query: 511 PTAPHKRTNTKLVIGLVLGICFGTGLIISMLALWILSKRRIIPGGDPDKIELDTISSTSN 570
H+R + + +G+ F II ++ + I SKRR + + I S S+
Sbjct: 706 DHQSHRR-QASMASSIAMGLLFSLFCII-VIIIAIGSKRRRLKNEEASTSRDIYIDSRSH 763
Query: 571 FG-VSPEADKDASLVMLFPNNT----NEIKDLTIYELLKATDNFSQANIIGCGGFGLVYK 625
++ + ++ S L N +++LT+ +L++AT+ F A IG GGFG VYK
Sbjct: 764 SATMNSDWRQNLSGTNLLSINLAAFEKPLQNLTLADLVEATNGFHIACQIGSGGFGDVYK 823
Query: 626 ATLANGTTLAIKKLSGDLGLMEREFKAEVEALSTAQHKNLVSLQGYCVHQGFRLLIYSYM 685
A L +G +AIKKL G +REF AE+E + +H+NLV L GYC RLL+Y YM
Sbjct: 824 AQLKDGKVVAIKKLIHVSGQGDREFTAEMETIGKIKHRNLVPLLGYCKAGEERLLVYDYM 883
Query: 686 ENGSLDYWLHEKADGASQLDWLTRLKIARGTSCGLAYMHQICEPHIVHRDIKSSNILLDD 745
+ GSL+ LH++ +L+W R KIA G + GLA++H C PHI+HRD+KSSN+L+D+
Sbjct: 884 KFGSLEDVLHDRKKIGKKLNWEARRKIAVGAARGLAFLHHNCIPHIIHRDMKSSNVLIDE 943
Query: 746 QFEAHLADFGLSRLILPYQTHVTTE-LVGTLGYIPPEYGQAWVATLRGDMYSFGVVMLEL 804
Q EA ++DFG++RL+ TH++ L GT GY+PPEY Q++ T +GD+YS+GVV+LEL
Sbjct: 944 QLEARVSDFGMARLMSVVDTHLSVSTLAGTPGYVPPEYYQSFRCTTKGDVYSYGVVLLEL 1003
Query: 805 LTGKRPVDVLKPKMSRELVGWVLKMRSEGKQDQVFDPIL--RGKGFDEEMLQVLDVACMC 862
LTGK P D LVGWV K ++ K VFDP L + E+L+ L +AC C
Sbjct: 1004 LTGKPPTDSADFGEDNNLVGWV-KQHTKLKITDVFDPELLKEDPSVELELLEHLKIACAC 1062
Query: 863 VSQNPFKRPTVKEVVEWLNNVGANRRNENK 892
+ P +RPT+ +V+ + A ++K
Sbjct: 1063 LDDRPSRRPTMLKVMAMFKEIQAGSTVDSK 1092
|
|
| TAIR|locus:2020457 BRL1 "BRI1 like" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 905 (323.6 bits), Expect = 9.3e-91, P = 9.3e-91
Identities = 199/504 (39%), Positives = 295/504 (58%)
Query: 392 LANNSLSGNIPVEIGQLKSLHVLDLSNNNFSGTIPDELSDLSNLEKLDLSGNHLVGEIPI 451
++ N++SG IP G + L VL+L +N +GTIPD L + LDLS N+L G +P
Sbjct: 646 ISYNAVSGFIPPGYGNMGYLQVLNLGHNRITGTIPDSFGGLKAIGVLDLSHNNLQGYLPG 705
Query: 452 SLKGLHFLSSFSVAHNNLQGAVPSGGQFDTFPSFSFEGNPELCGSVVQRPCAISPGATHP 511
SL L FLS V++NNL G +P GGQ TFP + N LCG V RPC +P
Sbjct: 706 SLGSLSFLSDLDVSNNNLTGPIPFGGQLTTFPVSRYANNSGLCG-VPLRPCGSAPRRPIT 764
Query: 512 TAPHKRTNTKLVIGLVLGICFG-TGLIISMLALWILSKRRIIPGGDPDKIELDTISSTSN 570
+ H + T + ++ GI F ++ ++AL+ + K + IE S + +
Sbjct: 765 SRIHAKKQT-VATAVIAGIAFSFMCFVMLVMALYRVRKVQKKEQKREKYIESLPTSGSCS 823
Query: 571 FGVSPEADKDASLVMLFPNNTNEIKDLTIYELLKATDNFSQANIIGCGGFGLVYKATLAN 630
+ +S + + V F ++ LT LL+AT+ FS ++G GGFG VYKA L +
Sbjct: 824 WKLSSVPEPLSINVATFEK---PLRKLTFAHLLEATNGFSAETMVGSGGFGEVYKAQLRD 880
Query: 631 GTTLAIKKLSGDLGLMEREFKAEVEALSTAQHKNLVSLQGYCVHQGFRLLIYSYMENGSL 690
G+ +AIKKL G +REF AE+E + +H+NLV L GYC RLL+Y YM+ GSL
Sbjct: 881 GSVVAIKKLIRITGQGDREFMAEMETIGKIKHRNLVPLLGYCKVGEERLLVYEYMKWGSL 940
Query: 691 DYWLHEKAD--GASQLDWLTRLKIARGTSCGLAYMHQICEPHIVHRDIKSSNILLDDQFE 748
+ LHEK+ G L+W R KIA G + GLA++H C PHI+HRD+KSSN+LLD+ FE
Sbjct: 941 ETVLHEKSSKKGGIYLNWAARKKIAIGAARGLAFLHHSCIPHIIHRDMKSSNVLLDEDFE 1000
Query: 749 AHLADFGLSRLILPYQTHVTTE-LVGTLGYIPPEYGQAWVATLRGDMYSFGVVMLELLTG 807
A ++DFG++RL+ TH++ L GT GY+PPEY Q++ T +GD+YS+GV++LELL+G
Sbjct: 1001 ARVSDFGMARLVSALDTHLSVSTLAGTPGYVPPEYYQSFRCTAKGDVYSYGVILLELLSG 1060
Query: 808 KRPVDVLKPKMSRELVGWVLKMRSEGKQDQVFDP-ILRGKGFDEEMLQVLDVACMCVSQN 866
K+P+D + LVGW ++ E + ++ DP ++ K D E+ L +A C+
Sbjct: 1061 KKPIDPGEFGEDNNLVGWAKQLYREKRGAEILDPELVTDKSGDVELFHYLKIASQCLDDR 1120
Query: 867 PFKRPTVKEVVEWLNNVGANRRNE 890
PFKRPT+ +++ + A+ +
Sbjct: 1121 PFKRPTMIQLMAMFKEMKADTEED 1144
|
|
| TAIR|locus:2005498 BRI1 "BRASSINOSTEROID INSENSITIVE 1" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 893 (319.4 bits), Expect = 1.7e-89, P = 1.7e-89
Identities = 204/507 (40%), Positives = 297/507 (58%)
Query: 392 LANNSLSGNIPVEIGQLKSLHVLDLSNNNFSGTIPDELSDLSNLEKLDLSGNHLVGEIPI 451
++ N LSG IP EIG + L +L+L +N+ SG+IPDE+ DL L LDLS N L G IP
Sbjct: 661 MSYNMLSGYIPKEIGSMPYLFILNLGHNDISGSIPDEVGDLRGLNILDLSSNKLDGRIPQ 720
Query: 452 SLKGLHFLSSFSVAHNNLQGAVPSGGQFDTFPSFSFEGNPELCGSVVQRPCAIS--PGAT 509
++ L L+ +++NNL G +P GQF+TFP F NP LCG + R C S G
Sbjct: 721 AMSALTMLTEIDLSNNNLSGPIPEMGQFETFPPAKFLNNPGLCGYPLPR-CDPSNADGYA 779
Query: 510 HPTAPHKRTNTKLVIGLVLGICFGTGLIISMLALWI-LSKRRIIPGGDPDKIEL------ 562
H H R L + +G+ F I ++ + + KRR + +
Sbjct: 780 HHQRSHGRRPASLAGSVAMGLLFSFVCIFGLILVGREMRKRRRKKEAELEMYAEGHGNSG 839
Query: 563 DTISSTSNFGVSPEADKDASLVMLFPNNTNEIKDLTIYELLKATDNFSQANIIGCGGFGL 622
D ++ +N+ ++ K+A + L ++ LT +LL+AT+ F ++IG GGFG
Sbjct: 840 DRTANNTNWKLT--GVKEALSINLAAFE-KPLRKLTFADLLQATNGFHNDSLIGSGGFGD 896
Query: 623 VYKATLANGTTLAIKKLSGDLGLMEREFKAEVEALSTAQHKNLVSLQGYCVHQGFRLLIY 682
VYKA L +G+ +AIKKL G +REF AE+E + +H+NLV L GYC RLL+Y
Sbjct: 897 VYKAILKDGSAVAIKKLIHVSGQGDREFMAEMETIGKIKHRNLVPLLGYCKVGDERLLVY 956
Query: 683 SYMENGSLDYWLHEKADGASQLDWLTRLKIARGTSCGLAYMHQICEPHIVHRDIKSSNIL 742
+M+ GSL+ LH+ +L+W TR KIA G++ GLA++H C PHI+HRD+KSSN+L
Sbjct: 957 EFMKYGSLEDVLHDPKKAGVKLNWSTRRKIAIGSARGLAFLHHNCSPHIIHRDMKSSNVL 1016
Query: 743 LDDQFEAHLADFGLSRLILPYQTHVTTE-LVGTLGYIPPEYGQAWVATLRGDMYSFGVVM 801
LD+ EA ++DFG++RL+ TH++ L GT GY+PPEY Q++ + +GD+YS+GVV+
Sbjct: 1017 LDENLEARVSDFGMARLMSAMDTHLSVSTLAGTPGYVPPEYYQSFRCSTKGDVYSYGVVL 1076
Query: 802 LELLTGKRPVDVLKPKMS-RELVGWVLKMRSEGKQDQVFDPILRGK--GFDEEMLQVLDV 858
LELLTGKRP D P LVGWV K ++ + VFDP L + + E+LQ L V
Sbjct: 1077 LELLTGKRPTD--SPDFGDNNLVGWV-KQHAKLRISDVFDPELMKEDPALEIELLQHLKV 1133
Query: 859 ACMCVSQNPFKRPTVKEVVEWLNNVGA 885
A C+ ++RPT+ +V+ + A
Sbjct: 1134 AVACLDDRAWRRPTMVQVMAMFKEIQA 1160
|
|
| UNIPROTKB|Q8RZV7 P0413C03.22 "Putative extra sporogenous cells" [Oryza sativa Japonica Group (taxid:39947)] | Back alignment and assigned GO terms |
|---|
Score = 866 (309.9 bits), Expect = 4.5e-86, P = 4.5e-86
Identities = 213/532 (40%), Positives = 303/532 (56%)
Query: 365 ELPVFVMPSNA---TNQQYNQLSNLPPAIYLANNSLSGNIPVEIGQLK----SLHVLDLS 417
++ V + SNA T Q +N + ++NN LSG+I K +L + S
Sbjct: 748 KIAVLDLSSNALTGTLPQSLLCNNYLNHLDVSNNHLSGHIQFSCPDGKEYSSTLLFFNSS 807
Query: 418 NNNFSGTIPDELSDLSNLEKLDLSGNHLVGEIPISLKGLHFLSSFSVAHNNLQGAVPSGG 477
+N+FSG++ + +S+ + L LD+ N L G +P +L L L+ ++ NNL GA+P G
Sbjct: 808 SNHFSGSLDESISNFTQLSTLDIHNNSLTGRLPSALSDLSSLNYLDLSSNNLYGAIPCG- 866
Query: 478 QFDTFP-SFS-FEGNPELCGSVVQRPCAISPGATHPTAPHKRTNTKLVIGLVLGICFGTG 535
+ F SF+ F GN S+ CA + HK + + + IC T
Sbjct: 867 ICNIFGLSFANFSGNYIDMYSLAD--CAAGGICSTNGTDHKALHPYHRVRRAITICAFTF 924
Query: 536 LIISMLALWILSKRRIIPGGDPDKIELD-----TISSTSNFGVSPEADKDASLVMLFPNN 590
+II +L L + RR + P E T+ TS + + ++ + L
Sbjct: 925 VIIIVLVLLAVYLRRKLVRSRPLAFESASKAKATVEPTSTDELLGKKSREPLSINL-ATF 983
Query: 591 TNEIKDLTIYELLKATDNFSQANIIGCGGFGLVYKATLANGTTLAIKKLSGDLGLM-ERE 649
+ + +T ++LKAT+NFS+ +IIG GGFG VYKA L G +AIK+L G +RE
Sbjct: 984 EHALLRVTADDILKATENFSKVHIIGDGGFGTVYKAALPEGRRVAIKRLHGGHQFQGDRE 1043
Query: 650 FKAEVEALSTAQHKNLVSLQGYCVHQGFRLLIYSYMENGSLDYWLHEKADGASQLDWLTR 709
F AE+E + +H NLV L GYCV R LIY YMENGSL+ WL +AD L W R
Sbjct: 1044 FLAEMETIGKVKHPNLVPLLGYCVCGDERFLIYEYMENGSLEMWLRNRADALEALGWPDR 1103
Query: 710 LKIARGTSCGLAYMHQICEPHIVHRDIKSSNILLDDQFEAHLADFGLSRLILPYQTHVTT 769
LKI G++ GLA++H PHI+HRD+KSSNILLD+ FE ++DFGL+R+I +THV+T
Sbjct: 1104 LKICLGSARGLAFLHHGFVPHIIHRDMKSSNILLDENFEPRVSDFGLARIISACETHVST 1163
Query: 770 ELVGTLGYIPPEYGQAWVATLRGDMYSFGVVMLELLTGKRPVDVLKPKMSRELVGWVLKM 829
++ GT GYIPPEYG +T +GD+YSFGVVMLELLTG+ P + + LVGWV M
Sbjct: 1164 DIAGTFGYIPPEYGLTMKSTTKGDVYSFGVVMLELLTGRPPTGQEEVQGGGNLVGWVRWM 1223
Query: 830 RSEGKQDQVFDPILRGKG-FDEEMLQVLDVACMCVSQNPFKRPTVKEVVEWL 880
+ GKQ+++FDP L + E+M +VL +A C + PFKRPT+ EVV+ L
Sbjct: 1224 IARGKQNELFDPCLPVSSVWREQMARVLAIARDCTADEPFKRPTMLEVVKGL 1275
|
|
Prediction of Enzyme Commission (EC) Number
EC Number Prediction by Annotation Transfer from SWISS-PROT Entries
Original result of BLAST against SWISS-PROT
No confident hit for EC number transfering in SWISSPROT detected by BLAST
EC Number Prediction by Ezypred Server
Original result from Ezypred Server
Fail to connect to Ezypred Server
EC Number Prediction by EFICAz Software
| Prediction Level | EC number | Confidence of Prediction |
| 4th Layer | 2.7.11.1 | 0.824 |
| 3rd Layer | 2.7.11 | 0.766 |
Prediction of Functionally Associated Proteins
Functionally Associated Proteins Detected by STRING
Original result from the STRING server
| Your Input: |  |
 |
 |
 |
 |
 |
 |
 |
 |
||
 | grail3.0029001901 | hypothetical protein (1092 aa) | |||||||||
(Populus trichocarpa) | |||||||||||
Predicted Functional Partners: | |||||||||||
| Sorry, there are no predicted associations at the current settings. | |||||||||||
Conserved Domains and Related Protein Families
Conserved Domains Detected by RPS-BLAST
Original result of RPS-BLAST against CDD database part I
| ID | Alignment Graph | Length |
Definition |
E-value |
| Query | 894 | |||
| pfam09353 | 205 | pfam09353, DUF1995, Domain of unknown function (DU | 8e-55 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 9e-49 | |
| smart00220 | 254 | smart00220, S_TKc, Serine/Threonine protein kinase | 1e-45 | |
| pfam00069 | 260 | pfam00069, Pkinase, Protein kinase domain | 8e-45 | |
| cd00180 | 215 | cd00180, PKc, Catalytic domain of Protein Kinases | 3e-43 | |
| pfam07714 | 258 | pfam07714, Pkinase_Tyr, Protein tyrosine kinase | 9e-39 | |
| smart00219 | 257 | smart00219, TyrKc, Tyrosine kinase, catalytic doma | 6e-37 | |
| smart00221 | 258 | smart00221, STYKc, Protein kinase; unclassified sp | 2e-35 | |
| cd00192 | 262 | cd00192, PTKc, Catalytic domain of Protein Tyrosin | 3e-35 | |
| cd06606 | 260 | cd06606, STKc_MAPKKK, Catalytic domain of the Prot | 8e-32 | |
| cd08215 | 258 | cd08215, STKc_Nek, Catalytic domain of the Protein | 1e-29 | |
| cd06623 | 264 | cd06623, PKc_MAPKK_plant_like, Catalytic domain of | 3e-29 | |
| COG0515 | 384 | COG0515, SPS1, Serine/threonine protein kinase [Ge | 6e-28 | |
| cd07840 | 287 | cd07840, STKc_CDK9_like, Catalytic domain of Cycli | 9e-28 | |
| cd05122 | 253 | cd05122, PKc_STE, Catalytic domain of STE family P | 2e-27 | |
| cd06627 | 254 | cd06627, STKc_Cdc7_like, Catalytic domain of Cell | 1e-25 | |
| cd05039 | 256 | cd05039, PTKc_Csk_like, Catalytic domain of C-term | 2e-25 | |
| cd05033 | 266 | cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec | 3e-25 | |
| cd05049 | 280 | cd05049, PTKc_Trk, Catalytic domain of the Protein | 2e-24 | |
| cd07829 | 282 | cd07829, STKc_CDK_like, Catalytic domain of Cyclin | 1e-23 | |
| cd05578 | 258 | cd05578, STKc_Yank1, Catalytic domain of the Prote | 1e-23 | |
| cd08529 | 256 | cd08529, STKc_FA2-like, Catalytic domain of the Pr | 4e-23 | |
| cd06605 | 265 | cd06605, PKc_MAPKK, Catalytic domain of the dual-s | 4e-23 | |
| cd05123 | 250 | cd05123, STKc_AGC, Catalytic domain of AGC family | 5e-23 | |
| cd05059 | 256 | cd05059, PTKc_Tec_like, Catalytic domain of Tec-li | 6e-23 | |
| cd05112 | 256 | cd05112, PTKc_Itk, Catalytic domain of the Protein | 6e-23 | |
| cd06626 | 264 | cd06626, STKc_MEKK4, Catalytic domain of the Prote | 9e-23 | |
| cd05063 | 268 | cd05063, PTKc_EphR_A2, Catalytic domain of the Pro | 2e-22 | |
| cd06610 | 267 | cd06610, STKc_OSR1_SPAK, Catalytic domain of the P | 2e-21 | |
| PLN00034 | 353 | PLN00034, PLN00034, mitogen-activated protein kina | 5e-21 | |
| cd05038 | 284 | cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai | 1e-20 | |
| cd05048 | 283 | cd05048, PTKc_Ror, Catalytic Domain of the Protein | 3e-20 | |
| cd05148 | 261 | cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro | 3e-20 | |
| cd07845 | 309 | cd07845, STKc_CDK10, Catalytic domain of the Serin | 4e-20 | |
| cd05034 | 261 | cd05034, PTKc_Src_like, Catalytic domain of Src ki | 1e-19 | |
| cd06632 | 258 | cd06632, STKc_MEKK1_plant, Catalytic domain of the | 1e-19 | |
| cd05065 | 269 | cd05065, PTKc_EphR_B, Catalytic domain of the Prot | 1e-19 | |
| cd06621 | 287 | cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of | 2e-19 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 5e-19 | |
| cd06612 | 256 | cd06612, STKc_MST1_2, Catalytic domain of the Prot | 7e-19 | |
| cd05092 | 280 | cd05092, PTKc_TrkA, Catalytic domain of the Protei | 8e-19 | |
| cd05068 | 261 | cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re | 8e-19 | |
| cd05067 | 260 | cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro | 1e-18 | |
| cd08217 | 265 | cd08217, STKc_Nek2, Catalytic domain of the Protei | 1e-18 | |
| cd05066 | 267 | cd05066, PTKc_EphR_A, Catalytic domain of the Prot | 2e-18 | |
| cd07832 | 286 | cd07832, STKc_CCRK, Catalytic domain of the Serine | 5e-18 | |
| cd05094 | 291 | cd05094, PTKc_TrkC, Catalytic domain of the Protei | 5e-18 | |
| cd07834 | 330 | cd07834, STKc_MAPK, Catalytic domain of the Serine | 7e-18 | |
| cd06614 | 286 | cd06614, STKc_PAK, Catalytic domain of the Protein | 7e-18 | |
| cd05050 | 288 | cd05050, PTKc_Musk, Catalytic domain of the Protei | 7e-18 | |
| cd06620 | 284 | cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of | 9e-18 | |
| cd05093 | 288 | cd05093, PTKc_TrkB, Catalytic domain of the Protei | 1e-17 | |
| cd05052 | 263 | cd05052, PTKc_Abl, Catalytic domain of the Protein | 1e-17 | |
| cd06613 | 262 | cd06613, STKc_MAP4K3_like, Catalytic domain of Mit | 2e-17 | |
| cd05032 | 277 | cd05032, PTKc_InsR_like, Catalytic domain of Insul | 2e-17 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 3e-17 | |
| cd06630 | 268 | cd06630, STKc_MEKK1, Catalytic domain of the Prote | 3e-17 | |
| cd06625 | 263 | cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ | 3e-17 | |
| cd05114 | 256 | cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro | 3e-17 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 4e-17 | |
| cd05045 | 290 | cd05045, PTKc_RET, Catalytic domain of the Protein | 4e-17 | |
| cd05072 | 261 | cd05072, PTKc_Lyn, Catalytic domain of the Protein | 4e-17 | |
| cd07830 | 283 | cd07830, STKc_MAK_like, Catalytic domain of Male g | 5e-17 | |
| cd08220 | 256 | cd08220, STKc_Nek8, Catalytic domain of the Protei | 6e-17 | |
| cd05113 | 256 | cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro | 1e-16 | |
| cd05057 | 279 | cd05057, PTKc_EGFR_like, Catalytic domain of Epide | 1e-16 | |
| cd05041 | 251 | cd05041, PTKc_Fes_like, Catalytic domain of Fes-li | 1e-16 | |
| cd05080 | 283 | cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma | 1e-16 | |
| cd05071 | 262 | cd05071, PTKc_Src, Catalytic domain of the Protein | 2e-16 | |
| cd05060 | 257 | cd05060, PTKc_Syk_like, Catalytic domain of Spleen | 2e-16 | |
| cd08530 | 256 | cd08530, STKc_CNK2-like, Catalytic domain of the P | 2e-16 | |
| cd05118 | 283 | cd05118, STKc_CMGC, Catalytic domain of CMGC famil | 3e-16 | |
| cd07833 | 288 | cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep | 3e-16 | |
| cd05058 | 262 | cd05058, PTKc_Met_Ron, Catalytic domain of the Pro | 3e-16 | |
| cd06629 | 272 | cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o | 3e-16 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 5e-16 | |
| cd07843 | 293 | cd07843, STKc_CDC2L1, Catalytic domain of the Seri | 6e-16 | |
| cd07841 | 298 | cd07841, STKc_CDK7, Catalytic domain of the Serine | 6e-16 | |
| cd05581 | 280 | cd05581, STKc_PDK1, Catalytic domain of the Protei | 6e-16 | |
| cd05577 | 277 | cd05577, STKc_GRK, Catalytic domain of the Protein | 8e-16 | |
| cd05630 | 285 | cd05630, STKc_GRK6, Catalytic domain of the Protei | 9e-16 | |
| cd07835 | 283 | cd07835, STKc_CDK1_like, Catalytic domain of Cycli | 1e-15 | |
| cd05070 | 260 | cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro | 1e-15 | |
| cd06609 | 274 | cd06609, STKc_MST3_like, Catalytic domain of Mamma | 3e-15 | |
| cd05073 | 260 | cd05073, PTKc_Hck, Catalytic domain of the Protein | 3e-15 | |
| cd08221 | 256 | cd08221, STKc_Nek9, Catalytic domain of the Protei | 3e-15 | |
| cd05053 | 293 | cd05053, PTKc_FGFR, Catalytic domain of the Protei | 3e-15 | |
| cd07864 | 302 | cd07864, STKc_CDK12, Catalytic domain of the Serin | 6e-15 | |
| cd05036 | 277 | cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro | 7e-15 | |
| cd05042 | 269 | cd05042, PTKc_Aatyk, Catalytic domain of the Prote | 7e-15 | |
| cd05081 | 284 | cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) | 7e-15 | |
| cd05579 | 265 | cd05579, STKc_MAST_like, Catalytic domain of Micro | 8e-15 | |
| cd06631 | 265 | cd06631, STKc_YSK4, Catalytic domain of the Protei | 8e-15 | |
| cd05069 | 260 | cd05069, PTKc_Yes, Catalytic domain of the Protein | 8e-15 | |
| cd05572 | 262 | cd05572, STKc_cGK_PKG, Catalytic domain of the Pro | 9e-15 | |
| cd07838 | 287 | cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc | 1e-14 | |
| cd06624 | 268 | cd06624, STKc_ASK, Catalytic domain of the Protein | 1e-14 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 2e-14 | |
| cd06628 | 267 | cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o | 2e-14 | |
| cd06608 | 275 | cd06608, STKc_myosinIII_like, Catalytic domain of | 2e-14 | |
| cd05611 | 260 | cd05611, STKc_Rim15_like, Catalytic domain of fung | 4e-14 | |
| cd07866 | 311 | cd07866, STKc_BUR1, Catalytic domain of the Serine | 5e-14 | |
| cd06615 | 308 | cd06615, PKc_MEK, Catalytic domain of the dual-spe | 6e-14 | |
| cd05088 | 303 | cd05088, PTKc_Tie2, Catalytic domain of the Protei | 7e-14 | |
| cd07865 | 310 | cd07865, STKc_CDK9, Catalytic domain of the Serine | 7e-14 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 8e-14 | |
| cd08225 | 257 | cd08225, STKc_Nek5, Catalytic domain of the Protei | 8e-14 | |
| cd05089 | 297 | cd05089, PTKc_Tie1, Catalytic domain of the Protei | 9e-14 | |
| cd05631 | 285 | cd05631, STKc_GRK4, Catalytic domain of the Protei | 1e-13 | |
| PTZ00024 | 335 | PTZ00024, PTZ00024, cyclin-dependent protein kinas | 1e-13 | |
| cd05083 | 254 | cd05083, PTKc_Chk, Catalytic domain of the Protein | 1e-13 | |
| cd05035 | 273 | cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li | 1e-13 | |
| cd07856 | 328 | cd07856, STKc_Sty1_Hog1, Catalytic domain of the S | 2e-13 | |
| cd05619 | 316 | cd05619, STKc_nPKC_theta, Catalytic domain of the | 2e-13 | |
| cd05110 | 303 | cd05110, PTKc_HER4, Catalytic domain of the Protei | 2e-13 | |
| cd05097 | 295 | cd05097, PTKc_DDR_like, Catalytic domain of Discoi | 2e-13 | |
| cd08218 | 256 | cd08218, STKc_Nek1, Catalytic domain of the Protei | 2e-13 | |
| cd06607 | 307 | cd06607, STKc_TAO, Catalytic domain of the Protein | 2e-13 | |
| cd06642 | 277 | cd06642, STKc_STK25-YSK1, Catalytic domain of the | 3e-13 | |
| cd05044 | 269 | cd05044, PTKc_c-ros, Catalytic domain of the Prote | 3e-13 | |
| cd05607 | 277 | cd05607, STKc_GRK7, Catalytic domain of the Protei | 3e-13 | |
| cd05620 | 316 | cd05620, STKc_nPKC_delta, Catalytic domain of the | 3e-13 | |
| cd06653 | 264 | cd06653, STKc_MEKK3_like_1, Catalytic domain of MA | 3e-13 | |
| cd06619 | 279 | cd06619, PKc_MKK5, Catalytic domain of the dual-sp | 4e-13 | |
| cd05055 | 302 | cd05055, PTKc_PDGFR, Catalytic domain of the Prote | 4e-13 | |
| cd08229 | 267 | cd08229, STKc_Nek7, Catalytic domain of the Protei | 4e-13 | |
| cd05632 | 285 | cd05632, STKc_GRK5, Catalytic domain of the Protei | 4e-13 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 5e-13 | |
| cd05605 | 285 | cd05605, STKc_GRK4_like, Catalytic domain of G pro | 5e-13 | |
| cd05082 | 256 | cd05082, PTKc_Csk, Catalytic domain of the Protein | 7e-13 | |
| cd06636 | 282 | cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr | 8e-13 | |
| cd05040 | 257 | cd05040, PTKc_Ack_like, Catalytic domain of the Pr | 9e-13 | |
| cd06917 | 277 | cd06917, STKc_NAK1_like, Catalytic domain of Funga | 1e-12 | |
| cd06649 | 331 | cd06649, PKc_MEK2, Catalytic domain of the dual-sp | 1e-12 | |
| cd05592 | 316 | cd05592, STKc_nPKC_theta_delta, Catalytic domain o | 1e-12 | |
| cd07860 | 284 | cd07860, STKc_CDK2_3, Catalytic domain of the Seri | 1e-12 | |
| cd06640 | 277 | cd06640, STKc_MST4, Catalytic domain of the Protei | 1e-12 | |
| cd07847 | 286 | cd07847, STKc_CDKL1_4, Catalytic domain of the Ser | 1e-12 | |
| cd06650 | 333 | cd06650, PKc_MEK1, Catalytic domain of the dual-sp | 2e-12 | |
| cd05046 | 275 | cd05046, PTK_CCK4, Pseudokinase domain of the Prot | 2e-12 | |
| cd07861 | 285 | cd07861, STKc_CDK1_euk, Catalytic domain of the Se | 2e-12 | |
| cd06633 | 313 | cd06633, STKc_TAO3, Catalytic domain of the Protei | 2e-12 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 3e-12 | |
| cd05570 | 318 | cd05570, STKc_PKC, Catalytic domain of the Protein | 3e-12 | |
| cd05108 | 316 | cd05108, PTKc_EGFR, Catalytic domain of the Protei | 3e-12 | |
| cd05051 | 296 | cd05051, PTKc_DDR, Catalytic domain of the Protein | 3e-12 | |
| PTZ00283 | 496 | PTZ00283, PTZ00283, serine/threonine protein kinas | 3e-12 | |
| cd06635 | 317 | cd06635, STKc_TAO1, Catalytic domain of the Protei | 4e-12 | |
| cd07842 | 316 | cd07842, STKc_CDK8_like, Catalytic domain of Cycli | 4e-12 | |
| cd06611 | 280 | cd06611, STKc_SLK_like, Catalytic domain of Ste20- | 4e-12 | |
| cd05085 | 250 | cd05085, PTKc_Fer, Catalytic domain of the Protein | 5e-12 | |
| cd05606 | 278 | cd05606, STKc_beta_ARK, Catalytic domain of the Pr | 6e-12 | |
| cd06651 | 266 | cd06651, STKc_MEKK3, Catalytic domain of the Prote | 6e-12 | |
| cd05096 | 304 | cd05096, PTKc_DDR1, Catalytic domain of the Protei | 7e-12 | |
| cd05056 | 270 | cd05056, PTKc_FAK, Catalytic domain of the Protein | 7e-12 | |
| cd05047 | 270 | cd05047, PTKc_Tie, Catalytic domain of Tie Protein | 7e-12 | |
| cd06637 | 272 | cd06637, STKc_TNIK, Catalytic domain of the Protei | 8e-12 | |
| cd05062 | 277 | cd05062, PTKc_IGF-1R, Catalytic domain of the Prot | 1e-11 | |
| cd05583 | 288 | cd05583, STKc_MSK_N, N-terminal catalytic domain o | 1e-11 | |
| cd07851 | 343 | cd07851, STKc_p38, Catalytic domain of the Serine/ | 1e-11 | |
| cd06639 | 291 | cd06639, STKc_myosinIIIB, Catalytic domain of the | 1e-11 | |
| cd06645 | 267 | cd06645, STKc_MAP4K3, Catalytic domain of the Prot | 1e-11 | |
| cd05061 | 288 | cd05061, PTKc_InsR, Catalytic domain of the Protei | 1e-11 | |
| cd06622 | 286 | cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of | 1e-11 | |
| PLN00009 | 294 | PLN00009, PLN00009, cyclin-dependent kinase A; Pro | 2e-11 | |
| cd08224 | 267 | cd08224, STKc_Nek6_Nek7, Catalytic domain of the P | 2e-11 | |
| cd06655 | 296 | cd06655, STKc_PAK2, Catalytic domain of the Protei | 2e-11 | |
| cd06647 | 293 | cd06647, STKc_PAK_I, Catalytic domain of the Prote | 2e-11 | |
| cd06616 | 288 | cd06616, PKc_MKK4, Catalytic domain of the dual-sp | 3e-11 | |
| cd05633 | 279 | cd05633, STKc_GRK3, Catalytic domain of the Protei | 3e-11 | |
| cd07852 | 337 | cd07852, STKc_MAPK15, Catalytic domain of the Seri | 3e-11 | |
| cd07869 | 303 | cd07869, STKc_PFTAIRE1, Catalytic domain of the Se | 3e-11 | |
| cd07879 | 342 | cd07879, STKc_p38delta_MAPK13, Catalytic domain of | 3e-11 | |
| cd08219 | 255 | cd08219, STKc_Nek3, Catalytic domain of the Protei | 3e-11 | |
| cd06641 | 277 | cd06641, STKc_MST3, Catalytic domain of the Protei | 4e-11 | |
| cd08223 | 257 | cd08223, STKc_Nek4, Catalytic domain of the Protei | 5e-11 | |
| cd05601 | 330 | cd05601, STKc_CRIK, Catalytic domain of the Protei | 5e-11 | |
| cd05079 | 284 | cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma | 6e-11 | |
| cd06634 | 308 | cd06634, STKc_TAO2, Catalytic domain of the Protei | 7e-11 | |
| cd06617 | 283 | cd06617, PKc_MKK3_6, Catalytic domain of the dual- | 7e-11 | |
| cd07844 | 291 | cd07844, STKc_PCTAIRE_like, Catalytic domain of PC | 9e-11 | |
| cd06654 | 296 | cd06654, STKc_PAK1, Catalytic domain of the Protei | 1e-10 | |
| cd07855 | 334 | cd07855, STKc_ERK5, Catalytic domain of the Serine | 1e-10 | |
| cd05624 | 331 | cd05624, STKc_MRCK_beta, Catalytic domain of the P | 1e-10 | |
| TIGR03903 | 1266 | TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas | 1e-10 | |
| cd06656 | 297 | cd06656, STKc_PAK3, Catalytic domain of the Protei | 1e-10 | |
| cd05623 | 332 | cd05623, STKc_MRCK_alpha, Catalytic domain of the | 1e-10 | |
| cd06644 | 292 | cd06644, STKc_STK10_LOK, Catalytic domain of the P | 1e-10 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 2e-10 | |
| cd07871 | 288 | cd07871, STKc_PCTAIRE3, Catalytic domain of the Se | 2e-10 | |
| cd07849 | 336 | cd07849, STKc_ERK1_2_like, Catalytic domain of Ext | 2e-10 | |
| cd05095 | 296 | cd05095, PTKc_DDR2, Catalytic domain of the Protei | 2e-10 | |
| cd05090 | 283 | cd05090, PTKc_Ror1, Catalytic domain of the Protei | 2e-10 | |
| cd05087 | 269 | cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of t | 3e-10 | |
| cd05582 | 318 | cd05582, STKc_RSK_N, N-terminal catalytic domain o | 3e-10 | |
| cd05573 | 350 | cd05573, STKc_ROCK_NDR_like, Catalytic domain of R | 3e-10 | |
| cd05580 | 290 | cd05580, STKc_PKA, Catalytic domain of the Protein | 3e-10 | |
| cd05613 | 290 | cd05613, STKc_MSK1_N, N-terminal catalytic domain | 3e-10 | |
| cd05614 | 332 | cd05614, STKc_MSK2_N, N-terminal catalytic domain | 4e-10 | |
| cd07831 | 282 | cd07831, STKc_MOK, Catalytic domain of the Serine/ | 4e-10 | |
| cd05612 | 291 | cd05612, STKc_PRKX_like, Catalytic domain of PRKX- | 4e-10 | |
| cd05074 | 273 | cd05074, PTKc_Tyro3, Catalytic domain of the Prote | 4e-10 | |
| cd08222 | 260 | cd08222, STKc_Nek11, Catalytic domain of the Prote | 5e-10 | |
| cd07839 | 284 | cd07839, STKc_CDK5, Catalytic domain of the Serine | 5e-10 | |
| cd05597 | 331 | cd05597, STKc_DMPK_like, Catalytic domain of Myoto | 6e-10 | |
| cd07836 | 284 | cd07836, STKc_Pho85, Catalytic domain of the Serin | 7e-10 | |
| cd07846 | 286 | cd07846, STKc_CDKL2_3, Catalytic domain of the Ser | 7e-10 | |
| cd06646 | 267 | cd06646, STKc_MAP4K5, Catalytic domain of the Prot | 8e-10 | |
| cd06652 | 265 | cd06652, STKc_MEKK2, Catalytic domain of the Prote | 8e-10 | |
| cd07870 | 291 | cd07870, STKc_PFTAIRE2, Catalytic domain of the Se | 8e-10 | |
| cd05037 | 259 | cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) dom | 9e-10 | |
| cd05608 | 280 | cd05608, STKc_GRK1, Catalytic domain of the Protei | 9e-10 | |
| cd07863 | 288 | cd07863, STKc_CDK4, Catalytic domain of the Serine | 1e-09 | |
| cd08228 | 267 | cd08228, STKc_Nek6, Catalytic domain of the Protei | 1e-09 | |
| cd05086 | 268 | cd05086, PTKc_Aatyk2, Catalytic domain of the Prot | 1e-09 | |
| cd05115 | 257 | cd05115, PTKc_Zap-70, Catalytic domain of the Prot | 2e-09 | |
| cd07853 | 372 | cd07853, STKc_NLK, Catalytic domain of the Serine/ | 2e-09 | |
| cd05101 | 304 | cd05101, PTKc_FGFR2, Catalytic domain of the Prote | 2e-09 | |
| cd07873 | 301 | cd07873, STKc_PCTAIRE1, Catalytic domain of the Se | 2e-09 | |
| cd05591 | 321 | cd05591, STKc_nPKC_epsilon, Catalytic domain of th | 2e-09 | |
| cd08528 | 269 | cd08528, STKc_Nek10, Catalytic domain of the Prote | 2e-09 | |
| cd05084 | 252 | cd05084, PTKc_Fes, Catalytic domain of the Protein | 3e-09 | |
| cd05584 | 323 | cd05584, STKc_p70S6K, Catalytic domain of the Prot | 3e-09 | |
| cd05590 | 320 | cd05590, STKc_nPKC_eta, Catalytic domain of the Pr | 4e-09 | |
| cd05604 | 325 | cd05604, STKc_SGK3, Catalytic domain of the Protei | 5e-09 | |
| cd05043 | 280 | cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece | 5e-09 | |
| PTZ00267 | 478 | PTZ00267, PTZ00267, NIMA-related protein kinase; P | 5e-09 | |
| cd05098 | 307 | cd05098, PTKc_FGFR1, Catalytic domain of the Prote | 6e-09 | |
| cd06618 | 296 | cd06618, PKc_MKK7, Catalytic domain of the dual-sp | 7e-09 | |
| cd05091 | 283 | cd05091, PTKc_Ror2, Catalytic domain of the Protei | 7e-09 | |
| cd05111 | 279 | cd05111, PTK_HER3, Pseudokinase domain of the Prot | 8e-09 | |
| cd05064 | 266 | cd05064, PTKc_EphR_A10, Catalytic domain of the Pr | 8e-09 | |
| cd06657 | 292 | cd06657, STKc_PAK4, Catalytic domain of the Protei | 9e-09 | |
| cd06643 | 282 | cd06643, STKc_SLK, Catalytic domain of the Protein | 9e-09 | |
| cd05609 | 305 | cd05609, STKc_MAST, Catalytic domain of the Protei | 9e-09 | |
| cd07872 | 309 | cd07872, STKc_PCTAIRE2, Catalytic domain of the Se | 9e-09 | |
| cd05600 | 333 | cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun | 9e-09 | |
| cd06648 | 285 | cd06648, STKc_PAK_II, Catalytic domain of the Prot | 1e-08 | |
| PHA03390 | 267 | PHA03390, pk1, serine/threonine-protein kinase 1; | 1e-08 | |
| cd05618 | 329 | cd05618, STKc_aPKC_iota, Catalytic domain of the P | 2e-08 | |
| cd05588 | 329 | cd05588, STKc_aPKC, Catalytic domain of the Protei | 2e-08 | |
| cd05109 | 279 | cd05109, PTKc_HER2, Catalytic domain of the Protei | 2e-08 | |
| cd05575 | 323 | cd05575, STKc_SGK, Catalytic domain of the Protein | 3e-08 | |
| cd07848 | 287 | cd07848, STKc_CDKL5, Catalytic domain of the Serin | 3e-08 | |
| cd05100 | 334 | cd05100, PTKc_FGFR3, Catalytic domain of the Prote | 3e-08 | |
| cd05116 | 257 | cd05116, PTKc_Syk, Catalytic domain of the Protein | 3e-08 | |
| cd05617 | 327 | cd05617, STKc_aPKC_zeta, Catalytic domain of the P | 3e-08 | |
| cd05602 | 325 | cd05602, STKc_SGK1, Catalytic domain of the Protei | 4e-08 | |
| cd07880 | 343 | cd07880, STKc_p38gamma_MAPK12, Catalytic domain of | 5e-08 | |
| cd05585 | 312 | cd05585, STKc_YPK1_like, Catalytic domain of Yeast | 6e-08 | |
| PHA03210 | 501 | PHA03210, PHA03210, serine/threonine kinase US3; P | 7e-08 | |
| pfam13855 | 60 | pfam13855, LRR_8, Leucine rich repeat | 8e-08 | |
| cd05078 | 258 | cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat | 8e-08 | |
| cd05615 | 323 | cd05615, STKc_cPKC_alpha, Catalytic domain of the | 8e-08 | |
| cd07857 | 332 | cd07857, STKc_MPK1, Catalytic domain of the Serine | 8e-08 | |
| cd05571 | 323 | cd05571, STKc_PKB, Catalytic domain of the Protein | 1e-07 | |
| cd05603 | 321 | cd05603, STKc_SGK2, Catalytic domain of the Protei | 1e-07 | |
| PRK13184 | 932 | PRK13184, pknD, serine/threonine-protein kinase; R | 1e-07 | |
| cd05599 | 364 | cd05599, STKc_NDR_like, Catalytic domain of Nuclea | 1e-07 | |
| cd07877 | 345 | cd07877, STKc_p38alpha_MAPK14, Catalytic domain of | 1e-07 | |
| pfam13855 | 60 | pfam13855, LRR_8, Leucine rich repeat | 2e-07 | |
| cd06659 | 297 | cd06659, STKc_PAK6, Catalytic domain of the Protei | 2e-07 | |
| cd05587 | 324 | cd05587, STKc_cPKC, Catalytic domain of the Protei | 2e-07 | |
| cd05075 | 272 | cd05075, PTKc_Axl, Catalytic domain of the Protein | 2e-07 | |
| COG4886 | 394 | COG4886, COG4886, Leucine-rich repeat (LRR) protei | 2e-07 | |
| cd05596 | 370 | cd05596, STKc_ROCK, Catalytic domain of the Protei | 2e-07 | |
| cd05099 | 314 | cd05099, PTKc_FGFR4, Catalytic domain of the Prote | 3e-07 | |
| cd05586 | 330 | cd05586, STKc_Sck1_like, Catalytic domain of Suppr | 3e-07 | |
| cd06638 | 286 | cd06638, STKc_myosinIIIA, Catalytic domain of the | 3e-07 | |
| cd07837 | 295 | cd07837, STKc_CdkB_plant, Catalytic domain of the | 4e-07 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 5e-07 | |
| cd05589 | 324 | cd05589, STKc_PKN, Catalytic domain of the Protein | 5e-07 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 7e-07 | |
| PHA02988 | 283 | PHA02988, PHA02988, hypothetical protein; Provisio | 7e-07 | |
| cd06658 | 292 | cd06658, STKc_PAK5, Catalytic domain of the Protei | 7e-07 | |
| cd05616 | 323 | cd05616, STKc_cPKC_beta, Catalytic domain of the P | 9e-07 | |
| PTZ00426 | 340 | PTZ00426, PTZ00426, cAMP-dependent protein kinase | 1e-06 | |
| cd05077 | 262 | cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) do | 2e-06 | |
| cd07878 | 343 | cd07878, STKc_p38beta_MAPK11, Catalytic domain of | 2e-06 | |
| cd05593 | 328 | cd05593, STKc_PKB_gamma, Catalytic domain of the P | 2e-06 | |
| cd07854 | 342 | cd07854, STKc_MAPK4_6, Catalytic domain of the Ser | 2e-06 | |
| PTZ00036 | 440 | PTZ00036, PTZ00036, glycogen synthase kinase; Prov | 3e-06 | |
| cd08216 | 314 | cd08216, PK_STRAD, Pseudokinase domain of STE20-re | 4e-06 | |
| COG4886 | 394 | COG4886, COG4886, Leucine-rich repeat (LRR) protei | 5e-06 | |
| cd05103 | 343 | cd05103, PTKc_VEGFR2, Catalytic domain of the Prot | 5e-06 | |
| cd05120 | 155 | cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphot | 6e-06 | |
| cd05106 | 374 | cd05106, PTKc_CSF-1R, Catalytic domain of the Prot | 6e-06 | |
| cd05627 | 360 | cd05627, STKc_NDR2, Catalytic domain of the Protei | 6e-06 | |
| cd07862 | 290 | cd07862, STKc_CDK6, Catalytic domain of the Serine | 7e-06 | |
| PHA03209 | 357 | PHA03209, PHA03209, serine/threonine kinase US3; P | 8e-06 | |
| cd07868 | 317 | cd07868, STKc_CDK8, Catalytic domain of the Serine | 8e-06 | |
| PHA03207 | 392 | PHA03207, PHA03207, serine/threonine kinase US3; P | 1e-05 | |
| PTZ00263 | 329 | PTZ00263, PTZ00263, protein kinase A catalytic sub | 1e-05 | |
| cd05594 | 325 | cd05594, STKc_PKB_alpha, Catalytic domain of the P | 1e-05 | |
| cd07858 | 337 | cd07858, STKc_TEY_MAPK_plant, Catalytic domain of | 1e-05 | |
| cd07876 | 359 | cd07876, STKc_JNK2, Catalytic domain of the Serine | 2e-05 | |
| cd05102 | 338 | cd05102, PTKc_VEGFR3, Catalytic domain of the Prot | 2e-05 | |
| cd07859 | 338 | cd07859, STKc_TDY_MAPK_plant, Catalytic domain of | 2e-05 | |
| cd05598 | 376 | cd05598, STKc_LATS, Catalytic domain of the Protei | 2e-05 | |
| cd05054 | 337 | cd05054, PTKc_VEGFR, Catalytic domain of the Prote | 3e-05 | |
| cd05595 | 323 | cd05595, STKc_PKB_beta, Catalytic domain of the Pr | 3e-05 | |
| cd05629 | 377 | cd05629, STKc_NDR_like_fungal, Catalytic domain of | 3e-05 | |
| pfam12799 | 43 | pfam12799, LRR_4, Leucine Rich repeats (2 copies) | 3e-05 | |
| cd05610 | 669 | cd05610, STKc_MASTL, Catalytic domain of the Prote | 5e-05 | |
| cd05076 | 274 | cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) do | 6e-05 | |
| cd05625 | 382 | cd05625, STKc_LATS1, Catalytic domain of the Prote | 9e-05 | |
| cd05621 | 370 | cd05621, STKc_ROCK2, Catalytic domain of the Prote | 1e-04 | |
| cd05628 | 363 | cd05628, STKc_NDR1, Catalytic domain of the Protei | 1e-04 | |
| cd07874 | 355 | cd07874, STKc_JNK3, Catalytic domain of the Serine | 1e-04 | |
| cd05622 | 371 | cd05622, STKc_ROCK1, Catalytic domain of the Prote | 1e-04 | |
| cd05576 | 237 | cd05576, STKc_RPK118_like, Catalytic domain of the | 1e-04 | |
| cd07867 | 317 | cd07867, STKc_CDC2L6, Catalytic domain of Serine/T | 1e-04 | |
| cd05104 | 375 | cd05104, PTKc_Kit, Catalytic domain of the Protein | 2e-04 | |
| cd07875 | 364 | cd07875, STKc_JNK1, Catalytic domain of the Serine | 3e-04 | |
| PHA02882 | 294 | PHA02882, PHA02882, putative serine/threonine kina | 3e-04 | |
| PHA03212 | 391 | PHA03212, PHA03212, serine/threonine kinase US3; P | 3e-04 | |
| PTZ00266 | 1021 | PTZ00266, PTZ00266, NIMA-related protein kinase; P | 4e-04 | |
| cd05104 | 375 | cd05104, PTKc_Kit, Catalytic domain of the Protein | 6e-04 | |
| cd07850 | 353 | cd07850, STKc_JNK, Catalytic domain of the Serine/ | 6e-04 | |
| COG4886 | 394 | COG4886, COG4886, Leucine-rich repeat (LRR) protei | 8e-04 | |
| cd05106 | 374 | cd05106, PTKc_CSF-1R, Catalytic domain of the Prot | 0.001 | |
| pfam12799 | 43 | pfam12799, LRR_4, Leucine Rich repeats (2 copies) | 0.001 | |
| cd05626 | 381 | cd05626, STKc_LATS2, Catalytic domain of the Prote | 0.002 | |
| PTZ00284 | 467 | PTZ00284, PTZ00284, protein kinase; Provisional | 0.004 |
| >gnl|CDD|220198 pfam09353, DUF1995, Domain of unknown function (DUF1995) | Back alignment and domain information |
|---|
Score = 188 bits (479), Expect = 8e-55
Identities = 88/223 (39%), Positives = 117/223 (52%), Gaps = 23/223 (10%)
Query: 98 LPSDLEGAVRQSSQASSLFVSAGGMRAIVELLIPQLQFLDDEGAQAELWELSRLFVDTLI 157
LP+DLE A Q+ +A + G R VEL P L+ L L+ L
Sbjct: 1 LPADLEEAEEQAKEALLAALKDGKTRLQVELRFPGLK----------LMPLALRLARALA 50
Query: 158 EETGSQRVKAIFPDAGAAALLKYRWKDAAFGFSSLSDRKPVE---KEDEIIVMVVPDYQM 214
EE +R+ +FPDAGAAAL + W D AF SLSDRK E K D+I+++V P
Sbjct: 51 EEG--RRLLVVFPDAGAAALARRDWGDLAFKILSLSDRKLSEDESKIDDILILVAPQPSD 108
Query: 215 LGYVEKIASDLSDDPPRPLIMWNPRLISED-VGVGINVRNLRRYFLSTFTPVYSMRPLPS 273
L VE + RP+IM NPRL VG+G R RR FLST+ Y +RPL
Sbjct: 109 LEEVEALCELAGG---RPVIMLNPRLEDAAAVGIGSVARERRRRFLSTWEVAYYLRPLER 165
Query: 274 -GAVFRCYPGLWKVFYDDKDRPNRYLLAKELVSRPNADDLEII 315
GA+FRCYPG W++F +D Y L E SRP+ ++++ +
Sbjct: 166 GGALFRCYPGPWQLFKED---NGGYRLVAEFESRPDPEEIDAL 205
|
This family of proteins are functionally uncharacterized. Length = 205 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 186 bits (475), Expect = 9e-49
Identities = 161/589 (27%), Positives = 259/589 (43%), Gaps = 86/589 (14%)
Query: 332 QANLLSGEFPKELTALPA-----LVSEAANDEVDRSYLELPVFVMPSNATNQ-------- 378
Q N SGE P E T LP + + ++ ++P M S A N+
Sbjct: 412 QDNSFSGELPSEFTKLPLVYFLDISNNNLQGRINSRKWDMPSLQMLSLARNKFFGGLPDS 471
Query: 379 -----------QYNQLSNLPPA----------IYLANNSLSGNIPVEIGQLKSLHVLDLS 417
NQ S P + L+ N LSG IP E+ K L LDLS
Sbjct: 472 FGSKRLENLDLSRNQFSGAVPRKLGSLSELMQLKLSENKLSGEIPDELSSCKKLVSLDLS 531
Query: 418 NNNFSGTIPDELSDLSNLEKLDLSGNHLVGEIPISLKGLHFLSSFSVAHNNLQGAVPSGG 477
+N SG IP S++ L +LDLS N L GEIP +L + L +++HN+L G++PS G
Sbjct: 532 HNQLSGQIPASFSEMPVLSQLDLSQNQLSGEIPKNLGNVESLVQVNISHNHLHGSLPSTG 591
Query: 478 QFDTFPSFSFEGNPELCGSVVQRPCAISPGATHPTAPHKRTNTKLVIGLVLGICFGTGLI 537
F + + GN +LCG T P KR + G L+
Sbjct: 592 AFLAINASAVAGNIDLCGG----------DTTSGLPPCKRVRKTPSWWFYITCTLGAFLV 641
Query: 538 ISMLALWILSKRRIIPGGDPDKIELDTISSTSNFGVSPEADKDASLVMLFPNNTNEIKDL 597
++++A + R + +EL + ++D + + F ++ K +
Sbjct: 642 LALVAFGFVFIRG------RNNLELKRVE-----------NEDGTWELQF-FDSKVSKSI 683
Query: 598 TIYELLKATDNFSQANIIGCGGFGLVYKA-TLANGTTLAIKKLSGDLGLMEREFKAEVEA 656
TI ++L + + N+I G G YK ++ NG +K+++ D+ + A++
Sbjct: 684 TINDILSSL---KEENVISRGKKGASYKGKSIKNGMQFVVKEIN-DVNSIPSSEIADMGK 739
Query: 657 LSTAQHKNLVSLQGYCVHQGFRLLIYSYMENGSLDYWLHEKADGASQLDWLTRLKIARGT 716
L QH N+V L G C + LI+ Y+E +L L L W R KIA G
Sbjct: 740 L---QHPNIVKLIGLCRSEKGAYLIHEYIEGKNLSEVL-------RNLSWERRRKIAIGI 789
Query: 717 SCGLAYMHQICEPHIVHRDIKSSNILLDDQFEAHLADFGLSRLILPYQTHVTTELVGTLG 776
+ L ++H C P +V ++ I++D + E HL RL LP T+ +
Sbjct: 790 AKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHL------RLSLPGLLCTDTKCFISSA 843
Query: 777 YIPPEYGQAWVATLRGDMYSFGVVMLELLTGKRPVDVLKPKMSRELVGWVLKMRSEGKQD 836
Y+ PE + T + D+Y FG++++ELLTGK P D + + +V W S+ D
Sbjct: 844 YVAPETRETKDITEKSDIYGFGLILIELLTGKSPADA-EFGVHGSIVEWARYCYSDCHLD 902
Query: 837 QVFDPILRGKGF--DEEMLQVLDVACMCVSQNPFKRPTVKEVVEWLNNV 883
DP +RG E+++V+++A C + +P RP +V++ L +
Sbjct: 903 MWIDPSIRGDVSVNQNEIVEVMNLALHCTATDPTARPCANDVLKTLESA 951
|
Length = 968 |
| >gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Score = 164 bits (417), Expect = 1e-45
Identities = 83/292 (28%), Positives = 121/292 (41%), Gaps = 55/292 (18%)
Query: 600 YELLKATDNFSQANIIGCGGFGLVYKAT-LANGTTLAIKKLSGDLGLMERE-FKAEVEAL 657
YE+L+ +G G FG VY A G +AIK + +RE E++ L
Sbjct: 1 YEILE---------KLGEGSFGKVYLARDKKTGKLVAIKVIKKKKIKKDRERILREIKIL 51
Query: 658 STAQHKNLVSLQGYCVHQGFRLLIYSYMENGSLDYWLHEKADGASQLDWLTRLKIARGTS 717
+H N+V L + L+ Y E G L L ++ +L R
Sbjct: 52 KKLKHPNIVRLYDVFEDEDKLYLVMEYCEGGDLFDLLKKR----GRLSEDEARFYLRQIL 107
Query: 718 CGLAYMHQICEPHIVHRDIKSSNILLDDQFEAHLADFGLSRLILPYQTHVTTELVGTLGY 777
L Y+H IVHRD+K NILLD+ LADFGL+R + P T VGT Y
Sbjct: 108 SALEYLHSK---GIVHRDLKPENILLDEDGHVKLADFGLARQLDP--GEKLTTFVGTPEY 162
Query: 778 IPPE------YGQAWVATLRGDMYSFGVVMLELLTGKRPVDVLKPKMSRELVGWVLKMRS 831
+ PE YG+A D++S GV++ ELLTGK P
Sbjct: 163 MAPEVLLGKGYGKAV------DIWSLGVILYELLTGKPPFP------------------G 198
Query: 832 EGKQDQVFDPILRGKG-FDEEMLQVLDVACMCVSQ----NPFKRPTVKEVVE 878
+ + ++F I + K F + A + + +P KR T +E ++
Sbjct: 199 DDQLLELFKKIGKPKPPFPPPEWDISPEAKDLIRKLLVKDPEKRLTAEEALQ 250
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254 |
| >gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain | Back alignment and domain information |
|---|
Score = 162 bits (411), Expect = 8e-45
Identities = 79/271 (29%), Positives = 121/271 (44%), Gaps = 26/271 (9%)
Query: 614 IIGCGGFGLVYKATLAN-GTTLAIKKL--SGDLGLMEREFKAEVEALSTAQHKNLVSLQG 670
+G G FG VYKA G +A+K L + ++ + E+ L H N+V L
Sbjct: 6 KLGSGSFGTVYKAKHKGTGKIVAVKILKKRSEKSKKDQTARREIRILRRLSHPNIVRLID 65
Query: 671 YCVHQGFRLLIYSYMENGSLDYWLHEKADGASQLDWLTRLKIARGTSCGLAYMHQICEPH 730
+ L+ Y E G L +L L KIA GL Y+H
Sbjct: 66 AFEDKDHLYLVMEYCEGGDLFDYLSRG----GPLSEDEAKKIALQILRGLEYLHSN---G 118
Query: 731 IVHRDIKSSNILLDDQFEAHLADFGLSRLILPYQTHVTTELVGTLGYIPPE---YGQAWV 787
I+HRD+K NILLD+ +ADFGL++ +L + +TT VGT Y+ PE G +
Sbjct: 119 IIHRDLKPENILLDENGVVKIADFGLAKKLLKSSSSLTT-FVGTPWYMAPEVLLGGNGY- 176
Query: 788 ATLRGDMYSFGVVMLELLTGKRPVDVLKPKMSRELVGWVLKMRSEGKQDQVFDPILRGKG 847
+ D++S GV++ ELLTGK P +L+ +L E + + K
Sbjct: 177 -GPKVDVWSLGVILYELLTGKPPFSGENILDQLQLIRRILGPPLEFDEPKWSSGSEEAKD 235
Query: 848 FDEEMLQVLDVACMCVSQNPFKRPTVKEVVE 878
++ L ++P KRPT +E+++
Sbjct: 236 LIKKCLN----------KDPSKRPTAEEILQ 256
|
Length = 260 |
| >gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Score = 155 bits (395), Expect = 3e-43
Identities = 76/268 (28%), Positives = 109/268 (40%), Gaps = 59/268 (22%)
Query: 615 IGCGGFGLVYKAT-LANGTTLAIKKLS-GDLGLMEREFKAEVEALSTAQHKNLVSLQGYC 672
+G GGFG VY A G +AIK + D + E E+E L H N+V L G
Sbjct: 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVF 60
Query: 673 VHQGFRLLIYSYMENGSLDYWLHEKADGASQLDWLTRLKIARGTSCGLAYMHQICEPHIV 732
+ L+ Y E GSL L E L L+I GL Y+H I+
Sbjct: 61 EDENHLYLVMEYCEGGSLKDLLKENEGK---LSEDEILRILLQILEGLEYLHSN---GII 114
Query: 733 HRDIKSSNILLD-DQFEAHLADFGLSRLILPYQTHVTTELVGTLGYIPPEYGQAWV-ATL 790
HRD+K NILLD D + LADFGLS+ +L + +VGT Y+ PE +
Sbjct: 115 HRDLKPENILLDSDNGKVKLADFGLSK-LLTSDKSLLKTIVGTPAYMAPEVLLGKGYYSE 173
Query: 791 RGDMYSFGVVMLELLTGKRPVDVLKPKMSRELVGWVLKMRSEGKQDQVFDPILRGKGFDE 850
+ D++S GV++ EL
Sbjct: 174 KSDIWSLGVILYEL---------------------------------------------P 188
Query: 851 EMLQVLDVACMCVSQNPFKRPTVKEVVE 878
E+ ++ + ++P KRP+ KE++E
Sbjct: 189 ELKDLIR---KMLQKDPEKRPSAKEILE 213
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215 |
| >gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase | Back alignment and domain information |
|---|
Score = 144 bits (366), Expect = 9e-39
Identities = 74/280 (26%), Positives = 124/280 (44%), Gaps = 46/280 (16%)
Query: 615 IGCGGFGLVYKATL-----ANGTTLAIKKLSGDLGLMER-EFKAEVEALSTAQHKNLVSL 668
+G G FG VYK TL T +A+K L ER EF E + H N+V L
Sbjct: 7 LGEGAFGEVYKGTLKGDGEGTETKVAVKTLKEGASEEEREEFLEEASIMKKLSHPNIVRL 66
Query: 669 QGYCVHQGFRLLIYSYMENGSLDYWLHEKADGASQLDWLTRLKIARGTSCGLAYMHQICE 728
G C ++ YM G L +L + + +L L++A + G+ Y+
Sbjct: 67 LGVCTQGEPLYIVTEYMPGGDLLDFLRKHGE---KLTLKDLLQMALQIAKGMEYLESK-- 121
Query: 729 PHIVHRDIKSSNILLDDQFEAHLADFGLSRLILPYQTHVTTELVGTLGYIPPEYGQAWVA 788
+ VHRD+ + N L+ + ++DFGLSR I + G +P W+A
Sbjct: 122 -NFVHRDLAARNCLVTENLVVKISDFGLSRDIYEDDYYR----KRGGGKLPI----KWMA 172
Query: 789 ---------TLRGDMYSFGVVMLELLT-GKRPVDVLKPKMSRELVGWVLKMRSEGKQDQV 838
T + D++SFGV++ E+ T G++P + + VL++ +G +
Sbjct: 173 PESLKDGKFTSKSDVWSFGVLLWEIFTLGEQPYPGMSNEE-------VLELLEDGYR--- 222
Query: 839 FDPILRGKGFDEEMLQVLDVACMCVSQNPFKRPTVKEVVE 878
+ R + +E+ +++ C + +P RPT E+VE
Sbjct: 223 ---LPRPENCPDELYELM---LQCWAYDPEDRPTFSELVE 256
|
Length = 258 |
| >gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Score = 139 bits (352), Expect = 6e-37
Identities = 66/277 (23%), Positives = 116/277 (41%), Gaps = 35/277 (12%)
Query: 614 IIGCGGFGLVYKATL-----ANGTTLAIKKLSGDLGLMER-EFKAEVEALSTAQHKNLVS 667
+G G FG VYK L +A+K L D + EF E + H N+V
Sbjct: 6 KLGEGAFGEVYKGKLKGKGGKKKVEVAVKTLKEDASEQQIEEFLREARIMRKLDHPNVVK 65
Query: 668 LQGYCVHQGFRLLIYSYMENGSLDYWLHEKADGASQLDWLTRLKIARGTSCGLAYMHQIC 727
L G C + ++ YME G L +L + +L L A + G+ Y+
Sbjct: 66 LLGVCTEEEPLYIVMEYMEGGDLLSYLRKNRP---KLSLSDLLSFALQIARGMEYLESK- 121
Query: 728 EPHIVHRDIKSSNILLDDQFEAHLADFGLSRLILPYQTHVTTELVGTLGYIPPE---YGQ 784
+ +HRD+ + N L+ + ++DFGLSR + + + ++ PE G+
Sbjct: 122 --NFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYRKRGGKLPIRWMAPESLKEGK 179
Query: 785 AWVATLRGDMYSFGVVMLELLT-GKRPVDVLKPKMSRELVGWVLKMRSEGKQDQVFDPIL 843
+ D++SFGV++ E+ T G++P + + E++ ++ + +
Sbjct: 180 FTSKS---DVWSFGVLLWEIFTLGEQPYPGMSNE---EVLEYLKNGYRLPQPPNCPPEL- 232
Query: 844 RGKGFDEEMLQVLDVACMCVSQNPFKRPTVKEVVEWL 880
D+ C +++P RPT E+VE L
Sbjct: 233 ------------YDLMLQCWAEDPEDRPTFSELVEIL 257
|
Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257 |
| >gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Score = 135 bits (342), Expect = 2e-35
Identities = 67/277 (24%), Positives = 113/277 (40%), Gaps = 34/277 (12%)
Query: 614 IIGCGGFGLVYKATL-----ANGTTLAIKKLSGD-LGLMEREFKAEVEALSTAQHKNLVS 667
+G G FG VYK TL +A+K L D EF E + H N+V
Sbjct: 6 KLGEGAFGEVYKGTLKGKGDGKEVEVAVKTLKEDASEQQIEEFLREARIMRKLDHPNIVK 65
Query: 668 LQGYCVHQGFRLLIYSYMENGSLDYWLHEKADGASQLDWLTRLKIARGTSCGLAYMHQIC 727
L G C + +++ YM G L +L + L L A + G+ Y+
Sbjct: 66 LLGVCTEEEPLMIVMEYMPGGDLLDYLRKNRPKE--LSLSDLLSFALQIARGMEYLESK- 122
Query: 728 EPHIVHRDIKSSNILLDDQFEAHLADFGLSRLILPYQTHVTTELVGTLGYIPPE---YGQ 784
+ +HRD+ + N L+ + ++DFGLSR + + + ++ PE G+
Sbjct: 123 --NFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYKVKGGKLPIRWMAPESLKEGK 180
Query: 785 AWVATLRGDMYSFGVVMLELLT-GKRPVDVLKPKMSRELVGWVLKMRSEGKQDQVFDPIL 843
+ D++SFGV++ E+ T G+ P + E++ ++ K K +
Sbjct: 181 FTSKS---DVWSFGVLLWEIFTLGEEPYPGMSNA---EVLEYLKKGYRLPKPPNCPPEL- 233
Query: 844 RGKGFDEEMLQVLDVACMCVSQNPFKRPTVKEVVEWL 880
+ C +++P RPT E+VE L
Sbjct: 234 ------------YKLMLQCWAEDPEDRPTFSELVEIL 258
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258 |
| >gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 134 bits (340), Expect = 3e-35
Identities = 77/282 (27%), Positives = 122/282 (43%), Gaps = 39/282 (13%)
Query: 613 NIIGCGGFGLVYKATL---ANGTTL-AIKKLSGDLGLMER-EFKAEVEALSTAQHKNLVS 667
+G G FG VYK L TT A+K L D ER +F E + H N+V
Sbjct: 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVR 60
Query: 668 LQGYCVHQGFRLLIYSYMENGSLDYWLHEKADGA-----SQLDWLTRLKIARGTSCGLAY 722
L G C + L+ YME G L +L + S L L A + G+ Y
Sbjct: 61 LLGVCTEEEPLYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEY 120
Query: 723 MHQICEPHIVHRDIKSSNILLDDQFEAHLADFGLSRLILPYQTHVTTELVGTLGYIP--- 779
+ VHRD+ + N L+ + ++DFGLSR + + T G +P
Sbjct: 121 LASK---KFVHRDLAARNCLVGEDLVVKISDFGLSRDVYDDDYYRKK----TGGKLPIRW 173
Query: 780 --PEYGQAWVATLRGDMYSFGVVMLELLT-GKRPVDVLKPKMSRELVGWVLKMRSEGKQD 836
PE + + T + D++SFGV++ E+ T G P L + E++ ++ K G +
Sbjct: 174 MAPESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGLSNE---EVLEYLRK----GYR- 225
Query: 837 QVFDPILRGKGFDEEMLQVLDVACMCVSQNPFKRPTVKEVVE 878
+ + + +E+ +++ C +P RPT E+VE
Sbjct: 226 -----LPKPEYCPDELYELM---LSCWQLDPEDRPTFSELVE 259
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262 |
| >gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Score = 124 bits (314), Expect = 8e-32
Identities = 66/204 (32%), Positives = 93/204 (45%), Gaps = 13/204 (6%)
Query: 613 NIIGCGGFGLVYKAT-LANGTTLAIKK--LSGDLGLMEREFKAEVEALSTAQHKNLVSLQ 669
++G G FG VY A G +A+K LSGD + E+ LS+ QH N+V
Sbjct: 6 ELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYY 65
Query: 670 GYCVH--QGFRLLIYSYMENGSLDYWLHEKADGASQLDWLTRLKIARGTSCGLAYMHQIC 727
G + + Y+ GSL L K G + R K R GLAY+H
Sbjct: 66 GSERDEEKNTLNIFLEYVSGGSLSSLL--KKFGKLPEP-VIR-KYTRQILEGLAYLH--- 118
Query: 728 EPHIVHRDIKSSNILLDDQFEAHLADFGLSRLI-LPYQTHVTTELVGTLGYIPPEYGQAW 786
IVHRDIK +NIL+D LADFG ++ + T + GT ++ PE +
Sbjct: 119 SNGIVHRDIKGANILVDSDGVVKLADFGCAKRLGDIETGEGTGSVRGTPYWMAPEVIRGE 178
Query: 787 VATLRGDMYSFGVVMLELLTGKRP 810
D++S G ++E+ TGK P
Sbjct: 179 EYGRAADIWSLGCTVIEMATGKPP 202
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260 |
| >gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Score = 118 bits (298), Expect = 1e-29
Identities = 72/300 (24%), Positives = 121/300 (40%), Gaps = 72/300 (24%)
Query: 600 YELLKATDNFSQANIIGCGGFGLVYKAT-LANGTTLAIKKLSGDLGLMEREFKA----EV 654
YE++K IG G FG VY ++G +K++ DL M + + EV
Sbjct: 2 YEIIKQ---------IGKGSFGKVYLVRRKSDGKLYVLKEI--DLSNMSEKEREDALNEV 50
Query: 655 EALSTAQHKNLVSLQGYCVHQGFRLLIYSYMENGSLDYWLHEKADGASQ------LDWLT 708
+ L H N++ +G ++ Y + G L + ++ LDW
Sbjct: 51 KILKKLNHPNIIKYYESFEEKGKLCIVMEYADGGDLSQKIKKQKKEGKPFPEEQILDWFV 110
Query: 709 RLKIARGTSCGLAYMHQICEPHIVHRDIKSSNILLDDQFEAHLADFGLSRLILPYQTHVT 768
+L +A L Y+H I+HRDIK NI L L DFG+S+ +L +
Sbjct: 111 QLCLA------LKYLH---SRKILHRDIKPQNIFLTSNGLVKLGDFGISK-VLSSTVDLA 160
Query: 769 TELVGTLGYIPPE------YGQAWVATLRGDMYSFGVVMLELLTGKRPVDVLKPKMSREL 822
+VGT Y+ PE Y + D++S G V+ EL T K P +
Sbjct: 161 KTVVGTPYYLSPELCQNKPYNY------KSDIWSLGCVLYELCTLKHPFE---------- 204
Query: 823 VGWVLKMRSEGKQDQVFDPILRGK------GFDEEMLQVLDVACMCVSQNPFKRPTVKEV 876
G L + IL+G+ + E+ ++ + ++P +RP++ ++
Sbjct: 205 -GENLLE--------LALKILKGQYPPIPSQYSSELRNLVS---SLLQKDPEERPSIAQI 252
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258 |
| >gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Score = 117 bits (295), Expect = 3e-29
Identities = 74/280 (26%), Positives = 125/280 (44%), Gaps = 39/280 (13%)
Query: 615 IGCGGFGLVYKATL-ANGTTLAIKKLSGDLGLMER-EFKAEVEALSTAQHKNLVSLQGYC 672
+G G G+VYK G A+KK+ D R + E++ L + + +V G
Sbjct: 9 LGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVKCYGAF 68
Query: 673 VHQGFRLLIYSYMENGSLDYWLHEKADGAS--QLDWLTRLKIARGTSCGLAYMHQICEPH 730
+G ++ YM+ GSL L +K L ++ R +I +G L Y+H + H
Sbjct: 69 YKEGEISIVLEYMDGGSLAD-LLKKVGKIPEPVLAYIAR-QILKG----LDYLHT--KRH 120
Query: 731 IVHRDIKSSNILLDDQFEAHLADFGLSRLILPYQTHVTTELVGTLGYIPPE------YGQ 784
I+HRDIK SN+L++ + E +ADFG+S+++ VGT+ Y+ PE Y
Sbjct: 121 IIHRDIKPSNLLINSKGEVKIADFGISKVLENTLD-QCNTFVGTVTYMSPERIQGESYSY 179
Query: 785 AWVATLRGDMYSFGVVMLELLTGKRPVDVLKPKMSRELVGWVLKMRSEGKQDQVFDPILR 844
A D++S G+ +LE GK P + M++ P L
Sbjct: 180 A------ADIWSLGLTLLECALGKFPFLPPGQP------SFFELMQAICDGPP---PSLP 224
Query: 845 GKGFDEEMLQVLDVACMCVSQNPFKRPTVKEVVE--WLNN 882
+ F E + C+ ++P KRP+ E+++ ++
Sbjct: 225 AEEFSPEFRDFIS---ACLQKDPKKRPSAAELLQHPFIKK 261
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264 |
| >gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Score = 116 bits (291), Expect = 6e-28
Identities = 70/277 (25%), Positives = 112/277 (40%), Gaps = 23/277 (8%)
Query: 615 IGCGGFGLVYKATLANGTTLAIKKLSGDL---GLMEREFKAEVEALSTAQH-KNLVSLQG 670
+G G FG VY A + +A+K L+ L F E++ L++ H N+V L
Sbjct: 8 LGEGSFGEVYLAR--DRKLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYD 65
Query: 671 YCVHQGFRLLIYSYMENGSLDYWLHEKADGASQLDWLTRLKIARGTSCGLAYMHQICEPH 730
+ +G L+ Y++ GSL+ L + L L I L Y+H
Sbjct: 66 FFQDEGSLYLVMEYVDGGSLEDLLKKIGRKGP-LSESEALFILAQILSALEYLHSK---G 121
Query: 731 IVHRDIKSSNILLD-DQFEAHLADFGLSRLILPYQTHV-----TTELVGTLGYIPPEYGQ 784
I+HRDIK NILLD D L DFGL++L+ + + VGT GY+ PE
Sbjct: 122 IIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSVGTPGYMAPEVLL 181
Query: 785 AWV---ATLRGDMYSFGVVMLELLTGKRPVDVLKPKMSRELVGWVLKMRSEGKQDQVFDP 841
A+ D++S G+ + ELLTG P + K + + +
Sbjct: 182 GLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQT--LKIILELPTPSLASPL 239
Query: 842 ILRGKGFDEEMLQVLDVACMCVSQNPFKRPTVKEVVE 878
+ D+ ++++P R + +
Sbjct: 240 SPSNPELISKAAS--DLLKKLLAKDPKNRLSSSSDLS 274
|
Length = 384 |
| >gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 113 bits (286), Expect = 9e-28
Identities = 68/219 (31%), Positives = 99/219 (45%), Gaps = 47/219 (21%)
Query: 613 NIIGCGGFGLVYKA-TLANGTTLAIKKLSGDLGLMERE-----FKAEVEALSTAQHKNLV 666
IG G +G VYKA G +A+KK+ + E+E E++ L +H N+V
Sbjct: 5 AQIGEGTYGQVYKARNKKTGELVALKKIRME---NEKEGFPITAIREIKLLQKLRHPNIV 61
Query: 667 SLQGYCV--HQGFRLLIYSYME---NGSLDYWLHEKAD---GASQLDWLTR--LKIARGT 716
L+ +G +++ YM+ G L + + SQ+ + L+
Sbjct: 62 RLKEIVTSKGKGSIYMVFEYMDHDLTG-----LLDSPEVKFTESQIKCYMKQLLE----- 111
Query: 717 SCGLAYMHQICEPHIVHRDIKSSNILLDDQFEAHLADFGLSRLILPYQTHVTTELVGTLG 776
GL Y+H I+HRDIK SNIL+++ LADFGL+R + T V TL
Sbjct: 112 --GLQYLHSN---GILHRDIKGSNILINNDGVLKLADFGLARPYTKRNSADYTNRVITLW 166
Query: 777 YIPPE-------YGQAWVATLRGDMYSFGVVMLELLTGK 808
Y PPE YG V DM+S G ++ EL GK
Sbjct: 167 YRPPELLLGATRYGPE-V-----DMWSVGCILAELFLGK 199
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287 |
| >gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Score = 111 bits (281), Expect = 2e-27
Identities = 76/266 (28%), Positives = 118/266 (44%), Gaps = 31/266 (11%)
Query: 615 IGCGGFGLVYKAT-LANGTTLAIKKLSGDLGLMEREFKAEVEALSTAQHKNLVSLQGYCV 673
IG GGFG VYKA G +AIK + + + + E++ L +H N+V G +
Sbjct: 8 IGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVKYYGSYL 67
Query: 674 HQGFRLLIYSYMENGSLDYWLHEKADGASQLDWLTRLKIA---RGTSCGLAYMHQICEPH 730
+ ++ + GSL L LT +IA + GL Y+H
Sbjct: 68 KKDELWIVMEFCSGGSLKDLLKSTNQT------LTESQIAYVCKELLKGLEYLH---SNG 118
Query: 731 IVHRDIKSSNILLDDQFEAHLADFGLS-RLILPYQTHVTTELVGTLGYIPPEYGQAWVAT 789
I+HRDIK++NILL E L DFGLS +L T +VGT ++ PE
Sbjct: 119 IIHRDIKAANILLTSDGEVKLIDFGLSAQLS---DTKARNTMVGTPYWMAPEVINGKPYD 175
Query: 790 LRGDMYSFGVVMLELLTGKRPVDVLKPKMSRELVGWVLKMRSEGKQDQVFDPILRGKGFD 849
+ D++S G+ +EL GK P + + L K+ + G + + +
Sbjct: 176 YKADIWSLGITAIELAEGKPP--YSELPPMKALF----KIATNG-----PPGLRNPEKWS 224
Query: 850 EEMLQVLDVACMCVSQNPFKRPTVKE 875
+E + D C+ +NP KRPT ++
Sbjct: 225 DE-FK--DFLKKCLQKNPEKRPTAEQ 247
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253 |
| >gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 106 bits (267), Expect = 1e-25
Identities = 66/215 (30%), Positives = 98/215 (45%), Gaps = 17/215 (7%)
Query: 608 NFSQANIIGCGGFGLVYKA-TLANGTTLAIKKLS--GDLGLMEREFKAEVEALSTAQHKN 664
N+ ++IG G FG+VYK L G +AIK++S + E++ L +H N
Sbjct: 1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPN 60
Query: 665 LVSLQGYCVHQGFRLLIYSYMENGSLDYWLHEKADGASQLDWLTRLKIARGTS---CGLA 721
+V G +I Y ENGSL + +A GLA
Sbjct: 61 IVKYIGSIETSDSLYIILEYAENGSL-------RQIIKKFGPFPESLVAVYVYQVLQGLA 113
Query: 722 YMHQICEPHIVHRDIKSSNILLDDQFEAHLADFGLSRLILPYQTHVTTELVGTLGYIPPE 781
Y+H E ++HRDIK++NIL LADFG++ L + +VGT ++ PE
Sbjct: 114 YLH---EQGVIHRDIKAANILTTKDGVVKLADFGVA-TKLNDVSKDDASVVGTPYWMAPE 169
Query: 782 YGQAWVATLRGDMYSFGVVMLELLTGKRPVDVLKP 816
+ A+ D++S G ++ELLTG P L P
Sbjct: 170 VIEMSGASTASDIWSLGCTVIELLTGNPPYYDLNP 204
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254 |
| >gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 106 bits (266), Expect = 2e-25
Identities = 73/280 (26%), Positives = 123/280 (43%), Gaps = 50/280 (17%)
Query: 615 IGCGGFGLVYKATLANGTTLAIKKLSGDLGLMEREFKAEVEALSTAQHKNLVSLQGYCVH 674
IG G FG V G +A+K L D + F AE ++T +H NLV L G +
Sbjct: 14 IGKGEFGDVMLGDYR-GQKVAVKCLKDDST-AAQAFLAEASVMTTLRHPNLVQLLGVVLQ 71
Query: 675 QGFRLLIYSYMENGSL-DYWLHEKADGASQLDWLTRLKIARGTSCGLAYMHQICEPHIVH 733
++ YM GSL DY ++ G + + +L A G+ Y+ E + VH
Sbjct: 72 GNPLYIVTEYMAKGSLVDYL---RSRGRAVITLAQQLGFALDVCEGMEYLE---EKNFVH 125
Query: 734 RDIKSSNILLDDQFEAHLADFGLSRLILPYQTHVTTELVGTLGYIP-----PEYGQAWVA 788
RD+ + N+L+ + A ++DFGL++ G +P PE +
Sbjct: 126 RDLAARNVLVSEDLVAKVSDFGLAK---------EASQGQDSGKLPVKWTAPEALREKKF 176
Query: 789 TLRGDMYSFGVVMLELLT-GKRPVDVLKPKMS-RELVGWVLK---MRS-EGKQDQVFDPI 842
+ + D++SFG+++ E+ + G+ P P++ +++V V K M + EG +V+ +
Sbjct: 177 STKSDVWSFGILLWEIYSFGRVPY----PRIPLKDVVPHVEKGYRMEAPEGCPPEVYKVM 232
Query: 843 LRGKGFDEEMLQVLDVACMCVSQNPFKRPTVKEVVEWLNN 882
C +P KRPT K++ E L
Sbjct: 233 K-----------------DCWELDPAKRPTFKQLREQLAL 255
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256 |
| >gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 105 bits (265), Expect = 3e-25
Identities = 67/209 (32%), Positives = 103/209 (49%), Gaps = 21/209 (10%)
Query: 613 NIIGCGGFGLVYKATLA----NGTTLAIKKL-SGDLGLMEREFKAEVEALSTAQHKNLVS 667
+IG G FG V + L +AIK L +G +F E + H N++
Sbjct: 10 KVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNIIR 69
Query: 668 LQGYCVHQGFRLLIYSYMENGSLDYWLHEKADGASQLDWLTRLKIARGTSCGLAYMHQIC 727
L+G ++I YMENGSLD +L E DG + + + RG + G+ Y+ ++
Sbjct: 70 LEGVVTKSRPVMIITEYMENGSLDKFLREN-DG--KFTVGQLVGMLRGIASGMKYLSEMN 126
Query: 728 EPHIVHRDIKSSNILLDDQFEAHLADFGLSRLILPYQTHVTTELVGTLGYIP-----PEY 782
VHRD+ + NIL++ ++DFGLSR + + TT+ G G IP PE
Sbjct: 127 ---YVHRDLAARNILVNSNLVCKVSDFGLSRRLEDSEATYTTK--G--GKIPIRWTAPEA 179
Query: 783 GQAWVATLRGDMYSFGVVMLELLT-GKRP 810
T D++SFG+VM E+++ G+RP
Sbjct: 180 IAYRKFTSASDVWSFGIVMWEVMSYGERP 208
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Score = 103 bits (259), Expect = 2e-24
Identities = 64/220 (29%), Positives = 103/220 (46%), Gaps = 32/220 (14%)
Query: 615 IGCGGFGLVYKATLANG------TTLAIKKLS-GDLGLMEREFKAEVEALSTAQHKNLVS 667
+G G FG V+ + +A+K L ++F+ E E L+ QH+N+V
Sbjct: 13 LGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENIVK 72
Query: 668 LQGYCVHQGFRLLIYSYMENGSLDYWLHEKADGASQLDW-------LTR---LKIARGTS 717
G C ++++ YME+G L+ +L A+ L LT L+IA +
Sbjct: 73 FYGVCTEGDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIA 132
Query: 718 CGLAYMHQICEPHIVHRDIKSSNILLDDQFEAHLADFGLSRLILP---YQTHVTTELVGT 774
G+ Y+ H VHRD+ + N L+ + DFG+SR + Y+ T L
Sbjct: 133 SGMVYL---ASQHFVHRDLATRNCLVGYDLVVKIGDFGMSRDVYTTDYYRVGGHTML--P 187
Query: 775 LGYIPPE---YGQAWVATLRGDMYSFGVVMLELLT-GKRP 810
+ ++PPE Y + T D++SFGVV+ E+ T GK+P
Sbjct: 188 IRWMPPESIMYRK---FTTESDVWSFGVVLWEIFTYGKQP 224
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280 |
| >gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 101 bits (255), Expect = 1e-23
Identities = 67/217 (30%), Positives = 100/217 (46%), Gaps = 38/217 (17%)
Query: 609 FSQANIIGCGGFGLVYKAT-LANGTTLAIKKLSGDLGLMERE-FKA----EVEALSTAQH 662
+ + +G G +G+VYKA G +A+KK+ D E E + E+ L +H
Sbjct: 1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLD---NEEEGIPSTALREISLLKELKH 57
Query: 663 KNLVSLQGYCVHQGFRLLIYSYMENGSLDYWLH---EKADGASQLDWLTRLKIARGTSCG 719
N+V L + L++ Y + D L +K G + + I G
Sbjct: 58 PNIVKLLDVIHTERKLYLVFEYCDM---D--LKKYLDKRPGPLSPNLI--KSIMYQLLRG 110
Query: 720 LAYMHQICEPHIVHRDIKSSNILLDDQFEAHLADFGLSRLI-LPYQTHVTTELVGTLGYI 778
LAY H I+HRD+K NIL++ LADFGL+R +P +T+ T E+V TL Y
Sbjct: 111 LAYCHSH---RILHRDLKPQNILINRDGVLKLADFGLARAFGIPLRTY-THEVV-TLWYR 165
Query: 779 PPE-------YGQAWVATLRGDMYSFGVVMLELLTGK 808
PE Y A V D++S G + E++TGK
Sbjct: 166 APEILLGSKHYSTA-V-----DIWSVGCIFAEMITGK 196
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282 |
| >gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Score = 100 bits (252), Expect = 1e-23
Identities = 62/241 (25%), Positives = 94/241 (39%), Gaps = 33/241 (13%)
Query: 608 NFSQANIIGCGGFGLVYKATL-ANGTTLAIKKLSGDLGLMEREFKA---EVEALSTAQHK 663
+F +IG G FG V A+K ++ + + + E L H
Sbjct: 1 HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHP 60
Query: 664 NLVSLQGYCVHQGFR-----LLIYSYMENGSLDYWLHEK---ADGASQLDWLTRLKIARG 715
LV+L F+ L+ + G L Y L +K ++ + W+ +
Sbjct: 61 FLVNL-----WYSFQDEENMYLVVDLLLGGDLRYHLSQKVKFSEEQVKF-WICEI----- 109
Query: 716 TSCGLAYMHQICEPHIVHRDIKSSNILLDDQFEAHLADFGLSRLILPYQTHVTTELVGTL 775
L Y+H I+HRDIK NILLD+Q H+ DF ++ + T TT GT
Sbjct: 110 -VLALEYLH---SKGIIHRDIKPDNILLDEQGHVHITDFNIAT-KVTPDTL-TTSTSGTP 163
Query: 776 GYIPPEYGQAWVATLRGDMYSFGVVMLELLTGKRPVDVLKPKMSRELVGWVLKMRSEGKQ 835
GY+ PE ++ D +S GV E L GKRP SR + + +
Sbjct: 164 GYMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKRPY----RGHSRTIRDQIRAKQETADV 219
Query: 836 D 836
Sbjct: 220 L 220
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258 |
| >gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Score = 99.5 bits (248), Expect = 4e-23
Identities = 75/270 (27%), Positives = 125/270 (46%), Gaps = 31/270 (11%)
Query: 608 NFSQANIIGCGGFGLVYKATL-ANGTTLAIKKLSGDLGLMEREFKAEV--EA--LSTAQH 662
+F N IG G FG+V+K A+ A+K++ DL M R + E EA L+
Sbjct: 1 DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQI--DLSKMNRREREEAIDEARVLAKLDS 58
Query: 663 KNLVSLQGYCVHQGFRLLIYSYMENGSLDYWLHEKADGASQLDWLTRLKIARGTSCGLAY 722
++ + +G ++ Y ENG L L + D + R I GLA+
Sbjct: 59 SYIIRYYESFLDKGKLNIVMEYAENGDLHKLLKMQRGRPLPEDQVWRFFIQ--ILLGLAH 116
Query: 723 MHQICEPHIVHRDIKSSNILLDDQFEAHLADFGLSRLILPYQTHVTTELVGTLGYIPPEY 782
+H I+HRDIKS N+ LD + D G+++L+ T+ +VGT Y+ PE
Sbjct: 117 LHS---KKILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSD-NTNFANTIVGTPYYLSPEL 172
Query: 783 GQAWVATLRGDMYSFGVVMLELLTGKRPVDVLKPKMSRELVGWVLK-MRSEGKQDQVFDP 841
+ + D+++ GVV+ E TGK P D +LK +R VF P
Sbjct: 173 CEDKPYNEKSDVWALGVVLYECCTGKHPFDA------NNQGALILKIIRG------VFPP 220
Query: 842 ILRGKGFDEEMLQVLDVACMCVSQNPFKRP 871
+ + + +++ Q++D C++++ +RP
Sbjct: 221 V--SQMYSQQLAQLID---QCLTKDYRQRP 245
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256 |
| >gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Score = 99.7 bits (249), Expect = 4e-23
Identities = 77/279 (27%), Positives = 128/279 (45%), Gaps = 30/279 (10%)
Query: 607 DNFSQANIIGCGGFGLVYKAT-LANGTTLAIKKLSGDLGLMEREFKA---EVEALSTAQH 662
D+ +G G G+V K G +A+K + L + E K E++ L
Sbjct: 1 DDLEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIR--LEINEAIQKQILRELDILHKCNS 58
Query: 663 KNLVSLQGYCVHQGFRLLIYSYMENGSLDYWLHEKADGASQLDWLTRLKIARGTSCGLAY 722
+V G + G + YM+ GSLD L E G L KIA GL Y
Sbjct: 59 PYIVGFYGAFYNNGDISICMEYMDGGSLDKILKE-VQGRIPERILG--KIAVAVLKGLTY 115
Query: 723 MHQICEPHIVHRDIKSSNILLDDQFEAHLADFGLS-RLILPYQTHVTTELVGTLGYIPPE 781
+H+ + I+HRD+K SNIL++ + + L DFG+S +L+ + VGT Y+ PE
Sbjct: 116 LHE--KHKIIHRDVKPSNILVNSRGQIKLCDFGVSGQLV----NSLAKTFVGTSSYMAPE 169
Query: 782 YGQAWVATLRGDMYSFGVVMLELLTGKRPVD--VLKPKMSRELVGWVLKMRSEGKQDQVF 839
Q +++ D++S G+ ++EL TG+ P P EL+ +++
Sbjct: 170 RIQGNDYSVKSDIWSLGLSLIELATGRFPYPPENDPPDGIFELLQYIVNEPP-------- 221
Query: 840 DPILRGKGFDEEMLQVLDVACMCVSQNPFKRPTVKEVVE 878
P L F + +++ C+ ++P +RP+ KE++E
Sbjct: 222 -PRLPSGKFSPDFQDFVNL---CLIKDPRERPSYKELLE 256
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265 |
| >gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 98.7 bits (247), Expect = 5e-23
Identities = 60/206 (29%), Positives = 82/206 (39%), Gaps = 24/206 (11%)
Query: 615 IGCGGFGLVYKAT-LANGTTLAIKKLSGDLGLMEREF---KAEVEALSTAQHKNLVSLQG 670
+G G FG V G A+K L + +E E LS H +V L
Sbjct: 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKL-- 58
Query: 671 YCVHQGF----RL-LIYSYMENGSLDYWLHEKADGASQLD-WLTRLKIARGTSCGLAYMH 724
H F +L L+ Y G L L + + R A L Y+H
Sbjct: 59 ---HYAFQTEEKLYLVLEYAPGGELFSHLSK----EGRFSEERARFYAAE-IVLALEYLH 110
Query: 725 QICEPHIVHRDIKSSNILLDDQFEAHLADFGLSRLILPYQTHVTTELVGTLGYIPPEYGQ 784
+ I++RD+K NILLD L DFGL++ L + T GT Y+ PE
Sbjct: 111 SL---GIIYRDLKPENILLDADGHIKLTDFGLAK-ELSSEGSRTNTFCGTPEYLAPEVLL 166
Query: 785 AWVATLRGDMYSFGVVMLELLTGKRP 810
D +S GV++ E+LTGK P
Sbjct: 167 GKGYGKAVDWWSLGVLLYEMLTGKPP 192
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250 |
| >gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 99.1 bits (247), Expect = 6e-23
Identities = 71/274 (25%), Positives = 116/274 (42%), Gaps = 38/274 (13%)
Query: 615 IGCGGFGLVYKATLANGTTLAIKKLSGDLGLM-EREFKAEVEALSTAQHKNLVSLQGYCV 673
+G G FG+V+ +AIK + G M E +F E + + H NLV L G C
Sbjct: 12 LGSGQFGVVHLGKWRGKIDVAIKMIRE--GAMSEDDFIEEAKVMMKLSHPNLVQLYGVCT 69
Query: 674 HQGFRLLIYSYMENGSLDYWLHEKADGASQLDWLTRLKIARGTSCGLAYMHQICEPHIVH 733
Q ++ YM NG L +L E+ G +WL L + + Y+ +H
Sbjct: 70 KQRPIFIVTEYMANGCLLNYLRER-KGKLGTEWL--LDMCSDVCEAMEYLESNG---FIH 123
Query: 734 RDIKSSNILLDDQFEAHLADFGLSRLILPYQTHVTTELVGT---LGYIPPEYGQAWVATL 790
RD+ + N L+ + ++DFGL+R +L Q T GT + + PPE +
Sbjct: 124 RDLAARNCLVGEDNVVKVSDFGLARYVLDDQ---YTSSQGTKFPVKWAPPEVFDYSRFSS 180
Query: 791 RGDMYSFGVVMLELLT-GKRPVDVLKPKMSRELVGWVLKMRSEGKQDQVFDPILRGKGFD 849
+ D++SFGV+M E+ + GK P + + +V + + G
Sbjct: 181 KSDVWSFGVLMWEVFSEGKMPYE-----------RF--------SNSEVVESVSAGYRLY 221
Query: 850 EEML---QVLDVACMCVSQNPFKRPTVKEVVEWL 880
L +V + C + P RP K+++ L
Sbjct: 222 RPKLAPTEVYTIMYSCWHEKPEDRPAFKKLLSQL 255
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256 |
| >gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Score = 98.9 bits (246), Expect = 6e-23
Identities = 65/242 (26%), Positives = 109/242 (45%), Gaps = 30/242 (12%)
Query: 615 IGCGGFGLVYKATLANGTTLAIKKLSGDLGLM-EREFKAEVEALSTAQHKNLVSLQGYCV 673
IG G FGLV+ +AIK + G M E +F E + + H LV L G C
Sbjct: 12 IGSGQFGLVWLGYWLEKRKVAIKTIRE--GAMSEEDFIEEAQVMMKLSHPKLVQLYGVCT 69
Query: 674 HQGFRLLIYSYMENGSLDYWLHEKADGASQLDWLTRLKIARGTSCGLAYMHQICEPHIVH 733
+ L++ +ME+G L +L + SQ T L + G+AY+ ++H
Sbjct: 70 ERSPICLVFEFMEHGCLSDYLRAQRGKFSQ---ETLLGMCLDVCEGMAYLESSN---VIH 123
Query: 734 RDIKSSNILLDDQFEAHLADFGLSRLILPYQTHVTTELVGTLGYIPPEYGQAWVATLRGD 793
RD+ + N L+ + ++DFG++R +L Q +T + + PE + + D
Sbjct: 124 RDLAARNCLVGENQVVKVSDFGMTRFVLDDQYTSSTGTKFPVKWSSPEVFSFSKYSSKSD 183
Query: 794 MYSFGVVMLELLT-GKRPVD----------------VLKPKMSR----ELVGWVLKMRSE 832
++SFGV+M E+ + GK P + + KP+++ EL+ K R E
Sbjct: 184 VWSFGVLMWEVFSEGKTPYENRSNSEVVETINAGFRLYKPRLASQSVYELMQHCWKERPE 243
Query: 833 GK 834
+
Sbjct: 244 DR 245
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256 |
| >gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Score = 98.6 bits (246), Expect = 9e-23
Identities = 72/211 (34%), Positives = 102/211 (48%), Gaps = 20/211 (9%)
Query: 611 QANIIGCGGFGLVYKA-TLANGTTLAIKKLS---GDLGLMEREFKAEVEALSTAQHKNLV 666
+ N IG G FG VY A L G +A+K++ D + +E E++ L +H NLV
Sbjct: 4 RGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTI-KEIADEMKVLELLKHPNLV 62
Query: 667 SLQGYCVHQGFRLLIY-SYMENGSLDYWLHEKADGASQLDWLTRLKIARGTSCGLAYMHQ 725
G VH+ ++ I+ Y G+L+ L G + + R+ + GLAY+H
Sbjct: 63 KYYGVEVHRE-KVYIFMEYCSGGTLEELLEH---GRILDEHVIRVYTLQLLE-GLAYLH- 116
Query: 726 ICEPHIVHRDIKSSNILLDDQFEAHLADFGLSRLILPYQTHVTTE---LVGTLGYIPPEY 782
IVHRDIK +NI LD L DFG + + T + E L GT Y+ PE
Sbjct: 117 --SHGIVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTTMGEEVQSLAGTPAYMAPEV 174
Query: 783 --GQAWVATLRG-DMYSFGVVMLELLTGKRP 810
G R D++S G V+LE+ TGKRP
Sbjct: 175 ITGGKGKGHGRAADIWSLGCVVLEMATGKRP 205
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264 |
| >gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Score = 97.7 bits (243), Expect = 2e-22
Identities = 63/209 (30%), Positives = 108/209 (51%), Gaps = 14/209 (6%)
Query: 610 SQANIIGCGGFGLVYKATLA----NGTTLAIKKLSGDLGLMER-EFKAEVEALSTAQHKN 664
++ +IG G FG V++ L +AIK L +R +F +E + H N
Sbjct: 8 TKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHN 67
Query: 665 LVSLQGYCVHQGFRLLIYSYMENGSLDYWLHEKADGASQLDWLTRLKIARGTSCGLAYMH 724
++ L+G ++I YMENG+LD +L + DG + + + RG + G+ Y+
Sbjct: 68 IIRLEGVVTKFKPAMIITEYMENGALDKYLRDH-DG--EFSSYQLVGMLRGIAAGMKYLS 124
Query: 725 QICEPHIVHRDIKSSNILLDDQFEAHLADFGLSRLI--LPYQTHVTTELVGTLGYIPPEY 782
+ + VHRD+ + NIL++ E ++DFGLSR++ P T+ T+ + + PE
Sbjct: 125 DM---NYVHRDLAARNILVNSNLECKVSDFGLSRVLEDDPEGTYTTSGGKIPIRWTAPEA 181
Query: 783 GQAWVATLRGDMYSFGVVMLELLT-GKRP 810
T D++SFG+VM E+++ G+RP
Sbjct: 182 IAYRKFTSASDVWSFGIVMWEVMSFGERP 210
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268 |
| >gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Score = 94.7 bits (236), Expect = 2e-21
Identities = 79/299 (26%), Positives = 125/299 (41%), Gaps = 58/299 (19%)
Query: 600 YELLKATDNFSQANIIGCGGFGLVYKA-TLANGTTLAIKKLSGDLGLMEREFKA---EVE 655
YEL+ +IG G +VY A L N +AIK++ DL + EV+
Sbjct: 3 YELI---------EVIGVGATAVVYAAICLPNNEKVAIKRI--DLEKCQTSVDELRKEVQ 51
Query: 656 ALSTAQHKNLVSLQGYCVHQGFRLLIYSYMENGSLDYWLHEKADGASQLDWLTRLKIARG 715
A+S H N+V V L+ Y+ GSL + + + LD + +
Sbjct: 52 AMSQCNHPNVVKYYTSFVVGDELWLVMPYLSGGSL-LDIMKSSYPRGGLDEAIIATVLKE 110
Query: 716 TSCGLAYMHQICEPHIVHRDIKSSNILLDDQFEAHLADFGLSRLILPY---QTHVTTELV 772
GL Y+H I HRDIK+ NILL + +ADFG+S + V V
Sbjct: 111 VLKGLEYLHS--NGQI-HRDIKAGNILLGEDGSVKIADFGVSASLADGGDRTRKVRKTFV 167
Query: 773 GTLGYIPPE-------YGQAWVATLRGDMYSFGVVMLELLTGKRPVDVLKPKMSRELVGW 825
GT ++ PE Y + D++SFG+ +EL TG P P
Sbjct: 168 GTPCWMAPEVMEQVHGYDF------KADIWSFGITAIELATGAAPYSKYPPMKV-----L 216
Query: 826 VLKMRS------EGKQDQVFDPILRGKGFDEEMLQVLDVACMCVSQNPFKRPTVKEVVE 878
+L +++ G + + K F +M+ +C+ ++P KRPT +E+++
Sbjct: 217 MLTLQNDPPSLETGADYKKY-----SKSF-RKMIS------LCLQKDPSKRPTAEELLK 263
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267 |
| >gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Score = 95.3 bits (237), Expect = 5e-21
Identities = 70/219 (31%), Positives = 99/219 (45%), Gaps = 22/219 (10%)
Query: 605 ATDNFSQ---ANIIGCGGFGLVYKAT-LANGTTLAIKKLSGDL-GLMEREFKAEVEALST 659
A + S+ N IG G G VYK G A+K + G+ + R+ E+E L
Sbjct: 69 AAKSLSELERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVRRQICREIEILRD 128
Query: 660 AQHKNLVSLQGYCVHQGFRLLIYSYMENGSLDYWLHEKADGASQLDWLTRLKIARGTSCG 719
H N+V H G ++ +M+ GSL+ G D +AR G
Sbjct: 129 VNHPNVVKCHDMFDHNGEIQVLLEFMDGGSLE--------GTHIADEQFLADVARQILSG 180
Query: 720 LAYMHQICEPHIVHRDIKSSNILLDDQFEAHLADFGLSRLILPYQTHVTTELVGTLGYIP 779
+AY+H+ HIVHRDIK SN+L++ +ADFG+SR IL VGT+ Y+
Sbjct: 181 IAYLHR---RHIVHRDIKPSNLLINSAKNVKIADFGVSR-ILAQTMDPCNSSVGTIAYMS 236
Query: 780 PE-----YGQAWVATLRGDMYSFGVVMLELLTGKRPVDV 813
PE GD++S GV +LE G+ P V
Sbjct: 237 PERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGV 275
|
Length = 353 |
| >gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 92.9 bits (231), Expect = 1e-20
Identities = 58/211 (27%), Positives = 95/211 (45%), Gaps = 22/211 (10%)
Query: 613 NIIGCGGFGLVYKAT---LANGTTL--AIKKLSGDLG-LMEREFKAEVEALSTAQHKNLV 666
+G G FG V L + T A+K L+ +F+ E+E L T H+N+V
Sbjct: 10 KQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIV 69
Query: 667 SLQGYCVHQGFR--LLIYSYMENGSLDYWLHEKADGASQLDWLTRLKIARGTSCGLAYMH 724
+G C G R LI Y+ +GSL +L D Q++ L + G+ Y+
Sbjct: 70 KYKGVCEKPGGRSLRLIMEYLPSGSLRDYLQRHRD---QINLKRLLLFSSQICKGMDYLG 126
Query: 725 QICEPHIVHRDIKSSNILLDDQFEAHLADFGLSRLILPYQTHVTTELVGTLGYIP----- 779
+HRD+ + NIL++ + ++DFGL++++ + + V G P
Sbjct: 127 ---SQRYIHRDLAARNILVESEDLVKISDFGLAKVLPEDKDYYY---VKEPGESPIFWYA 180
Query: 780 PEYGQAWVATLRGDMYSFGVVMLELLTGKRP 810
PE + + D++SFGV + EL T P
Sbjct: 181 PECLRTSKFSSASDVWSFGVTLYELFTYGDP 211
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284 |
| >gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Score = 91.7 bits (228), Expect = 3e-20
Identities = 68/234 (29%), Positives = 111/234 (47%), Gaps = 32/234 (13%)
Query: 601 ELLKATDNFSQANIIGCGGFGLVYKA---TLANG---TTLAIKKLSGD-LGLMEREFKAE 653
E+ + F + +G G FG VYK T++AIK L + +++EF+ E
Sbjct: 1 EIPLSAVRFLEE--LGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQE 58
Query: 654 VEALSTAQHKNLVSLQGYCVHQGFRLLIYSYMENGSLDYWL------------HEKADGA 701
E +S QH N+V L G C + +++ Y+ +G L +L
Sbjct: 59 AELMSDLQHPNIVCLLGVCTKEQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVK 118
Query: 702 SQLDWLTRLKIARGTSCGLAYMHQICEPHIVHRDIKSSNILLDDQFEAHLADFGLSRLIL 761
S LD L IA + G+ Y+ H VHRD+ + N L+ + ++DFGLSR I
Sbjct: 119 SSLDCSDFLHIAIQIAAGMEYL---SSHHFVHRDLAARNCLVGEGLTVKISDFGLSRDIY 175
Query: 762 PYQTH-VTTELVGTLGYIPPE---YGQAWVATLRGDMYSFGVVMLELLT-GKRP 810
+ V ++ + + ++PPE YG+ T D++SFGVV+ E+ + G +P
Sbjct: 176 SADYYRVQSKSLLPVRWMPPEAILYGK---FTTESDIWSFGVVLWEIFSYGLQP 226
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283 |
| >gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Score = 91.0 bits (226), Expect = 3e-20
Identities = 65/210 (30%), Positives = 105/210 (50%), Gaps = 21/210 (10%)
Query: 609 FSQANIIGCGGFGLVYKATLANGTTLAIKKLSGDLGLMEREFKAEVEALSTAQHKNLVSL 668
F+ +G G FG V++ N +AIK L D L +++F+ EV+AL +HK+L+SL
Sbjct: 8 FTLERKLGSGYFGEVWEGLWKNRVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLISL 67
Query: 669 QGYCVHQGFRLLIYSYMENGSLDYWLHEKADGASQLDWLTRLKIARGTSCGLAYMHQICE 728
C +I ME GSL +L +G L + + +A + G+AY+ E
Sbjct: 68 FAVCSVGEPVYIITELMEKGSLLAFLRS-PEGQV-LPVASLIDMACQVAEGMAYLE---E 122
Query: 729 PHIVHRDIKSSNILLDDQFEAHLADFGLSRLILP--YQTHVTTELVGTLGYIP-----PE 781
+ +HRD+ + NIL+ + +ADFGL+RLI Y + IP PE
Sbjct: 123 QNSIHRDLAARNILVGEDLVCKVADFGLARLIKEDVYLSSDKK--------IPYKWTAPE 174
Query: 782 YGQAWVATLRGDMYSFGVVMLELLT-GKRP 810
+ + D++SFG+++ E+ T G+ P
Sbjct: 175 AASHGTFSTKSDVWSFGILLYEMFTYGQVP 204
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261 |
| >gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Score = 91.7 bits (228), Expect = 4e-20
Identities = 69/222 (31%), Positives = 101/222 (45%), Gaps = 44/222 (19%)
Query: 608 NFSQANIIGCGGFGLVYKA-TLANGTTLAIKKLSGDLGLMEREFKA-------EVEALST 659
F + N IG G +G+VY+A +G +A+KK+ M+ E E+ L
Sbjct: 8 EFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVR-----MDNERDGIPISSLREITLLLN 62
Query: 660 AQHKNLVSLQGYCVHQGFRL----LIYSYMENGSLDYWLHEKADGASQLDWLTR------ 709
+H N+V L+ V G L L+ Y E D AS LD +
Sbjct: 63 LRHPNIVELKE--VVVGKHLDSIFLVMEYCEQ-----------DLASLLDNMPTPFSESQ 109
Query: 710 LK-IARGTSCGLAYMHQICEPHIVHRDIKSSNILLDDQFEAHLADFGLSRLILPYQTHVT 768
+K + GL Y+H+ I+HRD+K SN+LL D+ +ADFGL+R +T
Sbjct: 110 VKCLMLQLLRGLQYLHENF---IIHRDLKVSNLLLTDKGCLKIADFGLARTYGLPAKPMT 166
Query: 769 TELVGTLGYIPPE--YGQAWVATLRGDMYSFGVVMLELLTGK 808
++V TL Y PE G T DM++ G ++ ELL K
Sbjct: 167 PKVV-TLWYRAPELLLG-CTTYTTAIDMWAVGCILAELLAHK 206
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309 |
| >gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 89.7 bits (223), Expect = 1e-19
Identities = 72/263 (27%), Positives = 120/263 (45%), Gaps = 31/263 (11%)
Query: 615 IGCGGFGLVYKATLANGTTLAIKKLSGDLGLMERE-FKAEVEALSTAQHKNLVSLQGYCV 673
+G G FG V+ T T +A+K L G M E F E + + +H LV L C
Sbjct: 14 LGAGQFGEVWMGTWNGTTKVAVKTLKP--GTMSPEAFLQEAQIMKKLRHDKLVQLYAVCS 71
Query: 674 HQGFRLLIYSYMENGSLDYWLHEKADGASQLDWLTRLKIARGTSCGLAYMHQICEPHIVH 733
+ ++ YM GSL +L +L + +A + G+AY+ + +H
Sbjct: 72 EEEPIYIVTEYMSKGSLLDFLKS--GEGKKLRLPQLVDMAAQIAEGMAYLE---SRNYIH 126
Query: 734 RDIKSSNILLDDQFEAHLADFGLSRLILP--YQTHVTTELVGTLGYIPPEYGQAWVATLR 791
RD+ + NIL+ + +ADFGL+RLI Y + + + PE T++
Sbjct: 127 RDLAARNILVGENLVCKIADFGLARLIEDDEYTAREGAKF--PIKWTAPEAANYGRFTIK 184
Query: 792 GDMYSFGVVMLELLT-GKRPVDVLKPKMS-RELVGWVLKMRSEGKQDQVFDPILRGKGFD 849
D++SFG+++ E++T G+ P P M+ RE VL+ G + + R
Sbjct: 185 SDVWSFGILLTEIVTYGRVPY----PGMTNRE----VLEQVERGYR------MPRPPNCP 230
Query: 850 EEMLQVLDVACMCVSQNPFKRPT 872
EE+ ++ C ++P +RPT
Sbjct: 231 EELYDLM---LQCWDKDPEERPT 250
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261 |
| >gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 89.4 bits (222), Expect = 1e-19
Identities = 78/276 (28%), Positives = 119/276 (43%), Gaps = 41/276 (14%)
Query: 615 IGCGGFGLVYKA-TLANGTTLAIKKLS-GDLGLMERE----FKAEVEALSTAQHKNLVSL 668
+G G FG VY+ L +G A+K++S D G +E + E+ LS QH N+V
Sbjct: 8 LGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQY 67
Query: 669 QGYCVHQGFRLLIY-SYMENGSLDYWLHEKADGASQLDWLTRLKIARGTS---CGLAYMH 724
G + L I+ + GSL L + I T GL Y+H
Sbjct: 68 LG-TEREEDNLYIFLELVPGGSLAKLLKK-------YGSFPEPVIRLYTRQILLGLEYLH 119
Query: 725 QICEPHIVHRDIKSSNILLDDQFEAHLADFGLSRLILPYQTHVTTELVGTLGYIPPEY-G 783
+ + VHRDIK +NIL+D LADFG+++ ++ + G+ ++ PE
Sbjct: 120 ---DRNTVHRDIKGANILVDTNGVVKLADFGMAKQVVEFSF--AKSFKGSPYWMAPEVIA 174
Query: 784 QAWVATLRGDMYSFGVVMLELLTGKRPVDVLKPKMSRELVGWVLKMRSEGKQDQVFDPI- 842
Q L D++S G +LE+ TGK P L+ V V K+ + + D +
Sbjct: 175 QQGGYGLAADIWSLGCTVLEMATGKPPWSQLEG------VAAVFKIGRSKELPPIPDHLS 228
Query: 843 LRGKGFDEEMLQVLDVACMCVSQNPFKRPTVKEVVE 878
K F + LQ +P RPT E++E
Sbjct: 229 DEAKDFILKCLQR----------DPSLRPTAAELLE 254
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258 |
| >gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Score = 89.5 bits (222), Expect = 1e-19
Identities = 67/211 (31%), Positives = 106/211 (50%), Gaps = 24/211 (11%)
Query: 614 IIGCGGFGLVYKATLA----NGTTLAIKKLSGDLGLME---REFKAEVEALSTAQHKNLV 666
+IG G FG V + L +AIK L G E R+F +E + H N++
Sbjct: 11 VIGAGEFGEVCRGRLKLPGKREIFVAIKTLKS--GYTEKQRRDFLSEASIMGQFDHPNII 68
Query: 667 SLQGYCVHQGFRLLIYSYMENGSLDYWLHEKADGASQLDWLTRLKIARGTSCGLAYMHQI 726
L+G ++I +MENG+LD +L + DG Q + + + RG + G+ Y+
Sbjct: 69 HLEGVVTKSRPVMIITEFMENGALDSFLRQN-DG--QFTVIQLVGMLRGIAAGMKYL--- 122
Query: 727 CEPHIVHRDIKSSNILLDDQFEAHLADFGLSRLILPYQTHVT-TELVGTLGYIP-----P 780
E + VHRD+ + NIL++ ++DFGLSR + + T T +G G IP P
Sbjct: 123 SEMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSSLG--GKIPIRWTAP 180
Query: 781 EYGQAWVATLRGDMYSFGVVMLELLT-GKRP 810
E T D++S+G+VM E+++ G+RP
Sbjct: 181 EAIAYRKFTSASDVWSYGIVMWEVMSYGERP 211
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269 |
| >gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 89.4 bits (222), Expect = 2e-19
Identities = 70/279 (25%), Positives = 123/279 (44%), Gaps = 21/279 (7%)
Query: 607 DNFSQANIIGCGGFGLVYKATL-ANGTTLAIKKLSGDLGLM-EREFKAEVEALSTAQHKN 664
+ + + +G G G V K L G A+K ++ D +++ E+E + +
Sbjct: 1 EKIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPY 60
Query: 665 LVSLQGYCV--HQGFRLLIYSYMENGSLDYWLHEKADGASQLDWLTRLKIARGTSCGLAY 722
+V G + + Y E GSLD + ++ KIA GL+Y
Sbjct: 61 IVKYYGAFLDESSSSIGIAMEYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSY 120
Query: 723 MHQICEPHIVHRDIKSSNILLDDQFEAHLADFGLS-RLILPYQTHVTTELVGTLGYIPPE 781
+H I+HRDIK SNILL + + L DFG+S L+ + GT Y+ PE
Sbjct: 121 LH---SRKIIHRDIKPSNILLTRKGQVKLCDFGVSGELV----NSLAGTFTGTSFYMAPE 173
Query: 782 YGQAWVATLRGDMYSFGVVMLELLTGKRPV--DVLKPKMSRELVGWVLKMRSEGKQDQVF 839
Q ++ D++S G+ +LE+ + P + P EL+ +++ M + +D+
Sbjct: 174 RIQGKPYSITSDVWSLGLTLLEVAQNRFPFPPEGEPPLGPIELLSYIVNMPNPELKDEPG 233
Query: 840 DPILRGKGFDEEMLQVLDVACMCVSQNPFKRPTVKEVVE 878
+ I + F D C+ ++P +RPT +++E
Sbjct: 234 NGIKWSEEFK-------DFIKQCLEKDPTRRPTPWDMLE 265
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 91.8 bits (228), Expect = 5e-19
Identities = 54/163 (33%), Positives = 74/163 (45%), Gaps = 36/163 (22%)
Query: 389 AIYLANNSLSGNIPVEIGQLKSLHVLDLSNNNFSGTIPDELSDLSNLEKLDLSGNHLVGE 448
+I L+ NS+ GNIP +G + SL VLDLS N+F+G+IP+ L L++L L+L+GN L G
Sbjct: 446 SINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSIPESLGQLTSLRILNLNGNSLSGR 505
Query: 449 IPISLKGLHFLSSFSVAHNNLQGAVPSGGQFDTFPSFSFEGNPELCGSVVQRPCAISPGA 508
+P +L G L A SF+F N LCG R C
Sbjct: 506 VPAALGGRL-----------LHRA-----------SFNFTDNAGLCGIPGLRAC------ 537
Query: 509 THPTAPHKRTNTKLVIGLVLGICFGTGLIISMLALWILSKRRI 551
PH K IG+ G+ ++ W KRR
Sbjct: 538 ----GPHLSVGAK--IGIAFGVSVAFLFLVICAMCWW--KRRQ 572
|
Length = 623 |
| >gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Score = 86.9 bits (216), Expect = 7e-19
Identities = 64/221 (28%), Positives = 94/221 (42%), Gaps = 44/221 (19%)
Query: 614 IIGCGGFGLVYKAT-LANGTTLAIKKLSGDLGLMEREFKAEVEALSTAQHKNLVSLQGYC 672
+G G +G VYKA G +AIK + + L +E E+ L +V G
Sbjct: 10 KLGEGSYGSVYKAIHKETGQVVAIKVVPVEEDL--QEIIKEISILKQCDSPYIVKYYG-- 65
Query: 673 VHQGFRLLIYSYMENGSLDYW-LHEKADGASQLDW-------LTRLKIA---RGTSCGLA 721
SY +N D W + E S D LT +IA T GL
Sbjct: 66 ----------SYFKNT--DLWIVMEYCGAGSVSDIMKITNKTLTEEEIAAILYQTLKGLE 113
Query: 722 YMHQICEPHIVHRDIKSSNILLDDQFEAHLADFGLSRLILPYQTHVTTELVGTLGYIPPE 781
Y+H +HRDIK+ NILL+++ +A LADFG+S L ++GT ++ PE
Sbjct: 114 YLHSN---KKIHRDIKAGNILLNEEGQAKLADFGVSG-QLTDTMAKRNTVIGTPFWMAPE 169
Query: 782 ------YGQAWVATLRGDMYSFGVVMLELLTGKRPVDVLKP 816
Y + D++S G+ +E+ GK P + P
Sbjct: 170 VIQEIGYNN------KADIWSLGITAIEMAEGKPPYSDIHP 204
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256 |
| >gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Score = 87.4 bits (216), Expect = 8e-19
Identities = 64/217 (29%), Positives = 99/217 (45%), Gaps = 26/217 (11%)
Query: 615 IGCGGFGLVYKATLAN------GTTLAIKKLSGDLGLMEREFKAEVEALSTAQHKNLVSL 668
+G G FG V+ A N +A+K L ++F+ E E L+ QH+++V
Sbjct: 13 LGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVRF 72
Query: 669 QGYCVHQGFRLLIYSYMENGSLDYWLHEKADGA-----------SQLDWLTRLKIARGTS 717
G C L+++ YM +G L+ +L A QL L IA +
Sbjct: 73 YGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIA 132
Query: 718 CGLAYMHQICEPHIVHRDIKSSNILLDDQFEAHLADFGLSRLILPYQT---HVTTELVGT 774
G+ Y+ + H VHRD+ + N L+ + DFG+SR I Y T V +
Sbjct: 133 SGMVYLASL---HFVHRDLATRNCLVGQGLVVKIGDFGMSRDI--YSTDYYRVGGRTMLP 187
Query: 775 LGYIPPEYGQAWVATLRGDMYSFGVVMLELLT-GKRP 810
+ ++PPE T D++SFGVV+ E+ T GK+P
Sbjct: 188 IRWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQP 224
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280 |
| >gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 86.7 bits (215), Expect = 8e-19
Identities = 71/269 (26%), Positives = 129/269 (47%), Gaps = 30/269 (11%)
Query: 615 IGCGGFGLVYKATLANGTTLAIKKLSGDLGLME-REFKAEVEALSTAQHKNLVSLQGYCV 673
+G G FG V++ N T +A+K L G M+ ++F AE + + +H L+ L C
Sbjct: 14 LGAGQFGEVWEGLWNNTTPVAVKTLKP--GTMDPKDFLAEAQIMKKLRHPKLIQLYAVCT 71
Query: 674 HQGFRLLIYSYMENGSLDYWLHEKADGASQLDWLTRLKIARGTSCGLAYMHQICEPHIVH 733
+ ++ M+ GSL +L A A +L L + +A + G+AY+ + +H
Sbjct: 72 LEEPIYIVTELMKYGSLLEYLQGGAGRALKLPQL--IDMAAQVASGMAYLEA---QNYIH 126
Query: 734 RDIKSSNILLDDQFEAHLADFGLSRLILP--YQTHVTTELVGTLGYIPPEYGQAWVATLR 791
RD+ + N+L+ + +ADFGL+R+I Y+ + + + PE +++
Sbjct: 127 RDLAARNVLVGENNICKVADFGLARVIKEDIYEAREGAKF--PIKWTAPEAALYNRFSIK 184
Query: 792 GDMYSFGVVMLELLT-GKRPVDVLKPKMSRELVGWVLKMRSEGKQDQVFDPILRGKGFDE 850
D++SFG+++ E++T G+ P P M+ VL+ +G ++ P K +
Sbjct: 185 SDVWSFGILLTEIVTYGRMPY----PGMTN---AEVLQQVDQGY--RMPCPPGCPKELYD 235
Query: 851 EMLQVLDVACMCVSQNPFKRPTVKEVVEW 879
ML C ++P RPT E ++W
Sbjct: 236 IMLD-------CWKEDPDDRPTF-ETLQW 256
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261 |
| >gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Score = 86.4 bits (214), Expect = 1e-18
Identities = 59/196 (30%), Positives = 96/196 (48%), Gaps = 9/196 (4%)
Query: 615 IGCGGFGLVYKATLANGTTLAIKKLSGDLGLMERE-FKAEVEALSTAQHKNLVSLQGYCV 673
+G G FG V+ T +AIK L G M E F AE + QH LV L
Sbjct: 14 LGAGQFGEVWMGYYNGHTKVAIKSLKQ--GSMSPEAFLAEANLMKQLQHPRLVRLYAVVT 71
Query: 674 HQGFRLLIYSYMENGSLDYWLHEKADGASQLDWLTRLKIARGTSCGLAYMHQICEPHIVH 733
+ +I YMENGSL +L K +L + +A + G+A++ + + +H
Sbjct: 72 QEPI-YIITEYMENGSLVDFL--KTPEGIKLTINKLIDMAAQIAEGMAFIER---KNYIH 125
Query: 734 RDIKSSNILLDDQFEAHLADFGLSRLILPYQTHVTTELVGTLGYIPPEYGQAWVATLRGD 793
RD++++NIL+ + +ADFGL+RLI + + + PE T++ D
Sbjct: 126 RDLRAANILVSETLCCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGTFTIKSD 185
Query: 794 MYSFGVVMLELLTGKR 809
++SFG+++ E++T R
Sbjct: 186 VWSFGILLTEIVTYGR 201
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260 |
| >gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Score = 86.5 bits (215), Expect = 1e-18
Identities = 76/295 (25%), Positives = 124/295 (42%), Gaps = 51/295 (17%)
Query: 600 YELLKATDNFSQANIIGCGGFGLVYKAT-LANGTTLAIKKLS-GDLGLMERE-FKAEVEA 656
YE+L+ IG G FG V K ++G L K++ G++ E++ +EV
Sbjct: 2 YEVLE---------TIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNI 52
Query: 657 LSTAQHKNLVSLQGYCVHQGFR--LLIYSYME---NGSLD------YWLHEKADGASQLD 705
L +H N+V Y R +Y ME G L + +
Sbjct: 53 LRELKHPNIV---RYYDRIIDRSNQTLYIVMEYCEGGDLAQLIQKCKKERKYIEEEFIWR 109
Query: 706 WLTRLKIARGTSCGLAYMH--QICEPHIVHRDIKSSNILLDDQFEAHLADFGLSRLILPY 763
LT+L +A L H ++HRD+K +NI LD L DFGL++ IL +
Sbjct: 110 ILTQLLLA------LYECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAK-ILGH 162
Query: 764 QTHVTTELVGTLGYIPPEYGQAWVATLRGDMYSFGVVMLELLTGKRPVDVLKPKMSRELV 823
+ VGT Y+ PE + D++S G ++ EL P + +L
Sbjct: 163 DSSFAKTYVGTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPP---FTARNQLQLA 219
Query: 824 GWVLKMRSEGKQDQVFDPILRGKGFDEEMLQVLDVACMCVSQNPFKRPTVKEVVE 878
K++ EGK F I + E+ +V+ + + V +P KRP+ +E+++
Sbjct: 220 S---KIK-EGK----FRRI--PYRYSSELNEVIK-SMLNV--DPDKRPSTEELLQ 261
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265 |
| >gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Score = 86.1 bits (213), Expect = 2e-18
Identities = 67/212 (31%), Positives = 103/212 (48%), Gaps = 28/212 (13%)
Query: 614 IIGCGGFGLVYKATLA----NGTTLAIKKLSGDLGLME---REFKAEVEALSTAQHKNLV 666
+IG G FG V L +AIK L G E R+F +E + H N++
Sbjct: 11 VIGAGEFGEVCSGRLKLPGKREIPVAIKTLKA--GYTEKQRRDFLSEASIMGQFDHPNII 68
Query: 667 SLQGYCVHQGFRLLIYSYMENGSLDYWLHEKADGASQLDWLTRLKIARGTSCGLAYMHQI 726
L+G +++ YMENGSLD +L K DG Q + + + RG + G+ Y+ +
Sbjct: 69 HLEGVVTKSKPVMIVTEYMENGSLDAFL-RKHDG--QFTVIQLVGMLRGIASGMKYLSDM 125
Query: 727 CEPHIVHRDIKSSNILLDDQFEAHLADFGLSRLIL--PYQTHVTTELVGTLGYIP----- 779
VHRD+ + NIL++ ++DFGLSR++ P + T G IP
Sbjct: 126 ---GYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEAAYTTRG-----GKIPIRWTA 177
Query: 780 PEYGQAWVATLRGDMYSFGVVMLELLT-GKRP 810
PE T D++S+G+VM E+++ G+RP
Sbjct: 178 PEAIAYRKFTSASDVWSYGIVMWEVMSYGERP 209
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267 |
| >gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Score = 85.0 bits (211), Expect = 5e-18
Identities = 60/206 (29%), Positives = 95/206 (46%), Gaps = 29/206 (14%)
Query: 615 IGCGGFGLVYKAT-LANGTTLAIKKLSGD--LGLMEREFKAEVEALSTAQHKNLVSLQG- 670
IG G G+V+KA G T+A+KK++ G + + E++AL QH +V L
Sbjct: 8 IGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDV 67
Query: 671 YCVHQGFRLLIYSYMENGSLDYWLHEKAD--GASQLDWLTRLKIARGTSCGLAYMHQICE 728
+ GF +L+ YM L L ++ +Q+ R+ + G+AYMH
Sbjct: 68 FPHGSGF-VLVMEYMP-SDLSEVLRDEERPLPEAQVKSYMRMLLK-----GVAYMH---A 117
Query: 729 PHIVHRDIKSSNILLDDQFEAHLADFGLSRLILPYQTHVTTELVGTLGYIPPE------- 781
I+HRD+K +N+L+ +ADFGL+RL + + + V T Y PE
Sbjct: 118 NGIMHRDLKPANLLISADGVLKIADFGLARLFSEEEPRLYSHQVATRWYRAPELLYGARK 177
Query: 782 YGQAWVATLRGDMYSFGVVMLELLTG 807
Y D+++ G + ELL G
Sbjct: 178 YDPGV------DLWAVGCIFAELLNG 197
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286 |
| >gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Score = 85.1 bits (210), Expect = 5e-18
Identities = 73/295 (24%), Positives = 127/295 (43%), Gaps = 49/295 (16%)
Query: 615 IGCGGFGLVYKATLANGTT------LAIKKLSGDLGLMEREFKAEVEALSTAQHKNLVSL 668
+G G FG V+ A N + +A+K L ++F+ E E L+ QH+++V
Sbjct: 13 LGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKF 72
Query: 669 QGYCVHQGFRLLIYSYMENGSLDYWLHEKADGA------------SQLDWLTRLKIARGT 716
G C ++++ YM++G L+ +L A +L L IA
Sbjct: 73 YGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQI 132
Query: 717 SCGLAYMHQICEPHIVHRDIKSSNILLDDQFEAHLADFGLSRLILPYQT---HVTTELVG 773
+ G+ Y+ H VHRD+ + N L+ + DFG+SR + Y T V +
Sbjct: 133 ASGMVYL---ASQHFVHRDLATRNCLVGANLLVKIGDFGMSRDV--YSTDYYRVGGHTML 187
Query: 774 TLGYIPPEYGQAWVATLRGDMYSFGVVMLELLT-GKRPVDVLKPKMSRELVGWVLKMRSE 832
+ ++PPE T D++SFGV++ E+ T GK+P L
Sbjct: 188 PIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSNTE-------------- 233
Query: 833 GKQDQVFDPILRGKGFDEEML---QVLDVACMCVSQNPFKRPTVKEVVEWLNNVG 884
V + I +G+ + + +V D+ C + P +R +KE+ + L+ +G
Sbjct: 234 -----VIECITQGRVLERPRVCPKEVYDIMLGCWQREPQQRLNIKEIYKILHALG 283
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291 |
| >gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 85.7 bits (213), Expect = 7e-18
Identities = 84/331 (25%), Positives = 125/331 (37%), Gaps = 96/331 (29%)
Query: 600 YELLKATDNFSQANIIGCGGFGLVYKAT-LANGTTLAIKKLSGDLGLMEREFKAEVEA-- 656
YELLK IG G +G+V A G +AIKK+S F ++A
Sbjct: 2 YELLK---------PIGSGAYGVVCSAVDKRTGRKVAIKKIS-------NVFDDLIDAKR 45
Query: 657 -------LSTAQHKNLVSLQGYCVHQGFRLL----------IY---SYMENGSLDYWLHE 696
L +H+N++ L +L +Y ME L +
Sbjct: 46 ILREIKLLRHLRHENIIGL--------LDILRPPSPEDFNDVYIVTELMET-DLHKVIKS 96
Query: 697 KADGASQLDWLTRLKIARGTS---CGLAYMHQICEPHIVHRDIKSSNILLDDQFEAHLAD 753
LT I GL Y+H +++HRD+K SNIL++ + + D
Sbjct: 97 PQP-------LTDDHIQYFLYQILRGLKYLH---SANVIHRDLKPSNILVNSNCDLKICD 146
Query: 754 FGLSRLILPYQTHVT--TELVGTLGYIPPE-------YGQAWVATLRGDMYSFGVVMLEL 804
FGL+R + P + TE V T Y PE Y +A + D++S G + EL
Sbjct: 147 FGLARGVDPDEDEKGFLTEYVVTRWYRAPELLLSSSRYTKA-I-----DIWSVGCIFAEL 200
Query: 805 LTGKRP--------------VDVL-KPKMSRELVGWVL--KMRSEGKQDQVFDPILRGKG 847
LT K P V+VL P S E + ++ K R+ K K
Sbjct: 201 LTRK-PLFPGRDYIDQLNLIVEVLGTP--SEEDLKFITSEKARNYLKSLPKKPKKPLSKL 257
Query: 848 FDEEMLQVLDVACMCVSQNPFKRPTVKEVVE 878
F + +D+ + +P KR T E +
Sbjct: 258 FPGASPEAIDLLEKMLVFDPKKRITADEALA 288
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330 |
| >gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Score = 84.6 bits (210), Expect = 7e-18
Identities = 65/222 (29%), Positives = 97/222 (43%), Gaps = 46/222 (20%)
Query: 607 DNFSQANIIGCGGFGLVYKAT-LANGTTLAIKKLSGDLGLMEREFKAEVEALSTAQHKNL 665
N + IG G G VYKAT A G +AIKK+ E E+ + +H N+
Sbjct: 22 KNLEK---IGEGASGEVYKATDRATGKEVAIKKMRLRKQNKELIIN-EILIMKDCKHPNI 77
Query: 666 VSLQGYCVHQGFRLLIYSYMENGSLDYWL-HEKADGASQLDWLT----RLK------IAR 714
V SY+ L W+ E DG S D +T R+ + R
Sbjct: 78 VDY------------YDSYLVGDEL--WVVMEYMDGGSLTDIITQNFVRMNEPQIAYVCR 123
Query: 715 GTSCGLAYMHQICEPHIVHRDIKSSNILLDDQFEAHLADFGLSRLILPYQTHVTTELVGT 774
GL Y+H +++HRDIKS NILL LADFG + + ++ + +VGT
Sbjct: 124 EVLQGLEYLHSQ---NVIHRDIKSDNILLSKDGSVKLADFGFAAQLTKEKSKRNS-VVGT 179
Query: 775 LGYIPPE------YGQAWVATLRGDMYSFGVVMLELLTGKRP 810
++ PE YG + D++S G++ +E+ G+ P
Sbjct: 180 PYWMAPEVIKRKDYGP------KVDIWSLGIMCIEMAEGEPP 215
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286 |
| >gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Score = 84.9 bits (210), Expect = 7e-18
Identities = 60/220 (27%), Positives = 97/220 (44%), Gaps = 33/220 (15%)
Query: 615 IGCGGFGLVYKATLANG-------TTLAIKKLSGDLGL-MEREFKAEVEALSTAQHKNLV 666
IG G FG V++A A G T +A+K L + M+ +F+ E ++ H N+V
Sbjct: 13 IGQGAFGRVFQAR-APGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHPNIV 71
Query: 667 SLQGYCVHQGFRLLIYSYMENGSLD--------YWLHEKADGAS----------QLDWLT 708
L G C L++ YM G L+ + S L
Sbjct: 72 KLLGVCAVGKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTE 131
Query: 709 RLKIARGTSCGLAYMHQICEPHIVHRDIKSSNILLDDQFEAHLADFGLSRLILP--YQTH 766
+L IA+ + G+AY+ E VHRD+ + N L+ + +ADFGLSR I Y
Sbjct: 132 QLCIAKQVAAGMAYL---SERKFVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKA 188
Query: 767 VTTELVGTLGYIPPEYGQAWVATLRGDMYSFGVVMLELLT 806
+ + + ++PPE T D++++GVV+ E+ +
Sbjct: 189 SENDAI-PIRWMPPESIFYNRYTTESDVWAYGVVLWEIFS 227
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288 |
| >gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 84.5 bits (209), Expect = 9e-18
Identities = 75/278 (26%), Positives = 124/278 (44%), Gaps = 41/278 (14%)
Query: 615 IGCGGFGLVYKAT-LANGTTLAIKK-LSGDLGLMEREFKAEVEALSTAQHKNLVSLQGYC 672
+G G G V K + GT +A K G + ++ E++ + + +VS G
Sbjct: 13 LGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQILRELQIMHECRSPYIVSFYGAF 72
Query: 673 VHQGFRLLIYSYMENGSLDYWLHEKADGASQLDWLTRLKIARGTSCGLAYMHQICEPHIV 732
+++ + +M+ GSLD K G ++ L KIA GL Y++ I+
Sbjct: 73 LNENNICMCMEFMDCGSLDRIY--KKGGPIPVEILG--KIAVAVVEGLTYLYN--VHRIM 126
Query: 733 HRDIKSSNILLDDQFEAHLADFGLS-RLILPYQTHVTTELVGTLGYIPPEYGQAWVATLR 791
HRDIK SNIL++ + + L DFG+S LI + VGT Y+ PE Q T++
Sbjct: 127 HRDIKPSNILVNSRGQIKLCDFGVSGELI----NSIADTFVGTSTYMSPERIQGGKYTVK 182
Query: 792 GDMYSFGVVMLELLTGKRPVDVLKPKMSRELVGWVLKMRSEGKQDQ--VFD--------- 840
D++S G+ ++EL GK P S +G+ D + D
Sbjct: 183 SDVWSLGISIIELALGKFPFA-----FSNID--------DDGQDDPMGILDLLQQIVQEP 229
Query: 841 -PILRGKGFDEEMLQVLDVACMCVSQNPFKRPTVKEVV 877
P L F E++ +D C+ ++P +RPT +++
Sbjct: 230 PPRLPSSDFPEDLRDFVDA---CLLKDPTERPTPQQLC 264
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284 |
| >gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Score = 84.3 bits (208), Expect = 1e-17
Identities = 61/215 (28%), Positives = 101/215 (46%), Gaps = 24/215 (11%)
Query: 615 IGCGGFGLVYKATLAN------GTTLAIKKLSGDLGLMEREFKAEVEALSTAQHKNLVSL 668
+G G FG V+ A N +A+K L ++F E E L+ QH+++V
Sbjct: 13 LGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKF 72
Query: 669 QGYCVHQGFRLLIYSYMENGSLDYWLHEKADGA---------SQLDWLTRLKIARGTSCG 719
G CV ++++ YM++G L+ +L A ++L L IA+ + G
Sbjct: 73 YGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAG 132
Query: 720 LAYMHQICEPHIVHRDIKSSNILLDDQFEAHLADFGLSRLILPYQT---HVTTELVGTLG 776
+ Y+ H VHRD+ + N L+ + + DFG+SR + Y T V + +
Sbjct: 133 MVYL---ASQHFVHRDLATRNCLVGENLLVKIGDFGMSRDV--YSTDYYRVGGHTMLPIR 187
Query: 777 YIPPEYGQAWVATLRGDMYSFGVVMLELLT-GKRP 810
++PPE T D++S GVV+ E+ T GK+P
Sbjct: 188 WMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQP 222
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288 |
| >gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Score = 83.4 bits (206), Expect = 1e-17
Identities = 71/276 (25%), Positives = 122/276 (44%), Gaps = 30/276 (10%)
Query: 613 NIIGCGGFGLVYKATLAN-GTTLAIKKLSGDLGLMEREFKAEVEALSTAQHKNLVSLQGY 671
+ +G G +G VY+ T+A+K L D +E EF E + +H NLV L G
Sbjct: 12 HKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVE-EFLKEAAVMKEIKHPNLVQLLGV 70
Query: 672 CVHQGFRLLIYSYMENGSLDYWLHEKADGASQLDWLTRLKIARGTSCGLAYMHQICEPHI 731
C + +I +M G+L +L E +++ + L +A S + Y+ + +
Sbjct: 71 CTREPPFYIITEFMTYGNLLDYLRE--CNRQEVNAVVLLYMATQISSAMEYLEK---KNF 125
Query: 732 VHRDIKSSNILLDDQFEAHLADFGLSRLIL--PYQTHVTTELVGTLGYIPPEYGQAWVAT 789
+HRD+ + N L+ + +ADFGLSRL+ Y H + + + PE +
Sbjct: 126 IHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKF--PIKWTAPESLAYNKFS 183
Query: 790 LRGDMYSFGVVMLELLT-GKRPVDVLKPKMSRELVGWVLKM-RSEGKQDQVFDPILRGKG 847
++ D+++FGV++ E+ T G P + EL+ +M R EG +V+
Sbjct: 184 IKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKGYRMERPEGCPPKVY-------- 235
Query: 848 FDEEMLQVLDVACMCVSQNPFKRPTVKEVVEWLNNV 883
E M C NP RP+ E+ + +
Sbjct: 236 --ELMRA-------CWQWNPSDRPSFAEIHQAFETM 262
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263 |
| >gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 83.1 bits (206), Expect = 2e-17
Identities = 79/303 (26%), Positives = 126/303 (41%), Gaps = 72/303 (23%)
Query: 597 LTIYELLKATDNFSQANIIGCGGFGLVYKA-TLANGTTLAIKKLSGDLGLMEREFKAEVE 655
YEL++ IG G +G VYKA +A G +AIK + + G + E+
Sbjct: 2 QEDYELIQR---------IGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEIS 52
Query: 656 ALSTAQHKNLVSLQGYCVHQGFRLLIYSYMENGSLDYWLHEKADGASQLDWLTRLKIA-- 713
L +H N+V+ G + + ++ Y GSL G L+ L+IA
Sbjct: 53 MLKECRHPNIVAYFGSYLRRDKLWIVMEYCGGGSLQDIYQV-TRGP-----LSELQIAYV 106
Query: 714 -RGTSCGLAYMHQICEPHIVHRDIKSSNILLDDQFEAHLADFGLSRLILPYQTHVT---T 769
R T GLAY+H+ +HRDIK +NILL + + LADFG+S + T
Sbjct: 107 CRETLKGLAYLHET---GKIHRDIKGANILLTEDGDVKLADFGVSAQL----TATIAKRK 159
Query: 770 ELVGTLGYIPPE---------YGQAWVATLRGDMYSFGVVMLELLTGKRPVDVLKPKMSR 820
+GT ++ PE Y + D+++ G+ +EL + P+ L P
Sbjct: 160 SFIGTPYWMAPEVAAVERKGGYDG------KCDIWALGITAIELAELQPPMFDLHP---- 209
Query: 821 ELVGWVLKMRSEGKQDQVFDPILRGKGFDEEMLQ--------VLDVACMCVSQNPFKRPT 872
MR+ +F ++ F L+ D C++++P KRPT
Sbjct: 210 --------MRA------LF--LISKSNFPPPKLKDKEKWSPVFHDFIKKCLTKDPKKRPT 253
Query: 873 VKE 875
+
Sbjct: 254 ATK 256
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262 |
| >gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 83.2 bits (206), Expect = 2e-17
Identities = 75/291 (25%), Positives = 122/291 (41%), Gaps = 54/291 (18%)
Query: 615 IGCGGFGLVYKATLAN------GTTLAIKKLSGDLGLMER-EFKAEVEALSTAQHKNLVS 667
+G G FG+VY+ T +AIK ++ + + ER EF E + ++V
Sbjct: 14 LGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHVVR 73
Query: 668 LQGYCVHQGFRLLIYSYMENGSLDYWLHE---KADGASQLDWLTRLKI---ARGTSCGLA 721
L G L++ M G L +L +A+ L T K A + G+A
Sbjct: 74 LLGVVSTGQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMA 133
Query: 722 YMHQICEPHIVHRDIKSSNILLDDQFEAHLADFGLSRLILPYQTHVTTELVGTLGYIP-- 779
Y+ VHRD+ + N ++ + + DFG++R I Y+T + G G +P
Sbjct: 134 YLA---AKKFVHRDLAARNCMVAEDLTVKIGDFGMTRDI--YETDYYRK--GGKGLLPVR 186
Query: 780 ---PEYGQAWVATLRGDMYSFGVVMLELLT-GKRPVDVLKPKMSRELVGWVLKMRSEGKQ 835
PE + V T + D++SFGVV+ E+ T ++P +G
Sbjct: 187 WMAPESLKDGVFTTKSDVWSFGVVLWEMATLAEQPY--------------------QGLS 226
Query: 836 -DQVFDPILRGKGFD-----EEMLQVLDVACMCVSQNPFKRPTVKEVVEWL 880
++V ++ G D + L L++ MC NP RPT E+V L
Sbjct: 227 NEEVLKFVIDGGHLDLPENCPDKL--LELMRMCWQYNPKMRPTFLEIVSSL 275
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 86.4 bits (214), Expect = 3e-17
Identities = 58/155 (37%), Positives = 78/155 (50%), Gaps = 17/155 (10%)
Query: 334 NLLSGEFPKELTALP----------ALVSEAANDEVDRSYLELPVFVMPSNATNQQ---- 379
N+LSGE P ++ + LV + N + + LE + SN Q
Sbjct: 150 NMLSGEIPNDIGSFSSLKVLDLGGNVLVGKIPNSLTNLTSLE--FLTLASNQLVGQIPRE 207
Query: 380 YNQLSNLPPAIYLANNSLSGNIPVEIGQLKSLHVLDLSNNNFSGTIPDELSDLSNLEKLD 439
Q+ +L IYL N+LSG IP EIG L SL+ LDL NN +G IP L +L NL+ L
Sbjct: 208 LGQMKSLK-WIYLGYNNLSGEIPYEIGGLTSLNHLDLVYNNLTGPIPSSLGNLKNLQYLF 266
Query: 440 LSGNHLVGEIPISLKGLHFLSSFSVAHNNLQGAVP 474
L N L G IP S+ L L S ++ N+L G +P
Sbjct: 267 LYQNKLSGPIPPSIFSLQKLISLDLSDNSLSGEIP 301
|
Length = 968 |
| >gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 82.6 bits (204), Expect = 3e-17
Identities = 69/293 (23%), Positives = 126/293 (43%), Gaps = 54/293 (18%)
Query: 608 NFSQANIIGCGGFGLVYKAT-LANGTTLAIKKLS------GDLGLMEREFKAEVEALSTA 660
+ + +G G F Y+A + GT +A+K+++ + + + E+ ++
Sbjct: 1 EWLKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARL 60
Query: 661 QHKNLVSLQGYCVHQGFRLLIYSYMENGSLDYWLHEKADGASQLDWLTR--LKIARGTSC 718
H +++ + G L +M GS+ + L + GA + + ++ RG
Sbjct: 61 NHPHIIRMLGATCEDSHFNLFVEWMAGGSVSHLLSKY--GAFKEAVIINYTEQLLRG--- 115
Query: 719 GLAYMHQICEPHIVHRDIKSSNILLDDQFE-AHLADFGLSRLILPYQT---HVTTELVGT 774
L+Y+H E I+HRD+K +N+L+D + +ADFG + + T +L+GT
Sbjct: 116 -LSYLH---ENQIIHRDVKGANLLIDSTGQRLRIADFGAAARLAAKGTGAGEFQGQLLGT 171
Query: 775 LGYIPPEYGQAWVATLRG-------DMYSFGVVMLELLTGKRPVDVLKPKMSRELVGWVL 827
+ ++ PE LRG D++S G V++E+ T K P + K S L +
Sbjct: 172 IAFMAPE-------VLRGEQYGRSCDVWSVGCVIIEMATAKPPWN--AEKHSNHL-ALIF 221
Query: 828 KMRSEGKQDQV---FDPILRGKGFDEEMLQVLDVACMCVSQNPFKRPTVKEVV 877
K+ S + P LR DV C+ P RP +E++
Sbjct: 222 KIASATTAPSIPEHLSPGLR------------DVTLRCLELQPEDRPPSRELL 262
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268 |
| >gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 82.2 bits (203), Expect = 3e-17
Identities = 68/218 (31%), Positives = 102/218 (46%), Gaps = 29/218 (13%)
Query: 608 NFSQANIIGCGGFGLVYKATLAN-GTTLAIKK-----LSGDLGLMEREFKAEVEALSTAQ 661
N+ + ++G G FG VY + G LA+K+ S + + E++ L Q
Sbjct: 3 NWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQ 62
Query: 662 HKNLVSLQGYCVHQGFRLLIY-SYMENGSLDYWLHEKADGASQLDWLTRLKIARGTSCGL 720
H+ +V G C+ L I+ YM GS+ L KA GA + +TR K R G+
Sbjct: 63 HERIVQYYG-CLRDDETLSIFMEYMPGGSVKDQL--KAYGALT-ETVTR-KYTRQILEGV 117
Query: 721 AYMHQICEPHIVHRDIKSSNILLDDQFEAHLADFGLSRLILPYQTHVT--TELVGTLGYI 778
Y+H IVHRDIK +NIL D L DFG S+ + + T + GT ++
Sbjct: 118 EYLH---SNMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICSSGTGMKSVTGTPYWM 174
Query: 779 PPE------YGQAWVATLRGDMYSFGVVMLELLTGKRP 810
PE YG+ + D++S G ++E+LT K P
Sbjct: 175 SPEVISGEGYGR------KADVWSVGCTVVEMLTEKPP 206
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263 |
| >gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Score = 81.8 bits (202), Expect = 3e-17
Identities = 72/266 (27%), Positives = 123/266 (46%), Gaps = 26/266 (9%)
Query: 615 IGCGGFGLVYKATLANGTTLAIKKLSGDLGLM-EREFKAEVEALSTAQHKNLVSLQGYCV 673
+G G FG+V+ +AIK ++ G M E +F E + + H LV L G C
Sbjct: 12 LGSGQFGVVHLGKWRAQIKVAIKAINE--GAMSEEDFIEEAKVMMKLSHPKLVQLYGVCT 69
Query: 674 HQGFRLLIYSYMENGSLDYWLHEKADGASQLDWLTRLKIARGTSCGLAYMHQICEPHIVH 733
Q ++ +MENG L +L ++ G D L L + + G+ Y+ + +H
Sbjct: 70 QQKPLYIVTEFMENGCLLNYLRQR-QGKLSKDML--LSMCQDVCEGMEYLER---NSFIH 123
Query: 734 RDIKSSNILLDDQFEAHLADFGLSRLILPYQTHVTTELVGTLGYIPPEYGQAWVATLRGD 793
RD+ + N L+ ++DFG++R +L + ++ + + PPE + + D
Sbjct: 124 RDLAARNCLVSSTGVVKVSDFGMTRYVLDDEYTSSSGAKFPVKWSPPEVFNFSKYSSKSD 183
Query: 794 MYSFGVVMLELLT-GKRPVDVLKPKMSRELVGWVLKMRSEGKQDQVFDPILRGKGFDEEM 852
++SFGV+M E+ T GK P + K + E V++M S G +++ P L
Sbjct: 184 VWSFGVLMWEVFTEGKMP---FEKKSNYE----VVEMISRG--FRLYRPKLASM------ 228
Query: 853 LQVLDVACMCVSQNPFKRPTVKEVVE 878
V +V C + P RPT E++
Sbjct: 229 -TVYEVMYSCWHEKPEGRPTFAELLR 253
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 86.4 bits (214), Expect = 4e-17
Identities = 60/160 (37%), Positives = 85/160 (53%), Gaps = 23/160 (14%)
Query: 334 NLLSGEFPKELTALPALVSEAANDEVDRSYLELPVFVMPS--NATNQQY-----NQLSN- 385
N LSGE P E+ L +L + +D Y L + S N N QY N+LS
Sbjct: 222 NNLSGEIPYEIGGLTSL------NHLDLVYNNLTGPIPSSLGNLKNLQYLFLYQNKLSGP 275
Query: 386 LPPAIY---------LANNSLSGNIPVEIGQLKSLHVLDLSNNNFSGTIPDELSDLSNLE 436
+PP+I+ L++NSLSG IP + QL++L +L L +NNF+G IP L+ L L+
Sbjct: 276 IPPSIFSLQKLISLDLSDNSLSGEIPELVIQLQNLEILHLFSNNFTGKIPVALTSLPRLQ 335
Query: 437 KLDLSGNHLVGEIPISLKGLHFLSSFSVAHNNLQGAVPSG 476
L L N GEIP +L + L+ ++ NNL G +P G
Sbjct: 336 VLQLWSNKFSGEIPKNLGKHNNLTVLDLSTNNLTGEIPEG 375
|
Length = 968 |
| >gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Score = 82.7 bits (204), Expect = 4e-17
Identities = 80/314 (25%), Positives = 129/314 (41%), Gaps = 58/314 (18%)
Query: 608 NFSQANIIGCGGFGLVYKAT------LANGTTLAIKKLSGDLGLME-REFKAEVEALSTA 660
N +G G FG V KAT A TT+A+K L + E R+ +E L
Sbjct: 1 NLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQV 60
Query: 661 QHKNLVSLQGYCVHQGFRLLIYSYMENGSLDYWLHEK--------------------ADG 700
H +++ L G C G LLI Y + GSL +L E
Sbjct: 61 NHPHVIKLYGACSQDGPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPD 120
Query: 701 ASQLDWLTRLKIARGTSCGLAYMHQICEPHIVHRDIKSSNILLDDQFEAHLADFGLSRLI 760
L + A S G+ Y+ E +VHRD+ + N+L+ + + ++DFGLSR +
Sbjct: 121 ERALTMGDLISFAWQISRGMQYL---AEMKLVHRDLAARNVLVAEGRKMKISDFGLSRDV 177
Query: 761 LPYQTHVTTELVGTLGYIP-----PEYGQAWVATLRGDMYSFGVVMLELLT-GKRPVDVL 814
++V + G IP E + T + D++SFGV++ E++T G P +
Sbjct: 178 YEEDSYVKR----SKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGI 233
Query: 815 KPKMSRELVGWVLKM-RSEGKQDQVFDPILRGKGFDEEMLQVLDVACMCVSQNPFKRPTV 873
P+ L+ +M R E +++++ +L C Q P KRPT
Sbjct: 234 APERLFNLLKTGYRMERPENCSEEMYNLMLT-----------------CWKQEPDKRPTF 276
Query: 874 KEVVEWLNNVGANR 887
++ + L +
Sbjct: 277 ADISKELEKMMVKS 290
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290 |
| >gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Score = 82.0 bits (202), Expect = 4e-17
Identities = 56/198 (28%), Positives = 98/198 (49%), Gaps = 9/198 (4%)
Query: 615 IGCGGFGLVYKATLANGTTLAIKKLSGDLGLMERE-FKAEVEALSTAQHKNLVSLQGYCV 673
+G G FG V+ N T +A+K L G M + F E + T QH LV L
Sbjct: 14 LGAGQFGEVWMGYYNNSTKVAVKTLKP--GTMSVQAFLEEANLMKTLQHDKLVRLYAVVT 71
Query: 674 HQGFRLLIYSYMENGSLDYWLHEKADGASQLDWLTRLKIARGTSCGLAYMHQICEPHIVH 733
+ +I YM GSL +L K+D ++ + + + G+AY+ + + +H
Sbjct: 72 KEEPIYIITEYMAKGSLLDFL--KSDEGGKVLLPKLIDFSAQIAEGMAYIER---KNYIH 126
Query: 734 RDIKSSNILLDDQFEAHLADFGLSRLILPYQTHVTTELVGTLGYIPPEYGQAWVATLRGD 793
RD++++N+L+ + +ADFGL+R+I + + + PE T++ D
Sbjct: 127 RDLRAANVLVSESLMCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINFGSFTIKSD 186
Query: 794 MYSFGVVMLELLT-GKRP 810
++SFG+++ E++T GK P
Sbjct: 187 VWSFGILLYEIVTYGKIP 204
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261 |
| >gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 82.2 bits (204), Expect = 5e-17
Identities = 63/219 (28%), Positives = 93/219 (42%), Gaps = 54/219 (24%)
Query: 615 IGCGGFGLVYKAT-LANGTTLAIKKLSGDLGLMEREFKA--------EVEALSTAQ-HKN 664
+G G FG VY A G +AIKK M+++F + EV++L H N
Sbjct: 7 LGDGTFGSVYLARNKETGELVAIKK-------MKKKFYSWEECMNLREVKSLRKLNEHPN 59
Query: 665 LVSL-----QGYCVHQGFRLLIYSYMENGSLDYWLHEKADGASQLDWLTRLKIARGTSCG 719
+V L + ++ ++ YME G+L Y L + G I G
Sbjct: 60 IVKLKEVFRENDELY-----FVFEYME-GNL-YQLMKDRKG-KPFSESVIRSIIYQILQG 111
Query: 720 LAYMHQICEPHIVHRDIKSSNILLDDQFEAHLADFGLSRLIL---PYQTHVTTELVGTLG 776
LA++H+ HRD+K N+L+ +ADFGL+R I PY T+ V T
Sbjct: 112 LAHIHKH---GFFHRDLKPENLLVSGPEVVKIADFGLAREIRSRPPY-----TDYVSTRW 163
Query: 777 YIPPE-------YGQAWVATLRGDMYSFGVVMLELLTGK 808
Y PE Y V D+++ G +M EL T +
Sbjct: 164 YRAPEILLRSTSYSSP-V-----DIWALGCIMAELYTLR 196
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283 |
| >gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Score = 81.4 bits (201), Expect = 6e-17
Identities = 67/279 (24%), Positives = 125/279 (44%), Gaps = 37/279 (13%)
Query: 608 NFSQANIIGCGGFGLVYKATLANGTTLAIKKLSGDLGLMEREFKA---EVEALSTAQHKN 664
+ + ++G G FG+V+ L I K + + E A E + L H N
Sbjct: 1 KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPN 60
Query: 665 LVSLQGYCVHQGFRLLIYSYMENGSLDYWLHEKA----DGASQLDWLTRLKIARGTSCGL 720
++ + +++ Y G+L ++ ++ D + L + ++ +A L
Sbjct: 61 IIEYYENFLEDKALMIVMEYAPGGTLAEYIQKRCNSLLDEDTILHFFVQILLA------L 114
Query: 721 AYMHQICEPHIVHRDIKSSNILLDD-QFEAHLADFGLSRLILPYQTHVTTELVGTLGYIP 779
++H I+HRD+K+ NILLD + + DFG+S+ IL ++ T +VGT YI
Sbjct: 115 HHVHT---KLILHRDLKTQNILLDKHKMVVKIGDFGISK-ILSSKSKAYT-VVGTPCYIS 169
Query: 780 PEYGQAWVATLRGDMYSFGVVMLELLTGKRPVDVLKPKMSRELVGWVLK-MRSEGKQDQV 838
PE + + D+++ G V+ EL + KR + + L VLK M
Sbjct: 170 PELCEGKPYNQKSDIWALGCVLYELASLKRAFE------AANLPALVLKIMSGT------ 217
Query: 839 FDPILRGKGFDEEMLQVLDVACMCVSQNPFKRPTVKEVV 877
F PI + ++ Q+ + M ++ +P KRP + +++
Sbjct: 218 FAPI--SDRYSPDLRQL--ILSM-LNLDPSKRPQLSQIM 251
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256 |
| >gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Score = 80.7 bits (199), Expect = 1e-16
Identities = 74/269 (27%), Positives = 125/269 (46%), Gaps = 34/269 (12%)
Query: 615 IGCGGFGLVYKATLANGTTLAIKKLSGDLGLMEREFKAEVEALSTAQHKNLVSLQGYCVH 674
+G G FG+V +AIK + + + E EF E + + H+ LV L G C
Sbjct: 12 LGTGQFGVVKYGKWRGQYDVAIKMIK-EGSMSEDEFIEEAKVMMKLSHEKLVQLYGVCTK 70
Query: 675 QGFRLLIYSYMENGSLDYWLHEKADG--ASQLDWLTRLKIARGTSCGLAYMHQICEPHIV 732
Q ++ YM NG L +L E SQL L++ + G+AY+ +
Sbjct: 71 QRPIYIVTEYMSNGCLLNYLREHGKRFQPSQL-----LEMCKDVCEGMAYLES---KQFI 122
Query: 733 HRDIKSSNILLDDQFEAHLADFGLSRLILPYQTHVTTELVGT---LGYIPPEYGQAWVAT 789
HRD+ + N L+DDQ ++DFGLSR +L + T VG+ + + PPE +
Sbjct: 123 HRDLAARNCLVDDQGCVKVSDFGLSRYVLDDE---YTSSVGSKFPVRWSPPEVLLYSKFS 179
Query: 790 LRGDMYSFGVVMLELLT-GKRPVDVLKPKMSRELVGWVLKMRSEGKQDQVFDPILRGKGF 848
+ D+++FGV+M E+ + GK P + + E V S+G +++ P L +
Sbjct: 180 SKSDVWAFGVLMWEVYSLGKMPYERFNNSETVEKV-------SQGL--RLYRPHLASE-- 228
Query: 849 DEEMLQVLDVACMCVSQNPFKRPTVKEVV 877
+V + C + +RPT ++++
Sbjct: 229 -----KVYAIMYSCWHEKAEERPTFQQLL 252
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256 |
| >gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 80.9 bits (200), Expect = 1e-16
Identities = 57/219 (26%), Positives = 96/219 (43%), Gaps = 29/219 (13%)
Query: 609 FSQANIIGCGGFGLVYKATL-----ANGTTLAIKKLSGDLG-LMEREFKAEVEALSTAQH 662
+ ++G G FG VYK +AIK L + +E E +++ H
Sbjct: 9 LEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDH 68
Query: 663 KNLVSLQGYCVHQGFRLLIYSYMENGSLDYWLHEKAD--GASQ-LDWLTRLKIARGTSCG 719
++V L G C+ LI M G L ++ D G+ L+W +IA+G
Sbjct: 69 PHVVRLLGICLSSQV-QLITQLMPLGCLLDYVRNHKDNIGSQYLLNWCV--QIAKG---- 121
Query: 720 LAYMHQICEPHIVHRDIKSSNILLDDQFEAHLADFGLSRLILPYQTHVTTELVGTLGYIP 779
M + E +VHRD+ + N+L+ + DFGL++L+ + E G +P
Sbjct: 122 ---MSYLEEKRLVHRDLAARNVLVKTPQHVKITDFGLAKLLDVDEKEYHAE----GGKVP 174
Query: 780 -----PEYGQAWVATLRGDMYSFGVVMLELLT-GKRPVD 812
E + T + D++S+GV + EL+T G +P +
Sbjct: 175 IKWMALESILHRIYTHKSDVWSYGVTVWELMTFGAKPYE 213
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279 |
| >gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 80.2 bits (198), Expect = 1e-16
Identities = 60/219 (27%), Positives = 102/219 (46%), Gaps = 23/219 (10%)
Query: 615 IGCGGFGLVYKATLANGTTLAIKKLSGDL-GLMEREFKAEVEALSTAQHKNLVSLQGYCV 673
IG G FG VYK L T +A+K L ++R+F E E L H N+V L G CV
Sbjct: 3 IGKGNFGDVYKGVLKGNTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGVCV 62
Query: 674 HQGFRLLIYSYMENGSLDYWLHEKADGASQLDWLTRLKIARGTSCGLAYMHQICEPHIVH 733
+ ++ + GSL +L +K + +L L+++ + G+ Y+ +H
Sbjct: 63 QKQPIYIVMELVPGGSLLTFLRKKKN---RLTVKKLLQMSLDAAAGMEYLESKN---CIH 116
Query: 734 RDIKSSNILLDDQFEAHLADFGLSRLILPYQTHVTTELVGTLGYIP-----PE---YGQA 785
RD+ + N L+ + ++DFG+SR + + L IP PE YG+
Sbjct: 117 RDLAARNCLVGENNVLKISDFGMSR----EEEGGIYTVSDGLKQIPIKWTAPEALNYGR- 171
Query: 786 WVATLRGDMYSFGVVMLELLT-GKRPVDVLKPKMSRELV 823
T D++S+G+++ E + G P + + +RE +
Sbjct: 172 --YTSESDVWSYGILLWETFSLGDTPYPGMSNQQTRERI 208
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251 |
| >gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 80.7 bits (199), Expect = 1e-16
Identities = 67/212 (31%), Positives = 96/212 (45%), Gaps = 38/212 (17%)
Query: 615 IGCGGFGLV--YKATLAN---GTTLAIKKLSGDLGLMERE-FKAEVEALSTAQHKNLVSL 668
+G G FG V Y AN G +A+K L + G +K E+ L T H+N+V
Sbjct: 12 LGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIVKY 71
Query: 669 QGYCVHQGFR--LLIYSYMENGSLDYWLHEKADGASQLDWLTRLKIARGTSCGLAYMHQI 726
+G C QG + LI Y+ GSL +L + +QL L A+ G+AY+H
Sbjct: 72 KGCCSEQGGKGLQLIMEYVPLGSLRDYLPKHKLNLAQL-----LLFAQQICEGMAYLHS- 125
Query: 727 CEPHIVHRDIKSSNILLDDQFEAHLADFGLSRLILPYQTHVTTELVGTLGYIPPEYGQA- 785
H +HRD+ + N+LLD+ + DFGL++ V G Y E G +
Sbjct: 126 --QHYIHRDLAARNVLLDNDRLVKIGDFGLAK-------AVPE---GHEYYRVREDGDSP 173
Query: 786 --WVAT---------LRGDMYSFGVVMLELLT 806
W A D++SFGV + ELLT
Sbjct: 174 VFWYAVECLKENKFSYASDVWSFGVTLYELLT 205
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283 |
| >gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Score = 80.1 bits (197), Expect = 2e-16
Identities = 74/272 (27%), Positives = 122/272 (44%), Gaps = 30/272 (11%)
Query: 615 IGCGGFGLVYKATLANGTTLAIKKLSGDLGLMERE-FKAEVEALSTAQHKNLVSLQGYCV 673
+G G FG V+ T T +AIK L G M E F E + + +H+ LV L
Sbjct: 14 LGQGCFGEVWMGTWNGTTRVAIKTLKP--GTMSPEAFLQEAQVMKKLRHEKLVQLYAVVS 71
Query: 674 HQGFRLLIYSYMENGSLDYWLHEKADGASQLDWLTRLKIARGTSCGLAYMHQICEPHIVH 733
+ ++ YM GSL +L K + L + +A + G+AY+ ++ + VH
Sbjct: 72 EEPI-YIVTEYMSKGSLLDFL--KGEMGKYLRLPQLVDMAAQIASGMAYVERM---NYVH 125
Query: 734 RDIKSSNILLDDQFEAHLADFGLSRLILPYQTHVTTELVGTLGYIPPEYGQAWVATLRGD 793
RD++++NIL+ + +ADFGL+RLI + + + PE T++ D
Sbjct: 126 RDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSD 185
Query: 794 MYSFGVVMLELLTGKRPVDVLKPKMSRELVGWVLKMRSEGKQDQVFDPILRGKGF---DE 850
++SFG+++ EL T R V P M +V D + RG E
Sbjct: 186 VWSFGILLTELTTKGR---VPYPGMVNR---------------EVLDQVERGYRMPCPPE 227
Query: 851 EMLQVLDVACMCVSQNPFKRPTVKEVVEWLNN 882
+ D+ C C + P +RPT + + +L +
Sbjct: 228 CPESLHDLMCQCWRKEPEERPTFEYLQAFLED 259
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262 |
| >gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 80.1 bits (198), Expect = 2e-16
Identities = 65/282 (23%), Positives = 122/282 (43%), Gaps = 44/282 (15%)
Query: 615 IGCGGFGLVYKAT--LANGT--TLAIKKLS-GDLGLMEREFKAEVEALSTAQHKNLVSLQ 669
+G G FG V K + +G +A+K L + ++EF E ++ H +V L
Sbjct: 3 LGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLI 62
Query: 670 GYCVHQGFRLLIYSYMENGSLDYWLHEKAD--GASQLDWLTRLKIARGTSCGLAYMHQIC 727
G C + +L+ G L +L ++ + + + ++ + G+AY+
Sbjct: 63 GVCKGEPL-MLVMELAPLGPLLKYLKKRREIPVSDLKELAHQV------AMGMAYLE--- 112
Query: 728 EPHIVHRDIKSSNILLDDQFEAHLADFGLSRLILPYQTHVTTELVGT--LGYIPPE---Y 782
H VHRD+ + N+LL ++ +A ++DFG+SR + + G L + PE Y
Sbjct: 113 SKHFVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYRATTAGRWPLKWYAPECINY 172
Query: 783 GQAWVATLRGDMYSFGVVMLELLT-GKRPVDVLKPKMSRELVGW-VLKMRSEGKQDQVFD 840
G+ + + D++S+GV + E + G +P E+ G V+ M G++
Sbjct: 173 GK---FSSKSDVWSYGVTLWEAFSYGAKPY--------GEMKGAEVIAMLESGER----- 216
Query: 841 PILRGKGFDEEMLQVLDVACMCVSQNPFKRPTVKEVVEWLNN 882
+ R + +E+ ++ C P RPT E+
Sbjct: 217 -LPRPEECPQEIYSIML---SCWKYRPEDRPTFSELESTFRR 254
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257 |
| >gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Score = 79.4 bits (196), Expect = 2e-16
Identities = 60/283 (21%), Positives = 122/283 (43%), Gaps = 47/283 (16%)
Query: 608 NFSQANIIGCGGFGLVYKAT-LANGTTLAIKKLSGDLGLMEREFKA----EVEALSTAQH 662
+F +G G +G VYK L++ A+K++ DLG M ++ + E+ L++ H
Sbjct: 1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEV--DLGSMSQKEREDAVNEIRILASVNH 58
Query: 663 KNLVSLQGYCVHQGF----RLLIYS-YMENGSLDYWLHEKADGASQLD----WLTRLKIA 713
N++ + F +L I Y G L + ++ + W +++
Sbjct: 59 PNII-----SYKEAFLDGNKLCIVMEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLL 113
Query: 714 RGTSCGLAYMHQICEPHIVHRDIKSSNILLDDQFEAHLADFGLSRLILPYQTHVTTELVG 773
RG +H E I+HRD+KS+NILL + D G+S+++ + ++ +G
Sbjct: 114 RGLQA----LH---EQKILHRDLKSANILLVANDLVKIGDLGISKVL---KKNMAKTQIG 163
Query: 774 TLGYIPPEYGQAWVATLRGDMYSFGVVMLELLTGKRPVDVLKPKMSRELVGWVLKMRSEG 833
T Y+ PE + + + D++S G ++ E+ T P + + ++L V + +
Sbjct: 164 TPHYMAPEVWKGRPYSYKSDIWSLGCLLYEMATFAPP---FEARSMQDLRYKVQRGK--- 217
Query: 834 KQDQVFDPILRGKGFDEEMLQVLDVACMCVSQNPFKRPTVKEV 876
+ PI + +++ + + P RP ++
Sbjct: 218 -----YPPI--PPIYSQDLQNFIR---SMLQVKPKLRPNCDKI 250
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256 |
| >gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 79.7 bits (197), Expect = 3e-16
Identities = 57/208 (27%), Positives = 88/208 (42%), Gaps = 32/208 (15%)
Query: 615 IGCGGFGLVYKA-TLANGTTLAIKKLSGDLGLMEREFKA----EVEALSTAQHKNLVSLQ 669
IG G +G+VYKA G +AIKK+ L E++ L H N++ L
Sbjct: 7 IGEGTYGVVYKARDKLTGEIVAIKKIK--LRFESEGIPKTALREIKLLKELNHPNIIKLL 64
Query: 670 GYCVHQGFRLLIYSYMENGSLDYWLHEKADGASQLDWLTRLK-IARGTSCGLAYMHQICE 728
H+G L++ +M+ L++ + + +K GLA+ H
Sbjct: 65 DVFRHKGDLYLVFEFMDTD-----LYKLIKDRQRGLPESLIKSYLYQLLQGLAFCHS--- 116
Query: 729 PH-IVHRDIKSSNILLDDQFEAHLADFGLSRLILPYQTHVTTELVGTLGYIPPE------ 781
H I+HRD+K N+L++ + LADFGL+R T V T Y PE
Sbjct: 117 -HGILHRDLKPENLLINTEGVLKLADFGLARSFGS-PVRPYTHYVVTRWYRAPELLLGDK 174
Query: 782 -YGQAWVATLRGDMYSFGVVMLELLTGK 808
Y D++S G + ELL+ +
Sbjct: 175 GYSTPV------DIWSVGCIFAELLSRR 196
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283 |
| >gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 79.7 bits (197), Expect = 3e-16
Identities = 61/206 (29%), Positives = 92/206 (44%), Gaps = 24/206 (11%)
Query: 615 IGCGGFGLVYKA-TLANGTTLAIKKL--SGDLGLMEREFKAEVEALSTAQHKNLVSLQGY 671
+G G +G+V K A G +AIKK S D +++ EV+ L +H+N+V+L+
Sbjct: 9 VGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLKEA 68
Query: 672 CVHQGFRLLIYSYMENGSLDYWLHEKADGASQLDWLTRLKIARGTSCGLAYMHQICEPHI 731
+G L++ Y+E L+ L G L +AY H +I
Sbjct: 69 FRRKGRLYLVFEYVERTLLEL-LEASPGG---LPPDAVRSYIWQLLQAIAYCHSH---NI 121
Query: 732 VHRDIKSSNILLDDQFEAHLADFGLSRLILPYQTHVTTELVGTLGYIPPE-------YGQ 784
+HRDIK NIL+ + L DFG +R + T+ V T Y PE YG+
Sbjct: 122 IHRDIKPENILVSESGVLKLCDFGFARALRARPASPLTDYVATRWYRAPELLVGDTNYGK 181
Query: 785 AWVATLRGDMYSFGVVMLELLTGKRP 810
D+++ G +M ELL G P
Sbjct: 182 P------VDVWAIGCIMAELLDG-EP 200
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288 |
| >gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Score = 79.4 bits (196), Expect = 3e-16
Identities = 63/205 (30%), Positives = 101/205 (49%), Gaps = 19/205 (9%)
Query: 613 NIIGCGGFGLVYKATL----ANGTTLAIKKLS--GDLGLMEREFKAEVEALSTAQHKNLV 666
+IG G FG VY TL A+K L+ DL +E +F E + H N++
Sbjct: 1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVE-QFLKEGIIMKDFSHPNVL 59
Query: 667 SLQGYCV-HQGFRLLIYSYMENGSLDYWLHEKADGASQLDWLT-RLKIARGTSCGLAYMH 724
SL G C+ +G L++ YM++G L ++ + + D + L++A+G M
Sbjct: 60 SLLGICLPSEGSPLVVLPYMKHGDLRNFIRSETHNPTVKDLIGFGLQVAKG-------ME 112
Query: 725 QICEPHIVHRDIKSSNILLDDQFEAHLADFGLSRLILP---YQTHVTTELVGTLGYIPPE 781
+ VHRD+ + N +LD+ F +ADFGL+R I Y H T + ++ E
Sbjct: 113 YLASKKFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYSVHNHTGAKLPVKWMALE 172
Query: 782 YGQAWVATLRGDMYSFGVVMLELLT 806
Q T + D++SFGV++ EL+T
Sbjct: 173 SLQTQKFTTKSDVWSFGVLLWELMT 197
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262 |
| >gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 79.5 bits (196), Expect = 3e-16
Identities = 69/281 (24%), Positives = 122/281 (43%), Gaps = 36/281 (12%)
Query: 614 IIGCGGFGLVYKA-TLANGTTLAIKKLSGDLGLMERE----------FKAEVEALSTAQH 662
+IG G +G VY A + G +A+K++ + R ++E+E L H
Sbjct: 8 LIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDH 67
Query: 663 KNLVSLQGYCVHQGFRLLIYSYMENGSLDYWLHEKADGASQLDWLTRLKIARGTSCGLAY 722
N+V G+ + + + Y+ GS+ L QL R GLAY
Sbjct: 68 LNIVQYLGFETTEEYLSIFLEYVPGGSIGSCLRTYGRFEEQL---VRF-FTEQVLEGLAY 123
Query: 723 MHQICEPHIVHRDIKSSNILLDDQFEAHLADFGLSRLILP-YQTHVTTELVGTLGYIPPE 781
+H I+HRD+K+ N+L+D ++DFG+S+ Y + G++ ++ PE
Sbjct: 124 LHS---KGILHRDLKADNLLVDADGICKISDFGISKKSDDIYDNDQNMSMQGSVFWMAPE 180
Query: 782 ----YGQAWVATLRGDMYSFGVVMLELLTGKRPVDVLKPKMSRELVGWVLKMRSEGKQDQ 837
Y Q + A + D++S G V+LE+ G+RP E + + K+ ++
Sbjct: 181 VIHSYSQGYSAKV--DIWSLGCVVLEMFAGRRPWSDE------EAIAAMFKLGNKRSAPP 232
Query: 838 VFDPILRGKGFDEEMLQVLDVACMCVSQNPFKRPTVKEVVE 878
+ + L L+ C + NP RPT +E+++
Sbjct: 233 IPPDVS--MNLSPVALDFLNA---CFTINPDNRPTARELLQ 268
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 82.6 bits (204), Expect = 5e-16
Identities = 49/129 (37%), Positives = 72/129 (55%), Gaps = 17/129 (13%)
Query: 358 EVDRSYLELPVFVMPSNATNQQYNQLS-NLPPAIY----------LANNSLSGNIPVEIG 406
++ + LP ++ N +N NQLS +P I+ L+NN+ +G+IP G
Sbjct: 84 KISSAIFRLP-YIQTINLSN---NQLSGPIPDDIFTTSSSLRYLNLSNNNFTGSIPR--G 137
Query: 407 QLKSLHVLDLSNNNFSGTIPDELSDLSNLEKLDLSGNHLVGEIPISLKGLHFLSSFSVAH 466
+ +L LDLSNN SG IP+++ S+L+ LDL GN LVG+IP SL L L ++A
Sbjct: 138 SIPNLETLDLSNNMLSGEIPNDIGSFSSLKVLDLGGNVLVGKIPNSLTNLTSLEFLTLAS 197
Query: 467 NNLQGAVPS 475
N L G +P
Sbjct: 198 NQLVGQIPR 206
|
Length = 968 |
| >gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Score = 79.2 bits (196), Expect = 6e-16
Identities = 64/224 (28%), Positives = 103/224 (45%), Gaps = 46/224 (20%)
Query: 607 DNFSQANIIGCGGFGLVYKAT-LANGTTLAIKKLSGDLGLMEREFKA-------EVEALS 658
D + + N I G +G+VY+A G +A+KKL ME+E + E+ L
Sbjct: 5 DEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLK-----MEKEKEGFPITSLREINILL 59
Query: 659 TAQHKNLVSLQ----GYCVHQGFRLLIYSYMENGSLDYWLHEKADGASQLDWLTRLK-IA 713
QH N+V+++ G + + + ++ Y+E+ L + Q + + +
Sbjct: 60 KLQHPNIVTVKEVVVGSNLDKIY--MVMEYVEH-DLKSLMETMKQPFLQSEVKCLMLQLL 116
Query: 714 RGTSCGLAYMHQICEPHIVHRDIKSSNILLDDQFEAHLADFGLSRLILPYQ--THVTTEL 771
G A++H I+HRD+K+SN+LL+++ + DFGL+R Y T+L
Sbjct: 117 SGV----AHLHD---NWILHRDLKTSNLLLNNRGILKICDFGLAR---EYGSPLKPYTQL 166
Query: 772 VGTLGYIPPE-------YGQAWVATLRGDMYSFGVVMLELLTGK 808
V TL Y PE Y A DM+S G + ELLT K
Sbjct: 167 VVTLWYRAPELLLGAKEYSTAI------DMWSVGCIFAELLTKK 204
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293 |
| >gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Score = 79.2 bits (196), Expect = 6e-16
Identities = 62/216 (28%), Positives = 93/216 (43%), Gaps = 45/216 (20%)
Query: 615 IGCGGFGLVYKAT-LANGTTLAIKKL------SGDLGLMEREFKA--EVEALSTAQHKNL 665
+G G + +VYKA G +AIKK+ G+ F A E++ L +H N+
Sbjct: 8 LGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGI---NFTALREIKLLQELKHPNI 64
Query: 666 VSLQGYCVHQGFRLLIYSYME--------NGSLDYWLHEKADGASQLDWLTRLKIARGTS 717
+ L H+ L++ +ME + S+ AD S + R
Sbjct: 65 IGLLDVFGHKSNINLVFEFMETDLEKVIKDKSIVL---TPADIKSYMLMTLR-------- 113
Query: 718 CGLAYMHQICEPHIVHRDIKSSNILLDDQFEAHLADFGLSRLILPYQTHVTTELVGTLGY 777
GL Y+H I+HRD+K +N+L+ LADFGL+R +T ++V T Y
Sbjct: 114 -GLEYLH---SNWILHRDLKPNNLLIASDGVLKLADFGLARSFGSPNRKMTHQVV-TRWY 168
Query: 778 IPPE--YGQAWVATLRG---DMYSFGVVMLELLTGK 808
PE +G A G DM+S G + ELL
Sbjct: 169 RAPELLFG----ARHYGVGVDMWSVGCIFAELLLRV 200
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298 |
| >gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Score = 78.8 bits (195), Expect = 6e-16
Identities = 62/231 (26%), Positives = 89/231 (38%), Gaps = 37/231 (16%)
Query: 607 DNFSQANIIGCGGFGLVYKATL-ANGTTLAIKKLSGDLGLMEREFKA---EVEALS-TAQ 661
D+F IIG G F V A AIK L + E++ K E E L+
Sbjct: 1 DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNG 60
Query: 662 HKNLVSLQGYCVHQGFRLL--IYSYMENGSLDYWLHEKADGASQLDW-LTRLKIARGTSC 718
H ++ L Y Q L + Y NG L ++ + LD TR A
Sbjct: 61 HPGIIKL--YYTFQDEENLYFVLEYAPNGELLQYIRKY----GSLDEKCTRFYAAEILL- 113
Query: 719 GLAYMHQICEPHIVHRDIKSSNILLDDQFEAHLADFGLSRL------------------- 759
L Y+H I+HRD+K NILLD + DFG +++
Sbjct: 114 ALEYLHSK---GIIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSPESNKGDATNIDS 170
Query: 760 ILPYQTHVTTELVGTLGYIPPEYGQAWVATLRGDMYSFGVVMLELLTGKRP 810
+ VGT Y+ PE A D+++ G ++ ++LTGK P
Sbjct: 171 QIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPP 221
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280 |
| >gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Score = 78.3 bits (193), Expect = 8e-16
Identities = 60/212 (28%), Positives = 89/212 (41%), Gaps = 13/212 (6%)
Query: 615 IGCGGFGLVYKATLAN-GTTLAIKKLSGDLGLMEREFKA---EVEALSTAQHKNLVSLQG 670
+G GGFG V + G A KKL + + E + L + +VSL
Sbjct: 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSL-A 59
Query: 671 YCVHQGFRL-LIYSYMENGSLDYWLHEKADGASQLDWLTRLKIARGTSCGLAYMHQICEP 729
Y L L+ + M G L Y H G + A CGL ++HQ
Sbjct: 60 YAFETKDDLCLVMTLMNGGDLKY--HIYNVGEPGFPEARAIFYAAQIICGLEHLHQR--- 114
Query: 730 HIVHRDIKSSNILLDDQFEAHLADFGLSRLILPYQTHVTTELVGTLGYIPPEYGQAWVAT 789
IV+RD+K N+LLDD ++D GL+ + + GT GY+ PE Q V
Sbjct: 115 RIVYRDLKPENVLLDDHGNVRISDLGLAVELKGGKK--IKGRAGTPGYMAPEVLQGEVYD 172
Query: 790 LRGDMYSFGVVMLELLTGKRPVDVLKPKMSRE 821
D ++ G + E++ G+ P K K+ +E
Sbjct: 173 FSVDWFALGCTLYEMIAGRSPFRQRKEKVEKE 204
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277 |
| >gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Score = 78.5 bits (193), Expect = 9e-16
Identities = 68/227 (29%), Positives = 105/227 (46%), Gaps = 17/227 (7%)
Query: 609 FSQANIIGCGGFGLVYKATL-ANGTTLAIKKLSGDLGLMEREFKAEVEALSTAQ------ 661
F Q ++G GGFG V + A G A KKL ++ K E AL+ Q
Sbjct: 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKK---RIKKRKGESMALNEKQILEKVN 58
Query: 662 HKNLVSLQGYCVHQGFRLLIYSYMENGSLDYWLHEKADGASQLDWLTRLKIARGTSCGLA 721
+ +VSL + L+ + M G L + ++ G + + + A CGL
Sbjct: 59 SRFVVSLAYAYETKDALCLVLTLMNGGDLKFHIYHM--GEAGFEEGRAVFYAAEICCGLE 116
Query: 722 YMHQICEPHIVHRDIKSSNILLDDQFEAHLADFGLSRLILPYQTHVTTELVGTLGYIPPE 781
+HQ IV+RD+K NILLDD ++D GL+ + QT VGT+GY+ PE
Sbjct: 117 DLHQ---ERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQT--IKGRVGTVGYMAPE 171
Query: 782 YGQAWVATLRGDMYSFGVVMLELLTGKRPVDVLKPKMSRELVGWVLK 828
+ T D ++ G ++ E++ G+ P K K+ RE V ++K
Sbjct: 172 VVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVK 218
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285 |
| >gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 78.1 bits (193), Expect = 1e-15
Identities = 66/215 (30%), Positives = 102/215 (47%), Gaps = 42/215 (19%)
Query: 615 IGCGGFGLVYKA-TLANGTTLAIKKLSGDLGLMEREFKA-------EVEALSTAQHKNLV 666
IG G +G+VYKA G +A+KK+ +E E + E+ L H N+V
Sbjct: 7 IGEGTYGVVYKARDKLTGEIVALKKIR-----LETEDEGVPSTAIREISLLKELNHPNIV 61
Query: 667 SLQGYCVHQGFRL-LIYSYMENGSLDYWLHEKADGASQLDWLTRLKIARGTSCGLAYMHQ 725
L VH +L L++ + LD L + D + L I Y++Q
Sbjct: 62 RLLD-VVHSENKLYLVFEF-----LDLDLKKYMDSSPL-TGLDPPLIKS-------YLYQ 107
Query: 726 I------CEPH-IVHRDIKSSNILLDDQFEAHLADFGLSRLI-LPYQTHVTTELVGTLGY 777
+ C H ++HRD+K N+L+D + LADFGL+R +P +T+ T E+V TL Y
Sbjct: 108 LLQGIAYCHSHRVLHRDLKPQNLLIDREGALKLADFGLARAFGVPVRTY-THEVV-TLWY 165
Query: 778 IPPE--YGQAWVATLRGDMYSFGVVMLELLTGKRP 810
PE G +T D++S G + E++ +RP
Sbjct: 166 RAPEILLGSRQYST-PVDIWSIGCIFAEMVN-RRP 198
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283 |
| >gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Score = 77.7 bits (191), Expect = 1e-15
Identities = 80/271 (29%), Positives = 130/271 (47%), Gaps = 28/271 (10%)
Query: 615 IGCGGFGLVYKATLANGTTLAIKKLSGDLGLMERE-FKAEVEALSTAQHKNLVSLQGYCV 673
+G G FG V+ T T +A+K L G M E F E + + +H LV L
Sbjct: 14 LGNGQFGEVWMGTWNGNTKVAVKTLKP--GTMSPESFLEEAQIMKKLRHDKLVQLYAVVS 71
Query: 674 HQGFRLLIYSYMENGSLDYWLHEKADGASQLDWLTRLKIARGTSCGLAYMHQICEPHIVH 733
+ ++ YM GSL +L + A +L L + +A + G+AY+ ++ + +H
Sbjct: 72 EEPI-YIVTEYMSKGSLLDFLKDGEGRALKLPNL--VDMAAQVAAGMAYIERM---NYIH 125
Query: 734 RDIKSSNILLDDQFEAHLADFGLSRLILPYQTHVTTELVGTLGYIPPEYGQAWVATLRGD 793
RD++S+NIL+ D +ADFGL+RLI + + + PE T++ D
Sbjct: 126 RDLRSANILVGDGLVCKIADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSD 185
Query: 794 MYSFGVVMLELLTGKRPVDVLKPKM-SRELVGWVLK-MRSEGKQDQVFDPILRGKGFDEE 851
++SFG+++ EL+T R V P M +RE++ V + R QD PI E
Sbjct: 186 VWSFGILLTELVTKGR---VPYPGMNNREVLEQVERGYRMPCPQDC---PI----SLHEL 235
Query: 852 MLQVLDVACMCVSQNPFKRPTVKEVVEWLNN 882
MLQ C ++P +RPT + + +L +
Sbjct: 236 MLQ-------CWKKDPEERPTFEYLQSFLED 259
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260 |
| >gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 76.5 bits (189), Expect = 3e-15
Identities = 76/283 (26%), Positives = 120/283 (42%), Gaps = 54/283 (19%)
Query: 609 FSQANIIGCGGFGLVYKAT-LANGTTLAIKKL-----SGDLGLMEREFKAEVEALSTAQH 662
F+ IG G FG VYKA +AIK + ++ +++E ++ LS +
Sbjct: 3 FTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQE----IQFLSQCRS 58
Query: 663 KNLVSLQGYCVHQGFRL-LIYSYMENGS-LD----YWLHEKADGASQLDWLTRLKIARGT 716
+ G +G +L +I Y GS LD L E I R
Sbjct: 59 PYITKYYG-SFLKGSKLWIIMEYCGGGSCLDLLKPGKLDETYIAF----------ILREV 107
Query: 717 SCGLAYMHQICEPHIVHRDIKSSNILLDDQFEAHLADFG----LSRLILPYQTHVTTELV 772
GL Y+H E +HRDIK++NILL ++ + LADFG L+ + T V
Sbjct: 108 LLGLEYLH---EEGKIHRDIKAANILLSEEGDVKLADFGVSGQLTSTMSKRNT-----FV 159
Query: 773 GTLGYIPPEYGQAWVATLRGDMYSFGVVMLELLTGKRPVDVLKPKMSRELVGWVLKMRSE 832
GT ++ PE + + D++S G+ +EL G+ P+ L P MR
Sbjct: 160 GTPFWMAPEVIKQSGYDEKADIWSLGITAIELAKGEPPLSDLHP------------MRVL 207
Query: 833 GKQDQVFDPILRGKGFDEEMLQVLDVACMCVSQNPFKRPTVKE 875
+ P L G F + + +C++++P +RP+ KE
Sbjct: 208 FLIPKNNPPSLEGNKFSKPFKDFVS---LCLNKDPKERPSAKE 247
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274 |
| >gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Score = 76.2 bits (187), Expect = 3e-15
Identities = 68/261 (26%), Positives = 119/261 (45%), Gaps = 28/261 (10%)
Query: 615 IGCGGFGLVYKATLANGTTLAIKKLSGDLGLMERE-FKAEVEALSTAQHKNLVSLQGYCV 673
+G G FG V+ AT T +A+K + G M E F AE + T QH LV L
Sbjct: 14 LGAGQFGEVWMATYNKHTKVAVKTMKP--GSMSVEAFLAEANVMKTLQHDKLVKLHAVVT 71
Query: 674 HQGFRLLIYSYMENGSLDYWLHEKADGASQLDWLTRLKIARGTSCGLAYMHQICEPHIVH 733
+ +I +M GSL +L L L + + + G+A++ Q + +H
Sbjct: 72 KEPI-YIITEFMAKGSLLDFLKSDEGSKQPLPKL--IDFSAQIAEGMAFIEQ---RNYIH 125
Query: 734 RDIKSSNILLDDQFEAHLADFGLSRLILPYQTHVTTELVGTLGYIPPEYGQAWVATLRGD 793
RD++++NIL+ +ADFGL+R+I + + + PE T++ D
Sbjct: 126 RDLRAANILVSASLVCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINFGSFTIKSD 185
Query: 794 MYSFGVVMLELLT-GKRPV-DVLKPKMSRELVGWVLKMRSEGKQDQVFDPILRGKGFDEE 851
++SFG++++E++T G+ P + P++ R L R E +++++ ++R
Sbjct: 186 VWSFGILLMEIVTYGRIPYPGMSNPEVIRALERGYRMPRPENCPEELYNIMMR------- 238
Query: 852 MLQVLDVACMCVSQNPFKRPT 872
C P +RPT
Sbjct: 239 ----------CWKNRPEERPT 249
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260 |
| >gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Score = 76.3 bits (188), Expect = 3e-15
Identities = 72/287 (25%), Positives = 123/287 (42%), Gaps = 51/287 (17%)
Query: 608 NFSQANIIGCGGFG--LVYKATLANGTTLAIKKLSGDLGLMEREFK---AEVEALSTAQH 662
++ ++G G FG +Y+ T + +L + K L E+E + E+ LS QH
Sbjct: 1 HYIPIRVLGKGAFGEATLYRRTEDD--SLVVWKEVNLTRLSEKERRDALNEIVILSLLQH 58
Query: 663 KNLVSLQGYCVHQGFRLLIYSYMENGSLDYWLHEKADGASQLDWLTRLK----------- 711
N+++ +M++ +L + E A+G + D + R K
Sbjct: 59 PNIIAYYN------------HFMDDNTLLIEM-EYANGGTLYDKIVRQKGQLFEEEMVLW 105
Query: 712 IARGTSCGLAYMHQICEPHIVHRDIKSSNILLDDQFEAHLADFGLSRLILPYQTHVTTEL 771
++Y+H+ I+HRDIK+ NI L L DFG+S+ IL + + +
Sbjct: 106 YLFQIVSAVSYIHKA---GILHRDIKTLNIFLTKAGLIKLGDFGISK-ILGSEYSMAETV 161
Query: 772 VGTLGYIPPEYGQAWVATLRGDMYSFGVVMLELLTGKRPVDVLKPKMSRELVGWVLKMRS 831
VGT Y+ PE Q + D+++ G V+ ELLT KR D P +V V +
Sbjct: 162 VGTPYYMSPELCQGVKYNFKSDIWALGCVLYELLTLKRTFDATNP--LNLVVKIVQGNYT 219
Query: 832 EGKQDQVFDPILRGKGFDEEMLQVLDVACMCVSQNPFKRPTVKEVVE 878
+ E++ ++ + Q+P KRPT EV++
Sbjct: 220 PVVS-----------VYSSELISLVH---SLLQQDPEKRPTADEVLD 252
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256 |
| >gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 77.1 bits (190), Expect = 3e-15
Identities = 75/313 (23%), Positives = 131/313 (41%), Gaps = 73/313 (23%)
Query: 607 DNFSQANIIGCGGFGLVYKATL------ANGTTLAIKKLSGDLGLMEREFK---AEVEAL 657
D + +G G FG V KA +T+A+K L D E++ +E+E +
Sbjct: 12 DRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDA--TEKDLSDLVSEMEMM 69
Query: 658 ST-AQHKNLVSLQGYCVHQGFRLLIYSYMENGSLDYWL---------------HEKADGA 701
+HKN+++L G C +G ++ Y +G+L +L +
Sbjct: 70 KMIGKHKNIINLLGVCTQEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETL 129
Query: 702 SQLDWLT-RLKIARGTSCGLAYMHQICEPHIVHRDIKSSNILLDDQFEAHLADFGLSRLI 760
+Q D ++ ++ARG M + +HRD+ + N+L+ + +ADFGL+R I
Sbjct: 130 TQKDLVSFAYQVARG-------MEFLASKKCIHRDLAARNVLVTEDHVMKIADFGLARDI 182
Query: 761 LP---YQTHVTTELVGTLGYIP-----PEYGQAWVATLRGDMYSFGVVMLELLT-GKRPV 811
Y+ T G +P PE V T + D++SFGV++ E+ T G P
Sbjct: 183 HHIDYYRKT-------TNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPY 235
Query: 812 DVLKPKMSRELVGWVLKMRSEGKQDQVFDPILRGKGFDEEMLQVLDV---ACMCVSQNPF 868
P + E ++F + G ++ ++ C + P
Sbjct: 236 ----PGIPVE---------------ELFKLLKEGYRMEKPQNCTQELYHLMRDCWHEVPS 276
Query: 869 KRPTVKEVVEWLN 881
+RPT K++VE L+
Sbjct: 277 QRPTFKQLVEDLD 289
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293 |
| >gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Score = 76.4 bits (188), Expect = 6e-15
Identities = 74/236 (31%), Positives = 108/236 (45%), Gaps = 56/236 (23%)
Query: 607 DNFSQANIIGCGGFGLVYKAT-LANGTTLAIKKLSGDLGLMERE-FKA----EVEALSTA 660
D F IG G +G VYKA G +A+KK+ D E+E F E++ L
Sbjct: 7 DKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLD---NEKEGFPITAIREIKILRQL 63
Query: 661 QHKNLVSLQGYCV----------HQGFRLLIYSYM--------ENGSLDYWLHEKADGAS 702
H+N+V+L+ +G L++ YM E+G + +
Sbjct: 64 NHRNIVNLKEIVTDKQDALDFKKDKGAFYLVFEYMDHDLMGLLESGLVHFSEDHIKSFMK 123
Query: 703 QLDWLTRLKIARGTSCGLAYMHQICEPHIVHRDIKSSNILLDDQFEAHLADFGLSRLILP 762
QL L+ GL Y H+ + +HRDIK SNILL+++ + LADFGL+RL
Sbjct: 124 QL-----LE-------GLNYCHK---KNFLHRDIKCSNILLNNKGQIKLADFGLARLYNS 168
Query: 763 YQTHVTTELVGTLGYIPPE-------YGQAWVATLRGDMYSFGVVMLELLTGKRPV 811
++ T V TL Y PPE YG A D++S G ++ EL T K+P+
Sbjct: 169 EESRPYTNKVITLWYRPPELLLGEERYGPAI------DVWSCGCILGELFT-KKPI 217
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302 |
| >gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Score = 75.6 bits (186), Expect = 7e-15
Identities = 63/233 (27%), Positives = 100/233 (42%), Gaps = 28/233 (12%)
Query: 605 ATDNFSQANIIGCGGFGLVYKATL------ANGTTLAIKKLSGDL-GLMEREFKAEVEAL 657
D+ + +G G FG VY+ A +A+K L E +F E +
Sbjct: 4 PRDSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIM 63
Query: 658 STAQHKNLVSLQGYCVHQGFRLLIYSYMENGSLDYWLHE---KADGASQLDWLTRLKIAR 714
S H+N+V L G + R ++ M G L +L E + + S L L AR
Sbjct: 64 SKFNHQNIVRLIGVSFERLPRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCAR 123
Query: 715 GTSCGLAYMHQICEPHIVHRDIKSSNILLDD---QFEAHLADFGLSRLILP---YQTHVT 768
+ G Y+ E H +HRDI + N LL A +ADFG++R I Y+
Sbjct: 124 DVAKGCKYLE---ENHFIHRDIAARNCLLTCKGPGRVAKIADFGMARDIYRASYYRKGGR 180
Query: 769 TELVGTLGYIPPEYGQAWVATLRGDMYSFGVVMLELL-------TGKRPVDVL 814
L + ++PPE + T + D++SFGV++ E+ G+ +V+
Sbjct: 181 AML--PIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPYPGRTNQEVM 231
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277 |
| >gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Score = 75.3 bits (185), Expect = 7e-15
Identities = 73/282 (25%), Positives = 116/282 (41%), Gaps = 33/282 (11%)
Query: 615 IGCGGFGLVYKATLANGTTLA---IKKLSGDLGLMER-EFKAEVEALSTAQHKNLVSLQG 670
IG G FG V G + A +K+L E+ F EV+ H N++ G
Sbjct: 3 IGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCLG 62
Query: 671 YCVHQGFRLLIYSYMENGSLDYWL---HEKADGASQLDWLTRLKIARGTSCGLAYMHQIC 727
C+ LL+ + G L +L +Q D L R+ A + GL ++HQ
Sbjct: 63 QCIESIPYLLVLEFCPLGDLKNYLRSNRGMVAQMAQKDVLQRM--ACEVASGLLWLHQA- 119
Query: 728 EPHIVHRDIKSSNILLDDQFEAHLADFGLSRLILPYQTHVTTE-LVGTLGYIPPE----Y 782
+H D+ N L + D+GL+ P ++T + L ++ PE
Sbjct: 120 --DFIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYITKDCHAVPLRWLAPELVEIR 177
Query: 783 GQAWVA---TLRGDMYSFGVVMLELLT-GKRPVDVLKPKMSRELVGWVLKMRSEGKQDQV 838
GQ + T + +++S GV M EL T +P P +S E VLK + ++
Sbjct: 178 GQDLLPKDQTKKSNIWSLGVTMWELFTAADQPY----PDLSDE---QVLKQVVREQDIKL 230
Query: 839 FDPILRGKGFDEEMLQVLDVACMCVSQNPFKRPTVKEVVEWL 880
P L K + + +V+ + +P RPT +EV E L
Sbjct: 231 PKPQLDLK-YSDRWYEVMQFCWL----DPETRPTAEEVHELL 267
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269 |
| >gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 75.6 bits (186), Expect = 7e-15
Identities = 64/218 (29%), Positives = 94/218 (43%), Gaps = 49/218 (22%)
Query: 615 IGCGGFGLV----YKATLAN-GTTLAIKKLSGDLGLMEREFKAEVEALSTAQHKNLVSLQ 669
+G G FG V Y N G +A+KKL R+F+ E+E L + QH N+V +
Sbjct: 12 LGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNIVKYK 71
Query: 670 GYCVHQGFR--LLIYSYMENGSLDYWLHEKADGASQLDWLTRLKIARGTSCGLAYMHQIC 727
G C G R L+ Y+ GSL D+L + + L Y QIC
Sbjct: 72 GVCYSAGRRNLRLVMEYLPYGSL-------------RDYLQKHRERLDHRKLLLYASQIC 118
Query: 728 -------EPHIVHRDIKSSNILLDDQFEAHLADFGLSRLILPYQTHVTTELVGTLGYIPP 780
VHRD+ + NIL++ + + DFGL++ +LP Y
Sbjct: 119 KGMEYLGSKRYVHRDLATRNILVESENRVKIGDFGLTK-VLPQDKEY---------YKVR 168
Query: 781 EYGQA---WVA---------TLRGDMYSFGVVMLELLT 806
E G++ W A ++ D++SFGVV+ EL T
Sbjct: 169 EPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFT 206
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284 |
| >gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Score = 75.4 bits (186), Expect = 8e-15
Identities = 65/223 (29%), Positives = 90/223 (40%), Gaps = 50/223 (22%)
Query: 615 IGCGGFGLVYKATLANGTTLAIKKLSGDLGLME-------------REFKAEVEALSTAQ 661
I G +G V+ LA KK +GD+ ++ + E + LS AQ
Sbjct: 1 ISKGAYGRVF---------LAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQ 51
Query: 662 HKNLVSLQGYCVHQGFR--LLIYSYMENGSLDYWLHEKADGASQLDWLTRLKIARGTSCG 719
+V L Y QG + L+ Y+ G L L G+ D R+ IA
Sbjct: 52 SPYVVKL--YYSFQGKKNLYLVMEYLPGGDLASLLENV--GSLDEDV-ARIYIAE-IVLA 105
Query: 720 LAYMHQICEPHIVHRDIKSSNILLDDQFEAHLADFGLSRLIL-------PYQTHVTTELV 772
L Y+H I+HRD+K NIL+D L DFGLS++ L +V
Sbjct: 106 LEYLHSN---GIIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEKEDKRIV 162
Query: 773 GTLGYIPPEYGQAWVATLRG-----DMYSFGVVMLELLTGKRP 810
GT YI PE V +G D +S G ++ E L G P
Sbjct: 163 GTPDYIAPE-----VILGQGHSKTVDWWSLGCILYEFLVGIPP 200
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265 |
| >gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Score = 75.3 bits (185), Expect = 8e-15
Identities = 58/225 (25%), Positives = 103/225 (45%), Gaps = 30/225 (13%)
Query: 609 FSQANIIGCGGFGLVYKATLANGTTLAIKKL---SGDLGLMEREFKA---EVEALSTAQH 662
+++ ++G G +G VY G +A+K++ + ++ E+E++ EV+ L + +H
Sbjct: 2 WTKGEVLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKH 61
Query: 663 KNLVSLQGYCVHQGFRLLIYSYMENGSLDYWLHEKADGASQLDWLTRLKIARGTSCGLAY 722
N+V G C+ + ++ GS+ L G L K + G+AY
Sbjct: 62 VNIVQYLGTCLDDNTISIFMEFVPGGSISSIL--NRFGP--LPEPVFCKYTKQILDGVAY 117
Query: 723 MHQICEPHIVHRDIKSSNILLDDQFEAHLADFGLSRLILPYQTHVT-----TELVGTLGY 777
+H C +VHRDIK +N++L L DFG +R + H T + GT +
Sbjct: 118 LHNNC---VVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLHGTHSNMLKSMHGTPYW 174
Query: 778 IPPE------YGQAWVATLRGDMYSFGVVMLELLTGKRPVDVLKP 816
+ PE YG+ + D++S G + E+ TGK P+ +
Sbjct: 175 MAPEVINESGYGR------KSDIWSIGCTVFEMATGKPPLASMDR 213
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265 |
| >gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Score = 75.1 bits (184), Expect = 8e-15
Identities = 71/274 (25%), Positives = 126/274 (45%), Gaps = 34/274 (12%)
Query: 615 IGCGGFGLVYKATLANGTTLAIKKLSGDLGLMEREFKAEVEALSTAQHKNLVSLQGYCVH 674
+G G FG V+ T T +AIK L +M F E + + +H LV L
Sbjct: 14 LGQGCFGEVWMGTWNGTTKVAIKTLKPGT-MMPEAFLQEAQIMKKLRHDKLVPLYAVVSE 72
Query: 675 QGFRLLIYSYMENGSLDYWLHEKADGASQLDWLTRLKIARGTSCGLAYMHQICEPHIVHR 734
+ ++ +M GSL +L E DG L + +A + G+AY+ ++ + +HR
Sbjct: 73 EPI-YIVTEFMGKGSLLDFLKE-GDG-KYLKLPQLVDMAAQIADGMAYIERM---NYIHR 126
Query: 735 DIKSSNILLDDQFEAHLADFGLSRLILPYQTHVTTELVGTLGYIPPEYGQAWVATLRGDM 794
D++++NIL+ D +ADFGL+RLI + + + PE T++ D+
Sbjct: 127 DLRAANILVGDNLVCKIADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDV 186
Query: 795 YSFGVVMLELLTGKRPVDVLKPKMSRELVGWVLKMRSEGKQDQVFDPILRG------KGF 848
+SFG+++ EL+T R V P M +V + + RG +G
Sbjct: 187 WSFGILLTELVTKGR---VPYPGMVNR---------------EVLEQVERGYRMPCPQGC 228
Query: 849 DEEMLQVLDVACMCVSQNPFKRPTVKEVVEWLNN 882
E + +++ +C ++P +RPT + + +L +
Sbjct: 229 PESLHELMK---LCWKKDPDERPTFEYIQSFLED 259
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260 |
| >gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 75.0 bits (185), Expect = 9e-15
Identities = 59/213 (27%), Positives = 89/213 (41%), Gaps = 39/213 (18%)
Query: 615 IGCGGFGLVYKATLAN-GTTLAIKKLSG----DLGLMEREFKAEVEALSTAQHKNLVSLQ 669
+G GGFG V + + T A+K + + G + +E E L H +V L
Sbjct: 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQ-QEHIFSEKEILEECNHPFIVKL- 58
Query: 670 GYCVHQGFR--LLIYSYME---NGSLDYWLHEKADGASQLD-WLTRLKIARGTSCGLAYM 723
++ F+ IY ME G L L ++ D + R IA Y+
Sbjct: 59 ----YRTFKDKKYIYMLMEYCLGGELWTILRDRG----LFDEYTARFYIACVVL-AFEYL 109
Query: 724 HQICEPHIVHRDIKSSNILLDDQFEAHLADFGLSRLILPYQTHVTTELVGTLGYIPPE-- 781
H I++RD+K N+LLD L DFG ++ + Q T GT Y+ PE
Sbjct: 110 HNR---GIIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQK--TWTFCGTPEYVAPEII 164
Query: 782 ----YGQAWVATLRGDMYSFGVVMLELLTGKRP 810
Y + D +S G+++ ELLTG+ P
Sbjct: 165 LNKGYDFS------VDYWSLGILLYELLTGRPP 191
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262 |
| >gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 75.4 bits (186), Expect = 1e-14
Identities = 61/212 (28%), Positives = 102/212 (48%), Gaps = 29/212 (13%)
Query: 609 FSQANIIGCGGFGLVYKAT-LANGTTLAIKKLS---GDLGL---MEREFKAEVEALSTAQ 661
+ + IG G +G VYKA L G +A+KK+ + G+ RE A ++ L + +
Sbjct: 1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREI-ALLKQLESFE 59
Query: 662 HKNLVSL----QGYCVHQGFRL-LIYSYMENGSLDYWLHEKADGAS--QLDWLTRLKIAR 714
H N+V L G + +L L++ +++ Y G + L R ++ R
Sbjct: 60 HPNIVRLLDVCHGPRTDRELKLTLVFEHVDQDLATYLSKCPKPGLPPETIKDLMR-QLLR 118
Query: 715 GTSCGLAYMHQICEPHIVHRDIKSSNILLDDQFEAHLADFGLSRLILPYQTHVTTELVGT 774
G + ++H IVHRD+K NIL+ + +ADFGL+R I ++ +T+ +V T
Sbjct: 119 G----VDFLHSHR---IVHRDLKPQNILVTSDGQVKIADFGLAR-IYSFEMALTSVVV-T 169
Query: 775 LGYIPPE--YGQAWVATLRGDMYSFGVVMLEL 804
L Y PE ++ + DM+S G + EL
Sbjct: 170 LWYRAPEVLLQSSYATPV--DMWSVGCIFAEL 199
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287 |
| >gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Score = 74.9 bits (184), Expect = 1e-14
Identities = 61/219 (27%), Positives = 95/219 (43%), Gaps = 29/219 (13%)
Query: 606 TDNFSQANIIGCGGFGLVYKA-TLANGTTLAIKKLSGDLGLMEREFKAEVEALSTAQHKN 664
D + ++G G +G+VY A L+ +AIK++ + E+ S +H+N
Sbjct: 7 YDENGERVVLGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHRN 66
Query: 665 LVSLQGYCVHQGFRLLIYSYMENGSLDYWLHEK----ADGASQLDWLTRLKIARGTSCGL 720
+V G GF + + GSL L K D + + T+ + GL
Sbjct: 67 IVQYLGSDSENGFFKIFMEQVPGGSLSALLRSKWGPLKDNEQTIIFYTKQILE-----GL 121
Query: 721 AYMHQICEPHIVHRDIKSSNILLDDQFEA-HLADFGLSRLILPYQTHVTTELVGTLGYIP 779
Y+H + IVHRDIK N+L++ ++DFG S+ L T GTL Y+
Sbjct: 122 KYLH---DNQIVHRDIKGDNVLVNTYSGVVKISDFGTSKR-LAGINPCTETFTGTLQYMA 177
Query: 780 PE--------YGQAWVATLRGDMYSFGVVMLELLTGKRP 810
PE YG D++S G ++E+ TGK P
Sbjct: 178 PEVIDKGPRGYGAP------ADIWSLGCTIVEMATGKPP 210
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 77.6 bits (191), Expect = 2e-14
Identities = 55/154 (35%), Positives = 77/154 (50%), Gaps = 12/154 (7%)
Query: 327 PSLFSQANLLSGEFPKELTA--LPALVSEAANDEVDRSYLELPVFVMPSNATNQQYNQLS 384
PS+FS L+S + + +P LV + N E+ L +F +N T + L+
Sbjct: 278 PSIFSLQKLISLDLSDNSLSGEIPELVIQLQNLEI------LHLF--SNNFTGKIPVALT 329
Query: 385 NLP--PAIYLANNSLSGNIPVEIGQLKSLHVLDLSNNNFSGTIPDELSDLSNLEKLDLSG 442
+LP + L +N SG IP +G+ +L VLDLS NN +G IP+ L NL KL L
Sbjct: 330 SLPRLQVLQLWSNKFSGEIPKNLGKHNNLTVLDLSTNNLTGEIPEGLCSSGNLFKLILFS 389
Query: 443 NHLVGEIPISLKGLHFLSSFSVAHNNLQGAVPSG 476
N L GEIP SL L + N+ G +PS
Sbjct: 390 NSLEGEIPKSLGACRSLRRVRLQDNSFSGELPSE 423
|
Length = 968 |
| >gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 74.5 bits (183), Expect = 2e-14
Identities = 62/212 (29%), Positives = 103/212 (48%), Gaps = 22/212 (10%)
Query: 614 IIGCGGFGLVYKATLA-NGTTLAIKKL---SGDLGLMERE------FKAEVEALSTAQHK 663
+IG G FG VY A +G +A+K++ S +R+ E+ L QH+
Sbjct: 7 LIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHE 66
Query: 664 NLVSLQGYCVHQGFRLLIYSYMENGSLDYWLHEKADGASQLDWLTRLKIARGTSCGLAYM 723
N+V G + + Y+ GS+ L+ GA + + L R R GL Y+
Sbjct: 67 NIVQYLGSSLDADHLNIFLEYVPGGSVAALLNNY--GAFE-ETLVR-NFVRQILKGLNYL 122
Query: 724 HQICEPHIVHRDIKSSNILLDDQFEAHLADFGLSRLILPYQTHVTT-----ELVGTLGYI 778
H I+HRDIK +NIL+D++ ++DFG+S+ + T L G++ ++
Sbjct: 123 HN---RGIIHRDIKGANILVDNKGGIKISDFGISKKLEANSLSTKTNGARPSLQGSVFWM 179
Query: 779 PPEYGQAWVATLRGDMYSFGVVMLELLTGKRP 810
PE + T + D++S G +++E+LTGK P
Sbjct: 180 APEVVKQTSYTRKADIWSLGCLVVEMLTGKHP 211
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267 |
| >gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 74.2 bits (183), Expect = 2e-14
Identities = 67/234 (28%), Positives = 90/234 (38%), Gaps = 42/234 (17%)
Query: 602 LLKATDNFSQANIIGCGGFGLVYKATLANGTTLAIKKLSGDLGLMEREFKAEVEALST-A 660
L T F +IG G +G VYKA L K+ + E E K E L +
Sbjct: 1 LPDPTGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIEDEEEEIKEEYNILRKYS 60
Query: 661 QHKNLVSLQG------YCVHQGFRLLIYSYMENGSLDYWLHEKADGASQLDWL-TRLK-- 711
H N+ + G + L+ GS+ D L RLK
Sbjct: 61 NHPNIATFYGAFIKKNPPGNDDQLWLVMELCGGGSV-------TDLVKGLRKKGKRLKEE 113
Query: 712 ----IARGTSCGLAYMHQICEPHIVHRDIKSSNILLDDQFEAHLADFGLSRLILPYQTHV 767
I R T GLAY+H E ++HRDIK NILL E L DFG+S +
Sbjct: 114 WIAYILRETLRGLAYLH---ENKVIHRDIKGQNILLTKNAEVKLVDFGVSA-------QL 163
Query: 768 TTEL------VGTLGYIPPE-----YGQAWVATLRGDMYSFGVVMLELLTGKRP 810
+ L +GT ++ PE R D++S G+ +EL GK P
Sbjct: 164 DSTLGRRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPP 217
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275 |
| >gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 72.9 bits (179), Expect = 4e-14
Identities = 65/248 (26%), Positives = 92/248 (37%), Gaps = 58/248 (23%)
Query: 615 IGCGGFGLVYKATLANGTTLAIKKLSGDLGLMEREFKAEVEALSTAQHKNLVSLQGYCVH 674
I G FG VY LA K+ +GD ++ K+++ A + Q N+ + + +
Sbjct: 4 ISKGAFGSVY---------LAKKRSTGDYFAIKVLKKSDMIAKN--QVTNVKAERAIMMI 52
Query: 675 QG----------------FRLLIYSYMENGSLDYWLHEKADGASQLDWLTRLKIARGTSC 718
QG + L+ Y+ G + K G DW +
Sbjct: 53 QGESPYVAKLYYSFQSKDYLYLVMEYLNGGDCASLI--KTLGGLPEDWAK--QYIAEVVL 108
Query: 719 GLAYMHQICEPHIVHRDIKSSNILLDDQFEAHLADFGLSRLILPYQTHVTTELVGTLGYI 778
G+ +HQ I+HRDIK N+L+D L DFGLSR L + VGT Y+
Sbjct: 109 GVEDLHQ---RGIIHRDIKPENLLIDQTGHLKLTDFGLSRNGL-----ENKKFVGTPDYL 160
Query: 779 PPEYGQAWVATLRGDMYSFGVVMLELLTGKRPVDVLKPKMSRELVGWVLKMRSEGKQDQV 838
PE D +S G V+ E L G P P D V
Sbjct: 161 APETILGVGDDKMSDWWSLGCVIFEFLFGYPPFHAETP-------------------DAV 201
Query: 839 FDPILRGK 846
FD IL +
Sbjct: 202 FDNILSRR 209
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260 |
| >gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Score = 73.5 bits (181), Expect = 5e-14
Identities = 71/236 (30%), Positives = 101/236 (42%), Gaps = 69/236 (29%)
Query: 615 IGCGGFGLVYKA-TLANGTTLAIKKLSGDLGLMERE-FKA----EVEALSTAQHKNLVSL 668
+G G FG VYKA + G +A+KK+ L E++ F E++ L +H N+V L
Sbjct: 16 LGEGTFGEVYKARQIKTGRVVALKKI---LMHNEKDGFPITALREIKILKKLKHPNVVPL 72
Query: 669 QGYCV-----HQGFRLLIYS---YMENGSLDYWLHEKADGASQLD----WLTRLKIARGT 716
V + R +Y YM+ D + L+ LT +I
Sbjct: 73 IDMAVERPDKSKRKRGSVYMVTPYMD-----------HDLSGLLENPSVKLTESQI---- 117
Query: 717 SC-------GLAYMHQICEPHIVHRDIKSSNILLDDQFEAHLADFGLSRLIL--PYQ--- 764
C G+ Y+H E HI+HRDIK++NIL+D+Q +ADFGL+R P
Sbjct: 118 KCYMLQLLEGINYLH---ENHILHRDIKAANILIDNQGILKIADFGLARPYDGPPPNPKG 174
Query: 765 -----THVTTELVGTLGYIPPE-------YGQAWVATLRGDMYSFGVVMLELLTGK 808
T T LV T Y PPE Y A D++ G V E+ T +
Sbjct: 175 GGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAV------DIWGIGCVFAEMFTRR 224
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311 |
| >gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Score = 73.2 bits (180), Expect = 6e-14
Identities = 60/217 (27%), Positives = 95/217 (43%), Gaps = 38/217 (17%)
Query: 684 YMENGSLDYWLHEKADGASQLDWLTRLKIARGTSCGLAYMHQICEPHIVHRDIKSSNILL 743
+M+ GSLD L K G + L ++ IA GL Y+ + + I+HRD+K SNIL+
Sbjct: 80 HMDGGSLDQVL--KKAGRIPENILGKISIA--VLRGLTYLRE--KHKIMHRDVKPSNILV 133
Query: 744 DDQFEAHLADFGLS-RLILPYQTHVTTELVGTLGYIPPEYGQAWVATLRGDMYSFGVVML 802
+ + E L DFG+S +LI + VGT Y+ PE Q T++ D++S G+ ++
Sbjct: 134 NSRGEIKLCDFGVSGQLI----DSMANSFVGTRSYMSPERLQGTHYTVQSDIWSLGLSLV 189
Query: 803 ELLTGKRPVDV-----LKPKMSRELVGWVLKMRSEGKQDQVFD----------------- 840
E+ G+ P+ L+ R + K D
Sbjct: 190 EMAIGRYPIPPPDAKELEAMFGRPVSEGEAKESHRPVSGHPPDSPRPMAIFELLDYIVNE 249
Query: 841 --PILRGKGFDEEMLQVLDVACMCVSQNPFKRPTVKE 875
P L F +E +D C+ +NP +R +KE
Sbjct: 250 PPPKLPSGAFSDEFQDFVDK---CLKKNPKERADLKE 283
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308 |
| >gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Score = 73.1 bits (179), Expect = 7e-14
Identities = 78/306 (25%), Positives = 134/306 (43%), Gaps = 63/306 (20%)
Query: 613 NIIGCGGFGLVYKATL-ANGTTL--AIKKL----SGDLGLMEREFKAEVEAL-STAQHKN 664
++IG G FG V KA + +G + AIK++ S D R+F E+E L H N
Sbjct: 13 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKD---DHRDFAGELEVLCKLGHHPN 69
Query: 665 LVSLQGYCVHQGFRLLIYSYMENGSLDYWLHEKA------------DGASQLDWLTRLKI 712
+++L G C H+G+ L Y +G+L +L + AS L L
Sbjct: 70 IINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHF 129
Query: 713 ARGTSCGLAYMHQICEPHIVHRDIKSSNILLDDQFEAHLADFGLSRLILPYQTHVTTELV 772
A + G+ Y+ Q +HRD+ + NIL+ + + A +ADFGLSR + +V
Sbjct: 130 AADVARGMDYLSQ---KQFIHRDLAARNILVGENYVAKIADFGLSR---GQEVYVKK--- 180
Query: 773 GTLGYIPPEYGQAWVA---------TLRGDMYSFGVVMLELLT-GKRPVDVLKPKMSREL 822
T+G +P W+A T D++S+GV++ E+++ G P + E
Sbjct: 181 -TMGRLPVR----WMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEK 235
Query: 823 VGWVLKMRSEGKQDQVFDPILRGKGFDEEMLQVLDVACMCVSQNPFKRPTVKEVVEWLNN 882
+ ++ D +V D+ C + P++RP+ +++ LN
Sbjct: 236 LPQGYRLEKPLNCDD----------------EVYDLMRQCWREKPYERPSFAQILVSLNR 279
Query: 883 VGANRR 888
+ R+
Sbjct: 280 MLEERK 285
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303 |
| >gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Score = 73.2 bits (180), Expect = 7e-14
Identities = 67/250 (26%), Positives = 101/250 (40%), Gaps = 75/250 (30%)
Query: 594 IKDLTIYELLKATDNFSQANIIGCGGFGLVYKA-TLANGTTLAIKKLSGDLGLMEREFKA 652
+++ YE L IG G FG V+KA +A+KK+ LME E +
Sbjct: 8 CDEVSKYEKL---------AKIGQGTFGEVFKARHKKTKQIVALKKV-----LMENEKEG 53
Query: 653 -------EVEALSTAQHKNLVSLQGYC-----VHQGFRLLIYSYME-----------NGS 689
E++ L +H+N+V+L C + ++ Y E N +
Sbjct: 54 FPITALREIKILQLLKHENVVNLIEICRTKATPYNRYKGSFYLVFEFCEHDLAGLLSNKN 113
Query: 690 LDYWLHEKADGASQLDWLTRLKIARGTSCGLAYMHQICEPHIVHRDIKSSNILLDDQFEA 749
+ + L E L L GL Y+H+ I+HRD+K++NIL+
Sbjct: 114 VKFTLSEIKKVMKML--LN----------GLYYIHR---NKILHRDMKAANILITKDGIL 158
Query: 750 HLADFGLSRLILPY------QTHVTTELVGTLGYIPPE-------YGQAWVATLRGDMYS 796
LADFGL+R + + + T V TL Y PPE YG DM+
Sbjct: 159 KLADFGLAR---AFSLSKNSKPNRYTNRVVTLWYRPPELLLGERDYGPPI------DMWG 209
Query: 797 FGVVMLELLT 806
G +M E+ T
Sbjct: 210 AGCIMAEMWT 219
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 75.7 bits (186), Expect = 8e-14
Identities = 39/83 (46%), Positives = 52/83 (62%)
Query: 392 LANNSLSGNIPVEIGQLKSLHVLDLSNNNFSGTIPDELSDLSNLEKLDLSGNHLVGEIPI 451
L+NN LSG IP +IG SL VLDL N G IP+ L++L++LE L L+ N LVG+IP
Sbjct: 147 LSNNMLSGEIPNDIGSFSSLKVLDLGGNVLVGKIPNSLTNLTSLEFLTLASNQLVGQIPR 206
Query: 452 SLKGLHFLSSFSVAHNNLQGAVP 474
L + L + +NNL G +P
Sbjct: 207 ELGQMKSLKWIYLGYNNLSGEIP 229
|
Length = 968 |
| >gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Score = 71.9 bits (176), Expect = 8e-14
Identities = 82/291 (28%), Positives = 123/291 (42%), Gaps = 58/291 (19%)
Query: 608 NFSQANIIGCGGFGLVYKAT-LANGTTLAIKKLS-GDLGLMEREF-KAEVEALSTAQHKN 664
+ IG G FG +Y A ++ IK++ + + E+E K EV L+ +H N
Sbjct: 1 RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPN 60
Query: 665 LVSLQGYCVHQGFRLLIYSYMENGSLDYWLHEKADGASQLDWLTRLKIARGT-------- 716
+V+ S+ ENG L + + E DG D + R+ RG
Sbjct: 61 IVTF------------FASFQENGRL-FIVMEYCDGG---DLMKRINRQRGVLFSEDQIL 104
Query: 717 ------SCGLAYMHQICEPHIVHRDIKSSNILLD-DQFEAHLADFGLSRLILPYQTHVTT 769
S GL ++H + I+HRDIKS NI L + A L DFG++R L +
Sbjct: 105 SWFVQISLGLKHIH---DRKILHRDIKSQNIFLSKNGMVAKLGDFGIAR-QLNDSMELAY 160
Query: 770 ELVGTLGYIPPEYGQAWVATLRGDMYSFGVVMLELLTGKRPVDVLKPKMSRELVGWVLKM 829
VGT Y+ PE Q + D++S G V+ EL T K P + L VLK+
Sbjct: 161 TCVGTPYYLSPEICQNRPYNNKTDIWSLGCVLYELCTLKHPFE------GNNLHQLVLKI 214
Query: 830 RSEGKQDQVFDPILRGKGFDEEML--QVLDVACMCVSQNPFKRPTVKEVVE 878
+G F PI D L Q+ V+ P RP++ +++
Sbjct: 215 -CQGY----FAPISPNFSRDLRSLISQLFKVS-------PRDRPSITSILK 253
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257 |
| >gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Score = 72.7 bits (178), Expect = 9e-14
Identities = 61/220 (27%), Positives = 102/220 (46%), Gaps = 40/220 (18%)
Query: 613 NIIGCGGFGLVYKATL---ANGTTLAIKKLSGDLGLME-REFKAEVEAL-STAQHKNLVS 667
++IG G FG V +A + AIK L + R+F E+E L H N+++
Sbjct: 8 DVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNIIN 67
Query: 668 LQGYCVHQGFRLLIYSYMENGSLDYWLHE-----------KADG-ASQLDWLTRLKIARG 715
L G C ++G+ + Y G+L +L + K G AS L L+ A
Sbjct: 68 LLGACENRGYLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASD 127
Query: 716 TSCGLAYMHQICEPHIVHRDIKSSNILLDDQFEAHLADFGLSRLILPYQTHVTTELVGTL 775
+ G M + E +HRD+ + N+L+ + + +ADFGLSR + +V T+
Sbjct: 128 VATG---MQYLSEKQFIHRDLAARNVLVGENLASKIADFGLSR---GEEVYVKK----TM 177
Query: 776 GYIPPEYGQAWVA---------TLRGDMYSFGVVMLELLT 806
G +P W+A T + D++SFGV++ E+++
Sbjct: 178 GRLPVR----WMAIESLNYSVYTTKSDVWSFGVLLWEIVS 213
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297 |
| >gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Score = 72.3 bits (177), Expect = 1e-13
Identities = 73/268 (27%), Positives = 116/268 (43%), Gaps = 28/268 (10%)
Query: 609 FSQANIIGCGGFGLVYKATL-ANGTTLAIKKLSGDLGLMEREFKA----EVEALSTAQHK 663
F ++G GGFG V + A G A KKL + +R+ +A E L +
Sbjct: 2 FRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKR-IKKRKGEAMALNEKRILEKVNSR 60
Query: 664 NLVSLQGYCVHQGFRL-LIYSYMENGSLDYWLHEKADGASQLDWLTRLKIARGTSCGLAY 722
+VSL Y L L+ + M G L + ++ G D + A CGL
Sbjct: 61 FVVSL-AYAYETKDALCLVLTIMNGGDLKFHIYNM--GNPGFDEQRAIFYAAELCCGLED 117
Query: 723 MHQICEPHIVHRDIKSSNILLDDQFEAHLADFGLSRLILPYQTHVTTELVGTLGYIPPEY 782
+ + IV+RD+K NILLDD+ ++D GL+ I +T VGT+GY+ PE
Sbjct: 118 LQR---ERIVYRDLKPENILLDDRGHIRISDLGLAVQIPEGET--VRGRVGTVGYMAPEV 172
Query: 783 GQAWVATLRGDMYSFGVVMLELLTGKRPVDVLKPKMSRELVGWVLKMRSEGKQDQVFDPI 842
T D + G ++ E++ G+ P K ++ RE V +K E ++
Sbjct: 173 INNEKYTFSPDWWGLGCLIYEMIQGQSPFRKRKERVKREEVDRRVKEDQEEYSEK----- 227
Query: 843 LRGKGFDEEMLQVLDVACMCVSQNPFKR 870
F E+ + M +++NP +R
Sbjct: 228 -----FSED---AKSICRMLLTKNPKER 247
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285 |
| >gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 72.9 bits (179), Expect = 1e-13
Identities = 62/242 (25%), Positives = 90/242 (37%), Gaps = 71/242 (29%)
Query: 613 NIIGCGGFGLVYKA-TLANGTTLAIKKLS---------------GDLGL---MEREFKAE 653
+G G +G V KA G +AIKK+ G G+ RE K
Sbjct: 15 AHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIM 74
Query: 654 VEALSTAQHKNLVSLQGYCVHQGFRLLIYSYMENGSLDYWLHEKADGASQLDWLTRLKIA 713
E +H+N++ L V F L+ M +D +D RL +
Sbjct: 75 NEI----KHENIMGLVDVYVEGDFINLVMDIMA-----------SDLKKVVDRKIRLTES 119
Query: 714 RGTSC-------GLAYMHQICEPHIVHRDIKSSNILLDDQFEAHLADFGLSR-------- 758
+ C GL +H+ + +HRD+ +NI ++ + +ADFGL+R
Sbjct: 120 Q-VKCILLQILNGLNVLHKW---YFMHRDLSPANIFINSKGICKIADFGLARRYGYPPYS 175
Query: 759 -----LILPYQTHVTTELVGTLGYIPPE-------YGQAWVATLRGDMYSFGVVMLELLT 806
+ T V TL Y PE Y A DM+S G + ELLT
Sbjct: 176 DTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAV------DMWSVGCIFAELLT 229
Query: 807 GK 808
GK
Sbjct: 230 GK 231
|
Length = 335 |
| >gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Score = 71.5 bits (175), Expect = 1e-13
Identities = 70/271 (25%), Positives = 120/271 (44%), Gaps = 36/271 (13%)
Query: 614 IIGCGGFGLVYKATLANGTTLAIKKLSGDLGLMEREFKAEVEALSTAQHKNLVSLQGYCV 673
IIG G FG V + G +A+K + D+ + F E ++ HKNLV L G +
Sbjct: 13 IIGEGEFGAVLQGEYT-GQKVAVKNIKCDV--TAQAFLEETAVMTKLHHKNLVRLLGVIL 69
Query: 674 HQGFRLLIYSYMENGSLDYWLHEKADGASQLDWLTR--LKIARGTSCGLAYMHQICEPHI 731
H G +++ M G+L +L + + L + L +A G M + +
Sbjct: 70 HNGLYIVM-ELMSKGNLVNFLRTRGRALVSVIQLLQFSLDVAEG-------MEYLESKKL 121
Query: 732 VHRDIKSSNILLDDQFEAHLADFGLSRLILPYQTHVTTELVGTLGYIPPEYGQAWVATLR 791
VHRD+ + NIL+ + A ++DFGL+R+ V + + + PE + + +
Sbjct: 122 VHRDLAARNILVSEDGVAKVSDFGLARV---GSMGVDNSKL-PVKWTAPEALKHKKFSSK 177
Query: 792 GDMYSFGVVMLELLT-GKRPVDVLKPKMSRELVGWVLKMRSEG-KQDQVFDPILRGKGFD 849
D++S+GV++ E+ + G+ P PKMS LK E ++ +P +
Sbjct: 178 SDVWSYGVLLWEVFSYGRAPY----PKMS-------LKEVKECVEKGYRMEPP------E 220
Query: 850 EEMLQVLDVACMCVSQNPFKRPTVKEVVEWL 880
V + C P KRP+ ++ E L
Sbjct: 221 GCPADVYVLMTSCWETEPKKRPSFHKLREKL 251
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254 |
| >gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 71.8 bits (176), Expect = 1e-13
Identities = 72/299 (24%), Positives = 127/299 (42%), Gaps = 51/299 (17%)
Query: 609 FSQANIIGCGGFGLVYKATLA--NGTTL--AIKKLSGDLGLMERE---FKAEVEALSTAQ 661
I+G G FG V + L+ +G+ L A+K + D E F +E +
Sbjct: 1 LKLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLD-IHTYSEIEEFLSEAACMKDFD 59
Query: 662 HKNLVSLQGYCVHQGFR------LLIYSYMENGSL-DYWLHEKADGASQ-LDWLTRLKIA 713
H N++ L G C ++I +M++G L + L+ + G + L T LK
Sbjct: 60 HPNVMKLIGVCFEASSLQKIPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFM 119
Query: 714 RGTSCGLAYMHQICEPHIVHRDIKSSNILLDDQFEAHLADFGLSRLILP----YQTHVTT 769
+ G+ Y+ + +HRD+ + N +L + +ADFGLS+ I Q +
Sbjct: 120 VDIALGMEYLSN---RNFIHRDLAARNCMLREDMTVCVADFGLSKKIYSGDYYRQGRIAK 176
Query: 770 ELVGTLGYIPPEYGQAWVATLRGDMYSFGVVMLELLT-GKRPVDVLKPKMSRELVGWVLK 828
V +I E V T + D+++FGV M E+ T G+ P
Sbjct: 177 MPV---KWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTPY----------------- 216
Query: 829 MRSEGKQD-QVFDPILRG---KGFDEEMLQVLDVACMCVSQNPFKRPTVKEVVEWLNNV 883
G ++ +++D + G K ++ + ++ D+ C +P RPT ++ E L N+
Sbjct: 217 ---PGVENHEIYDYLRHGNRLKQPEDCLDELYDLMYSCWRADPKDRPTFTKLREVLENI 272
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273 |
| >gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Score = 72.2 bits (177), Expect = 2e-13
Identities = 66/230 (28%), Positives = 104/230 (45%), Gaps = 49/230 (21%)
Query: 598 TIYELLKATDNFSQANIIGCGGFGLVYKAT-LANGTTLAIKKLSGDLG---LMEREFKAE 653
T++E+ T+ + +G G FGLV A G +AIKK+ L +R ++ E
Sbjct: 4 TVFEI---TNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYR-E 59
Query: 654 VEALSTAQHKNLVSLQG---------YCVHQGF-----RLLIYSYMENGSLDYWLHEKAD 699
++ L +H+N++SL Y V + RLL +E + Y+L++
Sbjct: 60 LKLLKHLRHENIISLSDIFISPLEDIYFVTELLGTDLHRLLTSRPLEKQFIQYFLYQ--- 116
Query: 700 GASQLDWLTRLKIARGTSCGLAYMHQICEPHIVHRDIKSSNILLDDQFEAHLADFGLSRL 759
I RG L Y+H +VHRD+K SNIL+++ + + DFGL+R+
Sbjct: 117 ------------ILRG----LKYVHS---AGVVHRDLKPSNILINENCDLKICDFGLARI 157
Query: 760 ILPYQTHVTTELVGTLGYIPPEYGQAWVA-TLRGDMYSFGVVMLELLTGK 808
Q T V T Y PE W + D++S G + E+L GK
Sbjct: 158 ----QDPQMTGYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGK 203
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328 |
| >gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Score = 71.9 bits (176), Expect = 2e-13
Identities = 66/206 (32%), Positives = 95/206 (46%), Gaps = 21/206 (10%)
Query: 614 IIGCGGFGLVYKATL-ANGTTLAIKKLSGDLGLMEREFK---AEVEALSTA-QHKNLVSL 668
++G G FG V+ A L AIK L D+ LM+ + + E LS A +H L L
Sbjct: 2 MLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHL 61
Query: 669 QGYCVHQGFRLLIY--SYMENGSLDYWLHEKADGASQLDWLTRLKIARGTSCGLAYMHQI 726
YC Q L + Y+ G L + + + D A CGL ++H
Sbjct: 62 --YCTFQTKENLFFVMEYLNGGDLMFHIQS----CHKFDLPRATFYAAEIICGLQFLHS- 114
Query: 727 CEPHIVHRDIKSSNILLDDQFEAHLADFGLSRLILPYQTHVTTELVGTLGYIPPE--YGQ 784
IV+RD+K NILLD +ADFG+ + + T GT YI PE GQ
Sbjct: 115 --KGIVYRDLKLDNILLDTDGHIKIADFGMCKENMLGDAK-TCTFCGTPDYIAPEILLGQ 171
Query: 785 AWVATLRGDMYSFGVVMLELLTGKRP 810
+ ++ D +SFGV++ E+L G+ P
Sbjct: 172 KYNTSV--DWWSFGVLLYEMLIGQSP 195
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316 |
| >gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Score = 71.6 bits (175), Expect = 2e-13
Identities = 69/230 (30%), Positives = 112/230 (48%), Gaps = 38/230 (16%)
Query: 602 LLKATDNFSQANIIGCGGFGLVYKAT-LANGTTL----AIKKLSGDLGLMER-EFKAEVE 655
+LK T+ + ++G G FG VYK + G T+ AIK L+ G EF E
Sbjct: 3 ILKETE-LKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEAL 61
Query: 656 ALSTAQHKNLVSLQGYCVHQGFRLLIYSYMENGSLDYWLHEKADG-ASQL--DWLTRLKI 712
+++ H +LV L G C+ +L + M +G L ++HE D SQL +W ++I
Sbjct: 62 IMASMDHPHLVRLLGVCLSPTIQL-VTQLMPHGCLLDYVHEHKDNIGSQLLLNWC--VQI 118
Query: 713 ARGTSCGLAYMHQICEPHIVHRDIKSSNILLDDQFEAHLADFGLSRLILPYQTHVTTELV 772
A+G M + E +VHRD+ + N+L+ + DFGL+RL+ + +
Sbjct: 119 AKG-------MMYLEERRLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNAD-- 169
Query: 773 GTLGYIPPEYGQAWVA---------TLRGDMYSFGVVMLELLT-GKRPVD 812
G +P + W+A T + D++S+GV + EL+T G +P D
Sbjct: 170 --GGKMPIK----WMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYD 213
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303 |
| >gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 71.5 bits (175), Expect = 2e-13
Identities = 66/267 (24%), Positives = 120/267 (44%), Gaps = 40/267 (14%)
Query: 634 LAIKKLSGDLGLMER-EFKAEVEALSTAQHKNLVSLQGYCVHQGFRLLIYSYMENGSLDY 692
+A+K L D+ R +F E++ +S ++ N++ L G CV +I YMENG L+
Sbjct: 47 VAVKMLRADVTKTARNDFLKEIKIMSRLKNPNIIRLLGVCVSDDPLCMITEYMENGDLNQ 106
Query: 693 WLHE--------KADGASQLDWLTRLKIARGTSCGLAYMHQICEPHIVHRDIKSSNILLD 744
+L + A+ + L +A + G+ Y+ + + VHRD+ + N L+
Sbjct: 107 FLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASL---NFVHRDLATRNCLVG 163
Query: 745 DQFEAHLADFGLSRLILP---YQTHVTTELVGTLGYIPPEYGQAWVATLRG------DMY 795
+ + +ADFG+SR + Y+ L P AW + L G D++
Sbjct: 164 NHYTIKIADFGMSRNLYSGDYYRIQGRAVL--------PIRWMAWESILLGKFTTASDVW 215
Query: 796 SFGVVMLEL--LTGKRPVDVLKPKMSRELVGWVLKMRSEGKQDQVFDPILRGKGFDEEML 853
+FGV + E+ L ++P +L + E G R++G+Q + L + M+
Sbjct: 216 AFGVTLWEMFTLCKEQPYSLLSDEQVIENTGEFF--RNQGRQIYLSQTPLCPSPVFKLMM 273
Query: 854 QVLDVACMCVSQNPFKRPTVKEVVEWL 880
+ C S++ RPT ++ +L
Sbjct: 274 R-------CWSRDIKDRPTFNKIHHFL 293
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295 |
| >gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Score = 70.6 bits (173), Expect = 2e-13
Identities = 75/278 (26%), Positives = 118/278 (42%), Gaps = 47/278 (16%)
Query: 615 IGCGGFGLVYKATLA----NGTTLAIKKLS-GDLGLMER-EFKAEVEALSTAQHKNLVSL 668
IG G FG KA L +G IK+++ + ER E + EV LS +H N+V
Sbjct: 8 IGEGSFG---KAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQY 64
Query: 669 QGYCVHQGFRLLIYSYMENGSLDYWLHEKADGASQ----LDWLTRLKIARGTSCGLAYMH 724
Q G ++ Y E G L ++ + LDW ++ +A L ++H
Sbjct: 65 QESFEENGNLYIVMDYCEGGDLYKKINAQRGVLFPEDQILDWFVQICLA------LKHVH 118
Query: 725 QICEPHIVHRDIKSSNILLDDQFEAHLADFGLSRLILPYQTHVTTEL----VGTLGYIPP 780
+ I+HRDIKS NI L L DFG++R++ + T EL +GT Y+ P
Sbjct: 119 ---DRKILHRDIKSQNIFLTKDGTIKLGDFGIARVL-----NSTVELARTCIGTPYYLSP 170
Query: 781 EYGQAWVATLRGDMYSFGVVMLELLTGKRPVDVLKPKMSRELVGWVLKMRSEGKQDQVFD 840
E + + D+++ G V+ E+ T K + K VLK+ +
Sbjct: 171 EICENRPYNNKSDIWALGCVLYEMCTLKHAFEAGNMK------NLVLKIIRGS-----YP 219
Query: 841 PILRGKGFDEEMLQVLDVACMCVSQNPFKRPTVKEVVE 878
P+ +D L +NP RP+V ++E
Sbjct: 220 PVSSHYSYDLRNL-----VSQLFKRNPRDRPSVNSILE 252
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256 |
| >gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Score = 71.8 bits (176), Expect = 2e-13
Identities = 71/233 (30%), Positives = 100/233 (42%), Gaps = 38/233 (16%)
Query: 596 DLTIYELLKATDN---FSQANIIGCGGFGLVYKAT-LANGTTLAIKKLSGDLGLMERE-- 649
D I EL D F+ IG G FG VY A + +AIKK+S G E
Sbjct: 1 DPEIAELFSKDDPEKLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYS-GKQSNEKW 59
Query: 650 --FKAEVEALSTAQHKNLVSLQGYCVHQGFRLLIYSYMENGSLDYW-LHEKADGASQLDW 706
EV L +H N + +G + + L+ Y + D +H+K
Sbjct: 60 QDIIKEVRFLQQLRHPNTIEYKGCYLREHTAWLVMEYCLGSASDILEVHKKP-------- 111
Query: 707 LTRLKIA---RGTSCGLAYMHQICEPHIVHRDIKSSNILLDDQFEAHLADFGLSRLILPY 763
L ++IA G GLAY+H +HRDIK+ NILL + LADFG + L+ P
Sbjct: 112 LQEVEIAAICHGALQGLAYLHSHER---IHRDIKAGNILLTEPGTVKLADFGSASLVSPA 168
Query: 764 QTHVTTELVGTLGYIPPEY------GQAWVATLRGDMYSFGVVMLELLTGKRP 810
+ VGT ++ PE GQ + D++S G+ +EL K P
Sbjct: 169 NS-----FVGTPYWMAPEVILAMDEGQ---YDGKVDVWSLGITCIELAERKPP 213
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307 |
| >gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Score = 70.8 bits (173), Expect = 3e-13
Identities = 81/283 (28%), Positives = 122/283 (43%), Gaps = 49/283 (17%)
Query: 609 FSQANIIGCGGFGLVYKATLANGT--TLAIKKLSGDLGLMEREF---KAEVEALSTAQHK 663
F++ IG G FG VYK + N T +AIK + DL E E + E+ LS
Sbjct: 6 FTKLERIGKGSFGEVYKG-IDNRTKEVVAIKII--DLEEAEDEIEDIQQEITVLSQCDSP 62
Query: 664 NLVSLQGYCVHQGFRLLIYSYMENGSLDYWLHEKADGASQLDWLTR--------LKIARG 715
+ G SY++ L + + E G S LD L I R
Sbjct: 63 YITRYYG------------SYLKGTKL-WIIMEYLGGGSALDLLKPGPLEETYIATILRE 109
Query: 716 TSCGLAYMHQICEPHIVHRDIKSSNILLDDQFEAHLADFGLSRLILPYQTHVTTELVGTL 775
GL Y+H +HRDIK++N+LL +Q + LADFG++ + Q T VGT
Sbjct: 110 ILKGLDYLHS---ERKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNT-FVGTP 165
Query: 776 GYIPPEYGQAWVATLRGDMYSFGVVMLELLTGKRPVDVLKPKMSRELVGWVLKMRSEGKQ 835
++ PE + + D++S G+ +EL G+ P L P L+ EG+
Sbjct: 166 FWMAPEVIKQSAYDFKADIWSLGITAIELAKGEPPNSDLHPMRVLFLIPKNSPPTLEGQY 225
Query: 836 DQVFDPILRGKGFDEEMLQVLDVACMCVSQNPFKRPTVKEVVE 878
+ F K F E C++++P RPT KE+++
Sbjct: 226 SKPF------KEFVEA----------CLNKDPRFRPTAKELLK 252
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277 |
| >gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Score = 70.7 bits (173), Expect = 3e-13
Identities = 80/290 (27%), Positives = 131/290 (45%), Gaps = 41/290 (14%)
Query: 613 NIIGCGGFGLVYKAT----LANGT---TLAIKKL-SGDLGLMEREFKAEVEALSTAQHKN 664
N +G G FG VY+ T L G+ +A+K L G ++EF E +S H N
Sbjct: 1 NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPN 60
Query: 665 LVSLQGYCVHQGFRLLIYSYMENGSLDYWLHEKADGASQLDWLT---RLKIARGTSCGLA 721
+V L G C+ + +I ME G L +L + LT L I + G
Sbjct: 61 IVKLLGVCLLNEPQYIIMELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCV 120
Query: 722 YMHQICEPHIVHRDIKSSNILLDD-QFEA----HLADFGLSRLILP---YQTHVTTELVG 773
Y+ Q+ H +HRD+ + N L+ + ++A + DFGL+R I Y+ E +
Sbjct: 121 YLEQM---HFIHRDLAARNCLVSEKGYDADRVVKIGDFGLARDIYKSDYYR--KEGEGLL 175
Query: 774 TLGYIPPEYGQAWVATLRGDMYSFGVVMLELLT-GKRPVDVLKPKMSRELVGWVLKMRSE 832
+ ++ PE T + D++SFGV+M E+LT G++P L ++E++ V +
Sbjct: 176 PVRWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQPYPALN---NQEVLQHV---TAG 229
Query: 833 GKQDQVFDPILRGKGFDEEMLQVLDVACMCVSQNPFKRPTVKEVVEWLNN 882
G+ + K + + C +Q+P +RPT + E L N
Sbjct: 230 GRLQK--PENCPDK--------IYQLMTNCWAQDPSERPTFDRIQEILQN 269
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269 |
| >gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Score = 70.7 bits (173), Expect = 3e-13
Identities = 65/218 (29%), Positives = 104/218 (47%), Gaps = 25/218 (11%)
Query: 615 IGCGGFGLVYKATLAN-GTTLAIKKL--------SGD-LGLMEREFKAEVEALSTAQHKN 664
+G GGFG V + N G A KKL SG+ + L+E+E +V +
Sbjct: 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPF------ 54
Query: 665 LVSLQGYCVHQGFRL-LIYSYMENGSLDYWLHEKADGASQLDWLTRLKIARGTSCGLAYM 723
+V+L Y L L+ S M G L Y H G L+ + + +CG+ ++
Sbjct: 55 IVNL-AYAFESKTHLCLVMSLMNGGDLKY--HIYNVGERGLEMERVIHYSAQITCGILHL 111
Query: 724 HQICEPHIVHRDIKSSNILLDDQFEAHLADFGLSRLILPYQTHVTTELVGTLGYIPPEYG 783
H + IV+RD+K N+LLDDQ L+D GL+ + +T T+ GT GY+ PE
Sbjct: 112 HSM---DIVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGKT--ITQRAGTNGYMAPEIL 166
Query: 784 QAWVATLRGDMYSFGVVMLELLTGKRPVDVLKPKMSRE 821
+ + D ++ G + E++ G+ P K K+++E
Sbjct: 167 KEEPYSYPVDWFAMGCSIYEMVAGRTPFKDHKEKVAKE 204
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277 |
| >gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Score = 71.5 bits (175), Expect = 3e-13
Identities = 59/209 (28%), Positives = 94/209 (44%), Gaps = 27/209 (12%)
Query: 614 IIGCGGFGLVYKATL-ANGTTLAIKKLSGDLGLMEREFK---AEVEALSTAQHKNLVSLQ 669
++G G FG V A L G A+K L D+ L++ + + E L+ A ++
Sbjct: 2 VLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLT-H 60
Query: 670 GYCVHQGFRLLIY--SYMENGSLDYWLHEKADGASQLDWLTRLKIARGT------SCGLA 721
YC Q L + ++ G L + + +K R + R T CGL
Sbjct: 61 LYCTFQTKEHLFFVMEFLNGGDLMFHIQDKG----------RFDLYRATFYAAEIVCGLQ 110
Query: 722 YMHQICEPHIVHRDIKSSNILLDDQFEAHLADFGLSRLILPYQTHVTTELVGTLGYIPPE 781
++H I++RD+K N++LD +ADFG+ + + +T GT YI PE
Sbjct: 111 FLHS---KGIIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGDNRAST-FCGTPDYIAPE 166
Query: 782 YGQAWVATLRGDMYSFGVVMLELLTGKRP 810
Q T D +SFGV++ E+L G+ P
Sbjct: 167 ILQGLKYTFSVDWWSFGVLLYEMLIGQSP 195
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316 |
| >gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 70.4 bits (172), Expect = 3e-13
Identities = 68/214 (31%), Positives = 102/214 (47%), Gaps = 19/214 (8%)
Query: 608 NFSQANIIGCGGFGLVYKATLAN-GTTLAIKKLSGDLGLME--REFKA---EVEALSTAQ 661
N+ ++G G FG VY A+ G LA+K++ D E +E A E++ L +
Sbjct: 3 NWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLR 62
Query: 662 HKNLVSLQGYCV--HQGFRLLIY-SYMENGSLDYWLHEKADGASQLDWLTRLKIARGTSC 718
H +V G C+ + +L I+ YM GS+ L KA GA + +TR + R
Sbjct: 63 HDRIVQYYG-CLRDPEEKKLSIFVEYMPGGSIKDQL--KAYGALT-ENVTR-RYTRQILQ 117
Query: 719 GLAYMHQICEPHIVHRDIKSSNILLDDQFEAHLADFGLSRLILPYQTHVT--TELVGTLG 776
G++Y+H IVHRDIK +NIL D L DFG S+ I T + GT
Sbjct: 118 GVSYLHS---NMIVHRDIKGANILRDSAGNVKLGDFGASKRIQTICMSGTGIKSVTGTPY 174
Query: 777 YIPPEYGQAWVATLRGDMYSFGVVMLELLTGKRP 810
++ PE + D++S ++E+LT K P
Sbjct: 175 WMSPEVISGEGYGRKADVWSVACTVVEMLTEKPP 208
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264 |
| >gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Score = 70.7 bits (173), Expect = 4e-13
Identities = 56/202 (27%), Positives = 95/202 (47%), Gaps = 20/202 (9%)
Query: 613 NIIGCGGFGLVYKAT-LANGTTLAIKKLSGDLGL-MEREFKAEVEALSTAQHKNLVSLQG 670
I+G G G VYKA L LA+K + D+ + ++++ +E+E L ++ G
Sbjct: 7 EILGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFYG 66
Query: 671 YCVHQGFRLLIYSYMENGSLD-YW-LHEKADGASQLDWLTRLKIARGTSCGLAYMHQICE 728
+ + +M+ GSLD Y + E G +IA GL Y+ +
Sbjct: 67 AFFVENRISICTEFMDGGSLDVYRKIPEHVLG----------RIAVAVVKGLTYLWSL-- 114
Query: 729 PHIVHRDIKSSNILLDDQFEAHLADFGLSRLILPYQTHVTTELVGTLGYIPPEYGQAWVA 788
I+HRD+K SN+L++ + + L DFG+S ++ + VGT Y+ PE
Sbjct: 115 -KILHRDVKPSNMLVNTRGQVKLCDFGVSTQLV---NSIAKTYVGTNAYMAPERISGEQY 170
Query: 789 TLRGDMYSFGVVMLELLTGKRP 810
+ D++S G+ +EL G+ P
Sbjct: 171 GIHSDVWSLGISFMELALGRFP 192
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279 |
| >gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 71.0 bits (174), Expect = 4e-13
Identities = 60/214 (28%), Positives = 100/214 (46%), Gaps = 24/214 (11%)
Query: 607 DNFSQANIIGCGGFGLVYKATLANG-------TTLAIKKLSGDLGLMERE-FKAEVEALS 658
+N S +G G FG V +AT A G +A+K L ERE +E++ +S
Sbjct: 35 NNLSFGKTLGAGAFGKVVEAT-AYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMS 93
Query: 659 -TAQHKNLVSLQGYCVHQGFRLLIYSYMENGSLDYWLHEKADGASQLDWLTRL--KIARG 715
H+N+V+L G C G L+I Y G L +L K + L+ L ++A+G
Sbjct: 94 HLGNHENIVNLLGACTIGGPILVITEYCCYGDLLNFLRRKRESFLTLEDLLSFSYQVAKG 153
Query: 716 TSCGLAYMHQICEPHIVHRDIKSSNILLDDQFEAHLADFGLSRLILPYQTHV---TTELV 772
M + + +HRD+ + N+LL + DFGL+R I+ +V L
Sbjct: 154 -------MAFLASKNCIHRDLAARNVLLTHGKIVKICDFGLARDIMNDSNYVVKGNARL- 205
Query: 773 GTLGYIPPEYGQAWVATLRGDMYSFGVVMLELLT 806
+ ++ PE V T D++S+G+++ E+ +
Sbjct: 206 -PVKWMAPESIFNCVYTFESDVWSYGILLWEIFS 238
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302 |
| >gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Score = 70.4 bits (172), Expect = 4e-13
Identities = 69/275 (25%), Positives = 115/275 (41%), Gaps = 25/275 (9%)
Query: 608 NFSQANIIGCGGFGLVYKAT-LANGTTLAIKKLSGDLGLMEREFKA----EVEALSTAQH 662
NF IG G F VY+AT L +G +A+KK+ LM+ + +A E++ L H
Sbjct: 3 NFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQ-IFDLMDAKARADCIKEIDLLKQLNH 61
Query: 663 KNLVSLQGYCVHQGFRLLIYSYMENGSLDYWLHEKADGASQLDWLTRLKIARGTSCGLAY 722
N++ + ++ + G L + + T K L +
Sbjct: 62 PNVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEH 121
Query: 723 MHQICEPHIVHRDIKSSNILLDDQFEAHLADFGLSRLILPYQTHVTTELVGTLGYIPPEY 782
MH ++HRDIK +N+ + L D GL R +T LVGT Y+ PE
Sbjct: 122 MHS---RRVMHRDIKPANVFITATGVVKLGDLGLGRF-FSSKTTAAHSLVGTPYYMSPER 177
Query: 783 GQAWVATLRGDMYSFGVVMLELLTGKRPVDVLKPKMSRELVGWVLKMRSEGKQDQVFD-P 841
+ D++S G ++ E+ + P G + + S K+ + D P
Sbjct: 178 IHENGYNFKSDIWSLGCLLYEMAALQSP-----------FYGDKMNLYSLCKKIEQCDYP 226
Query: 842 ILRGKGFDEEMLQVLDVACMCVSQNPFKRPTVKEV 876
L + EE+ Q+++ MC++ +P KRP + V
Sbjct: 227 PLPSDHYSEELRQLVN---MCINPDPEKRPDITYV 258
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Score = 70.4 bits (172), Expect = 4e-13
Identities = 64/222 (28%), Positives = 101/222 (45%), Gaps = 17/222 (7%)
Query: 609 FSQANIIGCGGFGLVYKATL-ANGTTLAIKKLSGDLGLMEREFKAEVEALSTAQ------ 661
F Q ++G GGFG V + A G A K+L ++ K E AL+ Q
Sbjct: 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKK---RIKKRKGESMALNEKQILEKVN 58
Query: 662 HKNLVSLQGYCVHQGFRLLIYSYMENGSLDYWLHEKADGASQLDWLTRLKIARGTSCGLA 721
+ +V+L + L+ + M G L + ++ G + L A CGL
Sbjct: 59 SQFVVNLAYAYETKDALCLVLTIMNGGDLKFHIYNM--GNPGFEEERALFYAAEILCGLE 116
Query: 722 YMHQICEPHIVHRDIKSSNILLDDQFEAHLADFGLSRLILPYQTHVTTELVGTLGYIPPE 781
+H+ + V+RD+K NILLDD ++D GL+ + +P + VGT+GY+ PE
Sbjct: 117 DLHR---ENTVYRDLKPENILLDDYGHIRISDLGLA-VKIP-EGESIRGRVGTVGYMAPE 171
Query: 782 YGQAWVATLRGDMYSFGVVMLELLTGKRPVDVLKPKMSRELV 823
TL D + G ++ E++ G+ P K K+ RE V
Sbjct: 172 VLNNQRYTLSPDYWGLGCLIYEMIEGQSPFRGRKEKVKREEV 213
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 73.0 bits (179), Expect = 5e-13
Identities = 54/146 (36%), Positives = 73/146 (50%), Gaps = 13/146 (8%)
Query: 329 LFSQANLLSGEFPKELTALPALVSEAANDEVDRSYLELPVFVMPSNATNQQYNQLSNLPP 388
LF N LSG P + +L L+S +D E+P V+ QL NL
Sbjct: 265 LFLYQNKLSGPIPPSIFSLQKLISLDLSDNSLSG--EIPELVI----------QLQNL-E 311
Query: 389 AIYLANNSLSGNIPVEIGQLKSLHVLDLSNNNFSGTIPDELSDLSNLEKLDLSGNHLVGE 448
++L +N+ +G IPV + L L VL L +N FSG IP L +NL LDLS N+L GE
Sbjct: 312 ILHLFSNNFTGKIPVALTSLPRLQVLQLWSNKFSGEIPKNLGKHNNLTVLDLSTNNLTGE 371
Query: 449 IPISLKGLHFLSSFSVAHNNLQGAVP 474
IP L L + N+L+G +P
Sbjct: 372 IPEGLCSSGNLFKLILFSNSLEGEIP 397
|
Length = 968 |
| >gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 70.2 bits (172), Expect = 5e-13
Identities = 68/225 (30%), Positives = 102/225 (45%), Gaps = 23/225 (10%)
Query: 609 FSQANIIGCGGFGLVYKATL-ANGTTLAIKKLSGDLGLMEREFKAEVEALSTAQHKNL-- 665
F ++G GGFG V + A G A KKL +R K + EA++ + + L
Sbjct: 2 FRHYRVLGKGGFGEVCACQVRATGKMYACKKLE-----KKRIKKRKGEAMALNEKQILEK 56
Query: 666 ------VSLQGYCVHQGFRL-LIYSYMENGSLDYWLHEKADGASQLDWLTRLKIARGTSC 718
VSL Y L L+ + M G L + ++ + D + A +C
Sbjct: 57 VNSRFVVSL-AYAYETKDALCLVLTLMNGGDLKFHIYNMGNPG--FDEERAVFYAAEITC 113
Query: 719 GLAYMHQICEPHIVHRDIKSSNILLDDQFEAHLADFGLSRLILPYQTHVTTELVGTLGYI 778
GL +H+ IV+RD+K NILLDD ++D GL+ I +T VGT+GY+
Sbjct: 114 GLEDLHR---ERIVYRDLKPENILLDDYGHIRISDLGLAVEIPEGET--IRGRVGTVGYM 168
Query: 779 PPEYGQAWVATLRGDMYSFGVVMLELLTGKRPVDVLKPKMSRELV 823
PE + T D + G ++ E++ GK P K K+ RE V
Sbjct: 169 APEVVKNERYTFSPDWWGLGCLIYEMIEGKSPFRQRKEKVKREEV 213
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285 |
| >gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Score = 69.2 bits (169), Expect = 7e-13
Identities = 72/274 (26%), Positives = 118/274 (43%), Gaps = 34/274 (12%)
Query: 614 IIGCGGFGLVYKATLANGTTLAIKKLSGDLGLMEREFKAEVEALSTAQHKNLVSLQGYCV 673
IG G FG V G +A+K + D + F AE ++ +H NLV L G V
Sbjct: 13 TIGKGEFGDVMLGDY-RGNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIV 69
Query: 674 HQGFRLLIYS-YMENGSLDYWLHEKADGASQLDWLTRLKIARGTSCGLAYMHQICEPHIV 732
+ L I + YM GSL +L + G S L LK + + Y+ + V
Sbjct: 70 EEKGGLYIVTEYMAKGSLVDYLRSR--GRSVLGGDCLLKFSLDVCEAMEYLEA---NNFV 124
Query: 733 HRDIKSSNILLDDQFEAHLADFGLSRLILPYQTHVTTELVGTLGYIPPEYGQAWVATLRG 792
HRD+ + N+L+ + A ++DFGL++ Q T +L + + PE + + +
Sbjct: 125 HRDLAARNVLVSEDNVAKVSDFGLTKEASSTQD--TGKL--PVKWTAPEALREKKFSTKS 180
Query: 793 DMYSFGVVMLELLTGKR---PVDVLKPKMSRELVGWVLKMRSEGKQDQVFDPILRGKGFD 849
D++SFG+++ E+ + R P LK + R G+ KM + V
Sbjct: 181 DVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGY--KMDAPDGCPPV----------- 227
Query: 850 EEMLQVLDVACMCVSQNPFKRPTVKEVVEWLNNV 883
V DV C + RP+ ++ E L ++
Sbjct: 228 -----VYDVMKQCWHLDAATRPSFLQLREQLEHI 256
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256 |
| >gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Score = 69.6 bits (170), Expect = 8e-13
Identities = 67/282 (23%), Positives = 117/282 (41%), Gaps = 33/282 (11%)
Query: 609 FSQANIIGCGGFGLVYKATLANGTTLAIKKLSGDLGLMEREFKAEVEALST-AQHKNLVS 667
F ++G G +G VYK LA K+ E E K E+ L + H+N+ +
Sbjct: 18 FELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTEDEEEEIKLEINMLKKYSHHRNIAT 77
Query: 668 LQGYCV------HQGFRLLIYSYMENGSLDYWLHEKADGASQLDWLTRLKIARGTSCGLA 721
G + H L+ + GS+ + A + DW+ I R GLA
Sbjct: 78 YYGAFIKKSPPGHDDQLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAY--ICREILRGLA 135
Query: 722 YMHQICEPHIVHRDIKSSNILLDDQFEAHLADFGLSRLILPYQTHVTTELVGTLGYIPPE 781
++H ++HRDIK N+LL + E L DFG+S L +GT ++ PE
Sbjct: 136 HLHA---HKVIHRDIKGQNVLLTENAEVKLVDFGVSAQ-LDRTVGRRNTFIGTPYWMAPE 191
Query: 782 Y-----GQAWVATLRGDMYSFGVVMLELLTGKRPVDVLKPKMSRELVGWVLKMRSEGKQD 836
R D++S G+ +E+ G P+ + P MR+
Sbjct: 192 VIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMHP------------MRALFLIP 239
Query: 837 QVFDPILRGKGFDEEMLQVLDVACMCVSQNPFKRPTVKEVVE 878
+ P L+ K + ++ + ++ C+ +N RP+ +++++
Sbjct: 240 RNPPPKLKSKKWSKKFIDFIEG---CLVKNYLSRPSTEQLLK 278
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282 |
| >gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Score = 68.9 bits (169), Expect = 9e-13
Identities = 54/207 (26%), Positives = 91/207 (43%), Gaps = 20/207 (9%)
Query: 615 IGCGGFGLVYKATL--ANGTTL--AIKKLSGD--LGLMEREFKAEVEALSTAQHKNLVSL 668
+G G FG+V + + G + A+K L D +M+ +F E + + H+NL+ L
Sbjct: 3 LGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMD-DFLKEAAIMHSLDHENLIRL 61
Query: 669 QGYCVHQGFRLLIYSYMENGSLDYWLHEKADGASQLD--WLTRLKIARGTSCGLAYMHQI 726
G V +++ GSL L + A G + ++IA G+ Y+
Sbjct: 62 YG-VVLTHPLMMVTELAPLGSLLDRLRKDALGHFLISTLCDYAVQIA----NGMRYLES- 115
Query: 727 CEPHIVHRDIKSSNILLDDQFEAHLADFGLSRLILPYQTHVTTE--LVGTLGYIPPEYGQ 784
+HRD+ + NILL + + DFGL R + + H E L + PE +
Sbjct: 116 --KRFIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYVMEEHLKVPFAWCAPESLR 173
Query: 785 AWVATLRGDMYSFGVVMLELLT-GKRP 810
+ D++ FGV + E+ T G+ P
Sbjct: 174 TRTFSHASDVWMFGVTLWEMFTYGEEP 200
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257 |
| >gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 69.0 bits (169), Expect = 1e-12
Identities = 58/212 (27%), Positives = 102/212 (48%), Gaps = 23/212 (10%)
Query: 609 FSQANIIGCGGFGLVYKAT-LANGTTLAIKKL-----SGDLGLMEREFKAEVEALSTAQH 662
+ + +IG G +G VY+ + G +A+K + D+ ++RE A + L +Q
Sbjct: 3 YQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREV-ALLSQLRQSQP 61
Query: 663 KNLVSLQGYCVHQGFRL-LIYSYMENGSLDYWLHEKADGASQLDWLTRLKIARGTSCGLA 721
N+ G +G RL +I Y E GS+ + A + I R L
Sbjct: 62 PNITKYYG-SYLKGPRLWIIMEYAEGGSVRTLMK-----AGPIAEKYISVIIREVLVALK 115
Query: 722 YMHQICEPHIVHRDIKSSNILLDDQFEAHLADFGLSRLILPYQTHVTTELVGTLGYIPPE 781
Y+H++ ++HRDIK++NIL+ + L DFG++ L+ + +T VGT ++ PE
Sbjct: 116 YIHKV---GVIHRDIKAANILVTNTGNVKLCDFGVAALLNQNSSKRST-FVGTPYWMAPE 171
Query: 782 Y---GQAWVATLRGDMYSFGVVMLELLTGKRP 810
G+ + + D++S G+ + E+ TG P
Sbjct: 172 VITEGKYYDT--KADIWSLGITIYEMATGNPP 201
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277 |
| >gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Score = 69.7 bits (170), Expect = 1e-12
Identities = 59/218 (27%), Positives = 106/218 (48%), Gaps = 14/218 (6%)
Query: 607 DNFSQANIIGCGGFGLVYKAT-LANGTTLAIKKLSGDLG-LMEREFKAEVEALSTAQHKN 664
D+F + + +G G G+V K +G +A K + ++ + + E++ L
Sbjct: 5 DDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPY 64
Query: 665 LVSLQGYCVHQGFRLLIYSYMENGSLDYWLHEKADGASQLDWLTRLKIARGTSCGLAYMH 724
+V G G + +M+ GSLD L E ++ + + RG LAY+
Sbjct: 65 IVGFYGAFYSDGEISICMEHMDGGSLDQVLKEAKRIPEEILGKVSIAVLRG----LAYLR 120
Query: 725 QICEPHIVHRDIKSSNILLDDQFEAHLADFGLSRLILPYQTHVTTELVGTLGYIPPEYGQ 784
+ + I+HRD+K SNIL++ + E L DFG+S ++ + VGT Y+ PE Q
Sbjct: 121 E--KHQIMHRDVKPSNILVNSRGEIKLCDFGVSGQLI---DSMANSFVGTRSYMSPERLQ 175
Query: 785 AWVATLRGDMYSFGVVMLELLTGKRPVDVLKPKMSREL 822
+++ D++S G+ ++EL G+ P+ P ++EL
Sbjct: 176 GTHYSVQSDIWSMGLSLVELAIGRYPI---PPPDAKEL 210
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331 |
| >gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Score = 69.8 bits (171), Expect = 1e-12
Identities = 64/213 (30%), Positives = 98/213 (46%), Gaps = 35/213 (16%)
Query: 614 IIGCGGFGLVYKATLANGTT--LAIKKLSGDLGLMEREFKA---EVEALSTA-QHKNLVS 667
++G G FG V A L GT AIK L D+ L + + + E L+ A +H L
Sbjct: 2 VLGKGSFGKVMLAEL-KGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTH 60
Query: 668 LQGYCVHQGFRLLIY--SYMENGSLDYWLHEKADGASQLDWLTRLKIARGT------SCG 719
L +C Q L + Y+ G L + + R AR CG
Sbjct: 61 L--FCTFQTKEHLFFVMEYLNGGDLMFHIQSSG----------RFDEARARFYAAEIICG 108
Query: 720 LAYMHQICEPHIVHRDIKSSNILLDDQFEAHLADFGLSRLILPYQTHVTTELVGTLGYIP 779
L ++H+ I++RD+K N+LLD +ADFG+ + + + +T GT YI
Sbjct: 109 LQFLHK---KGIIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGEGKAST-FCGTPDYIA 164
Query: 780 PEY--GQAWVATLRGDMYSFGVVMLELLTGKRP 810
PE GQ + ++ D +SFGV++ E+L G+ P
Sbjct: 165 PEILKGQKYNESV--DWWSFGVLLYEMLIGQSP 195
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316 |
| >gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Score = 69.1 bits (169), Expect = 1e-12
Identities = 63/216 (29%), Positives = 106/216 (49%), Gaps = 33/216 (15%)
Query: 608 NFSQANIIGCGGFGLVYKA-TLANGTTLAIKKLSGDL---GLMEREFKAEVEALSTAQHK 663
NF + IG G +G+VYKA G +A+KK+ D G+ + E+ L H
Sbjct: 1 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIR-EISLLKELNHP 59
Query: 664 NLVSLQGYCVHQGFRL-LIYSYMENGSLDYWLHEKADGASQLDWLTRLKIARGTSCGLAY 722
N+V L +H +L L++ ++ L + D + L+ + + S Y
Sbjct: 60 NIVKLLD-VIHTENKLYLVFEFLHQD-----LKKFMDASP----LSGIPLPLIKS----Y 105
Query: 723 MHQI------CEPH-IVHRDIKSSNILLDDQFEAHLADFGLSRLI-LPYQTHVTTELVGT 774
+ Q+ C H ++HRD+K N+L++ + LADFGL+R +P +T+ T E+V T
Sbjct: 106 LFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTY-THEVV-T 163
Query: 775 LGYIPPE--YGQAWVATLRGDMYSFGVVMLELLTGK 808
L Y PE G + +T D++S G + E++T +
Sbjct: 164 LWYRAPEILLGCKYYSTAV-DIWSLGCIFAEMVTRR 198
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284 |
| >gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Score = 68.9 bits (168), Expect = 1e-12
Identities = 77/281 (27%), Positives = 123/281 (43%), Gaps = 45/281 (16%)
Query: 609 FSQANIIGCGGFGLVYKATLANGTTLAIKKLSGDLGLMEREF---KAEVEALSTAQHKNL 665
F++ IG G FG V+K + N T + DL E E + E+ LS +
Sbjct: 6 FTKLERIGKGSFGEVFKG-IDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYV 64
Query: 666 VSLQGYCVHQGFRLLIYSYMENGSLDYWLHEKADGASQLDWL-----TRLKIA---RGTS 717
G SY++ G+ + + E G S LD L +IA +
Sbjct: 65 TKYYG------------SYLK-GTKLWIIMEYLGGGSALDLLRAGPFDEFQIATMLKEIL 111
Query: 718 CGLAYMHQICEPHIVHRDIKSSNILLDDQFEAHLADFGLSRLILPYQTHVTTELVGTLGY 777
GL Y+H +HRDIK++N+LL +Q + LADFG++ + Q T VGT +
Sbjct: 112 KGLDYLHS---EKKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNT-FVGTPFW 167
Query: 778 IPPEYGQAWVATLRGDMYSFGVVMLELLTGKRPVDVLKPKMSRELVGWVLKMRSEGKQDQ 837
+ PE Q + D++S G+ +EL G+ P + P MR +
Sbjct: 168 MAPEVIQQSAYDSKADIWSLGITAIELAKGEPPNSDMHP------------MRVLFLIPK 215
Query: 838 VFDPILRGKGFDEEMLQVLDVACMCVSQNPFKRPTVKEVVE 878
P L G+ F + + +D C++++P RPT KE+++
Sbjct: 216 NNPPTLTGE-FSKPFKEFIDA---CLNKDPSFRPTAKELLK 252
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277 |
| >gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Score = 68.9 bits (169), Expect = 1e-12
Identities = 60/212 (28%), Positives = 95/212 (44%), Gaps = 42/212 (19%)
Query: 615 IGCGGFGLVYKA-TLANGTTLAIKKL--SGDLGLMEREFKAEVEALSTAQHKNLVSLQGY 671
IG G +G+V+K G +AIKK S D ++++ E+ L +H NLV+L
Sbjct: 9 IGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNL--- 65
Query: 672 CVHQGFRL-----LIYSYMENGSLDYWLHEKADGASQLDWLTRLKIARGTSCGLAYMHQI 726
+ FR L++ Y ++ ++ L+E + KI T + + H+
Sbjct: 66 --IEVFRRKRKLHLVFEYCDH-TV---LNELEKNPRGVPEHLIKKIIWQTLQAVNFCHK- 118
Query: 727 CEPHIVHRDIKSSNILLDDQFEAHLADFGLSRLILP----YQTHVTTE-------LVGTL 775
+ +HRD+K NIL+ Q + L DFG +R++ Y +V T LVG
Sbjct: 119 --HNCIHRDVKPENILITKQGQIKLCDFGFARILTGPGDDYTDYVATRWYRAPELLVGDT 176
Query: 776 GYIPPEYGQAWVATLRGDMYSFGVVMLELLTG 807
Y PP D+++ G V ELLTG
Sbjct: 177 QYGPPV-----------DVWAIGCVFAELLTG 197
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286 |
| >gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Score = 69.3 bits (169), Expect = 2e-12
Identities = 61/219 (27%), Positives = 109/219 (49%), Gaps = 16/219 (7%)
Query: 607 DNFSQANIIGCGGFGLVYKAT-LANGTTLAIKKLSGDLG-LMEREFKAEVEALSTAQHKN 664
D+F + + +G G G+V+K + +G +A K + ++ + + E++ L
Sbjct: 5 DDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPY 64
Query: 665 LVSLQGYCVHQGFRLLIYSYMENGSLDYWLHEKADGASQLDWLTRLKIARGTSCGLAYMH 724
+V G G + +M+ GSLD L + Q+ L ++ IA GL Y+
Sbjct: 65 IVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQI--LGKVSIA--VIKGLTYLR 120
Query: 725 QICEPH-IVHRDIKSSNILLDDQFEAHLADFGLSRLILPYQTHVTTELVGTLGYIPPEYG 783
E H I+HRD+K SNIL++ + E L DFG+S ++ + VGT Y+ PE
Sbjct: 121 ---EKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLI---DSMANSFVGTRSYMSPERL 174
Query: 784 QAWVATLRGDMYSFGVVMLELLTGKRPVDVLKPKMSREL 822
Q +++ D++S G+ ++E+ G+ P+ P ++EL
Sbjct: 175 QGTHYSVQSDIWSMGLSLVEMAIGRYPI---PPPDAKEL 210
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333 |
| >gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Score = 68.3 bits (167), Expect = 2e-12
Identities = 72/298 (24%), Positives = 117/298 (39%), Gaps = 51/298 (17%)
Query: 608 NFSQANIIGCGGFGLVYKATL-----ANGTTL-AIKKLSG-DLGLMEREFKAEVEALSTA 660
N + +G G FG V+ A G TL +K L ++ EF+ E++
Sbjct: 6 NLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKL 65
Query: 661 QHKNLVSLQGYCVHQGFRLLIYSYMENGSLDYWL--HEKADGASQLDWLTRLKIARGTSC 718
HKN+V L G C +I Y + G L +L + D + L+ T
Sbjct: 66 SHKNVVRLLGLCREAEPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLS-------TKQ 118
Query: 719 GLAYMHQICE-------PHIVHRDIKSSNILLDDQFEAHLADFGLSRLILPYQTHVTTEL 771
+A QI VHRD+ + N L+ Q E ++ LS+ + + +
Sbjct: 119 KVALCTQIALGMDHLSNARFVHRDLAARNCLVSSQREVKVSLLSLSKDVYNSEYYKLRNA 178
Query: 772 VGTLGYIPPEYGQAWVATLRGDMYSFGVVMLELLT-GKRPVDVLKPKMSRELVGWVLKMR 830
+ L ++ PE Q + + D++SFGV+M E+ T G+ P +S E V L+
Sbjct: 179 LIPLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFTQGELPF----YGLSDEEVLNRLQAG 234
Query: 831 S------EGKQDQVFDPILRGKGFDEEMLQVLDVACMCVSQNPFKRPTVKEVVEWLNN 882
EG +++ + R C + NP RP+ E+V L
Sbjct: 235 KLELPVPEGCPSRLYKLMTR-----------------CWAVNPKDRPSFSELVSALGE 275
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275 |
| >gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Score = 68.2 bits (167), Expect = 2e-12
Identities = 66/219 (30%), Positives = 108/219 (49%), Gaps = 33/219 (15%)
Query: 608 NFSQANIIGCGGFGLVYKA-TLANGTTLAIKKL---SGDLGLMEREFKAEVEALSTAQHK 663
++++ IG G +G+VYK G +A+KK+ S + G+ + E+ L QH
Sbjct: 1 DYTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIR-EISLLKELQHP 59
Query: 664 NLVSLQGYCVHQGFRL-LIYSYMENGSLDYWLHEKADGASQLDWLTRLKIARGTSCGLAY 722
N+V LQ + Q RL LI+ ++ S+D + + Q +K +Y
Sbjct: 60 NIVCLQD-VLMQESRLYLIFEFL---SMDLKKYLDSLPKGQYMDAELVK---------SY 106
Query: 723 MHQI------CEPH-IVHRDIKSSNILLDDQFEAHLADFGLSRLI-LPYQTHVTTELVGT 774
++QI C ++HRD+K N+L+D++ LADFGL+R +P + V T V T
Sbjct: 107 LYQILQGILFCHSRRVLHRDLKPQNLLIDNKGVIKLADFGLARAFGIPVR--VYTHEVVT 164
Query: 775 LGYIPPE--YGQAWVATLRGDMYSFGVVMLELLTGKRPV 811
L Y PE G +T D++S G + E+ T K+P+
Sbjct: 165 LWYRAPEVLLGSPRYST-PVDIWSIGTIFAEMAT-KKPL 201
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285 |
| >gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Score = 68.5 bits (167), Expect = 2e-12
Identities = 69/234 (29%), Positives = 104/234 (44%), Gaps = 34/234 (14%)
Query: 594 IKDLTIYELLKATDN---FSQANIIGCGGFGLVYKATLANGTT---LAIKKLSGDLGLME 647
+KD I +L D F + IG G FG VY AT N T +A+KK+S
Sbjct: 5 VKDPEIADLFYKDDPEEIFVGLHEIGHGSFGAVYFAT--NSHTNEVVAVKKMSYSGKQTN 62
Query: 648 REFK---AEVEALSTAQHKNLVSLQGYCVHQGFRLLIYSYMENGSLDYW-LHEKADGASQ 703
+++ EV+ L +H N + +G + + L+ Y + D +H+K
Sbjct: 63 EKWQDIIKEVKFLQQLKHPNTIEYKGCYLKEHTAWLVMEYCLGSASDLLEVHKKP----- 117
Query: 704 LDWLTRLKIARGTSCGLAYMHQICEPHIVHRDIKSSNILLDDQFEAHLADFGLSRLILPY 763
L + I G GLAY+H ++HRDIK+ NILL + + LADFG + P
Sbjct: 118 LQEVEIAAITHGALQGLAYLHSHN---MIHRDIKAGNILLTEPGQVKLADFGSASKSSP- 173
Query: 764 QTHVTTELVGTLGYIPPEYGQAWVATLRG------DMYSFGVVMLELLTGKRPV 811
VGT ++ PE +A G D++S G+ +EL K P+
Sbjct: 174 ----ANSFVGTPYWMAPE---VILAMDEGQYDGKVDVWSLGITCIELAERKPPL 220
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 70.3 bits (172), Expect = 3e-12
Identities = 34/84 (40%), Positives = 47/84 (55%)
Query: 392 LANNSLSGNIPVEIGQLKSLHVLDLSNNNFSGTIPDELSDLSNLEKLDLSGNHLVGEIPI 451
L N L G IP + L SL L L++N G IP EL + +L+ + L N+L GEIP
Sbjct: 171 LGGNVLVGKIPNSLTNLTSLEFLTLASNQLVGQIPRELGQMKSLKWIYLGYNNLSGEIPY 230
Query: 452 SLKGLHFLSSFSVAHNNLQGAVPS 475
+ GL L+ + +NNL G +PS
Sbjct: 231 EIGGLTSLNHLDLVYNNLTGPIPS 254
|
Length = 968 |
| >gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Score = 68.6 bits (168), Expect = 3e-12
Identities = 59/213 (27%), Positives = 91/213 (42%), Gaps = 31/213 (14%)
Query: 614 IIGCGGFGLVYKATLANGTTL-AIKKLSGDLGLMEREFKA---EVEALSTA-QHKNLVSL 668
++G G FG V A L L A+K L D+ L + + + E L+ A +H L L
Sbjct: 2 VLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQL 61
Query: 669 QGYCVHQGFRLLIY--SYMENGSLDYWLHEKADGASQLDWLTRLKIARGT------SCGL 720
+ Q L + Y+ G L + + R R GL
Sbjct: 62 --HSCFQTKDRLFFVMEYVNGGDLMFHIQR----------SGRFDEPRARFYAAEIVLGL 109
Query: 721 AYMHQICEPHIVHRDIKSSNILLDDQFEAHLADFGLSRL-ILPYQTHVTTELVGTLGYIP 779
++H E I++RD+K N+LLD + +ADFG+ + IL T T+ GT YI
Sbjct: 110 QFLH---ERGIIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGGVT--TSTFCGTPDYIA 164
Query: 780 PEYGQAWVATLRGDMYSFGVVMLELLTGKRPVD 812
PE D ++ GV++ E+L G+ P +
Sbjct: 165 PEILSYQPYGPAVDWWALGVLLYEMLAGQSPFE 197
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318 |
| >gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Score = 68.5 bits (167), Expect = 3e-12
Identities = 63/226 (27%), Positives = 107/226 (47%), Gaps = 30/226 (13%)
Query: 602 LLKATDNFSQANIIGCGGFGLVYKAT-LANGTTL----AIKKL-SGDLGLMEREFKAEVE 655
+LK T+ F + ++G G FG VYK + G + AIK+L +E E
Sbjct: 3 ILKETE-FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAY 61
Query: 656 ALSTAQHKNLVSLQGYCVHQGFRLLIYSYMENGSL-DYWLHEKADGASQ--LDWLTRLKI 712
+++ + ++ L G C+ +L I M G L DY K + SQ L+W ++I
Sbjct: 62 VMASVDNPHVCRLLGICLTSTVQL-ITQLMPFGCLLDYVREHKDNIGSQYLLNWC--VQI 118
Query: 713 ARGTSCGLAYMHQICEPHIVHRDIKSSNILLDDQFEAHLADFGLSRLILPYQTHVTTELV 772
A+G M+ + E +VHRD+ + N+L+ + DFGL++L+ E
Sbjct: 119 AKG-------MNYLEERRLVHRDLAARNVLVKTPQHVKITDFGLAKLL----GADEKEYH 167
Query: 773 GTLGYIPPEYG-----QAWVATLRGDMYSFGVVMLELLT-GKRPVD 812
G +P ++ + T + D++S+GV + EL+T G +P D
Sbjct: 168 AEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYD 213
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316 |
| >gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Score = 68.1 bits (167), Expect = 3e-12
Identities = 73/309 (23%), Positives = 119/309 (38%), Gaps = 66/309 (21%)
Query: 615 IGCGGFGLVYKATL----------------ANGTTL-AIKKL--SGDLGLMEREFKAEVE 655
+G G FG V+ A+ L A+K L E +F EV+
Sbjct: 13 LGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNARE-DFLKEVK 71
Query: 656 ALSTAQHKNLVSLQGYCVHQGFRLLIYSYMENGSLDYWL--HEKADGASQLDWLTRLKIA 713
LS N+ L G C +I YMENG L+ +L H + + ++
Sbjct: 72 ILSRLSDPNIARLLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKS---LS 128
Query: 714 RGTSCGLAYMH-QIC-------EPHIVHRDIKSSNILLDDQFEAHLADFGLSRLILP--- 762
T L YM QI + VHRD+ + N L+ + +ADFG+SR +
Sbjct: 129 FST---LLYMATQIASGMRYLESLNFVHRDLATRNCLVGKNYTIKIADFGMSRNLYSSDY 185
Query: 763 YQTHVTTELVGTLGYIPPEYGQAWVATLRG------DMYSFGVVMLELLT--GKRPVDVL 814
Y+ L P AW + L G D+++FGV + E+LT ++P + L
Sbjct: 186 YRVQGRAPL--------PIRWMAWESVLLGKFTTKSDVWAFGVTLWEILTLCREQPYEHL 237
Query: 815 KPKMSRELVGWVLKMRSEGKQDQVFDPIL-RGKGFDEEMLQVLDVACMCVSQNPFKRPTV 873
+ V++ +D L R ++ + ++ C ++ RPT
Sbjct: 238 TDQ-------QVIENAGHFFRDDGRQIYLPRPPNCPKD---IYELMLECWRRDEEDRPTF 287
Query: 874 KEVVEWLNN 882
+E+ +L
Sbjct: 288 REIHLFLQR 296
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296 |
| >gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 69.5 bits (170), Expect = 3e-12
Identities = 47/164 (28%), Positives = 80/164 (48%), Gaps = 27/164 (16%)
Query: 720 LAYMHQICEPHIVHRDIKSSNILLDDQFEAHLADFGLSRLILPYQTHVTTEL----VGTL 775
L +H + H++HRDIKS+NILL L DFG S++ Y V+ ++ GT
Sbjct: 153 LLAVHHVHSKHMIHRDIKSANILLCSNGLVKLGDFGFSKM---YAATVSDDVGRTFCGTP 209
Query: 776 GYIPPEYGQAWVATLRGDMYSFGVVMLELLTGKRPVD--VLKPKMSRELVGWVLKMRSEG 833
Y+ PE + + + DM+S GV++ ELLT KRP D ++ M + L G
Sbjct: 210 YYVAPEIWRRKPYSKKADMFSLGVLLYELLTLKRPFDGENMEEVMHKTLAG--------- 260
Query: 834 KQDQVFDPILRGKGFDEEMLQVLDVACMCVSQNPFKRPTVKEVV 877
+DP+ ++ ++ +S +P +RP+ +++
Sbjct: 261 ----RYDPLP-----PSISPEMQEIVTALLSSDPKRRPSSSKLL 295
|
Length = 496 |
| >gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Score = 68.2 bits (166), Expect = 4e-12
Identities = 68/237 (28%), Positives = 104/237 (43%), Gaps = 30/237 (12%)
Query: 589 NNTNEIKDLTIYELLKATDN---FSQANIIGCGGFGLVYKATLANGT-TLAIKKLSGDLG 644
+ +KD I EL D F+ IG G FG VY A +AIKK+S
Sbjct: 4 SRAGSLKDPEIAELFFKEDPEKLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGK 63
Query: 645 LMEREFK---AEVEALSTAQHKNLVSLQGYCVHQGFRLLIYSYMENGSLDYW-LHEKADG 700
+++ EV+ L +H N + +G + + L+ Y + D +H+K
Sbjct: 64 QSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLREHTAWLVMEYCLGSASDLLEVHKKP-- 121
Query: 701 ASQLDWLTRLKIARGTSCGLAYMHQICEPHIVHRDIKSSNILLDDQFEAHLADFGLSRLI 760
L + I G GLAY+H +++HRDIK+ NILL + + LADFG + +
Sbjct: 122 ---LQEVEIAAITHGALQGLAYLHS---HNMIHRDIKAGNILLTEPGQVKLADFGSASIA 175
Query: 761 LPYQTHVTTELVGTLGYIPPEYGQAWVATLRG------DMYSFGVVMLELLTGKRPV 811
P VGT ++ PE +A G D++S G+ +EL K P+
Sbjct: 176 SP-----ANSFVGTPYWMAPE---VILAMDEGQYDGKVDVWSLGITCIELAERKPPL 224
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317 |
| >gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 68.1 bits (167), Expect = 4e-12
Identities = 59/225 (26%), Positives = 92/225 (40%), Gaps = 47/225 (20%)
Query: 613 NIIGC---GGFGLVYKATLANGTT---LAIKKLSGDLGLME-------REFKAEVEALST 659
I GC G +G VYKA NG AIKK GD RE + L
Sbjct: 3 EIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACRE----IALLRE 58
Query: 660 AQHKNLVSLQGYCVHQGFRL--LIYSYMENGSLDYWL---HEKADGASQLDWLTRLKIAR 714
+H+N+VSL + + L++ Y E+ D W + + +
Sbjct: 59 LKHENVVSLVEVFLEHADKSVYLLFDYAEH---DLWQIIKFHRQAKRVSIPPSMVKSLLW 115
Query: 715 GTSCGLAYMHQICEPHIVHRDIKSSNILL----DDQFEAHLADFGLSRLIL-PYQTHVTT 769
G+ Y+H ++HRD+K +NIL+ ++ + D GL+RL P +
Sbjct: 116 QILNGVHYLH---SNWVLHRDLKPANILVMGEGPERGVVKIGDLGLARLFNAPLKPLADL 172
Query: 770 E-LVGTLGYIPPE-------YGQAWVATLRGDMYSFGVVMLELLT 806
+ +V T+ Y PE Y +A D+++ G + ELLT
Sbjct: 173 DPVVVTIWYRAPELLLGARHYTKAI------DIWAIGCIFAELLT 211
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316 |
| >gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 67.5 bits (165), Expect = 4e-12
Identities = 60/217 (27%), Positives = 96/217 (44%), Gaps = 31/217 (14%)
Query: 615 IGCGGFGLVYKATLANGTTLAIKKLSGDLGLMER--EFKAEVEALSTAQHKNLVSLQGYC 672
+G G FG VYKA A K+ + E +F E++ LS +H N+V L
Sbjct: 13 LGDGAFGKVYKAQHKETGLFAAAKII-QIESEEELEDFMVEIDILSECKHPNIVGLYEAY 71
Query: 673 VHQGFRLLIYSYMENGSLDYWLHEKADGASQLDWLTRLKIA---RGTSCGLAYMHQICEP 729
++ ++ + + G+LD + E G LT +I R L ++H
Sbjct: 72 FYENKLWILIEFCDGGALDSIMLELERG------LTEPQIRYVCRQMLEALNFLH---SH 122
Query: 730 HIVHRDIKSSNILLDDQFEAHLADFGLS-RLILPYQTHVTTELVGTLGYIPPEYGQAWVA 788
++HRD+K+ NILL + LADFG+S + Q T +GT ++ PE VA
Sbjct: 123 KVIHRDLKAGNILLTLDGDVKLADFGVSAKNKSTLQKRDT--FIGTPYWMAPEV----VA 176
Query: 789 T---------LRGDMYSFGVVMLELLTGKRPVDVLKP 816
+ D++S G+ ++EL + P L P
Sbjct: 177 CETFKDNPYDYKADIWSLGITLIELAQMEPPHHELNP 213
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280 |
| >gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Score = 66.6 bits (162), Expect = 5e-12
Identities = 64/223 (28%), Positives = 103/223 (46%), Gaps = 30/223 (13%)
Query: 614 IIGCGGFGLVYKATLANGTTLAIKKLSGDL-GLMEREFKAEVEALSTAQHKNLVSLQGYC 672
++G G FG V+K TL + T +A+K DL ++ +F +E L H N+V L G C
Sbjct: 2 LLGKGNFGEVFKGTLKDKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVC 61
Query: 673 VHQGFRLLIYSYME---NGSLDYWLHEKADGASQLDWLTRLKIARGTSCGLAYMHQICEP 729
R IY ME G +L +K D +L +K A + G+AY+
Sbjct: 62 TQ---RQPIYIVMELVPGGDFLSFLRKKKD---ELKTKQLVKFALDAAAGMAYLES---K 112
Query: 730 HIVHRDIKSSNILLDDQFEAHLADFGLSRLILPYQTHVTTELVGTLGYIP-----PE--- 781
+ +HRD+ + N L+ + ++DFG+SR Q L IP PE
Sbjct: 113 NCIHRDLAARNCLVGENNVLKISDFGMSR-----QEDDGIYSSSGLKQIPIKWTAPEALN 167
Query: 782 YGQAWVATLRGDMYSFGVVMLELLT-GKRPVDVLKPKMSRELV 823
YG+ + D++S+G+++ E + G P + + +RE V
Sbjct: 168 YGR---YSSESDVWSYGILLWETFSLGVCPYPGMTNQQAREQV 207
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250 |
| >gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Score = 66.9 bits (163), Expect = 6e-12
Identities = 73/233 (31%), Positives = 100/233 (42%), Gaps = 30/233 (12%)
Query: 614 IIGCGGFGLVYKATLAN-GTTLAIKKLSGDLGLMEREFKAEVEALSTAQHKNLVSLQ--- 669
IIG GGFG VY A+ G A+K L M+ + E AL+ +LVS
Sbjct: 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMK---QGETLALNERIMLSLVSTGDCP 57
Query: 670 -----GYCVHQGFRL-LIYSYMENGSLDYWLHEKADGASQLDWLTRLKI---ARGTSCGL 720
Y H +L I M G L Y L SQ + ++ A GL
Sbjct: 58 FIVCMSYAFHTPDKLSFILDLMNGGDLHYHL-------SQHGVFSEAEMRFYAAEIILGL 110
Query: 721 AYMHQICEPHIVHRDIKSSNILLDDQFEAHLADFGLSRLILPYQTHVTTELVGTLGYIPP 780
+MH +V+RD+K +NILLD+ ++D GL+ + H + VGT GY+ P
Sbjct: 111 EHMHN---RFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHAS---VGTHGYMAP 164
Query: 781 EYGQAWVA-TLRGDMYSFGVVMLELLTGKRPVDVLKPKMSRELVGWVLKMRSE 832
E Q VA D +S G ++ +LL G P K K E+ L M E
Sbjct: 165 EVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVE 217
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278 |
| >gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Score = 66.6 bits (162), Expect = 6e-12
Identities = 67/213 (31%), Positives = 99/213 (46%), Gaps = 17/213 (7%)
Query: 608 NFSQANIIGCGGFGLVYKA-TLANGTTLAIKKLSGDLGLME--REFKA---EVEALSTAQ 661
N+ + ++G G FG VY + G LA K++ D E +E A E++ L Q
Sbjct: 3 NWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQ 62
Query: 662 HKNLVSLQGYCVHQGFRLL--IYSYMENGSLDYWLHEKADGASQLDWLTRLKIARGTSCG 719
H+ +V G + + L YM GS+ L KA GA + +TR K R G
Sbjct: 63 HERIVQYYGCLRDRAEKTLTIFMEYMPGGSVKDQL--KAYGALT-ESVTR-KYTRQILEG 118
Query: 720 LAYMHQICEPHIVHRDIKSSNILLDDQFEAHLADFGLSRLILPYQTHVT--TELVGTLGY 777
++Y+H IVHRDIK +NIL D L DFG S+ + T + GT +
Sbjct: 119 MSYLHS---NMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICMSGTGIRSVTGTPYW 175
Query: 778 IPPEYGQAWVATLRGDMYSFGVVMLELLTGKRP 810
+ PE + D++S G ++E+LT K P
Sbjct: 176 MSPEVISGEGYGRKADVWSLGCTVVEMLTEKPP 208
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266 |
| >gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Score = 67.3 bits (164), Expect = 7e-12
Identities = 72/270 (26%), Positives = 118/270 (43%), Gaps = 47/270 (17%)
Query: 634 LAIKKLSGDLGLMER-EFKAEVEALSTAQHKNLVSLQGYCVHQGFRLLIYSYMENGSLDY 692
+A+K L D R +F EV+ LS + N++ L G CV + +I YMENG L+
Sbjct: 49 VAVKILRPDANKNARNDFLKEVKILSRLKDPNIIRLLGVCVDEDPLCMITEYMENGDLNQ 108
Query: 693 WL--HEKADGASQ-------------LDWLTRLKIARGTSCGLAYMHQICEPHIVHRDIK 737
+L H D + + + L +A + G+ Y+ + + VHRD+
Sbjct: 109 FLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSL---NFVHRDLA 165
Query: 738 SSNILLDDQFEAHLADFGLSRLILP---YQTHVTTELVGTLGYIPPEYGQAWVATLRG-- 792
+ N L+ + +ADFG+SR + Y+ L P AW L G
Sbjct: 166 TRNCLVGENLTIKIADFGMSRNLYAGDYYRIQGRAVL--------PIRWMAWECILMGKF 217
Query: 793 ----DMYSFGVVMLELLT--GKRPVDVLKPKMSRELVGWVLKMRSEGKQDQVFDPILRGK 846
D+++FGV + E+L ++P L + E G R +G+Q +F P +
Sbjct: 218 TTASDVWAFGVTLWEILMLCKEQPYGELTDEQVIENAGEFF--RDQGRQVYLFRPPPCPQ 275
Query: 847 GFDEEMLQVLDVACMCVSQNPFKRPTVKEV 876
G E MLQ C S++ +RP+ ++
Sbjct: 276 GLYELMLQ-------CWSRDCRERPSFSDI 298
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304 |
| >gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Score = 66.7 bits (163), Expect = 7e-12
Identities = 67/281 (23%), Positives = 106/281 (37%), Gaps = 39/281 (13%)
Query: 614 IIGCGGFGLVYKATLAN----GTTLAIKKLSGDLGLMERE-FKAEVEALSTAQHKNLVSL 668
IG G FG VY+ + +A+K RE F E + H ++V L
Sbjct: 13 CIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIVKL 72
Query: 669 QGYCVHQGFRLLIYSYME---NGSLDYWLHEKADGASQLDWLTRLKIARGTSCGLAYMHQ 725
G ++ ME G L +L LD + + + S LAY+
Sbjct: 73 IGVITENP----VWIVMELAPLGELRSYLQVNKY---SLDLASLILYSYQLSTALAYLES 125
Query: 726 ICEPHIVHRDIKSSNILLDDQFEAHLADFGLSRLI--LPYQTHVTTELVGTLGYIPPEYG 783
VHRDI + N+L+ L DFGLSR + Y +L + ++ PE
Sbjct: 126 K---RFVHRDIAARNVLVSSPDCVKLGDFGLSRYLEDESYYKASKGKL--PIKWMAPESI 180
Query: 784 QAWVATLRGDMYSFGVVMLELLT-GKRPVDVLKPKMSRELVGWVLKMRSEGKQDQVFDPI 842
T D++ FGV M E+L G +P +K + +++G + P
Sbjct: 181 NFRRFTSASDVWMFGVCMWEILMLGVKPFQGVK---NNDVIGRIENGERLPMPPNC-PPT 236
Query: 843 LRGKGFDEEMLQVLDVACMCVSQNPFKRPTVKEVVEWLNNV 883
L + C + +P KRP E+ L+++
Sbjct: 237 L------------YSLMTKCWAYDPSKRPRFTELKAQLSDI 265
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270 |
| >gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 66.6 bits (162), Expect = 7e-12
Identities = 59/222 (26%), Positives = 99/222 (44%), Gaps = 44/222 (19%)
Query: 613 NIIGCGGFGLVYKATLA------NGTTLAIKKLSGDLGLMEREFKAEVEAL-STAQHKNL 665
++IG G FG V KA + + +K+ + R+F E+E L H N+
Sbjct: 1 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDD--HRDFAGELEVLCKLGHHPNI 58
Query: 666 VSLQGYCVHQGFRLLIYSYMENGSL------------DYWLHEKADGASQLDWLTRLKIA 713
++L G C H+G+ L Y +G+L D AS L L A
Sbjct: 59 INLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFA 118
Query: 714 RGTSCGLAYMHQICEPHIVHRDIKSSNILLDDQFEAHLADFGLSRLILPYQTHVTTELVG 773
+ G+ Y+ + +HRD+ + NIL+ + + A +ADFGLSR + +V
Sbjct: 119 ADVARGMDYLS---QKQFIHRDLAARNILVGENYVAKIADFGLSR---GQEVYVKK---- 168
Query: 774 TLGYIPPEYGQAWVA---------TLRGDMYSFGVVMLELLT 806
T+G +P W+A T D++S+GV++ E+++
Sbjct: 169 TMGRLPVR----WMAIESLNYSVYTTNSDVWSYGVLLWEIVS 206
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270 |
| >gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Score = 66.3 bits (161), Expect = 8e-12
Identities = 67/282 (23%), Positives = 121/282 (42%), Gaps = 33/282 (11%)
Query: 609 FSQANIIGCGGFGLVYKATLANGTTLAIKKLSGDLGLMEREFKAEVEALST-AQHKNLVS 667
F ++G G +G VYK LA K+ G E E K E+ L + H+N+ +
Sbjct: 8 FELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQEINMLKKYSHHRNIAT 67
Query: 668 LQGYCVHQ---GFRLLIYSYME---NGSLDYWLHEKADGASQLDWLTRLKIARGTSCGLA 721
G + + G ++ ME GS+ + + +W+ I R GL+
Sbjct: 68 YYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAY--ICREILRGLS 125
Query: 722 YMHQICEPHIVHRDIKSSNILLDDQFEAHLADFGLSRLILPYQTHVTTELVGTLGYIPPE 781
++HQ ++HRDIK N+LL + E L DFG+S L +GT ++ PE
Sbjct: 126 HLHQ---HKVIHRDIKGQNVLLTENAEVKLVDFGVSAQ-LDRTVGRRNTFIGTPYWMAPE 181
Query: 782 Y-----GQAWVATLRGDMYSFGVVMLELLTGKRPVDVLKPKMSRELVGWVLKMRSEGKQD 836
+ D++S G+ +E+ G P+ + P + L+ R+
Sbjct: 182 VIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIP-----RNPA--- 233
Query: 837 QVFDPILRGKGFDEEMLQVLDVACMCVSQNPFKRPTVKEVVE 878
P L+ K + ++ ++ C+ +N +RPT +++++
Sbjct: 234 ----PRLKSKKWSKKFQSFIE---SCLVKNHSQRPTTEQLMK 268
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272 |
| >gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 65.8 bits (160), Expect = 1e-11
Identities = 79/297 (26%), Positives = 131/297 (44%), Gaps = 52/297 (17%)
Query: 605 ATDNFSQANIIGCGGFGLVYKATLANG-------TTLAIKKLSGDLGLMER-EFKAEVEA 656
A + + + +G G FG+VY+ +A G T +AIK ++ + ER EF E
Sbjct: 4 AREKITMSRELGQGSFGMVYEG-IAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASV 62
Query: 657 LSTAQHKNLVSLQGYCVHQGFRLLIYSYMENGSLDYWLH-----EKADGASQLDWLTRL- 710
+ ++V L G L+I M G L +L + + L ++
Sbjct: 63 MKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMI 122
Query: 711 KIARGTSCGLAYMHQICEPHIVHRDIKSSNILLDDQFEAHLADFGLSRLILPYQTHVTTE 770
++A + G+AY++ VHRD+ + N ++ + F + DFG++R I Y+T +
Sbjct: 123 QMAGEIADGMAYLNA---NKFVHRDLAARNCMVAEDFTVKIGDFGMTRDI--YETDYYRK 177
Query: 771 LVGTLGYIP-----PEYGQAWVATLRGDMYSFGVVMLELLT-GKRPVDVLKPKMSRELVG 824
G G +P PE + V T D++SFGVV+ E+ T ++P MS E
Sbjct: 178 --GGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQ----GMSNE--- 228
Query: 825 WVLKMRSEG----KQDQVFDPILRGKGFDEEMLQVLDVACMCVSQNPFKRPTVKEVV 877
VL+ EG K D D + E+++ MC NP RP+ E++
Sbjct: 229 QVLRFVMEGGLLDKPDNCPDMLF-------ELMR------MCWQYNPKMRPSFLEII 272
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277 |
| >gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Score = 66.0 bits (161), Expect = 1e-11
Identities = 38/103 (36%), Positives = 51/103 (49%), Gaps = 19/103 (18%)
Query: 720 LAYMHQICEPHIVHRDIKSSNILLDDQFEAHLADFGLSRLILPYQTHVTTELVGTLGYIP 779
L ++HQ+ I++RDIK NILLD + L DFGLS+ L + GT+ Y+
Sbjct: 118 LDHLHQL---GIIYRDIKLENILLDSEGHVVLTDFGLSKEFLAEEEERAYSFCGTIEYMA 174
Query: 780 PEYGQAWVATLRG---------DMYSFGVVMLELLTGKRPVDV 813
PE +RG D +S GV+ ELLTG P V
Sbjct: 175 PE-------VIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTV 210
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288 |
| >gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 66.5 bits (163), Expect = 1e-11
Identities = 84/309 (27%), Positives = 120/309 (38%), Gaps = 85/309 (27%)
Query: 615 IGCGGFGLVYKATLA-NGTTLAIKKLSGDLGLMEREFKAEVEA---------LSTAQHKN 664
+G G +G V A G +AIKKLS R F++ + A L H+N
Sbjct: 23 VGSGAYGQVCSAFDTKTGRKVAIKKLS-------RPFQSAIHAKRTYRELRLLKHMDHEN 75
Query: 665 LVS-LQGYCVHQGFRLLIYSYMENGSLDYWLHE----KADGASQLDWLTRLKIARGTSCG 719
++ L + Y+ + L+ + + +L +I RG
Sbjct: 76 VIGLLDVFTPASSLEDFQDVYLVTHLMGADLNNIVKCQKLSDDHIQFLV-YQILRG---- 130
Query: 720 LAYMHQICEPHIVHRDIKSSNILLDDQFEAHLADFGLSRLILPYQTHVTTELVGTLGYIP 779
L Y+H I+HRD+K SNI +++ E + DFGL+R T V T Y
Sbjct: 131 LKYIHS---AGIIHRDLKPSNIAVNEDCELKILDFGLARH----TDDEMTGYVATRWYRA 183
Query: 780 PE-------YGQAWVATLRGDMYSFGVVMLELLTGK------RPVDVLKPKMSRELVG-- 824
PE Y Q D++S G +M ELLTGK +D LK M LVG
Sbjct: 184 PEIMLNWMHYNQT------VDIWSVGCIMAELLTGKTLFPGSDHIDQLKRIM--NLVGTP 235
Query: 825 ---WVLKMRSEGKQDQVFD-PILRGKGFD--------------EEMLQVLDVACMCVSQN 866
+ K+ SE ++ + P + K F E+ML VLD
Sbjct: 236 DEELLQKISSESARNYIQSLPQMPKKDFKEVFSGANPLAIDLLEKML-VLD--------- 285
Query: 867 PFKRPTVKE 875
P KR T E
Sbjct: 286 PDKRITAAE 294
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343 |
| >gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Score = 66.2 bits (161), Expect = 1e-11
Identities = 71/244 (29%), Positives = 107/244 (43%), Gaps = 22/244 (9%)
Query: 586 LFPNNTNEIKDLTIYELLKATDNFSQANIIGCGGFGLVYKATLANGTTLAIKKLSGDLGL 645
LFP N++ L + L TD + IG G +G VYK T +LA K+ +
Sbjct: 4 LFPYNSSM---LGLESLGDPTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPISD 60
Query: 646 MEREFKAEVEAL-STAQHKNLVSLQG--YCVHQ---GFRLLIYSYMENGSLDYWLHEKAD 699
++ E +AE L S H N+V G Y + G L+ GS+ +
Sbjct: 61 VDEEIEAEYNILQSLPNHPNVVKFYGMFYKADKLVGGQLWLVLELCNGGSVTELVKGLLI 120
Query: 700 GASQLDWLTRLKIARGTSCGLAYMHQICEPHIVHRDIKSSNILLDDQFEAHLADFGLSRL 759
+LD I G GL ++H I+HRD+K +NILL + L DFG+S
Sbjct: 121 CGQRLDEAMISYILYGALLGLQHLHN---NRIIHRDVKGNNILLTTEGGVKLVDFGVSAQ 177
Query: 760 ILPYQTHVTTELVGTLGYIPPE-------YGQAWVATLRGDMYSFGVVMLELLTGKRPVD 812
+ + T VGT ++ PE Y ++ A R D++S G+ +EL G P+
Sbjct: 178 LTSTRLRRNTS-VGTPFWMAPEVIACEQQYDYSYDA--RCDVWSLGITAIELGDGDPPLF 234
Query: 813 VLKP 816
+ P
Sbjct: 235 DMHP 238
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291 |
| >gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Score = 65.5 bits (159), Expect = 1e-11
Identities = 74/281 (26%), Positives = 122/281 (43%), Gaps = 34/281 (12%)
Query: 607 DNFSQANIIGCGGFGLVYKA-TLANGTTLAIKKLSGDLGLMEREFKAEVEALSTAQHKNL 665
++F IG G +G VYKA + G AIK + + G + E+ + +H N+
Sbjct: 9 EDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMKDCKHSNI 68
Query: 666 VSLQGYCVHQGFRLLIYSYMENGSLDYWLHEKADGASQLDWLTRLKIA---RGTSCGLAY 722
V+ G + + + + GSL H L+ +IA R T GL Y
Sbjct: 69 VAYFGSYLRRDKLWICMEFCGGGSLQDIYHVTGP-------LSESQIAYVSRETLQGLYY 121
Query: 723 MHQICEPHIVHRDIKSSNILLDDQFEAHLADFGLSRLILPYQTHVTTELVGTLGYIPPEY 782
+H + +HRDIK +NILL D LADFG+S I + +GT ++ PE
Sbjct: 122 LHSKGK---MHRDIKGANILLTDNGHVKLADFGVSAQITATIAKRKS-FIGTPYWMAPEV 177
Query: 783 GQAWVATLRG-----DMYSFGVVMLELLTGKRPVDVLKPKMSRELVGWVLKMRSEGKQDQ 837
A V G D+++ G+ +EL + P+ L P + L +S + +
Sbjct: 178 --AAVERKGGYNQLCDIWAVGITAIELAELQPPMFDLHP-----MRALFLMTKSNFQPPK 230
Query: 838 VFDPILRGKGFDEEMLQVLDVACMCVSQNPFKRPTVKEVVE 878
+ D + F M +++NP KRPT +++++
Sbjct: 231 LKDKMKWSNSFHH-------FVKMALTKNPKKRPTAEKLLQ 264
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267 |
| >gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Score = 66.1 bits (161), Expect = 1e-11
Identities = 75/288 (26%), Positives = 121/288 (42%), Gaps = 48/288 (16%)
Query: 615 IGCGGFGLVYKATLAN------GTTLAIKKLSGDLGLMER-EFKAEVEALSTAQHKNLVS 667
+G G FG+VY+ + T +A+K ++ L ER EF E + ++V
Sbjct: 14 LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVR 73
Query: 668 LQGYCVHQGFRLLIYSYMENGSLDYWLH------EKADGASQLDWLTRLKIARGTSCGLA 721
L G L++ M +G L +L E G +++A + G+A
Sbjct: 74 LLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMA 133
Query: 722 YMHQICEPHIVHRDIKSSNILLDDQFEAHLADFGLSRLILPYQTHVTTELVGTLGYIP-- 779
Y++ VHRD+ + N ++ F + DFG++R I Y+T + G G +P
Sbjct: 134 YLNA---KKFVHRDLAARNCMVAHDFTVKIGDFGMTRDI--YETDYYRK--GGKGLLPVR 186
Query: 780 ---PEYGQAWVATLRGDMYSFGVVMLELLT-GKRPVDVLKPKMSRELVGWVLKMRSEGKQ 835
PE + V T DM+SFGVV+ E+ + ++P L
Sbjct: 187 WMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGL-------------------SN 227
Query: 836 DQVFDPILRGKGFDEE---MLQVLDVACMCVSQNPFKRPTVKEVVEWL 880
+QV ++ G D+ +V D+ MC NP RPT E+V L
Sbjct: 228 EQVLKFVMDGGYLDQPDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLL 275
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288 |
| >gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 66.0 bits (161), Expect = 1e-11
Identities = 71/278 (25%), Positives = 125/278 (44%), Gaps = 33/278 (11%)
Query: 615 IGCGGFGLVYKAT-LANGTTLAIKKLSGDLGLMEREFKA---EVEALSTAQHKNLVSLQG 670
+G G +G VYK G T+A+K++ L L E +F E++ L A +V G
Sbjct: 9 LGKGNYGSVYKVLHRPTGVTMAMKEIR--LELDESKFNQIIMELDILHKAVSPYIVDFYG 66
Query: 671 YCVHQGFRLLIYSYMENGSLDYWLHEKADGASQLDWLTRLKIARGTSCGLAYMHQICEPH 730
+G + YM+ GSLD L+ + +I GL ++ + E +
Sbjct: 67 AFFIEGAVYMCMEYMDAGSLDK-LYAGGVATEGIPEDVLRRITYAVVKGLKFLKE--EHN 123
Query: 731 IVHRDIKSSNILLDDQFEAHLADFGLSRLILPYQTHVTTELVGTLGYIPPEY------GQ 784
I+HRD+K +N+L++ + L DFG+S ++ + +G Y+ PE Q
Sbjct: 124 IIHRDVKPTNVLVNGNGQVKLCDFGVSGNLV---ASLAKTNIGCQSYMAPERIKSGGPNQ 180
Query: 785 AWVATLRGDMYSFGVVMLELLTGKRPVDVLKPKMSRELVGWVLKMRSEGKQDQVFDPILR 844
T++ D++S G+ +LE+ G+ P P + + L +G DP
Sbjct: 181 NPTYTVQSDVWSLGLSILEMALGRYPY----PPETYANIFAQLSAIVDG------DPPTL 230
Query: 845 GKGFDEEMLQVLDVACMCVSQNPFKRPTVKEVVE--WL 880
G+ ++ D C+++ P +RPT +++E WL
Sbjct: 231 PSGYSDD---AQDFVAKCLNKIPNRRPTYAQLLEHPWL 265
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286 |
| >gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Score = 65.6 bits (160), Expect = 2e-11
Identities = 74/218 (33%), Positives = 107/218 (49%), Gaps = 34/218 (15%)
Query: 607 DNFSQANIIGCGGFGLVYKAT-LANGTTLAIKKL---SGDLGLMEREFKAEVEALSTAQH 662
D + + IG G +G+VYKA T+A+KK+ D G+ + E+ L QH
Sbjct: 2 DQYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIR-EISLLKEMQH 60
Query: 663 KNLVSLQGYCVHQGFRL-LIYSYMENGSLDYWLHEKADGASQLDWLTRL------KIARG 715
N+V LQ VH RL L++ Y LD L + D + RL +I RG
Sbjct: 61 GNIVRLQD-VVHSEKRLYLVFEY-----LDLDLKKHMDSSPDFAKNPRLIKTYLYQILRG 114
Query: 716 TSCGLAYMHQICEPH-IVHRDIKSSNILLDDQFEA-HLADFGLSRLI-LPYQTHVTTELV 772
+AY C H ++HRD+K N+L+D + A LADFGL+R +P +T T E+V
Sbjct: 115 ----IAY----CHSHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTF-THEVV 165
Query: 773 GTLGYIPPE--YGQAWVATLRGDMYSFGVVMLELLTGK 808
TL Y PE G +T D++S G + E++ K
Sbjct: 166 -TLWYRAPEILLGSRHYST-PVDIWSVGCIFAEMVNQK 201
|
Length = 294 |
| >gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Score = 65.1 bits (159), Expect = 2e-11
Identities = 65/278 (23%), Positives = 111/278 (39%), Gaps = 23/278 (8%)
Query: 606 TDNFSQANIIGCGGFGLVYKAT-LANGTTLAIKKLSGDLGLMEREFKA----EVEALSTA 660
NF IG G F +VYKA L +G +A+KK+ +M+ + + E++ L
Sbjct: 1 LGNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQ-IFEMMDAKARQDCLKEIDLLKQL 59
Query: 661 QHKNLVSLQGYCVHQGFRLLIYSYMENGSLDYWLHEKADGASQLDWLTRLKIARGTSCGL 720
H N++ + ++ + G L + + T K L
Sbjct: 60 DHPNVIKYLASFIENNELNIVLELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSAL 119
Query: 721 AYMHQICEPHIVHRDIKSSNILLDDQFEAHLADFGLSRLILPYQTHVTTELVGTLGYIPP 780
+MH I+HRDIK +N+ + L D GL R +T LVGT Y+ P
Sbjct: 120 EHMHS---KRIMHRDIKPANVFITATGVVKLGDLGLGR-FFSSKTTAAHSLVGTPYYMSP 175
Query: 781 EYGQAWVATLRGDMYSFGVVMLELLTGKRPVDVLKPKMSRELVGWVLKMRSEGKQDQVFD 840
E + D++S G ++ E+ + P KM+ K ++
Sbjct: 176 ERIHENGYNFKSDIWSLGCLLYEMAALQSPFY--GDKMNL--------YSLCKKIEKCDY 225
Query: 841 PILRGKGFDEEMLQVLDVACMCVSQNPFKRPTVKEVVE 878
P L + EE+ ++ C++ +P KRP + V++
Sbjct: 226 PPLPADHYSEELRDLVS---RCINPDPEKRPDISYVLQ 260
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Score = 65.5 bits (159), Expect = 2e-11
Identities = 68/283 (24%), Positives = 120/283 (42%), Gaps = 26/283 (9%)
Query: 598 TIYELLKATDNFSQANIIGCGGFGLVYKAT-LANGTTLAIKKLSGDLGLMEREFKAEVEA 656
TI + +++ IG G G V+ A +A G +AIK+++ + E+
Sbjct: 10 TIVSIGDPKKKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIINEILV 69
Query: 657 LSTAQHKNLVS-LQGYCVHQGFRLLIYSYMENGSLDYWLHEKADGASQLDWLTRLKIARG 715
+ ++ N+V+ L + V ++ Y+ GSL + E +Q+ + R
Sbjct: 70 MKELKNPNIVNFLDSFLVGDEL-FVVMEYLAGGSLTDVVTETCMDEAQI-----AAVCRE 123
Query: 716 TSCGLAYMHQICEPHIVHRDIKSSNILLDDQFEAHLADFGLSRLILPYQTHVTTELVGTL 775
L ++H ++HRDIKS N+LL L DFG I P Q+ +T +VGT
Sbjct: 124 CLQALEFLHA---NQVIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQSKRST-MVGTP 179
Query: 776 GYIPPEYGQAWVATLRGDMYSFGVVMLELLTGKRPVDVLKPKMSRELVGWVLKMRSEGKQ 835
++ PE + D++S G++ +E++ G+ P L R L E +
Sbjct: 180 YWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPP--YLNENPLRALYLIATNGTPELQN 237
Query: 836 DQVFDPILRGKGFDEEMLQVLDVACMCVSQNPFKRPTVKEVVE 878
+ PI R D C+ + KR + KE+++
Sbjct: 238 PEKLSPIFR------------DFLNRCLEMDVEKRGSAKELLQ 268
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296 |
| >gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Score = 65.3 bits (159), Expect = 2e-11
Identities = 57/198 (28%), Positives = 93/198 (46%), Gaps = 12/198 (6%)
Query: 615 IGCGGFGLVYKAT-LANGTTLAIKKLSGDLGLMEREFKAEVEALSTAQHKNLVS-LQGYC 672
IG G G VY A +A G +AIK+++ + E+ + +H N+V+ L Y
Sbjct: 27 IGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELIINEILVMRENKHPNIVNYLDSYL 86
Query: 673 VHQGFRLLIYSYMENGSLDYWLHEKADGASQLDWLTRLKIARGTSCGLAYMHQICEPHIV 732
V ++ Y+ GSL + E + +D + R L ++H ++
Sbjct: 87 VGDEL-WVVMEYLAGGSLTDVVTE-----TCMDEGQIAAVCRECLQALEFLHS---NQVI 137
Query: 733 HRDIKSSNILLDDQFEAHLADFGLSRLILPYQTHVTTELVGTLGYIPPEYGQAWVATLRG 792
HRDIKS NILL L DFG I P Q+ +T +VGT ++ PE +
Sbjct: 138 HRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRST-MVGTPYWMAPEVVTRKAYGPKV 196
Query: 793 DMYSFGVVMLELLTGKRP 810
D++S G++ +E++ G+ P
Sbjct: 197 DIWSLGIMAIEMVEGEPP 214
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293 |
| >gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Score = 65.1 bits (159), Expect = 3e-11
Identities = 60/206 (29%), Positives = 94/206 (45%), Gaps = 18/206 (8%)
Query: 615 IGCGGFGLVYKATLAN-GTTLAIKKL-SGDLGLMEREFKAEVEALSTAQH-KNLVSLQGY 671
IG G FG V K GT +A+K++ S ++ +++ + + +V G
Sbjct: 12 IGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSSDCPYIVKFYGA 71
Query: 672 CVHQGFRLLIYSYMENGSLD--Y-WLHEKADGASQLDWLTRLKIARGTSCGLAYMHQICE 728
+G + M+ SLD Y +++E + L KIA T L Y+ + E
Sbjct: 72 LFREGDCWICMELMDI-SLDKFYKYVYEVLKSVIPEEILG--KIAVATVKALNYLKE--E 126
Query: 729 PHIVHRDIKSSNILLDDQFEAHLADFGLS-RLILPYQTHVTTELVGTLGYIPPEYGQAWV 787
I+HRD+K SNILLD L DFG+S +L+ + T G Y+ PE
Sbjct: 127 LKIIHRDVKPSNILLDRNGNIKLCDFGISGQLV---DSIAKTRDAGCRPYMAPERIDPSA 183
Query: 788 AT---LRGDMYSFGVVMLELLTGKRP 810
+R D++S G+ + E+ TGK P
Sbjct: 184 RDGYDVRSDVWSLGITLYEVATGKFP 209
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288 |
| >gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Score = 65.0 bits (158), Expect = 3e-11
Identities = 76/252 (30%), Positives = 106/252 (42%), Gaps = 28/252 (11%)
Query: 614 IIGCGGFGLVYKATLAN-GTTLAIKKLSGDLGLMEREFKAEVEALSTAQHKNLVSL---- 668
IIG GGFG VY A+ G A+K L M+ + E AL+ +LVS
Sbjct: 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMK---QGETLALNERIMLSLVSTGDCP 57
Query: 669 ----QGYCVHQGFRL-LIYSYMENGSLDYWLHEKADGASQLDWLTRLKIARGTSCGLAYM 723
Y H +L I M G L Y L + + + +I GL +M
Sbjct: 58 FIVCMTYAFHTPDKLCFILDLMNGGDLHYHLSQHGVFSEKEMRFYATEII----LGLEHM 113
Query: 724 HQICEPHIVHRDIKSSNILLDDQFEAHLADFGLSRLILPYQTHVTTELVGTLGYIPPEYG 783
H +V+RD+K +NILLD+ ++D GL+ + H + VGT GY+ PE
Sbjct: 114 HN---RFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHAS---VGTHGYMAPEVL 167
Query: 784 QAWVA-TLRGDMYSFGVVMLELLTGKRPVDVLKPKMSRELVGWVLKMRSEGKQDQVFDPI 842
Q A D +S G ++ +LL G P K K E+ L + E F P
Sbjct: 168 QKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTVNVE--LPDSFSPE 225
Query: 843 LRGKGFDEEMLQ 854
L K E +LQ
Sbjct: 226 L--KSLLEGLLQ 235
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279 |
| >gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Score = 65.7 bits (161), Expect = 3e-11
Identities = 82/314 (26%), Positives = 127/314 (40%), Gaps = 90/314 (28%)
Query: 615 IGCGGFGLVYKAT-LANGTTLAIKKL------SGDLGLMEREFKAEVEALST-AQHKNLV 666
+G G +G+V+KA +A+KK+ + D +R F+ E+ L H N+V
Sbjct: 15 LGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATD---AQRTFR-EIMFLQELGDHPNIV 70
Query: 667 SLQGYCVHQGFR----LLIYSYMENGSLDYWLHE--KAD---------GASQLDWLTRLK 711
L V + L++ YME D LH +A+ QL LK
Sbjct: 71 KL--LNVIKAENDKDIYLVFEYMET---D--LHAVIRANILEDVHKRYIMYQL-----LK 118
Query: 712 IARGTSCGLAYMHQICEPHIVHRDIKSSNILLDDQFEAHLADFGLSRLIL----PYQTHV 767
L Y+H +++HRD+K SNILL+ LADFGL+R + + V
Sbjct: 119 -------ALKYIHS---GNVIHRDLKPSNILLNSDCRVKLADFGLARSLSELEENPENPV 168
Query: 768 TTELVGTLGYIPPE-------YGQAWVATLRGDMYSFGVVMLELLTGK------------ 808
T+ V T Y PE Y T DM+S G ++ E+L GK
Sbjct: 169 LTDYVATRWYRAPEILLGSTRY------TKGVDMWSVGCILGEMLLGKPLFPGTSTLNQL 222
Query: 809 -RPVDVLKPKMSRELVGWVLKMRSEGKQDQVFDPILRGKGFD-EEML-----QVLDVACM 861
+ ++V+ S E + ++S + D + +E+L LD+
Sbjct: 223 EKIIEVI-GPPSAED---IESIKSPF-AATMLDSLPSRPRKPLDELLPKASDDALDLLKK 277
Query: 862 CVSQNPFKRPTVKE 875
+ NP KR T +E
Sbjct: 278 LLVFNPNKRLTAEE 291
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337 |
| >gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 65.1 bits (158), Expect = 3e-11
Identities = 64/211 (30%), Positives = 100/211 (47%), Gaps = 25/211 (11%)
Query: 607 DNFSQANIIGCGGFGLVYKA-TLANGTTLAIKKLSGDLGLMERE---FKAEVEA--LSTA 660
D++ + +G G + VYK + NG +A+K + L E E F A EA L
Sbjct: 5 DSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIR----LQEEEGTPFTAIREASLLKGL 60
Query: 661 QHKNLVSLQGYCVHQGFRLLIYSYMENGSLDYWLHEKADGASQLD--WLTRLKIARGTSC 718
+H N+V L + L++ Y+ Y +K G + L ++ RG
Sbjct: 61 KHANIVLLHDIIHTKETLTLVFEYVHTDLCQYM--DKHPGGLHPENVKLFLFQLLRG--- 115
Query: 719 GLAYMHQICEPHIVHRDIKSSNILLDDQFEAHLADFGLSRLILPYQTHVTTELVGTLGYI 778
L+Y+HQ +I+HRD+K N+L+ D E LADFGL+R +H + V TL Y
Sbjct: 116 -LSYIHQ---RYILHRDLKPQNLLISDTGELKLADFGLAR-AKSVPSHTYSNEVVTLWYR 170
Query: 779 PPE--YGQAWVATLRGDMYSFGVVMLELLTG 807
PP+ G +T DM+ G + +E++ G
Sbjct: 171 PPDVLLGSTEYSTCL-DMWGVGCIFVEMIQG 200
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303 |
| >gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 65.3 bits (159), Expect = 3e-11
Identities = 64/231 (27%), Positives = 99/231 (42%), Gaps = 47/231 (20%)
Query: 598 TIYELLKATDNFSQANIIGCGGFGLVYKAT-LANGTTLAIKKLSGDLGLMEREFKAEVEA 656
T++EL + ++ +G G +G V A G +AIKKLS R F++E+ A
Sbjct: 9 TVWELPE---RYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLS-------RPFQSEIFA 58
Query: 657 ---------LSTAQHKNLVSLQGYCVHQ----GFR--LLIYSYMENGSLDYWLHEKADGA 701
L QH+N++ L F+ L+ YM+ H ++
Sbjct: 59 KRAYRELTLLKHMQHENVIGLLDVFTSAVSGDEFQDFYLVMPYMQTDLQKIMGHPLSEDK 118
Query: 702 SQLDWLTRLKIARGTSCGLAYMHQICEPHIVHRDIKSSNILLDDQFEAHLADFGLSRLIL 761
Q + CGL Y+H I+HRD+K N+ +++ E + DFGL+R
Sbjct: 119 VQY-------LVYQMLCGLKYIHS---AGIIHRDLKPGNLAVNEDCELKILDFGLAR--- 165
Query: 762 PYQTHVTTELVG---TLGYIPPEYGQAWVA-TLRGDMYSFGVVMLELLTGK 808
H E+ G T Y PE W+ D++S G +M E+LTGK
Sbjct: 166 ----HADAEMTGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGK 212
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342 |
| >gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Score = 64.2 bits (156), Expect = 3e-11
Identities = 51/171 (29%), Positives = 79/171 (46%), Gaps = 28/171 (16%)
Query: 651 KAEVEALSTAQHKNLVSLQGYCVHQGFRLLIYSYMENGSLDYWLHEKADGASQLDWLTRL 710
+ E L+ +H N+V+ + S+ +G L Y + E DG D + ++
Sbjct: 46 RKEAVLLAKMKHPNIVAFK------------ESFEADGHL-YIVMEYCDGG---DLMQKI 89
Query: 711 KIARGT----SCGLAYMHQIC-------EPHIVHRDIKSSNILLDDQFEAHLADFGLSRL 759
K+ RG L + Q+C E ++HRDIKS NI L + L DFG +RL
Sbjct: 90 KLQRGKLFPEDTILQWFVQMCLGVQHIHEKRVLHRDIKSKNIFLTQNGKVKLGDFGSARL 149
Query: 760 ILPYQTHVTTELVGTLGYIPPEYGQAWVATLRGDMYSFGVVMLELLTGKRP 810
+ + T VGT Y+PPE + + D++S G ++ EL T K P
Sbjct: 150 LTSPGAYACT-YVGTPYYVPPEIWENMPYNNKSDIWSLGCILYELCTLKHP 199
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255 |
| >gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Score = 64.3 bits (156), Expect = 4e-11
Identities = 74/275 (26%), Positives = 118/275 (42%), Gaps = 33/275 (12%)
Query: 609 FSQANIIGCGGFGLVYKATLANGT--TLAIKKLSGDLGLMEREF---KAEVEALSTAQHK 663
F++ IG G FG V+K + N T +AIK + DL E E + E+ LS
Sbjct: 6 FTKLEKIGKGSFGEVFKG-IDNRTQKVVAIKII--DLEEAEDEIEDIQQEITVLSQCDSP 62
Query: 664 NLVSLQGYCVHQGFRLLIYSYMENGSLDYWLHEKADGASQLDWLTRLKIARGTSCGLAYM 723
+ G + +I Y+ GS L LD I R GL Y+
Sbjct: 63 YVTKYYGSYLKDTKLWIIMEYLGGGSALDLLE-----PGPLDETQIATILREILKGLDYL 117
Query: 724 HQICEPHIVHRDIKSSNILLDDQFEAHLADFGLSRLILPYQTHVTTELVGTLGYIPPEYG 783
H +HRDIK++N+LL + E LADFG++ + Q VGT ++ PE
Sbjct: 118 HS---EKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIK-RNTFVGTPFWMAPEVI 173
Query: 784 QAWVATLRGDMYSFGVVMLELLTGKRPVDVLKPKMSRELVGWVLKMRSEGKQDQVFDPIL 843
+ + D++S G+ +EL G+ P L P L+ + P L
Sbjct: 174 KQSAYDSKADIWSLGITAIELAKGEPPHSELHPMKVLFLI------------PKNNPPTL 221
Query: 844 RGKGFDEEMLQVLDVACMCVSQNPFKRPTVKEVVE 878
G + + + + ++ C+++ P RPT KE+++
Sbjct: 222 EGN-YSKPLKEFVEA---CLNKEPSFRPTAKELLK 252
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277 |
| >gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Score = 63.8 bits (155), Expect = 5e-11
Identities = 75/277 (27%), Positives = 125/277 (45%), Gaps = 44/277 (15%)
Query: 614 IIGCGGFG---LVYKATLANGTTLAIKKLSGDLGLMEREFKAEVEA--LSTAQHKNLV-- 666
++G G +G LV T G IKKL+ AE EA LS +H N+V
Sbjct: 7 VVGKGSYGEVSLVRHRTD--GKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAY 64
Query: 667 --SLQGYCVHQGFRLLIYSYMENGSLDYWLHEKADG----ASQLDWLTRLKIARGTSCGL 720
S +G G ++ + E G L + L E+ ++W ++ +A L
Sbjct: 65 RESWEG---EDGLLYIVMGFCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMA------L 115
Query: 721 AYMHQICEPHIVHRDIKSSNILLDDQFEAHLADFGLSRLILPYQTHVTTELVGTLGYIPP 780
Y+H E HI+HRD+K+ N+ L + D G++R +L Q + + L+GT Y+ P
Sbjct: 116 QYLH---EKHILHRDLKTQNVFLTRTNIIKVGDLGIAR-VLENQCDMASTLIGTPYYMSP 171
Query: 781 EYGQAWVATLRGDMYSFGVVMLELLTGKRPVDVLKPKMSRELVGWVLKMRSEGKQDQVFD 840
E + D+++ G + E+ T K + K LV ++ EGK +
Sbjct: 172 ELFSNKPYNYKSDVWALGCCVYEMATLKHAFNA---KDMNSLVYRII----EGKLPPM-- 222
Query: 841 PILRGKGFDEEMLQVLDVACMCVSQNPFKRPTVKEVV 877
K + E+ ++ +A M +S+ P KRP+VK ++
Sbjct: 223 ----PKDYSPELGEL--IATM-LSKRPEKRPSVKSIL 252
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257 |
| >gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Score = 64.8 bits (158), Expect = 5e-11
Identities = 66/225 (29%), Positives = 95/225 (42%), Gaps = 38/225 (16%)
Query: 607 DNFSQANIIGCGGFGLVY----KATLANGTTLAIKKLSGDLGLMERE---FKAEVEALST 659
+F +++G G FG V KAT G A+K + + L + F+ E + LS
Sbjct: 1 KDFDVKSLVGRGHFGEVQVVREKAT---GDIYAMKVMKKSVLLAQETVSFFEEERDILSI 57
Query: 660 AQHKNLVSLQGYCVHQGFRL-LIYSYMENGSLDYWLHEKADGASQLD------WLTRLKI 712
+ + LQ Y L L+ Y G L L+ D Q D +L L +
Sbjct: 58 SNSPWIPQLQ-YAFQDKDNLYLVMEYQPGGDLLSLLNRYED---QFDEDMAQFYLAELVL 113
Query: 713 ARGTSCGLAYMHQICEPHIVHRDIKSSNILLDDQFEAHLADFGLSRLILPYQTHVTTEL- 771
A +H + + VHRDIK N+L+D LADFG S L V ++L
Sbjct: 114 A---------IHSVHQMGYVHRDIKPENVLIDRTGHIKLADFG-SAARLTANKMVNSKLP 163
Query: 772 VGTLGYIPPEYGQAWVATLRG------DMYSFGVVMLELLTGKRP 810
VGT YI PE +G D +S GV+ E++ G+ P
Sbjct: 164 VGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSP 208
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330 |
| >gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 63.8 bits (155), Expect = 6e-11
Identities = 67/264 (25%), Positives = 123/264 (46%), Gaps = 34/264 (12%)
Query: 631 GTTLAIKKLS-GDLGLMEREFKAEVEALSTAQHKNLVSLQGYCVHQGFR--LLIYSYMEN 687
G +A+K L G + K E+E L H+N+V +G C G LI ++ +
Sbjct: 33 GEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGIKLIMEFLPS 92
Query: 688 GSLDYWLHEKADGASQLDWLTRLKIARGTSCGLAYMHQICEPHIVHRDIKSSNILLDDQF 747
GSL +L ++++ +LK A G+ Y+ VHRD+ + N+L++ +
Sbjct: 93 GSLKEYLPRNK---NKINLKQQLKYAVQICKGMDYLGS---RQYVHRDLAARNVLVESEH 146
Query: 748 EAHLADFGLSRLILPYQTHVTT--ELVGTLGYIPPE---YGQAWVATLRGDMYSFGVVML 802
+ + DFGL++ I + + T +L + + PE + ++A+ D++SFGV +
Sbjct: 147 QVKIGDFGLTKAIETDKEYYTVKDDLDSPVFWYAPECLIQSKFYIAS---DVWSFGVTLY 203
Query: 803 ELLT----GKRPVDV----LKPKMSRELVGWVLKMRSEGKQDQVFDPILRGKGFDEEMLQ 854
ELLT P+ + + P + V ++++ EGK+ + R EE+ Q
Sbjct: 204 ELLTYCDSESSPMTLFLKMIGPTHGQMTVTRLVRVLEEGKR------LPRPPNCPEEVYQ 257
Query: 855 VLDVACMCVSQNPFKRPTVKEVVE 878
++ C P KR T + ++E
Sbjct: 258 LMR---KCWEFQPSKRTTFQNLIE 278
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284 |
| >gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Score = 63.9 bits (155), Expect = 7e-11
Identities = 61/214 (28%), Positives = 96/214 (44%), Gaps = 27/214 (12%)
Query: 609 FSQANIIGCGGFGLVYKA-TLANGTTLAIKKLSGDLGLMEREFK---AEVEALSTAQHKN 664
FS IG G FG VY A + N +AIKK+S +++ EV L +H N
Sbjct: 17 FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPN 76
Query: 665 LVSLQGYCVHQGFRLLIYSYMENGSLDYW-LHEKADGASQLDWLTRLKIARGTSCGLAYM 723
+ +G + + L+ Y + D +H+K L + + G GLAY+
Sbjct: 77 TIQYRGCYLREHTAWLVMEYCLGSASDLLEVHKKP-----LQEVEIAAVTHGALQGLAYL 131
Query: 724 HQICEPHIVHRDIKSSNILLDDQFEAHLADFGLSRLILPYQTHVTTELVGTLGYIPPEYG 783
H +++HRD+K+ NILL + L DFG + ++ P VGT ++ PE
Sbjct: 132 HS---HNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAP-----ANXFVGTPYWMAPE-- 181
Query: 784 QAWVATLRG------DMYSFGVVMLELLTGKRPV 811
+A G D++S G+ +EL K P+
Sbjct: 182 -VILAMDEGQYDGKVDVWSLGITCIELAERKPPL 214
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308 |
| >gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Score = 63.6 bits (155), Expect = 7e-11
Identities = 48/173 (27%), Positives = 76/173 (43%), Gaps = 24/173 (13%)
Query: 711 KIARGTSCGLAYMHQICEPHIVHRDIKSSNILLDDQFEAHLADFGLS-RLILPYQTHVTT 769
KIA L Y+H + ++HRD+K SN+L++ + L DFG+S L+ + T
Sbjct: 107 KIAVSIVKALEYLHS--KLSVIHRDVKPSNVLINRNGQVKLCDFGISGYLV---DSVAKT 161
Query: 770 ELVGTLGYIPPEY----GQAWVATLRGDMYSFGVVMLELLTGKRPVDVLKPKMSRELVGW 825
G Y+ PE ++ D++S G+ M+EL TG+ P D K +
Sbjct: 162 IDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKTPFQQ----- 216
Query: 826 VLKMRSEGKQDQVFDPILRGKGFDEEMLQVLDVACMCVSQNPFKRPTVKEVVE 878
LK E P L + F E D C+ +N +RP E+++
Sbjct: 217 -LKQVVEEPS-----PQLPAEKFSPE---FQDFVNKCLKKNYKERPNYPELLQ 260
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283 |
| >gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 63.6 bits (155), Expect = 9e-11
Identities = 65/215 (30%), Positives = 103/215 (47%), Gaps = 42/215 (19%)
Query: 615 IGCGGFGLVYKA-TLANGTTLAIKKLSGDLGLMERE----FKA--EVEALSTAQHKNLVS 667
+G G + VYK + G +A+K++ +E E F A E L +H N+V+
Sbjct: 13 LGEGSYATVYKGRSKLTGQLVALKEIR-----LEHEEGAPFTAIREASLLKDLKHANIVT 67
Query: 668 LQGYCVHQGFRL-LIYSYMENGSLDYWLHEKADGASQLD--WLTRLKIARGTSCGLAYMH 724
L +H L L++ Y++ Y + G + L ++ RG LAY H
Sbjct: 68 LHD-IIHTKKTLTLVFEYLDTDLKQYM--DDCGGGLSMHNVRLFLFQLLRG----LAYCH 120
Query: 725 QICEPHIVHRDIKSSNILLDDQFEAHLADFGLSRL-ILPYQTHVTTELVGTLGYIPP--- 780
Q ++HRD+K N+L+ ++ E LADFGL+R +P +T+ + E+V TL Y PP
Sbjct: 121 Q---RRVLHRDLKPQNLLISERGELKLADFGLARAKSVPSKTY-SNEVV-TLWYRPPDVL 175
Query: 781 ----EYGQAWVATLRGDMYSFGVVMLELLTGKRPV 811
EY + DM+ G + E+ TG RP+
Sbjct: 176 LGSTEY------STSLDMWGVGCIFYEMATG-RPL 203
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291 |
| >gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Score = 63.6 bits (154), Expect = 1e-10
Identities = 54/204 (26%), Positives = 94/204 (46%), Gaps = 12/204 (5%)
Query: 609 FSQANIIGCGGFGLVYKAT-LANGTTLAIKKLSGDLGLMEREFKAEVEALSTAQHKNLVS 667
+++ IG G G VY A +A G +AI++++ + E+ + ++ N+V+
Sbjct: 22 YTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVN 81
Query: 668 -LQGYCVHQGFRLLIYSYMENGSLDYWLHEKADGASQLDWLTRLKIARGTSCGLAYMHQI 726
L Y V ++ Y+ GSL + E Q+ + R L ++H
Sbjct: 82 YLDSYLVGDEL-WVVMEYLAGGSLTDVVTETCMDEGQI-----AAVCRECLQALEFLHS- 134
Query: 727 CEPHIVHRDIKSSNILLDDQFEAHLADFGLSRLILPYQTHVTTELVGTLGYIPPEYGQAW 786
++HRDIKS NILL L DFG I P Q+ + +VGT ++ PE
Sbjct: 135 --NQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSK-RSTMVGTPYWMAPEVVTRK 191
Query: 787 VATLRGDMYSFGVVMLELLTGKRP 810
+ D++S G++ +E++ G+ P
Sbjct: 192 AYGPKVDIWSLGIMAIEMIEGEPP 215
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296 |
| >gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Score = 63.9 bits (156), Expect = 1e-10
Identities = 64/251 (25%), Positives = 101/251 (40%), Gaps = 75/251 (29%)
Query: 607 DNFSQANIIGCGGFGLVYKAT-LANGTTLAIKKL---SGDLGLMEREFKAEVEALSTAQH 662
+ IG G +G+V A +G +AIKK+ L +R + E++ L +H
Sbjct: 5 SRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLR-ELKILRHFKH 63
Query: 663 KNLVSLQG------------YCV--------HQGFRLLIYSY--MENGSLDYWLHEKADG 700
N+++++ Y V H +I+S + + Y+L+
Sbjct: 64 DNIIAIRDILRPPGADFKDVYVVMDLMESDLHH----IIHSDQPLTEEHIRYFLY----- 114
Query: 701 ASQLDWLTRLKIARGTSCGLAYMHQICEPHIVHRDIKSSNILLDDQFEAHLADFGLSRLI 760
QL GL Y+H ++HRD+K SN+L+++ E + DFG++R +
Sbjct: 115 --QL------------LRGLKYIHSAN---VIHRDLKPSNLLVNEDCELRIGDFGMARGL 157
Query: 761 LPYQTHVT---TELVGTLGYIPPE-------YGQAWVATLRGDMYSFGVV---ML---EL 804
T TE V T Y PE Y A DM+S G + ML +L
Sbjct: 158 SSSPTEHKYFMTEYVATRWYRAPELLLSLPEYTTAI------DMWSVGCIFAEMLGRRQL 211
Query: 805 LTGKRPVDVLK 815
GK V LK
Sbjct: 212 FPGKNYVHQLK 222
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334 |
| >gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Score = 63.5 bits (154), Expect = 1e-10
Identities = 62/213 (29%), Positives = 91/213 (42%), Gaps = 15/213 (7%)
Query: 607 DNFSQANIIGCGGFGLVYKATLANGTTLAIKKLSGDLGLMERE----FKAEVEALSTAQH 662
D+F +IG G FG V + + + K+ +++R F+ E L
Sbjct: 1 DDFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDC 60
Query: 663 KNLVSLQGYCVHQGFRLLIYSYMENGSLDYWLHEKADGASQLDWLTRLKIARGTSCGLAY 722
+ + +L + + L+ Y G L L + D + + R IA LA
Sbjct: 61 QWITTLHYAFQDENYLYLVMDYYVGGDLLTLLSKFEDRLPED--MARFYIAEMV---LA- 114
Query: 723 MHQICEPHIVHRDIKSSNILLDDQFEAHLADFGLSRLILPYQTHVTTELVGTLGYIPPEY 782
+H I + H VHRDIK N+LLD LADFG + T ++ VGT YI PE
Sbjct: 115 IHSIHQLHYVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQDGTVQSSVAVGTPDYISPEI 174
Query: 783 GQAWVATL-----RGDMYSFGVVMLELLTGKRP 810
QA + D +S GV M E+L G+ P
Sbjct: 175 LQAMEDGMGKYGPECDWWSLGVCMYEMLYGETP 207
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331 |
| >gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein | Back alignment and domain information |
|---|
Score = 65.3 bits (159), Expect = 1e-10
Identities = 58/195 (29%), Positives = 85/195 (43%), Gaps = 22/195 (11%)
Query: 631 GTTLAIKKLSGDLGLMERE---FKAEVEALSTAQHKNLVSL--QGYCVHQGFRLLIYSYM 685
G +AIK L D E + F+ E + H N+V+L G G ++ Y+
Sbjct: 3 GHEVAIKLLRTDAPEEEHQRARFRRETALCARLYHPNIVALLDSGEA-PPGLLFAVFEYV 61
Query: 686 ENGSLDYWLHEKADGASQLDWLTRLKIARGTSCGLAYMHQICEPHIVHRDIKSSNILL-- 743
+L L ADGA L ++ LA H IVHRD+K NI++
Sbjct: 62 PGRTLREVL--AADGA--LPAGETGRLMLQVLDALACAH---NQGIVHRDLKPQNIMVSQ 114
Query: 744 -DDQFEAHLADFGLSRL------ILPYQTHVTTELVGTLGYIPPEYGQAWVATLRGDMYS 796
+ A + DFG+ L TTE++GT Y PE + T D+Y+
Sbjct: 115 TGVRPHAKVLDFGIGTLLPGVRDADVATLTRTTEVLGTPTYCAPEQLRGEPVTPNSDLYA 174
Query: 797 FGVVMLELLTGKRPV 811
+G++ LE LTG+R V
Sbjct: 175 WGLIFLECLTGQRVV 189
|
This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266 |
| >gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Score = 63.2 bits (153), Expect = 1e-10
Identities = 56/204 (27%), Positives = 95/204 (46%), Gaps = 12/204 (5%)
Query: 609 FSQANIIGCGGFGLVYKA-TLANGTTLAIKKLSGDLGLMEREFKAEVEALSTAQHKNLVS 667
+++ IG G G VY A +A G +AIK+++ + E+ + ++ N+V+
Sbjct: 21 YTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEILVMRENKNPNIVN 80
Query: 668 -LQGYCVHQGFRLLIYSYMENGSLDYWLHEKADGASQLDWLTRLKIARGTSCGLAYMHQI 726
L Y V ++ Y+ GSL + E Q+ + R L ++H
Sbjct: 81 YLDSYLVGDEL-WVVMEYLAGGSLTDVVTETCMDEGQI-----AAVCRECLQALDFLHS- 133
Query: 727 CEPHIVHRDIKSSNILLDDQFEAHLADFGLSRLILPYQTHVTTELVGTLGYIPPEYGQAW 786
++HRDIKS NILL L DFG I P Q+ +T +VGT ++ PE
Sbjct: 134 --NQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRST-MVGTPYWMAPEVVTRK 190
Query: 787 VATLRGDMYSFGVVMLELLTGKRP 810
+ D++S G++ +E++ G+ P
Sbjct: 191 AYGPKVDIWSLGIMAIEMVEGEPP 214
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297 |
| >gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Score = 63.5 bits (154), Expect = 1e-10
Identities = 61/214 (28%), Positives = 94/214 (43%), Gaps = 17/214 (7%)
Query: 607 DNFSQANIIGCGGFGLVYKATLANGTTLAIKKLSGDLGLMERE----FKAEVEALSTAQH 662
++F +IG G FG V L N + K+ +++R F+ E + L +
Sbjct: 1 EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDN 60
Query: 663 KNLVSLQGYCVHQGFRLLIYSYMENGSLDYWLHEKADGASQLDWLTRLKIARGTSCGLAY 722
+ + +L + L+ Y G L L + D + + R +A +
Sbjct: 61 QWITTLHYAFQDENNLYLVMDYYVGGDLLTLLSKFEDRLPED--MARFYLAE-MVIAIDS 117
Query: 723 MHQICEPHIVHRDIKSSNILLDDQFEAHLADFGLSRLILPYQTHVTTELVGTLGYIPPEY 782
+HQ+ H VHRDIK NIL+D LADFG ++ T ++ VGT YI PE
Sbjct: 118 VHQL---HYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQSSVAVGTPDYISPEI 174
Query: 783 GQAWVATLRG------DMYSFGVVMLELLTGKRP 810
QA + +G D +S GV M E+L G+ P
Sbjct: 175 LQA-MEDGKGKYGPECDWWSLGVCMYEMLYGETP 207
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332 |
| >gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Score = 62.7 bits (152), Expect = 1e-10
Identities = 57/215 (26%), Positives = 91/215 (42%), Gaps = 27/215 (12%)
Query: 615 IGCGGFGLVYKATLANGTTLAIKKLSGDLGLMERE-FKAEVEALSTAQHKNLVSLQGYCV 673
+G G FG VYKA LA K+ E E + E+E L+T H +V L G
Sbjct: 20 LGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGAFY 79
Query: 674 HQGFRLLIYSYMENGSLDYWLHEKADGASQLDWLTRLKIARGTSCGLAYMHQICEPHIVH 733
G ++ + G++D + E G ++ I R L Y+H + I+H
Sbjct: 80 WDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQV---ICRQMLEALQYLHSM---KIIH 133
Query: 734 RDIKSSNILLDDQFEAHLADFGLSR------------LILPYQTHVTTELVGTLGYIPPE 781
RD+K+ N+LL + LADFG+S + PY + T+ P +
Sbjct: 134 RDLKAGNVLLTLDGDIKLADFGVSAKNVKTLQRRDSFIGTPYWMAPEVVMCETMKDTPYD 193
Query: 782 YGQAWVATLRGDMYSFGVVMLELLTGKRPVDVLKP 816
Y + D++S G+ ++E+ + P L P
Sbjct: 194 Y--------KADIWSLGITLIEMAQIEPPHHELNP 220
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 64.9 bits (158), Expect = 2e-10
Identities = 31/94 (32%), Positives = 47/94 (50%), Gaps = 3/94 (3%)
Query: 390 IYLANNSLSGNIPVEIGQLKSLHVLDLSNNNFSGTIPDELSDLSNLEKLDLSGNHLVGEI 449
+ L +NS SG +P E +L ++ LD+SNNN G I D+ +L+ L L+ N G +
Sbjct: 409 VRLQDNSFSGELPSEFTKLPLVYFLDISNNNLQGRINSRKWDMPSLQMLSLARNKFFGGL 468
Query: 450 PISLKGLHFLSSFSVAHNNLQGAVPSGGQFDTFP 483
P S G L + ++ N GAVP +
Sbjct: 469 PDSF-GSKRLENLDLSRNQFSGAVPRK--LGSLS 499
|
Length = 968 |
| >gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Score = 62.7 bits (152), Expect = 2e-10
Identities = 54/164 (32%), Positives = 88/164 (53%), Gaps = 18/164 (10%)
Query: 653 EVEALSTAQHKNLVSLQGYCVHQGFRL-LIYSYMENGSLDYWLHEKADGASQLDWLTRLK 711
EV L +H N+V+L +H L L++ Y+++ L + D L + +K
Sbjct: 53 EVSLLKNLKHANIVTLHD-IIHTERCLTLVFEYLDSD-----LKQYLDNCGNLMSMHNVK 106
Query: 712 IARGTSC-GLAYMHQICEPHIVHRDIKSSNILLDDQFEAHLADFGLSRL-ILPYQTHVTT 769
I GL+Y H + I+HRD+K N+L++++ E LADFGL+R +P +T+ +
Sbjct: 107 IFMFQLLRGLSYCH---KRKILHRDLKPQNLLINEKGELKLADFGLARAKSVPTKTY-SN 162
Query: 770 ELVGTLGYIPPE--YGQAWVATLRGDMYSFGVVMLELLTGKRPV 811
E+V TL Y PP+ G +T DM+ G ++ E+ TG RP+
Sbjct: 163 EVV-TLWYRPPDVLLGSTEYST-PIDMWGVGCILYEMATG-RPM 203
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288 |
| >gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 63.1 bits (154), Expect = 2e-10
Identities = 59/238 (24%), Positives = 99/238 (41%), Gaps = 71/238 (29%)
Query: 607 DNFSQANIIGCGGFGLVYKAT-LANGTTLAIKKLSGDLGLMEREFKA-----EVEALSTA 660
+ + IG G +G+V AT G +AIKK+S E + E++ L
Sbjct: 5 PRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISP----FEHQTFCQRTLREIKILRRF 60
Query: 661 QHKNLVSLQ------GYCVHQGFR--LLIYSYME-------------NGSLDYWLHEKAD 699
+H+N++ + + F ++ ME N + Y+L++
Sbjct: 61 KHENIIGILDIIRPPSFES---FNDVYIVQELMETDLYKLIKTQHLSNDHIQYFLYQ--- 114
Query: 700 GASQLDWLTRLKIARGTSCGLAYMHQICEPHIVHRDIKSSNILLDDQFEAHLADFGLSRL 759
I RG L Y+H +++HRD+K SN+LL+ + + DFGL+R+
Sbjct: 115 ------------ILRG----LKYIHS---ANVLHRDLKPSNLLLNTNCDLKICDFGLARI 155
Query: 760 ILPYQTH--VTTELVGTLGYIPPE-------YGQAWVATLRGDMYSFGVVMLELLTGK 808
P H TE V T Y PE Y +A D++S G ++ E+L+ +
Sbjct: 156 ADPEHDHTGFLTEYVATRWYRAPEIMLNSKGYTKAI------DIWSVGCILAEMLSNR 207
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336 |
| >gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Score = 62.6 bits (152), Expect = 2e-10
Identities = 68/262 (25%), Positives = 118/262 (45%), Gaps = 39/262 (14%)
Query: 634 LAIKKLSGDLGLMER-EFKAEVEALSTAQHKNLVSLQGYCVHQGFRLLIYSYMENGSLDY 692
+A+K L D R +F E++ +S + N++ L C+ +I YMENG L+
Sbjct: 49 VAVKMLREDANKNARNDFLKEIKIMSRLKDPNIIRLLAVCITSDPLCMITEYMENGDLNQ 108
Query: 693 WL--HEKADGASQLD-----WLTRLKIARGTSCGLAYMHQICEPHIVHRDIKSSNILLDD 745
+L HE + A + D + T + +A + G+ Y+ + + VHRD+ + N L+
Sbjct: 109 FLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSL---NFVHRDLATRNCLVGK 165
Query: 746 QFEAHLADFGLSRLILP---YQTHVTTELVGTLGYIPPEYGQAWVATLRG------DMYS 796
+ +ADFG+SR + Y+ L P +W + L G D+++
Sbjct: 166 NYTIKIADFGMSRNLYSGDYYRIQGRAVL--------PIRWMSWESILLGKFTTASDVWA 217
Query: 797 FGVVMLELLT--GKRPVDVLKPKMSRELVGWVLKMRSEGKQDQVFDPILRGKGFDEEMLQ 854
FGV + E+LT ++P L + E G R +G+Q + P L + ML
Sbjct: 218 FGVTLWEILTLCKEQPYSQLSDEQVIENTGEFF--RDQGRQVYLPKPALCPDSLYKLMLS 275
Query: 855 VLDVACMCVSQNPFKRPTVKEV 876
C +N +RP+ +E+
Sbjct: 276 -------CWRRNAKERPSFQEI 290
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296 |
| >gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Score = 62.3 bits (151), Expect = 2e-10
Identities = 61/221 (27%), Positives = 104/221 (47%), Gaps = 32/221 (14%)
Query: 615 IGCGGFGLVYKATL-----ANGTTLAIKKLSGDLGLMER--EFKAEVEALSTAQHKNLVS 667
+G FG +YK L + +AIK L D+ ++ EF+ E ++ H N+V
Sbjct: 13 LGECAFGKIYKGHLYLPGMDHAQLVAIKTLK-DINNPQQWGEFQQEASLMAELHHPNIVC 71
Query: 668 LQGYCVHQGFRLLIYSYMENGSLDYWLHEKA-----------DGA--SQLDWLTRLKIAR 714
L G + +++ Y+ G L +L ++ DG S LD L IA
Sbjct: 72 LLGVVTQEQPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAI 131
Query: 715 GTSCGLAYMHQICEPHIVHRDIKSSNILLDDQFEAHLADFGLSRLILPYQTH-VTTELVG 773
+ G+ Y+ VH+D+ + NIL+ +Q ++D GLSR I + V + +
Sbjct: 132 QIAAGMEYL---SSHFFVHKDLAARNILIGEQLHVKISDLGLSREIYSADYYRVQPKSLL 188
Query: 774 TLGYIPPE---YGQAWVATLRGDMYSFGVVMLELLT-GKRP 810
+ ++PPE YG+ + D++SFGVV+ E+ + G +P
Sbjct: 189 PIRWMPPEAIMYGK---FSSDSDIWSFGVVLWEIFSFGLQP 226
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283 |
| >gnl|CDD|173646 cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Score = 61.9 bits (150), Expect = 3e-10
Identities = 73/280 (26%), Positives = 123/280 (43%), Gaps = 37/280 (13%)
Query: 615 IGCGGFGLVYKATLANGTTLA---IKKLSGDLGLME-REFKAEVEALSTAQHKNLVSLQG 670
IG G FG V + +G T A +K+L + E +F E + + QH NL+ G
Sbjct: 3 IGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCLG 62
Query: 671 YCVHQGFRLLIYSYMENGSLDYWLH--EKADGASQLDWLTRLKIARGTSCGLAYMHQICE 728
C LL+ + G L +L KA+ + D T ++A + GL ++H+
Sbjct: 63 QCTEVTPYLLVMEFCPLGDLKGYLRSCRKAELMTP-DPTTLQRMACEIALGLLHLHK--- 118
Query: 729 PHIVHRDIKSSNILLDDQFEAHLADFGLSRLILPYQTHVTTE-LVGTLGYIPPE-----Y 782
+ +H D+ N LL + D+GLS +VT + L L +I PE +
Sbjct: 119 NNFIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYVTPDQLWVPLRWIAPELVDEVH 178
Query: 783 GQAWVA--TLRGDMYSFGVVMLELLT-GKRPVDVLKPKMS-RELVGWVLKMRSEGKQDQV 838
G V T +++S GV + EL G +P +S +++ + ++ +Q ++
Sbjct: 179 GNLLVVDQTKESNVWSLGVTIWELFELGSQPY----RHLSDEQVLTYTVRE----QQLKL 230
Query: 839 FDPILRGKGFDE--EMLQVLDVACMCVSQNPFKRPTVKEV 876
P L+ D E++Q C Q P +RP+ +EV
Sbjct: 231 PKPRLKLPLSDRWYEVMQ------FCWLQ-PEQRPSAEEV 263
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells. Aatyk1 has been implicated in neural differentiation, and is a regulator of the Na-K-2Cl cotransporter, a membrane protein involved in cell proliferation and survival, epithelial transport, and blood pressure control. The function of Aatyk3 is still unknown. Length = 269 |
| >gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 62.5 bits (152), Expect = 3e-10
Identities = 65/206 (31%), Positives = 98/206 (47%), Gaps = 20/206 (9%)
Query: 614 IIGCGGFG---LVYKATLAN-GTTLAIKKL-SGDLGLMER-EFKAEVEALSTAQHKNLVS 667
++G G FG LV K T + G A+K L L + +R K E + L+ H +V
Sbjct: 3 VLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVK 62
Query: 668 LQGYCVHQGFRLLIYSYMENGSLDYWLHEKADGASQLD---WLTRLKIARGTSCGLAYMH 724
L +G LI ++ G L L K ++ D +L L +A L ++H
Sbjct: 63 LHYAFQTEGKLYLILDFLRGGDLFTRL-SKEVMFTEEDVKFYLAELALA------LDHLH 115
Query: 725 QICEPHIVHRDIKSSNILLDDQFEAHLADFGLSRLILPYQTHVTTELVGTLGYIPPEYGQ 784
+ I++RD+K NILLD++ L DFGLS+ + ++ GT+ Y+ PE
Sbjct: 116 SL---GIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKK-AYSFCGTVEYMAPEVVN 171
Query: 785 AWVATLRGDMYSFGVVMLELLTGKRP 810
T D +SFGV+M E+LTG P
Sbjct: 172 RRGHTQSADWWSFGVLMFEMLTGSLP 197
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318 |
| >gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 62.3 bits (152), Expect = 3e-10
Identities = 67/247 (27%), Positives = 92/247 (37%), Gaps = 61/247 (24%)
Query: 607 DNFSQANIIGCGGFGLVY----KATLANGTTLAIKKLSGDLGLMERE----FKAEVEALS 658
D+F +IG G FG V+ K T G A+K L +++R +AE + L+
Sbjct: 1 DDFEVIKVIGRGAFGEVWLVRDKDT---GQVYAMKVLRKSD-MIKRNQIAHVRAERDILA 56
Query: 659 TAQHKNLVSLQGYCVHQGFRLLIYSYMENGSLDYWLHEKADGASQLDW-LTRLKIARGTS 717
A +V L + L+ YM G L L K R IA
Sbjct: 57 DADSPWIVKLYYSFQDEEHLYLVMEYMPGGDLMNLLIRK----DVFPEETARFYIAE-LV 111
Query: 718 CGLAYMHQICEPHIVHRDIKSSNILLDDQFEAHLADFGLS---------------RLILP 762
L +H++ +HRDIK NIL+D LADFGL L
Sbjct: 112 LALDSVHKL---GFIHRDIKPDNILIDADGHIKLADFGLCKKMNKAKDREYYLNDSHNLL 168
Query: 763 YQTHVTTE-------------LVGTLGYIPPE------YGQAWVATLRGDMYSFGVVMLE 803
++ +V VGT YI PE YG D +S GV++ E
Sbjct: 169 FRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGL------ECDWWSLGVILYE 222
Query: 804 LLTGKRP 810
+L G P
Sbjct: 223 MLYGFPP 229
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350 |
| >gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 61.8 bits (151), Expect = 3e-10
Identities = 60/224 (26%), Positives = 93/224 (41%), Gaps = 47/224 (20%)
Query: 607 DNFSQANIIGCGGFGLVYKATL-ANGTTLAIKKLSGD----LGLMEREFKAEVEALSTAQ 661
D+F +G G FG V +G A+K LS L +E E L + +
Sbjct: 1 DDFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVE-HVLNEKRILQSIR 59
Query: 662 HKNLVSLQGYCVHQGFRLLIYSYMENGSLDYWLHEKADGASQLDWLTR-----LKIARGT 716
H LV+L G S+ ++ +L Y + E G L + +AR
Sbjct: 60 HPFLVNLYG------------SFQDDSNL-YLVMEYVPGGELFSHLRKSGRFPEPVARFY 106
Query: 717 S----CGLAYMHQICEPHIVHRDIKSSNILLDDQFEAHLADFGLSRLILPYQTHVTTELV 772
+ L Y+H + IV+RD+K N+LLD + DFG ++ + T L
Sbjct: 107 AAQVVLALEYLHSL---DIVYRDLKPENLLLDSDGYIKITDFGFAKRVKG----RTYTLC 159
Query: 773 GTLGYIPPE------YGQAWVATLRGDMYSFGVVMLELLTGKRP 810
GT Y+ PE YG+A D ++ G+++ E+L G P
Sbjct: 160 GTPEYLAPEIILSKGYGKAV------DWWALGILIYEMLAGYPP 197
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290 |
| >gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Score = 61.6 bits (149), Expect = 3e-10
Identities = 66/232 (28%), Positives = 95/232 (40%), Gaps = 48/232 (20%)
Query: 608 NFSQANIIGCGGFGLVYKATLANGTTLAIKKLSGDLGLMEREFKAE-VEALSTAQHKN-- 664
NF ++G G +G V+ +G SG L M+ KA V+ T +H
Sbjct: 1 NFELLKVLGTGAYGKVFLVRKVSGHD------SGKLYAMKVLKKATIVQKAKTTEHTRTE 54
Query: 665 ------------LVSLQGYCVHQGFRL-LIYSYMENGSLDYWLHEKADGASQLDWLTRLK 711
LV+L Y +L LI Y+ G L L ++ Q ++
Sbjct: 55 RQVLEHIRQSPFLVTLH-YAFQTDTKLHLILDYINGGELFTHLSQRERFKEQ-----EVQ 108
Query: 712 IARG-TSCGLAYMHQICEPHIVHRDIKSSNILLDDQFEAHLADFGLSRLILPYQTHVTTE 770
I G L ++H++ I++RDIK NILLD L DFGLS+ +
Sbjct: 109 IYSGEIVLALEHLHKL---GIIYRDIKLENILLDSNGHVVLTDFGLSKEFHEDEVERAYS 165
Query: 771 LVGTLGYIPPEYGQAWVATLRG---------DMYSFGVVMLELLTGKRPVDV 813
GT+ Y+ P+ +RG D +S GV+M ELLTG P V
Sbjct: 166 FCGTIEYMAPD-------IVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTV 210
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290 |
| >gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Score = 62.3 bits (151), Expect = 4e-10
Identities = 65/222 (29%), Positives = 99/222 (44%), Gaps = 35/222 (15%)
Query: 608 NFSQANIIGCGGFG---LVYKATLANGTTLAIKKLSGDLGLMERE-----FKAEVEALS- 658
NF ++G G +G LV K T + L K+ L+++ + E L
Sbjct: 1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEH 60
Query: 659 TAQHKNLVSLQGYCVHQGFRL-LIYSYMENGSLDYWLHEKADGASQLDWLTRLKIARG-T 716
Q LV+L Y +L LI Y+ G + L+++ D S+ ++ G
Sbjct: 61 VRQSPFLVTLH-YAFQTEAKLHLILDYVSGGEMFTHLYQR-DNFSE----DEVRFYSGEI 114
Query: 717 SCGLAYMHQICEPHIVHRDIKSSNILLDDQFEAHLADFGLSRLILPYQTHVTTELVGTLG 776
L ++H++ IV+RDIK NILLD + L DFGLS+ L + T GT+
Sbjct: 115 ILALEHLHKL---GIVYRDIKLENILLDSEGHVVLTDFGLSKEFLSEEKERTYSFCGTIE 171
Query: 777 YIPPEYGQAWVATLRG--------DMYSFGVVMLELLTGKRP 810
Y+ PE +RG D +S G+++ ELLTG P
Sbjct: 172 YMAPE-------IIRGKGGHGKAVDWWSLGILIFELLTGASP 206
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332 |
| >gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Score = 61.1 bits (149), Expect = 4e-10
Identities = 75/301 (24%), Positives = 121/301 (40%), Gaps = 66/301 (21%)
Query: 615 IGCGGFGLVYKA-TLANGTTLAIKKLSGDL-GLMEREFKAEVEAL-STAQHKNLVSLQGY 671
IG G F V KA + G AIK + L + E++AL + H N++ L
Sbjct: 7 IGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQVNNLREIQALRRLSPHPNILRLIEV 66
Query: 672 -------CVHQGFRLL---IYSYMENGSLDYWLHEKADGASQLDWLTRLKIARGTSCGLA 721
+ F L+ +Y ++ L EK ++ +L L
Sbjct: 67 LFDRKTGRLALVFELMDMNLYELIKGRK--RPLPEK----RVKSYMYQL------LKSLD 114
Query: 722 YMHQICEPHIVHRDIKSSNILLDDQFEAHLADFGLSRLILPYQTHVTTELVGTLGYIPPE 781
+MH+ I HRDIK NIL+ D LADFG R I Y TE + T Y PE
Sbjct: 115 HMHRN---GIFHRDIKPENILIKDD-ILKLADFGSCRGI--YSKPPYTEYISTRWYRAPE 168
Query: 782 -------YGQAWVATLRGDMYSFGVVMLELLT------GKRPVDVLKPKMSR--ELVG-- 824
YG D+++ G V E+L+ G +D ++++ +++G
Sbjct: 169 CLLTDGYYGPKM------DIWAVGCVFFEILSLFPLFPGTNELD----QIAKIHDVLGTP 218
Query: 825 --WVLKMRSEGKQDQVFDPILRGKGFDEEML-----QVLDVACMCVSQNPFKRPTVKEVV 877
VLK + + P +G G ++L + LD+ ++ +P +R T K+ +
Sbjct: 219 DAEVLKKFRKSRHMNYNFPSKKGTGL-RKLLPNASAEGLDLLKKLLAYDPDERITAKQAL 277
Query: 878 E 878
Sbjct: 278 R 278
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282 |
| >gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 61.3 bits (149), Expect = 4e-10
Identities = 54/210 (25%), Positives = 91/210 (43%), Gaps = 19/210 (9%)
Query: 607 DNFSQANIIGCGGFGLVYKAT-LANGTTLAIKKLS-GDLGLMERE--FKAEVEALSTAQH 662
D+ + +G G FG V+ + A+K ++ ++ +++E E L H
Sbjct: 1 DDLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSH 60
Query: 663 KNLVSLQGYCVH--QGFRLLIYSYMENGSLDYWLHEKADGASQLDWLTRLKIARGTSCGL 720
++ L + Q F ++ Y+ G L +L ++ T L A C L
Sbjct: 61 PFIIRL--FWTEHDQRFLYMLMEYVPGGELFSYLRNSGRFSNS----TGLFYASEIVCAL 114
Query: 721 AYMHQICEPHIVHRDIKSSNILLDDQFEAHLADFGLSRLILPYQTHVTTELVGTLGYIPP 780
Y+H IV+RD+K NILLD + L DFG ++ + T L GT Y+ P
Sbjct: 115 EYLHSK---EIVYRDLKPENILLDKEGHIKLTDFGFAKKLRDR----TWTLCGTPEYLAP 167
Query: 781 EYGQAWVATLRGDMYSFGVVMLELLTGKRP 810
E Q+ D ++ G+++ E+L G P
Sbjct: 168 EVIQSKGHNKAVDWWALGILIYEMLVGYPP 197
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291 |
| >gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Score = 61.1 bits (148), Expect = 4e-10
Identities = 66/293 (22%), Positives = 128/293 (43%), Gaps = 39/293 (13%)
Query: 609 FSQANIIGCGGFGLVYKATL----ANGTTLAIKKLSGDLGLME--REFKAEVEALSTAQH 662
F+ ++G G FG V +A L + +A+K L D+ EF E + H
Sbjct: 1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDH 60
Query: 663 KNLVSLQGYCVHQGFR------LLIYSYMENGSLDYWL--HEKADGASQLDWLTRLKIAR 714
N++ L G + + ++I +M++G L +L + L T ++
Sbjct: 61 PNVIKLIGVSLRSRAKGRLPIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMI 120
Query: 715 GTSCGLAYMHQICEPHIVHRDIKSSNILLDDQFEAHLADFGLSRLILP---YQTHVTTEL 771
+ G+ Y+ + +HRD+ + N +L++ +ADFGLS+ I Y+ ++L
Sbjct: 121 DIASGMEYLSS---KNFIHRDLAARNCMLNENMTVCVADFGLSKKIYSGDYYRQGCASKL 177
Query: 772 VGTLGYIPPEYGQAWVATLRGDMYSFGVVMLELLT-GKRPVDVLKPKMSRELVGWVLKMR 830
+ ++ E V T D+++FGV M E++T G+ P ++ + E+ +++K
Sbjct: 178 --PVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPYAGVE---NSEIYNYLIKGN 232
Query: 831 SEGKQDQVFDPILRGKGFDEEMLQVLDVACMCVSQNPFKRPTVKEVVEWLNNV 883
R K + + V ++ C C S P RP+ + + + L +
Sbjct: 233 -------------RLKQPPDCLEDVYELMCQCWSPEPKCRPSFQHLRDQLELI 272
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273 |
| >gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Score = 61.1 bits (148), Expect = 5e-10
Identities = 58/203 (28%), Positives = 90/203 (44%), Gaps = 25/203 (12%)
Query: 615 IGCGGFGLVY----KATLANGTTLAIKKLS-GDLGLMEREFKAEVEA--LSTAQHKNLVS 667
+G G FG VY K +A +K++ G+L E +A EA LS H +V
Sbjct: 8 LGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNE-TVQANQEAQLLSKLDHPAIVK 66
Query: 668 LQGYCVHQGFRLLIYSYMENGSLDYWLHEKADGASQL------DWLTRLKIARGTSCGLA 721
+ + +I Y E LD L E L +W +L + G+
Sbjct: 67 FHASFLERDAFCIITEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLL------GVH 120
Query: 722 YMHQICEPHIVHRDIKSSNILLDDQFEAHLADFGLSRLILPYQTHVTTELVGTLGYIPPE 781
YMHQ I+HRD+K+ NI L + + DFG+SRL++ + T GT Y+ PE
Sbjct: 121 YMHQ---RRILHRDLKAKNIFLKNNL-LKIGDFGVSRLLMG-SCDLATTFTGTPYYMSPE 175
Query: 782 YGQAWVATLRGDMYSFGVVMLEL 804
+ + D++S G ++ E+
Sbjct: 176 ALKHQGYDSKSDIWSLGCILYEM 198
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260 |
| >gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Score = 61.3 bits (149), Expect = 5e-10
Identities = 63/217 (29%), Positives = 101/217 (46%), Gaps = 44/217 (20%)
Query: 615 IGCGGFGLVYKATLAN-GTTLAIKKL---SGDLGLMEREFKAEVEALSTAQHKNLVSLQG 670
IG G +G V+KA +A+K++ D G+ + E+ L +HKN+V L
Sbjct: 8 IGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALR-EICLLKELKHKNIVRLYD 66
Query: 671 YCVHQGFRL-LIYSYME----------NGSLDYWLHEKADGASQLDWLTRLKIARGTSCG 719
+H +L L++ Y + NG +D S + L + G
Sbjct: 67 -VLHSDKKLTLVFEYCDQDLKKYFDSCNGDID-----PEIVKSFMFQLLK---------G 111
Query: 720 LAYMHQICEPHIVHRDIKSSNILLDDQFEAHLADFGLSRLILPYQTHV---TTELVGTLG 776
LA+ H +++HRD+K N+L++ E LADFGL+R + V + E+V TL
Sbjct: 112 LAFCHS---HNVLHRDLKPQNLLINKNGELKLADFGLAR---AFGIPVRCYSAEVV-TLW 164
Query: 777 YIPPE--YGQAWVATLRGDMYSFGVVMLELLTGKRPV 811
Y PP+ +G A + + DM+S G + EL RP+
Sbjct: 165 YRPPDVLFG-AKLYSTSIDMWSAGCIFAELANAGRPL 200
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284 |
| >gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 61.3 bits (149), Expect = 6e-10
Identities = 38/94 (40%), Positives = 48/94 (51%), Gaps = 10/94 (10%)
Query: 723 MHQICEPHIVHRDIKSSNILLDDQFEAHLADFGLSRLILPYQTHVTTELVGTLGYIPPEY 782
+HQ+ VHRDIK N+LLD LADFG +L T + VGT YI PE
Sbjct: 118 VHQL---GYVHRDIKPDNVLLDKNGHIRLADFGSCLRLLADGTVQSNVAVGTPDYISPEI 174
Query: 783 GQAWVATLRG------DMYSFGVVMLELLTGKRP 810
QA + +G D +S GV M E+L G+ P
Sbjct: 175 LQA-MEDGKGRYGPECDWWSLGVCMYEMLYGETP 207
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331 |
| >gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Score = 60.6 bits (147), Expect = 7e-10
Identities = 64/208 (30%), Positives = 101/208 (48%), Gaps = 17/208 (8%)
Query: 608 NFSQANIIGCGGFGLVYKA-TLANGTTLAIK--KLSGDLGLMEREFKAEVEALSTAQHKN 664
NF Q +G G + VYK G +A+K L + G + E+ + +H+N
Sbjct: 1 NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIR-EISLMKELKHEN 59
Query: 665 LVSLQGYCVHQGFRL-LIYSYMENGSLDYWLHEKADGASQLDWLTRLKIARGTSCGLAYM 723
+V L +H +L L++ YM+ Y GA LD T G+A+
Sbjct: 60 IVRLHD-VIHTENKLMLVFEYMDKDLKKYMDTHGVRGA--LDPNTVKSFTYQLLKGIAFC 116
Query: 724 HQICEPHIVHRDIKSSNILLDDQFEAHLADFGLSRLI-LPYQTHVTTELVGTLGYIPPE- 781
H E ++HRD+K N+L++ + E LADFGL+R +P T + E+V TL Y P+
Sbjct: 117 H---ENRVLHRDLKPQNLLINKRGELKLADFGLARAFGIPVNT-FSNEVV-TLWYRAPDV 171
Query: 782 -YGQAWVATLRGDMYSFGVVMLELLTGK 808
G +T D++S G +M E++TG+
Sbjct: 172 LLGSRTYST-SIDIWSVGCIMAEMITGR 198
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284 |
| >gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Score = 60.5 bits (147), Expect = 7e-10
Identities = 60/204 (29%), Positives = 94/204 (46%), Gaps = 24/204 (11%)
Query: 614 IIGCGGFGLVYKATLAN-GTTLAIKKL--SGDLGLMEREFKAEVEALSTAQHKNLVSLQG 670
++G G +G+V K G +AIKK S D ++++ E+ L +H+NLV+L
Sbjct: 8 LVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIE 67
Query: 671 YCVHQGFRLLIYSYMENGSLDYWLHEKADGASQLDWLTRLKIARGTSCGLAYMHQICEPH 730
+ L++ ++++ LD EK LD K G+ + H +
Sbjct: 68 VFRRKKRLYLVFEFVDHTVLDDL--EKYPNG--LDESRVRKYLFQILRGIEFCHS---HN 120
Query: 731 IVHRDIKSSNILLDDQFEAHLADFGLSRLILPYQTHVTTELVGTLGYIPPE-------YG 783
I+HRDIK NIL+ L DFG +R L V T+ V T Y PE YG
Sbjct: 121 IIHRDIKPENILVSQSGVVKLCDFGFAR-TLAAPGEVYTDYVATRWYRAPELLVGDTKYG 179
Query: 784 QAWVATLRGDMYSFGVVMLELLTG 807
+A D+++ G ++ E+LTG
Sbjct: 180 RAV------DIWAVGCLVTEMLTG 197
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286 |
| >gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Score = 60.4 bits (146), Expect = 8e-10
Identities = 73/272 (26%), Positives = 120/272 (44%), Gaps = 34/272 (12%)
Query: 615 IGCGGFGLVYKA-TLANGTTLAIKKLSGDLGLMEREFKAEVEALSTAQHKNLVSLQGYCV 673
+G G +G VYKA L G A+K + + G + E+ + +H N+V+ G +
Sbjct: 17 VGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQEIFMVKECKHCNIVAYFGSYL 76
Query: 674 HQGFRLLIYSYMENGSLDYWLHEKADGASQLDWLTRLKIA---RGTSCGLAYMHQICEPH 730
+ + Y GSL H L+ L+IA R T GLAY+H +
Sbjct: 77 SREKLWICMEYCGGGSLQDIYHVTGP-------LSELQIAYVCRETLQGLAYLHSKGK-- 127
Query: 731 IVHRDIKSSNILLDDQFEAHLADFGLSRLILPYQTHVTTELVGTLGYIPPEYGQAWVATL 790
+HRDIK +NILL D + LADFG++ I + +GT ++ PE A V
Sbjct: 128 -MHRDIKGANILLTDNGDVKLADFGVAAKITATIAKRKS-FIGTPYWMAPEV--AAVEKN 183
Query: 791 RG-----DMYSFGVVMLELLTGKRPVDVLKPKMSRELVGWVLKMRSEGKQDQVFDPILRG 845
G D+++ G+ +EL + P+ L P + L +S + ++ D
Sbjct: 184 GGYNQLCDIWAVGITAIELAELQPPMFDLHP-----MRALFLMSKSNFQPPKLKDKTKWS 238
Query: 846 KGFDEEMLQVLDVACMCVSQNPFKRPTVKEVV 877
F + + +++NP KRPT + ++
Sbjct: 239 STFH-------NFVKISLTKNPKKRPTAERLL 263
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267 |
| >gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Score = 60.4 bits (146), Expect = 8e-10
Identities = 66/213 (30%), Positives = 98/213 (46%), Gaps = 17/213 (7%)
Query: 608 NFSQANIIGCGGFGLVYKATLAN-GTTLAIKKLSGDLGLME--REFKA---EVEALSTAQ 661
N+ ++G G FG VY A+ G LA+K++ D E +E A E++ L
Sbjct: 3 NWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLL 62
Query: 662 HKNLVSLQGYCVHQGFRLL--IYSYMENGSLDYWLHEKADGASQLDWLTRLKIARGTSCG 719
H+ +V G R L +M GS+ L K+ GA + +TR K R G
Sbjct: 63 HERIVQYYGCLRDPMERTLSIFMEHMPGGSIKDQL--KSYGALT-ENVTR-KYTRQILEG 118
Query: 720 LAYMHQICEPHIVHRDIKSSNILLDDQFEAHLADFGLSRLILPYQTHVT--TELVGTLGY 777
++Y+H IVHRDIK +NIL D L DFG S+ + T + GT +
Sbjct: 119 VSYLHS---NMIVHRDIKGANILRDSVGNVKLGDFGASKRLQTICLSGTGMKSVTGTPYW 175
Query: 778 IPPEYGQAWVATLRGDMYSFGVVMLELLTGKRP 810
+ PE + D++S G ++E+LT K P
Sbjct: 176 MSPEVISGEGYGRKADIWSVGCTVVEMLTEKPP 208
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265 |
| >gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 60.8 bits (147), Expect = 8e-10
Identities = 64/209 (30%), Positives = 97/209 (46%), Gaps = 35/209 (16%)
Query: 615 IGCGGFGLVYKA-TLANGTTLAIKKLSGDLGLMERE----FKAEVEA--LSTAQHKNLVS 667
+G G + VYK + NG +A+K +S M+ E F A EA L +H N+V
Sbjct: 13 LGEGSYATVYKGISRINGQLVALKVIS-----MKTEEGVPFTAIREASLLKGLKHANIVL 67
Query: 668 LQGYCVHQGFRLLIYSYMENGSLDYWLHEKADGASQLDWLTRLKIARGTSCGLAYMHQIC 727
L + ++ YM Y + L ++ RG LAY+H
Sbjct: 68 LHDIIHTKETLTFVFEYMHTDLAQYMIQHPGGLHPYNVRLFMFQLLRG----LAYIHG-- 121
Query: 728 EPHIVHRDIKSSNILLDDQFEAHLADFGLSRL-ILPYQTHVTTELVGTLGYIPP------ 780
HI+HRD+K N+L+ E LADFGL+R +P QT+ ++E+V TL Y PP
Sbjct: 122 -QHILHRDLKPQNLLISYLGELKLADFGLARAKSIPSQTY-SSEVV-TLWYRPPDVLLGA 178
Query: 781 -EYGQAWVATLRGDMYSFGVVMLELLTGK 808
+Y A D++ G + +E+L G+
Sbjct: 179 TDYSSAL------DIWGAGCIFIEMLQGQ 201
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291 |
| >gnl|CDD|173627 cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 60.2 bits (146), Expect = 9e-10
Identities = 72/290 (24%), Positives = 119/290 (41%), Gaps = 56/290 (19%)
Query: 615 IGCGGFGLVYKATL-------ANGTTLAIKKLSGDLGLMEREFKAEVEALST---AQHKN 664
+G G F +YK L G + + LG R+ A E S HK+
Sbjct: 3 LGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRDSLAFFETASLMSQLSHKH 62
Query: 665 LVSLQGYCVHQGFRLLIYSYMENGSLDYWLHEKADGASQLDWLTRLKIARGTSCGLAYMH 724
LV L G CV +++ Y++ G LD +LH + + S L W L +A+ + L Y+
Sbjct: 63 LVKLYGVCVRDEN-IMVEEYVKFGPLDVFLHREKNNVS-LHWK--LDVAKQLASALHYLE 118
Query: 725 QICEPHIVHRDIKSSNILL-------DDQFEAHLADFGLSRLILPYQTHVTTELVGTLGY 777
+ +VH ++ NIL+ L+D G+ +L + E V + +
Sbjct: 119 ---DKKLVHGNVCGKNILVARYGLNEGYVPFIKLSDPGIPITVLSRE-----ERVERIPW 170
Query: 778 IPPEY---GQAWVATLRGDMYSFGVVMLELLT-GKRPVDVLKP--KMSRELVGWVLKMRS 831
I PE GQA + T+ D +SFG +LE+ + G+ P+ L K L M
Sbjct: 171 IAPECIRNGQASL-TIAADKWSFGTTLLEICSNGEEPLSTLSSSEKERFYQDQHRLPMPD 229
Query: 832 EGKQDQVFDPILRGKGFDEEMLQVLDVACMCVSQNPFKRPTVKEVVEWLN 881
++ + I + C + +P KRP+ + ++ LN
Sbjct: 230 ---CAELANLINQ-----------------CWTYDPTKRPSFRAILRDLN 259
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 259 |
| >gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Score = 60.2 bits (146), Expect = 9e-10
Identities = 52/201 (25%), Positives = 86/201 (42%), Gaps = 10/201 (4%)
Query: 615 IGCGGFGLVYKATL-ANGTTLAIKKLSGDLGLMEREFKA---EVEALSTAQHKNLVSLQG 670
+G GGFG V + A G A KKL+ + ++ E L+ + +VSL
Sbjct: 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSL-A 59
Query: 671 YCVHQGFRL-LIYSYMENGSLDYWLHEKADGASQLDWLTRLKIARGTSCGLAYMHQICEP 729
Y L L+ + M G L Y ++ + GL ++HQ
Sbjct: 60 YAFQTKTDLCLVMTIMNGGDLRYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQ---R 116
Query: 730 HIVHRDIKSSNILLDDQFEAHLADFGLSRLILPYQTHVTTELVGTLGYIPPEYGQAWVAT 789
I++RD+K N+LLD+ ++D GL+ + Q+ T GT G++ PE Q
Sbjct: 117 RIIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQSK-TKGYAGTPGFMAPELLQGEEYD 175
Query: 790 LRGDMYSFGVVMLELLTGKRP 810
D ++ GV + E++ + P
Sbjct: 176 FSVDYFALGVTLYEMIAARGP 196
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280 |
| >gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Score = 60.0 bits (145), Expect = 1e-09
Identities = 65/208 (31%), Positives = 95/208 (45%), Gaps = 25/208 (12%)
Query: 615 IGCGGFGLVYKA-TLANGTTLAIKKL---SGDLGL---MEREFKAEVEALSTAQHKNLVS 667
IG G +G VYKA +G +A+K + + + GL RE A ++ L H N+V
Sbjct: 8 IGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREV-ALLKRLEAFDHPNIVR 66
Query: 668 LQGYCV-----HQGFRLLIYSYMENGSLDYWLHEKADGASQLDWLTRLKIARGTSCGLAY 722
L C + L++ +++ Y G L T + R GL +
Sbjct: 67 LMDVCATSRTDRETKVTLVFEHVDQDLRTYLDKVPPPG---LPAETIKDLMRQFLRGLDF 123
Query: 723 MHQICEPHIVHRDIKSSNILLDDQFEAHLADFGLSRLILPYQTHVT-TELVGTLGYIPPE 781
+H C IVHRD+K NIL+ + LADFGL+R+ Y + T +V TL Y PE
Sbjct: 124 LHANC---IVHRDLKPENILVTSGGQVKLADFGLARI---YSCQMALTPVVVTLWYRAPE 177
Query: 782 -YGQAWVATLRGDMYSFGVVMLELLTGK 808
Q+ AT DM+S G + E+ K
Sbjct: 178 VLLQSTYAT-PVDMWSVGCIFAEMFRRK 204
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288 |
| >gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Score = 59.7 bits (144), Expect = 1e-09
Identities = 66/285 (23%), Positives = 118/285 (41%), Gaps = 41/285 (14%)
Query: 608 NFSQANIIGCGGFGLVYKAT-LANGTTLAIKKLSGDLGLMEREFK----AEVEALSTAQH 662
NF IG G F VY+AT L + +A+KK+ +M+ + + E++ L H
Sbjct: 3 NFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQ-IFEMMDAKARQDCVKEIDLLKQLNH 61
Query: 663 KNLVSLQGYCVHQGFRLLIYSYMENGSLDYWLH--EKADGASQLDWLTRLKIARGTSCGL 720
N++ + S++E+ L+ L + D + + + + K
Sbjct: 62 PNVIKY------------LDSFIEDNELNIVLELADAGDLSQMIKYFKKQKRLIPERTVW 109
Query: 721 AYMHQICEP-------HIVHRDIKSSNILLDDQFEAHLADFGLSRLILPYQTHVTTELVG 773
Y Q+C ++HRDIK +N+ + L D GL R +T LVG
Sbjct: 110 KYFVQLCSAVEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRF-FSSKTTAAHSLVG 168
Query: 774 TLGYIPPEYGQAWVATLRGDMYSFGVVMLELLTGKRPVDVLKPKMSRELVGWVLKMRSEG 833
T Y+ PE + D++S G ++ E+ + P KM+ L K+
Sbjct: 169 TPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSP--FYGDKMN--LFSLCQKI---- 220
Query: 834 KQDQVFDPILRGKGFDEEMLQVLDVACMCVSQNPFKRPTVKEVVE 878
+Q P L + + E++ ++ MC+ +P +RP + V +
Sbjct: 221 --EQCDYPPLPTEHYSEKL---RELVSMCIYPDPDQRPDIGYVHQ 260
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267 |
| >gnl|CDD|133217 cd05086, PTKc_Aatyk2, Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 59.5 bits (144), Expect = 1e-09
Identities = 74/281 (26%), Positives = 122/281 (43%), Gaps = 40/281 (14%)
Query: 615 IGCGGFGLVYKATLANGTTLA---IKKLSGDLGLMER-EFKAEVEALSTAQHKNLVSLQG 670
IG G FG V + + T +A +K+L + E+ EF + + QH N++ G
Sbjct: 3 IGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQCLG 62
Query: 671 YCVHQGFRLLIYSYMENGSLDYWL--HEKADGASQLDWLTRLKIARGTSCGLAYMHQICE 728
CV LL++ Y E G L +L + SQL L R+ A + G+ +MH+
Sbjct: 63 QCVEAIPYLLVFEYCELGDLKSYLSQEQWHRRNSQLLLLQRM--ACEIAAGVTHMHKH-- 118
Query: 729 PHIVHRDIKSSNILLDDQFEAHLADFGLSRLILPY---QTHVTTE--LVGTLGYIPPE-- 781
+ +H D+ N L + D+G I P + ++ TE L ++ PE
Sbjct: 119 -NFLHSDLALRNCFLTSDLTVKVGDYG----IGPSRYKEDYIETEDDKCVPLRWLAPELV 173
Query: 782 ---YGQAWVA--TLRGDMYSFGVVMLELL-TGKRPVDVLKPKMSRELVGWVLKMRSEGKQ 835
+G A T ++++ GV + EL +P L RE++ V+K +Q
Sbjct: 174 GEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLS---DREVLNHVIK----DQQ 226
Query: 836 DQVFDPILRGKGFDEEMLQVLDVACMCVSQNPFKRPTVKEV 876
++F P L + E +VL + +P KR T +EV
Sbjct: 227 VKLFKPQLE-LPYSERWYEVLQFCWL----SPEKRATAEEV 262
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage spermatogenesis. Although it is classified as a tyr kinase based on sequence similarity and the phylogenetic tree, Aatyk2 has been characterized as a serine/threonine kinase. Length = 268 |
| >gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Score = 59.2 bits (143), Expect = 2e-09
Identities = 52/208 (25%), Positives = 94/208 (45%), Gaps = 14/208 (6%)
Query: 615 IGCGGFGLVYKATL---ANGTTLAIKKL-SGDLGLMEREFKAEVEALSTAQHKNLVSLQG 670
+G G FG V K +AIK L + + + E E E + + +V + G
Sbjct: 3 LGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMIG 62
Query: 671 YCVHQGFRLLIYSYMENGSLDYWLHEKADGASQLDWLTRLKIARGTSCGLAYMHQICEPH 730
C + +L+ G L+ +L K D ++ +++ S G+ Y+ +
Sbjct: 63 VCEAEAL-MLVMEMASGGPLNKFLSGKKD---EITVSNVVELMHQVSMGMKYLE---GKN 115
Query: 731 IVHRDIKSSNILLDDQFEAHLADFGLSRLILPYQTHVTTELVGT--LGYIPPEYGQAWVA 788
VHRD+ + N+LL +Q A ++DFGLS+ + ++ G L + PE
Sbjct: 116 FVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKARSAGKWPLKWYAPECINFRKF 175
Query: 789 TLRGDMYSFGVVMLELLT-GKRPVDVLK 815
+ R D++S+G+ M E + G++P +K
Sbjct: 176 SSRSDVWSYGITMWEAFSYGQKPYKKMK 203
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257 |
| >gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Score = 60.1 bits (146), Expect = 2e-09
Identities = 65/218 (29%), Positives = 99/218 (45%), Gaps = 47/218 (21%)
Query: 615 IGCGGFGLVYKAT-LANGTTLAIKKLSG---DLGLMEREFKAEVEALSTAQHKNLVS--- 667
IG G FG+V+ T +G +A+KK+ +L +R F+ E++ L +H N++S
Sbjct: 8 IGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCKRVFR-ELKMLCFFKHDNVLSALD 66
Query: 668 -LQGYCVHQGFRLLIYSYMENGSLDYWLHE--------KADGASQLDWLTRLKIARGTSC 718
LQ H IY E D LH+ +D + +I RG
Sbjct: 67 ILQP--PHIDPFEEIYVVTELMQSD--LHKIIVSPQPLSSDHVK----VFLYQILRG--- 115
Query: 719 GLAYMHQICEPHIVHRDIKSSNILLDDQFEAHLADFGLSRLILPYQT-HVTTELVGTLGY 777
L Y+H I+HRDIK N+L++ + DFGL+R+ P ++ H+T E+V T Y
Sbjct: 116 -LKYLHS---AGILHRDIKPGNLLVNSNCVLKICDFGLARVEEPDESKHMTQEVV-TQYY 170
Query: 778 IPPE-------YGQAWVATLRGDMYSFGVVMLELLTGK 808
PE Y A D++S G + ELL +
Sbjct: 171 RAPEILMGSRHYTSAV------DIWSVGCIFAELLGRR 202
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372 |
| >gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 59.7 bits (144), Expect = 2e-09
Identities = 77/314 (24%), Positives = 132/314 (42%), Gaps = 55/314 (17%)
Query: 607 DNFSQANIIGCGGFGLVYKATL--------ANGTTLAIKKLSGDLGLME-REFKAEVEAL 657
D + +G G FG V A T+A+K L D + + +E+E +
Sbjct: 15 DKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMM 74
Query: 658 ST-AQHKNLVSLQGYCVHQGFRLLIYSYMENGSLDYWLHEKADGASQLDW-LTRL----- 710
+HKN+++L G C G +I Y G+L +L + + + + R+
Sbjct: 75 KMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQM 134
Query: 711 ----------KIARGTSCGLAYMHQICEPHIVHRDIKSSNILLDDQFEAHLADFGLSRLI 760
++ARG M + +HRD+ + N+L+ + +ADFGL+R +
Sbjct: 135 TFKDLVSCTYQVARG-------MEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARDV 187
Query: 761 --LPYQTHVTTELVGTLGYIPPEYGQAWVATLRGDMYSFGVVMLELLT-GKRPVDVLKPK 817
+ Y T + + ++ PE V T + D++SFGV+M E+ T G P P
Sbjct: 188 NNIDYYKKTTNGRL-PVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPY----PG 242
Query: 818 MSRELVGWVLKMRSEG-KQDQVFDPILRGKGFDEEMLQVLDVACMCVSQNPFKRPTVKEV 876
+ E + K+ EG + D+ +E + + D C P RPT K++
Sbjct: 243 IPVE---ELFKLLKEGHRMDK------PANCTNELYMMMRD----CWHAIPSHRPTFKQL 289
Query: 877 VEWLNNVGANRRNE 890
VE L+ + NE
Sbjct: 290 VEDLDRILTLTTNE 303
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304 |
| >gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 59.6 bits (144), Expect = 2e-09
Identities = 61/208 (29%), Positives = 101/208 (48%), Gaps = 28/208 (13%)
Query: 615 IGCGGFGLVYKA-TLANGTTLAIKKLSGDLGLMEREFKA------EVEALSTAQHKNLVS 667
+G G + VYK + +A+K++ +E E A EV L +H N+V+
Sbjct: 14 LGEGTYATVYKGRSKLTDNLVALKEIR-----LEHEEGAPCTAIREVSLLKDLKHANIVT 68
Query: 668 LQGYCVHQGFRLLIYSYMENGSLDYWLHEKADGASQLDWLTRLKIARGTSC-GLAYMHQI 726
L + L++ Y LD L + D + +K+ GL Y H+
Sbjct: 69 LHDIIHTEKSLTLVFEY-----LDKDLKQYLDDCGNSINMHNVKLFLFQLLRGLNYCHR- 122
Query: 727 CEPHIVHRDIKSSNILLDDQFEAHLADFGLSRL-ILPYQTHVTTELVGTLGYIPPE--YG 783
++HRD+K N+L++++ E LADFGL+R +P +T+ + E+V TL Y PP+ G
Sbjct: 123 --RKVLHRDLKPQNLLINERGELKLADFGLARAKSIPTKTY-SNEVV-TLWYRPPDILLG 178
Query: 784 QAWVATLRGDMYSFGVVMLELLTGKRPV 811
+T + DM+ G + E+ TG RP+
Sbjct: 179 STDYST-QIDMWGVGCIFYEMSTG-RPL 204
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301 |
| >gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Score = 59.5 bits (144), Expect = 2e-09
Identities = 73/242 (30%), Positives = 110/242 (45%), Gaps = 42/242 (17%)
Query: 614 IIGCGGFGLVYKATLANGT--TLAIKKLSGDLGLMEREF-----KAEVEALSTAQHKNLV 666
++G G FG V A L GT AIK L D+ L + + + + AL+ A+H L
Sbjct: 2 VLGKGSFGKVMLAEL-KGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALA-AKHPFLT 59
Query: 667 SLQGYCVHQGFRLLIY--SYMENGSLDYWLHEKADGASQLDWLTRLKIARGTSCGLAYMH 724
+L +C Q L + Y+ G L + + + + D A + L ++H
Sbjct: 60 AL--HCCFQTKDRLFFVMEYVNGGDLMFQIQR----SRKFDEPRSRFYAAEVTLALMFLH 113
Query: 725 QICEPH-IVHRDIKSSNILLDDQFEAHLADFGLSRL-ILPYQTHVTTELVGTLGYIPPEY 782
+ H +++RD+K NILLD + LADFG+ + IL T TT GT YI PE
Sbjct: 114 R----HGVIYRDLKLDNILLDAEGHCKLADFGMCKEGILNGVT--TTTFCGTPDYIAPEI 167
Query: 783 GQAWVATLRGDMYSFGVVMLELLTGKRPV---------------DVLKPK-MSRELVGWV 826
Q D ++ GV+M E++ G+ P DVL P +S+E V +
Sbjct: 168 LQELEYGPSVDWWALGVLMYEMMAGQPPFEADNEDDLFESILHDDVLYPVWLSKEAVS-I 226
Query: 827 LK 828
LK
Sbjct: 227 LK 228
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321 |
| >gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Score = 58.7 bits (142), Expect = 2e-09
Identities = 69/289 (23%), Positives = 122/289 (42%), Gaps = 60/289 (20%)
Query: 615 IGCGGFGLVYKATLANG--TTLAIKKLS---GDLGLMEREFKAEVEALSTA--------Q 661
+G G FG VYK N LA+K+++ G +RE + + + +
Sbjct: 8 LGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLR 67
Query: 662 HKNLVSLQGYCVHQGFRLLIYSYMENGSLDYWLHEKADGASQLDWLTRLKIARGT----- 716
H N+V ++ F +EN L Y + + +GA + LK +
Sbjct: 68 HPNIVRY-----YKTF-------LENDRL-YIVMDLIEGAPLGEHFNSLKEKKQRFTEER 114
Query: 717 --------SCGLAYMHQICEPHIVHRDIKSSNILLDDQFEAHLADFGLSRLILPYQTHVT 768
L Y+H+ E IVHRD+ +NI+L + + + DFGL++ P
Sbjct: 115 IWNIFVQMVLALRYLHK--EKRIVHRDLTPNNIMLGEDDKVTITDFGLAKQKQPESK--L 170
Query: 769 TELVGTLGYIPPEYGQAWVATLRGDMYSFGVVMLELLTGKRPVDVLKPKM-SRELVGWVL 827
T +VGT+ Y PE + + D+++FG ++ ++ T L+P S ++
Sbjct: 171 TSVVGTILYSCPEIVKNEPYGEKADVWAFGCILYQMCT-------LQPPFYSTNMLSLAT 223
Query: 828 KMRSEGKQDQVFDPILRGKGFDEEMLQVLDVACMCVSQNPFKRPTVKEV 876
K+ + V++P L + E V DV C++ + RP + +V
Sbjct: 224 KI-----VEAVYEP-LPEGMYSE---DVTDVITSCLTPDAEARPDIIQV 263
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269 |
| >gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Score = 58.5 bits (141), Expect = 3e-09
Identities = 55/220 (25%), Positives = 100/220 (45%), Gaps = 24/220 (10%)
Query: 615 IGCGGFGLVYKATL-ANGTTLAIKKLSGDLGL-MEREFKAEVEALSTAQHKNLVSLQGYC 672
IG G FG V+ L A+ T +A+K L ++ +F E L H N+V L G C
Sbjct: 3 IGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVC 62
Query: 673 VHQGFRLLIYSYMENGSLDYWLHEKADGASQLDWLTRLKIARGTSCGLAYMHQICEPHIV 732
+ ++ ++ G D+ + +G +L +++ + G+ Y+ H +
Sbjct: 63 TQKQPIYIVMELVQGG--DFLTFLRTEGP-RLKVKELIQMVENAAAGMEYLES---KHCI 116
Query: 733 HRDIKSSNILLDDQFEAHLADFGLSRLILPYQTHVTTELVGTLGYIP-----PE---YGQ 784
HRD+ + N L+ ++ ++DFG+SR + G + IP PE YG+
Sbjct: 117 HRDLAARNCLVTEKNVLKISDFGMSR----EEEDGVYASTGGMKQIPVKWTAPEALNYGR 172
Query: 785 AWVATLRGDMYSFGVVMLELLT-GKRPVDVLKPKMSRELV 823
+ D++SFG+++ E + G P L + +RE +
Sbjct: 173 ---YSSESDVWSFGILLWEAFSLGAVPYANLSNQQTREAI 209
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252 |
| >gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 59.0 bits (143), Expect = 3e-09
Identities = 64/216 (29%), Positives = 102/216 (47%), Gaps = 38/216 (17%)
Query: 614 IIGCGGFGLVYKATLANGT----TLAIKKLSGDLGLMERE----FKAEVEALSTAQHKNL 665
++G GG+G V++ G A+K L + ++ KAE L +H +
Sbjct: 3 VLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFI 62
Query: 666 VSLQGYCVHQGFRL-LIYSYMENGSLDYWLHEKADGASQLD----WLTRLKIARGTSCGL 720
V L Y G +L LI Y+ G L ++H + +G D +L+ + +A L
Sbjct: 63 VDLI-YAFQTGGKLYLILEYLSGGEL--FMHLEREGIFMEDTACFYLSEISLA------L 113
Query: 721 AYMHQICEPHIVHRDIKSSNILLDDQFEAHLADFGLSRLILPYQTHVTTELVGTLGYIPP 780
++HQ I++RD+K NILLD Q L DFGL + + ++ VT GT+ Y+ P
Sbjct: 114 EHLHQQ---GIIYRDLKPENILLDAQGHVKLTDFGLCKESI-HEGTVTHTFCGTIEYMAP 169
Query: 781 E------YGQAWVATLRGDMYSFGVVMLELLTGKRP 810
E +G+A D +S G +M ++LTG P
Sbjct: 170 EILMRSGHGKAV------DWWSLGALMYDMLTGAPP 199
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323 |
| >gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Score = 58.8 bits (142), Expect = 4e-09
Identities = 63/208 (30%), Positives = 92/208 (44%), Gaps = 21/208 (10%)
Query: 614 IIGCGGFGLVYKATL-ANGTTLAIKKLSGDLGLMEREFKA---EVEALSTA-QHKNLVSL 668
++G G FG V A L +G A+K L D+ L + + + E LS A H L L
Sbjct: 2 VLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQL 61
Query: 669 QGYCVHQGFRLLIYSYMENGSLDYWLH----EKADGASQLDWLTRLKIARGTSCGLAYMH 724
C RL NG D H + D A R A TS L ++H
Sbjct: 62 Y-CCFQTPDRLFFVMEFVNGG-DLMFHIQKSRRFDEAR-----ARFYAAEITS-ALMFLH 113
Query: 725 QICEPHIVHRDIKSSNILLDDQFEAHLADFGLSRLILPYQTHVTTELVGTLGYIPPEYGQ 784
+ I++RD+K N+LLD + LADFG+ + + + T+ GT YI PE Q
Sbjct: 114 ---DKGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGI-FNGKTTSTFCGTPDYIAPEILQ 169
Query: 785 AWVATLRGDMYSFGVVMLELLTGKRPVD 812
+ D ++ GV++ E+L G P +
Sbjct: 170 EMLYGPSVDWWAMGVLLYEMLCGHAPFE 197
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320 |
| >gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Score = 58.5 bits (141), Expect = 5e-09
Identities = 67/205 (32%), Positives = 93/205 (45%), Gaps = 19/205 (9%)
Query: 614 IIGCGGFGLVYKATLA-NGTTLAIKKLSGDLGLMEREFK---AEVEAL-STAQHKNLVSL 668
+IG G FG V A +G A+K L + L +E K AE L +H LV L
Sbjct: 2 VIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGL 61
Query: 669 QGYCVHQGFRL-LIYSYMENGSLDYWLHEKADGASQLDWLTRLKIARGTSCGLAYMHQIC 727
Y +L + ++ G L + L + S + R A S L Y+H I
Sbjct: 62 H-YSFQTTEKLYFVLDFVNGGELFFHLQRER---SFPEPRARFYAAEIAS-ALGYLHSI- 115
Query: 728 EPHIVHRDIKSSNILLDDQFEAHLADFGLSRLILPYQTHVTTELVGTLGYIPPEY--GQA 785
+IV+RD+K NILLD Q L DFGL + + Q+ TT GT Y+ PE Q
Sbjct: 116 --NIVYRDLKPENILLDSQGHVVLTDFGLCKEGIA-QSDTTTTFCGTPEYLAPEVIRKQP 172
Query: 786 WVATLRGDMYSFGVVMLELLTGKRP 810
+ T+ D + G V+ E+L G P
Sbjct: 173 YDNTV--DWWCLGAVLYEMLYGLPP 195
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325 |
| >gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Score = 57.8 bits (140), Expect = 5e-09
Identities = 41/168 (24%), Positives = 79/168 (47%), Gaps = 24/168 (14%)
Query: 657 LSTAQHKNLVSLQGYCVHQ-GFRLLIYSYMENGSLDYWL----HEKADGASQLDWLTRLK 711
L H+N++ + C+ ++Y YM G+L +L +A+ L +
Sbjct: 62 LYGLSHQNILPILHVCIEDGEPPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVH 121
Query: 712 IARGTSCGLAYMHQICEPHIVHRDIKSSNILLDDQFEAHLADFGLSRLILPYQTHVTTEL 771
+A +CG++Y+H+ ++H+DI + N ++D++ + + D LSR + P H
Sbjct: 122 MAIQIACGMSYLHKR---GVIHKDIAARNCVIDEELQVKITDNALSRDLFPMDYH----- 173
Query: 772 VGTLG--------YIPPEYGQAWVATLRGDMYSFGVVMLELLT-GKRP 810
LG ++ E + D++SFGV++ EL+T G+ P
Sbjct: 174 --CLGDNENRPVKWMALESLVNKEYSSASDVWSFGVLLWELMTLGQTP 219
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280 |
| >gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 59.3 bits (143), Expect = 5e-09
Identities = 50/152 (32%), Positives = 74/152 (48%), Gaps = 23/152 (15%)
Query: 731 IVHRDIKSSNILLDDQFEAHLADFGLSRLILPYQTHVT----TELVGTLGYIPPEYGQAW 786
++HRD+KS+NI L L DFG S+ Y V+ + GT Y+ PE +
Sbjct: 190 MMHRDLKSANIFLMPTGIIKLGDFGFSK---QYSDSVSLDVASSFCGTPYYLAPELWERK 246
Query: 787 VATLRGDMYSFGVVMLELLTGKRPVDVLKPKMSRELVGWVLKMRSEGKQDQVFDPILRGK 846
+ + DM+S GV++ ELLT RP K RE++ VL GK D P+ G
Sbjct: 247 RYSKKADMWSLGVILYELLTLHRP---FKGPSQREIMQQVLY----GKYDPFPCPVSSG- 298
Query: 847 GFDEEMLQVLDVACMCVSQNPFKRPTVKEVVE 878
M +LD +S+NP RPT ++++
Sbjct: 299 -----MKALLDP---LLSKNPALRPTTQQLLH 322
|
Length = 478 |
| >gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Score = 58.1 bits (140), Expect = 6e-09
Identities = 70/281 (24%), Positives = 119/281 (42%), Gaps = 47/281 (16%)
Query: 632 TTLAIKKLSGDLGLME-REFKAEVEALST-AQHKNLVSLQGYCVHQGFRLLIYSYMENGS 689
T +A+K L D + + +E+E + +HKN+++L G C G +I Y G+
Sbjct: 51 TKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGN 110
Query: 690 LDYWLHEKADGASQLDW------LTRLKIARGTSCGLAY-----MHQICEPHIVHRDIKS 738
L +L + + + +L SC AY M + +HRD+ +
Sbjct: 111 LREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSC--AYQVARGMEYLASKKCIHRDLAA 168
Query: 739 SNILLDDQFEAHLADFGLSRLILPYQTHVTTELVGTLGYIP-----PEYGQAWVATLRGD 793
N+L+ + +ADFGL+R I H+ T G +P PE + T + D
Sbjct: 169 RNVLVTEDNVMKIADFGLARDI----HHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSD 224
Query: 794 MYSFGVVMLELLT-GKRPVDVLKPKMSRELVGWVLKMRSEGKQDQVFDPILRGKGFDEEM 852
++SFGV++ E+ T G P P + E ++F + G D+
Sbjct: 225 VWSFGVLLWEIFTLGGSPY----PGVPVE---------------ELFKLLKEGHRMDKPS 265
Query: 853 LQVLDVACM---CVSQNPFKRPTVKEVVEWLNNVGANRRNE 890
++ M C P +RPT K++VE L+ + A N+
Sbjct: 266 NCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILALTSNQ 306
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307 |
| >gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Score = 57.8 bits (140), Expect = 7e-09
Identities = 48/163 (29%), Positives = 81/163 (49%), Gaps = 24/163 (14%)
Query: 723 MHQICEPH-IVHRDIKSSNILLDDQFEAHLADFGLS-RLILPYQTHVTTELVGTLGYIPP 780
+H + E H ++HRD+K SNILLD L DFG+S RL+ + T G Y+ P
Sbjct: 127 LHYLKEKHGVIHRDVKPSNILLDASGNVKLCDFGISGRLV---DSKAKTRSAGCAAYMAP 183
Query: 781 EYGQAWVAT----LRGDMYSFGVVMLELLTGKRPVDVLKPKMSRELVGWVLKMRSEGKQD 836
E +R D++S G+ ++EL TG+ P K E++ +L Q+
Sbjct: 184 ERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYK--NCKTEFEVLTKIL-------QE 234
Query: 837 QVFDPILRG-KGFDEEMLQVLDVACMCVSQNPFKRPTVKEVVE 878
+ P L +GF + +D +C++++ KRP +E+++
Sbjct: 235 EP--PSLPPNEGFSPDFCSFVD---LCLTKDHRKRPKYRELLQ 272
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296 |
| >gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Score = 57.7 bits (139), Expect = 7e-09
Identities = 56/218 (25%), Positives = 99/218 (45%), Gaps = 36/218 (16%)
Query: 620 FGLVYKATLANGT------TLAIKKLSGDL-GLMEREFKAEVEALSTAQHKNLVSLQGYC 672
FG VYK L +AIK L G + EFK E S QH N+V L G
Sbjct: 18 FGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAMMRSRLQHPNIVCLLGVV 77
Query: 673 VHQGFRLLIYSYMENGSLDYWLHEKADGA------------SQLDWLTRLKIARGTSCGL 720
+ +I+SY + L +L ++ + S L+ + I + G+
Sbjct: 78 TKEQPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGM 137
Query: 721 AYMHQICEPHIVHRDIKSSNILLDDQFEAHLADFGLSRLILPYQTHVTTELVGT----LG 776
++ H+VH+D+ + N+L+ D+ ++D GL R + + +L+G +
Sbjct: 138 EFLSS---HHVVHKDLATRNVLVFDKLNVKISDLGLFREVYAADYY---KLMGNSLLPIR 191
Query: 777 YIPPE---YGQAWVATLRGDMYSFGVVMLELLT-GKRP 810
++ PE YG+ ++ D++S+GVV+ E+ + G +P
Sbjct: 192 WMSPEAIMYGK---FSIDSDIWSYGVVLWEVFSYGLQP 226
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283 |
| >gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Score = 57.7 bits (139), Expect = 8e-09
Identities = 69/293 (23%), Positives = 129/293 (44%), Gaps = 52/293 (17%)
Query: 602 LLKATDNFSQANIIGCGGFGLVYKAT-LANGTTL----AIKKLSGDLGLMEREFKAEVE- 655
+LK T+ + ++G G FG V+K + G ++ AIK + G + F+ +
Sbjct: 3 ILKETE-LRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSG--RQTFQEITDH 59
Query: 656 --ALSTAQHKNLVSLQGYCVHQGFRLLIYSYMENGSLDYWLHEKADGASQ---LDWLTRL 710
A+ + H +V L G C +L + GSL + + D L+W +
Sbjct: 60 MLAMGSLDHAYIVRLLGICPGASLQL-VTQLSPLGSLLDHVRQHRDSLDPQRLLNWC--V 116
Query: 711 KIARGTSCGLAYMHQICEPHIVHRDIKSSNILLDDQFEAHLADFGLSRLILP-YQTHVTT 769
+IA+G M+ + E +VHR++ + NILL +ADFG++ L+ P + + +
Sbjct: 117 QIAKG-------MYYLEEHRMVHRNLAARNILLKSDSIVQIADFGVADLLYPDDKKYFYS 169
Query: 770 ELVGTLGYIPPEYGQAWVATLRGDMYSFGVVMLELLT-GKRPVDVLKPKMSRELVGWVLK 828
E + ++ E T + D++S+GV + E+++ G P ++P
Sbjct: 170 EHKTPIKWMALESILFGRYTHQSDVWSYGVTVWEMMSYGAEPYAGMRPH----------- 218
Query: 829 MRSEGKQDQVFDPILRGKGFDEEMLQVLD-----VACMCVSQNPFKRPTVKEV 876
+V D + +G+ + + +D V C + +N RPT KE+
Sbjct: 219 --------EVPDLLEKGERLAQPQICTIDVYMVMVKCWMIDEN--VRPTFKEL 261
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279 |
| >gnl|CDD|133195 cd05064, PTKc_EphR_A10, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Score = 57.2 bits (138), Expect = 8e-09
Identities = 58/222 (26%), Positives = 96/222 (43%), Gaps = 34/222 (15%)
Query: 614 IIGCGGFGLVYKATLA----NGTTLAIKKL-SGDLGLMEREFKAEVEALSTAQHKNLVSL 668
I+G G FG + + L +AI L +G R F AE L H N+V L
Sbjct: 12 ILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFDHSNIVRL 71
Query: 669 QGYCVHQGFRLLIYSYMENGSLDYWL--HEKADGASQLDWLTRLKIARGTSCGLAYMHQI 726
+G +++ YM NG+LD +L HE A QL + + G + G+ Y+
Sbjct: 72 EGVITRGNTMMIVTEYMSNGALDSFLRKHEGQLVAGQL-----MGMLPGLASGMKYL--- 123
Query: 727 CEPHIVHRDIKSSNILLDDQFEAHLADFGLSRLILPYQTHVTTELVGTLG------YIPP 780
E VH+ + + +L++ ++ F Q + + T+ + P
Sbjct: 124 SEMGYVHKGLAAHKVLVNSDLVCKISGFR------RLQEDKSEAIYTTMSGKSPVLWAAP 177
Query: 781 EYGQAWVATLRGDMYSFGVVMLELLT-GKRPV------DVLK 815
E Q + D++SFG+VM E+++ G+RP DV+K
Sbjct: 178 EAIQYHHFSSASDVWSFGIVMWEVMSYGERPYWDMSGQDVIK 219
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). EphA10, which contains an inactive tyr kinase domain, may function to attenuate signals of co-clustered active receptors. EphA10 is mainly expressed in the testis. Ephrin/EphR interaction results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Score = 57.3 bits (138), Expect = 9e-09
Identities = 74/276 (26%), Positives = 121/276 (43%), Gaps = 38/276 (13%)
Query: 607 DNFSQANIIGCGGFGLVYKATL-ANGTTLAIKKLSGDLGLMERE--FKAEVEALSTAQHK 663
DNF + IG G G+V AT+ ++G +A+KK+ DL +R EV + QH+
Sbjct: 23 DNFIK---IGEGSTGIVCIATVKSSGKLVAVKKM--DLRKQQRRELLFNEVVIMRDYQHE 77
Query: 664 NLVSLQGYCVHQGFRLLIYSYMENGSL-DYWLHEKADGASQLDWLTRLKIARGTSCGLAY 722
N+V + + ++ ++E G+L D H TR+ + + LA
Sbjct: 78 NVVEMYNSYLVGDELWVVMEFLEGGALTDIVTH------------TRMNEEQIAAVCLAV 125
Query: 723 MHQICEPH---IVHRDIKSSNILLDDQFEAHLADFGLSRLILPYQTHVTTELVGTLGYIP 779
+ + H ++HRDIKS +ILL L+DFG + + LVGT ++
Sbjct: 126 LKALSVLHAQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQV-SKEVPRRKSLVGTPYWMA 184
Query: 780 PEYGQAWVATLRGDMYSFGVVMLELLTGKRPVDVLKP----KMSRELVGWVLKMRSEGKQ 835
PE D++S G++++E++ G+ P P KM R+ + + K
Sbjct: 185 PELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRD------NLPPKLKN 238
Query: 836 DQVFDPILRGKGFDEEMLQVLDVACMCVSQNPFKRP 871
P L KGF + +L V D A + K P
Sbjct: 239 LHKVSPSL--KGFLDRLL-VRDPAQRATAAELLKHP 271
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292 |
| >gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Score = 57.3 bits (138), Expect = 9e-09
Identities = 56/214 (26%), Positives = 93/214 (43%), Gaps = 25/214 (11%)
Query: 615 IGCGGFGLVYKATLANGTTLAIKKLSGDLGLMERE-FKAEVEALSTAQHKNLVSLQGYCV 673
+G G FG VYKA LA K+ E E + E++ L++ H N+V L
Sbjct: 13 LGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFY 72
Query: 674 HQGFRLLIYSYMENGSLDYWLHE--KADGASQLDWLTRLKIARGTSCGLAYMHQICEPHI 731
++ ++ + G++D + E + Q+ + + T L Y+H E I
Sbjct: 73 YENNLWILIEFCAGGAVDAVMLELERPLTEPQIR-----VVCKQTLEALNYLH---ENKI 124
Query: 732 VHRDIKSSNILLDDQFEAHLADFGLS----RLILPYQTHVTTELVGTLGYIPPEYGQAWV 787
+HRD+K+ NIL + LADFG+S R I +GT ++ PE
Sbjct: 125 IHRDLKAGNILFTLDGDIKLADFGVSAKNTRTI-----QRRDSFIGTPYWMAPEVVMCET 179
Query: 788 ATLR-----GDMYSFGVVMLELLTGKRPVDVLKP 816
+ R D++S G+ ++E+ + P L P
Sbjct: 180 SKDRPYDYKADVWSLGITLIEMAQIEPPHHELNP 213
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282 |
| >gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Score = 57.5 bits (139), Expect = 9e-09
Identities = 64/233 (27%), Positives = 104/233 (44%), Gaps = 47/233 (20%)
Query: 607 DNFSQANIIGCGGFGLVY----KATLANGTTLAIKKLSGDLGLMEREFK---AEVEALST 659
++F +I G +G VY K T A+KK++ ++ + + E + L+
Sbjct: 1 EDFETIKLISNGAYGAVYLVRHKETR---QRFAMKKINKQNLILRNQIQQVFVERDILTF 57
Query: 660 AQHKNLVSLQGYCVHQGFRLL--IYSYMENGSLDYWLHEKADGASQLDWLTRLKIARGTS 717
A++ +VS+ +C + R L + Y+E G L K GA +D + R+ A T
Sbjct: 58 AENPFVVSM--FCSFETKRHLCMVMEYVEGGDCATLL--KNIGALPVD-MARMYFAE-TV 111
Query: 718 CGLAYMHQICEPHIVHRDIKSSNILLDDQFEAHLADFGLSRLILP------YQTHVTTE- 770
L Y+H IVHRD+K N+L+ L DFGLS++ L Y+ H+ +
Sbjct: 112 LALEYLHNY---GIVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLTTNLYEGHIEKDT 168
Query: 771 -------LVGTLGYIPPE------YGQAWVATLRGDMYSFGVVMLELLTGKRP 810
+ GT YI PE YG+ D ++ G+++ E L G P
Sbjct: 169 REFLDKQVCGTPEYIAPEVILRQGYGKPV------DWWAMGIILYEFLVGCVP 215
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305 |
| >gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 57.7 bits (139), Expect = 9e-09
Identities = 55/164 (33%), Positives = 88/164 (53%), Gaps = 18/164 (10%)
Query: 653 EVEALSTAQHKNLVSLQGYCVHQGFRL-LIYSYMENGSLDYWLHEKADGASQLDWLTRLK 711
EV L +H N+V+L VH L L++ Y LD L + D + + +K
Sbjct: 54 EVSLLKDLKHANIVTLHD-IVHTDKSLTLVFEY-----LDKDLKQYMDDCGNIMSMHNVK 107
Query: 712 IARGTSC-GLAYMHQICEPHIVHRDIKSSNILLDDQFEAHLADFGLSRL-ILPYQTHVTT 769
I GLAY H+ ++HRD+K N+L++++ E LADFGL+R +P +T+ +
Sbjct: 108 IFLYQILRGLAYCHR---RKVLHRDLKPQNLLINERGELKLADFGLARAKSVPTKTY-SN 163
Query: 770 ELVGTLGYIPPE--YGQAWVATLRGDMYSFGVVMLELLTGKRPV 811
E+V TL Y PP+ G + +T + DM+ G + E+ +G RP+
Sbjct: 164 EVV-TLWYRPPDVLLGSSEYST-QIDMWGVGCIFFEMASG-RPL 204
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309 |
| >gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 57.8 bits (140), Expect = 9e-09
Identities = 57/213 (26%), Positives = 92/213 (43%), Gaps = 37/213 (17%)
Query: 615 IGCGGFGLVYKATLAN-GTTLAIKKLSGDL--GLME-REFKAEVEALSTAQHKNLVSLQG 670
+G GG+G V+ A + G +A+K++ L L E R E + L+T + + LV L
Sbjct: 9 VGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKL-- 66
Query: 671 YCVHQGFRLLIYSYMENGSLDYWLHEKADGASQLDWLTRLKIARGTS---------CGLA 721
+Y++ ++ L Y E G L L + +
Sbjct: 67 ----------LYAFQDDEYL-YLAMEYVPGGDFRTLLNNLGVLSEDHARFYMAEMFEAVD 115
Query: 722 YMHQICEPHIVHRDIKSSNILLDDQFEAHLADFGLSRLILPYQTHVTTELVGTLGYIPPE 781
+H++ +HRD+K N L+D L DFGLS+ I+ Y V VG+ Y+ PE
Sbjct: 116 ALHEL---GYIHRDLKPENFLIDASGHIKLTDFGLSKGIVTYANSV----VGSPDYMAPE 168
Query: 782 --YGQAWVATLRGDMYSFGVVMLELLTGKRPVD 812
G+ + T+ D +S G ++ E L G P
Sbjct: 169 VLRGKGYDFTV--DYWSLGCMLYEFLCGFPPFS 199
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333 |
| >gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Score = 57.1 bits (138), Expect = 1e-08
Identities = 69/230 (30%), Positives = 107/230 (46%), Gaps = 63/230 (27%)
Query: 607 DNFSQANIIGCGGFGLVYKAT-LANGTTLAIKKLSGDLGLMERE---FKAEVEALSTAQH 662
DNF + IG G G+V AT + G +A+KK+ DL +R F EV + QH
Sbjct: 22 DNFVK---IGEGSTGIVCIATDKSTGRQVAVKKM--DLRKQQRRELLFN-EVVIMRDYQH 75
Query: 663 KNLVSLQG-YCVHQGFRL-LIYSYMENGSLDYWLHEKADGASQLDWLTRL---KIARGTS 717
N+V + Y V G L ++ ++E G+L D + TR+ +IA T
Sbjct: 76 PNIVEMYSSYLV--GDELWVVMEFLEGGAL-------TDIVTH----TRMNEEQIA--TV 120
Query: 718 C-----GLAYMHQICEPHIVHRDIKSSNILLDDQFEAHLADFGLSRLILPYQTHVTTE-- 770
C L+++H ++HRDIKS +ILL L+DFG + V+ E
Sbjct: 121 CLAVLKALSFLHA---QGVIHRDIKSDSILLTSDGRVKLSDFG-------FCAQVSKEVP 170
Query: 771 ----LVGTLGYIPPE------YGQAWVATLRGDMYSFGVVMLELLTGKRP 810
LVGT ++ PE YG D++S G++++E++ G+ P
Sbjct: 171 RRKSLVGTPYWMAPEVISRLPYGT------EVDIWSLGIMVIEMVDGEPP 214
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285 |
| >gnl|CDD|223069 PHA03390, pk1, serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Score = 56.4 bits (137), Expect = 1e-08
Identities = 56/200 (28%), Positives = 83/200 (41%), Gaps = 47/200 (23%)
Query: 662 HKNLVSLQGYCVHQ-GFRLLIYSYMENGSL-DYWLHEKADGASQLDWLTRLKIARGTSCG 719
+ N + L Y V +LI Y+++G L D E L KI R
Sbjct: 68 NPNFIKLY-YSVTTLKGHVLIMDYIKDGDLFDLLKKEGK-----LSEAEVKKIIRQLVEA 121
Query: 720 LAYMHQICEPHIVHRDIKSSNILLD---DQFEAHLADFGLSRLILPYQTHVTTELVGTLG 776
L +H+ +I+H DIK N+L D D+ +L D+GL ++I + GTL
Sbjct: 122 LNDLHKH---NIIHNDIKLENVLYDRAKDR--IYLCDYGLCKII-----GTPSCYDGTLD 171
Query: 777 YIPPEYGQAWVATLRGDMY--SF-----GVVMLELLTGKRP----------VDVLKPKMS 819
Y PE ++G Y SF GV+ ELLTGK P ++ L +
Sbjct: 172 YFSPE-------KIKGHNYDVSFDWWAVGVLTYELLTGKHPFKEDEDEELDLESLLKRQQ 224
Query: 820 RELVGWVLKMRSEGKQDQVF 839
++L +K S+ D V
Sbjct: 225 KKLP--FIKNVSKNANDFVQ 242
|
Length = 267 |
| >gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Score = 56.6 bits (136), Expect = 2e-08
Identities = 38/106 (35%), Positives = 55/106 (51%), Gaps = 20/106 (18%)
Query: 717 SCGLAYMHQICEPHIVHRDIKSSNILLDDQFEAHLADFGLSRLIL-PYQTHVTTELVGTL 775
S L Y+H E I++RD+K N+LLD + L D+G+ + L P T T+ GT
Sbjct: 106 SLALNYLH---ERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDT--TSTFCGTP 160
Query: 776 GYIPPEYGQAWVATLRGDMYSF-------GVVMLELLTGKRPVDVL 814
YI PE LRG+ Y F GV+M E++ G+ P D++
Sbjct: 161 NYIAPE-------ILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIV 199
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329 |
| >gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Score = 56.4 bits (136), Expect = 2e-08
Identities = 37/106 (34%), Positives = 55/106 (51%), Gaps = 20/106 (18%)
Query: 717 SCGLAYMHQICEPHIVHRDIKSSNILLDDQFEAHLADFGLSRL-ILPYQTHVTTELVGTL 775
S L ++H E I++RD+K N+LLD + L D+G+ + I P T T+ GT
Sbjct: 106 SLALNFLH---ERGIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRPGDT--TSTFCGTP 160
Query: 776 GYIPPEYGQAWVATLRGDMYSF-------GVVMLELLTGKRPVDVL 814
YI PE LRG+ Y F GV+M E++ G+ P D++
Sbjct: 161 NYIAPE-------ILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIV 199
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329 |
| >gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Score = 55.8 bits (134), Expect = 2e-08
Identities = 66/241 (27%), Positives = 111/241 (46%), Gaps = 38/241 (15%)
Query: 602 LLKATDNFSQANIIGCGGFGLVYKATLA-NGTTL----AIKKLSGDLG-LMEREFKAEVE 655
+LK T+ + ++G G FG VYK +G + AIK L + +E E
Sbjct: 3 ILKETE-LKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAY 61
Query: 656 ALSTAQHKNLVSLQGYCVHQGFRLLIYSYMENGSL-DYWLHEKADGASQ--LDWLTRLKI 712
++ + L G C+ +L + M G L DY K SQ L+W ++I
Sbjct: 62 VMAGVGSPYVCRLLGICLTSTVQL-VTQLMPYGCLLDYVRENKDRIGSQDLLNWC--VQI 118
Query: 713 ARGTSCGLAYMHQICEPHIVHRDIKSSNILLDDQFEAHLADFGLSRLILPYQTHVTTELV 772
A+G S Y+ ++ +VHRD+ + N+L+ + DFGL+RL+ + TE
Sbjct: 119 AKGMS----YLEEV---RLVHRDLAARNVLVKSPNHVKITDFGLARLLDIDE----TEYH 167
Query: 773 GTLGYIPPEYGQAWVA---------TLRGDMYSFGVVMLELLT-GKRPVDVLKPKMSREL 822
G +P + W+A T + D++S+GV + EL+T G +P D + + +L
Sbjct: 168 ADGGKVPIK----WMALESILHRRFTHQSDVWSYGVTVWELMTFGAKPYDGIPAREIPDL 223
Query: 823 V 823
+
Sbjct: 224 L 224
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279 |
| >gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Score = 56.3 bits (136), Expect = 3e-08
Identities = 66/206 (32%), Positives = 94/206 (45%), Gaps = 21/206 (10%)
Query: 614 IIGCGGFGLVYKAT-LANGTTLAIKKLSGDLGLMEREFK---AEVEAL-STAQHKNLVSL 668
+IG G FG V A A+G A+K L L ++E K AE L +H LV L
Sbjct: 2 VIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGL 61
Query: 669 QGYCVHQGFRL-LIYSYMENGSLDYWLHEKADGASQLDWLTRLKIARGTSCGLAYMHQIC 727
Y +L + Y+ G L + L + S + R A + L Y+H +
Sbjct: 62 H-YSFQTADKLYFVLDYVNGGELFFHLQRER---SFPEPRARFYAAE-IASALGYLHSL- 115
Query: 728 EPHIVHRDIKSSNILLDDQFEAHLADFGLSRL-ILPYQTHVTTELVGTLGYIPPE--YGQ 784
+I++RD+K NILLD Q L DFGL + I +T T+ GT Y+ PE Q
Sbjct: 116 --NIIYRDLKPENILLDSQGHVVLTDFGLCKEGIEHSKT--TSTFCGTPEYLAPEVLRKQ 171
Query: 785 AWVATLRGDMYSFGVVMLELLTGKRP 810
+ T+ D + G V+ E+L G P
Sbjct: 172 PYDRTV--DWWCLGAVLYEMLYGLPP 195
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323 |
| >gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Score = 55.8 bits (134), Expect = 3e-08
Identities = 59/213 (27%), Positives = 90/213 (42%), Gaps = 26/213 (12%)
Query: 607 DNFSQANIIGCGGFGLVYKATLANGTTL-AIKKLSGDLGLMEREFKA----EVEALSTAQ 661
+ F ++G G +G+V K + AIKK E K E++ L T +
Sbjct: 1 NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEE--NEEVKETTLRELKMLRTLK 58
Query: 662 HKNLVSLQGYCVHQGFRLLIYSYMENGSLDYWLHEKADGASQLDWLTRLKIARGTSCGLA 721
+N+V L+ +G L++ Y+E L+ L E +G K+ +
Sbjct: 59 QENIVELKEAFRRRGKLYLVFEYVEKNMLEL-LEEMPNGVPPE------KVRSYIYQLIK 111
Query: 722 YMHQICEPHIVHRDIKSSNILLDDQFEAHLADFGLSRLILPYQTHVTTELVGTLGYIPPE 781
+H + IVHRDIK N+L+ L DFG +R + TE V T Y PE
Sbjct: 112 AIHWCHKNDIVHRDIKPENLLISHNDVLKLCDFGFARNLSEGSNANYTEYVATRWYRSPE 171
Query: 782 ------YGQAWVATLRGDMYSFGVVMLELLTGK 808
YG+A DM+S G ++ EL G+
Sbjct: 172 LLLGAPYGKAV------DMWSVGCILGELSDGQ 198
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287 |
| >gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 56.2 bits (135), Expect = 3e-08
Identities = 73/295 (24%), Positives = 128/295 (43%), Gaps = 47/295 (15%)
Query: 615 IGCGGFGLVYKATL--------ANGTTLAIKKLSGDLGLME-REFKAEVEALST-AQHKN 664
+G G FG V A T+A+K L D + + +E+E + +HKN
Sbjct: 20 LGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKN 79
Query: 665 LVSLQGYCVHQGFRLLIYSYMENGSLDYWLHEKADGA------------SQLDWLTRLKI 712
+++L G C G ++ Y G+L +L + QL + +
Sbjct: 80 IINLLGACTQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSC 139
Query: 713 ARGTSCGLAYM-HQICEPHIVHRDIKSSNILLDDQFEAHLADFGLSRLI--LPYQTHVTT 769
A + G+ Y+ Q C +HRD+ + N+L+ + +ADFGL+R + + Y T
Sbjct: 140 AYQVARGMEYLASQKC----IHRDLAARNVLVTEDNVMKIADFGLARDVHNIDYYKKTTN 195
Query: 770 ELVGTLGYIPPEYGQAWVATLRGDMYSFGVVMLELLT-GKRPVDVLKPKMSRELVGWVLK 828
+ + ++ PE V T + D++SFGV++ E+ T G P P + E + K
Sbjct: 196 GRL-PVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPY----PGIPVE---ELFK 247
Query: 829 MRSEGKQDQVFDPILRGKGFDEEMLQVLDVACMCVSQNPFKRPTVKEVVEWLNNV 883
+ EG + + + E+ ++ C P +RPT K++VE L+ V
Sbjct: 248 LLKEGHR------MDKPANCTHELYMIMR---ECWHAVPSQRPTFKQLVEDLDRV 293
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334 |
| >gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Score = 55.4 bits (133), Expect = 3e-08
Identities = 52/209 (24%), Positives = 97/209 (46%), Gaps = 16/209 (7%)
Query: 615 IGCGGFGLVYKA---TLANGTTLAIKKLSGDLG--LMEREFKAEVEALSTAQHKNLVSLQ 669
+G G FG V K + T+A+K L D ++ E E + + +V +
Sbjct: 3 LGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMI 62
Query: 670 GYCVHQGFRLLIYSYMENGSLDYWLHEKADGASQLDWLTRLKIARGTSCGLAYMHQICEP 729
G C + + +L+ E G L+ +L + + ++ S G+ Y+ E
Sbjct: 63 GICEAESW-MLVMELAELGPLNKFLQKNKHVTEK----NITELVHQVSMGMKYLE---ET 114
Query: 730 HIVHRDIKSSNILLDDQFEAHLADFGLSRLILPYQTHVTTELVGT--LGYIPPEYGQAWV 787
+ VHRD+ + N+LL Q A ++DFGLS+ + + + + G + + PE +
Sbjct: 115 NFVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYKAKTHGKWPVKWYAPECMNYYK 174
Query: 788 ATLRGDMYSFGVVMLELLT-GKRPVDVLK 815
+ + D++SFGV+M E + G++P +K
Sbjct: 175 FSSKSDVWSFGVLMWEAFSYGQKPYKGMK 203
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257 |
| >gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Score = 55.8 bits (134), Expect = 3e-08
Identities = 39/117 (33%), Positives = 57/117 (48%), Gaps = 26/117 (22%)
Query: 722 YMHQIC-------EPHIVHRDIKSSNILLDDQFEAHLADFGLSRL-ILPYQTHVTTELVG 773
Y +IC E I++RD+K N+LLD L D+G+ + + P T T+ G
Sbjct: 101 YAAEICIALNFLHERGIIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGPGDT--TSTFCG 158
Query: 774 TLGYIPPEYGQAWVATLRGDMYSF-------GVVMLELLTGKRPVDVL--KPKMSRE 821
T YI PE LRG+ Y F GV+M E++ G+ P D++ P M+ E
Sbjct: 159 TPNYIAPE-------ILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIITDNPDMNTE 208
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327 |
| >gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Score = 55.8 bits (134), Expect = 4e-08
Identities = 65/206 (31%), Positives = 91/206 (44%), Gaps = 21/206 (10%)
Query: 614 IIGCGGFGLVYKAT-LANGTTLAIKKLSGDLGLMEREFKAEVEA----LSTAQHKNLVSL 668
+IG G FG V A A A+K L L ++E K + L +H LV L
Sbjct: 2 VIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGL 61
Query: 669 QGYCVHQGFRL-LIYSYMENGSLDYWLHEKADGASQLDWLTRLKIARGTSCGLAYMHQIC 727
+ +L + Y+ G L Y L + L+ R A S L Y+H +
Sbjct: 62 H-FSFQTADKLYFVLDYINGGELFYHLQRER---CFLEPRARFYAAEIAS-ALGYLHSL- 115
Query: 728 EPHIVHRDIKSSNILLDDQFEAHLADFGLSRL-ILPYQTHVTTELVGTLGYIPPE--YGQ 784
+IV+RD+K NILLD Q L DFGL + I T T+ GT Y+ PE + Q
Sbjct: 116 --NIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNGT--TSTFCGTPEYLAPEVLHKQ 171
Query: 785 AWVATLRGDMYSFGVVMLELLTGKRP 810
+ T+ D + G V+ E+L G P
Sbjct: 172 PYDRTV--DWWCLGAVLYEMLYGLPP 195
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325 |
| >gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 55.7 bits (134), Expect = 5e-08
Identities = 61/228 (26%), Positives = 101/228 (44%), Gaps = 40/228 (17%)
Query: 598 TIYELLKATDNFSQANIIGCGGFGLV-YKATLANGTTLAIKKL----SGDLGLMEREFKA 652
TI+E+ D + +G G +G V G +AIKKL +L +R ++
Sbjct: 9 TIWEV---PDRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSEL-FAKRAYR- 63
Query: 653 EVEALSTAQHKNLVSLQGYCV--------HQGFRLLIYSYMENGSLDYWLHEKADGASQL 704
E+ L +H+N++ L H + L+ +M HEK ++
Sbjct: 64 ELRLLKHMKHENVIGLLDVFTPDLSLDRFHDFY--LVMPFMGTDLGKLMKHEKL-SEDRI 120
Query: 705 DWLTRLKIARGTSCGLAYMHQICEPHIVHRDIKSSNILLDDQFEAHLADFGLSRLILPYQ 764
+L ++ +G L Y+H I+HRD+K N+ +++ E + DFGL+R
Sbjct: 121 QFLV-YQMLKG----LKYIHA---AGIIHRDLKPGNLAVNEDCELKILDFGLAR------ 166
Query: 765 THVTTELVG---TLGYIPPEYGQAWVA-TLRGDMYSFGVVMLELLTGK 808
+E+ G T Y PE W+ T D++S G +M E+LTGK
Sbjct: 167 -QTDSEMTGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGK 213
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343 |
| >gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 54.9 bits (132), Expect = 6e-08
Identities = 36/107 (33%), Positives = 55/107 (51%), Gaps = 5/107 (4%)
Query: 718 CGLAYMHQICEPHIVHRDIKSSNILLDDQFEAHLADFGLSRLILPYQTHVTTELVGTLGY 777
C L +H+ ++++RD+K NILLD Q L DFGL +L + T GT Y
Sbjct: 104 CALENLHKF---NVIYRDLKPENILLDYQGHIALCDFGLCKLNMK-DDDKTNTFCGTPEY 159
Query: 778 IPPEYGQAWVATLRGDMYSFGVVMLELLTGKRPV-DVLKPKMSRELV 823
+ PE T D ++ GV++ E+LTG P D +M R+++
Sbjct: 160 LAPELLLGHGYTKAVDWWTLGVLLYEMLTGLPPFYDENVNEMYRKIL 206
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312 |
| >gnl|CDD|165476 PHA03210, PHA03210, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 55.9 bits (134), Expect = 7e-08
Identities = 44/177 (24%), Positives = 75/177 (42%), Gaps = 49/177 (27%)
Query: 653 EVEALSTAQHKNLVSLQ--------GYCVHQGFRLLIYSYMENGSLDYWLHEKADGASQL 704
E+ AL H+N++ ++ Y + Q + +YS+M + + D+ L
Sbjct: 213 EILALGRLNHENILKIEEILRSEANTYMITQKYDFDLYSFMYDEAFDW-------KDRPL 265
Query: 705 DWLTRLKIARGTSCGLAYMHQICEPHIVHRDIKSSNILLDDQFEAHLADFGLSRLILPYQ 764
TR I + C + Y+H + ++HRDIK NI L+ + L DFG +P++
Sbjct: 266 LKQTR-AIMKQLLCAVEYIH---DKKLIHRDIKLENIFLNCDGKIVLGDFG---TAMPFE 318
Query: 765 THVTTELVGTLGYIPPEYGQAWVAT--------LRGDMY-------SFGVVMLELLT 806
+YG WV T L GD Y S G+++L++L+
Sbjct: 319 KE----------REAFDYG--WVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLS 363
|
Length = 501 |
| >gnl|CDD|206026 pfam13855, LRR_8, Leucine rich repeat | Back alignment and domain information |
|---|
Score = 49.5 bits (119), Expect = 8e-08
Identities = 26/57 (45%), Positives = 34/57 (59%), Gaps = 2/57 (3%)
Query: 390 IYLANNSLSGNIPVEI-GQLKSLHVLDLSNNNFSGTIPDELSDLSNLEKLDLSGNHL 445
+ L+NN L+ IP L +L VLDLS NN + P+ S L +L LDLSGN+L
Sbjct: 5 LDLSNNRLT-VIPDGAFKGLPNLKVLDLSGNNLTSISPEAFSGLPSLRSLDLSGNNL 60
|
Length = 60 |
| >gnl|CDD|133209 cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 54.1 bits (130), Expect = 8e-08
Identities = 47/182 (25%), Positives = 88/182 (48%), Gaps = 24/182 (13%)
Query: 646 MEREFKAEVEALSTAQHKNLVSLQGYCVHQGFRLLIYSYMENGSLDYWLHEKADGASQLD 705
E F+A +S HK+LV G CV +++ Y++ GSLD +L +K +
Sbjct: 43 SESFFEA-ASMMSQLSHKHLVLNYGVCVCGDESIMVQEYVKFGSLDTYL-KKNKNLINIS 100
Query: 706 WLTRLKIARGTSCGLAY-MHQICEPHIVHRDIKSSNILLDDQFEAH--------LADFGL 756
W +L++A+ LA+ +H + + + H ++ + N+LL + + L+D G+
Sbjct: 101 W--KLEVAK----QLAWALHFLEDKGLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGI 154
Query: 757 SRLILPYQTHVTTELVGTLGYIPPE-YGQAWVATLRGDMYSFGVVMLELLTG-KRPVDVL 814
S +LP + L+ + ++PPE +L D +SFG + E+ +G +P+ L
Sbjct: 155 SITVLPKEI-----LLERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLSAL 209
Query: 815 KP 816
Sbjct: 210 DS 211
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 258 |
| >gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Score = 54.6 bits (131), Expect = 8e-08
Identities = 53/212 (25%), Positives = 88/212 (41%), Gaps = 15/212 (7%)
Query: 606 TDNFSQANIIGCGGFGLVYKATL-ANGTTLAIKKLSGDLGLMEREFK---AEVEALSTAQ 661
NF ++G G FG V A AIK L D+ + + + + E L+
Sbjct: 1 DFNFLM--VLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQD 58
Query: 662 HKNLVSLQGYCVHQGFRL-LIYSYMENGSLDYWLHEKADGASQLDWLTRLKIARGTSCGL 720
++ C RL + Y+ G L Y + + + + A S GL
Sbjct: 59 KPPFLTQLHSCFQTVDRLYFVMEYVNGGDLMYHIQQ----VGKFKEPQAVFYAAEISVGL 114
Query: 721 AYMHQICEPHIVHRDIKSSNILLDDQFEAHLADFGLSRLILPYQTHVTTELVGTLGYIPP 780
++H I++RD+K N++LD + +ADFG+ + + T GT YI P
Sbjct: 115 FFLH---RRGIIYRDLKLDNVMLDSEGHIKIADFGMCKEHM-VDGVTTRTFCGTPDYIAP 170
Query: 781 EYGQAWVATLRGDMYSFGVVMLELLTGKRPVD 812
E D +++GV++ E+L G+ P D
Sbjct: 171 EIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFD 202
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323 |
| >gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Score = 54.7 bits (132), Expect = 8e-08
Identities = 62/215 (28%), Positives = 95/215 (44%), Gaps = 31/215 (14%)
Query: 615 IGCGGFGLVYKATLA---NGTTLAIKKLSGDLG---LMEREFKAEVEALSTAQ-HKNLVS 667
+G G +G+V A A T+AIKK++ L +R + E++ L + HKN+
Sbjct: 8 LGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALR-ELKLLRHFRGHKNITC 66
Query: 668 LQGY-CVHQGFRLLIYSYMENGSLDYWLHEKADGASQLDWLTRLKIARGTSCGLAYMHQI 726
L V G +Y Y E ++ LH+ L CGL Y+H
Sbjct: 67 LYDMDIVFPGNFNELYLYEE--LMEADLHQIIRSGQPLTDAHFQSFIYQILCGLKYIHS- 123
Query: 727 CEPHIVHRDIKSSNILLDDQFEAHLADFGLSRLILPYQTHVT---TELVGTLGYIPPE-- 781
+++HRD+K N+L++ E + DFGL+R TE V T Y PE
Sbjct: 124 --ANVLHRDLKPGNLLVNADCELKICDFGLARGFSENPGENAGFMTEYVATRWYRAPEIM 181
Query: 782 -----YGQAWVATLRGDMYSFGVVMLELLTGKRPV 811
Y +A D++S G ++ ELL G++PV
Sbjct: 182 LSFQSYTKAI------DVWSVGCILAELL-GRKPV 209
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332 |
| >gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Score = 54.4 bits (131), Expect = 1e-07
Identities = 61/211 (28%), Positives = 91/211 (43%), Gaps = 32/211 (15%)
Query: 614 IIGCGGFGLVY----KATLANGTTLAIKKLSGDLGLMEREFK---AEVEALSTAQHKNLV 666
++G G FG V KAT G A+K L ++ + + E E L +H L
Sbjct: 2 LLGKGTFGKVILVREKAT---GKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLT 58
Query: 667 SLQGYCVHQGFRL-LIYSYMENGSLDYWLHEKADGASQLDWLTRLKIARGTSCGLAYMHQ 725
+L+ Y RL + Y G L + H + D R A S L Y+H
Sbjct: 59 ALK-YSFQTHDRLCFVMEYANGGEL--FFHLSRERVFSED-RARFYGAEIVS-ALGYLHS 113
Query: 726 ICEPHIVHRDIKSSNILLDDQFEAHLADFGLSRLILPYQTHVTTELVGTLGYIPPE---- 781
C+ +V+RD+K N++LD + DFGL + + + T GT Y+ PE
Sbjct: 114 -CD--VVYRDLKLENLMLDKDGHIKITDFGLCKEGISDGATMKT-FCGTPEYLAPEVLED 169
Query: 782 --YGQAWVATLRGDMYSFGVVMLELLTGKRP 810
YG+A D + GVVM E++ G+ P
Sbjct: 170 NDYGRAV------DWWGLGVVMYEMMCGRLP 194
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323 |
| >gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Score = 54.2 bits (130), Expect = 1e-07
Identities = 61/204 (29%), Positives = 92/204 (45%), Gaps = 17/204 (8%)
Query: 614 IIGCGGFGLVYKATL-ANGTTLAIKKLSGDLGLMEREFK---AEVEAL-STAQHKNLVSL 668
+IG G FG V A ++G+ A+K L L ++E AE L +H LV L
Sbjct: 2 VIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGL 61
Query: 669 QGYCVHQGFRL-LIYSYMENGSLDYWLHEKADGASQLDWLTRLKIARGTSCGLAYMHQIC 727
Y +L + Y+ G L + L + L+ R A + + Y+H +
Sbjct: 62 H-YSFQTAEKLYFVLDYVNGGELFFHLQRER---CFLEPRARFYAAE-VASAIGYLHSL- 115
Query: 728 EPHIVHRDIKSSNILLDDQFEAHLADFGLSRL-ILPYQTHVTTELVGTLGYIPPEYGQAW 786
+I++RD+K NILLD Q L DFGL + + P +T T+ GT Y+ PE +
Sbjct: 116 --NIIYRDLKPENILLDSQGHVVLTDFGLCKEGVEPEET--TSTFCGTPEYLAPEVLRKE 171
Query: 787 VATLRGDMYSFGVVMLELLTGKRP 810
D + G V+ E+L G P
Sbjct: 172 PYDRTVDWWCLGAVLYEMLYGLPP 195
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321 |
| >gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Score = 55.2 bits (133), Expect = 1e-07
Identities = 60/231 (25%), Positives = 95/231 (41%), Gaps = 43/231 (18%)
Query: 614 IIGCGGFGLVYKA-TLANGTTLAIKKLSGDLG---LMEREFKAEVEALSTAQHKNLVSL- 668
+IG GG G VY A +A+KK+ DL L+++ F E + + H +V +
Sbjct: 9 LIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVY 68
Query: 669 ----QGYCVH------QGFRL--LIYSYMENGSLDYWLHEKADGASQLDWLTRLKIARGT 716
G V+ +G+ L L+ S + SL L EK L I
Sbjct: 69 SICSDGDPVYYTMPYIEGYTLKSLLKSVWQKESLSKELAEKTSVG------AFLSIFHKI 122
Query: 717 SCGLAYMHQICEPHIVHRDIKSSNILLDDQFEAHLADFGLS-----------------RL 759
+ Y+H ++HRD+K NILL E + D+G + R
Sbjct: 123 CATIEYVHS---KGVLHRDLKPDNILLGLFGEVVILDWGAAIFKKLEEEDLLDIDVDERN 179
Query: 760 ILPYQTHVTTELVGTLGYIPPEYGQAWVATLRGDMYSFGVVMLELLTGKRP 810
I + ++VGT Y+ PE A+ D+Y+ GV++ ++LT P
Sbjct: 180 ICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFP 230
|
Length = 932 |
| >gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 54.3 bits (131), Expect = 1e-07
Identities = 74/266 (27%), Positives = 99/266 (37%), Gaps = 90/266 (33%)
Query: 607 DNFSQANIIGCGGFG---LVYKATLANGTTLAIKKLSGDLGLMERE----FKAEVEALST 659
D+F +IG G FG LV K G A+KKL ++E+E +AE + L+
Sbjct: 1 DDFESIKVIGRGAFGEVRLVQKKD--TGHIYAMKKLRKS-EMLEKEQVAHVRAERDILAE 57
Query: 660 AQHKNLVSLQGYCVHQG--FRLLIYSYMENGSLDYWLHEKADGASQLDWLT----RLKIA 713
A + +V L Y Q + LI Y+ G + L +K D T R IA
Sbjct: 58 ADNPWVVKL--YYSFQDENYLYLIMEYLPGGDMMTLLMKK-------DTFTEEETRFYIA 108
Query: 714 RGTSCGLAYMHQICEPHIVHRDIKSSNILLDDQFEAHLADFGLS---------------- 757
LA + I + +HRDIK N+LLD + L+DFGL
Sbjct: 109 E---TILA-IDSIHKLGYIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKSHRTEFYRILS 164
Query: 758 ---------------------------RLILPYQTHVTTELVGTLGYIPPE------YGQ 784
R L Y T VGT YI PE Y +
Sbjct: 165 HALPSNFLDFISKPMSSKRKAETWKRNRRALAYST------VGTPDYIAPEVFLQTGYNK 218
Query: 785 AWVATLRGDMYSFGVVMLELLTGKRP 810
D +S GV+M E+L G P
Sbjct: 219 E------CDWWSLGVIMYEMLVGYPP 238
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364 |
| >gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 54.3 bits (130), Expect = 1e-07
Identities = 34/94 (36%), Positives = 49/94 (52%), Gaps = 14/94 (14%)
Query: 719 GLAYMHQICEPHIVHRDIKSSNILLDDQFEAHLADFGLSRLILPYQTHVTTELVG---TL 775
GL Y+H I+HRD+K SN+ +++ E + DFGL+R H E+ G T
Sbjct: 132 GLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLAR-------HTDDEMTGYVATR 181
Query: 776 GYIPPEYGQAWVA-TLRGDMYSFGVVMLELLTGK 808
Y PE W+ D++S G +M ELLTG+
Sbjct: 182 WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 215
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345 |
| >gnl|CDD|206026 pfam13855, LRR_8, Leucine rich repeat | Back alignment and domain information |
|---|
Score = 48.3 bits (116), Expect = 2e-07
Identities = 28/61 (45%), Positives = 35/61 (57%), Gaps = 2/61 (3%)
Query: 410 SLHVLDLSNNNFSGTIPDE-LSDLSNLEKLDLSGNHLVGEIPISLKGLHFLSSFSVAHNN 468
+L LDLSNN + IPD L NL+ LDLSGN+L P + GL L S ++ NN
Sbjct: 1 NLKSLDLSNNRLT-VIPDGAFKGLPNLKVLDLSGNNLTSISPEAFSGLPSLRSLDLSGNN 59
Query: 469 L 469
L
Sbjct: 60 L 60
|
Length = 60 |
| >gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Score = 53.9 bits (129), Expect = 2e-07
Identities = 76/280 (27%), Positives = 124/280 (44%), Gaps = 54/280 (19%)
Query: 615 IGCGGFGLVYKATLA-NGTTLAIKKLSGDLGLMERE--FKAEVEALSTAQHKNLVSL-QG 670
IG G G+V A +G +A+K + DL +R EV + QH+N+V + +
Sbjct: 29 IGEGSTGIVCIAREKHSGRQVAVKMM--DLRKQQRRELLFNEVVIMRDYQHQNVVEMYKS 86
Query: 671 YCVHQGFRLLIYSYMENGSLDYWLHEKADGASQLDWLTRLKIARGTSC-----GLAYMHQ 725
Y V + +L+ +++ G+L D SQ L +IA T C L Y+H
Sbjct: 87 YLVGEELWVLM-EFLQGGAL-------TDIVSQTR-LNEEQIA--TVCESVLQALCYLHS 135
Query: 726 ICEPHIVHRDIKSSNILLDDQFEAHLADFGLSRLI---LPYQTHVTTELVGTLGYIPPEY 782
++HRDIKS +ILL L+DFG I +P + LVGT ++ PE
Sbjct: 136 ---QGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKR----KSLVGTPYWMAPEV 188
Query: 783 GQAWVATLRGDMYSFGVVMLELLTGKRPVDVLKPKMSRELVGWVLKMRSE----GKQDQV 838
D++S G++++E++ G+ P S V + ++R K
Sbjct: 189 ISRTPYGTEVDIWSLGIMVIEMVDGE------PPYFSDSPVQAMKRLRDSPPPKLKNAHK 242
Query: 839 FDPILRGKGFDEEMLQVLDVACMCVSQNPFKRPTVKEVVE 878
P+LR F E ML ++ P +R T +E+++
Sbjct: 243 ISPVLR--DFLERML----------TREPQERATAQELLD 270
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297 |
| >gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Score = 53.6 bits (129), Expect = 2e-07
Identities = 34/101 (33%), Positives = 54/101 (53%), Gaps = 18/101 (17%)
Query: 719 GLAYMHQICEPHIVHRDIKSSNILLDDQFEAHLADFGLSRL-ILPYQTHVTTELVGTLGY 777
GL ++H I++RD+K N++LD + +ADFG+ + I +T T GT Y
Sbjct: 113 GLFFLHS---KGIIYRDLKLDNVMLDAEGHIKIADFGMCKENIFGGKT--TRTFCGTPDY 167
Query: 778 IPPE------YGQAWVATLRGDMYSFGVVMLELLTGKRPVD 812
I PE YG++ D ++FGV++ E+L G+ P D
Sbjct: 168 IAPEIIAYQPYGKSV------DWWAFGVLLYEMLAGQPPFD 202
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324 |
| >gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Score = 53.1 bits (127), Expect = 2e-07
Identities = 55/221 (24%), Positives = 101/221 (45%), Gaps = 38/221 (17%)
Query: 615 IGCGGFGLVYKATLANGTTL---AIKKLSGDLGLMER----EFKAEVEALSTAQHKNLVS 667
+G G FG V + L ++ A+K + + + R +F +E + H N++
Sbjct: 7 LGEGEFGSVMEGQLNQDDSILKVAVKTMK--IAICTRSEMEDFLSEAVCMKEFDHPNVMR 64
Query: 668 LQGYCVH----QGFR--LLIYSYMENGSL-DYWLHEK-ADGASQLDWLTRLKIARGTSCG 719
L G C+ +G+ ++I +M++G L + L+ + D L +K + G
Sbjct: 65 LIGVCLQTVESEGYPSPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASG 124
Query: 720 LAYMHQICEPHIVHRDIKSSNILLDDQFEAHLADFGLSRLILPYQTHVTTELVGTLGYIP 779
+ Y+ +HRD+ + N +L++ +ADFGLS+ I Y + G + +P
Sbjct: 125 MEYLSS---KSFIHRDLAARNCMLNENMNVCVADFGLSKKI--YNGDYYRQ--GRIAKMP 177
Query: 780 PEYGQAWVA---------TLRGDMYSFGVVMLELLT-GKRP 810
+ W+A T + D++SFGV M E+ T G+ P
Sbjct: 178 VK----WIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTP 214
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272 |
| >gnl|CDD|227223 COG4886, COG4886, Leucine-rich repeat (LRR) protein [Function unknown] | Back alignment and domain information |
|---|
Score = 53.8 bits (129), Expect = 2e-07
Identities = 39/123 (31%), Positives = 60/123 (48%), Gaps = 11/123 (8%)
Query: 379 QYNQLSNLPPAIYLANN----SLSGN----IPVEIGQLKSLHVLDLSNNNFSGTIPDELS 430
+N LS+LP + +N LSGN +P EI L +L LDLSNN+ + LS
Sbjct: 171 SFNDLSDLPKLLSNLSNLNNLDLSGNKISDLPPEIELLSALEELDLSNNSII-ELLSSLS 229
Query: 431 DLSNLEKLDLSGNHLVGEIPISLKGLHFLSSFSVAHNNLQGAVPSGGQFDTFPSFSFEGN 490
+L NL L+LS N + ++P S+ L L + +++N + ++ S G GN
Sbjct: 230 NLKNLSGLELSNN-KLEDLPESIGNLSNLETLDLSNNQIS-SISSLGSLTNLRELDLSGN 287
Query: 491 PEL 493
Sbjct: 288 SLS 290
|
Length = 394 |
| >gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Score = 53.6 bits (129), Expect = 2e-07
Identities = 67/239 (28%), Positives = 96/239 (40%), Gaps = 45/239 (18%)
Query: 592 NEIKDLTIYELLKATDNFSQANIIGCGGFGLV----YKATLANGTTLAIKKLSGDLGLME 647
+I L + KA D F +IG G FG V +K++ A+K LS +++
Sbjct: 33 EKITKLRM----KAED-FDVIKVIGRGAFGEVQLVRHKSS---KQVYAMKLLSKF-EMIK 83
Query: 648 RE----FKAEVEALSTAQHKNLVSLQGYCVHQGFRLL--IYSYMENGSL-----DYWLHE 696
R F E + ++ A + +V L Q + L + YM G L +Y + E
Sbjct: 84 RSDSAFFWEERDIMAHANSEWIVQLH--YAFQDDKYLYMVMEYMPGGDLVNLMSNYDIPE 141
Query: 697 KADGASQLDWLTRLKIARGTSCGLAYMHQICEPHIVHRDIKSSNILLDDQFEAHLADFGL 756
K W R A L +H + +HRD+K N+LLD LADFG
Sbjct: 142 K--------W-ARFYTAE-VVLALDAIHSM---GFIHRDVKPDNMLLDKSGHLKLADFGT 188
Query: 757 S-RLILPYQTHVTTELVGTLGYIPPEY----GQAWVATLRGDMYSFGVVMLELLTGKRP 810
++ T VGT YI PE G D +S GV + E+L G P
Sbjct: 189 CMKMDANGMVRCDTA-VGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTP 246
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370 |
| >gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Score = 53.0 bits (127), Expect = 3e-07
Identities = 76/317 (23%), Positives = 133/317 (41%), Gaps = 61/317 (19%)
Query: 607 DNFSQANIIGCGGFGLVYKATLANG---------TTLAIKKLSGDLGLME-REFKAEVEA 656
D +G G FG V +A A G T+A+K L + + + +E+E
Sbjct: 12 DRLVLGKPLGEGCFGQVVRAE-AYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMEL 70
Query: 657 LST-AQHKNLVSLQGYCVHQGFRLLIYSYMENGSLDYWLHEKADGASQLDW-LTRL---- 710
+ +HKN+++L G C +G +I Y G+L +L + + +T++
Sbjct: 71 MKLIGKHKNIINLLGVCTQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQ 130
Query: 711 -----------KIARGTSCGLAYMHQICEPHIVHRDIKSSNILLDDQFEAHLADFGLSRL 759
++ARG M + +HRD+ + N+L+ + +ADFGL+R
Sbjct: 131 LSFKDLVSCAYQVARG-------MEYLESRRCIHRDLAARNVLVTEDNVMKIADFGLARG 183
Query: 760 ILPYQTHVTTELVGTLGYIP-----PEYGQAWVATLRGDMYSFGVVMLELLT-GKRPVDV 813
+ + T + G +P PE V T + D++SFG++M E+ T G P
Sbjct: 184 VHDIDYYKKT----SNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFTLGGSPYPG 239
Query: 814 LKPKMSRELVGWVLKMRSEGKQDQVFDPILRGKGFDEEMLQVLDVACMCVSQNPFKRPTV 873
+ V + K+ EG + + + E+ ++ C P +RPT
Sbjct: 240 IP-------VEELFKLLREGHR------MDKPSNCTHELYMLMR---ECWHAVPTQRPTF 283
Query: 874 KEVVEWLNNVGANRRNE 890
K++VE L+ V A E
Sbjct: 284 KQLVEALDKVLAAVSEE 300
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314 |
| >gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 53.0 bits (127), Expect = 3e-07
Identities = 59/211 (27%), Positives = 87/211 (41%), Gaps = 30/211 (14%)
Query: 615 IGCGGFGLVYKATLAN-GTTLAIKKLSGDLGLMEREFKAEVEALSTAQHKNLVSLQGYCV 673
IG G FG VY+ + A+K LS + ++E + + + L+ + V
Sbjct: 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILV-RTLLDESPFIV 59
Query: 674 HQGFRL-------LIYSYMENGSLDYWLHEKADGASQLDWLTRLKIARGTSCGLAYMHQI 726
F L+ YM G L +W H + +G D + IA L ++H
Sbjct: 60 GLKFSFQTDSDLYLVTDYMSGGEL-FW-HLQKEGRFSED-RAKFYIAE-LVLALEHLH-- 113
Query: 727 CEPHIVHRDIKSSNILLDDQFEAHLADFGLSRLILPYQTHVTTELVGTLGYIPPE----- 781
+ IV+RD+K NILLD L DFGLS+ L T GT Y+ PE
Sbjct: 114 -KYDIVYRDLKPENILLDATGHIALCDFGLSKANLT-DNKTTNTFCGTTEYLAPEVLLDE 171
Query: 782 --YGQAWVATLRGDMYSFGVVMLELLTGKRP 810
Y + D +S GV++ E+ G P
Sbjct: 172 KGYTK------HVDFWSLGVLVFEMCCGWSP 196
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330 |
| >gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Score = 52.3 bits (125), Expect = 3e-07
Identities = 75/294 (25%), Positives = 123/294 (41%), Gaps = 49/294 (16%)
Query: 606 TDNFSQANIIGCGGFGLVYKA-TLANGTTLAIKKLSGDLGLMEREFKAEVEAL-STAQHK 663
+D + IG G +G V+K NG+ A+K L + ++ E +AE L + + H
Sbjct: 17 SDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILD-PIHDIDEEIEAEYNILKALSDHP 75
Query: 664 NLVSLQGYCVHQGFRLLIYSYMENGSLDYWLHEKADGASQLDWLTRLKIARGTSC----- 718
N+V G + ++NG + + E +G S D L + + RG
Sbjct: 76 NVVKFYG--------MYYKKDVKNGDQLWLVLELCNGGSVTD-LVKGFLKRGERMEEPII 126
Query: 719 ---------GLAYMHQICEPHIVHRDIKSSNILLDDQFEAHLADFGLSRLILPYQTHVTT 769
GL ++H +HRD+K +NILL + L DFG+S + + T
Sbjct: 127 AYILHEALMGLQHLH---VNKTIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRLRRNT 183
Query: 770 ELVGTLGYIPPEY---GQAWVATL--RGDMYSFGVVMLELLTGKRPVDVLKPKMSRELVG 824
VGT ++ PE Q +T R D++S G+ +EL G P+ L P
Sbjct: 184 S-VGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHP-------- 234
Query: 825 WVLKMRSEGKQDQVFDPILRGKGFDEEMLQVLDVACMCVSQNPFKRPTVKEVVE 878
MR+ K + P L D C++++ KRPTV ++++
Sbjct: 235 ----MRALFKIPRNPPPTLHQPELWSNEFN--DFIRKCLTKDYEKRPTVSDLLQ 282
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286 |
| >gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Score = 52.5 bits (126), Expect = 4e-07
Identities = 61/220 (27%), Positives = 95/220 (43%), Gaps = 31/220 (14%)
Query: 607 DNFSQANIIGCGGFGLVYKA-TLANGTTLAIKKLSGDLGLMEREFKAEVEALSTAQHKNL 665
D + + IG G +G VYKA G +A+KK + M+ E AL +
Sbjct: 1 DAYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLE---MDEE-GIPPTALREISLLQM 56
Query: 666 VSLQGYCVHQGFRLLIYSYMENGS---LDYWLHE--KADGASQLDWLTRLKIARGTSCGL 720
+S Y V RLL ++E + Y + E +D +D R
Sbjct: 57 LSESIYIV----RLLDVEHVEEKNGKPSLYLVFEYLDSDLKKFMD-SNGRGPGRPLPAKT 111
Query: 721 A--YMHQI------CEPH-IVHRDIKSSNILLDDQFEA-HLADFGLSR-LILPYQTHVTT 769
+M+Q+ C H ++HRD+K N+L+D Q +AD GL R +P +++ T
Sbjct: 112 IKSFMYQLLKGVAHCHKHGVMHRDLKPQNLLVDKQKGLLKIADLGLGRAFSIPVKSY-TH 170
Query: 770 ELVGTLGYIPPE--YGQAWVATLRGDMYSFGVVMLELLTG 807
E+V TL Y PE G +T D++S G + E+
Sbjct: 171 EIV-TLWYRAPEVLLGSTHYST-PVDIWSVGCIFAEMSRK 208
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 53.3 bits (128), Expect = 5e-07
Identities = 35/109 (32%), Positives = 48/109 (44%), Gaps = 23/109 (21%)
Query: 389 AIYLANNSLSGNIPVEIGQLKSLHVLDLSNNNFSGTIPDELSDLS--------------- 433
+I L+ ++SG I I +L + ++LSNN SG IPD++ S
Sbjct: 73 SIDLSGKNISGKISSAIFRLPYIQTINLSNNQLSGPIPDDIFTTSSSLRYLNLSNNNFTG 132
Query: 434 --------NLEKLDLSGNHLVGEIPISLKGLHFLSSFSVAHNNLQGAVP 474
NLE LDLS N L GEIP + L + N L G +P
Sbjct: 133 SIPRGSIPNLETLDLSNNMLSGEIPNDIGSFSSLKVLDLGGNVLVGKIP 181
|
Length = 968 |
| >gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Score = 52.4 bits (126), Expect = 5e-07
Identities = 63/223 (28%), Positives = 96/223 (43%), Gaps = 54/223 (24%)
Query: 614 IIGCGGFGLV----YKATLANGTTLAIKKLS-GDLGLMEREFKAEVEAL----------S 658
++G G FG V YK T G AIK L GD+ + R+ EVE+L +
Sbjct: 6 VLGRGHFGKVLLAEYKKT---GELYAIKALKKGDI--IARD---EVESLMCEKRIFETAN 57
Query: 659 TAQHKNLVSLQGYCVHQGFRL-LIYSYMENGSLDYWLHEKADGASQLDWLTRLKIARGTS 717
+ +H LV+L C + + Y G L +H + A +
Sbjct: 58 SERHPFLVNLFA-CFQTEDHVCFVMEYAAGGDLMMHIHTDVFSEPR---------AVFYA 107
Query: 718 C----GLAYMHQICEPHIVHRDIKSSNILLDDQFEAHLADFGLSRLILPYQTHVTTELVG 773
GL Y+H E IV+RD+K N+LLD + +ADFGL + + + +T G
Sbjct: 108 ACVVLGLQYLH---ENKIVYRDLKLDNLLLDTEGFVKIADFGLCKEGMGFGDRTST-FCG 163
Query: 774 TLGYIPPE------YGQAWVATLRGDMYSFGVVMLELLTGKRP 810
T ++ PE Y +A D + GV++ E+L G+ P
Sbjct: 164 TPEFLAPEVLTETSYTRAV------DWWGLGVLIYEMLVGESP 200
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 52.9 bits (127), Expect = 7e-07
Identities = 44/147 (29%), Positives = 68/147 (46%), Gaps = 15/147 (10%)
Query: 329 LFSQANLLSGEFPKELTALPALVSEAANDEVDRSYLELPVFVMPSNATNQQYNQLSNLPP 388
LFS N +G+ P LT+LP L +V + + +P N N L+ L
Sbjct: 315 LFS--NNFTGKIPVALTSLPRL-------QVLQLWSNKFSGEIPKNLGKH--NNLTVLD- 362
Query: 389 AIYLANNSLSGNIPVEIGQLKSLHVLDLSNNNFSGTIPDELSDLSNLEKLDLSGNHLVGE 448
L+ N+L+G IP + +L L L +N+ G IP L +L ++ L N GE
Sbjct: 363 ---LSTNNLTGEIPEGLCSSGNLFKLILFSNSLEGEIPKSLGACRSLRRVRLQDNSFSGE 419
Query: 449 IPISLKGLHFLSSFSVAHNNLQGAVPS 475
+P L + +++NNLQG + S
Sbjct: 420 LPSEFTKLPLVYFLDISNNNLQGRINS 446
|
Length = 968 |
| >gnl|CDD|165291 PHA02988, PHA02988, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 51.7 bits (124), Expect = 7e-07
Identities = 62/309 (20%), Positives = 120/309 (38%), Gaps = 55/309 (17%)
Query: 586 LFPNNTNEIKDLTIYELLKATDNFSQANIIGCGGFGLVYKATLANGTTLAI---KKLSGD 642
+ E D+ Y + +N N I G F N + I KK
Sbjct: 9 INDIKCIESDDIDKYTSVLIKEN--DQNSIYKGIF---------NNKEVIIRTFKKFHKG 57
Query: 643 LGLMEREFKAEVEALSTAQHKNLVSLQGYCVHQGFRLLIYSYMENGSLDYWLHEKADGAS 702
++ + E++ L N++ + G+ + L S + +L E D
Sbjct: 58 HKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDDLPRLSLILEYCTRGYLREVLDKEK 117
Query: 703 QLDWLTRLKIARGTSCGLAYMHQ-ICEPHIVHRDIKSSNILLDDQFEAHLADFGLSRLIL 761
L + T+L +A GL +++ +P+ +++ S + L+ + ++ + GL +++
Sbjct: 118 DLSFKTKLDMAIDCCKGLYNLYKYTNKPY---KNLTSVSFLVTENYKLKIICHGLEKILS 174
Query: 762 --PYQTHVTTELVGTLGYIPP--------EYGQAWVATLRGDMYSFGVVMLELLTGKRPV 811
P++ V + Y EY T++ D+YS GVV+ E+ TGK P
Sbjct: 175 SPPFKN------VNFMVYFSYKMLNDIFSEY------TIKDDIYSLGVVLWEIFTGKIPF 222
Query: 812 DVLKPKMSRELVGWVLKMRSEGKQDQVFDPILRGKGFDEEMLQVLDVACMCVSQNPFKRP 871
+ L K E+ ++ + K + L++ + C S + KRP
Sbjct: 223 ENLTTK---EIYDLIINKNNSLKLPL------------DCPLEIKCIVEACTSHDSIKRP 267
Query: 872 TVKEVVEWL 880
+KE++ L
Sbjct: 268 NIKEILYNL 276
|
Length = 283 |
| >gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Score = 51.6 bits (123), Expect = 7e-07
Identities = 58/213 (27%), Positives = 98/213 (46%), Gaps = 29/213 (13%)
Query: 607 DNFSQANIIGCGGFGLVYKATLAN-GTTLAIKKLSGDLGLMERE--FKAEVEALSTAQHK 663
D+F + IG G G+V AT + G +A+KK+ DL +R EV + H+
Sbjct: 25 DSFIK---IGEGSTGIVCIATEKHTGKQVAVKKM--DLRKQQRRELLFNEVVIMRDYHHE 79
Query: 664 NLVSLQGYCVHQGFRLLIYSYMENGSL-DYWLHEKADGASQLDWLTRLKIARGTSC---- 718
N+V + + ++ ++E G+L D H + + +IA T C
Sbjct: 80 NVVDMYNSYLVGDELWVVMEFLEGGALTDIVTHTR---------MNEEQIA--TVCLSVL 128
Query: 719 -GLAYMHQICEPHIVHRDIKSSNILLDDQFEAHLADFGLSRLILPYQTHVTTELVGTLGY 777
L+Y+H ++HRDIKS +ILL L+DFG + + LVGT +
Sbjct: 129 RALSYLHN---QGVIHRDIKSDSILLTSDGRIKLSDFGFCAQV-SKEVPKRKSLVGTPYW 184
Query: 778 IPPEYGQAWVATLRGDMYSFGVVMLELLTGKRP 810
+ PE D++S G++++E++ G+ P
Sbjct: 185 MAPEVISRLPYGTEVDIWSLGIMVIEMIDGEPP 217
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292 |
| >gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Score = 51.5 bits (123), Expect = 9e-07
Identities = 57/221 (25%), Positives = 100/221 (45%), Gaps = 35/221 (15%)
Query: 608 NFSQANIIGCGGFGLVYKATLANGTTL-AIKKLSGDLGLMEREFKAEVEALSTAQHKNLV 666
+F+ ++G G FG V A L AIK L D+ + + + + T K ++
Sbjct: 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVEC------TMVEKRVL 54
Query: 667 SLQGYCVHQGFRLLIYSYMENGSLDYWLHEKADGAS---QLDWLTRLK------IARGTS 717
+L G F ++S + Y++ E +G Q+ + R K A +
Sbjct: 55 ALSG---KPPFLTQLHSCFQTMDRLYFVMEYVNGGDLMYQIQQVGRFKEPHAVFYAAEIA 111
Query: 718 CGLAYMHQICEPHIVHRDIKSSNILLDDQFEAHLADFGLSRLILPYQTHVTTELVGTLGY 777
GL ++H I++RD+K N++LD + +ADFG+ + + + T GT Y
Sbjct: 112 IGLFFLHS---KGIIYRDLKLDNVMLDSEGHIKIADFGMCKENM-WDGVTTKTFCGTPDY 167
Query: 778 IPPE------YGQAWVATLRGDMYSFGVVMLELLTGKRPVD 812
I PE YG++ D ++FGV++ E+L G+ P +
Sbjct: 168 IAPEIIAYQPYGKSV------DWWAFGVLLYEMLAGQAPFE 202
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323 |
| >gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 51.5 bits (123), Expect = 1e-06
Identities = 58/240 (24%), Positives = 101/240 (42%), Gaps = 38/240 (15%)
Query: 588 PNNTNEIKDLTIYELLKATDNFSQANIIGCGGFGLVYKATLANGT--TLAIKKLSGDLGL 645
P N++K YE +F+ +G G FG V AT N +AIK+ +
Sbjct: 21 PKRKNKMK----YE------DFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKII 70
Query: 646 MEREFK---AEVEALSTAQHKNLVSLQGYCVHQGFRLLIYSYMENGSLDYWLHEKADGAS 702
+++ +E + L+ H V+L G + + L+ ++ G +L +
Sbjct: 71 KQKQVDHVFSERKILNYINHPFCVNLYGSFKDESYLYLVLEFVIGGEFFTFLRRNKRFPN 130
Query: 703 QLDWLTRLKIARGTSCGLAYMHQICEPHIVHRDIKSSNILLDDQFEAHLADFGLSRLILP 762
+ +I Y+ + +IV+RD+K N+LLD + DFG ++++
Sbjct: 131 DVGCFYAAQIV----LIFEYLQSL---NIVYRDLKPENLLLDKDGFIKMTDFGFAKVV-- 181
Query: 763 YQTHVTTELVGTLGYIPPE------YGQAWVATLRGDMYSFGVVMLELLTGKRPVDVLKP 816
T T L GT YI PE +G+A D ++ G+ + E+L G P +P
Sbjct: 182 -DTRTYT-LCGTPEYIAPEILLNVGHGKA------ADWWTLGIFIYEILVGCPPFYANEP 233
|
Length = 340 |
| >gnl|CDD|173643 cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 49.9 bits (119), Expect = 2e-06
Identities = 57/229 (24%), Positives = 105/229 (45%), Gaps = 38/229 (16%)
Query: 662 HKNLVSLQGYCVHQGFRLLIYSYMENGSLDYWLHEKADGASQLDWLTRLKIARGTSCGLA 721
HK++V L G CV +++ ++E G LD ++H K+D + W + K+A+ + L+
Sbjct: 63 HKHIVLLYGVCVRDVENIMVEEFVEFGPLDLFMHRKSDVLTT-PW--KFKVAKQLASALS 119
Query: 722 YMHQICEPHIVHRDIKSSNILL-----DDQFEA--HLADFGLSRLILPYQTHVTTELVGT 774
Y+ + +VH ++ + NILL D + L+D G+ +L Q E V
Sbjct: 120 YLE---DKDLVHGNVCTKNILLAREGIDGECGPFIKLSDPGIPITVLSRQ-----ECVER 171
Query: 775 LGYIPPE-YGQAWVATLRGDMYSFGVVMLEL-LTGKRPVDVLKPKMSRELVGWVLKMRSE 832
+ +I PE + ++ D +SFG + E+ G+ P LK K E K R
Sbjct: 172 IPWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIP---LKDKTLAE------KERFY 222
Query: 833 GKQDQVFDPILRGKGFDEEMLQVLDVACMCVSQNPFKRPTVKEVVEWLN 881
Q + P + ++ D+ C++ +P +RP + ++ +N
Sbjct: 223 EGQCMLVTPSCK---------ELADLMTHCMNYDPNQRPFFRAIMRDIN 262
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 262 |
| >gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 50.4 bits (120), Expect = 2e-06
Identities = 34/92 (36%), Positives = 48/92 (52%), Gaps = 10/92 (10%)
Query: 719 GLAYMHQICEPHIVHRDIKSSNILLDDQFEAHLADFGLSRLILPYQT-HVTTELVGTLGY 777
GL Y+H I+HRD+K SN+ +++ E + DFGL+R Q T V T Y
Sbjct: 130 GLKYIHS---AGIIHRDLKPSNVAVNEDCELRILDFGLAR-----QADDEMTGYVATRWY 181
Query: 778 IPPEYGQAWVATLRG-DMYSFGVVMLELLTGK 808
PE W+ + D++S G +M ELL GK
Sbjct: 182 RAPEIMLNWMHYNQTVDIWSVGCIMAELLKGK 213
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343 |
| >gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Score = 50.5 bits (120), Expect = 2e-06
Identities = 59/208 (28%), Positives = 91/208 (43%), Gaps = 26/208 (12%)
Query: 614 IIGCGGFG-LVYKATLANGTTLAIKKLSGDLGLMEREFK---AEVEALSTAQHKNLVSLQ 669
++G G FG ++ A+G A+K L ++ + + E E L +H L SL+
Sbjct: 2 LLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLK 61
Query: 670 GYCVHQGFRL-LIYSYMENGSLDYWLHEKADGASQLDWLTRLKIARGTSCGLAYMHQICE 728
Y RL + Y+ G L + L + + TR A S L Y+H
Sbjct: 62 -YSFQTKDRLCFVMEYVNGGELFFHLSRERVFSEDR---TRFYGAEIVS-ALDYLHS--- 113
Query: 729 PHIVHRDIKSSNILLDDQFEAHLADFGLSRLILPYQTHVTTELVGTLGYIPPE------Y 782
IV+RD+K N++LD + DFGL + + + T GT Y+ PE Y
Sbjct: 114 GKIVYRDLKLENLMLDKDGHIKITDFGLCKEGITDAATMKT-FCGTPEYLAPEVLEDNDY 172
Query: 783 GQAWVATLRGDMYSFGVVMLELLTGKRP 810
G+A D + GVVM E++ G+ P
Sbjct: 173 GRAV------DWWGLGVVMYEMMCGRLP 194
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328 |
| >gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Score = 50.2 bits (120), Expect = 2e-06
Identities = 30/100 (30%), Positives = 53/100 (53%), Gaps = 19/100 (19%)
Query: 719 GLAYMHQICEPHIVHRDIKSSNILLD-DQFEAHLADFGLSRLILPYQTH--VTTELVGTL 775
GL Y+H +++HRD+K +N+ ++ + + DFGL+R++ P+ +H +E + T
Sbjct: 126 GLKYIHS---ANVLHRDLKPANVFINTEDLVLKIGDFGLARIVDPHYSHKGYLSEGLVTK 182
Query: 776 GYIPPE-------YGQAWVATLRGDMYSFGVVMLELLTGK 808
Y P Y +A DM++ G + E+LTGK
Sbjct: 183 WYRSPRLLLSPNNYTKA------IDMWAAGCIFAEMLTGK 216
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342 |
| >gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Score = 50.4 bits (120), Expect = 3e-06
Identities = 56/214 (26%), Positives = 95/214 (44%), Gaps = 27/214 (12%)
Query: 608 NFSQANIIGCGGFGLVYKAT-LANGTTLAIKKLSGDLGLMEREFKAEVEALSTAQHKNLV 666
++ NIIG G FG+VY+A + +AIKK+ D RE + H N++
Sbjct: 67 SYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDPQYKNRELL----IMKNLNHINII 122
Query: 667 SLQGYCVHQGFRL--------LIYSYMENGSLDYWLHEKADGASQLDWLTRL---KIARG 715
L+ Y + F+ ++ ++ Y H + + +L +L ++ R
Sbjct: 123 FLKDYYYTECFKKNEKNIFLNVVMEFIPQTVHKYMKHYARNNHALPLFLVKLYSYQLCR- 181
Query: 716 TSCGLAYMHQICEPHIVHRDIKSSNILLDDQFEA-HLADFGLSRLILPYQTHVTTELVGT 774
LAY+H I HRD+K N+L+D L DFG ++ +L Q V+ + +
Sbjct: 182 ---ALAYIHS---KFICHRDLKPQNLLIDPNTHTLKLCDFGSAKNLLAGQRSVS--YICS 233
Query: 775 LGYIPPEYG-QAWVATLRGDMYSFGVVMLELLTG 807
Y PE A T D++S G ++ E++ G
Sbjct: 234 RFYRAPELMLGATNYTTHIDLWSLGCIIAEMILG 267
|
Length = 440 |
| >gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Score = 49.3 bits (118), Expect = 4e-06
Identities = 30/148 (20%), Positives = 51/148 (34%), Gaps = 26/148 (17%)
Query: 618 GGFGLVYKATLANGTTLAIKKLSGDLGLMER--EFKAEVEALSTAQHKNLVSLQGYCVHQ 675
+ K T +A+KK++ D E + E+ QH N++ +
Sbjct: 13 LMIVHLAKHK-PTNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSFIVD 71
Query: 676 GFRLLIYSYMENGSLDYWLHEKADGASQL------DWLTRLKIA---RGTSCGLAYMHQI 726
++ M GS L + L L IA + L Y+H
Sbjct: 72 SELYVVSPLMAYGS-----------CEDLLKTHFPEGLPELAIAFILKDVLNALDYIHSK 120
Query: 727 CEPHIVHRDIKSSNILLDDQFEAHLADF 754
+HR +K+S+ILL + L+
Sbjct: 121 ---GFIHRSVKASHILLSGDGKVVLSGL 145
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314 |
| >gnl|CDD|227223 COG4886, COG4886, Leucine-rich repeat (LRR) protein [Function unknown] | Back alignment and domain information |
|---|
Score = 49.6 bits (118), Expect = 5e-06
Identities = 35/127 (27%), Positives = 56/127 (44%), Gaps = 8/127 (6%)
Query: 349 ALVSEAANDEVDRSYLELPVFVMPSNATNQQYNQLSN------LPPAIYLANNSLSGNIP 402
AL + + S L + + + + S P++ L N L NI
Sbjct: 51 ALNLSSNTLLLLPSSLSRLLSLDLLSPSGISSLDGSENLLNLLPLPSLDLNLNRLRSNIS 110
Query: 403 VEIGQLKSLHVLDLSNNNFSGTIPDELSDLSNLEKLDLSGNHLVGEIPISLKGLHFLSSF 462
E+ +L +L LDL NNN + P SNL++LDLS N + +P L+ L L +
Sbjct: 111 -ELLELTNLTSLDLDNNNITDIPPLIGLLKSNLKELDLSDNKI-ESLPSPLRNLPNLKNL 168
Query: 463 SVAHNNL 469
++ N+L
Sbjct: 169 DLSFNDL 175
|
Length = 394 |
| >gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 49.3 bits (117), Expect = 5e-06
Identities = 48/158 (30%), Positives = 75/158 (47%), Gaps = 25/158 (15%)
Query: 732 VHRDIKSSNILLDDQFEAHLADFGLSRLILPYQTHVTT-ELVGTLGYIPPEYGQAWVATL 790
+HRD+ + NILL + + DFGL+R I +V + L ++ PE V T+
Sbjct: 201 IHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTI 260
Query: 791 RGDMYSFGVVMLELLT-GKRPVDVLK--PKMSRELVGWVLKMRSEGKQDQVFDPILRGKG 847
+ D++SFGV++ E+ + G P +K + R L EG + +R
Sbjct: 261 QSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRL--------KEGTR-------MRAPD 305
Query: 848 FDE-EMLQ-VLDVACMCVSQNPFKRPTVKEVVEWLNNV 883
+ EM Q +LD C P +RPT E+VE L N+
Sbjct: 306 YTTPEMYQTMLD----CWHGEPSQRPTFSELVEHLGNL 339
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343 |
| >gnl|CDD|240159 cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Score = 46.6 bits (111), Expect = 6e-06
Identities = 31/152 (20%), Positives = 53/152 (34%), Gaps = 16/152 (10%)
Query: 614 IIGCGGFGLVYKATLANGTTLAIKKLSGDLGLMEREFKAEVEALSTAQHKNLVSLQGYCV 673
++ G VY + +K +RE EV L K L +
Sbjct: 5 LLKGGLTNRVYLLGTKDED-YVLKINPSREKGADRE--REVAILQLLARKGLPVPKVLAS 61
Query: 674 --HQGFRLLIYSYMENGSLDYWLHEKADGASQLDWLTRLKIARGTSCGLAYMHQICEPHI 731
G+ L+ ++E +LD + + D +L LA +HQ+ +
Sbjct: 62 GESDGWSYLLMEWIEGETLD-----EVSEEEKEDIAEQLAEL------LAKLHQLPLLVL 110
Query: 732 VHRDIKSSNILLDDQFEAHLADFGLSRLILPY 763
H D+ NIL+DD + D+ + P
Sbjct: 111 CHGDLHPGNILVDDGKILGIIDWEYAGYGPPA 142
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves as precursors to the synthesis of important biological compounds, such as the major phospholipids, phosphatidylcholine and phosphatidylethanolamine and the amino acids, threonine, methionine, and isoleucine. Length = 155 |
| >gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 49.1 bits (117), Expect = 6e-06
Identities = 37/101 (36%), Positives = 50/101 (49%), Gaps = 8/101 (7%)
Query: 607 DNFSQANIIGCGGFGLVYKATLA------NGTTLAIKKLSGDLGLMERE-FKAEVEALS- 658
DN +G G FG V +AT N +A+K L ERE +E++ LS
Sbjct: 38 DNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAHTDEREALMSELKILSH 97
Query: 659 TAQHKNLVSLQGYCVHQGFRLLIYSYMENGSLDYWLHEKAD 699
QHKN+V+L G C H G L+I Y G L +L +KA+
Sbjct: 98 LGQHKNIVNLLGACTHGGPVLVITEYCCYGDLLNFLRKKAE 138
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374 |
| >gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Score = 48.9 bits (116), Expect = 6e-06
Identities = 72/286 (25%), Positives = 106/286 (37%), Gaps = 78/286 (27%)
Query: 607 DNFSQANIIGCGGFGLVYKATLANGTTLAIKKLSGDLGLMEREFKAEVEALSTAQHKNLV 666
D+F +IG G FG V + + K+ ++E+E A + A + LV
Sbjct: 1 DDFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRA----ERDILV 56
Query: 667 SLQGYCVHQGFRLLIYSYMENGSLDYWLHEKADGASQLDWL----------TRLKIARGT 716
G V + F YS+ + +L Y + E G + L T+ IA T
Sbjct: 57 EADGAWVVKMF----YSFQDKRNL-YLIMEFLPGGDMMTLLMKKDTLSEEATQFYIAE-T 110
Query: 717 SCGLAYMHQICEPHIVHRDIKSSNILLDDQFEAHLADFGL-------------------- 756
+ +HQ+ +HRDIK N+LLD + L+DFGL
Sbjct: 111 VLAIDAIHQL---GFIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKAHRTEFYRNLTHNP 167
Query: 757 --------------------SRLILPYQTHVTTELVGTLGYIPPEYGQAWVATLRGDMYS 796
+R L Y T VGT YI PE D +S
Sbjct: 168 PSDFSFQNMNSKRKAETWKKNRRQLAYST------VGTPDYIAPEVFMQTGYNKLCDWWS 221
Query: 797 FGVVMLELLTGKRPVDVLKPKMS-RELVGWVLKMRSEGKQDQVFDP 841
GV+M E+L G P P+ + R+++ W K+ VF P
Sbjct: 222 LGVIMYEMLIGYPPFCSETPQETYRKVMNW--------KETLVFPP 259
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360 |
| >gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Score = 48.5 bits (115), Expect = 7e-06
Identities = 63/212 (29%), Positives = 106/212 (50%), Gaps = 27/212 (12%)
Query: 615 IGCGGFGLVYKA-TLANGTT-LAIKKL---SGDLGLMEREFK--AEVEALSTAQHKNLVS 667
IG G +G V+KA L NG +A+K++ +G+ G+ + A + L T +H N+V
Sbjct: 9 IGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVR 68
Query: 668 LQGYC-VHQGFR----LLIYSYMENGSLDYWLHEKADGASQLDWLT--RLKIARGTSCGL 720
L C V + R L++ +++ L +L + + + + ++ RG L
Sbjct: 69 LFDVCTVSRTDRETKLTLVFEHVDQ-DLTTYLDKVPEPGVPTETIKDMMFQLLRG----L 123
Query: 721 AYMHQICEPHIVHRDIKSSNILLDDQFEAHLADFGLSRLILPYQTHVTTELVGTLGYIPP 780
++H +VHRD+K NIL+ + LADFGL+R I +Q T +V TL Y P
Sbjct: 124 DFLHS---HRVVHRDLKPQNILVTSSGQIKLADFGLAR-IYSFQM-ALTSVVVTLWYRAP 178
Query: 781 E-YGQAWVATLRGDMYSFGVVMLELLTGKRPV 811
E Q+ AT D++S G + E+ ++P+
Sbjct: 179 EVLLQSSYAT-PVDLWSVGCIFAEMFR-RKPL 208
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290 |
| >gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 48.7 bits (116), Expect = 8e-06
Identities = 26/87 (29%), Positives = 43/87 (49%), Gaps = 5/87 (5%)
Query: 719 GLAYMHQICEPHIVHRDIKSSNILLDDQFEAHLADFGLSRLILPYQTHVTTELVGTLGYI 778
GL Y+H I+HRD+K+ NI ++D + + D G ++ P L GT+
Sbjct: 169 GLRYLHAQ---RIIHRDVKTENIFINDVDQVCIGDLGAAQ--FPVVAPAFLGLAGTVETN 223
Query: 779 PPEYGQAWVATLRGDMYSFGVVMLELL 805
PE + D++S G+V+ E+L
Sbjct: 224 APEVLARDKYNSKADIWSAGIVLFEML 250
|
Length = 357 |
| >gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Score = 48.5 bits (115), Expect = 8e-06
Identities = 57/213 (26%), Positives = 100/213 (46%), Gaps = 27/213 (12%)
Query: 615 IGCGGFGLVYKATLANGTT---LAIKKLSGDLGLMEREFKAEVEALSTAQHKNLVSLQGY 671
+G G +G VYKA +G A+K++ G G+ + E+ L +H N++SLQ
Sbjct: 9 VGRGTYGHVYKAKRKDGKDDRDYALKQIEGT-GISMSACR-EIALLRELKHPNVISLQKV 66
Query: 672 CVHQGFR--LLIYSYMENGSLDYWLHEKADGASQLDWLTRLKIARGTSCGLAY-----MH 724
+ R L++ Y E+ D W K AS+ + +++ RG L Y +H
Sbjct: 67 FLSHADRKVWLLFDYAEH---DLWHIIKFHRASKAN-KKPVQLPRGMVKSLLYQILDGIH 122
Query: 725 QICEPHIVHRDIKSSNILL----DDQFEAHLADFGLSRLI-LPYQTHVTTE-LVGTLGYI 778
+ ++HRD+K +NIL+ ++ +AD G +RL P + + +V T Y
Sbjct: 123 YLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYR 182
Query: 779 PPEY---GQAWVATLRGDMYSFGVVMLELLTGK 808
PE + + + D+++ G + ELLT +
Sbjct: 183 APELLLGARHYTKAI--DIWAIGCIFAELLTSE 213
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317 |
| >gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 48.7 bits (116), Expect = 1e-05
Identities = 42/173 (24%), Positives = 65/173 (37%), Gaps = 37/173 (21%)
Query: 653 EVEALSTAQHKNLVSLQGYCVHQGFRLLIYSYMENGSLDYWLHEKADGASQLDWLTRLKI 712
E++ L T H+ +++L +H +R M L D + L + I
Sbjct: 136 EIDILKTISHRAIINL----IH-AYRWKSTVCMVMPKYKCDLFTYVDRSGPLPLEQAITI 190
Query: 713 ARGTSCGLAYMHQICEPHIVHRDIKSSNILLDDQFEAHLADFGLSRLILPYQTHVTTELV 772
R LAY+H I+HRD+K+ NI LD+ A L DFG + +
Sbjct: 191 QRRLLEALAYLH---GRGIIHRDVKTENIFLDEPENAVLGDFGAA-----CKLDAHP--- 239
Query: 773 GTLGYIPPEYGQAWVATL---------------RGDMYSFGVVMLELLTGKRP 810
P YG W TL + D++S G+V+ E+
Sbjct: 240 ----DTPQCYG--WSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVT 286
|
Length = 392 |
| >gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 48.3 bits (115), Expect = 1e-05
Identities = 27/89 (30%), Positives = 45/89 (50%), Gaps = 7/89 (7%)
Query: 722 YMHQICEPHIVHRDIKSSNILLDDQFEAHLADFGLSRLILPYQTHVTTELVGTLGYIPPE 781
Y+H I++RD+K N+LLD++ + DFG ++ + T L GT Y+ PE
Sbjct: 133 YLH---SKDIIYRDLKPENLLLDNKGHVKVTDFGFAKKV----PDRTFTLCGTPEYLAPE 185
Query: 782 YGQAWVATLRGDMYSFGVVMLELLTGKRP 810
Q+ D ++ GV++ E + G P
Sbjct: 186 VIQSKGHGKAVDWWTMGVLLYEFIAGYPP 214
|
Length = 329 |
| >gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Score = 48.1 bits (114), Expect = 1e-05
Identities = 58/208 (27%), Positives = 91/208 (43%), Gaps = 25/208 (12%)
Query: 614 IIGCGGFG-LVYKATLANGTTLAIKKLSGDLGLMEREFK---AEVEALSTAQHKNLVSLQ 669
++G G FG ++ A G A+K L ++ + + E E L ++H L +L+
Sbjct: 2 LLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALK 61
Query: 670 GYCVHQGFRL-LIYSYMENGSLDYWLHEKADGASQLDWLTRLKIARGTSCGLAYMHQICE 728
Y RL + Y G L + H + D R A S L Y+H E
Sbjct: 62 -YSFQTHDRLCFVMEYANGGEL--FFHLSRERVFSED-RARFYGAEIVS-ALDYLHS--E 114
Query: 729 PHIVHRDIKSSNILLDDQFEAHLADFGLSRLILPYQTHVTTELVGTLGYIPPE------Y 782
++V+RD+K N++LD + DFGL + + + T GT Y+ PE Y
Sbjct: 115 KNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKT-FCGTPEYLAPEVLEDNDY 173
Query: 783 GQAWVATLRGDMYSFGVVMLELLTGKRP 810
G+A D + GVVM E++ G+ P
Sbjct: 174 GRAV------DWWGLGVVMYEMMCGRLP 195
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325 |
| >gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 47.8 bits (114), Expect = 1e-05
Identities = 33/97 (34%), Positives = 47/97 (48%), Gaps = 17/97 (17%)
Query: 719 GLAYMHQICEPHIVHRDIKSSNILLDDQFEAHLADFGLSRLILPYQTHVTTELVGTLGYI 778
GL Y+H +++HRD+K SN+LL+ + + DFGL+R + TE V T Y
Sbjct: 120 GLKYIHS---ANVLHRDLKPSNLLLNANCDLKICDFGLARTTSE-KGDFMTEYVVTRWYR 175
Query: 779 PPE-------YGQAWVATLRGDMYSFGVVMLELLTGK 808
PE Y A D++S G + ELL K
Sbjct: 176 APELLLNCSEYTTAI------DVWSVGCIFAELLGRK 206
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337 |
| >gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Score = 47.7 bits (113), Expect = 2e-05
Identities = 59/208 (28%), Positives = 91/208 (43%), Gaps = 21/208 (10%)
Query: 609 FSQANIIGCGGFGLVYKA-TLANGTTLAIKKLSGDLGLMEREFKA--EVEALSTAQHKNL 665
+ Q IG G G+V A G +A+KKLS +A E+ L HKN+
Sbjct: 23 YQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNI 82
Query: 666 VSLQGYCVHQG----FRLLIYSYME--NGSLDYWLHEKADGASQLDWLTRLKIARGTSCG 719
+SL Q F+ + Y ME + +L +H + D ++ +L + CG
Sbjct: 83 ISLLNVFTPQKSLEEFQDV-YLVMELMDANLCQVIHMELD-HERMSYLLYQML-----CG 135
Query: 720 LAYMHQICEPHIVHRDIKSSNILLDDQFEAHLADFGLSRLILPYQTHVTTELVGTLGYIP 779
+ ++H I+HRD+K SNI++ + DFGL+R + T V T Y
Sbjct: 136 IKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDFGLAR--TACTNFMMTPYVVTRYYRA 190
Query: 780 PEYGQAWVATLRGDMYSFGVVMLELLTG 807
PE D++S G +M EL+ G
Sbjct: 191 PEVILGMGYKENVDIWSVGCIMGELVKG 218
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359 |
| >gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 47.3 bits (112), Expect = 2e-05
Identities = 73/352 (20%), Positives = 131/352 (37%), Gaps = 99/352 (28%)
Query: 607 DNFSQANIIGCGGFGLVYKATL------ANGTTLAIKKL-SGDLGLMEREFKAEVEAL-S 658
D ++G G FG V +A+ ++ T+A+K L G + +E++ L
Sbjct: 7 DRLRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGATASEHKALMSELKILIH 66
Query: 659 TAQHKNLVSLQGYCVH-QGFRLLIYSYMENGSLDYWLHEKADG----------------- 700
H N+V+L G C G ++I + + G+L +L K +
Sbjct: 67 IGNHLNVVNLLGACTKPNGPLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRA 126
Query: 701 ---ASQLD--------------------------------WLTRL----------KIARG 715
S++D W + L ++ARG
Sbjct: 127 MVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPPQETDDLWKSPLTMEDLICYSFQVARG 186
Query: 716 TSCGLAYMHQICEPHIVHRDIKSSNILLDDQFEAHLADFGLSRLILPYQTHV---TTELV 772
M + +HRD+ + NILL + + DFGL+R I +V + L
Sbjct: 187 -------MEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARL- 238
Query: 773 GTLGYIPPEYGQAWVATLRGDMYSFGVVMLELLT-GKRPVDVLKPKMSRELVGWVLKMRS 831
L ++ PE V T + D++SFGV++ E+ + G P + +++ E
Sbjct: 239 -PLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGV--QINEEFC-------- 287
Query: 832 EGKQDQVFDPILRGKGFDEEMLQVLDVACMCVSQNPFKRPTVKEVVEWLNNV 883
Q R + + ++ + C +P +RPT +VE L ++
Sbjct: 288 -----QRLKDGTRMRAPENATPEIYRIMLACWQGDPKERPTFSALVEILGDL 334
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338 |
| >gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 47.5 bits (113), Expect = 2e-05
Identities = 31/95 (32%), Positives = 48/95 (50%), Gaps = 9/95 (9%)
Query: 719 GLAYMHQICEPHIVHRDIKSSNILLDDQFEAHLADFGLSRLIL---PYQTHVTTELVGTL 775
L Y+H ++ HRD+K NIL + + + DFGL+R+ P T+ V T
Sbjct: 115 ALKYIHT---ANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAI-FWTDYVATR 170
Query: 776 GYIPPEYGQAWVA--TLRGDMYSFGVVMLELLTGK 808
Y PE ++ + T D++S G + E+LTGK
Sbjct: 171 WYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGK 205
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338 |
| >gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Score = 47.5 bits (113), Expect = 2e-05
Identities = 65/257 (25%), Positives = 93/257 (36%), Gaps = 71/257 (27%)
Query: 609 FSQANIIGCGGFGLVYKATLANGTTL-AIKKLSGDLGLMERE---FKAEVEALSTAQHKN 664
F + IG G FG V + L A+K L LM + KAE + L+ A ++
Sbjct: 3 FVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEW 62
Query: 665 LVSLQGYCVHQGFRLLIYSYMENGSLDYWLHEKADGASQLDWLTRLKI-----AR----G 715
+V L YS+ + +L Y++ + G + L RL I AR
Sbjct: 63 VVKL------------YYSFQDKDNL-YFVMDYIPGGDMMSLLIRLGIFEEDLARFYIAE 109
Query: 716 TSCGLAYMHQICEPHIVHRDIKSSNILLDDQFEAHLADFGL------------------- 756
+C + +H++ +HRDIK NIL+D L DFGL
Sbjct: 110 LTCAIESVHKM---GFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQKGDHH 166
Query: 757 ----------------------SRLILPYQTHVTTE-LVGTLGYIPPEYGQAWVATLRGD 793
R LVGT YI PE T D
Sbjct: 167 RQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCD 226
Query: 794 MYSFGVVMLELLTGKRP 810
+S GV++ E+L G+ P
Sbjct: 227 WWSVGVILYEMLVGQPP 243
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376 |
| >gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 47.2 bits (112), Expect = 3e-05
Identities = 43/176 (24%), Positives = 75/176 (42%), Gaps = 24/176 (13%)
Query: 710 LKIARGTSCGLAYMHQICEPHIVHRDIKSSNILLDDQFEAHLADFGLSRLILPYQTHVTT 769
++ARG M + +HRD+ + NILL + + DFGL+R I +V
Sbjct: 180 FQVARG-------MEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRK 232
Query: 770 -ELVGTLGYIPPEYGQAWVATLRGDMYSFGVVMLELLT-GKRPVDVLKPKMSRELVGWVL 827
+ L ++ PE V T + D++SFGV++ E+ + G P + ++ E +
Sbjct: 233 GDARLPLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGV--QIDEEFCRRLK 290
Query: 828 KMRSEGKQDQVFDPILRGKGFDEEMLQVLDVACMCVSQNPFKRPTVKEVVEWLNNV 883
+ + E+ ++ C NP RPT E+VE L ++
Sbjct: 291 EGTRMRAPEYA----------TPEIYSIM---LDCWHNNPEDRPTFSELVEILGDL 333
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337 |
| >gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Score = 46.9 bits (111), Expect = 3e-05
Identities = 57/208 (27%), Positives = 88/208 (42%), Gaps = 26/208 (12%)
Query: 614 IIGCGGFG-LVYKATLANGTTLAIKKLSGDLGLMEREFK---AEVEALSTAQHKNLVSLQ 669
++G G FG ++ A G A+K L ++ + + E E L +H L +L+
Sbjct: 2 LLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALK 61
Query: 670 GYCVHQGFRL-LIYSYMENGSLDYWLHEKADGASQLDWLTRLKIARGTSCGLAYMHQICE 728
Y RL + Y G L + L + + R A S L Y+H
Sbjct: 62 -YAFQTHDRLCFVMEYANGGELFFHLSRERVFTEER---ARFYGAEIVS-ALEYLHS--- 113
Query: 729 PHIVHRDIKSSNILLDDQFEAHLADFGLSRLILPYQTHVTTELVGTLGYIPPE------Y 782
+V+RDIK N++LD + DFGL + + + T GT Y+ PE Y
Sbjct: 114 RDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKT-FCGTPEYLAPEVLEDNDY 172
Query: 783 GQAWVATLRGDMYSFGVVMLELLTGKRP 810
G+A D + GVVM E++ G+ P
Sbjct: 173 GRAV------DWWGLGVVMYEMMCGRLP 194
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323 |
| >gnl|CDD|173718 cd05629, STKc_NDR_like_fungal, Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 46.8 bits (111), Expect = 3e-05
Identities = 73/273 (26%), Positives = 97/273 (35%), Gaps = 95/273 (34%)
Query: 607 DNFSQANIIGCGGFG---LVYKATLANGTTLAIKKLSGDLGLMEREFK--------AEVE 655
++F +IG G FG LV K G A+K L L FK AE +
Sbjct: 1 EDFHTVKVIGKGAFGEVRLVQK--KDTGKIYAMKTL-----LKSEMFKKDQLAHVKAERD 53
Query: 656 ALSTAQHKNLVSLQGYCVHQGFRLLIYSYMENGSLDYWLHEKADGASQLDWLTRLKIARG 715
L+ + +VSL + LI ++ G L L K D S+ D +TR +A
Sbjct: 54 VLAESDSPWVVSLYYSFQDAQYLYLIMEFLPGGDLMTML-IKYDTFSE-D-VTRFYMAE- 109
Query: 716 TSCGLAYMHQICEPHIVHRDIKSSNILLDDQFEAHLADFGLS------------------ 757
C LA + + + +HRDIK NIL+D L+DFGLS
Sbjct: 110 --CVLA-IEAVHKLGFIHRDIKPDNILIDRGGHIKLSDFGLSTGFHKQHDSAYYQKLLQG 166
Query: 758 ----------------------------------RLILPYQTHVTTELVGTLGYIPPE-- 781
R ++ Y T VGT YI PE
Sbjct: 167 KSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYST------VGTPDYIAPEIF 220
Query: 782 ----YGQAWVATLRGDMYSFGVVMLELLTGKRP 810
YGQ D +S G +M E L G P
Sbjct: 221 LQQGYGQ------ECDWWSLGAIMFECLIGWPP 247
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of Ace2p activity and cellular morphogenesis) network. CBK1 and Orb6 play similar roles in coordinating cell morphology with cell cycle progression. Ukc1 is involved in morphogenesis, pathogenicity, and pigment formation. Cot1 plays a role in polar tip extension. Length = 377 |
| >gnl|CDD|205079 pfam12799, LRR_4, Leucine Rich repeats (2 copies) | Back alignment and domain information |
|---|
Score = 41.3 bits (98), Expect = 3e-05
Identities = 20/37 (54%), Positives = 25/37 (67%), Gaps = 2/37 (5%)
Query: 409 KSLHVLDLSNNNFSGTIPDELSDLSNLEKLDLSGNHL 445
+L LDLSNN + +P LS+L NLE LDLSGN +
Sbjct: 1 TNLETLDLSNNQIT-DLP-PLSNLPNLETLDLSGNKI 35
|
Leucine rich repeats are short sequence motifs present in a number of proteins with diverse functions and cellular locations. These repeats are usually involved in protein-protein interactions. Each Leucine Rich Repeat is composed of a beta-alpha unit. These units form elongated non-globular structures. Leucine Rich Repeats are often flanked by cysteine rich domains. Length = 43 |
| >gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Score = 46.8 bits (111), Expect = 5e-05
Identities = 44/159 (27%), Positives = 70/159 (44%), Gaps = 27/159 (16%)
Query: 615 IGCGGFGLVYKATLANGTTL-AIKKLSGDLGL---MEREFKAEVEALSTAQHKNLVSLQG 670
I G FG VY N + L A+K + + M + +AE +AL+ +S
Sbjct: 12 ISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALA-------LSKSP 64
Query: 671 YCVHQGFRL-------LIYSYMENGSLDYWLHEKADGASQLDWLTRLKIARGTSCGLAYM 723
+ VH + L L+ Y+ G + LH D +K + L Y+
Sbjct: 65 FIVHLYYSLQSANNVYLVMEYLIGGDVKSLLHIYG----YFDEEMAVKYISEVALALDYL 120
Query: 724 HQICEPH-IVHRDIKSSNILLDDQFEAHLADFGLSRLIL 761
H+ H I+HRD+K N+L+ ++ L DFGLS++ L
Sbjct: 121 HR----HGIIHRDLKPDNMLISNEGHIKLTDFGLSKVTL 155
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669 |
| >gnl|CDD|133207 cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 45.7 bits (108), Expect = 6e-05
Identities = 51/232 (21%), Positives = 101/232 (43%), Gaps = 42/232 (18%)
Query: 657 LSTAQHKNLVSLQGYCVHQGFRLLIYSYMENGSLDYWLHEKADGASQLDWLTRLKIARGT 716
+S H +L + G CV +++ ++E+G LD L K G + W ++ +A+
Sbjct: 70 MSQVSHIHLAFVHGVCVRGSENIMVEEFVEHGPLDVCL-RKEKGRVPVAW--KITVAQQL 126
Query: 717 SCGLAYMHQICEPHIVHRDIKSSNILL-------DDQFEAHLADFGLSRLILPYQTHVTT 769
+ L+Y+ + ++VH ++ + NILL L+D G+S L +
Sbjct: 127 ASALSYLE---DKNLVHGNVCAKNILLARLGLAEGTSPFIKLSDPGVSFTALSRE----- 178
Query: 770 ELVGTLGYIPPEYGQAWVATLR--GDMYSFGVVMLEL-LTGKRPVDVLKPKMSRELVGWV 826
E V + +I PE +L D +SFG +LE+ G+ P
Sbjct: 179 ERVERIPWIAPECVPG-GNSLSTAADKWSFGTTLLEICFDGEVP---------------- 221
Query: 827 LKMRSEGKQDQVFDPILRGKGFDEEMLQVL-DVACMCVSQNPFKRPTVKEVV 877
LK R+ ++++ ++ + E + L + C++ P +RP+ + ++
Sbjct: 222 LKERTPSEKERFYE---KKHRLPEPSCKELATLISQCLTYEPTQRPSFRTIL 270
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 274 |
| >gnl|CDD|173714 cd05625, STKc_LATS1, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Score = 45.4 bits (107), Expect = 9e-05
Identities = 64/277 (23%), Positives = 101/277 (36%), Gaps = 76/277 (27%)
Query: 609 FSQANIIGCGGFGLVYKATLANGTTL-AIKKLSGDLGLMEREF---KAEVEALSTAQHKN 664
F + +G G FG V A + L A+K L L+ + KAE + L+ A ++
Sbjct: 3 FVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEW 62
Query: 665 LVSLQGYCVHQGFRLLIYSYMENGSLDYWLHEKADGASQLDWLTRLKIARGT-------- 716
+V L YS+ + +L Y++ + G + L R+ I
Sbjct: 63 VVRL------------YYSFQDKDNL-YFVMDYIPGGDMMSLLIRMGIFPEDLARFYIAE 109
Query: 717 -SCGLAYMHQICEPHIVHRDIKSSNILLDDQFEAHLADFGLS------------------ 757
+C + +H++ +HRDIK NIL+D L DFGL
Sbjct: 110 LTCAVESVHKM---GFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQSGDHV 166
Query: 758 ----------------------------RLILPYQTHVTTELVGTLGYIPPEYGQAWVAT 789
R +Q + LVGT YI PE T
Sbjct: 167 RQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYT 226
Query: 790 LRGDMYSFGVVMLELLTGKRPVDVLKP-KMSRELVGW 825
D +S GV++ E+L G+ P P + +++ W
Sbjct: 227 QLCDWWSVGVILYEMLVGQPPFLAQTPLETQMKVINW 263
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype and poor prognosis. LATS1 induces G2 arrest and promotes cytokinesis. It may be a component of the mitotic exit network in higher eukaryotes. Length = 382 |
| >gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Score = 45.4 bits (107), Expect = 1e-04
Identities = 62/230 (26%), Positives = 92/230 (40%), Gaps = 45/230 (19%)
Query: 603 LKATDNFSQANIIGCGGFGLVYKATLANGTTLAIKKLSGDLGLMERE----FKAEVEALS 658
+KA D + +IG G FG V + + KL +++R F E + ++
Sbjct: 40 MKAED-YDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMA 98
Query: 659 TAQHKNLVSLQGYCVHQGFRLL--IYSYMENGSL-----DYWLHEKADGASQLDWLTRLK 711
A +V L +C Q + L + YM G L +Y + EK W +
Sbjct: 99 FANSPWVVQL--FCAFQDDKYLYMVMEYMPGGDLVNLMSNYDVPEK--------W-AKFY 147
Query: 712 IARGTSCGLAYMHQICEPHIVHRDIKSSNILLDDQFEAHLADFGLS-RLILPYQTHVTTE 770
A L +H + ++HRD+K N+LLD LADFG ++ T
Sbjct: 148 TAE-VVLALDAIHSM---GLIHRDVKPDNMLLDKHGHLKLADFGTCMKMDETGMVRCDTA 203
Query: 771 LVGTLGYIPPE----------YGQAWVATLRGDMYSFGVVMLELLTGKRP 810
VGT YI PE YG+ D +S GV + E+L G P
Sbjct: 204 -VGTPDYISPEVLKSQGGDGYYGR------ECDWWSVGVFLFEMLVGDTP 246
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370 |
| >gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Score = 45.4 bits (107), Expect = 1e-04
Identities = 64/259 (24%), Positives = 104/259 (40%), Gaps = 48/259 (18%)
Query: 607 DNFSQANIIGCGGFGLVYKATLANGTTLAIKKLSGDLGLMERE----FKAEVEALSTAQH 662
++F +IG G FG V + + K+ ++E+E +AE + L A
Sbjct: 1 EDFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADS 60
Query: 663 KNLVSLQGYCVHQGFRL-LIYSYMENGSLDYWLHEKADGASQLDWLTRLKIARGTSCGLA 721
+V + Y L LI ++ G + L +K D ++ + T+ IA T +
Sbjct: 61 LWVVKM-FYSFQDKLNLYLIMEFLPGGDMMTLLMKK-DTLTEEE--TQFYIAE-TVLAID 115
Query: 722 YMHQICEPHIVHRDIKSSNILLDDQFEAHLADFGL-SRLILPYQTHVTTEL--------- 771
+HQ+ +HRDIK N+LLD + L+DFGL + L ++T L
Sbjct: 116 SIHQL---GFIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAHRTEFYRNLNHSLPSDFT 172
Query: 772 ------------------------VGTLGYIPPEYGQAWVATLRGDMYSFGVVMLELLTG 807
VGT YI PE D +S GV+M E+L G
Sbjct: 173 FQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIG 232
Query: 808 KRPVDVLKPKMS-RELVGW 825
P P+ + ++++ W
Sbjct: 233 YPPFCSETPQETYKKVMNW 251
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363 |
| >gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Score = 45.1 bits (106), Expect = 1e-04
Identities = 63/229 (27%), Positives = 95/229 (41%), Gaps = 33/229 (14%)
Query: 593 EIKDLTIYELLKATDNFSQANIIGCGGFGLV---YKATLANGTTLAIKKLSGDLGLMERE 649
E+ D T + +LK N IG G G+V Y A L +AIKKLS
Sbjct: 7 EVGDST-FTVLKRYQNLKP---IGSGAQGIVCAAYDAVLDR--NVAIKKLSRPFQNQTHA 60
Query: 650 FKA--EVEALSTAQHKNLVSLQGYCVHQGFRLLIYSYMENGSLDYWLHEKADG------A 701
+A E+ + HKN++SL Q +E Y + E D
Sbjct: 61 KRAYRELVLMKCVNHKNIISLLNVFTPQ-------KSLEEFQDVYLVMELMDANLCQVIQ 113
Query: 702 SQLDWLTRLKIARGTSCGLAYMHQICEPHIVHRDIKSSNILLDDQFEAHLADFGLSRLIL 761
+LD + CG+ ++H I+HRD+K SNI++ + DFGL+R
Sbjct: 114 MELDHERMSYLLYQMLCGIKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDFGLAR--T 168
Query: 762 PYQTHVTTELVGTLGYIPPE--YGQAWVATLRGDMYSFGVVMLELLTGK 808
+ + T V T Y PE G + + D++S G +M E++ K
Sbjct: 169 AGTSFMMTPYVVTRYYRAPEVILGMGYKENV--DIWSVGCIMGEMVRHK 215
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355 |
| >gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Score = 44.6 bits (105), Expect = 1e-04
Identities = 63/243 (25%), Positives = 94/243 (38%), Gaps = 43/243 (17%)
Query: 587 FPNNTNEIKDLTIYELLKATDNFSQANIIGCGGFGLVYKATLANGTTLAIKKLSGDLGLM 646
+ + N+I+DL +KA D + +IG G FG V + + KL ++
Sbjct: 28 YKDTINKIRDLR----MKAED-YEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMI 82
Query: 647 ERE----FKAEVEALSTAQHKNLVSLQGYCVHQGFRLLIYSYMENGSL-----DYWLHEK 697
+R F E + ++ A +V L + ++ YM G L +Y + EK
Sbjct: 83 KRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDRYLYMVMEYMPGGDLVNLMSNYDVPEK 142
Query: 698 ADGASQLDWLTRLKIARGTSCGLAYMHQICEPHIVHRDIKSSNILLDDQFEAHLADFGLS 757
W R A L +H + +HRD+K N+LLD LADFG
Sbjct: 143 --------W-ARFYTAE-VVLALDAIHSM---GFIHRDVKPDNMLLDKSGHLKLADFGTC 189
Query: 758 RLILPYQTHVTTELVGTLGYIPPE----------YGQAWVATLRGDMYSFGVVMLELLTG 807
+ VGT YI PE YG+ D +S GV + E+L G
Sbjct: 190 MKMNKEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGR------ECDWWSVGVFLYEMLVG 243
Query: 808 KRP 810
P
Sbjct: 244 DTP 246
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371 |
| >gnl|CDD|173667 cd05576, STKc_RPK118_like, Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Score = 44.1 bits (104), Expect = 1e-04
Identities = 43/151 (28%), Positives = 62/151 (41%), Gaps = 23/151 (15%)
Query: 664 NLVSLQGYCVHQGFRLLIYSYMENGSLDYW------LHEKADGASQLDWLTRLKIARGTS 717
N+V L Y V + L+ + E G L W L+ + + W + +A
Sbjct: 46 NMVCLHKYIVSEDSVFLVLQHAEGGKL--WSHISKFLNIPEECVKR--WAAEMVVA---- 97
Query: 718 CGLAYMHQICEPHIVHRDIKSSNILLDDQFEAHLADFGLSRLILPYQTHVTTELVGTLGY 777
L +H+ IV RD+ +NILLDD+ L F + E V + Y
Sbjct: 98 --LDALHR---EGIVCRDLNPNNILLDDRGHIQLTYFSRWSEVED---SCDGEAVENM-Y 148
Query: 778 IPPEYGQAWVATLRGDMYSFGVVMLELLTGK 808
PE G T D +S G ++ ELLTGK
Sbjct: 149 CAPEVGGISEETEACDWWSLGAILFELLTGK 179
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phosphate (SPP), a lipid messenger involved in many cellular events. RPK118 may be involved in transmitting SPP-mediated signaling. RPK118 also binds the antioxidant peroxiredoxin-3 (PRDX3). RPK118 may be involved in the transport of PRDX3 from the cytoplasm to its site of function in the mitochondria. Length = 237 |
| >gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Score = 44.7 bits (105), Expect = 1e-04
Identities = 55/213 (25%), Positives = 99/213 (46%), Gaps = 27/213 (12%)
Query: 615 IGCGGFGLVYKATLANGT---TLAIKKLSGDLGLMEREFKAEVEALSTAQHKNLVSLQGY 671
+G G +G VYKA +G A+K++ G G+ + E+ L +H N+++LQ
Sbjct: 9 VGRGTYGHVYKAKRKDGKDEKEYALKQIEGT-GISMSACR-EIALLRELKHPNVIALQKV 66
Query: 672 CVHQGFR--LLIYSYMENGSLDYWLHEKADGASQLDWLTRLKIARGTSCGLAY-----MH 724
+ R L++ Y E+ D W K AS+ + +++ R L Y +H
Sbjct: 67 FLSHSDRKVWLLFDYAEH---DLWHIIKFHRASKAN-KKPMQLPRSMVKSLLYQILDGIH 122
Query: 725 QICEPHIVHRDIKSSNILL----DDQFEAHLADFGLSRLI-LPYQTHVTTE-LVGTLGYI 778
+ ++HRD+K +NIL+ ++ +AD G +RL P + + +V T Y
Sbjct: 123 YLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYR 182
Query: 779 PPEY---GQAWVATLRGDMYSFGVVMLELLTGK 808
PE + + + D+++ G + ELLT +
Sbjct: 183 APELLLGARHYTKAI--DIWAIGCIFAELLTSE 213
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317 |
| >gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Score = 44.5 bits (105), Expect = 2e-04
Identities = 43/157 (27%), Positives = 69/157 (43%), Gaps = 33/157 (21%)
Query: 732 VHRDIKSSNILLDDQFEAHLADFGLSRLILPYQTHVTTELVGT----LGYIPPEYGQAWV 787
+HRD+ + NILL + DFGL+R I +V G + ++ PE V
Sbjct: 236 IHRDLAARNILLTHGRITKICDFGLARDIRNDSNYVVK---GNARLPVKWMAPESIFNCV 292
Query: 788 ATLRGDMYSFGVVMLELLT------GKRPVDVLKPKMSRELVGWVLKMRSEGKQDQVFDP 841
T D++S+G+++ E+ + PVD KM +E G+ +M S P
Sbjct: 293 YTFESDVWSYGILLWEIFSLGSSPYPGMPVDSKFYKMIKE--GY--RMLSPE-----CAP 343
Query: 842 ILRGKGFDEEMLQVLDVACMCVSQNPFKRPTVKEVVE 878
EM ++ C +P KRPT K++V+
Sbjct: 344 --------SEMYDIMK---SCWDADPLKRPTFKQIVQ 369
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375 |
| >gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Score = 43.9 bits (103), Expect = 3e-04
Identities = 66/233 (28%), Positives = 101/233 (43%), Gaps = 41/233 (17%)
Query: 593 EIKDLTIYELLKATDNFSQANIIGCGGFGLV---YKATLANGTTLAIKKLSGDLGLMERE 649
EI D T + +LK N IG G G+V Y A L +AIKKLS R
Sbjct: 14 EIGDST-FTVLKRYQNLKP---IGSGAQGIVCAAYDAILER--NVAIKKLS-------RP 60
Query: 650 FKAEVEALSTAQHKNLVSLQGYCV-HQGFRLLIYSYMENGSLD-----YWLHEKADG--- 700
F+ + A ++ LV ++ CV H+ L+ + SL+ Y + E D
Sbjct: 61 FQNQTHA--KRAYRELVLMK--CVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLC 116
Query: 701 ---ASQLDWLTRLKIARGTSCGLAYMHQICEPHIVHRDIKSSNILLDDQFEAHLADFGLS 757
+LD + CG+ ++H I+HRD+K SNI++ + DFGL+
Sbjct: 117 QVIQMELDHERMSYLLYQMLCGIKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDFGLA 173
Query: 758 RLILPYQTHVTTELVGTLGYIPPE--YGQAWVATLRGDMYSFGVVMLELLTGK 808
R + + T V T Y PE G + + D++S G +M E++ G
Sbjct: 174 R--TAGTSFMMTPYVVTRYYRAPEVILGMGYKENV--DIWSVGCIMGEMIKGG 222
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364 |
| >gnl|CDD|165211 PHA02882, PHA02882, putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Score = 43.4 bits (102), Expect = 3e-04
Identities = 52/224 (23%), Positives = 84/224 (37%), Gaps = 29/224 (12%)
Query: 614 IIGCGGFGLVYKATLANGTTLAIKKLSGDLGLMEREFKAEVEALSTAQHKNLVSLQGYCV 673
+IGCGGFG VY+ A+ + + ++ L E + + ++L +
Sbjct: 19 LIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKN-I 77
Query: 674 HQGFRLLIYSYMENGSLDY--------WLHEKADGASQLDWLTRLK---------IARGT 716
H L I Y GS L + + ++ R+K I +
Sbjct: 78 HNIDHLGIPKYYGCGSFKRCRMYYRFILLEKLVENTKEI--FKRIKCKNKKLIKNIMKDM 135
Query: 717 SCGLAYMHQICEPHIVHRDIKSSNILLDDQFEAHLADFGLSRLILPYQTHVTTEL----- 771
L Y+H E I H DIK NI++D ++ D+G++ + + H+
Sbjct: 136 LTTLEYIH---EHGISHGDIKPENIMVDGNNRGYIIDYGIASHFIIHGKHIEYSKEQKDL 192
Query: 772 -VGTLGYIPPEYGQAWVATLRGDMYSFGVVMLELLTGKRPVDVL 814
GTL Y + T RGD+ S G ML+ K P
Sbjct: 193 HRGTLYYAGLDAHNGACVTRRGDLESLGYCMLKWAGIKLPWKGF 236
|
Length = 294 |
| >gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 43.8 bits (103), Expect = 3e-04
Identities = 31/105 (29%), Positives = 47/105 (44%), Gaps = 15/105 (14%)
Query: 710 LKIARGTSCGLAYMHQICEPHIVHRDIKSSNILLDDQFEAHLADFGLSRLILPYQTHVTT 769
L I R + Y+H E I+HRDIK+ NI ++ + L DFG + + +
Sbjct: 185 LAIERSVLRAIQYLH---ENRIIHRDIKAENIFINHPGDVCLGDFGAACFPVDINANKYY 241
Query: 770 ELVGTLGYIPPE------YGQAWVATLRGDMYSFGVVMLELLTGK 808
GT+ PE YG A D++S G+V+ E+ T
Sbjct: 242 GWAGTIATNAPELLARDPYGPAV------DIWSAGIVLFEMATCH 280
|
Length = 391 |
| >gnl|CDD|173502 PTZ00266, PTZ00266, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 43.6 bits (102), Expect = 4e-04
Identities = 60/243 (24%), Positives = 94/243 (38%), Gaps = 41/243 (16%)
Query: 597 LTIYELLKATDNFSQANIIGCGGFGLVYKATLANGTTLAIKKLSGDLGLMERE---FKAE 653
L YE++K IG G FG V+ K GL ERE E
Sbjct: 12 LNEYEVIKK---------IGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVIE 62
Query: 654 VEALSTAQHKNLVSLQGYCVHQGFRLL--IYSYMENGSLDYWLHEKADGASQLDWLTRLK 711
V + +HKN+V +++ + L + + + G L + + +++ +
Sbjct: 63 VNVMRELKHKNIVRYIDRFLNKANQKLYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVD 122
Query: 712 IARGTSCGLAYMHQICE----PHIVHRDIKSSNILLDDQFE-----------------AH 750
I R LAY H + + ++HRD+K NI L A
Sbjct: 123 ITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKITAQANNLNGRPIAK 182
Query: 751 LADFGLSRLI-LPYQTHVTTELVGTLGYIPPEYGQAWVATL--RGDMYSFGVVMLELLTG 807
+ DFGLS+ I + H VGT Y PE + + DM++ G ++ EL +G
Sbjct: 183 IGDFGLSKNIGIESMAH---SCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSG 239
Query: 808 KRP 810
K P
Sbjct: 240 KTP 242
|
Length = 1021 |
| >gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Score = 43.0 bits (101), Expect = 6e-04
Identities = 36/102 (35%), Positives = 48/102 (47%), Gaps = 10/102 (9%)
Query: 607 DNFSQANIIGCGGFGLVYKATLANG-------TTLAIKKLSGDLGLMERE-FKAEVEALS 658
+ S +G G FG V +AT A G T+A+K L L ERE +E++ LS
Sbjct: 35 NRLSFGKTLGAGAFGKVVEAT-AYGLFKSDAAMTVAVKMLKPSAHLTEREALMSELKVLS 93
Query: 659 -TAQHKNLVSLQGYCVHQGFRLLIYSYMENGSLDYWLHEKAD 699
H N+V+L G C G L+I Y G L +L K D
Sbjct: 94 YLGNHINIVNLLGACTVGGPTLVITEYCCYGDLLNFLRRKRD 135
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375 |
| >gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Score = 42.8 bits (101), Expect = 6e-04
Identities = 60/231 (25%), Positives = 92/231 (39%), Gaps = 77/231 (33%)
Query: 615 IGCGGFGLVYKA-TLANGTTLAIKKLSGDLGLMEREFKAEVEA---------LSTAQHKN 664
IG G G+V A G +AIKKLS R F+ A + HKN
Sbjct: 24 IGSGAQGIVCAAYDTVTGQNVAIKKLS-------RPFQNVTHAKRAYRELVLMKLVNHKN 76
Query: 665 LVSLQGYCVHQGFRLL-----IYSYME----------NGSLDYWLHEKADGASQLDWLTR 709
++ L Q + L +Y ME LD HE+ + +L
Sbjct: 77 IIGLLNVFTPQ--KSLEEFQDVYLVMELMDANLCQVIQMDLD---HER------MSYLLY 125
Query: 710 LKIARGTSCGLAYMHQICEPHIVHRDIKSSNILLDDQFEAHLADFGLSR------LILPY 763
+ CG+ ++H I+HRD+K SNI++ + DFGL+R ++ PY
Sbjct: 126 QML-----CGIKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPY 177
Query: 764 QTHVTT------ELVGTLGYIPPEYGQAWVATLRGDMYSFGVVMLELLTGK 808
V T E++ +GY + V D++S G +M E++ G
Sbjct: 178 ---VVTRYYRAPEVILGMGY------KENV-----DIWSVGCIMGEMIRGT 214
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353 |
| >gnl|CDD|227223 COG4886, COG4886, Leucine-rich repeat (LRR) protein [Function unknown] | Back alignment and domain information |
|---|
Score = 42.6 bits (100), Expect = 8e-04
Identities = 31/94 (32%), Positives = 44/94 (46%), Gaps = 12/94 (12%)
Query: 377 NQQYNQLSNLPPAI---------YLANNSLSGNIPVEIGQLKSLHVLDLSNNNFSGTIPD 427
+ N + L ++ L+NN L ++P IG L +L LDLSNN +
Sbjct: 215 DLSNNSIIELLSSLSNLKNLSGLELSNNKLE-DLPESIGNLSNLETLDLSNNQ--ISSIS 271
Query: 428 ELSDLSNLEKLDLSGNHLVGEIPISLKGLHFLSS 461
L L+NL +LDLSGN L +P+ L L
Sbjct: 272 SLGSLTNLRELDLSGNSLSNALPLIALLLLLLEL 305
|
Length = 394 |
| >gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 41.8 bits (98), Expect = 0.001
Identities = 43/158 (27%), Positives = 74/158 (46%), Gaps = 29/158 (18%)
Query: 732 VHRDIKSSNILLDDQFEAHLADFGLSRLILPYQTHVTTELVGT----LGYIPPEYGQAWV 787
+HRD+ + N+LL D A + DFGL+R I+ +V G + ++ PE V
Sbjct: 234 IHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNYVVK---GNARLPVKWMAPESIFDCV 290
Query: 788 ATLRGDMYSFGVVMLELLT-GKRPVDVLKPKMSRELVGWVL-KMRSEGKQ--DQVFDPIL 843
T++ D++S+G+++ E+ + GK P P + LV KM G Q F P
Sbjct: 291 YTVQSDVWSYGILLWEIFSLGKSPY----PGI---LVNSKFYKMVKRGYQMSRPDFAPP- 342
Query: 844 RGKGFDEEMLQVLDVACMCVSQNPFKRPTVKEVVEWLN 881
E+ ++ MC + P +RPT ++ + +
Sbjct: 343 -------EIYSIMK---MCWNLEPTERPTFSQISQLIQ 370
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374 |
| >gnl|CDD|205079 pfam12799, LRR_4, Leucine Rich repeats (2 copies) | Back alignment and domain information |
|---|
Score = 37.1 bits (87), Expect = 0.001
Identities = 15/48 (31%), Positives = 25/48 (52%), Gaps = 10/48 (20%)
Query: 390 IYLANNSLSGNIPVEIGQLKSLHVLDLSNNNFSGTIPDELSDLSNLEK 437
+ L+NN ++ ++P + L +L LDLS N ++DLS L
Sbjct: 6 LDLSNNQIT-DLP-PLSNLPNLETLDLSGNK--------ITDLSPLSN 43
|
Leucine rich repeats are short sequence motifs present in a number of proteins with diverse functions and cellular locations. These repeats are usually involved in protein-protein interactions. Each Leucine Rich Repeat is composed of a beta-alpha unit. These units form elongated non-globular structures. Leucine Rich Repeats are often flanked by cysteine rich domains. Length = 43 |
| >gnl|CDD|173715 cd05626, STKc_LATS2, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Score = 41.2 bits (96), Expect = 0.002
Identities = 62/274 (22%), Positives = 99/274 (36%), Gaps = 70/274 (25%)
Query: 609 FSQANIIGCGGFGLVYKATLANGTTLAIKKLSGDLGLMER----EFKAEVEALSTAQHKN 664
F + +G G FG V A + L K ++ R KAE + L+ A ++
Sbjct: 3 FVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEW 62
Query: 665 LVSLQGYCVHQGFRLLIYSYMENGSLDYWLHEKADGASQLDWLTRLKI-----ARGTSCG 719
+V L YS+ + +L Y++ + G + L R+++ AR
Sbjct: 63 VVKL------------YYSFQDKDNL-YFVMDYIPGGDMMSLLIRMEVFPEVLARFYIAE 109
Query: 720 LAY-MHQICEPHIVHRDIKSSNILLDDQFEAHLADFGL---------------------- 756
L + + + +HRDIK NIL+D L DFGL
Sbjct: 110 LTLAIESVHKMGFIHRDIKPDNILIDLDGHIKLTDFGLCTGFRWTHNSKYYQKGSHIRQD 169
Query: 757 ------------------------SRLILPYQTHVTTELVGTLGYIPPEYGQAWVATLRG 792
R +Q + LVGT YI PE T
Sbjct: 170 SMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLC 229
Query: 793 DMYSFGVVMLELLTGKRPVDVLKPKMSR-ELVGW 825
D +S GV++ E+L G+ P P ++ +++ W
Sbjct: 230 DWWSVGVILFEMLVGQPPFLAPTPTETQLKVINW 263
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with poor prognosis in acute lymphoblastic leukemia and breast cancer. Length = 381 |
| >gnl|CDD|140307 PTZ00284, PTZ00284, protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 40.3 bits (94), Expect = 0.004
Identities = 38/134 (28%), Positives = 55/134 (41%), Gaps = 31/134 (23%)
Query: 700 GASQLDWLTR---------LKIARGTSCGLAYMHQICEPHIVHRDIKSSNILLDDQFEAH 750
G LDW+ + +I T L Y H E H++H D+K NIL++
Sbjct: 215 GPCLLDWIMKHGPFSHRHLAQIIFQTGVALDYFHT--ELHLMHTDLKPENILMETSDTV- 271
Query: 751 LADFGLSRLILPY--------------QTHVTTELVGTLGYIPPE--YGQAWVATLRGDM 794
D +R + P + H T +V T Y PE G W+ + DM
Sbjct: 272 -VDPVTNRALPPDPCRVRICDLGGCCDERHSRTAIVSTRHYRSPEVVLGLGWMYST--DM 328
Query: 795 YSFGVVMLELLTGK 808
+S G ++ EL TGK
Sbjct: 329 WSMGCIIYELYTGK 342
|
Length = 467 |
Conserved Domains Detected by HHsearch
Original result of HHsearch against CDD database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 894 | |||
| PLN00113 | 968 | leucine-rich repeat receptor-like protein kinase; | 100.0 | |
| KOG1187 | 361 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| PF09353 | 209 | DUF1995: Domain of unknown function (DUF1995); Int | 100.0 | |
| PLN02842 | 505 | nucleotide kinase | 100.0 | |
| KOG0192 | 362 | consensus Tyrosine kinase specific for activated ( | 100.0 | |
| KOG0581 | 364 | consensus Mitogen-activated protein kinase kinase | 100.0 | |
| KOG0575 | 592 | consensus Polo-like serine/threonine protein kinas | 100.0 | |
| KOG0197 | 468 | consensus Tyrosine kinases [Signal transduction me | 100.0 | |
| KOG0615 | 475 | consensus Serine/threonine protein kinase Chk2 and | 100.0 | |
| KOG0595 | 429 | consensus Serine/threonine-protein kinase involved | 100.0 | |
| KOG1026 | 774 | consensus Nerve growth factor receptor TRKA and re | 100.0 | |
| KOG0591 | 375 | consensus NIMA (never in mitosis)-related G2-speci | 100.0 | |
| KOG0593 | 396 | consensus Predicted protein kinase KKIAMRE [Genera | 100.0 | |
| KOG0598 | 357 | consensus Ribosomal protein S6 kinase and related | 100.0 | |
| KOG0582 | 516 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| KOG0600 | 560 | consensus Cdc2-related protein kinase [Cell cycle | 100.0 | |
| KOG0198 | 313 | consensus MEKK and related serine/threonine protei | 100.0 | |
| KOG0659 | 318 | consensus Cdk activating kinase (CAK)/RNA polymera | 100.0 | |
| KOG0661 | 538 | consensus MAPK related serine/threonine protein ki | 100.0 | |
| KOG0592 | 604 | consensus 3-phosphoinositide-dependent protein kin | 100.0 | |
| KOG0193 | 678 | consensus Serine/threonine protein kinase RAF [Sig | 100.0 | |
| KOG0578 | 550 | consensus p21-activated serine/threonine protein k | 100.0 | |
| cd05102 | 338 | PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG0196 | 996 | consensus Tyrosine kinase, EPH (ephrin) receptor f | 100.0 | |
| KOG0597 | 808 | consensus Serine-threonine protein kinase FUSED [G | 100.0 | |
| KOG0583 | 370 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| PHA02988 | 283 | hypothetical protein; Provisional | 100.0 | |
| cd05096 | 304 | PTKc_DDR1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0616 | 355 | consensus cAMP-dependent protein kinase catalytic | 100.0 | |
| cd05631 | 285 | STKc_GRK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG1095 | 1025 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| KOG0194 | 474 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| cd06649 | 331 | PKc_MEK2 Catalytic domain of the dual-specificity | 100.0 | |
| KOG0605 | 550 | consensus NDR and related serine/threonine kinases | 100.0 | |
| cd05064 | 266 | PTKc_EphR_A10 Catalytic domain of the Protein Tyro | 100.0 | |
| KOG4721 | 904 | consensus Serine/threonine protein kinase, contain | 100.0 | |
| cd05104 | 375 | PTKc_Kit Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07848 | 287 | STKc_CDKL5 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd05072 | 261 | PTKc_Lyn Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0588 | 786 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| KOG0201 | 467 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05114 | 256 | PTKc_Tec_Rlk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05612 | 291 | STKc_PRKX_like Catalytic domain of PRKX-like Prote | 100.0 | |
| KOG0611 | 668 | consensus Predicted serine/threonine protein kinas | 100.0 | |
| cd05106 | 374 | PTKc_CSF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05600 | 333 | STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- | 100.0 | |
| PF07714 | 259 | Pkinase_Tyr: Protein tyrosine kinase Protein kinas | 100.0 | |
| KOG1989 | 738 | consensus ARK protein kinase family [Signal transd | 100.0 | |
| cd05068 | 261 | PTKc_Frk_like Catalytic domain of Fyn-related kina | 100.0 | |
| cd07859 | 338 | STKc_TDY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| KOG0658 | 364 | consensus Glycogen synthase kinase-3 [Carbohydrate | 100.0 | |
| KOG1094 | 807 | consensus Discoidin domain receptor DDR1 [Signal t | 100.0 | |
| cd06650 | 333 | PKc_MEK1 Catalytic domain of the dual-specificity | 100.0 | |
| cd08228 | 267 | STKc_Nek6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07871 | 288 | STKc_PCTAIRE3 Catalytic domain of the Serine/Threo | 100.0 | |
| KOG0580 | 281 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| PTZ00267 | 478 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd05148 | 261 | PTKc_Srm_Brk Catalytic domain of the Protein Tyros | 100.0 | |
| cd07869 | 303 | STKc_PFTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05052 | 263 | PTKc_Abl Catalytic domain of the Protein Tyrosine | 100.0 | |
| PTZ00263 | 329 | protein kinase A catalytic subunit; Provisional | 100.0 | |
| KOG0585 | 576 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd05048 | 283 | PTKc_Ror Catalytic Domain of the Protein Tyrosine | 100.0 | |
| cd05571 | 323 | STKc_PKB Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05049 | 280 | PTKc_Trk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05033 | 266 | PTKc_EphR Catalytic domain of Ephrin Receptor Prot | 100.0 | |
| PHA03212 | 391 | serine/threonine kinase US3; Provisional | 100.0 | |
| KOG4278 | 1157 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| cd05108 | 316 | PTKc_EGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05093 | 288 | PTKc_TrkB Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05113 | 256 | PTKc_Btk_Bmx Catalytic domain of the Protein Tyros | 100.0 | |
| KOG0694 | 694 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG2345 | 302 | consensus Serine/threonine protein kinase/TGF-beta | 100.0 | |
| cd05080 | 283 | PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd05614 | 332 | STKc_MSK2_N N-terminal catalytic domain of the Pro | 100.0 | |
| cd05059 | 256 | PTKc_Tec_like Catalytic domain of Tec-like Protein | 100.0 | |
| cd08224 | 267 | STKc_Nek6_Nek7 Catalytic domain of the Protein Ser | 100.0 | |
| cd05094 | 291 | PTKc_TrkC Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd08229 | 267 | STKc_Nek7 Catalytic domain of the Protein Serine/T | 100.0 | |
| PLN00034 | 353 | mitogen-activated protein kinase kinase; Provision | 100.0 | |
| cd05608 | 280 | STKc_GRK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05105 | 400 | PTKc_PDGFR_alpha Catalytic domain of the Protein T | 100.0 | |
| PTZ00426 | 340 | cAMP-dependent protein kinase catalytic subunit; P | 100.0 | |
| cd05070 | 260 | PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros | 100.0 | |
| cd07862 | 290 | STKc_CDK6 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05595 | 323 | STKc_PKB_beta Catalytic domain of the Protein Seri | 100.0 | |
| KOG0663 | 419 | consensus Protein kinase PITSLRE and related kinas | 100.0 | |
| cd05585 | 312 | STKc_YPK1_like Catalytic domain of Yeast Protein K | 100.0 | |
| KOG0660 | 359 | consensus Mitogen-activated protein kinase [Signal | 100.0 | |
| PTZ00036 | 440 | glycogen synthase kinase; Provisional | 100.0 | |
| cd05573 | 350 | STKc_ROCK_NDR_like Catalytic domain of ROCK- and N | 100.0 | |
| cd05081 | 284 | PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of | 100.0 | |
| cd05062 | 277 | PTKc_IGF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05090 | 283 | PTKc_Ror1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| PTZ00283 | 496 | serine/threonine protein kinase; Provisional | 100.0 | |
| cd05067 | 260 | PTKc_Lck_Blk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05601 | 330 | STKc_CRIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05593 | 328 | STKc_PKB_gamma Catalytic domain of the Protein Ser | 100.0 | |
| cd06619 | 279 | PKc_MKK5 Catalytic domain of the dual-specificity | 100.0 | |
| cd05605 | 285 | STKc_GRK4_like Catalytic domain of G protein-coupl | 100.0 | |
| cd05045 | 290 | PTKc_RET Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05071 | 262 | PTKc_Src Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05599 | 364 | STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel | 100.0 | |
| cd05111 | 279 | PTK_HER3 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd05054 | 337 | PTKc_VEGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05596 | 370 | STKc_ROCK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05097 | 295 | PTKc_DDR_like Catalytic domain of Discoidin Domain | 100.0 | |
| cd05626 | 381 | STKc_LATS2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05084 | 252 | PTKc_Fes Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG3653 | 534 | consensus Transforming growth factor beta/activin | 100.0 | |
| cd07853 | 372 | STKc_NLK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05043 | 280 | PTK_Ryk Pseudokinase domain of Ryk (Receptor relat | 100.0 | |
| cd05085 | 250 | PTKc_Fer Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05584 | 323 | STKc_p70S6K Catalytic domain of the Protein Serine | 100.0 | |
| KOG0589 | 426 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd05628 | 363 | STKc_NDR1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06646 | 267 | STKc_MAP4K5 Catalytic domain of the Protein Serine | 100.0 | |
| cd05095 | 296 | PTKc_DDR2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05035 | 273 | PTKc_Axl_like Catalytic Domain of Axl-like Protein | 100.0 | |
| cd05053 | 293 | PTKc_FGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05075 | 272 | PTKc_Axl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05092 | 280 | PTKc_TrkA Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05607 | 277 | STKc_GRK7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05069 | 260 | PTKc_Yes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06625 | 263 | STKc_MEKK3_like Catalytic domain of MAP/ERK kinase | 100.0 | |
| cd05594 | 325 | STKc_PKB_alpha Catalytic domain of the Protein Ser | 100.0 | |
| cd05589 | 324 | STKc_PKN Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05032 | 277 | PTKc_InsR_like Catalytic domain of Insulin Recepto | 100.0 | |
| cd05101 | 304 | PTKc_FGFR2 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05034 | 261 | PTKc_Src_like Catalytic domain of Src kinase-like | 100.0 | |
| cd05621 | 370 | STKc_ROCK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05051 | 296 | PTKc_DDR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05618 | 329 | STKc_aPKC_iota Catalytic domain of the Protein Ser | 100.0 | |
| cd05036 | 277 | PTKc_ALK_LTK Catalytic domain of the Protein Tyros | 100.0 | |
| cd05089 | 297 | PTKc_Tie1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0594 | 323 | consensus Protein kinase PCTAIRE and related kinas | 100.0 | |
| cd05592 | 316 | STKc_nPKC_theta_delta Catalytic domain of the Prot | 100.0 | |
| cd05588 | 329 | STKc_aPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05629 | 377 | STKc_NDR_like_fungal Catalytic domain of Fungal Nu | 100.0 | |
| cd05098 | 307 | PTKc_FGFR1 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05063 | 268 | PTKc_EphR_A2 Catalytic domain of the Protein Tyros | 100.0 | |
| cd05109 | 279 | PTKc_HER2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0033 | 355 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd08529 | 256 | STKc_FA2-like Catalytic domain of the Protein Seri | 100.0 | |
| cd05073 | 260 | PTKc_Hck Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05039 | 256 | PTKc_Csk_like Catalytic domain of C-terminal Src k | 100.0 | |
| cd05632 | 285 | STKc_GRK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05587 | 324 | STKc_cPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05625 | 382 | STKc_LATS1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05598 | 376 | STKc_LATS Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05590 | 320 | STKc_nPKC_eta Catalytic domain of the Protein Seri | 100.0 | |
| cd05056 | 270 | PTKc_FAK Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06615 | 308 | PKc_MEK Catalytic domain of the dual-specificity P | 100.0 | |
| cd05107 | 401 | PTKc_PDGFR_beta Catalytic domain of the Protein Ty | 100.0 | |
| PF00069 | 260 | Pkinase: Protein kinase domain Protein kinase; unc | 100.0 | |
| cd07872 | 309 | STKc_PCTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05630 | 285 | STKc_GRK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05066 | 267 | PTKc_EphR_A Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd06654 | 296 | STKc_PAK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05116 | 257 | PTKc_Syk Catalytic domain of the Protein Tyrosine | 100.0 | |
| PHA03209 | 357 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05591 | 321 | STKc_nPKC_epsilon Catalytic domain of the Protein | 100.0 | |
| cd05619 | 316 | STKc_nPKC_theta Catalytic domain of the Protein Se | 100.0 | |
| cd05091 | 283 | PTKc_Ror2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05088 | 303 | PTKc_Tie2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05616 | 323 | STKc_cPKC_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd05112 | 256 | PTKc_Itk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05060 | 257 | PTKc_Syk_like Catalytic domain of Spleen Tyrosine | 100.0 | |
| cd05115 | 257 | PTKc_Zap-70 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05055 | 302 | PTKc_PDGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05622 | 371 | STKc_ROCK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05597 | 331 | STKc_DMPK_like Catalytic domain of Myotonic Dystro | 100.0 | |
| cd05050 | 288 | PTKc_Musk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05061 | 288 | PTKc_InsR Catalytic domain of the Protein Tyrosine | 100.0 | |
| PRK13184 | 932 | pknD serine/threonine-protein kinase; Reviewed | 100.0 | |
| cd05617 | 327 | STKc_aPKC_zeta Catalytic domain of the Protein Ser | 100.0 | |
| cd05040 | 257 | PTKc_Ack_like Catalytic domain of the Protein Tyro | 100.0 | |
| cd05082 | 256 | PTKc_Csk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05087 | 269 | PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein | 100.0 | |
| PTZ00284 | 467 | protein kinase; Provisional | 100.0 | |
| KOG0032 | 382 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd06655 | 296 | STKc_PAK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05103 | 343 | PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd06624 | 268 | STKc_ASK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05077 | 262 | PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd05079 | 284 | PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd06644 | 292 | STKc_STK10_LOK Catalytic domain of the Protein Ser | 100.0 | |
| cd05099 | 314 | PTKc_FGFR4 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05065 | 269 | PTKc_EphR_B Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd06656 | 297 | STKc_PAK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05620 | 316 | STKc_nPKC_delta Catalytic domain of the Protein Se | 100.0 | |
| cd06620 | 284 | PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr | 100.0 | |
| cd00192 | 262 | PTKc Catalytic domain of Protein Tyrosine Kinases. | 100.0 | |
| cd06622 | 286 | PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS | 100.0 | |
| cd05582 | 318 | STKc_RSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| cd05038 | 284 | PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P | 100.0 | |
| KOG0599 | 411 | consensus Phosphorylase kinase gamma subunit [Carb | 100.0 | |
| cd05047 | 270 | PTKc_Tie Catalytic domain of Tie Protein Tyrosine | 100.0 | |
| cd05570 | 318 | STKc_PKC Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05076 | 274 | PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd06637 | 272 | STKc_TNIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06643 | 282 | STKc_SLK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06612 | 256 | STKc_MST1_2 Catalytic domain of the Protein Serine | 100.0 | |
| cd07876 | 359 | STKc_JNK2 Catalytic domain of the Serine/Threonine | 100.0 | |
| PTZ00266 | 1021 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd05041 | 251 | PTKc_Fes_like Catalytic domain of Fes-like Protein | 100.0 | |
| cd08528 | 269 | STKc_Nek10 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07873 | 301 | STKc_PCTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd07863 | 288 | STKc_CDK4 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05046 | 275 | PTK_CCK4 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| KOG0610 | 459 | consensus Putative serine/threonine protein kinase | 100.0 | |
| cd06609 | 274 | STKc_MST3_like Catalytic domain of Mammalian Ste20 | 100.0 | |
| cd05575 | 323 | STKc_SGK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05623 | 332 | STKc_MRCK_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd06645 | 267 | STKc_MAP4K3 Catalytic domain of the Protein Serine | 100.0 | |
| cd06621 | 287 | PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek | 100.0 | |
| cd06631 | 265 | STKc_YSK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05624 | 331 | STKc_MRCK_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd08227 | 327 | PK_STRAD_alpha Pseudokinase domain of STE20-relate | 100.0 | |
| cd06613 | 262 | STKc_MAP4K3_like Catalytic domain of Mitogen-activ | 100.0 | |
| cd05037 | 259 | PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the | 100.0 | |
| cd06611 | 280 | STKc_SLK_like Catalytic domain of Ste20-like kinas | 100.0 | |
| cd05627 | 360 | STKc_NDR2 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG4717 | 864 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05615 | 323 | STKc_cPKC_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd06638 | 286 | STKc_myosinIIIA Catalytic domain of the Protein Se | 100.0 | |
| cd05058 | 262 | PTKc_Met_Ron Catalytic domain of the Protein Tyros | 100.0 | |
| cd07874 | 355 | STKc_JNK3 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd08219 | 255 | STKc_Nek3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05602 | 325 | STKc_SGK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06639 | 291 | STKc_myosinIIIB Catalytic domain of the Protein Se | 100.0 | |
| cd07875 | 364 | STKc_JNK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05057 | 279 | PTKc_EGFR_like Catalytic domain of Epidermal Growt | 100.0 | |
| cd05604 | 325 | STKc_SGK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06642 | 277 | STKc_STK25-YSK1 Catalytic domain of the Protein Se | 100.0 | |
| cd07868 | 317 | STKc_CDK8 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0667 | 586 | consensus Dual-specificity tyrosine-phosphorylatio | 100.0 | |
| cd07861 | 285 | STKc_CDK1_euk Catalytic domain of the Serine/Threo | 100.0 | |
| smart00219 | 258 | TyrKc Tyrosine kinase, catalytic domain. Phosphotr | 100.0 | |
| PHA03207 | 392 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd06640 | 277 | STKc_MST4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05044 | 269 | PTKc_c-ros Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05086 | 268 | PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd06623 | 264 | PKc_MAPKK_plant_like Catalytic domain of Plant dua | 100.0 | |
| cd07878 | 343 | STKc_p38beta_MAPK11 Catalytic domain of the Serine | 100.0 | |
| KOG4279 | 1226 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0577 | 948 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd06632 | 258 | STKc_MEKK1_plant Catalytic domain of the Protein S | 100.0 | |
| cd05100 | 334 | PTKc_FGFR3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05110 | 303 | PTKc_HER4 Catalytic domain of the Protein Tyrosine | 100.0 | |
| PHA03211 | 461 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05603 | 321 | STKc_SGK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG4257 | 974 | consensus Focal adhesion tyrosine kinase FAK, cont | 100.0 | |
| cd05042 | 269 | PTKc_Aatyk Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd06610 | 267 | STKc_OSR1_SPAK Catalytic domain of the Protein Ser | 100.0 | |
| cd06630 | 268 | STKc_MEKK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd08221 | 256 | STKc_Nek9 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08217 | 265 | STKc_Nek2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05078 | 258 | PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain | 100.0 | |
| cd06628 | 267 | STKc_MAPKKK_Byr2_like Catalytic domain of fungal B | 100.0 | |
| cd07847 | 286 | STKc_CDKL1_4 Catalytic domain of the Serine/Threon | 100.0 | |
| cd06636 | 282 | STKc_MAP4K4_6 Catalytic domain of the Protein Seri | 100.0 | |
| cd08223 | 257 | STKc_Nek4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07846 | 286 | STKc_CDKL2_3 Catalytic domain of the Serine/Threon | 100.0 | |
| cd06617 | 283 | PKc_MKK3_6 Catalytic domain of the dual-specificit | 100.0 | |
| cd07833 | 288 | STKc_CDKL Catalytic domain of Cyclin-Dependent pro | 100.0 | |
| KOG2052 | 513 | consensus Activin A type IB receptor, serine/threo | 100.0 | |
| cd05083 | 254 | PTKc_Chk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07832 | 286 | STKc_CCRK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06651 | 266 | STKc_MEKK3 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06647 | 293 | STKc_PAK_I Catalytic domain of the Protein Serine/ | 100.0 | |
| cd08218 | 256 | STKc_Nek1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05574 | 316 | STKc_phototropin_like Catalytic domain of Phototro | 100.0 | |
| cd07867 | 317 | STKc_CDC2L6 Catalytic domain of Serine/Threonine K | 100.0 | |
| cd06605 | 265 | PKc_MAPKK Catalytic domain of the dual-specificity | 100.0 | |
| cd06629 | 272 | STKc_MAPKKK_Bck1_like Catalytic domain of fungal B | 100.0 | |
| cd06626 | 264 | STKc_MEKK4 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06658 | 292 | STKc_PAK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06652 | 265 | STKc_MEKK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG0574 | 502 | consensus STE20-like serine/threonine kinase MST [ | 100.0 | |
| cd08220 | 256 | STKc_Nek8 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07839 | 284 | STKc_CDK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06608 | 275 | STKc_myosinIII_like Catalytic domain of Class III | 100.0 | |
| cd06659 | 297 | STKc_PAK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07841 | 298 | STKc_CDK7 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05074 | 273 | PTKc_Tyro3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd06917 | 277 | STKc_NAK1_like Catalytic domain of Fungal Nak1-lik | 100.0 | |
| KOG0199 | 1039 | consensus ACK and related non-receptor tyrosine ki | 100.0 | |
| cd05609 | 305 | STKc_MAST Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05586 | 330 | STKc_Sck1_like Catalytic domain of Suppressor of l | 100.0 | |
| cd07844 | 291 | STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like | 100.0 | |
| cd07870 | 291 | STKc_PFTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05122 | 253 | PKc_STE Catalytic domain of STE family Protein Kin | 100.0 | |
| cd05580 | 290 | STKc_PKA Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06614 | 286 | STKc_PAK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07837 | 295 | STKc_CdkB_plant Catalytic domain of the Serine/Thr | 100.0 | |
| cd06616 | 288 | PKc_MKK4 Catalytic domain of the dual-specificity | 100.0 | |
| cd06648 | 285 | STKc_PAK_II Catalytic domain of the Protein Serine | 100.0 | |
| cd06641 | 277 | STKc_MST3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07840 | 287 | STKc_CDK9_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| KOG1025 | 1177 | consensus Epidermal growth factor receptor EGFR an | 100.0 | |
| cd06607 | 307 | STKc_TAO Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06606 | 260 | STKc_MAPKKK Catalytic domain of the Protein Serine | 100.0 | |
| cd07842 | 316 | STKc_CDK8_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd07860 | 284 | STKc_CDK2_3 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd07843 | 293 | STKc_CDC2L1 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd07835 | 283 | STKc_CDK1_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd08225 | 257 | STKc_Nek5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07849 | 336 | STKc_ERK1_2_like Catalytic domain of Extracellular | 100.0 | |
| cd08530 | 256 | STKc_CNK2-like Catalytic domain of the Protein Ser | 100.0 | |
| cd08226 | 328 | PK_STRAD_beta Pseudokinase domain of STE20-related | 100.0 | |
| cd07836 | 284 | STKc_Pho85 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd05578 | 258 | STKc_Yank1 Catalytic domain of the Protein Serine/ | 100.0 | |
| PLN00009 | 294 | cyclin-dependent kinase A; Provisional | 100.0 | |
| cd05577 | 277 | STKc_GRK Catalytic domain of the Protein Serine/Th | 100.0 | |
| PHA03210 | 501 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd07855 | 334 | STKc_ERK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07831 | 282 | STKc_MOK Catalytic domain of the Serine/Threonine | 99.98 | |
| KOG0596 | 677 | consensus Dual specificity; serine/threonine and t | 99.98 | |
| cd07845 | 309 | STKc_CDK10 Catalytic domain of the Serine/Threonin | 99.98 | |
| cd07864 | 302 | STKc_CDK12 Catalytic domain of the Serine/Threonin | 99.98 | |
| cd08215 | 258 | STKc_Nek Catalytic domain of the Protein Serine/Th | 99.98 | |
| cd07834 | 330 | STKc_MAPK Catalytic domain of the Serine/Threonine | 99.98 | |
| cd07850 | 353 | STKc_JNK Catalytic domain of the Serine/Threonine | 99.98 | |
| cd07858 | 337 | STKc_TEY_MAPK_plant Catalytic domain of the Serine | 99.98 | |
| cd07852 | 337 | STKc_MAPK15 Catalytic domain of the Serine/Threoni | 99.98 | |
| cd05572 | 262 | STKc_cGK_PKG Catalytic domain of the Protein Serin | 99.98 | |
| PHA02882 | 294 | putative serine/threonine kinase; Provisional | 99.98 | |
| cd06635 | 317 | STKc_TAO1 Catalytic domain of the Protein Serine/T | 99.98 | |
| KOG0986 | 591 | consensus G protein-coupled receptor kinase [Signa | 99.98 | |
| KOG1024 | 563 | consensus Receptor-like protein tyrosine kinase RY | 99.98 | |
| cd08216 | 314 | PK_STRAD Pseudokinase domain of STE20-related kina | 99.98 | |
| cd06657 | 292 | STKc_PAK4 Catalytic domain of the Protein Serine/T | 99.98 | |
| cd05633 | 279 | STKc_GRK3 Catalytic domain of the Protein Serine/T | 99.98 | |
| KOG0584 | 632 | consensus Serine/threonine protein kinase [General | 99.98 | |
| cd06627 | 254 | STKc_Cdc7_like Catalytic domain of Cell division c | 99.98 | |
| cd06618 | 296 | PKc_MKK7 Catalytic domain of the dual-specificity | 99.98 | |
| cd05118 | 283 | STKc_CMGC Catalytic domain of CMGC family Serine/T | 99.98 | |
| cd05579 | 265 | STKc_MAST_like Catalytic domain of Microtubule-ass | 99.98 | |
| KOG0579 | 1187 | consensus Ste20-like serine/threonine protein kina | 99.98 | |
| cd07865 | 310 | STKc_CDK9 Catalytic domain of the Serine/Threonine | 99.98 | |
| PHA03390 | 267 | pk1 serine/threonine-protein kinase 1; Provisional | 99.97 | |
| cd07879 | 342 | STKc_p38delta_MAPK13 Catalytic domain of the Serin | 99.97 | |
| cd06653 | 264 | STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina | 99.97 | |
| cd05583 | 288 | STKc_MSK_N N-terminal catalytic domain of the Prot | 99.97 | |
| cd05613 | 290 | STKc_MSK1_N N-terminal catalytic domain of the Pro | 99.97 | |
| cd07838 | 287 | STKc_CDK4_6_like Catalytic domain of Cyclin-Depend | 99.97 | |
| cd07877 | 345 | STKc_p38alpha_MAPK14 Catalytic domain of the Serin | 99.97 | |
| cd05611 | 260 | STKc_Rim15_like Catalytic domain of fungal Rim15-l | 99.97 | |
| KOG0983 | 391 | consensus Mitogen-activated protein kinase (MAPK) | 99.97 | |
| cd07830 | 283 | STKc_MAK_like Catalytic domain of Male germ cell-A | 99.97 | |
| KOG0200 | 609 | consensus Fibroblast/platelet-derived growth facto | 99.97 | |
| KOG0586 | 596 | consensus Serine/threonine protein kinase [General | 99.97 | |
| KOG4250 | 732 | consensus TANK binding protein kinase TBK1 [Signal | 99.97 | |
| cd07856 | 328 | STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre | 99.97 | |
| PTZ00024 | 335 | cyclin-dependent protein kinase; Provisional | 99.97 | |
| cd05581 | 280 | STKc_PDK1 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd05606 | 278 | STKc_beta_ARK Catalytic domain of the Protein Seri | 99.97 | |
| KOG4645 | 1509 | consensus MAPKKK (MAP kinase kinase kinase) SSK2 a | 99.97 | |
| cd06633 | 313 | STKc_TAO3 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd08222 | 260 | STKc_Nek11 Catalytic domain of the Protein Serine/ | 99.97 | |
| cd07866 | 311 | STKc_BUR1 Catalytic domain of the Serine/Threonine | 99.97 | |
| KOG0607 | 463 | consensus MAP kinase-interacting kinase and relate | 99.97 | |
| cd06634 | 308 | STKc_TAO2 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd07880 | 343 | STKc_p38gamma_MAPK12 Catalytic domain of the Serin | 99.97 | |
| cd07854 | 342 | STKc_MAPK4_6 Catalytic domain of the Serine/Threon | 99.97 | |
| cd07829 | 282 | STKc_CDK_like Catalytic domain of Cyclin-Dependent | 99.97 | |
| cd07857 | 332 | STKc_MPK1 Catalytic domain of the Serine/Threonine | 99.97 | |
| KOG1006 | 361 | consensus Mitogen-activated protein kinase (MAPK) | 99.97 | |
| cd07851 | 343 | STKc_p38 Catalytic domain of the Serine/Threonine | 99.97 | |
| KOG0604 | 400 | consensus MAP kinase-activated protein kinase 2 [S | 99.97 | |
| KOG0690 | 516 | consensus Serine/threonine protein kinase [Signal | 99.97 | |
| KOG0612 | 1317 | consensus Rho-associated, coiled-coil containing p | 99.97 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 99.97 | |
| cd05123 | 250 | STKc_AGC Catalytic domain of AGC family Protein Se | 99.97 | |
| KOG4236 | 888 | consensus Serine/threonine protein kinase PKC mu/P | 99.97 | |
| KOG0666 | 438 | consensus Cyclin C-dependent kinase CDK8 [Transcri | 99.97 | |
| cd05610 | 669 | STKc_MASTL Catalytic domain of the Protein Serine/ | 99.97 | |
| KOG0587 | 953 | consensus Traf2- and Nck-interacting kinase and re | 99.97 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.97 | |
| cd05576 | 237 | STKc_RPK118_like Catalytic domain of the Protein S | 99.96 | |
| KOG0662 | 292 | consensus Cyclin-dependent kinase CDK5 [Intracellu | 99.96 | |
| PLN03225 | 566 | Serine/threonine-protein kinase SNT7; Provisional | 99.96 | |
| KOG0671 | 415 | consensus LAMMER dual specificity kinases [Signal | 99.96 | |
| PLN03224 | 507 | probable serine/threonine protein kinase; Provisio | 99.96 | |
| smart00220 | 244 | S_TKc Serine/Threonine protein kinases, catalytic | 99.96 | |
| KOG1151 | 775 | consensus Tousled-like protein kinase [Signal tran | 99.96 | |
| KOG0696 | 683 | consensus Serine/threonine protein kinase [Signal | 99.96 | |
| KOG0984 | 282 | consensus Mitogen-activated protein kinase (MAPK) | 99.96 | |
| KOG0695 | 593 | consensus Serine/threonine protein kinase [Signal | 99.95 | |
| KOG0669 | 376 | consensus Cyclin T-dependent kinase CDK9 [Cell cyc | 99.95 | |
| KOG0614 | 732 | consensus cGMP-dependent protein kinase [Signal tr | 99.95 | |
| KOG0608 | 1034 | consensus Warts/lats-like serine threonine kinases | 99.95 | |
| KOG1027 | 903 | consensus Serine/threonine protein kinase and endo | 99.95 | |
| KOG0664 | 449 | consensus Nemo-like MAPK-related serine/threonine | 99.94 | |
| cd00180 | 215 | PKc Catalytic domain of Protein Kinases. Protein K | 99.94 | |
| KOG0668 | 338 | consensus Casein kinase II, alpha subunit [Signal | 99.94 | |
| smart00221 | 225 | STYKc Protein kinase; unclassified specificity. Ph | 99.93 | |
| KOG1152 | 772 | consensus Signal transduction serine/threonine kin | 99.93 | |
| KOG0665 | 369 | consensus Jun-N-terminal kinase (JNK) [Signal tran | 99.93 | |
| KOG1290 | 590 | consensus Serine/threonine protein kinase [Signal | 99.93 | |
| KOG0670 | 752 | consensus U4/U6-associated splicing factor PRP4 [R | 99.93 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 99.92 | |
| KOG1345 | 378 | consensus Serine/threonine kinase [Signal transduc | 99.9 | |
| KOG1167 | 418 | consensus Serine/threonine protein kinase of the C | 99.89 | |
| PLN00181 | 793 | protein SPA1-RELATED; Provisional | 99.89 | |
| smart00750 | 176 | KIND kinase non-catalytic C-lobe domain. It is an | 99.88 | |
| KOG0195 | 448 | consensus Integrin-linked kinase [Signal transduct | 99.87 | |
| KOG1164 | 322 | consensus Casein kinase (serine/threonine/tyrosine | 99.87 | |
| KOG1165 | 449 | consensus Casein kinase (serine/threonine/tyrosine | 99.86 | |
| PRK09188 | 365 | serine/threonine protein kinase; Provisional | 99.86 | |
| KOG1163 | 341 | consensus Casein kinase (serine/threonine/tyrosine | 99.85 | |
| COG0515 | 384 | SPS1 Serine/threonine protein kinase [General func | 99.84 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.82 | |
| KOG1240 | 1431 | consensus Protein kinase containing WD40 repeats [ | 99.77 | |
| PRK10359 | 232 | lipopolysaccharide core biosynthesis protein; Prov | 99.77 | |
| cd05147 | 190 | RIO1_euk RIO kinase family; eukaryotic RIO1, catal | 99.77 | |
| PRK12274 | 218 | serine/threonine protein kinase; Provisional | 99.75 | |
| cd05145 | 190 | RIO1_like RIO kinase family; RIO1, RIO3 and simila | 99.74 | |
| KOG1023 | 484 | consensus Natriuretic peptide receptor, guanylate | 99.73 | |
| PF14531 | 288 | Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_ | 99.73 | |
| PLN00113 | 968 | leucine-rich repeat receptor-like protein kinase; | 99.71 | |
| KOG4194 | 873 | consensus Membrane glycoprotein LIG-1 [Signal tran | 99.69 | |
| KOG1166 | 974 | consensus Mitotic checkpoint serine/threonine prot | 99.69 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.68 | |
| KOG0617 | 264 | consensus Ras suppressor protein (contains leucine | 99.68 | |
| PRK10345 | 210 | hypothetical protein; Provisional | 99.68 | |
| KOG4194 | 873 | consensus Membrane glycoprotein LIG-1 [Signal tran | 99.64 | |
| PRK14879 | 211 | serine/threonine protein kinase; Provisional | 99.64 | |
| KOG0444 | 1255 | consensus Cytoskeletal regulator Flightless-I (con | 99.63 | |
| smart00090 | 237 | RIO RIO-like kinase. | 99.63 | |
| cd05144 | 198 | RIO2_C RIO kinase family; RIO2, C-terminal catalyt | 99.62 | |
| KOG0444 | 1255 | consensus Cytoskeletal regulator Flightless-I (con | 99.62 | |
| TIGR03724 | 199 | arch_bud32 Kae1-associated kinase Bud32. Members o | 99.6 | |
| PRK09605 | 535 | bifunctional UGMP family protein/serine/threonine | 99.6 | |
| KOG1033 | 516 | consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati | 99.6 | |
| KOG0472 | 565 | consensus Leucine-rich repeat protein [Function un | 99.58 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.58 | |
| PLN03150 | 623 | hypothetical protein; Provisional | 99.58 | |
| KOG4158 | 598 | consensus BRPK/PTEN-induced protein kinase [Signal | 99.57 | |
| cd05120 | 155 | APH_ChoK_like Aminoglycoside 3'-phosphotransferase | 99.53 | |
| KOG4237 | 498 | consensus Extracellular matrix protein slit, conta | 99.5 | |
| cd05119 | 187 | RIO RIO kinase family, catalytic domain. The RIO k | 99.48 | |
| KOG0472 | 565 | consensus Leucine-rich repeat protein [Function un | 99.48 | |
| KOG0617 | 264 | consensus Ras suppressor protein (contains leucine | 99.48 | |
| PRK01723 | 239 | 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | 99.43 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.38 | |
| KOG1266 | 458 | consensus Protein kinase [Signal transduction mech | 99.35 | |
| PRK15387 | 788 | E3 ubiquitin-protein ligase SspH2; Provisional | 99.33 | |
| KOG0618 | 1081 | consensus Serine/threonine phosphatase 2C containi | 99.33 | |
| TIGR01982 | 437 | UbiB 2-polyprenylphenol 6-hydroxylase. This model | 99.32 | |
| KOG0532 | 722 | consensus Leucine-rich repeat (LRR) protein, conta | 99.31 | |
| KOG0618 | 1081 | consensus Serine/threonine phosphatase 2C containi | 99.22 | |
| KOG1243 | 690 | consensus Protein kinase [General function predict | 99.2 | |
| PRK15370 | 754 | E3 ubiquitin-protein ligase SlrP; Provisional | 99.19 | |
| PRK15370 | 754 | E3 ubiquitin-protein ligase SlrP; Provisional | 99.16 | |
| PRK04750 | 537 | ubiB putative ubiquinone biosynthesis protein UbiB | 99.16 | |
| PRK15387 | 788 | E3 ubiquitin-protein ligase SspH2; Provisional | 99.15 | |
| cd05151 | 170 | ChoK Choline Kinase (ChoK). The ChoK subfamily is | 99.14 | |
| PLN03150 | 623 | hypothetical protein; Provisional | 99.12 | |
| KOG0532 | 722 | consensus Leucine-rich repeat (LRR) protein, conta | 99.1 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.07 | |
| PF14580 | 175 | LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQ | 99.06 | |
| KOG4237 | 498 | consensus Extracellular matrix protein slit, conta | 99.03 | |
| PF14580 | 175 | LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQ | 99.0 | |
| PLN03210 | 1153 | Resistant to P. syringae 6; Provisional | 98.94 | |
| cd05154 | 223 | ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an | 98.94 | |
| COG4886 | 394 | Leucine-rich repeat (LRR) protein [Function unknow | 98.94 | |
| KOG1259 | 490 | consensus Nischarin, modulator of integrin alpha5 | 98.92 | |
| cd05146 | 197 | RIO3_euk RIO kinase family; eukaryotic RIO3, catal | 98.89 | |
| COG3642 | 204 | Mn2+-dependent serine/threonine protein kinase [Si | 98.87 | |
| PLN03210 | 1153 | Resistant to P. syringae 6; Provisional | 98.86 | |
| KOG3087 | 229 | consensus Serine/threonine protein kinase [General | 98.81 | |
| KOG3741 | 655 | consensus Poly(A) ribonuclease subunit [RNA proces | 98.79 | |
| cd00116 | 319 | LRR_RI Leucine-rich repeats (LRRs), ribonuclease i | 98.79 | |
| PF13855 | 61 | LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RF | 98.78 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 98.78 | |
| cd00116 | 319 | LRR_RI Leucine-rich repeats (LRRs), ribonuclease i | 98.76 | |
| COG4886 | 394 | Leucine-rich repeat (LRR) protein [Function unknow | 98.75 | |
| KOG1259 | 490 | consensus Nischarin, modulator of integrin alpha5 | 98.7 | |
| PF01163 | 188 | RIO1: RIO1 family; InterPro: IPR018934 Protein pho | 98.65 | |
| PF13855 | 61 | LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RF | 98.64 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 98.61 | |
| PRK15123 | 268 | lipopolysaccharide core heptose(I) kinase RfaP; Pr | 98.58 | |
| COG4248 | 637 | Uncharacterized protein with protein kinase and he | 98.58 | |
| KOG1859 | 1096 | consensus Leucine-rich repeat proteins [General fu | 98.55 | |
| KOG4579 | 177 | consensus Leucine-rich repeat (LRR) protein associ | 98.54 | |
| KOG0531 | 414 | consensus Protein phosphatase 1, regulatory subuni | 98.53 | |
| KOG2137 | 700 | consensus Protein kinase [Signal transduction mech | 98.43 | |
| KOG3207 | 505 | consensus Beta-tubulin folding cofactor E [Posttra | 98.37 | |
| COG0478 | 304 | RIO-like serine/threonine protein kinase fused to | 98.27 | |
| KOG0531 | 414 | consensus Protein phosphatase 1, regulatory subuni | 98.27 | |
| COG0661 | 517 | AarF Predicted unusual protein kinase [General fun | 98.22 | |
| TIGR02172 | 226 | Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou | 98.15 | |
| PRK09902 | 216 | hypothetical protein; Provisional | 98.14 | |
| PF06293 | 206 | Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; | 98.14 | |
| KOG3207 | 505 | consensus Beta-tubulin folding cofactor E [Posttra | 98.09 | |
| PF12799 | 44 | LRR_4: Leucine Rich repeats (2 copies); PDB: 2OMT_ | 98.01 | |
| PF06176 | 229 | WaaY: Lipopolysaccharide core biosynthesis protein | 98.0 | |
| KOG4579 | 177 | consensus Leucine-rich repeat (LRR) protein associ | 97.99 |
| >PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-57 Score=578.08 Aligned_cols=535 Identities=28% Similarity=0.424 Sum_probs=343.9
Q ss_pred eeecCCCChhhHHHHHhhc-------cCCCCCCcccccccccccccccccccCccccchhcccccccccccCccccccCC
Q 002673 301 KELVSRPNADDLEIIFGEV-------EGKSDEGPSLFSQANLLSGEFPKELTALPALVSEAANDEVDRSYLELPVFVMPS 373 (894)
Q Consensus 301 ~~~~~~p~le~l~~~~n~~-------~~~l~~L~~L~L~~N~l~~~~p~~~~~L~~L~~L~L~~n~~~~~~~~~~~~~~~ 373 (894)
..+..+++++.|++..|.. +..+++|..|++++|.+++.+|..+..+++|+.|+|++|.+....+........
T Consensus 398 ~~~~~~~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~~~~~~p~~~~~~~L 477 (968)
T PLN00113 398 KSLGACRSLRRVRLQDNSFSGELPSEFTKLPLVYFLDISNNNLQGRINSRKWDMPSLQMLSLARNKFFGGLPDSFGSKRL 477 (968)
T ss_pred HHHhCCCCCCEEECcCCEeeeECChhHhcCCCCCEEECcCCcccCccChhhccCCCCcEEECcCceeeeecCcccccccc
Confidence 3344455555555444332 233445555666666666655555566666666666665554333222211222
Q ss_pred CCCcccccCCCC-CC---------CeEEccCCcCCcCCchhhcCCCCCcEEeccCCcCCCCCCccccCCCCCCEEecCCC
Q 002673 374 NATNQQYNQLSN-LP---------PAIYLANNSLSGNIPVEIGQLKSLHVLDLSNNNFSGTIPDELSDLSNLEKLDLSGN 443 (894)
Q Consensus 374 ~~~~l~~n~L~~-Lp---------~~L~L~~N~l~~~~p~~~~~L~~L~~L~L~~N~l~~~~p~~~~~L~~L~~L~Ls~N 443 (894)
+.++++.|+++. +| +.|+|++|++++.+|..+.+|++|++|+|++|++++.+|..|.++++|+.|+|++|
T Consensus 478 ~~L~ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N 557 (968)
T PLN00113 478 ENLDLSRNQFSGAVPRKLGSLSELMQLKLSENKLSGEIPDELSSCKKLVSLDLSHNQLSGQIPASFSEMPVLSQLDLSQN 557 (968)
T ss_pred eEEECcCCccCCccChhhhhhhccCEEECcCCcceeeCChHHcCccCCCEEECCCCcccccCChhHhCcccCCEEECCCC
Confidence 334444444431 11 44666677766666666666667777777777776666666667777777777777
Q ss_pred cccCcCCCcccCCCccccccccccccCCCCCCCCCCCCCCccccCCCCCCCCCcccCCCcCCCCCCCCCCCCCCCCcceE
Q 002673 444 HLVGEIPISLKGLHFLSSFSVAHNNLQGAVPSGGQFDTFPSFSFEGNPELCGSVVQRPCAISPGATHPTAPHKRTNTKLV 523 (894)
Q Consensus 444 ~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~l~~L~~l~l~~Np~~c~~~~~~~C~~~~~~~~~~~p~~~~~~~ii 523 (894)
++++.+|..+.++++|+.|++++|++++.+|..+.+..+....+.+||.+|+...... .+.+...+. ...
T Consensus 558 ~l~~~~p~~l~~l~~L~~l~ls~N~l~~~~p~~~~~~~~~~~~~~~n~~lc~~~~~~~--------~~~c~~~~~-~~~- 627 (968)
T PLN00113 558 QLSGEIPKNLGNVESLVQVNISHNHLHGSLPSTGAFLAINASAVAGNIDLCGGDTTSG--------LPPCKRVRK-TPS- 627 (968)
T ss_pred cccccCChhHhcCcccCEEeccCCcceeeCCCcchhcccChhhhcCCccccCCccccC--------CCCCccccc-cce-
Confidence 7766666666666667777777777766666666666666666667776666432110 011111111 111
Q ss_pred EEEEeceecccchhhhh-hhhhhhhhcccCCCCCCCCcccccccCCCCCCCCCcccccCceEeecCCCCCcccccCHHHH
Q 002673 524 IGLVLGICFGTGLIISM-LALWILSKRRIIPGGDPDKIELDTISSTSNFGVSPEADKDASLVMLFPNNTNEIKDLTIYEL 602 (894)
Q Consensus 524 i~ivvgi~~~~~~lv~v-~~~~~~~rrr~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~el 602 (894)
..+++++++++++++++ +++++++++|+... .+..+.. ...+. ...+. ......++..++
T Consensus 628 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~----~~~~~-----------~~~~~--~~~~~~~~~~~~ 688 (968)
T PLN00113 628 WWFYITCTLGAFLVLALVAFGFVFIRGRNNLE--LKRVENE----DGTWE-----------LQFFD--SKVSKSITINDI 688 (968)
T ss_pred eeeehhHHHHHHHHHHHHHHHHHHHHhhhccc--ccccccc----ccccc-----------ccccc--cccchhhhHHHH
Confidence 12222222222222222 22222222221110 0100000 00000 00000 001112333333
Q ss_pred HHhccCCCccceEeecCcEEEEEEEE-cCCCeEEEEEEcCcchhhHHHHHHHHHHHHhcCCCceeeecceeeecceEEEE
Q 002673 603 LKATDNFSQANIIGCGGFGLVYKATL-ANGTTLAIKKLSGDLGLMEREFKAEVEALSTAQHKNLVSLQGYCVHQGFRLLI 681 (894)
Q Consensus 603 ~~a~~~f~~~~~LG~G~fg~Vy~a~~-~~g~~vAvK~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~lV 681 (894)
. ..|...+.||+|+||.||+|.. .++..||||++...... ...|++.+++++|||||+++|+|.+.+..++|
T Consensus 689 ~---~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~----~~~~~~~l~~l~HpnIv~~~~~~~~~~~~~lv 761 (968)
T PLN00113 689 L---SSLKEENVISRGKKGASYKGKSIKNGMQFVVKEINDVNSI----PSSEIADMGKLQHPNIVKLIGLCRSEKGAYLI 761 (968)
T ss_pred H---hhCCcccEEccCCCeeEEEEEECCCCcEEEEEEccCCccc----cHHHHHHHhhCCCCCcceEEEEEEcCCCCEEE
Confidence 3 4577788999999999999985 67899999998753321 23468899999999999999999999999999
Q ss_pred EEeccCCCHHHHHhhhcCCCCCcCHHHHHHHHHHHHHHHHHHHhccCCCeeecCCCCCCeEECCCCcEEEEEcccccccC
Q 002673 682 YSYMENGSLDYWLHEKADGASQLDWLTRLKIARGTSCGLAYMHQICEPHIVHRDIKSSNILLDDQFEAHLADFGLSRLIL 761 (894)
Q Consensus 682 ~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDLkp~NILld~~~~vkl~DFGla~~~~ 761 (894)
|||+++|+|.++++. ++|..+..|+.|+++||+|||+.+.++|+||||||+||+++.++.+++. ||......
T Consensus 762 ~Ey~~~g~L~~~l~~-------l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlkp~Nil~~~~~~~~~~-~~~~~~~~ 833 (968)
T PLN00113 762 HEYIEGKNLSEVLRN-------LSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR-LSLPGLLC 833 (968)
T ss_pred EeCCCCCcHHHHHhc-------CCHHHHHHHHHHHHHHHHHhccCCCCCeecCCCCHHhEEECCCCceEEE-eccccccc
Confidence 999999999999962 7899999999999999999997767899999999999999999988876 66554321
Q ss_pred CCCCcccccccccCCccCcccccCcCCCccccHHHHHHHHHHHHcCCCCCCCCCcchhhhHHHHHHHHhhcCCCCccccc
Q 002673 762 PYQTHVTTELVGTLGYIPPEYGQAWVATLRGDMYSFGVVMLELLTGKRPVDVLKPKMSRELVGWVLKMRSEGKQDQVFDP 841 (894)
Q Consensus 762 ~~~~~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwS~GvlL~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 841 (894)
. .....+|+.|+|||++.+..++.++|||||||++|||+||+.||+... ........|.+..........++|+
T Consensus 834 ~-----~~~~~~t~~y~aPE~~~~~~~~~~sDv~S~Gvvl~el~tg~~p~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~ 907 (968)
T PLN00113 834 T-----DTKCFISSAYVAPETRETKDITEKSDIYGFGLILIELLTGKSPADAEF-GVHGSIVEWARYCYSDCHLDMWIDP 907 (968)
T ss_pred c-----CCCccccccccCcccccCCCCCcccchhhHHHHHHHHHhCCCCCCccc-CCCCcHHHHHHHhcCccchhheeCc
Confidence 1 122367899999999999999999999999999999999999996432 2234566676655545555556666
Q ss_pred cccCC--CChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhccc
Q 002673 842 ILRGK--GFDEEMLQVLDVACMCVSQNPFKRPTVKEVVEWLNNVGA 885 (894)
Q Consensus 842 ~l~~~--~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~i~~ 885 (894)
.+... ...++..++.+++.+||+.||++||||+++++.|+++..
T Consensus 908 ~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~L~~~~~ 953 (968)
T PLN00113 908 SIRGDVSVNQNEIVEVMNLALHCTATDPTARPCANDVLKTLESASR 953 (968)
T ss_pred cccCCCCccHHHHHHHHHHHHhhCcCCchhCcCHHHHHHHHHHhhc
Confidence 55332 234566788899999999999999999999999998855
|
|
| >KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-51 Score=457.11 Aligned_cols=290 Identities=48% Similarity=0.809 Sum_probs=255.4
Q ss_pred cccccCHHHHHHhccCCCccceEeecCcEEEEEEEEcCCCeEEEEEEcCcchhhHHHHHHHHHHHHhcCCCceeeeccee
Q 002673 593 EIKDLTIYELLKATDNFSQANIIGCGGFGLVYKATLANGTTLAIKKLSGDLGLMEREFKAEVEALSTAQHKNLVSLQGYC 672 (894)
Q Consensus 593 ~~~~~~~~el~~a~~~f~~~~~LG~G~fg~Vy~a~~~~g~~vAvK~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~ 672 (894)
....|++.++.+||++|+..+.||+|+||.||+|.+.+|..||||++........++|.+|+.++.+++|||+|+|+|||
T Consensus 61 ~~~~fs~~el~~AT~~Fs~~~~ig~Ggfg~VYkG~l~~~~~vAVK~~~~~~~~~~~eF~~Ei~~ls~l~H~Nlv~LlGyC 140 (361)
T KOG1187|consen 61 PLRSFSYDELRKATNNFSESNLIGEGGFGTVYKGVLSDGTVVAVKRLSSNSGQGEREFLNEVEILSRLRHPNLVKLLGYC 140 (361)
T ss_pred CcceeeHHHHHHHHhCCchhcceecCCCeEEEEEEECCCCEEEEEEecCCCCcchhHHHHHHHHHhcCCCcCcccEEEEE
Confidence 46678999999999999999999999999999999999999999988765433156699999999999999999999999
Q ss_pred eecc-eEEEEEEeccCCCHHHHHhhhcCCCCCcCHHHHHHHHHHHHHHHHHHHhccCCCeeecCCCCCCeEECCCCcEEE
Q 002673 673 VHQG-FRLLIYSYMENGSLDYWLHEKADGASQLDWLTRLKIARGTSCGLAYMHQICEPHIVHRDIKSSNILLDDQFEAHL 751 (894)
Q Consensus 673 ~~~~-~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDLkp~NILld~~~~vkl 751 (894)
.+.+ +.+||||||++|+|.++++..... .++|..|++||.++|+||+|||+.+.++||||||||+|||||+++++||
T Consensus 141 ~e~~~~~~LVYEym~nGsL~d~L~~~~~~--~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILLD~~~~aKl 218 (361)
T KOG1187|consen 141 LEGGEHRLLVYEYMPNGSLEDHLHGKKGE--PLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILLDEDFNAKL 218 (361)
T ss_pred ecCCceEEEEEEccCCCCHHHHhCCCCCC--CCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeECCCCCEEc
Confidence 9998 599999999999999999976433 7899999999999999999999998889999999999999999999999
Q ss_pred EEcccccccCCCCCcccccc-cccCCccCcccccCcCCCccccHHHHHHHHHHHHcCCCCCCCCCcchhhhHHHHHHHHh
Q 002673 752 ADFGLSRLILPYQTHVTTEL-VGTLGYIPPEYGQAWVATLRGDMYSFGVVMLELLTGKRPVDVLKPKMSRELVGWVLKMR 830 (894)
Q Consensus 752 ~DFGla~~~~~~~~~~~~~~-~gt~~Y~APE~~~~~~~s~ksDVwS~GvlL~elltG~~Pf~~~~~~~~~~~~~~~~~~~ 830 (894)
+|||+|+........ .... .||.+|+|||++..+..+.|+|||||||+|+||+||+.|.+...+.....++.|.....
T Consensus 219 sDFGLa~~~~~~~~~-~~~~~~gt~gY~~PEy~~~g~lt~KsDVySFGVvllElitgr~~~d~~~~~~~~~l~~w~~~~~ 297 (361)
T KOG1187|consen 219 SDFGLAKLGPEGDTS-VSTTVMGTFGYLAPEYASTGKLTEKSDVYSFGVVLLELITGRKAVDQSRPRGELSLVEWAKPLL 297 (361)
T ss_pred cCccCcccCCccccc-eeeecCCCCccCChhhhccCCcCcccccccchHHHHHHHhCCcccCCCCCcccccHHHHHHHHH
Confidence 999999765331111 1112 79999999999999999999999999999999999999988655444556899998888
Q ss_pred hcCCCCcccccccc-CCCCh-HHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhccc
Q 002673 831 SEGKQDQVFDPILR-GKGFD-EEMLQVLDVACMCVSQNPFKRPTVKEVVEWLNNVGA 885 (894)
Q Consensus 831 ~~~~~~~~~d~~l~-~~~~~-~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~i~~ 885 (894)
..+...+++|+.+. +.+.. .++..+..++.+|++.+|.+||+|.+|+++|+.+..
T Consensus 298 ~~~~~~eiiD~~l~~~~~~~~~~~~~~~~~a~~C~~~~~~~RP~m~~Vv~~L~~~~~ 354 (361)
T KOG1187|consen 298 EEGKLREIVDPRLKEGEYPDEKEVKKLAELALRCLRPDPKERPTMSQVVKELEGILS 354 (361)
T ss_pred HCcchhheeCCCccCCCCChHHHHHHHHHHHHHHcCcCCCcCcCHHHHHHHHHhhcc
Confidence 88899999999987 44443 678889999999999999999999999999976543
|
|
| >PF09353 DUF1995: Domain of unknown function (DUF1995); InterPro: IPR018962 This family of proteins are functionally uncharacterised | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-45 Score=380.01 Aligned_cols=201 Identities=43% Similarity=0.730 Sum_probs=183.6
Q ss_pred CCCCHHHHHHHHHHHHHHHHHcCCceEEEEEeCCCccccChhhhHHHHHHHHHHHHHHHHhhhCCCceEEEecChhhHHH
Q 002673 98 LPSDLEGAVRQSSQASSLFVSAGGMRAIVELLIPQLQFLDDEGAQAELWELSRLFVDTLIEETGSQRVKAIFPDAGAAAL 177 (894)
Q Consensus 98 lP~~~~~~~~qa~~a~~~a~~~g~~r~~ve~~~p~l~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~fpd~g~~~l 177 (894)
||.|++||+.||++|+++|+++|.+|++||+.||+|+. ..++++++|++.|.+. +++++++|||+|++++
T Consensus 1 lP~s~~ea~~qA~~Av~~Al~~g~~r~~ve~~fP~l~~--------~~~~la~~~~~~l~~~--~~~~~~~~pd~g~~al 70 (209)
T PF09353_consen 1 LPSSLEEAVEQAAEAVQAALEDGDSRQLVELEFPGLNP--------SNMPLAREFARKLAAS--GRRVRVVFPDAGEAAL 70 (209)
T ss_pred CCCCHHHHHHHHHHHHHHHHHcCCCeEEEEEECCCcch--------hHHHHHHHHHHHHHhc--CceEEEEcCChHHHHH
Confidence 79999999999999999999999999999999999922 3446777777776664 6999999999999999
Q ss_pred hhcccCCCccccccCCCCCCCCCC---CcEEEEEcCCcccHHHHHHHHHhcCCCCCCcEEEECCcccccC-cccchhhHH
Q 002673 178 LKYRWKDAAFGFSSLSDRKPVEKE---DEIIVMVVPDYQMLGYVEKIASDLSDDPPRPLIMWNPRLISED-VGVGINVRN 253 (894)
Q Consensus 178 a~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~p~~~~~~~~e~~~~~~~~~~~~p~v~~N~~l~~~~-~Gig~~~r~ 253 (894)
|+++|++..+++.++++....... |+++|+|+|++.+++++|+||+.+++ ||+|||||+|+|.+ +|+|+++|+
T Consensus 71 A~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~vvv~p~~~~l~~~e~~~~~~~~---rpvvl~Np~l~~~~~~g~g~~~r~ 147 (209)
T PF09353_consen 71 ARRDWGDGSFKIASLDDWSSSEDESKFDDILVVVAPSPQELDDVEKLCEAAGG---RPVVLLNPQLEDVRSVGFGFPGRK 147 (209)
T ss_pred HhccccCCCeEEeeccCccccccccccCCEEEEEECChhhHHHHHHHHHhcCC---CeEEEEecccccCCccccccccHH
Confidence 999999999999999997554433 79999999999999999999999987 99999999999999 999999999
Q ss_pred hHHHhhcCcceeEEEeec--CC-eeEEeecCCCceEeeecccCCCceeeceeecCCCChhhHH
Q 002673 254 LRRYFLSTFTPVYSMRPL--PS-GAVFRCYPGLWKVFYDDKDRPNRYLLAKELVSRPNADDLE 313 (894)
Q Consensus 254 ~r~~fl~~~~~~y~l~~l--~~-gal~r~yP~~w~v~~~d~~~~~~y~~i~~~~~~p~le~l~ 313 (894)
+|++|+++||+||||||+ .+ |+|||+|||+||||+. ..+|+|+++++++.+|++++|+
T Consensus 148 ~~~~Fl~~fe~vY~l~~l~~~~~gal~r~yP~~Wqv~~~--~~~~~y~~v~~~~~rP~~~e~~ 208 (209)
T PF09353_consen 148 LRERFLSSFETVYYLRPLRISGNGALFRCYPGPWQVFRE--DDDGEYECVAEFEERPTYEELE 208 (209)
T ss_pred HHHHHHhhceEEEEEEeeccCCcEEEEEeCCCCcEEEEE--cCCCcEEEEEecccCCChHHhh
Confidence 999999999999999999 67 9999999999999973 3389999999999999999987
|
|
| >PLN02842 nucleotide kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-45 Score=411.07 Aligned_cols=208 Identities=25% Similarity=0.411 Sum_probs=194.6
Q ss_pred HHHHHHHHHHHHHcCCceEEEEEeCCCccccChhhhHHHHHHHHHHHHHHHHhhhCCCceEEEecC-hhhHHH-------
Q 002673 106 VRQSSQASSLFVSAGGMRAIVELLIPQLQFLDDEGAQAELWELSRLFVDTLIEETGSQRVKAIFPD-AGAAAL------- 177 (894)
Q Consensus 106 ~~qa~~a~~~a~~~g~~r~~ve~~~p~l~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~fpd-~g~~~l------- 177 (894)
.++|.+||++|++||++|++||+.||||++..+.++.+++++++|+|+..|++. +++|||+||| +|++||
T Consensus 244 ~~~~~~a~~~a~~~g~~r~~~~~~~pel~~~~~~~~~~~~~~l~~~~~~~~~~~--~~~~kv~~~~~~g~~~~~~~~~~~ 321 (505)
T PLN02842 244 YDDVLQATQRAVNDGRTRLKVEINIPELNPEMDVYRIGTLMELVRVLALSFADD--GKRVKVCVQGSMGEGALAGMPLQL 321 (505)
T ss_pred HHHHHHHHHHHHhCCcceEEEEEecCccccccccccchhHHHHHHHHHHHHhhc--CCceEEEecCCcchhHhccCcccc
Confidence 679999999999999999999999999999988888889999999999998888 7999999999 999999
Q ss_pred -------hhcccCCCcc-----ccccCCCCCCCCCCCcEEEEEcCCcc----cHHHHHHHHHhcCCCCCCcEEEECCccc
Q 002673 178 -------LKYRWKDAAF-----GFSSLSDRKPVEKEDEIIVMVVPDYQ----MLGYVEKIASDLSDDPPRPLIMWNPRLI 241 (894)
Q Consensus 178 -------a~~~~~~~~~-----~~~~~~~~~~~~~~~~~~~~~~p~~~----~~~~~e~~~~~~~~~~~~p~v~~N~~l~ 241 (894)
|+|||+|.+| ++.++++ +.++++|++||+|+||+. ++++||+||+.+++ |||||+|||||
T Consensus 322 ~~~~~~~~~~dw~~~~~~~~~~~~~~~~~-~~~~~~d~~~i~v~P~~~v~~~~~~~~e~~~~~~~~---rpvillnp~Le 397 (505)
T PLN02842 322 AGTRKILEFMDWGDYGAKGTFVKIGAIGA-KEVDEEDDMFILVAPQNAVGNCIIDDLQAMTTAAGK---RPVILVNPRLK 397 (505)
T ss_pred ccchhhhhhcccccccccccceeeccccc-CCCCCCCcEEEEEcCCccccccchHHHHHHHHHhCC---CeEEEECCccc
Confidence 9999999998 8889988 888999999999999995 99999999999998 99999999999
Q ss_pred ccC--cccc-hhhHHhHHHhhcCcceeEEEeecCC--------eeEEeecCCCceEeeecc--cCCCceeeceeecCCCC
Q 002673 242 SED--VGVG-INVRNLRRYFLSTFTPVYSMRPLPS--------GAVFRCYPGLWKVFYDDK--DRPNRYLLAKELVSRPN 308 (894)
Q Consensus 242 ~~~--~Gig-~~~r~~r~~fl~~~~~~y~l~~l~~--------gal~r~yP~~w~v~~~d~--~~~~~y~~i~~~~~~p~ 308 (894)
|+. |||| ++||++|++|+++||+|||||||+. |||+|+||++|+||+.+. +.+++|+++++++++|+
T Consensus 398 D~~~~vGig~~~~R~~R~~f~~t~~~~Y~~~~l~~~~~~~~~~gal~~~yp~~w~l~~~~~~~~~~~~y~~~~~~~~~P~ 477 (505)
T PLN02842 398 DLPGSSGIMQTMGREQRLEYAASFENCYSFRLLYYAGTQYPIMGALRMSYPYRYELYKRVDEENGKEKYIILATFSERPT 477 (505)
T ss_pred ccccccchhHHHHHHHHHHHHHHhhheeEEEeccccccccccceeeeecCCCCeeEEEecCccccCcceEEeeecCCCCC
Confidence 974 9999 9999999999999999999999976 999999999999997632 35679999999999999
Q ss_pred hhhHHHHHhhc
Q 002673 309 ADDLEIIFGEV 319 (894)
Q Consensus 309 le~l~~~~n~~ 319 (894)
.++|+.++++.
T Consensus 478 ~e~i~~~~~~~ 488 (505)
T PLN02842 478 PDEINDAFSGR 488 (505)
T ss_pred HHHHHHHhCCC
Confidence 99999998664
|
|
| >KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-43 Score=389.55 Aligned_cols=256 Identities=31% Similarity=0.477 Sum_probs=208.6
Q ss_pred CCccceEeecCcEEEEEEEEcCCCeEEEEEEcCcchhh--HHHHHHHHHHHHhcCCCceeeecceeeecc-eEEEEEEec
Q 002673 609 FSQANIIGCGGFGLVYKATLANGTTLAIKKLSGDLGLM--EREFKAEVEALSTAQHKNLVSLQGYCVHQG-FRLLIYSYM 685 (894)
Q Consensus 609 f~~~~~LG~G~fg~Vy~a~~~~g~~vAvK~~~~~~~~~--~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~-~~~lV~E~~ 685 (894)
+...+.||+|+||+||+|.+.....||||++....... .++|.+|+.+|.+++|||||+++|+|.+.. ..++|||||
T Consensus 43 l~~~~~iG~G~~g~V~~~~~~g~~~vavK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~f~G~~~~~~~~~~iVtEy~ 122 (362)
T KOG0192|consen 43 LPIEEVLGSGSFGTVYKGKWRGTDVVAVKIISDPDFDDESRKAFRREASLLSRLRHPNIVQFYGACTSPPGSLCIVTEYM 122 (362)
T ss_pred hhhhhhcccCCceeEEEEEeCCceeEEEEEecchhcChHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCceEEEEEeC
Confidence 34456699999999999999765559999998654222 568999999999999999999999999887 799999999
Q ss_pred cCCCHHHHHhhhcCCCCCcCHHHHHHHHHHHHHHHHHHHhccCCC-eeecCCCCCCeEECCCC-cEEEEEcccccccCCC
Q 002673 686 ENGSLDYWLHEKADGASQLDWLTRLKIARGTSCGLAYMHQICEPH-IVHRDIKSSNILLDDQF-EAHLADFGLSRLILPY 763 (894)
Q Consensus 686 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~-ivHrDLkp~NILld~~~-~vkl~DFGla~~~~~~ 763 (894)
++|+|.++++.. ....+++..++.|+.|||+||.|||+. + ||||||||+|||++.++ ++||+|||+++.....
T Consensus 123 ~~GsL~~~l~~~--~~~~l~~~~~l~~aldiArGm~YLH~~---~~iIHrDLK~~NiLv~~~~~~~KI~DFGlsr~~~~~ 197 (362)
T KOG0192|consen 123 PGGSLSVLLHKK--RKRKLPLKVRLRIALDIARGMEYLHSE---GPIIHRDLKSDNILVDLKGKTLKIADFGLSREKVIS 197 (362)
T ss_pred CCCcHHHHHhhc--ccCCCCHHHHHHHHHHHHHHHHHHhcC---CCeeecccChhhEEEcCCCCEEEECCCccceeeccc
Confidence 999999999975 346799999999999999999999984 5 99999999999999997 9999999999876432
Q ss_pred CCcccccccccCCccCccccc--CcCCCccccHHHHHHHHHHHHcCCCCCCCCCcchhhhHHHHHHHHhhcCCCCccccc
Q 002673 764 QTHVTTELVGTLGYIPPEYGQ--AWVATLRGDMYSFGVVMLELLTGKRPVDVLKPKMSRELVGWVLKMRSEGKQDQVFDP 841 (894)
Q Consensus 764 ~~~~~~~~~gt~~Y~APE~~~--~~~~s~ksDVwS~GvlL~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 841 (894)
. ...+...||+.|||||++. ...|+.|+||||||+++|||+||+.||....... ... .....+....+...
T Consensus 198 ~-~~~~~~~GT~~wMAPEv~~~~~~~~~~K~DvySFgIvlWEl~t~~~Pf~~~~~~~---~~~---~v~~~~~Rp~~p~~ 270 (362)
T KOG0192|consen 198 K-TSMTSVAGTYRWMAPEVLRGEKSPYTEKSDVYSFGIVLWELLTGEIPFEDLAPVQ---VAS---AVVVGGLRPPIPKE 270 (362)
T ss_pred c-ccccCCCCCccccChhhhcCCCCcCCccchhhhHHHHHHHHHHCCCCCCCCCHHH---HHH---HHHhcCCCCCCCcc
Confidence 2 2233468999999999999 5699999999999999999999999999776421 111 11112221111111
Q ss_pred cccCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhccc
Q 002673 842 ILRGKGFDEEMLQVLDVACMCVSQNPFKRPTVKEVVEWLNNVGA 885 (894)
Q Consensus 842 ~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~i~~ 885 (894)
....+..++.+||+.||+.||++.+++..|+.+..
T Consensus 271 ---------~~~~l~~l~~~CW~~dp~~RP~f~ei~~~l~~~~~ 305 (362)
T KOG0192|consen 271 ---------CPPHLSSLMERCWLVDPSRRPSFLEIVSRLESIMS 305 (362)
T ss_pred ---------CCHHHHHHHHHhCCCCCCcCCCHHHHHHHHHHHHH
Confidence 22356678889999999999999999999987754
|
|
| >KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-43 Score=371.36 Aligned_cols=254 Identities=28% Similarity=0.484 Sum_probs=209.5
Q ss_pred CCccceEeecCcEEEEEEEE-cCCCeEEEEEEcCcc-hhhHHHHHHHHHHHHhcCCCceeeecceeeecc-eEEEEEEec
Q 002673 609 FSQANIIGCGGFGLVYKATL-ANGTTLAIKKLSGDL-GLMEREFKAEVEALSTAQHKNLVSLQGYCVHQG-FRLLIYSYM 685 (894)
Q Consensus 609 f~~~~~LG~G~fg~Vy~a~~-~~g~~vAvK~~~~~~-~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~-~~~lV~E~~ 685 (894)
.+..+.||+|..|+|||+.+ .++..+|+|++.... ....+++.+|+++++..+||+||.++|.|..+. ...++||||
T Consensus 81 le~~~~lG~G~gG~V~kv~Hk~t~~i~AlK~I~~~~~~~~~~Qi~rEl~il~~~~spyIV~~ygaF~~~~~~isI~mEYM 160 (364)
T KOG0581|consen 81 LERLGVLGSGNGGTVYKVRHKPTGKIYALKVILLNIDPALQKQILRELEILRSCQSPYIVGFYGAFYSNGEEISICMEYM 160 (364)
T ss_pred hhhhhhcccCCCcEEEEEEEcCCCeEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCeeeEeEEEEeCCceEEeehhhc
Confidence 34468899999999999985 578999999996544 345688999999999999999999999999998 499999999
Q ss_pred cCCCHHHHHhhhcCCCCCcCHHHHHHHHHHHHHHHHHHHhccCCCeeecCCCCCCeEECCCCcEEEEEcccccccCCCCC
Q 002673 686 ENGSLDYWLHEKADGASQLDWLTRLKIARGTSCGLAYMHQICEPHIVHRDIKSSNILLDDQFEAHLADFGLSRLILPYQT 765 (894)
Q Consensus 686 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDLkp~NILld~~~~vkl~DFGla~~~~~~~~ 765 (894)
++|+|+.++... .++++...-+|+.+|++||.|||+ .++||||||||+|||++..|+|||||||.++.+...
T Consensus 161 DgGSLd~~~k~~----g~i~E~~L~~ia~~VL~GL~YLh~--~~~IIHRDIKPsNlLvNskGeVKicDFGVS~~lvnS-- 232 (364)
T KOG0581|consen 161 DGGSLDDILKRV----GRIPEPVLGKIARAVLRGLSYLHE--ERKIIHRDIKPSNLLVNSKGEVKICDFGVSGILVNS-- 232 (364)
T ss_pred CCCCHHHHHhhc----CCCCHHHHHHHHHHHHHHHHHHhh--ccCeeeccCCHHHeeeccCCCEEeccccccHHhhhh--
Confidence 999999999864 458889999999999999999996 379999999999999999999999999999987543
Q ss_pred cccccccccCCccCcccccCcCCCccccHHHHHHHHHHHHcCCCCCCCCCc--chhhhHHHHHHHHhhcCCCCccccccc
Q 002673 766 HVTTELVGTLGYIPPEYGQAWVATLRGDMYSFGVVMLELLTGKRPVDVLKP--KMSRELVGWVLKMRSEGKQDQVFDPIL 843 (894)
Q Consensus 766 ~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwS~GvlL~elltG~~Pf~~~~~--~~~~~~~~~~~~~~~~~~~~~~~d~~l 843 (894)
.....+||..|||||.+++..|+.++||||||+.++|+.+|+.||..... ....+++.++ . .+. .|.+
T Consensus 233 -~a~tfvGT~~YMsPERi~g~~Ys~~sDIWSLGLsllE~a~GrfP~~~~~~~~~~~~~Ll~~I---v-~~p-----pP~l 302 (364)
T KOG0581|consen 233 -IANTFVGTSAYMSPERISGESYSVKSDIWSLGLSLLELAIGRFPYPPPNPPYLDIFELLCAI---V-DEP-----PPRL 302 (364)
T ss_pred -hcccccccccccChhhhcCCcCCcccceecccHHHHHHhhCCCCCCCcCCCCCCHHHHHHHH---h-cCC-----CCCC
Confidence 45678999999999999999999999999999999999999999975411 1112222221 1 111 1222
Q ss_pred cCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHH--HHHhc
Q 002673 844 RGKGFDEEMLQVLDVACMCVSQNPFKRPTVKEVVE--WLNNV 883 (894)
Q Consensus 844 ~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~--~L~~i 883 (894)
....+++ ++.+++..|++.||.+||+++|+++ |+.+.
T Consensus 303 P~~~fS~---ef~~FV~~CL~Kdp~~R~s~~qLl~Hpfi~~~ 341 (364)
T KOG0581|consen 303 PEGEFSP---EFRSFVSCCLRKDPSERPSAKQLLQHPFIKKF 341 (364)
T ss_pred CcccCCH---HHHHHHHHHhcCCcccCCCHHHHhcCHHHhhc
Confidence 2222333 4667888999999999999999998 66654
|
|
| >KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-42 Score=379.93 Aligned_cols=249 Identities=24% Similarity=0.394 Sum_probs=210.9
Q ss_pred cCCCccceEeecCcEEEEEEEE-cCCCeEEEEEEcCcc---hhhHHHHHHHHHHHHhcCCCceeeecceeeecceEEEEE
Q 002673 607 DNFSQANIIGCGGFGLVYKATL-ANGTTLAIKKLSGDL---GLMEREFKAEVEALSTAQHKNLVSLQGYCVHQGFRLLIY 682 (894)
Q Consensus 607 ~~f~~~~~LG~G~fg~Vy~a~~-~~g~~vAvK~~~~~~---~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~lV~ 682 (894)
..|..++.||+|+|+.||.++. .+|+.||+|++.+.. ......+.+||++.+.|+|||||+++++|++.++.|||.
T Consensus 18 ~~Y~~g~~LGkGgFA~cYe~~~~~tge~~A~KvVpk~~l~k~~~reKv~~EIeIHr~L~HpnIV~f~~~FEDs~nVYivL 97 (592)
T KOG0575|consen 18 KRYKRGRFLGKGGFARCYEARDLDTGEVVAVKVVPKKLLKKPKQREKVLNEIEIHRSLKHPNIVQFYHFFEDSNNVYIVL 97 (592)
T ss_pred ceeeeeeeeccCcceEEEEEEEcCCCcEEEEEEeehHHhcCcchHHHHHHHHHHHHhcCCCcEEeeeeEeecCCceEEEE
Confidence 5688999999999999999995 899999999998633 334567889999999999999999999999999999999
Q ss_pred EeccCCCHHHHHhhhcCCCCCcCHHHHHHHHHHHHHHHHHHHhccCCCeeecCCCCCCeEECCCCcEEEEEcccccccCC
Q 002673 683 SYMENGSLDYWLHEKADGASQLDWLTRLKIARGTSCGLAYMHQICEPHIVHRDIKSSNILLDDQFEAHLADFGLSRLILP 762 (894)
Q Consensus 683 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDLkp~NILld~~~~vkl~DFGla~~~~~ 762 (894)
|+|..|+|..+++.. ..+++.++..+.+||+.||.|||+ ++|+|||||-.|+||+++.+|||+|||+|..+..
T Consensus 98 ELC~~~sL~el~Krr----k~ltEpEary~l~QIv~GlkYLH~---~~IiHRDLKLGNlfL~~~~~VKIgDFGLAt~le~ 170 (592)
T KOG0575|consen 98 ELCHRGSLMELLKRR----KPLTEPEARYFLRQIVEGLKYLHS---LGIIHRDLKLGNLFLNENMNVKIGDFGLATQLEY 170 (592)
T ss_pred EecCCccHHHHHHhc----CCCCcHHHHHHHHHHHHHHHHHHh---cCceecccchhheeecCcCcEEecccceeeeecC
Confidence 999999999999843 579999999999999999999998 4899999999999999999999999999998753
Q ss_pred CCCcccccccccCCccCcccccCcCCCccccHHHHHHHHHHHHcCCCCCCCCCcchhhhHHHHHHHHhhcCCCCcccccc
Q 002673 763 YQTHVTTELVGTLGYIPPEYGQAWVATLRGDMYSFGVVMLELLTGKRPVDVLKPKMSRELVGWVLKMRSEGKQDQVFDPI 842 (894)
Q Consensus 763 ~~~~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwS~GvlL~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 842 (894)
. .....+.+|||.|+|||++....++..+||||+|||||-|+.|++||+... +.+....+...... +.
T Consensus 171 ~-~Erk~TlCGTPNYIAPEVl~k~gHsfEvDiWSlGcvmYtLL~G~PPFetk~------vkety~~Ik~~~Y~---~P-- 238 (592)
T KOG0575|consen 171 D-GERKKTLCGTPNYIAPEVLNKSGHSFEVDIWSLGCVMYTLLVGRPPFETKT------VKETYNKIKLNEYS---MP-- 238 (592)
T ss_pred c-ccccceecCCCcccChhHhccCCCCCchhhhhhhhHHHhhhhCCCCcccch------HHHHHHHHHhcCcc---cc--
Confidence 3 345667899999999999999999999999999999999999999998433 22222222222111 10
Q ss_pred ccCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHH--HH
Q 002673 843 LRGKGFDEEMLQVLDVACMCVSQNPFKRPTVKEVVE--WL 880 (894)
Q Consensus 843 l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~--~L 880 (894)
.....+..+||..+|+.||.+|||+++|+. ++
T Consensus 239 ------~~ls~~A~dLI~~lL~~~P~~Rpsl~~vL~h~Ff 272 (592)
T KOG0575|consen 239 ------SHLSAEAKDLIRKLLRPNPSERPSLDEVLDHPFF 272 (592)
T ss_pred ------cccCHHHHHHHHHHhcCCcccCCCHHHHhcCHhh
Confidence 111234568888999999999999999997 55
|
|
| >KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-42 Score=381.81 Aligned_cols=255 Identities=25% Similarity=0.422 Sum_probs=211.3
Q ss_pred CCccceEeecCcEEEEEEEEcCCCeEEEEEEcCcchhhHHHHHHHHHHHHhcCCCceeeecceeeecceEEEEEEeccCC
Q 002673 609 FSQANIIGCGGFGLVYKATLANGTTLAIKKLSGDLGLMEREFKAEVEALSTAQHKNLVSLQGYCVHQGFRLLIYSYMENG 688 (894)
Q Consensus 609 f~~~~~LG~G~fg~Vy~a~~~~g~~vAvK~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~lV~E~~~~g 688 (894)
+...+.||+|.||.||.|.++....||+|.+... ....++|.+|+.+|++++|+|||+++|+|..+...+||||||+.|
T Consensus 208 l~l~~~LG~G~FG~V~~g~~~~~~~vavk~ik~~-~m~~~~f~~Ea~iMk~L~H~~lV~l~gV~~~~~piyIVtE~m~~G 286 (468)
T KOG0197|consen 208 LKLIRELGSGQFGEVWLGKWNGSTKVAVKTIKEG-SMSPEAFLREAQIMKKLRHEKLVKLYGVCTKQEPIYIVTEYMPKG 286 (468)
T ss_pred HHHHHHhcCCccceEEEEEEcCCCcccceEEecc-ccChhHHHHHHHHHHhCcccCeEEEEEEEecCCceEEEEEecccC
Confidence 3456789999999999999988889999999865 344578899999999999999999999999988999999999999
Q ss_pred CHHHHHhhhcCCCCCcCHHHHHHHHHHHHHHHHHHHhccCCCeeecCCCCCCeEECCCCcEEEEEcccccccCCCCCccc
Q 002673 689 SLDYWLHEKADGASQLDWLTRLKIARGTSCGLAYMHQICEPHIVHRDIKSSNILLDDQFEAHLADFGLSRLILPYQTHVT 768 (894)
Q Consensus 689 sL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDLkp~NILld~~~~vkl~DFGla~~~~~~~~~~~ 768 (894)
+|.++|+. .++..+...+.+.++.|||+||+||++ +++|||||.++|||++++..+||+|||+++...+......
T Consensus 287 sLl~yLr~--~~~~~l~~~~Ll~~a~qIaeGM~YLes---~~~IHRDLAARNiLV~~~~~vKIsDFGLAr~~~d~~Y~~~ 361 (468)
T KOG0197|consen 287 SLLDYLRT--REGGLLNLPQLLDFAAQIAEGMAYLES---KNYIHRDLAARNILVDEDLVVKISDFGLARLIGDDEYTAS 361 (468)
T ss_pred cHHHHhhh--cCCCccchHHHHHHHHHHHHHHHHHHh---CCccchhhhhhheeeccCceEEEcccccccccCCCceeec
Confidence 99999997 345678889999999999999999997 6999999999999999999999999999996544333333
Q ss_pred ccccccCCccCcccccCcCCCccccHHHHHHHHHHHHc-CCCCCCCCCcchhhhHHHHHHHHhhcCCCCccccccccCCC
Q 002673 769 TELVGTLGYIPPEYGQAWVATLRGDMYSFGVVMLELLT-GKRPVDVLKPKMSRELVGWVLKMRSEGKQDQVFDPILRGKG 847 (894)
Q Consensus 769 ~~~~gt~~Y~APE~~~~~~~s~ksDVwS~GvlL~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~ 847 (894)
....-...|+|||.+..+.++.|||||||||+||||+| |+.|+..+...+. ++.+ .+...+. +...
T Consensus 362 ~~~kfPIkWtAPEa~~~~~FS~kSDVWSFGVlL~E~fT~G~~py~~msn~ev---~~~l---e~GyRlp-------~P~~ 428 (468)
T KOG0197|consen 362 EGGKFPIKWTAPEALNYGKFSSKSDVWSFGVLLWELFTYGRVPYPGMSNEEV---LELL---ERGYRLP-------RPEG 428 (468)
T ss_pred CCCCCCceecCHHHHhhCCcccccceeehhhhHHHHhccCCCCCCCCCHHHH---HHHH---hccCcCC-------CCCC
Confidence 33344668999999999999999999999999999999 9999987654322 2211 1111111 1233
Q ss_pred ChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhccc
Q 002673 848 FDEEMLQVLDVACMCVSQNPFKRPTVKEVVEWLNNVGA 885 (894)
Q Consensus 848 ~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~i~~ 885 (894)
+++ .+.+++..||+.+|++|||++.+...|+.+..
T Consensus 429 CP~---~vY~lM~~CW~~~P~~RPtF~~L~~~l~~~~~ 463 (468)
T KOG0197|consen 429 CPD---EVYELMKSCWHEDPEDRPTFETLREVLEDFFT 463 (468)
T ss_pred CCH---HHHHHHHHHhhCCcccCCCHHHHHHHHHHhhh
Confidence 444 46678889999999999999999999988754
|
|
| >KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-42 Score=367.13 Aligned_cols=255 Identities=26% Similarity=0.414 Sum_probs=204.8
Q ss_pred cCCCccceEeecCcEEEEEEE-EcCCCeEEEEEEcCcchh-------hHHHHHHHHHHHHhcCCCceeeecceeeecceE
Q 002673 607 DNFSQANIIGCGGFGLVYKAT-LANGTTLAIKKLSGDLGL-------MEREFKAEVEALSTAQHKNLVSLQGYCVHQGFR 678 (894)
Q Consensus 607 ~~f~~~~~LG~G~fg~Vy~a~-~~~g~~vAvK~~~~~~~~-------~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~ 678 (894)
+.|.+.+.||+|+||.|-+|. ..+|+.||||++.+.... ....+.+|+++|++++|||||++++++...+..
T Consensus 172 d~yii~~~LGsGafg~Vkla~e~~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~HP~IV~~~d~f~~~ds~ 251 (475)
T KOG0615|consen 172 DYYIISKTLGSGAFGLVKLAYEKKTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLSHPNIVRIKDFFEVPDSS 251 (475)
T ss_pred ceeEeeeeecCCceeEEEEEEEcccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhcCCCCEEEEeeeeecCCce
Confidence 557788999999999999997 678999999999764311 123467999999999999999999999999999
Q ss_pred EEEEEeccCCCHHHHHhhhcCCCCCcCHHHHHHHHHHHHHHHHHHHhccCCCeeecCCCCCCeEECCC---CcEEEEEcc
Q 002673 679 LLIYSYMENGSLDYWLHEKADGASQLDWLTRLKIARGTSCGLAYMHQICEPHIVHRDIKSSNILLDDQ---FEAHLADFG 755 (894)
Q Consensus 679 ~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDLkp~NILld~~---~~vkl~DFG 755 (894)
|||||||+||+|.+++-.+. .+....-..++.|++.|+.|||+ +||+||||||+|||++.+ ..+||+|||
T Consensus 252 YmVlE~v~GGeLfd~vv~nk----~l~ed~~K~~f~Qll~avkYLH~---~GI~HRDiKPeNILl~~~~e~~llKItDFG 324 (475)
T KOG0615|consen 252 YMVLEYVEGGELFDKVVANK----YLREDLGKLLFKQLLTAVKYLHS---QGIIHRDIKPENILLSNDAEDCLLKITDFG 324 (475)
T ss_pred EEEEEEecCccHHHHHHhcc----ccccchhHHHHHHHHHHHHHHHH---cCcccccCCcceEEeccCCcceEEEecccc
Confidence 99999999999999987643 35555667899999999999997 699999999999999866 779999999
Q ss_pred cccccCCCCCcccccccccCCccCcccccCcCC---CccccHHHHHHHHHHHHcCCCCCCCCCcchhhhHHHHHHHHhhc
Q 002673 756 LSRLILPYQTHVTTELVGTLGYIPPEYGQAWVA---TLRGDMYSFGVVMLELLTGKRPVDVLKPKMSRELVGWVLKMRSE 832 (894)
Q Consensus 756 la~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~---s~ksDVwS~GvlL~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~ 832 (894)
+|+... ....+.+.+||+.|.|||++.+..+ ..++|+||+||+||-+++|.+||.+...... +.+.+ ..
T Consensus 325 lAK~~g--~~sfm~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLsG~pPFS~~~~~~s--l~eQI----~~ 396 (475)
T KOG0615|consen 325 LAKVSG--EGSFMKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLSGYPPFSEEYTDPS--LKEQI----LK 396 (475)
T ss_pred hhhccc--cceehhhhcCCccccChhheecCCeecccchheeeeccceEEEEeccCCCcccccCCcc--HHHHH----hc
Confidence 999874 3445677899999999999887643 3477999999999999999999986543321 11111 11
Q ss_pred CCCCccccccccCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHH--HHHh
Q 002673 833 GKQDQVFDPILRGKGFDEEMLQVLDVACMCVSQNPFKRPTVKEVVE--WLNN 882 (894)
Q Consensus 833 ~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~--~L~~ 882 (894)
+... +-| ..+.....+..++|.+||..||++|||++|+++ ||+.
T Consensus 397 G~y~--f~p----~~w~~Iseea~dlI~~mL~VdP~~R~s~~eaL~hpW~~~ 442 (475)
T KOG0615|consen 397 GRYA--FGP----LQWDRISEEALDLINWMLVVDPENRPSADEALNHPWFKD 442 (475)
T ss_pred Cccc--ccC----hhhhhhhHHHHHHHHHhhEeCcccCcCHHHHhcChhhhc
Confidence 1111 111 123344556789999999999999999999998 8873
|
|
| >KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-41 Score=359.88 Aligned_cols=200 Identities=28% Similarity=0.498 Sum_probs=179.3
Q ss_pred cCCCccceEeecCcEEEEEEE-EcCCCeEEEEEEcCc--chhhHHHHHHHHHHHHhcCCCceeeecceeeecceEEEEEE
Q 002673 607 DNFSQANIIGCGGFGLVYKAT-LANGTTLAIKKLSGD--LGLMEREFKAEVEALSTAQHKNLVSLQGYCVHQGFRLLIYS 683 (894)
Q Consensus 607 ~~f~~~~~LG~G~fg~Vy~a~-~~~g~~vAvK~~~~~--~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~lV~E 683 (894)
.+|...+.||+|+||+||+|+ ..++..||||.+... .....+....|+.+|+.++|||||++++++..++..|||||
T Consensus 10 ~~y~~~~~iG~GsfavVykg~h~~~~~~VAIK~i~~~~l~~k~~e~L~~Ei~iLkel~H~nIV~l~d~~~~~~~i~lVME 89 (429)
T KOG0595|consen 10 GDYELSREIGSGSFAVVYKGRHKKSGTEVAIKCIAKKKLNKKLVELLLSEIKILKELKHPNIVRLLDCIEDDDFIYLVME 89 (429)
T ss_pred ccceehhhccCcceEEEEEeEeccCCceEEeeeehhhccCHHHHHHHHHHHHHHHhcCCcceeeEEEEEecCCeEEEEEE
Confidence 567788889999999999998 457899999999876 34445667899999999999999999999999999999999
Q ss_pred eccCCCHHHHHhhhcCCCCCcCHHHHHHHHHHHHHHHHHHHhccCCCeeecCCCCCCeEECCC------CcEEEEEcccc
Q 002673 684 YMENGSLDYWLHEKADGASQLDWLTRLKIARGTSCGLAYMHQICEPHIVHRDIKSSNILLDDQ------FEAHLADFGLS 757 (894)
Q Consensus 684 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDLkp~NILld~~------~~vkl~DFGla 757 (894)
||.||+|.+|++.+. .++...+..++.|+|.||++||+ ++||||||||.||||+.. -.+||+|||+|
T Consensus 90 yC~gGDLs~yi~~~~----~l~e~t~r~Fm~QLA~alq~L~~---~~IiHRDLKPQNiLLs~~~~~~~~~~LKIADFGfA 162 (429)
T KOG0595|consen 90 YCNGGDLSDYIRRRG----RLPEATARHFMQQLASALQFLHE---NNIIHRDLKPQNILLSTTARNDTSPVLKIADFGFA 162 (429)
T ss_pred eCCCCCHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHH---CCeeeccCCcceEEeccCCCCCCCceEEecccchh
Confidence 999999999999763 68999999999999999999997 799999999999999864 46999999999
Q ss_pred cccCCCCCcccccccccCCccCcccccCcCCCccccHHHHHHHHHHHHcCCCCCCCCC
Q 002673 758 RLILPYQTHVTTELVGTLGYIPPEYGQAWVATLRGDMYSFGVVMLELLTGKRPVDVLK 815 (894)
Q Consensus 758 ~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwS~GvlL~elltG~~Pf~~~~ 815 (894)
+.+.+ .....+.+|++-|||||+++..+|+.|+|+||+|+|+|+|++|+.||+...
T Consensus 163 R~L~~--~~~a~tlcGSplYMAPEV~~~~~YdAKADLWSiG~Ilyq~l~g~~Pf~a~t 218 (429)
T KOG0595|consen 163 RFLQP--GSMAETLCGSPLYMAPEVIMSQQYDAKADLWSIGTILYQCLTGKPPFDAET 218 (429)
T ss_pred hhCCc--hhHHHHhhCCccccCHHHHHhccccchhhHHHHHHHHHHHHhCCCCccccC
Confidence 98753 333456799999999999999999999999999999999999999998544
|
|
| >KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-41 Score=390.22 Aligned_cols=260 Identities=27% Similarity=0.439 Sum_probs=216.4
Q ss_pred cCCCccceEeecCcEEEEEEEEc------CCCeEEEEEEcCcchh-hHHHHHHHHHHHHhcCCCceeeecceeeecceEE
Q 002673 607 DNFSQANIIGCGGFGLVYKATLA------NGTTLAIKKLSGDLGL-MEREFKAEVEALSTAQHKNLVSLQGYCVHQGFRL 679 (894)
Q Consensus 607 ~~f~~~~~LG~G~fg~Vy~a~~~------~g~~vAvK~~~~~~~~-~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~ 679 (894)
.+....+.||+|+||.||+|+.. +...||||.++..... ..++|++|++++..++|||||+++|+|.+++..+
T Consensus 486 ~~i~~~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~a~~~~~~dF~REaeLla~l~H~nIVrLlGVC~~~~P~~ 565 (774)
T KOG1026|consen 486 SDIVFKEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDKAENQARQDFRREAELLAELQHPNIVRLLGVCREGDPLC 565 (774)
T ss_pred hheeehhhhcCchhhhhhhhhccCCCCCccceehhHhhhcccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEccCCeeE
Confidence 44556688999999999999843 3567999999987655 6789999999999999999999999999999999
Q ss_pred EEEEeccCCCHHHHHhhhcC------C----CCCcCHHHHHHHHHHHHHHHHHHHhccCCCeeecCCCCCCeEECCCCcE
Q 002673 680 LIYSYMENGSLDYWLHEKAD------G----ASQLDWLTRLKIARGTSCGLAYMHQICEPHIVHRDIKSSNILLDDQFEA 749 (894)
Q Consensus 680 lV~E~~~~gsL~~~l~~~~~------~----~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDLkp~NILld~~~~v 749 (894)
||+|||..|||.+||..... + ..+++..+.+.||.|||.||.||-+ +.+|||||..+|+||.++..|
T Consensus 566 MvFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs~---~~FVHRDLATRNCLVge~l~V 642 (774)
T KOG1026|consen 566 MVFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLSS---HHFVHRDLATRNCLVGENLVV 642 (774)
T ss_pred EEEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHh---CcccccchhhhhceeccceEE
Confidence 99999999999999985331 1 2348899999999999999999997 599999999999999999999
Q ss_pred EEEEcccccccCCCCCcccc-cccccCCccCcccccCcCCCccccHHHHHHHHHHHHc-CCCCCCCCCcchhhhHHHHHH
Q 002673 750 HLADFGLSRLILPYQTHVTT-ELVGTLGYIPPEYGQAWVATLRGDMYSFGVVMLELLT-GKRPVDVLKPKMSRELVGWVL 827 (894)
Q Consensus 750 kl~DFGla~~~~~~~~~~~~-~~~gt~~Y~APE~~~~~~~s~ksDVwS~GvlL~ellt-G~~Pf~~~~~~~~~~~~~~~~ 827 (894)
||+|||+++.....+.+... +..-..+|||||.++.++||.+||||||||+|||+++ |+.||.+...++. +
T Consensus 643 KIsDfGLsRdiYssDYYk~~~~t~lPIRWMppEsIly~kFTteSDVWs~GVvLWEIFsyG~QPy~glSn~EV---I---- 715 (774)
T KOG1026|consen 643 KISDFGLSRDIYSSDYYKVRGNTLLPIRWMPPESILYGKFTTESDVWSFGVVLWEIFSYGKQPYYGLSNQEV---I---- 715 (774)
T ss_pred EecccccchhhhhhhhhcccCCceeeeecCCHHHhhcCcccchhhhhhhhhhhhhhhccccCcccccchHHH---H----
Confidence 99999999987554444333 3445679999999999999999999999999999999 9999987765432 2
Q ss_pred HHhhcCCCCccccccccCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhccc
Q 002673 828 KMRSEGKQDQVFDPILRGKGFDEEMLQVLDVACMCVSQNPFKRPTVKEVVEWLNNVGA 885 (894)
Q Consensus 828 ~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~i~~ 885 (894)
...+.++.-.. .......+++|+..||+.+|.+||+++||-..|+....
T Consensus 716 e~i~~g~lL~~---------Pe~CP~~vY~LM~~CW~~~P~~RPsF~eI~~~L~~~~~ 764 (774)
T KOG1026|consen 716 ECIRAGQLLSC---------PENCPTEVYSLMLECWNENPKRRPSFKEIHSRLQAWAQ 764 (774)
T ss_pred HHHHcCCcccC---------CCCCCHHHHHHHHHHhhcCcccCCCHHHHHHHHHHHHh
Confidence 23334433211 11223467889999999999999999999999987754
|
|
| >KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-42 Score=346.81 Aligned_cols=258 Identities=23% Similarity=0.344 Sum_probs=209.2
Q ss_pred CCCccceEeecCcEEEEEEE-EcCCCeEEEEEEcCcc--hhhHHHHHHHHHHHHhcCCCceeeecc-eeeecce-EEEEE
Q 002673 608 NFSQANIIGCGGFGLVYKAT-LANGTTLAIKKLSGDL--GLMEREFKAEVEALSTAQHKNLVSLQG-YCVHQGF-RLLIY 682 (894)
Q Consensus 608 ~f~~~~~LG~G~fg~Vy~a~-~~~g~~vAvK~~~~~~--~~~~~~~~~Ei~~l~~l~HpnIv~l~g-~~~~~~~-~~lV~ 682 (894)
+|++.++||+|.||.|||+. ..+|..||.|.++-+. ....++...|+.+|++++|||||++++ -+.++.. .++||
T Consensus 20 ~y~Il~~IG~GsFg~vykv~~~~~g~l~a~K~i~f~~md~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~f~~~~evlnivm 99 (375)
T KOG0591|consen 20 DYQILKKIGRGSFGEVYKVQCLLDGKLVALKKIQFGMMDAKARQDCVKEISLLKQLNHPNIVQYYAHSFIEDNEVLNIVM 99 (375)
T ss_pred HHHHHHHHcCCcchheEEeeeccCcchhhhhhcchhhccHHHHHHHHHHHHHHHhcCCchHHHHHHHhhhccchhhHHHH
Confidence 46677899999999999997 7899999999987433 334567889999999999999999998 4555554 78999
Q ss_pred EeccCCCHHHHHhhhcCCCCCcCHHHHHHHHHHHHHHHHHHHhccC-CCeeecCCCCCCeEECCCCcEEEEEcccccccC
Q 002673 683 SYMENGSLDYWLHEKADGASQLDWLTRLKIARGTSCGLAYMHQICE-PHIVHRDIKSSNILLDDQFEAHLADFGLSRLIL 761 (894)
Q Consensus 683 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~-~~ivHrDLkp~NILld~~~~vkl~DFGla~~~~ 761 (894)
||+..|+|...++........++...+++++.|++.||.++|+... +-|+||||||.||+|+.+|.|||+|||+++.+.
T Consensus 100 E~c~~GDLsqmIk~~K~qkr~ipE~~Vwk~f~QL~~AL~~cH~~~~r~~VmHRDIKPaNIFl~~~gvvKLGDfGL~r~l~ 179 (375)
T KOG0591|consen 100 ELCDAGDLSQMIKHFKKQKRLIPEKTVWKYFVQLCRALYHCHSKIPRGTVMHRDIKPANIFLTANGVVKLGDFGLGRFLS 179 (375)
T ss_pred HhhcccCHHHHHHHHHhccccCchHHHHHHHHHHHHHHHHHhccccccceeeccCcchheEEcCCCceeeccchhHhHhc
Confidence 9999999999999877777889999999999999999999998322 238999999999999999999999999999875
Q ss_pred CCCCcccccccccCCccCcccccCcCCCccccHHHHHHHHHHHHcCCCCCCCCCcchhhhHHHHHHHHhhcCCCCccccc
Q 002673 762 PYQTHVTTELVGTLGYIPPEYGQAWVATLRGDMYSFGVVMLELLTGKRPVDVLKPKMSRELVGWVLKMRSEGKQDQVFDP 841 (894)
Q Consensus 762 ~~~~~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwS~GvlL~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 841 (894)
... ......+|||.||+||.+.+..|+.||||||+||++|||+.-.+||.+. ++.+...++. .+....+.+
T Consensus 180 s~~-tfA~S~VGTPyYMSPE~i~~~~Y~~kSDiWslGCllyEMcaL~~PF~g~------n~~~L~~KI~-qgd~~~~p~- 250 (375)
T KOG0591|consen 180 SKT-TFAHSLVGTPYYMSPERIHESGYNFKSDIWSLGCLLYEMCALQSPFYGD------NLLSLCKKIE-QGDYPPLPD- 250 (375)
T ss_pred chh-HHHHhhcCCCcccCHHHHhcCCCCcchhHHHHHHHHHHHHhcCCCcccc------cHHHHHHHHH-cCCCCCCcH-
Confidence 433 3345689999999999999999999999999999999999999999853 3333333322 222221211
Q ss_pred cccCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 002673 842 ILRGKGFDEEMLQVLDVACMCVSQNPFKRPTVKEVVEWLN 881 (894)
Q Consensus 842 ~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~ 881 (894)
...+.++.+++..|+..||+.||+...+++.++
T Consensus 251 -------~~YS~~l~~li~~ci~vd~~~RP~t~~~v~di~ 283 (375)
T KOG0591|consen 251 -------EHYSTDLRELINMCIAVDPEQRPDTVPYVQDIQ 283 (375)
T ss_pred -------HHhhhHHHHHHHHHccCCcccCCCcchHHHHHH
Confidence 123456778899999999999999655555433
|
|
| >KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-40 Score=334.55 Aligned_cols=264 Identities=22% Similarity=0.268 Sum_probs=204.0
Q ss_pred cCCCccceEeecCcEEEEEEE-EcCCCeEEEEEEcCcc--hhhHHHHHHHHHHHHhcCCCceeeecceeeecceEEEEEE
Q 002673 607 DNFSQANIIGCGGFGLVYKAT-LANGTTLAIKKLSGDL--GLMEREFKAEVEALSTAQHKNLVSLQGYCVHQGFRLLIYS 683 (894)
Q Consensus 607 ~~f~~~~~LG~G~fg~Vy~a~-~~~g~~vAvK~~~~~~--~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~lV~E 683 (894)
+.|+...++|+|+||.|||++ ..+|+.||||++.... ....+-..+|+++|++++|+|+|.++++|......+||+|
T Consensus 2 ekYE~LgkvGEGSYGvV~KCrnk~TgqIVAIKkF~Esedd~~VkKIAlREIrmLKqLkH~NLVnLiEVFrrkrklhLVFE 81 (396)
T KOG0593|consen 2 EKYEKLGKVGEGSYGVVMKCRNKDTGQIVAIKKFVESEDDPVVKKIALREIRMLKQLKHENLVNLIEVFRRKRKLHLVFE 81 (396)
T ss_pred cHHhhhhccccCcceEEEEeccCCcccEEEEEeeccCCccHHHHHHHHHHHHHHHhcccchHHHHHHHHHhcceeEEEee
Confidence 357777899999999999998 4579999999996532 3445567899999999999999999999999999999999
Q ss_pred eccCCCHHHHHhhhcCCCCCcCHHHHHHHHHHHHHHHHHHHhccCCCeeecCCCCCCeEECCCCcEEEEEcccccccCCC
Q 002673 684 YMENGSLDYWLHEKADGASQLDWLTRLKIARGTSCGLAYMHQICEPHIVHRDIKSSNILLDDQFEAHLADFGLSRLILPY 763 (894)
Q Consensus 684 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDLkp~NILld~~~~vkl~DFGla~~~~~~ 763 (894)
||+. ++.+-+.... ..++.....+++.|++.|+.|+|+ +++|||||||+|||++.++.+||||||+|+.+..
T Consensus 82 ~~dh-TvL~eLe~~p---~G~~~~~vk~~l~Q~l~ai~~cHk---~n~IHRDIKPENILit~~gvvKLCDFGFAR~L~~- 153 (396)
T KOG0593|consen 82 YCDH-TVLHELERYP---NGVPSELVKKYLYQLLKAIHFCHK---NNCIHRDIKPENILITQNGVVKLCDFGFARTLSA- 153 (396)
T ss_pred ecch-HHHHHHHhcc---CCCCHHHHHHHHHHHHHHhhhhhh---cCeecccCChhheEEecCCcEEeccchhhHhhcC-
Confidence 9986 4444444443 447888899999999999999997 5999999999999999999999999999998764
Q ss_pred CCcccccccccCCccCcccccC-cCCCccccHHHHHHHHHHHHcCCCCCCCCCcchhhhHHHHHH--------HHh-hcC
Q 002673 764 QTHVTTELVGTLGYIPPEYGQA-WVATLRGDMYSFGVVMLELLTGKRPVDVLKPKMSRELVGWVL--------KMR-SEG 833 (894)
Q Consensus 764 ~~~~~~~~~gt~~Y~APE~~~~-~~~s~ksDVwS~GvlL~elltG~~Pf~~~~~~~~~~~~~~~~--------~~~-~~~ 833 (894)
.....+..+.|.+|.|||.+.+ ..|...+||||+||++.||++|.+-|.+.++-+....+.... .+. ...
T Consensus 154 pgd~YTDYVATRWYRaPELLvGDtqYG~pVDiWAiGCv~aEl~~G~pL~PG~SDiDQLy~I~ktLG~L~prhq~iF~~N~ 233 (396)
T KOG0593|consen 154 PGDNYTDYVATRWYRAPELLVGDTQYGKPVDIWAIGCVFAELLTGEPLWPGRSDIDQLYLIRKTLGNLIPRHQSIFSSNP 233 (396)
T ss_pred CcchhhhhhhhhhccChhhhcccCcCCCcccchhhhHHHHHHhcCCcCCCCcchHHHHHHHHHHHcccCHHHHHHhccCC
Confidence 3344566788999999999888 689999999999999999999999997654322211111100 000 000
Q ss_pred C-----CCccccccccCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 002673 834 K-----QDQVFDPILRGKGFDEEMLQVLDVACMCVSQNPFKRPTVKEVVE 878 (894)
Q Consensus 834 ~-----~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~ 878 (894)
. +.+.-++..-...++....-+++++..|++.||.+|++.++++.
T Consensus 234 ~F~Gv~lP~~~~~epLe~k~p~~s~~~ld~~k~cL~~dP~~R~sc~qll~ 283 (396)
T KOG0593|consen 234 FFHGVRLPEPEHPEPLERKYPKISNVLLDLLKKCLKMDPDDRLSCEQLLH 283 (396)
T ss_pred ceeeeecCCCCCccchhhhcccchHHHHHHHHHHhcCCccccccHHHHhc
Confidence 0 01111111111223334446789999999999999999999987
|
|
| >KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-40 Score=345.17 Aligned_cols=242 Identities=28% Similarity=0.336 Sum_probs=200.8
Q ss_pred ccCCCccceEeecCcEEEEEEE-EcCCCeEEEEEEcCcch---hhHHHHHHHHHHHHhcCCCceeeecceeeecceEEEE
Q 002673 606 TDNFSQANIIGCGGFGLVYKAT-LANGTTLAIKKLSGDLG---LMEREFKAEVEALSTAQHKNLVSLQGYCVHQGFRLLI 681 (894)
Q Consensus 606 ~~~f~~~~~LG~G~fg~Vy~a~-~~~g~~vAvK~~~~~~~---~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~lV 681 (894)
.++|+..++||+|+||.||.++ .++++.+|+|++++..- ...+....|..+|.+++||+||.++-.|.+....|||
T Consensus 24 ~~dF~~lkviGkG~fGkV~~Vrk~dt~kiYAmKvl~K~~iv~~~e~~~~~~Er~IL~~v~hPFiv~l~ysFQt~~kLylV 103 (357)
T KOG0598|consen 24 PDDFEILKVIGKGSFGKVFQVRKKDTGKIYAMKVLKKKKIVEKKEVRHTKAERNILSKIKHPFIVKLIYSFQTEEKLYLV 103 (357)
T ss_pred hhheeeeeeeeccCCceEEEEEEcccCceeehhhhhhhHhhhhhhHHHHHHHHHHHHhCCCCcEeeeEEecccCCeEEEE
Confidence 4678999999999999999997 56799999999987542 2345678999999999999999999999999999999
Q ss_pred EEeccCCCHHHHHhhhcCCCCCcCHHHHHHHHHHHHHHHHHHHhccCCCeeecCCCCCCeEECCCCcEEEEEcccccccC
Q 002673 682 YSYMENGSLDYWLHEKADGASQLDWLTRLKIARGTSCGLAYMHQICEPHIVHRDIKSSNILLDDQFEAHLADFGLSRLIL 761 (894)
Q Consensus 682 ~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDLkp~NILld~~~~vkl~DFGla~~~~ 761 (894)
+||+.||.|..+|++. ..++...+..++..|+.||.|||+ ++||||||||+|||||++|+++|+|||+|+...
T Consensus 104 ld~~~GGeLf~hL~~e----g~F~E~~arfYlaEi~lAL~~LH~---~gIiyRDlKPENILLd~~GHi~LtDFgL~k~~~ 176 (357)
T KOG0598|consen 104 LDYLNGGELFYHLQRE----GRFSEDRARFYLAEIVLALGYLHS---KGIIYRDLKPENILLDEQGHIKLTDFGLCKEDL 176 (357)
T ss_pred EeccCCccHHHHHHhc----CCcchhHHHHHHHHHHHHHHHHHh---CCeeeccCCHHHeeecCCCcEEEeccccchhcc
Confidence 9999999999999864 468888899999999999999997 599999999999999999999999999999643
Q ss_pred CCCCcccccccccCCccCcccccCcCCCccccHHHHHHHHHHHHcCCCCCCCCCcchhhhHHHHHHHHhhcCCCCccccc
Q 002673 762 PYQTHVTTELVGTLGYIPPEYGQAWVATLRGDMYSFGVVMLELLTGKRPVDVLKPKMSRELVGWVLKMRSEGKQDQVFDP 841 (894)
Q Consensus 762 ~~~~~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwS~GvlL~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 841 (894)
. ....+...+||+.|||||++.+..|+..+|+||+|+++|||++|.+||....... +...+.... ..
T Consensus 177 ~-~~~~t~tfcGT~eYmAPEil~~~gy~~~vDWWsLGillYeML~G~pPF~~~~~~~------~~~~I~~~k-~~----- 243 (357)
T KOG0598|consen 177 K-DGDATRTFCGTPEYMAPEILLGKGYDKAVDWWSLGILLYEMLTGKPPFYAEDVKK------MYDKILKGK-LP----- 243 (357)
T ss_pred c-CCCccccccCCccccChHHHhcCCCCcccchHhHHHHHHHHhhCCCCCcCccHHH------HHHHHhcCc-CC-----
Confidence 2 2334566899999999999999999999999999999999999999998544322 222222221 00
Q ss_pred cccCCCChHHHHHHHHHHHHhcccCCCCCC
Q 002673 842 ILRGKGFDEEMLQVLDVACMCVSQNPFKRP 871 (894)
Q Consensus 842 ~l~~~~~~~~~~~l~~li~~Cl~~dP~~RP 871 (894)
......+ ....+++...+..||++|.
T Consensus 244 -~~p~~ls---~~ardll~~LL~rdp~~RL 269 (357)
T KOG0598|consen 244 -LPPGYLS---EEARDLLKKLLKRDPRQRL 269 (357)
T ss_pred -CCCccCC---HHHHHHHHHHhccCHHHhc
Confidence 0011122 2456788899999999996
|
|
| >KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-38 Score=341.08 Aligned_cols=267 Identities=24% Similarity=0.364 Sum_probs=212.9
Q ss_pred cCCCccceEeecCcEEEEEEE-EcCCCeEEEEEEcCcchh-hHHHHHHHHHHHHhcCCCceeeecceeeecceEEEEEEe
Q 002673 607 DNFSQANIIGCGGFGLVYKAT-LANGTTLAIKKLSGDLGL-MEREFKAEVEALSTAQHKNLVSLQGYCVHQGFRLLIYSY 684 (894)
Q Consensus 607 ~~f~~~~~LG~G~fg~Vy~a~-~~~g~~vAvK~~~~~~~~-~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~lV~E~ 684 (894)
+.|+..+.||.|..++||+|+ .+.++.||||++.-+... ..+.+++|+..|+.++||||+.++..|..+...|+||.|
T Consensus 26 ~~YeL~e~IG~G~sa~V~~A~c~p~~e~VAIK~inLEkc~~~ld~l~kE~~~msl~~HPNIv~~~~sFvv~~~LWvVmpf 105 (516)
T KOG0582|consen 26 KDYELQEVIGVGASAVVYLARCIPTNEVVAIKIINLEKCNNDLDALRKEVQTMSLIDHPNIVTYHCSFVVDSELWVVMPF 105 (516)
T ss_pred cceeEEEEEeccceeEeeeeeecccCCEEEEEEeehhhhhhhHHHHHHHHHHhhhcCCCCcceEEEEEEecceeEEeehh
Confidence 578888999999999999998 678899999999765432 347899999999999999999999999999999999999
Q ss_pred ccCCCHHHHHhhhcCCCCCcCHHHHHHHHHHHHHHHHHHHhccCCCeeecCCCCCCeEECCCCcEEEEEcccccccCCCC
Q 002673 685 MENGSLDYWLHEKADGASQLDWLTRLKIARGTSCGLAYMHQICEPHIVHRDIKSSNILLDDQFEAHLADFGLSRLILPYQ 764 (894)
Q Consensus 685 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDLkp~NILld~~~~vkl~DFGla~~~~~~~ 764 (894)
|.+|++.+.++.... ..++...+..|++++++||.|||+ +|.||||||+.||||+++|.|||+|||.+..+....
T Consensus 106 Ma~GS~ldIik~~~~--~Gl~E~~Ia~iLre~LkaL~YLH~---~G~IHRdvKAgnILi~~dG~VkLadFgvsa~l~~~G 180 (516)
T KOG0582|consen 106 MAGGSLLDIIKTYYP--DGLEEASIATILREVLKALDYLHQ---NGHIHRDVKAGNILIDSDGTVKLADFGVSASLFDSG 180 (516)
T ss_pred hcCCcHHHHHHHHcc--ccccHHHHHHHHHHHHHHHHHHHh---cCceecccccccEEEcCCCcEEEcCceeeeeecccC
Confidence 999999999987654 338889999999999999999997 699999999999999999999999999987764432
Q ss_pred Cc---ccccccccCCccCcccccC--cCCCccccHHHHHHHHHHHHcCCCCCCCCCcchhhhHHHHHHHHhhcCCCCccc
Q 002673 765 TH---VTTELVGTLGYIPPEYGQA--WVATLRGDMYSFGVVMLELLTGKRPVDVLKPKMSRELVGWVLKMRSEGKQDQVF 839 (894)
Q Consensus 765 ~~---~~~~~~gt~~Y~APE~~~~--~~~s~ksDVwS~GvlL~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 839 (894)
.. .....+||++|||||+++. ..|+.|+||||||+...||.+|..||..+++-. .+.. . -.+......
T Consensus 181 ~R~~~rf~tfvgtp~wmAPEvl~q~~~GYdfKaDIwSfGITA~ELA~G~aPf~k~pPmk--vLl~---t--Lqn~pp~~~ 253 (516)
T KOG0582|consen 181 DRQVTRFNTFVGTPCWMAPEVLMQQLHGYDFKADIWSFGITACELAHGHAPFSKYPPMK--VLLL---T--LQNDPPTLL 253 (516)
T ss_pred ceeeEeeccccCcccccChHHhhhcccCccchhhhhhhhHHHHHHhcCCCCcccCChHH--HHHH---H--hcCCCCCcc
Confidence 11 1145689999999998443 479999999999999999999999999776521 1111 1 111111111
Q ss_pred cccccCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHH--HHHhccc
Q 002673 840 DPILRGKGFDEEMLQVLDVACMCVSQNPFKRPTVKEVVE--WLNNVGA 885 (894)
Q Consensus 840 d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~--~L~~i~~ 885 (894)
...+..+........+.+++..|++.||.+|||++++++ ++++.+.
T Consensus 254 t~~~~~d~~k~~~ksf~e~i~~CL~kDP~kRptAskLlkh~FFk~~k~ 301 (516)
T KOG0582|consen 254 TSGLDKDEDKKFSKSFREMIALCLVKDPSKRPTASKLLKHAFFKKAKS 301 (516)
T ss_pred cccCChHHhhhhcHHHHHHHHHHhhcCcccCCCHHHHhccHHHhhccc
Confidence 111111111122236778999999999999999999998 7776543
|
|
| >KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-39 Score=349.85 Aligned_cols=262 Identities=29% Similarity=0.379 Sum_probs=206.0
Q ss_pred cCCCccceEeecCcEEEEEEE-EcCCCeEEEEEEcCcch--hhHHHHHHHHHHHHhcCCCceeeecceeeec--ceEEEE
Q 002673 607 DNFSQANIIGCGGFGLVYKAT-LANGTTLAIKKLSGDLG--LMEREFKAEVEALSTAQHKNLVSLQGYCVHQ--GFRLLI 681 (894)
Q Consensus 607 ~~f~~~~~LG~G~fg~Vy~a~-~~~g~~vAvK~~~~~~~--~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~--~~~~lV 681 (894)
+.|+..++||+|.||.||+|+ ..+|+.||+|+++.+.. ....-..+||.+|++++||||++|.+...+. ...|||
T Consensus 117 ~~feki~kIGeGTyg~VYkAr~~~tgkivALKKvr~d~~~~~~~~t~~REI~ILr~l~HpNIikL~eivt~~~~~siYlV 196 (560)
T KOG0600|consen 117 DSFEKIEKIGEGTYGQVYKARDLETGKIVALKKVRFDNEKEGFPITAIREIKILRRLDHPNIIKLEEIVTSKLSGSIYLV 196 (560)
T ss_pred HHHHHHHHhcCcchhheeEeeecccCcEEEEEEeecccCCCcchHHHHHHHHHHHhcCCCcccceeeEEEecCCceEEEE
Confidence 457777899999999999998 77899999999986542 2335578999999999999999999998876 689999
Q ss_pred EEeccCCCHHHHHhhhcCCCCCcCHHHHHHHHHHHHHHHHHHHhccCCCeeecCCCCCCeEECCCCcEEEEEcccccccC
Q 002673 682 YSYMENGSLDYWLHEKADGASQLDWLTRLKIARGTSCGLAYMHQICEPHIVHRDIKSSNILLDDQFEAHLADFGLSRLIL 761 (894)
Q Consensus 682 ~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDLkp~NILld~~~~vkl~DFGla~~~~ 761 (894)
+|||++ +|.-++... ...++..++..++.|++.||+|+|+ ++|+|||||.+|||||.+|.+||+|||+|+.+.
T Consensus 197 FeYMdh-DL~GLl~~p---~vkft~~qIKc~mkQLl~Gl~~cH~---~gvlHRDIK~SNiLidn~G~LKiaDFGLAr~y~ 269 (560)
T KOG0600|consen 197 FEYMDH-DLSGLLSSP---GVKFTEPQIKCYMKQLLEGLEYCHS---RGVLHRDIKGSNILIDNNGVLKIADFGLARFYT 269 (560)
T ss_pred Eecccc-hhhhhhcCC---CcccChHHHHHHHHHHHHHHHHHhh---cCeeeccccccceEEcCCCCEEeccccceeecc
Confidence 999986 787777642 3579999999999999999999997 699999999999999999999999999999887
Q ss_pred CCCCcccccccccCCccCcccccCc-CCCccccHHHHHHHHHHHHcCCCCCCCCCcchhhhHHHHHHHH---hhcCCCC-
Q 002673 762 PYQTHVTTELVGTLGYIPPEYGQAW-VATLRGDMYSFGVVMLELLTGKRPVDVLKPKMSRELVGWVLKM---RSEGKQD- 836 (894)
Q Consensus 762 ~~~~~~~~~~~gt~~Y~APE~~~~~-~~s~ksDVwS~GvlL~elltG~~Pf~~~~~~~~~~~~~~~~~~---~~~~~~~- 836 (894)
.......+..+-|.+|.|||++.|. .|+..+|+||.||||.||++|++.|.+...-. .+..+.++ ..+..+.
T Consensus 270 ~~~~~~~T~rVvTLWYRpPELLLG~t~Yg~aVDlWS~GCIl~El~~gkPI~~G~tEve---Ql~kIfklcGSP~e~~W~~ 346 (560)
T KOG0600|consen 270 PSGSAPYTSRVVTLWYRPPELLLGATSYGTAVDLWSVGCILAELFLGKPILQGRTEVE---QLHKIFKLCGSPTEDYWPV 346 (560)
T ss_pred CCCCcccccceEEeeccChHHhcCCcccccceeehhhhHHHHHHHcCCCCcCCccHHH---HHHHHHHHhCCCChhcccc
Confidence 7666667778889999999998885 79999999999999999999999997543211 11111111 1111111
Q ss_pred ------ccccccccCCC-----ChHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 002673 837 ------QVFDPILRGKG-----FDEEMLQVLDVACMCVSQNPFKRPTVKEVVE 878 (894)
Q Consensus 837 ------~~~d~~l~~~~-----~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~ 878 (894)
..+.+.-.-.. +.......++|+..+|..||.+|.|+.++++
T Consensus 347 ~kLP~~~~~kp~~~y~r~l~E~~~~~~~~~l~Ll~~lL~ldP~kR~tA~~aL~ 399 (560)
T KOG0600|consen 347 SKLPHATIFKPQQPYKRRLRETFKDFPASALDLLEKLLSLDPDKRGTASSALQ 399 (560)
T ss_pred ccCCcccccCCCCcccchHHHHhccCCHHHHHHHHHHhccCccccccHHHHhc
Confidence 11111000000 0111224568888999999999999999997
|
|
| >KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-38 Score=342.43 Aligned_cols=256 Identities=30% Similarity=0.443 Sum_probs=203.5
Q ss_pred cCCCccceEeecCcEEEEEEEEc-CCCeEEEEEEcCcchhhHHHHHHHHHHHHhcCCCceeeecceeeecc--eEEEEEE
Q 002673 607 DNFSQANIIGCGGFGLVYKATLA-NGTTLAIKKLSGDLGLMEREFKAEVEALSTAQHKNLVSLQGYCVHQG--FRLLIYS 683 (894)
Q Consensus 607 ~~f~~~~~LG~G~fg~Vy~a~~~-~g~~vAvK~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~--~~~lV~E 683 (894)
.+|...+.||+|+||+||++... +|...|||.+........+.+.+|+.+|++++|||||+.+|...... ..++.||
T Consensus 17 ~~~~~~~~lG~Gs~G~V~l~~~~~~g~~~AvK~v~~~~~~~~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~~~~~~~i~mE 96 (313)
T KOG0198|consen 17 SNWSKGKLLGRGSFGSVYLATNKKTGELMAVKSVELEDSPTSESLEREIRILSRLNHPNIVQYYGSSSSRENDEYNIFME 96 (313)
T ss_pred chhhhhccccCccceEEEEEEecCCCcceeeeeeecccchhHHHHHHHHHHHHhCCCCCEEeeCCccccccCeeeEeeee
Confidence 45677899999999999999854 58999999987653333567899999999999999999999855544 5889999
Q ss_pred eccCCCHHHHHhhhcCCCCCcCHHHHHHHHHHHHHHHHHHHhccCCCeeecCCCCCCeEECC-CCcEEEEEcccccccCC
Q 002673 684 YMENGSLDYWLHEKADGASQLDWLTRLKIARGTSCGLAYMHQICEPHIVHRDIKSSNILLDD-QFEAHLADFGLSRLILP 762 (894)
Q Consensus 684 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDLkp~NILld~-~~~vkl~DFGla~~~~~ 762 (894)
|+++|+|.+++.... . .++...+..+.+||++||+|||+ ++||||||||+|||++. ++.+||+|||+++....
T Consensus 97 y~~~GsL~~~~~~~g--~-~l~E~~v~~ytr~iL~GL~ylHs---~g~vH~DiK~~NiLl~~~~~~~KlaDFG~a~~~~~ 170 (313)
T KOG0198|consen 97 YAPGGSLSDLIKRYG--G-KLPEPLVRRYTRQILEGLAYLHS---KGIVHCDIKPANILLDPSNGDVKLADFGLAKKLES 170 (313)
T ss_pred ccCCCcHHHHHHHcC--C-CCCHHHHHHHHHHHHHHHHHHHh---CCEeccCcccceEEEeCCCCeEEeccCcccccccc
Confidence 999999999998753 2 69999999999999999999997 69999999999999999 79999999999987653
Q ss_pred --CCCcccccccccCCccCcccccCc-CCCccccHHHHHHHHHHHHcCCCCCCCCCcchhhhHHHHHHHHhhcCCCCccc
Q 002673 763 --YQTHVTTELVGTLGYIPPEYGQAW-VATLRGDMYSFGVVMLELLTGKRPVDVLKPKMSRELVGWVLKMRSEGKQDQVF 839 (894)
Q Consensus 763 --~~~~~~~~~~gt~~Y~APE~~~~~-~~s~ksDVwS~GvlL~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 839 (894)
..........||+.|||||++..+ ....++|||||||++.||+||+.||... .....+............+.
T Consensus 171 ~~~~~~~~~~~~Gtp~~maPEvi~~g~~~~~~sDiWSlGCtVvEM~Tg~~PW~~~-----~~~~~~~~~ig~~~~~P~ip 245 (313)
T KOG0198|consen 171 KGTKSDSELSVQGTPNYMAPEVIRNGEVARRESDIWSLGCTVVEMLTGKPPWSEF-----FEEAEALLLIGREDSLPEIP 245 (313)
T ss_pred ccccccccccccCCccccCchhhcCCCcCCccchhhhcCCEEEeccCCCCcchhh-----cchHHHHHHHhccCCCCCCC
Confidence 222234457899999999999853 3345999999999999999999999863 11122222222222222221
Q ss_pred cccccCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHH--HHHh
Q 002673 840 DPILRGKGFDEEMLQVLDVACMCVSQNPFKRPTVKEVVE--WLNN 882 (894)
Q Consensus 840 d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~--~L~~ 882 (894)
+ ....+..+++..|++.||++|||++++++ ++++
T Consensus 246 ~---------~ls~~a~~Fl~~C~~~~p~~Rpta~eLL~hpf~~~ 281 (313)
T KOG0198|consen 246 D---------SLSDEAKDFLRKCFKRDPEKRPTAEELLEHPFLKQ 281 (313)
T ss_pred c---------ccCHHHHHHHHHHhhcCcccCcCHHHHhhChhhhc
Confidence 1 12235568899999999999999999998 4443
|
|
| >KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-38 Score=318.13 Aligned_cols=265 Identities=25% Similarity=0.312 Sum_probs=210.3
Q ss_pred cCCCccceEeecCcEEEEEEE-EcCCCeEEEEEEcCcc--hhhHHHHHHHHHHHHhcCCCceeeecceeeecceEEEEEE
Q 002673 607 DNFSQANIIGCGGFGLVYKAT-LANGTTLAIKKLSGDL--GLMEREFKAEVEALSTAQHKNLVSLQGYCVHQGFRLLIYS 683 (894)
Q Consensus 607 ~~f~~~~~LG~G~fg~Vy~a~-~~~g~~vAvK~~~~~~--~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~lV~E 683 (894)
++|...+.||+|.||.||+|+ ..+|+.||||+++... +.......+||+.|+.++|+||+.++++|...+...||+|
T Consensus 2 ~rY~~~~~lGEG~~gvVyka~d~~t~~~VAIKKIkl~~~kdGi~~talREIK~Lqel~h~nIi~LiD~F~~~~~l~lVfE 81 (318)
T KOG0659|consen 2 DRYEKLEKLGEGTYGVVYKARDTETGKRVAIKKIKLGNAKDGINRTALREIKLLQELKHPNIIELIDVFPHKSNLSLVFE 81 (318)
T ss_pred chhhhhhhhcCcceEEEEEEEecCCCcEEEEEEeeccccccCccHHHHHHHHHHHHccCcchhhhhhhccCCCceEEEEE
Confidence 457778899999999999998 6789999999997543 2234567899999999999999999999999999999999
Q ss_pred eccCCCHHHHHhhhcCCCCCcCHHHHHHHHHHHHHHHHHHHhccCCCeeecCCCCCCeEECCCCcEEEEEcccccccCCC
Q 002673 684 YMENGSLDYWLHEKADGASQLDWLTRLKIARGTSCGLAYMHQICEPHIVHRDIKSSNILLDDQFEAHLADFGLSRLILPY 763 (894)
Q Consensus 684 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDLkp~NILld~~~~vkl~DFGla~~~~~~ 763 (894)
||+. +|+..++++. ..++..++..++.++.+|++|||. +.|+||||||.|+|++++|.+||+|||+++.+...
T Consensus 82 fm~t-dLe~vIkd~~---i~l~pa~iK~y~~m~LkGl~y~H~---~~IlHRDlKPnNLLis~~g~lKiADFGLAr~f~~p 154 (318)
T KOG0659|consen 82 FMPT-DLEVVIKDKN---IILSPADIKSYMLMTLKGLAYCHS---KWILHRDLKPNNLLISSDGQLKIADFGLARFFGSP 154 (318)
T ss_pred eccc-cHHHHhcccc---cccCHHHHHHHHHHHHHHHHHHHh---hhhhcccCCccceEEcCCCcEEeecccchhccCCC
Confidence 9964 8999998653 578889999999999999999997 59999999999999999999999999999988654
Q ss_pred CCcccccccccCCccCcccccCc-CCCccccHHHHHHHHHHHHcCCCCCCCCCcchhhhHHHHHHHHhhcCCCCcccc--
Q 002673 764 QTHVTTELVGTLGYIPPEYGQAW-VATLRGDMYSFGVVMLELLTGKRPVDVLKPKMSRELVGWVLKMRSEGKQDQVFD-- 840 (894)
Q Consensus 764 ~~~~~~~~~gt~~Y~APE~~~~~-~~s~ksDVwS~GvlL~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d-- 840 (894)
... ....+-|..|.|||.+.|. .|+..+||||.|||+.||+-|.+-|.+..+- +....+.........+++.+
T Consensus 155 ~~~-~~~~V~TRWYRAPELLfGsr~Yg~~VDmWavGCI~AELllr~P~fpG~sDi---dQL~~If~~LGTP~~~~WP~~~ 230 (318)
T KOG0659|consen 155 NRI-QTHQVVTRWYRAPELLFGSRQYGTGVDMWAVGCIFAELLLRVPFFPGDSDI---DQLSKIFRALGTPTPDQWPEMT 230 (318)
T ss_pred Ccc-cccceeeeeccChHHhccchhcCCcchhhhHHHHHHHHHccCCCCCCCchH---HHHHHHHHHcCCCCcccCcccc
Confidence 433 3334789999999998875 7899999999999999999998877654332 22222222211111111111
Q ss_pred ------------ccccCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHH--HHHh
Q 002673 841 ------------PILRGKGFDEEMLQVLDVACMCVSQNPFKRPTVKEVVE--WLNN 882 (894)
Q Consensus 841 ------------~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~--~L~~ 882 (894)
.......++....+.++++..++..||.+|+|++|+++ .+.+
T Consensus 231 ~lpdY~~~~~~P~~~~~~lf~aas~d~ldLl~~m~~ynP~~Rita~qaL~~~yf~~ 286 (318)
T KOG0659|consen 231 SLPDYVKIQQFPKPPLNNLFPAASSDALDLLSKMLTYNPKKRITASQALKHPYFKS 286 (318)
T ss_pred ccccHHHHhcCCCCccccccccccHHHHHHHHhhhccCchhcccHHHHhcchhhhc
Confidence 11111244555667799999999999999999999997 5554
|
|
| >KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-39 Score=347.51 Aligned_cols=263 Identities=23% Similarity=0.296 Sum_probs=206.6
Q ss_pred ccCCCccceEeecCcEEEEEEE-EcCCCeEEEEEEcCcchhhHH-HHHHHHHHHHhcC-CCceeeecceeeecc-eEEEE
Q 002673 606 TDNFSQANIIGCGGFGLVYKAT-LANGTTLAIKKLSGDLGLMER-EFKAEVEALSTAQ-HKNLVSLQGYCVHQG-FRLLI 681 (894)
Q Consensus 606 ~~~f~~~~~LG~G~fg~Vy~a~-~~~g~~vAvK~~~~~~~~~~~-~~~~Ei~~l~~l~-HpnIv~l~g~~~~~~-~~~lV 681 (894)
.++|...++||.|.||.||+|+ ..+|+.||||+++......++ .=.+|+..|++++ |||||++.+++.+.+ ..++|
T Consensus 9 m~RY~~i~klGDGTfGsV~la~~~~~~~~VAIK~MK~Kf~s~ee~~nLREvksL~kln~hpniikL~Evi~d~~~~L~fV 88 (538)
T KOG0661|consen 9 MDRYTVIRKLGDGTFGSVYLAKSKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNPHPNIIKLKEVIRDNDRILYFV 88 (538)
T ss_pred HHHHHHHHHhcCCcceeEEEeeecCCCceeeHHHHHhhhccHHHHHHHHHHHHHHhcCCCCcchhhHHHhhccCceEeee
Confidence 3578888999999999999998 678999999999876544333 3468999999998 999999999999888 89999
Q ss_pred EEeccCCCHHHHHhhhcCCCCCcCHHHHHHHHHHHHHHHHHHHhccCCCeeecCCCCCCeEECCCCcEEEEEcccccccC
Q 002673 682 YSYMENGSLDYWLHEKADGASQLDWLTRLKIARGTSCGLAYMHQICEPHIVHRDIKSSNILLDDQFEAHLADFGLSRLIL 761 (894)
Q Consensus 682 ~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDLkp~NILld~~~~vkl~DFGla~~~~ 761 (894)
||||+ .+|.++++++ ...++...+..|+.||++||+|+|. +|+.|||+||+|||+..+..+||+|||+|+.+.
T Consensus 89 fE~Md-~NLYqLmK~R---~r~fse~~irnim~QilqGL~hiHk---~GfFHRDlKPENiLi~~~~~iKiaDFGLARev~ 161 (538)
T KOG0661|consen 89 FEFMD-CNLYQLMKDR---NRLFSESDIRNIMYQILQGLAHIHK---HGFFHRDLKPENILISGNDVIKIADFGLAREVR 161 (538)
T ss_pred HHhhh-hhHHHHHhhc---CCcCCHHHHHHHHHHHHHHHHHHHh---cCcccccCChhheEecccceeEecccccccccc
Confidence 99996 4999999875 4689999999999999999999997 599999999999999999999999999999874
Q ss_pred CCCCcccccccccCCccCccc-ccCcCCCccccHHHHHHHHHHHHcCCCCCCCCCcchh-hhHHHHHHHHhhcCCCCcc-
Q 002673 762 PYQTHVTTELVGTLGYIPPEY-GQAWVATLRGDMYSFGVVMLELLTGKRPVDVLKPKMS-RELVGWVLKMRSEGKQDQV- 838 (894)
Q Consensus 762 ~~~~~~~~~~~gt~~Y~APE~-~~~~~~s~ksDVwS~GvlL~elltG~~Pf~~~~~~~~-~~~~~~~~~~~~~~~~~~~- 838 (894)
. ....+.++.|.+|+|||+ ++.+.|+.+.||||+|||++|+.+-++-|.+...-+. ..+++. ........+.+.
T Consensus 162 S--kpPYTeYVSTRWYRAPEvLLrs~~Ys~pvD~wA~GcI~aEl~sLrPLFPG~sE~Dqi~KIc~V-LGtP~~~~~~eg~ 238 (538)
T KOG0661|consen 162 S--KPPYTEYVSTRWYRAPEVLLRSGYYSSPVDMWAVGCIMAELYSLRPLFPGASEIDQIYKICEV-LGTPDKDSWPEGY 238 (538)
T ss_pred c--CCCcchhhhcccccchHHhhhccccCCchHHHHHHHHHHHHHHhcccCCCCcHHHHHHHHHHH-hCCCccccchhHH
Confidence 3 334566789999999997 5667899999999999999999999998876543211 111111 111111111110
Q ss_pred -----cc---ccccC----CCChHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 002673 839 -----FD---PILRG----KGFDEEMLQVLDVACMCVSQNPFKRPTVKEVVE 878 (894)
Q Consensus 839 -----~d---~~l~~----~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~ 878 (894)
+. |...+ ...+....+.++++.+|+.+||.+|||++++++
T Consensus 239 ~La~~mnf~~P~~~~~~l~~L~p~~s~~~~~li~~ll~WDP~kRpTA~~al~ 290 (538)
T KOG0661|consen 239 NLASAMNFRFPQVKPSPLKDLLPNASSEAASLIERLLAWDPDKRPTASQALQ 290 (538)
T ss_pred HHHHHhccCCCcCCCCChHHhCcccCHHHHHHHHHHhcCCCccCccHHHHhc
Confidence 00 00000 112234557889999999999999999999998
|
|
| >KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-38 Score=343.81 Aligned_cols=252 Identities=25% Similarity=0.348 Sum_probs=207.5
Q ss_pred HHhccCCCccceEeecCcEEEEEEE-EcCCCeEEEEEEcCcchhhH---HHHHHHHHHHHhc-CCCceeeecceeeecce
Q 002673 603 LKATDNFSQANIIGCGGFGLVYKAT-LANGTTLAIKKLSGDLGLME---REFKAEVEALSTA-QHKNLVSLQGYCVHQGF 677 (894)
Q Consensus 603 ~~a~~~f~~~~~LG~G~fg~Vy~a~-~~~g~~vAvK~~~~~~~~~~---~~~~~Ei~~l~~l-~HpnIv~l~g~~~~~~~ 677 (894)
.+...+|..++.||+|+|++|++|+ ..++..+|||++.+..-..+ +-+..|-.+|.+| .||.|++|+-.|.++..
T Consensus 69 kk~~~DF~Fg~~lGeGSYStV~~A~~~~t~keYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~~hPgivkLy~TFQD~~s 148 (604)
T KOG0592|consen 69 KKTPNDFKFGKILGEGSYSTVVLAREKATGKEYAIKVLDKRYIIKEKKVKYVTREKEALTQLSGHPGIVKLYFTFQDEES 148 (604)
T ss_pred cCChhhcchhheeccccceeEEEeeecCCCceeeHhhhhHHHHHhhcccchhhHHHHHHHHhhCCCCeEEEEEEeecccc
Confidence 3445789999999999999999998 66899999999876432222 3366788899999 89999999999999999
Q ss_pred EEEEEEeccCCCHHHHHhhhcCCCCCcCHHHHHHHHHHHHHHHHHHHhccCCCeeecCCCCCCeEECCCCcEEEEEcccc
Q 002673 678 RLLIYSYMENGSLDYWLHEKADGASQLDWLTRLKIARGTSCGLAYMHQICEPHIVHRDIKSSNILLDDQFEAHLADFGLS 757 (894)
Q Consensus 678 ~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDLkp~NILld~~~~vkl~DFGla 757 (894)
.|+|+||+++|+|.++++.. ..++......++.+|+.||+|||+ +|||||||||+|||||.++++||+|||.|
T Consensus 149 LYFvLe~A~nGdll~~i~K~----Gsfde~caR~YAAeIldAleylH~---~GIIHRDlKPENILLd~dmhikITDFGsA 221 (604)
T KOG0592|consen 149 LYFVLEYAPNGDLLDLIKKY----GSFDETCARFYAAEILDALEYLHS---NGIIHRDLKPENILLDKDGHIKITDFGSA 221 (604)
T ss_pred eEEEEEecCCCcHHHHHHHh----CcchHHHHHHHHHHHHHHHHHHHh---cCceeccCChhheeEcCCCcEEEeecccc
Confidence 99999999999999999976 468999999999999999999997 59999999999999999999999999999
Q ss_pred cccCCCCCc---------c---cccccccCCccCcccccCcCCCccccHHHHHHHHHHHHcCCCCCCCCCcchhhhHHHH
Q 002673 758 RLILPYQTH---------V---TTELVGTLGYIPPEYGQAWVATLRGDMYSFGVVMLELLTGKRPVDVLKPKMSRELVGW 825 (894)
Q Consensus 758 ~~~~~~~~~---------~---~~~~~gt~~Y~APE~~~~~~~s~ksDVwS~GvlL~elltG~~Pf~~~~~~~~~~~~~~ 825 (894)
+.+.+.... . ...++||..|.+||++.....+..+|+|+||||||+|+.|++||..... +...
T Consensus 222 K~l~~~~~~~~~~~~~~~a~s~~~SFVGTAeYVSPElL~~~~~~~~sDiWAlGCilyQmlaG~PPFra~Ne-----yliF 296 (604)
T KOG0592|consen 222 KILSPSQKSQENPVDPNQASSRRSSFVGTAEYVSPELLNDSPAGPSSDLWALGCILYQMLAGQPPFRAANE-----YLIF 296 (604)
T ss_pred ccCChhhccccCccCcccccCcccceeeeecccCHHHhcCCCCCcccchHHHHHHHHHHhcCCCCCccccH-----HHHH
Confidence 988543221 1 1447999999999999999999999999999999999999999985432 1111
Q ss_pred HHHHhhcCCCCccccccccCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 002673 826 VLKMRSEGKQDQVFDPILRGKGFDEEMLQVLDVACMCVSQNPFKRPTVKEVVE 878 (894)
Q Consensus 826 ~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~ 878 (894)
.+.+...-...+-+ + ....+|+.+.|..||.+|+|.++|-+
T Consensus 297 qkI~~l~y~fp~~f---------p---~~a~dLv~KLLv~dp~~Rlt~~qIk~ 337 (604)
T KOG0592|consen 297 QKIQALDYEFPEGF---------P---EDARDLIKKLLVRDPSDRLTSQQIKA 337 (604)
T ss_pred HHHHHhcccCCCCC---------C---HHHHHHHHHHHccCccccccHHHHhh
Confidence 11121222222221 2 24568889999999999999999877
|
|
| >KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-38 Score=349.72 Aligned_cols=265 Identities=26% Similarity=0.423 Sum_probs=208.9
Q ss_pred HHHHHhccCCCccceEeecCcEEEEEEEEcCCCeEEEEEEcCcc--hhhHHHHHHHHHHHHhcCCCceeeecceeeecce
Q 002673 600 YELLKATDNFSQANIIGCGGFGLVYKATLANGTTLAIKKLSGDL--GLMEREFKAEVEALSTAQHKNLVSLQGYCVHQGF 677 (894)
Q Consensus 600 ~el~~a~~~f~~~~~LG~G~fg~Vy~a~~~~g~~vAvK~~~~~~--~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~ 677 (894)
+++....+++.++..||+|.||+||+|.|.. .||||++..+. ....+.|+.|+.++++-+|.||+-++|||.....
T Consensus 385 ~~WeIp~~ev~l~~rIGsGsFGtV~Rg~whG--dVAVK~Lnv~~pt~~qlqaFKnEVa~lkkTRH~NIlLFMG~~~~p~~ 462 (678)
T KOG0193|consen 385 EEWEIPPEEVLLGERIGSGSFGTVYRGRWHG--DVAVKLLNVDDPTPEQLQAFKNEVAVLKKTRHENILLFMGACMNPPL 462 (678)
T ss_pred cccccCHHHhhccceeccccccceeeccccc--ceEEEEEecCCCCHHHHHHHHHHHHHHhhcchhhheeeehhhcCCce
Confidence 4455555677788999999999999999853 59999998654 3345789999999999999999999999998877
Q ss_pred EEEEEEeccCCCHHHHHhhhcCCCCCcCHHHHHHHHHHHHHHHHHHHhccCCCeeecCCCCCCeEECCCCcEEEEEcccc
Q 002673 678 RLLIYSYMENGSLDYWLHEKADGASQLDWLTRLKIARGTSCGLAYMHQICEPHIVHRDIKSSNILLDDQFEAHLADFGLS 757 (894)
Q Consensus 678 ~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDLkp~NILld~~~~vkl~DFGla 757 (894)
.+|+.||+|-+|..++|... ..++..+...||+||++||.|||. ++|||||||+.||+|.++++|||+|||++
T Consensus 463 -AIiTqwCeGsSLY~hlHv~e---tkfdm~~~idIAqQiaqGM~YLHA---K~IIHrDLKSnNIFl~~~~kVkIgDFGLa 535 (678)
T KOG0193|consen 463 -AIITQWCEGSSLYTHLHVQE---TKFDMNTTIDIAQQIAQGMDYLHA---KNIIHRDLKSNNIFLHEDLKVKIGDFGLA 535 (678)
T ss_pred -eeeehhccCchhhhhccchh---hhhhHHHHHHHHHHHHHhhhhhhh---hhhhhhhccccceEEccCCcEEEecccce
Confidence 99999999999999999654 568999999999999999999997 69999999999999999999999999999
Q ss_pred cccCCCC-CcccccccccCCccCcccccC---cCCCccccHHHHHHHHHHHHcCCCCCCCCCcchhhhHHHHHHHHhhcC
Q 002673 758 RLILPYQ-THVTTELVGTLGYIPPEYGQA---WVATLRGDMYSFGVVMLELLTGKRPVDVLKPKMSRELVGWVLKMRSEG 833 (894)
Q Consensus 758 ~~~~~~~-~~~~~~~~gt~~Y~APE~~~~---~~~s~ksDVwS~GvlL~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~ 833 (894)
....... ........|...|||||+++. ..|++.+||||||+++|||++|..||.....+. +-| +...+
T Consensus 536 tvk~~w~g~~q~~qp~gsilwmAPEvIRmqd~nPfS~qSDVYaFGiV~YELltg~lPysi~~~dq----Iif---mVGrG 608 (678)
T KOG0193|consen 536 TVKTRWSGEQQLEQPHGSLLWMAPEVIRMQDDNPFSFQSDVYAFGIVWYELLTGELPYSIQNRDQ----IIF---MVGRG 608 (678)
T ss_pred eeeeeeccccccCCCccchhhhcHHHHhhcccCCCCcccchhhhhHHHHHHHhCcCCcCCCChhh----eEE---Eeccc
Confidence 8653221 111222357789999998764 468999999999999999999999998433221 111 11111
Q ss_pred CCCccccccccCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhccc
Q 002673 834 KQDQVFDPILRGKGFDEEMLQVLDVACMCVSQNPFKRPTVKEVVEWLNNVGA 885 (894)
Q Consensus 834 ~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~i~~ 885 (894)
.-..|.......++ .++.+|+..||..++++||.+.+|+..|+.+..
T Consensus 609 --~l~pd~s~~~s~~p---k~mk~Ll~~C~~~~~~eRP~F~~il~~l~~l~~ 655 (678)
T KOG0193|consen 609 --YLMPDLSKIRSNCP---KAMKRLLSDCWKFDREERPLFPQLLSKLEELLP 655 (678)
T ss_pred --ccCccchhhhccCH---HHHHHHHHHHHhcCcccCccHHHHHHHHHHhhh
Confidence 11122222222333 355677789999999999999999998877755
|
|
| >KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-38 Score=346.96 Aligned_cols=252 Identities=25% Similarity=0.371 Sum_probs=211.4
Q ss_pred cCCCccceEeecCcEEEEEEE-EcCCCeEEEEEEcCcchhhHHHHHHHHHHHHhcCCCceeeecceeeecceEEEEEEec
Q 002673 607 DNFSQANIIGCGGFGLVYKAT-LANGTTLAIKKLSGDLGLMEREFKAEVEALSTAQHKNLVSLQGYCVHQGFRLLIYSYM 685 (894)
Q Consensus 607 ~~f~~~~~LG~G~fg~Vy~a~-~~~g~~vAvK~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~lV~E~~ 685 (894)
..|..-.+||+|+.|.||.|. ..+++.||||++.......++-+.+|+.+|+..+|+|||.+++.|..+++.|+|||||
T Consensus 273 ~~y~~~~kigqgaSG~vy~A~~~~~~~~VaiK~m~l~~Q~~keLilnEi~Vm~~~~H~NiVnfl~Sylv~deLWVVMEym 352 (550)
T KOG0578|consen 273 SKYTDFKKIGQGATGGVYVARKISTKQEVAIKRMDLRKQPKKELLLNEILVMRDLHHPNIVNFLDSYLVGDELWVVMEYM 352 (550)
T ss_pred hhhcchhhhccccccceeeeeeccCCceEEEEEEEeccCCchhhhHHHHHHHHhccchHHHHHHHHhcccceeEEEEeec
Confidence 467778899999999999997 6788999999998766666677899999999999999999999999999999999999
Q ss_pred cCCCHHHHHhhhcCCCCCcCHHHHHHHHHHHHHHHHHHHhccCCCeeecCCCCCCeEECCCCcEEEEEcccccccCCCCC
Q 002673 686 ENGSLDYWLHEKADGASQLDWLTRLKIARGTSCGLAYMHQICEPHIVHRDIKSSNILLDDQFEAHLADFGLSRLILPYQT 765 (894)
Q Consensus 686 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDLkp~NILld~~~~vkl~DFGla~~~~~~~~ 765 (894)
+||+|.+.+... .+++.++..|..++++||+|||. ++|+|||||..|||++.+|.+||+|||+|..+.....
T Consensus 353 ~ggsLTDvVt~~-----~~~E~qIA~Icre~l~aL~fLH~---~gIiHrDIKSDnILL~~~g~vKltDFGFcaqi~~~~~ 424 (550)
T KOG0578|consen 353 EGGSLTDVVTKT-----RMTEGQIAAICREILQGLKFLHA---RGIIHRDIKSDNILLTMDGSVKLTDFGFCAQISEEQS 424 (550)
T ss_pred CCCchhhhhhcc-----cccHHHHHHHHHHHHHHHHHHHh---cceeeeccccceeEeccCCcEEEeeeeeeeccccccC
Confidence 999999999754 48899999999999999999996 6999999999999999999999999999998755443
Q ss_pred cccccccccCCccCcccccCcCCCccccHHHHHHHHHHHHcCCCCCCCCCcchhhhHHHHHHHHhhcCCCCccccccccC
Q 002673 766 HVTTELVGTLGYIPPEYGQAWVATLRGDMYSFGVVMLELLTGKRPVDVLKPKMSRELVGWVLKMRSEGKQDQVFDPILRG 845 (894)
Q Consensus 766 ~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwS~GvlL~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~ 845 (894)
.....+||+.|||||+.....|..|.||||||++++||+-|.+||-...+- +. ...+...+.. ++
T Consensus 425 -KR~TmVGTPYWMAPEVvtrk~YG~KVDIWSLGIMaIEMveGEPPYlnE~Pl--rA----lyLIa~ng~P-~l------- 489 (550)
T KOG0578|consen 425 -KRSTMVGTPYWMAPEVVTRKPYGPKVDIWSLGIMAIEMVEGEPPYLNENPL--RA----LYLIATNGTP-KL------- 489 (550)
T ss_pred -ccccccCCCCccchhhhhhcccCccccchhhhhHHHHHhcCCCCccCCChH--HH----HHHHhhcCCC-Cc-------
Confidence 455678999999999999999999999999999999999999999642221 11 1111122221 11
Q ss_pred CCChHHHHHHHHHHHHhcccCCCCCCCHHHHHH--HHH
Q 002673 846 KGFDEEMLQVLDVACMCVSQNPFKRPTVKEVVE--WLN 881 (894)
Q Consensus 846 ~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~--~L~ 881 (894)
.........+.+|+.+||+.|+++|+++.|+|+ .|+
T Consensus 490 k~~~klS~~~kdFL~~cL~~dv~~RasA~eLL~HpFl~ 527 (550)
T KOG0578|consen 490 KNPEKLSPELKDFLDRCLVVDVEQRASAKELLEHPFLK 527 (550)
T ss_pred CCccccCHHHHHHHHHHhhcchhcCCCHHHHhcChhhh
Confidence 112233446778999999999999999999998 553
|
|
| >cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-37 Score=346.16 Aligned_cols=262 Identities=24% Similarity=0.396 Sum_probs=203.8
Q ss_pred ccCCCccceEeecCcEEEEEEEE------cCCCeEEEEEEcCcch-hhHHHHHHHHHHHHhc-CCCceeeecceeeecc-
Q 002673 606 TDNFSQANIIGCGGFGLVYKATL------ANGTTLAIKKLSGDLG-LMEREFKAEVEALSTA-QHKNLVSLQGYCVHQG- 676 (894)
Q Consensus 606 ~~~f~~~~~LG~G~fg~Vy~a~~------~~g~~vAvK~~~~~~~-~~~~~~~~Ei~~l~~l-~HpnIv~l~g~~~~~~- 676 (894)
.++|++.+.||+|+||.||+|.. .++..||||++..... .....+.+|+.++..+ +||||++++++|...+
T Consensus 6 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~ 85 (338)
T cd05102 6 RDRLRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGATASEHKALMSELKILIHIGNHLNVVNLLGACTKPNG 85 (338)
T ss_pred hhHceeeeEeccCCcceEEEEEEeccCCcccchhhheeccccccchHHHHHHHHHHHHHHHhccCcceeeEEeEecCCCC
Confidence 46788999999999999999973 2356899999975432 2345788999999999 8999999999887644
Q ss_pred eEEEEEEeccCCCHHHHHhhhcCC--------------------------------------------------------
Q 002673 677 FRLLIYSYMENGSLDYWLHEKADG-------------------------------------------------------- 700 (894)
Q Consensus 677 ~~~lV~E~~~~gsL~~~l~~~~~~-------------------------------------------------------- 700 (894)
..++||||+++|+|.+++......
T Consensus 86 ~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 165 (338)
T cd05102 86 PLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPPQETDD 165 (338)
T ss_pred ceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCcccccchhccc
Confidence 578999999999999999753210
Q ss_pred --CCCcCHHHHHHHHHHHHHHHHHHHhccCCCeeecCCCCCCeEECCCCcEEEEEcccccccCCCCCc-ccccccccCCc
Q 002673 701 --ASQLDWLTRLKIARGTSCGLAYMHQICEPHIVHRDIKSSNILLDDQFEAHLADFGLSRLILPYQTH-VTTELVGTLGY 777 (894)
Q Consensus 701 --~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDLkp~NILld~~~~vkl~DFGla~~~~~~~~~-~~~~~~gt~~Y 777 (894)
...+++..+..++.||+.||.|||+ ++|+||||||+|||++.++.+||+|||+++........ ......++..|
T Consensus 166 ~~~~~l~~~~~~~~~~qi~~aL~~LH~---~~ivHrDiKp~Nil~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~y 242 (338)
T cd05102 166 LWKSPLTMEDLICYSFQVARGMEFLAS---RKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARLPLKW 242 (338)
T ss_pred cccCCCCHHHHHHHHHHHHHHHHHHHH---CCEECCCCccceEEEcCCCcEEEeecccccccccCcchhcccCCCCCccc
Confidence 1347888899999999999999997 69999999999999999999999999999865332221 12233466789
Q ss_pred cCcccccCcCCCccccHHHHHHHHHHHHc-CCCCCCCCCcchhhhHHHHHHHHhhcCCCCccccccccCCCChHHHHHHH
Q 002673 778 IPPEYGQAWVATLRGDMYSFGVVMLELLT-GKRPVDVLKPKMSRELVGWVLKMRSEGKQDQVFDPILRGKGFDEEMLQVL 856 (894)
Q Consensus 778 ~APE~~~~~~~s~ksDVwS~GvlL~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~ 856 (894)
+|||++.+..++.++|||||||++|||++ |..||....... .... .. ..+..... .......+.
T Consensus 243 ~aPE~~~~~~~~~~sDiwslG~il~el~~~g~~pf~~~~~~~--~~~~---~~-~~~~~~~~---------~~~~~~~l~ 307 (338)
T cd05102 243 MAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQINE--EFCQ---RL-KDGTRMRA---------PENATPEIY 307 (338)
T ss_pred cCcHHhhcCCCCcccCHHHHHHHHHHHHhCCCCCCCCCCccH--HHHH---HH-hcCCCCCC---------CCCCCHHHH
Confidence 99999999999999999999999999997 999997543221 1111 11 11111110 011123577
Q ss_pred HHHHHhcccCCCCCCCHHHHHHHHHhccc
Q 002673 857 DVACMCVSQNPFKRPTVKEVVEWLNNVGA 885 (894)
Q Consensus 857 ~li~~Cl~~dP~~RPs~~evl~~L~~i~~ 885 (894)
+++.+||+.||++|||+.++++.|+.+..
T Consensus 308 ~li~~cl~~dp~~RPs~~el~~~l~~~~~ 336 (338)
T cd05102 308 RIMLACWQGDPKERPTFSALVEILGDLLQ 336 (338)
T ss_pred HHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence 89999999999999999999999998754
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V |
| >KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-39 Score=361.37 Aligned_cols=259 Identities=26% Similarity=0.441 Sum_probs=214.0
Q ss_pred cCCCccceEeecCcEEEEEEEEc----CCCeEEEEEEcCcc-hhhHHHHHHHHHHHHhcCCCceeeecceeeecceEEEE
Q 002673 607 DNFSQANIIGCGGFGLVYKATLA----NGTTLAIKKLSGDL-GLMEREFKAEVEALSTAQHKNLVSLQGYCVHQGFRLLI 681 (894)
Q Consensus 607 ~~f~~~~~LG~G~fg~Vy~a~~~----~g~~vAvK~~~~~~-~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~lV 681 (894)
....+.++||.|.||.||+|+++ ....||||.++... ...+++|..|..+|.++.||||++|-|+.......++|
T Consensus 629 s~i~Ie~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~GytekqrrdFL~EAsIMGQFdHPNIIrLEGVVTks~PvMIi 708 (996)
T KOG0196|consen 629 SCVKIEKVIGAGEFGEVCSGRLKLPGKREITVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIRLEGVVTKSKPVMII 708 (996)
T ss_pred hheEEEEEEecccccceecccccCCCCcceeEEEeeeccCccHHHHhhhhhhhhhcccCCCCcEEEEEEEEecCceeEEE
Confidence 45567899999999999999864 34679999998754 45567899999999999999999999999999999999
Q ss_pred EEeccCCCHHHHHhhhcCCCCCcCHHHHHHHHHHHHHHHHHHHhccCCCeeecCCCCCCeEECCCCcEEEEEcccccccC
Q 002673 682 YSYMENGSLDYWLHEKADGASQLDWLTRLKIARGTSCGLAYMHQICEPHIVHRDIKSSNILLDDQFEAHLADFGLSRLIL 761 (894)
Q Consensus 682 ~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDLkp~NILld~~~~vkl~DFGla~~~~ 761 (894)
+|||++|+|+.||+.+. .++.+.+...++++||.||+||-++ ++|||||.++|||++.+..+||+|||+++.+.
T Consensus 709 TEyMENGsLDsFLR~~D---GqftviQLVgMLrGIAsGMkYLsdm---~YVHRDLAARNILVNsnLvCKVsDFGLSRvle 782 (996)
T KOG0196|consen 709 TEYMENGSLDSFLRQND---GQFTVIQLVGMLRGIASGMKYLSDM---NYVHRDLAARNILVNSNLVCKVSDFGLSRVLE 782 (996)
T ss_pred hhhhhCCcHHHHHhhcC---CceEeehHHHHHHHHHHHhHHHhhc---CchhhhhhhhheeeccceEEEeccccceeecc
Confidence 99999999999999765 4699999999999999999999986 99999999999999999999999999999775
Q ss_pred CCCCcccccccc--cCCccCcccccCcCCCccccHHHHHHHHHHHHc-CCCCCCCCCcchhhhHHHHHHHHhhcCCCCcc
Q 002673 762 PYQTHVTTELVG--TLGYIPPEYGQAWVATLRGDMYSFGVVMLELLT-GKRPVDVLKPKMSRELVGWVLKMRSEGKQDQV 838 (894)
Q Consensus 762 ~~~~~~~~~~~g--t~~Y~APE~~~~~~~s~ksDVwS~GvlL~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 838 (894)
++.....+...| ..+|.|||.+..++++.+||||||||+|||.++ |..||-++...+ .+..+ ...-.+..-
T Consensus 783 dd~~~~ytt~GGKIPiRWTAPEAIa~RKFTsASDVWSyGIVmWEVmSyGERPYWdmSNQd---VIkaI---e~gyRLPpP 856 (996)
T KOG0196|consen 783 DDPEAAYTTLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQD---VIKAI---EQGYRLPPP 856 (996)
T ss_pred cCCCccccccCCccceeecChhHhhhcccCchhhccccceEEEEecccCCCcccccchHH---HHHHH---HhccCCCCC
Confidence 444222222222 458999999999999999999999999999988 999997766432 22111 112222211
Q ss_pred ccccccCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhccccc
Q 002673 839 FDPILRGKGFDEEMLQVLDVACMCVSQNPFKRPTVKEVVEWLNNVGANR 887 (894)
Q Consensus 839 ~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~i~~~~ 887 (894)
.+....|.+|+..||+.|-.+||++.+|+..|.++..++
T Consensus 857 ----------mDCP~aL~qLMldCWqkdR~~RP~F~qiV~~lDklIrnP 895 (996)
T KOG0196|consen 857 ----------MDCPAALYQLMLDCWQKDRNRRPKFAQIVSTLDKLIRNP 895 (996)
T ss_pred ----------CCCcHHHHHHHHHHHHHHhhcCCCHHHHHHHHHHHhcCc
Confidence 223346788999999999999999999999999886543
|
|
| >KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-37 Score=339.57 Aligned_cols=246 Identities=25% Similarity=0.344 Sum_probs=209.7
Q ss_pred cCCCccceEeecCcEEEEEEE-EcCCCeEEEEEEcCcc--hhhHHHHHHHHHHHHhcCCCceeeecceeeecceEEEEEE
Q 002673 607 DNFSQANIIGCGGFGLVYKAT-LANGTTLAIKKLSGDL--GLMEREFKAEVEALSTAQHKNLVSLQGYCVHQGFRLLIYS 683 (894)
Q Consensus 607 ~~f~~~~~LG~G~fg~Vy~a~-~~~g~~vAvK~~~~~~--~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~lV~E 683 (894)
++|.+.+.||+|+||.||||+ ..+.+.||+|.+.+.. ....+.+.+|+++++.++|||||.++++|++..+.|+|+|
T Consensus 2 e~yhv~e~iG~Gsfg~VYKgrrK~t~~~vAik~i~K~gr~~k~l~~l~~ev~i~r~lkHpniv~m~esfEt~~~~~vVte 81 (808)
T KOG0597|consen 2 EQYHVYEMIGEGSFGRVYKGRRKYTIQVVAIKFIDKSGRNEKELKNLRQEVRILRSLKHPNIVEMLESFETSAHLWVVTE 81 (808)
T ss_pred cchhHHHHhcCCccceeeecccccceeEEEEEEehhcCCchHHHHHHHHHHHHHHhcCCcchhhHHHhhcccceEEEEeh
Confidence 467778899999999999997 5578999999997653 3345679999999999999999999999999999999999
Q ss_pred eccCCCHHHHHhhhcCCCCCcCHHHHHHHHHHHHHHHHHHHhccCCCeeecCCCCCCeEECCCCcEEEEEcccccccCCC
Q 002673 684 YMENGSLDYWLHEKADGASQLDWLTRLKIARGTSCGLAYMHQICEPHIVHRDIKSSNILLDDQFEAHLADFGLSRLILPY 763 (894)
Q Consensus 684 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDLkp~NILld~~~~vkl~DFGla~~~~~~ 763 (894)
|+.| +|..++... ..++...+..|+.+++.||.|||+ .+|+|||+||.|||++..+.+|+||||+|+.+..
T Consensus 82 ~a~g-~L~~il~~d----~~lpEe~v~~~a~~LVsaL~yLhs---~rilhrd~kPqniLl~~~~~~KlcdFg~Ar~m~~- 152 (808)
T KOG0597|consen 82 YAVG-DLFTILEQD----GKLPEEQVRAIAYDLVSALYYLHS---NRILHRDMKPQNILLEKGGTLKLCDFGLARAMST- 152 (808)
T ss_pred hhhh-hHHHHHHhc----cCCCHHHHHHHHHHHHHHHHHHHh---cCcccccCCcceeeecCCCceeechhhhhhhccc-
Confidence 9976 999999864 468999999999999999999997 5999999999999999999999999999998643
Q ss_pred CCcccccccccCCccCcccccCcCCCccccHHHHHHHHHHHHcCCCCCCCCCcchhhhHHHHHHHHhhcCCCCccccccc
Q 002673 764 QTHVTTELVGTLGYIPPEYGQAWVATLRGDMYSFGVVMLELLTGKRPVDVLKPKMSRELVGWVLKMRSEGKQDQVFDPIL 843 (894)
Q Consensus 764 ~~~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwS~GvlL~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l 843 (894)
.....+...|||-|||||+..+..|+..+|+||+|||+|||++|++||- ..++.+.+..+..+...
T Consensus 153 ~t~vltsikGtPlYmAPElv~e~pyd~~sDlWslGcilYE~~~G~PPF~------a~si~~Lv~~I~~d~v~-------- 218 (808)
T KOG0597|consen 153 NTSVLTSIKGTPLYMAPELVEEQPYDHTSDLWSLGCILYELYVGQPPFY------ARSITQLVKSILKDPVK-------- 218 (808)
T ss_pred CceeeeeccCcccccCHHHHcCCCccchhhHHHHHHHHHHHhcCCCCch------HHHHHHHHHHHhcCCCC--------
Confidence 3344556789999999999999999999999999999999999999996 33444444444332211
Q ss_pred cCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 002673 844 RGKGFDEEMLQVLDVACMCVSQNPFKRPTVKEVVE 878 (894)
Q Consensus 844 ~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~ 878 (894)
........+.+++...+..||.+|.|..+++.
T Consensus 219 ---~p~~~S~~f~nfl~gLL~kdP~~RltW~~Ll~ 250 (808)
T KOG0597|consen 219 ---PPSTASSSFVNFLQGLLIKDPAQRLTWTDLLG 250 (808)
T ss_pred ---CcccccHHHHHHHHHHhhcChhhcccHHHHhc
Confidence 11234457889999999999999999999987
|
|
| >KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-37 Score=342.07 Aligned_cols=254 Identities=26% Similarity=0.375 Sum_probs=207.5
Q ss_pred hccCCCccceEeecCcEEEEEEE-EcCCCeEEEEEEcCc----ch-hhHHHHHHHHHHHHhcC-CCceeeecceeeecce
Q 002673 605 ATDNFSQANIIGCGGFGLVYKAT-LANGTTLAIKKLSGD----LG-LMEREFKAEVEALSTAQ-HKNLVSLQGYCVHQGF 677 (894)
Q Consensus 605 a~~~f~~~~~LG~G~fg~Vy~a~-~~~g~~vAvK~~~~~----~~-~~~~~~~~Ei~~l~~l~-HpnIv~l~g~~~~~~~ 677 (894)
..+.|..++.||+|+||+|+.|. ..++..||+|.+... .. .....+.+|+.++++++ ||||++++.++.....
T Consensus 15 ~~g~y~~~~~lG~GsfgkV~~a~~~~t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~~t~~~ 94 (370)
T KOG0583|consen 15 SIGKYELGRTLGSGSFGKVKLAKHRLTGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLEVFATPTK 94 (370)
T ss_pred ccCceeeeeeecCCCCeeEEEeeeccCCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEEEEecCCe
Confidence 34678999999999999999997 567899999977653 11 23456778999999998 9999999999999999
Q ss_pred EEEEEEeccCCCHHHHHhhhcCCCCCcCHHHHHHHHHHHHHHHHHHHhccCCCeeecCCCCCCeEECCC-CcEEEEEccc
Q 002673 678 RLLIYSYMENGSLDYWLHEKADGASQLDWLTRLKIARGTSCGLAYMHQICEPHIVHRDIKSSNILLDDQ-FEAHLADFGL 756 (894)
Q Consensus 678 ~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDLkp~NILld~~-~~vkl~DFGl 756 (894)
.++||||+.+|+|.+++... .++....+..+++|++.|++|||+ ++|+||||||+|||+|.+ +++||+|||+
T Consensus 95 ~~ivmEy~~gGdL~~~i~~~----g~l~E~~ar~~F~Qlisav~y~H~---~gi~HRDLK~ENilld~~~~~~Kl~DFG~ 167 (370)
T KOG0583|consen 95 IYIVMEYCSGGDLFDYIVNK----GRLKEDEARKYFRQLISAVAYCHS---RGIVHRDLKPENILLDGNEGNLKLSDFGL 167 (370)
T ss_pred EEEEEEecCCccHHHHHHHc----CCCChHHHHHHHHHHHHHHHHHHh---CCEeeCCCCHHHEEecCCCCCEEEecccc
Confidence 99999999999999999873 357778999999999999999997 599999999999999999 9999999999
Q ss_pred ccccCCCCCcccccccccCCccCcccccCcC-CC-ccccHHHHHHHHHHHHcCCCCCCCCCcchhhhHHHHHHHHhhcCC
Q 002673 757 SRLILPYQTHVTTELVGTLGYIPPEYGQAWV-AT-LRGDMYSFGVVMLELLTGKRPVDVLKPKMSRELVGWVLKMRSEGK 834 (894)
Q Consensus 757 a~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~-~s-~ksDVwS~GvlL~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~ 834 (894)
+.... .........+||+.|+|||++.+.. |+ .++||||+||+||.|++|+.||++.... ....++ ..+.
T Consensus 168 s~~~~-~~~~~l~t~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~GViLy~ml~G~~PF~d~~~~------~l~~ki-~~~~ 239 (370)
T KOG0583|consen 168 SAISP-GEDGLLKTFCGSPAYAAPEVLSGKGTYSGKAADVWSLGVILYVLLCGRLPFDDSNVP------NLYRKI-RKGE 239 (370)
T ss_pred ccccC-CCCCcccCCCCCcccCCHHHhCCCCCcCCchhhhhhhHHHHHHHHhCCCCCCCccHH------HHHHHH-hcCC
Confidence 99763 2233455679999999999999977 75 7899999999999999999999863211 111111 1111
Q ss_pred CCccccccccCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHH--HHHh
Q 002673 835 QDQVFDPILRGKGFDEEMLQVLDVACMCVSQNPFKRPTVKEVVE--WLNN 882 (894)
Q Consensus 835 ~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~--~L~~ 882 (894)
.. +...+. ..++..++.+|+..||.+|+|+.+|+. |++.
T Consensus 240 ~~--~p~~~~-------S~~~~~Li~~mL~~~P~~R~t~~~i~~h~w~~~ 280 (370)
T KOG0583|consen 240 FK--IPSYLL-------SPEARSLIEKMLVPDPSTRITLLEILEHPWFQK 280 (370)
T ss_pred cc--CCCCcC-------CHHHHHHHHHHcCCCcccCCCHHHHhhChhhcc
Confidence 10 111110 346678999999999999999999997 7875
|
|
| >PHA02988 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-37 Score=332.54 Aligned_cols=247 Identities=21% Similarity=0.313 Sum_probs=198.4
Q ss_pred cceEeecCcEEEEEEEEcCCCeEEEEEEcCcchhh---HHHHHHHHHHHHhcCCCceeeecceeee----cceEEEEEEe
Q 002673 612 ANIIGCGGFGLVYKATLANGTTLAIKKLSGDLGLM---EREFKAEVEALSTAQHKNLVSLQGYCVH----QGFRLLIYSY 684 (894)
Q Consensus 612 ~~~LG~G~fg~Vy~a~~~~g~~vAvK~~~~~~~~~---~~~~~~Ei~~l~~l~HpnIv~l~g~~~~----~~~~~lV~E~ 684 (894)
...||+|++|.||+|.+ +|+.||||++....... .+.+.+|+.++++++||||++++|++.+ ....++||||
T Consensus 25 ~~~i~~g~~~~v~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~~~~~~~~~~lv~Ey 103 (283)
T PHA02988 25 SVLIKENDQNSIYKGIF-NNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDDLPRLSLILEY 103 (283)
T ss_pred CeEEeeCCceEEEEEEE-CCEEEEEEeccccccccHHHHHHHHHHHHHHHhcCCCCEEEEeeeEEecccCCCceEEEEEe
Confidence 36799999999999998 68899999997643222 3668899999999999999999999876 3467899999
Q ss_pred ccCCCHHHHHhhhcCCCCCcCHHHHHHHHHHHHHHHHHHHhccCCCeeecCCCCCCeEECCCCcEEEEEcccccccCCCC
Q 002673 685 MENGSLDYWLHEKADGASQLDWLTRLKIARGTSCGLAYMHQICEPHIVHRDIKSSNILLDDQFEAHLADFGLSRLILPYQ 764 (894)
Q Consensus 685 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDLkp~NILld~~~~vkl~DFGla~~~~~~~ 764 (894)
+++|+|.+++... ..+++.....++.+++.||.|||+. .+++||||||+||++++++.+||+|||+++.....
T Consensus 104 ~~~g~L~~~l~~~----~~~~~~~~~~i~~~i~~~l~~lH~~--~~~~Hrdlkp~nill~~~~~~kl~dfg~~~~~~~~- 176 (283)
T PHA02988 104 CTRGYLREVLDKE----KDLSFKTKLDMAIDCCKGLYNLYKY--TNKPYKNLTSVSFLVTENYKLKIICHGLEKILSSP- 176 (283)
T ss_pred CCCCcHHHHHhhC----CCCChhHHHHHHHHHHHHHHHHHhc--CCCCCCcCChhhEEECCCCcEEEcccchHhhhccc-
Confidence 9999999999753 3588999999999999999999973 47889999999999999999999999999865321
Q ss_pred CcccccccccCCccCcccccC--cCCCccccHHHHHHHHHHHHcCCCCCCCCCcchhhhHHHHHHHHhhcCCCCcccccc
Q 002673 765 THVTTELVGTLGYIPPEYGQA--WVATLRGDMYSFGVVMLELLTGKRPVDVLKPKMSRELVGWVLKMRSEGKQDQVFDPI 842 (894)
Q Consensus 765 ~~~~~~~~gt~~Y~APE~~~~--~~~s~ksDVwS~GvlL~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 842 (894)
.....|+..|+|||++.+ ..++.++|||||||++|||++|+.||...... +.... ......... ++
T Consensus 177 ---~~~~~~~~~y~aPE~~~~~~~~~~~k~Di~SlGvil~el~~g~~Pf~~~~~~---~~~~~---i~~~~~~~~-~~-- 244 (283)
T PHA02988 177 ---PFKNVNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFENLTTK---EIYDL---IINKNNSLK-LP-- 244 (283)
T ss_pred ---cccccCcccccCHHHhhhccccccchhhhhHHHHHHHHHHHCCCCCCCCCHH---HHHHH---HHhcCCCCC-CC--
Confidence 123467899999999876 68899999999999999999999999865422 11111 111111100 11
Q ss_pred ccCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhcc
Q 002673 843 LRGKGFDEEMLQVLDVACMCVSQNPFKRPTVKEVVEWLNNVG 884 (894)
Q Consensus 843 l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~i~ 884 (894)
......+.+++.+||+.||++|||++++++.|+.+.
T Consensus 245 ------~~~~~~l~~li~~cl~~dp~~Rps~~ell~~l~~~~ 280 (283)
T PHA02988 245 ------LDCPLEIKCIVEACTSHDSIKRPNIKEILYNLSLYK 280 (283)
T ss_pred ------CcCcHHHHHHHHHHhcCCcccCcCHHHHHHHHHHHH
Confidence 012235778999999999999999999999998764
|
|
| >cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-36 Score=333.36 Aligned_cols=264 Identities=23% Similarity=0.353 Sum_probs=203.5
Q ss_pred cCCCccceEeecCcEEEEEEEEcC-----------------CCeEEEEEEcCcc-hhhHHHHHHHHHHHHhcCCCceeee
Q 002673 607 DNFSQANIIGCGGFGLVYKATLAN-----------------GTTLAIKKLSGDL-GLMEREFKAEVEALSTAQHKNLVSL 668 (894)
Q Consensus 607 ~~f~~~~~LG~G~fg~Vy~a~~~~-----------------g~~vAvK~~~~~~-~~~~~~~~~Ei~~l~~l~HpnIv~l 668 (894)
++|...+.||+|+||.||+|.+.+ +..||+|.+.... ......+.+|+.++.+++||||+++
T Consensus 5 ~~~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~ 84 (304)
T cd05096 5 GHLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFLKEVKILSRLKDPNIIRL 84 (304)
T ss_pred hhCeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCCCHHHHHHHHHHHHHHhhcCCCCeeEE
Confidence 468888999999999999997532 3369999987643 3344678999999999999999999
Q ss_pred cceeeecceEEEEEEeccCCCHHHHHhhhcC---------------CCCCcCHHHHHHHHHHHHHHHHHHHhccCCCeee
Q 002673 669 QGYCVHQGFRLLIYSYMENGSLDYWLHEKAD---------------GASQLDWLTRLKIARGTSCGLAYMHQICEPHIVH 733 (894)
Q Consensus 669 ~g~~~~~~~~~lV~E~~~~gsL~~~l~~~~~---------------~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivH 733 (894)
++++...+..++||||+++|+|.+++..... ....++|...+.++.||+.||.|||+ .+|+|
T Consensus 85 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~---~~ivH 161 (304)
T cd05096 85 LGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSS---LNFVH 161 (304)
T ss_pred EEEEecCCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHH---CCccc
Confidence 9999999999999999999999999865321 12357888999999999999999997 59999
Q ss_pred cCCCCCCeEECCCCcEEEEEcccccccCCCCC-cccccccccCCccCcccccCcCCCccccHHHHHHHHHHHHc--CCCC
Q 002673 734 RDIKSSNILLDDQFEAHLADFGLSRLILPYQT-HVTTELVGTLGYIPPEYGQAWVATLRGDMYSFGVVMLELLT--GKRP 810 (894)
Q Consensus 734 rDLkp~NILld~~~~vkl~DFGla~~~~~~~~-~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwS~GvlL~ellt--G~~P 810 (894)
|||||+|||++.++.+||+|||+++....... .......++..|+|||++.+..++.++||||||+++|||++ +..|
T Consensus 162 ~dlkp~Nill~~~~~~kl~DfG~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p 241 (304)
T cd05096 162 RDLATRNCLVGENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEILMLCKEQP 241 (304)
T ss_pred cCcchhheEEcCCccEEECCCccceecccCceeEecCcCCCCccccCHHHHhcCCCCchhhhHHHHHHHHHHHHccCCCC
Confidence 99999999999999999999999986533221 12223456789999999988899999999999999999987 6678
Q ss_pred CCCCCcchhhhHHHHHHHHhhcCCCCccccccccCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHh
Q 002673 811 VDVLKPKMSRELVGWVLKMRSEGKQDQVFDPILRGKGFDEEMLQVLDVACMCVSQNPFKRPTVKEVVEWLNN 882 (894)
Q Consensus 811 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~ 882 (894)
|...... ................... ...+.....+.+++.+||+.||++|||+.+|.+.|++
T Consensus 242 ~~~~~~~---~~~~~~~~~~~~~~~~~~~------~~~~~~~~~~~~li~~cl~~~p~~RPs~~~i~~~l~~ 304 (304)
T cd05096 242 YGELTDE---QVIENAGEFFRDQGRQVYL------FRPPPCPQGLYELMLQCWSRDCRERPSFSDIHAFLTE 304 (304)
T ss_pred CCcCCHH---HHHHHHHHHhhhccccccc------cCCCCCCHHHHHHHHHHccCCchhCcCHHHHHHHHhC
Confidence 8754432 2222222211111100000 0001122357889999999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k |
| >KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-37 Score=313.44 Aligned_cols=236 Identities=25% Similarity=0.318 Sum_probs=197.3
Q ss_pred cCCCccceEeecCcEEEEEEE-EcCCCeEEEEEEcCcchhhH---HHHHHHHHHHHhcCCCceeeecceeeecceEEEEE
Q 002673 607 DNFSQANIIGCGGFGLVYKAT-LANGTTLAIKKLSGDLGLME---REFKAEVEALSTAQHKNLVSLQGYCVHQGFRLLIY 682 (894)
Q Consensus 607 ~~f~~~~~LG~G~fg~Vy~a~-~~~g~~vAvK~~~~~~~~~~---~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~lV~ 682 (894)
++|+..+.||.|+||.|..++ ..+|..+|+|++.+..-... +...+|..+|+.+.||+++++++.|.+.+..+|||
T Consensus 44 ~dfe~~~tlGtGSFGrV~LVr~k~~g~yYAmKvL~k~~vVklKQveH~~nEk~vL~~v~~PFlv~l~~t~~d~~~lymvm 123 (355)
T KOG0616|consen 44 QDFERLKTLGTGSFGRVHLVREKHSGNYYAMKVLDKQKVVKLKQVEHTHNEKRVLKAVSHPFLVKLYGTFKDNSNLYMVM 123 (355)
T ss_pred hhhhheeeeccCccceEEEEEEccCCceeehhhcCHHHHHHHHHHHHHhhHHHHHhhccCceeEEEEEeeccCCeEEEEE
Confidence 467888999999999999998 45789999999987643333 34678999999999999999999999999999999
Q ss_pred EeccCCCHHHHHhhhcCCCCCcCHHHHHHHHHHHHHHHHHHHhccCCCeeecCCCCCCeEECCCCcEEEEEcccccccCC
Q 002673 683 SYMENGSLDYWLHEKADGASQLDWLTRLKIARGTSCGLAYMHQICEPHIVHRDIKSSNILLDDQFEAHLADFGLSRLILP 762 (894)
Q Consensus 683 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDLkp~NILld~~~~vkl~DFGla~~~~~ 762 (894)
||++||-|..+++.. .+++...+..+|.+|+.||+|||+ .+|++|||||+|||||.+|.+||+|||+|+...
T Consensus 124 eyv~GGElFS~Lrk~----~rF~e~~arFYAAeivlAleylH~---~~iiYRDLKPENiLlD~~G~iKitDFGFAK~v~- 195 (355)
T KOG0616|consen 124 EYVPGGELFSYLRKS----GRFSEPHARFYAAEIVLALEYLHS---LDIIYRDLKPENLLLDQNGHIKITDFGFAKRVS- 195 (355)
T ss_pred eccCCccHHHHHHhc----CCCCchhHHHHHHHHHHHHHHHHh---cCeeeccCChHHeeeccCCcEEEEeccceEEec-
Confidence 999999999999865 468999999999999999999998 599999999999999999999999999999863
Q ss_pred CCCcccccccccCCccCcccccCcCCCccccHHHHHHHHHHHHcCCCCCCCCCcchhhhHHHHHHHHhhcCCCCcccccc
Q 002673 763 YQTHVTTELVGTLGYIPPEYGQAWVATLRGDMYSFGVVMLELLTGKRPVDVLKPKMSRELVGWVLKMRSEGKQDQVFDPI 842 (894)
Q Consensus 763 ~~~~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwS~GvlL~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 842 (894)
..+.+.+|||.|+|||++++..|..++|+|||||++|||+.|.+||....+... ..++. .+... +
T Consensus 196 ---~rT~TlCGTPeYLAPEii~sk~ynkavDWWalGVLIYEMlaG~pPF~~~~~~~i------Y~KI~-~~~v~--f--- 260 (355)
T KOG0616|consen 196 ---GRTWTLCGTPEYLAPEIIQSKGYNKAVDWWALGVLIYEMLAGYPPFYDDNPIQI------YEKIL-EGKVK--F--- 260 (355)
T ss_pred ---CcEEEecCCccccChHHhhcCCCCcchhHHHHHHHHHHHHcCCCCCcCCChHHH------HHHHH-hCccc--C---
Confidence 346778999999999999999999999999999999999999999986544211 11111 11110 1
Q ss_pred ccCCCChHHHHHHHHHHHHhcccCCCCC
Q 002673 843 LRGKGFDEEMLQVLDVACMCVSQNPFKR 870 (894)
Q Consensus 843 l~~~~~~~~~~~l~~li~~Cl~~dP~~R 870 (894)
.+--...+.+|+...++.|-.+|
T Consensus 261 -----P~~fs~~~kdLl~~LL~vD~t~R 283 (355)
T KOG0616|consen 261 -----PSYFSSDAKDLLKKLLQVDLTKR 283 (355)
T ss_pred -----CcccCHHHHHHHHHHHhhhhHhh
Confidence 11112245688889999998888
|
|
| >cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-36 Score=328.79 Aligned_cols=256 Identities=26% Similarity=0.359 Sum_probs=203.1
Q ss_pred CCccceEeecCcEEEEEEEE-cCCCeEEEEEEcCcch---hhHHHHHHHHHHHHhcCCCceeeecceeeecceEEEEEEe
Q 002673 609 FSQANIIGCGGFGLVYKATL-ANGTTLAIKKLSGDLG---LMEREFKAEVEALSTAQHKNLVSLQGYCVHQGFRLLIYSY 684 (894)
Q Consensus 609 f~~~~~LG~G~fg~Vy~a~~-~~g~~vAvK~~~~~~~---~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~lV~E~ 684 (894)
|+..+.||+|+||.||+|.. .+|+.||+|.+..... .....+.+|+.++++++|+||+++.+++.+++..++||||
T Consensus 2 f~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~iv~~~~~~~~~~~~~lv~e~ 81 (285)
T cd05631 2 FRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAYAYETKDALCLVLTI 81 (285)
T ss_pred ceEEEEEecCCCEEEEEEEEecCCceEEEEEeeHhhhhhhhhHHHHHHHHHHHHhcCCCcEEEEEEEEccCCeEEEEEEe
Confidence 67788999999999999984 6799999999875421 2234578899999999999999999999999999999999
Q ss_pred ccCCCHHHHHhhhcCCCCCcCHHHHHHHHHHHHHHHHHHHhccCCCeeecCCCCCCeEECCCCcEEEEEcccccccCCCC
Q 002673 685 MENGSLDYWLHEKADGASQLDWLTRLKIARGTSCGLAYMHQICEPHIVHRDIKSSNILLDDQFEAHLADFGLSRLILPYQ 764 (894)
Q Consensus 685 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDLkp~NILld~~~~vkl~DFGla~~~~~~~ 764 (894)
+++|+|..++.... ...+++..+..++.|++.||.|||+ ++|+||||||+|||+++++.+||+|||++.......
T Consensus 82 ~~~g~L~~~~~~~~--~~~~~~~~~~~~~~qi~~~l~~lH~---~~iiH~dikp~Nill~~~~~~kl~Dfg~~~~~~~~~ 156 (285)
T cd05631 82 MNGGDLKFHIYNMG--NPGFDEQRAIFYAAELCCGLEDLQR---ERIVYRDLKPENILLDDRGHIRISDLGLAVQIPEGE 156 (285)
T ss_pred cCCCcHHHHHHhhC--CCCCCHHHHHHHHHHHHHHHHHHHh---CCEEeCCCCHHHEEECCCCCEEEeeCCCcEEcCCCC
Confidence 99999998886432 2458899999999999999999997 599999999999999999999999999998653221
Q ss_pred CcccccccccCCccCcccccCcCCCccccHHHHHHHHHHHHcCCCCCCCCCcchhhhHHHHHHHHhhcCCCCcccccccc
Q 002673 765 THVTTELVGTLGYIPPEYGQAWVATLRGDMYSFGVVMLELLTGKRPVDVLKPKMSRELVGWVLKMRSEGKQDQVFDPILR 844 (894)
Q Consensus 765 ~~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwS~GvlL~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~ 844 (894)
......||..|+|||++.+..++.++|||||||++|||++|+.||............ ......... .
T Consensus 157 --~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~---~~~~~~~~~-~------- 223 (285)
T cd05631 157 --TVRGRVGTVGYMAPEVINNEKYTFSPDWWGLGCLIYEMIQGQSPFRKRKERVKREEV---DRRVKEDQE-E------- 223 (285)
T ss_pred --eecCCCCCCCccCHhhhcCCCCCcccCchhHHHHHHHHHhCCCCCCCCCcchhHHHH---HHHhhcccc-c-------
Confidence 223457899999999999999999999999999999999999999754432111111 111111100 0
Q ss_pred CCCChHHHHHHHHHHHHhcccCCCCCCC-----HHHHHH--HHHhcc
Q 002673 845 GKGFDEEMLQVLDVACMCVSQNPFKRPT-----VKEVVE--WLNNVG 884 (894)
Q Consensus 845 ~~~~~~~~~~l~~li~~Cl~~dP~~RPs-----~~evl~--~L~~i~ 884 (894)
........+.+++.+||+.||.+||+ ++++++ |++.+.
T Consensus 224 --~~~~~s~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~h~~~~~~~ 268 (285)
T cd05631 224 --YSEKFSEDAKSICRMLLTKNPKERLGCRGNGAAGVKQHPIFKNIN 268 (285)
T ss_pred --CCccCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHhcCHhhcCCC
Confidence 01111235678999999999999997 899988 676653
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i |
| >KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-37 Score=364.32 Aligned_cols=260 Identities=29% Similarity=0.455 Sum_probs=210.9
Q ss_pred cCCCccceEeecCcEEEEEEEEcC--CC----eEEEEEEcCcc-hhhHHHHHHHHHHHHhcCCCceeeecceeeecceEE
Q 002673 607 DNFSQANIIGCGGFGLVYKATLAN--GT----TLAIKKLSGDL-GLMEREFKAEVEALSTAQHKNLVSLQGYCVHQGFRL 679 (894)
Q Consensus 607 ~~f~~~~~LG~G~fg~Vy~a~~~~--g~----~vAvK~~~~~~-~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~ 679 (894)
+..+..+.||+|+||.||.|.+.+ |. .||||.+.... .....+|.+|..+|+.++|||||+++|+|.+....+
T Consensus 692 ~~v~l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~~~~~~~~~~Fl~Ea~~m~~f~HpNiv~liGv~l~~~~~~ 771 (1025)
T KOG1095|consen 692 KNVTLLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKRLSSEQEVSDFLKEALLMSKFDHPNIVSLIGVCLDSGPPL 771 (1025)
T ss_pred hheEeeeeeccccccceEEEEEecCCCCccceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCcceeeEEEeecCCCCcE
Confidence 445667899999999999998543 43 38999998754 445678999999999999999999999999999999
Q ss_pred EEEEeccCCCHHHHHhhhcC---CCCCcCHHHHHHHHHHHHHHHHHHHhccCCCeeecCCCCCCeEECCCCcEEEEEccc
Q 002673 680 LIYSYMENGSLDYWLHEKAD---GASQLDWLTRLKIARGTSCGLAYMHQICEPHIVHRDIKSSNILLDDQFEAHLADFGL 756 (894)
Q Consensus 680 lV~E~~~~gsL~~~l~~~~~---~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDLkp~NILld~~~~vkl~DFGl 756 (894)
+++|||++|+|..||++... ....++..+.+.++.|||+|+.||++ +++|||||.++|+||+....|||+|||+
T Consensus 772 i~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe~---~~fvHRDLAaRNCLL~~~r~VKIaDFGl 848 (1025)
T KOG1095|consen 772 ILLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLES---KHFVHRDLAARNCLLDERRVVKIADFGL 848 (1025)
T ss_pred EEehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHHh---CCCcCcchhhhheeecccCcEEEcccch
Confidence 99999999999999997522 24568899999999999999999997 6999999999999999999999999999
Q ss_pred ccccCCCCCcccccc-cccCCccCcccccCcCCCccccHHHHHHHHHHHHc-CCCCCCCCCcchhhhHHHHHHHHhhcCC
Q 002673 757 SRLILPYQTHVTTEL-VGTLGYIPPEYGQAWVATLRGDMYSFGVVMLELLT-GKRPVDVLKPKMSRELVGWVLKMRSEGK 834 (894)
Q Consensus 757 a~~~~~~~~~~~~~~-~gt~~Y~APE~~~~~~~s~ksDVwS~GvlL~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~ 834 (894)
|+.+.....+..... .-...|||||.+..+.++.|+|||||||+|||++| |..||...... ++... ....+.
T Consensus 849 ArDiy~~~yyr~~~~a~lPvkWm~PEsl~d~iFtskSDvWsFGVllWEifslG~~PY~~~~n~---~v~~~---~~~ggR 922 (1025)
T KOG1095|consen 849 ARDIYDKDYYRKHGEAMLPVKWMPPESLKDGIFTSKSDVWSFGVLLWEIFSLGATPYPSRSNF---EVLLD---VLEGGR 922 (1025)
T ss_pred hHhhhhchheeccCccccceecCCHHHHhhcccccccchhhhHHHHHHHHhCCCCCCCCcchH---HHHHH---HHhCCc
Confidence 997654443333222 33468999999999999999999999999999999 99999865432 22221 122232
Q ss_pred CCccccccccCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhccc
Q 002673 835 QDQVFDPILRGKGFDEEMLQVLDVACMCVSQNPFKRPTVKEVVEWLNNVGA 885 (894)
Q Consensus 835 ~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~i~~ 885 (894)
++ ...++++ .+++++..||+.+|++||++..|++.+..+..
T Consensus 923 L~-------~P~~CP~---~ly~lM~~CW~~~pe~RP~F~~i~~q~~~i~~ 963 (1025)
T KOG1095|consen 923 LD-------PPSYCPE---KLYQLMLQCWKHDPEDRPSFRTIVEQDPAISN 963 (1025)
T ss_pred cC-------CCCCCCh---HHHHHHHHHccCChhhCccHHHHHhhhhhhhh
Confidence 21 1233333 56789999999999999999999998877643
|
|
| >KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-37 Score=343.54 Aligned_cols=258 Identities=25% Similarity=0.403 Sum_probs=205.5
Q ss_pred CCCccceEeecCcEEEEEEEEcC--C--Ce-EEEEEEcCcc---hhhHHHHHHHHHHHHhcCCCceeeecceeeecceEE
Q 002673 608 NFSQANIIGCGGFGLVYKATLAN--G--TT-LAIKKLSGDL---GLMEREFKAEVEALSTAQHKNLVSLQGYCVHQGFRL 679 (894)
Q Consensus 608 ~f~~~~~LG~G~fg~Vy~a~~~~--g--~~-vAvK~~~~~~---~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~ 679 (894)
+....++||+|+||.||+|.+.. + .. ||||...... .....+|.+|.++|+.++|||||+++|++..+...+
T Consensus 158 ~v~l~kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~~~~~~~~~~e~m~EArvMr~l~H~NVVr~yGVa~~~~Pl~ 237 (474)
T KOG0194|consen 158 DIELGKKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGSSELTKEQIKEFMKEARVMRQLNHPNVVRFYGVAVLEEPLM 237 (474)
T ss_pred CccccceeecccccEEEEEEEEecCCceeeeeEEEeecccccccHHHHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCccE
Confidence 44456899999999999998543 2 23 8999998632 445578999999999999999999999999999999
Q ss_pred EEEEeccCCCHHHHHhhhcCCCCCcCHHHHHHHHHHHHHHHHHHHhccCCCeeecCCCCCCeEECCCCcEEEEEcccccc
Q 002673 680 LIYSYMENGSLDYWLHEKADGASQLDWLTRLKIARGTSCGLAYMHQICEPHIVHRDIKSSNILLDDQFEAHLADFGLSRL 759 (894)
Q Consensus 680 lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDLkp~NILld~~~~vkl~DFGla~~ 759 (894)
+|||+|.||+|.++|+... ..++..++..++.+.|+||+|||+ ++++||||.++|+|++.++.+||+|||+++.
T Consensus 238 ivmEl~~gGsL~~~L~k~~---~~v~~~ek~~~~~~AA~Gl~YLh~---k~~IHRDIAARNcL~~~~~~vKISDFGLs~~ 311 (474)
T KOG0194|consen 238 LVMELCNGGSLDDYLKKNK---KSLPTLEKLRFCYDAARGLEYLHS---KNCIHRDIAARNCLYSKKGVVKISDFGLSRA 311 (474)
T ss_pred EEEEecCCCcHHHHHHhCC---CCCCHHHHHHHHHHHHhHHHHHHH---CCCcchhHhHHHheecCCCeEEeCccccccC
Confidence 9999999999999999754 268999999999999999999997 5999999999999999999999999999886
Q ss_pred cCCCCCcccccccccCCccCcccccCcCCCccccHHHHHHHHHHHHc-CCCCCCCCCcchhhhHHHHHHHHhhcCCCCcc
Q 002673 760 ILPYQTHVTTELVGTLGYIPPEYGQAWVATLRGDMYSFGVVMLELLT-GKRPVDVLKPKMSRELVGWVLKMRSEGKQDQV 838 (894)
Q Consensus 760 ~~~~~~~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwS~GvlL~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 838 (894)
....... .....-...|+|||.+....|++++|||||||++||+++ |..||.+....+ +..++ ...+.....
T Consensus 312 ~~~~~~~-~~~~klPirWLAPEtl~~~~~s~kTDV~sfGV~~~Eif~~g~~Py~g~~~~~---v~~kI---~~~~~r~~~ 384 (474)
T KOG0194|consen 312 GSQYVMK-KFLKKLPIRWLAPETLNTGIFSFKTDVWSFGVLLWEIFENGAEPYPGMKNYE---VKAKI---VKNGYRMPI 384 (474)
T ss_pred Ccceeec-cccccCcceecChhhhccCccccccchhheeeeEEeeeccCCCCCCCCCHHH---HHHHH---HhcCccCCC
Confidence 4311111 111224568999999999999999999999999999999 899998765432 22222 111211111
Q ss_pred ccccccCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhccccc
Q 002673 839 FDPILRGKGFDEEMLQVLDVACMCVSQNPFKRPTVKEVVEWLNNVGANR 887 (894)
Q Consensus 839 ~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~i~~~~ 887 (894)
. ... ...+..++.+||..+|++||+|.++.++|+.+....
T Consensus 385 ~------~~~---p~~~~~~~~~c~~~~p~~R~tm~~i~~~l~~~~~~~ 424 (474)
T KOG0194|consen 385 P------SKT---PKELAKVMKQCWKKDPEDRPTMSTIKKKLEALEKKK 424 (474)
T ss_pred C------CCC---HHHHHHHHHHhccCChhhccCHHHHHHHHHHHHhcc
Confidence 0 112 234556777999999999999999999998876543
|
|
| >cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-36 Score=333.53 Aligned_cols=266 Identities=25% Similarity=0.384 Sum_probs=206.1
Q ss_pred ccCCCccceEeecCcEEEEEEEE-cCCCeEEEEEEcCcch-hhHHHHHHHHHHHHhcCCCceeeecceeeecceEEEEEE
Q 002673 606 TDNFSQANIIGCGGFGLVYKATL-ANGTTLAIKKLSGDLG-LMEREFKAEVEALSTAQHKNLVSLQGYCVHQGFRLLIYS 683 (894)
Q Consensus 606 ~~~f~~~~~LG~G~fg~Vy~a~~-~~g~~vAvK~~~~~~~-~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~lV~E 683 (894)
.++|++.+.||+|+||.||++.. .++..||+|.+..... .....+.+|++++++++||||+++++++..++..++|||
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 83 (331)
T cd06649 4 DDDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME 83 (331)
T ss_pred cccceEEEeecCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEee
Confidence 36789999999999999999985 4688999999876432 334678999999999999999999999999999999999
Q ss_pred eccCCCHHHHHhhhcCCCCCcCHHHHHHHHHHHHHHHHHHHhccCCCeeecCCCCCCeEECCCCcEEEEEcccccccCCC
Q 002673 684 YMENGSLDYWLHEKADGASQLDWLTRLKIARGTSCGLAYMHQICEPHIVHRDIKSSNILLDDQFEAHLADFGLSRLILPY 763 (894)
Q Consensus 684 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDLkp~NILld~~~~vkl~DFGla~~~~~~ 763 (894)
|+++|+|.+++... ..+++..+..++.|++.||.|||+. .+|+||||||+|||++.++.+||+|||++......
T Consensus 84 ~~~~~~L~~~l~~~----~~~~~~~~~~~~~~i~~~l~~lH~~--~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~ 157 (331)
T cd06649 84 HMDGGSLDQVLKEA----KRIPEEILGKVSIAVLRGLAYLREK--HQIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS 157 (331)
T ss_pred cCCCCcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHhhc--CCEEcCCCChhhEEEcCCCcEEEccCccccccccc
Confidence 99999999999754 3578889999999999999999972 46999999999999999999999999999765322
Q ss_pred CCcccccccccCCccCcccccCcCCCccccHHHHHHHHHHHHcCCCCCCCCCcchhhhHHHHHHHHhhcCC---CC----
Q 002673 764 QTHVTTELVGTLGYIPPEYGQAWVATLRGDMYSFGVVMLELLTGKRPVDVLKPKMSRELVGWVLKMRSEGK---QD---- 836 (894)
Q Consensus 764 ~~~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwS~GvlL~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~---~~---- 836 (894)
......||+.|+|||++.+..++.++|||||||++|||++|+.||....... +............ ..
T Consensus 158 ---~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~ 231 (331)
T cd06649 158 ---MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGRYPIPPPDAKE---LEAIFGRPVVDGEEGEPHSISP 231 (331)
T ss_pred ---ccccCCCCcCcCCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHH---HHHHhcccccccccCCccccCc
Confidence 2234568999999999999999999999999999999999999997543221 1111100000000 00
Q ss_pred -----------------------ccccccc----cCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHH--HHHhc
Q 002673 837 -----------------------QVFDPIL----RGKGFDEEMLQVLDVACMCVSQNPFKRPTVKEVVE--WLNNV 883 (894)
Q Consensus 837 -----------------------~~~d~~l----~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~--~L~~i 883 (894)
...+... ..........++.+++.+||+.||++|||++++++ |+...
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~~P~~Rpt~~ell~h~~~~~~ 307 (331)
T cd06649 232 RPRPPGRPVSGHGMDSRPAMAIFELLDYIVNEPPPKLPNGVFTPDFQEFVNKCLIKNPAERADLKMLMNHTFIKRS 307 (331)
T ss_pred ccccccccccccccccccchhHHHHHHHHHhCCCcCCCCccccHHHHHHHHHHccCCcccCCCHHHHhcChHHhhc
Confidence 0000000 00000112346789999999999999999999998 76654
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst |
| >KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-36 Score=331.16 Aligned_cols=256 Identities=27% Similarity=0.344 Sum_probs=208.0
Q ss_pred ccCCCccceEeecCcEEEEEEE-EcCCCeEEEEEEcCcchhh---HHHHHHHHHHHHhcCCCceeeecceeeecceEEEE
Q 002673 606 TDNFSQANIIGCGGFGLVYKAT-LANGTTLAIKKLSGDLGLM---EREFKAEVEALSTAQHKNLVSLQGYCVHQGFRLLI 681 (894)
Q Consensus 606 ~~~f~~~~~LG~G~fg~Vy~a~-~~~g~~vAvK~~~~~~~~~---~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~lV 681 (894)
.++|+....||+|+||.||.|+ ..+|..+|+|++++..-.. ...++.|-.+|....+|.||+++-.|.+....|||
T Consensus 140 ~~DFe~Lk~IgkGAfGeVrLarKk~Tg~iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~~ds~~vVKLyYsFQD~~~LYLi 219 (550)
T KOG0605|consen 140 LDDFELLKVIGKGAFGEVRLARKKDTGEIYAMKILKKSEMLKKNQVEHVRAERDILAEVDSPWVVKLYYSFQDKEYLYLI 219 (550)
T ss_pred cccchhheeeccccceeEEEEEEccCCcEEeeecccHHHHHhhhhHHHHHHHHHHhhhcCCCcEEEEEEEecCCCeeEEE
Confidence 4789999999999999999998 5689999999998754333 34577899999999999999999999999999999
Q ss_pred EEeccCCCHHHHHhhhcCCCCCcCHHHHHHHHHHHHHHHHHHHhccCCCeeecCCCCCCeEECCCCcEEEEEcccccccC
Q 002673 682 YSYMENGSLDYWLHEKADGASQLDWLTRLKIARGTSCGLAYMHQICEPHIVHRDIKSSNILLDDQFEAHLADFGLSRLIL 761 (894)
Q Consensus 682 ~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDLkp~NILld~~~~vkl~DFGla~~~~ 761 (894)
|||++||++..+|... ..|+...+..++.+++.|+.-+|++ |+|||||||+|+|||..|++||+|||+|..+.
T Consensus 220 MEylPGGD~mTLL~~~----~~L~e~~arfYiaE~vlAI~~iH~~---gyIHRDIKPdNlLiD~~GHiKLSDFGLs~gl~ 292 (550)
T KOG0605|consen 220 MEYLPGGDMMTLLMRK----DTLTEDWARFYIAETVLAIESIHQL---GYIHRDIKPDNLLIDAKGHIKLSDFGLSTGLD 292 (550)
T ss_pred EEecCCccHHHHHHhc----CcCchHHHHHHHHHHHHHHHHHHHc---CcccccCChhheeecCCCCEeeccccccchhh
Confidence 9999999999999865 4688888999999999999999985 99999999999999999999999999996431
Q ss_pred C----------------------CCCc-----c-------------------cccccccCCccCcccccCcCCCccccHH
Q 002673 762 P----------------------YQTH-----V-------------------TTELVGTLGYIPPEYGQAWVATLRGDMY 795 (894)
Q Consensus 762 ~----------------------~~~~-----~-------------------~~~~~gt~~Y~APE~~~~~~~s~ksDVw 795 (894)
. .... . ....+|||.|||||++.+..|+..+|+|
T Consensus 293 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVll~kgY~~~cDwW 372 (550)
T KOG0605|consen 293 KKHRIESYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVLLGKGYGKECDWW 372 (550)
T ss_pred hhhhhhhhcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHHhcCCCCccccHH
Confidence 1 0000 0 0124799999999999999999999999
Q ss_pred HHHHHHHHHHcCCCCCCCCCcchh-hhHHHHHHHHhhcCCCCccccccccCCCChHHHHHHHHHHHHhcccCCCCCCC--
Q 002673 796 SFGVVMLELLTGKRPVDVLKPKMS-RELVGWVLKMRSEGKQDQVFDPILRGKGFDEEMLQVLDVACMCVSQNPFKRPT-- 872 (894)
Q Consensus 796 S~GvlL~elltG~~Pf~~~~~~~~-~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs-- 872 (894)
|+|||||||+.|.+||....+... +.++.|...+....... .+ .+..++|.+|+. ||++|.-
T Consensus 373 SLG~ImyEmLvGyPPF~s~tp~~T~rkI~nwr~~l~fP~~~~-----------~s---~eA~DLI~rll~-d~~~RLG~~ 437 (550)
T KOG0605|consen 373 SLGCIMYEMLVGYPPFCSETPQETYRKIVNWRETLKFPEEVD-----------LS---DEAKDLITRLLC-DPENRLGSK 437 (550)
T ss_pred HHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhhhccCCCcCc-----------cc---HHHHHHHHHHhc-CHHHhcCcc
Confidence 999999999999999987665543 45556654332222111 11 355689999999 9999985
Q ss_pred -HHHHHH--HHHhc
Q 002673 873 -VKEVVE--WLNNV 883 (894)
Q Consensus 873 -~~evl~--~L~~i 883 (894)
++||-+ +++.+
T Consensus 438 G~~EIK~HPfF~~v 451 (550)
T KOG0605|consen 438 GAEEIKKHPFFKGV 451 (550)
T ss_pred cHHHHhcCCccccC
Confidence 666655 45444
|
|
| >cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-36 Score=325.03 Aligned_cols=255 Identities=22% Similarity=0.328 Sum_probs=203.0
Q ss_pred cCCCccceEeecCcEEEEEEEEc----CCCeEEEEEEcCcch-hhHHHHHHHHHHHHhcCCCceeeecceeeecceEEEE
Q 002673 607 DNFSQANIIGCGGFGLVYKATLA----NGTTLAIKKLSGDLG-LMEREFKAEVEALSTAQHKNLVSLQGYCVHQGFRLLI 681 (894)
Q Consensus 607 ~~f~~~~~LG~G~fg~Vy~a~~~----~g~~vAvK~~~~~~~-~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~lV 681 (894)
++|++.+.||+|+||.||+|.+. .+..||+|.++.... .....+.+|+.++++++||||+++++++..++..++|
T Consensus 5 ~~~~~~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv 84 (266)
T cd05064 5 KSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFDHSNIVRLEGVITRGNTMMIV 84 (266)
T ss_pred HHeEEeeeecccCCCeEEEEEEecCCCceeeEEEEecCCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEecCCCcEEE
Confidence 56888899999999999999753 456899999886532 3345788999999999999999999999999999999
Q ss_pred EEeccCCCHHHHHhhhcCCCCCcCHHHHHHHHHHHHHHHHHHHhccCCCeeecCCCCCCeEECCCCcEEEEEcccccccC
Q 002673 682 YSYMENGSLDYWLHEKADGASQLDWLTRLKIARGTSCGLAYMHQICEPHIVHRDIKSSNILLDDQFEAHLADFGLSRLIL 761 (894)
Q Consensus 682 ~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDLkp~NILld~~~~vkl~DFGla~~~~ 761 (894)
|||+++|+|.+++.... ..+++..++.++.|++.||+|||+ ++++||||||+||+++.++.+|++|||.+....
T Consensus 85 ~e~~~~~~L~~~l~~~~---~~l~~~~~~~~~~~i~~al~~lH~---~~iiH~dikp~nili~~~~~~~l~dfg~~~~~~ 158 (266)
T cd05064 85 TEYMSNGALDSFLRKHE---GQLVAGQLMGMLPGLASGMKYLSE---MGYVHKGLAAHKVLVNSDLVCKISGFRRLQEDK 158 (266)
T ss_pred EEeCCCCcHHHHHHhCC---CCCCHHHHHHHHHHHHHHHHHHHH---CCEeeccccHhhEEEcCCCcEEECCCccccccc
Confidence 99999999999997542 468999999999999999999997 599999999999999999999999999876532
Q ss_pred CCCCcccccccccCCccCcccccCcCCCccccHHHHHHHHHHHHc-CCCCCCCCCcchhhhHHHHHHHHhhcCCCCcccc
Q 002673 762 PYQTHVTTELVGTLGYIPPEYGQAWVATLRGDMYSFGVVMLELLT-GKRPVDVLKPKMSRELVGWVLKMRSEGKQDQVFD 840 (894)
Q Consensus 762 ~~~~~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwS~GvlL~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 840 (894)
...........++..|+|||++.+..++.++|||||||++||+++ |+.||...... ...... ..+....
T Consensus 159 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~p~~~~~~~---~~~~~~----~~~~~~~--- 228 (266)
T cd05064 159 SEAIYTTMSGKSPVLWAAPEAIQYHHFSSASDVWSFGIVMWEVMSYGERPYWDMSGQ---DVIKAV----EDGFRLP--- 228 (266)
T ss_pred ccchhcccCCCCceeecCHHHHhhCCccchhHHHHHHHHHHHHhcCCCCCcCcCCHH---HHHHHH----HCCCCCC---
Confidence 221111222345678999999999999999999999999999875 99999755432 111111 1111100
Q ss_pred ccccCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhc
Q 002673 841 PILRGKGFDEEMLQVLDVACMCVSQNPFKRPTVKEVVEWLNNV 883 (894)
Q Consensus 841 ~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~i 883 (894)
. .......+.+++..||+.+|++||++++|++.|+.+
T Consensus 229 --~----~~~~~~~~~~li~~c~~~~p~~RP~~~~i~~~l~~~ 265 (266)
T cd05064 229 --A----PRNCPNLLHQLMLDCWQKERGERPRFSQIHSILSKM 265 (266)
T ss_pred --C----CCCCCHHHHHHHHHHcCCCchhCCCHHHHHHHHHhh
Confidence 0 011223567899999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor |
| >KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-37 Score=336.43 Aligned_cols=240 Identities=23% Similarity=0.404 Sum_probs=195.6
Q ss_pred cceEeecCcEEEEEEEEcCCCeEEEEEEcCcchhhHHHHHHHHHHHHhcCCCceeeecceeeecceEEEEEEeccCCCHH
Q 002673 612 ANIIGCGGFGLVYKATLANGTTLAIKKLSGDLGLMEREFKAEVEALSTAQHKNLVSLQGYCVHQGFRLLIYSYMENGSLD 691 (894)
Q Consensus 612 ~~~LG~G~fg~Vy~a~~~~g~~vAvK~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~lV~E~~~~gsL~ 691 (894)
.+-||.|+.|.||+|++. ++.||||+++.. -..+|+-|++++||||+.+.|+|....-++||||||..|-|.
T Consensus 129 LeWlGSGaQGAVF~Grl~-netVAVKKV~el-------kETdIKHLRkLkH~NII~FkGVCtqsPcyCIiMEfCa~GqL~ 200 (904)
T KOG4721|consen 129 LEWLGSGAQGAVFLGRLH-NETVAVKKVREL-------KETDIKHLRKLKHPNIITFKGVCTQSPCYCIIMEFCAQGQLY 200 (904)
T ss_pred hhhhccCcccceeeeecc-CceehhHHHhhh-------hhhhHHHHHhccCcceeeEeeeecCCceeEEeeeccccccHH
Confidence 467999999999999985 688999988632 246789999999999999999999999999999999999999
Q ss_pred HHHhhhcCCCCCcCHHHHHHHHHHHHHHHHHHHhccCCCeeecCCCCCCeEECCCCcEEEEEcccccccCCCCCcccccc
Q 002673 692 YWLHEKADGASQLDWLTRLKIARGTSCGLAYMHQICEPHIVHRDIKSSNILLDDQFEAHLADFGLSRLILPYQTHVTTEL 771 (894)
Q Consensus 692 ~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDLkp~NILld~~~~vkl~DFGla~~~~~~~~~~~~~~ 771 (894)
..|+.. ..+.......|..+||.||.|||.+ .|||||||+-||||+.+..|||+|||-++..... .....+
T Consensus 201 ~VLka~----~~itp~llv~Wsk~IA~GM~YLH~h---KIIHRDLKSPNiLIs~~d~VKIsDFGTS~e~~~~--STkMSF 271 (904)
T KOG4721|consen 201 EVLKAG----RPITPSLLVDWSKGIAGGMNYLHLH---KIIHRDLKSPNILISYDDVVKISDFGTSKELSDK--STKMSF 271 (904)
T ss_pred HHHhcc----CccCHHHHHHHHHHhhhhhHHHHHh---hHhhhccCCCceEeeccceEEeccccchHhhhhh--hhhhhh
Confidence 999864 4577778889999999999999985 9999999999999999999999999999876432 334568
Q ss_pred cccCCccCcccccCcCCCccccHHHHHHHHHHHHcCCCCCCCCCcchhhhHHHHHHHHhhcCCCCccccccccCCCChHH
Q 002673 772 VGTLGYIPPEYGQAWVATLRGDMYSFGVVMLELLTGKRPVDVLKPKMSRELVGWVLKMRSEGKQDQVFDPILRGKGFDEE 851 (894)
Q Consensus 772 ~gt~~Y~APE~~~~~~~s~ksDVwS~GvlL~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~ 851 (894)
+||..|||||++.+...++|+||||||||||||+||..||.+.... .+-|-. ..+.-.+ .....++
T Consensus 272 aGTVaWMAPEvIrnePcsEKVDIwSfGVVLWEmLT~EiPYkdVdss----AIIwGV----GsNsL~L----pvPstcP-- 337 (904)
T KOG4721|consen 272 AGTVAWMAPEVIRNEPCSEKVDIWSFGVVLWEMLTGEIPYKDVDSS----AIIWGV----GSNSLHL----PVPSTCP-- 337 (904)
T ss_pred hhhHhhhCHHHhhcCCcccccceehhHHHHHHHHhcCCCccccchh----eeEEec----cCCcccc----cCcccCc--
Confidence 8999999999999999999999999999999999999999753321 111110 0111111 0111222
Q ss_pred HHHHHHHHHHhcccCCCCCCCHHHHHHHHHhc
Q 002673 852 MLQVLDVACMCVSQNPFKRPTVKEVVEWLNNV 883 (894)
Q Consensus 852 ~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~i 883 (894)
..+.-|+++||+-.|..||++.+|+..|+-.
T Consensus 338 -~GfklL~Kqcw~sKpRNRPSFrqil~HldIa 368 (904)
T KOG4721|consen 338 -DGFKLLLKQCWNSKPRNRPSFRQILLHLDIA 368 (904)
T ss_pred -hHHHHHHHHHHhcCCCCCccHHHHHHHHhhc
Confidence 3455677899999999999999999977644
|
|
| >cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-36 Score=338.82 Aligned_cols=260 Identities=27% Similarity=0.424 Sum_probs=203.9
Q ss_pred ccCCCccceEeecCcEEEEEEEE------cCCCeEEEEEEcCcc-hhhHHHHHHHHHHHHhc-CCCceeeecceeeecce
Q 002673 606 TDNFSQANIIGCGGFGLVYKATL------ANGTTLAIKKLSGDL-GLMEREFKAEVEALSTA-QHKNLVSLQGYCVHQGF 677 (894)
Q Consensus 606 ~~~f~~~~~LG~G~fg~Vy~a~~------~~g~~vAvK~~~~~~-~~~~~~~~~Ei~~l~~l-~HpnIv~l~g~~~~~~~ 677 (894)
.++|++.+.||+|+||.||+|.+ .++..||||+++... ....+.+.+|+.++..+ +||||++++++|...+.
T Consensus 34 ~~~~~~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~il~~l~~HpnIv~l~~~~~~~~~ 113 (375)
T cd05104 34 RNRLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHINIVNLLGACTVGGP 113 (375)
T ss_pred hHHeehhheecCCccceEEEEEEeccccCccceeEEEEeccCCcCcHHHHHHHHHHHHHHHhcCCcceeeeeeeeccCCc
Confidence 34688899999999999999963 245689999987543 23345788999999999 89999999999999999
Q ss_pred EEEEEEeccCCCHHHHHhhhcC----------------------------------------------------------
Q 002673 678 RLLIYSYMENGSLDYWLHEKAD---------------------------------------------------------- 699 (894)
Q Consensus 678 ~~lV~E~~~~gsL~~~l~~~~~---------------------------------------------------------- 699 (894)
.++||||+++|+|.++++....
T Consensus 114 ~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 193 (375)
T cd05104 114 TLVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKRRSVRSGS 193 (375)
T ss_pred ceeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCcccccccccccccccccce
Confidence 9999999999999999975321
Q ss_pred -------------CCCCcCHHHHHHHHHHHHHHHHHHHhccCCCeeecCCCCCCeEECCCCcEEEEEcccccccCCCCCc
Q 002673 700 -------------GASQLDWLTRLKIARGTSCGLAYMHQICEPHIVHRDIKSSNILLDDQFEAHLADFGLSRLILPYQTH 766 (894)
Q Consensus 700 -------------~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDLkp~NILld~~~~vkl~DFGla~~~~~~~~~ 766 (894)
....+++..+..++.||+.||.|||+ ++|+||||||+|||++.++.+||+|||+++........
T Consensus 194 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~---~~ivH~Dlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~ 270 (375)
T cd05104 194 YIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLAS---KNCIHRDLAARNILLTHGRITKICDFGLARDIRNDSNY 270 (375)
T ss_pred ecccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHH---CCeeccCCchhhEEEECCCcEEEecCccceeccCcccc
Confidence 11247888999999999999999997 59999999999999999999999999999865432221
Q ss_pred -ccccccccCCccCcccccCcCCCccccHHHHHHHHHHHHc-CCCCCCCCCcchhhhHHHHHHHHhhcCCCCcccccccc
Q 002673 767 -VTTELVGTLGYIPPEYGQAWVATLRGDMYSFGVVMLELLT-GKRPVDVLKPKMSRELVGWVLKMRSEGKQDQVFDPILR 844 (894)
Q Consensus 767 -~~~~~~gt~~Y~APE~~~~~~~s~ksDVwS~GvlL~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~ 844 (894)
......++..|+|||++.+..++.++|||||||++|||++ |..||...... .....+. ..+.... .+
T Consensus 271 ~~~~~~~~~~~y~aPE~~~~~~~~~~sDi~slG~~l~ellt~g~~p~~~~~~~--~~~~~~~----~~~~~~~--~~--- 339 (375)
T cd05104 271 VVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSPYPGMPVD--SKFYKMI----KEGYRML--SP--- 339 (375)
T ss_pred cccCCCCCCcceeChhHhcCCCCCCCCCHHHHHHHHHHHHhcCCCCCCCCCch--HHHHHHH----HhCccCC--CC---
Confidence 1122345668999999999999999999999999999998 89999754322 1111111 1111000 00
Q ss_pred CCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhc
Q 002673 845 GKGFDEEMLQVLDVACMCVSQNPFKRPTVKEVVEWLNNV 883 (894)
Q Consensus 845 ~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~i 883 (894)
.. ...++.+++.+||+.||++|||+.+|++.|++.
T Consensus 340 -~~---~~~~l~~li~~cl~~dP~~RPs~~eil~~l~~~ 374 (375)
T cd05104 340 -EC---APSEMYDIMKSCWDADPLKRPTFKQIVQLIEQQ 374 (375)
T ss_pred -CC---CCHHHHHHHHHHccCChhHCcCHHHHHHHHHhh
Confidence 11 123577899999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce |
| >cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-36 Score=326.41 Aligned_cols=265 Identities=22% Similarity=0.231 Sum_probs=200.8
Q ss_pred cCCCccceEeecCcEEEEEEEEc-CCCeEEEEEEcCcc--hhhHHHHHHHHHHHHhcCCCceeeecceeeecceEEEEEE
Q 002673 607 DNFSQANIIGCGGFGLVYKATLA-NGTTLAIKKLSGDL--GLMEREFKAEVEALSTAQHKNLVSLQGYCVHQGFRLLIYS 683 (894)
Q Consensus 607 ~~f~~~~~LG~G~fg~Vy~a~~~-~g~~vAvK~~~~~~--~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~lV~E 683 (894)
++|++.+.||+|+||.||+|+.. +++.||+|++.... ......+.+|+.+++.++||||+++++++..++..++|||
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 80 (287)
T cd07848 1 NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKEAFRRRGKLYLVFE 80 (287)
T ss_pred CCceEEEEecccCCEEEEEEEECCCCcEEEEEEEecccccccchhhHHHHHHHHHhCCCccccchhhhEecCCEEEEEEe
Confidence 36888999999999999999864 68899999987542 2234567899999999999999999999999999999999
Q ss_pred eccCCCHHHHHhhhcCCCCCcCHHHHHHHHHHHHHHHHHHHhccCCCeeecCCCCCCeEECCCCcEEEEEcccccccCCC
Q 002673 684 YMENGSLDYWLHEKADGASQLDWLTRLKIARGTSCGLAYMHQICEPHIVHRDIKSSNILLDDQFEAHLADFGLSRLILPY 763 (894)
Q Consensus 684 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDLkp~NILld~~~~vkl~DFGla~~~~~~ 763 (894)
|++++.+..+... ...+++..+..++.|++.||.|||+ ++|+||||||+||+++.++.+||+|||++......
T Consensus 81 ~~~~~~l~~~~~~----~~~~~~~~~~~~~~qi~~~L~~lH~---~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~ 153 (287)
T cd07848 81 YVEKNMLELLEEM----PNGVPPEKVRSYIYQLIKAIHWCHK---NDIVHRDIKPENLLISHNDVLKLCDFGFARNLSEG 153 (287)
T ss_pred cCCCCHHHHHHhc----CCCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHEEEcCCCcEEEeeccCccccccc
Confidence 9998777655432 2358888999999999999999997 59999999999999999999999999999876433
Q ss_pred CCcccccccccCCccCcccccCcCCCccccHHHHHHHHHHHHcCCCCCCCCCcchhhhHHHHH---------HHHhhcCC
Q 002673 764 QTHVTTELVGTLGYIPPEYGQAWVATLRGDMYSFGVVMLELLTGKRPVDVLKPKMSRELVGWV---------LKMRSEGK 834 (894)
Q Consensus 764 ~~~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwS~GvlL~elltG~~Pf~~~~~~~~~~~~~~~---------~~~~~~~~ 834 (894)
.........||+.|+|||++.+..++.++|||||||++|||++|+.||............... ........
T Consensus 154 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (287)
T cd07848 154 SNANYTEYVATRWYRSPELLLGAPYGKAVDMWSVGCILGELSDGQPLFPGESEIDQLFTIQKVLGPLPAEQMKLFYSNPR 233 (287)
T ss_pred ccccccccccccccCCcHHHcCCCCCCchhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCHHHHHhhhccch
Confidence 322333457899999999999888999999999999999999999999754322111110000 00000000
Q ss_pred CCccccccccC------CCChHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 002673 835 QDQVFDPILRG------KGFDEEMLQVLDVACMCVSQNPFKRPTVKEVVE 878 (894)
Q Consensus 835 ~~~~~d~~l~~------~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~ 878 (894)
......+.... .........+.+++.+|++.||++|||++++++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~~P~~R~s~~~~l~ 283 (287)
T cd07848 234 FHGLRFPAVNHPQSLERRYLGILSGVLLDLMKNLLKLNPTDRYLTEQCLN 283 (287)
T ss_pred hcccccCcccCcccHHHhhhcccCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence 00000000000 000112346889999999999999999999885
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes |
| >cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-36 Score=321.31 Aligned_cols=256 Identities=23% Similarity=0.394 Sum_probs=206.6
Q ss_pred ccCCCccceEeecCcEEEEEEEEcCCCeEEEEEEcCcchhhHHHHHHHHHHHHhcCCCceeeecceeeecceEEEEEEec
Q 002673 606 TDNFSQANIIGCGGFGLVYKATLANGTTLAIKKLSGDLGLMEREFKAEVEALSTAQHKNLVSLQGYCVHQGFRLLIYSYM 685 (894)
Q Consensus 606 ~~~f~~~~~LG~G~fg~Vy~a~~~~g~~vAvK~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~lV~E~~ 685 (894)
.++|++.++||+|+||.||+|...++..||+|.+.... ...+.+.+|+.+++.++|+||+++++++...+..+++|||+
T Consensus 5 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~v~iK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 83 (261)
T cd05072 5 RESIKLVKKLGAGQFGEVWMGYYNNSTKVAVKTLKPGT-MSVQAFLEEANLMKTLQHDKLVRLYAVVTKEEPIYIITEYM 83 (261)
T ss_pred hHHeEEeeecCCcCCceEEEEEecCCceEEEEEccCCc-hhHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCcEEEEecC
Confidence 35788899999999999999998888899999987542 23567899999999999999999999999999999999999
Q ss_pred cCCCHHHHHhhhcCCCCCcCHHHHHHHHHHHHHHHHHHHhccCCCeeecCCCCCCeEECCCCcEEEEEcccccccCCCCC
Q 002673 686 ENGSLDYWLHEKADGASQLDWLTRLKIARGTSCGLAYMHQICEPHIVHRDIKSSNILLDDQFEAHLADFGLSRLILPYQT 765 (894)
Q Consensus 686 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDLkp~NILld~~~~vkl~DFGla~~~~~~~~ 765 (894)
++|+|.++++... ...+++..++.++.|++.||+|||+ .+++||||||+||+++.++.+||+|||++........
T Consensus 84 ~~~~L~~~l~~~~--~~~~~~~~~~~~~~~l~~~l~~LH~---~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~ 158 (261)
T cd05072 84 AKGSLLDFLKSDE--GGKVLLPKLIDFSAQIAEGMAYIER---KNYIHRDLRAANVLVSESLMCKIADFGLARVIEDNEY 158 (261)
T ss_pred CCCcHHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHH---CCeeccccchhhEEecCCCcEEECCCccceecCCCce
Confidence 9999999997643 3467888999999999999999997 5999999999999999999999999999987643222
Q ss_pred cccccccccCCccCcccccCcCCCccccHHHHHHHHHHHHc-CCCCCCCCCcchhhhHHHHHHHHhhcCCCCcccccccc
Q 002673 766 HVTTELVGTLGYIPPEYGQAWVATLRGDMYSFGVVMLELLT-GKRPVDVLKPKMSRELVGWVLKMRSEGKQDQVFDPILR 844 (894)
Q Consensus 766 ~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwS~GvlL~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~ 844 (894)
.......++..|+|||+..+..++.++|||||||++|+|++ |+.||...... ....... ..... +..
T Consensus 159 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~---~~~~~~~---~~~~~-----~~~- 226 (261)
T cd05072 159 TAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLYEIVTYGKIPYPGMSNS---DVMSALQ---RGYRM-----PRM- 226 (261)
T ss_pred eccCCCccceecCCHHHhccCCCChhhhhhhhHHHHHHHHccCCCCCCCCCHH---HHHHHHH---cCCCC-----CCC-
Confidence 22223345678999999988889999999999999999998 99999754322 1111111 11110 000
Q ss_pred CCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhc
Q 002673 845 GKGFDEEMLQVLDVACMCVSQNPFKRPTVKEVVEWLNNV 883 (894)
Q Consensus 845 ~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~i 883 (894)
.. ....+.+++.+|+..+|++||++++++++|+++
T Consensus 227 -~~---~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~ 261 (261)
T cd05072 227 -EN---CPDELYDIMKTCWKEKAEERPTFDYLQSVLDDF 261 (261)
T ss_pred -CC---CCHHHHHHHHHHccCCcccCcCHHHHHHHHhcC
Confidence 11 123567899999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa |
| >KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-36 Score=336.88 Aligned_cols=253 Identities=25% Similarity=0.352 Sum_probs=210.0
Q ss_pred cCCCccceEeecCcEEEEEEE-EcCCCeEEEEEEcCcch---hhHHHHHHHHHHHHhcCCCceeeecceeeecceEEEEE
Q 002673 607 DNFSQANIIGCGGFGLVYKAT-LANGTTLAIKKLSGDLG---LMEREFKAEVEALSTAQHKNLVSLQGYCVHQGFRLLIY 682 (894)
Q Consensus 607 ~~f~~~~~LG~G~fg~Vy~a~-~~~g~~vAvK~~~~~~~---~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~lV~ 682 (894)
.-|+.++.||.|+.|.|-.|+ ..+|+.+|||++.+... .....+.+||-+|+.+.|||++++++++.+..+.|+|.
T Consensus 12 GpwkLgkTLG~Gstg~vrlakh~~TGqlaaiKii~k~~~~s~s~~~~IerEIviMkLi~HpnVl~LydVwe~~~~lylvl 91 (786)
T KOG0588|consen 12 GPWKLGKTLGKGSTGCVRLAKHAETGQLAAIKIIPKRSELSSSQPAGIEREIVIMKLIEHPNVLRLYDVWENKQHLYLVL 91 (786)
T ss_pred cceeccccccCCCCceehhhhcccccceeEEEeeccccccccccccchhhhhHHHHHhcCCCeeeeeeeeccCceEEEEE
Confidence 457788999999999999998 57899999999987632 22356889999999999999999999999999999999
Q ss_pred EeccCCCHHHHHhhhcCCCCCcCHHHHHHHHHHHHHHHHHHHhccCCCeeecCCCCCCeEECCCCcEEEEEcccccccCC
Q 002673 683 SYMENGSLDYWLHEKADGASQLDWLTRLKIARGTSCGLAYMHQICEPHIVHRDIKSSNILLDDQFEAHLADFGLSRLILP 762 (894)
Q Consensus 683 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDLkp~NILld~~~~vkl~DFGla~~~~~ 762 (894)
||+++|-|.+++-.+. .++..++.++++||+.|+.|+|.. +|+|||+||+|+|||..+++||+|||+|..-.+
T Consensus 92 Eyv~gGELFdylv~kG----~l~e~eaa~ff~QIi~gv~yCH~~---~icHRDLKpENlLLd~~~nIKIADFGMAsLe~~ 164 (786)
T KOG0588|consen 92 EYVPGGELFDYLVRKG----PLPEREAAHFFRQILDGVSYCHAF---NICHRDLKPENLLLDVKNNIKIADFGMASLEVP 164 (786)
T ss_pred EecCCchhHHHHHhhC----CCCCHHHHHHHHHHHHHHHHHhhh---cceeccCCchhhhhhcccCEeeeccceeecccC
Confidence 9999999999998763 588899999999999999999986 999999999999999999999999999986533
Q ss_pred CCCcccccccccCCccCcccccCcCC-CccccHHHHHHHHHHHHcCCCCCCCCCcchhhhHHHHHHHHhhcCCCCccccc
Q 002673 763 YQTHVTTELVGTLGYIPPEYGQAWVA-TLRGDMYSFGVVMLELLTGKRPVDVLKPKMSRELVGWVLKMRSEGKQDQVFDP 841 (894)
Q Consensus 763 ~~~~~~~~~~gt~~Y~APE~~~~~~~-s~ksDVwS~GvlL~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 841 (894)
...-.+.||++.|.|||+++|..| ..++||||+|||||.|+||+.||++ +..+.+...+ +.+..+ +.
T Consensus 165 --gklLeTSCGSPHYA~PEIV~G~pYdG~~sDVWSCGVILfALLtG~LPFdD---dNir~LLlKV----~~G~f~-MP-- 232 (786)
T KOG0588|consen 165 --GKLLETSCGSPHYAAPEIVSGRPYDGRPSDVWSCGVILFALLTGKLPFDD---DNIRVLLLKV----QRGVFE-MP-- 232 (786)
T ss_pred --CccccccCCCcccCCchhhcCCCCCCCccccchhHHHHHHHHhCCCCCCC---ccHHHHHHHH----HcCccc-CC--
Confidence 233456789999999999999987 5789999999999999999999983 2333333322 222211 10
Q ss_pred cccCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHH--HHHhccc
Q 002673 842 ILRGKGFDEEMLQVLDVACMCVSQNPFKRPTVKEVVE--WLNNVGA 885 (894)
Q Consensus 842 ~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~--~L~~i~~ 885 (894)
.....+..+|+.+|+..||++|.|++||++ ||.....
T Consensus 233 -------s~Is~eaQdLLr~ml~VDp~~RiT~~eI~kHP~l~g~~~ 271 (786)
T KOG0588|consen 233 -------SNISSEAQDLLRRMLDVDPSTRITTEEILKHPFLSGYTS 271 (786)
T ss_pred -------CcCCHHHHHHHHHHhccCccccccHHHHhhCchhhcCCC
Confidence 111234568888999999999999999999 7776543
|
|
| >KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-37 Score=331.61 Aligned_cols=248 Identities=28% Similarity=0.403 Sum_probs=206.9
Q ss_pred cCCCccceEeecCcEEEEEEE-EcCCCeEEEEEEcCcchh-hHHHHHHHHHHHHhcCCCceeeecceeeecceEEEEEEe
Q 002673 607 DNFSQANIIGCGGFGLVYKAT-LANGTTLAIKKLSGDLGL-MEREFKAEVEALSTAQHKNLVSLQGYCVHQGFRLLIYSY 684 (894)
Q Consensus 607 ~~f~~~~~LG~G~fg~Vy~a~-~~~g~~vAvK~~~~~~~~-~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~lV~E~ 684 (894)
..|+..+.||+|.||.||+|. ..+++.||+|++.-+... ...++++|+.++..++|+||.+.+|.+..+...+++|||
T Consensus 13 ~~~~~~~~IgrGsfG~Vyk~~d~~t~k~vAiKii~Le~~~deIediqqei~~Ls~~~~~~it~yygsyl~g~~LwiiMey 92 (467)
T KOG0201|consen 13 LLYTKLELIGRGSFGEVYKAIDNKTKKVVAIKIIDLEEAEDEIEDIQQEISVLSQCDSPNITEYYGSYLKGTKLWIIMEY 92 (467)
T ss_pred cccccchhccccccceeeeeeeccccceEEEEEechhhcchhhHHHHHHHHHHHhcCcchHHhhhhheeecccHHHHHHH
Confidence 456777899999999999998 567899999999876543 346789999999999999999999999999999999999
Q ss_pred ccCCCHHHHHhhhcCCCCCcCHHHHHHHHHHHHHHHHHHHhccCCCeeecCCCCCCeEECCCCcEEEEEcccccccCCCC
Q 002673 685 MENGSLDYWLHEKADGASQLDWLTRLKIARGTSCGLAYMHQICEPHIVHRDIKSSNILLDDQFEAHLADFGLSRLILPYQ 764 (894)
Q Consensus 685 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDLkp~NILld~~~~vkl~DFGla~~~~~~~ 764 (894)
|.||++.+.++... .++......|.+++..|+.|||+ ++.+|||||+.|||+..+|.|||+|||.+..+....
T Consensus 93 ~~gGsv~~lL~~~~----~~~E~~i~~ilre~l~~l~ylH~---~~kiHrDIKaanil~s~~g~vkl~DfgVa~ql~~~~ 165 (467)
T KOG0201|consen 93 CGGGSVLDLLKSGN----ILDEFEIAVILREVLKGLDYLHS---EKKIHRDIKAANILLSESGDVKLADFGVAGQLTNTV 165 (467)
T ss_pred hcCcchhhhhccCC----CCccceeeeehHHHHHHhhhhhh---cceecccccccceeEeccCcEEEEecceeeeeechh
Confidence 99999999998643 34666777889999999999997 599999999999999999999999999998875443
Q ss_pred CcccccccccCCccCcccccCcCCCccccHHHHHHHHHHHHcCCCCCCCCCcchhhhHHHHHHHHhhcCCCCcccccccc
Q 002673 765 THVTTELVGTLGYIPPEYGQAWVATLRGDMYSFGVVMLELLTGKRPVDVLKPKMSRELVGWVLKMRSEGKQDQVFDPILR 844 (894)
Q Consensus 765 ~~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwS~GvlL~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~ 844 (894)
.. ...++||+.|||||++....|+.|+||||||++.+||.+|.+|+....+- .-.-.+..-..|.+.
T Consensus 166 ~r-r~tfvGTPfwMAPEVI~~~~Y~~KADIWSLGITaiEla~GePP~s~~hPm------------rvlflIpk~~PP~L~ 232 (467)
T KOG0201|consen 166 KR-RKTFVGTPFWMAPEVIKQSGYDTKADIWSLGITAIELAKGEPPHSKLHPM------------RVLFLIPKSAPPRLD 232 (467)
T ss_pred hc-cccccccccccchhhhccccccchhhhhhhhHHHHHHhcCCCCCcccCcc------------eEEEeccCCCCCccc
Confidence 33 36789999999999999889999999999999999999999999866541 011111222334444
Q ss_pred CCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 002673 845 GKGFDEEMLQVLDVACMCVSQNPFKRPTVKEVVE 878 (894)
Q Consensus 845 ~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~ 878 (894)
+ .+ ...+.+|+..|++.||+.||++.++++
T Consensus 233 ~-~~---S~~~kEFV~~CL~k~P~~RpsA~~LLK 262 (467)
T KOG0201|consen 233 G-DF---SPPFKEFVEACLDKNPEFRPSAKELLK 262 (467)
T ss_pred c-cc---CHHHHHHHHHHhhcCcccCcCHHHHhh
Confidence 3 22 234668888999999999999999997
|
|
| >cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-36 Score=320.46 Aligned_cols=251 Identities=25% Similarity=0.436 Sum_probs=202.6
Q ss_pred cCCCccceEeecCcEEEEEEEEcCCCeEEEEEEcCcchhhHHHHHHHHHHHHhcCCCceeeecceeeecceEEEEEEecc
Q 002673 607 DNFSQANIIGCGGFGLVYKATLANGTTLAIKKLSGDLGLMEREFKAEVEALSTAQHKNLVSLQGYCVHQGFRLLIYSYME 686 (894)
Q Consensus 607 ~~f~~~~~LG~G~fg~Vy~a~~~~g~~vAvK~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~lV~E~~~ 686 (894)
++|+..+.||+|+||.||++.+.++..+|+|.+... .....++.+|+.++++++||||+++++++..+...++||||++
T Consensus 4 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~a~K~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e~~~ 82 (256)
T cd05114 4 SELTFMKELGSGQFGVVHLGKWRAQIKVAIKAINEG-AMSEEDFIEEAKVMMKLSHPKLVQLYGVCTQQKPLYIVTEFME 82 (256)
T ss_pred HHcEEeeEecCCcCceEEEEEeccCceEEEEecccC-CccHHHHHHHHHHHHHCCCCCceeEEEEEccCCCEEEEEEcCC
Confidence 457788999999999999999888889999988743 2334678899999999999999999999999999999999999
Q ss_pred CCCHHHHHhhhcCCCCCcCHHHHHHHHHHHHHHHHHHHhccCCCeeecCCCCCCeEECCCCcEEEEEcccccccCCCCCc
Q 002673 687 NGSLDYWLHEKADGASQLDWLTRLKIARGTSCGLAYMHQICEPHIVHRDIKSSNILLDDQFEAHLADFGLSRLILPYQTH 766 (894)
Q Consensus 687 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDLkp~NILld~~~~vkl~DFGla~~~~~~~~~ 766 (894)
+|+|.++++... ..+++..+..++.|++.||.|||+ ++++||||||+||+++.++.+||+|||+++........
T Consensus 83 ~~~L~~~~~~~~---~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dl~p~ni~i~~~~~~kl~d~g~~~~~~~~~~~ 156 (256)
T cd05114 83 NGCLLNYLRQRQ---GKLSKDMLLSMCQDVCEGMEYLER---NSFIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDDEYT 156 (256)
T ss_pred CCcHHHHHHhCc---cCCCHHHHHHHHHHHHHHHHHHHH---CCccccccCcceEEEcCCCeEEECCCCCccccCCCcee
Confidence 999999987542 358899999999999999999997 59999999999999999999999999999865332222
Q ss_pred ccccccccCCccCcccccCcCCCccccHHHHHHHHHHHHc-CCCCCCCCCcchhhhHHHHHHHHhhcCCCCccccccccC
Q 002673 767 VTTELVGTLGYIPPEYGQAWVATLRGDMYSFGVVMLELLT-GKRPVDVLKPKMSRELVGWVLKMRSEGKQDQVFDPILRG 845 (894)
Q Consensus 767 ~~~~~~gt~~Y~APE~~~~~~~s~ksDVwS~GvlL~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~ 845 (894)
......++..|+|||+..+..++.++||||||+++|||++ |+.||..... .+..... ..... ...+.
T Consensus 157 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~s~G~~l~el~~~g~~p~~~~~~---~~~~~~i---~~~~~---~~~~~--- 224 (256)
T cd05114 157 SSSGAKFPVKWSPPEVFNFSKYSSKSDVWSFGVLMWEVFTEGKMPFEKKSN---YEVVEMI---SRGFR---LYRPK--- 224 (256)
T ss_pred ccCCCCCchhhCChhhcccCccchhhhhHHHHHHHHHHHcCCCCCCCCCCH---HHHHHHH---HCCCC---CCCCC---
Confidence 2222345668999999998889999999999999999999 9999975432 1122211 11111 11111
Q ss_pred CCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 002673 846 KGFDEEMLQVLDVACMCVSQNPFKRPTVKEVVEWL 880 (894)
Q Consensus 846 ~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L 880 (894)
. ....+.+++.+||+.+|++||++.++++.|
T Consensus 225 -~---~~~~~~~li~~c~~~~p~~Rps~~~l~~~l 255 (256)
T cd05114 225 -L---ASMTVYEVMYSCWHEKPEGRPTFAELLRAI 255 (256)
T ss_pred -C---CCHHHHHHHHHHccCCcccCcCHHHHHHhh
Confidence 1 123578999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h |
| >cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-36 Score=328.56 Aligned_cols=249 Identities=26% Similarity=0.363 Sum_probs=201.8
Q ss_pred cCCCccceEeecCcEEEEEEEE-cCCCeEEEEEEcCcch---hhHHHHHHHHHHHHhcCCCceeeecceeeecceEEEEE
Q 002673 607 DNFSQANIIGCGGFGLVYKATL-ANGTTLAIKKLSGDLG---LMEREFKAEVEALSTAQHKNLVSLQGYCVHQGFRLLIY 682 (894)
Q Consensus 607 ~~f~~~~~LG~G~fg~Vy~a~~-~~g~~vAvK~~~~~~~---~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~lV~ 682 (894)
++|++.+.||+|+||.||+|.. .+++.||+|++..... .....+.+|+.++++++||||+++++++.++...++||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 80 (291)
T cd05612 1 DDLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLFWTEHDQRFLYMLM 80 (291)
T ss_pred CCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhhHHHHHHHHHHHHHHhCCCCcHhhhHhhhccCCeEEEEE
Confidence 3688899999999999999985 4789999999865321 23356889999999999999999999999999999999
Q ss_pred EeccCCCHHHHHhhhcCCCCCcCHHHHHHHHHHHHHHHHHHHhccCCCeeecCCCCCCeEECCCCcEEEEEcccccccCC
Q 002673 683 SYMENGSLDYWLHEKADGASQLDWLTRLKIARGTSCGLAYMHQICEPHIVHRDIKSSNILLDDQFEAHLADFGLSRLILP 762 (894)
Q Consensus 683 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDLkp~NILld~~~~vkl~DFGla~~~~~ 762 (894)
||+++|+|.+++... ..+++..+..++.|++.||.|||+ ++|+||||||+|||++.++.+||+|||+++....
T Consensus 81 e~~~~~~L~~~~~~~----~~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dlkp~NIli~~~~~~kl~Dfg~~~~~~~ 153 (291)
T cd05612 81 EYVPGGELFSYLRNS----GRFSNSTGLFYASEIVCALEYLHS---KEIVYRDLKPENILLDKEGHIKLTDFGFAKKLRD 153 (291)
T ss_pred eCCCCCCHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHH---CCeeecCCCHHHeEECCCCCEEEEecCcchhccC
Confidence 999999999999754 358888999999999999999997 5999999999999999999999999999986532
Q ss_pred CCCcccccccccCCccCcccccCcCCCccccHHHHHHHHHHHHcCCCCCCCCCcchhhhHHHHHHHHhhcCCCCcccccc
Q 002673 763 YQTHVTTELVGTLGYIPPEYGQAWVATLRGDMYSFGVVMLELLTGKRPVDVLKPKMSRELVGWVLKMRSEGKQDQVFDPI 842 (894)
Q Consensus 763 ~~~~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwS~GvlL~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 842 (894)
......||+.|+|||++.+..++.++|||||||++|+|++|+.||....... ... .... +... +.
T Consensus 154 ----~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~---~~~---~i~~-~~~~--~~-- 218 (291)
T cd05612 154 ----RTWTLCGTPEYLAPEVIQSKGHNKAVDWWALGILIYEMLVGYPPFFDDNPFG---IYE---KILA-GKLE--FP-- 218 (291)
T ss_pred ----CcccccCChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH---HHH---HHHh-CCcC--CC--
Confidence 1223568999999999999899999999999999999999999997543211 111 1111 1110 00
Q ss_pred ccCCCChHHHHHHHHHHHHhcccCCCCCCC-----HHHHHH--HHHhc
Q 002673 843 LRGKGFDEEMLQVLDVACMCVSQNPFKRPT-----VKEVVE--WLNNV 883 (894)
Q Consensus 843 l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs-----~~evl~--~L~~i 883 (894)
. .....+.+++.+|++.||.+||+ ++++++ |+..+
T Consensus 219 ---~---~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h~~~~~~ 260 (291)
T cd05612 219 ---R---HLDLYAKDLIKKLLVVDRTRRLGNMKNGADDVKNHRWFKSV 260 (291)
T ss_pred ---c---cCCHHHHHHHHHHcCCCHHHccCCccCCHHHHhcCccccCC
Confidence 0 11235678999999999999995 899887 66543
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt |
| >KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=319.99 Aligned_cols=245 Identities=24% Similarity=0.371 Sum_probs=206.1
Q ss_pred cCCCccceEeecCcEEEEEEE-EcCCCeEEEEEEcCcchhhH---HHHHHHHHHHHhcCCCceeeecceeeecceEEEEE
Q 002673 607 DNFSQANIIGCGGFGLVYKAT-LANGTTLAIKKLSGDLGLME---REFKAEVEALSTAQHKNLVSLQGYCVHQGFRLLIY 682 (894)
Q Consensus 607 ~~f~~~~~LG~G~fg~Vy~a~-~~~g~~vAvK~~~~~~~~~~---~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~lV~ 682 (894)
.+|++.+.||+|.||.|-+|. ...|+.||||.++++.-.++ -.+++||++|+.++||||+.++.+|.+.+...+||
T Consensus 53 HRyE~~etLGkGTYGKVk~A~e~~sgR~VAiKsIrKdkIkdeqDlvhIRREIeIMSsLNHPhII~IyEVFENkdKIvivM 132 (668)
T KOG0611|consen 53 HRYEITETLGKGTYGKVKLAYEHKSGREVAIKSIRKDKIKDEQDLVHIRREIEIMSSLNHPHIIQIYEVFENKDKIVIVM 132 (668)
T ss_pred hHHHHHHHhcCCcccceeehhhccCCcEeehhhhhhhhcccHHHHHHHHHHHHHHhhcCCCceeehhhhhcCCceEEEEE
Confidence 467777899999999999998 57899999999988654443 35789999999999999999999999999999999
Q ss_pred EeccCCCHHHHHhhhcCCCCCcCHHHHHHHHHHHHHHHHHHHhccCCCeeecCCCCCCeEECCCCcEEEEEcccccccCC
Q 002673 683 SYMENGSLDYWLHEKADGASQLDWLTRLKIARGTSCGLAYMHQICEPHIVHRDIKSSNILLDDQFEAHLADFGLSRLILP 762 (894)
Q Consensus 683 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDLkp~NILld~~~~vkl~DFGla~~~~~ 762 (894)
||..+|.|.+|+.+. ..++...+.++++||..|+.|+|. ++++|||||-+|||||+++++||+|||++..+..
T Consensus 133 EYaS~GeLYDYiSer----~~LsErEaRhfFRQIvSAVhYCHk---nrVvHRDLKLENILLD~N~NiKIADFGLSNly~~ 205 (668)
T KOG0611|consen 133 EYASGGELYDYISER----GSLSEREARHFFRQIVSAVHYCHK---NRVVHRDLKLENILLDQNNNIKIADFGLSNLYAD 205 (668)
T ss_pred EecCCccHHHHHHHh----ccccHHHHHHHHHHHHHHHHHHhh---ccceecccchhheeecCCCCeeeeccchhhhhcc
Confidence 999999999999875 469999999999999999999997 6999999999999999999999999999988743
Q ss_pred CCCcccccccccCCccCcccccCcCC-CccccHHHHHHHHHHHHcCCCCCCCCCcchhhhHHHHHHHHhhcCCCCccccc
Q 002673 763 YQTHVTTELVGTLGYIPPEYGQAWVA-TLRGDMYSFGVVMLELLTGKRPVDVLKPKMSRELVGWVLKMRSEGKQDQVFDP 841 (894)
Q Consensus 763 ~~~~~~~~~~gt~~Y~APE~~~~~~~-s~ksDVwS~GvlL~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 841 (894)
......++|++-|.+||++.|..| ...+|-||+||+||-|+.|..||++.+.. ..++++......+ |
T Consensus 206 --~kfLqTFCGSPLYASPEIvNG~PY~GPEVDsWsLGvLLYtLVyGtMPFDG~Dhk------~lvrQIs~GaYrE----P 273 (668)
T KOG0611|consen 206 --KKFLQTFCGSPLYASPEIVNGTPYKGPEVDSWSLGVLLYTLVYGTMPFDGRDHK------RLVRQISRGAYRE----P 273 (668)
T ss_pred --ccHHHHhcCCcccCCccccCCCCCCCCccchhhHHHHHHHHhhcccccCCchHH------HHHHHhhcccccC----C
Confidence 233566899999999999999987 56799999999999999999999965432 2233332222211 1
Q ss_pred cccCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 002673 842 ILRGKGFDEEMLQVLDVACMCVSQNPFKRPTVKEVVE 878 (894)
Q Consensus 842 ~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~ 878 (894)
+......-+|.+|+..||++|.|+.+|..
T Consensus 274 --------~~PSdA~gLIRwmLmVNP~RRATieDiAs 302 (668)
T KOG0611|consen 274 --------ETPSDASGLIRWMLMVNPERRATIEDIAS 302 (668)
T ss_pred --------CCCchHHHHHHHHHhcCcccchhHHHHhh
Confidence 11123346888999999999999999987
|
|
| >cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-36 Score=337.52 Aligned_cols=259 Identities=29% Similarity=0.447 Sum_probs=202.7
Q ss_pred cCCCccceEeecCcEEEEEEEE------cCCCeEEEEEEcCcch-hhHHHHHHHHHHHHhc-CCCceeeecceeeecceE
Q 002673 607 DNFSQANIIGCGGFGLVYKATL------ANGTTLAIKKLSGDLG-LMEREFKAEVEALSTA-QHKNLVSLQGYCVHQGFR 678 (894)
Q Consensus 607 ~~f~~~~~LG~G~fg~Vy~a~~------~~g~~vAvK~~~~~~~-~~~~~~~~Ei~~l~~l-~HpnIv~l~g~~~~~~~~ 678 (894)
++|++.+.||+|+||.||+|.. .++..||||++..... .....+.+|+.+++.+ +|+||++++++|...+..
T Consensus 38 ~~~~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~~h~nIv~~~~~~~~~~~~ 117 (374)
T cd05106 38 DNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAHTDEREALMSELKILSHLGQHKNIVNLLGACTHGGPV 117 (374)
T ss_pred HHceehheecCCCcccEEEEEEecCCcccccceeEEEeccCCCCHHHHHHHHHHHHHHHhhccCCceeeEeeEecCCCCe
Confidence 5788899999999999999873 2335799999976433 2345688999999999 899999999999999999
Q ss_pred EEEEEeccCCCHHHHHhhhcC-----------------------------------------------------------
Q 002673 679 LLIYSYMENGSLDYWLHEKAD----------------------------------------------------------- 699 (894)
Q Consensus 679 ~lV~E~~~~gsL~~~l~~~~~----------------------------------------------------------- 699 (894)
++||||+++|+|.++++....
T Consensus 118 ~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 197 (374)
T cd05106 118 LVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVSSSSSQSSDS 197 (374)
T ss_pred EEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCccccccccccc
Confidence 999999999999999864321
Q ss_pred -------CCCCcCHHHHHHHHHHHHHHHHHHHhccCCCeeecCCCCCCeEECCCCcEEEEEcccccccCCCCCc-ccccc
Q 002673 700 -------GASQLDWLTRLKIARGTSCGLAYMHQICEPHIVHRDIKSSNILLDDQFEAHLADFGLSRLILPYQTH-VTTEL 771 (894)
Q Consensus 700 -------~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDLkp~NILld~~~~vkl~DFGla~~~~~~~~~-~~~~~ 771 (894)
....+++..+++++.||+.||.|||+ ++|+||||||+|||+++++.+||+|||+++........ .....
T Consensus 198 ~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~---~giiHrDLkp~Nil~~~~~~~kL~DfGla~~~~~~~~~~~~~~~ 274 (374)
T cd05106 198 KDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLAS---KNCIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNYVVKGNA 274 (374)
T ss_pred cchhccCCCCCcCHHHHHHHHHHHHHHHHHHHH---CCEEeccCchheEEEeCCCeEEEeeceeeeeccCCcceeeccCC
Confidence 11247888999999999999999997 69999999999999999999999999999865332211 11223
Q ss_pred cccCCccCcccccCcCCCccccHHHHHHHHHHHHc-CCCCCCCCCcchhhhHHHHHHHHhhcCCCCccccccccCCCChH
Q 002673 772 VGTLGYIPPEYGQAWVATLRGDMYSFGVVMLELLT-GKRPVDVLKPKMSRELVGWVLKMRSEGKQDQVFDPILRGKGFDE 850 (894)
Q Consensus 772 ~gt~~Y~APE~~~~~~~s~ksDVwS~GvlL~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~ 850 (894)
.++..|+|||++.+..++.++|||||||++|||++ |+.||....... .... ....+..... + ..
T Consensus 275 ~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt~G~~Pf~~~~~~~--~~~~----~~~~~~~~~~--~----~~--- 339 (374)
T cd05106 275 RLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSPYPGILVNS--KFYK----MVKRGYQMSR--P----DF--- 339 (374)
T ss_pred CCccceeCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCccccccH--HHHH----HHHcccCccC--C----CC---
Confidence 35668999999998899999999999999999997 999997543221 1111 1111100000 0 01
Q ss_pred HHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhc
Q 002673 851 EMLQVLDVACMCVSQNPFKRPTVKEVVEWLNNV 883 (894)
Q Consensus 851 ~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~i 883 (894)
....+.+++.+||+.||++|||+.++++.|+++
T Consensus 340 ~~~~l~~li~~cl~~dp~~RPs~~~l~~~l~~~ 372 (374)
T cd05106 340 APPEIYSIMKMCWNLEPTERPTFSQISQLIQRQ 372 (374)
T ss_pred CCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence 123577899999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti |
| >cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-36 Score=333.80 Aligned_cols=256 Identities=21% Similarity=0.288 Sum_probs=204.1
Q ss_pred cCCCccceEeecCcEEEEEEEEc-CCCeEEEEEEcCcch---hhHHHHHHHHHHHHhcCCCceeeecceeeecceEEEEE
Q 002673 607 DNFSQANIIGCGGFGLVYKATLA-NGTTLAIKKLSGDLG---LMEREFKAEVEALSTAQHKNLVSLQGYCVHQGFRLLIY 682 (894)
Q Consensus 607 ~~f~~~~~LG~G~fg~Vy~a~~~-~g~~vAvK~~~~~~~---~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~lV~ 682 (894)
++|++.+.||+|+||.||+|... +++.||+|++..... .....+..|+.++..++||||+++++++...+..++||
T Consensus 1 ~~y~~~~~ig~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~ 80 (333)
T cd05600 1 KDFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLYAFQDDEYLYLAM 80 (333)
T ss_pred CCcEEEEEEeecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhCCCCCCccEEEEEEcCCEEEEEE
Confidence 36888999999999999999864 689999999975432 23356788999999999999999999999999999999
Q ss_pred EeccCCCHHHHHhhhcCCCCCcCHHHHHHHHHHHHHHHHHHHhccCCCeeecCCCCCCeEECCCCcEEEEEcccccccCC
Q 002673 683 SYMENGSLDYWLHEKADGASQLDWLTRLKIARGTSCGLAYMHQICEPHIVHRDIKSSNILLDDQFEAHLADFGLSRLILP 762 (894)
Q Consensus 683 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDLkp~NILld~~~~vkl~DFGla~~~~~ 762 (894)
||+++|+|.+++... ..+++..+..++.|++.||.|||+ ++|+||||||+|||++.++.+||+|||++.....
T Consensus 81 e~~~g~~L~~~l~~~----~~l~~~~~~~~~~qi~~~l~~lH~---~~ivH~dlkp~Nil~~~~~~~kL~Dfg~a~~~~~ 153 (333)
T cd05600 81 EYVPGGDFRTLLNNL----GVLSEDHARFYMAEMFEAVDALHE---LGYIHRDLKPENFLIDASGHIKLTDFGLSKGIVT 153 (333)
T ss_pred eCCCCCCHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHH---CCccccCCCHHHEEECCCCCEEEEeCcCCccccc
Confidence 999999999999754 357888999999999999999997 5999999999999999999999999999986532
Q ss_pred CCCcccccccccCCccCcccccCcCCCccccHHHHHHHHHHHHcCCCCCCCCCcchhhhHHHHHHHHhhcCCCCcccccc
Q 002673 763 YQTHVTTELVGTLGYIPPEYGQAWVATLRGDMYSFGVVMLELLTGKRPVDVLKPKMSRELVGWVLKMRSEGKQDQVFDPI 842 (894)
Q Consensus 763 ~~~~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwS~GvlL~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 842 (894)
......||+.|+|||++.+..++.++|||||||++|||++|+.||........ .................++.
T Consensus 154 ----~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~---~~~i~~~~~~~~~~~~~~~~ 226 (333)
T cd05600 154 ----YANSVVGSPDYMAPEVLRGKGYDFTVDYWSLGCMLYEFLCGFPPFSGSTPNET---WENLKYWKETLQRPVYDDPR 226 (333)
T ss_pred ----ccCCcccCccccChhHhcCCCCCCccceecchHHHhhhhhCCCCCCCCCHHHH---HHHHHhccccccCCCCCccc
Confidence 23445789999999999999999999999999999999999999975443221 11111100000000000000
Q ss_pred ccCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHH--HHHh
Q 002673 843 LRGKGFDEEMLQVLDVACMCVSQNPFKRPTVKEVVE--WLNN 882 (894)
Q Consensus 843 l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~--~L~~ 882 (894)
.....++.+++.+|+..+|.+||+++++++ |+..
T Consensus 227 ------~~~s~~~~~li~~~l~~~~~rr~s~~~ll~h~~~~~ 262 (333)
T cd05600 227 ------FNLSDEAWDLITKLINDPSRRFGSLEDIKNHPFFKE 262 (333)
T ss_pred ------cccCHHHHHHHHHHhhChhhhcCCHHHHHhCcccCC
Confidence 112335678899999999999999999997 4543
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. |
| >PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-36 Score=323.40 Aligned_cols=249 Identities=32% Similarity=0.512 Sum_probs=193.1
Q ss_pred ccceEeecCcEEEEEEEEc-----CCCeEEEEEEcCcch-hhHHHHHHHHHHHHhcCCCceeeecceeeecceEEEEEEe
Q 002673 611 QANIIGCGGFGLVYKATLA-----NGTTLAIKKLSGDLG-LMEREFKAEVEALSTAQHKNLVSLQGYCVHQGFRLLIYSY 684 (894)
Q Consensus 611 ~~~~LG~G~fg~Vy~a~~~-----~g~~vAvK~~~~~~~-~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~lV~E~ 684 (894)
..+.||.|.||.||+|.+. .+..|+||.+..... ...+.+.+|++.+++++||||++++|+|...+..++||||
T Consensus 3 ~~~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~g~~~~~~~~~lv~e~ 82 (259)
T PF07714_consen 3 LIKQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKPSSSEEEEEEFLNEIQILRKLRHPNIVKLYGFCIENEPLFLVMEY 82 (259)
T ss_dssp EEEEEEEESSEEEEEEEEESTTTSSEEEEEEEEESTTSSHHHHHHHHHHHHHHHTHSBTTBE-EEEEEESSSSEEEEEE-
T ss_pred EeeEEccCCCcEEEEEEEEcccCCCCEEEEEEEeccccccccceeeeecccccccccccccccccccccccccccccccc
Confidence 3578999999999999976 357899999965433 3467899999999999999999999999988889999999
Q ss_pred ccCCCHHHHHhhhcCCCCCcCHHHHHHHHHHHHHHHHHHHhccCCCeeecCCCCCCeEECCCCcEEEEEcccccccCCCC
Q 002673 685 MENGSLDYWLHEKADGASQLDWLTRLKIARGTSCGLAYMHQICEPHIVHRDIKSSNILLDDQFEAHLADFGLSRLILPYQ 764 (894)
Q Consensus 685 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDLkp~NILld~~~~vkl~DFGla~~~~~~~ 764 (894)
+++|+|.++++.. ....+++..+..|+.||+.||.|||+ ++++|+||+++||++++++.+||+|||++.......
T Consensus 83 ~~~g~L~~~L~~~--~~~~~~~~~~~~i~~~i~~~l~~Lh~---~~iiH~~l~~~nill~~~~~~Kl~~f~~~~~~~~~~ 157 (259)
T PF07714_consen 83 CPGGSLDDYLKSK--NKEPLSEQQRLSIAIQIAEALSYLHS---NNIIHGNLSPSNILLDSNGQVKLSDFGLSRPISEKS 157 (259)
T ss_dssp -TTEBHHHHHHHT--CTTTSBHHHHHHHHHHHHHHHHHHHH---TTEEEST-SGGGEEEETTTEEEEESTTTGEETTTSS
T ss_pred ccccccccccccc--cccccccccccccccccccccccccc---cccccccccccccccccccccccccccccccccccc
Confidence 9999999999976 23568999999999999999999997 589999999999999999999999999998763221
Q ss_pred C-cccccccccCCccCcccccCcCCCccccHHHHHHHHHHHHc-CCCCCCCCCcchhhhHHHHHHHHhhcCCCCcccccc
Q 002673 765 T-HVTTELVGTLGYIPPEYGQAWVATLRGDMYSFGVVMLELLT-GKRPVDVLKPKMSRELVGWVLKMRSEGKQDQVFDPI 842 (894)
Q Consensus 765 ~-~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwS~GvlL~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 842 (894)
. ...........|+|||.+.+..++.++||||||+++|||++ |+.||...... +..... ..+..... .
T Consensus 158 ~~~~~~~~~~~~~~~aPE~~~~~~~~~ksDVysfG~~l~ei~~~~~~p~~~~~~~---~~~~~~----~~~~~~~~-~-- 227 (259)
T PF07714_consen 158 KYKNDSSQQLPLRYLAPEVLKDGEYTKKSDVYSFGMLLYEILTLGKFPFSDYDNE---EIIEKL----KQGQRLPI-P-- 227 (259)
T ss_dssp SEEESTTSESGGGGS-HHHHHHSEESHHHHHHHHHHHHHHHHTTSSGTTTTSCHH---HHHHHH----HTTEETTS-B--
T ss_pred ccccccccccccccccccccccccccccccccccccccccccccccccccccccc---cccccc----ccccccee-c--
Confidence 1 22233456779999999999889999999999999999999 78998765322 222222 11111111 0
Q ss_pred ccCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 002673 843 LRGKGFDEEMLQVLDVACMCVSQNPFKRPTVKEVVEWL 880 (894)
Q Consensus 843 l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L 880 (894)
..+ ...+.+++..||..+|++|||+.++++.|
T Consensus 228 ---~~~---~~~~~~li~~C~~~~p~~RPs~~~i~~~L 259 (259)
T PF07714_consen 228 ---DNC---PKDIYSLIQQCWSHDPEKRPSFQEILQEL 259 (259)
T ss_dssp ---TTS---BHHHHHHHHHHT-SSGGGS--HHHHHHHH
T ss_pred ---cch---hHHHHHHHHHHcCCChhhCcCHHHHHhcC
Confidence 111 23467899999999999999999999876
|
Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A .... |
| >KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-36 Score=345.69 Aligned_cols=261 Identities=23% Similarity=0.296 Sum_probs=212.6
Q ss_pred cCCCccceEeecCcEEEEEEEEcCC-CeEEEEEEcCcchhhHHHHHHHHHHHHhcC-CCceeeecce-eee------cce
Q 002673 607 DNFSQANIIGCGGFGLVYKATLANG-TTLAIKKLSGDLGLMEREFKAEVEALSTAQ-HKNLVSLQGY-CVH------QGF 677 (894)
Q Consensus 607 ~~f~~~~~LG~G~fg~Vy~a~~~~g-~~vAvK~~~~~~~~~~~~~~~Ei~~l~~l~-HpnIv~l~g~-~~~------~~~ 677 (894)
.++++.+.|.+|||+.||.|....+ ..||+|++-.......+.+.+||++|+.|+ |+|||.+++. ... ..+
T Consensus 37 ~~v~V~~vLAEGGFa~VYla~~~~~~~~~AlKrm~~~de~~L~~v~~EI~~MK~L~gh~nIV~yidss~~~~~~~~~~~E 116 (738)
T KOG1989|consen 37 HRVTVEKVLAEGGFAQVYLAQDVKGGKKYALKRMYVNDEEALNAVKREIDIMKLLSGHKNIVSYIDSSAINRSSNNGVWE 116 (738)
T ss_pred EEEEEEEEEccCCcEEEEEEEecCCCceeeeeeeecCCHHHHHHHHHHHHHHHHhcCCCceeeEeccccccccCCCceeE
Confidence 4567789999999999999996665 999999998776677788999999999996 9999999993 221 236
Q ss_pred EEEEEEeccCCCHHHHHhhhcCCCCCcCHHHHHHHHHHHHHHHHHHHhccCCCeeecCCCCCCeEECCCCcEEEEEcccc
Q 002673 678 RLLIYSYMENGSLDYWLHEKADGASQLDWLTRLKIARGTSCGLAYMHQICEPHIVHRDIKSSNILLDDQFEAHLADFGLS 757 (894)
Q Consensus 678 ~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDLkp~NILld~~~~vkl~DFGla 757 (894)
.+|+||||.+|.|-+++..+... .|+..++++|+.|+++|+++||.. .++|||||||-+||||+.+++.||||||.+
T Consensus 117 vllLmEyC~gg~Lvd~mn~Rlq~--~lte~eVLkIf~dv~~AVa~mH~~-~pPiIHRDLKiENvLls~~g~~KLCDFGSa 193 (738)
T KOG1989|consen 117 VLLLMEYCKGGSLVDFMNTRLQT--RLTEDEVLKIFYDVCEAVAAMHYL-KPPIIHRDLKIENVLLSADGNYKLCDFGSA 193 (738)
T ss_pred EEeehhhccCCcHHHHHHHHHhc--cCChHHHHHHHHHHHHHHHHHhcC-CCccchhhhhhhheEEcCCCCEEeCccccc
Confidence 78999999999999999876543 399999999999999999999985 789999999999999999999999999999
Q ss_pred cccCCCCCcc--------cccccccCCccCcccc---cCcCCCccccHHHHHHHHHHHHcCCCCCCCCCcchhhhHHHHH
Q 002673 758 RLILPYQTHV--------TTELVGTLGYIPPEYG---QAWVATLRGDMYSFGVVMLELLTGKRPVDVLKPKMSRELVGWV 826 (894)
Q Consensus 758 ~~~~~~~~~~--------~~~~~gt~~Y~APE~~---~~~~~s~ksDVwS~GvlL~elltG~~Pf~~~~~~~~~~~~~~~ 826 (894)
.......... .-....|+.|+|||++ .+..+++|+|||+|||+||-|+....||+....
T Consensus 194 tt~~~~~~~~~e~~~ve~eI~k~TTp~YRsPEMIDlysg~pI~eKsDIWALGclLYkLCy~t~PFe~sg~---------- 263 (738)
T KOG1989|consen 194 TTKILSPTSAQEVNYVEEEIEKYTTPQYRSPEMIDLYSGLPIGEKSDIWALGCLLYKLCYFTTPFEESGK---------- 263 (738)
T ss_pred ccccCCCccHHHHHHHHHHHHhhCCccccChHHHhhhcCCCCcchhHHHHHHHHHHHHHHhCCCcCcCcc----------
Confidence 8643222110 0123579999999964 567889999999999999999999999984311
Q ss_pred HHHhhcCCCCccccccccCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhccccccC
Q 002673 827 LKMRSEGKQDQVFDPILRGKGFDEEMLQVLDVACMCVSQNPFKRPTVKEVVEWLNNVGANRRN 889 (894)
Q Consensus 827 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~i~~~~~~ 889 (894)
-.+++....-...+.+...+.+||..||+.||++||++-+++..+..+......
T Consensus 264 ---------laIlng~Y~~P~~p~ys~~l~~LI~~mL~~nP~~RPnI~Qv~~~~~~l~~~~~~ 317 (738)
T KOG1989|consen 264 ---------LAILNGNYSFPPFPNYSDRLKDLIRTMLQPNPDERPNIYQVLEEIFELANKPCP 317 (738)
T ss_pred ---------eeEEeccccCCCCccHHHHHHHHHHHHhccCcccCCCHHHHHHHHHHHhcCCCC
Confidence 112222222223356777889999999999999999999999988888765443
|
|
| >cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-35 Score=318.39 Aligned_cols=256 Identities=22% Similarity=0.373 Sum_probs=206.1
Q ss_pred ccCCCccceEeecCcEEEEEEEEcCCCeEEEEEEcCcchhhHHHHHHHHHHHHhcCCCceeeecceeeecceEEEEEEec
Q 002673 606 TDNFSQANIIGCGGFGLVYKATLANGTTLAIKKLSGDLGLMEREFKAEVEALSTAQHKNLVSLQGYCVHQGFRLLIYSYM 685 (894)
Q Consensus 606 ~~~f~~~~~LG~G~fg~Vy~a~~~~g~~vAvK~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~lV~E~~ 685 (894)
.++|++.+.||+|+||.||+|...++..||+|.+.... ....++.+|+.++++++||||+++++++...+..++||||+
T Consensus 5 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~v~iK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 83 (261)
T cd05068 5 RTSIQLLRKLGAGQFGEVWEGLWNNTTPVAVKTLKPGT-MDPKDFLAEAQIMKKLRHPKLIQLYAVCTLEEPIYIVTELM 83 (261)
T ss_pred hhheeeEEEecccCCccEEEEEecCCeEEEEEeeCCCc-ccHHHHHHHHHHHHHCCCCCccceeEEEecCCCeeeeeecc
Confidence 45688889999999999999998778889999987543 33567889999999999999999999999999999999999
Q ss_pred cCCCHHHHHhhhcCCCCCcCHHHHHHHHHHHHHHHHHHHhccCCCeeecCCCCCCeEECCCCcEEEEEcccccccCCCCC
Q 002673 686 ENGSLDYWLHEKADGASQLDWLTRLKIARGTSCGLAYMHQICEPHIVHRDIKSSNILLDDQFEAHLADFGLSRLILPYQT 765 (894)
Q Consensus 686 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDLkp~NILld~~~~vkl~DFGla~~~~~~~~ 765 (894)
++++|.+++.... ...+++..+..++.|++.|+.|||+ ++++||||||+||++++++.+||+|||+++.......
T Consensus 84 ~~~~L~~~~~~~~--~~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~ 158 (261)
T cd05068 84 KYGSLLEYLQGGA--GRALKLPQLIDMAAQVASGMAYLEA---QNYIHRDLAARNVLVGENNICKVADFGLARVIKEDIY 158 (261)
T ss_pred cCCcHHHHHhccC--CCCCCHHHHHHHHHHHHHHHHHHHh---CCeeeccCCcceEEEcCCCCEEECCcceEEEccCCcc
Confidence 9999999997643 3568999999999999999999997 5999999999999999999999999999987642221
Q ss_pred cccccccccCCccCcccccCcCCCccccHHHHHHHHHHHHc-CCCCCCCCCcchhhhHHHHHHHHhhcCCCCcccccccc
Q 002673 766 HVTTELVGTLGYIPPEYGQAWVATLRGDMYSFGVVMLELLT-GKRPVDVLKPKMSRELVGWVLKMRSEGKQDQVFDPILR 844 (894)
Q Consensus 766 ~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwS~GvlL~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~ 844 (894)
........+..|+|||+..+..++.++||||||+++|||++ |+.||....... ... ......... .
T Consensus 159 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~---~~~---~~~~~~~~~--~----- 225 (261)
T cd05068 159 EAREGAKFPIKWTAPEAALYNRFSIKSDVWSFGILLTEIVTYGRMPYPGMTNAE---VLQ---QVDQGYRMP--C----- 225 (261)
T ss_pred cccCCCcCceeccCccccccCCCCchhhHHHHHHHHHHHHhcCCCCCCCCCHHH---HHH---HHHcCCCCC--C-----
Confidence 11111223457999999999899999999999999999999 999997543221 111 111111100 0
Q ss_pred CCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhc
Q 002673 845 GKGFDEEMLQVLDVACMCVSQNPFKRPTVKEVVEWLNNV 883 (894)
Q Consensus 845 ~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~i 883 (894)
.......+.+++.+|++.+|++||+++++++.|+.+
T Consensus 226 ---~~~~~~~~~~li~~~l~~~P~~Rp~~~~l~~~l~~~ 261 (261)
T cd05068 226 ---PPGCPKELYDIMLDCWKEDPDDRPTFETLQWKLEDF 261 (261)
T ss_pred ---CCcCCHHHHHHHHHHhhcCcccCCCHHHHHHHHhcC
Confidence 011224577899999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a |
| >cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-36 Score=333.56 Aligned_cols=268 Identities=21% Similarity=0.306 Sum_probs=199.7
Q ss_pred CCCccceEeecCcEEEEEEEE-cCCCeEEEEEEcCcc--hhhHHHHHHHHHHHHhcCCCceeeecceeeec-----ceEE
Q 002673 608 NFSQANIIGCGGFGLVYKATL-ANGTTLAIKKLSGDL--GLMEREFKAEVEALSTAQHKNLVSLQGYCVHQ-----GFRL 679 (894)
Q Consensus 608 ~f~~~~~LG~G~fg~Vy~a~~-~~g~~vAvK~~~~~~--~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~-----~~~~ 679 (894)
+|++.+.||+|+||.||+|.. .+|..||||++.... ......+.+|+.++++++||||+++++++... ...+
T Consensus 1 ry~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~ 80 (338)
T cd07859 1 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIY 80 (338)
T ss_pred CeEEEEEEeecCCeEEEEEEECCCCCEEEEEEechhhccchhHHHHHHHHHHHHhCCCCCEeeecceEeccCCCCCceEE
Confidence 478889999999999999984 578999999987432 22335688999999999999999999988643 2479
Q ss_pred EEEEeccCCCHHHHHhhhcCCCCCcCHHHHHHHHHHHHHHHHHHHhccCCCeeecCCCCCCeEECCCCcEEEEEcccccc
Q 002673 680 LIYSYMENGSLDYWLHEKADGASQLDWLTRLKIARGTSCGLAYMHQICEPHIVHRDIKSSNILLDDQFEAHLADFGLSRL 759 (894)
Q Consensus 680 lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDLkp~NILld~~~~vkl~DFGla~~ 759 (894)
+||||+. ++|.+++... ..+++..+..++.||+.||.|||+ ++|+||||||+|||++.++.+||+|||+++.
T Consensus 81 lv~e~~~-~~L~~~l~~~----~~~~~~~~~~i~~qi~~aL~~LH~---~~ivH~dlkp~NIll~~~~~~kL~Dfg~~~~ 152 (338)
T cd07859 81 VVFELME-SDLHQVIKAN----DDLTPEHHQFFLYQLLRALKYIHT---ANVFHRDLKPKNILANADCKLKICDFGLARV 152 (338)
T ss_pred EEEecCC-CCHHHHHHhc----ccCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHeEECCCCcEEEccCccccc
Confidence 9999995 6898888653 358899999999999999999997 5999999999999999999999999999986
Q ss_pred cCCCCC--cccccccccCCccCcccccC--cCCCccccHHHHHHHHHHHHcCCCCCCCCCcchhhhHHHHHHHHhhc---
Q 002673 760 ILPYQT--HVTTELVGTLGYIPPEYGQA--WVATLRGDMYSFGVVMLELLTGKRPVDVLKPKMSRELVGWVLKMRSE--- 832 (894)
Q Consensus 760 ~~~~~~--~~~~~~~gt~~Y~APE~~~~--~~~s~ksDVwS~GvlL~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~--- 832 (894)
...... .......||+.|+|||++.+ ..++.++|||||||++|||++|+.||........ ..........
T Consensus 153 ~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DvwSlGvvl~el~tg~~pf~~~~~~~~---~~~~~~~~~~~~~ 229 (338)
T cd07859 153 AFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQ---LDLITDLLGTPSP 229 (338)
T ss_pred cccccCccccccCCCCCCCcCCHHHHhccccccCchhHHHHHHHHHHHHHcCCCCCCCCChHHH---HHHHHHHhCCCCH
Confidence 432211 11234578999999999866 5789999999999999999999999975432111 1110000000
Q ss_pred --------CCCCccccc------cccCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHH--HHHhcccc
Q 002673 833 --------GKQDQVFDP------ILRGKGFDEEMLQVLDVACMCVSQNPFKRPTVKEVVE--WLNNVGAN 886 (894)
Q Consensus 833 --------~~~~~~~d~------~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~--~L~~i~~~ 886 (894)
......+.. .......+.....+.+++.+|++.||++|||++++++ |++.+...
T Consensus 230 ~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~e~l~hp~f~~~~~~ 299 (338)
T cd07859 230 ETISRVRNEKARRYLSSMRKKQPVPFSQKFPNADPLALRLLERLLAFDPKDRPTAEEALADPYFKGLAKV 299 (338)
T ss_pred HHHHHhhhhhHHHHHHhhcccCCCchHHhcCCCChHHHHHHHHHcCcCcccCCCHHHHhcCchhhhcCcc
Confidence 000000000 0000000111235678999999999999999999998 78776553
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos |
| >KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=320.87 Aligned_cols=265 Identities=24% Similarity=0.328 Sum_probs=203.1
Q ss_pred CCCccceEeecCcEEEEEEEE-cCCCeEEEEEEcCcchhhHHHHHHHHHHHHhcCCCceeeecceeeecce-----EEEE
Q 002673 608 NFSQANIIGCGGFGLVYKATL-ANGTTLAIKKLSGDLGLMEREFKAEVEALSTAQHKNLVSLQGYCVHQGF-----RLLI 681 (894)
Q Consensus 608 ~f~~~~~LG~G~fg~Vy~a~~-~~g~~vAvK~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~-----~~lV 681 (894)
.|...+++|.|+||.||+|.. .+++.||||+.-.+.. --.+|+.+|+.+.|||||++.-+|..... ..+|
T Consensus 25 ~~~~~~liG~GsFg~Vyq~~~~e~~~~vAIKKv~~d~r----~knrEl~im~~l~HpNIV~L~~~f~~~~~~d~~~lnlV 100 (364)
T KOG0658|consen 25 SYEAVRLIGSGSFGVVYQAKLRETEEEVAIKKVLQDKR----YKNRELQIMRKLDHPNIVRLLYFFSSSTESDEVYLNLV 100 (364)
T ss_pred EEEeeEEEeecccceEEEEEEcCCCceeEEEEecCCCC----cCcHHHHHHHhcCCcCeeeEEEEEEecCCCchhHHHHH
Confidence 466779999999999999984 5679999999876533 22479999999999999999988875432 2589
Q ss_pred EEeccCCCHHHHHhhhcCCCCCcCHHHHHHHHHHHHHHHHHHHhccCCCeeecCCCCCCeEECCC-CcEEEEEccccccc
Q 002673 682 YSYMENGSLDYWLHEKADGASQLDWLTRLKIARGTSCGLAYMHQICEPHIVHRDIKSSNILLDDQ-FEAHLADFGLSRLI 760 (894)
Q Consensus 682 ~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDLkp~NILld~~-~~vkl~DFGla~~~ 760 (894)
||||+. +|...++.......+++...+.-+..||.+||.|||+ .+|+||||||.|+|+|.+ |.+||||||.|+.+
T Consensus 101 leymP~-tL~~~~r~~~~~~~~mp~~~iKLYt~Qlfrgl~yLh~---~~IcHRDIKPqNlLvD~~tg~LKicDFGSAK~L 176 (364)
T KOG0658|consen 101 LEYMPE-TLYRVIRHYTRANQRMPLLEIKLYTYQLFRGLAYLHS---HGICHRDIKPQNLLVDPDTGVLKICDFGSAKVL 176 (364)
T ss_pred HHhchH-HHHHHHHHHhhcCCCCceeeeHHHHHHHHHHHHHHHh---cCcccCCCChheEEEcCCCCeEEeccCCcceee
Confidence 999975 8999998765556778888889999999999999998 599999999999999976 99999999999988
Q ss_pred CCCCCcccccccccCCccCcccccCc-CCCccccHHHHHHHHHHHHcCCCCCCCCCcchhhhHHHHHHHHhhcCCCC---
Q 002673 761 LPYQTHVTTELVGTLGYIPPEYGQAW-VATLRGDMYSFGVVMLELLTGKRPVDVLKPKMSRELVGWVLKMRSEGKQD--- 836 (894)
Q Consensus 761 ~~~~~~~~~~~~gt~~Y~APE~~~~~-~~s~ksDVwS~GvlL~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~--- 836 (894)
...... .....|..|.|||.+.+. .|+.+.||||.|||+.||+-|++-|.+.+... .+...+.-+ .....+
T Consensus 177 ~~~epn--iSYicSRyYRaPELifga~~Yt~~IDiWSaGCV~aELl~g~plFpG~s~~d--QL~eIik~l-G~Pt~e~I~ 251 (364)
T KOG0658|consen 177 VKGEPN--ISYICSRYYRAPELIFGATEYTTSIDIWSAGCVMAELLKGQPLFPGDSSVD--QLVEIIKVL-GTPTREDIK 251 (364)
T ss_pred ccCCCc--eeEEEeccccCHHHHcCccccCceeEEhhhhHHHHHHhcCCcccCCCCHHH--HHHHHHHHh-CCCCHHHHh
Confidence 654433 445679999999998875 79999999999999999999999998644322 222222111 111111
Q ss_pred -------ccccccccCC-----CChHHHHHHHHHHHHhcccCCCCCCCHHHHHH--HHHhccc
Q 002673 837 -------QVFDPILRGK-----GFDEEMLQVLDVACMCVSQNPFKRPTVKEVVE--WLNNVGA 885 (894)
Q Consensus 837 -------~~~d~~l~~~-----~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~--~L~~i~~ 885 (894)
+.-.+.+... .......+.++++.++++.+|.+|.++.|++. .++.++.
T Consensus 252 ~mn~~y~~~~~p~ik~~~~~~~~~~~~~~d~~dll~~~L~Y~P~~R~~~~~~l~h~fFdelr~ 314 (364)
T KOG0658|consen 252 SMNPNYTEFKFPQIKAHPWHKVFFKRLPPDALDLLSKLLQYSPSKRLSALEALAHPFFDELRD 314 (364)
T ss_pred hcCcccccccCcccccccceeecccCCCHHHHHHHHHHhccChhhcCCHHHHhcchhhHHhhC
Confidence 1111111111 12233457789999999999999999999997 5665543
|
|
| >KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-36 Score=331.46 Aligned_cols=265 Identities=24% Similarity=0.357 Sum_probs=212.7
Q ss_pred ccCCCccceEeecCcEEEEEEEEcCCCeEEEEEEcCcchhh-HHHHHHHHHHHHhcCCCceeeecceeeecceEEEEEEe
Q 002673 606 TDNFSQANIIGCGGFGLVYKATLANGTTLAIKKLSGDLGLM-EREFKAEVEALSTAQHKNLVSLQGYCVHQGFRLLIYSY 684 (894)
Q Consensus 606 ~~~f~~~~~LG~G~fg~Vy~a~~~~g~~vAvK~~~~~~~~~-~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~lV~E~ 684 (894)
.+...+.++||+|-||.|..+....+..||||+++.+.... ..+|.+|+++|.+++|||||+++|+|..++..++|+||
T Consensus 537 Rs~L~~~ekiGeGqFGEVhLCeveg~lkVAVK~Lr~~a~~~~r~~F~kEIkiLsqLkhPNIveLvGVC~~DePicmI~EY 616 (807)
T KOG1094|consen 537 RSRLRFKEKIGEGQFGEVHLCEVEGPLKVAVKILRPDATKNARNDFLKEIKILSRLKHPNIVELLGVCVQDDPLCMITEY 616 (807)
T ss_pred hhheehhhhhcCcccceeEEEEecCceEEEEeecCcccchhHHHHHHHHHHHHhccCCCCeeEEEeeeecCCchHHHHHH
Confidence 34567789999999999999999888999999999876544 47899999999999999999999999999999999999
Q ss_pred ccCCCHHHHHhhhcCCCCCcCHHHHHHHHHHHHHHHHHHHhccCCCeeecCCCCCCeEECCCCcEEEEEcccccccCCCC
Q 002673 685 MENGSLDYWLHEKADGASQLDWLTRLKIARGTSCGLAYMHQICEPHIVHRDIKSSNILLDDQFEAHLADFGLSRLILPYQ 764 (894)
Q Consensus 685 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDLkp~NILld~~~~vkl~DFGla~~~~~~~ 764 (894)
|++|+|..|+...... .+.-....+|+.||+.||+||.+. ++|||||.++|+|+|.++++||+|||+++-+....
T Consensus 617 mEnGDLnqFl~aheap--t~~t~~~vsi~tqiasgmaYLes~---nfVHrd~a~rNcLv~~e~~iKiadfgmsR~lysg~ 691 (807)
T KOG1094|consen 617 MENGDLNQFLSAHELP--TAETAPGVSICTQIASGMAYLESL---NFVHRDLATRNCLVDGEFTIKIADFGMSRNLYSGD 691 (807)
T ss_pred HhcCcHHHHHHhccCc--ccccchhHHHHHHHHHHHHHHHhh---chhhccccccceeecCcccEEecCcccccccccCC
Confidence 9999999999875321 134455678999999999999986 99999999999999999999999999999665444
Q ss_pred Ccc-cccccccCCccCcccccCcCCCccccHHHHHHHHHHHHc--CCCCCCCCCcchhhhHHHHHHHHhhcCCCCccccc
Q 002673 765 THV-TTELVGTLGYIPPEYGQAWVATLRGDMYSFGVVMLELLT--GKRPVDVLKPKMSRELVGWVLKMRSEGKQDQVFDP 841 (894)
Q Consensus 765 ~~~-~~~~~gt~~Y~APE~~~~~~~s~ksDVwS~GvlL~ellt--G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 841 (894)
.+. ....+-...|||+|.+..++++.+||||+||+.+||+++ ...||..+.++.. ++-...+...+......
T Consensus 692 yy~vqgr~vlpiRwmawEsillgkFttaSDvWafgvTlwE~~~~C~e~Py~~lt~e~v---ven~~~~~~~~~~~~~l-- 766 (807)
T KOG1094|consen 692 YYRVQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEVFMLCREQPYSQLTDEQV---VENAGEFFRDQGRQVVL-- 766 (807)
T ss_pred ceeeecceeeeeeehhHHHHHhccccchhhhhhhHHHHHHHHHHHhhCchhhhhHHHH---HHhhhhhcCCCCcceec--
Confidence 332 334556789999999999999999999999999999876 8889986654322 22222222222221111
Q ss_pred cccCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhcc
Q 002673 842 ILRGKGFDEEMLQVLDVACMCVSQNPFKRPTVKEVVEWLNNVG 884 (894)
Q Consensus 842 ~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~i~ 884 (894)
.+... ....+++++.+||+.+-.+||+++++...|++..
T Consensus 767 -~~P~~---cp~~lyelml~Cw~~es~~RPsFe~lh~~lq~~~ 805 (807)
T KOG1094|consen 767 -SRPPA---CPQGLYELMLRCWRRESEQRPSFEQLHLFLQEDA 805 (807)
T ss_pred -cCCCc---CcHHHHHHHHHHhchhhhcCCCHHHHHHHHHHhc
Confidence 11122 2346779999999999999999999999887653
|
|
| >cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-35 Score=328.12 Aligned_cols=266 Identities=24% Similarity=0.395 Sum_probs=204.7
Q ss_pred ccCCCccceEeecCcEEEEEEEEc-CCCeEEEEEEcCcc-hhhHHHHHHHHHHHHhcCCCceeeecceeeecceEEEEEE
Q 002673 606 TDNFSQANIIGCGGFGLVYKATLA-NGTTLAIKKLSGDL-GLMEREFKAEVEALSTAQHKNLVSLQGYCVHQGFRLLIYS 683 (894)
Q Consensus 606 ~~~f~~~~~LG~G~fg~Vy~a~~~-~g~~vAvK~~~~~~-~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~lV~E 683 (894)
.++|+..+.||+|+||.||++... ++..+|+|.+.... ......+.+|+++++.++||||++++++|..++..++|||
T Consensus 4 ~~~y~~~~~lg~g~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 83 (333)
T cd06650 4 DDDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME 83 (333)
T ss_pred hhhhheeccccCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCcccceeEEEEECCEEEEEEe
Confidence 367899999999999999999854 68889999887543 2334678999999999999999999999999999999999
Q ss_pred eccCCCHHHHHhhhcCCCCCcCHHHHHHHHHHHHHHHHHHHhccCCCeeecCCCCCCeEECCCCcEEEEEcccccccCCC
Q 002673 684 YMENGSLDYWLHEKADGASQLDWLTRLKIARGTSCGLAYMHQICEPHIVHRDIKSSNILLDDQFEAHLADFGLSRLILPY 763 (894)
Q Consensus 684 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDLkp~NILld~~~~vkl~DFGla~~~~~~ 763 (894)
|+++|+|.+++... ..+++.....++.|++.||.|||+ ..+++||||||+|||+++++.+||+|||++......
T Consensus 84 ~~~~~~L~~~l~~~----~~~~~~~~~~~~~~l~~~l~~lH~--~~~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~ 157 (333)
T cd06650 84 HMDGGSLDQVLKKA----GRIPEQILGKVSIAVIKGLTYLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS 157 (333)
T ss_pred cCCCCcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHh--cCCEEecCCChhhEEEcCCCCEEEeeCCcchhhhhh
Confidence 99999999999753 347888889999999999999996 247999999999999999999999999998765321
Q ss_pred CCcccccccccCCccCcccccCcCCCccccHHHHHHHHHHHHcCCCCCCCCCcchhhhHHHHHHHHhhcCCCCc------
Q 002673 764 QTHVTTELVGTLGYIPPEYGQAWVATLRGDMYSFGVVMLELLTGKRPVDVLKPKMSRELVGWVLKMRSEGKQDQ------ 837 (894)
Q Consensus 764 ~~~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwS~GvlL~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~------ 837 (894)
......|+..|+|||++.+..++.++|||||||++|+|++|+.||............ .....+....
T Consensus 158 ---~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~----~~~~~~~~~~~~~~~~ 230 (333)
T cd06650 158 ---MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGRYPIPPPDAKELELMF----GCPVEGDPAESETSPR 230 (333)
T ss_pred ---ccccCCCCccccCHHHhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcchhHHHHHh----cCcccCCccccccCcc
Confidence 123356899999999999988999999999999999999999999754321111100 0000000000
Q ss_pred -----------------------cccccccC----CCChHHHHHHHHHHHHhcccCCCCCCCHHHHHH--HHHhcc
Q 002673 838 -----------------------VFDPILRG----KGFDEEMLQVLDVACMCVSQNPFKRPTVKEVVE--WLNNVG 884 (894)
Q Consensus 838 -----------------------~~d~~l~~----~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~--~L~~i~ 884 (894)
+.+..... ........++.+++.+||+.||++|||+.++++ +|+...
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~P~~Rpt~~ell~h~~~~~~~ 306 (333)
T cd06650 231 PRPPGRPLSSYGPDSRPPMAIFELLDYIVNEPPPKLPSGVFGAEFQDFVNKCLIKNPAERADLKQLMVHAFIKRSE 306 (333)
T ss_pred cCCccchhhhhcccccccccHHHHHHHHhcCCCccCCCCCcCHHHHHHHHHhccCCcccCcCHHHHhhCHHHhcCc
Confidence 00000000 000011235778999999999999999999987 776543
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-35 Score=315.22 Aligned_cols=261 Identities=21% Similarity=0.304 Sum_probs=208.5
Q ss_pred cCCCccceEeecCcEEEEEEEE-cCCCeEEEEEEcCcc---hhhHHHHHHHHHHHHhcCCCceeeecceeeecceEEEEE
Q 002673 607 DNFSQANIIGCGGFGLVYKATL-ANGTTLAIKKLSGDL---GLMEREFKAEVEALSTAQHKNLVSLQGYCVHQGFRLLIY 682 (894)
Q Consensus 607 ~~f~~~~~LG~G~fg~Vy~a~~-~~g~~vAvK~~~~~~---~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~lV~ 682 (894)
++|++.+.||+|+||.||+|+. .++..||||.+.... ......+.+|+++++.++||||+++++++...+..++|+
T Consensus 2 ~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 81 (267)
T cd08228 2 ANFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLDSFIEDNELNIVL 81 (267)
T ss_pred cceeeeeeeccCCCeeEEEEEEeCCCCEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCcceeeeeeeEEECCeEEEEE
Confidence 4788899999999999999984 578999999875422 233456889999999999999999999999999999999
Q ss_pred EeccCCCHHHHHhhhcCCCCCcCHHHHHHHHHHHHHHHHHHHhccCCCeeecCCCCCCeEECCCCcEEEEEcccccccCC
Q 002673 683 SYMENGSLDYWLHEKADGASQLDWLTRLKIARGTSCGLAYMHQICEPHIVHRDIKSSNILLDDQFEAHLADFGLSRLILP 762 (894)
Q Consensus 683 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDLkp~NILld~~~~vkl~DFGla~~~~~ 762 (894)
||+++|+|.+++.........++...+..++.|++.||.|||+ ++++|+||||+||+++.++.++|+|||++.....
T Consensus 82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~---~~i~H~dl~~~nil~~~~~~~~l~d~g~~~~~~~ 158 (267)
T cd08228 82 ELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHS---RRVMHRDIKPANVFITATGVVKLGDLGLGRFFSS 158 (267)
T ss_pred EecCCCcHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhh---CCeeCCCCCHHHEEEcCCCCEEECccccceeccc
Confidence 9999999999987544334568888999999999999999997 6999999999999999999999999999886532
Q ss_pred CCCcccccccccCCccCcccccCcCCCccccHHHHHHHHHHHHcCCCCCCCCCcchhhhHHHHHHHHhhcCCCCcccccc
Q 002673 763 YQTHVTTELVGTLGYIPPEYGQAWVATLRGDMYSFGVVMLELLTGKRPVDVLKPKMSRELVGWVLKMRSEGKQDQVFDPI 842 (894)
Q Consensus 763 ~~~~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwS~GvlL~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 842 (894)
.. .......++..|+|||.+.+..++.++||||||+++|||++|+.||...... ...+......... . +.
T Consensus 159 ~~-~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~----~~~~~~~~~~~~~-~----~~ 228 (267)
T cd08228 159 KT-TAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMN----LFSLCQKIEQCDY-P----PL 228 (267)
T ss_pred hh-HHHhcCCCCccccChhhhccCCCCchhhHHHHHHHHHHHhcCCCCCcccccc----HHHHHHHHhcCCC-C----CC
Confidence 22 1122346888999999998888999999999999999999999998643221 1111111111111 0 00
Q ss_pred ccCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhcc
Q 002673 843 LRGKGFDEEMLQVLDVACMCVSQNPFKRPTVKEVVEWLNNVG 884 (894)
Q Consensus 843 l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~i~ 884 (894)
. .......+.+++.+||+.+|++||++.++++.|++++
T Consensus 229 ~----~~~~~~~~~~li~~cl~~~p~~Rp~~~~vl~~~~~~~ 266 (267)
T cd08228 229 P----TEHYSEKLRELVSMCIYPDPDQRPDIGYVHQIAKQMH 266 (267)
T ss_pred C----hhhcCHHHHHHHHHHCCCCcccCcCHHHHHHHHHHhc
Confidence 0 1122346778999999999999999999999999875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase |
| >cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-35 Score=324.12 Aligned_cols=261 Identities=20% Similarity=0.276 Sum_probs=197.7
Q ss_pred cCCCccceEeecCcEEEEEEEE-cCCCeEEEEEEcCcch-hhHHHHHHHHHHHHhcCCCceeeecceeeecceEEEEEEe
Q 002673 607 DNFSQANIIGCGGFGLVYKATL-ANGTTLAIKKLSGDLG-LMEREFKAEVEALSTAQHKNLVSLQGYCVHQGFRLLIYSY 684 (894)
Q Consensus 607 ~~f~~~~~LG~G~fg~Vy~a~~-~~g~~vAvK~~~~~~~-~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~lV~E~ 684 (894)
++|+..+.||+|+||.||+|.. .++..||+|++..... .....+.+|+.++++++||||+++++++..++..++||||
T Consensus 5 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 84 (288)
T cd07871 5 ETYVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVTLHDIIHTERCLTLVFEY 84 (288)
T ss_pred ccceEeeEEecCCCEEEEEEEECCCCCEEEEEEecccccCCcchhHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEEEEeC
Confidence 5688899999999999999985 4789999999875332 2234678899999999999999999999999999999999
Q ss_pred ccCCCHHHHHhhhcCCCCCcCHHHHHHHHHHHHHHHHHHHhccCCCeeecCCCCCCeEECCCCcEEEEEcccccccCCCC
Q 002673 685 MENGSLDYWLHEKADGASQLDWLTRLKIARGTSCGLAYMHQICEPHIVHRDIKSSNILLDDQFEAHLADFGLSRLILPYQ 764 (894)
Q Consensus 685 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDLkp~NILld~~~~vkl~DFGla~~~~~~~ 764 (894)
++ |+|.+++.... ..+++..+..++.||+.||+|||+ ++|+||||||+|||++.++.+||+|||+++......
T Consensus 85 ~~-~~l~~~l~~~~---~~~~~~~~~~~~~qi~~aL~~LH~---~~ivH~dlkp~Nil~~~~~~~kl~DfG~~~~~~~~~ 157 (288)
T cd07871 85 LD-SDLKQYLDNCG---NLMSMHNVKIFMFQLLRGLSYCHK---RKILHRDLKPQNLLINEKGELKLADFGLARAKSVPT 157 (288)
T ss_pred CC-cCHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCCHHHEEECCCCCEEECcCcceeeccCCC
Confidence 97 58988886542 357888999999999999999997 599999999999999999999999999997643221
Q ss_pred CcccccccccCCccCcccccC-cCCCccccHHHHHHHHHHHHcCCCCCCCCCcchhhhHHHHHHHHhhc---CCCCc---
Q 002673 765 THVTTELVGTLGYIPPEYGQA-WVATLRGDMYSFGVVMLELLTGKRPVDVLKPKMSRELVGWVLKMRSE---GKQDQ--- 837 (894)
Q Consensus 765 ~~~~~~~~gt~~Y~APE~~~~-~~~s~ksDVwS~GvlL~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~---~~~~~--- 837 (894)
.......+++.|+|||++.+ ..++.++||||+||++|||++|+.||........ .......... ..+..
T Consensus 158 -~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~ 233 (288)
T cd07871 158 -KTYSNEVVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGSTVKEE---LHLIFRLLGTPTEETWPGITS 233 (288)
T ss_pred -ccccCceecccccChHHhcCCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHH---HHHHHHHhCCCChHHhhcccc
Confidence 12234567999999998765 5689999999999999999999999975432211 1111111100 00000
Q ss_pred ------cccccccCCC----ChHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 002673 838 ------VFDPILRGKG----FDEEMLQVLDVACMCVSQNPFKRPTVKEVVE 878 (894)
Q Consensus 838 ------~~d~~l~~~~----~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~ 878 (894)
...+...... ......+..+++.+|++.||.+|||++|+++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dp~~R~t~~~~l~ 284 (288)
T cd07871 234 NEEFRSYLFPQYRAQPLINHAPRLDTDGIDLLSSLLLYETKSRISAEAALR 284 (288)
T ss_pred chhhhccccCccCCCchHHhCCCCCHHHHHHHHHhcCcCcccCCCHHHHhc
Confidence 0000000000 0011235679999999999999999999985
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament |
| >KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-36 Score=300.40 Aligned_cols=252 Identities=28% Similarity=0.403 Sum_probs=209.0
Q ss_pred ccCCCccceEeecCcEEEEEEE-EcCCCeEEEEEEcCcc---hhhHHHHHHHHHHHHhcCCCceeeecceeeecceEEEE
Q 002673 606 TDNFSQANIIGCGGFGLVYKAT-LANGTTLAIKKLSGDL---GLMEREFKAEVEALSTAQHKNLVSLQGYCVHQGFRLLI 681 (894)
Q Consensus 606 ~~~f~~~~~LG~G~fg~Vy~a~-~~~g~~vAvK~~~~~~---~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~lV 681 (894)
.++|++++.||+|.||.||.|+ ..++-.||+|++.+.. ....+++.+|+++-+.++||||++++++|.+....||+
T Consensus 21 l~dfeigr~LgkgkFG~vYlarekks~~IvalKVlfKsqi~~~~v~~qlrREiEIqs~L~hpnilrlY~~fhd~~riyLi 100 (281)
T KOG0580|consen 21 LDDFEIGRPLGKGKFGNVYLAREKKSLFIVALKVLFKSQILKTQVEHQLRREIEIQSHLRHPNILRLYGYFHDSKRIYLI 100 (281)
T ss_pred hhhccccccccCCccccEeEeeeccCCcEEEEeeeeHHHHHHhcchhhhhheeEeecccCCccHHhhhhheeccceeEEE
Confidence 3678999999999999999998 5578899999987643 33457899999999999999999999999999999999
Q ss_pred EEeccCCCHHHHHhhhcCCCCCcCHHHHHHHHHHHHHHHHHHHhccCCCeeecCCCCCCeEECCCCcEEEEEcccccccC
Q 002673 682 YSYMENGSLDYWLHEKADGASQLDWLTRLKIARGTSCGLAYMHQICEPHIVHRDIKSSNILLDDQFEAHLADFGLSRLIL 761 (894)
Q Consensus 682 ~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDLkp~NILld~~~~vkl~DFGla~~~~ 761 (894)
+||...|.|...|.+.. ..+++......+..|+|.||.|+|. ++|+||||||+|+|++..+.+||+|||.+....
T Consensus 101 lEya~~gel~k~L~~~~--~~~f~e~~~a~Yi~q~A~Al~y~h~---k~VIhRdiKpenlLlg~~~~lkiAdfGwsV~~p 175 (281)
T KOG0580|consen 101 LEYAPRGELYKDLQEGR--MKRFDEQRAATYIKQLANALLYCHL---KRVIHRDIKPENLLLGSAGELKIADFGWSVHAP 175 (281)
T ss_pred EEecCCchHHHHHHhcc--cccccccchhHHHHHHHHHHHHhcc---CCcccCCCCHHHhccCCCCCeeccCCCceeecC
Confidence 99999999999998543 3567778888999999999999996 799999999999999999999999999987542
Q ss_pred CCCCcccccccccCCccCcccccCcCCCccccHHHHHHHHHHHHcCCCCCCCCCcchhhhHHHHHHHHhhcCCCCccccc
Q 002673 762 PYQTHVTTELVGTLGYIPPEYGQAWVATLRGDMYSFGVVMLELLTGKRPVDVLKPKMSRELVGWVLKMRSEGKQDQVFDP 841 (894)
Q Consensus 762 ~~~~~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwS~GvlL~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 841 (894)
.......+||..|.+||...+..++..+|+|++|++.||++.|.+||+....+.... .+.. .++.+|
T Consensus 176 ---~~kR~tlcgt~dyl~pEmv~~~~hd~~Vd~w~lgvl~yeflvg~ppFes~~~~etYk------rI~k----~~~~~p 242 (281)
T KOG0580|consen 176 ---SNKRKTLCGTLDYLPPEMVEGRGHDKFVDLWSLGVLCYEFLVGLPPFESQSHSETYK------RIRK----VDLKFP 242 (281)
T ss_pred ---CCCceeeecccccCCHhhcCCCCccchhhHHHHHHHHHHHHhcCCchhhhhhHHHHH------HHHH----ccccCC
Confidence 334456789999999999999999999999999999999999999998654322211 1111 111111
Q ss_pred cccCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHH--HHHh
Q 002673 842 ILRGKGFDEEMLQVLDVACMCVSQNPFKRPTVKEVVE--WLNN 882 (894)
Q Consensus 842 ~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~--~L~~ 882 (894)
+.......++|.+|+..+|.+|.+..|++. |+..
T Consensus 243 -------~~is~~a~dlI~~ll~~~p~~r~~l~~v~~hpwI~a 278 (281)
T KOG0580|consen 243 -------STISGGAADLISRLLVKNPIERLALTEVMDHPWIVA 278 (281)
T ss_pred -------cccChhHHHHHHHHhccCccccccHHHHhhhHHHHh
Confidence 112235678999999999999999999987 5543
|
|
| >PTZ00267 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-35 Score=344.85 Aligned_cols=252 Identities=22% Similarity=0.263 Sum_probs=203.2
Q ss_pred CCCccceEeecCcEEEEEEEE-cC-CCeEEEEEEcCcchhhHHHHHHHHHHHHhcCCCceeeecceeeecceEEEEEEec
Q 002673 608 NFSQANIIGCGGFGLVYKATL-AN-GTTLAIKKLSGDLGLMEREFKAEVEALSTAQHKNLVSLQGYCVHQGFRLLIYSYM 685 (894)
Q Consensus 608 ~f~~~~~LG~G~fg~Vy~a~~-~~-g~~vAvK~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~lV~E~~ 685 (894)
.|...+.||+|+||.||+|.. .+ +..||+|.+..........+.+|+.+++.++|||||++++++..++..++||||+
T Consensus 68 ~y~~~~~lg~G~~g~vy~a~~~~~~~~~vv~K~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv~E~~ 147 (478)
T PTZ00267 68 MYVLTTLVGRNPTTAAFVATRGSDPKEKVVAKFVMLNDERQAAYARSELHCLAACDHFGIVKHFDDFKSDDKLLLIMEYG 147 (478)
T ss_pred eEEEEEEEEeCCCcEEEEEEEcCCCCeEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEECCEEEEEEECC
Confidence 378889999999999999974 34 6788999876554445567888999999999999999999999999999999999
Q ss_pred cCCCHHHHHhhhcCCCCCcCHHHHHHHHHHHHHHHHHHHhccCCCeeecCCCCCCeEECCCCcEEEEEcccccccCCCCC
Q 002673 686 ENGSLDYWLHEKADGASQLDWLTRLKIARGTSCGLAYMHQICEPHIVHRDIKSSNILLDDQFEAHLADFGLSRLILPYQT 765 (894)
Q Consensus 686 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDLkp~NILld~~~~vkl~DFGla~~~~~~~~ 765 (894)
++|+|.++++........+++..+..++.||+.||.|||+ ++|+||||||+|||++.++.+||+|||+++.+.....
T Consensus 148 ~gg~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~---~~ivHrDlkp~NIll~~~~~~kL~DFgla~~~~~~~~ 224 (478)
T PTZ00267 148 SGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHS---RKMMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSVS 224 (478)
T ss_pred CCCCHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHh---CCEEECCcCHHhEEECCCCcEEEEeCcCceecCCccc
Confidence 9999999987644344568899999999999999999997 5999999999999999999999999999987643221
Q ss_pred -cccccccccCCccCcccccCcCCCccccHHHHHHHHHHHHcCCCCCCCCCcchhhhHHHHHHHHhhcCCCCcccccccc
Q 002673 766 -HVTTELVGTLGYIPPEYGQAWVATLRGDMYSFGVVMLELLTGKRPVDVLKPKMSRELVGWVLKMRSEGKQDQVFDPILR 844 (894)
Q Consensus 766 -~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwS~GvlL~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~ 844 (894)
......+||+.|+|||++.+..++.++|||||||++|||++|+.||...... ..... ... +..... .
T Consensus 225 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~Pf~~~~~~---~~~~~---~~~-~~~~~~-----~ 292 (478)
T PTZ00267 225 LDVASSFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLTLHRPFKGPSQR---EIMQQ---VLY-GKYDPF-----P 292 (478)
T ss_pred cccccccCCCccccCHhHhCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHH---HHHHH---HHh-CCCCCC-----C
Confidence 1234457999999999999999999999999999999999999999754321 11111 111 111100 0
Q ss_pred CCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 002673 845 GKGFDEEMLQVLDVACMCVSQNPFKRPTVKEVVE 878 (894)
Q Consensus 845 ~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~ 878 (894)
. .....+.+++..||+.||++||++.++++
T Consensus 293 -~---~~s~~~~~li~~~L~~dP~~Rps~~~~l~ 322 (478)
T PTZ00267 293 -C---PVSSGMKALLDPLLSKNPALRPTTQQLLH 322 (478)
T ss_pred -c---cCCHHHHHHHHHHhccChhhCcCHHHHHh
Confidence 0 11235678999999999999999999976
|
|
| >cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-35 Score=318.08 Aligned_cols=256 Identities=27% Similarity=0.435 Sum_probs=209.4
Q ss_pred ccCCCccceEeecCcEEEEEEEEcCCCeEEEEEEcCcchhhHHHHHHHHHHHHhcCCCceeeecceeeecceEEEEEEec
Q 002673 606 TDNFSQANIIGCGGFGLVYKATLANGTTLAIKKLSGDLGLMEREFKAEVEALSTAQHKNLVSLQGYCVHQGFRLLIYSYM 685 (894)
Q Consensus 606 ~~~f~~~~~LG~G~fg~Vy~a~~~~g~~vAvK~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~lV~E~~ 685 (894)
..+|+..+.||.|+||.||+|...++..+++|.+..........+..|+.+++.++|+||+++++++......++||||+
T Consensus 5 ~~~y~~~~~ig~g~~~~vy~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~ 84 (261)
T cd05148 5 REEFTLERKLGSGYFGEVWEGLWKNRVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLISLFAVCSVGEPVYIITELM 84 (261)
T ss_pred HHHHHHhhhhccCCCccEEEeEecCCCcEEEEeccccchhhHHHHHHHHHHHhcCCCcchhheeeeEecCCCeEEEEeec
Confidence 45688889999999999999998889999999998765555677899999999999999999999999999999999999
Q ss_pred cCCCHHHHHhhhcCCCCCcCHHHHHHHHHHHHHHHHHHHhccCCCeeecCCCCCCeEECCCCcEEEEEcccccccCCCCC
Q 002673 686 ENGSLDYWLHEKADGASQLDWLTRLKIARGTSCGLAYMHQICEPHIVHRDIKSSNILLDDQFEAHLADFGLSRLILPYQT 765 (894)
Q Consensus 686 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDLkp~NILld~~~~vkl~DFGla~~~~~~~~ 765 (894)
++|+|.+++.... ...+++..+..++.|++.||.|||+ ++++|+||||+||++++++.+||+|||++.......
T Consensus 85 ~~~~L~~~~~~~~--~~~~~~~~~~~~~~~i~~al~~lH~---~~i~h~dl~~~nilv~~~~~~kl~d~g~~~~~~~~~- 158 (261)
T cd05148 85 EKGSLLAFLRSPE--GQVLPVASLIDMACQVAEGMAYLEE---QNSIHRDLAARNILVGEDLVCKVADFGLARLIKEDV- 158 (261)
T ss_pred ccCCHHHHHhcCC--CCCCCHHHHHHHHHHHHHHHHHHHH---CCeeccccCcceEEEcCCceEEEccccchhhcCCcc-
Confidence 9999999998643 3468999999999999999999997 699999999999999999999999999998653321
Q ss_pred cccccccccCCccCcccccCcCCCccccHHHHHHHHHHHHc-CCCCCCCCCcchhhhHHHHHHHHhhcCCCCcccccccc
Q 002673 766 HVTTELVGTLGYIPPEYGQAWVATLRGDMYSFGVVMLELLT-GKRPVDVLKPKMSRELVGWVLKMRSEGKQDQVFDPILR 844 (894)
Q Consensus 766 ~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwS~GvlL~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~ 844 (894)
.......++..|+|||...+..++.++||||||+++|+|++ |+.||...... ....... ..... ..
T Consensus 159 ~~~~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~~l~~l~~~g~~p~~~~~~~---~~~~~~~---~~~~~-~~------ 225 (261)
T cd05148 159 YLSSDKKIPYKWTAPEAASHGTFSTKSDVWSFGILLYEMFTYGQVPYPGMNNH---EVYDQIT---AGYRM-PC------ 225 (261)
T ss_pred ccccCCCCceEecCHHHHccCCCCchhhHHHHHHHHHHHHcCCCCCCCcCCHH---HHHHHHH---hCCcC-CC------
Confidence 11223345678999999988889999999999999999998 89999754422 1221111 11110 00
Q ss_pred CCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhc
Q 002673 845 GKGFDEEMLQVLDVACMCVSQNPFKRPTVKEVVEWLNNV 883 (894)
Q Consensus 845 ~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~i 883 (894)
.......+.+++.+|++.||.+|||+.++++.|+.+
T Consensus 226 ---~~~~~~~~~~~i~~~l~~~p~~Rpt~~~l~~~L~~~ 261 (261)
T cd05148 226 ---PAKCPQEIYKIMLECWAAEPEDRPSFKALREELDNI 261 (261)
T ss_pred ---CCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHhcC
Confidence 011223567899999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom |
| >cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-35 Score=322.74 Aligned_cols=271 Identities=23% Similarity=0.320 Sum_probs=203.4
Q ss_pred ccCCCccceEeecCcEEEEEEEEc-CCCeEEEEEEcCcch-hhHHHHHHHHHHHHhcCCCceeeecceeeecceEEEEEE
Q 002673 606 TDNFSQANIIGCGGFGLVYKATLA-NGTTLAIKKLSGDLG-LMEREFKAEVEALSTAQHKNLVSLQGYCVHQGFRLLIYS 683 (894)
Q Consensus 606 ~~~f~~~~~LG~G~fg~Vy~a~~~-~g~~vAvK~~~~~~~-~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~lV~E 683 (894)
.++|++.+.||+|+||.||+|... +++.||||++..... .....+.+|+.+++.++||||+++++++.++...++|||
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 83 (303)
T cd07869 4 ADSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGLKHANIVLLHDIIHTKETLTLVFE 83 (303)
T ss_pred cccceEeeeEEecCCEEEEEEEECCCCCEEEEEEeccccccccchhHHHHHHHHhhCCCCCcCeEEEEEecCCeEEEEEE
Confidence 468999999999999999999854 789999999875432 223457789999999999999999999999999999999
Q ss_pred eccCCCHHHHHhhhcCCCCCcCHHHHHHHHHHHHHHHHHHHhccCCCeeecCCCCCCeEECCCCcEEEEEcccccccCCC
Q 002673 684 YMENGSLDYWLHEKADGASQLDWLTRLKIARGTSCGLAYMHQICEPHIVHRDIKSSNILLDDQFEAHLADFGLSRLILPY 763 (894)
Q Consensus 684 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDLkp~NILld~~~~vkl~DFGla~~~~~~ 763 (894)
|+. ++|.+++.... ..++...+..++.|++.||.|||+ ++|+||||||+|||++.++.+||+|||+++.....
T Consensus 84 ~~~-~~l~~~~~~~~---~~~~~~~~~~~~~qi~~al~~lH~---~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~ 156 (303)
T cd07869 84 YVH-TDLCQYMDKHP---GGLHPENVKLFLFQLLRGLSYIHQ---RYILHRDLKPQNLLISDTGELKLADFGLARAKSVP 156 (303)
T ss_pred CCC-cCHHHHHHhCC---CCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHEEECCCCCEEECCCCcceeccCC
Confidence 995 68888776532 457888899999999999999997 59999999999999999999999999998754322
Q ss_pred CCcccccccccCCccCcccccC-cCCCccccHHHHHHHHHHHHcCCCCCCCCCcchhhhHHHHHHHHhhcCCCCc-----
Q 002673 764 QTHVTTELVGTLGYIPPEYGQA-WVATLRGDMYSFGVVMLELLTGKRPVDVLKPKMSRELVGWVLKMRSEGKQDQ----- 837 (894)
Q Consensus 764 ~~~~~~~~~gt~~Y~APE~~~~-~~~s~ksDVwS~GvlL~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~----- 837 (894)
. .......+|+.|+|||++.+ ..++.++|||||||++|||++|+.||...... ..................
T Consensus 157 ~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~ 233 (303)
T cd07869 157 S-HTYSNEVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGMKDI--QDQLERIFLVLGTPNEDTWPGVH 233 (303)
T ss_pred C-ccCCCCcccCCCCChHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCccH--HHHHHHHHHHhCCCChhhccchh
Confidence 1 22234568999999998765 45788999999999999999999999864321 111111111110000000
Q ss_pred ---ccccc-c---cCCCChH------HHHHHHHHHHHhcccCCCCCCCHHHHHH--HHHhcccc
Q 002673 838 ---VFDPI-L---RGKGFDE------EMLQVLDVACMCVSQNPFKRPTVKEVVE--WLNNVGAN 886 (894)
Q Consensus 838 ---~~d~~-l---~~~~~~~------~~~~l~~li~~Cl~~dP~~RPs~~evl~--~L~~i~~~ 886 (894)
.+++. . ....... ....+.+++.+|++.||.+|||+.++++ |+.++...
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dp~~R~s~~~~l~h~~f~~~~~~ 297 (303)
T cd07869 234 SLPHFKPERFTLYSPKNLRQAWNKLSYVNHAEDLASKLLQCFPKNRLSAQAALSHEYFSDLPPR 297 (303)
T ss_pred hccccccccccccCCccHHHHhhccCCChHHHHHHHHHhccCchhccCHHHHhcCcccccCChh
Confidence 00000 0 0000000 1235678999999999999999999998 88776543
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an |
| >cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-35 Score=316.52 Aligned_cols=255 Identities=24% Similarity=0.399 Sum_probs=204.0
Q ss_pred cCCCccceEeecCcEEEEEEEE-cCCCeEEEEEEcCcchhhHHHHHHHHHHHHhcCCCceeeecceeeecceEEEEEEec
Q 002673 607 DNFSQANIIGCGGFGLVYKATL-ANGTTLAIKKLSGDLGLMEREFKAEVEALSTAQHKNLVSLQGYCVHQGFRLLIYSYM 685 (894)
Q Consensus 607 ~~f~~~~~LG~G~fg~Vy~a~~-~~g~~vAvK~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~lV~E~~ 685 (894)
.+|+..+.||+|+||.||+|.. .++..||+|.+..+ .....++.+|+++++.++|+||+++++++..++..++||||+
T Consensus 6 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 84 (263)
T cd05052 6 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED-TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFM 84 (263)
T ss_pred HHeEEeeecCCcccceEEEEEEecCCceEEEEEecCC-chHHHHHHHHHHHHHhCCCCChhheEEEEcCCCCcEEEEEeC
Confidence 3577788999999999999985 45889999998754 333467889999999999999999999999999999999999
Q ss_pred cCCCHHHHHhhhcCCCCCcCHHHHHHHHHHHHHHHHHHHhccCCCeeecCCCCCCeEECCCCcEEEEEcccccccCCCCC
Q 002673 686 ENGSLDYWLHEKADGASQLDWLTRLKIARGTSCGLAYMHQICEPHIVHRDIKSSNILLDDQFEAHLADFGLSRLILPYQT 765 (894)
Q Consensus 686 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDLkp~NILld~~~~vkl~DFGla~~~~~~~~ 765 (894)
++++|.+++.... ...+++..++.++.|++.||+|||+ ++++||||||+||++++++.+||+|||++........
T Consensus 85 ~~~~L~~~~~~~~--~~~l~~~~~~~~~~ql~~~l~~lH~---~~i~H~dlkp~nil~~~~~~~kl~df~~~~~~~~~~~ 159 (263)
T cd05052 85 TYGNLLDYLRECN--RQEVNAVVLLYMATQISSAMEYLEK---KNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTY 159 (263)
T ss_pred CCCcHHHHHHhCC--CCCCCHHHHHHHHHHHHHHHHHHHh---CCEeecccCcceEEEcCCCcEEeCCCcccccccccee
Confidence 9999999997542 3458999999999999999999997 5999999999999999999999999999987543222
Q ss_pred cccccccccCCccCcccccCcCCCccccHHHHHHHHHHHHc-CCCCCCCCCcchhhhHHHHHHHHhhcCCCCcccccccc
Q 002673 766 HVTTELVGTLGYIPPEYGQAWVATLRGDMYSFGVVMLELLT-GKRPVDVLKPKMSRELVGWVLKMRSEGKQDQVFDPILR 844 (894)
Q Consensus 766 ~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwS~GvlL~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~ 844 (894)
.......++..|+|||++.+..++.++|||||||++|||++ |..||...... +... ........ . ..
T Consensus 160 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~---~~~~---~~~~~~~~-~-----~~ 227 (263)
T cd05052 160 TAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLS---QVYE---LLEKGYRM-E-----RP 227 (263)
T ss_pred eccCCCCCccccCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHH---HHHH---HHHCCCCC-C-----CC
Confidence 22222334668999999999999999999999999999998 99998753321 1111 11111110 0 00
Q ss_pred CCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhc
Q 002673 845 GKGFDEEMLQVLDVACMCVSQNPFKRPTVKEVVEWLNNV 883 (894)
Q Consensus 845 ~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~i 883 (894)
.. ....+.+++.+|++.+|++||++.++++.|+.+
T Consensus 228 -~~---~~~~~~~li~~cl~~~p~~Rp~~~~l~~~l~~~ 262 (263)
T cd05052 228 -EG---CPPKVYELMRACWQWNPSDRPSFAEIHQAFETM 262 (263)
T ss_pred -CC---CCHHHHHHHHHHccCCcccCCCHHHHHHHHHhh
Confidence 11 123577899999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays |
| >PTZ00263 protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-35 Score=330.59 Aligned_cols=244 Identities=23% Similarity=0.289 Sum_probs=198.6
Q ss_pred cCCCccceEeecCcEEEEEEEE-cCCCeEEEEEEcCcch---hhHHHHHHHHHHHHhcCCCceeeecceeeecceEEEEE
Q 002673 607 DNFSQANIIGCGGFGLVYKATL-ANGTTLAIKKLSGDLG---LMEREFKAEVEALSTAQHKNLVSLQGYCVHQGFRLLIY 682 (894)
Q Consensus 607 ~~f~~~~~LG~G~fg~Vy~a~~-~~g~~vAvK~~~~~~~---~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~lV~ 682 (894)
++|++.+.||+|+||.||+|.. .+++.||+|.+..... ...+.+.+|+.++++++||||+++++++..++..++||
T Consensus 18 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 97 (329)
T PTZ00263 18 SDFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMCSFQDENRVYFLL 97 (329)
T ss_pred hheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCcEEEEEEcCCEEEEEE
Confidence 5688889999999999999985 4689999999875421 22356889999999999999999999999999999999
Q ss_pred EeccCCCHHHHHhhhcCCCCCcCHHHHHHHHHHHHHHHHHHHhccCCCeeecCCCCCCeEECCCCcEEEEEcccccccCC
Q 002673 683 SYMENGSLDYWLHEKADGASQLDWLTRLKIARGTSCGLAYMHQICEPHIVHRDIKSSNILLDDQFEAHLADFGLSRLILP 762 (894)
Q Consensus 683 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDLkp~NILld~~~~vkl~DFGla~~~~~ 762 (894)
||+++|+|.+++... ..+++..+..++.|++.||.|||+ ++|+||||||+|||++.++.+||+|||+++....
T Consensus 98 e~~~~~~L~~~l~~~----~~~~~~~~~~~~~qi~~aL~~LH~---~~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~ 170 (329)
T PTZ00263 98 EFVVGGELFTHLRKA----GRFPNDVAKFYHAELVLAFEYLHS---KDIIYRDLKPENLLLDNKGHVKVTDFGFAKKVPD 170 (329)
T ss_pred cCCCCChHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHH---CCeeecCCCHHHEEECCCCCEEEeeccCceEcCC
Confidence 999999999999754 357888889999999999999997 5999999999999999999999999999986532
Q ss_pred CCCcccccccccCCccCcccccCcCCCccccHHHHHHHHHHHHcCCCCCCCCCcchhhhHHHHHHHHhhcCCCCcccccc
Q 002673 763 YQTHVTTELVGTLGYIPPEYGQAWVATLRGDMYSFGVVMLELLTGKRPVDVLKPKMSRELVGWVLKMRSEGKQDQVFDPI 842 (894)
Q Consensus 763 ~~~~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwS~GvlL~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 842 (894)
. .....||+.|+|||++.+..++.++|||||||++|||++|+.||...... ... .... .+... +.
T Consensus 171 ~----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~---~~~---~~i~-~~~~~--~p-- 235 (329)
T PTZ00263 171 R----TFTLCGTPEYLAPEVIQSKGHGKAVDWWTMGVLLYEFIAGYPPFFDDTPF---RIY---EKIL-AGRLK--FP-- 235 (329)
T ss_pred C----cceecCChhhcCHHHHcCCCCCCcceeechHHHHHHHHcCCCCCCCCCHH---HHH---HHHh-cCCcC--CC--
Confidence 1 22357899999999999999999999999999999999999999754321 111 1111 11110 00
Q ss_pred ccCCCChHHHHHHHHHHHHhcccCCCCCCC-----HHHHHH
Q 002673 843 LRGKGFDEEMLQVLDVACMCVSQNPFKRPT-----VKEVVE 878 (894)
Q Consensus 843 l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs-----~~evl~ 878 (894)
... ...+.+++.+||+.||.+||+ +++++.
T Consensus 236 ---~~~---~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~ 270 (329)
T PTZ00263 236 ---NWF---DGRARDLVKGLLQTDHTKRLGTLKGGVADVKN 270 (329)
T ss_pred ---CCC---CHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhc
Confidence 011 124668999999999999997 788875
|
|
| >KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-36 Score=321.35 Aligned_cols=252 Identities=24% Similarity=0.301 Sum_probs=196.2
Q ss_pred hccCCCccceEeecCcEEEEEEE-EcCCCeEEEEEEcCcch--------------hhHHHHHHHHHHHHhcCCCceeeec
Q 002673 605 ATDNFSQANIIGCGGFGLVYKAT-LANGTTLAIKKLSGDLG--------------LMEREFKAEVEALSTAQHKNLVSLQ 669 (894)
Q Consensus 605 a~~~f~~~~~LG~G~fg~Vy~a~-~~~g~~vAvK~~~~~~~--------------~~~~~~~~Ei~~l~~l~HpnIv~l~ 669 (894)
..++|++.+.||+|.||.|-+|+ ..+++.||||++.+... ...+.+++||.+|++++|||||+|+
T Consensus 95 ~lNqy~l~~eiG~G~yGkVkLar~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~H~nVV~Li 174 (576)
T KOG0585|consen 95 QLNQYELIKEIGSGQYGKVKLARDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLHHPNVVKLI 174 (576)
T ss_pred ehhheehhhhhcCCccceEEEEeecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcCCcCeeEEE
Confidence 34678889999999999999998 56799999999875221 1124688999999999999999999
Q ss_pred ceeee--cceEEEEEEeccCCCHHHHHhhhcCCCCCcCHHHHHHHHHHHHHHHHHHHhccCCCeeecCCCCCCeEECCCC
Q 002673 670 GYCVH--QGFRLLIYSYMENGSLDYWLHEKADGASQLDWLTRLKIARGTSCGLAYMHQICEPHIVHRDIKSSNILLDDQF 747 (894)
Q Consensus 670 g~~~~--~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDLkp~NILld~~~ 747 (894)
++..+ .+..|||+|||..|.+...-..+ ..++..++++++++++.||+|||. ++||||||||+|+||+++|
T Consensus 175 EvLDDP~s~~~YlVley~s~G~v~w~p~d~----~els~~~Ar~ylrDvv~GLEYLH~---QgiiHRDIKPsNLLl~~~g 247 (576)
T KOG0585|consen 175 EVLDDPESDKLYLVLEYCSKGEVKWCPPDK----PELSEQQARKYLRDVVLGLEYLHY---QGIIHRDIKPSNLLLSSDG 247 (576)
T ss_pred EeecCcccCceEEEEEeccCCccccCCCCc----ccccHHHHHHHHHHHHHHHHHHHh---cCeeccccchhheEEcCCC
Confidence 99875 45789999999998775333222 238999999999999999999997 6999999999999999999
Q ss_pred cEEEEEcccccccCCCCC----cccccccccCCccCcccccCcC----CCccccHHHHHHHHHHHHcCCCCCCCCCcchh
Q 002673 748 EAHLADFGLSRLILPYQT----HVTTELVGTLGYIPPEYGQAWV----ATLRGDMYSFGVVMLELLTGKRPVDVLKPKMS 819 (894)
Q Consensus 748 ~vkl~DFGla~~~~~~~~----~~~~~~~gt~~Y~APE~~~~~~----~s~ksDVwS~GvlL~elltG~~Pf~~~~~~~~ 819 (894)
+|||+|||.+..+..... ......+|||.|+|||...++. .+.+.||||+||.||.|+.|+.||-+..
T Consensus 248 ~VKIsDFGVs~~~~~~~~~~~d~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGVTLYCllfG~~PF~~~~---- 323 (576)
T KOG0585|consen 248 TVKISDFGVSNEFPQGSDEGSDDQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALGVTLYCLLFGQLPFFDDF---- 323 (576)
T ss_pred cEEeeccceeeecccCCccccHHHHhhcCCCccccchHhhcCCCCccccchhhhhhhhhhhHHHhhhccCCcccch----
Confidence 999999999987633211 1123468999999999877632 3678899999999999999999996322
Q ss_pred hhHHHHHHHHhhcCCCCccccccccCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 002673 820 RELVGWVLKMRSEGKQDQVFDPILRGKGFDEEMLQVLDVACMCVSQNPFKRPTVKEVVE 878 (894)
Q Consensus 820 ~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~ 878 (894)
..+...++.... +.-...+++...+.+++.++|+.||++|.+..+|..
T Consensus 324 --~~~l~~KIvn~p---------L~fP~~pe~~e~~kDli~~lL~KdP~~Ri~l~~ik~ 371 (576)
T KOG0585|consen 324 --ELELFDKIVNDP---------LEFPENPEINEDLKDLIKRLLEKDPEQRITLPDIKL 371 (576)
T ss_pred --HHHHHHHHhcCc---------ccCCCcccccHHHHHHHHHHhhcChhheeehhhhee
Confidence 122222221111 111122233456779999999999999999999876
|
|
| >cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-35 Score=319.64 Aligned_cols=258 Identities=28% Similarity=0.469 Sum_probs=205.3
Q ss_pred cCCCccceEeecCcEEEEEEEEcC-C-----CeEEEEEEcCcc-hhhHHHHHHHHHHHHhcCCCceeeecceeeecceEE
Q 002673 607 DNFSQANIIGCGGFGLVYKATLAN-G-----TTLAIKKLSGDL-GLMEREFKAEVEALSTAQHKNLVSLQGYCVHQGFRL 679 (894)
Q Consensus 607 ~~f~~~~~LG~G~fg~Vy~a~~~~-g-----~~vAvK~~~~~~-~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~ 679 (894)
++|++.+.||+|+||.||+|.... + ..||+|.+.... ......+.+|+.++++++||||+++++++......+
T Consensus 5 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~ 84 (283)
T cd05048 5 SAVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHPNIVCLLGVCTKEQPTC 84 (283)
T ss_pred HHcchhhcccCccCCcEEEEEEecCCCCcceeeEEEEecccCCCHHHHHHHHHHHHHHHhcCCcccceEEEEEcCCCceE
Confidence 467888999999999999998533 2 579999987543 233467899999999999999999999999888999
Q ss_pred EEEEeccCCCHHHHHhhhcCC------------CCCcCHHHHHHHHHHHHHHHHHHHhccCCCeeecCCCCCCeEECCCC
Q 002673 680 LIYSYMENGSLDYWLHEKADG------------ASQLDWLTRLKIARGTSCGLAYMHQICEPHIVHRDIKSSNILLDDQF 747 (894)
Q Consensus 680 lV~E~~~~gsL~~~l~~~~~~------------~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDLkp~NILld~~~ 747 (894)
++|||+++|+|.+++...... ...+++...+.++.|++.||.|||+ ++++|+||||+||++++++
T Consensus 85 ~~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH~---~~i~H~dlkp~Nil~~~~~ 161 (283)
T cd05048 85 MLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSS---HHFVHRDLAARNCLVGEGL 161 (283)
T ss_pred EEEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHHh---CCeeccccccceEEEcCCC
Confidence 999999999999999764211 1457888999999999999999997 5999999999999999999
Q ss_pred cEEEEEcccccccCCCCC-cccccccccCCccCcccccCcCCCccccHHHHHHHHHHHHc-CCCCCCCCCcchhhhHHHH
Q 002673 748 EAHLADFGLSRLILPYQT-HVTTELVGTLGYIPPEYGQAWVATLRGDMYSFGVVMLELLT-GKRPVDVLKPKMSRELVGW 825 (894)
Q Consensus 748 ~vkl~DFGla~~~~~~~~-~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwS~GvlL~ellt-G~~Pf~~~~~~~~~~~~~~ 825 (894)
.+||+|||+++....... .......++..|+|||++.+..++.++|||||||++|||++ |..||...... +....
T Consensus 162 ~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~slG~il~el~~~g~~p~~~~~~~---~~~~~ 238 (283)
T cd05048 162 TVKISDFGLSRDIYSADYYRVQSKSLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEIFSYGLQPYYGFSNQ---EVIEM 238 (283)
T ss_pred cEEECCCcceeeccccccccccCCCcccccccCHHHhccCcCchhhhHHHHHHHHHHHHcCCCCCCCCCCHH---HHHHH
Confidence 999999999986533221 12233456789999999988899999999999999999998 99999765432 22221
Q ss_pred HHHHhhcCCCCccccccccCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhc
Q 002673 826 VLKMRSEGKQDQVFDPILRGKGFDEEMLQVLDVACMCVSQNPFKRPTVKEVVEWLNNV 883 (894)
Q Consensus 826 ~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~i 883 (894)
+. ....... .......+.+++.+||+.||.+||++++|++.|+++
T Consensus 239 i~----~~~~~~~---------~~~~~~~~~~l~~~c~~~~p~~Rp~~~~i~~~l~~~ 283 (283)
T cd05048 239 IR----SRQLLPC---------PEDCPARVYALMIECWNEIPARRPRFKDIHTRLRSW 283 (283)
T ss_pred HH----cCCcCCC---------cccCCHHHHHHHHHHccCChhhCcCHHHHHHHHhcC
Confidence 11 1111111 112234677899999999999999999999999753
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer |
| >cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-35 Score=328.60 Aligned_cols=245 Identities=21% Similarity=0.277 Sum_probs=196.7
Q ss_pred ceEeecCcEEEEEEEE-cCCCeEEEEEEcCcch---hhHHHHHHHHHHHHhcCCCceeeecceeeecceEEEEEEeccCC
Q 002673 613 NIIGCGGFGLVYKATL-ANGTTLAIKKLSGDLG---LMEREFKAEVEALSTAQHKNLVSLQGYCVHQGFRLLIYSYMENG 688 (894)
Q Consensus 613 ~~LG~G~fg~Vy~a~~-~~g~~vAvK~~~~~~~---~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~lV~E~~~~g 688 (894)
+.||+|+||.||++.. .+|+.||+|++..... .....+.+|+.++++++||||+++++++..++..++||||+++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~ 80 (323)
T cd05571 1 KLLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALKYSFQTHDRLCFVMEYANGG 80 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCCEEEEEEcCCEEEEEEeCCCCC
Confidence 4699999999999984 5789999999975432 22345778999999999999999999999999999999999999
Q ss_pred CHHHHHhhhcCCCCCcCHHHHHHHHHHHHHHHHHHHhccCCCeeecCCCCCCeEECCCCcEEEEEcccccccCCCCCccc
Q 002673 689 SLDYWLHEKADGASQLDWLTRLKIARGTSCGLAYMHQICEPHIVHRDIKSSNILLDDQFEAHLADFGLSRLILPYQTHVT 768 (894)
Q Consensus 689 sL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDLkp~NILld~~~~vkl~DFGla~~~~~~~~~~~ 768 (894)
+|.+++... ..+++..+..++.||+.||+|||+ ++|+||||||+|||++.++.+||+|||+++..... ....
T Consensus 81 ~L~~~l~~~----~~~~~~~~~~~~~qi~~~L~~lH~---~~ivHrDlkp~NIll~~~~~~kl~DfG~a~~~~~~-~~~~ 152 (323)
T cd05571 81 ELFFHLSRE----RVFSEDRARFYGAEIVSALGYLHS---CDVVYRDLKLENLMLDKDGHIKITDFGLCKEGISD-GATM 152 (323)
T ss_pred cHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHh---CCeEeCCCCHHHEEECCCCCEEEeeCCCCcccccC-CCcc
Confidence 999998753 358899999999999999999997 59999999999999999999999999998753221 1223
Q ss_pred ccccccCCccCcccccCcCCCccccHHHHHHHHHHHHcCCCCCCCCCcchhhhHHHHHHHHhhcCCCCccccccccCCCC
Q 002673 769 TELVGTLGYIPPEYGQAWVATLRGDMYSFGVVMLELLTGKRPVDVLKPKMSRELVGWVLKMRSEGKQDQVFDPILRGKGF 848 (894)
Q Consensus 769 ~~~~gt~~Y~APE~~~~~~~s~ksDVwS~GvlL~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~ 848 (894)
....||+.|+|||++.+..++.++|||||||++|||++|+.||....... .... .. .... . +.
T Consensus 153 ~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~---~~~~---~~-~~~~-~-----~p---- 215 (323)
T cd05571 153 KTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEK---LFEL---IL-MEEI-R-----FP---- 215 (323)
T ss_pred cceecCccccChhhhcCCCCCccccCcccchhhhhhhcCCCCCCCCCHHH---HHHH---HH-cCCC-C-----CC----
Confidence 34579999999999999999999999999999999999999997543211 1111 11 1111 0 00
Q ss_pred hHHHHHHHHHHHHhcccCCCCCC-----CHHHHHH--HHHh
Q 002673 849 DEEMLQVLDVACMCVSQNPFKRP-----TVKEVVE--WLNN 882 (894)
Q Consensus 849 ~~~~~~l~~li~~Cl~~dP~~RP-----s~~evl~--~L~~ 882 (894)
......+.+++.+|++.||++|| ++.++++ |+..
T Consensus 216 ~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~h~~f~~ 256 (323)
T cd05571 216 RTLSPEAKSLLAGLLKKDPKQRLGGGPEDAKEIMEHRFFAS 256 (323)
T ss_pred CCCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHHcCCCcCC
Confidence 11123567899999999999999 8999987 5543
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be |
| >cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-35 Score=317.47 Aligned_cols=257 Identities=28% Similarity=0.466 Sum_probs=205.5
Q ss_pred cCCCccceEeecCcEEEEEEEEc------CCCeEEEEEEcCcchh-hHHHHHHHHHHHHhcCCCceeeecceeeecceEE
Q 002673 607 DNFSQANIIGCGGFGLVYKATLA------NGTTLAIKKLSGDLGL-MEREFKAEVEALSTAQHKNLVSLQGYCVHQGFRL 679 (894)
Q Consensus 607 ~~f~~~~~LG~G~fg~Vy~a~~~------~g~~vAvK~~~~~~~~-~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~ 679 (894)
++|.+.+.||+|+||.||+|... ++..||||.+...... ..+.+.+|+++++.++|+||+++++++......+
T Consensus 5 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~ 84 (280)
T cd05049 5 DTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENIVKFYGVCTEGDPPI 84 (280)
T ss_pred HHhhHHhhccccCCceEeeeeeccccCcCCcceEEEEeecccCCHHHHHHHHHHHHHHHhcCCCCchheeeEEecCCCeE
Confidence 45777899999999999999853 3478999999765443 4568999999999999999999999999999999
Q ss_pred EEEEeccCCCHHHHHhhhcC----------CCCCcCHHHHHHHHHHHHHHHHHHHhccCCCeeecCCCCCCeEECCCCcE
Q 002673 680 LIYSYMENGSLDYWLHEKAD----------GASQLDWLTRLKIARGTSCGLAYMHQICEPHIVHRDIKSSNILLDDQFEA 749 (894)
Q Consensus 680 lV~E~~~~gsL~~~l~~~~~----------~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDLkp~NILld~~~~v 749 (894)
+||||+++|+|.+++..... ....+++..+..++.|++.|+.|||+ ++++||||||+||+++.++.+
T Consensus 85 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~---~~i~h~dlkp~nili~~~~~~ 161 (280)
T cd05049 85 MVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLAS---QHFVHRDLATRNCLVGYDLVV 161 (280)
T ss_pred EEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHhh---CCeeccccccceEEEcCCCeE
Confidence 99999999999999976421 23457889999999999999999997 599999999999999999999
Q ss_pred EEEEcccccccCCCCC-cccccccccCCccCcccccCcCCCccccHHHHHHHHHHHHc-CCCCCCCCCcchhhhHHHHHH
Q 002673 750 HLADFGLSRLILPYQT-HVTTELVGTLGYIPPEYGQAWVATLRGDMYSFGVVMLELLT-GKRPVDVLKPKMSRELVGWVL 827 (894)
Q Consensus 750 kl~DFGla~~~~~~~~-~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwS~GvlL~ellt-G~~Pf~~~~~~~~~~~~~~~~ 827 (894)
||+|||+++....... .......+++.|+|||++.+..++.++|||||||++|||++ |+.||...... .......
T Consensus 162 kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~e~~~~g~~p~~~~~~~---~~~~~~~ 238 (280)
T cd05049 162 KIGDFGMSRDVYTTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQPWYGLSNE---EVIECIT 238 (280)
T ss_pred EECCcccceecccCcceecCCCCcccceecChhhhccCCcchhhhHHHHHHHHHHHHhcCCCCCCCCCHH---HHHHHHH
Confidence 9999999976432221 11223345788999999999999999999999999999998 99999754332 1221111
Q ss_pred HHhhcCCCCccccccccCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHh
Q 002673 828 KMRSEGKQDQVFDPILRGKGFDEEMLQVLDVACMCVSQNPFKRPTVKEVVEWLNN 882 (894)
Q Consensus 828 ~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~ 882 (894)
.+...... ......+.+++.+||+.||++||++.|+++.|++
T Consensus 239 ----~~~~~~~~---------~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~l~~ 280 (280)
T cd05049 239 ----QGRLLQRP---------RTCPSEVYDIMLGCWKRDPQQRINIKDIHERLQK 280 (280)
T ss_pred ----cCCcCCCC---------CCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhhC
Confidence 11111110 1122457789999999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt |
| >cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-35 Score=314.99 Aligned_cols=255 Identities=26% Similarity=0.401 Sum_probs=204.8
Q ss_pred cCCCccceEeecCcEEEEEEEEcC----CCeEEEEEEcCcc-hhhHHHHHHHHHHHHhcCCCceeeecceeeecceEEEE
Q 002673 607 DNFSQANIIGCGGFGLVYKATLAN----GTTLAIKKLSGDL-GLMEREFKAEVEALSTAQHKNLVSLQGYCVHQGFRLLI 681 (894)
Q Consensus 607 ~~f~~~~~LG~G~fg~Vy~a~~~~----g~~vAvK~~~~~~-~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~lV 681 (894)
++|+..+.||+|+||.||+|.+.. ...||||.+.... ......+.+|+.+++.++||||+++++++...+..++|
T Consensus 4 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv 83 (266)
T cd05033 4 SYVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNIIRLEGVVTKSRPVMII 83 (266)
T ss_pred HHceeeeEecCCccceEEEEEEccCCCCcceEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCcceEeEEEecCCceEEE
Confidence 568889999999999999998642 4579999987543 33446788999999999999999999999999999999
Q ss_pred EEeccCCCHHHHHhhhcCCCCCcCHHHHHHHHHHHHHHHHHHHhccCCCeeecCCCCCCeEECCCCcEEEEEcccccccC
Q 002673 682 YSYMENGSLDYWLHEKADGASQLDWLTRLKIARGTSCGLAYMHQICEPHIVHRDIKSSNILLDDQFEAHLADFGLSRLIL 761 (894)
Q Consensus 682 ~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDLkp~NILld~~~~vkl~DFGla~~~~ 761 (894)
|||+++|+|.+++.... ..+++..++.++.|++.||.|||+ ++|+|+||||+||++++++.++|+|||+++...
T Consensus 84 ~e~~~~~~L~~~~~~~~---~~~~~~~~~~~~~~l~~~l~~Lh~---~~i~H~di~p~nili~~~~~~~l~dfg~~~~~~ 157 (266)
T cd05033 84 TEYMENGSLDKFLREND---GKFTVGQLVGMLRGIASGMKYLSE---MNYVHRDLAARNILVNSNLVCKVSDFGLSRRLE 157 (266)
T ss_pred EEcCCCCCHHHHHHhcc---CCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCCcceEEEcCCCCEEECccchhhccc
Confidence 99999999999997643 368999999999999999999997 699999999999999999999999999998764
Q ss_pred CCCC-cccccccccCCccCcccccCcCCCccccHHHHHHHHHHHHc-CCCCCCCCCcchhhhHHHHHHHHhhcCCCCccc
Q 002673 762 PYQT-HVTTELVGTLGYIPPEYGQAWVATLRGDMYSFGVVMLELLT-GKRPVDVLKPKMSRELVGWVLKMRSEGKQDQVF 839 (894)
Q Consensus 762 ~~~~-~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwS~GvlL~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 839 (894)
.... .......++..|+|||...+..++.++||||||+++|+|++ |..||...... ....... .......
T Consensus 158 ~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Dv~slG~~l~~l~~~g~~p~~~~~~~---~~~~~~~---~~~~~~~-- 229 (266)
T cd05033 158 DSEATYTTKGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSYGERPYWDMSNQ---DVIKAVE---DGYRLPP-- 229 (266)
T ss_pred ccccceeccCCCCCccccChhhhccCCCccccchHHHHHHHHHHHccCCCCCCCCCHH---HHHHHHH---cCCCCCC--
Confidence 2221 11222345678999999998899999999999999999998 99999654322 1221111 1111000
Q ss_pred cccccCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhc
Q 002673 840 DPILRGKGFDEEMLQVLDVACMCVSQNPFKRPTVKEVVEWLNNV 883 (894)
Q Consensus 840 d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~i 883 (894)
.......+.+++.+|++.+|++||+++++++.|+++
T Consensus 230 --------~~~~~~~l~~li~~cl~~~p~~Rp~~~ei~~~l~~~ 265 (266)
T cd05033 230 --------PMDCPSALYQLMLDCWQKDRNERPTFSQIVSTLDKM 265 (266)
T ss_pred --------CCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 011223577999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment |
| >PHA03212 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-35 Score=333.87 Aligned_cols=266 Identities=19% Similarity=0.287 Sum_probs=201.4
Q ss_pred cCCCccceEeecCcEEEEEEEE-cCCCeEEEEEEcCcchhhHHHHHHHHHHHHhcCCCceeeecceeeecceEEEEEEec
Q 002673 607 DNFSQANIIGCGGFGLVYKATL-ANGTTLAIKKLSGDLGLMEREFKAEVEALSTAQHKNLVSLQGYCVHQGFRLLIYSYM 685 (894)
Q Consensus 607 ~~f~~~~~LG~G~fg~Vy~a~~-~~g~~vAvK~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~lV~E~~ 685 (894)
.+|++.+.||+|+||.||++.. .+++.||+|+... ..+.+|+.++++++||||+++++++..+...++|+|++
T Consensus 92 ~~y~~~~~lg~G~~g~V~~~~d~~~~~~vaiK~~~~------~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~lv~e~~ 165 (391)
T PHA03212 92 AGFSILETFTPGAEGFAFACIDNKTCEHVVIKAGQR------GGTATEAHILRAINHPSIIQLKGTFTYNKFTCLILPRY 165 (391)
T ss_pred CCcEEEEEEcCCCCeEEEEEEECCCCCEEEEechhh------hhhHHHHHHHHhCCCCCCCCEeEEEEECCeeEEEEecC
Confidence 5799999999999999999984 5789999997542 34678999999999999999999999999999999999
Q ss_pred cCCCHHHHHhhhcCCCCCcCHHHHHHHHHHHHHHHHHHHhccCCCeeecCCCCCCeEECCCCcEEEEEcccccccCCCCC
Q 002673 686 ENGSLDYWLHEKADGASQLDWLTRLKIARGTSCGLAYMHQICEPHIVHRDIKSSNILLDDQFEAHLADFGLSRLILPYQT 765 (894)
Q Consensus 686 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDLkp~NILld~~~~vkl~DFGla~~~~~~~~ 765 (894)
. ++|..++... ..+++..++.++.||+.||.|||+ ++|+||||||+|||++.++.+||+|||+++.......
T Consensus 166 ~-~~L~~~l~~~----~~l~~~~~~~i~~qi~~aL~ylH~---~~IvHrDiKP~NIll~~~~~vkL~DFG~a~~~~~~~~ 237 (391)
T PHA03212 166 K-TDLYCYLAAK----RNIAICDILAIERSVLRAIQYLHE---NRIIHRDIKAENIFINHPGDVCLGDFGAACFPVDINA 237 (391)
T ss_pred C-CCHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCChHhEEEcCCCCEEEEeCCcccccccccc
Confidence 5 7888888653 357899999999999999999997 5999999999999999999999999999975432222
Q ss_pred cccccccccCCccCcccccCcCCCccccHHHHHHHHHHHHcCCCCCCCCCcch----hhhHHHHHHHHhhcCCCC-----
Q 002673 766 HVTTELVGTLGYIPPEYGQAWVATLRGDMYSFGVVMLELLTGKRPVDVLKPKM----SRELVGWVLKMRSEGKQD----- 836 (894)
Q Consensus 766 ~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwS~GvlL~elltG~~Pf~~~~~~~----~~~~~~~~~~~~~~~~~~----- 836 (894)
.......||+.|+|||++.+..++.++|||||||++|||++|+.||-...... ..................
T Consensus 238 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~l~~i~~~~g~~p~~~~~~~ 317 (391)
T PHA03212 238 NKYYGWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCHDSLFEKDGLDGDCDSDRQIKLIIRRSGTHPNEFPIDA 317 (391)
T ss_pred cccccccCccCCCChhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCcCCcccccccCchhHHHHHHHHHhcCChhhcCcch
Confidence 23344679999999999999899999999999999999999998874322100 001111110000000000
Q ss_pred -----ccc---------cccccC--CCChHHHHHHHHHHHHhcccCCCCCCCHHHHHH--HHHhcccc
Q 002673 837 -----QVF---------DPILRG--KGFDEEMLQVLDVACMCVSQNPFKRPTVKEVVE--WLNNVGAN 886 (894)
Q Consensus 837 -----~~~---------d~~l~~--~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~--~L~~i~~~ 886 (894)
..+ .+..+. ........++.+++.+||+.||.+|||++|+++ |++.+...
T Consensus 318 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~mL~~dP~~Rpta~elL~hp~f~~~~~~ 385 (391)
T PHA03212 318 QANLDEIYIGLAKKSSRKPGSRPLWTNLYELPIDLEYLICKMLAFDAHHRPSAEALLDFAAFQDIPDP 385 (391)
T ss_pred hHHHHHHHHHHHhccCCCCCCCCCHHHHhhhhhhHHHHHHHHhcCChhhCCCHHHHhcChhhccCCCC
Confidence 000 000000 000122346789999999999999999999997 88776543
|
|
| >KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-36 Score=328.09 Aligned_cols=255 Identities=25% Similarity=0.412 Sum_probs=209.6
Q ss_pred cCCCccceEeecCcEEEEEEEEcC-CCeEEEEEEcCcchhhHHHHHHHHHHHHhcCCCceeeecceeeecceEEEEEEec
Q 002673 607 DNFSQANIIGCGGFGLVYKATLAN-GTTLAIKKLSGDLGLMEREFKAEVEALSTAQHKNLVSLQGYCVHQGFRLLIYSYM 685 (894)
Q Consensus 607 ~~f~~~~~LG~G~fg~Vy~a~~~~-g~~vAvK~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~lV~E~~ 685 (894)
.+....++||.|-||.||.|.|+. .-.||||.++.+ ....++|..|..+|+.++|||+|+|+|+|..+...|||+|||
T Consensus 267 tdItMkhKLGGGQYGeVYeGvWKkyslTvAVKtLKED-tMeveEFLkEAAvMKeikHpNLVqLLGVCT~EpPFYIiTEfM 345 (1157)
T KOG4278|consen 267 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED-TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTHEPPFYIITEFM 345 (1157)
T ss_pred hheeeeeccCCCcccceeeeeeeccceeeehhhhhhc-chhHHHHHHHHHHHHhhcCccHHHHhhhhccCCCeEEEEecc
Confidence 455677899999999999999764 567999999865 445678999999999999999999999999999999999999
Q ss_pred cCCCHHHHHhhhcCCCCCcCHHHHHHHHHHHHHHHHHHHhccCCCeeecCCCCCCeEECCCCcEEEEEcccccccCCCCC
Q 002673 686 ENGSLDYWLHEKADGASQLDWLTRLKIARGTSCGLAYMHQICEPHIVHRDIKSSNILLDDQFEAHLADFGLSRLILPYQT 765 (894)
Q Consensus 686 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDLkp~NILld~~~~vkl~DFGla~~~~~~~~ 765 (894)
..|+|.+||++... ..++-...+.++.||+.||+||.. +++|||||.++|+|+.++..|||+|||+++.+..+..
T Consensus 346 ~yGNLLdYLRecnr--~ev~avvLlyMAtQIsSaMeYLEk---knFIHRDLAARNCLVgEnhiVKvADFGLsRlMtgDTY 420 (1157)
T KOG4278|consen 346 CYGNLLDYLRECNR--SEVPAVVLLYMATQISSAMEYLEK---KNFIHRDLAARNCLVGENHIVKVADFGLSRLMTGDTY 420 (1157)
T ss_pred cCccHHHHHHHhch--hhcchhHHHHHHHHHHHHHHHHHH---hhhhhhhhhhhhccccccceEEeeccchhhhhcCCce
Confidence 99999999998653 456677789999999999999996 6999999999999999999999999999998754433
Q ss_pred cccccccccCCccCcccccCcCCCccccHHHHHHHHHHHHc-CCCCCCCCCcchhhhHHHHHHHHhhcCCCCcccccccc
Q 002673 766 HVTTELVGTLGYIPPEYGQAWVATLRGDMYSFGVVMLELLT-GKRPVDVLKPKMSRELVGWVLKMRSEGKQDQVFDPILR 844 (894)
Q Consensus 766 ~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwS~GvlL~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~ 844 (894)
.......-...|.|||-+....++.|+|||+|||+|||+.| |..||.+.+......+++ .+...+ .
T Consensus 421 TAHAGAKFPIKWTAPEsLAyNtFSiKSDVWAFGVLLWEIATYGMsPYPGidlSqVY~LLE-------kgyRM~------~ 487 (1157)
T KOG4278|consen 421 TAHAGAKFPIKWTAPESLAYNTFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYGLLE-------KGYRMD------G 487 (1157)
T ss_pred ecccCccCcccccCcccccccccccchhhHHHHHHHHHHHhcCCCCCCCccHHHHHHHHh-------cccccc------C
Confidence 33333334568999999999999999999999999999999 999997655433333222 111110 1
Q ss_pred CCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhc
Q 002673 845 GKGFDEEMLQVLDVACMCVSQNPFKRPTVKEVVEWLNNV 883 (894)
Q Consensus 845 ~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~i 883 (894)
.+++ ...+++|+..||+++|.+||++.|+-+.|+.+
T Consensus 488 PeGC---PpkVYeLMraCW~WsPsDRPsFaeiHqafEtm 523 (1157)
T KOG4278|consen 488 PEGC---PPKVYELMRACWNWSPSDRPSFAEIHQAFETM 523 (1157)
T ss_pred CCCC---CHHHHHHHHHHhcCCcccCccHHHHHHHHHHH
Confidence 1223 23577899999999999999999999988765
|
|
| >cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-35 Score=325.09 Aligned_cols=257 Identities=22% Similarity=0.388 Sum_probs=202.6
Q ss_pred cCCCccceEeecCcEEEEEEEEc-CCC----eEEEEEEcCcc-hhhHHHHHHHHHHHHhcCCCceeeecceeeecceEEE
Q 002673 607 DNFSQANIIGCGGFGLVYKATLA-NGT----TLAIKKLSGDL-GLMEREFKAEVEALSTAQHKNLVSLQGYCVHQGFRLL 680 (894)
Q Consensus 607 ~~f~~~~~LG~G~fg~Vy~a~~~-~g~----~vAvK~~~~~~-~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~l 680 (894)
.+|+..+.||+|+||.||+|.+. ++. .||+|++.... ....+.+.+|+.+++.++||||++++|+|... ..++
T Consensus 7 ~~f~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~g~~~~~-~~~~ 85 (316)
T cd05108 7 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQL 85 (316)
T ss_pred hhceeeeeeecCCCceEEEEEEecCCCccceeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEcCC-Ccee
Confidence 46888999999999999999853 444 38999987543 33456788999999999999999999999865 5679
Q ss_pred EEEeccCCCHHHHHhhhcCCCCCcCHHHHHHHHHHHHHHHHHHHhccCCCeeecCCCCCCeEECCCCcEEEEEccccccc
Q 002673 681 IYSYMENGSLDYWLHEKADGASQLDWLTRLKIARGTSCGLAYMHQICEPHIVHRDIKSSNILLDDQFEAHLADFGLSRLI 760 (894)
Q Consensus 681 V~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDLkp~NILld~~~~vkl~DFGla~~~ 760 (894)
|+||+++|+|.+++.... ..+++...+.++.||+.||+|||+ ++|+||||||+|||++.++.+||+|||+++..
T Consensus 86 v~e~~~~g~l~~~l~~~~---~~~~~~~~~~~~~qi~~~L~~LH~---~~iiH~dlkp~Nill~~~~~~kl~DfG~a~~~ 159 (316)
T cd05108 86 ITQLMPFGCLLDYVREHK---DNIGSQYLLNWCVQIAKGMNYLEE---RRLVHRDLAARNVLVKTPQHVKITDFGLAKLL 159 (316)
T ss_pred eeecCCCCCHHHHHHhcc---ccCCHHHHHHHHHHHHHHHHHHHh---cCeeccccchhheEecCCCcEEEccccccccc
Confidence 999999999999998643 357888999999999999999997 59999999999999999999999999999876
Q ss_pred CCCCCcc-cccccccCCccCcccccCcCCCccccHHHHHHHHHHHHc-CCCCCCCCCcchhhhHHHHHHHHhhcCCCCcc
Q 002673 761 LPYQTHV-TTELVGTLGYIPPEYGQAWVATLRGDMYSFGVVMLELLT-GKRPVDVLKPKMSRELVGWVLKMRSEGKQDQV 838 (894)
Q Consensus 761 ~~~~~~~-~~~~~gt~~Y~APE~~~~~~~s~ksDVwS~GvlL~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 838 (894)
....... .....++..|+|||++.+..++.++|||||||++|||++ |+.||+...... +.... ......
T Consensus 160 ~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slGv~l~el~t~g~~p~~~~~~~~---~~~~~----~~~~~~-- 230 (316)
T cd05108 160 GADEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASE---ISSIL----EKGERL-- 230 (316)
T ss_pred cCCCcceeccCCccceeecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHHH---HHHHH----hCCCCC--
Confidence 4332211 122234668999999999999999999999999999998 999997543221 11111 111100
Q ss_pred ccccccCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhcccc
Q 002673 839 FDPILRGKGFDEEMLQVLDVACMCVSQNPFKRPTVKEVVEWLNNVGAN 886 (894)
Q Consensus 839 ~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~i~~~ 886 (894)
..+ . .....+.+++..||+.+|++||++.+++..|..+...
T Consensus 231 ~~~----~---~~~~~~~~li~~cl~~~p~~Rps~~~l~~~l~~~~~~ 271 (316)
T cd05108 231 PQP----P---ICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARD 271 (316)
T ss_pred CCC----C---CCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHcC
Confidence 000 1 1123567899999999999999999999998877543
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor |
| >cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-35 Score=318.39 Aligned_cols=261 Identities=27% Similarity=0.470 Sum_probs=208.7
Q ss_pred cCCCccceEeecCcEEEEEEEE------cCCCeEEEEEEcCcchhhHHHHHHHHHHHHhcCCCceeeecceeeecceEEE
Q 002673 607 DNFSQANIIGCGGFGLVYKATL------ANGTTLAIKKLSGDLGLMEREFKAEVEALSTAQHKNLVSLQGYCVHQGFRLL 680 (894)
Q Consensus 607 ~~f~~~~~LG~G~fg~Vy~a~~------~~g~~vAvK~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~l 680 (894)
++|.+.+.||+|+||.||++.. .++..+|+|.+..........+.+|+.++++++||||+++++++...+..++
T Consensus 5 ~~~~~~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 84 (288)
T cd05093 5 HNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLIM 84 (288)
T ss_pred HHeeeccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCCcCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccEE
Confidence 5688889999999999999974 2345689999886655556789999999999999999999999999999999
Q ss_pred EEEeccCCCHHHHHhhhc---------CCCCCcCHHHHHHHHHHHHHHHHHHHhccCCCeeecCCCCCCeEECCCCcEEE
Q 002673 681 IYSYMENGSLDYWLHEKA---------DGASQLDWLTRLKIARGTSCGLAYMHQICEPHIVHRDIKSSNILLDDQFEAHL 751 (894)
Q Consensus 681 V~E~~~~gsL~~~l~~~~---------~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDLkp~NILld~~~~vkl 751 (894)
||||+++++|.+++.... .....+++..++.++.|++.||+|||+ ++++||||||+||++++++.+||
T Consensus 85 v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~---~~i~H~dlkp~Nili~~~~~~kl 161 (288)
T cd05093 85 VFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLAS---QHFVHRDLATRNCLVGENLLVKI 161 (288)
T ss_pred EEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHh---CCeeecccCcceEEEccCCcEEe
Confidence 999999999999997542 122358999999999999999999997 59999999999999999999999
Q ss_pred EEcccccccCCCCC-cccccccccCCccCcccccCcCCCccccHHHHHHHHHHHHc-CCCCCCCCCcchhhhHHHHHHHH
Q 002673 752 ADFGLSRLILPYQT-HVTTELVGTLGYIPPEYGQAWVATLRGDMYSFGVVMLELLT-GKRPVDVLKPKMSRELVGWVLKM 829 (894)
Q Consensus 752 ~DFGla~~~~~~~~-~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwS~GvlL~ellt-G~~Pf~~~~~~~~~~~~~~~~~~ 829 (894)
+|||+++....... .......++..|+|||++.+..++.++|||||||++|+|++ |..||....... .....
T Consensus 162 ~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~t~g~~p~~~~~~~~---~~~~i--- 235 (288)
T cd05093 162 GDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNE---VIECI--- 235 (288)
T ss_pred ccCCccccccCCceeecCCCCCccccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHH---HHHHH---
Confidence 99999986532221 11223345778999999998899999999999999999998 999997544321 11111
Q ss_pred hhcCCCCccccccccCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhcccc
Q 002673 830 RSEGKQDQVFDPILRGKGFDEEMLQVLDVACMCVSQNPFKRPTVKEVVEWLNNVGAN 886 (894)
Q Consensus 830 ~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~i~~~ 886 (894)
..+..... ... ....+.+++.+||+.||.+|||+.++++.|+++...
T Consensus 236 -~~~~~~~~------~~~---~~~~l~~li~~~l~~~p~~Rpt~~~v~~~l~~~~~~ 282 (288)
T cd05093 236 -TQGRVLQR------PRT---CPKEVYDLMLGCWQREPHMRLNIKEIHSLLQNLAKA 282 (288)
T ss_pred -HcCCcCCC------CCC---CCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHHHh
Confidence 11111110 011 123578999999999999999999999999988653
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly |
| >cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-35 Score=315.71 Aligned_cols=252 Identities=26% Similarity=0.419 Sum_probs=202.1
Q ss_pred cCCCccceEeecCcEEEEEEEEcCCCeEEEEEEcCcchhhHHHHHHHHHHHHhcCCCceeeecceeeecceEEEEEEecc
Q 002673 607 DNFSQANIIGCGGFGLVYKATLANGTTLAIKKLSGDLGLMEREFKAEVEALSTAQHKNLVSLQGYCVHQGFRLLIYSYME 686 (894)
Q Consensus 607 ~~f~~~~~LG~G~fg~Vy~a~~~~g~~vAvK~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~lV~E~~~ 686 (894)
++|+..+.||+|+||.||+|.+.++..+|+|.+.... .....+.+|+.++++++||||+++++++......++||||+.
T Consensus 4 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~aik~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 82 (256)
T cd05113 4 KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGS-MSEDEFIEEAKVMMKLSHEKLVQLYGVCTKQRPIYIVTEYMS 82 (256)
T ss_pred HHeEEeeEecCcccceEEEEEecCCCcEEEEEcCCCc-ccHHHHHHHHHHHhcCCCCCeeeEEEEEccCCCcEEEEEcCC
Confidence 4577889999999999999998777789999987543 334678999999999999999999999998888999999999
Q ss_pred CCCHHHHHhhhcCCCCCcCHHHHHHHHHHHHHHHHHHHhccCCCeeecCCCCCCeEECCCCcEEEEEcccccccCCCCCc
Q 002673 687 NGSLDYWLHEKADGASQLDWLTRLKIARGTSCGLAYMHQICEPHIVHRDIKSSNILLDDQFEAHLADFGLSRLILPYQTH 766 (894)
Q Consensus 687 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDLkp~NILld~~~~vkl~DFGla~~~~~~~~~ 766 (894)
+|+|.+++.... ..+++..++.++.||+.||.|||+ ++++|+||||+||+++.++.+||+|||+++........
T Consensus 83 ~~~l~~~i~~~~---~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dl~p~nili~~~~~~kl~d~g~~~~~~~~~~~ 156 (256)
T cd05113 83 NGCLLNYLREHG---KRFQPSQLLEMCKDVCEGMAYLES---KQFIHRDLAARNCLVDDQGCVKVSDFGLSRYVLDDEYT 156 (256)
T ss_pred CCcHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHh---CCeeccccCcceEEEcCCCCEEECCCccceecCCCcee
Confidence 999999997542 358999999999999999999997 59999999999999999999999999998865332221
Q ss_pred ccccccccCCccCcccccCcCCCccccHHHHHHHHHHHHc-CCCCCCCCCcchhhhHHHHHHHHhhcCCCCccccccccC
Q 002673 767 VTTELVGTLGYIPPEYGQAWVATLRGDMYSFGVVMLELLT-GKRPVDVLKPKMSRELVGWVLKMRSEGKQDQVFDPILRG 845 (894)
Q Consensus 767 ~~~~~~gt~~Y~APE~~~~~~~s~ksDVwS~GvlL~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~ 845 (894)
......++..|+|||+..+..++.++||||||+++|+|++ |+.||....... ..... . .+..... +
T Consensus 157 ~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~---~~~~~---~-~~~~~~~--~---- 223 (256)
T cd05113 157 SSVGSKFPVRWSPPEVLLYSKFSSKSDVWAFGVLMWEVYSLGKMPYERFNNSE---TVEKV---S-QGLRLYR--P---- 223 (256)
T ss_pred ecCCCccChhhCCHHHHhcCcccchhHHHHHHHHHHHHhcCCCCCcCcCCHHH---HHHHH---h-cCCCCCC--C----
Confidence 1222335678999999988889999999999999999999 999997544321 11111 1 1111100 0
Q ss_pred CCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 002673 846 KGFDEEMLQVLDVACMCVSQNPFKRPTVKEVVEWLN 881 (894)
Q Consensus 846 ~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~ 881 (894)
. .....+.+++.+||+.+|.+||++.++++.|+
T Consensus 224 ~---~~~~~~~~li~~cl~~~p~~Rp~~~~ll~~~~ 256 (256)
T cd05113 224 H---LASEKVYAIMYSCWHEKAEERPTFQQLLSSIE 256 (256)
T ss_pred C---CCCHHHHHHHHHHcCCCcccCCCHHHHHHhhC
Confidence 0 11246788999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds |
| >KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-36 Score=335.53 Aligned_cols=240 Identities=26% Similarity=0.341 Sum_probs=198.6
Q ss_pred ccCCCccceEeecCcEEEEEEEE-cCCCeEEEEEEcCcchh---hHHHHHHHHHHHHhc-CCCceeeecceeeecceEEE
Q 002673 606 TDNFSQANIIGCGGFGLVYKATL-ANGTTLAIKKLSGDLGL---MEREFKAEVEALSTA-QHKNLVSLQGYCVHQGFRLL 680 (894)
Q Consensus 606 ~~~f~~~~~LG~G~fg~Vy~a~~-~~g~~vAvK~~~~~~~~---~~~~~~~Ei~~l~~l-~HpnIv~l~g~~~~~~~~~l 680 (894)
-++|...++||+|+||+|+++.. .+++.+|||+++++.-. +.+..+.|-+++... +||.+++++..|.+.++.++
T Consensus 367 l~~F~~l~vLGkGsFGkV~lae~k~~~e~yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~~HPFL~~L~~~fQT~~~l~f 446 (694)
T KOG0694|consen 367 LDDFRLLAVLGRGSFGKVLLAELKGTNEYYAIKVLKKGDILQRDEVESLMCEKRIFELANRHPFLVNLFSCFQTKEHLFF 446 (694)
T ss_pred ccceEEEEEeccCcCceEEEEEEcCCCcEEEEEEeeccceeccccHHHHHHHHHHHHHhccCCeEeecccccccCCeEEE
Confidence 46889999999999999999984 57889999999986532 234567788888777 59999999999999999999
Q ss_pred EEEeccCCCHHHHHhhhcCCCCCcCHHHHHHHHHHHHHHHHHHHhccCCCeeecCCCCCCeEECCCCcEEEEEccccccc
Q 002673 681 IYSYMENGSLDYWLHEKADGASQLDWLTRLKIARGTSCGLAYMHQICEPHIVHRDIKSSNILLDDQFEAHLADFGLSRLI 760 (894)
Q Consensus 681 V~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDLkp~NILld~~~~vkl~DFGla~~~ 760 (894)
||||+.||++..+.+ ...++...+..++..|+.||.|||+ ++||+||||-+|||||.+|.+||+|||+++..
T Consensus 447 vmey~~Ggdm~~~~~-----~~~F~e~rarfyaAev~l~L~fLH~---~~IIYRDlKLdNiLLD~eGh~kiADFGlcKe~ 518 (694)
T KOG0694|consen 447 VMEYVAGGDLMHHIH-----TDVFSEPRARFYAAEVVLGLQFLHE---NGIIYRDLKLDNLLLDTEGHVKIADFGLCKEG 518 (694)
T ss_pred EEEecCCCcEEEEEe-----cccccHHHHHHHHHHHHHHHHHHHh---cCceeeecchhheEEcccCcEEeccccccccc
Confidence 999999999544443 2469999999999999999999997 69999999999999999999999999999964
Q ss_pred CCCCCcccccccccCCccCcccccCcCCCccccHHHHHHHHHHHHcCCCCCCCCCcchhhhHHHHHHHHhhcCCCCcccc
Q 002673 761 LPYQTHVTTELVGTLGYIPPEYGQAWVATLRGDMYSFGVVMLELLTGKRPVDVLKPKMSRELVGWVLKMRSEGKQDQVFD 840 (894)
Q Consensus 761 ~~~~~~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwS~GvlL~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 840 (894)
.. ....+++.+||+.|||||++.+..|+..+|+|||||+||||+.|..||.+...++ ++|
T Consensus 519 m~-~g~~TsTfCGTpey~aPEil~e~~Yt~aVDWW~lGVLlyeML~Gq~PF~gddEee-------------------~Fd 578 (694)
T KOG0694|consen 519 MG-QGDRTSTFCGTPEFLAPEVLTEQSYTRAVDWWGLGVLLYEMLVGESPFPGDDEEE-------------------VFD 578 (694)
T ss_pred CC-CCCccccccCChhhcChhhhccCcccchhhHHHHHHHHHHHHcCCCCCCCCCHHH-------------------HHH
Confidence 32 3346788999999999999999999999999999999999999999998544322 111
Q ss_pred ccccC--CCChHHHHHHHHHHHHhcccCCCCCCCH
Q 002673 841 PILRG--KGFDEEMLQVLDVACMCVSQNPFKRPTV 873 (894)
Q Consensus 841 ~~l~~--~~~~~~~~~l~~li~~Cl~~dP~~RPs~ 873 (894)
.++.. .+..-...+.++++.+++..+|++|.-+
T Consensus 579 sI~~d~~~yP~~ls~ea~~il~~ll~k~p~kRLG~ 613 (694)
T KOG0694|consen 579 SIVNDEVRYPRFLSKEAIAIMRRLLRKNPEKRLGS 613 (694)
T ss_pred HHhcCCCCCCCcccHHHHHHHHHHhccCcccccCC
Confidence 11110 1111223456788889999999999977
|
|
| >KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-35 Score=295.77 Aligned_cols=264 Identities=23% Similarity=0.266 Sum_probs=211.8
Q ss_pred ccCCCccceEeecCcEEEEEEE-EcCCCeEEEEEEcCcchhhHHHHHHHHHHHHhcCCCceeeecceeeecc-----eEE
Q 002673 606 TDNFSQANIIGCGGFGLVYKAT-LANGTTLAIKKLSGDLGLMEREFKAEVEALSTAQHKNLVSLQGYCVHQG-----FRL 679 (894)
Q Consensus 606 ~~~f~~~~~LG~G~fg~Vy~a~-~~~g~~vAvK~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~-----~~~ 679 (894)
.++|.+.+.||+|||+.||.+. ..++..+|+|++.-......+..++|++..++++|||++++++++..+. +.|
T Consensus 20 ~~Ryri~~~LgeGGfsfv~LV~~~s~~~~YAlKkI~c~~~~~~e~~~rEid~~rkf~s~~vl~l~dh~l~~~~D~~~~~y 99 (302)
T KOG2345|consen 20 NKRYRIQRLLGEGGFSFVDLVKGLSTGHLYALKKILCHSQEDIEEALREIDNHRKFNSPNVLRLVDHQLREEKDGKHEAY 99 (302)
T ss_pred CceEEEeeeecCCCceeeeeecccCcccchhhheeeccchHHHHHHHHHHHHHHhhCCcchHHHHHHHHHhhccCceeEE
Confidence 4689999999999999999998 7889999999998776667788999999999999999999999886543 589
Q ss_pred EEEEeccCCCHHHHHhhhcCCCCCcCHHHHHHHHHHHHHHHHHHHhccCCCeeecCCCCCCeEECCCCcEEEEEcccccc
Q 002673 680 LIYSYMENGSLDYWLHEKADGASQLDWLTRLKIARGTSCGLAYMHQICEPHIVHRDIKSSNILLDDQFEAHLADFGLSRL 759 (894)
Q Consensus 680 lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDLkp~NILld~~~~vkl~DFGla~~ 759 (894)
++++|...|+|.+.+......+..++..+.++|+.+|++||++||.. .+++.||||||.|||+++++.+++.|||.++.
T Consensus 100 ll~Pyy~~Gsl~d~i~~~k~kg~~~sE~~iL~if~gic~gL~~lH~~-~~~yAH~DiKP~NILls~~~~~vl~D~GS~~~ 178 (302)
T KOG2345|consen 100 LLLPYYKRGSLLDEIERLKIKGNFVSEAQILWIFLGICRGLEALHEK-EPPYAHRDIKPANILLSDSGLPVLMDLGSATQ 178 (302)
T ss_pred EEeehhccccHHHHHHHHhhcCCccCHHHHHHHHHHHHHHHHHHhcc-CCcccccCCCcceeEecCCCceEEEeccCccc
Confidence 99999999999999998777778899999999999999999999985 55799999999999999999999999999986
Q ss_pred cCCCCCcc--------cccccccCCccCccccc---CcCCCccccHHHHHHHHHHHHcCCCCCCCCCcchhhhHHHHHHH
Q 002673 760 ILPYQTHV--------TTELVGTLGYIPPEYGQ---AWVATLRGDMYSFGVVMLELLTGKRPVDVLKPKMSRELVGWVLK 828 (894)
Q Consensus 760 ~~~~~~~~--------~~~~~gt~~Y~APE~~~---~~~~s~ksDVwS~GvlL~elltG~~Pf~~~~~~~~~~~~~~~~~ 828 (894)
..-.-... ......|..|.|||.+. +...++++|||||||+||.|+.|..||+....
T Consensus 179 a~i~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk~~~ti~ertDIWSLGCtLYa~mf~~sPfe~~~~------------ 246 (302)
T KOG2345|consen 179 APIQIEGSRQALRLQEWAEERCTIPYRAPELFNVKSHCTITERTDIWSLGCTLYAMMFGESPFERIYQ------------ 246 (302)
T ss_pred cceEeechHHHHHHHHHHHHhCCCcccCchheecccCcccccccchhhhhHHHHHHHHcCCcchHHhh------------
Confidence 53111100 11234688999999764 34568999999999999999999999973221
Q ss_pred HhhcCCCC-ccccccccCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhcc
Q 002673 829 MRSEGKQD-QVFDPILRGKGFDEEMLQVLDVACMCVSQNPFKRPTVKEVVEWLNNVG 884 (894)
Q Consensus 829 ~~~~~~~~-~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~i~ 884 (894)
+.+.+. .+....+.-...+.....+.+++.+|++.||.+||++.+++..++.+.
T Consensus 247 --~GgSlaLAv~n~q~s~P~~~~yse~l~~lik~mlqvdP~qRP~i~~ll~~~d~Li 301 (302)
T KOG2345|consen 247 --QGGSLALAVQNAQISIPNSSRYSEALHQLIKSMLQVDPNQRPTIPELLSKLDDLI 301 (302)
T ss_pred --cCCeEEEeeeccccccCCCCCccHHHHHHHHHHhcCCcccCCCHHHHHHHHHhhc
Confidence 111110 111111111111224556788999999999999999999999887653
|
|
| >cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-35 Score=318.06 Aligned_cols=267 Identities=25% Similarity=0.353 Sum_probs=200.0
Q ss_pred CCccceEeecCcEEEEEEEE-----cCCCeEEEEEEcCcch-hhHHHHHHHHHHHHhcCCCceeeecceeeec--ceEEE
Q 002673 609 FSQANIIGCGGFGLVYKATL-----ANGTTLAIKKLSGDLG-LMEREFKAEVEALSTAQHKNLVSLQGYCVHQ--GFRLL 680 (894)
Q Consensus 609 f~~~~~LG~G~fg~Vy~a~~-----~~g~~vAvK~~~~~~~-~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~--~~~~l 680 (894)
|+..+.||+|+||.||++.. .++..||+|.+..... .....+.+|++++++++||||+++++++... ...++
T Consensus 6 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~l 85 (283)
T cd05080 6 LKKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIVKYKGCCSEQGGKGLQL 85 (283)
T ss_pred ceeceecccCCCcEEEEeeEccccCCCCceEEEEEeccccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCceEEE
Confidence 37789999999999988653 3678899999976532 3456788999999999999999999988754 35789
Q ss_pred EEEeccCCCHHHHHhhhcCCCCCcCHHHHHHHHHHHHHHHHHHHhccCCCeeecCCCCCCeEECCCCcEEEEEccccccc
Q 002673 681 IYSYMENGSLDYWLHEKADGASQLDWLTRLKIARGTSCGLAYMHQICEPHIVHRDIKSSNILLDDQFEAHLADFGLSRLI 760 (894)
Q Consensus 681 V~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDLkp~NILld~~~~vkl~DFGla~~~ 760 (894)
||||+++|+|.+++... .+++..+..++.|++.||.|||+ ++++||||||+||++++++.+||+|||+++..
T Consensus 86 v~e~~~~~~l~~~~~~~-----~l~~~~~~~i~~~l~~~l~~lH~---~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~ 157 (283)
T cd05080 86 IMEYVPLGSLRDYLPKH-----KLNLAQLLLFAQQICEGMAYLHS---QHYIHRDLAARNVLLDNDRLVKIGDFGLAKAV 157 (283)
T ss_pred EecCCCCCCHHHHHHHc-----CCCHHHHHHHHHHHHHHHHHHHH---CCeeccccChheEEEcCCCcEEEeeccccccc
Confidence 99999999999999753 48999999999999999999997 59999999999999999999999999999865
Q ss_pred CCCCCc--ccccccccCCccCcccccCcCCCccccHHHHHHHHHHHHcCCCCCCCCCcchhhhHHHHHHHHhhcCCCCcc
Q 002673 761 LPYQTH--VTTELVGTLGYIPPEYGQAWVATLRGDMYSFGVVMLELLTGKRPVDVLKPKMSRELVGWVLKMRSEGKQDQV 838 (894)
Q Consensus 761 ~~~~~~--~~~~~~gt~~Y~APE~~~~~~~s~ksDVwS~GvlL~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 838 (894)
...... ......++..|+|||...+..++.++||||||+++|||++|+.||....... .+.................
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~-~~~~~~~~~~~~~~~~~~~ 236 (283)
T cd05080 158 PEGHEYYRVREDGDSPVFWYAVECLKENKFSYASDVWSFGVTLYELLTHCDSKQSPPKKF-EEMIGPKQGQMTVVRLIEL 236 (283)
T ss_pred CCcchhhccCCCCCCCceeeCHhHhcccCCCcccccHHHHHHHHHHHhCCCCCCCCcchh-hhhhcccccccchhhhhhh
Confidence 432211 1122335667999999988889999999999999999999999986443211 1111000000000000000
Q ss_pred ccccccCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhcc
Q 002673 839 FDPILRGKGFDEEMLQVLDVACMCVSQNPFKRPTVKEVVEWLNNVG 884 (894)
Q Consensus 839 ~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~i~ 884 (894)
.+..............+.+++..||+.+|++|||+++++++|+++.
T Consensus 237 ~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~i~~~l~~~~ 282 (283)
T cd05080 237 LERGMRLPCPKNCPQEVYILMKNCWETEAKFRPTFRSLIPILKEMH 282 (283)
T ss_pred hhcCCCCCCCCCCCHHHHHHHHHHhccChhhCCCHHHHHHHHHHhh
Confidence 0000000011122346788999999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign |
| >cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-35 Score=326.06 Aligned_cols=251 Identities=25% Similarity=0.308 Sum_probs=197.9
Q ss_pred CCCccceEeecCcEEEEEEEE----cCCCeEEEEEEcCcch----hhHHHHHHHHHHHHhc-CCCceeeecceeeecceE
Q 002673 608 NFSQANIIGCGGFGLVYKATL----ANGTTLAIKKLSGDLG----LMEREFKAEVEALSTA-QHKNLVSLQGYCVHQGFR 678 (894)
Q Consensus 608 ~f~~~~~LG~G~fg~Vy~a~~----~~g~~vAvK~~~~~~~----~~~~~~~~Ei~~l~~l-~HpnIv~l~g~~~~~~~~ 678 (894)
+|++.+.||+|+||.||+++. .++..||+|++..... .....+..|+.++..+ +|+||+++++++..++..
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~ 80 (332)
T cd05614 1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAFQTEAKL 80 (332)
T ss_pred CceEEEEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEEEecCCEE
Confidence 478889999999999999974 3688999999875321 2234578899999999 599999999999999999
Q ss_pred EEEEEeccCCCHHHHHhhhcCCCCCcCHHHHHHHHHHHHHHHHHHHhccCCCeeecCCCCCCeEECCCCcEEEEEccccc
Q 002673 679 LLIYSYMENGSLDYWLHEKADGASQLDWLTRLKIARGTSCGLAYMHQICEPHIVHRDIKSSNILLDDQFEAHLADFGLSR 758 (894)
Q Consensus 679 ~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDLkp~NILld~~~~vkl~DFGla~ 758 (894)
++||||+++|+|.+++... ..+++..+..++.||+.||.|||+ ++|+||||||+|||++.++.+||+|||+++
T Consensus 81 ~lv~e~~~~g~L~~~l~~~----~~~~~~~~~~~~~qi~~~l~~lH~---~~ivHrDlkp~Nili~~~~~~kl~DfG~~~ 153 (332)
T cd05614 81 HLILDYVSGGEMFTHLYQR----DNFSEDEVRFYSGEIILALEHLHK---LGIVYRDIKLENILLDSEGHVVLTDFGLSK 153 (332)
T ss_pred EEEEeCCCCCcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHH---CCcEecCCCHHHeEECCCCCEEEeeCcCCc
Confidence 9999999999999998754 358889999999999999999997 599999999999999999999999999998
Q ss_pred ccCCCCCcccccccccCCccCcccccCc-CCCccccHHHHHHHHHHHHcCCCCCCCCCcchhhhHHHHHHHHhhcCCCCc
Q 002673 759 LILPYQTHVTTELVGTLGYIPPEYGQAW-VATLRGDMYSFGVVMLELLTGKRPVDVLKPKMSRELVGWVLKMRSEGKQDQ 837 (894)
Q Consensus 759 ~~~~~~~~~~~~~~gt~~Y~APE~~~~~-~~s~ksDVwS~GvlL~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 837 (894)
..............||+.|+|||++.+. .++.++|||||||++|||++|+.||............ ........
T Consensus 154 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~--~~~~~~~~---- 227 (332)
T cd05614 154 EFLSEEKERTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLEGERNTQSEV--SRRILKCD---- 227 (332)
T ss_pred cccccCCCccccccCCccccCHHHhcCCCCCCCccccccchhhhhhhhcCCCCCCCCCCCCCHHHH--HHHHhcCC----
Confidence 6544333334456799999999998875 4788999999999999999999999744322111111 11111100
Q ss_pred cccccccCCCChHHHHHHHHHHHHhcccCCCCCC-----CHHHHHH
Q 002673 838 VFDPILRGKGFDEEMLQVLDVACMCVSQNPFKRP-----TVKEVVE 878 (894)
Q Consensus 838 ~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RP-----s~~evl~ 878 (894)
+.+. ......+.+++.+|++.||++|| +++++++
T Consensus 228 ---~~~~----~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~ 266 (332)
T cd05614 228 ---PPFP----SFIGPEAQDLLHKLLRKDPKKRLGAGPQGASEIKE 266 (332)
T ss_pred ---CCCC----CCCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHHc
Confidence 1111 01123466889999999999999 7888886
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-35 Score=313.73 Aligned_cols=251 Identities=25% Similarity=0.420 Sum_probs=200.5
Q ss_pred cCCCccceEeecCcEEEEEEEEcCCCeEEEEEEcCcchhhHHHHHHHHHHHHhcCCCceeeecceeeecceEEEEEEecc
Q 002673 607 DNFSQANIIGCGGFGLVYKATLANGTTLAIKKLSGDLGLMEREFKAEVEALSTAQHKNLVSLQGYCVHQGFRLLIYSYME 686 (894)
Q Consensus 607 ~~f~~~~~LG~G~fg~Vy~a~~~~g~~vAvK~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~lV~E~~~ 686 (894)
.+|+..+.||+|+||.||+|.+.++..+|+|.+.... .....+.+|+.+++.++||||+++++++...+..++||||++
T Consensus 4 ~~~~~~~~lg~G~~~~v~~~~~~~~~~~~iK~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~ 82 (256)
T cd05059 4 SELTFLKELGSGQFGVVHLGKWRGKIDVAIKMIREGA-MSEDDFIEEAKVMMKLSHPNLVQLYGVCTKQRPIFIVTEYMA 82 (256)
T ss_pred HHcchhhhhccCCCceEEEeEecCCccEEEEEeccCC-CCHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCceEEEEecCC
Confidence 3577889999999999999998777889999986532 234568889999999999999999999999999999999999
Q ss_pred CCCHHHHHhhhcCCCCCcCHHHHHHHHHHHHHHHHHHHhccCCCeeecCCCCCCeEECCCCcEEEEEcccccccCCCCCc
Q 002673 687 NGSLDYWLHEKADGASQLDWLTRLKIARGTSCGLAYMHQICEPHIVHRDIKSSNILLDDQFEAHLADFGLSRLILPYQTH 766 (894)
Q Consensus 687 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDLkp~NILld~~~~vkl~DFGla~~~~~~~~~ 766 (894)
+++|.+++.... ..+++..++.++.|++.||+|||+ ++++||||||+||++++++.+||+|||+++........
T Consensus 83 ~~~L~~~l~~~~---~~~~~~~~~~i~~qi~~~l~~lH~---~~i~H~dl~p~ni~i~~~~~~kl~dfg~~~~~~~~~~~ 156 (256)
T cd05059 83 NGCLLNYLRERK---GKLGTEWLLDMCSDVCEAMEYLES---NGFIHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQYT 156 (256)
T ss_pred CCCHHHHHHhcc---cCCCHHHHHHHHHHHHHHHHHHHH---CCcccccccHhhEEECCCCcEEECCcccceeccccccc
Confidence 999999997543 368999999999999999999997 59999999999999999999999999998765322211
Q ss_pred ccccccccCCccCcccccCcCCCccccHHHHHHHHHHHHc-CCCCCCCCCcchhhhHHHHHHHHhhcCCCCccccccccC
Q 002673 767 VTTELVGTLGYIPPEYGQAWVATLRGDMYSFGVVMLELLT-GKRPVDVLKPKMSRELVGWVLKMRSEGKQDQVFDPILRG 845 (894)
Q Consensus 767 ~~~~~~gt~~Y~APE~~~~~~~s~ksDVwS~GvlL~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~ 845 (894)
......++..|+|||+..+..++.++||||||+++|+|++ |+.||....... ... ........ . .+
T Consensus 157 ~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~---~~~---~~~~~~~~-~--~~---- 223 (256)
T cd05059 157 SSQGTKFPVKWAPPEVFDYSRFSSKSDVWSFGVLMWEVFSEGKMPYERFSNSE---VVE---SVSAGYRL-Y--RP---- 223 (256)
T ss_pred ccCCCCCCccccCHHHhccCCCCchhhHHHHHHHHHHHhccCCCCCCCCCHHH---HHH---HHHcCCcC-C--CC----
Confidence 1112223457999999998899999999999999999999 899997543321 111 11111000 0 00
Q ss_pred CCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 002673 846 KGFDEEMLQVLDVACMCVSQNPFKRPTVKEVVEWL 880 (894)
Q Consensus 846 ~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L 880 (894)
. .....+.+++.+|++.+|++|||+.++++.|
T Consensus 224 ~---~~~~~~~~li~~cl~~~p~~Rpt~~~~l~~l 255 (256)
T cd05059 224 K---LAPTEVYTIMYSCWHEKPEDRPAFKKLLSQL 255 (256)
T ss_pred C---CCCHHHHHHHHHHhcCChhhCcCHHHHHHHh
Confidence 1 1233577899999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows |
| >cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-34 Score=310.06 Aligned_cols=262 Identities=24% Similarity=0.328 Sum_probs=209.9
Q ss_pred cCCCccceEeecCcEEEEEEEEc-CCCeEEEEEEcCcc---hhhHHHHHHHHHHHHhcCCCceeeecceeeecceEEEEE
Q 002673 607 DNFSQANIIGCGGFGLVYKATLA-NGTTLAIKKLSGDL---GLMEREFKAEVEALSTAQHKNLVSLQGYCVHQGFRLLIY 682 (894)
Q Consensus 607 ~~f~~~~~LG~G~fg~Vy~a~~~-~g~~vAvK~~~~~~---~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~lV~ 682 (894)
++|+..+.||+|+||.||+|... +|+.||+|.++... ......+.+|++++++++|+|++++++++..++..++||
T Consensus 2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~ei~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 81 (267)
T cd08224 2 GNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLASFIENNELNIVL 81 (267)
T ss_pred CceeeeeeeccCCceEEEEEEEcCCCCEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEEE
Confidence 57888999999999999999865 88999999886422 223467889999999999999999999999999999999
Q ss_pred EeccCCCHHHHHhhhcCCCCCcCHHHHHHHHHHHHHHHHHHHhccCCCeeecCCCCCCeEECCCCcEEEEEcccccccCC
Q 002673 683 SYMENGSLDYWLHEKADGASQLDWLTRLKIARGTSCGLAYMHQICEPHIVHRDIKSSNILLDDQFEAHLADFGLSRLILP 762 (894)
Q Consensus 683 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDLkp~NILld~~~~vkl~DFGla~~~~~ 762 (894)
||+++|+|..++.........+++..++.++.+++.||.|||+ .+++||||+|+||+++.++.++|+|||++.....
T Consensus 82 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~---~~i~h~dl~p~nil~~~~~~~~l~d~~~~~~~~~ 158 (267)
T cd08224 82 ELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHS---KRIMHRDIKPANVFITATGVVKLGDLGLGRFFSS 158 (267)
T ss_pred ecCCCCCHHHHHHHhcccCCCcCHHHHHHHHHHHHHHHHHHHh---CCEecCCcChhhEEECCCCcEEEeccceeeeccC
Confidence 9999999999987644444568999999999999999999997 5999999999999999999999999999876533
Q ss_pred CCCcccccccccCCccCcccccCcCCCccccHHHHHHHHHHHHcCCCCCCCCCcchhhhHHHHHHHHhhcCCCCcccccc
Q 002673 763 YQTHVTTELVGTLGYIPPEYGQAWVATLRGDMYSFGVVMLELLTGKRPVDVLKPKMSRELVGWVLKMRSEGKQDQVFDPI 842 (894)
Q Consensus 763 ~~~~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwS~GvlL~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 842 (894)
... ......++..|+|||++.+..++.++|||||||++|+|++|+.||...... ........ ..+.....
T Consensus 159 ~~~-~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~----~~~~~~~~-~~~~~~~~---- 228 (267)
T cd08224 159 KTT-AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMN----LYSLCKKI-EKCDYPPL---- 228 (267)
T ss_pred CCc-ccceecCCccccCHHHhccCCCCchhcHHHHHHHHHHHHHCCCCcccCCcc----HHHHHhhh-hcCCCCCC----
Confidence 221 123346888999999998888999999999999999999999999643211 11111111 11111111
Q ss_pred ccCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhccc
Q 002673 843 LRGKGFDEEMLQVLDVACMCVSQNPFKRPTVKEVVEWLNNVGA 885 (894)
Q Consensus 843 l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~i~~ 885 (894)
. .......+.+++.+|++.+|++|||+.+|++.|+++.+
T Consensus 229 ~----~~~~~~~~~~~i~~cl~~~p~~Rp~~~~il~~~~~~~~ 267 (267)
T cd08224 229 P----ADHYSEELRDLVSRCINPDPEKRPDISYVLQVAKEMHA 267 (267)
T ss_pred C----hhhcCHHHHHHHHHHcCCCcccCCCHHHHHHHHHHhcC
Confidence 0 01223467789999999999999999999999998753
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a |
| >cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-35 Score=317.91 Aligned_cols=261 Identities=26% Similarity=0.444 Sum_probs=209.2
Q ss_pred cCCCccceEeecCcEEEEEEEEc------CCCeEEEEEEcCcchhhHHHHHHHHHHHHhcCCCceeeecceeeecceEEE
Q 002673 607 DNFSQANIIGCGGFGLVYKATLA------NGTTLAIKKLSGDLGLMEREFKAEVEALSTAQHKNLVSLQGYCVHQGFRLL 680 (894)
Q Consensus 607 ~~f~~~~~LG~G~fg~Vy~a~~~------~g~~vAvK~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~l 680 (894)
.+|...+.||+|+||.||+|... ++..+++|.+........+.+.+|+.++++++|+||+++++++...+..++
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 84 (291)
T cd05094 5 RDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKFYGVCGDGDPLIM 84 (291)
T ss_pred HHeEEeeeecccCCCeEEEeEeeccCCCCcceeeEEEecCCccHHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCceEE
Confidence 45777899999999999999742 345689999887665556789999999999999999999999999999999
Q ss_pred EEEeccCCCHHHHHhhhcC------------CCCCcCHHHHHHHHHHHHHHHHHHHhccCCCeeecCCCCCCeEECCCCc
Q 002673 681 IYSYMENGSLDYWLHEKAD------------GASQLDWLTRLKIARGTSCGLAYMHQICEPHIVHRDIKSSNILLDDQFE 748 (894)
Q Consensus 681 V~E~~~~gsL~~~l~~~~~------------~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDLkp~NILld~~~~ 748 (894)
||||+++++|.+++..... ....+++..++.++.||+.||+|||+ ++++||||||+||+++.++.
T Consensus 85 v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~---~~i~H~dlkp~Nil~~~~~~ 161 (291)
T cd05094 85 VFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLAS---QHFVHRDLATRNCLVGANLL 161 (291)
T ss_pred EEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHHh---CCeeecccCcceEEEccCCc
Confidence 9999999999999976431 12358999999999999999999997 69999999999999999999
Q ss_pred EEEEEcccccccCCCCC-cccccccccCCccCcccccCcCCCccccHHHHHHHHHHHHc-CCCCCCCCCcchhhhHHHHH
Q 002673 749 AHLADFGLSRLILPYQT-HVTTELVGTLGYIPPEYGQAWVATLRGDMYSFGVVMLELLT-GKRPVDVLKPKMSRELVGWV 826 (894)
Q Consensus 749 vkl~DFGla~~~~~~~~-~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwS~GvlL~ellt-G~~Pf~~~~~~~~~~~~~~~ 826 (894)
++|+|||+++....... .......++..|+|||++.+..++.++||||||+++|||++ |+.||....... ....
T Consensus 162 ~~l~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~---~~~~- 237 (291)
T cd05094 162 VKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSNTE---VIEC- 237 (291)
T ss_pred EEECCCCcccccCCCceeecCCCCCcceeecChHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHH---HHHH-
Confidence 99999999976533221 12233456788999999999999999999999999999999 999987544321 1111
Q ss_pred HHHhhcCCCCccccccccCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhcccc
Q 002673 827 LKMRSEGKQDQVFDPILRGKGFDEEMLQVLDVACMCVSQNPFKRPTVKEVVEWLNNVGAN 886 (894)
Q Consensus 827 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~i~~~ 886 (894)
...+...... . .....+.+++.+||+.+|++||++++++++|+++...
T Consensus 238 ---~~~~~~~~~~------~---~~~~~~~~li~~~l~~~P~~Rpt~~~v~~~l~~~~~~ 285 (291)
T cd05094 238 ---ITQGRVLERP------R---VCPKEVYDIMLGCWQREPQQRLNIKEIYKILHALGKA 285 (291)
T ss_pred ---HhCCCCCCCC------c---cCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHHhh
Confidence 1111111110 1 1223577999999999999999999999999998553
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n |
| >cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-35 Score=313.56 Aligned_cols=261 Identities=24% Similarity=0.326 Sum_probs=208.1
Q ss_pred cCCCccceEeecCcEEEEEEE-EcCCCeEEEEEEcCcc---hhhHHHHHHHHHHHHhcCCCceeeecceeeecceEEEEE
Q 002673 607 DNFSQANIIGCGGFGLVYKAT-LANGTTLAIKKLSGDL---GLMEREFKAEVEALSTAQHKNLVSLQGYCVHQGFRLLIY 682 (894)
Q Consensus 607 ~~f~~~~~LG~G~fg~Vy~a~-~~~g~~vAvK~~~~~~---~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~lV~ 682 (894)
++|++.+.||+|+||.||+|. ..++..+|||.+.... ......+.+|+.+++.++|+||+++++++..++..+++|
T Consensus 2 ~~y~~~~~ig~g~~g~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~ 81 (267)
T cd08229 2 ANFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVL 81 (267)
T ss_pred chhhhhhhhcccCCeEEEEEeecCCCceEEEEeeeehhhhhHHHHHHHHHHHHHHHHccCCchhhhhheeEeCCeEEEEE
Confidence 467788999999999999998 4688999999876432 223457889999999999999999999999999999999
Q ss_pred EeccCCCHHHHHhhhcCCCCCcCHHHHHHHHHHHHHHHHHHHhccCCCeeecCCCCCCeEECCCCcEEEEEcccccccCC
Q 002673 683 SYMENGSLDYWLHEKADGASQLDWLTRLKIARGTSCGLAYMHQICEPHIVHRDIKSSNILLDDQFEAHLADFGLSRLILP 762 (894)
Q Consensus 683 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDLkp~NILld~~~~vkl~DFGla~~~~~ 762 (894)
||+++++|.+++.........+++..++.++.|++.||.|||+ ++++|+||||+||+++.++.++|+|||++.....
T Consensus 82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~---~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~ 158 (267)
T cd08229 82 ELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHS---RRVMHRDIKPANVFITATGVVKLGDLGLGRFFSS 158 (267)
T ss_pred EecCCCCHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHEEEcCCCCEEECcchhhhcccc
Confidence 9999999999997644344568999999999999999999997 5999999999999999999999999999876532
Q ss_pred CCCcccccccccCCccCcccccCcCCCccccHHHHHHHHHHHHcCCCCCCCCCcchhhhHHHHHHHHhhcCCCCcccccc
Q 002673 763 YQTHVTTELVGTLGYIPPEYGQAWVATLRGDMYSFGVVMLELLTGKRPVDVLKPKMSRELVGWVLKMRSEGKQDQVFDPI 842 (894)
Q Consensus 763 ~~~~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwS~GvlL~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 842 (894)
.. .......++..|+|||+..+..++.++||||||+++|+|++|..||...... .......... . ..+.
T Consensus 159 ~~-~~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~----~~~~~~~~~~-~-----~~~~ 227 (267)
T cd08229 159 KT-TAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMN----LYSLCKKIEQ-C-----DYPP 227 (267)
T ss_pred CC-cccccccCCcCccCHHHhcCCCccchhhHHHHHHHHHHHHhCCCCcccccch----HHHHhhhhhc-C-----CCCC
Confidence 22 1123356889999999999888999999999999999999999999643221 1111111110 0 0011
Q ss_pred ccCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhcc
Q 002673 843 LRGKGFDEEMLQVLDVACMCVSQNPFKRPTVKEVVEWLNNVG 884 (894)
Q Consensus 843 l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~i~ 884 (894)
... ......+.+++.+|++.+|++||||.+|++.+.++.
T Consensus 228 ~~~---~~~~~~~~~li~~~l~~~p~~Rpt~~~i~~~~~~~~ 266 (267)
T cd08229 228 LPS---DHYSEELRQLVNMCINPDPEKRPDITYVYDVAKRMH 266 (267)
T ss_pred CCc---ccccHHHHHHHHHhcCCCcccCCCHHHHHHHHhhhc
Confidence 111 112335778899999999999999999999998874
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. |
| >PLN00034 mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-35 Score=329.79 Aligned_cols=252 Identities=28% Similarity=0.438 Sum_probs=194.0
Q ss_pred cCCCccceEeecCcEEEEEEEE-cCCCeEEEEEEcCcc-hhhHHHHHHHHHHHHhcCCCceeeecceeeecceEEEEEEe
Q 002673 607 DNFSQANIIGCGGFGLVYKATL-ANGTTLAIKKLSGDL-GLMEREFKAEVEALSTAQHKNLVSLQGYCVHQGFRLLIYSY 684 (894)
Q Consensus 607 ~~f~~~~~LG~G~fg~Vy~a~~-~~g~~vAvK~~~~~~-~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~lV~E~ 684 (894)
++|+..+.||+|+||.||+|.. .+++.||||++.... ......+.+|+++++.++|+||+++++++...+..++||||
T Consensus 74 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 153 (353)
T PLN00034 74 SELERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVRRQICREIEILRDVNHPNVVKCHDMFDHNGEIQVLLEF 153 (353)
T ss_pred HHHhhhhhccCCCCeEEEEEEECCCCCEEEEEEEecCCcHHHHHHHHHHHHHHHhCCCCCcceeeeEeccCCeEEEEEec
Confidence 3456678899999999999985 478999999986543 23346789999999999999999999999999999999999
Q ss_pred ccCCCHHHHHhhhcCCCCCcCHHHHHHHHHHHHHHHHHHHhccCCCeeecCCCCCCeEECCCCcEEEEEcccccccCCCC
Q 002673 685 MENGSLDYWLHEKADGASQLDWLTRLKIARGTSCGLAYMHQICEPHIVHRDIKSSNILLDDQFEAHLADFGLSRLILPYQ 764 (894)
Q Consensus 685 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDLkp~NILld~~~~vkl~DFGla~~~~~~~ 764 (894)
+++|+|.... ...+..+..++.||+.||.|||+ ++|+||||||+|||+++++.+||+|||+++.+....
T Consensus 154 ~~~~~L~~~~--------~~~~~~~~~i~~qi~~aL~~LH~---~~ivHrDlkp~NIll~~~~~~kL~DfG~~~~~~~~~ 222 (353)
T PLN00034 154 MDGGSLEGTH--------IADEQFLADVARQILSGIAYLHR---RHIVHRDIKPSNLLINSAKNVKIADFGVSRILAQTM 222 (353)
T ss_pred CCCCcccccc--------cCCHHHHHHHHHHHHHHHHHHHH---CCEeecCCCHHHEEEcCCCCEEEcccccceeccccc
Confidence 9999985432 24566778899999999999997 599999999999999999999999999998753221
Q ss_pred CcccccccccCCccCcccccC-----cCCCccccHHHHHHHHHHHHcCCCCCCCCCcchhhhHHHHHHHHhhcCCCCccc
Q 002673 765 THVTTELVGTLGYIPPEYGQA-----WVATLRGDMYSFGVVMLELLTGKRPVDVLKPKMSRELVGWVLKMRSEGKQDQVF 839 (894)
Q Consensus 765 ~~~~~~~~gt~~Y~APE~~~~-----~~~s~ksDVwS~GvlL~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 839 (894)
.......||..|+|||++.. ...+.++|||||||++|||++|+.||............. .... ......
T Consensus 223 -~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~~---~~~~-~~~~~~- 296 (353)
T PLN00034 223 -DPCNSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQGDWASLMC---AICM-SQPPEA- 296 (353)
T ss_pred -ccccccccCccccCccccccccccCcCCCcchhHHHHHHHHHHHHhCCCCCCCCCCccHHHHHH---HHhc-cCCCCC-
Confidence 12234578999999998743 234568999999999999999999997332221111111 1100 000000
Q ss_pred cccccCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHH--HHHhc
Q 002673 840 DPILRGKGFDEEMLQVLDVACMCVSQNPFKRPTVKEVVE--WLNNV 883 (894)
Q Consensus 840 d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~--~L~~i 883 (894)
......++.+++.+||+.||++|||+.|+++ ||.+.
T Consensus 297 --------~~~~~~~l~~li~~~l~~~P~~Rpt~~ell~hp~~~~~ 334 (353)
T PLN00034 297 --------PATASREFRHFISCCLQREPAKRWSAMQLLQHPFILRA 334 (353)
T ss_pred --------CCccCHHHHHHHHHHccCChhhCcCHHHHhcCcccccC
Confidence 0112235778999999999999999999998 66554
|
|
| >cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-35 Score=316.53 Aligned_cols=252 Identities=22% Similarity=0.269 Sum_probs=198.6
Q ss_pred EeecCcEEEEEEEE-cCCCeEEEEEEcCcchh---hHHHHHHHHHHHHhcCCCceeeecceeeecceEEEEEEeccCCCH
Q 002673 615 IGCGGFGLVYKATL-ANGTTLAIKKLSGDLGL---MEREFKAEVEALSTAQHKNLVSLQGYCVHQGFRLLIYSYMENGSL 690 (894)
Q Consensus 615 LG~G~fg~Vy~a~~-~~g~~vAvK~~~~~~~~---~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~lV~E~~~~gsL 690 (894)
||+|+||.||++.. .+++.||+|++...... ....+..|+.+++.++|+||+++.+++..+...++||||+++|+|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~g~L 80 (280)
T cd05608 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAYAFQTKTDLCLVMTIMNGGDL 80 (280)
T ss_pred CCCCCceeEEEEEEccCCcEEEEEeeeHHHHhhhHHHHHHHHHHHHHHhCCCCcEeeeeEEEcCCCeEEEEEeCCCCCCH
Confidence 69999999999984 57899999998754322 224567899999999999999999999999999999999999999
Q ss_pred HHHHhhhcCCCCCcCHHHHHHHHHHHHHHHHHHHhccCCCeeecCCCCCCeEECCCCcEEEEEcccccccCCCCCccccc
Q 002673 691 DYWLHEKADGASQLDWLTRLKIARGTSCGLAYMHQICEPHIVHRDIKSSNILLDDQFEAHLADFGLSRLILPYQTHVTTE 770 (894)
Q Consensus 691 ~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDLkp~NILld~~~~vkl~DFGla~~~~~~~~~~~~~ 770 (894)
..++.........+++..+..++.||+.||.|||+ ++|+||||||+||+++.++.+||+|||++........ ....
T Consensus 81 ~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~---~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~-~~~~ 156 (280)
T cd05608 81 RYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQ---RRIIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQS-KTKG 156 (280)
T ss_pred HHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEECCCCCEEEeeCccceecCCCCc-cccc
Confidence 98886544444578999999999999999999997 5999999999999999999999999999976543222 2334
Q ss_pred ccccCCccCcccccCcCCCccccHHHHHHHHHHHHcCCCCCCCCCcchhhhHHHHHHHHhhcCCCCccccccccCCCChH
Q 002673 771 LVGTLGYIPPEYGQAWVATLRGDMYSFGVVMLELLTGKRPVDVLKPKMSRELVGWVLKMRSEGKQDQVFDPILRGKGFDE 850 (894)
Q Consensus 771 ~~gt~~Y~APE~~~~~~~s~ksDVwS~GvlL~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~ 850 (894)
..||+.|+|||++.+..++.++|||||||++|||++|+.||......... ........ .... .....
T Consensus 157 ~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~--~~~~~~~~-~~~~----------~~~~~ 223 (280)
T cd05608 157 YAGTPGFMAPELLQGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVEN--KELKQRIL-NDSV----------TYPDK 223 (280)
T ss_pred cCCCcCccCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCcchhH--HHHHHhhc-ccCC----------CCccc
Confidence 57899999999999999999999999999999999999999754321111 01111110 0000 00111
Q ss_pred HHHHHHHHHHHhcccCCCCCC-----CHHHHHH--HHHhc
Q 002673 851 EMLQVLDVACMCVSQNPFKRP-----TVKEVVE--WLNNV 883 (894)
Q Consensus 851 ~~~~l~~li~~Cl~~dP~~RP-----s~~evl~--~L~~i 883 (894)
....+.+++..|++.||++|| +++++++ |++.+
T Consensus 224 ~~~~~~~li~~~l~~~P~~R~~~~~~~~~~~l~h~~~~~~ 263 (280)
T cd05608 224 FSPASKSFCEALLAKDPEKRLGFRDGNCDGLRTHPLFRDL 263 (280)
T ss_pred CCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHhcChhhhcC
Confidence 233567889999999999999 7888887 67654
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g |
| >cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-34 Score=330.43 Aligned_cols=261 Identities=24% Similarity=0.381 Sum_probs=204.5
Q ss_pred ccCCCccceEeecCcEEEEEEEEc------CCCeEEEEEEcCcch-hhHHHHHHHHHHHHhcC-CCceeeecceeeecce
Q 002673 606 TDNFSQANIIGCGGFGLVYKATLA------NGTTLAIKKLSGDLG-LMEREFKAEVEALSTAQ-HKNLVSLQGYCVHQGF 677 (894)
Q Consensus 606 ~~~f~~~~~LG~G~fg~Vy~a~~~------~g~~vAvK~~~~~~~-~~~~~~~~Ei~~l~~l~-HpnIv~l~g~~~~~~~ 677 (894)
.++|.+.+.||+|+||.||+|... .+..||||++..... ...+.+.+|+.+++++. ||||++++++|...+.
T Consensus 36 ~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~~l~~l~~HpnIv~l~~~~~~~~~ 115 (400)
T cd05105 36 RDGLVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTARSSEKQALMSELKIMTHLGPHLNIVNLLGACTKSGP 115 (400)
T ss_pred ccceehhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCCeeeEEEEEccCCc
Confidence 467888999999999999999742 134699999975433 33457899999999996 9999999999999999
Q ss_pred EEEEEEeccCCCHHHHHhhhcC----------------------------------------------------------
Q 002673 678 RLLIYSYMENGSLDYWLHEKAD---------------------------------------------------------- 699 (894)
Q Consensus 678 ~~lV~E~~~~gsL~~~l~~~~~---------------------------------------------------------- 699 (894)
.++||||+++|+|.++++....
T Consensus 116 ~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 195 (400)
T cd05105 116 IYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTTQYVPMLEIK 195 (400)
T ss_pred eEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhcccccccccccccccccchhhhhh
Confidence 9999999999999999875321
Q ss_pred ----------------------------------CCCCcCHHHHHHHHHHHHHHHHHHHhccCCCeeecCCCCCCeEECC
Q 002673 700 ----------------------------------GASQLDWLTRLKIARGTSCGLAYMHQICEPHIVHRDIKSSNILLDD 745 (894)
Q Consensus 700 ----------------------------------~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDLkp~NILld~ 745 (894)
....+++..+..++.|++.||.|||+ ++|+||||||+|||++.
T Consensus 196 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~---~~ivH~dikp~Nill~~ 272 (400)
T cd05105 196 EASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLAS---KNCVHRDLAARNVLLAQ 272 (400)
T ss_pred hhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHh---CCeeCCCCChHhEEEeC
Confidence 11347888899999999999999997 59999999999999999
Q ss_pred CCcEEEEEcccccccCCCCCc-ccccccccCCccCcccccCcCCCccccHHHHHHHHHHHHc-CCCCCCCCCcchhhhHH
Q 002673 746 QFEAHLADFGLSRLILPYQTH-VTTELVGTLGYIPPEYGQAWVATLRGDMYSFGVVMLELLT-GKRPVDVLKPKMSRELV 823 (894)
Q Consensus 746 ~~~vkl~DFGla~~~~~~~~~-~~~~~~gt~~Y~APE~~~~~~~s~ksDVwS~GvlL~ellt-G~~Pf~~~~~~~~~~~~ 823 (894)
++.+||+|||+++........ ......++..|+|||.+.+..++.++|||||||++|||++ |..||....... ...
T Consensus 273 ~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt~g~~P~~~~~~~~--~~~ 350 (400)
T cd05105 273 GKIVKICDFGLARDIMHDSNYVSKGSTFLPVKWMAPESIFDNLYTTLSDVWSYGILLWEIFSLGGTPYPGMIVDS--TFY 350 (400)
T ss_pred CCEEEEEeCCcceeccccccccccCCcCCCcceEChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCcccchhH--HHH
Confidence 999999999999865332221 1223456788999999998899999999999999999997 999997543211 111
Q ss_pred HHHHHHhhcCCCCccccccccCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhcc
Q 002673 824 GWVLKMRSEGKQDQVFDPILRGKGFDEEMLQVLDVACMCVSQNPFKRPTVKEVVEWLNNVG 884 (894)
Q Consensus 824 ~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~i~ 884 (894)
.. . ..+..... .......+.+++.+||+.+|++||++.++.++|+++.
T Consensus 351 ~~---~-~~~~~~~~---------~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~l~~l~ 398 (400)
T cd05105 351 NK---I-KSGYRMAK---------PDHATQEVYDIMVKCWNSEPEKRPSFLHLSDIVESLL 398 (400)
T ss_pred HH---H-hcCCCCCC---------CccCCHHHHHHHHHHCccCHhHCcCHHHHHHHHHHHc
Confidence 11 1 11110000 0112245778999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF- |
| >PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-35 Score=328.68 Aligned_cols=248 Identities=25% Similarity=0.337 Sum_probs=200.0
Q ss_pred cCCCccceEeecCcEEEEEEEEcC--CCeEEEEEEcCcc---hhhHHHHHHHHHHHHhcCCCceeeecceeeecceEEEE
Q 002673 607 DNFSQANIIGCGGFGLVYKATLAN--GTTLAIKKLSGDL---GLMEREFKAEVEALSTAQHKNLVSLQGYCVHQGFRLLI 681 (894)
Q Consensus 607 ~~f~~~~~LG~G~fg~Vy~a~~~~--g~~vAvK~~~~~~---~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~lV 681 (894)
++|++.+.||+|+||.||+|...+ +..||+|++.... ......+.+|+.+++.++||||+++++++.+++..++|
T Consensus 30 ~~y~~~~~ig~G~~g~Vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lv 109 (340)
T PTZ00426 30 EDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLYGSFKDESYLYLV 109 (340)
T ss_pred hhcEEEEEEeecCCeEEEEEEEECCCCeEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCCcceEEEEEeCCEEEEE
Confidence 468889999999999999998543 3689999986532 12235678899999999999999999999999999999
Q ss_pred EEeccCCCHHHHHhhhcCCCCCcCHHHHHHHHHHHHHHHHHHHhccCCCeeecCCCCCCeEECCCCcEEEEEcccccccC
Q 002673 682 YSYMENGSLDYWLHEKADGASQLDWLTRLKIARGTSCGLAYMHQICEPHIVHRDIKSSNILLDDQFEAHLADFGLSRLIL 761 (894)
Q Consensus 682 ~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDLkp~NILld~~~~vkl~DFGla~~~~ 761 (894)
|||+++|+|.+++... ..+++..+..++.|++.||.|||+ ++|+||||||+|||++.++.+||+|||+++...
T Consensus 110 ~Ey~~~g~L~~~i~~~----~~~~~~~~~~~~~qi~~aL~~LH~---~~ivHrDLkp~NILl~~~~~ikL~DFG~a~~~~ 182 (340)
T PTZ00426 110 LEFVIGGEFFTFLRRN----KRFPNDVGCFYAAQIVLIFEYLQS---LNIVYRDLKPENLLLDKDGFIKMTDFGFAKVVD 182 (340)
T ss_pred EeCCCCCcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHH---CCeEccCCCHHHEEECCCCCEEEecCCCCeecC
Confidence 9999999999999754 358888999999999999999997 599999999999999999999999999998653
Q ss_pred CCCCcccccccccCCccCcccccCcCCCccccHHHHHHHHHHHHcCCCCCCCCCcchhhhHHHHHHHHhhcCCCCccccc
Q 002673 762 PYQTHVTTELVGTLGYIPPEYGQAWVATLRGDMYSFGVVMLELLTGKRPVDVLKPKMSRELVGWVLKMRSEGKQDQVFDP 841 (894)
Q Consensus 762 ~~~~~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwS~GvlL~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 841 (894)
. ......||+.|+|||++.+..++.++|||||||++|||++|+.||........ . .... .+.. .+.
T Consensus 183 ~----~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~---~---~~i~-~~~~--~~p- 248 (340)
T PTZ00426 183 T----RTYTLCGTPEYIAPEILLNVGHGKAADWWTLGIFIYEILVGCPPFYANEPLLI---Y---QKIL-EGII--YFP- 248 (340)
T ss_pred C----CcceecCChhhcCHHHHhCCCCCccccccchhhHHHHHhcCCCCCCCCCHHHH---H---HHHh-cCCC--CCC-
Confidence 2 12345789999999999998899999999999999999999999975432211 1 1111 1111 011
Q ss_pred cccCCCChHHHHHHHHHHHHhcccCCCCCC-----CHHHHHH--HHHh
Q 002673 842 ILRGKGFDEEMLQVLDVACMCVSQNPFKRP-----TVKEVVE--WLNN 882 (894)
Q Consensus 842 ~l~~~~~~~~~~~l~~li~~Cl~~dP~~RP-----s~~evl~--~L~~ 882 (894)
...+ ..+.+++.+|++.||.+|+ +++++++ |+..
T Consensus 249 ----~~~~---~~~~~li~~~l~~dp~~R~~~~~~~~~~~~~hp~f~~ 289 (340)
T PTZ00426 249 ----KFLD---NNCKHLMKKLLSHDLTKRYGNLKKGAQNVKEHPWFGN 289 (340)
T ss_pred ----CCCC---HHHHHHHHHHcccCHHHcCCCCCCCHHHHHcCCCcCC
Confidence 1111 2456889999999999995 8999987 5544
|
|
| >cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-35 Score=312.01 Aligned_cols=253 Identities=25% Similarity=0.421 Sum_probs=202.7
Q ss_pred cCCCccceEeecCcEEEEEEEEcCCCeEEEEEEcCcchhhHHHHHHHHHHHHhcCCCceeeecceeeecceEEEEEEecc
Q 002673 607 DNFSQANIIGCGGFGLVYKATLANGTTLAIKKLSGDLGLMEREFKAEVEALSTAQHKNLVSLQGYCVHQGFRLLIYSYME 686 (894)
Q Consensus 607 ~~f~~~~~LG~G~fg~Vy~a~~~~g~~vAvK~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~lV~E~~~ 686 (894)
++|++.+.||+|+||.||+|...++..||+|.+..... ..+.+.+|+.++++++|+|++++++++. ....+++|||++
T Consensus 6 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~k~~~~~~~-~~~~~~~E~~~l~~l~~~~i~~~~~~~~-~~~~~lv~e~~~ 83 (260)
T cd05070 6 ESLQLIKKLGNGQFGEVWMGTWNGNTKVAVKTLKPGTM-SPESFLEEAQIMKKLRHDKLVQLYAVVS-EEPIYIVTEYMS 83 (260)
T ss_pred HHhhhhheeccccCceEEEEEecCCceeEEEEecCCCC-CHHHHHHHHHHHHhcCCCceEEEEeEEC-CCCcEEEEEecC
Confidence 46788899999999999999988888999999876433 3457899999999999999999999875 456789999999
Q ss_pred CCCHHHHHhhhcCCCCCcCHHHHHHHHHHHHHHHHHHHhccCCCeeecCCCCCCeEECCCCcEEEEEcccccccCCCCCc
Q 002673 687 NGSLDYWLHEKADGASQLDWLTRLKIARGTSCGLAYMHQICEPHIVHRDIKSSNILLDDQFEAHLADFGLSRLILPYQTH 766 (894)
Q Consensus 687 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDLkp~NILld~~~~vkl~DFGla~~~~~~~~~ 766 (894)
+++|.++++... ...+++..++.++.|++.||.|||+ ++++||||||+||++++++.++|+|||++.........
T Consensus 84 ~~~L~~~~~~~~--~~~~~~~~~~~~~~~l~~al~~lH~---~~i~H~di~p~Nili~~~~~~~l~dfg~~~~~~~~~~~ 158 (260)
T cd05070 84 KGSLLDFLKDGE--GRALKLPNLVDMAAQVAAGMAYIER---MNYIHRDLRSANILVGDGLVCKIADFGLARLIEDNEYT 158 (260)
T ss_pred CCcHHHHHHhcC--CCCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCccceEEEeCCceEEeCCceeeeeccCcccc
Confidence 999999997532 2458899999999999999999997 59999999999999999999999999999865432222
Q ss_pred ccccccccCCccCcccccCcCCCccccHHHHHHHHHHHHc-CCCCCCCCCcchhhhHHHHHHHHhhcCCCCccccccccC
Q 002673 767 VTTELVGTLGYIPPEYGQAWVATLRGDMYSFGVVMLELLT-GKRPVDVLKPKMSRELVGWVLKMRSEGKQDQVFDPILRG 845 (894)
Q Consensus 767 ~~~~~~gt~~Y~APE~~~~~~~s~ksDVwS~GvlL~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~ 845 (894)
......++..|+|||+..+..++.++||||||+++|+|++ |+.||...... +..... ...... ..
T Consensus 159 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~---~~~~~~---~~~~~~-~~------- 224 (260)
T cd05070 159 ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMNNR---EVLEQV---ERGYRM-PC------- 224 (260)
T ss_pred cccCCCCCccccChHHHhcCCCcchhhhHHHHHHHHHHHhcCCCCCCCCCHH---HHHHHH---HcCCCC-CC-------
Confidence 2222345668999999988889999999999999999999 89999754322 122111 111110 00
Q ss_pred CCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHh
Q 002673 846 KGFDEEMLQVLDVACMCVSQNPFKRPTVKEVVEWLNN 882 (894)
Q Consensus 846 ~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~ 882 (894)
.......+.+++.+|++.+|++|||+.++.++|++
T Consensus 225 --~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~ 259 (260)
T cd05070 225 --PQDCPISLHELMLQCWKKDPEERPTFEYLQSFLED 259 (260)
T ss_pred --CCcCCHHHHHHHHHHcccCcccCcCHHHHHHHHhc
Confidence 01122357799999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r |
| >cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-35 Score=319.38 Aligned_cols=261 Identities=25% Similarity=0.292 Sum_probs=193.5
Q ss_pred cCCCccceEeecCcEEEEEEEE-c-CCCeEEEEEEcCcch--hhHHHHHHHHHHHHhc---CCCceeeecceeee-----
Q 002673 607 DNFSQANIIGCGGFGLVYKATL-A-NGTTLAIKKLSGDLG--LMEREFKAEVEALSTA---QHKNLVSLQGYCVH----- 674 (894)
Q Consensus 607 ~~f~~~~~LG~G~fg~Vy~a~~-~-~g~~vAvK~~~~~~~--~~~~~~~~Ei~~l~~l---~HpnIv~l~g~~~~----- 674 (894)
++|++.+.||+|+||.||+|.. . ++..||+|++..... .....+.+|+.+++.+ +||||++++++|..
T Consensus 1 ~~Y~~~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~~~~ 80 (290)
T cd07862 1 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDR 80 (290)
T ss_pred CCcceeeEeccCCCeEEEEEEEcCCCCeEEEEEEEecccCCCCchHHHHHHHHHHHhhcccCCCCcceEEEEEecccCCC
Confidence 3688899999999999999985 3 468899999865332 2233456677777665 69999999998852
Q ss_pred cceEEEEEEeccCCCHHHHHhhhcCCCCCcCHHHHHHHHHHHHHHHHHHHhccCCCeeecCCCCCCeEECCCCcEEEEEc
Q 002673 675 QGFRLLIYSYMENGSLDYWLHEKADGASQLDWLTRLKIARGTSCGLAYMHQICEPHIVHRDIKSSNILLDDQFEAHLADF 754 (894)
Q Consensus 675 ~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDLkp~NILld~~~~vkl~DF 754 (894)
....++||||++ ++|.+++.... ...+++..+..++.|++.||.|||+ ++|+||||||+|||++.++.+||+||
T Consensus 81 ~~~~~lv~e~~~-~~l~~~~~~~~--~~~~~~~~~~~i~~qi~~aL~~lH~---~~iiH~dlkp~Nil~~~~~~~kl~Df 154 (290)
T cd07862 81 ETKLTLVFEHVD-QDLTTYLDKVP--EPGVPTETIKDMMFQLLRGLDFLHS---HRVVHRDLKPQNILVTSSGQIKLADF 154 (290)
T ss_pred CCcEEEEEccCC-CCHHHHHHhCC--CCCCCHHHHHHHHHHHHHHHHHHHH---CCeeeCCCCHHHEEEcCCCCEEEccc
Confidence 346899999996 68999987543 2458899999999999999999997 59999999999999999999999999
Q ss_pred ccccccCCCCCcccccccccCCccCcccccCcCCCccccHHHHHHHHHHHHcCCCCCCCCCcchhhhHHHHHHHHhhcC-
Q 002673 755 GLSRLILPYQTHVTTELVGTLGYIPPEYGQAWVATLRGDMYSFGVVMLELLTGKRPVDVLKPKMSRELVGWVLKMRSEG- 833 (894)
Q Consensus 755 Gla~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwS~GvlL~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~- 833 (894)
|+++..... .......||+.|+|||.+.+..++.++|||||||++|||++|++||....... ............
T Consensus 155 g~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~---~~~~i~~~~~~~~ 229 (290)
T cd07862 155 GLARIYSFQ--MALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVD---QLGKILDVIGLPG 229 (290)
T ss_pred cceEeccCC--cccccccccccccChHHHhCCCCCCccchHHHHHHHHHHHcCCCCcCCCCHHH---HHHHHHHHhCCCC
Confidence 999865322 22344568999999999988899999999999999999999999997644321 111111110000
Q ss_pred --CC-------CccccccccC---CCChHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 002673 834 --KQ-------DQVFDPILRG---KGFDEEMLQVLDVACMCVSQNPFKRPTVKEVVE 878 (894)
Q Consensus 834 --~~-------~~~~d~~l~~---~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~ 878 (894)
.. ...+.+.... ...+.....+.+++.+|++.||++|||+.++++
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~ 286 (290)
T cd07862 230 EEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS 286 (290)
T ss_pred hhhchhhhcccchhccCCCCCCHHHHccCCCHHHHHHHHHHhccCchhcCCHHHHhc
Confidence 00 0000000000 000112235678999999999999999999985
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla |
| >cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-35 Score=324.48 Aligned_cols=241 Identities=22% Similarity=0.286 Sum_probs=193.5
Q ss_pred ceEeecCcEEEEEEEE-cCCCeEEEEEEcCcch---hhHHHHHHHHHHHHhcCCCceeeecceeeecceEEEEEEeccCC
Q 002673 613 NIIGCGGFGLVYKATL-ANGTTLAIKKLSGDLG---LMEREFKAEVEALSTAQHKNLVSLQGYCVHQGFRLLIYSYMENG 688 (894)
Q Consensus 613 ~~LG~G~fg~Vy~a~~-~~g~~vAvK~~~~~~~---~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~lV~E~~~~g 688 (894)
+.||+|+||.||++.. .+|..||+|++..... .....+.+|+.+++.++||||+++++++...+..++||||+++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv~E~~~~~ 80 (323)
T cd05595 1 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGG 80 (323)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCcceeeEEecCCEEEEEEeCCCCC
Confidence 4699999999999984 5789999999976432 22345678999999999999999999999999999999999999
Q ss_pred CHHHHHhhhcCCCCCcCHHHHHHHHHHHHHHHHHHHhccCCCeeecCCCCCCeEECCCCcEEEEEcccccccCCCCCccc
Q 002673 689 SLDYWLHEKADGASQLDWLTRLKIARGTSCGLAYMHQICEPHIVHRDIKSSNILLDDQFEAHLADFGLSRLILPYQTHVT 768 (894)
Q Consensus 689 sL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDLkp~NILld~~~~vkl~DFGla~~~~~~~~~~~ 768 (894)
+|..++... ..+++..+..++.||+.||.|||+ ++|+||||||+|||++.++.+||+|||+++...... ...
T Consensus 81 ~L~~~l~~~----~~~~~~~~~~~~~qi~~aL~~LH~---~~ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~-~~~ 152 (323)
T cd05595 81 ELFFHLSRE----RVFTEERARFYGAEIVSALEYLHS---RDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDG-ATM 152 (323)
T ss_pred cHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHH---CCeEecCCCHHHEEEcCCCCEEecccHHhccccCCC-Ccc
Confidence 999888753 358899999999999999999997 599999999999999999999999999987532211 122
Q ss_pred ccccccCCccCcccccCcCCCccccHHHHHHHHHHHHcCCCCCCCCCcchhhhHHHHHHHHhhcCCCCccccccccCCCC
Q 002673 769 TELVGTLGYIPPEYGQAWVATLRGDMYSFGVVMLELLTGKRPVDVLKPKMSRELVGWVLKMRSEGKQDQVFDPILRGKGF 848 (894)
Q Consensus 769 ~~~~gt~~Y~APE~~~~~~~s~ksDVwS~GvlL~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~ 848 (894)
....||+.|+|||++.+..++.++|||||||++|||++|+.||....... ... .... ... . +. ...
T Consensus 153 ~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~---~~~---~~~~-~~~-~-----~p-~~~ 218 (323)
T cd05595 153 KTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHER---LFE---LILM-EEI-R-----FP-RTL 218 (323)
T ss_pred ccccCCcCcCCcccccCCCCCchhchhhhHHHHHHHHhCCCCCCCCCHHH---HHH---HHhc-CCC-C-----CC-CCC
Confidence 34578999999999999999999999999999999999999997543221 111 1111 110 0 00 111
Q ss_pred hHHHHHHHHHHHHhcccCCCCCC-----CHHHHHH
Q 002673 849 DEEMLQVLDVACMCVSQNPFKRP-----TVKEVVE 878 (894)
Q Consensus 849 ~~~~~~l~~li~~Cl~~dP~~RP-----s~~evl~ 878 (894)
...+.+++.+|++.||.+|| ++.++++
T Consensus 219 ---~~~~~~li~~~L~~dP~~R~~~~~~~~~~~l~ 250 (323)
T cd05595 219 ---SPEAKSLLAGLLKKDPKQRLGGGPSDAKEVME 250 (323)
T ss_pred ---CHHHHHHHHHHccCCHHHhCCCCCCCHHHHHc
Confidence 23466888999999999998 8999886
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in |
| >KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-35 Score=305.57 Aligned_cols=268 Identities=25% Similarity=0.254 Sum_probs=202.6
Q ss_pred cCCCccceEeecCcEEEEEEE-EcCCCeEEEEEEcCcchhh--HHHHHHHHHHHHhcCCCceeeecceeeec--ceEEEE
Q 002673 607 DNFSQANIIGCGGFGLVYKAT-LANGTTLAIKKLSGDLGLM--EREFKAEVEALSTAQHKNLVSLQGYCVHQ--GFRLLI 681 (894)
Q Consensus 607 ~~f~~~~~LG~G~fg~Vy~a~-~~~g~~vAvK~~~~~~~~~--~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~--~~~~lV 681 (894)
++|+..+.|++|.||.||+|+ ..+++.||+|+++-+.... --.-.+||.+|.+.+|||||.+..+.+.. +..|||
T Consensus 76 ~efe~lnrI~EGtyGiVYRakdk~t~eIVALKr~kmekek~GFPItsLREIniLl~~~H~NIV~vkEVVvG~~~d~iy~V 155 (419)
T KOG0663|consen 76 EEFEKLNRIEEGTYGVVYRAKDKKTDEIVALKRLKMEKEKEGFPITSLREINILLKARHPNIVEVKEVVVGSNMDKIYIV 155 (419)
T ss_pred HHHHHHhhcccCcceeEEEeccCCcceeEEeeecccccccCCCcchhHHHHHHHHhcCCCCeeeeEEEEeccccceeeee
Confidence 356778899999999999998 5678999999997543111 12357999999999999999998887754 478999
Q ss_pred EEeccCCCHHHHHhhhcCCCCCcCHHHHHHHHHHHHHHHHHHHhccCCCeeecCCCCCCeEECCCCcEEEEEcccccccC
Q 002673 682 YSYMENGSLDYWLHEKADGASQLDWLTRLKIARGTSCGLAYMHQICEPHIVHRDIKSSNILLDDQFEAHLADFGLSRLIL 761 (894)
Q Consensus 682 ~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDLkp~NILld~~~~vkl~DFGla~~~~ 761 (894)
||||+. +|..+++... ..+...++..+..|+++|++|||. +.|+|||||++|+|+++.|.+||+|||+|+.+.
T Consensus 156 Me~~Eh-DLksl~d~m~---q~F~~~evK~L~~QlL~glk~lH~---~wilHRDLK~SNLLm~~~G~lKiaDFGLAR~yg 228 (419)
T KOG0663|consen 156 MEYVEH-DLKSLMETMK---QPFLPGEVKTLMLQLLRGLKHLHD---NWILHRDLKTSNLLLSHKGILKIADFGLAREYG 228 (419)
T ss_pred HHHHHh-hHHHHHHhcc---CCCchHHHHHHHHHHHHHHHHHhh---ceeEecccchhheeeccCCcEEecccchhhhhc
Confidence 999986 8988888654 568889999999999999999997 699999999999999999999999999999875
Q ss_pred CCCCcccccccccCCccCcccccCc-CCCccccHHHHHHHHHHHHcCCCCCCCCCcchhhhHHHHHHHHhhcCCCCcccc
Q 002673 762 PYQTHVTTELVGTLGYIPPEYGQAW-VATLRGDMYSFGVVMLELLTGKRPVDVLKPKMSRELVGWVLKMRSEGKQDQVFD 840 (894)
Q Consensus 762 ~~~~~~~~~~~gt~~Y~APE~~~~~-~~s~ksDVwS~GvlL~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 840 (894)
... ...+..+-|.+|.|||++.+. .|+..+|+||+|||+.||+++++-|.+...-...+.+-.......+..+.....
T Consensus 229 sp~-k~~T~lVVTLWYRaPELLLG~~tyst~iDMWSvGCI~aE~l~~kPlf~G~sE~dQl~~If~llGtPte~iwpg~~~ 307 (419)
T KOG0663|consen 229 SPL-KPYTPLVVTLWYRAPELLLGAKTYSTAVDMWSVGCIFAELLTQKPLFPGKSEIDQLDKIFKLLGTPSEAIWPGYSE 307 (419)
T ss_pred CCc-ccCcceEEEeeecCHHHhcCCcccCcchhhhhHHHHHHHHHhcCCCCCCCchHHHHHHHHHHhCCCccccCCCccc
Confidence 443 235567789999999988775 799999999999999999999998876443211111111111112221211111
Q ss_pred cc------ccCC-------CChH--HHHHHHHHHHHhcccCCCCCCCHHHHHH--HHHh
Q 002673 841 PI------LRGK-------GFDE--EMLQVLDVACMCVSQNPFKRPTVKEVVE--WLNN 882 (894)
Q Consensus 841 ~~------l~~~-------~~~~--~~~~l~~li~~Cl~~dP~~RPs~~evl~--~L~~ 882 (894)
.. +... .+.. ....-++++..++..||.+|.|+++.++ ++.+
T Consensus 308 lp~~k~~~f~~~pyn~lr~kF~~~~lse~g~~Lln~llt~dP~kR~tA~~~L~h~~F~e 366 (419)
T KOG0663|consen 308 LPAVKKMTFSEHPYNNLRKKFGALSLSEQGFDLLNKLLTYDPGKRITAEDGLKHEYFRE 366 (419)
T ss_pred cchhhccccCCCCchhhhhhccccccchhHHHHHHHHhccCccccccHHHhhccccccc
Confidence 00 0000 0001 1234568888999999999999999997 6654
|
|
| >cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-35 Score=324.26 Aligned_cols=239 Identities=25% Similarity=0.309 Sum_probs=191.5
Q ss_pred EeecCcEEEEEEEE-cCCCeEEEEEEcCcc---hhhHHHHHHHHHHHHhcCCCceeeecceeeecceEEEEEEeccCCCH
Q 002673 615 IGCGGFGLVYKATL-ANGTTLAIKKLSGDL---GLMEREFKAEVEALSTAQHKNLVSLQGYCVHQGFRLLIYSYMENGSL 690 (894)
Q Consensus 615 LG~G~fg~Vy~a~~-~~g~~vAvK~~~~~~---~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~lV~E~~~~gsL 690 (894)
||+|+||.||+|.. .+++.||+|++.... ......+.+|+.++++++||||+++++++...+..++||||+++|+|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L 80 (312)
T cd05585 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKFSFQSPEKLYLVLAFINGGEL 80 (312)
T ss_pred CCcCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCcEeceeeEEecCCeEEEEEcCCCCCcH
Confidence 69999999999985 468899999987532 22335678899999999999999999999999999999999999999
Q ss_pred HHHHhhhcCCCCCcCHHHHHHHHHHHHHHHHHHHhccCCCeeecCCCCCCeEECCCCcEEEEEcccccccCCCCCccccc
Q 002673 691 DYWLHEKADGASQLDWLTRLKIARGTSCGLAYMHQICEPHIVHRDIKSSNILLDDQFEAHLADFGLSRLILPYQTHVTTE 770 (894)
Q Consensus 691 ~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDLkp~NILld~~~~vkl~DFGla~~~~~~~~~~~~~ 770 (894)
.+++... ..+++..+..++.|++.||.|||+ ++|+||||||+|||++.++.+||+|||+++...... .....
T Consensus 81 ~~~l~~~----~~~~~~~~~~~~~qi~~~l~~lH~---~~i~HrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~-~~~~~ 152 (312)
T cd05585 81 FHHLQRE----GRFDLSRARFYTAELLCALENLHK---FNVIYRDLKPENILLDYQGHIALCDFGLCKLNMKDD-DKTNT 152 (312)
T ss_pred HHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHh---CCeEeCCCCHHHeEECCCCcEEEEECcccccCccCC-Ccccc
Confidence 9999753 358899999999999999999997 599999999999999999999999999998543221 22344
Q ss_pred ccccCCccCcccccCcCCCccccHHHHHHHHHHHHcCCCCCCCCCcchhhhHHHHHHHHhhcCCCCccccccccCCCChH
Q 002673 771 LVGTLGYIPPEYGQAWVATLRGDMYSFGVVMLELLTGKRPVDVLKPKMSRELVGWVLKMRSEGKQDQVFDPILRGKGFDE 850 (894)
Q Consensus 771 ~~gt~~Y~APE~~~~~~~s~ksDVwS~GvlL~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~ 850 (894)
..||+.|+|||++.+..++.++|||||||++|||++|+.||...... ......... .. . +. ..
T Consensus 153 ~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf~~~~~~------~~~~~~~~~-~~-~-~~-----~~--- 215 (312)
T cd05585 153 FCGTPEYLAPELLLGHGYTKAVDWWTLGVLLYEMLTGLPPFYDENVN------EMYRKILQE-PL-R-FP-----DG--- 215 (312)
T ss_pred ccCCcccCCHHHHcCCCCCCccceechhHHHHHHHhCCCCcCCCCHH------HHHHHHHcC-CC-C-CC-----Cc---
Confidence 57999999999999999999999999999999999999999753321 111111111 10 0 00 11
Q ss_pred HHHHHHHHHHHhcccCCCCCCC---HHHHHH
Q 002673 851 EMLQVLDVACMCVSQNPFKRPT---VKEVVE 878 (894)
Q Consensus 851 ~~~~l~~li~~Cl~~dP~~RPs---~~evl~ 878 (894)
....+.+++.+||+.||.+||+ +.+++.
T Consensus 216 ~~~~~~~li~~~L~~dp~~R~~~~~~~e~l~ 246 (312)
T cd05585 216 FDRDAKDLLIGLLSRDPTRRLGYNGAQEIKN 246 (312)
T ss_pred CCHHHHHHHHHHcCCCHHHcCCCCCHHHHHc
Confidence 1235678899999999999985 667665
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl |
| >KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=312.42 Aligned_cols=272 Identities=24% Similarity=0.298 Sum_probs=203.0
Q ss_pred ccCCCccceEeecCcEEEEEEE-EcCCCeEEEEEEcC--cchhhHHHHHHHHHHHHhcCCCceeeecceeee-----cce
Q 002673 606 TDNFSQANIIGCGGFGLVYKAT-LANGTTLAIKKLSG--DLGLMEREFKAEVEALSTAQHKNLVSLQGYCVH-----QGF 677 (894)
Q Consensus 606 ~~~f~~~~~LG~G~fg~Vy~a~-~~~g~~vAvK~~~~--~~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~-----~~~ 677 (894)
...|...+.||+|+||.|+.+. ..+|+.||||++.. ......+...+|+++|+.++|+||+.+.+++.. -+.
T Consensus 21 ~~~y~~~~~iG~GAyGvVcsA~~~~t~~~VAIKKi~~~F~~~~~akRtlRElklLr~~~HeNIi~l~di~~p~~~~~f~D 100 (359)
T KOG0660|consen 21 PRYYVLIEPIGRGAYGVVCSAKDKRTGEKVAIKKILNPFENQIDAKRTLRELKLLRHLRHENIIGLLDIFRPPSRDKFND 100 (359)
T ss_pred cceecccccccCcceeeEEEEEEcCCCCEeehhhhhhhhhchHHHHHHHHHHHHHHHhcCCCcceEEeecccccccccce
Confidence 3456667889999999999998 56899999999984 334445678899999999999999999998875 357
Q ss_pred EEEEEEeccCCCHHHHHhhhcCCCCCcCHHHHHHHHHHHHHHHHHHHhccCCCeeecCCCCCCeEECCCCcEEEEEcccc
Q 002673 678 RLLIYSYMENGSLDYWLHEKADGASQLDWLTRLKIARGTSCGLAYMHQICEPHIVHRDIKSSNILLDDQFEAHLADFGLS 757 (894)
Q Consensus 678 ~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDLkp~NILld~~~~vkl~DFGla 757 (894)
.|+|+|+| .-+|...++.. ..++..+...+..|+++||+|+|+. +|+||||||+|++++.+..+||+|||+|
T Consensus 101 vYiV~elM-etDL~~iik~~----~~L~d~H~q~f~YQiLrgLKyiHSA---nViHRDLKPsNll~n~~c~lKI~DFGLA 172 (359)
T KOG0660|consen 101 VYLVFELM-ETDLHQIIKSQ----QDLTDDHAQYFLYQILRGLKYIHSA---NVIHRDLKPSNLLLNADCDLKICDFGLA 172 (359)
T ss_pred eEEehhHH-hhHHHHHHHcC----ccccHHHHHHHHHHHHHhcchhhcc---cccccccchhheeeccCCCEEeccccce
Confidence 89999999 45888888754 3488899999999999999999984 9999999999999999999999999999
Q ss_pred cccCCC-CCcccccccccCCccCcccccC-cCCCccccHHHHHHHHHHHHcCCCCCCCCCcchhhhHHHHHHHHhhcCCC
Q 002673 758 RLILPY-QTHVTTELVGTLGYIPPEYGQA-WVATLRGDMYSFGVVMLELLTGKRPVDVLKPKMSRELVGWVLKMRSEGKQ 835 (894)
Q Consensus 758 ~~~~~~-~~~~~~~~~gt~~Y~APE~~~~-~~~s~ksDVwS~GvlL~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~ 835 (894)
+..... .....+..+-|.+|.|||++.+ ..|+..+||||.|||+.||++|++-|.+.+.-..-.++........+..+
T Consensus 173 R~~~~~~~~~~mTeYVaTRWYRAPElll~~~~Yt~aiDiWSvGCI~AEmL~gkplFpG~d~v~Ql~lI~~~lGtP~~e~l 252 (359)
T KOG0660|consen 173 RYLDKFFEDGFMTEYVATRWYRAPELLLNSSEYTKAIDIWSVGCILAEMLTGKPLFPGKDYVHQLQLILELLGTPSEEDL 252 (359)
T ss_pred eeccccCcccchhcceeeeeecCHHHHhccccccchhhhhhhhHHHHHHHcCCCCCCCCchHHHHHHHHHhcCCCCHHHH
Confidence 987432 1223356788999999997654 58999999999999999999999998754431111111100000000000
Q ss_pred Cccc--------------cccccCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHH--HHHhccc
Q 002673 836 DQVF--------------DPILRGKGFDEEMLQVLDVACMCVSQNPFKRPTVKEVVE--WLNNVGA 885 (894)
Q Consensus 836 ~~~~--------------d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~--~L~~i~~ 885 (894)
..+- .+.-....++......++++.+|+..||.+|+|++|+++ -|.....
T Consensus 253 ~~i~s~~ar~yi~slp~~p~~~f~~~fp~a~p~AidLlekmL~fdP~kRita~eAL~hPYl~~~hd 318 (359)
T KOG0660|consen 253 QKIRSEKARPYIKSLPQIPKQPFSSIFPNANPLAIDLLEKMLVFDPKKRITAEEALAHPYLAPYHD 318 (359)
T ss_pred HHhccHHHHHHHHhCCCCCCCCHHHHcCCCCHHHHHHHHHHhccCccccCCHHHHhcChhhhhhcC
Confidence 0000 000000111222335678999999999999999999998 5655543
|
|
| >PTZ00036 glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-35 Score=337.53 Aligned_cols=268 Identities=22% Similarity=0.303 Sum_probs=198.3
Q ss_pred ccCCCccceEeecCcEEEEEEEE-cCCCeEEEEEEcCcchhhHHHHHHHHHHHHhcCCCceeeecceeeec--------c
Q 002673 606 TDNFSQANIIGCGGFGLVYKATL-ANGTTLAIKKLSGDLGLMEREFKAEVEALSTAQHKNLVSLQGYCVHQ--------G 676 (894)
Q Consensus 606 ~~~f~~~~~LG~G~fg~Vy~a~~-~~g~~vAvK~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~--------~ 676 (894)
.++|+..+.||+|+||.||+|.. .+++.||||++.... ....+|+.+++.++||||+++++++... .
T Consensus 65 ~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~----~~~~~Ei~il~~l~h~niv~l~~~~~~~~~~~~~~~~ 140 (440)
T PTZ00036 65 NKSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDP----QYKNRELLIMKNLNHINIIFLKDYYYTECFKKNEKNI 140 (440)
T ss_pred CCeEEEeEEEEeCCCEEEEEEEECCCCCEEEEEEEecCc----chHHHHHHHHHhcCCCCCcceeeeEeecccccCCCce
Confidence 46799999999999999999985 578999999986532 2345799999999999999999876432 2
Q ss_pred eEEEEEEeccCCCHHHHHhhhcCCCCCcCHHHHHHHHHHHHHHHHHHHhccCCCeeecCCCCCCeEECCCC-cEEEEEcc
Q 002673 677 FRLLIYSYMENGSLDYWLHEKADGASQLDWLTRLKIARGTSCGLAYMHQICEPHIVHRDIKSSNILLDDQF-EAHLADFG 755 (894)
Q Consensus 677 ~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDLkp~NILld~~~-~vkl~DFG 755 (894)
..++||||++ ++|.+++.........+++..+..++.||+.||.|||+ ++|+||||||+|||++.++ .+||+|||
T Consensus 141 ~l~lvmE~~~-~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~gL~yLH~---~~IiHrDLKp~NILl~~~~~~vkL~DFG 216 (440)
T PTZ00036 141 FLNVVMEFIP-QTVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIHS---KFICHRDLKPQNLLIDPNTHTLKLCDFG 216 (440)
T ss_pred EEEEEEecCC-ccHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHH---CCEecCCcCHHHEEEcCCCCceeeeccc
Confidence 4678999997 47877776544445678999999999999999999997 5999999999999999664 79999999
Q ss_pred cccccCCCCCcccccccccCCccCcccccCc-CCCccccHHHHHHHHHHHHcCCCCCCCCCcchhhhHHHHHHHHhhc--
Q 002673 756 LSRLILPYQTHVTTELVGTLGYIPPEYGQAW-VATLRGDMYSFGVVMLELLTGKRPVDVLKPKMSRELVGWVLKMRSE-- 832 (894)
Q Consensus 756 la~~~~~~~~~~~~~~~gt~~Y~APE~~~~~-~~s~ksDVwS~GvlL~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~-- 832 (894)
+++.+.... ......||+.|+|||++.+. .++.++|||||||++|||++|++||........ +..........
T Consensus 217 la~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~--~~~i~~~~~~p~~ 292 (440)
T PTZ00036 217 SAKNLLAGQ--RSVSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQSSVDQ--LVRIIQVLGTPTE 292 (440)
T ss_pred cchhccCCC--CcccCCCCcCccCHHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHH--HHHHHHHhCCCCH
Confidence 998764322 22345789999999987664 689999999999999999999999975433211 11111100000
Q ss_pred -------CCC-----CccccccccCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHH--HHHhccc
Q 002673 833 -------GKQ-----DQVFDPILRGKGFDEEMLQVLDVACMCVSQNPFKRPTVKEVVE--WLNNVGA 885 (894)
Q Consensus 833 -------~~~-----~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~--~L~~i~~ 885 (894)
... ..+....+..........++.+++.+||+.||.+|||+.++++ |++.+..
T Consensus 293 ~~~~~~~~~~~~~~~~~~~~~~l~~~~p~~~~~~~~~li~~~L~~dP~~R~ta~e~l~hp~f~~~~~ 359 (440)
T PTZ00036 293 DQLKEMNPNYADIKFPDVKPKDLKKVFPKGTPDDAINFISQFLKYEPLKRLNPIEALADPFFDDLRD 359 (440)
T ss_pred HHHHHhchhhhcccCCccCchhHHHHhccCCCHHHHHHHHHHCCCChhHCcCHHHHhCChhHHhhhc
Confidence 000 0000000000000112236789999999999999999999997 8877654
|
|
| >cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-35 Score=331.24 Aligned_cols=254 Identities=26% Similarity=0.324 Sum_probs=203.5
Q ss_pred cCCCccceEeecCcEEEEEEEEc-CCCeEEEEEEcCcch---hhHHHHHHHHHHHHhcCCCceeeecceeeecceEEEEE
Q 002673 607 DNFSQANIIGCGGFGLVYKATLA-NGTTLAIKKLSGDLG---LMEREFKAEVEALSTAQHKNLVSLQGYCVHQGFRLLIY 682 (894)
Q Consensus 607 ~~f~~~~~LG~G~fg~Vy~a~~~-~g~~vAvK~~~~~~~---~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~lV~ 682 (894)
++|++.+.||+|+||.||+|... +|+.||||++..... .....+..|+.++..++||||+++++++.+++..++||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (350)
T cd05573 1 DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKLYYSFQDEEHLYLVM 80 (350)
T ss_pred CCceEEEEEEeCCcEEEEEEEECCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhcCCCCccchhhheecCCeEEEEE
Confidence 46888999999999999999854 789999999975421 23456889999999999999999999999999999999
Q ss_pred EeccCCCHHHHHhhhcCCCCCcCHHHHHHHHHHHHHHHHHHHhccCCCeeecCCCCCCeEECCCCcEEEEEcccccccCC
Q 002673 683 SYMENGSLDYWLHEKADGASQLDWLTRLKIARGTSCGLAYMHQICEPHIVHRDIKSSNILLDDQFEAHLADFGLSRLILP 762 (894)
Q Consensus 683 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDLkp~NILld~~~~vkl~DFGla~~~~~ 762 (894)
||+++|+|.+++... ..+++..+..++.||+.||.|||+ ++|+||||||+|||++.++.+||+|||++.....
T Consensus 81 e~~~~~~L~~~l~~~----~~l~~~~~~~i~~qi~~aL~~LH~---~giiH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~ 153 (350)
T cd05573 81 EYMPGGDLMNLLIRK----DVFPEETARFYIAELVLALDSVHK---LGFIHRDIKPDNILIDADGHIKLADFGLCKKMNK 153 (350)
T ss_pred cCCCCCCHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHH---CCeeccCCCHHHeEECCCCCEEeecCCCCccCcc
Confidence 999999999999864 458889999999999999999997 6999999999999999999999999999986543
Q ss_pred CC----------------------------CcccccccccCCccCcccccCcCCCccccHHHHHHHHHHHHcCCCCCCCC
Q 002673 763 YQ----------------------------THVTTELVGTLGYIPPEYGQAWVATLRGDMYSFGVVMLELLTGKRPVDVL 814 (894)
Q Consensus 763 ~~----------------------------~~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwS~GvlL~elltG~~Pf~~~ 814 (894)
.. ........||+.|+|||++.+..++.++|||||||++|||++|+.||...
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~ 233 (350)
T cd05573 154 AKDREYYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYGFPPFYSD 233 (350)
T ss_pred cCcccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCceeeEecchhhhhhccCCCCCCCC
Confidence 22 11223456899999999999999999999999999999999999999754
Q ss_pred CcchhhhHHHHHHHHhh-cCCCCccccccccCCCChHHHHHHHHHHHHhcccCCCCCCC-HHHHHH--HHHh
Q 002673 815 KPKMSRELVGWVLKMRS-EGKQDQVFDPILRGKGFDEEMLQVLDVACMCVSQNPFKRPT-VKEVVE--WLNN 882 (894)
Q Consensus 815 ~~~~~~~~~~~~~~~~~-~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs-~~evl~--~L~~ 882 (894)
..... . ..... ..... + +.. .. ....+.+++.+|++ ||.+||+ ++++++ |++.
T Consensus 234 ~~~~~---~---~~i~~~~~~~~--~-p~~--~~---~~~~~~~li~~ll~-dp~~R~~s~~~ll~hp~~~~ 290 (350)
T cd05573 234 TLQET---Y---NKIINWKESLR--F-PPD--PP---VSPEAIDLICRLLC-DPEDRLGSFEEIKSHPFFKG 290 (350)
T ss_pred CHHHH---H---HHHhccCCccc--C-CCC--CC---CCHHHHHHHHHHcc-ChhhcCCCHHHHhcCCCcCC
Confidence 42211 1 11111 00000 0 000 00 22356788889998 9999999 999998 5544
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the |
| >cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-35 Score=318.20 Aligned_cols=263 Identities=24% Similarity=0.368 Sum_probs=200.8
Q ss_pred cCCCccceEeecCcEEEEEEEE-----cCCCeEEEEEEcCcchhhHHHHHHHHHHHHhcCCCceeeecceeee--cceEE
Q 002673 607 DNFSQANIIGCGGFGLVYKATL-----ANGTTLAIKKLSGDLGLMEREFKAEVEALSTAQHKNLVSLQGYCVH--QGFRL 679 (894)
Q Consensus 607 ~~f~~~~~LG~G~fg~Vy~a~~-----~~g~~vAvK~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~--~~~~~ 679 (894)
.+|++.+.||+|+||.||++.. .++..||+|++........+.+.+|+++++.++||||+++++++.. ....+
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 83 (284)
T cd05081 4 RHLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLR 83 (284)
T ss_pred ccceeeeeccCCCCceEEEEEecCCcCCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEccCCCCceE
Confidence 4678889999999999999974 3578999999987655556788999999999999999999998754 34678
Q ss_pred EEEEeccCCCHHHHHhhhcCCCCCcCHHHHHHHHHHHHHHHHHHHhccCCCeeecCCCCCCeEECCCCcEEEEEcccccc
Q 002673 680 LIYSYMENGSLDYWLHEKADGASQLDWLTRLKIARGTSCGLAYMHQICEPHIVHRDIKSSNILLDDQFEAHLADFGLSRL 759 (894)
Q Consensus 680 lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDLkp~NILld~~~~vkl~DFGla~~ 759 (894)
+||||+++|+|.+++.... ..+++..+..++.|++.||.|||+ ++++||||||+||++++++.+||+|||++..
T Consensus 84 lv~e~~~~~~L~~~l~~~~---~~l~~~~~~~~~~~l~~aL~~LH~---~~i~H~dlkp~nili~~~~~~~l~dfg~~~~ 157 (284)
T cd05081 84 LVMEYLPYGSLRDYLQKHR---ERLDHRKLLLYASQICKGMEYLGS---KRYVHRDLATRNILVESENRVKIGDFGLTKV 157 (284)
T ss_pred EEEEecCCCCHHHHHHhcC---cCCCHHHHHHHHHHHHHHHHHHHH---CCceeccCCHhhEEECCCCeEEECCCccccc
Confidence 9999999999999997542 358999999999999999999997 5999999999999999999999999999987
Q ss_pred cCCCCCcc--cccccccCCccCcccccCcCCCccccHHHHHHHHHHHHcCCCCCCCCCcchhh---------hHHHHHHH
Q 002673 760 ILPYQTHV--TTELVGTLGYIPPEYGQAWVATLRGDMYSFGVVMLELLTGKRPVDVLKPKMSR---------ELVGWVLK 828 (894)
Q Consensus 760 ~~~~~~~~--~~~~~gt~~Y~APE~~~~~~~s~ksDVwS~GvlL~elltG~~Pf~~~~~~~~~---------~~~~~~~~ 828 (894)
........ .....++..|+|||+..+..++.++||||||+++|||++|..|+......... ........
T Consensus 158 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (284)
T cd05081 158 LPQDKEYYKVREPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYSDKSCSPPAEFMRMMGNDKQGQMIVYHLIE 237 (284)
T ss_pred ccCCCcceeecCCCCCceEeeCHHHhccCCcChHHHHHHHHHHHHHHhhcCCcCCCcchhhhhhcccccccccchHHHHH
Confidence 64322211 11122345699999999889999999999999999999988776432211000 00000000
Q ss_pred HhhcCCCCccccccccCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhcc
Q 002673 829 MRSEGKQDQVFDPILRGKGFDEEMLQVLDVACMCVSQNPFKRPTVKEVVEWLNNVG 884 (894)
Q Consensus 829 ~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~i~ 884 (894)
........ .........+.+++.+||+.+|++|||+.++++.|+.++
T Consensus 238 ~~~~~~~~---------~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~~~ 284 (284)
T cd05081 238 LLKNNGRL---------PAPPGCPAEIYAIMKECWNNDPSQRPSFSELALQVEAIR 284 (284)
T ss_pred HHhcCCcC---------CCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHhcC
Confidence 00000000 000111235778999999999999999999999998763
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th |
| >cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-35 Score=315.20 Aligned_cols=259 Identities=24% Similarity=0.373 Sum_probs=202.8
Q ss_pred hccCCCccceEeecCcEEEEEEEEc------CCCeEEEEEEcCcc-hhhHHHHHHHHHHHHhcCCCceeeecceeeecce
Q 002673 605 ATDNFSQANIIGCGGFGLVYKATLA------NGTTLAIKKLSGDL-GLMEREFKAEVEALSTAQHKNLVSLQGYCVHQGF 677 (894)
Q Consensus 605 a~~~f~~~~~LG~G~fg~Vy~a~~~------~g~~vAvK~~~~~~-~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~ 677 (894)
..++|+..+.||+|+||.||+|... ++..||||++.... .....++.+|+.+++.++||||+++++++..+..
T Consensus 4 ~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~ 83 (277)
T cd05062 4 AREKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQP 83 (277)
T ss_pred cHHHceeeeeeccccCCeEEEEEeccCCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCC
Confidence 4567899999999999999999753 34679999986533 2334568899999999999999999999999999
Q ss_pred EEEEEEeccCCCHHHHHhhhcCC------CCCcCHHHHHHHHHHHHHHHHHHHhccCCCeeecCCCCCCeEECCCCcEEE
Q 002673 678 RLLIYSYMENGSLDYWLHEKADG------ASQLDWLTRLKIARGTSCGLAYMHQICEPHIVHRDIKSSNILLDDQFEAHL 751 (894)
Q Consensus 678 ~~lV~E~~~~gsL~~~l~~~~~~------~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDLkp~NILld~~~~vkl 751 (894)
.++||||+++|+|.+++...... ...+++..+..++.|++.||.|||+ ++++|+||||+||++++++.+||
T Consensus 84 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~---~~~vH~dlkp~Nil~~~~~~~~l 160 (277)
T cd05062 84 TLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNA---NKFVHRDLAARNCMVAEDFTVKI 160 (277)
T ss_pred eEEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCcchheEEEcCCCCEEE
Confidence 99999999999999999753211 2346788899999999999999997 59999999999999999999999
Q ss_pred EEcccccccCCCCCc-ccccccccCCccCcccccCcCCCccccHHHHHHHHHHHHc-CCCCCCCCCcchhhhHHHHHHHH
Q 002673 752 ADFGLSRLILPYQTH-VTTELVGTLGYIPPEYGQAWVATLRGDMYSFGVVMLELLT-GKRPVDVLKPKMSRELVGWVLKM 829 (894)
Q Consensus 752 ~DFGla~~~~~~~~~-~~~~~~gt~~Y~APE~~~~~~~s~ksDVwS~GvlL~ellt-G~~Pf~~~~~~~~~~~~~~~~~~ 829 (894)
+|||+++........ ......++..|+|||++.+..++.++|||||||++|||++ |..||...... ......
T Consensus 161 ~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~p~~~~~~~---~~~~~~--- 234 (277)
T cd05062 161 GDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGMSNE---QVLRFV--- 234 (277)
T ss_pred CCCCCccccCCcceeecCCCCccCHhhcChhHhhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHH---HHHHHH---
Confidence 999998765332211 1122345778999999998899999999999999999999 78998754322 111111
Q ss_pred hhcCCCCccccccccCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHh
Q 002673 830 RSEGKQDQVFDPILRGKGFDEEMLQVLDVACMCVSQNPFKRPTVKEVVEWLNN 882 (894)
Q Consensus 830 ~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~ 882 (894)
......... .. ....+.+++.+|++.+|++|||+.++++.|++
T Consensus 235 -~~~~~~~~~------~~---~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~~ 277 (277)
T cd05062 235 -MEGGLLDKP------DN---CPDMLFELMRMCWQYNPKMRPSFLEIISSIKE 277 (277)
T ss_pred -HcCCcCCCC------CC---CCHHHHHHHHHHcCCChhhCcCHHHHHHHhhC
Confidence 111111110 11 12357789999999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh |
| >cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-34 Score=314.89 Aligned_cols=257 Identities=25% Similarity=0.400 Sum_probs=202.4
Q ss_pred cCCCccceEeecCcEEEEEEEE-----cCCCeEEEEEEcCcc-hhhHHHHHHHHHHHHhcCCCceeeecceeeecceEEE
Q 002673 607 DNFSQANIIGCGGFGLVYKATL-----ANGTTLAIKKLSGDL-GLMEREFKAEVEALSTAQHKNLVSLQGYCVHQGFRLL 680 (894)
Q Consensus 607 ~~f~~~~~LG~G~fg~Vy~a~~-----~~g~~vAvK~~~~~~-~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~l 680 (894)
++|+..+.||+|+||.||+|.+ .++..|++|.+.... ......+.+|+.++++++||||+++++++..+...++
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l 84 (283)
T cd05090 5 SAVRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVCLLGVVTQEQPVCM 84 (283)
T ss_pred hhceeeeeccccCCcceEEEEEecCCCCCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCCceEE
Confidence 4577889999999999999974 246789999997543 2334678899999999999999999999999999999
Q ss_pred EEEeccCCCHHHHHhhhcC-------------CCCCcCHHHHHHHHHHHHHHHHHHHhccCCCeeecCCCCCCeEECCCC
Q 002673 681 IYSYMENGSLDYWLHEKAD-------------GASQLDWLTRLKIARGTSCGLAYMHQICEPHIVHRDIKSSNILLDDQF 747 (894)
Q Consensus 681 V~E~~~~gsL~~~l~~~~~-------------~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDLkp~NILld~~~ 747 (894)
||||+++|+|.+++..... ....+++.+.+.++.|++.||.|||+ ++++||||||+|||+++++
T Consensus 85 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~---~~i~H~dlkp~nili~~~~ 161 (283)
T cd05090 85 LFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSS---HFFVHKDLAARNILIGEQL 161 (283)
T ss_pred EEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHh---cCeehhccccceEEEcCCC
Confidence 9999999999999864321 12357889999999999999999997 5999999999999999999
Q ss_pred cEEEEEcccccccCCCC-CcccccccccCCccCcccccCcCCCccccHHHHHHHHHHHHc-CCCCCCCCCcchhhhHHHH
Q 002673 748 EAHLADFGLSRLILPYQ-THVTTELVGTLGYIPPEYGQAWVATLRGDMYSFGVVMLELLT-GKRPVDVLKPKMSRELVGW 825 (894)
Q Consensus 748 ~vkl~DFGla~~~~~~~-~~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwS~GvlL~ellt-G~~Pf~~~~~~~~~~~~~~ 825 (894)
.+||+|||+++...... ........++..|+|||++.+..++.++||||||+++|||++ |..||...... .....
T Consensus 162 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~g~~p~~~~~~~---~~~~~ 238 (283)
T cd05090 162 HVKISDLGLSREIYSADYYRVQPKSLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQPYYGFSNQ---EVIEM 238 (283)
T ss_pred cEEeccccccccccCCcceecccCCCccceecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHH---HHHHH
Confidence 99999999998653322 112233445778999999988889999999999999999998 99999754321 12221
Q ss_pred HHHHhhcCCCCccccccccCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHh
Q 002673 826 VLKMRSEGKQDQVFDPILRGKGFDEEMLQVLDVACMCVSQNPFKRPTVKEVVEWLNN 882 (894)
Q Consensus 826 ~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~ 882 (894)
.. ...... .. ... ...+.+++.+|++.||++||++.++.+.|..
T Consensus 239 ~~----~~~~~~-----~~-~~~---~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~~ 282 (283)
T cd05090 239 VR----KRQLLP-----CS-EDC---PPRMYSLMTECWQEGPSRRPRFKDIHTRLRS 282 (283)
T ss_pred HH----cCCcCC-----CC-CCC---CHHHHHHHHHHcccCcccCcCHHHHHHHhhc
Confidence 11 111110 00 111 2356788899999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >PTZ00283 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-34 Score=337.50 Aligned_cols=255 Identities=24% Similarity=0.350 Sum_probs=203.4
Q ss_pred hccCCCccceEeecCcEEEEEEE-EcCCCeEEEEEEcCcc--hhhHHHHHHHHHHHHhcCCCceeeecceeeecc-----
Q 002673 605 ATDNFSQANIIGCGGFGLVYKAT-LANGTTLAIKKLSGDL--GLMEREFKAEVEALSTAQHKNLVSLQGYCVHQG----- 676 (894)
Q Consensus 605 a~~~f~~~~~LG~G~fg~Vy~a~-~~~g~~vAvK~~~~~~--~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~----- 676 (894)
..++|.+.+.||+|+||.||+|. ..+|+.||||++.... ......+.+|+..+..++|+|++++.+.+...+
T Consensus 30 ~~~rY~i~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~~~h~~iv~~~~~~~~~~~~~~~ 109 (496)
T PTZ00283 30 QAKKYWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNRAQAEVCCLLNCDFFSIVKCHEDFAKKDPRNPE 109 (496)
T ss_pred cCCCEEEEEEEecCCCEEEEEEEEcCCCCEEEEEEEecccCCHHHHHHHHHHHHHHhcCCCCcEEEeecceecccccCcc
Confidence 34689999999999999999997 5679999999986542 233456889999999999999999988765432
Q ss_pred ---eEEEEEEeccCCCHHHHHhhhcCCCCCcCHHHHHHHHHHHHHHHHHHHhccCCCeeecCCCCCCeEECCCCcEEEEE
Q 002673 677 ---FRLLIYSYMENGSLDYWLHEKADGASQLDWLTRLKIARGTSCGLAYMHQICEPHIVHRDIKSSNILLDDQFEAHLAD 753 (894)
Q Consensus 677 ---~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDLkp~NILld~~~~vkl~D 753 (894)
..++||||+++|+|.++++........+++..+..++.|++.||.|||+ ++|+||||||+|||++.++.+||+|
T Consensus 110 ~~~~i~lV~Ey~~~gsL~~~l~~~~~~~~~l~e~~~~~i~~qll~aL~~lH~---~~IiHrDLKP~NILl~~~~~vkL~D 186 (496)
T PTZ00283 110 NVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVHS---KHMIHRDIKSANILLCSNGLVKLGD 186 (496)
T ss_pred cceEEEEEEeCCCCCcHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHh---CCEecCCCCHHHEEEeCCCCEEEEe
Confidence 3679999999999999998755455678999999999999999999997 5999999999999999999999999
Q ss_pred cccccccCCCC-CcccccccccCCccCcccccCcCCCccccHHHHHHHHHHHHcCCCCCCCCCcchhhhHHHHHHHHhhc
Q 002673 754 FGLSRLILPYQ-THVTTELVGTLGYIPPEYGQAWVATLRGDMYSFGVVMLELLTGKRPVDVLKPKMSRELVGWVLKMRSE 832 (894)
Q Consensus 754 FGla~~~~~~~-~~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwS~GvlL~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~ 832 (894)
||+++.+.... ........||+.|+|||++.+..++.++|||||||++|||++|+.||...... ... .... .
T Consensus 187 FGls~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~k~DVwSlGvilyeLltG~~Pf~~~~~~---~~~---~~~~-~ 259 (496)
T PTZ00283 187 FGFSKMYAATVSDDVGRTFCGTPYYVAPEIWRRKPYSKKADMFSLGVLLYELLTLKRPFDGENME---EVM---HKTL-A 259 (496)
T ss_pred cccCeeccccccccccccccCCcceeCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHH---HHH---HHHh-c
Confidence 99998754322 12234467999999999999999999999999999999999999999754321 111 1111 1
Q ss_pred CCCCccccccccCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 002673 833 GKQDQVFDPILRGKGFDEEMLQVLDVACMCVSQNPFKRPTVKEVVE 878 (894)
Q Consensus 833 ~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~ 878 (894)
+..... . ......+.+++..||+.||.+||++.++++
T Consensus 260 ~~~~~~-~--------~~~~~~l~~li~~~L~~dP~~RPs~~ell~ 296 (496)
T PTZ00283 260 GRYDPL-P--------PSISPEMQEIVTALLSSDPKRRPSSSKLLN 296 (496)
T ss_pred CCCCCC-C--------CCCCHHHHHHHHHHcccChhhCcCHHHHHh
Confidence 111111 1 111235678999999999999999999986
|
|
| >cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-34 Score=310.70 Aligned_cols=254 Identities=25% Similarity=0.393 Sum_probs=203.8
Q ss_pred ccCCCccceEeecCcEEEEEEEEcCCCeEEEEEEcCcchhhHHHHHHHHHHHHhcCCCceeeecceeeecceEEEEEEec
Q 002673 606 TDNFSQANIIGCGGFGLVYKATLANGTTLAIKKLSGDLGLMEREFKAEVEALSTAQHKNLVSLQGYCVHQGFRLLIYSYM 685 (894)
Q Consensus 606 ~~~f~~~~~LG~G~fg~Vy~a~~~~g~~vAvK~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~lV~E~~ 685 (894)
.++|++.++||+|+||.||+|...+++.||+|.+..... ....+.+|+.++++++|+||+++++++. .+..+++|||+
T Consensus 5 ~~~~~~~~~ig~G~~g~v~~~~~~~~~~~a~K~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e~~ 82 (260)
T cd05067 5 RETLKLVKKLGAGQFGEVWMGYYNGHTKVAIKSLKQGSM-SPEAFLAEANLMKQLQHPRLVRLYAVVT-QEPIYIITEYM 82 (260)
T ss_pred hHHceeeeeeccCccceEEeeecCCCceEEEEEecCCCC-cHHHHHHHHHHHHhcCCcCeeeEEEEEc-cCCcEEEEEcC
Confidence 356888899999999999999988899999999876432 3457889999999999999999999874 45689999999
Q ss_pred cCCCHHHHHhhhcCCCCCcCHHHHHHHHHHHHHHHHHHHhccCCCeeecCCCCCCeEECCCCcEEEEEcccccccCCCCC
Q 002673 686 ENGSLDYWLHEKADGASQLDWLTRLKIARGTSCGLAYMHQICEPHIVHRDIKSSNILLDDQFEAHLADFGLSRLILPYQT 765 (894)
Q Consensus 686 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDLkp~NILld~~~~vkl~DFGla~~~~~~~~ 765 (894)
++|+|.+++.... ...+++..+..++.|++.||+|||+ .+++||||||+||++++++.++|+|||++........
T Consensus 83 ~~~~L~~~~~~~~--~~~~~~~~~~~i~~~i~~al~~LH~---~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~ 157 (260)
T cd05067 83 ENGSLVDFLKTPE--GIKLTINKLIDMAAQIAEGMAFIER---KNYIHRDLRAANILVSETLCCKIADFGLARLIEDNEY 157 (260)
T ss_pred CCCCHHHHHHhcC--CCCCCHHHHHHHHHHHHHHHHHHhc---CCeecccccHHhEEEcCCCCEEEccCcceeecCCCCc
Confidence 9999999987543 3468899999999999999999997 5999999999999999999999999999976542222
Q ss_pred cccccccccCCccCcccccCcCCCccccHHHHHHHHHHHHc-CCCCCCCCCcchhhhHHHHHHHHhhcCCCCcccccccc
Q 002673 766 HVTTELVGTLGYIPPEYGQAWVATLRGDMYSFGVVMLELLT-GKRPVDVLKPKMSRELVGWVLKMRSEGKQDQVFDPILR 844 (894)
Q Consensus 766 ~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwS~GvlL~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~ 844 (894)
.......++..|+|||++.+..++.++||||||+++|||++ |+.||...... ...... ...... .. .
T Consensus 158 ~~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~---~~~~~~---~~~~~~-~~-----~ 225 (260)
T cd05067 158 TAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTYGRIPYPGMTNP---EVIQNL---ERGYRM-PR-----P 225 (260)
T ss_pred ccccCCcccccccCHHHhccCCcCcccchHHHHHHHHHHHhCCCCCCCCCChH---HHHHHH---HcCCCC-CC-----C
Confidence 22223345678999999988889999999999999999999 99999754322 111111 111100 00 0
Q ss_pred CCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHh
Q 002673 845 GKGFDEEMLQVLDVACMCVSQNPFKRPTVKEVVEWLNN 882 (894)
Q Consensus 845 ~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~ 882 (894)
.. ...++.+++.+|++.+|++||++++++.+|+.
T Consensus 226 -~~---~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~ 259 (260)
T cd05067 226 -DN---CPEELYELMRLCWKEKPEERPTFEYLRSVLED 259 (260)
T ss_pred -CC---CCHHHHHHHHHHccCChhhCCCHHHHHHHhhc
Confidence 11 12357889999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr |
| >cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-35 Score=327.51 Aligned_cols=256 Identities=22% Similarity=0.224 Sum_probs=202.1
Q ss_pred cCCCccceEeecCcEEEEEEEE-cCCCeEEEEEEcCcch---hhHHHHHHHHHHHHhcCCCceeeecceeeecceEEEEE
Q 002673 607 DNFSQANIIGCGGFGLVYKATL-ANGTTLAIKKLSGDLG---LMEREFKAEVEALSTAQHKNLVSLQGYCVHQGFRLLIY 682 (894)
Q Consensus 607 ~~f~~~~~LG~G~fg~Vy~a~~-~~g~~vAvK~~~~~~~---~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~lV~ 682 (894)
++|++.+.||+|+||.||++.. .+|+.||+|++..... .....+.+|+.+++.++|+||+++++++.+.+..++||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (330)
T cd05601 1 KDFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQYAFQDKDNLYLVM 80 (330)
T ss_pred CCceEEEEEEeccCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceeeEEecCCeEEEEE
Confidence 4688899999999999999984 5789999999986432 23456789999999999999999999999999999999
Q ss_pred EeccCCCHHHHHhhhcCCCCCcCHHHHHHHHHHHHHHHHHHHhccCCCeeecCCCCCCeEECCCCcEEEEEcccccccCC
Q 002673 683 SYMENGSLDYWLHEKADGASQLDWLTRLKIARGTSCGLAYMHQICEPHIVHRDIKSSNILLDDQFEAHLADFGLSRLILP 762 (894)
Q Consensus 683 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDLkp~NILld~~~~vkl~DFGla~~~~~ 762 (894)
||+++|+|.+++.... ..+++..+..++.|++.||.|||+ ++|+||||||+|||++.++.+||+|||++.....
T Consensus 81 e~~~~~~L~~~l~~~~---~~l~~~~~~~~~~qi~~aL~~lH~---~~i~H~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~ 154 (330)
T cd05601 81 EYQPGGDLLSLLNRYE---DQFDEDMAQFYLAELVLAIHSVHQ---MGYVHRDIKPENVLIDRTGHIKLADFGSAARLTA 154 (330)
T ss_pred CCCCCCCHHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHH---CCeEcccCchHheEECCCCCEEeccCCCCeECCC
Confidence 9999999999998642 358889999999999999999997 5999999999999999999999999999987644
Q ss_pred CCCcccccccccCCccCccccc------CcCCCccccHHHHHHHHHHHHcCCCCCCCCCcchhhhHHHHHHHHhhcCCCC
Q 002673 763 YQTHVTTELVGTLGYIPPEYGQ------AWVATLRGDMYSFGVVMLELLTGKRPVDVLKPKMSRELVGWVLKMRSEGKQD 836 (894)
Q Consensus 763 ~~~~~~~~~~gt~~Y~APE~~~------~~~~s~ksDVwS~GvlL~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~ 836 (894)
..........||+.|+|||++. ...++.++|||||||++|||++|+.||....... ............
T Consensus 155 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~------~~~~i~~~~~~~ 228 (330)
T cd05601 155 NKMVNSKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTSAK------TYNNIMNFQRFL 228 (330)
T ss_pred CCceeeecccCCccccCHHHhccccccccCCCCCcceeecccceeeeeccCCCCCCCCCHHH------HHHHHHcCCCcc
Confidence 3332233457899999999876 4567899999999999999999999997543211 111111111111
Q ss_pred ccccccccCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHH--HHHh
Q 002673 837 QVFDPILRGKGFDEEMLQVLDVACMCVSQNPFKRPTVKEVVE--WLNN 882 (894)
Q Consensus 837 ~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~--~L~~ 882 (894)
...+ .......+.+++..|++ +|.+||++.++++ |+..
T Consensus 229 ~~~~-------~~~~~~~~~~li~~ll~-~p~~R~t~~~l~~h~~~~~ 268 (330)
T cd05601 229 KFPE-------DPKVSSDFLDLIQSLLC-GQKERLGYEGLCCHPFFSK 268 (330)
T ss_pred CCCC-------CCCCCHHHHHHHHHHcc-ChhhCCCHHHHhCCCCcCC
Confidence 1000 01122356788889998 9999999999996 5554
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor |
| >cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-35 Score=323.97 Aligned_cols=241 Identities=22% Similarity=0.274 Sum_probs=194.0
Q ss_pred ceEeecCcEEEEEEEE-cCCCeEEEEEEcCcch---hhHHHHHHHHHHHHhcCCCceeeecceeeecceEEEEEEeccCC
Q 002673 613 NIIGCGGFGLVYKATL-ANGTTLAIKKLSGDLG---LMEREFKAEVEALSTAQHKNLVSLQGYCVHQGFRLLIYSYMENG 688 (894)
Q Consensus 613 ~~LG~G~fg~Vy~a~~-~~g~~vAvK~~~~~~~---~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~lV~E~~~~g 688 (894)
+.||+|+||.||++.. .+|..||+|++..... .....+.+|+.+++.++||||+++++++..++..++||||+++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~Ey~~~g 80 (328)
T cd05593 1 KLLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKYSFQTKDRLCFVMEYVNGG 80 (328)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCEEEEEEeCCCCC
Confidence 4699999999999984 5789999999975432 23356788999999999999999999999999999999999999
Q ss_pred CHHHHHhhhcCCCCCcCHHHHHHHHHHHHHHHHHHHhccCCCeeecCCCCCCeEECCCCcEEEEEcccccccCCCCCccc
Q 002673 689 SLDYWLHEKADGASQLDWLTRLKIARGTSCGLAYMHQICEPHIVHRDIKSSNILLDDQFEAHLADFGLSRLILPYQTHVT 768 (894)
Q Consensus 689 sL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDLkp~NILld~~~~vkl~DFGla~~~~~~~~~~~ 768 (894)
+|..++... ..+++..+..++.||+.||.|||+ ++|+||||||+|||++.++.+||+|||+++..... ....
T Consensus 81 ~L~~~l~~~----~~l~~~~~~~~~~qi~~aL~~LH~---~~ivHrDikp~NIll~~~~~~kL~DfG~~~~~~~~-~~~~ 152 (328)
T cd05593 81 ELFFHLSRE----RVFSEDRTRFYGAEIVSALDYLHS---GKIVYRDLKLENLMLDKDGHIKITDFGLCKEGITD-AATM 152 (328)
T ss_pred CHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHh---CCeEecccCHHHeEECCCCcEEEecCcCCccCCCc-cccc
Confidence 999888653 358899999999999999999997 59999999999999999999999999998753221 1223
Q ss_pred ccccccCCccCcccccCcCCCccccHHHHHHHHHHHHcCCCCCCCCCcchhhhHHHHHHHHhhcCCCCccccccccCCCC
Q 002673 769 TELVGTLGYIPPEYGQAWVATLRGDMYSFGVVMLELLTGKRPVDVLKPKMSRELVGWVLKMRSEGKQDQVFDPILRGKGF 848 (894)
Q Consensus 769 ~~~~gt~~Y~APE~~~~~~~s~ksDVwS~GvlL~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~ 848 (894)
....||+.|+|||++.+..++.++|||||||++|+|++|+.||....... ... .... ... .+. ..
T Consensus 153 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~~~~---~~~---~~~~-~~~------~~p-~~- 217 (328)
T cd05593 153 KTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEK---LFE---LILM-EDI------KFP-RT- 217 (328)
T ss_pred ccccCCcCccChhhhcCCCCCccCCccccchHHHHHhhCCCCCCCCCHHH---HHH---Hhcc-CCc------cCC-CC-
Confidence 34579999999999999899999999999999999999999997543211 111 1111 100 011 11
Q ss_pred hHHHHHHHHHHHHhcccCCCCCC-----CHHHHHH
Q 002673 849 DEEMLQVLDVACMCVSQNPFKRP-----TVKEVVE 878 (894)
Q Consensus 849 ~~~~~~l~~li~~Cl~~dP~~RP-----s~~evl~ 878 (894)
....+.+++.+|++.||.+|| ++.++++
T Consensus 218 --~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~ 250 (328)
T cd05593 218 --LSADAKSLLSGLLIKDPNKRLGGGPDDAKEIMR 250 (328)
T ss_pred --CCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHhc
Confidence 123567888999999999997 8999986
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate |
| >cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-34 Score=311.49 Aligned_cols=254 Identities=23% Similarity=0.386 Sum_probs=199.4
Q ss_pred cCCCccceEeecCcEEEEEEE-EcCCCeEEEEEEcCcc-hhhHHHHHHHHHHHHhcCCCceeeecceeeecceEEEEEEe
Q 002673 607 DNFSQANIIGCGGFGLVYKAT-LANGTTLAIKKLSGDL-GLMEREFKAEVEALSTAQHKNLVSLQGYCVHQGFRLLIYSY 684 (894)
Q Consensus 607 ~~f~~~~~LG~G~fg~Vy~a~-~~~g~~vAvK~~~~~~-~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~lV~E~ 684 (894)
++|+..+.||+|+||.||+|. ..++..||+|.+.... ......+.+|+.++++++||||+++++++..++..++||||
T Consensus 1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 80 (279)
T cd06619 1 QDIQYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFYGAFFVENRISICTEF 80 (279)
T ss_pred CcchheeeeccCCCeEEEEEEEcCCCcEEEEEEEecCCChHHHHHHHHHHHHHHhCCCCCeeeEEEEEEECCEEEEEEec
Confidence 357788999999999999998 4678999999987543 33346788999999999999999999999999999999999
Q ss_pred ccCCCHHHHHhhhcCCCCCcCHHHHHHHHHHHHHHHHHHHhccCCCeeecCCCCCCeEECCCCcEEEEEcccccccCCCC
Q 002673 685 MENGSLDYWLHEKADGASQLDWLTRLKIARGTSCGLAYMHQICEPHIVHRDIKSSNILLDDQFEAHLADFGLSRLILPYQ 764 (894)
Q Consensus 685 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDLkp~NILld~~~~vkl~DFGla~~~~~~~ 764 (894)
+++|+|..+. .+++..+..++.|++.||.|||+ .+|+|+||||+||+++.++.++|+|||++......
T Consensus 81 ~~~~~l~~~~--------~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dlkp~Nill~~~~~~~l~dfg~~~~~~~~- 148 (279)
T cd06619 81 MDGGSLDVYR--------KIPEHVLGRIAVAVVKGLTYLWS---LKILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVNS- 148 (279)
T ss_pred CCCCChHHhh--------cCCHHHHHHHHHHHHHHHHHHHH---CCEeeCCCCHHHEEECCCCCEEEeeCCcceecccc-
Confidence 9999996542 36777888999999999999997 59999999999999999999999999999765322
Q ss_pred CcccccccccCCccCcccccCcCCCccccHHHHHHHHHHHHcCCCCCCCCCcchhh-hHHHHHHHHhhcCCCCccccccc
Q 002673 765 THVTTELVGTLGYIPPEYGQAWVATLRGDMYSFGVVMLELLTGKRPVDVLKPKMSR-ELVGWVLKMRSEGKQDQVFDPIL 843 (894)
Q Consensus 765 ~~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwS~GvlL~elltG~~Pf~~~~~~~~~-~~~~~~~~~~~~~~~~~~~d~~l 843 (894)
......||..|+|||++.+..++.++||||||+++|+|++|+.||......... ........... .... .+
T Consensus 149 --~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~-~~~~-----~~ 220 (279)
T cd06619 149 --IAKTYVGTNAYMAPERISGEQYGIHSDVWSLGISFMELALGRFPYPQIQKNQGSLMPLQLLQCIVD-EDPP-----VL 220 (279)
T ss_pred --cccCCCCChhhcCceeecCCCCCCcchHHHHHHHHHHHHhCCCCchhhcccccccchHHHHHHHhc-cCCC-----CC
Confidence 223457899999999999989999999999999999999999999753322111 01111111111 1000 01
Q ss_pred cCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHH--HHHhc
Q 002673 844 RGKGFDEEMLQVLDVACMCVSQNPFKRPTVKEVVE--WLNNV 883 (894)
Q Consensus 844 ~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~--~L~~i 883 (894)
.. .....++.+++.+|++.+|++||+++++++ |+...
T Consensus 221 ~~---~~~~~~~~~li~~~l~~~P~~Rp~~~eil~~~~~~~~ 259 (279)
T cd06619 221 PV---GQFSEKFVHFITQCMRKQPKERPAPENLMDHPFIVQY 259 (279)
T ss_pred CC---CcCCHHHHHHHHHHhhCChhhCCCHHHHhcCcccccc
Confidence 01 112235678999999999999999999987 55443
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p |
| >cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-34 Score=314.16 Aligned_cols=255 Identities=27% Similarity=0.352 Sum_probs=201.4
Q ss_pred CCCccceEeecCcEEEEEEEE-cCCCeEEEEEEcCcch---hhHHHHHHHHHHHHhcCCCceeeecceeeecceEEEEEE
Q 002673 608 NFSQANIIGCGGFGLVYKATL-ANGTTLAIKKLSGDLG---LMEREFKAEVEALSTAQHKNLVSLQGYCVHQGFRLLIYS 683 (894)
Q Consensus 608 ~f~~~~~LG~G~fg~Vy~a~~-~~g~~vAvK~~~~~~~---~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~lV~E 683 (894)
.|+..+.||+|+||.||++.. .+++.||+|++..... .....+.+|+.+++.++||||+++++++..++..++|||
T Consensus 1 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 80 (285)
T cd05605 1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLT 80 (285)
T ss_pred CceEEEEEecCCCeEEEEEEEcCCCceEEEEEEehhhhhhhhhHHHHHHHHHHHHhcCCCCEeeeeeeecCCCeEEEEEe
Confidence 377789999999999999985 4789999999875332 123457789999999999999999999999999999999
Q ss_pred eccCCCHHHHHhhhcCCCCCcCHHHHHHHHHHHHHHHHHHHhccCCCeeecCCCCCCeEECCCCcEEEEEcccccccCCC
Q 002673 684 YMENGSLDYWLHEKADGASQLDWLTRLKIARGTSCGLAYMHQICEPHIVHRDIKSSNILLDDQFEAHLADFGLSRLILPY 763 (894)
Q Consensus 684 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDLkp~NILld~~~~vkl~DFGla~~~~~~ 763 (894)
|+++|+|.+++.... ...+++..+..++.|++.||.|||+ ++++||||||+||++++++.++|+|||++......
T Consensus 81 ~~~~~~L~~~~~~~~--~~~~~~~~~~~~~~qi~~~l~~lH~---~~ivH~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~ 155 (285)
T cd05605 81 LMNGGDLKFHIYNMG--NPGFDEERAVFYAAEITCGLEDLHR---ERIVYRDLKPENILLDDYGHIRISDLGLAVEIPEG 155 (285)
T ss_pred ccCCCcHHHHHHhcC--cCCCCHHHHHHHHHHHHHHHHHHHH---CCcEecCCCHHHEEECCCCCEEEeeCCCceecCCC
Confidence 999999998887532 2458999999999999999999997 59999999999999999999999999999865322
Q ss_pred CCcccccccccCCccCcccccCcCCCccccHHHHHHHHHHHHcCCCCCCCCCcchhhhHHHHHHHHhhcCCCCccccccc
Q 002673 764 QTHVTTELVGTLGYIPPEYGQAWVATLRGDMYSFGVVMLELLTGKRPVDVLKPKMSRELVGWVLKMRSEGKQDQVFDPIL 843 (894)
Q Consensus 764 ~~~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwS~GvlL~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l 843 (894)
. ......|+..|+|||++.+..++.++|||||||++|||++|+.||.......... ...........
T Consensus 156 ~--~~~~~~~~~~y~aPE~~~~~~~~~~~Diws~G~~l~el~~g~~pf~~~~~~~~~~---~~~~~~~~~~~-------- 222 (285)
T cd05605 156 E--TIRGRVGTVGYMAPEVVKNERYTFSPDWWGLGCLIYEMIEGKSPFRQRKEKVKRE---EVERRVKEDQE-------- 222 (285)
T ss_pred C--ccccccCCCCccCcHHhcCCCCCccccchhHHHHHHHHHHCCCCCCCCchhhHHH---HHHHHhhhccc--------
Confidence 1 1233468999999999998899999999999999999999999997543221111 11111111110
Q ss_pred cCCCChHHHHHHHHHHHHhcccCCCCCC-----CHHHHHH--HHHh
Q 002673 844 RGKGFDEEMLQVLDVACMCVSQNPFKRP-----TVKEVVE--WLNN 882 (894)
Q Consensus 844 ~~~~~~~~~~~l~~li~~Cl~~dP~~RP-----s~~evl~--~L~~ 882 (894)
.........+.+++.+|++.||++|| +++++++ |+..
T Consensus 223 --~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~~~~~~~ 266 (285)
T cd05605 223 --EYSEKFSEAARSICRQLLTKDPGFRLGCRGEGAEEVKAHPFFRT 266 (285)
T ss_pred --ccCcccCHHHHHHHHHHccCCHHHhcCCCCCCHHHHhcCcCccC
Confidence 00111233567899999999999999 8889977 4543
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, |
| >cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-34 Score=315.60 Aligned_cols=259 Identities=27% Similarity=0.412 Sum_probs=203.9
Q ss_pred CCCccceEeecCcEEEEEEEEc------CCCeEEEEEEcCcch-hhHHHHHHHHHHHHhcCCCceeeecceeeecceEEE
Q 002673 608 NFSQANIIGCGGFGLVYKATLA------NGTTLAIKKLSGDLG-LMEREFKAEVEALSTAQHKNLVSLQGYCVHQGFRLL 680 (894)
Q Consensus 608 ~f~~~~~LG~G~fg~Vy~a~~~------~g~~vAvK~~~~~~~-~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~l 680 (894)
+|++.+.||+|+||.||+|... ....+++|.+..... .....+.+|+.+++.++||||+++++.+..++..++
T Consensus 1 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 80 (290)
T cd05045 1 NLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHVIKLYGACSQDGPLLL 80 (290)
T ss_pred CccccccccCcCCcceEEEEEecCCCCCcceeEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCCcEE
Confidence 4677889999999999999742 235688998875432 334678899999999999999999999999999999
Q ss_pred EEEeccCCCHHHHHhhhcC--------------------CCCCcCHHHHHHHHHHHHHHHHHHHhccCCCeeecCCCCCC
Q 002673 681 IYSYMENGSLDYWLHEKAD--------------------GASQLDWLTRLKIARGTSCGLAYMHQICEPHIVHRDIKSSN 740 (894)
Q Consensus 681 V~E~~~~gsL~~~l~~~~~--------------------~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDLkp~N 740 (894)
|+||+.+|+|.+++..... ....+++..++.++.|++.||.|||+ ++++||||||+|
T Consensus 81 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~---~~ivH~dikp~n 157 (290)
T cd05045 81 IVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAE---MKLVHRDLAARN 157 (290)
T ss_pred EEEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHHH---CCeehhhhhhhe
Confidence 9999999999999875321 12458899999999999999999997 599999999999
Q ss_pred eEECCCCcEEEEEcccccccCCCCCcc-cccccccCCccCcccccCcCCCccccHHHHHHHHHHHHc-CCCCCCCCCcch
Q 002673 741 ILLDDQFEAHLADFGLSRLILPYQTHV-TTELVGTLGYIPPEYGQAWVATLRGDMYSFGVVMLELLT-GKRPVDVLKPKM 818 (894)
Q Consensus 741 ILld~~~~vkl~DFGla~~~~~~~~~~-~~~~~gt~~Y~APE~~~~~~~s~ksDVwS~GvlL~ellt-G~~Pf~~~~~~~ 818 (894)
|++++++.+||+|||+++......... .....++..|+|||+..+..++.++||||||+++|||++ |+.||......
T Consensus 158 ill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~- 236 (290)
T cd05045 158 VLVAEGRKMKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIAPE- 236 (290)
T ss_pred EEEcCCCcEEeccccccccccCccchhcccCCCCCccccCHHHHccCCcchHhHHHHHHHHHHHHHhcCCCCCCCCCHH-
Confidence 999999999999999998653322211 122345678999999988889999999999999999998 99999754322
Q ss_pred hhhHHHHHHHHhhcCCCCccccccccCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhccc
Q 002673 819 SRELVGWVLKMRSEGKQDQVFDPILRGKGFDEEMLQVLDVACMCVSQNPFKRPTVKEVVEWLNNVGA 885 (894)
Q Consensus 819 ~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~i~~ 885 (894)
.+..+.. ...... . ... ....+.+++.+|++.+|++||++.++++.|+++..
T Consensus 237 --~~~~~~~----~~~~~~-----~-~~~---~~~~~~~~i~~cl~~~P~~Rp~~~~i~~~l~~~~~ 288 (290)
T cd05045 237 --RLFNLLK----TGYRME-----R-PEN---CSEEMYNLMLTCWKQEPDKRPTFADISKELEKMMV 288 (290)
T ss_pred --HHHHHHh----CCCCCC-----C-CCC---CCHHHHHHHHHHccCCcccCCCHHHHHHHHHHHHh
Confidence 2222211 110000 0 011 12357789999999999999999999999998754
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi |
| >cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-34 Score=310.60 Aligned_cols=254 Identities=25% Similarity=0.397 Sum_probs=202.3
Q ss_pred cCCCccceEeecCcEEEEEEEEcCCCeEEEEEEcCcchhhHHHHHHHHHHHHhcCCCceeeecceeeecceEEEEEEecc
Q 002673 607 DNFSQANIIGCGGFGLVYKATLANGTTLAIKKLSGDLGLMEREFKAEVEALSTAQHKNLVSLQGYCVHQGFRLLIYSYME 686 (894)
Q Consensus 607 ~~f~~~~~LG~G~fg~Vy~a~~~~g~~vAvK~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~lV~E~~~ 686 (894)
++|++.+.||+|+||.||+|...+...||+|++..... ....+.+|+.++++++||||+++++++. ....++||||++
T Consensus 6 ~~~~~~~~lg~g~~~~v~~~~~~~~~~valK~~~~~~~-~~~~~~~E~~~l~~l~~~~i~~~~~~~~-~~~~~lv~e~~~ 83 (262)
T cd05071 6 ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTM-SPEAFLQEAQVMKKLRHEKLVQLYAVVS-EEPIYIVTEYMS 83 (262)
T ss_pred HHeeEeeecCCCCCCcEEEEEecCCceEEEEecccCcc-CHHHHHHHHHHHHhCCCCCcceEEEEEC-CCCcEEEEEcCC
Confidence 46888999999999999999877777899999975332 3457899999999999999999999875 455799999999
Q ss_pred CCCHHHHHhhhcCCCCCcCHHHHHHHHHHHHHHHHHHHhccCCCeeecCCCCCCeEECCCCcEEEEEcccccccCCCCCc
Q 002673 687 NGSLDYWLHEKADGASQLDWLTRLKIARGTSCGLAYMHQICEPHIVHRDIKSSNILLDDQFEAHLADFGLSRLILPYQTH 766 (894)
Q Consensus 687 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDLkp~NILld~~~~vkl~DFGla~~~~~~~~~ 766 (894)
+|+|.+++.... ...+++..+..++.|++.||.|||+ ++++||||||+||++++++.+||+|||.+.........
T Consensus 84 ~~~L~~~~~~~~--~~~~~~~~~~~~~~~l~~aL~~lH~---~~i~H~dl~p~Nill~~~~~~~L~dfg~~~~~~~~~~~ 158 (262)
T cd05071 84 KGSLLDFLKGEM--GKYLRLPQLVDMAAQIASGMAYVER---MNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYT 158 (262)
T ss_pred CCcHHHHHhhcc--ccCCCHHHHHHHHHHHHHHHHHHHH---CCccccccCcccEEEcCCCcEEeccCCceeeccccccc
Confidence 999999997532 2457899999999999999999997 59999999999999999999999999999866433222
Q ss_pred ccccccccCCccCcccccCcCCCccccHHHHHHHHHHHHc-CCCCCCCCCcchhhhHHHHHHHHhhcCCCCccccccccC
Q 002673 767 VTTELVGTLGYIPPEYGQAWVATLRGDMYSFGVVMLELLT-GKRPVDVLKPKMSRELVGWVLKMRSEGKQDQVFDPILRG 845 (894)
Q Consensus 767 ~~~~~~gt~~Y~APE~~~~~~~s~ksDVwS~GvlL~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~ 845 (894)
......++..|+|||+..+..++.++||||||+++|||++ |+.||....... ... .........
T Consensus 159 ~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~ellt~g~~p~~~~~~~~---~~~---~~~~~~~~~--------- 223 (262)
T cd05071 159 ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNRE---VLD---QVERGYRMP--------- 223 (262)
T ss_pred cccCCcccceecCHhHhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCChHH---HHH---HHhcCCCCC---------
Confidence 2223346678999999988899999999999999999999 888987543221 111 111110000
Q ss_pred CCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhc
Q 002673 846 KGFDEEMLQVLDVACMCVSQNPFKRPTVKEVVEWLNNV 883 (894)
Q Consensus 846 ~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~i 883 (894)
........+.+++.+|++.+|++||++.+++++|+..
T Consensus 224 -~~~~~~~~l~~li~~~l~~~p~~Rp~~~~~~~~l~~~ 260 (262)
T cd05071 224 -CPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDY 260 (262)
T ss_pred -CccccCHHHHHHHHHHccCCcccCCCHHHHHHHHHHh
Confidence 0112234677999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo |
| >cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-35 Score=330.43 Aligned_cols=254 Identities=25% Similarity=0.306 Sum_probs=198.9
Q ss_pred cCCCccceEeecCcEEEEEEEE-cCCCeEEEEEEcCcc---hhhHHHHHHHHHHHHhcCCCceeeecceeeecceEEEEE
Q 002673 607 DNFSQANIIGCGGFGLVYKATL-ANGTTLAIKKLSGDL---GLMEREFKAEVEALSTAQHKNLVSLQGYCVHQGFRLLIY 682 (894)
Q Consensus 607 ~~f~~~~~LG~G~fg~Vy~a~~-~~g~~vAvK~~~~~~---~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~lV~ 682 (894)
++|+..+.||+|+||.||+|.. .+|+.||||++.... ......+.+|+.++..++||||+++++++.+++..++||
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~ 80 (364)
T cd05599 1 DDFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKLYYSFQDENYLYLIM 80 (364)
T ss_pred CCceEEEEEEecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCeEEEEE
Confidence 4688899999999999999985 468999999997532 122345788999999999999999999999999999999
Q ss_pred EeccCCCHHHHHhhhcCCCCCcCHHHHHHHHHHHHHHHHHHHhccCCCeeecCCCCCCeEECCCCcEEEEEcccccccCC
Q 002673 683 SYMENGSLDYWLHEKADGASQLDWLTRLKIARGTSCGLAYMHQICEPHIVHRDIKSSNILLDDQFEAHLADFGLSRLILP 762 (894)
Q Consensus 683 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDLkp~NILld~~~~vkl~DFGla~~~~~ 762 (894)
||+++|+|.+++... ..+++..+..++.|++.||.|||+ ++|+||||||+|||++.++.+||+|||+++.+..
T Consensus 81 E~~~~g~L~~~l~~~----~~l~~~~~~~~~~qi~~aL~~lH~---~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~ 153 (364)
T cd05599 81 EYLPGGDMMTLLMKK----DTFTEEETRFYIAETILAIDSIHK---LGYIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKK 153 (364)
T ss_pred CCCCCcHHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHH---CCeEeccCCHHHeEECCCCCEEEeecccceeccc
Confidence 999999999999754 358899999999999999999997 5999999999999999999999999999876432
Q ss_pred CCCc-------------------------------------ccccccccCCccCcccccCcCCCccccHHHHHHHHHHHH
Q 002673 763 YQTH-------------------------------------VTTELVGTLGYIPPEYGQAWVATLRGDMYSFGVVMLELL 805 (894)
Q Consensus 763 ~~~~-------------------------------------~~~~~~gt~~Y~APE~~~~~~~s~ksDVwS~GvlL~ell 805 (894)
.... .....+||+.|+|||++.+..++.++|||||||++|||+
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~ 233 (364)
T cd05599 154 SHRTEFYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGVIMYEML 233 (364)
T ss_pred cccccccccccccccccccccccccccccccccchhhcccccccccccCccccCHHHHcCCCCCCeeeeecchhHHHHhh
Confidence 1100 011246999999999999999999999999999999999
Q ss_pred cCCCCCCCCCcchhhhHHHHHHHHhhcCCCCccccccccCCCChHHHHHHHHHHHHhcccCCCCCCC---HHHHHH--HH
Q 002673 806 TGKRPVDVLKPKMSRELVGWVLKMRSEGKQDQVFDPILRGKGFDEEMLQVLDVACMCVSQNPFKRPT---VKEVVE--WL 880 (894)
Q Consensus 806 tG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs---~~evl~--~L 880 (894)
+|..||....... ........ .... .. .. ....+ ..+.+++.+|+. +|.+|++ +.++++ |+
T Consensus 234 ~G~~Pf~~~~~~~---~~~~i~~~--~~~~-~~-~~---~~~~s---~~~~~li~~ll~-~p~~R~~~~~~~~ll~h~~~ 299 (364)
T cd05599 234 VGYPPFCSDNPQE---TYRKIINW--KETL-QF-PD---EVPLS---PEAKDLIKRLCC-EAERRLGNNGVNEIKSHPFF 299 (364)
T ss_pred cCCCCCCCCCHHH---HHHHHHcC--CCcc-CC-CC---CCCCC---HHHHHHHHHHcc-CHhhcCCCCCHHHHhcCCCc
Confidence 9999997544221 11111100 0000 00 00 01112 245678888886 9999998 999987 55
Q ss_pred H
Q 002673 881 N 881 (894)
Q Consensus 881 ~ 881 (894)
.
T Consensus 300 ~ 300 (364)
T cd05599 300 K 300 (364)
T ss_pred C
Confidence 3
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica |
| >cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-34 Score=313.43 Aligned_cols=257 Identities=24% Similarity=0.383 Sum_probs=201.0
Q ss_pred cCCCccceEeecCcEEEEEEEE-cCCC----eEEEEEEcCcch-hhHHHHHHHHHHHHhcCCCceeeecceeeecceEEE
Q 002673 607 DNFSQANIIGCGGFGLVYKATL-ANGT----TLAIKKLSGDLG-LMEREFKAEVEALSTAQHKNLVSLQGYCVHQGFRLL 680 (894)
Q Consensus 607 ~~f~~~~~LG~G~fg~Vy~a~~-~~g~----~vAvK~~~~~~~-~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~l 680 (894)
++|+..+.||+|+||.||+|.+ .+++ .|++|.+..... ....++..|+..+++++||||+++++++.. ...++
T Consensus 7 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~l~~l~h~~iv~~~~~~~~-~~~~~ 85 (279)
T cd05111 7 TELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIVRLLGICPG-ASLQL 85 (279)
T ss_pred hhceeccccCccCCcceEEEEEcCCCCceeeEEEEeecccccchHHHHHHHHHHHHHhcCCCCCcceEEEEECC-CccEE
Confidence 4677889999999999999985 3454 477888764432 233567888889999999999999998864 45788
Q ss_pred EEEeccCCCHHHHHhhhcCCCCCcCHHHHHHHHHHHHHHHHHHHhccCCCeeecCCCCCCeEECCCCcEEEEEccccccc
Q 002673 681 IYSYMENGSLDYWLHEKADGASQLDWLTRLKIARGTSCGLAYMHQICEPHIVHRDIKSSNILLDDQFEAHLADFGLSRLI 760 (894)
Q Consensus 681 V~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDLkp~NILld~~~~vkl~DFGla~~~ 760 (894)
++||+++|+|.+++.... ..+++..+..++.||+.||.|||+ ++++||||||+||++++++.+||+|||+++..
T Consensus 86 i~e~~~~gsL~~~l~~~~---~~~~~~~~~~i~~qi~~~l~~lH~---~~iiH~dlkp~nili~~~~~~kl~Dfg~~~~~ 159 (279)
T cd05111 86 VTQLSPLGSLLDHVRQHR---DSLDPQRLLNWCVQIAKGMYYLEE---HRMVHRNLAARNILLKSDSIVQIADFGVADLL 159 (279)
T ss_pred EEEeCCCCcHHHHHHhcc---cCCCHHHHHHHHHHHHHHHHHHHH---CCEeccccCcceEEEcCCCcEEEcCCccceec
Confidence 999999999999997543 458999999999999999999997 58999999999999999999999999999876
Q ss_pred CCCCCc-ccccccccCCccCcccccCcCCCccccHHHHHHHHHHHHc-CCCCCCCCCcchhhhHHHHHHHHhhcCCCCcc
Q 002673 761 LPYQTH-VTTELVGTLGYIPPEYGQAWVATLRGDMYSFGVVMLELLT-GKRPVDVLKPKMSRELVGWVLKMRSEGKQDQV 838 (894)
Q Consensus 761 ~~~~~~-~~~~~~gt~~Y~APE~~~~~~~s~ksDVwS~GvlL~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 838 (894)
...... ......++..|+|||+..+..++.++||||||+++|||++ |+.||.........+. . ..+...
T Consensus 160 ~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~~~~~---~----~~~~~~-- 230 (279)
T cd05111 160 YPDDKKYFYSEHKTPIKWMALESILFGRYTHQSDVWSYGVTVWEMMSYGAEPYAGMRPHEVPDL---L----EKGERL-- 230 (279)
T ss_pred cCCCcccccCCCCCcccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHH---H----HCCCcC--
Confidence 433221 2233456778999999998899999999999999999998 9999976543221111 1 111111
Q ss_pred ccccccCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhcccc
Q 002673 839 FDPILRGKGFDEEMLQVLDVACMCVSQNPFKRPTVKEVVEWLNNVGAN 886 (894)
Q Consensus 839 ~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~i~~~ 886 (894)
..+ ..+ ...+.+++.+||..||++|||+.++++.|..+...
T Consensus 231 ~~~----~~~---~~~~~~li~~c~~~~p~~Rps~~el~~~l~~~~~~ 271 (279)
T cd05111 231 AQP----QIC---TIDVYMVMVKCWMIDENVRPTFKELANEFTRMARD 271 (279)
T ss_pred CCC----CCC---CHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHhC
Confidence 111 111 12456788999999999999999999999887643
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r |
| >cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-34 Score=322.33 Aligned_cols=260 Identities=27% Similarity=0.411 Sum_probs=202.2
Q ss_pred cCCCccceEeecCcEEEEEEEEc------CCCeEEEEEEcCcch-hhHHHHHHHHHHHHhc-CCCceeeecceeeec-ce
Q 002673 607 DNFSQANIIGCGGFGLVYKATLA------NGTTLAIKKLSGDLG-LMEREFKAEVEALSTA-QHKNLVSLQGYCVHQ-GF 677 (894)
Q Consensus 607 ~~f~~~~~LG~G~fg~Vy~a~~~------~g~~vAvK~~~~~~~-~~~~~~~~Ei~~l~~l-~HpnIv~l~g~~~~~-~~ 677 (894)
++|++.+.||+|+||.||+|... +++.||+|++..... ...+.+..|+.++.++ +|+||++++++|... ..
T Consensus 7 ~~~~i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~~~~l~~h~niv~~~~~~~~~~~~ 86 (337)
T cd05054 7 DRLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGATASEYKALMTELKILIHIGHHLNVVNLLGACTKPGGP 86 (337)
T ss_pred HHhhhhcccccCcCceEEeccccccccccccceeeeeeccCCCCHHHHHHHHHHHHHHHhhccCcchhheeeeEecCCCC
Confidence 57888999999999999999632 347899999875432 2335678899999999 899999999988654 56
Q ss_pred EEEEEEeccCCCHHHHHhhhcCC---------------------------------------------------------
Q 002673 678 RLLIYSYMENGSLDYWLHEKADG--------------------------------------------------------- 700 (894)
Q Consensus 678 ~~lV~E~~~~gsL~~~l~~~~~~--------------------------------------------------------- 700 (894)
.+++|||+++|+|.+++......
T Consensus 87 ~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 166 (337)
T cd05054 87 LMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDEEGDELY 166 (337)
T ss_pred EEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcccchhhhHHh
Confidence 78999999999999998643210
Q ss_pred CCCcCHHHHHHHHHHHHHHHHHHHhccCCCeeecCCCCCCeEECCCCcEEEEEcccccccCCCCCcc-cccccccCCccC
Q 002673 701 ASQLDWLTRLKIARGTSCGLAYMHQICEPHIVHRDIKSSNILLDDQFEAHLADFGLSRLILPYQTHV-TTELVGTLGYIP 779 (894)
Q Consensus 701 ~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDLkp~NILld~~~~vkl~DFGla~~~~~~~~~~-~~~~~gt~~Y~A 779 (894)
...++|..+..++.||+.||.|||+ ++|+||||||+|||++.++.+||+|||++..+....... .....++..|+|
T Consensus 167 ~~~l~~~~~~~~~~qi~~aL~~lH~---~~ivHrDikp~Nill~~~~~vkL~DfG~a~~~~~~~~~~~~~~~~~~~~y~a 243 (337)
T cd05054 167 KEPLTLEDLISYSFQVARGMEFLAS---RKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMA 243 (337)
T ss_pred hcCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCcceEEEeCCCcEEEeccccchhcccCcchhhccCCCCCccccC
Confidence 1368999999999999999999997 599999999999999999999999999998764322221 223445678999
Q ss_pred cccccCcCCCccccHHHHHHHHHHHHc-CCCCCCCCCcchhhhHHHHHHHHhhcCCCCccccccccCCCChHHHHHHHHH
Q 002673 780 PEYGQAWVATLRGDMYSFGVVMLELLT-GKRPVDVLKPKMSRELVGWVLKMRSEGKQDQVFDPILRGKGFDEEMLQVLDV 858 (894)
Q Consensus 780 PE~~~~~~~s~ksDVwS~GvlL~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l 858 (894)
||++.+..++.++|||||||++|||++ |..||....... .... .......... + . .....+.++
T Consensus 244 PE~~~~~~~~~~~Di~SlGv~l~el~t~g~~p~~~~~~~~--~~~~----~~~~~~~~~~--~----~---~~~~~~~~l 308 (337)
T cd05054 244 PESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQIDE--EFCR----RLKEGTRMRA--P----E---YATPEIYSI 308 (337)
T ss_pred cHHhcCCCCCccccHHHHHHHHHHHHHcCCCCCCCCCccH--HHHH----HHhccCCCCC--C----c---cCCHHHHHH
Confidence 999999999999999999999999998 999997543221 1111 1111111100 0 1 112357789
Q ss_pred HHHhcccCCCCCCCHHHHHHHHHhcc
Q 002673 859 ACMCVSQNPFKRPTVKEVVEWLNNVG 884 (894)
Q Consensus 859 i~~Cl~~dP~~RPs~~evl~~L~~i~ 884 (894)
+.+||+.+|++||++.++++.|+.+.
T Consensus 309 ~~~cl~~~p~~RPs~~ell~~l~~~~ 334 (337)
T cd05054 309 MLDCWHNNPEDRPTFSELVEILGDLL 334 (337)
T ss_pred HHHHccCChhhCcCHHHHHHHHHHHH
Confidence 99999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto |
| >cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-35 Score=329.44 Aligned_cols=256 Identities=23% Similarity=0.253 Sum_probs=200.5
Q ss_pred hccCCCccceEeecCcEEEEEEEE-cCCCeEEEEEEcCcc---hhhHHHHHHHHHHHHhcCCCceeeecceeeecceEEE
Q 002673 605 ATDNFSQANIIGCGGFGLVYKATL-ANGTTLAIKKLSGDL---GLMEREFKAEVEALSTAQHKNLVSLQGYCVHQGFRLL 680 (894)
Q Consensus 605 a~~~f~~~~~LG~G~fg~Vy~a~~-~~g~~vAvK~~~~~~---~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~l 680 (894)
..++|++.+.||+|+||.||++.. .++..||+|++.... ......+.+|+.+++.++||||+++++++.+++..++
T Consensus 41 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~h~~iv~~~~~~~~~~~~~l 120 (370)
T cd05596 41 KAEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQLHYAFQDDKYLYM 120 (370)
T ss_pred CHHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEEEE
Confidence 346789999999999999999985 468899999997532 1223457789999999999999999999999999999
Q ss_pred EEEeccCCCHHHHHhhhcCCCCCcCHHHHHHHHHHHHHHHHHHHhccCCCeeecCCCCCCeEECCCCcEEEEEccccccc
Q 002673 681 IYSYMENGSLDYWLHEKADGASQLDWLTRLKIARGTSCGLAYMHQICEPHIVHRDIKSSNILLDDQFEAHLADFGLSRLI 760 (894)
Q Consensus 681 V~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDLkp~NILld~~~~vkl~DFGla~~~ 760 (894)
||||+++|+|.+++... .++...+..++.|++.||.|||+ ++|+||||||+|||++.++.+||+|||++...
T Consensus 121 v~Ey~~gg~L~~~l~~~-----~l~~~~~~~~~~qi~~aL~~LH~---~~ivHrDLkp~NILl~~~~~~kL~DfG~~~~~ 192 (370)
T cd05596 121 VMEYMPGGDLVNLMSNY-----DIPEKWARFYTAEVVLALDAIHS---MGFIHRDVKPDNMLLDKSGHLKLADFGTCMKM 192 (370)
T ss_pred EEcCCCCCcHHHHHHhc-----CCCHHHHHHHHHHHHHHHHHHHH---CCeeccCCCHHHEEEcCCCCEEEEeccceeec
Confidence 99999999999998753 36777888899999999999997 59999999999999999999999999999876
Q ss_pred CCCCCcccccccccCCccCcccccCc----CCCccccHHHHHHHHHHHHcCCCCCCCCCcchhhhHHHHHHHHhhcCCCC
Q 002673 761 LPYQTHVTTELVGTLGYIPPEYGQAW----VATLRGDMYSFGVVMLELLTGKRPVDVLKPKMSRELVGWVLKMRSEGKQD 836 (894)
Q Consensus 761 ~~~~~~~~~~~~gt~~Y~APE~~~~~----~~s~ksDVwS~GvlL~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~ 836 (894)
............||+.|+|||++.+. .++.++|||||||++|||++|+.||....... ....+.......
T Consensus 193 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~------~~~~i~~~~~~~ 266 (370)
T cd05596 193 DANGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVG------TYSKIMDHKNSL 266 (370)
T ss_pred cCCCcccCCCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHHHhCCCCcCCCCHHH------HHHHHHcCCCcC
Confidence 43322223446799999999987653 47889999999999999999999997543211 111111111000
Q ss_pred ccccccccCCCChHHHHHHHHHHHHhcccCCCC--CCCHHHHHH--HHH
Q 002673 837 QVFDPILRGKGFDEEMLQVLDVACMCVSQNPFK--RPTVKEVVE--WLN 881 (894)
Q Consensus 837 ~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~--RPs~~evl~--~L~ 881 (894)
.. .. .......+.+++..|++.+|.+ ||+++++++ |+.
T Consensus 267 ~~-~~------~~~~s~~~~~li~~~L~~~p~r~~R~s~~ell~h~~~~ 308 (370)
T cd05596 267 TF-PD------DIEISKQAKDLICAFLTDREVRLGRNGVDEIKSHPFFK 308 (370)
T ss_pred CC-CC------cCCCCHHHHHHHHHHccChhhccCCCCHHHHhcCcccC
Confidence 00 00 0112345678899999999988 999999987 554
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in |
| >cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-34 Score=314.95 Aligned_cols=264 Identities=22% Similarity=0.364 Sum_probs=201.7
Q ss_pred cCCCccceEeecCcEEEEEEEEcC---------------CCeEEEEEEcCcch-hhHHHHHHHHHHHHhcCCCceeeecc
Q 002673 607 DNFSQANIIGCGGFGLVYKATLAN---------------GTTLAIKKLSGDLG-LMEREFKAEVEALSTAQHKNLVSLQG 670 (894)
Q Consensus 607 ~~f~~~~~LG~G~fg~Vy~a~~~~---------------g~~vAvK~~~~~~~-~~~~~~~~Ei~~l~~l~HpnIv~l~g 670 (894)
++|++.+.||+|+||.||++...+ ...||+|.+..... .....+.+|++++++++|+|++++++
T Consensus 5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~ 84 (295)
T cd05097 5 QQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEIKIMSRLKNPNIIRLLG 84 (295)
T ss_pred HhCeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCcCeEEE
Confidence 578889999999999999987532 23589999876532 33457899999999999999999999
Q ss_pred eeeecceEEEEEEeccCCCHHHHHhhhcC--------CCCCcCHHHHHHHHHHHHHHHHHHHhccCCCeeecCCCCCCeE
Q 002673 671 YCVHQGFRLLIYSYMENGSLDYWLHEKAD--------GASQLDWLTRLKIARGTSCGLAYMHQICEPHIVHRDIKSSNIL 742 (894)
Q Consensus 671 ~~~~~~~~~lV~E~~~~gsL~~~l~~~~~--------~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDLkp~NIL 742 (894)
++...+..++||||+++++|.+++..... ....+++..++.++.|++.||.|||+ .+++||||||+||+
T Consensus 85 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~---~~i~H~dlkp~Nil 161 (295)
T cd05097 85 VCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLAS---LNFVHRDLATRNCL 161 (295)
T ss_pred EEcCCCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHHh---cCeeccccChhhEE
Confidence 99999999999999999999999965321 11247888999999999999999997 59999999999999
Q ss_pred ECCCCcEEEEEcccccccCCCCCc-ccccccccCCccCcccccCcCCCccccHHHHHHHHHHHHc--CCCCCCCCCcchh
Q 002673 743 LDDQFEAHLADFGLSRLILPYQTH-VTTELVGTLGYIPPEYGQAWVATLRGDMYSFGVVMLELLT--GKRPVDVLKPKMS 819 (894)
Q Consensus 743 ld~~~~vkl~DFGla~~~~~~~~~-~~~~~~gt~~Y~APE~~~~~~~s~ksDVwS~GvlL~ellt--G~~Pf~~~~~~~~ 819 (894)
+++++.+||+|||++......... ......++..|+|||+..+..++.++|||||||++|+|++ |..||.......
T Consensus 162 l~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~~l~el~~~~~~~p~~~~~~~~- 240 (295)
T cd05097 162 VGNHYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFTLCKEQPYSLLSDEQ- 240 (295)
T ss_pred EcCCCcEEecccccccccccCcceeccCcCcCceeecChhhhccCCcCchhhHHHHHHHHHHHHHcCCCCCCcccChHH-
Confidence 999999999999999765322211 1222345678999999988899999999999999999998 677887544322
Q ss_pred hhHHHHHHHHhhcCCCCccccccccCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHh
Q 002673 820 RELVGWVLKMRSEGKQDQVFDPILRGKGFDEEMLQVLDVACMCVSQNPFKRPTVKEVVEWLNN 882 (894)
Q Consensus 820 ~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~ 882 (894)
............... ... .........+.+++.+|++.||++|||+++|++.|++
T Consensus 241 --~~~~~~~~~~~~~~~-~~~-----~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~~l~~ 295 (295)
T cd05097 241 --VIENTGEFFRNQGRQ-IYL-----SQTPLCPSPVFKLMMRCWSRDIKDRPTFNKIHHFLRE 295 (295)
T ss_pred --HHHHHHHhhhhcccc-ccC-----CCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHhC
Confidence 111111111111000 000 0001112367899999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including |
| >cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-34 Score=329.41 Aligned_cols=255 Identities=23% Similarity=0.305 Sum_probs=196.1
Q ss_pred CCCccceEeecCcEEEEEEE-EcCCCeEEEEEEcCcc---hhhHHHHHHHHHHHHhcCCCceeeecceeeecceEEEEEE
Q 002673 608 NFSQANIIGCGGFGLVYKAT-LANGTTLAIKKLSGDL---GLMEREFKAEVEALSTAQHKNLVSLQGYCVHQGFRLLIYS 683 (894)
Q Consensus 608 ~f~~~~~LG~G~fg~Vy~a~-~~~g~~vAvK~~~~~~---~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~lV~E 683 (894)
.|+..+.||+|+||.||+|. ..++..||+|++.... ......+.+|+.+++.++||||+++++++.+.+..++|||
T Consensus 2 ~f~~~~~LG~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~lv~E 81 (381)
T cd05626 2 MFVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMD 81 (381)
T ss_pred CceEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhcCCCCeeeeEEEEecCCEEEEEEe
Confidence 57888999999999999998 4578899999997532 2233568899999999999999999999999999999999
Q ss_pred eccCCCHHHHHhhhcCCCCCcCHHHHHHHHHHHHHHHHHHHhccCCCeeecCCCCCCeEECCCCcEEEEEcccccccCCC
Q 002673 684 YMENGSLDYWLHEKADGASQLDWLTRLKIARGTSCGLAYMHQICEPHIVHRDIKSSNILLDDQFEAHLADFGLSRLILPY 763 (894)
Q Consensus 684 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDLkp~NILld~~~~vkl~DFGla~~~~~~ 763 (894)
|+++|+|.+++... ..+++..+..++.||+.||.|||+ .+|+||||||+|||++.++.+||+|||+++.+...
T Consensus 82 ~~~gg~L~~~l~~~----~~~~e~~~~~~~~qi~~aL~~LH~---~givHrDlKp~Nili~~~~~~kL~DFGl~~~~~~~ 154 (381)
T cd05626 82 YIPGGDMMSLLIRM----EVFPEVLARFYIAELTLAIESVHK---MGFIHRDIKPDNILIDLDGHIKLTDFGLCTGFRWT 154 (381)
T ss_pred cCCCCcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHh---CCeeecCCcHHHEEECCCCCEEEeeCcCCcccccc
Confidence 99999999999754 357888889999999999999997 59999999999999999999999999997643110
Q ss_pred CC----------------------------------------------cccccccccCCccCcccccCcCCCccccHHHH
Q 002673 764 QT----------------------------------------------HVTTELVGTLGYIPPEYGQAWVATLRGDMYSF 797 (894)
Q Consensus 764 ~~----------------------------------------------~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwS~ 797 (894)
.. ......+||+.|+|||++.+..++.++|||||
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSl 234 (381)
T cd05626 155 HNSKYYQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDWWSV 234 (381)
T ss_pred cccccccccccccccccCcccccccccccccccccchhhccccccccccccccccCCccccCHHHHcCCCCCCccceeeh
Confidence 00 00123579999999999998899999999999
Q ss_pred HHHHHHHHcCCCCCCCCCcchhhhHHHHHHHHhhcCCCCccccccccCCCChHHHHHHHHHHHH--hcccCCCCCCCHHH
Q 002673 798 GVVMLELLTGKRPVDVLKPKMSRELVGWVLKMRSEGKQDQVFDPILRGKGFDEEMLQVLDVACM--CVSQNPFKRPTVKE 875 (894)
Q Consensus 798 GvlL~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~--Cl~~dP~~RPs~~e 875 (894)
||++|||++|+.||......... ...........+ .+ ....+ .++.+++.+ |+..++..||++.+
T Consensus 235 G~il~elltG~~Pf~~~~~~~~~------~~i~~~~~~~~~-~~---~~~~s---~~~~dli~~ll~~~~~~~~R~~~~~ 301 (381)
T cd05626 235 GVILFEMLVGQPPFLAPTPTETQ------LKVINWENTLHI-PP---QVKLS---PEAVDLITKLCCSAEERLGRNGADD 301 (381)
T ss_pred hhHHHHHHhCCCCCcCCCHHHHH------HHHHccccccCC-CC---CCCCC---HHHHHHHHHHccCcccccCCCCHHH
Confidence 99999999999999754322111 011100000000 00 00112 245567766 55566677999999
Q ss_pred HHH--HHHh
Q 002673 876 VVE--WLNN 882 (894)
Q Consensus 876 vl~--~L~~ 882 (894)
+++ ++++
T Consensus 302 ~l~hp~f~~ 310 (381)
T cd05626 302 IKAHPFFSE 310 (381)
T ss_pred HhcCcccCC
Confidence 998 5554
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po |
| >cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-34 Score=308.30 Aligned_cols=248 Identities=23% Similarity=0.369 Sum_probs=195.7
Q ss_pred ceEeecCcEEEEEEEE-cCCCeEEEEEEcCcc-hhhHHHHHHHHHHHHhcCCCceeeecceeeecceEEEEEEeccCCCH
Q 002673 613 NIIGCGGFGLVYKATL-ANGTTLAIKKLSGDL-GLMEREFKAEVEALSTAQHKNLVSLQGYCVHQGFRLLIYSYMENGSL 690 (894)
Q Consensus 613 ~~LG~G~fg~Vy~a~~-~~g~~vAvK~~~~~~-~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~lV~E~~~~gsL 690 (894)
+.||+|+||.||+|.. .+++.||+|.+.... ......+.+|++++++++||||++++++|......++||||+++++|
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (252)
T cd05084 1 ERIGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGDF 80 (252)
T ss_pred CccCcccCccEEEEEEecCCceEEEEecCccCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEcCCCCeEEEEeeccCCcH
Confidence 3689999999999985 578999999886543 23446789999999999999999999999999999999999999999
Q ss_pred HHHHhhhcCCCCCcCHHHHHHHHHHHHHHHHHHHhccCCCeeecCCCCCCeEECCCCcEEEEEcccccccCCCCCccc-c
Q 002673 691 DYWLHEKADGASQLDWLTRLKIARGTSCGLAYMHQICEPHIVHRDIKSSNILLDDQFEAHLADFGLSRLILPYQTHVT-T 769 (894)
Q Consensus 691 ~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDLkp~NILld~~~~vkl~DFGla~~~~~~~~~~~-~ 769 (894)
.+++.... ..+++..++.++.|++.||.|||+ ++++||||||+||+++.++.+||+|||++........... .
T Consensus 81 ~~~~~~~~---~~~~~~~~~~~~~qi~~~L~~lH~---~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~ 154 (252)
T cd05084 81 LTFLRTEG---PRLKVKELIQMVENAAAGMEYLES---KHCIHRDLAARNCLVTEKNVLKISDFGMSREEEDGVYASTGG 154 (252)
T ss_pred HHHHHhCC---CCCCHHHHHHHHHHHHHHHHHHHh---CCccccccchheEEEcCCCcEEECccccCcccccccccccCC
Confidence 99997532 458899999999999999999997 5999999999999999999999999999876432111111 1
Q ss_pred cccccCCccCcccccCcCCCccccHHHHHHHHHHHHc-CCCCCCCCCcchhhhHHHHHHHHhhcCCCCccccccccCCCC
Q 002673 770 ELVGTLGYIPPEYGQAWVATLRGDMYSFGVVMLELLT-GKRPVDVLKPKMSRELVGWVLKMRSEGKQDQVFDPILRGKGF 848 (894)
Q Consensus 770 ~~~gt~~Y~APE~~~~~~~s~ksDVwS~GvlL~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~ 848 (894)
....+..|+|||.+.+..++.++||||||+++|||++ |..||............ ....... ..
T Consensus 155 ~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~e~~~~~~~p~~~~~~~~~~~~~-------~~~~~~~-~~-------- 218 (252)
T cd05084 155 MKQIPVKWTAPEALNYGRYSSESDVWSFGILLWEAFSLGAVPYANLSNQQTREAI-------EQGVRLP-CP-------- 218 (252)
T ss_pred CCCCceeecCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccCHHHHHHHH-------HcCCCCC-Cc--------
Confidence 1123457999999999899999999999999999998 99999754332111111 1110000 00
Q ss_pred hHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHh
Q 002673 849 DEEMLQVLDVACMCVSQNPFKRPTVKEVVEWLNN 882 (894)
Q Consensus 849 ~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~ 882 (894)
......+.+++.+|++.+|++|||+.++++.|+.
T Consensus 219 ~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~~ 252 (252)
T cd05084 219 ELCPDAVYRLMERCWEYDPGQRPSFSTVHQELQS 252 (252)
T ss_pred ccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHhC
Confidence 1112357789999999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular |
| >KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-35 Score=312.98 Aligned_cols=259 Identities=26% Similarity=0.394 Sum_probs=196.2
Q ss_pred ccceEeecCcEEEEEEEEcCCCeEEEEEEcCcchhhHHHHHHHHHHHH--hcCCCceeeecceeeecc----eEEEEEEe
Q 002673 611 QANIIGCGGFGLVYKATLANGTTLAIKKLSGDLGLMEREFKAEVEALS--TAQHKNLVSLQGYCVHQG----FRLLIYSY 684 (894)
Q Consensus 611 ~~~~LG~G~fg~Vy~a~~~~g~~vAvK~~~~~~~~~~~~~~~Ei~~l~--~l~HpnIv~l~g~~~~~~----~~~lV~E~ 684 (894)
..++||+|+||.||||.+. ++.||||++.. ...+.|+.|-.+.+ .++|+||++++++-.... +.+||+||
T Consensus 214 l~eli~~Grfg~V~KaqL~-~~~VAVKifp~---~~kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t~~~~eywLVt~f 289 (534)
T KOG3653|consen 214 LLELIGRGRFGCVWKAQLD-NRLVAVKIFPE---QEKQSFQNEKNIYSLPGMKHENILQFIGAEKRGTADRMEYWLVTEF 289 (534)
T ss_pred hHHHhhcCccceeehhhcc-CceeEEEecCH---HHHHHHHhHHHHHhccCccchhHHHhhchhccCCccccceeEEeee
Confidence 3467999999999999985 59999999974 34556777666665 458999999999866554 78999999
Q ss_pred ccCCCHHHHHhhhcCCCCCcCHHHHHHHHHHHHHHHHHHHhc------cCCCeeecCCCCCCeEECCCCcEEEEEccccc
Q 002673 685 MENGSLDYWLHEKADGASQLDWLTRLKIARGTSCGLAYMHQI------CEPHIVHRDIKSSNILLDDQFEAHLADFGLSR 758 (894)
Q Consensus 685 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~------~~~~ivHrDLkp~NILld~~~~vkl~DFGla~ 758 (894)
.+.|+|.+||..+ .++|....+|+..+++||+|||+. .+++|+|||||++|||+.+|+++.|+|||+|.
T Consensus 290 h~kGsL~dyL~~n-----tisw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~DlTccIaDFGLAl 364 (534)
T KOG3653|consen 290 HPKGSLCDYLKAN-----TISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKNDLTCCIADFGLAL 364 (534)
T ss_pred ccCCcHHHHHHhc-----cccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEccCCcEEeeccceeE
Confidence 9999999999864 589999999999999999999975 35679999999999999999999999999999
Q ss_pred ccCCCCCc-ccccccccCCccCcccccCcCC------CccccHHHHHHHHHHHHcCCCCCCC-CCc------------ch
Q 002673 759 LILPYQTH-VTTELVGTLGYIPPEYGQAWVA------TLRGDMYSFGVVMLELLTGKRPVDV-LKP------------KM 818 (894)
Q Consensus 759 ~~~~~~~~-~~~~~~gt~~Y~APE~~~~~~~------s~ksDVwS~GvlL~elltG~~Pf~~-~~~------------~~ 818 (894)
.+.+.... ..-..+||.+|||||++.+... -.+.||||+|.|||||+++..-++. ..+ ..
T Consensus 365 ~~~p~~~~~d~~~qVGT~RYMAPEvLEgainl~d~~Afkr~DvYamgLVLWEi~SRC~~~~~~~vp~Yqlpfe~evG~hP 444 (534)
T KOG3653|consen 365 RLEPGKPQGDTHGQVGTRRYMAPEVLEGAINLQDRDAFKRIDVYAMGLVLWEIASRCTDADPGPVPEYQLPFEAEVGNHP 444 (534)
T ss_pred EecCCCCCcchhhhhhhhhhcCHHHHhhhcccccHHHHHHHHHHHHHHHHHHHHhhcccccCCCCCcccCchhHHhcCCC
Confidence 88654432 2334789999999999877532 2468999999999999996644421 000 00
Q ss_pred -hhhHHHHHHHHhhcCCCCccccccccCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhccc
Q 002673 819 -SRELVGWVLKMRSEGKQDQVFDPILRGKGFDEEMLQVLDVACMCVSQNPFKRPTVKEVVEWLNNVGA 885 (894)
Q Consensus 819 -~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~i~~ 885 (894)
..+....+.. ......+.|.... ...+..+.+.+..||+-||+.|.|+.=+-+.+.++..
T Consensus 445 t~e~mq~~VV~---kK~RP~~p~~W~~----h~~~~~l~et~EeCWDhDaeARLTA~Cv~eR~~~l~~ 505 (534)
T KOG3653|consen 445 TLEEMQELVVR---KKQRPKIPDAWRK----HAGMAVLCETIEECWDHDAEARLTAGCVEERMAELMM 505 (534)
T ss_pred CHHHHHHHHHh---hccCCCChhhhhc----CccHHHHHHHHHHHcCCchhhhhhhHHHHHHHHHHhc
Confidence 0111111111 1111222222221 1446678899999999999999999988887777654
|
|
| >cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-34 Score=326.59 Aligned_cols=266 Identities=21% Similarity=0.272 Sum_probs=200.1
Q ss_pred CCCccceEeecCcEEEEEEEE-cCCCeEEEEEEcCcc--hhhHHHHHHHHHHHHhcCCCceeeecceeeecc-----eEE
Q 002673 608 NFSQANIIGCGGFGLVYKATL-ANGTTLAIKKLSGDL--GLMEREFKAEVEALSTAQHKNLVSLQGYCVHQG-----FRL 679 (894)
Q Consensus 608 ~f~~~~~LG~G~fg~Vy~a~~-~~g~~vAvK~~~~~~--~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~-----~~~ 679 (894)
+|+..+.||+|+||.||++.. .+|+.||||++.... ....+.+.+|+++++.++|+||+++++++...+ ..+
T Consensus 1 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 80 (372)
T cd07853 1 DVEPDRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCKRVFRELKMLCFFKHDNVLSALDILQPPHIDPFEEIY 80 (372)
T ss_pred CCcccceeeeCCCEEEEEEEECCCCCEEEEEeccccccchHHHHHHHHHHHHHHhCCCCCcCCHhheecCCCccccceEE
Confidence 477889999999999999985 578999999986532 223457889999999999999999999998776 789
Q ss_pred EEEEeccCCCHHHHHhhhcCCCCCcCHHHHHHHHHHHHHHHHHHHhccCCCeeecCCCCCCeEECCCCcEEEEEcccccc
Q 002673 680 LIYSYMENGSLDYWLHEKADGASQLDWLTRLKIARGTSCGLAYMHQICEPHIVHRDIKSSNILLDDQFEAHLADFGLSRL 759 (894)
Q Consensus 680 lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDLkp~NILld~~~~vkl~DFGla~~ 759 (894)
+|+||+. ++|.+++... ..+++..+..++.||+.||.|||+ ++|+||||||+|||++.++.+||+|||+++.
T Consensus 81 lv~e~~~-~~l~~~~~~~----~~l~~~~~~~~~~qi~~aL~~LH~---~~ivH~dlkp~Nili~~~~~~kL~Dfg~a~~ 152 (372)
T cd07853 81 VVTELMQ-SDLHKIIVSP----QPLSSDHVKVFLYQILRGLKYLHS---AGILHRDIKPGNLLVNSNCVLKICDFGLARV 152 (372)
T ss_pred EEeeccc-cCHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHHh---CCeeCCCCChHHEEECCCCCEEeccccceee
Confidence 9999996 5787777542 458899999999999999999997 5999999999999999999999999999986
Q ss_pred cCCCCCcccccccccCCccCcccccCc-CCCccccHHHHHHHHHHHHcCCCCCCCCCcchhhhHHHH-------------
Q 002673 760 ILPYQTHVTTELVGTLGYIPPEYGQAW-VATLRGDMYSFGVVMLELLTGKRPVDVLKPKMSRELVGW------------- 825 (894)
Q Consensus 760 ~~~~~~~~~~~~~gt~~Y~APE~~~~~-~~s~ksDVwS~GvlL~elltG~~Pf~~~~~~~~~~~~~~------------- 825 (894)
.............+|+.|+|||++.+. .++.++|||||||++|||++|+.||...........+..
T Consensus 153 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~ 232 (372)
T cd07853 153 EEPDESKHMTQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQQLDLITDLLGTPSLEAMRSA 232 (372)
T ss_pred cccCccccCCCCCcCCCcCCHHHHcCCCCCCcHHHHHhHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHcCCCCHHHHHHh
Confidence 543332233345678999999998774 578999999999999999999999976543211111100
Q ss_pred ---HHHHh-hcCCCCccccccccCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHH--HHHhc
Q 002673 826 ---VLKMR-SEGKQDQVFDPILRGKGFDEEMLQVLDVACMCVSQNPFKRPTVKEVVE--WLNNV 883 (894)
Q Consensus 826 ---~~~~~-~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~--~L~~i 883 (894)
..... ............. .........+.+++.+|++.||.+|||+.++++ |++..
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp~~~~~ 294 (372)
T cd07853 233 CEGARAHILRGPHKPPSLPVLY--TLSSQATHEAVHLLCRMLVFDPDKRISAADALAHPYLDEG 294 (372)
T ss_pred hHHHHHHHHhCCCCCCchHHhc--ccCCCCCHHHHHHHHHhCCCChhhCcCHHHHhcCHhhCCC
Confidence 00000 0000000000000 000111335778999999999999999999997 67653
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription |
| >cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-34 Score=311.48 Aligned_cols=262 Identities=22% Similarity=0.407 Sum_probs=208.0
Q ss_pred ccCCCccceEeecCcEEEEEEEEcC-----CCeEEEEEEcCcc-hhhHHHHHHHHHHHHhcCCCceeeecceeee-cceE
Q 002673 606 TDNFSQANIIGCGGFGLVYKATLAN-----GTTLAIKKLSGDL-GLMEREFKAEVEALSTAQHKNLVSLQGYCVH-QGFR 678 (894)
Q Consensus 606 ~~~f~~~~~LG~G~fg~Vy~a~~~~-----g~~vAvK~~~~~~-~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~-~~~~ 678 (894)
.++|+..+.||+|+||.||+|...+ +..|++|++.... ......+.+|+.++++++|+||+++++++.. +...
T Consensus 5 ~~~~~~~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~ 84 (280)
T cd05043 5 RDRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGLSHQNILPILHVCIEDGEPP 84 (280)
T ss_pred hhheEEeeeecccCCceEEEEEEecCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCCCC
Confidence 4678889999999999999998655 7889999987543 3345668899999999999999999998876 4678
Q ss_pred EEEEEeccCCCHHHHHhhhcCC----CCCcCHHHHHHHHHHHHHHHHHHHhccCCCeeecCCCCCCeEECCCCcEEEEEc
Q 002673 679 LLIYSYMENGSLDYWLHEKADG----ASQLDWLTRLKIARGTSCGLAYMHQICEPHIVHRDIKSSNILLDDQFEAHLADF 754 (894)
Q Consensus 679 ~lV~E~~~~gsL~~~l~~~~~~----~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDLkp~NILld~~~~vkl~DF 754 (894)
++++||+++|+|.+++...... ...+++..++.++.|++.||.|||+ ++++||||||+||++++++.+||+||
T Consensus 85 ~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~---~~i~H~di~p~nil~~~~~~~kl~d~ 161 (280)
T cd05043 85 FVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHK---RGVIHKDIAARNCVIDEELQVKITDN 161 (280)
T ss_pred EEEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHH---CCEeecccCHhhEEEcCCCcEEECCC
Confidence 9999999999999999764322 2568999999999999999999997 59999999999999999999999999
Q ss_pred ccccccCCCCCcc-cccccccCCccCcccccCcCCCccccHHHHHHHHHHHHc-CCCCCCCCCcchhhhHHHHHHHHhhc
Q 002673 755 GLSRLILPYQTHV-TTELVGTLGYIPPEYGQAWVATLRGDMYSFGVVMLELLT-GKRPVDVLKPKMSRELVGWVLKMRSE 832 (894)
Q Consensus 755 Gla~~~~~~~~~~-~~~~~gt~~Y~APE~~~~~~~s~ksDVwS~GvlL~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~ 832 (894)
|+++.+....... .....++..|+|||++.+..++.++||||||+++||+++ |+.||..... .++..+.. ..
T Consensus 162 g~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~---~~~~~~~~---~~ 235 (280)
T cd05043 162 ALSRDLFPMDYHCLGDNENRPVKWMALESLVNKEYSSASDVWSFGVLLWELMTLGQTPYVEIDP---FEMAAYLK---DG 235 (280)
T ss_pred CCcccccCCceEEeCCCCCcchhccCHHHHhcCCCCchhhHHHhHHHHHHHhcCCCCCcCcCCH---HHHHHHHH---cC
Confidence 9998664332221 122345678999999988889999999999999999999 9999975432 12222211 11
Q ss_pred CCCCccccccccCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhcccc
Q 002673 833 GKQDQVFDPILRGKGFDEEMLQVLDVACMCVSQNPFKRPTVKEVVEWLNNVGAN 886 (894)
Q Consensus 833 ~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~i~~~ 886 (894)
..... .......+.+++.+||+.+|++|||+.+++++|+.+..+
T Consensus 236 ~~~~~----------~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~~~~~~ 279 (280)
T cd05043 236 YRLAQ----------PINCPDELFAVMACCWALDPEERPSFSQLVQCLTDFHAQ 279 (280)
T ss_pred CCCCC----------CCcCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHhc
Confidence 11110 011123567899999999999999999999999987643
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It |
| >cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-34 Score=305.53 Aligned_cols=247 Identities=24% Similarity=0.354 Sum_probs=197.6
Q ss_pred ceEeecCcEEEEEEEEcCCCeEEEEEEcCcch-hhHHHHHHHHHHHHhcCCCceeeecceeeecceEEEEEEeccCCCHH
Q 002673 613 NIIGCGGFGLVYKATLANGTTLAIKKLSGDLG-LMEREFKAEVEALSTAQHKNLVSLQGYCVHQGFRLLIYSYMENGSLD 691 (894)
Q Consensus 613 ~~LG~G~fg~Vy~a~~~~g~~vAvK~~~~~~~-~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~lV~E~~~~gsL~ 691 (894)
++||+|+||.||+|...++..+|+|.+..... .....+.+|+.+++.++||||+++++++...+..++||||+++|+|.
T Consensus 1 ~~ig~g~~g~vy~~~~~~~~~~a~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~ 80 (250)
T cd05085 1 ELLGKGNFGEVFKGTLKDKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVCTQRQPIYIVMELVPGGDFL 80 (250)
T ss_pred CccCCCCCceEEEEEecCCcEEEEEecCCcCCHHHHHHHHHHHHHHHhCCCCCcCeEEEEEecCCccEEEEECCCCCcHH
Confidence 36899999999999988899999999876543 23456889999999999999999999999999999999999999999
Q ss_pred HHHhhhcCCCCCcCHHHHHHHHHHHHHHHHHHHhccCCCeeecCCCCCCeEECCCCcEEEEEcccccccCCCCCcccccc
Q 002673 692 YWLHEKADGASQLDWLTRLKIARGTSCGLAYMHQICEPHIVHRDIKSSNILLDDQFEAHLADFGLSRLILPYQTHVTTEL 771 (894)
Q Consensus 692 ~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDLkp~NILld~~~~vkl~DFGla~~~~~~~~~~~~~~ 771 (894)
+++.... ..+++..+..++.|++.+|.|||+ ++++||||||+||+++.++.+||+|||++..............
T Consensus 81 ~~~~~~~---~~~~~~~~~~~~~~i~~~l~~lH~---~~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~ 154 (250)
T cd05085 81 SFLRKKK---DELKTKQLVKFALDAAAGMAYLES---KNCIHRDLAARNCLVGENNVLKISDFGMSRQEDDGIYSSSGLK 154 (250)
T ss_pred HHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHh---CCeeecccChheEEEcCCCeEEECCCccceeccccccccCCCC
Confidence 9987542 357899999999999999999997 5999999999999999999999999999875432221111222
Q ss_pred cccCCccCcccccCcCCCccccHHHHHHHHHHHHc-CCCCCCCCCcchhhhHHHHHHHHhhcCCCCccccccccCCCChH
Q 002673 772 VGTLGYIPPEYGQAWVATLRGDMYSFGVVMLELLT-GKRPVDVLKPKMSRELVGWVLKMRSEGKQDQVFDPILRGKGFDE 850 (894)
Q Consensus 772 ~gt~~Y~APE~~~~~~~s~ksDVwS~GvlL~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~ 850 (894)
.++..|+|||+..+..++.++||||||+++|+|++ |..||....... ..... ........ ...
T Consensus 155 ~~~~~y~aPE~~~~~~~~~~~Di~slG~ll~~~~~~g~~p~~~~~~~~---~~~~~----~~~~~~~~---------~~~ 218 (250)
T cd05085 155 QIPIKWTAPEALNYGRYSSESDVWSYGILLWETFSLGVCPYPGMTNQQ---AREQV----EKGYRMSC---------PQK 218 (250)
T ss_pred CCcccccCHHHhccCCCCchhHHHHHHHHHHHHhcCCCCCCCCCCHHH---HHHHH----HcCCCCCC---------CCC
Confidence 34568999999998899999999999999999998 999997543221 11111 11110000 011
Q ss_pred HHHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 002673 851 EMLQVLDVACMCVSQNPFKRPTVKEVVEWLN 881 (894)
Q Consensus 851 ~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~ 881 (894)
....+.+++.+|++.+|++||++.++++.|.
T Consensus 219 ~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~ 249 (250)
T cd05085 219 CPDDVYKVMQRCWDYKPENRPKFSELQKELA 249 (250)
T ss_pred CCHHHHHHHHHHcccCcccCCCHHHHHHHhc
Confidence 2346788999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c |
| >cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-34 Score=320.03 Aligned_cols=241 Identities=29% Similarity=0.347 Sum_probs=193.0
Q ss_pred ceEeecCcEEEEEEEE----cCCCeEEEEEEcCcc----hhhHHHHHHHHHHHHhcCCCceeeecceeeecceEEEEEEe
Q 002673 613 NIIGCGGFGLVYKATL----ANGTTLAIKKLSGDL----GLMEREFKAEVEALSTAQHKNLVSLQGYCVHQGFRLLIYSY 684 (894)
Q Consensus 613 ~~LG~G~fg~Vy~a~~----~~g~~vAvK~~~~~~----~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~lV~E~ 684 (894)
+.||+|+||.||++.. .+++.||+|++.... ......+..|+.+++.++||||+++++++..++..++||||
T Consensus 2 ~~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~e~ 81 (323)
T cd05584 2 KVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIVDLIYAFQTGGKLYLILEY 81 (323)
T ss_pred ceeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhCCCCchhceeeEEecCCeEEEEEeC
Confidence 5799999999999974 357899999987532 12234577899999999999999999999999999999999
Q ss_pred ccCCCHHHHHhhhcCCCCCcCHHHHHHHHHHHHHHHHHHHhccCCCeeecCCCCCCeEECCCCcEEEEEcccccccCCCC
Q 002673 685 MENGSLDYWLHEKADGASQLDWLTRLKIARGTSCGLAYMHQICEPHIVHRDIKSSNILLDDQFEAHLADFGLSRLILPYQ 764 (894)
Q Consensus 685 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDLkp~NILld~~~~vkl~DFGla~~~~~~~ 764 (894)
+++|+|.+++... ..+.+..+..++.|++.||.|||+ ++|+||||||+|||++.++.+||+|||+++......
T Consensus 82 ~~~~~L~~~~~~~----~~~~~~~~~~~~~qi~~~l~~lH~---~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~ 154 (323)
T cd05584 82 LSGGELFMHLERE----GIFMEDTACFYLSEISLALEHLHQ---QGIIYRDLKPENILLDAQGHVKLTDFGLCKESIHEG 154 (323)
T ss_pred CCCchHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHeEECCCCCEEEeeCcCCeecccCC
Confidence 9999999998754 346778888999999999999997 599999999999999999999999999987543222
Q ss_pred CcccccccccCCccCcccccCcCCCccccHHHHHHHHHHHHcCCCCCCCCCcchhhhHHHHHHHHhhcCCCCcccccccc
Q 002673 765 THVTTELVGTLGYIPPEYGQAWVATLRGDMYSFGVVMLELLTGKRPVDVLKPKMSRELVGWVLKMRSEGKQDQVFDPILR 844 (894)
Q Consensus 765 ~~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwS~GvlL~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~ 844 (894)
.......||+.|+|||++.+..++.++|||||||++|||++|+.||....... . ...... +.. . +.+
T Consensus 155 -~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~pf~~~~~~~---~---~~~~~~-~~~-~-~~~--- 221 (323)
T cd05584 155 -TVTHTFCGTIEYMAPEILMRSGHGKAVDWWSLGALMYDMLTGAPPFTAENRKK---T---IDKILK-GKL-N-LPP--- 221 (323)
T ss_pred -CcccccCCCccccChhhccCCCCCCcceecccHHHHHHHhcCCCCCCCCCHHH---H---HHHHHc-CCC-C-CCC---
Confidence 22334578999999999998889999999999999999999999997543211 1 111111 111 0 111
Q ss_pred CCCChHHHHHHHHHHHHhcccCCCCCC-----CHHHHHH
Q 002673 845 GKGFDEEMLQVLDVACMCVSQNPFKRP-----TVKEVVE 878 (894)
Q Consensus 845 ~~~~~~~~~~l~~li~~Cl~~dP~~RP-----s~~evl~ 878 (894)
. ....+.+++.+|++.+|++|| ++.++++
T Consensus 222 --~---~~~~~~~li~~~l~~~p~~R~~~~~~~~~~l~~ 255 (323)
T cd05584 222 --Y---LTPEARDLLKKLLKRNPSSRLGAGPGDAAEVQS 255 (323)
T ss_pred --C---CCHHHHHHHHHHcccCHhHcCCCCCCCHHHHhc
Confidence 1 123567899999999999999 8888877
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in |
| >KOG0589 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-35 Score=324.49 Aligned_cols=250 Identities=24% Similarity=0.369 Sum_probs=209.9
Q ss_pred cCCCccceEeecCcEEEEEEE-EcCCCeEEEEEEcCcc--hhhHHHHHHHHHHHHhcCCCceeeecceeeecce-EEEEE
Q 002673 607 DNFSQANIIGCGGFGLVYKAT-LANGTTLAIKKLSGDL--GLMEREFKAEVEALSTAQHKNLVSLQGYCVHQGF-RLLIY 682 (894)
Q Consensus 607 ~~f~~~~~LG~G~fg~Vy~a~-~~~g~~vAvK~~~~~~--~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~-~~lV~ 682 (894)
++|...+++|+|+||.++.++ ..++..+++|++.... ....+...+|+.++++++|||||.+.+.+..++. .++||
T Consensus 4 ~~Ye~~~~iG~GafG~a~lvrhk~~~~~~vlK~I~l~~~t~~~r~~A~~E~~lis~~~hP~iv~y~ds~~~~~~~l~Ivm 83 (426)
T KOG0589|consen 4 DNYEVLRQVGRGAFGSALLVRHKSDDKLYVLKKINLEKLTEPERRSAIQEMDLLSKLLHPNIVEYKDSFEEDGQLLCIVM 83 (426)
T ss_pred chhhhhhhcCccccchhhhhhhccCCceEEEEEEeccccCchhhHHHHHHHHHHHhccCCCeeeeccchhcCCceEEEEE
Confidence 568888999999999999987 4567899999987543 3334578899999999999999999999999888 99999
Q ss_pred EeccCCCHHHHHhhhcCCCCCcCHHHHHHHHHHHHHHHHHHHhccCCCeeecCCCCCCeEECCCCcEEEEEcccccccCC
Q 002673 683 SYMENGSLDYWLHEKADGASQLDWLTRLKIARGTSCGLAYMHQICEPHIVHRDIKSSNILLDDQFEAHLADFGLSRLILP 762 (894)
Q Consensus 683 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDLkp~NILld~~~~vkl~DFGla~~~~~ 762 (894)
+|++||+|.+.+.... +..++...++.|+.|++.|+.|||+ +.|+|||||+.||+++.+..|||+|||+|+.+.+
T Consensus 84 ~Y~eGg~l~~~i~~~k--~~~f~E~~i~~~~~Q~~~av~ylH~---~~iLHRDlK~~Nifltk~~~VkLgDfGlaK~l~~ 158 (426)
T KOG0589|consen 84 EYCEGGDLAQLIKEQK--GVLFPEERILKWFVQILLAVNYLHE---NRVLHRDLKCANIFLTKDKKVKLGDFGLAKILNP 158 (426)
T ss_pred eecCCCCHHHHHHHHh--hccccHHHHHHHHHHHHHHHHHHHh---hhhhcccchhhhhhccccCceeecchhhhhhcCC
Confidence 9999999999998764 4678999999999999999999996 6999999999999999999999999999998865
Q ss_pred CCCcccccccccCCccCcccccCcCCCccccHHHHHHHHHHHHcCCCCCCCCCcchhhhHHHHHHHHhhcCCCCcccccc
Q 002673 763 YQTHVTTELVGTLGYIPPEYGQAWVATLRGDMYSFGVVMLELLTGKRPVDVLKPKMSRELVGWVLKMRSEGKQDQVFDPI 842 (894)
Q Consensus 763 ~~~~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwS~GvlL~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 842 (894)
.. .....++||+.||.||++.+..|..|+|||||||++|||++-+++|...+.. .++. ++.. ..++|.
T Consensus 159 ~~-~~a~tvvGTp~YmcPEil~d~pYn~KSDiWsLGC~~yEm~~lk~aF~a~~m~---~Li~---ki~~-----~~~~Pl 226 (426)
T KOG0589|consen 159 ED-SLASTVVGTPYYMCPEILSDIPYNEKSDIWSLGCCLYEMCTLKPAFKASNMS---ELIL---KINR-----GLYSPL 226 (426)
T ss_pred ch-hhhheecCCCcccCHHHhCCCCCCccCcchhhcchHHHHHhcccccCccchH---HHHH---HHhh-----ccCCCC
Confidence 44 2456689999999999999999999999999999999999999999854422 2221 1111 112221
Q ss_pred ccCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 002673 843 LRGKGFDEEMLQVLDVACMCVSQNPFKRPTVKEVVE 878 (894)
Q Consensus 843 l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~ 878 (894)
...+..++..++..|++.+|..||++.+++.
T Consensus 227 -----p~~ys~el~~lv~~~l~~~P~~RPsa~~LL~ 257 (426)
T KOG0589|consen 227 -----PSMYSSELRSLVKSMLRKNPEHRPSALELLR 257 (426)
T ss_pred -----CccccHHHHHHHHHHhhcCCccCCCHHHHhh
Confidence 2234556778889999999999999999998
|
|
| >cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-34 Score=325.30 Aligned_cols=202 Identities=27% Similarity=0.309 Sum_probs=174.3
Q ss_pred cCCCccceEeecCcEEEEEEEE-cCCCeEEEEEEcCcch---hhHHHHHHHHHHHHhcCCCceeeecceeeecceEEEEE
Q 002673 607 DNFSQANIIGCGGFGLVYKATL-ANGTTLAIKKLSGDLG---LMEREFKAEVEALSTAQHKNLVSLQGYCVHQGFRLLIY 682 (894)
Q Consensus 607 ~~f~~~~~LG~G~fg~Vy~a~~-~~g~~vAvK~~~~~~~---~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~lV~ 682 (894)
++|+..+.||+|+||.||+|.. .+++.||+|++..... .....+..|+.++..++|+||+++++.+.+....++||
T Consensus 1 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~~~~~~iv~~~~~~~~~~~~~lv~ 80 (363)
T cd05628 1 EDFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKMFYSFQDKLNLYLIM 80 (363)
T ss_pred CCceEeEEEEeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHhCCCCCcceEEEEEecCCeEEEEE
Confidence 4788899999999999999984 4689999999975422 22346788999999999999999999999999999999
Q ss_pred EeccCCCHHHHHhhhcCCCCCcCHHHHHHHHHHHHHHHHHHHhccCCCeeecCCCCCCeEECCCCcEEEEEcccccccCC
Q 002673 683 SYMENGSLDYWLHEKADGASQLDWLTRLKIARGTSCGLAYMHQICEPHIVHRDIKSSNILLDDQFEAHLADFGLSRLILP 762 (894)
Q Consensus 683 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDLkp~NILld~~~~vkl~DFGla~~~~~ 762 (894)
||+++|+|.+++... ..+++..+..++.|++.||.|||+ ++|+||||||+|||++.++.+||+|||+++....
T Consensus 81 E~~~gg~L~~~l~~~----~~l~~~~~~~~~~qi~~aL~~lH~---~givHrDlKp~NILi~~~~~vkL~DFGla~~~~~ 153 (363)
T cd05628 81 EFLPGGDMMTLLMKK----DTLTEEETQFYIAETVLAIDSIHQ---LGFIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKK 153 (363)
T ss_pred cCCCCCcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHh---CCeEecCCCHHHeEECCCCCEEEeeccCcccccc
Confidence 999999999999754 358899999999999999999997 5999999999999999999999999999875432
Q ss_pred CCC----------------------------------cccccccccCCccCcccccCcCCCccccHHHHHHHHHHHHcCC
Q 002673 763 YQT----------------------------------HVTTELVGTLGYIPPEYGQAWVATLRGDMYSFGVVMLELLTGK 808 (894)
Q Consensus 763 ~~~----------------------------------~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwS~GvlL~elltG~ 808 (894)
... ......+||+.|+|||++.+..++.++|||||||++|||++|+
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DvwSlGvil~ell~G~ 233 (363)
T cd05628 154 AHRTEFYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGY 233 (363)
T ss_pred cccccccccccccccccccccccccccccchhhhccccccccccCCccccCHHHHcCCCCCCchhhhhhHHHHHHHHhCC
Confidence 110 0012357999999999999999999999999999999999999
Q ss_pred CCCCCCC
Q 002673 809 RPVDVLK 815 (894)
Q Consensus 809 ~Pf~~~~ 815 (894)
.||....
T Consensus 234 ~Pf~~~~ 240 (363)
T cd05628 234 PPFCSET 240 (363)
T ss_pred CCCCCCC
Confidence 9997543
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus |
| >cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-34 Score=310.05 Aligned_cols=253 Identities=26% Similarity=0.359 Sum_probs=200.0
Q ss_pred cCCCccceEeecCcEEEEEEEE-cCCCeEEEEEEcCcchhhHHHHHHHHHHHHhcCCCceeeecceeeecceEEEEEEec
Q 002673 607 DNFSQANIIGCGGFGLVYKATL-ANGTTLAIKKLSGDLGLMEREFKAEVEALSTAQHKNLVSLQGYCVHQGFRLLIYSYM 685 (894)
Q Consensus 607 ~~f~~~~~LG~G~fg~Vy~a~~-~~g~~vAvK~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~lV~E~~ 685 (894)
++|++.+.||+|+||.||+|.. .+++.||+|++..........+.+|+.++++++||||+++++++..++..++||||+
T Consensus 9 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~~~~~~~~~e~~~l~~~~h~~ii~~~~~~~~~~~~~iv~e~~ 88 (267)
T cd06646 9 HDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQEIFMVKECKHCNIVAYFGSYLSREKLWICMEYC 88 (267)
T ss_pred hhcchhheeecCCCeEEEEEEECCCCeEEEEEEEecCccchHHHHHHHHHHHHhcCCCCeeeeeEEEEeCCEEEEEEeCC
Confidence 5788899999999999999985 578899999997654444567889999999999999999999999999999999999
Q ss_pred cCCCHHHHHhhhcCCCCCcCHHHHHHHHHHHHHHHHHHHhccCCCeeecCCCCCCeEECCCCcEEEEEcccccccCCCCC
Q 002673 686 ENGSLDYWLHEKADGASQLDWLTRLKIARGTSCGLAYMHQICEPHIVHRDIKSSNILLDDQFEAHLADFGLSRLILPYQT 765 (894)
Q Consensus 686 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDLkp~NILld~~~~vkl~DFGla~~~~~~~~ 765 (894)
++|+|.++++.. ..+++..+..++.|++.||.|||+ ++|+||||||+||+++.++.+||+|||++.......
T Consensus 89 ~~~~L~~~~~~~----~~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~~- 160 (267)
T cd06646 89 GGGSLQDIYHVT----GPLSELQIAYVCRETLQGLAYLHS---KGKMHRDIKGANILLTDNGDVKLADFGVAAKITATI- 160 (267)
T ss_pred CCCcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHH---CCccccCCCHHHEEECCCCCEEECcCccceeecccc-
Confidence 999999998753 357889999999999999999997 599999999999999999999999999998653221
Q ss_pred cccccccccCCccCccccc---CcCCCccccHHHHHHHHHHHHcCCCCCCCCCcchhhhHHHHHHHHhhcCCCCcccccc
Q 002673 766 HVTTELVGTLGYIPPEYGQ---AWVATLRGDMYSFGVVMLELLTGKRPVDVLKPKMSRELVGWVLKMRSEGKQDQVFDPI 842 (894)
Q Consensus 766 ~~~~~~~gt~~Y~APE~~~---~~~~s~ksDVwS~GvlL~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 842 (894)
.......|+..|+|||.+. ...++.++|||||||++|||++|+.||........ .. .... . ....+.
T Consensus 161 ~~~~~~~~~~~y~~PE~~~~~~~~~~~~~~Dvws~G~il~el~~g~~p~~~~~~~~~--~~----~~~~-~---~~~~~~ 230 (267)
T cd06646 161 AKRKSFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRA--LF----LMSK-S---NFQPPK 230 (267)
T ss_pred cccCccccCccccCHhHcccccCCCCcchhhHHHHHHHHHHHHhCCCCccccchhhh--he----eeec-C---CCCCCC
Confidence 1123346888999999874 34578899999999999999999999864332111 00 0000 0 000011
Q ss_pred ccCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 002673 843 LRGKGFDEEMLQVLDVACMCVSQNPFKRPTVKEVVEW 879 (894)
Q Consensus 843 l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~ 879 (894)
.. ........+.+++.+||+.+|++|||++++++.
T Consensus 231 ~~--~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~ 265 (267)
T cd06646 231 LK--DKTKWSSTFHNFVKISLTKNPKKRPTAERLLTH 265 (267)
T ss_pred Cc--cccccCHHHHHHHHHHhhCChhhCcCHHHHhcC
Confidence 10 011123467789999999999999999999864
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-34 Score=313.04 Aligned_cols=264 Identities=23% Similarity=0.346 Sum_probs=202.2
Q ss_pred cCCCccceEeecCcEEEEEEEEc-----------------CCCeEEEEEEcCcc-hhhHHHHHHHHHHHHhcCCCceeee
Q 002673 607 DNFSQANIIGCGGFGLVYKATLA-----------------NGTTLAIKKLSGDL-GLMEREFKAEVEALSTAQHKNLVSL 668 (894)
Q Consensus 607 ~~f~~~~~LG~G~fg~Vy~a~~~-----------------~g~~vAvK~~~~~~-~~~~~~~~~Ei~~l~~l~HpnIv~l 668 (894)
++|++.+.||+|+||.||++... ++..||+|++.... ......+.+|+.+++.++|+||+++
T Consensus 5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~ 84 (296)
T cd05095 5 KRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLKEIKIMSRLKDPNIIRL 84 (296)
T ss_pred hhceeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceE
Confidence 56888999999999999998532 23468999987543 3345678999999999999999999
Q ss_pred cceeeecceEEEEEEeccCCCHHHHHhhhcCC-------CCCcCHHHHHHHHHHHHHHHHHHHhccCCCeeecCCCCCCe
Q 002673 669 QGYCVHQGFRLLIYSYMENGSLDYWLHEKADG-------ASQLDWLTRLKIARGTSCGLAYMHQICEPHIVHRDIKSSNI 741 (894)
Q Consensus 669 ~g~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~-------~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDLkp~NI 741 (894)
++++..++..++||||+++|+|.+++...... ...+++..+..++.|++.||+|||+ .+++|+||||+||
T Consensus 85 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~---~~i~H~dlkp~Ni 161 (296)
T cd05095 85 LAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSS---LNFVHRDLATRNC 161 (296)
T ss_pred EEEEecCCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHHH---CCeecccCChheE
Confidence 99999999999999999999999999764321 2347888999999999999999997 5999999999999
Q ss_pred EECCCCcEEEEEcccccccCCCCCc-ccccccccCCccCcccccCcCCCccccHHHHHHHHHHHHc--CCCCCCCCCcch
Q 002673 742 LLDDQFEAHLADFGLSRLILPYQTH-VTTELVGTLGYIPPEYGQAWVATLRGDMYSFGVVMLELLT--GKRPVDVLKPKM 818 (894)
Q Consensus 742 Lld~~~~vkl~DFGla~~~~~~~~~-~~~~~~gt~~Y~APE~~~~~~~s~ksDVwS~GvlL~ellt--G~~Pf~~~~~~~ 818 (894)
+++.++.++|+|||+++.+...... ......++..|+|||...+..++.++|||||||++|||++ |..||.......
T Consensus 162 li~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~DiwSlG~~l~el~~~~~~~p~~~~~~~~ 241 (296)
T cd05095 162 LVGKNYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILTLCKEQPYSQLSDEQ 241 (296)
T ss_pred EEcCCCCEEeccCcccccccCCcceeccCcCcCccccCCHHHHhcCCccchhhhhHHHHHHHHHHHhCCCCCccccChHH
Confidence 9999999999999999865332211 1222344678999999888889999999999999999998 778887543322
Q ss_pred hhhHHHHHHHHhhcCCCCccccccccCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHh
Q 002673 819 SRELVGWVLKMRSEGKQDQVFDPILRGKGFDEEMLQVLDVACMCVSQNPFKRPTVKEVVEWLNN 882 (894)
Q Consensus 819 ~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~ 882 (894)
. ............. ....+. .. .....+.+++.+||+.||.+||++.+|++.|++
T Consensus 242 ~---~~~~~~~~~~~~~-~~~~~~--~~---~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~~ 296 (296)
T cd05095 242 V---IENTGEFFRDQGR-QVYLPK--PA---LCPDSLYKLMLSCWRRNAKERPSFQEIHATLLE 296 (296)
T ss_pred H---HHHHHHHHhhccc-cccCCC--CC---CCCHHHHHHHHHHcCCCcccCCCHHHHHHHHhC
Confidence 1 1111111111100 000000 01 112467789999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit |
| >cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-34 Score=306.60 Aligned_cols=256 Identities=25% Similarity=0.418 Sum_probs=200.3
Q ss_pred CCccceEeecCcEEEEEEEEc-C---CCeEEEEEEcCcc--hhhHHHHHHHHHHHHhcCCCceeeecceeeecce-----
Q 002673 609 FSQANIIGCGGFGLVYKATLA-N---GTTLAIKKLSGDL--GLMEREFKAEVEALSTAQHKNLVSLQGYCVHQGF----- 677 (894)
Q Consensus 609 f~~~~~LG~G~fg~Vy~a~~~-~---g~~vAvK~~~~~~--~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~----- 677 (894)
|.+.+.||+|+||.||+|... + +..||+|++..+. ......+.+|++.++.++||||+++++++.....
T Consensus 1 ~~~~~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 80 (273)
T cd05035 1 LKLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKLIGVCFEASSLQKIP 80 (273)
T ss_pred CccccccCcCCCceEEEEEEecCCCCcceEEEEEeccCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEeeeccCCccccCc
Confidence 566789999999999999853 2 3679999987543 2334578999999999999999999998876554
Q ss_pred -EEEEEEeccCCCHHHHHhhhc--CCCCCcCHHHHHHHHHHHHHHHHHHHhccCCCeeecCCCCCCeEECCCCcEEEEEc
Q 002673 678 -RLLIYSYMENGSLDYWLHEKA--DGASQLDWLTRLKIARGTSCGLAYMHQICEPHIVHRDIKSSNILLDDQFEAHLADF 754 (894)
Q Consensus 678 -~~lV~E~~~~gsL~~~l~~~~--~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDLkp~NILld~~~~vkl~DF 754 (894)
.++++||+++|+|..++.... .....+++.....++.|++.||.|||+ ++++||||||+||++++++.+||+||
T Consensus 81 ~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH~---~~i~H~dlkp~Nil~~~~~~~kl~df 157 (273)
T cd05035 81 KPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSN---RNFIHRDLAARNCMLREDMTVCVADF 157 (273)
T ss_pred ccEEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHHh---CCeeccccchheEEECCCCeEEECCc
Confidence 789999999999999986542 123468999999999999999999997 59999999999999999999999999
Q ss_pred ccccccCCCCCcc-cccccccCCccCcccccCcCCCccccHHHHHHHHHHHHc-CCCCCCCCCcchhhhHHHHHHHHhhc
Q 002673 755 GLSRLILPYQTHV-TTELVGTLGYIPPEYGQAWVATLRGDMYSFGVVMLELLT-GKRPVDVLKPKMSRELVGWVLKMRSE 832 (894)
Q Consensus 755 Gla~~~~~~~~~~-~~~~~gt~~Y~APE~~~~~~~s~ksDVwS~GvlL~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~ 832 (894)
|+++......... .....++..|+|||++.+..++.++|||||||++|||++ |..||...... ....+.. .
T Consensus 158 g~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~SlG~il~el~~~g~~p~~~~~~~---~~~~~~~----~ 230 (273)
T cd05035 158 GLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTPYPGVENH---EIYDYLR----H 230 (273)
T ss_pred cceeeccccccccccccccCCccccCHhhcccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCHH---HHHHHHH----c
Confidence 9998764332221 112234678999999988899999999999999999999 99999754322 1222111 1
Q ss_pred CCCCccccccccCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhc
Q 002673 833 GKQDQVFDPILRGKGFDEEMLQVLDVACMCVSQNPFKRPTVKEVVEWLNNV 883 (894)
Q Consensus 833 ~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~i 883 (894)
+..... .......+.+++.+|++.||++|||+.++++.|+++
T Consensus 231 ~~~~~~---------~~~~~~~~~~li~~~l~~~p~~Rp~~~e~~~~l~~~ 272 (273)
T cd05035 231 GNRLKQ---------PEDCLDELYDLMYSCWRADPKDRPTFTKLREVLENI 272 (273)
T ss_pred CCCCCC---------CcCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 111111 011234678899999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu |
| >cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-34 Score=315.59 Aligned_cols=260 Identities=26% Similarity=0.409 Sum_probs=205.2
Q ss_pred ccCCCccceEeecCcEEEEEEEEc------CCCeEEEEEEcCcc-hhhHHHHHHHHHHHHhc-CCCceeeecceeeecce
Q 002673 606 TDNFSQANIIGCGGFGLVYKATLA------NGTTLAIKKLSGDL-GLMEREFKAEVEALSTA-QHKNLVSLQGYCVHQGF 677 (894)
Q Consensus 606 ~~~f~~~~~LG~G~fg~Vy~a~~~------~g~~vAvK~~~~~~-~~~~~~~~~Ei~~l~~l-~HpnIv~l~g~~~~~~~ 677 (894)
.++|+..+.||+|+||.||++... +...+|+|.+.... ......+.+|+.++.++ +|+||+++++++..++.
T Consensus 11 ~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~ 90 (293)
T cd05053 11 RDRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGVCTQEGP 90 (293)
T ss_pred HhHeEEeeEecccccccEEEEEEecCCCCCCceeEEEEEccCCCCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEcCCCC
Confidence 456888899999999999999853 23679999987643 23345688999999999 89999999999999999
Q ss_pred EEEEEEeccCCCHHHHHhhhc------------CCCCCcCHHHHHHHHHHHHHHHHHHHhccCCCeeecCCCCCCeEECC
Q 002673 678 RLLIYSYMENGSLDYWLHEKA------------DGASQLDWLTRLKIARGTSCGLAYMHQICEPHIVHRDIKSSNILLDD 745 (894)
Q Consensus 678 ~~lV~E~~~~gsL~~~l~~~~------------~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDLkp~NILld~ 745 (894)
.+++|||+++|+|..+++... .....+++..++.++.|++.||.|||+ ++|+||||||+||+++.
T Consensus 91 ~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~---~~ivH~dlkp~Nil~~~ 167 (293)
T cd05053 91 LYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLAS---KKCIHRDLAARNVLVTE 167 (293)
T ss_pred eEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHH---CCccccccceeeEEEcC
Confidence 999999999999999997532 234568999999999999999999997 59999999999999999
Q ss_pred CCcEEEEEcccccccCCCCCc-ccccccccCCccCcccccCcCCCccccHHHHHHHHHHHHc-CCCCCCCCCcchhhhHH
Q 002673 746 QFEAHLADFGLSRLILPYQTH-VTTELVGTLGYIPPEYGQAWVATLRGDMYSFGVVMLELLT-GKRPVDVLKPKMSRELV 823 (894)
Q Consensus 746 ~~~vkl~DFGla~~~~~~~~~-~~~~~~gt~~Y~APE~~~~~~~s~ksDVwS~GvlL~ellt-G~~Pf~~~~~~~~~~~~ 823 (894)
++.+||+|||+++........ ......++..|+|||+..+..++.++|||||||++|||++ |..||....... ..
T Consensus 168 ~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~---~~ 244 (293)
T cd05053 168 DHVMKIADFGLARDIHHIDYYRKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEE---LF 244 (293)
T ss_pred CCeEEeCccccccccccccceeccCCCCCCccccCHHHhccCCcCcccceeehhhHHHHHhcCCCCCCCCCCHHH---HH
Confidence 999999999999875432211 1122335678999999988899999999999999999998 999987543221 11
Q ss_pred HHHHHHhhcCCCCccccccccCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhcc
Q 002673 824 GWVLKMRSEGKQDQVFDPILRGKGFDEEMLQVLDVACMCVSQNPFKRPTVKEVVEWLNNVG 884 (894)
Q Consensus 824 ~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~i~ 884 (894)
.. .. ...... ........+.+++.+|++.||++|||+.++++.|+.+.
T Consensus 245 ~~---~~-~~~~~~---------~~~~~~~~~~~li~~~l~~~p~~Rps~~eil~~l~~~~ 292 (293)
T cd05053 245 KL---LK-EGYRME---------KPQNCTQELYHLMRDCWHEVPSQRPTFKQLVEDLDRML 292 (293)
T ss_pred HH---HH-cCCcCC---------CCCCCCHHHHHHHHHHcccCcccCcCHHHHHHHHHHhh
Confidence 11 11 111000 00112235778999999999999999999999998763
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, |
| >cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-34 Score=309.06 Aligned_cols=256 Identities=23% Similarity=0.381 Sum_probs=196.9
Q ss_pred CCccceEeecCcEEEEEEEEcC-CC--eEEEEEEcCcc--hhhHHHHHHHHHHHHhcCCCceeeecceeeec------ce
Q 002673 609 FSQANIIGCGGFGLVYKATLAN-GT--TLAIKKLSGDL--GLMEREFKAEVEALSTAQHKNLVSLQGYCVHQ------GF 677 (894)
Q Consensus 609 f~~~~~LG~G~fg~Vy~a~~~~-g~--~vAvK~~~~~~--~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~------~~ 677 (894)
|.+.+.||+|+||.||+|.+.+ +. .||+|.++... ......+..|+.+++.++|+||+++++++... ..
T Consensus 1 ~~i~~~ig~G~~g~V~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 80 (272)
T cd05075 1 LALGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEGYPS 80 (272)
T ss_pred CccccccCcccCceEEEeEEccCCCeeeEEEEecccCcCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEccCCcccCCCC
Confidence 3467889999999999998654 33 58999886542 33346788999999999999999999987532 24
Q ss_pred EEEEEEeccCCCHHHHHhhhc--CCCCCcCHHHHHHHHHHHHHHHHHHHhccCCCeeecCCCCCCeEECCCCcEEEEEcc
Q 002673 678 RLLIYSYMENGSLDYWLHEKA--DGASQLDWLTRLKIARGTSCGLAYMHQICEPHIVHRDIKSSNILLDDQFEAHLADFG 755 (894)
Q Consensus 678 ~~lV~E~~~~gsL~~~l~~~~--~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDLkp~NILld~~~~vkl~DFG 755 (894)
.+++|||+++|+|.+++.... .....+++.....++.|++.||.|||+ ++|+||||||+|||+++++.+||+|||
T Consensus 81 ~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dlkp~Nil~~~~~~~kl~Dfg 157 (272)
T cd05075 81 PVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLSS---KSFIHRDLAARNCMLNENMNVCVADFG 157 (272)
T ss_pred cEEEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHHH---CCeeccccchhheEEcCCCCEEECCCC
Confidence 689999999999999885322 223458999999999999999999997 599999999999999999999999999
Q ss_pred cccccCCCCCcc-cccccccCCccCcccccCcCCCccccHHHHHHHHHHHHc-CCCCCCCCCcchhhhHHHHHHHHhhcC
Q 002673 756 LSRLILPYQTHV-TTELVGTLGYIPPEYGQAWVATLRGDMYSFGVVMLELLT-GKRPVDVLKPKMSRELVGWVLKMRSEG 833 (894)
Q Consensus 756 la~~~~~~~~~~-~~~~~gt~~Y~APE~~~~~~~s~ksDVwS~GvlL~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~ 833 (894)
+++......... .....+++.|+|||+..+..++.++||||||+++|||++ |+.||...... ..... . ..+
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~---~~~~~---~-~~~ 230 (272)
T cd05075 158 LSKKIYNGDYYRQGRIAKMPVKWIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTPYPGVENS---EIYDY---L-RQG 230 (272)
T ss_pred cccccCcccceecCCcccCCcccCCHHHccCCCcChHHHHHHHHHHHHHHHcCCCCCCCCCCHH---HHHHH---H-HcC
Confidence 998764322111 122345678999999999999999999999999999999 89999754322 11111 1 111
Q ss_pred CCCccccccccCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhc
Q 002673 834 KQDQVFDPILRGKGFDEEMLQVLDVACMCVSQNPFKRPTVKEVVEWLNNV 883 (894)
Q Consensus 834 ~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~i 883 (894)
..... . .. ....+.+++.+||+.+|++|||+.++++.|+++
T Consensus 231 ~~~~~-~-----~~---~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~~~ 271 (272)
T cd05075 231 NRLKQ-P-----PD---CLDGLYSLMSSCWLLNPKDRPSFETLRCELEKA 271 (272)
T ss_pred CCCCC-C-----CC---CCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 11000 0 11 123567899999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor |
| >cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-34 Score=312.85 Aligned_cols=257 Identities=26% Similarity=0.424 Sum_probs=203.7
Q ss_pred cCCCccceEeecCcEEEEEEEEc------CCCeEEEEEEcCcchhhHHHHHHHHHHHHhcCCCceeeecceeeecceEEE
Q 002673 607 DNFSQANIIGCGGFGLVYKATLA------NGTTLAIKKLSGDLGLMEREFKAEVEALSTAQHKNLVSLQGYCVHQGFRLL 680 (894)
Q Consensus 607 ~~f~~~~~LG~G~fg~Vy~a~~~------~g~~vAvK~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~l 680 (894)
++|...+.||+|+||.||++... ++..+|+|.+..........+.+|+++++.++|+||+++++++...+..++
T Consensus 5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 84 (280)
T cd05092 5 RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVRFYGVCTEGRPLLM 84 (280)
T ss_pred HhceeccccCCccCCeEEEeEEecCCCCCCceEEEEEecCcCCHHHHHHHHHHHHHHhcCCCCCCceEEEEEecCCceEE
Confidence 46777899999999999999632 456899999887666666789999999999999999999999999999999
Q ss_pred EEEeccCCCHHHHHhhhcC-----------CCCCcCHHHHHHHHHHHHHHHHHHHhccCCCeeecCCCCCCeEECCCCcE
Q 002673 681 IYSYMENGSLDYWLHEKAD-----------GASQLDWLTRLKIARGTSCGLAYMHQICEPHIVHRDIKSSNILLDDQFEA 749 (894)
Q Consensus 681 V~E~~~~gsL~~~l~~~~~-----------~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDLkp~NILld~~~~v 749 (894)
+|||+++|+|.+++..... ....+++..++.++.|++.|++|||+ ++++||||||+|||+++++.+
T Consensus 85 v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~---~~i~H~dlkp~nil~~~~~~~ 161 (280)
T cd05092 85 VFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLAS---LHFVHRDLATRNCLVGQGLVV 161 (280)
T ss_pred EEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHH---CCeecccccHhhEEEcCCCCE
Confidence 9999999999999976432 11358899999999999999999997 599999999999999999999
Q ss_pred EEEEcccccccCCCCCc-ccccccccCCccCcccccCcCCCccccHHHHHHHHHHHHc-CCCCCCCCCcchhhhHHHHHH
Q 002673 750 HLADFGLSRLILPYQTH-VTTELVGTLGYIPPEYGQAWVATLRGDMYSFGVVMLELLT-GKRPVDVLKPKMSRELVGWVL 827 (894)
Q Consensus 750 kl~DFGla~~~~~~~~~-~~~~~~gt~~Y~APE~~~~~~~s~ksDVwS~GvlL~ellt-G~~Pf~~~~~~~~~~~~~~~~ 827 (894)
||+|||+++........ ......+++.|+|||+..+..++.++|||||||++|||++ |+.||....... .....
T Consensus 162 kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~---~~~~~- 237 (280)
T cd05092 162 KIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQPWYQLSNTE---AIECI- 237 (280)
T ss_pred EECCCCceeEcCCCceeecCCCccccccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCccCCHHH---HHHHH-
Confidence 99999999765322211 1222345678999999999899999999999999999998 999996543221 11111
Q ss_pred HHhhcCCCCccccccccCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHh
Q 002673 828 KMRSEGKQDQVFDPILRGKGFDEEMLQVLDVACMCVSQNPFKRPTVKEVVEWLNN 882 (894)
Q Consensus 828 ~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~ 882 (894)
...... .. . ... ...+.+++.+||+.||.+||++.++++.|+.
T Consensus 238 --~~~~~~-~~-~-----~~~---~~~~~~li~~cl~~~P~~Rp~~~~l~~~l~~ 280 (280)
T cd05092 238 --TQGREL-ER-P-----RTC---PPEVYAIMQGCWQREPQQRMVIKDIHSRLQA 280 (280)
T ss_pred --HcCccC-CC-C-----CCC---CHHHHHHHHHHccCChhhCCCHHHHHHHHhC
Confidence 111110 00 0 111 2346789999999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory |
| >cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-34 Score=310.80 Aligned_cols=244 Identities=25% Similarity=0.345 Sum_probs=191.4
Q ss_pred EeecCcEEEEEEEE-cCCCeEEEEEEcCcch---hhHHHHHHHHHHHHhcCCCceeeecceeeecceEEEEEEeccCCCH
Q 002673 615 IGCGGFGLVYKATL-ANGTTLAIKKLSGDLG---LMEREFKAEVEALSTAQHKNLVSLQGYCVHQGFRLLIYSYMENGSL 690 (894)
Q Consensus 615 LG~G~fg~Vy~a~~-~~g~~vAvK~~~~~~~---~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~lV~E~~~~gsL 690 (894)
||+|+||.||++.. .+|+.||+|++..... .....+..|++++++++||||+++++++..+...++||||+++|+|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~il~~l~hp~i~~~~~~~~~~~~~~lv~e~~~g~~L 80 (277)
T cd05607 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAYAFESKTHLCLVMSLMNGGDL 80 (277)
T ss_pred CCCCCceEEEEEEEccCCcEEEEEEEcHHHhhcchhhHHHHHHHHHHHhcCCCcEEEEEEEEecCCeEEEEEecCCCCCH
Confidence 69999999999984 5689999999864321 2234566799999999999999999999999999999999999999
Q ss_pred HHHHhhhcCCCCCcCHHHHHHHHHHHHHHHHHHHhccCCCeeecCCCCCCeEECCCCcEEEEEcccccccCCCCCccccc
Q 002673 691 DYWLHEKADGASQLDWLTRLKIARGTSCGLAYMHQICEPHIVHRDIKSSNILLDDQFEAHLADFGLSRLILPYQTHVTTE 770 (894)
Q Consensus 691 ~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDLkp~NILld~~~~vkl~DFGla~~~~~~~~~~~~~ 770 (894)
.+++.... ...+++..+..++.|++.||.|||+ ++++||||||+||+++.++.++|+|||++....... ....
T Consensus 81 ~~~~~~~~--~~~~~~~~~~~~~~qi~~al~~lH~---~~ivH~dikp~Nili~~~~~~~l~Dfg~~~~~~~~~--~~~~ 153 (277)
T cd05607 81 KYHIYNVG--ERGLEMERVIHYSAQITCGILHLHS---MDIVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGK--TITQ 153 (277)
T ss_pred HHHHHhcc--ccCCCHHHHHHHHHHHHHHHHHHHH---CCEEEccCChHhEEEcCCCCEEEeeceeeeecCCCc--eeec
Confidence 98886542 2458889999999999999999997 599999999999999999999999999988653321 2233
Q ss_pred ccccCCccCcccccCcCCCccccHHHHHHHHHHHHcCCCCCCCCCcchhhhHHHHHHHHhhcCCCCccccccccCCCChH
Q 002673 771 LVGTLGYIPPEYGQAWVATLRGDMYSFGVVMLELLTGKRPVDVLKPKMSRELVGWVLKMRSEGKQDQVFDPILRGKGFDE 850 (894)
Q Consensus 771 ~~gt~~Y~APE~~~~~~~s~ksDVwS~GvlL~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~ 850 (894)
..|+..|+|||++.+..++.++|||||||++|||++|+.||.......... ........ .... .....
T Consensus 154 ~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~p~~~~~~~~~~~--~~~~~~~~-~~~~------~~~~~--- 221 (277)
T cd05607 154 RAGTNGYMAPEILKEEPYSYPVDWFAMGCSIYEMVAGRTPFKDHKEKVAKE--ELKRRTLE-DEVK------FEHQN--- 221 (277)
T ss_pred cCCCCCccCHHHHccCCCCCchhHHHHHHHHHHHHhCCCCCCCCcchhhHH--HHHHHhhc-cccc------ccccc---
Confidence 568999999999998889999999999999999999999997543321111 11111111 1100 00011
Q ss_pred HHHHHHHHHHHhcccCCCCCCCHHHHH
Q 002673 851 EMLQVLDVACMCVSQNPFKRPTVKEVV 877 (894)
Q Consensus 851 ~~~~l~~li~~Cl~~dP~~RPs~~evl 877 (894)
...++.+++..||+.||++||++.|++
T Consensus 222 ~~~~~~~li~~~L~~~P~~R~~~~~~~ 248 (277)
T cd05607 222 FTEESKDICRLFLAKKPEDRLGSREKN 248 (277)
T ss_pred CCHHHHHHHHHHhccCHhhCCCCccch
Confidence 123567899999999999999996554
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr |
| >cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-34 Score=306.47 Aligned_cols=253 Identities=25% Similarity=0.406 Sum_probs=201.2
Q ss_pred cCCCccceEeecCcEEEEEEEEcCCCeEEEEEEcCcchhhHHHHHHHHHHHHhcCCCceeeecceeeecceEEEEEEecc
Q 002673 607 DNFSQANIIGCGGFGLVYKATLANGTTLAIKKLSGDLGLMEREFKAEVEALSTAQHKNLVSLQGYCVHQGFRLLIYSYME 686 (894)
Q Consensus 607 ~~f~~~~~LG~G~fg~Vy~a~~~~g~~vAvK~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~lV~E~~~ 686 (894)
++|.+.+.||+|+||.||+|....+..+|+|.+.... ...+.+.+|+.++++++|+|++++++++. .+..++||||++
T Consensus 6 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~lK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e~~~ 83 (260)
T cd05069 6 ESLRLDVKLGQGCFGEVWMGTWNGTTKVAIKTLKPGT-MMPEAFLQEAQIMKKLRHDKLVPLYAVVS-EEPIYIVTEFMG 83 (260)
T ss_pred HHeeeeeeecCcCCCeEEEEEEcCCceEEEEEcccCC-ccHHHHHHHHHHHHhCCCCCeeeEEEEEc-CCCcEEEEEcCC
Confidence 4578889999999999999998777789999887543 23467889999999999999999999875 456789999999
Q ss_pred CCCHHHHHhhhcCCCCCcCHHHHHHHHHHHHHHHHHHHhccCCCeeecCCCCCCeEECCCCcEEEEEcccccccCCCCCc
Q 002673 687 NGSLDYWLHEKADGASQLDWLTRLKIARGTSCGLAYMHQICEPHIVHRDIKSSNILLDDQFEAHLADFGLSRLILPYQTH 766 (894)
Q Consensus 687 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDLkp~NILld~~~~vkl~DFGla~~~~~~~~~ 766 (894)
+|+|.++++... ...+++..+..++.|++.||.|||+ .+++|+||||+||++++++.++|+|||++.........
T Consensus 84 ~~~L~~~~~~~~--~~~~~~~~~~~~~~~l~~al~~lH~---~~i~H~dl~~~Nill~~~~~~~l~dfg~~~~~~~~~~~ 158 (260)
T cd05069 84 KGSLLDFLKEGD--GKYLKLPQLVDMAAQIADGMAYIER---MNYIHRDLRAANILVGDNLVCKIADFGLARLIEDNEYT 158 (260)
T ss_pred CCCHHHHHhhCC--CCCCCHHHHHHHHHHHHHHHHHHHh---CCEeecccCcceEEEcCCCeEEECCCccceEccCCccc
Confidence 999999997642 2457899999999999999999997 59999999999999999999999999999765332211
Q ss_pred ccccccccCCccCcccccCcCCCccccHHHHHHHHHHHHc-CCCCCCCCCcchhhhHHHHHHHHhhcCCCCccccccccC
Q 002673 767 VTTELVGTLGYIPPEYGQAWVATLRGDMYSFGVVMLELLT-GKRPVDVLKPKMSRELVGWVLKMRSEGKQDQVFDPILRG 845 (894)
Q Consensus 767 ~~~~~~gt~~Y~APE~~~~~~~s~ksDVwS~GvlL~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~ 845 (894)
......++..|+|||+..+..++.++||||||+++|||++ |+.||...... ....+. ...... . .
T Consensus 159 ~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~---~~~~~~---~~~~~~-~-----~-- 224 (260)
T cd05069 159 ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMVNR---EVLEQV---ERGYRM-P-----C-- 224 (260)
T ss_pred ccCCCccchhhCCHHHhccCCcChHHHHHHHHHHHHHHHhCCCCCCCCCCHH---HHHHHH---HcCCCC-C-----C--
Confidence 1222345678999999988899999999999999999999 99999754322 111111 111110 0 0
Q ss_pred CCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHh
Q 002673 846 KGFDEEMLQVLDVACMCVSQNPFKRPTVKEVVEWLNN 882 (894)
Q Consensus 846 ~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~ 882 (894)
.......+.+++.+|+..||++||++++++++|++
T Consensus 225 --~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~ 259 (260)
T cd05069 225 --PQGCPESLHELMKLCWKKDPDERPTFEYIQSFLED 259 (260)
T ss_pred --CcccCHHHHHHHHHHccCCcccCcCHHHHHHHHhc
Confidence 01123457789999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an |
| >cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-33 Score=304.04 Aligned_cols=250 Identities=26% Similarity=0.370 Sum_probs=199.8
Q ss_pred cCCCccceEeecCcEEEEEEEE-cCCCeEEEEEEcCcch-----hhHHHHHHHHHHHHhcCCCceeeecceeeecceEEE
Q 002673 607 DNFSQANIIGCGGFGLVYKATL-ANGTTLAIKKLSGDLG-----LMEREFKAEVEALSTAQHKNLVSLQGYCVHQGFRLL 680 (894)
Q Consensus 607 ~~f~~~~~LG~G~fg~Vy~a~~-~~g~~vAvK~~~~~~~-----~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~l 680 (894)
++|+..+.||+|++|.||+|.. .++..||+|.+..... .....+.+|+.++++++||||+++++++..+...++
T Consensus 2 ~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~ 81 (263)
T cd06625 2 TNWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYGCLRDDETLSI 81 (263)
T ss_pred CcccccceecCCCceEEEEEEEcCCCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEccCCeEEE
Confidence 5688899999999999999984 5789999998864321 123468889999999999999999999999999999
Q ss_pred EEEeccCCCHHHHHhhhcCCCCCcCHHHHHHHHHHHHHHHHHHHhccCCCeeecCCCCCCeEECCCCcEEEEEccccccc
Q 002673 681 IYSYMENGSLDYWLHEKADGASQLDWLTRLKIARGTSCGLAYMHQICEPHIVHRDIKSSNILLDDQFEAHLADFGLSRLI 760 (894)
Q Consensus 681 V~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDLkp~NILld~~~~vkl~DFGla~~~ 760 (894)
|+||+++++|.+++... ..+++..+..++.|++.||.|||+ .+++||||+|+||++++++.++|+|||+++..
T Consensus 82 v~e~~~~~~l~~~~~~~----~~~~~~~~~~~~~~l~~~l~~lH~---~~i~H~dl~p~nilv~~~~~~~l~dfg~~~~~ 154 (263)
T cd06625 82 FMEYMPGGSVKDQLKAY----GALTETVTRKYTRQILEGVEYLHS---NMIVHRDIKGANILRDSAGNVKLGDFGASKRL 154 (263)
T ss_pred EEEECCCCcHHHHHHHh----CCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEEcCCCCEEEeecccceec
Confidence 99999999999998754 347888899999999999999997 59999999999999999999999999999765
Q ss_pred CCCCCccc--ccccccCCccCcccccCcCCCccccHHHHHHHHHHHHcCCCCCCCCCcchhhhHHHHHHHHhhcCCCCcc
Q 002673 761 LPYQTHVT--TELVGTLGYIPPEYGQAWVATLRGDMYSFGVVMLELLTGKRPVDVLKPKMSRELVGWVLKMRSEGKQDQV 838 (894)
Q Consensus 761 ~~~~~~~~--~~~~gt~~Y~APE~~~~~~~s~ksDVwS~GvlL~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 838 (894)
........ ....++..|+|||++.+..++.++||||||+++|||++|+.||....... .. ...........
T Consensus 155 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~---~~---~~~~~~~~~~~- 227 (263)
T cd06625 155 QTICSSGTGMKSVTGTPYWMSPEVISGEGYGRKADVWSVGCTVVEMLTEKPPWAEFEAMA---AI---FKIATQPTNPQ- 227 (263)
T ss_pred cccccccccccCCCcCccccCcceeccCCCCchhhhHHHHHHHHHHHhCCCCccccchHH---HH---HHHhccCCCCC-
Confidence 33221111 23457889999999999889999999999999999999999997543211 11 11111111111
Q ss_pred ccccccCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 002673 839 FDPILRGKGFDEEMLQVLDVACMCVSQNPFKRPTVKEVVE 878 (894)
Q Consensus 839 ~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~ 878 (894)
+. ......+.+++.+||..+|.+|||+.++++
T Consensus 228 ----~~----~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~ 259 (263)
T cd06625 228 ----LP----SHVSPDARNFLRRTFVENAKKRPSAEELLR 259 (263)
T ss_pred ----CC----ccCCHHHHHHHHHHhhcCcccCCCHHHHhh
Confidence 11 112235678999999999999999999986
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t |
| >cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-34 Score=322.82 Aligned_cols=242 Identities=21% Similarity=0.282 Sum_probs=193.6
Q ss_pred ceEeecCcEEEEEEEE-cCCCeEEEEEEcCcch---hhHHHHHHHHHHHHhcCCCceeeecceeeecceEEEEEEeccCC
Q 002673 613 NIIGCGGFGLVYKATL-ANGTTLAIKKLSGDLG---LMEREFKAEVEALSTAQHKNLVSLQGYCVHQGFRLLIYSYMENG 688 (894)
Q Consensus 613 ~~LG~G~fg~Vy~a~~-~~g~~vAvK~~~~~~~---~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~lV~E~~~~g 688 (894)
+.||+|+||.||++.. .+|..||+|.+..... .....+..|++++..++||||+++.+++..++..++||||+++|
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~~ 80 (325)
T cd05594 1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGG 80 (325)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCCceEEEEEcCCEEEEEEeCCCCC
Confidence 4699999999999984 5789999999976432 22345678999999999999999999999999999999999999
Q ss_pred CHHHHHhhhcCCCCCcCHHHHHHHHHHHHHHHHHHHhccCCCeeecCCCCCCeEECCCCcEEEEEcccccccCCCCCccc
Q 002673 689 SLDYWLHEKADGASQLDWLTRLKIARGTSCGLAYMHQICEPHIVHRDIKSSNILLDDQFEAHLADFGLSRLILPYQTHVT 768 (894)
Q Consensus 689 sL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDLkp~NILld~~~~vkl~DFGla~~~~~~~~~~~ 768 (894)
+|..++... ..+++..+..++.||+.||.|||+ .++|+||||||+|||++.++.+||+|||+++...... ...
T Consensus 81 ~L~~~l~~~----~~l~~~~~~~~~~qi~~aL~~lH~--~~~ivHrDikp~NIll~~~~~~kL~Dfg~~~~~~~~~-~~~ 153 (325)
T cd05594 81 ELFFHLSRE----RVFSEDRARFYGAEIVSALDYLHS--EKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDG-ATM 153 (325)
T ss_pred cHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHh--cCCEEecCCCCCeEEECCCCCEEEecCCCCeecCCCC-ccc
Confidence 999888753 358899999999999999999996 2599999999999999999999999999987542221 122
Q ss_pred ccccccCCccCcccccCcCCCccccHHHHHHHHHHHHcCCCCCCCCCcchhhhHHHHHHHHhhcCCCCccccccccCCCC
Q 002673 769 TELVGTLGYIPPEYGQAWVATLRGDMYSFGVVMLELLTGKRPVDVLKPKMSRELVGWVLKMRSEGKQDQVFDPILRGKGF 848 (894)
Q Consensus 769 ~~~~gt~~Y~APE~~~~~~~s~ksDVwS~GvlL~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~ 848 (894)
....||+.|+|||++.+..++.++|||||||++|||++|+.||....... ..... . ..... +. ...
T Consensus 154 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tG~~Pf~~~~~~~---~~~~i---~-~~~~~------~p-~~~ 219 (325)
T cd05594 154 KTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEK---LFELI---L-MEEIR------FP-RTL 219 (325)
T ss_pred ccccCCcccCCHHHHccCCCCCccccccccceeeeeccCCCCCCCCCHHH---HHHHH---h-cCCCC------CC-CCC
Confidence 34569999999999999999999999999999999999999997543221 11111 0 11100 00 111
Q ss_pred hHHHHHHHHHHHHhcccCCCCCC-----CHHHHHH
Q 002673 849 DEEMLQVLDVACMCVSQNPFKRP-----TVKEVVE 878 (894)
Q Consensus 849 ~~~~~~l~~li~~Cl~~dP~~RP-----s~~evl~ 878 (894)
...+.+++.+|++.||++|+ ++.++++
T Consensus 220 ---~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~ 251 (325)
T cd05594 220 ---SPEAKSLLSGLLKKDPKQRLGGGPDDAKEIMQ 251 (325)
T ss_pred ---CHHHHHHHHHHhhcCHHHhCCCCCCCHHHHhc
Confidence 23567889999999999997 8999986
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien |
| >cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-34 Score=321.17 Aligned_cols=244 Identities=23% Similarity=0.324 Sum_probs=192.2
Q ss_pred CCccceEeecCcEEEEEEEE-cCCCeEEEEEEcCcch---hhHHHHHHHHHHH---HhcCCCceeeecceeeecceEEEE
Q 002673 609 FSQANIIGCGGFGLVYKATL-ANGTTLAIKKLSGDLG---LMEREFKAEVEAL---STAQHKNLVSLQGYCVHQGFRLLI 681 (894)
Q Consensus 609 f~~~~~LG~G~fg~Vy~a~~-~~g~~vAvK~~~~~~~---~~~~~~~~Ei~~l---~~l~HpnIv~l~g~~~~~~~~~lV 681 (894)
|++.+.||+|+||.||+|.. .+++.||||++..... ...+.+.+|++++ +.++||||+++++++...+..++|
T Consensus 1 y~i~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv 80 (324)
T cd05589 1 FRCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVNLFACFQTEDHVCFV 80 (324)
T ss_pred CeEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccccCCCChhceeeEEEcCCEEEEE
Confidence 56778999999999999985 5789999999975421 1224456666554 566899999999999999999999
Q ss_pred EEeccCCCHHHHHhhhcCCCCCcCHHHHHHHHHHHHHHHHHHHhccCCCeeecCCCCCCeEECCCCcEEEEEcccccccC
Q 002673 682 YSYMENGSLDYWLHEKADGASQLDWLTRLKIARGTSCGLAYMHQICEPHIVHRDIKSSNILLDDQFEAHLADFGLSRLIL 761 (894)
Q Consensus 682 ~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDLkp~NILld~~~~vkl~DFGla~~~~ 761 (894)
|||+++|+|..+++. ..+++..+..++.|++.||.|||+ ++|+||||||+||+++.++.+||+|||+++...
T Consensus 81 ~E~~~~~~L~~~~~~-----~~l~~~~~~~~~~qi~~al~~lH~---~~ivHrdlkp~Nill~~~~~~kL~Dfg~~~~~~ 152 (324)
T cd05589 81 MEYAAGGDLMMHIHT-----DVFSEPRAVFYAACVVLGLQYLHE---NKIVYRDLKLDNLLLDTEGFVKIADFGLCKEGM 152 (324)
T ss_pred EcCCCCCcHHHHhhc-----CCCCHHHHHHHHHHHHHHHHHHHh---CCeEecCCCHHHeEECCCCcEEeCcccCCccCC
Confidence 999999999888764 358999999999999999999997 599999999999999999999999999987542
Q ss_pred CCCCcccccccccCCccCcccccCcCCCccccHHHHHHHHHHHHcCCCCCCCCCcchhhhHHHHHHHHhhcCCCCccccc
Q 002673 762 PYQTHVTTELVGTLGYIPPEYGQAWVATLRGDMYSFGVVMLELLTGKRPVDVLKPKMSRELVGWVLKMRSEGKQDQVFDP 841 (894)
Q Consensus 762 ~~~~~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwS~GvlL~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 841 (894)
.. ........|++.|+|||++.+..++.++|||||||++|||++|+.||....... ... ...... .. +.
T Consensus 153 ~~-~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~G~~pf~~~~~~~---~~~---~i~~~~-~~--~p- 221 (324)
T cd05589 153 GF-GDRTSTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIYEMLVGESPFPGDDEEE---VFD---SIVNDE-VR--YP- 221 (324)
T ss_pred CC-CCcccccccCccccCHhHhcCCCCCcccchhhHHHHHHHHHhCCCCCCCCCHHH---HHH---HHHhCC-CC--CC-
Confidence 22 122344679999999999999999999999999999999999999997543221 111 111111 00 00
Q ss_pred cccCCCChHHHHHHHHHHHHhcccCCCCCC-----CHHHHHH
Q 002673 842 ILRGKGFDEEMLQVLDVACMCVSQNPFKRP-----TVKEVVE 878 (894)
Q Consensus 842 ~l~~~~~~~~~~~l~~li~~Cl~~dP~~RP-----s~~evl~ 878 (894)
.. ....+.+++.+|++.||.+|| ++.++++
T Consensus 222 ----~~---~~~~~~~li~~~L~~dP~~R~~~~~~~~~~l~~ 256 (324)
T cd05589 222 ----RF---LSREAISIMRRLLRRNPERRLGSGEKDAEDVKK 256 (324)
T ss_pred ----CC---CCHHHHHHHHHHhhcCHhHcCCCCCCCHHHHhh
Confidence 11 123567899999999999999 5777766
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved |
| >cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-34 Score=311.35 Aligned_cols=257 Identities=25% Similarity=0.404 Sum_probs=204.4
Q ss_pred cCCCccceEeecCcEEEEEEEEc------CCCeEEEEEEcCcc-hhhHHHHHHHHHHHHhcCCCceeeecceeeecceEE
Q 002673 607 DNFSQANIIGCGGFGLVYKATLA------NGTTLAIKKLSGDL-GLMEREFKAEVEALSTAQHKNLVSLQGYCVHQGFRL 679 (894)
Q Consensus 607 ~~f~~~~~LG~G~fg~Vy~a~~~------~g~~vAvK~~~~~~-~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~ 679 (894)
++|++.+.||+|+||.||+|... ++..||+|.+.... ......+.+|+.+++.++||||+++++++......+
T Consensus 6 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~ 85 (277)
T cd05032 6 EKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHVVRLLGVVSTGQPTL 85 (277)
T ss_pred HHeeEEeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCccCHHHHHHHHHHHHHHHhCCCCceeEEEEEEcCCCCcE
Confidence 57888899999999999999854 23689999987543 233457889999999999999999999999999999
Q ss_pred EEEEeccCCCHHHHHhhhcCC------CCCcCHHHHHHHHHHHHHHHHHHHhccCCCeeecCCCCCCeEECCCCcEEEEE
Q 002673 680 LIYSYMENGSLDYWLHEKADG------ASQLDWLTRLKIARGTSCGLAYMHQICEPHIVHRDIKSSNILLDDQFEAHLAD 753 (894)
Q Consensus 680 lV~E~~~~gsL~~~l~~~~~~------~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDLkp~NILld~~~~vkl~D 753 (894)
+||||+++|+|.+++...... ...+++..++.++.|++.||.|||+ ++++||||||+||+++.++.+||+|
T Consensus 86 ~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~di~p~nill~~~~~~kl~d 162 (277)
T cd05032 86 VVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAA---KKFVHRDLAARNCMVAEDLTVKIGD 162 (277)
T ss_pred EEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHHh---CCccccccChheEEEcCCCCEEECC
Confidence 999999999999999754321 2347889999999999999999997 6999999999999999999999999
Q ss_pred cccccccCCCCC-cccccccccCCccCcccccCcCCCccccHHHHHHHHHHHHc-CCCCCCCCCcchhhhHHHHHHHHhh
Q 002673 754 FGLSRLILPYQT-HVTTELVGTLGYIPPEYGQAWVATLRGDMYSFGVVMLELLT-GKRPVDVLKPKMSRELVGWVLKMRS 831 (894)
Q Consensus 754 FGla~~~~~~~~-~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwS~GvlL~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~ 831 (894)
||+++....... .......++..|+|||.+.+..++.++|||||||++|||++ |+.||...... ....+..
T Consensus 163 fg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~---~~~~~~~---- 235 (277)
T cd05032 163 FGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTKSDVWSFGVVLWEMATLAEQPYQGLSNE---EVLKFVI---- 235 (277)
T ss_pred cccchhhccCcccccCCCCCccccccCHHHHhcCCCCcccchHHHHHHHHHhhccCCCCCccCCHH---HHHHHHh----
Confidence 999986543221 12233456789999999988889999999999999999998 99999754322 2222111
Q ss_pred cCCCCccccccccCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHh
Q 002673 832 EGKQDQVFDPILRGKGFDEEMLQVLDVACMCVSQNPFKRPTVKEVVEWLNN 882 (894)
Q Consensus 832 ~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~ 882 (894)
.+...... ... ...+.+++.+|++.+|++|||+.++++.|++
T Consensus 236 ~~~~~~~~------~~~---~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~ 277 (277)
T cd05032 236 DGGHLDLP------ENC---PDKLLELMRMCWQYNPKMRPTFLEIVSSLKD 277 (277)
T ss_pred cCCCCCCC------CCC---CHHHHHHHHHHcCCChhhCCCHHHHHHHhcC
Confidence 11111111 111 3467799999999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological |
| >cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-34 Score=315.45 Aligned_cols=265 Identities=25% Similarity=0.373 Sum_probs=207.6
Q ss_pred ccCCCccceEeecCcEEEEEEEEc--------CCCeEEEEEEcCcc-hhhHHHHHHHHHHHHhc-CCCceeeecceeeec
Q 002673 606 TDNFSQANIIGCGGFGLVYKATLA--------NGTTLAIKKLSGDL-GLMEREFKAEVEALSTA-QHKNLVSLQGYCVHQ 675 (894)
Q Consensus 606 ~~~f~~~~~LG~G~fg~Vy~a~~~--------~g~~vAvK~~~~~~-~~~~~~~~~Ei~~l~~l-~HpnIv~l~g~~~~~ 675 (894)
.++|.+.+.||+|+||.||+|... ++..||+|.+.... ....+.+.+|+.+++.+ +||||+++++++...
T Consensus 14 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~ 93 (304)
T cd05101 14 RDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQD 93 (304)
T ss_pred HHHeeecceeeccCCceEEEEEEeccCCCCCCcceeEEeeecccccchHHHHHHHHHHHHHHhhccCCCchheeEEEecC
Confidence 356788899999999999999731 24579999987543 23446788999999999 899999999999999
Q ss_pred ceEEEEEEeccCCCHHHHHhhhcC------------CCCCcCHHHHHHHHHHHHHHHHHHHhccCCCeeecCCCCCCeEE
Q 002673 676 GFRLLIYSYMENGSLDYWLHEKAD------------GASQLDWLTRLKIARGTSCGLAYMHQICEPHIVHRDIKSSNILL 743 (894)
Q Consensus 676 ~~~~lV~E~~~~gsL~~~l~~~~~------------~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDLkp~NILl 743 (894)
...++||||+++|+|.+++..... ....+++..+..++.||+.||.|||+ ++++||||||+||++
T Consensus 94 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~---~givH~dlkp~Nili 170 (304)
T cd05101 94 GPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLAS---QKCIHRDLAARNVLV 170 (304)
T ss_pred CceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHHH---CCeeecccccceEEE
Confidence 999999999999999999986422 12457889999999999999999997 599999999999999
Q ss_pred CCCCcEEEEEcccccccCCCCCc-ccccccccCCccCcccccCcCCCccccHHHHHHHHHHHHc-CCCCCCCCCcchhhh
Q 002673 744 DDQFEAHLADFGLSRLILPYQTH-VTTELVGTLGYIPPEYGQAWVATLRGDMYSFGVVMLELLT-GKRPVDVLKPKMSRE 821 (894)
Q Consensus 744 d~~~~vkl~DFGla~~~~~~~~~-~~~~~~gt~~Y~APE~~~~~~~s~ksDVwS~GvlL~ellt-G~~Pf~~~~~~~~~~ 821 (894)
+.++.+||+|||+++........ ......++..|+|||++.+..++.++||||||+++|+|++ |..||.......
T Consensus 171 ~~~~~~kl~D~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~--- 247 (304)
T cd05101 171 TENNVMKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEE--- 247 (304)
T ss_pred cCCCcEEECCCccceecccccccccccCCCCCceeeCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCHHH---
Confidence 99999999999999876432221 1222345678999999998889999999999999999998 888886543221
Q ss_pred HHHHHHHHhhcCCCCccccccccCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhccccccC
Q 002673 822 LVGWVLKMRSEGKQDQVFDPILRGKGFDEEMLQVLDVACMCVSQNPFKRPTVKEVVEWLNNVGANRRN 889 (894)
Q Consensus 822 ~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~i~~~~~~ 889 (894)
.. ......... .. .......+.+++.+||+.+|.+|||+.++++.|+++.....+
T Consensus 248 ~~---~~~~~~~~~-~~---------~~~~~~~~~~li~~cl~~~p~~Rps~~e~l~~l~~~~~~~~~ 302 (304)
T cd05101 248 LF---KLLKEGHRM-DK---------PANCTNELYMMMRDCWHAIPSHRPTFKQLVEDLDRILTLTTN 302 (304)
T ss_pred HH---HHHHcCCcC-CC---------CCCCCHHHHHHHHHHcccChhhCCCHHHHHHHHHHHHHhhhc
Confidence 11 111111111 00 011223567889999999999999999999999988665443
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-34 Score=306.96 Aligned_cols=255 Identities=24% Similarity=0.422 Sum_probs=205.4
Q ss_pred ccCCCccceEeecCcEEEEEEEEcCCCeEEEEEEcCcchhhHHHHHHHHHHHHhcCCCceeeecceeeecceEEEEEEec
Q 002673 606 TDNFSQANIIGCGGFGLVYKATLANGTTLAIKKLSGDLGLMEREFKAEVEALSTAQHKNLVSLQGYCVHQGFRLLIYSYM 685 (894)
Q Consensus 606 ~~~f~~~~~LG~G~fg~Vy~a~~~~g~~vAvK~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~lV~E~~ 685 (894)
.++|++.+.||+|+||.||+|...++..||||.+.... ....++.+|+.++++++|+||+++++++......++||||+
T Consensus 5 ~~~~~i~~~ig~g~~~~v~~~~~~~~~~~~vK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~ 83 (261)
T cd05034 5 RESLKLERKLGAGQFGEVWMGTWNGTTKVAVKTLKPGT-MSPEAFLQEAQIMKKLRHDKLVQLYAVCSEEEPIYIVTEYM 83 (261)
T ss_pred hhheeeeeeeccCcceEEEEEEEcCCceEEEEEecCCc-cCHHHHHHHHHHHhhCCCCCEeeeeeeeecCCceEEEEecc
Confidence 36788899999999999999998888899999987543 33467899999999999999999999999888999999999
Q ss_pred cCCCHHHHHhhhcCCCCCcCHHHHHHHHHHHHHHHHHHHhccCCCeeecCCCCCCeEECCCCcEEEEEcccccccCCCCC
Q 002673 686 ENGSLDYWLHEKADGASQLDWLTRLKIARGTSCGLAYMHQICEPHIVHRDIKSSNILLDDQFEAHLADFGLSRLILPYQT 765 (894)
Q Consensus 686 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDLkp~NILld~~~~vkl~DFGla~~~~~~~~ 765 (894)
++++|.+++.... ...+++..+..++.|++.|+.|||+ ++++|+||||+||++++++.+||+|||++........
T Consensus 84 ~~~~L~~~i~~~~--~~~~~~~~~~~~~~~i~~al~~lh~---~~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~ 158 (261)
T cd05034 84 SKGSLLDFLKSGE--GKKLRLPQLVDMAAQIAEGMAYLES---RNYIHRDLAARNILVGENLVCKIADFGLARLIEDDEY 158 (261)
T ss_pred CCCCHHHHHhccc--cCCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCcchheEEEcCCCCEEECccccceeccchhh
Confidence 9999999997642 2468999999999999999999997 5999999999999999999999999999986643211
Q ss_pred cccccccccCCccCcccccCcCCCccccHHHHHHHHHHHHc-CCCCCCCCCcchhhhHHHHHHHHhhcCCCCcccccccc
Q 002673 766 HVTTELVGTLGYIPPEYGQAWVATLRGDMYSFGVVMLELLT-GKRPVDVLKPKMSRELVGWVLKMRSEGKQDQVFDPILR 844 (894)
Q Consensus 766 ~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwS~GvlL~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~ 844 (894)
.......++..|+|||.+.+..++.++||||||+++|+|++ |+.||...... ...... ....... . .
T Consensus 159 ~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~---~~~~~~---~~~~~~~-~-~---- 226 (261)
T cd05034 159 TAREGAKFPIKWTAPEAANYGRFTIKSDVWSFGILLTEIVTYGRVPYPGMTNR---EVLEQV---ERGYRMP-R-P---- 226 (261)
T ss_pred hhhhccCCCccccCHHHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHH---HHHHHH---HcCCCCC-C-C----
Confidence 11122234568999999998889999999999999999998 99999654321 111111 1110000 0 0
Q ss_pred CCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHh
Q 002673 845 GKGFDEEMLQVLDVACMCVSQNPFKRPTVKEVVEWLNN 882 (894)
Q Consensus 845 ~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~ 882 (894)
.. ....+.+++.+|++.+|++||+++++++.|+.
T Consensus 227 -~~---~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~l~~ 260 (261)
T cd05034 227 -PN---CPEELYDLMLQCWDKDPEERPTFEYLQSFLED 260 (261)
T ss_pred -CC---CCHHHHHHHHHHcccCcccCCCHHHHHHHHhc
Confidence 01 12357789999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t |
| >cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-34 Score=326.62 Aligned_cols=258 Identities=22% Similarity=0.248 Sum_probs=199.5
Q ss_pred HhccCCCccceEeecCcEEEEEEEE-cCCCeEEEEEEcCcc---hhhHHHHHHHHHHHHhcCCCceeeecceeeecceEE
Q 002673 604 KATDNFSQANIIGCGGFGLVYKATL-ANGTTLAIKKLSGDL---GLMEREFKAEVEALSTAQHKNLVSLQGYCVHQGFRL 679 (894)
Q Consensus 604 ~a~~~f~~~~~LG~G~fg~Vy~a~~-~~g~~vAvK~~~~~~---~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~ 679 (894)
...++|++.+.||+|+||.||++.. .+++.||+|.+.+.. ......+.+|+.+++.++||||+++++++.+++..+
T Consensus 40 ~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~~~ 119 (370)
T cd05621 40 MKAEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFCAFQDDKYLY 119 (370)
T ss_pred CCHHHCeEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEE
Confidence 3457899999999999999999985 468899999986432 122345788999999999999999999999999999
Q ss_pred EEEEeccCCCHHHHHhhhcCCCCCcCHHHHHHHHHHHHHHHHHHHhccCCCeeecCCCCCCeEECCCCcEEEEEcccccc
Q 002673 680 LIYSYMENGSLDYWLHEKADGASQLDWLTRLKIARGTSCGLAYMHQICEPHIVHRDIKSSNILLDDQFEAHLADFGLSRL 759 (894)
Q Consensus 680 lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDLkp~NILld~~~~vkl~DFGla~~ 759 (894)
+||||+++|+|.+++... .++...+..++.||+.||+|||+ ++|+||||||+|||++.++.+||+|||++..
T Consensus 120 lv~Ey~~gg~L~~~l~~~-----~~~~~~~~~~~~qil~aL~~LH~---~~IvHrDLKp~NILl~~~~~~kL~DFG~a~~ 191 (370)
T cd05621 120 MVMEYMPGGDLVNLMSNY-----DVPEKWAKFYTAEVVLALDAIHS---MGLIHRDVKPDNMLLDKHGHLKLADFGTCMK 191 (370)
T ss_pred EEEcCCCCCcHHHHHHhc-----CCCHHHHHHHHHHHHHHHHHHHH---CCeEecCCCHHHEEECCCCCEEEEeccccee
Confidence 999999999999998643 37788889999999999999997 5999999999999999999999999999987
Q ss_pred cCCCCCcccccccccCCccCcccccCc----CCCccccHHHHHHHHHHHHcCCCCCCCCCcchhhhHHHHHHHHhhcCCC
Q 002673 760 ILPYQTHVTTELVGTLGYIPPEYGQAW----VATLRGDMYSFGVVMLELLTGKRPVDVLKPKMSRELVGWVLKMRSEGKQ 835 (894)
Q Consensus 760 ~~~~~~~~~~~~~gt~~Y~APE~~~~~----~~s~ksDVwS~GvlL~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~ 835 (894)
.............||+.|+|||++.+. .++.++|||||||++|||++|+.||....... ...........
T Consensus 192 ~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell~G~~Pf~~~~~~~------~~~~i~~~~~~ 265 (370)
T cd05621 192 MDETGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADSLVG------TYSKIMDHKNS 265 (370)
T ss_pred cccCCceecccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHHHhCCCCCCCCCHHH------HHHHHHhCCcc
Confidence 643322223456799999999988654 37889999999999999999999997543211 11111111110
Q ss_pred CccccccccCCCChHHHHHHHHHHHHhcccCCCC--CCCHHHHHH--HHHh
Q 002673 836 DQVFDPILRGKGFDEEMLQVLDVACMCVSQNPFK--RPTVKEVVE--WLNN 882 (894)
Q Consensus 836 ~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~--RPs~~evl~--~L~~ 882 (894)
..+.+ .......+.+++..|+..++.+ |+++.++++ |++.
T Consensus 266 ~~~p~-------~~~~s~~~~~li~~~L~~~~~r~~R~~~~e~l~hp~~~~ 309 (370)
T cd05621 266 LNFPE-------DVEISKHAKNLICAFLTDREVRLGRNGVEEIKQHPFFKN 309 (370)
T ss_pred cCCCC-------cccCCHHHHHHHHHHccCchhccCCCCHHHHhcCcccCC
Confidence 01100 0011234567888888755544 899999998 6654
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found |
| >cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-34 Score=312.19 Aligned_cols=265 Identities=23% Similarity=0.368 Sum_probs=205.4
Q ss_pred ccCCCccceEeecCcEEEEEEEEcC-----------------CCeEEEEEEcCcch-hhHHHHHHHHHHHHhcCCCceee
Q 002673 606 TDNFSQANIIGCGGFGLVYKATLAN-----------------GTTLAIKKLSGDLG-LMEREFKAEVEALSTAQHKNLVS 667 (894)
Q Consensus 606 ~~~f~~~~~LG~G~fg~Vy~a~~~~-----------------g~~vAvK~~~~~~~-~~~~~~~~Ei~~l~~l~HpnIv~ 667 (894)
..+|++.+.||+|+||.||+|...+ +..||+|.+..... .....+.+|++++++++||||++
T Consensus 4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~ 83 (296)
T cd05051 4 RQPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDFLKEVKILSRLSDPNIAR 83 (296)
T ss_pred hhhCcccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCccCHHHHHHHHHHHHHHHhcCCCCEeE
Confidence 3578889999999999999997532 24589999876542 34567899999999999999999
Q ss_pred ecceeeecceEEEEEEeccCCCHHHHHhhhcC-------CCCCcCHHHHHHHHHHHHHHHHHHHhccCCCeeecCCCCCC
Q 002673 668 LQGYCVHQGFRLLIYSYMENGSLDYWLHEKAD-------GASQLDWLTRLKIARGTSCGLAYMHQICEPHIVHRDIKSSN 740 (894)
Q Consensus 668 l~g~~~~~~~~~lV~E~~~~gsL~~~l~~~~~-------~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDLkp~N 740 (894)
+++++..++..++||||+++++|.+++..... ....+++..++.++.|++.||.|||+ .+++||||||+|
T Consensus 84 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH~---~~i~H~dlkp~N 160 (296)
T cd05051 84 LLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLES---LNFVHRDLATRN 160 (296)
T ss_pred EEEEEecCCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHHH---cCccccccchhc
Confidence 99999999999999999999999999976431 12368999999999999999999997 599999999999
Q ss_pred eEECCCCcEEEEEcccccccCCCCC-cccccccccCCccCcccccCcCCCccccHHHHHHHHHHHHc--CCCCCCCCCcc
Q 002673 741 ILLDDQFEAHLADFGLSRLILPYQT-HVTTELVGTLGYIPPEYGQAWVATLRGDMYSFGVVMLELLT--GKRPVDVLKPK 817 (894)
Q Consensus 741 ILld~~~~vkl~DFGla~~~~~~~~-~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwS~GvlL~ellt--G~~Pf~~~~~~ 817 (894)
|+++.++.++|+|||+++....... .......++..|+|||+..+..++.++|||||||++|||++ |..||......
T Consensus 161 ili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p~~~~~~~ 240 (296)
T cd05051 161 CLVGKNYTIKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILTLCREQPYEHLTDQ 240 (296)
T ss_pred eeecCCCceEEccccceeecccCcceeecCcCCCCceecCHHHhhcCCCCccchhhhhHHHHHHHHhcCCCCCCCCcChH
Confidence 9999999999999999986532221 12233456778999999988889999999999999999998 77888654321
Q ss_pred hhhhHHHHHHHHhhcCCCCccccccccCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHh
Q 002673 818 MSRELVGWVLKMRSEGKQDQVFDPILRGKGFDEEMLQVLDVACMCVSQNPFKRPTVKEVVEWLNN 882 (894)
Q Consensus 818 ~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~ 882 (894)
.................... .......++.+++.+|++.||.+|||+.+++++|++
T Consensus 241 ---~~~~~~~~~~~~~~~~~~~~------~~~~~~~~l~~li~~cl~~~p~~Rpt~~el~~~L~~ 296 (296)
T cd05051 241 ---QVIENAGHFFRDDGRQIYLP------RPPNCPKDIYELMLECWRRDEEDRPTFREIHLFLQR 296 (296)
T ss_pred ---HHHHHHHhccccccccccCC------CccCCCHHHHHHHHHHhccChhcCCCHHHHHHHhcC
Confidence 22222221111111111100 001122467899999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke |
| >cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-34 Score=320.03 Aligned_cols=248 Identities=21% Similarity=0.342 Sum_probs=193.1
Q ss_pred ceEeecCcEEEEEEEE-cCCCeEEEEEEcCcc---hhhHHHHHHHHHHHHhc-CCCceeeecceeeecceEEEEEEeccC
Q 002673 613 NIIGCGGFGLVYKATL-ANGTTLAIKKLSGDL---GLMEREFKAEVEALSTA-QHKNLVSLQGYCVHQGFRLLIYSYMEN 687 (894)
Q Consensus 613 ~~LG~G~fg~Vy~a~~-~~g~~vAvK~~~~~~---~~~~~~~~~Ei~~l~~l-~HpnIv~l~g~~~~~~~~~lV~E~~~~ 687 (894)
+.||+|+||.||+|.. .+++.||+|++.... ......+..|+.++.++ +||||+++++++...+..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~~~~ 80 (329)
T cd05618 1 RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNG 80 (329)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEhhHhcchhHHHHHHHHHHHHHhcCCCCcCCceeeEEEeCCEEEEEEeCCCC
Confidence 4699999999999985 468899999997642 22334577888888877 899999999999999999999999999
Q ss_pred CCHHHHHhhhcCCCCCcCHHHHHHHHHHHHHHHHHHHhccCCCeeecCCCCCCeEECCCCcEEEEEcccccccCCCCCcc
Q 002673 688 GSLDYWLHEKADGASQLDWLTRLKIARGTSCGLAYMHQICEPHIVHRDIKSSNILLDDQFEAHLADFGLSRLILPYQTHV 767 (894)
Q Consensus 688 gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDLkp~NILld~~~~vkl~DFGla~~~~~~~~~~ 767 (894)
|+|..++... ..+++..+..++.|++.||.|||+ ++|+||||||+||+++.++.+||+|||+++..... ...
T Consensus 81 ~~L~~~~~~~----~~l~~~~~~~i~~qi~~~l~~lH~---~~ivH~Dikp~Nili~~~~~~kL~DfG~~~~~~~~-~~~ 152 (329)
T cd05618 81 GDLMFHMQRQ----RKLPEEHARFYSAEISLALNYLHE---RGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRP-GDT 152 (329)
T ss_pred CCHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHH---CCeeeCCCCHHHEEECCCCCEEEeeCCccccccCC-CCc
Confidence 9999888653 358899999999999999999997 59999999999999999999999999998753221 122
Q ss_pred cccccccCCccCcccccCcCCCccccHHHHHHHHHHHHcCCCCCCCCCcch--hhhHHHHHHHHhhcCCCCccccccccC
Q 002673 768 TTELVGTLGYIPPEYGQAWVATLRGDMYSFGVVMLELLTGKRPVDVLKPKM--SRELVGWVLKMRSEGKQDQVFDPILRG 845 (894)
Q Consensus 768 ~~~~~gt~~Y~APE~~~~~~~s~ksDVwS~GvlL~elltG~~Pf~~~~~~~--~~~~~~~~~~~~~~~~~~~~~d~~l~~ 845 (894)
.....||+.|+|||++.+..++.++|||||||++|||++|+.||....... ......+.......... .+ .
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~i~~~~~-~~-p----- 225 (329)
T cd05618 153 TSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQI-RI-P----- 225 (329)
T ss_pred cccccCCccccCHHHHcCCCCCCccceecccHHHHHHhhCCCCCccCCCcCCcccccHHHHHHHHhcCCC-CC-C-----
Confidence 334678999999999999999999999999999999999999996322111 11111222221111111 01 1
Q ss_pred CCChHHHHHHHHHHHHhcccCCCCCCC------HHHHHH
Q 002673 846 KGFDEEMLQVLDVACMCVSQNPFKRPT------VKEVVE 878 (894)
Q Consensus 846 ~~~~~~~~~l~~li~~Cl~~dP~~RPs------~~evl~ 878 (894)
......+.+++.+|++.||.+||+ +.++++
T Consensus 226 ---~~~~~~~~~ll~~~L~~dP~~R~~~~~~~~~~~i~~ 261 (329)
T cd05618 226 ---RSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQG 261 (329)
T ss_pred ---CCCCHHHHHHHHHHhcCCHHHcCCCCCCCCHHHHhc
Confidence 111235678999999999999998 567765
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o |
| >cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-34 Score=311.11 Aligned_cols=258 Identities=26% Similarity=0.389 Sum_probs=202.1
Q ss_pred ccCCCccceEeecCcEEEEEEEEc------CCCeEEEEEEcCcc-hhhHHHHHHHHHHHHhcCCCceeeecceeeecceE
Q 002673 606 TDNFSQANIIGCGGFGLVYKATLA------NGTTLAIKKLSGDL-GLMEREFKAEVEALSTAQHKNLVSLQGYCVHQGFR 678 (894)
Q Consensus 606 ~~~f~~~~~LG~G~fg~Vy~a~~~------~g~~vAvK~~~~~~-~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~ 678 (894)
+++|++.+.||+|+||.||+|.+. .+..||+|.+.... ......+..|+.+++.++|+||+++++++.+....
T Consensus 5 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~ 84 (277)
T cd05036 5 RDSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNIVRLIGVSFERLPR 84 (277)
T ss_pred HHHcEeeeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCc
Confidence 467888999999999999999864 35778999887543 33346789999999999999999999999998899
Q ss_pred EEEEEeccCCCHHHHHhhhcC---CCCCcCHHHHHHHHHHHHHHHHHHHhccCCCeeecCCCCCCeEECCCC---cEEEE
Q 002673 679 LLIYSYMENGSLDYWLHEKAD---GASQLDWLTRLKIARGTSCGLAYMHQICEPHIVHRDIKSSNILLDDQF---EAHLA 752 (894)
Q Consensus 679 ~lV~E~~~~gsL~~~l~~~~~---~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDLkp~NILld~~~---~vkl~ 752 (894)
++||||+++|+|.++++.... ....+++..++.++.||+.||.|||+ ++++||||||+||+++.++ .+||+
T Consensus 85 ~lv~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~---~~ivH~dlkp~nil~~~~~~~~~~kl~ 161 (277)
T cd05036 85 FILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEE---NHFIHRDIAARNCLLTCKGPGRVAKIA 161 (277)
T ss_pred EEEEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHH---CCEeecccchheEEEeccCCCcceEec
Confidence 999999999999999986532 12358999999999999999999997 5899999999999998754 59999
Q ss_pred EcccccccCCCCCcc-cccccccCCccCcccccCcCCCccccHHHHHHHHHHHHc-CCCCCCCCCcchhhhHHHHHHHHh
Q 002673 753 DFGLSRLILPYQTHV-TTELVGTLGYIPPEYGQAWVATLRGDMYSFGVVMLELLT-GKRPVDVLKPKMSRELVGWVLKMR 830 (894)
Q Consensus 753 DFGla~~~~~~~~~~-~~~~~gt~~Y~APE~~~~~~~s~ksDVwS~GvlL~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~ 830 (894)
|||+++......... ......+..|+|||++.+..++.++|||||||++|||++ |+.||....... .... ..
T Consensus 162 dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~~g~~pf~~~~~~~---~~~~---~~ 235 (277)
T cd05036 162 DFGMARDIYRASYYRKGGRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPYPGRTNQE---VMEF---VT 235 (277)
T ss_pred cCccccccCCccceecCCCCCccHhhCCHHHHhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHHH---HHHH---HH
Confidence 999998763221111 112233568999999999999999999999999999997 999997543321 1111 11
Q ss_pred hcCCCCccccccccCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHh
Q 002673 831 SEGKQDQVFDPILRGKGFDEEMLQVLDVACMCVSQNPFKRPTVKEVVEWLNN 882 (894)
Q Consensus 831 ~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~ 882 (894)
...... . . . .....+.+++.+|++.+|++||++.++++.|+.
T Consensus 236 ~~~~~~-~-~-----~---~~~~~~~~~i~~cl~~~p~~Rps~~~vl~~l~~ 277 (277)
T cd05036 236 GGGRLD-P-P-----K---GCPGPVYRIMTDCWQHTPEDRPNFATILERIQY 277 (277)
T ss_pred cCCcCC-C-C-----C---CCCHHHHHHHHHHcCCCcccCcCHHHHHHHhhC
Confidence 111111 0 0 1 112357789999999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well |
| >cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-34 Score=314.28 Aligned_cols=259 Identities=26% Similarity=0.410 Sum_probs=201.1
Q ss_pred cCCCccceEeecCcEEEEEEEEc-CCC--eEEEEEEcCcc-hhhHHHHHHHHHHHHhc-CCCceeeecceeeecceEEEE
Q 002673 607 DNFSQANIIGCGGFGLVYKATLA-NGT--TLAIKKLSGDL-GLMEREFKAEVEALSTA-QHKNLVSLQGYCVHQGFRLLI 681 (894)
Q Consensus 607 ~~f~~~~~LG~G~fg~Vy~a~~~-~g~--~vAvK~~~~~~-~~~~~~~~~Ei~~l~~l-~HpnIv~l~g~~~~~~~~~lV 681 (894)
++|++.+.||+|+||.||+|... ++. .+++|.++... ....+.+.+|+.++.++ +||||+++++++...+..++|
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv 81 (297)
T cd05089 2 EDIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNIINLLGACENRGYLYIA 81 (297)
T ss_pred ccceeeeeecCCCcceEEEEEecCCCCcceeEEEEccccCCHHHHHHHHHHHHHHHhhcCCCchhheEEEEccCCcceEE
Confidence 57888999999999999999864 333 47888887432 33446788999999999 799999999999999999999
Q ss_pred EEeccCCCHHHHHhhhcC------------CCCCcCHHHHHHHHHHHHHHHHHHHhccCCCeeecCCCCCCeEECCCCcE
Q 002673 682 YSYMENGSLDYWLHEKAD------------GASQLDWLTRLKIARGTSCGLAYMHQICEPHIVHRDIKSSNILLDDQFEA 749 (894)
Q Consensus 682 ~E~~~~gsL~~~l~~~~~------------~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDLkp~NILld~~~~v 749 (894)
+||+++|+|.++++.... ....+++..+..++.|++.||+|||+ ++++||||||+|||+++++.+
T Consensus 82 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~---~~ivH~dlkp~Nill~~~~~~ 158 (297)
T cd05089 82 IEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSE---KQFIHRDLAARNVLVGENLAS 158 (297)
T ss_pred EEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHHH---CCcccCcCCcceEEECCCCeE
Confidence 999999999999975321 12358889999999999999999997 599999999999999999999
Q ss_pred EEEEcccccccCCCCCcccccccccCCccCcccccCcCCCccccHHHHHHHHHHHHc-CCCCCCCCCcchhhhHHHHHHH
Q 002673 750 HLADFGLSRLILPYQTHVTTELVGTLGYIPPEYGQAWVATLRGDMYSFGVVMLELLT-GKRPVDVLKPKMSRELVGWVLK 828 (894)
Q Consensus 750 kl~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwS~GvlL~ellt-G~~Pf~~~~~~~~~~~~~~~~~ 828 (894)
||+|||++...... ........+..|+|||+..+..++.++|||||||++|||++ |..||....... ... .
T Consensus 159 kl~dfg~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~el~t~g~~pf~~~~~~~---~~~---~ 230 (297)
T cd05089 159 KIADFGLSRGEEVY--VKKTMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVSLGGTPYCGMTCAE---LYE---K 230 (297)
T ss_pred EECCcCCCccccce--eccCCCCcCccccCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHHH---HHH---H
Confidence 99999998643211 11111223557999999988889999999999999999997 999997543221 111 1
Q ss_pred HhhcCCCCccccccccCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhcccc
Q 002673 829 MRSEGKQDQVFDPILRGKGFDEEMLQVLDVACMCVSQNPFKRPTVKEVVEWLNNVGAN 886 (894)
Q Consensus 829 ~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~i~~~ 886 (894)
...... .. .. .. ....+.+++.+|++.+|.+||++.++++.|+.+...
T Consensus 231 ~~~~~~-~~-----~~-~~---~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~~~~ 278 (297)
T cd05089 231 LPQGYR-ME-----KP-RN---CDDEVYELMRQCWRDRPYERPPFAQISVQLSRMLEA 278 (297)
T ss_pred HhcCCC-CC-----CC-CC---CCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHh
Confidence 111100 00 00 11 123567899999999999999999999998877654
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. |
| >KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-34 Score=304.88 Aligned_cols=271 Identities=22% Similarity=0.284 Sum_probs=206.1
Q ss_pred cCCCccceEeecCcEEEEEEE-EcCCCeEEEEEEcCcchh--hHHHHHHHHHHHHhcCCCc-eeeecceeeecc------
Q 002673 607 DNFSQANIIGCGGFGLVYKAT-LANGTTLAIKKLSGDLGL--MEREFKAEVEALSTAQHKN-LVSLQGYCVHQG------ 676 (894)
Q Consensus 607 ~~f~~~~~LG~G~fg~Vy~a~-~~~g~~vAvK~~~~~~~~--~~~~~~~Ei~~l~~l~Hpn-Iv~l~g~~~~~~------ 676 (894)
..|...++||+|+||+||+|+ ..+|+.||+|+++-+... .-....+|+.+++.++|+| ||.+++++...+
T Consensus 11 ~~~~~~eklGeGtyg~Vykar~~~~g~~VALKkirl~~~~EG~P~taiREisllk~L~~~~~iv~L~dv~~~~~~~~~~~ 90 (323)
T KOG0594|consen 11 FDYEKVEKLGEGTYGVVYKARSKRTGKFVALKKIRLEFEEEGVPSTAIREISLLKRLSHANHIVRLHDVIHTSNNHRGIG 90 (323)
T ss_pred HHHHHHHHhCCCCceEEEEEEEecCCCEEEEEEEeccccccCCCchhhHHHHHHHHhCCCcceEEEEeeeeecccccccc
Confidence 345666789999999999998 668899999999765432 3345689999999999999 999999999877
Q ss_pred eEEEEEEeccCCCHHHHHhhhcCCCCCcCHHHHHHHHHHHHHHHHHHHhccCCCeeecCCCCCCeEECCCCcEEEEEccc
Q 002673 677 FRLLIYSYMENGSLDYWLHEKADGASQLDWLTRLKIARGTSCGLAYMHQICEPHIVHRDIKSSNILLDDQFEAHLADFGL 756 (894)
Q Consensus 677 ~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDLkp~NILld~~~~vkl~DFGl 756 (894)
..++|+||++ -+|..++.........++...+..+..||+.||+|||+ ++|+||||||.|||++++|.+||+|||+
T Consensus 91 ~l~lvfe~~d-~DL~~ymd~~~~~~~g~~~~~ik~~m~Qll~gl~~~H~---~~IlHRDLKPQNlLi~~~G~lKlaDFGl 166 (323)
T KOG0594|consen 91 KLYLVFEFLD-RDLKKYMDSLPKKPQGLPPRLIKSFMRQLLRGLAFLHS---HGILHRDLKPQNLLISSSGVLKLADFGL 166 (323)
T ss_pred eEEEEEEeec-ccHHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHHh---CCeecccCCcceEEECCCCcEeeeccch
Confidence 7889999995 48999998765322346667899999999999999998 5999999999999999999999999999
Q ss_pred ccccCCCCCcccccccccCCccCcccccCc-CCCccccHHHHHHHHHHHHcCCCCCCCCCcchhhhHHHHHHHH--hhcC
Q 002673 757 SRLILPYQTHVTTELVGTLGYIPPEYGQAW-VATLRGDMYSFGVVMLELLTGKRPVDVLKPKMSRELVGWVLKM--RSEG 833 (894)
Q Consensus 757 a~~~~~~~~~~~~~~~gt~~Y~APE~~~~~-~~s~ksDVwS~GvlL~elltG~~Pf~~~~~~~~~~~~~~~~~~--~~~~ 833 (894)
|+.+.-.. ...+..++|..|.|||++.+. .|+...||||+|||++||++++.-|.+... ...+....... ..+.
T Consensus 167 Ara~~ip~-~~yt~evvTlWYRaPEvLlGs~~Ys~~vDiWs~GcIfaEm~~~~~LFpG~se--~~ql~~If~~lGtP~e~ 243 (323)
T KOG0594|consen 167 ARAFSIPM-RTYTPEVVTLWYRAPEVLLGSTSYSTSVDIWSLGCIFAEMFTRRPLFPGDSE--IDQLFRIFRLLGTPNEK 243 (323)
T ss_pred HHHhcCCc-ccccccEEEeeccCHHHhcCCCcCCCCcchHhHHHHHHHHHhCCCCCCCCcH--HHHHHHHHHHcCCCCcc
Confidence 99764222 224556789999999998887 799999999999999999999998876554 22222222111 1112
Q ss_pred CCCccc-----cccccC----CCChH----HHHHHHHHHHHhcccCCCCCCCHHHHHH--HHHhcc
Q 002673 834 KQDQVF-----DPILRG----KGFDE----EMLQVLDVACMCVSQNPFKRPTVKEVVE--WLNNVG 884 (894)
Q Consensus 834 ~~~~~~-----d~~l~~----~~~~~----~~~~l~~li~~Cl~~dP~~RPs~~evl~--~L~~i~ 884 (894)
.+..+. +..... ..... ......+++.+|++.+|.+|.|++.++. .+..+.
T Consensus 244 ~Wp~v~~~~~~k~~f~~~~~~~~l~~~~~~~~~~~~dll~~~L~y~p~~R~Sa~~al~h~yf~~~~ 309 (323)
T KOG0594|consen 244 DWPGVSSLPDYKAPFPKWPGPKDLSSILPKLDPDGIELLSKLLQYDPAKRISAKGALTHPYFSELP 309 (323)
T ss_pred CCCCccccccccccCcCCCCccchHHhccccCccHHHHHHHHhccCcccCcCHHHHhcChhhcccc
Confidence 222111 001111 11111 1136789999999999999999999998 366553
|
|
| >cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-34 Score=318.01 Aligned_cols=241 Identities=26% Similarity=0.384 Sum_probs=188.7
Q ss_pred ceEeecCcEEEEEEEE-cCCCeEEEEEEcCcch---hhHHHHHHHHHHHHhc-CCCceeeecceeeecceEEEEEEeccC
Q 002673 613 NIIGCGGFGLVYKATL-ANGTTLAIKKLSGDLG---LMEREFKAEVEALSTA-QHKNLVSLQGYCVHQGFRLLIYSYMEN 687 (894)
Q Consensus 613 ~~LG~G~fg~Vy~a~~-~~g~~vAvK~~~~~~~---~~~~~~~~Ei~~l~~l-~HpnIv~l~g~~~~~~~~~lV~E~~~~ 687 (894)
+.||+|+||.||+|.. .+++.||+|++..... .....+..|..++... +||||+++++++..++..++||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~g 80 (316)
T cd05592 1 KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLFCTFQTKEHLFFVMEYLNG 80 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 3699999999999985 4678999999976432 2223455666666654 899999999999999999999999999
Q ss_pred CCHHHHHhhhcCCCCCcCHHHHHHHHHHHHHHHHHHHhccCCCeeecCCCCCCeEECCCCcEEEEEcccccccCCCCCcc
Q 002673 688 GSLDYWLHEKADGASQLDWLTRLKIARGTSCGLAYMHQICEPHIVHRDIKSSNILLDDQFEAHLADFGLSRLILPYQTHV 767 (894)
Q Consensus 688 gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDLkp~NILld~~~~vkl~DFGla~~~~~~~~~~ 767 (894)
|+|..++... ..++...+..++.|++.||.|||+ ++|+||||||+|||++.++.+||+|||+++...... ..
T Consensus 81 g~L~~~~~~~----~~~~~~~~~~~~~qi~~al~~LH~---~~ivH~dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~-~~ 152 (316)
T cd05592 81 GDLMFHIQSS----GRFDEARARFYAAEIICGLQFLHK---KGIIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGE-GK 152 (316)
T ss_pred CcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHH---CCEEeCCCCHHHeEECCCCCEEEccCcCCeECCCCC-Cc
Confidence 9999988754 358888999999999999999997 599999999999999999999999999998643222 22
Q ss_pred cccccccCCccCcccccCcCCCccccHHHHHHHHHHHHcCCCCCCCCCcchhhhHHHHHHHHhhcCCCCccccccccCCC
Q 002673 768 TTELVGTLGYIPPEYGQAWVATLRGDMYSFGVVMLELLTGKRPVDVLKPKMSRELVGWVLKMRSEGKQDQVFDPILRGKG 847 (894)
Q Consensus 768 ~~~~~gt~~Y~APE~~~~~~~s~ksDVwS~GvlL~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~ 847 (894)
.....||+.|+|||++.+..++.++|||||||++|||++|+.||...... .... ..... . ..++ ..
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~Pf~~~~~~---~~~~---~i~~~-~--~~~~-----~~ 218 (316)
T cd05592 153 ASTFCGTPDYIAPEILKGQKYNESVDWWSFGVLLYEMLIGQSPFHGEDED---ELFD---SILND-R--PHFP-----RW 218 (316)
T ss_pred cccccCCccccCHHHHcCCCCCCcccchhHHHHHHHHHhCCCCCCCCCHH---HHHH---HHHcC-C--CCCC-----CC
Confidence 34467999999999999989999999999999999999999999754321 1111 11111 0 0011 11
Q ss_pred ChHHHHHHHHHHHHhcccCCCCCCCHH-HHHH
Q 002673 848 FDEEMLQVLDVACMCVSQNPFKRPTVK-EVVE 878 (894)
Q Consensus 848 ~~~~~~~l~~li~~Cl~~dP~~RPs~~-evl~ 878 (894)
. ...+.+++.+||+.||++||++. ++++
T Consensus 219 ~---~~~~~~ll~~~l~~~P~~R~~~~~~l~~ 247 (316)
T cd05592 219 I---SKEAKDCLSKLFERDPTKRLGVDGDIRQ 247 (316)
T ss_pred C---CHHHHHHHHHHccCCHHHcCCChHHHHc
Confidence 1 22456888999999999999975 5544
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp |
| >cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-34 Score=320.43 Aligned_cols=248 Identities=21% Similarity=0.330 Sum_probs=194.3
Q ss_pred ceEeecCcEEEEEEEE-cCCCeEEEEEEcCcch---hhHHHHHHHHHHHHhc-CCCceeeecceeeecceEEEEEEeccC
Q 002673 613 NIIGCGGFGLVYKATL-ANGTTLAIKKLSGDLG---LMEREFKAEVEALSTA-QHKNLVSLQGYCVHQGFRLLIYSYMEN 687 (894)
Q Consensus 613 ~~LG~G~fg~Vy~a~~-~~g~~vAvK~~~~~~~---~~~~~~~~Ei~~l~~l-~HpnIv~l~g~~~~~~~~~lV~E~~~~ 687 (894)
++||+|+||.||+|.. .++..||+|+++.... .....+..|..++..+ +||||+++++++.+.+..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~~~~~~lv~e~~~~ 80 (329)
T cd05588 1 RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQTESRLFFVIEFVSG 80 (329)
T ss_pred CeEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCCCCceEEEEEcCCEEEEEEeCCCC
Confidence 4699999999999985 4688999999975422 2234578899999988 799999999999999999999999999
Q ss_pred CCHHHHHhhhcCCCCCcCHHHHHHHHHHHHHHHHHHHhccCCCeeecCCCCCCeEECCCCcEEEEEcccccccCCCCCcc
Q 002673 688 GSLDYWLHEKADGASQLDWLTRLKIARGTSCGLAYMHQICEPHIVHRDIKSSNILLDDQFEAHLADFGLSRLILPYQTHV 767 (894)
Q Consensus 688 gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDLkp~NILld~~~~vkl~DFGla~~~~~~~~~~ 767 (894)
|+|..++... ..+++..+..++.|++.||.|||+ ++|+||||||+|||++.++.+||+|||+++..... ...
T Consensus 81 g~L~~~~~~~----~~l~~~~~~~~~~qi~~~l~~lH~---~~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~-~~~ 152 (329)
T cd05588 81 GDLMFHMQRQ----RKLPEEHARFYSAEISLALNFLHE---RGIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRP-GDT 152 (329)
T ss_pred CCHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHH---CCeEecCCCHHHeEECCCCCEEECcCccccccccC-CCc
Confidence 9999888653 358999999999999999999997 59999999999999999999999999998753211 122
Q ss_pred cccccccCCccCcccccCcCCCccccHHHHHHHHHHHHcCCCCCCCCCcch--hhhHHHHHHHHhhcCCCCccccccccC
Q 002673 768 TTELVGTLGYIPPEYGQAWVATLRGDMYSFGVVMLELLTGKRPVDVLKPKM--SRELVGWVLKMRSEGKQDQVFDPILRG 845 (894)
Q Consensus 768 ~~~~~gt~~Y~APE~~~~~~~s~ksDVwS~GvlL~elltG~~Pf~~~~~~~--~~~~~~~~~~~~~~~~~~~~~d~~l~~ 845 (894)
.....||+.|+|||++.+..++.++|||||||++|+|++|+.||+...... ......+........... + .
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~-~-p----- 225 (329)
T cd05588 153 TSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQNTEDYLFQVILEKQIR-I-P----- 225 (329)
T ss_pred cccccCCccccCHHHHcCCCCCCccceechHHHHHHHHHCCCCcccccccccccccchHHHHHHHHcCCCC-C-C-----
Confidence 334678999999999999999999999999999999999999997432111 111112222211111111 0 0
Q ss_pred CCChHHHHHHHHHHHHhcccCCCCCCC------HHHHHH
Q 002673 846 KGFDEEMLQVLDVACMCVSQNPFKRPT------VKEVVE 878 (894)
Q Consensus 846 ~~~~~~~~~l~~li~~Cl~~dP~~RPs------~~evl~ 878 (894)
.. ....+.+++.+|++.||.+||+ +.++++
T Consensus 226 ~~---~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~i~~ 261 (329)
T cd05588 226 RS---LSVKASSVLKGFLNKDPKERLGCHPQTGFRDIKS 261 (329)
T ss_pred CC---CCHHHHHHHHHHhccCHHHcCCCCCCCCHHHHhc
Confidence 11 1235678999999999999997 678875
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl |
| >cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-34 Score=328.36 Aligned_cols=255 Identities=24% Similarity=0.251 Sum_probs=196.5
Q ss_pred cCCCccceEeecCcEEEEEEEE-cCCCeEEEEEEcCcc---hhhHHHHHHHHHHHHhcCCCceeeecceeeecceEEEEE
Q 002673 607 DNFSQANIIGCGGFGLVYKATL-ANGTTLAIKKLSGDL---GLMEREFKAEVEALSTAQHKNLVSLQGYCVHQGFRLLIY 682 (894)
Q Consensus 607 ~~f~~~~~LG~G~fg~Vy~a~~-~~g~~vAvK~~~~~~---~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~lV~ 682 (894)
++|++.+.||+|+||.||++.. .+++.||||++.... ......+.+|+++++.++||||+++++++.+.+..++||
T Consensus 1 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~ 80 (377)
T cd05629 1 EDFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSLYYSFQDAQYLYLIM 80 (377)
T ss_pred CCceEeEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHHHHhHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCeeEEEE
Confidence 4688899999999999999974 578999999986532 122356788999999999999999999999999999999
Q ss_pred EeccCCCHHHHHhhhcCCCCCcCHHHHHHHHHHHHHHHHHHHhccCCCeeecCCCCCCeEECCCCcEEEEEcccccccCC
Q 002673 683 SYMENGSLDYWLHEKADGASQLDWLTRLKIARGTSCGLAYMHQICEPHIVHRDIKSSNILLDDQFEAHLADFGLSRLILP 762 (894)
Q Consensus 683 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDLkp~NILld~~~~vkl~DFGla~~~~~ 762 (894)
||+++|+|.+++... ..+++..+..++.|++.||+|||+ ++|+||||||+|||++.++.+||+|||+++.+..
T Consensus 81 E~~~gg~L~~~l~~~----~~~~~~~~~~~~~ql~~aL~~LH~---~givHrDlkp~NIll~~~~~~kl~DfGla~~~~~ 153 (377)
T cd05629 81 EFLPGGDLMTMLIKY----DTFSEDVTRFYMAECVLAIEAVHK---LGFIHRDIKPDNILIDRGGHIKLSDFGLSTGFHK 153 (377)
T ss_pred eCCCCCcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHh---CCeeccCCCHHHEEECCCCCEEEeeccccccccc
Confidence 999999999999753 357888889999999999999997 5999999999999999999999999999964321
Q ss_pred CCCc----------------------------------------------ccccccccCCccCcccccCcCCCccccHHH
Q 002673 763 YQTH----------------------------------------------VTTELVGTLGYIPPEYGQAWVATLRGDMYS 796 (894)
Q Consensus 763 ~~~~----------------------------------------------~~~~~~gt~~Y~APE~~~~~~~s~ksDVwS 796 (894)
.... .....+||+.|+|||++.+..++.++||||
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwS 233 (377)
T cd05629 154 QHDSAYYQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYGQECDWWS 233 (377)
T ss_pred ccccccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccCCCccccCHHHHccCCCCCceeeEe
Confidence 0000 001246999999999999999999999999
Q ss_pred HHHHHHHHHcCCCCCCCCCcchhhhHHHHHHHHhhcCCCCccccccccCCCChHHHHHHHHHHHHhcccCCCCC---CCH
Q 002673 797 FGVVMLELLTGKRPVDVLKPKMSRELVGWVLKMRSEGKQDQVFDPILRGKGFDEEMLQVLDVACMCVSQNPFKR---PTV 873 (894)
Q Consensus 797 ~GvlL~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~R---Ps~ 873 (894)
|||++|||++|+.||....... ... .+......... + . ......++.+++.+|+. +|.+| +++
T Consensus 234 lGvil~elltG~~Pf~~~~~~~---~~~---~i~~~~~~~~~--p---~--~~~~s~~~~dli~~lL~-~~~~r~~r~~~ 299 (377)
T cd05629 234 LGAIMFECLIGWPPFCSENSHE---TYR---KIINWRETLYF--P---D--DIHLSVEAEDLIRRLIT-NAENRLGRGGA 299 (377)
T ss_pred cchhhhhhhcCCCCCCCCCHHH---HHH---HHHccCCccCC--C---C--CCCCCHHHHHHHHHHhc-CHhhcCCCCCH
Confidence 9999999999999997543211 111 11110000000 0 0 00112356688889997 66665 599
Q ss_pred HHHHH--HHHh
Q 002673 874 KEVVE--WLNN 882 (894)
Q Consensus 874 ~evl~--~L~~ 882 (894)
.++++ |+..
T Consensus 300 ~~~l~hp~~~~ 310 (377)
T cd05629 300 HEIKSHPFFRG 310 (377)
T ss_pred HHHhcCCCcCC
Confidence 99988 5543
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of |
| >cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-34 Score=316.08 Aligned_cols=261 Identities=27% Similarity=0.391 Sum_probs=204.8
Q ss_pred cCCCccceEeecCcEEEEEEEEc--------CCCeEEEEEEcCcc-hhhHHHHHHHHHHHHhc-CCCceeeecceeeecc
Q 002673 607 DNFSQANIIGCGGFGLVYKATLA--------NGTTLAIKKLSGDL-GLMEREFKAEVEALSTA-QHKNLVSLQGYCVHQG 676 (894)
Q Consensus 607 ~~f~~~~~LG~G~fg~Vy~a~~~--------~g~~vAvK~~~~~~-~~~~~~~~~Ei~~l~~l-~HpnIv~l~g~~~~~~ 676 (894)
++|.+.+.||+|+||.||+|... +...+|+|.+.... ......+..|+.+++.+ +||||+++++++..++
T Consensus 18 ~~~~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~ 97 (307)
T cd05098 18 DRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDG 97 (307)
T ss_pred HHeEEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCCCChHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecCC
Confidence 56889999999999999999742 23569999998643 23345688899999999 7999999999999999
Q ss_pred eEEEEEEeccCCCHHHHHhhhcC------------CCCCcCHHHHHHHHHHHHHHHHHHHhccCCCeeecCCCCCCeEEC
Q 002673 677 FRLLIYSYMENGSLDYWLHEKAD------------GASQLDWLTRLKIARGTSCGLAYMHQICEPHIVHRDIKSSNILLD 744 (894)
Q Consensus 677 ~~~lV~E~~~~gsL~~~l~~~~~------------~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDLkp~NILld 744 (894)
..++||||+++|+|.+++..... ....+++..++.++.|++.||+|||+ ++++||||||+||+++
T Consensus 98 ~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~---~gi~H~dlkp~Nill~ 174 (307)
T cd05098 98 PLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLAS---KKCIHRDLAARNVLVT 174 (307)
T ss_pred ceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHH---CCcccccccHHheEEc
Confidence 99999999999999999986432 12358999999999999999999997 5999999999999999
Q ss_pred CCCcEEEEEcccccccCCCCCc-ccccccccCCccCcccccCcCCCccccHHHHHHHHHHHHc-CCCCCCCCCcchhhhH
Q 002673 745 DQFEAHLADFGLSRLILPYQTH-VTTELVGTLGYIPPEYGQAWVATLRGDMYSFGVVMLELLT-GKRPVDVLKPKMSREL 822 (894)
Q Consensus 745 ~~~~vkl~DFGla~~~~~~~~~-~~~~~~gt~~Y~APE~~~~~~~s~ksDVwS~GvlL~ellt-G~~Pf~~~~~~~~~~~ 822 (894)
.++.+||+|||+++........ ......++..|+|||++.+..++.++|||||||++|||++ |+.||...... ..
T Consensus 175 ~~~~~kL~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~~g~~p~~~~~~~---~~ 251 (307)
T cd05098 175 EDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVE---EL 251 (307)
T ss_pred CCCcEEECCCcccccccccchhhccccCCCccceeChHHhccCCCCcHHHHHHHHHHHHHHHcCCCCCCCcCCHH---HH
Confidence 9999999999998765322111 1112234568999999998889999999999999999998 88998654321 11
Q ss_pred HHHHHHHhhcCCCCccccccccCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhcccc
Q 002673 823 VGWVLKMRSEGKQDQVFDPILRGKGFDEEMLQVLDVACMCVSQNPFKRPTVKEVVEWLNNVGAN 886 (894)
Q Consensus 823 ~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~i~~~ 886 (894)
.. .. ........ .......+.+++.+|++.+|++|||+.++++.|+++...
T Consensus 252 ~~---~~-~~~~~~~~---------~~~~~~~~~~li~~~l~~~p~~Rps~~evl~~l~~~~~~ 302 (307)
T cd05098 252 FK---LL-KEGHRMDK---------PSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILAL 302 (307)
T ss_pred HH---HH-HcCCCCCC---------CCcCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHHHH
Confidence 11 11 11111010 011223667899999999999999999999999987654
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-34 Score=305.81 Aligned_cols=255 Identities=26% Similarity=0.456 Sum_probs=202.4
Q ss_pred cCCCccceEeecCcEEEEEEEEc-CC---CeEEEEEEcCcc-hhhHHHHHHHHHHHHhcCCCceeeecceeeecceEEEE
Q 002673 607 DNFSQANIIGCGGFGLVYKATLA-NG---TTLAIKKLSGDL-GLMEREFKAEVEALSTAQHKNLVSLQGYCVHQGFRLLI 681 (894)
Q Consensus 607 ~~f~~~~~LG~G~fg~Vy~a~~~-~g---~~vAvK~~~~~~-~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~lV 681 (894)
++|+..+.||+|+||.||+|... ++ ..+|+|.+.... ....+.+..|++++++++|+|++++++++...+..++|
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 84 (268)
T cd05063 5 SHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNIIRLEGVVTKFKPAMII 84 (268)
T ss_pred HHceEeeEecCCCCccEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCCCeeEEEEEEccCCCcEEE
Confidence 46778899999999999999864 33 379999987543 33456788999999999999999999999999999999
Q ss_pred EEeccCCCHHHHHhhhcCCCCCcCHHHHHHHHHHHHHHHHHHHhccCCCeeecCCCCCCeEECCCCcEEEEEcccccccC
Q 002673 682 YSYMENGSLDYWLHEKADGASQLDWLTRLKIARGTSCGLAYMHQICEPHIVHRDIKSSNILLDDQFEAHLADFGLSRLIL 761 (894)
Q Consensus 682 ~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDLkp~NILld~~~~vkl~DFGla~~~~ 761 (894)
|||+++++|.+++.... ..+++..+..++.|++.|+.|||+ .+++||||||+||+++.++.+||+|||++....
T Consensus 85 ~e~~~~~~L~~~~~~~~---~~~~~~~~~~~~~~l~~al~~lH~---~~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~ 158 (268)
T cd05063 85 TEYMENGALDKYLRDHD---GEFSSYQLVGMLRGIAAGMKYLSD---MNYVHRDLAARNILVNSNLECKVSDFGLSRVLE 158 (268)
T ss_pred EEcCCCCCHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHH---CCeeccccchhhEEEcCCCcEEECCCccceecc
Confidence 99999999999997542 468999999999999999999997 599999999999999999999999999998664
Q ss_pred CCCCccc--ccccccCCccCcccccCcCCCccccHHHHHHHHHHHHc-CCCCCCCCCcchhhhHHHHHHHHhhcCCCCcc
Q 002673 762 PYQTHVT--TELVGTLGYIPPEYGQAWVATLRGDMYSFGVVMLELLT-GKRPVDVLKPKMSRELVGWVLKMRSEGKQDQV 838 (894)
Q Consensus 762 ~~~~~~~--~~~~gt~~Y~APE~~~~~~~s~ksDVwS~GvlL~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 838 (894)
....... .....+..|+|||++.+..++.++|||||||++|||++ |+.||...... ... ..+........
T Consensus 159 ~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~il~ell~~g~~p~~~~~~~---~~~---~~i~~~~~~~~- 231 (268)
T cd05063 159 DDPEGTYTTSGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSFGERPYWDMSNH---EVM---KAINDGFRLPA- 231 (268)
T ss_pred cccccceeccCCCcCceecCHHHhhcCCcChHhHHHHHHHHHHHHHhCCCCCCCcCCHH---HHH---HHHhcCCCCCC-
Confidence 3221111 11223457999999988889999999999999999997 99999754321 111 11111111110
Q ss_pred ccccccCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhc
Q 002673 839 FDPILRGKGFDEEMLQVLDVACMCVSQNPFKRPTVKEVVEWLNNV 883 (894)
Q Consensus 839 ~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~i 883 (894)
.......+.+++.+|++.+|++||++.++++.|+++
T Consensus 232 ---------~~~~~~~~~~li~~c~~~~p~~Rp~~~~i~~~l~~~ 267 (268)
T cd05063 232 ---------PMDCPSAVYQLMLQCWQQDRARRPRFVDIVNLLDKL 267 (268)
T ss_pred ---------CCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 011223577999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored |
| >cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-34 Score=310.48 Aligned_cols=261 Identities=22% Similarity=0.370 Sum_probs=205.1
Q ss_pred ccCCCccceEeecCcEEEEEEEE-cCCC----eEEEEEEcCcc-hhhHHHHHHHHHHHHhcCCCceeeecceeeecceEE
Q 002673 606 TDNFSQANIIGCGGFGLVYKATL-ANGT----TLAIKKLSGDL-GLMEREFKAEVEALSTAQHKNLVSLQGYCVHQGFRL 679 (894)
Q Consensus 606 ~~~f~~~~~LG~G~fg~Vy~a~~-~~g~----~vAvK~~~~~~-~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~ 679 (894)
.++|+..+.||+|+||.||+|.+ .++. .||+|++.... ......+.+|+.++..++|+||+++++++.. ...+
T Consensus 6 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~-~~~~ 84 (279)
T cd05109 6 ETELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCRLLGICLT-STVQ 84 (279)
T ss_pred hhheeeeeecCCCCCceEEEEEEecCCCccceEEEEEEecCCCCHHHHHHHHHHHHHHHhcCCCCCceEEEEEcC-CCcE
Confidence 35688889999999999999984 4554 48999987543 3345678899999999999999999999975 4578
Q ss_pred EEEEeccCCCHHHHHhhhcCCCCCcCHHHHHHHHHHHHHHHHHHHhccCCCeeecCCCCCCeEECCCCcEEEEEcccccc
Q 002673 680 LIYSYMENGSLDYWLHEKADGASQLDWLTRLKIARGTSCGLAYMHQICEPHIVHRDIKSSNILLDDQFEAHLADFGLSRL 759 (894)
Q Consensus 680 lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDLkp~NILld~~~~vkl~DFGla~~ 759 (894)
+++||+++|+|.++++... ..+++..++.++.|++.||.|||+ ++++||||||+|||+++++.+||+|||+++.
T Consensus 85 l~~~~~~~g~l~~~l~~~~---~~~~~~~~~~~~~qi~~~L~~lH~---~~iiH~dlkp~Nil~~~~~~~kL~dfG~~~~ 158 (279)
T cd05109 85 LVTQLMPYGCLLDYVRENK---DRIGSQDLLNWCVQIAKGMSYLEE---VRLVHRDLAARNVLVKSPNHVKITDFGLARL 158 (279)
T ss_pred EEEEcCCCCCHHHHHhhcc---CCCCHHHHHHHHHHHHHHHHHHHH---CCeeccccccceEEEcCCCcEEECCCCceee
Confidence 9999999999999997542 468899999999999999999997 6999999999999999999999999999987
Q ss_pred cCCCCCcc-cccccccCCccCcccccCcCCCccccHHHHHHHHHHHHc-CCCCCCCCCcchhhhHHHHHHHHhhcCCCCc
Q 002673 760 ILPYQTHV-TTELVGTLGYIPPEYGQAWVATLRGDMYSFGVVMLELLT-GKRPVDVLKPKMSRELVGWVLKMRSEGKQDQ 837 (894)
Q Consensus 760 ~~~~~~~~-~~~~~gt~~Y~APE~~~~~~~s~ksDVwS~GvlL~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 837 (894)
........ .....++..|+|||...+..++.++|||||||++|||++ |..||+..... ....+.. ......
T Consensus 159 ~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~---~~~~~~~----~~~~~~ 231 (279)
T cd05109 159 LDIDETEYHADGGKVPIKWMALESILHRRFTHQSDVWSYGVTVWELMTFGAKPYDGIPAR---EIPDLLE----KGERLP 231 (279)
T ss_pred cccccceeecCCCccchhhCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHH---HHHHHHH----CCCcCC
Confidence 64322211 112234678999999988899999999999999999998 99999754432 1222211 111110
Q ss_pred cccccccCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhccccccC
Q 002673 838 VFDPILRGKGFDEEMLQVLDVACMCVSQNPFKRPTVKEVVEWLNNVGANRRN 889 (894)
Q Consensus 838 ~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~i~~~~~~ 889 (894)
. . ......+.+++.+||+.||++||++.++++.|+.+....++
T Consensus 232 ~-~--------~~~~~~~~~li~~~l~~dp~~Rp~~~~l~~~l~~~~~~~~~ 274 (279)
T cd05109 232 Q-P--------PICTIDVYMIMVKCWMIDSECRPRFRELVDEFSRMARDPSR 274 (279)
T ss_pred C-C--------ccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhcCCcC
Confidence 0 0 11123567899999999999999999999999988766544
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve |
| >KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-36 Score=297.63 Aligned_cols=254 Identities=24% Similarity=0.340 Sum_probs=204.0
Q ss_pred ccCCCccceEeecCcEEEEEEE-EcCCCeEEEEEEcCcc--hhhHHHHHHHHHHHHhcCCCceeeecceeeecceEEEEE
Q 002673 606 TDNFSQANIIGCGGFGLVYKAT-LANGTTLAIKKLSGDL--GLMEREFKAEVEALSTAQHKNLVSLQGYCVHQGFRLLIY 682 (894)
Q Consensus 606 ~~~f~~~~~LG~G~fg~Vy~a~-~~~g~~vAvK~~~~~~--~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~lV~ 682 (894)
++.|++.+.||+|.|+.||+.. ..+|+.+|+|.+.... ...-+.+.+|+++-+.++|||||++...+.+....|||+
T Consensus 10 ~d~y~l~e~igkG~FSvVrRc~~~~tg~~fa~kiin~~k~~~~~~e~l~rEarIC~~LqHP~IvrL~~ti~~~~~~ylvF 89 (355)
T KOG0033|consen 10 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVF 89 (355)
T ss_pred chhhhHHHHHccCchHHHHHHHhccchHHHHHHHhhhhhhccccHHHHHHHHHHHHhcCCCcEeehhhhhcccceeEEEE
Confidence 4667888899999999999996 5689999999875422 334567899999999999999999999999999999999
Q ss_pred EeccCCCHHHHHhhhcCCCCCcCHHHHHHHHHHHHHHHHHHHhccCCCeeecCCCCCCeEECC---CCcEEEEEcccccc
Q 002673 683 SYMENGSLDYWLHEKADGASQLDWLTRLKIARGTSCGLAYMHQICEPHIVHRDIKSSNILLDD---QFEAHLADFGLSRL 759 (894)
Q Consensus 683 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDLkp~NILld~---~~~vkl~DFGla~~ 759 (894)
|+|.||+|..-+-.. -.++...+-+.++||+++|.|+|. ++|||||+||+|++|-+ ..-+||+|||++..
T Consensus 90 e~m~G~dl~~eIV~R----~~ySEa~aSH~~rQiLeal~yCH~---n~IvHRDvkP~nllLASK~~~A~vKL~~FGvAi~ 162 (355)
T KOG0033|consen 90 DLVTGGELFEDIVAR----EFYSEADASHCIQQILEALAYCHS---NGIVHRDLKPENLLLASKAKGAAVKLADFGLAIE 162 (355)
T ss_pred ecccchHHHHHHHHH----HHHHHHHHHHHHHHHHHHHHHHHh---cCceeccCChhheeeeeccCCCceeecccceEEE
Confidence 999999997655433 246777888999999999999997 79999999999999953 44599999999998
Q ss_pred cCCCCCcccccccccCCccCcccccCcCCCccccHHHHHHHHHHHHcCCCCCCCCCcchhhhHHHHHHHHhhcCCCCccc
Q 002673 760 ILPYQTHVTTELVGTLGYIPPEYGQAWVATLRGDMYSFGVVMLELLTGKRPVDVLKPKMSRELVGWVLKMRSEGKQDQVF 839 (894)
Q Consensus 760 ~~~~~~~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwS~GvlL~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 839 (894)
+. ........+|||+|||||++....|+..+|||+.|||||-|+.|.+||.+.... ++.+.+. . +..
T Consensus 163 l~--~g~~~~G~~GtP~fmaPEvvrkdpy~kpvDiW~cGViLfiLL~G~~PF~~~~~~---rlye~I~---~-g~y---- 229 (355)
T KOG0033|consen 163 VN--DGEAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQH---RLYEQIK---A-GAY---- 229 (355)
T ss_pred eC--CccccccccCCCcccCHHHhhcCCCCCcchhhhhhHHHHHHHhCCCCCCCccHH---HHHHHHh---c-ccc----
Confidence 86 344556688999999999999999999999999999999999999999753321 2222111 1 110
Q ss_pred cccccCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHH--HHH
Q 002673 840 DPILRGKGFDEEMLQVLDVACMCVSQNPFKRPTVKEVVE--WLN 881 (894)
Q Consensus 840 d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~--~L~ 881 (894)
| ..+..++.......+++.+|+..||.+|.|+.|.++ |+.
T Consensus 230 d--~~~~~w~~is~~Ak~LvrrML~~dP~kRIta~EAL~HpWi~ 271 (355)
T KOG0033|consen 230 D--YPSPEWDTVTPEAKSLIRRMLTVNPKKRITADEALKHPWIC 271 (355)
T ss_pred C--CCCcccCcCCHHHHHHHHHHhccChhhhccHHHHhCCchhc
Confidence 0 111223333445668899999999999999999997 664
|
|
| >cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-33 Score=301.52 Aligned_cols=249 Identities=26% Similarity=0.369 Sum_probs=202.4
Q ss_pred CCCccceEeecCcEEEEEEEE-cCCCeEEEEEEcCc--chhhHHHHHHHHHHHHhcCCCceeeecceeeecceEEEEEEe
Q 002673 608 NFSQANIIGCGGFGLVYKATL-ANGTTLAIKKLSGD--LGLMEREFKAEVEALSTAQHKNLVSLQGYCVHQGFRLLIYSY 684 (894)
Q Consensus 608 ~f~~~~~LG~G~fg~Vy~a~~-~~g~~vAvK~~~~~--~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~lV~E~ 684 (894)
+|+..+.||+|++|.||+|.. .+++.|++|.+... .......+.+|+++++.++|||++++++++..++..++||||
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd08529 1 DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRYYESFLDKGKLNIVMEY 80 (256)
T ss_pred CceEeEEecCCCCeEEEEEEEcCCCcEEEEEEeehhhCCHHHHHHHHHHHHHHHhcCCCCeehheeeeccCCEEEEEEEe
Confidence 467788999999999999985 47899999998643 233456788999999999999999999999999999999999
Q ss_pred ccCCCHHHHHhhhcCCCCCcCHHHHHHHHHHHHHHHHHHHhccCCCeeecCCCCCCeEECCCCcEEEEEcccccccCCCC
Q 002673 685 MENGSLDYWLHEKADGASQLDWLTRLKIARGTSCGLAYMHQICEPHIVHRDIKSSNILLDDQFEAHLADFGLSRLILPYQ 764 (894)
Q Consensus 685 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDLkp~NILld~~~~vkl~DFGla~~~~~~~ 764 (894)
+++++|.++++... ...+++..+..++.|++.||.|||+ ++++|+||||+||+++.++.++|+|||+++......
T Consensus 81 ~~~~~L~~~l~~~~--~~~~~~~~~~~i~~~l~~al~~lH~---~~i~h~dl~~~nili~~~~~~~l~df~~~~~~~~~~ 155 (256)
T cd08529 81 AENGDLHKLLKMQR--GRPLPEDQVWRFFIQILLGLAHLHS---KKILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNT 155 (256)
T ss_pred CCCCcHHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCcceEEEeCCCCEEEcccccceeccCcc
Confidence 99999999998642 3468899999999999999999997 599999999999999999999999999988664322
Q ss_pred CcccccccccCCccCcccccCcCCCccccHHHHHHHHHHHHcCCCCCCCCCcchhhhHHHHHHHHhhcCCCCcccccccc
Q 002673 765 THVTTELVGTLGYIPPEYGQAWVATLRGDMYSFGVVMLELLTGKRPVDVLKPKMSRELVGWVLKMRSEGKQDQVFDPILR 844 (894)
Q Consensus 765 ~~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwS~GvlL~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~ 844 (894)
. ......|++.|+|||+..+..++.++||||||+++|+|++|+.||...... .... ... .+....+.
T Consensus 156 ~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~---~~~~---~~~-~~~~~~~~----- 222 (256)
T cd08529 156 N-FANTIVGTPYYLSPELCEDKPYNEKSDVWALGVVLYECCTGKHPFDANNQG---ALIL---KII-RGVFPPVS----- 222 (256)
T ss_pred c-hhhccccCccccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCHH---HHHH---HHH-cCCCCCCc-----
Confidence 2 223346889999999999989999999999999999999999999754321 1111 111 11111110
Q ss_pred CCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 002673 845 GKGFDEEMLQVLDVACMCVSQNPFKRPTVKEVVE 878 (894)
Q Consensus 845 ~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~ 878 (894)
......+.+++.+|++.+|++||++.++++
T Consensus 223 ----~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~ 252 (256)
T cd08529 223 ----QMYSQQLAQLIDQCLTKDYRQRPDTFQLLR 252 (256)
T ss_pred ----cccCHHHHHHHHHHccCCcccCcCHHHHhh
Confidence 112346788999999999999999999986
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc |
| >cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-34 Score=305.79 Aligned_cols=255 Identities=24% Similarity=0.399 Sum_probs=204.3
Q ss_pred ccCCCccceEeecCcEEEEEEEEcCCCeEEEEEEcCcchhhHHHHHHHHHHHHhcCCCceeeecceeeecceEEEEEEec
Q 002673 606 TDNFSQANIIGCGGFGLVYKATLANGTTLAIKKLSGDLGLMEREFKAEVEALSTAQHKNLVSLQGYCVHQGFRLLIYSYM 685 (894)
Q Consensus 606 ~~~f~~~~~LG~G~fg~Vy~a~~~~g~~vAvK~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~lV~E~~ 685 (894)
.++|++.+.||+|+||.||+|...++..+|+|.+.... .....+.+|+.+++.++|+||+++++++.. ...+++|||+
T Consensus 5 ~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~iK~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~~v~e~~ 82 (260)
T cd05073 5 RESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGS-MSVEAFLAEANVMKTLQHDKLVKLHAVVTK-EPIYIITEFM 82 (260)
T ss_pred ccceeEEeEecCccceEEEEEEecCCccEEEEecCCCh-hHHHHHHHHHHHHHhcCCCCcceEEEEEcC-CCeEEEEEeC
Confidence 35788899999999999999998788889999887542 234678899999999999999999999887 7789999999
Q ss_pred cCCCHHHHHhhhcCCCCCcCHHHHHHHHHHHHHHHHHHHhccCCCeeecCCCCCCeEECCCCcEEEEEcccccccCCCCC
Q 002673 686 ENGSLDYWLHEKADGASQLDWLTRLKIARGTSCGLAYMHQICEPHIVHRDIKSSNILLDDQFEAHLADFGLSRLILPYQT 765 (894)
Q Consensus 686 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDLkp~NILld~~~~vkl~DFGla~~~~~~~~ 765 (894)
++|+|.+++.... ...+++..+..++.|++.||.|||+ .+++|+||||+||+++.++.+||+|||.+........
T Consensus 83 ~~~~L~~~~~~~~--~~~~~~~~~~~~~~~l~~aL~~lH~---~~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~ 157 (260)
T cd05073 83 AKGSLLDFLKSDE--GSKQPLPKLIDFSAQIAEGMAFIEQ---RNYIHRDLRAANILVSASLVCKIADFGLARVIEDNEY 157 (260)
T ss_pred CCCcHHHHHHhCC--ccccCHHHHHHHHHHHHHHHHHHHh---CCccccccCcceEEEcCCCcEEECCCcceeeccCCCc
Confidence 9999999997642 3467888999999999999999997 5999999999999999999999999999976543222
Q ss_pred cccccccccCCccCcccccCcCCCccccHHHHHHHHHHHHc-CCCCCCCCCcchhhhHHHHHHHHhhcCCCCcccccccc
Q 002673 766 HVTTELVGTLGYIPPEYGQAWVATLRGDMYSFGVVMLELLT-GKRPVDVLKPKMSRELVGWVLKMRSEGKQDQVFDPILR 844 (894)
Q Consensus 766 ~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwS~GvlL~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~ 844 (894)
.......++..|+|||++.+..++.++|+|||||++|+|++ |+.||...... ....+.. .......
T Consensus 158 ~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~---~~~~~~~----~~~~~~~------ 224 (260)
T cd05073 158 TAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNP---EVIRALE----RGYRMPR------ 224 (260)
T ss_pred ccccCCcccccccCHhHhccCCcCccccchHHHHHHHHHHhcCCCCCCCCCHH---HHHHHHh----CCCCCCC------
Confidence 22223345678999999998889999999999999999999 99999754321 1111111 1110000
Q ss_pred CCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhc
Q 002673 845 GKGFDEEMLQVLDVACMCVSQNPFKRPTVKEVVEWLNNV 883 (894)
Q Consensus 845 ~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~i 883 (894)
......++.+++.+|++.+|++||++.++.+.|+.+
T Consensus 225 ---~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~L~~~ 260 (260)
T cd05073 225 ---PENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDDF 260 (260)
T ss_pred ---cccCCHHHHHHHHHHcccCcccCcCHHHHHHHHhcC
Confidence 011234577899999999999999999999999753
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa |
| >cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-34 Score=303.95 Aligned_cols=250 Identities=27% Similarity=0.417 Sum_probs=204.0
Q ss_pred cCCCccceEeecCcEEEEEEEEcCCCeEEEEEEcCcchhhHHHHHHHHHHHHhcCCCceeeecceeeecceEEEEEEecc
Q 002673 607 DNFSQANIIGCGGFGLVYKATLANGTTLAIKKLSGDLGLMEREFKAEVEALSTAQHKNLVSLQGYCVHQGFRLLIYSYME 686 (894)
Q Consensus 607 ~~f~~~~~LG~G~fg~Vy~a~~~~g~~vAvK~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~lV~E~~~ 686 (894)
++|+..+.||+|+||.||+|... |+.||+|.+..... ..+.+.+|+.+++.++|+||+++++++...+..++||||++
T Consensus 6 ~~~~~~~~ig~g~~g~v~~~~~~-~~~v~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~ 83 (256)
T cd05039 6 KELKLGATIGKGEFGDVMLGDYR-GQKVAVKCLKDDST-AAQAFLAEASVMTTLRHPNLVQLLGVVLQGNPLYIVTEYMA 83 (256)
T ss_pred hhccceeeeecCCCceEEEEEec-CcEEEEEEeccchh-HHHHHHHHHHHHHhcCCcceeeeEEEEcCCCCeEEEEEecC
Confidence 46788899999999999999864 78999999987644 45678999999999999999999999998899999999999
Q ss_pred CCCHHHHHhhhcCCCCCcCHHHHHHHHHHHHHHHHHHHhccCCCeeecCCCCCCeEECCCCcEEEEEcccccccCCCCCc
Q 002673 687 NGSLDYWLHEKADGASQLDWLTRLKIARGTSCGLAYMHQICEPHIVHRDIKSSNILLDDQFEAHLADFGLSRLILPYQTH 766 (894)
Q Consensus 687 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDLkp~NILld~~~~vkl~DFGla~~~~~~~~~ 766 (894)
+++|.+++.... ...+++..+..++.|++.||.|||+ ++++|+||||+||+++.++.+||+|||.++......
T Consensus 84 ~~~L~~~~~~~~--~~~~~~~~~~~~~~qi~~~l~~lh~---~~i~H~di~p~Nili~~~~~~~l~d~g~~~~~~~~~-- 156 (256)
T cd05039 84 KGSLVDYLRSRG--RAVITLAQQLGFALDVCEGMEYLEE---KNFVHRDLAARNVLVSEDLVAKVSDFGLAKEASQGQ-- 156 (256)
T ss_pred CCcHHHHHHhcC--CCCCCHHHHHHHHHHHHHHHHHHHh---CCccchhcccceEEEeCCCCEEEccccccccccccc--
Confidence 999999997643 2368999999999999999999997 599999999999999999999999999998753211
Q ss_pred ccccccccCCccCcccccCcCCCccccHHHHHHHHHHHHc-CCCCCCCCCcchhhhHHHHHHHHhhcCCCCccccccccC
Q 002673 767 VTTELVGTLGYIPPEYGQAWVATLRGDMYSFGVVMLELLT-GKRPVDVLKPKMSRELVGWVLKMRSEGKQDQVFDPILRG 845 (894)
Q Consensus 767 ~~~~~~gt~~Y~APE~~~~~~~s~ksDVwS~GvlL~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~ 845 (894)
....++..|+|||++.+..++.++||||||+++|||++ |..||...... +...... ........
T Consensus 157 --~~~~~~~~~~ape~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~---~~~~~~~----~~~~~~~~------ 221 (256)
T cd05039 157 --DSGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLK---DVVPHVE----KGYRMEAP------ 221 (256)
T ss_pred --ccCCCcccccCchhhcCCcCCcHHHHHHHHHHHHHHHhcCCCCCCCCCHH---HHHHHHh----cCCCCCCc------
Confidence 12334668999999988889999999999999999997 99999754322 1111111 11000000
Q ss_pred CCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhc
Q 002673 846 KGFDEEMLQVLDVACMCVSQNPFKRPTVKEVVEWLNNV 883 (894)
Q Consensus 846 ~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~i 883 (894)
......+.+++.+|+..+|++|||++++++.|+++
T Consensus 222 ---~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~~ 256 (256)
T cd05039 222 ---EGCPPEVYKVMKDCWELDPAKRPTFKQLREQLALI 256 (256)
T ss_pred ---cCCCHHHHHHHHHHhccChhhCcCHHHHHHHHhcC
Confidence 11124577899999999999999999999999764
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk |
| >cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-34 Score=309.14 Aligned_cols=255 Identities=27% Similarity=0.372 Sum_probs=200.9
Q ss_pred CCccceEeecCcEEEEEEEE-cCCCeEEEEEEcCcch---hhHHHHHHHHHHHHhcCCCceeeecceeeecceEEEEEEe
Q 002673 609 FSQANIIGCGGFGLVYKATL-ANGTTLAIKKLSGDLG---LMEREFKAEVEALSTAQHKNLVSLQGYCVHQGFRLLIYSY 684 (894)
Q Consensus 609 f~~~~~LG~G~fg~Vy~a~~-~~g~~vAvK~~~~~~~---~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~lV~E~ 684 (894)
|+..+.||+|+||.||+|.. .+++.||+|.+..... .....+.+|++++++++|+|++++.+++..++..++||||
T Consensus 2 ~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~ 81 (285)
T cd05632 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAYAYETKDALCLVLTI 81 (285)
T ss_pred ceEEEEEecCCCeEEEEEEECCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCcCceeEEEEEecCCEEEEEEEe
Confidence 56678999999999999985 5789999999865421 2234577899999999999999999999999999999999
Q ss_pred ccCCCHHHHHhhhcCCCCCcCHHHHHHHHHHHHHHHHHHHhccCCCeeecCCCCCCeEECCCCcEEEEEcccccccCCCC
Q 002673 685 MENGSLDYWLHEKADGASQLDWLTRLKIARGTSCGLAYMHQICEPHIVHRDIKSSNILLDDQFEAHLADFGLSRLILPYQ 764 (894)
Q Consensus 685 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDLkp~NILld~~~~vkl~DFGla~~~~~~~ 764 (894)
+++|+|.+++.... ...+++..+..++.|++.||.|||+ ++|+||||||+||++++++.+||+|||++.......
T Consensus 82 ~~~~~L~~~~~~~~--~~~~~~~~~~~~~~ql~~~l~~lH~---~~iiH~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~ 156 (285)
T cd05632 82 MNGGDLKFHIYNMG--NPGFEEERALFYAAEILCGLEDLHR---ENTVYRDLKPENILLDDYGHIRISDLGLAVKIPEGE 156 (285)
T ss_pred ccCccHHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHh---CCeeecCCCHHHEEECCCCCEEEecCCcceecCCCC
Confidence 99999998887542 2468999999999999999999997 599999999999999999999999999987643221
Q ss_pred CcccccccccCCccCcccccCcCCCccccHHHHHHHHHHHHcCCCCCCCCCcchhhhHHHHHHHHhhcCCCCcccccccc
Q 002673 765 THVTTELVGTLGYIPPEYGQAWVATLRGDMYSFGVVMLELLTGKRPVDVLKPKMSRELVGWVLKMRSEGKQDQVFDPILR 844 (894)
Q Consensus 765 ~~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwS~GvlL~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~ 844 (894)
......|+..|+|||++.+..++.++|+||||+++|||++|+.||............ .... .... ..+.
T Consensus 157 --~~~~~~g~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~P~~~~~~~~~~~~~--~~~~-~~~~--~~~~---- 225 (285)
T cd05632 157 --SIRGRVGTVGYMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQSPFRGRKEKVKREEV--DRRV-LETE--EVYS---- 225 (285)
T ss_pred --cccCCCCCcCccChHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHH--HHhh-hccc--cccC----
Confidence 123457899999999999889999999999999999999999999754332111111 1111 1110 0111
Q ss_pred CCCChHHHHHHHHHHHHhcccCCCCCCC-----HHHHHH--HHHhc
Q 002673 845 GKGFDEEMLQVLDVACMCVSQNPFKRPT-----VKEVVE--WLNNV 883 (894)
Q Consensus 845 ~~~~~~~~~~l~~li~~Cl~~dP~~RPs-----~~evl~--~L~~i 883 (894)
.. ....+.+++..|++.||++||+ +.++++ ++..+
T Consensus 226 -~~---~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~~~~~~~~ 267 (285)
T cd05632 226 -AK---FSEEAKSICKMLLTKDPKQRLGCQEEGAGEVKRHPFFRNM 267 (285)
T ss_pred -cc---CCHHHHHHHHHHccCCHhHcCCCcccChHHHHcChhhhcC
Confidence 11 1224568889999999999999 778887 66555
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with |
| >cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-34 Score=318.28 Aligned_cols=246 Identities=24% Similarity=0.317 Sum_probs=194.2
Q ss_pred CCCccceEeecCcEEEEEEEE-cCCCeEEEEEEcCcch---hhHHHHHHHHHHHHhcCCC-ceeeecceeeecceEEEEE
Q 002673 608 NFSQANIIGCGGFGLVYKATL-ANGTTLAIKKLSGDLG---LMEREFKAEVEALSTAQHK-NLVSLQGYCVHQGFRLLIY 682 (894)
Q Consensus 608 ~f~~~~~LG~G~fg~Vy~a~~-~~g~~vAvK~~~~~~~---~~~~~~~~Ei~~l~~l~Hp-nIv~l~g~~~~~~~~~lV~ 682 (894)
+|++.+.||+|+||.||+|.. .+++.||+|++..... ...+.+..|.+++..++|+ +|+.+++++...+..++||
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (324)
T cd05587 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVM 80 (324)
T ss_pred CceEEEEEeeccCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCEEEEEE
Confidence 478889999999999999985 4578999999976431 2335677899999999765 6888999999899999999
Q ss_pred EeccCCCHHHHHhhhcCCCCCcCHHHHHHHHHHHHHHHHHHHhccCCCeeecCCCCCCeEECCCCcEEEEEcccccccCC
Q 002673 683 SYMENGSLDYWLHEKADGASQLDWLTRLKIARGTSCGLAYMHQICEPHIVHRDIKSSNILLDDQFEAHLADFGLSRLILP 762 (894)
Q Consensus 683 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDLkp~NILld~~~~vkl~DFGla~~~~~ 762 (894)
||+++|+|.+++... ..+++..+..++.||+.||.|||+ ++|+||||||+|||++.++.+||+|||++.....
T Consensus 81 E~~~~g~L~~~~~~~----~~~~~~~~~~~~~qi~~al~~lH~---~~ivH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~ 153 (324)
T cd05587 81 EYVNGGDLMYHIQQV----GKFKEPHAVFYAAEIAIGLFFLHS---KGIIYRDLKLDNVMLDAEGHIKIADFGMCKENIF 153 (324)
T ss_pred cCCCCCcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHH---CCeEecCCCHHHeEEcCCCCEEEeecCcceecCC
Confidence 999999999998754 357889999999999999999997 5999999999999999999999999999875321
Q ss_pred CCCcccccccccCCccCcccccCcCCCccccHHHHHHHHHHHHcCCCCCCCCCcchhhhHHHHHHHHhhcCCCCcccccc
Q 002673 763 YQTHVTTELVGTLGYIPPEYGQAWVATLRGDMYSFGVVMLELLTGKRPVDVLKPKMSRELVGWVLKMRSEGKQDQVFDPI 842 (894)
Q Consensus 763 ~~~~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwS~GvlL~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 842 (894)
. ........||+.|+|||++.+..++.++|||||||++|||++|+.||...... ...... . .... .
T Consensus 154 ~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~---~~~~~i---~-~~~~-~----- 219 (324)
T cd05587 154 G-GKTTRTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDED---ELFQSI---M-EHNV-S----- 219 (324)
T ss_pred C-CCceeeecCCccccChhhhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHH---HHHHHH---H-cCCC-C-----
Confidence 1 12233457899999999999999999999999999999999999999754321 111111 1 1110 0
Q ss_pred ccCCCChHHHHHHHHHHHHhcccCCCCCCCH-----HHHHH
Q 002673 843 LRGKGFDEEMLQVLDVACMCVSQNPFKRPTV-----KEVVE 878 (894)
Q Consensus 843 l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~-----~evl~ 878 (894)
+. .. ....+.+++.+|+..||.+|++. .++.+
T Consensus 220 ~~-~~---~~~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~ 256 (324)
T cd05587 220 YP-KS---LSKEAVSICKGLLTKHPAKRLGCGPTGERDIRE 256 (324)
T ss_pred CC-CC---CCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhc
Confidence 00 01 12356789999999999999986 56654
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory |
| >cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-34 Score=327.59 Aligned_cols=254 Identities=24% Similarity=0.288 Sum_probs=194.4
Q ss_pred CCCccceEeecCcEEEEEEEE-cCCCeEEEEEEcCcc---hhhHHHHHHHHHHHHhcCCCceeeecceeeecceEEEEEE
Q 002673 608 NFSQANIIGCGGFGLVYKATL-ANGTTLAIKKLSGDL---GLMEREFKAEVEALSTAQHKNLVSLQGYCVHQGFRLLIYS 683 (894)
Q Consensus 608 ~f~~~~~LG~G~fg~Vy~a~~-~~g~~vAvK~~~~~~---~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~lV~E 683 (894)
.|+..+.||+|+||.||+|.. .+++.||+|++.... ......+.+|+.+++.++||||+++++.+.+++..++|||
T Consensus 2 ~f~~~~~LG~G~~g~Vy~a~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~~~h~~iv~~~~~~~~~~~~~lv~E 81 (382)
T cd05625 2 MFVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVMD 81 (382)
T ss_pred CcEEEEEEEeCCCEEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhCCCCcCCeEEEEEEeCCEEEEEEe
Confidence 578889999999999999984 578899999997542 1233568899999999999999999999999999999999
Q ss_pred eccCCCHHHHHhhhcCCCCCcCHHHHHHHHHHHHHHHHHHHhccCCCeeecCCCCCCeEECCCCcEEEEEcccccccCCC
Q 002673 684 YMENGSLDYWLHEKADGASQLDWLTRLKIARGTSCGLAYMHQICEPHIVHRDIKSSNILLDDQFEAHLADFGLSRLILPY 763 (894)
Q Consensus 684 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDLkp~NILld~~~~vkl~DFGla~~~~~~ 763 (894)
|+++|+|.+++... ..++...+..++.||+.||.|||+ ++|+||||||+|||++.++.+||+|||++..+...
T Consensus 82 ~~~gg~L~~~l~~~----~~~~e~~~~~~~~qi~~al~~lH~---~~ivHrDlKp~NILl~~~g~~kL~DFGla~~~~~~ 154 (382)
T cd05625 82 YIPGGDMMSLLIRM----GIFPEDLARFYIAELTCAVESVHK---MGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWT 154 (382)
T ss_pred CCCCCcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEECCCCCEEEeECCCCcccccc
Confidence 99999999998754 347888889999999999999997 59999999999999999999999999997533100
Q ss_pred C----------------------------------------------CcccccccccCCccCcccccCcCCCccccHHHH
Q 002673 764 Q----------------------------------------------THVTTELVGTLGYIPPEYGQAWVATLRGDMYSF 797 (894)
Q Consensus 764 ~----------------------------------------------~~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwS~ 797 (894)
. .......+||+.|+|||++.+..++.++|||||
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSl 234 (382)
T cd05625 155 HDSKYYQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSV 234 (382)
T ss_pred ccccccccccccccccccccccccccccccccccccchhhhhccccccccccccccCcccCCHHHhcCCCCCCeeeEEec
Confidence 0 000123468999999999999999999999999
Q ss_pred HHHHHHHHcCCCCCCCCCcchhhhHHHHHHHHhhcCCCCccccccccCCCChHHHHHHHHHHHHhcccCCCCCCC---HH
Q 002673 798 GVVMLELLTGKRPVDVLKPKMSRELVGWVLKMRSEGKQDQVFDPILRGKGFDEEMLQVLDVACMCVSQNPFKRPT---VK 874 (894)
Q Consensus 798 GvlL~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs---~~ 874 (894)
||++|||++|+.||......... ............ + .....+ .+..+++.+|+ .+|.+|++ +.
T Consensus 235 Gvil~elltG~~Pf~~~~~~~~~------~~i~~~~~~~~~--p--~~~~~s---~~~~~li~~l~-~~p~~R~~~~~~~ 300 (382)
T cd05625 235 GVILYEMLVGQPPFLAQTPLETQ------MKVINWQTSLHI--P--PQAKLS---PEASDLIIKLC-RGPEDRLGKNGAD 300 (382)
T ss_pred hHHHHHHHhCCCCCCCCCHHHHH------HHHHccCCCcCC--C--CcccCC---HHHHHHHHHHc-cCHhHcCCCCCHH
Confidence 99999999999999754332111 111110000000 0 001112 23456666665 49999997 88
Q ss_pred HHHH--HHHh
Q 002673 875 EVVE--WLNN 882 (894)
Q Consensus 875 evl~--~L~~ 882 (894)
++++ ++..
T Consensus 301 ei~~hp~f~~ 310 (382)
T cd05625 301 EIKAHPFFKT 310 (382)
T ss_pred HHhcCCCcCC
Confidence 8876 5543
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an |
| >cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-34 Score=328.55 Aligned_cols=255 Identities=23% Similarity=0.264 Sum_probs=196.3
Q ss_pred cCCCccceEeecCcEEEEEEEE-cCCCeEEEEEEcCcch---hhHHHHHHHHHHHHhcCCCceeeecceeeecceEEEEE
Q 002673 607 DNFSQANIIGCGGFGLVYKATL-ANGTTLAIKKLSGDLG---LMEREFKAEVEALSTAQHKNLVSLQGYCVHQGFRLLIY 682 (894)
Q Consensus 607 ~~f~~~~~LG~G~fg~Vy~a~~-~~g~~vAvK~~~~~~~---~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~lV~ 682 (894)
++|++.+.||+|+||.||+|.. .+++.||||++..... .....+.+|+++++.++|+||+++++.+.+++..++||
T Consensus 1 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~ 80 (376)
T cd05598 1 SMFVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVM 80 (376)
T ss_pred CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEcHHHHHhhhhHHHHHHHHHHHHhCCCCCcceEEEEEEcCCEEEEEE
Confidence 3688899999999999999984 5689999999875321 22345788999999999999999999999999999999
Q ss_pred EeccCCCHHHHHhhhcCCCCCcCHHHHHHHHHHHHHHHHHHHhccCCCeeecCCCCCCeEECCCCcEEEEEcccccccCC
Q 002673 683 SYMENGSLDYWLHEKADGASQLDWLTRLKIARGTSCGLAYMHQICEPHIVHRDIKSSNILLDDQFEAHLADFGLSRLILP 762 (894)
Q Consensus 683 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDLkp~NILld~~~~vkl~DFGla~~~~~ 762 (894)
||+++|+|.+++... ..++...+..++.||+.||+|||+ ++|+||||||+|||++.++.+||+|||++..+..
T Consensus 81 E~~~~g~L~~~i~~~----~~~~~~~~~~~~~qi~~al~~lH~---~~ivHrDlkp~Nill~~~~~ikL~DFG~a~~~~~ 153 (376)
T cd05598 81 DYIPGGDMMSLLIRL----GIFEEDLARFYIAELTCAIESVHK---MGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRW 153 (376)
T ss_pred eCCCCCcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHH---CCeEeCCCCHHHEEECCCCCEEEEeCCCCccccc
Confidence 999999999999753 357888888999999999999997 5999999999999999999999999999853310
Q ss_pred CC------------------------------------------CcccccccccCCccCcccccCcCCCccccHHHHHHH
Q 002673 763 YQ------------------------------------------THVTTELVGTLGYIPPEYGQAWVATLRGDMYSFGVV 800 (894)
Q Consensus 763 ~~------------------------------------------~~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwS~Gvl 800 (894)
.. .......+||+.|+|||++.+..++.++|||||||+
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvi 233 (376)
T cd05598 154 THDSKYYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVI 233 (376)
T ss_pred cccccccccccccccccccccccccccccccccchhhhhhhhcccccccccCCCccccCHHHHcCCCCCcceeeeeccce
Confidence 00 000113479999999999999999999999999999
Q ss_pred HHHHHcCCCCCCCCCcchhhhHHHHHHHHhhcCCCCccccccccCCCChHHHHHHHHHHHHhcccCCCCCC---CHHHHH
Q 002673 801 MLELLTGKRPVDVLKPKMSRELVGWVLKMRSEGKQDQVFDPILRGKGFDEEMLQVLDVACMCVSQNPFKRP---TVKEVV 877 (894)
Q Consensus 801 L~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RP---s~~evl 877 (894)
+|||++|+.||.......... ........... +. .... ...+.+++.+|+ .+|.+|+ ++.+++
T Consensus 234 lyell~G~~Pf~~~~~~~~~~------~i~~~~~~~~~--~~--~~~~---s~~~~~li~~l~-~~p~~R~~~~t~~ell 299 (376)
T cd05598 234 LYEMLVGQPPFLADTPAETQL------KVINWETTLHI--PS--QAKL---SREASDLILRLC-CGAEDRLGKNGADEIK 299 (376)
T ss_pred eeehhhCCCCCCCCCHHHHHH------HHhccCccccC--CC--CCCC---CHHHHHHHHHHh-cCHhhcCCCCCHHHHh
Confidence 999999999997654321111 11100000000 00 0111 224456676765 4999999 899998
Q ss_pred H--HHHh
Q 002673 878 E--WLNN 882 (894)
Q Consensus 878 ~--~L~~ 882 (894)
+ |++.
T Consensus 300 ~h~~~~~ 306 (376)
T cd05598 300 AHPFFKG 306 (376)
T ss_pred CCCCcCC
Confidence 7 5554
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. |
| >cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-34 Score=318.04 Aligned_cols=245 Identities=24% Similarity=0.350 Sum_probs=193.8
Q ss_pred ceEeecCcEEEEEEEE-cCCCeEEEEEEcCcch---hhHHHHHHHHHHHHhc-CCCceeeecceeeecceEEEEEEeccC
Q 002673 613 NIIGCGGFGLVYKATL-ANGTTLAIKKLSGDLG---LMEREFKAEVEALSTA-QHKNLVSLQGYCVHQGFRLLIYSYMEN 687 (894)
Q Consensus 613 ~~LG~G~fg~Vy~a~~-~~g~~vAvK~~~~~~~---~~~~~~~~Ei~~l~~l-~HpnIv~l~g~~~~~~~~~lV~E~~~~ 687 (894)
+.||+|+||.||+|.. .+++.||||++..... .....+..|..++..+ +||||+++++++...+..++||||+++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~~iv~Ey~~~ 80 (320)
T cd05590 1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCFQTPDRLFFVMEFVNG 80 (320)
T ss_pred CeeeeCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhccCCCchhceeeEEEcCCEEEEEEcCCCC
Confidence 3699999999999985 4688999999975421 2234567788888876 699999999999999999999999999
Q ss_pred CCHHHHHhhhcCCCCCcCHHHHHHHHHHHHHHHHHHHhccCCCeeecCCCCCCeEECCCCcEEEEEcccccccCCCCCcc
Q 002673 688 GSLDYWLHEKADGASQLDWLTRLKIARGTSCGLAYMHQICEPHIVHRDIKSSNILLDDQFEAHLADFGLSRLILPYQTHV 767 (894)
Q Consensus 688 gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDLkp~NILld~~~~vkl~DFGla~~~~~~~~~~ 767 (894)
|+|.+++... ..+++..+..++.|++.||.|||+ ++|+||||||+|||++.++.+||+|||+++..... ...
T Consensus 81 g~L~~~i~~~----~~l~~~~~~~~~~ql~~~L~~lH~---~~ivH~dlkp~NIli~~~~~~kL~DfG~~~~~~~~-~~~ 152 (320)
T cd05590 81 GDLMFHIQKS----RRFDEARARFYAAEITSALMFLHD---KGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFN-GKT 152 (320)
T ss_pred chHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHH---CCeEeCCCCHHHeEECCCCcEEEeeCCCCeecCcC-CCc
Confidence 9999988754 358889999999999999999997 59999999999999999999999999998754221 122
Q ss_pred cccccccCCccCcccccCcCCCccccHHHHHHHHHHHHcCCCCCCCCCcchhhhHHHHHHHHhhcCCCCccccccccCCC
Q 002673 768 TTELVGTLGYIPPEYGQAWVATLRGDMYSFGVVMLELLTGKRPVDVLKPKMSRELVGWVLKMRSEGKQDQVFDPILRGKG 847 (894)
Q Consensus 768 ~~~~~gt~~Y~APE~~~~~~~s~ksDVwS~GvlL~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~ 847 (894)
.....||+.|+|||++.+..++.++|||||||++|||++|+.||...... .... .... .... +. ..
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~---~~~~---~i~~-~~~~--~~-----~~ 218 (320)
T cd05590 153 TSTFCGTPDYIAPEILQEMLYGPSVDWWAMGVLLYEMLCGHAPFEAENED---DLFE---AILN-DEVV--YP-----TW 218 (320)
T ss_pred ccccccCccccCHHHHcCCCCCCccchhhhHHHHHHHhhCCCCCCCCCHH---HHHH---HHhc-CCCC--CC-----CC
Confidence 33457999999999999999999999999999999999999999754322 1111 1111 1100 00 01
Q ss_pred ChHHHHHHHHHHHHhcccCCCCCCCH------HHHHH--HHHh
Q 002673 848 FDEEMLQVLDVACMCVSQNPFKRPTV------KEVVE--WLNN 882 (894)
Q Consensus 848 ~~~~~~~l~~li~~Cl~~dP~~RPs~------~evl~--~L~~ 882 (894)
....+.+++.+|++.||.+||++ +++++ |+..
T Consensus 219 ---~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~~~~h~~f~~ 258 (320)
T cd05590 219 ---LSQDAVDILKAFMTKNPTMRLGSLTLGGEEAILRHPFFKE 258 (320)
T ss_pred ---CCHHHHHHHHHHcccCHHHCCCCCCCCCHHHHHcCCCcCC
Confidence 12356789999999999999998 77766 5543
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal |
| >cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-34 Score=307.14 Aligned_cols=257 Identities=23% Similarity=0.345 Sum_probs=202.9
Q ss_pred cCCCccceEeecCcEEEEEEEEcC----CCeEEEEEEcCcc-hhhHHHHHHHHHHHHhcCCCceeeecceeeecceEEEE
Q 002673 607 DNFSQANIIGCGGFGLVYKATLAN----GTTLAIKKLSGDL-GLMEREFKAEVEALSTAQHKNLVSLQGYCVHQGFRLLI 681 (894)
Q Consensus 607 ~~f~~~~~LG~G~fg~Vy~a~~~~----g~~vAvK~~~~~~-~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~lV 681 (894)
++|...+.||+|+||.||+|...+ ...|+||...... ....+.+.+|+.++++++||||+++++++.. ...++|
T Consensus 6 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~-~~~~lv 84 (270)
T cd05056 6 EDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIVKLIGVITE-NPVWIV 84 (270)
T ss_pred hhceeeeeeCCccceeEEEEEEecCCCCCcceEEEecCCcCCHHHHHHHHHHHHHHHhCCCCchhceeEEEcC-CCcEEE
Confidence 457788999999999999998543 2468999987655 3445678999999999999999999998875 457899
Q ss_pred EEeccCCCHHHHHhhhcCCCCCcCHHHHHHHHHHHHHHHHHHHhccCCCeeecCCCCCCeEECCCCcEEEEEcccccccC
Q 002673 682 YSYMENGSLDYWLHEKADGASQLDWLTRLKIARGTSCGLAYMHQICEPHIVHRDIKSSNILLDDQFEAHLADFGLSRLIL 761 (894)
Q Consensus 682 ~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDLkp~NILld~~~~vkl~DFGla~~~~ 761 (894)
|||+++|+|.+++.... ..+++..++.++.|++.||.|||+ ++++|+||||+||+++.++.+||+|||+++...
T Consensus 85 ~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~~~l~~~l~~lH~---~~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~ 158 (270)
T cd05056 85 MELAPLGELRSYLQVNK---YSLDLASLILYSYQLSTALAYLES---KRFVHRDIAARNVLVSSPDCVKLGDFGLSRYLE 158 (270)
T ss_pred EEcCCCCcHHHHHHhCC---CCCCHHHHHHHHHHHHHHHHHHHh---CCeeccccChheEEEecCCCeEEccCceeeecc
Confidence 99999999999997542 358999999999999999999997 599999999999999999999999999998654
Q ss_pred CCCCcccccccccCCccCcccccCcCCCccccHHHHHHHHHHHHc-CCCCCCCCCcchhhhHHHHHHHHhhcCCCCcccc
Q 002673 762 PYQTHVTTELVGTLGYIPPEYGQAWVATLRGDMYSFGVVMLELLT-GKRPVDVLKPKMSRELVGWVLKMRSEGKQDQVFD 840 (894)
Q Consensus 762 ~~~~~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwS~GvlL~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 840 (894)
...........++..|+|||.+.+..++.++||||||+++|||++ |..||...... ....+. ....... .
T Consensus 159 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~---~~~~~~---~~~~~~~-~-- 229 (270)
T cd05056 159 DESYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMLGVKPFQGVKNN---DVIGRI---ENGERLP-M-- 229 (270)
T ss_pred cccceecCCCCccccccChhhhccCCCCchhhhHHHHHHHHHHHHcCCCCCCCCCHH---HHHHHH---HcCCcCC-C--
Confidence 332222222334568999999988889999999999999999996 99999754422 111111 1111110 0
Q ss_pred ccccCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhcccc
Q 002673 841 PILRGKGFDEEMLQVLDVACMCVSQNPFKRPTVKEVVEWLNNVGAN 886 (894)
Q Consensus 841 ~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~i~~~ 886 (894)
. .. ....+.+++.+|+..+|++|||+.++++.|+.+...
T Consensus 230 ---~-~~---~~~~~~~li~~~l~~~P~~Rpt~~~~~~~l~~~~~~ 268 (270)
T cd05056 230 ---P-PN---CPPTLYSLMTKCWAYDPSKRPRFTELKAQLSDILQE 268 (270)
T ss_pred ---C-CC---CCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhc
Confidence 0 11 123577889999999999999999999999987654
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions |
| >cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-34 Score=312.56 Aligned_cols=262 Identities=26% Similarity=0.412 Sum_probs=203.3
Q ss_pred cCCCccceEeecCcEEEEEEEE-cCCCeEEEEEEcCcch-hhHHHHHHHHHHHHhcCCCceeeecceeeecceEEEEEEe
Q 002673 607 DNFSQANIIGCGGFGLVYKATL-ANGTTLAIKKLSGDLG-LMEREFKAEVEALSTAQHKNLVSLQGYCVHQGFRLLIYSY 684 (894)
Q Consensus 607 ~~f~~~~~LG~G~fg~Vy~a~~-~~g~~vAvK~~~~~~~-~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~lV~E~ 684 (894)
++|++.+.||+|+||.||++.. .++..+|+|.+..... ....++.+|++++++++||||+++++++..++..++||||
T Consensus 1 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ey 80 (308)
T cd06615 1 DDFEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEIKPAIRNQIIRELKVLHECNSPYIVGFYGAFYSDGEISICMEH 80 (308)
T ss_pred CCceEEeeccCCCCeEEEEEEEcCCCeEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCEEEEEeec
Confidence 3688899999999999999984 4688899998875432 3345688999999999999999999999999999999999
Q ss_pred ccCCCHHHHHhhhcCCCCCcCHHHHHHHHHHHHHHHHHHHhccCCCeeecCCCCCCeEECCCCcEEEEEcccccccCCCC
Q 002673 685 MENGSLDYWLHEKADGASQLDWLTRLKIARGTSCGLAYMHQICEPHIVHRDIKSSNILLDDQFEAHLADFGLSRLILPYQ 764 (894)
Q Consensus 685 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDLkp~NILld~~~~vkl~DFGla~~~~~~~ 764 (894)
+++++|.++++.. ..+++..+..++.|++.||.|||+ ..+++|+||||+||+++.++.+||+|||++......
T Consensus 81 ~~~~~L~~~l~~~----~~~~~~~~~~~~~~i~~~l~~lH~--~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~- 153 (308)
T cd06615 81 MDGGSLDQVLKKA----GRIPENILGKISIAVLRGLTYLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS- 153 (308)
T ss_pred cCCCcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHh--hCCEEECCCChHHEEEecCCcEEEccCCCccccccc-
Confidence 9999999999754 357888899999999999999996 248999999999999999999999999998755321
Q ss_pred CcccccccccCCccCcccccCcCCCccccHHHHHHHHHHHHcCCCCCCCCCcchhhhHHHHHHHHhhcCCCC--------
Q 002673 765 THVTTELVGTLGYIPPEYGQAWVATLRGDMYSFGVVMLELLTGKRPVDVLKPKMSRELVGWVLKMRSEGKQD-------- 836 (894)
Q Consensus 765 ~~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwS~GvlL~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~-------- 836 (894)
......++..|+|||.+.+..++.++||||||+++|+|++|+.||....... ...+...........
T Consensus 154 --~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~ 228 (308)
T cd06615 154 --MANSFVGTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYPIPPPDAKE---LEAMFGRPVSEGEAKESHRPVSG 228 (308)
T ss_pred --ccccCCCCcCccChhHhcCCCCCccchHHHHHHHHHHHHhCCCCCCCcchhh---HHHhhcCccccccccCCcccccC
Confidence 1234578899999999988889999999999999999999999996432211 111110000000000
Q ss_pred ------------ccc-------cccccCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHH--HHHhc
Q 002673 837 ------------QVF-------DPILRGKGFDEEMLQVLDVACMCVSQNPFKRPTVKEVVE--WLNNV 883 (894)
Q Consensus 837 ------------~~~-------d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~--~L~~i 883 (894)
+.. .+.+... .....+.+++.+|++.+|++|||+.++++ |+...
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~~~~~~ 293 (308)
T cd06615 229 HPPDSPRPMAIFELLDYIVNEPPPKLPSG---AFSDEFQDFVDKCLKKNPKERADLKELTKHPFIKRA 293 (308)
T ss_pred CCCCccchhhHHHHHHHHhcCCCccCcCc---ccCHHHHHHHHHHccCChhhCcCHHHHhcChhhhhc
Confidence 000 0000000 12235789999999999999999999998 67654
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down |
| >cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-34 Score=324.90 Aligned_cols=261 Identities=23% Similarity=0.379 Sum_probs=203.6
Q ss_pred ccCCCccceEeecCcEEEEEEEEc------CCCeEEEEEEcCcchh-hHHHHHHHHHHHHhcC-CCceeeecceeeecce
Q 002673 606 TDNFSQANIIGCGGFGLVYKATLA------NGTTLAIKKLSGDLGL-MEREFKAEVEALSTAQ-HKNLVSLQGYCVHQGF 677 (894)
Q Consensus 606 ~~~f~~~~~LG~G~fg~Vy~a~~~------~g~~vAvK~~~~~~~~-~~~~~~~Ei~~l~~l~-HpnIv~l~g~~~~~~~ 677 (894)
.++|.+.+.||+|+||.||+|++. .+..||+|++...... ..+.+.+|++++.++. ||||++++++|...+.
T Consensus 36 ~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~~H~niv~~~~~~~~~~~ 115 (401)
T cd05107 36 RDNLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTARSSEKQALMSELKIMSHLGPHLNIVNLLGACTKGGP 115 (401)
T ss_pred HHHeehhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCCChhHHHHHHHHHHHHHhcCCCCCeEEEEEEEccCCC
Confidence 346778899999999999999853 3467999999765332 2356889999999997 9999999999999999
Q ss_pred EEEEEEeccCCCHHHHHhhhcC----------------------------------------------------------
Q 002673 678 RLLIYSYMENGSLDYWLHEKAD---------------------------------------------------------- 699 (894)
Q Consensus 678 ~~lV~E~~~~gsL~~~l~~~~~---------------------------------------------------------- 699 (894)
.++||||+++|+|.++++....
T Consensus 116 ~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 195 (401)
T cd05107 116 IYIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDESADYVPMQDM 195 (401)
T ss_pred cEEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCccccCccchhcc
Confidence 9999999999999999975321
Q ss_pred ------------------------------------CCCCcCHHHHHHHHHHHHHHHHHHHhccCCCeeecCCCCCCeEE
Q 002673 700 ------------------------------------GASQLDWLTRLKIARGTSCGLAYMHQICEPHIVHRDIKSSNILL 743 (894)
Q Consensus 700 ------------------------------------~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDLkp~NILl 743 (894)
....+++...+.++.|++.||.|||+ ++++||||||+|||+
T Consensus 196 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~---~~ivHrdlkp~NiLl 272 (401)
T cd05107 196 KGTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLAS---KNCVHRDLAARNVLI 272 (401)
T ss_pred hhhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhc---CCcCcccCCcceEEE
Confidence 11246788889999999999999996 699999999999999
Q ss_pred CCCCcEEEEEcccccccCCCCC-cccccccccCCccCcccccCcCCCccccHHHHHHHHHHHHc-CCCCCCCCCcchhhh
Q 002673 744 DDQFEAHLADFGLSRLILPYQT-HVTTELVGTLGYIPPEYGQAWVATLRGDMYSFGVVMLELLT-GKRPVDVLKPKMSRE 821 (894)
Q Consensus 744 d~~~~vkl~DFGla~~~~~~~~-~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwS~GvlL~ellt-G~~Pf~~~~~~~~~~ 821 (894)
++++.+||+|||+++....... .......++..|+|||.+.+..++.++|||||||++|||++ |..||........
T Consensus 273 ~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~e~l~~g~~P~~~~~~~~~-- 350 (401)
T cd05107 273 CEGKLVKICDFGLARDIMRDSNYISKGSTFLPLKWMAPESIFNNLYTTLSDVWSFGILLWEIFTLGGTPYPELPMNEQ-- 350 (401)
T ss_pred eCCCEEEEEecCcceecccccccccCCCcCCCCceeChHHhcCCCCCcHhHHHHHHHHHHHHHHcCCCCCCCCCchHH--
Confidence 9999999999999986532221 11223456788999999988889999999999999999998 8999975432111
Q ss_pred HHHHHHHHhhcCCCCccccccccCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhcc
Q 002673 822 LVGWVLKMRSEGKQDQVFDPILRGKGFDEEMLQVLDVACMCVSQNPFKRPTVKEVVEWLNNVG 884 (894)
Q Consensus 822 ~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~i~ 884 (894)
.. .....+.... .+ ......+.+++.+||..+|.+||++++|++.|+.+.
T Consensus 351 ~~----~~~~~~~~~~--~p-------~~~~~~l~~li~~cl~~~P~~RPs~~ell~~L~~~~ 400 (401)
T cd05107 351 FY----NAIKRGYRMA--KP-------AHASDEIYEIMQKCWEEKFEIRPDFSQLVHLVGDLL 400 (401)
T ss_pred HH----HHHHcCCCCC--CC-------CCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHh
Confidence 11 1111111000 00 111236778999999999999999999999998763
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D |
| >PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-34 Score=306.39 Aligned_cols=252 Identities=32% Similarity=0.458 Sum_probs=200.1
Q ss_pred CCccceEeecCcEEEEEEEEc-CCCeEEEEEEcCcchhhHH--HHHHHHHHHHhcCCCceeeecceeeecceEEEEEEec
Q 002673 609 FSQANIIGCGGFGLVYKATLA-NGTTLAIKKLSGDLGLMER--EFKAEVEALSTAQHKNLVSLQGYCVHQGFRLLIYSYM 685 (894)
Q Consensus 609 f~~~~~LG~G~fg~Vy~a~~~-~g~~vAvK~~~~~~~~~~~--~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~lV~E~~ 685 (894)
|+..+.||+|+||+||++... +++.||+|.+......... ...+|+.++++++||||+++++++......++||||+
T Consensus 1 y~~~~~lg~G~~g~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~v~~~~ 80 (260)
T PF00069_consen 1 YRLVKKLGSGGFGTVYKAKNKKNGQKVAVKIIDKSEIEEEEREENIREIKILRRLRHPNIVQILDVFQDDNYLYIVMEYC 80 (260)
T ss_dssp EEEEEEEEEESSEEEEEEEETTTTEEEEEEEEESTTHHHHHHHHHHHHHHHHHHHTBTTBCHEEEEEEESSEEEEEEEEE
T ss_pred CEEeEEEEeCCCEEEEEEEECCCCeEEEEEEeccccccccccchhhhhhhcccccccccccccccccccccccccccccc
Confidence 567789999999999999854 5668999999876533332 3456999999999999999999999999999999999
Q ss_pred cCCCHHHHHhhhcCCCCCcCHHHHHHHHHHHHHHHHHHHhccCCCeeecCCCCCCeEECCCCcEEEEEcccccccCCCCC
Q 002673 686 ENGSLDYWLHEKADGASQLDWLTRLKIARGTSCGLAYMHQICEPHIVHRDIKSSNILLDDQFEAHLADFGLSRLILPYQT 765 (894)
Q Consensus 686 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDLkp~NILld~~~~vkl~DFGla~~~~~~~~ 765 (894)
++++|.+++... ..+++..++.++.|+++||.|||+ .+++|+||||+||++++++.++|+|||.+... ....
T Consensus 81 ~~~~L~~~l~~~----~~~~~~~~~~~~~qi~~~L~~Lh~---~~i~H~dikp~NIl~~~~~~~~l~Dfg~~~~~-~~~~ 152 (260)
T PF00069_consen 81 PGGSLQDYLQKN----KPLSEEEILKIAYQILEALAYLHS---KGIVHRDIKPENILLDENGEVKLIDFGSSVKL-SENN 152 (260)
T ss_dssp TTEBHHHHHHHH----SSBBHHHHHHHHHHHHHHHHHHHH---TTEEESSBSGGGEEESTTSEEEESSGTTTEES-TSTT
T ss_pred cccccccccccc----cccccccccccccccccccccccc---cccccccccccccccccccccccccccccccc-cccc
Confidence 999999999833 458999999999999999999998 59999999999999999999999999999754 1222
Q ss_pred cccccccccCCccCccccc-CcCCCccccHHHHHHHHHHHHcCCCCCCCCCcchhhhHHHHHHHHhhcCCCCcccccccc
Q 002673 766 HVTTELVGTLGYIPPEYGQ-AWVATLRGDMYSFGVVMLELLTGKRPVDVLKPKMSRELVGWVLKMRSEGKQDQVFDPILR 844 (894)
Q Consensus 766 ~~~~~~~gt~~Y~APE~~~-~~~~s~ksDVwS~GvlL~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~ 844 (894)
.......++..|+|||++. +..++.++||||+|+++|+|++|+.||.........................
T Consensus 153 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~-------- 224 (260)
T PF00069_consen 153 ENFNPFVGTPEYMAPEVLQQGKKYTRKSDIWSLGIILYELLTGKLPFEESNSDDQLEIIEKILKRPLPSSSQ-------- 224 (260)
T ss_dssp SEBSSSSSSGGGSCHHHHTTTSSBSTHHHHHHHHHHHHHHHHSSSSSTTSSHHHHHHHHHHHHHTHHHHHTT--------
T ss_pred cccccccccccccccccccccccccccccccccccccccccccccccccccchhhhhhhhhccccccccccc--------
Confidence 3344567899999999998 8889999999999999999999999998652222222221111100000000
Q ss_pred CCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 002673 845 GKGFDEEMLQVLDVACMCVSQNPFKRPTVKEVVE 878 (894)
Q Consensus 845 ~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~ 878 (894)
........+.+++..|++.||++||++.++++
T Consensus 225 --~~~~~~~~l~~li~~~l~~~p~~R~~~~~l~~ 256 (260)
T PF00069_consen 225 --QSREKSEELRDLIKKMLSKDPEQRPSAEELLK 256 (260)
T ss_dssp --SHTTSHHHHHHHHHHHSSSSGGGSTTHHHHHT
T ss_pred --ccchhHHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 00001156889999999999999999999986
|
Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A .... |
| >cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-34 Score=316.42 Aligned_cols=271 Identities=20% Similarity=0.293 Sum_probs=201.9
Q ss_pred cCCCccceEeecCcEEEEEEEE-cCCCeEEEEEEcCcch-hhHHHHHHHHHHHHhcCCCceeeecceeeecceEEEEEEe
Q 002673 607 DNFSQANIIGCGGFGLVYKATL-ANGTTLAIKKLSGDLG-LMEREFKAEVEALSTAQHKNLVSLQGYCVHQGFRLLIYSY 684 (894)
Q Consensus 607 ~~f~~~~~LG~G~fg~Vy~a~~-~~g~~vAvK~~~~~~~-~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~lV~E~ 684 (894)
++|...+.||+|+||.||+|+. .+++.||+|.+..... .....+.+|+.++++++||||+++++++..++..++||||
T Consensus 6 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 85 (309)
T cd07872 6 ETYIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIVHTDKSLTLVFEY 85 (309)
T ss_pred CceEEEEEecccCCEEEEEEEecCCCCeEEEEEeeccccCCcchhHHHHHHHHHhCCCCCcceEEEEEeeCCeEEEEEeC
Confidence 5688899999999999999985 4678899999875432 2234577899999999999999999999999999999999
Q ss_pred ccCCCHHHHHhhhcCCCCCcCHHHHHHHHHHHHHHHHHHHhccCCCeeecCCCCCCeEECCCCcEEEEEcccccccCCCC
Q 002673 685 MENGSLDYWLHEKADGASQLDWLTRLKIARGTSCGLAYMHQICEPHIVHRDIKSSNILLDDQFEAHLADFGLSRLILPYQ 764 (894)
Q Consensus 685 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDLkp~NILld~~~~vkl~DFGla~~~~~~~ 764 (894)
+++ +|.+++.... ..+++..+..++.|++.||.|||+ ++|+||||||+||+++.++.+||+|||+++......
T Consensus 86 ~~~-~l~~~~~~~~---~~~~~~~~~~~~~qi~~aL~~lH~---~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~ 158 (309)
T cd07872 86 LDK-DLKQYMDDCG---NIMSMHNVKIFLYQILRGLAYCHR---RKVLHRDLKPQNLLINERGELKLADFGLARAKSVPT 158 (309)
T ss_pred CCC-CHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHEEECCCCCEEECccccceecCCCc
Confidence 975 8888876532 357888999999999999999997 599999999999999999999999999997643222
Q ss_pred CcccccccccCCccCcccccC-cCCCccccHHHHHHHHHHHHcCCCCCCCCCcchhhhHHHHHHHHhhcCCCC------c
Q 002673 765 THVTTELVGTLGYIPPEYGQA-WVATLRGDMYSFGVVMLELLTGKRPVDVLKPKMSRELVGWVLKMRSEGKQD------Q 837 (894)
Q Consensus 765 ~~~~~~~~gt~~Y~APE~~~~-~~~s~ksDVwS~GvlL~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~------~ 837 (894)
.......+|+.|+|||++.+ ..++.++|||||||++|+|++|+.||.......................+. .
T Consensus 159 -~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (309)
T cd07872 159 -KTYSNEVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVEDELHLIFRLLGTPTEETWPGISSNDE 237 (309)
T ss_pred -cccccccccccccCCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhhcchhh
Confidence 12233467899999998765 468899999999999999999999997543322111111000000000000 0
Q ss_pred ccc---ccccC----CCChHHHHHHHHHHHHhcccCCCCCCCHHHHHH--HHHhccc
Q 002673 838 VFD---PILRG----KGFDEEMLQVLDVACMCVSQNPFKRPTVKEVVE--WLNNVGA 885 (894)
Q Consensus 838 ~~d---~~l~~----~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~--~L~~i~~ 885 (894)
..+ +.... .........+.+++.+|++.||.+|||+.|+++ |++.+..
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h~~~~~~~~ 294 (309)
T cd07872 238 FKNYNFPKYKPQPLINHAPRLDTEGIELLTKFLQYESKKRISAEEAMKHAYFRSLGT 294 (309)
T ss_pred hhhhhcCccCCCchhhhccCCCHHHHHHHHHhccCChhhCCCHHHHhcChhhhhccc
Confidence 000 00000 000112235678999999999999999999998 8887654
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play |
| >cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-33 Score=308.34 Aligned_cols=255 Identities=27% Similarity=0.380 Sum_probs=201.0
Q ss_pred CCccceEeecCcEEEEEEEE-cCCCeEEEEEEcCcch---hhHHHHHHHHHHHHhcCCCceeeecceeeecceEEEEEEe
Q 002673 609 FSQANIIGCGGFGLVYKATL-ANGTTLAIKKLSGDLG---LMEREFKAEVEALSTAQHKNLVSLQGYCVHQGFRLLIYSY 684 (894)
Q Consensus 609 f~~~~~LG~G~fg~Vy~a~~-~~g~~vAvK~~~~~~~---~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~lV~E~ 684 (894)
|+..+.||+|+||.||++.. .+++.||+|.+..... .....+..|+.++++++|+|++.+++.+..++..++||||
T Consensus 2 f~~~~~ig~G~~g~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~ 81 (285)
T cd05630 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLTL 81 (285)
T ss_pred ceeeEEeecCCCeEEEEEEEcCCCceEEEEEEehhhccchHHHHHHHHHHHHHHhCCCCCeeeeeEEEecCCEEEEEEEe
Confidence 66778999999999999984 5789999999865321 2234577899999999999999999999999999999999
Q ss_pred ccCCCHHHHHhhhcCCCCCcCHHHHHHHHHHHHHHHHHHHhccCCCeeecCCCCCCeEECCCCcEEEEEcccccccCCCC
Q 002673 685 MENGSLDYWLHEKADGASQLDWLTRLKIARGTSCGLAYMHQICEPHIVHRDIKSSNILLDDQFEAHLADFGLSRLILPYQ 764 (894)
Q Consensus 685 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDLkp~NILld~~~~vkl~DFGla~~~~~~~ 764 (894)
+++|+|.+++.... ...+++..+..++.|++.||.|||+ ++|+||||||+||+++.++.++|+|||++.......
T Consensus 82 ~~g~~L~~~l~~~~--~~~l~~~~~~~~~~qi~~~l~~lH~---~~iiH~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~ 156 (285)
T cd05630 82 MNGGDLKFHIYHMG--EAGFEEGRAVFYAAEICCGLEDLHQ---ERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQ 156 (285)
T ss_pred cCCCcHHHHHHHhc--ccCCCHHHHHHHHHHHHHHHHHHHh---CCEEeCCCCHHHEEECCCCCEEEeeccceeecCCCc
Confidence 99999999986532 2458889999999999999999997 599999999999999999999999999987653222
Q ss_pred CcccccccccCCccCcccccCcCCCccccHHHHHHHHHHHHcCCCCCCCCCcchhhhHHHHHHHHhhcCCCCcccccccc
Q 002673 765 THVTTELVGTLGYIPPEYGQAWVATLRGDMYSFGVVMLELLTGKRPVDVLKPKMSRELVGWVLKMRSEGKQDQVFDPILR 844 (894)
Q Consensus 765 ~~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwS~GvlL~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~ 844 (894)
......|+..|+|||++.+..++.++||||||+++|+|++|+.||.................... .. ..
T Consensus 157 --~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~~~~~~~~~~~~~-----~~----~~ 225 (285)
T cd05630 157 --TIKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKEVQ-----EE----YS 225 (285)
T ss_pred --cccCCCCCccccChHHHcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCccchHHHHHhhhhhhh-----hh----cC
Confidence 12234789999999999998999999999999999999999999975432211111111100000 00 00
Q ss_pred CCCChHHHHHHHHHHHHhcccCCCCCCC-----HHHHHH--HHHhc
Q 002673 845 GKGFDEEMLQVLDVACMCVSQNPFKRPT-----VKEVVE--WLNNV 883 (894)
Q Consensus 845 ~~~~~~~~~~l~~li~~Cl~~dP~~RPs-----~~evl~--~L~~i 883 (894)
. .....+.+++..||+.||++||| ++++++ |+.+.
T Consensus 226 -~---~~~~~~~~li~~~l~~~p~~R~s~~~~~~~~~~~h~~~~~~ 267 (285)
T cd05630 226 -E---KFSPDARSLCKMLLCKDPKERLGCQGGGAREVKEHPLFKQI 267 (285)
T ss_pred -c---cCCHHHHHHHHHHhhcCHHHccCCCCCchHHHHcChhhhcc
Confidence 1 11234678899999999999999 899998 66543
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as |
| >cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-34 Score=307.41 Aligned_cols=255 Identities=24% Similarity=0.408 Sum_probs=202.5
Q ss_pred cCCCccceEeecCcEEEEEEEEc-C---CCeEEEEEEcCcc-hhhHHHHHHHHHHHHhcCCCceeeecceeeecceEEEE
Q 002673 607 DNFSQANIIGCGGFGLVYKATLA-N---GTTLAIKKLSGDL-GLMEREFKAEVEALSTAQHKNLVSLQGYCVHQGFRLLI 681 (894)
Q Consensus 607 ~~f~~~~~LG~G~fg~Vy~a~~~-~---g~~vAvK~~~~~~-~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~lV 681 (894)
.+|++.+.||+|+||.||+|... + +..+|+|.+.... ......+..|+.++++++||||+++++++..++..++|
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 83 (267)
T cd05066 4 SCIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSKPVMIV 83 (267)
T ss_pred HHeEeeeeecccCCCceEEEEEecCCCCceEEEEEECCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccEEE
Confidence 46788899999999999999853 2 3379999987543 33446789999999999999999999999999999999
Q ss_pred EEeccCCCHHHHHhhhcCCCCCcCHHHHHHHHHHHHHHHHHHHhccCCCeeecCCCCCCeEECCCCcEEEEEcccccccC
Q 002673 682 YSYMENGSLDYWLHEKADGASQLDWLTRLKIARGTSCGLAYMHQICEPHIVHRDIKSSNILLDDQFEAHLADFGLSRLIL 761 (894)
Q Consensus 682 ~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDLkp~NILld~~~~vkl~DFGla~~~~ 761 (894)
|||+++|+|.+++.... ..+++.+++.++.|++.||.|||+ ++++||||||+||+++.++.++++|||++....
T Consensus 84 ~e~~~~~~L~~~~~~~~---~~~~~~~~~~i~~~i~~~l~~lH~---~~i~h~dlkp~nili~~~~~~~l~dfg~~~~~~ 157 (267)
T cd05066 84 TEYMENGSLDAFLRKHD---GQFTVIQLVGMLRGIASGMKYLSD---MGYVHRDLAARNILVNSNLVCKVSDFGLSRVLE 157 (267)
T ss_pred EEcCCCCCHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHH---CCEeehhhchhcEEECCCCeEEeCCCCcccccc
Confidence 99999999999997643 458999999999999999999997 599999999999999999999999999998764
Q ss_pred CCCCccc--ccccccCCccCcccccCcCCCccccHHHHHHHHHHHHc-CCCCCCCCCcchhhhHHHHHHHHhhcCCCCcc
Q 002673 762 PYQTHVT--TELVGTLGYIPPEYGQAWVATLRGDMYSFGVVMLELLT-GKRPVDVLKPKMSRELVGWVLKMRSEGKQDQV 838 (894)
Q Consensus 762 ~~~~~~~--~~~~gt~~Y~APE~~~~~~~s~ksDVwS~GvlL~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 838 (894)
....... ....++..|+|||++.+..++.++||||||+++||+++ |+.||...... +...... ......
T Consensus 158 ~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~ell~~g~~p~~~~~~~---~~~~~~~---~~~~~~-- 229 (267)
T cd05066 158 DDPEAAYTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWEMSNQ---DVIKAIE---EGYRLP-- 229 (267)
T ss_pred cccceeeecCCCccceeecCHhHhccCccCchhhhHHHHHHHHHHhcCCCCCcccCCHH---HHHHHHh---CCCcCC--
Confidence 3222111 11223567999999998899999999999999999887 99999754322 1222111 111000
Q ss_pred ccccccCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhc
Q 002673 839 FDPILRGKGFDEEMLQVLDVACMCVSQNPFKRPTVKEVVEWLNNV 883 (894)
Q Consensus 839 ~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~i 883 (894)
. .......+.+++.+|++.+|.+||+|.++++.|+++
T Consensus 230 ---~-----~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~ 266 (267)
T cd05066 230 ---A-----PMDCPAALHQLMLDCWQKDRNERPKFEQIVSILDKL 266 (267)
T ss_pred ---C-----CCCCCHHHHHHHHHHcccCchhCCCHHHHHHHHHhh
Confidence 0 011123567899999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul |
| >cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-34 Score=311.35 Aligned_cols=255 Identities=24% Similarity=0.356 Sum_probs=205.0
Q ss_pred cCCCccceEeecCcEEEEEEEE-cCCCeEEEEEEcCcchhhHHHHHHHHHHHHhcCCCceeeecceeeecceEEEEEEec
Q 002673 607 DNFSQANIIGCGGFGLVYKATL-ANGTTLAIKKLSGDLGLMEREFKAEVEALSTAQHKNLVSLQGYCVHQGFRLLIYSYM 685 (894)
Q Consensus 607 ~~f~~~~~LG~G~fg~Vy~a~~-~~g~~vAvK~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~lV~E~~ 685 (894)
.+|+..+.||+|+||.||+|.. .++..|++|.+..........+.+|+.+++.++|+|++++++++..+...++||||+
T Consensus 20 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~v~~~~~~~~~~~~~~lv~e~~ 99 (296)
T cd06654 20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYL 99 (296)
T ss_pred cceeeEEEecCCCCeEEEEEEECCCCcEEEEEEEecCCcchHHHHHHHHHHHHhCCCCCEeeEEEEEEeCCEEEEeeccc
Confidence 5788889999999999999984 578999999987655445567889999999999999999999999999999999999
Q ss_pred cCCCHHHHHhhhcCCCCCcCHHHHHHHHHHHHHHHHHHHhccCCCeeecCCCCCCeEECCCCcEEEEEcccccccCCCCC
Q 002673 686 ENGSLDYWLHEKADGASQLDWLTRLKIARGTSCGLAYMHQICEPHIVHRDIKSSNILLDDQFEAHLADFGLSRLILPYQT 765 (894)
Q Consensus 686 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDLkp~NILld~~~~vkl~DFGla~~~~~~~~ 765 (894)
++++|.+++... .+++.++..++.|++.||.|||+ .+|+||||||+||+++.++.+||+|||++........
T Consensus 100 ~~~~L~~~~~~~-----~~~~~~~~~i~~ql~~aL~~LH~---~gi~H~dLkp~Nill~~~~~~kl~dfg~~~~~~~~~~ 171 (296)
T cd06654 100 AGGSLTDVVTET-----CMDEGQIAAVCRECLQALEFLHS---NQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS 171 (296)
T ss_pred CCCCHHHHHHhc-----CCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEEcCCCCEEECccccchhcccccc
Confidence 999999998642 47888999999999999999997 5999999999999999999999999999876533221
Q ss_pred cccccccccCCccCcccccCcCCCccccHHHHHHHHHHHHcCCCCCCCCCcchhhhHHHHHHHHhhcCCCCccccccccC
Q 002673 766 HVTTELVGTLGYIPPEYGQAWVATLRGDMYSFGVVMLELLTGKRPVDVLKPKMSRELVGWVLKMRSEGKQDQVFDPILRG 845 (894)
Q Consensus 766 ~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwS~GvlL~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~ 845 (894)
......+++.|+|||++.+..++.++|||||||++|+|++|+.||...... ..... ...... ....
T Consensus 172 -~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~~l~~g~~pf~~~~~~--~~~~~----~~~~~~-~~~~------ 237 (296)
T cd06654 172 -KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPL--RALYL----IATNGT-PELQ------ 237 (296)
T ss_pred -ccCcccCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCHH--HhHHH----HhcCCC-CCCC------
Confidence 123346889999999998888999999999999999999999999754321 11111 111110 0000
Q ss_pred CCChHHHHHHHHHHHHhcccCCCCCCCHHHHHH--HHHhcc
Q 002673 846 KGFDEEMLQVLDVACMCVSQNPFKRPTVKEVVE--WLNNVG 884 (894)
Q Consensus 846 ~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~--~L~~i~ 884 (894)
........+.+++.+|+..+|++||++.++++ |+...+
T Consensus 238 -~~~~~~~~l~~li~~~l~~~p~~Rpt~~eil~~~~~~~~~ 277 (296)
T cd06654 238 -NPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQHQFLKIAK 277 (296)
T ss_pred -CccccCHHHHHHHHHHCcCCcccCcCHHHHhhChhhhccC
Confidence 01122245778999999999999999999998 565443
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-34 Score=304.85 Aligned_cols=246 Identities=24% Similarity=0.393 Sum_probs=194.2
Q ss_pred eEeecCcEEEEEEEE---cCCCeEEEEEEcCcc--hhhHHHHHHHHHHHHhcCCCceeeecceeeecceEEEEEEeccCC
Q 002673 614 IIGCGGFGLVYKATL---ANGTTLAIKKLSGDL--GLMEREFKAEVEALSTAQHKNLVSLQGYCVHQGFRLLIYSYMENG 688 (894)
Q Consensus 614 ~LG~G~fg~Vy~a~~---~~g~~vAvK~~~~~~--~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~lV~E~~~~g 688 (894)
.||+|+||.||+|.+ .++..+|+|++.... ....+++..|+.+++.++||||+++++++. .+..++||||+++|
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-~~~~~lv~e~~~~~ 80 (257)
T cd05116 2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMIGICE-AESWMLVMELAELG 80 (257)
T ss_pred cCCCcCCcceEEeEEecCCCceEEEEEEccCCCCcHHHHHHHHHHHHHHHhCCCCCcceEEEEEc-CCCcEEEEecCCCC
Confidence 589999999999964 357889999986543 233467899999999999999999999885 45678999999999
Q ss_pred CHHHHHhhhcCCCCCcCHHHHHHHHHHHHHHHHHHHhccCCCeeecCCCCCCeEECCCCcEEEEEcccccccCCCCCcc-
Q 002673 689 SLDYWLHEKADGASQLDWLTRLKIARGTSCGLAYMHQICEPHIVHRDIKSSNILLDDQFEAHLADFGLSRLILPYQTHV- 767 (894)
Q Consensus 689 sL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDLkp~NILld~~~~vkl~DFGla~~~~~~~~~~- 767 (894)
+|.+++... ..+++..+..++.|++.||.|||+ ++++||||||+||+++.++.+||+|||++..........
T Consensus 81 ~L~~~l~~~----~~~~~~~~~~i~~qi~~al~~lH~---~~i~H~dlkp~nill~~~~~~kl~Dfg~~~~~~~~~~~~~ 153 (257)
T cd05116 81 PLNKFLQKN----KHVTEKNITELVHQVSMGMKYLEE---TNFVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYK 153 (257)
T ss_pred cHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHH---CCEeecccchhhEEEcCCCeEEECCCccccccCCCCCeee
Confidence 999999753 358889999999999999999997 599999999999999999999999999998764332211
Q ss_pred -cccccccCCccCcccccCcCCCccccHHHHHHHHHHHHc-CCCCCCCCCcchhhhHHHHHHHHhhcCCCCccccccccC
Q 002673 768 -TTELVGTLGYIPPEYGQAWVATLRGDMYSFGVVMLELLT-GKRPVDVLKPKMSRELVGWVLKMRSEGKQDQVFDPILRG 845 (894)
Q Consensus 768 -~~~~~gt~~Y~APE~~~~~~~s~ksDVwS~GvlL~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~ 845 (894)
.....++..|+|||.+.+..++.++|||||||++|||++ |+.||...... ..... . ..+..... .
T Consensus 154 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~---~~~~~---i-~~~~~~~~-----~- 220 (257)
T cd05116 154 AKTHGKWPVKWYAPECMNYYKFSSKSDVWSFGVLMWEAFSYGQKPYKGMKGN---EVTQM---I-ESGERMEC-----P- 220 (257)
T ss_pred ecCCCCCCccccCHhHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHH---HHHHH---H-HCCCCCCC-----C-
Confidence 122234578999999988889999999999999999998 99999754332 11111 1 11111111 0
Q ss_pred CCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhc
Q 002673 846 KGFDEEMLQVLDVACMCVSQNPFKRPTVKEVVEWLNNV 883 (894)
Q Consensus 846 ~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~i 883 (894)
.. ...++.+++.+||+.||++||++.+|++.|++.
T Consensus 221 ~~---~~~~l~~li~~~~~~~p~~Rp~~~~i~~~l~~~ 255 (257)
T cd05116 221 QR---CPPEMYDLMKLCWTYGVDERPGFAVVELRLRNY 255 (257)
T ss_pred CC---CCHHHHHHHHHHhccCchhCcCHHHHHHHHhcc
Confidence 11 123567899999999999999999999998763
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio |
| >PHA03209 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-33 Score=318.20 Aligned_cols=192 Identities=21% Similarity=0.315 Sum_probs=164.3
Q ss_pred hccCCCccceEeecCcEEEEEEEEc-CCCeEEEEEEcCcchhhHHHHHHHHHHHHhcCCCceeeecceeeecceEEEEEE
Q 002673 605 ATDNFSQANIIGCGGFGLVYKATLA-NGTTLAIKKLSGDLGLMEREFKAEVEALSTAQHKNLVSLQGYCVHQGFRLLIYS 683 (894)
Q Consensus 605 a~~~f~~~~~LG~G~fg~Vy~a~~~-~g~~vAvK~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~lV~E 683 (894)
...+|++.+.||+|+||.||+|... ++..||+|..... ....|+.++++++||||+++++++......++|+|
T Consensus 64 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~valK~~~~~------~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 137 (357)
T PHA03209 64 ASLGYTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQKG------TTLIEAMLLQNVNHPSVIRMKDTLVSGAITCMVLP 137 (357)
T ss_pred hhcCcEEEEEecCCCCeEEEEEEECCCCceEEEEeCCcc------ccHHHHHHHHhCCCCCCcChhheEEeCCeeEEEEE
Confidence 4467999999999999999999854 5778999975432 23568999999999999999999999999999999
Q ss_pred eccCCCHHHHHhhhcCCCCCcCHHHHHHHHHHHHHHHHHHHhccCCCeeecCCCCCCeEECCCCcEEEEEcccccccCCC
Q 002673 684 YMENGSLDYWLHEKADGASQLDWLTRLKIARGTSCGLAYMHQICEPHIVHRDIKSSNILLDDQFEAHLADFGLSRLILPY 763 (894)
Q Consensus 684 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDLkp~NILld~~~~vkl~DFGla~~~~~~ 763 (894)
|+. |+|.+++.... ..+++..+..|+.||+.||.|||+ ++|+||||||+|||++.++.+||+|||+++....
T Consensus 138 ~~~-~~l~~~l~~~~---~~~~~~~~~~i~~qi~~aL~~LH~---~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~- 209 (357)
T PHA03209 138 HYS-SDLYTYLTKRS---RPLPIDQALIIEKQILEGLRYLHA---QRIIHRDVKTENIFINDVDQVCIGDLGAAQFPVV- 209 (357)
T ss_pred ccC-CcHHHHHHhcc---CCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHEEECCCCCEEEecCcccccccc-
Confidence 994 68888886532 468999999999999999999997 5999999999999999999999999999975322
Q ss_pred CCcccccccccCCccCcccccCcCCCccccHHHHHHHHHHHHcCCCCC
Q 002673 764 QTHVTTELVGTLGYIPPEYGQAWVATLRGDMYSFGVVMLELLTGKRPV 811 (894)
Q Consensus 764 ~~~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwS~GvlL~elltG~~Pf 811 (894)
........||..|+|||++.+..++.++|||||||++|||+++..|+
T Consensus 210 -~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvvl~ell~~~~~~ 256 (357)
T PHA03209 210 -APAFLGLAGTVETNAPEVLARDKYNSKADIWSAGIVLFEMLAYPSTI 256 (357)
T ss_pred -CcccccccccccccCCeecCCCCCCchhhHHHHHHHHHHHHHcCCcc
Confidence 11223456899999999999999999999999999999999865554
|
|
| >cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-34 Score=317.77 Aligned_cols=241 Identities=24% Similarity=0.347 Sum_probs=192.3
Q ss_pred ceEeecCcEEEEEEEE-cCCCeEEEEEEcCcch---hhHHHHHHHHHHHHhc-CCCceeeecceeeecceEEEEEEeccC
Q 002673 613 NIIGCGGFGLVYKATL-ANGTTLAIKKLSGDLG---LMEREFKAEVEALSTA-QHKNLVSLQGYCVHQGFRLLIYSYMEN 687 (894)
Q Consensus 613 ~~LG~G~fg~Vy~a~~-~~g~~vAvK~~~~~~~---~~~~~~~~Ei~~l~~l-~HpnIv~l~g~~~~~~~~~lV~E~~~~ 687 (894)
++||+|+||.||+|.. .+++.||+|++..... .....+..|.+++..+ +||||+++++++..++..++||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~ 80 (321)
T cd05591 1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCCFQTKDRLFFVMEYVNG 80 (321)
T ss_pred CccccCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCeEEEEEeCCCC
Confidence 3699999999999985 4678999999976432 2234567788888866 799999999999999999999999999
Q ss_pred CCHHHHHhhhcCCCCCcCHHHHHHHHHHHHHHHHHHHhccCCCeeecCCCCCCeEECCCCcEEEEEcccccccCCCCCcc
Q 002673 688 GSLDYWLHEKADGASQLDWLTRLKIARGTSCGLAYMHQICEPHIVHRDIKSSNILLDDQFEAHLADFGLSRLILPYQTHV 767 (894)
Q Consensus 688 gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDLkp~NILld~~~~vkl~DFGla~~~~~~~~~~ 767 (894)
|+|..++... ..+++..+..++.|++.||.|||+ ++|+||||||+|||++.++.+||+|||++....... ..
T Consensus 81 ~~L~~~l~~~----~~~~~~~~~~~~~qi~~aL~~LH~---~~ivHrDikp~Nill~~~~~~kL~Dfg~~~~~~~~~-~~ 152 (321)
T cd05591 81 GDLMFQIQRS----RKFDEPRSRFYAAEVTLALMFLHR---HGVIYRDLKLDNILLDAEGHCKLADFGMCKEGILNG-VT 152 (321)
T ss_pred CcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHH---CCeeccCCCHHHeEECCCCCEEEeecccceecccCC-cc
Confidence 9999888754 358889999999999999999997 599999999999999999999999999987543222 22
Q ss_pred cccccccCCccCcccccCcCCCccccHHHHHHHHHHHHcCCCCCCCCCcchhhhHHHHHHHHhhcCCCCccccccccCCC
Q 002673 768 TTELVGTLGYIPPEYGQAWVATLRGDMYSFGVVMLELLTGKRPVDVLKPKMSRELVGWVLKMRSEGKQDQVFDPILRGKG 847 (894)
Q Consensus 768 ~~~~~gt~~Y~APE~~~~~~~s~ksDVwS~GvlL~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~ 847 (894)
.....||+.|+|||++.+..++.++|||||||++|||++|+.||...... .... ....... .+.. .
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~Pf~~~~~~---~~~~---~i~~~~~---~~p~-----~ 218 (321)
T cd05591 153 TTTFCGTPDYIAPEILQELEYGPSVDWWALGVLMYEMMAGQPPFEADNED---DLFE---SILHDDV---LYPV-----W 218 (321)
T ss_pred ccccccCccccCHHHHcCCCCCCccceechhHHHHHHhcCCCCCCCCCHH---HHHH---HHHcCCC---CCCC-----C
Confidence 33457899999999999989999999999999999999999999754322 1111 1111110 0000 1
Q ss_pred ChHHHHHHHHHHHHhcccCCCCCC-------CHHHHHH
Q 002673 848 FDEEMLQVLDVACMCVSQNPFKRP-------TVKEVVE 878 (894)
Q Consensus 848 ~~~~~~~l~~li~~Cl~~dP~~RP-------s~~evl~ 878 (894)
. ..++.+++..|++.||++|| +++++++
T Consensus 219 ~---~~~~~~ll~~~L~~dp~~R~~~~~~~~~~~~~~~ 253 (321)
T cd05591 219 L---SKEAVSILKAFMTKNPNKRLGCVASQGGEDAIKQ 253 (321)
T ss_pred C---CHHHHHHHHHHhccCHHHcCCCCCCCCCHHHHhc
Confidence 1 23567899999999999999 8888876
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to |
| >cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-34 Score=316.49 Aligned_cols=241 Identities=27% Similarity=0.370 Sum_probs=190.4
Q ss_pred ceEeecCcEEEEEEEE-cCCCeEEEEEEcCcch---hhHHHHHHHHHHHHhc-CCCceeeecceeeecceEEEEEEeccC
Q 002673 613 NIIGCGGFGLVYKATL-ANGTTLAIKKLSGDLG---LMEREFKAEVEALSTA-QHKNLVSLQGYCVHQGFRLLIYSYMEN 687 (894)
Q Consensus 613 ~~LG~G~fg~Vy~a~~-~~g~~vAvK~~~~~~~---~~~~~~~~Ei~~l~~l-~HpnIv~l~g~~~~~~~~~lV~E~~~~ 687 (894)
+.||+|+||.||+|.. .+++.||||++..... .....+..|..++... +||||+++++++.+.+..++||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~ey~~~ 80 (316)
T cd05619 1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQTKENLFFVMEYLNG 80 (316)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCcCcceEEEEEeCCEEEEEEeCCCC
Confidence 4699999999999985 4578999999976431 2234456677788764 899999999999999999999999999
Q ss_pred CCHHHHHhhhcCCCCCcCHHHHHHHHHHHHHHHHHHHhccCCCeeecCCCCCCeEECCCCcEEEEEcccccccCCCCCcc
Q 002673 688 GSLDYWLHEKADGASQLDWLTRLKIARGTSCGLAYMHQICEPHIVHRDIKSSNILLDDQFEAHLADFGLSRLILPYQTHV 767 (894)
Q Consensus 688 gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDLkp~NILld~~~~vkl~DFGla~~~~~~~~~~ 767 (894)
|+|.+++... ..+++..+..++.|++.||.|||+ ++|+||||||+|||++.++.+||+|||+++...... ..
T Consensus 81 g~L~~~l~~~----~~~~~~~~~~~~~qi~~al~~LH~---~~ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~~~~-~~ 152 (316)
T cd05619 81 GDLMFHIQSC----HKFDLPRATFYAAEIICGLQFLHS---KGIVYRDLKLDNILLDTDGHIKIADFGMCKENMLGD-AK 152 (316)
T ss_pred CcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHh---CCeEeCCCCHHHEEECCCCCEEEccCCcceECCCCC-Cc
Confidence 9999998753 357888999999999999999997 599999999999999999999999999987532211 12
Q ss_pred cccccccCCccCcccccCcCCCccccHHHHHHHHHHHHcCCCCCCCCCcchhhhHHHHHHHHhhcCCCCccccccccCCC
Q 002673 768 TTELVGTLGYIPPEYGQAWVATLRGDMYSFGVVMLELLTGKRPVDVLKPKMSRELVGWVLKMRSEGKQDQVFDPILRGKG 847 (894)
Q Consensus 768 ~~~~~gt~~Y~APE~~~~~~~s~ksDVwS~GvlL~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~ 847 (894)
.....||+.|+|||++.+..++.++|||||||++|||++|+.||...... ....... . ... .+.. .
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~---~~~~~i~---~-~~~--~~~~-----~ 218 (316)
T cd05619 153 TCTFCGTPDYIAPEILLGQKYNTSVDWWSFGVLLYEMLIGQSPFHGHDEE---ELFQSIR---M-DNP--CYPR-----W 218 (316)
T ss_pred eeeecCCccccCHHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCCCHH---HHHHHHH---h-CCC--CCCc-----c
Confidence 33457899999999999989999999999999999999999999754322 1111111 1 100 0111 1
Q ss_pred ChHHHHHHHHHHHHhcccCCCCCCCHH-HHHH
Q 002673 848 FDEEMLQVLDVACMCVSQNPFKRPTVK-EVVE 878 (894)
Q Consensus 848 ~~~~~~~l~~li~~Cl~~dP~~RPs~~-evl~ 878 (894)
. ...+.+++.+|++.||++||++. ++.+
T Consensus 219 ~---~~~~~~li~~~l~~~P~~R~~~~~~l~~ 247 (316)
T cd05619 219 L---TREAKDILVKLFVREPERRLGVKGDIRQ 247 (316)
T ss_pred C---CHHHHHHHHHHhccCHhhcCCChHHHHc
Confidence 1 23467889999999999999997 6654
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in |
| >cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-34 Score=311.69 Aligned_cols=256 Identities=23% Similarity=0.374 Sum_probs=200.5
Q ss_pred CCCccceEeecCcEEEEEEEEc------CCCeEEEEEEcCcchh-hHHHHHHHHHHHHhcCCCceeeecceeeecceEEE
Q 002673 608 NFSQANIIGCGGFGLVYKATLA------NGTTLAIKKLSGDLGL-MEREFKAEVEALSTAQHKNLVSLQGYCVHQGFRLL 680 (894)
Q Consensus 608 ~f~~~~~LG~G~fg~Vy~a~~~------~g~~vAvK~~~~~~~~-~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~l 680 (894)
+|...+.||+|+||.||+|... ++..||+|++...... ....+..|+.++..++||||+++++++......++
T Consensus 6 ~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~~ 85 (283)
T cd05091 6 TVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAMMRSRLQHPNIVCLLGVVTKEQPLSM 85 (283)
T ss_pred HHHHHHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEcCCCceEE
Confidence 4566788999999999999853 2478999999865432 34568899999999999999999999999999999
Q ss_pred EEEeccCCCHHHHHhhhcC------------CCCCcCHHHHHHHHHHHHHHHHHHHhccCCCeeecCCCCCCeEECCCCc
Q 002673 681 IYSYMENGSLDYWLHEKAD------------GASQLDWLTRLKIARGTSCGLAYMHQICEPHIVHRDIKSSNILLDDQFE 748 (894)
Q Consensus 681 V~E~~~~gsL~~~l~~~~~------------~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDLkp~NILld~~~~ 748 (894)
++||+.+++|.+++..... ....+++..+..++.|++.||.|||+ ++|+||||||+||++++++.
T Consensus 86 ~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH~---~gi~H~dlkp~Nil~~~~~~ 162 (283)
T cd05091 86 IFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSS---HHVVHKDLATRNVLVFDKLN 162 (283)
T ss_pred EEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHH---cCccccccchhheEecCCCc
Confidence 9999999999999863211 12357888899999999999999997 59999999999999999999
Q ss_pred EEEEEcccccccCCCCC-cccccccccCCccCcccccCcCCCccccHHHHHHHHHHHHc-CCCCCCCCCcchhhhHHHHH
Q 002673 749 AHLADFGLSRLILPYQT-HVTTELVGTLGYIPPEYGQAWVATLRGDMYSFGVVMLELLT-GKRPVDVLKPKMSRELVGWV 826 (894)
Q Consensus 749 vkl~DFGla~~~~~~~~-~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwS~GvlL~ellt-G~~Pf~~~~~~~~~~~~~~~ 826 (894)
+||+|||+++....... .......+++.|+|||.+.+..++.++|||||||++|||++ |..||...... +.....
T Consensus 163 ~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~---~~~~~i 239 (283)
T cd05091 163 VKISDLGLFREVYAADYYKLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQ---DVIEMI 239 (283)
T ss_pred eEecccccccccccchheeeccCccCCccccCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCHH---HHHHHH
Confidence 99999999886533221 11233456789999999988889999999999999999998 88888754322 122111
Q ss_pred HHHhhcCCCCccccccccCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHh
Q 002673 827 LKMRSEGKQDQVFDPILRGKGFDEEMLQVLDVACMCVSQNPFKRPTVKEVVEWLNN 882 (894)
Q Consensus 827 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~ 882 (894)
. ....... ...+ ...+.+++..|++.+|.+||++++|++.|+.
T Consensus 240 ---~-~~~~~~~------~~~~---~~~~~~li~~cl~~~p~~RP~~~~i~~~l~~ 282 (283)
T cd05091 240 ---R-NRQVLPC------PDDC---PAWVYTLMLECWNEFPSRRPRFKDIHSRLRT 282 (283)
T ss_pred ---H-cCCcCCC------CCCC---CHHHHHHHHHHhCCCcccCCCHHHHHHHhhC
Confidence 1 1111111 0112 2346789999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-34 Score=313.73 Aligned_cols=259 Identities=29% Similarity=0.448 Sum_probs=201.4
Q ss_pred cCCCccceEeecCcEEEEEEEEc-CCC--eEEEEEEcCcc-hhhHHHHHHHHHHHHhc-CCCceeeecceeeecceEEEE
Q 002673 607 DNFSQANIIGCGGFGLVYKATLA-NGT--TLAIKKLSGDL-GLMEREFKAEVEALSTA-QHKNLVSLQGYCVHQGFRLLI 681 (894)
Q Consensus 607 ~~f~~~~~LG~G~fg~Vy~a~~~-~g~--~vAvK~~~~~~-~~~~~~~~~Ei~~l~~l-~HpnIv~l~g~~~~~~~~~lV 681 (894)
++|++.+.||+|+||.||+|.+. ++. .+++|.+.... ......+.+|++++.++ +|+||+++++++..++..++|
T Consensus 7 ~~~~~~~~lg~G~~g~V~~a~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~~~~~~~~lv 86 (303)
T cd05088 7 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLA 86 (303)
T ss_pred hhceeeeeecCCCCceEEEEEEccCCceeeEEEEEecccCCHHHHHHHHHHHHHHHHhcCCCCcceEEEEECCCCCceEE
Confidence 57888899999999999999854 444 46788776432 33446788999999999 899999999999999999999
Q ss_pred EEeccCCCHHHHHhhhcC------------CCCCcCHHHHHHHHHHHHHHHHHHHhccCCCeeecCCCCCCeEECCCCcE
Q 002673 682 YSYMENGSLDYWLHEKAD------------GASQLDWLTRLKIARGTSCGLAYMHQICEPHIVHRDIKSSNILLDDQFEA 749 (894)
Q Consensus 682 ~E~~~~gsL~~~l~~~~~------------~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDLkp~NILld~~~~v 749 (894)
|||+++|+|.++++.... ....+++..++.++.|++.||+|||+ ++++||||||+|||++.++.+
T Consensus 87 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~---~gi~H~dlkp~Nili~~~~~~ 163 (303)
T cd05088 87 IEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQ---KQFIHRDLAARNILVGENYVA 163 (303)
T ss_pred EEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHHh---CCccccccchheEEecCCCcE
Confidence 999999999999975421 12358899999999999999999997 699999999999999999999
Q ss_pred EEEEcccccccCCCCCcccccccccCCccCcccccCcCCCccccHHHHHHHHHHHHc-CCCCCCCCCcchhhhHHHHHHH
Q 002673 750 HLADFGLSRLILPYQTHVTTELVGTLGYIPPEYGQAWVATLRGDMYSFGVVMLELLT-GKRPVDVLKPKMSRELVGWVLK 828 (894)
Q Consensus 750 kl~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwS~GvlL~ellt-G~~Pf~~~~~~~~~~~~~~~~~ 828 (894)
||+|||++....... ......++..|+|||++.+..++.++|||||||++|||+| |..||...... +... .
T Consensus 164 kl~dfg~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~---~~~~---~ 235 (303)
T cd05088 164 KIADFGLSRGQEVYV--KKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCA---ELYE---K 235 (303)
T ss_pred EeCccccCcccchhh--hcccCCCcccccCHHHHhccCCcccccchhhhhHHHHHHhcCCCCcccCChH---HHHH---H
Confidence 999999986431111 1111234567999999988889999999999999999998 99999754321 1111 1
Q ss_pred HhhcCCCCccccccccCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhcccc
Q 002673 829 MRSEGKQDQVFDPILRGKGFDEEMLQVLDVACMCVSQNPFKRPTVKEVVEWLNNVGAN 886 (894)
Q Consensus 829 ~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~i~~~ 886 (894)
......... . . .....+.+++.+|++.+|++||+++++++.|+++...
T Consensus 236 ~~~~~~~~~------~-~---~~~~~~~~li~~~l~~~p~~Rp~~~~il~~l~~~~~~ 283 (303)
T cd05088 236 LPQGYRLEK------P-L---NCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEE 283 (303)
T ss_pred HhcCCcCCC------C-C---CCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHh
Confidence 111101100 0 0 1123567899999999999999999999988876543
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A |
| >cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-34 Score=317.20 Aligned_cols=246 Identities=23% Similarity=0.307 Sum_probs=194.4
Q ss_pred CCCccceEeecCcEEEEEEEEc-CCCeEEEEEEcCcch---hhHHHHHHHHHHHHhc-CCCceeeecceeeecceEEEEE
Q 002673 608 NFSQANIIGCGGFGLVYKATLA-NGTTLAIKKLSGDLG---LMEREFKAEVEALSTA-QHKNLVSLQGYCVHQGFRLLIY 682 (894)
Q Consensus 608 ~f~~~~~LG~G~fg~Vy~a~~~-~g~~vAvK~~~~~~~---~~~~~~~~Ei~~l~~l-~HpnIv~l~g~~~~~~~~~lV~ 682 (894)
+|++.+.||+|+||.||+|... ++..||+|.+..... .....+..|..++..+ +|++|+++++++...+..++||
T Consensus 1 df~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (323)
T cd05616 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLHSCFQTMDRLYFVM 80 (323)
T ss_pred CceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCeEeeEEEEEecCCEEEEEE
Confidence 4778899999999999999854 678999999976432 1223466778888777 5899999999999999999999
Q ss_pred EeccCCCHHHHHhhhcCCCCCcCHHHHHHHHHHHHHHHHHHHhccCCCeeecCCCCCCeEECCCCcEEEEEcccccccCC
Q 002673 683 SYMENGSLDYWLHEKADGASQLDWLTRLKIARGTSCGLAYMHQICEPHIVHRDIKSSNILLDDQFEAHLADFGLSRLILP 762 (894)
Q Consensus 683 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDLkp~NILld~~~~vkl~DFGla~~~~~ 762 (894)
||+++|+|.+++... ..+++..+..++.|++.||.|||+ ++|+||||||+|||++.++.+||+|||+++....
T Consensus 81 E~~~~g~L~~~~~~~----~~~~~~~~~~~~~qi~~aL~~LH~---~~ivHrDlkp~Nill~~~~~~kL~DfG~~~~~~~ 153 (323)
T cd05616 81 EYVNGGDLMYQIQQV----GRFKEPHAVFYAAEIAIGLFFLHS---KGIIYRDLKLDNVMLDSEGHIKIADFGMCKENMW 153 (323)
T ss_pred cCCCCCCHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHH---CCEEecCCCHHHeEECCCCcEEEccCCCceecCC
Confidence 999999999988754 358889999999999999999997 5999999999999999999999999999875422
Q ss_pred CCCcccccccccCCccCcccccCcCCCccccHHHHHHHHHHHHcCCCCCCCCCcchhhhHHHHHHHHhhcCCCCcccccc
Q 002673 763 YQTHVTTELVGTLGYIPPEYGQAWVATLRGDMYSFGVVMLELLTGKRPVDVLKPKMSRELVGWVLKMRSEGKQDQVFDPI 842 (894)
Q Consensus 763 ~~~~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwS~GvlL~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 842 (894)
. ........||+.|+|||++.+..++.++|||||||++|||++|+.||...... ...... .. .... +.
T Consensus 154 ~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~---~~~~~i---~~-~~~~--~p-- 221 (323)
T cd05616 154 D-GVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDED---ELFQSI---ME-HNVA--YP-- 221 (323)
T ss_pred C-CCccccCCCChhhcCHHHhcCCCCCCccchhchhHHHHHHHhCCCCCCCCCHH---HHHHHH---Hh-CCCC--CC--
Confidence 1 12233467899999999999999999999999999999999999999754422 111111 11 1110 00
Q ss_pred ccCCCChHHHHHHHHHHHHhcccCCCCCCCH-----HHHHH
Q 002673 843 LRGKGFDEEMLQVLDVACMCVSQNPFKRPTV-----KEVVE 878 (894)
Q Consensus 843 l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~-----~evl~ 878 (894)
.....++.+++.+|++.||++|++. .++.+
T Consensus 222 ------~~~s~~~~~li~~~l~~~p~~R~~~~~~~~~~i~~ 256 (323)
T cd05616 222 ------KSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKE 256 (323)
T ss_pred ------CcCCHHHHHHHHHHcccCHHhcCCCCCCCHHHHhc
Confidence 1112356789999999999999984 56654
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and |
| >cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-34 Score=304.62 Aligned_cols=252 Identities=25% Similarity=0.453 Sum_probs=201.6
Q ss_pred cCCCccceEeecCcEEEEEEEEcCCCeEEEEEEcCcchhhHHHHHHHHHHHHhcCCCceeeecceeeecceEEEEEEecc
Q 002673 607 DNFSQANIIGCGGFGLVYKATLANGTTLAIKKLSGDLGLMEREFKAEVEALSTAQHKNLVSLQGYCVHQGFRLLIYSYME 686 (894)
Q Consensus 607 ~~f~~~~~LG~G~fg~Vy~a~~~~g~~vAvK~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~lV~E~~~ 686 (894)
.+|+..+.||+|+||.||+|.+.++..+|+|.+.... ....++.+|++++++++|||++++++++......++||||++
T Consensus 4 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~k~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~ 82 (256)
T cd05112 4 SELTLVQEIGSGQFGLVWLGYWLEKRKVAIKTIREGA-MSEEDFIEEAQVMMKLSHPKLVQLYGVCTERSPICLVFEFME 82 (256)
T ss_pred hHeEEEeeecCcccceEEEEEEeCCCeEEEEECCCCC-CCHHHHHHHHHHHHhCCCCCeeeEEEEEccCCceEEEEEcCC
Confidence 4677789999999999999988778899999887543 234578899999999999999999999999999999999999
Q ss_pred CCCHHHHHhhhcCCCCCcCHHHHHHHHHHHHHHHHHHHhccCCCeeecCCCCCCeEECCCCcEEEEEcccccccCCCCCc
Q 002673 687 NGSLDYWLHEKADGASQLDWLTRLKIARGTSCGLAYMHQICEPHIVHRDIKSSNILLDDQFEAHLADFGLSRLILPYQTH 766 (894)
Q Consensus 687 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDLkp~NILld~~~~vkl~DFGla~~~~~~~~~ 766 (894)
+|+|.+++.... ..+++..+..++.|++.|++|||+ .+++|+||||+||+++.++.+||+|||++.........
T Consensus 83 ~~~L~~~~~~~~---~~~~~~~~~~~~~~l~~~l~~lH~---~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~~ 156 (256)
T cd05112 83 HGCLSDYLRAQR---GKFSQETLLGMCLDVCEGMAYLES---SNVIHRDLAARNCLVGENQVVKVSDFGMTRFVLDDQYT 156 (256)
T ss_pred CCcHHHHHHhCc---cCCCHHHHHHHHHHHHHHHHHHHH---CCccccccccceEEEcCCCeEEECCCcceeecccCccc
Confidence 999999987542 357889999999999999999997 59999999999999999999999999998765332211
Q ss_pred ccccccccCCccCcccccCcCCCccccHHHHHHHHHHHHc-CCCCCCCCCcchhhhHHHHHHHHhhcCCCCccccccccC
Q 002673 767 VTTELVGTLGYIPPEYGQAWVATLRGDMYSFGVVMLELLT-GKRPVDVLKPKMSRELVGWVLKMRSEGKQDQVFDPILRG 845 (894)
Q Consensus 767 ~~~~~~gt~~Y~APE~~~~~~~s~ksDVwS~GvlL~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~ 845 (894)
......++.+|+|||++.+..++.++||||||+++|||++ |+.||...... .... ... .+. ....+.
T Consensus 157 ~~~~~~~~~~~~aPe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~---~~~~---~~~-~~~--~~~~~~--- 224 (256)
T cd05112 157 SSTGTKFPVKWSSPEVFSFSKYSSKSDVWSFGVLMWEVFSEGKTPYENRSNS---EVVE---TIN-AGF--RLYKPR--- 224 (256)
T ss_pred ccCCCccchhhcCHhHhccCCcChHHHHHHHHHHHHHHHcCCCCCCCcCCHH---HHHH---HHh-CCC--CCCCCC---
Confidence 1222335678999999998899999999999999999998 99999753321 1111 111 110 111111
Q ss_pred CCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 002673 846 KGFDEEMLQVLDVACMCVSQNPFKRPTVKEVVEWLN 881 (894)
Q Consensus 846 ~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~ 881 (894)
.. ...+.+++.+||+.+|++|||+.+++++|.
T Consensus 225 -~~---~~~~~~l~~~~l~~~p~~Rp~~~~~l~~l~ 256 (256)
T cd05112 225 -LA---SQSVYELMQHCWKERPEDRPSFSLLLHQLA 256 (256)
T ss_pred -CC---CHHHHHHHHHHcccChhhCCCHHHHHHhhC
Confidence 11 245778999999999999999999999873
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ |
| >cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-33 Score=302.55 Aligned_cols=248 Identities=23% Similarity=0.365 Sum_probs=196.1
Q ss_pred ceEeecCcEEEEEEEEc-C---CCeEEEEEEcCcch-hhHHHHHHHHHHHHhcCCCceeeecceeeecceEEEEEEeccC
Q 002673 613 NIIGCGGFGLVYKATLA-N---GTTLAIKKLSGDLG-LMEREFKAEVEALSTAQHKNLVSLQGYCVHQGFRLLIYSYMEN 687 (894)
Q Consensus 613 ~~LG~G~fg~Vy~a~~~-~---g~~vAvK~~~~~~~-~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~lV~E~~~~ 687 (894)
++||+|+||.||+|.+. . +..+|+|.+..... ...+++..|+.+++.+.|+||+++++++. .+..++||||+++
T Consensus 1 ~~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~v~e~~~~ 79 (257)
T cd05060 1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLIGVCK-GEPLMLVMELAPL 79 (257)
T ss_pred CccCccCceeEEEeEeeccCCCcceEEEEecccccchHHHHHHHHHHHHHHhcCCCCeeeEEEEEc-CCceEEEEEeCCC
Confidence 46999999999999743 2 26899999886543 34567899999999999999999999876 4567999999999
Q ss_pred CCHHHHHhhhcCCCCCcCHHHHHHHHHHHHHHHHHHHhccCCCeeecCCCCCCeEECCCCcEEEEEcccccccCCCCCcc
Q 002673 688 GSLDYWLHEKADGASQLDWLTRLKIARGTSCGLAYMHQICEPHIVHRDIKSSNILLDDQFEAHLADFGLSRLILPYQTHV 767 (894)
Q Consensus 688 gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDLkp~NILld~~~~vkl~DFGla~~~~~~~~~~ 767 (894)
|+|.+++.... .+++..+..++.|++.||.|||+ ++++|+||||+||+++.++.+||+|||+++.........
T Consensus 80 ~~L~~~l~~~~----~~~~~~~~~~~~qi~~~l~~lh~---~~i~H~di~p~nili~~~~~~kl~df~~~~~~~~~~~~~ 152 (257)
T cd05060 80 GPLLKYLKKRR----EIPVSDLKELAHQVAMGMAYLES---KHFVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYY 152 (257)
T ss_pred CcHHHHHHhCC----CCCHHHHHHHHHHHHHHHHHHhh---cCeeccCcccceEEEcCCCcEEeccccccceeecCCccc
Confidence 99999997542 58899999999999999999997 589999999999999999999999999998764332221
Q ss_pred cc--cccccCCccCcccccCcCCCccccHHHHHHHHHHHHc-CCCCCCCCCcchhhhHHHHHHHHhhcCCCCcccccccc
Q 002673 768 TT--ELVGTLGYIPPEYGQAWVATLRGDMYSFGVVMLELLT-GKRPVDVLKPKMSRELVGWVLKMRSEGKQDQVFDPILR 844 (894)
Q Consensus 768 ~~--~~~gt~~Y~APE~~~~~~~s~ksDVwS~GvlL~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~ 844 (894)
.. ...++..|+|||...+..++.++||||||+++|+|++ |+.||..... .....+... .... ..
T Consensus 153 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~~g~~p~~~~~~---~~~~~~~~~---~~~~-~~------ 219 (257)
T cd05060 153 RATTAGRWPLKWYAPECINYGKFSSKSDVWSYGVTLWEAFSYGAKPYGEMKG---AEVIAMLES---GERL-PR------ 219 (257)
T ss_pred ccccCccccccccCHHHhcCCCCCccchHHHHHHHHHHHHcCCCCCcccCCH---HHHHHHHHc---CCcC-CC------
Confidence 11 1223467999999998899999999999999999998 9999975432 222222211 1110 00
Q ss_pred CCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhcc
Q 002673 845 GKGFDEEMLQVLDVACMCVSQNPFKRPTVKEVVEWLNNVG 884 (894)
Q Consensus 845 ~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~i~ 884 (894)
.. .....+.+++.+|++.+|++||++.++++.|+.+.
T Consensus 220 ~~---~~~~~l~~li~~cl~~~p~~Rp~~~~l~~~l~~~~ 256 (257)
T cd05060 220 PE---ECPQEIYSIMLSCWKYRPEDRPTFSELESTFRRDP 256 (257)
T ss_pred CC---CCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHhcc
Confidence 01 11235778999999999999999999999998763
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi |
| >cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-33 Score=303.75 Aligned_cols=247 Identities=23% Similarity=0.375 Sum_probs=193.6
Q ss_pred eEeecCcEEEEEEEEc---CCCeEEEEEEcCcch-hhHHHHHHHHHHHHhcCCCceeeecceeeecceEEEEEEeccCCC
Q 002673 614 IIGCGGFGLVYKATLA---NGTTLAIKKLSGDLG-LMEREFKAEVEALSTAQHKNLVSLQGYCVHQGFRLLIYSYMENGS 689 (894)
Q Consensus 614 ~LG~G~fg~Vy~a~~~---~g~~vAvK~~~~~~~-~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~lV~E~~~~gs 689 (894)
.||+|+||.||+|.+. ++..||+|++..... ...+.+.+|+.++++++||||+++++++. ....++||||+++|+
T Consensus 2 ~ig~G~~g~v~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~-~~~~~lv~e~~~~~~ 80 (257)
T cd05115 2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMIGVCE-AEALMLVMEMASGGP 80 (257)
T ss_pred ccCCCCcccEEEEEEecCCCceeEEEEEcccccChHHHHHHHHHHHHHHhcCCCCeEEEEEEEc-CCCeEEEEEeCCCCC
Confidence 3899999999999753 355799999876533 33456899999999999999999999886 456899999999999
Q ss_pred HHHHHhhhcCCCCCcCHHHHHHHHHHHHHHHHHHHhccCCCeeecCCCCCCeEECCCCcEEEEEcccccccCCCCCccc-
Q 002673 690 LDYWLHEKADGASQLDWLTRLKIARGTSCGLAYMHQICEPHIVHRDIKSSNILLDDQFEAHLADFGLSRLILPYQTHVT- 768 (894)
Q Consensus 690 L~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDLkp~NILld~~~~vkl~DFGla~~~~~~~~~~~- 768 (894)
|.+++.... ..+++..++.++.|++.||.|||+ ++++||||||+||+++.++.+||+|||++...........
T Consensus 81 L~~~l~~~~---~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~ 154 (257)
T cd05115 81 LNKFLSGKK---DEITVSNVVELMHQVSMGMKYLEG---KNFVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKA 154 (257)
T ss_pred HHHHHHhCC---CCCCHHHHHHHHHHHHHHHHHHHh---cCeeecccchheEEEcCCCcEEeccCCccccccCCccceec
Confidence 999987532 468999999999999999999997 5999999999999999999999999999986533222111
Q ss_pred -ccccccCCccCcccccCcCCCccccHHHHHHHHHHHHc-CCCCCCCCCcchhhhHHHHHHHHhhcCCCCccccccccCC
Q 002673 769 -TELVGTLGYIPPEYGQAWVATLRGDMYSFGVVMLELLT-GKRPVDVLKPKMSRELVGWVLKMRSEGKQDQVFDPILRGK 846 (894)
Q Consensus 769 -~~~~gt~~Y~APE~~~~~~~s~ksDVwS~GvlL~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~ 846 (894)
....++..|+|||+..+..++.++|||||||++|||++ |..||....... ....+ ..+.... .+
T Consensus 155 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~---~~~~~----~~~~~~~-~~------ 220 (257)
T cd05115 155 RSAGKWPLKWYAPECINFRKFSSRSDVWSYGITMWEAFSYGQKPYKKMKGPE---VMSFI----EQGKRLD-CP------ 220 (257)
T ss_pred cCCCCCCcccCCHHHHccCCCCchhhHHHHHHHHHHHhcCCCCCcCcCCHHH---HHHHH----HCCCCCC-CC------
Confidence 11223568999999988889999999999999999996 999997654321 11111 1111111 11
Q ss_pred CChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhc
Q 002673 847 GFDEEMLQVLDVACMCVSQNPFKRPTVKEVVEWLNNV 883 (894)
Q Consensus 847 ~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~i 883 (894)
.....++.+++.+||..+|++||++.+|.+.|+.+
T Consensus 221 --~~~~~~l~~li~~c~~~~~~~Rp~~~~i~~~l~~~ 255 (257)
T cd05115 221 --AECPPEMYALMKDCWIYKWEDRPNFAKVEERMRTY 255 (257)
T ss_pred --CCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHhhh
Confidence 11124567899999999999999999999988764
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho |
| >cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-34 Score=312.00 Aligned_cols=257 Identities=26% Similarity=0.418 Sum_probs=203.3
Q ss_pred cCCCccceEeecCcEEEEEEEEc------CCCeEEEEEEcCcc-hhhHHHHHHHHHHHHhc-CCCceeeecceeeecceE
Q 002673 607 DNFSQANIIGCGGFGLVYKATLA------NGTTLAIKKLSGDL-GLMEREFKAEVEALSTA-QHKNLVSLQGYCVHQGFR 678 (894)
Q Consensus 607 ~~f~~~~~LG~G~fg~Vy~a~~~------~g~~vAvK~~~~~~-~~~~~~~~~Ei~~l~~l-~HpnIv~l~g~~~~~~~~ 678 (894)
++|...+.||+|+||.||+|... ++..||+|++.... ......+.+|+.+++++ +||||+++++++...+..
T Consensus 35 ~~~~~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~ 114 (302)
T cd05055 35 NNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLGNHENIVNLLGACTIGGPI 114 (302)
T ss_pred HHeEEcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccCChHHHHHHHHHHHHHHhccCCCCcceEEEEEecCCce
Confidence 56888999999999999999741 34579999987543 23345788999999999 799999999999999999
Q ss_pred EEEEEeccCCCHHHHHhhhcCCCCCcCHHHHHHHHHHHHHHHHHHHhccCCCeeecCCCCCCeEECCCCcEEEEEccccc
Q 002673 679 LLIYSYMENGSLDYWLHEKADGASQLDWLTRLKIARGTSCGLAYMHQICEPHIVHRDIKSSNILLDDQFEAHLADFGLSR 758 (894)
Q Consensus 679 ~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDLkp~NILld~~~~vkl~DFGla~ 758 (894)
++||||+.+|+|.++++.... ..+++.++..++.|++.||.|||+ ++++|+||||+||+++.++.++++|||+++
T Consensus 115 ~lv~e~~~~~~L~~~i~~~~~--~~l~~~~~~~i~~~i~~~l~~lH~---~~ivH~dlkp~Nil~~~~~~~~l~dfg~~~ 189 (302)
T cd05055 115 LVITEYCCYGDLLNFLRRKRE--SFLTLEDLLSFSYQVAKGMAFLAS---KNCIHRDLAARNVLLTHGKIVKICDFGLAR 189 (302)
T ss_pred EEEEEcCCCCcHHHHHHhCCC--CCCCHHHHHHHHHHHHHHHHHHHH---CCeehhhhccceEEEcCCCeEEECCCcccc
Confidence 999999999999999975432 338999999999999999999997 599999999999999999999999999998
Q ss_pred ccCCCCCc-ccccccccCCccCcccccCcCCCccccHHHHHHHHHHHHc-CCCCCCCCCcchhhhHHHHHHHHhhcCCCC
Q 002673 759 LILPYQTH-VTTELVGTLGYIPPEYGQAWVATLRGDMYSFGVVMLELLT-GKRPVDVLKPKMSRELVGWVLKMRSEGKQD 836 (894)
Q Consensus 759 ~~~~~~~~-~~~~~~gt~~Y~APE~~~~~~~s~ksDVwS~GvlL~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~ 836 (894)
........ ......++..|+|||.+.+..++.++|||||||++|||++ |+.||....... ..... ...+...
T Consensus 190 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~t~g~~p~~~~~~~~--~~~~~----~~~~~~~ 263 (302)
T cd05055 190 DIMNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSNPYPGMPVDS--KFYKL----IKEGYRM 263 (302)
T ss_pred cccCCCceeecCCCCcccccCCHhhhccCCCCcHhHHHHHHHHHHHHHhCCCCCcCCCCchH--HHHHH----HHcCCcC
Confidence 65432211 1222345678999999999899999999999999999998 999997544321 11111 1111100
Q ss_pred ccccccccCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhc
Q 002673 837 QVFDPILRGKGFDEEMLQVLDVACMCVSQNPFKRPTVKEVVEWLNNV 883 (894)
Q Consensus 837 ~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~i 883 (894)
. . .. .....+.+++.+|++.+|++|||+.++++.|+++
T Consensus 264 ~-----~-~~---~~~~~~~~li~~cl~~~p~~Rpt~~ell~~l~~~ 301 (302)
T cd05055 264 A-----Q-PE---HAPAEIYDIMKTCWDADPLKRPTFKQIVQLIGKQ 301 (302)
T ss_pred C-----C-CC---CCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHhh
Confidence 0 0 01 1123577899999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept |
| >cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-34 Score=323.42 Aligned_cols=256 Identities=22% Similarity=0.249 Sum_probs=197.9
Q ss_pred HHHhccCCCccceEeecCcEEEEEEEE-cCCCeEEEEEEcCcc---hhhHHHHHHHHHHHHhcCCCceeeecceeeecce
Q 002673 602 LLKATDNFSQANIIGCGGFGLVYKATL-ANGTTLAIKKLSGDL---GLMEREFKAEVEALSTAQHKNLVSLQGYCVHQGF 677 (894)
Q Consensus 602 l~~a~~~f~~~~~LG~G~fg~Vy~a~~-~~g~~vAvK~~~~~~---~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~ 677 (894)
+....++|++.+.||+|+||.||++.. .+++.||+|++.... ......+.+|+.+++.++||||+++++++.++..
T Consensus 38 ~~~~~~~y~i~~~lG~G~fg~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~ 117 (371)
T cd05622 38 LRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDRY 117 (371)
T ss_pred cCcchhhcEEEEEEeecCCeEEEEEEECCCCcEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCE
Confidence 334457899999999999999999985 468899999986422 1223457789999999999999999999999999
Q ss_pred EEEEEEeccCCCHHHHHhhhcCCCCCcCHHHHHHHHHHHHHHHHHHHhccCCCeeecCCCCCCeEECCCCcEEEEEcccc
Q 002673 678 RLLIYSYMENGSLDYWLHEKADGASQLDWLTRLKIARGTSCGLAYMHQICEPHIVHRDIKSSNILLDDQFEAHLADFGLS 757 (894)
Q Consensus 678 ~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDLkp~NILld~~~~vkl~DFGla 757 (894)
.++||||+++|+|.+++... .++...+..++.||+.||.|||+ ++|+||||||+|||++.++.+||+|||++
T Consensus 118 ~~lv~Ey~~gg~L~~~~~~~-----~~~~~~~~~~~~qi~~aL~~LH~---~~ivHrDLkp~NIll~~~~~ikL~DfG~a 189 (371)
T cd05622 118 LYMVMEYMPGGDLVNLMSNY-----DVPEKWARFYTAEVVLALDAIHS---MGFIHRDVKPDNMLLDKSGHLKLADFGTC 189 (371)
T ss_pred EEEEEcCCCCCcHHHHHHhc-----CCCHHHHHHHHHHHHHHHHHHHH---CCEEeCCCCHHHEEECCCCCEEEEeCCce
Confidence 99999999999999998743 36778888999999999999997 59999999999999999999999999999
Q ss_pred cccCCCCCcccccccccCCccCcccccCc----CCCccccHHHHHHHHHHHHcCCCCCCCCCcchhhhHHHHHHHHhhcC
Q 002673 758 RLILPYQTHVTTELVGTLGYIPPEYGQAW----VATLRGDMYSFGVVMLELLTGKRPVDVLKPKMSRELVGWVLKMRSEG 833 (894)
Q Consensus 758 ~~~~~~~~~~~~~~~gt~~Y~APE~~~~~----~~s~ksDVwS~GvlL~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~ 833 (894)
+..............||+.|+|||++.+. .++.++|||||||++|||++|+.||...... .....+....
T Consensus 190 ~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~------~~~~~i~~~~ 263 (371)
T cd05622 190 MKMNKEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLV------GTYSKIMNHK 263 (371)
T ss_pred eEcCcCCcccccCcccCccccCHHHHhccCCCccCCCccceeehhHHHHHHHhCCCCCCCCCHH------HHHHHHHcCC
Confidence 87643332233456799999999998654 3788999999999999999999999754321 1111111111
Q ss_pred CCCccccccccCCCChHHHHHHHHHHHHhcccCCCC--CCCHHHHHH
Q 002673 834 KQDQVFDPILRGKGFDEEMLQVLDVACMCVSQNPFK--RPTVKEVVE 878 (894)
Q Consensus 834 ~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~--RPs~~evl~ 878 (894)
....+.+ .......+.+++..|+..++.+ ||++.++++
T Consensus 264 ~~~~~~~-------~~~~s~~~~~li~~~L~~~~~r~~r~~~~ei~~ 303 (371)
T cd05622 264 NSLTFPD-------DNDISKEAKNLICAFLTDREVRLGRNGVEEIKR 303 (371)
T ss_pred CcccCCC-------cCCCCHHHHHHHHHHcCChhhhcCCCCHHHHhc
Confidence 1111111 0112234567888999844443 789999988
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an |
| >cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-34 Score=316.51 Aligned_cols=258 Identities=25% Similarity=0.276 Sum_probs=196.4
Q ss_pred cCCCccceEeecCcEEEEEEEE-cCCCeEEEEEEcCcc---hhhHHHHHHHHHHHHhcCCCceeeecceeeecceEEEEE
Q 002673 607 DNFSQANIIGCGGFGLVYKATL-ANGTTLAIKKLSGDL---GLMEREFKAEVEALSTAQHKNLVSLQGYCVHQGFRLLIY 682 (894)
Q Consensus 607 ~~f~~~~~LG~G~fg~Vy~a~~-~~g~~vAvK~~~~~~---~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~lV~ 682 (894)
++|++.+.||+|+||.||++.. .+++.||+|++.... ......+.+|+.++..++|+||+++++++.+++..++||
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (331)
T cd05597 1 DDFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNLHYAFQDENNLYLVM 80 (331)
T ss_pred CCceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCceEEEEecCCeEEEEE
Confidence 4688899999999999999985 468999999987422 123345788999999999999999999999999999999
Q ss_pred EeccCCCHHHHHhhhcCCCCCcCHHHHHHHHHHHHHHHHHHHhccCCCeeecCCCCCCeEECCCCcEEEEEcccccccCC
Q 002673 683 SYMENGSLDYWLHEKADGASQLDWLTRLKIARGTSCGLAYMHQICEPHIVHRDIKSSNILLDDQFEAHLADFGLSRLILP 762 (894)
Q Consensus 683 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDLkp~NILld~~~~vkl~DFGla~~~~~ 762 (894)
||+++|+|.+++.... ..++...+..++.||+.||.|||+ ++|+||||||+|||++.++.+||+|||++.....
T Consensus 81 e~~~g~~L~~~l~~~~---~~~~~~~~~~~~~qi~~~l~~lH~---~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~ 154 (331)
T cd05597 81 DYYVGGDLLTLLSKFE---DRLPEDMARFYLAEMVLAIDSVHQ---LGYVHRDIKPDNVLLDKNGHIRLADFGSCLRLLA 154 (331)
T ss_pred ecCCCCcHHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHh---CCeEECCCCHHHEEECCCCCEEEEECCceeecCC
Confidence 9999999999997532 357888999999999999999997 5999999999999999999999999999876543
Q ss_pred CCCcccccccccCCccCcccccC-----cCCCccccHHHHHHHHHHHHcCCCCCCCCCcchhhhHHHHHHHHhhcCCCCc
Q 002673 763 YQTHVTTELVGTLGYIPPEYGQA-----WVATLRGDMYSFGVVMLELLTGKRPVDVLKPKMSRELVGWVLKMRSEGKQDQ 837 (894)
Q Consensus 763 ~~~~~~~~~~gt~~Y~APE~~~~-----~~~s~ksDVwS~GvlL~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 837 (894)
..........||+.|+|||++.. ..++.++|||||||++|||++|+.||....... .............
T Consensus 155 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~------~~~~i~~~~~~~~ 228 (331)
T cd05597 155 DGTVQSNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVE------TYGKIMNHKEHFQ 228 (331)
T ss_pred CCCccccceeccccccCHHHHhhccccccCCCCcceeehhhhHHHHHhhCCCCCCCCCHHH------HHHHHHcCCCccc
Confidence 33222333568999999998863 457889999999999999999999997543211 1111111111111
Q ss_pred cccccccCCCChHHHHHHHHHHHHhccc--CCCCCCCHHHHHH--HHHh
Q 002673 838 VFDPILRGKGFDEEMLQVLDVACMCVSQ--NPFKRPTVKEVVE--WLNN 882 (894)
Q Consensus 838 ~~d~~l~~~~~~~~~~~l~~li~~Cl~~--dP~~RPs~~evl~--~L~~ 882 (894)
+ .+.. ...+ ..+.+++.+|+.. ++..||+++++++ |+..
T Consensus 229 ~-~~~~--~~~~---~~~~~li~~ll~~~~~r~~r~~~~~~l~hp~~~~ 271 (331)
T cd05597 229 F-PPDV--TDVS---EEAKDLIRRLICSPETRLGRNGLQDFKDHPFFEG 271 (331)
T ss_pred C-CCcc--CCCC---HHHHHHHHHHccCcccccCCCCHHHHhcCCCCCC
Confidence 1 0000 1122 2455677776654 3344889999998 5543
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, |
| >cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-34 Score=310.32 Aligned_cols=258 Identities=27% Similarity=0.457 Sum_probs=203.8
Q ss_pred ccCCCccceEeecCcEEEEEEEEc------CCCeEEEEEEcCcc-hhhHHHHHHHHHHHHhcCCCceeeecceeeecceE
Q 002673 606 TDNFSQANIIGCGGFGLVYKATLA------NGTTLAIKKLSGDL-GLMEREFKAEVEALSTAQHKNLVSLQGYCVHQGFR 678 (894)
Q Consensus 606 ~~~f~~~~~LG~G~fg~Vy~a~~~------~g~~vAvK~~~~~~-~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~ 678 (894)
.++|+..+.||+|+||.||+|... ++..||+|.+.... ......+.+|+.++++++||||+++++++..+...
T Consensus 4 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~ei~~l~~l~h~~iv~~~~~~~~~~~~ 83 (288)
T cd05050 4 RNNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHPNIVKLLGVCAVGKPM 83 (288)
T ss_pred hHhceecccccccccccEEEEEEcccCCCCcceeEEEEecCCCcCHHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCcc
Confidence 467888999999999999999853 46789999987643 23446789999999999999999999999999999
Q ss_pred EEEEEeccCCCHHHHHhhhc------------------CCCCCcCHHHHHHHHHHHHHHHHHHHhccCCCeeecCCCCCC
Q 002673 679 LLIYSYMENGSLDYWLHEKA------------------DGASQLDWLTRLKIARGTSCGLAYMHQICEPHIVHRDIKSSN 740 (894)
Q Consensus 679 ~lV~E~~~~gsL~~~l~~~~------------------~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDLkp~N 740 (894)
++||||+++|+|.+++.... .....+++..++.++.|++.||.|||+ ++++||||||+|
T Consensus 84 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH~---~~i~H~dl~p~n 160 (288)
T cd05050 84 CLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSE---RKFVHRDLATRN 160 (288)
T ss_pred EEEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHHh---CCeecccccHhh
Confidence 99999999999999997532 112357888999999999999999997 699999999999
Q ss_pred eEECCCCcEEEEEcccccccCCCCC-cccccccccCCccCcccccCcCCCccccHHHHHHHHHHHHc-CCCCCCCCCcch
Q 002673 741 ILLDDQFEAHLADFGLSRLILPYQT-HVTTELVGTLGYIPPEYGQAWVATLRGDMYSFGVVMLELLT-GKRPVDVLKPKM 818 (894)
Q Consensus 741 ILld~~~~vkl~DFGla~~~~~~~~-~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwS~GvlL~ellt-G~~Pf~~~~~~~ 818 (894)
|+++.++.++|+|||++........ ........+..|+|||.+.+..++.++|||||||++|||++ |..||......
T Consensus 161 il~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~~~~p~~~~~~~- 239 (288)
T cd05050 161 CLVGENMVVKIADFGLSRNIYSADYYKASENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGMQPYYGMAHE- 239 (288)
T ss_pred eEecCCCceEECccccceecccCccccccCCCccChhhcCHHHHhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCHH-
Confidence 9999999999999999876432211 11122334667999999988899999999999999999998 88898654322
Q ss_pred hhhHHHHHHHHhhcCCCCccccccccCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHh
Q 002673 819 SRELVGWVLKMRSEGKQDQVFDPILRGKGFDEEMLQVLDVACMCVSQNPFKRPTVKEVVEWLNN 882 (894)
Q Consensus 819 ~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~ 882 (894)
+.. .... .+..... .......+.+++.+|++.+|++|||+.|+++.|++
T Consensus 240 --~~~---~~~~-~~~~~~~---------~~~~~~~l~~li~~~l~~~p~~Rpt~~el~~~l~~ 288 (288)
T cd05050 240 --EVI---YYVR-DGNVLSC---------PDNCPLELYNLMRLCWSKLPSDRPSFASINRILQR 288 (288)
T ss_pred --HHH---HHHh-cCCCCCC---------CCCCCHHHHHHHHHHcccCcccCCCHHHHHHHhhC
Confidence 111 1111 1111100 01122467889999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M |
| >cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-34 Score=309.42 Aligned_cols=260 Identities=25% Similarity=0.396 Sum_probs=202.9
Q ss_pred hccCCCccceEeecCcEEEEEEEEc------CCCeEEEEEEcCcch-hhHHHHHHHHHHHHhcCCCceeeecceeeecce
Q 002673 605 ATDNFSQANIIGCGGFGLVYKATLA------NGTTLAIKKLSGDLG-LMEREFKAEVEALSTAQHKNLVSLQGYCVHQGF 677 (894)
Q Consensus 605 a~~~f~~~~~LG~G~fg~Vy~a~~~------~g~~vAvK~~~~~~~-~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~ 677 (894)
..++|++.+.||+|+||.||+|... .+..||+|.+..... .....+.+|+.+++.++||||+++++++.....
T Consensus 4 ~~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~ 83 (288)
T cd05061 4 SREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVRLLGVVSKGQP 83 (288)
T ss_pred cHHHceeeeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCC
Confidence 4578999999999999999999743 245799998865432 233467889999999999999999999999999
Q ss_pred EEEEEEeccCCCHHHHHhhhcC------CCCCcCHHHHHHHHHHHHHHHHHHHhccCCCeeecCCCCCCeEECCCCcEEE
Q 002673 678 RLLIYSYMENGSLDYWLHEKAD------GASQLDWLTRLKIARGTSCGLAYMHQICEPHIVHRDIKSSNILLDDQFEAHL 751 (894)
Q Consensus 678 ~~lV~E~~~~gsL~~~l~~~~~------~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDLkp~NILld~~~~vkl 751 (894)
.++||||+++|+|.+++..... +....++..+..++.|++.||.|||+ ++|+||||||+||++++++.+||
T Consensus 84 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~---~~i~H~dikp~nili~~~~~~~L 160 (288)
T cd05061 84 TLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNA---KKFVHRDLAARNCMVAHDFTVKI 160 (288)
T ss_pred cEEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHh---CCCcCCCCChheEEEcCCCcEEE
Confidence 9999999999999999975321 12345777889999999999999997 69999999999999999999999
Q ss_pred EEcccccccCCCCCc-ccccccccCCccCcccccCcCCCccccHHHHHHHHHHHHc-CCCCCCCCCcchhhhHHHHHHHH
Q 002673 752 ADFGLSRLILPYQTH-VTTELVGTLGYIPPEYGQAWVATLRGDMYSFGVVMLELLT-GKRPVDVLKPKMSRELVGWVLKM 829 (894)
Q Consensus 752 ~DFGla~~~~~~~~~-~~~~~~gt~~Y~APE~~~~~~~s~ksDVwS~GvlL~ellt-G~~Pf~~~~~~~~~~~~~~~~~~ 829 (894)
+|||+++........ ......++..|+|||.+.+..++.++|||||||++|||++ |..||...... +.... .
T Consensus 161 ~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~DvwslG~~l~el~~~~~~p~~~~~~~---~~~~~---~ 234 (288)
T cd05061 161 GDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNE---QVLKF---V 234 (288)
T ss_pred CcCCccccccccccccccCCCcccccccCHHHhccCCCChHhHHHHHHHHHHHHHhCCCCCCCCCCHH---HHHHH---H
Confidence 999998865322211 1122345678999999998899999999999999999998 78898754322 11111 1
Q ss_pred hhcCCCCccccccccCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhc
Q 002673 830 RSEGKQDQVFDPILRGKGFDEEMLQVLDVACMCVSQNPFKRPTVKEVVEWLNNV 883 (894)
Q Consensus 830 ~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~i 883 (894)
....... . . . .....+.+++.+|++.+|++|||+.++++.|++.
T Consensus 235 ~~~~~~~-~-----~-~---~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~~ 278 (288)
T cd05061 235 MDGGYLD-Q-----P-D---NCPERVTDLMRMCWQFNPKMRPTFLEIVNLLKDD 278 (288)
T ss_pred HcCCCCC-C-----C-C---CCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHhh
Confidence 1111110 0 0 0 1123678999999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta |
| >PRK13184 pknD serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-34 Score=341.30 Aligned_cols=261 Identities=24% Similarity=0.327 Sum_probs=202.0
Q ss_pred cCCCccceEeecCcEEEEEEEE-cCCCeEEEEEEcCcc---hhhHHHHHHHHHHHHhcCCCceeeecceeeecceEEEEE
Q 002673 607 DNFSQANIIGCGGFGLVYKATL-ANGTTLAIKKLSGDL---GLMEREFKAEVEALSTAQHKNLVSLQGYCVHQGFRLLIY 682 (894)
Q Consensus 607 ~~f~~~~~LG~G~fg~Vy~a~~-~~g~~vAvK~~~~~~---~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~lV~ 682 (894)
++|++.++||+|+||.||+|.. .+|+.||+|++.... ....+.+.+|++++++++||||+++++++.+++..++||
T Consensus 2 grYeIi~~LGkGgfG~VYlA~d~~tg~~VAIK~I~~~l~~~e~~~~rflrEi~ILs~L~HPNIVkl~~v~~d~~~lyLVM 81 (932)
T PRK13184 2 QRYDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVYSICSDGDPVYYTM 81 (932)
T ss_pred CCeEEEEEEecCCCEEEEEEEECCCCcEEEEEEECcccccCHHHHHHHHHHHHHHHhCCCcCcCeEEEEEeeCCEEEEEE
Confidence 4788999999999999999985 468999999997543 223457889999999999999999999999999999999
Q ss_pred EeccCCCHHHHHhhhcC-------CCCCcCHHHHHHHHHHHHHHHHHHHhccCCCeeecCCCCCCeEECCCCcEEEEEcc
Q 002673 683 SYMENGSLDYWLHEKAD-------GASQLDWLTRLKIARGTSCGLAYMHQICEPHIVHRDIKSSNILLDDQFEAHLADFG 755 (894)
Q Consensus 683 E~~~~gsL~~~l~~~~~-------~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDLkp~NILld~~~~vkl~DFG 755 (894)
||+++|+|.+++..... ....+++..++.++.||++||+|||+ ++|+||||||+||+++.++.+||+|||
T Consensus 82 EY~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs---~GIIHRDLKPeNILLd~dg~vKLiDFG 158 (932)
T PRK13184 82 PYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHS---KGVLHRDLKPDNILLGLFGEVVILDWG 158 (932)
T ss_pred EcCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHH---CCccccCCchheEEEcCCCCEEEEecC
Confidence 99999999999875321 12346777889999999999999997 599999999999999999999999999
Q ss_pred cccccCCCCC-----------------cccccccccCCccCcccccCcCCCccccHHHHHHHHHHHHcCCCCCCCCCcch
Q 002673 756 LSRLILPYQT-----------------HVTTELVGTLGYIPPEYGQAWVATLRGDMYSFGVVMLELLTGKRPVDVLKPKM 818 (894)
Q Consensus 756 la~~~~~~~~-----------------~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwS~GvlL~elltG~~Pf~~~~~~~ 818 (894)
+++....... ......+||+.|+|||++.+..++.++|||||||++|||+||+.||......
T Consensus 159 LAk~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g~~~S~kSDIWSLGVILyELLTG~~PF~~~~~~- 237 (932)
T PRK13184 159 AAIFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFPYRRKKGR- 237 (932)
T ss_pred cceecccccccccccccccccccccccccCCCCCCCCCCCCHHHhcCCCCCcHhHHHHHHHHHHHHHHCCCCCCCcchh-
Confidence 9986521100 0112346999999999999999999999999999999999999999753221
Q ss_pred hhhHHHHHHHHhhcCCCCccccccccCCCChHHHHHHHHHHHHhcccCCCCCC-CHHHHHHHHHhcc
Q 002673 819 SRELVGWVLKMRSEGKQDQVFDPILRGKGFDEEMLQVLDVACMCVSQNPFKRP-TVKEVVEWLNNVG 884 (894)
Q Consensus 819 ~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RP-s~~evl~~L~~i~ 884 (894)
... ..... .++.-. .........+.+++.+|++.||++|| +++++.+.|+...
T Consensus 238 --ki~-~~~~i---------~~P~~~-~p~~~iP~~L~~LI~rcL~~DP~kR~ss~eeLl~~Le~~l 291 (932)
T PRK13184 238 --KIS-YRDVI---------LSPIEV-APYREIPPFLSQIAMKALAVDPAERYSSVQELKQDLEPHL 291 (932)
T ss_pred --hhh-hhhhc---------cChhhc-cccccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHH
Confidence 111 00000 000000 00011223567889999999999996 5666777777653
|
|
| >cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-34 Score=316.31 Aligned_cols=248 Identities=21% Similarity=0.319 Sum_probs=193.4
Q ss_pred ceEeecCcEEEEEEEE-cCCCeEEEEEEcCcch---hhHHHHHHHHHHHHhc-CCCceeeecceeeecceEEEEEEeccC
Q 002673 613 NIIGCGGFGLVYKATL-ANGTTLAIKKLSGDLG---LMEREFKAEVEALSTA-QHKNLVSLQGYCVHQGFRLLIYSYMEN 687 (894)
Q Consensus 613 ~~LG~G~fg~Vy~a~~-~~g~~vAvK~~~~~~~---~~~~~~~~Ei~~l~~l-~HpnIv~l~g~~~~~~~~~lV~E~~~~ 687 (894)
+.||+|+||.||+|.. .+++.||+|++..... .....+..|+.++.++ +||||+++++++...+..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (327)
T cd05617 1 RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQTTSRLFLVIEYVNG 80 (327)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEEEeCCEEEEEEeCCCC
Confidence 4699999999999985 5678999999986432 2234577899999888 699999999999999999999999999
Q ss_pred CCHHHHHhhhcCCCCCcCHHHHHHHHHHHHHHHHHHHhccCCCeeecCCCCCCeEECCCCcEEEEEcccccccCCCCCcc
Q 002673 688 GSLDYWLHEKADGASQLDWLTRLKIARGTSCGLAYMHQICEPHIVHRDIKSSNILLDDQFEAHLADFGLSRLILPYQTHV 767 (894)
Q Consensus 688 gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDLkp~NILld~~~~vkl~DFGla~~~~~~~~~~ 767 (894)
|+|..++... ..+++..+..++.|++.||.|||+ ++|+||||||+|||++.++.+||+|||+++..... ...
T Consensus 81 ~~L~~~~~~~----~~l~~~~~~~~~~qi~~al~~lH~---~~ivHrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~-~~~ 152 (327)
T cd05617 81 GDLMFHMQRQ----RKLPEEHARFYAAEICIALNFLHE---RGIIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGP-GDT 152 (327)
T ss_pred CcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHH---CCeeccCCCHHHEEEeCCCCEEEeccccceeccCC-CCc
Confidence 9999888653 358999999999999999999997 59999999999999999999999999998753221 122
Q ss_pred cccccccCCccCcccccCcCCCccccHHHHHHHHHHHHcCCCCCCCCCcchhhhHHHHHHHHhhcCCCCccccccccCCC
Q 002673 768 TTELVGTLGYIPPEYGQAWVATLRGDMYSFGVVMLELLTGKRPVDVLKPKMSRELVGWVLKMRSEGKQDQVFDPILRGKG 847 (894)
Q Consensus 768 ~~~~~gt~~Y~APE~~~~~~~s~ksDVwS~GvlL~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~ 847 (894)
.....||+.|+|||++.+..++.++|||||||++|||++|+.||.............+........... + . ..
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~-~-p-----~~ 225 (327)
T cd05617 153 TSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIITDNPDMNTEDYLFQVILEKPIR-I-P-----RF 225 (327)
T ss_pred eecccCCcccCCHHHHCCCCCCchheeehhHHHHHHHHhCCCCCCccCCCcccccHHHHHHHHHhCCCC-C-C-----CC
Confidence 344679999999999999999999999999999999999999996433222111112222211111111 0 0 01
Q ss_pred ChHHHHHHHHHHHHhcccCCCCCCCH------HHHHH
Q 002673 848 FDEEMLQVLDVACMCVSQNPFKRPTV------KEVVE 878 (894)
Q Consensus 848 ~~~~~~~l~~li~~Cl~~dP~~RPs~------~evl~ 878 (894)
....+.+++.+|++.||.+|+++ +++++
T Consensus 226 ---~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~i~~ 259 (327)
T cd05617 226 ---LSVKASHVLKGFLNKDPKERLGCQPQTGFSDIKS 259 (327)
T ss_pred ---CCHHHHHHHHHHhccCHHHcCCCCCCCCHHHHHc
Confidence 11345689999999999999984 57665
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways |
| >cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-33 Score=301.91 Aligned_cols=248 Identities=25% Similarity=0.392 Sum_probs=198.5
Q ss_pred ceEeecCcEEEEEEEEcC--C--CeEEEEEEcCcch-hhHHHHHHHHHHHHhcCCCceeeecceeeecceEEEEEEeccC
Q 002673 613 NIIGCGGFGLVYKATLAN--G--TTLAIKKLSGDLG-LMEREFKAEVEALSTAQHKNLVSLQGYCVHQGFRLLIYSYMEN 687 (894)
Q Consensus 613 ~~LG~G~fg~Vy~a~~~~--g--~~vAvK~~~~~~~-~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~lV~E~~~~ 687 (894)
+.||+|++|.||+|.+.+ + ..||+|.+..... ...+.+.+|+.++++++||||+++++++.. ...++||||+++
T Consensus 1 ~~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~v~e~~~~ 79 (257)
T cd05040 1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRLYGVVLT-HPLMMVTELAPL 79 (257)
T ss_pred CcCCccCcccEEeeeEecCCCCceEEEEeecCCcccHHHHHHHHHHHHHHhhcCCCCccceeEEEcC-CeEEEEEEecCC
Confidence 368999999999998643 3 3689999987655 456789999999999999999999999988 888999999999
Q ss_pred CCHHHHHhhhcCCCCCcCHHHHHHHHHHHHHHHHHHHhccCCCeeecCCCCCCeEECCCCcEEEEEcccccccCCCCCc-
Q 002673 688 GSLDYWLHEKADGASQLDWLTRLKIARGTSCGLAYMHQICEPHIVHRDIKSSNILLDDQFEAHLADFGLSRLILPYQTH- 766 (894)
Q Consensus 688 gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDLkp~NILld~~~~vkl~DFGla~~~~~~~~~- 766 (894)
|+|.+++..... ..+++...+.++.|++.||.|||+ ++++|+||||+||+++.++.+||+|||+++........
T Consensus 80 ~~L~~~l~~~~~--~~~~~~~~~~~~~qi~~~L~~lH~---~~i~H~di~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~ 154 (257)
T cd05040 80 GSLLDRLRKDAL--GHFLISTLCDYAVQIANGMRYLES---KRFIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHY 154 (257)
T ss_pred CcHHHHHHhccc--ccCcHHHHHHHHHHHHHHHHHHHh---CCccccccCcccEEEecCCEEEeccccccccccccccce
Confidence 999999986432 468999999999999999999997 69999999999999999999999999999876432211
Q ss_pred -ccccccccCCccCcccccCcCCCccccHHHHHHHHHHHHc-CCCCCCCCCcchhhhHHHHHHHHhhcCCCCcccccccc
Q 002673 767 -VTTELVGTLGYIPPEYGQAWVATLRGDMYSFGVVMLELLT-GKRPVDVLKPKMSRELVGWVLKMRSEGKQDQVFDPILR 844 (894)
Q Consensus 767 -~~~~~~gt~~Y~APE~~~~~~~s~ksDVwS~GvlL~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~ 844 (894)
......++..|+|||++.+..++.++|||||||++|||++ |+.||...... +...... ..... ...
T Consensus 155 ~~~~~~~~~~~y~~pE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~---~~~~~~~---~~~~~--~~~---- 222 (257)
T cd05040 155 VMEEHLKVPFAWCAPESLRTRTFSHASDVWMFGVTLWEMFTYGEEPWAGLSGS---QILKKID---KEGER--LER---- 222 (257)
T ss_pred ecccCCCCCceecCHHHhcccCcCchhhhHHHHHHHHHHHhCCCCCCCCCCHH---HHHHHHH---hcCCc--CCC----
Confidence 1123456789999999999899999999999999999999 99999754322 1111111 11110 000
Q ss_pred CCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 002673 845 GKGFDEEMLQVLDVACMCVSQNPFKRPTVKEVVEWLN 881 (894)
Q Consensus 845 ~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~ 881 (894)
.......+.+++.+|++.+|++||++.++++.|.
T Consensus 223 ---~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~ 256 (257)
T cd05040 223 ---PEACPQDIYNVMLQCWAHNPADRPTFAALREFLP 256 (257)
T ss_pred ---CccCCHHHHHHHHHHCCCCcccCCCHHHHHHHhc
Confidence 0112246778999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and |
| >cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-33 Score=301.35 Aligned_cols=249 Identities=26% Similarity=0.391 Sum_probs=198.8
Q ss_pred cCCCccceEeecCcEEEEEEEEcCCCeEEEEEEcCcchhhHHHHHHHHHHHHhcCCCceeeecceee-ecceEEEEEEec
Q 002673 607 DNFSQANIIGCGGFGLVYKATLANGTTLAIKKLSGDLGLMEREFKAEVEALSTAQHKNLVSLQGYCV-HQGFRLLIYSYM 685 (894)
Q Consensus 607 ~~f~~~~~LG~G~fg~Vy~a~~~~g~~vAvK~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~-~~~~~~lV~E~~ 685 (894)
++|++.+.||+|+||.||++... |..||+|.+..+. ..+.+.+|+.++++++|+|++++++++. .++..++||||+
T Consensus 6 ~~~~~~~~lg~g~~~~v~~~~~~-~~~~~~k~~~~~~--~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e~~ 82 (256)
T cd05082 6 KELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYM 82 (256)
T ss_pred HhCeeeeeecccCCCeEEEEEEc-CCcEEEEEeCCCc--hHHHHHHHHHHHHhCCCCCeeeEEEEEEcCCCceEEEEECC
Confidence 46888899999999999999764 7889999987543 3457889999999999999999999765 445789999999
Q ss_pred cCCCHHHHHhhhcCCCCCcCHHHHHHHHHHHHHHHHHHHhccCCCeeecCCCCCCeEECCCCcEEEEEcccccccCCCCC
Q 002673 686 ENGSLDYWLHEKADGASQLDWLTRLKIARGTSCGLAYMHQICEPHIVHRDIKSSNILLDDQFEAHLADFGLSRLILPYQT 765 (894)
Q Consensus 686 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDLkp~NILld~~~~vkl~DFGla~~~~~~~~ 765 (894)
++|+|.+++.... ...+++..++.++.|++.||+|||+ ++++||||||+||++++++.+||+|||++.......
T Consensus 83 ~~~~L~~~~~~~~--~~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~- 156 (256)
T cd05082 83 AKGSLVDYLRSRG--RSVLGGDCLLKFSLDVCEAMEYLEA---NNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ- 156 (256)
T ss_pred CCCcHHHHHHhcC--CCCCCHHHHHHHHHHHHHHHHHHHh---CCEeccccchheEEEcCCCcEEecCCccceeccccC-
Confidence 9999999997643 2458899999999999999999997 599999999999999999999999999987643211
Q ss_pred cccccccccCCccCcccccCcCCCccccHHHHHHHHHHHHc-CCCCCCCCCcchhhhHHHHHHHHhhcCCCCcccccccc
Q 002673 766 HVTTELVGTLGYIPPEYGQAWVATLRGDMYSFGVVMLELLT-GKRPVDVLKPKMSRELVGWVLKMRSEGKQDQVFDPILR 844 (894)
Q Consensus 766 ~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwS~GvlL~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~ 844 (894)
....++..|+|||+..+..++.++|||||||++|||++ |+.||..... ....... .. +......
T Consensus 157 ---~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~~l~~~g~~p~~~~~~---~~~~~~~---~~-~~~~~~~----- 221 (256)
T cd05082 157 ---DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPL---KDVVPRV---EK-GYKMDAP----- 221 (256)
T ss_pred ---CCCccceeecCHHHHccCCCCchhhhHHHHHHHHHHHhCCCCCCCCCCH---HHHHHHH---hc-CCCCCCC-----
Confidence 22334668999999998899999999999999999997 9999874322 1111111 11 1111110
Q ss_pred CCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhc
Q 002673 845 GKGFDEEMLQVLDVACMCVSQNPFKRPTVKEVVEWLNNV 883 (894)
Q Consensus 845 ~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~i 883 (894)
. .....+.+++.+|++.+|++|||+.++++.|+++
T Consensus 222 -~---~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~~ 256 (256)
T cd05082 222 -D---GCPPVVYDVMKQCWHLDAATRPSFLQLREQLEHI 256 (256)
T ss_pred -C---CCCHHHHHHHHHHhcCChhhCcCHHHHHHHHhcC
Confidence 1 1123567899999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re |
| >cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-33 Score=302.21 Aligned_cols=253 Identities=25% Similarity=0.341 Sum_probs=191.2
Q ss_pred eEeecCcEEEEEEEEcC---CCeEEEEEEcCcch-hhHHHHHHHHHHHHhcCCCceeeecceeeecceEEEEEEeccCCC
Q 002673 614 IIGCGGFGLVYKATLAN---GTTLAIKKLSGDLG-LMEREFKAEVEALSTAQHKNLVSLQGYCVHQGFRLLIYSYMENGS 689 (894)
Q Consensus 614 ~LG~G~fg~Vy~a~~~~---g~~vAvK~~~~~~~-~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~lV~E~~~~gs 689 (894)
.||+|+||.||+|.+.+ +..+|+|.++.... .....+.+|+.++++++||||+++++++.+....++||||+++|+
T Consensus 2 ~lg~G~~g~Vy~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~ 81 (269)
T cd05087 2 EIGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCLGQCTEVTPYLLVMEFCPLGD 81 (269)
T ss_pred cccccCCceEEEEEEcCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCCcEEEEECCCCCc
Confidence 58999999999998543 45799998876543 334578899999999999999999999999889999999999999
Q ss_pred HHHHHhhhcC-CCCCcCHHHHHHHHHHHHHHHHHHHhccCCCeeecCCCCCCeEECCCCcEEEEEcccccccCCCCCcc-
Q 002673 690 LDYWLHEKAD-GASQLDWLTRLKIARGTSCGLAYMHQICEPHIVHRDIKSSNILLDDQFEAHLADFGLSRLILPYQTHV- 767 (894)
Q Consensus 690 L~~~l~~~~~-~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDLkp~NILld~~~~vkl~DFGla~~~~~~~~~~- 767 (894)
|.++++.... .....++..+..++.|++.||.|||+ ++++|+||||+||+++.++.+||+|||+++.........
T Consensus 82 L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~---~~i~H~dlkp~nil~~~~~~~kL~dfg~~~~~~~~~~~~~ 158 (269)
T cd05087 82 LKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHK---NNFIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYVT 158 (269)
T ss_pred HHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHH---CCEeccccCcceEEEcCCCcEEECCccccccccCcceeec
Confidence 9999976432 22356777888999999999999997 599999999999999999999999999997543222111
Q ss_pred cccccccCCccCcccccCc-------CCCccccHHHHHHHHHHHHc-CCCCCCCCCcchhhhHHHHHHHHhhcCCCCccc
Q 002673 768 TTELVGTLGYIPPEYGQAW-------VATLRGDMYSFGVVMLELLT-GKRPVDVLKPKMSRELVGWVLKMRSEGKQDQVF 839 (894)
Q Consensus 768 ~~~~~gt~~Y~APE~~~~~-------~~s~ksDVwS~GvlL~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 839 (894)
.....++..|+|||++.+. .++.++||||||+++|||++ |+.||........ .... .........
T Consensus 159 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~~---~~~~----~~~~~~~~~ 231 (269)
T cd05087 159 PDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSDEQV---LTYT----VREQQLKLP 231 (269)
T ss_pred CCCcCCcccccCHhHhccccccccccCCCccchhHHHHHHHHHHHhCCCCCCCCCChHHH---HHHH----hhcccCCCC
Confidence 1234567889999987642 35789999999999999996 9999975443211 1110 011111112
Q ss_pred cccccCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 002673 840 DPILRGKGFDEEMLQVLDVACMCVSQNPFKRPTVKEVVEWLN 881 (894)
Q Consensus 840 d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~ 881 (894)
++.+.. .. ...+.+++..|+ .+|++|||+++|++.|+
T Consensus 232 ~~~~~~-~~---~~~~~~l~~~c~-~~P~~Rpt~~~l~~~l~ 268 (269)
T cd05087 232 KPRLKL-PL---SDRWYEVMQFCW-LQPEQRPSAEEVHLLLS 268 (269)
T ss_pred CCccCC-CC---ChHHHHHHHHHh-cCcccCCCHHHHHHHhc
Confidence 222111 11 224567888998 58999999999998875
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells |
| >PTZ00284 protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-33 Score=329.66 Aligned_cols=271 Identities=23% Similarity=0.275 Sum_probs=197.3
Q ss_pred HHhccCCCccceEeecCcEEEEEEEE-cCCCeEEEEEEcCcchhhHHHHHHHHHHHHhcCC------Cceeeecceeeec
Q 002673 603 LKATDNFSQANIIGCGGFGLVYKATL-ANGTTLAIKKLSGDLGLMEREFKAEVEALSTAQH------KNLVSLQGYCVHQ 675 (894)
Q Consensus 603 ~~a~~~f~~~~~LG~G~fg~Vy~a~~-~~g~~vAvK~~~~~~~~~~~~~~~Ei~~l~~l~H------pnIv~l~g~~~~~ 675 (894)
...+++|++.++||+|+||.||+|.. .+++.||||+++... ...+.+..|+.++..++| .+++.+++++...
T Consensus 125 ~~~~~~y~i~~~lG~G~fg~V~~a~~~~~~~~vAvK~i~~~~-~~~~~~~~e~~~l~~l~~~~~~~~~~i~~i~~~~~~~ 203 (467)
T PTZ00284 125 DVSTQRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVP-KYTRDAKIEIQFMEKVRQADPADRFPLMKIQRYFQNE 203 (467)
T ss_pred ccCCCcEEEEEEEEeccCEEEEEEEEcCCCeEEEEEEEecch-hhHHHHHHHHHHHHHHhhcCcccCcceeeeEEEEEcC
Confidence 34568899999999999999999984 568899999996432 223445667777776654 4588898888764
Q ss_pred -ceEEEEEEeccCCCHHHHHhhhcCCCCCcCHHHHHHHHHHHHHHHHHHHhccCCCeeecCCCCCCeEECCCC-------
Q 002673 676 -GFRLLIYSYMENGSLDYWLHEKADGASQLDWLTRLKIARGTSCGLAYMHQICEPHIVHRDIKSSNILLDDQF------- 747 (894)
Q Consensus 676 -~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDLkp~NILld~~~------- 747 (894)
...++|||++ +++|.+++... ..+++..+..|+.||+.||.|||+ +.+|+||||||+|||++.++
T Consensus 204 ~~~~~iv~~~~-g~~l~~~l~~~----~~l~~~~~~~i~~qi~~aL~yLH~--~~gIiHrDlKP~NILl~~~~~~~~~~~ 276 (467)
T PTZ00284 204 TGHMCIVMPKY-GPCLLDWIMKH----GPFSHRHLAQIIFQTGVALDYFHT--ELHLMHTDLKPENILMETSDTVVDPVT 276 (467)
T ss_pred CceEEEEEecc-CCCHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHh--cCCeecCCCCHHHEEEecCCccccccc
Confidence 4688999988 77898888754 358899999999999999999996 24999999999999998765
Q ss_pred ---------cEEEEEcccccccCCCCCcccccccccCCccCcccccCcCCCccccHHHHHHHHHHHHcCCCCCCCCCcch
Q 002673 748 ---------EAHLADFGLSRLILPYQTHVTTELVGTLGYIPPEYGQAWVATLRGDMYSFGVVMLELLTGKRPVDVLKPKM 818 (894)
Q Consensus 748 ---------~vkl~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwS~GvlL~elltG~~Pf~~~~~~~ 818 (894)
.+||+|||.+.... ......+||+.|+|||++.+..++.++|||||||++|||++|+.||+......
T Consensus 277 ~~~~~~~~~~vkl~DfG~~~~~~----~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~ 352 (467)
T PTZ00284 277 NRALPPDPCRVRICDLGGCCDER----HSRTAIVSTRHYRSPEVVLGLGWMYSTDMWSMGCIIYELYTGKLLYDTHDNLE 352 (467)
T ss_pred ccccCCCCceEEECCCCccccCc----cccccccCCccccCcHHhhcCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHH
Confidence 49999999886432 22344679999999999999999999999999999999999999997654322
Q ss_pred hhhHHHHHHH-----------------Hh-hcCCCCcccccc-----ccCCCCh--HHHHHHHHHHHHhcccCCCCCCCH
Q 002673 819 SRELVGWVLK-----------------MR-SEGKQDQVFDPI-----LRGKGFD--EEMLQVLDVACMCVSQNPFKRPTV 873 (894)
Q Consensus 819 ~~~~~~~~~~-----------------~~-~~~~~~~~~d~~-----l~~~~~~--~~~~~l~~li~~Cl~~dP~~RPs~ 873 (894)
....+..... +. ..+......++. ....... .....+.+|+.+||+.||.+|||+
T Consensus 353 ~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~R~ta 432 (467)
T PTZ00284 353 HLHLMEKTLGRLPSEWAGRCGTEEARLLYNSAGQLRPCTDPKHLARIARARPVREVIRDDLLCDLIYGLLHYDRQKRLNA 432 (467)
T ss_pred HHHHHHHHcCCCCHHHHhhccchhHHHHhhhcccccccCCHHHHHhhhcccchhhhhchHHHHHHHHHhCCcChhhCCCH
Confidence 1111111000 00 000000000100 0000000 012357799999999999999999
Q ss_pred HHHHH--HHHhccc
Q 002673 874 KEVVE--WLNNVGA 885 (894)
Q Consensus 874 ~evl~--~L~~i~~ 885 (894)
+|+++ ||.+...
T Consensus 433 ~e~L~Hp~~~~~~~ 446 (467)
T PTZ00284 433 RQMTTHPYVLKYYP 446 (467)
T ss_pred HHHhcCccccccCC
Confidence 99998 8876544
|
|
| >KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-34 Score=317.57 Aligned_cols=255 Identities=24% Similarity=0.326 Sum_probs=213.2
Q ss_pred ccCCCccceEeecCcEEEEEEEEc-CCCeEEEEEEcCcchh---hHHHHHHHHHHHHhcC-CCceeeecceeeecceEEE
Q 002673 606 TDNFSQANIIGCGGFGLVYKATLA-NGTTLAIKKLSGDLGL---MEREFKAEVEALSTAQ-HKNLVSLQGYCVHQGFRLL 680 (894)
Q Consensus 606 ~~~f~~~~~LG~G~fg~Vy~a~~~-~g~~vAvK~~~~~~~~---~~~~~~~Ei~~l~~l~-HpnIv~l~g~~~~~~~~~l 680 (894)
...|+..+.||+|.||.||+++.. +|+.+|+|.+.+.... ....+.+|+.+|+++. |||||.+.+++.+....++
T Consensus 34 ~~~Y~l~~~lG~G~Fg~v~~~~~~~tg~~~A~K~i~k~~~~~~~~~~~v~~Ev~il~~l~~hpniv~l~~~~e~~~~~~l 113 (382)
T KOG0032|consen 34 KEKYELGRELGRGQFGVVYLCREKSTGKEVACKVIPKRKLRGKEDREDVRREVAILQQLSGHPNIVQLKDAFEDPDSVYL 113 (382)
T ss_pred cccEEehhhhCCCCceEEEEEEecCCCceeEEEEeehhhccccccHHHHHHHHHHHHhccCCCCEEEEEEEEEcCCeEEE
Confidence 356888899999999999999854 5999999999875432 3468999999999998 9999999999999999999
Q ss_pred EEEeccCCCHHHHHhhhcCCCCCcCHHHHHHHHHHHHHHHHHHHhccCCCeeecCCCCCCeEECCC----CcEEEEEccc
Q 002673 681 IYSYMENGSLDYWLHEKADGASQLDWLTRLKIARGTSCGLAYMHQICEPHIVHRDIKSSNILLDDQ----FEAHLADFGL 756 (894)
Q Consensus 681 V~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDLkp~NILld~~----~~vkl~DFGl 756 (894)
|||++.||.|.+.+... .++...+..++.|++.++.|||+ .+|+||||||+|+|+... +.+|++|||+
T Consensus 114 vmEL~~GGeLfd~i~~~-----~~sE~da~~~~~~il~av~~lH~---~gvvHrDlKpEN~L~~~~~~~~~~ik~~DFGl 185 (382)
T KOG0032|consen 114 VMELCEGGELFDRIVKK-----HYSERDAAGIIRQILEAVKYLHS---LGVVHRDLKPENLLLASKDEGSGRIKLIDFGL 185 (382)
T ss_pred EEEecCCchHHHHHHHc-----cCCHHHHHHHHHHHHHHHHHHHh---CCceeccCCHHHeeeccccCCCCcEEEeeCCC
Confidence 99999999999999865 28999999999999999999998 599999999999999643 4799999999
Q ss_pred ccccCCCCCcccccccccCCccCcccccCcCCCccccHHHHHHHHHHHHcCCCCCCCCCcchhhhHHHHHHHHhhcCCCC
Q 002673 757 SRLILPYQTHVTTELVGTLGYIPPEYGQAWVATLRGDMYSFGVVMLELLTGKRPVDVLKPKMSRELVGWVLKMRSEGKQD 836 (894)
Q Consensus 757 a~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwS~GvlL~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~ 836 (894)
+....+ .......+||+.|+|||++....|+..+||||+||++|.|++|..||.......... ....+..
T Consensus 186 a~~~~~--~~~~~~~~Gtp~y~APEvl~~~~y~~~~DiWS~Gvi~yiLL~G~~PF~~~~~~~~~~-------~i~~~~~- 255 (382)
T KOG0032|consen 186 AKFIKP--GERLHTIVGTPEYVAPEVLGGRPYGDEVDVWSIGVILYILLSGVPPFWGETEFEIFL-------AILRGDF- 255 (382)
T ss_pred ceEccC--CceEeeecCCccccCchhhcCCCCCcccchhHHHHHHHHHhhCCCCCcCCChhHHHH-------HHHcCCC-
Confidence 998755 445667899999999999999999999999999999999999999998654322111 1111211
Q ss_pred ccccccccCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHH--HHHhc
Q 002673 837 QVFDPILRGKGFDEEMLQVLDVACMCVSQNPFKRPTVKEVVE--WLNNV 883 (894)
Q Consensus 837 ~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~--~L~~i 883 (894)
.+....+........+++..|+..||..|+|+.++++ |+...
T Consensus 256 -----~f~~~~w~~is~~akd~i~~ll~~dp~~R~ta~~~L~HpWi~~~ 299 (382)
T KOG0032|consen 256 -----DFTSEPWDDISESAKDFIRKLLEFDPRKRLTAAQALQHPWIKSI 299 (382)
T ss_pred -----CCCCCCccccCHHHHHHHHHhcccCcccCCCHHHHhcCccccCC
Confidence 1122334444556779999999999999999999999 77665
|
|
| >cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-33 Score=307.01 Aligned_cols=256 Identities=23% Similarity=0.360 Sum_probs=206.8
Q ss_pred cCCCccceEeecCcEEEEEEE-EcCCCeEEEEEEcCcchhhHHHHHHHHHHHHhcCCCceeeecceeeecceEEEEEEec
Q 002673 607 DNFSQANIIGCGGFGLVYKAT-LANGTTLAIKKLSGDLGLMEREFKAEVEALSTAQHKNLVSLQGYCVHQGFRLLIYSYM 685 (894)
Q Consensus 607 ~~f~~~~~LG~G~fg~Vy~a~-~~~g~~vAvK~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~lV~E~~ 685 (894)
.+|+..+.||.|+||.||+|. ..+++.|++|.+..........+.+|+.+++.++|||++++++++...+..++|+||+
T Consensus 19 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 98 (296)
T cd06655 19 KKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIINEILVMKELKNPNIVNFLDSFLVGDELFVVMEYL 98 (296)
T ss_pred ceEEEEEEEecCCCeEEEEEEEcCCCcEEEEEEEecccCchHHHHHHHHHHHHhcCCCceeeeeeeEecCceEEEEEEec
Confidence 468889999999999999998 4678999999997655445567889999999999999999999999999999999999
Q ss_pred cCCCHHHHHhhhcCCCCCcCHHHHHHHHHHHHHHHHHHHhccCCCeeecCCCCCCeEECCCCcEEEEEcccccccCCCCC
Q 002673 686 ENGSLDYWLHEKADGASQLDWLTRLKIARGTSCGLAYMHQICEPHIVHRDIKSSNILLDDQFEAHLADFGLSRLILPYQT 765 (894)
Q Consensus 686 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDLkp~NILld~~~~vkl~DFGla~~~~~~~~ 765 (894)
++++|..++... .+++.++..++.|++.||.|||+ .+++||||||+||+++.++.+||+|||++........
T Consensus 99 ~~~~L~~~~~~~-----~l~~~~~~~i~~~l~~al~~LH~---~~i~H~dL~p~Nili~~~~~~kl~dfg~~~~~~~~~~ 170 (296)
T cd06655 99 AGGSLTDVVTET-----CMDEAQIAAVCRECLQALEFLHA---NQVIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQS 170 (296)
T ss_pred CCCcHHHHHHhc-----CCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEECCCCCEEEccCccchhcccccc
Confidence 999999988642 47899999999999999999997 5999999999999999999999999999886543222
Q ss_pred cccccccccCCccCcccccCcCCCccccHHHHHHHHHHHHcCCCCCCCCCcchhhhHHHHHHHHhhcCCCCccccccccC
Q 002673 766 HVTTELVGTLGYIPPEYGQAWVATLRGDMYSFGVVMLELLTGKRPVDVLKPKMSRELVGWVLKMRSEGKQDQVFDPILRG 845 (894)
Q Consensus 766 ~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwS~GvlL~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~ 845 (894)
......++..|+|||.+.+..++.++|||||||++|+|++|+.||....... ... ...... ......
T Consensus 171 -~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~~lltg~~pf~~~~~~~--~~~----~~~~~~-~~~~~~----- 237 (296)
T cd06655 171 -KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLR--ALY----LIATNG-TPELQN----- 237 (296)
T ss_pred -cCCCcCCCccccCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH--HHH----HHHhcC-CcccCC-----
Confidence 2233568899999999998889999999999999999999999997543211 111 111111 000000
Q ss_pred CCChHHHHHHHHHHHHhcccCCCCCCCHHHHHH--HHHhccc
Q 002673 846 KGFDEEMLQVLDVACMCVSQNPFKRPTVKEVVE--WLNNVGA 885 (894)
Q Consensus 846 ~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~--~L~~i~~ 885 (894)
.......+.+++.+||+.||.+||++.++++ |++..+.
T Consensus 238 --~~~~~~~~~~li~~~l~~dp~~Rpt~~~il~~~~~~~~~~ 277 (296)
T cd06655 238 --PEKLSPIFRDFLNRCLEMDVEKRGSAKELLQHPFLKLAKP 277 (296)
T ss_pred --cccCCHHHHHHHHHHhhcChhhCCCHHHHhhChHhhhccc
Confidence 0111235678899999999999999999998 7776543
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-33 Score=316.74 Aligned_cols=260 Identities=27% Similarity=0.399 Sum_probs=200.7
Q ss_pred cCCCccceEeecCcEEEEEEEE------cCCCeEEEEEEcCcch-hhHHHHHHHHHHHHhc-CCCceeeecceeeec-ce
Q 002673 607 DNFSQANIIGCGGFGLVYKATL------ANGTTLAIKKLSGDLG-LMEREFKAEVEALSTA-QHKNLVSLQGYCVHQ-GF 677 (894)
Q Consensus 607 ~~f~~~~~LG~G~fg~Vy~a~~------~~g~~vAvK~~~~~~~-~~~~~~~~Ei~~l~~l-~HpnIv~l~g~~~~~-~~ 677 (894)
++|++.+.||+|+||.||+|.. .+++.||||+++.... .....+.+|+.++.++ +||||++++++|... ..
T Consensus 7 ~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~ 86 (343)
T cd05103 7 DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGP 86 (343)
T ss_pred hHhcccccccCCccceEEEEeeccCCccccceeEEEEEeccCCChHHHHHHHHHHHHHHhccCCccHhhhcceeecCCCc
Confidence 5788999999999999999963 3578899999976432 2345688999999999 789999999988654 46
Q ss_pred EEEEEEeccCCCHHHHHhhhcC----------------------------------------------------------
Q 002673 678 RLLIYSYMENGSLDYWLHEKAD---------------------------------------------------------- 699 (894)
Q Consensus 678 ~~lV~E~~~~gsL~~~l~~~~~---------------------------------------------------------- 699 (894)
.++||||+++|+|.++++....
T Consensus 87 ~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 166 (343)
T cd05103 87 LMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEEA 166 (343)
T ss_pred eEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCccccchhhhh
Confidence 7899999999999999875321
Q ss_pred -----CCCCcCHHHHHHHHHHHHHHHHHHHhccCCCeeecCCCCCCeEECCCCcEEEEEcccccccCCCCCc-ccccccc
Q 002673 700 -----GASQLDWLTRLKIARGTSCGLAYMHQICEPHIVHRDIKSSNILLDDQFEAHLADFGLSRLILPYQTH-VTTELVG 773 (894)
Q Consensus 700 -----~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDLkp~NILld~~~~vkl~DFGla~~~~~~~~~-~~~~~~g 773 (894)
....+++..+..++.|++.||.|||+ ++|+||||||+||+++.++.+||+|||++......... ......+
T Consensus 167 ~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~---~~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~ 243 (343)
T cd05103 167 EQEDLYKKVLTLEDLICYSFQVAKGMEFLAS---RKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARL 243 (343)
T ss_pred hhhhhhhccCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCccCeEEEcCCCcEEEEecccccccccCcchhhcCCCCC
Confidence 01246888899999999999999997 59999999999999999999999999999865322211 1122345
Q ss_pred cCCccCcccccCcCCCccccHHHHHHHHHHHHc-CCCCCCCCCcchhhhHHHHHHHHhhcCCCCccccccccCCCChHHH
Q 002673 774 TLGYIPPEYGQAWVATLRGDMYSFGVVMLELLT-GKRPVDVLKPKMSRELVGWVLKMRSEGKQDQVFDPILRGKGFDEEM 852 (894)
Q Consensus 774 t~~Y~APE~~~~~~~s~ksDVwS~GvlL~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~ 852 (894)
+..|+|||.+.+..++.++||||||+++|+|++ |..||....... .... ....+..... + ... .
T Consensus 244 ~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~--~~~~----~~~~~~~~~~--~----~~~---~ 308 (343)
T cd05103 244 PLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDE--EFCR----RLKEGTRMRA--P----DYT---T 308 (343)
T ss_pred CcceECcHHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCccccH--HHHH----HHhccCCCCC--C----CCC---C
Confidence 678999999988899999999999999999997 999997543221 1111 1111111100 0 011 1
Q ss_pred HHHHHHHHHhcccCCCCCCCHHHHHHHHHhcc
Q 002673 853 LQVLDVACMCVSQNPFKRPTVKEVVEWLNNVG 884 (894)
Q Consensus 853 ~~l~~li~~Cl~~dP~~RPs~~evl~~L~~i~ 884 (894)
..+.+++..||+.+|++|||+.++++.|+.+.
T Consensus 309 ~~~~~~~~~cl~~~p~~Rps~~eil~~l~~~~ 340 (343)
T cd05103 309 PEMYQTMLDCWHGEPSQRPTFSELVEHLGNLL 340 (343)
T ss_pred HHHHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence 25678999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp |
| >cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-33 Score=302.54 Aligned_cols=257 Identities=24% Similarity=0.354 Sum_probs=199.7
Q ss_pred HHhccCCCccceEeecCcEEEEEEEE-cCCCeEEEEEEcCcchhhHHHHHHHHHHHHhcCCCceeeecceeeecceEEEE
Q 002673 603 LKATDNFSQANIIGCGGFGLVYKATL-ANGTTLAIKKLSGDLGLMEREFKAEVEALSTAQHKNLVSLQGYCVHQGFRLLI 681 (894)
Q Consensus 603 ~~a~~~f~~~~~LG~G~fg~Vy~a~~-~~g~~vAvK~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~lV 681 (894)
..+++++.....||+|+||.||+|.. .++..|++|.+........+.+.+|+.+++.++|+||+++++++..++..++|
T Consensus 4 ~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv 83 (268)
T cd06624 4 EYEYDENGERVVLGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHRNIVQYLGSDSENGFFKIF 83 (268)
T ss_pred ccccccCCceEEEecCCceEEEEeEecCCCcEEEEEEecCCCHHHHHHHHHHHHHHHhcCCCCeeeeeeeeccCCEEEEE
Confidence 34566777778999999999999984 56788999998876555667899999999999999999999999999999999
Q ss_pred EEeccCCCHHHHHhhhcCCCCCcCHHHHHHHHHHHHHHHHHHHhccCCCeeecCCCCCCeEECC-CCcEEEEEccccccc
Q 002673 682 YSYMENGSLDYWLHEKADGASQLDWLTRLKIARGTSCGLAYMHQICEPHIVHRDIKSSNILLDD-QFEAHLADFGLSRLI 760 (894)
Q Consensus 682 ~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDLkp~NILld~-~~~vkl~DFGla~~~ 760 (894)
+||+++++|.+++..... ....++..+..++.||+.||.|||+ ++|+||||||+||+++. ++.++|+|||++...
T Consensus 84 ~e~~~~~~L~~~l~~~~~-~~~~~~~~~~~~~~qi~~al~~lH~---~~i~h~dl~p~nil~~~~~~~~~l~dfg~~~~~ 159 (268)
T cd06624 84 MEQVPGGSLSALLRSKWG-PLKDNEQTIIFYTKQILEGLKYLHD---NQIVHRDIKGDNVLVNTYSGVVKISDFGTSKRL 159 (268)
T ss_pred EecCCCCCHHHHHHHhcc-cCCCcHHHHHHHHHHHHHHHHHHHH---CCEeecCCCHHHEEEcCCCCeEEEecchhheec
Confidence 999999999999986421 1122778888999999999999997 69999999999999986 679999999998765
Q ss_pred CCCCCcccccccccCCccCcccccCc--CCCccccHHHHHHHHHHHHcCCCCCCCCCcchhhhHHHHHHHHhhcCCCCcc
Q 002673 761 LPYQTHVTTELVGTLGYIPPEYGQAW--VATLRGDMYSFGVVMLELLTGKRPVDVLKPKMSRELVGWVLKMRSEGKQDQV 838 (894)
Q Consensus 761 ~~~~~~~~~~~~gt~~Y~APE~~~~~--~~s~ksDVwS~GvlL~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 838 (894)
..... ......++..|+|||++.+. .++.++||||||+++|+|++|+.||........ ..+....... ...
T Consensus 160 ~~~~~-~~~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slGvvl~~l~~g~~p~~~~~~~~~---~~~~~~~~~~--~~~- 232 (268)
T cd06624 160 AGINP-CTETFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELGEPQA---AMFKVGMFKI--HPE- 232 (268)
T ss_pred ccCCC-ccccCCCCccccChhhhccccccCCchhhhHHHHHHHHHHHhCCCCCccccChhh---hHhhhhhhcc--CCC-
Confidence 32221 22234578999999998664 378899999999999999999999975332111 1111110000 000
Q ss_pred ccccccCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 002673 839 FDPILRGKGFDEEMLQVLDVACMCVSQNPFKRPTVKEVVE 878 (894)
Q Consensus 839 ~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~ 878 (894)
+ .......+.+++.+||+.+|.+|||+.++++
T Consensus 233 ----~----~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~ 264 (268)
T cd06624 233 ----I----PESLSAEAKNFILRCFEPDPDKRASAHDLLQ 264 (268)
T ss_pred ----C----CcccCHHHHHHHHHHcCCCchhCCCHHHHHh
Confidence 0 0111235678899999999999999999986
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina |
| >cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-33 Score=304.29 Aligned_cols=240 Identities=23% Similarity=0.395 Sum_probs=188.6
Q ss_pred ceEeecCcEEEEEEEEcC-------------CCeEEEEEEcCcchhhHHHHHHHHHHHHhcCCCceeeecceeeecceEE
Q 002673 613 NIIGCGGFGLVYKATLAN-------------GTTLAIKKLSGDLGLMEREFKAEVEALSTAQHKNLVSLQGYCVHQGFRL 679 (894)
Q Consensus 613 ~~LG~G~fg~Vy~a~~~~-------------g~~vAvK~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~ 679 (894)
+.||+|+||.||+|.+.+ ...|++|.+..........+.+|+.+++.++||||+++++++..+...+
T Consensus 1 ~~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~l~~l~hp~iv~~~~~~~~~~~~~ 80 (262)
T cd05077 1 EHLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSHRDISLAFFETASMMRQVSHKHIVLLYGVCVRDVENI 80 (262)
T ss_pred CccccCCcceEeeeecccCCCccccccchhhceeEEEeecChhhhhHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCE
Confidence 368999999999998532 2358899887654444567888999999999999999999999999999
Q ss_pred EEEEeccCCCHHHHHhhhcCCCCCcCHHHHHHHHHHHHHHHHHHHhccCCCeeecCCCCCCeEECCCCc-------EEEE
Q 002673 680 LIYSYMENGSLDYWLHEKADGASQLDWLTRLKIARGTSCGLAYMHQICEPHIVHRDIKSSNILLDDQFE-------AHLA 752 (894)
Q Consensus 680 lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDLkp~NILld~~~~-------vkl~ 752 (894)
+||||+++|+|..+++... ..+++..++.++.||+.||+|||+ ++|+||||||+|||++.++. ++++
T Consensus 81 lv~e~~~~~~l~~~~~~~~---~~~~~~~~~~i~~qi~~~l~~lH~---~~ivH~dlkp~Nill~~~~~~~~~~~~~~l~ 154 (262)
T cd05077 81 MVEEFVEFGPLDLFMHRKS---DVLTTPWKFKVAKQLASALSYLED---KDLVHGNVCTKNILLAREGIDGECGPFIKLS 154 (262)
T ss_pred EEEecccCCCHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHhhh---CCeECCCCCcccEEEecCCccCCCCceeEeC
Confidence 9999999999998887532 358889999999999999999997 69999999999999987664 8999
Q ss_pred EcccccccCCCCCcccccccccCCccCccccc-CcCCCccccHHHHHHHHHHHH-cCCCCCCCCCcchhhhHHHHHHHHh
Q 002673 753 DFGLSRLILPYQTHVTTELVGTLGYIPPEYGQ-AWVATLRGDMYSFGVVMLELL-TGKRPVDVLKPKMSRELVGWVLKMR 830 (894)
Q Consensus 753 DFGla~~~~~~~~~~~~~~~gt~~Y~APE~~~-~~~~s~ksDVwS~GvlL~ell-tG~~Pf~~~~~~~~~~~~~~~~~~~ 830 (894)
|||++..... .....++..|+|||++. +..++.++|||||||++|||+ +|+.||......... ...
T Consensus 155 d~g~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~-------~~~ 222 (262)
T cd05077 155 DPGIPITVLS-----RQECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPLKDKTLAEKE-------RFY 222 (262)
T ss_pred CCCCCccccC-----cccccccccccChhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCcchhHHH-------HHH
Confidence 9999875422 12345788999999886 467899999999999999997 588888643321110 000
Q ss_pred hcCCCCccccccccCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 002673 831 SEGKQDQVFDPILRGKGFDEEMLQVLDVACMCVSQNPFKRPTVKEVVEWLN 881 (894)
Q Consensus 831 ~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~ 881 (894)
. ... ... ......+.+++.+||+.||.+||++.+|++.|+
T Consensus 223 ~-~~~-~~~---------~~~~~~~~~li~~cl~~dp~~Rp~~~~il~~~~ 262 (262)
T cd05077 223 E-GQC-MLV---------TPSCKELADLMTHCMNYDPNQRPFFRAIMRDIN 262 (262)
T ss_pred h-cCc-cCC---------CCChHHHHHHHHHHcCCChhhCcCHHHHHHhcC
Confidence 0 100 010 111235778999999999999999999998763
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom |
| >cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-33 Score=306.18 Aligned_cols=262 Identities=25% Similarity=0.372 Sum_probs=201.0
Q ss_pred cCCCccceEeecCcEEEEEEEE-----cCCCeEEEEEEcCcc-hhhHHHHHHHHHHHHhcCCCceeeecceeeec--ceE
Q 002673 607 DNFSQANIIGCGGFGLVYKATL-----ANGTTLAIKKLSGDL-GLMEREFKAEVEALSTAQHKNLVSLQGYCVHQ--GFR 678 (894)
Q Consensus 607 ~~f~~~~~LG~G~fg~Vy~a~~-----~~g~~vAvK~~~~~~-~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~--~~~ 678 (894)
..|++.+.||+|+||.||++.+ .++..||+|.+.... ......+.+|+.+++.++|||++++++++... ...
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~ 83 (284)
T cd05079 4 RFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGI 83 (284)
T ss_pred hhhhhceecCCCCceeEEEEEEccCCCCccceEEEEEcCccccHHHHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCCce
Confidence 3467789999999999999974 357889999987543 33346789999999999999999999998875 568
Q ss_pred EEEEEeccCCCHHHHHhhhcCCCCCcCHHHHHHHHHHHHHHHHHHHhccCCCeeecCCCCCCeEECCCCcEEEEEccccc
Q 002673 679 LLIYSYMENGSLDYWLHEKADGASQLDWLTRLKIARGTSCGLAYMHQICEPHIVHRDIKSSNILLDDQFEAHLADFGLSR 758 (894)
Q Consensus 679 ~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDLkp~NILld~~~~vkl~DFGla~ 758 (894)
++||||+++++|.+++.... ..+++..++.++.|++.||.|||+ ++++||||||+||+++.++.+||+|||+++
T Consensus 84 ~lv~e~~~g~~L~~~l~~~~---~~~~~~~~~~i~~~i~~aL~~lH~---~gi~H~dlkp~Nil~~~~~~~~l~dfg~~~ 157 (284)
T cd05079 84 KLIMEFLPSGSLKEYLPRNK---NKINLKQQLKYAVQICKGMDYLGS---RQYVHRDLAARNVLVESEHQVKIGDFGLTK 157 (284)
T ss_pred EEEEEccCCCCHHHHHHhcc---CCCCHHHHHHHHHHHHHHHHHHHH---CCeeecccchheEEEcCCCCEEECCCcccc
Confidence 89999999999999997542 358999999999999999999997 699999999999999999999999999998
Q ss_pred ccCCCCCc--ccccccccCCccCcccccCcCCCccccHHHHHHHHHHHHcCCCCCCCCCcc--------hhhhHHHHHHH
Q 002673 759 LILPYQTH--VTTELVGTLGYIPPEYGQAWVATLRGDMYSFGVVMLELLTGKRPVDVLKPK--------MSRELVGWVLK 828 (894)
Q Consensus 759 ~~~~~~~~--~~~~~~gt~~Y~APE~~~~~~~s~ksDVwS~GvlL~elltG~~Pf~~~~~~--------~~~~~~~~~~~ 828 (894)
........ ......++..|+|||++.+..++.++||||||+++|||++++.|+...... ...........
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~ellt~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (284)
T cd05079 158 AIETDKEYYTVKDDLDSPVFWYAPECLIQSKFYIASDVWSFGVTLYELLTYCDSESSPMTLFLKMIGPTHGQMTVTRLVR 237 (284)
T ss_pred ccccCccceeecCCCCCCccccCHHHhccCCCCccccchhhhhhhhhhhcCCCCCccccchhhhhcccccccccHHHHHH
Confidence 76432221 122345677899999998888999999999999999999987765321100 00000011111
Q ss_pred HhhcCCCCccccccccCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhc
Q 002673 829 MRSEGKQDQVFDPILRGKGFDEEMLQVLDVACMCVSQNPFKRPTVKEVVEWLNNV 883 (894)
Q Consensus 829 ~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~i 883 (894)
....+.... ........+.+++.+|++.+|++|||++++++.|+.+
T Consensus 238 ~~~~~~~~~---------~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~~~ 283 (284)
T cd05079 238 VLEEGKRLP---------RPPNCPEEVYQLMRKCWEFQPSKRTTFQNLIEGFEAI 283 (284)
T ss_pred HHHcCccCC---------CCCCCCHHHHHHHHHHccCCcccCcCHHHHHHHHHhh
Confidence 111111100 0111234678999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a |
| >cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-33 Score=305.75 Aligned_cols=259 Identities=25% Similarity=0.371 Sum_probs=204.4
Q ss_pred cCCCccceEeecCcEEEEEEEE-cCCCeEEEEEEcCcchhhHHHHHHHHHHHHhcCCCceeeecceeeecceEEEEEEec
Q 002673 607 DNFSQANIIGCGGFGLVYKATL-ANGTTLAIKKLSGDLGLMEREFKAEVEALSTAQHKNLVSLQGYCVHQGFRLLIYSYM 685 (894)
Q Consensus 607 ~~f~~~~~LG~G~fg~Vy~a~~-~~g~~vAvK~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~lV~E~~ 685 (894)
+.|++.+.||.|+||.||+|.. .++..|++|.+........+.+.+|+.+++.++|+||+++++++..+...++||||+
T Consensus 12 ~~y~i~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 91 (292)
T cd06644 12 EVWEIIGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGAFYWDGKLWIMIEFC 91 (292)
T ss_pred hhhhhhheecCCCCeEEEEEEECCCCceEEEEEeccCCHHHHHHHHHHHHHHHhCCCCcEeeeEEEEEeCCeEEEEEecC
Confidence 5688889999999999999985 458999999998765556677899999999999999999999999999999999999
Q ss_pred cCCCHHHHHhhhcCCCCCcCHHHHHHHHHHHHHHHHHHHhccCCCeeecCCCCCCeEECCCCcEEEEEcccccccCCCCC
Q 002673 686 ENGSLDYWLHEKADGASQLDWLTRLKIARGTSCGLAYMHQICEPHIVHRDIKSSNILLDDQFEAHLADFGLSRLILPYQT 765 (894)
Q Consensus 686 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDLkp~NILld~~~~vkl~DFGla~~~~~~~~ 765 (894)
++++|..++.+.. ..+++..+..++.|++.+|.|||+ .+++||||||+||+++.++.+||+|||++.......
T Consensus 92 ~~~~l~~~~~~~~---~~l~~~~~~~~~~ql~~~l~~lH~---~~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~~- 164 (292)
T cd06644 92 PGGAVDAIMLELD---RGLTEPQIQVICRQMLEALQYLHS---MKIIHRDLKAGNVLLTLDGDIKLADFGVSAKNVKTL- 164 (292)
T ss_pred CCCcHHHHHHhhc---CCCCHHHHHHHHHHHHHHHHHHhc---CCeeecCCCcceEEEcCCCCEEEccCccceeccccc-
Confidence 9999988876542 358899999999999999999996 599999999999999999999999999987542221
Q ss_pred cccccccccCCccCccccc-----CcCCCccccHHHHHHHHHHHHcCCCCCCCCCcchhhhHHHHHHHHhhcCCCCcccc
Q 002673 766 HVTTELVGTLGYIPPEYGQ-----AWVATLRGDMYSFGVVMLELLTGKRPVDVLKPKMSRELVGWVLKMRSEGKQDQVFD 840 (894)
Q Consensus 766 ~~~~~~~gt~~Y~APE~~~-----~~~~s~ksDVwS~GvlL~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 840 (894)
.......++..|+|||++. ...++.++|||||||++|||++|+.||...... .. ......... .....
T Consensus 165 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~--~~----~~~~~~~~~-~~~~~ 237 (292)
T cd06644 165 QRRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPM--RV----LLKIAKSEP-PTLSQ 237 (292)
T ss_pred cccceecCCccccCceeeccccccCCCCCchhhhHhHHHHHHHHhcCCCCCccccHH--HH----HHHHhcCCC-ccCCC
Confidence 1123346788999999874 345688999999999999999999999754321 11 111111111 11100
Q ss_pred ccccCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHH--HHHhcccc
Q 002673 841 PILRGKGFDEEMLQVLDVACMCVSQNPFKRPTVKEVVE--WLNNVGAN 886 (894)
Q Consensus 841 ~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~--~L~~i~~~ 886 (894)
.......+.+++.+||+.+|++||++.++++ ++..+...
T Consensus 238 -------~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~~~~~~~ 278 (292)
T cd06644 238 -------PSKWSMEFRDFLKTALDKHPETRPSAAQLLEHPFVSSVTSN 278 (292)
T ss_pred -------CcccCHHHHHHHHHHhcCCcccCcCHHHHhcCccccccccc
Confidence 1112235778999999999999999999988 66655443
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. |
| >cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-33 Score=312.39 Aligned_cols=261 Identities=26% Similarity=0.400 Sum_probs=204.1
Q ss_pred cCCCccceEeecCcEEEEEEEEc--------CCCeEEEEEEcCcc-hhhHHHHHHHHHHHHhc-CCCceeeecceeeecc
Q 002673 607 DNFSQANIIGCGGFGLVYKATLA--------NGTTLAIKKLSGDL-GLMEREFKAEVEALSTA-QHKNLVSLQGYCVHQG 676 (894)
Q Consensus 607 ~~f~~~~~LG~G~fg~Vy~a~~~--------~g~~vAvK~~~~~~-~~~~~~~~~Ei~~l~~l-~HpnIv~l~g~~~~~~ 676 (894)
++|.+.+.||+|+||.||+|... ....+|+|.+.... ......+..|+.+++++ +||||+++++++..++
T Consensus 12 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~ 91 (314)
T cd05099 12 DRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKHKNIINLLGVCTQEG 91 (314)
T ss_pred HHeeeeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCCCChHHHHHHHHHHHHHHhccCCCCeeeEEEEEccCC
Confidence 56788899999999999999742 24568999987543 23345688999999999 6999999999999988
Q ss_pred eEEEEEEeccCCCHHHHHhhhcC------------CCCCcCHHHHHHHHHHHHHHHHHHHhccCCCeeecCCCCCCeEEC
Q 002673 677 FRLLIYSYMENGSLDYWLHEKAD------------GASQLDWLTRLKIARGTSCGLAYMHQICEPHIVHRDIKSSNILLD 744 (894)
Q Consensus 677 ~~~lV~E~~~~gsL~~~l~~~~~------------~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDLkp~NILld 744 (894)
..++||||+++|+|.+++..... ....+++..+..++.|++.||.|||+ ++++||||||+||+++
T Consensus 92 ~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~---~gi~H~dlkp~Nill~ 168 (314)
T cd05099 92 PLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLES---RRCIHRDLAARNVLVT 168 (314)
T ss_pred ceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHHH---CCeeeccccceeEEEc
Confidence 99999999999999999976421 12458999999999999999999997 5999999999999999
Q ss_pred CCCcEEEEEcccccccCCCCCc-ccccccccCCccCcccccCcCCCccccHHHHHHHHHHHHc-CCCCCCCCCcchhhhH
Q 002673 745 DQFEAHLADFGLSRLILPYQTH-VTTELVGTLGYIPPEYGQAWVATLRGDMYSFGVVMLELLT-GKRPVDVLKPKMSREL 822 (894)
Q Consensus 745 ~~~~vkl~DFGla~~~~~~~~~-~~~~~~gt~~Y~APE~~~~~~~s~ksDVwS~GvlL~ellt-G~~Pf~~~~~~~~~~~ 822 (894)
.++.+||+|||+++........ ......++..|+|||++.+..++.++||||||+++|||++ |..||....... .
T Consensus 169 ~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~---~ 245 (314)
T cd05099 169 EDNVMKIADFGLARGVHDIDYYKKTSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFTLGGSPYPGIPVEE---L 245 (314)
T ss_pred CCCcEEEccccccccccccccccccccCCCCccccCHHHHccCCcCccchhhHHHHHHHHHHhCCCCCCCCCCHHH---H
Confidence 9999999999999865432211 1112234467999999988899999999999999999999 899997543221 1
Q ss_pred HHHHHHHhhcCCCCccccccccCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhcccc
Q 002673 823 VGWVLKMRSEGKQDQVFDPILRGKGFDEEMLQVLDVACMCVSQNPFKRPTVKEVVEWLNNVGAN 886 (894)
Q Consensus 823 ~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~i~~~ 886 (894)
.... ........ ......++.+++.+|++.+|++|||+.++++.|+++...
T Consensus 246 ~~~~----~~~~~~~~---------~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~~l~~~~~~ 296 (314)
T cd05099 246 FKLL----REGHRMDK---------PSNCTHELYMLMRECWHAVPTQRPTFKQLVEALDKVLAA 296 (314)
T ss_pred HHHH----HcCCCCCC---------CCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHHH
Confidence 1111 11111110 011123567899999999999999999999999987654
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-33 Score=303.99 Aligned_cols=254 Identities=25% Similarity=0.439 Sum_probs=200.8
Q ss_pred CCCccceEeecCcEEEEEEEEc-CC---CeEEEEEEcCcc-hhhHHHHHHHHHHHHhcCCCceeeecceeeecceEEEEE
Q 002673 608 NFSQANIIGCGGFGLVYKATLA-NG---TTLAIKKLSGDL-GLMEREFKAEVEALSTAQHKNLVSLQGYCVHQGFRLLIY 682 (894)
Q Consensus 608 ~f~~~~~LG~G~fg~Vy~a~~~-~g---~~vAvK~~~~~~-~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~lV~ 682 (894)
+|++.+.||+|+||.||+|... ++ ..||||.+.... ......+..|+.+++.++||||+++++++..+...++||
T Consensus 5 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~ 84 (269)
T cd05065 5 CVKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSRPVMIIT 84 (269)
T ss_pred HeEEEeEecCCCCCeEEEEEEecCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCcCcceEEEEECCCCceEEEE
Confidence 4677899999999999999854 33 369999987642 334567999999999999999999999999999999999
Q ss_pred EeccCCCHHHHHhhhcCCCCCcCHHHHHHHHHHHHHHHHHHHhccCCCeeecCCCCCCeEECCCCcEEEEEcccccccCC
Q 002673 683 SYMENGSLDYWLHEKADGASQLDWLTRLKIARGTSCGLAYMHQICEPHIVHRDIKSSNILLDDQFEAHLADFGLSRLILP 762 (894)
Q Consensus 683 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDLkp~NILld~~~~vkl~DFGla~~~~~ 762 (894)
||+++|+|.+++.... ..+++.+++.++.|++.||.|||+ ++++|+||||+||+++.++.+||+|||++.....
T Consensus 85 e~~~~~~L~~~l~~~~---~~~~~~~~~~i~~~l~~al~~lH~---~g~~H~dl~p~nili~~~~~~kl~dfg~~~~~~~ 158 (269)
T cd05065 85 EFMENGALDSFLRQND---GQFTVIQLVGMLRGIAAGMKYLSE---MNYVHRDLAARNILVNSNLVCKVSDFGLSRFLED 158 (269)
T ss_pred ecCCCCcHHHHHhhCC---CCCCHHHHHHHHHHHHHHHHHHHH---CCEeecccChheEEEcCCCcEEECCCcccccccc
Confidence 9999999999997642 458999999999999999999997 5999999999999999999999999999876533
Q ss_pred CCCccc--cccc--ccCCccCcccccCcCCCccccHHHHHHHHHHHHc-CCCCCCCCCcchhhhHHHHHHHHhhcCCCCc
Q 002673 763 YQTHVT--TELV--GTLGYIPPEYGQAWVATLRGDMYSFGVVMLELLT-GKRPVDVLKPKMSRELVGWVLKMRSEGKQDQ 837 (894)
Q Consensus 763 ~~~~~~--~~~~--gt~~Y~APE~~~~~~~s~ksDVwS~GvlL~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 837 (894)
...... .... .+..|+|||++.+..++.++|||||||++|||++ |..||...... +...+.. .......
T Consensus 159 ~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~e~l~~g~~p~~~~~~~---~~~~~i~---~~~~~~~ 232 (269)
T cd05065 159 DTSDPTYTSSLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQ---DVINAIE---QDYRLPP 232 (269)
T ss_pred CccccccccccCCCcceeecCHhHhccCcccchhhhhhhHHHHHHHhcCCCCCCCCCCHH---HHHHHHH---cCCcCCC
Confidence 221111 1111 2357999999999999999999999999999987 99999754322 2222221 1111100
Q ss_pred cccccccCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhc
Q 002673 838 VFDPILRGKGFDEEMLQVLDVACMCVSQNPFKRPTVKEVVEWLNNV 883 (894)
Q Consensus 838 ~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~i 883 (894)
..+....+.+++.+||+.+|++||++.+++..|+++
T Consensus 233 ----------~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~ 268 (269)
T cd05065 233 ----------PMDCPTALHQLMLDCWQKDRNARPKFGQIVSTLDKM 268 (269)
T ss_pred ----------cccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 011123567899999999999999999999998865
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr |
| >cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-33 Score=310.37 Aligned_cols=258 Identities=24% Similarity=0.341 Sum_probs=207.3
Q ss_pred cCCCccceEeecCcEEEEEEEE-cCCCeEEEEEEcCcchhhHHHHHHHHHHHHhcCCCceeeecceeeecceEEEEEEec
Q 002673 607 DNFSQANIIGCGGFGLVYKATL-ANGTTLAIKKLSGDLGLMEREFKAEVEALSTAQHKNLVSLQGYCVHQGFRLLIYSYM 685 (894)
Q Consensus 607 ~~f~~~~~LG~G~fg~Vy~a~~-~~g~~vAvK~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~lV~E~~ 685 (894)
.+|+..+.||+|+||.||+|.. .+++.||+|.+........+.+.+|+.+++.++|+||+++++++..++..++||||+
T Consensus 19 ~~y~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~ 98 (297)
T cd06656 19 KKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYL 98 (297)
T ss_pred hhceeeeeeccCCCeEEEEEEECCCCCEEEEEEEecCccchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCEEEEeeccc
Confidence 5788899999999999999984 579999999997655445567889999999999999999999999999999999999
Q ss_pred cCCCHHHHHhhhcCCCCCcCHHHHHHHHHHHHHHHHHHHhccCCCeeecCCCCCCeEECCCCcEEEEEcccccccCCCCC
Q 002673 686 ENGSLDYWLHEKADGASQLDWLTRLKIARGTSCGLAYMHQICEPHIVHRDIKSSNILLDDQFEAHLADFGLSRLILPYQT 765 (894)
Q Consensus 686 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDLkp~NILld~~~~vkl~DFGla~~~~~~~~ 765 (894)
++++|.+++... .+++..+..++.|++.||.|||+ .+++||||||+||+++.++.++|+|||++........
T Consensus 99 ~~~~L~~~~~~~-----~~~~~~~~~~~~~l~~~L~~LH~---~~i~H~dL~p~Nili~~~~~~~l~Dfg~~~~~~~~~~ 170 (297)
T cd06656 99 AGGSLTDVVTET-----CMDEGQIAAVCRECLQALDFLHS---NQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS 170 (297)
T ss_pred CCCCHHHHHHhC-----CCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEECCCCCEEECcCccceEccCCcc
Confidence 999999998642 47888999999999999999997 5999999999999999999999999999876533221
Q ss_pred cccccccccCCccCcccccCcCCCccccHHHHHHHHHHHHcCCCCCCCCCcchhhhHHHHHHHHhhcCCCCccccccccC
Q 002673 766 HVTTELVGTLGYIPPEYGQAWVATLRGDMYSFGVVMLELLTGKRPVDVLKPKMSRELVGWVLKMRSEGKQDQVFDPILRG 845 (894)
Q Consensus 766 ~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwS~GvlL~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~ 845 (894)
......+++.|+|||...+..++.++|||||||++|+|++|+.||........ .. .....+ .....
T Consensus 171 -~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slGvil~~l~tg~~pf~~~~~~~~--~~----~~~~~~-~~~~~------ 236 (297)
T cd06656 171 -KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRA--LY----LIATNG-TPELQ------ 236 (297)
T ss_pred -CcCcccCCccccCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcchh--ee----eeccCC-CCCCC------
Confidence 12334688899999999988899999999999999999999999965332110 00 000000 00000
Q ss_pred CCChHHHHHHHHHHHHhcccCCCCCCCHHHHHH--HHHhccccc
Q 002673 846 KGFDEEMLQVLDVACMCVSQNPFKRPTVKEVVE--WLNNVGANR 887 (894)
Q Consensus 846 ~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~--~L~~i~~~~ 887 (894)
........+.+++.+||+.+|++||++.++++ |++..+...
T Consensus 237 -~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~~~~~~~~~ 279 (297)
T cd06656 237 -NPERLSAVFRDFLNRCLEMDVDRRGSAKELLQHPFLKLAKPLS 279 (297)
T ss_pred -CccccCHHHHHHHHHHccCChhhCcCHHHHhcCchhccccccc
Confidence 01112234678899999999999999999998 887666543
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-34 Score=314.40 Aligned_cols=240 Identities=26% Similarity=0.386 Sum_probs=189.6
Q ss_pred ceEeecCcEEEEEEEE-cCCCeEEEEEEcCcch---hhHHHHHHHHHHHHhc-CCCceeeecceeeecceEEEEEEeccC
Q 002673 613 NIIGCGGFGLVYKATL-ANGTTLAIKKLSGDLG---LMEREFKAEVEALSTA-QHKNLVSLQGYCVHQGFRLLIYSYMEN 687 (894)
Q Consensus 613 ~~LG~G~fg~Vy~a~~-~~g~~vAvK~~~~~~~---~~~~~~~~Ei~~l~~l-~HpnIv~l~g~~~~~~~~~lV~E~~~~ 687 (894)
+.||+|+||.||+|.. .+|+.||+|.+..... .....+..|..++... +||||+++++++.+++..++||||+++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~~~~ 80 (316)
T cd05620 1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCTFQTKEHLFFVMEFLNG 80 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCCccCeeEEEEeCCEEEEEECCCCC
Confidence 4699999999999985 4688999999975431 2234566777787754 899999999999999999999999999
Q ss_pred CCHHHHHhhhcCCCCCcCHHHHHHHHHHHHHHHHHHHhccCCCeeecCCCCCCeEECCCCcEEEEEcccccccCCCCCcc
Q 002673 688 GSLDYWLHEKADGASQLDWLTRLKIARGTSCGLAYMHQICEPHIVHRDIKSSNILLDDQFEAHLADFGLSRLILPYQTHV 767 (894)
Q Consensus 688 gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDLkp~NILld~~~~vkl~DFGla~~~~~~~~~~ 767 (894)
|+|..++... ..+++..+..++.|++.||+|||+ ++|+||||||+|||++.++.+||+|||+++..... ...
T Consensus 81 g~L~~~i~~~----~~~~~~~~~~~~~qi~~~l~~lH~---~~ivHrDlkp~Nil~~~~~~~kl~Dfg~~~~~~~~-~~~ 152 (316)
T cd05620 81 GDLMFHIQDK----GRFDLYRATFYAAEIVCGLQFLHS---KGIIYRDLKLDNVMLDRDGHIKIADFGMCKENVFG-DNR 152 (316)
T ss_pred CcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHH---CCeEecCCCHHHeEECCCCCEEeCccCCCeecccC-CCc
Confidence 9999988753 357888999999999999999997 59999999999999999999999999998753211 122
Q ss_pred cccccccCCccCcccccCcCCCccccHHHHHHHHHHHHcCCCCCCCCCcchhhhHHHHHHHHhhcCCCCccccccccCCC
Q 002673 768 TTELVGTLGYIPPEYGQAWVATLRGDMYSFGVVMLELLTGKRPVDVLKPKMSRELVGWVLKMRSEGKQDQVFDPILRGKG 847 (894)
Q Consensus 768 ~~~~~gt~~Y~APE~~~~~~~s~ksDVwS~GvlL~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~ 847 (894)
.....||+.|+|||++.+..++.++|||||||++|||++|+.||...... ...... .. .. +.+. ..
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~Pf~~~~~~---~~~~~~---~~-~~------~~~~-~~ 218 (316)
T cd05620 153 ASTFCGTPDYIAPEILQGLKYTFSVDWWSFGVLLYEMLIGQSPFHGDDED---ELFESI---RV-DT------PHYP-RW 218 (316)
T ss_pred eeccCCCcCccCHHHHcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHH---HHHHHH---Hh-CC------CCCC-CC
Confidence 34467899999999999999999999999999999999999999754321 111111 11 10 0010 01
Q ss_pred ChHHHHHHHHHHHHhcccCCCCCCCHH-HHH
Q 002673 848 FDEEMLQVLDVACMCVSQNPFKRPTVK-EVV 877 (894)
Q Consensus 848 ~~~~~~~l~~li~~Cl~~dP~~RPs~~-evl 877 (894)
....+.+++.+|++.||++||++. ++.
T Consensus 219 ---~~~~~~~li~~~l~~dP~~R~~~~~~~~ 246 (316)
T cd05620 219 ---ITKESKDILEKLFERDPTRRLGVVGNIR 246 (316)
T ss_pred ---CCHHHHHHHHHHccCCHHHcCCChHHHH
Confidence 123567889999999999999984 665
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I |
| >cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-33 Score=307.45 Aligned_cols=255 Identities=25% Similarity=0.372 Sum_probs=203.1
Q ss_pred cCCCccceEeecCcEEEEEEEE-cCCCeEEEEEEcCcc-hhhHHHHHHHHHHHHhcCCCceeeecceeeecceEEEEEEe
Q 002673 607 DNFSQANIIGCGGFGLVYKATL-ANGTTLAIKKLSGDL-GLMEREFKAEVEALSTAQHKNLVSLQGYCVHQGFRLLIYSY 684 (894)
Q Consensus 607 ~~f~~~~~LG~G~fg~Vy~a~~-~~g~~vAvK~~~~~~-~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~lV~E~ 684 (894)
++|++.+.||+|+||.||++.. .+|..||+|++.... ......+.+|+++++.++||||+++++++......++||||
T Consensus 5 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 84 (284)
T cd06620 5 EDLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQILRELQIMHECRSPYIVSFYGAFLNENNICMCMEF 84 (284)
T ss_pred HHHHHHHHcCCCCCeEEEEEEEcCCCcEEEEEEEEecCcchHHHHHHHHHHHHHHcCCCCcceEeeeEecCCEEEEEEec
Confidence 4677789999999999999985 468899999876543 33456789999999999999999999999999999999999
Q ss_pred ccCCCHHHHHhhhcCCCCCcCHHHHHHHHHHHHHHHHHHHhccCCCeeecCCCCCCeEECCCCcEEEEEcccccccCCCC
Q 002673 685 MENGSLDYWLHEKADGASQLDWLTRLKIARGTSCGLAYMHQICEPHIVHRDIKSSNILLDDQFEAHLADFGLSRLILPYQ 764 (894)
Q Consensus 685 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDLkp~NILld~~~~vkl~DFGla~~~~~~~ 764 (894)
+++|+|.+++... ..+++.....++.+++.||.|||+. .+++||||||+||+++.++.++|+|||++......
T Consensus 85 ~~~~~L~~~~~~~----~~~~~~~~~~~~~~i~~~l~~LH~~--~~i~H~dl~p~nil~~~~~~~~l~d~gl~~~~~~~- 157 (284)
T cd06620 85 MDCGSLDRIYKKG----GPIPVEILGKIAVAVVEGLTYLYNV--HRIMHRDIKPSNILVNSRGQIKLCDFGVSGELINS- 157 (284)
T ss_pred CCCCCHHHHHHhc----cCCCHHHHHHHHHHHHHHHHHHHHh--cCeeccCCCHHHEEECCCCcEEEccCCcccchhhh-
Confidence 9999999988753 3588999999999999999999962 58999999999999999999999999998754221
Q ss_pred CcccccccccCCccCcccccCcCCCccccHHHHHHHHHHHHcCCCCCCCCCcc-----hhhhHHHHHHHHhhcCCCCccc
Q 002673 765 THVTTELVGTLGYIPPEYGQAWVATLRGDMYSFGVVMLELLTGKRPVDVLKPK-----MSRELVGWVLKMRSEGKQDQVF 839 (894)
Q Consensus 765 ~~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwS~GvlL~elltG~~Pf~~~~~~-----~~~~~~~~~~~~~~~~~~~~~~ 839 (894)
......|+..|+|||++.+..++.++|||||||++|+|++|+.||...... .......+......... .
T Consensus 158 --~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~--- 231 (284)
T cd06620 158 --IADTFVGTSTYMSPERIQGGKYTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGILDLLQQIVQEPP-P--- 231 (284)
T ss_pred --ccCccccCcccCCHHHHccCCCCccchHHHHHHHHHHHHhCCCCCcccchhhhhhhhhhHHHHHHHHHhhccC-C---
Confidence 122356899999999998889999999999999999999999999754431 11122222222221111 0
Q ss_pred cccccCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 002673 840 DPILRGKGFDEEMLQVLDVACMCVSQNPFKRPTVKEVVEW 879 (894)
Q Consensus 840 d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~ 879 (894)
.+.. ......+.+++.+|++.||++|||+.++++.
T Consensus 232 --~~~~---~~~~~~~~~li~~~l~~dp~~Rpt~~e~~~~ 266 (284)
T cd06620 232 --RLPS---SDFPEDLRDFVDACLLKDPTERPTPQQLCAM 266 (284)
T ss_pred --CCCc---hhcCHHHHHHHHHHhcCCcccCcCHHHHhcC
Confidence 0100 1122357789999999999999999999984
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-33 Score=299.95 Aligned_cols=250 Identities=29% Similarity=0.448 Sum_probs=202.3
Q ss_pred ceEeecCcEEEEEEEEcC----CCeEEEEEEcCcchhh-HHHHHHHHHHHHhcCCCceeeecceeeecceEEEEEEeccC
Q 002673 613 NIIGCGGFGLVYKATLAN----GTTLAIKKLSGDLGLM-EREFKAEVEALSTAQHKNLVSLQGYCVHQGFRLLIYSYMEN 687 (894)
Q Consensus 613 ~~LG~G~fg~Vy~a~~~~----g~~vAvK~~~~~~~~~-~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~lV~E~~~~ 687 (894)
+.||+|+||.||+|.... +..|++|.+....... .+.+.+|++.++.++|+|++++++++..+...++||||+++
T Consensus 1 ~~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (262)
T cd00192 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVRLLGVCTEEEPLYLVLEYMEG 80 (262)
T ss_pred CccccCCceEEEEEEEecCCCCCceEEeEeeccccchhHHHHHHHHHHHHhhcCCCChheeeeeecCCCceEEEEEeccC
Confidence 468999999999998643 7889999998754433 57789999999999999999999999999999999999999
Q ss_pred CCHHHHHhhhcCC-----CCCcCHHHHHHHHHHHHHHHHHHHhccCCCeeecCCCCCCeEECCCCcEEEEEcccccccCC
Q 002673 688 GSLDYWLHEKADG-----ASQLDWLTRLKIARGTSCGLAYMHQICEPHIVHRDIKSSNILLDDQFEAHLADFGLSRLILP 762 (894)
Q Consensus 688 gsL~~~l~~~~~~-----~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDLkp~NILld~~~~vkl~DFGla~~~~~ 762 (894)
++|.+++...... ...+++..+..++.|++.||.|||+ ++++|+||||+||+++.++.+||+|||.+.....
T Consensus 81 ~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~---~~i~H~di~p~nili~~~~~~~l~dfg~~~~~~~ 157 (262)
T cd00192 81 GDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLAS---KKFVHRDLAARNCLVGEDLVVKISDFGLSRDVYD 157 (262)
T ss_pred CcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHHc---CCcccCccCcceEEECCCCcEEEccccccccccc
Confidence 9999999865221 3668999999999999999999997 6999999999999999999999999999987643
Q ss_pred CCC-cccccccccCCccCcccccCcCCCccccHHHHHHHHHHHHc-CCCCCCCCCcchhhhHHHHHHHHhhcCCCCcccc
Q 002673 763 YQT-HVTTELVGTLGYIPPEYGQAWVATLRGDMYSFGVVMLELLT-GKRPVDVLKPKMSRELVGWVLKMRSEGKQDQVFD 840 (894)
Q Consensus 763 ~~~-~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwS~GvlL~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 840 (894)
... .......++..|+|||...+..++.++||||||+++|+|++ |..||...... ...... .. +.....
T Consensus 158 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~---~~~~~~---~~-~~~~~~-- 228 (262)
T cd00192 158 DDYYRKKTGGKLPIRWMAPESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGLSNE---EVLEYL---RK-GYRLPK-- 228 (262)
T ss_pred ccccccccCCCcCccccCHHHhccCCcchhhccHHHHHHHHHHHhcCCCCCCCCCHH---HHHHHH---Hc-CCCCCC--
Confidence 321 12233457889999999988889999999999999999999 69999865322 122111 11 111000
Q ss_pred ccccCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 002673 841 PILRGKGFDEEMLQVLDVACMCVSQNPFKRPTVKEVVEWLN 881 (894)
Q Consensus 841 ~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~ 881 (894)
......++.+++.+|++.+|.+|||+.++++.|+
T Consensus 229 -------~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~ 262 (262)
T cd00192 229 -------PEYCPDELYELMLSCWQLDPEDRPTFSELVERLE 262 (262)
T ss_pred -------CccCChHHHHHHHHHccCCcccCcCHHHHHHhhC
Confidence 0111346778999999999999999999998874
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan |
| >cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-33 Score=305.10 Aligned_cols=260 Identities=24% Similarity=0.401 Sum_probs=203.5
Q ss_pred cCCCccceEeecCcEEEEEEEEc-CCCeEEEEEEcCcc-hhhHHHHHHHHHHHHhcCCCceeeecceeeecceEEEEEEe
Q 002673 607 DNFSQANIIGCGGFGLVYKATLA-NGTTLAIKKLSGDL-GLMEREFKAEVEALSTAQHKNLVSLQGYCVHQGFRLLIYSY 684 (894)
Q Consensus 607 ~~f~~~~~LG~G~fg~Vy~a~~~-~g~~vAvK~~~~~~-~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~lV~E~ 684 (894)
++|+..+.||+|+||.||++... ++..||+|.+.... ......+.+|+.++++++|+||+++++++...+..++||||
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~ 80 (286)
T cd06622 1 DEIEVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESKFNQIIMELDILHKAVSPYIVDFYGAFFIEGAVYMCMEY 80 (286)
T ss_pred ChhhhhhhhcccCCeEEEEEEEcCCCcEEEEEEeecccCHHHHHHHHHHHHHHHhcCCCcHHhhhhheecCCeEEEEEee
Confidence 36788899999999999999864 78999999887542 23346788999999999999999999999999999999999
Q ss_pred ccCCCHHHHHhhhcCCCCCcCHHHHHHHHHHHHHHHHHHHhccCCCeeecCCCCCCeEECCCCcEEEEEcccccccCCCC
Q 002673 685 MENGSLDYWLHEKADGASQLDWLTRLKIARGTSCGLAYMHQICEPHIVHRDIKSSNILLDDQFEAHLADFGLSRLILPYQ 764 (894)
Q Consensus 685 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDLkp~NILld~~~~vkl~DFGla~~~~~~~ 764 (894)
+++++|..+++... ....+++..+..++.|++.||.|||+ ..+++|+||||+||+++.++.+||+|||++......
T Consensus 81 ~~~~~l~~~~~~~~-~~~~~~~~~~~~~~~~i~~~l~~LH~--~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~- 156 (286)
T cd06622 81 MDAGSLDKLYAGGV-ATEGIPEDVLRRITYAVVKGLKFLKE--EHNIIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVAS- 156 (286)
T ss_pred cCCCCHHHHHHhcc-ccCCCCHHHHHHHHHHHHHHHHHHHh--cCCEeeCCCCHHHEEECCCCCEEEeecCCcccccCC-
Confidence 99999999887532 12468999999999999999999996 258999999999999999999999999998765321
Q ss_pred CcccccccccCCccCcccccCc------CCCccccHHHHHHHHHHHHcCCCCCCCCCcchhhhHHHHHHHHhhcCCCCcc
Q 002673 765 THVTTELVGTLGYIPPEYGQAW------VATLRGDMYSFGVVMLELLTGKRPVDVLKPKMSRELVGWVLKMRSEGKQDQV 838 (894)
Q Consensus 765 ~~~~~~~~gt~~Y~APE~~~~~------~~s~ksDVwS~GvlL~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 838 (894)
......++..|+|||++.+. .++.++|||||||++|+|++|+.||....... ......... ......+
T Consensus 157 --~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~---~~~~~~~~~-~~~~~~~ 230 (286)
T cd06622 157 --LAKTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPETYAN---IFAQLSAIV-DGDPPTL 230 (286)
T ss_pred --ccccCCCccCccCcchhcCCCCCccCCCCcccchHhHHHHHHHHHhCCCCCCCcchhh---HHHHHHHHh-hcCCCCC
Confidence 22334578899999987554 34889999999999999999999997433211 111111111 1111111
Q ss_pred ccccccCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHH--HHHhccc
Q 002673 839 FDPILRGKGFDEEMLQVLDVACMCVSQNPFKRPTVKEVVE--WLNNVGA 885 (894)
Q Consensus 839 ~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~--~L~~i~~ 885 (894)
.......+.+++.+|++.+|++||++.+++. |+...+.
T Consensus 231 ---------~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~~~~~~~~~ 270 (286)
T cd06622 231 ---------PSGYSDDAQDFVAKCLNKIPNRRPTYAQLLEHPWLVKYKN 270 (286)
T ss_pred ---------CcccCHHHHHHHHHHcccCcccCCCHHHHhcChhhhhccC
Confidence 1122345678999999999999999999998 6665543
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-34 Score=318.10 Aligned_cols=238 Identities=26% Similarity=0.310 Sum_probs=190.4
Q ss_pred ceEeecCcEEEEEEEE----cCCCeEEEEEEcCcchh--hHHHHHHHHHHHHhcCCCceeeecceeeecceEEEEEEecc
Q 002673 613 NIIGCGGFGLVYKATL----ANGTTLAIKKLSGDLGL--MEREFKAEVEALSTAQHKNLVSLQGYCVHQGFRLLIYSYME 686 (894)
Q Consensus 613 ~~LG~G~fg~Vy~a~~----~~g~~vAvK~~~~~~~~--~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~lV~E~~~ 686 (894)
+.||+|+||.||++.. .+|+.||+|++...... ....+..|++++++++||||+++++++..++..++||||++
T Consensus 2 ~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~ 81 (318)
T cd05582 2 KVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVKLHYAFQTEGKLYLILDFLR 81 (318)
T ss_pred ceeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhCCCCCcccEEEEEEcCCEEEEEEcCCC
Confidence 5799999999999874 36889999999754321 23456789999999999999999999999999999999999
Q ss_pred CCCHHHHHhhhcCCCCCcCHHHHHHHHHHHHHHHHHHHhccCCCeeecCCCCCCeEECCCCcEEEEEcccccccCCCCCc
Q 002673 687 NGSLDYWLHEKADGASQLDWLTRLKIARGTSCGLAYMHQICEPHIVHRDIKSSNILLDDQFEAHLADFGLSRLILPYQTH 766 (894)
Q Consensus 687 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDLkp~NILld~~~~vkl~DFGla~~~~~~~~~ 766 (894)
+|+|.+++... ..+++..+..++.||+.||.|||+ ++|+||||||+||+++.++.+||+|||+++...... .
T Consensus 82 ~~~L~~~l~~~----~~l~~~~~~~~~~qi~~~l~~lH~---~~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~-~ 153 (318)
T cd05582 82 GGDLFTRLSKE----VMFTEEDVKFYLAELALALDHLHS---LGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHE-K 153 (318)
T ss_pred CCcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHH---CCEecCCCCHHHeEECCCCcEEEeeccCCcccCCCC-C
Confidence 99999998653 358899999999999999999997 599999999999999999999999999998653321 2
Q ss_pred ccccccccCCccCcccccCcCCCccccHHHHHHHHHHHHcCCCCCCCCCcchhhhHHHHHHHHhhcCCCCccccccccCC
Q 002673 767 VTTELVGTLGYIPPEYGQAWVATLRGDMYSFGVVMLELLTGKRPVDVLKPKMSRELVGWVLKMRSEGKQDQVFDPILRGK 846 (894)
Q Consensus 767 ~~~~~~gt~~Y~APE~~~~~~~s~ksDVwS~GvlL~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~ 846 (894)
......||+.|+|||++.+..++.++|||||||++|||++|+.||...... .... .... ... . +. .
T Consensus 154 ~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~---~~~~---~i~~-~~~-~-~p-----~ 219 (318)
T cd05582 154 KAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGSLPFQGKDRK---ETMT---MILK-AKL-G-MP-----Q 219 (318)
T ss_pred ceecccCChhhcCHHHHcCCCCCCccceeccceEeeeeccCCCCCCCCCHH---HHHH---HHHc-CCC-C-CC-----C
Confidence 233467899999999999888999999999999999999999999754321 1111 1111 111 0 00 0
Q ss_pred CChHHHHHHHHHHHHhcccCCCCCCCHHH
Q 002673 847 GFDEEMLQVLDVACMCVSQNPFKRPTVKE 875 (894)
Q Consensus 847 ~~~~~~~~l~~li~~Cl~~dP~~RPs~~e 875 (894)
. ....+.+++.+||+.||++||++.+
T Consensus 220 ~---~~~~~~~li~~~l~~~P~~R~~a~~ 245 (318)
T cd05582 220 F---LSPEAQSLLRALFKRNPANRLGAGP 245 (318)
T ss_pred C---CCHHHHHHHHHHhhcCHhHcCCCCC
Confidence 1 1234668889999999999999443
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate |
| >cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-33 Score=305.29 Aligned_cols=263 Identities=24% Similarity=0.380 Sum_probs=203.9
Q ss_pred cCCCccceEeecCcEEEEEEEEc-----CCCeEEEEEEcCcchh-hHHHHHHHHHHHHhcCCCceeeecceeee--cceE
Q 002673 607 DNFSQANIIGCGGFGLVYKATLA-----NGTTLAIKKLSGDLGL-MEREFKAEVEALSTAQHKNLVSLQGYCVH--QGFR 678 (894)
Q Consensus 607 ~~f~~~~~LG~G~fg~Vy~a~~~-----~g~~vAvK~~~~~~~~-~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~--~~~~ 678 (894)
+.|+..+.||+|+||.||+|.+. ++..||||.+...... ....+.+|+++++.++|+||+++++++.. ....
T Consensus 4 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~ei~~l~~l~~~~i~~~~~~~~~~~~~~~ 83 (284)
T cd05038 4 RHLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIVKYKGVCEKPGGRSL 83 (284)
T ss_pred hhchhheeeccCCCeeEEEeeecCCCCCCceEEEEEEeccccchHHHHHHHHHHHHHHhCCCCChheEEeeeecCCCCce
Confidence 35677789999999999999853 3688999999865443 45789999999999999999999999877 5578
Q ss_pred EEEEEeccCCCHHHHHhhhcCCCCCcCHHHHHHHHHHHHHHHHHHHhccCCCeeecCCCCCCeEECCCCcEEEEEccccc
Q 002673 679 LLIYSYMENGSLDYWLHEKADGASQLDWLTRLKIARGTSCGLAYMHQICEPHIVHRDIKSSNILLDDQFEAHLADFGLSR 758 (894)
Q Consensus 679 ~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDLkp~NILld~~~~vkl~DFGla~ 758 (894)
++||||+++++|.+++.... ..+++..+..++.|++.||.|||+ .+++|+||||+||+++.++.++|+|||++.
T Consensus 84 ~lv~e~~~~~~l~~~l~~~~---~~~~~~~~~~~~~~l~~aL~~lH~---~~i~H~dl~p~nil~~~~~~~~l~dfg~~~ 157 (284)
T cd05038 84 RLIMEYLPSGSLRDYLQRHR---DQINLKRLLLFSSQICKGMDYLGS---QRYIHRDLAARNILVESEDLVKISDFGLAK 157 (284)
T ss_pred EEEEecCCCCCHHHHHHhCc---cccCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHhEEEcCCCCEEEccccccc
Confidence 99999999999999997543 358999999999999999999997 599999999999999999999999999998
Q ss_pred ccCCCCCcc--cccccccCCccCcccccCcCCCccccHHHHHHHHHHHHcCCCCCCCCCcchhh--------hHHHHHHH
Q 002673 759 LILPYQTHV--TTELVGTLGYIPPEYGQAWVATLRGDMYSFGVVMLELLTGKRPVDVLKPKMSR--------ELVGWVLK 828 (894)
Q Consensus 759 ~~~~~~~~~--~~~~~gt~~Y~APE~~~~~~~s~ksDVwS~GvlL~elltG~~Pf~~~~~~~~~--------~~~~~~~~ 828 (894)
......... .....++..|+|||...+..++.++||||||+++|||++|+.|+......... ........
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (284)
T cd05038 158 VLPEDKDYYYVKEPGESPIFWYAPECLRTSKFSSASDVWSFGVTLYELFTYGDPSQSPPAEFLRMIGIAQGQMIVTRLLE 237 (284)
T ss_pred ccccCCcceeccCCCCCcccccCcHHHccCCCCcccchHHHhhhhheeeccCCCcccccchhccccccccccccHHHHHH
Confidence 764322211 11233456799999998889999999999999999999999998643321100 00011111
Q ss_pred HhhcCCCCccccccccCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhcc
Q 002673 829 MRSEGKQDQVFDPILRGKGFDEEMLQVLDVACMCVSQNPFKRPTVKEVVEWLNNVG 884 (894)
Q Consensus 829 ~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~i~ 884 (894)
......... ........+.+++.+|++.+|++|||+.+++++|+.+.
T Consensus 238 ~~~~~~~~~---------~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~i~ 284 (284)
T cd05038 238 LLKEGERLP---------RPPSCPDEVYDLMKLCWEAEPQDRPSFADLILIVDRLR 284 (284)
T ss_pred HHHcCCcCC---------CCccCCHHHHHHHHHHhccChhhCCCHHHHHHHHhhcC
Confidence 111111000 00111245778999999999999999999999998763
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut |
| >KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-34 Score=289.23 Aligned_cols=257 Identities=28% Similarity=0.421 Sum_probs=208.8
Q ss_pred ccCCCccceEeecCcEEEEEEE-EcCCCeEEEEEEcCcc--------hhhHHHHHHHHHHHHhc-CCCceeeecceeeec
Q 002673 606 TDNFSQANIIGCGGFGLVYKAT-LANGTTLAIKKLSGDL--------GLMEREFKAEVEALSTA-QHKNLVSLQGYCVHQ 675 (894)
Q Consensus 606 ~~~f~~~~~LG~G~fg~Vy~a~-~~~g~~vAvK~~~~~~--------~~~~~~~~~Ei~~l~~l-~HpnIv~l~g~~~~~ 675 (894)
...|...++||+|..+.|-++. ..+|..+|+|++.... ....+.-.+|+.+|+++ .||+|+.+.+++.++
T Consensus 16 y~~y~pkeilgrgvss~vrRci~k~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D~yes~ 95 (411)
T KOG0599|consen 16 YAKYEPKEILGRGVSSVVRRCIHKETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQDVYESD 95 (411)
T ss_pred HhhcChHHHhcccchhhhhhhhhcccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEeeeeccCc
Confidence 3567788899999999998886 5678899999885321 11123456899999998 699999999999999
Q ss_pred ceEEEEEEeccCCCHHHHHhhhcCCCCCcCHHHHHHHHHHHHHHHHHHHhccCCCeeecCCCCCCeEECCCCcEEEEEcc
Q 002673 676 GFRLLIYSYMENGSLDYWLHEKADGASQLDWLTRLKIARGTSCGLAYMHQICEPHIVHRDIKSSNILLDDQFEAHLADFG 755 (894)
Q Consensus 676 ~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDLkp~NILld~~~~vkl~DFG 755 (894)
...++|+|.|+.|.|.+++.+. ..++.....+|++|+..|++|||. +.||||||||+|||+|++.++||+|||
T Consensus 96 sF~FlVFdl~prGELFDyLts~----VtlSEK~tR~iMrqlfegVeylHa---~~IVHRDLKpENILlddn~~i~isDFG 168 (411)
T KOG0599|consen 96 AFVFLVFDLMPRGELFDYLTSK----VTLSEKETRRIMRQLFEGVEYLHA---RNIVHRDLKPENILLDDNMNIKISDFG 168 (411)
T ss_pred chhhhhhhhcccchHHHHhhhh----eeecHHHHHHHHHHHHHHHHHHHH---hhhhhcccChhheeeccccceEEeccc
Confidence 9999999999999999999865 568999999999999999999997 699999999999999999999999999
Q ss_pred cccccCCCCCcccccccccCCccCcccccC------cCCCccccHHHHHHHHHHHHcCCCCCCCCCcchhhhHHHHHHHH
Q 002673 756 LSRLILPYQTHVTTELVGTLGYIPPEYGQA------WVATLRGDMYSFGVVMLELLTGKRPVDVLKPKMSRELVGWVLKM 829 (894)
Q Consensus 756 la~~~~~~~~~~~~~~~gt~~Y~APE~~~~------~~~s~ksDVwS~GvlL~elltG~~Pf~~~~~~~~~~~~~~~~~~ 829 (894)
+++.+.++. .....+|||+|+|||.+.- ..|+...|+|++|||||-|+.|.+||-... .+ ....+
T Consensus 169 Fa~~l~~Ge--kLrelCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVImyTLLaGcpPFwHRk------Qm-lMLR~ 239 (411)
T KOG0599|consen 169 FACQLEPGE--KLRELCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGVIMYTLLAGCPPFWHRK------QM-LMLRM 239 (411)
T ss_pred eeeccCCch--hHHHhcCCCcccChhheeeecccCCCCccchhhHHHHHHHHHHHHcCCCchhHHH------HH-HHHHH
Confidence 999886543 4567899999999997642 357888999999999999999999996221 11 11223
Q ss_pred hhcCCCCccccccccCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHH--HHHhcc
Q 002673 830 RSEGKQDQVFDPILRGKGFDEEMLQVLDVACMCVSQNPFKRPTVKEVVE--WLNNVG 884 (894)
Q Consensus 830 ~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~--~L~~i~ 884 (894)
..+++.. +....+.+......+++.+|++.||.+|.|++|+++ ++.++.
T Consensus 240 ImeGkyq------F~speWadis~~~KdLIsrlLqVdp~~Ritake~LaHpff~q~~ 290 (411)
T KOG0599|consen 240 IMEGKYQ------FRSPEWADISATVKDLISRLLQVDPTKRITAKEALAHPFFIQIA 290 (411)
T ss_pred HHhcccc------cCCcchhhccccHHHHHHHHHeeCchhcccHHHHhcChHHHHHH
Confidence 3333322 123345556667889999999999999999999998 665554
|
|
| >cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-33 Score=304.22 Aligned_cols=250 Identities=30% Similarity=0.458 Sum_probs=194.4
Q ss_pred ceEeecCcEEEEEEEEc-CCC--eEEEEEEcCcc-hhhHHHHHHHHHHHHhc-CCCceeeecceeeecceEEEEEEeccC
Q 002673 613 NIIGCGGFGLVYKATLA-NGT--TLAIKKLSGDL-GLMEREFKAEVEALSTA-QHKNLVSLQGYCVHQGFRLLIYSYMEN 687 (894)
Q Consensus 613 ~~LG~G~fg~Vy~a~~~-~g~--~vAvK~~~~~~-~~~~~~~~~Ei~~l~~l-~HpnIv~l~g~~~~~~~~~lV~E~~~~ 687 (894)
+.||+|+||.||+|... ++. .+++|.+.... ......+.+|++++.++ +||||+++++++...+..++||||+++
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~ 80 (270)
T cd05047 1 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPH 80 (270)
T ss_pred CcCCCCCCceEEEEEEcCCCCeeEEEEEEccccCCHHHHHHHHHHHHHHHhhccCCCeeeEEEEEecCCCceEEEEeCCC
Confidence 36899999999999864 343 46888887533 33446788999999999 899999999999999999999999999
Q ss_pred CCHHHHHhhhcC------------CCCCcCHHHHHHHHHHHHHHHHHHHhccCCCeeecCCCCCCeEECCCCcEEEEEcc
Q 002673 688 GSLDYWLHEKAD------------GASQLDWLTRLKIARGTSCGLAYMHQICEPHIVHRDIKSSNILLDDQFEAHLADFG 755 (894)
Q Consensus 688 gsL~~~l~~~~~------------~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDLkp~NILld~~~~vkl~DFG 755 (894)
|+|.+++..... ....+++..+..++.|++.||+|||+ ++++||||||+||++++++.+||+|||
T Consensus 81 ~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~---~~i~H~dikp~nili~~~~~~kl~dfg 157 (270)
T cd05047 81 GNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQ---KQFIHRDLAARNILVGENYVAKIADFG 157 (270)
T ss_pred CcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHHH---CCEeecccccceEEEcCCCeEEECCCC
Confidence 999999975421 12357899999999999999999997 699999999999999999999999999
Q ss_pred cccccCCCCCcccccccccCCccCcccccCcCCCccccHHHHHHHHHHHHc-CCCCCCCCCcchhhhHHHHHHHHhhcCC
Q 002673 756 LSRLILPYQTHVTTELVGTLGYIPPEYGQAWVATLRGDMYSFGVVMLELLT-GKRPVDVLKPKMSRELVGWVLKMRSEGK 834 (894)
Q Consensus 756 la~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwS~GvlL~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~ 834 (894)
++....... .......+..|+|||++.+..++.++||||||+++|||++ |..||...... +... .......
T Consensus 158 l~~~~~~~~--~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~---~~~~---~~~~~~~ 229 (270)
T cd05047 158 LSRGQEVYV--KKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCA---ELYE---KLPQGYR 229 (270)
T ss_pred Cccccchhh--hccCCCCccccCChHHHccCCCCchhhHHHHHHHHHHHHcCCCCCccccCHH---HHHH---HHhCCCC
Confidence 986322111 1111233567999999988889999999999999999997 99999654321 1111 1111111
Q ss_pred CCccccccccCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhc
Q 002673 835 QDQVFDPILRGKGFDEEMLQVLDVACMCVSQNPFKRPTVKEVVEWLNNV 883 (894)
Q Consensus 835 ~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~i 883 (894)
.. . . ......+.+++.+|++.+|.+|||+.++++.|+++
T Consensus 230 ~~-~-----~----~~~~~~~~~li~~~l~~~p~~Rps~~~il~~l~~~ 268 (270)
T cd05047 230 LE-K-----P----LNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRM 268 (270)
T ss_pred CC-C-----C----CcCCHHHHHHHHHHcccChhhCCCHHHHHHHHHHh
Confidence 11 0 0 01123567999999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l |
| >cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-34 Score=314.47 Aligned_cols=241 Identities=24% Similarity=0.325 Sum_probs=192.8
Q ss_pred ceEeecCcEEEEEEEEc-CCCeEEEEEEcCcch---hhHHHHHHHHHHHHhc-CCCceeeecceeeecceEEEEEEeccC
Q 002673 613 NIIGCGGFGLVYKATLA-NGTTLAIKKLSGDLG---LMEREFKAEVEALSTA-QHKNLVSLQGYCVHQGFRLLIYSYMEN 687 (894)
Q Consensus 613 ~~LG~G~fg~Vy~a~~~-~g~~vAvK~~~~~~~---~~~~~~~~Ei~~l~~l-~HpnIv~l~g~~~~~~~~~lV~E~~~~ 687 (894)
+.||+|+||.||+|... ++..||||++..... .....+..|.+++..+ +||||+++++++...+..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (318)
T cd05570 1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQTKDRLFFVMEYVNG 80 (318)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 46999999999999854 578999999975431 2234567888888888 799999999999999999999999999
Q ss_pred CCHHHHHhhhcCCCCCcCHHHHHHHHHHHHHHHHHHHhccCCCeeecCCCCCCeEECCCCcEEEEEcccccccCCCCCcc
Q 002673 688 GSLDYWLHEKADGASQLDWLTRLKIARGTSCGLAYMHQICEPHIVHRDIKSSNILLDDQFEAHLADFGLSRLILPYQTHV 767 (894)
Q Consensus 688 gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDLkp~NILld~~~~vkl~DFGla~~~~~~~~~~ 767 (894)
|+|..++... ..+++..+..++.|++.||.|||+ ++|+||||||+||++++++.+||+|||+++..... ...
T Consensus 81 ~~L~~~~~~~----~~l~~~~~~~~~~qi~~~l~~LH~---~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~-~~~ 152 (318)
T cd05570 81 GDLMFHIQRS----GRFDEPRARFYAAEIVLGLQFLHE---RGIIYRDLKLDNVLLDSEGHIKIADFGMCKEGILG-GVT 152 (318)
T ss_pred CCHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHh---CCeEccCCCHHHeEECCCCcEEecccCCCeecCcC-CCc
Confidence 9999888754 358999999999999999999997 59999999999999999999999999998753221 122
Q ss_pred cccccccCCccCcccccCcCCCccccHHHHHHHHHHHHcCCCCCCCCCcchhhhHHHHHHHHhhcCCCCccccccccCCC
Q 002673 768 TTELVGTLGYIPPEYGQAWVATLRGDMYSFGVVMLELLTGKRPVDVLKPKMSRELVGWVLKMRSEGKQDQVFDPILRGKG 847 (894)
Q Consensus 768 ~~~~~gt~~Y~APE~~~~~~~s~ksDVwS~GvlL~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~ 847 (894)
.....||+.|+|||++.+..++.++|||||||++|+|++|+.||...... .... .... ... .+. ..
T Consensus 153 ~~~~~g~~~y~aPE~~~~~~~~~~~DiwslGvil~~l~~G~~pf~~~~~~---~~~~---~i~~-~~~--~~~-----~~ 218 (318)
T cd05570 153 TSTFCGTPDYIAPEILSYQPYGPAVDWWALGVLLYEMLAGQSPFEGDDED---ELFQ---SILE-DEV--RYP-----RW 218 (318)
T ss_pred ccceecCccccCHHHhcCCCCCcchhhhhHHHHHHHHhhCCCCCCCCCHH---HHHH---HHHc-CCC--CCC-----Cc
Confidence 33456899999999999999999999999999999999999999754321 1111 1111 110 000 11
Q ss_pred ChHHHHHHHHHHHHhcccCCCCCCCH-----HHHHH
Q 002673 848 FDEEMLQVLDVACMCVSQNPFKRPTV-----KEVVE 878 (894)
Q Consensus 848 ~~~~~~~l~~li~~Cl~~dP~~RPs~-----~evl~ 878 (894)
....+.+++.+||+.||.+||++ .++++
T Consensus 219 ---~~~~~~~li~~~l~~dP~~R~s~~~~~~~~ll~ 251 (318)
T cd05570 219 ---LSKEAKSILKSFLTKNPEKRLGCLPTGEQDIKG 251 (318)
T ss_pred ---CCHHHHHHHHHHccCCHHHcCCCCCCCHHHHhc
Confidence 12356789999999999999999 88876
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re |
| >cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-34 Score=307.13 Aligned_cols=239 Identities=21% Similarity=0.363 Sum_probs=187.1
Q ss_pred eEeecCcEEEEEEEEcC-------------------------CCeEEEEEEcCcchhhHHHHHHHHHHHHhcCCCceeee
Q 002673 614 IIGCGGFGLVYKATLAN-------------------------GTTLAIKKLSGDLGLMEREFKAEVEALSTAQHKNLVSL 668 (894)
Q Consensus 614 ~LG~G~fg~Vy~a~~~~-------------------------g~~vAvK~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l 668 (894)
.||+|+||.||+|.+.. ...|++|++..........+.+|+.+++.++||||+++
T Consensus 2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~~~~l~h~niv~~ 81 (274)
T cd05076 2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPSHRDIALAFFETASLMSQVSHIHLAFV 81 (274)
T ss_pred CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChHHHHHHHHHHHHHHHHhcCCCCCeeeE
Confidence 58999999999997421 13588998875544445678889999999999999999
Q ss_pred cceeeecceEEEEEEeccCCCHHHHHhhhcCCCCCcCHHHHHHHHHHHHHHHHHHHhccCCCeeecCCCCCCeEECCCC-
Q 002673 669 QGYCVHQGFRLLIYSYMENGSLDYWLHEKADGASQLDWLTRLKIARGTSCGLAYMHQICEPHIVHRDIKSSNILLDDQF- 747 (894)
Q Consensus 669 ~g~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDLkp~NILld~~~- 747 (894)
+++|..+...++||||+++|+|..++... ...+++..+..++.||++||.|||+ ++|+||||||+|||++..+
T Consensus 82 ~~~~~~~~~~~lv~ey~~~g~L~~~l~~~---~~~~~~~~~~~i~~qi~~~l~~lH~---~~iiH~dlkp~Nill~~~~~ 155 (274)
T cd05076 82 HGVCVRGSENIMVEEFVEHGPLDVCLRKE---KGRVPVAWKITVAQQLASALSYLED---KNLVHGNVCAKNILLARLGL 155 (274)
T ss_pred EEEEEeCCceEEEEecCCCCcHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHc---CCccCCCCCcccEEEeccCc
Confidence 99999999999999999999999998753 2457889999999999999999996 6999999999999997643
Q ss_pred ------cEEEEEcccccccCCCCCcccccccccCCccCcccccC-cCCCccccHHHHHHHHHHH-HcCCCCCCCCCcchh
Q 002673 748 ------EAHLADFGLSRLILPYQTHVTTELVGTLGYIPPEYGQA-WVATLRGDMYSFGVVMLEL-LTGKRPVDVLKPKMS 819 (894)
Q Consensus 748 ------~vkl~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~~~~-~~~s~ksDVwS~GvlL~el-ltG~~Pf~~~~~~~~ 819 (894)
.+|++|||++...... ....++..|+|||.+.+ ..++.++||||||+++||| ++|+.||........
T Consensus 156 ~~~~~~~~kl~d~g~~~~~~~~-----~~~~~~~~~~aPe~~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~ 230 (274)
T cd05076 156 AEGTSPFIKLSDPGVSFTALSR-----EERVERIPWIAPECVPGGNSLSTAADKWSFGTTLLEICFDGEVPLKERTPSEK 230 (274)
T ss_pred ccCccceeeecCCccccccccc-----cccccCCcccCchhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCccccChHHH
Confidence 3899999988643221 22357788999998865 5689999999999999999 479999975433221
Q ss_pred hhHHHHHHHHhhcCCCCccccccccCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 002673 820 RELVGWVLKMRSEGKQDQVFDPILRGKGFDEEMLQVLDVACMCVSQNPFKRPTVKEVVEWLN 881 (894)
Q Consensus 820 ~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~ 881 (894)
.. ... ...... .. ....+.+++.+||+.+|++|||+.++++.|+
T Consensus 231 ~~---~~~---~~~~~~--------~~----~~~~~~~li~~cl~~~p~~Rps~~~il~~L~ 274 (274)
T cd05076 231 ER---FYE---KKHRLP--------EP----SCKELATLISQCLTYEPTQRPSFRTILRDLT 274 (274)
T ss_pred HH---HHH---hccCCC--------CC----CChHHHHHHHHHcccChhhCcCHHHHHHhhC
Confidence 11 111 000000 00 1125778999999999999999999998763
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt |
| >cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-33 Score=305.70 Aligned_cols=253 Identities=24% Similarity=0.391 Sum_probs=198.1
Q ss_pred HhccCCCccceEeecCcEEEEEEEE-cCCCeEEEEEEcCcchhhHHHHHHHHHHHHhc-CCCceeeecceeeec------
Q 002673 604 KATDNFSQANIIGCGGFGLVYKATL-ANGTTLAIKKLSGDLGLMEREFKAEVEALSTA-QHKNLVSLQGYCVHQ------ 675 (894)
Q Consensus 604 ~a~~~f~~~~~LG~G~fg~Vy~a~~-~~g~~vAvK~~~~~~~~~~~~~~~Ei~~l~~l-~HpnIv~l~g~~~~~------ 675 (894)
.+++.|+..+.||+|+||.||+|.. .+++.||+|.+.... .....+..|+.++.++ +|+||+++++++...
T Consensus 3 ~~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~-~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~ 81 (272)
T cd06637 3 DPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTG-DEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMD 81 (272)
T ss_pred ChhhhhhHHHheeecCCeEEEEEEEcCCCcEEEEEEEEcCC-ccHHHHHHHHHHHHHhcCCCCeeeEeeEEeecCCCCCC
Confidence 3567788889999999999999985 468899999987542 3345788999999998 799999999998753
Q ss_pred ceEEEEEEeccCCCHHHHHhhhcCCCCCcCHHHHHHHHHHHHHHHHHHHhccCCCeeecCCCCCCeEECCCCcEEEEEcc
Q 002673 676 GFRLLIYSYMENGSLDYWLHEKADGASQLDWLTRLKIARGTSCGLAYMHQICEPHIVHRDIKSSNILLDDQFEAHLADFG 755 (894)
Q Consensus 676 ~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDLkp~NILld~~~~vkl~DFG 755 (894)
...++||||+++|+|.+++.... ...+++..+..++.|++.||.|||+ ++|+|+||||+||++++++.+||+|||
T Consensus 82 ~~~~iv~e~~~~~~L~~~l~~~~--~~~l~~~~~~~~~~qi~~~l~~LH~---~~ivh~dl~~~nili~~~~~~~l~Dfg 156 (272)
T cd06637 82 DQLWLVMEFCGAGSVTDLIKNTK--GNTLKEEWIAYICREILRGLSHLHQ---HKVIHRDIKGQNVLLTENAEVKLVDFG 156 (272)
T ss_pred cEEEEEEEcCCCCcHHHHHHhcc--CCCCCHHHHHHHHHHHHHHHHHHHH---CCCccCCCCHHHEEECCCCCEEEccCC
Confidence 46789999999999999997532 3468899999999999999999997 599999999999999999999999999
Q ss_pred cccccCCCCCcccccccccCCccCccccc-----CcCCCccccHHHHHHHHHHHHcCCCCCCCCCcchhhhHHHHHHHHh
Q 002673 756 LSRLILPYQTHVTTELVGTLGYIPPEYGQ-----AWVATLRGDMYSFGVVMLELLTGKRPVDVLKPKMSRELVGWVLKMR 830 (894)
Q Consensus 756 la~~~~~~~~~~~~~~~gt~~Y~APE~~~-----~~~~s~ksDVwS~GvlL~elltG~~Pf~~~~~~~~~~~~~~~~~~~ 830 (894)
++....... .......|+..|+|||++. ...++.++|||||||++|||++|+.||......... . ...
T Consensus 157 ~~~~~~~~~-~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGv~l~el~~g~~p~~~~~~~~~~-----~-~~~ 229 (272)
T cd06637 157 VSAQLDRTV-GRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRAL-----F-LIP 229 (272)
T ss_pred Cceeccccc-ccCCcccccccccCHhHhccccCcCCCCCchhhHHHHHHHHHHHHhCCCCccccCHHHHH-----H-HHh
Confidence 998653222 1233456899999999875 345788999999999999999999999754321111 0 011
Q ss_pred hcCCCCccccccccCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 002673 831 SEGKQDQVFDPILRGKGFDEEMLQVLDVACMCVSQNPFKRPTVKEVVE 878 (894)
Q Consensus 831 ~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~ 878 (894)
. ..... ...... ...+.+++.+||..+|.+|||+.++++
T Consensus 230 ~-~~~~~-----~~~~~~---~~~~~~li~~~l~~~p~~Rpt~~~il~ 268 (272)
T cd06637 230 R-NPAPR-----LKSKKW---SKKFQSFIESCLVKNHSQRPTTEQLMK 268 (272)
T ss_pred c-CCCCC-----CCCCCc---CHHHHHHHHHHcCCChhhCCCHHHHhh
Confidence 1 11111 111111 235678999999999999999999976
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ |
| >cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-33 Score=304.37 Aligned_cols=249 Identities=23% Similarity=0.327 Sum_probs=197.5
Q ss_pred CCccceEeecCcEEEEEEEEc-CCCeEEEEEEcCcchhhHHHHHHHHHHHHhcCCCceeeecceeeecceEEEEEEeccC
Q 002673 609 FSQANIIGCGGFGLVYKATLA-NGTTLAIKKLSGDLGLMEREFKAEVEALSTAQHKNLVSLQGYCVHQGFRLLIYSYMEN 687 (894)
Q Consensus 609 f~~~~~LG~G~fg~Vy~a~~~-~g~~vAvK~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~lV~E~~~~ 687 (894)
|++.+.||+|+||.||+|... ++..+++|.+..........+.+|+++++.++|||++++++++..++..++|+||+++
T Consensus 7 ~~i~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~~v~e~~~~ 86 (282)
T cd06643 7 WEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFCAG 86 (282)
T ss_pred HHHHhhcccCCCeEEEEEEECCCCeEEEEEEeCCCCHHHHHHHHHHHHHHHHCCCCCeeeEEEEEeeCCEEEEEEEecCC
Confidence 566788999999999999854 5788899998765555566788999999999999999999999999999999999999
Q ss_pred CCHHHHHhhhcCCCCCcCHHHHHHHHHHHHHHHHHHHhccCCCeeecCCCCCCeEECCCCcEEEEEcccccccCCCCCcc
Q 002673 688 GSLDYWLHEKADGASQLDWLTRLKIARGTSCGLAYMHQICEPHIVHRDIKSSNILLDDQFEAHLADFGLSRLILPYQTHV 767 (894)
Q Consensus 688 gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDLkp~NILld~~~~vkl~DFGla~~~~~~~~~~ 767 (894)
|+|..++.... ..+++..+..++.|++.||.|||+ .+++||||||+||+++.++.+||+|||++...... ...
T Consensus 87 ~~l~~~~~~~~---~~l~~~~~~~~~~qi~~~L~~LH~---~~i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~-~~~ 159 (282)
T cd06643 87 GAVDAVMLELE---RPLTEPQIRVVCKQTLEALNYLHE---NKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRT-IQR 159 (282)
T ss_pred CcHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHH---CCeeecCCCcccEEEccCCCEEEcccccccccccc-ccc
Confidence 99998887532 458999999999999999999997 59999999999999999999999999998765322 112
Q ss_pred cccccccCCccCccccc-----CcCCCccccHHHHHHHHHHHHcCCCCCCCCCcchhhhHHHHHHHHhhcCCCCcccccc
Q 002673 768 TTELVGTLGYIPPEYGQ-----AWVATLRGDMYSFGVVMLELLTGKRPVDVLKPKMSRELVGWVLKMRSEGKQDQVFDPI 842 (894)
Q Consensus 768 ~~~~~gt~~Y~APE~~~-----~~~~s~ksDVwS~GvlL~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 842 (894)
.....++..|+|||++. +..++.++|||||||++|||++|+.||...... ..... ...... .....
T Consensus 160 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~--~~~~~----~~~~~~-~~~~~-- 230 (282)
T cd06643 160 RDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHELNPM--RVLLK----IAKSEP-PTLAQ-- 230 (282)
T ss_pred cccccccccccCHhhccccCCCCCCCCccchhhhHHHHHHHHccCCCCccccCHH--HHHHH----HhhcCC-CCCCC--
Confidence 23356889999999874 445788999999999999999999999754321 11111 111110 01100
Q ss_pred ccCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 002673 843 LRGKGFDEEMLQVLDVACMCVSQNPFKRPTVKEVVE 878 (894)
Q Consensus 843 l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~ 878 (894)
... ....+.+++.+||+.+|++||++.++++
T Consensus 231 --~~~---~~~~~~~li~~~l~~~p~~Rp~~~~il~ 261 (282)
T cd06643 231 --PSR---WSSEFKDFLKKCLEKNVDARWTTTQLLQ 261 (282)
T ss_pred --ccc---cCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 011 1235678999999999999999999987
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. |
| >cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-33 Score=300.56 Aligned_cols=249 Identities=25% Similarity=0.377 Sum_probs=202.2
Q ss_pred cCCCccceEeecCcEEEEEEEEcC-CCeEEEEEEcCcchhhHHHHHHHHHHHHhcCCCceeeecceeeecceEEEEEEec
Q 002673 607 DNFSQANIIGCGGFGLVYKATLAN-GTTLAIKKLSGDLGLMEREFKAEVEALSTAQHKNLVSLQGYCVHQGFRLLIYSYM 685 (894)
Q Consensus 607 ~~f~~~~~LG~G~fg~Vy~a~~~~-g~~vAvK~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~lV~E~~ 685 (894)
++|+..+.||+|+||.||+|...+ +..+++|.+..... ..++.+|++++++++|+||+++++++..+...++++||+
T Consensus 3 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~--~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~ 80 (256)
T cd06612 3 EVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEED--LQEIIKEISILKQCDSPYIVKYYGSYFKNTDLWIVMEYC 80 (256)
T ss_pred ccchhhhhhcCCCCeEEEEEEEcCCCcEEEEEEeecHHH--HHHHHHHHHHHHhCCCCcEeeeeeeeecCCcEEEEEecC
Confidence 578888999999999999998654 78999999876533 678999999999999999999999999999999999999
Q ss_pred cCCCHHHHHhhhcCCCCCcCHHHHHHHHHHHHHHHHHHHhccCCCeeecCCCCCCeEECCCCcEEEEEcccccccCCCCC
Q 002673 686 ENGSLDYWLHEKADGASQLDWLTRLKIARGTSCGLAYMHQICEPHIVHRDIKSSNILLDDQFEAHLADFGLSRLILPYQT 765 (894)
Q Consensus 686 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDLkp~NILld~~~~vkl~DFGla~~~~~~~~ 765 (894)
++++|.+++.... ..+++..+..++.|++.||.|||+ .+++|+||+|+||+++.++.+||+|||++........
T Consensus 81 ~~~~L~~~l~~~~---~~l~~~~~~~~~~~l~~~l~~lh~---~~i~H~dl~~~ni~~~~~~~~~l~dfg~~~~~~~~~~ 154 (256)
T cd06612 81 GAGSVSDIMKITN---KTLTEEEIAAILYQTLKGLEYLHS---NKKIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTMA 154 (256)
T ss_pred CCCcHHHHHHhCc---cCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCcceEEECCCCcEEEcccccchhcccCcc
Confidence 9999999987532 468999999999999999999997 5999999999999999999999999999987643221
Q ss_pred cccccccccCCccCcccccCcCCCccccHHHHHHHHHHHHcCCCCCCCCCcchhhhHHHHHHHHhhcCCCCccccccccC
Q 002673 766 HVTTELVGTLGYIPPEYGQAWVATLRGDMYSFGVVMLELLTGKRPVDVLKPKMSRELVGWVLKMRSEGKQDQVFDPILRG 845 (894)
Q Consensus 766 ~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwS~GvlL~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~ 845 (894)
......++..|+|||++.+..++.++||||||+++|+|++|+.||....... ... .. ...... .+
T Consensus 155 -~~~~~~~~~~y~~PE~~~~~~~~~~~Di~s~G~il~~l~~g~~p~~~~~~~~--~~~----~~-~~~~~~-----~~-- 219 (256)
T cd06612 155 -KRNTVIGTPFWMAPEVIQEIGYNNKADIWSLGITAIEMAEGKPPYSDIHPMR--AIF----MI-PNKPPP-----TL-- 219 (256)
T ss_pred -ccccccCCccccCHHHHhcCCCCchhhHHHHHHHHHHHHhCCCCCCCcchhh--hhh----hh-ccCCCC-----CC--
Confidence 2233457889999999998899999999999999999999999997543211 100 00 000000 00
Q ss_pred CCChHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 002673 846 KGFDEEMLQVLDVACMCVSQNPFKRPTVKEVVE 878 (894)
Q Consensus 846 ~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~ 878 (894)
.........+.+++.+|++.+|++|||++++++
T Consensus 220 ~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~il~ 252 (256)
T cd06612 220 SDPEKWSPEFNDFVKKCLVKDPEERPSAIQLLQ 252 (256)
T ss_pred CchhhcCHHHHHHHHHHHhcChhhCcCHHHHhc
Confidence 001112235778999999999999999999986
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a |
| >cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-33 Score=315.90 Aligned_cols=265 Identities=25% Similarity=0.289 Sum_probs=196.9
Q ss_pred ccCCCccceEeecCcEEEEEEEE-cCCCeEEEEEEcCcc--hhhHHHHHHHHHHHHhcCCCceeeecceeeecc------
Q 002673 606 TDNFSQANIIGCGGFGLVYKATL-ANGTTLAIKKLSGDL--GLMEREFKAEVEALSTAQHKNLVSLQGYCVHQG------ 676 (894)
Q Consensus 606 ~~~f~~~~~LG~G~fg~Vy~a~~-~~g~~vAvK~~~~~~--~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~------ 676 (894)
.++|++.+.||+|+||.||++.. .+|..||+|++.... ......+.+|+.+++.++||||+++++++....
T Consensus 20 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 99 (359)
T cd07876 20 LKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLEEFQ 99 (359)
T ss_pred hhceEEEEEeecCCCEEEEEEEEcCCCceeEEEEecccccchhHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCCccccc
Confidence 36899999999999999999984 568999999987532 233456789999999999999999999886543
Q ss_pred eEEEEEEeccCCCHHHHHhhhcCCCCCcCHHHHHHHHHHHHHHHHHHHhccCCCeeecCCCCCCeEECCCCcEEEEEccc
Q 002673 677 FRLLIYSYMENGSLDYWLHEKADGASQLDWLTRLKIARGTSCGLAYMHQICEPHIVHRDIKSSNILLDDQFEAHLADFGL 756 (894)
Q Consensus 677 ~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDLkp~NILld~~~~vkl~DFGl 756 (894)
..++||||+++ +|...++. .+++..+..++.|++.||.|||+ ++|+||||||+|||++.++.+||+|||+
T Consensus 100 ~~~lv~e~~~~-~l~~~~~~------~~~~~~~~~~~~qi~~~L~~LH~---~~ivHrDlkp~NIl~~~~~~~kl~Dfg~ 169 (359)
T cd07876 100 DVYLVMELMDA-NLCQVIHM------ELDHERMSYLLYQMLCGIKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDFGL 169 (359)
T ss_pred eeEEEEeCCCc-CHHHHHhc------cCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCCHHHEEECCCCCEEEecCCC
Confidence 46999999965 56666542 36788889999999999999997 5999999999999999999999999999
Q ss_pred ccccCCCCCcccccccccCCccCcccccCcCCCccccHHHHHHHHHHHHcCCCCCCCCCcchhhh-H-----------H-
Q 002673 757 SRLILPYQTHVTTELVGTLGYIPPEYGQAWVATLRGDMYSFGVVMLELLTGKRPVDVLKPKMSRE-L-----------V- 823 (894)
Q Consensus 757 a~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwS~GvlL~elltG~~Pf~~~~~~~~~~-~-----------~- 823 (894)
++.... ........||+.|+|||++.+..++.++|||||||++|+|++|+.||.......... . .
T Consensus 170 a~~~~~--~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 247 (359)
T cd07876 170 ARTACT--NFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELVKGSVIFQGTDHIDQWNKVIEQLGTPSAEFMN 247 (359)
T ss_pred cccccc--CccCCCCcccCCCCCchhccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCcHHHHH
Confidence 976422 222334578999999999999999999999999999999999999997543211100 0 0
Q ss_pred ---HHHHHHhhcC-C-----CCccccccccC---CCChHHHHHHHHHHHHhcccCCCCCCCHHHHHH--HHHh
Q 002673 824 ---GWVLKMRSEG-K-----QDQVFDPILRG---KGFDEEMLQVLDVACMCVSQNPFKRPTVKEVVE--WLNN 882 (894)
Q Consensus 824 ---~~~~~~~~~~-~-----~~~~~d~~l~~---~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~--~L~~ 882 (894)
.......... . ..+.+...... .........+.+++.+|++.||++|||+.|+++ |+..
T Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp~~~~ 320 (359)
T cd07876 248 RLQPTVRNYVENRPQYPGISFEELFPDWIFPSESERDKLKTSQARDLLSKMLVIDPDKRISVDEALRHPYITV 320 (359)
T ss_pred HHHHHHHHHHhhCCCCCCcchhhhccccccccccccccccchhHHHHHHHHhccCcccCCCHHHHhcCchhhh
Confidence 0000000000 0 00000000000 000011235779999999999999999999998 6653
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >PTZ00266 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-33 Score=340.02 Aligned_cols=262 Identities=23% Similarity=0.313 Sum_probs=202.2
Q ss_pred ccCCCccceEeecCcEEEEEEEE-cCCCeEEEEEEcCcc--hhhHHHHHHHHHHHHhcCCCceeeecceeee--cceEEE
Q 002673 606 TDNFSQANIIGCGGFGLVYKATL-ANGTTLAIKKLSGDL--GLMEREFKAEVEALSTAQHKNLVSLQGYCVH--QGFRLL 680 (894)
Q Consensus 606 ~~~f~~~~~LG~G~fg~Vy~a~~-~~g~~vAvK~~~~~~--~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~--~~~~~l 680 (894)
.++|.+.+.||+|+||.||+|.. .++..||+|.+.... ......+..|+.+++.++|||||+++++|.. ....++
T Consensus 12 l~~YeIl~kLG~GgFGtVYLAkdk~tg~~vAlKvIk~~~l~e~~~~~~~~EI~IL~~L~HPNIVrl~d~f~de~~~~lyI 91 (1021)
T PTZ00266 12 LNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVIEVNVMRELKHKNIVRYIDRFLNKANQKLYI 91 (1021)
T ss_pred cCCEEEEEEEecCCCeEEEEEEECCCCeEEEEEEEeccccCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEecCCCEEEE
Confidence 36799999999999999999984 467789999886532 2334678899999999999999999998864 356899
Q ss_pred EEEeccCCCHHHHHhhhcCCCCCcCHHHHHHHHHHHHHHHHHHHhcc----CCCeeecCCCCCCeEECC-----------
Q 002673 681 IYSYMENGSLDYWLHEKADGASQLDWLTRLKIARGTSCGLAYMHQIC----EPHIVHRDIKSSNILLDD----------- 745 (894)
Q Consensus 681 V~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~----~~~ivHrDLkp~NILld~----------- 745 (894)
||||+++|+|.+++.........+++..++.|+.||+.||.|||+.. .++||||||||+||||+.
T Consensus 92 VMEY~~gGSL~~lL~k~~~~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s~~~~lg~i~~~ 171 (1021)
T PTZ00266 92 LMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKITAQ 171 (1021)
T ss_pred EEeCCCCCcHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeecCcccccccccc
Confidence 99999999999999865444457999999999999999999999742 146999999999999964
Q ss_pred ------CCcEEEEEcccccccCCCCCcccccccccCCccCcccccC--cCCCccccHHHHHHHHHHHHcCCCCCCCCCcc
Q 002673 746 ------QFEAHLADFGLSRLILPYQTHVTTELVGTLGYIPPEYGQA--WVATLRGDMYSFGVVMLELLTGKRPVDVLKPK 817 (894)
Q Consensus 746 ------~~~vkl~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~~~~--~~~s~ksDVwS~GvlL~elltG~~Pf~~~~~~ 817 (894)
...+||+|||++..+... .......||+.|+|||++.+ ..++.++|||||||+||||++|+.||......
T Consensus 172 ~~n~ng~~iVKLsDFGlAr~l~~~--s~~~s~vGTp~YmAPEvL~ge~~~~s~KSDVWSLG~ILYELLTGk~PF~~~~~~ 249 (1021)
T PTZ00266 172 ANNLNGRPIAKIGDFGLSKNIGIE--SMAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTPFHKANNF 249 (1021)
T ss_pred ccccCCCCceEEccCCcccccccc--ccccccCCCccccCHHHHhccCCCCCchhHHHHHHHHHHHHHHCCCCCCcCCcH
Confidence 335999999999865322 12334578999999998854 45889999999999999999999999743321
Q ss_pred hhhhHHHHHHHHhhcCCCCccccccccCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHH--HHHhccc
Q 002673 818 MSRELVGWVLKMRSEGKQDQVFDPILRGKGFDEEMLQVLDVACMCVSQNPFKRPTVKEVVE--WLNNVGA 885 (894)
Q Consensus 818 ~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~--~L~~i~~ 885 (894)
..+ ...+..... +.... ....+.+|+..||+.+|.+||++.++++ ++..+..
T Consensus 250 --~ql---i~~lk~~p~--------lpi~~---~S~eL~dLI~~~L~~dPeeRPSa~QlL~h~~ik~i~~ 303 (1021)
T PTZ00266 250 --SQL---ISELKRGPD--------LPIKG---KSKELNILIKNLLNLSAKERPSALQCLGYQIIKNVGP 303 (1021)
T ss_pred --HHH---HHHHhcCCC--------CCcCC---CCHHHHHHHHHHhcCChhHCcCHHHHhccHHHhhcCC
Confidence 111 111111110 00011 1235778999999999999999999995 7765543
|
|
| >cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-33 Score=299.04 Aligned_cols=248 Identities=25% Similarity=0.392 Sum_probs=197.8
Q ss_pred ceEeecCcEEEEEEEEcCCCeEEEEEEcCcchh-hHHHHHHHHHHHHhcCCCceeeecceeeecceEEEEEEeccCCCHH
Q 002673 613 NIIGCGGFGLVYKATLANGTTLAIKKLSGDLGL-MEREFKAEVEALSTAQHKNLVSLQGYCVHQGFRLLIYSYMENGSLD 691 (894)
Q Consensus 613 ~~LG~G~fg~Vy~a~~~~g~~vAvK~~~~~~~~-~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~lV~E~~~~gsL~ 691 (894)
++||+|+||.||++...+++.||+|.+...... ....+.+|++++++++|+||+++++++......++||||+++++|.
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~l~ 80 (251)
T cd05041 1 EKIGKGNFGDVYKGVLKGNTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGVCVQKQPIYIVMELVPGGSLL 80 (251)
T ss_pred CccccCCCceEEEEEEeCCCcEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeEEEEEEEecCCCeEEEEEcCCCCcHH
Confidence 468999999999999767999999998765433 4567899999999999999999999999999999999999999999
Q ss_pred HHHhhhcCCCCCcCHHHHHHHHHHHHHHHHHHHhccCCCeeecCCCCCCeEECCCCcEEEEEcccccccCCCCCccc-cc
Q 002673 692 YWLHEKADGASQLDWLTRLKIARGTSCGLAYMHQICEPHIVHRDIKSSNILLDDQFEAHLADFGLSRLILPYQTHVT-TE 770 (894)
Q Consensus 692 ~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDLkp~NILld~~~~vkl~DFGla~~~~~~~~~~~-~~ 770 (894)
+++.... ..+++...+.++.+++.||.|||+ ++++||||||+||+++.++.+||+|||++........... ..
T Consensus 81 ~~l~~~~---~~~~~~~~~~~~~~~~~~l~~lH~---~~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~ 154 (251)
T cd05041 81 TFLRKKK---NRLTVKKLLQMSLDAAAGMEYLES---KNCIHRDLAARNCLVGENNVLKISDFGMSREEEGGIYTVSDGL 154 (251)
T ss_pred HHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHh---CCEehhhcCcceEEEcCCCcEEEeeccccccccCCcceecccc
Confidence 9997542 357888999999999999999996 6999999999999999999999999999986532111111 11
Q ss_pred ccccCCccCcccccCcCCCccccHHHHHHHHHHHHc-CCCCCCCCCcchhhhHHHHHHHHhhcCCCCccccccccCCCCh
Q 002673 771 LVGTLGYIPPEYGQAWVATLRGDMYSFGVVMLELLT-GKRPVDVLKPKMSRELVGWVLKMRSEGKQDQVFDPILRGKGFD 849 (894)
Q Consensus 771 ~~gt~~Y~APE~~~~~~~s~ksDVwS~GvlL~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~ 849 (894)
..++..|+|||.+.+..++.++||||||+++|||++ |..||.......... .. .... ... ...
T Consensus 155 ~~~~~~y~~PE~~~~~~~~~~~Di~slG~i~~~l~t~~~~p~~~~~~~~~~~---~~----~~~~--~~~-------~~~ 218 (251)
T cd05041 155 KQIPIKWTAPEALNYGRYTSESDVWSYGILLWETFSLGDTPYPGMSNQQTRE---RI----ESGY--RMP-------APQ 218 (251)
T ss_pred CcceeccCChHhhccCCCCcchhHHHHHHHHHHHHhccCCCCccCCHHHHHH---HH----hcCC--CCC-------CCc
Confidence 233567999999988889999999999999999999 899987544321111 11 1110 000 001
Q ss_pred HHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHh
Q 002673 850 EEMLQVLDVACMCVSQNPFKRPTVKEVVEWLNN 882 (894)
Q Consensus 850 ~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~ 882 (894)
.....+.+++.+|++.+|.+|||+.++++.|+.
T Consensus 219 ~~~~~~~~li~~~l~~~p~~Rp~~~ell~~l~~ 251 (251)
T cd05041 219 LCPEEIYRLMLQCWAYDPENRPSFSEIYNELQI 251 (251)
T ss_pred cCCHHHHHHHHHHhccChhhCcCHHHHHHHhhC
Confidence 122367789999999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k |
| >cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-33 Score=300.85 Aligned_cols=255 Identities=23% Similarity=0.339 Sum_probs=201.1
Q ss_pred CCCccceEeecCcEEEEEEEEcC--CCeEEEEEEcCcc----------hhhHHHHHHHHHHHHh-cCCCceeeecceeee
Q 002673 608 NFSQANIIGCGGFGLVYKATLAN--GTTLAIKKLSGDL----------GLMEREFKAEVEALST-AQHKNLVSLQGYCVH 674 (894)
Q Consensus 608 ~f~~~~~LG~G~fg~Vy~a~~~~--g~~vAvK~~~~~~----------~~~~~~~~~Ei~~l~~-l~HpnIv~l~g~~~~ 674 (894)
+|++.+.||+|+||.||+|.... +..+|+|.+.... ......+.+|+.++.+ ++||||+++++++..
T Consensus 1 ~y~~~~~ig~G~~~~v~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~ 80 (269)
T cd08528 1 EYAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFLE 80 (269)
T ss_pred CchhhhhhcCCCCceEEEEEEcCCCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeEcc
Confidence 47778899999999999998654 6889999875321 2223456778888865 799999999999999
Q ss_pred cceEEEEEEeccCCCHHHHHhhhcCCCCCcCHHHHHHHHHHHHHHHHHHHhccCCCeeecCCCCCCeEECCCCcEEEEEc
Q 002673 675 QGFRLLIYSYMENGSLDYWLHEKADGASQLDWLTRLKIARGTSCGLAYMHQICEPHIVHRDIKSSNILLDDQFEAHLADF 754 (894)
Q Consensus 675 ~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDLkp~NILld~~~~vkl~DF 754 (894)
++..++||||+++++|.+++.........+++..++.++.|++.||.|||+ ..+++|+||+|+||+++.++.+||+||
T Consensus 81 ~~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~--~~~i~H~dl~~~nil~~~~~~~~l~df 158 (269)
T cd08528 81 NDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLHK--EKRIVHRDLTPNNIMLGEDDKVTITDF 158 (269)
T ss_pred CCeEEEEEecCCCCcHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHhcc--CCceeecCCCHHHEEECCCCcEEEecc
Confidence 999999999999999999987544444578999999999999999999995 358999999999999999999999999
Q ss_pred ccccccCCCCCcccccccccCCccCcccccCcCCCccccHHHHHHHHHHHHcCCCCCCCCCcchhhhHHHHHHHHhhcCC
Q 002673 755 GLSRLILPYQTHVTTELVGTLGYIPPEYGQAWVATLRGDMYSFGVVMLELLTGKRPVDVLKPKMSRELVGWVLKMRSEGK 834 (894)
Q Consensus 755 Gla~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwS~GvlL~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~ 834 (894)
|++....... ......|+..|+|||+..+..++.++||||||+++|+|++|+.||...... ... .... ...
T Consensus 159 g~~~~~~~~~--~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~ll~~l~~g~~p~~~~~~~---~~~---~~~~-~~~ 229 (269)
T cd08528 159 GLAKQKQPES--KLTSVVGTILYSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPPFYSTNML---SLA---TKIV-EAV 229 (269)
T ss_pred cceeeccccc--ccccccCcccCcChhhhcCCCCchHHHHHHHHHHHHHHHhCCCcccccCHH---HHH---HHHh-hcc
Confidence 9998754322 234456889999999999888999999999999999999999999643221 111 1111 111
Q ss_pred CCccccccccCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 002673 835 QDQVFDPILRGKGFDEEMLQVLDVACMCVSQNPFKRPTVKEVVEWLN 881 (894)
Q Consensus 835 ~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~ 881 (894)
.... . .. .....+.+++.+|++.||++||++.++..++.
T Consensus 230 ~~~~----~-~~---~~~~~l~~li~~cl~~~p~~Rp~~~e~~~~~~ 268 (269)
T cd08528 230 YEPL----P-EG---MYSEDVTDVITSCLTPDAEARPDIIQVSAMIS 268 (269)
T ss_pred CCcC----C-cc---cCCHHHHHHHHHHCCCCCccCCCHHHHHHHhc
Confidence 1100 0 00 11235778999999999999999999999875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. |
| >cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-34 Score=311.30 Aligned_cols=268 Identities=21% Similarity=0.302 Sum_probs=201.9
Q ss_pred cCCCccceEeecCcEEEEEEEE-cCCCeEEEEEEcCcc-hhhHHHHHHHHHHHHhcCCCceeeecceeeecceEEEEEEe
Q 002673 607 DNFSQANIIGCGGFGLVYKATL-ANGTTLAIKKLSGDL-GLMEREFKAEVEALSTAQHKNLVSLQGYCVHQGFRLLIYSY 684 (894)
Q Consensus 607 ~~f~~~~~LG~G~fg~Vy~a~~-~~g~~vAvK~~~~~~-~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~lV~E~ 684 (894)
++|+..+.||+|+||.||+|.. .+++.||+|.+.... ......+.+|+.+++.++||||+++++++...+..++||||
T Consensus 6 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~lv~e~ 85 (301)
T cd07873 6 ETYIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEY 85 (301)
T ss_pred cceEEeeEeccCcCEEEEEEEEcCCCcEEEEEEEecccccCchhHHHHHHHHHHhcCCCCcceEEEEEecCCeEEEEEec
Confidence 5688899999999999999985 468899999986432 22334677899999999999999999999999999999999
Q ss_pred ccCCCHHHHHhhhcCCCCCcCHHHHHHHHHHHHHHHHHHHhccCCCeeecCCCCCCeEECCCCcEEEEEcccccccCCCC
Q 002673 685 MENGSLDYWLHEKADGASQLDWLTRLKIARGTSCGLAYMHQICEPHIVHRDIKSSNILLDDQFEAHLADFGLSRLILPYQ 764 (894)
Q Consensus 685 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDLkp~NILld~~~~vkl~DFGla~~~~~~~ 764 (894)
++ ++|..++.... ..+++..+..++.|++.||.|||+ ++++|+||||+||++++++.+||+|||++.......
T Consensus 86 ~~-~~l~~~l~~~~---~~~~~~~~~~~~~qi~~aL~~lH~---~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~ 158 (301)
T cd07873 86 LD-KDLKQYLDDCG---NSINMHNVKLFLFQLLRGLNYCHR---RKVLHRDLKPQNLLINERGELKLADFGLARAKSIPT 158 (301)
T ss_pred cc-cCHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHh---CCeeCCCCCHHHEEECCCCcEEECcCcchhccCCCC
Confidence 97 58988887542 357888999999999999999997 599999999999999999999999999997643221
Q ss_pred CcccccccccCCccCcccccCc-CCCccccHHHHHHHHHHHHcCCCCCCCCCcchhhhHHHHHHHHhh---cCCCCcccc
Q 002673 765 THVTTELVGTLGYIPPEYGQAW-VATLRGDMYSFGVVMLELLTGKRPVDVLKPKMSRELVGWVLKMRS---EGKQDQVFD 840 (894)
Q Consensus 765 ~~~~~~~~gt~~Y~APE~~~~~-~~s~ksDVwS~GvlL~elltG~~Pf~~~~~~~~~~~~~~~~~~~~---~~~~~~~~d 840 (894)
.......+++.|+|||++.+. .++.++|||||||++|||++|+.||....... .......... ...+..+.+
T Consensus 159 -~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~tg~~~f~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~ 234 (301)
T cd07873 159 -KTYSNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVEE---QLHFIFRILGTPTEETWPGILS 234 (301)
T ss_pred -CcccccceeecccCcHHHhCCCCCccHHHHHHHHHHHHHHHhCCCCCCCCCHHH---HHHHHHHHcCCCChhhchhhhc
Confidence 112334578899999987654 57889999999999999999999997543221 1111111100 000000000
Q ss_pred ---------ccccCC----CChHHHHHHHHHHHHhcccCCCCCCCHHHHHH--HHHhccc
Q 002673 841 ---------PILRGK----GFDEEMLQVLDVACMCVSQNPFKRPTVKEVVE--WLNNVGA 885 (894)
Q Consensus 841 ---------~~l~~~----~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~--~L~~i~~ 885 (894)
+..... ........+.+++.+|++.||.+|||++++++ |++.++.
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~eil~h~~f~~~~~ 294 (301)
T cd07873 235 NEEFKSYNYPKYRADCLHNHAPRLDSDGAELLSKLLQFEGRKRISAEEAMKHPYFHCLGE 294 (301)
T ss_pred cccccccccCccccccHHhhcCCCCHHHHHHHHHHhcCCcccCcCHHHHhcCcccccccc
Confidence 000000 00111235678999999999999999999998 8876654
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl |
| >cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-33 Score=307.49 Aligned_cols=262 Identities=25% Similarity=0.289 Sum_probs=192.0
Q ss_pred CCCccceEeecCcEEEEEEEE-cCCCeEEEEEEcCcch--hhHHHHHHHHHHHHhc---CCCceeeecceeee-----cc
Q 002673 608 NFSQANIIGCGGFGLVYKATL-ANGTTLAIKKLSGDLG--LMEREFKAEVEALSTA---QHKNLVSLQGYCVH-----QG 676 (894)
Q Consensus 608 ~f~~~~~LG~G~fg~Vy~a~~-~~g~~vAvK~~~~~~~--~~~~~~~~Ei~~l~~l---~HpnIv~l~g~~~~-----~~ 676 (894)
+|++.+.||+|+||.||+|.. .+++.||+|.+..... .....+.+|+.+++.+ +||||+++++++.. ..
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~~~~~ 80 (288)
T cd07863 1 QYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRLMDVCATSRTDRET 80 (288)
T ss_pred CceEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCcCCCCCchHHHHHHHHHHHhhhcCCCCeeeeeeeeccccCCCCc
Confidence 477889999999999999985 4789999999875321 1223455677766655 79999999998864 24
Q ss_pred eEEEEEEeccCCCHHHHHhhhcCCCCCcCHHHHHHHHHHHHHHHHHHHhccCCCeeecCCCCCCeEECCCCcEEEEEccc
Q 002673 677 FRLLIYSYMENGSLDYWLHEKADGASQLDWLTRLKIARGTSCGLAYMHQICEPHIVHRDIKSSNILLDDQFEAHLADFGL 756 (894)
Q Consensus 677 ~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDLkp~NILld~~~~vkl~DFGl 756 (894)
..++||||+. ++|.+++.... ...+++..+..++.|++.||.|||+ ++|+||||||+||+++.++.+||+|||+
T Consensus 81 ~~~lv~e~~~-~~l~~~~~~~~--~~~~~~~~~~~~~~qi~~al~~lH~---~~ivH~dikp~Nili~~~~~~kl~dfg~ 154 (288)
T cd07863 81 KVTLVFEHVD-QDLRTYLDKVP--PPGLPAETIKDLMRQFLRGLDFLHA---NCIVHRDLKPENILVTSGGQVKLADFGL 154 (288)
T ss_pred eEEEEEcccc-cCHHHHHHhcC--CCCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEECCCCCEEECccCc
Confidence 5789999997 58988887543 2458899999999999999999997 5999999999999999999999999999
Q ss_pred ccccCCCCCcccccccccCCccCcccccCcCCCccccHHHHHHHHHHHHcCCCCCCCCCcchhh-hHHHHHHHHhhcCCC
Q 002673 757 SRLILPYQTHVTTELVGTLGYIPPEYGQAWVATLRGDMYSFGVVMLELLTGKRPVDVLKPKMSR-ELVGWVLKMRSEGKQ 835 (894)
Q Consensus 757 a~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwS~GvlL~elltG~~Pf~~~~~~~~~-~~~~~~~~~~~~~~~ 835 (894)
++..... .......||..|+|||++.+..++.++|||||||++|+|++|++||......... ....... .......
T Consensus 155 ~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~-~~~~~~~ 231 (288)
T cd07863 155 ARIYSCQ--MALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIG-LPPEDDW 231 (288)
T ss_pred cccccCc--ccCCCccccccccCchHhhCCCCCCcchhhhHHHHHHHHHhCCcCcCCCCHHHHHHHHHHHhC-CCChhhC
Confidence 9865322 1223456899999999999889999999999999999999999999754332111 1111100 0000000
Q ss_pred -------Ccccccccc---CCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 002673 836 -------DQVFDPILR---GKGFDEEMLQVLDVACMCVSQNPFKRPTVKEVVE 878 (894)
Q Consensus 836 -------~~~~d~~l~---~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~ 878 (894)
...+.+... ....+.....+.+++.+|++.||++|||+.+++.
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~l~ 284 (288)
T cd07863 232 PRDVTLPRGAFSPRGPRPVQSVVPEIEESGAQLLLEMLTFNPHKRISAFRALQ 284 (288)
T ss_pred cccccccccccCCCCCCchHHhCcCcCHHHHHHHHHHhccCcccCCCHHHHhc
Confidence 000000000 0001112335679999999999999999999985
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou |
| >cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-33 Score=303.09 Aligned_cols=257 Identities=25% Similarity=0.402 Sum_probs=202.8
Q ss_pred cCCCccceEeecCcEEEEEEEEc------CCCeEEEEEEcCcchh-hHHHHHHHHHHHHhcCCCceeeecceeeecceEE
Q 002673 607 DNFSQANIIGCGGFGLVYKATLA------NGTTLAIKKLSGDLGL-MEREFKAEVEALSTAQHKNLVSLQGYCVHQGFRL 679 (894)
Q Consensus 607 ~~f~~~~~LG~G~fg~Vy~a~~~------~g~~vAvK~~~~~~~~-~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~ 679 (894)
++|+....||+|+||.||+|+.. +...|++|.+...... ....+.+|++++++++|+||+++++++.+....+
T Consensus 5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 84 (275)
T cd05046 5 SNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKLSHKNVVRLLGLCREAEPHY 84 (275)
T ss_pred HhceeeeeecccceeEEEEEEeccCCcCCCcceEEEEccCCccchHHHHHHHHHHHHHHhcCCcceeeeEEEECCCCcce
Confidence 56888899999999999999853 3467999988754433 3467899999999999999999999999988999
Q ss_pred EEEEeccCCCHHHHHhhhcCC-----CCCcCHHHHHHHHHHHHHHHHHHHhccCCCeeecCCCCCCeEECCCCcEEEEEc
Q 002673 680 LIYSYMENGSLDYWLHEKADG-----ASQLDWLTRLKIARGTSCGLAYMHQICEPHIVHRDIKSSNILLDDQFEAHLADF 754 (894)
Q Consensus 680 lV~E~~~~gsL~~~l~~~~~~-----~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDLkp~NILld~~~~vkl~DF 754 (894)
+||||+++|+|.++++..... ...+++..+..++.|++.||.|||+ ++|+||||||+||+++.++.++++||
T Consensus 85 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~---~~i~H~dlkp~Nili~~~~~~~l~~~ 161 (275)
T cd05046 85 MILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSN---ARFVHRDLAARNCLVSSQREVKVSLL 161 (275)
T ss_pred EEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhhh---cCcccCcCccceEEEeCCCcEEEccc
Confidence 999999999999999864321 1268999999999999999999997 59999999999999999999999999
Q ss_pred ccccccCCCCCcccccccccCCccCcccccCcCCCccccHHHHHHHHHHHHc-CCCCCCCCCcchhhhHHHHHHHHhhcC
Q 002673 755 GLSRLILPYQTHVTTELVGTLGYIPPEYGQAWVATLRGDMYSFGVVMLELLT-GKRPVDVLKPKMSRELVGWVLKMRSEG 833 (894)
Q Consensus 755 Gla~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwS~GvlL~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~ 833 (894)
|++...............++..|+|||.+.+..++.++||||||+++|+|++ |..||...... ...... ..+
T Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~~~~~p~~~~~~~---~~~~~~----~~~ 234 (275)
T cd05046 162 SLSKDVYNSEYYKLRNALIPLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFTQGELPFYGLSDE---EVLNRL----QAG 234 (275)
T ss_pred ccccccCcccccccCCceeEEeecChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCccccchH---HHHHHH----HcC
Confidence 9987543322222233456778999999988888999999999999999999 88898644321 111111 111
Q ss_pred CCCccccccccCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 002673 834 KQDQVFDPILRGKGFDEEMLQVLDVACMCVSQNPFKRPTVKEVVEWLN 881 (894)
Q Consensus 834 ~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~ 881 (894)
...... ... ....+.+++.+|++.+|.+||++.++++.|+
T Consensus 235 ~~~~~~-----~~~---~~~~l~~~i~~~l~~~p~~Rp~~~~~l~~l~ 274 (275)
T cd05046 235 KLELPV-----PEG---CPSRLYKLMTRCWAVNPKDRPSFSELVSALG 274 (275)
T ss_pred CcCCCC-----CCC---CCHHHHHHHHHHcCCCcccCCCHHHHHHHhc
Confidence 111000 011 1235778999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s |
| >KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-34 Score=302.09 Aligned_cols=257 Identities=23% Similarity=0.299 Sum_probs=206.9
Q ss_pred CCCccceEeecCcEEEEEEEEc-CCCeEEEEEEcCcchhh---HHHHHHHHHHHHhcCCCceeeecceeeecceEEEEEE
Q 002673 608 NFSQANIIGCGGFGLVYKATLA-NGTTLAIKKLSGDLGLM---EREFKAEVEALSTAQHKNLVSLQGYCVHQGFRLLIYS 683 (894)
Q Consensus 608 ~f~~~~~LG~G~fg~Vy~a~~~-~g~~vAvK~~~~~~~~~---~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~lV~E 683 (894)
.|+..+.||+|.-|+||.+.+. ++..+|+|++.+..-.. ....+.|-++|+.++||.++.|++.+..++..++|||
T Consensus 78 ~f~llk~LG~GdiG~VyL~~l~~t~~~fAmKVmdK~~l~~rkKl~Ra~tE~eIL~~lDHPFlPTLYa~fet~~~~cl~me 157 (459)
T KOG0610|consen 78 HFRLLKRLGCGDIGTVYLVELRGTNCLFAMKVMDKESLASRKKLKRAQTEREILSLLDHPFLPTLYASFETDKYSCLVME 157 (459)
T ss_pred HHHHHHHcCCCCceeEEEEEecCCCceEEEEEecHHHHhhhhHHHHHHHHHHHHHhcCCCccchhhheeeccceeEEEEe
Confidence 4566788999999999999965 45899999998765332 3456789999999999999999999999999999999
Q ss_pred eccCCCHHHHHhhhcCCCCCcCHHHHHHHHHHHHHHHHHHHhccCCCeeecCCCCCCeEECCCCcEEEEEcccccccCC-
Q 002673 684 YMENGSLDYWLHEKADGASQLDWLTRLKIARGTSCGLAYMHQICEPHIVHRDIKSSNILLDDQFEAHLADFGLSRLILP- 762 (894)
Q Consensus 684 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDLkp~NILld~~~~vkl~DFGla~~~~~- 762 (894)
||+||+|..+++.+. ...++...+..++..|+.||+|||.+ |||.|||||+||||.++|++-|+||.++.....
T Consensus 158 yCpGGdL~~LrqkQp--~~~fse~~aRFYaAEvl~ALEYLHml---GivYRDLKPENILvredGHIMLsDFDLS~~~~~~ 232 (459)
T KOG0610|consen 158 YCPGGDLHSLRQKQP--GKRFSESAARFYAAEVLLALEYLHML---GIVYRDLKPENILVREDGHIMLSDFDLSLRCPVS 232 (459)
T ss_pred cCCCccHHHHHhhCC--CCccchhhHHHHHHHHHHHHHHHHhh---ceeeccCCcceeEEecCCcEEeeeccccccCCCC
Confidence 999999999998754 46799999999999999999999985 999999999999999999999999998865310
Q ss_pred --------------------------------CCC----------------------cccccccccCCccCcccccCcCC
Q 002673 763 --------------------------------YQT----------------------HVTTELVGTLGYIPPEYGQAWVA 788 (894)
Q Consensus 763 --------------------------------~~~----------------------~~~~~~~gt~~Y~APE~~~~~~~ 788 (894)
... .....++||-.|+|||++.|...
T Consensus 233 Pt~~~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGThEYlAPEvI~G~GH 312 (459)
T KOG0610|consen 233 PTLVKSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFVGTHEYLAPEVIRGEGH 312 (459)
T ss_pred CeeeccCCCCCCCCCcccccccccccccchhccccccccccccccccchhhhcCCCCccccccccccccccceeeecCCC
Confidence 000 01123579999999999999999
Q ss_pred CccccHHHHHHHHHHHHcCCCCCCCCCcchhhhHHHHHHHHhhcCCCCccccccccCCCChHHHHHHHHHHHHhcccCCC
Q 002673 789 TLRGDMYSFGVVMLELLTGKRPVDVLKPKMSRELVGWVLKMRSEGKQDQVFDPILRGKGFDEEMLQVLDVACMCVSQNPF 868 (894)
Q Consensus 789 s~ksDVwS~GvlL~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~ 868 (894)
+.++|+|+|||++|||+.|+.||.+......-..+ +...+.-...+..+..+.+||...|.+||.
T Consensus 313 gsAVDWWtfGIflYEmLyG~TPFKG~~~~~Tl~NI---------------v~~~l~Fp~~~~vs~~akDLIr~LLvKdP~ 377 (459)
T KOG0610|consen 313 GSAVDWWTFGIFLYEMLYGTTPFKGSNNKETLRNI---------------VGQPLKFPEEPEVSSAAKDLIRKLLVKDPS 377 (459)
T ss_pred CchhhHHHHHHHHHHHHhCCCCcCCCCchhhHHHH---------------hcCCCcCCCCCcchhHHHHHHHHHhccChh
Confidence 99999999999999999999999876544332111 001111111223456788999999999999
Q ss_pred CCCC----HHHHHH--HHHhcc
Q 002673 869 KRPT----VKEVVE--WLNNVG 884 (894)
Q Consensus 869 ~RPs----~~evl~--~L~~i~ 884 (894)
+|.- +.||-+ .++.+.
T Consensus 378 kRlg~~rGA~eIK~HpFF~gVn 399 (459)
T KOG0610|consen 378 KRLGSKRGAAEIKRHPFFEGVN 399 (459)
T ss_pred hhhccccchHHhhcCccccCCC
Confidence 9998 788766 555443
|
|
| >cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-33 Score=303.31 Aligned_cols=253 Identities=26% Similarity=0.410 Sum_probs=204.3
Q ss_pred cCCCccceEeecCcEEEEEEEE-cCCCeEEEEEEcCcc-hhhHHHHHHHHHHHHhcCCCceeeecceeeecceEEEEEEe
Q 002673 607 DNFSQANIIGCGGFGLVYKATL-ANGTTLAIKKLSGDL-GLMEREFKAEVEALSTAQHKNLVSLQGYCVHQGFRLLIYSY 684 (894)
Q Consensus 607 ~~f~~~~~LG~G~fg~Vy~a~~-~~g~~vAvK~~~~~~-~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~lV~E~ 684 (894)
++|+..+.||.|+||.||+|.. .+++.||+|.+.... ......+.+|+.+++.++|+|++++++++.++...++|+||
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (274)
T cd06609 1 ELFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPYITKYYGSFLKGSKLWIIMEY 80 (274)
T ss_pred ChhhhhhhhcCCCCeEEEEEEECCCCeEEEEEEeeccccchHHHHHHHHHHHHHHcCCCCeeeeeEEEEECCeEEEEEEe
Confidence 3677888999999999999985 468999999987543 33346788999999999999999999999999999999999
Q ss_pred ccCCCHHHHHhhhcCCCCCcCHHHHHHHHHHHHHHHHHHHhccCCCeeecCCCCCCeEECCCCcEEEEEcccccccCCCC
Q 002673 685 MENGSLDYWLHEKADGASQLDWLTRLKIARGTSCGLAYMHQICEPHIVHRDIKSSNILLDDQFEAHLADFGLSRLILPYQ 764 (894)
Q Consensus 685 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDLkp~NILld~~~~vkl~DFGla~~~~~~~ 764 (894)
+++++|.+++... .+++..+..++.|++.||.|||+ ++++|+||+|+||++++++.++|+|||+++......
T Consensus 81 ~~~~~L~~~~~~~-----~~~~~~~~~~~~ql~~~l~~lh~---~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~ 152 (274)
T cd06609 81 CGGGSCLDLLKPG-----KLDETYIAFILREVLLGLEYLHE---EGKIHRDIKAANILLSEEGDVKLADFGVSGQLTSTM 152 (274)
T ss_pred eCCCcHHHHHhhc-----CCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCCHHHEEECCCCCEEEcccccceeecccc
Confidence 9999999998753 68899999999999999999997 599999999999999999999999999998764332
Q ss_pred CcccccccccCCccCcccccCcCCCccccHHHHHHHHHHHHcCCCCCCCCCcchhhhHHHHHHHHhhcCCCCcccccccc
Q 002673 765 THVTTELVGTLGYIPPEYGQAWVATLRGDMYSFGVVMLELLTGKRPVDVLKPKMSRELVGWVLKMRSEGKQDQVFDPILR 844 (894)
Q Consensus 765 ~~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwS~GvlL~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~ 844 (894)
.......++..|+|||++.+..++.++||||||+++|+|++|+.||....... .. .... ....... .
T Consensus 153 -~~~~~~~~~~~y~~PE~~~~~~~~~~sDv~slG~il~~l~tg~~p~~~~~~~~---~~---~~~~-~~~~~~~-----~ 219 (274)
T cd06609 153 -SKRNTFVGTPFWMAPEVIKQSGYDEKADIWSLGITAIELAKGEPPLSDLHPMR---VL---FLIP-KNNPPSL-----E 219 (274)
T ss_pred -cccccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCcccCchHH---HH---HHhh-hcCCCCC-----c
Confidence 22334568889999999998889999999999999999999999997543211 11 1111 1111111 1
Q ss_pred CCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHH--HHHhc
Q 002673 845 GKGFDEEMLQVLDVACMCVSQNPFKRPTVKEVVE--WLNNV 883 (894)
Q Consensus 845 ~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~--~L~~i 883 (894)
... ....+.+++.+|+..+|++|||++++++ ++...
T Consensus 220 ~~~---~~~~~~~~l~~~l~~~p~~Rpt~~~il~~~~~~~~ 257 (274)
T cd06609 220 GNK---FSKPFKDFVSLCLNKDPKERPSAKELLKHKFIKKA 257 (274)
T ss_pred ccc---cCHHHHHHHHHHhhCChhhCcCHHHHhhChhhcCC
Confidence 110 2235678899999999999999999998 66543
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) |
| >cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-33 Score=314.42 Aligned_cols=241 Identities=25% Similarity=0.324 Sum_probs=188.5
Q ss_pred ceEeecCcEEEEEEEE-cCCCeEEEEEEcCcch---hhHHHHHHHHH-HHHhcCCCceeeecceeeecceEEEEEEeccC
Q 002673 613 NIIGCGGFGLVYKATL-ANGTTLAIKKLSGDLG---LMEREFKAEVE-ALSTAQHKNLVSLQGYCVHQGFRLLIYSYMEN 687 (894)
Q Consensus 613 ~~LG~G~fg~Vy~a~~-~~g~~vAvK~~~~~~~---~~~~~~~~Ei~-~l~~l~HpnIv~l~g~~~~~~~~~lV~E~~~~ 687 (894)
+.||+|+||.||+|.. .+|+.||+|++..... .....+..|.. +++.++||||+++++++...+..++||||+++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~ 80 (323)
T cd05575 1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTADKLYFVLDYVNG 80 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhhCCCCCCCCeeEEEEeCCEEEEEEcCCCC
Confidence 4699999999999985 4789999999975321 12234444544 56789999999999999999999999999999
Q ss_pred CCHHHHHhhhcCCCCCcCHHHHHHHHHHHHHHHHHHHhccCCCeeecCCCCCCeEECCCCcEEEEEcccccccCCCCCcc
Q 002673 688 GSLDYWLHEKADGASQLDWLTRLKIARGTSCGLAYMHQICEPHIVHRDIKSSNILLDDQFEAHLADFGLSRLILPYQTHV 767 (894)
Q Consensus 688 gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDLkp~NILld~~~~vkl~DFGla~~~~~~~~~~ 767 (894)
|+|..++... ..+++..+..++.||+.||.|||+ ++|+||||||+|||++.++.+||+|||+++..... ...
T Consensus 81 g~L~~~l~~~----~~~~~~~~~~~~~qi~~~l~~lH~---~givH~dikp~NIll~~~~~~kl~Dfg~~~~~~~~-~~~ 152 (323)
T cd05575 81 GELFFHLQRE----RSFPEPRARFYAAEIASALGYLHS---LNIIYRDLKPENILLDSQGHVVLTDFGLCKEGIEH-SKT 152 (323)
T ss_pred CCHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHH---CCeEeCCCCHHHeEECCCCcEEEeccCCCcccccC-CCc
Confidence 9999988753 357888999999999999999997 59999999999999999999999999998753221 122
Q ss_pred cccccccCCccCcccccCcCCCccccHHHHHHHHHHHHcCCCCCCCCCcchhhhHHHHHHHHhhcCCCCccccccccCCC
Q 002673 768 TTELVGTLGYIPPEYGQAWVATLRGDMYSFGVVMLELLTGKRPVDVLKPKMSRELVGWVLKMRSEGKQDQVFDPILRGKG 847 (894)
Q Consensus 768 ~~~~~gt~~Y~APE~~~~~~~s~ksDVwS~GvlL~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~ 847 (894)
.....||+.|+|||++.+..++.++|||||||++|||++|+.||...... ... ..... .... +.+
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~---~~~---~~i~~-~~~~--~~~------ 217 (323)
T cd05575 153 TSTFCGTPEYLAPEVLRKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRDTA---EMY---DNILN-KPLR--LKP------ 217 (323)
T ss_pred cccccCChhhcChhhhcCCCCCccccccccchhhhhhhcCCCCCCCCCHH---HHH---HHHHc-CCCC--CCC------
Confidence 33457899999999999999999999999999999999999999754321 111 11111 1110 001
Q ss_pred ChHHHHHHHHHHHHhcccCCCCCCCHH----HHHH
Q 002673 848 FDEEMLQVLDVACMCVSQNPFKRPTVK----EVVE 878 (894)
Q Consensus 848 ~~~~~~~l~~li~~Cl~~dP~~RPs~~----evl~ 878 (894)
.....+.+++.+|++.||.+||++. ++++
T Consensus 218 --~~~~~~~~li~~~l~~~p~~R~~~~~~~~~il~ 250 (323)
T cd05575 218 --NISVSARHLLEGLLQKDRTKRLGAKDDFLEIKN 250 (323)
T ss_pred --CCCHHHHHHHHHHhhcCHHhCCCCCCCHHHHHc
Confidence 1123567899999999999999974 5554
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr |
| >cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-33 Score=314.30 Aligned_cols=258 Identities=24% Similarity=0.266 Sum_probs=196.6
Q ss_pred cCCCccceEeecCcEEEEEEEEc-CCCeEEEEEEcCcc---hhhHHHHHHHHHHHHhcCCCceeeecceeeecceEEEEE
Q 002673 607 DNFSQANIIGCGGFGLVYKATLA-NGTTLAIKKLSGDL---GLMEREFKAEVEALSTAQHKNLVSLQGYCVHQGFRLLIY 682 (894)
Q Consensus 607 ~~f~~~~~LG~G~fg~Vy~a~~~-~g~~vAvK~~~~~~---~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~lV~ 682 (894)
++|++.+.||+|+||.||++... +++.+|+|.+.+.. ......+..|+.++..++|+||+++++++.+.+..++||
T Consensus 1 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (332)
T cd05623 1 EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLHYAFQDENNLYLVM 80 (332)
T ss_pred CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEeHHHHHHhhHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCEEEEEE
Confidence 46888999999999999999854 57889999986432 122345788999999999999999999999999999999
Q ss_pred EeccCCCHHHHHhhhcCCCCCcCHHHHHHHHHHHHHHHHHHHhccCCCeeecCCCCCCeEECCCCcEEEEEcccccccCC
Q 002673 683 SYMENGSLDYWLHEKADGASQLDWLTRLKIARGTSCGLAYMHQICEPHIVHRDIKSSNILLDDQFEAHLADFGLSRLILP 762 (894)
Q Consensus 683 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDLkp~NILld~~~~vkl~DFGla~~~~~ 762 (894)
||+++|+|.+++.... ..+++..+..++.|++.||.|||+ ++|+||||||+|||++.++.+||+|||++.....
T Consensus 81 ey~~~g~L~~~l~~~~---~~l~~~~~~~~~~qi~~al~~lH~---~~iiHrDlkp~Nili~~~~~~kL~DfG~a~~~~~ 154 (332)
T cd05623 81 DYYVGGDLLTLLSKFE---DRLPEDMARFYLAEMVIAIDSVHQ---LHYVHRDIKPDNILMDMNGHIRLADFGSCLKLME 154 (332)
T ss_pred eccCCCcHHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHH---CCeEecCCCHHHEEECCCCCEEEeecchheeccc
Confidence 9999999999997632 358888899999999999999997 5999999999999999999999999999976543
Q ss_pred CCCcccccccccCCccCccccc-----CcCCCccccHHHHHHHHHHHHcCCCCCCCCCcchhhhHHHHHHHHhhcCCCCc
Q 002673 763 YQTHVTTELVGTLGYIPPEYGQ-----AWVATLRGDMYSFGVVMLELLTGKRPVDVLKPKMSRELVGWVLKMRSEGKQDQ 837 (894)
Q Consensus 763 ~~~~~~~~~~gt~~Y~APE~~~-----~~~~s~ksDVwS~GvlL~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 837 (894)
..........||+.|+|||++. ...++.++|||||||++|||++|+.||...... ..............
T Consensus 155 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell~g~~Pf~~~~~~------~~~~~i~~~~~~~~ 228 (332)
T cd05623 155 DGTVQSSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAESLV------ETYGKIMNHKERFQ 228 (332)
T ss_pred CCcceecccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHHhcCCCCCCCCCHH------HHHHHHhCCCcccc
Confidence 3322333457999999999876 346788999999999999999999999754321 11111111111000
Q ss_pred cccccccCCCChHHHHHHHHHHHHhcccCCCC--CCCHHHHHH--HHHh
Q 002673 838 VFDPILRGKGFDEEMLQVLDVACMCVSQNPFK--RPTVKEVVE--WLNN 882 (894)
Q Consensus 838 ~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~--RPs~~evl~--~L~~ 882 (894)
+.. ........+.+++.+|+..++.+ |+++.++++ |+..
T Consensus 229 -~p~-----~~~~~s~~~~~li~~ll~~~~~r~~r~~~~~~~~h~~f~~ 271 (332)
T cd05623 229 -FPA-----QVTDVSEDAKDLIRRLICSREHRLGQNGIEDFKQHPFFTG 271 (332)
T ss_pred -CCC-----ccccCCHHHHHHHHHHccChhhhcCCCCHHHHhCCCCcCC
Confidence 110 01112234667788877654444 789999987 5543
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw |
| >cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-33 Score=304.32 Aligned_cols=252 Identities=27% Similarity=0.356 Sum_probs=198.4
Q ss_pred cCCCccceEeecCcEEEEEEEE-cCCCeEEEEEEcCcchhhHHHHHHHHHHHHhcCCCceeeecceeeecceEEEEEEec
Q 002673 607 DNFSQANIIGCGGFGLVYKATL-ANGTTLAIKKLSGDLGLMEREFKAEVEALSTAQHKNLVSLQGYCVHQGFRLLIYSYM 685 (894)
Q Consensus 607 ~~f~~~~~LG~G~fg~Vy~a~~-~~g~~vAvK~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~lV~E~~ 685 (894)
++|+..+.||+|+||.||+|.. .++..||+|.++.........+.+|+.+++.++||||+++++++...+..++||||+
T Consensus 9 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~~~~l~h~~ii~~~~~~~~~~~~~lv~e~~ 88 (267)
T cd06645 9 EDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMKDCKHSNIVAYFGSYLRRDKLWICMEFC 88 (267)
T ss_pred HHHHHHHHhCCCCCeEEEEEEEcCCCcEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEEEEecc
Confidence 4677788999999999999984 568999999987654444556889999999999999999999999999999999999
Q ss_pred cCCCHHHHHhhhcCCCCCcCHHHHHHHHHHHHHHHHHHHhccCCCeeecCCCCCCeEECCCCcEEEEEcccccccCCCCC
Q 002673 686 ENGSLDYWLHEKADGASQLDWLTRLKIARGTSCGLAYMHQICEPHIVHRDIKSSNILLDDQFEAHLADFGLSRLILPYQT 765 (894)
Q Consensus 686 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDLkp~NILld~~~~vkl~DFGla~~~~~~~~ 765 (894)
++++|.+++... ..+++.+.+.++.|++.||.|||+ .+++|+||||+||+++.++.+||+|||++.......
T Consensus 89 ~~~~L~~~~~~~----~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~~~- 160 (267)
T cd06645 89 GGGSLQDIYHVT----GPLSESQIAYVSRETLQGLYYLHS---KGKMHRDIKGANILLTDNGHVKLADFGVSAQITATI- 160 (267)
T ss_pred CCCcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHEEECCCCCEEECcceeeeEccCcc-
Confidence 999999998753 358899999999999999999997 599999999999999999999999999987653221
Q ss_pred cccccccccCCccCccccc---CcCCCccccHHHHHHHHHHHHcCCCCCCCCCcchhhhHHHHHHHHhhcCCCCcccccc
Q 002673 766 HVTTELVGTLGYIPPEYGQ---AWVATLRGDMYSFGVVMLELLTGKRPVDVLKPKMSRELVGWVLKMRSEGKQDQVFDPI 842 (894)
Q Consensus 766 ~~~~~~~gt~~Y~APE~~~---~~~~s~ksDVwS~GvlL~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 842 (894)
.......|+..|+|||++. ...++.++|||||||++|+|++|+.||....... .... .............
T Consensus 161 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~DvwSlG~il~~l~~~~~p~~~~~~~~--~~~~----~~~~~~~~~~~~~- 233 (267)
T cd06645 161 AKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFDLHPMR--ALFL----MTKSNFQPPKLKD- 233 (267)
T ss_pred cccccccCcccccChhhhccccCCCCCchhhhHHHHHHHHHHhcCCCCcccccchh--hHHh----hhccCCCCCcccc-
Confidence 2223457899999999874 4568889999999999999999999986433211 1110 0001000000000
Q ss_pred ccCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 002673 843 LRGKGFDEEMLQVLDVACMCVSQNPFKRPTVKEVVE 878 (894)
Q Consensus 843 l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~ 878 (894)
...+ ...+.+++.+|++.+|++||+++++++
T Consensus 234 --~~~~---~~~~~~li~~~l~~~P~~R~~~~~ll~ 264 (267)
T cd06645 234 --KMKW---SNSFHHFVKMALTKNPKKRPTAEKLLQ 264 (267)
T ss_pred --cCCC---CHHHHHHHHHHccCCchhCcCHHHHhc
Confidence 0011 224678999999999999999999875
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-33 Score=305.44 Aligned_cols=267 Identities=25% Similarity=0.367 Sum_probs=206.8
Q ss_pred cCCCccceEeecCcEEEEEEEE-cCCCeEEEEEEcCcch-hhHHHHHHHHHHHHhcCCCceeeecceeeec--ceEEEEE
Q 002673 607 DNFSQANIIGCGGFGLVYKATL-ANGTTLAIKKLSGDLG-LMEREFKAEVEALSTAQHKNLVSLQGYCVHQ--GFRLLIY 682 (894)
Q Consensus 607 ~~f~~~~~LG~G~fg~Vy~a~~-~~g~~vAvK~~~~~~~-~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~--~~~~lV~ 682 (894)
++|...+.||.|++|.||++.. .+++.+|+|.+..... .....+.+|++++++++||||++++++|... +..++||
T Consensus 1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~ 80 (287)
T cd06621 1 EKIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPYIVKYYGAFLDESSSSIGIAM 80 (287)
T ss_pred CceEEEEEeccCCceEEEEEEECCCCeEEEEEEEecCCchHHHHHHHHHHHHHHhCCCCCeeeeeeEEEccCCCeEEEEE
Confidence 3577889999999999999986 4688999999875432 3456789999999999999999999988653 4689999
Q ss_pred EeccCCCHHHHHhhhcCCCCCcCHHHHHHHHHHHHHHHHHHHhccCCCeeecCCCCCCeEECCCCcEEEEEcccccccCC
Q 002673 683 SYMENGSLDYWLHEKADGASQLDWLTRLKIARGTSCGLAYMHQICEPHIVHRDIKSSNILLDDQFEAHLADFGLSRLILP 762 (894)
Q Consensus 683 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDLkp~NILld~~~~vkl~DFGla~~~~~ 762 (894)
||+++++|.+++.........++......++.|++.||.|||+ .+++|+||+|+||+++.++.++|+|||++.....
T Consensus 81 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~lH~---~~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~ 157 (287)
T cd06621 81 EYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHS---RKIIHRDIKPSNILLTRKGQVKLCDFGVSGELVN 157 (287)
T ss_pred EecCCCCHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEEecCCeEEEeeccccccccc
Confidence 9999999999887544344568888999999999999999997 5999999999999999999999999999876532
Q ss_pred CCCcccccccccCCccCcccccCcCCCccccHHHHHHHHHHHHcCCCCCCCCCc--chhhhHHHHHHHHhhcCCCCcccc
Q 002673 763 YQTHVTTELVGTLGYIPPEYGQAWVATLRGDMYSFGVVMLELLTGKRPVDVLKP--KMSRELVGWVLKMRSEGKQDQVFD 840 (894)
Q Consensus 763 ~~~~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwS~GvlL~elltG~~Pf~~~~~--~~~~~~~~~~~~~~~~~~~~~~~d 840 (894)
.. .....++..|+|||.+.+..++.++||||||+++|+|++|+.||..... ....+...+... .......+
T Consensus 158 ~~---~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~----~~~~~~~~ 230 (287)
T cd06621 158 SL---AGTFTGTSFYMAPERIQGKPYSITSDVWSLGLTLLEVAQNRFPFPPEGEPPLGPIELLSYIVN----MPNPELKD 230 (287)
T ss_pred cc---cccccCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCcccCCCCChHHHHHHHhc----CCchhhcc
Confidence 21 1234578899999999998999999999999999999999999975532 111122222211 11111111
Q ss_pred ccccCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHH--HHHhcccc
Q 002673 841 PILRGKGFDEEMLQVLDVACMCVSQNPFKRPTVKEVVE--WLNNVGAN 886 (894)
Q Consensus 841 ~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~--~L~~i~~~ 886 (894)
..... ......+.+++.+|++.+|++|||+.|+++ |+.....+
T Consensus 231 ~~~~~---~~~~~~~~~li~~~l~~~p~~Rpt~~eil~~~~~~~~~~~ 275 (287)
T cd06621 231 EPGNG---IKWSEEFKDFIKQCLEKDPTRRPTPWDMLEHPWIKAQMKK 275 (287)
T ss_pred CCCCC---CchHHHHHHHHHHHcCCCcccCCCHHHHHhCccccccccc
Confidence 00000 112346789999999999999999999999 77665544
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-33 Score=298.38 Aligned_cols=250 Identities=23% Similarity=0.385 Sum_probs=198.9
Q ss_pred CCCccceEeecCcEEEEEEEEcCCCeEEEEEEcCcch------hhHHHHHHHHHHHHhcCCCceeeecceeeecceEEEE
Q 002673 608 NFSQANIIGCGGFGLVYKATLANGTTLAIKKLSGDLG------LMEREFKAEVEALSTAQHKNLVSLQGYCVHQGFRLLI 681 (894)
Q Consensus 608 ~f~~~~~LG~G~fg~Vy~a~~~~g~~vAvK~~~~~~~------~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~lV 681 (894)
+|...+.||+|+||.||+|...+++.+|+|.+..... .....+.+|++++++++|+||+++++++.+.+..++|
T Consensus 1 ~~~~~~~ig~g~~~~v~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv 80 (265)
T cd06631 1 EWTKGEVLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTCLDDNTISIF 80 (265)
T ss_pred CccccceEeccCCeEEEEEEEcCCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcCCCCEeeEeeEeecCCeEEEE
Confidence 4778899999999999999988899999998864321 1234688999999999999999999999999999999
Q ss_pred EEeccCCCHHHHHhhhcCCCCCcCHHHHHHHHHHHHHHHHHHHhccCCCeeecCCCCCCeEECCCCcEEEEEcccccccC
Q 002673 682 YSYMENGSLDYWLHEKADGASQLDWLTRLKIARGTSCGLAYMHQICEPHIVHRDIKSSNILLDDQFEAHLADFGLSRLIL 761 (894)
Q Consensus 682 ~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDLkp~NILld~~~~vkl~DFGla~~~~ 761 (894)
+||+++++|.+++... ..+++..+..++.|++.||+|||+ .+++|+||+|+||++++++.++|+|||++....
T Consensus 81 ~e~~~~~~L~~~l~~~----~~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~ 153 (265)
T cd06631 81 MEFVPGGSISSILNRF----GPLPEPVFCKYTKQILDGVAYLHN---NCVVHRDIKGNNVMLMPNGIIKLIDFGCARRLA 153 (265)
T ss_pred EecCCCCcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCcCHHhEEECCCCeEEeccchhhHhhh
Confidence 9999999999999754 347888899999999999999997 589999999999999999999999999987653
Q ss_pred CCC-----CcccccccccCCccCcccccCcCCCccccHHHHHHHHHHHHcCCCCCCCCCcchhhhHHHHHHHHhhcCCCC
Q 002673 762 PYQ-----THVTTELVGTLGYIPPEYGQAWVATLRGDMYSFGVVMLELLTGKRPVDVLKPKMSRELVGWVLKMRSEGKQD 836 (894)
Q Consensus 762 ~~~-----~~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwS~GvlL~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~ 836 (894)
... ........|+..|+|||+..+..++.++||||||+++|+|++|+.||....... ..... ........
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~--~~~~~---~~~~~~~~ 228 (265)
T cd06631 154 WVGLHGTHSNMLKSMHGTPYWMAPEVINESGYGRKSDIWSIGCTVFEMATGKPPLASMDRLA--AMFYI---GAHRGLMP 228 (265)
T ss_pred hccccccccccccccCCCccccChhhhcCCCCcchhhHHHHHHHHHHHHhCCCccccCChHH--HHHHh---hhccCCCC
Confidence 211 111233568899999999999889999999999999999999999997543211 11100 00001111
Q ss_pred ccccccccCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 002673 837 QVFDPILRGKGFDEEMLQVLDVACMCVSQNPFKRPTVKEVVE 878 (894)
Q Consensus 837 ~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~ 878 (894)
. +. . .....+.+++.+|++.+|++||++.++++
T Consensus 229 ~-----~~-~---~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~ 261 (265)
T cd06631 229 R-----LP-D---SFSAAAIDFVTSCLTRDQHERPSALQLLR 261 (265)
T ss_pred C-----CC-C---CCCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence 1 11 1 12235678899999999999999999875
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. |
| >cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-33 Score=314.55 Aligned_cols=254 Identities=24% Similarity=0.256 Sum_probs=195.8
Q ss_pred cCCCccceEeecCcEEEEEEEE-cCCCeEEEEEEcCcc---hhhHHHHHHHHHHHHhcCCCceeeecceeeecceEEEEE
Q 002673 607 DNFSQANIIGCGGFGLVYKATL-ANGTTLAIKKLSGDL---GLMEREFKAEVEALSTAQHKNLVSLQGYCVHQGFRLLIY 682 (894)
Q Consensus 607 ~~f~~~~~LG~G~fg~Vy~a~~-~~g~~vAvK~~~~~~---~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~lV~ 682 (894)
++|++.+.||+|+||.||+++. .+++.||+|.+.... ......+.+|+.++..++|+||+++++++.+++..++||
T Consensus 1 d~y~i~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~l~~~~~~~~~~~lv~ 80 (331)
T cd05624 1 DDFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQWITTLHYAFQDENYLYLVM 80 (331)
T ss_pred CCceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHHHhhHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence 4788899999999999999985 467889999987532 122345788999999999999999999999999999999
Q ss_pred EeccCCCHHHHHhhhcCCCCCcCHHHHHHHHHHHHHHHHHHHhccCCCeeecCCCCCCeEECCCCcEEEEEcccccccCC
Q 002673 683 SYMENGSLDYWLHEKADGASQLDWLTRLKIARGTSCGLAYMHQICEPHIVHRDIKSSNILLDDQFEAHLADFGLSRLILP 762 (894)
Q Consensus 683 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDLkp~NILld~~~~vkl~DFGla~~~~~ 762 (894)
||+++|+|.+++.... ..+++..+..++.|++.||.|||+ ++|+||||||+|||++.++.+||+|||+++....
T Consensus 81 Ey~~gg~L~~~l~~~~---~~l~~~~~~~~~~qi~~~L~~lH~---~~iiHrDlkp~Nill~~~~~~kl~DfG~a~~~~~ 154 (331)
T cd05624 81 DYYVGGDLLTLLSKFE---DRLPEDMARFYIAEMVLAIHSIHQ---LHYVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQ 154 (331)
T ss_pred eCCCCCcHHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHH---CCeeeccCchHHEEEcCCCCEEEEeccceeeccC
Confidence 9999999999998632 357888999999999999999997 5999999999999999999999999999987643
Q ss_pred CCCcccccccccCCccCcccccC-----cCCCccccHHHHHHHHHHHHcCCCCCCCCCcchhhhHHHHHHHHhhcCCCCc
Q 002673 763 YQTHVTTELVGTLGYIPPEYGQA-----WVATLRGDMYSFGVVMLELLTGKRPVDVLKPKMSRELVGWVLKMRSEGKQDQ 837 (894)
Q Consensus 763 ~~~~~~~~~~gt~~Y~APE~~~~-----~~~s~ksDVwS~GvlL~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 837 (894)
..........||+.|+|||++.+ ..++.++|||||||++|||++|+.||....... .............
T Consensus 155 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~------~~~~i~~~~~~~~ 228 (331)
T cd05624 155 DGTVQSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAESLVE------TYGKIMNHEERFQ 228 (331)
T ss_pred CCceeeccccCCcccCCHHHHhccccCCCCCCCcccEEeeehhhhhhhhCCCCccCCCHHH------HHHHHHcCCCccc
Confidence 33222334579999999998865 467889999999999999999999997543211 1111111110000
Q ss_pred cccccccCCCChHHHHHHHHHHHHhcccCCCC--CCCHHHHHH
Q 002673 838 VFDPILRGKGFDEEMLQVLDVACMCVSQNPFK--RPTVKEVVE 878 (894)
Q Consensus 838 ~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~--RPs~~evl~ 878 (894)
+.+. .......+.+++.+|++.++.+ |++++++++
T Consensus 229 -~p~~-----~~~~~~~~~~li~~ll~~~~~~~~~~~~~~~~~ 265 (331)
T cd05624 229 -FPSH-----ITDVSEEAKDLIQRLICSRERRLGQNGIEDFKK 265 (331)
T ss_pred -CCCc-----cccCCHHHHHHHHHHccCchhhcCCCCHHHHhc
Confidence 1111 1112235667888888865544 568888886
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. |
| >cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-33 Score=312.44 Aligned_cols=263 Identities=19% Similarity=0.253 Sum_probs=197.6
Q ss_pred ccceEeec--CcEEEEEEE-EcCCCeEEEEEEcCcc--hhhHHHHHHHHHHHHhcCCCceeeecceeeecceEEEEEEec
Q 002673 611 QANIIGCG--GFGLVYKAT-LANGTTLAIKKLSGDL--GLMEREFKAEVEALSTAQHKNLVSLQGYCVHQGFRLLIYSYM 685 (894)
Q Consensus 611 ~~~~LG~G--~fg~Vy~a~-~~~g~~vAvK~~~~~~--~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~lV~E~~ 685 (894)
..++||+| +|++||++. ..+|+.||+|++.... ......+.+|+.+++.++||||+++++++..++..++||||+
T Consensus 2 ~~~~ig~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~ 81 (327)
T cd08227 2 LLTVIGRGFEDLMTVNLARYKPTGEYVTVRRINLEACTNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSFM 81 (327)
T ss_pred hhhhccccccceEEEEEEeecccCcEEEEEEechhhccHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEECCEEEEEEecc
Confidence 35689999 788999997 4678999999997543 233456788999999999999999999999999999999999
Q ss_pred cCCCHHHHHhhhcCCCCCcCHHHHHHHHHHHHHHHHHHHhccCCCeeecCCCCCCeEECCCCcEEEEEcccccccCCCCC
Q 002673 686 ENGSLDYWLHEKADGASQLDWLTRLKIARGTSCGLAYMHQICEPHIVHRDIKSSNILLDDQFEAHLADFGLSRLILPYQT 765 (894)
Q Consensus 686 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDLkp~NILld~~~~vkl~DFGla~~~~~~~~ 765 (894)
++|+|.+++..... ..+++..++.++.|++.||.|||+ ++|+||||||+|||++.++.++++||+..........
T Consensus 82 ~~~~l~~~~~~~~~--~~l~~~~~~~i~~qi~~~L~~LH~---~~iiH~dlkp~Nil~~~~~~~~l~~~~~~~~~~~~~~ 156 (327)
T cd08227 82 AYGSAKDLICTHFM--DGMSELAIAYILQGVLKALDYIHH---MGYVHRSVKASHILISVDGKVYLSGLRSNLSMINHGQ 156 (327)
T ss_pred CCCcHHHHHHhhcc--CCCCHHHHHHHHHHHHHHHHHHHH---CCEecCCCChhhEEEecCCcEEEcccchhhccccccc
Confidence 99999999975422 348899999999999999999997 5999999999999999999999999986544321110
Q ss_pred c------ccccccccCCccCcccccC--cCCCccccHHHHHHHHHHHHcCCCCCCCCCcchhhhHHHHHHHHhhcCCCCc
Q 002673 766 H------VTTELVGTLGYIPPEYGQA--WVATLRGDMYSFGVVMLELLTGKRPVDVLKPKMSRELVGWVLKMRSEGKQDQ 837 (894)
Q Consensus 766 ~------~~~~~~gt~~Y~APE~~~~--~~~s~ksDVwS~GvlL~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 837 (894)
. ......++..|+|||++.+ ..++.++|||||||++|||++|+.||....... ....... +....
T Consensus 157 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~--~~~~~~~-----~~~~~ 229 (327)
T cd08227 157 RLRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQ--MLLEKLN-----GTVPC 229 (327)
T ss_pred cccccccccccccceecccChHHhhcccCCCCchhhHHHHHHHHHHHHHCCCCCCCcchhH--HHHHHhc-----CCccc
Confidence 0 1122356778999999876 458899999999999999999999997543211 1111000 00000
Q ss_pred ccc-------------------ccc-----------------cCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHH--H
Q 002673 838 VFD-------------------PIL-----------------RGKGFDEEMLQVLDVACMCVSQNPFKRPTVKEVVE--W 879 (894)
Q Consensus 838 ~~d-------------------~~l-----------------~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~--~ 879 (894)
..+ ... ...........+.+++.+|++.||++|||++++++ |
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~ell~~p~ 309 (327)
T cd08227 230 LLDTTTIPAEELTMKPSRSGANSGLGESTTVSTPRPSNGESSSHPYNRTFSPHFHHFVEQCLQRNPDARPSASTLLNHSF 309 (327)
T ss_pred cccccchhhhhcccCCcccCCcCCCCcccccCCcCccccCCcccccccccCHHHHHHHHHHHhhCchhcCCHHHHhcChh
Confidence 000 000 00001112346789999999999999999999998 7
Q ss_pred HHhccc
Q 002673 880 LNNVGA 885 (894)
Q Consensus 880 L~~i~~ 885 (894)
++++..
T Consensus 310 f~~~~~ 315 (327)
T cd08227 310 FKQIKR 315 (327)
T ss_pred hhhcch
Confidence 877653
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype |
| >cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-33 Score=298.71 Aligned_cols=254 Identities=28% Similarity=0.394 Sum_probs=204.4
Q ss_pred ccCCCccceEeecCcEEEEEEEE-cCCCeEEEEEEcCcchhhHHHHHHHHHHHHhcCCCceeeecceeeecceEEEEEEe
Q 002673 606 TDNFSQANIIGCGGFGLVYKATL-ANGTTLAIKKLSGDLGLMEREFKAEVEALSTAQHKNLVSLQGYCVHQGFRLLIYSY 684 (894)
Q Consensus 606 ~~~f~~~~~LG~G~fg~Vy~a~~-~~g~~vAvK~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~lV~E~ 684 (894)
.++|+..+.||.|+||.||+|.. .++..+++|.+........+.+.+|+.++++++||||+++++++...+..+++|||
T Consensus 2 ~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~l~~e~ 81 (262)
T cd06613 2 QEDYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNIVAYFGSYLRRDKLWIVMEY 81 (262)
T ss_pred ccceEEEEEecCCCceEEEEeEecCCCCEEEEEEEEcCchhhHHHHHHHHHHHHhCCCCChhceEEEEEeCCEEEEEEeC
Confidence 35788899999999999999985 46788999999866555567889999999999999999999999999999999999
Q ss_pred ccCCCHHHHHhhhcCCCCCcCHHHHHHHHHHHHHHHHHHHhccCCCeeecCCCCCCeEECCCCcEEEEEcccccccCCCC
Q 002673 685 MENGSLDYWLHEKADGASQLDWLTRLKIARGTSCGLAYMHQICEPHIVHRDIKSSNILLDDQFEAHLADFGLSRLILPYQ 764 (894)
Q Consensus 685 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDLkp~NILld~~~~vkl~DFGla~~~~~~~ 764 (894)
+++++|.+++.... ..++...+..++.|++.||.|||+ .+++|+||+|+||++++++.+||+|||++.......
T Consensus 82 ~~~~~l~~~~~~~~---~~l~~~~~~~~~~ql~~~l~~lh~---~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~ 155 (262)
T cd06613 82 CGGGSLQDIYQVTR---GPLSELQIAYVCRETLKGLAYLHE---TGKIHRDIKGANILLTEDGDVKLADFGVSAQLTATI 155 (262)
T ss_pred CCCCcHHHHHHhhc---cCCCHHHHHHHHHHHHHHHHHHHh---CCceecCCChhhEEECCCCCEEECccccchhhhhhh
Confidence 99999999987642 358889999999999999999997 599999999999999999999999999998654321
Q ss_pred CcccccccccCCccCcccccCc---CCCccccHHHHHHHHHHHHcCCCCCCCCCcchhhhHHHHHHHHhhcCCCCccccc
Q 002673 765 THVTTELVGTLGYIPPEYGQAW---VATLRGDMYSFGVVMLELLTGKRPVDVLKPKMSRELVGWVLKMRSEGKQDQVFDP 841 (894)
Q Consensus 765 ~~~~~~~~gt~~Y~APE~~~~~---~~s~ksDVwS~GvlL~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 841 (894)
.......++..|+|||...+. .++.++||||||+++|+|++|+.||........ ... ..... . ..+
T Consensus 156 -~~~~~~~~~~~y~~Pe~~~~~~~~~~~~~~Di~slG~~l~~~~tg~~p~~~~~~~~~--~~~----~~~~~-~---~~~ 224 (262)
T cd06613 156 -AKRKSFIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPPMFDLHPMRA--LFL----ISKSN-F---PPP 224 (262)
T ss_pred -hccccccCCccccCchhhcccccCCcCchhhhHHHHHHHHHHHhCCCCCCCCCHHHH--HHH----HHhcc-C---CCc
Confidence 122335678899999998776 889999999999999999999999975442211 111 00110 0 000
Q ss_pred cccCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 002673 842 ILRGKGFDEEMLQVLDVACMCVSQNPFKRPTVKEVVE 878 (894)
Q Consensus 842 ~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~ 878 (894)
.+ .........+.+++.+|++.+|.+|||+++++.
T Consensus 225 ~~--~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~ 259 (262)
T cd06613 225 KL--KDKEKWSPVFHDFIKKCLTKDPKKRPTATKLLQ 259 (262)
T ss_pred cc--cchhhhhHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 00 111223456789999999999999999999875
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ |
| >cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-33 Score=301.38 Aligned_cols=238 Identities=26% Similarity=0.447 Sum_probs=189.5
Q ss_pred ceEeecCcEEEEEEEEcCCC-----------eEEEEEEcCcchhhHHHHHHHHHHHHhcCCCceeeecceeeecceEEEE
Q 002673 613 NIIGCGGFGLVYKATLANGT-----------TLAIKKLSGDLGLMEREFKAEVEALSTAQHKNLVSLQGYCVHQGFRLLI 681 (894)
Q Consensus 613 ~~LG~G~fg~Vy~a~~~~g~-----------~vAvK~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~lV 681 (894)
+.||+|+||.||+|...+.. .|++|.+...... ...+.+|+.+++.++||||+++++++.. ...++|
T Consensus 1 ~~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~-~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~lv 78 (259)
T cd05037 1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRD-SLAFFETASLMSQLSHKHLVKLYGVCVR-DENIMV 78 (259)
T ss_pred CcccccccceEEEEEEeccCCccccCCccceeeeeeccccchhh-HHHHHHHHHHHHcCCCcchhheeeEEec-CCcEEE
Confidence 46899999999999865433 5788877654332 6778999999999999999999999988 778999
Q ss_pred EEeccCCCHHHHHhhhcCCCCCcCHHHHHHHHHHHHHHHHHHHhccCCCeeecCCCCCCeEECCCC-------cEEEEEc
Q 002673 682 YSYMENGSLDYWLHEKADGASQLDWLTRLKIARGTSCGLAYMHQICEPHIVHRDIKSSNILLDDQF-------EAHLADF 754 (894)
Q Consensus 682 ~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDLkp~NILld~~~-------~vkl~DF 754 (894)
|||+++|+|.+++.... ..+++..+..++.||+.||.|||+ ++|+||||||+||+++.++ .+||+||
T Consensus 79 ~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~~~i~~~l~~LH~---~~i~H~dlkp~Nill~~~~~~~~~~~~~kl~Df 152 (259)
T cd05037 79 EEYVKFGPLDVFLHREK---NNVSLHWKLDVAKQLASALHYLED---KKLVHGNVCGKNILVARYGLNEGYVPFIKLSDP 152 (259)
T ss_pred EEcCCCCcHHHHHHhhc---cCCCHHHHHHHHHHHHHHHHHHhh---CCeecccCccceEEEecCccccCCceeEEeCCC
Confidence 99999999999998643 268889999999999999999997 6999999999999999888 7999999
Q ss_pred ccccccCCCCCcccccccccCCccCcccccCc--CCCccccHHHHHHHHHHHHc-CCCCCCCCCcchhhhHHHHHHHHhh
Q 002673 755 GLSRLILPYQTHVTTELVGTLGYIPPEYGQAW--VATLRGDMYSFGVVMLELLT-GKRPVDVLKPKMSRELVGWVLKMRS 831 (894)
Q Consensus 755 Gla~~~~~~~~~~~~~~~gt~~Y~APE~~~~~--~~s~ksDVwS~GvlL~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~ 831 (894)
|++..... .....++..|+|||++.+. .++.++||||||+++|||++ |..||....... ...+. ..
T Consensus 153 g~a~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~~~~~l~~~~~~p~~~~~~~~---~~~~~---~~ 221 (259)
T cd05037 153 GIPITVLS-----REERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLSSSE---KERFY---QD 221 (259)
T ss_pred Cccccccc-----ccccccCCCccChhhhcCCCCCcchhhHHHHHHHHHHHHHhCCCCCcccCCchh---HHHHH---hc
Confidence 99986532 2234567789999998876 78999999999999999999 578886543211 11111 10
Q ss_pred cCCCCccccccccCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 002673 832 EGKQDQVFDPILRGKGFDEEMLQVLDVACMCVSQNPFKRPTVKEVVEWLN 881 (894)
Q Consensus 832 ~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~ 881 (894)
... ...+ ....+.+++.+||..+|.+|||+.++++.|+
T Consensus 222 ~~~---~~~~---------~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~ 259 (259)
T cd05037 222 QHR---LPMP---------DCAELANLINQCWTYDPTKRPSFRAILRDLN 259 (259)
T ss_pred CCC---CCCC---------CchHHHHHHHHHhccChhhCCCHHHHHHhcC
Confidence 100 0000 0146779999999999999999999998763
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki |
| >cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-33 Score=303.82 Aligned_cols=256 Identities=25% Similarity=0.365 Sum_probs=204.1
Q ss_pred cCCCccceEeecCcEEEEEEEE-cCCCeEEEEEEcCcchhhHHHHHHHHHHHHhcCCCceeeecceeeecceEEEEEEec
Q 002673 607 DNFSQANIIGCGGFGLVYKATL-ANGTTLAIKKLSGDLGLMEREFKAEVEALSTAQHKNLVSLQGYCVHQGFRLLIYSYM 685 (894)
Q Consensus 607 ~~f~~~~~LG~G~fg~Vy~a~~-~~g~~vAvK~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~lV~E~~ 685 (894)
++|++.+.||.|+||.||+|.. .++..||+|.+..........+..|++++++++||||+++++++..+...++||||+
T Consensus 5 ~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 84 (280)
T cd06611 5 DIWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGLYEAYFYENKLWILIEFC 84 (280)
T ss_pred hHHHHHHHhcCCCCceEEEEEEcCCCcEEEEEEEeeCCHHHHHHHHHHHHHHHhCCCCceeEEEEEEecCCeEEEEeecc
Confidence 5688889999999999999985 468999999997665555677899999999999999999999999999999999999
Q ss_pred cCCCHHHHHhhhcCCCCCcCHHHHHHHHHHHHHHHHHHHhccCCCeeecCCCCCCeEECCCCcEEEEEcccccccCCCCC
Q 002673 686 ENGSLDYWLHEKADGASQLDWLTRLKIARGTSCGLAYMHQICEPHIVHRDIKSSNILLDDQFEAHLADFGLSRLILPYQT 765 (894)
Q Consensus 686 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDLkp~NILld~~~~vkl~DFGla~~~~~~~~ 765 (894)
++++|.+++.... ..+++..+..++.|++.||.|||+ ++|+|+||||+||+++.++.++|+|||++.......
T Consensus 85 ~~~~L~~~~~~~~---~~l~~~~~~~~~~ql~~~l~~lh~---~~i~h~dl~p~nili~~~~~~~l~d~g~~~~~~~~~- 157 (280)
T cd06611 85 DGGALDSIMLELE---RGLTEPQIRYVCRQMLEALNFLHS---HKVIHRDLKAGNILLTLDGDVKLADFGVSAKNKSTL- 157 (280)
T ss_pred CCCcHHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCChhhEEECCCCCEEEccCccchhhcccc-
Confidence 9999999987542 358899999999999999999997 599999999999999999999999999987643221
Q ss_pred cccccccccCCccCccccc-----CcCCCccccHHHHHHHHHHHHcCCCCCCCCCcchhhhHHHHHHHHhhcCCCCcccc
Q 002673 766 HVTTELVGTLGYIPPEYGQ-----AWVATLRGDMYSFGVVMLELLTGKRPVDVLKPKMSRELVGWVLKMRSEGKQDQVFD 840 (894)
Q Consensus 766 ~~~~~~~gt~~Y~APE~~~-----~~~~s~ksDVwS~GvlL~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 840 (894)
.......++..|+|||++. ...++.++||||||+++|+|++|+.||...... ... ..... .......
T Consensus 158 ~~~~~~~~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~~l~~g~~p~~~~~~~--~~~----~~~~~-~~~~~~~- 229 (280)
T cd06611 158 QKRDTFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHELNPM--RVL----LKILK-SEPPTLD- 229 (280)
T ss_pred cccceeecchhhcCHHHHhhcccCCCCCCccccHHHHHHHHHHHHhCCCCcccCCHH--HHH----HHHhc-CCCCCcC-
Confidence 1223456899999999874 345678999999999999999999999754321 111 11111 1110000
Q ss_pred ccccCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHH--HHHhc
Q 002673 841 PILRGKGFDEEMLQVLDVACMCVSQNPFKRPTVKEVVE--WLNNV 883 (894)
Q Consensus 841 ~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~--~L~~i 883 (894)
.... ....+.+++..||+.+|.+||++.++++ |+...
T Consensus 230 ---~~~~---~~~~~~~li~~~l~~~p~~Rps~~~il~~~~~~~~ 268 (280)
T cd06611 230 ---QPSK---WSSSFNDFLKSCLVKDPDDRPTAAELLKHPFVSDQ 268 (280)
T ss_pred ---Cccc---CCHHHHHHHHHHhccChhhCcCHHHHhcChhhccc
Confidence 0011 1235678899999999999999999998 66655
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti |
| >cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-34 Score=320.42 Aligned_cols=255 Identities=25% Similarity=0.297 Sum_probs=196.6
Q ss_pred cCCCccceEeecCcEEEEEEEE-cCCCeEEEEEEcCcc---hhhHHHHHHHHHHHHhcCCCceeeecceeeecceEEEEE
Q 002673 607 DNFSQANIIGCGGFGLVYKATL-ANGTTLAIKKLSGDL---GLMEREFKAEVEALSTAQHKNLVSLQGYCVHQGFRLLIY 682 (894)
Q Consensus 607 ~~f~~~~~LG~G~fg~Vy~a~~-~~g~~vAvK~~~~~~---~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~lV~ 682 (894)
++|+..+.||+|+||.||++.. .+++.||+|++.... ......+..|+.++..++||||+++++.+.+++..++||
T Consensus 1 ~~f~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~ 80 (360)
T cd05627 1 DDFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKMFYSFQDKRNLYLIM 80 (360)
T ss_pred CCceEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence 4688889999999999999985 468999999997532 122356788999999999999999999999999999999
Q ss_pred EeccCCCHHHHHhhhcCCCCCcCHHHHHHHHHHHHHHHHHHHhccCCCeeecCCCCCCeEECCCCcEEEEEcccccccCC
Q 002673 683 SYMENGSLDYWLHEKADGASQLDWLTRLKIARGTSCGLAYMHQICEPHIVHRDIKSSNILLDDQFEAHLADFGLSRLILP 762 (894)
Q Consensus 683 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDLkp~NILld~~~~vkl~DFGla~~~~~ 762 (894)
||+++|+|.+++... ..++...+..++.|++.||.|||+ ++|+||||||+|||++.++.+||+|||+++....
T Consensus 81 E~~~gg~L~~~l~~~----~~l~~~~~~~~~~qi~~~L~~lH~---~givHrDLkp~NIli~~~~~vkL~DfG~~~~~~~ 153 (360)
T cd05627 81 EFLPGGDMMTLLMKK----DTLSEEATQFYIAETVLAIDAIHQ---LGFIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKK 153 (360)
T ss_pred eCCCCccHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHH---CCeEccCCCHHHEEECCCCCEEEeeccCCccccc
Confidence 999999999999754 358888999999999999999997 5999999999999999999999999999875422
Q ss_pred CCC----------------------------------cccccccccCCccCcccccCcCCCccccHHHHHHHHHHHHcCC
Q 002673 763 YQT----------------------------------HVTTELVGTLGYIPPEYGQAWVATLRGDMYSFGVVMLELLTGK 808 (894)
Q Consensus 763 ~~~----------------------------------~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwS~GvlL~elltG~ 808 (894)
... ......+||+.|+|||++.+..++.++|||||||++|||++|+
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvilyel~tG~ 233 (360)
T cd05627 154 AHRTEFYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGY 233 (360)
T ss_pred ccccccccccccCCcccccccccccccccccccccccccccccCCCccccCHHHHcCCCCCCcceeccccceeeecccCC
Confidence 110 0112357999999999999999999999999999999999999
Q ss_pred CCCCCCCcchhhhHHHHHHHHhhcCCCCccccccccCCCChHHHHHHHHHHHHhcccCCCCCCC---HHHHHH--HHHh
Q 002673 809 RPVDVLKPKMSRELVGWVLKMRSEGKQDQVFDPILRGKGFDEEMLQVLDVACMCVSQNPFKRPT---VKEVVE--WLNN 882 (894)
Q Consensus 809 ~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs---~~evl~--~L~~ 882 (894)
.||......... ....... ....+.+. ...+ ..+.+++.+|+ .||.+|++ +.++++ |++.
T Consensus 234 ~Pf~~~~~~~~~------~~i~~~~-~~~~~p~~---~~~s---~~~~~li~~l~-~~p~~R~~~~~~~ei~~hp~f~~ 298 (360)
T cd05627 234 PPFCSETPQETY------RKVMNWK-ETLVFPPE---VPIS---EKAKDLILRFC-TDSENRIGSNGVEEIKSHPFFEG 298 (360)
T ss_pred CCCCCCCHHHHH------HHHHcCC-CceecCCC---CCCC---HHHHHHHHHhc-cChhhcCCCCCHHHHhcCCCCCC
Confidence 999754432111 1111100 00001110 0112 24556777766 49999985 777776 5544
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul |
| >KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-34 Score=305.71 Aligned_cols=254 Identities=24% Similarity=0.331 Sum_probs=210.7
Q ss_pred CCCccceEeecCcEEEEEEE-EcCCCeEEEEEEcCcc--hhhHHHHHHHHHHHHhcCCCceeeecceeeecceEEEEEEe
Q 002673 608 NFSQANIIGCGGFGLVYKAT-LANGTTLAIKKLSGDL--GLMEREFKAEVEALSTAQHKNLVSLQGYCVHQGFRLLIYSY 684 (894)
Q Consensus 608 ~f~~~~~LG~G~fg~Vy~a~-~~~g~~vAvK~~~~~~--~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~lV~E~ 684 (894)
-|...+.||+|.|+.|-.|+ .-+|+.||||++.+.. ......+.+|++.|+.++|||||+++++.......|||+|+
T Consensus 19 LYDLekTlG~GHFAVVKLArHVFTGekVAVKviDKTKlD~~st~hlfqEVRCMKLVQHpNiVRLYEViDTQTKlyLiLEL 98 (864)
T KOG4717|consen 19 LYDLEKTLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDTLSTGHLFQEVRCMKLVQHPNIVRLYEVIDTQTKLYLILEL 98 (864)
T ss_pred eehhhhhhcCCceehhhhhhhhcccceeEEEEecccccchhhhhHHHHHHHHHHHhcCcCeeeeeehhcccceEEEEEEe
Confidence 35556789999999999997 5689999999998643 22345688999999999999999999999999999999999
Q ss_pred ccCCCHHHHHhhhcCCCCCcCHHHHHHHHHHHHHHHHHHHhccCCCeeecCCCCCCeEE-CCCCcEEEEEcccccccCCC
Q 002673 685 MENGSLDYWLHEKADGASQLDWLTRLKIARGTSCGLAYMHQICEPHIVHRDIKSSNILL-DDQFEAHLADFGLSRLILPY 763 (894)
Q Consensus 685 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDLkp~NILl-d~~~~vkl~DFGla~~~~~~ 763 (894)
-++|+|.+|+-... ..+....+.+++.||+.|+.|+|+. ++|||||||+||.+ ..-|-|||+|||++..+.+.
T Consensus 99 GD~GDl~DyImKHe---~Gl~E~La~kYF~QI~~AI~YCHqL---HVVHRDLKPENVVFFEKlGlVKLTDFGFSNkf~PG 172 (864)
T KOG4717|consen 99 GDGGDLFDYIMKHE---EGLNEDLAKKYFAQIVHAISYCHQL---HVVHRDLKPENVVFFEKLGLVKLTDFGFSNKFQPG 172 (864)
T ss_pred cCCchHHHHHHhhh---ccccHHHHHHHHHHHHHHHHHHhhh---hhhcccCCcceeEEeeecCceEeeeccccccCCCc
Confidence 99999999997654 3478888999999999999999986 99999999999765 67889999999999887654
Q ss_pred CCcccccccccCCccCcccccCcCCC-ccccHHHHHHHHHHHHcCCCCCCCCCcchhhhHHHHHHHHhhcCCCCcccccc
Q 002673 764 QTHVTTELVGTLGYIPPEYGQAWVAT-LRGDMYSFGVVMLELLTGKRPVDVLKPKMSRELVGWVLKMRSEGKQDQVFDPI 842 (894)
Q Consensus 764 ~~~~~~~~~gt~~Y~APE~~~~~~~s-~ksDVwS~GvlL~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 842 (894)
.. ....+|+..|.|||++.|..|+ +++||||+|||||-|++|+.||+...+.+.. ..++|..
T Consensus 173 ~k--L~TsCGSLAYSAPEILLGDsYDAPAVDiWSLGVILyMLVCGq~PFqeANDSETL---------------TmImDCK 235 (864)
T KOG4717|consen 173 KK--LTTSCGSLAYSAPEILLGDSYDAPAVDIWSLGVILYMLVCGQPPFQEANDSETL---------------TMIMDCK 235 (864)
T ss_pred ch--hhcccchhhccCchhhhcCccCCcchhhhHHHHHHHHHHhCCCccccccchhhh---------------hhhhccc
Confidence 43 4557899999999999998875 5789999999999999999999865543321 1223322
Q ss_pred ccCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHH--HHHhcccc
Q 002673 843 LRGKGFDEEMLQVLDVACMCVSQNPFKRPTVKEVVE--WLNNVGAN 886 (894)
Q Consensus 843 l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~--~L~~i~~~ 886 (894)
. ........++.++|..|+..||.+|.+.++|+. ||+.+-..
T Consensus 236 Y--tvPshvS~eCrdLI~sMLvRdPkkRAslEeI~s~~Wlq~~D~~ 279 (864)
T KOG4717|consen 236 Y--TVPSHVSKECRDLIQSMLVRDPKKRASLEEIVSTSWLQAGDRG 279 (864)
T ss_pred c--cCchhhhHHHHHHHHHHHhcCchhhccHHHHhccccccCCCCC
Confidence 1 122344557889999999999999999999997 99876543
|
|
| >cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-33 Score=312.43 Aligned_cols=241 Identities=23% Similarity=0.305 Sum_probs=191.0
Q ss_pred CCCccceEeecCcEEEEEEEE-cCCCeEEEEEEcCcch---hhHHHHHHHHHHHHhcC-CCceeeecceeeecceEEEEE
Q 002673 608 NFSQANIIGCGGFGLVYKATL-ANGTTLAIKKLSGDLG---LMEREFKAEVEALSTAQ-HKNLVSLQGYCVHQGFRLLIY 682 (894)
Q Consensus 608 ~f~~~~~LG~G~fg~Vy~a~~-~~g~~vAvK~~~~~~~---~~~~~~~~Ei~~l~~l~-HpnIv~l~g~~~~~~~~~lV~ 682 (894)
+|+..+.||+|+||.||+|.. .+|+.||+|++..... .....+..|..++..+. |++|+++.+++...+..++||
T Consensus 1 ~f~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (323)
T cd05615 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLHSCFQTVDRLYFVM 80 (323)
T ss_pred CceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCchhheeeEEecCCEEEEEE
Confidence 367789999999999999984 5789999999975432 22345678888888885 577888999999999999999
Q ss_pred EeccCCCHHHHHhhhcCCCCCcCHHHHHHHHHHHHHHHHHHHhccCCCeeecCCCCCCeEECCCCcEEEEEcccccccCC
Q 002673 683 SYMENGSLDYWLHEKADGASQLDWLTRLKIARGTSCGLAYMHQICEPHIVHRDIKSSNILLDDQFEAHLADFGLSRLILP 762 (894)
Q Consensus 683 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDLkp~NILld~~~~vkl~DFGla~~~~~ 762 (894)
||+++|+|.+++... ..+++..+..++.|++.||.|||+ ++|+||||||+|||++.++.+||+|||+++....
T Consensus 81 Ey~~~g~L~~~i~~~----~~l~~~~~~~i~~qi~~al~~lH~---~~ivHrDikp~Nill~~~~~ikL~Dfg~~~~~~~ 153 (323)
T cd05615 81 EYVNGGDLMYHIQQV----GKFKEPQAVFYAAEISVGLFFLHR---RGIIYRDLKLDNVMLDSEGHIKIADFGMCKEHMV 153 (323)
T ss_pred cCCCCCcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHH---CCeeccCCCHHHeEECCCCCEEEeccccccccCC
Confidence 999999999998754 358899999999999999999997 5999999999999999999999999999875422
Q ss_pred CCCcccccccccCCccCcccccCcCCCccccHHHHHHHHHHHHcCCCCCCCCCcchhhhHHHHHHHHhhcCCCCcccccc
Q 002673 763 YQTHVTTELVGTLGYIPPEYGQAWVATLRGDMYSFGVVMLELLTGKRPVDVLKPKMSRELVGWVLKMRSEGKQDQVFDPI 842 (894)
Q Consensus 763 ~~~~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwS~GvlL~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 842 (894)
. ........||+.|+|||++.+..++.++|||||||++|||++|+.||...... ...... .. .... . .
T Consensus 154 ~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~---~~~~~i---~~-~~~~-~-p-- 221 (323)
T cd05615 154 D-GVTTRTFCGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFDGEDED---ELFQSI---ME-HNVS-Y-P-- 221 (323)
T ss_pred C-CccccCccCCccccCHHHHcCCCCCCccchhhhHHHHHHHHhCCCCCCCCCHH---HHHHHH---Hh-CCCC-C-C--
Confidence 1 12233456899999999999989999999999999999999999999754322 111111 11 1100 0 0
Q ss_pred ccCCCChHHHHHHHHHHHHhcccCCCCCCCH
Q 002673 843 LRGKGFDEEMLQVLDVACMCVSQNPFKRPTV 873 (894)
Q Consensus 843 l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~ 873 (894)
......+.+++.+|++.+|.+|++.
T Consensus 222 ------~~~~~~~~~li~~~l~~~p~~R~~~ 246 (323)
T cd05615 222 ------KSLSKEAVSICKGLMTKHPSKRLGC 246 (323)
T ss_pred ------ccCCHHHHHHHHHHcccCHhhCCCC
Confidence 0112356789999999999999984
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a |
| >cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-33 Score=304.55 Aligned_cols=258 Identities=26% Similarity=0.375 Sum_probs=199.9
Q ss_pred HHHhccCCCccceEeecCcEEEEEEEE-cCCCeEEEEEEcCcchhhHHHHHHHHHHHHhc-CCCceeeecceee-----e
Q 002673 602 LLKATDNFSQANIIGCGGFGLVYKATL-ANGTTLAIKKLSGDLGLMEREFKAEVEALSTA-QHKNLVSLQGYCV-----H 674 (894)
Q Consensus 602 l~~a~~~f~~~~~LG~G~fg~Vy~a~~-~~g~~vAvK~~~~~~~~~~~~~~~Ei~~l~~l-~HpnIv~l~g~~~-----~ 674 (894)
+..+.++|++.+.||+|+||.||++.. .+++.+|+|.+.... .....+..|+.+++.+ +||||+++++++. .
T Consensus 13 ~~~~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~-~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~ 91 (286)
T cd06638 13 FPDPSDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIH-DIDEEIEAEYNILKALSDHPNVVKFYGMYYKKDVKN 91 (286)
T ss_pred CCCcccceeeeeeeccCCCcEEEEEEECCCCceeEEEeecccc-chHHHHHHHHHHHHHHhcCCCeeeeeeeeeecccCC
Confidence 345678899999999999999999985 568899999886532 2345678899999999 6999999999884 3
Q ss_pred cceEEEEEEeccCCCHHHHHhhhcCCCCCcCHHHHHHHHHHHHHHHHHHHhccCCCeeecCCCCCCeEECCCCcEEEEEc
Q 002673 675 QGFRLLIYSYMENGSLDYWLHEKADGASQLDWLTRLKIARGTSCGLAYMHQICEPHIVHRDIKSSNILLDDQFEAHLADF 754 (894)
Q Consensus 675 ~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDLkp~NILld~~~~vkl~DF 754 (894)
++..++||||+++|+|.++++........+++..+..++.|++.||.|||+ ++++||||||+||+++.++.+||+||
T Consensus 92 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dlkp~nili~~~~~~kl~df 168 (286)
T cd06638 92 GDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLHV---NKTIHRDVKGNNILLTTEGGVKLVDF 168 (286)
T ss_pred CCeEEEEEeecCCCCHHHHHHHhhccCccccHHHHHHHHHHHHHHHHHHHh---CCccccCCCHHhEEECCCCCEEEccC
Confidence 456899999999999999887543334568889999999999999999997 59999999999999999999999999
Q ss_pred ccccccCCCCCcccccccccCCccCcccccC-----cCCCccccHHHHHHHHHHHHcCCCCCCCCCcchhhhHHHHHHHH
Q 002673 755 GLSRLILPYQTHVTTELVGTLGYIPPEYGQA-----WVATLRGDMYSFGVVMLELLTGKRPVDVLKPKMSRELVGWVLKM 829 (894)
Q Consensus 755 Gla~~~~~~~~~~~~~~~gt~~Y~APE~~~~-----~~~s~ksDVwS~GvlL~elltG~~Pf~~~~~~~~~~~~~~~~~~ 829 (894)
|+++...... .......|+..|+|||++.. ..++.++|||||||++|||++|+.||...... .... ..
T Consensus 169 g~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvi~~el~~g~~p~~~~~~~--~~~~----~~ 241 (286)
T cd06638 169 GVSAQLTSTR-LRRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHPM--RALF----KI 241 (286)
T ss_pred CceeecccCC-CccccccCCCcccChhhhchhhhccccccchhhhhhHHHHHHHHhcCCCCCCCCchh--HHHh----hc
Confidence 9988653321 12233468999999998753 45788999999999999999999999754321 1111 00
Q ss_pred hhcCCCCccccccccCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 002673 830 RSEGKQDQVFDPILRGKGFDEEMLQVLDVACMCVSQNPFKRPTVKEVVE 878 (894)
Q Consensus 830 ~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~ 878 (894)
. ........++ ... ...+.+++.+||+.||++|||+.++++
T Consensus 242 ~-~~~~~~~~~~----~~~---~~~~~~li~~~l~~~p~~Rps~~ell~ 282 (286)
T cd06638 242 P-RNPPPTLHQP----ELW---SNEFNDFIRKCLTKDYEKRPTVSDLLQ 282 (286)
T ss_pred c-ccCCCcccCC----CCc---CHHHHHHHHHHccCCcccCCCHHHHhh
Confidence 0 0111111111 111 235778999999999999999999987
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear |
| >cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-33 Score=300.89 Aligned_cols=250 Identities=26% Similarity=0.390 Sum_probs=191.5
Q ss_pred ceEeecCcEEEEEEEEc----CCCeEEEEEEcCcc-hhhHHHHHHHHHHHHhcCCCceeeecceee-ecceEEEEEEecc
Q 002673 613 NIIGCGGFGLVYKATLA----NGTTLAIKKLSGDL-GLMEREFKAEVEALSTAQHKNLVSLQGYCV-HQGFRLLIYSYME 686 (894)
Q Consensus 613 ~~LG~G~fg~Vy~a~~~----~g~~vAvK~~~~~~-~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~-~~~~~~lV~E~~~ 686 (894)
+.||+|+||.||+|.+. ++..||+|++.... ......+.+|+.+++.++||||+++++++. .++..++||||+.
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~~~ 80 (262)
T cd05058 1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLSLLGICLPSEGSPLVVLPYMK 80 (262)
T ss_pred CcccccCCceEEEEEEecCCCceEEEEEEecCccCCHHHHHHHHHHHHHHccCCCCCcceEEEEeecCCCCcEEEEecCC
Confidence 46899999999999853 23579999986432 334567889999999999999999999876 4556789999999
Q ss_pred CCCHHHHHhhhcCCCCCcCHHHHHHHHHHHHHHHHHHHhccCCCeeecCCCCCCeEECCCCcEEEEEcccccccCCCCC-
Q 002673 687 NGSLDYWLHEKADGASQLDWLTRLKIARGTSCGLAYMHQICEPHIVHRDIKSSNILLDDQFEAHLADFGLSRLILPYQT- 765 (894)
Q Consensus 687 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDLkp~NILld~~~~vkl~DFGla~~~~~~~~- 765 (894)
+|+|.+++.... ...++.....++.|++.||.|||+ .+++||||||+|||+++++.+||+|||+++.......
T Consensus 81 ~~~L~~~~~~~~---~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dlk~~nili~~~~~~kl~dfg~~~~~~~~~~~ 154 (262)
T cd05058 81 HGDLRNFIRSET---HNPTVKDLIGFGLQVAKGMEYLAS---KKFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYY 154 (262)
T ss_pred CCCHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHh---CCccccccCcceEEEcCCCcEEECCccccccccCCcce
Confidence 999999997542 346777888999999999999997 5999999999999999999999999999976532111
Q ss_pred --cccccccccCCccCcccccCcCCCccccHHHHHHHHHHHHcC-CCCCCCCCcchhhhHHHHHHHHhhcCCCCcccccc
Q 002673 766 --HVTTELVGTLGYIPPEYGQAWVATLRGDMYSFGVVMLELLTG-KRPVDVLKPKMSRELVGWVLKMRSEGKQDQVFDPI 842 (894)
Q Consensus 766 --~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwS~GvlL~elltG-~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 842 (894)
.......++..|+|||+..+..++.++|||||||++|||++| .+||..... ...... ........
T Consensus 155 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~---~~~~~~---~~~~~~~~------ 222 (262)
T cd05058 155 SVHNHTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVDS---FDITVY---LLQGRRLL------ 222 (262)
T ss_pred eecccccCcCCccccChhHhccCccchHHHHHHHHHHHHHHHcCCCCCCCCCCH---HHHHHH---HhcCCCCC------
Confidence 111223456789999999888999999999999999999995 566654322 112211 11111100
Q ss_pred ccCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhcc
Q 002673 843 LRGKGFDEEMLQVLDVACMCVSQNPFKRPTVKEVVEWLNNVG 884 (894)
Q Consensus 843 l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~i~ 884 (894)
. .... ...+.+++..||+.+|++||++.++++.|+++.
T Consensus 223 ~-~~~~---~~~~~~li~~cl~~~p~~Rp~~~~il~~l~~~~ 260 (262)
T cd05058 223 Q-PEYC---PDPLYEVMLSCWHPKPEMRPTFSELVSRIEQIF 260 (262)
T ss_pred C-CCcC---CHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHh
Confidence 0 0111 235778999999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca |
| >cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-33 Score=315.06 Aligned_cols=266 Identities=24% Similarity=0.263 Sum_probs=197.6
Q ss_pred hccCCCccceEeecCcEEEEEEEE-cCCCeEEEEEEcCcc--hhhHHHHHHHHHHHHhcCCCceeeecceeeec------
Q 002673 605 ATDNFSQANIIGCGGFGLVYKATL-ANGTTLAIKKLSGDL--GLMEREFKAEVEALSTAQHKNLVSLQGYCVHQ------ 675 (894)
Q Consensus 605 a~~~f~~~~~LG~G~fg~Vy~a~~-~~g~~vAvK~~~~~~--~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~------ 675 (894)
..++|+..+.||+|+||.||++.. ..+..||||++.... ......+.+|+.+++.++||||+++++++...
T Consensus 15 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 94 (355)
T cd07874 15 VLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKSLEEF 94 (355)
T ss_pred hhhceeEEEEeeecCCEEEEEEEecCCCceEEEEEeCCcccChHHHHHHHHHHHHHHHhCCCchhceeeeeecccccccc
Confidence 346899999999999999999984 468899999997542 22345677899999999999999999988643
Q ss_pred ceEEEEEEeccCCCHHHHHhhhcCCCCCcCHHHHHHHHHHHHHHHHHHHhccCCCeeecCCCCCCeEECCCCcEEEEEcc
Q 002673 676 GFRLLIYSYMENGSLDYWLHEKADGASQLDWLTRLKIARGTSCGLAYMHQICEPHIVHRDIKSSNILLDDQFEAHLADFG 755 (894)
Q Consensus 676 ~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDLkp~NILld~~~~vkl~DFG 755 (894)
...++||||+++ +|...+.. .+++..+..++.|++.||.|||+ ++|+||||||+|||++.++.+||+|||
T Consensus 95 ~~~~lv~e~~~~-~l~~~~~~------~l~~~~~~~~~~qi~~aL~~LH~---~givHrDikp~Nill~~~~~~kl~Dfg 164 (355)
T cd07874 95 QDVYLVMELMDA-NLCQVIQM------ELDHERMSYLLYQMLCGIKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDFG 164 (355)
T ss_pred ceeEEEhhhhcc-cHHHHHhh------cCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCChHHEEECCCCCEEEeeCc
Confidence 356999999965 66666642 37888889999999999999997 699999999999999999999999999
Q ss_pred cccccCCCCCcccccccccCCccCcccccCcCCCccccHHHHHHHHHHHHcCCCCCCCCCcchhhh-HHH----------
Q 002673 756 LSRLILPYQTHVTTELVGTLGYIPPEYGQAWVATLRGDMYSFGVVMLELLTGKRPVDVLKPKMSRE-LVG---------- 824 (894)
Q Consensus 756 la~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwS~GvlL~elltG~~Pf~~~~~~~~~~-~~~---------- 824 (894)
+++..... .......||..|+|||++.+..++.++|||||||++|+|++|+.||.......... ...
T Consensus 165 ~~~~~~~~--~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 242 (355)
T cd07874 165 LARTAGTS--FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFM 242 (355)
T ss_pred ccccCCCc--cccCCccccCCccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHH
Confidence 99865322 22334578999999999999999999999999999999999999997543211100 000
Q ss_pred -----HHHHHhhc-CCCCccccc-cccC-------CCChHHHHHHHHHHHHhcccCCCCCCCHHHHHH--HHHh
Q 002673 825 -----WVLKMRSE-GKQDQVFDP-ILRG-------KGFDEEMLQVLDVACMCVSQNPFKRPTVKEVVE--WLNN 882 (894)
Q Consensus 825 -----~~~~~~~~-~~~~~~~d~-~l~~-------~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~--~L~~ 882 (894)
........ ........+ .... .........+.+++.+|++.||++|||+.|+++ |++.
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rps~~ell~hp~~~~ 316 (355)
T cd07874 243 KKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDEALQHPYINV 316 (355)
T ss_pred HhhcHHHHHHHhcCCccccccchhhccccccccccccccccchHHHHHHHHHhcCCchhcCCHHHHhcCcchhc
Confidence 00000000 000000000 0000 000112346789999999999999999999998 6653
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok |
| >cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-33 Score=298.11 Aligned_cols=250 Identities=23% Similarity=0.357 Sum_probs=200.7
Q ss_pred CCCccceEeecCcEEEEEEEE-cCCCeEEEEEEcCcc-hhhHHHHHHHHHHHHhcCCCceeeecceeeecceEEEEEEec
Q 002673 608 NFSQANIIGCGGFGLVYKATL-ANGTTLAIKKLSGDL-GLMEREFKAEVEALSTAQHKNLVSLQGYCVHQGFRLLIYSYM 685 (894)
Q Consensus 608 ~f~~~~~LG~G~fg~Vy~a~~-~~g~~vAvK~~~~~~-~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~lV~E~~ 685 (894)
+|++.+.||+|+||.||++.. .++..+|+|.+.... ....+.+..|+.+++.++|+||+++++.+..++..++||||+
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 80 (255)
T cd08219 1 QYNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPNIVAFKESFEADGHLYIVMEYC 80 (255)
T ss_pred CceEEEEeeccCCeEEEEEEEcCCCceEEEEEEEcCcchHHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEeeC
Confidence 477889999999999999984 478999999986432 334467888999999999999999999999999999999999
Q ss_pred cCCCHHHHHhhhcCCCCCcCHHHHHHHHHHHHHHHHHHHhccCCCeeecCCCCCCeEECCCCcEEEEEcccccccCCCCC
Q 002673 686 ENGSLDYWLHEKADGASQLDWLTRLKIARGTSCGLAYMHQICEPHIVHRDIKSSNILLDDQFEAHLADFGLSRLILPYQT 765 (894)
Q Consensus 686 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDLkp~NILld~~~~vkl~DFGla~~~~~~~~ 765 (894)
++|+|.+++.... ...++....+.++.|++.||.|||+ ++++|+||||+||++++++.++++|||++.......
T Consensus 81 ~~~~l~~~~~~~~--~~~~~~~~~~~~~~~i~~al~~lH~---~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~- 154 (255)
T cd08219 81 DGGDLMQKIKLQR--GKLFPEDTILQWFVQMCLGVQHIHE---KRVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPG- 154 (255)
T ss_pred CCCcHHHHHHhcc--CCCCCHHHHHHHHHHHHHHHHHHhh---CCcccCCCCcceEEECCCCcEEEcccCcceeecccc-
Confidence 9999999887532 2457888999999999999999997 599999999999999999999999999997653322
Q ss_pred cccccccccCCccCcccccCcCCCccccHHHHHHHHHHHHcCCCCCCCCCcchhhhHHHHHHHHhhcCCCCccccccccC
Q 002673 766 HVTTELVGTLGYIPPEYGQAWVATLRGDMYSFGVVMLELLTGKRPVDVLKPKMSRELVGWVLKMRSEGKQDQVFDPILRG 845 (894)
Q Consensus 766 ~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwS~GvlL~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~ 845 (894)
.......|+..|+|||+..+..++.++||||||+++|+|++|+.||...... .. .... ..+..... .
T Consensus 155 ~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~---~~---~~~~-~~~~~~~~-~----- 221 (255)
T cd08219 155 AYACTYVGTPYYVPPEIWENMPYNNKSDIWSLGCILYELCTLKHPFQANSWK---NL---ILKV-CQGSYKPL-P----- 221 (255)
T ss_pred cccccccCCccccCHHHHccCCcCchhhhhhhchhheehhhccCCCCCCCHH---HH---HHHH-hcCCCCCC-C-----
Confidence 1223456889999999999888999999999999999999999999753321 11 1111 11111111 0
Q ss_pred CCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 002673 846 KGFDEEMLQVLDVACMCVSQNPFKRPTVKEVVEW 879 (894)
Q Consensus 846 ~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~ 879 (894)
. .....+.+++.+||+.||++||++.+++..
T Consensus 222 ~---~~~~~~~~li~~~l~~~P~~Rp~~~~il~~ 252 (255)
T cd08219 222 S---HYSYELRSLIKQMFKRNPRSRPSATTILSR 252 (255)
T ss_pred c---ccCHHHHHHHHHHHhCCcccCCCHHHHhhc
Confidence 1 112356789999999999999999999863
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati |
| >cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-33 Score=314.29 Aligned_cols=239 Identities=25% Similarity=0.288 Sum_probs=186.0
Q ss_pred ceEeecCcEEEEEEEEc-CCCeEEEEEEcCcch---hhHHHHHHHH-HHHHhcCCCceeeecceeeecceEEEEEEeccC
Q 002673 613 NIIGCGGFGLVYKATLA-NGTTLAIKKLSGDLG---LMEREFKAEV-EALSTAQHKNLVSLQGYCVHQGFRLLIYSYMEN 687 (894)
Q Consensus 613 ~~LG~G~fg~Vy~a~~~-~g~~vAvK~~~~~~~---~~~~~~~~Ei-~~l~~l~HpnIv~l~g~~~~~~~~~lV~E~~~~ 687 (894)
+.||+|+||.||+|... ++..||+|++..... .....+..|. .+++.++||||+++++++...+..++||||+++
T Consensus 1 ~~lg~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~~~~~~~~lv~e~~~~ 80 (325)
T cd05602 1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYING 80 (325)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHHhhhHHHHHHHHHHHHHHhCCCCCCCceeEEEEcCCeEEEEEeCCCC
Confidence 36999999999999854 678899999875321 1223344444 456788999999999999999999999999999
Q ss_pred CCHHHHHhhhcCCCCCcCHHHHHHHHHHHHHHHHHHHhccCCCeeecCCCCCCeEECCCCcEEEEEcccccccCCCCCcc
Q 002673 688 GSLDYWLHEKADGASQLDWLTRLKIARGTSCGLAYMHQICEPHIVHRDIKSSNILLDDQFEAHLADFGLSRLILPYQTHV 767 (894)
Q Consensus 688 gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDLkp~NILld~~~~vkl~DFGla~~~~~~~~~~ 767 (894)
|+|.+++... ..++...+..++.||+.||.|||+ .+|+||||||+|||++.++.+||+|||+++...... ..
T Consensus 81 ~~L~~~~~~~----~~~~~~~~~~~~~qi~~~L~~lH~---~giiHrDlkp~Nili~~~~~~kl~DfG~a~~~~~~~-~~ 152 (325)
T cd05602 81 GELFYHLQRE----RCFLEPRARFYAAEIASALGYLHS---LNIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHN-GT 152 (325)
T ss_pred CcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHH---CCeEecCCCHHHeEECCCCCEEEccCCCCcccccCC-CC
Confidence 9999998753 346778888899999999999997 599999999999999999999999999997542221 22
Q ss_pred cccccccCCccCcccccCcCCCccccHHHHHHHHHHHHcCCCCCCCCCcchhhhHHHHHHHHhhcCCCCccccccccCCC
Q 002673 768 TTELVGTLGYIPPEYGQAWVATLRGDMYSFGVVMLELLTGKRPVDVLKPKMSRELVGWVLKMRSEGKQDQVFDPILRGKG 847 (894)
Q Consensus 768 ~~~~~gt~~Y~APE~~~~~~~s~ksDVwS~GvlL~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~ 847 (894)
.....||+.|+|||++.+..++.++|||||||++|||++|+.||...... ...... .. .... +.+
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~---~~~~~i---~~-~~~~--~~~------ 217 (325)
T cd05602 153 TSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTA---EMYDNI---LN-KPLQ--LKP------ 217 (325)
T ss_pred cccccCCccccCHHHHcCCCCCCccccccccHHHHHHhcCCCCCCCCCHH---HHHHHH---Hh-CCcC--CCC------
Confidence 34467999999999999999999999999999999999999999754321 111111 11 1100 111
Q ss_pred ChHHHHHHHHHHHHhcccCCCCCCCHHHH
Q 002673 848 FDEEMLQVLDVACMCVSQNPFKRPTVKEV 876 (894)
Q Consensus 848 ~~~~~~~l~~li~~Cl~~dP~~RPs~~ev 876 (894)
.....+.+++.+|++.||.+||++.+.
T Consensus 218 --~~~~~~~~li~~~l~~~p~~R~~~~~~ 244 (325)
T cd05602 218 --NITNSARHLLEGLLQKDRTKRLGAKDD 244 (325)
T ss_pred --CCCHHHHHHHHHHcccCHHHCCCCCCC
Confidence 112356688899999999999987743
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt |
| >cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-33 Score=304.27 Aligned_cols=261 Identities=26% Similarity=0.362 Sum_probs=203.1
Q ss_pred HHHHHHhccCCCccceEeecCcEEEEEEEE-cCCCeEEEEEEcCcchhhHHHHHHHHHHHHhc-CCCceeeecceeeec-
Q 002673 599 IYELLKATDNFSQANIIGCGGFGLVYKATL-ANGTTLAIKKLSGDLGLMEREFKAEVEALSTA-QHKNLVSLQGYCVHQ- 675 (894)
Q Consensus 599 ~~el~~a~~~f~~~~~LG~G~fg~Vy~a~~-~~g~~vAvK~~~~~~~~~~~~~~~Ei~~l~~l-~HpnIv~l~g~~~~~- 675 (894)
..++..++++|++.+.||+|+||.||++.. .+++.+|+|.+.... .....+.+|+.++.++ +|||++++++++...
T Consensus 14 ~~~~~~~~~~y~~~~~l~~g~~~~vy~~~~~~~~~~~aik~~~~~~-~~~~~~~~e~~~l~~l~~h~ni~~~~~~~~~~~ 92 (291)
T cd06639 14 LESLGDPTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPIS-DVDEEIEAEYNILQSLPNHPNVVKFYGMFYKAD 92 (291)
T ss_pred cccCCCCCCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEecccc-cHHHHHHHHHHHHHHhcCCCCeEEEEEEEEecc
Confidence 345556788999999999999999999985 578899999986532 2345678899999998 899999999998754
Q ss_pred ----ceEEEEEEeccCCCHHHHHhhhcCCCCCcCHHHHHHHHHHHHHHHHHHHhccCCCeeecCCCCCCeEECCCCcEEE
Q 002673 676 ----GFRLLIYSYMENGSLDYWLHEKADGASQLDWLTRLKIARGTSCGLAYMHQICEPHIVHRDIKSSNILLDDQFEAHL 751 (894)
Q Consensus 676 ----~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDLkp~NILld~~~~vkl 751 (894)
...++||||+++|+|.++++........+++..++.++.|++.||.|||+ ++++||||||+||+++.++.+||
T Consensus 93 ~~~~~~~~lv~ey~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~---~~ivH~dlkp~nili~~~~~~kl 169 (291)
T cd06639 93 KLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLHN---NRIIHRDVKGNNILLTTEGGVKL 169 (291)
T ss_pred ccCCCeeEEEEEECCCCcHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHh---CCeeccCCCHHHEEEcCCCCEEE
Confidence 35799999999999999987543344568999999999999999999997 59999999999999999999999
Q ss_pred EEcccccccCCCCCcccccccccCCccCcccccCc-----CCCccccHHHHHHHHHHHHcCCCCCCCCCcchhhhHHHHH
Q 002673 752 ADFGLSRLILPYQTHVTTELVGTLGYIPPEYGQAW-----VATLRGDMYSFGVVMLELLTGKRPVDVLKPKMSRELVGWV 826 (894)
Q Consensus 752 ~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~~~~~-----~~s~ksDVwS~GvlL~elltG~~Pf~~~~~~~~~~~~~~~ 826 (894)
+|||++........ ......|+..|+|||++... .++.++|||||||++|||++|+.||....... .+..
T Consensus 170 ~dfg~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi~~el~~g~~p~~~~~~~~--~~~~-- 244 (291)
T cd06639 170 VDFGVSAQLTSTRL-RRNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHPVK--TLFK-- 244 (291)
T ss_pred eecccchhcccccc-cccCccCCccccChhhhcCCCCcccccCCccchHHHHHHHHHHhhCCCCCCCCcHHH--HHHH--
Confidence 99999886532221 12334688999999987543 36889999999999999999999997543211 1111
Q ss_pred HHHhhcCCCCccccccccCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 002673 827 LKMRSEGKQDQVFDPILRGKGFDEEMLQVLDVACMCVSQNPFKRPTVKEVVE 878 (894)
Q Consensus 827 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~ 878 (894)
... .......++ ......+.+++.+|++.+|++||++.++++
T Consensus 245 --~~~-~~~~~~~~~-------~~~~~~l~~li~~~l~~~p~~Rps~~~il~ 286 (291)
T cd06639 245 --IPR-NPPPTLLHP-------EKWCRSFNHFISQCLIKDFEARPSVTHLLE 286 (291)
T ss_pred --Hhc-CCCCCCCcc-------cccCHHHHHHHHHHhhcChhhCcCHHHHhc
Confidence 111 111111111 112235788999999999999999999986
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre |
| >cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-33 Score=316.39 Aligned_cols=265 Identities=23% Similarity=0.281 Sum_probs=197.6
Q ss_pred ccCCCccceEeecCcEEEEEEEE-cCCCeEEEEEEcCcc--hhhHHHHHHHHHHHHhcCCCceeeecceeeec------c
Q 002673 606 TDNFSQANIIGCGGFGLVYKATL-ANGTTLAIKKLSGDL--GLMEREFKAEVEALSTAQHKNLVSLQGYCVHQ------G 676 (894)
Q Consensus 606 ~~~f~~~~~LG~G~fg~Vy~a~~-~~g~~vAvK~~~~~~--~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~------~ 676 (894)
.++|+..+.||+|+||.||++.. ..++.||||++.... ......+.+|+.+++.++||||+++++++... .
T Consensus 23 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~~~~~~~ 102 (364)
T cd07875 23 LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQ 102 (364)
T ss_pred hcceeEEEEeecCCCeEEEEEEECCCCcEEEEEEeCccccCchhHHHHHHHHHHHHhcCCCCccccceeecccccccccC
Confidence 46899999999999999999984 468899999997542 23345678899999999999999999987643 3
Q ss_pred eEEEEEEeccCCCHHHHHhhhcCCCCCcCHHHHHHHHHHHHHHHHHHHhccCCCeeecCCCCCCeEECCCCcEEEEEccc
Q 002673 677 FRLLIYSYMENGSLDYWLHEKADGASQLDWLTRLKIARGTSCGLAYMHQICEPHIVHRDIKSSNILLDDQFEAHLADFGL 756 (894)
Q Consensus 677 ~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDLkp~NILld~~~~vkl~DFGl 756 (894)
..++||||+++ +|..++.. .+++..+..++.|++.||.|||+ ++|+||||||+|||++.++.+||+|||+
T Consensus 103 ~~~lv~e~~~~-~l~~~~~~------~~~~~~~~~~~~qi~~aL~~LH~---~~ivH~Dlkp~NIll~~~~~~kL~DfG~ 172 (364)
T cd07875 103 DVYIVMELMDA-NLCQVIQM------ELDHERMSYLLYQMLCGIKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDFGL 172 (364)
T ss_pred eEEEEEeCCCC-CHHHHHHh------cCCHHHHHHHHHHHHHHHHHHhh---CCeecCCCCHHHEEECCCCcEEEEeCCC
Confidence 57999999965 67776642 37788899999999999999997 6999999999999999999999999999
Q ss_pred ccccCCCCCcccccccccCCccCcccccCcCCCccccHHHHHHHHHHHHcCCCCCCCCCcchhhh-HHH--------H--
Q 002673 757 SRLILPYQTHVTTELVGTLGYIPPEYGQAWVATLRGDMYSFGVVMLELLTGKRPVDVLKPKMSRE-LVG--------W-- 825 (894)
Q Consensus 757 a~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwS~GvlL~elltG~~Pf~~~~~~~~~~-~~~--------~-- 825 (894)
++..... .......+|..|+|||++.+..++.++|||||||++|+|++|+.||.......... +.. +
T Consensus 173 a~~~~~~--~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 250 (364)
T cd07875 173 ARTAGTS--FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMK 250 (364)
T ss_pred ccccCCC--CcccCCcccCCcCCHHHHhCCCCCchhhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHH
Confidence 9865322 22334578999999999999999999999999999999999999997544321110 000 0
Q ss_pred -----HHHHhhcC-CC-----Ccccccccc---CCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHH--HHHh
Q 002673 826 -----VLKMRSEG-KQ-----DQVFDPILR---GKGFDEEMLQVLDVACMCVSQNPFKRPTVKEVVE--WLNN 882 (894)
Q Consensus 826 -----~~~~~~~~-~~-----~~~~d~~l~---~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~--~L~~ 882 (894)
........ .. ...+..... ..........+.+++.+|++.||.+|||+.++++ |++.
T Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~R~t~~e~L~hp~~~~ 323 (364)
T cd07875 251 KLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHPYINV 323 (364)
T ss_pred hhhHHHHHHHhhCCCcCCCChHhhCccccccccccccccccHHHHHHHHHhcCcCcccCCCHHHHhcCccccc
Confidence 00000000 00 000000000 0000111236789999999999999999999998 7754
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-33 Score=302.34 Aligned_cols=257 Identities=23% Similarity=0.400 Sum_probs=203.4
Q ss_pred cCCCccceEeecCcEEEEEEEEc-CCC----eEEEEEEcCcch-hhHHHHHHHHHHHHhcCCCceeeecceeeecceEEE
Q 002673 607 DNFSQANIIGCGGFGLVYKATLA-NGT----TLAIKKLSGDLG-LMEREFKAEVEALSTAQHKNLVSLQGYCVHQGFRLL 680 (894)
Q Consensus 607 ~~f~~~~~LG~G~fg~Vy~a~~~-~g~----~vAvK~~~~~~~-~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~l 680 (894)
.+|+..+.||+|+||.||+|.+. +|. .||+|.+..... .....+.+|+.++++++||||+++++++.. ...++
T Consensus 7 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~~ 85 (279)
T cd05057 7 TELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVRLLGICLS-SQVQL 85 (279)
T ss_pred HHcEEcceecCCCCccEEEEEEecCCCCcceEEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEec-CceEE
Confidence 46788899999999999999853 343 589998876543 344678899999999999999999999987 78899
Q ss_pred EEEeccCCCHHHHHhhhcCCCCCcCHHHHHHHHHHHHHHHHHHHhccCCCeeecCCCCCCeEECCCCcEEEEEccccccc
Q 002673 681 IYSYMENGSLDYWLHEKADGASQLDWLTRLKIARGTSCGLAYMHQICEPHIVHRDIKSSNILLDDQFEAHLADFGLSRLI 760 (894)
Q Consensus 681 V~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDLkp~NILld~~~~vkl~DFGla~~~ 760 (894)
||||+++|+|.+++.... ..+++..++.++.|++.||+|||+ ++++||||||+||++++++.+||+|||+++..
T Consensus 86 v~e~~~~g~L~~~l~~~~---~~~~~~~~~~~~~qi~~~l~~LH~---~~i~H~di~p~nil~~~~~~~kL~dfg~~~~~ 159 (279)
T cd05057 86 ITQLMPLGCLLDYVRNHK---DNIGSQYLLNWCVQIAKGMSYLEE---KRLVHRDLAARNVLVKTPQHVKITDFGLAKLL 159 (279)
T ss_pred EEecCCCCcHHHHHHhcc---CCCCHHHHHHHHHHHHHHHHHHHh---CCEEecccCcceEEEcCCCeEEECCCcccccc
Confidence 999999999999997643 348999999999999999999997 69999999999999999999999999999876
Q ss_pred CCCCCccc-ccccccCCccCcccccCcCCCccccHHHHHHHHHHHHc-CCCCCCCCCcchhhhHHHHHHHHhhcCCCCcc
Q 002673 761 LPYQTHVT-TELVGTLGYIPPEYGQAWVATLRGDMYSFGVVMLELLT-GKRPVDVLKPKMSRELVGWVLKMRSEGKQDQV 838 (894)
Q Consensus 761 ~~~~~~~~-~~~~gt~~Y~APE~~~~~~~s~ksDVwS~GvlL~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 838 (894)
........ ....++..|+|||......++.++||||||+++||+++ |+.||+..... +..... .......
T Consensus 160 ~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~---~~~~~~---~~~~~~~-- 231 (279)
T cd05057 160 DVDEKEYHAEGGKVPIKWMALESILHRIYTHKSDVWSYGVTVWELMTFGAKPYEGIPAV---EIPDLL---EKGERLP-- 231 (279)
T ss_pred cCcccceecCCCcccccccCHHHhhcCCcCchhhHHHHHHHHHHHhcCCCCCCCCCCHH---HHHHHH---hCCCCCC--
Confidence 43222111 11223568999999988889999999999999999999 99999865432 122111 1111100
Q ss_pred ccccccCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhcccc
Q 002673 839 FDPILRGKGFDEEMLQVLDVACMCVSQNPFKRPTVKEVVEWLNNVGAN 886 (894)
Q Consensus 839 ~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~i~~~ 886 (894)
.+ . .....+.+++.+||..+|.+||++.++++.|.++...
T Consensus 232 -~~----~---~~~~~~~~~~~~~l~~~p~~Rp~~~~l~~~l~~~~~~ 271 (279)
T cd05057 232 -QP----P---ICTIDVYMVLVKCWMIDAESRPTFKELINEFSKMARD 271 (279)
T ss_pred -CC----C---CCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHhC
Confidence 00 0 1123567889999999999999999999999987543
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea |
| >cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-34 Score=316.00 Aligned_cols=237 Identities=26% Similarity=0.333 Sum_probs=186.4
Q ss_pred ceEeecCcEEEEEEEE-cCCCeEEEEEEcCcch---hhHHHHHHHHH-HHHhcCCCceeeecceeeecceEEEEEEeccC
Q 002673 613 NIIGCGGFGLVYKATL-ANGTTLAIKKLSGDLG---LMEREFKAEVE-ALSTAQHKNLVSLQGYCVHQGFRLLIYSYMEN 687 (894)
Q Consensus 613 ~~LG~G~fg~Vy~a~~-~~g~~vAvK~~~~~~~---~~~~~~~~Ei~-~l~~l~HpnIv~l~g~~~~~~~~~lV~E~~~~ 687 (894)
+.||+|+||.||+|.. .+|+.||+|++..... .....+..|.. +++.++||||+++++++..++..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~~~~~~~~lv~e~~~~ 80 (325)
T cd05604 1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTTEKLYFVLDFVNG 80 (325)
T ss_pred CceeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHHhCCCCCCccEEEEEecCCEEEEEEcCCCC
Confidence 4699999999999984 5789999999975422 22234455554 56778999999999999999999999999999
Q ss_pred CCHHHHHhhhcCCCCCcCHHHHHHHHHHHHHHHHHHHhccCCCeeecCCCCCCeEECCCCcEEEEEcccccccCCCCCcc
Q 002673 688 GSLDYWLHEKADGASQLDWLTRLKIARGTSCGLAYMHQICEPHIVHRDIKSSNILLDDQFEAHLADFGLSRLILPYQTHV 767 (894)
Q Consensus 688 gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDLkp~NILld~~~~vkl~DFGla~~~~~~~~~~ 767 (894)
|+|..++... ..+++..+..++.||+.||.|||+ ++|+||||||+|||++.++.+||+|||+++..... ...
T Consensus 81 ~~L~~~l~~~----~~~~~~~~~~~~~qi~~al~~lH~---~givH~Dlkp~NIll~~~~~~kL~DfG~~~~~~~~-~~~ 152 (325)
T cd05604 81 GELFFHLQRE----RSFPEPRARFYAAEIASALGYLHS---INIVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQ-SDT 152 (325)
T ss_pred CCHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHH---CCeeecCCCHHHeEECCCCCEEEeecCCcccCCCC-CCC
Confidence 9999888643 358899999999999999999997 59999999999999999999999999998753221 122
Q ss_pred cccccccCCccCcccccCcCCCccccHHHHHHHHHHHHcCCCCCCCCCcchhhhHHHHHHHHhhcCCCCccccccccCCC
Q 002673 768 TTELVGTLGYIPPEYGQAWVATLRGDMYSFGVVMLELLTGKRPVDVLKPKMSRELVGWVLKMRSEGKQDQVFDPILRGKG 847 (894)
Q Consensus 768 ~~~~~gt~~Y~APE~~~~~~~s~ksDVwS~GvlL~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~ 847 (894)
.....||+.|+|||++.+..++.++|||||||++|||++|+.||...... ... ..... ... .+.+
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~---~~~---~~~~~-~~~--~~~~------ 217 (325)
T cd05604 153 TTTFCGTPEYLAPEVIRKQPYDNTVDWWCLGAVLYEMLYGLPPFYCRDVA---EMY---DNILH-KPL--VLRP------ 217 (325)
T ss_pred cccccCChhhCCHHHHcCCCCCCcCccccccceehhhhcCCCCCCCCCHH---HHH---HHHHc-CCc--cCCC------
Confidence 33457899999999999999999999999999999999999999754321 111 11111 110 0111
Q ss_pred ChHHHHHHHHHHHHhcccCCCCCCCHH
Q 002673 848 FDEEMLQVLDVACMCVSQNPFKRPTVK 874 (894)
Q Consensus 848 ~~~~~~~l~~li~~Cl~~dP~~RPs~~ 874 (894)
.....+.+++.+|++.+|.+||++.
T Consensus 218 --~~~~~~~~ll~~ll~~~p~~R~~~~ 242 (325)
T cd05604 218 --GASLTAWSILEELLEKDRQRRLGAK 242 (325)
T ss_pred --CCCHHHHHHHHHHhccCHHhcCCCC
Confidence 1123566889999999999999875
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, |
| >cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-33 Score=305.79 Aligned_cols=251 Identities=26% Similarity=0.385 Sum_probs=201.1
Q ss_pred CCCccceEeecCcEEEEEEEE-cCCCeEEEEEEcCcc-hhhHHHHHHHHHHHHhcCCCceeeecceeeecceEEEEEEec
Q 002673 608 NFSQANIIGCGGFGLVYKATL-ANGTTLAIKKLSGDL-GLMEREFKAEVEALSTAQHKNLVSLQGYCVHQGFRLLIYSYM 685 (894)
Q Consensus 608 ~f~~~~~LG~G~fg~Vy~a~~-~~g~~vAvK~~~~~~-~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~lV~E~~ 685 (894)
.|+..+.||+|+||.||+|.. .++..||+|.+.... ....+.+.+|+.++++++||||+++++++..++..++||||+
T Consensus 5 ~y~~~~~l~~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 84 (277)
T cd06642 5 LFTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITRYYGSYLKGTKLWIIMEYL 84 (277)
T ss_pred HHHHHHHhcCCCCeeEEEEEEcCCCeEEEEEEeccccchHHHHHHHHHHHHHHcCCCCccHhhhcccccCCceEEEEEcc
Confidence 355667899999999999985 467899999987543 334467889999999999999999999999999999999999
Q ss_pred cCCCHHHHHhhhcCCCCCcCHHHHHHHHHHHHHHHHHHHhccCCCeeecCCCCCCeEECCCCcEEEEEcccccccCCCCC
Q 002673 686 ENGSLDYWLHEKADGASQLDWLTRLKIARGTSCGLAYMHQICEPHIVHRDIKSSNILLDDQFEAHLADFGLSRLILPYQT 765 (894)
Q Consensus 686 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDLkp~NILld~~~~vkl~DFGla~~~~~~~~ 765 (894)
++++|.+++.. ..+++..+..++.|++.|+.|||+ ++++|+||+|+||++++++.++|+|||++.......
T Consensus 85 ~~~~L~~~~~~-----~~~~~~~~~~~~~~i~~~l~~lH~---~~ivH~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~- 155 (277)
T cd06642 85 GGGSALDLLKP-----GPLEETYIATILREILKGLDYLHS---ERKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQ- 155 (277)
T ss_pred CCCcHHHHhhc-----CCCCHHHHHHHHHHHHHHHHHHhc---CCeeccCCChheEEEeCCCCEEEccccccccccCcc-
Confidence 99999998863 347889999999999999999996 699999999999999999999999999997654322
Q ss_pred cccccccccCCccCcccccCcCCCccccHHHHHHHHHHHHcCCCCCCCCCcchhhhHHHHHHHHhhcCCCCccccccccC
Q 002673 766 HVTTELVGTLGYIPPEYGQAWVATLRGDMYSFGVVMLELLTGKRPVDVLKPKMSRELVGWVLKMRSEGKQDQVFDPILRG 845 (894)
Q Consensus 766 ~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwS~GvlL~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~ 845 (894)
.......++..|+|||++.+..++.++|||||||++|||++|+.||....... ...+ ...... +.+
T Consensus 156 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~---~~~~----~~~~~~-----~~~-- 221 (277)
T cd06642 156 IKRNTFVGTPFWMAPEVIKQSAYDFKADIWSLGITAIELAKGEPPNSDLHPMR---VLFL----IPKNSP-----PTL-- 221 (277)
T ss_pred hhhhcccCcccccCHHHhCcCCCchhhhHHHHHHHHHHHHhCCCCCcccchhh---HHhh----hhcCCC-----CCC--
Confidence 12223467889999999999899999999999999999999999987443211 1110 011110 111
Q ss_pred CCChHHHHHHHHHHHHhcccCCCCCCCHHHHHH--HHHhc
Q 002673 846 KGFDEEMLQVLDVACMCVSQNPFKRPTVKEVVE--WLNNV 883 (894)
Q Consensus 846 ~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~--~L~~i 883 (894)
.......+.+++.+|++.+|++||++.++++ ++...
T Consensus 222 --~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~~~~ 259 (277)
T cd06642 222 --EGQYSKPFKEFVEACLNKDPRFRPTAKELLKHKFITRY 259 (277)
T ss_pred --CcccCHHHHHHHHHHccCCcccCcCHHHHHHhHHHHHH
Confidence 1122345778999999999999999999998 66543
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 |
| >cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-33 Score=307.05 Aligned_cols=197 Identities=25% Similarity=0.327 Sum_probs=160.6
Q ss_pred cceEeecCcEEEEEEEEc---CCCeEEEEEEcCcchhhHHHHHHHHHHHHhcCCCceeeecceeee--cceEEEEEEecc
Q 002673 612 ANIIGCGGFGLVYKATLA---NGTTLAIKKLSGDLGLMEREFKAEVEALSTAQHKNLVSLQGYCVH--QGFRLLIYSYME 686 (894)
Q Consensus 612 ~~~LG~G~fg~Vy~a~~~---~g~~vAvK~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~--~~~~~lV~E~~~ 686 (894)
+++||+|+||.||+|... ++..||+|.+.... ....+.+|+.++++++||||+++++++.. +...++||||+.
T Consensus 6 ~~~lG~G~~g~Vy~~~~~~~~~~~~~aiK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~ 83 (317)
T cd07868 6 GCKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTG--ISMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFDYAE 83 (317)
T ss_pred ccccccCCCeEEEEEEEccCCCCceEEEEEECCCC--CcHHHHHHHHHHHhcCCCCCcceeeeEecCCCcEEEEEEeccC
Confidence 468999999999999854 46789999987542 23457789999999999999999998854 456789999985
Q ss_pred CCCHHHHHhhhc-----CCCCCcCHHHHHHHHHHHHHHHHHHHhccCCCeeecCCCCCCeEE----CCCCcEEEEEcccc
Q 002673 687 NGSLDYWLHEKA-----DGASQLDWLTRLKIARGTSCGLAYMHQICEPHIVHRDIKSSNILL----DDQFEAHLADFGLS 757 (894)
Q Consensus 687 ~gsL~~~l~~~~-----~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDLkp~NILl----d~~~~vkl~DFGla 757 (894)
++|.+++.... .....+++..+..++.||+.||.|||+ ++|+||||||+|||+ +.++.+||+|||++
T Consensus 84 -~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~---~~ivHrDlkp~Nil~~~~~~~~~~~kl~DfG~a 159 (317)
T cd07868 84 -HDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHA---NWVLHRDLKPANILVMGEGPERGRVKIADMGFA 159 (317)
T ss_pred -CCHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHHh---CCEEcCCCCHHHEEEecCCCCcCcEEEeecCce
Confidence 58888876422 122358889999999999999999997 599999999999999 45678999999999
Q ss_pred cccCCCCC--cccccccccCCccCcccccCc-CCCccccHHHHHHHHHHHHcCCCCCCCC
Q 002673 758 RLILPYQT--HVTTELVGTLGYIPPEYGQAW-VATLRGDMYSFGVVMLELLTGKRPVDVL 814 (894)
Q Consensus 758 ~~~~~~~~--~~~~~~~gt~~Y~APE~~~~~-~~s~ksDVwS~GvlL~elltG~~Pf~~~ 814 (894)
+....... .......||+.|+|||++.+. .++.++||||+||++|||++|+.||...
T Consensus 160 ~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~ 219 (317)
T cd07868 160 RLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCR 219 (317)
T ss_pred eccCCCCccccccCCccccccccCCHHHcCCCCcCchhhHHHHHHHHHHHHhCCCCccCC
Confidence 87543221 122346789999999998774 5899999999999999999999999643
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p |
| >KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-33 Score=317.72 Aligned_cols=197 Identities=25% Similarity=0.335 Sum_probs=171.9
Q ss_pred CCCccceEeecCcEEEEEEE-EcCCCeEEEEEEcCcchhhHHHHHHHHHHHHhcC-C-----CceeeecceeeecceEEE
Q 002673 608 NFSQANIIGCGGFGLVYKAT-LANGTTLAIKKLSGDLGLMEREFKAEVEALSTAQ-H-----KNLVSLQGYCVHQGFRLL 680 (894)
Q Consensus 608 ~f~~~~~LG~G~fg~Vy~a~-~~~g~~vAvK~~~~~~~~~~~~~~~Ei~~l~~l~-H-----pnIv~l~g~~~~~~~~~l 680 (894)
+|++.+.||+|+||.|-+|. ..+++.||||+++.. ..-..+...|+.+|..++ | -|+|+++++|...++.||
T Consensus 187 rY~V~e~LGkGtFGQVvk~~d~~T~e~VAIKIiKN~-k~f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~F~fr~Hlci 265 (586)
T KOG0667|consen 187 RYEVLEVLGKGSFGQVVKAYDHKTGEIVAIKIIKNK-KRFLRQAQIEIRILELLNKHDPDDKYNIVRMLDYFYFRNHLCI 265 (586)
T ss_pred EEEEEEEecccccceeEEEEecCCCcEEEEEeeccC-hHHHHHHHHHHHHHHHHhccCCCCCeeEEEeeeccccccceee
Confidence 78999999999999999998 567999999999865 344567788999999997 4 499999999999999999
Q ss_pred EEEeccCCCHHHHHhhhcCCCCCcCHHHHHHHHHHHHHHHHHHHhccCCCeeecCCCCCCeEECCC--CcEEEEEccccc
Q 002673 681 IYSYMENGSLDYWLHEKADGASQLDWLTRLKIARGTSCGLAYMHQICEPHIVHRDIKSSNILLDDQ--FEAHLADFGLSR 758 (894)
Q Consensus 681 V~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDLkp~NILld~~--~~vkl~DFGla~ 758 (894)
|+|.++ -+|.++++... ...++...+..|+.||+.||.+||+ .+|||+||||+||||.+. ..+||+|||.|+
T Consensus 266 VfELL~-~NLYellK~n~--f~Glsl~~ir~~~~Qil~~L~~L~~---l~IIHcDLKPENILL~~~~r~~vKVIDFGSSc 339 (586)
T KOG0667|consen 266 VFELLS-TNLYELLKNNK--FRGLSLPLVRKFAQQILTALLFLHE---LGIIHCDLKPENILLKDPKRSRIKVIDFGSSC 339 (586)
T ss_pred eehhhh-hhHHHHHHhcC--CCCCCHHHHHHHHHHHHHHHHHHHh---CCeeeccCChhheeeccCCcCceeEEeccccc
Confidence 999994 59999998754 4568999999999999999999997 599999999999999753 469999999999
Q ss_pred ccCCCCCcccccccccCCccCcccccCcCCCccccHHHHHHHHHHHHcCCCCCCCCC
Q 002673 759 LILPYQTHVTTELVGTLGYIPPEYGQAWVATLRGDMYSFGVVMLELLTGKRPVDVLK 815 (894)
Q Consensus 759 ~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwS~GvlL~elltG~~Pf~~~~ 815 (894)
.... .....+-+..|.|||++.|..|+.++||||||||++||++|.+-|.+..
T Consensus 340 ~~~q----~vytYiQSRfYRAPEVILGlpY~~~IDmWSLGCIlAEL~tG~PLfpG~n 392 (586)
T KOG0667|consen 340 FESQ----RVYTYIQSRFYRAPEVILGLPYDTAIDMWSLGCILAELFTGEPLFPGDN 392 (586)
T ss_pred ccCC----cceeeeeccccccchhhccCCCCCccceeehhhhHHhHhcCccccCCCC
Confidence 7532 2225677899999999999999999999999999999999988776543
|
|
| >cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-33 Score=304.95 Aligned_cols=263 Identities=24% Similarity=0.291 Sum_probs=196.4
Q ss_pred CCCccceEeecCcEEEEEEEE-cCCCeEEEEEEcCcc--hhhHHHHHHHHHHHHhcCCCceeeecceeeecceEEEEEEe
Q 002673 608 NFSQANIIGCGGFGLVYKATL-ANGTTLAIKKLSGDL--GLMEREFKAEVEALSTAQHKNLVSLQGYCVHQGFRLLIYSY 684 (894)
Q Consensus 608 ~f~~~~~LG~G~fg~Vy~a~~-~~g~~vAvK~~~~~~--~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~lV~E~ 684 (894)
+|+..+.||+|+||.||+|.. .++..||+|++.... ......+.+|+.+++.++||||+++++++..++..++||||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (285)
T cd07861 1 DYTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQDVLMQESRLYLIFEF 80 (285)
T ss_pred CceEeeEecccCceEEEEEEECCCCcEEEEEEeccccccCCchHHHHHHHHHHHhcCCCCEeeeEEEEeeCCeEEEEEec
Confidence 477889999999999999985 478999999986532 22335688999999999999999999999999999999999
Q ss_pred ccCCCHHHHHhhhcCCCCCcCHHHHHHHHHHHHHHHHHHHhccCCCeeecCCCCCCeEECCCCcEEEEEcccccccCCCC
Q 002673 685 MENGSLDYWLHEKADGASQLDWLTRLKIARGTSCGLAYMHQICEPHIVHRDIKSSNILLDDQFEAHLADFGLSRLILPYQ 764 (894)
Q Consensus 685 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDLkp~NILld~~~~vkl~DFGla~~~~~~~ 764 (894)
++ ++|.+++..... ...+++..+..++.|++.||.|||+ ++++|+||||+||+++.++.+||+|||++.......
T Consensus 81 ~~-~~l~~~~~~~~~-~~~~~~~~~~~~~~qi~~~L~~lH~---~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~ 155 (285)
T cd07861 81 LS-MDLKKYLDSLPK-GQYMDAELVKSYLYQILQGILFCHS---RRVLHRDLKPQNLLIDNKGVIKLADFGLARAFGIPV 155 (285)
T ss_pred CC-CCHHHHHhcCCC-CCcCCHHHHHHHHHHHHHHHHHHHh---CCeeecCCCHHHEEEcCCCcEEECcccceeecCCCc
Confidence 97 689888875432 3568999999999999999999997 599999999999999999999999999997653221
Q ss_pred CcccccccccCCccCcccccCc-CCCccccHHHHHHHHHHHHcCCCCCCCCCcchhhhHHHHHHHHhhc--CCC------
Q 002673 765 THVTTELVGTLGYIPPEYGQAW-VATLRGDMYSFGVVMLELLTGKRPVDVLKPKMSRELVGWVLKMRSE--GKQ------ 835 (894)
Q Consensus 765 ~~~~~~~~gt~~Y~APE~~~~~-~~s~ksDVwS~GvlL~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~--~~~------ 835 (894)
.......+++.|+|||++.+. .++.++||||||+++|+|++|+.||....... ............ ..+
T Consensus 156 -~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~ 232 (285)
T cd07861 156 -RVYTHEVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKKPLFHGDSEID--QLFRIFRILGTPTEDVWPGVTSL 232 (285)
T ss_pred -ccccCCcccccccChHHhcCCCCcCcHHHHHHHHHHHHHHHHCCCCCCCCCHHH--HHHHHHHHhCCCChhhhhcchhh
Confidence 122334578899999987654 57889999999999999999999997543211 111111000000 000
Q ss_pred ---CccccccccC---CCChHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 002673 836 ---DQVFDPILRG---KGFDEEMLQVLDVACMCVSQNPFKRPTVKEVVE 878 (894)
Q Consensus 836 ---~~~~d~~l~~---~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~ 878 (894)
...++..... ........++.+++.+|++.||.+|||+.+++.
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~~ll~ 281 (285)
T cd07861 233 PDYKNTFPKWKKGSLRSAVKNLDEDGLDLLEKMLIYDPAKRISAKKALN 281 (285)
T ss_pred HHHHhhccccCcchhHHhcCCCCHHHHHHHHHHhcCChhhCCCHHHHhc
Confidence 0000000000 000112235678999999999999999999975
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 |
| >smart00219 TyrKc Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-33 Score=296.06 Aligned_cols=251 Identities=27% Similarity=0.449 Sum_probs=200.6
Q ss_pred CCccceEeecCcEEEEEEEEcC-----CCeEEEEEEcCcchh-hHHHHHHHHHHHHhcCCCceeeecceeeecceEEEEE
Q 002673 609 FSQANIIGCGGFGLVYKATLAN-----GTTLAIKKLSGDLGL-MEREFKAEVEALSTAQHKNLVSLQGYCVHQGFRLLIY 682 (894)
Q Consensus 609 f~~~~~LG~G~fg~Vy~a~~~~-----g~~vAvK~~~~~~~~-~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~lV~ 682 (894)
|++.+.||+|+||.||++...+ +..||+|++...... ....+..|+.++..++|+||+++++++.+.+..+++|
T Consensus 1 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~i~ 80 (258)
T smart00219 1 LTLGKKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKEDADEQQIEEFLREARIMRKLDHPNIVKLLGVCTEEEPLMIVM 80 (258)
T ss_pred CcccceeccCCCcceEEEEecCCCCCCCceEEEEEccCCCChHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCeeEEEE
Confidence 3566889999999999998643 488999999765433 5578999999999999999999999999999999999
Q ss_pred EeccCCCHHHHHhhhcCCCCCcCHHHHHHHHHHHHHHHHHHHhccCCCeeecCCCCCCeEECCCCcEEEEEcccccccCC
Q 002673 683 SYMENGSLDYWLHEKADGASQLDWLTRLKIARGTSCGLAYMHQICEPHIVHRDIKSSNILLDDQFEAHLADFGLSRLILP 762 (894)
Q Consensus 683 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDLkp~NILld~~~~vkl~DFGla~~~~~ 762 (894)
||+++++|.+++..... ..+++..+..++.|++.||+|||+ .+++|+||||+||++++++.++|+|||++.....
T Consensus 81 e~~~~~~l~~~~~~~~~--~~~~~~~~~~~~~ql~~~l~~lh~---~~~~h~dl~~~nil~~~~~~~~l~dfg~~~~~~~ 155 (258)
T smart00219 81 EYMEGGDLLDYLRKNRP--KELSLSDLLSFALQIARGMEYLES---KNFIHRDLAARNCLVGENLVVKISDFGLSRDLYD 155 (258)
T ss_pred eccCCCCHHHHHHhhhh--ccCCHHHHHHHHHHHHHHHHHHhc---CCeeecccccceEEEccCCeEEEcccCCceeccc
Confidence 99999999999986432 128999999999999999999997 5999999999999999999999999999987654
Q ss_pred CCCcccccccccCCccCcccccCcCCCccccHHHHHHHHHHHHc-CCCCCCCCCcchhhhHHHHHHHHhhcCCCCccccc
Q 002673 763 YQTHVTTELVGTLGYIPPEYGQAWVATLRGDMYSFGVVMLELLT-GKRPVDVLKPKMSRELVGWVLKMRSEGKQDQVFDP 841 (894)
Q Consensus 763 ~~~~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwS~GvlL~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 841 (894)
..........++..|+|||...+..++.++||||+|+++|+|++ |+.||..... ........ . ......
T Consensus 156 ~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~i~~~l~~~g~~p~~~~~~---~~~~~~~~---~-~~~~~~--- 225 (258)
T smart00219 156 DDYYKKKGGKLPIRWMAPESLKDGKFTSKSDVWSFGVLLWEIFTLGESPYPGMSN---EEVLEYLK---K-GYRLPK--- 225 (258)
T ss_pred ccccccccCCCcccccChHHhccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCH---HHHHHHHh---c-CCCCCC---
Confidence 32222222336789999999988889999999999999999998 8888875332 12222111 1 111100
Q ss_pred cccCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 002673 842 ILRGKGFDEEMLQVLDVACMCVSQNPFKRPTVKEVVEWL 880 (894)
Q Consensus 842 ~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L 880 (894)
. ......+.+++.+|++.+|++|||+.+++++|
T Consensus 226 --~----~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~~l 258 (258)
T smart00219 226 --P----ENCPPEIYKLMLQCWAEDPEDRPTFSELVEIL 258 (258)
T ss_pred --C----CcCCHHHHHHHHHHCcCChhhCcCHHHHHhhC
Confidence 0 11233577899999999999999999999864
|
Phosphotransferases. Tyrosine-specific kinase subfamily. |
| >PHA03207 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-33 Score=318.14 Aligned_cols=261 Identities=20% Similarity=0.259 Sum_probs=200.3
Q ss_pred cCCCccceEeecCcEEEEEEEEc---CCCeEEEEEEcCcchhhHHHHHHHHHHHHhcCCCceeeecceeeecceEEEEEE
Q 002673 607 DNFSQANIIGCGGFGLVYKATLA---NGTTLAIKKLSGDLGLMEREFKAEVEALSTAQHKNLVSLQGYCVHQGFRLLIYS 683 (894)
Q Consensus 607 ~~f~~~~~LG~G~fg~Vy~a~~~---~g~~vAvK~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~lV~E 683 (894)
.+|.+.+.||+|+||.||++... .+..||+|.+... ....+|++++++++||||+++++++......++|||
T Consensus 92 ~~y~i~~~Lg~G~~g~Vy~~~~~~~~~~~~v~vK~~~~~-----~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~e 166 (392)
T PHA03207 92 MQYNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGG-----KTPGREIDILKTISHRAIINLIHAYRWKSTVCMVMP 166 (392)
T ss_pred CceEEEEeecCCCCeEEEEEEEcCCccceeEEEEecccc-----ccHHHHHHHHHhcCCCCccceeeeEeeCCEEEEEeh
Confidence 57999999999999999999743 4578999988653 245689999999999999999999999999999999
Q ss_pred eccCCCHHHHHhhhcCCCCCcCHHHHHHHHHHHHHHHHHHHhccCCCeeecCCCCCCeEECCCCcEEEEEcccccccCCC
Q 002673 684 YMENGSLDYWLHEKADGASQLDWLTRLKIARGTSCGLAYMHQICEPHIVHRDIKSSNILLDDQFEAHLADFGLSRLILPY 763 (894)
Q Consensus 684 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDLkp~NILld~~~~vkl~DFGla~~~~~~ 763 (894)
++. ++|.+++... ..+++..++.++.||+.||.|||+ ++|+||||||+|||++.++.+||+|||+++.....
T Consensus 167 ~~~-~~l~~~l~~~----~~l~~~~~~~i~~ql~~aL~~LH~---~givHrDlkp~Nill~~~~~~~l~DfG~a~~~~~~ 238 (392)
T PHA03207 167 KYK-CDLFTYVDRS----GPLPLEQAITIQRRLLEALAYLHG---RGIIHRDVKTENIFLDEPENAVLGDFGAACKLDAH 238 (392)
T ss_pred hcC-CCHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHH---CCccccCCCHHHEEEcCCCCEEEccCccccccCcc
Confidence 995 6888888432 468999999999999999999997 59999999999999999999999999999865432
Q ss_pred CCc-ccccccccCCccCcccccCcCCCccccHHHHHHHHHHHHcCCCCCCCCCcchhhhHHHHHHHHhhcCCCC------
Q 002673 764 QTH-VTTELVGTLGYIPPEYGQAWVATLRGDMYSFGVVMLELLTGKRPVDVLKPKMSRELVGWVLKMRSEGKQD------ 836 (894)
Q Consensus 764 ~~~-~~~~~~gt~~Y~APE~~~~~~~s~ksDVwS~GvlL~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~------ 836 (894)
... ......||+.|+|||++.+..++.++|||||||++|||++|+.||..............+..........
T Consensus 239 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~l~~i~~~~~~~~~~~~~~~~ 318 (392)
T PHA03207 239 PDTPQCYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVTLFGKQVKSSSSQLRSIIRCMQVHPLEFPQNGS 318 (392)
T ss_pred cccccccccccccCccCHhHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCCCCcHHHHHHHHHHhccCccccCCccc
Confidence 221 2234579999999999999999999999999999999999999997544322111111111111100000
Q ss_pred -----------------ccccccccCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHH--HHHhc
Q 002673 837 -----------------QVFDPILRGKGFDEEMLQVLDVACMCVSQNPFKRPTVKEVVE--WLNNV 883 (894)
Q Consensus 837 -----------------~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~--~L~~i 883 (894)
....+.+.... ....+.+++.+|+..||++|||+.+++. ++.+.
T Consensus 319 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~li~~ml~~dp~~Rpsa~e~l~~p~f~~~ 381 (392)
T PHA03207 319 TNLCKHFKQYAIVLRPPYTIPPVIRKYG---MHMDVEYLIAKMLTFDQEFRPSAQDILSLPLFTKE 381 (392)
T ss_pred hhHHHHHHhhcccccCCccccchhhccC---cchhHHHHHHHHhccChhhCCCHHHHhhCchhhcc
Confidence 00000010011 1235678899999999999999999998 66553
|
|
| >cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-33 Score=301.12 Aligned_cols=250 Identities=25% Similarity=0.369 Sum_probs=202.5
Q ss_pred CCCccceEeecCcEEEEEEEE-cCCCeEEEEEEcCcc-hhhHHHHHHHHHHHHhcCCCceeeecceeeecceEEEEEEec
Q 002673 608 NFSQANIIGCGGFGLVYKATL-ANGTTLAIKKLSGDL-GLMEREFKAEVEALSTAQHKNLVSLQGYCVHQGFRLLIYSYM 685 (894)
Q Consensus 608 ~f~~~~~LG~G~fg~Vy~a~~-~~g~~vAvK~~~~~~-~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~lV~E~~ 685 (894)
.|+..+.||.|+||.||+|.. .++..||+|.+.... ......+.+|+.++++++||||+++++++.++...++||||+
T Consensus 5 ~y~~~~~lg~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 84 (277)
T cd06640 5 LFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKGTKLWIIMEYL 84 (277)
T ss_pred hhhhhhhcccCCCeEEEEEEEccCCEEEEEEEEeccccHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEEecC
Confidence 466778899999999999985 468899999987543 344567889999999999999999999999999999999999
Q ss_pred cCCCHHHHHhhhcCCCCCcCHHHHHHHHHHHHHHHHHHHhccCCCeeecCCCCCCeEECCCCcEEEEEcccccccCCCCC
Q 002673 686 ENGSLDYWLHEKADGASQLDWLTRLKIARGTSCGLAYMHQICEPHIVHRDIKSSNILLDDQFEAHLADFGLSRLILPYQT 765 (894)
Q Consensus 686 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDLkp~NILld~~~~vkl~DFGla~~~~~~~~ 765 (894)
++|+|.+++.. ..+++.....++.|++.||.|||+ .+++|+||+|+||+++.++.++|+|||++.......
T Consensus 85 ~~~~L~~~i~~-----~~l~~~~~~~~~~~l~~~l~~lh~---~~ivH~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~- 155 (277)
T cd06640 85 GGGSALDLLRA-----GPFDEFQIATMLKEILKGLDYLHS---EKKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQ- 155 (277)
T ss_pred CCCcHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHh---CCccCcCCChhhEEEcCCCCEEEcccccceeccCCc-
Confidence 99999998864 247888899999999999999997 599999999999999999999999999997654322
Q ss_pred cccccccccCCccCcccccCcCCCccccHHHHHHHHHHHHcCCCCCCCCCcchhhhHHHHHHHHhhcCCCCccccccccC
Q 002673 766 HVTTELVGTLGYIPPEYGQAWVATLRGDMYSFGVVMLELLTGKRPVDVLKPKMSRELVGWVLKMRSEGKQDQVFDPILRG 845 (894)
Q Consensus 766 ~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwS~GvlL~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~ 845 (894)
.......++..|+|||++.+..++.++|||||||++|||++|+.||.......... .. ..... +
T Consensus 156 ~~~~~~~~~~~y~apE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~------~~-~~~~~-----~---- 219 (277)
T cd06640 156 IKRNTFVGTPFWMAPEVIQQSAYDSKADIWSLGITAIELAKGEPPNSDMHPMRVLF------LI-PKNNP-----P---- 219 (277)
T ss_pred cccccccCcccccCHhHhccCCCccHHHHHHHHHHHHHHHHCCCCCCCcChHhHhh------hh-hcCCC-----C----
Confidence 12233467889999999988889999999999999999999999997543221110 00 11111 1
Q ss_pred CCChHHHHHHHHHHHHhcccCCCCCCCHHHHHH--HHHh
Q 002673 846 KGFDEEMLQVLDVACMCVSQNPFKRPTVKEVVE--WLNN 882 (894)
Q Consensus 846 ~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~--~L~~ 882 (894)
.........+.+++.+||+.+|++||++.++++ ++..
T Consensus 220 ~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~~~ 258 (277)
T cd06640 220 TLTGEFSKPFKEFIDACLNKDPSFRPTAKELLKHKFIVK 258 (277)
T ss_pred CCchhhhHHHHHHHHHHcccCcccCcCHHHHHhChHhhh
Confidence 112234456789999999999999999999987 4443
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter |
| >cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-33 Score=302.29 Aligned_cols=251 Identities=30% Similarity=0.468 Sum_probs=196.3
Q ss_pred ceEeecCcEEEEEEEEcC-------CCeEEEEEEcCcc-hhhHHHHHHHHHHHHhcCCCceeeecceeeecceEEEEEEe
Q 002673 613 NIIGCGGFGLVYKATLAN-------GTTLAIKKLSGDL-GLMEREFKAEVEALSTAQHKNLVSLQGYCVHQGFRLLIYSY 684 (894)
Q Consensus 613 ~~LG~G~fg~Vy~a~~~~-------g~~vAvK~~~~~~-~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~lV~E~ 684 (894)
+.||+|+||.||+|...+ +..+|+|.+.... ......+.+|+.+++.++||||+++++++......++||||
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (269)
T cd05044 1 NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPNIVKLLGVCLLNEPQYIIMEL 80 (269)
T ss_pred CccccccceeEEeeeecccccCcccceeehhhhhhcccchhhHHHHHHHHHHHHhcCCCCeeeEeeeecCCCCeEEEEec
Confidence 368999999999998542 2578999886543 23456788999999999999999999999999999999999
Q ss_pred ccCCCHHHHHhhhcC---CCCCcCHHHHHHHHHHHHHHHHHHHhccCCCeeecCCCCCCeEECCCC-----cEEEEEccc
Q 002673 685 MENGSLDYWLHEKAD---GASQLDWLTRLKIARGTSCGLAYMHQICEPHIVHRDIKSSNILLDDQF-----EAHLADFGL 756 (894)
Q Consensus 685 ~~~gsL~~~l~~~~~---~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDLkp~NILld~~~-----~vkl~DFGl 756 (894)
+++|+|.+++..... ....+++..++.++.|++.||.|||+ .+++|+||||+||+++.++ .++++|||+
T Consensus 81 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~---~~i~H~dl~p~nil~~~~~~~~~~~~~l~dfg~ 157 (269)
T cd05044 81 MEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQ---MHFIHRDLAARNCLVSEKGYDADRVVKIGDFGL 157 (269)
T ss_pred cCCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHHh---CCcccCCCChheEEEecCCCCCCcceEECCccc
Confidence 999999999976432 22457889999999999999999997 5899999999999999887 899999999
Q ss_pred ccccCCCCCc-ccccccccCCccCcccccCcCCCccccHHHHHHHHHHHHc-CCCCCCCCCcchhhhHHHHHHHHhhcCC
Q 002673 757 SRLILPYQTH-VTTELVGTLGYIPPEYGQAWVATLRGDMYSFGVVMLELLT-GKRPVDVLKPKMSRELVGWVLKMRSEGK 834 (894)
Q Consensus 757 a~~~~~~~~~-~~~~~~gt~~Y~APE~~~~~~~s~ksDVwS~GvlL~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~ 834 (894)
++........ ......++..|+|||++.+..++.++|||||||++|||++ |+.||...... +..... .....
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt~g~~p~~~~~~~---~~~~~~---~~~~~ 231 (269)
T cd05044 158 ARDIYKSDYYRKEGEGLLPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQPYPALNNQ---EVLQHV---TAGGR 231 (269)
T ss_pred ccccccccccccCcccCCCccccCHHHHccCCcccchhHHHHHHHHHHHHHcCCCCCcccCHH---HHHHHH---hcCCc
Confidence 9765332211 1222345678999999999999999999999999999998 99999744321 111111 11110
Q ss_pred CCccccccccCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHh
Q 002673 835 QDQVFDPILRGKGFDEEMLQVLDVACMCVSQNPFKRPTVKEVVEWLNN 882 (894)
Q Consensus 835 ~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~ 882 (894)
. . ........+.+++.+||+.+|.+||+++++++.|++
T Consensus 232 ~-~---------~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~ 269 (269)
T cd05044 232 L-Q---------KPENCPDKIYQLMTNCWAQDPSERPTFDRIQEILQN 269 (269)
T ss_pred c-C---------CcccchHHHHHHHHHHcCCCcccCCCHHHHHHHHhC
Confidence 0 0 011123456789999999999999999999998863
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male |
| >cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-33 Score=298.93 Aligned_cols=253 Identities=23% Similarity=0.367 Sum_probs=189.0
Q ss_pred eEeecCcEEEEEEEEcCC---CeEEEEEEcCcc-hhhHHHHHHHHHHHHhcCCCceeeecceeeecceEEEEEEeccCCC
Q 002673 614 IIGCGGFGLVYKATLANG---TTLAIKKLSGDL-GLMEREFKAEVEALSTAQHKNLVSLQGYCVHQGFRLLIYSYMENGS 689 (894)
Q Consensus 614 ~LG~G~fg~Vy~a~~~~g---~~vAvK~~~~~~-~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~lV~E~~~~gs 689 (894)
.||+|+||.||+|...++ ..+++|.+.... ......+.+|+.+++.++||||+++++.|......++||||+++|+
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~ 81 (268)
T cd05086 2 EIGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQCLGQCVEAIPYLLVFEYCELGD 81 (268)
T ss_pred cCCCCcCceEEEEEEEcCCCcceEEEEEecCCCChHHHHHHHHHHHHHhccCCcchhheEEEecCCCccEEEEecCCCCc
Confidence 589999999999975443 346677766443 2345678999999999999999999999999999999999999999
Q ss_pred HHHHHhhhcCCCCCcCHHHHHHHHHHHHHHHHHHHhccCCCeeecCCCCCCeEECCCCcEEEEEcccccccCCCC-Cccc
Q 002673 690 LDYWLHEKADGASQLDWLTRLKIARGTSCGLAYMHQICEPHIVHRDIKSSNILLDDQFEAHLADFGLSRLILPYQ-THVT 768 (894)
Q Consensus 690 L~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDLkp~NILld~~~~vkl~DFGla~~~~~~~-~~~~ 768 (894)
|.++++.........++.....++.||+.||.|||+ .+++||||||+|||++.++.+||+|||++....... ....
T Consensus 82 L~~~l~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~---~~i~H~dikp~nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~ 158 (268)
T cd05086 82 LKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHK---HNFLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIETE 158 (268)
T ss_pred HHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHH---CCeeccCCccceEEEcCCccEEecccccccccCcchhhhcc
Confidence 999998654334456777888999999999999997 599999999999999999999999999986432111 1112
Q ss_pred ccccccCCccCcccccC-------cCCCccccHHHHHHHHHHHHc-CCCCCCCCCcchhhhHHHHHHHHhhcCCCCcccc
Q 002673 769 TELVGTLGYIPPEYGQA-------WVATLRGDMYSFGVVMLELLT-GKRPVDVLKPKMSRELVGWVLKMRSEGKQDQVFD 840 (894)
Q Consensus 769 ~~~~gt~~Y~APE~~~~-------~~~s~ksDVwS~GvlL~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 840 (894)
....++..|+|||++.. ..++.++||||||+++|||++ |..||...... +... ..... ......+
T Consensus 159 ~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~---~~~~---~~~~~-~~~~~~~ 231 (268)
T cd05086 159 DDKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLSDR---EVLN---HVIKD-QQVKLFK 231 (268)
T ss_pred cCCcCcccccCchhcccccCccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCHH---HHHH---HHHhh-cccccCC
Confidence 34567889999998743 245789999999999999997 57788654321 1111 11111 1122223
Q ss_pred ccccCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 002673 841 PILRGKGFDEEMLQVLDVACMCVSQNPFKRPTVKEVVEWLN 881 (894)
Q Consensus 841 ~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~ 881 (894)
+.+... ....+.+++..|| .+|++||++++|++.|.
T Consensus 232 ~~~~~~----~~~~~~~l~~~c~-~~P~~Rp~~~~i~~~l~ 267 (268)
T cd05086 232 PQLELP----YSERWYEVLQFCW-LSPEKRATAEEVHRLLT 267 (268)
T ss_pred CccCCC----CcHHHHHHHHHHh-hCcccCCCHHHHHHHhc
Confidence 322211 1234567888999 67999999999998874
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage |
| >cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-33 Score=296.11 Aligned_cols=258 Identities=27% Similarity=0.432 Sum_probs=208.4
Q ss_pred cCCCccceEeecCcEEEEEEEEc-CCCeEEEEEEcCcch-hhHHHHHHHHHHHHhcCCCceeeecceeeecceEEEEEEe
Q 002673 607 DNFSQANIIGCGGFGLVYKATLA-NGTTLAIKKLSGDLG-LMEREFKAEVEALSTAQHKNLVSLQGYCVHQGFRLLIYSY 684 (894)
Q Consensus 607 ~~f~~~~~LG~G~fg~Vy~a~~~-~g~~vAvK~~~~~~~-~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~lV~E~ 684 (894)
++|+..+.||+|++|.||+|... +++.|++|++..... .....+..|+..+.+++|+|++++++++......++||||
T Consensus 1 ~~~~~~~~i~~g~~~~v~~~~~~~~~~~~~vk~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 80 (264)
T cd06623 1 SDLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVKCYGAFYKEGEISIVLEY 80 (264)
T ss_pred CcceeeeeeeecCCeEEEEEEEcCCCcEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCeeeEEEEEccCCeEEEEEEe
Confidence 36788899999999999999865 599999999876543 4457799999999999999999999999999999999999
Q ss_pred ccCCCHHHHHhhhcCCCCCcCHHHHHHHHHHHHHHHHHHHhccCCCeeecCCCCCCeEECCCCcEEEEEcccccccCCCC
Q 002673 685 MENGSLDYWLHEKADGASQLDWLTRLKIARGTSCGLAYMHQICEPHIVHRDIKSSNILLDDQFEAHLADFGLSRLILPYQ 764 (894)
Q Consensus 685 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDLkp~NILld~~~~vkl~DFGla~~~~~~~ 764 (894)
+++++|.+++... ..++...++.++.|+++|+.|||+ ..+++|+||+|+||+++.++.++|+|||++.......
T Consensus 81 ~~~~~L~~~l~~~----~~l~~~~~~~~~~~l~~~l~~lh~--~~~~~H~~l~~~ni~~~~~~~~~l~df~~~~~~~~~~ 154 (264)
T cd06623 81 MDGGSLADLLKKV----GKIPEPVLAYIARQILKGLDYLHT--KRHIIHRDIKPSNLLINSKGEVKIADFGISKVLENTL 154 (264)
T ss_pred cCCCcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHhc--cCCCccCCCCHHHEEECCCCCEEEccCccceecccCC
Confidence 9999999999764 458899999999999999999996 1599999999999999999999999999998764322
Q ss_pred CcccccccccCCccCcccccCcCCCccccHHHHHHHHHHHHcCCCCCCCCCcchhhhHHHHHHHHhhcCCCCcccccccc
Q 002673 765 THVTTELVGTLGYIPPEYGQAWVATLRGDMYSFGVVMLELLTGKRPVDVLKPKMSRELVGWVLKMRSEGKQDQVFDPILR 844 (894)
Q Consensus 765 ~~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwS~GvlL~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~ 844 (894)
. ......++..|+|||...+..++.++||||||+++|+|++|+.||.............+.. .... .. ..
T Consensus 155 ~-~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~---~~~~-~~-----~~ 224 (264)
T cd06623 155 D-QCNTFVGTVTYMSPERIQGESYSYAADIWSLGLTLLECALGKFPFLPPGQPSFFELMQAIC---DGPP-PS-----LP 224 (264)
T ss_pred C-cccceeecccccCHhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCccccccCHHHHHHHHh---cCCC-CC-----CC
Confidence 2 1224567889999999999899999999999999999999999997654312222222211 1111 10 11
Q ss_pred CCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHH--HHHhc
Q 002673 845 GKGFDEEMLQVLDVACMCVSQNPFKRPTVKEVVE--WLNNV 883 (894)
Q Consensus 845 ~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~--~L~~i 883 (894)
... ....+.+++..|+..+|++||++.++++ +++.+
T Consensus 225 ~~~---~~~~l~~li~~~l~~~p~~R~~~~~ll~~~~~~~~ 262 (264)
T cd06623 225 AEE---FSPEFRDFISACLQKDPKKRPSAAELLQHPFIKKA 262 (264)
T ss_pred ccc---CCHHHHHHHHHHccCChhhCCCHHHHHhCHHHHhc
Confidence 010 2346778999999999999999999998 66654
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of |
| >cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-33 Score=315.72 Aligned_cols=264 Identities=23% Similarity=0.276 Sum_probs=198.1
Q ss_pred HhccCCCccceEeecCcEEEEEEEE-cCCCeEEEEEEcCcch--hhHHHHHHHHHHHHhcCCCceeeecceeeec-----
Q 002673 604 KATDNFSQANIIGCGGFGLVYKATL-ANGTTLAIKKLSGDLG--LMEREFKAEVEALSTAQHKNLVSLQGYCVHQ----- 675 (894)
Q Consensus 604 ~a~~~f~~~~~LG~G~fg~Vy~a~~-~~g~~vAvK~~~~~~~--~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~----- 675 (894)
...++|+..+.||+|+||.||+|.. .++..||||++..... .....+.+|+.+++.++||||+++++++...
T Consensus 12 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 91 (343)
T cd07878 12 EVPERYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLLDVFTPATSIEN 91 (343)
T ss_pred hhhhhhhhheecccCCCeEEEEEEECCCCCEEEEEEeCchhhhhHHHHHHHHHHHHHHhcCCCchhhhhhhhcccccccc
Confidence 3457899999999999999999984 5788999999875432 2234577899999999999999999987543
Q ss_pred -ceEEEEEEeccCCCHHHHHhhhcCCCCCcCHHHHHHHHHHHHHHHHHHHhccCCCeeecCCCCCCeEECCCCcEEEEEc
Q 002673 676 -GFRLLIYSYMENGSLDYWLHEKADGASQLDWLTRLKIARGTSCGLAYMHQICEPHIVHRDIKSSNILLDDQFEAHLADF 754 (894)
Q Consensus 676 -~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDLkp~NILld~~~~vkl~DF 754 (894)
...++++|++ +++|.+++.. ..+++..+..++.||+.||.|||+ ++|+||||||+||+++.++.+||+||
T Consensus 92 ~~~~~~~~~~~-~~~l~~~~~~-----~~l~~~~~~~i~~qi~~aL~~LH~---~~ivHrdikp~Nil~~~~~~~kl~Df 162 (343)
T cd07878 92 FNEVYLVTNLM-GADLNNIVKC-----QKLSDEHVQFLIYQLLRGLKYIHS---AGIIHRDLKPSNVAVNEDCELRILDF 162 (343)
T ss_pred cCcEEEEeecC-CCCHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHH---CCeecccCChhhEEECCCCCEEEcCC
Confidence 3568999988 7899888753 358899999999999999999997 59999999999999999999999999
Q ss_pred ccccccCCCCCcccccccccCCccCcccccC-cCCCccccHHHHHHHHHHHHcCCCCCCCCCcchhhhHHHHHHHHhhcC
Q 002673 755 GLSRLILPYQTHVTTELVGTLGYIPPEYGQA-WVATLRGDMYSFGVVMLELLTGKRPVDVLKPKMSRELVGWVLKMRSEG 833 (894)
Q Consensus 755 Gla~~~~~~~~~~~~~~~gt~~Y~APE~~~~-~~~s~ksDVwS~GvlL~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~ 833 (894)
|+++.... ......||+.|+|||++.+ ..++.++|||||||++|+|++|+.||....... .+..+. ......
T Consensus 163 g~~~~~~~----~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~--~~~~~~-~~~~~~ 235 (343)
T cd07878 163 GLARQADD----EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGNDYID--QLKRIM-EVVGTP 235 (343)
T ss_pred ccceecCC----CcCCccccccccCchHhcCCccCCchhhhHhHHHHHHHHHHCCCCCCCCCHHH--HHHHHH-HHhCCC
Confidence 99986532 1234568999999999877 568899999999999999999999997533211 111110 000000
Q ss_pred CCCcccc-----------ccc---cCC----CChHHHHHHHHHHHHhcccCCCCCCCHHHHHH--HHHhcc
Q 002673 834 KQDQVFD-----------PIL---RGK----GFDEEMLQVLDVACMCVSQNPFKRPTVKEVVE--WLNNVG 884 (894)
Q Consensus 834 ~~~~~~d-----------~~l---~~~----~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~--~L~~i~ 884 (894)
..+... ..+ ... ........+.+++.+|++.||.+|||+.++++ |+....
T Consensus 236 -~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dp~~R~s~~ell~hp~~~~~~ 305 (343)
T cd07878 236 -SPEVLKKISSEHARKYIQSLPHMPQQDLKKIFRGANPLAIDLLEKMLVLDSDKRISASEALAHPYFSQYH 305 (343)
T ss_pred -CHHHHHhcchhhHHHHhhccccccchhHHHhccCCCHHHHHHHHHHcCCChhhCCCHHHHhcCcchhccC
Confidence 000000 000 000 00001124678999999999999999999997 776654
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is |
| >KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-34 Score=317.06 Aligned_cols=252 Identities=27% Similarity=0.383 Sum_probs=203.8
Q ss_pred ceEeecCcEEEEEEEE-cCCCeEEEEEEcCcchhhHHHHHHHHHHHHhcCCCceeeecceeeecceEEEEEEeccCCCHH
Q 002673 613 NIIGCGGFGLVYKATL-ANGTTLAIKKLSGDLGLMEREFKAEVEALSTAQHKNLVSLQGYCVHQGFRLLIYSYMENGSLD 691 (894)
Q Consensus 613 ~~LG~G~fg~Vy~a~~-~~g~~vAvK~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~lV~E~~~~gsL~ 691 (894)
-+||+|.||+||.|+. .+...+|||.+........+.+..||...++++|.|||+++|.|.+++..-+.||-++||+|.
T Consensus 581 vVLGKGTYG~VYA~RD~~tqvrIaIKEIpekdsr~~QPLhEEIaLH~~LrHkNIVrYLGs~senGf~kIFMEqVPGGSLS 660 (1226)
T KOG4279|consen 581 VVLGKGTYGTVYAARDMDTQVRIAIKEIPEKDSREVQPLHEEIALHSTLRHKNIVRYLGSVSENGFFKIFMEQVPGGSLS 660 (1226)
T ss_pred EEeecCceeEEEeeccccceeEEEeeecccccchhhccHHHHHHHHHHHhhHhHHHHhhccCCCCeEEEEeecCCCCcHH
Confidence 3799999999999984 456679999998766666677899999999999999999999999999999999999999999
Q ss_pred HHHhhhcCCCCCcCHHHHHHHHHHHHHHHHHHHhccCCCeeecCCCCCCeEEC-CCCcEEEEEcccccccCCCCCccccc
Q 002673 692 YWLHEKADGASQLDWLTRLKIARGTSCGLAYMHQICEPHIVHRDIKSSNILLD-DQFEAHLADFGLSRLILPYQTHVTTE 770 (894)
Q Consensus 692 ~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDLkp~NILld-~~~~vkl~DFGla~~~~~~~~~~~~~ 770 (894)
++++.+.. .-.=.....-.+.+||++||.|||. +.|||||||-.|||++ -.|.+||+|||-++++.. -...+..
T Consensus 661 sLLrskWG-PlKDNEstm~fYtkQILeGLkYLHe---n~IVHRDIKGDNVLvNTySGvlKISDFGTsKRLAg-inP~TET 735 (1226)
T KOG4279|consen 661 SLLRSKWG-PLKDNESTMNFYTKQILEGLKYLHE---NKIVHRDIKGDNVLVNTYSGVLKISDFGTSKRLAG-INPCTET 735 (1226)
T ss_pred HHHHhccC-CCccchhHHHHHHHHHHHHhhhhhh---cceeeccccCCcEEEeeccceEEecccccchhhcc-CCccccc
Confidence 99998752 1222566777889999999999996 6999999999999996 589999999999998743 3345666
Q ss_pred ccccCCccCcccccCc--CCCccccHHHHHHHHHHHHcCCCCCCCCCcchhhhHHHHHHHHhhcCCCCccccccccCCCC
Q 002673 771 LVGTLGYIPPEYGQAW--VATLRGDMYSFGVVMLELLTGKRPVDVLKPKMSRELVGWVLKMRSEGKQDQVFDPILRGKGF 848 (894)
Q Consensus 771 ~~gt~~Y~APE~~~~~--~~s~ksDVwS~GvlL~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~ 848 (894)
+.||..|||||++..+ .|..++|||||||.+.||.||++||..+...... +.+.+-.. ......
T Consensus 736 FTGTLQYMAPEvIDqG~RGYG~aADIWS~GCT~vEMATGrPPF~ElgspqAA--------MFkVGmyK------vHP~iP 801 (1226)
T KOG4279|consen 736 FTGTLQYMAPEVIDQGPRGYGKAADIWSFGCTMVEMATGRPPFVELGSPQAA--------MFKVGMYK------VHPPIP 801 (1226)
T ss_pred cccchhhhChHhhccCCcCCCchhhhhhccceeEeeccCCCCeeecCChhHh--------hhhhccee------cCCCCc
Confidence 7899999999998765 6899999999999999999999999765432211 11111100 001122
Q ss_pred hHHHHHHHHHHHHhcccCCCCCCCHHHHHH--HHHhc
Q 002673 849 DEEMLQVLDVACMCVSQNPFKRPTVKEVVE--WLNNV 883 (894)
Q Consensus 849 ~~~~~~l~~li~~Cl~~dP~~RPs~~evl~--~L~~i 883 (894)
.+...+..+++.+|+.+||.+||+++++++ .|+.-
T Consensus 802 eelsaeak~FilrcFepd~~~R~sA~~LL~DpFlq~~ 838 (1226)
T KOG4279|consen 802 EELSAEAKNFILRCFEPDPCDRPSAKDLLQDPFLQHN 838 (1226)
T ss_pred HHHHHHHHHHHHHHcCCCcccCccHHHhccCcccccC
Confidence 344557789999999999999999999998 66544
|
|
| >KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-34 Score=315.73 Aligned_cols=245 Identities=29% Similarity=0.422 Sum_probs=199.9
Q ss_pred cCCCccceEeecCcEEEEEEE-EcCCCeEEEEEEcCcc---hhhHHHHHHHHHHHHhcCCCceeeecceeeecceEEEEE
Q 002673 607 DNFSQANIIGCGGFGLVYKAT-LANGTTLAIKKLSGDL---GLMEREFKAEVEALSTAQHKNLVSLQGYCVHQGFRLLIY 682 (894)
Q Consensus 607 ~~f~~~~~LG~G~fg~Vy~a~-~~~g~~vAvK~~~~~~---~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~lV~ 682 (894)
..|+..+.||.|+||.||-|+ ..+.+.||||++.... ...+.++..|++.|.+++|||+|.+.|+|..+...||||
T Consensus 26 klf~dLrEIGHGSFGAVYfArd~~n~evVAIKKMsySGKQs~EKWqDIlKEVrFL~~l~HPntieYkgCyLre~TaWLVM 105 (948)
T KOG0577|consen 26 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDILKEVRFLRQLRHPNTIEYKGCYLREHTAWLVM 105 (948)
T ss_pred HHHHHHHHhcCCccceeEEeeccCccceeeeeeccccccccHHHHHHHHHHHHHHHhccCCCcccccceeeccchHHHHH
Confidence 346777889999999999998 5678999999987532 344578999999999999999999999999999999999
Q ss_pred EeccCCCHHHHHhhhcCCCCCcCHHHHHHHHHHHHHHHHHHHhccCCCeeecCCCCCCeEECCCCcEEEEEcccccccCC
Q 002673 683 SYMENGSLDYWLHEKADGASQLDWLTRLKIARGTSCGLAYMHQICEPHIVHRDIKSSNILLDDQFEAHLADFGLSRLILP 762 (894)
Q Consensus 683 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDLkp~NILld~~~~vkl~DFGla~~~~~ 762 (894)
||| -|+-.+++.-.. .++-...+..|..+.+.||+|||++ +.||||||+.||||++.|.|||+|||.+....+
T Consensus 106 EYC-lGSAsDlleVhk---KplqEvEIAAi~~gaL~gLaYLHS~---~~IHRDiKAGNILLse~g~VKLaDFGSAsi~~P 178 (948)
T KOG0577|consen 106 EYC-LGSASDLLEVHK---KPLQEVEIAAITHGALQGLAYLHSH---NRIHRDIKAGNILLSEPGLVKLADFGSASIMAP 178 (948)
T ss_pred HHH-hccHHHHHHHHh---ccchHHHHHHHHHHHHHHHHHHHHh---hHHhhhccccceEecCCCeeeeccccchhhcCc
Confidence 999 568888876543 4577788899999999999999986 999999999999999999999999999976543
Q ss_pred CCCcccccccccCCccCcccc---cCcCCCccccHHHHHHHHHHHHcCCCCCCCCCcchhhhHHHHHHHHhhcCCCCccc
Q 002673 763 YQTHVTTELVGTLGYIPPEYG---QAWVATLRGDMYSFGVVMLELLTGKRPVDVLKPKMSRELVGWVLKMRSEGKQDQVF 839 (894)
Q Consensus 763 ~~~~~~~~~~gt~~Y~APE~~---~~~~~s~ksDVwS~GvlL~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 839 (894)
...++|||.|||||++ ..+.|+-|+||||+|+...||.-.++|+-.+.. +.....+-. .-
T Consensus 179 -----AnsFvGTPywMAPEVILAMDEGqYdgkvDvWSLGITCIELAERkPPlFnMNA------MSALYHIAQ------Ne 241 (948)
T KOG0577|consen 179 -----ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNA------MSALYHIAQ------NE 241 (948)
T ss_pred -----hhcccCCccccchhHheeccccccCCccceeeccchhhhhhhcCCCccCchH------HHHHHHHHh------cC
Confidence 3457999999999975 457899999999999999999999999764432 111111111 12
Q ss_pred cccccCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 002673 840 DPILRGKGFDEEMLQVLDVACMCVSQNPFKRPTVKEVVE 878 (894)
Q Consensus 840 d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~ 878 (894)
.|.+....|++ .+.+|+..|++.-|.+|||..++++
T Consensus 242 sPtLqs~eWS~---~F~~Fvd~CLqKipqeRptse~ll~ 277 (948)
T KOG0577|consen 242 SPTLQSNEWSD---YFRNFVDSCLQKIPQERPTSEELLK 277 (948)
T ss_pred CCCCCCchhHH---HHHHHHHHHHhhCcccCCcHHHHhh
Confidence 23444444444 4567778999999999999999887
|
|
| >cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-33 Score=295.85 Aligned_cols=247 Identities=27% Similarity=0.417 Sum_probs=198.6
Q ss_pred CCCccceEeecCcEEEEEEEEc-CCCeEEEEEEcCcc-----hhhHHHHHHHHHHHHhcCCCceeeecceeeecceEEEE
Q 002673 608 NFSQANIIGCGGFGLVYKATLA-NGTTLAIKKLSGDL-----GLMEREFKAEVEALSTAQHKNLVSLQGYCVHQGFRLLI 681 (894)
Q Consensus 608 ~f~~~~~LG~G~fg~Vy~a~~~-~g~~vAvK~~~~~~-----~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~lV 681 (894)
+|+..+.||+|+||.||+|... ++..|++|.+.... ....+.+.+|+.+++.++|+||+++++++..+...++|
T Consensus 1 ~~~~~~~ig~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv 80 (258)
T cd06632 1 RWRKGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLGTEREEDNLYIF 80 (258)
T ss_pred CccccceeeecCCceEEEEEEcCCCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhcCCCCchheeeeEecCCeEEEE
Confidence 4677889999999999999865 78999999886532 22346788999999999999999999999999999999
Q ss_pred EEeccCCCHHHHHhhhcCCCCCcCHHHHHHHHHHHHHHHHHHHhccCCCeeecCCCCCCeEECCCCcEEEEEcccccccC
Q 002673 682 YSYMENGSLDYWLHEKADGASQLDWLTRLKIARGTSCGLAYMHQICEPHIVHRDIKSSNILLDDQFEAHLADFGLSRLIL 761 (894)
Q Consensus 682 ~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDLkp~NILld~~~~vkl~DFGla~~~~ 761 (894)
+||+++++|.+++... ..+++..+..++.|++.||.|||+ .+++|+||+|+||+++.++.+||+|||++....
T Consensus 81 ~e~~~~~~L~~~~~~~----~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dl~~~ni~~~~~~~~kl~d~~~~~~~~ 153 (258)
T cd06632 81 LELVPGGSLAKLLKKY----GSFPEPVIRLYTRQILLGLEYLHD---RNTVHRDIKGANILVDTNGVVKLADFGMAKQVV 153 (258)
T ss_pred EEecCCCcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEECCCCCEEEccCccceecc
Confidence 9999999999999753 357889999999999999999997 599999999999999999999999999988653
Q ss_pred CCCCcccccccccCCccCcccccCcC-CCccccHHHHHHHHHHHHcCCCCCCCCCcchhhhHHHHHHHHhhcCCCCcccc
Q 002673 762 PYQTHVTTELVGTLGYIPPEYGQAWV-ATLRGDMYSFGVVMLELLTGKRPVDVLKPKMSRELVGWVLKMRSEGKQDQVFD 840 (894)
Q Consensus 762 ~~~~~~~~~~~gt~~Y~APE~~~~~~-~s~ksDVwS~GvlL~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 840 (894)
... ......++..|+|||...... ++.++|+||||+++|+|++|+.||...... ... ...........+ .
T Consensus 154 ~~~--~~~~~~~~~~y~~pe~~~~~~~~~~~~D~~slG~~l~~l~~g~~pf~~~~~~--~~~----~~~~~~~~~~~~-~ 224 (258)
T cd06632 154 EFS--FAKSFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQLEGV--AAV----FKIGRSKELPPI-P 224 (258)
T ss_pred ccc--cccccCCCcceeCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcccCcHH--HHH----HHHHhcccCCCc-C
Confidence 322 233456889999999887766 899999999999999999999999754321 111 111111111111 0
Q ss_pred ccccCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 002673 841 PILRGKGFDEEMLQVLDVACMCVSQNPFKRPTVKEVVE 878 (894)
Q Consensus 841 ~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~ 878 (894)
......+.+++.+|++.+|.+||++.++++
T Consensus 225 --------~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~ 254 (258)
T cd06632 225 --------DHLSDEAKDFILKCLQRDPSLRPTAAELLE 254 (258)
T ss_pred --------CCcCHHHHHHHHHHhhcCcccCcCHHHHhc
Confidence 111235678899999999999999999985
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops |
| >cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-33 Score=310.51 Aligned_cols=260 Identities=26% Similarity=0.389 Sum_probs=203.7
Q ss_pred cCCCccceEeecCcEEEEEEEEc--------CCCeEEEEEEcCcc-hhhHHHHHHHHHHHHhc-CCCceeeecceeeecc
Q 002673 607 DNFSQANIIGCGGFGLVYKATLA--------NGTTLAIKKLSGDL-GLMEREFKAEVEALSTA-QHKNLVSLQGYCVHQG 676 (894)
Q Consensus 607 ~~f~~~~~LG~G~fg~Vy~a~~~--------~g~~vAvK~~~~~~-~~~~~~~~~Ei~~l~~l-~HpnIv~l~g~~~~~~ 676 (894)
.+|++.+.||+|+||.||+|... ++..||+|.+.... ....+.+.+|+.+++++ +||||++++++|..++
T Consensus 12 ~~~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~ 91 (334)
T cd05100 12 TRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDG 91 (334)
T ss_pred hHeeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEcccccCHHHHHHHHHHHHHHHhhcCCCCeeeeeEEEccCC
Confidence 36888999999999999999742 12368999887543 23346789999999999 8999999999999999
Q ss_pred eEEEEEEeccCCCHHHHHhhhcC------------CCCCcCHHHHHHHHHHHHHHHHHHHhccCCCeeecCCCCCCeEEC
Q 002673 677 FRLLIYSYMENGSLDYWLHEKAD------------GASQLDWLTRLKIARGTSCGLAYMHQICEPHIVHRDIKSSNILLD 744 (894)
Q Consensus 677 ~~~lV~E~~~~gsL~~~l~~~~~------------~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDLkp~NILld 744 (894)
..+++|||+++|+|.+++..... ....+++..++.++.|++.||.|||+ ++++||||||+||+++
T Consensus 92 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~---~givH~dlkp~Nill~ 168 (334)
T cd05100 92 PLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLAS---QKCIHRDLAARNVLVT 168 (334)
T ss_pred ceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHH---CCeeccccccceEEEc
Confidence 99999999999999999976421 23458899999999999999999997 5999999999999999
Q ss_pred CCCcEEEEEcccccccCCCCCc-ccccccccCCccCcccccCcCCCccccHHHHHHHHHHHHc-CCCCCCCCCcchhhhH
Q 002673 745 DQFEAHLADFGLSRLILPYQTH-VTTELVGTLGYIPPEYGQAWVATLRGDMYSFGVVMLELLT-GKRPVDVLKPKMSREL 822 (894)
Q Consensus 745 ~~~~vkl~DFGla~~~~~~~~~-~~~~~~gt~~Y~APE~~~~~~~s~ksDVwS~GvlL~ellt-G~~Pf~~~~~~~~~~~ 822 (894)
.++.+||+|||+++........ ......++..|+|||++.+..++.++||||||+++|||++ |..||....... .
T Consensus 169 ~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~---~ 245 (334)
T cd05100 169 EDNVMKIADFGLARDVHNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEE---L 245 (334)
T ss_pred CCCcEEECCcccceecccccccccccCCCcCceEcCHHHhccCCcCchhhhHHHHHHHHHHHhcCCCCCCCCCHHH---H
Confidence 9999999999999865332211 1122234567999999999999999999999999999998 889987543221 1
Q ss_pred HHHHHHHhhcCCCCccccccccCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhccc
Q 002673 823 VGWVLKMRSEGKQDQVFDPILRGKGFDEEMLQVLDVACMCVSQNPFKRPTVKEVVEWLNNVGA 885 (894)
Q Consensus 823 ~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~i~~ 885 (894)
. ..... ...... .......+.+++.+|++.+|.+|||+.++++.|+.+..
T Consensus 246 ~---~~~~~-~~~~~~---------~~~~~~~l~~li~~cl~~~p~~Rps~~ell~~l~~~~~ 295 (334)
T cd05100 246 F---KLLKE-GHRMDK---------PANCTHELYMIMRECWHAVPSQRPTFKQLVEDLDRVLT 295 (334)
T ss_pred H---HHHHc-CCCCCC---------CCCCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHhh
Confidence 1 11111 111111 01112357789999999999999999999999998763
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-33 Score=307.58 Aligned_cols=257 Identities=25% Similarity=0.426 Sum_probs=201.0
Q ss_pred cCCCccceEeecCcEEEEEEEE-cCCC----eEEEEEEcCcch-hhHHHHHHHHHHHHhcCCCceeeecceeeecceEEE
Q 002673 607 DNFSQANIIGCGGFGLVYKATL-ANGT----TLAIKKLSGDLG-LMEREFKAEVEALSTAQHKNLVSLQGYCVHQGFRLL 680 (894)
Q Consensus 607 ~~f~~~~~LG~G~fg~Vy~a~~-~~g~----~vAvK~~~~~~~-~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~l 680 (894)
++|+..+.||+|+||.||+|.+ .+|. .||+|.+..... .....+.+|+.+++.++||||++++++|... ..++
T Consensus 7 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~-~~~~ 85 (303)
T cd05110 7 TELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRLLGVCLSP-TIQL 85 (303)
T ss_pred hhceeccccccCCCccEEEEEEecCCCcceeeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEcCC-Ccee
Confidence 5677889999999999999985 3454 478888875433 2334688999999999999999999998754 4678
Q ss_pred EEEeccCCCHHHHHhhhcCCCCCcCHHHHHHHHHHHHHHHHHHHhccCCCeeecCCCCCCeEECCCCcEEEEEccccccc
Q 002673 681 IYSYMENGSLDYWLHEKADGASQLDWLTRLKIARGTSCGLAYMHQICEPHIVHRDIKSSNILLDDQFEAHLADFGLSRLI 760 (894)
Q Consensus 681 V~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDLkp~NILld~~~~vkl~DFGla~~~ 760 (894)
++||+++|+|.+++.... ..+++..++.++.|++.||.|||+ ++|+||||||+||+++.++.+||+|||+++..
T Consensus 86 v~e~~~~g~l~~~~~~~~---~~~~~~~~~~~~~qi~~~L~~LH~---~~ivH~dikp~Nill~~~~~~kL~Dfg~~~~~ 159 (303)
T cd05110 86 VTQLMPHGCLLDYVHEHK---DNIGSQLLLNWCVQIAKGMMYLEE---RRLVHRDLAARNVLVKSPNHVKITDFGLARLL 159 (303)
T ss_pred eehhcCCCCHHHHHHhcc---cCCCHHHHHHHHHHHHHHHHHHhh---cCeeccccccceeeecCCCceEEccccccccc
Confidence 999999999999987542 357888999999999999999997 59999999999999999999999999999876
Q ss_pred CCCCCc-ccccccccCCccCcccccCcCCCccccHHHHHHHHHHHHc-CCCCCCCCCcchhhhHHHHHHHHhhcCCCCcc
Q 002673 761 LPYQTH-VTTELVGTLGYIPPEYGQAWVATLRGDMYSFGVVMLELLT-GKRPVDVLKPKMSRELVGWVLKMRSEGKQDQV 838 (894)
Q Consensus 761 ~~~~~~-~~~~~~gt~~Y~APE~~~~~~~s~ksDVwS~GvlL~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 838 (894)
...... ......++..|+|||++.+..++.++||||||+++|||++ |+.||...... ....+.. .+....
T Consensus 160 ~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~el~t~g~~p~~~~~~~---~~~~~~~----~~~~~~- 231 (303)
T cd05110 160 EGDEKEYNADGGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYDGIPTR---EIPDLLE----KGERLP- 231 (303)
T ss_pred cCcccccccCCCccccccCCHHHhccCCCChHHHHHHHHHHHHHHHhCCCCCCCCCCHH---HHHHHHH----CCCCCC-
Confidence 432221 1222345678999999999999999999999999999997 99999754322 1222211 111000
Q ss_pred ccccccCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhcccc
Q 002673 839 FDPILRGKGFDEEMLQVLDVACMCVSQNPFKRPTVKEVVEWLNNVGAN 886 (894)
Q Consensus 839 ~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~i~~~ 886 (894)
.+ ......+.+++..||..+|++||++.++++.|+.+...
T Consensus 232 -~~-------~~~~~~~~~li~~c~~~~p~~Rp~~~~l~~~l~~~~~~ 271 (303)
T cd05110 232 -QP-------PICTIDVYMVMVKCWMIDADSRPKFKELAAEFSRMARD 271 (303)
T ss_pred -CC-------CCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhc
Confidence 00 11224677899999999999999999999999887543
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin |
| >PHA03211 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-33 Score=321.37 Aligned_cols=260 Identities=19% Similarity=0.233 Sum_probs=194.9
Q ss_pred ccCCCccceEeecCcEEEEEEEEc-CCCeEEEEEEcCcchhhHHHHHHHHHHHHhcCCCceeeecceeeecceEEEEEEe
Q 002673 606 TDNFSQANIIGCGGFGLVYKATLA-NGTTLAIKKLSGDLGLMEREFKAEVEALSTAQHKNLVSLQGYCVHQGFRLLIYSY 684 (894)
Q Consensus 606 ~~~f~~~~~LG~G~fg~Vy~a~~~-~g~~vAvK~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~lV~E~ 684 (894)
...|.+.+.||+|+||.||+|... +++.||||.... ..+.+|++++++++|+|||++++++..++..++|||+
T Consensus 168 ~~gy~i~~~Lg~G~~G~Vy~a~~~~~~~~vavK~~~~------~~~~~E~~iL~~L~HpnIv~l~~~~~~~~~~~lv~e~ 241 (461)
T PHA03211 168 GLGFAIHRALTPGSEGCVFESSHPDYPQRVVVKAGWY------ASSVHEARLLRRLSHPAVLALLDVRVVGGLTCLVLPK 241 (461)
T ss_pred cCCeEEEEEEccCCCeEEEEEEECCCCCEEEEecccc------cCHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEEc
Confidence 346899999999999999999854 578899996432 2456899999999999999999999999999999999
Q ss_pred ccCCCHHHHHhhhcCCCCCcCHHHHHHHHHHHHHHHHHHHhccCCCeeecCCCCCCeEECCCCcEEEEEcccccccCCCC
Q 002673 685 MENGSLDYWLHEKADGASQLDWLTRLKIARGTSCGLAYMHQICEPHIVHRDIKSSNILLDDQFEAHLADFGLSRLILPYQ 764 (894)
Q Consensus 685 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDLkp~NILld~~~~vkl~DFGla~~~~~~~ 764 (894)
+. ++|..++.... ..++|..++.|+.|++.||.|||+ ++|+||||||+|||++.++.+||+|||+++......
T Consensus 242 ~~-~~L~~~l~~~~---~~l~~~~~~~i~~qi~~aL~yLH~---~gIvHrDLKP~NILl~~~~~vkL~DFGla~~~~~~~ 314 (461)
T PHA03211 242 YR-SDLYTYLGARL---RPLGLAQVTAVARQLLSAIDYIHG---EGIIHRDIKTENVLVNGPEDICLGDFGAACFARGSW 314 (461)
T ss_pred cC-CCHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHH---CCEEECcCCHHHEEECCCCCEEEcccCCceeccccc
Confidence 94 78888886532 368999999999999999999997 599999999999999999999999999998654322
Q ss_pred Cc-ccccccccCCccCcccccCcCCCccccHHHHHHHHHHHHcCCCCCCCCCcch-----hhhHHHHHHHHhhc-CCCCc
Q 002673 765 TH-VTTELVGTLGYIPPEYGQAWVATLRGDMYSFGVVMLELLTGKRPVDVLKPKM-----SRELVGWVLKMRSE-GKQDQ 837 (894)
Q Consensus 765 ~~-~~~~~~gt~~Y~APE~~~~~~~s~ksDVwS~GvlL~elltG~~Pf~~~~~~~-----~~~~~~~~~~~~~~-~~~~~ 837 (894)
.. ......||..|+|||++.+..++.++|||||||++|||++|..|+-...... ...+...+...... .....
T Consensus 315 ~~~~~~~~~GT~~Y~APE~~~~~~~~~~sDvwSlGviL~El~~g~~~lf~~~~~~~~~~~~~~l~~~i~~~~~~~~~~~~ 394 (461)
T PHA03211 315 STPFHYGIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFEAAVHTASLFSASRGDERRPYDAQILRIIRQAQVHVDEFPQ 394 (461)
T ss_pred ccccccccCCCcCCcCHHHHcCCCCCchHHHHHHHHHHHHHHHcCCCcccCCcccccCCcHHHHHHHHHhhccccccCCC
Confidence 11 2234579999999999999999999999999999999999887653222110 11111111111000 00000
Q ss_pred cc----------------cccccCCCCh---HHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 002673 838 VF----------------DPILRGKGFD---EEMLQVLDVACMCVSQNPFKRPTVKEVVE 878 (894)
Q Consensus 838 ~~----------------d~~l~~~~~~---~~~~~l~~li~~Cl~~dP~~RPs~~evl~ 878 (894)
.. .+......+. .....+.+|+.+||+.||.+|||+.|+++
T Consensus 395 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~DP~~RPsa~elL~ 454 (461)
T PHA03211 395 HAGSRLVSQYRHRAARNRRPAYTRPAWTRYYKLDLDVEYLVCRALTFDGARRPSAAELLR 454 (461)
T ss_pred CcchHHHHHHHhhhhcccCCccCCcchhhhccccchHHHHHHHHcccChhhCcCHHHHhh
Confidence 00 0000000011 11225778999999999999999999998
|
|
| >cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-33 Score=312.88 Aligned_cols=237 Identities=24% Similarity=0.301 Sum_probs=185.3
Q ss_pred ceEeecCcEEEEEEEE-cCCCeEEEEEEcCcch---hhHHHHHHHH-HHHHhcCCCceeeecceeeecceEEEEEEeccC
Q 002673 613 NIIGCGGFGLVYKATL-ANGTTLAIKKLSGDLG---LMEREFKAEV-EALSTAQHKNLVSLQGYCVHQGFRLLIYSYMEN 687 (894)
Q Consensus 613 ~~LG~G~fg~Vy~a~~-~~g~~vAvK~~~~~~~---~~~~~~~~Ei-~~l~~l~HpnIv~l~g~~~~~~~~~lV~E~~~~ 687 (894)
++||+|+||.||+|+. .+++.||+|++..... .....+..|. .+++.++||||+++++++.+.+..++||||+++
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~~~~ 80 (321)
T cd05603 1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLHYSFQTAEKLYFVLDYVNG 80 (321)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHHhCCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 4699999999999985 4688999999975422 1223444554 467889999999999999999999999999999
Q ss_pred CCHHHHHhhhcCCCCCcCHHHHHHHHHHHHHHHHHHHhccCCCeeecCCCCCCeEECCCCcEEEEEcccccccCCCCCcc
Q 002673 688 GSLDYWLHEKADGASQLDWLTRLKIARGTSCGLAYMHQICEPHIVHRDIKSSNILLDDQFEAHLADFGLSRLILPYQTHV 767 (894)
Q Consensus 688 gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDLkp~NILld~~~~vkl~DFGla~~~~~~~~~~ 767 (894)
|+|..++... ..++...+..++.||+.||.|||+ ++|+||||||+||+++.++.+||+|||+++...... ..
T Consensus 81 ~~L~~~l~~~----~~~~~~~~~~~~~qi~~~L~~lH~---~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~-~~ 152 (321)
T cd05603 81 GELFFHLQRE----RCFLEPRARFYAAEVASAIGYLHS---LNIIYRDLKPENILLDSQGHVVLTDFGLCKEGVEPE-ET 152 (321)
T ss_pred CCHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHH---CCeEeccCCHHHeEECCCCCEEEccCCCCccCCCCC-Cc
Confidence 9999888643 357788888999999999999997 599999999999999999999999999987532211 22
Q ss_pred cccccccCCccCcccccCcCCCccccHHHHHHHHHHHHcCCCCCCCCCcchhhhHHHHHHHHhhcCCCCccccccccCCC
Q 002673 768 TTELVGTLGYIPPEYGQAWVATLRGDMYSFGVVMLELLTGKRPVDVLKPKMSRELVGWVLKMRSEGKQDQVFDPILRGKG 847 (894)
Q Consensus 768 ~~~~~gt~~Y~APE~~~~~~~s~ksDVwS~GvlL~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~ 847 (894)
.....||+.|+|||++.+..++.++|||||||++|||++|+.||...... .... .... ... .+ .
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~---~~~~---~i~~-~~~-~~-----~--- 216 (321)
T cd05603 153 TSTFCGTPEYLAPEVLRKEPYDRTVDWWCLGAVLYEMLYGLPPFYSRDVS---QMYD---NILH-KPL-QL-----P--- 216 (321)
T ss_pred cccccCCcccCCHHHhcCCCCCCcCcccccchhhhhhhcCCCCCCCCCHH---HHHH---HHhc-CCC-CC-----C---
Confidence 33457899999999999989999999999999999999999999754321 1111 1111 110 00 0
Q ss_pred ChHHHHHHHHHHHHhcccCCCCCCCHH
Q 002673 848 FDEEMLQVLDVACMCVSQNPFKRPTVK 874 (894)
Q Consensus 848 ~~~~~~~l~~li~~Cl~~dP~~RPs~~ 874 (894)
......+.+++.+|++.||.+||+..
T Consensus 217 -~~~~~~~~~li~~~l~~~p~~R~~~~ 242 (321)
T cd05603 217 -GGKTVAACDLLVGLLHKDQRRRLGAK 242 (321)
T ss_pred -CCCCHHHHHHHHHHccCCHhhcCCCC
Confidence 11223567899999999999999753
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. |
| >KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-34 Score=311.24 Aligned_cols=256 Identities=26% Similarity=0.358 Sum_probs=206.8
Q ss_pred cCCCccceEeecCcEEEEEEEEcC---C--CeEEEEEEcCcc-hhhHHHHHHHHHHHHhcCCCceeeecceeeecceEEE
Q 002673 607 DNFSQANIIGCGGFGLVYKATLAN---G--TTLAIKKLSGDL-GLMEREFKAEVEALSTAQHKNLVSLQGYCVHQGFRLL 680 (894)
Q Consensus 607 ~~f~~~~~LG~G~fg~Vy~a~~~~---g--~~vAvK~~~~~~-~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~l 680 (894)
+.....++||+|-||.||+|.+.+ | -.||||.-+.+. ....+.|.+|..+|+.++|||||+++|+|.+. ..|+
T Consensus 389 e~Itl~r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d~t~d~tekflqEa~iMrnfdHphIikLIGv~~e~-P~Wi 467 (974)
T KOG4257|consen 389 ELITLKRLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTDCTPDDTEKFLQEASIMRNFDHPHIIKLIGVCVEQ-PMWI 467 (974)
T ss_pred hhccHHHhhcCCcccceeeeEecccccCcceeeeeehhccCCChhhHHHHHHHHHHHHhCCCcchhheeeeeecc-ceeE
Confidence 345567899999999999998532 3 358899888754 34457799999999999999999999999765 5799
Q ss_pred EEEeccCCCHHHHHhhhcCCCCCcCHHHHHHHHHHHHHHHHHHHhccCCCeeecCCCCCCeEECCCCcEEEEEccccccc
Q 002673 681 IYSYMENGSLDYWLHEKADGASQLDWLTRLKIARGTSCGLAYMHQICEPHIVHRDIKSSNILLDDQFEAHLADFGLSRLI 760 (894)
Q Consensus 681 V~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDLkp~NILld~~~~vkl~DFGla~~~ 760 (894)
|||.++.|-|..|++... ..++......++.||+.||+|||+ ..+|||||..+|||+.+.-.||++|||+++.+
T Consensus 468 vmEL~~~GELr~yLq~nk---~sL~l~tL~ly~~Qi~talaYLeS---krfVHRDIAaRNiLVsSp~CVKLaDFGLSR~~ 541 (974)
T KOG4257|consen 468 VMELAPLGELREYLQQNK---DSLPLRTLTLYCYQICTALAYLES---KRFVHRDIAARNILVSSPQCVKLADFGLSRYL 541 (974)
T ss_pred EEecccchhHHHHHHhcc---ccchHHHHHHHHHHHHHHHHHHHh---hchhhhhhhhhheeecCcceeeecccchhhhc
Confidence 999999999999998754 468888889999999999999998 59999999999999999999999999999998
Q ss_pred CCCCCcccccccccCCccCcccccCcCCCccccHHHHHHHHHHHHc-CCCCCCCCCcchhhhHHHHHHHHhhcCCCCccc
Q 002673 761 LPYQTHVTTELVGTLGYIPPEYGQAWVATLRGDMYSFGVVMLELLT-GKRPVDVLKPKMSRELVGWVLKMRSEGKQDQVF 839 (894)
Q Consensus 761 ~~~~~~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwS~GvlL~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 839 (894)
.....+..+...-...|||||.+....++.+||||.|||.|||+++ |..||.+....+.- .....+. ..
T Consensus 542 ed~~yYkaS~~kLPIKWmaPESINfRrFTtASDVWMFgVCmWEIl~lGvkPfqgvkNsDVI-------~~iEnGe--Rl- 611 (974)
T KOG4257|consen 542 EDDAYYKASRGKLPIKWMAPESINFRRFTTASDVWMFGVCMWEILSLGVKPFQGVKNSDVI-------GHIENGE--RL- 611 (974)
T ss_pred cccchhhccccccceeecCccccchhcccchhhHHHHHHHHHHHHHhcCCccccccccceE-------EEecCCC--CC-
Confidence 7655554444445678999999999999999999999999999988 99999865543210 0011111 11
Q ss_pred cccccCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhccc
Q 002673 840 DPILRGKGFDEEMLQVLDVACMCVSQNPFKRPTVKEVVEWLNNVGA 885 (894)
Q Consensus 840 d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~i~~ 885 (894)
...+.....++.++.+||..+|.+||++.++...|..+..
T Consensus 612 ------P~P~nCPp~LYslmskcWayeP~kRPrftei~~~lsdv~q 651 (974)
T KOG4257|consen 612 ------PCPPNCPPALYSLMSKCWAYEPSKRPRFTEIKAILSDVLQ 651 (974)
T ss_pred ------CCCCCCChHHHHHHHHHhccCcccCCcHHHHHHHHHHHHH
Confidence 1112223456789999999999999999999998776543
|
|
| >cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-32 Score=297.42 Aligned_cols=253 Identities=24% Similarity=0.341 Sum_probs=187.7
Q ss_pred eEeecCcEEEEEEEEcC---CCeEEEEEEcCcc-hhhHHHHHHHHHHHHhcCCCceeeecceeeecceEEEEEEeccCCC
Q 002673 614 IIGCGGFGLVYKATLAN---GTTLAIKKLSGDL-GLMEREFKAEVEALSTAQHKNLVSLQGYCVHQGFRLLIYSYMENGS 689 (894)
Q Consensus 614 ~LG~G~fg~Vy~a~~~~---g~~vAvK~~~~~~-~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~lV~E~~~~gs 689 (894)
.||+|+||.||+|...+ ...+++|.+.... ......+.+|+..++.++|+||+++++++......++||||+++|+
T Consensus 2 ~lg~G~fg~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~nii~~~~~~~~~~~~~lv~e~~~~g~ 81 (269)
T cd05042 2 EIGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCLGQCIESIPYLLVLEFCPLGD 81 (269)
T ss_pred cCCccCCceEEEEEEecCCCCeEEEEeecCccCChHHHHHHHHHHHHHHhCCCCCcceEEEEECCCCceEEEEEeCCCCc
Confidence 58999999999997543 3468888776443 2334568899999999999999999999999999999999999999
Q ss_pred HHHHHhhhcCC-CCCcCHHHHHHHHHHHHHHHHHHHhccCCCeeecCCCCCCeEECCCCcEEEEEcccccccCCCCCc-c
Q 002673 690 LDYWLHEKADG-ASQLDWLTRLKIARGTSCGLAYMHQICEPHIVHRDIKSSNILLDDQFEAHLADFGLSRLILPYQTH-V 767 (894)
Q Consensus 690 L~~~l~~~~~~-~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDLkp~NILld~~~~vkl~DFGla~~~~~~~~~-~ 767 (894)
|.+++...... ....++.....++.||+.||+|||+ ++|+||||||+|||++.++.+||+|||++......... .
T Consensus 82 L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~---~~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~~ 158 (269)
T cd05042 82 LKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQ---ADFIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYIT 158 (269)
T ss_pred HHHHHHhccccccccccHHHHHHHHHHHHHHHHHHHh---cCEecccccHhheEecCCCcEEEeccccccccccchheec
Confidence 99999864322 2335677888999999999999997 59999999999999999999999999998754322111 1
Q ss_pred cccccccCCccCccccc-------CcCCCccccHHHHHHHHHHHHc-CCCCCCCCCcchhhhHHHHHHHHhhcCCCCccc
Q 002673 768 TTELVGTLGYIPPEYGQ-------AWVATLRGDMYSFGVVMLELLT-GKRPVDVLKPKMSRELVGWVLKMRSEGKQDQVF 839 (894)
Q Consensus 768 ~~~~~gt~~Y~APE~~~-------~~~~s~ksDVwS~GvlL~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 839 (894)
.....++..|+|||+.. ...++.++|||||||++|||++ |..||....... ... ...... ...+.
T Consensus 159 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~---~~~---~~~~~~-~~~~~ 231 (269)
T cd05042 159 KDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSDEQ---VLK---QVVREQ-DIKLP 231 (269)
T ss_pred cCCCCCcccccCHHHHhhccccccccccchhhHHHHHHHHHHHHHhCCCCCCCcCCHHH---HHH---HHhhcc-CccCC
Confidence 12234567899999864 3456889999999999999999 888887543221 111 111111 11111
Q ss_pred cccccCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 002673 840 DPILRGKGFDEEMLQVLDVACMCVSQNPFKRPTVKEVVEWLN 881 (894)
Q Consensus 840 d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~ 881 (894)
++... ... ...+.+++..|+ .||++|||+++|++.|.
T Consensus 232 ~~~~~-~~~---~~~~~~~~~~~~-~dp~~Rpt~~~v~~~l~ 268 (269)
T cd05042 232 KPQLD-LKY---SDRWYEVMQFCW-LDPETRPTAEEVHELLT 268 (269)
T ss_pred CCccc-ccC---CHHHHHHHHHHh-cCcccccCHHHHHHHhc
Confidence 22211 112 234456777888 59999999999999874
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina |
| >cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-33 Score=297.08 Aligned_cols=257 Identities=27% Similarity=0.417 Sum_probs=204.2
Q ss_pred cCCCccceEeecCcEEEEEEEE-cCCCeEEEEEEcCcc-hhhHHHHHHHHHHHHhcCCCceeeecceeeecceEEEEEEe
Q 002673 607 DNFSQANIIGCGGFGLVYKATL-ANGTTLAIKKLSGDL-GLMEREFKAEVEALSTAQHKNLVSLQGYCVHQGFRLLIYSY 684 (894)
Q Consensus 607 ~~f~~~~~LG~G~fg~Vy~a~~-~~g~~vAvK~~~~~~-~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~lV~E~ 684 (894)
++|++.+.||.|+||.||+|.. .++..+++|++.... ......+.+|++.++.++|+|++++++.+..++..++|+||
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~ 80 (267)
T cd06610 1 DDYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVKYYTSFVVGDELWLVMPY 80 (267)
T ss_pred CcceeeeeecCCCCeEEEEEEEcCCCcEEEEEEeccCCcchHHHHHHHHHHHHHhcCCCCEEEEEEEEeeCCEEEEEEec
Confidence 4688899999999999999984 478899999987543 23456789999999999999999999999999999999999
Q ss_pred ccCCCHHHHHhhhcCCCCCcCHHHHHHHHHHHHHHHHHHHhccCCCeeecCCCCCCeEECCCCcEEEEEcccccccCCCC
Q 002673 685 MENGSLDYWLHEKADGASQLDWLTRLKIARGTSCGLAYMHQICEPHIVHRDIKSSNILLDDQFEAHLADFGLSRLILPYQ 764 (894)
Q Consensus 685 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDLkp~NILld~~~~vkl~DFGla~~~~~~~ 764 (894)
+++++|.++++.... ...+++.....++.|++.||.|||+ ++++|+||+|+||++++++.++|+|||++.......
T Consensus 81 ~~~~~l~~~~~~~~~-~~~~~~~~~~~~~~ql~~al~~lh~---~~i~h~~l~p~ni~~~~~~~~~l~df~~~~~~~~~~ 156 (267)
T cd06610 81 LSGGSLLDIMKSSYP-RGGLDEAIIATVLKEVLKGLEYLHS---NGQIHRDIKAGNILLGEDGSVKIADFGVSASLADGG 156 (267)
T ss_pred cCCCcHHHHHHHhcc-cCCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHhEEEcCCCCEEEcccchHHHhccCc
Confidence 999999999986432 2468899999999999999999997 599999999999999999999999999998764432
Q ss_pred Cc---ccccccccCCccCcccccCc-CCCccccHHHHHHHHHHHHcCCCCCCCCCcchhhhHHHHHHHHhhcCCCCcccc
Q 002673 765 TH---VTTELVGTLGYIPPEYGQAW-VATLRGDMYSFGVVMLELLTGKRPVDVLKPKMSRELVGWVLKMRSEGKQDQVFD 840 (894)
Q Consensus 765 ~~---~~~~~~gt~~Y~APE~~~~~-~~s~ksDVwS~GvlL~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 840 (894)
.. ......|+..|+|||++... .++.++|||||||++|+|++|+.||....... ...... .... . ...
T Consensus 157 ~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~--~~~~~~----~~~~-~-~~~ 228 (267)
T cd06610 157 DRTRKVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKYPPMK--VLMLTL----QNDP-P-SLE 228 (267)
T ss_pred cccccccccccCChhhcChHHHccccCcCcccchHhHhHHHHHHHhCCCCccccChhh--hHHHHh----cCCC-C-CcC
Confidence 22 22335688999999998776 78999999999999999999999997543321 111111 1110 0 000
Q ss_pred ccccCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 002673 841 PILRGKGFDEEMLQVLDVACMCVSQNPFKRPTVKEVVE 878 (894)
Q Consensus 841 ~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~ 878 (894)
.. .........+.+++..|++.||++||++.++++
T Consensus 229 ~~---~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~ll~ 263 (267)
T cd06610 229 TG---ADYKKYSKSFRKMISLCLQKDPSKRPTAEELLK 263 (267)
T ss_pred Cc---cccccccHHHHHHHHHHcCCChhhCcCHHHHhh
Confidence 00 001122346778999999999999999999986
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 |
| >cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-33 Score=297.81 Aligned_cols=252 Identities=23% Similarity=0.392 Sum_probs=199.3
Q ss_pred CCCccceEeecCcEEEEEEE-EcCCCeEEEEEEcCcc------hhhHHHHHHHHHHHHhcCCCceeeecceeeecceEEE
Q 002673 608 NFSQANIIGCGGFGLVYKAT-LANGTTLAIKKLSGDL------GLMEREFKAEVEALSTAQHKNLVSLQGYCVHQGFRLL 680 (894)
Q Consensus 608 ~f~~~~~LG~G~fg~Vy~a~-~~~g~~vAvK~~~~~~------~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~l 680 (894)
+|+..+.||+|+||.||+|. ..+++.||+|++.... ....+.+.+|+.++++++|+||+++++++.+.+..++
T Consensus 1 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~ 80 (268)
T cd06630 1 EWLKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGATCEDSHFNL 80 (268)
T ss_pred CccccceecCcCceEEEEEEEcCCCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcCCCceehhhceeccCCeEEE
Confidence 47788999999999999998 4678999999987432 1134578899999999999999999999999999999
Q ss_pred EEEeccCCCHHHHHhhhcCCCCCcCHHHHHHHHHHHHHHHHHHHhccCCCeeecCCCCCCeEECCCC-cEEEEEcccccc
Q 002673 681 IYSYMENGSLDYWLHEKADGASQLDWLTRLKIARGTSCGLAYMHQICEPHIVHRDIKSSNILLDDQF-EAHLADFGLSRL 759 (894)
Q Consensus 681 V~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDLkp~NILld~~~-~vkl~DFGla~~ 759 (894)
|+||+++++|.+++... ..+++..+..++.|++.||.|||+ ++++|+||+|+||+++.++ .+||+|||++..
T Consensus 81 v~e~~~~~~L~~~l~~~----~~~~~~~~~~~~~ql~~al~~LH~---~~i~H~~i~~~nil~~~~~~~~~l~dfg~~~~ 153 (268)
T cd06630 81 FVEWMAGGSVSHLLSKY----GAFKEAVIINYTEQLLRGLSYLHE---NQIIHRDVKGANLLIDSTGQRLRIADFGAAAR 153 (268)
T ss_pred EEeccCCCcHHHHHHHh----CCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEEcCCCCEEEEcccccccc
Confidence 99999999999999754 357888999999999999999997 5999999999999998776 599999999987
Q ss_pred cCCCCC---cccccccccCCccCcccccCcCCCccccHHHHHHHHHHHHcCCCCCCCCCcchhhhHHHHHHHHhhcCCCC
Q 002673 760 ILPYQT---HVTTELVGTLGYIPPEYGQAWVATLRGDMYSFGVVMLELLTGKRPVDVLKPKMSRELVGWVLKMRSEGKQD 836 (894)
Q Consensus 760 ~~~~~~---~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwS~GvlL~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~ 836 (894)
...... .......++..|+|||++.+..++.++||||+|+++|+|++|+.||........... ...........
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~---~~~~~~~~~~~ 230 (268)
T cd06630 154 LAAKGTGAGEFQGQLLGTIAFMAPEVLRGEQYGRSCDVWSVGCVIIEMATAKPPWNAEKHSNHLAL---IFKIASATTAP 230 (268)
T ss_pred cccccccCCccccccccccceeCHhHhccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcchHHH---HHHHhccCCCC
Confidence 643211 112234678899999999888899999999999999999999999964332111111 11111111101
Q ss_pred ccccccccCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 002673 837 QVFDPILRGKGFDEEMLQVLDVACMCVSQNPFKRPTVKEVVE 878 (894)
Q Consensus 837 ~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~ 878 (894)
.........+.+++.+|++.+|++||++.++++
T Consensus 231 ---------~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~ll~ 263 (268)
T cd06630 231 ---------SIPEHLSPGLRDVTLRCLELQPEDRPPSRELLK 263 (268)
T ss_pred ---------CCchhhCHHHHHHHHHHcCCCcccCcCHHHHhc
Confidence 011122346778999999999999999999985
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their |
| >cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-32 Score=294.38 Aligned_cols=250 Identities=26% Similarity=0.375 Sum_probs=202.3
Q ss_pred CCCccceEeecCcEEEEEEE-EcCCCeEEEEEEcCcc--hhhHHHHHHHHHHHHhcCCCceeeecceeeecceEEEEEEe
Q 002673 608 NFSQANIIGCGGFGLVYKAT-LANGTTLAIKKLSGDL--GLMEREFKAEVEALSTAQHKNLVSLQGYCVHQGFRLLIYSY 684 (894)
Q Consensus 608 ~f~~~~~LG~G~fg~Vy~a~-~~~g~~vAvK~~~~~~--~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~lV~E~ 684 (894)
+|+..+.||.|+||.||.++ ..++..+++|.+.... ......+.+|+.++++++|+||+++++++.+.+..+++|||
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~~~e~ 80 (256)
T cd08221 1 HYIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYNHFMDDNTLLIEMEY 80 (256)
T ss_pred CceEeeEecccCCceEEEEEEcCCCcEEEEEEEeecccchhHHHHHHHHHHHHHhCCCCCeeEEEeEEecCCeEEEEEEe
Confidence 47888999999999999997 4578999999886532 33446788999999999999999999999999999999999
Q ss_pred ccCCCHHHHHhhhcCCCCCcCHHHHHHHHHHHHHHHHHHHhccCCCeeecCCCCCCeEECCCCcEEEEEcccccccCCCC
Q 002673 685 MENGSLDYWLHEKADGASQLDWLTRLKIARGTSCGLAYMHQICEPHIVHRDIKSSNILLDDQFEAHLADFGLSRLILPYQ 764 (894)
Q Consensus 685 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDLkp~NILld~~~~vkl~DFGla~~~~~~~ 764 (894)
+++|+|.+++.... ...+++..+..++.|++.||.|||+ .+++|+||+|+||+++.++.+||+|||++.......
T Consensus 81 ~~~~~L~~~~~~~~--~~~~~~~~~~~~~~~l~~~l~~lh~---~~i~h~dl~p~ni~~~~~~~~kl~d~~~~~~~~~~~ 155 (256)
T cd08221 81 ANGGTLYDKIVRQK--GQLFEEEMVLWYLFQIVSAVSYIHK---AGILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEY 155 (256)
T ss_pred cCCCcHHHHHHhcc--ccCCCHHHHHHHHHHHHHHHHHHHh---CCccccCCChHhEEEeCCCCEEECcCcceEEccccc
Confidence 99999999998643 2468899999999999999999997 599999999999999999999999999998654332
Q ss_pred CcccccccccCCccCcccccCcCCCccccHHHHHHHHHHHHcCCCCCCCCCcchhhhHHHHHHHHhhcCCCCcccccccc
Q 002673 765 THVTTELVGTLGYIPPEYGQAWVATLRGDMYSFGVVMLELLTGKRPVDVLKPKMSRELVGWVLKMRSEGKQDQVFDPILR 844 (894)
Q Consensus 765 ~~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwS~GvlL~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~ 844 (894)
. ......+++.|+|||+..+..++.++||||||+++|||++|+.||...... .. ..... .+......
T Consensus 156 ~-~~~~~~~~~~y~ape~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~---~~---~~~~~-~~~~~~~~----- 222 (256)
T cd08221 156 S-MAETVVGTPYYMSPELCQGVKYNFKSDIWALGCVLYELLTLKRTFDATNPL---NL---VVKIV-QGNYTPVV----- 222 (256)
T ss_pred c-cccccCCCccccCHhhcCCCCCCCcchhHHHHHHHHHHHHCCCCCCCCCHH---HH---HHHHH-cCCCCCCc-----
Confidence 1 233456899999999998888899999999999999999999999753321 11 11111 11111110
Q ss_pred CCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 002673 845 GKGFDEEMLQVLDVACMCVSQNPFKRPTVKEVVEW 879 (894)
Q Consensus 845 ~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~ 879 (894)
......+.+++.+|++.+|.+||+++++++.
T Consensus 223 ----~~~~~~~~~~i~~~l~~~p~~R~s~~~ll~~ 253 (256)
T cd08221 223 ----SVYSSELISLVHSLLQQDPEKRPTADEVLDQ 253 (256)
T ss_pred ----cccCHHHHHHHHHHcccCcccCCCHHHHhhC
Confidence 1122356788999999999999999999874
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa |
| >cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-32 Score=295.27 Aligned_cols=254 Identities=23% Similarity=0.336 Sum_probs=202.5
Q ss_pred CCCccceEeecCcEEEEEEE-EcCCCeEEEEEEcCcc--hhhHHHHHHHHHHHHhcCCCceeeecceeee--cceEEEEE
Q 002673 608 NFSQANIIGCGGFGLVYKAT-LANGTTLAIKKLSGDL--GLMEREFKAEVEALSTAQHKNLVSLQGYCVH--QGFRLLIY 682 (894)
Q Consensus 608 ~f~~~~~LG~G~fg~Vy~a~-~~~g~~vAvK~~~~~~--~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~--~~~~~lV~ 682 (894)
+|++.+.||.|+||.||++. ..++..||+|.+.... ....+.+..|+.+++.++|+||+++++++.. +...+++|
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~ 80 (265)
T cd08217 1 DYEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYYDRIIDRSNQTLYIVM 80 (265)
T ss_pred CceeeeeeccCCCeEEEEeeecCCCCEEEEEEEecccCCHHHHHHHHHHHHHHHhcCCCccceeeeeeecCCCCEEEEEe
Confidence 47788999999999999998 4578899999986432 3334568899999999999999999998764 44678999
Q ss_pred EeccCCCHHHHHhhhcCCCCCcCHHHHHHHHHHHHHHHHHHHhcc--CCCeeecCCCCCCeEECCCCcEEEEEccccccc
Q 002673 683 SYMENGSLDYWLHEKADGASQLDWLTRLKIARGTSCGLAYMHQIC--EPHIVHRDIKSSNILLDDQFEAHLADFGLSRLI 760 (894)
Q Consensus 683 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~--~~~ivHrDLkp~NILld~~~~vkl~DFGla~~~ 760 (894)
||+++++|.+++.........+++..++.++.|++.||.|||..+ ..+++|+||||+||+++.++.+||+|||++...
T Consensus 81 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~~i~h~dl~p~nili~~~~~~kl~d~g~~~~~ 160 (265)
T cd08217 81 EYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKIL 160 (265)
T ss_pred hhccCCCHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhcCccccCcceecCCCHHHEEEecCCCEEEecccccccc
Confidence 999999999999875444567899999999999999999999332 369999999999999999999999999999876
Q ss_pred CCCCCcccccccccCCccCcccccCcCCCccccHHHHHHHHHHHHcCCCCCCCCCcchhhhHHHHHHHHhhcCCCCcccc
Q 002673 761 LPYQTHVTTELVGTLGYIPPEYGQAWVATLRGDMYSFGVVMLELLTGKRPVDVLKPKMSRELVGWVLKMRSEGKQDQVFD 840 (894)
Q Consensus 761 ~~~~~~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwS~GvlL~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 840 (894)
..... ......++..|+|||++.+..++.++||||||+++|+|++|+.||...... ...... ..+....
T Consensus 161 ~~~~~-~~~~~~~~~~~~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~---~~~~~~----~~~~~~~--- 229 (265)
T cd08217 161 GHDSS-FAKTYVGTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPPFTARNQL---QLASKI----KEGKFRR--- 229 (265)
T ss_pred cCCcc-cccccccCCCccChhhhcCCCCCchhHHHHHHHHHHHHHHCCCcccCcCHH---HHHHHH----hcCCCCC---
Confidence 43322 123356899999999999888999999999999999999999999754321 111111 1111111
Q ss_pred ccccCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 002673 841 PILRGKGFDEEMLQVLDVACMCVSQNPFKRPTVKEVVE 878 (894)
Q Consensus 841 ~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~ 878 (894)
+ .......+.+++.+|++.+|++||++.+|++
T Consensus 230 --~----~~~~~~~~~~l~~~~l~~~p~~Rp~~~~il~ 261 (265)
T cd08217 230 --I----PYRYSSELNEVIKSMLNVDPDKRPSTEELLQ 261 (265)
T ss_pred --C----ccccCHHHHHHHHHHccCCcccCCCHHHHhh
Confidence 1 1122346779999999999999999999986
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi |
| >cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-33 Score=303.42 Aligned_cols=240 Identities=23% Similarity=0.407 Sum_probs=188.9
Q ss_pred ceEeecCcEEEEEEEEcC--------CCeEEEEEEcCcchhhHHHHHHHHHHHHhcCCCceeeecceeeecceEEEEEEe
Q 002673 613 NIIGCGGFGLVYKATLAN--------GTTLAIKKLSGDLGLMEREFKAEVEALSTAQHKNLVSLQGYCVHQGFRLLIYSY 684 (894)
Q Consensus 613 ~~LG~G~fg~Vy~a~~~~--------g~~vAvK~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~lV~E~ 684 (894)
+.||+|+||.||+|.... ...|++|.+........+.+.+|+.+++.++|||++++++++..+...++||||
T Consensus 1 ~~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~ 80 (258)
T cd05078 1 ESLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKHLVLNYGVCVCGDESIMVQEY 80 (258)
T ss_pred CCCCcccchhheeeeecccccccccccchhhHHhhcchhHHHHHHHHHHHHHHHhCCCCChhheeeEEEeCCCcEEEEec
Confidence 368999999999997532 234888888765445556788999999999999999999999998999999999
Q ss_pred ccCCCHHHHHhhhcCCCCCcCHHHHHHHHHHHHHHHHHHHhccCCCeeecCCCCCCeEECCCCc--------EEEEEccc
Q 002673 685 MENGSLDYWLHEKADGASQLDWLTRLKIARGTSCGLAYMHQICEPHIVHRDIKSSNILLDDQFE--------AHLADFGL 756 (894)
Q Consensus 685 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDLkp~NILld~~~~--------vkl~DFGl 756 (894)
+++|+|.++++... ..+++..++.++.||+.||.|||+ ++|+||||||+||+++.++. ++++|||+
T Consensus 81 ~~~g~L~~~l~~~~---~~~~~~~~~~~~~qi~~~l~~lH~---~~iiH~dlkp~nili~~~~~~~~~~~~~~~l~d~g~ 154 (258)
T cd05078 81 VKFGSLDTYLKKNK---NLINISWKLEVAKQLAWALHFLED---KGLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGI 154 (258)
T ss_pred CCCCcHHHHHhcCC---CCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCccceEEEecccccccCCCceEEeccccc
Confidence 99999999998543 357889999999999999999997 59999999999999987765 69999998
Q ss_pred ccccCCCCCcccccccccCCccCcccccCc-CCCccccHHHHHHHHHHHHcCC-CCCCCCCcchhhhHHHHHHHHhhcCC
Q 002673 757 SRLILPYQTHVTTELVGTLGYIPPEYGQAW-VATLRGDMYSFGVVMLELLTGK-RPVDVLKPKMSRELVGWVLKMRSEGK 834 (894)
Q Consensus 757 a~~~~~~~~~~~~~~~gt~~Y~APE~~~~~-~~s~ksDVwS~GvlL~elltG~-~Pf~~~~~~~~~~~~~~~~~~~~~~~ 834 (894)
+..... .....++..|+|||++.+. .++.++||||||+++|||++|. .||.......... ......
T Consensus 155 ~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~~~~~~~~~~~~~~------~~~~~~- 222 (258)
T cd05078 155 SITVLP-----KEILLERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLSALDSQKKLQ------FYEDRH- 222 (258)
T ss_pred ccccCC-----chhccccCCccCchhccCCCCCCchhhHHHHHHHHHHHHcCCCCChhhccHHHHHH------HHHccc-
Confidence 875432 2234578899999998764 5789999999999999999985 6665433211111 011111
Q ss_pred CCccccccccCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 002673 835 QDQVFDPILRGKGFDEEMLQVLDVACMCVSQNPFKRPTVKEVVEWLN 881 (894)
Q Consensus 835 ~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~ 881 (894)
... .....++.+++.+||+.+|++|||++++++.|+
T Consensus 223 --~~~---------~~~~~~~~~li~~~l~~~p~~Rps~~~il~~l~ 258 (258)
T cd05078 223 --QLP---------APKWTELANLINQCMDYEPDFRPSFRAIIRDLN 258 (258)
T ss_pred --cCC---------CCCcHHHHHHHHHHhccChhhCCCHHHHHHhcC
Confidence 110 011235789999999999999999999998763
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity |
| >cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-33 Score=298.21 Aligned_cols=248 Identities=25% Similarity=0.409 Sum_probs=197.2
Q ss_pred CCCccceEeecCcEEEEEEEE-cCCCeEEEEEEcCcchh---------hHHHHHHHHHHHHhcCCCceeeecceeeecce
Q 002673 608 NFSQANIIGCGGFGLVYKATL-ANGTTLAIKKLSGDLGL---------MEREFKAEVEALSTAQHKNLVSLQGYCVHQGF 677 (894)
Q Consensus 608 ~f~~~~~LG~G~fg~Vy~a~~-~~g~~vAvK~~~~~~~~---------~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~ 677 (894)
+|.....||+|+||.||+|.. .++..||+|.+...... ..+.+.+|+.++++++||||+++++++...+.
T Consensus 1 ~~~~~~~ig~g~~~~v~~a~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 80 (267)
T cd06628 1 KWIKGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYLGSSLDADH 80 (267)
T ss_pred CccccceeecCCCeEEEEEEecCCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCc
Confidence 367788999999999999985 46889999988653211 12467889999999999999999999999999
Q ss_pred EEEEEEeccCCCHHHHHhhhcCCCCCcCHHHHHHHHHHHHHHHHHHHhccCCCeeecCCCCCCeEECCCCcEEEEEcccc
Q 002673 678 RLLIYSYMENGSLDYWLHEKADGASQLDWLTRLKIARGTSCGLAYMHQICEPHIVHRDIKSSNILLDDQFEAHLADFGLS 757 (894)
Q Consensus 678 ~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDLkp~NILld~~~~vkl~DFGla 757 (894)
.++||||+++++|.+++... ..+++..+..++.|++.||.|||+ .+++||||+|+||++++++.+||+|||++
T Consensus 81 ~~lv~e~~~~~~L~~~l~~~----~~l~~~~~~~~~~~l~~~l~~lH~---~~ivH~di~p~nil~~~~~~~~l~dfg~~ 153 (267)
T cd06628 81 LNIFLEYVPGGSVAALLNNY----GAFEETLVRNFVRQILKGLNYLHN---RGIIHRDIKGANILVDNKGGIKISDFGIS 153 (267)
T ss_pred cEEEEEecCCCCHHHHHHhc----cCccHHHHHHHHHHHHHHHHHHHh---cCcccccCCHHHEEEcCCCCEEecccCCC
Confidence 99999999999999999754 347888899999999999999997 59999999999999999999999999999
Q ss_pred cccCCCCC-----cccccccccCCccCcccccCcCCCccccHHHHHHHHHHHHcCCCCCCCCCcchhhhHHHHHHHHhhc
Q 002673 758 RLILPYQT-----HVTTELVGTLGYIPPEYGQAWVATLRGDMYSFGVVMLELLTGKRPVDVLKPKMSRELVGWVLKMRSE 832 (894)
Q Consensus 758 ~~~~~~~~-----~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwS~GvlL~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~ 832 (894)
+....... .......|+..|+|||.+.+..++.++||||||+++|+|++|+.||...... ... .....
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~--~~~----~~~~~- 226 (267)
T cd06628 154 KKLEANSLSTKTNGARPSLQGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHPFPDCTQL--QAI----FKIGE- 226 (267)
T ss_pred cccccccccCCccccccccCCCcCccChhHhccCCCCchhhhHHHHHHHHHHhhCCCCCCCccHH--HHH----HHHhc-
Confidence 87642111 1112245788999999999888999999999999999999999999754321 111 11111
Q ss_pred CCCCccccccccCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 002673 833 GKQDQVFDPILRGKGFDEEMLQVLDVACMCVSQNPFKRPTVKEVVE 878 (894)
Q Consensus 833 ~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~ 878 (894)
..... +. ......+.+++.+||+.||.+||++.++++
T Consensus 227 ~~~~~-----~~----~~~~~~~~~li~~~l~~~p~~Rp~~~~il~ 263 (267)
T cd06628 227 NASPE-----IP----SNISSEAIDFLEKTFEIDHNKRPTAAELLK 263 (267)
T ss_pred cCCCc-----CC----cccCHHHHHHHHHHccCCchhCcCHHHHhh
Confidence 10001 11 112235678899999999999999999986
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate |
| >cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-33 Score=301.79 Aligned_cols=262 Identities=23% Similarity=0.281 Sum_probs=198.8
Q ss_pred cCCCccceEeecCcEEEEEEEEc-CCCeEEEEEEcCcc--hhhHHHHHHHHHHHHhcCCCceeeecceeeecceEEEEEE
Q 002673 607 DNFSQANIIGCGGFGLVYKATLA-NGTTLAIKKLSGDL--GLMEREFKAEVEALSTAQHKNLVSLQGYCVHQGFRLLIYS 683 (894)
Q Consensus 607 ~~f~~~~~LG~G~fg~Vy~a~~~-~g~~vAvK~~~~~~--~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~lV~E 683 (894)
++|+..+.||+|+||.||+|... +|+.||+|++.... ....+.+.+|+.++++++|+|++++++++......++|||
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~e 80 (286)
T cd07847 1 EKYEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLIEVFRRKRKLHLVFE 80 (286)
T ss_pred CceeeeeeecccCCeEEEEEEECCCCcEEEEEEEeecccCccccHHHHHHHHHHHhCCCCCEeeeeeEEeeCCEEEEEEe
Confidence 46888899999999999999865 68999999886432 2233567899999999999999999999999999999999
Q ss_pred eccCCCHHHHHhhhcCCCCCcCHHHHHHHHHHHHHHHHHHHhccCCCeeecCCCCCCeEECCCCcEEEEEcccccccCCC
Q 002673 684 YMENGSLDYWLHEKADGASQLDWLTRLKIARGTSCGLAYMHQICEPHIVHRDIKSSNILLDDQFEAHLADFGLSRLILPY 763 (894)
Q Consensus 684 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDLkp~NILld~~~~vkl~DFGla~~~~~~ 763 (894)
|+++++|..++... ..+++..+..++.|++.||.|||+ ++++||||||+||+++.++.+||+|||++......
T Consensus 81 ~~~~~~l~~~~~~~----~~~~~~~~~~~~~ql~~~l~~LH~---~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~ 153 (286)
T cd07847 81 YCDHTVLNELEKNP----RGVPEHLIKKIIWQTLQAVNFCHK---HNCIHRDVKPENILITKQGQIKLCDFGFARILTGP 153 (286)
T ss_pred ccCccHHHHHHhCC----CCCCHHHHHHHHHHHHHHHHHHHH---CCceecCCChhhEEEcCCCcEEECccccceecCCC
Confidence 99998888776532 358999999999999999999997 59999999999999999999999999999876432
Q ss_pred CCcccccccccCCccCcccccC-cCCCccccHHHHHHHHHHHHcCCCCCCCCCcchhhhHHHHHHHHhh----------c
Q 002673 764 QTHVTTELVGTLGYIPPEYGQA-WVATLRGDMYSFGVVMLELLTGKRPVDVLKPKMSRELVGWVLKMRS----------E 832 (894)
Q Consensus 764 ~~~~~~~~~gt~~Y~APE~~~~-~~~s~ksDVwS~GvlL~elltG~~Pf~~~~~~~~~~~~~~~~~~~~----------~ 832 (894)
.. ......++..|+|||++.+ ..++.++||||||+++|+|++|+.||.......... ........ .
T Consensus 154 ~~-~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~i~~~l~~g~~p~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~ 230 (286)
T cd07847 154 GD-DYTDYVATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQPLWPGKSDVDQLY--LIRKTLGDLIPRHQQIFST 230 (286)
T ss_pred cc-cccCcccccccCCHHHHhCCCCcCchhhhHHHHHHHHHHHhCCCCCCCCChHHHHH--HHHHHhCCCChHHhhhccc
Confidence 21 2233457889999998876 467889999999999999999999997554322111 11100000 0
Q ss_pred CC-CCccccccccCC-----CChHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 002673 833 GK-QDQVFDPILRGK-----GFDEEMLQVLDVACMCVSQNPFKRPTVKEVVE 878 (894)
Q Consensus 833 ~~-~~~~~d~~l~~~-----~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~ 878 (894)
.. ......+..... ..+.....+.+++.+|++.+|++||++.+++.
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~ 282 (286)
T cd07847 231 NQFFKGLSIPEPETREPLESKFPNISSPALSFLKGCLQMDPTERLSCEELLE 282 (286)
T ss_pred ccccccccCCCcccccCHHHHhccCCHHHHHHHHHHhcCCccccCCHHHHhc
Confidence 00 000000000000 00112346789999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio |
| >cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-33 Score=301.82 Aligned_cols=260 Identities=25% Similarity=0.397 Sum_probs=201.6
Q ss_pred cCHHHHHHhccCCCccceEeecCcEEEEEEEE-cCCCeEEEEEEcCcchhhHHHHHHHHHHHHhc-CCCceeeecceeee
Q 002673 597 LTIYELLKATDNFSQANIIGCGGFGLVYKATL-ANGTTLAIKKLSGDLGLMEREFKAEVEALSTA-QHKNLVSLQGYCVH 674 (894)
Q Consensus 597 ~~~~el~~a~~~f~~~~~LG~G~fg~Vy~a~~-~~g~~vAvK~~~~~~~~~~~~~~~Ei~~l~~l-~HpnIv~l~g~~~~ 674 (894)
.++.++..+.+.|+..+.||.|+||.||+|.. .+++.+|+|.+.... .....+..|+.+++++ +|+||+++++++..
T Consensus 6 ~~~~~~~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~a~K~~~~~~-~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~ 84 (282)
T cd06636 6 IDLSALRDPAGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTE-DEEEEIKLEINMLKKYSHHRNIATYYGAFIK 84 (282)
T ss_pred hhhhhhcChhhhhhhheeeccCCCeEEEEEEEcCCCcEEEEEEEecCh-HHHHHHHHHHHHHHHhcCCCcEEEEeeehhc
Confidence 34556666778899999999999999999985 568899999986543 2345688899999998 79999999999853
Q ss_pred ------cceEEEEEEeccCCCHHHHHhhhcCCCCCcCHHHHHHHHHHHHHHHHHHHhccCCCeeecCCCCCCeEECCCCc
Q 002673 675 ------QGFRLLIYSYMENGSLDYWLHEKADGASQLDWLTRLKIARGTSCGLAYMHQICEPHIVHRDIKSSNILLDDQFE 748 (894)
Q Consensus 675 ------~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDLkp~NILld~~~~ 748 (894)
....+++|||+++|+|.+++.... ...+++..+..++.|++.||.|||+ ++++|+||||+||++++++.
T Consensus 85 ~~~~~~~~~~~iv~e~~~~~~L~~~~~~~~--~~~~~~~~~~~~~~qi~~al~~LH~---~~ivH~dl~~~nili~~~~~ 159 (282)
T cd06636 85 KSPPGHDDQLWLVMEFCGAGSVTDLVKNTK--GNALKEDWIAYICREILRGLAHLHA---HKVIHRDIKGQNVLLTENAE 159 (282)
T ss_pred ccccCCCCEEEEEEEeCCCCcHHHHHHHcc--CCCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEECCCCC
Confidence 457899999999999999987543 2347788889999999999999997 59999999999999999999
Q ss_pred EEEEEcccccccCCCCCcccccccccCCccCccccc-----CcCCCccccHHHHHHHHHHHHcCCCCCCCCCcchhhhHH
Q 002673 749 AHLADFGLSRLILPYQTHVTTELVGTLGYIPPEYGQ-----AWVATLRGDMYSFGVVMLELLTGKRPVDVLKPKMSRELV 823 (894)
Q Consensus 749 vkl~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~~~-----~~~~s~ksDVwS~GvlL~elltG~~Pf~~~~~~~~~~~~ 823 (894)
++|+|||++....... .......|+..|+|||.+. ...++.++|||||||++|||++|+.||........ ..
T Consensus 160 ~~l~dfg~~~~~~~~~-~~~~~~~~~~~y~aPE~l~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~~--~~ 236 (282)
T cd06636 160 VKLVDFGVSAQLDRTV-GRRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMHPMRA--LF 236 (282)
T ss_pred EEEeeCcchhhhhccc-cCCCcccccccccCHhhcCcccCcCcCCCcccchhHHHHHHHHHHhCCCCccccCHHhh--hh
Confidence 9999999987653221 1223356889999999875 34678899999999999999999999975432111 10
Q ss_pred HHHHHHhhcCCCCccccccccCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 002673 824 GWVLKMRSEGKQDQVFDPILRGKGFDEEMLQVLDVACMCVSQNPFKRPTVKEVVE 878 (894)
Q Consensus 824 ~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~ 878 (894)
...... .+..... .....+.+++.+||+.||.+||++.++++
T Consensus 237 ----~~~~~~------~~~~~~~---~~~~~~~~li~~cl~~~p~~Rp~~~ell~ 278 (282)
T cd06636 237 ----LIPRNP------PPKLKSK---KWSKKFIDFIEGCLVKNYLSRPSTEQLLK 278 (282)
T ss_pred ----hHhhCC------CCCCccc---ccCHHHHHHHHHHhCCChhhCcCHHHHhc
Confidence 000000 0011111 12335778999999999999999999975
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea |
| >cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-32 Score=293.23 Aligned_cols=249 Identities=23% Similarity=0.370 Sum_probs=198.2
Q ss_pred CCCccceEeecCcEEEEEEEE-cCCCeEEEEEEcCcc--hhhHHHHHHHHHHHHhcCCCceeeecceeee-cceEEEEEE
Q 002673 608 NFSQANIIGCGGFGLVYKATL-ANGTTLAIKKLSGDL--GLMEREFKAEVEALSTAQHKNLVSLQGYCVH-QGFRLLIYS 683 (894)
Q Consensus 608 ~f~~~~~LG~G~fg~Vy~a~~-~~g~~vAvK~~~~~~--~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~-~~~~~lV~E 683 (894)
+|++.+.||+|++|.||++.. .+++.||+|++.... ....+.+.+|++++++++|+|++++++.+.. +...++|||
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e 80 (257)
T cd08223 1 AYCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRESWEGEDGLLYIVMG 80 (257)
T ss_pred CceEEEEecCCCCeEEEEEEEcCCCcEEEEEEEehhhcCHHHHHHHHHHHHHHHhCCCCCeeeeeeeecCCCCEEEEEec
Confidence 478889999999999999984 467899999986543 2334568899999999999999999988764 446789999
Q ss_pred eccCCCHHHHHhhhcCCCCCcCHHHHHHHHHHHHHHHHHHHhccCCCeeecCCCCCCeEECCCCcEEEEEcccccccCCC
Q 002673 684 YMENGSLDYWLHEKADGASQLDWLTRLKIARGTSCGLAYMHQICEPHIVHRDIKSSNILLDDQFEAHLADFGLSRLILPY 763 (894)
Q Consensus 684 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDLkp~NILld~~~~vkl~DFGla~~~~~~ 763 (894)
|+++++|.+++.... ...+++.++..++.+++.|+.|||+ ++++||||||+||+++.++.++|+|||++......
T Consensus 81 ~~~~~~l~~~l~~~~--~~~l~~~~~~~~~~~l~~~l~~lH~---~~i~H~di~p~nil~~~~~~~~l~df~~~~~~~~~ 155 (257)
T cd08223 81 FCEGGDLYHKLKEQK--GKLLPENQVVEWFVQIAMALQYLHE---KHILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQ 155 (257)
T ss_pred ccCCCcHHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHh---CCeeccCCCchhEEEecCCcEEEecccceEEeccc
Confidence 999999999998642 2458999999999999999999997 59999999999999999999999999999865322
Q ss_pred CCcccccccccCCccCcccccCcCCCccccHHHHHHHHHHHHcCCCCCCCCCcchhhhHHHHHHHHhhcCCCCccccccc
Q 002673 764 QTHVTTELVGTLGYIPPEYGQAWVATLRGDMYSFGVVMLELLTGKRPVDVLKPKMSRELVGWVLKMRSEGKQDQVFDPIL 843 (894)
Q Consensus 764 ~~~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwS~GvlL~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l 843 (894)
. .......+++.|+|||+..+..++.++||||||+++|+|++|+.||...... . ...... .+.... +
T Consensus 156 ~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~---~---~~~~~~-~~~~~~-----~ 222 (257)
T cd08223 156 C-DMASTLIGTPYYMSPELFSNKPYNYKSDVWALGCCVYEMATLKHAFNAKDMN---S---LVYRII-EGKLPP-----M 222 (257)
T ss_pred C-CccccccCCcCccChhHhcCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCHH---H---HHHHHH-hcCCCC-----C
Confidence 2 2233456889999999999999999999999999999999999999743321 1 111111 111111 0
Q ss_pred cCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 002673 844 RGKGFDEEMLQVLDVACMCVSQNPFKRPTVKEVVE 878 (894)
Q Consensus 844 ~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~ 878 (894)
.......+.+++.+|++.+|++||++.++++
T Consensus 223 ----~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~ 253 (257)
T cd08223 223 ----PKDYSPELGELIATMLSKRPEKRPSVKSILR 253 (257)
T ss_pred ----ccccCHHHHHHHHHHhccCcccCCCHHHHhc
Confidence 1122346778999999999999999999986
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. |
| >cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-33 Score=303.75 Aligned_cols=264 Identities=24% Similarity=0.359 Sum_probs=198.2
Q ss_pred cCCCccceEeecCcEEEEEEEEc-CCCeEEEEEEcCcch--hhHHHHHHHHHHHHhcCCCceeeecceeeecceEEEEEE
Q 002673 607 DNFSQANIIGCGGFGLVYKATLA-NGTTLAIKKLSGDLG--LMEREFKAEVEALSTAQHKNLVSLQGYCVHQGFRLLIYS 683 (894)
Q Consensus 607 ~~f~~~~~LG~G~fg~Vy~a~~~-~g~~vAvK~~~~~~~--~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~lV~E 683 (894)
++|+..+.||+|+||.||+|... +++.||+|++..... ...+.+.+|+++++.++||||+++++++..++..++|||
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 80 (286)
T cd07846 1 EKYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIEVFRRKKRLYLVFE 80 (286)
T ss_pred CceeEeeeeccCCCeEEEEEEECCCCCEEEEEeHhhccCcchhhHHHHHHHHHHHhcCCcchhhHHHhcccCCeEEEEEe
Confidence 36788899999999999999864 589999998865332 234568899999999999999999999999999999999
Q ss_pred eccCCCHHHHHhhhcCCCCCcCHHHHHHHHHHHHHHHHHHHhccCCCeeecCCCCCCeEECCCCcEEEEEcccccccCCC
Q 002673 684 YMENGSLDYWLHEKADGASQLDWLTRLKIARGTSCGLAYMHQICEPHIVHRDIKSSNILLDDQFEAHLADFGLSRLILPY 763 (894)
Q Consensus 684 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDLkp~NILld~~~~vkl~DFGla~~~~~~ 763 (894)
|+++++|..+.... ..+++..++.++.|++.||.|||+ ++++|+||+|+||++++++.++|+|||++......
T Consensus 81 ~~~~~~l~~~~~~~----~~~~~~~~~~~~~~i~~~l~~LH~---~~i~h~~l~p~ni~~~~~~~~~l~dfg~~~~~~~~ 153 (286)
T cd07846 81 FVDHTVLDDLEKYP----NGLDESRVRKYLFQILRGIEFCHS---HNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAP 153 (286)
T ss_pred cCCccHHHHHHhcc----CCCCHHHHHHHHHHHHHHHHHHHH---CCccccCCCHHHEEECCCCcEEEEeeeeeeeccCC
Confidence 99999988876542 348999999999999999999997 59999999999999999999999999999865433
Q ss_pred CCcccccccccCCccCcccccC-cCCCccccHHHHHHHHHHHHcCCCCCCCCCcchh-hhHHHHHHHHhhcC----CCCc
Q 002673 764 QTHVTTELVGTLGYIPPEYGQA-WVATLRGDMYSFGVVMLELLTGKRPVDVLKPKMS-RELVGWVLKMRSEG----KQDQ 837 (894)
Q Consensus 764 ~~~~~~~~~gt~~Y~APE~~~~-~~~s~ksDVwS~GvlL~elltG~~Pf~~~~~~~~-~~~~~~~~~~~~~~----~~~~ 837 (894)
. .......++..|+|||+..+ ..++.++||||||+++|||++|+.||........ ..+..+........ ....
T Consensus 154 ~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (286)
T cd07846 154 G-EVYTDYVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDSDIDQLYHIIKCLGNLIPRHQEIFQKNP 232 (286)
T ss_pred c-cccCcccceeeccCcHHhccccccCchHhHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHHHhCCCchhhHHHhccch
Confidence 2 22233567889999998875 4578899999999999999999999964332111 01111000000000 0000
Q ss_pred ccc----ccccC-----CCChHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 002673 838 VFD----PILRG-----KGFDEEMLQVLDVACMCVSQNPFKRPTVKEVVE 878 (894)
Q Consensus 838 ~~d----~~l~~-----~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~ 878 (894)
+.+ +.... ...+.....+.+++.+||+.+|++||++.++++
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~ 282 (286)
T cd07846 233 LFAGMRLPEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQLLH 282 (286)
T ss_pred HhhccccccccCcchHHHhCCCcCHHHHHHHHHHhcCCcccchhHHHHhc
Confidence 000 00000 001122346789999999999999999999886
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI |
| >cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-32 Score=299.26 Aligned_cols=259 Identities=24% Similarity=0.375 Sum_probs=198.2
Q ss_pred cCCCccceEeecCcEEEEEEEE-cCCCeEEEEEEcCcch-hhHHHHHHHHHH-HHhcCCCceeeecceeeecceEEEEEE
Q 002673 607 DNFSQANIIGCGGFGLVYKATL-ANGTTLAIKKLSGDLG-LMEREFKAEVEA-LSTAQHKNLVSLQGYCVHQGFRLLIYS 683 (894)
Q Consensus 607 ~~f~~~~~LG~G~fg~Vy~a~~-~~g~~vAvK~~~~~~~-~~~~~~~~Ei~~-l~~l~HpnIv~l~g~~~~~~~~~lV~E 683 (894)
++|++.+.||+|+||.||+|.. .+|..||+|++..... .....+..|+.. ++..+||||+++++++..++..++|||
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~iv~~~~~~~~~~~~~lv~e 80 (283)
T cd06617 1 DDLEVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQEQKRLLMDLDISMRSVDCPYTVTFYGALFREGDVWICME 80 (283)
T ss_pred CCceEEEEecccCCeEEEEEEEcCCCcEEEEEEEecCCCcHHHHHHHHHHHHHHHHcCCCCeeeeeEEEecCCcEEEEhh
Confidence 4688889999999999999985 4699999999876432 233455556664 666799999999999999999999999
Q ss_pred eccCCCHHHHHhhhcCCCCCcCHHHHHHHHHHHHHHHHHHHhccCCCeeecCCCCCCeEECCCCcEEEEEcccccccCCC
Q 002673 684 YMENGSLDYWLHEKADGASQLDWLTRLKIARGTSCGLAYMHQICEPHIVHRDIKSSNILLDDQFEAHLADFGLSRLILPY 763 (894)
Q Consensus 684 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDLkp~NILld~~~~vkl~DFGla~~~~~~ 763 (894)
|++ |+|.+++.........+++..++.++.|++.||.|||+. .+++||||||+||+++.++.+||+|||++......
T Consensus 81 ~~~-~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~--~~i~h~dlkp~nil~~~~~~~kl~dfg~~~~~~~~ 157 (283)
T cd06617 81 VMD-TSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHSK--LSVIHRDVKPSNVLINRNGQVKLCDFGISGYLVDS 157 (283)
T ss_pred hhc-ccHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhc--CCeecCCCCHHHEEECCCCCEEEeecccccccccc
Confidence 996 689888876443446789999999999999999999962 38999999999999999999999999998865321
Q ss_pred CCcccccccccCCccCcccccC----cCCCccccHHHHHHHHHHHHcCCCCCCCCCcchhhhHHHHHHHHhhcCCCCccc
Q 002673 764 QTHVTTELVGTLGYIPPEYGQA----WVATLRGDMYSFGVVMLELLTGKRPVDVLKPKMSRELVGWVLKMRSEGKQDQVF 839 (894)
Q Consensus 764 ~~~~~~~~~gt~~Y~APE~~~~----~~~s~ksDVwS~GvlL~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 839 (894)
. ......++..|+|||.+.+ ..++.++|+||||+++|+|++|+.||...... ...+. .... .....
T Consensus 158 ~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~-~~~~~----~~~~-~~~~~-- 227 (283)
T cd06617 158 V--AKTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKTP-FQQLK----QVVE-EPSPQ-- 227 (283)
T ss_pred c--ccccccCCccccChhhcCCcccccccCccccchhhHHHHHHHHhCCCCCCccccC-HHHHH----HHHh-cCCCC--
Confidence 1 1223467889999998765 45688999999999999999999999643221 11111 1111 11111
Q ss_pred cccccCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHH--HHHhcc
Q 002673 840 DPILRGKGFDEEMLQVLDVACMCVSQNPFKRPTVKEVVE--WLNNVG 884 (894)
Q Consensus 840 d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~--~L~~i~ 884 (894)
+..... ...+.+++.+|+..+|.+||++.++++ |++...
T Consensus 228 ---~~~~~~---~~~l~~li~~~l~~~p~~Rp~~~~il~~~~~~~~~ 268 (283)
T cd06617 228 ---LPAEKF---SPEFQDFVNKCLKKNYKERPNYPELLQHPFFELHL 268 (283)
T ss_pred ---CCcccc---CHHHHHHHHHHccCChhhCcCHHHHhcCchhhhcc
Confidence 111111 235778999999999999999999998 666544
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs |
| >cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-33 Score=302.77 Aligned_cols=263 Identities=24% Similarity=0.298 Sum_probs=200.1
Q ss_pred cCCCccceEeecCcEEEEEEEEc-CCCeEEEEEEcCcc--hhhHHHHHHHHHHHHhcCCCceeeecceeeecceEEEEEE
Q 002673 607 DNFSQANIIGCGGFGLVYKATLA-NGTTLAIKKLSGDL--GLMEREFKAEVEALSTAQHKNLVSLQGYCVHQGFRLLIYS 683 (894)
Q Consensus 607 ~~f~~~~~LG~G~fg~Vy~a~~~-~g~~vAvK~~~~~~--~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~lV~E 683 (894)
++|+..+.||+|+||.||+|... +++.||+|++.... ......+.+|++++++++|+||+++++++..++..++|||
T Consensus 1 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e 80 (288)
T cd07833 1 NKYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLKEAFRRKGRLYLVFE 80 (288)
T ss_pred CceeEEEEecccCCeeEEEEEeCCCCcEEEEehhhhhcccccchhHHHHHHHHHHhcCCCCeeehhheEEECCEEEEEEe
Confidence 36888899999999999999854 68899999886532 2234678899999999999999999999999999999999
Q ss_pred eccCCCHHHHHhhhcCCCCCcCHHHHHHHHHHHHHHHHHHHhccCCCeeecCCCCCCeEECCCCcEEEEEcccccccCCC
Q 002673 684 YMENGSLDYWLHEKADGASQLDWLTRLKIARGTSCGLAYMHQICEPHIVHRDIKSSNILLDDQFEAHLADFGLSRLILPY 763 (894)
Q Consensus 684 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDLkp~NILld~~~~vkl~DFGla~~~~~~ 763 (894)
|++++.+..+.... ..+++..+..++.|++.||.|||+ ++++|+||+|+||++++++.+||+|||++......
T Consensus 81 ~~~~~~l~~~~~~~----~~~~~~~~~~~~~~i~~~l~~LH~---~~i~H~dl~~~ni~~~~~~~~kl~d~g~~~~~~~~ 153 (288)
T cd07833 81 YVERTLLELLEASP----GGLPPDAVRSYIWQLLQAIAYCHS---HNIIHRDIKPENILVSESGVLKLCDFGFARALRAR 153 (288)
T ss_pred cCCCCHHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHeEECCCCCEEEEeeecccccCCC
Confidence 99987776655432 347889999999999999999997 59999999999999999999999999999876543
Q ss_pred CCcccccccccCCccCcccccCc-CCCccccHHHHHHHHHHHHcCCCCCCCCCcchhhhHHHHHHHHhh-----------
Q 002673 764 QTHVTTELVGTLGYIPPEYGQAW-VATLRGDMYSFGVVMLELLTGKRPVDVLKPKMSRELVGWVLKMRS----------- 831 (894)
Q Consensus 764 ~~~~~~~~~gt~~Y~APE~~~~~-~~s~ksDVwS~GvlL~elltG~~Pf~~~~~~~~~~~~~~~~~~~~----------- 831 (894)
.........++..|+|||++.+. .++.++||||||+++|+|++|+.||....... .+.........
T Consensus 154 ~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~ 231 (288)
T cd07833 154 PASPLTDYVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEPLFPGDSDID--QLYLIQKCLGPLPPSHQELFSS 231 (288)
T ss_pred ccccccCcccccCCcCCchhcCCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCHHH--HHHHHHHHhCCCCHHHhhhccc
Confidence 33233445678899999999888 88999999999999999999999997543211 11110000000
Q ss_pred cCCCC-----cccccc-ccCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 002673 832 EGKQD-----QVFDPI-LRGKGFDEEMLQVLDVACMCVSQNPFKRPTVKEVVE 878 (894)
Q Consensus 832 ~~~~~-----~~~d~~-l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~ 878 (894)
..... ...++. ...........++.+++.+||..+|++||+++++++
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 284 (288)
T cd07833 232 NPRFAGVAFPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLTCDELLQ 284 (288)
T ss_pred CccccccccCCCCCcHHHHHhcCCccchHHHHHHHHHhccCchhcccHHHHhc
Confidence 00000 000000 000001112456889999999999999999999975
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning |
| >KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-33 Score=298.38 Aligned_cols=265 Identities=27% Similarity=0.352 Sum_probs=201.7
Q ss_pred hccCCCccceEeecCcEEEEEEEEcCCCeEEEEEEcCcchhhHHHHHHHHHHHHh--cCCCceeeecceeeecc----eE
Q 002673 605 ATDNFSQANIIGCGGFGLVYKATLANGTTLAIKKLSGDLGLMEREFKAEVEALST--AQHKNLVSLQGYCVHQG----FR 678 (894)
Q Consensus 605 a~~~f~~~~~LG~G~fg~Vy~a~~~~g~~vAvK~~~~~~~~~~~~~~~Ei~~l~~--l~HpnIv~l~g~~~~~~----~~ 678 (894)
...+....+.||+|.||.||+|.|+ |+.||||++... +++.+.+|.++... ++|+||+.+++.-..+. ..
T Consensus 209 iarqI~L~e~IGkGRyGEVwrG~wr-Ge~VAVKiF~sr---dE~SWfrEtEIYqTvmLRHENILgFIaaD~~~~gs~TQL 284 (513)
T KOG2052|consen 209 IARQIVLQEIIGKGRFGEVWRGRWR-GEDVAVKIFSSR---DERSWFRETEIYQTVMLRHENILGFIAADNKDNGSWTQL 284 (513)
T ss_pred hhheeEEEEEecCccccceeecccc-CCceEEEEeccc---chhhhhhHHHHHHHHHhccchhhhhhhccccCCCceEEE
Confidence 3456778899999999999999995 889999999753 45666777777765 49999999998765443 67
Q ss_pred EEEEEeccCCCHHHHHhhhcCCCCCcCHHHHHHHHHHHHHHHHHHHhc-----cCCCeeecCCCCCCeEECCCCcEEEEE
Q 002673 679 LLIYSYMENGSLDYWLHEKADGASQLDWLTRLKIARGTSCGLAYMHQI-----CEPHIVHRDIKSSNILLDDQFEAHLAD 753 (894)
Q Consensus 679 ~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~-----~~~~ivHrDLkp~NILld~~~~vkl~D 753 (894)
|||++|.+.|||.+||... .++....++++..+|.||+|||.. .++.|.|||||+.|||+..++...|+|
T Consensus 285 wLvTdYHe~GSL~DyL~r~-----tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNILVKkn~~C~IAD 359 (513)
T KOG2052|consen 285 WLVTDYHEHGSLYDYLNRN-----TVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIAD 359 (513)
T ss_pred EEeeecccCCcHHHHHhhc-----cCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccEEEccCCcEEEee
Confidence 9999999999999999864 488889999999999999999964 367899999999999999999999999
Q ss_pred cccccccCCCCCc---ccccccccCCccCcccccCcCC------CccccHHHHHHHHHHHHc----------CCCCCCCC
Q 002673 754 FGLSRLILPYQTH---VTTELVGTLGYIPPEYGQAWVA------TLRGDMYSFGVVMLELLT----------GKRPVDVL 814 (894)
Q Consensus 754 FGla~~~~~~~~~---~~~~~~gt~~Y~APE~~~~~~~------s~ksDVwS~GvlL~ellt----------G~~Pf~~~ 814 (894)
+|+|......... .....+||.+|||||++..... -..+||||||.|+||+.- -+.||.+.
T Consensus 360 LGLAv~h~~~t~~idi~~N~rVGTKRYMAPEvLdetin~~~Fesyk~ADIYafgLVlWEiarRc~~ggi~eey~~Pyyd~ 439 (513)
T KOG2052|consen 360 LGLAVRHDSDTDTIDIPPNPRVGTKRYMAPEVLDETINMKHFESYKRADIYAFGLVLWEIARRCESGGIVEEYQLPYYDV 439 (513)
T ss_pred ceeeEEecccCCcccCCCCCccceeeccChHHhhhhcChhhhhhhhHHHHHHHHHHHHHHHHHhhcCCEehhhcCCcccC
Confidence 9999877544322 2345789999999998765421 245899999999999975 23677544
Q ss_pred Ccch-hhhHHHHHHHHhhcCCCCccccccc-cCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhccc
Q 002673 815 KPKM-SRELVGWVLKMRSEGKQDQVFDPIL-RGKGFDEEMLQVLDVACMCVSQNPFKRPTVKEVVEWLNNVGA 885 (894)
Q Consensus 815 ~~~~-~~~~~~~~~~~~~~~~~~~~~d~~l-~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~i~~ 885 (894)
-+.+ ..+.+ ++..-. +. +.|.+ ......+.+..+.++++.||..||.-|.|+=.|-+.|.++..
T Consensus 440 Vp~DPs~eeM---rkVVCv---~~-~RP~ipnrW~s~~~l~~m~klMkeCW~~Np~aRltALriKKtl~~l~~ 505 (513)
T KOG2052|consen 440 VPSDPSFEEM---RKVVCV---QK-LRPNIPNRWKSDPALRVMAKLMKECWYANPAARLTALRIKKTLAKLSN 505 (513)
T ss_pred CCCCCCHHHH---hcceee---cc-cCCCCCcccccCHHHHHHHHHHHHhhcCCchhhhHHHHHHHHHHHHhc
Confidence 3321 11111 111111 11 11111 122334567788899999999999999999999888887763
|
|
| >cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-33 Score=297.34 Aligned_cols=247 Identities=25% Similarity=0.426 Sum_probs=197.2
Q ss_pred cCCCccceEeecCcEEEEEEEEcCCCeEEEEEEcCcchhhHHHHHHHHHHHHhcCCCceeeecceeeecceEEEEEEecc
Q 002673 607 DNFSQANIIGCGGFGLVYKATLANGTTLAIKKLSGDLGLMEREFKAEVEALSTAQHKNLVSLQGYCVHQGFRLLIYSYME 686 (894)
Q Consensus 607 ~~f~~~~~LG~G~fg~Vy~a~~~~g~~vAvK~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~lV~E~~~ 686 (894)
++|++.+.||+|+||.||++.. ++..||+|.+.... ....+.+|+.++++++|||++++++++..+ ..++||||++
T Consensus 6 ~~~~~~~~lg~g~~g~v~~~~~-~~~~~~iK~~~~~~--~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-~~~~v~e~~~ 81 (254)
T cd05083 6 QKLTLGEIIGEGEFGAVLQGEY-TGQKVAVKNIKCDV--TAQAFLEETAVMTKLHHKNLVRLLGVILHN-GLYIVMELMS 81 (254)
T ss_pred HHceeeeeeccCCCCceEeccc-CCCceEEEeecCcc--hHHHHHHHHHHHHhCCCCCcCeEEEEEcCC-CcEEEEECCC
Confidence 4578889999999999999975 67889999987543 345788999999999999999999998754 4799999999
Q ss_pred CCCHHHHHhhhcCCCCCcCHHHHHHHHHHHHHHHHHHHhccCCCeeecCCCCCCeEECCCCcEEEEEcccccccCCCCCc
Q 002673 687 NGSLDYWLHEKADGASQLDWLTRLKIARGTSCGLAYMHQICEPHIVHRDIKSSNILLDDQFEAHLADFGLSRLILPYQTH 766 (894)
Q Consensus 687 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDLkp~NILld~~~~vkl~DFGla~~~~~~~~~ 766 (894)
+|+|.+++.... ...+++..++.++.|++.||.|||+ ++++||||||+||+++.++.+||+|||++......
T Consensus 82 ~~~L~~~l~~~~--~~~~~~~~~~~~~~qi~~al~~lH~---~~~~H~dl~p~nili~~~~~~kl~Dfg~~~~~~~~--- 153 (254)
T cd05083 82 KGNLVNFLRTRG--RALVSVIQLLQFSLDVAEGMEYLES---KKLVHRDLAARNILVSEDGVAKVSDFGLARVGSMG--- 153 (254)
T ss_pred CCCHHHHHHhcC--cCCCCHHHHHHHHHHHHHHHHHHHh---CCeeccccCcceEEEcCCCcEEECCCccceecccc---
Confidence 999999997642 3457889999999999999999997 69999999999999999999999999998754221
Q ss_pred ccccccccCCccCcccccCcCCCccccHHHHHHHHHHHHc-CCCCCCCCCcchhhhHHHHHHHHhhcCCCCccccccccC
Q 002673 767 VTTELVGTLGYIPPEYGQAWVATLRGDMYSFGVVMLELLT-GKRPVDVLKPKMSRELVGWVLKMRSEGKQDQVFDPILRG 845 (894)
Q Consensus 767 ~~~~~~gt~~Y~APE~~~~~~~s~ksDVwS~GvlL~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~ 845 (894)
......+..|+|||++.+..++.++||||||+++|||++ |+.||....... ... .... +... ++
T Consensus 154 -~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~---~~~---~~~~-~~~~---~~---- 218 (254)
T cd05083 154 -VDNSKLPVKWTAPEALKHKKFSSKSDVWSYGVLLWEVFSYGRAPYPKMSLKE---VKE---CVEK-GYRM---EP---- 218 (254)
T ss_pred -CCCCCCCceecCHHHhccCCcCchhhHHHHHHHHHHHHhCCCCCCccCCHHH---HHH---HHhC-CCCC---CC----
Confidence 112234568999999988899999999999999999998 999997544321 111 1111 1100 00
Q ss_pred CCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHh
Q 002673 846 KGFDEEMLQVLDVACMCVSQNPFKRPTVKEVVEWLNN 882 (894)
Q Consensus 846 ~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~ 882 (894)
.......+.+++.+|++.+|++||+++++++.|+.
T Consensus 219 --~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~ 253 (254)
T cd05083 219 --PEGCPADVYVLMTSCWETEPKKRPSFHKLREKLEK 253 (254)
T ss_pred --CCcCCHHHHHHHHHHcCCChhhCcCHHHHHHHHcc
Confidence 01122356789999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki |
| >cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-33 Score=300.59 Aligned_cols=261 Identities=26% Similarity=0.324 Sum_probs=200.8
Q ss_pred CCCccceEeecCcEEEEEEEE-cCCCeEEEEEEcCcc--hhhHHHHHHHHHHHHhcCCCceeeecceeeecceEEEEEEe
Q 002673 608 NFSQANIIGCGGFGLVYKATL-ANGTTLAIKKLSGDL--GLMEREFKAEVEALSTAQHKNLVSLQGYCVHQGFRLLIYSY 684 (894)
Q Consensus 608 ~f~~~~~LG~G~fg~Vy~a~~-~~g~~vAvK~~~~~~--~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~lV~E~ 684 (894)
+|++.+.||+|+||.||+|.. .+|+.||+|++.... ......+.+|+.++++++||||+++++++..+...++||||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~ 80 (286)
T cd07832 1 RYKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDVFPHGSGFVLVMEY 80 (286)
T ss_pred CceEEeecccCCCcEEEEEEECCCCceEEEEEEEcccccchhhHHHHHHHHHHHhCCCCCCcceeeEEecCCeeEEEecc
Confidence 477889999999999999985 478999999987643 23346789999999999999999999999999999999999
Q ss_pred ccCCCHHHHHhhhcCCCCCcCHHHHHHHHHHHHHHHHHHHhccCCCeeecCCCCCCeEECCCCcEEEEEcccccccCCCC
Q 002673 685 MENGSLDYWLHEKADGASQLDWLTRLKIARGTSCGLAYMHQICEPHIVHRDIKSSNILLDDQFEAHLADFGLSRLILPYQ 764 (894)
Q Consensus 685 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDLkp~NILld~~~~vkl~DFGla~~~~~~~ 764 (894)
+ +++|.+++.... ..+++..+..++.||+.||.|||+ .+++|+||||+||+++.++.++|+|||++.......
T Consensus 81 ~-~~~L~~~~~~~~---~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dl~p~ni~~~~~~~~~l~dfg~~~~~~~~~ 153 (286)
T cd07832 81 M-PSDLSEVLRDEE---RPLPEAQVKSYMRMLLKGVAYMHA---NGIMHRDLKPANLLISADGVLKIADFGLARLFSEEE 153 (286)
T ss_pred c-CCCHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCcCHHHEEEcCCCcEEEeeeeecccccCCC
Confidence 9 999999987543 458999999999999999999997 599999999999999999999999999998764433
Q ss_pred CcccccccccCCccCcccccCc-CCCccccHHHHHHHHHHHHcCCCCCCCCCcchhhhHHHHHHHHhhcC----------
Q 002673 765 THVTTELVGTLGYIPPEYGQAW-VATLRGDMYSFGVVMLELLTGKRPVDVLKPKMSRELVGWVLKMRSEG---------- 833 (894)
Q Consensus 765 ~~~~~~~~gt~~Y~APE~~~~~-~~s~ksDVwS~GvlL~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~---------- 833 (894)
........++..|+|||++.+. .++.++||||+|+++|||++|.+||...... ....+........
T Consensus 154 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~ 230 (286)
T cd07832 154 PRLYSHQVATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGSPLFPGENDI---EQLAIVFRTLGTPNEETWPGLTS 230 (286)
T ss_pred CCccccccCcccccCceeeeccccCCchhHHHHHHHHHHHHHcCCcCcCCCCHH---HHHHHHHHHcCCCChHHHhhccC
Confidence 2223345688999999987654 4689999999999999999998888643321 1111111110000
Q ss_pred --CCCcccccccc----CCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 002673 834 --KQDQVFDPILR----GKGFDEEMLQVLDVACMCVSQNPFKRPTVKEVVE 878 (894)
Q Consensus 834 --~~~~~~d~~l~----~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~ 878 (894)
....+..+... ....++....+.+++.+|++.+|++|||++++++
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~l~ 281 (286)
T cd07832 231 LPDYNKITFPESKPIPLEEIFPDASPEALDLLKGLLVYDPSKRLSAAEALR 281 (286)
T ss_pred cchhhcccCCCCCcchHHHhCCCccHHHHHHHHHHhccChhhCCCHHHHhh
Confidence 00000000000 0001122357789999999999999999999986
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea |
| >cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-32 Score=294.82 Aligned_cols=249 Identities=26% Similarity=0.370 Sum_probs=192.9
Q ss_pred cCCCccceEeecCcEEEEEEEE-cCCCeEEEEEEcCcc-----hhhHHHHHHHHHHHHhcCCCceeeecceeee--cceE
Q 002673 607 DNFSQANIIGCGGFGLVYKATL-ANGTTLAIKKLSGDL-----GLMEREFKAEVEALSTAQHKNLVSLQGYCVH--QGFR 678 (894)
Q Consensus 607 ~~f~~~~~LG~G~fg~Vy~a~~-~~g~~vAvK~~~~~~-----~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~--~~~~ 678 (894)
.+|+..+.||+|+||.||+|.. .++..|++|++.... ......+.+|+.+++.++||||+++++++.. +...
T Consensus 2 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (266)
T cd06651 2 INWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQYYGCLRDRAEKTL 81 (266)
T ss_pred CCccccceecCCCCEEEEEEEEcCCCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcCCCCeeeEEEEEEcCCCCEE
Confidence 4688899999999999999985 568999999886432 1223468889999999999999999998865 3567
Q ss_pred EEEEEeccCCCHHHHHhhhcCCCCCcCHHHHHHHHHHHHHHHHHHHhccCCCeeecCCCCCCeEECCCCcEEEEEccccc
Q 002673 679 LLIYSYMENGSLDYWLHEKADGASQLDWLTRLKIARGTSCGLAYMHQICEPHIVHRDIKSSNILLDDQFEAHLADFGLSR 758 (894)
Q Consensus 679 ~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDLkp~NILld~~~~vkl~DFGla~ 758 (894)
++++||+++++|.+++... ..+++...+.++.|++.||.|||+ .+++||||||+||+++.++.+||+|||++.
T Consensus 82 ~l~~e~~~~~~L~~~l~~~----~~l~~~~~~~~~~qi~~~l~~LH~---~~i~H~~l~p~nil~~~~~~~~l~dfg~~~ 154 (266)
T cd06651 82 TIFMEYMPGGSVKDQLKAY----GALTESVTRKYTRQILEGMSYLHS---NMIVHRDIKGANILRDSAGNVKLGDFGASK 154 (266)
T ss_pred EEEEeCCCCCcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHh---CCeeeCCCCHHHEEECCCCCEEEccCCCcc
Confidence 8999999999999999753 247888899999999999999996 599999999999999999999999999987
Q ss_pred ccCCCCC--cccccccccCCccCcccccCcCCCccccHHHHHHHHHHHHcCCCCCCCCCcchhhhHHHHHHHHhhcCCCC
Q 002673 759 LILPYQT--HVTTELVGTLGYIPPEYGQAWVATLRGDMYSFGVVMLELLTGKRPVDVLKPKMSRELVGWVLKMRSEGKQD 836 (894)
Q Consensus 759 ~~~~~~~--~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwS~GvlL~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~ 836 (894)
....... .......++..|+|||++.+..++.++|||||||++|||++|+.||...... ...........
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~el~~g~~pf~~~~~~------~~~~~~~~~~~-- 226 (266)
T cd06651 155 RLQTICMSGTGIRSVTGTPYWMSPEVISGEGYGRKADVWSLGCTVVEMLTEKPPWAEYEAM------AAIFKIATQPT-- 226 (266)
T ss_pred ccccccccCCccccCCccccccCHHHhCCCCCCchhhhHHHHHHHHHHHHCCCCccccchH------HHHHHHhcCCC--
Confidence 6532111 1112345788999999999988999999999999999999999999754321 11111111111
Q ss_pred ccccccccCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 002673 837 QVFDPILRGKGFDEEMLQVLDVACMCVSQNPFKRPTVKEVVE 878 (894)
Q Consensus 837 ~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~ 878 (894)
.+.+. ......+.+++ .||..+|++||+++++++
T Consensus 227 ---~~~~~----~~~~~~~~~li-~~~~~~p~~Rp~~~eil~ 260 (266)
T cd06651 227 ---NPQLP----SHISEHARDFL-GCIFVEARHRPSAEELLR 260 (266)
T ss_pred ---CCCCc----hhcCHHHHHHH-HHhcCChhhCcCHHHHhc
Confidence 11111 11122344555 688899999999999986
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development |
| >cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-32 Score=301.35 Aligned_cols=255 Identities=25% Similarity=0.365 Sum_probs=204.6
Q ss_pred cCCCccceEeecCcEEEEEEEE-cCCCeEEEEEEcCcchhhHHHHHHHHHHHHhcCCCceeeecceeeecceEEEEEEec
Q 002673 607 DNFSQANIIGCGGFGLVYKATL-ANGTTLAIKKLSGDLGLMEREFKAEVEALSTAQHKNLVSLQGYCVHQGFRLLIYSYM 685 (894)
Q Consensus 607 ~~f~~~~~LG~G~fg~Vy~a~~-~~g~~vAvK~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~lV~E~~ 685 (894)
++|...+.||+|+||.||++.. .++..||+|.+........+.+.+|+.+++.++|||++++++++...+..++|+||+
T Consensus 19 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~ 98 (293)
T cd06647 19 KKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELIINEILVMRENKHPNIVNYLDSYLVGDELWVVMEYL 98 (293)
T ss_pred hhceeeeEecCCCCeEEEEEEEcCCCCEEEEEEeccccchHHHHHHHHHHHHhhcCCCCeeehhheeeeCCcEEEEEecC
Confidence 5788889999999999999984 578899999987554445567889999999999999999999999999999999999
Q ss_pred cCCCHHHHHhhhcCCCCCcCHHHHHHHHHHHHHHHHHHHhccCCCeeecCCCCCCeEECCCCcEEEEEcccccccCCCCC
Q 002673 686 ENGSLDYWLHEKADGASQLDWLTRLKIARGTSCGLAYMHQICEPHIVHRDIKSSNILLDDQFEAHLADFGLSRLILPYQT 765 (894)
Q Consensus 686 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDLkp~NILld~~~~vkl~DFGla~~~~~~~~ 765 (894)
++++|.+++... .+++..+..++.|++.||.|||+ ++++|+||||+||+++.++.+||+|||++........
T Consensus 99 ~~~~L~~~~~~~-----~l~~~~~~~i~~~l~~al~~LH~---~gi~H~dL~p~Nili~~~~~~kL~dfg~~~~~~~~~~ 170 (293)
T cd06647 99 AGGSLTDVVTET-----CMDEGQIAAVCRECLQALEFLHS---NQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS 170 (293)
T ss_pred CCCcHHHHHhhc-----CCCHHHHHHHHHHHHHHHHHHHh---CCEeeccCCHHHEEEcCCCCEEEccCcceeccccccc
Confidence 999999998753 47888999999999999999997 5999999999999999999999999999876543222
Q ss_pred cccccccccCCccCcccccCcCCCccccHHHHHHHHHHHHcCCCCCCCCCcchhhhHHHHHHHHhhcCCCCccccccccC
Q 002673 766 HVTTELVGTLGYIPPEYGQAWVATLRGDMYSFGVVMLELLTGKRPVDVLKPKMSRELVGWVLKMRSEGKQDQVFDPILRG 845 (894)
Q Consensus 766 ~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwS~GvlL~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~ 845 (894)
......+++.|+|||++.+..++.++||||||+++|+|++|+.||........ . ......+.. . .
T Consensus 171 -~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~ll~~ll~g~~pf~~~~~~~~---~---~~~~~~~~~-~-----~-- 235 (293)
T cd06647 171 -KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRA---L---YLIATNGTP-E-----L-- 235 (293)
T ss_pred -ccccccCChhhcCchhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhhh---e---eehhcCCCC-C-----C--
Confidence 22334688899999999888899999999999999999999999975432111 0 000001100 0 0
Q ss_pred CCChHHHHHHHHHHHHhcccCCCCCCCHHHHHH--HHHhcc
Q 002673 846 KGFDEEMLQVLDVACMCVSQNPFKRPTVKEVVE--WLNNVG 884 (894)
Q Consensus 846 ~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~--~L~~i~ 884 (894)
.........+.+++.+||+.+|++||++.+++. +++..+
T Consensus 236 ~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~h~~~~~~~ 276 (293)
T cd06647 236 QNPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQHPFLKIAK 276 (293)
T ss_pred CCccccCHHHHHHHHHHccCChhhCcCHHHHhcCHHHhcCc
Confidence 001112235778999999999999999999998 666554
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi |
| >cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-32 Score=293.35 Aligned_cols=249 Identities=25% Similarity=0.360 Sum_probs=200.2
Q ss_pred CCCccceEeecCcEEEEEEEE-cCCCeEEEEEEcCcc--hhhHHHHHHHHHHHHhcCCCceeeecceeeecceEEEEEEe
Q 002673 608 NFSQANIIGCGGFGLVYKATL-ANGTTLAIKKLSGDL--GLMEREFKAEVEALSTAQHKNLVSLQGYCVHQGFRLLIYSY 684 (894)
Q Consensus 608 ~f~~~~~LG~G~fg~Vy~a~~-~~g~~vAvK~~~~~~--~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~lV~E~ 684 (894)
+|+..+.||+|+||.||++.. .+|+.||+|.+.... .....++.+|+.++++++||||+++++++...+..++||||
T Consensus 1 ~y~~~~~lg~g~~g~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd08218 1 KYVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQESFEENGNLYIVMDY 80 (256)
T ss_pred CceEEEEeccCCceEEEEEEEcCCCCEEEEEEEEhHhCChHHHHHHHHHHHHHHhCCCCCeeeeEeeecCCCeEEEEEec
Confidence 478889999999999999984 578999999986432 23345789999999999999999999999999999999999
Q ss_pred ccCCCHHHHHhhhcCCCCCcCHHHHHHHHHHHHHHHHHHHhccCCCeeecCCCCCCeEECCCCcEEEEEcccccccCCCC
Q 002673 685 MENGSLDYWLHEKADGASQLDWLTRLKIARGTSCGLAYMHQICEPHIVHRDIKSSNILLDDQFEAHLADFGLSRLILPYQ 764 (894)
Q Consensus 685 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDLkp~NILld~~~~vkl~DFGla~~~~~~~ 764 (894)
+++++|.+++.... ...+++..++.++.|++.||.|||+ ++++|+||+|+||+++.++.++|+|||++.......
T Consensus 81 ~~~~~l~~~~~~~~--~~~~~~~~~~~~~~~l~~~l~~lh~---~~i~h~~l~~~nil~~~~~~~~l~d~~~~~~~~~~~ 155 (256)
T cd08218 81 CEGGDLYKKINAQR--GVLFPEDQILDWFVQICLALKHVHD---RKILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTV 155 (256)
T ss_pred CCCCcHHHHHHhcc--CCCCCHHHHHHHHHHHHHHHHHHHh---CCEecCCCCHHHEEEcCCCCEEEeeccceeecCcch
Confidence 99999999987532 2357888999999999999999997 599999999999999999999999999997653321
Q ss_pred CcccccccccCCccCcccccCcCCCccccHHHHHHHHHHHHcCCCCCCCCCcchhhhHHHHHHHHhhcCCCCcccccccc
Q 002673 765 THVTTELVGTLGYIPPEYGQAWVATLRGDMYSFGVVMLELLTGKRPVDVLKPKMSRELVGWVLKMRSEGKQDQVFDPILR 844 (894)
Q Consensus 765 ~~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwS~GvlL~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~ 844 (894)
.......|+..|+|||+..+..++.++|||||||++++|++|+.||...... + ....... +.....
T Consensus 156 -~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~---~---~~~~~~~-~~~~~~------ 221 (256)
T cd08218 156 -ELARTCIGTPYYLSPEICENRPYNNKSDIWALGCVLYEMCTLKHAFEAGNMK---N---LVLKIIR-GSYPPV------ 221 (256)
T ss_pred -hhhhhccCCccccCHHHhCCCCCCCccchhHHHHHHHHHHcCCCCccCCCHH---H---HHHHHhc-CCCCCC------
Confidence 1223346888999999999888999999999999999999999999743221 1 1111111 111110
Q ss_pred CCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 002673 845 GKGFDEEMLQVLDVACMCVSQNPFKRPTVKEVVE 878 (894)
Q Consensus 845 ~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~ 878 (894)
.......+.+++.+|++.+|++||++.++++
T Consensus 222 ---~~~~~~~~~~li~~~l~~~p~~Rp~~~~vl~ 252 (256)
T cd08218 222 ---SSHYSYDLRNLVSQLFKRNPRDRPSVNSILE 252 (256)
T ss_pred ---cccCCHHHHHHHHHHhhCChhhCcCHHHHhh
Confidence 0112335778999999999999999999986
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti |
| >cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-33 Score=305.64 Aligned_cols=258 Identities=24% Similarity=0.300 Sum_probs=204.7
Q ss_pred cCCCccceEeecCcEEEEEEEEc-CCCeEEEEEEcCcchh---hHHHHHHHHHHHHhcCCCceeeecceeeecceEEEEE
Q 002673 607 DNFSQANIIGCGGFGLVYKATLA-NGTTLAIKKLSGDLGL---MEREFKAEVEALSTAQHKNLVSLQGYCVHQGFRLLIY 682 (894)
Q Consensus 607 ~~f~~~~~LG~G~fg~Vy~a~~~-~g~~vAvK~~~~~~~~---~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~lV~ 682 (894)
++|+..+.||+|+||.||+|... ++..||+|.+...... ..+.+..|+++++.++|+||+++++++..+...++||
T Consensus 1 ~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 80 (316)
T cd05574 1 KHFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLYASFQTETYLCLVM 80 (316)
T ss_pred CceEEeeeecCCccEEEEEEEEcCCCcEEEEEEEeccccchHHHHHHHHHHHHHHHhCCCCCchhheeeeecCCEEEEEE
Confidence 36888899999999999999854 5899999999764322 3456889999999999999999999999999999999
Q ss_pred EeccCCCHHHHHhhhcCCCCCcCHHHHHHHHHHHHHHHHHHHhccCCCeeecCCCCCCeEECCCCcEEEEEcccccccCC
Q 002673 683 SYMENGSLDYWLHEKADGASQLDWLTRLKIARGTSCGLAYMHQICEPHIVHRDIKSSNILLDDQFEAHLADFGLSRLILP 762 (894)
Q Consensus 683 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDLkp~NILld~~~~vkl~DFGla~~~~~ 762 (894)
||+.+++|.+++.... ...+++..+..++.|++.||.|||+ .+++|+||||+||+++.++.++|+|||++.....
T Consensus 81 e~~~~~~L~~~~~~~~--~~~l~~~~~~~~~~qi~~~l~~lH~---~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~ 155 (316)
T cd05574 81 DYCPGGELFRLLQRQP--GKCLSEEVARFYAAEVLLALEYLHL---LGIVYRDLKPENILLHESGHIMLSDFDLSKQSDV 155 (316)
T ss_pred EecCCCCHHHHHHhCC--CCccCHHHHHHHHHHHHHHHHHHHH---CCeeccCCChHHeEEcCCCCEEEeecchhhcccc
Confidence 9999999999987532 3468999999999999999999997 5999999999999999999999999999876432
Q ss_pred CCCc----------------------------ccccccccCCccCcccccCcCCCccccHHHHHHHHHHHHcCCCCCCCC
Q 002673 763 YQTH----------------------------VTTELVGTLGYIPPEYGQAWVATLRGDMYSFGVVMLELLTGKRPVDVL 814 (894)
Q Consensus 763 ~~~~----------------------------~~~~~~gt~~Y~APE~~~~~~~s~ksDVwS~GvlL~elltG~~Pf~~~ 814 (894)
.... ......||..|+|||++.+..++.++||||||+++|+|++|+.||...
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~ 235 (316)
T cd05574 156 EPPPVSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLYGTTPFKGS 235 (316)
T ss_pred cccccccccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHcCCCCCchHHHHHHHHHHHHHhhCCCCCCCC
Confidence 1110 111346888999999999988999999999999999999999999754
Q ss_pred CcchhhhHHHHHHHHhhcCCCCccccccccCCCChHHHHHHHHHHHHhcccCCCCCCC----HHHHHH--HHHhcc
Q 002673 815 KPKMSRELVGWVLKMRSEGKQDQVFDPILRGKGFDEEMLQVLDVACMCVSQNPFKRPT----VKEVVE--WLNNVG 884 (894)
Q Consensus 815 ~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs----~~evl~--~L~~i~ 884 (894)
..... .. ...... .. .. ........+.+++.+|++.+|++||| +.++++ |+++..
T Consensus 236 ~~~~~--~~----~~~~~~-~~------~~--~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~ll~~~~~~~~~ 296 (316)
T cd05574 236 NRDET--FS----NILKKE-VT------FP--GSPPVSSSARDLIRKLLVKDPSKRLGSKRGAAEIKQHPFFRGVN 296 (316)
T ss_pred chHHH--HH----HHhcCC-cc------CC--CccccCHHHHHHHHHHccCCHhHCCCchhhHHHHHcCchhhcCC
Confidence 43211 10 111100 00 00 00112346788999999999999999 888887 776653
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin |
| >cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-32 Score=303.53 Aligned_cols=197 Identities=25% Similarity=0.327 Sum_probs=160.2
Q ss_pred cceEeecCcEEEEEEEEc---CCCeEEEEEEcCcchhhHHHHHHHHHHHHhcCCCceeeecceeee--cceEEEEEEecc
Q 002673 612 ANIIGCGGFGLVYKATLA---NGTTLAIKKLSGDLGLMEREFKAEVEALSTAQHKNLVSLQGYCVH--QGFRLLIYSYME 686 (894)
Q Consensus 612 ~~~LG~G~fg~Vy~a~~~---~g~~vAvK~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~--~~~~~lV~E~~~ 686 (894)
+.+||+|+||.||+|... ++..||+|.+.... ....+.+|+.+++.++||||+++++++.. +...++||||++
T Consensus 6 g~~lG~G~~g~Vy~~~~~~~~~~~~~a~k~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~ 83 (317)
T cd07867 6 GCKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTG--ISMSACREIALLRELKHPNVIALQKVFLSHSDRKVWLLFDYAE 83 (317)
T ss_pred ceEeccCCCeeEEEEEecCCCccceEEEEEecCCC--CcHHHHHHHHHHHhCCCCCeeeEEEEEeccCCCeEEEEEeeeC
Confidence 468999999999999854 45789999987542 23457889999999999999999998854 457789999986
Q ss_pred CCCHHHHHhhhc-----CCCCCcCHHHHHHHHHHHHHHHHHHHhccCCCeeecCCCCCCeEE----CCCCcEEEEEcccc
Q 002673 687 NGSLDYWLHEKA-----DGASQLDWLTRLKIARGTSCGLAYMHQICEPHIVHRDIKSSNILL----DDQFEAHLADFGLS 757 (894)
Q Consensus 687 ~gsL~~~l~~~~-----~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDLkp~NILl----d~~~~vkl~DFGla 757 (894)
++|.+++.... .....+++..+..++.|++.||.|||+ ++|+||||||+|||+ +.++.+||+|||++
T Consensus 84 -~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~---~~ivH~Dlkp~Nil~~~~~~~~~~~kl~DfG~a 159 (317)
T cd07867 84 -HDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHA---NWVLHRDLKPANILVMGEGPERGRVKIADMGFA 159 (317)
T ss_pred -CcHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHh---CCEEcCCCCHHHEEEccCCCCCCcEEEeeccce
Confidence 47777775321 122358889999999999999999997 599999999999999 56779999999999
Q ss_pred cccCCCCC--cccccccccCCccCcccccCc-CCCccccHHHHHHHHHHHHcCCCCCCCC
Q 002673 758 RLILPYQT--HVTTELVGTLGYIPPEYGQAW-VATLRGDMYSFGVVMLELLTGKRPVDVL 814 (894)
Q Consensus 758 ~~~~~~~~--~~~~~~~gt~~Y~APE~~~~~-~~s~ksDVwS~GvlL~elltG~~Pf~~~ 814 (894)
+....... .......||+.|+|||++.+. .++.++|||||||++|||+||+.||...
T Consensus 160 ~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~el~tg~~~f~~~ 219 (317)
T cd07867 160 RLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCR 219 (317)
T ss_pred eccCCCcccccccCcceecccccCcHHhcCCCccCcHHHHHhHHHHHHHHHhCCCCcccc
Confidence 87643221 122345789999999988764 5789999999999999999999999743
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as |
| >cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-33 Score=297.76 Aligned_cols=257 Identities=26% Similarity=0.428 Sum_probs=204.3
Q ss_pred CCCccceEeecCcEEEEEEEEc-CCCeEEEEEEcCcc-hhhHHHHHHHHHHHHhcCCCceeeecceeeecceEEEEEEec
Q 002673 608 NFSQANIIGCGGFGLVYKATLA-NGTTLAIKKLSGDL-GLMEREFKAEVEALSTAQHKNLVSLQGYCVHQGFRLLIYSYM 685 (894)
Q Consensus 608 ~f~~~~~LG~G~fg~Vy~a~~~-~g~~vAvK~~~~~~-~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~lV~E~~ 685 (894)
+|+..+.||+|+||.||++... +++.||+|.+.... .....++.+|++++++++||||+++++++..++..++++||+
T Consensus 2 ~~~~~~~ig~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~ 81 (265)
T cd06605 2 DLEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPYIVGFYGAFYNNGDISICMEYM 81 (265)
T ss_pred cchHHHHhcCCCCeEEEEEEEcCCCcEEEEEEEecccChHHHHHHHHHHHHHHHCCCCchhhhheeeecCCEEEEEEEec
Confidence 5777889999999999999864 68999999987654 334567889999999999999999999999999999999999
Q ss_pred cCCCHHHHHhhhcCCCCCcCHHHHHHHHHHHHHHHHHHHhccCCCeeecCCCCCCeEECCCCcEEEEEcccccccCCCCC
Q 002673 686 ENGSLDYWLHEKADGASQLDWLTRLKIARGTSCGLAYMHQICEPHIVHRDIKSSNILLDDQFEAHLADFGLSRLILPYQT 765 (894)
Q Consensus 686 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDLkp~NILld~~~~vkl~DFGla~~~~~~~~ 765 (894)
++++|.+++.... ..++......++.|++.||.|||+ ..+++|+||||+||++++++.++|+|||.+........
T Consensus 82 ~~~~L~~~~~~~~---~~~~~~~~~~~~~~l~~~l~~lH~--~~~i~H~dl~~~ni~~~~~~~~~l~d~g~~~~~~~~~~ 156 (265)
T cd06605 82 DGGSLDKILKEVQ---GRIPERILGKIAVAVLKGLTYLHE--KHKIIHRDVKPSNILVNSRGQIKLCDFGVSGQLVNSLA 156 (265)
T ss_pred CCCcHHHHHHHcc---CCCCHHHHHHHHHHHHHHHHHHcC--CCCeecCCCCHHHEEECCCCCEEEeecccchhhHHHHh
Confidence 9999999998643 467888899999999999999996 25999999999999999999999999999876532211
Q ss_pred cccccccccCCccCcccccCcCCCccccHHHHHHHHHHHHcCCCCCCCCCcchhhhHHHHHHHHhhcCCCCccccccccC
Q 002673 766 HVTTELVGTLGYIPPEYGQAWVATLRGDMYSFGVVMLELLTGKRPVDVLKPKMSRELVGWVLKMRSEGKQDQVFDPILRG 845 (894)
Q Consensus 766 ~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwS~GvlL~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~ 845 (894)
....++..|+|||+..+..++.++||||||+++|+|++|+.||...... ................. .+..
T Consensus 157 ---~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~-~~~~~~~~~~~~~~~~~------~~~~ 226 (265)
T cd06605 157 ---KTFVGTSSYMAPERIQGNDYSVKSDIWSLGLSLIELATGRFPYPPENDP-PDGIFELLQYIVNEPPP------RLPS 226 (265)
T ss_pred ---hcccCChhccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCccccc-cccHHHHHHHHhcCCCC------CCCh
Confidence 1266888999999999999999999999999999999999999754211 11112222221111110 0100
Q ss_pred CCChHHHHHHHHHHHHhcccCCCCCCCHHHHHH--HHHh
Q 002673 846 KGFDEEMLQVLDVACMCVSQNPFKRPTVKEVVE--WLNN 882 (894)
Q Consensus 846 ~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~--~L~~ 882 (894)
. .....+.+++..|+..+|.+|||+.++++ |++.
T Consensus 227 ~---~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~~~~~~ 262 (265)
T cd06605 227 G---KFSPDFQDFVNLCLIKDPRERPSYKELLEHPFIKK 262 (265)
T ss_pred h---hcCHHHHHHHHHHcCCCchhCcCHHHHhhCchhhc
Confidence 0 02335778999999999999999999997 6643
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity |
| >cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-32 Score=296.34 Aligned_cols=253 Identities=25% Similarity=0.423 Sum_probs=196.5
Q ss_pred CCCccceEeecCcEEEEEEEE-cCCCeEEEEEEcCcch----------hhHHHHHHHHHHHHhcCCCceeeecceeeecc
Q 002673 608 NFSQANIIGCGGFGLVYKATL-ANGTTLAIKKLSGDLG----------LMEREFKAEVEALSTAQHKNLVSLQGYCVHQG 676 (894)
Q Consensus 608 ~f~~~~~LG~G~fg~Vy~a~~-~~g~~vAvK~~~~~~~----------~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~ 676 (894)
+|...+.||.|+||.||+|.. .+|+.||+|.+..... ...+.+..|+.+++.++|||++++++++...+
T Consensus 2 ~~~~~~~lg~g~~~~vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 81 (272)
T cd06629 2 KWVKGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQYLGFETTEE 81 (272)
T ss_pred ceeecceecccCceEEEEEeecCCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCCCCcceEEEEeccCC
Confidence 467788999999999999974 5789999998853211 11235788999999999999999999999999
Q ss_pred eEEEEEEeccCCCHHHHHhhhcCCCCCcCHHHHHHHHHHHHHHHHHHHhccCCCeeecCCCCCCeEECCCCcEEEEEccc
Q 002673 677 FRLLIYSYMENGSLDYWLHEKADGASQLDWLTRLKIARGTSCGLAYMHQICEPHIVHRDIKSSNILLDDQFEAHLADFGL 756 (894)
Q Consensus 677 ~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDLkp~NILld~~~~vkl~DFGl 756 (894)
..++||||+++|+|.+++... ..+++..+..++.|++.||.|||+ ++++||||+|+||+++.++.++|+|||+
T Consensus 82 ~~~lv~e~~~~~~L~~~l~~~----~~l~~~~~~~~~~qi~~~l~~lH~---~~i~H~dl~~~nil~~~~~~~~l~d~~~ 154 (272)
T cd06629 82 YLSIFLEYVPGGSIGSCLRTY----GRFEEQLVRFFTEQVLEGLAYLHS---KGILHRDLKADNLLVDADGICKISDFGI 154 (272)
T ss_pred ceEEEEecCCCCcHHHHHhhc----cCCCHHHHHHHHHHHHHHHHHHhh---CCeeecCCChhhEEEcCCCeEEEeeccc
Confidence 999999999999999999754 358888999999999999999997 5999999999999999999999999999
Q ss_pred ccccCCCCCc-ccccccccCCccCcccccCcC--CCccccHHHHHHHHHHHHcCCCCCCCCCcchhhhHHHHHHHHhhcC
Q 002673 757 SRLILPYQTH-VTTELVGTLGYIPPEYGQAWV--ATLRGDMYSFGVVMLELLTGKRPVDVLKPKMSRELVGWVLKMRSEG 833 (894)
Q Consensus 757 a~~~~~~~~~-~~~~~~gt~~Y~APE~~~~~~--~s~ksDVwS~GvlL~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~ 833 (894)
++........ ......++..|+|||...... ++.++||||||+++|+|++|+.||...... .... ......
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~--~~~~----~~~~~~ 228 (272)
T cd06629 155 SKKSDDIYDNDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEAI--AAMF----KLGNKR 228 (272)
T ss_pred cccccccccccccccccCCccccCHHHhccccCCCCccchhHHHHHHHHHHHhCCCCCcCcchH--HHHH----Hhhccc
Confidence 9865322111 123346788999999887654 789999999999999999999999643221 1111 111111
Q ss_pred CCCccccccccCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 002673 834 KQDQVFDPILRGKGFDEEMLQVLDVACMCVSQNPFKRPTVKEVVE 878 (894)
Q Consensus 834 ~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~ 878 (894)
....++. .........+.+++..|+..+|++||++.++++
T Consensus 229 -~~~~~~~----~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 268 (272)
T cd06629 229 -SAPPIPP----DVSMNLSPVALDFLNACFTINPDNRPTARELLQ 268 (272)
T ss_pred -cCCcCCc----cccccCCHHHHHHHHHHhcCChhhCCCHHHHhh
Confidence 1111111 111122346778999999999999999999986
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte |
| >cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-32 Score=293.97 Aligned_cols=251 Identities=30% Similarity=0.429 Sum_probs=200.0
Q ss_pred CCCccceEeecCcEEEEEEEE-cCCCeEEEEEEcCcchh--hHHHHHHHHHHHHhcCCCceeeecceeeecceEEEEEEe
Q 002673 608 NFSQANIIGCGGFGLVYKATL-ANGTTLAIKKLSGDLGL--MEREFKAEVEALSTAQHKNLVSLQGYCVHQGFRLLIYSY 684 (894)
Q Consensus 608 ~f~~~~~LG~G~fg~Vy~a~~-~~g~~vAvK~~~~~~~~--~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~lV~E~ 684 (894)
+|+..+.||+|+||.||+|.. .++..|++|.+...... ..+.+..|+.++++++|+||+++++++...+..++|+||
T Consensus 1 ~y~~~~~lg~G~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~lv~e~ 80 (264)
T cd06626 1 RWQRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYYGVEVHREKVYIFMEY 80 (264)
T ss_pred CceeeeEeecCCCcEEEEEEECCCCcEEEEEEEECcccchHHHHHHHHHHHHHHhCCCCChhheeeeEecCCEEEEEEec
Confidence 477889999999999999985 47899999998765442 557789999999999999999999999999999999999
Q ss_pred ccCCCHHHHHhhhcCCCCCcCHHHHHHHHHHHHHHHHHHHhccCCCeeecCCCCCCeEECCCCcEEEEEcccccccCCCC
Q 002673 685 MENGSLDYWLHEKADGASQLDWLTRLKIARGTSCGLAYMHQICEPHIVHRDIKSSNILLDDQFEAHLADFGLSRLILPYQ 764 (894)
Q Consensus 685 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDLkp~NILld~~~~vkl~DFGla~~~~~~~ 764 (894)
+++++|.+++... ..+++..+..++.+++.||.|||+ .+++|+||+|+||++++++.+||+|||++.......
T Consensus 81 ~~~~~L~~~~~~~----~~~~~~~~~~i~~~i~~~l~~lh~---~~i~H~dl~~~nil~~~~~~~kl~d~g~~~~~~~~~ 153 (264)
T cd06626 81 CSGGTLEELLEHG----RILDEHVIRVYTLQLLEGLAYLHS---HGIVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNT 153 (264)
T ss_pred CCCCcHHHHHhhc----CCCChHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEECCCCCEEEcccccccccCCCC
Confidence 9999999999753 347888899999999999999997 599999999999999999999999999998764332
Q ss_pred Cccc---ccccccCCccCcccccCcC---CCccccHHHHHHHHHHHHcCCCCCCCCCcchhhhHHHHHHHHhhcCCCCcc
Q 002673 765 THVT---TELVGTLGYIPPEYGQAWV---ATLRGDMYSFGVVMLELLTGKRPVDVLKPKMSRELVGWVLKMRSEGKQDQV 838 (894)
Q Consensus 765 ~~~~---~~~~gt~~Y~APE~~~~~~---~s~ksDVwS~GvlL~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 838 (894)
.... ....++..|+|||++.+.. ++.++||||||+++|+|++|+.||....... .. ...... .....+
T Consensus 154 ~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~~~Dv~s~G~il~~l~~g~~pf~~~~~~~--~~---~~~~~~-~~~~~~ 227 (264)
T cd06626 154 TTMGEEVQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELDNEF--QI---MFHVGA-GHKPPI 227 (264)
T ss_pred CcccccccCCcCCcCccChhhccCCCCCCCCcccchHHHHHHHHHHHhCCCCccCCcchH--HH---HHHHhc-CCCCCC
Confidence 2211 1346788999999988766 8899999999999999999999997543211 11 111111 111111
Q ss_pred ccccccCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 002673 839 FDPILRGKGFDEEMLQVLDVACMCVSQNPFKRPTVKEVVE 878 (894)
Q Consensus 839 ~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~ 878 (894)
.. .......+.+++.+|++.+|.+|||+.+++.
T Consensus 228 -~~------~~~~~~~~~~li~~~l~~~p~~R~~~~~i~~ 260 (264)
T cd06626 228 -PD------SLQLSPEGKDFLDRCLESDPKKRPTASELLQ 260 (264)
T ss_pred -Cc------ccccCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence 00 0111335678999999999999999999875
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4 |
| >cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-33 Score=303.69 Aligned_cols=252 Identities=22% Similarity=0.329 Sum_probs=199.9
Q ss_pred CCccceEeecCcEEEEEEEE-cCCCeEEEEEEcCcchhhHHHHHHHHHHHHhcCCCceeeecceeeecceEEEEEEeccC
Q 002673 609 FSQANIIGCGGFGLVYKATL-ANGTTLAIKKLSGDLGLMEREFKAEVEALSTAQHKNLVSLQGYCVHQGFRLLIYSYMEN 687 (894)
Q Consensus 609 f~~~~~LG~G~fg~Vy~a~~-~~g~~vAvK~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~lV~E~~~~ 687 (894)
|.....||+|+||.||++.. .++..||||++..........+.+|+..++.++|+||+++++.+...+..++||||+++
T Consensus 24 ~~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~lv~e~~~~ 103 (292)
T cd06658 24 LDSFIKIGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNSYLVGDELWVVMEFLEG 103 (292)
T ss_pred HhhhhcccCCCCeEEEEEEECCCCCEEEEEEEecchHHHHHHHHHHHHHHHhCCCCcHHHHHHheecCCeEEEEEeCCCC
Confidence 33446799999999999985 46889999998765555556788999999999999999999999999999999999999
Q ss_pred CCHHHHHhhhcCCCCCcCHHHHHHHHHHHHHHHHHHHhccCCCeeecCCCCCCeEECCCCcEEEEEcccccccCCCCCcc
Q 002673 688 GSLDYWLHEKADGASQLDWLTRLKIARGTSCGLAYMHQICEPHIVHRDIKSSNILLDDQFEAHLADFGLSRLILPYQTHV 767 (894)
Q Consensus 688 gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDLkp~NILld~~~~vkl~DFGla~~~~~~~~~~ 767 (894)
++|.+++.. ..+++..+..++.||+.||.|||+ ++++||||||+||++++++.+||+|||++........ .
T Consensus 104 ~~L~~~~~~-----~~l~~~~~~~~~~qi~~~l~~LH~---~~ivH~dlkp~Nill~~~~~~kL~dfg~~~~~~~~~~-~ 174 (292)
T cd06658 104 GALTDIVTH-----TRMNEEQIATVCLSVLRALSYLHN---QGVIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEVP-K 174 (292)
T ss_pred CcHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHH---CCEeecCCCHHHEEEcCCCCEEEccCcchhhcccccc-c
Confidence 999998853 247889999999999999999997 5999999999999999999999999999876532221 2
Q ss_pred cccccccCCccCcccccCcCCCccccHHHHHHHHHHHHcCCCCCCCCCcchhhhHHHHHHHHhhcCCCCccccccccCCC
Q 002673 768 TTELVGTLGYIPPEYGQAWVATLRGDMYSFGVVMLELLTGKRPVDVLKPKMSRELVGWVLKMRSEGKQDQVFDPILRGKG 847 (894)
Q Consensus 768 ~~~~~gt~~Y~APE~~~~~~~s~ksDVwS~GvlL~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~ 847 (894)
.....|+..|+|||+..+..++.++||||||+++|||++|+.||....... ... .... . +.+.+..
T Consensus 175 ~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~---~~~---~~~~-~-----~~~~~~~-- 240 (292)
T cd06658 175 RKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDGEPPYFNEPPLQ---AMR---RIRD-N-----LPPRVKD-- 240 (292)
T ss_pred CceeecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH---HHH---HHHh-c-----CCCcccc--
Confidence 233568899999999988889999999999999999999999997543211 111 1110 0 0011100
Q ss_pred ChHHHHHHHHHHHHhcccCCCCCCCHHHHHH--HHHhc
Q 002673 848 FDEEMLQVLDVACMCVSQNPFKRPTVKEVVE--WLNNV 883 (894)
Q Consensus 848 ~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~--~L~~i 883 (894)
.......+.+++..|+..||.+|||++++++ +++..
T Consensus 241 ~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~~~~~~~~ 278 (292)
T cd06658 241 SHKVSSVLRGFLDLMLVREPSQRATAQELLQHPFLKLA 278 (292)
T ss_pred ccccCHHHHHHHHHHccCChhHCcCHHHHhhChhhhcc
Confidence 0112235668889999999999999999997 55543
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express |
| >cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-32 Score=293.22 Aligned_cols=249 Identities=24% Similarity=0.316 Sum_probs=194.5
Q ss_pred cCCCccceEeecCcEEEEEEEE-cCCCeEEEEEEcCcc-----hhhHHHHHHHHHHHHhcCCCceeeecceeeec--ceE
Q 002673 607 DNFSQANIIGCGGFGLVYKATL-ANGTTLAIKKLSGDL-----GLMEREFKAEVEALSTAQHKNLVSLQGYCVHQ--GFR 678 (894)
Q Consensus 607 ~~f~~~~~LG~G~fg~Vy~a~~-~~g~~vAvK~~~~~~-----~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~--~~~ 678 (894)
.+|++.+.||+|+||.||+|.. .++..||+|.+.... ......+.+|+.++++++||||+++++++.+. ...
T Consensus 2 ~~~~~~~~l~~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (265)
T cd06652 2 TNWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQYYGCLRDPMERTL 81 (265)
T ss_pred CcceEeeEEecCCceEEEEEEEcCCCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcCCCCeeeEEeEeccCCCceE
Confidence 4788899999999999999985 568999999885322 12235688899999999999999999988763 467
Q ss_pred EEEEEeccCCCHHHHHhhhcCCCCCcCHHHHHHHHHHHHHHHHHHHhccCCCeeecCCCCCCeEECCCCcEEEEEccccc
Q 002673 679 LLIYSYMENGSLDYWLHEKADGASQLDWLTRLKIARGTSCGLAYMHQICEPHIVHRDIKSSNILLDDQFEAHLADFGLSR 758 (894)
Q Consensus 679 ~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDLkp~NILld~~~~vkl~DFGla~ 758 (894)
++||||+++|+|.+++... ..+++...+.++.|++.||.|||+ ++++|+||||+||+++.++.++|+|||++.
T Consensus 82 ~~v~e~~~~~~L~~~l~~~----~~~~~~~~~~~~~~l~~~l~~lH~---~~i~H~dl~p~nil~~~~~~~~l~Dfg~~~ 154 (265)
T cd06652 82 SIFMEHMPGGSIKDQLKSY----GALTENVTRKYTRQILEGVSYLHS---NMIVHRDIKGANILRDSVGNVKLGDFGASK 154 (265)
T ss_pred EEEEEecCCCcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHh---CCEecCCCCHHHEEecCCCCEEECcCcccc
Confidence 8999999999999998754 247788889999999999999997 599999999999999999999999999998
Q ss_pred ccCCCCC--cccccccccCCccCcccccCcCCCccccHHHHHHHHHHHHcCCCCCCCCCcchhhhHHHHHHHHhhcCCCC
Q 002673 759 LILPYQT--HVTTELVGTLGYIPPEYGQAWVATLRGDMYSFGVVMLELLTGKRPVDVLKPKMSRELVGWVLKMRSEGKQD 836 (894)
Q Consensus 759 ~~~~~~~--~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwS~GvlL~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~ 836 (894)
....... .......++..|+|||...+..++.++||||||+++|+|++|+.||....... .. ........
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~--~~----~~~~~~~~-- 226 (265)
T cd06652 155 RLQTICLSGTGMKSVTGTPYWMSPEVISGEGYGRKADIWSVGCTVVEMLTEKPPWAEFEAMA--AI----FKIATQPT-- 226 (265)
T ss_pred ccccccccccccccCCCCccccChhhhcCCCCCcchhHHHHHHHHHHHhhCCCCCCccchHH--HH----HHHhcCCC--
Confidence 6532111 11223468889999999988889999999999999999999999997543211 11 11111110
Q ss_pred ccccccccCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 002673 837 QVFDPILRGKGFDEEMLQVLDVACMCVSQNPFKRPTVKEVVE 878 (894)
Q Consensus 837 ~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~ 878 (894)
.+ .........+.+++.+|+. +|++||+++++++
T Consensus 227 ---~~----~~~~~~~~~~~~~i~~~l~-~p~~Rp~~~~il~ 260 (265)
T cd06652 227 ---NP----VLPPHVSDHCRDFLKRIFV-EAKLRPSADELLR 260 (265)
T ss_pred ---CC----CCchhhCHHHHHHHHHHhc-ChhhCCCHHHHhc
Confidence 01 1112233456788889985 9999999999986
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re |
| >KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=294.72 Aligned_cols=247 Identities=26% Similarity=0.394 Sum_probs=205.1
Q ss_pred CCccceEeecCcEEEEEEE-EcCCCeEEEEEEcCcchhhHHHHHHHHHHHHhcCCCceeeecceeeecceEEEEEEeccC
Q 002673 609 FSQANIIGCGGFGLVYKAT-LANGTTLAIKKLSGDLGLMEREFKAEVEALSTAQHKNLVSLQGYCVHQGFRLLIYSYMEN 687 (894)
Q Consensus 609 f~~~~~LG~G~fg~Vy~a~-~~~g~~vAvK~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~lV~E~~~~ 687 (894)
|.+..+||+|+||.||+|. ...|..||||++..+ .+.+++..|+.+|.+.+.|++|+++|.+......|+|||||..
T Consensus 35 FDi~~KLGEGSYGSV~KAIH~EsG~v~AIK~VPV~--sDLQEIIKEISIMQQC~S~yVVKYYGSYFK~sDLWIVMEYCGA 112 (502)
T KOG0574|consen 35 FDIVGKLGEGSYGSVHKAIHRESGHVLAIKKVPVD--TDLQEIIKEISIMQQCKSKYVVKYYGSYFKHSDLWIVMEYCGA 112 (502)
T ss_pred HHHHHHhcCCcchHHHHHHHhccCcEEEEEecCcc--chHHHHHHHHHHHHHcCCchhhhhhhhhccCCceEeehhhcCC
Confidence 5567889999999999997 557999999998754 4567899999999999999999999999999999999999999
Q ss_pred CCHHHHHhhhcCCCCCcCHHHHHHHHHHHHHHHHHHHhccCCCeeecCCCCCCeEECCCCcEEEEEcccccccCCCCCcc
Q 002673 688 GSLDYWLHEKADGASQLDWLTRLKIARGTSCGLAYMHQICEPHIVHRDIKSSNILLDDQFEAHLADFGLSRLILPYQTHV 767 (894)
Q Consensus 688 gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDLkp~NILld~~~~vkl~DFGla~~~~~~~~~~ 767 (894)
|+..+.++.+. ..++..++..+++..++||+|||.+ .-+|||||+.||||+.+|.+||+|||.+..+.+.. ..
T Consensus 113 GSiSDI~R~R~---K~L~E~EIs~iL~~TLKGL~YLH~~---~KIHRDIKAGNILLNT~G~AKLADFGVAGQLTDTM-AK 185 (502)
T KOG0574|consen 113 GSISDIMRARR---KPLSEQEISAVLRDTLKGLQYLHDL---KKIHRDIKAGNILLNTDGIAKLADFGVAGQLTDTM-AK 185 (502)
T ss_pred CcHHHHHHHhc---CCccHHHHHHHHHHHHhHHHHHHHH---HHHHhhcccccEEEcccchhhhhhccccchhhhhH-Hh
Confidence 99999998653 5789999999999999999999986 78999999999999999999999999998764322 22
Q ss_pred cccccccCCccCcccccCcCCCccccHHHHHHHHHHHHcCCCCCCCCCcchhhhHHHHHHHHhhcCCCCccccccccCCC
Q 002673 768 TTELVGTLGYIPPEYGQAWVATLRGDMYSFGVVMLELLTGKRPVDVLKPKMSRELVGWVLKMRSEGKQDQVFDPILRGKG 847 (894)
Q Consensus 768 ~~~~~gt~~Y~APE~~~~~~~s~ksDVwS~GvlL~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~ 847 (894)
...+.||+.|||||++..-.|..+.||||+|+...||..|++||.+..+- +. ..+..... .|.++ .
T Consensus 186 RNTVIGTPFWMAPEVI~EIGY~~~ADIWSLGITaIEMAEG~PPYsDIHPM--RA-----IFMIPT~P-----PPTF~--K 251 (502)
T KOG0574|consen 186 RNTVIGTPFWMAPEVIEEIGYDTKADIWSLGITAIEMAEGRPPYSDIHPM--RA-----IFMIPTKP-----PPTFK--K 251 (502)
T ss_pred hCccccCcccccHHHHHHhccchhhhHhhhcchhhhhhcCCCCccccccc--ce-----eEeccCCC-----CCCCC--C
Confidence 34578999999999999999999999999999999999999999765431 00 00111111 11221 1
Q ss_pred ChHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 002673 848 FDEEMLQVLDVACMCVSQNPFKRPTVKEVVE 878 (894)
Q Consensus 848 ~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~ 878 (894)
......++-+++..|+-.+|++|-|+.++++
T Consensus 252 PE~WS~~F~DFi~~CLiK~PE~R~TA~~L~~ 282 (502)
T KOG0574|consen 252 PEEWSSEFNDFIRSCLIKKPEERKTALRLCE 282 (502)
T ss_pred hHhhhhHHHHHHHHHhcCCHHHHHHHHHHhh
Confidence 2233457889999999999999999998876
|
|
| >cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-32 Score=290.21 Aligned_cols=248 Identities=24% Similarity=0.386 Sum_probs=199.2
Q ss_pred CCCccceEeecCcEEEEEEEE-cCCCeEEEEEEcCcc--hhhHHHHHHHHHHHHhcCCCceeeecceeeecceEEEEEEe
Q 002673 608 NFSQANIIGCGGFGLVYKATL-ANGTTLAIKKLSGDL--GLMEREFKAEVEALSTAQHKNLVSLQGYCVHQGFRLLIYSY 684 (894)
Q Consensus 608 ~f~~~~~LG~G~fg~Vy~a~~-~~g~~vAvK~~~~~~--~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~lV~E~ 684 (894)
+|+..+.||+|+||.||++.. .+++.+|+|.+.... ......+.+|+.+++.++|||++++++.+..++..++||||
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd08220 1 KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYENFLEDKALMIVMEY 80 (256)
T ss_pred CceEEEEecccCceEEEEEEEcCCCcEEEEEEEeccccccHHHHHHHHHHHHHhhCCCCchhheeeeEecCCEEEEEEec
Confidence 477889999999999999984 578899999987542 23356788999999999999999999999999999999999
Q ss_pred ccCCCHHHHHhhhcCCCCCcCHHHHHHHHHHHHHHHHHHHhccCCCeeecCCCCCCeEECCC-CcEEEEEcccccccCCC
Q 002673 685 MENGSLDYWLHEKADGASQLDWLTRLKIARGTSCGLAYMHQICEPHIVHRDIKSSNILLDDQ-FEAHLADFGLSRLILPY 763 (894)
Q Consensus 685 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDLkp~NILld~~-~~vkl~DFGla~~~~~~ 763 (894)
+++++|.+++.... ...+++..+..++.+++.+|.|||+ ++++|+||||+||+++++ +.+||+|||++......
T Consensus 81 ~~~~~L~~~~~~~~--~~~~~~~~~~~~~~~i~~~l~~lh~---~~i~h~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~ 155 (256)
T cd08220 81 APGGTLAEYIQKRC--NSLLDEDTILHFFVQILLALHHVHT---KLILHRDLKTQNILLDKHKMVVKIGDFGISKILSSK 155 (256)
T ss_pred CCCCCHHHHHHHhc--ccCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEEcCCCCEEEEccCCCceecCCC
Confidence 99999999998643 2457899999999999999999997 599999999999999865 46899999999876432
Q ss_pred CCcccccccccCCccCcccccCcCCCccccHHHHHHHHHHHHcCCCCCCCCCcchhhhHHHHHHHHhhcCCCCccccccc
Q 002673 764 QTHVTTELVGTLGYIPPEYGQAWVATLRGDMYSFGVVMLELLTGKRPVDVLKPKMSRELVGWVLKMRSEGKQDQVFDPIL 843 (894)
Q Consensus 764 ~~~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwS~GvlL~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l 843 (894)
. ......++..|+|||.+.+..++.++||||||+++|+|++|+.||...... .... .... .....+.+
T Consensus 156 ~--~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~---~~~~---~~~~-~~~~~~~~--- 223 (256)
T cd08220 156 S--KAYTVVGTPCYISPELCEGKPYNQKSDIWALGCVLYELASLKRAFEAANLP---ALVL---KIMS-GTFAPISD--- 223 (256)
T ss_pred c--cccccccCCcccCchhccCCCCCcccchHHHHHHHHHHHhCCCCcccCchH---HHHH---HHHh-cCCCCCCC---
Confidence 2 223356889999999999888999999999999999999999999754321 1111 1111 11111111
Q ss_pred cCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 002673 844 RGKGFDEEMLQVLDVACMCVSQNPFKRPTVKEVVE 878 (894)
Q Consensus 844 ~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~ 878 (894)
.....+.+++.+||+.+|++|||+.++++
T Consensus 224 ------~~~~~l~~li~~~l~~~p~~Rpt~~~ll~ 252 (256)
T cd08220 224 ------RYSPDLRQLILSMLNLDPSKRPQLSQIMA 252 (256)
T ss_pred ------CcCHHHHHHHHHHccCChhhCCCHHHHhh
Confidence 11235678999999999999999999986
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with |
| >cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-33 Score=300.21 Aligned_cols=261 Identities=23% Similarity=0.289 Sum_probs=194.3
Q ss_pred CCCccceEeecCcEEEEEEEE-cCCCeEEEEEEcCcch--hhHHHHHHHHHHHHhcCCCceeeecceeeecceEEEEEEe
Q 002673 608 NFSQANIIGCGGFGLVYKATL-ANGTTLAIKKLSGDLG--LMEREFKAEVEALSTAQHKNLVSLQGYCVHQGFRLLIYSY 684 (894)
Q Consensus 608 ~f~~~~~LG~G~fg~Vy~a~~-~~g~~vAvK~~~~~~~--~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~lV~E~ 684 (894)
+|+..+.||+|+||.||+|.. .+|+.||+|++..... .....+.+|+.+++.++||||+++++++.+....++|+||
T Consensus 1 ~y~~~~~l~~g~~~~vy~~~~~~~g~~~~~k~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 80 (284)
T cd07839 1 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYDVLHSDKKLTLVFEY 80 (284)
T ss_pred CceeEEEecccCCeEEEEEEECCCCcEEEEEEeecccccccCccchhHHHHHHHhcCCCCeeeHHHHhccCCceEEEEec
Confidence 477789999999999999985 4789999999865322 2234677899999999999999999999999999999999
Q ss_pred ccCCCHHHHHhhhcCCCCCcCHHHHHHHHHHHHHHHHHHHhccCCCeeecCCCCCCeEECCCCcEEEEEcccccccCCCC
Q 002673 685 MENGSLDYWLHEKADGASQLDWLTRLKIARGTSCGLAYMHQICEPHIVHRDIKSSNILLDDQFEAHLADFGLSRLILPYQ 764 (894)
Q Consensus 685 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDLkp~NILld~~~~vkl~DFGla~~~~~~~ 764 (894)
++ ++|.+++.... ..+++..+..++.||++||.|||+ ++++||||||+||+++.++.+||+|||+++......
T Consensus 81 ~~-~~l~~~~~~~~---~~~~~~~~~~~~~qi~~al~~LH~---~~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~ 153 (284)
T cd07839 81 CD-QDLKKYFDSCN---GDIDPEIVKSFMFQLLKGLAFCHS---HNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPV 153 (284)
T ss_pred CC-CCHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHH---CCEecCCCCHHHEEEcCCCcEEECccchhhccCCCC
Confidence 96 57888876532 358999999999999999999997 599999999999999999999999999998653222
Q ss_pred CcccccccccCCccCcccccCc-CCCccccHHHHHHHHHHHHcCCCCCCCCCcchhhhHHHHHHHHhhcCC------CCc
Q 002673 765 THVTTELVGTLGYIPPEYGQAW-VATLRGDMYSFGVVMLELLTGKRPVDVLKPKMSRELVGWVLKMRSEGK------QDQ 837 (894)
Q Consensus 765 ~~~~~~~~gt~~Y~APE~~~~~-~~s~ksDVwS~GvlL~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~------~~~ 837 (894)
.......++..|+|||++.+. .++.++|||||||++|+|++|+.|+...... ............... ...
T Consensus 154 -~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~ 230 (284)
T cd07839 154 -RCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDV--DDQLKRIFRLLGTPTEESWPGVSK 230 (284)
T ss_pred -CCcCCCccccCCcChHHHhCCcccCcHHHHHHHHHHHHHHHhcCCCCcCCCCH--HHHHHHHHHHhCCCChHHhHHhhh
Confidence 112334578899999987764 4689999999999999999999986432221 111111111000000 000
Q ss_pred ccc----ccccC-----CCChHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 002673 838 VFD----PILRG-----KGFDEEMLQVLDVACMCVSQNPFKRPTVKEVVE 878 (894)
Q Consensus 838 ~~d----~~l~~-----~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~ 878 (894)
..+ +.... ...+.....+.+++.+|++.||.+|||+.++++
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~il~ 280 (284)
T cd07839 231 LPDYKPYPMYPATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRISAEEALQ 280 (284)
T ss_pred cccccccCCCCCcchhhhhcccCCHHHHHHHHHHhcCChhhcCCHHHHhc
Confidence 000 00000 001112346678999999999999999999975
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also |
| >cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-32 Score=295.95 Aligned_cols=256 Identities=29% Similarity=0.393 Sum_probs=200.7
Q ss_pred HhccCCCccceEeecCcEEEEEEEE-cCCCeEEEEEEcCcchhhHHHHHHHHHHHHhc-CCCceeeecceeeecc-----
Q 002673 604 KATDNFSQANIIGCGGFGLVYKATL-ANGTTLAIKKLSGDLGLMEREFKAEVEALSTA-QHKNLVSLQGYCVHQG----- 676 (894)
Q Consensus 604 ~a~~~f~~~~~LG~G~fg~Vy~a~~-~~g~~vAvK~~~~~~~~~~~~~~~Ei~~l~~l-~HpnIv~l~g~~~~~~----- 676 (894)
.++++|+..+.||+|+||.||+|.. .+++.+++|++..... ...++.+|+.+++++ +|+||+++++++....
T Consensus 3 ~~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~-~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~ 81 (275)
T cd06608 3 DPTGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIED-EEEEIKEEYNILRKYSNHPNIATFYGAFIKKNPPGND 81 (275)
T ss_pred CchhheeheeeecCCCCeEEEEEEECCCCcEEEEEEEecCch-hHHHHHHHHHHHHHhcCCCChheEEEEEEecCCCCcc
Confidence 3568899999999999999999986 4678999999876533 346789999999999 7999999999997644
Q ss_pred -eEEEEEEeccCCCHHHHHhhhcCCCCCcCHHHHHHHHHHHHHHHHHHHhccCCCeeecCCCCCCeEECCCCcEEEEEcc
Q 002673 677 -FRLLIYSYMENGSLDYWLHEKADGASQLDWLTRLKIARGTSCGLAYMHQICEPHIVHRDIKSSNILLDDQFEAHLADFG 755 (894)
Q Consensus 677 -~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDLkp~NILld~~~~vkl~DFG 755 (894)
..++||||+++++|.+++.........+++..+..++.|++.||.|||+ .+++|+||+|+||+++.++.+||+|||
T Consensus 82 ~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~---~~i~H~~l~p~ni~~~~~~~~~l~d~~ 158 (275)
T cd06608 82 DQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLHE---NKVIHRDIKGQNILLTKNAEVKLVDFG 158 (275)
T ss_pred eEEEEEEEcCCCCcHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhc---CCcccCCCCHHHEEEccCCeEEECCCc
Confidence 4899999999999999987644334578999999999999999999997 599999999999999999999999999
Q ss_pred cccccCCCCCcccccccccCCccCcccccC-----cCCCccccHHHHHHHHHHHHcCCCCCCCCCcchhhhHHHHHHHHh
Q 002673 756 LSRLILPYQTHVTTELVGTLGYIPPEYGQA-----WVATLRGDMYSFGVVMLELLTGKRPVDVLKPKMSRELVGWVLKMR 830 (894)
Q Consensus 756 la~~~~~~~~~~~~~~~gt~~Y~APE~~~~-----~~~s~ksDVwS~GvlL~elltG~~Pf~~~~~~~~~~~~~~~~~~~ 830 (894)
++....... .......|+..|+|||++.. ..++.++||||||+++|+|++|+.||...... .... ...
T Consensus 159 ~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~--~~~~----~~~ 231 (275)
T cd06608 159 VSAQLDSTL-GRRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMHPM--RALF----KIP 231 (275)
T ss_pred cceecccch-hhhcCccccccccCHhHhcccccccCCccccccHHHhHHHHHHHHhCCCCccccchH--HHHH----Hhh
Confidence 987653222 22234568899999998753 34678999999999999999999999743321 1111 111
Q ss_pred hcCCCCccccccccCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 002673 831 SEGKQDQVFDPILRGKGFDEEMLQVLDVACMCVSQNPFKRPTVKEVVE 878 (894)
Q Consensus 831 ~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~ 878 (894)
. ....... ........+.+++.+|+..||++|||+.++++
T Consensus 232 ~-~~~~~~~-------~~~~~~~~~~~li~~~l~~dp~~Rpt~~~ll~ 271 (275)
T cd06608 232 R-NPPPTLK-------SPENWSKKFNDFISECLIKNYEQRPFMEELLE 271 (275)
T ss_pred c-cCCCCCC-------chhhcCHHHHHHHHHHhhcChhhCcCHHHHhc
Confidence 1 1111110 01112346778999999999999999999986
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I |
| >cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-32 Score=301.25 Aligned_cols=246 Identities=22% Similarity=0.298 Sum_probs=196.7
Q ss_pred CccceEeecCcEEEEEEEE-cCCCeEEEEEEcCcchhhHHHHHHHHHHHHhcCCCceeeecceeeecceEEEEEEeccCC
Q 002673 610 SQANIIGCGGFGLVYKATL-ANGTTLAIKKLSGDLGLMEREFKAEVEALSTAQHKNLVSLQGYCVHQGFRLLIYSYMENG 688 (894)
Q Consensus 610 ~~~~~LG~G~fg~Vy~a~~-~~g~~vAvK~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~lV~E~~~~g 688 (894)
+....||+|+||.||+|.. .+++.||+|.+..........+.+|+.+++.++|||++++++++..++..++|+||++++
T Consensus 24 ~~~~~ig~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~iv~e~~~~~ 103 (297)
T cd06659 24 ENYIKIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYKSYLVGEELWVLMEFLQGG 103 (297)
T ss_pred HhhhhcCCCCceeEEEEEEcCCCCEEEEEEEEecccchHHHHHHHHHHHHhCCCCchhhhhhheeeCCeEEEEEecCCCC
Confidence 3345799999999999985 478999999987544444567889999999999999999999999999999999999999
Q ss_pred CHHHHHhhhcCCCCCcCHHHHHHHHHHHHHHHHHHHhccCCCeeecCCCCCCeEECCCCcEEEEEcccccccCCCCCccc
Q 002673 689 SLDYWLHEKADGASQLDWLTRLKIARGTSCGLAYMHQICEPHIVHRDIKSSNILLDDQFEAHLADFGLSRLILPYQTHVT 768 (894)
Q Consensus 689 sL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDLkp~NILld~~~~vkl~DFGla~~~~~~~~~~~ 768 (894)
+|..++.. ..+++..++.++.|++.||.|||+ ++++||||||+||+++.++.+||+|||++....... ...
T Consensus 104 ~L~~~~~~-----~~~~~~~~~~~~~qi~~~L~~LH~---~~ivH~dl~p~Nill~~~~~~kL~dfg~~~~~~~~~-~~~ 174 (297)
T cd06659 104 ALTDIVSQ-----TRLNEEQIATVCESVLQALCYLHS---QGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDV-PKR 174 (297)
T ss_pred CHHHHHhh-----cCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHeEEccCCcEEEeechhHhhccccc-ccc
Confidence 99988754 347889999999999999999997 599999999999999999999999999987553221 122
Q ss_pred ccccccCCccCcccccCcCCCccccHHHHHHHHHHHHcCCCCCCCCCcchhhhHHHHHHHHhhcCCCCccccccccCCCC
Q 002673 769 TELVGTLGYIPPEYGQAWVATLRGDMYSFGVVMLELLTGKRPVDVLKPKMSRELVGWVLKMRSEGKQDQVFDPILRGKGF 848 (894)
Q Consensus 769 ~~~~gt~~Y~APE~~~~~~~s~ksDVwS~GvlL~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~ 848 (894)
....|+..|+|||++.+..++.++|||||||++|||++|+.||...... ..... .. ........ ..
T Consensus 175 ~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~---~~~~~---~~-~~~~~~~~-------~~ 240 (297)
T cd06659 175 KSLVGTPYWMAPEVISRTPYGTEVDIWSLGIMVIEMVDGEPPYFSDSPV---QAMKR---LR-DSPPPKLK-------NA 240 (297)
T ss_pred cceecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH---HHHHH---Hh-ccCCCCcc-------cc
Confidence 3456899999999998888999999999999999999999999743321 11111 11 11100000 00
Q ss_pred hHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 002673 849 DEEMLQVLDVACMCVSQNPFKRPTVKEVVE 878 (894)
Q Consensus 849 ~~~~~~l~~li~~Cl~~dP~~RPs~~evl~ 878 (894)
......+.+++.+|++.+|++||+++++++
T Consensus 241 ~~~~~~l~~~i~~~l~~~P~~Rps~~~ll~ 270 (297)
T cd06659 241 HKISPVLRDFLERMLTREPQERATAQELLD 270 (297)
T ss_pred CCCCHHHHHHHHHHhcCCcccCcCHHHHhh
Confidence 111235678999999999999999999998
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i |
| >cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-32 Score=301.04 Aligned_cols=266 Identities=24% Similarity=0.263 Sum_probs=200.8
Q ss_pred CCCccceEeecCcEEEEEEEE-cCCCeEEEEEEcCcchh-----hHHHHHHHHHHHHhcCCCceeeecceeeecceEEEE
Q 002673 608 NFSQANIIGCGGFGLVYKATL-ANGTTLAIKKLSGDLGL-----MEREFKAEVEALSTAQHKNLVSLQGYCVHQGFRLLI 681 (894)
Q Consensus 608 ~f~~~~~LG~G~fg~Vy~a~~-~~g~~vAvK~~~~~~~~-----~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~lV 681 (894)
+|+..+.||+|+||.||+|.. .+++.||||++...... ....+..|+++++.++|+||+++++++.+.+..++|
T Consensus 1 ~y~~~~~lg~g~~~~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv 80 (298)
T cd07841 1 RYEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGLLDVFGHKSNINLV 80 (298)
T ss_pred CceeeeeeeeccccEEEEEEECCCCcEEEEEEEeccccccccchhhHHHHHHHHHHhhcCCCCChhhhheeecCCEEEEE
Confidence 477788999999999999985 46899999999764322 335577899999999999999999999999999999
Q ss_pred EEeccCCCHHHHHhhhcCCCCCcCHHHHHHHHHHHHHHHHHHHhccCCCeeecCCCCCCeEECCCCcEEEEEcccccccC
Q 002673 682 YSYMENGSLDYWLHEKADGASQLDWLTRLKIARGTSCGLAYMHQICEPHIVHRDIKSSNILLDDQFEAHLADFGLSRLIL 761 (894)
Q Consensus 682 ~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDLkp~NILld~~~~vkl~DFGla~~~~ 761 (894)
|||+ +|+|.+++.... ..+++..+..++.||++||.|||+ .+++|+||||+||+++.++.++|+|||+++...
T Consensus 81 ~e~~-~~~L~~~i~~~~---~~~~~~~~~~~~~qi~~al~~lH~---~~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~ 153 (298)
T cd07841 81 FEFM-ETDLEKVIKDKS---IVLTPADIKSYMLMTLRGLEYLHS---NWILHRDLKPNNLLIASDGVLKLADFGLARSFG 153 (298)
T ss_pred Eccc-CCCHHHHHhccC---CCCCHHHHHHHHHHHHHHHHHHHh---CCeeecCCChhhEEEcCCCCEEEccceeeeecc
Confidence 9999 899999997542 368999999999999999999997 599999999999999999999999999998764
Q ss_pred CCCCcccccccccCCccCcccccC-cCCCccccHHHHHHHHHHHHcCCCCCCCCCcchhhhHHHHHHHHhhc--------
Q 002673 762 PYQTHVTTELVGTLGYIPPEYGQA-WVATLRGDMYSFGVVMLELLTGKRPVDVLKPKMSRELVGWVLKMRSE-------- 832 (894)
Q Consensus 762 ~~~~~~~~~~~gt~~Y~APE~~~~-~~~s~ksDVwS~GvlL~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~-------- 832 (894)
.... ......++..|+|||.+.+ ..++.++|||||||++|||++|..||........ ...........
T Consensus 154 ~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~e~~~g~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~ 230 (298)
T cd07841 154 SPNR-KMTHQVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFLPGDSDIDQ--LGKIFEALGTPTEENWPGV 230 (298)
T ss_pred CCCc-cccccccceeeeCHHHHhCCCCCCcHHHHHHHHHHHHHHHcCCccccCCccHHH--HHHHHHHcCCCchhhhhhc
Confidence 3221 2223456788999998755 4678999999999999999999888865432111 11110000000
Q ss_pred CCCCccccccccC-----CCChHHHHHHHHHHHHhcccCCCCCCCHHHHHH--HHHhc
Q 002673 833 GKQDQVFDPILRG-----KGFDEEMLQVLDVACMCVSQNPFKRPTVKEVVE--WLNNV 883 (894)
Q Consensus 833 ~~~~~~~d~~l~~-----~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~--~L~~i 883 (894)
............. .........+.+++.+||+.+|++|||+.++++ |+++-
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~e~l~~~~~~~~ 288 (298)
T cd07841 231 TSLPDYVEFKPFPPTPLKQIFPAASDDALDLLQRLLTLNPNKRITARQALEHPYFSND 288 (298)
T ss_pred ccccccccccccCCcchhhhcccccHHHHHHHHHHhcCCcccCcCHHHHhhCccccCC
Confidence 0000000000000 001122346789999999999999999999998 67654
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is |
| >cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-32 Score=294.35 Aligned_cols=256 Identities=24% Similarity=0.430 Sum_probs=197.9
Q ss_pred CCccceEeecCcEEEEEEEEc----CCCeEEEEEEcCcc--hhhHHHHHHHHHHHHhcCCCceeeecceeeecc------
Q 002673 609 FSQANIIGCGGFGLVYKATLA----NGTTLAIKKLSGDL--GLMEREFKAEVEALSTAQHKNLVSLQGYCVHQG------ 676 (894)
Q Consensus 609 f~~~~~LG~G~fg~Vy~a~~~----~g~~vAvK~~~~~~--~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~------ 676 (894)
|.+.+.||+|+||.||+|.+. ++..||||.+..+. ....+++.+|+.+++.++||||+++++++....
T Consensus 1 ~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 80 (273)
T cd05074 1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIKLIGVSLRSRAKGRLP 80 (273)
T ss_pred CcchhcccCCCCCCEEeeEeeccCCCceEEEEEEeccccCChHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCCCCccc
Confidence 556788999999999999753 36889999987643 234567889999999999999999999886532
Q ss_pred eEEEEEEeccCCCHHHHHhhhc--CCCCCcCHHHHHHHHHHHHHHHHHHHhccCCCeeecCCCCCCeEECCCCcEEEEEc
Q 002673 677 FRLLIYSYMENGSLDYWLHEKA--DGASQLDWLTRLKIARGTSCGLAYMHQICEPHIVHRDIKSSNILLDDQFEAHLADF 754 (894)
Q Consensus 677 ~~~lV~E~~~~gsL~~~l~~~~--~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDLkp~NILld~~~~vkl~DF 754 (894)
..++++||+.+|+|.+++.... .....+++...+.++.|++.||+|||+ ++|+||||||+||+++.++.+||+||
T Consensus 81 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~---~~i~H~dikp~nili~~~~~~kl~df 157 (273)
T cd05074 81 IPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSS---KNFIHRDLAARNCMLNENMTVCVADF 157 (273)
T ss_pred ceEEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHh---CCEeecccchhhEEEcCCCCEEECcc
Confidence 2478899999999998876432 122357888999999999999999997 59999999999999999999999999
Q ss_pred ccccccCCCCCc-ccccccccCCccCcccccCcCCCccccHHHHHHHHHHHHc-CCCCCCCCCcchhhhHHHHHHHHhhc
Q 002673 755 GLSRLILPYQTH-VTTELVGTLGYIPPEYGQAWVATLRGDMYSFGVVMLELLT-GKRPVDVLKPKMSRELVGWVLKMRSE 832 (894)
Q Consensus 755 Gla~~~~~~~~~-~~~~~~gt~~Y~APE~~~~~~~s~ksDVwS~GvlL~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~ 832 (894)
|+++........ ......++..|++||.+.+..++.++||||||+++|||++ |+.||...... ....+.. ..
T Consensus 158 g~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~sDi~slG~il~el~~~g~~p~~~~~~~---~~~~~~~---~~ 231 (273)
T cd05074 158 GLSKKIYSGDYYRQGCASKLPVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPYAGVENS---EIYNYLI---KG 231 (273)
T ss_pred cccccccCCcceecCCCccCchhhcCHhHHhcCccchhhhhHHHHHHHHHHhhCCCCCCCCCCHH---HHHHHHH---cC
Confidence 999865332211 1122345678999999988889999999999999999999 89998754321 1111111 11
Q ss_pred CCCCccccccccCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhc
Q 002673 833 GKQDQVFDPILRGKGFDEEMLQVLDVACMCVSQNPFKRPTVKEVVEWLNNV 883 (894)
Q Consensus 833 ~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~i 883 (894)
..... . ......+.+++.+|++.+|++||++.++++.|+++
T Consensus 232 ~~~~~--~--------~~~~~~~~~l~~~~l~~~p~~Rps~~~~~~~l~~~ 272 (273)
T cd05074 232 NRLKQ--P--------PDCLEDVYELMCQCWSPEPKCRPSFQHLRDQLELI 272 (273)
T ss_pred CcCCC--C--------CCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 11100 0 11224678999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac |
| >cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-32 Score=296.34 Aligned_cols=253 Identities=23% Similarity=0.400 Sum_probs=201.2
Q ss_pred CCCccceEeecCcEEEEEEEE-cCCCeEEEEEEcCcc-hhhHHHHHHHHHHHHhcC---CCceeeecceeeecceEEEEE
Q 002673 608 NFSQANIIGCGGFGLVYKATL-ANGTTLAIKKLSGDL-GLMEREFKAEVEALSTAQ---HKNLVSLQGYCVHQGFRLLIY 682 (894)
Q Consensus 608 ~f~~~~~LG~G~fg~Vy~a~~-~~g~~vAvK~~~~~~-~~~~~~~~~Ei~~l~~l~---HpnIv~l~g~~~~~~~~~lV~ 682 (894)
.|+..+.||+|+||.||+|.. .++..||+|.+.... ......+.+|+.+++.++ |||++++++++..+...++||
T Consensus 2 ~y~~~~~l~~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~~~~~~~lv~ 81 (277)
T cd06917 2 LYQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKYYGSYLKGPRLWIIM 81 (277)
T ss_pred hhhhhhheeccCCceEEEEEEcCCCcEEEEEEecCCCCchhHHHHHHHHHHHHHhccCCCCCeeeEeeeeeeCCEEEEEE
Confidence 467778999999999999985 578999999987543 233456889999999997 999999999999999999999
Q ss_pred EeccCCCHHHHHhhhcCCCCCcCHHHHHHHHHHHHHHHHHHHhccCCCeeecCCCCCCeEECCCCcEEEEEcccccccCC
Q 002673 683 SYMENGSLDYWLHEKADGASQLDWLTRLKIARGTSCGLAYMHQICEPHIVHRDIKSSNILLDDQFEAHLADFGLSRLILP 762 (894)
Q Consensus 683 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDLkp~NILld~~~~vkl~DFGla~~~~~ 762 (894)
||+++++|.+++... .+++...+.++.|++.||.|||+ .+++|+||+|+||+++.++.++|+|||++.....
T Consensus 82 e~~~~~~L~~~~~~~-----~l~~~~~~~i~~~i~~~l~~lh~---~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~ 153 (277)
T cd06917 82 EYAEGGSVRTLMKAG-----PIAEKYISVIIREVLVALKYIHK---VGVIHRDIKAANILVTNTGNVKLCDFGVAALLNQ 153 (277)
T ss_pred ecCCCCcHHHHHHcc-----CCCHHHHHHHHHHHHHHHHHHHh---CCcccCCcCHHHEEEcCCCCEEEccCCceeecCC
Confidence 999999999988642 58899999999999999999997 5999999999999999999999999999987643
Q ss_pred CCCcccccccccCCccCcccccCc-CCCccccHHHHHHHHHHHHcCCCCCCCCCcchhhhHHHHHHHHhhcCCCCccccc
Q 002673 763 YQTHVTTELVGTLGYIPPEYGQAW-VATLRGDMYSFGVVMLELLTGKRPVDVLKPKMSRELVGWVLKMRSEGKQDQVFDP 841 (894)
Q Consensus 763 ~~~~~~~~~~gt~~Y~APE~~~~~-~~s~ksDVwS~GvlL~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 841 (894)
.. .......|+..|+|||+..+. .++.++|||||||++|+|++|+.||....... ..... ... ..+
T Consensus 154 ~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~------~~~~~-~~~-----~~~ 220 (277)
T cd06917 154 NS-SKRSTFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSDVDAFR------AMMLI-PKS-----KPP 220 (277)
T ss_pred Cc-cccccccCCcceeCHHHhccCCccccchhHHHHHHHHHHHHhCCCCCCCCChhh------hhhcc-ccC-----CCC
Confidence 33 223345688999999987654 56889999999999999999999997543211 11000 000 111
Q ss_pred cccCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHH--HHHhcc
Q 002673 842 ILRGKGFDEEMLQVLDVACMCVSQNPFKRPTVKEVVE--WLNNVG 884 (894)
Q Consensus 842 ~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~--~L~~i~ 884 (894)
.+.... ....+.+++.+|++.||++||++.++++ |+++..
T Consensus 221 ~~~~~~---~~~~~~~~i~~~l~~~p~~R~~~~~il~~~~~~~~~ 262 (277)
T cd06917 221 RLEDNG---YSKLLREFVAACLDEEPKERLSAEELLKSKWIKAHS 262 (277)
T ss_pred CCCccc---CCHHHHHHHHHHcCCCcccCcCHHHHhhChHhhccc
Confidence 111111 2345778999999999999999999998 665544
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent |
| >KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-33 Score=313.18 Aligned_cols=247 Identities=23% Similarity=0.340 Sum_probs=200.1
Q ss_pred CccceEeecCcEEEEEEEEc--CC--CeEEEEEEcCcchh-hHHHHHHHHHHHHhcCCCceeeecceeeecceEEEEEEe
Q 002673 610 SQANIIGCGGFGLVYKATLA--NG--TTLAIKKLSGDLGL-MEREFKAEVEALSTAQHKNLVSLQGYCVHQGFRLLIYSY 684 (894)
Q Consensus 610 ~~~~~LG~G~fg~Vy~a~~~--~g--~~vAvK~~~~~~~~-~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~lV~E~ 684 (894)
...++||+|.||.|++|.|. +| -.||||.+..+... ...+|.+|+.+|.+|+|||+++|+|+..+ ....||||+
T Consensus 113 ~l~e~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~l~~~mddflrEas~M~~L~H~hliRLyGvVl~-qp~mMV~EL 191 (1039)
T KOG0199|consen 113 KLYELLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDSLNAIMDDFLREASHMLKLQHPHLIRLYGVVLD-QPAMMVFEL 191 (1039)
T ss_pred HHHHHhcCcceeeEeeccccCCCCcEEeEEEEeccCCccchhHHHHHHHHHHHHhccCcceeEEeeeecc-chhhHHhhh
Confidence 34577999999999999874 33 45899999877644 56789999999999999999999999887 667899999
Q ss_pred ccCCCHHHHHhhhcCCCCCcCHHHHHHHHHHHHHHHHHHHhccCCCeeecCCCCCCeEECCCCcEEEEEcccccccCCCC
Q 002673 685 MENGSLDYWLHEKADGASQLDWLTRLKIARGTSCGLAYMHQICEPHIVHRDIKSSNILLDDQFEAHLADFGLSRLILPYQ 764 (894)
Q Consensus 685 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDLkp~NILld~~~~vkl~DFGla~~~~~~~ 764 (894)
++.|+|.+.|+. .....|.......++.|||.||.||.+ +++|||||.++|+||-....|||+|||+.+.+....
T Consensus 192 aplGSLldrLrk--a~~~~llv~~Lcdya~QiA~aM~YLes---krlvHRDLAARNlllasprtVKI~DFGLmRaLg~ne 266 (1039)
T KOG0199|consen 192 APLGSLLDRLRK--AKKAILLVSRLCDYAMQIAKAMQYLES---KRLVHRDLAARNLLLASPRTVKICDFGLMRALGENE 266 (1039)
T ss_pred cccchHHHHHhh--ccccceeHHHHHHHHHHHHHHHHHHhh---hhhhhhhhhhhhheecccceeeeecccceeccCCCC
Confidence 999999999997 234567788889999999999999997 699999999999999999999999999999875433
Q ss_pred Ccc--cccccccCCccCcccccCcCCCccccHHHHHHHHHHHHc-CCCCCCCCCcchhhhHHHHHHHHhhcCCCCccccc
Q 002673 765 THV--TTELVGTLGYIPPEYGQAWVATLRGDMYSFGVVMLELLT-GKRPVDVLKPKMSRELVGWVLKMRSEGKQDQVFDP 841 (894)
Q Consensus 765 ~~~--~~~~~gt~~Y~APE~~~~~~~s~ksDVwS~GvlL~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 841 (894)
... .....-.+.|.|||.+....++.+||||+|||.||||+| |..||-+.........+ ..+ +.+
T Consensus 267 d~Yvm~p~rkvPfAWCaPEsLrh~kFShaSDvWmyGVTiWEMFtyGEePW~G~~g~qIL~~i-------D~~--erL--- 334 (1039)
T KOG0199|consen 267 DMYVMAPQRKVPFAWCAPESLRHRKFSHASDVWMYGVTIWEMFTYGEEPWVGCRGIQILKNI-------DAG--ERL--- 334 (1039)
T ss_pred cceEecCCCcCcccccCHhHhccccccccchhhhhhhhHHhhhccCCCCCCCCCHHHHHHhc-------ccc--ccC---
Confidence 221 112234568999999999999999999999999999999 89999876643222111 111 111
Q ss_pred cccCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 002673 842 ILRGKGFDEEMLQVLDVACMCVSQNPFKRPTVKEVVE 878 (894)
Q Consensus 842 ~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~ 878 (894)
-+.+.+ ...+++++..||..+|.+|||+..|.+
T Consensus 335 -pRPk~c---sedIY~imk~cWah~paDRptFsair~ 367 (1039)
T KOG0199|consen 335 -PRPKYC---SEDIYQIMKNCWAHNPADRPTFSAIRE 367 (1039)
T ss_pred -CCCCCC---hHHHHHHHHHhccCCccccccHHHHHH
Confidence 112233 446789999999999999999999985
|
|
| >cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-32 Score=298.67 Aligned_cols=254 Identities=24% Similarity=0.291 Sum_probs=196.4
Q ss_pred cCCCccceEeecCcEEEEEEEE-cCCCeEEEEEEcCcch---hhHHHHHHHHHHHHhcCCCceeeecceeeecceEEEEE
Q 002673 607 DNFSQANIIGCGGFGLVYKATL-ANGTTLAIKKLSGDLG---LMEREFKAEVEALSTAQHKNLVSLQGYCVHQGFRLLIY 682 (894)
Q Consensus 607 ~~f~~~~~LG~G~fg~Vy~a~~-~~g~~vAvK~~~~~~~---~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~lV~ 682 (894)
++|+..+.||+|+||.||++.. .+++.|++|.+..... .....+.+|+.+++.++||||+++++.+..++..++||
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (305)
T cd05609 1 EDFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAENPFVVSMFCSFETKRHLCMVM 80 (305)
T ss_pred CCceEeeEeecCCCeeEEEEEECCCCcEEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEecCCEEEEEE
Confidence 3688889999999999999985 4678999999876432 22356789999999999999999999999999999999
Q ss_pred EeccCCCHHHHHhhhcCCCCCcCHHHHHHHHHHHHHHHHHHHhccCCCeeecCCCCCCeEECCCCcEEEEEcccccccCC
Q 002673 683 SYMENGSLDYWLHEKADGASQLDWLTRLKIARGTSCGLAYMHQICEPHIVHRDIKSSNILLDDQFEAHLADFGLSRLILP 762 (894)
Q Consensus 683 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDLkp~NILld~~~~vkl~DFGla~~~~~ 762 (894)
||+++++|.+++... ..+++..+..++.|++.||.|||+ ++++||||||+||+++.++.+||+|||+++....
T Consensus 81 e~~~g~~L~~~l~~~----~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dl~p~NIll~~~~~~~l~dfg~~~~~~~ 153 (305)
T cd05609 81 EYVEGGDCATLLKNI----GALPVDMARMYFAETVLALEYLHN---YGIVHRDLKPDNLLITSMGHIKLTDFGLSKIGLM 153 (305)
T ss_pred ecCCCCcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHH---CCccccCCchHHEEECCCCCEEEeeCCCccccCc
Confidence 999999999999754 358888999999999999999997 5999999999999999999999999999874211
Q ss_pred CC--------------CcccccccccCCccCcccccCcCCCccccHHHHHHHHHHHHcCCCCCCCCCcchhhhHHHHHHH
Q 002673 763 YQ--------------THVTTELVGTLGYIPPEYGQAWVATLRGDMYSFGVVMLELLTGKRPVDVLKPKMSRELVGWVLK 828 (894)
Q Consensus 763 ~~--------------~~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwS~GvlL~elltG~~Pf~~~~~~~~~~~~~~~~~ 828 (894)
.. ........++..|+|||++.+..++.++|+||||+++|||++|+.||...... ... ..
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~vl~el~~g~~pf~~~~~~---~~~---~~ 227 (305)
T cd05609 154 SLTTNLYEGHIEKDTREFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPE---ELF---GQ 227 (305)
T ss_pred CccccccccccccchhhccccCCccCccccCchhccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH---HHH---HH
Confidence 00 00111245788999999998888999999999999999999999999743321 111 11
Q ss_pred HhhcCCCCccccccccCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 002673 829 MRSEGKQDQVFDPILRGKGFDEEMLQVLDVACMCVSQNPFKRPTVKEVVEWLN 881 (894)
Q Consensus 829 ~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~ 881 (894)
.... ... .+... .. ....+.+++.+|++.+|++||++.++.+.|+
T Consensus 228 ~~~~-~~~---~~~~~-~~---~~~~~~~li~~~l~~~P~~R~~~~~~~~ll~ 272 (305)
T cd05609 228 VISD-DIE---WPEGD-EA---LPADAQDLISRLLRQNPLERLGTGGAFEVKQ 272 (305)
T ss_pred HHhc-ccC---CCCcc-cc---CCHHHHHHHHHHhccChhhccCccCHHHHHh
Confidence 1111 100 00000 01 1234678999999999999999655555443
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a |
| >cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-33 Score=311.64 Aligned_cols=240 Identities=25% Similarity=0.276 Sum_probs=184.9
Q ss_pred EeecCcEEEEEEEE-cCCCeEEEEEEcCcchh---hHHHHHHHHHHHHhc---CCCceeeecceeeecceEEEEEEeccC
Q 002673 615 IGCGGFGLVYKATL-ANGTTLAIKKLSGDLGL---MEREFKAEVEALSTA---QHKNLVSLQGYCVHQGFRLLIYSYMEN 687 (894)
Q Consensus 615 LG~G~fg~Vy~a~~-~~g~~vAvK~~~~~~~~---~~~~~~~Ei~~l~~l---~HpnIv~l~g~~~~~~~~~lV~E~~~~ 687 (894)
||+|+||.||+|.. .+++.||||++...... ....+..|..++... +||||+++++++......++||||+++
T Consensus 1 lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~~~~~~lv~e~~~~ 80 (330)
T cd05586 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQTDSDLYLVTDYMSG 80 (330)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEEeHHHHhhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEEecCCeEEEEEcCCCC
Confidence 69999999999985 46899999998653221 122344566666655 699999999999999999999999999
Q ss_pred CCHHHHHhhhcCCCCCcCHHHHHHHHHHHHHHHHHHHhccCCCeeecCCCCCCeEECCCCcEEEEEcccccccCCCCCcc
Q 002673 688 GSLDYWLHEKADGASQLDWLTRLKIARGTSCGLAYMHQICEPHIVHRDIKSSNILLDDQFEAHLADFGLSRLILPYQTHV 767 (894)
Q Consensus 688 gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDLkp~NILld~~~~vkl~DFGla~~~~~~~~~~ 767 (894)
|+|..++... ..+++..+..++.||+.||+|||+ ++|+||||||+|||++.++.+||+|||+++...... ..
T Consensus 81 g~L~~~l~~~----~~~~~~~~~~~~~qil~al~~LH~---~~ivHrDlkp~Nili~~~~~~kl~Dfg~a~~~~~~~-~~ 152 (330)
T cd05586 81 GELFWHLQKE----GRFSEDRAKFYIAELVLALEHLHK---YDIVYRDLKPENILLDATGHIALCDFGLSKANLTDN-KT 152 (330)
T ss_pred ChHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHH---CCeEeccCCHHHeEECCCCCEEEecCCcCcCCCCCC-CC
Confidence 9999888753 358889999999999999999997 599999999999999999999999999987543222 22
Q ss_pred cccccccCCccCcccccCc-CCCccccHHHHHHHHHHHHcCCCCCCCCCcchhhhHHHHHHHHhhcCCCCccccccccCC
Q 002673 768 TTELVGTLGYIPPEYGQAW-VATLRGDMYSFGVVMLELLTGKRPVDVLKPKMSRELVGWVLKMRSEGKQDQVFDPILRGK 846 (894)
Q Consensus 768 ~~~~~gt~~Y~APE~~~~~-~~s~ksDVwS~GvlL~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~ 846 (894)
.....||..|+|||++.+. .++.++|||||||++|+|++|+.||...... ... ... ..+.. .+ ...
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~elltG~~Pf~~~~~~---~~~---~~i-~~~~~-~~-----~~~ 219 (330)
T cd05586 153 TNTFCGTTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYAEDTQ---QMY---RNI-AFGKV-RF-----PKN 219 (330)
T ss_pred ccCccCCccccCHHHHcCCCCCCCccceeccccEEEEeccCCCCCCCCCHH---HHH---HHH-HcCCC-CC-----CCc
Confidence 3345799999999988764 4789999999999999999999999753321 111 111 11111 01 001
Q ss_pred CChHHHHHHHHHHHHhcccCCCCCC----CHHHHHH
Q 002673 847 GFDEEMLQVLDVACMCVSQNPFKRP----TVKEVVE 878 (894)
Q Consensus 847 ~~~~~~~~l~~li~~Cl~~dP~~RP----s~~evl~ 878 (894)
.. ...+.+++.+||+.||.+|| ++.++++
T Consensus 220 ~~---~~~~~~li~~~L~~~P~~R~~~~~~~~~ll~ 252 (330)
T cd05586 220 VL---SDEGRQFVKGLLNRNPQHRLGAHRDAVELKE 252 (330)
T ss_pred cC---CHHHHHHHHHHcCCCHHHCCCCCCCHHHHhc
Confidence 11 22456889999999999998 6777776
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of |
| >cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-32 Score=299.09 Aligned_cols=261 Identities=22% Similarity=0.301 Sum_probs=195.1
Q ss_pred cCCCccceEeecCcEEEEEEEEc-CCCeEEEEEEcCcchh-hHHHHHHHHHHHHhcCCCceeeecceeeecceEEEEEEe
Q 002673 607 DNFSQANIIGCGGFGLVYKATLA-NGTTLAIKKLSGDLGL-MEREFKAEVEALSTAQHKNLVSLQGYCVHQGFRLLIYSY 684 (894)
Q Consensus 607 ~~f~~~~~LG~G~fg~Vy~a~~~-~g~~vAvK~~~~~~~~-~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~lV~E~ 684 (894)
++|+..+.||+|++|.||+|... +++.||+|.+...... ....+.+|+++++.++|+||+++++++.+++..++||||
T Consensus 5 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 84 (291)
T cd07844 5 ETYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPFTAIREASLLKDLKHANIVTLHDIIHTKKTLTLVFEY 84 (291)
T ss_pred cceeEEEEEeecCCeEEEEEEEcCCCcEEEEEEEecccccCCchhHHHHHHHHhhCCCcceeeEEEEEecCCeEEEEEec
Confidence 57888999999999999999854 6899999998754321 224567899999999999999999999999999999999
Q ss_pred ccCCCHHHHHhhhcCCCCCcCHHHHHHHHHHHHHHHHHHHhccCCCeeecCCCCCCeEECCCCcEEEEEcccccccCCCC
Q 002673 685 MENGSLDYWLHEKADGASQLDWLTRLKIARGTSCGLAYMHQICEPHIVHRDIKSSNILLDDQFEAHLADFGLSRLILPYQ 764 (894)
Q Consensus 685 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDLkp~NILld~~~~vkl~DFGla~~~~~~~ 764 (894)
+. ++|.+++.... ..+++.....++.|++.||.|||+ ++++||||||+||+++.++.+||+|||+++......
T Consensus 85 ~~-~~L~~~~~~~~---~~~~~~~~~~~~~ql~~al~~lH~---~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~ 157 (291)
T cd07844 85 LD-TDLKQYMDDCG---GGLSMHNVRLFLFQLLRGLAYCHQ---RRVLHRDLKPQNLLISERGELKLADFGLARAKSVPS 157 (291)
T ss_pred CC-CCHHHHHHhCC---CCCCHHHHHHHHHHHHHHHHHHHh---CCeecccCCHHHEEEcCCCCEEECccccccccCCCC
Confidence 97 49999887543 367889999999999999999997 599999999999999999999999999987542211
Q ss_pred CcccccccccCCccCcccccC-cCCCccccHHHHHHHHHHHHcCCCCCCCCCcchhhhHHHHHHHHhhcC---CCCcc--
Q 002673 765 THVTTELVGTLGYIPPEYGQA-WVATLRGDMYSFGVVMLELLTGKRPVDVLKPKMSRELVGWVLKMRSEG---KQDQV-- 838 (894)
Q Consensus 765 ~~~~~~~~gt~~Y~APE~~~~-~~~s~ksDVwS~GvlL~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~---~~~~~-- 838 (894)
.......++..|+|||+..+ ..++.++||||||+++|+|++|+.||...... .+............ .....
T Consensus 158 -~~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~ 234 (291)
T cd07844 158 -KTYSNEVVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGSTDV--EDQLHKIFRVLGTPTEETWPGVSS 234 (291)
T ss_pred -ccccccccccccCCcHHhhcCcccCcHHHHHHHHHHHHHHHhCCCCCCCCccH--HHHHHHHHHhcCCCChhhhhhhhh
Confidence 11122346889999998765 45789999999999999999999999654311 11111000000000 00000
Q ss_pred -----------c-cccccCCCChH--HHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 002673 839 -----------F-DPILRGKGFDE--EMLQVLDVACMCVSQNPFKRPTVKEVVE 878 (894)
Q Consensus 839 -----------~-d~~l~~~~~~~--~~~~l~~li~~Cl~~dP~~RPs~~evl~ 878 (894)
. ...+. ..... ....+.+++.+|++.+|++|||+.++++
T Consensus 235 ~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~li~~~L~~~p~~Rps~~e~l~ 287 (291)
T cd07844 235 NPEFKPYSFPFYPPRPLI-NHAPRLDRIPHGEELALKFLQYEPKKRISAAEAMK 287 (291)
T ss_pred ccccccccccccCChhHH-HhCcCCCCchhHHHHHHHHhccCcccccCHHHHhc
Confidence 0 00000 00000 1146678999999999999999999875
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the |
| >cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-32 Score=297.71 Aligned_cols=265 Identities=23% Similarity=0.262 Sum_probs=195.7
Q ss_pred hccCCCccceEeecCcEEEEEEEE-cCCCeEEEEEEcCcch-hhHHHHHHHHHHHHhcCCCceeeecceeeecceEEEEE
Q 002673 605 ATDNFSQANIIGCGGFGLVYKATL-ANGTTLAIKKLSGDLG-LMEREFKAEVEALSTAQHKNLVSLQGYCVHQGFRLLIY 682 (894)
Q Consensus 605 a~~~f~~~~~LG~G~fg~Vy~a~~-~~g~~vAvK~~~~~~~-~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~lV~ 682 (894)
++++|.+.+.||+|+||.||+|.. .+|..||+|.+..... .....+.+|+.+++.++|+||+++++++..++..++||
T Consensus 3 ~~~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~ 82 (291)
T cd07870 3 AATSYLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAIREASLLKGLKHANIVLLHDIIHTKETLTFVF 82 (291)
T ss_pred ccceeEEEEEEEecCCEEEEEEEEcCCCcEEEEEEecccCcCCCcHHHHHHHHHHHhcCCCCEeEEEEEEecCCeEEEEE
Confidence 457899999999999999999984 5789999999875432 22346778999999999999999999999999999999
Q ss_pred EeccCCCHHHHHhhhcCCCCCcCHHHHHHHHHHHHHHHHHHHhccCCCeeecCCCCCCeEECCCCcEEEEEcccccccCC
Q 002673 683 SYMENGSLDYWLHEKADGASQLDWLTRLKIARGTSCGLAYMHQICEPHIVHRDIKSSNILLDDQFEAHLADFGLSRLILP 762 (894)
Q Consensus 683 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDLkp~NILld~~~~vkl~DFGla~~~~~ 762 (894)
||+. ++|.+++.... ..+.+..+..++.|++.||.|||+ .+++|+||||+||+++.++.+||+|||+++....
T Consensus 83 e~~~-~~l~~~~~~~~---~~~~~~~~~~~~~qi~~~L~~lH~---~~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~ 155 (291)
T cd07870 83 EYMH-TDLAQYMIQHP---GGLHPYNVRLFMFQLLRGLAYIHG---QHILHRDLKPQNLLISYLGELKLADFGLARAKSI 155 (291)
T ss_pred eccc-CCHHHHHHhCC---CCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCChHHEEEcCCCcEEEeccccccccCC
Confidence 9995 67777765432 346788888999999999999997 5999999999999999999999999999875432
Q ss_pred CCCcccccccccCCccCcccccCc-CCCccccHHHHHHHHHHHHcCCCCCCCCCcchhhhHHHHHHHHh-----------
Q 002673 763 YQTHVTTELVGTLGYIPPEYGQAW-VATLRGDMYSFGVVMLELLTGKRPVDVLKPKMSRELVGWVLKMR----------- 830 (894)
Q Consensus 763 ~~~~~~~~~~gt~~Y~APE~~~~~-~~s~ksDVwS~GvlL~elltG~~Pf~~~~~~~~~~~~~~~~~~~----------- 830 (894)
.. .......++..|+|||++.+. .++.++|||||||++|+|++|+.||+...... ..+........
T Consensus 156 ~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~f~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~ 233 (291)
T cd07870 156 PS-QTYSSEVVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAFPGVSDVF-EQLEKIWTVLGVPTEDTWPGVS 233 (291)
T ss_pred CC-CCCCCccccccccCCceeecCCCCCcHHHHHHHHHHHHHHHhCCCCCCCchhHH-HHHHHHHHHcCCCChhhhhhhh
Confidence 11 112334578899999998764 57889999999999999999999997544311 11111000000
Q ss_pred hc-CCCCccccccccCC-----CChHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 002673 831 SE-GKQDQVFDPILRGK-----GFDEEMLQVLDVACMCVSQNPFKRPTVKEVVE 878 (894)
Q Consensus 831 ~~-~~~~~~~d~~l~~~-----~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~ 878 (894)
.. .............. ........+.+++.+|++.||.+|||+++++.
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dp~~R~t~~~~l~ 287 (291)
T cd07870 234 KLPNYKPEWFLPCKPQQLRVVWKRLSRPPKAEDLASQMLMMFPKDRISAQDALL 287 (291)
T ss_pred hcccccchhccccCCcchhhhccccCCChHHHHHHHHHhCcCcccCcCHHHHhc
Confidence 00 00000000000000 00001235678999999999999999999875
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess |
| >cd05122 PKc_STE Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-32 Score=285.65 Aligned_cols=249 Identities=29% Similarity=0.436 Sum_probs=203.5
Q ss_pred CCCccceEeecCcEEEEEEEEc-CCCeEEEEEEcCcchhhHHHHHHHHHHHHhcCCCceeeecceeeecceEEEEEEecc
Q 002673 608 NFSQANIIGCGGFGLVYKATLA-NGTTLAIKKLSGDLGLMEREFKAEVEALSTAQHKNLVSLQGYCVHQGFRLLIYSYME 686 (894)
Q Consensus 608 ~f~~~~~LG~G~fg~Vy~a~~~-~g~~vAvK~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~lV~E~~~ 686 (894)
+|+..+.||+|++|.||++... ++..+++|++..........+.+|++.++.++|+|++++++++..+...++++||++
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l~~e~~~ 80 (253)
T cd05122 1 LFEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVKYYGSYLKKDELWIVMEFCS 80 (253)
T ss_pred CceeeeeeccCCceEEEEEEECCCCcEEEEEEecccchhHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEecCC
Confidence 4777899999999999999864 789999999987655456789999999999999999999999999999999999999
Q ss_pred CCCHHHHHhhhcCCCCCcCHHHHHHHHHHHHHHHHHHHhccCCCeeecCCCCCCeEECCCCcEEEEEcccccccCCCCCc
Q 002673 687 NGSLDYWLHEKADGASQLDWLTRLKIARGTSCGLAYMHQICEPHIVHRDIKSSNILLDDQFEAHLADFGLSRLILPYQTH 766 (894)
Q Consensus 687 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDLkp~NILld~~~~vkl~DFGla~~~~~~~~~ 766 (894)
+++|.+++.... ..+++..+..++.|++.||.|||+ .+++||||+|+||++++++.++|+|||.+........
T Consensus 81 ~~~L~~~~~~~~---~~~~~~~~~~i~~~i~~~l~~lh~---~~i~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~- 153 (253)
T cd05122 81 GGSLKDLLKSTN---QTLTESQIAYVCKELLKGLEYLHS---NGIIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKA- 153 (253)
T ss_pred CCcHHHHHhhcC---CCCCHHHHHHHHHHHHHHHHHhhc---CCEecCCCCHHHEEEccCCeEEEeecccccccccccc-
Confidence 999999987642 468999999999999999999997 6999999999999999999999999999987644322
Q ss_pred ccccccccCCccCcccccCcCCCccccHHHHHHHHHHHHcCCCCCCCCCcchhhhHHHHHHHHhhcCCCCccccccccCC
Q 002673 767 VTTELVGTLGYIPPEYGQAWVATLRGDMYSFGVVMLELLTGKRPVDVLKPKMSRELVGWVLKMRSEGKQDQVFDPILRGK 846 (894)
Q Consensus 767 ~~~~~~gt~~Y~APE~~~~~~~s~ksDVwS~GvlL~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~ 846 (894)
.....++..|+|||++.+..++.++||||||+++|+|++|+.||....... ... .... ......... .
T Consensus 154 -~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~---~~~---~~~~-~~~~~~~~~----~ 221 (253)
T cd05122 154 -RNTMVGTPYWMAPEVINGKPYDYKADIWSLGITAIELAEGKPPYSELPPMK---ALF---KIAT-NGPPGLRNP----E 221 (253)
T ss_pred -ccceecCCcccCHHHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCchHH---HHH---HHHh-cCCCCcCcc----c
Confidence 344568899999999988889999999999999999999999997543211 111 1111 111111110 0
Q ss_pred CChHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 002673 847 GFDEEMLQVLDVACMCVSQNPFKRPTVKEVVE 878 (894)
Q Consensus 847 ~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~ 878 (894)
.....+.+++.+|++.||++|||+.++++
T Consensus 222 ---~~~~~~~~~i~~~l~~~p~~R~t~~~~l~ 250 (253)
T cd05122 222 ---KWSDEFKDFLKKCLQKNPEKRPTAEQLLK 250 (253)
T ss_pred ---ccCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 01245778999999999999999999875
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core |
| >cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-32 Score=296.55 Aligned_cols=244 Identities=25% Similarity=0.301 Sum_probs=199.0
Q ss_pred cCCCccceEeecCcEEEEEEEE-cCCCeEEEEEEcCcc---hhhHHHHHHHHHHHHhcCCCceeeecceeeecceEEEEE
Q 002673 607 DNFSQANIIGCGGFGLVYKATL-ANGTTLAIKKLSGDL---GLMEREFKAEVEALSTAQHKNLVSLQGYCVHQGFRLLIY 682 (894)
Q Consensus 607 ~~f~~~~~LG~G~fg~Vy~a~~-~~g~~vAvK~~~~~~---~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~lV~ 682 (894)
++|+..+.||+|+||.||++.. .+++.||+|++.... ......+.+|++++++++||||+++++++..++..++||
T Consensus 1 ~~y~~~~~ig~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 80 (290)
T cd05580 1 DDFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYGSFQDDSNLYLVM 80 (290)
T ss_pred CceEEEEEeecCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCccceeeEEEcCCeEEEEE
Confidence 3688889999999999999985 468999999987532 123456889999999999999999999999999999999
Q ss_pred EeccCCCHHHHHhhhcCCCCCcCHHHHHHHHHHHHHHHHHHHhccCCCeeecCCCCCCeEECCCCcEEEEEcccccccCC
Q 002673 683 SYMENGSLDYWLHEKADGASQLDWLTRLKIARGTSCGLAYMHQICEPHIVHRDIKSSNILLDDQFEAHLADFGLSRLILP 762 (894)
Q Consensus 683 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDLkp~NILld~~~~vkl~DFGla~~~~~ 762 (894)
||+++++|.+++... ..++...+..++.|++.||.|||+ ++++|+||+|+||+++.++.+||+|||++.....
T Consensus 81 e~~~~~~L~~~~~~~----~~l~~~~~~~~~~qil~~l~~lH~---~~i~H~dl~p~nili~~~~~~kl~dfg~~~~~~~ 153 (290)
T cd05580 81 EYVPGGELFSHLRKS----GRFPEPVARFYAAQVVLALEYLHS---LDIVYRDLKPENLLLDSDGYIKITDFGFAKRVKG 153 (290)
T ss_pred ecCCCCCHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHH---CCEecCCCCHHHEEECCCCCEEEeeCCCccccCC
Confidence 999999999999764 358889999999999999999997 6999999999999999999999999999987543
Q ss_pred CCCcccccccccCCccCcccccCcCCCccccHHHHHHHHHHHHcCCCCCCCCCcchhhhHHHHHHHHhhcCCCCcccccc
Q 002673 763 YQTHVTTELVGTLGYIPPEYGQAWVATLRGDMYSFGVVMLELLTGKRPVDVLKPKMSRELVGWVLKMRSEGKQDQVFDPI 842 (894)
Q Consensus 763 ~~~~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwS~GvlL~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 842 (894)
. .....+++.|+|||.+.+...+.++||||||+++|+|++|+.||...... ..... .. .+... +.
T Consensus 154 ~----~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~---~~~~~---~~-~~~~~--~~-- 218 (290)
T cd05580 154 R----TYTLCGTPEYLAPEIILSKGYGKAVDWWALGILIYEMLAGYPPFFDDNPI---QIYEK---IL-EGKVR--FP-- 218 (290)
T ss_pred C----CCCCCCCccccChhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCHH---HHHHH---Hh-cCCcc--CC--
Confidence 2 33456889999999998888899999999999999999999999754321 11111 11 11110 00
Q ss_pred ccCCCChHHHHHHHHHHHHhcccCCCCCC-----CHHHHHH
Q 002673 843 LRGKGFDEEMLQVLDVACMCVSQNPFKRP-----TVKEVVE 878 (894)
Q Consensus 843 l~~~~~~~~~~~l~~li~~Cl~~dP~~RP-----s~~evl~ 878 (894)
.. ....+.+++.+||..||.+|| ++.++++
T Consensus 219 ---~~---~~~~l~~li~~~l~~~p~~R~~~~~~~~~~l~~ 253 (290)
T cd05580 219 ---SF---FSPDAKDLIRNLLQVDLTKRLGNLKNGVNDIKN 253 (290)
T ss_pred ---cc---CCHHHHHHHHHHccCCHHHccCcccCCHHHHHc
Confidence 01 123567899999999999999 8888875
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi |
| >cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-32 Score=293.76 Aligned_cols=257 Identities=25% Similarity=0.369 Sum_probs=207.1
Q ss_pred hccCCCccceEeecCcEEEEEEEEc-CCCeEEEEEEcCcchhhHHHHHHHHHHHHhcCCCceeeecceeeecceEEEEEE
Q 002673 605 ATDNFSQANIIGCGGFGLVYKATLA-NGTTLAIKKLSGDLGLMEREFKAEVEALSTAQHKNLVSLQGYCVHQGFRLLIYS 683 (894)
Q Consensus 605 a~~~f~~~~~LG~G~fg~Vy~a~~~-~g~~vAvK~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~lV~E 683 (894)
.++.|+..+.||+|+||.||+|... ++..|++|++..... ....+.+|++.++.++|+|++++++++......++|+|
T Consensus 17 ~~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e 95 (286)
T cd06614 17 PRELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQ-NKELIINEILIMKDCKHPNIVDYYDSYLVGDELWVVME 95 (286)
T ss_pred ccccchHhHhccCCCCeEEEEEEEccCCcEEEEEEEecCch-hHHHHHHHHHHHHHCCCCCeeEEEEEEEECCEEEEEEe
Confidence 4567888899999999999999865 689999999976544 45678899999999999999999999999999999999
Q ss_pred eccCCCHHHHHhhhcCCCCCcCHHHHHHHHHHHHHHHHHHHhccCCCeeecCCCCCCeEECCCCcEEEEEcccccccCCC
Q 002673 684 YMENGSLDYWLHEKADGASQLDWLTRLKIARGTSCGLAYMHQICEPHIVHRDIKSSNILLDDQFEAHLADFGLSRLILPY 763 (894)
Q Consensus 684 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDLkp~NILld~~~~vkl~DFGla~~~~~~ 763 (894)
|+++++|.+++.... ..+++..+..++.|++.||.|||+ .+++|+||+|+||+++.++.++|+|||++......
T Consensus 96 ~~~~~~L~~~l~~~~---~~l~~~~~~~i~~~i~~~L~~lH~---~gi~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~ 169 (286)
T cd06614 96 YMDGGSLTDIITQNF---VRMNEPQIAYVCREVLQGLEYLHS---QNVIHRDIKSDNILLSKDGSVKLADFGFAAQLTKE 169 (286)
T ss_pred ccCCCcHHHHHHHhc---cCCCHHHHHHHHHHHHHHHHHHHh---CCeeeCCCChhhEEEcCCCCEEECccchhhhhccc
Confidence 999999999998653 368999999999999999999997 69999999999999999999999999998765322
Q ss_pred CCcccccccccCCccCcccccCcCCCccccHHHHHHHHHHHHcCCCCCCCCCcchhhhHHHHHHHHhhcCCCCccccccc
Q 002673 764 QTHVTTELVGTLGYIPPEYGQAWVATLRGDMYSFGVVMLELLTGKRPVDVLKPKMSRELVGWVLKMRSEGKQDQVFDPIL 843 (894)
Q Consensus 764 ~~~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwS~GvlL~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l 843 (894)
. .......++..|+|||++.+..++.++||||||+++|+|++|+.||........ .. .... .......+
T Consensus 170 ~-~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slGvil~~l~~g~~p~~~~~~~~~--~~----~~~~-~~~~~~~~--- 238 (286)
T cd06614 170 K-SKRNSVVGTPYWMAPEVIKRKDYGPKVDIWSLGIMCIEMAEGEPPYLREPPLRA--LF----LITT-KGIPPLKN--- 238 (286)
T ss_pred h-hhhccccCCcccCCHhHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCHHHH--HH----HHHh-cCCCCCcc---
Confidence 2 122334578899999999888899999999999999999999999975432211 11 1111 11111100
Q ss_pred cCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHH--HHHhc
Q 002673 844 RGKGFDEEMLQVLDVACMCVSQNPFKRPTVKEVVE--WLNNV 883 (894)
Q Consensus 844 ~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~--~L~~i 883 (894)
.......+.+++.+|++.+|.+||++.++++ ++.+.
T Consensus 239 ----~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~~~~~~~ 276 (286)
T cd06614 239 ----PEKWSPEFKDFLNKCLVKDPEKRPSAEELLQHPFLKKA 276 (286)
T ss_pred ----hhhCCHHHHHHHHHHhccChhhCcCHHHHhhChHhhcc
Confidence 0112235778999999999999999999997 66663
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou |
| >cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-32 Score=298.08 Aligned_cols=265 Identities=22% Similarity=0.248 Sum_probs=195.3
Q ss_pred cCCCccceEeecCcEEEEEEEE-cCCCeEEEEEEcCcchh--hHHHHHHHHHHHHhcC-CCceeeecceeeecce-----
Q 002673 607 DNFSQANIIGCGGFGLVYKATL-ANGTTLAIKKLSGDLGL--MEREFKAEVEALSTAQ-HKNLVSLQGYCVHQGF----- 677 (894)
Q Consensus 607 ~~f~~~~~LG~G~fg~Vy~a~~-~~g~~vAvK~~~~~~~~--~~~~~~~Ei~~l~~l~-HpnIv~l~g~~~~~~~----- 677 (894)
++|+..+.||+|+||.||+|.. .+++.||+|.+...... ....+.+|+.+++.++ ||||+++++++.....
T Consensus 1 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~lK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~~ 80 (295)
T cd07837 1 DAYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRLLDVEHVEEKNGKPS 80 (295)
T ss_pred CCceEeeEecccCCeEEEEEEECCCCcEEEEEeehhhccccCCchHHHHHHHHHHHccCCCCccceeeeEeecCCCCCce
Confidence 4688889999999999999985 47899999988654322 2356788999999994 6999999999887665
Q ss_pred EEEEEEeccCCCHHHHHhhhcCC-CCCcCHHHHHHHHHHHHHHHHHHHhccCCCeeecCCCCCCeEECC-CCcEEEEEcc
Q 002673 678 RLLIYSYMENGSLDYWLHEKADG-ASQLDWLTRLKIARGTSCGLAYMHQICEPHIVHRDIKSSNILLDD-QFEAHLADFG 755 (894)
Q Consensus 678 ~~lV~E~~~~gsL~~~l~~~~~~-~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDLkp~NILld~-~~~vkl~DFG 755 (894)
.++||||+++ +|.+++...... ...+++..++.++.||+.||.|||+ ++++||||||+||+++. ++.+||+|||
T Consensus 81 ~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~---~~i~H~dl~~~nil~~~~~~~~kl~dfg 156 (295)
T cd07837 81 LYLVFEYLDS-DLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHK---HGVMHRDLKPQNLLVDKQKGLLKIADLG 156 (295)
T ss_pred EEEEeeccCc-CHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHH---CCeeecCCChHHEEEecCCCeEEEeecc
Confidence 7999999985 898888754332 3568999999999999999999997 59999999999999998 8899999999
Q ss_pred cccccCCCCCcccccccccCCccCcccccC-cCCCccccHHHHHHHHHHHHcCCCCCCCCCcchhhhHHHHHHHHhhcC-
Q 002673 756 LSRLILPYQTHVTTELVGTLGYIPPEYGQA-WVATLRGDMYSFGVVMLELLTGKRPVDVLKPKMSRELVGWVLKMRSEG- 833 (894)
Q Consensus 756 la~~~~~~~~~~~~~~~gt~~Y~APE~~~~-~~~s~ksDVwS~GvlL~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~- 833 (894)
++........ ......+++.|+|||++.+ ..++.++||||||+++|+|++|+.||...... ..............
T Consensus 157 ~~~~~~~~~~-~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~--~~~~~~~~~~~~~~~ 233 (295)
T cd07837 157 LGRAFSIPVK-SYTHEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDSEL--QQLLHIFKLLGTPTE 233 (295)
T ss_pred cceecCCCcc-ccCCcccccCCCChHHhhCCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHH--HHHHHHHHHhCCCCh
Confidence 9886532211 1223356889999998765 45789999999999999999999999754321 11111111000000
Q ss_pred -CCCcccc-------cccc----CCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 002673 834 -KQDQVFD-------PILR----GKGFDEEMLQVLDVACMCVSQNPFKRPTVKEVVE 878 (894)
Q Consensus 834 -~~~~~~d-------~~l~----~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~ 878 (894)
....... +... ....+.....+.+++.+|++.||.+||++++++.
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~R~~~~eil~ 290 (295)
T cd07837 234 QVWPGVSKLRDWHEFPQWKPQDLSRAVPDLSPEGLDLLQKMLRYDPAKRISAKAALT 290 (295)
T ss_pred hhCcchhhccchhhcCcccchhHHHhccccCHHHHHHHHHHccCChhhcCCHHHHhc
Confidence 0000000 0000 0000112345789999999999999999999986
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm |
| >cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-32 Score=298.08 Aligned_cols=260 Identities=26% Similarity=0.382 Sum_probs=196.7
Q ss_pred CCCccceEeecCcEEEEEEEE-cCCCeEEEEEEcCcc-hhhHHHHHHHHHHHHhcC-CCceeeecceeeecceEEEEEEe
Q 002673 608 NFSQANIIGCGGFGLVYKATL-ANGTTLAIKKLSGDL-GLMEREFKAEVEALSTAQ-HKNLVSLQGYCVHQGFRLLIYSY 684 (894)
Q Consensus 608 ~f~~~~~LG~G~fg~Vy~a~~-~~g~~vAvK~~~~~~-~~~~~~~~~Ei~~l~~l~-HpnIv~l~g~~~~~~~~~lV~E~ 684 (894)
+|...+.||+|+||.||++.. .+++.||+|.+.... ......+.+|+.++.++. |+||+++++++..+...+++|||
T Consensus 5 ~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~~~~~~~~~e~ 84 (288)
T cd06616 5 DLKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSSDCPYIVKFYGALFREGDCWICMEL 84 (288)
T ss_pred HhHHHHHhCCCCceEEEEEEECCCCCEEEEEEehhccChHHHHHHHHHHHHHHHhcCCCCEeeeeeEEecCCcEEEEEec
Confidence 455667899999999999984 468999999987543 234567889999999996 99999999999988899999999
Q ss_pred ccCCCHHHHHhhh-cCCCCCcCHHHHHHHHHHHHHHHHHHHhccCCCeeecCCCCCCeEECCCCcEEEEEcccccccCCC
Q 002673 685 MENGSLDYWLHEK-ADGASQLDWLTRLKIARGTSCGLAYMHQICEPHIVHRDIKSSNILLDDQFEAHLADFGLSRLILPY 763 (894)
Q Consensus 685 ~~~gsL~~~l~~~-~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDLkp~NILld~~~~vkl~DFGla~~~~~~ 763 (894)
+. +++.++.... ......+++.....++.+++.||+|||+ ..+++||||||+||+++.++.+||+|||++......
T Consensus 85 ~~-~~l~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~--~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~ 161 (288)
T cd06616 85 MD-ISLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKE--ELKIIHRDVKPSNILLDRNGNIKLCDFGISGQLVDS 161 (288)
T ss_pred cc-CCHHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhh--cCCeeccCCCHHHEEEccCCcEEEeecchhHHhccC
Confidence 86 4555543321 1122568999999999999999999996 358999999999999999999999999999765322
Q ss_pred CCcccccccccCCccCcccccCc---CCCccccHHHHHHHHHHHHcCCCCCCCCCcchhhhHHHHHHHHhhcCCCCcccc
Q 002673 764 QTHVTTELVGTLGYIPPEYGQAW---VATLRGDMYSFGVVMLELLTGKRPVDVLKPKMSRELVGWVLKMRSEGKQDQVFD 840 (894)
Q Consensus 764 ~~~~~~~~~gt~~Y~APE~~~~~---~~s~ksDVwS~GvlL~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 840 (894)
. ......|+..|+|||++.+. .++.++|||||||++|||++|+.||.... ........... +..
T Consensus 162 ~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~-----~~~~~~~~~~~-~~~----- 228 (288)
T cd06616 162 I--AKTRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWN-----SVFDQLTQVVK-GDP----- 228 (288)
T ss_pred C--ccccccCccCccCHHHhccccccCCcchhhhhHHHHHHHHHHhCCCCchhcc-----hHHHHHhhhcC-CCC-----
Confidence 1 12234678899999998776 68999999999999999999999997433 11111111111 110
Q ss_pred ccccCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHH--HHHhc
Q 002673 841 PILRGKGFDEEMLQVLDVACMCVSQNPFKRPTVKEVVE--WLNNV 883 (894)
Q Consensus 841 ~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~--~L~~i 883 (894)
+.+...........+.+++.+|++.+|++|||+++|++ +++..
T Consensus 229 ~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~i~~~~~~~~~ 273 (288)
T cd06616 229 PILSNSEEREFSPSFVNFINLCLIKDESKRPKYKELLEHPFIKDY 273 (288)
T ss_pred CcCCCcCCCccCHHHHHHHHHHccCChhhCcCHHHHhcChhhhch
Confidence 11111111123346789999999999999999999998 66553
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates |
| >cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-32 Score=293.77 Aligned_cols=253 Identities=22% Similarity=0.320 Sum_probs=201.7
Q ss_pred CCccceEeecCcEEEEEEEE-cCCCeEEEEEEcCcchhhHHHHHHHHHHHHhcCCCceeeecceeeecceEEEEEEeccC
Q 002673 609 FSQANIIGCGGFGLVYKATL-ANGTTLAIKKLSGDLGLMEREFKAEVEALSTAQHKNLVSLQGYCVHQGFRLLIYSYMEN 687 (894)
Q Consensus 609 f~~~~~LG~G~fg~Vy~a~~-~~g~~vAvK~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~lV~E~~~~ 687 (894)
|...+.||+|++|.||++.. .+++.+++|++........+.+.+|+.+++.++||||+++++++...+..++|+||+++
T Consensus 21 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~~~h~~vv~~~~~~~~~~~~~~v~e~~~~ 100 (285)
T cd06648 21 LDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQRRELLFNEVVIMRDYQHPNIVEMYSSYLVGDELWVVMEFLEG 100 (285)
T ss_pred hhcceEeccCCCeEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHHcCCCChheEEEEEEcCCeEEEEEeccCC
Confidence 44557999999999999984 57899999998755444556788999999999999999999999999999999999999
Q ss_pred CCHHHHHhhhcCCCCCcCHHHHHHHHHHHHHHHHHHHhccCCCeeecCCCCCCeEECCCCcEEEEEcccccccCCCCCcc
Q 002673 688 GSLDYWLHEKADGASQLDWLTRLKIARGTSCGLAYMHQICEPHIVHRDIKSSNILLDDQFEAHLADFGLSRLILPYQTHV 767 (894)
Q Consensus 688 gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDLkp~NILld~~~~vkl~DFGla~~~~~~~~~~ 767 (894)
++|.+++.. ..+++..+..++.|++.||+|||+ ++++||||+|+||+++.++.++|+|||++........ .
T Consensus 101 ~~L~~~~~~-----~~~~~~~~~~~~~ql~~~l~~lH~---~~i~H~dl~p~Nil~~~~~~~~l~d~g~~~~~~~~~~-~ 171 (285)
T cd06648 101 GALTDIVTH-----TRMNEEQIATVCLAVLKALSFLHA---QGVIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEVP-R 171 (285)
T ss_pred CCHHHHHHh-----CCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCChhhEEEcCCCcEEEcccccchhhccCCc-c
Confidence 999999875 247888999999999999999997 5999999999999999999999999998875533221 1
Q ss_pred cccccccCCccCcccccCcCCCccccHHHHHHHHHHHHcCCCCCCCCCcchhhhHHHHHHHHhhcCCCCccccccccCCC
Q 002673 768 TTELVGTLGYIPPEYGQAWVATLRGDMYSFGVVMLELLTGKRPVDVLKPKMSRELVGWVLKMRSEGKQDQVFDPILRGKG 847 (894)
Q Consensus 768 ~~~~~gt~~Y~APE~~~~~~~s~ksDVwS~GvlL~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~ 847 (894)
.....|+..|+|||...+..++.++||||||+++|+|++|+.||...... ......... .......
T Consensus 172 ~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGv~l~ell~g~~p~~~~~~~------~~~~~~~~~-~~~~~~~------- 237 (285)
T cd06648 172 RKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMVDGEPPYFNEPPL------QAMKRIRDN-LPPKLKN------- 237 (285)
T ss_pred cccccCCccccCHHHhcCCCCCCcccHHHHHHHHHHHHhCCCCCcCCCHH------HHHHHHHhc-CCCCCcc-------
Confidence 23356889999999998888999999999999999999999999643321 111111111 1111100
Q ss_pred ChHHHHHHHHHHHHhcccCCCCCCCHHHHHH--HHHhcc
Q 002673 848 FDEEMLQVLDVACMCVSQNPFKRPTVKEVVE--WLNNVG 884 (894)
Q Consensus 848 ~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~--~L~~i~ 884 (894)
.......+.+++.+|++.+|++||++.++++ ++...+
T Consensus 238 ~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~~~~~~~~ 276 (285)
T cd06648 238 LHKVSPRLRSFLDRMLVRDPAQRATAAELLNHPFLAKAG 276 (285)
T ss_pred cccCCHHHHHHHHHHcccChhhCcCHHHHccCcccccCC
Confidence 0112236789999999999999999999997 665544
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun |
| >cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-32 Score=292.00 Aligned_cols=249 Identities=26% Similarity=0.394 Sum_probs=200.0
Q ss_pred CCCccceEeecCcEEEEEEEE-cCCCeEEEEEEcCcc-hhhHHHHHHHHHHHHhcCCCceeeecceeeecceEEEEEEec
Q 002673 608 NFSQANIIGCGGFGLVYKATL-ANGTTLAIKKLSGDL-GLMEREFKAEVEALSTAQHKNLVSLQGYCVHQGFRLLIYSYM 685 (894)
Q Consensus 608 ~f~~~~~LG~G~fg~Vy~a~~-~~g~~vAvK~~~~~~-~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~lV~E~~ 685 (894)
-|+..+.||+|+||.||+|.. .++..||+|.+.... ......+.+|+.++++++||||+++++++..++..++||||+
T Consensus 5 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 84 (277)
T cd06641 5 LFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYL 84 (277)
T ss_pred hhhhheeEeecCCeEEEEEEECCCCcEEEEEEeccccchHHHHHHHHHHHHHHhcCCCCEeEEEEEEEeCCeEEEEEEeC
Confidence 366778999999999999985 468899999886433 233467889999999999999999999999999999999999
Q ss_pred cCCCHHHHHhhhcCCCCCcCHHHHHHHHHHHHHHHHHHHhccCCCeeecCCCCCCeEECCCCcEEEEEcccccccCCCCC
Q 002673 686 ENGSLDYWLHEKADGASQLDWLTRLKIARGTSCGLAYMHQICEPHIVHRDIKSSNILLDDQFEAHLADFGLSRLILPYQT 765 (894)
Q Consensus 686 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDLkp~NILld~~~~vkl~DFGla~~~~~~~~ 765 (894)
++++|.+++.. ..+++..+..++.|++.++.|||+ .+++|+||+|+||+++.++.++|+|||++.......
T Consensus 85 ~~~~l~~~i~~-----~~~~~~~~~~~~~~l~~~l~~lh~---~~i~h~dl~p~Ni~i~~~~~~~l~dfg~~~~~~~~~- 155 (277)
T cd06641 85 GGGSALDLLEP-----GPLDETQIATILREILKGLDYLHS---EKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQ- 155 (277)
T ss_pred CCCcHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHcc---CCeecCCCCHHhEEECCCCCEEEeecccceecccch-
Confidence 99999999864 247899999999999999999996 699999999999999999999999999987653321
Q ss_pred cccccccccCCccCcccccCcCCCccccHHHHHHHHHHHHcCCCCCCCCCcchhhhHHHHHHHHhhcCCCCccccccccC
Q 002673 766 HVTTELVGTLGYIPPEYGQAWVATLRGDMYSFGVVMLELLTGKRPVDVLKPKMSRELVGWVLKMRSEGKQDQVFDPILRG 845 (894)
Q Consensus 766 ~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwS~GvlL~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~ 845 (894)
.......++..|+|||+..+..++.++|||||||++|+|++|..||....... .. .... ...... +.
T Consensus 156 ~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~---~~---~~~~-~~~~~~-----~~- 222 (277)
T cd06641 156 IKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPHSELHPMK---VL---FLIP-KNNPPT-----LE- 222 (277)
T ss_pred hhhccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCccchHH---HH---HHHh-cCCCCC-----CC-
Confidence 12233467889999999988888999999999999999999999997543211 11 1111 111110 11
Q ss_pred CCChHHHHHHHHHHHHhcccCCCCCCCHHHHHH--HHH
Q 002673 846 KGFDEEMLQVLDVACMCVSQNPFKRPTVKEVVE--WLN 881 (894)
Q Consensus 846 ~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~--~L~ 881 (894)
......+.+++.+|++.+|.+||++.++++ ++.
T Consensus 223 ---~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~~~~~~ 257 (277)
T cd06641 223 ---GNYSKPLKEFVEACLNKEPSFRPTAKELLKHKFIV 257 (277)
T ss_pred ---cccCHHHHHHHHHHccCChhhCcCHHHHHhCHHHh
Confidence 112245678999999999999999999998 454
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int |
| >cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-32 Score=295.69 Aligned_cols=260 Identities=26% Similarity=0.311 Sum_probs=197.3
Q ss_pred CCccceEeecCcEEEEEEEEc-CCCeEEEEEEcCcc--hhhHHHHHHHHHHHHhcCCCceeeecceeeec--ceEEEEEE
Q 002673 609 FSQANIIGCGGFGLVYKATLA-NGTTLAIKKLSGDL--GLMEREFKAEVEALSTAQHKNLVSLQGYCVHQ--GFRLLIYS 683 (894)
Q Consensus 609 f~~~~~LG~G~fg~Vy~a~~~-~g~~vAvK~~~~~~--~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~--~~~~lV~E 683 (894)
|++.+.||+|+||.||+|... +++.+|+|++.... ......+.+|+++++.++|+|++++++++... +..++|+|
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e 80 (287)
T cd07840 1 YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNIVRLKEIVTSKGKGSIYMVFE 80 (287)
T ss_pred CeeeEEeccCCCeEEEEEEECCCCeEEEEEEEecccccccchHHHHHHHHHHHhccCCCeeeheeeEecCCCCcEEEEec
Confidence 566789999999999999854 58899999998653 23345688999999999999999999999988 78999999
Q ss_pred eccCCCHHHHHhhhcCCCCCcCHHHHHHHHHHHHHHHHHHHhccCCCeeecCCCCCCeEECCCCcEEEEEcccccccCCC
Q 002673 684 YMENGSLDYWLHEKADGASQLDWLTRLKIARGTSCGLAYMHQICEPHIVHRDIKSSNILLDDQFEAHLADFGLSRLILPY 763 (894)
Q Consensus 684 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDLkp~NILld~~~~vkl~DFGla~~~~~~ 763 (894)
|+++ +|.+++.... ..+++..++.++.|++.||+|||+ .+++|+||||+||++++++.+||+|||++......
T Consensus 81 ~~~~-~l~~~~~~~~---~~~~~~~~~~i~~~i~~al~~LH~---~~~~h~dl~p~nil~~~~~~~~l~d~g~~~~~~~~ 153 (287)
T cd07840 81 YMDH-DLTGLLDSPE---VKFTESQIKCYMKQLLEGLQYLHS---NGILHRDIKGSNILINNDGVLKLADFGLARPYTKR 153 (287)
T ss_pred cccc-cHHHHHhccC---CCCCHHHHHHHHHHHHHHHHHHHH---CCceeccCcHHHeEEcCCCCEEEccccceeeccCC
Confidence 9974 8888886532 468999999999999999999997 59999999999999999999999999999876443
Q ss_pred CCcccccccccCCccCcccccC-cCCCccccHHHHHHHHHHHHcCCCCCCCCCcchhhhHHHHHHHHhhcC---CCCcc-
Q 002673 764 QTHVTTELVGTLGYIPPEYGQA-WVATLRGDMYSFGVVMLELLTGKRPVDVLKPKMSRELVGWVLKMRSEG---KQDQV- 838 (894)
Q Consensus 764 ~~~~~~~~~gt~~Y~APE~~~~-~~~s~ksDVwS~GvlL~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~---~~~~~- 838 (894)
.........++..|+|||.+.+ ..++.++||||||+++|||++|+.||........ ........... .....
T Consensus 154 ~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~t~~~p~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~ 230 (287)
T cd07840 154 NSADYTNRVITLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGKPIFQGSTELEQ---LEKIFELCGSPTDENWPGVS 230 (287)
T ss_pred CcccccccccccccCCceeeEccccCChHHHHHHHHHHHHHHHhCCCCCCCCChHHH---HHHHHHHhCCCchhhccccc
Confidence 3222334457889999997665 4678999999999999999999999975443211 11111110000 00000
Q ss_pred -------------ccccccCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 002673 839 -------------FDPILRGKGFDEEMLQVLDVACMCVSQNPFKRPTVKEVVE 878 (894)
Q Consensus 839 -------------~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~ 878 (894)
....+.......+...+.+++.+|++.+|.+||++.++++
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~ 283 (287)
T cd07840 231 KLPWFENLKPKKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRISADQALQ 283 (287)
T ss_pred cchhhhhccccccchhHHHHHhcccCCHHHHHHHHHHcCCChhhCcCHHHHhh
Confidence 0000000000001446789999999999999999999986
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po |
| >KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-33 Score=316.10 Aligned_cols=253 Identities=25% Similarity=0.385 Sum_probs=207.6
Q ss_pred CccceEeecCcEEEEEEEE-cCCC----eEEEEEEcCcch-hhHHHHHHHHHHHHhcCCCceeeecceeeecceEEEEEE
Q 002673 610 SQANIIGCGGFGLVYKATL-ANGT----TLAIKKLSGDLG-LMEREFKAEVEALSTAQHKNLVSLQGYCVHQGFRLLIYS 683 (894)
Q Consensus 610 ~~~~~LG~G~fg~Vy~a~~-~~g~----~vAvK~~~~~~~-~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~lV~E 683 (894)
...++||+|+||+||+|.| .+|+ +||||++..... ....++.+|+-+|.+++|||+++++|+|.... ..||++
T Consensus 699 kk~kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~~t~~~~s~e~LdeAl~masldHpnl~RLLgvc~~s~-~qlvtq 777 (1177)
T KOG1025|consen 699 KKDKVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIEFTSPKASIELLDEALRMASLDHPNLLRLLGVCMLST-LQLVTQ 777 (1177)
T ss_pred hhhceeccccceeEEeeeEecCCceecceeEEEEeeccCCchhhHHHHHHHHHHhcCCCchHHHHhhhcccch-HHHHHH
Confidence 4468899999999999984 5554 689998876543 34578999999999999999999999998766 789999
Q ss_pred eccCCCHHHHHhhhcCCCCCcCHHHHHHHHHHHHHHHHHHHhccCCCeeecCCCCCCeEECCCCcEEEEEcccccccCCC
Q 002673 684 YMENGSLDYWLHEKADGASQLDWLTRLKIARGTSCGLAYMHQICEPHIVHRDIKSSNILLDDQFEAHLADFGLSRLILPY 763 (894)
Q Consensus 684 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDLkp~NILld~~~~vkl~DFGla~~~~~~ 763 (894)
||+.|+|.++++... ..+.-...+.|..|||+||.|||. +.++||||.++|||+.+-..+||.|||+++...+.
T Consensus 778 ~mP~G~LlDyvr~hr---~~igsq~lLnw~~QIAkgM~YLe~---qrlVHrdLaaRNVLVksP~hvkitdfgla~ll~~d 851 (1177)
T KOG1025|consen 778 LMPLGCLLDYVREHR---DNIGSQDLLNWCYQIAKGMKYLEE---QRLVHRDLAARNVLVKSPNHVKITDFGLAKLLAPD 851 (1177)
T ss_pred hcccchHHHHHHHhh---ccccHHHHHHHHHHHHHHHHHHHh---cchhhhhhhhhheeecCCCeEEEEecchhhccCcc
Confidence 999999999999754 457777889999999999999996 69999999999999999999999999999988665
Q ss_pred CCcccc-cccccCCccCcccccCcCCCccccHHHHHHHHHHHHc-CCCCCCCCCcchhhhHHHHHHHHhhcCCCCccccc
Q 002673 764 QTHVTT-ELVGTLGYIPPEYGQAWVATLRGDMYSFGVVMLELLT-GKRPVDVLKPKMSRELVGWVLKMRSEGKQDQVFDP 841 (894)
Q Consensus 764 ~~~~~~-~~~gt~~Y~APE~~~~~~~s~ksDVwS~GvlL~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 841 (894)
...... ...-.+.|||-|.+....|+.++|||||||.+||++| |..|++..+.++..++.+. ..++
T Consensus 852 ~~ey~~~~gK~pikwmale~i~~~~~thqSDVWsfGVtiWElmTFGa~Py~gi~~~eI~dlle~------geRL------ 919 (1177)
T KOG1025|consen 852 EKEYSAPGGKVPIKWMALESIRIRKYTHQSDVWSFGVTIWELMTFGAKPYDGIPAEEIPDLLEK------GERL------ 919 (1177)
T ss_pred cccccccccccCcHHHHHHHhhccCCCchhhhhhhhhhHHHHHhcCCCccCCCCHHHhhHHHhc------cccC------
Confidence 443322 2334568999999999999999999999999999999 9999998776554443321 1111
Q ss_pred cccCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhccc
Q 002673 842 ILRGKGFDEEMLQVLDVACMCVSQNPFKRPTVKEVVEWLNNVGA 885 (894)
Q Consensus 842 ~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~i~~ 885 (894)
...+....++.-++.+||..|+..||+++++...+.++..
T Consensus 920 ----sqPpiCtiDVy~~mvkCwmid~~~rp~fkel~~~fs~~ar 959 (1177)
T KOG1025|consen 920 ----SQPPICTIDVYMVMVKCWMIDADSRPTFKELAEEFSRMAR 959 (1177)
T ss_pred ----CCCCCccHHHHHHHHHHhccCcccCccHHHHHHHHHHHhc
Confidence 1122334567788999999999999999999998887654
|
|
| >cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-31 Score=295.31 Aligned_cols=245 Identities=28% Similarity=0.394 Sum_probs=194.3
Q ss_pred cCCCccceEeecCcEEEEEEEE-cCCCeEEEEEEcCcc---hhhHHHHHHHHHHHHhcCCCceeeecceeeecceEEEEE
Q 002673 607 DNFSQANIIGCGGFGLVYKATL-ANGTTLAIKKLSGDL---GLMEREFKAEVEALSTAQHKNLVSLQGYCVHQGFRLLIY 682 (894)
Q Consensus 607 ~~f~~~~~LG~G~fg~Vy~a~~-~~g~~vAvK~~~~~~---~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~lV~ 682 (894)
+.|+..+.||+|+||.||+|.. .+++.||+|.+.... ......+.+|+++++.++||||++++++|..++..++||
T Consensus 15 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~lv~ 94 (307)
T cd06607 15 KLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKGCYLREHTAWLVM 94 (307)
T ss_pred hhhhhheeecCCCCeEEEEEEEcCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHHhCCCCCEEEEEEEEEeCCeEEEEH
Confidence 4588889999999999999985 468999999986432 223356889999999999999999999999999999999
Q ss_pred EeccCCCHHHHHhhhcCCCCCcCHHHHHHHHHHHHHHHHHHHhccCCCeeecCCCCCCeEECCCCcEEEEEcccccccCC
Q 002673 683 SYMENGSLDYWLHEKADGASQLDWLTRLKIARGTSCGLAYMHQICEPHIVHRDIKSSNILLDDQFEAHLADFGLSRLILP 762 (894)
Q Consensus 683 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDLkp~NILld~~~~vkl~DFGla~~~~~ 762 (894)
||++ |++.+++.... ..+++..+..++.|++.||.|||+ .+++||||+|+||+++.++.+||+|||++.....
T Consensus 95 e~~~-g~l~~~~~~~~---~~l~~~~~~~~~~ql~~~L~~LH~---~~i~H~dl~p~nIl~~~~~~~kL~dfg~~~~~~~ 167 (307)
T cd06607 95 EYCL-GSASDILEVHK---KPLQEVEIAAICHGALQGLAYLHS---HERIHRDIKAGNILLTEPGTVKLADFGSASLVSP 167 (307)
T ss_pred HhhC-CCHHHHHHHcc---cCCCHHHHHHHHHHHHHHHHHHHH---CCceecCCCcccEEECCCCCEEEeecCcceecCC
Confidence 9996 67777776432 358999999999999999999997 5999999999999999999999999999876432
Q ss_pred CCCcccccccccCCccCccccc---CcCCCccccHHHHHHHHHHHHcCCCCCCCCCcchhhhHHHHHHHHhhcCCCCccc
Q 002673 763 YQTHVTTELVGTLGYIPPEYGQ---AWVATLRGDMYSFGVVMLELLTGKRPVDVLKPKMSRELVGWVLKMRSEGKQDQVF 839 (894)
Q Consensus 763 ~~~~~~~~~~gt~~Y~APE~~~---~~~~s~ksDVwS~GvlL~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 839 (894)
. ....++..|+|||++. ...++.++||||||+++|||++|+.||........ ........ .
T Consensus 168 ~-----~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~s~G~il~el~tg~~p~~~~~~~~~------~~~~~~~~-~---- 231 (307)
T cd06607 168 A-----NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSA------LYHIAQND-S---- 231 (307)
T ss_pred C-----CCccCCccccCceeeeccCCCCCCcccchHHHHHHHHHHHcCCCCCCCccHHHH------HHHHhcCC-C----
Confidence 2 2346788999999874 45688899999999999999999999975432111 11111111 0
Q ss_pred cccccCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 002673 840 DPILRGKGFDEEMLQVLDVACMCVSQNPFKRPTVKEVVE 878 (894)
Q Consensus 840 d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~ 878 (894)
+.+.. ......+.+++.+||+.+|++||++.++++
T Consensus 232 -~~~~~---~~~~~~~~~li~~~l~~~p~~Rp~~~~il~ 266 (307)
T cd06607 232 -PTLSS---NDWSDYFRNFVDSCLQKIPQDRPSSEELLK 266 (307)
T ss_pred -CCCCc---hhhCHHHHHHHHHHhcCChhhCcCHHHHhc
Confidence 01111 112345788999999999999999999987
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily |
| >cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-31 Score=284.73 Aligned_cols=250 Identities=29% Similarity=0.407 Sum_probs=202.9
Q ss_pred CCCccceEeecCcEEEEEEEEc-CCCeEEEEEEcCcch--hhHHHHHHHHHHHHhcCCCceeeecceeeec--ceEEEEE
Q 002673 608 NFSQANIIGCGGFGLVYKATLA-NGTTLAIKKLSGDLG--LMEREFKAEVEALSTAQHKNLVSLQGYCVHQ--GFRLLIY 682 (894)
Q Consensus 608 ~f~~~~~LG~G~fg~Vy~a~~~-~g~~vAvK~~~~~~~--~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~--~~~~lV~ 682 (894)
+|+..+.||+|++|.||+|... ++..|++|++..... ...+.+.+|+..+++++|+||+++++.+... ...++|+
T Consensus 1 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~ 80 (260)
T cd06606 1 EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYYGSERDEEKNTLNIFL 80 (260)
T ss_pred CceeeeEeeecCceEEEEEEECCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHcCCCCEeeEEEEEecCCCCeEEEEE
Confidence 4677899999999999999865 789999999876542 3456789999999999999999999999988 8899999
Q ss_pred EeccCCCHHHHHhhhcCCCCCcCHHHHHHHHHHHHHHHHHHHhccCCCeeecCCCCCCeEECCCCcEEEEEcccccccCC
Q 002673 683 SYMENGSLDYWLHEKADGASQLDWLTRLKIARGTSCGLAYMHQICEPHIVHRDIKSSNILLDDQFEAHLADFGLSRLILP 762 (894)
Q Consensus 683 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDLkp~NILld~~~~vkl~DFGla~~~~~ 762 (894)
||+++++|.+++.... .+++..+..++.|++.||.|||+ .+++|+||+|+||+++.++.++|+|||.+.....
T Consensus 81 e~~~~~~L~~~~~~~~----~~~~~~~~~~~~~l~~~l~~lh~---~~~~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~ 153 (260)
T cd06606 81 EYVSGGSLSSLLKKFG----KLPEPVIRKYTRQILEGLAYLHS---NGIVHRDIKGANILVDSDGVVKLADFGCAKRLGD 153 (260)
T ss_pred EecCCCcHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHH---CCccccCCCHHHEEEcCCCCEEEcccccEEeccc
Confidence 9999999999998642 68999999999999999999997 6999999999999999999999999999987644
Q ss_pred CCCc-ccccccccCCccCcccccCcCCCccccHHHHHHHHHHHHcCCCCCCCCCcchhhhHHHHHHHHhhcCCCCccccc
Q 002673 763 YQTH-VTTELVGTLGYIPPEYGQAWVATLRGDMYSFGVVMLELLTGKRPVDVLKPKMSRELVGWVLKMRSEGKQDQVFDP 841 (894)
Q Consensus 763 ~~~~-~~~~~~gt~~Y~APE~~~~~~~s~ksDVwS~GvlL~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 841 (894)
.... ......++..|+|||...+...+.++||||||+++|+|++|+.||...... ...............+
T Consensus 154 ~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~-----~~~~~~~~~~~~~~~~--- 225 (260)
T cd06606 154 IETGEGTGSVRGTPYWMAPEVIRGEEYGRAADIWSLGCTVIEMATGKPPWSELGNP-----MAALYKIGSSGEPPEI--- 225 (260)
T ss_pred ccccccccCCCCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCch-----HHHHHhccccCCCcCC---
Confidence 3221 123456888999999998888999999999999999999999999765411 1111111111111111
Q ss_pred cccCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 002673 842 ILRGKGFDEEMLQVLDVACMCVSQNPFKRPTVKEVVE 878 (894)
Q Consensus 842 ~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~ 878 (894)
.......+.+++.+|++.+|++||++.++++
T Consensus 226 ------~~~~~~~l~~~i~~~l~~~p~~Rp~~~~ll~ 256 (260)
T cd06606 226 ------PEHLSEEAKDFLRKCLRRDPKKRPTADELLQ 256 (260)
T ss_pred ------CcccCHHHHHHHHHhCcCChhhCCCHHHHhh
Confidence 1111346778999999999999999999986
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK |
| >cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-32 Score=299.74 Aligned_cols=267 Identities=24% Similarity=0.296 Sum_probs=196.4
Q ss_pred CCCccceEeecCcEEEEEEEEc---CCCeEEEEEEcCcc---hhhHHHHHHHHHHHHhcCCCceeeecceeeec--ceEE
Q 002673 608 NFSQANIIGCGGFGLVYKATLA---NGTTLAIKKLSGDL---GLMEREFKAEVEALSTAQHKNLVSLQGYCVHQ--GFRL 679 (894)
Q Consensus 608 ~f~~~~~LG~G~fg~Vy~a~~~---~g~~vAvK~~~~~~---~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~--~~~~ 679 (894)
+|++.+.||+|+||.||+|... ++..||+|.+.... ......+.+|+.++++++||||+++++++... ...+
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~alK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 80 (316)
T cd07842 1 KYEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSLVEVFLEHADKSVY 80 (316)
T ss_pred CceEEEEeccCCcEEEEEEEecCCCCCCeEEEEEeccccccccCccHHHHHHHHHHHhcCCCCccceEEEEeCCCCceEE
Confidence 4777889999999999999854 57899999998633 23345678899999999999999999999988 7899
Q ss_pred EEEEeccCCCHHHHHhhhcCC-CCCcCHHHHHHHHHHHHHHHHHHHhccCCCeeecCCCCCCeEECC----CCcEEEEEc
Q 002673 680 LIYSYMENGSLDYWLHEKADG-ASQLDWLTRLKIARGTSCGLAYMHQICEPHIVHRDIKSSNILLDD----QFEAHLADF 754 (894)
Q Consensus 680 lV~E~~~~gsL~~~l~~~~~~-~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDLkp~NILld~----~~~vkl~DF 754 (894)
+||||+++ +|.+++...... ...++...+..++.|++.||.|||+ ++++||||||+||+++. ++.+||+||
T Consensus 81 lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~---~~i~h~dlkp~Nil~~~~~~~~~~~kl~Df 156 (316)
T cd07842 81 LLFDYAEH-DLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHS---NWVLHRDLKPANILVMGEGPERGVVKIGDL 156 (316)
T ss_pred EEEeCCCc-CHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHHh---CCEeeCCCCHHHEEEcCCCCccceEEECCC
Confidence 99999975 677776543322 2368889999999999999999997 59999999999999999 999999999
Q ss_pred ccccccCCCCC--cccccccccCCccCcccccCc-CCCccccHHHHHHHHHHHHcCCCCCCCCCcchh-------hhHHH
Q 002673 755 GLSRLILPYQT--HVTTELVGTLGYIPPEYGQAW-VATLRGDMYSFGVVMLELLTGKRPVDVLKPKMS-------RELVG 824 (894)
Q Consensus 755 Gla~~~~~~~~--~~~~~~~gt~~Y~APE~~~~~-~~s~ksDVwS~GvlL~elltG~~Pf~~~~~~~~-------~~~~~ 824 (894)
|++........ .......++..|+|||++.+. .++.++||||||+++|+|++|+.||........ .....
T Consensus 157 g~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (316)
T cd07842 157 GLARLFNAPLKPLADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGREAKIKKSNPFQRDQLER 236 (316)
T ss_pred ccccccCCCcccccccCCccccccccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhcCCCCcCCcccccccchhHHHHHHH
Confidence 99986533221 112335678899999987664 578999999999999999999999975543220 00111
Q ss_pred HHHHHhh-----------cCCCCccccc----cccCCCCh-------HHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 002673 825 WVLKMRS-----------EGKQDQVFDP----ILRGKGFD-------EEMLQVLDVACMCVSQNPFKRPTVKEVVE 878 (894)
Q Consensus 825 ~~~~~~~-----------~~~~~~~~d~----~l~~~~~~-------~~~~~l~~li~~Cl~~dP~~RPs~~evl~ 878 (894)
....+.. ........+. ........ .....+.+++.+|++.||++|||+.++++
T Consensus 237 ~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~eil~ 312 (316)
T cd07842 237 IFEVLGTPTEKDWPDIKKMPEYDTLMKDFKTKTYPSNSLAKWMEKHKKPDSQGFDLLRKLLEYDPTKRITAEEALE 312 (316)
T ss_pred HHHHhCCCchhHHHHHhhcccchhhhhhccCCCCCCccHHHHHHhccCCCHHHHHHHHHHhcCCcccCcCHHHHhc
Confidence 1100000 0000000000 00000000 12346789999999999999999999985
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the |
| >cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-32 Score=295.20 Aligned_cols=261 Identities=23% Similarity=0.269 Sum_probs=195.7
Q ss_pred CCCccceEeecCcEEEEEEEE-cCCCeEEEEEEcCcch--hhHHHHHHHHHHHHhcCCCceeeecceeeecceEEEEEEe
Q 002673 608 NFSQANIIGCGGFGLVYKATL-ANGTTLAIKKLSGDLG--LMEREFKAEVEALSTAQHKNLVSLQGYCVHQGFRLLIYSY 684 (894)
Q Consensus 608 ~f~~~~~LG~G~fg~Vy~a~~-~~g~~vAvK~~~~~~~--~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~lV~E~ 684 (894)
+|+..+.||.|++|.||+|.. .+|..||||++..... .....+.+|++++++++||||+++++++.+++..++||||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (284)
T cd07860 1 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEF 80 (284)
T ss_pred CceeeeeecCCCceEEEEEEECCCCCEEEEEEccccccccccchHHHHHHHHHHhcCCCCCcchhhhcccCCcEEEEeec
Confidence 477889999999999999985 4789999999875432 2235688999999999999999999999999999999999
Q ss_pred ccCCCHHHHHhhhcCCCCCcCHHHHHHHHHHHHHHHHHHHhccCCCeeecCCCCCCeEECCCCcEEEEEcccccccCCCC
Q 002673 685 MENGSLDYWLHEKADGASQLDWLTRLKIARGTSCGLAYMHQICEPHIVHRDIKSSNILLDDQFEAHLADFGLSRLILPYQ 764 (894)
Q Consensus 685 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDLkp~NILld~~~~vkl~DFGla~~~~~~~ 764 (894)
+. ++|.+++.... ...+++..+..++.|++.||+|||+ ++++|+||+|+||+++.++.+||+|||++.......
T Consensus 81 ~~-~~l~~~~~~~~--~~~l~~~~~~~~~~~i~~~l~~lh~---~~i~H~~l~p~nill~~~~~~~l~dfg~~~~~~~~~ 154 (284)
T cd07860 81 LH-QDLKKFMDASP--LSGIPLPLIKSYLFQLLQGLAFCHS---HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPV 154 (284)
T ss_pred cc-cCHHHHHHhCC--CCCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHEEECCCCCEEEeeccchhhcccCc
Confidence 95 68988887543 3468899999999999999999997 599999999999999999999999999987653222
Q ss_pred CcccccccccCCccCcccccCcC-CCccccHHHHHHHHHHHHcCCCCCCCCCcchhhhHHHHHHHHhhcC----------
Q 002673 765 THVTTELVGTLGYIPPEYGQAWV-ATLRGDMYSFGVVMLELLTGKRPVDVLKPKMSRELVGWVLKMRSEG---------- 833 (894)
Q Consensus 765 ~~~~~~~~gt~~Y~APE~~~~~~-~s~ksDVwS~GvlL~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~---------- 833 (894)
.......++..|+|||+..+.. ++.++||||||+++|||+||+.||...... ..............
T Consensus 155 -~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~ 231 (284)
T cd07860 155 -RTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEI--DQLFRIFRTLGTPDEVVWPGVTSL 231 (284)
T ss_pred -cccccccccccccCCeEEecCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHH--HHHHHHHHHhCCCChhhhhhhhHH
Confidence 1123345688999999876644 588999999999999999999999653321 11111111100000
Q ss_pred -----CCCccccccccCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 002673 834 -----KQDQVFDPILRGKGFDEEMLQVLDVACMCVSQNPFKRPTVKEVVE 878 (894)
Q Consensus 834 -----~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~ 878 (894)
.........+. .........+.+++.+|++.||++|||++++++
T Consensus 232 ~~~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~ 280 (284)
T cd07860 232 PDYKPSFPKWARQDFS-KVVPPLDEDGRDLLSQMLHYDPNKRISAKAALA 280 (284)
T ss_pred HHHHhhcccccccCHH-HHcccCCHHHHHHHHHhcCCCcccCCCHHHHhc
Confidence 00000000000 000011235678999999999999999999985
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex |
| >cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-32 Score=295.83 Aligned_cols=263 Identities=25% Similarity=0.283 Sum_probs=196.7
Q ss_pred cCCCccceEeecCcEEEEEEEEc-CCCeEEEEEEcCcchh--hHHHHHHHHHHHHhcCCCceeeecceeeec--ceEEEE
Q 002673 607 DNFSQANIIGCGGFGLVYKATLA-NGTTLAIKKLSGDLGL--MEREFKAEVEALSTAQHKNLVSLQGYCVHQ--GFRLLI 681 (894)
Q Consensus 607 ~~f~~~~~LG~G~fg~Vy~a~~~-~g~~vAvK~~~~~~~~--~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~--~~~~lV 681 (894)
++|+..+.||+|+||.||+|... +++.+|+|.++..... ....+.+|+.++++++||||+++++++... ...++|
T Consensus 5 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~lv 84 (293)
T cd07843 5 DEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLREINILLKLQHPNIVTVKEVVVGSNLDKIYMV 84 (293)
T ss_pred hhhhhhhhhcCCCCeEEEEEEECCCCcEEEEEEEeeccccccchhhHHHHHHHHHhcCCCCEEEEEEEEEecCCCcEEEE
Confidence 46788899999999999999864 6889999998754322 224567899999999999999999998877 889999
Q ss_pred EEeccCCCHHHHHhhhcCCCCCcCHHHHHHHHHHHHHHHHHHHhccCCCeeecCCCCCCeEECCCCcEEEEEcccccccC
Q 002673 682 YSYMENGSLDYWLHEKADGASQLDWLTRLKIARGTSCGLAYMHQICEPHIVHRDIKSSNILLDDQFEAHLADFGLSRLIL 761 (894)
Q Consensus 682 ~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDLkp~NILld~~~~vkl~DFGla~~~~ 761 (894)
|||++ ++|.+++.... ..+++..+..++.|++.||.|||+ ++++|+||||+||+++.++.+||+|||++....
T Consensus 85 ~e~~~-~~L~~~~~~~~---~~l~~~~~~~i~~qi~~aL~~LH~---~~i~H~dl~p~nili~~~~~~~l~d~g~~~~~~ 157 (293)
T cd07843 85 MEYVE-HDLKSLMETMK---QPFLQSEVKCLMLQLLSGVAHLHD---NWILHRDLKTSNLLLNNRGILKICDFGLAREYG 157 (293)
T ss_pred ehhcC-cCHHHHHHhcc---CCCCHHHHHHHHHHHHHHHHHHHH---CCeeeccCCHHHEEECCCCcEEEeecCceeecc
Confidence 99997 59998887543 368999999999999999999997 599999999999999999999999999998764
Q ss_pred CCCCcccccccccCCccCcccccCc-CCCccccHHHHHHHHHHHHcCCCCCCCCCcchhhh-HHH---------HHH--H
Q 002673 762 PYQTHVTTELVGTLGYIPPEYGQAW-VATLRGDMYSFGVVMLELLTGKRPVDVLKPKMSRE-LVG---------WVL--K 828 (894)
Q Consensus 762 ~~~~~~~~~~~gt~~Y~APE~~~~~-~~s~ksDVwS~GvlL~elltG~~Pf~~~~~~~~~~-~~~---------~~~--~ 828 (894)
... .......+++.|+|||.+.+. .++.++|+||||+++|+|++|+.||.......... +.. |.. .
T Consensus 158 ~~~-~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (293)
T cd07843 158 SPL-KPYTQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGKSEIDQLNKIFKLLGTPTEKIWPGFSE 236 (293)
T ss_pred CCc-cccccccccccccCchhhcCCccccchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchHHHHHhhc
Confidence 322 112334578899999988764 46889999999999999999999997544321111 000 000 0
Q ss_pred Hhhc--CCCCccccccccCCCChH--HHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 002673 829 MRSE--GKQDQVFDPILRGKGFDE--EMLQVLDVACMCVSQNPFKRPTVKEVVE 878 (894)
Q Consensus 829 ~~~~--~~~~~~~d~~l~~~~~~~--~~~~l~~li~~Cl~~dP~~RPs~~evl~ 878 (894)
+... ..........+.. ..+. ....+.+++.+|++.+|++|||+.|+++
T Consensus 237 ~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~li~~~l~~~p~~R~t~~ell~ 289 (293)
T cd07843 237 LPGAKKKTFTKYPYNQLRK-KFPALSLSDNGFDLLNRLLTYDPAKRISAEDALK 289 (293)
T ss_pred cchhcccccccccchhhhc-cccccCCChHHHHHHHHHhccCccccCCHHHHhc
Confidence 0000 0000000000100 1111 2345778999999999999999999986
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the |
| >cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-32 Score=293.99 Aligned_cols=260 Identities=23% Similarity=0.270 Sum_probs=196.0
Q ss_pred CCccceEeecCcEEEEEEEE-cCCCeEEEEEEcCcch--hhHHHHHHHHHHHHhcCCCceeeecceeeecceEEEEEEec
Q 002673 609 FSQANIIGCGGFGLVYKATL-ANGTTLAIKKLSGDLG--LMEREFKAEVEALSTAQHKNLVSLQGYCVHQGFRLLIYSYM 685 (894)
Q Consensus 609 f~~~~~LG~G~fg~Vy~a~~-~~g~~vAvK~~~~~~~--~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~lV~E~~ 685 (894)
|+..+.||.|++|.||+|.. .+|..||+|++..... .....+.+|+++++.++|||++++++++.+.+..+++|||+
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~~~~iv~~~~~~~~~~~~~iv~e~~ 80 (283)
T cd07835 1 YQKVEKIGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLDVVHSENKLYLVFEFL 80 (283)
T ss_pred CchheEecCCCCeEEEEEEEcCCCCEEEEEEeecccccccchhHHHHHHHHHHhcCCCCccCHhheeccCCeEEEEEecc
Confidence 56778999999999999985 4799999999875432 22356788999999999999999999999999999999999
Q ss_pred cCCCHHHHHhhhcCCCCCcCHHHHHHHHHHHHHHHHHHHhccCCCeeecCCCCCCeEECCCCcEEEEEcccccccCCCCC
Q 002673 686 ENGSLDYWLHEKADGASQLDWLTRLKIARGTSCGLAYMHQICEPHIVHRDIKSSNILLDDQFEAHLADFGLSRLILPYQT 765 (894)
Q Consensus 686 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDLkp~NILld~~~~vkl~DFGla~~~~~~~~ 765 (894)
+ ++|.+++..... ..+++..++.++.|+++||.|||+ ++++||||+|+||+++.++.++|+|||++........
T Consensus 81 ~-~~l~~~~~~~~~--~~~~~~~~~~~~~~i~~~L~~lH~---~~~~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~ 154 (283)
T cd07835 81 D-LDLKKYMDSSPL--TGLDPPLIKSYLYQLLQGIAYCHS---HRVLHRDLKPQNLLIDREGALKLADFGLARAFGVPVR 154 (283)
T ss_pred C-cCHHHHHhhCCC--CCCCHHHHHHHHHHHHHHHHHHHH---CCeeCCCCCHHHEEEcCCCcEEEeecccccccCCCcc
Confidence 5 689999875432 468999999999999999999997 5999999999999999999999999999976532211
Q ss_pred cccccccccCCccCcccccCc-CCCccccHHHHHHHHHHHHcCCCCCCCCCcchhhhHHHHHHHHhhcC--------CCC
Q 002673 766 HVTTELVGTLGYIPPEYGQAW-VATLRGDMYSFGVVMLELLTGKRPVDVLKPKMSRELVGWVLKMRSEG--------KQD 836 (894)
Q Consensus 766 ~~~~~~~gt~~Y~APE~~~~~-~~s~ksDVwS~GvlL~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~--------~~~ 836 (894)
......++..|+|||++.+. .++.++||||||+++|+|++|+.||...... .............. ...
T Consensus 155 -~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (283)
T cd07835 155 -TYTHEVVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFPGDSEI--DQLFRIFRTLGTPDEDVWPGVTSLP 231 (283)
T ss_pred -ccCccccccCCCCCceeecCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHH--HHHHHHHHHhCCCChHHhhhhhhch
Confidence 12233568899999987654 5788999999999999999999999754321 11111111100000 000
Q ss_pred c-------cccccccCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 002673 837 Q-------VFDPILRGKGFDEEMLQVLDVACMCVSQNPFKRPTVKEVVE 878 (894)
Q Consensus 837 ~-------~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~ 878 (894)
+ ...... ..........+.+++.+|++.+|++|||++++++
T Consensus 232 ~~~~~~~~~~~~~~-~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~ 279 (283)
T cd07835 232 DYKPTFPKWARQDL-SKVVPNLDEDGLDLLSKMLVYDPAKRISAKAALQ 279 (283)
T ss_pred hhhhhcccccccch-hhhcCCCCHHHHHHHHHHhcCChhhCcCHHHHhc
Confidence 0 000000 0001112246779999999999999999999985
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc |
| >cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-32 Score=289.25 Aligned_cols=249 Identities=26% Similarity=0.343 Sum_probs=198.8
Q ss_pred CCCccceEeecCcEEEEEEEE-cCCCeEEEEEEcCcc--hhhHHHHHHHHHHHHhcCCCceeeecceeeecceEEEEEEe
Q 002673 608 NFSQANIIGCGGFGLVYKATL-ANGTTLAIKKLSGDL--GLMEREFKAEVEALSTAQHKNLVSLQGYCVHQGFRLLIYSY 684 (894)
Q Consensus 608 ~f~~~~~LG~G~fg~Vy~a~~-~~g~~vAvK~~~~~~--~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~lV~E~ 684 (894)
+|+..+.||+|+||.||+|.. .+|..||+|.+.... ....+.+.+|+.+++.++|+||+++++.+..+...++|+||
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~ 80 (257)
T cd08225 1 RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFFASFQENGRLFIVMEY 80 (257)
T ss_pred CceEEEEecCCCcceEEEEEEcCCCceEEEEEeeHhhccchhhHHHHHHHHHHHhCCCCChhhhhheeccCCeEEEEEec
Confidence 477889999999999999985 468899999986532 12345688999999999999999999999999999999999
Q ss_pred ccCCCHHHHHhhhcCCCCCcCHHHHHHHHHHHHHHHHHHHhccCCCeeecCCCCCCeEECCCC-cEEEEEcccccccCCC
Q 002673 685 MENGSLDYWLHEKADGASQLDWLTRLKIARGTSCGLAYMHQICEPHIVHRDIKSSNILLDDQF-EAHLADFGLSRLILPY 763 (894)
Q Consensus 685 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDLkp~NILld~~~-~vkl~DFGla~~~~~~ 763 (894)
+++++|.+++.... ...+++..+..++.|++.||.|||+ .+++|+||||+||++++++ .+||+|||.+......
T Consensus 81 ~~~~~L~~~~~~~~--~~~~~~~~~~~~~~~l~~~l~~lh~---~~i~H~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~ 155 (257)
T cd08225 81 CDGGDLMKRINRQR--GVLFSEDQILSWFVQISLGLKHIHD---RKILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDS 155 (257)
T ss_pred CCCCcHHHHHHhcc--CCCCCHHHHHHHHHHHHHHHHHHHH---CCcccccCCHHHEEEcCCCCeEEecccccchhccCC
Confidence 99999999997542 2457899999999999999999997 5999999999999999885 4799999999866432
Q ss_pred CCcccccccccCCccCcccccCcCCCccccHHHHHHHHHHHHcCCCCCCCCCcchhhhHHHHHHHHhhcCCCCccccccc
Q 002673 764 QTHVTTELVGTLGYIPPEYGQAWVATLRGDMYSFGVVMLELLTGKRPVDVLKPKMSRELVGWVLKMRSEGKQDQVFDPIL 843 (894)
Q Consensus 764 ~~~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwS~GvlL~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l 843 (894)
. .......|++.|+|||+..+..++.++||||||+++|||++|+.||..... ..+...... ...... .
T Consensus 156 ~-~~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~------~~~~~~~~~-~~~~~~-~--- 223 (257)
T cd08225 156 M-ELAYTCVGTPYYLSPEICQNRPYNNKTDIWSLGCVLYELCTLKHPFEGNNL------HQLVLKICQ-GYFAPI-S--- 223 (257)
T ss_pred c-ccccccCCCccccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCccH------HHHHHHHhc-ccCCCC-C---
Confidence 2 222334688999999999888899999999999999999999999974321 111111111 111111 0
Q ss_pred cCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 002673 844 RGKGFDEEMLQVLDVACMCVSQNPFKRPTVKEVVE 878 (894)
Q Consensus 844 ~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~ 878 (894)
+.....+.+++.+|++.+|++|||+.++++
T Consensus 224 -----~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~ 253 (257)
T cd08225 224 -----PNFSRDLRSLISQLFKVSPRDRPSITSILK 253 (257)
T ss_pred -----CCCCHHHHHHHHHHhccChhhCcCHHHHhh
Confidence 111235778899999999999999999986
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. |
| >cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-32 Score=305.60 Aligned_cols=268 Identities=25% Similarity=0.325 Sum_probs=198.8
Q ss_pred ccCCCccceEeecCcEEEEEEE-EcCCCeEEEEEEcCcc-hhhHHHHHHHHHHHHhcCCCceeeecceeeec-----ceE
Q 002673 606 TDNFSQANIIGCGGFGLVYKAT-LANGTTLAIKKLSGDL-GLMEREFKAEVEALSTAQHKNLVSLQGYCVHQ-----GFR 678 (894)
Q Consensus 606 ~~~f~~~~~LG~G~fg~Vy~a~-~~~g~~vAvK~~~~~~-~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~-----~~~ 678 (894)
.++|++.+.||+|+||.||+|. ..+|+.||+|++.... ......+.+|+.++++++|+||+++++++... ...
T Consensus 4 ~~~y~i~~~lg~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 83 (336)
T cd07849 4 GPRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRTLREIKILRRFKHENIIGILDIIRPPSFESFNDV 83 (336)
T ss_pred ccceEEEEEEEecCCeEEEEEEEcCCCCeEEEEEecccccchhHHHHHHHHHHHHhCCCCCcCchhheeecccccccceE
Confidence 4689999999999999999998 4578999999986432 22345678899999999999999999987644 357
Q ss_pred EEEEEeccCCCHHHHHhhhcCCCCCcCHHHHHHHHHHHHHHHHHHHhccCCCeeecCCCCCCeEECCCCcEEEEEccccc
Q 002673 679 LLIYSYMENGSLDYWLHEKADGASQLDWLTRLKIARGTSCGLAYMHQICEPHIVHRDIKSSNILLDDQFEAHLADFGLSR 758 (894)
Q Consensus 679 ~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDLkp~NILld~~~~vkl~DFGla~ 758 (894)
++|+||+. ++|..++.. ..+++..+..++.|++.||.|||+ .+|+||||||+||+++.++.+||+|||++.
T Consensus 84 ~lv~e~~~-~~l~~~~~~-----~~l~~~~~~~i~~ql~~aL~~LH~---~~ivH~dlkp~Nill~~~~~~kl~dfg~~~ 154 (336)
T cd07849 84 YIVQELME-TDLYKLIKT-----QHLSNDHIQYFLYQILRGLKYIHS---ANVLHRDLKPSNLLLNTNCDLKICDFGLAR 154 (336)
T ss_pred EEEehhcc-cCHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHh---CCeeccCCCHHHEEECCCCCEEECccccee
Confidence 99999996 488777753 358899999999999999999997 599999999999999999999999999998
Q ss_pred ccCCCCCc--ccccccccCCccCcccccC-cCCCccccHHHHHHHHHHHHcCCCCCCCCCcchhhhHHHHHHHHhhcCCC
Q 002673 759 LILPYQTH--VTTELVGTLGYIPPEYGQA-WVATLRGDMYSFGVVMLELLTGKRPVDVLKPKMSRELVGWVLKMRSEGKQ 835 (894)
Q Consensus 759 ~~~~~~~~--~~~~~~gt~~Y~APE~~~~-~~~s~ksDVwS~GvlL~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~ 835 (894)
........ ......||..|+|||.+.+ ..++.++|||||||++|+|++|+.||....... ..............
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGvil~el~~G~~~f~~~~~~~---~~~~~~~~~~~~~~ 231 (336)
T cd07849 155 IADPEHDHTGFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGKDYLH---QLNLILGVLGTPSQ 231 (336)
T ss_pred eccccccccCCcCCcCcCCCccChHHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHH---HHHHHHHHcCCCCH
Confidence 65332211 1223568899999998654 568899999999999999999999996533211 11111111000000
Q ss_pred ---Ccccccc-------cc---C----CCChHHHHHHHHHHHHhcccCCCCCCCHHHHHH--HHHhccc
Q 002673 836 ---DQVFDPI-------LR---G----KGFDEEMLQVLDVACMCVSQNPFKRPTVKEVVE--WLNNVGA 885 (894)
Q Consensus 836 ---~~~~d~~-------l~---~----~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~--~L~~i~~ 885 (894)
..+.+.. .. . ...+.....+.+++.+||+.+|++|||+.++++ +++....
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~e~l~hp~~~~~~~ 300 (336)
T cd07849 232 EDLNCIISLRARNYIKSLPFKPKVPWNKLFPNADPKALDLLDKMLTFNPHKRITVEEALAHPYLEQYHD 300 (336)
T ss_pred HHHHHhhchhhhhHHhhcCcCCcccHHHHhcccCcHHHHHHHHHcCCChhhCcCHHHHhcCccccccCC
Confidence 0000000 00 0 000112346789999999999999999999998 6776653
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase |
| >cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-32 Score=287.50 Aligned_cols=249 Identities=21% Similarity=0.310 Sum_probs=203.3
Q ss_pred CCCccceEeecCcEEEEEEE-EcCCCeEEEEEEcCcc--hhhHHHHHHHHHHHHhcCCCceeeecceeeecceEEEEEEe
Q 002673 608 NFSQANIIGCGGFGLVYKAT-LANGTTLAIKKLSGDL--GLMEREFKAEVEALSTAQHKNLVSLQGYCVHQGFRLLIYSY 684 (894)
Q Consensus 608 ~f~~~~~LG~G~fg~Vy~a~-~~~g~~vAvK~~~~~~--~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~lV~E~ 684 (894)
+|++.+.||+|+||.||++. ..+++.+++|.+.... ......+.+|+++++.++|+||+++++++......++||||
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~ 80 (256)
T cd08530 1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNIISYKEAFLDGNKLCIVMEY 80 (256)
T ss_pred CceEeeeecCCCceeEEEEEECCCCCEEEEEEEehhhccHHHHHHHHHHHHHHHhCCCCCchhhhhhhccCCEEEEEehh
Confidence 47788999999999999997 4578899999987532 23345678899999999999999999999999999999999
Q ss_pred ccCCCHHHHHhhhcCCCCCcCHHHHHHHHHHHHHHHHHHHhccCCCeeecCCCCCCeEECCCCcEEEEEcccccccCCCC
Q 002673 685 MENGSLDYWLHEKADGASQLDWLTRLKIARGTSCGLAYMHQICEPHIVHRDIKSSNILLDDQFEAHLADFGLSRLILPYQ 764 (894)
Q Consensus 685 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDLkp~NILld~~~~vkl~DFGla~~~~~~~ 764 (894)
+++++|.+++.........+++..++.++.|++.||.|||+ .+++|+||+|+||++++++.+||+|||++......
T Consensus 81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lh~---~~i~h~~l~~~ni~~~~~~~~kl~d~g~~~~~~~~- 156 (256)
T cd08530 81 APFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHE---QKILHRDLKSANILLVANDLVKIGDLGISKVLKKN- 156 (256)
T ss_pred cCCCCHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhh---CCcccCCCCcceEEEecCCcEEEeeccchhhhccC-
Confidence 99999999998754444678999999999999999999997 59999999999999999999999999999876433
Q ss_pred CcccccccccCCccCcccccCcCCCccccHHHHHHHHHHHHcCCCCCCCCCcchhhhHHHHHHHHhhcCCCCcccccccc
Q 002673 765 THVTTELVGTLGYIPPEYGQAWVATLRGDMYSFGVVMLELLTGKRPVDVLKPKMSRELVGWVLKMRSEGKQDQVFDPILR 844 (894)
Q Consensus 765 ~~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwS~GvlL~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~ 844 (894)
......++..|+|||...+..++.++|+||||+++|+|++|+.||....... .... .........
T Consensus 157 --~~~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~~---~~~~----~~~~~~~~~------ 221 (256)
T cd08530 157 --MAKTQIGTPHYMAPEVWKGRPYSYKSDIWSLGCLLYEMATFAPPFEARSMQD---LRYK----VQRGKYPPI------ 221 (256)
T ss_pred --CcccccCCccccCHHHHCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH---HHHH----HhcCCCCCC------
Confidence 2233567889999999999899999999999999999999999997544211 1111 111111111
Q ss_pred CCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 002673 845 GKGFDEEMLQVLDVACMCVSQNPFKRPTVKEVVE 878 (894)
Q Consensus 845 ~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~ 878 (894)
......++.+++.+|++.+|++||++.++++
T Consensus 222 ---~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~ 252 (256)
T cd08530 222 ---PPIYSQDLQNFIRSMLQVKPKLRPNCDKILA 252 (256)
T ss_pred ---chhhCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence 1123346789999999999999999999975
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an |
| >cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-31 Score=299.02 Aligned_cols=270 Identities=20% Similarity=0.261 Sum_probs=198.7
Q ss_pred ceEeec--CcEEEEEEEE-cCCCeEEEEEEcCcc--hhhHHHHHHHHHHHHhcCCCceeeecceeeecceEEEEEEeccC
Q 002673 613 NIIGCG--GFGLVYKATL-ANGTTLAIKKLSGDL--GLMEREFKAEVEALSTAQHKNLVSLQGYCVHQGFRLLIYSYMEN 687 (894)
Q Consensus 613 ~~LG~G--~fg~Vy~a~~-~~g~~vAvK~~~~~~--~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~lV~E~~~~ 687 (894)
..||+| +||+||++.. .+|+.||+|.+.... ....+.+.+|+.+++.++||||++++++|..++..++|+||+.+
T Consensus 4 ~~ig~g~~~~~~v~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~~v~e~~~~ 83 (328)
T cd08226 4 VEIGRGFCNLTSVYLARHTPTGTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTSWTVFTTGSWLWVISPFMAY 83 (328)
T ss_pred HHhCCcccCceeEEEEEEcCCCcEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceEeeeEecCCceEEEEecccC
Confidence 346666 9999999985 579999999987532 22346788999999999999999999999999999999999999
Q ss_pred CCHHHHHhhhcCCCCCcCHHHHHHHHHHHHHHHHHHHhccCCCeeecCCCCCCeEECCCCcEEEEEcccccccCCCCCcc
Q 002673 688 GSLDYWLHEKADGASQLDWLTRLKIARGTSCGLAYMHQICEPHIVHRDIKSSNILLDDQFEAHLADFGLSRLILPYQTHV 767 (894)
Q Consensus 688 gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDLkp~NILld~~~~vkl~DFGla~~~~~~~~~~ 767 (894)
|+|.+++.... ...+++..+..++.|++.||+|||+ ++++||||||+||+++.++.++++||+.+..........
T Consensus 84 ~~l~~~l~~~~--~~~~~~~~~~~~~~qi~~aL~~lH~---~~ivHrDlkp~Nill~~~~~~~~~~~~~~~~~~~~~~~~ 158 (328)
T cd08226 84 GSANSLLKTYF--PEGMSEALIGNILFGALRGLNYLHQ---NGYIHRNIKASHILISGDGLVSLSGLSHLYSLVRNGQKA 158 (328)
T ss_pred CCHHHHHHhhc--ccCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEEeCCCcEEEechHHHhhhhccCccc
Confidence 99999988643 2358888999999999999999997 599999999999999999999999998654332111100
Q ss_pred ------cccccccCCccCcccccCc--CCCccccHHHHHHHHHHHHcCCCCCCCCCcchhhhHHHHHHHHh---------
Q 002673 768 ------TTELVGTLGYIPPEYGQAW--VATLRGDMYSFGVVMLELLTGKRPVDVLKPKMSRELVGWVLKMR--------- 830 (894)
Q Consensus 768 ------~~~~~gt~~Y~APE~~~~~--~~s~ksDVwS~GvlL~elltG~~Pf~~~~~~~~~~~~~~~~~~~--------- 830 (894)
.....++..|+|||++.+. .++.++|||||||++|||++|+.||....... ..........
T Consensus 159 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~--~~~~~~~~~~~~~~~~~~~ 236 (328)
T cd08226 159 KVVYDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQDMLRTQ--MLLQKLKGPPYSPLDITTF 236 (328)
T ss_pred cccccccccccCccCccChhhhcCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcChHH--HHHHHhcCCCCCCcccccc
Confidence 0112345679999998763 47899999999999999999999997543211 1111000000
Q ss_pred -----------------------hcCCCCccccccccCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHH--HHHhccc
Q 002673 831 -----------------------SEGKQDQVFDPILRGKGFDEEMLQVLDVACMCVSQNPFKRPTVKEVVE--WLNNVGA 885 (894)
Q Consensus 831 -----------------------~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~--~L~~i~~ 885 (894)
.........+..+...........+.+++.+||+.||++|||++++++ |+..++.
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpta~e~l~~~~~~~~~~ 316 (328)
T cd08226 237 PCEESRMKNSQSGVDSGIGESVVAAGMTQTMTSERLRTPSSKTFSPAFQNLVELCLQQDPEKRPSASSLLSHAFFKQVKE 316 (328)
T ss_pred chhhhhhccchhhhhcccccchhccccccccccccccchhhhhhhHHHHHHHHHHccCCcccCCCHHHHhhCHHHHHHHH
Confidence 000000000011111111234457889999999999999999999997 8888876
Q ss_pred cccC
Q 002673 886 NRRN 889 (894)
Q Consensus 886 ~~~~ 889 (894)
...+
T Consensus 317 ~~~~ 320 (328)
T cd08226 317 QTQG 320 (328)
T ss_pred hccc
Confidence 6544
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig |
| >cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-32 Score=292.82 Aligned_cols=265 Identities=22% Similarity=0.295 Sum_probs=197.6
Q ss_pred CCCccceEeecCcEEEEEEEE-cCCCeEEEEEEcCcch-hhHHHHHHHHHHHHhcCCCceeeecceeeecceEEEEEEec
Q 002673 608 NFSQANIIGCGGFGLVYKATL-ANGTTLAIKKLSGDLG-LMEREFKAEVEALSTAQHKNLVSLQGYCVHQGFRLLIYSYM 685 (894)
Q Consensus 608 ~f~~~~~LG~G~fg~Vy~a~~-~~g~~vAvK~~~~~~~-~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~lV~E~~ 685 (894)
+|+..+.||.|++|.||+|.. .+|..||||++..... .....+.+|+.+++.++|+||+++++++...+..++||||+
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 80 (284)
T cd07836 1 NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENIVRLHDVIHTENKLMLVFEYM 80 (284)
T ss_pred CceEeeeeccCCceEEEEEEECCCCeEEEEEEecccccccchHHHHHHHHHHHhhcCCCEeeeeeeEeeCCcEEEEEecC
Confidence 478889999999999999986 4689999999876432 22356778999999999999999999999999999999999
Q ss_pred cCCCHHHHHhhhcCCCCCcCHHHHHHHHHHHHHHHHHHHhccCCCeeecCCCCCCeEECCCCcEEEEEcccccccCCCCC
Q 002673 686 ENGSLDYWLHEKADGASQLDWLTRLKIARGTSCGLAYMHQICEPHIVHRDIKSSNILLDDQFEAHLADFGLSRLILPYQT 765 (894)
Q Consensus 686 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDLkp~NILld~~~~vkl~DFGla~~~~~~~~ 765 (894)
++ +|.+++..... ...+++..+..++.|++.||.|||+ .+++||||||+||++++++.++|+|||++........
T Consensus 81 ~~-~l~~~~~~~~~-~~~~~~~~~~~~~~qi~~~l~~lH~---~~i~h~dl~p~ni~~~~~~~~~l~d~g~~~~~~~~~~ 155 (284)
T cd07836 81 DK-DLKKYMDTHGV-RGALDPNTVKSFTYQLLKGIAFCHE---NRVLHRDLKPQNLLINKRGELKLADFGLARAFGIPVN 155 (284)
T ss_pred Cc-cHHHHHHhcCC-CCCcCHHHHHHHHHHHHHHHHHHHH---CCeeeCCCCHHHEEECCCCcEEEeecchhhhhcCCcc
Confidence 84 88888875432 3468999999999999999999997 5999999999999999999999999999976532211
Q ss_pred cccccccccCCccCcccccCc-CCCccccHHHHHHHHHHHHcCCCCCCCCCcchhh-hHHHHH--------HHHhhcCCC
Q 002673 766 HVTTELVGTLGYIPPEYGQAW-VATLRGDMYSFGVVMLELLTGKRPVDVLKPKMSR-ELVGWV--------LKMRSEGKQ 835 (894)
Q Consensus 766 ~~~~~~~gt~~Y~APE~~~~~-~~s~ksDVwS~GvlL~elltG~~Pf~~~~~~~~~-~~~~~~--------~~~~~~~~~ 835 (894)
......++..|++||++.+. .++.++||||||+++|+|++|+.||......... ...... .........
T Consensus 156 -~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (284)
T cd07836 156 -TFSNEVVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFPGTNNEDQLLKIFRIMGTPTESTWPGISQLPEY 234 (284)
T ss_pred -ccccccccccccChHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhHHHHhcCchh
Confidence 12334578899999987664 5788999999999999999999999754432111 111000 000000000
Q ss_pred Ccccccc---ccCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 002673 836 DQVFDPI---LRGKGFDEEMLQVLDVACMCVSQNPFKRPTVKEVVE 878 (894)
Q Consensus 836 ~~~~d~~---l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~ 878 (894)
...+... ......+.....+.+++.+|++.||.+||++.++++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~ 280 (284)
T cd07836 235 KPTFPRYPPQDLQQLFPHADPLGIDLLHRLLQLNPELRISAHDALQ 280 (284)
T ss_pred cccccCCChHHHHHHhhhcCcHHHHHHHHHhcCCcccCCCHHHHhc
Confidence 0000000 000001112346779999999999999999999985
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. |
| >cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-32 Score=290.32 Aligned_cols=247 Identities=26% Similarity=0.335 Sum_probs=199.7
Q ss_pred CCCccceEeecCcEEEEEEEEc-CCCeEEEEEEcCcch---hhHHHHHHHHHHHHhcCCCceeeecceeeecceEEEEEE
Q 002673 608 NFSQANIIGCGGFGLVYKATLA-NGTTLAIKKLSGDLG---LMEREFKAEVEALSTAQHKNLVSLQGYCVHQGFRLLIYS 683 (894)
Q Consensus 608 ~f~~~~~LG~G~fg~Vy~a~~~-~g~~vAvK~~~~~~~---~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~lV~E 683 (894)
+|+..+.||.|+||.||+|... ++..||+|.+..... ...+.+.+|++++++++||||+++++++.++...++|+|
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 80 (258)
T cd05578 1 HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWYSFQDEENMYLVVD 80 (258)
T ss_pred CceEEEEeccCCCceEEEEEEccCCcEEEEEEEehhhhcchhHHHHHHHHHHHHHhCCCCChHHHHHhhcCCCeEEEEEe
Confidence 4778899999999999999864 689999999975432 334678899999999999999999999999999999999
Q ss_pred eccCCCHHHHHhhhcCCCCCcCHHHHHHHHHHHHHHHHHHHhccCCCeeecCCCCCCeEECCCCcEEEEEcccccccCCC
Q 002673 684 YMENGSLDYWLHEKADGASQLDWLTRLKIARGTSCGLAYMHQICEPHIVHRDIKSSNILLDDQFEAHLADFGLSRLILPY 763 (894)
Q Consensus 684 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDLkp~NILld~~~~vkl~DFGla~~~~~~ 763 (894)
|+.+++|..++... ..+++..+..++.|+++||.|||+ ++++|+||+|+||++++++.++|+|||++......
T Consensus 81 ~~~~~~L~~~l~~~----~~l~~~~~~~~~~~i~~~l~~lh~---~~i~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~ 153 (258)
T cd05578 81 LLLGGDLRYHLSQK----VKFSEEQVKFWICEIVLALEYLHS---KGIIHRDIKPDNILLDEQGHVHITDFNIATKVTPD 153 (258)
T ss_pred CCCCCCHHHHHHhc----CCcCHHHHHHHHHHHHHHHHHHHh---CCeeccCCCHHHeEEcCCCCEEEeecccccccCCC
Confidence 99999999999754 357889999999999999999997 59999999999999999999999999998875432
Q ss_pred CCcccccccccCCccCcccccCcCCCccccHHHHHHHHHHHHcCCCCCCCCCcchhhhHHHHHHHHhhcCCCCccccccc
Q 002673 764 QTHVTTELVGTLGYIPPEYGQAWVATLRGDMYSFGVVMLELLTGKRPVDVLKPKMSRELVGWVLKMRSEGKQDQVFDPIL 843 (894)
Q Consensus 764 ~~~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwS~GvlL~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l 843 (894)
. ......|+..|+|||+..+..++.++|+||||+++|+|++|+.||............ ..... ......
T Consensus 154 ~--~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~----~~~~~--~~~~~~--- 222 (258)
T cd05578 154 T--LTTSTSGTPGYMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKRPYRGHSRTIRDQIR----AKQET--ADVLYP--- 222 (258)
T ss_pred c--cccccCCChhhcCHHHHcccCCCCcccchhhHHHHHHHHhCCCCCCCCCccHHHHHH----HHhcc--ccccCc---
Confidence 2 223356788999999998888999999999999999999999999865432111111 11111 001111
Q ss_pred cCCCChHHHHHHHHHHHHhcccCCCCCCCH--HHHH
Q 002673 844 RGKGFDEEMLQVLDVACMCVSQNPFKRPTV--KEVV 877 (894)
Q Consensus 844 ~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~--~evl 877 (894)
......+.+++.+||+.||.+||++ ++++
T Consensus 223 -----~~~~~~~~~~i~~~l~~~p~~R~~~~~~~l~ 253 (258)
T cd05578 223 -----ATWSTEAIDAINKLLERDPQKRLGDNLKDLK 253 (258)
T ss_pred -----ccCcHHHHHHHHHHccCChhHcCCccHHHHh
Confidence 1112467789999999999999999 6654
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. |
| >PLN00009 cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-32 Score=294.74 Aligned_cols=268 Identities=24% Similarity=0.304 Sum_probs=198.1
Q ss_pred cCCCccceEeecCcEEEEEEEE-cCCCeEEEEEEcCcch--hhHHHHHHHHHHHHhcCCCceeeecceeeecceEEEEEE
Q 002673 607 DNFSQANIIGCGGFGLVYKATL-ANGTTLAIKKLSGDLG--LMEREFKAEVEALSTAQHKNLVSLQGYCVHQGFRLLIYS 683 (894)
Q Consensus 607 ~~f~~~~~LG~G~fg~Vy~a~~-~~g~~vAvK~~~~~~~--~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~lV~E 683 (894)
++|+..+.||+|++|.||+|.. .+|+.||+|.+..... .....+.+|++++++++||||+++++++......++|||
T Consensus 2 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 81 (294)
T PLN00009 2 DQYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKRLYLVFE 81 (294)
T ss_pred CceEEEEEecCCCCEEEEEEEecCCCcEEEEEehhhccccccchHHHHHHHHHHHhccCCCEeeEEEEEecCCeEEEEEe
Confidence 4688889999999999999985 4789999999865322 223568889999999999999999999999999999999
Q ss_pred eccCCCHHHHHhhhcCCCCCcCHHHHHHHHHHHHHHHHHHHhccCCCeeecCCCCCCeEECC-CCcEEEEEcccccccCC
Q 002673 684 YMENGSLDYWLHEKADGASQLDWLTRLKIARGTSCGLAYMHQICEPHIVHRDIKSSNILLDD-QFEAHLADFGLSRLILP 762 (894)
Q Consensus 684 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDLkp~NILld~-~~~vkl~DFGla~~~~~ 762 (894)
|++ ++|.+++.... ...+++.....++.||+.||.|||+ ++++|+||+|+||+++. ++.+||+|||++.....
T Consensus 82 ~~~-~~l~~~~~~~~--~~~~~~~~~~~~~~qi~~aL~~LH~---~~i~H~dl~p~nill~~~~~~~kl~dfg~~~~~~~ 155 (294)
T PLN00009 82 YLD-LDLKKHMDSSP--DFAKNPRLIKTYLYQILRGIAYCHS---HRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGI 155 (294)
T ss_pred ccc-ccHHHHHHhCC--CCCcCHHHHHHHHHHHHHHHHHHHh---CCeeCCCCCcceEEEECCCCEEEEcccccccccCC
Confidence 996 57877775432 2346778888999999999999997 59999999999999985 56799999999976532
Q ss_pred CCCcccccccccCCccCcccccC-cCCCccccHHHHHHHHHHHHcCCCCCCCCCcchhhhHHHHHHHHhhcCCCCcccc-
Q 002673 763 YQTHVTTELVGTLGYIPPEYGQA-WVATLRGDMYSFGVVMLELLTGKRPVDVLKPKMSRELVGWVLKMRSEGKQDQVFD- 840 (894)
Q Consensus 763 ~~~~~~~~~~gt~~Y~APE~~~~-~~~s~ksDVwS~GvlL~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d- 840 (894)
.. .......+++.|+|||++.+ ..++.++||||||+++|+|+||+.||....... ...... ...... .....+
T Consensus 156 ~~-~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~i~~~l~tg~~pf~~~~~~~--~~~~~~-~~~~~~-~~~~~~~ 230 (294)
T PLN00009 156 PV-RTFTHEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEID--ELFKIF-RILGTP-NEETWPG 230 (294)
T ss_pred Cc-cccccCceeecccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHH--HHHHHH-HHhCCC-Chhhccc
Confidence 21 11233467889999998766 457889999999999999999999997543211 111110 000000 000000
Q ss_pred -----------ccccCC----CChHHHHHHHHHHHHhcccCCCCCCCHHHHHH--HHHhccc
Q 002673 841 -----------PILRGK----GFDEEMLQVLDVACMCVSQNPFKRPTVKEVVE--WLNNVGA 885 (894)
Q Consensus 841 -----------~~l~~~----~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~--~L~~i~~ 885 (894)
+..... ........+.+++.+|++.+|++||++.++++ |++....
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~~l~~~~~~~~~~ 292 (294)
T PLN00009 231 VTSLPDYKSAFPKWPPKDLATVVPTLEPAGVDLLSKMLRLDPSKRITARAALEHEYFKDLGD 292 (294)
T ss_pred cccchhhhhhcccCCCCCHHHhCcCCChHHHHHHHHHccCChhhCcCHHHHhcCchHhHHhc
Confidence 000000 00112235778999999999999999999998 7776543
|
|
| >cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-31 Score=291.19 Aligned_cols=249 Identities=27% Similarity=0.356 Sum_probs=194.8
Q ss_pred EeecCcEEEEEEEE-cCCCeEEEEEEcCcc---hhhHHHHHHHHHHHHhcCCCceeeecceeeecceEEEEEEeccCCCH
Q 002673 615 IGCGGFGLVYKATL-ANGTTLAIKKLSGDL---GLMEREFKAEVEALSTAQHKNLVSLQGYCVHQGFRLLIYSYMENGSL 690 (894)
Q Consensus 615 LG~G~fg~Vy~a~~-~~g~~vAvK~~~~~~---~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~lV~E~~~~gsL 690 (894)
||+|+||+||++.. .+|+.||+|.+.... ......+..|+++++.++||||+++++++...+..++||||+++++|
T Consensus 1 lg~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (277)
T cd05577 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAYAFETKDDLCLVMTLMNGGDL 80 (277)
T ss_pred CCCCCceeEEEEEEcCCCcEEEEEEEehhhhhhhhhhHHHHHHHHHHHhCCCCCEeeeeeEEecCCeEEEEEecCCCCcH
Confidence 68999999999974 578999999986532 12234567899999999999999999999999999999999999999
Q ss_pred HHHHhhhcCCCCCcCHHHHHHHHHHHHHHHHHHHhccCCCeeecCCCCCCeEECCCCcEEEEEcccccccCCCCCccccc
Q 002673 691 DYWLHEKADGASQLDWLTRLKIARGTSCGLAYMHQICEPHIVHRDIKSSNILLDDQFEAHLADFGLSRLILPYQTHVTTE 770 (894)
Q Consensus 691 ~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDLkp~NILld~~~~vkl~DFGla~~~~~~~~~~~~~ 770 (894)
.+++..... ..+++..+..++.|++.||.|||+ .+++||||+|+||+++.++.+||+|||++..... ......
T Consensus 81 ~~~l~~~~~--~~~~~~~~~~~~~ql~~~l~~lH~---~~i~H~di~p~Nil~~~~~~~~l~dfg~~~~~~~--~~~~~~ 153 (277)
T cd05577 81 KYHIYNVGE--PGFPEARAIFYAAQIICGLEHLHQ---RRIVYRDLKPENVLLDDHGNVRISDLGLAVELKG--GKKIKG 153 (277)
T ss_pred HHHHHHcCc--CCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCCHHHEEECCCCCEEEccCcchhhhcc--CCcccc
Confidence 999976432 468899999999999999999997 5999999999999999999999999999876533 122233
Q ss_pred ccccCCccCcccccCcCCCccccHHHHHHHHHHHHcCCCCCCCCCcchhhhHHHHHHHHhhcCCCCccccccccCCCChH
Q 002673 771 LVGTLGYIPPEYGQAWVATLRGDMYSFGVVMLELLTGKRPVDVLKPKMSRELVGWVLKMRSEGKQDQVFDPILRGKGFDE 850 (894)
Q Consensus 771 ~~gt~~Y~APE~~~~~~~s~ksDVwS~GvlL~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~ 850 (894)
..++..|+|||+..+..++.++||||||+++|+|++|+.||............. ... ... .. .....
T Consensus 154 ~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~--~~~-~~~-~~---------~~~~~ 220 (277)
T cd05577 154 RAGTPGYMAPEVLQGEVYDFSVDWFALGCTLYEMIAGRSPFRQRKEKVEKEELK--RRT-LEM-AV---------EYPDK 220 (277)
T ss_pred ccCCCCcCCHHHhcCCCCCchhhhHHHHHHHHHHhhCCCCCCCCcccccHHHHH--hcc-ccc-cc---------cCCcc
Confidence 467889999999988889999999999999999999999997544311111110 000 000 00 00011
Q ss_pred HHHHHHHHHHHhcccCCCCCC-----CHHHHHH--HHHhc
Q 002673 851 EMLQVLDVACMCVSQNPFKRP-----TVKEVVE--WLNNV 883 (894)
Q Consensus 851 ~~~~l~~li~~Cl~~dP~~RP-----s~~evl~--~L~~i 883 (894)
....+.+++.+||+.+|++|| ++.+++. |+..+
T Consensus 221 ~~~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~h~~~~~~ 260 (277)
T cd05577 221 FSPEAKDLCEALLQKDPEKRLGCRGGSADEVREHPLFKDL 260 (277)
T ss_pred CCHHHHHHHHHHccCChhHccCCCcccHHHHHhChhhhcC
Confidence 133567899999999999999 7777876 55444
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of |
| >PHA03210 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-32 Score=320.38 Aligned_cols=268 Identities=19% Similarity=0.254 Sum_probs=190.3
Q ss_pred ccCCCccceEeecCcEEEEEEEEcC--CCeEEEEEEc--------------C---cchhhHHHHHHHHHHHHhcCCCcee
Q 002673 606 TDNFSQANIIGCGGFGLVYKATLAN--GTTLAIKKLS--------------G---DLGLMEREFKAEVEALSTAQHKNLV 666 (894)
Q Consensus 606 ~~~f~~~~~LG~G~fg~Vy~a~~~~--g~~vAvK~~~--------------~---~~~~~~~~~~~Ei~~l~~l~HpnIv 666 (894)
.++|++.+.||+|+||.||++.... +..+++|.+. + ........+.+|+.++++++||||+
T Consensus 147 ~~~Y~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~Ei~il~~l~HpnIv 226 (501)
T PHA03210 147 LAHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVKAGSRAAIQLENEILALGRLNHENIL 226 (501)
T ss_pred hhccEEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhhcchHHHHHHHHHHHHHHhCCCCCcC
Confidence 4689999999999999999986432 2222222110 0 1112334678999999999999999
Q ss_pred eecceeeecceEEEEEEeccCCCHHHHHhhhc-CCCCCcCHHHHHHHHHHHHHHHHHHHhccCCCeeecCCCCCCeEECC
Q 002673 667 SLQGYCVHQGFRLLIYSYMENGSLDYWLHEKA-DGASQLDWLTRLKIARGTSCGLAYMHQICEPHIVHRDIKSSNILLDD 745 (894)
Q Consensus 667 ~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~~~-~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDLkp~NILld~ 745 (894)
++++++...+..++|+|++. ++|..++.... .............|+.|++.||.|||+ ++|+||||||+|||++.
T Consensus 227 ~l~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH~---~gIiHrDLKP~NILl~~ 302 (501)
T PHA03210 227 KIEEILRSEANTYMITQKYD-FDLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHD---KKLIHRDIKLENIFLNC 302 (501)
T ss_pred cEeEEEEECCeeEEEEeccc-cCHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEECC
Confidence 99999999999999999985 57777765432 111223455677899999999999997 59999999999999999
Q ss_pred CCcEEEEEcccccccCCCCCcccccccccCCccCcccccCcCCCccccHHHHHHHHHHHHcCCC-CCCCCCcchhhhHHH
Q 002673 746 QFEAHLADFGLSRLILPYQTHVTTELVGTLGYIPPEYGQAWVATLRGDMYSFGVVMLELLTGKR-PVDVLKPKMSRELVG 824 (894)
Q Consensus 746 ~~~vkl~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwS~GvlL~elltG~~-Pf~~~~~~~~~~~~~ 824 (894)
++.+||+|||+++.+............||..|+|||++.+..++.++|||||||++|||++|.. |+..........+..
T Consensus 303 ~~~vkL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~~~~~p~~~~~~~~~~~~~~ 382 (501)
T PHA03210 303 DGKIVLGDFGTAMPFEKEREAFDYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLSHDFCPIGDGGGKPGKQLLK 382 (501)
T ss_pred CCCEEEEeCCCceecCcccccccccccCCcCCCCchhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCccCCCCCHHHHHHH
Confidence 9999999999998765433333345679999999999999999999999999999999999875 444332222222222
Q ss_pred HHHHHhhcCCCCcccc----------------------ccccCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHH--HH
Q 002673 825 WVLKMRSEGKQDQVFD----------------------PILRGKGFDEEMLQVLDVACMCVSQNPFKRPTVKEVVE--WL 880 (894)
Q Consensus 825 ~~~~~~~~~~~~~~~d----------------------~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~--~L 880 (894)
....... ...++.+ +.+.... ....+.+++.+|++.||.+|||+.|+++ |+
T Consensus 383 ~~~~~~~--~~~~~p~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~---~~~~~~~li~kmL~~DP~~Rpsa~elL~hp~f 457 (501)
T PHA03210 383 IIDSLSV--CDEEFPDPPCKLFDYIDSAEIDHAGHSVPPLIRNLG---LPADFEYPLVKMLTFDWHLRPGAAELLALPLF 457 (501)
T ss_pred HHHhccc--ChhhcCCcHHHHHHHhhhhhcccCccchhhHHHhcC---CChHHHHHHHHHhccCcccCcCHHHHhhChhh
Confidence 1111100 0000000 0011000 1124667888999999999999999997 55
Q ss_pred Hh
Q 002673 881 NN 882 (894)
Q Consensus 881 ~~ 882 (894)
..
T Consensus 458 ~~ 459 (501)
T PHA03210 458 SA 459 (501)
T ss_pred hc
Confidence 43
|
|
| >cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-32 Score=303.80 Aligned_cols=271 Identities=23% Similarity=0.318 Sum_probs=202.0
Q ss_pred ccCCCccceEeecCcEEEEEEEE-cCCCeEEEEEEcCcch--hhHHHHHHHHHHHHhcCCCceeeecceeee----cceE
Q 002673 606 TDNFSQANIIGCGGFGLVYKATL-ANGTTLAIKKLSGDLG--LMEREFKAEVEALSTAQHKNLVSLQGYCVH----QGFR 678 (894)
Q Consensus 606 ~~~f~~~~~LG~G~fg~Vy~a~~-~~g~~vAvK~~~~~~~--~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~----~~~~ 678 (894)
.++|+..+.||+|+||.||+|.. .+|..||+|++..... .....+.+|+.+++.++||||+++++++.. ....
T Consensus 4 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 83 (334)
T cd07855 4 GSRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHDNIIAIRDILRPPGADFKDV 83 (334)
T ss_pred hhceeeeeeeecCCCeEEEEEEEcCCCCEEEEEEeccccccccchHHHHHHHHHHHhcCCCCccCHHHhccccCCCCceE
Confidence 36888999999999999999984 5799999999875432 234567789999999999999999998763 3467
Q ss_pred EEEEEeccCCCHHHHHhhhcCCCCCcCHHHHHHHHHHHHHHHHHHHhccCCCeeecCCCCCCeEECCCCcEEEEEccccc
Q 002673 679 LLIYSYMENGSLDYWLHEKADGASQLDWLTRLKIARGTSCGLAYMHQICEPHIVHRDIKSSNILLDDQFEAHLADFGLSR 758 (894)
Q Consensus 679 ~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDLkp~NILld~~~~vkl~DFGla~ 758 (894)
++||||+. |+|.+++... ..+++..+..++.||+.||.|||+ ++++||||||+||++++++.+||+|||++.
T Consensus 84 ~lv~e~~~-~~l~~~~~~~----~~~~~~~~~~i~~qi~~aL~~LH~---~~ivH~dlkp~Nil~~~~~~~kl~dfg~~~ 155 (334)
T cd07855 84 YVVMDLME-SDLHHIIHSD----QPLTEEHIRYFLYQLLRGLKYIHS---ANVIHRDLKPSNLLVNEDCELRIGDFGMAR 155 (334)
T ss_pred EEEEehhh-hhHHHHhccC----CCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHEEEcCCCcEEecccccce
Confidence 99999995 6898888643 348999999999999999999997 599999999999999999999999999997
Q ss_pred ccCCCCC---cccccccccCCccCcccccC-cCCCccccHHHHHHHHHHHHcCCCCCCCCCcchhhhHHHHHHHHhhcC-
Q 002673 759 LILPYQT---HVTTELVGTLGYIPPEYGQA-WVATLRGDMYSFGVVMLELLTGKRPVDVLKPKMSRELVGWVLKMRSEG- 833 (894)
Q Consensus 759 ~~~~~~~---~~~~~~~gt~~Y~APE~~~~-~~~s~ksDVwS~GvlL~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~- 833 (894)
....... .......++..|+|||.+.+ ..++.++|||||||++|||++|+.||........ ...........
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~~~~~~---~~~~~~~~g~~~ 232 (334)
T cd07855 156 GLSSSPTEHKYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYVHQ---LKLILSVLGSPS 232 (334)
T ss_pred eecccCcCCCcccccccccccccChHHhcCCcccccccchHHHHHHHHHHHcCCCccCCCChHHH---HHHHHHHhCCCh
Confidence 6533221 11223468899999998765 4688999999999999999999999975432111 11111000000
Q ss_pred ----------CCCcccccc--ccC----CCChHHHHHHHHHHHHhcccCCCCCCCHHHHHH--HHHhccccc
Q 002673 834 ----------KQDQVFDPI--LRG----KGFDEEMLQVLDVACMCVSQNPFKRPTVKEVVE--WLNNVGANR 887 (894)
Q Consensus 834 ----------~~~~~~d~~--l~~----~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~--~L~~i~~~~ 887 (894)
......+.. ... ...+.....+.+++.+|++.+|.+||++.++++ |+++.....
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~~~~~~~~~~~ 304 (334)
T cd07855 233 EEVLNRIGSDRVRKYIQNLPRKQPVPWSKIFPKASPEALDLLSQMLQFDPEERITVEQALQHPFLAQYHDPD 304 (334)
T ss_pred hHhhhhhchhhHHHHHhhcccCCCCCHHHHcccCCHHHHHHHHHHccCChhhCcCHHHHHhChhhhhccCCc
Confidence 000000000 000 001122446789999999999999999999998 887765543
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the |
| >cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Probab=99.98 E-value=7.8e-32 Score=292.46 Aligned_cols=257 Identities=24% Similarity=0.242 Sum_probs=191.8
Q ss_pred CCccceEeecCcEEEEEEEE-cCCCeEEEEEEcCcch-hhHHHHHHHHHHHHhcC-CCceeeecceeeec--ceEEEEEE
Q 002673 609 FSQANIIGCGGFGLVYKATL-ANGTTLAIKKLSGDLG-LMEREFKAEVEALSTAQ-HKNLVSLQGYCVHQ--GFRLLIYS 683 (894)
Q Consensus 609 f~~~~~LG~G~fg~Vy~a~~-~~g~~vAvK~~~~~~~-~~~~~~~~Ei~~l~~l~-HpnIv~l~g~~~~~--~~~~lV~E 683 (894)
|++.+.||+|+||.||+|.. .++..||+|++..... ........|+.++.++. |+|++++++++.+. +..++|||
T Consensus 1 y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~lv~e 80 (282)
T cd07831 1 YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQVNNLREIQALRRLSPHPNILRLIEVLFDRKTGRLALVFE 80 (282)
T ss_pred CceEeeccccccceEEEEEEcCCCcEEEEEEehhccCCchhhhHHHHHHHHhhcCCCCCccceEEEEecCCCCcEEEEEe
Confidence 56678899999999999984 5789999999875422 22234457888898885 99999999999987 88999999
Q ss_pred eccCCCHHHHHhhhcCCCCCcCHHHHHHHHHHHHHHHHHHHhccCCCeeecCCCCCCeEECCCCcEEEEEcccccccCCC
Q 002673 684 YMENGSLDYWLHEKADGASQLDWLTRLKIARGTSCGLAYMHQICEPHIVHRDIKSSNILLDDQFEAHLADFGLSRLILPY 763 (894)
Q Consensus 684 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDLkp~NILld~~~~vkl~DFGla~~~~~~ 763 (894)
|++ |+|.+++.... ..+++..+..++.|++.||.|||+ .+++||||||+||+++. +.+||+|||+++.....
T Consensus 81 ~~~-~~l~~~l~~~~---~~~~~~~~~~~~~qi~~~L~~LH~---~~i~H~dl~p~ni~l~~-~~~kl~dfg~~~~~~~~ 152 (282)
T cd07831 81 LMD-MNLYELIKGRK---RPLPEKRVKSYMYQLLKSLDHMHR---NGIFHRDIKPENILIKD-DILKLADFGSCRGIYSK 152 (282)
T ss_pred cCC-ccHHHHHHhcc---CCCCHHHHHHHHHHHHHHHHHHHH---CCceecccCHHHEEEcC-CCeEEEecccccccccC
Confidence 996 58888876532 468999999999999999999997 59999999999999999 99999999999876332
Q ss_pred CCcccccccccCCccCccccc-CcCCCccccHHHHHHHHHHHHcCCCCCCCCCcchhhhHHHHHHHHh-----------h
Q 002673 764 QTHVTTELVGTLGYIPPEYGQ-AWVATLRGDMYSFGVVMLELLTGKRPVDVLKPKMSRELVGWVLKMR-----------S 831 (894)
Q Consensus 764 ~~~~~~~~~gt~~Y~APE~~~-~~~~s~ksDVwS~GvlL~elltG~~Pf~~~~~~~~~~~~~~~~~~~-----------~ 831 (894)
.. .....++..|+|||++. +..++.++|||||||++|||++|+.||....... ...+..... .
T Consensus 153 ~~--~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slGv~l~el~~~~~p~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~ 227 (282)
T cd07831 153 PP--YTEYISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPLFPGTNELD---QIAKIHDVLGTPDAEVLKKFR 227 (282)
T ss_pred CC--cCCCCCCcccCChhHhhcCCCCCcchhHHHHHHHHHHHHcCCcCCCCCCHHH---HHHHHHHHcCCCCHHHHHhhc
Confidence 21 22345788999999764 4567889999999999999999999997543211 111111100 0
Q ss_pred cCCCCccccccccCC----CChHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 002673 832 EGKQDQVFDPILRGK----GFDEEMLQVLDVACMCVSQNPFKRPTVKEVVE 878 (894)
Q Consensus 832 ~~~~~~~~d~~l~~~----~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~ 878 (894)
.........+..... ........+.+++.+|++.+|++||+++++++
T Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~ 278 (282)
T cd07831 228 KSRHMNYNFPSKKGTGLRKLLPNASAEGLDLLKKLLAYDPDERITAKQALR 278 (282)
T ss_pred ccccccccCcccccccHHHHcccccHHHHHHHHHHhccCcccccCHHHHhh
Confidence 000000000000000 01123457889999999999999999999986
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. |
| >KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.98 E-value=3.2e-32 Score=297.58 Aligned_cols=251 Identities=24% Similarity=0.387 Sum_probs=194.7
Q ss_pred cCCCccceEeecCcEEEEEEEEcCCCeEEEEEEcCcc--hhhHHHHHHHHHHHHhc-CCCceeeecceeeecceEEEEEE
Q 002673 607 DNFSQANIIGCGGFGLVYKATLANGTTLAIKKLSGDL--GLMEREFKAEVEALSTA-QHKNLVSLQGYCVHQGFRLLIYS 683 (894)
Q Consensus 607 ~~f~~~~~LG~G~fg~Vy~a~~~~g~~vAvK~~~~~~--~~~~~~~~~Ei~~l~~l-~HpnIv~l~g~~~~~~~~~lV~E 683 (894)
..|++.++||+||.+.||++...+.+.+|+|++.... ......|..|+..|.++ .|.+||++++|-..++..|||||
T Consensus 361 ~~Yeilk~iG~GGSSkV~kV~~s~~~iyalkkv~~~~~D~qtl~gy~nEI~lL~KLkg~~~IIqL~DYEv~d~~lYmvmE 440 (677)
T KOG0596|consen 361 REYEILKQIGSGGSSKVFKVLNSDKQIYALKKVVLLEADNQTLDGYRNEIALLNKLKGHDKIIQLYDYEVTDGYLYMVME 440 (677)
T ss_pred chhhHHHhhcCCCcceeeeeecCCCcchhhhHHHHhhcCHHHHHHHHHHHHHHHHhcCCceEEEEeeeeccCceEEEEee
Confidence 5688889999999999999998888899998875432 33456799999999999 59999999999999999999999
Q ss_pred eccCCCHHHHHhhhcCCCCCcCHHHHHHHHHHHHHHHHHHHhccCCCeeecCCCCCCeEECCCCcEEEEEcccccccCCC
Q 002673 684 YMENGSLDYWLHEKADGASQLDWLTRLKIARGTSCGLAYMHQICEPHIVHRDIKSSNILLDDQFEAHLADFGLSRLILPY 763 (894)
Q Consensus 684 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDLkp~NILld~~~~vkl~DFGla~~~~~~ 763 (894)
|= .-+|.++|..+.. ....| .+..+..|++.++.+.|++ +|||.||||.|+|+-. |.+||+|||+|..+...
T Consensus 441 ~G-d~DL~kiL~k~~~--~~~~~-~lk~ywkqML~aV~~IH~~---gIVHSDLKPANFLlVk-G~LKLIDFGIA~aI~~D 512 (677)
T KOG0596|consen 441 CG-DIDLNKILKKKKS--IDPDW-FLKFYWKQMLLAVKTIHQH---GIVHSDLKPANFLLVK-GRLKLIDFGIANAIQPD 512 (677)
T ss_pred cc-cccHHHHHHhccC--CCchH-HHHHHHHHHHHHHHHHHHh---ceeecCCCcccEEEEe-eeEEeeeechhcccCcc
Confidence 86 4599999987642 22334 6788999999999999985 9999999999999965 48999999999987654
Q ss_pred CCc-ccccccccCCccCcccccCc-----------CCCccccHHHHHHHHHHHHcCCCCCCCCCcchhhhHHHHHHHHhh
Q 002673 764 QTH-VTTELVGTLGYIPPEYGQAW-----------VATLRGDMYSFGVVMLELLTGKRPVDVLKPKMSRELVGWVLKMRS 831 (894)
Q Consensus 764 ~~~-~~~~~~gt~~Y~APE~~~~~-----------~~s~ksDVwS~GvlL~elltG~~Pf~~~~~~~~~~~~~~~~~~~~ 831 (894)
... .....+||+.||+||.+... +.+.++||||+|||||+|+.|+.||.... ........+..
T Consensus 513 TTsI~kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqMvYgktPf~~~~-----n~~aKl~aI~~ 587 (677)
T KOG0596|consen 513 TTSIVKDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQMVYGKTPFGQII-----NQIAKLHAITD 587 (677)
T ss_pred ccceeeccccCcccccCHHHHhhccccccCCCcceeecCccchhhhhhHHHHHHhcCCchHHHH-----HHHHHHHhhcC
Confidence 433 34567999999999976432 25689999999999999999999997432 11111111111
Q ss_pred cCCCCccccccccCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 002673 832 EGKQDQVFDPILRGKGFDEEMLQVLDVACMCVSQNPFKRPTVKEVVE 878 (894)
Q Consensus 832 ~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~ 878 (894)
.+ .++.=+.+. ... +++++++.||..||.+|||+.++++
T Consensus 588 P~--~~Iefp~~~---~~~---~li~~mK~CL~rdPkkR~si~eLLq 626 (677)
T KOG0596|consen 588 PN--HEIEFPDIP---END---ELIDVMKCCLARDPKKRWSIPELLQ 626 (677)
T ss_pred CC--ccccccCCC---Cch---HHHHHHHHHHhcCcccCCCcHHHhc
Confidence 11 111101111 111 2889999999999999999999998
|
|
| >cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Probab=99.98 E-value=8.6e-32 Score=296.92 Aligned_cols=269 Identities=26% Similarity=0.302 Sum_probs=199.2
Q ss_pred ccCCCccceEeecCcEEEEEEEE-cCCCeEEEEEEcCcchh--hHHHHHHHHHHHHhcCCCceeeecceeeec--ceEEE
Q 002673 606 TDNFSQANIIGCGGFGLVYKATL-ANGTTLAIKKLSGDLGL--MEREFKAEVEALSTAQHKNLVSLQGYCVHQ--GFRLL 680 (894)
Q Consensus 606 ~~~f~~~~~LG~G~fg~Vy~a~~-~~g~~vAvK~~~~~~~~--~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~--~~~~l 680 (894)
.++|+..+.||+|+||.||+|.. .+|+.||+|++...... ....+.+|+.++++++|+||+++++++... +..++
T Consensus 6 ~~~y~~~~~ig~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~l 85 (309)
T cd07845 6 VTEFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPNIVELKEVVVGKHLDSIFL 85 (309)
T ss_pred ccceeEeeeeeecCCEEEEEEEECCCCcEEEEEEEEeccCCCCCcchhhHHHHHHHhCCCCCCcceEEEEecCCCCeEEE
Confidence 35788899999999999999985 46899999998643221 123466899999999999999999998755 46899
Q ss_pred EEEeccCCCHHHHHhhhcCCCCCcCHHHHHHHHHHHHHHHHHHHhccCCCeeecCCCCCCeEECCCCcEEEEEccccccc
Q 002673 681 IYSYMENGSLDYWLHEKADGASQLDWLTRLKIARGTSCGLAYMHQICEPHIVHRDIKSSNILLDDQFEAHLADFGLSRLI 760 (894)
Q Consensus 681 V~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDLkp~NILld~~~~vkl~DFGla~~~ 760 (894)
||||++ ++|.+++.... ..+++..+..++.|++.||.|||+ .+++||||||+||+++.++.+||+|||++...
T Consensus 86 v~e~~~-~~l~~~l~~~~---~~l~~~~~~~~~~qi~~~l~~lH~---~~i~H~dl~p~nil~~~~~~~kL~dfg~~~~~ 158 (309)
T cd07845 86 VMEYCE-QDLASLLDNMP---TPFSESQVKCLMLQLLRGLQYLHE---NFIIHRDLKVSNLLLTDKGCLKIADFGLARTY 158 (309)
T ss_pred EEecCC-CCHHHHHHhcc---cCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEECCCCCEEECccceeeec
Confidence 999996 48888887532 468999999999999999999997 59999999999999999999999999999876
Q ss_pred CCCCCcccccccccCCccCcccccC-cCCCccccHHHHHHHHHHHHcCCCCCCCCCcchhhhHHHHHHHHhhcC---CCC
Q 002673 761 LPYQTHVTTELVGTLGYIPPEYGQA-WVATLRGDMYSFGVVMLELLTGKRPVDVLKPKMSRELVGWVLKMRSEG---KQD 836 (894)
Q Consensus 761 ~~~~~~~~~~~~gt~~Y~APE~~~~-~~~s~ksDVwS~GvlL~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~---~~~ 836 (894)
..... ......++..|+|||.+.+ ..++.++|||||||++|||++|+.||........ ........... ...
T Consensus 159 ~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~~f~~~~~~~~---~~~~~~~~~~~~~~~~~ 234 (309)
T cd07845 159 GLPAK-PMTPKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLLPGKSEIEQ---LDLIIQLLGTPNESIWP 234 (309)
T ss_pred CCccC-CCCcccccccccChhhhcCCCCcCchHHHHHHHHHHHHHHhCCCCCCCCCHHHH---HHHHHHhcCCCChhhch
Confidence 43221 1223345788999998865 4678999999999999999999999975433211 11111110000 000
Q ss_pred cccc------ccccCC---C----ChHHHHHHHHHHHHhcccCCCCCCCHHHHHH--HHHhccc
Q 002673 837 QVFD------PILRGK---G----FDEEMLQVLDVACMCVSQNPFKRPTVKEVVE--WLNNVGA 885 (894)
Q Consensus 837 ~~~d------~~l~~~---~----~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~--~L~~i~~ 885 (894)
...+ ..+... . .......+.+++.+|++.||++|||++++++ |+++...
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~~il~h~~f~~~~~ 298 (309)
T cd07845 235 GFSDLPLVGKFTLPKQPYNNLKHKFPWLSEAGLRLLNFLLMYDPKKRATAEEALESSYFKEKPL 298 (309)
T ss_pred hhhcccccccccccCCCCCchHHhccccCHHHHHHHHHHhcCChhhCcCHHHHhcChhhccCCC
Confidence 0000 000000 0 0112345678999999999999999999998 7765543
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing |
| >cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Probab=99.98 E-value=8.6e-32 Score=295.47 Aligned_cols=264 Identities=28% Similarity=0.331 Sum_probs=195.9
Q ss_pred hccCCCccceEeecCcEEEEEEEEc-CCCeEEEEEEcCcc--hhhHHHHHHHHHHHHhcCCCceeeecceeeecc-----
Q 002673 605 ATDNFSQANIIGCGGFGLVYKATLA-NGTTLAIKKLSGDL--GLMEREFKAEVEALSTAQHKNLVSLQGYCVHQG----- 676 (894)
Q Consensus 605 a~~~f~~~~~LG~G~fg~Vy~a~~~-~g~~vAvK~~~~~~--~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~----- 676 (894)
..++|++.+.||+|+||.||+|... +|+.||+|++.... ......+.+|+.++++++||||+++++++.+..
T Consensus 5 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~~~ 84 (302)
T cd07864 5 CVDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQLNHRNIVNLKEIVTDKQDALDF 84 (302)
T ss_pred hhhhhheeeeecccCCEEEEEEEECCCCcEEEEEEEeecccccCchHHHHHHHHHHHhCCCCCeeeeeheecCcchhhhc
Confidence 3467889999999999999999864 68999999987543 223356778999999999999999999987654
Q ss_pred -----eEEEEEEeccCCCHHHHHhhhcCCCCCcCHHHHHHHHHHHHHHHHHHHhccCCCeeecCCCCCCeEECCCCcEEE
Q 002673 677 -----FRLLIYSYMENGSLDYWLHEKADGASQLDWLTRLKIARGTSCGLAYMHQICEPHIVHRDIKSSNILLDDQFEAHL 751 (894)
Q Consensus 677 -----~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDLkp~NILld~~~~vkl 751 (894)
..++|+||+++ ++...+... ...+++..+..++.|++.||+|||+ .+|+|+||||+||++++++.+||
T Consensus 85 ~~~~~~~~lv~e~~~~-~l~~~l~~~---~~~~~~~~~~~i~~qi~~aL~~LH~---~~i~H~dl~p~nili~~~~~~kl 157 (302)
T cd07864 85 KKDKGAFYLVFEYMDH-DLMGLLESG---LVHFSEDHIKSFMKQLLEGLNYCHK---KNFLHRDIKCSNILLNNKGQIKL 157 (302)
T ss_pred cccCCcEEEEEcccCc-cHHHHHhcC---CCCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEECCCCcEEe
Confidence 78999999976 677776643 2468999999999999999999997 59999999999999999999999
Q ss_pred EEcccccccCCCCCcccccccccCCccCcccccC-cCCCccccHHHHHHHHHHHHcCCCCCCCCCcchhhhHHHHHHHHh
Q 002673 752 ADFGLSRLILPYQTHVTTELVGTLGYIPPEYGQA-WVATLRGDMYSFGVVMLELLTGKRPVDVLKPKMSRELVGWVLKMR 830 (894)
Q Consensus 752 ~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~~~~-~~~s~ksDVwS~GvlL~elltG~~Pf~~~~~~~~~~~~~~~~~~~ 830 (894)
+|||++...............++..|+|||.+.+ ..++.++|||||||++|||++|+.||........ ........
T Consensus 158 ~dfg~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~~~el~~g~~~~~~~~~~~~---~~~~~~~~ 234 (302)
T cd07864 158 ADFGLARLYNSEESRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQELAQ---LELISRLC 234 (302)
T ss_pred CcccccccccCCcccccccceeccCccChHHhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHH---HHHHHHHh
Confidence 9999998764332222223356788999998765 3578899999999999999999999975432111 11111111
Q ss_pred hcCC---CCcc--------cccccc-----CCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 002673 831 SEGK---QDQV--------FDPILR-----GKGFDEEMLQVLDVACMCVSQNPFKRPTVKEVVE 878 (894)
Q Consensus 831 ~~~~---~~~~--------~d~~l~-----~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~ 878 (894)
.... ...+ .+.... ..........+.+++.+||+.+|++||++.++++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~ 298 (302)
T cd07864 235 GSPCPAVWPDVIKLPYFNTMKPKKQYRRRLREEFSFIPTPALDLLDHMLTLDPSKRCTAEEALN 298 (302)
T ss_pred CCCChhhcccccccccccccccccccccchhhhcCCCCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 0000 0000 000000 0000111346789999999999999999999975
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely |
| >cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Probab=99.98 E-value=3e-31 Score=282.90 Aligned_cols=251 Identities=24% Similarity=0.378 Sum_probs=204.2
Q ss_pred CCCccceEeecCcEEEEEEEEc-CCCeEEEEEEcCcch--hhHHHHHHHHHHHHhcCCCceeeecceeeecceEEEEEEe
Q 002673 608 NFSQANIIGCGGFGLVYKATLA-NGTTLAIKKLSGDLG--LMEREFKAEVEALSTAQHKNLVSLQGYCVHQGFRLLIYSY 684 (894)
Q Consensus 608 ~f~~~~~LG~G~fg~Vy~a~~~-~g~~vAvK~~~~~~~--~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~lV~E~ 684 (894)
+|+..+.||+|+||.||++... ++..|++|++..... .....+.+|+++++.++|+|++++++.+......++|+||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~lv~e~ 80 (258)
T cd08215 1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYYESFEEKGKLCIVMEY 80 (258)
T ss_pred CceEEeeeccCCCeEEEEEEEcCCCcEEEEEEeecccCChHHHHHHHHHHHHHHhcCCCChhheEEEEecCCEEEEEEEe
Confidence 4777899999999999999854 689999999876432 4456788999999999999999999999999999999999
Q ss_pred ccCCCHHHHHhhhcCCCCCcCHHHHHHHHHHHHHHHHHHHhccCCCeeecCCCCCCeEECCCCcEEEEEcccccccCCCC
Q 002673 685 MENGSLDYWLHEKADGASQLDWLTRLKIARGTSCGLAYMHQICEPHIVHRDIKSSNILLDDQFEAHLADFGLSRLILPYQ 764 (894)
Q Consensus 685 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDLkp~NILld~~~~vkl~DFGla~~~~~~~ 764 (894)
+++++|.+++.........+++..+..++.+++.||.|||+ .+++|+||+|+||+++.++.++|+|||.+.......
T Consensus 81 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~---~~~~H~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~ 157 (258)
T cd08215 81 ADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHS---RKILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTV 157 (258)
T ss_pred cCCCcHHHHHHHhhccCCCcCHHHHHHHHHHHHHHHHHHHh---CCEecccCChHHeEEcCCCcEEECCccceeecccCc
Confidence 99999999998754344679999999999999999999997 599999999999999999999999999998754332
Q ss_pred CcccccccccCCccCcccccCcCCCccccHHHHHHHHHHHHcCCCCCCCCCcchhhhHHHHHHHHhhcCCCCcccccccc
Q 002673 765 THVTTELVGTLGYIPPEYGQAWVATLRGDMYSFGVVMLELLTGKRPVDVLKPKMSRELVGWVLKMRSEGKQDQVFDPILR 844 (894)
Q Consensus 765 ~~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwS~GvlL~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~ 844 (894)
.......|++.|+|||...+..++.++||||+|+++|+|++|+.||...... ... ..... .....+ .
T Consensus 158 -~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~---~~~---~~~~~-~~~~~~-----~ 224 (258)
T cd08215 158 -DLAKTVVGTPYYLSPELCQNKPYNYKSDIWSLGCVLYELCTLKHPFEGENLL---ELA---LKILK-GQYPPI-----P 224 (258)
T ss_pred -ceecceeeeecccChhHhccCCCCccccHHHHHHHHHHHHcCCCCCCCCcHH---HHH---HHHhc-CCCCCC-----C
Confidence 2233456888999999998888999999999999999999999999754321 111 11111 111111 0
Q ss_pred CCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 002673 845 GKGFDEEMLQVLDVACMCVSQNPFKRPTVKEVVE 878 (894)
Q Consensus 845 ~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~ 878 (894)
. .....+.+++.+|+..+|++|||+.++++
T Consensus 225 -~---~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~ 254 (258)
T cd08215 225 -S---QYSSELRNLVSSLLQKDPEERPSIAQILQ 254 (258)
T ss_pred -C---CCCHHHHHHHHHHcCCChhhCcCHHHHhc
Confidence 0 11235678999999999999999999986
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They |
| >cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.98 E-value=6.1e-32 Score=300.87 Aligned_cols=268 Identities=24% Similarity=0.295 Sum_probs=205.1
Q ss_pred CCCccceEeecCcEEEEEEEEc-CCCeEEEEEEcCcc--hhhHHHHHHHHHHHHhcCCCceeeecceeeecc-----eEE
Q 002673 608 NFSQANIIGCGGFGLVYKATLA-NGTTLAIKKLSGDL--GLMEREFKAEVEALSTAQHKNLVSLQGYCVHQG-----FRL 679 (894)
Q Consensus 608 ~f~~~~~LG~G~fg~Vy~a~~~-~g~~vAvK~~~~~~--~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~-----~~~ 679 (894)
+|++.+.||+|+||.||+|... ++..||||++.... ....+.+.+|+.+++.++|+||+++++++.... ..+
T Consensus 1 ~y~i~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~ 80 (330)
T cd07834 1 RYELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILREIKLLRHLRHENIIGLLDILRPPSPEDFNDVY 80 (330)
T ss_pred CceeeeeecCCCCeEEEEEEeCCCCcEEEEEeeccccccchhhhhHHHHHHHHHhcCCcchhhhhhhhcccCcccccceE
Confidence 4778899999999999999854 58999999987643 334467889999999999999999999988765 789
Q ss_pred EEEEeccCCCHHHHHhhhcCCCCCcCHHHHHHHHHHHHHHHHHHHhccCCCeeecCCCCCCeEECCCCcEEEEEcccccc
Q 002673 680 LIYSYMENGSLDYWLHEKADGASQLDWLTRLKIARGTSCGLAYMHQICEPHIVHRDIKSSNILLDDQFEAHLADFGLSRL 759 (894)
Q Consensus 680 lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDLkp~NILld~~~~vkl~DFGla~~ 759 (894)
+||||++ ++|.+++... ..+++..+..++.|++.||.|||+ ++|+||||||+||+++.++.++|+|||++..
T Consensus 81 lv~e~~~-~~l~~~l~~~----~~l~~~~~~~i~~~l~~~l~~LH~---~gi~H~dlkp~nili~~~~~~~L~dfg~~~~ 152 (330)
T cd07834 81 IVTELME-TDLHKVIKSP----QPLTDDHIQYFLYQILRGLKYLHS---ANVIHRDLKPSNILVNSNCDLKICDFGLARG 152 (330)
T ss_pred EEecchh-hhHHHHHhCC----CCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEEcCCCCEEEcccCceEe
Confidence 9999997 5888888643 368999999999999999999997 5999999999999999999999999999987
Q ss_pred cCCCCC--cccccccccCCccCcccccCc-CCCccccHHHHHHHHHHHHcCCCCCCCCCcchhhhHHHHHHHHhhcCCCC
Q 002673 760 ILPYQT--HVTTELVGTLGYIPPEYGQAW-VATLRGDMYSFGVVMLELLTGKRPVDVLKPKMSRELVGWVLKMRSEGKQD 836 (894)
Q Consensus 760 ~~~~~~--~~~~~~~gt~~Y~APE~~~~~-~~s~ksDVwS~GvlL~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~ 836 (894)
...... .......++..|+|||++.+. .++.++||||||+++|+|++|+.||......... .............
T Consensus 153 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~il~~l~~g~~pf~~~~~~~~~---~~i~~~~~~~~~~ 229 (330)
T cd07834 153 VDPDEDEKGFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRDYIDQL---NLIVEVLGTPSEE 229 (330)
T ss_pred ecccccccccccccccccCcCCceeeecccCCCcchhHHHHHHHHHHHHcCCCCcCCCCHHHHH---HHHHHhcCCCChh
Confidence 644321 112334678899999999887 8899999999999999999999999755432111 1111100000000
Q ss_pred -----------ccccc------cccCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHH--HHHhcccc
Q 002673 837 -----------QVFDP------ILRGKGFDEEMLQVLDVACMCVSQNPFKRPTVKEVVE--WLNNVGAN 886 (894)
Q Consensus 837 -----------~~~d~------~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~--~L~~i~~~ 886 (894)
..... .-.....+.....+.+++.+||+.+|++||+++++++ |++++...
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~~~~~~~~~ 298 (330)
T cd07834 230 DLKFITSEKARNYLKSLPKKPKKPLSKLFPGASPEAIDLLEKMLVFDPKKRITADEALAHPYLAQLHDP 298 (330)
T ss_pred HhhhccccchhhHHhhcccCCcchhHHhcccCCHHHHHHHHHHccCChhhCCCHHHHHhCccHHhhccc
Confidence 00000 0000001112346789999999999999999999999 88887654
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and |
| >cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.1e-31 Score=301.90 Aligned_cols=265 Identities=23% Similarity=0.288 Sum_probs=197.5
Q ss_pred ccCCCccceEeecCcEEEEEEEE-cCCCeEEEEEEcCcc--hhhHHHHHHHHHHHHhcCCCceeeecceeeec------c
Q 002673 606 TDNFSQANIIGCGGFGLVYKATL-ANGTTLAIKKLSGDL--GLMEREFKAEVEALSTAQHKNLVSLQGYCVHQ------G 676 (894)
Q Consensus 606 ~~~f~~~~~LG~G~fg~Vy~a~~-~~g~~vAvK~~~~~~--~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~------~ 676 (894)
.++|+..+.||+|+||.||+|.. .+|..||+|.+.... ......+.+|+.++++++||||+++++++... .
T Consensus 15 ~~~y~~~~~lg~g~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 94 (353)
T cd07850 15 LKRYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQNVTHAKRAYRELVLMKLVNHKNIIGLLNVFTPQKSLEEFQ 94 (353)
T ss_pred hcceEEEEEeccCCCEEEEEEEECCCCCEEEEEecCccccChhHHHHHHHHHHHHHhcCCCCCcceeeeeccCCCccccC
Confidence 46799999999999999999984 578999999986432 22335677899999999999999999987643 3
Q ss_pred eEEEEEEeccCCCHHHHHhhhcCCCCCcCHHHHHHHHHHHHHHHHHHHhccCCCeeecCCCCCCeEECCCCcEEEEEccc
Q 002673 677 FRLLIYSYMENGSLDYWLHEKADGASQLDWLTRLKIARGTSCGLAYMHQICEPHIVHRDIKSSNILLDDQFEAHLADFGL 756 (894)
Q Consensus 677 ~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDLkp~NILld~~~~vkl~DFGl 756 (894)
..++||||+. ++|.+.+.. .++...+..++.|++.||.|||+ ++++||||||+||+++.++.+||+|||+
T Consensus 95 ~~~lv~e~~~-~~l~~~~~~------~l~~~~~~~~~~ql~~aL~~LH~---~gi~H~dlkp~Nil~~~~~~~kL~Dfg~ 164 (353)
T cd07850 95 DVYLVMELMD-ANLCQVIQM------DLDHERMSYLLYQMLCGIKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDFGL 164 (353)
T ss_pred cEEEEEeccC-CCHHHHHhh------cCCHHHHHHHHHHHHHHHHHHHh---CCeeeCCCCHHHEEECCCCCEEEccCcc
Confidence 5699999995 588887753 27888889999999999999997 5999999999999999999999999999
Q ss_pred ccccCCCCCcccccccccCCccCcccccCcCCCccccHHHHHHHHHHHHcCCCCCCCCCcchhh-hHHH-----------
Q 002673 757 SRLILPYQTHVTTELVGTLGYIPPEYGQAWVATLRGDMYSFGVVMLELLTGKRPVDVLKPKMSR-ELVG----------- 824 (894)
Q Consensus 757 a~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwS~GvlL~elltG~~Pf~~~~~~~~~-~~~~----------- 824 (894)
++..... .......++..|+|||.+.+..++.++|||||||++|+|++|+.||......... .+..
T Consensus 165 ~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (353)
T cd07850 165 ARTAGTS--FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGTVLFPGTDHIDQWNKIIEQLGTPSDEFMS 242 (353)
T ss_pred ceeCCCC--CCCCCCcccccccCHHHHhCCCCCCchhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCCCHHHHH
Confidence 9865322 1223346788999999999999999999999999999999999999754321100 0000
Q ss_pred H----HHHHhh-cC-----CCCcccccccc----CCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHH--HHHh
Q 002673 825 W----VLKMRS-EG-----KQDQVFDPILR----GKGFDEEMLQVLDVACMCVSQNPFKRPTVKEVVE--WLNN 882 (894)
Q Consensus 825 ~----~~~~~~-~~-----~~~~~~d~~l~----~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~--~L~~ 882 (894)
. ...... .. .....+..... ..........+.+++.+|++.||++|||+.++++ ||+.
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eiL~~~~~~~ 316 (353)
T cd07850 243 RLQPTVRNYVENRPKYAGYSFEELFPDVLFPPDSESHNKLKASQARDLLSKMLVIDPEKRISVDDALQHPYINV 316 (353)
T ss_pred HhhhhhhHHhhcCCCCCCcchhhhCcccccCcccccccccchhHHHHHHHHHcCCChhhCcCHHHHhcChhHhh
Confidence 0 000000 00 00011111000 0001122345779999999999999999999997 7753
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK |
| >cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=99.98 E-value=5.7e-32 Score=302.33 Aligned_cols=270 Identities=23% Similarity=0.297 Sum_probs=199.9
Q ss_pred ccCCCccceEeecCcEEEEEEE-EcCCCeEEEEEEcCcc--hhhHHHHHHHHHHHHhcCCCceeeecceeeec-----ce
Q 002673 606 TDNFSQANIIGCGGFGLVYKAT-LANGTTLAIKKLSGDL--GLMEREFKAEVEALSTAQHKNLVSLQGYCVHQ-----GF 677 (894)
Q Consensus 606 ~~~f~~~~~LG~G~fg~Vy~a~-~~~g~~vAvK~~~~~~--~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~-----~~ 677 (894)
.++|.+.+.||+|+||.||+|. ..++..||||.+.... ......+.+|+.+++.++|+||+++++++... ..
T Consensus 4 ~~~y~~~~~lg~G~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~~~~ 83 (337)
T cd07858 4 DTKYVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLDHENVIAIKDIMPPPHREAFND 83 (337)
T ss_pred ccceeEEEEeccCCCeEEEEEEecCCCCeEEEEEecccccccchhHHHHHHHHHHHhcCCCCccchHHheecccccccCc
Confidence 4578899999999999999998 4578999999987532 22335677899999999999999999988654 34
Q ss_pred EEEEEEeccCCCHHHHHhhhcCCCCCcCHHHHHHHHHHHHHHHHHHHhccCCCeeecCCCCCCeEECCCCcEEEEEcccc
Q 002673 678 RLLIYSYMENGSLDYWLHEKADGASQLDWLTRLKIARGTSCGLAYMHQICEPHIVHRDIKSSNILLDDQFEAHLADFGLS 757 (894)
Q Consensus 678 ~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDLkp~NILld~~~~vkl~DFGla 757 (894)
.++|+||+. ++|.+++... ..+++..+..++.|++.||.|||+ ++++||||||+||+++.++.+||+|||++
T Consensus 84 ~~lv~e~~~-~~L~~~~~~~----~~l~~~~~~~i~~qi~~aL~~LH~---~~i~H~dlkp~Nil~~~~~~~kL~Dfg~~ 155 (337)
T cd07858 84 VYIVYELMD-TDLHQIIRSS----QTLSDDHCQYFLYQLLRGLKYIHS---ANVLHRDLKPSNLLLNANCDLKICDFGLA 155 (337)
T ss_pred EEEEEeCCC-CCHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHHh---CCEecCCCCHHHEEEcCCCCEEECcCccc
Confidence 799999995 6888888643 358899999999999999999997 59999999999999999999999999999
Q ss_pred cccCCCCCcccccccccCCccCcccccC-cCCCccccHHHHHHHHHHHHcCCCCCCCCCcchhhhHHHHHHHHhhcCCCC
Q 002673 758 RLILPYQTHVTTELVGTLGYIPPEYGQA-WVATLRGDMYSFGVVMLELLTGKRPVDVLKPKMSRELVGWVLKMRSEGKQD 836 (894)
Q Consensus 758 ~~~~~~~~~~~~~~~gt~~Y~APE~~~~-~~~s~ksDVwS~GvlL~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~ 836 (894)
+...... .......++..|+|||.+.+ ..++.++|||||||++|+|++|+.||.........................
T Consensus 156 ~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (337)
T cd07858 156 RTTSEKG-DFMTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPLFPGKDYVHQLKLITELLGSPSEEDLG 234 (337)
T ss_pred cccCCCc-ccccccccccCccChHHHhcCCCCCCcccHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCChHHhh
Confidence 8654322 22234467889999998764 468899999999999999999999997543211111000000000000000
Q ss_pred ccc---------------cccccCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHH--HHHhccc
Q 002673 837 QVF---------------DPILRGKGFDEEMLQVLDVACMCVSQNPFKRPTVKEVVE--WLNNVGA 885 (894)
Q Consensus 837 ~~~---------------d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~--~L~~i~~ 885 (894)
.+. ++... ...+.....+.+++.+|++.+|++|||++++++ |++.+..
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~~l~~~P~~Rps~~ell~h~~~~~~~~ 299 (337)
T cd07858 235 FIRNEKARRYIRSLPYTPRQSFA-RLFPHANPLAIDLLEKMLVFDPSKRITVEEALAHPYLASLHD 299 (337)
T ss_pred hcCchhhhHHHHhcCcccccCHH-HHcccCCHHHHHHHHHHhcCChhhccCHHHHHcCcchhhhcC
Confidence 000 00000 001122346789999999999999999999998 7876643
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati |
| >cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Probab=99.98 E-value=6.4e-32 Score=301.87 Aligned_cols=271 Identities=25% Similarity=0.311 Sum_probs=199.5
Q ss_pred ccCCCccceEeecCcEEEEEEEEc-CCCeEEEEEEcCcc--hhhHHHHHHHHHHHHhc-CCCceeeecceeeec--ceEE
Q 002673 606 TDNFSQANIIGCGGFGLVYKATLA-NGTTLAIKKLSGDL--GLMEREFKAEVEALSTA-QHKNLVSLQGYCVHQ--GFRL 679 (894)
Q Consensus 606 ~~~f~~~~~LG~G~fg~Vy~a~~~-~g~~vAvK~~~~~~--~~~~~~~~~Ei~~l~~l-~HpnIv~l~g~~~~~--~~~~ 679 (894)
.++|+..+.||+|+||.||+|... +++.+|+|++.... ......+.+|+.+++++ +||||++++++|... ...+
T Consensus 6 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~~~~~~~~ 85 (337)
T cd07852 6 LRKYEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQRTFREIMFLQELGDHPNIVKLLNVIKAENDKDIY 85 (337)
T ss_pred hhHHHHhHhhcCCCCeeEEEEEEcCCCeEEEEEeeccccCcchhhhhhhHHHHHHHHhcCCCCccceeeeeccCCCceEE
Confidence 457888899999999999999854 68899999886432 22334577899999999 999999999988653 3679
Q ss_pred EEEEeccCCCHHHHHhhhcCCCCCcCHHHHHHHHHHHHHHHHHHHhccCCCeeecCCCCCCeEECCCCcEEEEEcccccc
Q 002673 680 LIYSYMENGSLDYWLHEKADGASQLDWLTRLKIARGTSCGLAYMHQICEPHIVHRDIKSSNILLDDQFEAHLADFGLSRL 759 (894)
Q Consensus 680 lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDLkp~NILld~~~~vkl~DFGla~~ 759 (894)
+||||++ ++|..++... .+++..+..++.||+.||.|||+ .+|+||||||+||+++.++.+||+|||++..
T Consensus 86 lv~e~~~-~~L~~~~~~~-----~~~~~~~~~i~~qi~~~L~~LH~---~~i~H~dl~p~nill~~~~~~kl~d~g~~~~ 156 (337)
T cd07852 86 LVFEYME-TDLHAVIRAN-----ILEDVHKRYIMYQLLKALKYIHS---GNVIHRDLKPSNILLNSDCRVKLADFGLARS 156 (337)
T ss_pred EEecccc-cCHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHEEEcCCCcEEEeeccchhc
Confidence 9999997 5898888642 57888999999999999999997 5999999999999999999999999999987
Q ss_pred cCCCCC----cccccccccCCccCcccccC-cCCCccccHHHHHHHHHHHHcCCCCCCCCCcchhhh-HHHHHHH-----
Q 002673 760 ILPYQT----HVTTELVGTLGYIPPEYGQA-WVATLRGDMYSFGVVMLELLTGKRPVDVLKPKMSRE-LVGWVLK----- 828 (894)
Q Consensus 760 ~~~~~~----~~~~~~~gt~~Y~APE~~~~-~~~s~ksDVwS~GvlL~elltG~~Pf~~~~~~~~~~-~~~~~~~----- 828 (894)
...... .......|+..|+|||++.+ ..++.++||||||+++|+|++|+.||.......... .......
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~ 236 (337)
T cd07852 157 LSELEENPENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLNQLEKIIEVIGPPSAED 236 (337)
T ss_pred cccccccccCcchhcccccccccCceeeeccccccccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHH
Confidence 643221 12233568999999998755 467889999999999999999999997543321111 0000000
Q ss_pred --HhhcCCCCcccccccc------CCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHH--HHHhccc
Q 002673 829 --MRSEGKQDQVFDPILR------GKGFDEEMLQVLDVACMCVSQNPFKRPTVKEVVE--WLNNVGA 885 (894)
Q Consensus 829 --~~~~~~~~~~~d~~l~------~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~--~L~~i~~ 885 (894)
.........+++.... ..........+.+++.+|++.+|++|||+.++++ +++++..
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rps~~~il~~~~~~~~~~ 303 (337)
T cd07852 237 IESIKSPFAATMLDSLPSRPRKPLDELLPKASDDALDLLKKLLVFNPNKRLTAEEALEHPYVAQFHN 303 (337)
T ss_pred HHHHHhhhHHHhhhhcccccccchhhhccCCCHHHHHHHHHhccCCcccccCHHHHhhChhhhhhcc
Confidence 0000000000000000 0001112346789999999999999999999998 7877754
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul |
| >cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=99.98 E-value=2.2e-31 Score=285.97 Aligned_cols=247 Identities=24% Similarity=0.320 Sum_probs=197.5
Q ss_pred EeecCcEEEEEEEEc-CCCeEEEEEEcCcch---hhHHHHHHHHHHHHhcCCCceeeecceeeecceEEEEEEeccCCCH
Q 002673 615 IGCGGFGLVYKATLA-NGTTLAIKKLSGDLG---LMEREFKAEVEALSTAQHKNLVSLQGYCVHQGFRLLIYSYMENGSL 690 (894)
Q Consensus 615 LG~G~fg~Vy~a~~~-~g~~vAvK~~~~~~~---~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~lV~E~~~~gsL 690 (894)
||.|+||.||++... ++..||+|.+..... .....+.+|+.+++.++||||+++++++.++...++|+||+++++|
T Consensus 1 lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (262)
T cd05572 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYRTFKDKKYIYMLMEYCLGGEL 80 (262)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEEehhcchhhhHHHHHHHHHHHHHhCCCCCEeeeeeeEEcCCccEEEEecCCCCcH
Confidence 689999999999864 589999999875432 2346789999999999999999999999999999999999999999
Q ss_pred HHHHhhhcCCCCCcCHHHHHHHHHHHHHHHHHHHhccCCCeeecCCCCCCeEECCCCcEEEEEcccccccCCCCCccccc
Q 002673 691 DYWLHEKADGASQLDWLTRLKIARGTSCGLAYMHQICEPHIVHRDIKSSNILLDDQFEAHLADFGLSRLILPYQTHVTTE 770 (894)
Q Consensus 691 ~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDLkp~NILld~~~~vkl~DFGla~~~~~~~~~~~~~ 770 (894)
.+++... ..+++..+..++.|++.||.|||+ ++++|+||+|+||+++.++.++|+|||++....... ....
T Consensus 81 ~~~l~~~----~~l~~~~~~~~~~~i~~~l~~lH~---~~~~h~dl~~~nilv~~~~~~~l~df~~~~~~~~~~--~~~~ 151 (262)
T cd05572 81 WTILRDR----GLFDEYTARFYIACVVLAFEYLHN---RGIIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQ--KTWT 151 (262)
T ss_pred HHHHhhc----CCCCHHHHHHHHHHHHHHHHHHhh---CCcccCCCCHHHEEEcCCCCEEEeeCCcccccCccc--cccc
Confidence 9999754 247888999999999999999997 699999999999999999999999999998764322 2233
Q ss_pred ccccCCccCcccccCcCCCccccHHHHHHHHHHHHcCCCCCCCCCcchhhhHHHHHHHHhhcCCCCccccccccCCCChH
Q 002673 771 LVGTLGYIPPEYGQAWVATLRGDMYSFGVVMLELLTGKRPVDVLKPKMSRELVGWVLKMRSEGKQDQVFDPILRGKGFDE 850 (894)
Q Consensus 771 ~~gt~~Y~APE~~~~~~~s~ksDVwS~GvlL~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~ 850 (894)
..++..|+|||.+.+..++.++|+||||+++|+|++|+.||.....+. ............... + ...
T Consensus 152 ~~~~~~~~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~----~~~~~~~~~~~~~~~-~--------~~~ 218 (262)
T cd05572 152 FCGTPEYVAPEIILNKGYDFSVDYWSLGILLYELLTGRPPFGEDDEDP----MEIYNDILKGNGKLE-F--------PNY 218 (262)
T ss_pred ccCCcCccChhHhcCCCCCChhhhhhhHHHHHHHHhCCCCcCCCCCCH----HHHHHHHhccCCCCC-C--------Ccc
Confidence 568899999999988889999999999999999999999997554211 111111111010000 0 001
Q ss_pred HHHHHHHHHHHhcccCCCCCCC-----HHHHHH--HHHhc
Q 002673 851 EMLQVLDVACMCVSQNPFKRPT-----VKEVVE--WLNNV 883 (894)
Q Consensus 851 ~~~~l~~li~~Cl~~dP~~RPs-----~~evl~--~L~~i 883 (894)
....+.+++.+||+.+|++||+ +.|+++ |+.+.
T Consensus 219 ~~~~~~~~i~~~l~~~p~~R~~~~~~~~~~l~~~~~~~~~ 258 (262)
T cd05572 219 IDKAAKDLIKQLLRRNPEERLGNLKGGIKDIKKHKWFNGF 258 (262)
T ss_pred cCHHHHHHHHHHccCChhhCcCCcccCHHHHhcChhhhCC
Confidence 1346789999999999999999 888887 76654
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi |
| >PHA02882 putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.98 E-value=2.4e-31 Score=291.53 Aligned_cols=254 Identities=20% Similarity=0.258 Sum_probs=181.7
Q ss_pred cCCCccceEeecCcEEEEEEEEcC----CCeEEEEEEcCcchhh--H---------HHHHHHHHHHHhcCCCceeeecce
Q 002673 607 DNFSQANIIGCGGFGLVYKATLAN----GTTLAIKKLSGDLGLM--E---------REFKAEVEALSTAQHKNLVSLQGY 671 (894)
Q Consensus 607 ~~f~~~~~LG~G~fg~Vy~a~~~~----g~~vAvK~~~~~~~~~--~---------~~~~~Ei~~l~~l~HpnIv~l~g~ 671 (894)
++|.+.++||+|+||.||+|...+ +..+|+|+........ + .....+...+..++|+|++++++.
T Consensus 12 ~~y~i~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~ 91 (294)
T PHA02882 12 KEWKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNIDHLGIPKYYGC 91 (294)
T ss_pred CceEEeeEEecCCCceEEEEEEcCCcccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccCCCCCCCcEEEe
Confidence 578999999999999999998644 3456666543222111 1 112234445566789999999987
Q ss_pred eeecc----eEEEEEEeccCCCHHHHHhhhcCCCCCcCHHHHHHHHHHHHHHHHHHHhccCCCeeecCCCCCCeEECCCC
Q 002673 672 CVHQG----FRLLIYSYMENGSLDYWLHEKADGASQLDWLTRLKIARGTSCGLAYMHQICEPHIVHRDIKSSNILLDDQF 747 (894)
Q Consensus 672 ~~~~~----~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDLkp~NILld~~~ 747 (894)
+.... ..++++|++. .++.+.+... ...++..+..++.|++.||.|||+ ++|+||||||+|||++.++
T Consensus 92 ~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~----~~~~~~~~~~i~~qi~~~l~~lH~---~~iiHrDiKp~Nill~~~~ 163 (294)
T PHA02882 92 GSFKRCRMYYRFILLEKLV-ENTKEIFKRI----KCKNKKLIKNIMKDMLTTLEYIHE---HGISHGDIKPENIMVDGNN 163 (294)
T ss_pred eeEecCCceEEEEEEehhc-cCHHHHHHhh----ccCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEEcCCC
Confidence 65443 3467777763 3666665532 235677888999999999999997 5999999999999999999
Q ss_pred cEEEEEcccccccCCCCCc------ccccccccCCccCcccccCcCCCccccHHHHHHHHHHHHcCCCCCCCCCcch-hh
Q 002673 748 EAHLADFGLSRLILPYQTH------VTTELVGTLGYIPPEYGQAWVATLRGDMYSFGVVMLELLTGKRPVDVLKPKM-SR 820 (894)
Q Consensus 748 ~vkl~DFGla~~~~~~~~~------~~~~~~gt~~Y~APE~~~~~~~s~ksDVwS~GvlL~elltG~~Pf~~~~~~~-~~ 820 (894)
.++|+|||+++.+...... ......||+.|+|||+..+..++.++|||||||++|||++|+.||....... ..
T Consensus 164 ~~~l~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~~~~~~~~~DiwSlG~~l~el~~g~~P~~~~~~~~~~~ 243 (294)
T PHA02882 164 RGYIIDYGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNGACVTRRGDLESLGYCMLKWAGIKLPWKGFGHNGNLI 243 (294)
T ss_pred cEEEEEcCCceeeccCCcccccccccccccCCCccccCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCccccchHHH
Confidence 9999999999876432111 1123469999999999999999999999999999999999999998653211 11
Q ss_pred h--HHHHHHHHhhcCCCCccccccccCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 002673 821 E--LVGWVLKMRSEGKQDQVFDPILRGKGFDEEMLQVLDVACMCVSQNPFKRPTVKEVVEWL 880 (894)
Q Consensus 821 ~--~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L 880 (894)
. ..++...+.. +.. ..... ...+.+++..|++.+|++||++.++++.|
T Consensus 244 ~~~~~~~~~~~~~-~~~--------~~~~~---~~~~~~~~~~~~~~~~~~rp~~~~l~~~~ 293 (294)
T PHA02882 244 HAAKCDFIKRLHE-GKI--------KIKNA---NKFIYDFIECVTKLSYEEKPDYDALIKIF 293 (294)
T ss_pred HHhHHHHHHHhhh-hhh--------ccCCC---CHHHHHHHHHHHhCCCCCCCCHHHHHHhh
Confidence 1 1111111111 110 00111 24577899999999999999999999876
|
|
| >cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Probab=99.98 E-value=3.8e-31 Score=293.10 Aligned_cols=245 Identities=28% Similarity=0.392 Sum_probs=193.3
Q ss_pred CCCccceEeecCcEEEEEEEE-cCCCeEEEEEEcCcc---hhhHHHHHHHHHHHHhcCCCceeeecceeeecceEEEEEE
Q 002673 608 NFSQANIIGCGGFGLVYKATL-ANGTTLAIKKLSGDL---GLMEREFKAEVEALSTAQHKNLVSLQGYCVHQGFRLLIYS 683 (894)
Q Consensus 608 ~f~~~~~LG~G~fg~Vy~a~~-~~g~~vAvK~~~~~~---~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~lV~E 683 (894)
.|+..+.||+|+||.||+|.. .++..||+|++.... ......+.+|+++++.++|||++++++++..+...++|||
T Consensus 26 ~f~~~~~lg~G~~~~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 105 (317)
T cd06635 26 LFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLREHTAWLVME 105 (317)
T ss_pred hhhhhheeccCCCeEEEEEEEcCCCcEEEEEEEecCCCCchHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCeEEEEEe
Confidence 366778999999999999984 578999999986432 2233568899999999999999999999999999999999
Q ss_pred eccCCCHHHHHhhhcCCCCCcCHHHHHHHHHHHHHHHHHHHhccCCCeeecCCCCCCeEECCCCcEEEEEcccccccCCC
Q 002673 684 YMENGSLDYWLHEKADGASQLDWLTRLKIARGTSCGLAYMHQICEPHIVHRDIKSSNILLDDQFEAHLADFGLSRLILPY 763 (894)
Q Consensus 684 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDLkp~NILld~~~~vkl~DFGla~~~~~~ 763 (894)
|+. |+|.+++.... ..+++..+..++.|++.||.|||+ ++++||||+|+||+++.++.+||+|||++.....
T Consensus 106 ~~~-g~l~~~~~~~~---~~l~~~~~~~i~~~i~~~l~~lH~---~~i~H~dL~p~Nil~~~~~~~kl~dfg~~~~~~~- 177 (317)
T cd06635 106 YCL-GSASDLLEVHK---KPLQEVEIAAITHGALQGLAYLHS---HNMIHRDIKAGNILLTEPGQVKLADFGSASIASP- 177 (317)
T ss_pred CCC-CCHHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCcccEEECCCCCEEEecCCCccccCC-
Confidence 996 57877775432 458999999999999999999997 5999999999999999999999999999875432
Q ss_pred CCcccccccccCCccCccccc---CcCCCccccHHHHHHHHHHHHcCCCCCCCCCcchhhhHHHHHHHHhhcCCCCcccc
Q 002673 764 QTHVTTELVGTLGYIPPEYGQ---AWVATLRGDMYSFGVVMLELLTGKRPVDVLKPKMSRELVGWVLKMRSEGKQDQVFD 840 (894)
Q Consensus 764 ~~~~~~~~~gt~~Y~APE~~~---~~~~s~ksDVwS~GvlL~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 840 (894)
.....++..|+|||++. +..++.++|||||||++|||++|+.||........ .. .........
T Consensus 178 ----~~~~~~~~~y~aPE~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~--~~----~~~~~~~~~---- 243 (317)
T cd06635 178 ----ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSA--LY----HIAQNESPT---- 243 (317)
T ss_pred ----cccccCCccccChhhhhcCCCCCCCccccHHHHHHHHHHHHhCCCCCCCccHHHH--HH----HHHhccCCC----
Confidence 22346788999999873 45688999999999999999999999875422111 11 111111100
Q ss_pred ccccCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 002673 841 PILRGKGFDEEMLQVLDVACMCVSQNPFKRPTVKEVVEW 879 (894)
Q Consensus 841 ~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~ 879 (894)
.. .......+.+++.+|++.+|.+||++.++++.
T Consensus 244 --~~---~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~ 277 (317)
T cd06635 244 --LQ---SNEWSDYFRNFVDSCLQKIPQDRPTSEELLKH 277 (317)
T ss_pred --CC---CccccHHHHHHHHHHccCCcccCcCHHHHHhC
Confidence 00 11122357789999999999999999999983
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron |
| >KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.1e-32 Score=294.69 Aligned_cols=248 Identities=29% Similarity=0.387 Sum_probs=198.6
Q ss_pred cCCCccceEeecCcEEEEEEE-EcCCCeEEEEEEcCcc---hhhHHHHHHHHHHHHhcCCCceeeecceeeecceEEEEE
Q 002673 607 DNFSQANIIGCGGFGLVYKAT-LANGTTLAIKKLSGDL---GLMEREFKAEVEALSTAQHKNLVSLQGYCVHQGFRLLIY 682 (894)
Q Consensus 607 ~~f~~~~~LG~G~fg~Vy~a~-~~~g~~vAvK~~~~~~---~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~lV~ 682 (894)
+.|+.-++||+|+||.||-+. -.+|..+|.|++.+.. ...+.....|-.+|.+++.+.||.+--.|.+.+..++|+
T Consensus 185 n~F~~~RvlGkGGFGEV~acqvraTGKMYAcKkL~KKRiKkr~ge~maLnEk~iL~kV~s~FiVslaYAfeTkd~LClVL 264 (591)
T KOG0986|consen 185 NTFRVYRVLGKGGFGEVCACQVRATGKMYACKKLDKKRIKKRKGETMALNEKQILEKVSSPFIVSLAYAFETKDALCLVL 264 (591)
T ss_pred cceeeeEEEecccccceeEEEEecchhhHHHHHHHHHHHHHhhhhHHhhHHHHHHHHhccCcEEEEeeeecCCCceEEEE
Confidence 567888999999999999997 5579999999886543 223345678999999999999999999999999999999
Q ss_pred EeccCCCHHHHHhhhcCCCCCcCHHHHHHHHHHHHHHHHHHHhccCCCeeecCCCCCCeEECCCCcEEEEEcccccccCC
Q 002673 683 SYMENGSLDYWLHEKADGASQLDWLTRLKIARGTSCGLAYMHQICEPHIVHRDIKSSNILLDDQFEAHLADFGLSRLILP 762 (894)
Q Consensus 683 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDLkp~NILld~~~~vkl~DFGla~~~~~ 762 (894)
..|.||+|.-++.... ...++...+..++.+|+.||++||. .+||.||+||+|||||++|+++|+|.|+|..+..
T Consensus 265 tlMNGGDLkfHiyn~g--~~gF~e~ra~FYAAEi~cGLehlH~---~~iVYRDLKPeNILLDd~GhvRISDLGLAvei~~ 339 (591)
T KOG0986|consen 265 TLMNGGDLKFHIYNHG--NPGFDEQRARFYAAEIICGLEHLHR---RRIVYRDLKPENILLDDHGHVRISDLGLAVEIPE 339 (591)
T ss_pred EeecCCceeEEeeccC--CCCCchHHHHHHHHHHHhhHHHHHh---cceeeccCChhheeeccCCCeEeeccceEEecCC
Confidence 9999999998887653 3679999999999999999999997 6999999999999999999999999999998754
Q ss_pred CCCcccccccccCCccCcccccCcCCCccccHHHHHHHHHHHHcCCCCCCCCCcchhhhHHHHHHHHhhcCCCCcccccc
Q 002673 763 YQTHVTTELVGTLGYIPPEYGQAWVATLRGDMYSFGVVMLELLTGKRPVDVLKPKMSRELVGWVLKMRSEGKQDQVFDPI 842 (894)
Q Consensus 763 ~~~~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwS~GvlL~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 842 (894)
... ....+||.+|||||++++..|+...|+||+||+||||+.|+.||.........+.++. .... |+.
T Consensus 340 g~~--~~~rvGT~GYMAPEvl~ne~Y~~s~Dwf~lGCllYemi~G~sPFr~~KeKvk~eEvdr---r~~~-------~~~ 407 (591)
T KOG0986|consen 340 GKP--IRGRVGTVGYMAPEVLQNEVYDFSPDWFSLGCLLYEMIAGHSPFRQRKEKVKREEVDR---RTLE-------DPE 407 (591)
T ss_pred CCc--cccccCcccccCHHHHcCCcccCCccHHHHHhHHHHHHcccCchhhhhhhhhHHHHHH---HHhc-------chh
Confidence 433 3445899999999999999999999999999999999999999975544332222211 1000 010
Q ss_pred ccCCCChHHHHHHHHHHHHhcccCCCCCCCHH
Q 002673 843 LRGKGFDEEMLQVLDVACMCVSQNPFKRPTVK 874 (894)
Q Consensus 843 l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~ 874 (894)
--...++++. .++-...+..||.+|.-..
T Consensus 408 ey~~kFS~ea---kslc~~LL~Kdp~~RLGcr 436 (591)
T KOG0986|consen 408 EYSDKFSEEA---KSLCEGLLTKDPEKRLGCR 436 (591)
T ss_pred hcccccCHHH---HHHHHHHHccCHHHhccCC
Confidence 0012333443 4555588899999997543
|
|
| >KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=2.7e-32 Score=286.57 Aligned_cols=268 Identities=22% Similarity=0.324 Sum_probs=211.2
Q ss_pred HHHHHhccCCCccceEeecCcEEEEEEEEcC------CCeEEEEEEcCcch-hhHHHHHHHHHHHHhcCCCceeeeccee
Q 002673 600 YELLKATDNFSQANIIGCGGFGLVYKATLAN------GTTLAIKKLSGDLG-LMEREFKAEVEALSTAQHKNLVSLQGYC 672 (894)
Q Consensus 600 ~el~~a~~~f~~~~~LG~G~fg~Vy~a~~~~------g~~vAvK~~~~~~~-~~~~~~~~Ei~~l~~l~HpnIv~l~g~~ 672 (894)
.++.....+++...++-+|.||.||+|.|.+ .+.|-+|.++.... .....+..|-..+..+.|||+.++.+++
T Consensus 277 ~~l~v~r~Rv~l~~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk~~AS~iQv~~~L~es~lly~~sH~nll~V~~V~ 356 (563)
T KOG1024|consen 277 QELTVQRCRVRLSCLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVKQHASQIQVNLLLQESMLLYGASHPNLLSVLGVS 356 (563)
T ss_pred HhhhhhhhheechhhhhcCchhheeeeeecccCCcchHHHHHHHHHHhcccHHHHHHHHHHHHHHhcCcCCCccceeEEE
Confidence 4444555678888999999999999997653 34566776664432 2335578899999999999999999999
Q ss_pred eec-ceEEEEEEeccCCCHHHHHhhh----cCCCCCcCHHHHHHHHHHHHHHHHHHHhccCCCeeecCCCCCCeEECCCC
Q 002673 673 VHQ-GFRLLIYSYMENGSLDYWLHEK----ADGASQLDWLTRLKIARGTSCGLAYMHQICEPHIVHRDIKSSNILLDDQF 747 (894)
Q Consensus 673 ~~~-~~~~lV~E~~~~gsL~~~l~~~----~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDLkp~NILld~~~ 747 (894)
.++ ...+.+|.++..|+|..|+... ....+.++-.+...++.|++.|++|||. .+|||.||.++|++||+..
T Consensus 357 ie~~~~P~V~y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh~---~~ViHkDiAaRNCvIdd~L 433 (563)
T KOG1024|consen 357 IEDYATPFVLYPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLHN---HGVIHKDIAARNCVIDDQL 433 (563)
T ss_pred eeccCcceEEEeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHHh---cCcccchhhhhcceehhhe
Confidence 865 4678899999999999999832 2334567788899999999999999997 4999999999999999999
Q ss_pred cEEEEEcccccccCCCCCcccc-cccccCCccCcccccCcCCCccccHHHHHHHHHHHHc-CCCCCCCCCcchhhhHHHH
Q 002673 748 EAHLADFGLSRLILPYQTHVTT-ELVGTLGYIPPEYGQAWVATLRGDMYSFGVVMLELLT-GKRPVDVLKPKMSRELVGW 825 (894)
Q Consensus 748 ~vkl~DFGla~~~~~~~~~~~~-~~~gt~~Y~APE~~~~~~~s~ksDVwS~GvlL~ellt-G~~Pf~~~~~~~~~~~~~~ 825 (894)
+|||+|-.+++.+.+.+.+.-. +......||+||.+.+..|+..+|||||||+||||+| |+.|+.+.++-+...+.
T Consensus 434 qVkltDsaLSRDLFP~DYhcLGDnEnRPvkWMslEal~n~~yssasDvWsfGVllWELmtlg~~PyaeIDPfEm~~yl-- 511 (563)
T KOG1024|consen 434 QVKLTDSALSRDLFPGDYHCLGDNENRPVKWMSLEALQNSHYSSASDVWSFGVLLWELMTLGKLPYAEIDPFEMEHYL-- 511 (563)
T ss_pred eEEeccchhccccCcccccccCCCCCCcccccCHHHHhhhhhcchhhhHHHHHHHHHHHhcCCCCccccCHHHHHHHH--
Confidence 9999999999998776655433 2345668999999999999999999999999999999 99999876654332221
Q ss_pred HHHHhhcCCCCccccccccCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhcccc
Q 002673 826 VLKMRSEGKQDQVFDPILRGKGFDEEMLQVLDVACMCVSQNPFKRPTVKEVVEWLNNVGAN 886 (894)
Q Consensus 826 ~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~i~~~ 886 (894)
.....+.+ .-.+++ +++.++..||...|++||++++++..|.+...+
T Consensus 512 ----kdGyRlaQ-------P~NCPD---eLf~vMacCWallpeeRPsf~Qlv~cLseF~~q 558 (563)
T KOG1024|consen 512 ----KDGYRLAQ-------PFNCPD---ELFTVMACCWALLPEERPSFSQLVICLSEFHTQ 558 (563)
T ss_pred ----hccceecC-------CCCCcH---HHHHHHHHHHhcCcccCCCHHHHHHHHHHHHHH
Confidence 11111111 122333 577888999999999999999999999877654
|
|
| >cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Probab=99.98 E-value=3.4e-31 Score=292.63 Aligned_cols=267 Identities=19% Similarity=0.201 Sum_probs=196.8
Q ss_pred ccceEeecCcEEEEEEEEcCCCeEEEEEEcCc--chhhHHHHHHHHHHHHhcCCCceeeecceeeecceEEEEEEeccCC
Q 002673 611 QANIIGCGGFGLVYKATLANGTTLAIKKLSGD--LGLMEREFKAEVEALSTAQHKNLVSLQGYCVHQGFRLLIYSYMENG 688 (894)
Q Consensus 611 ~~~~LG~G~fg~Vy~a~~~~g~~vAvK~~~~~--~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~lV~E~~~~g 688 (894)
+++.+|.|+++.||++.. ++..||||++... .......+.+|+.+++.++|+||+++++++..++..+++|||+++|
T Consensus 6 i~~~~~~~~~v~~~~~~~-~~~~~avK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~e~~~~~ 84 (314)
T cd08216 6 IGKCFEDLMIVHLAKHKP-TNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSFIVDSELYVVSPLMAYG 84 (314)
T ss_pred hhHhhcCCceEEEEEecC-CCCEEEEEEEeccccchhHHHHHHHHHHHHHhcCCcchhhhhheeecCCeEEEEEeccCCC
Confidence 344455666666666554 7899999998764 2334567999999999999999999999999999999999999999
Q ss_pred CHHHHHhhhcCCCCCcCHHHHHHHHHHHHHHHHHHHhccCCCeeecCCCCCCeEECCCCcEEEEEcccccccCCCCC---
Q 002673 689 SLDYWLHEKADGASQLDWLTRLKIARGTSCGLAYMHQICEPHIVHRDIKSSNILLDDQFEAHLADFGLSRLILPYQT--- 765 (894)
Q Consensus 689 sL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDLkp~NILld~~~~vkl~DFGla~~~~~~~~--- 765 (894)
+|.+++..... ..+++.....++.|++.||.|||+ .+|+||||||+||+++.++.+||+|||.+........
T Consensus 85 ~l~~~l~~~~~--~~~~~~~~~~~~~~l~~~L~~LH~---~~ivH~dlk~~Nili~~~~~~kl~d~~~~~~~~~~~~~~~ 159 (314)
T cd08216 85 SCEDLLKTHFP--EGLPELAIAFILKDVLNALDYIHS---KGFIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQR 159 (314)
T ss_pred CHHHHHHHhcc--cCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCcceEEEecCCceEEecCccceeecccccccc
Confidence 99999986432 357888899999999999999997 5999999999999999999999999999876532111
Q ss_pred ---cccccccccCCccCcccccC--cCCCccccHHHHHHHHHHHHcCCCCCCCCCcchhhhHHHHHHHHhh----c----
Q 002673 766 ---HVTTELVGTLGYIPPEYGQA--WVATLRGDMYSFGVVMLELLTGKRPVDVLKPKMSRELVGWVLKMRS----E---- 832 (894)
Q Consensus 766 ---~~~~~~~gt~~Y~APE~~~~--~~~s~ksDVwS~GvlL~elltG~~Pf~~~~~~~~~~~~~~~~~~~~----~---- 832 (894)
.......++..|+|||++.. ..++.++|||||||++|||++|+.||...... ....+....... .
T Consensus 160 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Diws~G~il~el~~g~~pf~~~~~~--~~~~~~~~~~~~~~~~~~~~~ 237 (314)
T cd08216 160 VVHDFPKSSVKNLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKDMPAT--QMLLEKVRGTVPCLLDKSTYP 237 (314)
T ss_pred ccccccccccccccccCHHHhcCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHH--HHHHHHHhccCccccccCchh
Confidence 11123456788999999866 35788999999999999999999999754321 111111110000 0
Q ss_pred ---CCCCc----cccccc----cCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHH--HHHhccc
Q 002673 833 ---GKQDQ----VFDPIL----RGKGFDEEMLQVLDVACMCVSQNPFKRPTVKEVVE--WLNNVGA 885 (894)
Q Consensus 833 ---~~~~~----~~d~~l----~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~--~L~~i~~ 885 (894)
..... ..++.. ..........++.+++..||+.||++|||++++++ ++..++.
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~p~~~~~~~ 303 (314)
T cd08216 238 LYEDSMSQSRSSNEHPNNRDSVDHPYTRTFSEHFHQFVELCLQRDPESRPSASQLLNHSFFKQCKR 303 (314)
T ss_pred hhcCCcCcccccccccchhhhhhcchhhHHHHHHHHHHHHHhhcCCCcCcCHHHHhcCchHhhhcc
Confidence 00000 000000 00111122346789999999999999999999998 8887763
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc |
| >cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Probab=99.98 E-value=2.6e-31 Score=290.89 Aligned_cols=250 Identities=22% Similarity=0.319 Sum_probs=199.3
Q ss_pred ceEeecCcEEEEEEEE-cCCCeEEEEEEcCcchhhHHHHHHHHHHHHhcCCCceeeecceeeecceEEEEEEeccCCCHH
Q 002673 613 NIIGCGGFGLVYKATL-ANGTTLAIKKLSGDLGLMEREFKAEVEALSTAQHKNLVSLQGYCVHQGFRLLIYSYMENGSLD 691 (894)
Q Consensus 613 ~~LG~G~fg~Vy~a~~-~~g~~vAvK~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~lV~E~~~~gsL~ 691 (894)
..||+|+||.||++.. .+++.||||++..........+.+|+.+++.++|+|++++++++...+..++||||+++++|.
T Consensus 26 ~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~ 105 (292)
T cd06657 26 IKIGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGALT 105 (292)
T ss_pred HHcCCCCCeEEEEEEEcCCCeEEEEEEecccchhHHHHHHHHHHHHHhcCCcchhheeeEEEeCCEEEEEEecCCCCcHH
Confidence 5799999999999985 578999999987554445567899999999999999999999999999999999999999999
Q ss_pred HHHhhhcCCCCCcCHHHHHHHHHHHHHHHHHHHhccCCCeeecCCCCCCeEECCCCcEEEEEcccccccCCCCCcccccc
Q 002673 692 YWLHEKADGASQLDWLTRLKIARGTSCGLAYMHQICEPHIVHRDIKSSNILLDDQFEAHLADFGLSRLILPYQTHVTTEL 771 (894)
Q Consensus 692 ~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDLkp~NILld~~~~vkl~DFGla~~~~~~~~~~~~~~ 771 (894)
+++.. ..+++.....++.|++.||+|||+ ++++|+||+|+||+++.++.++|+|||++....... ......
T Consensus 106 ~~~~~-----~~~~~~~~~~~~~ql~~~l~~lH~---~givH~dl~p~Nilv~~~~~~~l~dfg~~~~~~~~~-~~~~~~ 176 (292)
T cd06657 106 DIVTH-----TRMNEEQIAAVCLAVLKALSVLHA---QGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEV-PRRKSL 176 (292)
T ss_pred HHHhc-----CCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHEEECCCCCEEEcccccceeccccc-cccccc
Confidence 88753 247888999999999999999997 599999999999999999999999999987653322 122335
Q ss_pred cccCCccCcccccCcCCCccccHHHHHHHHHHHHcCCCCCCCCCcchhhhHHHHHHHHhhcCCCCccccccccCCCChHH
Q 002673 772 VGTLGYIPPEYGQAWVATLRGDMYSFGVVMLELLTGKRPVDVLKPKMSRELVGWVLKMRSEGKQDQVFDPILRGKGFDEE 851 (894)
Q Consensus 772 ~gt~~Y~APE~~~~~~~s~ksDVwS~GvlL~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~ 851 (894)
.|+..|+|||+..+..++.++||||||+++|+|++|+.||...... ........ ..... +. .....
T Consensus 177 ~~~~~y~~pE~~~~~~~~~~~Dv~slGvil~el~tg~~p~~~~~~~---~~~~~~~~----~~~~~-----~~--~~~~~ 242 (292)
T cd06657 177 VGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPL---KAMKMIRD----NLPPK-----LK--NLHKV 242 (292)
T ss_pred ccCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH---HHHHHHHh----hCCcc-----cC--CcccC
Confidence 6889999999998888899999999999999999999999743321 11111111 10000 00 00112
Q ss_pred HHHHHHHHHHhcccCCCCCCCHHHHHH--HHHhccc
Q 002673 852 MLQVLDVACMCVSQNPFKRPTVKEVVE--WLNNVGA 885 (894)
Q Consensus 852 ~~~l~~li~~Cl~~dP~~RPs~~evl~--~L~~i~~ 885 (894)
...+.+++.+|++.+|.+||++.++++ +|.....
T Consensus 243 ~~~l~~li~~~l~~~P~~R~~~~~ll~~~~~~~~~~ 278 (292)
T cd06657 243 SPSLKGFLDRLLVRDPAQRATAAELLKHPFLAKAGP 278 (292)
T ss_pred CHHHHHHHHHHHhCCcccCcCHHHHhcChHHhccCC
Confidence 235678899999999999999999998 7766543
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo |
| >cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Probab=99.98 E-value=2.4e-31 Score=289.18 Aligned_cols=246 Identities=28% Similarity=0.321 Sum_probs=187.3
Q ss_pred eEeecCcEEEEEEEE-cCCCeEEEEEEcCcch---hhHHHHHHHHHHHH---hcCCCceeeecceeeecceEEEEEEecc
Q 002673 614 IIGCGGFGLVYKATL-ANGTTLAIKKLSGDLG---LMEREFKAEVEALS---TAQHKNLVSLQGYCVHQGFRLLIYSYME 686 (894)
Q Consensus 614 ~LG~G~fg~Vy~a~~-~~g~~vAvK~~~~~~~---~~~~~~~~Ei~~l~---~l~HpnIv~l~g~~~~~~~~~lV~E~~~ 686 (894)
.||+|+||.||++.. .+++.+|+|.+..... .....+.+|..++. ..+|||++.+.+++..++..++||||++
T Consensus 1 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~ 80 (279)
T cd05633 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMTYAFHTPDKLCFILDLMN 80 (279)
T ss_pred CcccCCCeEEEEEEECCCCcEEEEEEEEccccccchHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEecCCeEEEEEecCC
Confidence 489999999999985 5689999998865321 12223344444333 3479999999999999999999999999
Q ss_pred CCCHHHHHhhhcCCCCCcCHHHHHHHHHHHHHHHHHHHhccCCCeeecCCCCCCeEECCCCcEEEEEcccccccCCCCCc
Q 002673 687 NGSLDYWLHEKADGASQLDWLTRLKIARGTSCGLAYMHQICEPHIVHRDIKSSNILLDDQFEAHLADFGLSRLILPYQTH 766 (894)
Q Consensus 687 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDLkp~NILld~~~~vkl~DFGla~~~~~~~~~ 766 (894)
+|+|.+++... ..+++..+..++.|++.||.|||+ ++++||||||+||++++++.++|+|||++.......
T Consensus 81 ~~~L~~~i~~~----~~l~~~~~~~i~~qi~~al~~lH~---~~ivH~dikp~Nil~~~~~~~~l~dfg~~~~~~~~~-- 151 (279)
T cd05633 81 GGDLHYHLSQH----GVFSEKEMRFYATEIILGLEHMHN---RFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKK-- 151 (279)
T ss_pred CCCHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHH---CCcCCCCCCHHHEEECCCCCEEEccCCcceeccccC--
Confidence 99999988754 358999999999999999999997 599999999999999999999999999987653221
Q ss_pred ccccccccCCccCccccc-CcCCCccccHHHHHHHHHHHHcCCCCCCCCCcchhhhHHHHHHHHhhcCCCCccccccccC
Q 002673 767 VTTELVGTLGYIPPEYGQ-AWVATLRGDMYSFGVVMLELLTGKRPVDVLKPKMSRELVGWVLKMRSEGKQDQVFDPILRG 845 (894)
Q Consensus 767 ~~~~~~gt~~Y~APE~~~-~~~~s~ksDVwS~GvlL~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~ 845 (894)
.....|+..|+|||... +..++.++|||||||++|+|++|+.||............ ...... ...+.
T Consensus 152 -~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~----~~~~~~------~~~~~- 219 (279)
T cd05633 152 -PHASVGTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEID----RMTLTV------NVELP- 219 (279)
T ss_pred -ccCcCCCcCccCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcCCCCCcCHHHHH----HHhhcC------CcCCc-
Confidence 22346899999999876 456889999999999999999999999754332211111 111000 00011
Q ss_pred CCChHHHHHHHHHHHHhcccCCCCCC-----CHHHHHH--HHHhc
Q 002673 846 KGFDEEMLQVLDVACMCVSQNPFKRP-----TVKEVVE--WLNNV 883 (894)
Q Consensus 846 ~~~~~~~~~l~~li~~Cl~~dP~~RP-----s~~evl~--~L~~i 883 (894)
......+.+++.+|++.||++|| +++++++ +++.+
T Consensus 220 ---~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~~~~h~~~~~~ 261 (279)
T cd05633 220 ---DSFSPELKSLLEGLLQRDVSKRLGCLGRGAQEVKEHVFFKGI 261 (279)
T ss_pred ---cccCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHhCccccCC
Confidence 11223567888999999999999 6999988 45443
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi |
| >KOG0584 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.2e-32 Score=306.87 Aligned_cols=248 Identities=24% Similarity=0.369 Sum_probs=193.6
Q ss_pred ccceEeecCcEEEEEEEE-cCCCeEE---EEEEcC-cchhhHHHHHHHHHHHHhcCCCceeeecceeeecce--EEEEEE
Q 002673 611 QANIIGCGGFGLVYKATL-ANGTTLA---IKKLSG-DLGLMEREFKAEVEALSTAQHKNLVSLQGYCVHQGF--RLLIYS 683 (894)
Q Consensus 611 ~~~~LG~G~fg~Vy~a~~-~~g~~vA---vK~~~~-~~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~--~~lV~E 683 (894)
...+||+|+|-+||||.. .+|..|| ||.-.. ......+.|..|+.+|+.|+|||||+++.++.+... ..+|+|
T Consensus 44 ~~evLGrGafKtVYka~De~~giEVAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL~H~NIirfy~SW~d~~n~~in~iTE 123 (632)
T KOG0584|consen 44 FDEVLGRGAFKTVYKAFDEEEGIEVAWNQVKIRDVTQSPEELERLYSEVHLLKSLKHPNIIRFYDSWVDTDNKTINFITE 123 (632)
T ss_pred hhhhcccccceeeeeccccccchhhHHHHHhHHHhhcChHHHHHHHHHHHHHccCCCCceeeeeeheecCCCceeeeeee
Confidence 346899999999999974 4566665 221110 112334679999999999999999999999987655 778999
Q ss_pred eccCCCHHHHHhhhcCCCCCcCHHHHHHHHHHHHHHHHHHHhccCCCeeecCCCCCCeEECC-CCcEEEEEcccccccCC
Q 002673 684 YMENGSLDYWLHEKADGASQLDWLTRLKIARGTSCGLAYMHQICEPHIVHRDIKSSNILLDD-QFEAHLADFGLSRLILP 762 (894)
Q Consensus 684 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDLkp~NILld~-~~~vkl~DFGla~~~~~ 762 (894)
.|..|+|..|+.+.. ..+......|++||++||.|||++ .++|||||||=.||+|+. .|.|||+|+|+|+....
T Consensus 124 L~TSGtLr~Y~kk~~----~vn~kaik~W~RQILkGL~yLHs~-~PPIIHRDLKCDNIFinG~~G~VKIGDLGLAtl~r~ 198 (632)
T KOG0584|consen 124 LFTSGTLREYRKKHR----RVNIKAIKSWCRQILKGLVYLHSQ-DPPIIHRDLKCDNIFVNGNLGEVKIGDLGLATLLRK 198 (632)
T ss_pred cccCCcHHHHHHHhc----cCCHHHHHHHHHHHHHHhhhhhcC-CCCccccccccceEEEcCCcCceeecchhHHHHhhc
Confidence 999999999998763 577788999999999999999996 789999999999999985 68999999999998743
Q ss_pred CCCcccccccccCCccCcccccCcCCCccccHHHHHHHHHHHHcCCCCCCCCCcchhhhHHHHHHHHhhcCCCCcccccc
Q 002673 763 YQTHVTTELVGTLGYIPPEYGQAWVATLRGDMYSFGVVMLELLTGKRPVDVLKPKMSRELVGWVLKMRSEGKQDQVFDPI 842 (894)
Q Consensus 763 ~~~~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwS~GvlL~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 842 (894)
.. ...++|||.|||||+.. ..|.+.+||||||+.|+||+|+..||...... ..+...+..-.....+..+-||
T Consensus 199 s~---aksvIGTPEFMAPEmYE-E~YnE~VDVYaFGMCmLEMvT~eYPYsEC~n~--AQIYKKV~SGiKP~sl~kV~dP- 271 (632)
T KOG0584|consen 199 SH---AKSVIGTPEFMAPEMYE-ENYNELVDVYAFGMCMLEMVTSEYPYSECTNP--AQIYKKVTSGIKPAALSKVKDP- 271 (632)
T ss_pred cc---cceeccCccccChHHHh-hhcchhhhhhhhhHHHHHHHhccCChhhhCCH--HHHHHHHHcCCCHHHhhccCCH-
Confidence 22 23478999999999887 78999999999999999999999999765432 1111111111111222233232
Q ss_pred ccCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHH--HHHh
Q 002673 843 LRGKGFDEEMLQVLDVACMCVSQNPFKRPTVKEVVE--WLNN 882 (894)
Q Consensus 843 l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~--~L~~ 882 (894)
++.+||.+|+.. .++|||+.|+++ +|..
T Consensus 272 -----------evr~fIekCl~~-~~~R~sa~eLL~d~Ff~~ 301 (632)
T KOG0584|consen 272 -----------EVREFIEKCLAT-KSERLSAKELLKDPFFDE 301 (632)
T ss_pred -----------HHHHHHHHHhcC-chhccCHHHHhhChhhcc
Confidence 456899999999 999999999998 5544
|
|
| >cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.98 E-value=4.6e-31 Score=281.24 Aligned_cols=247 Identities=28% Similarity=0.426 Sum_probs=200.5
Q ss_pred CCCccceEeecCcEEEEEEEEc-CCCeEEEEEEcCcch--hhHHHHHHHHHHHHhcCCCceeeecceeeecceEEEEEEe
Q 002673 608 NFSQANIIGCGGFGLVYKATLA-NGTTLAIKKLSGDLG--LMEREFKAEVEALSTAQHKNLVSLQGYCVHQGFRLLIYSY 684 (894)
Q Consensus 608 ~f~~~~~LG~G~fg~Vy~a~~~-~g~~vAvK~~~~~~~--~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~lV~E~ 684 (894)
+|+..+.||+|++|.||++... +++.|++|.+..... .....+.+|++++++++|+|++++++++.+....+++|||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~ 80 (254)
T cd06627 1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYIGSIETSDSLYIILEY 80 (254)
T ss_pred CceeeeEEcccCCeEEEEEEEcCCCcEEEEEEecccccCHHHHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEEEEEEec
Confidence 4778899999999999999854 678999999976543 3456789999999999999999999999999999999999
Q ss_pred ccCCCHHHHHhhhcCCCCCcCHHHHHHHHHHHHHHHHHHHhccCCCeeecCCCCCCeEECCCCcEEEEEcccccccCCCC
Q 002673 685 MENGSLDYWLHEKADGASQLDWLTRLKIARGTSCGLAYMHQICEPHIVHRDIKSSNILLDDQFEAHLADFGLSRLILPYQ 764 (894)
Q Consensus 685 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDLkp~NILld~~~~vkl~DFGla~~~~~~~ 764 (894)
+++++|.+++... ..+++..+..++.|++.||.|||+ .+++||||+|+||+++.++.++|+|||++.......
T Consensus 81 ~~~~~L~~~~~~~----~~l~~~~~~~~~~~i~~~l~~lH~---~~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~ 153 (254)
T cd06627 81 AENGSLRQIIKKF----GPFPESLVAVYVYQVLQGLAYLHE---QGVIHRDIKAANILTTKDGVVKLADFGVATKLNDVS 153 (254)
T ss_pred CCCCcHHHHHHhc----cCCCHHHHHHHHHHHHHHHHHHhh---CCcccCCCCHHHEEECCCCCEEEeccccceecCCCc
Confidence 9999999998754 458999999999999999999997 599999999999999999999999999998764332
Q ss_pred CcccccccccCCccCcccccCcCCCccccHHHHHHHHHHHHcCCCCCCCCCcchhhhHHHHHHHHhhcCCCCcccccccc
Q 002673 765 THVTTELVGTLGYIPPEYGQAWVATLRGDMYSFGVVMLELLTGKRPVDVLKPKMSRELVGWVLKMRSEGKQDQVFDPILR 844 (894)
Q Consensus 765 ~~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwS~GvlL~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~ 844 (894)
.. .....++..|+|||...+..++.++||||+|+++|+|++|+.||...... ... + .... ..... +.+
T Consensus 154 ~~-~~~~~~~~~y~~pe~~~~~~~~~~~Dv~~lG~~l~~l~~g~~p~~~~~~~---~~~-~--~~~~-~~~~~-~~~--- 221 (254)
T cd06627 154 KD-DASVVGTPYWMAPEVIEMSGASTASDIWSLGCTVIELLTGNPPYYDLNPM---AAL-F--RIVQ-DDHPP-LPE--- 221 (254)
T ss_pred cc-ccccccchhhcCHhhhcCCCCCcchhHHHHHHHHHHHHhCCCCCCCccHH---HHH-H--HHhc-cCCCC-CCC---
Confidence 21 23356788999999988888899999999999999999999999754321 111 1 1111 11111 111
Q ss_pred CCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 002673 845 GKGFDEEMLQVLDVACMCVSQNPFKRPTVKEVVE 878 (894)
Q Consensus 845 ~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~ 878 (894)
.....+.+++.+|+..+|++|||+.+++.
T Consensus 222 -----~~~~~~~~~i~~~l~~~p~~R~~~~~~l~ 250 (254)
T cd06627 222 -----GISPELKDFLMQCFQKDPNLRPTAKQLLK 250 (254)
T ss_pred -----CCCHHHHHHHHHHHhCChhhCcCHHHHhc
Confidence 11235678999999999999999999875
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast |
| >cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Probab=99.98 E-value=2.3e-31 Score=291.62 Aligned_cols=258 Identities=22% Similarity=0.367 Sum_probs=196.3
Q ss_pred cCCCccceEeecCcEEEEEEEEcC-CCeEEEEEEcCcc-hhhHHHHHHHHHHHHhcC-CCceeeecceeeecceEEEEEE
Q 002673 607 DNFSQANIIGCGGFGLVYKATLAN-GTTLAIKKLSGDL-GLMEREFKAEVEALSTAQ-HKNLVSLQGYCVHQGFRLLIYS 683 (894)
Q Consensus 607 ~~f~~~~~LG~G~fg~Vy~a~~~~-g~~vAvK~~~~~~-~~~~~~~~~Ei~~l~~l~-HpnIv~l~g~~~~~~~~~lV~E 683 (894)
++|+..+.||+|+||.||+|...+ +..||||.+.... ......+..|+.++.+.. ||||+++++++..+...++|||
T Consensus 15 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e 94 (296)
T cd06618 15 NDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVKCYGYFITDSDVFICME 94 (296)
T ss_pred chheeeeEeeccCCeEEEEEEECCCCeEEEEEEEeccCChHHHHHHHHHHHHHHhccCCCchHhhheeeecCCeEEEEee
Confidence 567888999999999999999754 8999999997543 223455667777777775 9999999999999999999999
Q ss_pred eccCCCHHHHHhhhcCCCCCcCHHHHHHHHHHHHHHHHHHHhccCCCeeecCCCCCCeEECCCCcEEEEEcccccccCCC
Q 002673 684 YMENGSLDYWLHEKADGASQLDWLTRLKIARGTSCGLAYMHQICEPHIVHRDIKSSNILLDDQFEAHLADFGLSRLILPY 763 (894)
Q Consensus 684 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDLkp~NILld~~~~vkl~DFGla~~~~~~ 763 (894)
|+. +++.+++.... ..+++..+..++.|++.||.|||+ .++|+||||+|+||++++++.+||+|||++..+...
T Consensus 95 ~~~-~~l~~l~~~~~---~~l~~~~~~~i~~~i~~~l~~lH~--~~~i~H~dl~p~nill~~~~~~kL~dfg~~~~~~~~ 168 (296)
T cd06618 95 LMS-TCLDKLLKRIQ---GPIPEDILGKMTVAIVKALHYLKE--KHGVIHRDVKPSNILLDASGNVKLCDFGISGRLVDS 168 (296)
T ss_pred ccC-cCHHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHh--hCCEecCCCcHHHEEEcCCCCEEECccccchhccCC
Confidence 985 57777766532 368899999999999999999996 258999999999999999999999999998765322
Q ss_pred CCcccccccccCCccCcccccCcC----CCccccHHHHHHHHHHHHcCCCCCCCCCcchhhhHHHHHHHHhhcCCCCccc
Q 002673 764 QTHVTTELVGTLGYIPPEYGQAWV----ATLRGDMYSFGVVMLELLTGKRPVDVLKPKMSRELVGWVLKMRSEGKQDQVF 839 (894)
Q Consensus 764 ~~~~~~~~~gt~~Y~APE~~~~~~----~s~ksDVwS~GvlL~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 839 (894)
.. .....++..|+|||++.+.. ++.++||||||+++|+|++|+.||...... .+... ...... .....
T Consensus 169 ~~--~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~--~~~~~---~~~~~~-~~~~~ 240 (296)
T cd06618 169 KA--KTRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKTE--FEVLT---KILQEE-PPSLP 240 (296)
T ss_pred Cc--ccCCCCCccccCHhhcCCCCCccccccchhHHHHHHHHHHHHhCCCCCCcchhH--HHHHH---HHhcCC-CCCCC
Confidence 21 22335788999999987654 788999999999999999999999743221 11111 111111 01110
Q ss_pred cccccCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHH--HHHhccc
Q 002673 840 DPILRGKGFDEEMLQVLDVACMCVSQNPFKRPTVKEVVE--WLNNVGA 885 (894)
Q Consensus 840 d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~--~L~~i~~ 885 (894)
. .. .....+.+++.+|++.||++||++.++++ |++....
T Consensus 241 ~----~~---~~~~~l~~li~~~l~~~p~~Rp~~~~il~~~~~~~~~~ 281 (296)
T cd06618 241 P----NE---GFSPDFCSFVDLCLTKDHRKRPKYRELLQHPFIRRYET 281 (296)
T ss_pred C----CC---CCCHHHHHHHHHHccCChhhCCCHHHHhcChhhhccch
Confidence 0 00 12235778999999999999999999998 5555443
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it |
| >cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.98 E-value=2e-31 Score=289.19 Aligned_cols=260 Identities=25% Similarity=0.294 Sum_probs=197.9
Q ss_pred CCccceEeecCcEEEEEEEE-cCCCeEEEEEEcCcchh--hHHHHHHHHHHHHhcCCCceeeecceeeecceEEEEEEec
Q 002673 609 FSQANIIGCGGFGLVYKATL-ANGTTLAIKKLSGDLGL--MEREFKAEVEALSTAQHKNLVSLQGYCVHQGFRLLIYSYM 685 (894)
Q Consensus 609 f~~~~~LG~G~fg~Vy~a~~-~~g~~vAvK~~~~~~~~--~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~lV~E~~ 685 (894)
|+..+.||.|++|.||+|.. .+++.+++|++...... ....+.+|+.++++++|+||+++++++..+...++|+||+
T Consensus 1 y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~ 80 (283)
T cd05118 1 YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDVFRHKGDLYLVFEFM 80 (283)
T ss_pred CccceeeecCCCceEEEEEcCCCCcEEEEEEeccccccchhHHHHHHHHHHHHHhcCCCcchHHHhhccCCCEEEEEecc
Confidence 55678899999999999985 47899999998754322 3467888999999999999999999999999999999999
Q ss_pred cCCCHHHHHhhhcCCCCCcCHHHHHHHHHHHHHHHHHHHhccCCCeeecCCCCCCeEECCCCcEEEEEcccccccCCCCC
Q 002673 686 ENGSLDYWLHEKADGASQLDWLTRLKIARGTSCGLAYMHQICEPHIVHRDIKSSNILLDDQFEAHLADFGLSRLILPYQT 765 (894)
Q Consensus 686 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDLkp~NILld~~~~vkl~DFGla~~~~~~~~ 765 (894)
++ +|.+++.... ..+++..+..++.|++.||.|||+ ++++|+||||+||+++.++.+||+|||.+.......
T Consensus 81 ~~-~l~~~l~~~~---~~~~~~~~~~~~~~i~~~l~~LH~---~~i~H~dl~p~nili~~~~~~~l~df~~~~~~~~~~- 152 (283)
T cd05118 81 DT-DLYKLIKDRQ---RGLPESLIKSYLYQLLQGLAFCHS---HGILHRDLKPENLLINTEGVLKLADFGLARSFGSPV- 152 (283)
T ss_pred CC-CHHHHHHhhc---ccCCHHHHHHHHHHHHHHHHHHHH---CCeeecCcCHHHEEECCCCcEEEeeeeeeEecCCCc-
Confidence 75 8888887542 468999999999999999999997 599999999999999999999999999998764432
Q ss_pred cccccccccCCccCcccccCc-CCCccccHHHHHHHHHHHHcCCCCCCCCCcchhhhHHHHHHHHhhc--CCCCcccc--
Q 002673 766 HVTTELVGTLGYIPPEYGQAW-VATLRGDMYSFGVVMLELLTGKRPVDVLKPKMSRELVGWVLKMRSE--GKQDQVFD-- 840 (894)
Q Consensus 766 ~~~~~~~gt~~Y~APE~~~~~-~~s~ksDVwS~GvlL~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~--~~~~~~~d-- 840 (894)
.......++..|+|||.+.+. .++.++||||||+++|+|++|+.||........ ........... .......+
T Consensus 153 ~~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~ 230 (283)
T cd05118 153 RPYTHYVVTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRRPLFPGKSEIDQ--LFKIFRTLGTPDPEVWPKFTSLA 230 (283)
T ss_pred ccccCccCcccccCcHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHH--HHHHHHHcCCCchHhcccchhhh
Confidence 122334678899999998776 789999999999999999999999965432111 00000000000 00000000
Q ss_pred ----cccc-------CCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 002673 841 ----PILR-------GKGFDEEMLQVLDVACMCVSQNPFKRPTVKEVVE 878 (894)
Q Consensus 841 ----~~l~-------~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~ 878 (894)
.... ....+.....+.+++..||+.||.+||++.+++.
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~ll~ 279 (283)
T cd05118 231 RNYKFSFPKKAGMPLPKLFPNASPQALDLLSQMLHYDPHKRITAEQALA 279 (283)
T ss_pred hhhhhhhccccccCHHHhhhhhCHHHHHHHHHHhccCcccCcCHHHHhh
Confidence 0000 0011123457889999999999999999999986
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They |
| >cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.5e-31 Score=286.63 Aligned_cols=242 Identities=27% Similarity=0.340 Sum_probs=191.9
Q ss_pred EeecCcEEEEEEEEc-CCCeEEEEEEcCcch---hhHHHHHHHHHHHHhcCCCceeeecceeeecceEEEEEEeccCCCH
Q 002673 615 IGCGGFGLVYKATLA-NGTTLAIKKLSGDLG---LMEREFKAEVEALSTAQHKNLVSLQGYCVHQGFRLLIYSYMENGSL 690 (894)
Q Consensus 615 LG~G~fg~Vy~a~~~-~g~~vAvK~~~~~~~---~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~lV~E~~~~gsL 690 (894)
||.|+||.||++... +|+.+++|.+..... .....+.+|++++++++||||+++++.+..+...++||||+++++|
T Consensus 1 lg~g~~~~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (265)
T cd05579 1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSFQGKKNLYLVMEYLPGGDL 80 (265)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEecchhhhhhhHHHHHHHHHHHHHhCCCcchhHHHHheecCcEEEEEEecCCCCcH
Confidence 589999999999965 599999999876433 3445788999999999999999999999999999999999999999
Q ss_pred HHHHhhhcCCCCCcCHHHHHHHHHHHHHHHHHHHhccCCCeeecCCCCCCeEECCCCcEEEEEcccccccCCCCC-----
Q 002673 691 DYWLHEKADGASQLDWLTRLKIARGTSCGLAYMHQICEPHIVHRDIKSSNILLDDQFEAHLADFGLSRLILPYQT----- 765 (894)
Q Consensus 691 ~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDLkp~NILld~~~~vkl~DFGla~~~~~~~~----- 765 (894)
.+++.... .+++..+..++.|++.||.|||+ ++++|+||+|+||++++++.++|+|||++........
T Consensus 81 ~~~l~~~~----~~~~~~~~~i~~qi~~~L~~lH~---~~i~H~di~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~ 153 (265)
T cd05579 81 ASLLENVG----SLDEDVARIYIAEIVLALEYLHS---NGIIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLND 153 (265)
T ss_pred HHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHH---cCeecCCCCHHHeEEcCCCCEEEEecccchhcccCccccccc
Confidence 99997642 58999999999999999999997 5999999999999999999999999999876432211
Q ss_pred --cccccccccCCccCcccccCcCCCccccHHHHHHHHHHHHcCCCCCCCCCcchhhhHHHHHHHHhhcCCCCccccccc
Q 002673 766 --HVTTELVGTLGYIPPEYGQAWVATLRGDMYSFGVVMLELLTGKRPVDVLKPKMSRELVGWVLKMRSEGKQDQVFDPIL 843 (894)
Q Consensus 766 --~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwS~GvlL~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l 843 (894)
.......++..|+|||.......+.++||||||+++|+|++|+.||....... ... .... +... . ..
T Consensus 154 ~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~---~~~---~~~~-~~~~-~-~~-- 222 (265)
T cd05579 154 DEKEDKRIVGTPDYIAPEVILGQGHSKTVDWWSLGCILYEFLVGIPPFHGETPEE---IFQ---NILN-GKIE-W-PE-- 222 (265)
T ss_pred ccccccCcccCccccCHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHH---HHH---HHhc-CCcC-C-Cc--
Confidence 12233567889999999988889999999999999999999999997544221 111 1111 1110 0 00
Q ss_pred cCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 002673 844 RGKGFDEEMLQVLDVACMCVSQNPFKRPTVKEVVE 878 (894)
Q Consensus 844 ~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~ 878 (894)
.. .....+.+++.+|++.+|.+|||+..+.+
T Consensus 223 ---~~-~~~~~~~~~i~~~l~~~p~~Rpt~~~~~~ 253 (265)
T cd05579 223 ---DV-EVSDEAIDLISKLLVPDPEKRLGAKSIEE 253 (265)
T ss_pred ---cc-cCCHHHHHHHHHHhcCCHhhcCCCccHHH
Confidence 00 01345678999999999999999944433
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re |
| >KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.2e-32 Score=302.29 Aligned_cols=252 Identities=23% Similarity=0.340 Sum_probs=203.4
Q ss_pred CCccceEeecCcEEEEEEEEc-CCCeEEEEEEcCcchhhHHHHHHHHHHHHhcCCCceeeecceeeecceEEEEEEeccC
Q 002673 609 FSQANIIGCGGFGLVYKATLA-NGTTLAIKKLSGDLGLMEREFKAEVEALSTAQHKNLVSLQGYCVHQGFRLLIYSYMEN 687 (894)
Q Consensus 609 f~~~~~LG~G~fg~Vy~a~~~-~g~~vAvK~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~lV~E~~~~ 687 (894)
|.+...||.|+||.||+|..+ ++-..|.|++.-.......++.-||++|..+.||+||++++.|..++..|++.|||.|
T Consensus 34 WeIiGELGDGAFGKVyKA~nket~~lAAaKvIetkseEELEDylVEIeILa~CdHP~ivkLl~ayy~enkLwiliEFC~G 113 (1187)
T KOG0579|consen 34 WEIIGELGDGAFGKVYKAVNKETKLLAAAKVIETKSEEELEDYLVEIEILAECDHPVIVKLLSAYYFENKLWILIEFCGG 113 (1187)
T ss_pred HHHHhhhcCccchhhhhhhcccchhhhhhhhhcccchhHHhhhhhhhhhhhcCCChHHHHHHHHHhccCceEEEEeecCC
Confidence 455677999999999999854 4455678888777677778999999999999999999999999999999999999999
Q ss_pred CCHHHHHhhhcCCCCCcCHHHHHHHHHHHHHHHHHHHhccCCCeeecCCCCCCeEECCCCcEEEEEcccccccCCCCCcc
Q 002673 688 GSLDYWLHEKADGASQLDWLTRLKIARGTSCGLAYMHQICEPHIVHRDIKSSNILLDDQFEAHLADFGLSRLILPYQTHV 767 (894)
Q Consensus 688 gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDLkp~NILld~~~~vkl~DFGla~~~~~~~~~~ 767 (894)
|-++..+-... ..+...++..+..|++.||.|||+ +.|||||||+.|||++-+|.++|+|||.+.... .....
T Consensus 114 GAVDaimlEL~---r~LtE~QIqvvc~q~ldALn~LHs---~~iIHRDLKAGNiL~TldGdirLADFGVSAKn~-~t~qk 186 (1187)
T KOG0579|consen 114 GAVDAIMLELG---RVLTEDQIQVVCYQVLDALNWLHS---QNIIHRDLKAGNILLTLDGDIRLADFGVSAKNK-STRQK 186 (1187)
T ss_pred chHhHHHHHhc---cccchHHHHHHHHHHHHHHHHHhh---cchhhhhccccceEEEecCcEeeecccccccch-hHHhh
Confidence 99998887643 568899999999999999999997 699999999999999999999999999886432 12233
Q ss_pred cccccccCCccCccccc-----CcCCCccccHHHHHHHHHHHHcCCCCCCCCCcchhhhHHHHHHHHhhcCCCCcccccc
Q 002673 768 TTELVGTLGYIPPEYGQ-----AWVATLRGDMYSFGVVMLELLTGKRPVDVLKPKMSRELVGWVLKMRSEGKQDQVFDPI 842 (894)
Q Consensus 768 ~~~~~gt~~Y~APE~~~-----~~~~s~ksDVwS~GvlL~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 842 (894)
...+.|||.|||||+.+ ...|+.++||||||+.|.||..+.+|-+...+ .+-+ .++.. .....+..
T Consensus 187 RDsFIGTPYWMAPEVvmCET~KD~PYDykaDiWSlGITLIEMAqiEPPHhelnp--MRVl----lKiaK-SePPTLlq-- 257 (1187)
T KOG0579|consen 187 RDSFIGTPYWMAPEVVMCETFKDQPYDYKADIWSLGITLIEMAQIEPPHHELNP--MRVL----LKIAK-SEPPTLLQ-- 257 (1187)
T ss_pred hccccCCcccccchheeeccccCCCchhhhhHHhhhhHHHHHhccCCCccccch--HHHH----HHHhh-cCCCcccC--
Confidence 45689999999999754 46789999999999999999999999875442 1111 11111 11122222
Q ss_pred ccCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHH--HHH
Q 002673 843 LRGKGFDEEMLQVLDVACMCVSQNPFKRPTVKEVVE--WLN 881 (894)
Q Consensus 843 l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~--~L~ 881 (894)
.+.....+.+++..|+..||..||++.++++ |++
T Consensus 258 -----PS~Ws~~F~DfLk~cL~Knp~~Rp~aaqll~Hpfv~ 293 (1187)
T KOG0579|consen 258 -----PSHWSRSFSDFLKRCLVKNPRNRPPAAQLLKHPFVQ 293 (1187)
T ss_pred -----cchhhhHHHHHHHHHHhcCCccCCCHHHHhhCcccc
Confidence 1233446778999999999999999999997 544
|
|
| >cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.7e-31 Score=294.01 Aligned_cols=265 Identities=25% Similarity=0.289 Sum_probs=193.2
Q ss_pred cCCCccceEeecCcEEEEEEEE-cCCCeEEEEEEcCcch--hhHHHHHHHHHHHHhcCCCceeeecceeeecc-------
Q 002673 607 DNFSQANIIGCGGFGLVYKATL-ANGTTLAIKKLSGDLG--LMEREFKAEVEALSTAQHKNLVSLQGYCVHQG------- 676 (894)
Q Consensus 607 ~~f~~~~~LG~G~fg~Vy~a~~-~~g~~vAvK~~~~~~~--~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~------- 676 (894)
++|+..+.||+|+||.||+|.. .+++.||||.+..... .....+.+|+.++++++||||++++++|....
T Consensus 12 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 91 (310)
T cd07865 12 SKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPYNRYK 91 (310)
T ss_pred hheEEEEEeecCCCEEEEEEEECCCCcEEEEEEEeccCCcCCchhHHHHHHHHHHhCCCCCccceEEEEecccccccCCC
Confidence 5788899999999999999985 4789999998864322 22345678999999999999999999987654
Q ss_pred -eEEEEEEeccCCCHHHHHhhhcCCCCCcCHHHHHHHHHHHHHHHHHHHhccCCCeeecCCCCCCeEECCCCcEEEEEcc
Q 002673 677 -FRLLIYSYMENGSLDYWLHEKADGASQLDWLTRLKIARGTSCGLAYMHQICEPHIVHRDIKSSNILLDDQFEAHLADFG 755 (894)
Q Consensus 677 -~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDLkp~NILld~~~~vkl~DFG 755 (894)
..++||||+. ++|.+++.... ..+++..++.++.|++.||.|||+ ++++|+||||+||+++.++.+||+|||
T Consensus 92 ~~~~lv~e~~~-~~l~~~l~~~~---~~~~~~~~~~i~~qi~~al~~lH~---~~i~H~dl~p~nil~~~~~~~kl~dfg 164 (310)
T cd07865 92 GSFYLVFEFCE-HDLAGLLSNKN---VKFTLSEIKKVMKMLLNGLYYIHR---NKILHRDMKAANILITKDGILKLADFG 164 (310)
T ss_pred ceEEEEEcCCC-cCHHHHHHhcc---cCCCHHHHHHHHHHHHHHHHHHHH---CCeeccCCCHHHEEECCCCcEEECcCC
Confidence 4599999996 58888776432 358999999999999999999997 599999999999999999999999999
Q ss_pred cccccCCCCCc---ccccccccCCccCcccccCc-CCCccccHHHHHHHHHHHHcCCCCCCCCCcchhhhHHHHHHHHhh
Q 002673 756 LSRLILPYQTH---VTTELVGTLGYIPPEYGQAW-VATLRGDMYSFGVVMLELLTGKRPVDVLKPKMSRELVGWVLKMRS 831 (894)
Q Consensus 756 la~~~~~~~~~---~~~~~~gt~~Y~APE~~~~~-~~s~ksDVwS~GvlL~elltG~~Pf~~~~~~~~~~~~~~~~~~~~ 831 (894)
++......... ......++..|+|||++.+. .++.++||||||+++|||++|+.||....................
T Consensus 165 ~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~el~t~~~~~~~~~~~~~~~~~~~~~~~~~ 244 (310)
T cd07865 165 LARAFSLSKNSKPNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQGNTEQHQLTLISQLCGSIT 244 (310)
T ss_pred CcccccCCcccCCCCccCcccCccccCcHHhcCCcccCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCC
Confidence 99865432211 12234578899999987664 468899999999999999999999975443222222111110000
Q ss_pred cCCCC-----cccccc-ccCC---CCh------HHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 002673 832 EGKQD-----QVFDPI-LRGK---GFD------EEMLQVLDVACMCVSQNPFKRPTVKEVVE 878 (894)
Q Consensus 832 ~~~~~-----~~~d~~-l~~~---~~~------~~~~~l~~li~~Cl~~dP~~RPs~~evl~ 878 (894)
..... ...+.. .... ... .....+.+++.+|++.||++|||++++++
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~dli~~~l~~~P~~R~t~~e~l~ 306 (310)
T cd07865 245 PEVWPGVDKLELFKKMELPQGQKRKVKERLKPYVKDPHALDLIDKLLVLDPAKRIDADTALN 306 (310)
T ss_pred hhhcccccchhhhhhccCCCccchhhHHhcccccCCHHHHHHHHHHhcCChhhccCHHHHhc
Confidence 00000 000000 0000 000 01224568999999999999999999985
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl |
| >PHA03390 pk1 serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.7e-31 Score=284.35 Aligned_cols=248 Identities=24% Similarity=0.248 Sum_probs=189.8
Q ss_pred HHHHhccCCCccceE--eecCcEEEEEEEE-cCCCeEEEEEEcCcchhhHHHHHHHHHHHHhc-CCCceeeecceeeecc
Q 002673 601 ELLKATDNFSQANII--GCGGFGLVYKATL-ANGTTLAIKKLSGDLGLMEREFKAEVEALSTA-QHKNLVSLQGYCVHQG 676 (894)
Q Consensus 601 el~~a~~~f~~~~~L--G~G~fg~Vy~a~~-~~g~~vAvK~~~~~~~~~~~~~~~Ei~~l~~l-~HpnIv~l~g~~~~~~ 676 (894)
+.....++|++.+.+ |+|+||.||++.. .++..+|+|.+....... .|+.....+ +|||++++++++...+
T Consensus 8 ~~~~~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~-----~e~~~~~~~~~h~~iv~~~~~~~~~~ 82 (267)
T PHA03390 8 ELVQFLKNCEIVKKLKLIDGKFGKVSVLKHKPTQKLFVQKIIKAKNFNA-----IEPMVHQLMKDNPNFIKLYYSVTTLK 82 (267)
T ss_pred HHHHHHHhhccccceeecCCCceEEEEEEEcCCCcEEEEEEEehhhcch-----hhHHHHHHhhcCCCEEEEEEEEecCC
Confidence 334445667766666 9999999999984 578889999986432111 122222222 7999999999999999
Q ss_pred eEEEEEEeccCCCHHHHHhhhcCCCCCcCHHHHHHHHHHHHHHHHHHHhccCCCeeecCCCCCCeEECCCC-cEEEEEcc
Q 002673 677 FRLLIYSYMENGSLDYWLHEKADGASQLDWLTRLKIARGTSCGLAYMHQICEPHIVHRDIKSSNILLDDQF-EAHLADFG 755 (894)
Q Consensus 677 ~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDLkp~NILld~~~-~vkl~DFG 755 (894)
..++||||+++|+|.+++... ..+++..+..++.|+++||.|||+ .+++||||||+||+++.++ .++|+|||
T Consensus 83 ~~~iv~e~~~~~~L~~~l~~~----~~l~~~~~~~~~~qi~~~l~~lH~---~~i~H~dl~p~nil~~~~~~~~~l~dfg 155 (267)
T PHA03390 83 GHVLIMDYIKDGDLFDLLKKE----GKLSEAEVKKIIRQLVEALNDLHK---HNIIHNDIKLENVLYDRAKDRIYLCDYG 155 (267)
T ss_pred eeEEEEEcCCCCcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHh---CCeeeCCCCHHHEEEeCCCCeEEEecCc
Confidence 999999999999999999754 268999999999999999999997 5899999999999999988 99999999
Q ss_pred cccccCCCCCcccccccccCCccCcccccCcCCCccccHHHHHHHHHHHHcCCCCCCCCCcchhhhHHHHHHHHhhcCCC
Q 002673 756 LSRLILPYQTHVTTELVGTLGYIPPEYGQAWVATLRGDMYSFGVVMLELLTGKRPVDVLKPKMSRELVGWVLKMRSEGKQ 835 (894)
Q Consensus 756 la~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwS~GvlL~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~ 835 (894)
++...... ....++..|+|||++.+..++.++||||||+++|||++|+.||....... .....+.... ...
T Consensus 156 ~~~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~-~~~~~~~~~~--~~~- 226 (267)
T PHA03390 156 LCKIIGTP-----SCYDGTLDYFSPEKIKGHNYDVSFDWWAVGVLTYELLTGKHPFKEDEDEE-LDLESLLKRQ--QKK- 226 (267)
T ss_pred cceecCCC-----ccCCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCcch-hhHHHHHHhh--ccc-
Confidence 98765321 22457899999999999899999999999999999999999997443221 1111221111 110
Q ss_pred CccccccccCCCChHHHHHHHHHHHHhcccCCCCCCC-HHHHHH
Q 002673 836 DQVFDPILRGKGFDEEMLQVLDVACMCVSQNPFKRPT-VKEVVE 878 (894)
Q Consensus 836 ~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs-~~evl~ 878 (894)
... .......+.+++.+|++.+|.+||+ ++++++
T Consensus 227 ~~~---------~~~~~~~~~~li~~~l~~~p~~R~~~~~~~l~ 261 (267)
T PHA03390 227 LPF---------IKNVSKNANDFVQSMLKYNINYRLTNYNEIIK 261 (267)
T ss_pred CCc---------ccccCHHHHHHHHHHhccChhhCCchHHHHhc
Confidence 000 1122345778999999999999996 699885
|
|
| >cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.3e-31 Score=300.12 Aligned_cols=267 Identities=25% Similarity=0.316 Sum_probs=196.1
Q ss_pred ccCCCccceEeecCcEEEEEEEE-cCCCeEEEEEEcCcc--hhhHHHHHHHHHHHHhcCCCceeeecceeeec------c
Q 002673 606 TDNFSQANIIGCGGFGLVYKATL-ANGTTLAIKKLSGDL--GLMEREFKAEVEALSTAQHKNLVSLQGYCVHQ------G 676 (894)
Q Consensus 606 ~~~f~~~~~LG~G~fg~Vy~a~~-~~g~~vAvK~~~~~~--~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~------~ 676 (894)
.++|...+.||+|+||.||+|.. .+|+.||+|++.... ......+.+|+.+++.++||||+++++++... .
T Consensus 14 ~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 93 (342)
T cd07879 14 PERYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENVIGLLDVFTSAVSGDEFQ 93 (342)
T ss_pred ccceEEEEEeeecCCeEEEEEEeCCCCcEEEEEEecCccccccchhHHHHHHHHHHhcCCCCccchhheecccccCCCCc
Confidence 36899999999999999999985 578999999987532 22235678999999999999999999998754 2
Q ss_pred eEEEEEEeccCCCHHHHHhhhcCCCCCcCHHHHHHHHHHHHHHHHHHHhccCCCeeecCCCCCCeEECCCCcEEEEEccc
Q 002673 677 FRLLIYSYMENGSLDYWLHEKADGASQLDWLTRLKIARGTSCGLAYMHQICEPHIVHRDIKSSNILLDDQFEAHLADFGL 756 (894)
Q Consensus 677 ~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDLkp~NILld~~~~vkl~DFGl 756 (894)
..++|+||+.. +|..+.. ..+++..+..++.|++.||.|||+ .+++||||||+||+++.++.+||+|||+
T Consensus 94 ~~~lv~e~~~~-~l~~~~~------~~~~~~~~~~~~~qi~~aL~~LH~---~~i~H~dlkp~NIll~~~~~~kL~dfg~ 163 (342)
T cd07879 94 DFYLVMPYMQT-DLQKIMG------HPLSEDKVQYLVYQMLCGLKYIHS---AGIIHRDLKPGNLAVNEDCELKILDFGL 163 (342)
T ss_pred eEEEEeccccc-CHHHHHc------CCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEECCCCCEEEeeCCC
Confidence 46899999964 6766542 247889999999999999999997 5999999999999999999999999999
Q ss_pred ccccCCCCCcccccccccCCccCcccccC-cCCCccccHHHHHHHHHHHHcCCCCCCCCCcchhhhHHHHHHH-------
Q 002673 757 SRLILPYQTHVTTELVGTLGYIPPEYGQA-WVATLRGDMYSFGVVMLELLTGKRPVDVLKPKMSRELVGWVLK------- 828 (894)
Q Consensus 757 a~~~~~~~~~~~~~~~gt~~Y~APE~~~~-~~~s~ksDVwS~GvlL~elltG~~Pf~~~~~~~~~~~~~~~~~------- 828 (894)
++.... ......++..|+|||.+.+ ..++.++|||||||++|||++|+.||.................
T Consensus 164 ~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 239 (342)
T cd07879 164 ARHADA----EMTGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGPEFV 239 (342)
T ss_pred CcCCCC----CCCCceeeecccChhhhcCccccCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHH
Confidence 876422 1223467889999998876 4688999999999999999999999975432111000000000
Q ss_pred -HhhcCCCCcccc--ccccCC----CChHHHHHHHHHHHHhcccCCCCCCCHHHHHH--HHHhcccc
Q 002673 829 -MRSEGKQDQVFD--PILRGK----GFDEEMLQVLDVACMCVSQNPFKRPTVKEVVE--WLNNVGAN 886 (894)
Q Consensus 829 -~~~~~~~~~~~d--~~l~~~----~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~--~L~~i~~~ 886 (894)
............ +..... ..+.....+.+++.+|++.||++||+++++++ +++.++..
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~~~~e~l~h~~f~~~~~~ 306 (342)
T cd07879 240 QKLEDKAAKSYIKSLPKYPRKDFSTLFPKASPQAVDLLEKMLELDVDKRLTATEALEHPYFDSFRDA 306 (342)
T ss_pred HHhcccchHHHHhhcCCcccchHHHHhcCCCHHHHHHHHHHcCCChhhCcCHHHHhcCcchhhcccc
Confidence 000000000000 000000 00112235779999999999999999999996 78887653
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13 |
| >cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=1e-30 Score=281.50 Aligned_cols=249 Identities=24% Similarity=0.317 Sum_probs=194.3
Q ss_pred cCCCccceEeecCcEEEEEEEE-cCCCeEEEEEEcCcc-----hhhHHHHHHHHHHHHhcCCCceeeecceeeec--ceE
Q 002673 607 DNFSQANIIGCGGFGLVYKATL-ANGTTLAIKKLSGDL-----GLMEREFKAEVEALSTAQHKNLVSLQGYCVHQ--GFR 678 (894)
Q Consensus 607 ~~f~~~~~LG~G~fg~Vy~a~~-~~g~~vAvK~~~~~~-----~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~--~~~ 678 (894)
.+|++.+.||+|+||.||+|.. .++..||+|.+.... ......+.+|++++++++|+||+++++++.+. ...
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (264)
T cd06653 2 VNWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQYYGCLRDPEEKKL 81 (264)
T ss_pred CceeeeeeEccCCCeEEEEEEEcCCCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHcCCCCcceEEEEEEcCCCCEE
Confidence 4688899999999999999984 568999999875321 22335788999999999999999999998754 457
Q ss_pred EEEEEeccCCCHHHHHhhhcCCCCCcCHHHHHHHHHHHHHHHHHHHhccCCCeeecCCCCCCeEECCCCcEEEEEccccc
Q 002673 679 LLIYSYMENGSLDYWLHEKADGASQLDWLTRLKIARGTSCGLAYMHQICEPHIVHRDIKSSNILLDDQFEAHLADFGLSR 758 (894)
Q Consensus 679 ~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDLkp~NILld~~~~vkl~DFGla~ 758 (894)
++++||+++++|.+++... ..+++.....++.|++.||.|||+ ++++|+||||+||+++.++.++|+|||+++
T Consensus 82 ~~v~e~~~~~~L~~~~~~~----~~l~~~~~~~~~~~i~~al~~LH~---~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~ 154 (264)
T cd06653 82 SIFVEYMPGGSIKDQLKAY----GALTENVTRRYTRQILQGVSYLHS---NMIVHRDIKGANILRDSAGNVKLGDFGASK 154 (264)
T ss_pred EEEEEeCCCCcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHh---CCEecCCCCHHHEEEcCCCCEEECcccccc
Confidence 8999999999999998753 247888899999999999999997 599999999999999999999999999998
Q ss_pred ccCCCC--CcccccccccCCccCcccccCcCCCccccHHHHHHHHHHHHcCCCCCCCCCcchhhhHHHHHHHHhhcCCCC
Q 002673 759 LILPYQ--THVTTELVGTLGYIPPEYGQAWVATLRGDMYSFGVVMLELLTGKRPVDVLKPKMSRELVGWVLKMRSEGKQD 836 (894)
Q Consensus 759 ~~~~~~--~~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwS~GvlL~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~ 836 (894)
...... ........++..|+|||++.+..++.++|||||||++|+|++|+.||...... .. ..+........
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~--~~----~~~~~~~~~~~ 228 (264)
T cd06653 155 RIQTICMSGTGIKSVTGTPYWMSPEVISGEGYGRKADVWSVACTVVEMLTEKPPWAEYEAM--AA----IFKIATQPTKP 228 (264)
T ss_pred ccccccccCccccccCCcccccCHhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCccCHH--HH----HHHHHcCCCCC
Confidence 653211 11122346889999999999888999999999999999999999999754321 11 11111111111
Q ss_pred ccccccccCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 002673 837 QVFDPILRGKGFDEEMLQVLDVACMCVSQNPFKRPTVKEVVE 878 (894)
Q Consensus 837 ~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~ 878 (894)
.+ .......+.+++.+|++ +|..||+..+++.
T Consensus 229 ~~---------p~~~~~~~~~~i~~~l~-~~~~r~~~~~~~~ 260 (264)
T cd06653 229 ML---------PDGVSDACRDFLKQIFV-EEKRRPTAEFLLR 260 (264)
T ss_pred CC---------CcccCHHHHHHHHHHhc-CcccCccHHHHhc
Confidence 11 11122356788899999 5799999998764
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho |
| >cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.9e-31 Score=287.67 Aligned_cols=255 Identities=25% Similarity=0.283 Sum_probs=196.7
Q ss_pred CCCccceEeecCcEEEEEEEE----cCCCeEEEEEEcCcch----hhHHHHHHHHHHHHhc-CCCceeeecceeeecceE
Q 002673 608 NFSQANIIGCGGFGLVYKATL----ANGTTLAIKKLSGDLG----LMEREFKAEVEALSTA-QHKNLVSLQGYCVHQGFR 678 (894)
Q Consensus 608 ~f~~~~~LG~G~fg~Vy~a~~----~~g~~vAvK~~~~~~~----~~~~~~~~Ei~~l~~l-~HpnIv~l~g~~~~~~~~ 678 (894)
+|++.+.||+|+||.||++.. .+++.||||.+..... .....+..|+.++.++ +||||+++++.+..+...
T Consensus 1 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~~~~~~~ 80 (288)
T cd05583 1 NFELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAFQTDTKL 80 (288)
T ss_pred CceEEEEeccCCCceEEEEEEeccccCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhhheeeecCCEE
Confidence 367789999999999999974 3578899999875321 2234578899999999 699999999999999999
Q ss_pred EEEEEeccCCCHHHHHhhhcCCCCCcCHHHHHHHHHHHHHHHHHHHhccCCCeeecCCCCCCeEECCCCcEEEEEccccc
Q 002673 679 LLIYSYMENGSLDYWLHEKADGASQLDWLTRLKIARGTSCGLAYMHQICEPHIVHRDIKSSNILLDDQFEAHLADFGLSR 758 (894)
Q Consensus 679 ~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDLkp~NILld~~~~vkl~DFGla~ 758 (894)
++||||+++|+|.+++... ..+++..+..++.|+++||.|||+ .+++||||||+||+++.++.++|+|||+++
T Consensus 81 ~lv~e~~~~~~L~~~~~~~----~~~~~~~~~~~~~ql~~~l~~lH~---~~~~H~dl~p~nil~~~~~~~~l~dfg~~~ 153 (288)
T cd05583 81 HLILDYVNGGELFTHLYQR----EHFTESEVRVYIAEIVLALDHLHQ---LGIIYRDIKLENILLDSEGHVVLTDFGLSK 153 (288)
T ss_pred EEEEecCCCCcHHHHHhhc----CCcCHHHHHHHHHHHHHHHHHHHH---CCeeccCCCHHHeEECCCCCEEEEECcccc
Confidence 9999999999999998753 357888999999999999999997 599999999999999999999999999988
Q ss_pred ccCCCCCcccccccccCCccCcccccCcC--CCccccHHHHHHHHHHHHcCCCCCCCCCcchhhhHHHHHHHHhhcCCCC
Q 002673 759 LILPYQTHVTTELVGTLGYIPPEYGQAWV--ATLRGDMYSFGVVMLELLTGKRPVDVLKPKMSRELVGWVLKMRSEGKQD 836 (894)
Q Consensus 759 ~~~~~~~~~~~~~~gt~~Y~APE~~~~~~--~s~ksDVwS~GvlL~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~ 836 (894)
..............|+..|+|||...+.. .+.++||||||+++|+|++|..||........ .............
T Consensus 154 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~--~~~~~~~~~~~~~-- 229 (288)
T cd05583 154 EFLAEEEERAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQNS--QSEISRRILKSKP-- 229 (288)
T ss_pred ccccccccccccccCCccccCHHHhcCCCCCCcchhhhHHHHHHHHHHHhCCCCcccCcccch--HHHHHHHHHccCC--
Confidence 76443332233456889999999987665 78899999999999999999999963321111 1111111111100
Q ss_pred ccccccccCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHh
Q 002673 837 QVFDPILRGKGFDEEMLQVLDVACMCVSQNPFKRPTVKEVVEWLNN 882 (894)
Q Consensus 837 ~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~ 882 (894)
... ......+.+++.+|++.+|++|||+.++.+.|+.
T Consensus 230 -----~~~----~~~~~~l~~li~~~l~~~p~~R~t~~~~~~~l~~ 266 (288)
T cd05583 230 -----PFP----KTMSAEARDFIQKLLEKDPKKRLGANGADEIKNH 266 (288)
T ss_pred -----CCC----cccCHHHHHHHHHHhcCCHhhccCcchHHHHhcC
Confidence 000 0112356788999999999999998877665543
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines |
| >cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.9e-31 Score=286.35 Aligned_cols=256 Identities=25% Similarity=0.317 Sum_probs=197.1
Q ss_pred CCCccceEeecCcEEEEEEEE----cCCCeEEEEEEcCcch----hhHHHHHHHHHHHHhc-CCCceeeecceeeecceE
Q 002673 608 NFSQANIIGCGGFGLVYKATL----ANGTTLAIKKLSGDLG----LMEREFKAEVEALSTA-QHKNLVSLQGYCVHQGFR 678 (894)
Q Consensus 608 ~f~~~~~LG~G~fg~Vy~a~~----~~g~~vAvK~~~~~~~----~~~~~~~~Ei~~l~~l-~HpnIv~l~g~~~~~~~~ 678 (894)
+|++.+.||.|+||.||++.. .+|..||+|++..... ...+.+..|+.++.++ +|+||+++++.+..+...
T Consensus 1 ~y~~~~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~ 80 (290)
T cd05613 1 NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTDTKL 80 (290)
T ss_pred CceeeeeeccCCcceEEEEEeccCCCCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCChhceeeEeecCCeE
Confidence 477789999999999999985 4789999999875322 2235678899999999 699999999999998899
Q ss_pred EEEEEeccCCCHHHHHhhhcCCCCCcCHHHHHHHHHHHHHHHHHHHhccCCCeeecCCCCCCeEECCCCcEEEEEccccc
Q 002673 679 LLIYSYMENGSLDYWLHEKADGASQLDWLTRLKIARGTSCGLAYMHQICEPHIVHRDIKSSNILLDDQFEAHLADFGLSR 758 (894)
Q Consensus 679 ~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDLkp~NILld~~~~vkl~DFGla~ 758 (894)
++||||+++++|.+++... ..+++..+..++.|++.||.|||+ .+++||||+|+|||++.++.+||+|||++.
T Consensus 81 ~lv~e~~~~~~L~~~l~~~----~~l~~~~~~~~~~qi~~al~~lH~---~~i~H~dl~p~nil~~~~~~~kl~dfg~~~ 153 (290)
T cd05613 81 HLILDYINGGELFTHLSQR----ERFKEQEVQIYSGEIVLALEHLHK---LGIIYRDIKLENILLDSNGHVVLTDFGLSK 153 (290)
T ss_pred EEEEecCCCCcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHh---CCeeccCCCHHHeEECCCCCEEEeeCccce
Confidence 9999999999999999754 357888889999999999999997 699999999999999999999999999998
Q ss_pred ccCCCCCcccccccccCCccCcccccCc--CCCccccHHHHHHHHHHHHcCCCCCCCCCcchhhhHHHHHHHHhhcCCCC
Q 002673 759 LILPYQTHVTTELVGTLGYIPPEYGQAW--VATLRGDMYSFGVVMLELLTGKRPVDVLKPKMSRELVGWVLKMRSEGKQD 836 (894)
Q Consensus 759 ~~~~~~~~~~~~~~gt~~Y~APE~~~~~--~~s~ksDVwS~GvlL~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~ 836 (894)
..............|+..|+|||++.+. .++.++||||||+++|+|++|+.||........ .............
T Consensus 154 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~--~~~~~~~~~~~~~-- 229 (290)
T cd05613 154 EFHEDEVERAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGEKNS--QAEISRRILKSEP-- 229 (290)
T ss_pred ecccccccccccccCCcccCChhhccCCCCCCCccccHHHHHHHHHHHhcCCCCCCcCCcccc--HHHHHHHhhccCC--
Confidence 6543322223345688999999988653 467899999999999999999999964322111 1111111111110
Q ss_pred ccccccccCCCChHHHHHHHHHHHHhcccCCCCCC-----CHHHHHH--HHHhc
Q 002673 837 QVFDPILRGKGFDEEMLQVLDVACMCVSQNPFKRP-----TVKEVVE--WLNNV 883 (894)
Q Consensus 837 ~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RP-----s~~evl~--~L~~i 883 (894)
. .. ......+.+++.+|++.+|++|| ++++++. +++.+
T Consensus 230 ~-~~--------~~~~~~~~~ll~~~l~~~p~~R~~~~~~~~~~l~~~~~~~~~ 274 (290)
T cd05613 230 P-YP--------QEMSALAKDIIQRLLMKDPKKRLGCGPSDADEIKKHPFFQKI 274 (290)
T ss_pred C-CC--------ccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHcCcccccC
Confidence 0 00 01123566889999999999997 7788876 45444
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.6e-31 Score=285.26 Aligned_cols=260 Identities=25% Similarity=0.295 Sum_probs=194.0
Q ss_pred CCccceEeecCcEEEEEEEEc-CCCeEEEEEEcCcch--hhHHHHHHHHHHHHhc---CCCceeeecceeeecce-----
Q 002673 609 FSQANIIGCGGFGLVYKATLA-NGTTLAIKKLSGDLG--LMEREFKAEVEALSTA---QHKNLVSLQGYCVHQGF----- 677 (894)
Q Consensus 609 f~~~~~LG~G~fg~Vy~a~~~-~g~~vAvK~~~~~~~--~~~~~~~~Ei~~l~~l---~HpnIv~l~g~~~~~~~----- 677 (894)
|++.+.||+|+||.||+|... ++..||+|++..... .....+.+|+.+++++ +|+|++++++++...+.
T Consensus 1 y~~~~~l~~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~~ 80 (287)
T cd07838 1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTDRELK 80 (287)
T ss_pred CeEEEEecccCceEEEEEEECCCCCEEEEEEeccccccchhhhhHHHHHHHHHHhhccCCCCcceEEEEEeeccCCCCce
Confidence 567789999999999999965 589999999974322 2234566777777666 59999999999988776
Q ss_pred EEEEEEeccCCCHHHHHhhhcCCCCCcCHHHHHHHHHHHHHHHHHHHhccCCCeeecCCCCCCeEECCCCcEEEEEcccc
Q 002673 678 RLLIYSYMENGSLDYWLHEKADGASQLDWLTRLKIARGTSCGLAYMHQICEPHIVHRDIKSSNILLDDQFEAHLADFGLS 757 (894)
Q Consensus 678 ~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDLkp~NILld~~~~vkl~DFGla 757 (894)
.+++|||+. ++|.+++..... ..+++..++.++.|++.||.|||+ .+++|+||+|+||+++.++.+||+|||++
T Consensus 81 ~~l~~e~~~-~~l~~~l~~~~~--~~l~~~~~~~~~~~i~~al~~LH~---~~i~h~~l~~~nili~~~~~~~l~dfg~~ 154 (287)
T cd07838 81 LTLVFEHVD-QDLATYLSKCPK--PGLPPETIKDLMRQLLRGVDFLHS---HRIVHRDLKPQNILVTSDGQVKIADFGLA 154 (287)
T ss_pred eEEEehhcc-cCHHHHHHHccC--CCCCHHHHHHHHHHHHHHHHHHHH---CCeeeccCChhhEEEccCCCEEEeccCcc
Confidence 899999996 589888875432 358999999999999999999997 59999999999999999999999999999
Q ss_pred cccCCCCCcccccccccCCccCcccccCcCCCccccHHHHHHHHHHHHcCCCCCCCCCcchhhhHHHHHHHHhhcCCCC-
Q 002673 758 RLILPYQTHVTTELVGTLGYIPPEYGQAWVATLRGDMYSFGVVMLELLTGKRPVDVLKPKMSRELVGWVLKMRSEGKQD- 836 (894)
Q Consensus 758 ~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwS~GvlL~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~- 836 (894)
....... ......++..|+|||++.+..++.++|||||||++|||++|+.||........ ...+...........
T Consensus 155 ~~~~~~~--~~~~~~~~~~~~~PE~~~~~~~~~~~Di~s~G~~l~~l~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~ 230 (287)
T cd07838 155 RIYSFEM--ALTSVVVTLWYRAPEVLLQSSYATPVDMWSVGCIFAELFRRRPLFRGTSEADQ--LDKIFDVIGLPSEEEW 230 (287)
T ss_pred eeccCCc--ccccccccccccChHHhccCCCCCcchhhhHHHHHHHHHhCCCcccCCChHHH--HHHHHHHcCCCChHhc
Confidence 7753221 12234578899999999998999999999999999999999999975443211 111111110000000
Q ss_pred --------cccccccc---CCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 002673 837 --------QVFDPILR---GKGFDEEMLQVLDVACMCVSQNPFKRPTVKEVVE 878 (894)
Q Consensus 837 --------~~~d~~l~---~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~ 878 (894)
..+..... ....+.....+.+++.+||+.||.+||++.++++
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~il~ 283 (287)
T cd07838 231 PRNVSLPRSSFPSYTPRSFKSFVPEICEEGLDLLKKMLTFNPHKRISAFEALQ 283 (287)
T ss_pred CCCcccchhhcccccccchhhhhhhhhHHHHHHHHHHhccCCccCCCHHHHhc
Confidence 00000000 0011122346779999999999999999999985
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both |
| >cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.1e-31 Score=298.86 Aligned_cols=275 Identities=22% Similarity=0.252 Sum_probs=202.9
Q ss_pred CHHHHHHhccCCCccceEeecCcEEEEEEE-EcCCCeEEEEEEcCcch--hhHHHHHHHHHHHHhcCCCceeeecceeee
Q 002673 598 TIYELLKATDNFSQANIIGCGGFGLVYKAT-LANGTTLAIKKLSGDLG--LMEREFKAEVEALSTAQHKNLVSLQGYCVH 674 (894)
Q Consensus 598 ~~~el~~a~~~f~~~~~LG~G~fg~Vy~a~-~~~g~~vAvK~~~~~~~--~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~ 674 (894)
...++...+++|+..+.||+|+||.||+|. ..+++.||+|++..... .....+.+|+.++++++||||+++++++..
T Consensus 8 ~~~~~~~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~iv~~~~~~~~ 87 (345)
T cd07877 8 LNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTP 87 (345)
T ss_pred HHHHHhhccCceEEEEEeeecCCeEEEEEEEcCCCeEEEEEEecCcchhhHHHHHHHHHHHHHHHcCCCcccceeeeeee
Confidence 345667788999999999999999999997 45789999999975432 224567889999999999999999998764
Q ss_pred c------ceEEEEEEeccCCCHHHHHhhhcCCCCCcCHHHHHHHHHHHHHHHHHHHhccCCCeeecCCCCCCeEECCCCc
Q 002673 675 Q------GFRLLIYSYMENGSLDYWLHEKADGASQLDWLTRLKIARGTSCGLAYMHQICEPHIVHRDIKSSNILLDDQFE 748 (894)
Q Consensus 675 ~------~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDLkp~NILld~~~~ 748 (894)
. ...+++++++ +++|.+++.. ..+++..+..++.|+++||.|||+ ++|+||||||+||++++++.
T Consensus 88 ~~~~~~~~~~~lv~~~~-~~~L~~~~~~-----~~l~~~~~~~i~~qi~~aL~~LH~---~~ivH~dlkp~NIll~~~~~ 158 (345)
T cd07877 88 ARSLEEFNDVYLVTHLM-GADLNNIVKC-----QKLTDDHVQFLIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCE 158 (345)
T ss_pred cccccccccEEEEehhc-ccCHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHH---CCeeecCCChHHEEEcCCCC
Confidence 3 3467888877 7899888763 248899999999999999999997 59999999999999999999
Q ss_pred EEEEEcccccccCCCCCcccccccccCCccCcccccC-cCCCccccHHHHHHHHHHHHcCCCCCCCCCcchhh-hHHHHH
Q 002673 749 AHLADFGLSRLILPYQTHVTTELVGTLGYIPPEYGQA-WVATLRGDMYSFGVVMLELLTGKRPVDVLKPKMSR-ELVGWV 826 (894)
Q Consensus 749 vkl~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~~~~-~~~s~ksDVwS~GvlL~elltG~~Pf~~~~~~~~~-~~~~~~ 826 (894)
+||+|||++..... ......++..|+|||...+ ..++.++|||||||++|||++|+.||......... .+....
T Consensus 159 ~kl~dfg~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~ 234 (345)
T cd07877 159 LKILDFGLARHTDD----EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLV 234 (345)
T ss_pred EEEecccccccccc----cccccccCCCccCHHHHhCccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHh
Confidence 99999999876422 2233567889999998766 46788999999999999999999999644321110 110000
Q ss_pred H----HHh---hcC-------CCCccccccccCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHH--HHHhcccc
Q 002673 827 L----KMR---SEG-------KQDQVFDPILRGKGFDEEMLQVLDVACMCVSQNPFKRPTVKEVVE--WLNNVGAN 886 (894)
Q Consensus 827 ~----~~~---~~~-------~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~--~L~~i~~~ 886 (894)
. ... ... ........... .........+.+++.+|++.||.+||++.++++ ++.+....
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h~~f~~~~~~ 309 (345)
T cd07877 235 GTPGAELLKKISSESARNYIQSLTQMPKMNFA-NVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDP 309 (345)
T ss_pred CCCCHHHHhhcccHhHHHHHHHhcccCCcchh-hhcCCCCHHHHHHHHHHcCCChhhcCCHHHHhcChhhhhcCCC
Confidence 0 000 000 00000000000 000011235679999999999999999999998 77766543
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14 |
| >cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.7e-31 Score=281.92 Aligned_cols=239 Identities=25% Similarity=0.308 Sum_probs=183.5
Q ss_pred ceEeecCcEEEEEEEE-cCCCeEEEEEEcCcch---hhHHHHHHHHHHH-HhcCCCceeeecceeeecceEEEEEEeccC
Q 002673 613 NIIGCGGFGLVYKATL-ANGTTLAIKKLSGDLG---LMEREFKAEVEAL-STAQHKNLVSLQGYCVHQGFRLLIYSYMEN 687 (894)
Q Consensus 613 ~~LG~G~fg~Vy~a~~-~~g~~vAvK~~~~~~~---~~~~~~~~Ei~~l-~~l~HpnIv~l~g~~~~~~~~~lV~E~~~~ 687 (894)
+.||+|+||.||+|.. .+|+.||+|.+..... .....+..|..++ ...+|+|++++++++..++..++|+||+++
T Consensus 2 ~~l~~g~~~~v~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 81 (260)
T cd05611 2 KPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSFQSKDYLYLVMEYLNG 81 (260)
T ss_pred ccCCcCCCeeEEEEEecCCCCeEEEEEecchhhhHHHHHHHHHHHHHHHhhcCCCCCeeeeeeeEEcCCeEEEEEeccCC
Confidence 4689999999999985 5689999999875422 1123344454444 455899999999999999999999999999
Q ss_pred CCHHHHHhhhcCCCCCcCHHHHHHHHHHHHHHHHHHHhccCCCeeecCCCCCCeEECCCCcEEEEEcccccccCCCCCcc
Q 002673 688 GSLDYWLHEKADGASQLDWLTRLKIARGTSCGLAYMHQICEPHIVHRDIKSSNILLDDQFEAHLADFGLSRLILPYQTHV 767 (894)
Q Consensus 688 gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDLkp~NILld~~~~vkl~DFGla~~~~~~~~~~ 767 (894)
++|.+++... ..+++..+..++.|++.||.|||+ .+++||||+|+||++++++.+||+|||++.....
T Consensus 82 ~~L~~~l~~~----~~~~~~~~~~i~~qi~~aL~~lH~---~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~----- 149 (260)
T cd05611 82 GDCASLIKTL----GGLPEDWAKQYIAEVVLGVEDLHQ---RGIIHRDIKPENLLIDQTGHLKLTDFGLSRNGLE----- 149 (260)
T ss_pred CCHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHeEECCCCcEEEeecccceeccc-----
Confidence 9999999754 357888899999999999999997 5999999999999999999999999999875422
Q ss_pred cccccccCCccCcccccCcCCCccccHHHHHHHHHHHHcCCCCCCCCCcchhhhHHHHHHHHhhcCCCCccccccccCCC
Q 002673 768 TTELVGTLGYIPPEYGQAWVATLRGDMYSFGVVMLELLTGKRPVDVLKPKMSRELVGWVLKMRSEGKQDQVFDPILRGKG 847 (894)
Q Consensus 768 ~~~~~gt~~Y~APE~~~~~~~s~ksDVwS~GvlL~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~ 847 (894)
.....++..|+|||...+..++.++||||||+++|+|++|..||....... ... ... ..... .....
T Consensus 150 ~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~---~~~---~~~-~~~~~--~~~~~---- 216 (260)
T cd05611 150 NKKFVGTPDYLAPETILGVGDDKMSDWWSLGCVIFEFLFGYPPFHAETPDA---VFD---NIL-SRRIN--WPEEV---- 216 (260)
T ss_pred cccCCCCcCccChhhhcCCCCcchhhhHHHHHHHHHHHHCCCCCCCCCHHH---HHH---HHH-hcccC--CCCcc----
Confidence 223467889999999988888999999999999999999999997543221 111 110 11100 00000
Q ss_pred ChHHHHHHHHHHHHhcccCCCCCCCHHHH
Q 002673 848 FDEEMLQVLDVACMCVSQNPFKRPTVKEV 876 (894)
Q Consensus 848 ~~~~~~~l~~li~~Cl~~dP~~RPs~~ev 876 (894)
.......+.+++.+|++.+|++||++.++
T Consensus 217 ~~~~~~~~~~~i~~~l~~~p~~R~~~~~~ 245 (260)
T cd05611 217 KEFCSPEAVDLINRLLCMDPAKRLGANGY 245 (260)
T ss_pred cccCCHHHHHHHHHHccCCHHHccCCCcH
Confidence 01123457789999999999999966433
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do |
| >KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=3e-32 Score=274.60 Aligned_cols=249 Identities=22% Similarity=0.364 Sum_probs=193.9
Q ss_pred CCccceEeecCcEEEEEEEE-cCCCeEEEEEEcCcch-hhHHHHHHHHHHHHhcC-CCceeeecceeeecceEEEEEEec
Q 002673 609 FSQANIIGCGGFGLVYKATL-ANGTTLAIKKLSGDLG-LMEREFKAEVEALSTAQ-HKNLVSLQGYCVHQGFRLLIYSYM 685 (894)
Q Consensus 609 f~~~~~LG~G~fg~Vy~a~~-~~g~~vAvK~~~~~~~-~~~~~~~~Ei~~l~~l~-HpnIv~l~g~~~~~~~~~lV~E~~ 685 (894)
.+....||.|..|.|++++. .+|..+|||.+..... ...+.+...+.++..-+ +|.||+.+|||..+...++.||.|
T Consensus 94 l~~l~dlGsGtcG~V~k~~~rs~~~iiAVK~M~rt~Nkee~kRILmDldvv~~s~dcpyIV~c~GyFi~n~dV~IcMelM 173 (391)
T KOG0983|consen 94 LENLGDLGSGTCGQVWKMRFRSTGHIIAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVQCFGYFITNTDVFICMELM 173 (391)
T ss_pred hhhHHhhcCCCccceEEEEEcccceEEEEEeecccCCHHHHHHHHHhhhHHhhccCCCeeeeeeeEEeeCchHHHHHHHH
Confidence 34456799999999999984 5689999999987543 33466788888877775 899999999999999999999998
Q ss_pred cCCCHHHHHhhhcCCCCCcCHHHHHHHHHHHHHHHHHHHhccCCCeeecCCCCCCeEECCCCcEEEEEcccccccCCCCC
Q 002673 686 ENGSLDYWLHEKADGASQLDWLTRLKIARGTSCGLAYMHQICEPHIVHRDIKSSNILLDDQFEAHLADFGLSRLILPYQT 765 (894)
Q Consensus 686 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDLkp~NILld~~~~vkl~DFGla~~~~~~~~ 765 (894)
. ..++.++..-. ..+++.-+-++...+.+||.||.+ +++|+|||+||+|||+|+.|++|+||||++.++.++.
T Consensus 174 s-~C~ekLlkrik---~piPE~ilGk~tva~v~AL~YLKe--KH~viHRDvKPSNILlDe~GniKlCDFGIsGrlvdSk- 246 (391)
T KOG0983|consen 174 S-TCAEKLLKRIK---GPIPERILGKMTVAIVKALYYLKE--KHGVIHRDVKPSNILLDERGNIKLCDFGISGRLVDSK- 246 (391)
T ss_pred H-HHHHHHHHHhc---CCchHHhhhhhHHHHHHHHHHHHH--hcceeecccCccceEEccCCCEEeecccccceeeccc-
Confidence 4 34555555432 357777788899999999999997 5799999999999999999999999999999875433
Q ss_pred cccccccccCCccCcccccC---cCCCccccHHHHHHHHHHHHcCCCCCCCCCcchhhhHHHHHHHHhhcCCCCcccccc
Q 002673 766 HVTTELVGTLGYIPPEYGQA---WVATLRGDMYSFGVVMLELLTGKRPVDVLKPKMSRELVGWVLKMRSEGKQDQVFDPI 842 (894)
Q Consensus 766 ~~~~~~~gt~~Y~APE~~~~---~~~s~ksDVwS~GvlL~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 842 (894)
..+...|.+.|||||.+.- ..|+.++||||||+.++||.||..||.....+.. .+..+ .... .|.
T Consensus 247 -AhtrsAGC~~YMaPERidp~~~~kYDiRaDVWSlGITlveLaTg~yPy~~c~tdFe--~ltkv---ln~e------PP~ 314 (391)
T KOG0983|consen 247 -AHTRSAGCAAYMAPERIDPPDKPKYDIRADVWSLGITLVELATGQYPYKGCKTDFE--VLTKV---LNEE------PPL 314 (391)
T ss_pred -ccccccCCccccCccccCCCCCCccchhhhhhhhccchhhhhcccCCCCCCCccHH--HHHHH---HhcC------CCC
Confidence 3455679999999998764 4789999999999999999999999987554321 11111 1111 122
Q ss_pred ccCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 002673 843 LRGKGFDEEMLQVLDVACMCVSQNPFKRPTVKEVVE 878 (894)
Q Consensus 843 l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~ 878 (894)
+++.. .-..++.+++..|+..|+.+||...++++
T Consensus 315 L~~~~--gFSp~F~~fv~~CL~kd~r~RP~Y~~Ll~ 348 (391)
T KOG0983|consen 315 LPGHM--GFSPDFQSFVKDCLTKDHRKRPKYNKLLE 348 (391)
T ss_pred CCccc--CcCHHHHHHHHHHhhcCcccCcchHHHhc
Confidence 32211 02345678888999999999999998875
|
|
| >cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.5e-31 Score=286.76 Aligned_cols=262 Identities=24% Similarity=0.301 Sum_probs=195.8
Q ss_pred CCccceEeecCcEEEEEEEEc-CCCeEEEEEEcCcch-hhHHHHHHHHHHHHhcC-CCceeeecceeeecceEEEEEEec
Q 002673 609 FSQANIIGCGGFGLVYKATLA-NGTTLAIKKLSGDLG-LMEREFKAEVEALSTAQ-HKNLVSLQGYCVHQGFRLLIYSYM 685 (894)
Q Consensus 609 f~~~~~LG~G~fg~Vy~a~~~-~g~~vAvK~~~~~~~-~~~~~~~~Ei~~l~~l~-HpnIv~l~g~~~~~~~~~lV~E~~ 685 (894)
|++.+.||+|+||.||+|... +++.|+||++..... .......+|+..+++++ |+|++++++++..++..++||||+
T Consensus 1 y~~~~~ig~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e~~ 80 (283)
T cd07830 1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNEHPNIVKLKEVFRENDELYFVFEYM 80 (283)
T ss_pred CeeheeeccCCceEEEEEEECCCCcEEEEEEehhhccchhHHHHHHHHHHHHhccCCCCchhHHHHhhcCCcEEEEEecC
Confidence 566789999999999999964 578899999875433 22334567999999999 999999999999999999999999
Q ss_pred cCCCHHHHHhhhcCCCCCcCHHHHHHHHHHHHHHHHHHHhccCCCeeecCCCCCCeEECCCCcEEEEEcccccccCCCCC
Q 002673 686 ENGSLDYWLHEKADGASQLDWLTRLKIARGTSCGLAYMHQICEPHIVHRDIKSSNILLDDQFEAHLADFGLSRLILPYQT 765 (894)
Q Consensus 686 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDLkp~NILld~~~~vkl~DFGla~~~~~~~~ 765 (894)
+|+|.+++.... ...+++..+..++.|++.+|.|||+ ++++|+||+|+||+++.++.++|+|||++.......
T Consensus 81 -~~~l~~~~~~~~--~~~~~~~~~~~~~~~l~~~l~~Lh~---~~i~H~dl~~~ni~i~~~~~~~l~d~~~~~~~~~~~- 153 (283)
T cd07830 81 -EGNLYQLMKDRK--GKPFSESVIRSIIYQILQGLAHIHK---HGFFHRDLKPENLLVSGPEVVKIADFGLAREIRSRP- 153 (283)
T ss_pred -CCCHHHHHHhcc--cccCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCChhhEEEcCCCCEEEeecccceeccCCC-
Confidence 889998887643 2468999999999999999999997 599999999999999999999999999998653322
Q ss_pred cccccccccCCccCccccc-CcCCCccccHHHHHHHHHHHHcCCCCCCCCCcchhh-hHHH---------HHHHHhhcCC
Q 002673 766 HVTTELVGTLGYIPPEYGQ-AWVATLRGDMYSFGVVMLELLTGKRPVDVLKPKMSR-ELVG---------WVLKMRSEGK 834 (894)
Q Consensus 766 ~~~~~~~gt~~Y~APE~~~-~~~~s~ksDVwS~GvlL~elltG~~Pf~~~~~~~~~-~~~~---------~~~~~~~~~~ 834 (894)
......++..|+|||++. +..++.++|+||||+++|||++|+.||......... .... |.........
T Consensus 154 -~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~s~G~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (283)
T cd07830 154 -PYTDYVSTRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLRPLFPGSSEIDQLYKICSVLGTPTKQDWPEGYKLASK 232 (283)
T ss_pred -CcCCCCCcccccCceeeecCcCcCCccchhhHHHHHHHHHhCCCccCCCChHHHHHHHHHhcCCCChhhhhhHhhhhcc
Confidence 123356788999999774 456789999999999999999999999654321111 0000 0000000000
Q ss_pred CCcccccccc---CCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 002673 835 QDQVFDPILR---GKGFDEEMLQVLDVACMCVSQNPFKRPTVKEVVE 878 (894)
Q Consensus 835 ~~~~~d~~l~---~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~ 878 (894)
....+..... ..........+.+++.+|++.+|++|||++|++.
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~ 279 (283)
T cd07830 233 LGFRFPQFAPTSLHQLIPNASPEAIDLIKDMLRWDPKKRPTASQALQ 279 (283)
T ss_pred ccccccccccccHHHHcccCCHHHHHHHHHhcccCcccCCCHHHHhh
Confidence 0000000000 0001112346889999999999999999999976
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili |
| >KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.3e-31 Score=315.04 Aligned_cols=260 Identities=29% Similarity=0.468 Sum_probs=206.5
Q ss_pred ccCCCccceEeecCcEEEEEEEEc----C----CCeEEEEEEcCcch-hhHHHHHHHHHHHHhc-CCCceeeecceeeec
Q 002673 606 TDNFSQANIIGCGGFGLVYKATLA----N----GTTLAIKKLSGDLG-LMEREFKAEVEALSTA-QHKNLVSLQGYCVHQ 675 (894)
Q Consensus 606 ~~~f~~~~~LG~G~fg~Vy~a~~~----~----g~~vAvK~~~~~~~-~~~~~~~~Ei~~l~~l-~HpnIv~l~g~~~~~ 675 (894)
.++..+.+.||+|.||.|++|... . ...||||.++.... ...+.+..|+++|+.+ +|+||+.++|+|..+
T Consensus 295 ~~~l~~~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~~~~~~~~~~~El~~m~~~g~H~niv~llG~~t~~ 374 (609)
T KOG0200|consen 295 RENLKLGKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENASSSEKKDLMSELNVLKELGKHPNIVNLLGACTQD 374 (609)
T ss_pred hhhccccceeecccccceEeEEEeecccccccceEEEEEEecccccCcHHHHHHHHHHHHHHHhcCCcchhhheeeeccC
Confidence 344456679999999999999742 1 45799999986543 3457899999999999 699999999999999
Q ss_pred ceEEEEEEeccCCCHHHHHhhhc-----CC-----C--CCcCHHHHHHHHHHHHHHHHHHHhccCCCeeecCCCCCCeEE
Q 002673 676 GFRLLIYSYMENGSLDYWLHEKA-----DG-----A--SQLDWLTRLKIARGTSCGLAYMHQICEPHIVHRDIKSSNILL 743 (894)
Q Consensus 676 ~~~~lV~E~~~~gsL~~~l~~~~-----~~-----~--~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDLkp~NILl 743 (894)
+..++|+||+..|+|.++++... .. . ..++..+.+.++.|||.|++||++ .++|||||.++|||+
T Consensus 375 ~~~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~~---~~~vHRDLAaRNVLi 451 (609)
T KOG0200|consen 375 GPLYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLAS---VPCVHRDLAARNVLI 451 (609)
T ss_pred CceEEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHhh---CCccchhhhhhhEEe
Confidence 99999999999999999998765 00 1 238889999999999999999997 589999999999999
Q ss_pred CCCCcEEEEEcccccccCCCCCcccccccc--cCCccCcccccCcCCCccccHHHHHHHHHHHHc-CCCCCCCCCcchhh
Q 002673 744 DDQFEAHLADFGLSRLILPYQTHVTTELVG--TLGYIPPEYGQAWVATLRGDMYSFGVVMLELLT-GKRPVDVLKPKMSR 820 (894)
Q Consensus 744 d~~~~vkl~DFGla~~~~~~~~~~~~~~~g--t~~Y~APE~~~~~~~s~ksDVwS~GvlL~ellt-G~~Pf~~~~~~~~~ 820 (894)
+.+..+||+|||+++...+..........+ ...|||||.+....|+.|+|||||||+||||+| |..||.+... ..
T Consensus 452 ~~~~~~kIaDFGlar~~~~~~~y~~~~~~~~LP~kWmApEsl~~~~ft~kSDVWSfGI~L~EifsLG~~PYp~~~~--~~ 529 (609)
T KOG0200|consen 452 TKNKVIKIADFGLARDHYNKDYYRTKSSAGTLPVKWMAPESLFDRVFTSKSDVWSFGILLWEIFTLGGTPYPGIPP--TE 529 (609)
T ss_pred cCCCEEEEccccceeccCCCCceEecCCCCccceeecCHHHhccCcccccchhhHHHHHHHHHhhCCCCCCCCCCc--HH
Confidence 999999999999999765544433232232 346999999999999999999999999999999 9999975321 12
Q ss_pred hHHHHHHHHhhcCCCCccccccccCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhc
Q 002673 821 ELVGWVLKMRSEGKQDQVFDPILRGKGFDEEMLQVLDVACMCVSQNPFKRPTVKEVVEWLNNV 883 (894)
Q Consensus 821 ~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~i 883 (894)
++.++ .+.+...+. ...+ ..++++++..||+.+|++||++.++.+.|+..
T Consensus 530 ~l~~~----l~~G~r~~~------P~~c---~~eiY~iM~~CW~~~p~~RP~F~~~~~~~~~~ 579 (609)
T KOG0200|consen 530 ELLEF----LKEGNRMEQ------PEHC---SDEIYDLMKSCWNADPEDRPTFSECVEFFEKH 579 (609)
T ss_pred HHHHH----HhcCCCCCC------CCCC---CHHHHHHHHHHhCCCcccCCCHHHHHHHHHHH
Confidence 23322 223322111 1222 33567899999999999999999999988773
|
|
| >KOG0586 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.7e-31 Score=297.60 Aligned_cols=244 Identities=26% Similarity=0.349 Sum_probs=201.8
Q ss_pred cCCCccceEeecCcEEEEEEE-EcCCCeEEEEEEcCcch--hhHHHHHHHHHHHHhcCCCceeeecceeeecceEEEEEE
Q 002673 607 DNFSQANIIGCGGFGLVYKAT-LANGTTLAIKKLSGDLG--LMEREFKAEVEALSTAQHKNLVSLQGYCVHQGFRLLIYS 683 (894)
Q Consensus 607 ~~f~~~~~LG~G~fg~Vy~a~-~~~g~~vAvK~~~~~~~--~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~lV~E 683 (894)
..|.+...||+|.|+.|..|+ ..++..||||.+.+... ...+.+.+|+++|+.++|||||+++++.......|+|||
T Consensus 56 g~y~i~~tig~g~f~~V~La~~~~t~~~VaiK~idkt~ln~~~~~k~~rev~imk~l~HPnIvkl~~v~~t~~~lylV~e 135 (596)
T KOG0586|consen 56 GLYVIIKTIGKGNFAKVKLARHILTGTEVAIKIIDKTQLNPSKRQKLGREVDIMKSLNHPNIVKLFSVIETEATLYLVME 135 (596)
T ss_pred cceeeeeeeccceeEEEEeeEecCCCceEEEEEehhcccChHHHHHHHHHHHHHHhcCCcceeeeeeeeeecceeEEEEE
Confidence 467788999999999999998 55799999999987542 223458899999999999999999999999999999999
Q ss_pred eccCCCHHHHHhhhcCCCCCcCHHHHHHHHHHHHHHHHHHHhccCCCeeecCCCCCCeEECCCCcEEEEEcccccccCCC
Q 002673 684 YMENGSLDYWLHEKADGASQLDWLTRLKIARGTSCGLAYMHQICEPHIVHRDIKSSNILLDDQFEAHLADFGLSRLILPY 763 (894)
Q Consensus 684 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDLkp~NILld~~~~vkl~DFGla~~~~~~ 763 (894)
|..+|.+.+++.... ......+..++.|+.+|++|||+ +.|+|||||++||||+.+.++||+|||++..+.
T Consensus 136 ya~~ge~~~yl~~~g----r~~e~~ar~~F~q~vsaveYcH~---k~ivHrdLk~eNilL~~~mnikIaDfgfS~~~~-- 206 (596)
T KOG0586|consen 136 YASGGELFDYLVKHG----RMKEKEARAKFRQIVSAVEYCHS---KNIVHRDLKAENILLDENMNIKIADFGFSTFFD-- 206 (596)
T ss_pred eccCchhHHHHHhcc----cchhhhhhhhhHHHHHHHHHHhh---cceeccccchhhcccccccceeeeccccceeec--
Confidence 999999999998753 34447788999999999999997 699999999999999999999999999999875
Q ss_pred CCcccccccccCCccCcccccCcCC-CccccHHHHHHHHHHHHcCCCCCCCCCcchhhhHHHHHHHHhhcCCCCcccccc
Q 002673 764 QTHVTTELVGTLGYIPPEYGQAWVA-TLRGDMYSFGVVMLELLTGKRPVDVLKPKMSRELVGWVLKMRSEGKQDQVFDPI 842 (894)
Q Consensus 764 ~~~~~~~~~gt~~Y~APE~~~~~~~-s~ksDVwS~GvlL~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 842 (894)
........+|++.|.|||+..+..| .+.+|+||+|+++|-|+.|..||++..-. +.-++.
T Consensus 207 ~~~~lqt~cgsppyAaPEl~~g~~y~gpe~D~Wslgvvly~LV~GsLPFDG~~lk-------------------~Lr~rv 267 (596)
T KOG0586|consen 207 YGLMLQTFCGSPPYAAPELFNGKKYDGPEVDIWSLGVVLYALVEGSLPFDGQNLK-------------------ELRPRV 267 (596)
T ss_pred ccccccccCCCCCccChHhhcCcccCCcceehhhhhhhheeeeecccccCCcccc-------------------cccchh
Confidence 2334566799999999999999876 67899999999999999999999853221 111111
Q ss_pred ccCCCC--hHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 002673 843 LRGKGF--DEEMLQVLDVACMCVSQNPFKRPTVKEVVE 878 (894)
Q Consensus 843 l~~~~~--~~~~~~l~~li~~Cl~~dP~~RPs~~evl~ 878 (894)
+.+.+- .-...++-+++++++-.+|.+|++++++..
T Consensus 268 l~gk~rIp~~ms~dce~lLrk~lvl~Pskr~~~dqim~ 305 (596)
T KOG0586|consen 268 LRGKYRIPFYMSCDCEDLLRKFLVLNPSKRGPCDQIMK 305 (596)
T ss_pred eeeeecccceeechhHHHHHHhhccCccccCCHHHhhh
Confidence 111110 011235668899999999999999999987
|
|
| >KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1e-31 Score=302.80 Aligned_cols=269 Identities=24% Similarity=0.323 Sum_probs=201.9
Q ss_pred CCccceEeecCcEEEEEEE-EcCCCeEEEEEEcCcch-hhHHHHHHHHHHHHhcCCCceeeecceeeec------ceEEE
Q 002673 609 FSQANIIGCGGFGLVYKAT-LANGTTLAIKKLSGDLG-LMEREFKAEVEALSTAQHKNLVSLQGYCVHQ------GFRLL 680 (894)
Q Consensus 609 f~~~~~LG~G~fg~Vy~a~-~~~g~~vAvK~~~~~~~-~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~------~~~~l 680 (894)
|...+.||+|+||.||+|+ ..+|+.||||.++.... ...+...+|+++|++++|+|||+++++=.+. ....+
T Consensus 15 W~~~e~LG~Ga~g~V~rgrnketG~~vAvK~~~~~~~~r~~e~~~~EieilkKLnh~NIVk~f~iee~~~~~~~~~~~vl 94 (732)
T KOG4250|consen 15 WEMDERLGKGAFGNVYRGRNKETGRLVAVKTFNKESSLRPRERWCREIEILKKLNHPNIVKLFDIEETKFLGLVTRLPVL 94 (732)
T ss_pred eeehhhhcCCccceeeeecccccccchhHHhhhhhcccchHHHHHHHHHHHHHcCchhhhhhcccCCccccCcccccceE
Confidence 4456789999999999999 66899999999987542 2345678999999999999999999876543 35689
Q ss_pred EEEeccCCCHHHHHhhhcCCCCCcCHHHHHHHHHHHHHHHHHHHhccCCCeeecCCCCCCeEEC--CCC--cEEEEEccc
Q 002673 681 IYSYMENGSLDYWLHEKADGASQLDWLTRLKIARGTSCGLAYMHQICEPHIVHRDIKSSNILLD--DQF--EAHLADFGL 756 (894)
Q Consensus 681 V~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDLkp~NILld--~~~--~vkl~DFGl 756 (894)
|||||.+|||...+.+- .+...++....+.+..+++.||.|||+ ++|+||||||.||++- .+| .-||+|||.
T Consensus 95 vmEyC~gGsL~~~L~~P-EN~~GLpE~e~l~lL~d~~~al~~LrE---n~IvHRDlKP~NIvl~~Gedgq~IyKLtDfG~ 170 (732)
T KOG4250|consen 95 VMEYCSGGSLRKVLNSP-ENAYGLPESEFLDLLSDLVSALRHLRE---NGIVHRDLKPGNIVLQIGEDGQSIYKLTDFGA 170 (732)
T ss_pred EEeecCCCcHHHHhcCc-ccccCCCHHHHHHHHHHHHHHHHHHHH---cCceeccCCCCcEEEeecCCCceEEeeecccc
Confidence 99999999999999863 455679999999999999999999996 6999999999999983 333 489999999
Q ss_pred ccccCCCCCcccccccccCCccCcccccC-cCCCccccHHHHHHHHHHHHcCCCCCCCCCcchhhhHHHHHHHHhhcCCC
Q 002673 757 SRLILPYQTHVTTELVGTLGYIPPEYGQA-WVATLRGDMYSFGVVMLELLTGKRPVDVLKPKMSRELVGWVLKMRSEGKQ 835 (894)
Q Consensus 757 a~~~~~~~~~~~~~~~gt~~Y~APE~~~~-~~~s~ksDVwS~GvlL~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~ 835 (894)
|+.+.+. ......+||..|.+||+... +.|+..+|.|||||++|+..||..||...........+.|..........
T Consensus 171 Arel~d~--s~~~S~vGT~~YLhPel~E~q~~y~~tVDLWS~GvtlY~caTG~lPF~p~~~pk~~~~~~~~~~tkkp~~v 248 (732)
T KOG4250|consen 171 ARELDDN--SLFTSLVGTEEYLHPELYERQKKYTATVDLWSFGVTLYECATGELPFIPFGGPKNNKEIMWHIITKKPSGV 248 (732)
T ss_pred cccCCCC--CeeeeecCchhhcChHHHhhccCcCceeehhhhhhHHHHHhccCCCCCcCCCccccchhhhhhhccCCCce
Confidence 9987543 35677899999999999984 88999999999999999999999999755443222223333332222211
Q ss_pred Ccccc-----cc-----c--cCCCChHHHHHHHHHHHHhcccCCCCCC--CHHHHHHHHHhc
Q 002673 836 DQVFD-----PI-----L--RGKGFDEEMLQVLDVACMCVSQNPFKRP--TVKEVVEWLNNV 883 (894)
Q Consensus 836 ~~~~d-----~~-----l--~~~~~~~~~~~l~~li~~Cl~~dP~~RP--s~~evl~~L~~i 883 (894)
..... |. + .....+.....+-..+..++..+|.+|- .+.+....+..|
T Consensus 249 ~i~~~~~eNgpv~~s~~lP~p~~Ls~~l~~~~~kwLa~~L~~~~~~~~~~~~~~~Fa~~~dI 310 (732)
T KOG4250|consen 249 AIGAQEEENGPVEWSSTLPQPNHLSRGLATRLTKWLASMLEWNPRKRGHEGFDRFFAEVDDI 310 (732)
T ss_pred eEeeecccCCceeeeccCCCcccccHHHHhhhhHHHHHHHhhhHHHhCCCCcchHHHHHHHH
Confidence 11111 11 0 0111222333556777788888999988 655555544433
|
|
| >cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.7e-31 Score=295.77 Aligned_cols=269 Identities=24% Similarity=0.342 Sum_probs=199.8
Q ss_pred HHhccCCCccceEeecCcEEEEEEE-EcCCCeEEEEEEcCcc--hhhHHHHHHHHHHHHhcCCCceeeecceeee-cceE
Q 002673 603 LKATDNFSQANIIGCGGFGLVYKAT-LANGTTLAIKKLSGDL--GLMEREFKAEVEALSTAQHKNLVSLQGYCVH-QGFR 678 (894)
Q Consensus 603 ~~a~~~f~~~~~LG~G~fg~Vy~a~-~~~g~~vAvK~~~~~~--~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~-~~~~ 678 (894)
...+++|+..+.||+|+||.||+|. ..++..||+|++.... ....+.+..|+.+++.++||||+++++++.. ....
T Consensus 6 ~~~~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~ 85 (328)
T cd07856 6 FEITNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRHENIISLSDIFISPLEDI 85 (328)
T ss_pred eccccceEEEEeecccCCeEEEEEEECCCCCEEEEEEecccccccchhHHHHHHHHHHHhcCCCCeeeEeeeEecCCCcE
Confidence 4467889999999999999999998 4578999999886432 2234667889999999999999999998865 5578
Q ss_pred EEEEEeccCCCHHHHHhhhcCCCCCcCHHHHHHHHHHHHHHHHHHHhccCCCeeecCCCCCCeEECCCCcEEEEEccccc
Q 002673 679 LLIYSYMENGSLDYWLHEKADGASQLDWLTRLKIARGTSCGLAYMHQICEPHIVHRDIKSSNILLDDQFEAHLADFGLSR 758 (894)
Q Consensus 679 ~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDLkp~NILld~~~~vkl~DFGla~ 758 (894)
++|+||+ +++|.+++.. ..+++.....++.|+++||.|||+ ++++||||+|+||++++++.+||+|||++.
T Consensus 86 ~lv~e~~-~~~L~~~~~~-----~~~~~~~~~~~~~ql~~aL~~LH~---~~iiH~dl~p~Nili~~~~~~~l~dfg~~~ 156 (328)
T cd07856 86 YFVTELL-GTDLHRLLTS-----RPLEKQFIQYFLYQILRGLKYVHS---AGVVHRDLKPSNILINENCDLKICDFGLAR 156 (328)
T ss_pred EEEeehh-ccCHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCCHHHEeECCCCCEEeCcccccc
Confidence 9999998 5689888863 246778888999999999999997 599999999999999999999999999987
Q ss_pred ccCCCCCcccccccccCCccCcccccC-cCCCccccHHHHHHHHHHHHcCCCCCCCCCcchhhhHH-HH--------HHH
Q 002673 759 LILPYQTHVTTELVGTLGYIPPEYGQA-WVATLRGDMYSFGVVMLELLTGKRPVDVLKPKMSRELV-GW--------VLK 828 (894)
Q Consensus 759 ~~~~~~~~~~~~~~gt~~Y~APE~~~~-~~~s~ksDVwS~GvlL~elltG~~Pf~~~~~~~~~~~~-~~--------~~~ 828 (894)
.... ......++..|+|||++.+ ..++.++||||||+++|+|++|+.||............ .. ...
T Consensus 157 ~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (328)
T cd07856 157 IQDP----QMTGYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKDHVNQFSIITDLLGTPPDDVINT 232 (328)
T ss_pred ccCC----CcCCCcccccccCceeeeccCCcCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHh
Confidence 5422 1223457889999998766 56899999999999999999999999754431111110 00 000
Q ss_pred HhhcCCCCcccccc-ccCC-----CChHHHHHHHHHHHHhcccCCCCCCCHHHHHH--HHHhccc
Q 002673 829 MRSEGKQDQVFDPI-LRGK-----GFDEEMLQVLDVACMCVSQNPFKRPTVKEVVE--WLNNVGA 885 (894)
Q Consensus 829 ~~~~~~~~~~~d~~-l~~~-----~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~--~L~~i~~ 885 (894)
..... ..+.+... .... ........+.+++.+|++.+|++|||+.+++. |++..+.
T Consensus 233 ~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~ell~~~~~~~~~~ 296 (328)
T cd07856 233 ICSEN-TLRFVQSLPKREPVPFSEKFKNADPSAIDLLEKMLVFDPQKRISAAEALAHPYLAPYHD 296 (328)
T ss_pred ccchh-hHHHHhhccccCCCcHHHHcCCCCHHHHHHHHHHcCCChhhCCCHHHHhcCCccccccC
Confidence 00000 00000000 0000 00112246778999999999999999999998 6765544
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U |
| >PTZ00024 cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.5e-31 Score=293.41 Aligned_cols=266 Identities=24% Similarity=0.253 Sum_probs=197.0
Q ss_pred cCCC-ccceEeecCcEEEEEEEE-cCCCeEEEEEEcCcchhh--------------HHHHHHHHHHHHhcCCCceeeecc
Q 002673 607 DNFS-QANIIGCGGFGLVYKATL-ANGTTLAIKKLSGDLGLM--------------EREFKAEVEALSTAQHKNLVSLQG 670 (894)
Q Consensus 607 ~~f~-~~~~LG~G~fg~Vy~a~~-~~g~~vAvK~~~~~~~~~--------------~~~~~~Ei~~l~~l~HpnIv~l~g 670 (894)
++|. +.+.||+|+||.||+|.. .+++.||||++....... ...+.+|+++++.++|+||+++++
T Consensus 8 ~ry~~~~~~ig~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~ 87 (335)
T PTZ00024 8 ERYIQKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHENIMGLVD 87 (335)
T ss_pred cchhhhhhcccCCCceeEEEEEECCCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCCCcceeeeeE
Confidence 3454 357799999999999984 478999999986532211 124678999999999999999999
Q ss_pred eeeecceEEEEEEeccCCCHHHHHhhhcCCCCCcCHHHHHHHHHHHHHHHHHHHhccCCCeeecCCCCCCeEECCCCcEE
Q 002673 671 YCVHQGFRLLIYSYMENGSLDYWLHEKADGASQLDWLTRLKIARGTSCGLAYMHQICEPHIVHRDIKSSNILLDDQFEAH 750 (894)
Q Consensus 671 ~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDLkp~NILld~~~~vk 750 (894)
++..++..++||||+. |+|.+++... ..+++.....++.|++.||.|||+ .+++|+||+|+||+++.++.+|
T Consensus 88 ~~~~~~~~~lv~e~~~-~~l~~~l~~~----~~~~~~~~~~~~~ql~~aL~~LH~---~~i~H~dl~~~nill~~~~~~k 159 (335)
T PTZ00024 88 VYVEGDFINLVMDIMA-SDLKKVVDRK----IRLTESQVKCILLQILNGLNVLHK---WYFMHRDLSPANIFINSKGICK 159 (335)
T ss_pred EEecCCcEEEEEeccc-cCHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHh---CCeecccccHHHeEECCCCCEE
Confidence 9999999999999996 6898888643 358889999999999999999997 5999999999999999999999
Q ss_pred EEEcccccccCCCC-------------CcccccccccCCccCcccccCc-CCCccccHHHHHHHHHHHHcCCCCCCCCCc
Q 002673 751 LADFGLSRLILPYQ-------------THVTTELVGTLGYIPPEYGQAW-VATLRGDMYSFGVVMLELLTGKRPVDVLKP 816 (894)
Q Consensus 751 l~DFGla~~~~~~~-------------~~~~~~~~gt~~Y~APE~~~~~-~~s~ksDVwS~GvlL~elltG~~Pf~~~~~ 816 (894)
|+|||++....... ........++..|+|||++.+. .++.++|||||||++|||++|+.||.....
T Consensus 160 l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~ 239 (335)
T PTZ00024 160 IADFGLARRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFPGENE 239 (335)
T ss_pred ECCccceeecccccccccccccccccccccccccccccCCCCChhcccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCH
Confidence 99999998654110 1111223467899999988764 468999999999999999999999975543
Q ss_pred chhhhHHHHHHHHhhcCC---CCcc------------ccccccCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHH--H
Q 002673 817 KMSRELVGWVLKMRSEGK---QDQV------------FDPILRGKGFDEEMLQVLDVACMCVSQNPFKRPTVKEVVE--W 879 (894)
Q Consensus 817 ~~~~~~~~~~~~~~~~~~---~~~~------------~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~--~ 879 (894)
.. ............. +... ..+... .........+.+++.+|++.+|++|||+++++. |
T Consensus 240 ~~---~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~~~~ 315 (335)
T PTZ00024 240 ID---QLGRIFELLGTPNEDNWPQAKKLPLYTEFTPRKPKDLK-TIFPNASDDAIDLLQSLLKLNPLERISAKEALKHEY 315 (335)
T ss_pred HH---HHHHHHHHhCCCchhhCcchhhcccccccCcCCcccHH-HhCcCCChHHHHHHHHHcCCCchhccCHHHHhcCcc
Confidence 21 1111111111000 0000 000000 001112345779999999999999999999998 6
Q ss_pred HHhcc
Q 002673 880 LNNVG 884 (894)
Q Consensus 880 L~~i~ 884 (894)
++.-.
T Consensus 316 ~~~~~ 320 (335)
T PTZ00024 316 FKSDP 320 (335)
T ss_pred cCCCC
Confidence 65443
|
|
| >cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.9e-31 Score=284.31 Aligned_cols=248 Identities=26% Similarity=0.345 Sum_probs=199.6
Q ss_pred cCCCccceEeecCcEEEEEEEE-cCCCeEEEEEEcCcc---hhhHHHHHHHHHHHHhcC-CCceeeecceeeecceEEEE
Q 002673 607 DNFSQANIIGCGGFGLVYKATL-ANGTTLAIKKLSGDL---GLMEREFKAEVEALSTAQ-HKNLVSLQGYCVHQGFRLLI 681 (894)
Q Consensus 607 ~~f~~~~~LG~G~fg~Vy~a~~-~~g~~vAvK~~~~~~---~~~~~~~~~Ei~~l~~l~-HpnIv~l~g~~~~~~~~~lV 681 (894)
++|...+.||+|+||.||+|.. .++..||+|++.... ......+..|+.++++++ ||||+++++++..++..++|
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv 80 (280)
T cd05581 1 DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTFQDEENLYFV 80 (280)
T ss_pred CCceEeeeecCCCceEEEEEEEcCCCCEEEEEEechHhccchHHHHHHHHHHHHHHhcccCCCchhHHHHhcCCceEEEE
Confidence 4688889999999999999985 478999999987532 233466889999999998 99999999999999999999
Q ss_pred EEeccCCCHHHHHhhhcCCCCCcCHHHHHHHHHHHHHHHHHHHhccCCCeeecCCCCCCeEECCCCcEEEEEcccccccC
Q 002673 682 YSYMENGSLDYWLHEKADGASQLDWLTRLKIARGTSCGLAYMHQICEPHIVHRDIKSSNILLDDQFEAHLADFGLSRLIL 761 (894)
Q Consensus 682 ~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDLkp~NILld~~~~vkl~DFGla~~~~ 761 (894)
|||+++++|.+++... ..+++..+..++.|++.||.|||+ .+++|+||+|+||+++.++.++++|||++....
T Consensus 81 ~e~~~~~~L~~~l~~~----~~l~~~~~~~i~~ql~~~l~~Lh~---~~~~H~dl~~~ni~i~~~~~~~l~df~~~~~~~ 153 (280)
T cd05581 81 LEYAPNGELLQYIRKY----GSLDEKCTRFYAAEILLALEYLHS---KGIIHRDLKPENILLDKDMHIKITDFGTAKVLD 153 (280)
T ss_pred EcCCCCCcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHH---CCeeecCCCHHHeEECCCCCEEecCCccccccC
Confidence 9999999999999754 368999999999999999999997 599999999999999999999999999998764
Q ss_pred CCCC-------------------cccccccccCCccCcccccCcCCCccccHHHHHHHHHHHHcCCCCCCCCCcchhhhH
Q 002673 762 PYQT-------------------HVTTELVGTLGYIPPEYGQAWVATLRGDMYSFGVVMLELLTGKRPVDVLKPKMSREL 822 (894)
Q Consensus 762 ~~~~-------------------~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwS~GvlL~elltG~~Pf~~~~~~~~~~~ 822 (894)
.... .......++..|+|||...+..++.++||||||++++++++|+.||...... ..
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~---~~ 230 (280)
T cd05581 154 PNSSPESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPPFRGSNEY---LT 230 (280)
T ss_pred CccccccCCCCCccccccccccccccccccCCccccCHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCccHH---HH
Confidence 3221 1222346788999999988888999999999999999999999999754321 11
Q ss_pred HHHHHHHhhcCCCCccccccccCCCChHHHHHHHHHHHHhcccCCCCCCCH----HHHHH
Q 002673 823 VGWVLKMRSEGKQDQVFDPILRGKGFDEEMLQVLDVACMCVSQNPFKRPTV----KEVVE 878 (894)
Q Consensus 823 ~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~----~evl~ 878 (894)
.. .... ... .+. ......+.+++.+|++.+|++||++ +++++
T Consensus 231 ~~---~~~~-~~~--~~~--------~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~ll~ 276 (280)
T cd05581 231 FQ---KILK-LEY--SFP--------PNFPPDAKDLIEKLLVLDPQDRLGVNEGYDELKA 276 (280)
T ss_pred HH---HHHh-cCC--CCC--------CccCHHHHHHHHHHhcCCHhhCCCcccCHHHHhc
Confidence 11 1110 000 000 1112356789999999999999999 77764
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto |
| >cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.8e-30 Score=282.02 Aligned_cols=246 Identities=26% Similarity=0.287 Sum_probs=187.9
Q ss_pred eEeecCcEEEEEEEE-cCCCeEEEEEEcCcch---hhHHHHHHHH---HHHHhcCCCceeeecceeeecceEEEEEEecc
Q 002673 614 IIGCGGFGLVYKATL-ANGTTLAIKKLSGDLG---LMEREFKAEV---EALSTAQHKNLVSLQGYCVHQGFRLLIYSYME 686 (894)
Q Consensus 614 ~LG~G~fg~Vy~a~~-~~g~~vAvK~~~~~~~---~~~~~~~~Ei---~~l~~l~HpnIv~l~g~~~~~~~~~lV~E~~~ 686 (894)
.||+|+||.||+|.. .+++.||+|.+..... .....+..|. ..++..+||||+.+++++...+..++||||++
T Consensus 1 ~ig~g~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~ 80 (278)
T cd05606 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMN 80 (278)
T ss_pred CcccCCCeEEEEEEEecCCCEEEEEEeeccccccchhHHHHHHHHHHHHHHHhCCCCcEeeeeeeeecCCEEEEEEecCC
Confidence 489999999999984 5689999999875321 1112233343 34455689999999999999999999999999
Q ss_pred CCCHHHHHhhhcCCCCCcCHHHHHHHHHHHHHHHHHHHhccCCCeeecCCCCCCeEECCCCcEEEEEcccccccCCCCCc
Q 002673 687 NGSLDYWLHEKADGASQLDWLTRLKIARGTSCGLAYMHQICEPHIVHRDIKSSNILLDDQFEAHLADFGLSRLILPYQTH 766 (894)
Q Consensus 687 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDLkp~NILld~~~~vkl~DFGla~~~~~~~~~ 766 (894)
+|+|..++... ..+++..+..++.|++.||.|||+ ++++||||||+||+++.++.+||+|||++..+...
T Consensus 81 g~~L~~~l~~~----~~l~~~~~~~~~~ql~~~l~~lH~---~~i~H~di~p~nili~~~~~~kl~dfg~~~~~~~~--- 150 (278)
T cd05606 81 GGDLHYHLSQH----GVFSEAEMRFYAAEIILGLEHMHN---RFVVYRDLKPANILLDEHGHVRISDLGLACDFSKK--- 150 (278)
T ss_pred CCcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHH---CCEEcCCCCHHHEEECCCCCEEEccCcCccccCcc---
Confidence 99999888643 358999999999999999999997 59999999999999999999999999998765322
Q ss_pred ccccccccCCccCcccccCc-CCCccccHHHHHHHHHHHHcCCCCCCCCCcchhhhHHHHHHHHhhcCCCCccccccccC
Q 002673 767 VTTELVGTLGYIPPEYGQAW-VATLRGDMYSFGVVMLELLTGKRPVDVLKPKMSRELVGWVLKMRSEGKQDQVFDPILRG 845 (894)
Q Consensus 767 ~~~~~~gt~~Y~APE~~~~~-~~s~ksDVwS~GvlL~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~ 845 (894)
......|+..|+|||++.++ .++.++||||+|+++|||++|+.||............ .... .. +..+..
T Consensus 151 ~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~s~G~~l~~l~~g~~p~~~~~~~~~~~~~---~~~~-~~------~~~~~~ 220 (278)
T cd05606 151 KPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEID---RMTL-TM------AVELPD 220 (278)
T ss_pred CCcCcCCCcCCcCcHHhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCccchHHHH---HHhh-cc------CCCCCC
Confidence 12234689999999998754 6889999999999999999999999754322111110 0000 00 001111
Q ss_pred CCChHHHHHHHHHHHHhcccCCCCCC-----CHHHHHH--HHHhc
Q 002673 846 KGFDEEMLQVLDVACMCVSQNPFKRP-----TVKEVVE--WLNNV 883 (894)
Q Consensus 846 ~~~~~~~~~l~~li~~Cl~~dP~~RP-----s~~evl~--~L~~i 883 (894)
.....+.+++.+|+..+|.+|| ++.++++ |+..+
T Consensus 221 ----~~s~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~~~~~~~~ 261 (278)
T cd05606 221 ----SFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKEHPFFRSL 261 (278)
T ss_pred ----cCCHHHHHHHHHHhhcCHHhccCCCCCCHHHHHhCccccCC
Confidence 1134677889999999999999 9999996 55544
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co |
| >KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=8.4e-33 Score=326.80 Aligned_cols=250 Identities=32% Similarity=0.413 Sum_probs=200.3
Q ss_pred ccCCCccceEeecCcEEEEEEE-EcCCCeEEEEEEcCcch--hhHHHHHHHHHHHHhcCCCceeeecceeeecceEEEEE
Q 002673 606 TDNFSQANIIGCGGFGLVYKAT-LANGTTLAIKKLSGDLG--LMEREFKAEVEALSTAQHKNLVSLQGYCVHQGFRLLIY 682 (894)
Q Consensus 606 ~~~f~~~~~LG~G~fg~Vy~a~-~~~g~~vAvK~~~~~~~--~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~lV~ 682 (894)
+-++..+..||.|.||.||-|. .++|+..|+|-+.-... ...+.+.+|+.++..++|||+|+.+|+=..++..+|.|
T Consensus 1234 ~~rWqrg~~Ig~G~fG~VYtavN~~tGellAvKEI~iq~~~~k~~~~i~eEm~vlE~lnHpNlV~YyGVEvHRekv~IFM 1313 (1509)
T KOG4645|consen 1234 TFRWQRGNFIGGGTFGKVYTAVNLDTGELLAVKEIKIQDSDHKTFKLIAEEMKVLEGLNHPNLVRYYGVEVHREKVYIFM 1313 (1509)
T ss_pred eeeeccccccCCcceeeeEEeecCCccchhhhhhhhcCccccccCcchHHHHHHHHhccCccccccCceeecHHHHHHHH
Confidence 3467788999999999999998 77899999998765432 23356889999999999999999999999999999999
Q ss_pred EeccCCCHHHHHhhhcCCCCCcCHHHHHHHHHHHHHHHHHHHhccCCCeeecCCCCCCeEECCCCcEEEEEcccccccCC
Q 002673 683 SYMENGSLDYWLHEKADGASQLDWLTRLKIARGTSCGLAYMHQICEPHIVHRDIKSSNILLDDQFEAHLADFGLSRLILP 762 (894)
Q Consensus 683 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDLkp~NILld~~~~vkl~DFGla~~~~~ 762 (894)
|||++|+|.+.+... ...+......+..|++.|++|||++ |||||||||.||+|+.+|.+|++|||.|..+.+
T Consensus 1314 EyC~~GsLa~ll~~g----ri~dE~vt~vyt~qll~gla~LH~~---gIVHRDIK~aNI~Ld~~g~iK~~DFGsa~ki~~ 1386 (1509)
T KOG4645|consen 1314 EYCEGGSLASLLEHG----RIEDEMVTRVYTKQLLEGLAYLHEH---GIVHRDIKPANILLDFNGLIKYGDFGSAVKIKN 1386 (1509)
T ss_pred HHhccCcHHHHHHhc----chhhhhHHHHHHHHHHHHHHHHHhc---CceecCCCccceeeecCCcEEeecccceeEecC
Confidence 999999999999854 3456666677889999999999974 999999999999999999999999999988754
Q ss_pred CCCc---ccccccccCCccCcccccCc---CCCccccHHHHHHHHHHHHcCCCCCCCCCcchhhhHHHHHHHH-hhcCCC
Q 002673 763 YQTH---VTTELVGTLGYIPPEYGQAW---VATLRGDMYSFGVVMLELLTGKRPVDVLKPKMSRELVGWVLKM-RSEGKQ 835 (894)
Q Consensus 763 ~~~~---~~~~~~gt~~Y~APE~~~~~---~~s~ksDVwS~GvlL~elltG~~Pf~~~~~~~~~~~~~~~~~~-~~~~~~ 835 (894)
.... .....+||+-|||||++.+. ....+.||||+|||+.||+||+.||..++.. |...+ ...+..
T Consensus 1387 ~~~~~~~el~~~~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVVlEM~tGkrPW~~~dne-------~aIMy~V~~gh~ 1459 (1509)
T KOG4645|consen 1387 NAQTMPGELQSMMGTPMYMAPEVITGTKGKGHGGAADIWSLGCVVLEMATGKRPWAELDNE-------WAIMYHVAAGHK 1459 (1509)
T ss_pred chhcCCHHHHhhcCCchhcCchhhcccccCCCCcchhhhcccceEEEeecCCCchhhccch-------hHHHhHHhccCC
Confidence 3211 12346899999999998764 3566899999999999999999999866542 22211 122222
Q ss_pred CccccccccCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 002673 836 DQVFDPILRGKGFDEEMLQVLDVACMCVSQNPFKRPTVKEVVE 878 (894)
Q Consensus 836 ~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~ 878 (894)
..+. .....+-.+++.+|+..||..|.++.|+++
T Consensus 1460 Pq~P---------~~ls~~g~dFle~Cl~~dP~~Rw~~~qlle 1493 (1509)
T KOG4645|consen 1460 PQIP---------ERLSSEGRDFLEHCLEQDPKMRWTASQLLE 1493 (1509)
T ss_pred CCCc---------hhhhHhHHHHHHHHHhcCchhhhHHHHHHH
Confidence 2221 113345568999999999999999888776
|
|
| >cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.9e-30 Score=285.49 Aligned_cols=243 Identities=27% Similarity=0.390 Sum_probs=191.2
Q ss_pred CCccceEeecCcEEEEEEEE-cCCCeEEEEEEcCcch---hhHHHHHHHHHHHHhcCCCceeeecceeeecceEEEEEEe
Q 002673 609 FSQANIIGCGGFGLVYKATL-ANGTTLAIKKLSGDLG---LMEREFKAEVEALSTAQHKNLVSLQGYCVHQGFRLLIYSY 684 (894)
Q Consensus 609 f~~~~~LG~G~fg~Vy~a~~-~~g~~vAvK~~~~~~~---~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~lV~E~ 684 (894)
|...+.||+|+||.||+|+. .++..|++|++..... .....+.+|+++++.++|||++++++++.++...++||||
T Consensus 23 ~~~~~~lg~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 102 (313)
T cd06633 23 FVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKGCYLKEHTAWLVMEY 102 (313)
T ss_pred hhcceeeccCCCeEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEEec
Confidence 55567899999999999985 5688999999865322 2335678899999999999999999999999999999999
Q ss_pred ccCCCHHHHHhhhcCCCCCcCHHHHHHHHHHHHHHHHHHHhccCCCeeecCCCCCCeEECCCCcEEEEEcccccccCCCC
Q 002673 685 MENGSLDYWLHEKADGASQLDWLTRLKIARGTSCGLAYMHQICEPHIVHRDIKSSNILLDDQFEAHLADFGLSRLILPYQ 764 (894)
Q Consensus 685 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDLkp~NILld~~~~vkl~DFGla~~~~~~~ 764 (894)
+. |++.+++.... ..+++..+..++.|++.|+.|||+ ++++|+||+|+||+++.++.+||+|||++.....
T Consensus 103 ~~-~~l~~~l~~~~---~~l~~~~~~~~~~qi~~al~~LH~---~gi~H~dl~p~nili~~~~~~kL~dfg~~~~~~~-- 173 (313)
T cd06633 103 CL-GSASDLLEVHK---KPLQEVEIAAITHGALQGLAYLHS---HNMIHRDIKAGNILLTEPGQVKLADFGSASKSSP-- 173 (313)
T ss_pred CC-CCHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCChhhEEECCCCCEEEeecCCCcccCC--
Confidence 95 67877776432 458899999999999999999997 5999999999999999999999999998864321
Q ss_pred CcccccccccCCccCccccc---CcCCCccccHHHHHHHHHHHHcCCCCCCCCCcchhhhHHHHHHHHhhcCCCCccccc
Q 002673 765 THVTTELVGTLGYIPPEYGQ---AWVATLRGDMYSFGVVMLELLTGKRPVDVLKPKMSRELVGWVLKMRSEGKQDQVFDP 841 (894)
Q Consensus 765 ~~~~~~~~gt~~Y~APE~~~---~~~~s~ksDVwS~GvlL~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 841 (894)
.....|+..|+|||++. +..++.++|||||||++|+|++|..||...... ... ........ ...
T Consensus 174 ---~~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~slGvil~el~~g~~p~~~~~~~---~~~---~~~~~~~~-~~~--- 240 (313)
T cd06633 174 ---ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAM---SAL---YHIAQNDS-PTL--- 240 (313)
T ss_pred ---CCCccccccccChhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChH---HHH---HHHHhcCC-CCC---
Confidence 22356888999999874 456888999999999999999999998754321 111 11111111 111
Q ss_pred cccCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 002673 842 ILRGKGFDEEMLQVLDVACMCVSQNPFKRPTVKEVVE 878 (894)
Q Consensus 842 ~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~ 878 (894)
....+ ...+.+++.+|++.+|.+||++.++++
T Consensus 241 --~~~~~---~~~l~~li~~~l~~~P~~Rp~~~~~l~ 272 (313)
T cd06633 241 --QSNEW---TDSFRGFVDYCLQKIPQERPASAELLR 272 (313)
T ss_pred --Ccccc---CHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 01111 234678999999999999999999997
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co |
| >cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Probab=99.97 E-value=9.8e-31 Score=280.62 Aligned_cols=250 Identities=24% Similarity=0.309 Sum_probs=194.6
Q ss_pred CCCccceEeecCcEEEEEEEEc-CCCeEEEEEEcCc-----chhhHHHHHHHHHHHHhcCCCceeeecceeeecceEEEE
Q 002673 608 NFSQANIIGCGGFGLVYKATLA-NGTTLAIKKLSGD-----LGLMEREFKAEVEALSTAQHKNLVSLQGYCVHQGFRLLI 681 (894)
Q Consensus 608 ~f~~~~~LG~G~fg~Vy~a~~~-~g~~vAvK~~~~~-----~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~lV 681 (894)
+|.+.+.||+|+||.||++... .+..+++|.++.. ......++..|+.+++.++||||+++++++......++|
T Consensus 1 ~y~i~~~ig~g~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 80 (260)
T cd08222 1 RYILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKFHASFLERDAFCII 80 (260)
T ss_pred CceeeeeecCCCCceEEEEEecCCCCcceEEEeccccccccCcchHHHHHHHHHHHHhCCCCcHHHHHHHHhcCCceEEE
Confidence 4778899999999999999854 3445555655431 112334577899999999999999999999999999999
Q ss_pred EEeccCCCHHHHHhhhcCCCCCcCHHHHHHHHHHHHHHHHHHHhccCCCeeecCCCCCCeEECCCCcEEEEEcccccccC
Q 002673 682 YSYMENGSLDYWLHEKADGASQLDWLTRLKIARGTSCGLAYMHQICEPHIVHRDIKSSNILLDDQFEAHLADFGLSRLIL 761 (894)
Q Consensus 682 ~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDLkp~NILld~~~~vkl~DFGla~~~~ 761 (894)
|||+++++|.+++.........+++..++.++.|++.||.|||+ .+++|+||+|+||++++ +.+||+|||++....
T Consensus 81 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~---~~i~h~~l~~~nili~~-~~~~l~d~g~~~~~~ 156 (260)
T cd08222 81 TEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQ---RRILHRDLKAKNIFLKN-NLLKIGDFGVSRLLM 156 (260)
T ss_pred EEeCCCCCHHHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHH---cCccccCCChhheEeec-CCEeecccCceeecC
Confidence 99999999999998654445679999999999999999999997 59999999999999986 569999999987653
Q ss_pred CCCCcccccccccCCccCcccccCcCCCccccHHHHHHHHHHHHcCCCCCCCCCcchhhhHHHHHHHHhhcCCCCccccc
Q 002673 762 PYQTHVTTELVGTLGYIPPEYGQAWVATLRGDMYSFGVVMLELLTGKRPVDVLKPKMSRELVGWVLKMRSEGKQDQVFDP 841 (894)
Q Consensus 762 ~~~~~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwS~GvlL~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 841 (894)
... .......|+..|+|||...+..++.++|+||||+++|+|++|..||..... ......... +....
T Consensus 157 ~~~-~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~~------~~~~~~~~~-~~~~~---- 224 (260)
T cd08222 157 GSC-DLATTFTGTPYYMSPEALKHQGYDSKSDIWSLGCILYEMCCLAHAFEGQNF------LSVVLRIVE-GPTPS---- 224 (260)
T ss_pred CCc-ccccCCCCCcCccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCccH------HHHHHHHHc-CCCCC----
Confidence 322 222335678899999999888889999999999999999999999964321 111111111 11111
Q ss_pred cccCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 002673 842 ILRGKGFDEEMLQVLDVACMCVSQNPFKRPTVKEVVE 878 (894)
Q Consensus 842 ~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~ 878 (894)
. .......+.+++.+|++.+|++||++.++++
T Consensus 225 -~----~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~ 256 (260)
T cd08222 225 -L----PETYSRQLNSIMQSMLNKDPSLRPSAAEILR 256 (260)
T ss_pred -C----cchhcHHHHHHHHHHhcCChhhCcCHHHHhh
Confidence 1 1122346778999999999999999999986
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check |
| >cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.4e-31 Score=290.79 Aligned_cols=265 Identities=27% Similarity=0.317 Sum_probs=192.9
Q ss_pred ccCCCccceEeecCcEEEEEEEE-cCCCeEEEEEEcCcchh--hHHHHHHHHHHHHhcCCCceeeecceeeecc------
Q 002673 606 TDNFSQANIIGCGGFGLVYKATL-ANGTTLAIKKLSGDLGL--MEREFKAEVEALSTAQHKNLVSLQGYCVHQG------ 676 (894)
Q Consensus 606 ~~~f~~~~~LG~G~fg~Vy~a~~-~~g~~vAvK~~~~~~~~--~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~------ 676 (894)
.++|++.+.||+|+||.||+|.. .+++.||+|++...... ....+.+|+++++.++||||+++++++....
T Consensus 7 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 86 (311)
T cd07866 7 LRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALREIKILKKLKHPNVVPLIDMAVERPDKSKRK 86 (311)
T ss_pred cccEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEEeccCCCCcchhHHHHHHHHHhcCCCCccchhhheeccccccccc
Confidence 46899999999999999999985 46899999988643321 2345678999999999999999999875433
Q ss_pred --eEEEEEEeccCCCHHHHHhhhcCCCCCcCHHHHHHHHHHHHHHHHHHHhccCCCeeecCCCCCCeEECCCCcEEEEEc
Q 002673 677 --FRLLIYSYMENGSLDYWLHEKADGASQLDWLTRLKIARGTSCGLAYMHQICEPHIVHRDIKSSNILLDDQFEAHLADF 754 (894)
Q Consensus 677 --~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDLkp~NILld~~~~vkl~DF 754 (894)
..++|+||+.+ +|...+... ...+++..+..++.|+++||.|||+ ++++|+||||+||++++++.+||+||
T Consensus 87 ~~~~~lv~~~~~~-~l~~~~~~~---~~~~~~~~~~~i~~~l~~al~~lH~---~~i~H~dl~p~nil~~~~~~~~l~df 159 (311)
T cd07866 87 RGSVYMVTPYMDH-DLSGLLENP---SVKLTESQIKCYMLQLLEGINYLHE---NHILHRDIKAANILIDNQGILKIADF 159 (311)
T ss_pred CceEEEEEecCCc-CHHHHHhcc---ccCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEECCCCCEEECcC
Confidence 46999999964 677666542 2468999999999999999999997 59999999999999999999999999
Q ss_pred ccccccCCCCCc----------ccccccccCCccCcccccCc-CCCccccHHHHHHHHHHHHcCCCCCCCCCcchhhhHH
Q 002673 755 GLSRLILPYQTH----------VTTELVGTLGYIPPEYGQAW-VATLRGDMYSFGVVMLELLTGKRPVDVLKPKMSRELV 823 (894)
Q Consensus 755 Gla~~~~~~~~~----------~~~~~~gt~~Y~APE~~~~~-~~s~ksDVwS~GvlL~elltG~~Pf~~~~~~~~~~~~ 823 (894)
|++......... ......+++.|+|||++.+. .++.++|||||||++|||++|+.||............
T Consensus 160 g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~~g~~~~~~~~~~~~~~~~ 239 (311)
T cd07866 160 GLARPYDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQGKSDIDQLHLI 239 (311)
T ss_pred ccchhccCCCcccccCCcccccccccceeccCcCChHHhhCCCccCchhHhHHHHHHHHHHHhCCCCCCCCCHHHHHHHH
Confidence 999865332111 11234568889999987654 5789999999999999999999999754432211111
Q ss_pred HHHHHHhhcC------CCCcc--------ccccccCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 002673 824 GWVLKMRSEG------KQDQV--------FDPILRGKGFDEEMLQVLDVACMCVSQNPFKRPTVKEVVE 878 (894)
Q Consensus 824 ~~~~~~~~~~------~~~~~--------~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~ 878 (894)
.......... ..... ..+.+.. ........+.+++.+|++.||++|||+.+++.
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~i~~~l~~~p~~R~t~~ell~ 307 (311)
T cd07866 240 FKLCGTPTEETWPGWRSLPGCEGVHSFTNYPRTLEE-RFGKLGPEGLDLLSKLLSLDPYKRLTASDALE 307 (311)
T ss_pred HHHhCCCChhhchhhhhcccccccccCCCCCccHHH-HcccCChhHHHHHHHHcccCcccCcCHHHHhc
Confidence 1000000000 00000 0000000 01112246789999999999999999999875
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic |
| >KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.2e-31 Score=271.24 Aligned_cols=261 Identities=21% Similarity=0.344 Sum_probs=204.4
Q ss_pred cceEeecCcEEEEEEE-EcCCCeEEEEEEcCcchhhHHHHHHHHHHHHhc-CCCceeeecceeeecceEEEEEEeccCCC
Q 002673 612 ANIIGCGGFGLVYKAT-LANGTTLAIKKLSGDLGLMEREFKAEVEALSTA-QHKNLVSLQGYCVHQGFRLLIYSYMENGS 689 (894)
Q Consensus 612 ~~~LG~G~fg~Vy~a~-~~~g~~vAvK~~~~~~~~~~~~~~~Ei~~l~~l-~HpnIv~l~g~~~~~~~~~lV~E~~~~gs 689 (894)
.+.||+|+|+.|.-+. +.+|..+|||++.+..+.....+.+|++++.+. .|+||++++++|.++...|||||-|.||.
T Consensus 83 ~e~LGeGAyasVqtcv~i~t~~EYAVKiidKq~gHsR~RvfREVe~f~~Cqgh~nilqLiefFEdd~~FYLVfEKm~GGp 162 (463)
T KOG0607|consen 83 SELLGEGAYASVQTCVSIQTGKEYAVKIIDKQPGHSRSRVFREVETFYQCQGHKNILQLIEFFEDDTRFYLVFEKMRGGP 162 (463)
T ss_pred HHHhcCccceeeeeeeeeccchhhhhhhhhcCCchHHHHHHHHHHHHHHhcCCccHHHHHHHhcccceEEEEEecccCch
Confidence 4689999999999987 789999999999988777888899999999999 49999999999999999999999999999
Q ss_pred HHHHHhhhcCCCCCcCHHHHHHHHHHHHHHHHHHHhccCCCeeecCCCCCCeEECCCCc---EEEEEcccccccC--CCC
Q 002673 690 LDYWLHEKADGASQLDWLTRLKIARGTSCGLAYMHQICEPHIVHRDIKSSNILLDDQFE---AHLADFGLSRLIL--PYQ 764 (894)
Q Consensus 690 L~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDLkp~NILld~~~~---vkl~DFGla~~~~--~~~ 764 (894)
|..++++. ..++..++..+..+|+.||.|||. ++|.|||+||+|||..+-.. +|||||.+..-+. ...
T Consensus 163 lLshI~~~----~~F~E~EAs~vvkdia~aLdFlH~---kgIAHRDlKPENiLC~~pn~vsPvKiCDfDLgSg~k~~~~~ 235 (463)
T KOG0607|consen 163 LLSHIQKR----KHFNEREASRVVKDIASALDFLHT---KGIAHRDLKPENILCESPNKVSPVKICDFDLGSGIKLNNDC 235 (463)
T ss_pred HHHHHHHh----hhccHHHHHHHHHHHHHHHHHHhh---cCcccccCCccceeecCCCCcCceeeeccccccccccCCCC
Confidence 99999865 468899999999999999999996 79999999999999976543 9999998875431 111
Q ss_pred Ccc----cccccccCCccCcccc-----cCcCCCccccHHHHHHHHHHHHcCCCCCCCCCcchh----hhH---HH-HHH
Q 002673 765 THV----TTELVGTLGYIPPEYG-----QAWVATLRGDMYSFGVVMLELLTGKRPVDVLKPKMS----REL---VG-WVL 827 (894)
Q Consensus 765 ~~~----~~~~~gt~~Y~APE~~-----~~~~~s~ksDVwS~GvlL~elltG~~Pf~~~~~~~~----~~~---~~-~~~ 827 (894)
+.. ....+|+..|||||+. ....|+.++|.||+|||+|-|++|.+||.+....+- .+. ++ ...
T Consensus 236 spastP~L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYImLsGYpPFvG~Cg~dCGWdrGe~Cr~CQ~~LF 315 (463)
T KOG0607|consen 236 SPASTPELLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVILYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLF 315 (463)
T ss_pred CCCCCccccCcccchhhcchhHHhhhccccccccccccHHHHHHHHHHHHhCCCCccCccCCcCCccCCCccHHHHHHHH
Confidence 111 1235788899999964 345789999999999999999999999976654221 011 11 111
Q ss_pred HHhhcCCCCccccccccCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHH--HHHhccc
Q 002673 828 KMRSEGKQDQVFDPILRGKGFDEEMLQVLDVACMCVSQNPFKRPTVKEVVE--WLNNVGA 885 (894)
Q Consensus 828 ~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~--~L~~i~~ 885 (894)
.-.+++..+ + ....+.....+..+++...+..++.+|.++.++++ |.+.+..
T Consensus 316 esIQEGkYe-F-----PdkdWahIS~eakdlisnLlvrda~~rlsa~~vlnhPw~~~~~~ 369 (463)
T KOG0607|consen 316 ESIQEGKYE-F-----PDKDWAHISSEAKDLISNLLVRDAKQRLSAAQVLNHPWVQRCAP 369 (463)
T ss_pred HHHhccCCc-C-----ChhhhHHhhHHHHHHHHHHHhccHHhhhhhhhccCCccccccch
Confidence 122223221 1 12233444556678888999999999999999998 6665543
|
|
| >cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Probab=99.97 E-value=9.7e-31 Score=288.59 Aligned_cols=244 Identities=27% Similarity=0.385 Sum_probs=191.7
Q ss_pred CCCccceEeecCcEEEEEEEE-cCCCeEEEEEEcCc---chhhHHHHHHHHHHHHhcCCCceeeecceeeecceEEEEEE
Q 002673 608 NFSQANIIGCGGFGLVYKATL-ANGTTLAIKKLSGD---LGLMEREFKAEVEALSTAQHKNLVSLQGYCVHQGFRLLIYS 683 (894)
Q Consensus 608 ~f~~~~~LG~G~fg~Vy~a~~-~~g~~vAvK~~~~~---~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~lV~E 683 (894)
.|+..+.||+|+||.||+|+. .++..||+|.+... ......++.+|+++++.++|+|++++++++......++|||
T Consensus 16 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 95 (308)
T cd06634 16 LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVME 95 (308)
T ss_pred HHHHHHheeeCCCEEEEEEEEcCCCcEEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCcccEEEEEEcCCeeEEEEE
Confidence 466678899999999999985 46889999998642 22234567889999999999999999999999999999999
Q ss_pred eccCCCHHHHHhhhcCCCCCcCHHHHHHHHHHHHHHHHHHHhccCCCeeecCCCCCCeEECCCCcEEEEEcccccccCCC
Q 002673 684 YMENGSLDYWLHEKADGASQLDWLTRLKIARGTSCGLAYMHQICEPHIVHRDIKSSNILLDDQFEAHLADFGLSRLILPY 763 (894)
Q Consensus 684 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDLkp~NILld~~~~vkl~DFGla~~~~~~ 763 (894)
|+. |++.+++.... ..+++..+..++.|++.|+.|||+ ++++||||+|+||+++.++.+||+|||++.....
T Consensus 96 ~~~-~~l~~~~~~~~---~~l~~~~~~~~~~~l~~~l~~LH~---~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~- 167 (308)
T cd06634 96 YCL-GSASDLLEVHK---KPLQEVEIAAVTHGALQGLAYLHS---HNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAP- 167 (308)
T ss_pred ccC-CCHHHHHHHcC---CCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCCHHhEEECCCCcEEECCcccceeecC-
Confidence 996 68887776432 357889999999999999999997 5999999999999999999999999999876532
Q ss_pred CCcccccccccCCccCccccc---CcCCCccccHHHHHHHHHHHHcCCCCCCCCCcchhhhHHHHHHHHhhcCCCCcccc
Q 002673 764 QTHVTTELVGTLGYIPPEYGQ---AWVATLRGDMYSFGVVMLELLTGKRPVDVLKPKMSRELVGWVLKMRSEGKQDQVFD 840 (894)
Q Consensus 764 ~~~~~~~~~gt~~Y~APE~~~---~~~~s~ksDVwS~GvlL~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 840 (894)
.....++..|+|||++. ...++.++|||||||++|+|++|+.||........ ......... .
T Consensus 168 ----~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~------~~~~~~~~~-~---- 232 (308)
T cd06634 168 ----ANXFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSA------LYHIAQNES-P---- 232 (308)
T ss_pred ----cccccCCccccCHHHHhhcccCCCCcccchHHHHHHHHHHHcCCCCCccccHHHH------HHHHhhcCC-C----
Confidence 22346788999999864 35678899999999999999999999865432111 111111110 0
Q ss_pred ccccCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 002673 841 PILRGKGFDEEMLQVLDVACMCVSQNPFKRPTVKEVVE 878 (894)
Q Consensus 841 ~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~ 878 (894)
..... .....+.+++.+||+.+|.+||++.++++
T Consensus 233 -~~~~~---~~~~~~~~li~~cl~~~P~~Rp~~~~ll~ 266 (308)
T cd06634 233 -ALQSG---HWSEYFRNFVDSCLQKIPQDRPTSEVLLK 266 (308)
T ss_pred -CcCcc---cccHHHHHHHHHHhhCCcccCCCHHHHhh
Confidence 00011 12235678999999999999999999998
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin |
| >cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.9e-30 Score=290.90 Aligned_cols=268 Identities=24% Similarity=0.303 Sum_probs=199.3
Q ss_pred hccCCCccceEeecCcEEEEEEE-EcCCCeEEEEEEcCcc--hhhHHHHHHHHHHHHhcCCCceeeecceeeecc-----
Q 002673 605 ATDNFSQANIIGCGGFGLVYKAT-LANGTTLAIKKLSGDL--GLMEREFKAEVEALSTAQHKNLVSLQGYCVHQG----- 676 (894)
Q Consensus 605 a~~~f~~~~~LG~G~fg~Vy~a~-~~~g~~vAvK~~~~~~--~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~----- 676 (894)
..++|++.+.||+|+||.||+|. ..++..||||++.... ......+.+|+.+++.++||||+++++++..+.
T Consensus 13 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 92 (343)
T cd07880 13 VPDRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHENVIGLLDVFTPDLSLDRF 92 (343)
T ss_pred cccceEEEEEeeecCCeEEEEEEECCCCcEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCccceeeeecCCcccccc
Confidence 45789999999999999999998 4578999999986432 223456789999999999999999999887553
Q ss_pred -eEEEEEEeccCCCHHHHHhhhcCCCCCcCHHHHHHHHHHHHHHHHHHHhccCCCeeecCCCCCCeEECCCCcEEEEEcc
Q 002673 677 -FRLLIYSYMENGSLDYWLHEKADGASQLDWLTRLKIARGTSCGLAYMHQICEPHIVHRDIKSSNILLDDQFEAHLADFG 755 (894)
Q Consensus 677 -~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDLkp~NILld~~~~vkl~DFG 755 (894)
..++||||+ +++|.+++.. ..+++..+..++.|++.||.|||+ .+|+||||||+||+++.++.+||+|||
T Consensus 93 ~~~~lv~e~~-~~~l~~~~~~-----~~l~~~~~~~i~~qi~~al~~LH~---~gi~H~dlkp~Nill~~~~~~kl~dfg 163 (343)
T cd07880 93 HDFYLVMPFM-GTDLGKLMKH-----EKLSEDRIQFLVYQMLKGLKYIHA---AGIIHRDLKPGNLAVNEDCELKILDFG 163 (343)
T ss_pred ceEEEEEecC-CCCHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEEcCCCCEEEeecc
Confidence 458999999 7799888763 348899999999999999999997 599999999999999999999999999
Q ss_pred cccccCCCCCcccccccccCCccCcccccC-cCCCccccHHHHHHHHHHHHcCCCCCCCCCcchh-hhHHH--------H
Q 002673 756 LSRLILPYQTHVTTELVGTLGYIPPEYGQA-WVATLRGDMYSFGVVMLELLTGKRPVDVLKPKMS-RELVG--------W 825 (894)
Q Consensus 756 la~~~~~~~~~~~~~~~gt~~Y~APE~~~~-~~~s~ksDVwS~GvlL~elltG~~Pf~~~~~~~~-~~~~~--------~ 825 (894)
++...... .....+++.|+|||.+.+ ..++.++||||||+++|+|++|+.||........ ..... +
T Consensus 164 ~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 239 (343)
T cd07880 164 LARQTDSE----MTGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHLDQLMEIMKVTGTPSKEF 239 (343)
T ss_pred cccccccC----ccccccCCcccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHH
Confidence 99765321 223457889999998876 4588999999999999999999999975432110 00000 0
Q ss_pred HHHHhhc------CCCCccccccccCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHH--HHHhcccc
Q 002673 826 VLKMRSE------GKQDQVFDPILRGKGFDEEMLQVLDVACMCVSQNPFKRPTVKEVVE--WLNNVGAN 886 (894)
Q Consensus 826 ~~~~~~~------~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~--~L~~i~~~ 886 (894)
....... ..........+. .........+.+++.+|++.||++|||+.++++ +++.....
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~~l~~dP~~R~t~~~~l~~~~~~~~~~~ 307 (343)
T cd07880 240 VQKLQSEDAKNYVKKLPRFRKKDFR-SLLPNANPLAVNVLEKMLVLDAESRITAAEALAHPYFEEFHDP 307 (343)
T ss_pred HHhhcchhHHHHHHhccccCcchHH-HhccCCChHHHHHHHHHcCCChhhCCCHHHHhcCccHhhhcCc
Confidence 0000000 000000000000 000112235779999999999999999999996 88876543
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12 |
| >cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Probab=99.97 E-value=3e-31 Score=297.19 Aligned_cols=267 Identities=21% Similarity=0.296 Sum_probs=195.5
Q ss_pred cCCCccceEeecCcEEEEEEEE-cCCCeEEEEEEcCcchhhHHHHHHHHHHHHhcCCCceeeecceeeec----------
Q 002673 607 DNFSQANIIGCGGFGLVYKATL-ANGTTLAIKKLSGDLGLMEREFKAEVEALSTAQHKNLVSLQGYCVHQ---------- 675 (894)
Q Consensus 607 ~~f~~~~~LG~G~fg~Vy~a~~-~~g~~vAvK~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~---------- 675 (894)
.+|...+.||.|+||.||+|.. .+|..||+|++........+.+.+|++++++++||||+++++++...
T Consensus 5 ~~y~~~~~Lg~g~~g~vy~~~~~~~~~~v~iK~i~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~ 84 (342)
T cd07854 5 SRYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDLTEDVGS 84 (342)
T ss_pred cceEEEEEecCCCCEEEEEEEECCCCcEEEEEEEecCCCchHHHHHHHHHHHHhcCCCcchhhHhhhccccccccccccc
Confidence 6788999999999999999985 56899999998765545556788999999999999999999876543
Q ss_pred ----ceEEEEEEeccCCCHHHHHhhhcCCCCCcCHHHHHHHHHHHHHHHHHHHhccCCCeeecCCCCCCeEEC-CCCcEE
Q 002673 676 ----GFRLLIYSYMENGSLDYWLHEKADGASQLDWLTRLKIARGTSCGLAYMHQICEPHIVHRDIKSSNILLD-DQFEAH 750 (894)
Q Consensus 676 ----~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDLkp~NILld-~~~~vk 750 (894)
...++||||++ ++|.+++.. ..+++..+..++.||+.||.|||+ .+++||||||+||+++ +++.+|
T Consensus 85 ~~~~~~~~lv~e~~~-~~L~~~~~~-----~~l~~~~~~~~~~qi~~aL~~LH~---~givH~dikp~Nili~~~~~~~k 155 (342)
T cd07854 85 LTELNSVYIVQEYME-TDLANVLEQ-----GPLSEEHARLFMYQLLRGLKYIHS---ANVLHRDLKPANVFINTEDLVLK 155 (342)
T ss_pred ccccceEEEEeeccc-ccHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCCHHHEEEcCCCceEE
Confidence 35789999997 588888753 247889999999999999999997 5999999999999998 456799
Q ss_pred EEEcccccccCCCCCc--ccccccccCCccCcccccC-cCCCccccHHHHHHHHHHHHcCCCCCCCCCcchhhhHHHHHH
Q 002673 751 LADFGLSRLILPYQTH--VTTELVGTLGYIPPEYGQA-WVATLRGDMYSFGVVMLELLTGKRPVDVLKPKMSRELVGWVL 827 (894)
Q Consensus 751 l~DFGla~~~~~~~~~--~~~~~~gt~~Y~APE~~~~-~~~s~ksDVwS~GvlL~elltG~~Pf~~~~~~~~~~~~~~~~ 827 (894)
++|||++......... ......++..|+|||.+.+ ..++.++|||||||++|+|++|+.||........ ......
T Consensus 156 l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~--~~~~~~ 233 (342)
T cd07854 156 IGDFGLARIVDPHYSHKGYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELEQ--MQLILE 233 (342)
T ss_pred ECCcccceecCCccccccccccccccccccCHHHHhCccccCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH--HHHHHH
Confidence 9999999865322111 1123457889999997654 5678899999999999999999999975432111 000000
Q ss_pred HHhhcC--CCCccc---cccc-----cCCC-----ChHHHHHHHHHHHHhcccCCCCCCCHHHHHH--HHHhcc
Q 002673 828 KMRSEG--KQDQVF---DPIL-----RGKG-----FDEEMLQVLDVACMCVSQNPFKRPTVKEVVE--WLNNVG 884 (894)
Q Consensus 828 ~~~~~~--~~~~~~---d~~l-----~~~~-----~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~--~L~~i~ 884 (894)
...... ...... .... .... ......++.+++.+|++.||.+|||++++++ |++...
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~h~~~~~~~ 307 (342)
T cd07854 234 SVPVVREEDRNELLNVIPSFVRNDGGEPRRPLRDLLPGVNPEALDFLEQILTFNPMDRLTAEEALMHPYMSCYS 307 (342)
T ss_pred hcCCCChHHhhhhhhhhhhhhhhcccccCCCHHHHccCCCHHHHHHHHHHhCCCchhccCHHHHhCCCcccccc
Confidence 000000 000000 0000 0000 0112235778999999999999999999996 887554
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi |
| >cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.1e-30 Score=283.27 Aligned_cols=259 Identities=26% Similarity=0.301 Sum_probs=197.3
Q ss_pred CCccceEeecCcEEEEEEEEc-CCCeEEEEEEcCcc--hhhHHHHHHHHHHHHhcCCCceeeecceeeecceEEEEEEec
Q 002673 609 FSQANIIGCGGFGLVYKATLA-NGTTLAIKKLSGDL--GLMEREFKAEVEALSTAQHKNLVSLQGYCVHQGFRLLIYSYM 685 (894)
Q Consensus 609 f~~~~~LG~G~fg~Vy~a~~~-~g~~vAvK~~~~~~--~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~lV~E~~ 685 (894)
|+..+.||+|+||.||+|... +++.||+|.+.... ......+..|+.+++.++|+|++++++++......++||||+
T Consensus 1 y~~~~~ig~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~~ 80 (282)
T cd07829 1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALREISLLKELKHPNIVKLLDVIHTERKLYLVFEYC 80 (282)
T ss_pred CeeehcccccCcceEEEeeecCCCcEEEEEEeccccccccccHHHHHHHHHHHhcCCCCHHHHHhhhhcCCceEEEecCc
Confidence 456678999999999999854 58999999998653 223356788999999999999999999999999999999999
Q ss_pred cCCCHHHHHhhhcCCCCCcCHHHHHHHHHHHHHHHHHHHhccCCCeeecCCCCCCeEECCCCcEEEEEcccccccCCCCC
Q 002673 686 ENGSLDYWLHEKADGASQLDWLTRLKIARGTSCGLAYMHQICEPHIVHRDIKSSNILLDDQFEAHLADFGLSRLILPYQT 765 (894)
Q Consensus 686 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDLkp~NILld~~~~vkl~DFGla~~~~~~~~ 765 (894)
+ ++|.+++.... ..+++..+..++.|++.||.|||+ ++++||||+|+||++++++.+||+|||.+........
T Consensus 81 ~-~~l~~~i~~~~---~~~~~~~~~~~~~~i~~~l~~LH~---~~i~H~~l~~~ni~~~~~~~~~l~d~g~~~~~~~~~~ 153 (282)
T cd07829 81 D-MDLKKYLDKRP---GPLSPNLIKSIMYQLLRGLAYCHS---HRILHRDLKPQNILINRDGVLKLADFGLARAFGIPLR 153 (282)
T ss_pred C-cCHHHHHHhhc---cCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCChheEEEcCCCCEEEecCCcccccCCCcc
Confidence 7 58999998643 358999999999999999999997 5999999999999999999999999999986543221
Q ss_pred cccccccccCCccCcccccCc-CCCccccHHHHHHHHHHHHcCCCCCCCCCcchhhhHHHHHHHHhhcC---------C-
Q 002673 766 HVTTELVGTLGYIPPEYGQAW-VATLRGDMYSFGVVMLELLTGKRPVDVLKPKMSRELVGWVLKMRSEG---------K- 834 (894)
Q Consensus 766 ~~~~~~~gt~~Y~APE~~~~~-~~s~ksDVwS~GvlL~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~---------~- 834 (894)
......++..|+|||.+.+. .++.++||||||+++|||++|+.||........ ........... .
T Consensus 154 -~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~ 229 (282)
T cd07829 154 -TYTHEVVTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGKPLFPGDSEIDQ---LFKIFQILGTPTEESWPGVTKL 229 (282)
T ss_pred -ccCccccCcCcCChHHhcCCcCCCccccHHHHHHHHHHHHhCCCCCCCccHHHH---HHHHHHHhCCCcHHHHHhhccc
Confidence 22234567789999998776 889999999999999999999999965432111 11111100000 0
Q ss_pred --CCccccccc---cCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 002673 835 --QDQVFDPIL---RGKGFDEEMLQVLDVACMCVSQNPFKRPTVKEVVE 878 (894)
Q Consensus 835 --~~~~~d~~l---~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~ 878 (894)
....+.... .....+.....+.+++..|++.+|++||++.+++.
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~ 278 (282)
T cd07829 230 PDYKPTFPKFPPKDLEKVLPRLDPEGIDLLSKMLQYNPAKRISAKEALK 278 (282)
T ss_pred ccccccccccCccchHHhcccccHHHHHHHHHhhccCcccCCCHHHHhh
Confidence 000000000 00011112346889999999999999999999986
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the |
| >cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.3e-31 Score=292.76 Aligned_cols=268 Identities=24% Similarity=0.297 Sum_probs=194.4
Q ss_pred CCCccceEeecCcEEEEEEEEc-C--CCeEEEEEEcCcc--hhhHHHHHHHHHHHHhc-CCCceeeecceeeec----ce
Q 002673 608 NFSQANIIGCGGFGLVYKATLA-N--GTTLAIKKLSGDL--GLMEREFKAEVEALSTA-QHKNLVSLQGYCVHQ----GF 677 (894)
Q Consensus 608 ~f~~~~~LG~G~fg~Vy~a~~~-~--g~~vAvK~~~~~~--~~~~~~~~~Ei~~l~~l-~HpnIv~l~g~~~~~----~~ 677 (894)
+|++.+.||+|+||.||++... + +..||+|++.... ....+.+.+|+.+++++ +||||+++++++... ..
T Consensus 1 ~y~~~~~lg~G~~g~vy~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~~ 80 (332)
T cd07857 1 RYELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALRELKLLRHFRGHKNITCLYDMDIVFPGNFNE 80 (332)
T ss_pred CceEEEEccccCCeEEEEEEeCCCCcCceEEEEEeccccccchhHHHHHHHHHHHHHhcCCCChheeeeeeeeccccCCc
Confidence 4777889999999999999854 4 7889999987532 22345678899999999 599999999875432 45
Q ss_pred EEEEEEeccCCCHHHHHhhhcCCCCCcCHHHHHHHHHHHHHHHHHHHhccCCCeeecCCCCCCeEECCCCcEEEEEcccc
Q 002673 678 RLLIYSYMENGSLDYWLHEKADGASQLDWLTRLKIARGTSCGLAYMHQICEPHIVHRDIKSSNILLDDQFEAHLADFGLS 757 (894)
Q Consensus 678 ~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDLkp~NILld~~~~vkl~DFGla 757 (894)
.++++||+. ++|.+++... ..+++..+..++.||+.||.|||+ .+++||||||+||+++.++.+||+|||++
T Consensus 81 ~~~~~e~~~-~~L~~~l~~~----~~~~~~~~~~~~~qi~~aL~~LH~---~givH~dlkp~Nili~~~~~~kl~Dfg~a 152 (332)
T cd07857 81 LYLYEELME-ADLHQIIRSG----QPLTDAHFQSFIYQILCGLKYIHS---ANVLHRDLKPGNLLVNADCELKICDFGLA 152 (332)
T ss_pred EEEEEeccc-CCHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCCHHHeEEcCCCCEEeCcCCCc
Confidence 688889885 6898888643 458899999999999999999997 59999999999999999999999999999
Q ss_pred cccCCCCCc---ccccccccCCccCcccccC-cCCCccccHHHHHHHHHHHHcCCCCCCCCCcchhhh-HHH--------
Q 002673 758 RLILPYQTH---VTTELVGTLGYIPPEYGQA-WVATLRGDMYSFGVVMLELLTGKRPVDVLKPKMSRE-LVG-------- 824 (894)
Q Consensus 758 ~~~~~~~~~---~~~~~~gt~~Y~APE~~~~-~~~s~ksDVwS~GvlL~elltG~~Pf~~~~~~~~~~-~~~-------- 824 (894)
+........ ......||..|+|||+..+ ..++.++|||||||++|+|++|+.||.......... ...
T Consensus 153 ~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slGv~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~ 232 (332)
T cd07857 153 RGFSENPGENAGFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGKDYVDQLNQILQVLGTPDEE 232 (332)
T ss_pred eecccccccccccccCcccCccccCcHHHhCCCCCCcHHHHHHHHHHHHHHHhCCcCCCCCCHHHHHHHHHHHhCCCCHH
Confidence 865432211 1223568999999998765 468899999999999999999999997543211000 000
Q ss_pred HHHHHhhcC------CCCccccccccCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHH--HHHhcc
Q 002673 825 WVLKMRSEG------KQDQVFDPILRGKGFDEEMLQVLDVACMCVSQNPFKRPTVKEVVE--WLNNVG 884 (894)
Q Consensus 825 ~~~~~~~~~------~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~--~L~~i~ 884 (894)
+........ .........+ ....+.....+.+++.+|++.||.+|||+.++++ ||.+.+
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~ll~~~~~~~~~ 299 (332)
T cd07857 233 TLSRIGSPKAQNYIRSLPNIPKKPF-ESIFPNANPLALDLLEKLLAFDPTKRISVEEALEHPYLAIWH 299 (332)
T ss_pred HHHhhhhhhHHHHHHhccccCCcch-HhhCCCCCHHHHHHHHHHccCCcccCCCHHHHhcChhhhhhc
Confidence 000000000 0000000000 0001112346779999999999999999999998 887654
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co |
| >KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.7e-33 Score=278.49 Aligned_cols=253 Identities=23% Similarity=0.320 Sum_probs=194.5
Q ss_pred ccceEeecCcEEEEEEE-EcCCCeEEEEEEcCcch-hhHHHHHHHHHHHHhc-CCCceeeecceeeecceEEEEEEeccC
Q 002673 611 QANIIGCGGFGLVYKAT-LANGTTLAIKKLSGDLG-LMEREFKAEVEALSTA-QHKNLVSLQGYCVHQGFRLLIYSYMEN 687 (894)
Q Consensus 611 ~~~~LG~G~fg~Vy~a~-~~~g~~vAvK~~~~~~~-~~~~~~~~Ei~~l~~l-~HpnIv~l~g~~~~~~~~~lV~E~~~~ 687 (894)
....||.|+||+|+|.. .+.|+..|||+++.... ...+++..|.+...+- +.||||+++|.+..++..|+.||.|+
T Consensus 68 dlg~iG~G~fG~V~KM~hk~sg~~mAVKrIr~~n~~keq~rll~e~d~~mks~~cp~IVkfyGa~F~EGdcWiCMELMd- 146 (361)
T KOG1006|consen 68 DLGEIGNGAFGTVNKMLHKPSGKLMAVKRIRSNNIEKEQKRLLMEHDTVMKSSNCPNIVKFYGALFSEGDCWICMELMD- 146 (361)
T ss_pred HHHHhcCCcchhhhhhhcCccCcEEEEEEeeeccchHHHHHHHHHHHHHHhhcCCcHHHHHhhhhhcCCceeeeHHHHh-
Confidence 34679999999999997 56799999999987654 4556788888765554 79999999999999999999999995
Q ss_pred CCHHHHHhh-hcCCCCCcCHHHHHHHHHHHHHHHHHHHhccCCCeeecCCCCCCeEECCCCcEEEEEcccccccCCCCCc
Q 002673 688 GSLDYWLHE-KADGASQLDWLTRLKIARGTSCGLAYMHQICEPHIVHRDIKSSNILLDDQFEAHLADFGLSRLILPYQTH 766 (894)
Q Consensus 688 gsL~~~l~~-~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDLkp~NILld~~~~vkl~DFGla~~~~~~~~~ 766 (894)
.||+.+... ..-....++..-.-+|...++.||.||.. +..|||||+||+|||+|..|.+||||||++..+.. +.
T Consensus 147 ~SlDklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~--~lkiIHRDvKPSNILldr~G~vKLCDFGIcGqLv~--Si 222 (361)
T KOG1006|consen 147 ISLDKLYKRVYSVQKSRIPENILGHITVATVDALDYLKE--ELKIIHRDVKPSNILLDRHGDVKLCDFGICGQLVD--SI 222 (361)
T ss_pred hhHHHHHHHHHHHHhccCcHhhhhheeeeehhHHHHHHH--HhhhhhccCChhheEEecCCCEeeecccchHhHHH--HH
Confidence 466655432 11122567887778888999999999997 47999999999999999999999999999987643 23
Q ss_pred ccccccccCCccCcccccCc--CCCccccHHHHHHHHHHHHcCCCCCCCCCcchhhhHHHHHHHHhhcCCCCcccccccc
Q 002673 767 VTTELVGTLGYIPPEYGQAW--VATLRGDMYSFGVVMLELLTGKRPVDVLKPKMSRELVGWVLKMRSEGKQDQVFDPILR 844 (894)
Q Consensus 767 ~~~~~~gt~~Y~APE~~~~~--~~s~ksDVwS~GvlL~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~ 844 (894)
..+.-.|...|||||.+... .|+.+|||||+|+.|||+.||+.|+..... +.+...+...... ..+ +.
T Consensus 223 AkT~daGCrpYmAPERi~p~~~gyDiRSDvWSLGITL~EvAtG~fPyr~w~s-----vfeql~~Vv~gdp-p~l----~~ 292 (361)
T KOG1006|consen 223 AKTVDAGCRPYMAPERIDPSDKGYDIRSDVWSLGITLYEVATGNFPYRKWDS-----VFEQLCQVVIGDP-PIL----LF 292 (361)
T ss_pred HhhhccCCccccChhccCCccCCcchhhhhhhhcceEeeeecCCCCcchHHH-----HHHHHHHHHcCCC-Cee----cC
Confidence 34456789999999987643 589999999999999999999999975432 2222222221111 111 11
Q ss_pred CCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 002673 845 GKGFDEEMLQVLDVACMCVSQNPFKRPTVKEVVE 878 (894)
Q Consensus 845 ~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~ 878 (894)
.....+....+..++..|+-.|-+.||+++++.+
T Consensus 293 ~~~~~~~s~~~~~fintCl~Kd~~~Rpky~~Lk~ 326 (361)
T KOG1006|consen 293 DKECVHYSFSMVRFINTCLIKDRSDRPKYDDLKK 326 (361)
T ss_pred cccccccCHHHHHHHHHHhhcccccCcchhhhhc
Confidence 2222344557788999999999999999999886
|
|
| >cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.6e-31 Score=294.02 Aligned_cols=265 Identities=25% Similarity=0.320 Sum_probs=199.9
Q ss_pred hccCCCccceEeecCcEEEEEEEE-cCCCeEEEEEEcCcc--hhhHHHHHHHHHHHHhcCCCceeeecceeeecce----
Q 002673 605 ATDNFSQANIIGCGGFGLVYKATL-ANGTTLAIKKLSGDL--GLMEREFKAEVEALSTAQHKNLVSLQGYCVHQGF---- 677 (894)
Q Consensus 605 a~~~f~~~~~LG~G~fg~Vy~a~~-~~g~~vAvK~~~~~~--~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~---- 677 (894)
..++|+..+.||+|+||.||+|.. .++..||||++.... ......+.+|+.+++.++|+|++++++++...+.
T Consensus 13 ~~~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 92 (343)
T cd07851 13 VPDRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHMDHENVIGLLDVFTPASSLEDF 92 (343)
T ss_pred ccCceEEEEEeccCCceEEEEEEECCCCcEEEEEecccccchhhHHHHHHHHHHHHHhccCCCHHHHHHHhhcccccccc
Confidence 457899999999999999999985 468899999986532 2233567789999999999999999998876554
Q ss_pred --EEEEEEeccCCCHHHHHhhhcCCCCCcCHHHHHHHHHHHHHHHHHHHhccCCCeeecCCCCCCeEECCCCcEEEEEcc
Q 002673 678 --RLLIYSYMENGSLDYWLHEKADGASQLDWLTRLKIARGTSCGLAYMHQICEPHIVHRDIKSSNILLDDQFEAHLADFG 755 (894)
Q Consensus 678 --~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDLkp~NILld~~~~vkl~DFG 755 (894)
.++|+||+ +++|.+++.. ..+++..+..++.|++.||.|||+ .+|+||||||+||+++.++.+||+|||
T Consensus 93 ~~~~lv~e~~-~~~L~~~~~~-----~~l~~~~~~~~~~ql~~aL~~LH~---~gi~H~dlkp~Nill~~~~~~kL~dfg 163 (343)
T cd07851 93 QDVYLVTHLM-GADLNNIVKC-----QKLSDDHIQFLVYQILRGLKYIHS---AGIIHRDLKPSNIAVNEDCELKILDFG 163 (343)
T ss_pred ccEEEEEecC-CCCHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHeEECCCCCEEEcccc
Confidence 89999998 6799988874 358999999999999999999997 599999999999999999999999999
Q ss_pred cccccCCCCCcccccccccCCccCcccccC-cCCCccccHHHHHHHHHHHHcCCCCCCCCCcchhhhHHHHHHHHhhcCC
Q 002673 756 LSRLILPYQTHVTTELVGTLGYIPPEYGQA-WVATLRGDMYSFGVVMLELLTGKRPVDVLKPKMSRELVGWVLKMRSEGK 834 (894)
Q Consensus 756 la~~~~~~~~~~~~~~~gt~~Y~APE~~~~-~~~s~ksDVwS~GvlL~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~ 834 (894)
++...... .....++..|+|||.+.+ ..++.++|||||||++|+|++|+.||....... ........... .
T Consensus 164 ~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~---~~~~i~~~~~~-~ 235 (343)
T cd07851 164 LARHTDDE----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGSDHID---QLKRIMNLVGT-P 235 (343)
T ss_pred cccccccc----ccCCcccccccCHHHHhCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHH---HHHHHHHhcCC-C
Confidence 99865322 233467889999998765 367889999999999999999999997543211 11111110000 0
Q ss_pred CCcc------------ccccc--cCCC----ChHHHHHHHHHHHHhcccCCCCCCCHHHHHH--HHHhcccc
Q 002673 835 QDQV------------FDPIL--RGKG----FDEEMLQVLDVACMCVSQNPFKRPTVKEVVE--WLNNVGAN 886 (894)
Q Consensus 835 ~~~~------------~d~~l--~~~~----~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~--~L~~i~~~ 886 (894)
.+.+ +.... .... .......+.+++.+|++.+|++|||+.++++ |+++....
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dli~~~l~~~P~~Rpt~~ell~h~~~~~~~~~ 307 (343)
T cd07851 236 DEELLQKISSESARNYIQSLPQMPKKDFKEVFSGANPLAIDLLEKMLVLDPDKRITAAEALAHPYLAEYHDP 307 (343)
T ss_pred CHHHHhhccchhHHHHHHhccccCCCCHHHHhccCCHHHHHHHHHhCCCChhhCCCHHHHhcCCCccccCCC
Confidence 0000 00000 0000 0112346789999999999999999999998 77766443
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK |
| >KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.6e-31 Score=268.70 Aligned_cols=258 Identities=22% Similarity=0.304 Sum_probs=200.9
Q ss_pred ccCCCcc-ceEeecCcEEEEEEE-EcCCCeEEEEEEcCcchhhHHHHHHHHHHHHhc-CCCceeeecceeee----cceE
Q 002673 606 TDNFSQA-NIIGCGGFGLVYKAT-LANGTTLAIKKLSGDLGLMEREFKAEVEALSTA-QHKNLVSLQGYCVH----QGFR 678 (894)
Q Consensus 606 ~~~f~~~-~~LG~G~fg~Vy~a~-~~~g~~vAvK~~~~~~~~~~~~~~~Ei~~l~~l-~HpnIv~l~g~~~~----~~~~ 678 (894)
+++|++. ++||-|-.|.|-.+. ..+++.+|+|++... ...++|++..-.. .|||||.+++++.+ ..-.
T Consensus 60 tedY~is~qvLG~GinGkV~~C~~k~T~ekfALKvL~Ds-----~KARrEVeLHw~~s~h~~iV~IidVyeNs~~~rkcL 134 (400)
T KOG0604|consen 60 TEDYSISWQVLGAGINGKVVQCVHKRTQEKFALKVLLDS-----PKARREVELHWMASGHPHIVSIIDVYENSYQGRKCL 134 (400)
T ss_pred hhhheehhhhhccccCCceEEEEeccchhhhHHHHHhcC-----HHHHhHhhhhhhhcCCCceEEeehhhhhhccCceee
Confidence 4566553 589999999999886 568999999998632 3456788776555 69999999998874 3456
Q ss_pred EEEEEeccCCCHHHHHhhhcCCCCCcCHHHHHHHHHHHHHHHHHHHhccCCCeeecCCCCCCeEECC---CCcEEEEEcc
Q 002673 679 LLIYSYMENGSLDYWLHEKADGASQLDWLTRLKIARGTSCGLAYMHQICEPHIVHRDIKSSNILLDD---QFEAHLADFG 755 (894)
Q Consensus 679 ~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDLkp~NILld~---~~~vkl~DFG 755 (894)
++|||.|+||.|.+.++++. ...++..++-.|.+||..|+.|||++ +|.||||||+|+|.+. |..+||+|||
T Consensus 135 LiVmE~meGGeLfsriq~~g--~~afTErea~eI~~qI~~Av~~lH~~---nIAHRDlKpENLLyt~t~~na~lKLtDfG 209 (400)
T KOG0604|consen 135 LIVMECMEGGELFSRIQDRG--DQAFTEREASEIMKQIGLAVRYLHSM---NIAHRDLKPENLLYTTTSPNAPLKLTDFG 209 (400)
T ss_pred EeeeecccchHHHHHHHHcc--cccchHHHHHHHHHHHHHHHHHHHhc---chhhccCChhheeeecCCCCcceEecccc
Confidence 79999999999999998764 35789999999999999999999985 9999999999999964 5679999999
Q ss_pred cccccCCCCCcccccccccCCccCcccccCcCCCccccHHHHHHHHHHHHcCCCCCCCCCcchhhhHHHHHHHHhhcCCC
Q 002673 756 LSRLILPYQTHVTTELVGTLGYIPPEYGQAWVATLRGDMYSFGVVMLELLTGKRPVDVLKPKMSRELVGWVLKMRSEGKQ 835 (894)
Q Consensus 756 la~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwS~GvlL~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~ 835 (894)
+|+.... .......+-|+.|.|||++...+|+..+|+||+||+||-|++|.+||..........- .+.....+..
T Consensus 210 FAK~t~~--~~~L~TPc~TPyYvaPevlg~eKydkscdmwSlgVimYIlLCGyPPFYS~hg~aispg---Mk~rI~~gqy 284 (400)
T KOG0604|consen 210 FAKETQE--PGDLMTPCFTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPG---MKRRIRTGQY 284 (400)
T ss_pred cccccCC--CccccCCcccccccCHHHhCchhcCCCCCccchhHHHHHhhcCCCcccccCCccCChh---HHhHhhccCc
Confidence 9986532 2223445679999999999999999999999999999999999999975543211100 0111111211
Q ss_pred CccccccccCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHH--HHHhcc
Q 002673 836 DQVFDPILRGKGFDEEMLQVLDVACMCVSQNPFKRPTVKEVVE--WLNNVG 884 (894)
Q Consensus 836 ~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~--~L~~i~ 884 (894)
+ +....++..+....++|+.+++.+|.+|.|+++++. |+.+..
T Consensus 285 ~------FP~pEWs~VSe~aKdlIR~LLkt~PteRlTI~~~m~hpwi~~~~ 329 (400)
T KOG0604|consen 285 E------FPEPEWSCVSEAAKDLIRKLLKTEPTERLTIEEVMDHPWINQYE 329 (400)
T ss_pred c------CCChhHhHHHHHHHHHHHHHhcCCchhheeHHHhhcCchhcccc
Confidence 1 122345556667789999999999999999999998 776543
|
|
| >KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.1e-31 Score=272.40 Aligned_cols=247 Identities=26% Similarity=0.346 Sum_probs=198.9
Q ss_pred cCCCccceEeecCcEEEEEEE-EcCCCeEEEEEEcCcchhhHHH---HHHHHHHHHhcCCCceeeecceeeecceEEEEE
Q 002673 607 DNFSQANIIGCGGFGLVYKAT-LANGTTLAIKKLSGDLGLMERE---FKAEVEALSTAQHKNLVSLQGYCVHQGFRLLIY 682 (894)
Q Consensus 607 ~~f~~~~~LG~G~fg~Vy~a~-~~~g~~vAvK~~~~~~~~~~~~---~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~lV~ 682 (894)
++|...++||+|.||.|..++ ..+++.+|+|+++++.-....+ -..|-++|...+||.+..+.-.|...+..++||
T Consensus 168 ~dFdfLKvLGkGTFGKVIL~rEKat~k~YAiKIlkKeviiakdEVAHTlTE~RVL~~~~HPFLt~LKYsFQt~drlCFVM 247 (516)
T KOG0690|consen 168 EDFDFLKVLGKGTFGKVILCREKATGKLYAIKILKKEVIIAKDEVAHTLTENRVLQNCRHPFLTSLKYSFQTQDRLCFVM 247 (516)
T ss_pred chhhHHHHhcCCccceEEEEeecccCceeehhhhhhhheeehHHhhhhhhHHHHHHhccCcHHHHhhhhhccCceEEEEE
Confidence 678888999999999999998 5689999999999876444333 457889999999999999999999999999999
Q ss_pred EeccCCCHHHHHhhhcCCCCCcCHHHHHHHHHHHHHHHHHHHhccCCCeeecCCCCCCeEECCCCcEEEEEcccccccCC
Q 002673 683 SYMENGSLDYWLHEKADGASQLDWLTRLKIARGTSCGLAYMHQICEPHIVHRDIKSSNILLDDQFEAHLADFGLSRLILP 762 (894)
Q Consensus 683 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDLkp~NILld~~~~vkl~DFGla~~~~~ 762 (894)
||..||.|..+|.+. ..++......+-..|+.||.|||+ ++||.||||-+|.|||.+|++||+|||+++.-..
T Consensus 248 eyanGGeLf~HLsre----r~FsE~RtRFYGaEIvsAL~YLHs---~~ivYRDlKLENLlLDkDGHIKitDFGLCKE~I~ 320 (516)
T KOG0690|consen 248 EYANGGELFFHLSRE----RVFSEDRTRFYGAEIVSALGYLHS---RNIVYRDLKLENLLLDKDGHIKITDFGLCKEEIK 320 (516)
T ss_pred EEccCceEeeehhhh----hcccchhhhhhhHHHHHHhhhhhh---CCeeeeechhhhheeccCCceEeeecccchhccc
Confidence 999999998888753 467888888889999999999997 6999999999999999999999999999985322
Q ss_pred CCCcccccccccCCccCcccccCcCCCccccHHHHHHHHHHHHcCCCCCCCCCcchhhhHHHHHHHHhhcCCCCcccccc
Q 002673 763 YQTHVTTELVGTLGYIPPEYGQAWVATLRGDMYSFGVVMLELLTGKRPVDVLKPKMSRELVGWVLKMRSEGKQDQVFDPI 842 (894)
Q Consensus 763 ~~~~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwS~GvlL~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 842 (894)
....+..++|||.|+|||++....|...+|+|.+||+||||++|+.||...+.+.--.++ . -.+-. +.
T Consensus 321 -~g~t~kTFCGTPEYLAPEVleDnDYgraVDWWG~GVVMYEMmCGRLPFyn~dh~kLFeLI---l--~ed~k----FP-- 388 (516)
T KOG0690|consen 321 -YGDTTKTFCGTPEYLAPEVLEDNDYGRAVDWWGVGVVMYEMMCGRLPFYNKDHEKLFELI---L--MEDLK----FP-- 388 (516)
T ss_pred -ccceeccccCChhhcCchhhccccccceeehhhhhHHHHHHHhccCcccccchhHHHHHH---H--hhhcc----CC--
Confidence 233466789999999999999999999999999999999999999999754432211111 0 00000 11
Q ss_pred ccCCCChHHHHHHHHHHHHhcccCCCCCC-----CHHHHHH
Q 002673 843 LRGKGFDEEMLQVLDVACMCVSQNPFKRP-----TVKEVVE 878 (894)
Q Consensus 843 l~~~~~~~~~~~l~~li~~Cl~~dP~~RP-----s~~evl~ 878 (894)
...+. +...++...+..||.+|. .+.||.+
T Consensus 389 ---r~ls~---eAktLLsGLL~kdP~kRLGgGpdDakEi~~ 423 (516)
T KOG0690|consen 389 ---RTLSP---EAKTLLSGLLKKDPKKRLGGGPDDAKEIMR 423 (516)
T ss_pred ---ccCCH---HHHHHHHHHhhcChHhhcCCCchhHHHHHh
Confidence 11122 344677789999999997 4566654
|
|
| >KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.8e-31 Score=307.13 Aligned_cols=257 Identities=25% Similarity=0.253 Sum_probs=205.2
Q ss_pred HHHHhccCCCccceEeecCcEEEEEEEE-cCCCeEEEEEEcCcch---hhHHHHHHHHHHHHhcCCCceeeecceeeecc
Q 002673 601 ELLKATDNFSQANIIGCGGFGLVYKATL-ANGTTLAIKKLSGDLG---LMEREFKAEVEALSTAQHKNLVSLQGYCVHQG 676 (894)
Q Consensus 601 el~~a~~~f~~~~~LG~G~fg~Vy~a~~-~~g~~vAvK~~~~~~~---~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~ 676 (894)
++.-..++|.+.++||+|+||.|..++. .+++.+|+|++.+..- ..-.-|..|-.+|..-+.+=|++++-.|.++.
T Consensus 69 ~lrl~~~DfeilKvIGrGaFGEV~lVr~k~t~~VYAMK~lnK~eMlKr~~tA~F~EERDimv~~ns~Wiv~LhyAFQD~~ 148 (1317)
T KOG0612|consen 69 ELRLKAEDFEILKVIGRGAFGEVALVRHKSTEKVYAMKILNKWEMLKRAETACFREERDIMVFGNSEWIVQLHYAFQDER 148 (1317)
T ss_pred HHhCCHHhhHHHHHhcccccceeEEEEeeccccchhHHHhhHHHHhhchhHHHHHHHhHHHHcCCcHHHHHHHHHhcCcc
Confidence 3444458999999999999999999984 6789999999987532 22345889999999999999999999999999
Q ss_pred eEEEEEEeccCCCHHHHHhhhcCCCCCcCHHHHHHHHHHHHHHHHHHHhccCCCeeecCCCCCCeEECCCCcEEEEEccc
Q 002673 677 FRLLIYSYMENGSLDYWLHEKADGASQLDWLTRLKIARGTSCGLAYMHQICEPHIVHRDIKSSNILLDDQFEAHLADFGL 756 (894)
Q Consensus 677 ~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDLkp~NILld~~~~vkl~DFGl 756 (894)
+.|||||||+||+|-.++.... .++...+..++..|+-||.-||++ |+|||||||.|||||..|++||+|||.
T Consensus 149 ~LYlVMdY~pGGDlltLlSk~~----~~pE~~ArFY~aEiVlAldslH~m---gyVHRDiKPDNvLld~~GHikLADFGs 221 (1317)
T KOG0612|consen 149 YLYLVMDYMPGGDLLTLLSKFD----RLPEDWARFYTAEIVLALDSLHSM---GYVHRDIKPDNVLLDKSGHIKLADFGS 221 (1317)
T ss_pred ceEEEEecccCchHHHHHhhcC----CChHHHHHHHHHHHHHHHHHHHhc---cceeccCCcceeEecccCcEeeccchh
Confidence 9999999999999999998652 588888889999999999999986 999999999999999999999999999
Q ss_pred ccccCCCCCcccccccccCCccCccccc----C-cCCCccccHHHHHHHHHHHHcCCCCCCCCCcchhhhHHHHHHHHhh
Q 002673 757 SRLILPYQTHVTTELVGTLGYIPPEYGQ----A-WVATLRGDMYSFGVVMLELLTGKRPVDVLKPKMSRELVGWVLKMRS 831 (894)
Q Consensus 757 a~~~~~~~~~~~~~~~gt~~Y~APE~~~----~-~~~s~ksDVwS~GvlL~elltG~~Pf~~~~~~~~~~~~~~~~~~~~ 831 (894)
|-.+.....-.....+|||.|++||++. + +.|+..+|+||+||++|||+.|..||.. ..+++...++-.
T Consensus 222 Clkm~~dG~V~s~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMlyG~TPFYa------dslveTY~KIm~ 295 (1317)
T KOG0612|consen 222 CLKMDADGTVRSSVAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEMLYGETPFYA------DSLVETYGKIMN 295 (1317)
T ss_pred HHhcCCCCcEEeccccCCCCccCHHHHHhhcCCccccCCccchhhhHHHHHHHHcCCCcchH------HHHHHHHHHHhc
Confidence 9888766666667789999999999864 3 5788999999999999999999999973 344444433322
Q ss_pred cCCCCccccccccCCCChHHHHHHHHHHHHhcccCCCCCCC---HHHHHH
Q 002673 832 EGKQDQVFDPILRGKGFDEEMLQVLDVACMCVSQNPFKRPT---VKEVVE 878 (894)
Q Consensus 832 ~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs---~~evl~ 878 (894)
....-.+.+.. +.+.+..+||...+. +|+.|.. ++++-.
T Consensus 296 hk~~l~FP~~~-------~VSeeakdLI~~ll~-~~e~RLgrngiedik~ 337 (1317)
T KOG0612|consen 296 HKESLSFPDET-------DVSEEAKDLIEALLC-DREVRLGRNGIEDIKN 337 (1317)
T ss_pred hhhhcCCCccc-------ccCHHHHHHHHHHhc-ChhhhcccccHHHHHh
Confidence 22221121111 122344566666555 6777877 888765
|
|
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.5e-30 Score=306.78 Aligned_cols=253 Identities=28% Similarity=0.400 Sum_probs=184.3
Q ss_pred hccCCCccceEeecCcEEEEEEEE-cCCCeEEEEEEcCcc-hhhHHHHHHHHHHHHhcCCCceeeecceeeec-------
Q 002673 605 ATDNFSQANIIGCGGFGLVYKATL-ANGTTLAIKKLSGDL-GLMEREFKAEVEALSTAQHKNLVSLQGYCVHQ------- 675 (894)
Q Consensus 605 a~~~f~~~~~LG~G~fg~Vy~a~~-~~g~~vAvK~~~~~~-~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~------- 675 (894)
...+|++.++||+||||.|||++. -||..+|||+|.-.. ......+.+|++++++++|||||+++..+.+.
T Consensus 477 Y~~DFEEL~lLGkGGFG~VvkVRNKlDGr~YAIKKIpl~~s~~~~skI~rEVk~LArLnHpNVVRYysAWVEs~~~~~~~ 556 (1351)
T KOG1035|consen 477 YLNDFEELELLGKGGFGSVVKVRNKLDGREYAIKKIPLKASDKLYSKILREVKLLARLNHPNVVRYYSAWVESTAELTVL 556 (1351)
T ss_pred HhhhhHHHHHhcCCCCceEEEEeecccchhhhhhhccCchHHHHHHHHHHHHHHHhhcCCcceeeeehhhhccCCccccc
Confidence 346788899999999999999984 489999999998653 23345688999999999999999986532110
Q ss_pred --------------------------------------------------------------------------------
Q 002673 676 -------------------------------------------------------------------------------- 675 (894)
Q Consensus 676 -------------------------------------------------------------------------------- 675 (894)
T Consensus 557 ei~~~~~~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~~~S~tS~~ 636 (1351)
T KOG1035|consen 557 EIVASDSESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGRNLSNTSDS 636 (1351)
T ss_pred cccccchhhhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCccccccccccccccccccc
Confidence
Q ss_pred --------------------------------ceEEEEEEeccCCCHHHHHhhhcCCCCCcCHHHHHHHHHHHHHHHHHH
Q 002673 676 --------------------------------GFRLLIYSYMENGSLDYWLHEKADGASQLDWLTRLKIARGTSCGLAYM 723 (894)
Q Consensus 676 --------------------------------~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yL 723 (894)
...|+=||||+.-++.++++++.-.. .....++++++|++||.|+
T Consensus 637 e~~~~~d~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N~~~~---~~d~~wrLFreIlEGLaYI 713 (1351)
T KOG1035|consen 637 EGSVILDDTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRRNHFNS---QRDEAWRLFREILEGLAYI 713 (1351)
T ss_pred CCccccCcchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHhcccch---hhHHHHHHHHHHHHHHHHH
Confidence 01256678888777776666532110 2456789999999999999
Q ss_pred HhccCCCeeecCCCCCCeEECCCCcEEEEEcccccccC----------------C-CCCcccccccccCCccCcccccCc
Q 002673 724 HQICEPHIVHRDIKSSNILLDDQFEAHLADFGLSRLIL----------------P-YQTHVTTELVGTLGYIPPEYGQAW 786 (894)
Q Consensus 724 H~~~~~~ivHrDLkp~NILld~~~~vkl~DFGla~~~~----------------~-~~~~~~~~~~gt~~Y~APE~~~~~ 786 (894)
|+ ++||||||||.||+||++..|||+|||+++... . ......+..+||.-|+|||++.+.
T Consensus 714 H~---~giIHRDLKP~NIFLd~~~~VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAPEll~~~ 790 (1351)
T KOG1035|consen 714 HD---QGIIHRDLKPRNIFLDSRNSVKIGDFGLATDLKENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVAPELLSDT 790 (1351)
T ss_pred Hh---CceeeccCCcceeEEcCCCCeeecccccchhhhhhhhhHhhccCccccccCCCCcccccccceeeeecHHHhccc
Confidence 97 599999999999999999999999999999821 0 011123457899999999998765
Q ss_pred C---CCccccHHHHHHHHHHHHcCCCCCCCCCcchhhhHHHHHHHHhhcCCCCccccccccCCCChHHHHHHHHHHHHhc
Q 002673 787 V---ATLRGDMYSFGVVMLELLTGKRPVDVLKPKMSRELVGWVLKMRSEGKQDQVFDPILRGKGFDEEMLQVLDVACMCV 863 (894)
Q Consensus 787 ~---~s~ksDVwS~GvlL~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl 863 (894)
. |+.|+|+||+|||++||+. ||.. .+.+ .... .-.+.+.+..- +.+ +.+++..=..+|.+++
T Consensus 791 ~~~~Yn~KiDmYSLGIVlFEM~y---PF~T---sMER--a~iL-~~LR~g~iP~~--~~f----~~~~~~~e~slI~~Ll 855 (1351)
T KOG1035|consen 791 SSNKYNSKIDMYSLGIVLFEMLY---PFGT---SMER--ASIL-TNLRKGSIPEP--ADF----FDPEHPEEASLIRWLL 855 (1351)
T ss_pred ccccccchhhhHHHHHHHHHHhc---cCCc---hHHH--HHHH-HhcccCCCCCC--ccc----ccccchHHHHHHHHHh
Confidence 4 9999999999999999986 4542 1111 1111 11223333222 111 1122223347889999
Q ss_pred ccCCCCCCCHHHHHH
Q 002673 864 SQNPFKRPTVKEVVE 878 (894)
Q Consensus 864 ~~dP~~RPs~~evl~ 878 (894)
+.||.+|||+.|++.
T Consensus 856 ~hdP~kRPtA~eLL~ 870 (1351)
T KOG1035|consen 856 SHDPSKRPTATELLN 870 (1351)
T ss_pred cCCCccCCCHHHHhh
Confidence 999999999999987
|
|
| >cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=9.1e-30 Score=270.96 Aligned_cols=236 Identities=26% Similarity=0.288 Sum_probs=190.5
Q ss_pred EeecCcEEEEEEEEc-CCCeEEEEEEcCcch---hhHHHHHHHHHHHHhcCCCceeeecceeeecceEEEEEEeccCCCH
Q 002673 615 IGCGGFGLVYKATLA-NGTTLAIKKLSGDLG---LMEREFKAEVEALSTAQHKNLVSLQGYCVHQGFRLLIYSYMENGSL 690 (894)
Q Consensus 615 LG~G~fg~Vy~a~~~-~g~~vAvK~~~~~~~---~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~lV~E~~~~gsL 690 (894)
||+|+||.||++... +++.+|+|.+..... .....+..|+.+++.++|+||+++++.+..+...++||||+++++|
T Consensus 1 lg~G~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L 80 (250)
T cd05123 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHYAFQTEEKLYLVLEYAPGGEL 80 (250)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEeehhhhcchHHHHHHHHHHHHHHHcCCCcHHHHHHHeecCCeeEEEEecCCCCcH
Confidence 689999999999854 589999999876432 2345788999999999999999999999999999999999999999
Q ss_pred HHHHhhhcCCCCCcCHHHHHHHHHHHHHHHHHHHhccCCCeeecCCCCCCeEECCCCcEEEEEcccccccCCCCCccccc
Q 002673 691 DYWLHEKADGASQLDWLTRLKIARGTSCGLAYMHQICEPHIVHRDIKSSNILLDDQFEAHLADFGLSRLILPYQTHVTTE 770 (894)
Q Consensus 691 ~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDLkp~NILld~~~~vkl~DFGla~~~~~~~~~~~~~ 770 (894)
.+++... ..+++.....++.|++.||.|||+ ++++|+||+|+||+++.++.++|+|||++....... .....
T Consensus 81 ~~~l~~~----~~l~~~~~~~~~~qi~~~l~~lh~---~~~~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~~-~~~~~ 152 (250)
T cd05123 81 FSHLSKE----GRFSEERARFYAAEIVLALEYLHS---LGIIYRDLKPENILLDADGHIKLTDFGLAKELSSEG-SRTNT 152 (250)
T ss_pred HHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHH---CCceecCCCcceEEEcCCCcEEEeecCcceecccCC-CcccC
Confidence 9999754 258899999999999999999997 699999999999999999999999999998754322 22344
Q ss_pred ccccCCccCcccccCcCCCccccHHHHHHHHHHHHcCCCCCCCCCcchhhhHHHHHHHHhhcCCCCccccccccCCCChH
Q 002673 771 LVGTLGYIPPEYGQAWVATLRGDMYSFGVVMLELLTGKRPVDVLKPKMSRELVGWVLKMRSEGKQDQVFDPILRGKGFDE 850 (894)
Q Consensus 771 ~~gt~~Y~APE~~~~~~~s~ksDVwS~GvlL~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~ 850 (894)
..++..|+|||...+...+.++|+||||+++|+|++|+.||..... ..... .... ... .+...
T Consensus 153 ~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~---~~~~~---~~~~-~~~--~~~~~-------- 215 (250)
T cd05123 153 FCGTPEYLAPEVLLGKGYGKAVDWWSLGVLLYEMLTGKPPFYAEDR---KEIYE---KILK-DPL--RFPEF-------- 215 (250)
T ss_pred CcCCccccChHHhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCH---HHHHH---HHhc-CCC--CCCCC--------
Confidence 5678899999999888889999999999999999999999975432 11111 1111 110 01110
Q ss_pred HHHHHHHHHHHhcccCCCCCCCHHH
Q 002673 851 EMLQVLDVACMCVSQNPFKRPTVKE 875 (894)
Q Consensus 851 ~~~~l~~li~~Cl~~dP~~RPs~~e 875 (894)
....+.+++.+|+..||++||++.+
T Consensus 216 ~~~~l~~~i~~~l~~~p~~R~~~~~ 240 (250)
T cd05123 216 LSPEARDLISGLLQKDPTKRLGSGG 240 (250)
T ss_pred CCHHHHHHHHHHhcCCHhhCCCccc
Confidence 1235678999999999999999943
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the |
| >KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.5e-31 Score=285.28 Aligned_cols=250 Identities=23% Similarity=0.329 Sum_probs=201.7
Q ss_pred cceEeecCcEEEEEEE-EcCCCeEEEEEEcCcc--hhhHHHHHHHHHHHHhcCCCceeeecceeeecceEEEEEEeccCC
Q 002673 612 ANIIGCGGFGLVYKAT-LANGTTLAIKKLSGDL--GLMEREFKAEVEALSTAQHKNLVSLQGYCVHQGFRLLIYSYMENG 688 (894)
Q Consensus 612 ~~~LG~G~fg~Vy~a~-~~~g~~vAvK~~~~~~--~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~lV~E~~~~g 688 (894)
.+.||+|-||+||-|+ .++|+.||||++.+.. ...+.+++.|+.+|..++||.||.+--.|++.+..++|||-+ +|
T Consensus 569 devLGSGQFG~VYgg~hRktGrdVAvKvIdKlrFp~kqesqlR~EVaILq~l~HPGiV~le~M~ET~ervFVVMEKl-~G 647 (888)
T KOG4236|consen 569 DEVLGSGQFGTVYGGKHRKTGRDVAVKVIDKLRFPTKQESQLRNEVAILQNLHHPGIVNLECMFETPERVFVVMEKL-HG 647 (888)
T ss_pred HhhccCCcceeeecceecccCceeeeeeeecccCCCchHHHHHHHHHHHHhcCCCCeeEEEEeecCCceEEEEehhh-cc
Confidence 4789999999999998 5689999999997643 344578999999999999999999999999999999999999 45
Q ss_pred CHHHHHhhhcCCCCCcCHHHHHHHHHHHHHHHHHHHhccCCCeeecCCCCCCeEECCCC---cEEEEEcccccccCCCCC
Q 002673 689 SLDYWLHEKADGASQLDWLTRLKIARGTSCGLAYMHQICEPHIVHRDIKSSNILLDDQF---EAHLADFGLSRLILPYQT 765 (894)
Q Consensus 689 sL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDLkp~NILld~~~---~vkl~DFGla~~~~~~~~ 765 (894)
+..+.+-... ..+++...-..+..||+.||.|||. ++|+|+||||+||||.+.. ++||||||+|+.+...
T Consensus 648 DMLEMILSsE--kgRL~er~TkFlvtQIL~ALr~LH~---knIvHCDLKPENVLLas~~~FPQvKlCDFGfARiIgEk-- 720 (888)
T KOG4236|consen 648 DMLEMILSSE--KGRLPERITKFLVTQILVALRYLHF---KNIVHCDLKPENVLLASASPFPQVKLCDFGFARIIGEK-- 720 (888)
T ss_pred hHHHHHHHhh--cccchHHHHHHHHHHHHHHHHHhhh---cceeeccCCchheeeccCCCCCceeeccccceeecchh--
Confidence 6655554332 3568888888899999999999997 6999999999999997643 5999999999988543
Q ss_pred cccccccccCCccCcccccCcCCCccccHHHHHHHHHHHHcCCCCCCCCCcchhhhHHHHHHHHhhcCCCCccccccccC
Q 002673 766 HVTTELVGTLGYIPPEYGQAWVATLRGDMYSFGVVMLELLTGKRPVDVLKPKMSRELVGWVLKMRSEGKQDQVFDPILRG 845 (894)
Q Consensus 766 ~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwS~GvlL~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~ 845 (894)
......+||+.|+|||++.++.|...-|+||.|||+|--++|..||.... +..+.++-...+.....
T Consensus 721 sFRrsVVGTPAYLaPEVLrnkGyNrSLDMWSVGVIiYVsLSGTFPFNEdE--dIndQIQNAaFMyPp~P----------- 787 (888)
T KOG4236|consen 721 SFRRSVVGTPAYLAPEVLRNKGYNRSLDMWSVGVIIYVSLSGTFPFNEDE--DINDQIQNAAFMYPPNP----------- 787 (888)
T ss_pred hhhhhhcCCccccCHHHHhhccccccccceeeeEEEEEEecccccCCCcc--chhHHhhccccccCCCc-----------
Confidence 33456799999999999999999999999999999999999999997432 23333322222222222
Q ss_pred CCChHHHHHHHHHHHHhcccCCCCCCCHHHHHH--HHHhcc
Q 002673 846 KGFDEEMLQVLDVACMCVSQNPFKRPTVKEVVE--WLNNVG 884 (894)
Q Consensus 846 ~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~--~L~~i~ 884 (894)
+.+.....+++|...++..=.+|-|.+..+. ||+...
T Consensus 788 --W~eis~~AidlIn~LLqVkm~kRysvdk~lsh~Wlq~yq 826 (888)
T KOG4236|consen 788 --WSEISPEAIDLINNLLQVKMRKRYSVDKSLSHPWLQDYQ 826 (888)
T ss_pred --hhhcCHHHHHHHHHHHHHHHHHhcchHhhccchhhhcch
Confidence 2333446678899999999999999999887 776543
|
|
| >KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1e-30 Score=267.74 Aligned_cols=268 Identities=25% Similarity=0.295 Sum_probs=198.2
Q ss_pred cCCCccceEeecCcEEEEEEEEc---C--CCeEEEEEEcCcch--hhHHHHHHHHHHHHhcCCCceeeecceeee-cceE
Q 002673 607 DNFSQANIIGCGGFGLVYKATLA---N--GTTLAIKKLSGDLG--LMEREFKAEVEALSTAQHKNLVSLQGYCVH-QGFR 678 (894)
Q Consensus 607 ~~f~~~~~LG~G~fg~Vy~a~~~---~--g~~vAvK~~~~~~~--~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~-~~~~ 678 (894)
..|+....||+|.||.||+|.-. + ...+|+|+++.... .......+|+..++.++|||++.+..++.+ +...
T Consensus 24 ~~ye~ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd~tGiS~SAcREiaL~REl~h~nvi~Lv~Vfl~~d~~v 103 (438)
T KOG0666|consen 24 FEYEGIGKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKDGTGISMSACREIALLRELKHPNVISLVKVFLSHDKKV 103 (438)
T ss_pred HHhhccceecccccceeeEeeeccCCcccchhhHHHHHhccCCCCCcCHHHHHHHHHHHHhcCCcchhHHHHHhccCceE
Confidence 46888899999999999999632 2 23689999986532 234567899999999999999999999988 7789
Q ss_pred EEEEEeccCCCHHHHHhhhc-CCCCCcCHHHHHHHHHHHHHHHHHHHhccCCCeeecCCCCCCeEECCC----CcEEEEE
Q 002673 679 LLIYSYMENGSLDYWLHEKA-DGASQLDWLTRLKIARGTSCGLAYMHQICEPHIVHRDIKSSNILLDDQ----FEAHLAD 753 (894)
Q Consensus 679 ~lV~E~~~~gsL~~~l~~~~-~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDLkp~NILld~~----~~vkl~D 753 (894)
+|++||.+. +|.+.++-.. .....++......|+.||+.|+.|||+ +-|+||||||.|||+..+ |.|||+|
T Consensus 104 ~l~fdYAEh-DL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH~---NWvlHRDLKPaNIlvmgdgperG~VKIaD 179 (438)
T KOG0666|consen 104 WLLFDYAEH-DLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLHS---NWVLHRDLKPANILVMGDGPERGRVKIAD 179 (438)
T ss_pred EEEehhhhh-hHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHhh---hheeeccCCcceEEEeccCCccCeeEeec
Confidence 999999986 7888876433 223578889999999999999999997 689999999999999876 9999999
Q ss_pred cccccccCCCCCc--ccccccccCCccCcccccCc-CCCccccHHHHHHHHHHHHcCCCCCCCCCcchh------hhHHH
Q 002673 754 FGLSRLILPYQTH--VTTELVGTLGYIPPEYGQAW-VATLRGDMYSFGVVMLELLTGKRPVDVLKPKMS------RELVG 824 (894)
Q Consensus 754 FGla~~~~~~~~~--~~~~~~gt~~Y~APE~~~~~-~~s~ksDVwS~GvlL~elltG~~Pf~~~~~~~~------~~~~~ 824 (894)
||+++.+...-.. ....++-|..|.|||.+.|. .||.++|||+.|||+.||+|-++-|.+...+.. .+.+.
T Consensus 180 lGlaR~~~~plkpl~s~d~VVVTiWYRAPELLLGa~hYT~AiDvWAiGCIfaElLtl~PlF~g~E~k~~~~~Pfq~dQl~ 259 (438)
T KOG0666|consen 180 LGLARLFNNPLKPLASLDPVVVTIWYRAPELLLGARHYTKAIDVWAIGCIFAELLTLEPLFKGREEKIKTKNPFQHDQLD 259 (438)
T ss_pred ccHHHHhhccccccccCCceEEEEEecChHHhcccccccchhhhHHHHHHHHHHHccCccccchhhhcccCCCchHHHHH
Confidence 9999987543222 23456789999999998875 689999999999999999998888864432211 11222
Q ss_pred HHHHHhhcCCCCccccc-----------cccCCCCh-----HH-------HHHHHHHHHHhcccCCCCCCCHHHHHH
Q 002673 825 WVLKMRSEGKQDQVFDP-----------ILRGKGFD-----EE-------MLQVLDVACMCVSQNPFKRPTVKEVVE 878 (894)
Q Consensus 825 ~~~~~~~~~~~~~~~d~-----------~l~~~~~~-----~~-------~~~l~~li~~Cl~~dP~~RPs~~evl~ 878 (894)
.+...........+.+- .++..++. .. ...-++++..++..||-+|.|+++.++
T Consensus 260 rIf~vLG~Pt~~~Wp~lkk~Pe~q~~ls~f~~~~~~n~sL~~~~~~~k~k~~~a~~LL~klL~yDP~kRIta~qAle 336 (438)
T KOG0666|consen 260 RIFEVLGTPTDKDWPDLKKMPEYQTLLSDFRRHYYDNVSLHKYYHKHKVKDPSALDLLQKLLTYDPIKRITAEQALE 336 (438)
T ss_pred HHHHHcCCCccccchhhhhCcchHHHHHHhHHhhcCcchHHHHHHHhcCCCchHHHHHHHHhccCchhhccHHHHhc
Confidence 22111111111111110 00000000 00 012568899999999999999999988
|
|
| >cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.1e-29 Score=303.38 Aligned_cols=145 Identities=28% Similarity=0.388 Sum_probs=129.6
Q ss_pred cCCCccceEeecCcEEEEEEEEc-CCCeEEEEEEcCcc---hhhHHHHHHHHHHHHhcCCCceeeecceeeecceEEEEE
Q 002673 607 DNFSQANIIGCGGFGLVYKATLA-NGTTLAIKKLSGDL---GLMEREFKAEVEALSTAQHKNLVSLQGYCVHQGFRLLIY 682 (894)
Q Consensus 607 ~~f~~~~~LG~G~fg~Vy~a~~~-~g~~vAvK~~~~~~---~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~lV~ 682 (894)
++|.+.+.||+|+||.||+|... +++.||||++.... ......+..|+.++..++||||+++++++......++||
T Consensus 4 ~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiKvi~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lVm 83 (669)
T cd05610 4 EEFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYYSLQSANNVYLVM 83 (669)
T ss_pred CCEEEEEEEecCCCeEEEEEEECCCCcEEEEEEEehhhccCHHHHHHHHHHHHHHHhcCCCCcCeEEEEEEECCEEEEEE
Confidence 57888999999999999999854 78999999987532 223467889999999999999999999999999999999
Q ss_pred EeccCCCHHHHHhhhcCCCCCcCHHHHHHHHHHHHHHHHHHHhccCCCeeecCCCCCCeEECCCCcEEEEEccccc
Q 002673 683 SYMENGSLDYWLHEKADGASQLDWLTRLKIARGTSCGLAYMHQICEPHIVHRDIKSSNILLDDQFEAHLADFGLSR 758 (894)
Q Consensus 683 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDLkp~NILld~~~~vkl~DFGla~ 758 (894)
||+.+++|.+++... ..+++..++.|+.||+.||.|||+ ++|+||||||+|||++.++.+||+|||+++
T Consensus 84 Ey~~g~~L~~li~~~----~~l~~~~~~~i~~qil~aL~yLH~---~gIiHrDLKP~NILl~~~g~vkL~DFGls~ 152 (669)
T cd05610 84 EYLIGGDVKSLLHIY----GYFDEEMAVKYISEVALALDYLHR---HGIIHRDLKPDNMLISNEGHIKLTDFGLSK 152 (669)
T ss_pred eCCCCCCHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHh---CCEEeCCccHHHEEEcCCCCEEEEeCCCCc
Confidence 999999999999753 347888899999999999999997 599999999999999999999999999986
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481 |
| >KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1e-29 Score=291.42 Aligned_cols=254 Identities=25% Similarity=0.372 Sum_probs=208.4
Q ss_pred HhccCCCccceEeecCcEEEEEEE-EcCCCeEEEEEEcCcchhhHHHHHHHHHHHHhc-CCCceeeecceeee-----cc
Q 002673 604 KATDNFSQANIIGCGGFGLVYKAT-LANGTTLAIKKLSGDLGLMEREFKAEVEALSTA-QHKNLVSLQGYCVH-----QG 676 (894)
Q Consensus 604 ~a~~~f~~~~~LG~G~fg~Vy~a~-~~~g~~vAvK~~~~~~~~~~~~~~~Ei~~l~~l-~HpnIv~l~g~~~~-----~~ 676 (894)
..++-|++.+.||.|.+|.||+++ .++++.+|+|+...+. ....++..|.++++.. +|||++.++|++.. ++
T Consensus 16 dp~d~~ei~evig~Gtygkv~k~k~~~~~~~aa~kI~~~~~-d~deEiE~eynil~~~~~hpnv~~fyg~~~k~~~~~~D 94 (953)
T KOG0587|consen 16 DPADIFEIIEVIGNGTYGKVYKGRHVKTGQLAAIKIMDPTE-DEEEEIELEYNMLKKYSHHPNVATFYGAFIKKDPGNGD 94 (953)
T ss_pred CCCCccEEEEEEeeccceeEEEEeeeecCceeeeEeecCCc-cccHHHHHHHHHHHhccCCCCcceEEEEEEEecCCCCC
Confidence 345678889999999999999998 6789999999887653 3445678889999888 79999999999863 56
Q ss_pred eEEEEEEeccCCCHHHHHhhhcCCCCCcCHHHHHHHHHHHHHHHHHHHhccCCCeeecCCCCCCeEECCCCcEEEEEccc
Q 002673 677 FRLLIYSYMENGSLDYWLHEKADGASQLDWLTRLKIARGTSCGLAYMHQICEPHIVHRDIKSSNILLDDQFEAHLADFGL 756 (894)
Q Consensus 677 ~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDLkp~NILld~~~~vkl~DFGl 756 (894)
..|||||||.+||..++++... +..+.|..+..|++.++.|+.+||. +.++|||||-.|||++.++.||++|||.
T Consensus 95 qLWLVMEfC~gGSVTDLVKn~~--g~rl~E~~IaYI~re~lrgl~HLH~---nkviHRDikG~NiLLT~e~~VKLvDFGv 169 (953)
T KOG0587|consen 95 QLWLVMEFCGGGSVTDLVKNTK--GNRLKEEWIAYILREILRGLAHLHN---NKVIHRDIKGQNVLLTENAEVKLVDFGV 169 (953)
T ss_pred eEEEEeeccCCccHHHHHhhhc--ccchhhHHHHHHHHHHHHHHHHHhh---cceeeecccCceEEEeccCcEEEeeeee
Confidence 8999999999999999998755 5789999999999999999999996 6999999999999999999999999999
Q ss_pred ccccCCCCCcccccccccCCccCcccccC-----cCCCccccHHHHHHHHHHHHcCCCCCCCCCcchhhhHHHHHHHHhh
Q 002673 757 SRLILPYQTHVTTELVGTLGYIPPEYGQA-----WVATLRGDMYSFGVVMLELLTGKRPVDVLKPKMSRELVGWVLKMRS 831 (894)
Q Consensus 757 a~~~~~~~~~~~~~~~gt~~Y~APE~~~~-----~~~s~ksDVwS~GvlL~elltG~~Pf~~~~~~~~~~~~~~~~~~~~ 831 (894)
+..+.. ........+||+.|||||++.. ..|+.++|+||+|++..||--|.+|+.++.+-. - .
T Consensus 170 SaQlds-T~grRnT~iGtP~WMAPEViac~e~~d~tyd~R~D~WsLGITaIEladG~PPl~DmHPmr--a----L----- 237 (953)
T KOG0587|consen 170 SAQLDS-TVGRRNTFIGTPYWMAPEVIACDESPDATYDYRSDLWSLGITAIEMAEGAPPLCDMHPMR--A----L----- 237 (953)
T ss_pred eeeeec-ccccccCcCCCcccccceeeecccCCCCCcccccchhhccceeehhcCCCCCccCcchhh--h----h-----
Confidence 987643 2334556789999999998754 346788999999999999999999997665421 1 0
Q ss_pred cCCCCccccccccCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 002673 832 EGKQDQVFDPILRGKGFDEEMLQVLDVACMCVSQNPFKRPTVKEVVE 878 (894)
Q Consensus 832 ~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~ 878 (894)
-.+.....|.+ ..+..-..++.++|..|+..|.++||++.++++
T Consensus 238 -F~IpRNPPPkL--krp~kWs~~FndFIs~cL~Kd~e~RP~~~~ll~ 281 (953)
T KOG0587|consen 238 -FLIPRNPPPKL--KRPKKWSKKFNDFISTCLVKDYEQRPSTEELLK 281 (953)
T ss_pred -ccCCCCCCccc--cchhhHHHHHHHHHHHHHhhccccCcchhhhcc
Confidence 11111122222 234455678899999999999999999999986
|
|
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.1e-30 Score=288.97 Aligned_cols=242 Identities=21% Similarity=0.251 Sum_probs=193.5
Q ss_pred hccCCCccceEeecCcEEEEEEE-EcCCCeEEEEEEcCcchhhHHHHHHHHHHHHhc-CCCceeeecceeeecceEEEEE
Q 002673 605 ATDNFSQANIIGCGGFGLVYKAT-LANGTTLAIKKLSGDLGLMEREFKAEVEALSTA-QHKNLVSLQGYCVHQGFRLLIY 682 (894)
Q Consensus 605 a~~~f~~~~~LG~G~fg~Vy~a~-~~~g~~vAvK~~~~~~~~~~~~~~~Ei~~l~~l-~HpnIv~l~g~~~~~~~~~lV~ 682 (894)
.++.|.....+|.|+|+.|-.+. ..+++..+||++.+. ..+-.+|+.++... +||||+++.+.+.+..+.|+||
T Consensus 320 ~~~~y~~~~~~~~gs~s~~~~~~~~~t~~~~~vkii~~~----~~~~~~e~~~~~~~~~h~niv~~~~v~~~~~~~~~v~ 395 (612)
T KOG0603|consen 320 FTESYEFREELGEGSFSAVKYCESSPTDQEPAVKIISKR----ADDNQDEIPISLLVRDHPNIVKSHDVYEDGKEIYLVM 395 (612)
T ss_pred cchhhccccccCCCCccceeeeeccccccchhheecccc----ccccccccchhhhhcCCCcceeecceecCCceeeeee
Confidence 35678888889999999998887 567889999999865 23345677666665 7999999999999999999999
Q ss_pred EeccCCCHHHHHhhhcCCCCCcCHHHHHHHHHHHHHHHHHHHhccCCCeeecCCCCCCeEE-CCCCcEEEEEcccccccC
Q 002673 683 SYMENGSLDYWLHEKADGASQLDWLTRLKIARGTSCGLAYMHQICEPHIVHRDIKSSNILL-DDQFEAHLADFGLSRLIL 761 (894)
Q Consensus 683 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDLkp~NILl-d~~~~vkl~DFGla~~~~ 761 (894)
|++.+|-+.+.+.... ... ..+..|+.+|+.|+.|||. +|||||||||+|||+ ++.++++|+|||.++...
T Consensus 396 e~l~g~ell~ri~~~~----~~~-~e~~~w~~~lv~Av~~LH~---~gvvhRDLkp~NIL~~~~~g~lrltyFG~a~~~~ 467 (612)
T KOG0603|consen 396 ELLDGGELLRRIRSKP----EFC-SEASQWAAELVSAVDYLHE---QGVVHRDLKPGNILLDGSAGHLRLTYFGFWSELE 467 (612)
T ss_pred hhccccHHHHHHHhcc----hhH-HHHHHHHHHHHHHHHHHHh---cCeeecCCChhheeecCCCCcEEEEEechhhhCc
Confidence 9999998777766442 122 6777899999999999997 699999999999999 699999999999998765
Q ss_pred CCCCcccccccccCCccCcccccCcCCCccccHHHHHHHHHHHHcCCCCCCCCCcchhhhHHHHHHHHhhcCCCCccccc
Q 002673 762 PYQTHVTTELVGTLGYIPPEYGQAWVATLRGDMYSFGVVMLELLTGKRPVDVLKPKMSRELVGWVLKMRSEGKQDQVFDP 841 (894)
Q Consensus 762 ~~~~~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwS~GvlL~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 841 (894)
+. ....+-|..|.|||++....|++++||||||++||+|++|+.||...+.+ .++ ......+...+
T Consensus 468 ~~----~~tp~~t~~y~APEvl~~~~yt~acD~WSLGvlLy~ML~G~tp~~~~P~~--~ei----~~~i~~~~~s~---- 533 (612)
T KOG0603|consen 468 RS----CDTPALTLQYVAPEVLAIQEYTEACDWWSLGVLLYEMLTGRTLFAAHPAG--IEI----HTRIQMPKFSE---- 533 (612)
T ss_pred hh----hcccchhhcccChhhhccCCCCcchhhHHHHHHHHHHHhCCCccccCCch--HHH----HHhhcCCcccc----
Confidence 43 22235588999999999999999999999999999999999999876654 111 11122222111
Q ss_pred cccCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHH--HH
Q 002673 842 ILRGKGFDEEMLQVLDVACMCVSQNPFKRPTVKEVVE--WL 880 (894)
Q Consensus 842 ~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~--~L 880 (894)
..+....+|+.+||+.||.+||+|+++.. |+
T Consensus 534 --------~vS~~AKdLl~~LL~~dP~~Rl~~~~i~~h~w~ 566 (612)
T KOG0603|consen 534 --------CVSDEAKDLLQQLLQVDPALRLGADEIGAHPWF 566 (612)
T ss_pred --------ccCHHHHHHHHHhccCChhhCcChhhhccCcch
Confidence 11224568888999999999999999987 66
|
|
| >cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.3e-29 Score=265.59 Aligned_cols=220 Identities=22% Similarity=0.212 Sum_probs=174.6
Q ss_pred cCcEEEEEEEE-cCCCeEEEEEEcCcchhhHHHHHHHHHHHHhcCCCceeeecceeeecceEEEEEEeccCCCHHHHHhh
Q 002673 618 GGFGLVYKATL-ANGTTLAIKKLSGDLGLMEREFKAEVEALSTAQHKNLVSLQGYCVHQGFRLLIYSYMENGSLDYWLHE 696 (894)
Q Consensus 618 G~fg~Vy~a~~-~~g~~vAvK~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~ 696 (894)
|.+|.||++.. .+++.||+|++.... .+..|...+....||||+++++++...+..++||||+++|+|.+++..
T Consensus 4 g~~~~v~~~~~~~~~~~~~~K~i~~~~-----~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~ 78 (237)
T cd05576 4 GVIDKVLLVMDTRTQQTFILKGLRKSS-----EYSRERLTIIPHCVPNMVCLHKYIVSEDSVFLVLQHAEGGKLWSHISK 78 (237)
T ss_pred cccceEEEEEEccCCcEEEEEeecchh-----hhhhHHHHHHhcCCCceeehhhheecCCeEEEEEecCCCCCHHHHHHH
Confidence 88999999984 578999999997642 233455555666799999999999999999999999999999999875
Q ss_pred hcCCCCCcCHHHHHHHHHHHHHHHHHHHhccCCCeeecCCCCCCeEECCCCcEEEEEcccccccCCCCCcccccccccCC
Q 002673 697 KADGASQLDWLTRLKIARGTSCGLAYMHQICEPHIVHRDIKSSNILLDDQFEAHLADFGLSRLILPYQTHVTTELVGTLG 776 (894)
Q Consensus 697 ~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDLkp~NILld~~~~vkl~DFGla~~~~~~~~~~~~~~~gt~~ 776 (894)
. ..+++..+..++.|++.||.|||+ ++++||||||+||+++.++.++++|||.+...... .....++..
T Consensus 79 ~----~~l~~~~~~~~~~ql~~~l~~lH~---~~i~H~dlkp~Nil~~~~~~~~l~df~~~~~~~~~----~~~~~~~~~ 147 (237)
T cd05576 79 F----LNIPEECVKRWAAEMVVALDALHR---EGIVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDS----CDGEAVENM 147 (237)
T ss_pred h----cCCCHHHHHHHHHHHHHHHHHHHh---CCeeccCCCHHHEEEcCCCCEEEecccchhccccc----cccCCcCcc
Confidence 4 248899999999999999999997 69999999999999999999999999987655321 222345778
Q ss_pred ccCcccccCcCCCccccHHHHHHHHHHHHcCCCCCCCCCcchhhhHHHHHHHHhhcCCCCccccccccCCCChHHHHHHH
Q 002673 777 YIPPEYGQAWVATLRGDMYSFGVVMLELLTGKRPVDVLKPKMSRELVGWVLKMRSEGKQDQVFDPILRGKGFDEEMLQVL 856 (894)
Q Consensus 777 Y~APE~~~~~~~s~ksDVwS~GvlL~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~ 856 (894)
|+|||...+..++.++||||+|+++|||++|+.|+....... ... ..+ .+. ......+.
T Consensus 148 y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~~~~~~~~~~-------------~~~-~~~---~~~----~~~~~~~~ 206 (237)
T cd05576 148 YCAPEVGGISEETEACDWWSLGAILFELLTGKTLVECHPSGI-------------NTH-TTL---NIP----EWVSEEAR 206 (237)
T ss_pred ccCCcccCCCCCCchhhHHHHHHHHHHHHHCcchhhcCchhc-------------ccc-ccc---CCc----ccCCHHHH
Confidence 999999988888999999999999999999998875322110 000 000 000 01123567
Q ss_pred HHHHHhcccCCCCCCCHH
Q 002673 857 DVACMCVSQNPFKRPTVK 874 (894)
Q Consensus 857 ~li~~Cl~~dP~~RPs~~ 874 (894)
+++.+|++.||++||++.
T Consensus 207 ~li~~~l~~dp~~R~~~~ 224 (237)
T cd05576 207 SLLQQLLQFNPTERLGAG 224 (237)
T ss_pred HHHHHHccCCHHHhcCCC
Confidence 899999999999999973
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha |
| >KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.1e-29 Score=241.32 Aligned_cols=263 Identities=22% Similarity=0.255 Sum_probs=196.9
Q ss_pred CCCccceEeecCcEEEEEEE-EcCCCeEEEEEEcCcc--hhhHHHHHHHHHHHHhcCCCceeeecceeeecceEEEEEEe
Q 002673 608 NFSQANIIGCGGFGLVYKAT-LANGTTLAIKKLSGDL--GLMEREFKAEVEALSTAQHKNLVSLQGYCVHQGFRLLIYSY 684 (894)
Q Consensus 608 ~f~~~~~LG~G~fg~Vy~a~-~~~g~~vAvK~~~~~~--~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~lV~E~ 684 (894)
+|...++||+|.||+||+|+ +.+++.||+|+++-+. ...-....+|+-+++.++|.|||+++++...+...-+|+||
T Consensus 3 ~ydkmekigegtygtvfkarn~~t~eivalkrvrlddddegvpssalreicllkelkhknivrl~dvlhsdkkltlvfe~ 82 (292)
T KOG0662|consen 3 KYDKMEKIGEGTYGTVFKARNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFEF 82 (292)
T ss_pred chHHHHhhcCCcceeeEecccCCccceEEEEEEeccCCCCCCcHHHHHHHHHHHHhhhcceeehhhhhccCceeEEeHHH
Confidence 45566889999999999998 6678999999987543 22335678999999999999999999999999999999999
Q ss_pred ccCCCHHHHHhhhcCCCCCcCHHHHHHHHHHHHHHHHHHHhccCCCeeecCCCCCCeEECCCCcEEEEEcccccccCCCC
Q 002673 685 MENGSLDYWLHEKADGASQLDWLTRLKIARGTSCGLAYMHQICEPHIVHRDIKSSNILLDDQFEAHLADFGLSRLILPYQ 764 (894)
Q Consensus 685 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDLkp~NILld~~~~vkl~DFGla~~~~~~~ 764 (894)
|. .+|..+..... ..++......++.|+.+||.|+|++ ++.|||+||.|.||+.+|++|++|||+++.+.-.
T Consensus 83 cd-qdlkkyfdsln---g~~d~~~~rsfmlqllrgl~fchsh---nvlhrdlkpqnllin~ngelkladfglarafgip- 154 (292)
T KOG0662|consen 83 CD-QDLKKYFDSLN---GDLDPEIVRSFMLQLLRGLGFCHSH---NVLHRDLKPQNLLINRNGELKLADFGLARAFGIP- 154 (292)
T ss_pred hh-HHHHHHHHhcC---CcCCHHHHHHHHHHHHhhhhhhhhh---hhhhccCCcceEEeccCCcEEecccchhhhcCCc-
Confidence 95 47888877643 4578888999999999999999985 9999999999999999999999999999977432
Q ss_pred CcccccccccCCccCcccccCc-CCCccccHHHHHHHHHHHHc-CCCCCCCCCcchhhhHHHHHHHHhhcCCCCcc---c
Q 002673 765 THVTTELVGTLGYIPPEYGQAW-VATLRGDMYSFGVVMLELLT-GKRPVDVLKPKMSRELVGWVLKMRSEGKQDQV---F 839 (894)
Q Consensus 765 ~~~~~~~~gt~~Y~APE~~~~~-~~s~ksDVwS~GvlL~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~---~ 839 (894)
....+..+-|..|.+|.++.+. -|+...|+||-|||+.|+.. |++-|.+.+.++....+-|......+..+..+ .
T Consensus 155 vrcysaevvtlwyrppdvlfgakly~tsidmwsagcifaelanagrplfpg~dvddqlkrif~~lg~p~ed~wps~t~lp 234 (292)
T KOG0662|consen 155 VRCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEDQWPSMTKLP 234 (292)
T ss_pred eEeeeceeeeeeccCcceeeeeehhccchHhhhcchHHHHHhhcCCCCCCCCcHHHHHHHHHHHhCCCccccCCccccCC
Confidence 2233445678999999998886 57889999999999999988 55556544332222222222223333332221 1
Q ss_pred cccc----cC-CCChHH----HHHHHHHHHHhcccCCCCCCCHHHHHH
Q 002673 840 DPIL----RG-KGFDEE----MLQVLDVACMCVSQNPFKRPTVKEVVE 878 (894)
Q Consensus 840 d~~l----~~-~~~~~~----~~~l~~li~~Cl~~dP~~RPs~~evl~ 878 (894)
|-.. .. ..+++. ...-.+++...+.-+|.+|.++++.++
T Consensus 235 dyk~yp~ypattswsqivp~lns~grdllqkll~cnp~qrisaeaalq 282 (292)
T KOG0662|consen 235 DYKPYPIYPATTSWSQIVPKLNSTGRDLLQKLLKCNPAQRISAEAALQ 282 (292)
T ss_pred CCcccCCccccchHHHHhhhhcchhHHHHHHHhccCcccccCHHHHhc
Confidence 1110 00 011111 113357788888899999999998876
|
|
| >PLN03225 Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Probab=99.96 E-value=5.3e-29 Score=294.39 Aligned_cols=266 Identities=20% Similarity=0.231 Sum_probs=172.5
Q ss_pred hccCCCccceEeecCcEEEEEEEEc-C----CCeEEEEEEcCcchhhHHHHHHHHHHHHhcCCCceeeecce------ee
Q 002673 605 ATDNFSQANIIGCGGFGLVYKATLA-N----GTTLAIKKLSGDLGLMEREFKAEVEALSTAQHKNLVSLQGY------CV 673 (894)
Q Consensus 605 a~~~f~~~~~LG~G~fg~Vy~a~~~-~----g~~vAvK~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~------~~ 673 (894)
..++|+..+.||+|+||.||+|.+. + +..||||++...... + ....+ .+....+.+++.++.. +.
T Consensus 130 ~~~~y~l~~~LG~G~FG~VYka~~~~~~~~~~~~vAvK~~~~~~~~-e-~~~~e--~l~~~~~~~~~~~~~~~~~~~~~~ 205 (566)
T PLN03225 130 KKDDFVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYGAV-E-IWMNE--RVRRACPNSCADFVYGFLEPVSSK 205 (566)
T ss_pred ccCCeEEeEEEeeCCCeEEEEEEEcCCccccCcEEEEEEecccchh-H-HHHHH--HHHhhchhhHHHHHHhhhcccccc
Confidence 4578999999999999999999864 4 689999998643211 1 11111 1222222233222221 24
Q ss_pred ecceEEEEEEeccCCCHHHHHhhhcCC----------------CCCcCHHHHHHHHHHHHHHHHHHHhccCCCeeecCCC
Q 002673 674 HQGFRLLIYSYMENGSLDYWLHEKADG----------------ASQLDWLTRLKIARGTSCGLAYMHQICEPHIVHRDIK 737 (894)
Q Consensus 674 ~~~~~~lV~E~~~~gsL~~~l~~~~~~----------------~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDLk 737 (894)
.+...++||||+.+++|.+++...... ........+..++.|++.||.|||+ ++|+|||||
T Consensus 206 ~~~~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~---~gIiHRDLK 282 (566)
T PLN03225 206 KEDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHS---TGIVHRDVK 282 (566)
T ss_pred cCCceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHH---CCEEeCcCC
Confidence 566789999999999999998753210 0111233456799999999999997 599999999
Q ss_pred CCCeEECC-CCcEEEEEcccccccCCCCCcccccccccCCccCcccccCc----------------------CCCccccH
Q 002673 738 SSNILLDD-QFEAHLADFGLSRLILPYQTHVTTELVGTLGYIPPEYGQAW----------------------VATLRGDM 794 (894)
Q Consensus 738 p~NILld~-~~~vkl~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~~~~~----------------------~~s~ksDV 794 (894)
|+|||++. ++.+||+|||+++.+............+|+.|+|||.+... .++.++||
T Consensus 283 P~NILl~~~~~~~KL~DFGlA~~l~~~~~~~~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~l~~~~~~~k~DV 362 (566)
T PLN03225 283 PQNIIFSEGSGSFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDI 362 (566)
T ss_pred HHHEEEeCCCCcEEEEeCCCccccccccccCCcccccCCCccChHHhhccCCCCCCccccccccccchhccccCCCCccc
Confidence 99999986 67999999999987644444444567889999999954321 23456799
Q ss_pred HHHHHHHHHHHcCCCCCCCCCcch-------hhhHHHHHHHHhhcCCCCccccccccC--CCChHHHHHHHHHHHHhccc
Q 002673 795 YSFGVVMLELLTGKRPVDVLKPKM-------SRELVGWVLKMRSEGKQDQVFDPILRG--KGFDEEMLQVLDVACMCVSQ 865 (894)
Q Consensus 795 wS~GvlL~elltG~~Pf~~~~~~~-------~~~~~~~~~~~~~~~~~~~~~d~~l~~--~~~~~~~~~l~~li~~Cl~~ 865 (894)
|||||++|||+++..|++...... ..+...|....... ..+.+.. ...........+|+.+|++.
T Consensus 363 wSlGviL~el~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~------~~~~~~~~~~~~d~~~~~~~dLi~~mL~~ 436 (566)
T PLN03225 363 YSAGLIFLQMAFPNLRSDSNLIQFNRQLKRNDYDLVAWRKLVEPR------ASPDLRRGFEVLDLDGGAGWELLKSMMRF 436 (566)
T ss_pred HHHHHHHHHHHhCcCCCchHHHHHHHHHHhcCCcHHHHHHhhccc------cchhhhhhhhhccccchHHHHHHHHHccC
Confidence 999999999999877754211000 00011111110000 0000000 00000111345899999999
Q ss_pred CCCCCCCHHHHHH--HHHhc
Q 002673 866 NPFKRPTVKEVVE--WLNNV 883 (894)
Q Consensus 866 dP~~RPs~~evl~--~L~~i 883 (894)
||++|||++++++ |++..
T Consensus 437 dP~kR~ta~e~L~Hpff~~~ 456 (566)
T PLN03225 437 KGRQRISAKAALAHPYFDRE 456 (566)
T ss_pred CcccCCCHHHHhCCcCcCCC
Confidence 9999999999998 66543
|
|
| >KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=7.2e-30 Score=269.49 Aligned_cols=267 Identities=20% Similarity=0.291 Sum_probs=204.2
Q ss_pred ccCCCccceEeecCcEEEEEEEE-cCCCeEEEEEEcCcchhhHHHHHHHHHHHHhcCC--C----ceeeecceeeecceE
Q 002673 606 TDNFSQANIIGCGGFGLVYKATL-ANGTTLAIKKLSGDLGLMEREFKAEVEALSTAQH--K----NLVSLQGYCVHQGFR 678 (894)
Q Consensus 606 ~~~f~~~~~LG~G~fg~Vy~a~~-~~g~~vAvK~~~~~~~~~~~~~~~Ei~~l~~l~H--p----nIv~l~g~~~~~~~~ 678 (894)
+.+|.+...+|+|.||.|-.+.. ..+..||||+++. .....+..+-|++++.++.+ | -+|++.+||...++.
T Consensus 88 ~~Ry~i~~~lGeGtFGkV~ec~D~~~~~~vAlKIik~-V~kYreAa~iEi~vLqki~~~DP~g~~rcv~m~~wFdyrghi 166 (415)
T KOG0671|consen 88 TNRYEIVDLLGEGTFGKVVECWDRETKEHVALKIIKN-VDKYREAALIEIEVLQKINESDPNGKFRCVQMRDWFDYRGHI 166 (415)
T ss_pred ccceehhhhhcCCcccceEEEeecCCCceehHHHHHH-HHHHhhHHHHHHHHHHHHHhcCCCCceEEEeeehhhhccCce
Confidence 57889999999999999999974 3478999999874 34445667789999999943 2 478889999999999
Q ss_pred EEEEEeccCCCHHHHHhhhcCCCCCcCHHHHHHHHHHHHHHHHHHHhccCCCeeecCCCCCCeEECC-------------
Q 002673 679 LLIYSYMENGSLDYWLHEKADGASQLDWLTRLKIARGTSCGLAYMHQICEPHIVHRDIKSSNILLDD------------- 745 (894)
Q Consensus 679 ~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDLkp~NILld~------------- 745 (894)
++|+|.+ |-|+.+++... +...++..++..|+.|++++++|||+ .+++|-||||+|||+.+
T Consensus 167 Civfell-G~S~~dFlk~N--~y~~fpi~~ir~m~~QL~~sv~fLh~---~kl~HTDLKPENILfvss~~~~~~~~k~~~ 240 (415)
T KOG0671|consen 167 CIVFELL-GLSTFDFLKEN--NYIPFPIDHIRHMGYQLLESVAFLHD---LKLTHTDLKPENILFVSSEYFKTYNPKKKV 240 (415)
T ss_pred EEEEecc-ChhHHHHhccC--CccccchHHHHHHHHHHHHHHHHHHh---cceeecCCChheEEEeccceEEEeccCCcc
Confidence 9999998 56999999864 45778999999999999999999997 59999999999999841
Q ss_pred -------CCcEEEEEcccccccCCCCCcccccccccCCccCcccccCcCCCccccHHHHHHHHHHHHcCCCCCCCCCcch
Q 002673 746 -------QFEAHLADFGLSRLILPYQTHVTTELVGTLGYIPPEYGQAWVATLRGDMYSFGVVMLELLTGKRPVDVLKPKM 818 (894)
Q Consensus 746 -------~~~vkl~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwS~GvlL~elltG~~Pf~~~~~~~ 818 (894)
+..+||+|||.|+.-.. .....+.|..|.|||++.+-.++.++||||+||||.|++||..-|...+..+
T Consensus 241 ~~~r~~ks~~I~vIDFGsAtf~~e----~hs~iVsTRHYRAPEViLgLGwS~pCDvWSiGCIL~ElytG~~LFqtHen~E 316 (415)
T KOG0671|consen 241 CFIRPLKSTAIKVIDFGSATFDHE----HHSTIVSTRHYRAPEVILGLGWSQPCDVWSIGCILVELYTGETLFQTHENLE 316 (415)
T ss_pred ceeccCCCcceEEEecCCcceecc----CcceeeeccccCCchheeccCcCCccCceeeeeEEEEeeccceecccCCcHH
Confidence 34599999999986432 2355678999999999999999999999999999999999999997655333
Q ss_pred hhhHHHHHHH--------------HhhcCCCC-----------cccccc--c--cCCCChHHHHHHHHHHHHhcccCCCC
Q 002673 819 SRELVGWVLK--------------MRSEGKQD-----------QVFDPI--L--RGKGFDEEMLQVLDVACMCVSQNPFK 869 (894)
Q Consensus 819 ~~~~~~~~~~--------------~~~~~~~~-----------~~~d~~--l--~~~~~~~~~~~l~~li~~Cl~~dP~~ 869 (894)
....++.+.+ ....+.++ ..+++. + .-.....+..+|++|+..|+..||.+
T Consensus 317 HLaMMerIlGp~P~~mi~r~~~~Kyf~~~rldw~e~~~~~~~k~v~~~ckpl~~~~~~~d~e~~~LfDLl~~mL~fDP~~ 396 (415)
T KOG0671|consen 317 HLAMMERILGPIPSRMIKKTRKEKYFRRGRLDWPEVSSKGKSKYVFEPCKPLKKYMLQDDLEHVQLFDLLRRMLEFDPAR 396 (415)
T ss_pred HHHHHHHhhCCCcHHHhhhhhhHhhhhcccccCccccccccchhhhcCCccHHHHhccCcHHHhHHHHHHHHHHccCccc
Confidence 2222222111 00111000 000000 0 00122345668999999999999999
Q ss_pred CCCHHHHHH--HHHhc
Q 002673 870 RPTVKEVVE--WLNNV 883 (894)
Q Consensus 870 RPs~~evl~--~L~~i 883 (894)
|+|+.|++. ++...
T Consensus 397 RiTl~EAL~HpFF~~~ 412 (415)
T KOG0671|consen 397 RITLREALSHPFFARL 412 (415)
T ss_pred cccHHHHhcCHHhhcC
Confidence 999999997 55443
|
|
| >PLN03224 probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.1e-28 Score=282.39 Aligned_cols=260 Identities=21% Similarity=0.289 Sum_probs=181.0
Q ss_pred ccCCCccceEeecCcEEEEEEEE-----------------cCCCeEEEEEEcCcchhhHHH--------------HHHHH
Q 002673 606 TDNFSQANIIGCGGFGLVYKATL-----------------ANGTTLAIKKLSGDLGLMERE--------------FKAEV 654 (894)
Q Consensus 606 ~~~f~~~~~LG~G~fg~Vy~a~~-----------------~~g~~vAvK~~~~~~~~~~~~--------------~~~Ei 654 (894)
.++|++.++||+|+||.||+|.. .+++.||||++........++ ...|+
T Consensus 144 ~d~F~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~~vE~ 223 (507)
T PLN03224 144 SDDFQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETGMVEA 223 (507)
T ss_pred ccCceEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccchhHHHH
Confidence 57899999999999999999963 245679999987543322222 33467
Q ss_pred HHHHhcCCCce-----eeecceeee--------cceEEEEEEeccCCCHHHHHhhhcC--------------------CC
Q 002673 655 EALSTAQHKNL-----VSLQGYCVH--------QGFRLLIYSYMENGSLDYWLHEKAD--------------------GA 701 (894)
Q Consensus 655 ~~l~~l~HpnI-----v~l~g~~~~--------~~~~~lV~E~~~~gsL~~~l~~~~~--------------------~~ 701 (894)
.++.+++|.++ ++++++|.. .+..+|||||+++|+|.++++.... ..
T Consensus 224 ~~l~~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~~~~ 303 (507)
T PLN03224 224 YMCAKIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDNMPQ 303 (507)
T ss_pred HHHHHhhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhhccc
Confidence 77777776654 677787753 3568999999999999999975321 01
Q ss_pred CCcCHHHHHHHHHHHHHHHHHHHhccCCCeeecCCCCCCeEECCCCcEEEEEcccccccCCCCCcccccccccCCccCcc
Q 002673 702 SQLDWLTRLKIARGTSCGLAYMHQICEPHIVHRDIKSSNILLDDQFEAHLADFGLSRLILPYQTHVTTELVGTLGYIPPE 781 (894)
Q Consensus 702 ~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDLkp~NILld~~~~vkl~DFGla~~~~~~~~~~~~~~~gt~~Y~APE 781 (894)
..++|..+..++.|++.+|.|||+ ++|+||||||+|||++.++.+||+|||++...............+|+.|+|||
T Consensus 304 ~~~~~~~~~~i~~ql~~aL~~lH~---~~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~g~~tp~Y~aPE 380 (507)
T PLN03224 304 DKRDINVIKGVMRQVLTGLRKLHR---IGIVHRDIKPENLLVTVDGQVKIIDFGAAVDMCTGINFNPLYGMLDPRYSPPE 380 (507)
T ss_pred ccCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCchHhEEECCCCcEEEEeCcCccccccCCccCccccCCCcceeChh
Confidence 235677889999999999999997 58999999999999999999999999999765332222222234578999999
Q ss_pred cccCcC----------------------CCccccHHHHHHHHHHHHcCCC-CCCCCCcch------hhhHHHHHHHHhhc
Q 002673 782 YGQAWV----------------------ATLRGDMYSFGVVMLELLTGKR-PVDVLKPKM------SRELVGWVLKMRSE 832 (894)
Q Consensus 782 ~~~~~~----------------------~s~ksDVwS~GvlL~elltG~~-Pf~~~~~~~------~~~~~~~~~~~~~~ 832 (894)
.+.... ...+.||||+||++|+|++|.. ||.....-. ..+...|.. ...
T Consensus 381 ~l~~~~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~~~~~~f~~~~~~~~~~~~~~r~--~~~ 458 (507)
T PLN03224 381 ELVMPQSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPVANIRLFNTELRQYDNDLNRWRM--YKG 458 (507)
T ss_pred hhcCCCCCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCccchhhhhhHHhhccchHHHHHh--hcc
Confidence 865322 1234799999999999999886 765322110 011111211 111
Q ss_pred CCCCccccccccCCCChHHHHHHHHHHHHhcccCC---CCCCCHHHHHH
Q 002673 833 GKQDQVFDPILRGKGFDEEMLQVLDVACMCVSQNP---FKRPTVKEVVE 878 (894)
Q Consensus 833 ~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP---~~RPs~~evl~ 878 (894)
.... ++ ..........+++.+|+..+| .+|+|++|+++
T Consensus 459 ~~~~--~~------~~d~~s~~~~dLi~~LL~~~~~~~~~RlSa~eaL~ 499 (507)
T PLN03224 459 QKYD--FS------LLDRNKEAGWDLACKLITKRDQANRGRLSVGQALS 499 (507)
T ss_pred cCCC--cc------cccccChHHHHHHHHHhccCCCCcccCCCHHHHhC
Confidence 1110 10 011122356688889998765 68999999987
|
|
| >smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.7e-28 Score=255.76 Aligned_cols=238 Identities=30% Similarity=0.346 Sum_probs=192.0
Q ss_pred CcEEEEEEEEc-CCCeEEEEEEcCcchhh-HHHHHHHHHHHHhcCCCceeeecceeeecceEEEEEEeccCCCHHHHHhh
Q 002673 619 GFGLVYKATLA-NGTTLAIKKLSGDLGLM-EREFKAEVEALSTAQHKNLVSLQGYCVHQGFRLLIYSYMENGSLDYWLHE 696 (894)
Q Consensus 619 ~fg~Vy~a~~~-~g~~vAvK~~~~~~~~~-~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~ 696 (894)
+||.||+|... +|+.+|+|++....... .+.+.+|++.+++++|+|++++++++......++++||+++++|.+++..
T Consensus 1 ~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L~~~~~~ 80 (244)
T smart00220 1 SFGKVYLARDKKTGKLVAIKVIKKEKIKKKRERILREISILKKLKHPNIVRLYDVFEDEDKLYLVMEYCDGGDLFDLLKK 80 (244)
T ss_pred CceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHhCCCCcHHHHHhheeeCCEEEEEEeCCCCCCHHHHHHh
Confidence 58999999965 58999999998654433 67899999999999999999999999999999999999999999999875
Q ss_pred hcCCCCCcCHHHHHHHHHHHHHHHHHHHhccCCCeeecCCCCCCeEECCCCcEEEEEcccccccCCCCCcccccccccCC
Q 002673 697 KADGASQLDWLTRLKIARGTSCGLAYMHQICEPHIVHRDIKSSNILLDDQFEAHLADFGLSRLILPYQTHVTTELVGTLG 776 (894)
Q Consensus 697 ~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDLkp~NILld~~~~vkl~DFGla~~~~~~~~~~~~~~~gt~~ 776 (894)
.. .+++..++.++.+++.++.|||+ .+++|+||+|+||+++.++.++|+|||.+....... ......++..
T Consensus 81 ~~----~~~~~~~~~~~~~l~~~l~~lh~---~~i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~--~~~~~~~~~~ 151 (244)
T smart00220 81 RG----RLSEDEARFYARQILSALEYLHS---NGIIHRDLKPENILLDEDGHVKLADFGLARQLDPGG--LLTTFVGTPE 151 (244)
T ss_pred cc----CCCHHHHHHHHHHHHHHHHHHHH---cCeecCCcCHHHeEECCCCcEEEccccceeeecccc--ccccccCCcC
Confidence 42 28889999999999999999997 599999999999999999999999999998764332 2344568889
Q ss_pred ccCcccccCcCCCccccHHHHHHHHHHHHcCCCCCCCCCcchhhhHHHHHHHHhhcCCCCccccccccCCCChHHHHHHH
Q 002673 777 YIPPEYGQAWVATLRGDMYSFGVVMLELLTGKRPVDVLKPKMSRELVGWVLKMRSEGKQDQVFDPILRGKGFDEEMLQVL 856 (894)
Q Consensus 777 Y~APE~~~~~~~s~ksDVwS~GvlL~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~ 856 (894)
|++||...+..++.++||||||+++|+|++|..||..... ......+.. ....... .........+.
T Consensus 152 ~~~pE~~~~~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~--~~~~~~~~~----~~~~~~~-------~~~~~~~~~~~ 218 (244)
T smart00220 152 YMAPEVLLGKGYGKAVDVWSLGVILYELLTGKPPFPGDDQ--LLELFKKIG----KPKPPFP-------PPEWKISPEAK 218 (244)
T ss_pred CCCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCc--HHHHHHHHh----ccCCCCc-------cccccCCHHHH
Confidence 9999999888889999999999999999999999975321 111221111 1111100 00000224677
Q ss_pred HHHHHhcccCCCCCCCHHHHHH
Q 002673 857 DVACMCVSQNPFKRPTVKEVVE 878 (894)
Q Consensus 857 ~li~~Cl~~dP~~RPs~~evl~ 878 (894)
+++.+|+..+|++||++.++++
T Consensus 219 ~~i~~~l~~~p~~Rp~~~~~~~ 240 (244)
T smart00220 219 DLIRKLLVKDPEKRLTAEEALQ 240 (244)
T ss_pred HHHHHHccCCchhccCHHHHhh
Confidence 8999999999999999999986
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. |
| >KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.3e-29 Score=267.26 Aligned_cols=256 Identities=23% Similarity=0.317 Sum_probs=195.7
Q ss_pred cCCCccceEeecCcEEEEEEE-EcCCCeEEEEEEcCcchh-------hHHHHHHHHHHHHhcCCCceeeecceeeec-ce
Q 002673 607 DNFSQANIIGCGGFGLVYKAT-LANGTTLAIKKLSGDLGL-------MEREFKAEVEALSTAQHKNLVSLQGYCVHQ-GF 677 (894)
Q Consensus 607 ~~f~~~~~LG~G~fg~Vy~a~-~~~g~~vAvK~~~~~~~~-------~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~-~~ 677 (894)
++|-..++||+|+|+.||+|. +...+.||||+-...... ..+...+|.++.+.+.||.||++++|+.-+ +.
T Consensus 463 ~RYLlLhLLGrGGFSEVyKAFDl~EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeLDHpRIVKlYDyfslDtds 542 (775)
T KOG1151|consen 463 DRYLLLHLLGRGGFSEVYKAFDLTEQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKELDHPRIVKLYDYFSLDTDS 542 (775)
T ss_pred HHHHHHHHhccccHHHHHHhcccchhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhccCcceeeeeeeeeeecccc
Confidence 456777899999999999997 667788999975432211 113456899999999999999999998754 56
Q ss_pred EEEEEEeccCCCHHHHHhhhcCCCCCcCHHHHHHHHHHHHHHHHHHHhccCCCeeecCCCCCCeEEC---CCCcEEEEEc
Q 002673 678 RLLIYSYMENGSLDYWLHEKADGASQLDWLTRLKIARGTSCGLAYMHQICEPHIVHRDIKSSNILLD---DQFEAHLADF 754 (894)
Q Consensus 678 ~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDLkp~NILld---~~~~vkl~DF 754 (894)
.|-|+|||+|.+|+.+|+.. ..++...+..|+.||+.||.||... .++|||-||||.||||. .-|.+||+||
T Consensus 543 FCTVLEYceGNDLDFYLKQh----klmSEKEARSIiMQiVnAL~YLNEi-kpPIIHYDLKPgNILLv~GtacGeIKITDF 617 (775)
T KOG1151|consen 543 FCTVLEYCEGNDLDFYLKQH----KLMSEKEARSIIMQIVNALKYLNEI-KPPIIHYDLKPGNILLVNGTACGEIKITDF 617 (775)
T ss_pred ceeeeeecCCCchhHHHHhh----hhhhHHHHHHHHHHHHHHHHHHhcc-CCCeeeeccCCccEEEecCcccceeEeeec
Confidence 78999999999999999875 3578899999999999999999986 78999999999999995 4578999999
Q ss_pred ccccccCCCCC------cccccccccCCccCcccccC----cCCCccccHHHHHHHHHHHHcCCCCCCCCCcchhhhHHH
Q 002673 755 GLSRLILPYQT------HVTTELVGTLGYIPPEYGQA----WVATLRGDMYSFGVVMLELLTGKRPVDVLKPKMSRELVG 824 (894)
Q Consensus 755 Gla~~~~~~~~------~~~~~~~gt~~Y~APE~~~~----~~~s~ksDVwS~GvlL~elltG~~Pf~~~~~~~~~~~~~ 824 (894)
|+++.+..... ..+....||.+|++||.+.- ...+.|+||||+|||+|+.+.|+.||..... .+++++
T Consensus 618 GLSKIMdddSy~~vdGmeLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVWSvGVIFyQClYGrKPFGhnqs--QQdILq 695 (775)
T KOG1151|consen 618 GLSKIMDDDSYNSVDGMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVIFYQCLYGRKPFGHNQS--QQDILQ 695 (775)
T ss_pred chhhhccCCccCcccceeeecccCceeeecCcceeecCCCCCccccceeeEeeehhhhhhhccCCCCCCchh--HHHHHh
Confidence 99998854322 23455789999999997543 2578899999999999999999999974321 223332
Q ss_pred HHHHHhhcCCCCccccccccCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 002673 825 WVLKMRSEGKQDQVFDPILRGKGFDEEMLQVLDVACMCVSQNPFKRPTVKEVVE 878 (894)
Q Consensus 825 ~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~ 878 (894)
..-.+ ....+..... +....+...+|.+|++.--++|....++..
T Consensus 696 eNTIl-kAtEVqFP~K--------PvVsseAkaFIRRCLaYRKeDR~DV~qLA~ 740 (775)
T KOG1151|consen 696 ENTIL-KATEVQFPPK--------PVVSSEAKAFIRRCLAYRKEDRIDVQQLAC 740 (775)
T ss_pred hhchh-cceeccCCCC--------CccCHHHHHHHHHHHHhhhhhhhhHHHHcc
Confidence 22111 1111111111 112234568899999999999999888875
|
|
| >KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=4e-29 Score=263.67 Aligned_cols=241 Identities=24% Similarity=0.326 Sum_probs=189.6
Q ss_pred cCCCccceEeecCcEEEEEEE-EcCCCeEEEEEEcCcchhhHHH---HHHHHHHHHhc-CCCceeeecceeeecceEEEE
Q 002673 607 DNFSQANIIGCGGFGLVYKAT-LANGTTLAIKKLSGDLGLMERE---FKAEVEALSTA-QHKNLVSLQGYCVHQGFRLLI 681 (894)
Q Consensus 607 ~~f~~~~~LG~G~fg~Vy~a~-~~~g~~vAvK~~~~~~~~~~~~---~~~Ei~~l~~l-~HpnIv~l~g~~~~~~~~~lV 681 (894)
.+|....+||+|+||.|-.|. ..+.+.+|||+++++.-...++ -+.|-++|... +-|.+++++..|.+-+..|+|
T Consensus 349 tDFnFl~VlGKGSFGKVlLaerkgtdELyAiKiLkKDViiQdDDvectm~EKrvLAL~~kppFL~qlHScFQTmDRLyFV 428 (683)
T KOG0696|consen 349 TDFNFLMVLGKGSFGKVLLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLVQLHSCFQTMDRLYFV 428 (683)
T ss_pred cccceEEEeccCccceeeeecccCcchhhhhhhhccceeeecCcccceehhhhheecCCCCchHHHHHHHhhhhhheeeE
Confidence 478888999999999999997 4456889999998876333222 24566677665 568999999999999999999
Q ss_pred EEeccCCCHHHHHhhhcCCCCCcCHHHHHHHHHHHHHHHHHHHhccCCCeeecCCCCCCeEECCCCcEEEEEcccccccC
Q 002673 682 YSYMENGSLDYWLHEKADGASQLDWLTRLKIARGTSCGLAYMHQICEPHIVHRDIKSSNILLDDQFEAHLADFGLSRLIL 761 (894)
Q Consensus 682 ~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDLkp~NILld~~~~vkl~DFGla~~~~ 761 (894)
|||+.||+|--++++.. .+....+..+|..||-||-+||+ ++||.||||-.|||||.+|++||+|||+++.-.
T Consensus 429 MEyvnGGDLMyhiQQ~G----kFKEp~AvFYAaEiaigLFFLh~---kgIiYRDLKLDNvmLd~eGHiKi~DFGmcKEni 501 (683)
T KOG0696|consen 429 MEYVNGGDLMYHIQQVG----KFKEPVAVFYAAEIAIGLFFLHS---KGIIYRDLKLDNVMLDSEGHIKIADFGMCKENI 501 (683)
T ss_pred EEEecCchhhhHHHHhc----ccCCchhhhhhHHHHHHhhhhhc---CCeeeeeccccceEeccCCceEeeecccccccc
Confidence 99999999988887653 46677888999999999999996 799999999999999999999999999998532
Q ss_pred CCCCcccccccccCCccCcccccCcCCCccccHHHHHHHHHHHHcCCCCCCCCCcchhhhHHHHHHHHhhcCCCCccccc
Q 002673 762 PYQTHVTTELVGTLGYIPPEYGQAWVATLRGDMYSFGVVMLELLTGKRPVDVLKPKMSRELVGWVLKMRSEGKQDQVFDP 841 (894)
Q Consensus 762 ~~~~~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwS~GvlL~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 841 (894)
- ....+...+||+.|+|||++....|+..+|+|||||+||||+.|++||++.+.++ +...+. +.+.
T Consensus 502 ~-~~~TTkTFCGTPdYiAPEIi~YqPYgksvDWWa~GVLLyEmlaGQpPFdGeDE~e---lF~aI~----ehnv------ 567 (683)
T KOG0696|consen 502 F-DGVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDE---LFQAIM----EHNV------ 567 (683)
T ss_pred c-CCcceeeecCCCcccccceEEecccccchhHHHHHHHHHHHHcCCCCCCCCCHHH---HHHHHH----HccC------
Confidence 2 2334567899999999999999999999999999999999999999998654321 211111 1110
Q ss_pred cccCCCChHHHHHHHHHHHHhcccCCCCCCC
Q 002673 842 ILRGKGFDEEMLQVLDVACMCVSQNPFKRPT 872 (894)
Q Consensus 842 ~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs 872 (894)
.+....+.+.+.+....+...|.+|.-
T Consensus 568 ----syPKslSkEAv~ickg~ltK~P~kRLG 594 (683)
T KOG0696|consen 568 ----SYPKSLSKEAVAICKGLLTKHPGKRLG 594 (683)
T ss_pred ----cCcccccHHHHHHHHHHhhcCCccccC
Confidence 111122234556677888889988863
|
|
| >KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=6.7e-29 Score=241.50 Aligned_cols=204 Identities=22% Similarity=0.370 Sum_probs=169.9
Q ss_pred cCCCccceEeecCcEEEEEEE-EcCCCeEEEEEEcCcchh-hHHHHHHHHHHHHhc-CCCceeeecceeeecceEEEEEE
Q 002673 607 DNFSQANIIGCGGFGLVYKAT-LANGTTLAIKKLSGDLGL-MEREFKAEVEALSTA-QHKNLVSLQGYCVHQGFRLLIYS 683 (894)
Q Consensus 607 ~~f~~~~~LG~G~fg~Vy~a~-~~~g~~vAvK~~~~~~~~-~~~~~~~Ei~~l~~l-~HpnIv~l~g~~~~~~~~~lV~E 683 (894)
++......||+|++|.|-+.+ ..+|...|+|++...... ..+...+|+.+..+. .+|.+|+++|........++.||
T Consensus 46 d~L~~i~elGrGayG~vekmrh~~sg~imAvKri~~tvn~q~q~r~L~dldi~~r~~~CPf~V~FyGa~~regdvwIcME 125 (282)
T KOG0984|consen 46 DDLVGIEELGRGAYGVVEKMRHIQSGTIMAVKRIRATVNSQEQKRLLMDLDIIMRTVDCPFTVHFYGALFREGDVWICME 125 (282)
T ss_pred hhhhhhhhhcCCccchhhheeeccCCeEEEEeeehhhcChHHHHHHHHhhhhhccCCCCCeEEEeehhhhccccEEEeHH
Confidence 344456779999999998887 568999999999875543 335567777766554 79999999999999999999999
Q ss_pred eccCCCHHHHHhhhcCCCCCcCHHHHHHHHHHHHHHHHHHHhccCCCeeecCCCCCCeEECCCCcEEEEEcccccccCCC
Q 002673 684 YMENGSLDYWLHEKADGASQLDWLTRLKIARGTSCGLAYMHQICEPHIVHRDIKSSNILLDDQFEAHLADFGLSRLILPY 763 (894)
Q Consensus 684 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDLkp~NILld~~~~vkl~DFGla~~~~~~ 763 (894)
.|+ -||+.+-.+-...+..+++...-+|+..+.+||.|||+ +-.++|||+||+|||++.+|+||+||||++..+.++
T Consensus 126 ~M~-tSldkfy~~v~~~g~~ipE~vlGkIa~Svv~al~~L~~--kL~vIHRDvKPsNiLIn~~GqVKiCDFGIsG~L~dS 202 (282)
T KOG0984|consen 126 LMD-TSLDKFYRKVLKKGGTIPEDVLGKIAVSVVHALEFLHS--KLSVIHRDVKPSNILINYDGQVKICDFGISGYLVDS 202 (282)
T ss_pred Hhh-hhHHHHHHHHHhcCCcCchHHhhHhHHHHHHHHHHHHH--HhhhhhccCCcceEEEccCCcEEEcccccceeehhh
Confidence 995 58888887766666788999999999999999999998 478999999999999999999999999999876432
Q ss_pred CCcccccccccCCccCcccccC----cCCCccccHHHHHHHHHHHHcCCCCCCCCC
Q 002673 764 QTHVTTELVGTLGYIPPEYGQA----WVATLRGDMYSFGVVMLELLTGKRPVDVLK 815 (894)
Q Consensus 764 ~~~~~~~~~gt~~Y~APE~~~~----~~~s~ksDVwS~GvlL~elltG~~Pf~~~~ 815 (894)
-..+...|...|||||.+.. ..|+.|+||||+|+.+.||.+++.||+...
T Consensus 203 --iAkt~daGCkpYmaPEri~~e~n~~gY~vksDvWSLGItmiElA~lr~PY~~w~ 256 (282)
T KOG0984|consen 203 --IAKTMDAGCKPYMAPERINPELNQKGYSVKSDVWSLGITMIEMAILRFPYESWG 256 (282)
T ss_pred --hHHHHhcCCCccCChhhcCcccCcccceeehhhhhhhhhhhhhhhccccccccC
Confidence 22233568889999997643 478999999999999999999999998543
|
|
| >KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.3e-28 Score=251.81 Aligned_cols=248 Identities=20% Similarity=0.311 Sum_probs=195.3
Q ss_pred cCCCccceEeecCcEEEEEEE-EcCCCeEEEEEEcCcc---hhhHHHHHHHHHHHHhc-CCCceeeecceeeecceEEEE
Q 002673 607 DNFSQANIIGCGGFGLVYKAT-LANGTTLAIKKLSGDL---GLMEREFKAEVEALSTA-QHKNLVSLQGYCVHQGFRLLI 681 (894)
Q Consensus 607 ~~f~~~~~LG~G~fg~Vy~a~-~~~g~~vAvK~~~~~~---~~~~~~~~~Ei~~l~~l-~HpnIv~l~g~~~~~~~~~lV 681 (894)
.+|....+||+|+|+.|..++ .++.+.+|+|++++.. ..+.+.++.|-.+.... +||.+|.+...|.++...++|
T Consensus 250 ~df~ll~vigrgsyakvl~~~~~~t~qiyamkvvkkel~nddedidwvqtek~vfe~asn~pflvglhscfqtesrlffv 329 (593)
T KOG0695|consen 250 QDFDLLRVIGRGSYAKVLLVRLKKTDQIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNNPFLVGLHSCFQTESRLFFV 329 (593)
T ss_pred ccceeeeeecCcchhhhhheehcccceeeehhhHHHHhcCCcccchhHHhhHHHHHhccCCCeEEehhhhhcccceEEEE
Confidence 578889999999999999998 4567899999988643 22334567777777766 799999999999999999999
Q ss_pred EEeccCCCHHHHHhhhcCCCCCcCHHHHHHHHHHHHHHHHHHHhccCCCeeecCCCCCCeEECCCCcEEEEEcccccccC
Q 002673 682 YSYMENGSLDYWLHEKADGASQLDWLTRLKIARGTSCGLAYMHQICEPHIVHRDIKSSNILLDDQFEAHLADFGLSRLIL 761 (894)
Q Consensus 682 ~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDLkp~NILld~~~~vkl~DFGla~~~~ 761 (894)
.||++||+|-.++++. +.++...+..+...|.-||.|||+ +|||.||||-.|||+|..|++|++|+|+++.-.
T Consensus 330 ieyv~ggdlmfhmqrq----rklpeeharfys~ei~lal~flh~---rgiiyrdlkldnvlldaeghikltdygmcke~l 402 (593)
T KOG0695|consen 330 IEYVNGGDLMFHMQRQ----RKLPEEHARFYSAEICLALNFLHE---RGIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGL 402 (593)
T ss_pred EEEecCcceeeehhhh----hcCcHHHhhhhhHHHHHHHHHHhh---cCeeeeeccccceEEccCCceeecccchhhcCC
Confidence 9999999998777754 468999999999999999999997 799999999999999999999999999998642
Q ss_pred CCCCcccccccccCCccCcccccCcCCCccccHHHHHHHHHHHHcCCCCCCCCCcchh-hhHHHHHHHHhhcCCCCcccc
Q 002673 762 PYQTHVTTELVGTLGYIPPEYGQAWVATLRGDMYSFGVVMLELLTGKRPVDVLKPKMS-RELVGWVLKMRSEGKQDQVFD 840 (894)
Q Consensus 762 ~~~~~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwS~GvlL~elltG~~Pf~~~~~~~~-~~~~~~~~~~~~~~~~~~~~d 840 (894)
.....++.++||+.|+|||++.+..|....|+|++||+|+||+.|+.||+....+.. .+..++..+..-+..+. +
T Consensus 403 -~~gd~tstfcgtpnyiapeilrgeeygfsvdwwalgvlmfemmagrspfdivgm~n~d~ntedylfqvilekqir-i-- 478 (593)
T KOG0695|consen 403 -GPGDTTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIVGMDNPDMNTEDYLFQVILEKQIR-I-- 478 (593)
T ss_pred -CCCcccccccCCCcccchhhhcccccCceehHHHHHHHHHHHHcCCCCcceecCCCcccchhHHHHHHHhhhccc-c--
Confidence 233456778999999999999999999999999999999999999999974332211 11222222222222111 0
Q ss_pred ccccCCCChHHHHHHHHHHHHhcccCCCCCCC
Q 002673 841 PILRGKGFDEEMLQVLDVACMCVSQNPFKRPT 872 (894)
Q Consensus 841 ~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs 872 (894)
..........+++.-+..||.+|.-
T Consensus 479 -------prslsvkas~vlkgflnkdp~erlg 503 (593)
T KOG0695|consen 479 -------PRSLSVKASHVLKGFLNKDPKERLG 503 (593)
T ss_pred -------cceeehhhHHHHHHhhcCCcHHhcC
Confidence 0111223446677888999998863
|
|
| >KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.4e-29 Score=252.45 Aligned_cols=264 Identities=25% Similarity=0.347 Sum_probs=192.3
Q ss_pred CCCccceEeecCcEEEEEEE-EcCCCeEEEEEEcCc--chhhHHHHHHHHHHHHhcCCCceeeecceeeec--------c
Q 002673 608 NFSQANIIGCGGFGLVYKAT-LANGTTLAIKKLSGD--LGLMEREFKAEVEALSTAQHKNLVSLQGYCVHQ--------G 676 (894)
Q Consensus 608 ~f~~~~~LG~G~fg~Vy~a~-~~~g~~vAvK~~~~~--~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~--------~ 676 (894)
.|+...+||+|.||.||+|+ -++|+.||+|++--+ ....-....+|+++|..++|+|++.+++.|... .
T Consensus 18 ~yek~~kigqGtfgeVFkAr~~n~~kkvalkkvlmeneKeGfpitalreikiL~~lkHenv~nliEic~tk~Tp~~r~r~ 97 (376)
T KOG0669|consen 18 KYEKLAKIGQGTFGEVFKARSKNTGKKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPTNRDRA 97 (376)
T ss_pred HHHHHHhcCCchHHHHHHHhhcCccchhHHHHHHHhccccCCcHHHHHHHHHHHHhcchhHHHHHHHHhhccCCcccccc
Confidence 34455789999999999998 456788898865321 112224567899999999999999999988743 3
Q ss_pred eEEEEEEeccCCCHHHHHhhhcCCCCCcCHHHHHHHHHHHHHHHHHHHhccCCCeeecCCCCCCeEECCCCcEEEEEccc
Q 002673 677 FRLLIYSYMENGSLDYWLHEKADGASQLDWLTRLKIARGTSCGLAYMHQICEPHIVHRDIKSSNILLDDQFEAHLADFGL 756 (894)
Q Consensus 677 ~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDLkp~NILld~~~~vkl~DFGl 756 (894)
..|+||.+|+. +|..++... ..+++..++.++..++..||.|+|. ..|+|||+||.|+||+.++.+||+|||+
T Consensus 98 t~ylVf~~ceh-DLaGlLsn~---~vr~sls~Ikk~Mk~Lm~GL~~iHr---~kilHRDmKaaNvLIt~dgilklADFGl 170 (376)
T KOG0669|consen 98 TFYLVFDFCEH-DLAGLLSNR---KVRFSLSEIKKVMKGLMNGLYYIHR---NKILHRDMKAANVLITKDGILKLADFGL 170 (376)
T ss_pred eeeeeHHHhhh-hHHHHhcCc---cccccHHHHHHHHHHHHHHHHHHHH---hhHHhhcccHhhEEEcCCceEEeecccc
Confidence 57999999976 677777543 2568899999999999999999997 5999999999999999999999999999
Q ss_pred ccccCCCCCc---ccccccccCCccCcccccC-cCCCccccHHHHHHHHHHHHcCCCCCCCCCcchhhhHHHHHHHHhhc
Q 002673 757 SRLILPYQTH---VTTELVGTLGYIPPEYGQA-WVATLRGDMYSFGVVMLELLTGKRPVDVLKPKMSRELVGWVLKMRSE 832 (894)
Q Consensus 757 a~~~~~~~~~---~~~~~~gt~~Y~APE~~~~-~~~s~ksDVwS~GvlL~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~ 832 (894)
++.+...... ..++.+-|..|.+||.+.| ..|+.+.|||.-|||+.||+||.+-+.+........++.....-...
T Consensus 171 ar~fs~~~n~~kprytnrvvTLwYrppEllLG~r~yg~~iDiWgAgCimaeMwtrspimqgnteqqql~~Is~LcGs~tk 250 (376)
T KOG0669|consen 171 ARAFSTSKNVVKPRYTNRVVTLWYRPPELLLGDREYGPPIDIWGAGCIMAEMWTRSPIMQGNTEQQQLHLISQLCGSITK 250 (376)
T ss_pred ccceecccccCCCCcccceeeeecCCHHHhhcccccCCcchhHhHHHHHHHHHccCccccCChHHHHHHHHHHHhccCCc
Confidence 9877533222 2345567999999998776 47999999999999999999999988754433222222222111111
Q ss_pred CCCCcccc----------ccccCC--CChHHHH------HHHHHHHHhcccCCCCCCCHHHHHH
Q 002673 833 GKQDQVFD----------PILRGK--GFDEEML------QVLDVACMCVSQNPFKRPTVKEVVE 878 (894)
Q Consensus 833 ~~~~~~~d----------~~l~~~--~~~~~~~------~l~~li~~Cl~~dP~~RPs~~evl~ 878 (894)
..+..+.. |...+. ...+... ...+++..++..||.+|+++++++.
T Consensus 251 evWP~~d~lpL~~sie~ePl~~~~~rkv~n~~kp~~kd~~a~dLle~ll~~DP~kR~~ad~aln 314 (376)
T KOG0669|consen 251 EVWPNVDNLPLYQSIELEPLPKGQKRKVKNRLKPYVKDDEALDLLEKLLKLDPTKRIDADQALN 314 (376)
T ss_pred ccCCCcccchHHHhccCCCCCcchhhhhhhhcccccCChhHHHHHHHHhccCcccCcchHhhhc
Confidence 11111100 000000 0111111 4568888999999999999999986
|
|
| >KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=7.4e-29 Score=267.94 Aligned_cols=252 Identities=22% Similarity=0.326 Sum_probs=200.1
Q ss_pred CCCccceEeecCcEEEEEEEEcCCC-eEEEEEEcCcc---hhhHHHHHHHHHHHHhcCCCceeeecceeeecceEEEEEE
Q 002673 608 NFSQANIIGCGGFGLVYKATLANGT-TLAIKKLSGDL---GLMEREFKAEVEALSTAQHKNLVSLQGYCVHQGFRLLIYS 683 (894)
Q Consensus 608 ~f~~~~~LG~G~fg~Vy~a~~~~g~-~vAvK~~~~~~---~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~lV~E 683 (894)
+++....||-|+||.|-.+..+... .+|+|.+++.. ......+..|-.+|...+.|.||+++-.|.++...||+||
T Consensus 421 dl~~iaTLGvGgFGRVELV~~~~~~~~fAlKilkK~hIVdtkQqeHv~sEr~Im~~~~s~fIvrLYrTfrd~kyvYmLmE 500 (732)
T KOG0614|consen 421 DLKRIATLGVGGFGRVELVKVNSQKATFALKILKKKHIVDTKQQEHVFSERNIMMECRSDFIVRLYRTFRDSKYVYMLME 500 (732)
T ss_pred hhhhhhhcccCccceEEEEEecccchHHHHHHHhHhhccchhHHHHHHhHHHHHHhcCchHHHHHHHHhccchhhhhhHH
Confidence 3445567999999999999865433 48888876532 2334557789999999999999999999999999999999
Q ss_pred eccCCCHHHHHhhhcCCCCCcCHHHHHHHHHHHHHHHHHHHhccCCCeeecCCCCCCeEECCCCcEEEEEcccccccCCC
Q 002673 684 YMENGSLDYWLHEKADGASQLDWLTRLKIARGTSCGLAYMHQICEPHIVHRDIKSSNILLDDQFEAHLADFGLSRLILPY 763 (894)
Q Consensus 684 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDLkp~NILld~~~~vkl~DFGla~~~~~~ 763 (894)
-|-||.|+..++.+ ..++......++..+.+|++|||. ++||.|||||+|.+||.+|-+||.|||+|+.+..
T Consensus 501 aClGGElWTiLrdR----g~Fdd~tarF~~acv~EAfeYLH~---k~iIYRDLKPENllLd~~Gy~KLVDFGFAKki~~- 572 (732)
T KOG0614|consen 501 ACLGGELWTILRDR----GSFDDYTARFYVACVLEAFEYLHR---KGIIYRDLKPENLLLDNRGYLKLVDFGFAKKIGS- 572 (732)
T ss_pred hhcCchhhhhhhhc----CCcccchhhhhHHHHHHHHHHHHh---cCceeccCChhheeeccCCceEEeehhhHHHhcc-
Confidence 99999999999875 357778888999999999999997 5999999999999999999999999999998754
Q ss_pred CCcccccccccCCccCcccccCcCCCccccHHHHHHHHHHHHcCCCCCCCCCcchhhhHHHHHHHHhhcCCCCccccccc
Q 002673 764 QTHVTTELVGTLGYIPPEYGQAWVATLRGDMYSFGVVMLELLTGKRPVDVLKPKMSRELVGWVLKMRSEGKQDQVFDPIL 843 (894)
Q Consensus 764 ~~~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwS~GvlL~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l 843 (894)
...+-.++||+.|.|||++.+...+..+|.||+|+++|||++|++||...++-...+++-. .+ ..+ ++ |
T Consensus 573 -g~KTwTFcGTpEYVAPEIILnKGHD~avDyWaLGIli~ELL~G~pPFs~~dpmktYn~ILk--Gi---d~i-~~--P-- 641 (732)
T KOG0614|consen 573 -GRKTWTFCGTPEYVAPEIILNKGHDRAVDYWALGILIYELLTGSPPFSGVDPMKTYNLILK--GI---DKI-EF--P-- 641 (732)
T ss_pred -CCceeeecCCcccccchhhhccCcchhhHHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHh--hh---hhh-hc--c--
Confidence 3345668999999999999999999999999999999999999999987655333332211 10 000 00 0
Q ss_pred cCCCChHHHHHHHHHHHHhcccCCCCCCC-----HHHHHH--HHHhc
Q 002673 844 RGKGFDEEMLQVLDVACMCVSQNPFKRPT-----VKEVVE--WLNNV 883 (894)
Q Consensus 844 ~~~~~~~~~~~l~~li~~Cl~~dP~~RPs-----~~evl~--~L~~i 883 (894)
........+++.+.++.+|.+|.- +.+|-+ |++..
T Consensus 642 -----r~I~k~a~~Lik~LCr~~P~ERLG~~~~gI~DIkkH~Wf~gf 683 (732)
T KOG0614|consen 642 -----RRITKTATDLIKKLCRDNPTERLGYQKGGINDIKKHRWFEGF 683 (732)
T ss_pred -----cccchhHHHHHHHHHhcCcHhhhccccCChHHHHhhhhhhcC
Confidence 111123457888999999999986 566655 66543
|
|
| >KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.95 E-value=8.4e-28 Score=264.96 Aligned_cols=206 Identities=28% Similarity=0.350 Sum_probs=174.6
Q ss_pred cCCCccceEeecCcEEEEEEE-EcCCCeEEEEEEcCcchhhH---HHHHHHHHHHHhcCCCceeeecceeeecceEEEEE
Q 002673 607 DNFSQANIIGCGGFGLVYKAT-LANGTTLAIKKLSGDLGLME---REFKAEVEALSTAQHKNLVSLQGYCVHQGFRLLIY 682 (894)
Q Consensus 607 ~~f~~~~~LG~G~fg~Vy~a~-~~~g~~vAvK~~~~~~~~~~---~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~lV~ 682 (894)
.-|...+.||-|+||.|.++. .++...+|+|.+++...... ..++.|-.+|.....+=||+|+-.|.+++..|+||
T Consensus 629 SmFvkik~iGvGAFGeV~Lv~KvDT~~lYAmKTLrKaDVl~rnQvaHVKAERDILAEADn~WVVrLyySFQDkdnLYFVM 708 (1034)
T KOG0608|consen 629 SMFVKIKTIGVGAFGEVCLVRKVDTRALYAMKTLRKADVLMRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVM 708 (1034)
T ss_pred cceEEEeeecccccceeEEEeecchhhHHHHhhhHHHHHHhhhhhhhhhhhhhhHhhcCCcceEEEEEEeccCCceEEEE
Confidence 346677899999999999997 66778899999987543322 34678999999999999999999999999999999
Q ss_pred EeccCCCHHHHHhhhcCCCCCcCHHHHHHHHHHHHHHHHHHHhccCCCeeecCCCCCCeEECCCCcEEEEEcccccccCC
Q 002673 683 SYMENGSLDYWLHEKADGASQLDWLTRLKIARGTSCGLAYMHQICEPHIVHRDIKSSNILLDDQFEAHLADFGLSRLILP 762 (894)
Q Consensus 683 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDLkp~NILld~~~~vkl~DFGla~~~~~ 762 (894)
+|++||++-.+|.+. ..+.+..+..++..+.+|+++.|.+ |+|||||||.|||||.+|++||+|||+|.-+.-
T Consensus 709 dYIPGGDmMSLLIrm----gIFeE~LARFYIAEltcAiesVHkm---GFIHRDiKPDNILIDrdGHIKLTDFGLCTGfRW 781 (1034)
T KOG0608|consen 709 DYIPGGDMMSLLIRM----GIFEEDLARFYIAELTCAIESVHKM---GFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRW 781 (1034)
T ss_pred eccCCccHHHHHHHh----ccCHHHHHHHHHHHHHHHHHHHHhc---cceecccCccceEEccCCceeeeecccccccee
Confidence 999999999998865 3577888888999999999999986 999999999999999999999999999976520
Q ss_pred --------CCCcc---------------------------------cccccccCCccCcccccCcCCCccccHHHHHHHH
Q 002673 763 --------YQTHV---------------------------------TTELVGTLGYIPPEYGQAWVATLRGDMYSFGVVM 801 (894)
Q Consensus 763 --------~~~~~---------------------------------~~~~~gt~~Y~APE~~~~~~~s~ksDVwS~GvlL 801 (894)
...+. .-..+||+.|+|||++....|+.-+|+||.||||
T Consensus 782 THdskYYq~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl~r~g~~q~cdwws~gvil 861 (1034)
T KOG0608|consen 782 THDSKYYQEGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEVLARTGYTQLCDWWSVGVIL 861 (1034)
T ss_pred ccccccccCCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccChHHhcccCccccchhhHhhHHH
Confidence 00000 0124799999999999999999999999999999
Q ss_pred HHHHcCCCCCCCCCcchh
Q 002673 802 LELLTGKRPVDVLKPKMS 819 (894)
Q Consensus 802 ~elltG~~Pf~~~~~~~~ 819 (894)
|||+.|+.||....+...
T Consensus 862 ~em~~g~~pf~~~tp~~t 879 (1034)
T KOG0608|consen 862 YEMLVGQPPFLADTPGET 879 (1034)
T ss_pred HHHhhCCCCccCCCCCcc
Confidence 999999999976655444
|
|
| >KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.2e-28 Score=279.32 Aligned_cols=247 Identities=23% Similarity=0.359 Sum_probs=187.2
Q ss_pred CCCccceEeecCcEE-EEEEEEcCCCeEEEEEEcCcchhhHHHHHHHHHHHHhc-CCCceeeecceeeecceEEEEEEec
Q 002673 608 NFSQANIIGCGGFGL-VYKATLANGTTLAIKKLSGDLGLMEREFKAEVEALSTA-QHKNLVSLQGYCVHQGFRLLIYSYM 685 (894)
Q Consensus 608 ~f~~~~~LG~G~fg~-Vy~a~~~~g~~vAvK~~~~~~~~~~~~~~~Ei~~l~~l-~HpnIv~l~g~~~~~~~~~lV~E~~ 685 (894)
-|...+++|.|+.|+ ||+|.+ +|+.||||++-.. ...-.++|+..|+.- +|||||++++.-.++...|+..|.|
T Consensus 510 ~~~~~eilG~Gs~Gt~Vf~G~y-e~R~VAVKrll~e---~~~~A~rEi~lL~eSD~H~NviRyyc~E~d~qF~YIalELC 585 (903)
T KOG1027|consen 510 FFSPKEILGYGSNGTVVFRGVY-EGREVAVKRLLEE---FFDFAQREIQLLQESDEHPNVIRYYCSEQDRQFLYIALELC 585 (903)
T ss_pred eeccHHHcccCCCCcEEEEEee-CCceehHHHHhhH---hHHHHHHHHHHHHhccCCCceEEEEeeccCCceEEEEehHh
Confidence 355567899998884 899998 5789999998642 234567899999888 6999999999888889999999999
Q ss_pred cCCCHHHHHhhhcCCCCCcCHHHHHHHHHHHHHHHHHHHhccCCCeeecCCCCCCeEECC-----CCcEEEEEccccccc
Q 002673 686 ENGSLDYWLHEKADGASQLDWLTRLKIARGTSCGLAYMHQICEPHIVHRDIKSSNILLDD-----QFEAHLADFGLSRLI 760 (894)
Q Consensus 686 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDLkp~NILld~-----~~~vkl~DFGla~~~ 760 (894)
. -+|.+++...........-...+.+..|++.||++||+. +||||||||.||||+. ...++|+|||+++.+
T Consensus 586 ~-~sL~dlie~~~~d~~~~~~i~~~~~l~q~~~GlaHLHsl---~iVHRDLkPQNILI~~~~~~~~~ra~iSDfglsKkl 661 (903)
T KOG1027|consen 586 A-CSLQDLIESSGLDVEMQSDIDPISVLSQIASGLAHLHSL---KIVHRDLKPQNILISVPSADGTLRAKISDFGLSKKL 661 (903)
T ss_pred h-hhHHHHHhccccchhhcccccHHHHHHHHHHHHHHHHhc---ccccccCCCceEEEEccCCCcceeEEeccccccccc
Confidence 5 599999987411111112144578889999999999985 9999999999999975 257999999999998
Q ss_pred CCCCCcc--cccccccCCccCcccccCcCCCccccHHHHHHHHHHHHcC-CCCCCCCCcchhhhHHHHHHHHhhcCCCCc
Q 002673 761 LPYQTHV--TTELVGTLGYIPPEYGQAWVATLRGDMYSFGVVMLELLTG-KRPVDVLKPKMSRELVGWVLKMRSEGKQDQ 837 (894)
Q Consensus 761 ~~~~~~~--~~~~~gt~~Y~APE~~~~~~~s~ksDVwS~GvlL~elltG-~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 837 (894)
....... .....||.||+|||++....-+.++||||+||++|+.++| ++||.+.-..+. +++ ........
T Consensus 662 ~~~~sS~~r~s~~sGt~GW~APE~L~~~~~~~avDiFslGCvfyYvltgG~HpFGd~~~R~~-NIl------~~~~~L~~ 734 (903)
T KOG1027|consen 662 AGGKSSFSRLSGGSGTSGWQAPEQLREDRKTQAVDIFSLGCVFYYVLTGGSHPFGDSLERQA-NIL------TGNYTLVH 734 (903)
T ss_pred CCCcchhhcccCCCCcccccCHHHHhccccCcccchhhcCceEEEEecCCccCCCchHHhhh-hhh------cCccceee
Confidence 6554332 3456799999999999998888899999999999999995 999974321100 000 01111111
Q ss_pred cccccccCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 002673 838 VFDPILRGKGFDEEMLQVLDVACMCVSQNPFKRPTVKEVVE 878 (894)
Q Consensus 838 ~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~ 878 (894)
+ . ...+. +..++|.+|+..+|..||++.+|+.
T Consensus 735 L-----~--~~~d~--eA~dLI~~ml~~dP~~RPsa~~VL~ 766 (903)
T KOG1027|consen 735 L-----E--PLPDC--EAKDLISRMLNPDPQLRPSATDVLN 766 (903)
T ss_pred e-----c--cCchH--HHHHHHHHhcCCCcccCCCHHHHhC
Confidence 1 0 00111 5668999999999999999999986
|
|
| >KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=9.8e-28 Score=241.43 Aligned_cols=261 Identities=25% Similarity=0.305 Sum_probs=189.9
Q ss_pred ccceEeecCcEEEEEEEE-cCCCeEEEEEEcCcch--hhHHHHHHHHHHHHhcCCCceeeecceeeec-----ceEEEEE
Q 002673 611 QANIIGCGGFGLVYKATL-ANGTTLAIKKLSGDLG--LMEREFKAEVEALSTAQHKNLVSLQGYCVHQ-----GFRLLIY 682 (894)
Q Consensus 611 ~~~~LG~G~fg~Vy~a~~-~~g~~vAvK~~~~~~~--~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~-----~~~~lV~ 682 (894)
..+.||-|+||.||.++. ++|+.||.|++..-.. ..-+.+-+|+++|...+|.|++..+++..-. .+.|+++
T Consensus 57 PDRPIGYGAFGVVWsVTDPRdgrrvalkK~pnvfq~L~s~krvFre~kmLcfFkHdNVLSaLDILQPph~dfFqEiYV~T 136 (449)
T KOG0664|consen 57 PDRPIGYGAFGVVWSVTDPRSGKRVALKKMPNVFQNLASCKRVFREIKMLSSFRHDNVLSLLDILQPANPSFFQELYVLT 136 (449)
T ss_pred CCCcccccceeEEEeccCCCCccchhHhhcchHHHHHHHHHHHHHHHHHHHhhccccHHHHHHhcCCCCchHHHHHHHHH
Confidence 346799999999999984 5899999999865322 2345678999999999999999988865533 2457788
Q ss_pred EeccCCCHHHHHhhhcCCCCCcCHHHHHHHHHHHHHHHHHHHhccCCCeeecCCCCCCeEECCCCcEEEEEcccccccCC
Q 002673 683 SYMENGSLDYWLHEKADGASQLDWLTRLKIARGTSCGLAYMHQICEPHIVHRDIKSSNILLDDQFEAHLADFGLSRLILP 762 (894)
Q Consensus 683 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDLkp~NILld~~~~vkl~DFGla~~~~~ 762 (894)
|.|. .+|.+.+- +...++-..+.-+..||++||+|||+ .+|.||||||.|.|++++..+||||||+++....
T Consensus 137 ELmQ-SDLHKIIV----SPQ~Ls~DHvKVFlYQILRGLKYLHs---A~ILHRDIKPGNLLVNSNCvLKICDFGLARvee~ 208 (449)
T KOG0664|consen 137 ELMQ-SDLHKIIV----SPQALTPDHVKVFVYQILRGLKYLHT---ANILHRDIKPGNLLVNSNCILKICDFGLARTWDQ 208 (449)
T ss_pred HHHH-hhhhheec----cCCCCCcchhhhhHHHHHhhhHHHhh---cchhhccCCCccEEeccCceEEecccccccccch
Confidence 8874 35554443 34567878888899999999999998 4999999999999999999999999999998765
Q ss_pred CCCcccccccccCCccCcccccCc-CCCccccHHHHHHHHHHHHcCCCCCCCCCcchhhhHHHHHHH--------HhhcC
Q 002673 763 YQTHVTTELVGTLGYIPPEYGQAW-VATLRGDMYSFGVVMLELLTGKRPVDVLKPKMSRELVGWVLK--------MRSEG 833 (894)
Q Consensus 763 ~~~~~~~~~~gt~~Y~APE~~~~~-~~s~ksDVwS~GvlL~elltG~~Pf~~~~~~~~~~~~~~~~~--------~~~~~ 833 (894)
......+..+-|..|.|||+++|. .|+...||||.|||+.|++..+.-|....+-...+++..... .-.++
T Consensus 209 d~~~hMTqEVVTQYYRAPEiLMGaRhYs~AvDiWSVGCIFaELLgRrILFQAq~PiqQL~lItdLLGTPs~EaMr~ACEG 288 (449)
T KOG0664|consen 209 RDRLNMTHEVVTQYYRAPELLMGARRYTGAVDIWSVGCIFAELLQRKILFQAAGPIEQLQMIIDLLGTPSQEAMKYACEG 288 (449)
T ss_pred hhhhhhHHHHHHHHhccHHHhhcchhhcCccceehhhHHHHHHHhhhhhhhccChHHHHHHHHHHhCCCcHHHHHHHhhh
Confidence 555555566778999999999886 689999999999999999999998875544322222211100 00011
Q ss_pred CCCcccc-----c---cc-cCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 002673 834 KQDQVFD-----P---IL-RGKGFDEEMLQVLDVACMCVSQNPFKRPTVKEVVEW 879 (894)
Q Consensus 834 ~~~~~~d-----~---~l-~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~ 879 (894)
-...++. | .+ .-........+-+.+...++..||+.|.+..+.+.-
T Consensus 289 Ak~H~LR~~~k~Ps~~vLYtlsS~~~~~heav~~~~~~l~~d~dkris~~~A~~~ 343 (449)
T KOG0664|consen 289 AKNHVLRAGLRAPDTQRLYKIASPDDKNHEAVDLLQKLLHFDPDKRISVEEALQH 343 (449)
T ss_pred hHHHhhccCCCCCCccceeeecCCcccchHHHHHHHHHhCCCCcccccHhhhccc
Confidence 1011100 0 00 000111222345577788999999999999988873
|
|
| >cd00180 PKc Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.3e-25 Score=230.07 Aligned_cols=210 Identities=35% Similarity=0.542 Sum_probs=182.0
Q ss_pred EeecCcEEEEEEEEc-CCCeEEEEEEcCcchh-hHHHHHHHHHHHHhcCCCceeeecceeeecceEEEEEEeccCCCHHH
Q 002673 615 IGCGGFGLVYKATLA-NGTTLAIKKLSGDLGL-MEREFKAEVEALSTAQHKNLVSLQGYCVHQGFRLLIYSYMENGSLDY 692 (894)
Q Consensus 615 LG~G~fg~Vy~a~~~-~g~~vAvK~~~~~~~~-~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~lV~E~~~~gsL~~ 692 (894)
||+|.+|.||++... +++.+++|++...... ....+.+|+..++.++|++++++++++......++++||+++++|.+
T Consensus 1 l~~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~~~e~~~~~~l~~ 80 (215)
T cd00180 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVFEDENHLYLVMEYCEGGSLKD 80 (215)
T ss_pred CCcCCceEEEEEEecCCCcEEEEEEeccccchhHHHHHHHHHHHHHhcCCCCeeeEeeeeecCCeEEEEEecCCCCcHHH
Confidence 689999999999865 4899999999865432 34678999999999999999999999999899999999999999999
Q ss_pred HHhhhcCCCCCcCHHHHHHHHHHHHHHHHHHHhccCCCeeecCCCCCCeEECC-CCcEEEEEcccccccCCCCCcccccc
Q 002673 693 WLHEKADGASQLDWLTRLKIARGTSCGLAYMHQICEPHIVHRDIKSSNILLDD-QFEAHLADFGLSRLILPYQTHVTTEL 771 (894)
Q Consensus 693 ~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDLkp~NILld~-~~~vkl~DFGla~~~~~~~~~~~~~~ 771 (894)
++.... ..+++..+..++.++++++.|||+ .+++|+||+|.||+++. ++.++|+|||.+........ .....
T Consensus 81 ~~~~~~---~~~~~~~~~~~~~~l~~~l~~lh~---~~~~H~dl~~~ni~~~~~~~~~~l~d~~~~~~~~~~~~-~~~~~ 153 (215)
T cd00180 81 LLKENE---GKLSEDEILRILLQILEGLEYLHS---NGIIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKS-LLKTI 153 (215)
T ss_pred HHHhcc---CCCCHHHHHHHHHHHHHHHHHHHh---CCeeccCCCHhhEEEeCCCCcEEEecCCceEEccCCcc-hhhcc
Confidence 997642 358889999999999999999997 59999999999999999 89999999999987643221 13335
Q ss_pred cccCCccCcccccCc-CCCccccHHHHHHHHHHHHcCCCCCCCCCcchhhhHHHHHHHHhhcCCCCccccccccCCCChH
Q 002673 772 VGTLGYIPPEYGQAW-VATLRGDMYSFGVVMLELLTGKRPVDVLKPKMSRELVGWVLKMRSEGKQDQVFDPILRGKGFDE 850 (894)
Q Consensus 772 ~gt~~Y~APE~~~~~-~~s~ksDVwS~GvlL~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~ 850 (894)
.+...|++||..... .++.+.|+|++|+++++|
T Consensus 154 ~~~~~~~~pe~~~~~~~~~~~~D~~~lg~~~~~l---------------------------------------------- 187 (215)
T cd00180 154 VGTPAYMAPEVLLGKGYYSEKSDIWSLGVILYEL---------------------------------------------- 187 (215)
T ss_pred cCCCCccChhHhcccCCCCchhhhHHHHHHHHHH----------------------------------------------
Confidence 578899999998887 888999999999999999
Q ss_pred HHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 002673 851 EMLQVLDVACMCVSQNPFKRPTVKEVVEW 879 (894)
Q Consensus 851 ~~~~l~~li~~Cl~~dP~~RPs~~evl~~ 879 (894)
..+.+++..|++.+|++||++.++++.
T Consensus 188 --~~~~~~l~~~l~~~p~~R~~~~~l~~~ 214 (215)
T cd00180 188 --PELKDLIRKMLQKDPEKRPSAKEILEH 214 (215)
T ss_pred --HHHHHHHHHHhhCCcccCcCHHHHhhC
Confidence 246689999999999999999999864
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which |
| >KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription] | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.6e-26 Score=227.80 Aligned_cols=263 Identities=21% Similarity=0.296 Sum_probs=195.5
Q ss_pred ccCCCccceEeecCcEEEEEEE-EcCCCeEEEEEEcCcchhhHHHHHHHHHHHHhcC-CCceeeecceeeec--ceEEEE
Q 002673 606 TDNFSQANIIGCGGFGLVYKAT-LANGTTLAIKKLSGDLGLMEREFKAEVEALSTAQ-HKNLVSLQGYCVHQ--GFRLLI 681 (894)
Q Consensus 606 ~~~f~~~~~LG~G~fg~Vy~a~-~~~g~~vAvK~~~~~~~~~~~~~~~Ei~~l~~l~-HpnIv~l~g~~~~~--~~~~lV 681 (894)
.++|++.+++|+|.|+.||.|. ..+++.++||+++. ...+.+.+|+.+|..+. ||||++++++..+. ....||
T Consensus 37 ~ddYeivrk~GRGKYSEVFeg~~~~~~eK~ViKiLKP---VkkkKIkREikIL~nL~gg~NIi~L~DiV~Dp~SktpaLi 113 (338)
T KOG0668|consen 37 QDDYEIVRKVGRGKYSEVFEGINITNNEKCVIKILKP---VKKKKIKREIKILQNLRGGPNIIKLLDIVKDPESKTPSLI 113 (338)
T ss_pred cchHHHHHHHcCccHhhHhcccccCCCceEEEeeech---HHHHHHHHHHHHHHhccCCCCeeehhhhhcCccccCchhH
Confidence 4678888999999999999997 67889999999974 45678999999999997 99999999998765 456799
Q ss_pred EEeccCCCHHHHHhhhcCCCCCcCHHHHHHHHHHHHHHHHHHHhccCCCeeecCCCCCCeEECC-CCcEEEEEccccccc
Q 002673 682 YSYMENGSLDYWLHEKADGASQLDWLTRLKIARGTSCGLAYMHQICEPHIVHRDIKSSNILLDD-QFEAHLADFGLSRLI 760 (894)
Q Consensus 682 ~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDLkp~NILld~-~~~vkl~DFGla~~~ 760 (894)
+||+++.+...+.. .++...+...+.+++.||.|+|++ ||+|||+||.|+++|. ...++|+|+|+|...
T Consensus 114 FE~v~n~Dfk~ly~-------tl~d~dIryY~~elLkALdyCHS~---GImHRDVKPhNvmIdh~~rkLrlIDWGLAEFY 183 (338)
T KOG0668|consen 114 FEYVNNTDFKQLYP-------TLTDYDIRYYIYELLKALDYCHSM---GIMHRDVKPHNVMIDHELRKLRLIDWGLAEFY 183 (338)
T ss_pred hhhhccccHHHHhh-------hhchhhHHHHHHHHHHHHhHHHhc---CcccccCCcceeeechhhceeeeeecchHhhc
Confidence 99999877665543 466778899999999999999985 9999999999999996 456999999999987
Q ss_pred CCCCCcccccccccCCccCcccccC-cCCCccccHHHHHHHHHHHHcCCCCCCCCCcchhhhHHH------------HHH
Q 002673 761 LPYQTHVTTELVGTLGYIPPEYGQA-WVATLRGDMYSFGVVMLELLTGKRPVDVLKPKMSRELVG------------WVL 827 (894)
Q Consensus 761 ~~~~~~~~~~~~gt~~Y~APE~~~~-~~~s~ksDVwS~GvlL~elltG~~Pf~~~~~~~~~~~~~------------~~~ 827 (894)
.+.... ...+.+..|.-||.+-. ..|+..-|+|||||++..|+..+.||-.... ....++. ++.
T Consensus 184 Hp~~eY--nVRVASRyfKGPELLVdy~~YDYSLD~WS~GcmlA~miFrkepFFhG~d-N~DQLVkIakVLGt~el~~Yl~ 260 (338)
T KOG0668|consen 184 HPGKEY--NVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHD-NYDQLVKIAKVLGTDELYAYLN 260 (338)
T ss_pred CCCcee--eeeeehhhcCCchheeechhccccHHHHHHHHHHHHHHhccCcccCCCC-CHHHHHHHHHHhChHHHHHHHH
Confidence 654433 22356778899998755 4678889999999999999999999843221 1122222 111
Q ss_pred HHhhcCCCCcccccccc-------C-----CCChHHHHHHHHHHHHhcccCCCCCCCHHHHHH--HHHhcccc
Q 002673 828 KMRSEGKQDQVFDPILR-------G-----KGFDEEMLQVLDVACMCVSQNPFKRPTVKEVVE--WLNNVGAN 886 (894)
Q Consensus 828 ~~~~~~~~~~~~d~~l~-------~-----~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~--~L~~i~~~ 886 (894)
+..-. ++.-++..+. . ....-...+.++++...+..|..+|||++|++. .+..+...
T Consensus 261 KY~i~--Ldp~~~~i~~~~~rk~w~~Fi~~~n~hl~~peaiDlldklLrYDHqeRlTakEam~HpyF~~~~~~ 331 (338)
T KOG0668|consen 261 KYQID--LDPQFEDILGRHSRKPWSRFINSENQHLVSPEAIDLLDKLLRYDHQERLTAKEAMAHPYFAPVREA 331 (338)
T ss_pred HHccC--CChhHhhHhhccccccHHHhCCccccccCChHHHHHHHHHHhhccccccchHHHhcCchHHHHHHH
Confidence 11100 1111111110 0 000001235678888999999999999999987 55555443
|
|
| >smart00221 STYKc Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.93 E-value=3.5e-25 Score=230.99 Aligned_cols=199 Identities=32% Similarity=0.411 Sum_probs=172.5
Q ss_pred CCccceEeecCcEEEEEEEEcC-CCeEEEEEEcCcchh-hHHHHHHHHHHHHhcCCCceeeecceeeecceEEEEEEecc
Q 002673 609 FSQANIIGCGGFGLVYKATLAN-GTTLAIKKLSGDLGL-MEREFKAEVEALSTAQHKNLVSLQGYCVHQGFRLLIYSYME 686 (894)
Q Consensus 609 f~~~~~LG~G~fg~Vy~a~~~~-g~~vAvK~~~~~~~~-~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~lV~E~~~ 686 (894)
|+..+.||.|++|.||++...+ ++.+++|.+...... ....+.+|++.+++++|+|++++++++......++++||++
T Consensus 1 ~~~~~~i~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~ 80 (225)
T smart00221 1 YELGKKLGEGAFGKVYLARDKGTGELVAVKVLKKEKTEKQREEFLREIRILKKLKHPNIVKLYGVFEDPEPLYLVMEYCE 80 (225)
T ss_pred CceeeEeecCCCeEEEEEEEcCCCcEEEEEeeccccchHHHHHHHHHHHHHHhCCCCChhhheeeeecCCceEEEEeccC
Confidence 4567889999999999998654 899999999876544 56788999999999999999999999999899999999999
Q ss_pred CCCHHHHHhhhcCCCCCcCHHHHHHHHHHHHHHHHHHHhccCCCeeecCCCCCCeEECCCCcEEEEEcccccccCCCCCc
Q 002673 687 NGSLDYWLHEKADGASQLDWLTRLKIARGTSCGLAYMHQICEPHIVHRDIKSSNILLDDQFEAHLADFGLSRLILPYQTH 766 (894)
Q Consensus 687 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDLkp~NILld~~~~vkl~DFGla~~~~~~~~~ 766 (894)
+++|.+++..... .+++.....++.+++.++.|||+ .+++|+||+|+||+++.++.++|+|||.+.........
T Consensus 81 ~~~L~~~~~~~~~---~~~~~~~~~~~~~l~~~l~~lh~---~~i~h~di~~~ni~v~~~~~~~l~d~g~~~~~~~~~~~ 154 (225)
T smart00221 81 GGDLFDYLRKKGG---KLSEEEARFYLRQILEALEYLHS---LGIVHRDLKPENILLGMDGLVKLADFGLARFIHRDLAA 154 (225)
T ss_pred CCCHHHHHHhccc---CCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEEcCCCCEEEeeCceeeEecCcccc
Confidence 9999999986431 17888999999999999999997 49999999999999999999999999999876543211
Q ss_pred ccccccccCCccCcccc-cCcCCCccccHHHHHHHHHHHHcCCCCCCC
Q 002673 767 VTTELVGTLGYIPPEYG-QAWVATLRGDMYSFGVVMLELLTGKRPVDV 813 (894)
Q Consensus 767 ~~~~~~gt~~Y~APE~~-~~~~~s~ksDVwS~GvlL~elltG~~Pf~~ 813 (894)
......++..|++||.. ....++.++|||+||+++++|++|+.||..
T Consensus 155 ~~~~~~~~~~~~~pe~~~~~~~~~~~~Dv~~lG~~~~~l~~g~~pf~~ 202 (225)
T smart00221 155 LLKTVKGTPFYLAPEVLLGGKGYGEAVDIWSLGVILYELLWGPEPFSG 202 (225)
T ss_pred cccceeccCCcCCHhHhcCCCCCCchhhHHHHHHHHHHHHHCCCCccc
Confidence 23345678899999998 666788899999999999999999999964
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. |
| >KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.7e-26 Score=253.35 Aligned_cols=197 Identities=23% Similarity=0.350 Sum_probs=169.3
Q ss_pred ccCCCccceEeecCcEEEEEEEEc-CCCeEEEEEEcCcchhhH---H-----HHHHHHHHHHhcC---CCceeeecceee
Q 002673 606 TDNFSQANIIGCGGFGLVYKATLA-NGTTLAIKKLSGDLGLME---R-----EFKAEVEALSTAQ---HKNLVSLQGYCV 673 (894)
Q Consensus 606 ~~~f~~~~~LG~G~fg~Vy~a~~~-~g~~vAvK~~~~~~~~~~---~-----~~~~Ei~~l~~l~---HpnIv~l~g~~~ 673 (894)
..+|+..+.+|+|+||.|+.|.++ +...|+||.+.+..-... + .+-.||.+|..++ |+||++++++|+
T Consensus 560 ~s~yttlq~lG~GAyGkV~lai~K~n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NIlKlLdfFE 639 (772)
T KOG1152|consen 560 FSDYTTLQPLGEGAYGKVNLAIHKENNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENILKLLDFFE 639 (772)
T ss_pred cccceeeeeccccccceEEEeeecccceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccchhhhhheee
Confidence 356888999999999999999854 567799999876432111 1 2457999999998 999999999999
Q ss_pred ecceEEEEEEec-cCCCHHHHHhhhcCCCCCcCHHHHHHHHHHHHHHHHHHHhccCCCeeecCCCCCCeEECCCCcEEEE
Q 002673 674 HQGFRLLIYSYM-ENGSLDYWLHEKADGASQLDWLTRLKIARGTSCGLAYMHQICEPHIVHRDIKSSNILLDDQFEAHLA 752 (894)
Q Consensus 674 ~~~~~~lV~E~~-~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDLkp~NILld~~~~vkl~ 752 (894)
+++..||+||-. ++.+|.+++..+ ..++...+..|++||+.|+++||+ ++|||||||-+||.++.+|-+||+
T Consensus 640 ddd~yyl~te~hg~gIDLFd~IE~k----p~m~E~eAk~IFkQV~agi~hlh~---~~ivhrdikdenvivd~~g~~kli 712 (772)
T KOG1152|consen 640 DDDYYYLETEVHGEGIDLFDFIEFK----PRMDEPEAKLIFKQVVAGIKHLHD---QGIVHRDIKDENVIVDSNGFVKLI 712 (772)
T ss_pred cCCeeEEEecCCCCCcchhhhhhcc----CccchHHHHHHHHHHHhccccccc---cCceecccccccEEEecCCeEEEe
Confidence 999999999975 566999999866 458899999999999999999997 699999999999999999999999
Q ss_pred EcccccccCCCCCcccccccccCCccCcccccCcCC-CccccHHHHHHHHHHHHcCCCCCC
Q 002673 753 DFGLSRLILPYQTHVTTELVGTLGYIPPEYGQAWVA-TLRGDMYSFGVVMLELLTGKRPVD 812 (894)
Q Consensus 753 DFGla~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~-s~ksDVwS~GvlL~elltG~~Pf~ 812 (894)
|||.+... .+.....++||.+|.|||++.|..| ...-|||++|++||.++....||.
T Consensus 713 dfgsaa~~---ksgpfd~f~gtv~~aapevl~g~~y~gk~qdiwalgillytivykenpyy 770 (772)
T KOG1152|consen 713 DFGSAAYT---KSGPFDVFVGTVDYAAPEVLGGEKYLGKPQDIWALGILLYTIVYKENPYY 770 (772)
T ss_pred eccchhhh---cCCCcceeeeeccccchhhhCCCccCCCcchhhhhhheeeEEEeccCCCc
Confidence 99999765 3344566889999999999999877 556799999999999999988874
|
|
| >KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.93 E-value=2.3e-26 Score=237.75 Aligned_cols=254 Identities=26% Similarity=0.321 Sum_probs=191.6
Q ss_pred cCCCccceEeecCcEEEEEEE-EcCCCeEEEEEEcCcc--hhhHHHHHHHHHHHHhcCCCceeeecceeeec------ce
Q 002673 607 DNFSQANIIGCGGFGLVYKAT-LANGTTLAIKKLSGDL--GLMEREFKAEVEALSTAQHKNLVSLQGYCVHQ------GF 677 (894)
Q Consensus 607 ~~f~~~~~LG~G~fg~Vy~a~-~~~g~~vAvK~~~~~~--~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~------~~ 677 (894)
.+|.....+|.|.- .|..+. .-.++.||+|+..... ....+...+|..++..++|+||++++.++.-. .+
T Consensus 17 ~Ry~nL~p~~~g~~-~v~~a~D~v~~~~v~ikk~~~pf~n~~~akra~rel~l~~~v~~~nii~l~n~ftP~~~l~~~~e 95 (369)
T KOG0665|consen 17 KRYVNLKPIGSGAQ-IVVAAFDQVLGRPVAIKKLSRPFQNQTHAKRAYRELKLMKCVNHKNIISLLNVFTPQKTLEEFQE 95 (369)
T ss_pred eeeeeecccCCCCc-eEEecchhhccCceehhhhcCccccCccchhhhhhhhhhhhhcccceeeeeeccCccccHHHHHh
Confidence 45666677888877 555554 3368899999886542 23345678999999999999999999998743 36
Q ss_pred EEEEEEeccCCCHHHHHhhhcCCCCCcCHHHHHHHHHHHHHHHHHHHhccCCCeeecCCCCCCeEECCCCcEEEEEcccc
Q 002673 678 RLLIYSYMENGSLDYWLHEKADGASQLDWLTRLKIARGTSCGLAYMHQICEPHIVHRDIKSSNILLDDQFEAHLADFGLS 757 (894)
Q Consensus 678 ~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDLkp~NILld~~~~vkl~DFGla 757 (894)
.|+||||| .++|...++.. ++-.....|..|+++|++|||+ .+|+||||||+||++..+..+||.|||++
T Consensus 96 ~y~v~e~m-~~nl~~vi~~e------lDH~tis~i~yq~~~~ik~lhs---~~IihRdLkPsnivv~~~~~lKi~dfg~a 165 (369)
T KOG0665|consen 96 VYLVMELM-DANLCQVILME------LDHETISYILYQMLCGIKHLHS---AGIIHRDLKPSNIVVNSDCTLKILDFGLA 165 (369)
T ss_pred HHHHHHhh-hhHHHHHHHHh------cchHHHHHHHHHHHHHHHHHHh---cceeecccCcccceecchhheeeccchhh
Confidence 79999999 46888888732 5567788999999999999998 59999999999999999999999999999
Q ss_pred cccCCCCCcccccccccCCccCcccccCcCCCccccHHHHHHHHHHHHcCCCCCCCCCcchhhhHHHHHHHHhhcCCCC-
Q 002673 758 RLILPYQTHVTTELVGTLGYIPPEYGQAWVATLRGDMYSFGVVMLELLTGKRPVDVLKPKMSRELVGWVLKMRSEGKQD- 836 (894)
Q Consensus 758 ~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwS~GvlL~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~- 836 (894)
+.-... ...+..+.|..|.|||++.+..+.+.+||||.||++.||++|+.-|.+.. .+-+|.+.....+...
T Consensus 166 r~e~~~--~~mtpyVvtRyyrapevil~~~~ke~vdiwSvGci~gEli~~~Vlf~g~d-----~idQ~~ki~~~lgtpd~ 238 (369)
T KOG0665|consen 166 RTEDTD--FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELILGTVLFPGKD-----HIDQWNKIIEQLGTPDP 238 (369)
T ss_pred cccCcc--cccCchhheeeccCchheeccCCcccchhhhhhhHHHHHhhceEEecCch-----HHHHHHHHHHHhcCCCH
Confidence 865332 35667789999999999999889999999999999999999999886322 1222322222222111
Q ss_pred --------------------------cccc-ccccC--CCChHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 002673 837 --------------------------QVFD-PILRG--KGFDEEMLQVLDVACMCVSQNPFKRPTVKEVVE 878 (894)
Q Consensus 837 --------------------------~~~d-~~l~~--~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~ 878 (894)
+.+. ..... ....-......+++.+||..||++|.+++++++
T Consensus 239 ~F~~qL~~~~r~yv~~~~~y~~~~f~~~fpD~~f~~~~e~~~~~~~~ardll~~MLvi~pe~Risv~daL~ 309 (369)
T KOG0665|consen 239 SFMKQLQPTVRNYVENRPQYQAISFSELFPDSLFPVVLEGSKLDCSLARDLLSKMLVIDPEKRISVDDALR 309 (369)
T ss_pred HHHHHhhHHHHHHhhcChHhhccchhhhCCcccccccccCCccchHHHHHHHHHhhccChhhcccHHHHhc
Confidence 1111 11110 011123446779999999999999999999997
|
|
| >KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.93 E-value=2.8e-25 Score=240.40 Aligned_cols=269 Identities=22% Similarity=0.283 Sum_probs=197.4
Q ss_pred cCCCccceEeecCcEEEEEEE-EcCCCeEEEEEEcCcchhhHHHHHHHHHHHHhcC-----C---Cceeeecceeee---
Q 002673 607 DNFSQANIIGCGGFGLVYKAT-LANGTTLAIKKLSGDLGLMEREFKAEVEALSTAQ-----H---KNLVSLQGYCVH--- 674 (894)
Q Consensus 607 ~~f~~~~~LG~G~fg~Vy~a~-~~~g~~vAvK~~~~~~~~~~~~~~~Ei~~l~~l~-----H---pnIv~l~g~~~~--- 674 (894)
.+|.+.++||-|.|++||++. ..+.+.||+|+.+.. ....+....||++|++++ | .+||+|+++|..
T Consensus 78 gRY~v~rKLGWGHFSTVWLawDtq~~r~VAlKVvKSA-qhYtEaAlDEIklL~~v~~~Dp~~~~~~~VV~LlD~FkhsGp 156 (590)
T KOG1290|consen 78 GRYHVQRKLGWGHFSTVWLAWDTQNKRYVALKVVKSA-QHYTEAALDEIKLLQQVREGDPNDPGKKCVVQLLDHFKHSGP 156 (590)
T ss_pred ceEEEEEeccccccceeEEEeeccCCeEEEEEEEehh-hHHHHHHHHHHHHHHHHHhcCCCCCCCceeeeeeccceecCC
Confidence 578899999999999999997 567789999998854 333455778999999884 2 489999999974
Q ss_pred -cceEEEEEEeccCCCHHHHHhhhcCCCCCcCHHHHHHHHHHHHHHHHHHHhccCCCeeecCCCCCCeEECCC-------
Q 002673 675 -QGFRLLIYSYMENGSLDYWLHEKADGASQLDWLTRLKIARGTSCGLAYMHQICEPHIVHRDIKSSNILLDDQ------- 746 (894)
Q Consensus 675 -~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDLkp~NILld~~------- 746 (894)
+.+.+||+|++ |.+|..++... ..+.++...+.+|++||+.||.|||.. -+|||-||||+|||+..+
T Consensus 157 NG~HVCMVfEvL-GdnLLklI~~s--~YrGlpl~~VK~I~~qvL~GLdYLH~e--cgIIHTDlKPENvLl~~~e~~~~~~ 231 (590)
T KOG1290|consen 157 NGQHVCMVFEVL-GDNLLKLIKYS--NYRGLPLSCVKEICRQVLTGLDYLHRE--CGIIHTDLKPENVLLCSTEIDPAKD 231 (590)
T ss_pred CCcEEEEEehhh-hhHHHHHHHHh--CCCCCcHHHHHHHHHHHHHHHHHHHHh--cCccccCCCcceeeeeccccchhhh
Confidence 45899999999 77899999864 346688999999999999999999985 599999999999998311
Q ss_pred --------------------------------------------------------------------------------
Q 002673 747 -------------------------------------------------------------------------------- 746 (894)
Q Consensus 747 -------------------------------------------------------------------------------- 746 (894)
T Consensus 232 ~~~a~e~~~~~p~~s~s~~~t~~d~~~~~~~~~~s~~~~k~~~kk~~r~~~~~~~~l~~~~~~~~~~~~~s~n~~~~~n~ 311 (590)
T KOG1290|consen 232 AREAGEATTSLPKMSPSAVSTRPDALQRMAAEPMSKSKFKKMKKKLKRQAKKLEASLAGLEGIEEEPNQESYNNEPRING 311 (590)
T ss_pred hhhhccccccCCCCCcccccccccccchhhccccchhhHHHHHHHHhhhhhhhhhhhcccccccccccccccccccCCCc
Confidence
Q ss_pred -------------------------------------------------------------------------------C
Q 002673 747 -------------------------------------------------------------------------------F 747 (894)
Q Consensus 747 -------------------------------------------------------------------------------~ 747 (894)
.
T Consensus 312 ~~~~v~~~~~~~~~~~~~~~~n~~~k~~e~~~~~~~sl~~~~~~~~~t~~~~~~~s~~s~~~~~~n~~v~p~~~~~~~di 391 (590)
T KOG1290|consen 312 NESTVERSTLEEDSNENGNRENLPIKSPENFRGNNTSLPESQLRDSATPSDGSLSSPSSPGTIASNPLVNPDIPLPECDI 391 (590)
T ss_pred cccchhhcccccccccccCCccccccCccccccccccccchhcccccccccccccCcCCccccccccccCCCCCCCccce
Confidence 0
Q ss_pred cEEEEEcccccccCCCCCcccccccccCCccCcccccCcCCCccccHHHHHHHHHHHHcCCCCCCCCCcchh----h---
Q 002673 748 EAHLADFGLSRLILPYQTHVTTELVGTLGYIPPEYGQAWVATLRGDMYSFGVVMLELLTGKRPVDVLKPKMS----R--- 820 (894)
Q Consensus 748 ~vkl~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwS~GvlL~elltG~~Pf~~~~~~~~----~--- 820 (894)
.+||+|||-|+.+. ...+.-.-|..|.|||++.+..|+..+|||||+|+++||.||..-|+....... .
T Consensus 392 ~vKIaDlGNACW~~----khFT~DIQTRQYRapEVllGsgY~~~ADiWS~AC~~FELaTGDyLFePhsG~~Y~rDEDHiA 467 (590)
T KOG1290|consen 392 RVKIADLGNACWVH----KHFTEDIQTRQYRAPEVLLGSGYSTSADIWSTACMAFELATGDYLFEPHSGENYSRDEDHIA 467 (590)
T ss_pred eEEEeeccchhhhh----hhhchhhhhhhccCcceeecCCCCCchhHHHHHHHHHHhhcCceeecCCCCCCCCccHHHHH
Confidence 13344444443321 011223457889999999999999999999999999999999999975443211 1
Q ss_pred hHHHHHH----HHhhcC-CCCcccccc--------cc----------C-CCChHHHHHHHHHHHHhcccCCCCCCCHHHH
Q 002673 821 ELVGWVL----KMRSEG-KQDQVFDPI--------LR----------G-KGFDEEMLQVLDVACMCVSQNPFKRPTVKEV 876 (894)
Q Consensus 821 ~~~~~~~----~~~~~~-~~~~~~d~~--------l~----------~-~~~~~~~~~l~~li~~Cl~~dP~~RPs~~ev 876 (894)
.+++... ++...+ ...++|+.. |+ . ....++..++.+++.-||+.+|++|||+.++
T Consensus 468 ~i~ELLG~iPr~ia~~Gk~SRdFFnr~G~LrhI~~LK~WpL~~VL~eKY~~s~e~A~~fsdFL~PmLef~PeKR~tA~~c 547 (590)
T KOG1290|consen 468 LIMELLGKIPRKIALGGKYSRDFFNRRGELRHIRRLKPWPLYEVLIEKYEWSEEDAQQFSDFLSPMLEFDPEKRPTAAQC 547 (590)
T ss_pred HHHHHHhhccHHHHhcCcchHhhhccccceecccccCCCcHHHHHHHHhCCCHHHHHHHHHHHHHHHhcCccccccHHHH
Confidence 1122211 111111 122233321 10 0 1234567789999999999999999999999
Q ss_pred HH--HHHhccc
Q 002673 877 VE--WLNNVGA 885 (894)
Q Consensus 877 l~--~L~~i~~ 885 (894)
++ ||..+..
T Consensus 548 l~hPwLn~~~~ 558 (590)
T KOG1290|consen 548 LKHPWLNPVAG 558 (590)
T ss_pred hcCccccCCCC
Confidence 97 9986644
|
|
| >KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=99.93 E-value=4.9e-26 Score=246.82 Aligned_cols=263 Identities=23% Similarity=0.237 Sum_probs=200.8
Q ss_pred cCCCccceEeecCcEEEEEEEE-cCCCeEEEEEEcCcchhhHHHHHHHHHHHHhcC------CCceeeecceeeecceEE
Q 002673 607 DNFSQANIIGCGGFGLVYKATL-ANGTTLAIKKLSGDLGLMEREFKAEVEALSTAQ------HKNLVSLQGYCVHQGFRL 679 (894)
Q Consensus 607 ~~f~~~~~LG~G~fg~Vy~a~~-~~g~~vAvK~~~~~~~~~~~~~~~Ei~~l~~l~------HpnIv~l~g~~~~~~~~~ 679 (894)
.+|.+....|+|-|++|.+|.. ..|..||||+|.... ...+.=+.|+++|++|+ .-|+++++..|...++.|
T Consensus 432 ~RY~V~~~~GkGvFs~Vvra~D~~r~~~vAiKIIRnNE-~M~KtGl~EleiLkKL~~AD~Edk~Hclrl~r~F~hknHLC 510 (752)
T KOG0670|consen 432 SRYEVQGYTGKGVFSTVVRARDQARGQEVAIKIIRNNE-VMHKTGLKELEILKKLNDADPEDKFHCLRLFRHFKHKNHLC 510 (752)
T ss_pred ceeEEEeccccceeeeeeeccccCCCCeeEEEEeecch-HHhhhhhHHHHHHHHhhccCchhhhHHHHHHHHhhhcceeE
Confidence 5788888999999999999984 457899999998652 33344568999999996 348999999999999999
Q ss_pred EEEEeccCCCHHHHHhhhcCCCCCcCHHHHHHHHHHHHHHHHHHHhccCCCeeecCCCCCCeEECCC-CcEEEEEccccc
Q 002673 680 LIYSYMENGSLDYWLHEKADGASQLDWLTRLKIARGTSCGLAYMHQICEPHIVHRDIKSSNILLDDQ-FEAHLADFGLSR 758 (894)
Q Consensus 680 lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDLkp~NILld~~-~~vkl~DFGla~ 758 (894)
||+|-+ .-+|.+.|+.... ...|....+..++.|+.-||..|-.. +|+|.||||.|||+++. ..+||||||.|.
T Consensus 511 lVFE~L-slNLRevLKKyG~-nvGL~ikaVRsYaqQLflALklLK~c---~vlHaDIKPDNiLVNE~k~iLKLCDfGSA~ 585 (752)
T KOG0670|consen 511 LVFEPL-SLNLREVLKKYGR-NVGLHIKAVRSYAQQLFLALKLLKKC---GVLHADIKPDNILVNESKNILKLCDFGSAS 585 (752)
T ss_pred EEehhh-hchHHHHHHHhCc-ccceeehHHHHHHHHHHHHHHHHHhc---CeeecccCccceEeccCcceeeeccCcccc
Confidence 999988 4589999987643 35577788899999999999999975 99999999999999874 569999999997
Q ss_pred ccCCCCCcccccccccCCccCcccccCcCCCccccHHHHHHHHHHHHcCCCCCCCCCcchhhhHHHHH-----HHHhhcC
Q 002673 759 LILPYQTHVTTELVGTLGYIPPEYGQAWVATLRGDMYSFGVVMLELLTGKRPVDVLKPKMSRELVGWV-----LKMRSEG 833 (894)
Q Consensus 759 ~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwS~GvlL~elltG~~Pf~~~~~~~~~~~~~~~-----~~~~~~~ 833 (894)
.... .. .+.+.-+..|.|||++.|..|+...|+||.||.||||+||+.-|.+........+.--+ .++.+.+
T Consensus 586 ~~~e--ne-itPYLVSRFYRaPEIiLG~~yd~~iD~WSvgctLYElYtGkIlFpG~TNN~MLrl~me~KGk~p~KmlRKg 662 (752)
T KOG0670|consen 586 FASE--NE-ITPYLVSRFYRAPEIILGLPYDYPIDTWSVGCTLYELYTGKILFPGRTNNQMLRLFMELKGKFPNKMLRKG 662 (752)
T ss_pred cccc--cc-ccHHHHHHhccCcceeecCcccCCccceeeceeeEEeeccceecCCCCcHHHHHHHHHhcCCCcHHHhhhc
Confidence 6532 22 23345578999999999999999999999999999999999999765443222221111 1122211
Q ss_pred C-CCccccccc---------------------------------cCCCC----hHHHHHHHHHHHHhcccCCCCCCCHHH
Q 002673 834 K-QDQVFDPIL---------------------------------RGKGF----DEEMLQVLDVACMCVSQNPFKRPTVKE 875 (894)
Q Consensus 834 ~-~~~~~d~~l---------------------------------~~~~~----~~~~~~l~~li~~Cl~~dP~~RPs~~e 875 (894)
. .+.-||..+ ..+.+ ....+++.+|+..|+..||++|.|..+
T Consensus 663 qF~dqHFD~d~nf~~~e~D~vT~r~~~~vm~~vkPtkdl~s~l~~~q~~~deq~~~~~~~rdLLdkml~LdP~KRit~nq 742 (752)
T KOG0670|consen 663 QFKDQHFDQDLNFLYIEVDKVTEREKRTVMVNVKPTKDLGSELIAVQRLPDEQPKIVQQLRDLLDKMLILDPEKRITVNQ 742 (752)
T ss_pred chhhhhcccccceEEEeccccccceeEEEecccCcchhHHHHHhccCCCCchhHHHHHHHHHHHHHHhccChhhcCCHHH
Confidence 1 111222111 00111 233557889999999999999999999
Q ss_pred HHH
Q 002673 876 VVE 878 (894)
Q Consensus 876 vl~ 878 (894)
+++
T Consensus 743 AL~ 745 (752)
T KOG0670|consen 743 ALK 745 (752)
T ss_pred Hhc
Confidence 886
|
|
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.92 E-value=5.4e-26 Score=253.47 Aligned_cols=253 Identities=28% Similarity=0.383 Sum_probs=201.4
Q ss_pred ccCCCccceEeecCcEEEEEEE-EcCCCeEEEEEEcCcchhhHHHHHHHHHHHHhcCCCceeeecceeeecceEEEEEEe
Q 002673 606 TDNFSQANIIGCGGFGLVYKAT-LANGTTLAIKKLSGDLGLMEREFKAEVEALSTAQHKNLVSLQGYCVHQGFRLLIYSY 684 (894)
Q Consensus 606 ~~~f~~~~~LG~G~fg~Vy~a~-~~~g~~vAvK~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~lV~E~ 684 (894)
.++|+....+|.|.||.|||++ ..+++..|+|+++-........+++|+-+++..+|||||.++|.+..++..|++|||
T Consensus 14 ~ddyellqrvgsgTygdvyKaRd~~s~elaavkvVkLep~dd~~~iqqei~~~~dc~h~nivay~gsylr~dklwicMEy 93 (829)
T KOG0576|consen 14 QDDYELLQRVGSGTYGDVYKARDKRSGELAAVKVVKLEPGDDFSGIQQEIGMLRDCRHPNIVAYFGSYLRRDKLWICMEY 93 (829)
T ss_pred ccchhheeeecCCcccchhhhcccccCchhhheeeeccCCccccccccceeeeecCCCcChHHHHhhhhhhcCcEEEEEe
Confidence 4678888999999999999998 568999999999877777777889999999999999999999999999999999999
Q ss_pred ccCCCHHHHHhhhcCCCCCcCHHHHHHHHHHHHHHHHHHHhccCCCeeecCCCCCCeEECCCCcEEEEEcccccccCCCC
Q 002673 685 MENGSLDYWLHEKADGASQLDWLTRLKIARGTSCGLAYMHQICEPHIVHRDIKSSNILLDDQFEAHLADFGLSRLILPYQ 764 (894)
Q Consensus 685 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDLkp~NILld~~~~vkl~DFGla~~~~~~~ 764 (894)
|.+|+|++..+-. ..++..++..+.+...+|++|||+ .+-+|||||-.||++++.|.+|++|||.+..+...-
T Consensus 94 cgggslQdiy~~T----gplselqiayvcRetl~gl~ylhs---~gk~hRdiKGanilltd~gDvklaDfgvsaqitati 166 (829)
T KOG0576|consen 94 CGGGSLQDIYHVT----GPLSELQIAYVCRETLQGLKYLHS---QGKIHRDIKGANILLTDEGDVKLADFGVSAQITATI 166 (829)
T ss_pred cCCCcccceeeec----ccchhHHHHHHHhhhhccchhhhc---CCcccccccccceeecccCceeecccCchhhhhhhh
Confidence 9999999887743 468888899999999999999997 588999999999999999999999999987764322
Q ss_pred CcccccccccCCccCcccc---cCcCCCccccHHHHHHHHHHHHcCCCCCCCCCcchhhhHHHHHHHHhhcCCCCccccc
Q 002673 765 THVTTELVGTLGYIPPEYG---QAWVATLRGDMYSFGVVMLELLTGKRPVDVLKPKMSRELVGWVLKMRSEGKQDQVFDP 841 (894)
Q Consensus 765 ~~~~~~~~gt~~Y~APE~~---~~~~~s~ksDVwS~GvlL~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 841 (894)
.....+.||+.|||||+. ..+.|..++|||+.|+...|+---++|..+..+- +.+. ............-|+
T Consensus 167 -~KrksfiGtpywmapEvaaverkggynqlcdiwa~gitAiel~eLqpplfdlhpm--r~l~---LmTkS~~qpp~lkDk 240 (829)
T KOG0576|consen 167 -AKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWALGITAIELGELQPPLFDLHPM--RALF---LMTKSGFQPPTLKDK 240 (829)
T ss_pred -hhhhcccCCccccchhHHHHHhcccccccccccccccchhhhhhcCCcccccchH--HHHH---HhhccCCCCCcccCC
Confidence 223457899999999974 4567899999999999999998777775433221 1110 011111111122222
Q ss_pred cccCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 002673 842 ILRGKGFDEEMLQVLDVACMCVSQNPFKRPTVKEVVE 878 (894)
Q Consensus 842 ~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~ 878 (894)
. .+ ...+-++++.|+-.+|.+||+++.+++
T Consensus 241 ~----kw---s~~fh~fvK~altknpKkRptaeklL~ 270 (829)
T KOG0576|consen 241 T----KW---SEFFHNFVKGALTKNPKKRPTAEKLLQ 270 (829)
T ss_pred c----cc---hHHHHHHHHHHhcCCCccCCChhhhee
Confidence 1 12 234668889999999999999988765
|
|
| >KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.90 E-value=7.7e-24 Score=213.92 Aligned_cols=260 Identities=20% Similarity=0.305 Sum_probs=184.0
Q ss_pred cCCCccceEeecCcEEEEEEEE-cCCCeEEEEEEcCcchhhHHHHHHHHHHHHhc-CCCceeeecce-eeecceEEEEEE
Q 002673 607 DNFSQANIIGCGGFGLVYKATL-ANGTTLAIKKLSGDLGLMEREFKAEVEALSTA-QHKNLVSLQGY-CVHQGFRLLIYS 683 (894)
Q Consensus 607 ~~f~~~~~LG~G~fg~Vy~a~~-~~g~~vAvK~~~~~~~~~~~~~~~Ei~~l~~l-~HpnIv~l~g~-~~~~~~~~lV~E 683 (894)
+.|.+.+.||+|.||.+-.+.. .+.+.+++|.+... ....++|.+|..---.+ .|.||+.-+++ |.+.+..++++|
T Consensus 24 d~y~I~k~lgeG~FgkIlL~eHr~s~t~ivlKavp~p-~tt~~dF~rEfhY~~~Ls~H~hIi~tY~vaFqt~d~YvF~qE 102 (378)
T KOG1345|consen 24 DVYTINKQLGEGRFGKILLAEHRQSKTRIVLKAVPRP-QTTQADFVREFHYSFFLSPHQHIIDTYEVAFQTSDAYVFVQE 102 (378)
T ss_pred hhhhHHHHhcccceeeEEeeeccCCceEEEeeccCcc-hhhHHHHHHHhccceeeccchhhhHHHHHHhhcCceEEEeec
Confidence 5688889999999999999985 46788999988764 33457788888765555 58999987764 556677789999
Q ss_pred eccCCCHHHHHhhhcCCCCCcCHHHHHHHHHHHHHHHHHHHhccCCCeeecCCCCCCeEE-C-CCCcEEEEEcccccccC
Q 002673 684 YMENGSLDYWLHEKADGASQLDWLTRLKIARGTSCGLAYMHQICEPHIVHRDIKSSNILL-D-DQFEAHLADFGLSRLIL 761 (894)
Q Consensus 684 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDLkp~NILl-d-~~~~vkl~DFGla~~~~ 761 (894)
|++.|+|.+-+... .+.......++.|+++|+.|+|+ +.+||||||.+|||| + +...+||||||+.+..+
T Consensus 103 ~aP~gdL~snv~~~-----GigE~~~K~v~~ql~SAi~fMHs---knlVHRdlK~eNiLif~~df~rvKlcDFG~t~k~g 174 (378)
T KOG1345|consen 103 FAPRGDLRSNVEAA-----GIGEANTKKVFAQLLSAIEFMHS---KNLVHRDLKAENILIFDADFYRVKLCDFGLTRKVG 174 (378)
T ss_pred cCccchhhhhcCcc-----cccHHHHHHHHHHHHHHHHHhhc---cchhhcccccceEEEecCCccEEEeeecccccccC
Confidence 99999998877642 36667778999999999999997 699999999999999 3 33479999999987542
Q ss_pred CCCCcccccccccCCccCcccccCc-----CCCccccHHHHHHHHHHHHcCCCCCCCCCcchhhhHHHHHHHHhhcC-CC
Q 002673 762 PYQTHVTTELVGTLGYIPPEYGQAW-----VATLRGDMYSFGVVMLELLTGKRPVDVLKPKMSRELVGWVLKMRSEG-KQ 835 (894)
Q Consensus 762 ~~~~~~~~~~~gt~~Y~APE~~~~~-----~~s~ksDVwS~GvlL~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~-~~ 835 (894)
.. ......+..|.+||..... .....+|||.||++++.++||+.||... ..+...++.|..-..+.. ..
T Consensus 175 ~t----V~~~~~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f~cltG~~PWQka-~~~d~~Y~~~~~w~~rk~~~~ 249 (378)
T KOG1345|consen 175 TT----VKYLEYVNNYHAPELCDTVVNEKLVVNPSTDIWQFGIIFFYCLTGKFPWQKA-SIMDKPYWEWEQWLKRKNPAL 249 (378)
T ss_pred ce----ehhhhhhcccCCcHHHhhccccceEecccccchheeeeeeeeecCCCcchhh-hccCchHHHHHHHhcccCccC
Confidence 21 1112345679999965332 3466789999999999999999999832 223344555543322221 11
Q ss_pred CccccccccCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHH-----HHHhccccccC
Q 002673 836 DQVFDPILRGKGFDEEMLQVLDVACMCVSQNPFKRPTVKEVVE-----WLNNVGANRRN 889 (894)
Q Consensus 836 ~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~-----~L~~i~~~~~~ 889 (894)
...+. .-...+..+.++-+..++++|=...++-+ |.+......++
T Consensus 250 P~~F~---------~fs~~a~r~Fkk~lt~~~~drcki~~~kk~rk~~w~E~~i~t~k~ 299 (378)
T KOG1345|consen 250 PKKFN---------PFSEKALRLFKKSLTPRFKDRCKIWTAKKMRKCLWKEKLIKTVKR 299 (378)
T ss_pred chhhc---------ccCHHHHHHHHHhcCCcccccchhHHHHHHHHHHHHHhhhccccC
Confidence 11111 11224456677888999999944444433 45554443333
|
|
| >KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=99.89 E-value=1.7e-23 Score=224.57 Aligned_cols=198 Identities=29% Similarity=0.362 Sum_probs=163.8
Q ss_pred ccCCCccceEeecCcEEEEEEEEc----CCCeEEEEEEcCcchhhHHHHHHHHHHHHhc-CCCceeeecceeeecceEEE
Q 002673 606 TDNFSQANIIGCGGFGLVYKATLA----NGTTLAIKKLSGDLGLMEREFKAEVEALSTA-QHKNLVSLQGYCVHQGFRLL 680 (894)
Q Consensus 606 ~~~f~~~~~LG~G~fg~Vy~a~~~----~g~~vAvK~~~~~~~~~~~~~~~Ei~~l~~l-~HpnIv~l~g~~~~~~~~~l 680 (894)
.+.|...++||+|.|++||++.+. ..+.||+|.+.... .-..+..|+++|..+ .+.||+++.+.+..++...+
T Consensus 35 ~~~~~~v~kigeGsFssv~~a~~~~~~~~~~~valk~i~~ts--~p~ri~~El~~L~~~gG~~ni~~~~~~~rnnd~v~i 112 (418)
T KOG1167|consen 35 SNAYKVVNKIGEGSFSSVYKATDIEQDTKRRYVALKAIYRTS--SPSRILNELEMLYRLGGSDNIIKLNGCFRNNDQVAI 112 (418)
T ss_pred hhhhhhhccccccchhhhhhhhHhhhccccceEeeeeccccc--CchHHHHHHHHHHHhccchhhhcchhhhccCCeeEE
Confidence 467888999999999999999743 46889999987532 234588999999999 59999999999999999999
Q ss_pred EEEeccCCCHHHHHhhhcCCCCCcCHHHHHHHHHHHHHHHHHHHhccCCCeeecCCCCCCeEECC-CCcEEEEEcccccc
Q 002673 681 IYSYMENGSLDYWLHEKADGASQLDWLTRLKIARGTSCGLAYMHQICEPHIVHRDIKSSNILLDD-QFEAHLADFGLSRL 759 (894)
Q Consensus 681 V~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDLkp~NILld~-~~~vkl~DFGla~~ 759 (894)
|+||++.....++... ++...+..+++.+..||.++|+ +|||||||||+|+|.+. .+.-.|.|||++..
T Consensus 113 vlp~~~H~~f~~l~~~-------l~~~~i~~Yl~~ll~Al~~~h~---~GIvHRDiKpsNFL~n~~t~rg~LvDFgLA~~ 182 (418)
T KOG1167|consen 113 VLPYFEHDRFRDLYRS-------LSLAEIRWYLRNLLKALAHLHK---NGIVHRDIKPSNFLYNRRTQRGVLVDFGLAQR 182 (418)
T ss_pred EecccCccCHHHHHhc-------CCHHHHHHHHHHHHHHhhhhhc---cCccccCCCccccccccccCCceEEechhHHH
Confidence 9999999888887763 5678889999999999999997 69999999999999985 56788999999983
Q ss_pred cCCCC------C---------------------------c----------ccccccccCCccCcccccCc-CCCccccHH
Q 002673 760 ILPYQ------T---------------------------H----------VTTELVGTLGYIPPEYGQAW-VATLRGDMY 795 (894)
Q Consensus 760 ~~~~~------~---------------------------~----------~~~~~~gt~~Y~APE~~~~~-~~s~ksDVw 795 (894)
..... . . ......||+||.|||++... ..+.++|||
T Consensus 183 ~d~~~~~~~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPEvL~k~~~QttaiDiw 262 (418)
T KOG1167|consen 183 YDGYQQTEHSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFRAPEVLFRCPRQTTAIDIW 262 (418)
T ss_pred HHhhhhhhhhhhhhcccCCccccCcccccccccccCCCCceeccCCCccceecccCCCCCCCchHHHhhccCcCCcccee
Confidence 21000 0 0 01124699999999988765 568899999
Q ss_pred HHHHHHHHHHcCCCCCCCCC
Q 002673 796 SFGVVMLELLTGKRPVDVLK 815 (894)
Q Consensus 796 S~GvlL~elltG~~Pf~~~~ 815 (894)
|.|||++-+++++.||-...
T Consensus 263 s~GVI~Lslls~~~PFf~a~ 282 (418)
T KOG1167|consen 263 SAGVILLSLLSRRYPFFKAK 282 (418)
T ss_pred eccceeehhhccccccccCc
Confidence 99999999999999996443
|
|
| >PLN00181 protein SPA1-RELATED; Provisional | Back alignment and domain information |
|---|
Probab=99.89 E-value=4.1e-24 Score=264.87 Aligned_cols=199 Identities=17% Similarity=0.207 Sum_probs=139.7
Q ss_pred hcCC-Cceeeecceee-------ecceEEEEEEeccCCCHHHHHhhhcCCCCCcCHHHHHHHHHHHHHHHHHHHhccCCC
Q 002673 659 TAQH-KNLVSLQGYCV-------HQGFRLLIYSYMENGSLDYWLHEKADGASQLDWLTRLKIARGTSCGLAYMHQICEPH 730 (894)
Q Consensus 659 ~l~H-pnIv~l~g~~~-------~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ 730 (894)
.++| +||++++++|. .....++++||+ +++|.+++... ...+++.+++.++.||++||.|||+ ++
T Consensus 28 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~-~~~L~~~l~~~---~~~~~~~~~~~i~~qi~~al~~lH~---~g 100 (793)
T PLN00181 28 SLSHIDYVRSLLGSHKEGNLDGLDDDSIVRALECE-DVSLRQWLDNP---DRSVDAFECFHVFRQIVEIVNAAHS---QG 100 (793)
T ss_pred hhhHHHHHHHhhcccCCccccccccchhhhhhccC-CccHHHHHhcc---cccccHHHHHHHHHHHHHHHHHHHh---CC
Confidence 4456 68888888872 234567788887 66999999743 2458999999999999999999997 69
Q ss_pred eeecCCCCCCeEECCCC-------------------cEEEEEcccccccCCCC--------C-------cccccccccCC
Q 002673 731 IVHRDIKSSNILLDDQF-------------------EAHLADFGLSRLILPYQ--------T-------HVTTELVGTLG 776 (894)
Q Consensus 731 ivHrDLkp~NILld~~~-------------------~vkl~DFGla~~~~~~~--------~-------~~~~~~~gt~~ 776 (894)
|+||||||+||||+..+ .+|++|||+++...... . ......+||+.
T Consensus 101 IvHrDlKP~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~ 180 (793)
T PLN00181 101 IVVHNVRPSCFVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEMSW 180 (793)
T ss_pred eeeccCCchhEEEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCcccccccCCCcc
Confidence 99999999999996544 45555666554321000 0 00112457889
Q ss_pred ccCcccccCcCCCccccHHHHHHHHHHHHcCCCCCCCCCcchhhhHHHHHHHHhhcCCCCccccccccCCCChHHHHHHH
Q 002673 777 YIPPEYGQAWVATLRGDMYSFGVVMLELLTGKRPVDVLKPKMSRELVGWVLKMRSEGKQDQVFDPILRGKGFDEEMLQVL 856 (894)
Q Consensus 777 Y~APE~~~~~~~s~ksDVwS~GvlL~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~ 856 (894)
|||||++.+..++.++|||||||+||||++|..|+..... ........ ..++.. ........
T Consensus 181 Y~APE~~~~~~~~~~sDVwSlGviL~ELl~~~~~~~~~~~----~~~~~~~~---------~~~~~~-----~~~~~~~~ 242 (793)
T PLN00181 181 YTSPEEDNGSSSNCASDVYRLGVLLFELFCPVSSREEKSR----TMSSLRHR---------VLPPQI-----LLNWPKEA 242 (793)
T ss_pred eEChhhhccCCCCchhhhhhHHHHHHHHhhCCCchhhHHH----HHHHHHHh---------hcChhh-----hhcCHHHH
Confidence 9999999999999999999999999999999988752110 00011000 011100 01122345
Q ss_pred HHHHHhcccCCCCCCCHHHHHH--HHHh
Q 002673 857 DVACMCVSQNPFKRPTVKEVVE--WLNN 882 (894)
Q Consensus 857 ~li~~Cl~~dP~~RPs~~evl~--~L~~ 882 (894)
+++.+||+.+|.+||+|.++++ ++..
T Consensus 243 ~~~~~~L~~~P~~Rps~~eil~h~~~~~ 270 (793)
T PLN00181 243 SFCLWLLHPEPSCRPSMSELLQSEFINE 270 (793)
T ss_pred HHHHHhCCCChhhCcChHHHhhchhhhh
Confidence 7788999999999999999997 5543
|
|
| >smart00750 KIND kinase non-catalytic C-lobe domain | Back alignment and domain information |
|---|
Probab=99.88 E-value=2.1e-22 Score=203.03 Aligned_cols=168 Identities=21% Similarity=0.169 Sum_probs=125.4
Q ss_pred CCHHHHHhhhcCCCCCcCHHHHHHHHHHHHHHHHHHHhccCCCeeecCCCCCCeEECCCCcEEEEEcccccccCCCCCcc
Q 002673 688 GSLDYWLHEKADGASQLDWLTRLKIARGTSCGLAYMHQICEPHIVHRDIKSSNILLDDQFEAHLADFGLSRLILPYQTHV 767 (894)
Q Consensus 688 gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDLkp~NILld~~~~vkl~DFGla~~~~~~~~~~ 767 (894)
|+|.++++... ..+++..++.|+.|++.||.|||+. + ||+|||++.++.+|+ ||+++.....
T Consensus 1 GsL~~~l~~~~---~~l~~~~~~~i~~qi~~~L~~lH~~---~------kp~Nil~~~~~~~~~--fG~~~~~~~~---- 62 (176)
T smart00750 1 VSLADILEVRG---RPLNEEEIWAVCLQCLRALRELHRQ---A------KSGNILLTWDGLLKL--DGSVAFKTPE---- 62 (176)
T ss_pred CcHHHHHHHhC---CCCCHHHHHHHHHHHHHHHHHHHhc---C------CcccEeEcCccceee--ccceEeeccc----
Confidence 78999997542 4599999999999999999999974 3 999999999999999 9998865332
Q ss_pred cccccccCCccCcccccCcCCCccccHHHHHHHHHHHHcCCCCCCCCCcchhhhHHHHHHHHhhcCCCCccccccccCCC
Q 002673 768 TTELVGTLGYIPPEYGQAWVATLRGDMYSFGVVMLELLTGKRPVDVLKPKMSRELVGWVLKMRSEGKQDQVFDPILRGKG 847 (894)
Q Consensus 768 ~~~~~gt~~Y~APE~~~~~~~s~ksDVwS~GvlL~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~ 847 (894)
...||+.|||||++.+..++.++|||||||++|||++|+.||...... ......+......... . +. ..
T Consensus 63 --~~~g~~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~p~~~~~~~-~~~~~~~~~~~~~~~~-~---~~----~~ 131 (176)
T smart00750 63 --QSRVDPYFMAPEVIQGQSYTEKADIYSLGITLYEALDYELPYNEEREL-SAILEILLNGMPADDP-R---DR----SN 131 (176)
T ss_pred --cCCCcccccChHHhcCCCCcchhhHHHHHHHHHHHHhCCCCccccchh-cHHHHHHHHHhccCCc-c---cc----cc
Confidence 125889999999999999999999999999999999999999643321 1111111111111100 0 00 00
Q ss_pred ChHHH--HHHHHHHHHhcccCCCCCCCHHHHHHHHHhcc
Q 002673 848 FDEEM--LQVLDVACMCVSQNPFKRPTVKEVVEWLNNVG 884 (894)
Q Consensus 848 ~~~~~--~~l~~li~~Cl~~dP~~RPs~~evl~~L~~i~ 884 (894)
..... ..+.+++.+|++.+|.+||++.++++.+..+.
T Consensus 132 ~~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~ll~~~~~~~ 170 (176)
T smart00750 132 LESVSAARSFADFMRVCASRLPQRREAANHYLAHCRALF 170 (176)
T ss_pred HHHHHhhhhHHHHHHHHHhcccccccCHHHHHHHHHHHH
Confidence 11111 25889999999999999999999999776554
|
It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features |
| >KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.87 E-value=6.5e-23 Score=206.77 Aligned_cols=248 Identities=22% Similarity=0.335 Sum_probs=187.2
Q ss_pred cceEeecCcEEEEEEEEcCCCeEEEEEEcC--cchhhHHHHHHHHHHHHhcCCCceeeecceeeecceEEEEEEeccCCC
Q 002673 612 ANIIGCGGFGLVYKATLANGTTLAIKKLSG--DLGLMEREFKAEVEALSTAQHKNLVSLQGYCVHQGFRLLIYSYMENGS 689 (894)
Q Consensus 612 ~~~LG~G~fg~Vy~a~~~~g~~vAvK~~~~--~~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~lV~E~~~~gs 689 (894)
..+|.+...|..|+|+|..+. +++|++.. ......++|..|.-.|+.+.||||++++|.|....+..++..||+.|+
T Consensus 195 ~tkl~e~hsgelwrgrwqgnd-ivakil~vr~~t~risrdfneefp~lrifshpnilpvlgacnsppnlv~isq~mp~gs 273 (448)
T KOG0195|consen 195 ITKLAESHSGELWRGRWQGND-IVAKILNVREVTARISRDFNEEFPALRIFSHPNILPVLGACNSPPNLVIISQYMPFGS 273 (448)
T ss_pred hhhhccCCCcccccccccCcc-hhhhhhhhhhcchhhcchhhhhCcceeeecCCchhhhhhhccCCCCceEeeeeccchH
Confidence 456888999999999997544 55666643 233445789999999999999999999999999999999999999999
Q ss_pred HHHHHhhhcCCCCCcCHHHHHHHHHHHHHHHHHHHhccCCCeeecCCCCCCeEECCCCcEEEEEcccccccCCCCCcccc
Q 002673 690 LDYWLHEKADGASQLDWLTRLKIARGTSCGLAYMHQICEPHIVHRDIKSSNILLDDQFEAHLADFGLSRLILPYQTHVTT 769 (894)
Q Consensus 690 L~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDLkp~NILld~~~~vkl~DFGla~~~~~~~~~~~~ 769 (894)
|...+++.. ....+-.++.+++.+|++|++|||+. ++-|.---|.++.|++|++.+++|+ .+-.+. +....
T Consensus 274 lynvlhe~t--~vvvd~sqav~faldiargmaflhsl-ep~ipr~~lns~hvmidedltaris-mad~kf-----sfqe~ 344 (448)
T KOG0195|consen 274 LYNVLHEQT--SVVVDHSQAVRFALDIARGMAFLHSL-EPMIPRFYLNSKHVMIDEDLTARIS-MADTKF-----SFQEV 344 (448)
T ss_pred HHHHHhcCc--cEEEecchHHHHHHHHHhhHHHHhhc-chhhhhhhcccceEEecchhhhhee-ccccee-----eeecc
Confidence 999999753 35677789999999999999999997 4444455689999999999998875 111111 11112
Q ss_pred cccccCCccCcccccCcCC---CccccHHHHHHHHHHHHcCCCCCCCCCcchhhhHHHHHHHHhhcCCCCccccccccCC
Q 002673 770 ELVGTLGYIPPEYGQAWVA---TLRGDMYSFGVVMLELLTGKRPVDVLKPKMSRELVGWVLKMRSEGKQDQVFDPILRGK 846 (894)
Q Consensus 770 ~~~gt~~Y~APE~~~~~~~---s~ksDVwS~GvlL~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~ 846 (894)
.....+.||+||.++...- -..+|+|||.+++||+.|...||.+..+-+... ++.-++-...
T Consensus 345 gr~y~pawmspealqrkped~n~raadmwsfaillwel~trevpfadlspmecgm------kialeglrv~--------- 409 (448)
T KOG0195|consen 345 GRAYSPAWMSPEALQRKPEDLNIRAADMWSFAILLWELNTREVPFADLSPMECGM------KIALEGLRVH--------- 409 (448)
T ss_pred ccccCcccCCHHHHhcCchhcchhhhhHHHHHHHHHHhhccccccccCCchhhhh------hhhhcccccc---------
Confidence 2345789999998877643 357899999999999999999998766532211 1111121111
Q ss_pred CChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhcc
Q 002673 847 GFDEEMLQVLDVACMCVSQNPFKRPTVKEVVEWLNNVG 884 (894)
Q Consensus 847 ~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~i~ 884 (894)
..+.....+.+++.-|+..||.+||.++.|+-.|+++.
T Consensus 410 ippgis~hm~klm~icmnedpgkrpkfdmivpilekm~ 447 (448)
T KOG0195|consen 410 IPPGISRHMNKLMNICMNEDPGKRPKFDMIVPILEKMI 447 (448)
T ss_pred CCCCccHHHHHHHHHHhcCCCCcCCCcceehhhHHHhc
Confidence 11222334567777899999999999999999999874
|
|
| >KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.87 E-value=8.1e-21 Score=210.77 Aligned_cols=261 Identities=24% Similarity=0.273 Sum_probs=194.8
Q ss_pred CCCccceEeecCcEEEEEEEEcCC--CeEEEEEEcCcchhhHHHHHHHHHHHHhcCC----Cceeeeccee-eecceEEE
Q 002673 608 NFSQANIIGCGGFGLVYKATLANG--TTLAIKKLSGDLGLMEREFKAEVEALSTAQH----KNLVSLQGYC-VHQGFRLL 680 (894)
Q Consensus 608 ~f~~~~~LG~G~fg~Vy~a~~~~g--~~vAvK~~~~~~~~~~~~~~~Ei~~l~~l~H----pnIv~l~g~~-~~~~~~~l 680 (894)
+|.+.+.||+|+||.||.+...+. ..+|+|............+..|+.++..+.+ +++..+++.. ..+...++
T Consensus 19 ~~~i~~~iG~G~fG~V~~v~~~~~~~~~~a~K~e~~~~~~~~~~l~~E~~vl~~l~~~~~~~~~~~~~~~G~~~~~~~~i 98 (322)
T KOG1164|consen 19 RYKLGKKIGEGGFGAVYLVSDKSEKNKEYAKKLEKKELGSKPSVLKIEIQVLKKLEKKNGPSHFPKLLDHGRSTEDFNFI 98 (322)
T ss_pred ceEEeeeccccCCceEEEEEecCCCCeeEEEEEEEecccCCCccchhHHHHHHHHhhhcCCCCCCEEEEeccCCCceeEE
Confidence 789999999999999999985443 4788888775433322367888888888863 5888888888 47778899
Q ss_pred EEEeccCCCHHHHHhhhcCCCCCcCHHHHHHHHHHHHHHHHHHHhccCCCeeecCCCCCCeEECCC-----CcEEEEEcc
Q 002673 681 IYSYMENGSLDYWLHEKADGASQLDWLTRLKIARGTSCGLAYMHQICEPHIVHRDIKSSNILLDDQ-----FEAHLADFG 755 (894)
Q Consensus 681 V~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDLkp~NILld~~-----~~vkl~DFG 755 (894)
||+.+ |.+|.++..... ...++..+.+.|+.|++.+|++||+ .|++||||||.|+++... ..++|.|||
T Consensus 99 VM~l~-G~sL~dl~~~~~--~~~fs~~T~l~ia~q~l~~l~~lH~---~G~iHRDiKp~N~~~g~~~~~~~~~~~llDfG 172 (322)
T KOG1164|consen 99 VMSLL-GPSLEDLRKRNP--PGRFSRKTVLRIAIQNLNALEDLHS---KGFIHRDIKPENFVVGQSSRSEVRTLYLLDFG 172 (322)
T ss_pred EEecc-CccHHHHHHhCC--CCCcCHhHHHHHHHHHHHHHHHHHh---cCcccCCcCHHHeeecCCCCcccceEEEEecC
Confidence 99988 789999886554 4679999999999999999999997 599999999999999864 469999999
Q ss_pred ccc--ccCCCCCc-----c--cccccccCCccCcccccCcCCCccccHHHHHHHHHHHHcCCCCCCCCCcchhhhHHHHH
Q 002673 756 LSR--LILPYQTH-----V--TTELVGTLGYIPPEYGQAWVATLRGDMYSFGVVMLELLTGKRPVDVLKPKMSRELVGWV 826 (894)
Q Consensus 756 la~--~~~~~~~~-----~--~~~~~gt~~Y~APE~~~~~~~s~ksDVwS~GvlL~elltG~~Pf~~~~~~~~~~~~~~~ 826 (894)
+++ .+...... . .....||..|.++....+...+.+.|+||++.++.|++.|..||............
T Consensus 173 lar~~~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~~~e~~r~DDles~~Y~l~el~~g~LPW~~~~~~~~~~~~--- 249 (322)
T KOG1164|consen 173 LARRFKYVGDSGGNLRPPRPQKGLFRGTLRYASINVHLGIEQGRRDDLESLFYMLLELLKGSLPWEALEMTDLKSKF--- 249 (322)
T ss_pred CCccccccCCCCcccccCCCCccCCCCccccccHHHhCCCccCCchhhhhHHHHHHHHhcCCCCCccccccchHHHH---
Confidence 999 43222211 1 22355999999999999999999999999999999999999999765532221111
Q ss_pred HHHhhcCCCCccccccccCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhcccc
Q 002673 827 LKMRSEGKQDQVFDPILRGKGFDEEMLQVLDVACMCVSQNPFKRPTVKEVVEWLNNVGAN 886 (894)
Q Consensus 827 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~i~~~ 886 (894)
........... .....+.+ +.++...+-..+..++|....+...|++....
T Consensus 250 ~~~~~~~~~~~------~~~~~~~~---~~~~~~~~~~~~~~~~Pdy~~~~~~l~~~~~~ 300 (322)
T KOG1164|consen 250 EKDPRKLLTDR------FGDLKPEE---FAKILEYIDSLDYEDKPDYEKLAELLKDVFDS 300 (322)
T ss_pred HHHhhhhcccc------ccCCChHH---HHHHHHHhhccCCcCCCCHHHHHHHHHHHHHh
Confidence 11111111110 11222333 34444455568999999999999988776443
|
|
| >KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.86 E-value=4.4e-21 Score=199.12 Aligned_cols=259 Identities=20% Similarity=0.304 Sum_probs=201.6
Q ss_pred CCCccceEeecCcEEEEEEE-EcCCCeEEEEEEcCcchhhHHHHHHHHHHHHhcC-CCceeeecceeeecceEEEEEEec
Q 002673 608 NFSQANIIGCGGFGLVYKAT-LANGTTLAIKKLSGDLGLMEREFKAEVEALSTAQ-HKNLVSLQGYCVHQGFRLLIYSYM 685 (894)
Q Consensus 608 ~f~~~~~LG~G~fg~Vy~a~-~~~g~~vAvK~~~~~~~~~~~~~~~Ei~~l~~l~-HpnIv~l~g~~~~~~~~~lV~E~~ 685 (894)
.|.++++||+|+||..+.|+ +-+++.||||.-... ....++..|.+..+.+. .++|..++-|-..+.+-.||+|.+
T Consensus 29 hyrVGkKIGeGsFG~lf~G~Nl~nne~VAIKfEPrk--S~APQLrdEYr~YKlL~g~~GIP~vYYFGqeG~~NiLVidLL 106 (449)
T KOG1165|consen 29 HYRVGKKIGEGSFGVLFLGKNLYNNEPVAIKFEPRK--SEAPQLRDEYRTYKLLGGTEGIPQVYYFGQEGKYNILVIDLL 106 (449)
T ss_pred cceeccccccCcceeeecccccccCceEEEEecccc--CCcchHHHHHHHHHHHcCCCCCCceeeeccccchhhhhhhhh
Confidence 58899999999999999998 678999999987543 33457888999988884 689999888888888889999998
Q ss_pred cCCCHHHHHhhhcCCCCCcCHHHHHHHHHHHHHHHHHHHhccCCCeeecCCCCCCeEECC-----CCcEEEEEccccccc
Q 002673 686 ENGSLDYWLHEKADGASQLDWLTRLKIARGTSCGLAYMHQICEPHIVHRDIKSSNILLDD-----QFEAHLADFGLSRLI 760 (894)
Q Consensus 686 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDLkp~NILld~-----~~~vkl~DFGla~~~ 760 (894)
|.||+++..-.. +.++..+...+|.|+..-++|+|+ +.+|.|||||+|+||.. ...+.|+|||+|+.+
T Consensus 107 -GPSLEDLFD~Cg---R~FSvKTV~miA~Qmi~rie~vH~---k~LIYRDIKPdNFLIGrp~~k~~n~IhiiDFGmAK~Y 179 (449)
T KOG1165|consen 107 -GPSLEDLFDLCG---RRFSVKTVAMIAKQMITRIEYVHE---KDLIYRDIKPDNFLIGRPGTKDANVIHIIDFGMAKEY 179 (449)
T ss_pred -CcCHHHHHHHhc---CcccHHhHHHHHHHHHHHHHHHHh---cceeecccCccceeecCCCCCCCceEEEEeccchhhh
Confidence 789999887553 579999999999999999999997 59999999999999964 345999999999987
Q ss_pred CCCCCcc------cccccccCCccCcccccCcCCCccccHHHHHHHHHHHHcCCCCCCCCCcchhhhHHHHHHHHhhcCC
Q 002673 761 LPYQTHV------TTELVGTLGYIPPEYGQAWVATLRGDMYSFGVVMLELLTGKRPVDVLKPKMSRELVGWVLKMRSEGK 834 (894)
Q Consensus 761 ~~~~~~~------~~~~~gt~~Y~APE~~~~~~~s~ksDVwS~GvlL~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~ 834 (894)
.+..... .....||..||+-....+.+.+.+.|+-|+|.|+++.+-|..||.+..........+.+....+...
T Consensus 180 rDp~TkqHIPYrE~KSLsGTARYMSINTHlGrEQSRRDDLEaLGHvFmYFLRGsLPWQGLKA~tnK~kYeKIGe~Kr~T~ 259 (449)
T KOG1165|consen 180 RDPKTKQHIPYREHKSLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKADTNKEKYEKIGETKRSTP 259 (449)
T ss_pred cCccccccCccccccccccceeeeEeeccccchhhhhhhHHHhhhhhhhhccCCCccccccCcchHHHHHHhccccccCC
Confidence 5433221 2346799999999999999999999999999999999999999998876543332222211111111
Q ss_pred CCccccccccCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhcc
Q 002673 835 QDQVFDPILRGKGFDEEMLQVLDVACMCVSQNPFKRPTVKEVVEWLNNVG 884 (894)
Q Consensus 835 ~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~i~ 884 (894)
+...+ .++++++...+..+. ..+-.+-|..+-+...+.++-
T Consensus 260 ----i~~Lc--~g~P~efa~Yl~yvR---~L~F~E~PDYdylr~Lf~dvl 300 (449)
T KOG1165|consen 260 ----IEVLC--EGFPEEFATYLRYVR---RLDFFETPDYDYLRKLFDDVL 300 (449)
T ss_pred ----HHHHH--hcCHHHHHHHHHHHH---hcCcccCCCHHHHHHHHHHHH
Confidence 11222 346666666665554 567788899888877666553
|
|
| >PRK09188 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.86 E-value=2.7e-21 Score=214.72 Aligned_cols=164 Identities=20% Similarity=0.222 Sum_probs=127.0
Q ss_pred ccCCCccceEeecCcEEEEEEEEc--CCCeEEEEEEcCcc-----hhhHHHHHHHHHHHHhcCCCceeeecceeeecceE
Q 002673 606 TDNFSQANIIGCGGFGLVYKATLA--NGTTLAIKKLSGDL-----GLMEREFKAEVEALSTAQHKNLVSLQGYCVHQGFR 678 (894)
Q Consensus 606 ~~~f~~~~~LG~G~fg~Vy~a~~~--~g~~vAvK~~~~~~-----~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~ 678 (894)
.++|...+.||+|+||.||+|... +++.||||++.... ......+.+|+++|++++|+|+++.+.. .+..
T Consensus 17 ~~~Y~~~~~IG~G~fg~Vy~a~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~h~~iv~~l~~---~~~~ 93 (365)
T PRK09188 17 SARFVETAVLKRDVFSTVERGYFAGDPGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTVRGIGVVPQLLA---TGKD 93 (365)
T ss_pred cCCceEccEEeecCcEEEEEEEEcCCCCeEEEEEEecccccccccHHHHHHHHHHHHHHHhccCCCCCcEEEE---cCCc
Confidence 467999999999999999999854 57888999875331 2234568999999999999999853322 2457
Q ss_pred EEEEEeccCCCHHHHHhhhcCCCCCcCHHHHHHHHHHHHHHHHHHHhccCCCeeecCC-CCCCeEECCCCcEEEEEcccc
Q 002673 679 LLIYSYMENGSLDYWLHEKADGASQLDWLTRLKIARGTSCGLAYMHQICEPHIVHRDI-KSSNILLDDQFEAHLADFGLS 757 (894)
Q Consensus 679 ~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDL-kp~NILld~~~~vkl~DFGla 757 (894)
++||||+++++|.. +.. . . ...++.+++++|.|||+ ++|+|||| ||+|||++.++.+||+|||++
T Consensus 94 ~LVmE~~~G~~L~~-~~~--~--~------~~~~~~~i~~aL~~lH~---~gIiHrDL~KP~NILv~~~~~ikLiDFGlA 159 (365)
T PRK09188 94 GLVRGWTEGVPLHL-ARP--H--G------DPAWFRSAHRALRDLHR---AGITHNDLAKPQNWLMGPDGEAAVIDFQLA 159 (365)
T ss_pred EEEEEccCCCCHHH-hCc--c--c------hHHHHHHHHHHHHHHHH---CCCeeCCCCCcceEEEcCCCCEEEEECccc
Confidence 99999999999962 211 0 0 14578899999999997 59999999 999999999999999999999
Q ss_pred cccCCCCCc-c------cccccccCCccCcccccCc
Q 002673 758 RLILPYQTH-V------TTELVGTLGYIPPEYGQAW 786 (894)
Q Consensus 758 ~~~~~~~~~-~------~~~~~gt~~Y~APE~~~~~ 786 (894)
+.+...... . -....+++.|+|||++...
T Consensus 160 ~~~~~~~~~~~~~~~~d~~~~~~~~~~~~pe~~~~~ 195 (365)
T PRK09188 160 SVFRRRGALYRIAAYEDLRHLLKHKRTYAPDALTPR 195 (365)
T ss_pred eecccCcchhhhhhhhhhhhhhccCccCCcccCChh
Confidence 976432211 1 1345788899999987543
|
|
| >KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.85 E-value=1.2e-20 Score=188.04 Aligned_cols=259 Identities=22% Similarity=0.298 Sum_probs=197.9
Q ss_pred ccCCCccceEeecCcEEEEEEE-EcCCCeEEEEEEcCcchhhHHHHHHHHHHHHhcCC-CceeeecceeeecceEEEEEE
Q 002673 606 TDNFSQANIIGCGGFGLVYKAT-LANGTTLAIKKLSGDLGLMEREFKAEVEALSTAQH-KNLVSLQGYCVHQGFRLLIYS 683 (894)
Q Consensus 606 ~~~f~~~~~LG~G~fg~Vy~a~-~~~g~~vAvK~~~~~~~~~~~~~~~Ei~~l~~l~H-pnIv~l~g~~~~~~~~~lV~E 683 (894)
...|.+.++||+|+||.+|.|. ..+|+.||||.-+.... ..++..|.++.+.++| ..|..+..|..+...-.|||+
T Consensus 14 ~gky~lvrkiGsGSFGdIy~~~~i~~ge~VAiK~Es~~a~--hpqL~yEskvY~iL~~g~GiP~i~~y~~e~~ynvlVMd 91 (341)
T KOG1163|consen 14 GGKYKLVRKIGSGSFGDIYLGISITSGEEVAIKLESSKAK--HPQLLYESKVYRILQGGVGIPHIRHYGTEKDYNVLVMD 91 (341)
T ss_pred ccceEEEEeecCCchhheeeeeeccCCceEEEEeecccCC--CcchhHHHHHHHHhccCCCCchhhhhccccccceeeee
Confidence 3578999999999999999997 78899999999876432 3467788899999875 678888888888889999999
Q ss_pred eccCCCHHHHHhhhcCCCCCcCHHHHHHHHHHHHHHHHHHHhccCCCeeecCCCCCCeEECC---CCcEEEEEccccccc
Q 002673 684 YMENGSLDYWLHEKADGASQLDWLTRLKIARGTSCGLAYMHQICEPHIVHRDIKSSNILLDD---QFEAHLADFGLSRLI 760 (894)
Q Consensus 684 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDLkp~NILld~---~~~vkl~DFGla~~~ 760 (894)
.+ |.+|++++.-.. +.++..+.+-++-|++.-++|+|. +++|||||||.|+|..- ...+.++|||+|+.+
T Consensus 92 LL-GPsLEdLfnfC~---R~ftmkTvLMLaDQml~RiEyvH~---r~fiHRDIKPdNFLMGlgrh~~kl~LIDFGLaKky 164 (341)
T KOG1163|consen 92 LL-GPSLEDLFNFCS---RRFTMKTVLMLADQMLSRIEYVHL---RNFIHRDIKPDNFLMGLGRHCNKLYLIDFGLAKKY 164 (341)
T ss_pred cc-CccHHHHHHHHh---hhhhHHhHHHHHHHHHHHHHHHHh---hccccccCCccceeeccccccceEEEEeccchhhh
Confidence 98 789999887653 468889999999999999999996 69999999999999863 456999999999987
Q ss_pred CCCCCc------ccccccccCCccCcccccCcCCCccccHHHHHHHHHHHHcCCCCCCCCCcchhhhHHHHHHHHhhcCC
Q 002673 761 LPYQTH------VTTELVGTLGYIPPEYGQAWVATLRGDMYSFGVVMLELLTGKRPVDVLKPKMSRELVGWVLKMRSEGK 834 (894)
Q Consensus 761 ~~~~~~------~~~~~~gt~~Y~APE~~~~~~~s~ksDVwS~GvlL~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~ 834 (894)
.+.... ......||..|.+--...+...+.+.|+-|+|.+|..+--|..||.+..........+.+. +..
T Consensus 165 ~d~~t~~HIpyre~r~ltGTaRYASinAh~g~eqSRRDDmeSvgYvLmYfnrG~LPWQglka~tk~QKyEkI~----EkK 240 (341)
T KOG1163|consen 165 RDIRTRQHIPYREDRNLTGTARYASINAHLGIEQSRRDDMESVGYVLMYFNRGSLPWQGLKAATKKQKYEKIS----EKK 240 (341)
T ss_pred ccccccccCccccCCccceeeeehhhhhhhhhhhhhhhhhhhhcceeeeeecCCCcccccchhhHHHHHHHHH----Hhh
Confidence 543222 1234679999998888888888999999999999999999999999876543222222111 111
Q ss_pred CCccccccccCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHh
Q 002673 835 QDQVFDPILRGKGFDEEMLQVLDVACMCVSQNPFKRPTVKEVVEWLNN 882 (894)
Q Consensus 835 ~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~ 882 (894)
....+.... .+++.| +.-.+..|-..--++-|...-+-+.+.-
T Consensus 241 ~s~~ie~LC--~G~P~E---F~myl~Y~R~L~F~E~Pdy~ylrqlFri 283 (341)
T KOG1163|consen 241 MSTPIEVLC--KGFPAE---FAMYLNYCRGLGFEEKPDYMYLRQLFRI 283 (341)
T ss_pred cCCCHHHHh--CCCcHH---HHHHHHHHhhcCCCCCCcHHHHHHHHHH
Confidence 111111111 233333 4455567888888888888777665543
|
|
| >COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Probab=99.84 E-value=3.7e-19 Score=194.18 Aligned_cols=259 Identities=27% Similarity=0.402 Sum_probs=195.8
Q ss_pred CCccceEeecCcEEEEEEEEcCCCeEEEEEEcCcchh---hHHHHHHHHHHHHhcCCC-ceeeecceeeecceEEEEEEe
Q 002673 609 FSQANIIGCGGFGLVYKATLANGTTLAIKKLSGDLGL---MEREFKAEVEALSTAQHK-NLVSLQGYCVHQGFRLLIYSY 684 (894)
Q Consensus 609 f~~~~~LG~G~fg~Vy~a~~~~g~~vAvK~~~~~~~~---~~~~~~~Ei~~l~~l~Hp-nIv~l~g~~~~~~~~~lV~E~ 684 (894)
|...+.||.|+||.||++... ..+++|.+...... ....+.+|+.++..+.|+ +++++.+++......+++++|
T Consensus 2 ~~~~~~l~~g~~~~v~~~~~~--~~~~~k~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 79 (384)
T COG0515 2 YRILRKLGEGSFGEVYLARDR--KLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYDFFQDEGSLYLVMEY 79 (384)
T ss_pred ceeEEeecCCCCeEEEEEEec--cEEEEEeechhhccchhHHHHHHHHHHHHHHccCCcceeeEEEEEecCCEEEEEEec
Confidence 566788999999999999876 78899998765433 356789999999999988 799999999777778999999
Q ss_pred ccCCCHHHHHhhhcCCCCCcCHHHHHHHHHHHHHHHHHHHhccCCCeeecCCCCCCeEECCCC-cEEEEEcccccccCCC
Q 002673 685 MENGSLDYWLHEKADGASQLDWLTRLKIARGTSCGLAYMHQICEPHIVHRDIKSSNILLDDQF-EAHLADFGLSRLILPY 763 (894)
Q Consensus 685 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDLkp~NILld~~~-~vkl~DFGla~~~~~~ 763 (894)
+.++++.+++...... ..+.......+..|++.++.|+|+ .+++|||+||+||+++..+ .++++|||.+......
T Consensus 80 ~~~~~l~~~~~~~~~~-~~~~~~~~~~~~~~~~~~l~~~H~---~~~~hrd~kp~nil~~~~~~~~~l~dfg~~~~~~~~ 155 (384)
T COG0515 80 VDGGSLEDLLKKIGRK-GPLSESEALFILAQILSALEYLHS---KGIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDP 155 (384)
T ss_pred CCCCcHHHHHHhcccc-cCCCHHHHHHHHHHHHHHHHHHHh---CCeeccCCCHHHeeecCCCCeEEEeccCcceecCCC
Confidence 9999999766643211 357888899999999999999997 5899999999999999988 7999999999865433
Q ss_pred CCc-----ccccccccCCccCcccccC---cCCCccccHHHHHHHHHHHHcCCCCCCCCCcc-hhhhHHHHHHHHhhcCC
Q 002673 764 QTH-----VTTELVGTLGYIPPEYGQA---WVATLRGDMYSFGVVMLELLTGKRPVDVLKPK-MSRELVGWVLKMRSEGK 834 (894)
Q Consensus 764 ~~~-----~~~~~~gt~~Y~APE~~~~---~~~s~ksDVwS~GvlL~elltG~~Pf~~~~~~-~~~~~~~~~~~~~~~~~ 834 (894)
... ......||..|+|||...+ ..++...|+||+|++++++++|..||...... ............... .
T Consensus 156 ~~~~~~~~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~s~g~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~-~ 234 (384)
T COG0515 156 GSTSSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIILELPTP-S 234 (384)
T ss_pred CccccccccccccccccccCCHHHhcCCCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCccccHHHHHHHHHhcCCc-c
Confidence 221 2356789999999999887 57888999999999999999999997654421 011111111111110 0
Q ss_pred CCccccccccCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 002673 835 QDQVFDPILRGKGFDEEMLQVLDVACMCVSQNPFKRPTVKEVVE 878 (894)
Q Consensus 835 ~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~ 878 (894)
....... .........+.+++..|+..+|..|.++.+...
T Consensus 235 ~~~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~~~~ 274 (384)
T COG0515 235 LASPLSP----SNPELISKAASDLLKKLLAKDPKNRLSSSSDLS 274 (384)
T ss_pred cccccCc----cccchhhHHHHHHHHHHHhcCchhcCCHHHHhh
Confidence 0000000 000122245678889999999999999998776
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.82 E-value=8.8e-21 Score=223.92 Aligned_cols=261 Identities=18% Similarity=0.238 Sum_probs=191.1
Q ss_pred CccceEeecCcEEEEEEE-EcCCCeEEEEEEc----Cc-chhh-HHHHHHHHHHHHhcCCCceeeecceeeecceEEEEE
Q 002673 610 SQANIIGCGGFGLVYKAT-LANGTTLAIKKLS----GD-LGLM-EREFKAEVEALSTAQHKNLVSLQGYCVHQGFRLLIY 682 (894)
Q Consensus 610 ~~~~~LG~G~fg~Vy~a~-~~~g~~vAvK~~~----~~-~~~~-~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~lV~ 682 (894)
...+++|.|++|.|+... ....+..+.|.+. .. .... ...+..|+.+-..++|+|++..+..+.+.....-+|
T Consensus 321 ~~~~~~g~ga~g~~~~~~~~~~~~~~~~~~~r~~~~~~~s~~~~~~~i~sE~~i~~~l~h~~~~e~l~~~~~~~~~~~~m 400 (601)
T KOG0590|consen 321 KPGRVLGSGAYGSVRIAKRRSDLKSFPEKEFRVRVKPTESERKYNYNITSEFCIGSSLSHPNIIETLDIVQEIDGILQSM 400 (601)
T ss_pred CccceeeecccCceEEEEecCCCccchhhhhhcccCCcccHHHHhhhhhhheeecccccCCchhhhHHHHhhcccchhhh
Confidence 356789999999887775 3344445555443 11 1111 122667888888899999998888777766666669
Q ss_pred EeccCCCHHHHHhhhcCCCCCcCHHHHHHHHHHHHHHHHHHHhccCCCeeecCCCCCCeEECCCCcEEEEEcccccccCC
Q 002673 683 SYMENGSLDYWLHEKADGASQLDWLTRLKIARGTSCGLAYMHQICEPHIVHRDIKSSNILLDDQFEAHLADFGLSRLILP 762 (894)
Q Consensus 683 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDLkp~NILld~~~~vkl~DFGla~~~~~ 762 (894)
||+++ +|..++... ..+....+..++.|+..|+.|+|++ +|.|||+|++|++++.++.+||+|||.+..+.-
T Consensus 401 E~~~~-Dlf~~~~~~----~~~~~~e~~c~fKqL~~Gv~y~h~~---GiahrdlK~enll~~~~g~lki~Dfg~~~vf~~ 472 (601)
T KOG0590|consen 401 EYCPY-DLFSLVMSN----GKLTPLEADCFFKQLLRGVKYLHSM---GLAHRDLKLENLLVTENGILKIIDFGAASVFRY 472 (601)
T ss_pred hcccH-HHHHHHhcc----cccchhhhhHHHHHHHHHHHHHHhc---CceeccCccccEEEecCCceEEeecCcceeecc
Confidence 99999 999998753 3477788899999999999999985 999999999999999999999999999987643
Q ss_pred CCC---cccccccccCCccCcccccCcCCCc-cccHHHHHHHHHHHHcCCCCCCCCCcchhhhHHHHHHHHhhcCCCCcc
Q 002673 763 YQT---HVTTELVGTLGYIPPEYGQAWVATL-RGDMYSFGVVMLELLTGKRPVDVLKPKMSRELVGWVLKMRSEGKQDQV 838 (894)
Q Consensus 763 ~~~---~~~~~~~gt~~Y~APE~~~~~~~s~-ksDVwS~GvlL~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 838 (894)
... ......+|+..|+|||++.+..|.. ..||||.|++++.|++|+.||......+... ............
T Consensus 473 ~~e~~~~~~~g~~gS~pY~apE~~~~~~ydpr~vDiwS~~ii~~~m~~~~~~Wk~a~~~~~~~-----~~~~~~~~~~~~ 547 (601)
T KOG0590|consen 473 PWEKNIHESSGIVGSDPYLAPEVLTGKEYDPRAVDVWSCGIIYICMILGRFPWKVAKKSDNSF-----KTNNYSDQRNIF 547 (601)
T ss_pred CcchhhhhhcCcccCCcCcCcccccccccCcchhhhhhccceEEEEecCCCccccccccccch-----hhhccccccccc
Confidence 222 4456678999999999999988864 5799999999999999999997554332211 000000000000
Q ss_pred ccccccCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHH--HHHhcccc
Q 002673 839 FDPILRGKGFDEEMLQVLDVACMCVSQNPFKRPTVKEVVE--WLNNVGAN 886 (894)
Q Consensus 839 ~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~--~L~~i~~~ 886 (894)
..+ .............++.++++.||.+|.|+++|++ |++++...
T Consensus 548 ~~~---~~~~~~lp~~~~~~~~~~l~~~P~~R~ti~~i~~d~W~~~i~~c 594 (601)
T KOG0590|consen 548 EGP---NRLLSLLPRETRIIIYRMLQLDPTKRITIEQILNDEWIRSIECC 594 (601)
T ss_pred cCh---HHHHHhchhhHHHHHHHHccCChhheecHHHHhhChHhhhcceE
Confidence 000 0111222335568889999999999999999998 99988654
|
|
| >KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.77 E-value=1e-19 Score=213.35 Aligned_cols=245 Identities=21% Similarity=0.219 Sum_probs=176.0
Q ss_pred CCCccceEeecCcEEEEEEEEcCCCeEEEEEEcCcc-hhhHHHHHHHHHH--HHhcCCCceeeecceeeecceEEEEEEe
Q 002673 608 NFSQANIIGCGGFGLVYKATLANGTTLAIKKLSGDL-GLMEREFKAEVEA--LSTAQHKNLVSLQGYCVHQGFRLLIYSY 684 (894)
Q Consensus 608 ~f~~~~~LG~G~fg~Vy~a~~~~g~~vAvK~~~~~~-~~~~~~~~~Ei~~--l~~l~HpnIv~l~g~~~~~~~~~lV~E~ 684 (894)
+|...+.||++.|=+|.+|+.++|. |+||++-+.. ....+.|.++++- ...++|||++++.-+-..+.-.|||-+|
T Consensus 24 e~~~~~~LGstRFlKv~r~k~~eG~-vVvKVFvk~~p~~sL~~~~qrL~~ik~~l~~~pn~lPfqk~~~t~kAAylvRqy 102 (1431)
T KOG1240|consen 24 ECHYVENLGSTRFLKVARAKDREGL-VVVKVFVKQDPTISLRPFKQRLEEIKFALMKAPNCLPFQKVLVTDKAAYLVRQY 102 (1431)
T ss_pred ceeeecccCchhhhhhhhccCCCce-EEEEEEeccCCCCCchHHHHHHHHHHHHhhcCCcccchHHHHHhhHHHHHHHHH
Confidence 5666788999999999999998888 8899886544 3334444443333 5556899999998887777778899899
Q ss_pred ccCCCHHHHHhhhcCCCCCcCHHHHHHHHHHHHHHHHHHHhccCCCeeecCCCCCCeEECCCCcEEEEEcccccccC--C
Q 002673 685 MENGSLDYWLHEKADGASQLDWLTRLKIARGTSCGLAYMHQICEPHIVHRDIKSSNILLDDQFEAHLADFGLSRLIL--P 762 (894)
Q Consensus 685 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDLkp~NILld~~~~vkl~DFGla~~~~--~ 762 (894)
+.+ +|.+.+..+ .-+...+..+|+.|++.||.-+|. .+|.|||||.+||||+.-.-+.|+||-.-+... .
T Consensus 103 vkh-nLyDRlSTR----PFL~~iEKkWiaFQLL~al~qcH~---~gVcHGDIKsENILiTSWNW~~LtDFAsFKPtYLPe 174 (1431)
T KOG1240|consen 103 VKH-NLYDRLSTR----PFLVLIEKKWIAFQLLKALSQCHK---LGVCHGDIKSENILITSWNWLYLTDFASFKPTYLPE 174 (1431)
T ss_pred Hhh-hhhhhhccc----hHHHHHHHHHHHHHHHHHHHHHHH---cCccccccccceEEEeeechhhhhcccccCCccCCC
Confidence 854 787777643 346777889999999999999997 599999999999999999999999998766431 1
Q ss_pred CCCccc----ccccccCCccCcccccC----------c-CCCccccHHHHHHHHHHHHc-CCCCCCCCCcchhhhHHHHH
Q 002673 763 YQTHVT----TELVGTLGYIPPEYGQA----------W-VATLRGDMYSFGVVMLELLT-GKRPVDVLKPKMSRELVGWV 826 (894)
Q Consensus 763 ~~~~~~----~~~~gt~~Y~APE~~~~----------~-~~s~ksDVwS~GvlL~ellt-G~~Pf~~~~~~~~~~~~~~~ 826 (894)
+..... .+...-.+|+|||.... . ..+++.||||+||++.||++ |++||.- ..+..+.
T Consensus 175 DNPadf~fFFDTSrRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf~Eg~PlF~L------SQL~aYr 248 (1431)
T KOG1240|consen 175 DNPADFTFFFDTSRRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELFLEGRPLFTL------SQLLAYR 248 (1431)
T ss_pred CCcccceEEEecCCceeeecChHhhhccccccccCCcccccChhhhhhhhhHHHHHHHhcCCCcccH------HHHHhHh
Confidence 111111 11222348999995432 1 15678999999999999999 7888861 1122211
Q ss_pred HH--HhhcCCCCccccccccCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 002673 827 LK--MRSEGKQDQVFDPILRGKGFDEEMLQVLDVACMCVSQNPFKRPTVKEVVEW 879 (894)
Q Consensus 827 ~~--~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~ 879 (894)
.. ...+..++.+-|+ .+.+++..|++.||++|.++++.++.
T Consensus 249 ~~~~~~~e~~Le~Ied~------------~~Rnlil~Mi~rdPs~RlSAedyL~~ 291 (1431)
T KOG1240|consen 249 SGNADDPEQLLEKIEDV------------SLRNLILSMIQRDPSKRLSAEDYLQK 291 (1431)
T ss_pred ccCccCHHHHHHhCcCc------------cHHHHHHHHHccCchhccCHHHHHHh
Confidence 10 0000011112121 46689999999999999999999885
|
|
| >PRK10359 lipopolysaccharide core biosynthesis protein; Provisional | Back alignment and domain information |
|---|
Probab=99.77 E-value=9.7e-19 Score=181.11 Aligned_cols=170 Identities=12% Similarity=0.140 Sum_probs=131.5
Q ss_pred ccCCCccceEeecCcEEEEEEEEcCCCeEEEEEEcCcchhhHHH---------HHHHHHHHHhcCCCceeeecceeeec-
Q 002673 606 TDNFSQANIIGCGGFGLVYKATLANGTTLAIKKLSGDLGLMERE---------FKAEVEALSTAQHKNLVSLQGYCVHQ- 675 (894)
Q Consensus 606 ~~~f~~~~~LG~G~fg~Vy~a~~~~g~~vAvK~~~~~~~~~~~~---------~~~Ei~~l~~l~HpnIv~l~g~~~~~- 675 (894)
..+|...++||.|+||.||.+.. ++..+|||.+.......... +.+|+..+.+++|++|..+..++...
T Consensus 30 ~~~y~~~~~l~~~~f~~v~l~~~-~~~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l~rL~~~GI~~~~d~~~~~~ 108 (232)
T PRK10359 30 SYNIKTIKVFRNIDDTKVSLIDT-DYGKYILKVFAPKVKRTERFLKSFVKGDYYENLIVQTDRVRSEGLASLNDFYLLAE 108 (232)
T ss_pred hCceEEEEEecCCCceEEEEEec-CCCcEEEEEechhcCchHHHHHhhhhhHHHHHHHHHHHHHHHCCCCcceEeeeecc
Confidence 57899999999999999999766 57789999997544322222 67899999999999999998886533
Q ss_pred -------ceEEEEEEeccCCCHHHHHhhhcCCCCCcCHHHHHHHHHHHHHHHHHHHhccCCCeeecCCCCCCeEECCCCc
Q 002673 676 -------GFRLLIYSYMENGSLDYWLHEKADGASQLDWLTRLKIARGTSCGLAYMHQICEPHIVHRDIKSSNILLDDQFE 748 (894)
Q Consensus 676 -------~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDLkp~NILld~~~~ 748 (894)
...++||||++|.+|.++.. ++. ....+++.++..+|. .+++|||+||+||+++.++
T Consensus 109 ~~~~~~~~~~~lvmEyi~G~tL~~~~~--------~~~----~~~~~i~~~l~~lH~---~gi~H~Dikp~Nili~~~g- 172 (232)
T PRK10359 109 RKTLRYAHTYIMLIEYIEGVELNDMPE--------ISE----DVKAKIKASIESLHQ---HGMVSGDPHKGNFIVSKNG- 172 (232)
T ss_pred cccccccCCeEEEEEEECCccHHHhhh--------ccH----HHHHHHHHHHHHHHH---cCCccCCCChHHEEEeCCC-
Confidence 35789999999999987732 121 245689999999997 5999999999999999988
Q ss_pred EEEEEcccccccCCCCCcccccccccCCccCcccccCcCCCccccHHHHHHHHHHHH
Q 002673 749 AHLADFGLSRLILPYQTHVTTELVGTLGYIPPEYGQAWVATLRGDMYSFGVVMLELL 805 (894)
Q Consensus 749 vkl~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwS~GvlL~ell 805 (894)
++|+|||........... ..+.....+..+.|+||||+.+..+.
T Consensus 173 i~liDfg~~~~~~e~~a~-------------d~~vler~y~~~~di~~lg~~~~~~~ 216 (232)
T PRK10359 173 LRIIDLSGKRCTAQRKAK-------------DRIDLERHYGIKNEIKDLGYYLLIYK 216 (232)
T ss_pred EEEEECCCcccccchhhH-------------HHHHHHhHhcccccccceeEeehHHH
Confidence 999999987654211110 01334445667899999999987653
|
|
| >cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain | Back alignment and domain information |
|---|
Probab=99.77 E-value=1.8e-18 Score=176.61 Aligned_cols=139 Identities=17% Similarity=0.129 Sum_probs=107.1
Q ss_pred cceEeecCcEEEEEEEEcCCCeEEEEEEcCcchhh--------------------------HHHHHHHHHHHHhcCCCce
Q 002673 612 ANIIGCGGFGLVYKATLANGTTLAIKKLSGDLGLM--------------------------EREFKAEVEALSTAQHKNL 665 (894)
Q Consensus 612 ~~~LG~G~fg~Vy~a~~~~g~~vAvK~~~~~~~~~--------------------------~~~~~~Ei~~l~~l~HpnI 665 (894)
...||+|+||.||+|...+|+.||||+++...... ......|++.+.++.|+++
T Consensus 2 ~~~ig~G~~~~Vy~a~~~~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~v 81 (190)
T cd05147 2 NGCISTGKEANVYHATTANGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRLVTAGI 81 (190)
T ss_pred CCccccccceEEEEEECCCCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHHHHCCC
Confidence 36799999999999997789999999997542110 1122459999999988776
Q ss_pred eeecceeeecceEEEEEEeccCCCHHHHHhhhcCCCCCcCHHHHHHHHHHHHHHHHHH-HhccCCCeeecCCCCCCeEEC
Q 002673 666 VSLQGYCVHQGFRLLIYSYMENGSLDYWLHEKADGASQLDWLTRLKIARGTSCGLAYM-HQICEPHIVHRDIKSSNILLD 744 (894)
Q Consensus 666 v~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yL-H~~~~~~ivHrDLkp~NILld 744 (894)
.....+.. ...++||||++++++....... ..++......++.|++.+|.|+ |+ .+|+||||||+|||++
T Consensus 82 ~~p~~~~~--~~~~iVmE~i~g~~l~~~~~~~----~~~~~~~~~~i~~qi~~~L~~l~H~---~giiHrDlkP~NIli~ 152 (190)
T cd05147 82 PCPEPILL--KSHVLVMEFIGDDGWAAPRLKD----APLSESKARELYLQVIQIMRILYQD---CRLVHADLSEYNLLYH 152 (190)
T ss_pred CCCcEEEe--cCCEEEEEEeCCCCCcchhhhc----CCCCHHHHHHHHHHHHHHHHHHHHh---CCcccCCCCHHHEEEE
Confidence 44333222 2238999999988776443221 3578889999999999999999 55 5999999999999998
Q ss_pred CCCcEEEEEccccccc
Q 002673 745 DQFEAHLADFGLSRLI 760 (894)
Q Consensus 745 ~~~~vkl~DFGla~~~ 760 (894)
++.++|+|||++...
T Consensus 153 -~~~v~LiDFG~a~~~ 167 (190)
T cd05147 153 -DGKLYIIDVSQSVEH 167 (190)
T ss_pred -CCcEEEEEccccccC
Confidence 478999999999754
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c |
| >PRK12274 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.75 E-value=1.5e-17 Score=168.76 Aligned_cols=184 Identities=16% Similarity=0.109 Sum_probs=137.6
Q ss_pred CccceEeecCcEEEEEEEEcCCCeEEEEEEcCcchhh----HHHHHHHHHHHHhcC-CCceeeecceeeecceEEEEEEe
Q 002673 610 SQANIIGCGGFGLVYKATLANGTTLAIKKLSGDLGLM----EREFKAEVEALSTAQ-HKNLVSLQGYCVHQGFRLLIYSY 684 (894)
Q Consensus 610 ~~~~~LG~G~fg~Vy~a~~~~g~~vAvK~~~~~~~~~----~~~~~~Ei~~l~~l~-HpnIv~l~g~~~~~~~~~lV~E~ 684 (894)
.+...|++|+||+||.+.. .+.+++.+.+....... ...+.+|+++|++++ |+++++++++ +..+++|||
T Consensus 5 ~~~~~l~~~~f~~v~~~~~-~~~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~----~~~~lvmey 79 (218)
T PRK12274 5 AVNEPLKSDTFGRILLVRG-GERKFVRRDLSAAPWWLRGVAWWLARREALALRQLDGLPRTPRLLHW----DGRHLDRSY 79 (218)
T ss_pred ccceeecCCCcceEEEeec-CCceeeecccccchhhhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEE----cCEEEEEee
Confidence 3457899999999997765 67888878776543211 125789999999995 5789998886 346999999
Q ss_pred ccCCCHHHHHhhhcCCCCCcCHHHHHHHHHHHHHHHHHHHhccCCCeeecCC-CCCCeEECCCCcEEEEEcccccccCCC
Q 002673 685 MENGSLDYWLHEKADGASQLDWLTRLKIARGTSCGLAYMHQICEPHIVHRDI-KSSNILLDDQFEAHLADFGLSRLILPY 763 (894)
Q Consensus 685 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDL-kp~NILld~~~~vkl~DFGla~~~~~~ 763 (894)
+.|.+|...... ....++.|+..+|.++|. ++|+|||| ||+|||++.++.++|+|||++......
T Consensus 80 I~G~~L~~~~~~-----------~~~~~~~qi~~~L~~lH~---~GIvHrDL~kp~NILv~~~g~i~LIDFG~A~~~~~~ 145 (218)
T PRK12274 80 LAGAAMYQRPPR-----------GDLAYFRAARRLLQQLHR---CGVAHNDLAKEANWLVQEDGSPAVIDFQLAVRGNPR 145 (218)
T ss_pred ecCccHHhhhhh-----------hhHHHHHHHHHHHHHHHH---CcCccCCCCCcceEEEcCCCCEEEEECCCceecCCc
Confidence 999998654321 113467899999999997 59999999 799999999999999999999865432
Q ss_pred CCc----c--------cccccccCCccCcccccC--cCCCccccHHHHHHHHHHHHcCCCCCC
Q 002673 764 QTH----V--------TTELVGTLGYIPPEYGQA--WVATLRGDMYSFGVVMLELLTGKRPVD 812 (894)
Q Consensus 764 ~~~----~--------~~~~~gt~~Y~APE~~~~--~~~s~ksDVwS~GvlL~elltG~~Pf~ 812 (894)
... . ......++.|+.|+...- ...-...++++-|+.+|.++||..++-
T Consensus 146 ~~~~r~L~~rDl~~llk~~~~y~~~~l~~~~~~~l~~~~~~~~~w~~~g~~~~~~~~~~~~~~ 208 (218)
T PRK12274 146 ARWMRLLAREDLRHLLKHKRMYCPAALTPVERRVLKRTSWIRELWFATGKPVYRFVTRRVLHW 208 (218)
T ss_pred chHHHHHHHHHHHHHHHHHHhcCCCCCCHHHHhhhccchhHHHHHHHhcchHHHHHhccCCcc
Confidence 210 0 111236788888874322 122256799999999999999998864
|
|
| >cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain | Back alignment and domain information |
|---|
Probab=99.74 E-value=1.9e-17 Score=169.38 Aligned_cols=140 Identities=16% Similarity=0.132 Sum_probs=109.8
Q ss_pred cceEeecCcEEEEEEEEcCCCeEEEEEEcCcchh--------------------------hHHHHHHHHHHHHhcCCCce
Q 002673 612 ANIIGCGGFGLVYKATLANGTTLAIKKLSGDLGL--------------------------MEREFKAEVEALSTAQHKNL 665 (894)
Q Consensus 612 ~~~LG~G~fg~Vy~a~~~~g~~vAvK~~~~~~~~--------------------------~~~~~~~Ei~~l~~l~HpnI 665 (894)
...||+|+||.||+|...+|+.||||+++..... ....+..|.+.+.++.|+++
T Consensus 2 ~~~ig~G~~~~Vy~a~~~~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i 81 (190)
T cd05145 2 NGCISTGKEANVYHARTGDGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRLYEAGV 81 (190)
T ss_pred CceeecCCCcEEEEEEcCCCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHHHhCCC
Confidence 4679999999999999778999999998764211 01124578999999999987
Q ss_pred eeecceeeecceEEEEEEeccCCCHHHH-HhhhcCCCCCcCHHHHHHHHHHHHHHHHHHHhccCCCeeecCCCCCCeEEC
Q 002673 666 VSLQGYCVHQGFRLLIYSYMENGSLDYW-LHEKADGASQLDWLTRLKIARGTSCGLAYMHQICEPHIVHRDIKSSNILLD 744 (894)
Q Consensus 666 v~l~g~~~~~~~~~lV~E~~~~gsL~~~-l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDLkp~NILld 744 (894)
.....+... ..++||||++++++... +.. ..++......++.|++.++.++|+ ..+|+||||||+||+++
T Consensus 82 ~~p~~~~~~--~~~lVmE~~~g~~~~~~~l~~-----~~~~~~~~~~i~~~l~~~l~~lH~--~~givHrDlkP~NIll~ 152 (190)
T cd05145 82 PVPEPILLK--KNVLVMEFIGDDGSPAPRLKD-----VPLEEEEAEELYEQVVEQMRRLYQ--EAGLVHGDLSEYNILYH 152 (190)
T ss_pred CCceEEEec--CCEEEEEEecCCCchhhhhhh-----ccCCHHHHHHHHHHHHHHHHHHHH--hCCEecCCCChhhEEEE
Confidence 544443332 24899999998855433 332 246677889999999999999997 25999999999999999
Q ss_pred CCCcEEEEEcccccccC
Q 002673 745 DQFEAHLADFGLSRLIL 761 (894)
Q Consensus 745 ~~~~vkl~DFGla~~~~ 761 (894)
++.++|+|||++....
T Consensus 153 -~~~~~liDFG~a~~~~ 168 (190)
T cd05145 153 -DGKPYIIDVSQAVELD 168 (190)
T ss_pred -CCCEEEEEcccceecC
Confidence 8899999999998753
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro |
| >KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.73 E-value=1e-17 Score=189.31 Aligned_cols=218 Identities=29% Similarity=0.428 Sum_probs=163.9
Q ss_pred HHhcCCCceeeecceeeecceEEEEEEeccCCCHHHHHhhhcCCCCCcCHHHHHHHHHHHHHHHHHHHhccCCCeeecCC
Q 002673 657 LSTAQHKNLVSLQGYCVHQGFRLLIYSYMENGSLDYWLHEKADGASQLDWLTRLKIARGTSCGLAYMHQICEPHIVHRDI 736 (894)
Q Consensus 657 l~~l~HpnIv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDL 736 (894)
|+.+.|.|+.+++|.+.++...+.|.+||..|+|.+.+... ...++|.....+.++|+.||.|||+. +-..|+.+
T Consensus 1 l~~l~h~n~~~f~g~~~~~~~~~~i~~~c~rGsl~D~i~~~---~~~~d~~F~~s~~rdi~~Gl~ylh~s--~i~~hg~l 75 (484)
T KOG1023|consen 1 LRQLDHDNLNKFIGASVDGPEMIVIWEYCSRGSLLDILSNE---DIKLDYFFILSFIRDISKGLAYLHNS--PIGYHGAL 75 (484)
T ss_pred CcccchhhhhhheeeEecCCceEEEEeeecCccHHhHHhcc---ccCccHHHHHHHHHHHHHHHHHHhcC--cceeeeee
Confidence 35678999999999999999999999999999999999863 36799999999999999999999973 34499999
Q ss_pred CCCCeEECCCCcEEEEEcccccccCCCC-CcccccccccCCccCcccccCcC-------CCccccHHHHHHHHHHHHcCC
Q 002673 737 KSSNILLDDQFEAHLADFGLSRLILPYQ-THVTTELVGTLGYIPPEYGQAWV-------ATLRGDMYSFGVVMLELLTGK 808 (894)
Q Consensus 737 kp~NILld~~~~vkl~DFGla~~~~~~~-~~~~~~~~gt~~Y~APE~~~~~~-------~s~ksDVwS~GvlL~elltG~ 808 (894)
+++|+++|..+.+|++|||+........ ........-..-|.|||.+.+.. .+.+.||||||++++|+++.+
T Consensus 76 ~s~nClvd~~w~lklt~~Gl~~~~~~~~~~~~~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiYs~~ii~~ei~~r~ 155 (484)
T KOG1023|consen 76 KSSNCLVDSRWVLKLTDFGLNSLLEETAEPEAHHPIRKALLWTAPELLRGALSQSLESALTQKGDIYSFGIIMYEILFRS 155 (484)
T ss_pred ccccceeeeeEEEEechhhhcccccccccccccchhHHHHhccCHHHhcccccccccccccccCCeehHHHHHHHHHhcc
Confidence 9999999999999999999987653210 01111112345799999887641 466799999999999999999
Q ss_pred CCCCCCCcchh-hhHHHHHHHHhhcCCCCccccccccCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhcccc
Q 002673 809 RPVDVLKPKMS-RELVGWVLKMRSEGKQDQVFDPILRGKGFDEEMLQVLDVACMCVSQNPFKRPTVKEVVEWLNNVGAN 886 (894)
Q Consensus 809 ~Pf~~~~~~~~-~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~~i~~~ 886 (894)
.||+....... .+++.++.. .....+-|.+.... +....+..++..||..+|.+||++++|-..++.+...
T Consensus 156 ~~~~~~~~~~~~~eii~~~~~-----~~~~~~rP~i~~~~--e~~~~l~~l~~~cw~e~P~~rPs~~~i~~~~~~~~~~ 227 (484)
T KOG1023|consen 156 GPFDLRNLVEDPDEIILRVKK-----GGSNPFRPSIELLN--ELPPELLLLVARCWEEIPEKRPSIEQIRSKLLTINKG 227 (484)
T ss_pred CccccccccCChHHHHHHHHh-----cCCCCcCcchhhhh--hcchHHHHHHHHhcccChhhCccHHHHHhhhhhhccc
Confidence 99986433222 233333322 11122222222111 1222578899999999999999999999888777554
|
|
| >PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A | Back alignment and domain information |
|---|
Probab=99.73 E-value=2.9e-17 Score=175.07 Aligned_cols=233 Identities=23% Similarity=0.297 Sum_probs=147.4
Q ss_pred CCccceEeecCcEEEEEEEE-cCCCeEEEEEEcCcc---hhhHHHHHHHHHHHHhcCC-----------Cc-----eeee
Q 002673 609 FSQANIIGCGGFGLVYKATL-ANGTTLAIKKLSGDL---GLMEREFKAEVEALSTAQH-----------KN-----LVSL 668 (894)
Q Consensus 609 f~~~~~LG~G~fg~Vy~a~~-~~g~~vAvK~~~~~~---~~~~~~~~~Ei~~l~~l~H-----------pn-----Iv~l 668 (894)
+..+..||.|+++.||.++. .+|+.+|+|++.... ....+++++|.-....+.+ .- ++++
T Consensus 14 l~~~~~i~~g~~~~v~~v~d~~t~~~~avkvf~~~~~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~P~d~~~i 93 (288)
T PF14531_consen 14 LVRGRIIGKGGFSIVFEVTDVETGEEFAVKVFLLPADASANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLVPLDLLRI 93 (288)
T ss_dssp EEEEEEEEEETTEEEEEEEETTTTEEEEEEEEEESSTTHTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B---SEEEEE
T ss_pred EEEccccccCCceEEEEEEEccCCceEEEEEEecccccchHHHHHHHHHHHHhhhhccCCCHHHHHHhceEEeeeEEEEE
Confidence 34568899999999999985 468999999875432 2234556666544444322 11 1222
Q ss_pred cc---eeeecc--------eEEEEEEeccCCCHHHHHhh---hcCCCCCcCHHHHHHHHHHHHHHHHHHHhccCCCeeec
Q 002673 669 QG---YCVHQG--------FRLLIYSYMENGSLDYWLHE---KADGASQLDWLTRLKIARGTSCGLAYMHQICEPHIVHR 734 (894)
Q Consensus 669 ~g---~~~~~~--------~~~lV~E~~~~gsL~~~l~~---~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHr 734 (894)
-+ ++.... +.+++|+-+ .++|.+++.. .......+....++.+..|+++.+++||+ .|++|+
T Consensus 94 ~~~~~~~~~~~~~~~~~v~n~~~l~P~~-~~dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh~---~GlVHg 169 (288)
T PF14531_consen 94 PGKPPFFERGPGQSIYWVLNRFLLMPRA-QGDLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLHS---YGLVHG 169 (288)
T ss_dssp TTS-SEEEECETTEEEEEESEEEEEE---SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHH---TTEEES
T ss_pred cCCCcceecCCCCccceeehhhhccchh-hhcHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHhh---cceEec
Confidence 11 111111 236677777 5688877553 32223345666778888999999999998 499999
Q ss_pred CCCCCCeEECCCCcEEEEEcccccccCCCCCcccccccccCCccCcccccC--------cCCCccccHHHHHHHHHHHHc
Q 002673 735 DIKSSNILLDDQFEAHLADFGLSRLILPYQTHVTTELVGTLGYIPPEYGQA--------WVATLRGDMYSFGVVMLELLT 806 (894)
Q Consensus 735 DLkp~NILld~~~~vkl~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~~~~--------~~~s~ksDVwS~GvlL~ellt 806 (894)
||+|+|++++.+|.++|+||+....... .......+..|.+||.... ..++.+.|.|++|+++|.|++
T Consensus 170 di~~~nfll~~~G~v~Lg~F~~~~r~g~----~~~~~~~~~~~~PPe~~~~~~~~~~~~~~~t~~~DaW~LG~~ly~lWC 245 (288)
T PF14531_consen 170 DIKPENFLLDQDGGVFLGDFSSLVRAGT----RYRCSEFPVAFTPPELESCAGQFGQNNAPYTFATDAWQLGITLYSLWC 245 (288)
T ss_dssp T-SGGGEEE-TTS-EEE--GGGEEETTE----EEEGGGS-TTTS-HHHHHHHTSCHHSEEEE-HHHHHHHHHHHHHHHHH
T ss_pred ccceeeEEEcCCCCEEEcChHHHeecCc----eeeccCCCcccCChhhhhhhcccCcccceeeeccCHHHHHHHHHHHHH
Confidence 9999999999999999999988775422 1111344578999996533 357889999999999999999
Q ss_pred CCCCCCCCCcchhhhHHHHHHHHhhcCCCCccccccccCCCChHHHHHHHHHHHHhcccCCCCC
Q 002673 807 GKRPVDVLKPKMSRELVGWVLKMRSEGKQDQVFDPILRGKGFDEEMLQVLDVACMCVSQNPFKR 870 (894)
Q Consensus 807 G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~R 870 (894)
|..||+........+. .+ ..|.+....+..+|..+++.||.+|
T Consensus 246 ~~lPf~~~~~~~~~~~-------------------~f--~~C~~~Pe~v~~LI~~lL~~~~~~R 288 (288)
T PF14531_consen 246 GRLPFGLSSPEADPEW-------------------DF--SRCRDMPEPVQFLIRGLLQRNPEDR 288 (288)
T ss_dssp SS-STCCCGGGSTSGG-------------------GG--TTSS---HHHHHHHHHHT-SSGGGS
T ss_pred ccCCCCCCCccccccc-------------------cc--hhcCCcCHHHHHHHHHHccCCcccC
Confidence 9999985433211110 01 2233455567788999999999987
|
|
| >PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.71 E-value=8.4e-18 Score=214.04 Aligned_cols=195 Identities=29% Similarity=0.393 Sum_probs=153.0
Q ss_pred eecCCCChhhHHHHHhhc-------cCCCCCCcccccccccccccccccccCccccchhcccccccccccCcccc-ccCC
Q 002673 302 ELVSRPNADDLEIIFGEV-------EGKSDEGPSLFSQANLLSGEFPKELTALPALVSEAANDEVDRSYLELPVF-VMPS 373 (894)
Q Consensus 302 ~~~~~p~le~l~~~~n~~-------~~~l~~L~~L~L~~N~l~~~~p~~~~~L~~L~~L~L~~n~~~~~~~~~~~-~~~~ 373 (894)
.+...+.++.+++..|.. +..+++|+.|++++|++++.+|..|.++++|+.|+|++|.+....+.... ....
T Consensus 375 ~~~~~~~L~~L~l~~n~l~~~~p~~~~~~~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L 454 (968)
T PLN00113 375 GLCSSGNLFKLILFSNSLEGEIPKSLGACRSLRRVRLQDNSFSGELPSEFTKLPLVYFLDISNNNLQGRINSRKWDMPSL 454 (968)
T ss_pred hHhCcCCCCEEECcCCEecccCCHHHhCCCCCCEEECcCCEeeeECChhHhcCCCCCEEECcCCcccCccChhhccCCCC
Confidence 333444445444443332 33455777788888888777788888888888888888777654433211 2223
Q ss_pred CCCcccccCCC----------CCCCeEEccCCcCCcCCchhhcCCCCCcEEeccCCcCCCCCCccccCCCCCCEEecCCC
Q 002673 374 NATNQQYNQLS----------NLPPAIYLANNSLSGNIPVEIGQLKSLHVLDLSNNNFSGTIPDELSDLSNLEKLDLSGN 443 (894)
Q Consensus 374 ~~~~l~~n~L~----------~Lp~~L~L~~N~l~~~~p~~~~~L~~L~~L~L~~N~l~~~~p~~~~~L~~L~~L~Ls~N 443 (894)
+.++++.|++. +| +.|+|++|++++.+|..|.++++|+.|+|++|++++.+|..|.+|++|+.|+|++|
T Consensus 455 ~~L~L~~n~~~~~~p~~~~~~~L-~~L~ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N 533 (968)
T PLN00113 455 QMLSLARNKFFGGLPDSFGSKRL-ENLDLSRNQFSGAVPRKLGSLSELMQLKLSENKLSGEIPDELSSCKKLVSLDLSHN 533 (968)
T ss_pred cEEECcCceeeeecCcccccccc-eEEECcCCccCCccChhhhhhhccCEEECcCCcceeeCChHHcCccCCCEEECCCC
Confidence 45566666654 33 56899999999999999999999999999999999999999999999999999999
Q ss_pred cccCcCCCcccCCCccccccccccccCCCCCC-CCCCCCCCccccCCCCCCCCCc
Q 002673 444 HLVGEIPISLKGLHFLSSFSVAHNNLQGAVPS-GGQFDTFPSFSFEGNPELCGSV 497 (894)
Q Consensus 444 ~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~-~~~l~~L~~l~l~~Np~~c~~~ 497 (894)
++++.+|..|.++++|+.|+|++|++++.+|. +..+.+|+.|++++|+..+..+
T Consensus 534 ~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~l~ls~N~l~~~~p 588 (968)
T PLN00113 534 QLSGQIPASFSEMPVLSQLDLSQNQLSGEIPKNLGNVESLVQVNISHNHLHGSLP 588 (968)
T ss_pred cccccCChhHhCcccCCEEECCCCcccccCChhHhcCcccCEEeccCCcceeeCC
Confidence 99999999999999999999999999987774 4889999999999999876443
|
|
| >KOG4194 consensus Membrane glycoprotein LIG-1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.69 E-value=1.4e-18 Score=191.62 Aligned_cols=191 Identities=18% Similarity=0.170 Sum_probs=121.1
Q ss_pred eeecCCCChhhHHHHHhh-------ccCCCCCCcccccccccccccccccccCccccchhcccccccccccCcccccc-C
Q 002673 301 KELVSRPNADDLEIIFGE-------VEGKSDEGPSLFSQANLLSGEFPKELTALPALVSEAANDEVDRSYLELPVFVM-P 372 (894)
Q Consensus 301 ~~~~~~p~le~l~~~~n~-------~~~~l~~L~~L~L~~N~l~~~~p~~~~~L~~L~~L~L~~n~~~~~~~~~~~~~-~ 372 (894)
..|..+|.++.||+-.|+ .|.++++|+.|.|+.|.|...-.+.|..|.++++|+|..|.+........+.+ .
T Consensus 215 r~Fk~L~~L~~LdLnrN~irive~ltFqgL~Sl~nlklqrN~I~kL~DG~Fy~l~kme~l~L~~N~l~~vn~g~lfgLt~ 294 (873)
T KOG4194|consen 215 RSFKRLPKLESLDLNRNRIRIVEGLTFQGLPSLQNLKLQRNDISKLDDGAFYGLEKMEHLNLETNRLQAVNEGWLFGLTS 294 (873)
T ss_pred HHhhhcchhhhhhccccceeeehhhhhcCchhhhhhhhhhcCcccccCcceeeecccceeecccchhhhhhcccccccch
Confidence 445556777777776665 25566677777777777766666677777777777777776666665543332 2
Q ss_pred CCCCcccccCCCCCC----------CeEEccCCcCCcCCchhhcCCCCCcEEeccCCcCCCCCCccccCCCCCCEEecCC
Q 002673 373 SNATNQQYNQLSNLP----------PAIYLANNSLSGNIPVEIGQLKSLHVLDLSNNNFSGTIPDELSDLSNLEKLDLSG 442 (894)
Q Consensus 373 ~~~~~l~~n~L~~Lp----------~~L~L~~N~l~~~~p~~~~~L~~L~~L~L~~N~l~~~~p~~~~~L~~L~~L~Ls~ 442 (894)
...+++++|.+..+. ++|+|++|+|+...+++|..|..|++|+|++|+|+..-...|.++++|++|||++
T Consensus 295 L~~L~lS~NaI~rih~d~WsftqkL~~LdLs~N~i~~l~~~sf~~L~~Le~LnLs~Nsi~~l~e~af~~lssL~~LdLr~ 374 (873)
T KOG4194|consen 295 LEQLDLSYNAIQRIHIDSWSFTQKLKELDLSSNRITRLDEGSFRVLSQLEELNLSHNSIDHLAEGAFVGLSSLHKLDLRS 374 (873)
T ss_pred hhhhccchhhhheeecchhhhcccceeEeccccccccCChhHHHHHHHhhhhcccccchHHHHhhHHHHhhhhhhhcCcC
Confidence 255566666665542 4466777777666666666666677777777776655556666677777777777
Q ss_pred CcccCcCCC---cccCCCccccccccccccCCCCC-CCCCCCCCCccccCCCC
Q 002673 443 NHLVGEIPI---SLKGLHFLSSFSVAHNNLQGAVP-SGGQFDTFPSFSFEGNP 491 (894)
Q Consensus 443 N~l~~~~p~---~~~~l~~L~~L~Ls~N~l~~~~~-~~~~l~~L~~l~l~~Np 491 (894)
|.|++.+.+ .|.+|++|+.|+|.+|+|+.++. .+..|.+|+.|+|.+|+
T Consensus 375 N~ls~~IEDaa~~f~gl~~LrkL~l~gNqlk~I~krAfsgl~~LE~LdL~~Na 427 (873)
T KOG4194|consen 375 NELSWCIEDAAVAFNGLPSLRKLRLTGNQLKSIPKRAFSGLEALEHLDLGDNA 427 (873)
T ss_pred CeEEEEEecchhhhccchhhhheeecCceeeecchhhhccCcccceecCCCCc
Confidence 766655543 35666666777777777664333 23566666667766664
|
|
| >KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.69 E-value=1.6e-16 Score=191.13 Aligned_cols=195 Identities=23% Similarity=0.244 Sum_probs=157.5
Q ss_pred hccCCCccceEeecCcEEEEEEEEcCCCeEEEEEEcCcchhhHHHHHHHHHHHHhcC---CCceeeecceeeecceEEEE
Q 002673 605 ATDNFSQANIIGCGGFGLVYKATLANGTTLAIKKLSGDLGLMEREFKAEVEALSTAQ---HKNLVSLQGYCVHQGFRLLI 681 (894)
Q Consensus 605 a~~~f~~~~~LG~G~fg~Vy~a~~~~g~~vAvK~~~~~~~~~~~~~~~Ei~~l~~l~---HpnIv~l~g~~~~~~~~~lV 681 (894)
-.+.|.+.+.||+|+||+||+|...+|+.||+|+-+.... .+|.--.+++.+|+ -+.|.++...+.-.+..+||
T Consensus 696 ~~~~~~I~~e~G~g~y~~vy~a~~~~~~~~alK~e~P~~~---WEfYI~~q~~~RLk~~~~~~~~~~~~a~~~~~~S~lv 772 (974)
T KOG1166|consen 696 GGEKFCISKEIGEGSYGSVYVATHSNGKLVALKVEKPPNP---WEFYICLQVMERLKPQMLPSIMHISSAHVFQNASVLV 772 (974)
T ss_pred cceeEEEEeeeccccceEEEEeecCCCcEEEEEeecCCCc---eeeeehHHHHHhhchhhhcchHHHHHHHccCCcceee
Confidence 3467888999999999999999988899999998765432 12222233333443 34556666666677788999
Q ss_pred EEeccCCCHHHHHhhhcCCCCCcCHHHHHHHHHHHHHHHHHHHhccCCCeeecCCCCCCeEEC-------CCCcEEEEEc
Q 002673 682 YSYMENGSLDYWLHEKADGASQLDWLTRLKIARGTSCGLAYMHQICEPHIVHRDIKSSNILLD-------DQFEAHLADF 754 (894)
Q Consensus 682 ~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDLkp~NILld-------~~~~vkl~DF 754 (894)
+||.+.|+|.+++. +....+|...+.++.|++..+++||.+ +|||+||||.|+||. ....++|+||
T Consensus 773 ~ey~~~Gtlld~~N----~~~~m~e~lv~~~~~qml~ive~lH~~---~IIHgDiKPDNfll~~~~~~~~~~~~l~lIDf 845 (974)
T KOG1166|consen 773 SEYSPYGTLLDLIN----TNKVMDEYLVMFFSCQMLRIVEHLHAM---GIIHGDIKPDNFLLRREICADSDSKGLYLIDF 845 (974)
T ss_pred eeccccccHHHhhc----cCCCCCchhhhHHHHHHHHHHHHHHhc---ceecccCCcceeEeecccCCCCcccceEEEec
Confidence 99999999999998 346789999999999999999999975 999999999999994 3446999999
Q ss_pred ccccccCCC-CCcccccccccCCccCcccccCcCCCccccHHHHHHHHHHHHcCCC
Q 002673 755 GLSRLILPY-QTHVTTELVGTLGYIPPEYGQAWVATLRGDMYSFGVVMLELLTGKR 809 (894)
Q Consensus 755 Gla~~~~~~-~~~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwS~GvlL~elltG~~ 809 (894)
|.+..+.-- ........++|-.+-.+|+..|+.++..+|.|.++-+++-|+.|+.
T Consensus 846 G~siDm~lfp~~~~F~~~~~td~f~C~EM~~grpWtYq~DyfGlAa~~h~mLFG~y 901 (974)
T KOG1166|consen 846 GRSIDMKLFPDGTKFKAVWHTDLFDCIEMREGRPWTYQIDYFGLAATVHVMLFGKY 901 (974)
T ss_pred ccceeeeEcCCCcEEeeeeccccchhHHHhcCCCCchhhhhHHHHHHHHHHHHHHH
Confidence 999876422 2234556788999999999999999999999999999999999874
|
|
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.68 E-value=8.7e-18 Score=189.39 Aligned_cols=224 Identities=25% Similarity=0.274 Sum_probs=170.4
Q ss_pred EeecCcEEEEEEE----EcCCCeEEEEEEcCcchhh--HHHHHHHHHHHHhcC-CCceeeecceeeecceEEEEEEeccC
Q 002673 615 IGCGGFGLVYKAT----LANGTTLAIKKLSGDLGLM--EREFKAEVEALSTAQ-HKNLVSLQGYCVHQGFRLLIYSYMEN 687 (894)
Q Consensus 615 LG~G~fg~Vy~a~----~~~g~~vAvK~~~~~~~~~--~~~~~~Ei~~l~~l~-HpnIv~l~g~~~~~~~~~lV~E~~~~ 687 (894)
+|.|.||.|+.+. .+.|..+|+|+.++..... ......|-.++...+ ||.+|.+.-.+..+...+++++|..+
T Consensus 2 lg~g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~~~~~~t~~er~il~~~~~~~f~v~lhyafqt~~kl~l~ld~~rg 81 (612)
T KOG0603|consen 2 LGQGSYGKVFLVRKAGGADAGHLYAMKVLKKATLKVRDRTHTKQERIILAFVHNTPFLVKLHYAFQTDGKLYLILDFLRG 81 (612)
T ss_pred CCcCCCcchHHHHHhccccccchhhhhcccccccccccccccccHHHHHhhccCCCceeeeeeeeccccchhHhhhhccc
Confidence 6899999998774 2356778888876543211 123456778888886 99999999999999999999999999
Q ss_pred CCHHHHHhhhcCCCCCcCHHHHHHHHHHHHHHHHHHHhccCCCeeecCCCCCCeEECCCCcEEEEEcccccccCCCCCcc
Q 002673 688 GSLDYWLHEKADGASQLDWLTRLKIARGTSCGLAYMHQICEPHIVHRDIKSSNILLDDQFEAHLADFGLSRLILPYQTHV 767 (894)
Q Consensus 688 gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDLkp~NILld~~~~vkl~DFGla~~~~~~~~~~ 767 (894)
|.|...+... ..+.......+...++-++.++|+. +++|||+|++||+++.+|.+++.|||+++........
T Consensus 82 g~lft~l~~~----~~f~~~~~~~~~aelaLald~lh~l---~iiyrd~k~enilld~~Ghi~~tdfglske~v~~~~~- 153 (612)
T KOG0603|consen 82 GDLFTRLSKE----VMFDELDVAFYLAELALALDHLHKL---GIAYRDYKLENVLLLLEGHIKLTDFGLSKEAVKEKIA- 153 (612)
T ss_pred chhhhccccC----CchHHHHHHHHHHHHHHHHhhcchh---HHHHhcccccceeecccCccccCCchhhhHhHhhhhc-
Confidence 9998777643 3456666677778888999999975 9999999999999999999999999999876433222
Q ss_pred cccccccCCccCcccccCcCCCccccHHHHHHHHHHHHcCCCCCCCCCcchhhhHHHHHHHHhhcCCCCccccccccCCC
Q 002673 768 TTELVGTLGYIPPEYGQAWVATLRGDMYSFGVVMLELLTGKRPVDVLKPKMSRELVGWVLKMRSEGKQDQVFDPILRGKG 847 (894)
Q Consensus 768 ~~~~~gt~~Y~APE~~~~~~~s~ksDVwS~GvlL~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~ 847 (894)
+||..|||||++. ......|.||||++++||+||..||.. +.... +.... . ..
T Consensus 154 ----cgt~eymApEI~~--gh~~a~D~ws~gvl~felltg~~pf~~-------~~~~~---Il~~~----~-------~~ 206 (612)
T KOG0603|consen 154 ----CGTYEYRAPEIIN--GHLSAADWWSFGVLAFELLTGTLPFGG-------DTMKR---ILKAE----L-------EM 206 (612)
T ss_pred ----ccchhhhhhHhhh--ccCCcccchhhhhhHHHHhhCCCCCch-------HHHHH---Hhhhc----c-------CC
Confidence 8999999999998 456789999999999999999999975 11111 11100 0 11
Q ss_pred ChHHHHHHHHHHHHhcccCCCCCCCH
Q 002673 848 FDEEMLQVLDVACMCVSQNPFKRPTV 873 (894)
Q Consensus 848 ~~~~~~~l~~li~~Cl~~dP~~RPs~ 873 (894)
..+......+++..+...+|..|.-.
T Consensus 207 p~~l~~~a~~~~~~l~~r~p~nrLg~ 232 (612)
T KOG0603|consen 207 PRELSAEARSLFRQLFKRNPENRLGA 232 (612)
T ss_pred chhhhHHHHHHHHHHHhhCHHHHhcc
Confidence 12223345567778888888888754
|
|
| >KOG0617 consensus Ras suppressor protein (contains leucine-rich repeats) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.68 E-value=1.1e-18 Score=165.55 Aligned_cols=166 Identities=23% Similarity=0.299 Sum_probs=126.4
Q ss_pred CCcccccccccccccccccccCccccchhcccccccccccCccccccCCCCCcccccCCCCCC---------CeEEccCC
Q 002673 325 EGPSLFSQANLLSGEFPKELTALPALVSEAANDEVDRSYLELPVFVMPSNATNQQYNQLSNLP---------PAIYLANN 395 (894)
Q Consensus 325 ~L~~L~L~~N~l~~~~p~~~~~L~~L~~L~L~~n~~~~~~~~~~~~~~~~~~~l~~n~L~~Lp---------~~L~L~~N 395 (894)
+.+.|.|++|+++. +|..+..|.+|+.|++.+|++..++.........+.+++..|+|..+| +.|+|.+|
T Consensus 34 ~ITrLtLSHNKl~~-vppnia~l~nlevln~~nnqie~lp~~issl~klr~lnvgmnrl~~lprgfgs~p~levldltyn 112 (264)
T KOG0617|consen 34 NITRLTLSHNKLTV-VPPNIAELKNLEVLNLSNNQIEELPTSISSLPKLRILNVGMNRLNILPRGFGSFPALEVLDLTYN 112 (264)
T ss_pred hhhhhhcccCceee-cCCcHHHhhhhhhhhcccchhhhcChhhhhchhhhheecchhhhhcCccccCCCchhhhhhcccc
Confidence 45678899999987 778899999999999999998887776555555566666666666666 34678877
Q ss_pred cCCc-CCchhhcCCCCCcEEeccCCcCCCCCCccccCCCCCCEEecCCCcccCcCCCcccCCCccccccccccccCCCCC
Q 002673 396 SLSG-NIPVEIGQLKSLHVLDLSNNNFSGTIPDELSDLSNLEKLDLSGNHLVGEIPISLKGLHFLSSFSVAHNNLQGAVP 474 (894)
Q Consensus 396 ~l~~-~~p~~~~~L~~L~~L~L~~N~l~~~~p~~~~~L~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~ 474 (894)
+|+. .+|+.|..|+.|+.|+|+.|.+. .+|+.+++|++|+.|.+..|.+- .+|..++.|++|++|++.+|+|+-+||
T Consensus 113 nl~e~~lpgnff~m~tlralyl~dndfe-~lp~dvg~lt~lqil~lrdndll-~lpkeig~lt~lrelhiqgnrl~vlpp 190 (264)
T KOG0617|consen 113 NLNENSLPGNFFYMTTLRALYLGDNDFE-ILPPDVGKLTNLQILSLRDNDLL-SLPKEIGDLTRLRELHIQGNRLTVLPP 190 (264)
T ss_pred ccccccCCcchhHHHHHHHHHhcCCCcc-cCChhhhhhcceeEEeeccCchh-hCcHHHHHHHHHHHHhcccceeeecCh
Confidence 7754 56777888888888888888887 77888888888888888888877 778888888888888888888887777
Q ss_pred CCCCCCCC---CccccCCCCCC
Q 002673 475 SGGQFDTF---PSFSFEGNPEL 493 (894)
Q Consensus 475 ~~~~l~~L---~~l~l~~Np~~ 493 (894)
+++++.-+ ..+.+.+|||.
T Consensus 191 el~~l~l~~~k~v~r~E~NPwv 212 (264)
T KOG0617|consen 191 ELANLDLVGNKQVMRMEENPWV 212 (264)
T ss_pred hhhhhhhhhhHHHHhhhhCCCC
Confidence 76554432 33556777775
|
|
| >PRK10345 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.68 E-value=4.3e-16 Score=160.81 Aligned_cols=137 Identities=15% Similarity=0.149 Sum_probs=105.8
Q ss_pred CCccceEeecCcEEEEEEEEcCCCeEEEEEEcCcchhhHHHHHHHHHHHHhc-----CCCceeeecceeeecc---e-EE
Q 002673 609 FSQANIIGCGGFGLVYKATLANGTTLAIKKLSGDLGLMEREFKAEVEALSTA-----QHKNLVSLQGYCVHQG---F-RL 679 (894)
Q Consensus 609 f~~~~~LG~G~fg~Vy~a~~~~g~~vAvK~~~~~~~~~~~~~~~Ei~~l~~l-----~HpnIv~l~g~~~~~~---~-~~ 679 (894)
++..+.||+|+||.||. .-.++.. +||++........+++.+|+.+++.+ .||||++++|++.++. . ..
T Consensus 4 L~~~~~LG~G~~~~Vy~-hp~~~~k-~IKv~~~~~~~~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~g~g~v~~ 81 (210)
T PRK10345 4 LSEQSPLGTGRHRKCYA-HPEDAQR-CIKIVYHRGDGGDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDCGTGYVYD 81 (210)
T ss_pred cCCcceecCCCceEEEE-CCCCcCe-EEEEEeccccchHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCCCCeEEEE
Confidence 34467899999999996 3334444 79988765444567899999999999 5799999999998874 3 33
Q ss_pred EEEEe--ccCCCHHHHHhhhcCCCCCcCHHHHHHHHHHHHHHH-HHHHhccCCCeeecCCCCCCeEECC----CCcEEEE
Q 002673 680 LIYSY--MENGSLDYWLHEKADGASQLDWLTRLKIARGTSCGL-AYMHQICEPHIVHRDIKSSNILLDD----QFEAHLA 752 (894)
Q Consensus 680 lV~E~--~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL-~yLH~~~~~~ivHrDLkp~NILld~----~~~vkl~ 752 (894)
+|+|| +.+|+|.+++.+. .++.. ..++.+++.++ +|||+ ++|+||||||+|||++. ++.++|+
T Consensus 82 ~I~e~~G~~~~tL~~~l~~~-----~~~e~--~~~~~~~L~~l~~yLh~---~~IvhrDlKp~NILl~~~~~~~~~~~Li 151 (210)
T PRK10345 82 VIADFDGKPSITLTEFAEQC-----RYEED--VAQLRQLLKKLKRYLLD---NRIVTMELKPQNILCQRISESEVIPVVC 151 (210)
T ss_pred EEecCCCCcchhHHHHHHcc-----cccHh--HHHHHHHHHHHHHHHHH---CCEeecCCCHHHEEEeccCCCCCcEEEE
Confidence 78999 5579999999652 24443 35577888777 99997 59999999999999974 3479999
Q ss_pred Ecccc
Q 002673 753 DFGLS 757 (894)
Q Consensus 753 DFGla 757 (894)
||+-+
T Consensus 152 Dg~G~ 156 (210)
T PRK10345 152 DNIGE 156 (210)
T ss_pred ECCCC
Confidence 95434
|
|
| >KOG4194 consensus Membrane glycoprotein LIG-1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.64 E-value=1.5e-17 Score=183.62 Aligned_cols=248 Identities=20% Similarity=0.163 Sum_probs=134.0
Q ss_pred CcEEEECCcccccCcccchhh----HHhHHHhhcCcceeEEEeecCCeeEEeecCCCceEeeecccCCCc-eeeceeecC
Q 002673 231 RPLIMWNPRLISEDVGVGINV----RNLRRYFLSTFTPVYSMRPLPSGAVFRCYPGLWKVFYDDKDRPNR-YLLAKELVS 305 (894)
Q Consensus 231 ~p~v~~N~~l~~~~~Gig~~~----r~~r~~fl~~~~~~y~l~~l~~gal~r~yP~~w~v~~~d~~~~~~-y~~i~~~~~ 305 (894)
.-|-|-+.+|+.+.-+.+-.+ =.+|.+.+++++. -=...||..-.|= ...+.- +-....|..
T Consensus 105 q~v~l~~N~Lt~IP~f~~~sghl~~L~L~~N~I~sv~s----------e~L~~l~alrslD---LSrN~is~i~~~sfp~ 171 (873)
T KOG4194|consen 105 QEVNLNKNELTRIPRFGHESGHLEKLDLRHNLISSVTS----------EELSALPALRSLD---LSRNLISEIPKPSFPA 171 (873)
T ss_pred eeeeeccchhhhcccccccccceeEEeeeccccccccH----------HHHHhHhhhhhhh---hhhchhhcccCCCCCC
Confidence 335566667776553332221 1344444444432 1112334333332 333433 333356677
Q ss_pred CCChhhHHHHHhhc-------cCCCCCCcccccccccccccccccccCccccchhcccccccccccCccccccCC-CCCc
Q 002673 306 RPNADDLEIIFGEV-------EGKSDEGPSLFSQANLLSGEFPKELTALPALVSEAANDEVDRSYLELPVFVMPS-NATN 377 (894)
Q Consensus 306 ~p~le~l~~~~n~~-------~~~l~~L~~L~L~~N~l~~~~p~~~~~L~~L~~L~L~~n~~~~~~~~~~~~~~~-~~~~ 377 (894)
.++++.|++..|.+ |..+.+|..|.|+.|+|+.+.+..|.+|++|+.|+|+.|.|.....+.+..+++ +.+.
T Consensus 172 ~~ni~~L~La~N~It~l~~~~F~~lnsL~tlkLsrNrittLp~r~Fk~L~~L~~LdLnrN~irive~ltFqgL~Sl~nlk 251 (873)
T KOG4194|consen 172 KVNIKKLNLASNRITTLETGHFDSLNSLLTLKLSRNRITTLPQRSFKRLPKLESLDLNRNRIRIVEGLTFQGLPSLQNLK 251 (873)
T ss_pred CCCceEEeeccccccccccccccccchheeeecccCcccccCHHHhhhcchhhhhhccccceeeehhhhhcCchhhhhhh
Confidence 78888888877773 555667888888888888877778888888888888888888775554443333 3444
Q ss_pred ccccCCCCCC----------CeEEccCCcC------------------------CcCCchhhcCCCCCcEEeccCCcCCC
Q 002673 378 QQYNQLSNLP----------PAIYLANNSL------------------------SGNIPVEIGQLKSLHVLDLSNNNFSG 423 (894)
Q Consensus 378 l~~n~L~~Lp----------~~L~L~~N~l------------------------~~~~p~~~~~L~~L~~L~L~~N~l~~ 423 (894)
++.|.+..|. +.|+|+.|++ ..+-+++.....+|++|+|++|+|+.
T Consensus 252 lqrN~I~kL~DG~Fy~l~kme~l~L~~N~l~~vn~g~lfgLt~L~~L~lS~NaI~rih~d~WsftqkL~~LdLs~N~i~~ 331 (873)
T KOG4194|consen 252 LQRNDISKLDDGAFYGLEKMEHLNLETNRLQAVNEGWLFGLTSLEQLDLSYNAIQRIHIDSWSFTQKLKELDLSSNRITR 331 (873)
T ss_pred hhhcCcccccCcceeeecccceeecccchhhhhhcccccccchhhhhccchhhhheeecchhhhcccceeEecccccccc
Confidence 4444444442 3344444444 44444444444444444444444443
Q ss_pred CCCccccCCCCCCEEecCCCcccCcCCCcccCCCccccccccccccCCCCCCC----CCCCCCCccccCCCC
Q 002673 424 TIPDELSDLSNLEKLDLSGNHLVGEIPISLKGLHFLSSFSVAHNNLQGAVPSG----GQFDTFPSFSFEGNP 491 (894)
Q Consensus 424 ~~p~~~~~L~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~----~~l~~L~~l~l~~Np 491 (894)
..+++|..|..|++|+|++|.|+..-..+|.++++|+.|||++|.|+..+... ..|++|+.|.|.||.
T Consensus 332 l~~~sf~~L~~Le~LnLs~Nsi~~l~e~af~~lssL~~LdLr~N~ls~~IEDaa~~f~gl~~LrkL~l~gNq 403 (873)
T KOG4194|consen 332 LDEGSFRVLSQLEELNLSHNSIDHLAEGAFVGLSSLHKLDLRSNELSWCIEDAAVAFNGLPSLRKLRLTGNQ 403 (873)
T ss_pred CChhHHHHHHHhhhhcccccchHHHHhhHHHHhhhhhhhcCcCCeEEEEEecchhhhccchhhhheeecCce
Confidence 33444444444444444444444333344555555555555555555444422 335555556666654
|
|
| >PRK14879 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.64 E-value=1.7e-15 Score=157.46 Aligned_cols=134 Identities=21% Similarity=0.307 Sum_probs=112.8
Q ss_pred ceEeecCcEEEEEEEEcCCCeEEEEEEcCcch--------hhHHHHHHHHHHHHhcCCCceeeecceeeecceEEEEEEe
Q 002673 613 NIIGCGGFGLVYKATLANGTTLAIKKLSGDLG--------LMEREFKAEVEALSTAQHKNLVSLQGYCVHQGFRLLIYSY 684 (894)
Q Consensus 613 ~~LG~G~fg~Vy~a~~~~g~~vAvK~~~~~~~--------~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~lV~E~ 684 (894)
+.||+|++|.||+|.. +|..|++|+...... .....+.+|+.++..++|+++.....++......++||||
T Consensus 2 ~~l~~G~~~~vy~~~~-~~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~ 80 (211)
T PRK14879 2 KLIKRGAEAEIYLGDF-LGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGVNVPAVYFVDPENFIIVMEY 80 (211)
T ss_pred cccccCceEEEEEEee-CCCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHHHCCCCCCeEEEEeCCCCEEEEEE
Confidence 5789999999999987 677899998654321 1124577899999999999988877777777788999999
Q ss_pred ccCCCHHHHHhhhcCCCCCcCHHHHHHHHHHHHHHHHHHHhccCCCeeecCCCCCCeEECCCCcEEEEEcccccc
Q 002673 685 MENGSLDYWLHEKADGASQLDWLTRLKIARGTSCGLAYMHQICEPHIVHRDIKSSNILLDDQFEAHLADFGLSRL 759 (894)
Q Consensus 685 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDLkp~NILld~~~~vkl~DFGla~~ 759 (894)
++|++|.+++.... + .+..++.+++.+|.++|+ .+++|+|++|+|||++ ++.++|+|||.+..
T Consensus 81 ~~G~~L~~~~~~~~-------~-~~~~i~~~i~~~l~~lH~---~~i~H~Dl~p~Nil~~-~~~~~liDf~~a~~ 143 (211)
T PRK14879 81 IEGEPLKDLINSNG-------M-EELELSREIGRLVGKLHS---AGIIHGDLTTSNMILS-GGKIYLIDFGLAEF 143 (211)
T ss_pred eCCcCHHHHHHhcc-------H-HHHHHHHHHHHHHHHHHh---CCcccCCCCcccEEEE-CCCEEEEECCcccC
Confidence 99999999986431 1 778999999999999997 5999999999999999 78999999998864
|
|
| >KOG0444 consensus Cytoskeletal regulator Flightless-I (contains leucine-rich and gelsolin repeats) [Cytoskeleton] | Back alignment and domain information |
|---|
Probab=99.63 E-value=1.3e-17 Score=184.49 Aligned_cols=196 Identities=24% Similarity=0.359 Sum_probs=148.3
Q ss_pred CCceeeceeecCCCChhhHHHHHhhc---cC---CCCCCcccccccccccc-cccccccCccccchhcccccccccccCc
Q 002673 294 PNRYLLAKELVSRPNADDLEIIFGEV---EG---KSDEGPSLFSQANLLSG-EFPKELTALPALVSEAANDEVDRSYLEL 366 (894)
Q Consensus 294 ~~~y~~i~~~~~~p~le~l~~~~n~~---~~---~l~~L~~L~L~~N~l~~-~~p~~~~~L~~L~~L~L~~n~~~~~~~~ 366 (894)
.+.-.+++++..+..++.|.+..|+. ++ .++.|.++.+..|++.. -+|..+..|..|+.|+|++|+++..+..
T Consensus 42 t~L~~vPeEL~~lqkLEHLs~~HN~L~~vhGELs~Lp~LRsv~~R~N~LKnsGiP~diF~l~dLt~lDLShNqL~EvP~~ 121 (1255)
T KOG0444|consen 42 TKLEQVPEELSRLQKLEHLSMAHNQLISVHGELSDLPRLRSVIVRDNNLKNSGIPTDIFRLKDLTILDLSHNQLREVPTN 121 (1255)
T ss_pred hhhhhChHHHHHHhhhhhhhhhhhhhHhhhhhhccchhhHHHhhhccccccCCCCchhcccccceeeecchhhhhhcchh
Confidence 44556778888888888888888873 33 45566677788887642 3688888899999999999988888877
Q ss_pred cccccCCCCCcccccCCCCCCCe----------EEccCCcCCcCCchhhcCCCCCcEEeccCCcCC--------------
Q 002673 367 PVFVMPSNATNQQYNQLSNLPPA----------IYLANNSLSGNIPVEIGQLKSLHVLDLSNNNFS-------------- 422 (894)
Q Consensus 367 ~~~~~~~~~~~l~~n~L~~Lp~~----------L~L~~N~l~~~~p~~~~~L~~L~~L~L~~N~l~-------------- 422 (894)
.......-.+++++|++.++|.. |+||+|+|. .+|+.+-.|..|++|+|++|.|.
T Consensus 122 LE~AKn~iVLNLS~N~IetIPn~lfinLtDLLfLDLS~NrLe-~LPPQ~RRL~~LqtL~Ls~NPL~hfQLrQLPsmtsL~ 200 (1255)
T KOG0444|consen 122 LEYAKNSIVLNLSYNNIETIPNSLFINLTDLLFLDLSNNRLE-MLPPQIRRLSMLQTLKLSNNPLNHFQLRQLPSMTSLS 200 (1255)
T ss_pred hhhhcCcEEEEcccCccccCCchHHHhhHhHhhhccccchhh-hcCHHHHHHhhhhhhhcCCChhhHHHHhcCccchhhh
Confidence 66666667788888888888843 588888888 77778888888888888888653
Q ss_pred -----------CCCCccccCCCCCCEEecCCCcccCcCCCcccCCCccccccccccccCCCCCCCCCCCCCCccccCCCC
Q 002673 423 -----------GTIPDELSDLSNLEKLDLSGNHLVGEIPISLKGLHFLSSFSVAHNNLQGAVPSGGQFDTFPSFSFEGNP 491 (894)
Q Consensus 423 -----------~~~p~~~~~L~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~l~~L~~l~l~~Np 491 (894)
..+|.++..|.+|..+|||+|.|. .+|+.+.++++|+.|+||+|+|+.+--..+.+.+|+.|+++.|.
T Consensus 201 vLhms~TqRTl~N~Ptsld~l~NL~dvDlS~N~Lp-~vPecly~l~~LrrLNLS~N~iteL~~~~~~W~~lEtLNlSrNQ 279 (1255)
T KOG0444|consen 201 VLHMSNTQRTLDNIPTSLDDLHNLRDVDLSENNLP-IVPECLYKLRNLRRLNLSGNKITELNMTEGEWENLETLNLSRNQ 279 (1255)
T ss_pred hhhcccccchhhcCCCchhhhhhhhhccccccCCC-cchHHHhhhhhhheeccCcCceeeeeccHHHHhhhhhhccccch
Confidence 236677777888888888888888 78888888888888888888777655555566666666666664
|
|
| >smart00090 RIO RIO-like kinase | Back alignment and domain information |
|---|
Probab=99.63 E-value=1.9e-15 Score=159.79 Aligned_cols=147 Identities=15% Similarity=0.095 Sum_probs=112.0
Q ss_pred HHHhccCCCccceEeecCcEEEEEEE--EcCCCeEEEEEEcCcchh------------------------hHHHHHHHHH
Q 002673 602 LLKATDNFSQANIIGCGGFGLVYKAT--LANGTTLAIKKLSGDLGL------------------------MEREFKAEVE 655 (894)
Q Consensus 602 l~~a~~~f~~~~~LG~G~fg~Vy~a~--~~~g~~vAvK~~~~~~~~------------------------~~~~~~~Ei~ 655 (894)
+.+...-|++.+.||+|+||.||+|. ..+|+.||+|++...... ....+..|+.
T Consensus 23 ~~~~~~~~~i~~~Lg~G~~g~Vy~a~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~ 102 (237)
T smart00090 23 LLNRGILSAIGGCISTGKEANVYHALDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFR 102 (237)
T ss_pred HHhcCchHHhCCeeccCcceeEEEEEecCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHH
Confidence 33444568889999999999999998 568999999998743210 1123568999
Q ss_pred HHHhcCCCc--eeeecceeeecceEEEEEEeccCCCHHHHHhhhcCCCCCcCHHHHHHHHHHHHHHHHHHHhccCCC-ee
Q 002673 656 ALSTAQHKN--LVSLQGYCVHQGFRLLIYSYMENGSLDYWLHEKADGASQLDWLTRLKIARGTSCGLAYMHQICEPH-IV 732 (894)
Q Consensus 656 ~l~~l~Hpn--Iv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~-iv 732 (894)
.+.++.+.. +..++++ ...++||||+++++|..+.... ..+.......++.|++.++.+||+ .+ ++
T Consensus 103 ~L~~L~~~~i~~p~~~~~----~~~~lV~E~~~g~~L~~~~~~~----~~~~~~~~~~i~~qi~~~l~~LH~---~g~ii 171 (237)
T smart00090 103 NLQRLYEAGVPVPKPIAW----RRNVLVMEFIGGDGLPAPRLKD----VEPEEEEEFELYDDILEEMRKLYK---EGELV 171 (237)
T ss_pred HHHHHHhcCCCCCeeeEe----cCceEEEEEecCCccccccccc----CCcchHHHHHHHHHHHHHHHHHHh---cCCEE
Confidence 999997533 3334432 2358999999998886654221 234555667899999999999997 47 99
Q ss_pred ecCCCCCCeEECCCCcEEEEEccccccc
Q 002673 733 HRDIKSSNILLDDQFEAHLADFGLSRLI 760 (894)
Q Consensus 733 HrDLkp~NILld~~~~vkl~DFGla~~~ 760 (894)
||||||+||+++ ++.++|+|||.+...
T Consensus 172 H~Dikp~NIli~-~~~i~LiDFg~a~~~ 198 (237)
T smart00090 172 HGDLSEYNILVH-DGKVVIIDVSQSVEL 198 (237)
T ss_pred eCCCChhhEEEE-CCCEEEEEChhhhcc
Confidence 999999999999 889999999998754
|
|
| >cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain | Back alignment and domain information |
|---|
Probab=99.62 E-value=3.1e-15 Score=154.11 Aligned_cols=144 Identities=19% Similarity=0.093 Sum_probs=111.1
Q ss_pred HHHHhccCCCccceEeecCcEEEEEEEEcCCCeEEEEEEcCcchh----------------------hHHHHHHHHHHHH
Q 002673 601 ELLKATDNFSQANIIGCGGFGLVYKATLANGTTLAIKKLSGDLGL----------------------MEREFKAEVEALS 658 (894)
Q Consensus 601 el~~a~~~f~~~~~LG~G~fg~Vy~a~~~~g~~vAvK~~~~~~~~----------------------~~~~~~~Ei~~l~ 658 (894)
++......|...+.||+|+||.||++...+|+.||||++...... ....+..|+..+.
T Consensus 9 ~~~~~~~~~~~~~~i~~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~ 88 (198)
T cd05144 9 TLVKRGVVESLGNQIGVGKESDVYLALDPDGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAALK 88 (198)
T ss_pred HHHHcCchhhcCCccccCcceEEEEEEcCCCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHHH
Confidence 333444447788999999999999999888999999987643210 1123567899999
Q ss_pred hcCCCc--eeeecceeeecceEEEEEEeccCCCHHHHHhhhcCCCCCcCHHHHHHHHHHHHHHHHHHHhccCCCeeecCC
Q 002673 659 TAQHKN--LVSLQGYCVHQGFRLLIYSYMENGSLDYWLHEKADGASQLDWLTRLKIARGTSCGLAYMHQICEPHIVHRDI 736 (894)
Q Consensus 659 ~l~Hpn--Iv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDL 736 (894)
.+.|++ +...++ ....++||||+++++|...... .....++.+++.++.++|+ .+++||||
T Consensus 89 ~l~~~~i~v~~~~~----~~~~~lv~e~~~g~~L~~~~~~----------~~~~~~~~~i~~~l~~lh~---~gi~H~Dl 151 (198)
T cd05144 89 ALYEEGFPVPKPID----WNRHAVVMEYIDGVELYRVRVL----------EDPEEVLDEILEEIVKAYK---HGIIHGDL 151 (198)
T ss_pred HHHHcCCCCCceee----cCCceEEEEEeCCcchhhcccc----------ccHHHHHHHHHHHHHHHHH---CCCCcCCC
Confidence 998874 333333 2345899999999998765431 2345788999999999997 59999999
Q ss_pred CCCCeEECCCCcEEEEEcccccccC
Q 002673 737 KSSNILLDDQFEAHLADFGLSRLIL 761 (894)
Q Consensus 737 kp~NILld~~~~vkl~DFGla~~~~ 761 (894)
||+||++++++.++|+|||++....
T Consensus 152 ~p~Nill~~~~~~~liDfg~~~~~~ 176 (198)
T cd05144 152 SEFNILVDDDEKIYIIDWPQMVSTD 176 (198)
T ss_pred CcccEEEcCCCcEEEEECCccccCC
Confidence 9999999999999999999997653
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom |
| >KOG0444 consensus Cytoskeletal regulator Flightless-I (contains leucine-rich and gelsolin repeats) [Cytoskeleton] | Back alignment and domain information |
|---|
Probab=99.62 E-value=2.2e-17 Score=182.77 Aligned_cols=170 Identities=22% Similarity=0.240 Sum_probs=125.3
Q ss_pred CCcccccccccccccccccccCccccchhcccccccccccCccccccCCCCCcccccC-----CCCCC------------
Q 002673 325 EGPSLFSQANLLSGEFPKELTALPALVSEAANDEVDRSYLELPVFVMPSNATNQQYNQ-----LSNLP------------ 387 (894)
Q Consensus 325 ~L~~L~L~~N~l~~~~p~~~~~L~~L~~L~L~~n~~~~~~~~~~~~~~~~~~~l~~n~-----L~~Lp------------ 387 (894)
++-.|+|++|+|..|.-+-|-+|+.|-.|+|++|++..+++....+...+.+.++.|. |..||
T Consensus 127 n~iVLNLS~N~IetIPn~lfinLtDLLfLDLS~NrLe~LPPQ~RRL~~LqtL~Ls~NPL~hfQLrQLPsmtsL~vLhms~ 206 (1255)
T KOG0444|consen 127 NSIVLNLSYNNIETIPNSLFINLTDLLFLDLSNNRLEMLPPQIRRLSMLQTLKLSNNPLNHFQLRQLPSMTSLSVLHMSN 206 (1255)
T ss_pred CcEEEEcccCccccCCchHHHhhHhHhhhccccchhhhcCHHHHHHhhhhhhhcCCChhhHHHHhcCccchhhhhhhccc
Confidence 3445556666665533344556666666666666666655544333333333333332 22222
Q ss_pred ---------C---------eEEccCCcCCcCCchhhcCCCCCcEEeccCCcCCCCCCccccCCCCCCEEecCCCcccCcC
Q 002673 388 ---------P---------AIYLANNSLSGNIPVEIGQLKSLHVLDLSNNNFSGTIPDELSDLSNLEKLDLSGNHLVGEI 449 (894)
Q Consensus 388 ---------~---------~L~L~~N~l~~~~p~~~~~L~~L~~L~L~~N~l~~~~p~~~~~L~~L~~L~Ls~N~l~~~~ 449 (894)
. .++||.|.|. .+|+.+.++.+|+.|+||+|+|+ .+....+...+|++|+||+|+|+ .+
T Consensus 207 TqRTl~N~Ptsld~l~NL~dvDlS~N~Lp-~vPecly~l~~LrrLNLS~N~it-eL~~~~~~W~~lEtLNlSrNQLt-~L 283 (1255)
T KOG0444|consen 207 TQRTLDNIPTSLDDLHNLRDVDLSENNLP-IVPECLYKLRNLRRLNLSGNKIT-ELNMTEGEWENLETLNLSRNQLT-VL 283 (1255)
T ss_pred ccchhhcCCCchhhhhhhhhccccccCCC-cchHHHhhhhhhheeccCcCcee-eeeccHHHHhhhhhhccccchhc-cc
Confidence 1 1478999999 89999999999999999999999 78888888999999999999999 89
Q ss_pred CCcccCCCcccccccccccc--CCCCCCCCCCCCCCccccCCCC------CCCCCc
Q 002673 450 PISLKGLHFLSSFSVAHNNL--QGAVPSGGQFDTFPSFSFEGNP------ELCGSV 497 (894)
Q Consensus 450 p~~~~~l~~L~~L~Ls~N~l--~~~~~~~~~l~~L~~l~l~~Np------~~c~~~ 497 (894)
|+.+++|++|+.|++.+|+| .|+|..++.|.+|+.+...+|. .+|.|+
T Consensus 284 P~avcKL~kL~kLy~n~NkL~FeGiPSGIGKL~~Levf~aanN~LElVPEglcRC~ 339 (1255)
T KOG0444|consen 284 PDAVCKLTKLTKLYANNNKLTFEGIPSGIGKLIQLEVFHAANNKLELVPEGLCRCV 339 (1255)
T ss_pred hHHHhhhHHHHHHHhccCcccccCCccchhhhhhhHHHHhhccccccCchhhhhhH
Confidence 99999999999999999986 4777788999999999998884 557774
|
|
| >TIGR03724 arch_bud32 Kae1-associated kinase Bud32 | Back alignment and domain information |
|---|
Probab=99.60 E-value=5.4e-15 Score=152.31 Aligned_cols=130 Identities=23% Similarity=0.332 Sum_probs=106.4
Q ss_pred eEeecCcEEEEEEEEcCCCeEEEEEEcCcc--------hhhHHHHHHHHHHHHhcCCCceeeecceeeecceEEEEEEec
Q 002673 614 IIGCGGFGLVYKATLANGTTLAIKKLSGDL--------GLMEREFKAEVEALSTAQHKNLVSLQGYCVHQGFRLLIYSYM 685 (894)
Q Consensus 614 ~LG~G~fg~Vy~a~~~~g~~vAvK~~~~~~--------~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~lV~E~~ 685 (894)
.||+|+||.||+|.+ +|..|++|+..... ......+.+|++++..++|+++.....++......++||||+
T Consensus 1 ~ig~G~~~~vy~~~~-~~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~~ 79 (199)
T TIGR03724 1 LIAKGAEAIIYLGDF-LGLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAGVNTPVVYDVDPDNKTIVMEYI 79 (199)
T ss_pred CCCCCceEEEEEeec-CCccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEECCCCEEEEEEE
Confidence 379999999999985 57889999865321 111245778999999999887666555666667779999999
Q ss_pred cCCCHHHHHhhhcCCCCCcCHHHHHHHHHHHHHHHHHHHhccCCCeeecCCCCCCeEECCCCcEEEEEcccccc
Q 002673 686 ENGSLDYWLHEKADGASQLDWLTRLKIARGTSCGLAYMHQICEPHIVHRDIKSSNILLDDQFEAHLADFGLSRL 759 (894)
Q Consensus 686 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDLkp~NILld~~~~vkl~DFGla~~ 759 (894)
+|++|.+++.... ..++.+++.+|.+||+ .+++|+|++|+||+++ ++.++++|||++..
T Consensus 80 ~g~~l~~~~~~~~-----------~~~~~~i~~~l~~lH~---~gi~H~Dl~~~Nil~~-~~~~~liDfg~a~~ 138 (199)
T TIGR03724 80 EGKPLKDVIEEGN-----------DELLREIGRLVGKLHK---AGIVHGDLTTSNIIVR-DDKLYLIDFGLGKY 138 (199)
T ss_pred CCccHHHHHhhcH-----------HHHHHHHHHHHHHHHH---CCeecCCCCcceEEEE-CCcEEEEECCCCcC
Confidence 9999998876421 0788999999999997 5999999999999999 88999999998875
|
Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine. |
| >PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated | Back alignment and domain information |
|---|
Probab=99.60 E-value=4.7e-15 Score=175.83 Aligned_cols=137 Identities=21% Similarity=0.274 Sum_probs=110.3
Q ss_pred cCCCccceEeecCcEEEEEEEEcCCCeEEEEEEcCcc-------hhhHHHHHHHHHHHHhcCCCceeeecceeeecceEE
Q 002673 607 DNFSQANIIGCGGFGLVYKATLANGTTLAIKKLSGDL-------GLMEREFKAEVEALSTAQHKNLVSLQGYCVHQGFRL 679 (894)
Q Consensus 607 ~~f~~~~~LG~G~fg~Vy~a~~~~g~~vAvK~~~~~~-------~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~ 679 (894)
..|...+.||+|+||.||+|.+.+...++.++..+.. ......+.+|++++..++|++++....++......+
T Consensus 333 ~~~~~~~~iG~G~~g~Vy~~~~~~~~~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~ 412 (535)
T PRK09605 333 RRKIPDHLIGKGAEADIKKGEYLGRDAVIKERVPKGYRHPELDERLRTERTRAEARLLSEARRAGVPTPVIYDVDPEEKT 412 (535)
T ss_pred cccCccceeccCCcEEEEEEeecCccceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhcccCCCeeEEEEEeCCCCE
Confidence 3446678999999999999987554433333332211 112345789999999999999998888877777789
Q ss_pred EEEEeccCCCHHHHHhhhcCCCCCcCHHHHHHHHHHHHHHHHHHHhccCCCeeecCCCCCCeEECCCCcEEEEEcccccc
Q 002673 680 LIYSYMENGSLDYWLHEKADGASQLDWLTRLKIARGTSCGLAYMHQICEPHIVHRDIKSSNILLDDQFEAHLADFGLSRL 759 (894)
Q Consensus 680 lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDLkp~NILld~~~~vkl~DFGla~~ 759 (894)
+||||+++++|.+++. ....++.+++.+|.|||+ .+++||||||+|||+ +++.++|+|||+++.
T Consensus 413 lv~E~~~g~~L~~~l~------------~~~~~~~~i~~~L~~lH~---~giiHrDlkp~NILl-~~~~~~liDFGla~~ 476 (535)
T PRK09605 413 IVMEYIGGKDLKDVLE------------GNPELVRKVGEIVAKLHK---AGIVHGDLTTSNFIV-RDDRLYLIDFGLGKY 476 (535)
T ss_pred EEEEecCCCcHHHHHH------------HHHHHHHHHHHHHHHHHh---CCCccCCCChHHEEE-ECCcEEEEeCccccc
Confidence 9999999999998885 245789999999999997 599999999999999 677999999999975
|
|
| >KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=99.60 E-value=2e-16 Score=175.27 Aligned_cols=173 Identities=25% Similarity=0.391 Sum_probs=129.4
Q ss_pred eEEEEEEeccCCCHHHHHhhhcCCCCCcCHHHHHHHHHHHHHHHHHHHhccCCCeeecCCCCCCeEECCCCcEEEEEccc
Q 002673 677 FRLLIYSYMENGSLDYWLHEKADGASQLDWLTRLKIARGTSCGLAYMHQICEPHIVHRDIKSSNILLDDQFEAHLADFGL 756 (894)
Q Consensus 677 ~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDLkp~NILld~~~~vkl~DFGl 756 (894)
..++.|++|...+|.+|+.... .....++...+.++.|++.|+.| ++.+|+|+||.||+...+..+||.|||+
T Consensus 330 ~lyI~Mn~c~~~tledWl~rr~-~~e~~s~s~~~~~~~q~~~~~~y------k~~ihrdlkp~nif~~~d~q~kIgDFgl 402 (516)
T KOG1033|consen 330 YLYIQMNLCEKETLEDWLRRRR-TGEERSLSLMLDIFKQIAPAVEY------KGLIHRDLKPSNIFFSDDDQLKIGDFGL 402 (516)
T ss_pred chhhhhhhhhhhhHHHHhhCCC-cccccchhHHHHHHHhhccchhh------ccchhhhccccccccccchhhhhhhhhh
Confidence 4679999999999999997543 34567888999999999999999 4899999999999999999999999999
Q ss_pred ccccCCCC-----CcccccccccCCccCcccccCcCCCccccHHHHHHHHHHHHc-CCCCCCCCCcchhhhHHHHHHHHh
Q 002673 757 SRLILPYQ-----THVTTELVGTLGYIPPEYGQAWVATLRGDMYSFGVVMLELLT-GKRPVDVLKPKMSRELVGWVLKMR 830 (894)
Q Consensus 757 a~~~~~~~-----~~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwS~GvlL~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~ 830 (894)
........ ....+..+||..||+||.+.+..|+.|+||||||+||+|+++ =..+++.. . ...-.
T Consensus 403 ~ts~~~~~~~~~~~a~~t~~~gt~~YmsPEQi~g~~y~~kvdIyaLGlil~EL~~~f~T~~er~---------~-t~~d~ 472 (516)
T KOG1033|consen 403 VTSQDKDETVAPAAASHTQQVGTLLYMSPEQIRGQQYSEKVDIYALGLILAELLIQFSTQFERI---------A-TLTDI 472 (516)
T ss_pred eeecccCCcccchhhhhhhcccccccCCHHHHhhhhhhhhcchhhHHHHHHHHHHHhccHHHHH---------H-hhhhh
Confidence 98765433 224456789999999999999999999999999999999987 22222100 0 00011
Q ss_pred hcCCCCccccccccCCCChHHHHHHHHHHHHhcccCCCCCCCHHH
Q 002673 831 SEGKQDQVFDPILRGKGFDEEMLQVLDVACMCVSQNPFKRPTVKE 875 (894)
Q Consensus 831 ~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~e 875 (894)
+.+ .++|.....+ +++ ..++.+++...|.+||++.+
T Consensus 473 r~g----~ip~~~~~d~-p~e----~~ll~~lls~~p~~RP~~~~ 508 (516)
T KOG1033|consen 473 RDG----IIPPEFLQDY-PEE----YTLLQQLLSPSPEERPSAIE 508 (516)
T ss_pred hcC----CCChHHhhcC-cHH----HHHHHHhcCCCcccCchHHH
Confidence 112 2222221111 222 36778999999999995443
|
|
| >KOG0472 consensus Leucine-rich repeat protein [Function unknown] | Back alignment and domain information |
|---|
Probab=99.58 E-value=4.3e-17 Score=173.21 Aligned_cols=180 Identities=22% Similarity=0.275 Sum_probs=135.1
Q ss_pred CCceeeceeecCCCChhhHHHHHhhcc------CCCCCCcccccccccccccccccccCccccchhcccccccccccCcc
Q 002673 294 PNRYLLAKELVSRPNADDLEIIFGEVE------GKSDEGPSLFSQANLLSGEFPKELTALPALVSEAANDEVDRSYLELP 367 (894)
Q Consensus 294 ~~~y~~i~~~~~~p~le~l~~~~n~~~------~~l~~L~~L~L~~N~l~~~~p~~~~~L~~L~~L~L~~n~~~~~~~~~ 367 (894)
+..-+++.++..+-++++++...|+.. ..+.++..|++.+|+++.. |+..-+++.|++|+...|.+..+++.
T Consensus 124 n~~~el~~~i~~~~~l~dl~~~~N~i~slp~~~~~~~~l~~l~~~~n~l~~l-~~~~i~m~~L~~ld~~~N~L~tlP~~- 201 (565)
T KOG0472|consen 124 NELKELPDSIGRLLDLEDLDATNNQISSLPEDMVNLSKLSKLDLEGNKLKAL-PENHIAMKRLKHLDCNSNLLETLPPE- 201 (565)
T ss_pred cceeecCchHHHHhhhhhhhccccccccCchHHHHHHHHHHhhccccchhhC-CHHHHHHHHHHhcccchhhhhcCChh-
Confidence 445556666666666666666555532 1222455566666666653 33333366666666666555544432
Q ss_pred ccccCCCCCcccccCCCCCCCeEEccCCcCCcCCchhhcCCCCCcEEeccCCcCCCCCCcccc-CCCCCCEEecCCCccc
Q 002673 368 VFVMPSNATNQQYNQLSNLPPAIYLANNSLSGNIPVEIGQLKSLHVLDLSNNNFSGTIPDELS-DLSNLEKLDLSGNHLV 446 (894)
Q Consensus 368 ~~~~~~~~~~l~~n~L~~Lp~~L~L~~N~l~~~~p~~~~~L~~L~~L~L~~N~l~~~~p~~~~-~L~~L~~L~Ls~N~l~ 446 (894)
...+++| +-|||.+|+|. .+| +|.++..|++|+++.|+|+ .+|.+.. +|.+|..|||.+|+|+
T Consensus 202 ------------lg~l~~L-~~LyL~~Nki~-~lP-ef~gcs~L~Elh~g~N~i~-~lpae~~~~L~~l~vLDLRdNklk 265 (565)
T KOG0472|consen 202 ------------LGGLESL-ELLYLRRNKIR-FLP-EFPGCSLLKELHVGENQIE-MLPAEHLKHLNSLLVLDLRDNKLK 265 (565)
T ss_pred ------------hcchhhh-HHHHhhhcccc-cCC-CCCccHHHHHHHhcccHHH-hhHHHHhcccccceeeeccccccc
Confidence 2233344 45799999999 788 8999999999999999999 8888877 9999999999999999
Q ss_pred CcCCCcccCCCccccccccccccCCCCCCCCCCCCCCccccCCCCCC
Q 002673 447 GEIPISLKGLHFLSSFSVAHNNLQGAVPSGGQFDTFPSFSFEGNPEL 493 (894)
Q Consensus 447 ~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~l~~L~~l~l~~Np~~ 493 (894)
..|+.++-|++|..||+|+|.|+++|++++++ .|+.|-+.|||..
T Consensus 266 -e~Pde~clLrsL~rLDlSNN~is~Lp~sLgnl-hL~~L~leGNPlr 310 (565)
T KOG0472|consen 266 -EVPDEICLLRSLERLDLSNNDISSLPYSLGNL-HLKFLALEGNPLR 310 (565)
T ss_pred -cCchHHHHhhhhhhhcccCCccccCCcccccc-eeeehhhcCCchH
Confidence 99999999999999999999999999999999 9999999999843
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.58 E-value=9.3e-16 Score=180.64 Aligned_cols=214 Identities=25% Similarity=0.323 Sum_probs=141.6
Q ss_pred ccCCCccceEeecCcEEEEEEEEc-CCCeEEEEEEcCcchhhHHHHHHHHHHHHhcCCCceeeecceeeecceEEEEEEe
Q 002673 606 TDNFSQANIIGCGGFGLVYKATLA-NGTTLAIKKLSGDLGLMEREFKAEVEALSTAQHKNLVSLQGYCVHQGFRLLIYSY 684 (894)
Q Consensus 606 ~~~f~~~~~LG~G~fg~Vy~a~~~-~g~~vAvK~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~lV~E~ 684 (894)
..+|..++.|..|+||.||.++.+ +.+.+|+ ++.++... .+- ++.....|.+|
T Consensus 82 e~df~~IklisngAygavylvrh~~trqrfa~-kiNkq~li-----lRn--ilt~a~npfvv------------------ 135 (1205)
T KOG0606|consen 82 ESDFNTIKLISNGAYGAVYLVRHKETRQRFAM-KINKQNLI-----LRN--ILTFAGNPFVV------------------ 135 (1205)
T ss_pred ccccceeEeeccCCCCceeeeeccccccchhh-cccccchh-----hhc--cccccCCccee------------------
Confidence 367888999999999999999854 5678888 45433111 010 22222333333
Q ss_pred ccCCCHHHHHhhhcCCCCCcCHHHHHHHHHHHHHHHHHHHhccCCCeeecCCCCCCeEECCCCcEEEEEcccccccCCCC
Q 002673 685 MENGSLDYWLHEKADGASQLDWLTRLKIARGTSCGLAYMHQICEPHIVHRDIKSSNILLDDQFEAHLADFGLSRLILPYQ 764 (894)
Q Consensus 685 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDLkp~NILld~~~~vkl~DFGla~~~~~~~ 764 (894)
|+-...++.. ..++. +++.+++|||+. +|+|||+||.|.+|+.-|++|++|||+++......
T Consensus 136 ---gDc~tllk~~----g~lPv--------dmvla~Eylh~y---givhrdlkpdnllIT~mGhiKlTDfgLsk~GLms~ 197 (1205)
T KOG0606|consen 136 ---GDCATLLKNI----GPLPV--------DMVLAVEYLHSY---GIVHRDLKPDNLLITSMGHIKLTDFGLSKKGLMSL 197 (1205)
T ss_pred ---chhhhhcccC----CCCcc--------hhhHHhHhhccC---CeecCCCCCCcceeeecccccccchhhhhhhhhhc
Confidence 3333334321 12221 226789999985 99999999999999999999999999998642111
Q ss_pred --------------CcccccccccCCccCcccccCcCCCccccHHHHHHHHHHHHcCCCCCCCCCcchhhhHHHHHHHHh
Q 002673 765 --------------THVTTELVGTLGYIPPEYGQAWVATLRGDMYSFGVVMLELLTGKRPVDVLKPKMSRELVGWVLKMR 830 (894)
Q Consensus 765 --------------~~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwS~GvlL~elltG~~Pf~~~~~~~~~~~~~~~~~~~ 830 (894)
.......+||+.|+|||++....|...+|+|++|+|+||.+-|+.||.+.-+++ +...+..
T Consensus 198 atnl~eg~I~k~t~Ef~dKqvcgTPeyiaPeVilrqgygkpvdwwamGiIlyeFLVgcvpffGdtpee---lfg~vis-- 272 (1205)
T KOG0606|consen 198 ATNLKEGHIEKDTHEFQDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEE---LFGQVIS-- 272 (1205)
T ss_pred cchhhhcchHHHHHHhhhccccCCccccChhhhhhhccCCCccHHHHHHHHHHHheeeeeccCCCHHH---HHhhhhh--
Confidence 011234689999999999999999999999999999999999999998653321 1111111
Q ss_pred hcCCCCccccccccCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHH
Q 002673 831 SEGKQDQVFDPILRGKGFDEEMLQVLDVACMCVSQNPFKRPTVKEVV 877 (894)
Q Consensus 831 ~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl 877 (894)
....+.+- |.. ...+..+++.+.++.+|.+|--....+
T Consensus 273 d~i~wpE~-dea--------~p~Ea~dli~~LL~qnp~~Rlgt~ga~ 310 (1205)
T KOG0606|consen 273 DDIEWPEE-DEA--------LPPEAQDLIEQLLRQNPLCRLGTGGAL 310 (1205)
T ss_pred hhcccccc-CcC--------CCHHHHHHHHHHHHhChHhhcccchhh
Confidence 01111111 111 122456788899999999997544333
|
|
| >PLN03150 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.58 E-value=2.4e-15 Score=180.37 Aligned_cols=116 Identities=39% Similarity=0.621 Sum_probs=106.1
Q ss_pred CeEEccCCcCCcCCchhhcCCCCCcEEeccCCcCCCCCCccccCCCCCCEEecCCCcccCcCCCcccCCCcccccccccc
Q 002673 388 PAIYLANNSLSGNIPVEIGQLKSLHVLDLSNNNFSGTIPDELSDLSNLEKLDLSGNHLVGEIPISLKGLHFLSSFSVAHN 467 (894)
Q Consensus 388 ~~L~L~~N~l~~~~p~~~~~L~~L~~L~L~~N~l~~~~p~~~~~L~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N 467 (894)
..|+|++|.|+|.+|..|++|++|+.|+|++|+|+|.+|..|+.|++|+.|+|++|+|+|.+|..+++|++|+.|+|++|
T Consensus 421 ~~L~L~~n~L~g~ip~~i~~L~~L~~L~Ls~N~l~g~iP~~~~~l~~L~~LdLs~N~lsg~iP~~l~~L~~L~~L~Ls~N 500 (623)
T PLN03150 421 DGLGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSIPESLGQLTSLRILNLNGN 500 (623)
T ss_pred EEEECCCCCccccCCHHHhCCCCCCEEECCCCcccCcCChHHhCCCCCCEEECCCCCCCCCCchHHhcCCCCCEEECcCC
Confidence 67899999999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred ccCCCCCCC-C-CCCCCCccccCCCCCCCCCcccCCCc
Q 002673 468 NLQGAVPSG-G-QFDTFPSFSFEGNPELCGSVVQRPCA 503 (894)
Q Consensus 468 ~l~~~~~~~-~-~l~~L~~l~l~~Np~~c~~~~~~~C~ 503 (894)
+|++.+|.. + .+.++..+++.+|+.+|+.+....|.
T Consensus 501 ~l~g~iP~~l~~~~~~~~~l~~~~N~~lc~~p~l~~C~ 538 (623)
T PLN03150 501 SLSGRVPAALGGRLLHRASFNFTDNAGLCGIPGLRACG 538 (623)
T ss_pred cccccCChHHhhccccCceEEecCCccccCCCCCCCCc
Confidence 999988854 3 34567789999999999986656663
|
|
| >KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.57 E-value=2e-14 Score=153.01 Aligned_cols=197 Identities=20% Similarity=0.217 Sum_probs=132.9
Q ss_pred CCCceeeecceeee---------------------------cceEEEEEEeccCCCHHHHHhhhcCCCCCcCHHHHHHHH
Q 002673 661 QHKNLVSLQGYCVH---------------------------QGFRLLIYSYMENGSLDYWLHEKADGASQLDWLTRLKIA 713 (894)
Q Consensus 661 ~HpnIv~l~g~~~~---------------------------~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~ 713 (894)
+|||||++.++|.+ ....|+||.-.+ -+|..++... ..+.....-|+
T Consensus 274 ~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g~~~tlylvMkrY~-~tLr~yl~~~-----~~s~r~~~~~l 347 (598)
T KOG4158|consen 274 KHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAGEPKTLYLVMKRYR-QTLREYLWTR-----HRSYRTGRVIL 347 (598)
T ss_pred CCCCEEeehhhhhhhhccCCchhhhCcccccceecccccCCCceEEEehhcch-hhHHHHHhcC-----CCchHHHHHHH
Confidence 59999999887753 124578887664 3788888753 34556677789
Q ss_pred HHHHHHHHHHHhccCCCeeecCCCCCCeEEC--CCC--cEEEEEcccccccCC-----CCCcccccccccCCccCccccc
Q 002673 714 RGTSCGLAYMHQICEPHIVHRDIKSSNILLD--DQF--EAHLADFGLSRLILP-----YQTHVTTELVGTLGYIPPEYGQ 784 (894)
Q Consensus 714 ~~ia~aL~yLH~~~~~~ivHrDLkp~NILld--~~~--~vkl~DFGla~~~~~-----~~~~~~~~~~gt~~Y~APE~~~ 784 (894)
.|+++|+.|||. ++|.|||+|+.|||+. +++ .+.|+|||.+-.-.. .-........|...-||||+..
T Consensus 348 aQlLEav~hL~~---hgvAhRDlKSDNiL~ElddD~~P~LVvaDFGCcLAd~~hGlqlpy~S~~Vd~GGNa~lmAPEi~t 424 (598)
T KOG4158|consen 348 AQLLEAVTHLHK---HGVAHRDLKSDNILLELDDDEIPQLVVADFGCCLADDNHGLQLPYESDEVDLGGNAKLMAPEIAT 424 (598)
T ss_pred HHHHHHHHHHHH---ccchhhcccccceEEEecCCCCcEEEEcccceeeeccccccccccccccccCCCcceecchhhhh
Confidence 999999999997 4999999999999983 444 378899998743111 0011112245777899999865
Q ss_pred CcC------CCccccHHHHHHHHHHHHcCCCCCCCCCcchhhhHHHHHHHHhhcCCCCccccccccCCCChHHHHHHHHH
Q 002673 785 AWV------ATLRGDMYSFGVVMLELLTGKRPVDVLKPKMSRELVGWVLKMRSEGKQDQVFDPILRGKGFDEEMLQVLDV 858 (894)
Q Consensus 785 ~~~------~s~ksDVwS~GvlL~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l 858 (894)
... ...|.|.|+.|-+.||+++...||... .+...+... .++..+..+.+ . ....+.++
T Consensus 425 a~PGp~avvny~kAD~WA~GalaYEIfg~~NPFY~r-Gem~L~~r~-----Yqe~qLPalp~------~---vpp~~rql 489 (598)
T KOG4158|consen 425 AVPGPNAVVNYEKADTWAAGALAYEIFGRSNPFYKR-GEMLLDTRT-----YQESQLPALPS------R---VPPVARQL 489 (598)
T ss_pred cCCCCceeeccchhhhhhhhhhHHHHhccCCccccc-chheechhh-----hhhhhCCCCcc------c---CChHHHHH
Confidence 432 246899999999999999999999741 111111111 11121111111 1 11235578
Q ss_pred HHHhcccCCCCCCCHHHHHHHHH
Q 002673 859 ACMCVSQNPFKRPTVKEVVEWLN 881 (894)
Q Consensus 859 i~~Cl~~dP~~RPs~~evl~~L~ 881 (894)
+...++.||++|++..-....|+
T Consensus 490 V~~lL~r~pskRvsp~iAANvl~ 512 (598)
T KOG4158|consen 490 VFDLLKRDPSKRVSPNIAANVLN 512 (598)
T ss_pred HHHHhcCCccccCCccHHHhHHH
Confidence 88999999999999877666543
|
|
| >cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Probab=99.53 E-value=5.3e-14 Score=136.73 Aligned_cols=134 Identities=19% Similarity=0.193 Sum_probs=113.5
Q ss_pred cceEeecCcEEEEEEEEcCCCeEEEEEEcCcchhhHHHHHHHHHHHHhcCC--CceeeecceeeecceEEEEEEeccCCC
Q 002673 612 ANIIGCGGFGLVYKATLANGTTLAIKKLSGDLGLMEREFKAEVEALSTAQH--KNLVSLQGYCVHQGFRLLIYSYMENGS 689 (894)
Q Consensus 612 ~~~LG~G~fg~Vy~a~~~~g~~vAvK~~~~~~~~~~~~~~~Ei~~l~~l~H--pnIv~l~g~~~~~~~~~lV~E~~~~gs 689 (894)
.+.||+|.++.||++...+ ..+++|....... ...+..|+..+..++| .++++++++....+..+++|||++++.
T Consensus 3 ~~~i~~g~~~~v~~~~~~~-~~~~iK~~~~~~~--~~~~~~e~~~~~~l~~~~~~~p~~~~~~~~~~~~~~v~e~~~g~~ 79 (155)
T cd05120 3 IKLLKGGLTNRVYLLGTKD-EDYVLKINPSREK--GADREREVAILQLLARKGLPVPKVLASGESDGWSYLLMEWIEGET 79 (155)
T ss_pred ceecccccccceEEEEecC-CeEEEEecCCCCc--hhHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCccEEEEEecCCee
Confidence 4679999999999999754 7899999876543 5678899999999976 588899888888788999999998876
Q ss_pred HHHHHhhhcCCCCCcCHHHHHHHHHHHHHHHHHHHhccCCCeeecCCCCCCeEECCCCcEEEEEcccccc
Q 002673 690 LDYWLHEKADGASQLDWLTRLKIARGTSCGLAYMHQICEPHIVHRDIKSSNILLDDQFEAHLADFGLSRL 759 (894)
Q Consensus 690 L~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDLkp~NILld~~~~vkl~DFGla~~ 759 (894)
+..+ +......++.+++.+++++|.....+++|+|++|+||++++.+.++++|||.+..
T Consensus 80 ~~~~-----------~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~~~~~~l~Df~~~~~ 138 (155)
T cd05120 80 LDEV-----------SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDGKILGIIDWEYAGY 138 (155)
T ss_pred cccC-----------CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEECCcEEEEEecccccC
Confidence 6433 4456678899999999999986556899999999999999989999999998864
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves |
| >KOG4237 consensus Extracellular matrix protein slit, contains leucine-rich and EGF-like repeats [Extracellular structures; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.50 E-value=1.6e-15 Score=161.45 Aligned_cols=96 Identities=22% Similarity=0.274 Sum_probs=87.7
Q ss_pred hhhcCCCCCcEEeccCCcCCCCCCccccCCCCCCEEecCCCcccCcCCCcccCCCccccccccccccCCCCCC-CCCCCC
Q 002673 403 VEIGQLKSLHVLDLSNNNFSGTIPDELSDLSNLEKLDLSGNHLVGEIPISLKGLHFLSSFSVAHNNLQGAVPS-GGQFDT 481 (894)
Q Consensus 403 ~~~~~L~~L~~L~L~~N~l~~~~p~~~~~L~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~-~~~l~~ 481 (894)
..|.+|++|+.|+|++|+|+++-+.+|.++.+|++|+|..|+|...-...|.+|..|++|+|.+|+|+..-|. +..+..
T Consensus 268 ~cf~~L~~L~~lnlsnN~i~~i~~~aFe~~a~l~eL~L~~N~l~~v~~~~f~~ls~L~tL~L~~N~it~~~~~aF~~~~~ 347 (498)
T KOG4237|consen 268 KCFKKLPNLRKLNLSNNKITRIEDGAFEGAAELQELYLTRNKLEFVSSGMFQGLSGLKTLSLYDNQITTVAPGAFQTLFS 347 (498)
T ss_pred HHHhhcccceEeccCCCccchhhhhhhcchhhhhhhhcCcchHHHHHHHhhhccccceeeeecCCeeEEEecccccccce
Confidence 3588999999999999999999999999999999999999999966677899999999999999999977664 377888
Q ss_pred CCccccCCCCCCCCCcc
Q 002673 482 FPSFSFEGNPELCGSVV 498 (894)
Q Consensus 482 L~~l~l~~Np~~c~~~~ 498 (894)
|..|++-.|||.|+|.+
T Consensus 348 l~~l~l~~Np~~CnC~l 364 (498)
T KOG4237|consen 348 LSTLNLLSNPFNCNCRL 364 (498)
T ss_pred eeeeehccCcccCccch
Confidence 99999999999999965
|
|
| >cd05119 RIO RIO kinase family, catalytic domain | Back alignment and domain information |
|---|
Probab=99.48 E-value=1.9e-13 Score=139.20 Aligned_cols=136 Identities=18% Similarity=0.173 Sum_probs=96.4
Q ss_pred cceEeecCcEEEEEEEEcCCCeEEEEEEcCcchhhH--HH----------------------HHHHHHHHHhcCCCc--e
Q 002673 612 ANIIGCGGFGLVYKATLANGTTLAIKKLSGDLGLME--RE----------------------FKAEVEALSTAQHKN--L 665 (894)
Q Consensus 612 ~~~LG~G~fg~Vy~a~~~~g~~vAvK~~~~~~~~~~--~~----------------------~~~Ei~~l~~l~Hpn--I 665 (894)
.+.||+|+||.||+|...+++.||||++........ .. ...|...+..+.+.. +
T Consensus 2 ~~~lg~G~~g~Vy~a~~~~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~ 81 (187)
T cd05119 2 GGPIGTGKEADVYLALDGDGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYEAGVPV 81 (187)
T ss_pred CcccccccceeEEEEECCCCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHHcCCCC
Confidence 467999999999999987899999999875432111 11 134555565554432 3
Q ss_pred eeecceeeecceEEEEEEeccCCCHHH-HHhhhcCCCCCcCHHHHHHHHHHHHHHHHHHHhccCCCeeecCCCCCCeEEC
Q 002673 666 VSLQGYCVHQGFRLLIYSYMENGSLDY-WLHEKADGASQLDWLTRLKIARGTSCGLAYMHQICEPHIVHRDIKSSNILLD 744 (894)
Q Consensus 666 v~l~g~~~~~~~~~lV~E~~~~gsL~~-~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDLkp~NILld 744 (894)
.+.+++ ...++||||++++.+.. .+.... .. .....++.+++.++.++|. .++|+|+||||+||+++
T Consensus 82 ~~~~~~----~~~~lv~e~~~g~~~~~~~l~~~~-----~~-~~~~~~~~~~~~~l~~lh~--~~~ivH~Dl~p~Nili~ 149 (187)
T cd05119 82 PKPIDL----NRHVLVMEFIGGDGIPAPRLKDVR-----LL-EDPEELYDQILELMRKLYR--EAGLVHGDLSEYNILVD 149 (187)
T ss_pred CceEec----CCCEEEEEEeCCCCccChhhhhhh-----hc-ccHHHHHHHHHHHHHHHhh--ccCcCcCCCChhhEEEE
Confidence 333332 23589999999854321 111110 00 4567899999999999997 25999999999999999
Q ss_pred CCCcEEEEEccccccc
Q 002673 745 DQFEAHLADFGLSRLI 760 (894)
Q Consensus 745 ~~~~vkl~DFGla~~~ 760 (894)
++.++++|||.+...
T Consensus 150 -~~~~~liDfg~a~~~ 164 (187)
T cd05119 150 -DGKVYIIDVPQAVEI 164 (187)
T ss_pred -CCcEEEEECcccccc
Confidence 889999999999755
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct |
| >KOG0472 consensus Leucine-rich repeat protein [Function unknown] | Back alignment and domain information |
|---|
Probab=99.48 E-value=3.9e-16 Score=166.04 Aligned_cols=193 Identities=21% Similarity=0.223 Sum_probs=150.0
Q ss_pred CCceeeceeecCCCChhhHHHHHhhc------cCCCCCCcccccccccccccccccccCccccchhcccccccccccCcc
Q 002673 294 PNRYLLAKELVSRPNADDLEIIFGEV------EGKSDEGPSLFSQANLLSGEFPKELTALPALVSEAANDEVDRSYLELP 367 (894)
Q Consensus 294 ~~~y~~i~~~~~~p~le~l~~~~n~~------~~~l~~L~~L~L~~N~l~~~~p~~~~~L~~L~~L~L~~n~~~~~~~~~ 367 (894)
+..-+++.....+..+..++..+|.. .+.+.++..|+.+.|.+.. +|+.++.+..|..|+..+|.+.+.++..
T Consensus 78 n~l~~lp~aig~l~~l~~l~vs~n~ls~lp~~i~s~~~l~~l~~s~n~~~e-l~~~i~~~~~l~dl~~~~N~i~slp~~~ 156 (565)
T KOG0472|consen 78 NKLSQLPAAIGELEALKSLNVSHNKLSELPEQIGSLISLVKLDCSSNELKE-LPDSIGRLLDLEDLDATNNQISSLPEDM 156 (565)
T ss_pred chhhhCCHHHHHHHHHHHhhcccchHhhccHHHhhhhhhhhhhccccceee-cCchHHHHhhhhhhhccccccccCchHH
Confidence 33444554444444444455544442 2334466777788888776 6777888888888888888888877776
Q ss_pred ccccCCCCCcccccCCCCCC---------CeEEccCCcCCcCCchhhcCCCCCcEEeccCCcCCCCCCccccCCCCCCEE
Q 002673 368 VFVMPSNATNQQYNQLSNLP---------PAIYLANNSLSGNIPVEIGQLKSLHVLDLSNNNFSGTIPDELSDLSNLEKL 438 (894)
Q Consensus 368 ~~~~~~~~~~l~~n~L~~Lp---------~~L~L~~N~l~~~~p~~~~~L~~L~~L~L~~N~l~~~~p~~~~~L~~L~~L 438 (894)
++......+.+..|+++.+| +.|+..+|-|+ .+|+.+++|.+|..|+|..|+|. .+| +|.++..|.+|
T Consensus 157 ~~~~~l~~l~~~~n~l~~l~~~~i~m~~L~~ld~~~N~L~-tlP~~lg~l~~L~~LyL~~Nki~-~lP-ef~gcs~L~El 233 (565)
T KOG0472|consen 157 VNLSKLSKLDLEGNKLKALPENHIAMKRLKHLDCNSNLLE-TLPPELGGLESLELLYLRRNKIR-FLP-EFPGCSLLKEL 233 (565)
T ss_pred HHHHHHHHhhccccchhhCCHHHHHHHHHHhcccchhhhh-cCChhhcchhhhHHHHhhhcccc-cCC-CCCccHHHHHH
Confidence 66655566667778888887 34788889898 88889999999999999999998 788 79999999999
Q ss_pred ecCCCcccCcCCCccc-CCCccccccccccccCCCCCCCCCCCCCCccccCCCC
Q 002673 439 DLSGNHLVGEIPISLK-GLHFLSSFSVAHNNLQGAVPSGGQFDTFPSFSFEGNP 491 (894)
Q Consensus 439 ~Ls~N~l~~~~p~~~~-~l~~L~~L~Ls~N~l~~~~~~~~~l~~L~~l~l~~Np 491 (894)
+++.|+|+ .+|.... +|++|..|||.+|+|+..|.++..+.+|..|++++|-
T Consensus 234 h~g~N~i~-~lpae~~~~L~~l~vLDLRdNklke~Pde~clLrsL~rLDlSNN~ 286 (565)
T KOG0472|consen 234 HVGENQIE-MLPAEHLKHLNSLLVLDLRDNKLKEVPDEICLLRSLERLDLSNND 286 (565)
T ss_pred HhcccHHH-hhHHHHhcccccceeeeccccccccCchHHHHhhhhhhhcccCCc
Confidence 99999999 8888776 8999999999999999888888889999999999984
|
|
| >KOG0617 consensus Ras suppressor protein (contains leucine-rich repeats) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.48 E-value=1.1e-15 Score=145.40 Aligned_cols=149 Identities=21% Similarity=0.280 Sum_probs=119.4
Q ss_pred cccCccccchhcccccccccccCccccccCCCCCcccccCCCCCCC---------eEEccCCcCCcCCchhhcCCCCCcE
Q 002673 343 ELTALPALVSEAANDEVDRSYLELPVFVMPSNATNQQYNQLSNLPP---------AIYLANNSLSGNIPVEIGQLKSLHV 413 (894)
Q Consensus 343 ~~~~L~~L~~L~L~~n~~~~~~~~~~~~~~~~~~~l~~n~L~~Lp~---------~L~L~~N~l~~~~p~~~~~L~~L~~ 413 (894)
.+.++.+.+.|.|++|+++.+++...-......+++..|+++.||. .|+++-|+|. ++|..|+.++.|+.
T Consensus 28 gLf~~s~ITrLtLSHNKl~~vppnia~l~nlevln~~nnqie~lp~~issl~klr~lnvgmnrl~-~lprgfgs~p~lev 106 (264)
T KOG0617|consen 28 GLFNMSNITRLTLSHNKLTVVPPNIAELKNLEVLNLSNNQIEELPTSISSLPKLRILNVGMNRLN-ILPRGFGSFPALEV 106 (264)
T ss_pred cccchhhhhhhhcccCceeecCCcHHHhhhhhhhhcccchhhhcChhhhhchhhhheecchhhhh-cCccccCCCchhhh
Confidence 3556788888999999999999887777777778888888888773 3577888888 78888888888888
Q ss_pred EeccCCcCC-CCCCccccCCCCCCEEecCCCcccCcCCCcccCCCccccccccccccCCCCCCCCCCCCCCccccCCCCC
Q 002673 414 LDLSNNNFS-GTIPDELSDLSNLEKLDLSGNHLVGEIPISLKGLHFLSSFSVAHNNLQGAVPSGGQFDTFPSFSFEGNPE 492 (894)
Q Consensus 414 L~L~~N~l~-~~~p~~~~~L~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~l~~L~~l~l~~Np~ 492 (894)
|||.+|++. ..+|+.|..|+.|+.|+|++|.+. .+|..+++|++|+.|.+..|.|-++|.+++.+..|++|.++||..
T Consensus 107 ldltynnl~e~~lpgnff~m~tlralyl~dndfe-~lp~dvg~lt~lqil~lrdndll~lpkeig~lt~lrelhiqgnrl 185 (264)
T KOG0617|consen 107 LDLTYNNLNENSLPGNFFYMTTLRALYLGDNDFE-ILPPDVGKLTNLQILSLRDNDLLSLPKEIGDLTRLRELHIQGNRL 185 (264)
T ss_pred hhccccccccccCCcchhHHHHHHHHHhcCCCcc-cCChhhhhhcceeEEeeccCchhhCcHHHHHHHHHHHHhccccee
Confidence 888888876 356888888888888888888888 778888888888888888888877777778888888888888854
Q ss_pred C
Q 002673 493 L 493 (894)
Q Consensus 493 ~ 493 (894)
.
T Consensus 186 ~ 186 (264)
T KOG0617|consen 186 T 186 (264)
T ss_pred e
Confidence 3
|
|
| >PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | Back alignment and domain information |
|---|
Probab=99.43 E-value=1.1e-12 Score=138.85 Aligned_cols=135 Identities=22% Similarity=0.236 Sum_probs=104.0
Q ss_pred cceEe-ecCcEEEEEEEEcCCCeEEEEEEcCcc-------------hhhHHHHHHHHHHHHhcCCCce--eeecceeeec
Q 002673 612 ANIIG-CGGFGLVYKATLANGTTLAIKKLSGDL-------------GLMEREFKAEVEALSTAQHKNL--VSLQGYCVHQ 675 (894)
Q Consensus 612 ~~~LG-~G~fg~Vy~a~~~~g~~vAvK~~~~~~-------------~~~~~~~~~Ei~~l~~l~HpnI--v~l~g~~~~~ 675 (894)
...|| .|+.|+||.+... +..++||.+.... ......+.+|++++.+++|+++ +..+++...+
T Consensus 36 ~~~lg~~~g~gtv~~v~~~-~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~~~gi~vP~pl~~~~~~ 114 (239)
T PRK01723 36 ARVVGSAKGRGTTWFVQTP-GVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLYEAGLPVPRPIAARVVR 114 (239)
T ss_pred CceeecCCCCccEEEEEeC-CceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHHhCCCCCceeEeeeeee
Confidence 45787 8999999999874 6778999875311 1223457889999999998875 6677665433
Q ss_pred c----eEEEEEEeccC-CCHHHHHhhhcCCCCCcCHHHHHHHHHHHHHHHHHHHhccCCCeeecCCCCCCeEECCCCcEE
Q 002673 676 G----FRLLIYSYMEN-GSLDYWLHEKADGASQLDWLTRLKIARGTSCGLAYMHQICEPHIVHRDIKSSNILLDDQFEAH 750 (894)
Q Consensus 676 ~----~~~lV~E~~~~-gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDLkp~NILld~~~~vk 750 (894)
. ..++||||+++ .+|.+++... .++. ..+.+++.++.+||+ ++|+||||||.|||++.++.++
T Consensus 115 ~~~~~~~~lV~e~l~G~~~L~~~l~~~-----~l~~----~~~~~i~~~l~~lH~---~GI~HrDlkp~NILv~~~~~v~ 182 (239)
T PRK01723 115 HGLFYRADILIERIEGARDLVALLQEA-----PLSE----EQWQAIGQLIARFHD---AGVYHADLNAHNILLDPDGKFW 182 (239)
T ss_pred cCcceeeeEEEEecCCCCCHHHHHhcC-----CCCH----HHHHHHHHHHHHHHH---CCCCCCCCCchhEEEcCCCCEE
Confidence 2 23599999997 6898887642 2333 235789999999997 5999999999999999999999
Q ss_pred EEEcccccc
Q 002673 751 LADFGLSRL 759 (894)
Q Consensus 751 l~DFGla~~ 759 (894)
|+|||.+..
T Consensus 183 LIDfg~~~~ 191 (239)
T PRK01723 183 LIDFDRGEL 191 (239)
T ss_pred EEECCCccc
Confidence 999998875
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.38 E-value=4.7e-14 Score=167.09 Aligned_cols=258 Identities=25% Similarity=0.326 Sum_probs=186.6
Q ss_pred CCCccceEeecCcEEEEEEEE--cCCCeEEEEEEcCcc--hhhHHHHHHHHHHHHhcC-CCceeeecceeeecceEEEEE
Q 002673 608 NFSQANIIGCGGFGLVYKATL--ANGTTLAIKKLSGDL--GLMEREFKAEVEALSTAQ-HKNLVSLQGYCVHQGFRLLIY 682 (894)
Q Consensus 608 ~f~~~~~LG~G~fg~Vy~a~~--~~g~~vAvK~~~~~~--~~~~~~~~~Ei~~l~~l~-HpnIv~l~g~~~~~~~~~lV~ 682 (894)
.|...+.||+|+|+.|-.... .....+|+|.+.... .........|..+-..+. |+|++++++........++++
T Consensus 21 ~~~~~~~ig~gs~~~~~~~~~~~~~~~~~a~~~~s~~~~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~~~~~~~~~~~~ 100 (601)
T KOG0590|consen 21 QYKLSRSIGKGSFSSSALASNSRDPESSSATKPISIPPKSEDSSEHIDTETDIQKKLSKHSNTVHMIEPSSSPRSYLLSL 100 (601)
T ss_pred cccccccccccccchhhhhhhcCCCcceeeccCCCCCCCccchhhhcCccccccccccccccccccCCccCCCccccccc
Confidence 455567799999999988764 334556666665432 222344556777777776 999999999999999999999
Q ss_pred EeccCCCHHHHH-hhhcCCCCCcCHHHHHHHHHHHHHHHHHHHhccCCCeeecCCCCCCeEECCCC-cEEEEEccccccc
Q 002673 683 SYMENGSLDYWL-HEKADGASQLDWLTRLKIARGTSCGLAYMHQICEPHIVHRDIKSSNILLDDQF-EAHLADFGLSRLI 760 (894)
Q Consensus 683 E~~~~gsL~~~l-~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDLkp~NILld~~~-~vkl~DFGla~~~ 760 (894)
+|..+|++.+.+ +... ...+-...-.++.|+..++.|+|. ..++.|+||||+|.+++..+ ..+++|||+|..+
T Consensus 101 ~~s~g~~~f~~i~~~~~---~~~~~~~~~~~~~ql~s~l~~~H~--~~~~~h~~ikP~n~~l~~s~~~l~~~df~~At~~ 175 (601)
T KOG0590|consen 101 SYSDGGSLFSKISHPDS---TGTSSSSASRYLPQLNSGLSYLHP--ENGVTHRDIKPSNSLLDESGSALKIADFGLATAY 175 (601)
T ss_pred CcccccccccccccCCc---cCCCCcchhhhhhhhccCccccCc--ccccccCCCCCccchhccCCCcccCCCchhhccc
Confidence 999999998877 3221 134445667889999999999994 26999999999999999999 9999999999987
Q ss_pred CC--CCCcccccccc-cCCccCcccccCc-CCCccccHHHHHHHHHHHHcCCCCCCCCCcchhhhHHHHHHHHhhcCCCC
Q 002673 761 LP--YQTHVTTELVG-TLGYIPPEYGQAW-VATLRGDMYSFGVVMLELLTGKRPVDVLKPKMSRELVGWVLKMRSEGKQD 836 (894)
Q Consensus 761 ~~--~~~~~~~~~~g-t~~Y~APE~~~~~-~~s~ksDVwS~GvlL~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~ 836 (894)
.. .........+| ++.|+|||...+. ......|+||.|+++.-+++|..||+...... .....|.... ..
T Consensus 176 ~~~~g~~~~~~~~~g~s~~y~a~E~~~~~~~~~~~~d~~S~g~~l~~~~~g~~p~~~~~~~~-~~~~~~~~~~---~~-- 249 (601)
T KOG0590|consen 176 RNKNGAERSLKDRCGSSPPYGAPEHLSGKAYRGPSVDVWSLGIVLSAMLTGELPWDFPSRKD-GRYSSWKSNK---GR-- 249 (601)
T ss_pred cccCCcceeeecccCCCCCCCCcccccchhhcCCCcccccccccccccccCCCCcccccccc-ccceeecccc---cc--
Confidence 65 22223344567 9999999998884 44677899999999999999999998654432 1222222111 00
Q ss_pred ccccccccCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHH--HHHh
Q 002673 837 QVFDPILRGKGFDEEMLQVLDVACMCVSQNPFKRPTVKEVVE--WLNN 882 (894)
Q Consensus 837 ~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~--~L~~ 882 (894)
+.... +........++...++..+|+.|.+.+++.. |+..
T Consensus 250 --~~~~~----~~~~~~~~~~~l~k~l~~~~~~r~s~~~~~~d~~~~~ 291 (601)
T KOG0590|consen 250 --FTQLP----WNSISDQAHDLLHKILKENPSNRLSIEELKLDNWLSS 291 (601)
T ss_pred --cccCc----cccCChhhhhcccccccCCchhccccccccccccccc
Confidence 00001 1111224456777888899999999998876 5544
|
|
| >KOG1266 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.35 E-value=1.5e-12 Score=136.03 Aligned_cols=205 Identities=21% Similarity=0.304 Sum_probs=142.8
Q ss_pred HHHHHHHhcCCCceeeecceeeecc-----eEEEEEEeccCCCHHHHHhhhcCCCCCcCHHHHHHHHHHHHHHHHHHHhc
Q 002673 652 AEVEALSTAQHKNLVSLQGYCVHQG-----FRLLIYSYMENGSLDYWLHEKADGASQLDWLTRLKIARGTSCGLAYMHQI 726 (894)
Q Consensus 652 ~Ei~~l~~l~HpnIv~l~g~~~~~~-----~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~ 726 (894)
.-...+-.+.|.|||+++.|+.+.. ...+++|||..|++..+|++.......+......+|..||..||.|||+
T Consensus 116 ~vFdnllqlvHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~~fLkrt~~~~~a~~~~~wkkw~tqIlsal~yLhs- 194 (458)
T KOG1266|consen 116 AVFDNLLQLVHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLKQFLKRTKKNQKALFQKAWKKWCTQILSALSYLHS- 194 (458)
T ss_pred HHHHHHHHHHHHHHHHHHHhhcccccccccceEEEEecccchhHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhhhhhhc-
Confidence 3344555667999999999987543 4678999999999999999866555667777778999999999999998
Q ss_pred cCCCeeecCCCCCCeEECCCCcEEEEEcccccccCCC----CCcccccccccCCccCcccccCcCCCccccHHHHHHHHH
Q 002673 727 CEPHIVHRDIKSSNILLDDQFEAHLADFGLSRLILPY----QTHVTTELVGTLGYIPPEYGQAWVATLRGDMYSFGVVML 802 (894)
Q Consensus 727 ~~~~ivHrDLkp~NILld~~~~vkl~DFGla~~~~~~----~~~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwS~GvlL~ 802 (894)
|.++|+|+++.-+-|++..++-+|+. .+.-...... .........+-++|.+||+-.....+.++|||+||+...
T Consensus 195 ~~PpiihgnlTc~tifiq~ngLIkig-~~ap~s~h~s~~~~~~~Ek~~~~~~~g~~a~~sg~~tn~~~a~dIy~fgmcAl 273 (458)
T KOG1266|consen 195 CDPPIIHGNLTCDTIFIQHNGLIKIG-SVAPDSTHPSVNSTREAEKSVNTSLPGFSAPESGTTTNTTGASDIYKFGMCAL 273 (458)
T ss_pred cCCccccCCcchhheeecCCceEEec-ccCccccchhhhhhhHhhhhccccCCccccCCcCcccccccchhhhhhhHHHH
Confidence 58999999999999999999988874 2211111110 000111223568999999988888888999999999999
Q ss_pred HHHcCCCCCCCCCcch-hhhHHHHHHHHhhcCCCCccccccccCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 002673 803 ELLTGKRPVDVLKPKM-SRELVGWVLKMRSEGKQDQVFDPILRGKGFDEEMLQVLDVACMCVSQNPFKRPTVKEVVE 878 (894)
Q Consensus 803 elltG~~Pf~~~~~~~-~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~ 878 (894)
||-.+..--....... .......+ .. ..-++. =.+++..|++..|..||+|.+++.
T Consensus 274 emailEiq~tnseS~~~~ee~ia~~--i~------~len~l------------qr~~i~kcl~~eP~~rp~ar~llf 330 (458)
T KOG1266|consen 274 EMAILEIQSTNSESKVEVEENIANV--II------GLENGL------------QRGSITKCLEGEPNGRPDARLLLF 330 (458)
T ss_pred HHHHheeccCCCcceeehhhhhhhh--ee------eccCcc------------ccCcCcccccCCCCCCcchhhhhc
Confidence 9988765321111100 00000000 00 000000 025677899999999999999875
|
|
| >PRK15387 E3 ubiquitin-protein ligase SspH2; Provisional | Back alignment and domain information |
|---|
Probab=99.33 E-value=1.8e-12 Score=155.73 Aligned_cols=154 Identities=28% Similarity=0.296 Sum_probs=95.8
Q ss_pred CCcccccccccccccccccccCccccchhcccccccccccCcccc-----------------ccCCCCCcccccCCCCCC
Q 002673 325 EGPSLFSQANLLSGEFPKELTALPALVSEAANDEVDRSYLELPVF-----------------VMPSNATNQQYNQLSNLP 387 (894)
Q Consensus 325 ~L~~L~L~~N~l~~~~p~~~~~L~~L~~L~L~~n~~~~~~~~~~~-----------------~~~~~~~~l~~n~L~~Lp 387 (894)
+|..|++.+|+|+. +|. .+++|+.|+|++|.+..++..... ......++++.|+|+.+|
T Consensus 283 ~L~~L~Ls~N~Lt~-LP~---~p~~L~~LdLS~N~L~~Lp~lp~~L~~L~Ls~N~L~~LP~lp~~Lq~LdLS~N~Ls~LP 358 (788)
T PRK15387 283 GLCKLWIFGNQLTS-LPV---LPPGLQELSVSDNQLASLPALPSELCKLWAYNNQLTSLPTLPSGLQELSVSDNQLASLP 358 (788)
T ss_pred hcCEEECcCCcccc-ccc---cccccceeECCCCccccCCCCcccccccccccCccccccccccccceEecCCCccCCCC
Confidence 45556666666655 343 235566666666666655432111 011233444445555444
Q ss_pred ------CeEEccCCcCCcCCchhhcCCCCCcEEeccCCcCCCCCCccccCCCCCCEEecCCCcccCcCCCcccCCCcccc
Q 002673 388 ------PAIYLANNSLSGNIPVEIGQLKSLHVLDLSNNNFSGTIPDELSDLSNLEKLDLSGNHLVGEIPISLKGLHFLSS 461 (894)
Q Consensus 388 ------~~L~L~~N~l~~~~p~~~~~L~~L~~L~L~~N~l~~~~p~~~~~L~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~ 461 (894)
..|++++|+|+ .+|.. +.+|+.|+|++|+|+ .+|.. .++|+.|+|++|+|+ .+|..+ .+|+.
T Consensus 359 ~lp~~L~~L~Ls~N~L~-~LP~l---~~~L~~LdLs~N~Lt-~LP~l---~s~L~~LdLS~N~Ls-sIP~l~---~~L~~ 426 (788)
T PRK15387 359 TLPSELYKLWAYNNRLT-SLPAL---PSGLKELIVSGNRLT-SLPVL---PSELKELMVSGNRLT-SLPMLP---SGLLS 426 (788)
T ss_pred CCCcccceehhhccccc-cCccc---ccccceEEecCCccc-CCCCc---ccCCCEEEccCCcCC-CCCcch---hhhhh
Confidence 12445555555 34432 246777788888877 46643 357888888888888 567533 46788
Q ss_pred ccccccccCCCCCCCCCCCCCCccccCCCCCCC
Q 002673 462 FSVAHNNLQGAVPSGGQFDTFPSFSFEGNPELC 494 (894)
Q Consensus 462 L~Ls~N~l~~~~~~~~~l~~L~~l~l~~Np~~c 494 (894)
|+|++|+|+.+|..+..+.+|..|++++||+..
T Consensus 427 L~Ls~NqLt~LP~sl~~L~~L~~LdLs~N~Ls~ 459 (788)
T PRK15387 427 LSVYRNQLTRLPESLIHLSSETTVNLEGNPLSE 459 (788)
T ss_pred hhhccCcccccChHHhhccCCCeEECCCCCCCc
Confidence 999999999777777889999999999998764
|
|
| >KOG0618 consensus Serine/threonine phosphatase 2C containing leucine-rich repeats, similar to SCN circadian oscillatory protein (SCOP) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.33 E-value=3.9e-14 Score=164.89 Aligned_cols=199 Identities=26% Similarity=0.321 Sum_probs=132.7
Q ss_pred cccCCCceeeceeecCCCChhhHHHHHhhcc------CCCCCCcccccccccccccccccccCccccchhcccccccccc
Q 002673 290 DKDRPNRYLLAKELVSRPNADDLEIIFGEVE------GKSDEGPSLFSQANLLSGEFPKELTALPALVSEAANDEVDRSY 363 (894)
Q Consensus 290 d~~~~~~y~~i~~~~~~p~le~l~~~~n~~~------~~l~~L~~L~L~~N~l~~~~p~~~~~L~~L~~L~L~~n~~~~~ 363 (894)
|-..+..-.++......++++.|+..+|... ..+.+|.+|....|.++. +|....+++.|++|+|..|.+...
T Consensus 247 dis~n~l~~lp~wi~~~~nle~l~~n~N~l~~lp~ri~~~~~L~~l~~~~nel~y-ip~~le~~~sL~tLdL~~N~L~~l 325 (1081)
T KOG0618|consen 247 DISHNNLSNLPEWIGACANLEALNANHNRLVALPLRISRITSLVSLSAAYNELEY-IPPFLEGLKSLRTLDLQSNNLPSL 325 (1081)
T ss_pred ecchhhhhcchHHHHhcccceEecccchhHHhhHHHHhhhhhHHHHHhhhhhhhh-CCCcccccceeeeeeehhcccccc
Confidence 3455555556677777888888888777742 224478888888898877 788888899999999999888887
Q ss_pred cCccccccCC--CCCcccccCCCCCC----------------------------------CeEEccCCcCCcCCc-hhhc
Q 002673 364 LELPVFVMPS--NATNQQYNQLSNLP----------------------------------PAIYLANNSLSGNIP-VEIG 406 (894)
Q Consensus 364 ~~~~~~~~~~--~~~~l~~n~L~~Lp----------------------------------~~L~L~~N~l~~~~p-~~~~ 406 (894)
++..+..... +.++.+.|.++.+| +.|+|++|+|. .+| ..+.
T Consensus 326 p~~~l~v~~~~l~~ln~s~n~l~~lp~~~e~~~~~Lq~LylanN~Ltd~c~p~l~~~~hLKVLhLsyNrL~-~fpas~~~ 404 (1081)
T KOG0618|consen 326 PDNFLAVLNASLNTLNVSSNKLSTLPSYEENNHAALQELYLANNHLTDSCFPVLVNFKHLKVLHLSYNRLN-SFPASKLR 404 (1081)
T ss_pred chHHHhhhhHHHHHHhhhhccccccccccchhhHHHHHHHHhcCcccccchhhhccccceeeeeecccccc-cCCHHHHh
Confidence 7743222221 34455566666665 22456666666 333 3355
Q ss_pred CCCCCcEEeccCCcCCCCCCccccCCCCCCEEecCCCcccCcCCCcccCCCccccccccccccCCCC-CCCCCCCCCCcc
Q 002673 407 QLKSLHVLDLSNNNFSGTIPDELSDLSNLEKLDLSGNHLVGEIPISLKGLHFLSSFSVAHNNLQGAV-PSGGQFDTFPSF 485 (894)
Q Consensus 407 ~L~~L~~L~L~~N~l~~~~p~~~~~L~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~-~~~~~l~~L~~l 485 (894)
+|..|+.|+||+|+|+ .+|.++.++..|++|...+|+|. .+| .+..+++|+.+|||.|+|+... +.....++|++|
T Consensus 405 kle~LeeL~LSGNkL~-~Lp~tva~~~~L~tL~ahsN~l~-~fP-e~~~l~qL~~lDlS~N~L~~~~l~~~~p~p~LkyL 481 (1081)
T KOG0618|consen 405 KLEELEELNLSGNKLT-TLPDTVANLGRLHTLRAHSNQLL-SFP-ELAQLPQLKVLDLSCNNLSEVTLPEALPSPNLKYL 481 (1081)
T ss_pred chHHhHHHhcccchhh-hhhHHHHhhhhhHHHhhcCCcee-ech-hhhhcCcceEEecccchhhhhhhhhhCCCccccee
Confidence 5666666666666666 56666666666666666666666 566 6777778888888888877432 222334789999
Q ss_pred ccCCCCCC
Q 002673 486 SFEGNPEL 493 (894)
Q Consensus 486 ~l~~Np~~ 493 (894)
+|+||+|+
T Consensus 482 dlSGN~~l 489 (1081)
T KOG0618|consen 482 DLSGNTRL 489 (1081)
T ss_pred eccCCccc
Confidence 99999985
|
|
| >TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase | Back alignment and domain information |
|---|
Probab=99.32 E-value=9.3e-12 Score=143.17 Aligned_cols=141 Identities=18% Similarity=0.227 Sum_probs=99.7
Q ss_pred cceEeecCcEEEEEEEEcCCCeEEEEEEcCcchhh----------------------------------------HHHHH
Q 002673 612 ANIIGCGGFGLVYKATLANGTTLAIKKLSGDLGLM----------------------------------------EREFK 651 (894)
Q Consensus 612 ~~~LG~G~fg~Vy~a~~~~g~~vAvK~~~~~~~~~----------------------------------------~~~~~ 651 (894)
.+.||.|++|.||+|++.+|+.||||+.+...... +-+|.
T Consensus 122 ~~plasaSigQVh~A~l~~G~~VaVKv~rp~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~~~l~~Eldf~ 201 (437)
T TIGR01982 122 EKPLAAASIAQVHRARLVDGKEVAVKVLRPGIEKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFEKTLRRELDLR 201 (437)
T ss_pred CcceeeeehhheEEEEecCCCEEEEEeeCCCcHHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHHHHHHHHHCHH
Confidence 36799999999999999999999999986542110 00244
Q ss_pred HHHHHHHhcC----CCceeeecceee-ecceEEEEEEeccCCCHHHHHhhhcCCCCCcCHHHHHHHHHHHHHH-HHHHHh
Q 002673 652 AEVEALSTAQ----HKNLVSLQGYCV-HQGFRLLIYSYMENGSLDYWLHEKADGASQLDWLTRLKIARGTSCG-LAYMHQ 725 (894)
Q Consensus 652 ~Ei~~l~~l~----HpnIv~l~g~~~-~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~a-L~yLH~ 725 (894)
+|...+.+++ |.+-+.+-.++. .....+|||||++|++|.++......+ . .+..++..++.. +..+|.
T Consensus 202 ~Ea~n~~~~~~~~~~~~~v~vP~v~~~~~~~~vLvmE~i~G~~L~~~~~~~~~~---~---~~~~ia~~~~~~~l~ql~~ 275 (437)
T TIGR01982 202 REAANASELGENFKNDPGVYVPEVYWDRTSERVLTMEWIDGIPLSDIAALDEAG---L---DRKALAENLARSFLNQVLR 275 (437)
T ss_pred HHHHHHHHHHHhcCCCCCEEeCCEehhhcCCceEEEEeECCcccccHHHHHhcC---C---CHHHHHHHHHHHHHHHHHh
Confidence 4555555552 333333333332 234579999999999998876542211 1 234566666653 566775
Q ss_pred ccCCCeeecCCCCCCeEECCCCcEEEEEcccccccC
Q 002673 726 ICEPHIVHRDIKSSNILLDDQFEAHLADFGLSRLIL 761 (894)
Q Consensus 726 ~~~~~ivHrDLkp~NILld~~~~vkl~DFGla~~~~ 761 (894)
.+++|+|+||.||+++.++.++++|||++..+.
T Consensus 276 ---~g~~H~D~hPgNilv~~~g~i~liDfG~~~~l~ 308 (437)
T TIGR01982 276 ---DGFFHADLHPGNIFVLKDGKIIALDFGIVGRLS 308 (437)
T ss_pred ---CCceeCCCCcccEEECCCCcEEEEeCCCeeECC
Confidence 699999999999999999999999999998764
|
This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species. |
| >KOG0532 consensus Leucine-rich repeat (LRR) protein, contains calponin homology domain [Cytoskeleton] | Back alignment and domain information |
|---|
Probab=99.31 E-value=9.9e-14 Score=153.88 Aligned_cols=141 Identities=24% Similarity=0.398 Sum_probs=78.9
Q ss_pred CCcccccccccccccccccccCccccchhcccccccccccCccccccCCCCCcccccCCCCCCCe---------EEccCC
Q 002673 325 EGPSLFSQANLLSGEFPKELTALPALVSEAANDEVDRSYLELPVFVMPSNATNQQYNQLSNLPPA---------IYLANN 395 (894)
Q Consensus 325 ~L~~L~L~~N~l~~~~p~~~~~L~~L~~L~L~~n~~~~~~~~~~~~~~~~~~~l~~n~L~~Lp~~---------L~L~~N 395 (894)
.|..|.|+.|.|.. +|..+.+|..|+.|+|+.|.+...+.. .+..+.+.+-++.|+++.+|+. |+.+.|
T Consensus 99 ~Le~liLy~n~~r~-ip~~i~~L~~lt~l~ls~NqlS~lp~~-lC~lpLkvli~sNNkl~~lp~~ig~~~tl~~ld~s~n 176 (722)
T KOG0532|consen 99 SLESLILYHNCIRT-IPEAICNLEALTFLDLSSNQLSHLPDG-LCDLPLKVLIVSNNKLTSLPEEIGLLPTLAHLDVSKN 176 (722)
T ss_pred HHHHHHHHhcccee-cchhhhhhhHHHHhhhccchhhcCChh-hhcCcceeEEEecCccccCCcccccchhHHHhhhhhh
Confidence 45566677777754 677777777777777777776665544 2333344444555555555532 244555
Q ss_pred cCCcCCchhhcCCCCCcEEeccCCcCCCCCCccccCCCCCCEEecCCCcccCcCCCcccCCCccccccccccccCC
Q 002673 396 SLSGNIPVEIGQLKSLHVLDLSNNNFSGTIPDELSDLSNLEKLDLSGNHLVGEIPISLKGLHFLSSFSVAHNNLQG 471 (894)
Q Consensus 396 ~l~~~~p~~~~~L~~L~~L~L~~N~l~~~~p~~~~~L~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~ 471 (894)
.|. .+|..+++|.+|+.|.+..|++. .+|.++..| .|..||+|+|+|+ .+|..|.+|+.|++|-|.+|.|++
T Consensus 177 ei~-slpsql~~l~slr~l~vrRn~l~-~lp~El~~L-pLi~lDfScNkis-~iPv~fr~m~~Lq~l~LenNPLqS 248 (722)
T KOG0532|consen 177 EIQ-SLPSQLGYLTSLRDLNVRRNHLE-DLPEELCSL-PLIRLDFSCNKIS-YLPVDFRKMRHLQVLQLENNPLQS 248 (722)
T ss_pred hhh-hchHHhhhHHHHHHHHHhhhhhh-hCCHHHhCC-ceeeeecccCcee-ecchhhhhhhhheeeeeccCCCCC
Confidence 555 45555555555555555555555 455555522 4555555555555 555555555555555555555553
|
|
| >KOG0618 consensus Serine/threonine phosphatase 2C containing leucine-rich repeats, similar to SCN circadian oscillatory protein (SCOP) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.22 E-value=7.8e-13 Score=154.23 Aligned_cols=187 Identities=22% Similarity=0.269 Sum_probs=129.9
Q ss_pred eceeecCCCChhhHHHHHhh------ccCCCCCCccccccccccccccccccc--------------------------C
Q 002673 299 LAKELVSRPNADDLEIIFGE------VEGKSDEGPSLFSQANLLSGEFPKELT--------------------------A 346 (894)
Q Consensus 299 ~i~~~~~~p~le~l~~~~n~------~~~~l~~L~~L~L~~N~l~~~~p~~~~--------------------------~ 346 (894)
++........+..+....|+ ..+++..+..|+|..|+|.. .|..|- .
T Consensus 279 lp~ri~~~~~L~~l~~~~nel~yip~~le~~~sL~tLdL~~N~L~~-lp~~~l~v~~~~l~~ln~s~n~l~~lp~~~e~~ 357 (1081)
T KOG0618|consen 279 LPLRISRITSLVSLSAAYNELEYIPPFLEGLKSLRTLDLQSNNLPS-LPDNFLAVLNASLNTLNVSSNKLSTLPSYEENN 357 (1081)
T ss_pred hHHHHhhhhhHHHHHhhhhhhhhCCCcccccceeeeeeehhccccc-cchHHHhhhhHHHHHHhhhhccccccccccchh
Confidence 33334444455555555555 23345577777787777765 343322 2
Q ss_pred ccccchhcccccccccc-cCccccccCCCCCcccccCCCCCC----------CeEEccCCcCCcCCchhhcCCCCCcEEe
Q 002673 347 LPALVSEAANDEVDRSY-LELPVFVMPSNATNQQYNQLSNLP----------PAIYLANNSLSGNIPVEIGQLKSLHVLD 415 (894)
Q Consensus 347 L~~L~~L~L~~n~~~~~-~~~~~~~~~~~~~~l~~n~L~~Lp----------~~L~L~~N~l~~~~p~~~~~L~~L~~L~ 415 (894)
++.|+.|+|.+|.++.- -+........+++++++|+|..+| ++|+||+|+|+ .+|..+.++..|++|.
T Consensus 358 ~~~Lq~LylanN~Ltd~c~p~l~~~~hLKVLhLsyNrL~~fpas~~~kle~LeeL~LSGNkL~-~Lp~tva~~~~L~tL~ 436 (1081)
T KOG0618|consen 358 HAALQELYLANNHLTDSCFPVLVNFKHLKVLHLSYNRLNSFPASKLRKLEELEELNLSGNKLT-TLPDTVANLGRLHTLR 436 (1081)
T ss_pred hHHHHHHHHhcCcccccchhhhccccceeeeeecccccccCCHHHHhchHHhHHHhcccchhh-hhhHHHHhhhhhHHHh
Confidence 34577788888776642 233344455689999999999888 56899999999 8999999999999999
Q ss_pred ccCCcCCCCCCccccCCCCCCEEecCCCcccC-cCCCcccCCCccccccccccc-cCCCCCCCCCCCCCCccccCCC
Q 002673 416 LSNNNFSGTIPDELSDLSNLEKLDLSGNHLVG-EIPISLKGLHFLSSFSVAHNN-LQGAVPSGGQFDTFPSFSFEGN 490 (894)
Q Consensus 416 L~~N~l~~~~p~~~~~L~~L~~L~Ls~N~l~~-~~p~~~~~l~~L~~L~Ls~N~-l~~~~~~~~~l~~L~~l~l~~N 490 (894)
..+|+|. .+| .+..++.|+.+|||.|+|+. .+|...-. ++|++|||++|. +.---..+..+..+..+++.-|
T Consensus 437 ahsN~l~-~fP-e~~~l~qL~~lDlS~N~L~~~~l~~~~p~-p~LkyLdlSGN~~l~~d~~~l~~l~~l~~~~i~~~ 510 (1081)
T KOG0618|consen 437 AHSNQLL-SFP-ELAQLPQLKVLDLSCNNLSEVTLPEALPS-PNLKYLDLSGNTRLVFDHKTLKVLKSLSQMDITLN 510 (1081)
T ss_pred hcCCcee-ech-hhhhcCcceEEecccchhhhhhhhhhCCC-cccceeeccCCcccccchhhhHHhhhhhheecccC
Confidence 9999999 899 89999999999999999973 34544333 899999999997 3211112233444444444444
|
|
| >KOG1243 consensus Protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.20 E-value=2.6e-10 Score=130.53 Aligned_cols=167 Identities=17% Similarity=0.195 Sum_probs=129.0
Q ss_pred EcCCCeEEEEEEcCcchhhHHHHHHHHHHHHhcCCCceeeecceeeecceEEEEEEeccCCCHHHHHhhhcCCCCCcCHH
Q 002673 628 LANGTTLAIKKLSGDLGLMEREFKAEVEALSTAQHKNLVSLQGYCVHQGFRLLIYSYMENGSLDYWLHEKADGASQLDWL 707 (894)
Q Consensus 628 ~~~g~~vAvK~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~ 707 (894)
..++.+|.|..++...........+-++.|+.++||||++++..+..++..|+|+|-+. -|..++.+.. -.
T Consensus 34 k~~~~~vsVF~~~~~~~~~~~~~~~A~k~lKtlRHP~Il~yL~t~e~~~~~ylvTErV~--Pl~~~lk~l~-------~~ 104 (690)
T KOG1243|consen 34 KADGGPVSVFVYKRSNGEVTELAKRAVKRLKTLRHPNILSYLDTTEEEGTLYLVTERVR--PLETVLKELG-------KE 104 (690)
T ss_pred eccCCceEEEEEeCCCchhhHHHHHHHHHhhhccCchhhhhhhhhcccCceEEEeeccc--cHHHHHHHhH-------HH
Confidence 45788888888876655444567888999999999999999999999999999999874 4666666432 34
Q ss_pred HHHHHHHHHHHHHHHHHhccCCCeeecCCCCCCeEECCCCcEEEEEcccccccCCCCCcccccccccCCccCcccccCcC
Q 002673 708 TRLKIARGTSCGLAYMHQICEPHIVHRDIKSSNILLDDQFEAHLADFGLSRLILPYQTHVTTELVGTLGYIPPEYGQAWV 787 (894)
Q Consensus 708 ~~~~i~~~ia~aL~yLH~~~~~~ivHrDLkp~NILld~~~~vkl~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~ 787 (894)
.....++||+.||.|||+ +.+++|++|.-..|+++..|..||++|.++........ ......--..|..|+.+....
T Consensus 105 ~v~~Gl~qIl~AL~FL~~--d~~lvHgNv~~~SVfVn~~GeWkLggle~v~~~~~~~~-~~~~~~~~~s~~~P~~~~~s~ 181 (690)
T KOG1243|consen 105 EVCLGLFQILAALSFLND--DCNLVHGNVCKDSVFVNESGEWKLGGLELVSKASGFNA-PAKSLYLIESFDDPEEIDPSE 181 (690)
T ss_pred HHHHHHHHHHHHHHHHhc--cCCeeeccEeeeeEEEcCCCcEEEeeeEEEeccccCCc-ccccchhhhcccChhhcCccc
Confidence 566788999999999997 46999999999999999999999999998865432221 011112223567777655443
Q ss_pred CCccccHHHHHHHHHHHHcCC
Q 002673 788 ATLRGDMYSFGVVMLELLTGK 808 (894)
Q Consensus 788 ~s~ksDVwS~GvlL~elltG~ 808 (894)
-..|.|-||++++|++.|.
T Consensus 182 --~s~D~~~Lg~li~el~ng~ 200 (690)
T KOG1243|consen 182 --WSIDSWGLGCLIEELFNGS 200 (690)
T ss_pred --cchhhhhHHHHHHHHhCcc
Confidence 2469999999999999993
|
|
| >PRK15370 E3 ubiquitin-protein ligase SlrP; Provisional | Back alignment and domain information |
|---|
Probab=99.19 E-value=1.2e-11 Score=149.46 Aligned_cols=135 Identities=21% Similarity=0.290 Sum_probs=57.1
Q ss_pred CCcccccccccccccccccccCccccchhcccccccccccCccccccCCCCCcccccCCCCCCC-------eEEccCCcC
Q 002673 325 EGPSLFSQANLLSGEFPKELTALPALVSEAANDEVDRSYLELPVFVMPSNATNQQYNQLSNLPP-------AIYLANNSL 397 (894)
Q Consensus 325 ~L~~L~L~~N~l~~~~p~~~~~L~~L~~L~L~~n~~~~~~~~~~~~~~~~~~~l~~n~L~~Lp~-------~L~L~~N~l 397 (894)
+|+.|+|++|+|.. +|..+. ++|+.|+|++|.+..++... ......++++.|+|+.+|. .|+|++|+|
T Consensus 242 ~L~~L~Ls~N~L~~-LP~~l~--s~L~~L~Ls~N~L~~LP~~l--~~sL~~L~Ls~N~Lt~LP~~lp~sL~~L~Ls~N~L 316 (754)
T PRK15370 242 TIQEMELSINRITE-LPERLP--SALQSLDLFHNKISCLPENL--PEELRYLSVYDNSIRTLPAHLPSGITHLNVQSNSL 316 (754)
T ss_pred cccEEECcCCccCc-CChhHh--CCCCEEECcCCccCcccccc--CCCCcEEECCCCccccCcccchhhHHHHHhcCCcc
Confidence 34555555555543 344332 24555555555544433211 1122334444444444432 134445555
Q ss_pred CcCCchhhcCCCCCcEEeccCCcCCCCCCccccCCCCCCEEecCCCcccCcCCCcccCCCccccccccccccCCCC
Q 002673 398 SGNIPVEIGQLKSLHVLDLSNNNFSGTIPDELSDLSNLEKLDLSGNHLVGEIPISLKGLHFLSSFSVAHNNLQGAV 473 (894)
Q Consensus 398 ~~~~p~~~~~L~~L~~L~L~~N~l~~~~p~~~~~L~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~ 473 (894)
+ .+|..+. ++|+.|++++|.|+ .+|..+. ++|+.|+|++|+|+ .+|..+. ++|+.|+|++|+|+.+|
T Consensus 317 t-~LP~~l~--~sL~~L~Ls~N~Lt-~LP~~l~--~sL~~L~Ls~N~L~-~LP~~lp--~~L~~LdLs~N~Lt~LP 383 (754)
T PRK15370 317 T-ALPETLP--PGLKTLEAGENALT-SLPASLP--PELQVLDVSKNQIT-VLPETLP--PTITTLDVSRNALTNLP 383 (754)
T ss_pred c-cCCcccc--ccceeccccCCccc-cCChhhc--CcccEEECCCCCCC-cCChhhc--CCcCEEECCCCcCCCCC
Confidence 4 2333222 34444444444444 2443332 34444444444444 3443331 34444444444444333
|
|
| >PRK15370 E3 ubiquitin-protein ligase SlrP; Provisional | Back alignment and domain information |
|---|
Probab=99.16 E-value=2.4e-11 Score=146.86 Aligned_cols=151 Identities=19% Similarity=0.286 Sum_probs=73.0
Q ss_pred CCcccccccccccccccccccCccccchhcccccccccccCccccccCCCCCcccccCCCCCC-------CeEEccCCcC
Q 002673 325 EGPSLFSQANLLSGEFPKELTALPALVSEAANDEVDRSYLELPVFVMPSNATNQQYNQLSNLP-------PAIYLANNSL 397 (894)
Q Consensus 325 ~L~~L~L~~N~l~~~~p~~~~~L~~L~~L~L~~n~~~~~~~~~~~~~~~~~~~l~~n~L~~Lp-------~~L~L~~N~l 397 (894)
+|+.|++++|+|+. +|..+. .+|+.|+|++|.+..++... ......++++.|+|+.+| +.|+|++|+|
T Consensus 221 nL~~L~Ls~N~Lts-LP~~l~--~~L~~L~Ls~N~L~~LP~~l--~s~L~~L~Ls~N~L~~LP~~l~~sL~~L~Ls~N~L 295 (754)
T PRK15370 221 NIKTLYANSNQLTS-IPATLP--DTIQEMELSINRITELPERL--PSALQSLDLFHNKISCLPENLPEELRYLSVYDNSI 295 (754)
T ss_pred CCCEEECCCCcccc-CChhhh--ccccEEECcCCccCcCChhH--hCCCCEEECcCCccCccccccCCCCcEEECCCCcc
Confidence 45556666666554 344332 24555566665555443221 112233444445554443 2245555555
Q ss_pred CcCCchhhcCCCCCcEEeccCCcCCCCCCccccCCCCCCEEecCCCcccCcCCCcccCCCccccccccccccCCCCCCCC
Q 002673 398 SGNIPVEIGQLKSLHVLDLSNNNFSGTIPDELSDLSNLEKLDLSGNHLVGEIPISLKGLHFLSSFSVAHNNLQGAVPSGG 477 (894)
Q Consensus 398 ~~~~p~~~~~L~~L~~L~L~~N~l~~~~p~~~~~L~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~ 477 (894)
+ .+|..+. .+|+.|+|++|+|+ .+|..+. ++|+.|++++|.|+ .+|..+. ++|+.|+|++|+|+.+|..+
T Consensus 296 t-~LP~~lp--~sL~~L~Ls~N~Lt-~LP~~l~--~sL~~L~Ls~N~Lt-~LP~~l~--~sL~~L~Ls~N~L~~LP~~l- 365 (754)
T PRK15370 296 R-TLPAHLP--SGITHLNVQSNSLT-ALPETLP--PGLKTLEAGENALT-SLPASLP--PELQVLDVSKNQITVLPETL- 365 (754)
T ss_pred c-cCcccch--hhHHHHHhcCCccc-cCCcccc--ccceeccccCCccc-cCChhhc--CcccEEECCCCCCCcCChhh-
Confidence 5 3343332 24555555555555 3443332 45556666666655 3454442 45666666666665433322
Q ss_pred CCCCCCccccCCCC
Q 002673 478 QFDTFPSFSFEGNP 491 (894)
Q Consensus 478 ~l~~L~~l~l~~Np 491 (894)
.++|+.|++++|.
T Consensus 366 -p~~L~~LdLs~N~ 378 (754)
T PRK15370 366 -PPTITTLDVSRNA 378 (754)
T ss_pred -cCCcCEEECCCCc
Confidence 2455666666654
|
|
| >PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed | Back alignment and domain information |
|---|
Probab=99.16 E-value=4.3e-11 Score=139.29 Aligned_cols=147 Identities=17% Similarity=0.214 Sum_probs=94.5
Q ss_pred cCCCccceEeecCcEEEEEEEEcC-CCeEEEEEEcCcchhh----------------------------------HH---
Q 002673 607 DNFSQANIIGCGGFGLVYKATLAN-GTTLAIKKLSGDLGLM----------------------------------ER--- 648 (894)
Q Consensus 607 ~~f~~~~~LG~G~fg~Vy~a~~~~-g~~vAvK~~~~~~~~~----------------------------------~~--- 648 (894)
.+|+. +.||+|++|.||+|++.+ |+.||||+.+...... .+
T Consensus 120 ~~fd~-~PlasaSiaQVh~A~l~~~G~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~v~e~~~~l~ 198 (537)
T PRK04750 120 DDFDI-KPLASASIAQVHFARLKDNGREVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPREVVAEFEKTLH 198 (537)
T ss_pred HhcCh-hhhcCCCccEEEEEEECCCCCEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHHHHHHHHHHHH
Confidence 35665 789999999999999877 9999999997542110 01
Q ss_pred ---HHHHHHHHHHhcC----CCceeeecceeee-cceEEEEEEeccCCCHHHHHhhhcCCCCCcCHHHHHHHHHHHHHHH
Q 002673 649 ---EFKAEVEALSTAQ----HKNLVSLQGYCVH-QGFRLLIYSYMENGSLDYWLHEKADGASQLDWLTRLKIARGTSCGL 720 (894)
Q Consensus 649 ---~~~~Ei~~l~~l~----HpnIv~l~g~~~~-~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL 720 (894)
++.+|...+.+++ +.+.+.+-.++.+ ....+|||||++|+.+.++-.-...+ .+ +..++...+.
T Consensus 199 ~ElD~~~Ea~N~~~~~~~f~~~~~v~VP~v~~d~st~~VLvmE~i~G~~l~d~~~l~~~g---~d---~~~la~~~v~-- 270 (537)
T PRK04750 199 DELDLMREAANASQLRRNFEDSDMLYVPEVYWDYCSETVMVMERMYGIPVSDVAALRAAG---TD---MKLLAERGVE-- 270 (537)
T ss_pred HhhCHHHHHHHHHHHHHHccCCCCeecceeecccCCCceEEEeeecCccHHhHHHHHhcC---CC---HHHHHHHHHH--
Confidence 1334444444442 3444444333332 34578999999999998753211111 11 1122222221
Q ss_pred HHHHhccCCCeeecCCCCCCeEECCCC----cEEEEEcccccccCC
Q 002673 721 AYMHQICEPHIVHRDIKSSNILLDDQF----EAHLADFGLSRLILP 762 (894)
Q Consensus 721 ~yLH~~~~~~ivHrDLkp~NILld~~~----~vkl~DFGla~~~~~ 762 (894)
.|+++....|++|+|+||.||+++.++ .+++.|||+...+..
T Consensus 271 ~~~~Qif~~GffHaDpHPGNIlv~~~g~~~~~i~llDFGivg~l~~ 316 (537)
T PRK04750 271 VFFTQVFRDGFFHADMHPGNIFVSYDPPENPRYIALDFGIVGSLNK 316 (537)
T ss_pred HHHHHHHhCCeeeCCCChHHeEEecCCCCCCeEEEEecceEEECCH
Confidence 223333346999999999999999988 999999999987743
|
|
| >PRK15387 E3 ubiquitin-protein ligase SspH2; Provisional | Back alignment and domain information |
|---|
Probab=99.15 E-value=2.1e-11 Score=146.65 Aligned_cols=153 Identities=24% Similarity=0.288 Sum_probs=114.2
Q ss_pred CChhhHHHHHhhccC--C-CCCCcccccccccccccccccccCccccchhcccccccccccCccccccCCCCCcccccCC
Q 002673 307 PNADDLEIIFGEVEG--K-SDEGPSLFSQANLLSGEFPKELTALPALVSEAANDEVDRSYLELPVFVMPSNATNQQYNQL 383 (894)
Q Consensus 307 p~le~l~~~~n~~~~--~-l~~L~~L~L~~N~l~~~~p~~~~~L~~L~~L~L~~n~~~~~~~~~~~~~~~~~~~l~~n~L 383 (894)
|.++.|++..|...+ . ..+|..|++.+|+|++ +|.. ..+|+.|+|++|.+..++... .....+.+..|+|
T Consensus 302 ~~L~~LdLS~N~L~~Lp~lp~~L~~L~Ls~N~L~~-LP~l---p~~Lq~LdLS~N~Ls~LP~lp---~~L~~L~Ls~N~L 374 (788)
T PRK15387 302 PGLQELSVSDNQLASLPALPSELCKLWAYNNQLTS-LPTL---PSGLQELSVSDNQLASLPTLP---SELYKLWAYNNRL 374 (788)
T ss_pred cccceeECCCCccccCCCCcccccccccccCcccc-cccc---ccccceEecCCCccCCCCCCC---cccceehhhcccc
Confidence 456666665554322 1 1256666677777765 4431 247889999999988876543 2234556778888
Q ss_pred CCCC------CeEEccCCcCCcCCchhhcCCCCCcEEeccCCcCCCCCCccccCCCCCCEEecCCCcccCcCCCcccCCC
Q 002673 384 SNLP------PAIYLANNSLSGNIPVEIGQLKSLHVLDLSNNNFSGTIPDELSDLSNLEKLDLSGNHLVGEIPISLKGLH 457 (894)
Q Consensus 384 ~~Lp------~~L~L~~N~l~~~~p~~~~~L~~L~~L~L~~N~l~~~~p~~~~~L~~L~~L~Ls~N~l~~~~p~~~~~l~ 457 (894)
+.+| +.|+|++|+|+ .+|.. .++|+.|+|++|+|+ .+|..+ .+|+.|+|++|+|+ .+|..|.+++
T Consensus 375 ~~LP~l~~~L~~LdLs~N~Lt-~LP~l---~s~L~~LdLS~N~Ls-sIP~l~---~~L~~L~Ls~NqLt-~LP~sl~~L~ 445 (788)
T PRK15387 375 TSLPALPSGLKELIVSGNRLT-SLPVL---PSELKELMVSGNRLT-SLPMLP---SGLLSLSVYRNQLT-RLPESLIHLS 445 (788)
T ss_pred ccCcccccccceEEecCCccc-CCCCc---ccCCCEEEccCCcCC-CCCcch---hhhhhhhhccCccc-ccChHHhhcc
Confidence 8876 45899999999 57743 368999999999999 578643 47889999999999 8999999999
Q ss_pred ccccccccccccCCCCCC
Q 002673 458 FLSSFSVAHNNLQGAVPS 475 (894)
Q Consensus 458 ~L~~L~Ls~N~l~~~~~~ 475 (894)
+|+.|+|++|+|++.++.
T Consensus 446 ~L~~LdLs~N~Ls~~~~~ 463 (788)
T PRK15387 446 SETTVNLEGNPLSERTLQ 463 (788)
T ss_pred CCCeEECCCCCCCchHHH
Confidence 999999999999976653
|
|
| >cd05151 ChoK Choline Kinase (ChoK) | Back alignment and domain information |
|---|
Probab=99.14 E-value=1.2e-10 Score=116.47 Aligned_cols=130 Identities=16% Similarity=0.128 Sum_probs=95.3
Q ss_pred ceEeecCcEEEEEEEEcCCCeEEEEEEcCcchhhHHHHHHHHHHHHhcCCCceee-ecceeeecceEEEEEEeccCCCHH
Q 002673 613 NIIGCGGFGLVYKATLANGTTLAIKKLSGDLGLMEREFKAEVEALSTAQHKNLVS-LQGYCVHQGFRLLIYSYMENGSLD 691 (894)
Q Consensus 613 ~~LG~G~fg~Vy~a~~~~g~~vAvK~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~-l~g~~~~~~~~~lV~E~~~~gsL~ 691 (894)
+.|+.|.++.||++... +..|++|....... ....+..|+.+++.+.+.++++ ++.+. ....++||||+++.++.
T Consensus 4 ~~l~~G~~~~vy~~~~~-~~~~~lK~~~~~~~-~~~~~~~E~~~l~~l~~~~~~P~~~~~~--~~~~~lv~e~i~G~~l~ 79 (170)
T cd05151 4 SPLKGGMTNKNYRVEVA-NKKYVVRIPGNGTE-LLINRENEAENSKLAAEAGIGPKLYYFD--PETGVLITEFIEGSELL 79 (170)
T ss_pred eecCCcccCceEEEEEC-CeEEEEEeCCCCcc-cccCHHHHHHHHHHHHHhCCCCceEEEe--CCCCeEEEEecCCCccc
Confidence 56889999999999874 77899998765432 2235678999999886655543 44333 33458999999998775
Q ss_pred HHHhhhcCCCCCcCHHHHHHHHHHHHHHHHHHHhcc--CCCeeecCCCCCCeEECCCCcEEEEEcccccc
Q 002673 692 YWLHEKADGASQLDWLTRLKIARGTSCGLAYMHQIC--EPHIVHRDIKSSNILLDDQFEAHLADFGLSRL 759 (894)
Q Consensus 692 ~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~--~~~ivHrDLkp~NILld~~~~vkl~DFGla~~ 759 (894)
... .....++.+++++|+.||+.. ...++|+|++|.||+++ ++.++++|||.+..
T Consensus 80 ~~~------------~~~~~~~~~l~~~l~~LH~~~~~~~~~~HgD~~~~Nil~~-~~~~~liDf~~a~~ 136 (170)
T cd05151 80 TED------------FSDPENLEKIAKLLKKLHSSPLPDLVPCHNDLLPGNFLLD-DGRLWLIDWEYAGM 136 (170)
T ss_pred ccc------------ccCHHHHHHHHHHHHHHhCCCCCCceeecCCCCcCcEEEE-CCeEEEEecccccC
Confidence 320 011345678999999999752 22369999999999999 66899999998753
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph |
| >PLN03150 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.12 E-value=7.4e-11 Score=141.83 Aligned_cols=89 Identities=43% Similarity=0.711 Sum_probs=80.4
Q ss_pred cCCCCCCCeEEccCCcCCcCCchhhcCCCCCcEEeccCCcCCCCCCccccCCCCCCEEecCCCcccCcCCCcccCC-Ccc
Q 002673 381 NQLSNLPPAIYLANNSLSGNIPVEIGQLKSLHVLDLSNNNFSGTIPDELSDLSNLEKLDLSGNHLVGEIPISLKGL-HFL 459 (894)
Q Consensus 381 n~L~~Lp~~L~L~~N~l~~~~p~~~~~L~~L~~L~L~~N~l~~~~p~~~~~L~~L~~L~Ls~N~l~~~~p~~~~~l-~~L 459 (894)
.++++| +.|+|++|+|+|.+|..+++|++|+.|+|++|+|+|.+|..|++|++|+.|+|++|+|+|.+|..+..+ .++
T Consensus 439 ~~L~~L-~~L~Ls~N~l~g~iP~~~~~l~~L~~LdLs~N~lsg~iP~~l~~L~~L~~L~Ls~N~l~g~iP~~l~~~~~~~ 517 (623)
T PLN03150 439 SKLRHL-QSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSIPESLGQLTSLRILNLNGNSLSGRVPAALGGRLLHR 517 (623)
T ss_pred hCCCCC-CEEECCCCcccCcCChHHhCCCCCCEEECCCCCCCCCCchHHhcCCCCCEEECcCCcccccCChHHhhccccC
Confidence 445555 789999999999999999999999999999999999999999999999999999999999999998864 467
Q ss_pred ccccccccccC
Q 002673 460 SSFSVAHNNLQ 470 (894)
Q Consensus 460 ~~L~Ls~N~l~ 470 (894)
..+++++|...
T Consensus 518 ~~l~~~~N~~l 528 (623)
T PLN03150 518 ASFNFTDNAGL 528 (623)
T ss_pred ceEEecCCccc
Confidence 88999999754
|
|
| >KOG0532 consensus Leucine-rich repeat (LRR) protein, contains calponin homology domain [Cytoskeleton] | Back alignment and domain information |
|---|
Probab=99.10 E-value=5.9e-12 Score=139.97 Aligned_cols=166 Identities=27% Similarity=0.337 Sum_probs=150.1
Q ss_pred CCCcccccccccccccccccccCccccchhcccccccccccCccccccCCCCCcccccCCCCCCC--------eEEccCC
Q 002673 324 DEGPSLFSQANLLSGEFPKELTALPALVSEAANDEVDRSYLELPVFVMPSNATNQQYNQLSNLPP--------AIYLANN 395 (894)
Q Consensus 324 ~~L~~L~L~~N~l~~~~p~~~~~L~~L~~L~L~~n~~~~~~~~~~~~~~~~~~~l~~n~L~~Lp~--------~L~L~~N 395 (894)
..-...+|+.|++.. +|..+..+..|+.|.|+.|.+..++.-...+.....++++.|+++.||. .|-+++|
T Consensus 75 tdt~~aDlsrNR~~e-lp~~~~~f~~Le~liLy~n~~r~ip~~i~~L~~lt~l~ls~NqlS~lp~~lC~lpLkvli~sNN 153 (722)
T KOG0532|consen 75 TDTVFADLSRNRFSE-LPEEACAFVSLESLILYHNCIRTIPEAICNLEALTFLDLSSNQLSHLPDGLCDLPLKVLIVSNN 153 (722)
T ss_pred cchhhhhcccccccc-CchHHHHHHHHHHHHHHhccceecchhhhhhhHHHHhhhccchhhcCChhhhcCcceeEEEecC
Confidence 344567899999987 8999999999999999999999988876666666788999999999984 4689999
Q ss_pred cCCcCCchhhcCCCCCcEEeccCCcCCCCCCccccCCCCCCEEecCCCcccCcCCCcccCCCccccccccccccCCCCCC
Q 002673 396 SLSGNIPVEIGQLKSLHVLDLSNNNFSGTIPDELSDLSNLEKLDLSGNHLVGEIPISLKGLHFLSSFSVAHNNLQGAVPS 475 (894)
Q Consensus 396 ~l~~~~p~~~~~L~~L~~L~L~~N~l~~~~p~~~~~L~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~ 475 (894)
+|+ .+|..++.+..|..||.+.|+|. .+|..+++|.+|+.|++..|++. .+|..++.|+ |..||+|+|+++.+|-.
T Consensus 154 kl~-~lp~~ig~~~tl~~ld~s~nei~-slpsql~~l~slr~l~vrRn~l~-~lp~El~~Lp-Li~lDfScNkis~iPv~ 229 (722)
T KOG0532|consen 154 KLT-SLPEEIGLLPTLAHLDVSKNEIQ-SLPSQLGYLTSLRDLNVRRNHLE-DLPEELCSLP-LIRLDFSCNKISYLPVD 229 (722)
T ss_pred ccc-cCCcccccchhHHHhhhhhhhhh-hchHHhhhHHHHHHHHHhhhhhh-hCCHHHhCCc-eeeeecccCceeecchh
Confidence 999 89999999999999999999999 89999999999999999999999 8999999664 89999999999988888
Q ss_pred CCCCCCCCccccCCCCCCC
Q 002673 476 GGQFDTFPSFSFEGNPELC 494 (894)
Q Consensus 476 ~~~l~~L~~l~l~~Np~~c 494 (894)
+..+..|+.|.|.+||...
T Consensus 230 fr~m~~Lq~l~LenNPLqS 248 (722)
T KOG0532|consen 230 FRKMRHLQVLQLENNPLQS 248 (722)
T ss_pred hhhhhhheeeeeccCCCCC
Confidence 9999999999999999763
|
|
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.07 E-value=1.1e-10 Score=132.62 Aligned_cols=246 Identities=23% Similarity=0.252 Sum_probs=175.4
Q ss_pred CCccceEee--cCcEEEEEEEE---cCCCeEEEEEEcCcch--hhHHHHHHHHHHHHhc-CCCceeeecceeeecceEEE
Q 002673 609 FSQANIIGC--GGFGLVYKATL---ANGTTLAIKKLSGDLG--LMEREFKAEVEALSTA-QHKNLVSLQGYCVHQGFRLL 680 (894)
Q Consensus 609 f~~~~~LG~--G~fg~Vy~a~~---~~g~~vAvK~~~~~~~--~~~~~~~~Ei~~l~~l-~HpnIv~l~g~~~~~~~~~l 680 (894)
|...+.+|. |.+|.||.+.. .++..+|+|+-+.... .....=.+|+....++ .|+|.++....+..++..++
T Consensus 116 ~~~~~~~g~~~g~~~s~~~~~~~~~~s~~~~a~k~s~~p~s~p~~~~~k~~~~~s~~~i~~~~~~v~~~~~~e~~~~lfi 195 (524)
T KOG0601|consen 116 FPISSRTGSLPGSKGSVFKSRCTNSESPHKFAVKKSKIPFSPPLDSKRKLREFLSHHKIDSHENPVRDSPAWEGSGILFI 195 (524)
T ss_pred cccccccccCCCCCceeecccCCcccCCcccccccccCCCCCccccccccchhhcccccCccccccccCcccccCCccee
Confidence 455677899 99999999975 4678899998443222 2222334566666666 49999998888888999999
Q ss_pred EEEeccCCCHHHHHhhhcCCCCCcCHHHHHHHHHHHHH----HHHHHHhccCCCeeecCCCCCCeEECCC-CcEEEEEcc
Q 002673 681 IYSYMENGSLDYWLHEKADGASQLDWLTRLKIARGTSC----GLAYMHQICEPHIVHRDIKSSNILLDDQ-FEAHLADFG 755 (894)
Q Consensus 681 V~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~----aL~yLH~~~~~~ivHrDLkp~NILld~~-~~vkl~DFG 755 (894)
-+|++. .+|..+.+... ..++....+.+..+... |+.++|+ ++++|-|+||.||+...+ ...+++|||
T Consensus 196 qtE~~~-~sl~~~~~~~~---~~~p~~~l~~~~~~~~~~~~~al~~~hs---~~~~~~~~kp~~i~~~~~~~s~~~~df~ 268 (524)
T KOG0601|consen 196 QTELCG-ESLQSYCHTPC---NFLPDNLLWNSLRDWLSRDVTALSHLHS---NNIVHDDLKPANIFTTSDWTSCKLTDFG 268 (524)
T ss_pred eecccc-chhHHhhhccc---ccCCchhhhhHHhhhhhcccccccccCC---CcccccccchhheecccccceeecCCcc
Confidence 999884 78888877532 23555666777777777 9999997 699999999999999999 889999999
Q ss_pred cccccCCCCCc----ccccccccCCccCcccccCcCCCccccHHHHHHHHHHHHcCCCCCCCCCcchhhhHHHHHHHHhh
Q 002673 756 LSRLILPYQTH----VTTELVGTLGYIPPEYGQAWVATLRGDMYSFGVVMLELLTGKRPVDVLKPKMSRELVGWVLKMRS 831 (894)
Q Consensus 756 la~~~~~~~~~----~~~~~~gt~~Y~APE~~~~~~~s~ksDVwS~GvlL~elltG~~Pf~~~~~~~~~~~~~~~~~~~~ 831 (894)
+...+....-. ......|...|++||...+ .++..+|+|++|.++.+-.+|..+...... ..|..
T Consensus 269 ~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~-l~~~~~di~sl~ev~l~~~l~~~~~~~g~~------~~W~~---- 337 (524)
T KOG0601|consen 269 LVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNG-LATFASDIFSLGEVILEAILGSHLPSVGKN------SSWSQ---- 337 (524)
T ss_pred eeEEccCCccccceeeeecCCCCceEeChhhhcc-ccchHhhhcchhhhhHhhHhhcccccCCCC------CCccc----
Confidence 99887554311 1122357778999998766 567789999999999999998876542210 01110
Q ss_pred cCCCCccccccccCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 002673 832 EGKQDQVFDPILRGKGFDEEMLQVLDVACMCVSQNPFKRPTVKEVVE 878 (894)
Q Consensus 832 ~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~ 878 (894)
.+..+ +...++......+...+..+++.+|-.|++.+.+..
T Consensus 338 ---~r~~~---ip~e~~~~~s~~l~~~~~~~~d~~~~~~~~~q~~~~ 378 (524)
T KOG0601|consen 338 ---LRQGY---IPLEFCEGGSSSLRSVTSQMLDEDPRLRLTAQILTA 378 (524)
T ss_pred ---ccccc---CchhhhcCcchhhhhHHHHhcCcchhhhhHHHHHhc
Confidence 00000 111222222334555888999999999999887765
|
|
| >PF14580 LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQD_A | Back alignment and domain information |
|---|
Probab=99.06 E-value=6.3e-11 Score=118.12 Aligned_cols=79 Identities=33% Similarity=0.475 Sum_probs=21.7
Q ss_pred CeEEccCCcCCcCCchhhcCCCCCcEEeccCCcCCCCCCccc-cCCCCCCEEecCCCcccCcCC--CcccCCCccccccc
Q 002673 388 PAIYLANNSLSGNIPVEIGQLKSLHVLDLSNNNFSGTIPDEL-SDLSNLEKLDLSGNHLVGEIP--ISLKGLHFLSSFSV 464 (894)
Q Consensus 388 ~~L~L~~N~l~~~~p~~~~~L~~L~~L~L~~N~l~~~~p~~~-~~L~~L~~L~Ls~N~l~~~~p--~~~~~l~~L~~L~L 464 (894)
+.|+|++|+|+ .++ .+..|++|++|+|++|+|+ .+++.+ ..+++|++|+|++|+|. .+- ..+..+++|+.|+|
T Consensus 45 ~~L~Ls~N~I~-~l~-~l~~L~~L~~L~L~~N~I~-~i~~~l~~~lp~L~~L~L~~N~I~-~l~~l~~L~~l~~L~~L~L 120 (175)
T PF14580_consen 45 EVLDLSNNQIT-KLE-GLPGLPRLKTLDLSNNRIS-SISEGLDKNLPNLQELYLSNNKIS-DLNELEPLSSLPKLRVLSL 120 (175)
T ss_dssp -EEE-TTS--S---T-T----TT--EEE--SS----S-CHHHHHH-TT--EEE-TTS----SCCCCGGGGG-TT--EEE-
T ss_pred CEEECCCCCCc-ccc-CccChhhhhhcccCCCCCC-ccccchHHhCCcCCEEECcCCcCC-ChHHhHHHHcCCCcceeec
Confidence 44555555555 233 3445555555555555555 333333 23555555555555554 111 12334444444444
Q ss_pred cccccC
Q 002673 465 AHNNLQ 470 (894)
Q Consensus 465 s~N~l~ 470 (894)
.+|.++
T Consensus 121 ~~NPv~ 126 (175)
T PF14580_consen 121 EGNPVC 126 (175)
T ss_dssp TT-GGG
T ss_pred cCCccc
Confidence 444444
|
|
| >KOG4237 consensus Extracellular matrix protein slit, contains leucine-rich and EGF-like repeats [Extracellular structures; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.03 E-value=1.5e-11 Score=131.42 Aligned_cols=138 Identities=24% Similarity=0.264 Sum_probs=119.3
Q ss_pred CCcccccccccccccccccccCccccchhcccccccccccCccccccCCCCCcccccCCCCCCCeEEccCCcCCcCCchh
Q 002673 325 EGPSLFSQANLLSGEFPKELTALPALVSEAANDEVDRSYLELPVFVMPSNATNQQYNQLSNLPPAIYLANNSLSGNIPVE 404 (894)
Q Consensus 325 ~L~~L~L~~N~l~~~~p~~~~~L~~L~~L~L~~n~~~~~~~~~~~~~~~~~~~l~~n~L~~Lp~~L~L~~N~l~~~~p~~ 404 (894)
+...++|..|+|+.+.|++|+.|++| +.|+|++|+|+.+-|+.
T Consensus 68 ~tveirLdqN~I~~iP~~aF~~l~~L-------------------------------------RrLdLS~N~Is~I~p~A 110 (498)
T KOG4237|consen 68 ETVEIRLDQNQISSIPPGAFKTLHRL-------------------------------------RRLDLSKNNISFIAPDA 110 (498)
T ss_pred cceEEEeccCCcccCChhhccchhhh-------------------------------------ceecccccchhhcChHh
Confidence 45678899999999888899999988 56788999999888999
Q ss_pred hcCCCCCcEEeccC-CcCCCCCCccccCCCCCCEEecCCCcccCcCCCcccCCCccccccccccccCCCCC-CCCCCCCC
Q 002673 405 IGQLKSLHVLDLSN-NNFSGTIPDELSDLSNLEKLDLSGNHLVGEIPISLKGLHFLSSFSVAHNNLQGAVP-SGGQFDTF 482 (894)
Q Consensus 405 ~~~L~~L~~L~L~~-N~l~~~~p~~~~~L~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~-~~~~l~~L 482 (894)
|.+|.+|..|-+-+ |+|+....+.|++|.+|+.|.+.-|++.-...+.|..|++|..|.|-+|.++.+.. .+..+..+
T Consensus 111 F~GL~~l~~Lvlyg~NkI~~l~k~~F~gL~slqrLllNan~i~Cir~~al~dL~~l~lLslyDn~~q~i~~~tf~~l~~i 190 (498)
T KOG4237|consen 111 FKGLASLLSLVLYGNNKITDLPKGAFGGLSSLQRLLLNANHINCIRQDALRDLPSLSLLSLYDNKIQSICKGTFQGLAAI 190 (498)
T ss_pred hhhhHhhhHHHhhcCCchhhhhhhHhhhHHHHHHHhcChhhhcchhHHHHHHhhhcchhcccchhhhhhccccccchhcc
Confidence 99999987765555 99996666789999999999999999997888899999999999999999996555 45788889
Q ss_pred CccccCCCCCCCCCccc
Q 002673 483 PSFSFEGNPELCGSVVQ 499 (894)
Q Consensus 483 ~~l~l~~Np~~c~~~~~ 499 (894)
+.+.+.-||..|+|.++
T Consensus 191 ~tlhlA~np~icdCnL~ 207 (498)
T KOG4237|consen 191 KTLHLAQNPFICDCNLP 207 (498)
T ss_pred chHhhhcCccccccccc
Confidence 99999999999999764
|
|
| >PF14580 LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQD_A | Back alignment and domain information |
|---|
Probab=99.00 E-value=1.4e-10 Score=115.63 Aligned_cols=103 Identities=33% Similarity=0.497 Sum_probs=41.8
Q ss_pred CCCCCeEEccCCcCCcCCchhhc-CCCCCcEEeccCCcCCCCCCccccCCCCCCEEecCCCcccCcCCCcc-cCCCcccc
Q 002673 384 SNLPPAIYLANNSLSGNIPVEIG-QLKSLHVLDLSNNNFSGTIPDELSDLSNLEKLDLSGNHLVGEIPISL-KGLHFLSS 461 (894)
Q Consensus 384 ~~Lp~~L~L~~N~l~~~~p~~~~-~L~~L~~L~L~~N~l~~~~p~~~~~L~~L~~L~Ls~N~l~~~~p~~~-~~l~~L~~ 461 (894)
..+ ++|+|++|+|+ .+. .++ .|.+|+.|+|++|+|+ .++ .|..|++|++|+|++|+|+ .+++.+ ..+++|+.
T Consensus 19 ~~~-~~L~L~~n~I~-~Ie-~L~~~l~~L~~L~Ls~N~I~-~l~-~l~~L~~L~~L~L~~N~I~-~i~~~l~~~lp~L~~ 92 (175)
T PF14580_consen 19 VKL-RELNLRGNQIS-TIE-NLGATLDKLEVLDLSNNQIT-KLE-GLPGLPRLKTLDLSNNRIS-SISEGLDKNLPNLQE 92 (175)
T ss_dssp --------------------S--TT-TT--EEE-TTS--S---T-T----TT--EEE--SS----S-CHHHHHH-TT--E
T ss_pred ccc-ccccccccccc-ccc-chhhhhcCCCEEECCCCCCc-ccc-CccChhhhhhcccCCCCCC-ccccchHHhCCcCCE
Confidence 344 67899999999 554 576 5899999999999999 665 5899999999999999999 666555 46899999
Q ss_pred ccccccccCCCCC--CCCCCCCCCccccCCCCC
Q 002673 462 FSVAHNNLQGAVP--SGGQFDTFPSFSFEGNPE 492 (894)
Q Consensus 462 L~Ls~N~l~~~~~--~~~~l~~L~~l~l~~Np~ 492 (894)
|+|++|+|...-. .+..+++|+.|++.+||.
T Consensus 93 L~L~~N~I~~l~~l~~L~~l~~L~~L~L~~NPv 125 (175)
T PF14580_consen 93 LYLSNNKISDLNELEPLSSLPKLRVLSLEGNPV 125 (175)
T ss_dssp EE-TTS---SCCCCGGGGG-TT--EEE-TT-GG
T ss_pred EECcCCcCCChHHhHHHHcCCCcceeeccCCcc
Confidence 9999999985422 336789999999999986
|
|
| >PLN03210 Resistant to P | Back alignment and domain information |
|---|
Probab=98.94 E-value=1.7e-09 Score=139.28 Aligned_cols=60 Identities=12% Similarity=-0.018 Sum_probs=41.2
Q ss_pred eceeecCCCChhhHHHHHhhc------cCCCCCCcccccccccccccccccccCccccchhccccc
Q 002673 299 LAKELVSRPNADDLEIIFGEV------EGKSDEGPSLFSQANLLSGEFPKELTALPALVSEAANDE 358 (894)
Q Consensus 299 ~i~~~~~~p~le~l~~~~n~~------~~~l~~L~~L~L~~N~l~~~~p~~~~~L~~L~~L~L~~n 358 (894)
+...+..+++++.|++..+.. +..+++|+.|+|++|.....+|..+.+|++|+.|+|++|
T Consensus 626 L~~~~~~l~~Lk~L~Ls~~~~l~~ip~ls~l~~Le~L~L~~c~~L~~lp~si~~L~~L~~L~L~~c 691 (1153)
T PLN03210 626 LWDGVHSLTGLRNIDLRGSKNLKEIPDLSMATNLETLKLSDCSSLVELPSSIQYLNKLEDLDMSRC 691 (1153)
T ss_pred cccccccCCCCCEEECCCCCCcCcCCccccCCcccEEEecCCCCccccchhhhccCCCCEEeCCCC
Confidence 344455667777777654432 234557888888887655567888888888888888874
|
syringae 6; Provisional |
| >cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins | Back alignment and domain information |
|---|
Probab=98.94 E-value=4.5e-09 Score=109.70 Aligned_cols=142 Identities=19% Similarity=0.254 Sum_probs=105.9
Q ss_pred ceEeecCcEEEEEEEEcCCCeEEEEEEcCcch-hhHHHHHHHHHHHHhcCCC--ceeeecceeeecc---eEEEEEEecc
Q 002673 613 NIIGCGGFGLVYKATLANGTTLAIKKLSGDLG-LMEREFKAEVEALSTAQHK--NLVSLQGYCVHQG---FRLLIYSYME 686 (894)
Q Consensus 613 ~~LG~G~fg~Vy~a~~~~g~~vAvK~~~~~~~-~~~~~~~~Ei~~l~~l~Hp--nIv~l~g~~~~~~---~~~lV~E~~~ 686 (894)
+.|+.|.++.||++...+|..+++|....... .....+..|+++++.+++. ++.+++.+..... ..++||||++
T Consensus 4 ~~l~~G~~n~~~~v~~~~g~~~ilK~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~~~~~~~~v~e~i~ 83 (223)
T cd05154 4 RQLSGGQSNLTYLLTAGGGRRLVLRRPPPGALLPSAHDVAREYRVLRALAGTGVPVPKVLALCEDPSVLGTPFYVMERVD 83 (223)
T ss_pred eecCCCccceEEEEEecCCcceEEEeCCCcccCcccccHHHHHHHHHHhhCCCCCCCCEEEECCCCCccCCceEEEEEeC
Confidence 56899999999999887778999998765332 1345688999999999764 4566777766542 5689999999
Q ss_pred CCCHHHHHhhhcCCCCCcCHHHHHHHHHHHHHHHHHHHhcc---------------------------------------
Q 002673 687 NGSLDYWLHEKADGASQLDWLTRLKIARGTSCGLAYMHQIC--------------------------------------- 727 (894)
Q Consensus 687 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~--------------------------------------- 727 (894)
|.++.+.+.. ..++..+...++.+++++|.+||+..
T Consensus 84 G~~l~~~~~~-----~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 158 (223)
T cd05154 84 GRVLRDRLLR-----PELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYDASRTDEPPAME 158 (223)
T ss_pred CEecCCCCCC-----CCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHHhhcccccHHHH
Confidence 9887654421 13455566677777777777777421
Q ss_pred --------------CCCeeecCCCCCCeEECC--CCcEEEEEcccccc
Q 002673 728 --------------EPHIVHRDIKSSNILLDD--QFEAHLADFGLSRL 759 (894)
Q Consensus 728 --------------~~~ivHrDLkp~NILld~--~~~vkl~DFGla~~ 759 (894)
...++|+|+++.||+++. ++.+.|+||+.+..
T Consensus 159 ~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~~~iID~e~~~~ 206 (223)
T cd05154 159 RLLRWLEAHLPADSRPGLVHGDYRLGNVLFHPDEPRVVAVLDWELATL 206 (223)
T ss_pred HHHHHHHhhCCCCCCcEEEECCCCcccEEEcCCCCcEEEEEecccccc
Confidence 245799999999999998 66789999998764
|
This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain |
| >COG4886 Leucine-rich repeat (LRR) protein [Function unknown] | Back alignment and domain information |
|---|
Probab=98.94 E-value=5.7e-10 Score=127.66 Aligned_cols=164 Identities=27% Similarity=0.363 Sum_probs=112.2
Q ss_pred CCcccccccccccccccccccCcc-ccchhcccccccccccCccccccCCCCCcccccCCCCCC---------CeEEccC
Q 002673 325 EGPSLFSQANLLSGEFPKELTALP-ALVSEAANDEVDRSYLELPVFVMPSNATNQQYNQLSNLP---------PAIYLAN 394 (894)
Q Consensus 325 ~L~~L~L~~N~l~~~~p~~~~~L~-~L~~L~L~~n~~~~~~~~~~~~~~~~~~~l~~n~L~~Lp---------~~L~L~~ 394 (894)
.+..|++..|.++. +|.....+. +|+.|++++|.+..++.........+.+.+++|+++.+| ..|++++
T Consensus 117 ~l~~L~l~~n~i~~-i~~~~~~~~~nL~~L~l~~N~i~~l~~~~~~l~~L~~L~l~~N~l~~l~~~~~~~~~L~~L~ls~ 195 (394)
T COG4886 117 NLTSLDLDNNNITD-IPPLIGLLKSNLKELDLSDNKIESLPSPLRNLPNLKNLDLSFNDLSDLPKLLSNLSNLNNLDLSG 195 (394)
T ss_pred ceeEEecCCccccc-CccccccchhhcccccccccchhhhhhhhhccccccccccCCchhhhhhhhhhhhhhhhheeccC
Confidence 44455555555544 344444442 555555555555444322222233344444444444444 4478999
Q ss_pred CcCCcCCchhhcCCCCCcEEeccCCcCCCCCCccccCCCCCCEEecCCCcccCcCCCcccCCCccccccccccccCCCCC
Q 002673 395 NSLSGNIPVEIGQLKSLHVLDLSNNNFSGTIPDELSDLSNLEKLDLSGNHLVGEIPISLKGLHFLSSFSVAHNNLQGAVP 474 (894)
Q Consensus 395 N~l~~~~p~~~~~L~~L~~L~L~~N~l~~~~p~~~~~L~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~ 474 (894)
|+++ .+|..+..+..|++|++++|.+. ..+..+.++.+|..|.+++|++. .++..++.+++|++|++++|+++....
T Consensus 196 N~i~-~l~~~~~~~~~L~~l~~~~N~~~-~~~~~~~~~~~l~~l~l~~n~~~-~~~~~~~~l~~l~~L~~s~n~i~~i~~ 272 (394)
T COG4886 196 NKIS-DLPPEIELLSALEELDLSNNSII-ELLSSLSNLKNLSGLELSNNKLE-DLPESIGNLSNLETLDLSNNQISSISS 272 (394)
T ss_pred Cccc-cCchhhhhhhhhhhhhhcCCcce-ecchhhhhcccccccccCCceee-eccchhccccccceecccccccccccc
Confidence 9998 78877777788999999999655 57778889999999999999988 667888888899999999999985555
Q ss_pred CCCCCCCCCccccCCCCCC
Q 002673 475 SGGQFDTFPSFSFEGNPEL 493 (894)
Q Consensus 475 ~~~~l~~L~~l~l~~Np~~ 493 (894)
++.+.+|+.|++++|...
T Consensus 273 -~~~~~~l~~L~~s~n~~~ 290 (394)
T COG4886 273 -LGSLTNLRELDLSGNSLS 290 (394)
T ss_pred -ccccCccCEEeccCcccc
Confidence 788888999999888543
|
|
| >KOG1259 consensus Nischarin, modulator of integrin alpha5 subunit action [Signal transduction mechanisms; Cytoskeleton] | Back alignment and domain information |
|---|
Probab=98.92 E-value=1.4e-10 Score=119.69 Aligned_cols=133 Identities=20% Similarity=0.285 Sum_probs=102.9
Q ss_pred ccccCccccchhcccccccccccCccccccCCCCCcccccCCCCCCCeEEccCCcCCcCCchhhcCCCCCcEEeccCCcC
Q 002673 342 KELTALPALVSEAANDEVDRSYLELPVFVMPSNATNQQYNQLSNLPPAIYLANNSLSGNIPVEIGQLKSLHVLDLSNNNF 421 (894)
Q Consensus 342 ~~~~~L~~L~~L~L~~n~~~~~~~~~~~~~~~~~~~l~~n~L~~Lp~~L~L~~N~l~~~~p~~~~~L~~L~~L~L~~N~l 421 (894)
..+...+.|++|+|+.|.|+.+-... --+.++ +.|+|++|.|. .+. .+..|.+|+.||||+|.+
T Consensus 278 ~~~dTWq~LtelDLS~N~I~~iDESv-------------KL~Pki-r~L~lS~N~i~-~v~-nLa~L~~L~~LDLS~N~L 341 (490)
T KOG1259|consen 278 VSADTWQELTELDLSGNLITQIDESV-------------KLAPKL-RRLILSQNRIR-TVQ-NLAELPQLQLLDLSGNLL 341 (490)
T ss_pred EecchHhhhhhccccccchhhhhhhh-------------hhccce-eEEecccccee-eeh-hhhhcccceEeecccchh
Confidence 44555667777777777776543321 112233 67899999998 444 488999999999999999
Q ss_pred CCCCCccccCCCCCCEEecCCCcccCcCCCcccCCCccccccccccccCCC--CCCCCCCCCCCccccCCCCCC
Q 002673 422 SGTIPDELSDLSNLEKLDLSGNHLVGEIPISLKGLHFLSSFSVAHNNLQGA--VPSGGQFDTFPSFSFEGNPEL 493 (894)
Q Consensus 422 ~~~~p~~~~~L~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~--~~~~~~l~~L~~l~l~~Np~~ 493 (894)
+ .+-+.-..|.+.++|.|+.|.|. .+. ++.+|-+|..||+++|+|+.. +..+++++.|+.+.|.+||..
T Consensus 342 s-~~~Gwh~KLGNIKtL~La~N~iE-~LS-GL~KLYSLvnLDl~~N~Ie~ldeV~~IG~LPCLE~l~L~~NPl~ 412 (490)
T KOG1259|consen 342 A-ECVGWHLKLGNIKTLKLAQNKIE-TLS-GLRKLYSLVNLDLSSNQIEELDEVNHIGNLPCLETLRLTGNPLA 412 (490)
T ss_pred H-hhhhhHhhhcCEeeeehhhhhHh-hhh-hhHhhhhheeccccccchhhHHHhcccccccHHHHHhhcCCCcc
Confidence 9 77778888999999999999998 443 678888999999999999854 346699999999999999853
|
|
| >cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain | Back alignment and domain information |
|---|
Probab=98.89 E-value=2.2e-08 Score=101.95 Aligned_cols=135 Identities=17% Similarity=0.128 Sum_probs=95.0
Q ss_pred ceEeecCcEEEEEEEEcC-------CCeEEEEEEcCcc----------------------hhhHHHH----HHHHHHHHh
Q 002673 613 NIIGCGGFGLVYKATLAN-------GTTLAIKKLSGDL----------------------GLMEREF----KAEVEALST 659 (894)
Q Consensus 613 ~~LG~G~fg~Vy~a~~~~-------g~~vAvK~~~~~~----------------------~~~~~~~----~~Ei~~l~~ 659 (894)
..||.|.-+.||.|...+ +..+|||+.+-.. ......+ .+|++.|.+
T Consensus 3 g~i~~GKEa~V~~~~~~~~~~~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r~L~r 82 (197)
T cd05146 3 GCISTGKESVVLHANGGSNETEQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMHNLKR 82 (197)
T ss_pred CccccCcceEEEEEecCcccccccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHHHHHH
Confidence 468999999999997543 4789999864211 0112223 389999999
Q ss_pred cCC--CceeeecceeeecceEEEEEEeccCCCHHH-HHhhhcCCCCCcCHHHHHHHHHHHHHHHHHH-HhccCCCeeecC
Q 002673 660 AQH--KNLVSLQGYCVHQGFRLLIYSYMENGSLDY-WLHEKADGASQLDWLTRLKIARGTSCGLAYM-HQICEPHIVHRD 735 (894)
Q Consensus 660 l~H--pnIv~l~g~~~~~~~~~lV~E~~~~gsL~~-~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yL-H~~~~~~ivHrD 735 (894)
+.. -++..++++ ...++||||+.++.+.. .+.+ ..++......+..+++.+|.+| |. .+++|+|
T Consensus 83 l~~~Gv~vP~pi~~----~~~~lvME~Ig~~~~~~~~Lkd-----~~~~~~~~~~i~~~i~~~l~~l~H~---~glVHGD 150 (197)
T cd05146 83 MQKAGIPCPEVVVL----KKHVLVMSFIGDDQVPAPKLKD-----AKLNDEEMKNAYYQVLSMMKQLYKE---CNLVHAD 150 (197)
T ss_pred HHHcCCCCCeEEEe----cCCEEEEEEcCCCCccchhhhc-----cccCHHHHHHHHHHHHHHHHHHHHh---CCeecCC
Confidence 854 345555543 45689999997653321 2221 1233345567789999999999 65 5999999
Q ss_pred CCCCCeEECCCCcEEEEEccccccc
Q 002673 736 IKSSNILLDDQFEAHLADFGLSRLI 760 (894)
Q Consensus 736 Lkp~NILld~~~~vkl~DFGla~~~ 760 (894)
|++.||+++ ++.++|+|||.+...
T Consensus 151 Ls~~NIL~~-~~~v~iIDF~qav~~ 174 (197)
T cd05146 151 LSEYNMLWH-DGKVWFIDVSQSVEP 174 (197)
T ss_pred CCHHHEEEE-CCcEEEEECCCceeC
Confidence 999999997 468999999988754
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown. |
| >COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.87 E-value=2e-08 Score=98.87 Aligned_cols=131 Identities=24% Similarity=0.366 Sum_probs=98.3
Q ss_pred ceEeecCcEEEEEEEEcCCCeEEEEE-EcCcc-------hhhHHHHHHHHHHHHhcCCCceeeecceeeecceEEEEEEe
Q 002673 613 NIIGCGGFGLVYKATLANGTTLAIKK-LSGDL-------GLMEREFKAEVEALSTAQHKNLVSLQGYCVHQGFRLLIYSY 684 (894)
Q Consensus 613 ~~LG~G~fg~Vy~a~~~~g~~vAvK~-~~~~~-------~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~lV~E~ 684 (894)
..+++|+-+.+|.+.+. |..+++|. +.+.- ........+|.+++.+++--.|....=+..+.+...++|||
T Consensus 2 ~~i~~GAEa~i~~~~~~-g~~av~K~Ri~K~YR~p~LD~klrr~Rt~~Earil~~a~~~GV~~P~v~dvD~~~~~I~me~ 80 (204)
T COG3642 2 DLIKQGAEAIIYLTDFL-GLPAVVKERIPKRYRHPELDEKLRRERTRREARILAKAREAGVPVPIVYDVDPDNGLIVMEY 80 (204)
T ss_pred chhhCCcceeEEeeecc-CcceEEEeecCcccCChHHHHHHHHHHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCEEEEEE
Confidence 35788999999999774 34455664 32211 11223466899999998766665555566677788999999
Q ss_pred ccCCCHHHHHhhhcCCCCCcCHHHHHHHHHHHHHHHHHHHhccCCCeeecCCCCCCeEECCCCcEEEEEcccccc
Q 002673 685 MENGSLDYWLHEKADGASQLDWLTRLKIARGTSCGLAYMHQICEPHIVHRDIKSSNILLDDQFEAHLADFGLSRL 759 (894)
Q Consensus 685 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDLkp~NILld~~~~vkl~DFGla~~ 759 (894)
++|..|.+.+... ...++..+-.-+.-||. .+|+|+||.++||+++.+. +.++|||++..
T Consensus 81 I~G~~lkd~l~~~-----------~~~~~r~vG~~vg~lH~---~givHGDLTtsNiIl~~~~-i~~IDfGLg~~ 140 (204)
T COG3642 81 IEGELLKDALEEA-----------RPDLLREVGRLVGKLHK---AGIVHGDLTTSNIILSGGR-IYFIDFGLGEF 140 (204)
T ss_pred eCChhHHHHHHhc-----------chHHHHHHHHHHHHHHh---cCeecCCCccceEEEeCCc-EEEEECCcccc
Confidence 9999888888754 24566677777888996 6999999999999998875 99999999974
|
|
| >PLN03210 Resistant to P | Back alignment and domain information |
|---|
Probab=98.86 E-value=3e-09 Score=136.97 Aligned_cols=181 Identities=18% Similarity=0.194 Sum_probs=105.1
Q ss_pred CCChhhHHHHHhh------ccCCCCCCcccccccccccccccccccCccccchhccccccc-ccccCccccccCCCCCcc
Q 002673 306 RPNADDLEIIFGE------VEGKSDEGPSLFSQANLLSGEFPKELTALPALVSEAANDEVD-RSYLELPVFVMPSNATNQ 378 (894)
Q Consensus 306 ~p~le~l~~~~n~------~~~~l~~L~~L~L~~N~l~~~~p~~~~~L~~L~~L~L~~n~~-~~~~~~~~~~~~~~~~~l 378 (894)
..++.+|++..+. ....+++|+.|+|++|.....+| .+..+++|++|+|++|.. ..++...........+++
T Consensus 610 ~~~L~~L~L~~s~l~~L~~~~~~l~~Lk~L~Ls~~~~l~~ip-~ls~l~~Le~L~L~~c~~L~~lp~si~~L~~L~~L~L 688 (1153)
T PLN03210 610 PENLVKLQMQGSKLEKLWDGVHSLTGLRNIDLRGSKNLKEIP-DLSMATNLETLKLSDCSSLVELPSSIQYLNKLEDLDM 688 (1153)
T ss_pred ccCCcEEECcCccccccccccccCCCCCEEECCCCCCcCcCC-ccccCCcccEEEecCCCCccccchhhhccCCCCEEeC
Confidence 3456666654443 24567899999999876445566 589999999999998653 222222111111222222
Q ss_pred cc-cCCCCCC--------CeEEccCCcCCcCCchhhcCCCCCcEEeccCCcCCCCCCccc--------------------
Q 002673 379 QY-NQLSNLP--------PAIYLANNSLSGNIPVEIGQLKSLHVLDLSNNNFSGTIPDEL-------------------- 429 (894)
Q Consensus 379 ~~-n~L~~Lp--------~~L~L~~N~l~~~~p~~~~~L~~L~~L~L~~N~l~~~~p~~~-------------------- 429 (894)
.. +.++.+| +.|+|++|...+.+|.. +.+|++|+|++|.|+ .+|..+
T Consensus 689 ~~c~~L~~Lp~~i~l~sL~~L~Lsgc~~L~~~p~~---~~nL~~L~L~~n~i~-~lP~~~~l~~L~~L~l~~~~~~~l~~ 764 (1153)
T PLN03210 689 SRCENLEILPTGINLKSLYRLNLSGCSRLKSFPDI---STNISWLDLDETAIE-EFPSNLRLENLDELILCEMKSEKLWE 764 (1153)
T ss_pred CCCCCcCccCCcCCCCCCCEEeCCCCCCccccccc---cCCcCeeecCCCccc-cccccccccccccccccccchhhccc
Confidence 22 2333333 34566665444344422 345666666666665 444322
Q ss_pred ----------cCCCCCCEEecCCCcccCcCCCcccCCCccccccccccc-cCCCCCCCCCCCCCCccccCCCCC
Q 002673 430 ----------SDLSNLEKLDLSGNHLVGEIPISLKGLHFLSSFSVAHNN-LQGAVPSGGQFDTFPSFSFEGNPE 492 (894)
Q Consensus 430 ----------~~L~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~-l~~~~~~~~~l~~L~~l~l~~Np~ 492 (894)
...++|+.|+|++|...+.+|..+++|++|+.|+|++|+ ++ .+|....+++|+.|++++|..
T Consensus 765 ~~~~l~~~~~~~~~sL~~L~Ls~n~~l~~lP~si~~L~~L~~L~Ls~C~~L~-~LP~~~~L~sL~~L~Ls~c~~ 837 (1153)
T PLN03210 765 RVQPLTPLMTMLSPSLTRLFLSDIPSLVELPSSIQNLHKLEHLEIENCINLE-TLPTGINLESLESLDLSGCSR 837 (1153)
T ss_pred cccccchhhhhccccchheeCCCCCCccccChhhhCCCCCCEEECCCCCCcC-eeCCCCCccccCEEECCCCCc
Confidence 112466777777776655777777777888888887754 44 344334677777777776643
|
syringae 6; Provisional |
| >KOG3087 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.81 E-value=4.7e-08 Score=95.67 Aligned_cols=143 Identities=20% Similarity=0.270 Sum_probs=103.0
Q ss_pred ccceEeecCcEEEEEEEEcCCCeEEEEE-EcCc-------chhhHHHHHHHHHHHHhcCCCceeeecceeeecceEEEEE
Q 002673 611 QANIIGCGGFGLVYKATLANGTTLAIKK-LSGD-------LGLMEREFKAEVEALSTAQHKNLVSLQGYCVHQGFRLLIY 682 (894)
Q Consensus 611 ~~~~LG~G~fg~Vy~a~~~~g~~vAvK~-~~~~-------~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~lV~ 682 (894)
....|.+|+-+.|+++.+. |+..+||. +.+. .....+...+|++.+.+++--.|.-..=++.+...-.++|
T Consensus 11 ~l~likQGAEArv~~~~~~-Ge~~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~~~~GI~~P~l~~~D~~~~~i~M 89 (229)
T KOG3087|consen 11 SLELIKQGAEARVPRGSFS-GEAAIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKCRALGIPAPRLIFIDTYGGQIYM 89 (229)
T ss_pred cceeeeccceeeEeeeccC-CceeEEeecccccccchHHHHHHHHHHHHHHHHHHHHHHHhCCCCceEEEEecCCCeEEE
Confidence 4578899999999999884 67766663 3221 1223456778999999987555555444566666678999
Q ss_pred EeccC-CCHHHHHhhhcCCCCCcCHHHHHHHHHHHHHHHHHHHhccCCCeeecCCCCCCeEECCCC---cEEEEEccccc
Q 002673 683 SYMEN-GSLDYWLHEKADGASQLDWLTRLKIARGTSCGLAYMHQICEPHIVHRDIKSSNILLDDQF---EAHLADFGLSR 758 (894)
Q Consensus 683 E~~~~-gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDLkp~NILld~~~---~vkl~DFGla~ 758 (894)
||+++ -++.+++...... .........++..|-+.+.-||. ++|+|+||..+||+|..++ .+.++|||++.
T Consensus 90 E~~~g~~~vk~~i~~~~~~--~~~d~~~~~~~~~iG~~igklH~---ndiiHGDLTTSNill~~~~~~~~~~lIdfgls~ 164 (229)
T KOG3087|consen 90 EFIDGASTVKDFILSTMED--ESEDEGLAELARRIGELIGKLHD---NDIIHGDLTTSNILLRSDGNQITPILIDFGLSS 164 (229)
T ss_pred EeccchhHHHHHHHHHccC--cccchhHHHHHHHHHHHHHHhhh---CCeecccccccceEEecCCCcCceEEEeecchh
Confidence 99976 3788887754321 12222235778888899999996 6999999999999997654 46899999986
Q ss_pred c
Q 002673 759 L 759 (894)
Q Consensus 759 ~ 759 (894)
.
T Consensus 165 ~ 165 (229)
T KOG3087|consen 165 V 165 (229)
T ss_pred c
Confidence 4
|
|
| >KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=98.79 E-value=1.4e-07 Score=105.06 Aligned_cols=170 Identities=19% Similarity=0.253 Sum_probs=129.9
Q ss_pred cEEEEEEE-EcCCCeEEEEEEcCcchhhHHHHHHHHHHHHhcCCCceeeecceeee----cceEEEEEEeccC-CCHHHH
Q 002673 620 FGLVYKAT-LANGTTLAIKKLSGDLGLMEREFKAEVEALSTAQHKNLVSLQGYCVH----QGFRLLIYSYMEN-GSLDYW 693 (894)
Q Consensus 620 fg~Vy~a~-~~~g~~vAvK~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~----~~~~~lV~E~~~~-gsL~~~ 693 (894)
..+.||+. ..||..++.|+++.+....-.....-+++++++.|+|+|++.+++.. +...++||+|.++ ++|.++
T Consensus 289 ~~Ttyk~~s~~DG~~YvLkRlhg~r~~~~nk~t~lve~wkkl~h~NvV~frevf~t~tF~D~SlvlvYDYyP~s~TL~d~ 368 (655)
T KOG3741|consen 289 SITTYKATSNVDGNAYVLKRLHGDRDQSTNKDTSLVEAWKKLCHTNVVPFREVFLTYTFGDLSLVLVYDYYPSSPTLYDL 368 (655)
T ss_pred cceeEeeeeccCCceeeeeeeccccccCcccchHHHHHHHHhccCceeehhhhhhhhccCcceEEEEEecCCCCchHHHH
Confidence 45789997 56899999999965543332234466889999999999999998873 4567899999875 577665
Q ss_pred Hhhhc-----------CCCCCcCHHHHHHHHHHHHHHHHHHHhccCCCeeecCCCCCCeEECCCCcEEEEEcccccccCC
Q 002673 694 LHEKA-----------DGASQLDWLTRLKIARGTSCGLAYMHQICEPHIVHRDIKSSNILLDDQFEAHLADFGLSRLILP 762 (894)
Q Consensus 694 l~~~~-----------~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDLkp~NILld~~~~vkl~DFGla~~~~~ 762 (894)
..... ..+...+....|.++.|+..||.++|+ .|+..+-|.+++|+++.+.+++|+.+|....+..
T Consensus 369 ~F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIHs---sGLAck~L~~~kIlv~G~~RIriS~C~i~Dvl~~ 445 (655)
T KOG3741|consen 369 YFANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIHS---SGLACKTLDLKKILVTGKMRIRISGCGIMDVLQE 445 (655)
T ss_pred HccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHHh---cCceeecccHhHeEeeCcceEEEecccceeeecC
Confidence 54221 223456788899999999999999998 4999999999999999999999999998876543
Q ss_pred CCCcccccccccCCccCcccccCcCCCccccHHHHHHHHHHHHcCCCC
Q 002673 763 YQTHVTTELVGTLGYIPPEYGQAWVATLRGDMYSFGVVMLELLTGKRP 810 (894)
Q Consensus 763 ~~~~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwS~GvlL~elltG~~P 810 (894)
... |-+.+ -.+-|.=.||.++.-|.||..-
T Consensus 446 d~~---------------~~le~---~Qq~D~~~lG~ll~aLAt~~~n 475 (655)
T KOG3741|consen 446 DPT---------------EPLES---QQQNDLRDLGLLLLALATGTEN 475 (655)
T ss_pred CCC---------------cchhH---HhhhhHHHHHHHHHHHhhcccc
Confidence 220 11111 2256899999999999999653
|
|
| >cd00116 LRR_RI Leucine-rich repeats (LRRs), ribonuclease inhibitor (RI)-like subfamily | Back alignment and domain information |
|---|
Probab=98.79 E-value=5.2e-10 Score=123.84 Aligned_cols=163 Identities=23% Similarity=0.212 Sum_probs=90.4
Q ss_pred cCCCCCCcccccccccccccccccccCccc---cchhcccccccccccCccccccCCCCCcccccCC-CCCCCeEEccCC
Q 002673 320 EGKSDEGPSLFSQANLLSGEFPKELTALPA---LVSEAANDEVDRSYLELPVFVMPSNATNQQYNQL-SNLPPAIYLANN 395 (894)
Q Consensus 320 ~~~l~~L~~L~L~~N~l~~~~p~~~~~L~~---L~~L~L~~n~~~~~~~~~~~~~~~~~~~l~~n~L-~~Lp~~L~L~~N 395 (894)
+..+++++.|++++|.+....+..|..+.+ |++|++++|.+...... . +......+ .+| +.|+|++|
T Consensus 77 l~~~~~L~~L~l~~~~~~~~~~~~~~~l~~~~~L~~L~ls~~~~~~~~~~-~-------l~~~l~~~~~~L-~~L~L~~n 147 (319)
T cd00116 77 LTKGCGLQELDLSDNALGPDGCGVLESLLRSSSLQELKLNNNGLGDRGLR-L-------LAKGLKDLPPAL-EKLVLGRN 147 (319)
T ss_pred HHhcCceeEEEccCCCCChhHHHHHHHHhccCcccEEEeeCCccchHHHH-H-------HHHHHHhCCCCc-eEEEcCCC
Confidence 344678888888888887656666666665 88888888765421000 0 00011122 334 55667777
Q ss_pred cCCcC----CchhhcCCCCCcEEeccCCcCCC----CCCccccCCCCCCEEecCCCcccCc----CCCcccCCCcccccc
Q 002673 396 SLSGN----IPVEIGQLKSLHVLDLSNNNFSG----TIPDELSDLSNLEKLDLSGNHLVGE----IPISLKGLHFLSSFS 463 (894)
Q Consensus 396 ~l~~~----~p~~~~~L~~L~~L~L~~N~l~~----~~p~~~~~L~~L~~L~Ls~N~l~~~----~p~~~~~l~~L~~L~ 463 (894)
.+++. ++..+..+.+|+.|+|++|.+++ .++..+..+++|+.|+|++|.|++. ++..+..+++|+.|+
T Consensus 148 ~l~~~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~l~~~l~~~~~L~~L~L~~n~i~~~~~~~l~~~~~~~~~L~~L~ 227 (319)
T cd00116 148 RLEGASCEALAKALRANRDLKELNLANNGIGDAGIRALAEGLKANCNLEVLDLNNNGLTDEGASALAETLASLKSLEVLN 227 (319)
T ss_pred cCCchHHHHHHHHHHhCCCcCEEECcCCCCchHHHHHHHHHHHhCCCCCEEeccCCccChHHHHHHHHHhcccCCCCEEe
Confidence 66632 23345555667777777776663 1233445556677777777766522 233445566677777
Q ss_pred ccccccCCCCC-CC-----CCCCCCCccccCCCC
Q 002673 464 VAHNNLQGAVP-SG-----GQFDTFPSFSFEGNP 491 (894)
Q Consensus 464 Ls~N~l~~~~~-~~-----~~l~~L~~l~l~~Np 491 (894)
+++|.+++... .+ .....|+.|++++|.
T Consensus 228 ls~n~l~~~~~~~l~~~~~~~~~~L~~L~l~~n~ 261 (319)
T cd00116 228 LGDNNLTDAGAAALASALLSPNISLLTLSLSCND 261 (319)
T ss_pred cCCCcCchHHHHHHHHHHhccCCCceEEEccCCC
Confidence 77776653111 11 113566666666664
|
LRRs are 20-29 residue sequence motifs present in many proteins that participate in protein-protein interactions and have different functions and cellular locations. LRRs correspond to structural units consisting of a beta strand (LxxLxLxxN/CxL conserved pattern) and an alpha helix. This alignment contains 12 strands corresponding to 11 full repeats, consistent with the extent observed in the subfamily acting as Ran GTPase Activating Proteins (RanGAP1). |
| >PF13855 LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RFS_A 3G39_A 3VQ2_A 3VQ1_B 2Z64_A 2Z66_C 3FXI_A 2Z63_A | Back alignment and domain information |
|---|
Probab=98.78 E-value=2.9e-09 Score=87.40 Aligned_cols=61 Identities=43% Similarity=0.591 Sum_probs=44.4
Q ss_pred CCCcEEeccCCcCCCCCCccccCCCCCCEEecCCCcccCcCCCcccCCCcccccccccccc
Q 002673 409 KSLHVLDLSNNNFSGTIPDELSDLSNLEKLDLSGNHLVGEIPISLKGLHFLSSFSVAHNNL 469 (894)
Q Consensus 409 ~~L~~L~L~~N~l~~~~p~~~~~L~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l 469 (894)
++|++|+|++|+|+...+..|.++++|++|+|++|+|+...|..|.++++|++|++++|+|
T Consensus 1 p~L~~L~l~~n~l~~i~~~~f~~l~~L~~L~l~~N~l~~i~~~~f~~l~~L~~L~l~~N~l 61 (61)
T PF13855_consen 1 PNLESLDLSNNKLTEIPPDSFSNLPNLETLDLSNNNLTSIPPDAFSNLPNLRYLDLSNNNL 61 (61)
T ss_dssp TTESEEEETSSTESEECTTTTTTGTTESEEEETSSSESEEETTTTTTSTTESEEEETSSSB
T ss_pred CcCcEEECCCCCCCccCHHHHcCCCCCCEeEccCCccCccCHHHHcCCCCCCEEeCcCCcC
Confidence 4677777777777755556777777777777777777766666777777777777777765
|
... |
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=98.78 E-value=6.2e-09 Score=118.51 Aligned_cols=245 Identities=20% Similarity=0.222 Sum_probs=170.8
Q ss_pred ccCCCccceEeecCcEEEEEEEE--cCCCeEEEEEEcCcchhhHHHH--HHHHHHHHhc-CCCceeeecceeeecceEEE
Q 002673 606 TDNFSQANIIGCGGFGLVYKATL--ANGTTLAIKKLSGDLGLMEREF--KAEVEALSTA-QHKNLVSLQGYCVHQGFRLL 680 (894)
Q Consensus 606 ~~~f~~~~~LG~G~fg~Vy~a~~--~~g~~vAvK~~~~~~~~~~~~~--~~Ei~~l~~l-~HpnIv~l~g~~~~~~~~~l 680 (894)
..+|.....||.|.|+.|++... .++..+++|...........++ ..|+.+...+ .|.++++....+......++
T Consensus 264 ~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~~~r~~~i 343 (524)
T KOG0601|consen 264 LTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLATFASDIFSLGEVILEAILGSHLPSVGKNSSWSQLRQGYI 343 (524)
T ss_pred cCCcceeEEccCCccccceeeeecCCCCceEeChhhhccccchHhhhcchhhhhHhhHhhcccccCCCCCCccccccccC
Confidence 45788889999999999999863 4678899998776543333322 3566666555 58888888777777777788
Q ss_pred EEEeccCCCHHHHHhhhcCCCCCcCHHHHHHHHHHHHHHHHHHHhccCCCeeecCCCCCCeEECCC-CcEEEEEcccccc
Q 002673 681 IYSYMENGSLDYWLHEKADGASQLDWLTRLKIARGTSCGLAYMHQICEPHIVHRDIKSSNILLDDQ-FEAHLADFGLSRL 759 (894)
Q Consensus 681 V~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDLkp~NILld~~-~~vkl~DFGla~~ 759 (894)
--||++++++.....- ...++...++.+..|++.++.++|+ +.++|+|+||+||++..+ +.-+++|||.+..
T Consensus 344 p~e~~~~~s~~l~~~~----~~~~d~~~~~~~~~q~~~~l~~i~s---~~~~~~d~~psni~i~~~~~~~~~~~~~~~t~ 416 (524)
T KOG0601|consen 344 PLEFCEGGSSSLRSVT----SQMLDEDPRLRLTAQILTALNVIHS---KLFVHLDVKPSNILISNDGFFSKLGDFGCWTR 416 (524)
T ss_pred chhhhcCcchhhhhHH----HHhcCcchhhhhHHHHHhccccccc---hhhhcccccccceeeccchhhhhccccccccc
Confidence 8999999988766532 1335566778899999999999997 599999999999999886 8899999999875
Q ss_pred cCCCCCcccccccccCCcc--CcccccCcCCCccccHHHHHHHHHHHHcCCCCCCCCCcchhhhHHHHHHHHhhcCCCCc
Q 002673 760 ILPYQTHVTTELVGTLGYI--PPEYGQAWVATLRGDMYSFGVVMLELLTGKRPVDVLKPKMSRELVGWVLKMRSEGKQDQ 837 (894)
Q Consensus 760 ~~~~~~~~~~~~~gt~~Y~--APE~~~~~~~s~ksDVwS~GvlL~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 837 (894)
+.-. ......+-+++ +++......+..+.|+||||.-+.+..+|..--.... .|.. ...+..
T Consensus 417 ~~~~----~~~~~~~~r~~p~~~~~~e~~~~~~~~~~~sl~~~~~e~~~~~~ls~~~~--------~~~~--i~~~~~-- 480 (524)
T KOG0601|consen 417 LAFS----SGVFHHIDRLYPIAEILLEDYPHLSKADIFSLGLSVDEAITGSPLSESGV--------QSLT--IRSGDT-- 480 (524)
T ss_pred ccee----cccccccccccccchhhccccccccccccccccccccccccCcccCcccc--------ccee--eecccc--
Confidence 3211 11122233444 5666667788899999999999999998875322111 1110 011111
Q ss_pred cccccccCCCChHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 002673 838 VFDPILRGKGFDEEMLQVLDVACMCVSQNPFKRPTVKEVVEWLN 881 (894)
Q Consensus 838 ~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~evl~~L~ 881 (894)
+.+ . ....++..+...+...++..||.+.++....+
T Consensus 481 ---p~~--~---~~~~~~q~~~kv~~~~~~~~~~l~~~l~~~~~ 516 (524)
T KOG0601|consen 481 ---PNL--P---GLKLQLQVLLKVMINPDRKRRPSAVELSLHSE 516 (524)
T ss_pred ---cCC--C---chHHhhhhhhhhhcCCccccchhhhhhcccch
Confidence 111 1 11134456667888999999999988876444
|
|
| >cd00116 LRR_RI Leucine-rich repeats (LRRs), ribonuclease inhibitor (RI)-like subfamily | Back alignment and domain information |
|---|
Probab=98.76 E-value=1.3e-09 Score=120.70 Aligned_cols=159 Identities=23% Similarity=0.250 Sum_probs=74.8
Q ss_pred CCCcccccccccccc----cccccccCc-cccchhcccccccccccCccccccCCCCCcccccCCCCCCCeEEccCCcCC
Q 002673 324 DEGPSLFSQANLLSG----EFPKELTAL-PALVSEAANDEVDRSYLELPVFVMPSNATNQQYNQLSNLPPAIYLANNSLS 398 (894)
Q Consensus 324 ~~L~~L~L~~N~l~~----~~p~~~~~L-~~L~~L~L~~n~~~~~~~~~~~~~~~~~~~l~~n~L~~Lp~~L~L~~N~l~ 398 (894)
++|+.|++++|+++. .+...+..+ ++|+.|+|++|.++...... ....+..+.+| +.|+|++|.++
T Consensus 108 ~~L~~L~ls~~~~~~~~~~~l~~~l~~~~~~L~~L~L~~n~l~~~~~~~--------~~~~~~~~~~L-~~L~l~~n~l~ 178 (319)
T cd00116 108 SSLQELKLNNNGLGDRGLRLLAKGLKDLPPALEKLVLGRNRLEGASCEA--------LAKALRANRDL-KELNLANNGIG 178 (319)
T ss_pred CcccEEEeeCCccchHHHHHHHHHHHhCCCCceEEEcCCCcCCchHHHH--------HHHHHHhCCCc-CEEECcCCCCc
Confidence 457777777777652 233445555 67777777776655211000 00011222334 45556666555
Q ss_pred cC----CchhhcCCCCCcEEeccCCcCCCC----CCccccCCCCCCEEecCCCcccCcCCCccc-----CCCcccccccc
Q 002673 399 GN----IPVEIGQLKSLHVLDLSNNNFSGT----IPDELSDLSNLEKLDLSGNHLVGEIPISLK-----GLHFLSSFSVA 465 (894)
Q Consensus 399 ~~----~p~~~~~L~~L~~L~L~~N~l~~~----~p~~~~~L~~L~~L~Ls~N~l~~~~p~~~~-----~l~~L~~L~Ls 465 (894)
+. ++..+..+++|+.|+|++|.+++. ++..+..+++|++|++++|.+++.....+. ..+.|+.|+++
T Consensus 179 ~~~~~~l~~~l~~~~~L~~L~L~~n~i~~~~~~~l~~~~~~~~~L~~L~ls~n~l~~~~~~~l~~~~~~~~~~L~~L~l~ 258 (319)
T cd00116 179 DAGIRALAEGLKANCNLEVLDLNNNGLTDEGASALAETLASLKSLEVLNLGDNNLTDAGAAALASALLSPNISLLTLSLS 258 (319)
T ss_pred hHHHHHHHHHHHhCCCCCEEeccCCccChHHHHHHHHHhcccCCCCEEecCCCcCchHHHHHHHHHHhccCCCceEEEcc
Confidence 21 222334445566666666655422 223344555566666666655531111111 12455666666
Q ss_pred ccccCC--C---CCCCCCCCCCCccccCCCC
Q 002673 466 HNNLQG--A---VPSGGQFDTFPSFSFEGNP 491 (894)
Q Consensus 466 ~N~l~~--~---~~~~~~l~~L~~l~l~~Np 491 (894)
+|.++. . ......+++|+.+++++|.
T Consensus 259 ~n~i~~~~~~~l~~~~~~~~~L~~l~l~~N~ 289 (319)
T cd00116 259 CNDITDDGAKDLAEVLAEKESLLELDLRGNK 289 (319)
T ss_pred CCCCCcHHHHHHHHHHhcCCCccEEECCCCC
Confidence 665541 1 1111233455555555554
|
LRRs are 20-29 residue sequence motifs present in many proteins that participate in protein-protein interactions and have different functions and cellular locations. LRRs correspond to structural units consisting of a beta strand (LxxLxLxxN/CxL conserved pattern) and an alpha helix. This alignment contains 12 strands corresponding to 11 full repeats, consistent with the extent observed in the subfamily acting as Ran GTPase Activating Proteins (RanGAP1). |
| >COG4886 Leucine-rich repeat (LRR) protein [Function unknown] | Back alignment and domain information |
|---|
Probab=98.75 E-value=4.2e-09 Score=120.57 Aligned_cols=147 Identities=30% Similarity=0.384 Sum_probs=114.9
Q ss_pred CCcccccccccccccccccccCccccchhcccccccccccCccccccCCCCCcccccCCCCCC---------CeEEccCC
Q 002673 325 EGPSLFSQANLLSGEFPKELTALPALVSEAANDEVDRSYLELPVFVMPSNATNQQYNQLSNLP---------PAIYLANN 395 (894)
Q Consensus 325 ~L~~L~L~~N~l~~~~p~~~~~L~~L~~L~L~~n~~~~~~~~~~~~~~~~~~~l~~n~L~~Lp---------~~L~L~~N 395 (894)
+++.|++++|.+.. +|..+.++++|+.|++++|.+..+............+.++.|+++.+| ++|++++|
T Consensus 141 nL~~L~l~~N~i~~-l~~~~~~l~~L~~L~l~~N~l~~l~~~~~~~~~L~~L~ls~N~i~~l~~~~~~~~~L~~l~~~~N 219 (394)
T COG4886 141 NLKELDLSDNKIES-LPSPLRNLPNLKNLDLSFNDLSDLPKLLSNLSNLNNLDLSGNKISDLPPEIELLSALEELDLSNN 219 (394)
T ss_pred hcccccccccchhh-hhhhhhccccccccccCCchhhhhhhhhhhhhhhhheeccCCccccCchhhhhhhhhhhhhhcCC
Confidence 56777777777765 556677777777777777777666665333333455566666666666 34689999
Q ss_pred cCCcCCchhhcCCCCCcEEeccCCcCCCCCCccccCCCCCCEEecCCCcccCcCCCcccCCCccccccccccccCCCCCC
Q 002673 396 SLSGNIPVEIGQLKSLHVLDLSNNNFSGTIPDELSDLSNLEKLDLSGNHLVGEIPISLKGLHFLSSFSVAHNNLQGAVPS 475 (894)
Q Consensus 396 ~l~~~~p~~~~~L~~L~~L~L~~N~l~~~~p~~~~~L~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~ 475 (894)
++. ..+..+.++.+|..|.+.+|++. .++..++.+++|++|++++|+++ .++. +..+.+|+.|++++|.+...++.
T Consensus 220 ~~~-~~~~~~~~~~~l~~l~l~~n~~~-~~~~~~~~l~~l~~L~~s~n~i~-~i~~-~~~~~~l~~L~~s~n~~~~~~~~ 295 (394)
T COG4886 220 SII-ELLSSLSNLKNLSGLELSNNKLE-DLPESIGNLSNLETLDLSNNQIS-SISS-LGSLTNLRELDLSGNSLSNALPL 295 (394)
T ss_pred cce-ecchhhhhcccccccccCCceee-eccchhccccccceecccccccc-cccc-ccccCccCEEeccCccccccchh
Confidence 655 57778999999999999999998 66889999999999999999999 6665 99999999999999999987775
Q ss_pred C
Q 002673 476 G 476 (894)
Q Consensus 476 ~ 476 (894)
.
T Consensus 296 ~ 296 (394)
T COG4886 296 I 296 (394)
T ss_pred h
Confidence 4
|
|
| >KOG1259 consensus Nischarin, modulator of integrin alpha5 subunit action [Signal transduction mechanisms; Cytoskeleton] | Back alignment and domain information |
|---|
Probab=98.70 E-value=3.1e-09 Score=110.01 Aligned_cols=100 Identities=24% Similarity=0.311 Sum_probs=87.0
Q ss_pred CeEEccCCcCCcCCchhhcCCCCCcEEeccCCcCCCCCCccccCCCCCCEEecCCCcccCcCCCcccCCCcccccccccc
Q 002673 388 PAIYLANNSLSGNIPVEIGQLKSLHVLDLSNNNFSGTIPDELSDLSNLEKLDLSGNHLVGEIPISLKGLHFLSSFSVAHN 467 (894)
Q Consensus 388 ~~L~L~~N~l~~~~p~~~~~L~~L~~L~L~~N~l~~~~p~~~~~L~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N 467 (894)
++++|++|.|+ .+.+++.-+++++.|+||+|.|. .+- .+..|++|+.||||+|.|+ .+...-.+|-+.++|.|+.|
T Consensus 287 telDLS~N~I~-~iDESvKL~Pkir~L~lS~N~i~-~v~-nLa~L~~L~~LDLS~N~Ls-~~~Gwh~KLGNIKtL~La~N 362 (490)
T KOG1259|consen 287 TELDLSGNLIT-QIDESVKLAPKLRRLILSQNRIR-TVQ-NLAELPQLQLLDLSGNLLA-ECVGWHLKLGNIKTLKLAQN 362 (490)
T ss_pred hhccccccchh-hhhhhhhhccceeEEecccccee-eeh-hhhhcccceEeecccchhH-hhhhhHhhhcCEeeeehhhh
Confidence 45899999999 88889999999999999999998 554 3999999999999999999 66666678889999999999
Q ss_pred ccCCCCCCCCCCCCCCccccCCCCC
Q 002673 468 NLQGAVPSGGQFDTFPSFSFEGNPE 492 (894)
Q Consensus 468 ~l~~~~~~~~~l~~L~~l~l~~Np~ 492 (894)
.|+ ....++.+-+|..|++.+|..
T Consensus 363 ~iE-~LSGL~KLYSLvnLDl~~N~I 386 (490)
T KOG1259|consen 363 KIE-TLSGLRKLYSLVNLDLSSNQI 386 (490)
T ss_pred hHh-hhhhhHhhhhheeccccccch
Confidence 998 455668888899999999953
|
|
| >PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.65 E-value=2e-07 Score=94.53 Aligned_cols=126 Identities=21% Similarity=0.211 Sum_probs=81.3
Q ss_pred EEEEEEEcCCCeEEEEEEcCcc--------------------------hhhHHHHHHHHHHHHhcCCC--ceeeecceee
Q 002673 622 LVYKATLANGTTLAIKKLSGDL--------------------------GLMEREFKAEVEALSTAQHK--NLVSLQGYCV 673 (894)
Q Consensus 622 ~Vy~a~~~~g~~vAvK~~~~~~--------------------------~~~~~~~~~Ei~~l~~l~Hp--nIv~l~g~~~ 673 (894)
.||.|...+|..+|+|..+... ........+|.+.|.++..- ++.+++++-
T Consensus 1 ~Vy~~~~~~~~~~a~K~~r~~~~~Fk~~~~y~~~~~r~~~~~~~~~~~~~~~~~~~~E~~~L~~l~~~Gv~vP~p~~~~- 79 (188)
T PF01163_consen 1 DVYHAIDPDGEEVAVKIYRTGRTSFKRRKKYRDYDYRFKKYRHKSSWRYLIREWAKKEFRNLKRLYEAGVPVPKPYDYN- 79 (188)
T ss_dssp EEEEEEECTTEEEEEEEE-S---SS-HHHHHTTTSTTSTTC--G--CHHHHHHHHHHHHHHHHHCCCTT-SS--EEEEE-
T ss_pred CEEEEECCCCCEEEEEEeccCceEEEEeeeeecccchhcccccccCHHHHHHHHHHHHHHHHHHHHHCCccCCcEEEEe-
Confidence 4899998899999999875311 01123467899999999866 445555432
Q ss_pred ecceEEEEEEecc--CCCHHHHHhhhcCCCCCcCHHHHHHHHHHHHHHHHHHHhccCCCeeecCCCCCCeEECCCCcEEE
Q 002673 674 HQGFRLLIYSYME--NGSLDYWLHEKADGASQLDWLTRLKIARGTSCGLAYMHQICEPHIVHRDIKSSNILLDDQFEAHL 751 (894)
Q Consensus 674 ~~~~~~lV~E~~~--~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDLkp~NILld~~~~vkl 751 (894)
...+||||++ |..+..+.... ++......++.++...+..+++ ..+++|+|+.+.||+++++ .+.|
T Consensus 80 ---~~~ivME~I~~~G~~~~~l~~~~------~~~~~~~~~~~~il~~~~~~~~--~~givHGDLs~~NIlv~~~-~~~i 147 (188)
T PF01163_consen 80 ---RNVIVMEYIGEDGVPLPRLKDVD------LSPEEPKELLEEILEEIIKMLH--KAGIVHGDLSEYNILVDDG-KVYI 147 (188)
T ss_dssp ---TTEEEEE--EETTEEGGCHHHCG------GGGSTHHHHHHHHHHHHHHHHH--CTTEEESS-STTSEEEETT-CEEE
T ss_pred ---CCEEEEEecCCCccchhhHHhcc------ccchhHHHHHHHHHHHHHHHHH--hcCceecCCChhhEEeecc-eEEE
Confidence 3479999998 54444333321 1122345677778886666532 3699999999999999988 9999
Q ss_pred EEccccccc
Q 002673 752 ADFGLSRLI 760 (894)
Q Consensus 752 ~DFGla~~~ 760 (894)
+|||.+...
T Consensus 148 IDf~qav~~ 156 (188)
T PF01163_consen 148 IDFGQAVDS 156 (188)
T ss_dssp --GTTEEET
T ss_pred EecCcceec
Confidence 999988754
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A. |
| >PF13855 LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RFS_A 3G39_A 3VQ2_A 3VQ1_B 2Z64_A 2Z66_C 3FXI_A 2Z63_A | Back alignment and domain information |
|---|
Probab=98.64 E-value=1.5e-08 Score=83.14 Aligned_cols=58 Identities=45% Similarity=0.626 Sum_probs=53.9
Q ss_pred CeEEccCCcCCcCCchhhcCCCCCcEEeccCCcCCCCCCccccCCCCCCEEecCCCcc
Q 002673 388 PAIYLANNSLSGNIPVEIGQLKSLHVLDLSNNNFSGTIPDELSDLSNLEKLDLSGNHL 445 (894)
Q Consensus 388 ~~L~L~~N~l~~~~p~~~~~L~~L~~L~L~~N~l~~~~p~~~~~L~~L~~L~Ls~N~l 445 (894)
+.|+|++|+|+.+.+..|.++++|++|+|++|.|+...|..|.+|++|++|+|++|+|
T Consensus 4 ~~L~l~~n~l~~i~~~~f~~l~~L~~L~l~~N~l~~i~~~~f~~l~~L~~L~l~~N~l 61 (61)
T PF13855_consen 4 ESLDLSNNKLTEIPPDSFSNLPNLETLDLSNNNLTSIPPDAFSNLPNLRYLDLSNNNL 61 (61)
T ss_dssp SEEEETSSTESEECTTTTTTGTTESEEEETSSSESEEETTTTTTSTTESEEEETSSSB
T ss_pred cEEECCCCCCCccCHHHHcCCCCCCEeEccCCccCccCHHHHcCCCCCCEEeCcCCcC
Confidence 6789999999976668899999999999999999988888999999999999999986
|
... |
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=98.61 E-value=8.6e-09 Score=122.84 Aligned_cols=248 Identities=21% Similarity=0.186 Sum_probs=158.8
Q ss_pred ccCCCccceEeecCcEEEEEEE-EcCCCeEEEEEEcCcch---hhHHHHHHHHHHHHhcCCCceeeecceeeecceEEEE
Q 002673 606 TDNFSQANIIGCGGFGLVYKAT-LANGTTLAIKKLSGDLG---LMEREFKAEVEALSTAQHKNLVSLQGYCVHQGFRLLI 681 (894)
Q Consensus 606 ~~~f~~~~~LG~G~fg~Vy~a~-~~~g~~vAvK~~~~~~~---~~~~~~~~Ei~~l~~l~HpnIv~l~g~~~~~~~~~lV 681 (894)
.+.+.+.+-+-+|.++.++.+. -..|...++|....... ...+....+-.++-..+||-++.....+.-....+||
T Consensus 803 ~d~~~i~~p~qS~sp~ss~p~~pa~sgh~~~~~v~~~ap~i~~~~~~s~r~~s~~~i~p~~P~v~~~~~s~~~rsP~~L~ 882 (1205)
T KOG0606|consen 803 PDGFEITKPSQSGSPSSSFPASPAGSGHTRPSKVHGLAPKIRTNDYESIRSKSNILITPRSPAVVRSFPSFPCRSPLPLV 882 (1205)
T ss_pred CccceecccccCCCCcccccCCccccccccchhhhccchhhccccccccCCccCccccCCCCceecccCCCCCCCCcchh
Confidence 4566667778889999998876 23344444443322110 0111222333333334567777665555556778999
Q ss_pred EEeccCCCHHHHHhhhcCCCCCcCHHHHHHHHHHHHHHHHHHHhccCCCeeecCCCCCCeEECCCCcEEEEEcccccccC
Q 002673 682 YSYMENGSLDYWLHEKADGASQLDWLTRLKIARGTSCGLAYMHQICEPHIVHRDIKSSNILLDDQFEAHLADFGLSRLIL 761 (894)
Q Consensus 682 ~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDLkp~NILld~~~~vkl~DFGla~~~~ 761 (894)
++|..+++|...++... ..+..-....+..+..+++|||. ..+.|+|++|.|++...++..+++|||......
T Consensus 883 ~~~~~~~~~~Skl~~~~----~~saepaRs~i~~~vqs~e~L~s---~~r~h~~~~p~~~l~~~~gh~~l~~~~t~~~vg 955 (1205)
T KOG0606|consen 883 GHYLNGGDLPSKLHNSG----CLSAEPARSPILERVQSLESLHS---SLRKHRDLKPDSLLIAYDGHRPLTDFGTLSKVG 955 (1205)
T ss_pred hHHhccCCchhhhhcCC----CcccccccchhHHHHhhhhcccc---chhhcccccccchhhcccCCcccCccccccccc
Confidence 99999999999998643 22323334455567788999997 358999999999999999999999998433211
Q ss_pred C------C----C--------------------CcccccccccCCccCcccccCcCCCccccHHHHHHHHHHHHcCCCCC
Q 002673 762 P------Y----Q--------------------THVTTELVGTLGYIPPEYGQAWVATLRGDMYSFGVVMLELLTGKRPV 811 (894)
Q Consensus 762 ~------~----~--------------------~~~~~~~~gt~~Y~APE~~~~~~~s~ksDVwS~GvlL~elltG~~Pf 811 (894)
- . . ........||+.|.+||...+.......|+|++|++++|.++|..||
T Consensus 956 ~~~p~~~~sg~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~lg~~hgs~ad~~~~g~~l~e~l~g~pp~ 1035 (1205)
T KOG0606|consen 956 LIPPTTDLSGPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILLGRRHGSAADWWSSGVCLFEVLTGIPPF 1035 (1205)
T ss_pred cccCcCCcccccccCccccccccccccccccchhhccccccCCCcccCCcccccccCCCcchhhhhhhhhhhhhcCCCCC
Confidence 0 0 0 00112346899999999999999999999999999999999999999
Q ss_pred CCCCcchhhhHHHHHHHHhhcCCCCccccccccCCCChHHHHHHHHHHHHhcccCCCCCCCHH
Q 002673 812 DVLKPKMSRELVGWVLKMRSEGKQDQVFDPILRGKGFDEEMLQVLDVACMCVSQNPFKRPTVK 874 (894)
Q Consensus 812 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~ 874 (894)
....+...- +- +....-+.. ...........+++...+..+|.+|-.+.
T Consensus 1036 na~tpq~~f---~n---------i~~~~~~~p--~g~~~~s~~aq~~~~~ll~~~~~qr~~a~ 1084 (1205)
T KOG0606|consen 1036 NAETPQQIF---EN---------ILNRDIPWP--EGPEEGSYEAQDLINRLLTEEPTQRLGAK 1084 (1205)
T ss_pred CCcchhhhh---hc---------cccCCCCCC--CCccccChhhhhhhhhhhccCchhccCcc
Confidence 755432211 00 000000000 11111122334566677788888888776
|
|
| >PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional | Back alignment and domain information |
|---|
Probab=98.58 E-value=9.3e-07 Score=94.97 Aligned_cols=141 Identities=14% Similarity=0.069 Sum_probs=99.5
Q ss_pred ceEeecCcEEEEEEEEcCCCeEEEEEEcCcchh-----------hHHHHHHHHHHHHhcCCCcee--eecceeee-----
Q 002673 613 NIIGCGGFGLVYKATLANGTTLAIKKLSGDLGL-----------MEREFKAEVEALSTAQHKNLV--SLQGYCVH----- 674 (894)
Q Consensus 613 ~~LG~G~fg~Vy~a~~~~g~~vAvK~~~~~~~~-----------~~~~~~~Ei~~l~~l~HpnIv--~l~g~~~~----- 674 (894)
+.+-......|++..+ +|+.+.||+....... ....+.+|...+.++...+|. .++++...
T Consensus 28 e~v~~~~~rrvvr~~~-~g~~~~vKr~~~~~~~~~~k~l~~~~~p~~~a~rE~~~l~~L~~~GIptP~pVa~~e~~~~~~ 106 (268)
T PRK15123 28 EVFRELEGRRTLRFEL-AGKSYFLKWHRGTGWGEIFKNLLSLRMPVLGADREWRAIHRLHEVGVDTMTGVAFGERGSNPA 106 (268)
T ss_pred cEEecCCCceEEEEEE-CCEEEEEEEecCCcHHHHhhhhcccccccHHHHHHHHHHHHHHHcCCCCCCeeEEEEecCCCc
Confidence 4444444455777766 5778999987543211 011377899999888544333 34555433
Q ss_pred cceEEEEEEeccCC-CHHHHHhhhcCCCCCcCHHHHHHHHHHHHHHHHHHHhccCCCeeecCCCCCCeEECC-------C
Q 002673 675 QGFRLLIYSYMENG-SLDYWLHEKADGASQLDWLTRLKIARGTSCGLAYMHQICEPHIVHRDIKSSNILLDD-------Q 746 (894)
Q Consensus 675 ~~~~~lV~E~~~~g-sL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDLkp~NILld~-------~ 746 (894)
....++|||++++- +|.+++..... ...+...+..++.+++..+.-||. .||+|+|++++|||++. +
T Consensus 107 ~~~s~LVte~l~~~~sL~~~~~~~~~--~~~~~~~~~~ll~~la~~i~~LH~---~Gi~HgDL~~~NiLl~~~~~~~~~~ 181 (268)
T PRK15123 107 TRTSFIITEDLAPTISLEDYCADWAT--NPPDPRLKRMLIKRVATMVRDMHA---AGINHRDCYICHFLLHLPFPGREED 181 (268)
T ss_pred cceeEEEEeeCCCCccHHHHHHhhcc--cCCCHHHHHHHHHHHHHHHHHHHH---CcCccCCCChhhEEEeccccCCCCC
Confidence 23578999999876 89888864211 234455677899999999999997 59999999999999975 5
Q ss_pred CcEEEEEcccccc
Q 002673 747 FEAHLADFGLSRL 759 (894)
Q Consensus 747 ~~vkl~DFGla~~ 759 (894)
..+.++||+.+..
T Consensus 182 ~~~~LIDl~r~~~ 194 (268)
T PRK15123 182 LKLSVIDLHRAQI 194 (268)
T ss_pred ceEEEEECCcccc
Confidence 6899999998753
|
|
| >COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.58 E-value=1.4e-06 Score=94.86 Aligned_cols=263 Identities=16% Similarity=0.202 Sum_probs=155.9
Q ss_pred ccceEeecCcEEEEEEEEcCCCeEEEEEEcCcchhhHHHHHHHHHHHHhc-CCCceeeecce----e--eecc-eEEEEE
Q 002673 611 QANIIGCGGFGLVYKATLANGTTLAIKKLSGDLGLMEREFKAEVEALSTA-QHKNLVSLQGY----C--VHQG-FRLLIY 682 (894)
Q Consensus 611 ~~~~LG~G~fg~Vy~a~~~~g~~vAvK~~~~~~~~~~~~~~~Ei~~l~~l-~HpnIv~l~g~----~--~~~~-~~~lV~ 682 (894)
.+..||+|+-+.+|-.--- .-.+.|++......... +.+..|... .||-+-.=+.+ . -++. ...++|
T Consensus 15 ~gr~LgqGgea~ly~l~e~--~d~VAKIYh~Pppa~~a---qk~a~la~~p~~p~~~~rvaWPqa~L~G~~~~~~iGflm 89 (637)
T COG4248 15 PGRPLGQGGEADLYTLGEV--RDQVAKIYHAPPPAAQA---QKVAELAATPDAPLLNYRVAWPQATLHGGRRGKVIGFLM 89 (637)
T ss_pred CCccccCCccceeeecchh--hchhheeecCCCchHHH---HHHHHhccCCCCcchhhhhcccHHHhhCCCccceeEEec
Confidence 4577999999999965311 11345777654332222 223333333 45533321111 1 1122 256778
Q ss_pred EeccCCC-HHHHHh--hhcCCCCCcCHHHHHHHHHHHHHHHHHHHhccCCCeeecCCCCCCeEECCCCcEEEEEcccccc
Q 002673 683 SYMENGS-LDYWLH--EKADGASQLDWLTRLKIARGTSCGLAYMHQICEPHIVHRDIKSSNILLDDQFEAHLADFGLSRL 759 (894)
Q Consensus 683 E~~~~gs-L~~~l~--~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDLkp~NILld~~~~vkl~DFGla~~ 759 (894)
..+.+.- ...++. ...++.....|...+++++.++.+.+.||.+ |.+-+|++++|+|+++++.|.|.|-..-..
T Consensus 90 P~v~g~~pI~~~y~p~tRRqs~P~~~w~fllrvaRnlA~aFA~lH~~---Gh~vGDVn~~~~lVsd~~~V~LVdsDsfqi 166 (637)
T COG4248 90 PKVSGKEPIHMIYSPATRRQSYPHCAWDFLLRVARNLASAFATLHEH---GHVVGDVNQNSFLVSDDSKVVLVDSDSFQI 166 (637)
T ss_pred ccCCCccchhhhcCchhhcccCCccccHHHHHHHHHHHHHHHHHHhc---CCcccccCccceeeecCceEEEEcccceee
Confidence 7776542 222222 1234556789999999999999999999974 999999999999999999999998654333
Q ss_pred cCCCCCcccccccccCCccCccccc-----CcCCCccccHHHHHHHHHHHHcC-CCCCCCCCcch-----hh-hHHHHHH
Q 002673 760 ILPYQTHVTTELVGTLGYIPPEYGQ-----AWVATLRGDMYSFGVVMLELLTG-KRPVDVLKPKM-----SR-ELVGWVL 827 (894)
Q Consensus 760 ~~~~~~~~~~~~~gt~~Y~APE~~~-----~~~~s~ksDVwS~GvlL~elltG-~~Pf~~~~~~~-----~~-~~~~~~~ 827 (894)
. .........+|...|++||... +..-+...|-|.+||++++++.| ++||.+..... .. ++..-..
T Consensus 167 ~--~ng~~~~cpVg~~eftPPElQ~~~sf~g~~r~~~hD~FGLavLiF~lL~ggrHPysGI~~~~~ap~p~E~~Ia~g~f 244 (637)
T COG4248 167 N--ANGTLHLCPVGVSEFTPPELQTLPSFVGFERTANHDNFGLAVLIFHLLFGGRHPYSGIPLISDAPNPLETDIAHGRF 244 (637)
T ss_pred c--cCCceEecccCccccCCHHHhccccccccCCCccccchhHHHHHHHHHhcCCCCCCcccccCCCCCcchhhhhccee
Confidence 2 2223344567899999999644 34456778999999999999886 99997543210 00 1110000
Q ss_pred HHhhcCCCCccccccccCCCChHHHHHHHHHHHHhccc--CCCCCCCHHHHHHHHHhccc
Q 002673 828 KMRSEGKQDQVFDPILRGKGFDEEMLQVLDVACMCVSQ--NPFKRPTVKEVVEWLNNVGA 885 (894)
Q Consensus 828 ~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~--dP~~RPs~~evl~~L~~i~~ 885 (894)
..-...... ..+.....-++.....+..+..+|+.. ++.-|||++..+..|..++.
T Consensus 245 ~ya~~~~~g--~~p~P~~~P~~~Lpp~vqAlF~qaF~~~~~~~~RP~a~aW~aAl~al~~ 302 (637)
T COG4248 245 AYASDQRRG--LKPPPRSIPLSMLPPDVQALFQQAFTESGVATPRPTAKAWVAALDALRQ 302 (637)
T ss_pred eechhccCC--CCCCCCCCChhhcCHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHHHH
Confidence 000000000 001011111111122344555678764 46789999999987766544
|
|
| >KOG1859 consensus Leucine-rich repeat proteins [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.55 E-value=3.8e-09 Score=120.61 Aligned_cols=148 Identities=24% Similarity=0.347 Sum_probs=106.4
Q ss_pred CCCChhhHHHHHhhccCCCC------CCcccccccccccccccccccCccccchhcccccccccccCccccccCCCCCcc
Q 002673 305 SRPNADDLEIIFGEVEGKSD------EGPSLFSQANLLSGEFPKELTALPALVSEAANDEVDRSYLELPVFVMPSNATNQ 378 (894)
Q Consensus 305 ~~p~le~l~~~~n~~~~~l~------~L~~L~L~~N~l~~~~p~~~~~L~~L~~L~L~~n~~~~~~~~~~~~~~~~~~~l 378 (894)
.-.+++.|+.++..-.+... +|...+.+.|++.. ...++.-|+.|
T Consensus 139 C~~Sl~Al~~v~ascggd~~ns~~Wn~L~~a~fsyN~L~~-mD~SLqll~al---------------------------- 189 (1096)
T KOG1859|consen 139 CHNSLDALRHVFASCGGDISNSPVWNKLATASFSYNRLVL-MDESLQLLPAL---------------------------- 189 (1096)
T ss_pred hhccHHHHHHHHHHhccccccchhhhhHhhhhcchhhHHh-HHHHHHHHHHh----------------------------
Confidence 34566777777766444433 45556666777654 55666666666
Q ss_pred cccCCCCCCCeEEccCCcCCcCCchhhcCCCCCcEEeccCCcCCCCCCc-cccCCCCCCEEecCCCcccCcCCCcccCCC
Q 002673 379 QYNQLSNLPPAIYLANNSLSGNIPVEIGQLKSLHVLDLSNNNFSGTIPD-ELSDLSNLEKLDLSGNHLVGEIPISLKGLH 457 (894)
Q Consensus 379 ~~n~L~~Lp~~L~L~~N~l~~~~p~~~~~L~~L~~L~L~~N~l~~~~p~-~~~~L~~L~~L~Ls~N~l~~~~p~~~~~l~ 457 (894)
+.|+|++|+++. .. .+-.|++|+.|||++|+|+ .+|. ...++. |+.|.|+||-++ .+- .+.+|+
T Consensus 190 ---------e~LnLshNk~~~-v~-~Lr~l~~LkhLDlsyN~L~-~vp~l~~~gc~-L~~L~lrnN~l~-tL~-gie~Lk 254 (1096)
T KOG1859|consen 190 ---------ESLNLSHNKFTK-VD-NLRRLPKLKHLDLSYNCLR-HVPQLSMVGCK-LQLLNLRNNALT-TLR-GIENLK 254 (1096)
T ss_pred ---------hhhccchhhhhh-hH-HHHhcccccccccccchhc-cccccchhhhh-heeeeecccHHH-hhh-hHHhhh
Confidence 556788888883 33 7888999999999999998 5653 344454 999999999998 443 678899
Q ss_pred ccccccccccccCCCCC--CCCCCCCCCccccCCCCCCCCC
Q 002673 458 FLSSFSVAHNNLQGAVP--SGGQFDTFPSFSFEGNPELCGS 496 (894)
Q Consensus 458 ~L~~L~Ls~N~l~~~~~--~~~~l~~L~~l~l~~Np~~c~~ 496 (894)
+|..|||++|-|.+.-. .+..|..|..|+|.|||.-|..
T Consensus 255 sL~~LDlsyNll~~hseL~pLwsLs~L~~L~LeGNPl~c~p 295 (1096)
T KOG1859|consen 255 SLYGLDLSYNLLSEHSELEPLWSLSSLIVLWLEGNPLCCAP 295 (1096)
T ss_pred hhhccchhHhhhhcchhhhHHHHHHHHHHHhhcCCccccCH
Confidence 99999999998875432 2366778889999999988864
|
|
| >KOG4579 consensus Leucine-rich repeat (LRR) protein associated with apoptosis in muscle tissue [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.54 E-value=4.3e-09 Score=97.58 Aligned_cols=135 Identities=19% Similarity=0.120 Sum_probs=104.2
Q ss_pred CCcccccccccccccccccccCccccchhcccccccccccCccccccCCCCCcccccCCCCCCCeEEccCCcCCcCCchh
Q 002673 325 EGPSLFSQANLLSGEFPKELTALPALVSEAANDEVDRSYLELPVFVMPSNATNQQYNQLSNLPPAIYLANNSLSGNIPVE 404 (894)
Q Consensus 325 ~L~~L~L~~N~l~~~~p~~~~~L~~L~~L~L~~n~~~~~~~~~~~~~~~~~~~l~~n~L~~Lp~~L~L~~N~l~~~~p~~ 404 (894)
.+..|+|+++.|.. +++....+....+| ..++|++|.+. ..|+.
T Consensus 28 E~h~ldLssc~lm~-i~davy~l~~~~el----------------------------------~~i~ls~N~fk-~fp~k 71 (177)
T KOG4579|consen 28 ELHFLDLSSCQLMY-IADAVYMLSKGYEL----------------------------------TKISLSDNGFK-KFPKK 71 (177)
T ss_pred HhhhcccccchhhH-HHHHHHHHhCCceE----------------------------------EEEecccchhh-hCCHH
Confidence 55677788888765 66776666655332 45789999999 67777
Q ss_pred hcCC-CCCcEEeccCCcCCCCCCccccCCCCCCEEecCCCcccCcCCCcccCCCccccccccccccCCCCCCCCCCCCCC
Q 002673 405 IGQL-KSLHVLDLSNNNFSGTIPDELSDLSNLEKLDLSGNHLVGEIPISLKGLHFLSSFSVAHNNLQGAVPSGGQFDTFP 483 (894)
Q Consensus 405 ~~~L-~~L~~L~L~~N~l~~~~p~~~~~L~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~l~~L~ 483 (894)
|... +.++.|+|++|+|+ .+|.+|..++.|+.|+++.|.|. ..|..+..|.+|-.|+..+|.+..++-.+..-....
T Consensus 72 ft~kf~t~t~lNl~~neis-dvPeE~Aam~aLr~lNl~~N~l~-~~p~vi~~L~~l~~Lds~~na~~eid~dl~~s~~~a 149 (177)
T KOG4579|consen 72 FTIKFPTATTLNLANNEIS-DVPEELAAMPALRSLNLRFNPLN-AEPRVIAPLIKLDMLDSPENARAEIDVDLFYSSLPA 149 (177)
T ss_pred Hhhccchhhhhhcchhhhh-hchHHHhhhHHhhhcccccCccc-cchHHHHHHHhHHHhcCCCCccccCcHHHhccccHH
Confidence 7654 58999999999999 89999999999999999999999 888889899999999999999885544432222233
Q ss_pred ccccCCCCCCCCCc
Q 002673 484 SFSFEGNPELCGSV 497 (894)
Q Consensus 484 ~l~l~~Np~~c~~~ 497 (894)
...+.+|||--+|.
T Consensus 150 l~~lgnepl~~~~~ 163 (177)
T KOG4579|consen 150 LIKLGNEPLGDETK 163 (177)
T ss_pred HHHhcCCcccccCc
Confidence 34567788876664
|
|
| >KOG0531 consensus Protein phosphatase 1, regulatory subunit, and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.53 E-value=1.5e-08 Score=116.70 Aligned_cols=152 Identities=27% Similarity=0.276 Sum_probs=108.0
Q ss_pred cCCCCCCcccccccccccccccccccCccccchhcccccccccccCccccccCCCCCcccccCCCCCCCeEEccCCcCCc
Q 002673 320 EGKSDEGPSLFSQANLLSGEFPKELTALPALVSEAANDEVDRSYLELPVFVMPSNATNQQYNQLSNLPPAIYLANNSLSG 399 (894)
Q Consensus 320 ~~~l~~L~~L~L~~N~l~~~~p~~~~~L~~L~~L~L~~n~~~~~~~~~~~~~~~~~~~l~~n~L~~Lp~~L~L~~N~l~~ 399 (894)
...+.++..|++..|+|.. +...+..+++|+.|+|++|.|+.+..+ +.+..| +.|++++|.|+
T Consensus 91 l~~~~~l~~l~l~~n~i~~-i~~~l~~~~~L~~L~ls~N~I~~i~~l--------------~~l~~L-~~L~l~~N~i~- 153 (414)
T KOG0531|consen 91 LSKLKSLEALDLYDNKIEK-IENLLSSLVNLQVLDLSFNKITKLEGL--------------STLTLL-KELNLSGNLIS- 153 (414)
T ss_pred cccccceeeeeccccchhh-cccchhhhhcchheeccccccccccch--------------hhccch-hhheeccCcch-
Confidence 3445678888888888887 333478888888888888888877666 333445 67888888888
Q ss_pred CCchhhcCCCCCcEEeccCCcCCCCCCcc-ccCCCCCCEEecCCCcccCcCCCcccCCCccccccccccccCCCCCCCCC
Q 002673 400 NIPVEIGQLKSLHVLDLSNNNFSGTIPDE-LSDLSNLEKLDLSGNHLVGEIPISLKGLHFLSSFSVAHNNLQGAVPSGGQ 478 (894)
Q Consensus 400 ~~p~~~~~L~~L~~L~L~~N~l~~~~p~~-~~~L~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~ 478 (894)
.+. .+..|.+|+.|+|++|+++ .+... ...+.+|+.|++.+|.+. . ...+..+..+..+++..|.++. +..+..
T Consensus 154 ~~~-~~~~l~~L~~l~l~~n~i~-~ie~~~~~~~~~l~~l~l~~n~i~-~-i~~~~~~~~l~~~~l~~n~i~~-~~~l~~ 228 (414)
T KOG0531|consen 154 DIS-GLESLKSLKLLDLSYNRIV-DIENDELSELISLEELDLGGNSIR-E-IEGLDLLKKLVLLSLLDNKISK-LEGLNE 228 (414)
T ss_pred hcc-CCccchhhhcccCCcchhh-hhhhhhhhhccchHHHhccCCchh-c-ccchHHHHHHHHhhccccccee-ccCccc
Confidence 444 5666888889999999988 44443 578888888888888887 3 3355666666777888888773 333333
Q ss_pred CCC--CCccccCCCCCC
Q 002673 479 FDT--FPSFSFEGNPEL 493 (894)
Q Consensus 479 l~~--L~~l~l~~Np~~ 493 (894)
+.. |+.+++.+|+..
T Consensus 229 ~~~~~L~~l~l~~n~i~ 245 (414)
T KOG0531|consen 229 LVMLHLRELYLSGNRIS 245 (414)
T ss_pred chhHHHHHHhcccCccc
Confidence 333 677788877643
|
|
| >KOG2137 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.43 E-value=5.9e-08 Score=111.97 Aligned_cols=150 Identities=18% Similarity=0.208 Sum_probs=102.6
Q ss_pred HHHHHHHHHHHhccCCCeeecCCCCCCeEECCCCcEEEEEcccccccCCCCCcc--------cccccccCCccCcccccC
Q 002673 714 RGTSCGLAYMHQICEPHIVHRDIKSSNILLDDQFEAHLADFGLSRLILPYQTHV--------TTELVGTLGYIPPEYGQA 785 (894)
Q Consensus 714 ~~ia~aL~yLH~~~~~~ivHrDLkp~NILld~~~~vkl~DFGla~~~~~~~~~~--------~~~~~gt~~Y~APE~~~~ 785 (894)
.+++.|+.|+|. ..++||++|.|++|.++.++..||+.|+.+....+..... .........|.|||++.+
T Consensus 106 ~~v~dgl~flh~--sAk~VH~ni~p~~i~~na~~~wkl~Gf~f~v~~~~~~~~p~~~yd~~lp~~~~~~~~f~apE~~~~ 183 (700)
T KOG2137|consen 106 GNVADGLAFLHR--SAKVVHGNIQPEAIVVNANGDWKLAGFSFCVNANGPTEYPFSEYDPPLPLLLQPHLNFLAPEYLLG 183 (700)
T ss_pred hcccchhhhhcc--CcceeecccchhheeeccCcceeeccchhhhccCCCCccccccCCCCCChhhccCcccccchhhcc
Confidence 345589999998 4899999999999999999999999999887543311111 111234568999999999
Q ss_pred cCCCccccHHHHHHHHHHHHc-CCCCCCCCCcchhhhHHHHHHHHhhcCCCCccccccccCCCChHHHHHHHHHHHHhcc
Q 002673 786 WVATLRGDMYSFGVVMLELLT-GKRPVDVLKPKMSRELVGWVLKMRSEGKQDQVFDPILRGKGFDEEMLQVLDVACMCVS 864 (894)
Q Consensus 786 ~~~s~ksDVwS~GvlL~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~ 864 (894)
...+.++|+||+|+++|.+.. |+.-+.............. ..+ -... .+..+...++.+=+.+++.
T Consensus 184 ~~~~~~sd~fSlG~li~~i~~~gk~i~~a~~~~~~~~~~~~-----~~~-------~~~~-~~s~~~p~el~~~l~k~l~ 250 (700)
T KOG2137|consen 184 TTNTPASDVFSLGVLIYTIYNGGKSIIAANGGLLSYSFSRN-----LLN-------AGAF-GYSNNLPSELRESLKKLLN 250 (700)
T ss_pred ccccccccceeeeeEEEEEecCCcchhhccCCcchhhhhhc-----ccc-------cccc-cccccCcHHHHHHHHHHhc
Confidence 888999999999999999994 5554443322211111100 000 0000 1112333466777788999
Q ss_pred cCCCCCCCHHHHHH
Q 002673 865 QNPFKRPTVKEVVE 878 (894)
Q Consensus 865 ~dP~~RPs~~evl~ 878 (894)
.++.-||++.++..
T Consensus 251 ~~~~~rp~~~~l~~ 264 (700)
T KOG2137|consen 251 GDSAVRPTLDLLLS 264 (700)
T ss_pred CCcccCcchhhhhc
Confidence 99999998888765
|
|
| >KOG3207 consensus Beta-tubulin folding cofactor E [Posttranslational modification, protein turnover, chaperones] | Back alignment and domain information |
|---|
Probab=98.37 E-value=8e-08 Score=104.80 Aligned_cols=176 Identities=20% Similarity=0.165 Sum_probs=108.0
Q ss_pred eecCCCChhhHHHHHhh---------ccCCCCCCccccccccccccccccc-ccCccccchhcccccccccccCcccccc
Q 002673 302 ELVSRPNADDLEIIFGE---------VEGKSDEGPSLFSQANLLSGEFPKE-LTALPALVSEAANDEVDRSYLELPVFVM 371 (894)
Q Consensus 302 ~~~~~p~le~l~~~~n~---------~~~~l~~L~~L~L~~N~l~~~~p~~-~~~L~~L~~L~L~~n~~~~~~~~~~~~~ 371 (894)
....+|...+|++..|- +..++++|+.|.|+.|++.....+. -..+++|+.|.|+.|-++. .+....
T Consensus 141 ~~k~~~~v~~LdLS~NL~~nw~~v~~i~eqLp~Le~LNls~Nrl~~~~~s~~~~~l~~lK~L~l~~CGls~-k~V~~~-- 217 (505)
T KOG3207|consen 141 YSKILPNVRDLDLSRNLFHNWFPVLKIAEQLPSLENLNLSSNRLSNFISSNTTLLLSHLKQLVLNSCGLSW-KDVQWI-- 217 (505)
T ss_pred hhhhCCcceeecchhhhHHhHHHHHHHHHhcccchhcccccccccCCccccchhhhhhhheEEeccCCCCH-HHHHHH--
Confidence 34456777777775544 3566788888888888776533222 2345667667777654441 111000
Q ss_pred CCCCCcccccCCCCCCCeEEccCCcCCcCCchhhcCCCCCcEEeccCCcCCCCCC--ccccCCCCCCEEecCCCcccCc-
Q 002673 372 PSNATNQQYNQLSNLPPAIYLANNSLSGNIPVEIGQLKSLHVLDLSNNNFSGTIP--DELSDLSNLEKLDLSGNHLVGE- 448 (894)
Q Consensus 372 ~~~~~~l~~n~L~~Lp~~L~L~~N~l~~~~p~~~~~L~~L~~L~L~~N~l~~~~p--~~~~~L~~L~~L~Ls~N~l~~~- 448 (894)
- -.+.+| +.|+|..|...+.-.....-+..|+.|||++|++- ..+ .-.+.|+.|+.|+++.+.|+..
T Consensus 218 -----~---~~fPsl-~~L~L~~N~~~~~~~~~~~i~~~L~~LdLs~N~li-~~~~~~~~~~l~~L~~Lnls~tgi~si~ 287 (505)
T KOG3207|consen 218 -----L---LTFPSL-EVLYLEANEIILIKATSTKILQTLQELDLSNNNLI-DFDQGYKVGTLPGLNQLNLSSTGIASIA 287 (505)
T ss_pred -----H---HhCCcH-HHhhhhcccccceecchhhhhhHHhhccccCCccc-ccccccccccccchhhhhccccCcchhc
Confidence 0 012222 56788888533344445566788899999998887 555 5678888888889888888733
Q ss_pred CCCc-----ccCCCccccccccccccCCCCCCC---CCCCCCCccccCCCC
Q 002673 449 IPIS-----LKGLHFLSSFSVAHNNLQGAVPSG---GQFDTFPSFSFEGNP 491 (894)
Q Consensus 449 ~p~~-----~~~l~~L~~L~Ls~N~l~~~~~~~---~~l~~L~~l~l~~Np 491 (894)
+|+. ...+++|++|+++.|++. ..+++ ..+.+|+.|.+..|+
T Consensus 288 ~~d~~s~~kt~~f~kL~~L~i~~N~I~-~w~sl~~l~~l~nlk~l~~~~n~ 337 (505)
T KOG3207|consen 288 EPDVESLDKTHTFPKLEYLNISENNIR-DWRSLNHLRTLENLKHLRITLNY 337 (505)
T ss_pred CCCccchhhhcccccceeeecccCccc-cccccchhhccchhhhhhccccc
Confidence 2443 356678899999999886 23333 334455555554543
|
|
| >COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.27 E-value=6.3e-06 Score=86.16 Aligned_cols=135 Identities=20% Similarity=0.133 Sum_probs=94.0
Q ss_pred CCccceEeecCcEEEEEEEEcCCCeEEEEEEcCcc----------------------hhhHHHHHHHHHHHHhcCCC--c
Q 002673 609 FSQANIIGCGGFGLVYKATLANGTTLAIKKLSGDL----------------------GLMEREFKAEVEALSTAQHK--N 664 (894)
Q Consensus 609 f~~~~~LG~G~fg~Vy~a~~~~g~~vAvK~~~~~~----------------------~~~~~~~~~Ei~~l~~l~Hp--n 664 (894)
..++..||-|.-+.||.|..++|.++|||.=+... .......++|.+.|.++... .
T Consensus 93 e~iG~~IGvGKEsdVY~~~~~~g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~~L~~L~~~G~~ 172 (304)
T COG0478 93 EAIGTKIGVGKESDVYVAIDPKGRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFEALQRLYPEGVK 172 (304)
T ss_pred HhhccccccCccceEEEEECCCCCEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHHHHHHhhhcCCC
Confidence 45678999999999999999999999999532110 11123467899999998655 6
Q ss_pred eeeecceeeecceEEEEEEeccCCCHHHHHhhhcCCCCCcCHHHHHHHHHHHHHHHHHHHhccCCCeeecCCCCCCeEEC
Q 002673 665 LVSLQGYCVHQGFRLLIYSYMENGSLDYWLHEKADGASQLDWLTRLKIARGTSCGLAYMHQICEPHIVHRDIKSSNILLD 744 (894)
Q Consensus 665 Iv~l~g~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDLkp~NILld 744 (894)
+...+++ +...+||||++|--|...- ++....-.++..|++-+.-+-. .||||+|+++-||+++
T Consensus 173 VP~P~~~----nRHaVvMe~ieG~eL~~~r---------~~~en~~~il~~il~~~~~~~~---~GiVHGDlSefNIlV~ 236 (304)
T COG0478 173 VPKPIAW----NRHAVVMEYIEGVELYRLR---------LDVENPDEILDKILEEVRKAYR---RGIVHGDLSEFNILVT 236 (304)
T ss_pred CCCcccc----ccceeeeehcccceeeccc---------CcccCHHHHHHHHHHHHHHHHH---cCccccCCchheEEEe
Confidence 6666553 3457999999886553322 1112223344444444433332 4999999999999999
Q ss_pred CCCcEEEEEcccccc
Q 002673 745 DQFEAHLADFGLSRL 759 (894)
Q Consensus 745 ~~~~vkl~DFGla~~ 759 (894)
++|.+.++||--+..
T Consensus 237 ~dg~~~vIDwPQ~v~ 251 (304)
T COG0478 237 EDGDIVVIDWPQAVP 251 (304)
T ss_pred cCCCEEEEeCccccc
Confidence 999999999976543
|
|
| >KOG0531 consensus Protein phosphatase 1, regulatory subunit, and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.27 E-value=1.4e-07 Score=108.69 Aligned_cols=126 Identities=28% Similarity=0.304 Sum_probs=61.5
Q ss_pred CCcccccccccccccccccccCccccchhcccccccccccCccccccCCCCCcccccCCCCCCCeEEccCCcCCcCCchh
Q 002673 325 EGPSLFSQANLLSGEFPKELTALPALVSEAANDEVDRSYLELPVFVMPSNATNQQYNQLSNLPPAIYLANNSLSGNIPVE 404 (894)
Q Consensus 325 ~L~~L~L~~N~l~~~~p~~~~~L~~L~~L~L~~n~~~~~~~~~~~~~~~~~~~l~~n~L~~Lp~~L~L~~N~l~~~~p~~ 404 (894)
.++.+.+..|.|.. +-..+..+++|+.|+|.+|.+..+... ...+.+| ..|+|++|+|+.+.+
T Consensus 73 ~l~~l~l~~n~i~~-~~~~l~~~~~l~~l~l~~n~i~~i~~~-------------l~~~~~L-~~L~ls~N~I~~i~~-- 135 (414)
T KOG0531|consen 73 SLKELNLRQNLIAK-ILNHLSKLKSLEALDLYDNKIEKIENL-------------LSSLVNL-QVLDLSFNKITKLEG-- 135 (414)
T ss_pred hHHhhccchhhhhh-hhcccccccceeeeeccccchhhcccc-------------hhhhhcc-hheeccccccccccc--
Confidence 44445556666554 223455556665555555555544441 1223333 445555555552222
Q ss_pred hcCCCCCcEEeccCCcCCCCCCccccCCCCCCEEecCCCcccCcCCCc-ccCCCccccccccccccC
Q 002673 405 IGQLKSLHVLDLSNNNFSGTIPDELSDLSNLEKLDLSGNHLVGEIPIS-LKGLHFLSSFSVAHNNLQ 470 (894)
Q Consensus 405 ~~~L~~L~~L~L~~N~l~~~~p~~~~~L~~L~~L~Ls~N~l~~~~p~~-~~~l~~L~~L~Ls~N~l~ 470 (894)
+..|+.|+.|++++|.|+ .++ .+..+++|+.|++++|+++ .++.. ...+.+|+.+++.+|.+.
T Consensus 136 l~~l~~L~~L~l~~N~i~-~~~-~~~~l~~L~~l~l~~n~i~-~ie~~~~~~~~~l~~l~l~~n~i~ 199 (414)
T KOG0531|consen 136 LSTLTLLKELNLSGNLIS-DIS-GLESLKSLKLLDLSYNRIV-DIENDELSELISLEELDLGGNSIR 199 (414)
T ss_pred hhhccchhhheeccCcch-hcc-CCccchhhhcccCCcchhh-hhhhhhhhhccchHHHhccCCchh
Confidence 444455555555555555 332 2444555555555555555 23221 344555555555555554
|
|
| >COG0661 AarF Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.22 E-value=5.6e-06 Score=96.22 Aligned_cols=142 Identities=20% Similarity=0.250 Sum_probs=93.0
Q ss_pred ceEeecCcEEEEEEEEcCCCeEEEEEEcCcchhh----------------------------------------HHHHHH
Q 002673 613 NIIGCGGFGLVYKATLANGTTLAIKKLSGDLGLM----------------------------------------EREFKA 652 (894)
Q Consensus 613 ~~LG~G~fg~Vy~a~~~~g~~vAvK~~~~~~~~~----------------------------------------~~~~~~ 652 (894)
+-|+.++-|.||+|++++|+.||||+.+.+.... +-++.+
T Consensus 131 ~PiAsASIaQVH~A~L~sG~~VAVKVqrPgi~~~i~~DL~il~~~a~~~~~~~~~~~~l~~~~vv~e~~~~l~~ElDy~~ 210 (517)
T COG0661 131 EPIASASIAQVHRAVLKSGEEVAVKVQRPGIRERIEADLKLLRRLARLIKRLPPGGRRLDLVEVVDEFEKRLREELDYRR 210 (517)
T ss_pred CchhhhhHhhheeEEecCCCEEEEEecCCChHHHHHHHHHHHHHHHHHHHHcCCccccCChHHHHHHHHHHHHHHhCHHH
Confidence 6799999999999999999999999976432110 011334
Q ss_pred HHHHHHhcC----CCceeeecceee-ecceEEEEEEeccCCCHHHHHhhhcCCCCCcCHHHHHHHHHHHHHHHHHHHhcc
Q 002673 653 EVEALSTAQ----HKNLVSLQGYCV-HQGFRLLIYSYMENGSLDYWLHEKADGASQLDWLTRLKIARGTSCGLAYMHQIC 727 (894)
Q Consensus 653 Ei~~l~~l~----HpnIv~l~g~~~-~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~ 727 (894)
|...+.+++ +..-+.+=.++. -.....|+|||++|-.+.+...-+..+ ++ +..++..++++ |+-+..
T Consensus 211 EA~n~~~~~~nf~~~~~v~VP~V~we~t~~~VLtmE~i~Gi~i~d~~~l~~~g---~d---~k~ia~~~~~~--f~~q~~ 282 (517)
T COG0661 211 EAANAERFRENFKDDPDVYVPKVYWEYTTRRVLTMEWIDGIKISDIAALKSAG---ID---RKELAELLVRA--FLRQLL 282 (517)
T ss_pred HHHHHHHHHHHcCCCCCeEeceeehhccCCcEEEEEeeCCEecccHHHHHhcC---CC---HHHHHHHHHHH--HHHHHH
Confidence 555554442 222223333333 345679999999998888875332222 33 22333333332 122222
Q ss_pred CCCeeecCCCCCCeEECCCCcEEEEEcccccccCC
Q 002673 728 EPHIVHRDIKSSNILLDDQFEAHLADFGLSRLILP 762 (894)
Q Consensus 728 ~~~ivHrDLkp~NILld~~~~vkl~DFGla~~~~~ 762 (894)
..+++|.|.+|.||+++.++.+.+.|||+...+.+
T Consensus 283 ~dgffHaDpHpGNi~v~~~g~i~~lDfGi~g~l~~ 317 (517)
T COG0661 283 RDGFFHADPHPGNILVRSDGRIVLLDFGIVGRLDP 317 (517)
T ss_pred hcCccccCCCccceEEecCCcEEEEcCcceecCCH
Confidence 34999999999999999999999999999987643
|
|
| >TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172 | Back alignment and domain information |
|---|
Probab=98.15 E-value=2.2e-05 Score=82.54 Aligned_cols=140 Identities=16% Similarity=0.181 Sum_probs=85.6
Q ss_pred ceEeecCcEEEEEEEEcCCCeEEEEEEcCcchhhHHHHHHHHHHHHhcCCCce--eeecceeeecceEEEEEEeccCCC-
Q 002673 613 NIIGCGGFGLVYKATLANGTTLAIKKLSGDLGLMEREFKAEVEALSTAQHKNL--VSLQGYCVHQGFRLLIYSYMENGS- 689 (894)
Q Consensus 613 ~~LG~G~fg~Vy~a~~~~g~~vAvK~~~~~~~~~~~~~~~Ei~~l~~l~HpnI--v~l~g~~~~~~~~~lV~E~~~~gs- 689 (894)
..||+|..+.||+. .+..+++|...... ......+|.++++.+..-.+ .+.+++....+...+|||+++|..
T Consensus 7 ~~i~~G~t~~~y~~---~~~~~VlR~~~~~~--~~~~i~~E~~~l~~l~~~glpvP~~~~~~~~~~~~glv~e~i~G~~~ 81 (226)
T TIGR02172 7 TQTGEGGNGESYTH---KTGKWMLKLYNPGF--DKETIKREFDASRKVFSLGIPTPHPFDLVEDGGRLGLIYELIVGKRS 81 (226)
T ss_pred eeecCCCCcceeEe---cCCCEEEEeCCCCC--CHHHHHHHHHHHHHHHHcCCCCCceEEEEecCCeeeeeeeecCCccc
Confidence 57899999999984 25567788876532 33457889999998864433 556777767777789999998863
Q ss_pred HHHHH---------------------hhhcCCCCCcCHHHHHHHHH----------HHHH-HHHHHHhc-cCCCeeecCC
Q 002673 690 LDYWL---------------------HEKADGASQLDWLTRLKIAR----------GTSC-GLAYMHQI-CEPHIVHRDI 736 (894)
Q Consensus 690 L~~~l---------------------~~~~~~~~~l~~~~~~~i~~----------~ia~-aL~yLH~~-~~~~ivHrDL 736 (894)
+...+ |........+... ...+.. .+.. ...+|... ....++|+|+
T Consensus 82 ~~~~~~~~~~~~~~l~~~la~~l~~lH~~~~~~~~l~~~-~~~~~~~l~~~~~~~~~~~~~l~~~l~~~~~~~~~~HgD~ 160 (226)
T TIGR02172 82 FSRIISDNPSRLEEIAKIFAEMAKKLHSTKCDTSTFQSY-KEKIRKFIEEKDFVPKDYKEKARAFIKEVPDTSTCLHGDF 160 (226)
T ss_pred hhhhhcCCHHHHHHHHHHHHHHHHHHhCCCCCCCcHHHH-HHHHHHHHHhccCCCHHHHHHHHHHHHhCCCCCceEecCC
Confidence 21111 1110001111100 000000 0111 12233222 1345789999
Q ss_pred CCCCeEECCCCcEEEEEcccccc
Q 002673 737 KSSNILLDDQFEAHLADFGLSRL 759 (894)
Q Consensus 737 kp~NILld~~~~vkl~DFGla~~ 759 (894)
.|.||++++++ +.|+||+.+..
T Consensus 161 ~~~Nii~~~~~-~~iIDwe~a~~ 182 (226)
T TIGR02172 161 QIGNLITSGKG-TYWIDLGDFGY 182 (226)
T ss_pred CCCcEEEcCCC-cEEEechhcCc
Confidence 99999999988 99999997753
|
This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636. |
| >PRK09902 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=98.14 E-value=2.8e-05 Score=79.52 Aligned_cols=137 Identities=18% Similarity=0.168 Sum_probs=100.8
Q ss_pred eecCcEEEEEEEEcCCCeEEEEEEcCcc------hhhHHHHHHHHHHHHhcCCC--ceeeecceeee-----cceEEEEE
Q 002673 616 GCGGFGLVYKATLANGTTLAIKKLSGDL------GLMEREFKAEVEALSTAQHK--NLVSLQGYCVH-----QGFRLLIY 682 (894)
Q Consensus 616 G~G~fg~Vy~a~~~~g~~vAvK~~~~~~------~~~~~~~~~Ei~~l~~l~Hp--nIv~l~g~~~~-----~~~~~lV~ 682 (894)
|+||-+-|++..+. |..+-+|+-.... ...+..|.+|+..+.++..- .+.+++ ++.. ....+||+
T Consensus 27 ~rgG~SgV~r~~~~-g~~~ylKrq~nhl~~s~r~P~g~ptf~rE~~~L~~L~~~GvPVP~pv-f~~~~k~~~~~rA~LVT 104 (216)
T PRK09902 27 RRNGMSGVQCVERN-GKKLYVKRMTHHLFHSVRYPFGRPTIVREVAVIKELERAGVIVPKIV-FGEAVKIEGEWRALLVT 104 (216)
T ss_pred CCCCcceEEEEEeC-CcEEEEEeccCcccccccCCCCchHHHHHHHHHHHHHHcCCCCCccc-eeeeeccCCceEEEEEE
Confidence 66888889887764 4468888765221 23456899999999998643 244444 3321 12468999
Q ss_pred EeccC-CCHHHHHhhhcCCCCCcCHHHHHHHHHHHHHHHHHHHhccCCCeeecCCCCCCeEECCCCc--EEEEEcccccc
Q 002673 683 SYMEN-GSLDYWLHEKADGASQLDWLTRLKIARGTSCGLAYMHQICEPHIVHRDIKSSNILLDDQFE--AHLADFGLSRL 759 (894)
Q Consensus 683 E~~~~-gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDLkp~NILld~~~~--vkl~DFGla~~ 759 (894)
|-+++ -+|.+++.+.. ..+.+...+..++.+++..+.-||+ .++.|+|+.+.||+++.++. ++++||.-++.
T Consensus 105 e~L~g~~~L~~~l~~~~--~~~~~~~~k~~il~~va~~ia~LH~---~Gv~Hgdly~khIll~~~g~~~v~lIDlEk~r~ 179 (216)
T PRK09902 105 EDMAGFISIADWYAQHA--VSPYSDEVRQAMLKAVALAFKKMHS---VNRQHGCCYVRHIYVKTEGKAEAGFLDLEKSRR 179 (216)
T ss_pred EeCCCCccHHHHHhcCC--cCCcchHHHHHHHHHHHHHHHHHHH---CCCcCCCCCHhheeecCCCCeeEEEEEhhccch
Confidence 97754 58998886532 2345667778999999999999997 59999999999999986667 99999986654
|
|
| >PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.14 E-value=1.4e-05 Score=82.87 Aligned_cols=106 Identities=24% Similarity=0.214 Sum_probs=81.1
Q ss_pred HHHHHHHHHHHhcCCCc--eeeecceeeec----ceEEEEEEeccCC-CHHHHHhhhcCCCCCcCHHHHHHHHHHHHHHH
Q 002673 648 REFKAEVEALSTAQHKN--LVSLQGYCVHQ----GFRLLIYSYMENG-SLDYWLHEKADGASQLDWLTRLKIARGTSCGL 720 (894)
Q Consensus 648 ~~~~~Ei~~l~~l~Hpn--Iv~l~g~~~~~----~~~~lV~E~~~~g-sL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL 720 (894)
....+|...+..+.... ....+++.... ...++|+|++++. +|.+++..... .+......++.+++..+
T Consensus 56 ~ra~~E~~~~~~L~~~Gi~tP~pva~~~~r~~~~~~s~lite~l~~~~~L~~~~~~~~~----~~~~~~~~ll~~l~~~i 131 (206)
T PF06293_consen 56 SRAKREWRNLQRLREAGIPTPEPVAYGERRKGGGYRSYLITEALPGAQDLRDLLQQWEQ----LDPSQRRELLRALARLI 131 (206)
T ss_pred hHHHHHHHHHHHHHHcCCCCCcEEEEEEEcCCCceeEEEEEEeCCCcccHHHHHHhhcc----cchhhHHHHHHHHHHHH
Confidence 35678888888775332 33455555442 2458999999874 89998876321 44556788999999999
Q ss_pred HHHHhccCCCeeecCCCCCCeEECCCC---cEEEEEccccccc
Q 002673 721 AYMHQICEPHIVHRDIKSSNILLDDQF---EAHLADFGLSRLI 760 (894)
Q Consensus 721 ~yLH~~~~~~ivHrDLkp~NILld~~~---~vkl~DFGla~~~ 760 (894)
+-||. .+|+|+|++++|||++.+. .+.++||+-++..
T Consensus 132 ~~lH~---~gi~H~Dl~~~NILv~~~~~~~~~~lIDld~~~~~ 171 (206)
T PF06293_consen 132 AKLHD---AGIYHGDLNPSNILVDPDDGQYRFYLIDLDRMRFR 171 (206)
T ss_pred HHHHH---CcCCCCCCCcccEEEeCCCCceeEEEEcchhceeC
Confidence 99997 5999999999999999887 8999999987653
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane |
| >KOG3207 consensus Beta-tubulin folding cofactor E [Posttranslational modification, protein turnover, chaperones] | Back alignment and domain information |
|---|
Probab=98.09 E-value=6.5e-07 Score=97.84 Aligned_cols=158 Identities=22% Similarity=0.232 Sum_probs=98.1
Q ss_pred CCCCCccccccccccccccc--ccccCccccchhcccccccccccCccccccCCCCCcccccCCCCCCCeEEccCCcCCc
Q 002673 322 KSDEGPSLFSQANLLSGEFP--KELTALPALVSEAANDEVDRSYLELPVFVMPSNATNQQYNQLSNLPPAIYLANNSLSG 399 (894)
Q Consensus 322 ~l~~L~~L~L~~N~l~~~~p--~~~~~L~~L~~L~L~~n~~~~~~~~~~~~~~~~~~~l~~n~L~~Lp~~L~L~~N~l~~ 399 (894)
.+++...|+|+.|.|....| .-...|++|+.|+|+.|++...... .... -+..| +.|.|+.+.|+-
T Consensus 144 ~~~~v~~LdLS~NL~~nw~~v~~i~eqLp~Le~LNls~Nrl~~~~~s--------~~~~---~l~~l-K~L~l~~CGls~ 211 (505)
T KOG3207|consen 144 ILPNVRDLDLSRNLFHNWFPVLKIAEQLPSLENLNLSSNRLSNFISS--------NTTL---LLSHL-KQLVLNSCGLSW 211 (505)
T ss_pred hCCcceeecchhhhHHhHHHHHHHHHhcccchhcccccccccCCccc--------cchh---hhhhh-heEEeccCCCCH
Confidence 34556666666665554222 3455666666666666654432211 0000 22233 556788887772
Q ss_pred C-CchhhcCCCCCcEEeccCCcCCCCCCccccCCCCCCEEecCCCcccCcCC--CcccCCCccccccccccccCCC-CCC
Q 002673 400 N-IPVEIGQLKSLHVLDLSNNNFSGTIPDELSDLSNLEKLDLSGNHLVGEIP--ISLKGLHFLSSFSVAHNNLQGA-VPS 475 (894)
Q Consensus 400 ~-~p~~~~~L~~L~~L~L~~N~l~~~~p~~~~~L~~L~~L~Ls~N~l~~~~p--~~~~~l~~L~~L~Ls~N~l~~~-~~~ 475 (894)
. +-..+..+++|+.|+|..|...+..-.....+..|+.|+|++|++- ..+ ...+.|+.|..|+++.+.++++ .|+
T Consensus 212 k~V~~~~~~fPsl~~L~L~~N~~~~~~~~~~~i~~~L~~LdLs~N~li-~~~~~~~~~~l~~L~~Lnls~tgi~si~~~d 290 (505)
T KOG3207|consen 212 KDVQWILLTFPSLEVLYLEANEIILIKATSTKILQTLQELDLSNNNLI-DFDQGYKVGTLPGLNQLNLSSTGIASIAEPD 290 (505)
T ss_pred HHHHHHHHhCCcHHHhhhhcccccceecchhhhhhHHhhccccCCccc-ccccccccccccchhhhhccccCcchhcCCC
Confidence 1 1122456788888888888543344555667788889999888876 555 4677888888888888888753 122
Q ss_pred C------CCCCCCCccccCCCCC
Q 002673 476 G------GQFDTFPSFSFEGNPE 492 (894)
Q Consensus 476 ~------~~l~~L~~l~l~~Np~ 492 (894)
. ..+++|+.|++..|+-
T Consensus 291 ~~s~~kt~~f~kL~~L~i~~N~I 313 (505)
T KOG3207|consen 291 VESLDKTHTFPKLEYLNISENNI 313 (505)
T ss_pred ccchhhhcccccceeeecccCcc
Confidence 2 5678888888888864
|
|
| >PF12799 LRR_4: Leucine Rich repeats (2 copies); PDB: 2OMT_A 1XEU_A 2OMX_A 2OMU_A 2UZY_A 2WQU_D 1D0B_A 2WQW_A 1OTO_A 2WQV_B | Back alignment and domain information |
|---|
Probab=98.01 E-value=3.5e-06 Score=63.97 Aligned_cols=37 Identities=54% Similarity=0.785 Sum_probs=24.8
Q ss_pred CCCcEEeccCCcCCCCCCccccCCCCCCEEecCCCccc
Q 002673 409 KSLHVLDLSNNNFSGTIPDELSDLSNLEKLDLSGNHLV 446 (894)
Q Consensus 409 ~~L~~L~L~~N~l~~~~p~~~~~L~~L~~L~Ls~N~l~ 446 (894)
++|++|+|++|+|+ .+|+.|++|++|+.|+|++|+|+
T Consensus 1 ~~L~~L~l~~N~i~-~l~~~l~~l~~L~~L~l~~N~i~ 37 (44)
T PF12799_consen 1 KNLEELDLSNNQIT-DLPPELSNLPNLETLNLSNNPIS 37 (44)
T ss_dssp TT-SEEEETSSS-S-SHGGHGTTCTTSSEEEETSSCCS
T ss_pred CcceEEEccCCCCc-ccCchHhCCCCCCEEEecCCCCC
Confidence 35677777777777 56666777777777777777776
|
... |
| >PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY) | Back alignment and domain information |
|---|
Probab=98.00 E-value=6.9e-05 Score=77.01 Aligned_cols=136 Identities=15% Similarity=0.176 Sum_probs=89.1
Q ss_pred ccCCCccceEeecCcEEEEEEEEcCCCeEEEEEEcCcchhhHHHHH---------HHHHHHHhcCCC---ceeeecceee
Q 002673 606 TDNFSQANIIGCGGFGLVYKATLANGTTLAIKKLSGDLGLMEREFK---------AEVEALSTAQHK---NLVSLQGYCV 673 (894)
Q Consensus 606 ~~~f~~~~~LG~G~fg~Vy~a~~~~g~~vAvK~~~~~~~~~~~~~~---------~Ei~~l~~l~Hp---nIv~l~g~~~ 673 (894)
..+|...+++.......|.+-.. +|..+++|..+......++.|. +++..+.+++.. ....++.+..
T Consensus 30 ~~~~~~~kv~k~~~r~~ValIei-~~~kyIlK~pr~~~~r~er~~~sf~kg~~~~~l~~~~~~i~~~g~~~~~~~yl~~e 108 (229)
T PF06176_consen 30 DNNYKIIKVFKNTKRNYVALIEI-DGKKYILKEPREENRRPERRFKSFFKGSEYSRLINNTDKIRNEGFTEPADPYLAAE 108 (229)
T ss_pred hCCceEEEeecCCCccEEEEEEE-CCcEEEEeccchhhhhHHHHHHHHhccHHHHHHHHHHHHHHHcCccccccceeeee
Confidence 36777778888777666666655 5788999988765444443332 344444444322 2222222221
Q ss_pred -----ecceEEEEEEeccCCCHHHHHhhhcCCCCCcCHHHHHHHHHHHHHHHHHHHhccCCCeeecCCCCCCeEECCCCc
Q 002673 674 -----HQGFRLLIYSYMENGSLDYWLHEKADGASQLDWLTRLKIARGTSCGLAYMHQICEPHIVHRDIKSSNILLDDQFE 748 (894)
Q Consensus 674 -----~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ivHrDLkp~NILld~~~~ 748 (894)
-....+|+|||++|..|.++.. ++. .++..+.+++.-||.+ |++|+|..|+|++++++ .
T Consensus 109 kk~~~~~~~~~ll~EYIeG~~l~d~~~--------i~e----~~~~ki~~~ikqlH~~---G~~HGD~hpgNFlv~~~-~ 172 (229)
T PF06176_consen 109 KKIFRYTSSYVLLMEYIEGVELNDIED--------IDE----DLAEKIVEAIKQLHKH---GFYHGDPHPGNFLVSNN-G 172 (229)
T ss_pred eeeccceeEEEEEEEEecCeecccchh--------cCH----HHHHHHHHHHHHHHHc---CCccCCCCcCcEEEECC-c
Confidence 2234578999999987755432 111 2455677789999975 99999999999999966 4
Q ss_pred EEEEEccccc
Q 002673 749 AHLADFGLSR 758 (894)
Q Consensus 749 vkl~DFGla~ 758 (894)
+++.||+..+
T Consensus 173 i~iID~~~k~ 182 (229)
T PF06176_consen 173 IRIIDTQGKR 182 (229)
T ss_pred EEEEECcccc
Confidence 9999998654
|
The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process |
| >KOG4579 consensus Leucine-rich repeat (LRR) protein associated with apoptosis in muscle tissue [General function prediction only] | Back alignment and domain information |
|---|
Probab=97.99 E-value=4.4e-07 Score=84.48 Aligned_cols=100 Identities=19% Similarity=0.254 Sum_probs=83.7
Q ss_pred eEEccCCcCCcCCchh---hcCCCCCcEEeccCCcCCCCCCccccCCC-CCCEEecCCCcccCcCCCcccCCCccccccc
Q 002673 389 AIYLANNSLSGNIPVE---IGQLKSLHVLDLSNNNFSGTIPDELSDLS-NLEKLDLSGNHLVGEIPISLKGLHFLSSFSV 464 (894)
Q Consensus 389 ~L~L~~N~l~~~~p~~---~~~L~~L~~L~L~~N~l~~~~p~~~~~L~-~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L 464 (894)
.++|++.+|- .+++. +.....|+..+|++|.+. .+|..|.... .++.|+|++|+|+ .+|..+..++.|+.|++
T Consensus 31 ~ldLssc~lm-~i~davy~l~~~~el~~i~ls~N~fk-~fp~kft~kf~t~t~lNl~~neis-dvPeE~Aam~aLr~lNl 107 (177)
T KOG4579|consen 31 FLDLSSCQLM-YIADAVYMLSKGYELTKISLSDNGFK-KFPKKFTIKFPTATTLNLANNEIS-DVPEELAAMPALRSLNL 107 (177)
T ss_pred hcccccchhh-HHHHHHHHHhCCceEEEEecccchhh-hCCHHHhhccchhhhhhcchhhhh-hchHHHhhhHHhhhccc
Confidence 4678888776 56655 455566777899999999 7888887764 8999999999999 89999999999999999
Q ss_pred cccccCCCCCCCCCCCCCCccccCCCC
Q 002673 465 AHNNLQGAVPSGGQFDTFPSFSFEGNP 491 (894)
Q Consensus 465 s~N~l~~~~~~~~~l~~L~~l~l~~Np 491 (894)
+.|.|...|..+..|.+|-.|+..+|.
T Consensus 108 ~~N~l~~~p~vi~~L~~l~~Lds~~na 134 (177)
T KOG4579|consen 108 RFNPLNAEPRVIAPLIKLDMLDSPENA 134 (177)
T ss_pred ccCccccchHHHHHHHhHHHhcCCCCc
Confidence 999999777777778888888887774
|
|
Homologous Structure Templates
Structure Templates Detected by BLAST
Original result of BLAST against Protein Data Bank
| ID | Alignment Graph | Length |
Definition |
E-value | |
| Query | 894 | ||||
| 3tl8_A | 349 | The Avrptob-Bak1 Complex Reveals Two Structurally S | 2e-63 | ||
| 3uim_A | 326 | Structural Basis For The Impact Of Phosphorylation | 2e-61 | ||
| 2qkw_B | 321 | Structural Basis For Activation Of Plant Immunity B | 3e-41 | ||
| 3hgk_A | 327 | Crystal Structure Of Effect Protein Avrptob Complex | 4e-41 | ||
| 2nry_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 6e-39 | ||
| 2nru_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 1e-38 | ||
| 2oib_A | 301 | Crystal Structure Of Irak4 Kinase Domain Apo Form L | 6e-38 | ||
| 2o8y_A | 298 | Apo Irak4 Kinase Domain Length = 298 | 2e-36 | ||
| 3ppz_A | 309 | Crystal Structure Of Ctr1 Kinase Domain In Complex | 2e-23 | ||
| 3p86_A | 309 | Crystal Structure Of Ctr1 Kinase Domain Mutant D676 | 2e-23 | ||
| 4f0f_A | 287 | Crystal Structure Of The Roco4 Kinase Domain Bound | 2e-21 | ||
| 3riz_A | 772 | Crystal Structure Of The Plant Steroid Receptor Bri | 3e-21 | ||
| 4f1o_A | 287 | Crystal Structure Of The L1180t Mutant Roco4 Kinase | 8e-21 | ||
| 4f1m_A | 287 | Crystal Structure Of The G1179s Roco4 Kinase Domain | 9e-21 | ||
| 3rgx_A | 768 | Structural Insight Into Brassinosteroid Perception | 1e-20 | ||
| 1mqb_A | 333 | Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro | 2e-20 | ||
| 3v5j_A | 266 | Crystal Structure Of Interleukin-2 Inducible T-Cell | 7e-18 | ||
| 1sm2_A | 264 | Crystal Structure Of The Phosphorylated Interleukin | 7e-18 | ||
| 4hct_A | 269 | Crystal Structure Of Itk In Complex With Compound 5 | 8e-18 | ||
| 2rei_A | 318 | Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep | 8e-18 | ||
| 3qgw_A | 286 | Crystal Structure Of Itk Kinase Bound To An Inhibit | 2e-17 | ||
| 3dtc_A | 271 | Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp | 2e-17 | ||
| 2fb8_A | 281 | Structure Of The B-Raf Kinase Domain Bound To Sb-59 | 2e-17 | ||
| 3ii5_A | 306 | The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi | 3e-17 | ||
| 2qoo_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 3e-17 | ||
| 4dbn_A | 284 | Crystal Structure Of The Kinase Domain Of Human B-R | 3e-17 | ||
| 3d4q_A | 307 | Pyrazole-Based Inhibitors Of B-Raf Kinase Length = | 3e-17 | ||
| 3q96_A | 282 | B-Raf Kinase Domain In Complex With A Tetrahydronap | 3e-17 | ||
| 4h58_A | 275 | Braf In Complex With Compound 3 Length = 275 | 3e-17 | ||
| 3t9t_A | 267 | Crystal Structure Of Btk Mutant (F435t,K596r) Compl | 3e-17 | ||
| 3c4c_A | 280 | B-Raf Kinase In Complex With Plx4720 Length = 280 | 3e-17 | ||
| 2vwu_A | 302 | Ephb4 Kinase Domain Inhibitor Complex Length = 302 | 3e-17 | ||
| 1uwh_A | 276 | The Complex Of Wild Type B-Raf And Bay439006 Length | 4e-17 | ||
| 2qof_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f | 4e-17 | ||
| 3dzq_A | 361 | Human Epha3 Kinase Domain In Complex With Inhibitor | 4e-17 | ||
| 2qoi_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 4e-17 | ||
| 2qoc_A | 344 | Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp | 4e-17 | ||
| 3miy_A | 266 | X-Ray Crystal Structure Of Itk Complexed With Sunit | 4e-17 | ||
| 2qod_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y602f | 4e-17 | ||
| 3fxx_A | 371 | Human Epha3 Kinase And Juxtamembrane Region Bound T | 4e-17 | ||
| 2gsf_A | 373 | The Human Epha3 Receptor Tyrosine Kinase And Juxtam | 5e-17 | ||
| 1jpa_A | 312 | Crystal Structure Of Unphosphorylated Ephb2 Recepto | 7e-17 | ||
| 3idp_A | 300 | B-Raf V600e Kinase Domain In Complex With An Aminoi | 8e-17 | ||
| 4g9r_A | 307 | B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr | 8e-17 | ||
| 2qok_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 8e-17 | ||
| 1uwj_A | 276 | The Complex Of Mutant V599e B-raf And Bay439006 Len | 8e-17 | ||
| 4fk3_A | 292 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 9e-17 | ||
| 4gs6_A | 315 | Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz | 1e-16 | ||
| 2xru_A | 280 | Aurora-A T288e Complexed With Pha-828300 Length = 2 | 1e-16 | ||
| 2qol_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596:y | 1e-16 | ||
| 2eva_A | 307 | Structural Basis For The Interaction Of Tak1 Kinase | 1e-16 | ||
| 3og7_A | 289 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 1e-16 | ||
| 3kul_A | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 2e-16 | ||
| 2r2p_A | 295 | Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep | 2e-16 | ||
| 4aw5_A | 291 | Complex Of The Ephb4 Kinase Domain With An Oxindole | 2e-16 | ||
| 2zm1_A | 285 | Crystal Structure Of Imidazo Pyrazin 1 Bound To The | 2e-16 | ||
| 2j4z_A | 306 | Structure Of Aurora-2 In Complex With Pha-680626 Le | 2e-16 | ||
| 2ofu_A | 273 | X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam | 2e-16 | ||
| 3kxz_A | 287 | The Complex Crystal Structure Of Lck With A Probe M | 3e-16 | ||
| 3kmm_A | 288 | Structure Of Human Lck Kinase With A Small Molecule | 3e-16 | ||
| 1qpe_A | 279 | Structural Analysis Of The Lymphocyte-Specific Kina | 3e-16 | ||
| 3lck_A | 271 | The Kinase Domain Of Human Lymphocyte Kinase (Lck), | 3e-16 | ||
| 2qon_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 3e-16 | ||
| 3bym_A | 272 | X-Ray Co-Crystal Structure Aminobenzimidazole Triaz | 3e-16 | ||
| 3kul_B | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 4e-16 | ||
| 3fdn_A | 279 | Structure-Based Drug Design Of Novel Aurora Kinase | 4e-16 | ||
| 2qob_A | 344 | Human Epha3 Kinase Domain, Base Structure Length = | 4e-16 | ||
| 3bys_A | 277 | Co-Crystal Structure Of Lck And Aminopyrimidine Ami | 4e-16 | ||
| 2ofv_A | 277 | Crystal Structure Of Aminoquinazoline 1 Bound To Lc | 4e-16 | ||
| 2qo7_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Dephos | 4e-16 | ||
| 2pl0_A | 289 | Lck Bound To Imatinib Length = 289 | 4e-16 | ||
| 2hel_A | 306 | Crystal Structure Of A Mutant Epha4 Kinase Domain ( | 4e-16 | ||
| 2wtw_A | 285 | Aurora-A Inhibitor Structure (2nd Crystal Form) Len | 4e-16 | ||
| 2of2_A | 271 | Crystal Structure Of Furanopyrimidine 8 Bound To Lc | 4e-16 | ||
| 2og8_A | 265 | Crystal Structure Of Aminoquinazoline 36 Bound To L | 4e-16 | ||
| 3v5q_A | 297 | Discovery Of A Selective Trk Inhibitor With Efficac | 5e-16 | ||
| 2c6e_A | 283 | Aurora A Kinase Activated Mutant (T287d) In Complex | 5e-16 | ||
| 1muo_A | 297 | Crystal Structure Of Aurora-2, An Oncogenic Serine- | 5e-16 | ||
| 3lau_A | 287 | Crystal Structure Of Aurora2 Kinase In Complex With | 5e-16 | ||
| 2c6d_A | 275 | Aurora A Kinase Activated Mutant (T287d) In Complex | 5e-16 | ||
| 3omv_A | 307 | Crystal Structure Of C-Raf (Raf-1) Length = 307 | 5e-16 | ||
| 2bmc_A | 306 | Aurora-2 T287d T288d Complexed With Pha-680632 Leng | 6e-16 | ||
| 2y6m_A | 291 | Crystal Structure Of Epha4 Kinase Domain Length = 2 | 8e-16 | ||
| 2vwi_A | 303 | Structure Of The Osr1 Kinase, A Hypertension Drug T | 8e-16 | ||
| 2j50_A | 280 | Structure Of Aurora-2 In Complex With Pha-739358 Le | 8e-16 | ||
| 2xng_A | 283 | Structure Of Aurora-A Bound To A Selective Imidazop | 8e-16 | ||
| 2x6d_A | 285 | Aurora-A Bound To An Inhibitor Length = 285 | 8e-16 | ||
| 2hen_A | 286 | Crystal Structure Of The Ephb2 Receptor Kinase Doma | 8e-16 | ||
| 3dak_A | 290 | Crystal Structure Of Domain-Swapped Osr1 Kinase Dom | 9e-16 | ||
| 2xyu_A | 285 | Crystal Structure Of Epha4 Kinase Domain In Complex | 9e-16 | ||
| 2h8h_A | 535 | Src Kinase In Complex With A Quinazoline Inhibitor | 9e-16 | ||
| 2dwb_A | 285 | Aurora-A Kinase Complexed With Amppnp Length = 285 | 1e-15 | ||
| 4asz_A | 299 | Crystal Structure Of Apo Trkb Kinase Domain Length | 1e-15 | ||
| 3dqw_A | 286 | C-Src Kinase Domain Thr338ile Mutant In Complex Wit | 1e-15 | ||
| 3o50_A | 267 | Crystal Structure Of Benzamide 9 Bound To Auroraa L | 1e-15 | ||
| 3e5a_A | 268 | Crystal Structure Of Aurora A In Complex With Vx-68 | 1e-15 | ||
| 1mq4_A | 272 | Crystal Structure Of Aurora-A Protein Kinase Length | 1e-15 | ||
| 3cok_A | 278 | Crystal Structure Of Plk4 Kinase Length = 278 | 1e-15 | ||
| 3qbn_A | 281 | Structure Of Human Aurora A In Complex With A Diami | 1e-15 | ||
| 3g6h_A | 286 | Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma | 2e-15 | ||
| 3mpm_A | 267 | Lck Complexed With A Pyrazolopyrimidine Length = 26 | 2e-15 | ||
| 2hk5_A | 270 | Hck Kinase In Complex With Lck Targetted Inhibitor | 2e-15 | ||
| 2w1d_A | 275 | Structure Determination Of Aurora Kinase In Complex | 2e-15 | ||
| 3coh_A | 268 | Crystal Structure Of Aurora-A In Complex With A Pen | 2e-15 | ||
| 1yi6_A | 276 | C-Term Tail Segment Of Human Tyrosine Kinase (258-5 | 2e-15 | ||
| 2wtv_A | 285 | Aurora-A Inhibitor Structure Length = 285 | 2e-15 | ||
| 3unz_A | 279 | Aurora A In Complex With Rpm1679 Length = 279 | 2e-15 | ||
| 1ol6_A | 282 | Structure Of Unphosphorylated D274n Mutant Of Auror | 2e-15 | ||
| 1ol5_A | 282 | Structure Of Aurora-A 122-403, Phosphorylated On Th | 3e-15 | ||
| 1qpd_A | 279 | Structural Analysis Of The Lymphocyte-specific Kina | 3e-15 | ||
| 3r21_A | 271 | Design, Synthesis, And Biological Evaluation Of Pyr | 3e-15 | ||
| 1fmk_A | 452 | Crystal Structure Of Human Tyrosine-Protein Kinase | 3e-15 | ||
| 1qcf_A | 454 | Crystal Structure Of Hck In Complex With A Src Fami | 3e-15 | ||
| 2wqe_A | 262 | Structure Of S155r Aurora-A Somatic Mutant Length = | 3e-15 | ||
| 3d7u_B | 277 | Structural Basis For The Recognition Of C-Src By It | 3e-15 | ||
| 1y57_A | 452 | Structure Of Unphosphorylated C-Src In Complex With | 3e-15 | ||
| 3nrm_A | 283 | Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito | 3e-15 | ||
| 3u4w_A | 275 | Src In Complex With Dna-Templated Macrocyclic Inhib | 3e-15 | ||
| 4an2_A | 301 | Crystal Structures Of Human Mek1 With Carboxamide-B | 3e-15 | ||
| 2bdf_A | 279 | Src Kinase In Complex With Inhibitor Ap23451 Length | 4e-15 | ||
| 3oez_A | 286 | Crystal Structure Of The L317i Mutant Of The Chicke | 4e-15 | ||
| 2oiq_A | 286 | Crystal Structure Of Chicken C-Src Kinase Domain In | 4e-15 | ||
| 2xne_A | 272 | Structure Of Aurora-A Bound To An Imidazopyrazine I | 4e-15 | ||
| 3h0y_A | 268 | Aurora A In Complex With A Bisanilinopyrimidine Len | 4e-15 | ||
| 1ksw_A | 452 | Structure Of Human C-Src Tyrosine Kinase (Thr338gly | 5e-15 | ||
| 3svv_A | 286 | Crystal Structure Of T338c C-Src Covalently Bound T | 5e-15 | ||
| 2g15_A | 318 | Structural Characterization Of Autoinhibited C-Met | 5e-15 | ||
| 4gg5_A | 319 | Crystal Structure Of Cmet In Complex With Novel Inh | 5e-15 | ||
| 3q6u_A | 308 | Structure Of The Apo Met Receptor Kinase In The Dua | 5e-15 | ||
| 2wd1_A | 292 | Human C-Met Kinase In Complex With Azaindole Inhibi | 6e-15 | ||
| 3ha6_A | 268 | Crystal Structure Of Aurora A In Complex With Tpx2 | 6e-15 | ||
| 3lq8_A | 302 | Structure Of The Kinase Domain Of C-Met Bound To Xl | 6e-15 | ||
| 2w1c_A | 275 | Structure Determination Of Aurora Kinase In Complex | 6e-15 | ||
| 2ptk_A | 453 | Chicken Src Tyrosine Kinase Length = 453 | 6e-15 | ||
| 2wgj_A | 306 | X-Ray Structure Of Pf-02341066 Bound To The Kinase | 6e-15 | ||
| 3i5n_A | 309 | Crystal Structure Of C-Met With Triazolopyridazine | 7e-15 | ||
| 3f66_A | 298 | Human C-Met Kinase In Complex With Quinoxaline Inhi | 7e-15 | ||
| 1yol_A | 283 | Crystal Structure Of Src Kinase Domain In Complex W | 8e-15 | ||
| 2rfn_A | 310 | X-ray Structure Of C-met With Inhibitor. Length = 3 | 8e-15 | ||
| 2ivs_A | 314 | Crystal Structure Of Non-Phosphorylated Ret Tyrosin | 9e-15 | ||
| 1yoj_A | 283 | Crystal Structure Of Src Kinase Domain Length = 283 | 9e-15 | ||
| 2xa4_A | 298 | Inhibitors Of Jak2 Kinase Domain Length = 298 | 9e-15 | ||
| 3geq_A | 286 | Structural Basis For The Chemical Rescue Of Src Kin | 1e-14 | ||
| 3orn_A | 307 | Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In | 1e-14 | ||
| 2dq7_X | 283 | Crystal Structure Of Fyn Kinase Domain Complexed Wi | 1e-14 | ||
| 2qq7_A | 286 | Crystal Structure Of Drug Resistant Src Kinase Doma | 1e-14 | ||
| 3dkg_A | 317 | Sgx Clone 5698a109kfg1h1 Length = 317 | 1e-14 | ||
| 2hwo_A | 286 | Crystal Structure Of Src Kinase Domain In Complex W | 1e-14 | ||
| 3rvg_A | 303 | Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido | 2e-14 | ||
| 3ugc_A | 295 | Structural Basis Of Jak2 Inhibition By The Type Ii | 2e-14 | ||
| 4hge_A | 300 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 | 2e-14 | ||
| 4e4m_A | 302 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 3 | 2e-14 | ||
| 3tjc_A | 298 | Co-Crystal Structure Of Jak2 With Thienopyridine 8 | 2e-14 | ||
| 2ivt_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 2e-14 | ||
| 3e62_A | 293 | Fragment Based Discovery Of Jak-2 Inhibitors Length | 2e-14 | ||
| 3lpb_A | 295 | Crystal Structure Of Jak2 Complexed With A Potent 2 | 2e-14 | ||
| 2w1i_A | 326 | Structure Determination Of Aurora Kinase In Complex | 2e-14 | ||
| 2ivv_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 2e-14 | ||
| 4aqc_A | 301 | Triazolopyridine-Based Inhibitor Of Janus Kinase 2 | 2e-14 | ||
| 3dk6_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 2e-14 | ||
| 3q32_A | 301 | Structure Of Janus Kinase 2 With A Pyrrolotriazine | 2e-14 | ||
| 2b7a_A | 293 | The Structural Basis Of Janus Kinase 2 Inhibition B | 2e-14 | ||
| 3a4o_X | 286 | Lyn Kinase Domain Length = 286 | 2e-14 | ||
| 3dk3_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 2e-14 | ||
| 3q6w_A | 307 | Structure Of Dually-phosphorylated Met Receptor Kin | 3e-14 | ||
| 3jy9_A | 311 | Janus Kinase 2 Inhibitors Length = 311 | 3e-14 | ||
| 3io7_A | 313 | 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel | 3e-14 | ||
| 3dk7_A | 277 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 3e-14 | ||
| 2oo8_X | 317 | Synthesis, Structural Analysis, And Sar Studies Of | 3e-14 | ||
| 4bbe_A | 298 | Aminoalkylpyrimidine Inhibitor Complexes With Jak2 | 3e-14 | ||
| 3c1x_A | 373 | Crystal Structure Of The Tyrosine Kinase Domain Of | 3e-14 | ||
| 4eqm_A | 294 | Structural Analysis Of Staphylococcus Aureus Serine | 3e-14 | ||
| 4e6d_A | 298 | Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W | 4e-14 | ||
| 1fvr_A | 327 | Tie2 Kinase Domain Length = 327 | 4e-14 | ||
| 3nyx_A | 302 | Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T | 4e-14 | ||
| 4aoj_A | 329 | Human Trka In Complex With The Inhibitor Az-23 Leng | 4e-14 | ||
| 1ad5_A | 438 | Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | 4e-14 | ||
| 3nz0_A | 302 | Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3 | 4e-14 | ||
| 3qrj_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain T | 5e-14 | ||
| 2y4i_C | 395 | Ksr2-Mek1 Heterodimer Length = 395 | 5e-14 | ||
| 3cth_A | 314 | Crystal Structure Of The Tyrosine Kinase Domain Of | 5e-14 | ||
| 2e2b_A | 293 | Crystal Structure Of The C-Abl Kinase Domain In Com | 5e-14 | ||
| 3qri_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain I | 5e-14 | ||
| 1r0p_A | 312 | Crystal Structure Of The Tyrosine Kinase Domain Of | 5e-14 | ||
| 3gen_A | 283 | The 1.6 A Crystal Structure Of Human Bruton's Tyros | 5e-14 | ||
| 3dkc_A | 317 | Sgx Clone 5698a65kfg1h1 Length = 317 | 5e-14 | ||
| 2hzi_A | 277 | Abl Kinase Domain In Complex With Pd180970 Length = | 5e-14 | ||
| 3qti_A | 314 | C-Met Kinase In Complex With Nvp-Bvu972 Length = 31 | 5e-14 | ||
| 3a4p_A | 319 | Human C-Met Kinase Domain Complexed With 6-Benzylox | 6e-14 | ||
| 1s9i_A | 354 | X-Ray Structure Of The Human Mitogen-Activated Prot | 6e-14 | ||
| 2hiw_A | 287 | Crystal Structure Of Inactive Conformation Abl Kina | 6e-14 | ||
| 3s95_A | 310 | Crystal Structure Of The Human Limk1 Kinase Domain | 6e-14 | ||
| 2hz0_A | 270 | Abl Kinase Domain In Complex With Nvp-Aeg082 Length | 6e-14 | ||
| 2g1t_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 7e-14 | ||
| 1fpu_A | 293 | Crystal Structure Of Abl Kinase Domain In Complex W | 7e-14 | ||
| 3k54_A | 283 | Structures Of Human Bruton's Tyrosine Kinase In Act | 7e-14 | ||
| 2hyy_A | 273 | Human Abl Kinase Domain In Complex With Imatinib (S | 7e-14 | ||
| 3pyy_A | 298 | Discovery And Characterization Of A Cell-Permeable, | 7e-14 | ||
| 3p08_A | 267 | Crystal Structure Of The Human Btk Kinase Domain Le | 8e-14 | ||
| 2p55_A | 333 | X-Ray Structure Of The Human Mitogen-Activated Prot | 9e-14 | ||
| 4gt5_A | 306 | Crystal Structure Of The Inactive Trka Kinase Domai | 9e-14 | ||
| 3oy3_A | 284 | Crystal Structure Of Abl T315i Mutant Kinase Domain | 9e-14 | ||
| 3eqc_A | 360 | X-Ray Structure Of The Human Mitogen-Activated Prot | 9e-14 | ||
| 1k2p_A | 263 | Crystal Structure Of Bruton's Tyrosine Kinase Domai | 9e-14 | ||
| 1s9j_A | 341 | X-Ray Structure Of The Human Mitogen-Activated Prot | 9e-14 | ||
| 3sls_A | 304 | Crystal Structure Of Human Mek-1 Kinase In Complex | 9e-14 | ||
| 3oxz_A | 284 | Crystal Structure Of Abl Kinase Domain Bound With A | 9e-14 | ||
| 3mbl_A | 328 | Crystal Structure Of The Human Mitogen-Activated Pr | 9e-14 | ||
| 3dv3_A | 322 | Mek1 With Pf-04622664 Bound Length = 322 | 9e-14 | ||
| 4f0i_A | 300 | Crystal Structure Of Apo Trka Length = 300 | 9e-14 | ||
| 3pix_A | 274 | Crystal Structure Of Btk Kinase Domain Complexed Wi | 1e-13 | ||
| 3ocs_A | 271 | Crystal Structure Of Bruton's Tyrosine Kinase In Co | 1e-13 | ||
| 2wqb_A | 324 | Structure Of The Tie2 Kinase Domain In Complex With | 1e-13 | ||
| 2z60_A | 288 | Crystal Structure Of The T315i Mutant Of Abl Kinase | 1e-13 | ||
| 2qoh_A | 288 | Crystal Structure Of Abl Kinase Bound With Ppy-a Le | 1e-13 | ||
| 3d14_A | 272 | Crystal Structure Of Mouse Aurora A (Asn186->gly, L | 1e-13 | ||
| 1opl_A | 537 | Structural Basis For The Auto-Inhibition Of C-Abl T | 1e-13 | ||
| 1opk_A | 495 | Structural Basis For The Auto-Inhibition Of C-Abl T | 2e-13 | ||
| 2fo0_A | 495 | Organization Of The Sh3-Sh2 Unit In Active And Inac | 2e-13 | ||
| 2a19_B | 284 | Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng | 2e-13 | ||
| 3qa8_A | 676 | Crystal Structure Of Inhibitor Of Kappa B Kinase Be | 2e-13 | ||
| 3oct_A | 265 | Crystal Structure Of Bruton's Tyrosine Kinase Mutan | 2e-13 | ||
| 3rzf_A | 677 | Crystal Structure Of Inhibitor Of Kappab Kinase Bet | 2e-13 | ||
| 2v7a_A | 286 | Crystal Structure Of The T315i Abl Mutant In Comple | 3e-13 | ||
| 2zv7_A | 279 | Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | 3e-13 | ||
| 2gqg_A | 278 | X-Ray Crystal Structure Of Dasatinib (Bms-354825) B | 3e-13 | ||
| 4apc_A | 350 | Crystal Structure Of Human Nima-Related Kinase 1 (N | 3e-13 | ||
| 1koa_A | 491 | Twitchin Kinase Fragment (C.Elegans), Autoregulated | 3e-13 | ||
| 3uto_A | 573 | Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin- | 4e-13 | ||
| 2f4j_A | 287 | Structure Of The Kinase Domain Of An Imatinib-Resis | 4e-13 | ||
| 2g2f_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 4e-13 | ||
| 3daj_A | 272 | Crystal Structure Of Aurora A Complexed With An Inh | 4e-13 | ||
| 3lxn_A | 318 | Structural And Thermodynamic Characterization Of Th | 5e-13 | ||
| 3pls_A | 298 | Ron In Complex With Ligand Amp-Pnp Length = 298 | 8e-13 | ||
| 3uiu_A | 306 | Crystal Structure Of Apo-Pkr Kinase Domain Length = | 8e-13 | ||
| 3lcd_A | 329 | Inhibitor Bound To A Dfg-In Structure Of The Kinase | 1e-12 | ||
| 2acx_A | 576 | Crystal Structure Of G Protein Coupled Receptor Kin | 1e-12 | ||
| 3q4t_A | 322 | Crystal Structure Of Activin Receptor Type-Iia (Acv | 1e-12 | ||
| 3nyn_A | 576 | Crystal Structure Of G Protein-Coupled Receptor Kin | 1e-12 | ||
| 3bbt_B | 328 | Crystal Structure Of The Erbb4 Kinase In Complex Wi | 1e-12 | ||
| 2r4b_A | 321 | Erbb4 Kinase Domain Complexed With A Thienopyrimidi | 1e-12 | ||
| 2clq_A | 295 | Structure Of Mitogen-Activated Protein Kinase Kinas | 1e-12 | ||
| 2yfx_A | 327 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 2e-12 | ||
| 2ogv_A | 317 | Crystal Structure Of The Autoinhibited Human C-Fms | 2e-12 | ||
| 2jed_A | 352 | The Crystal Structure Of The Kinase Domain Of The P | 2e-12 | ||
| 4fnw_A | 327 | Crystal Structure Of The Apo F1174l Anaplastic Lymp | 2e-12 | ||
| 3f69_A | 311 | Crystal Structure Of The Mycobacterium Tuberculosis | 2e-12 | ||
| 2xp2_A | 327 | Structure Of The Human Anaplastic Lymphoma Kinase I | 2e-12 | ||
| 4fnz_A | 327 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 2e-12 | ||
| 2xb7_A | 315 | Structure Of Human Anaplastic Lymphoma Kinase In Co | 2e-12 | ||
| 2qlu_A | 314 | Crystal Structure Of Activin Receptor Type Ii Kinas | 2e-12 | ||
| 2yjr_A | 342 | Structure Of F1174l Mutant Anaplastic Lymphoma Kina | 2e-12 | ||
| 3aox_A | 344 | X-Ray Crystal Structure Of Human Anaplastic Lymphom | 2e-12 | ||
| 4dce_A | 333 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 3e-12 | ||
| 2yhv_A | 342 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 3e-12 | ||
| 3lct_A | 344 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 3e-12 | ||
| 3krw_A | 688 | Human Grk2 In Complex With Gbetgamma Subunits And B | 3e-12 | ||
| 3vw6_A | 269 | Crystal Structure Of Human Apoptosis Signal-Regulat | 3e-12 | ||
| 3sxr_A | 268 | Crystal Structure Of Bmx Non-Receptor Tyrosine Kina | 3e-12 | ||
| 3cik_A | 689 | Human Grk2 In Complex With Gbetagamma Subunits Leng | 3e-12 | ||
| 3l9p_A | 367 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 3e-12 | ||
| 4fob_A | 353 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 3e-12 | ||
| 1omw_A | 689 | Crystal Structure Of The Complex Between G Protein- | 4e-12 | ||
| 3psc_A | 695 | Bovine Grk2 In Complex With Gbetagamma Subunits Len | 4e-12 | ||
| 2wqm_A | 310 | Structure Of Apo Human Nek7 Length = 310 | 4e-12 | ||
| 2yjs_A | 342 | Structure Of C1156y Mutant Anaplastic Lymphoma Kina | 4e-12 | ||
| 2qkr_A | 313 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 4e-12 | ||
| 2x4f_A | 373 | The Crystal Structure Of The Human Myosin Light Cha | 4e-12 | ||
| 3niz_A | 311 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 4e-12 | ||
| 4fr4_A | 384 | Crystal Structure Of Human SerineTHREONINE-Protein | 5e-12 | ||
| 3ori_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain L33d | 5e-12 | ||
| 3f61_A | 311 | Crystal Structure Of M. Tuberculosis Pknb Leu33aspV | 5e-12 | ||
| 2z7q_A | 321 | Crystal Structure Of The N-Terminal Kinase Domain O | 5e-12 | ||
| 1irk_A | 306 | Crystal Structure Of The Tyrosine Kinase Domain Of | 5e-12 | ||
| 1pkg_A | 329 | Structure Of A C-kit Kinase Product Complex Length | 5e-12 | ||
| 1i44_A | 306 | Crystallographic Studies Of An Activation Loop Muta | 5e-12 | ||
| 3g0f_A | 336 | Kit Kinase Domain Mutant D816h In Complex With Suni | 6e-12 | ||
| 3bea_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P | 6e-12 | ||
| 1t46_A | 313 | Structural Basis For The Autoinhibition And Sti-571 | 6e-12 | ||
| 3eta_A | 317 | Kinase Domain Of Insulin Receptor Complexed With A | 6e-12 | ||
| 3g0e_A | 336 | Kit Kinase Domain In Complex With Sunitinib Length | 6e-12 | ||
| 1t45_A | 331 | Structural Basis For The Autoinhibition And Sti-571 | 7e-12 | ||
| 1luf_A | 343 | Crystal Structure Of The Musk Tyrosine Kinase: Insi | 9e-12 | ||
| 4fnx_A | 327 | Crystal Structure Of The Apo R1275q Anaplastic Lymp | 9e-12 | ||
| 3orm_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain D76a | 1e-11 | ||
| 3gvu_A | 292 | The Crystal Structure Of Human Abl2 In Complex With | 1e-11 | ||
| 2i0v_A | 335 | C-Fms Tyrosine Kinase In Complex With A Quinolone I | 1e-11 | ||
| 4e7w_A | 394 | Structure Of Gsk3 From Ustilago Maydis Length = 394 | 1e-11 | ||
| 3g51_A | 325 | Structural Diversity Of The Active Conformation Of | 1e-11 | ||
| 4e20_A | 290 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 1e-11 | ||
| 2x7f_A | 326 | Crystal Structure Of The Kinase Domain Of Human Tra | 1e-11 | ||
| 4e1z_A | 291 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 1e-11 | ||
| 3ekk_A | 307 | Insulin Receptor Kinase Complexed With An Inhibitor | 2e-11 | ||
| 1p14_A | 306 | Crystal Structure Of A Catalytic-Loop Mutant Of The | 2e-11 | ||
| 1ir3_A | 306 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 2e-11 | ||
| 1xjd_A | 345 | Crystal Structure Of Pkc-Theta Complexed With Staur | 2e-11 | ||
| 1mru_A | 311 | Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob | 2e-11 | ||
| 2vrx_A | 285 | Structure Of Aurora B Kinase In Complex With Zm4474 | 2e-11 | ||
| 1rqq_A | 306 | Crystal Structure Of The Insulin Receptor Kinase In | 2e-11 | ||
| 2bfy_A | 284 | Complex Of Aurora-B With Incenp And Hesperidin. Len | 2e-11 | ||
| 2bfx_B | 284 | Mechanism Of Aurora-B Activation By Incenp And Inhi | 2e-11 | ||
| 3g2f_A | 336 | Crystal Structure Of The Kinase Domain Of Bone Morp | 2e-11 | ||
| 2i1m_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An | 3e-11 | ||
| 3ubd_A | 304 | Structure Of N-Terminal Domain Of Rsk2 Kinase In Co | 3e-11 | ||
| 2z8c_A | 303 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 3e-11 | ||
| 4el9_A | 305 | Structure Of N-Terminal Kinase Domain Of Rsk2 With | 3e-11 | ||
| 1yhv_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Two Po | 3e-11 | ||
| 1o6y_A | 299 | Catalytic Domain Of Pknb Kinase From Mycobacterium | 3e-11 | ||
| 1p4o_A | 322 | Structure Of Apo Unactivated Igf-1r Kinase Domain A | 3e-11 | ||
| 2w5a_A | 279 | Human Nek2 Kinase Adp-Bound Length = 279 | 4e-11 | ||
| 4a4x_A | 279 | Nek2-Ede Bound To Cct248662 Length = 279 | 4e-11 | ||
| 3com_A | 314 | Crystal Structure Of Mst1 Kinase Length = 314 | 4e-11 | ||
| 2jav_A | 279 | Human Kinase With Pyrrole-Indolinone Ligand Length | 4e-11 | ||
| 1f3m_C | 297 | Crystal Structure Of Human SerineTHREONINE KINASE P | 5e-11 | ||
| 3lco_A | 324 | Inhibitor Bound To A Dfg-Out Structure Of The Kinas | 5e-11 | ||
| 3ggf_A | 301 | Crystal Structure Of Human SerineTHREONINE-Protein | 5e-11 | ||
| 4aw2_A | 437 | Crystal Structure Of Cdc42 Binding Protein Kinase A | 6e-11 | ||
| 3lw0_A | 304 | Igf-1rk In Complex With Ligand Msc1609119a-1 Length | 6e-11 | ||
| 2xik_A | 294 | Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K | 7e-11 | ||
| 1u5q_A | 348 | Crystal Structure Of The Tao2 Kinase Domain: Activa | 7e-11 | ||
| 2v5q_A | 315 | Crystal Structure Of Wild-type Plk-1 Kinase Domain | 7e-11 | ||
| 1m7n_A | 322 | Crystal Structure Of Unactivated Apo Insulin-Like G | 8e-11 | ||
| 3kb7_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 8e-11 | ||
| 2yac_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 8e-11 | ||
| 2ou7_A | 335 | Structure Of The Catalytic Domain Of Human Polo-Lik | 9e-11 | ||
| 3thb_A | 333 | Structure Of Plk1 Kinase Domain In Complex With A B | 9e-11 | ||
| 3i81_A | 315 | Crystal Structure Of Insulin-Like Growth Factor 1 R | 1e-10 | ||
| 3txo_A | 353 | Pkc Eta Kinase In Complex With A Naphthyridine Leng | 1e-10 | ||
| 2q0b_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-10 | ||
| 3o23_A | 305 | Human Unphosphorylated Igf1-R Kinase Domain In Comp | 1e-10 | ||
| 2pvy_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-10 | ||
| 1jqh_A | 308 | Igf-1 Receptor Kinase Domain Length = 308 | 1e-10 | ||
| 2pz5_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-10 | ||
| 3qqu_A | 301 | Cocrystal Structure Of Unphosphorylated Igf With Py | 1e-10 | ||
| 3lvp_A | 336 | Crystal Structure Of Bisphosphorylated Igf1-R Kinas | 1e-10 | ||
| 2oj9_A | 307 | Structure Of Igf-1r Kinase Domain Complexed With A | 1e-10 | ||
| 2pzr_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-10 | ||
| 2y7j_A | 365 | Structure Of Human Phosphorylase Kinase, Gamma 2 Le | 1e-10 | ||
| 3d94_A | 301 | Crystal Structure Of The Insulin-Like Growth Factor | 1e-10 | ||
| 2py3_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-10 | ||
| 2j7t_A | 302 | Crystal Structure Of Human Serine Threonine Kinase- | 2e-10 | ||
| 3a62_A | 327 | Crystal Structure Of Phosphorylated P70s6k1 Length | 2e-10 | ||
| 4bc6_A | 293 | Crystal Structure Of Human Serine Threonine Kinase- | 2e-10 | ||
| 3fxz_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Ruthen | 2e-10 | ||
| 3q52_A | 306 | Structure Of Phosphorylated Pak1 Kinase Domain Leng | 2e-10 | ||
| 2psq_A | 370 | Crystal Structure Of Unphosphorylated Unactivated W | 2e-10 | ||
| 3a60_A | 327 | Crystal Structure Of Unphosphorylated P70s6k1 (Form | 2e-10 | ||
| 2phk_A | 277 | The Crystal Structure Of A Phosphorylase Kinase Pep | 2e-10 | ||
| 2rku_A | 294 | Structure Of Plk1 In Complex With Bi2536 Length = 2 | 2e-10 | ||
| 2pzp_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-10 | ||
| 3q4z_A | 306 | Structure Of Unphosphorylated Pak1 Kinase Domain Le | 2e-10 | ||
| 1k3a_A | 299 | Structure Of The Insulin-Like Growth Factor 1 Recep | 2e-10 | ||
| 2gcd_A | 309 | Tao2 Kinase Domain-Staurosporine Structure Length = | 2e-10 | ||
| 3db6_A | 301 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 2e-10 | ||
| 2pwl_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-10 | ||
| 1phk_A | 298 | Two Structures Of The Catalytic Domain Of Phosphory | 2e-10 | ||
| 2w99_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 3e-10 | ||
| 3d5v_A | 317 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 3e-10 | ||
| 3cly_A | 334 | Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase | 3e-10 | ||
| 1oec_A | 316 | The Fgfr2 Tyrosine Kinase Domain Length = 316 | 3e-10 | ||
| 3ri1_A | 313 | Crystal Structure Of The Catalytic Domain Of Fgfr2 | 3e-10 | ||
| 2pvf_A | 334 | Crystal Structure Of Tyrosine Phosphorylated Activa | 3e-10 | ||
| 1fot_A | 318 | Structure Of The Unliganded Camp-Dependent Protein | 3e-10 | ||
| 1ob3_A | 288 | Structure Of P. Falciparum Pfpk5 Length = 288 | 3e-10 | ||
| 4af3_A | 292 | Human Aurora B Kinase In Complex With Incenp And Vx | 3e-10 | ||
| 2w96_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 3e-10 | ||
| 1v0o_A | 288 | Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho | 3e-10 | ||
| 3orx_A | 316 | Pdk1 Mutant Bound To Allosteric Disulfide Fragment | 3e-10 | ||
| 1v0b_A | 288 | Crystal Structure Of The T198a Mutant Of Pfpk5 Leng | 3e-10 | ||
| 3zhp_C | 294 | Human Mst3 (stk24) In Complex With Mo25beta Length | 4e-10 | ||
| 3b2t_A | 311 | Structure Of Phosphotransferase Length = 311 | 4e-10 | ||
| 2w9f_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 4e-10 | ||
| 4e4l_A | 302 | Jak1 Kinase (Jh1 Domain) In Complex With Compound 3 | 4e-10 | ||
| 2p0c_A | 313 | Catalytic Domain Of The Proto-Oncogene Tyrosine-Pro | 5e-10 | ||
| 3d5w_A | 317 | Crystal Structure Of A Phosphorylated Polo-Like Kin | 5e-10 | ||
| 1h1w_A | 289 | High Resolution Crystal Structure Of The Human Pdk1 | 5e-10 | ||
| 2zoq_A | 382 | Structural Dissection Of Human Mitogen-Activated Ki | 5e-10 | ||
| 3ckw_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 5e-10 | ||
| 3d5u_A | 317 | Crystal Structure Of A Wildtype Polo-Like Kinase 1 | 5e-10 | ||
| 1uu9_A | 286 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 5e-10 | ||
| 3eyg_A | 290 | Crystal Structures Of Jak1 And Jak2 Inhibitor Compl | 5e-10 | ||
| 2zm3_A | 308 | Complex Structure Of Insulin-Like Growth Factor Rec | 5e-10 | ||
| 3qup_A | 323 | Inhibitor Bound Structure Of The Kinase Domain Of T | 6e-10 | ||
| 3cjf_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 6e-10 | ||
| 1xkk_A | 352 | Egfr Kinase Domain Complexed With A Quinazoline Inh | 6e-10 | ||
| 3cjg_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 6e-10 | ||
| 3is5_A | 285 | Crystal Structure Of Cdpk Kinase Domain From Toxopl | 6e-10 | ||
| 1z5m_A | 286 | Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr | 7e-10 | ||
| 3nus_A | 286 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra | 7e-10 | ||
| 3cd3_A | 377 | Crystal Structure Of Phosphorylated Human Feline Sa | 7e-10 | ||
| 1gz8_A | 299 | Human Cyclin Dependent Kinase 2 Complexed With The | 8e-10 | ||
| 3d7t_A | 269 | Structural Basis For The Recognition Of C-Src By It | 8e-10 | ||
| 3ika_A | 331 | Crystal Structure Of Egfr 696-1022 T790m Mutant Cov | 8e-10 | ||
| 4erw_A | 306 | Cdk2 In Complex With Staurosporine Length = 306 | 8e-10 | ||
| 3qfv_A | 415 | Mrck Beta In Complex With Tpca-1 Length = 415 | 8e-10 | ||
| 3pwy_A | 311 | Crystal Structure Of An Extender (Spd28345)-Modifie | 9e-10 | ||
| 2uv2_A | 287 | Crystal Structure Of Human Ste20-Like Kinase Bound | 9e-10 | ||
| 3tt0_A | 382 | Co-Structure Of Fibroblast Growth Factor Receptor 1 | 9e-10 | ||
| 3bkb_A | 377 | Crystal Structure Of Human Feline Sarcoma Viral Onc | 9e-10 | ||
| 3tku_A | 433 | Mrck Beta In Complex With Fasudil Length = 433 | 9e-10 | ||
| 2jiv_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 1e-09 | ||
| 3zgw_A | 347 | Crystal Structure Of Maternal Embryonic Leucine Zip | 1e-09 | ||
| 2ozo_A | 613 | Autoinhibited Intact Human Zap-70 Length = 613 | 1e-09 | ||
| 2jiu_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 1e-09 | ||
| 4hvd_A | 314 | Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h | 1e-09 | ||
| 3a7f_A | 303 | Human Mst3 Kinase Length = 303 | 1e-09 | ||
| 1ql6_A | 298 | The Catalytic Mechanism Of Phosphorylase Kinase Pro | 1e-09 | ||
| 4aaa_A | 331 | Crystal Structure Of The Human Cdkl2 Kinase Domain | 1e-09 | ||
| 4i24_A | 329 | Structure Of T790m Egfr Kinase Domain Co-crystalliz | 1e-09 | ||
| 3pjc_A | 315 | Crystal Structure Of Jak3 Complexed With A Potent A | 1e-09 | ||
| 3d7u_A | 263 | Structural Basis For The Recognition Of C-Src By It | 1e-09 | ||
| 1oit_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 1e-09 | ||
| 3vnt_A | 318 | Crystal Structure Of The Kinase Domain Of Human Veg | 1e-09 | ||
| 3iop_A | 312 | Pdk-1 In Complex With The Inhibitor Compound-8i Len | 1e-09 | ||
| 4eom_A | 301 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 1e-09 | ||
| 3g33_A | 308 | Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | 1e-09 | ||
| 3h9o_A | 311 | Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) | 1e-09 | ||
| 2r7b_A | 312 | Crystal Structure Of The Phosphoinositide-Dependent | 1e-09 | ||
| 4g5p_A | 330 | Crystal Structure Of Egfr Kinase T790m In Complex W | 1e-09 | ||
| 3gqi_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 1e-09 | ||
| 1vyw_A | 309 | Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = | 1e-09 | ||
| 3pxf_A | 306 | Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N | 1e-09 | ||
| 1byg_A | 278 | Kinase Domain Of Human C-Terminal Src Kinase (Csk) | 1e-09 | ||
| 2xir_A | 316 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 1e-09 | ||
| 3vjo_A | 334 | Crystal Structure Of The Wild-Type Egfr Kinase Doma | 1e-09 | ||
| 1zy4_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 1e-09 | ||
| 3lxk_A | 327 | Structural And Thermodynamic Characterization Of Th | 1e-09 | ||
| 2xch_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 2e-09 | ||
| 3ezr_A | 300 | Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ | 2e-09 | ||
| 2w17_A | 299 | Cdk2 In Complex With The Imidazole Pyrimidine Amide | 2e-09 | ||
| 1fin_A | 298 | Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = | 2e-09 | ||
| 1uu3_A | 310 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 2e-09 | ||
| 1ogq_A | 313 | The Crystal Structure Of Pgip (Polygalacturonase In | 2e-09 | ||
| 2jit_A | 327 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 2e-09 | ||
| 1pf8_A | 298 | Crystal Structure Of Human Cyclin-dependent Kinase | 2e-09 | ||
| 4eoi_A | 299 | Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc | 2e-09 | ||
| 3rwp_A | 311 | Discovery Of A Novel, Potent And Selective Inhibito | 2e-09 | ||
| 3sc1_A | 311 | Novel Isoquinolone Pdk1 Inhibitors Discovered Throu | 2e-09 | ||
| 2biy_A | 310 | Structure Of Pdk1-S241a Mutant Kinase Domain Length | 2e-09 | ||
| 3hrc_A | 311 | Crystal Structure Of A Mutant Of Human Pdk1 Kinase | 2e-09 | ||
| 4a07_A | 311 | Human Pdk1 Kinase Domain In Complex With Allosteric | 2e-09 | ||
| 3qc4_A | 314 | Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = | 2e-09 | ||
| 3ewh_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 2e-09 | ||
| 3u6j_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 2e-09 | ||
| 1m14_A | 333 | Tyrosine Kinase Domain From Epidermal Growth Factor | 2e-09 | ||
| 3pj8_A | 299 | Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D] | 2e-09 | ||
| 3ckx_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 2e-09 | ||
| 2pk9_A | 317 | Structure Of The Pho85-pho80 Cdk-cyclin Complex Of | 2e-09 | ||
| 4i23_A | 329 | Crystal Structure Of The Wild-type Egfr Kinase Doma | 2e-09 | ||
| 4eoj_A | 302 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 2e-09 | ||
| 3q5i_A | 504 | Crystal Structure Of Pbanka_031420 Length = 504 | 2e-09 | ||
| 4agc_A | 353 | Crystal Structure Of Vegfr2 (Juxtamembrane And Kina | 2e-09 | ||
| 3nun_A | 292 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea | 2e-09 | ||
| 1k9a_A | 450 | Crystal Structure Analysis Of Full-Length Carboxyl- | 2e-09 | ||
| 4h1j_A | 293 | Crystal Structure Of Pyk2 With The Pyrazole 13a Len | 2e-09 | ||
| 4eok_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 2e-09 | ||
| 3c7q_A | 316 | Structure Of Vegfr2 Kinase Domain In Complex With B | 2e-09 | ||
| 1u59_A | 287 | Crystal Structure Of The Zap-70 Kinase Domain In Co | 2e-09 | ||
| 4g5j_A | 330 | Crystal Structure Of Egfr Kinase In Complex With Bi | 2e-09 | ||
| 2j5e_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 2e-09 | ||
| 2r5t_A | 373 | Crystal Structure Of Inactive Serum And Glucocortic | 2e-09 | ||
| 4fie_A | 423 | Full-Length Human Pak4 Length = 423 | 2e-09 | ||
| 2oh4_A | 316 | Crystal Structure Of Vegfr2 With A Benzimidazole-Ur | 3e-09 | ||
| 2gs2_A | 330 | Crystal Structure Of The Active Egfr Kinase Domain | 3e-09 | ||
| 4hjo_A | 337 | Crystal Structure Of The Inactive Egfr Tyrosine Kin | 3e-09 | ||
| 3nax_A | 311 | Pdk1 In Complex With Inhibitor Mp7 Length = 311 | 3e-09 | ||
| 2j5f_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 3e-09 | ||
| 3js2_A | 317 | Crystal Structure Of Minimal Kinase Domain Of Fibro | 3e-09 | ||
| 2gs7_A | 330 | Crystal Structure Of The Inactive Egfr Kinase Domai | 3e-09 | ||
| 4eon_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 3e-09 | ||
| 3fzo_A | 277 | Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosin | 3e-09 | ||
| 3rhx_B | 306 | Crystal Structure Of The Catalytic Domain Of Fgfr1 | 3e-09 | ||
| 3nay_A | 311 | Pdk1 In Complex With Inhibitor Mp6 Length = 311 | 3e-09 | ||
| 3mdy_A | 337 | Crystal Structure Of The Cytoplasmic Domain Of The | 3e-09 | ||
| 1fgk_A | 310 | Crystal Structure Of The Tyrosine Kinase Domain Of | 3e-09 | ||
| 3kxx_A | 317 | Structure Of The Mutant Fibroblast Growth Factor Re | 3e-09 | ||
| 3gop_A | 361 | Crystal Structure Of The Egf Receptor Juxtamembrane | 3e-09 | ||
| 4eoq_A | 301 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 3e-09 | ||
| 3gql_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 3e-09 | ||
| 3lzb_A | 327 | Egfr Kinase Domain Complexed With An Imidazo[2,1-B] | 3e-09 | ||
| 3cc6_A | 281 | Crystal Structure Of Kinase Domain Of Protein Tyros | 3e-09 | ||
| 4f63_A | 309 | Crystal Structure Of Human Fibroblast Growth Factor | 3e-09 | ||
| 1vr2_A | 316 | Human Vascular Endothelial Growth Factor Receptor 2 | 3e-09 | ||
| 2j51_A | 325 | Crystal Structure Of Human Ste20-Like Kinase Bound | 3e-09 | ||
| 1ywn_A | 316 | Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p | 3e-09 | ||
| 3c4f_A | 302 | Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M | 3e-09 | ||
| 2jfm_A | 325 | Crystal Structure Of Human Ste20-Like Kinase (Unlig | 3e-09 | ||
| 3h4j_B | 336 | Crystal Structure Of Pombe Ampk Kdaid Fragment Leng | 4e-09 | ||
| 1h1p_A | 303 | Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP | 4e-09 | ||
| 2p2h_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 4e-09 | ||
| 2jfl_A | 325 | Crystal Structure Of Human Ste20-Like Kinase ( Diph | 4e-09 | ||
| 3bel_A | 315 | X-Ray Structure Of Egfr In Complex With Oxime Inhib | 4e-09 | ||
| 1pyx_A | 422 | Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | 4e-09 | ||
| 2rfd_A | 324 | Crystal Structure Of The Complex Between The Egfr K | 4e-09 | ||
| 3say_A | 430 | Crystal Structure Of Human Glycogen Synthase Kinase | 4e-09 | ||
| 2xck_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 4e-09 | ||
| 1vzo_A | 355 | The Structure Of The N-Terminal Kinase Domain Of Ms | 4e-09 | ||
| 2p2i_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 4e-09 | ||
| 2cdz_A | 303 | Crystal Structure Of The Human P21-Activated Kinase | 4e-09 | ||
| 4afj_A | 367 | 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec | 4e-09 | ||
| 1gng_A | 378 | Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With | 4e-09 | ||
| 2q0n_A | 301 | Structure Of Human P21 Activating Kinase 4 (Pak4) I | 4e-09 | ||
| 4i21_A | 329 | Crystal Structure Of L858r + T790m Egfr Kinase Doma | 5e-09 | ||
| 1i09_A | 420 | Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len | 5e-09 | ||
| 4dit_A | 382 | Crystal Structure Of Gsk3beta In Complex With A Imi | 5e-09 | ||
| 1gii_A | 298 | Human Cyclin Dependent Kinase 2 Complexed With The | 5e-09 | ||
| 1q5k_A | 414 | Crystal Structure Of Glycogen Synthase Kinase 3 In | 5e-09 | ||
| 3zrk_A | 371 | Identification Of 2-(4-Pyridyl)thienopyridinones As | 5e-09 | ||
| 2pml_X | 348 | Crystal Structure Of Pfpk7 In Complex With An Atp A | 5e-09 | ||
| 1q3d_A | 424 | Gsk-3 Beta Complexed With Staurosporine Length = 42 | 5e-09 | ||
| 4bcq_A | 301 | Structure Of Cdk2 In Complex With Cyclin A And A 2- | 5e-09 | ||
| 3ug1_A | 334 | Crystal Structure Of The Mutated Egfr Kinase Domain | 5e-09 | ||
| 4i1z_A | 329 | Crystal Structure Of The Monomeric (v948r) Form Of | 5e-09 | ||
| 3iw4_A | 360 | Crystal Structure Of Pkc Alpha In Complex With Nvp- | 5e-09 | ||
| 4eop_A | 300 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 5e-09 | ||
| 4eos_A | 300 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 5e-09 | ||
| 3zdi_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 5e-09 | ||
| 1w98_A | 298 | The Structural Basis Of Cdk2 Activation By Cyclin E | 5e-09 | ||
| 4fif_A | 346 | Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid | 5e-09 | ||
| 1qmz_A | 299 | Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com | 5e-09 | ||
| 3f7z_A | 350 | X-ray Co-crystal Structure Of Glycogen Synthase Kin | 5e-09 | ||
| 2o5k_A | 372 | Crystal Structure Of Gsk3beta In Complex With A Ben | 5e-09 | ||
| 1e9h_A | 297 | Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex | 5e-09 | ||
| 3bht_A | 300 | Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN | 5e-09 | ||
| 1ogu_A | 302 | Structure Of Human Thr160-phospho Cdk2/cyclin A Com | 6e-09 | ||
| 4fv7_A | 360 | Crystal Structure Of The Erk2 Complexed With E94 Le | 6e-09 | ||
| 4fv6_A | 360 | Crystal Structure Of The Erk2 Complexed With E57 Le | 6e-09 | ||
| 4fux_A | 360 | Crystal Structure Of The Erk2 Complexed With E75 Le | 6e-09 | ||
| 3f88_A | 349 | Glycogen Synthase Kinase 3beta Inhibitor Complex Le | 6e-09 | ||
| 2ow3_A | 352 | Glycogen Synthase Kinase-3 Beta In Complex With Bis | 6e-09 | ||
| 2bva_A | 292 | Crystal Structure Of The Human P21-Activated Kinase | 6e-09 | ||
| 2jgz_A | 289 | Crystal Structure Of Phospho-Cdk2 In Complex With C | 6e-09 | ||
| 2y9q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 6e-09 | ||
| 1h4l_A | 292 | Structure And Regulation Of The Cdk5-P25(Nck5a) Com | 6e-09 | ||
| 4eoo_A | 299 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 6e-09 | ||
| 1jst_A | 298 | Phosphorylated Cyclin-Dependent Kinase-2 Bound To C | 6e-09 | ||
| 1r0e_A | 391 | Glycogen Synthase Kinase-3 Beta In Complex With 3-I | 6e-09 | ||
| 4acc_A | 465 | Gsk3b In Complex With Inhibitor Length = 465 | 6e-09 | ||
| 1pme_A | 380 | Structure Of Penta Mutant Human Erk2 Map Kinase Com | 6e-09 | ||
| 4i3z_A | 296 | Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES | 7e-09 | ||
| 1wzy_A | 368 | Crystal Structure Of Human Erk2 Complexed With A Py | 7e-09 | ||
| 1tvo_A | 368 | The Structure Of Erk2 In Complex With A Small Molec | 7e-09 | ||
| 3sd0_A | 350 | Identification Of A Glycogen Synthase Kinase-3b Inh | 7e-09 | ||
| 2iw6_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com | 7e-09 | ||
| 2eb3_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (L8 | 7e-09 | ||
| 2x4z_A | 296 | Crystal Structure Of The Human P21-Activated Kinase | 7e-09 | ||
| 2iw8_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82 | 7e-09 | ||
| 3sa0_A | 360 | Complex Of Erk2 With Norathyriol Length = 360 | 7e-09 | ||
| 3gb2_A | 353 | Gsk3beta Inhibitor Complex Length = 353 | 8e-09 | ||
| 1oir_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 8e-09 | ||
| 1h01_A | 298 | Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili | 8e-09 | ||
| 3tub_A | 293 | Crystal Structure Of Syk Kinase Domain With 1-(5-(6 | 8e-09 | ||
| 3vf8_A | 299 | Crystal Structure Of Spleen Tyrosine Kinase Syk Cat | 8e-09 | ||
| 4i20_A | 329 | Crystal Structure Of Monomeric (v948r) Primary Onco | 8e-09 | ||
| 3qhr_A | 298 | Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic | 8e-09 | ||
| 2ojg_A | 380 | Crystal Structure Of Erk2 In Complex With N,n-dimet | 8e-09 | ||
| 3mfr_A | 351 | Cask-4m Cam Kinase Domain, Native Length = 351 | 8e-09 | ||
| 2eb2_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (G7 | 8e-09 | ||
| 1yvj_A | 290 | Crystal Structure Of The Jak3 Kinase Domain In Comp | 8e-09 | ||
| 4fl3_A | 635 | Structural And Biophysical Characterization Of The | 8e-09 | ||
| 3tei_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 9e-09 | ||
| 3w2o_A | 331 | Egfr Kinase Domain T790m/l858r Mutant With Tak-285 | 9e-09 | ||
| 3d83_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 9e-09 | ||
| 3vn9_A | 340 | Rifined Crystal Structure Of Non-Phosphorylated Map | 9e-09 | ||
| 3d7z_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 1e-08 | ||
| 4fl2_A | 636 | Structural And Biophysical Characterization Of The | 1e-08 | ||
| 3qyw_A | 364 | Crystal Structure Of Erk2 In Complex With An Inhibi | 1e-08 | ||
| 2baq_A | 365 | P38alpha Bound To Ro3201195 Length = 365 | 1e-08 | ||
| 3emg_A | 291 | Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylami | 1e-08 | ||
| 4gsb_A | 364 | Monoclinic Crystal Form Of The Apo-Erk2 Length = 36 | 1e-08 | ||
| 1zyc_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 1e-08 | ||
| 2gph_A | 364 | Docking Motif Interactions In The Map Kinase Erk2 L | 1e-08 | ||
| 2itt_A | 327 | Crystal Structure Of Egfr Kinase Domain L858r Mutat | 1e-08 | ||
| 3r63_A | 358 | Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | 1e-08 | ||
| 3o71_A | 358 | Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length | 1e-08 | ||
| 3zu7_A | 365 | Crystal Structure Of A Designed Selected Ankyrin Re | 1e-08 | ||
| 2z7l_A | 366 | Unphosphorylated Mitogen Activated Protein Kinase E | 1e-08 | ||
| 3c9w_A | 357 | Crystal Structure Of Erk-2 With Hypothemycin Covale | 1e-08 | ||
| 2fys_B | 364 | Crystal Structure Of Erk2 Complex With Kim Peptide | 1e-08 | ||
| 4h3q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 1e-08 | ||
| 2itn_A | 327 | Crystal Structure Of Egfr Kinase Domain G719s Mutat | 1e-08 | ||
| 2fsl_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a+f3 | 1e-08 | ||
| 3srv_B | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 1e-08 | ||
| 1xba_A | 291 | Crystal Structure Of Apo Syk Tyrosine Kinase Domain | 1e-08 | ||
| 2fso_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a) A | 1e-08 | ||
| 2fst_X | 367 | Mitogen Activated Protein Kinase P38alpha (d176a+f3 | 1e-08 | ||
| 2bal_A | 365 | P38alpha Map Kinase Bound To Pyrazoloamine Length = | 2e-08 | ||
| 4dfl_A | 274 | Crystal Structure Of Spleen Tyrosine Kinase Complex | 2e-08 | ||
| 3odz_X | 360 | Crystal Structure Of P38alpha Y323r Active Mutant L | 2e-08 | ||
| 4f4p_A | 273 | Syk In Complex With Ligand Lasw836 Length = 273 | 2e-08 | ||
| 1rjb_A | 344 | Crystal Structure Of Flt3 Length = 344 | 2e-08 | ||
| 3nnx_A | 354 | Crystal Structure Of Phosphorylated P38 Alpha In Co | 2e-08 | ||
| 3fi4_A | 372 | P38 Kinase Crystal Structure In Complex With Ro4499 | 2e-08 | ||
| 2r0i_A | 327 | Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len | 2e-08 | ||
| 1zmu_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 2e-08 | ||
| 3od6_X | 360 | Crystal Structure Of P38alpha Y323t Active Mutant L | 2e-08 | ||
| 3gcp_A | 360 | Human P38 Map Kinase In Complex With Sb203580 Lengt | 2e-08 | ||
| 3ody_X | 360 | Crystal Structure Of P38alpha Y323q Active Mutant L | 2e-08 | ||
| 3hvc_A | 362 | Crystal Structure Of Human P38alpha Map Kinase Leng | 2e-08 | ||
| 3oef_X | 360 | Crystal Structure Of Y323f Inactive Mutant Of P38al | 2e-08 | ||
| 3oht_A | 389 | Crystal Structure Of Salmo Salar P38alpha Length = | 2e-08 | ||
| 3mtf_A | 301 | Crystal Structure Of The Acvr1 Kinase In Complex Wi | 2e-08 | ||
| 2baj_A | 365 | P38alpha Bound To Pyrazolourea Length = 365 | 2e-08 | ||
| 3hrb_A | 359 | P38 Kinase Crystal Structure In Complex With Small | 2e-08 | ||
| 3h9r_A | 330 | Crystal Structure Of The Kinase Domain Of Type I Ac | 2e-08 | ||
| 3gcu_A | 360 | Human P38 Map Kinase In Complex With Rl48 Length = | 2e-08 | ||
| 1di9_A | 360 | The Structure Of P38 Mitogen-Activated Protein Kina | 2e-08 | ||
| 1zzl_A | 351 | Crystal Structure Of P38 With Triazolopyridine Leng | 2e-08 | ||
| 3s3i_A | 349 | P38 Kinase Crystal Structure In Complex With Small | 2e-08 | ||
| 2npq_A | 367 | A Novel Lipid Binding Site In The P38 Alpha Map Kin | 2e-08 | ||
| 3hec_A | 348 | P38 In Complex With Imatinib Length = 348 | 2e-08 | ||
| 3nnu_A | 354 | Crystal Structure Of P38 Alpha In Complex With Dp13 | 2e-08 | ||
| 1ywr_A | 360 | Crystal Structure Analysis Of Inactive P38 Kinase D | 2e-08 | ||
| 1yw2_A | 360 | Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | 2e-08 | ||
| 3k3j_A | 362 | P38alpha Bound To Novel Dfg-Out Compound Pf-0041612 | 2e-08 | ||
| 1oz1_A | 372 | P38 Mitogen-Activated Kinase In Complex With 4-Azai | 2e-08 | ||
| 3tg1_A | 380 | Crystal Structure Of P38alpha In Complex With A Map | 2e-08 | ||
| 2gfs_A | 372 | P38 Kinase Crystal Structure In Complex With Ro3201 | 2e-08 | ||
| 1bl6_A | 379 | The Complex Structure Of The Map Kinase P38SB216995 | 2e-08 | ||
| 3kq7_A | 380 | Structure Of Human P38alpha With N-[4-Methyl-3-(6-{ | 2e-08 | ||
| 3k3i_A | 350 | P38alpha Bound To Novel Dgf-Out Compound Pf-0021595 | 2e-08 | ||
| 3mpt_A | 371 | Crystal Structure Of P38 Kinase In Complex With A P | 2e-08 | ||
| 1gol_A | 364 | Coordinates Of Rat Map Kinase Erk2 With An Arginine | 2e-08 | ||
| 3dt1_A | 383 | P38 Complexed With A Quinazoline Inhibitor Length = | 2e-08 | ||
| 3e92_A | 371 | Crystal Structure Of P38 Kinase In Complex With A B | 2e-08 | ||
| 3zsg_A | 362 | X-Ray Structure Of P38alpha Bound To Tak-715 Length | 2e-08 | ||
| 2hak_A | 328 | Catalytic And Ubiqutin-Associated Domains Of Mark1P | 2e-08 | ||
| 1zrz_A | 364 | Crystal Structure Of The Catalytic Domain Of Atypic | 2e-08 | ||
| 2gtm_A | 348 | Mutated Mouse P38 Map Kinase Domain In Complex With | 2e-08 | ||
| 1lew_A | 360 | Crystal Structure Of Map Kinase P38 Complexed To Th | 2e-08 | ||
| 4dym_A | 301 | Crystal Structure Of The Acvr1 Kinase Domain In Com | 2e-08 | ||
| 1m7q_A | 366 | Crystal Structure Of P38 Map Kinase In Complex With | 2e-08 | ||
| 2wzj_A | 327 | Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82 | 2e-08 | ||
| 4dc2_A | 396 | Structure Of Pkc In Complex With A Substrate Peptid | 2e-08 | ||
| 3iec_A | 319 | Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K | 2e-08 | ||
| 3zh8_A | 349 | A Novel Small Molecule Apkc Inhibitor Length = 349 | 2e-08 | ||
| 2ghl_A | 348 | Mutant Mus Musculus P38 Kinase Domain In Complex Wi | 2e-08 | ||
| 2y8o_A | 362 | Crystal Structure Of Human P38alpha Complexed With | 2e-08 | ||
| 1bmk_A | 379 | The Complex Structure Of The Map Kinase P38SB218655 | 2e-08 | ||
| 2lgc_A | 359 | Joint Nmr And X-Ray Refinement Reveals The Structur | 3e-08 | ||
| 3py3_A | 380 | Crystal Structure Of Phosphorylated P38alpha Map Ki | 3e-08 | ||
| 3pfq_A | 674 | Crystal Structure And Allosteric Activation Of Prot | 3e-08 | ||
| 3a8w_A | 345 | Crystal Structure Of Pkciota Kinase Domain Length = | 3e-08 | ||
| 4ewq_A | 383 | Human P38 Alpha Mapk In Complex With A Pyridazine B | 3e-08 | ||
| 3oz6_A | 388 | Crystal Structure Of Mapk From Cryptosporidium Parv | 3e-08 | ||
| 1o9u_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 3e-08 | ||
| 3srv_A | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 3e-08 | ||
| 3mn3_A | 271 | An Inhibited Conformation For The Protein Kinase Do | 3e-08 | ||
| 1zmv_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 3e-08 | ||
| 1ove_A | 366 | The Structure Of P38 Alpha In Complex With A Dihydr | 3e-08 | ||
| 1uv5_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With 6-Br | 3e-08 | ||
| 3hyh_A | 275 | Crystal Structure Of The Protein Kinase Domain Of Y | 3e-08 | ||
| 1ung_A | 292 | Structural Mechanism For The Inhibition Of Cdk5-P25 | 3e-08 | ||
| 1a06_A | 332 | Calmodulin-Dependent Protein Kinase From Rat Length | 3e-08 | ||
| 1h8f_A | 352 | Glycogen Synthase Kinase 3 Beta. Length = 352 | 3e-08 | ||
| 1ian_A | 366 | Human P38 Map Kinase Inhibitor Complex Length = 366 | 4e-08 | ||
| 4gt4_A | 308 | Structure Of Unliganded, Inactive Ror2 Kinase Domai | 4e-08 | ||
| 2fh9_A | 274 | Structure And Dimerization Of The Kinase Domain Fro | 4e-08 | ||
| 2oza_B | 366 | Structure Of P38alpha Complex Length = 366 | 4e-08 | ||
| 3dae_A | 283 | Crystal Structure Of Phosphorylated Snf1 Kinase Dom | 4e-08 | ||
| 3lmg_A | 344 | Crystal Structure Of The Erbb3 Kinase Domain In Com | 4e-08 | ||
| 3kn5_A | 325 | Crystal Structure Of The C-Terminal Kinase Domain O | 4e-08 | ||
| 3mtl_A | 324 | Crystal Structure Of The Pctaire1 Kinase In Complex | 4e-08 | ||
| 3zuv_A | 364 | Crystal Structure Of A Designed Selected Ankyrin Re | 4e-08 | ||
| 2erk_A | 365 | Phosphorylated Map Kinase Erk2 Length = 365 | 4e-08 | ||
| 4exu_A | 371 | Mapk13, Inactive Form Length = 371 | 4e-08 | ||
| 3pp0_A | 338 | Crystal Structure Of The Kinase Domain Of Human Her | 4e-08 | ||
| 2puu_A | 348 | Crystal Structure Of P38 Complex With 1-(5-Tert-But | 4e-08 | ||
| 3p4k_A | 370 | The Third Conformation Of P38a Map Kinase Observed | 5e-08 | ||
| 3mh2_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 5e-08 | ||
| 3zzw_A | 289 | Crystal Structure Of The Kinase Domain Of Ror2 Leng | 5e-08 | ||
| 3igo_A | 486 | Crystal Structure Of Cryptosporidium Parvum Cdpk1, | 5e-08 | ||
| 3hmn_A | 342 | Crystal Structure Of Human Mps1 Catalytic Domain In | 5e-08 | ||
| 3c4w_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 5e-08 | ||
| 3c4x_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 5e-08 | ||
| 3t8o_A | 543 | Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu | 5e-08 | ||
| 3qc9_A | 543 | Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4 | 6e-08 | ||
| 2qnj_A | 328 | Kinase And Ubiquitin-Associated Domains Of Mark3PAR | 6e-08 | ||
| 3ma6_A | 298 | Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr | 6e-08 | ||
| 3fe3_A | 328 | Crystal Structure Of The Kinase Mark3PAR-1: T211a-S | 6e-08 | ||
| 2zmc_A | 390 | Crystal Structure Of Human Mitotic Checkpoint Kinas | 6e-08 | ||
| 3i79_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 6e-08 | ||
| 3bhy_A | 283 | Crystal Structure Of Human Death Associated Protein | 7e-08 | ||
| 4fsy_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 8e-08 | ||
| 2xuu_A | 334 | Crystal Structure Of A Dap-Kinase 1 Mutant Length = | 8e-08 | ||
| 4fsz_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 9e-08 | ||
| 4fg7_A | 293 | Crystal Structure Of Human Calcium/calmodulin-depen | 9e-08 | ||
| 2wei_A | 287 | Crystal Structure Of The Kinase Domain Of Cryptospo | 9e-08 | ||
| 2ydj_A | 276 | Discovery Of Checkpoint Kinase Inhibitor Azd7762 By | 9e-08 | ||
| 1zmw_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 1e-07 | ||
| 3dfa_A | 286 | Crystal Structure Of Kinase Domain Of Calcium-depen | 1e-07 | ||
| 4fg8_A | 315 | Crystal Structure Of Human Calcium/calmodulin-depen | 1e-07 | ||
| 2r0u_A | 323 | Crystal Structure Of Chek1 In Complex With Inhibito | 1e-07 | ||
| 2hog_A | 322 | Crystal Structure Of Chek1 In Complex With Inhibito | 1e-07 | ||
| 4ic7_A | 442 | Crystal Structure Of The Erk5 Kinase Domain In Comp | 1e-07 | ||
| 3ku2_A | 507 | Crystal Structure Of Inactivated Form Of Cdpk1 From | 1e-07 | ||
| 3dfc_B | 295 | Crystal Structure Of A Glycine-Rich Loop Mutant Of | 1e-07 | ||
| 2x9e_A | 317 | Human Mps1 In Complex With Nms-P715 Length = 317 | 1e-07 | ||
| 4agu_A | 311 | Crystal Structure Of The Human Cdkl1 Kinase Domain | 1e-07 | ||
| 3hx4_A | 508 | Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg | 1e-07 | ||
| 3my0_A | 305 | Crystal Structure Of The Acvrl1 (Alk1) Kinase Domai | 1e-07 | ||
| 4fg9_A | 320 | Crystal Structure Of Human Calcium/calmodulin-depen | 1e-07 | ||
| 3npc_A | 364 | Crystal Structure Of Jnk2 Complexed With Birb796 Le | 1e-07 | ||
| 3f5u_A | 295 | Crystal Structure Of The Death Associated Protein K | 1e-07 | ||
| 3dbq_A | 343 | Crystal Structure Of Ttk Kinase Domain Length = 343 | 1e-07 | ||
| 3cek_A | 313 | Crystal Structure Of Human Dual Specificity Protein | 1e-07 | ||
| 1wvw_A | 278 | Crystal Structures Of Kinase Domain Of Dap Kinase I | 1e-07 | ||
| 2br1_A | 297 | Structure-Based Design Of Novel Chk1 Inhibitors: In | 1e-07 | ||
| 1ia8_A | 289 | The 1.7 A Crystal Structure Of Human Cell Cycle Che | 1e-07 | ||
| 1zlt_A | 295 | Crystal Structure Of Chk1 Complexed With A Hymenald | 1e-07 | ||
| 4fsu_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 1e-07 | ||
| 2x0g_A | 334 | X-ray Structure Of A Dap-kinase Calmodulin Complex | 1e-07 | ||
| 1kob_A | 387 | Twitchin Kinase Fragment (Aplysia), Autoregulated P | 1e-07 | ||
| 4fsm_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 1e-07 | ||
| 2w4j_A | 277 | X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | 1e-07 | ||
| 1bi8_A | 326 | Mechanism Of G1 Cyclin Dependent Kinase Inhibition | 1e-07 | ||
| 2yak_A | 285 | Structure Of Death-Associated Protein Kinase 1 (Dap | 1e-07 | ||
| 1zys_A | 273 | Co-Crystal Structure Of Checkpoint Kinase Chk1 With | 1e-07 | ||
| 1yrp_A | 278 | Catalytic Domain Of Human Zip Kinase Phosphorylated | 2e-07 | ||
| 3gbz_A | 329 | Structure Of The Cmgc Cdk Kinase From Giardia Lambl | 2e-07 | ||
| 4ec8_A | 373 | Structure Of Full Length Cdk9 In Complex With Cycli | 2e-07 | ||
| 4fsn_A | 278 | Crystal Structure Of The Chk1 Length = 278 | 2e-07 | ||
| 2x8e_A | 276 | Discovery Of A Novel Class Of Triazolones As Checkp | 2e-07 | ||
| 3fme_A | 290 | Crystal Structure Of Human Mitogen-Activated Protei | 2e-07 | ||
| 4b99_A | 398 | Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le | 2e-07 | ||
| 2ghg_A | 269 | H-Chk1 Complexed With A431994 Length = 269 | 2e-07 | ||
| 3ot3_A | 273 | X-Ray Crystal Structure Of Compound 22k Bound To Hu | 2e-07 | ||
| 4fsw_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-07 | ||
| 2e9v_A | 268 | Structure Of H-Chk1 Complexed With A859017 Length = | 2e-07 | ||
| 3o8p_A | 360 | Conformational Plasticity Of P38 Map Kinase Dfg Mot | 2e-07 | ||
| 4ft3_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-07 | ||
| 2w4k_A | 302 | X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | 2e-07 | ||
| 3gu4_A | 295 | Crystal Structure Of Dapkq23v-Amppnp Length = 295 | 2e-07 | ||
| 2j90_A | 304 | Crystal Structure Of Human Zip Kinase In Complex Wi | 2e-07 | ||
| 3jvr_A | 271 | Characterization Of The Chk1 Allosteric Inhibitor B | 2e-07 | ||
| 2ayp_A | 269 | Crystal Structure Of Chk1 With An Indol Inhibitor L | 2e-07 | ||
| 3coi_A | 353 | Crystal Structure Of P38delta Kinase Length = 353 | 2e-07 | ||
| 1p4f_A | 293 | Death Associated Protein Kinase Catalytic Domain Wi | 2e-07 | ||
| 3gi3_A | 360 | Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana | 2e-07 | ||
| 4bcf_A | 331 | Structure Of Cdk9 In Complex With Cyclin T And A 2- | 2e-07 | ||
| 1ig1_A | 294 | 1.8a X-Ray Structure Of Ternary Complex Of A Cataly | 2e-07 | ||
| 3vqu_A | 320 | Crystal Structure Of Human Mps1 Catalytic Domain In | 2e-07 | ||
| 4fst_A | 269 | Crystal Structure Of The Chk1 Length = 269 | 2e-07 | ||
| 3mh0_A | 360 | Mutagenesis Of P38 Map Kinase Eshtablishes Key Role | 2e-07 | ||
| 3mh3_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 2e-07 | ||
| 1jow_B | 308 | Crystal Structure Of A Complex Of Human Cdk6 And A | 2e-07 | ||
| 1y8g_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 2e-07 | ||
| 3blh_A | 331 | Crystal Structure Of Human Cdk9CYCLINT1 Length = 33 | 2e-07 | ||
| 3nup_A | 307 | Cdk6 (Monomeric) In Complex With Inhibitor Length = | 2e-07 | ||
| 2zmd_A | 390 | Crystal Structure Of Human Mps1 Catalytic Domain T6 | 2e-07 | ||
| 3gu8_A | 295 | Crystal Structure Of Dapkl93g With N6-Cyclopentylad | 2e-07 | ||
| 3mi9_A | 351 | Crystal Structure Of Hiv-1 Tat Complexed With Human | 3e-07 | ||
| 4e5a_X | 360 | The W197a Mutant Of P38a Map Kinase Length = 360 | 3e-07 | ||
| 3kex_A | 325 | Crystal Structure Of The Catalytically Inactive Kin | 3e-07 | ||
| 2xzs_A | 312 | Death Associated Protein Kinase 1 Residues 1-312 Le | 3e-07 | ||
| 2y0a_A | 326 | Structure Of Dapk1 Construct Residues 1-304 Length | 3e-07 | ||
| 1ua2_A | 346 | Crystal Structure Of Human Cdk7 Length = 346 | 3e-07 | ||
| 1zxe_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 3e-07 | ||
| 2jc6_A | 334 | Crystal Structure Of Human Calmodulin-Dependent Pro | 3e-07 | ||
| 3mh1_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 3e-07 | ||
| 2y94_A | 476 | Structure Of An Active Form Of Mammalian Ampk Lengt | 3e-07 | ||
| 3gc9_A | 370 | The Structure Of P38beta C119s, C162s In Complex Wi | 4e-07 | ||
| 2bdw_A | 362 | Crystal Structure Of The Auto-Inhibited Kinase Doma | 4e-07 | ||
| 2jam_A | 304 | Crystal Structure Of Human Calmodulin-Dependent Pro | 4e-07 | ||
| 3kk8_A | 284 | Camkii Substrate Complex A Length = 284 | 4e-07 | ||
| 1cm8_A | 367 | Phosphorylated Map Kinase P38-Gamma Length = 367 | 4e-07 | ||
| 3kl8_A | 269 | Camkiintide Inhibitor Complex Length = 269 | 4e-07 | ||
| 3kk9_A | 282 | Camkii Substrate Complex B Length = 282 | 5e-07 | ||
| 2c30_A | 321 | Crystal Structure Of The Human P21-Activated Kinase | 5e-07 | ||
| 3i7c_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 5e-07 | ||
| 2i0e_A | 353 | Structure Of Catalytic Domain Of Human Protein Kina | 5e-07 | ||
| 2f57_A | 317 | Crystal Structure Of The Human P21-activated Kinase | 6e-07 | ||
| 3h9f_A | 313 | Crystal Structure Of Human Dual Specificity Protein | 6e-07 | ||
| 3gp0_A | 348 | Crystal Structure Of Human Mitogen Activated Protei | 6e-07 | ||
| 2f9g_A | 353 | Crystal Structure Of Fus3 Phosphorylated On Tyr182 | 6e-07 | ||
| 2b9f_A | 353 | Crystal Structure Of Non-Phosphorylated Fus3 Length | 6e-07 | ||
| 4ejn_A | 446 | Crystal Structure Of Autoinhibited Form Of Akt1 In | 7e-07 | ||
| 3o96_A | 446 | Crystal Structure Of Human Akt1 With An Allosteric | 7e-07 | ||
| 3dls_A | 335 | Crystal Structure Of Human Pas Kinase Bound To Adp | 7e-07 | ||
| 1b6c_B | 342 | Crystal Structure Of The Cytoplasmic Domain Of The | 8e-07 | ||
| 3f3z_A | 277 | Crystal Structure Of Cryptosporidium Parvum Calcium | 9e-07 | ||
| 2dyl_A | 318 | Crystal Structure Of Human Mitogen-Activated Protei | 9e-07 | ||
| 3ll6_A | 337 | Crystal Structure Of The Human Cyclin G Associated | 9e-07 | ||
| 3gc8_A | 370 | The Structure Of P38beta C162s In Complex With A Di | 1e-06 | ||
| 3c0g_A | 351 | Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Len | 1e-06 | ||
| 2qg5_A | 294 | Cryptosporidium Parvum Calcium Dependent Protein Ki | 1e-06 | ||
| 1rw8_A | 301 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 1e-06 | ||
| 3tac_A | 361 | Crystal Structure Of The Liprin-AlphaCASK COMPLEX L | 1e-06 | ||
| 3e7o_A | 360 | Crystal Structure Of Jnk2 Length = 360 | 1e-06 | ||
| 3bhh_A | 295 | Crystal Structure Of Human Calcium/calmodulin-depen | 1e-06 | ||
| 3tzm_A | 309 | Tgf-Beta Receptor Type 1 In Complex With Sb431542 L | 1e-06 | ||
| 1vjy_A | 303 | Crystal Structure Of A Naphthyridine Inhibitor Of H | 1e-06 | ||
| 2wot_A | 306 | Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl) | 1e-06 | ||
| 1py5_A | 326 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 1e-06 | ||
| 2h34_A | 309 | Apoenzyme Crystal Structure Of The Tuberculosis Ser | 1e-06 | ||
| 2h6d_A | 276 | Protein Kinase Domain Of The Human 5'-Amp-Activated | 1e-06 | ||
| 1gzn_A | 335 | Structure Of Pkb Kinase Domain Length = 335 | 1e-06 | ||
| 1gzk_A | 315 | Molecular Mechanism For The Regulation Of Protein K | 1e-06 | ||
| 2b9h_A | 353 | Crystal Structure Of Fus3 With A Docking Motif From | 2e-06 | ||
| 1mrv_A | 339 | Crystal Structure Of An Inactive Akt2 Kinase Domain | 2e-06 | ||
| 2hw6_A | 307 | Crystal Structure Of Mnk1 Catalytic Domain Length = | 2e-06 | ||
| 2v7o_A | 336 | Crystal Structure Of Human Calcium-Calmodulin-Depen | 2e-06 | ||
| 2ac5_A | 316 | Structure Of Human Mnk2 Kinase Domain Mutant D228g | 2e-06 | ||
| 2yza_A | 276 | Crystal Structure Of Kinase Domain Of Human 5'-Amp- | 2e-06 | ||
| 3ocb_A | 341 | Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor | 2e-06 | ||
| 3v8s_A | 410 | Human Rho-Associated Protein Kinase 1 (Rock 1) In C | 2e-06 | ||
| 3cqu_A | 342 | Crystal Structure Of Akt-1 Complexed With Substrate | 2e-06 | ||
| 4gv1_A | 340 | Pkb Alpha In Complex With Azd5363 Length = 340 | 2e-06 | ||
| 2esm_A | 415 | Crystal Structure Of Rock 1 Bound To Fasudil Length | 2e-06 | ||
| 2v55_A | 406 | Mechanism Of Multi-site Phosphorylation From A Rock | 3e-06 | ||
| 3uc3_A | 361 | The Crystal Structure Of Snf1-Related Kinase 2.3 Le | 3e-06 | ||
| 3aln_A | 327 | Crystal Structure Of Human Non-Phosphorylated Mkk4 | 3e-06 | ||
| 3fpq_A | 290 | Crystal Structure Of The Kinase Domain Of Wnk1 Leng | 3e-06 | ||
| 1o6k_A | 336 | Structure Of Activated Form Of Pkb Kinase Domain S4 | 4e-06 | ||
| 3e87_A | 335 | Crystal Structures Of The Kinase Domain Of Akt2 In | 4e-06 | ||
| 2f2u_A | 402 | Crystal Structure Of The Rho-Kinase Kinase Domain L | 4e-06 | ||
| 3udb_A | 317 | Crystal Structure Of Snrk2.6 Length = 317 | 4e-06 | ||
| 2jdo_A | 342 | Structure Of Pkb-Beta (Akt2) Complexed With Isoquin | 4e-06 | ||
| 1o6l_A | 337 | Crystal Structure Of An Activated Akt/protein Kinas | 4e-06 | ||
| 4fvp_A | 289 | Crystal Structure Of The Jak2 Pseudokinase Domain ( | 5e-06 | ||
| 3e3p_A | 360 | Glycogen Synthase Kinase From Leishmania Major Leng | 5e-06 | ||
| 3ujg_A | 361 | Crystal Structure Of Snrk2.6 In Complex With Hab1 L | 5e-06 | ||
| 2y4i_B | 319 | Ksr2-Mek1 Heterodimer Length = 319 | 5e-06 | ||
| 3lij_A | 494 | Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) | 6e-06 | ||
| 3ama_A | 351 | Protein Kinase A Sixfold Mutant Model Of Aurora B W | 6e-06 | ||
| 3enm_A | 316 | The Structure Of The Map2k Mek6 Reveals An Autoinhi | 6e-06 | ||
| 1zws_A | 288 | Crystal Structure Of The Catalytic Domain Of Human | 7e-06 | ||
| 2a27_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 7e-06 | ||
| 1z9x_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 7e-06 | ||
| 2a2a_A | 321 | High-resolution Crystallographic Analysis Of The Au | 8e-06 | ||
| 2wel_A | 327 | Crystal Structure Of Su6656-Bound CalciumCALMODULIN | 9e-06 | ||
| 2vd5_A | 412 | Structure Of Human Myotonic Dystrophy Protein Kinas | 9e-06 | ||
| 1wmk_A | 321 | Human Death-Associated Kinase Drp-1, Mutant S308d D | 9e-06 | ||
| 2ya9_A | 361 | Crystal Structure Of The Autoinhibited Form Of Mous | 9e-06 | ||
| 3kmw_A | 271 | Crystal Structure Of The IlkALPHA-Parvin Core Compl | 1e-05 | ||
| 3uc4_A | 362 | The Crystal Structure Of Snf1-Related Kinase 2.6 Le | 1e-05 | ||
| 2ac3_A | 316 | Structure Of Human Mnk2 Kinase Domain Length = 316 | 1e-05 | ||
| 3vid_A | 356 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 1e-05 | ||
| 3vhe_A | 359 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 1e-05 | ||
| 3vhk_A | 368 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 1e-05 | ||
| 4hzs_A | 341 | Crystal Structure Of Ack1 Kinase Domain With C-term | 1e-05 | ||
| 1y6a_A | 366 | Crystal Structure Of Vegfr2 In Complex With A 2-Ani | 1e-05 | ||
| 1smh_A | 350 | Protein Kinase A Variant Complex With Completely Or | 1e-05 | ||
| 1tki_A | 321 | Autoinhibited Serine Kinase Domain Of The Giant Mus | 1e-05 | ||
| 3i6w_A | 443 | Structure And Activation Mechanism Of The Chk2 Dna- | 1e-05 | ||
| 2vn9_A | 301 | Crystal Structure Of Human Calcium Calmodulin Depen | 1e-05 | ||
| 3lm0_A | 327 | Crystal Structure Of Human SerineTHREONINE KINASE 1 | 1e-05 | ||
| 3i6u_A | 419 | Structure And Activation Mechanism Of The Chk2 Dna- | 2e-05 | ||
| 1u54_A | 291 | Crystal Structures Of The Phosphorylated And Unphos | 2e-05 | ||
| 2w4o_A | 349 | Crystal Structure Of Human Camk4 In Complex With 4- | 2e-05 | ||
| 1u46_A | 291 | Crystal Structure Of The Unphosphorylated Kinase Do | 2e-05 | ||
| 3eqp_B | 276 | Crystal Structure Of Ack1 With Compound T95 Length | 2e-05 | ||
| 4ewh_B | 275 | Co-Crystal Structure Of Ack1 With Inhibitor Length | 2e-05 | ||
| 1xh9_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 2e-05 | ||
| 2gnj_A | 350 | Pka Three Fold Mutant Model Of Rho-Kinase With Y-27 | 2e-05 | ||
| 3ttj_A | 464 | Crystal Structure Of Jnk3 Complexed With Cc-359, A | 2e-05 | ||
| 1pmn_A | 364 | Crystal Structure Of Jnk3 In Complex With An Imidaz | 2e-05 | ||
| 2rio_A | 434 | Structure Of The Dual Enzyme Ire1 Reveals The Basis | 2e-05 | ||
| 3ptg_A | 363 | Design And Synthesis Of A Novel, Orally Efficacious | 2e-05 | ||
| 2o0u_A | 364 | Crystal Structure Of Human Jnk3 Complexed With N-{3 | 2e-05 | ||
| 3vui_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 2e-05 | ||
| 3oxi_A | 362 | Design And Synthesis Of Disubstituted Thiophene And | 2e-05 | ||
| 4id7_A | 273 | Ack1 Kinase In Complex With The Inhibitor Cis-3-[8- | 2e-05 | ||
| 2gu8_A | 337 | Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel | 2e-05 | ||
| 4hzr_A | 277 | Crystal Structure Of Ack1 Kinase Domain Length = 27 | 2e-05 | ||
| 1jnk_A | 423 | The C-Jun N-Terminal Kinase (Jnk3s) Complexed With | 2e-05 | ||
| 2exc_X | 356 | Inhibitor Complex Of Jnk3 Length = 356 | 2e-05 | ||
| 2ok1_A | 365 | Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3 | 2e-05 | ||
| 3vud_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 2e-05 | ||
| 3fv8_A | 355 | Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le | 2e-05 | ||
| 2b1p_A | 355 | Inhibitor Complex Of Jnk3 Length = 355 | 2e-05 | ||
| 1ukh_A | 369 | Structural Basis For The Selective Inhibition Of Jn | 2e-05 | ||
| 2xrw_A | 371 | Linear Binding Motifs For Jnk And For Calcineurin A | 2e-05 | ||
| 3vuh_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M3 | 2e-05 | ||
| 4h36_A | 356 | Crystal Structure Of Jnk3 In Complex With Atf2 Pept | 2e-05 | ||
| 2jkm_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 2e-05 | ||
| 2gnf_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 3e-05 | ||
| 2xk9_A | 322 | Structural Analysis Of Checkpoint Kinase 2 (Chk2) I | 3e-05 | ||
| 2ycf_A | 322 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 3e-05 | ||
| 1ctp_E | 350 | Structure Of The Mammalian Catalytic Subunit Of Cam | 3e-05 | ||
| 3vug_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 3e-05 | ||
| 1cmk_E | 350 | Crystal Structures Of The Myristylated Catalytic Su | 3e-05 | ||
| 2ycr_A | 323 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 3e-05 | ||
| 2w0j_A | 323 | Crystal Structure Of Chk2 In Complex With Nsc 10955 | 3e-05 | ||
| 2gng_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 3e-05 | ||
| 1cdk_A | 350 | Camp-Dependent Protein Kinase Catalytic Subunit (E. | 3e-05 | ||
| 3vum_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M7 | 3e-05 | ||
| 3v3v_A | 379 | Structural And Functional Analysis Of Quercetagetin | 3e-05 | ||
| 3pxk_A | 282 | Focal Adhesion Kinase Catalytic Domain In Complex W | 3e-05 | ||
| 3bz3_A | 276 | Crystal Structure Analysis Of Focal Adhesion Kinase | 3e-05 | ||
| 2cn5_A | 329 | Crystal Structure Of Human Chk2 In Complex With Adp | 3e-05 | ||
| 3vul_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 3e-05 | ||
| 4ebw_A | 304 | Structure Of Focal Adhesion Kinase Catalytic Domain | 3e-05 | ||
| 3zut_A | 362 | The Structure Of Ost1 (D160a) Kinase Length = 362 | 3e-05 | ||
| 2j0m_B | 276 | Crystal Structure A Two-Chain Complex Between The F | 3e-05 | ||
| 3fi2_A | 353 | Crystal Structure Of Jnk3 With Amino-Pyrazole Inhib | 3e-05 | ||
| 2etm_A | 281 | Crystal Structure Of Focal Adhesion Kinase Domain C | 3e-05 | ||
| 4dfy_A | 371 | Crystal Structure Of R194a Mutant Of Camp-Dependent | 3e-05 | ||
| 2qur_A | 350 | Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe | 3e-05 | ||
| 3sdj_A | 448 | Structure Of Rnase-Inactive Point Mutant Of Oligome | 3e-05 | ||
| 3fhi_A | 350 | Crystal Structure Of A Complex Between The Catalyti | 4e-05 | ||
| 1mp8_A | 281 | Crystal Structure Of Focal Adhesion Kinase (Fak) Le | 4e-05 | ||
| 2j0j_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 4e-05 | ||
| 2j0l_A | 276 | Crystal Structure Of A The Active Conformation Of T | 4e-05 | ||
| 2xs0_A | 386 | Linear Binding Motifs For Jnk And For Calcineurin A | 4e-05 | ||
| 4dfx_E | 350 | Crystal Structure Of Myristoylated K7c Catalytic Su | 4e-05 | ||
| 1l3r_E | 350 | Crystal Structure Of A Transition State Mimic Of Th | 4e-05 | ||
| 3qal_E | 350 | Crystal Structure Of Arg280ala Mutant Of Catalytic | 4e-05 | ||
| 1fmo_E | 350 | Crystal Structure Of A Polyhistidine-Tagged Recombi | 4e-05 | ||
| 2erz_E | 351 | Crystal Structure Of C-amp Dependent Kinase (pka) B | 4e-05 | ||
| 3fbv_A | 448 | Crystal Structure Of The Oligomer Formed By The Kin | 4e-05 | ||
| 2qcs_A | 350 | A Complex Structure Between The Catalytic And Regul | 4e-05 | ||
| 1bkx_A | 350 | A Binary Complex Of The Catalytic Subunit Of Camp-D | 4e-05 | ||
| 1apm_E | 350 | 2.0 Angstrom Refined Crystal Structure Of The Catal | 4e-05 | ||
| 1j3h_A | 350 | Crystal Structure Of Apoenzyme Camp-Dependent Prote | 4e-05 | ||
| 3elj_A | 369 | Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine | 4e-05 | ||
| 3pvb_A | 345 | Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca | 5e-05 | ||
| 4g31_A | 299 | Crystal Structure Of Gsk6414 Bound To Perk (R587-R1 | 5e-05 | ||
| 4eut_A | 396 | Structure Of Bx-795 Complexed With Unphosphorylated | 5e-05 | ||
| 4dg3_E | 371 | Crystal Structure Of R336a Mutant Of Camp-dependent | 5e-05 | ||
| 3l9m_A | 351 | Crystal Structure Of Pkab3 (Pka Triple Mutant V123a | 5e-05 | ||
| 4fvr_A | 289 | Crystal Structure Of The Jak2 Pseudokinase Domain M | 5e-05 | ||
| 3pze_A | 358 | Jnk1 In Complex With Inhibitor Length = 358 | 5e-05 | ||
| 1jbp_E | 350 | Crystal Structure Of The Catalytic Subunit Of Camp- | 5e-05 | ||
| 1yxs_A | 293 | Crystal Structure Of Kinase Pim1 With P123m Mutatio | 6e-05 | ||
| 3zuu_A | 362 | The Structure Of Ost1 (D160a, S175d) Kinase In Comp | 6e-05 | ||
| 1q24_A | 350 | Pka Double Mutant Model Of Pkb In Complex With Mgat | 6e-05 | ||
| 2jkk_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 6e-05 | ||
| 4ae6_A | 343 | Structure And Function Of The Human Sperm-specific | 6e-05 | ||
| 2j0k_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 6e-05 | ||
| 4euu_A | 319 | Structure Of Bx-795 Complexed With Human Tbk1 Kinas | 7e-05 | ||
| 1szm_A | 350 | Dual Binding Mode Of Bisindolylmaleimide 2 To Prote | 7e-05 | ||
| 4ae9_A | 343 | Structure And Function Of The Human Sperm-specific | 7e-05 | ||
| 3dxn_A | 287 | Crystal Structure Of The Calcium-dependent Kinase F | 7e-05 | ||
| 2qr8_A | 342 | 2.0a X-ray Structure Of C-terminal Kinase Domain Of | 7e-05 | ||
| 3agl_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 7e-05 | ||
| 1q61_A | 350 | Pka Triple Mutant Model Of Pkb Length = 350 | 7e-05 | ||
| 3nx8_A | 351 | Human Camp Dependent Protein Kinase In Complex With | 7e-05 | ||
| 3agm_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 7e-05 | ||
| 2jdt_A | 351 | Structure Of Pka-Pkb Chimera Complexed With Isoquin | 8e-05 | ||
| 3o7l_B | 350 | Crystal Structure Of Phospholamban (1-19):pka C-Sub | 8e-05 | ||
| 2vo0_A | 351 | Structure Of Pka-Pkb Chimera Complexed With C-(4-(4 | 8e-05 | ||
| 2uvy_A | 351 | Structure Of Pka-pkb Chimera Complexed With Methyl- | 8e-05 | ||
| 3dnd_A | 350 | Camp-Dependent Protein Kinase Pka Catalytic Subunit | 9e-05 | ||
| 2i6l_A | 320 | Crystal Structure Of Human Mitogen Activated Protei | 9e-05 | ||
| 3mvj_A | 371 | Human Cyclic Amp-Dependent Protein Kinase Pka Inhib | 9e-05 | ||
| 1svh_A | 350 | Crystal Structure Of Protein Kinase A In Complex Wi | 9e-05 | ||
| 2uzt_A | 336 | Pka Structures Of Akt, Indazole-Pyridine Inhibitors | 1e-04 | ||
| 2c1a_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 1e-04 | ||
| 1xh7_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 1e-04 | ||
| 2xix_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-1 Fro | 1e-04 | ||
| 4alv_A | 328 | Benzofuropyrimidinone Inhibitors Of Pim-1 Length = | 1e-04 | ||
| 2jds_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 1e-04 | ||
| 1syk_A | 350 | Crystal Structure Of E230q Mutant Of Camp-Dependent | 1e-04 | ||
| 1q8w_A | 350 | The Catalytic Subunit Of Camp-Dependent Protein Kin | 1e-04 | ||
| 1stc_E | 350 | Camp-Dependent Protein Kinase, Alpha-Catalytic Subu | 1e-04 | ||
| 2f7e_E | 351 | Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu | 1e-04 | ||
| 1ydt_E | 350 | Structure Of Camp-Dependent Protein Kinase, Alpha-C | 1e-04 | ||
| 2buj_A | 317 | Crystal Structure Of The Human Serine-Threonine Kin | 1e-04 | ||
| 1xws_A | 313 | Crystal Structure Of The Human Pim1 Kinase Domain L | 1e-04 | ||
| 3uix_A | 298 | Crystal Structure Of Pim1 Kinase In Complex With Sm | 1e-04 | ||
| 2xj0_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-4 Fro | 1e-04 | ||
| 2xiy_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-2 Fro | 1e-04 | ||
| 3f2a_A | 300 | Crystal Structure Of Human Pim-1 In Complex With Da | 1e-04 | ||
| 1xqz_A | 300 | Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolut | 1e-04 | ||
| 3vuk_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M5 | 1e-04 | ||
| 2qr7_A | 342 | 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of | 1e-04 | ||
| 3dcv_A | 328 | Crystal Structure Of Human Pim1 Kinase Complexed Wi | 1e-04 | ||
| 2obj_A | 333 | Crystal Structure Of Human Pim-1 Kinase In Complex | 1e-04 | ||
| 3r00_A | 299 | The Discovery Of Novel Benzofuran-2-Carboxylic Acid | 1e-04 | ||
| 3a99_A | 320 | Structure Of Pim-1 Kinase Crystallized In The Prese | 1e-04 | ||
| 4alu_A | 328 | Benzofuropyrimidinone Inhibitors Of Pim-1 Length = | 1e-04 | ||
| 1ywv_A | 293 | Crystal Structures Of Proto-Oncogene Kinase Pim1: A | 1e-04 | ||
| 3jxw_A | 294 | Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4- | 2e-04 | ||
| 3lj0_A | 434 | Ire1 Complexed With Adp And Quercetin Length = 434 | 2e-04 | ||
| 3c4e_A | 273 | Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7 | 2e-04 | ||
| 4a7c_A | 308 | Crystal Structure Of Pim1 Kinase With Etp46546 Leng | 2e-04 | ||
| 1yhs_A | 273 | Crystal Structure Of Pim-1 Bound To Staurosporine L | 2e-04 | ||
| 4dtk_A | 276 | Novel And Selective Pan-Pim Kinase Inhibitor Length | 2e-04 | ||
| 3p23_A | 432 | Crystal Structure Of The Human Kinase And Rnase Dom | 2e-04 | ||
| 3hzt_A | 467 | Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4 | 2e-04 | ||
| 3cy3_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 2e-04 | ||
| 3ma3_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 2e-04 | ||
| 2bik_B | 313 | Human Pim1 Phosphorylated On Ser261 Length = 313 | 2e-04 | ||
| 2j2i_B | 312 | Crystal Structure Of The Humab Pim1 In Complex With | 2e-04 | ||
| 2bil_B | 313 | The Human Protein Kinase Pim1 In Complex With Its C | 2e-04 | ||
| 3cxw_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 2e-04 | ||
| 3jpv_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 2e-04 | ||
| 2vz6_A | 313 | Structure Of Human Calcium Calmodulin Dependent Pro | 2e-04 | ||
| 3soa_A | 444 | Full-Length Human Camkii Length = 444 | 2e-04 | ||
| 3qam_E | 350 | Crystal Structure Of Glu208ala Mutant Of Catalytic | 2e-04 | ||
| 3uib_A | 362 | Map Kinase Lmampk10 From Leishmania Major In Comple | 3e-04 | ||
| 4as0_A | 273 | Cyclometalated Phthalimides As Protein Kinase Inhib | 3e-04 | ||
| 3pg1_A | 362 | Map Kinase Lmampk10 From Leishmania Major (1.95 Ang | 3e-04 | ||
| 3fi3_A | 364 | Crystal Structure Of Jnk3 With Indazole Inhibitor, | 4e-04 | ||
| 2wtk_C | 305 | Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2 | 4e-04 | ||
| 2g01_A | 370 | Pyrazoloquinolones As Novel, Selective Jnk1 Inhibit | 4e-04 | ||
| 2r9s_A | 356 | C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu | 4e-04 | ||
| 3nie_A | 429 | Crystal Structure Of Pf11_0147 Length = 429 | 4e-04 | ||
| 3o17_A | 370 | Crystal Structure Of Jnk1-Alpha1 Isoform Length = 3 | 4e-04 |
| >pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar Kinaseinteracting Domains In A Single Type Iii Effector Length = 349 | Back alignment and structure |
|
| >pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On Plant Receptor- Like Kinase Bak1 Activation Length = 326 | Back alignment and structure |
|
| >pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321 | Back alignment and structure |
|
| >pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327 | Back alignment and structure |
|
| >pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301 | Back alignment and structure |
|
| >pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|3RIZ|A Chain A, Crystal Structure Of The Plant Steroid Receptor Bri1 Ectodomain Length = 772 | Back alignment and structure |
|
| >pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287 | Back alignment and structure |
|
| >pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|3RGX|A Chain A, Structural Insight Into Brassinosteroid Perception By Bri1 Length = 768 | Back alignment and structure |
|
| >pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333 | Back alignment and structure |
|
| >pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266 | Back alignment and structure |
|
| >pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264 | Back alignment and structure |
|
| >pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269 | Back alignment and structure |
|
| >pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318 | Back alignment and structure |
|
| >pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271 | Back alignment and structure |
|
| >pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281 | Back alignment and structure |
|
| >pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306 | Back alignment and structure |
|
| >pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284 | Back alignment and structure |
|
| >pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307 | Back alignment and structure |
|
| >pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282 | Back alignment and structure |
|
| >pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275 | Back alignment and structure |
|
| >pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267 | Back alignment and structure |
|
| >pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280 | Back alignment and structure |
|
| >pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302 | Back alignment and structure |
|
| >pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361 | Back alignment and structure |
|
| >pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344 | Back alignment and structure |
|
| >pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266 | Back alignment and structure |
|
| >pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371 | Back alignment and structure |
|
| >pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373 | Back alignment and structure |
|
| >pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312 | Back alignment and structure |
|
| >pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300 | Back alignment and structure |
|
| >pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292 | Back alignment and structure |
|
| >pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315 | Back alignment and structure |
|
| >pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280 | Back alignment and structure |
|
| >pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307 | Back alignment and structure |
|
| >pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289 | Back alignment and structure |
|
| >pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295 | Back alignment and structure |
|
| >pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285 | Back alignment and structure |
|
| >pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306 | Back alignment and structure |
|
| >pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273 | Back alignment and structure |
|
| >pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287 | Back alignment and structure |
|
| >pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288 | Back alignment and structure |
|
| >pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271 | Back alignment and structure |
|
| >pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272 | Back alignment and structure |
|
| >pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279 | Back alignment and structure |
|
| >pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344 | Back alignment and structure |
|
| >pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277 | Back alignment and structure |
|
| >pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277 | Back alignment and structure |
|
| >pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373 | Back alignment and structure |
|
| >pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289 | Back alignment and structure |
|
| >pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306 | Back alignment and structure |
|
| >pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285 | Back alignment and structure |
|
| >pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271 | Back alignment and structure |
|
| >pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265 | Back alignment and structure |
|
| >pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297 | Back alignment and structure |
|
| >pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297 | Back alignment and structure |
|
| >pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275 | Back alignment and structure |
|
| >pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307 | Back alignment and structure |
|
| >pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306 | Back alignment and structure |
|
| >pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303 | Back alignment and structure |
|
| >pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280 | Back alignment and structure |
|
| >pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285 | Back alignment and structure |
|
| >pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286 | Back alignment and structure |
|
| >pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290 | Back alignment and structure |
|
| >pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285 | Back alignment and structure |
|
| >pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535 | Back alignment and structure |
|
| >pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285 | Back alignment and structure |
|
| >pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299 | Back alignment and structure |
|
| >pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286 | Back alignment and structure |
|
| >pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267 | Back alignment and structure |
|
| >pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268 | Back alignment and structure |
|
| >pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272 | Back alignment and structure |
|
| >pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278 | Back alignment and structure |
|
| >pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281 | Back alignment and structure |
|
| >pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286 | Back alignment and structure |
|
| >pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267 | Back alignment and structure |
|
| >pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270 | Back alignment and structure |
|
| >pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268 | Back alignment and structure |
|
| >pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276 | Back alignment and structure |
|
| >pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285 | Back alignment and structure |
|
| >pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279 | Back alignment and structure |
|
| >pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282 | Back alignment and structure |
|
| >pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282 | Back alignment and structure |
|
| >pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271 | Back alignment and structure |
|
| >pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452 | Back alignment and structure |
|
| >pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454 | Back alignment and structure |
|
| >pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262 | Back alignment and structure |
|
| >pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277 | Back alignment and structure |
|
| >pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452 | Back alignment and structure |
|
| >pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283 | Back alignment and structure |
|
| >pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275 | Back alignment and structure |
|
| >pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301 | Back alignment and structure |
|
| >pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279 | Back alignment and structure |
|
| >pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286 | Back alignment and structure |
|
| >pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286 | Back alignment and structure |
|
| >pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272 | Back alignment and structure |
|
| >pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268 | Back alignment and structure |
|
| >pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452 | Back alignment and structure |
|
| >pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286 | Back alignment and structure |
|
| >pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318 | Back alignment and structure |
|
| >pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308 | Back alignment and structure |
|
| >pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292 | Back alignment and structure |
|
| >pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268 | Back alignment and structure |
|
| >pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302 | Back alignment and structure |
|
| >pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453 | Back alignment and structure |
|
| >pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306 | Back alignment and structure |
|
| >pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309 | Back alignment and structure |
|
| >pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283 | Back alignment and structure |
|
| >pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310 | Back alignment and structure |
|
| >pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286 | Back alignment and structure |
|
| >pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307 | Back alignment and structure |
|
| >pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283 | Back alignment and structure |
|
| >pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303 | Back alignment and structure |
|
| >pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295 | Back alignment and structure |
|
| >pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300 | Back alignment and structure |
|
| >pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298 | Back alignment and structure |
|
| >pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293 | Back alignment and structure |
|
| >pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295 | Back alignment and structure |
|
| >pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314 | Back alignment and structure |
|
| >pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301 | Back alignment and structure |
|
| >pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286 | Back alignment and structure |
|
| >pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307 | Back alignment and structure |
|
| >pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311 | Back alignment and structure |
|
| >pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313 | Back alignment and structure |
|
| >pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277 | Back alignment and structure |
|
| >pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317 | Back alignment and structure |
|
| >pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298 | Back alignment and structure |
|
| >pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373 | Back alignment and structure |
|
| >pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294 | Back alignment and structure |
|
| >pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298 | Back alignment and structure |
|
| >pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327 | Back alignment and structure |
|
| >pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329 | Back alignment and structure |
|
| >pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | Back alignment and structure |
|
| >pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302 | Back alignment and structure |
|
| >pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277 | Back alignment and structure |
|
| >pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395 | Back alignment and structure |
|
| >pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293 | Back alignment and structure |
|
| >pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277 | Back alignment and structure |
|
| >pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312 | Back alignment and structure |
|
| >pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283 | Back alignment and structure |
|
| >pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277 | Back alignment and structure |
|
| >pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314 | Back alignment and structure |
|
| >pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354 | Back alignment and structure |
|
| >pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310 | Back alignment and structure |
|
| >pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270 | Back alignment and structure |
|
| >pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283 | Back alignment and structure |
|
| >pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273 | Back alignment and structure |
|
| >pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298 | Back alignment and structure |
|
| >pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267 | Back alignment and structure |
|
| >pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333 | Back alignment and structure |
|
| >pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284 | Back alignment and structure |
|
| >pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360 | Back alignment and structure |
|
| >pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263 | Back alignment and structure |
|
| >pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341 | Back alignment and structure |
|
| >pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304 | Back alignment and structure |
|
| >pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284 | Back alignment and structure |
|
| >pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328 | Back alignment and structure |
|
| >pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322 | Back alignment and structure |
|
| >pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300 | Back alignment and structure |
|
| >pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274 | Back alignment and structure |
|
| >pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271 | Back alignment and structure |
|
| >pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324 | Back alignment and structure |
|
| >pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288 | Back alignment and structure |
|
| >pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288 | Back alignment and structure |
|
| >pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272 | Back alignment and structure |
|
| >pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537 | Back alignment and structure |
|
| >pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495 | Back alignment and structure |
|
| >pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284 | Back alignment and structure |
|
| >pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676 | Back alignment and structure |
|
| >pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265 | Back alignment and structure |
|
| >pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677 | Back alignment and structure |
|
| >pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286 | Back alignment and structure |
|
| >pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | Back alignment and structure |
|
| >pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278 | Back alignment and structure |
|
| >pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350 | Back alignment and structure |
|
| >pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491 | Back alignment and structure |
|
| >pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573 | Back alignment and structure |
|
| >pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287 | Back alignment and structure |
|
| >pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272 | Back alignment and structure |
|
| >pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318 | Back alignment and structure |
|
| >pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298 | Back alignment and structure |
|
| >pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329 | Back alignment and structure |
|
| >pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576 | Back alignment and structure |
|
| >pdb|3Q4T|A Chain A, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a) Kinase Domain In Complex With Dorsomorphin Length = 322 | Back alignment and structure |
|
| >pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576 | Back alignment and structure |
|
| >pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328 | Back alignment and structure |
|
| >pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321 | Back alignment and structure |
|
| >pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295 | Back alignment and structure |
|
| >pdb|2YFX|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase In Complex With Crizotinib Length = 327 | Back alignment and structure |
|
| >pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317 | Back alignment and structure |
|
| >pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352 | Back alignment and structure |
|
| >pdb|4FNW|A Chain A, Crystal Structure Of The Apo F1174l Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311 | Back alignment and structure |
|
| >pdb|2XP2|A Chain A, Structure Of The Human Anaplastic Lymphoma Kinase In Complex With Crizotinib (Pf-02341066) Length = 327 | Back alignment and structure |
|
| >pdb|4FNZ|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Piperidine-Carboxamide Inhibitor 2 Length = 327 | Back alignment and structure |
|
| >pdb|2XB7|A Chain A, Structure Of Human Anaplastic Lymphoma Kinase In Complex With Nvp- Tae684 Length = 315 | Back alignment and structure |
|
| >pdb|2QLU|A Chain A, Crystal Structure Of Activin Receptor Type Ii Kinase Domain From Human Length = 314 | Back alignment and structure |
|
| >pdb|2YJR|A Chain A, Structure Of F1174l Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|3AOX|A Chain A, X-Ray Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Ch5424802 Length = 344 | Back alignment and structure |
|
| >pdb|4DCE|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With A Piperidine-Carboxamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2YHV|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|3LCT|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 344 | Back alignment and structure |
|
| >pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688 | Back alignment and structure |
|
| >pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268 | Back alignment and structure |
|
| >pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3L9P|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 367 | Back alignment and structure |
|
| >pdb|4FOB|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Acyliminobenzimidazole Inhibitor 1 Length = 353 | Back alignment and structure |
|
| >pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695 | Back alignment and structure |
|
| >pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310 | Back alignment and structure |
|
| >pdb|2YJS|A Chain A, Structure Of C1156y Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313 | Back alignment and structure |
|
| >pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373 | Back alignment and structure |
|
| >pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311 | Back alignment and structure |
|
| >pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384 | Back alignment and structure |
|
| >pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311 | Back alignment and structure |
|
| >pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311 | Back alignment and structure |
|
| >pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321 | Back alignment and structure |
|
| >pdb|1IRK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Human Insulin Receptor Length = 306 | Back alignment and structure |
|
| >pdb|1PKG|A Chain A, Structure Of A C-kit Kinase Product Complex Length = 329 | Back alignment and structure |
|
| >pdb|1I44|A Chain A, Crystallographic Studies Of An Activation Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|3G0F|A Chain A, Kit Kinase Domain Mutant D816h In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|1T46|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C-kit Tyrosine Kinase Length = 313 | Back alignment and structure |
|
| >pdb|3ETA|A Chain A, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo Pyridine Inhibitor Length = 317 | Back alignment and structure |
|
| >pdb|3G0E|A Chain A, Kit Kinase Domain In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|1T45|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C- Kit Tyrosine Kinase Length = 331 | Back alignment and structure |
|
| >pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights Into Receptor Autoregulation Length = 343 | Back alignment and structure |
|
| >pdb|4FNX|A Chain A, Crystal Structure Of The Apo R1275q Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311 | Back alignment and structure |
|
| >pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292 | Back alignment and structure |
|
| >pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335 | Back alignment and structure |
|
| >pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394 | Back alignment and structure |
|
| >pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325 | Back alignment and structure |
|
| >pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290 | Back alignment and structure |
|
| >pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|3EKK|A Chain A, Insulin Receptor Kinase Complexed With An Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|1P14|A Chain A, Crystal Structure Of A Catalytic-Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|1IR3|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With Peptide Substrate And Atp Analog Length = 306 | Back alignment and structure |
|
| >pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345 | Back alignment and structure |
|
| >pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311 | Back alignment and structure |
|
| >pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285 | Back alignment and structure |
|
| >pdb|1RQQ|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In Complex With The Sh2 Domain Of Aps Length = 306 | Back alignment and structure |
|
| >pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284 | Back alignment and structure |
|
| >pdb|3G2F|A Chain A, Crystal Structure Of The Kinase Domain Of Bone Morphogenetic Protein Receptor Type Ii (Bmpr2) At 2.35 A Resolution Length = 336 | Back alignment and structure |
|
| >pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304 | Back alignment and structure |
|
| >pdb|2Z8C|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin-2- Yl]amino}phenyl)acetic Acid Length = 303 | Back alignment and structure |
|
| >pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305 | Back alignment and structure |
|
| >pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297 | Back alignment and structure |
|
| >pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299 | Back alignment and structure |
|
| >pdb|1P4O|A Chain A, Structure Of Apo Unactivated Igf-1r Kinase Domain At 1.5a Resolution. Length = 322 | Back alignment and structure |
|
| >pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279 | Back alignment and structure |
|
| >pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279 | Back alignment and structure |
|
| >pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314 | Back alignment and structure |
|
| >pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279 | Back alignment and structure |
|
| >pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297 | Back alignment and structure |
|
| >pdb|3LCO|A Chain A, Inhibitor Bound To A Dfg-Out Structure Of The Kinase Domain Of Csf-1r Length = 324 | Back alignment and structure |
|
| >pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301 | Back alignment and structure |
|
| >pdb|4AW2|A Chain A, Crystal Structure Of Cdc42 Binding Protein Kinase Alpha (Mrck Alpha) Length = 437 | Back alignment and structure |
|
| >pdb|3LW0|A Chain A, Igf-1rk In Complex With Ligand Msc1609119a-1 Length = 304 | Back alignment and structure |
|
| >pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294 | Back alignment and structure |
|
| >pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348 | Back alignment and structure |
|
| >pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315 | Back alignment and structure |
|
| >pdb|1M7N|A Chain A, Crystal Structure Of Unactivated Apo Insulin-Like Growth Factor-1 Receptor Kinase Domain Length = 322 | Back alignment and structure |
|
| >pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311 | Back alignment and structure |
|
| >pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311 | Back alignment and structure |
|
| >pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335 | Back alignment and structure |
|
| >pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3I81|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor (Igf-1r-Wt) Complex With Bms-754807 [1-(4-((5-Cyclopropyl- 1h-Pyrazol-3-Yl)amino)pyrrolo[2,1-F][1,2, 4]triazin-2-Yl)-N- (6-Fluoro-3-Pyridinyl)-2-Methyl-L-Prolinamide] Length = 315 | Back alignment and structure |
|
| >pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353 | Back alignment and structure |
|
| >pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3O23|A Chain A, Human Unphosphorylated Igf1-R Kinase Domain In Complex With An Hydantoin Inhibitor Length = 305 | Back alignment and structure |
|
| >pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|1JQH|A Chain A, Igf-1 Receptor Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3QQU|A Chain A, Cocrystal Structure Of Unphosphorylated Igf With Pyrimidine 8 Length = 301 | Back alignment and structure |
|
| >pdb|3LVP|A Chain A, Crystal Structure Of Bisphosphorylated Igf1-R Kinase Domain (2p) In Complex With A Bis-Azaindole Inhibitor Length = 336 | Back alignment and structure |
|
| >pdb|2OJ9|A Chain A, Structure Of Igf-1r Kinase Domain Complexed With A Benzimidazole Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365 | Back alignment and structure |
|
| >pdb|3D94|A Chain A, Crystal Structure Of The Insulin-Like Growth Factor-1 Receptor Kinase In Complex With Pqip Length = 301 | Back alignment and structure |
|
| >pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302 | Back alignment and structure |
|
| >pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327 | Back alignment and structure |
|
| >pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293 | Back alignment and structure |
|
| >pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297 | Back alignment and structure |
|
| >pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370 | Back alignment and structure |
|
| >pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327 | Back alignment and structure |
|
| >pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277 | Back alignment and structure |
|
| >pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294 | Back alignment and structure |
|
| >pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|1K3A|A Chain A, Structure Of The Insulin-Like Growth Factor 1 Receptor Kinase Length = 299 | Back alignment and structure |
|
| >pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309 | Back alignment and structure |
|
| >pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301 | Back alignment and structure |
|
| >pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298 | Back alignment and structure |
|
| >pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317 | Back alignment and structure |
|
| >pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334 | Back alignment and structure |
|
| >pdb|1OEC|A Chain A, Fgfr2 Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313 | Back alignment and structure |
|
| >pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334 | Back alignment and structure |
|
| >pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318 | Back alignment and structure |
|
| >pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292 | Back alignment and structure |
|
| >pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288 | Back alignment and structure |
|
| >pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316 | Back alignment and structure |
|
| >pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294 | Back alignment and structure |
|
| >pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311 | Back alignment and structure |
|
| >pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|2P0C|A Chain A, Catalytic Domain Of The Proto-Oncogene Tyrosine-Protein Kina Length = 313 | Back alignment and structure |
|
| >pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317 | Back alignment and structure |
|
| >pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289 | Back alignment and structure |
|
| >pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382 | Back alignment and structure |
|
| >pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304 | Back alignment and structure |
|
| >pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317 | Back alignment and structure |
|
| >pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286 | Back alignment and structure |
|
| >pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290 | Back alignment and structure |
|
| >pdb|2ZM3|A Chain A, Complex Structure Of Insulin-Like Growth Factor Receptor And Isoquinolinedione Inhibitor Length = 308 | Back alignment and structure |
|
| >pdb|3QUP|A Chain A, Inhibitor Bound Structure Of The Kinase Domain Of The Murine Receptor Tyrosine Kinase Tyro3 (Sky) Length = 323 | Back alignment and structure |
|
| >pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352 | Back alignment and structure |
|
| >pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285 | Back alignment and structure |
|
| >pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286 | Back alignment and structure |
|
| >pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286 | Back alignment and structure |
|
| >pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377 | Back alignment and structure |
|
| >pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299 | Back alignment and structure |
|
| >pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269 | Back alignment and structure |
|
| >pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331 | Back alignment and structure |
|
| >pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306 | Back alignment and structure |
|
| >pdb|3QFV|A Chain A, Mrck Beta In Complex With Tpca-1 Length = 415 | Back alignment and structure |
|
| >pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311 | Back alignment and structure |
|
| >pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382 | Back alignment and structure |
|
| >pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377 | Back alignment and structure |
|
| >pdb|3TKU|A Chain A, Mrck Beta In Complex With Fasudil Length = 433 | Back alignment and structure |
|
| >pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328 | Back alignment and structure |
|
| >pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613 | Back alignment and structure |
|
| >pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328 | Back alignment and structure |
|
| >pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314 | Back alignment and structure |
|
| >pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303 | Back alignment and structure |
|
| >pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298 | Back alignment and structure |
|
| >pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331 | Back alignment and structure |
|
| >pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329 | Back alignment and structure |
|
| >pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315 | Back alignment and structure |
|
| >pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263 | Back alignment and structure |
|
| >pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318 | Back alignment and structure |
|
| >pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312 | Back alignment and structure |
|
| >pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | Back alignment and structure |
|
| >pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311 | Back alignment and structure |
|
| >pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312 | Back alignment and structure |
|
| >pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309 | Back alignment and structure |
|
| >pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306 | Back alignment and structure |
|
| >pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278 | Back alignment and structure |
|
| >pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316 | Back alignment and structure |
|
| >pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327 | Back alignment and structure |
|
| >pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300 | Back alignment and structure |
|
| >pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299 | Back alignment and structure |
|
| >pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298 | Back alignment and structure |
|
| >pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310 | Back alignment and structure |
|
| >pdb|1OGQ|A Chain A, The Crystal Structure Of Pgip (Polygalacturonase Inhibiting Protein), A Leucine Rich Repeat Protein Involved In Plant Defense Length = 313 | Back alignment and structure |
|
| >pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327 | Back alignment and structure |
|
| >pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299 | Back alignment and structure |
|
| >pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311 | Back alignment and structure |
|
| >pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311 | Back alignment and structure |
|
| >pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310 | Back alignment and structure |
|
| >pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311 | Back alignment and structure |
|
| >pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311 | Back alignment and structure |
|
| >pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314 | Back alignment and structure |
|
| >pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333 | Back alignment and structure |
|
| >pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299 | Back alignment and structure |
|
| >pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304 | Back alignment and structure |
|
| >pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317 | Back alignment and structure |
|
| >pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329 | Back alignment and structure |
|
| >pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302 | Back alignment and structure |
|
| >pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504 | Back alignment and structure |
|
| >pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353 | Back alignment and structure |
|
| >pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292 | Back alignment and structure |
|
| >pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450 | Back alignment and structure |
|
| >pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a Length = 293 | Back alignment and structure |
|
| >pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300 | Back alignment and structure |
|
| >pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316 | Back alignment and structure |
|
| >pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287 | Back alignment and structure |
|
| >pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327 | Back alignment and structure |
|
| >pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373 | Back alignment and structure |
|
| >pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423 | Back alignment and structure |
|
| >pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316 | Back alignment and structure |
|
| >pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330 | Back alignment and structure |
|
| >pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337 | Back alignment and structure |
|
| >pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311 | Back alignment and structure |
|
| >pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327 | Back alignment and structure |
|
| >pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317 | Back alignment and structure |
|
| >pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330 | Back alignment and structure |
|
| >pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine Kinase Length = 277 | Back alignment and structure |
|
| >pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306 | Back alignment and structure |
|
| >pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311 | Back alignment and structure |
|
| >pdb|3MDY|A Chain A, Crystal Structure Of The Cytoplasmic Domain Of The Bone Morp Protein Receptor Type-1b (Bmpr1b) In Complex With Fkbp12 An 193189 Length = 337 | Back alignment and structure |
|
| >pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310 | Back alignment and structure |
|
| >pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317 | Back alignment and structure |
|
| >pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And Kinase Domains Length = 361 | Back alignment and structure |
|
| >pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327 | Back alignment and structure |
|
| >pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine Kinase 2 Beta (ptk2b) Length = 281 | Back alignment and structure |
|
| >pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309 | Back alignment and structure |
|
| >pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316 | Back alignment and structure |
|
| >pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302 | Back alignment and structure |
|
| >pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325 | Back alignment and structure |
|
| >pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336 | Back alignment and structure |
|
| >pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303 | Back alignment and structure |
|
| >pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315 | Back alignment and structure |
|
| >pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | Back alignment and structure |
|
| >pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324 | Back alignment and structure |
|
| >pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430 | Back alignment and structure |
|
| >pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355 | Back alignment and structure |
|
| >pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303 | Back alignment and structure |
|
| >pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367 | Back alignment and structure |
|
| >pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378 | Back alignment and structure |
|
| >pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301 | Back alignment and structure |
|
| >pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In Complex With Mig6 Peptide Length = 329 | Back alignment and structure |
|
| >pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420 | Back alignment and structure |
|
| >pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382 | Back alignment and structure |
|
| >pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414 | Back alignment and structure |
|
| >pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371 | Back alignment and structure |
|
| >pdb|2PML|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp Analogue Length = 348 | Back alignment and structure |
|
| >pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424 | Back alignment and structure |
|
| >pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain (G719sT790M) IN The Apo Form Length = 334 | Back alignment and structure |
|
| >pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The Gefitinib/erlotinib Resistant Egfr Kinase Domain L858r+t790m Length = 329 | Back alignment and structure |
|
| >pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360 | Back alignment and structure |
|
| >pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350 | Back alignment and structure |
|
| >pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298 | Back alignment and structure |
|
| >pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346 | Back alignment and structure |
|
| >pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299 | Back alignment and structure |
|
| >pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350 | Back alignment and structure |
|
| >pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297 | Back alignment and structure |
|
| >pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300 | Back alignment and structure |
|
| >pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360 | Back alignment and structure |
|
| >pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360 | Back alignment and structure |
|
| >pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360 | Back alignment and structure |
|
| >pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349 | Back alignment and structure |
|
| >pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352 | Back alignment and structure |
|
| >pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292 | Back alignment and structure |
|
| >pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289 | Back alignment and structure |
|
| >pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292 | Back alignment and structure |
|
| >pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299 | Back alignment and structure |
|
| >pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298 | Back alignment and structure |
|
| >pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391 | Back alignment and structure |
|
| >pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465 | Back alignment and structure |
|
| >pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296 | Back alignment and structure |
|
| >pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368 | Back alignment and structure |
|
| >pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368 | Back alignment and structure |
|
| >pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350 | Back alignment and structure |
|
| >pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|2EB3|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (L858r) In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296 | Back alignment and structure |
|
| >pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360 | Back alignment and structure |
|
| >pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353 | Back alignment and structure |
|
| >pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7- Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2- Phenylcyclopropyl)urea Length = 293 | Back alignment and structure |
|
| >pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic Domain With Pyrazolylbenzimidazole Inhibitor 416 Length = 299 | Back alignment and structure |
|
| >pdb|4I20|A Chain A, Crystal Structure Of Monomeric (v948r) Primary Oncogenic Mutant L858r Egfr Kinase Domain Length = 329 | Back alignment and structure |
|
| >pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298 | Back alignment and structure |
|
| >pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351 | Back alignment and structure |
|
| >pdb|2EB2|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (G719s) Length = 334 | Back alignment and structure |
|
| >pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290 | Back alignment and structure |
|
| >pdb|4FL3|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 635 | Back alignment and structure |
|
| >pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3W2O|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Tak-285 Length = 331 | Back alignment and structure |
|
| >pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340 | Back alignment and structure |
|
| >pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|4FL2|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 636 | Back alignment and structure |
|
| >pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365 | Back alignment and structure |
|
| >pdb|3EMG|A Chain A, Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylaminopyrimidines As Potent Inhibitors Of Spleen Tyrosine Kinase (Syk) Length = 291 | Back alignment and structure |
|
| >pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|2ITT|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In Complex With Aee788 Length = 327 | Back alignment and structure |
|
| >pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | Back alignment and structure |
|
| >pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358 | Back alignment and structure |
|
| >pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366 | Back alignment and structure |
|
| >pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357 | Back alignment and structure |
|
| >pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364 | Back alignment and structure |
|
| >pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|2ITN|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In Complex With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367 | Back alignment and structure |
|
| >pdb|3SRV|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|1XBA|A Chain A, Crystal Structure Of Apo Syk Tyrosine Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365 | Back alignment and structure |
|
| >pdb|4DFL|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With A Sulfonamidopyrazine Piperidine Inhibitor Length = 274 | Back alignment and structure |
|
| >pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|4F4P|A Chain A, Syk In Complex With Ligand Lasw836 Length = 273 | Back alignment and structure |
|
| >pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344 | Back alignment and structure |
|
| >pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354 | Back alignment and structure |
|
| >pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372 | Back alignment and structure |
|
| >pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327 | Back alignment and structure |
|
| >pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327 | Back alignment and structure |
|
| >pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360 | Back alignment and structure |
|
| >pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362 | Back alignment and structure |
|
| >pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389 | Back alignment and structure |
|
| >pdb|3MTF|A Chain A, Crystal Structure Of The Acvr1 Kinase In Complex With A 2- Aminopyridine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365 | Back alignment and structure |
|
| >pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|3H9R|A Chain A, Crystal Structure Of The Kinase Domain Of Type I Activin Receptor (Acvr1) In Complex With Fkbp12 And Dorsomorphin Length = 330 | Back alignment and structure |
|
| >pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360 | Back alignment and structure |
|
| >pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360 | Back alignment and structure |
|
| >pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351 | Back alignment and structure |
|
| >pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367 | Back alignment and structure |
|
| >pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348 | Back alignment and structure |
|
| >pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354 | Back alignment and structure |
|
| >pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | Back alignment and structure |
|
| >pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362 | Back alignment and structure |
|
| >pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380 | Back alignment and structure |
|
| >pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372 | Back alignment and structure |
|
| >pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379 | Back alignment and structure |
|
| >pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350 | Back alignment and structure |
|
| >pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364 | Back alignment and structure |
|
| >pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362 | Back alignment and structure |
|
| >pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364 | Back alignment and structure |
|
| >pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348 | Back alignment and structure |
|
| >pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360 | Back alignment and structure |
|
| >pdb|4DYM|A Chain A, Crystal Structure Of The Acvr1 Kinase Domain In Complex With The Imidazo[1,2-B]pyridazine Inhibitor K00135 Length = 301 | Back alignment and structure |
|
| >pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327 | Back alignment and structure |
|
| >pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396 | Back alignment and structure |
|
| >pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319 | Back alignment and structure |
|
| >pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348 | Back alignment and structure |
|
| >pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379 | Back alignment and structure |
|
| >pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359 | Back alignment and structure |
|
| >pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674 | Back alignment and structure |
|
| >pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345 | Back alignment and structure |
|
| >pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388 | Back alignment and structure |
|
| >pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350 | Back alignment and structure |
|
| >pdb|3SRV|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271 | Back alignment and structure |
|
| >pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327 | Back alignment and structure |
|
| >pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366 | Back alignment and structure |
|
| >pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350 | Back alignment and structure |
|
| >pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275 | Back alignment and structure |
|
| >pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292 | Back alignment and structure |
|
| >pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332 | Back alignment and structure |
|
| >pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352 | Back alignment and structure |
|
| >pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366 | Back alignment and structure |
|
| >pdb|4GT4|A Chain A, Structure Of Unliganded, Inactive Ror2 Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274 | Back alignment and structure |
|
| >pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366 | Back alignment and structure |
|
| >pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex With Amp-Pnp Length = 344 | Back alignment and structure |
|
| >pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325 | Back alignment and structure |
|
| >pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324 | Back alignment and structure |
|
| >pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371 | Back alignment and structure |
|
| >pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2 (Erbb2). Length = 338 | Back alignment and structure |
|
| >pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348 | Back alignment and structure |
|
| >pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370 | Back alignment and structure |
|
| >pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3ZZW|A Chain A, Crystal Structure Of The Kinase Domain Of Ror2 Length = 289 | Back alignment and structure |
|
| >pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486 | Back alignment and structure |
|
| >pdb|3HMN|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With Atp Length = 342 | Back alignment and structure |
|
| >pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543 | Back alignment and structure |
|
| >pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543 | Back alignment and structure |
|
| >pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543 | Back alignment and structure |
|
| >pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543 | Back alignment and structure |
|
| >pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298 | Back alignment and structure |
|
| >pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328 | Back alignment and structure |
|
| >pdb|2ZMC|A Chain A, Crystal Structure Of Human Mitotic Checkpoint Kinase Mps1 Catalytic Domain Apo Form Length = 390 | Back alignment and structure |
|
| >pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484 | Back alignment and structure |
|
| >pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283 | Back alignment and structure |
|
| >pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334 | Back alignment and structure |
|
| >pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293 | Back alignment and structure |
|
| >pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287 | Back alignment and structure |
|
| >pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276 | Back alignment and structure |
|
| >pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327 | Back alignment and structure |
|
| >pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286 | Back alignment and structure |
|
| >pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315 | Back alignment and structure |
|
| >pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323 | Back alignment and structure |
|
| >pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322 | Back alignment and structure |
|
| >pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442 | Back alignment and structure |
|
| >pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507 | Back alignment and structure |
|
| >pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|2X9E|A Chain A, Human Mps1 In Complex With Nms-P715 Length = 317 | Back alignment and structure |
|
| >pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311 | Back alignment and structure |
|
| >pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508 | Back alignment and structure |
|
| >pdb|3MY0|A Chain A, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound To Ldn- 193189 Length = 305 | Back alignment and structure |
|
| >pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320 | Back alignment and structure |
|
| >pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364 | Back alignment and structure |
|
| >pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295 | Back alignment and structure |
|
| >pdb|3DBQ|A Chain A, Crystal Structure Of Ttk Kinase Domain Length = 343 | Back alignment and structure |
|
| >pdb|3CEK|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (ttk) Length = 313 | Back alignment and structure |
|
| >pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278 | Back alignment and structure |
|
| >pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297 | Back alignment and structure |
|
| >pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289 | Back alignment and structure |
|
| >pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295 | Back alignment and structure |
|
| >pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334 | Back alignment and structure |
|
| >pdb|1KOB|A Chain A, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein Kinase Domain Length = 387 | Back alignment and structure |
|
| >pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | Back alignment and structure |
|
| >pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326 | Back alignment and structure |
|
| >pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285 | Back alignment and structure |
|
| >pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273 | Back alignment and structure |
|
| >pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278 | Back alignment and structure |
|
| >pdb|3GBZ|A Chain A, Structure Of The Cmgc Cdk Kinase From Giardia Lamblia Length = 329 | Back alignment and structure |
|
| >pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373 | Back alignment and structure |
|
| >pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278 | Back alignment and structure |
|
| >pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276 | Back alignment and structure |
|
| >pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290 | Back alignment and structure |
|
| >pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398 | Back alignment and structure |
|
| >pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269 | Back alignment and structure |
|
| >pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273 | Back alignment and structure |
|
| >pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268 | Back alignment and structure |
|
| >pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360 | Back alignment and structure |
|
| >pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | Back alignment and structure |
|
| >pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304 | Back alignment and structure |
|
| >pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271 | Back alignment and structure |
|
| >pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353 | Back alignment and structure |
|
| >pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293 | Back alignment and structure |
|
| >pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331 | Back alignment and structure |
|
| >pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294 | Back alignment and structure |
|
| >pdb|3VQU|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With 4- [(4-Amino-5-Cyano-6-Ethoxypyridin-2- Yl)amino]benzamide Length = 320 | Back alignment and structure |
|
| >pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269 | Back alignment and structure |
|
| >pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308 | Back alignment and structure |
|
| >pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327 | Back alignment and structure |
|
| >pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331 | Back alignment and structure |
|
| >pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|2ZMD|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain T686a Mutant In Complex With Sp600125 Inhibitor Length = 390 | Back alignment and structure |
|
| >pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295 | Back alignment and structure |
|
| >pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351 | Back alignment and structure |
|
| >pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3KEX|A Chain A, Crystal Structure Of The Catalytically Inactive Kinase Domain Of The Human Epidermal Growth Factor Receptor 3 (Her3) Length = 325 | Back alignment and structure |
|
| >pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312 | Back alignment and structure |
|
| >pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326 | Back alignment and structure |
|
| >pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346 | Back alignment and structure |
|
| >pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303 | Back alignment and structure |
|
| >pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334 | Back alignment and structure |
|
| >pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476 | Back alignment and structure |
|
| >pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370 | Back alignment and structure |
|
| >pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362 | Back alignment and structure |
|
| >pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304 | Back alignment and structure |
|
| >pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284 | Back alignment and structure |
|
| >pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367 | Back alignment and structure |
|
| >pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269 | Back alignment and structure |
|
| >pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282 | Back alignment and structure |
|
| >pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321 | Back alignment and structure |
|
| >pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484 | Back alignment and structure |
|
| >pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353 | Back alignment and structure |
|
| >pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317 | Back alignment and structure |
|
| >pdb|3H9F|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (Ttk) In Complex With A Pyrimido-Diazepin Ligand Length = 313 | Back alignment and structure |
|
| >pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348 | Back alignment and structure |
|
| >pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353 | Back alignment and structure |
|
| >pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353 | Back alignment and structure |
|
| >pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446 | Back alignment and structure |
|
| >pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446 | Back alignment and structure |
|
| >pdb|3DLS|A Chain A, Crystal Structure Of Human Pas Kinase Bound To Adp Length = 335 | Back alignment and structure |
|
| >pdb|1B6C|B Chain B, Crystal Structure Of The Cytoplasmic Domain Of The Type I Tgf-Beta Receptor In Complex With Fkbp12 Length = 342 | Back alignment and structure |
|
| >pdb|3F3Z|A Chain A, Crystal Structure Of Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 In Presence Of Indirubin E804 Length = 277 | Back alignment and structure |
|
| >pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318 | Back alignment and structure |
|
| >pdb|3LL6|A Chain A, Crystal Structure Of The Human Cyclin G Associated Kinase (gak) Length = 337 | Back alignment and structure |
|
| >pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370 | Back alignment and structure |
|
| >pdb|3C0G|A Chain A, Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Length = 351 | Back alignment and structure |
|
| >pdb|2QG5|A Chain A, Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 Length = 294 | Back alignment and structure |
|
| >pdb|1RW8|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Atp Site Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|3TAC|A Chain A, Crystal Structure Of The Liprin-AlphaCASK COMPLEX Length = 361 | Back alignment and structure |
|
| >pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360 | Back alignment and structure |
|
| >pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295 | Back alignment and structure |
|
| >pdb|3TZM|A Chain A, Tgf-Beta Receptor Type 1 In Complex With Sb431542 Length = 309 | Back alignment and structure |
|
| >pdb|1VJY|A Chain A, Crystal Structure Of A Naphthyridine Inhibitor Of Human Tgf- Beta Type I Receptor Length = 303 | Back alignment and structure |
|
| >pdb|2WOT|A Chain A, Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)-3- Pyridyl)oxy)-N-(3,4,5-Trimethoxyphenyl)pyridin-2-Amine Length = 306 | Back alignment and structure |
|
| >pdb|1PY5|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|2H34|A Chain A, Apoenzyme Crystal Structure Of The Tuberculosis SerineTHREONINE Kinase, Pkne Length = 309 | Back alignment and structure |
|
| >pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276 | Back alignment and structure |
|
| >pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335 | Back alignment and structure |
|
| >pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315 | Back alignment and structure |
|
| >pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353 | Back alignment and structure |
|
| >pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339 | Back alignment and structure |
|
| >pdb|2HW6|A Chain A, Crystal Structure Of Mnk1 Catalytic Domain Length = 307 | Back alignment and structure |
|
| >pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336 | Back alignment and structure |
|
| >pdb|2AC5|A Chain A, Structure Of Human Mnk2 Kinase Domain Mutant D228g Length = 316 | Back alignment and structure |
|
| >pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276 | Back alignment and structure |
|
| >pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341 | Back alignment and structure |
|
| >pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410 | Back alignment and structure |
|
| >pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342 | Back alignment and structure |
|
| >pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340 | Back alignment and structure |
|
| >pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415 | Back alignment and structure |
|
| >pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406 | Back alignment and structure |
|
| >pdb|3UC3|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.3 Length = 361 | Back alignment and structure |
|
| >pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1 Length = 290 | Back alignment and structure |
|
| >pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336 | Back alignment and structure |
|
| >pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335 | Back alignment and structure |
|
| >pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402 | Back alignment and structure |
|
| >pdb|3UDB|A Chain A, Crystal Structure Of Snrk2.6 Length = 317 | Back alignment and structure |
|
| >pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342 | Back alignment and structure |
|
| >pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337 | Back alignment and structure |
|
| >pdb|4FVP|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain (Apo Form) Length = 289 | Back alignment and structure |
|
| >pdb|3E3P|A Chain A, Glycogen Synthase Kinase From Leishmania Major Length = 360 | Back alignment and structure |
|
| >pdb|3UJG|A Chain A, Crystal Structure Of Snrk2.6 In Complex With Hab1 Length = 361 | Back alignment and structure |
|
| >pdb|2Y4I|B Chain B, Ksr2-Mek1 Heterodimer Length = 319 | Back alignment and structure |
|
| >pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494 | Back alignment and structure |
|
| >pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351 | Back alignment and structure |
|
| >pdb|3ENM|A Chain A, The Structure Of The Map2k Mek6 Reveals An Autoinhibitory Dimer Length = 316 | Back alignment and structure |
|
| >pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288 | Back alignment and structure |
|
| >pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321 | Back alignment and structure |
|
| >pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327 | Back alignment and structure |
|
| >pdb|2VD5|A Chain A, Structure Of Human Myotonic Dystrophy Protein Kinase In Complex With The Bisindoylmaleide Inhibitor Bim Viii Length = 412 | Back alignment and structure |
|
| >pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321 | Back alignment and structure |
|
| >pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361 | Back alignment and structure |
|
| >pdb|3KMW|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Mgatp) Length = 271 | Back alignment and structure |
|
| >pdb|3UC4|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.6 Length = 362 | Back alignment and structure |
|
| >pdb|2AC3|A Chain A, Structure Of Human Mnk2 Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|3VID|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With Compound A Length = 356 | Back alignment and structure |
|
| >pdb|3VHE|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With A Novel Pyrrolopyrimidine Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|3VHK|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Back Pocket Binder Length = 368 | Back alignment and structure |
|
| >pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341 | Back alignment and structure |
|
| >pdb|1Y6A|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 2-Anilino-5-Aryl-Oxazole Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350 | Back alignment and structure |
|
| >pdb|1TKI|A Chain A, Autoinhibited Serine Kinase Domain Of The Giant Muscle Protein Titin Length = 321 | Back alignment and structure |
|
| >pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443 | Back alignment and structure |
|
| >pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301 | Back alignment and structure |
|
| >pdb|3LM0|A Chain A, Crystal Structure Of Human SerineTHREONINE KINASE 17B (STK17B) Length = 327 | Back alignment and structure |
|
| >pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419 | Back alignment and structure |
|
| >pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291 | Back alignment and structure |
|
| >pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349 | Back alignment and structure |
|
| >pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291 | Back alignment and structure |
|
| >pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276 | Back alignment and structure |
|
| >pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350 | Back alignment and structure |
|
| >pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk Inhibitor For The Prevention Of Ischemia-Reperfusion Injury Length = 464 | Back alignment and structure |
|
| >pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole- Pyrimidine Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|2RIO|A Chain A, Structure Of The Dual Enzyme Ire1 Reveals The Basis For Catalysis And Regulation Of Non-conventional Splicing Length = 434 | Back alignment and structure |
|
| >pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious Tri-Substituted Thiophene Based Jnk Inhibitor Length = 363 | Back alignment and structure |
|
| >pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With N-{3-Cyano-6-[3-(1- Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2, 3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide Length = 364 | Back alignment and structure |
|
| >pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And Thiazole Based Inhibitors Of Jnk For The Treatment Of Neurodegenerative Diseases Length = 362 | Back alignment and structure |
|
| >pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273 | Back alignment and structure |
|
| >pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337 | Back alignment and structure |
|
| >pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277 | Back alignment and structure |
|
| >pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With Mgamp-Pnp Length = 423 | Back alignment and structure |
|
| >pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3 Length = 356 | Back alignment and structure |
|
| >pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3- Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide Length = 365 | Back alignment and structure |
|
| >pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355 | Back alignment and structure |
|
| >pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3 Length = 355 | Back alignment and structure |
|
| >pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The Scaffolding Protein Jip1 And Sp600125 Length = 369 | Back alignment and structure |
|
| >pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371 | Back alignment and structure |
|
| >pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide Length = 356 | Back alignment and structure |
|
| >pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350 | Back alignment and structure |
|
| >pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322 | Back alignment and structure |
|
| >pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322 | Back alignment and structure |
|
| >pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350 | Back alignment and structure |
|
| >pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350 | Back alignment and structure |
|
| >pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323 | Back alignment and structure |
|
| >pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323 | Back alignment and structure |
|
| >pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350 | Back alignment and structure |
|
| >pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379 | Back alignment and structure |
|
| >pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282 | Back alignment and structure |
|
| >pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329 | Back alignment and structure |
|
| >pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304 | Back alignment and structure |
|
| >pdb|3ZUT|A Chain A, The Structure Of Ost1 (D160a) Kinase Length = 362 | Back alignment and structure |
|
| >pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276 | Back alignment and structure |
|
| >pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor, Sr- 3451 Length = 353 | Back alignment and structure |
|
| >pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281 | Back alignment and structure |
|
| >pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371 | Back alignment and structure |
|
| >pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3SDJ|A Chain A, Structure Of Rnase-Inactive Point Mutant Of Oligomeric KinaseRNASE Ire1 Length = 448 | Back alignment and structure |
|
| >pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350 | Back alignment and structure |
|
| >pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281 | Back alignment and structure |
|
| >pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656 | Back alignment and structure |
|
| >pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276 | Back alignment and structure |
|
| >pdb|2XS0|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 386 | Back alignment and structure |
|
| >pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350 | Back alignment and structure |
|
| >pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350 | Back alignment and structure |
|
| >pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351 | Back alignment and structure |
|
| >pdb|3FBV|A Chain A, Crystal Structure Of The Oligomer Formed By The Kinase-Ribonuclease Domain Of Ire1 Length = 448 | Back alignment and structure |
|
| >pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350 | Back alignment and structure |
|
| >pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350 | Back alignment and structure |
|
| >pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350 | Back alignment and structure |
|
| >pdb|3ELJ|A Chain A, Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine Inhibitor Length = 369 | Back alignment and structure |
|
| >pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345 | Back alignment and structure |
|
| >pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299 | Back alignment and structure |
|
| >pdb|4EUT|A Chain A, Structure Of Bx-795 Complexed With Unphosphorylated Human Tbk1 Kinase- Uld Domain Length = 396 | Back alignment and structure |
|
| >pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371 | Back alignment and structure |
|
| >pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351 | Back alignment and structure |
|
| >pdb|4FVR|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain Mutant V617f (Mg- Atp-Bound Form) Length = 289 | Back alignment and structure |
|
| >pdb|3PZE|A Chain A, Jnk1 In Complex With Inhibitor Length = 358 | Back alignment and structure |
|
| >pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|1YXS|A Chain A, Crystal Structure Of Kinase Pim1 With P123m Mutation Length = 293 | Back alignment and structure |
|
| >pdb|3ZUU|A Chain A, The Structure Of Ost1 (D160a, S175d) Kinase In Complex With Gold Length = 362 | Back alignment and structure |
|
| >pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350 | Back alignment and structure |
|
| >pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656 | Back alignment and structure |
|
| >pdb|4EUU|A Chain A, Structure Of Bx-795 Complexed With Human Tbk1 Kinase Domain Phosphorylated On Ser172 Length = 319 | Back alignment and structure |
|
| >pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350 | Back alignment and structure |
|
| >pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342 | Back alignment and structure |
|
| >pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351 | Back alignment and structure |
|
| >pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350 | Back alignment and structure |
|
| >pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351 | Back alignment and structure |
|
| >pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351 | Back alignment and structure |
|
| >pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351 | Back alignment and structure |
|
| >pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350 | Back alignment and structure |
|
| >pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351 | Back alignment and structure |
|
| >pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351 | Back alignment and structure |
|
| >pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350 | Back alignment and structure |
|
| >pdb|2I6L|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 6 (Mapk6) Length = 320 | Back alignment and structure |
|
| >pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371 | Back alignment and structure |
|
| >pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350 | Back alignment and structure |
|
| >pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336 | Back alignment and structure |
|
| >pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351 | Back alignment and structure |
|
| >pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|2XIX|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-1 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|4ALV|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328 | Back alignment and structure |
|
| >pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351 | Back alignment and structure |
|
| >pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350 | Back alignment and structure |
|
| >pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350 | Back alignment and structure |
|
| >pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350 | Back alignment and structure |
|
| >pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351 | Back alignment and structure |
|
| >pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350 | Back alignment and structure |
|
| >pdb|2BUJ|A Chain A, Crystal Structure Of The Human Serine-Threonine Kinase 16 In Complex With Staurosporine Length = 317 | Back alignment and structure |
|
| >pdb|1XWS|A Chain A, Crystal Structure Of The Human Pim1 Kinase Domain Length = 313 | Back alignment and structure |
|
| >pdb|3UIX|A Chain A, Crystal Structure Of Pim1 Kinase In Complex With Small Molecule Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|2XJ0|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-4 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|2XIY|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-2 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|3F2A|A Chain A, Crystal Structure Of Human Pim-1 In Complex With Dappa Length = 300 | Back alignment and structure |
|
| >pdb|1XQZ|A Chain A, Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolution Length = 300 | Back alignment and structure |
|
| >pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2QR7|A Chain A, 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2: Se-Met Derivative Length = 342 | Back alignment and structure |
|
| >pdb|3DCV|A Chain A, Crystal Structure Of Human Pim1 Kinase Complexed With 4-(4- Hydroxy-3-Methyl-Phenyl)-6-Phenylpyrimidin-2(1h)-One Length = 328 | Back alignment and structure |
|
| >pdb|2OBJ|A Chain A, Crystal Structure Of Human Pim-1 Kinase In Complex With Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3R00|A Chain A, The Discovery Of Novel Benzofuran-2-Carboxylic Acids As Potent Pim-1 Inhibitors Length = 299 | Back alignment and structure |
|
| >pdb|3A99|A Chain A, Structure Of Pim-1 Kinase Crystallized In The Presence Of P27kip1 Carboxy-Terminal Peptide Length = 320 | Back alignment and structure |
|
| >pdb|4ALU|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328 | Back alignment and structure |
|
| >pdb|1YWV|A Chain A, Crystal Structures Of Proto-Oncogene Kinase Pim1: A Target Of Aberrant Somatic Hypermutations In Diffuse Large Cell Lymphoma Length = 293 | Back alignment and structure |
|
| >pdb|3JXW|A Chain A, Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-Ones As Potent, Highly Selective And Orally Bioavailable Pim Kinases Inhibitors Length = 294 | Back alignment and structure |
|
| >pdb|3LJ0|A Chain A, Ire1 Complexed With Adp And Quercetin Length = 434 | Back alignment and structure |
|
| >pdb|3C4E|A Chain A, Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7- Azaindole Length = 273 | Back alignment and structure |
|
| >pdb|4A7C|A Chain A, Crystal Structure Of Pim1 Kinase With Etp46546 Length = 308 | Back alignment and structure |
|
| >pdb|1YHS|A Chain A, Crystal Structure Of Pim-1 Bound To Staurosporine Length = 273 | Back alignment and structure |
|
| >pdb|4DTK|A Chain A, Novel And Selective Pan-Pim Kinase Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|3P23|A Chain A, Crystal Structure Of The Human Kinase And Rnase Domains In Complex With Adp Length = 432 | Back alignment and structure |
|
| >pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467 | Back alignment and structure |
|
| >pdb|3CY3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And The Jnk Inhibitor V Length = 314 | Back alignment and structure |
|
| >pdb|3MA3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Naphtho-Difuran Ligand Length = 313 | Back alignment and structure |
|
| >pdb|2BIK|B Chain B, Human Pim1 Phosphorylated On Ser261 Length = 313 | Back alignment and structure |
|
| >pdb|2J2I|B Chain B, Crystal Structure Of The Humab Pim1 In Complex With Ly333531 Length = 312 | Back alignment and structure |
|
| >pdb|2BIL|B Chain B, The Human Protein Kinase Pim1 In Complex With Its Consensus Peptide Pimtide Length = 313 | Back alignment and structure |
|
| >pdb|3CXW|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Beta Carboline Ligand I Length = 314 | Back alignment and structure |
|
| >pdb|3JPV|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Pyrrolo[2,3- A]carbazole Ligand Length = 313 | Back alignment and structure |
|
| >pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313 | Back alignment and structure |
|
| >pdb|3SOA|A Chain A, Full-Length Human Camkii Length = 444 | Back alignment and structure |
|
| >pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3UIB|A Chain A, Map Kinase Lmampk10 From Leishmania Major In Complex With Sb203580 Length = 362 | Back alignment and structure |
|
| >pdb|4AS0|A Chain A, Cyclometalated Phthalimides As Protein Kinase Inhibitors Length = 273 | Back alignment and structure |
|
| >pdb|3PG1|A Chain A, Map Kinase Lmampk10 From Leishmania Major (1.95 Angs Resolution) Length = 362 | Back alignment and structure |
|
| >pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364 | Back alignment and structure |
|
| >pdb|2WTK|C Chain C, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 305 | Back alignment and structure |
|
| >pdb|2G01|A Chain A, Pyrazoloquinolones As Novel, Selective Jnk1 Inhibitors Length = 370 | Back alignment and structure |
|
| >pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356 | Back alignment and structure |
|
| >pdb|3NIE|A Chain A, Crystal Structure Of Pf11_0147 Length = 429 | Back alignment and structure |
|
| >pdb|3O17|A Chain A, Crystal Structure Of Jnk1-Alpha1 Isoform Length = 370 | Back alignment and structure |
|
Structure Templates Detected by RPS-BLAST
Original result of RPS-BLAST against PDB70 database
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326 | Back alignment and structure |
|---|
Score = 442 bits (1140), Expect = e-149
Identities = 133/323 (41%), Positives = 200/323 (61%), Gaps = 11/323 (3%)
Query: 571 FGVSPEADKDASLVMLFPNNTNEIKDLTIYELLKATDNFSQANIIGCGGFGLVYKATLAN 630
F V E D + L ++K ++ EL A+DNFS NI+G GGFG VYK LA+
Sbjct: 2 FDVPAEEDPEVHL--------GQLKRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLAD 53
Query: 631 GTTLAIKKLSGDLGLM-EREFKAEVEALSTAQHKNLVSLQGYCVHQGFRLLIYSYMENGS 689
GT +A+K+L + E +F+ EVE +S A H+NL+ L+G+C+ RLL+Y YM NGS
Sbjct: 54 GTLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGS 113
Query: 690 LDYWLHEKADGASQLDWLTRLKIARGTSCGLAYMHQICEPHIVHRDIKSSNILLDDQFEA 749
+ L E+ + LDW R +IA G++ GLAY+H C+P I+HRD+K++NILLD++FEA
Sbjct: 114 VASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEA 173
Query: 750 HLADFGLSRLILPYQTHVTTELVGTLGYIPPEYGQAWVATLRGDMYSFGVVMLELLTGKR 809
+ DFGL++L+ THVTT + GT+G+I PEY ++ + D++ +GV++LEL+TG+R
Sbjct: 174 VVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQR 233
Query: 810 PVDVLKPKMSRE--LVGWVLKMRSEGKQDQVFDPILRGKGFDEEMLQVLDVACMCVSQNP 867
D+ + + L+ WV + E K + + D L+G DEE+ Q++ VA +C +P
Sbjct: 234 AFDLARLANDDDVMLLDWVKGLLKEKKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSP 293
Query: 868 FKRPTVKEVVEWLNNVGANRRNE 890
+RP + EVV L G R E
Sbjct: 294 MERPKMSEVVRMLEGDGLAERWE 316
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321 | Back alignment and structure |
|---|
Score = 358 bits (921), Expect = e-117
Identities = 106/287 (36%), Positives = 162/287 (56%), Gaps = 10/287 (3%)
Query: 598 TIYELLKATDNFSQANIIGCGGFGLVYKATLANGTTLAIKKLSGDLGLMEREFKAEVEAL 657
+ +L +AT+NF +IG G FG VYK L +G +A+K+ + + EF+ E+E L
Sbjct: 30 PLVDLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPESSQGIEEFETEIETL 89
Query: 658 STAQHKNLVSLQGYCVHQGFRLLIYSYMENGSLDYWLHEKADGASQLDWLTRLKIARGTS 717
S +H +LVSL G+C + +LIY YMENG+L L+ + W RL+I G +
Sbjct: 90 SFCRHPHLVSLIGFCDERNEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAA 149
Query: 718 CGLAYMHQICEPHIVHRDIKSSNILLDDQFEAHLADFGLSRLILP-YQTHVTTELVGTLG 776
GL Y+H I+HRD+KS NILLD+ F + DFG+S+ QTH++T + GTLG
Sbjct: 150 RGLHYLH---TRAIIHRDVKSINILLDENFVPKITDFGISKKGTELDQTHLSTVVKGTLG 206
Query: 777 YIPPEY---GQAWVATLRGDMYSFGVVMLELLTGKRPVDVLKPKMSRELVGWVLKMRSEG 833
YI PEY G+ T + D+YSFGVV+ E+L + + P+ L W ++ + G
Sbjct: 207 YIDPEYFIKGR---LTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAVESHNNG 263
Query: 834 KQDQVFDPILRGKGFDEEMLQVLDVACMCVSQNPFKRPTVKEVVEWL 880
+ +Q+ DP L K E + + D A C++ + RP++ +V+ L
Sbjct: 264 QLEQIVDPNLADKIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKL 310
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307 | Back alignment and structure |
|---|
Score = 341 bits (876), Expect = e-110
Identities = 108/308 (35%), Positives = 165/308 (53%), Gaps = 27/308 (8%)
Query: 591 TNEIKDLTIYELLKATDNFSQ------ANIIGCGGFGLVYKATLANGTTLAIKKLSGDLG 644
+ YEL T+NF + N +G GGFG+VYK + N TT+A+KKL+ +
Sbjct: 9 DTRFHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYV-NNTTVAVKKLAAMVD 67
Query: 645 LM----EREFKAEVEALSTAQHKNLVSLQGYCVHQGFRLLIYSYMENGSLDYWLHEKADG 700
+ +++F E++ ++ QH+NLV L G+ L+Y YM NGSL L DG
Sbjct: 68 ITTEELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCL-DG 126
Query: 701 ASQLDWLTRLKIARGTSCGLAYMHQICEPHIVHRDIKSSNILLDDQFEAHLADFGLSRLI 760
L W R KIA+G + G+ ++H E H +HRDIKS+NILLD+ F A ++DFGL+R
Sbjct: 127 TPPLSWHMRCKIAQGAANGINFLH---ENHHIHRDIKSANILLDEAFTAKISDFGLARAS 183
Query: 761 LPYQ-THVTTELVGTLGYIPPEY--GQAWVATLRGDMYSFGVVMLELLTGKRPVDVLKPK 817
+ T +T+ +VGT Y+ PE G+ T + D+YSFGVV+LE++TG VD +
Sbjct: 184 EKFAQTVMTSRIVGTTAYMAPEALRGE---ITPKSDIYSFGVVLLEIITGLPAVDEHREP 240
Query: 818 MSRELVGWVLKMRSEGKQ-DQVFDPILRGKGFD-EEMLQVLDVACMCVSQNPFKRPTVKE 875
L+ ++ E K + D + D + + VA C+ + KRP +K+
Sbjct: 241 QL--LLDIKEEIEDEEKTIEDYIDKKMN--DADSTSVEAMYSVASQCLHEKKNKRPDIKK 296
Query: 876 VVEWLNNV 883
V + L +
Sbjct: 297 VQQLLQEM 304
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322 | Back alignment and structure |
|---|
Score = 248 bits (636), Expect = 2e-75
Identities = 78/306 (25%), Positives = 123/306 (40%), Gaps = 30/306 (9%)
Query: 601 ELLKATDNFSQANIIGCGGFGLVYKATLANGTTLAIKKLSGDLGLMEREFKAEVEALSTA 660
L + + G FG V+KA L +A+K + + EV +L
Sbjct: 18 NLYFQSMPLQLLEVKARGRFGCVWKAQL-LNEYVAVKIFPIQ-DKQSWQNEYEVYSLPGM 75
Query: 661 QHKNLVSLQGYCVH----QGFRLLIYSYMENGSLDYWLHEKADGASQLDWLTRLKIARGT 716
+H+N++ G LI ++ E GSL +L + W IA
Sbjct: 76 KHENILQFIGAEKRGTSVDVDLWLITAFHEKGSLSDFLKAN-----VVSWNELCHIAETM 130
Query: 717 SCGLAYMHQ-------ICEPHIVHRDIKSSNILLDDQFEAHLADFGLSRLILPYQTHV-T 768
+ GLAY+H+ +P I HRDIKS N+LL + A +ADFGL+ ++ T
Sbjct: 131 ARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGLALKFEAGKSAGDT 190
Query: 769 TELVGTLGYIPPEYGQAWV-----ATLRGDMYSFGVVMLELLTGKRPVDVLKPKMSRELV 823
VGT Y+ PE + + A LR DMY+ G+V+ EL + D +
Sbjct: 191 HGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYMLPFE 250
Query: 824 GWVLKMRS-EGKQDQV----FDPILRGKGFDEEMLQVL-DVACMCVSQNPFKRPTVKEVV 877
+ + S E Q+ V P+LR + +L + C + R + V
Sbjct: 251 EEIGQHPSLEDMQEVVVHKKKRPVLRDYWQKHAGMAMLCETIEECWDHDAEARLSAGCVG 310
Query: 878 EWLNNV 883
E + +
Sbjct: 311 ERITQM 316
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336 | Back alignment and structure |
|---|
Score = 193 bits (493), Expect = 2e-55
Identities = 68/318 (21%), Positives = 116/318 (36%), Gaps = 45/318 (14%)
Query: 601 ELLKATDNFSQANIIGCGGFGLVYKATLANGTTLAIKKLSGDLGLMEREFKAEVEALSTA 660
E DN +IG G +G VYK +L + +A+K S + F E
Sbjct: 7 EPSLDLDNLKLLELIGRGRYGAVYKGSL-DERPVAVKVFSFA---NRQNFINEKNIYRVP 62
Query: 661 --QHKNLVSLQGYCVHQGFR-----LLIYSYMENGSLDYWLHEKADGASQLDWLTRLKIA 713
+H N+ LL+ Y NGSL +L DW++ ++A
Sbjct: 63 LMEHDNIARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYLSLH-----TSDWVSSCRLA 117
Query: 714 RGTSCGLAYMHQ------ICEPHIVHRDIKSSNILLDDQFEAHLADFGLSRLILP----- 762
+ GLAY+H +P I HRD+ S N+L+ + ++DFGLS +
Sbjct: 118 HSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLTGNRLVR 177
Query: 763 --YQTHVTTELVGTLGYIPPEY-------GQAWVATLRGDMYSFGVVMLELLTGKRPVDV 813
+ + VGT+ Y+ PE A + DMY+ G++ E+ +
Sbjct: 178 PGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFP 237
Query: 814 LKPKMS-----RELVGW---VLKMRSEGKQDQVFDPILRGKGFDEEMLQVL-DVACMCVS 864
+ + VG M+ +++ + ++ L + C
Sbjct: 238 GESVPEYQMAFQTEVGNHPTFEDMQVLVSREKQRPKFPEAWKENSLAVRSLKETIEDCWD 297
Query: 865 QNPFKRPTVKEVVEWLNN 882
Q+ R T + E +
Sbjct: 298 QDAEARLTAQXAEERMAE 315
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307 | Back alignment and structure |
|---|
Score = 189 bits (482), Expect = 3e-54
Identities = 70/279 (25%), Positives = 129/279 (46%), Gaps = 41/279 (14%)
Query: 613 NIIGCGGFGLVYKATLANGTTLAIKKLSGDLGLMEREFKAEVEALSTAQHKNLVSLQGYC 672
++G G FG+V KA +AIK++ + + F E+ LS H N+V L G C
Sbjct: 14 EVVGRGAFGVVCKAKW-RAKDVAIKQIESES--ERKAFIVELRQLSRVNHPNIVKLYGAC 70
Query: 673 VHQGFRLLIYSYMENGSLDYWLHEKADGASQLDWLTRLKIARGTSCGLAYMHQICEPHIV 732
++ L+ Y E GSL LH A+ + S G+AY+H + ++
Sbjct: 71 LNPVC--LVMEYAEGGSLYNVLH-GAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALI 127
Query: 733 HRDIKSSNILLDDQFE-AHLADFGLSRLILPYQTHVTTELVGTLGYIPPE--YGQAWVAT 789
HRD+K N+LL + DFG + I QTH+T G+ ++ PE G + +
Sbjct: 128 HRDLKPPNLLLVAGGTVLKICDFGTACDI---QTHMTNN-KGSAAWMAPEVFEGSNY--S 181
Query: 790 LRGDMYSFGVVMLELLTGKRPVDVLKPKMSRELVGWVLKMRSEGKQDQVFDPILRG---- 845
+ D++S+G+++ E++T ++P D + G ++ + G
Sbjct: 182 EKCDVFSWGIILWEVITRRKPFDEI-----------------GGPAFRIMWAVHNGTRPP 224
Query: 846 --KGFDEEMLQVLDVACMCVSQNPFKRPTVKEVVEWLNN 882
K + + ++ C S++P +RP+++E+V+ + +
Sbjct: 225 LIKNLPKPIESLM---TRCWSKDPSQRPSMEEIVKIMTH 260
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287 | Back alignment and structure |
|---|
Score = 188 bits (480), Expect = 4e-54
Identities = 80/285 (28%), Positives = 135/285 (47%), Gaps = 38/285 (13%)
Query: 613 NIIGCGGFGLVYKAT-LANGTTLAIKKL-------SGDLGLMEREFKAEVEALSTAQHKN 664
IG GGFGLV+K + + + +AIK L ++ +EF+ EV +S H N
Sbjct: 25 KQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPN 84
Query: 665 LVSLQGYCVHQGFRLLIYSYMENGSLDYWLHEKADGASQLDWLTRLKIARGTSCGLAYMH 724
+V L G + ++ ++ G L + L +KA + W +L++ + G+ YM
Sbjct: 85 IVKLYGLMHNPPR--MVMEFVPCGDLYHRLLDKAH---PIKWSVKLRLMLDIALGIEYMQ 139
Query: 725 QICEPHIVHRDIKSSNILLDDQFE-----AHLADFGLSRLILPYQTHVTTELVGTLGYIP 779
P IVHRD++S NI L E A +ADFGLS+ H + L+G ++
Sbjct: 140 N-QNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQQ----SVHSVSGLLGNFQWMA 194
Query: 780 PE--YGQAWVATLRGDMYSFGVVMLELLTGKRPVDVLKPKMSRELVGWVLKMRSEGKQDQ 837
PE + T + D YSF +++ +LTG+ P D + S + ++ +R EG +
Sbjct: 195 PETIGAEEESYTEKADTYSFAMILYTILTGEGPFD----EYSYGKIKFINMIREEGLR-- 248
Query: 838 VFDPILRGKGFDEEMLQVLDVACMCVSQNPFKRPTVKEVVEWLNN 882
P + + + V++ +C S +P KRP +V+ L+
Sbjct: 249 ---PTIP-EDCPPRLRNVIE---LCWSGDPKKRPHFSYIVKELSE 286
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309 | Back alignment and structure |
|---|
Score = 186 bits (474), Expect = 6e-53
Identities = 78/282 (27%), Positives = 127/282 (45%), Gaps = 39/282 (13%)
Query: 613 NIIGCGGFGLVYKATLANGTTLAIKKLSGD--LGLMEREFKAEVEALSTAQHKNLVSLQG 670
IG G FG V++A +G+ +A+K L EF EV + +H N+V G
Sbjct: 43 EKIGAGSFGTVHRAEW-HGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMG 101
Query: 671 YCVHQGFRLLIYSYMENGSLDYWLHEKADGASQLDWLTRLKIARGTSCGLAYMHQICEPH 730
++ Y+ GSL LH K+ QLD RL +A + G+ Y+H P
Sbjct: 102 AVTQPPNLSIVTEYLSRGSLYRLLH-KSGAREQLDERRRLSMAYDVAKGMNYLHN-RNPP 159
Query: 731 IVHRDIKSSNILLDDQFEAHLADFGLSRLILPYQTHVTTELVGTLGYIPPEYGQAWVATL 790
IVHR++KS N+L+D ++ + DFGLSR + + GT ++ PE L
Sbjct: 160 IVHRNLKSPNLLVDKKYTVKVCDFGLSR-LKASTFLSSKSAAGTPEWMAPE-------VL 211
Query: 791 RG-------DMYSFGVVMLELLTGKRPVDVLKPKMSRELVGWVL--KMRSEGKQDQVFDP 841
R D+YSFGV++ EL T ++P L P ++V V R
Sbjct: 212 RDEPSNEKSDVYSFGVILWELATLQQPWGNLNP---AQVVAAVGFKCKR----------L 258
Query: 842 ILRGKGFDEEMLQVLDVACMCVSQNPFKRPTVKEVVEWLNNV 883
+ + + ++ ++ C + P+KRP+ +++ L +
Sbjct: 259 EIP-RNLNPQVAAII---EGCWTNEPWKRPSFATIMDLLRPL 296
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271 | Back alignment and structure |
|---|
Score = 179 bits (456), Expect = 6e-51
Identities = 68/285 (23%), Positives = 124/285 (43%), Gaps = 40/285 (14%)
Query: 613 NIIGCGGFGLVYKATLANGTTLAIKKL----SGDLGLMEREFKAEVEALSTAQHKNLVSL 668
IIG GGFG VY+A G +A+K D+ + E + + +H N+++L
Sbjct: 13 EIIGIGGFGKVYRAFW-IGDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIAL 71
Query: 669 QGYCVHQGFRLLIYSYMENGSLDYWLHEKADGASQLDWLTRLKIARGTSCGLAYMHQICE 728
+G C+ + L+ + G L+ L K ++ + A + G+ Y+H
Sbjct: 72 RGVCLKEPNLCLVMEFARGGPLNRVLSGK-----RIPPDILVNWAVQIARGMNYLHDEAI 126
Query: 729 PHIVHRDIKSSNILLDDQFEAH--------LADFGLSRLILPYQTHVTTELVGTLGYIPP 780
I+HRD+KSSNIL+ + E + DFGL+R ++T + G ++ P
Sbjct: 127 VPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAREW--HRTTKMSA-AGAYAWMAP 183
Query: 781 EYGQAWVATLRGDMYSFGVVMLELLTGKRPVDVLKPKMSRELVGWVL--KMRSEGKQDQV 838
E +A + + D++S+GV++ ELLTG+ P + + V K+
Sbjct: 184 EVIRASMFSKGSDVWSYGVLLWELLTGEVPFRGIDG---LAVAYGVAMNKLALP------ 234
Query: 839 FDPILRGKGFDEEMLQVLDVACMCVSQNPFKRPTVKEVVEWLNNV 883
E +++ C + +P RP+ +++ L +
Sbjct: 235 -----IPSTCPEPFAKLM---EDCWNPDPHSRPSFTNILDQLTTI 271
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271 | Back alignment and structure |
|---|
Score = 179 bits (456), Expect = 6e-51
Identities = 57/277 (20%), Positives = 108/277 (38%), Gaps = 32/277 (11%)
Query: 613 NIIGCGGFGLVYKATLANGTTLAIKKL--SGDLGLMEREFKAEVEALSTAQHKNLVSLQG 670
+ G ++K G + +K L R+F E L H N++ + G
Sbjct: 16 TKLNENHSGELWKGRW-QGNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLG 74
Query: 671 YCVHQ-GFRLLIYS-YMENGSLDYWLHEKADGASQLDWLTRLKIARGTSCGLAYMHQICE 728
C + + +M GSL LHE + +D +K A + G+A++H E
Sbjct: 75 ACQSPPAPHPTLITHWMPYGSLYNVLHEGTN--FVVDQSQAVKFALDMARGMAFLHT-LE 131
Query: 729 PHIVHRDIKSSNILLDDQFEAHLADFGLSRLILPYQTHVTTELVGTLGYIPPE---YGQA 785
P I + S ++++D+ A ++ + + + + ++ PE
Sbjct: 132 PLIPRHALNSRSVMIDEDMTARISMADVKF------SFQSPGRMYAPAWVAPEALQKKPE 185
Query: 786 WVATLRGDMYSFGVVMLELLTGKRPVDVLKPKMSRELVGWVLKMRSEGKQDQVFDPILRG 845
DM+SF V++ EL+T + P L E+ V EG + + P
Sbjct: 186 DTNRRSADMWSFAVLLWELVTREVPFADLSNM---EIGMKVA---LEGLRPTI--P---- 233
Query: 846 KGFDEEMLQVLDVACMCVSQNPFKRPTVKEVVEWLNN 882
G + +++ +C++++P KRP +V L
Sbjct: 234 PGISPHVSKLMK---ICMNEDPAKRPKFDMIVPILEK 267
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301 | Back alignment and structure |
|---|
Score = 178 bits (453), Expect = 3e-50
Identities = 70/295 (23%), Positives = 119/295 (40%), Gaps = 34/295 (11%)
Query: 613 NIIGCGGFGLVYKATLANGTTLAIKKLSGDLGLMEREFKAEVEALSTA--QHKNLVSLQG 670
+G G +G V++ + G +A+K S E+ + E E +T +H+N++
Sbjct: 14 ECVGKGRYGEVWRGSW-QGENVAVKIFSSRD---EKSWFRETELYNTVMLRHENILGFIA 69
Query: 671 YCVHQGFR----LLIYSYMENGSLDYWLHEKADGASQLDWLTRLKIARGTSCGLAYMH-- 724
+ LI Y E GSL +L LD ++ L+I + GLA++H
Sbjct: 70 SDMTSRHSSTQLWLITHYHEMGSLYDYLQLT-----TLDTVSCLRIVLSIASGLAHLHIE 124
Query: 725 ---QICEPHIVHRDIKSSNILLDDQFEAHLADFGLSRLILPYQTHV---TTELVGTLGYI 778
+P I HRD+KS NIL+ + +AD GL+ + + VGT Y+
Sbjct: 125 IFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRYM 184
Query: 779 PPE------YGQAWVATLRGDMYSFGVVMLELLTGKRPVDVLKPKMS--RELVGW---VL 827
PE + + R D+++FG+V+ E+ +++ ++V
Sbjct: 185 APEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYDVVPNDPSFE 244
Query: 828 KMRSEGKQDQVFDPILRGKGFDEEMLQVLDVACMCVSQNPFKRPTVKEVVEWLNN 882
MR DQ I D + + + C QNP R T + + L
Sbjct: 245 DMRKVVCVDQQRPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKKTLTK 299
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310 | Back alignment and structure |
|---|
Score = 174 bits (444), Expect = 6e-49
Identities = 63/282 (22%), Positives = 111/282 (39%), Gaps = 34/282 (12%)
Query: 613 NIIGCGGFGLVYKATL-ANGTTLAIKKLSGDLGLMEREFKAEVEALSTAQHKNLVSLQGY 671
++G G FG K T G + +K+L +R F EV+ + +H N++ G
Sbjct: 16 EVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIGV 75
Query: 672 CVHQGFRLLIYSYMENGSLDYWLHEKADGASQLDWLTRLKIARGTSCGLAYMHQICEPHI 731
I Y++ G+L + SQ W R+ A+ + G+AY+H + +I
Sbjct: 76 LYKDKRLNFITEYIKGGTLRGIIKSM---DSQYPWSQRVSFAKDIASGMAYLHSM---NI 129
Query: 732 VHRDIKSSNILLDDQFEAHLADFGLSRLILPYQTHVTTELVGTLGYIPPEYGQA----WV 787
+HRD+ S N L+ + +ADFGL+RL++ +T Y W+
Sbjct: 130 IHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTVVGNPYWM 189
Query: 788 A--TLRG-------DMYSFGVVMLELLTGKRPVDVLKPKMSRELVGWVLKMRSEGKQDQV 838
A + G D++SFG+V+ E++ P+ + + +
Sbjct: 190 APEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMDFGLNVRGFLDRYCPPN-- 247
Query: 839 FDPILRGKGFDEEMLQVLDVACMCVSQNPFKRPTVKEVVEWL 880
P + C +P KRP+ ++ WL
Sbjct: 248 CPP------------SFFPITVRCCDLDPEKRPSFVKLEHWL 277
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 175 bits (445), Expect = 9e-49
Identities = 74/295 (25%), Positives = 115/295 (38%), Gaps = 34/295 (11%)
Query: 613 NIIGCGGFGLVYKATLANGTTLAIKKLSGDLGLMEREFKAEVEALSTA--QHKNLVSLQG 670
IG G +G V+ G +A+K E + E E T +H+N++
Sbjct: 43 KQIGKGRYGEVWMGKW-RGEKVAVKVFFTTE---EASWFRETEIYQTVLMRHENILGFIA 98
Query: 671 YCVHQGFR----LLIYSYMENGSLDYWLHEKADGASQLDWLTRLKIARGTSCGLAYMH-- 724
+ LI Y ENGSL +L LD + LK+A + GL ++H
Sbjct: 99 ADIKGTGSWTQLYLITDYHENGSLYDYLKSTT-----LDAKSMLKLAYSSVSGLCHLHTE 153
Query: 725 ---QICEPHIVHRDIKSSNILLDDQFEAHLADFGLSRLILPYQTHV---TTELVGTLGYI 778
+P I HRD+KS NIL+ +AD GL+ + V VGT Y+
Sbjct: 154 IFSTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVKFISDTNEVDIPPNTRVGTKRYM 213
Query: 779 PPE------YGQAWVATLRGDMYSFGVVMLELLTGKRPVDVLKPKM--SRELVGW---VL 827
PPE + + + DMYSFG+++ E+ +++ +LV
Sbjct: 214 PPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQLPYHDLVPSDPSYE 273
Query: 828 KMRSEGKQDQVFDPILRGKGFDEEMLQVLDVACMCVSQNPFKRPTVKEVVEWLNN 882
MR ++ DE + Q+ + C + NP R T V + L
Sbjct: 274 DMREIVCIKKLRPSFPNRWSSDECLRQMGKLMTECWAHNPASRLTALRVKKTLAK 328
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 183 bits (468), Expect = 1e-48
Identities = 61/206 (29%), Positives = 91/206 (44%), Gaps = 14/206 (6%)
Query: 328 SLFSQANLLSGEFPKELTALPALVSEAANDEVDRSYLELP--VFVMPS-NATNQQYNQLS 384
S AN ++G+ + + + + + N N
Sbjct: 562 SGKIAANFIAGKRYVYIKNDGMKKECHGAGNLLEFQGIRSEQLNRLSTRNPCNITSRVYG 621
Query: 385 -NLPP---------AIYLANNSLSGNIPVEIGQLKSLHVLDLSNNNFSGTIPDELSDLSN 434
+ P + ++ N LSG IP EIG + L +L+L +N+ SG+IPDE+ DL
Sbjct: 622 GHTSPTFDNNGSMMFLDMSYNMLSGYIPKEIGSMPYLFILNLGHNDISGSIPDEVGDLRG 681
Query: 435 LEKLDLSGNHLVGEIPISLKGLHFLSSFSVAHNNLQGAVPSGGQFDTFPSFSFEGNPELC 494
L LDLS N L G IP ++ L L+ +++NNL G +P GQF+TFP F NP LC
Sbjct: 682 LNILDLSSNKLDGRIPQAMSALTMLTEIDLSNNNLSGPIPEMGQFETFPPAKFLNNPGLC 741
Query: 495 GSVVQRPCA-ISPGATHPTAPHKRTN 519
G + R + G H H +
Sbjct: 742 GYPLPRCDPSNADGYAHHQRSHHHHH 767
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 123 bits (312), Expect = 3e-29
Identities = 42/153 (27%), Positives = 56/153 (36%), Gaps = 33/153 (21%)
Query: 334 NLLSGEFPKELTALPALVSEAANDEVDRSYLELPVFVMPSNATNQQYNQLS-NLPPAI-- 390
N LSG P L +L L L+L N L +P +
Sbjct: 428 NYLSGTIPSSLGSLSKL-----------RDLKL------------WLNMLEGEIPQELMY 464
Query: 391 -------YLANNSLSGNIPVEIGQLKSLHVLDLSNNNFSGTIPDELSDLSNLEKLDLSGN 443
L N L+G IP + +L+ + LSNN +G IP + L NL L LS N
Sbjct: 465 VKTLETLILDFNDLTGEIPSGLSNCTNLNWISLSNNRLTGEIPKWIGRLENLAILKLSNN 524
Query: 444 HLVGEIPISLKGLHFLSSFSVAHNNLQGAVPSG 476
G IP L L + N G +P+
Sbjct: 525 SFSGNIPAELGDCRSLIWLDLNTNLFNGTIPAA 557
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 123 bits (312), Expect = 3e-29
Identities = 50/154 (32%), Positives = 62/154 (40%), Gaps = 34/154 (22%)
Query: 334 NLLSGEFPKELTALPALVSEAANDEVDRSYLELPVFVMPSNATNQQYNQLS-NLPPAI-- 390
N SGE P+ LT L A + L+L N S + P +
Sbjct: 353 NEFSGELPESLTNLSASLL----------TLDL------------SSNNFSGPILPNLCQ 390
Query: 391 ---------YLANNSLSGNIPVEIGQLKSLHVLDLSNNNFSGTIPDELSDLSNLEKLDLS 441
YL NN +G IP + L L LS N SGTIP L LS L L L
Sbjct: 391 NPKNTLQELYLQNNGFTGKIPPTLSNCSELVSLHLSFNYLSGTIPSSLGSLSKLRDLKLW 450
Query: 442 GNHLVGEIPISLKGLHFLSSFSVAHNNLQGAVPS 475
N L GEIP L + L + + N+L G +PS
Sbjct: 451 LNMLEGEIPQELMYVKTLETLILDFNDLTGEIPS 484
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 118 bits (298), Expect = 2e-27
Identities = 42/152 (27%), Positives = 62/152 (40%), Gaps = 33/152 (21%)
Query: 334 NLLSGEFPKELTALPALVSEAANDEVDRSYLELPVFVMPSNATNQQYNQLS-NLPPA--- 389
N LSG+F + ++ L L + NQ +PP
Sbjct: 233 NKLSGDFSRAISTCTELK-----------LLNI------------SSNQFVGPIPPLPLK 269
Query: 390 ----IYLANNSLSGNIPVEI-GQLKSLHVLDLSNNNFSGTIPDELSDLSNLEKLDLSGNH 444
+ LA N +G IP + G +L LDLS N+F G +P S LE L LS N+
Sbjct: 270 SLQYLSLAENKFTGEIPDFLSGACDTLTGLDLSGNHFYGAVPPFFGSCSLLESLALSSNN 329
Query: 445 LVGEIPI-SLKGLHFLSSFSVAHNNLQGAVPS 475
GE+P+ +L + L ++ N G +P
Sbjct: 330 FSGELPMDTLLKMRGLKVLDLSFNEFSGELPE 361
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 112 bits (283), Expect = 1e-25
Identities = 49/154 (31%), Positives = 69/154 (44%), Gaps = 37/154 (24%)
Query: 332 QANLLSGEFPKELTALPALVSEAANDEVDRSYLELPVFVMPSNATNQQYNQLS-NLPPAI 390
N+L GE P+EL + L L L +N L+ +P +
Sbjct: 450 WLNMLEGEIPQELMYVKTL-----------ETLIL------------DFNDLTGEIPSGL 486
Query: 391 ---------YLANNSLSGNIPVEIGQLKSLHVLDLSNNNFSGTIPDELSDLSNLEKLDLS 441
L+NN L+G IP IG+L++L +L LSNN+FSG IP EL D +L LDL+
Sbjct: 487 SNCTNLNWISLSNNRLTGEIPKWIGRLENLAILKLSNNSFSGNIPAELGDCRSLIWLDLN 546
Query: 442 GNHLVGEIPISLKGLHFLSSFSVAHNNLQGAVPS 475
N G IP ++ S +A N + G
Sbjct: 547 TNLFNGTIPAAMFKQ----SGKIAANFIAGKRYV 576
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 110 bits (277), Expect = 6e-25
Identities = 34/150 (22%), Positives = 54/150 (36%), Gaps = 31/150 (20%)
Query: 334 NLLSGEFPKELTALPALVSEAANDEVDRSYLELPVFVMPSNATNQQYNQLSNLPPA---- 389
N +SG +L + N++S
Sbjct: 161 NSISGANVVGWVLSDGCGE--------LKHLAI------------SGNKISGDVDVSRCV 200
Query: 390 ----IYLANNSLSGNIPVEIGQLKSLHVLDLSNNNFSGTIPDELSDLSNLEKLDLSGNHL 445
+ +++N+ S IP +G +L LD+S N SG +S + L+ L++S N
Sbjct: 201 NLEFLDVSSNNFSTGIP-FLGDCSALQHLDISGNKLSGDFSRAISTCTELKLLNISSNQF 259
Query: 446 VGEIPISLKGLHFLSSFSVAHNNLQGAVPS 475
VG IP L L S+A N G +P
Sbjct: 260 VGPIPPLP--LKSLQYLSLAENKFTGEIPD 287
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 108 bits (272), Expect = 2e-24
Identities = 43/157 (27%), Positives = 68/157 (43%), Gaps = 38/157 (24%)
Query: 334 NLLSGEFPKELTA-LPALVSEAANDEVDRSYLELPVFVMPSNATNQQYNQLS-NLPPAI- 390
N +GE P L+ L L+L N +PP
Sbjct: 279 NKFTGEIPDFLSGACDTLT-----------GLDL------------SGNHFYGAVPPFFG 315
Query: 391 --------YLANNSLSGNIPVE-IGQLKSLHVLDLSNNNFSGTIPDELSDLS-NLEKLDL 440
L++N+ SG +P++ + +++ L VLDLS N FSG +P+ L++LS +L LDL
Sbjct: 316 SCSLLESLALSSNNFSGELPMDTLLKMRGLKVLDLSFNEFSGELPESLTNLSASLLTLDL 375
Query: 441 SGNHLVGEIPISL--KGLHFLSSFSVAHNNLQGAVPS 475
S N+ G I +L + L + +N G +P
Sbjct: 376 SSNNFSGPILPNLCQNPKNTLQELYLQNNGFTGKIPP 412
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 101 bits (255), Expect = 3e-22
Identities = 43/170 (25%), Positives = 64/170 (37%), Gaps = 40/170 (23%)
Query: 334 NLLSGEFPKELTALPALVSEAANDEVDRSYLELPVFVMPSNATNQQYNQLS-NLPPAI-- 390
N L+GE P L+ L ++ L N+L+ +P I
Sbjct: 476 NDLTGEIPSGLSNCTNLN-----------WISL------------SNNRLTGEIPKWIGR 512
Query: 391 -------YLANNSLSGNIPVEIGQLKSLHVLDLSNNNFSGTIPDELSDLSNLEKLDLSGN 443
L+NNS SGNIP E+G +SL LDL+ N F+GTIP + S ++ N
Sbjct: 513 LENLAILKLSNNSFSGNIPAELGDCRSLIWLDLNTNLFNGTIPAAMFKQS----GKIAAN 568
Query: 444 HLVGEIPISLKGLHFLSSFSVAHN--NLQGAVPSG-GQFDTFPSFSFEGN 490
+ G+ + +K A N QG + T +
Sbjct: 569 FIAGKRYVYIKNDGMKKECHGAGNLLEFQGIRSEQLNRLSTRNPCNITSR 618
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 99.2 bits (248), Expect = 2e-21
Identities = 29/104 (27%), Positives = 45/104 (43%), Gaps = 8/104 (7%)
Query: 382 QLSNLPP--AIYLANNSLSGNIPVEIG-QLKSLHVLDLSNNNFSGTIPDEL---SDLSNL 435
L + + +++N+L V G +L SL VLDLS N+ SG L
Sbjct: 121 SLGSCSGLKFLNVSSNTLDFPGKVSGGLKLNSLEVLDLSANSISGANVVGWVLSDGCGEL 180
Query: 436 EKLDLSGNHLVGEIPISLKGLHFLSSFSVAHNNLQGAVPSGGQF 479
+ L +SGN + G++ +S L V+ NN +P G
Sbjct: 181 KHLAISGNKISGDVDVSR--CVNLEFLDVSSNNFSTGIPFLGDC 222
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 93.8 bits (234), Expect = 8e-20
Identities = 28/150 (18%), Positives = 52/150 (34%), Gaps = 31/150 (20%)
Query: 334 NLLSGEFPKELTALPALVSEAANDEVDRSYLELPVFVMPSNATNQQYNQLS-NLPPAIY- 391
N SG P EL +L+ +L+L N + +P A++
Sbjct: 524 NSFSGNIPAELGDCRSLI-----------WLDL------------NTNLFNGTIPAAMFK 560
Query: 392 ----LANNSLSGNIPVEIGQLKSLHVLDLSNN--NFSGTIPDELSDLSNLEKLDLSGNHL 445
+A N ++G V I + N F G ++L+ LS +++
Sbjct: 561 QSGKIAANFIAGKRYVYIKNDGMKKECHGAGNLLEFQGIRSEQLNRLSTRNPCNITSRVY 620
Query: 446 VGEIPISLKGLHFLSSFSVAHNNLQGAVPS 475
G + + +++N L G +P
Sbjct: 621 GGHTSPTFDNNGSMMFLDMSYNMLSGYIPK 650
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 65.3 bits (160), Expect = 6e-11
Identities = 19/73 (26%), Positives = 33/73 (45%), Gaps = 4/73 (5%)
Query: 410 SLHVLDLSNNNFS---GTIPDELSDLSNLEKLDLSGNHLVGEIPISLKGLHFLSSFSVAH 466
+ +DLS+ + + L L+ LE L LS +H+ G + K L+S ++
Sbjct: 51 KVTSIDLSSKPLNVGFSAVSSSLLSLTGLESLFLSNSHINGSVS-GFKCSASLTSLDLSR 109
Query: 467 NNLQGAVPSGGQF 479
N+L G V +
Sbjct: 110 NSLSGPVTTLTSL 122
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342 | Back alignment and structure |
|---|
Score = 173 bits (440), Expect = 5e-48
Identities = 68/295 (23%), Positives = 114/295 (38%), Gaps = 34/295 (11%)
Query: 613 NIIGCGGFGLVYKATLANGTTLAIKKLSGDLGLMEREFKAEVE--ALSTAQHKNLVSLQG 670
IG G FG V++ G +A+K S ER + E E +H+N++
Sbjct: 48 ESIGKGRFGEVWRGKW-RGEEVAVKIFSSRE---ERSWFREAEIYQTVMLRHENILGFIA 103
Query: 671 YCVHQGFR----LLIYSYMENGSLDYWLHEKADGASQLDWLTRLKIARGTSCGLAYMHQ- 725
L+ Y E+GSL +L+ + +K+A T+ GLA++H
Sbjct: 104 ADNKDNGTWTQLWLVSDYHEHGSLFDYLNRYT-----VTVEGMIKLALSTASGLAHLHME 158
Query: 726 ----ICEPHIVHRDIKSSNILLDDQFEAHLADFGLSRLILPYQTHVT---TELVGTLGYI 778
+P I HRD+KS NIL+ +AD GL+ + VGT Y+
Sbjct: 159 IVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYM 218
Query: 779 PPE------YGQAWVATLRGDMYSFGVVMLELLTGKRPVDVLKP--KMSRELVGW---VL 827
PE + + + R D+Y+ G+V E+ + + +LV V
Sbjct: 219 APEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVE 278
Query: 828 KMRSEGKQDQVFDPILRGKGFDEEMLQVLDVACMCVSQNPFKRPTVKEVVEWLNN 882
+MR + ++ I E + + + C N R T + + L+
Sbjct: 279 EMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQ 333
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 170 bits (433), Expect = 3e-47
Identities = 65/293 (22%), Positives = 113/293 (38%), Gaps = 43/293 (14%)
Query: 613 NIIGCGGFGLVYKATLANGTTLAIKKL--SGDLGLMEREFKAEVEALSTAQHKNLVSLQG 670
+IG G FG VY +G AI+ + D + FK EV A +H+N+V G
Sbjct: 39 ELIGKGRFGQVYHGRW-HGEV-AIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMG 96
Query: 671 YCVHQGFRLLIYSYMENGSLDYWLHEKADGASQLDWLTRLKIARGTSCGLAYMHQICEPH 730
C+ +I S + +L + + LD +IA+ G+ Y+H
Sbjct: 97 ACMSPPHLAIITSLCKGRTLYSVVRDAKI---VLDVNKTRQIAQEIVKGMGYLHA---KG 150
Query: 731 IVHRDIKSSNILLDDQFEAHLADFGLSRLI----LPYQTHVTTELVGTLGYIPPEYGQAW 786
I+H+D+KS N+ D+ + + DFGL + + G L ++ PE +
Sbjct: 151 ILHKDLKSKNVFYDN-GKVVITDFGLFSISGVLQAGRREDKLRIQNGWLCHLAPEIIRQL 209
Query: 787 VATLRG---------DMYSFGVVMLELLTGKRPVDVLKPKMSRELVGWVL--KMRSEGKQ 835
D+++ G + EL + P E + W + M+
Sbjct: 210 SPDTEEDKLPFSKHSDVFALGTIWYELHAREWPF----KTQPAEAIIWQMGTGMK----- 260
Query: 836 DQVFDPILRGKGFDEEMLQVLDVACMCVSQNPFKRPTVKEVVEWLNNVGANRR 888
P L G +E+ +L C + +RPT ++++ L + R
Sbjct: 261 -----PNLSQIGMGKEISDILL---FCWAFEQEERPTFTKLMDMLEKLPKRNR 305
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289 | Back alignment and structure |
|---|
Score = 169 bits (430), Expect = 3e-47
Identities = 68/274 (24%), Positives = 124/274 (45%), Gaps = 26/274 (9%)
Query: 615 IGCGGFGLVYKATLANGTTLAIKKL--SGDLGLMEREFKAEVEALSTAQHKNLVSLQGYC 672
IG G FG VYK +G A+K L + + FK EV L +H N++ GY
Sbjct: 32 IGSGSFGTVYKGKW-HGDV-AVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS 89
Query: 673 VHQGFRLLIYSYMENGSLDYWLHEKADGASQLDWLTRLKIARGTSCGLAYMHQICEPHIV 732
++ + E SL + LH ++ + + IAR T+ G+ Y+H I+
Sbjct: 90 TAPQL-AIVTQWCEGSSLYHHLHASE---TKFEMKKLIDIARQTARGMDYLHA---KSII 142
Query: 733 HRDIKSSNILLDDQFEAHLADFGLSRLI-LPYQTHVTTELVGTLGYIPPE---YGQAWVA 788
HRD+KS+NI L + + DFGL+ +H +L G++ ++ PE +
Sbjct: 143 HRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDSNPY 202
Query: 789 TLRGDMYSFGVVMLELLTGKRPVDVLKPKMSRELVGWVLKMRSEGKQDQVFDPILRGKGF 848
+ + D+Y+FG+V+ EL+TG+ P + R+ + ++ G+ D
Sbjct: 203 SFQSDVYAFGIVLYELMTGQLPYSNINN---RDQIIEMV-----GRGSLSPDLSKVRSNC 254
Query: 849 DEEMLQVLDVACMCVSQNPFKRPTVKEVVEWLNN 882
+ M +++ C+ + +RP+ ++ +
Sbjct: 255 PKRMKRLMA---ECLKKKRDERPSFPRILAEIEE 285
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313 | Back alignment and structure |
|---|
Score = 159 bits (405), Expect = 2e-43
Identities = 46/178 (25%), Positives = 72/178 (40%), Gaps = 33/178 (18%)
Query: 334 NLLSGEFPKELTALPALVSEAANDEVDRSYLELPVFVMPSNATNQQYNQLS-NLPPAI-- 390
N +SG P + L + + + N+L+ +PP
Sbjct: 159 NRISGAIPDSYGSFSKLFT----------SMTI------------SRNRLTGKIPPTFAN 196
Query: 391 ------YLANNSLSGNIPVEIGQLKSLHVLDLSNNNFSGTIPDELSDLSNLEKLDLSGNH 444
L+ N L G+ V G K+ + L+ N+ + + ++ NL LDL N
Sbjct: 197 LNLAFVDLSRNMLEGDASVLFGSDKNTQKIHLAKNSLAFDLG-KVGLSKNLNGLDLRNNR 255
Query: 445 LVGEIPISLKGLHFLSSFSVAHNNLQGAVPSGGQFDTFPSFSFEGNPELCGSVVQRPC 502
+ G +P L L FL S +V+ NNL G +P GG F ++ N LCGS + C
Sbjct: 256 IYGTLPQGLTQLKFLHSLNVSFNNLCGEIPQGGNLQRFDVSAYANNKCLCGSPLP-AC 312
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313 | Back alignment and structure |
|---|
Score = 118 bits (297), Expect = 3e-29
Identities = 37/107 (34%), Positives = 54/107 (50%), Gaps = 11/107 (10%)
Query: 380 YNQLS-NLPPAI---------YLANNSLSGNIPVEIGQLKSLHVLDLSNNNFSGTIPDEL 429
N L +PPAI Y+ + ++SG IP + Q+K+L LD S N SGT+P +
Sbjct: 86 INNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQIKTLVTLDFSYNALSGTLPPSI 145
Query: 430 SDLSNLEKLDLSGNHLVGEIPISLKGLHFLSSF-SVAHNNLQGAVPS 475
S L NL + GN + G IP S L + +++ N L G +P
Sbjct: 146 SSLPNLVGITFDGNRISGAIPDSYGSFSKLFTSMTISRNRLTGKIPP 192
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313 | Back alignment and structure |
|---|
Score = 116 bits (293), Expect = 1e-28
Identities = 38/127 (29%), Positives = 54/127 (42%), Gaps = 21/127 (16%)
Query: 370 VMPSNATNQ--------QYNQLS---NLPPAI---------YLAN-NSLSGNIPVEIGQL 408
V+ T L +P ++ Y+ N+L G IP I +L
Sbjct: 41 VLCDTDTQTYRVNNLDLSGLNLPKPYPIPSSLANLPYLNFLYIGGINNLVGPIPPAIAKL 100
Query: 409 KSLHVLDLSNNNFSGTIPDELSDLSNLEKLDLSGNHLVGEIPISLKGLHFLSSFSVAHNN 468
LH L +++ N SG IPD LS + L LD S N L G +P S+ L L + N
Sbjct: 101 TQLHYLYITHTNVSGAIPDFLSQIKTLVTLDFSYNALSGTLPPSISSLPNLVGITFDGNR 160
Query: 469 LQGAVPS 475
+ GA+P
Sbjct: 161 ISGAIPD 167
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313 | Back alignment and structure |
|---|
Score = 107 bits (270), Expect = 1e-25
Identities = 33/143 (23%), Positives = 52/143 (36%), Gaps = 39/143 (27%)
Query: 334 NLLSGEFPKELTALPALVSEAANDEVDRSYLELPVFVMPSNATNQQYNQLSNLPPAIYLA 393
+SG P L+ + LV+ + +
Sbjct: 111 TNVSGAIPDFLSQIKTLVT-------------------------------------LDFS 133
Query: 394 NNSLSGNIPVEIGQLKSLHVLDLSNNNFSGTIPDELSDLSNL-EKLDLSGNHLVGEIPIS 452
N+LSG +P I L +L + N SG IPD S L + +S N L G+IP +
Sbjct: 134 YNALSGTLPPSISSLPNLVGITFDGNRISGAIPDSYGSFSKLFTSMTISRNRLTGKIPPT 193
Query: 453 LKGLHFLSSFSVAHNNLQGAVPS 475
L+ L+ ++ N L+G
Sbjct: 194 FANLN-LAFVDLSRNMLEGDASV 215
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377 | Back alignment and structure |
|---|
Score = 133 bits (337), Expect = 6e-34
Identities = 63/301 (20%), Positives = 121/301 (40%), Gaps = 56/301 (18%)
Query: 607 DNFSQANIIGCGGFGLVYKATL-ANGTTLAIKKLSGDLGLMER-EFKAEVEALSTAQHKN 664
++ IG G FG V+ L A+ T +A+K L + +F E L H N
Sbjct: 114 EDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPN 173
Query: 665 LVSLQGYCVHQGFRLLIYSYMENGSLDYWLHEKADGASQLDWLTRLKIARGTSCGLAYMH 724
+V L G C + ++ ++ G +L + ++L T L++ + G+ Y+
Sbjct: 174 IVRLIGVCTQKQPIYIVMELVQGGDFLTFLRTEG---ARLRVKTLLQMVGDAAAGMEYLE 230
Query: 725 QICEPHIVHRDIKSSNILLDDQFEAHLADFGLSRLIL--PYQTHVTTELVGTLGYIP--- 779
+HRD+ + N L+ ++ ++DFG+SR Y G L +P
Sbjct: 231 SK---CCIHRDLAARNCLVTEKNVLKISDFGMSREEADGVYAAS------GGLRQVPVKW 281
Query: 780 --PE---YGQAWVATLRGDMYSFGVVMLELLT-GKRPVDVLKPKMSRELVGWVLKMRSEG 833
PE YG + D++SFG+++ E + G P P +S +
Sbjct: 282 TAPEALNYG---RYSSESDVWSFGILLWETFSLGASPY----PNLSNQ------------ 322
Query: 834 KQDQVFDPILRG------KGFDEEMLQVLDVACMCVSQNPFKRPTVKEVVEWLNNVGANR 887
Q + + +G + + + +++ C + P +RP+ + + L ++
Sbjct: 323 ---QTREFVEKGGRLPCPELCPDAVFRLM---EQCWAYEPGQRPSFSTIYQELQSIRKRH 376
Query: 888 R 888
R
Sbjct: 377 R 377
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290 | Back alignment and structure |
|---|
Score = 130 bits (330), Expect = 7e-34
Identities = 60/270 (22%), Positives = 105/270 (38%), Gaps = 31/270 (11%)
Query: 614 IIGCGGFGLVYKAT-LANGTTLAIK--KLSGDLGLMEREFKAEVEALSTAQHKNLVSLQG 670
IG G F VYK +A + + FK E E L QH N+V
Sbjct: 33 EIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYD 92
Query: 671 YCVH---QGFRLLIYS-YMENGSLDYWLHEKADGASQLDWLTRLKIARGTSCGLAYMHQI 726
+++ + M +G+L +L + R GL ++H
Sbjct: 93 SWESTVKGKKCIVLVTELMTSGTLKTYLKR----FKVMKIKVLRSWCRQILKGLQFLHT- 147
Query: 727 CEPHIVHRDIKSSNILLDDQF-EAHLADFGLSRLILPYQTHVTTELVGTLGYIPPEYGQA 785
P I+HRD+K NI + + D GL+ L + ++GT ++ PE +
Sbjct: 148 RTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLK---RASFAKAVIGTPEFMAPEMYEE 204
Query: 786 WVATLRGDMYSFGVVMLELLTGKRPVDVLKPKMSRELVGWVLKMRSEGKQDQVFDPILRG 845
D+Y+FG+ MLE+ T + P + + + + G + FD
Sbjct: 205 K-YDESVDVYAFGMCMLEMATSEYPYSECQNAAQ------IYRRVTSGVKPASFD----- 252
Query: 846 KGFDEEMLQVLDVACMCVSQNPFKRPTVKE 875
K E+ ++++ C+ QN +R ++K+
Sbjct: 253 KVAIPEVKEIIE---GCIRQNKDERYSIKD 279
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310 | Back alignment and structure |
|---|
Score = 130 bits (329), Expect = 2e-33
Identities = 66/275 (24%), Positives = 108/275 (39%), Gaps = 23/275 (8%)
Query: 607 DNFSQANIIGCGGFGLVYKAT-LANGTTLAIKK--LSGDLGLMEREF-KAEVEALSTAQH 662
NF IG G F VY+A L +G +A+KK + + R E++ L H
Sbjct: 32 ANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNH 91
Query: 663 KNLVSLQGYCVHQGFRLLIYS-YMENGSLDYWLHEKADGASQLDWLTRLKIARGTSCGLA 721
N++ + L I + G L + + T K L
Sbjct: 92 PNVIKYYASFIEDN-ELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALE 150
Query: 722 YMHQICEPHIVHRDIKSSNILLDDQFEAHLADFGLSRLILPYQTHVTTELVGTLGYIPPE 781
+MH ++HRDIK +N+ + L D GL R T + LVGT Y+ PE
Sbjct: 151 HMH---SRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHS-LVGTPYYMSPE 206
Query: 782 YGQAWVATLRGDMYSFGVVMLELLTGKRPVDVLKPKMSRELVGWVLKMRSEGKQDQVFDP 841
+ D++S G ++ E+ + P K + L + + + P
Sbjct: 207 RIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNL-YSLCKKIEQCD--------YPP 257
Query: 842 ILRGKGFDEEMLQVLDVACMCVSQNPFKRPTVKEV 876
+ + EE+ Q+++ MC++ +P KRP V V
Sbjct: 258 LPSDH-YSEELRQLVN---MCINPDPEKRPDVTYV 288
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284 | Back alignment and structure |
|---|
Score = 128 bits (324), Expect = 4e-33
Identities = 67/288 (23%), Positives = 117/288 (40%), Gaps = 51/288 (17%)
Query: 607 DNFSQANIIGCGGFGLVYKAT-LANGTTLAIKKLSGDLGLMERE-FKAEVEALSTAQHKN 664
+F + +IG GGFG V+KA +G T IK++ E + EV+AL+ H N
Sbjct: 11 MDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVK-----YNNEKAEREVKALAKLDHVN 65
Query: 665 LVSLQGYCVHQGFRLLIYS----------------YMENGSLDYWLHEKADGASQLDWLT 708
+V G + S + + G+L+ W+ ++ +LD +
Sbjct: 66 IVHYNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKR--RGEKLDKVL 123
Query: 709 RLKIARGTSCGLAYMHQICEPHIVHRDIKSSNILLDDQFEAHLADFGLSRLILPYQTHVT 768
L++ + G+ Y+H +++RD+K SNI L D + + DFGL +
Sbjct: 124 ALELFEQITKGVDYIH---SKKLINRDLKPSNIFLVDTKQVKIGDFGLVTSLKNDGKRTR 180
Query: 769 TELVGTLGYIPPEYGQAWVATLRGDMYSFGVVMLELLTGKRPVDVLKPKMSRELVGWVLK 828
+ GTL Y+ PE + D+Y+ G+++ ELL E +
Sbjct: 181 S--KGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTA--------FETSKFFTD 230
Query: 829 MRSEGKQDQVFDPILRGKGFDEEMLQVLDVACMCVSQNPFKRPTVKEV 876
+R +G +FD + +++L P RP E+
Sbjct: 231 LR-DGIISDIFDKKEK--TLLQKLLSK----------KPEDRPNTSEI 265
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299 | Back alignment and structure |
|---|
Score = 128 bits (323), Expect = 7e-33
Identities = 63/305 (20%), Positives = 115/305 (37%), Gaps = 63/305 (20%)
Query: 607 DNFSQANIIGCGGFGLVYKAT-LANGTTLAIKKLSGDLGLMEREFKA---EVEALSTAQH 662
+F +G GGFG+V++A + AIK++ L E + EV+AL+ +H
Sbjct: 5 TDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRI--RLPNRELAREKVMREVKALAKLEH 62
Query: 663 KNLVSL---------QGYCVHQGFRLLIYSYME---NGSLDYWLHEKADGASQLDWLTRL 710
+V ++ +Y M+ +L W++ + + + L
Sbjct: 63 PGIVRYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGR-CTIEERERSVCL 121
Query: 711 KIARGTSCGLAYMHQICEPHIVHRDIKSSNILLDDQFEAHLADFGLSRLI---------- 760
I + + ++H ++HRD+K SNI + DFGL +
Sbjct: 122 HIFLQIAEAVEFLH---SKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVL 178
Query: 761 -LPYQTHVTTELVGTLGYIPPE------YGQAWVATLRGDMYSFGVVMLELLTGKRPVDV 813
T VGT Y+ PE Y + D++S G+++ ELL P
Sbjct: 179 TPMPAYARHTGQVGTKLYMSPEQIHGNSYSH------KVDIFSLGLILFELLY---P--- 226
Query: 814 LKPKMSRELVGWVLKMRSEGKQDQVFDPILRGKGFDEEMLQVLDVACMCVSQNPFKRPTV 873
+M R + +R + F P+ F ++ + +S +P +RP
Sbjct: 227 FSTQMERVRT--LTDVR-----NLKFPPL-----FTQKYPCEYVMVQDMLSPSPMERPEA 274
Query: 874 KEVVE 878
++E
Sbjct: 275 INIIE 279
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279 | Back alignment and structure |
|---|
Score = 126 bits (318), Expect = 2e-32
Identities = 72/287 (25%), Positives = 120/287 (41%), Gaps = 40/287 (13%)
Query: 607 DNFSQANIIGCGGFGLVYKAT-LANGTTLAIKKLSGDLGLM---EREF-KAEVEALSTAQ 661
+++ IG G +G K ++G L K+L D G M E++ +EV L +
Sbjct: 6 EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKEL--DYGSMTEAEKQMLVSEVNLLRELK 63
Query: 662 HKNLVSLQG-YCVHQGFRLLIY-SYMENGSLDYWLHEKADGASQLDWLTRLKIARGTSCG 719
H N+V L I Y E G L + + LD L++ +
Sbjct: 64 HPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLA 123
Query: 720 LAYMHQ--ICEPHIVHRDIKSSNILLDDQFEAHLADFGLSRLILPYQTHVTTELVGTLGY 777
L H+ ++HRD+K +N+ LD + L DFGL+R IL + T VGT Y
Sbjct: 124 LKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLAR-ILNHDTSFAKTFVGTPYY 182
Query: 778 IPPE------YGQAWVATLRGDMYSFGVVMLELLTGKRPVDVLKPKMSRELVGWVLKMRS 831
+ PE Y + + D++S G ++ EL P + K+R
Sbjct: 183 MSPEQMNRMSYNE------KSDIWSLGCLLYELCALMPPFT------AFSQKELAGKIR- 229
Query: 832 EGKQDQVFDPILRGKGFDEEMLQVLDVACMCVSQNPFKRPTVKEVVE 878
EGK F I + +E+ +++ ++ + RP+V+E++E
Sbjct: 230 EGK----FRRI--PYRYSDELNEIIT---RMLNLKDYHRPSVEEILE 267
|
| >4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350 | Back alignment and structure |
|---|
Score = 128 bits (323), Expect = 2e-32
Identities = 68/285 (23%), Positives = 114/285 (40%), Gaps = 49/285 (17%)
Query: 607 DNFSQANIIGCGGFGLVYKAT-LANGTTLAIKKLSGDLGLM---EREF-KAEVEALSTAQ 661
+ + + IG G FG +G IK++ ++ M ERE + EV L+ +
Sbjct: 24 EKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEI--NISRMSSKEREESRREVAVLANMK 81
Query: 662 HKNLVSLQGYCVHQGFRLLIYSYMENGSLDYWLHEKADGASQ----LDWLTRLKIARGTS 717
H N+V + G ++ Y E G L ++ + Q LDW ++
Sbjct: 82 HPNIVQYRESFEENGSLYIVMDYCEGGDLFKRINAQKGVLFQEDQILDWFVQI------C 135
Query: 718 CGLAYMHQICEPHIVHRDIKSSNILLDDQFEAHLADFGLSRLILPYQTHVTTELVGTLGY 777
L ++H + I+HRDIKS NI L L DFG++R +L + +GT Y
Sbjct: 136 LALKHVH---DRKILHRDIKSQNIFLTKDGTVQLGDFGIAR-VLNSTVELARACIGTPYY 191
Query: 778 IPPE------YGQAWVATLRGDMYSFGVVMLELLTGKRPVDVLKPKMSRELVGWVLKMRS 831
+ PE Y D+++ G V+ EL T K + K LV ++
Sbjct: 192 LSPEICENKPYNNK------SDIWALGCVLYELCTLKHAFEAGSMK---NLVLKIISGS- 241
Query: 832 EGKQDQVFDPILRGKGFDEEMLQVLDVACMCVSQNPFKRPTVKEV 876
F P+ + ++ ++ +NP RP+V +
Sbjct: 242 -------FPPV--SLHYSYDLRSLVS---QLFKRNPRDRPSVNSI 274
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278 | Back alignment and structure |
|---|
Score = 125 bits (315), Expect = 5e-32
Identities = 66/286 (23%), Positives = 115/286 (40%), Gaps = 58/286 (20%)
Query: 613 NIIGCGGFGLVYKATLANGTTLAIKKLSGDLGLMEREFKAEVEALSTAQHKNLVSLQGYC 672
IG G FG V G +A+K + + F AE ++ +H NLV L G
Sbjct: 27 QTIGKGEFGDVMLGD-YRGNKVAVKCIKN--DATAQAFLAEASVMTQLRHSNLVQLLGVI 83
Query: 673 VHQGFRLLIYS-YMENGSLDYWLHEKADGASQLDWLTRLKIARGTSCGLAYMHQICEPHI 731
V + L I + YM GSL +L ++ G S L LK + + Y+ +
Sbjct: 84 VEEKGGLYIVTEYMAKGSLVDYL--RSRGRSVLGGDCLLKFSLDVCEAMEYLEGN---NF 138
Query: 732 VHRDIKSSNILLDDQFEAHLADFGLSRLILPYQTHVTTELVGTLGYIP-----PE---YG 783
VHRD+ + N+L+ + A ++DFGL++ T G +P PE
Sbjct: 139 VHRDLAARNVLVSEDNVAKVSDFGLTKEA--SSTQ-------DTGKLPVKWTAPEALREK 189
Query: 784 QAWVATLRGDMYSFGVVMLELLT-GKRPVDVLKPKMSRELVGWVLKMRSEGKQDQVFDPI 842
+ + D++SFG+++ E+ + G+ P P++ + V +
Sbjct: 190 ---KFSTKSDVWSFGILLWEIYSFGRVPY----PRIPLK---------------DVVPRV 227
Query: 843 LRG------KGFDEEMLQVLDVACMCVSQNPFKRPTVKEVVEWLNN 882
+G G + +V+ C + RP+ ++ E L +
Sbjct: 228 EKGYKMDAPDGCPPAVYEVM---KNCWHLDAAMRPSFLQLREQLEH 270
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495 | Back alignment and structure |
|---|
Score = 129 bits (325), Expect = 1e-31
Identities = 65/283 (22%), Positives = 116/283 (40%), Gaps = 50/283 (17%)
Query: 613 NIIGCGGFGLVYKATLAN-GTTLAIKKLSGDLGLMERE-FKAEVEALSTAQHKNLVSLQG 670
+ +G G +G VY+ T+A+K L ME E F E + +H NLV L G
Sbjct: 226 HKLGGGQYGEVYEGVWKKYSLTVAVKTLKE--DTMEVEEFLKEAAVMKEIKHPNLVQLLG 283
Query: 671 YCVHQGFRLLIYSYMENGSLDYWLHEKADGASQLDWLTRLKIARGTSCGLAYMHQICEPH 730
C + +I +M G+L +L + ++ + L +A S + Y+ + +
Sbjct: 284 VCTREPPFYIITEFMTYGNLLDYL--RECNRQEVSAVVLLYMATQISSAMEYLEKK---N 338
Query: 731 IVHRDIKSSNILLDDQFEAHLADFGLSRLIL--PYQTHVTTELVGTLGYIPPEYGQAWVA 788
+HR++ + N L+ + +ADFGLSRL+ Y H + + + PE
Sbjct: 339 FIHRNLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKF--PIKWTAPESLAYNKF 396
Query: 789 TLRGDMYSFGVVMLELLT-GKRPVDVLKPKMSRELVGWVLKMRSEGKQDQVFDPILRG-- 845
+++ D+++FGV++ E+ T G P P + QV++ + +
Sbjct: 397 SIKSDVWAFGVLLWEIATYGMSPY----PGIDLS---------------QVYELLEKDYR 437
Query: 846 --------KGFDEEMLQVLDVACMCVSQNPFKRPTVKEVVEWL 880
+ E M C NP RP+ E+ +
Sbjct: 438 MERPEGCPEKVYELMRA-------CWQWNPSDRPSFAEIHQAF 473
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452 | Back alignment and structure |
|---|
Score = 127 bits (322), Expect = 2e-31
Identities = 74/284 (26%), Positives = 123/284 (43%), Gaps = 50/284 (17%)
Query: 613 NIIGCGGFGLVYKATLANGTTLAIKKLSGDLGLMERE-FKAEVEALSTAQHKNLVSLQGY 671
+G G FG V+ T T +AIK L G M E F E + + +H+ LV L
Sbjct: 190 VKLGQGCFGEVWMGTWNGTTRVAIKTLKP--GTMSPEAFLQEAQVMKKLRHEKLVQLYAV 247
Query: 672 CVHQGFRLLIYSYMENGSLDYWLHEKADGASQLDWLTRLKIARGTSCGLAYMHQICEPHI 731
+ ++ YM GSL +L K + L + +A + G+AY+ ++ +
Sbjct: 248 VSEEPI-YIVTEYMSKGSLLDFL--KGETGKYLRLPQLVDMAAQIASGMAYVERM---NY 301
Query: 732 VHRDIKSSNILLDDQFEAHLADFGLSRLIL--PYQTHVTTELVGTLGYIPPEYGQAWVAT 789
VHRD++++NIL+ + +ADFGL+RLI Y + + + PE T
Sbjct: 302 VHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKF--PIKWTAPEAALYGRFT 359
Query: 790 LRGDMYSFGVVMLELLT-GKRPVDVLKPKMSRELVGWVLKMRSEGKQDQVFDPILRG--- 845
++ D++SFG+++ EL T G+ P P M +V D + RG
Sbjct: 360 IKSDVWSFGILLTELTTKGRVPY----PGMVNR---------------EVLDQVERGYRM 400
Query: 846 -------KGFDEEMLQVLDVACMCVSQNPFKRPTVKEVVEWLNN 882
+ + M Q C + P +RPT + + +L +
Sbjct: 401 PCPPECPESLHDLMCQ-------CWRKEPEERPTFEYLQAFLED 437
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317 | Back alignment and structure |
|---|
Score = 124 bits (313), Expect = 3e-31
Identities = 59/280 (21%), Positives = 106/280 (37%), Gaps = 33/280 (11%)
Query: 615 IGCGGFGLVYKAT-LANGTTLAIKKLSGDLGLMEREFKAEVEALSTAQHKNLVSLQGYCV 673
+G GGF V L +G A+K++ E + E + H N++ L YC+
Sbjct: 37 LGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLFNHPNILRLVAYCL 96
Query: 674 HQGFR----LLIYSYMENGSLDYWLHEKADGASQLDWLTRLKIARGTSCGLAYMHQICEP 729
+ L+ + + G+L + D + L L + G GL +H
Sbjct: 97 RERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHA---K 153
Query: 730 HIVHRDIKSSNILLDDQFEAHLADFGLSRLILPYQTHVTTEL--------VGTLGYIPPE 781
HRD+K +NILL D+ + L D G + L T+ Y PE
Sbjct: 154 GYAHRDLKPTNILLGDEGQPVLMDLGSMNQACIHVEGSRQALTLQDWAAQRCTISYRAPE 213
Query: 782 YGQAW---VATLRGDMYSFGVVMLELLTGKRPVDVLKPKMSRELVGWVLKMRSEGKQDQV 838
V R D++S G V+ ++ G+ P D++ K + + + +
Sbjct: 214 LFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKGD------SVALAVQNQLSIP 267
Query: 839 FDPILRGKGFDEEMLQVLDVACMCVSQNPFKRPTVKEVVE 878
P + Q+L+ ++ +P +RP + ++
Sbjct: 268 QSPR-----HSSALWQLLN---SMMTVDPHQRPHIPLLLS 299
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313 | Back alignment and structure |
|---|
Score = 123 bits (311), Expect = 4e-31
Identities = 66/305 (21%), Positives = 116/305 (38%), Gaps = 58/305 (19%)
Query: 600 YELLKATDNFSQANIIGCGGFGLVYKATLANGTTLAIK--KLSGDLGLMEREFKAEVEAL 657
Y +LK IG GG V++ AIK L ++ E+ L
Sbjct: 30 YSILK---------QIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYL 80
Query: 658 STAQHKNL--VSLQGYCVHQGFRLLIYSYME--NGSLDYWLHEKADGASQLDWLTRLKIA 713
+ Q + + L Y + + IY ME N L+ WL +K +D R
Sbjct: 81 NKLQQHSDKIIRLYDYEITDQY---IYMVMECGNIDLNSWLKKK----KSIDPWERKSYW 133
Query: 714 RGTSCGLAYMHQICEPHIVHRDIKSSNILLDDQFEAHLADFGLSRLILPYQTHVTTE-LV 772
+ + +HQ IVH D+K +N L+ D L DFG++ + P T V + V
Sbjct: 134 KNMLEAVHTIHQH---GIVHSDLKPANFLIVDG-MLKLIDFGIANQMQPDTTSVVKDSQV 189
Query: 773 GTLGYIPPE-----------YGQAWVATLRGDMYSFGVVMLELLTGKRPVDVLKPKMSRE 821
GT+ Y+PPE + + D++S G ++ + GK P + ++S+
Sbjct: 190 GTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISK- 248
Query: 822 LVGWVLKMRSEGKQDQVFDPIL--RGKGFDEEMLQVLDVACMCVSQNPFKRPTVKEVVE- 878
L + + F I + + L+ +P +R ++ E++
Sbjct: 249 -----LHAIIDPNHEIEFPDIPEKDLQDVLKCCLKR----------DPKQRISIPELLAH 293
Query: 879 -WLNN 882
++
Sbjct: 294 PYVQI 298
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343 | Back alignment and structure |
|---|
Score = 124 bits (313), Expect = 4e-31
Identities = 70/315 (22%), Positives = 123/315 (39%), Gaps = 57/315 (18%)
Query: 589 NNTNEIKDLTIYELLKATDNFSQANIIGCGGFGLVYKATLANGTTLAIK--KLSGDLGLM 646
N +K IY +LK IG GG V++ AIK L
Sbjct: 1 NECISVKG-RIYSILK---------QIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQT 50
Query: 647 EREFKAEVEALSTAQHKNL--VSLQGYCVHQGFRLLIYSYME--NGSLDYWLHEKADGAS 702
++ E+ L+ Q + + L Y + + IY ME N L+ WL +K
Sbjct: 51 LDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQY---IYMVMECGNIDLNSWLKKK----K 103
Query: 703 QLDWLTRLKIARGTSCGLAYMHQICEPHIVHRDIKSSNILLDDQFEAHLADFGLSRLILP 762
+D R + + +HQ IVH D+K +N L+ D L DFG++ + P
Sbjct: 104 SIDPWERKSYWKNMLEAVHTIHQH---GIVHSDLKPANFLIVDG-MLKLIDFGIANQMQP 159
Query: 763 YQTHVTTE-LVGTLGYIPPE-----------YGQAWVATLRGDMYSFGVVMLELLTGKRP 810
T V + VGT+ Y+PPE + + D++S G ++ + GK P
Sbjct: 160 DTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTP 219
Query: 811 VDVLKPKMSRELVGWVLKMRSEGKQDQVFDPILRGKGFDEEM-LQVLDVACMCVSQNPFK 869
+ ++S K+ + + + F + + DV C+ ++P +
Sbjct: 220 FQQIINQIS--------KLHAIIDPNHEIE-------FPDIPEKDLQDVLKCCLKRDPKQ 264
Query: 870 RPTVKEVVE--WLNN 882
R ++ E++ ++
Sbjct: 265 RISIPELLAHPYVQI 279
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371 | Back alignment and structure |
|---|
Score = 125 bits (314), Expect = 4e-31
Identities = 35/346 (10%), Positives = 76/346 (21%), Gaps = 54/346 (15%)
Query: 574 SPEADKDASLVMLFPNNTNEIKDLTIYELLKATDNFSQANIIGCGGFGLVYKAT-LANGT 632
P A +A ++P N L + + G +V+ +
Sbjct: 32 EPAAMVEAVTATVWPQNAETT---VDSLLSQGERKLKLVEPLRVGDRSVVFLVRDVERLE 88
Query: 633 TLAIKKLSGDL---GLMEREFKAEVEALSTAQHKNLVSLQGYC----------------- 672
A+K + A + ++ +
Sbjct: 89 DFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEARDRRRLLLPSDAVAVQSQPPF 148
Query: 673 -----------VHQGFRLLIYSYMENGSLDYWLHEKADGASQLDWLTRLKIARGTSCGLA 721
V L+ + ++ L L L + A
Sbjct: 149 AQLSPGQDDYAVANYLLLMPAASVDLELLFSTLDFVYVFRGDEGILALHILTAQLIRLAA 208
Query: 722 YMHQICEPHIVHRDIKSSNILLDDQFEAHLADFGLSRLILPYQTHVTTELVGTLGYIPPE 781
+ +VH N+ + L D + Y P E
Sbjct: 209 NLQ---SKGLVHGHFTPDNLFIMPDGRLMLGDVSALW----KVGTRGPASSVPVTYAPRE 261
Query: 782 Y--GQAWVATLRGDMYSFGVVMLELLTGKRPVDVLKPKMSRELVGWVLKMRSEGKQDQVF 839
+ T + + G+ + + P ++ P + K S
Sbjct: 262 FLNASTATFTHALNAWQLGLSIYRVWCLFLPFGLVTPGIKGS-----WKRPSLRVPGTDS 316
Query: 840 DPILRGKGFDEEMLQVLDVACMCVSQNPFKRPTVKEVVE--WLNNV 883
+ V + ++ + +R E +E +
Sbjct: 317 LAFGSCTPLPDF---VKTLIGRFLNFDRRRRLLPLEAMETPEFLQL 359
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267 | Back alignment and structure |
|---|
Score = 122 bits (308), Expect = 4e-31
Identities = 70/288 (24%), Positives = 113/288 (39%), Gaps = 58/288 (20%)
Query: 613 NIIGCGGFGLVYKATLANGTTLAIKKLSGDLGLMERE-FKAEVEALSTAQHKNLVSLQGY 671
IG G FGLV+ N +AIK + G M E F E E + H LV L G
Sbjct: 14 QEIGSGQFGLVHLGYWLNKDKVAIKTIRE--GAMSEEDFIEEAEVMMKLSHPKLVQLYGV 71
Query: 672 CVHQGFRLLIYSYMENGSLDYWLHEKADGASQLDWLTRLKIARGTSCGLAYMHQICEPHI 731
C+ Q L+ +ME+G L +L T L + G+AY+ + +
Sbjct: 72 CLEQAPICLVTEFMEHGCLSDYLRT---QRGLFAAETLLGMCLDVCEGMAYLEEA---CV 125
Query: 732 VHRDIKSSNILLDDQFEAHLADFGLSRLIL--PYQTHVTTELVGTLGYIP-----PE--- 781
+HRD+ + N L+ + ++DFG++R +L Y + T+ P PE
Sbjct: 126 IHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTK-------FPVKWASPEVFS 178
Query: 782 YGQAWVATLRGDMYSFGVVMLELLT-GKRPVDVLKPKMSRELVGWVLKMRSEGKQDQVFD 840
+ + + D++SFGV+M E+ + GK P S +V +
Sbjct: 179 FS---RYSSKSDVWSFGVLMWEVFSEGKIPY----ENRSNS---------------EVVE 216
Query: 841 PILRG------KGFDEEMLQVLDVACMCVSQNPFKRPTVKEVVEWLNN 882
I G + + Q++ C + P RP ++ L
Sbjct: 217 DISTGFRLYKPRLASTHVYQIM---NHCWRERPEDRPAFSRLLRQLAE 261
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450 | Back alignment and structure |
|---|
Score = 126 bits (318), Expect = 5e-31
Identities = 67/287 (23%), Positives = 115/287 (40%), Gaps = 60/287 (20%)
Query: 613 NIIGCGGFGLVYKATLANGTTLAIKKLSGDLGLMEREFKAEVEALSTAQHKNLVSLQGYC 672
IG G FG V G +A+K + D + F AE ++ +H NLV L G
Sbjct: 199 QTIGKGEFGDVMLGDY-RGNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVI 255
Query: 673 VHQGFRLLIYS-YMENGSLDYWLHEKADGASQLDWLTRLKIARGTSCGLAYMHQICEPHI 731
V + L I + YM GSL +L ++ G S L LK + + Y+ +
Sbjct: 256 VEEKGGLYIVTEYMAKGSLVDYL--RSRGRSVLGGDCLLKFSLDVCEAMEYLEGN---NF 310
Query: 732 VHRDIKSSNILLDDQFEAHLADFGLSRLILPYQTHVTTELVGTLGYIP-----PEYGQAW 786
VHRD+ + N+L+ + A ++DFGL++ T T + +P PE +
Sbjct: 311 VHRDLAARNVLVSEDNVAKVSDFGLTKEA--SSTQDTGK-------LPVKWTAPEALREK 361
Query: 787 VATLRGDMYSFGVVMLELLT-GKRPVDVLKPKMSRELVGWVLKMRSEGKQDQVFDPILRG 845
+ + D++SFG+++ E+ + G+ P P++ + V + +G
Sbjct: 362 KFSTKSDVWSFGILLWEIYSFGRVPY----PRIPLK---------------DVVPRVEKG 402
Query: 846 ----------KGFDEEMLQVLDVACMCVSQNPFKRPTVKEVVEWLNN 882
+ M C + RPT ++ E L +
Sbjct: 403 YKMDAPDGCPPAVYDVMKN-------CWHLDAATRPTFLQLREQLEH 442
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298 | Back alignment and structure |
|---|
Score = 122 bits (309), Expect = 6e-31
Identities = 70/303 (23%), Positives = 121/303 (39%), Gaps = 62/303 (20%)
Query: 613 NIIGCGGFGLVYKATLANG----TTLAIKKLSGDLGLMER-EFKAEVEALSTAQHKNLVS 667
+IG G FG VY TL + A+K L+ + E +F E + H N++S
Sbjct: 31 EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLS 90
Query: 668 LQGYCVH-QGFRLLIYSYMENGSLDYWLHEKADGASQLDWLTRLKIARGTSCGLAYMHQI 726
L G C+ +G L++ YM++G L ++ + + + G+ Y+
Sbjct: 91 LLGICLRSEGSPLVVLPYMKHGDLRNFIRNETH---NPTVKDLIGFGLQVAKGMKYLASK 147
Query: 727 CEPHIVHRDIKSSNILLDDQFEAHLADFGLSRLILPYQTHVTTELVGTLGYIP-----PE 781
VHRD+ + N +LD++F +ADFGL+R + Y + T +P E
Sbjct: 148 ---KFVHRDLAARNCMLDEKFTVKVADFGLARDM--YDKEYYSVHNKTGAKLPVKWMALE 202
Query: 782 ---YGQAWVATLRGDMYSFGVVMLELLT-GKRPVDVLKPKMSRELVGWVLKMRSEGKQDQ 837
T + D++SFGV++ EL+T G P P ++
Sbjct: 203 SLQTQ---KFTTKSDVWSFGVLLWELMTRGAPPY----PDVNTF---------------D 240
Query: 838 VFDPILRGKGFD----------EEMLQVLDVACMCVSQNPFKRPTVKEVVEWLNNVGANR 887
+ +L+G+ E ML+ C RP+ E+V ++ + +
Sbjct: 241 ITVYLLQGRRLLQPEYCPDPLYEVMLK-------CWHPKAEMRPSFSELVSRISAIFSTF 293
Query: 888 RNE 890
E
Sbjct: 294 IGE 296
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 122 bits (308), Expect = 6e-31
Identities = 76/298 (25%), Positives = 121/298 (40%), Gaps = 66/298 (22%)
Query: 607 DNFSQANIIGCGGFGLVYKATLANGTTLAIKKLSGDLGLMERE-FKAEVEALSTAQHKNL 665
+ +G G FG V+ T +A+K L G M + F AE + QH+ L
Sbjct: 13 ETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQ--GSMSPDAFLAEANLMKQLQHQRL 70
Query: 666 VSLQGYCVHQGFRLLIYSYMENGSLDYWLHEKADGASQLDWLTRLKIARGTSCGLAYMHQ 725
V L + +I YMENGSL +L K +L L +A + G+A++ +
Sbjct: 71 VRLYAVVTQEPI-YIITEYMENGSLVDFL--KTPSGIKLTINKLLDMAAQIAEGMAFIEE 127
Query: 726 ICEPHIVHRDIKSSNILLDDQFEAHLADFGLSRLIL--PYQTHVTTELVGTLGYIP---- 779
+ +HRD++++NIL+ D +ADFGL+RLI Y P
Sbjct: 128 R---NYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAR-------EGAKFPIKWT 177
Query: 780 -PE---YGQAWVATLRGDMYSFGVVMLELLT-GKRPVDVLKPKMSRELVGWVLKMRSEGK 834
PE YG T++ D++SFG+++ E++T G+ P P M+
Sbjct: 178 APEAINYG---TFTIKSDVWSFGILLTEIVTHGRIPY----PGMTNP------------- 217
Query: 835 QDQVFDPILRG----------KGFDEEMLQVLDVACMCVSQNPFKRPTVKEVVEWLNN 882
+V + RG + + M C + P RPT + L +
Sbjct: 218 --EVIQNLERGYRMVRPDNCPEELYQLMRL-------CWKERPEDRPTFDYLRSVLED 266
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 122 bits (308), Expect = 8e-31
Identities = 63/293 (21%), Positives = 108/293 (36%), Gaps = 56/293 (19%)
Query: 613 NIIGCGGFGLVYKATLANG----TTLAIKKLSGDLGLMER-EFKAEVEALSTAQHKNLVS 667
+IG G FG+VY + AIK LS + + F E + H N+++
Sbjct: 27 RVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVLA 86
Query: 668 LQGYCVH-QGFRLLIYSYMENGSLDYWLHEKADGASQLDWLTRLKIARGTSCGLAYMHQI 726
L G + +G ++ YM +G L ++ + + G+ Y+ +
Sbjct: 87 LIGIMLPPEGLPHVLLPYMCHGDLLQFIRSPQR---NPTVKDLISFGLQVARGMEYLAEQ 143
Query: 727 CEPHIVHRDIKSSNILLDDQFEAHLADFGLSRLILPYQTHVTTELVGTLGYIP-----PE 781
VHRD+ + N +LD+ F +ADFGL+R I + +P E
Sbjct: 144 ---KFVHRDLAARNCMLDESFTVKVADFGLARDI--LDREYYSVQQHRHARLPVKWTALE 198
Query: 782 ---YGQAWVATLRGDMYSFGVVMLELLT-GKRPVDVLKPKMSRELVGWVLKMRSEGKQDQ 837
T + D++SFGV++ ELLT G P +
Sbjct: 199 SLQTY---RFTTKSDVWSFGVLLWELLTRGAPPY----RHIDPF---------------D 236
Query: 838 VFDPILRGKGFDEEMLQ-------VLDVACMCVSQNPFKRPTVKEVVEWLNNV 883
+ + +G + Q + V C +P RPT + +V + +
Sbjct: 237 LTHFLAQG----RRLPQPEYCPDSLYQVMQQCWEADPAVRPTFRVLVGEVEQI 285
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535 | Back alignment and structure |
|---|
Score = 126 bits (319), Expect = 9e-31
Identities = 74/284 (26%), Positives = 123/284 (43%), Gaps = 50/284 (17%)
Query: 613 NIIGCGGFGLVYKATLANGTTLAIKKLSGDLGLMERE-FKAEVEALSTAQHKNLVSLQGY 671
+G G FG V+ T T +AIK L G M E F E + + +H+ LV L
Sbjct: 273 VKLGQGCFGEVWMGTWNGTTRVAIKTLKP--GTMSPEAFLQEAQVMKKLRHEKLVQLYAV 330
Query: 672 CVHQGFRLLIYSYMENGSLDYWLHEKADGASQLDWLTRLKIARGTSCGLAYMHQICEPHI 731
+ ++ YM GSL +L K + L + +A + G+AY+ ++ +
Sbjct: 331 VSEEPI-YIVTEYMSKGSLLDFL--KGETGKYLRLPQLVDMAAQIASGMAYVERM---NY 384
Query: 732 VHRDIKSSNILLDDQFEAHLADFGLSRLIL--PYQTHVTTELVGTLGYIPPEYGQAWVAT 789
VHRD++++NIL+ + +ADFGL+RLI Y + + + PE T
Sbjct: 385 VHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKF--PIKWTAPEAALYGRFT 442
Query: 790 LRGDMYSFGVVMLELLT-GKRPVDVLKPKMSRELVGWVLKMRSEGKQDQVFDPILRG--- 845
++ D++SFG+++ EL T G+ P P M +V D + RG
Sbjct: 443 IKSDVWSFGILLTELTTKGRVPY----PGMVNR---------------EVLDQVERGYRM 483
Query: 846 -------KGFDEEMLQVLDVACMCVSQNPFKRPTVKEVVEWLNN 882
+ + M Q C + P +RPT + + +L +
Sbjct: 484 PCPPECPESLHDLMCQ-------CWRKEPEERPTFEYLQAFLED 520
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283 | Back alignment and structure |
|---|
Score = 121 bits (306), Expect = 1e-30
Identities = 66/292 (22%), Positives = 116/292 (39%), Gaps = 54/292 (18%)
Query: 607 DNFSQANIIGCGGFGLVYKATLANGTTLAIKKLSGDLGLMERE-FKAEVEALSTAQHKNL 665
+ + +G G FG+V +AIK + G M + F E + + H+ L
Sbjct: 24 KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKE--GSMSEDEFIEEAKVMMNLSHEKL 81
Query: 666 VSLQGYCVHQGFRLLIYSYMENGSLDYWLHEKADGASQLDWLTRLKIARGTSCGLAYMHQ 725
V L G C Q +I YM NG L +L E + L++ + + Y+
Sbjct: 82 VQLYGVCTKQRPIFIITEYMANGCLLNYLRE---MRHRFQTQQLLEMCKDVCEAMEYLES 138
Query: 726 ICEPHIVHRDIKSSNILLDDQFEAHLADFGLSRLILPYQTHVTTELVGTLGYIP-----P 780
+HRD+ + N L++DQ ++DFGLSR + T VG+ P P
Sbjct: 139 K---QFLHRDLAARNCLVNDQGVVKVSDFGLSRYV---LDDEYTSSVGSK--FPVRWSPP 190
Query: 781 E---YGQAWVATLRGDMYSFGVVMLELLT-GKRPVDVLKPKMSRELVGWVLKMRSEGKQD 836
E Y + + D+++FGV+M E+ + GK P + +
Sbjct: 191 EVLMYS---KFSSKSDIWAFGVLMWEIYSLGKMPY----ERFTNS--------------- 228
Query: 837 QVFDPILRG------KGFDEEMLQVLDVACMCVSQNPFKRPTVKEVVEWLNN 882
+ + I +G E++ ++ C + +RPT K ++ + +
Sbjct: 229 ETAEHIAQGLRLYRPHLASEKVYTIM---YSCWHEKADERPTFKILLSNILD 277
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268 | Back alignment and structure |
|---|
Score = 120 bits (303), Expect = 2e-30
Identities = 61/294 (20%), Positives = 115/294 (39%), Gaps = 58/294 (19%)
Query: 607 DNFSQANIIGCGGFGLVYKATLANGTTLAIKKLSGDLGLMERE-FKAEVEALSTAQHKNL 665
+ + +G G FG+V +A+K + G M + F E + + H L
Sbjct: 8 EEITLLKELGSGQFGVVKLGKWKGQYDVAVKMIKE--GSMSEDEFFQEAQTMMKLSHPKL 65
Query: 666 VSLQGYCVHQGFRLLIYSYMENGSLDYWLHEKADGASQLDWLTRLKIARGTSCGLAYMHQ 725
V G C + ++ Y+ NG L +L L+ L++ G+A++
Sbjct: 66 VKFYGVCSKEYPIYIVTEYISNGCLLNYLRSHG---KGLEPSQLLEMCYDVCEGMAFLES 122
Query: 726 ICEPHIVHRDIKSSNILLDDQFEAHLADFGLSRLIL--PYQTHVTTELVGTLGYIP---- 779
+HRD+ + N L+D ++DFG++R +L Y + VGT P
Sbjct: 123 H---QFIHRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQYVSS-----VGTK--FPVKWS 172
Query: 780 -PE---YGQAWVATLRGDMYSFGVVMLELLT-GKRPVDVLKPKMSRELVGWVLKMRSEGK 834
PE Y + + D+++FG++M E+ + GK P +
Sbjct: 173 APEVFHYF---KYSSKSDVWAFGILMWEVFSLGKMPY----DLYTNS------------- 212
Query: 835 QDQVFDPILRG------KGFDEEMLQVLDVACMCVSQNPFKRPTVKEVVEWLNN 882
+V + +G + + Q++ C + P KRPT ++++ +
Sbjct: 213 --EVVLKVSQGHRLYRPHLASDTIYQIM---YSCWHELPEKRPTFQQLLSSIEP 261
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303 | Back alignment and structure |
|---|
Score = 120 bits (304), Expect = 3e-30
Identities = 63/310 (20%), Positives = 114/310 (36%), Gaps = 58/310 (18%)
Query: 606 TDNFSQANIIGCGGFGLVYKAT-LANGTTLAIKKLSGDLGLMEREFKAEVEALSTAQHKN 664
+F + ++G G FG V KA + AIKK+ +EV L++ H+
Sbjct: 5 ASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHTEE-KLSTILSEVMLLASLNHQY 63
Query: 665 LVSLQGYCVHQGFRLLIYSYMENGSLDYWLHEKADGASQLDWLTR----------LKIAR 714
+V + + + + ++ S + E + + D + ++ R
Sbjct: 64 VVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWRLFR 123
Query: 715 GTSCGLAYMHQICEPHIVHRDIKSSNILLDDQFEAHLADFGLSRLI-------------L 761
L+Y+H I+HRD+K NI +D+ + DFGL++ + L
Sbjct: 124 QILEALSYIHS---QGIIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQNL 180
Query: 762 PYQTHVTTELVGTLGYIPPE-------YGQAWVATLRGDMYSFGVVMLELLTGKRPVDVL 814
P + T +GT Y+ E Y + DMYS G++ E++
Sbjct: 181 PGSSDNLTSAIGTAMYVATEVLDGTGHYNEK------IDMYSLGIIFFEMIYP------F 228
Query: 815 KPKMSRELVGWVLKMRSEGKQDQVFDPILRGKGFDEEMLQVLDVACMCVSQNPFKRPTVK 874
M R + + K+R F P E + + + +P KRP +
Sbjct: 229 STGMERVNI--LKKLR---SVSIEFPPDFDDNKMKVE----KKIIRLLIDHDPNKRPGAR 279
Query: 875 EVVE--WLNN 882
++ WL
Sbjct: 280 TLLNSGWLPV 289
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390 | Back alignment and structure |
|---|
Score = 123 bits (309), Expect = 3e-30
Identities = 65/305 (21%), Positives = 115/305 (37%), Gaps = 58/305 (19%)
Query: 600 YELLKATDNFSQANIIGCGGFGLVYKATLANGTTLAIK--KLSGDLGLMEREFKAEVEAL 657
Y +LK IG GG V++ AIK L ++ E+ L
Sbjct: 58 YSILK---------QIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYL 108
Query: 658 STAQHKNL--VSLQGYCVHQGFRLLIYSYME--NGSLDYWLHEKADGASQLDWLTRLKIA 713
+ Q + + L Y + + IY ME N L+ WL +K +D R
Sbjct: 109 NKLQQHSDKIIRLYDYEITDQY---IYMVMECGNIDLNSWLKKK----KSIDPWERKSYW 161
Query: 714 RGTSCGLAYMHQICEPHIVHRDIKSSNILLDDQFEAHLADFGLSRLILPYQTHVTTE-LV 772
+ + +HQ IVH D+K +N L+ D L DFG++ + P T V + V
Sbjct: 162 KNMLEAVHTIHQH---GIVHSDLKPANFLIVDG-MLKLIDFGIANQMQPDTTSVVKDSQV 217
Query: 773 GTLGYIPPE-----------YGQAWVATLRGDMYSFGVVMLELLTGKRPVDVLKPKMSRE 821
G + Y+PPE + + D++S G ++ + GK P + ++S+
Sbjct: 218 GAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISK- 276
Query: 822 LVGWVLKMRSEGKQDQVFDPIL--RGKGFDEEMLQVLDVACMCVSQNPFKRPTVKEVVE- 878
L + + F I + + L+ +P +R ++ E++
Sbjct: 277 -----LHAIIDPNHEIEFPDIPEKDLQDVLKCCLKR----------DPKQRISIPELLAH 321
Query: 879 -WLNN 882
++
Sbjct: 322 PYVQI 326
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454 | Back alignment and structure |
|---|
Score = 124 bits (312), Expect = 4e-30
Identities = 71/291 (24%), Positives = 122/291 (41%), Gaps = 64/291 (21%)
Query: 613 NIIGCGGFGLVYKATLANGTTLAIKKLSGDLGLMEREFKAEVEALSTAQHKNLVSLQGYC 672
+G G FG V+ AT T +A+K + + F AE + T QH LV L
Sbjct: 194 KKLGAGQFGEVWMATYNKHTKVAVKTMKPG-SMSVEAFLAEANVMKTLQHDKLVKLHAVV 252
Query: 673 VHQGFRLLIYSYMENGSLDYWLHEKADGASQLDWLTRLKIARGTSCGLAYMHQICEPHIV 732
+ +I +M GSL +L K+D S+ + + + G+A++ Q + +
Sbjct: 253 TKEPI-YIITEFMAKGSLLDFL--KSDEGSKQPLPKLIDFSAQIAEGMAFIEQR---NYI 306
Query: 733 HRDIKSSNILLDDQFEAHLADFGLSRLIL--PYQTHVTTELVGTLGYIP-----PE---Y 782
HRD++++NIL+ +ADFGL+R+I Y P PE +
Sbjct: 307 HRDLRAANILVSASLVCKIADFGLARVIEDNEYTAR-------EGAKFPIKWTAPEAINF 359
Query: 783 GQAWVATLRGDMYSFGVVMLELLT-GKRPVDVLKPKMSRELVGWVLKMRSEGKQDQVFDP 841
G T++ D++SFG++++E++T G+ P P MS +V
Sbjct: 360 G---SFTIKSDVWSFGILLMEIVTYGRIPY----PGMSNP---------------EVIRA 397
Query: 842 ILRG----------KGFDEEMLQVLDVACMCVSQNPFKRPTVKEVVEWLNN 882
+ RG + M++ C P +RPT + + L++
Sbjct: 398 LERGYRMPRPENCPEELYNIMMR-------CWKNRPEERPTFEYIQSVLDD 441
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295 | Back alignment and structure |
|---|
Score = 120 bits (302), Expect = 4e-30
Identities = 56/209 (26%), Positives = 87/209 (41%), Gaps = 9/209 (4%)
Query: 606 TDNFSQANIIGCGGFGLVYKAT-LANGTTLAIKKLSGDLGLMEREFKAEVEALSTAQHKN 664
D ++G G +G+VY L+N +AIK++ + E+ +HKN
Sbjct: 21 YDENGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKN 80
Query: 665 LVSLQGYCVHQGFRLLIYSYMENGSLDYWLHEKADGASQLDWLTRLKIARGTSCGLAYMH 724
+V G GF + + GSL L K + + GL Y+H
Sbjct: 81 IVQYLGSFSENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIG-FYTKQILEGLKYLH 139
Query: 725 QICEPHIVHRDIKSSNILLDDQF-EAHLADFGLSRLILPYQTHVTTELVGTLGYIPPE-- 781
+ IVHRDIK N+L++ ++DFG S+ + T GTL Y+ PE
Sbjct: 140 ---DNQIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGINPCTET-FTGTLQYMAPEII 195
Query: 782 YGQAWVATLRGDMYSFGVVMLELLTGKRP 810
D++S G ++E+ TGK P
Sbjct: 196 DKGPRGYGKAADIWSLGCTIIEMATGKPP 224
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373 | Back alignment and structure |
|---|
Score = 121 bits (306), Expect = 5e-30
Identities = 69/303 (22%), Positives = 121/303 (39%), Gaps = 62/303 (20%)
Query: 613 NIIGCGGFGLVYKATLANG----TTLAIKKLSGDLGLMER-EFKAEVEALSTAQHKNLVS 667
+IG G FG VY TL + A+K L+ + E +F E + H N++S
Sbjct: 95 EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLS 154
Query: 668 LQGYCVH-QGFRLLIYSYMENGSLDYWLHEKADGASQLDWLTRLKIARGTSCGLAYMHQI 726
L G C+ +G L++ YM++G L ++ + + + G+ ++
Sbjct: 155 LLGICLRSEGSPLVVLPYMKHGDLRNFIRNETH---NPTVKDLIGFGLQVAKGMKFLASK 211
Query: 727 CEPHIVHRDIKSSNILLDDQFEAHLADFGLSRLILPYQTHVTTELVGTLGYIP-----PE 781
VHRD+ + N +LD++F +ADFGL+R + Y + T +P E
Sbjct: 212 ---KFVHRDLAARNCMLDEKFTVKVADFGLARDM--YDKEFDSVHNKTGAKLPVKWMALE 266
Query: 782 ---YGQAWVATLRGDMYSFGVVMLELLT-GKRPVDVLKPKMSRELVGWVLKMRSEGKQDQ 837
T + D++SFGV++ EL+T G P P ++
Sbjct: 267 SLQTQ---KFTTKSDVWSFGVLLWELMTRGAPPY----PDVNTF---------------D 304
Query: 838 VFDPILRGKGFD----------EEMLQVLDVACMCVSQNPFKRPTVKEVVEWLNNVGANR 887
+ +L+G+ E ML+ C RP+ E+V ++ + +
Sbjct: 305 ITVYLLQGRRLLQPEYCPDPLYEVMLK-------CWHPKAEMRPSFSELVSRISAIFSTF 357
Query: 888 RNE 890
E
Sbjct: 358 IGE 360
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302 | Back alignment and structure |
|---|
Score = 119 bits (301), Expect = 6e-30
Identities = 63/289 (21%), Positives = 115/289 (39%), Gaps = 37/289 (12%)
Query: 613 NIIGCGGFGLVYKATLA-----NGTTLAIKKLSGDLGLMER-EFKAEVEALSTAQHKNLV 666
+G G FG V G +A+K L + G + K E+E L H+N+V
Sbjct: 27 RDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIV 86
Query: 667 SLQGYCVHQGFR--LLIYSYMENGSLDYWLHEKADGASQLDWLTRLKIARGTSCGLAYMH 724
+G C G LI ++ +GSL +L + + +++ +LK A G+ Y+
Sbjct: 87 KYKGICTEDGGNGIKLIMEFLPSGSLKEYLPKNKN---KINLKQQLKYAVQICKGMDYLG 143
Query: 725 QICEPHIVHRDIKSSNILLDDQFEAHLADFGLSRLILPYQTHVTTELVGTLGYIP----- 779
VHRD+ + N+L++ + + + DFGL++ I + + T V P
Sbjct: 144 SR---QYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYT---VKDDRDSPVFWYA 197
Query: 780 PEYGQAWVATLRGDMYSFGVVMLELLTGKRPVDVLKPKMSRELVGWVLKMRSEGKQDQVF 839
PE + D++SFGV + ELLT + + +M ++
Sbjct: 198 PECLMQSKFYIASDVWSFGVTLHELLTYCDSDSSPMALFLKMIGPTHGQMTVT----RLV 253
Query: 840 DPILRGKGFDEEM-------LQVLDVACMCVSQNPFKRPTVKEVVEWLN 881
+ + G + + +V + C P R + + ++E
Sbjct: 254 NTLKEG----KRLPCPPNCPDEVYQLMRKCWEFQPSNRTSFQNLIEGFE 298
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327 | Back alignment and structure |
|---|
Score = 119 bits (300), Expect = 2e-29
Identities = 70/308 (22%), Positives = 117/308 (37%), Gaps = 60/308 (19%)
Query: 607 DNFSQANIIGCGGFGLVYKATLANG------TTLAIKKLSGDLGLMER-EFKAEVEALST 659
N + +G G FG VY+ ++ +A+K L + +F E +S
Sbjct: 30 KNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISK 89
Query: 660 AQHKNLVSLQGYCVHQGFRLLIYSYMENGSLDYWLHE---KADGASQLDWLTRLKIARGT 716
H+N+V G + R ++ M G L +L E + S L L L +AR
Sbjct: 90 FNHQNIVRCIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDI 149
Query: 717 SCGLAYMHQICEPHIVHRDIKSSNILLDDQFEAHL---ADFGLSRLILPYQTHVTTELVG 773
+CG Y+ + H +HRDI + N LL + DFG++R I Y+ G
Sbjct: 150 ACGCQYLEEN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDI--YRASYYR--KG 202
Query: 774 TLGYIP-----PE---YGQAWVATLRGDMYSFGVVMLELLT-GKRPVDVLKPKMSRELVG 824
+P PE G + T + D +SFGV++ E+ + G P P S +
Sbjct: 203 GCAMLPVKWMPPEAFMEG---IFTSKTDTWSFGVLLWEIFSLGYMPY----PSKSNQ--- 252
Query: 825 WVLKMRSEGKQDQVFDPILRG------KGFDEEMLQVLDVACMCVSQNPFKRPTVKEVVE 878
+V + + G K + +++ C P RP ++E
Sbjct: 253 ------------EVLEFVTSGGRMDPPKNCPGPVYRIM---TQCWQHQPEDRPNFAIILE 297
Query: 879 WLNNVGAN 886
+ +
Sbjct: 298 RIEYCTQD 305
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288 | Back alignment and structure |
|---|
Score = 118 bits (297), Expect = 2e-29
Identities = 67/289 (23%), Positives = 119/289 (41%), Gaps = 58/289 (20%)
Query: 613 NIIGCGGFGLVYKATLANGTTL-AIKKLSGDLGLMERE-FKAEVEALSTAQHKNLVSLQG 670
+ +G G +G VY+ + A+K L ME E F E + +H NLV L G
Sbjct: 19 HKLGGGQYGEVYEGVWKKYSLTVAVKTLKE--DTMEVEEFLKEAAVMKEIKHPNLVQLLG 76
Query: 671 YCVHQGFRLLIYSYMENGSLDYWLHEKADGASQLDWLTRLKIARGTSCGLAYMHQICEPH 730
C + +I +M G+L +L + ++ + L +A S + Y+ + +
Sbjct: 77 VCTREPPFYIITEFMTYGNLLDYL--RECNRQEVSAVVLLYMATQISSAMEYLEKK---N 131
Query: 731 IVHRDIKSSNILLDDQFEAHLADFGLSRLIL--PYQTHVTTELVGTLGYIP-----PE-- 781
+HRD+ + N L+ + +ADFGLSRL+ Y H P PE
Sbjct: 132 FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAH-------AGAKFPIKWTAPESL 184
Query: 782 -YGQAWVATLRGDMYSFGVVMLELLT-GKRPVDVLKPKMSRELVGWVLKMRSEGKQDQVF 839
Y +++ D+++FGV++ E+ T G P P + QV+
Sbjct: 185 AYN---KFSIKSDVWAFGVLLWEIATYGMSPY----PGIDLS---------------QVY 222
Query: 840 DPILRG------KGFDEEMLQVLDVACMCVSQNPFKRPTVKEVVEWLNN 882
+ + + +G E++ +++ C NP RP+ E+ +
Sbjct: 223 ELLEKDYRMERPEGCPEKVYELM---RACWQWNPSDRPSFAEIHQAFET 268
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327 | Back alignment and structure |
|---|
Score = 118 bits (299), Expect = 2e-29
Identities = 61/295 (20%), Positives = 112/295 (37%), Gaps = 53/295 (17%)
Query: 607 DNFSQANIIGCGGFGLVYKATLANG-----TTLAIKKL-SGDLGLMEREFKAEVEALSTA 660
F + ++G G FG VYK +AIK+L +E E +++
Sbjct: 15 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 74
Query: 661 QHKNLVSLQGYCVHQGFRLLIYSYMENGSLDYWLHEKADGASQLDWLTRLKIARGTSCGL 720
+ ++ L G C+ LI M G L ++ E D + L + G+
Sbjct: 75 DNPHVCRLLGICLTSTV-QLITQLMPFGCLLDYVREHKD---NIGSQYLLNWCVQIAKGM 130
Query: 721 AYMHQICEPHIVHRDIKSSNILLDDQFEAHLADFGLSRLILPYQTHVTTELVGTLGYIP- 779
Y+ + +VHRD+ + N+L+ + DFGL++L+ + E G G +P
Sbjct: 131 NYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAE--G--GKVPI 183
Query: 780 ----PEYGQAWVATLRGDMYSFGVVMLELLT-GKRPVDVLKPKMSRELVGWVLKMRSEGK 834
E + T + D++S+GV + EL+T G +P +
Sbjct: 184 KWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPY----DGIPAS------------- 226
Query: 835 QDQVFDPILRGKGFDEEMLQ-------VLDVACMCVSQNPFKRPTVKEVVEWLNN 882
++ + +G E + Q V + C + RP +E++ +
Sbjct: 227 --EISSILEKG----ERLPQPPICTIDVYMIMRKCWMIDADSRPKFRELIIEFSK 275
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329 | Back alignment and structure |
|---|
Score = 118 bits (299), Expect = 2e-29
Identities = 80/342 (23%), Positives = 134/342 (39%), Gaps = 60/342 (17%)
Query: 574 SPEADKDASLVMLFPNNTNEIKDLTIYELLKATDNFSQANIIGCGGFGLVYKATLANG-- 631
SP K + L N D ++ + + + +G G FG V+ A N
Sbjct: 10 SPTEGKGSGLQGHIIENPQYFSDACVHHIKR--RDIVLKWELGEGAFGKVFLAECHNLLP 67
Query: 632 ----TTLAIKKLSGDLGLMEREFKAEVEALSTAQHKNLVSLQGYCVHQGFRLLIYSYMEN 687
+A+K L ++F+ E E L+ QH+++V G C L+++ YM +
Sbjct: 68 EQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRFFGVCTEGRPLLMVFEYMRH 127
Query: 688 GSLDYWL-----------HEKADGASQLDWLTRLKIARGTSCGLAYMHQICEPHIVHRDI 736
G L+ +L + L L +A + G+ Y+ + H VHRD+
Sbjct: 128 GDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGL---HFVHRDL 184
Query: 737 KSSNILLDDQFEAHLADFGLSRLILPYQTHVTTELVGTLGYIP-----PE---YGQAWVA 788
+ N L+ + DFG+SR I Y T VG +P PE Y
Sbjct: 185 ATRNCLVGQGLVVKIGDFGMSRDI--YSTDYYR--VGGRTMLPIRWMPPESILYR---KF 237
Query: 789 TLRGDMYSFGVVMLELLT-GKRPVDVLKPKMSRELVGWVLKMRSEGKQDQVFDPILRGKG 847
T D++SFGVV+ E+ T GK+P ++S + D I +G+
Sbjct: 238 TTESDVWSFGVVLWEIFTYGKQPW----YQLSNT---------------EAIDCITQGRE 278
Query: 848 FDEEM---LQVLDVACMCVSQNPFKRPTVKEVVEWLNNVGAN 886
+ +V + C + P +R ++K+V L +
Sbjct: 279 LERPRACPPEVYAIMRGCWQREPQQRHSIKDVHARLQALAQA 320
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294 | Back alignment and structure |
|---|
Score = 118 bits (297), Expect = 2e-29
Identities = 56/216 (25%), Positives = 91/216 (42%), Gaps = 22/216 (10%)
Query: 600 YELLKATDNFSQANIIGCGGFGLVYKAT-LANGTTLAIK----KLSGDLGLMEREFKAEV 654
Y+++ +G GG VY A +AIK ++R F+ EV
Sbjct: 13 YKIVD---------KLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKR-FEREV 62
Query: 655 EALSTAQHKNLVSLQGYCVHQGFRLLIYSYMENGSLDYWLHEKADGASQLDWLTRLKIAR 714
S H+N+VS+ L+ Y+E +L ++ L T +
Sbjct: 63 HNSSQLSHQNIVSMIDVDEEDDCYYLVMEYIEGPTLSEYIESHG----PLSVDTAINFTN 118
Query: 715 GTSCGLAYMHQICEPHIVHRDIKSSNILLDDQFEAHLADFGLSRLILPYQTHVTTELVGT 774
G+ + H + IVHRDIK NIL+D + DFG+++ + T ++GT
Sbjct: 119 QILDGIKHAHDM---RIVHRDIKPQNILIDSNKTLKIFDFGIAKALSETSLTQTNHVLGT 175
Query: 775 LGYIPPEYGQAWVATLRGDMYSFGVVMLELLTGKRP 810
+ Y PE + D+YS G+V+ E+L G+ P
Sbjct: 176 VQYFSPEQAKGEATDECTDIYSIGIVLYEMLVGEPP 211
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287 | Back alignment and structure |
|---|
Score = 117 bits (296), Expect = 2e-29
Identities = 53/206 (25%), Positives = 92/206 (44%), Gaps = 20/206 (9%)
Query: 615 IGCGGFGLVYKATLANG---TTLAIKKLSGDLGLMER-EFKAEVEALSTAQHKNLVSLQG 670
+GCG FG V + +AIK L + E E + + + +V L G
Sbjct: 18 LGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIG 77
Query: 671 YCVHQGFRLLIYSYMENGSLDYWLHEKADGASQLDWLTRLKIARGTSCGLAYMHQICEPH 730
C + +L+ G L +L K + ++ ++ S G+ Y + E +
Sbjct: 78 VCQAEAL-MLVMEMAGGGPLHKFLVGKRE---EIPVSNVAELLHQVSMGMKY---LEEKN 130
Query: 731 IVHRDIKSSNILLDDQFEAHLADFGLSRLILPYQTHVTTELVGTLGYIP-----PEYGQA 785
VHRD+ + N+LL ++ A ++DFGLS+ + ++ T + G P PE
Sbjct: 131 FVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTAR---SAGKWPLKWYAPECINF 187
Query: 786 WVATLRGDMYSFGVVMLELLT-GKRP 810
+ R D++S+GV M E L+ G++P
Sbjct: 188 RKFSSRSDVWSYGVTMWEALSYGQKP 213
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367 | Back alignment and structure |
|---|
Score = 118 bits (298), Expect = 5e-29
Identities = 74/311 (23%), Positives = 117/311 (37%), Gaps = 66/311 (21%)
Query: 607 DNFSQANIIGCGGFGLVYKATLANG------TTLAIKKLSGDLGLMER-EFKAEVEALST 659
N + +G G FG VY+ ++ +A+K L + +F E +S
Sbjct: 71 KNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISK 130
Query: 660 AQHKNLVSLQGYCVHQGFRLLIYSYMENGSLDYWLHEKADGASQLDWLTR---LKIARGT 716
H+N+V G + R ++ M G L +L E SQ L L +AR
Sbjct: 131 FNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDI 190
Query: 717 SCGLAYMHQICEPHIVHRDIKSSNILLDDQFEAHL---ADFGLSRLILPYQTHVTTELVG 773
+CG Y+ + H +HRDI + N LL + DFG++R I Y+ G
Sbjct: 191 ACGCQYLEEN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDI--YRAGYYR--KG 243
Query: 774 TLGYIP-----PE---YGQAWVATLRGDMYSFGVVMLELLT-GKRPVDVLKPKMS-RELV 823
+P PE G + T + D +SFGV++ E+ + G P P S +E
Sbjct: 244 GCAMLPVKWMPPEAFMEG---IFTSKTDTWSFGVLLWEIFSLGYMPY----PSKSNQE-- 294
Query: 824 GWVLKMRSEGKQ--------DQVFDPILRGKGFDEEMLQVLDVACMCVSQNPFKRPTVKE 875
VL+ + G + V+ M Q C P RP
Sbjct: 295 --VLEFVTSGGRMDPPKNCPGPVY----------RIMTQ-------CWQHQPEDRPNFAI 335
Query: 876 VVEWLNNVGAN 886
++E + +
Sbjct: 336 ILERIEYCTQD 346
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322 | Back alignment and structure |
|---|
Score = 117 bits (296), Expect = 5e-29
Identities = 70/302 (23%), Positives = 121/302 (40%), Gaps = 60/302 (19%)
Query: 607 DNFSQANIIGCGGFGLVYKATLANG------TTLAIKKLSGDLGLMER-EFKAEVEALST 659
+ + + +G G FG+VY+ T +AIK ++ + ER EF E +
Sbjct: 25 EKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKE 84
Query: 660 AQHKNLVSLQGYCVHQGFRLLIYSYMENGSLDYWL------HEKADGASQLDWLTRLKIA 713
++V L G L+I M G L +L + +++A
Sbjct: 85 FNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMA 144
Query: 714 RGTSCGLAYMHQICEPHIVHRDIKSSNILLDDQFEAHLADFGLSRLILPYQTHVTTELVG 773
+ G+AY++ VHRD+ + N ++ + F + DFG++R I Y+T G
Sbjct: 145 GEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDI--YETDYYR--KG 197
Query: 774 TLGYIP-----PE---YGQAWVATLRGDMYSFGVVMLELLT-GKRPVDVLKPKMSRELVG 824
G +P PE G V T D++SFGVV+ E+ T ++P +S E
Sbjct: 198 GKGLLPVRWMSPESLKDG---VFTTYSDVWSFGVVLWEIATLAEQPY----QGLSNE--- 247
Query: 825 WVLKMRSEGKQDQVFDPILRG------KGFDEEMLQVLDVACMCVSQNPFKRPTVKEVVE 878
QV ++ G + + +++ MC NP RP+ E++
Sbjct: 248 ------------QVLRFVMEGGLLDKPDNCPDMLFELM---RMCWQYNPKMRPSFLEIIS 292
Query: 879 WL 880
+
Sbjct: 293 SI 294
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327 | Back alignment and structure |
|---|
Score = 117 bits (295), Expect = 6e-29
Identities = 64/298 (21%), Positives = 122/298 (40%), Gaps = 38/298 (12%)
Query: 613 NIIGCGGFGLVYKATL-----ANGTTLAIKKLSGDLGLMEREFKAEVEALSTAQHKNLVS 667
+ +G G FG V G +A+K+L +R+F+ E++ L +V
Sbjct: 29 SQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVK 88
Query: 668 LQGYCVHQGFR--LLIYSYMENGSLDYWLHEKADGASQLDWLTRLKIARGTSCGLAYMHQ 725
+G G + L+ Y+ +G L +L +LD L + G+ Y+
Sbjct: 89 YRGVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRA---RLDASRLLLYSSQICKGMEYLGS 145
Query: 726 ICEPHIVHRDIKSSNILLDDQFEAHLADFGLSRLILPYQTHVTTELVGTLGYIP-----P 780
VHRD+ + NIL++ + +ADFGL++L+ + + V G P P
Sbjct: 146 R---RCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYV---VREPGQSPIFWYAP 199
Query: 781 EYGQAWVATLRGDMYSFGVVMLELLT-GKRPVDVLKPKMSRELVGWVLKMRSEGKQDQVF 839
E + + + D++SFGVV+ EL T + S E + + R ++
Sbjct: 200 ESLSDNIFSRQSDVWSFGVVLYELFTYCDKSC-----SPSAEFLRMMGCERDVPALSRLL 254
Query: 840 DPILRGKGFDEEM-------LQVLDVACMCVSQNPFKRPTVKEVVEWLNNVGANRRNE 890
+ + G + + +V ++ +C + +P RP+ + L+ + + R
Sbjct: 255 ELLEEG----QRLPAPPACPAEVHELMKLCWAPSPQDRPSFSALGPQLDMLWSGSRGC 308
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318 | Back alignment and structure |
|---|
Score = 116 bits (293), Expect = 1e-28
Identities = 71/299 (23%), Positives = 121/299 (40%), Gaps = 41/299 (13%)
Query: 613 NIIGCGGFGLVYKATLAN-----GTTLAIKKLSGDLGLMER-EFKAEVEALSTAQHKNLV 666
+G G FG V G +A+K L D G R +K E++ L T H++++
Sbjct: 37 RDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHII 96
Query: 667 SLQGYCVHQGFR--LLIYSYMENGSLDYWLHEKADGASQLDWLTRLKIARGTSCGLAYMH 724
+G C G L+ Y+ GSL +L + G +QL L A+ G+AY+H
Sbjct: 97 KYKGCCEDAGAASLQLVMEYVPLGSLRDYLPRHSIGLAQL-----LLFAQQICEGMAYLH 151
Query: 725 QICEPHIVHRDIKSSNILLDDQFEAHLADFGLSRLILPYQTHVTTELVGTLGYIP----- 779
H +HRD+ + N+LLD+ + DFGL++ + V G P
Sbjct: 152 AQ---HYIHRDLAARNVLLDNDRLVKIGDFGLAKAV---PEGHEYYRVREDGDSPVFWYA 205
Query: 780 PEYGQAWVATLRGDMYSFGVVMLELLT-GKRPVDVLKPKMSRELVGWVLKMRSEGKQDQV 838
PE + + D++SFGV + ELLT + + + + + ++
Sbjct: 206 PECLKEYKFYYASDVWSFGVTLYELLTHCDSS-----QSPPTKFLELIGIAQGQMTVLRL 260
Query: 839 FDPILRGKGFDEEMLQ-------VLDVACMCVSQNPFKRPTVKEVVEWLNNVGANRRNE 890
+ + RG E + + V + C RPT + ++ L V + +
Sbjct: 261 TELLERG----ERLPRPDKCPAEVYHLMKNCWETEASFRPTFENLIPILKTVHEKYQGQ 315
|
| >3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289 | Back alignment and structure |
|---|
Score = 115 bits (291), Expect = 1e-28
Identities = 69/309 (22%), Positives = 115/309 (37%), Gaps = 76/309 (24%)
Query: 613 NIIGCGGFGLVYKATLANG------TTLAIKKLSGDLGLMER-EFKAEVEALSTAQHKNL 665
+G FG VYK L +AIK L R EF+ E + QH N+
Sbjct: 15 EELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNV 74
Query: 666 VSLQGYCVHQGFRLLIYSYMENGSLDYWLHEKADGA------------SQLDWLTRLKIA 713
V L G +I+SY +G L +L ++ + S L+ + +
Sbjct: 75 VCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLV 134
Query: 714 RGTSCGLAYMHQICEPHIVHRDIKSSNILLDDQFEAHLADFGLSRLILPYQTHVTTELVG 773
+ G+ Y+ H+VH+D+ + N+L+ D+ ++D GL R + Y +
Sbjct: 135 AQIAAGMEYLSSH---HVVHKDLATRNVLVYDKLNVKISDLGLFREV--YAADYYK--LL 187
Query: 774 TLGYIP-----PE---YGQAWVATLRGDMYSFGVVMLELLT-GKRPVDVLKPKMSRELVG 824
+P PE YG ++ D++S+GVV+ E+ + G +P S +
Sbjct: 188 GNSLLPIRWMAPEAIMYG---KFSIDSDIWSYGVVLWEVFSYGLQPY----CGYSNQ--- 237
Query: 825 WVLKMRSEGKQDQVFDPILRGKGFDEEMLQVLD--VAC---------MCVSQNPFKRPTV 873
V + I QVL C C ++ P +RP
Sbjct: 238 ------------DVVEMIRNR--------QVLPCPDDCPAWVYALMIECWNEFPSRRPRF 277
Query: 874 KEVVEWLNN 882
K++ L
Sbjct: 278 KDIHSRLRA 286
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432 | Back alignment and structure |
|---|
Score = 119 bits (299), Expect = 1e-28
Identities = 61/312 (19%), Positives = 123/312 (39%), Gaps = 58/312 (18%)
Query: 588 PNNTNEIKDLTIYELLKATDNFSQANIIGCGGFGLVYKATLANGTTLAIKKLS-GDLGLM 646
P+ + D ++ +F +++G G G + + + +A+K++
Sbjct: 5 PSLEQDDGDEETSVVIVGKISFCPKDVLGHGAEGTIVYRGMFDNRDVAVKRILPECFSFA 64
Query: 647 EREFKAEVEALST-AQHKNLVSLQGYCVHQGFRLLIYSYME--NGSLDYWLHEKADGASQ 703
+RE V+ L +H N++ +C + R Y +E +L ++ +K
Sbjct: 65 DRE----VQLLRESDEHPNVIRY--FCTEKD-RQFQYIAIELCAATLQEYVEQKDFAHLG 117
Query: 704 LDWLTRLKIARGTSCGLAYMHQICEPHIVHRDIKSSNILLDDQFE-----AHLADFGLSR 758
L+ + + + T+ GLA++H + +IVHRD+K NIL+ A ++DFGL +
Sbjct: 118 LE---PITLLQQTTSGLAHLHSL---NIVHRDLKPHNILISMPNAHGKIKAMISDFGLCK 171
Query: 759 LILPYQ--THVTTELVGTLGYIPPEYGQAWV---ATLRGDMYSFGVVMLELLTGKRP--- 810
+ + + + GT G+I PE T D++S G V +++
Sbjct: 172 KLAVGRHSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFG 231
Query: 811 ------VDVLKPKMSRELVGWVLKMRSEGKQDQVFDPILRGKGFDEEMLQVLDVACMCVS 864
++L S + + + + I + M+ +
Sbjct: 232 KSLQRQANILLGACSLDCLHPEKHEDVIAR-----ELIEK-------MIAM--------- 270
Query: 865 QNPFKRPTVKEV 876
+P KRP+ K V
Sbjct: 271 -DPQKRPSAKHV 281
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 116 bits (292), Expect = 1e-28
Identities = 70/283 (24%), Positives = 107/283 (37%), Gaps = 46/283 (16%)
Query: 607 DNFSQANIIGCGGFGLVYKAT-LANGTTLAIKKL-SGDLGLMERE-FKAEVEAL-STAQH 662
+F + + +G G +G V+K +G A+K+ S G +R AEV + QH
Sbjct: 57 QSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQH 116
Query: 663 KNLVSLQGYCVHQGFRLLIYSYME--NGSLDYWLHEKADGASQLDWLTRLKIARGTSCGL 720
V L+ +G L + E SL +A GAS L R T L
Sbjct: 117 PCCVRLEQ-AWEEGGILYLQ--TELCGPSLQQHC--EAWGAS-LPEAQVWGYLRDTLLAL 170
Query: 721 AYMHQICEPHIVHRDIKSSNILLDDQFEAHLADFGLSRLILPYQTHVTTELVGTLGYIPP 780
A++H +VH D+K +NI L + L DFGL + G Y+ P
Sbjct: 171 AHLH---SQGLVHLDVKPANIFLGPRGRCKLGDFGLLVELGT--AGAGEVQEGDPRYMAP 225
Query: 781 E-----YGQAWVATLRGDMYSFGVVMLELLTGKRPVDVLKPKMSRELVGWVLKMRSEGKQ 835
E YG A D++S G+ +LE+ P ++R +G
Sbjct: 226 ELLQGSYGTAA------DVFSLGLTILEVACNMEL-----PHGGEGW----QQLR-QGYL 269
Query: 836 DQVFDPILRGKGFDEEMLQVLDVACMCVSQNPFKRPTVKEVVE 878
F G E+ VL M + +P R T + ++
Sbjct: 270 PPEFTA-----GLSSELRSVLV---MMLEPDPKLRATAEALLA 304
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377 | Back alignment and structure |
|---|
Score = 117 bits (295), Expect = 2e-28
Identities = 42/319 (13%), Positives = 86/319 (26%), Gaps = 81/319 (25%)
Query: 614 IIGCGGFGLVYKAT-LANGTTLAIKKLS-------GDLGLMERE---------------- 649
++G +AT G + + + M+ E
Sbjct: 80 VLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQA 139
Query: 650 -----FKAEVEALSTAQHKNLVSLQG----YCVHQGFRLLIYSYMENGSLDYWLHEKADG 700
F + + Q K ++ ++ V F L + L +
Sbjct: 140 KVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSST 199
Query: 701 ASQLDWLTRLKIARGTSCGLAYMHQICEPHIVHRDIKSSNILLDDQFEAHLADFGLSRLI 760
L RL++ LA +H +VH ++ +I+LD + L F
Sbjct: 200 HKSLVHHARLQLTLQVIRLLASLHHY---GLVHTYLRPVDIVLDQRGGVFLTGFEHLV-- 254
Query: 761 LPYQTHVTTELVGTLGYIPPEY-----------GQAWVATLRGDMYSFGVVMLELLTGKR 809
+ + G+ PPE + + T D ++ G+V+ +
Sbjct: 255 ---RDGARVVSSVSRGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIYWIWCADL 311
Query: 810 PVDVLKPKMSRELVGWVLKMR---SEGKQDQVFDPILRGKGFDEEMLQVLDVACMCVSQN 866
P+ E W+ + + + +L G L+
Sbjct: 312 PITKDAALGGSE---WIFRSCKNIPQPVRA-----LLEG------FLRY----------P 347
Query: 867 PFKRPTVKEVVE--WLNNV 883
R + +E +
Sbjct: 348 KEDRLLPLQAMETPEYEQL 366
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325 | Back alignment and structure |
|---|
Score = 116 bits (292), Expect = 2e-28
Identities = 62/290 (21%), Positives = 106/290 (36%), Gaps = 53/290 (18%)
Query: 613 NIIGCGGFGLVYKATL-----ANGTTLAIKKLSGDLGLMER-EFKAEVEALSTAQHKNLV 666
++G G FG V+K + + IK + G + A+ + H ++V
Sbjct: 19 KVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIV 78
Query: 667 SLQGYCVHQGFRLLIYSYMENGSLDYWLHEKADGASQLDWLTRLKIARGTSCGLAYMHQI 726
L G C L+ Y+ GSL + + L L + G+ Y+
Sbjct: 79 RLLGLCPGSSL-QLVTQYLPLGSLLDHVRQHRG---ALGPQLLLNWGVQIAKGMYYLE-- 132
Query: 727 CEPHIVHRDIKSSNILLDDQFEAHLADFGLSRLILPYQTHVTTELVGTLGYIP-----PE 781
E +VHR++ + N+LL + +ADFG++ L+ P + + P E
Sbjct: 133 -EHGMVHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQLLY----SEAKTPIKWMALE 187
Query: 782 YGQAWVATLRGDMYSFGVVMLELLT-GKRPVDVLKPKMSRELVGWVLKMRSEGKQDQVFD 840
T + D++S+GV + EL+T G P + +V D
Sbjct: 188 SIHFGKYTHQSDVWSYGVTVWELMTFGAEPY----AGLRLA---------------EVPD 228
Query: 841 PILRGKGFDEEMLQ-------VLDVACMCVSQNPFKRPTVKEVVEWLNNV 883
+ +G E + Q V V C + RPT KE+ +
Sbjct: 229 LLEKG----ERLAQPQICTIDVYMVMVKCWMIDENIRPTFKELANEFTRM 274
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373 | Back alignment and structure |
|---|
Score = 117 bits (295), Expect = 2e-28
Identities = 59/211 (27%), Positives = 99/211 (46%), Gaps = 24/211 (11%)
Query: 613 NIIGCGGFGLVYKATL----ANGTTLAIKKLSGDLGLMER-EFKAEVEALSTAQHKNLVS 667
++G G FG V L ++AIK L +R +F E + H N++
Sbjct: 51 KVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIR 110
Query: 668 LQGYCVHQGFRLLIYSYMENGSLDYWLHEKADGASQLDWLTRLKIARGTSCGLAYMHQIC 727
L+G +++ YMENGSLD +L + Q + + + RG + G+ Y+ +
Sbjct: 111 LEGVVTKSKPVMIVTEYMENGSLDSFLRKHDA---QFTVIQLVGMLRGIASGMKYLSDM- 166
Query: 728 EPHIVHRDIKSSNILLDDQFEAHLADFGLSRLIL--PYQTHVTTELVGTLGYIP-----P 780
VHRD+ + NIL++ ++DFGL R++ P + T G IP P
Sbjct: 167 --GYVHRDLAARNILINSNLVCKVSDFGLGRVLEDDPEAAYTTRG-----GKIPIRWTSP 219
Query: 781 EYGQAWVATLRGDMYSFGVVMLELLT-GKRP 810
E T D++S+G+V+ E+++ G+RP
Sbjct: 220 EAIAYRKFTSASDVWSYGIVLWEVMSYGERP 250
|
| >3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297 | Back alignment and structure |
|---|
Score = 115 bits (290), Expect = 2e-28
Identities = 74/302 (24%), Positives = 125/302 (41%), Gaps = 67/302 (22%)
Query: 615 IGCGGFGLVYKATLANG------TTLAIKKLSGDLGLMEREFKAEVEALSTAQHKNLVSL 668
+G G FG V+ A N +A+K L ++F+ E E L+ QH+++V
Sbjct: 23 LGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKF 82
Query: 669 QGYCVHQGFRLLIYSYMENGSLDYWL------------HEKADGASQLDWLTRLKIARGT 716
G C ++++ YM++G L+ +L + +L L IA
Sbjct: 83 YGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQI 142
Query: 717 SCGLAYMHQICEPHIVHRDIKSSNILLDDQFEAHLADFGLSRLILPYQTHVTTELVGTLG 776
+ G+ Y+ H VHRD+ + N L+ + DFG+SR + Y T VG
Sbjct: 143 ASGMVYLASQ---HFVHRDLATRNCLVGANLLVKIGDFGMSRDV--YSTDYYR--VGGHT 195
Query: 777 YIP-----PE---YGQAWVATLRGDMYSFGVVMLELLT-GKRPVDVLKPKMSRELVGWVL 827
+P PE Y T D++SFGV++ E+ T GK+P ++S
Sbjct: 196 MLPIRWMPPESIMYR---KFTTESDVWSFGVILWEIFTYGKQPW----FQLSNT------ 242
Query: 828 KMRSEGKQDQVFDPILRGKGFDEEM-------LQVLDVACMCVSQNPFKRPTVKEVVEWL 880
+V + I +G+ + +V DV C + P +R +KE+ + L
Sbjct: 243 ---------EVIECITQGR----VLERPRVCPKEVYDVMLGCWQREPQQRLNIKEIYKIL 289
Query: 881 NN 882
+
Sbjct: 290 HA 291
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325 | Back alignment and structure |
|---|
Score = 116 bits (292), Expect = 2e-28
Identities = 65/214 (30%), Positives = 98/214 (45%), Gaps = 30/214 (14%)
Query: 613 NIIGCGGFGLVYKATL----ANGTTLAIKKLSGDLGLMER-EFKAEVEALSTAQHKNLVS 667
IIG G G V L +AIK L +R +F +E + H N++
Sbjct: 55 KIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIR 114
Query: 668 LQGYCVHQGFRLLIYSYMENGSLDYWLHEKADGASQLDWLTRLKIARGTSCGLAYMHQIC 727
L+G +++ YMENGSLD +L Q + + + RG G+ Y+ +
Sbjct: 115 LEGVVTRGRLAMIVTEYMENGSLDTFLRTHDG---QFTIMQLVGMLRGVGAGMRYLSDL- 170
Query: 728 EPHIVHRDIKSSNILLDDQFEAHLADFGLSRLIL--PYQTHVTTELVGTLGYIP-----P 780
VHRD+ + N+L+D ++DFGLSR++ P + TT G IP P
Sbjct: 171 --GYVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDPDAAYTTTG-----GKIPIRWTAP 223
Query: 781 E---YGQAWVATLRGDMYSFGVVMLELLT-GKRP 810
E + + D++SFGVVM E+L G+RP
Sbjct: 224 EAIAFR---TFSSASDVWSFGVVMWEVLAYGERP 254
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656 | Back alignment and structure |
|---|
Score = 120 bits (303), Expect = 3e-28
Identities = 72/371 (19%), Positives = 122/371 (32%), Gaps = 49/371 (13%)
Query: 526 LVLGICFGTGLIISMLALWILSKRRIIPGGDPDKIELDTISSTSNFGVSPEADKDASLVM 585
L+ G C + + + I ++ + ++ D +
Sbjct: 313 LIDGYCRL--VNGATQSFIIRPQKEGERALPSIPKLANNEKQGVRSHTVSVSETDDYAEI 370
Query: 586 LFPNNTNEIKDLTIYELLKATDNFSQANIIGCGGFGLVYKATLANG----TTLAIKKLSG 641
+ +T + YE+ + + IG G FG V++ + +AIK
Sbjct: 371 IDEEDTYTMPSTRDYEIQR--ERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKN 428
Query: 642 DLGLMER-EFKAEVEALSTAQHKNLVSLQGYCVHQGFRLLIYSYMENGSLDYWLHEKADG 700
R +F E + H ++V L G +I G L +L +
Sbjct: 429 CTSDSVREKFLQEALTMRQFDHPHIVKLIGVITENPV-WIIMELCTLGELRSFLQVRKF- 486
Query: 701 ASQLDWLTRLKIARGTSCGLAYMHQICEPHIVHRDIKSSNILLDDQFEAHLADFGLSRLI 760
LD + + A S LAY+ VHRDI + N+L+ L DFGLSR +
Sbjct: 487 --SLDLASLILYAYQLSTALAYLESK---RFVHRDIAARNVLVSSNDCVKLGDFGLSRYM 541
Query: 761 LPYQTHVTTELVGTLGYIP-----PEYGQAWVATLRGDMYSFGVVMLELLT-GKRPVDVL 814
+ + G +P PE T D++ FGV M E+L G +P
Sbjct: 542 --EDSTYYK---ASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPF--- 593
Query: 815 KPKMSRELVGWVLKMRSEGKQDQVFDPILRGKGFDEEM---LQVLDVACMCVSQNPFKRP 871
+ V I G+ + + C + +P +RP
Sbjct: 594 -QGVKNN---------------DVIGRIENGERLPMPPNCPPTLYSLMTKCWAYDPSRRP 637
Query: 872 TVKEVVEWLNN 882
E+ L+
Sbjct: 638 RFTELKAQLST 648
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311 | Back alignment and structure |
|---|
Score = 115 bits (289), Expect = 3e-28
Identities = 60/225 (26%), Positives = 99/225 (44%), Gaps = 34/225 (15%)
Query: 600 YELLKATDNFSQANIIGCGGFGLVYKAT-LANGTTLAIK----KLSGDLGLMEREFKAEV 654
YEL + I+G GG V+ A L + +A+K L+ D R F+ E
Sbjct: 14 YELGE---------ILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLR-FRRE- 62
Query: 655 EALSTAQ--HKNLVSLQGYCVHQGFRLLIYSY--ME--NG-SLDYWLHEKADGASQLDWL 707
A + A H +V++ + + Y ME +G +L +H + +
Sbjct: 63 -AQNAAALNHPAIVAVYDTGEAETPAGPLP-YIVMEYVDGVTLRDIVHTEG----PMTPK 116
Query: 708 TRLKIARGTSCGLAYMHQICEPHIVHRDIKSSNILLDDQFEAHLADFGLSRLILPYQTHV 767
+++ L + HQ I+HRD+K +NI++ + DFG++R I V
Sbjct: 117 RAIEVIADACQALNFSHQN---GIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSV 173
Query: 768 TT--ELVGTLGYIPPEYGQAWVATLRGDMYSFGVVMLELLTGKRP 810
T ++GT Y+ PE + R D+YS G V+ E+LTG+ P
Sbjct: 174 TQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPP 218
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613 | Back alignment and structure |
|---|
Score = 119 bits (300), Expect = 4e-28
Identities = 63/287 (21%), Positives = 111/287 (38%), Gaps = 54/287 (18%)
Query: 615 IGCGGFGLVYKATLANG---TTLAIKKLSGDLGLMER-EFKAEVEALSTAQHKNLVSLQG 670
+GCG FG V + +AIK L + E E + + + +V L G
Sbjct: 344 LGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIG 403
Query: 671 YCVHQGFRLLIYSYMENGSLDYWLHEKADGASQLDWLTRLKIARGTSCGLAYMHQICEPH 730
C + +L+ G L +L K + ++ ++ S G+ Y + E +
Sbjct: 404 VCQAEAL-MLVMEMAGGGPLHKFLVGKRE---EIPVSNVAELLHQVSMGMKY---LEEKN 456
Query: 731 IVHRDIKSSNILLDDQFEAHLADFGLSRLILPYQTHVTTELVGTLGYIP-----PEYGQA 785
VHR++ + N+LL ++ A ++DFGLS+ + ++ T + G P PE
Sbjct: 457 FVHRNLAARNVLLVNRHYAKISDFGLSKALGADDSYYTAR---SAGKWPLKWYAPECINF 513
Query: 786 WVATLRGDMYSFGVVMLELLT-GKRPVDVLKPKMS-RELVGWVLKMRSEGKQ-------- 835
+ R D++S+GV M E L+ G++P KM E V+ +GK+
Sbjct: 514 RKFSSRSDVWSYGVTMWEALSYGQKPY----KKMKGPE----VMAFIEQGKRMECPPECP 565
Query: 836 DQVFDPILRGKGFDEEMLQVLDVACMCVSQNPFKRPTVKEVVEWLNN 882
+++ M C RP V + +
Sbjct: 566 PELY----------ALMSD-------CWIYKWEDRPDFLTVEQRMRA 595
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313 | Back alignment and structure |
|---|
Score = 114 bits (288), Expect = 5e-28
Identities = 68/299 (22%), Positives = 115/299 (38%), Gaps = 60/299 (20%)
Query: 613 NIIGCGGFGLVYKATLANG----TTLAIKKL-SGDLGLMER-EFKAEVEALSTAQHKNLV 666
I+G G FG V + L +A+K + + E EF +E + H N++
Sbjct: 40 KILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVI 99
Query: 667 SLQGYC-----VHQGFRLLIYSYMENGSLDYWL--HEKADGASQLDWLTRLKIARGTSCG 719
L G C ++I +M+ G L +L G + T LK + G
Sbjct: 100 RLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALG 159
Query: 720 LAYMHQICEPHIVHRDIKSSNILLDDQFEAHLADFGLSRLILPYQTHVTTELVGTLGYIP 779
+ Y+ + +HRD+ + N +L D +ADFGLS+ I Y G + +P
Sbjct: 160 MEYLSNR---NFLHRDLAARNCMLRDDMTVCVADFGLSKKI--YSGDYYR--QGRIAKMP 212
Query: 780 -----PE---YGQAWVATLRGDMYSFGVVMLELLT-GKRPVDVLKPKMSRELVGWVLKMR 830
E V T + D+++FGV M E+ T G P P +
Sbjct: 213 VKWIAIESLADR---VYTSKSDVWAFGVTMWEIATRGMTPY----PGVQNH--------- 256
Query: 831 SEGKQDQVFDPILRG------KGFDEEMLQVLDVACMCVSQNPFKRPTVKEVVEWLNNV 883
+++D +L G + +E+ +++ C +P RPT + L +
Sbjct: 257 ------EMYDYLLHGHRLKQPEDCLDELYEIM---YSCWRTDPLDRPTFSVLRLQLEKL 306
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327 | Back alignment and structure |
|---|
Score = 115 bits (289), Expect = 5e-28
Identities = 74/302 (24%), Positives = 129/302 (42%), Gaps = 67/302 (22%)
Query: 613 NIIGCGGFGLVYKATLANG---TTLAIKKLSGDLGLMER-EFKAEVEALST-AQHKNLVS 667
++IG G FG V KA + AIK++ + +F E+E L H N+++
Sbjct: 31 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIIN 90
Query: 668 LQGYCVHQGFRLLIYSYMENGSLDYWLHEK------------ADGASQLDWLTRLKIARG 715
L G C H+G+ L Y +G+L +L + AS L L A
Sbjct: 91 LLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAAD 150
Query: 716 TSCGLAYMHQICEPHIVHRDIKSSNILLDDQFEAHLADFGLSRLILPYQTHVTTELVGTL 775
+ G+ Y+ Q +HRD+ + NIL+ + + A +ADFGLSR Y T+
Sbjct: 151 VARGMDYLSQK---QFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVK-------KTM 200
Query: 776 GYIP-----PE---YGQAWVATLRGDMYSFGVVMLELLT-GKRPVDVLKPKMSRELVGWV 826
G +P E Y V T D++S+GV++ E+++ G P M+
Sbjct: 201 GRLPVRWMAIESLNYS---VYTTNSDVWSYGVLLWEIVSLGGTPY----CGMTCA----- 248
Query: 827 LKMRSEGKQDQVFDPILRG------KGFDEEMLQVLDVACMCVSQNPFKRPTVKEVVEWL 880
++++ + +G D+E+ ++ C + P++RP+ +++ L
Sbjct: 249 ----------ELYEKLPQGYRLEKPLNCDDEVYDLM---RQCWREKPYERPSFAQILVSL 295
Query: 881 NN 882
N
Sbjct: 296 NR 297
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291 | Back alignment and structure |
|---|
Score = 113 bits (286), Expect = 5e-28
Identities = 65/292 (22%), Positives = 118/292 (40%), Gaps = 62/292 (21%)
Query: 614 IIGCGGFGLVYKATLANG---TTLAIKKLSGDL--GLMEREFKAEVEALSTAQHKNLVSL 668
+G G FG V K T+A+K L + ++ E AE + + +V +
Sbjct: 24 ELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRM 83
Query: 669 QGYCVHQGFRLLIYSYMENGSLDYWLHEKADGASQLDWLTRLKIARGTSCGLAYMHQICE 728
G C + + +L+ E G L+ +L + + +++ S G+ Y+ +
Sbjct: 84 IGICEAESW-MLVMEMAELGPLNKYLQQN----RHVKDKNIIELVHQVSMGMKYLEES-- 136
Query: 729 PHIVHRDIKSSNILLDDQFEAHLADFGLSRLILPYQTHVTTELVGTLGYIP-----PE-- 781
+ VHRD+ + N+LL Q A ++DFGLS+ + + + + T G P PE
Sbjct: 137 -NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQ---THGKWPVKWYAPECI 192
Query: 782 -YGQAWVATLRGDMYSFGVVMLELLT-GKRPVDVLKPKMS-RELVGWVLKMRSEGKQ--- 835
Y + + + D++SFGV+M E + G++P M E V M +G++
Sbjct: 193 NYYK---FSSKSDVWSFGVLMWEAFSYGQKPY----RGMKGSE----VTAMLEKGERMGC 241
Query: 836 -----DQVFDPILRGKGFDEEMLQVLDVACMCVSQNPFKRPTVKEVVEWLNN 882
+++ + M C + + RP V L N
Sbjct: 242 PAGCPREMY----------DLMNL-------CWTYDVENRPGFAAVELRLRN 276
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295 | Back alignment and structure |
|---|
Score = 113 bits (285), Expect = 7e-28
Identities = 64/290 (22%), Positives = 118/290 (40%), Gaps = 37/290 (12%)
Query: 613 NIIGCGGFGLVYKATL-----ANGTTLAIKKLSGDLGLMEREFKAEVEALSTAQHKNLVS 667
+G G FG V G +A+KKL R+F+ E+E L + QH N+V
Sbjct: 16 QQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVK 75
Query: 668 LQGYCVHQGFR--LLIYSYMENGSLDYWLHEKADGASQLDWLTRLKIARGTSCGLAYMHQ 725
+G C G R LI Y+ GSL +L + + ++D + L+ G+ Y+
Sbjct: 76 YKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKE---RIDHIKLLQYTSQICKGMEYLGT 132
Query: 726 ICEPHIVHRDIKSSNILLDDQFEAHLADFGLSRLILPYQTHVTTELVGTLGYIP-----P 780
+HRD+ + NIL++++ + DFGL++++ P V G P P
Sbjct: 133 K---RYIHRDLATRNILVENENRVKIGDFGLTKVL-PQDKEFFK--VKEPGESPIFWYAP 186
Query: 781 EYGQAWVATLRGDMYSFGVVMLELLTGKRPVDVLKPKMSRELVGWVLKMRSEG-KQDQVF 839
E ++ D++SFGVV+ EL T + R + + +
Sbjct: 187 ESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMI----GNDKQGQMIVFHLI 242
Query: 840 DPILRGKGFDEEM-------LQVLDVACMCVSQNPFKRPTVKEVVEWLNN 882
+ + + ++ + C + N +RP+ +++ ++
Sbjct: 243 ELLKNN----GRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQ 288
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333 | Back alignment and structure |
|---|
Score = 114 bits (287), Expect = 8e-28
Identities = 70/213 (32%), Positives = 105/213 (49%), Gaps = 29/213 (13%)
Query: 614 IIGCGGFGLVYKATLANGTTL-----AIKKLSGDLGLMER-EFKAEVEALSTAQHKNLVS 667
+IG G FG VYK L + AIK L +R +F E + H N++
Sbjct: 51 VIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIR 110
Query: 668 LQGYCVHQGFRLLIYSYMENGSLDYWLHEKADGASQLDWLTRLKIARGTSCGLAYMHQIC 727
L+G ++I YMENG+LD +L EK + L + + RG + G+ Y+ +
Sbjct: 111 LEGVISKYKPMMIITEYMENGALDKFLREKDG---EFSVLQLVGMLRGIAAGMKYLANM- 166
Query: 728 EPHIVHRDIKSSNILLDDQFEAHLADFGLSRLIL-PYQTHVTTELVGTLGYIP-----PE 781
+ VHRD+ + NIL++ ++DFGLSR++ + TT G G IP PE
Sbjct: 167 --NYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTS--G--GKIPIRWTAPE 220
Query: 782 ---YGQAWVATLRGDMYSFGVVMLELLT-GKRP 810
Y T D++SFG+VM E++T G+RP
Sbjct: 221 AISYR---KFTSASDVWSFGIVMWEVMTYGERP 250
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327 | Back alignment and structure |
|---|
Score = 113 bits (286), Expect = 9e-28
Identities = 59/295 (20%), Positives = 110/295 (37%), Gaps = 53/295 (17%)
Query: 607 DNFSQANIIGCGGFGLVYKATLANG-----TTLAIKKL-SGDLGLMEREFKAEVEALSTA 660
F + ++G G FG VYK +AIK+L +E E +++
Sbjct: 15 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 74
Query: 661 QHKNLVSLQGYCVHQGFRLLIYSYMENGSLDYWLHEKADGASQLDWLTRLKIARGTSCGL 720
+ ++ L G C+ LI M G L ++ E D + L + G+
Sbjct: 75 DNPHVCRLLGICLTSTV-QLITQLMPFGCLLDYVREHKD---NIGSQYLLNWCVQIAKGM 130
Query: 721 AYMHQICEPHIVHRDIKSSNILLDDQFEAHLADFGLSRLILPYQTHVTTELVGTLGYIP- 779
Y+ + +VHRD+ + N+L+ + DFGL++L+ + G +P
Sbjct: 131 NYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHA----EGGKVPI 183
Query: 780 ----PEYGQAWVATLRGDMYSFGVVMLELLT-GKRPVDVLKPKMSRELVGWVLKMRSEGK 834
E + T + D++S+GV + EL+T G +P +
Sbjct: 184 KWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPY----DGIPAS------------- 226
Query: 835 QDQVFDPILRGKGFDEEMLQ-------VLDVACMCVSQNPFKRPTVKEVVEWLNN 882
++ + +G E + Q V + C + RP +E++ +
Sbjct: 227 --EISSILEKG----ERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSK 275
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336 | Back alignment and structure |
|---|
Score = 114 bits (286), Expect = 1e-27
Identities = 57/223 (25%), Positives = 89/223 (39%), Gaps = 30/223 (13%)
Query: 600 YELLKATDNFSQANIIGCGGFGLVYKAT-LANGTTLAIKKLSGDLGLMEREFKAEVEALS 658
YE + + +G G FG V++ G A+KK+ +E E+ A +
Sbjct: 51 YEYREEVHWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVR-----LEVFRVEELVACA 105
Query: 659 TAQHKNLVSLQGYCVHQGFRLLIY-SYMENGSLDYWLHEKADGASQLDWLTRLKIARGTS 717
+V L G V +G + I+ +E GSL + K G L L
Sbjct: 106 GLSSPRIVPLYG-AVREGPWVNIFMELLEGGSLGQLI--KQMGC--LPEDRALYYLGQAL 160
Query: 718 CGLAYMHQICEPHIVHRDIKSSNILLDDQ-FEAHLADFGLSRLILPYQTHVTTE----LV 772
GL Y+H I+H D+K+ N+LL A L DFG + + P + +
Sbjct: 161 EGLEYLH---TRRILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIP 217
Query: 773 GTLGYIPPEYGQAWVATLRG-----DMYSFGVVMLELLTGKRP 810
GT ++ PE V + D++S +ML +L G P
Sbjct: 218 GTETHMAPE-----VVMGKPCDAKVDIWSSCCMMLHMLNGCHP 255
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309 | Back alignment and structure |
|---|
Score = 113 bits (285), Expect = 1e-27
Identities = 55/203 (27%), Positives = 82/203 (40%), Gaps = 17/203 (8%)
Query: 615 IGCGGFGLVYKAT-LANGTTLAIKKLSGDLGLMEREFKA--EVEALSTA--QHKNLVSLQ 669
+G GG G VY+A +A+K +S L + F+ + EA + Q ++V +
Sbjct: 42 VGRGGMGDVYEAEDTVRERIVALKLMSETLS-SDPVFRTRMQREARTAGRLQEPHVVPIH 100
Query: 670 GYCVHQGFRLLIYSYMENGSLDYWLHEKADGASQLDWLTRLKIARGTSCGLAYMHQICEP 729
+ G + + L L + L + I R L H
Sbjct: 101 DFGEIDGQLYVDMRLINGVDLAAMLRRQG----PLAPPRAVAIVRQIGSALDAAHAA--- 153
Query: 730 HIVHRDIKSSNILLDDQFEAHLADFGLSRLILPYQTHVTT--ELVGTLGYIPPEYGQAWV 787
HRD+K NIL+ A+L DFG++ +T VGTL Y+ PE
Sbjct: 154 GATHRDVKPENILVSADDFAYLVDFGIASATT--DEKLTQLGNTVGTLYYMAPERFSESH 211
Query: 788 ATLRGDMYSFGVVMLELLTGKRP 810
AT R D+Y+ V+ E LTG P
Sbjct: 212 ATYRADIYALTCVLYECLTGSPP 234
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360 | Back alignment and structure |
|---|
Score = 114 bits (286), Expect = 2e-27
Identities = 65/267 (24%), Positives = 121/267 (45%), Gaps = 16/267 (5%)
Query: 607 DNFSQANIIGCGGFGLVYKATL-ANGTTLAIKKLSGDLGLMEREF-KAEVEALSTAQHKN 664
D+F + + +G G G+V+K + +G +A K + ++ R E++ L
Sbjct: 33 DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPY 92
Query: 665 LVSLQGYCVHQGFRLLIYSYMENGSLDYWLHEKADGASQLDWLTRLKIARGTSCGLAYMH 724
+V G G + +M+ GSLD L K G L K++ GL Y+
Sbjct: 93 IVGFYGAFYSDGEISICMEHMDGGSLDQVL--KKAGRIPEQILG--KVSIAVIKGLTYLR 148
Query: 725 QICEPHIVHRDIKSSNILLDDQFEAHLADFGLS-RLILPYQTHVTTELVGTLGYIPPEYG 783
+ + I+HRD+K SNIL++ + E L DFG+S +LI + + VGT Y+ PE
Sbjct: 149 E--KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLI---DSMANS-FVGTRSYMSPERL 202
Query: 784 QAWVATLRGDMYSFGVVMLELLTGKRPVDVLKPKMSRELVGWVLKMRSEGKQDQVFDPIL 843
Q +++ D++S G+ ++E+ G+ P+ K + G ++ + + P
Sbjct: 203 QGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGR 262
Query: 844 RGKGFDEE---MLQVLDVACMCVSQNP 867
F + + + ++ V++ P
Sbjct: 263 PLNKFGMDSRPPMAIFELLDYIVNEPP 289
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351 | Back alignment and structure |
|---|
Score = 113 bits (286), Expect = 2e-27
Identities = 71/363 (19%), Positives = 124/363 (34%), Gaps = 112/363 (30%)
Query: 574 SPEADKDASLVMLFPNNTNEIKDLTIYELLKATDNFSQANIIGCGGFGLVYKAT-LANGT 632
SP ++ ++ +D +YEL + +IG G F +V + G
Sbjct: 2 SPGISGGGGGILDMADDDVLFED--VYELCE---------VIGKGPFSVVRRCINRETGQ 50
Query: 633 TLAIK-----KLSGDLGLMEREFKAEVEALSTAQHKNLVSLQGYCVHQGFRLLIYSYMEN 687
A+K K + GL + K E +H ++V L G +++ +M+
Sbjct: 51 QFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELLETYSSDGMLYMVFEFMDG 110
Query: 688 GSLDYWLHEKADGASQLDWLTRLKIARGTSCGL-------AYMHQICEP----H---IVH 733
L + + R + + YM QI E H I+H
Sbjct: 111 ADL-------------CF---EI-VKRADAGFVYSEAVASHYMRQILEALRYCHDNNIIH 153
Query: 734 RDIKSSNILLDDQFEAH---LADFGLSRLILPYQTHVTTELVGTLGYIPPE------YGQ 784
RD+K +LL + + L FG++ + V VGT ++ PE YG+
Sbjct: 154 RDVKPHCVLLASKENSAPVKLGGFGVAIQLGESGL-VAGGRVGTPHFMAPEVVKREPYGK 212
Query: 785 AWVATLRGDMYSFGVVMLELLTGKRPVDVLKPKMSRELVGWVLKMRSEGKQDQVFDPILR 844
D++ GV++ LL+G P G ++++F+ I++
Sbjct: 213 P------VDVWGCGVILFILLSGCLPFY--------------------GTKERLFEGIIK 246
Query: 845 GK-GFDEE---------------MLQVLDVACMCVSQNPFKRPTVKEVVE--WLNNVGAN 886
GK + ML + +P +R TV E + WL
Sbjct: 247 GKYKMNPRQWSHISESAKDLVRRMLML----------DPAERITVYEALNHPWLKERDRY 296
Query: 887 RRN 889
Sbjct: 297 AYK 299
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676 | Back alignment and structure |
|---|
Score = 117 bits (295), Expect = 2e-27
Identities = 69/309 (22%), Positives = 116/309 (37%), Gaps = 44/309 (14%)
Query: 604 KATDNFSQANIIGCGGFGLVYKAT-LANGTTLAIKKLSGDLGLMERE-FKAEVEALSTAQ 661
+ + +G GGFG V + G +AIK+ +L RE + E++ +
Sbjct: 11 QTCGPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLN 70
Query: 662 HKNLVSL------QGYCVHQGFRLLIYSYMENGSLDYWLHEKADGASQLDWLTRLKIARG 715
H N+VS LL Y E G L +L++ + L +
Sbjct: 71 HPNVVSAREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQF-ENCCGLKEGPIRTLLSD 129
Query: 716 TSCGLAYMHQICEPHIVHRDIKSSNILLDDQFEAH---LADFGLSRLILPYQTHVTTELV 772
S L Y+H+ I+HRD+K NI+L + + D G ++ + Q + TE V
Sbjct: 130 ISSALRYLHEN---RIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKEL--DQGELCTEFV 184
Query: 773 GTLGYIPPE------YGQAWVATLRGDMYSFGVVMLELLTGKRPVD----------VLKP 816
GTL Y+ PE Y D +SFG + E +TG RP ++
Sbjct: 185 GTLQYLAPELLEQKKYTVT------VDYWSFGTLAFECITGFRPFLPNWQPVQWHGKVRE 238
Query: 817 KMSRELVGWVLKMRSEGKQDQVFDPILRGKGFDEEMLQVLDVACMCVSQNPFKRPTVKEV 876
K + +V + + + P ++ + L CM + + +R T +
Sbjct: 239 KSNEHIVVYDDLTGAVKFSSVLPTPNHLSGILAGKLERWL--QCMLMW-HQRQRGTDPQN 295
Query: 877 --VEWLNNV 883
V +
Sbjct: 296 PNVGCFQAL 304
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 112 bits (283), Expect = 2e-27
Identities = 64/290 (22%), Positives = 118/290 (40%), Gaps = 37/290 (12%)
Query: 613 NIIGCGGFGLVYKATL-----ANGTTLAIKKLSGDLGLMEREFKAEVEALSTAQHKNLVS 667
+G G FG V G +A+KKL R+F+ E+E L + QH N+V
Sbjct: 47 QQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVK 106
Query: 668 LQGYCVHQGFR--LLIYSYMENGSLDYWLHEKADGASQLDWLTRLKIARGTSCGLAYMHQ 725
+G C G R LI Y+ GSL +L + + ++D + L+ G+ Y+
Sbjct: 107 YKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKE---RIDHIKLLQYTSQICKGMEYLGT 163
Query: 726 ICEPHIVHRDIKSSNILLDDQFEAHLADFGLSRLILPYQTHVTTELVGTLGYIP-----P 780
+HRD+ + NIL++++ + DFGL++++ P V G P P
Sbjct: 164 K---RYIHRDLATRNILVENENRVKIGDFGLTKVL-PQDKEYYK--VKEPGESPIFWYAP 217
Query: 781 EYGQAWVATLRGDMYSFGVVMLELLTGKRPVDVLKPKMSRELVGWVLKMRSEG-KQDQVF 839
E ++ D++SFGVV+ EL T + R + + +
Sbjct: 218 ESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMI----GNDKQGQMIVFHLI 273
Query: 840 DPILRGKGFDEEM-------LQVLDVACMCVSQNPFKRPTVKEVVEWLNN 882
+ + + ++ + C + N +RP+ +++ ++
Sbjct: 274 ELLKNN----GRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQ 319
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281 | Back alignment and structure |
|---|
Score = 111 bits (280), Expect = 3e-27
Identities = 55/211 (26%), Positives = 85/211 (40%), Gaps = 29/211 (13%)
Query: 614 IIGCGGFGLVYKATLANG----TTLAIKKL-SGDLGLMEREFKAEVEALSTAQHKNLVSL 668
I+G G FG VY+ N +A+K + +F +E + H ++V L
Sbjct: 19 ILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKL 78
Query: 669 QGYCVHQGFRLLIYSYMENGSLDYWLHEKADGASQLDWLTRLKIARGTSCGLAYMHQICE 728
G + +I G L ++L + L LT + + +AY+ I
Sbjct: 79 IGIIEEEPT-WIIMELYPYGELGHYLERNKN---SLKVLTLVLYSLQICKAMAYLESI-- 132
Query: 729 PHIVHRDIKSSNILLDDQFEAHLADFGLSRLILPYQTHVTTELVGTLGYIP-----PE-- 781
+ VHRDI NIL+ L DFGLSR I ++ +P PE
Sbjct: 133 -NCVHRDIAVRNILVASPECVKLGDFGLSRYI--EDEDYYK---ASVTRLPIKWMSPESI 186
Query: 782 -YGQAWVATLRGDMYSFGVVMLELLT-GKRP 810
+ T D++ F V M E+L+ GK+P
Sbjct: 187 NFR---RFTTASDVWMFAVCMWEILSFGKQP 214
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281 | Back alignment and structure |
|---|
Score = 111 bits (280), Expect = 3e-27
Identities = 64/286 (22%), Positives = 98/286 (34%), Gaps = 51/286 (17%)
Query: 614 IIGCGGFGLVYKATLANG----TTLAIKKLSGDLGLMER-EFKAEVEALSTAQHKNLVSL 668
IG G FG V++ + +AIK R +F E + H ++V L
Sbjct: 22 CIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKL 81
Query: 669 QGYCVHQGFRLLIYSYMENGSLDYWLHEKADGASQLDWLTRLKIARGTSCGLAYMHQICE 728
G +I G L +L + LD + + A S LAY+
Sbjct: 82 IGVITENPV-WIIMELCTLGELRSFLQVRKY---SLDLASLILYAYQLSTALAYLESK-- 135
Query: 729 PHIVHRDIKSSNILLDDQFEAHLADFGLSRLILPYQTHVTTELVGTLGYIP-----PEYG 783
VHRDI + N+L+ L DFGLSR + + + G +P PE
Sbjct: 136 -RFVHRDIAARNVLVSSNDCVKLGDFGLSRYM--EDSTYYK---ASKGKLPIKWMAPESI 189
Query: 784 QAWVATLRGDMYSFGVVMLELLT-GKRPVDVLKPKMSRELVGWVLKMRSEGKQDQVFDPI 842
T D++ FGV M E+L G +P + V I
Sbjct: 190 NFRRFTSASDVWMFGVCMWEILMHGVKPF----QGVKNN---------------DVIGRI 230
Query: 843 LRG------KGFDEEMLQVLDVACMCVSQNPFKRPTVKEVVEWLNN 882
G + ++ C + +P +RP E+ L+
Sbjct: 231 ENGERLPMPPNCPPTLYSLM---TKCWAYDPSRRPRFTELKAQLST 273
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289 | Back alignment and structure |
|---|
Score = 111 bits (280), Expect = 3e-27
Identities = 47/234 (20%), Positives = 92/234 (39%), Gaps = 53/234 (22%)
Query: 607 DNFSQANIIGCGGFGLVYKATL--------ANGTTLAIKKLSGDLGLMEREFKAEVEALS 658
++ +G G F ++K + T + +K L F +S
Sbjct: 8 EDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMS 67
Query: 659 TAQHKNLVSLQGYCVHQGFRLLIYSYMENGSLDYWLHEKADGASQLDWLTRLKIARGTSC 718
HK+LV G CV +L+ +++ GSLD +L + + ++ L +L++A+ +
Sbjct: 68 KLSHKHLVLNYGVCVCGDENILVQEFVKFGSLDTYLKK---NKNCINILWKLEVAKQLAA 124
Query: 719 GLAYMHQICEPHIVHRDIKSSNILLDDQFEAH--------LADFGLSRLILPYQTHVTTE 770
+ ++ + ++H ++ + NILL + + L+D G+S +L
Sbjct: 125 AMHFLEEN---TLIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITVL--------- 172
Query: 771 LVGTLGYIPPEYGQA---WVA----------TLRGDMYSFGVVMLELLT-GKRP 810
P + Q WV L D +SFG + E+ + G +P
Sbjct: 173 --------PKDILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKP 218
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332 | Back alignment and structure |
|---|
Score = 112 bits (282), Expect = 3e-27
Identities = 62/354 (17%), Positives = 116/354 (32%), Gaps = 104/354 (29%)
Query: 607 DNFSQANIIGCGGFGLVYKAT-LANGTTLAIKKLS-GDLGLMEREFKAEVEALSTAQHKN 664
+F +G GGFG+V++A + AIK++ + L + EV+AL+ +H
Sbjct: 6 TDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPG 65
Query: 665 LVSLQGYCVHQGFRLL-----------------------------------------IYS 683
+V +
Sbjct: 66 IVRYFNAWLETPPEKWQEEMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVG 125
Query: 684 YMENGSLDYWLH---EKADGASQLDWLTR------------LKIARGTSCGLAYMHQICE 728
++ S +L+ + + DW+ R L I + + ++H
Sbjct: 126 QLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREHGVCLHIFIQIAEAVEFLHS--- 182
Query: 729 PHIVHRDIKSSNILLDDQFEAHLADFGLSRLI-----------LPYQTHVTTELVGTLGY 777
++HRD+K SNI + DFGL + T VGT Y
Sbjct: 183 KGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKLY 242
Query: 778 IPPE------YGQAWVATLRGDMYSFGVVMLELLTGKRPVDVLKPKMSRELVGWVLKMRS 831
+ PE Y + D++S G+++ ELL +M R + + +R
Sbjct: 243 MSPEQIHGNNYSH------KVDIFSLGLILFELLYS------FSTQMERVRI--ITDVR- 287
Query: 832 EGKQDQVFDPILRGKGFDEEMLQVLDVACMCVSQNPFKRPTVKEVV--EWLNNV 883
+ F + F ++ Q + +S +P +RP +++ N+
Sbjct: 288 ----NLKFPLL-----FTQKYPQEHMMVQDMLSPSPTERPEATDIIENAIFENL 332
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 112 bits (281), Expect = 4e-27
Identities = 63/304 (20%), Positives = 108/304 (35%), Gaps = 46/304 (15%)
Query: 607 DNFSQANIIGCGGFGLVYKAT-LANGTTLAIK-----KLSGDLGLMEREFKAEVEALSTA 660
+ ++I+G G V++ G AIK + + RE E L
Sbjct: 9 HLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMRE----FEVLKKL 64
Query: 661 QHKNLVSLQGYCVHQGFR----LLIYSYMENGSLDYWLHEKADGASQLDWLTRLKIARGT 716
HKN+V L + + + +LI + GSL L E A L L + R
Sbjct: 65 NHKNIVKL--FAIEEETTTRHKVLIMEFCPCGSLYTVLEEP-SNAYGLPESEFLIVLRDV 121
Query: 717 SCGLAYMHQICEPHIVHRDIKSSNILLDDQFEAH----LADFGLSRLILPYQTHVTTELV 772
G+ ++ + IVHR+IK NI+ + L DFG +R + + V+ L
Sbjct: 122 VGGMNHLREN---GIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFVS--LY 176
Query: 773 GTLGYIPPEYGQAWVATLRG--------DMYSFGVVMLELLTGKRP-VDVLKPKMSRELV 823
GT Y+ P+ + V D++S GV TG P P+ ++E++
Sbjct: 177 GTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVM 236
Query: 824 GWVLKMRSEGKQDQVFDPILRGKGFDEEML-----------QVLDVACMCVSQNPFKRPT 872
++ + G V + +M + V + + K
Sbjct: 237 YKIITGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWG 296
Query: 873 VKEV 876
+
Sbjct: 297 FDQF 300
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289 | Back alignment and structure |
|---|
Score = 110 bits (278), Expect = 6e-27
Identities = 57/306 (18%), Positives = 103/306 (33%), Gaps = 69/306 (22%)
Query: 606 TDNFSQANIIGCGGFGLVYKAT-LANGTTLAIKKLSGDLGLM----EREFKAEVEALST- 659
T F + IG G FG V+K +G AIK+ L E+ EV A +
Sbjct: 10 TTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRS--KKPLAGSVDEQNALREVYAHAVL 67
Query: 660 AQHKNLVSLQGYCVHQGFRLLIYS-YMENGSLDYWLHEKADGASQLDWLTRLKIARGTSC 718
QH ++V +LI + Y GSL + E S +
Sbjct: 68 GQHSHVVRYFSAWAEDD-HMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGR 126
Query: 719 GLAYMHQICEPHIVHRDIKSSNILLD-------------------DQFEAHLADFGLSRL 759
GL Y+H +VH DIK SNI + ++ + D G
Sbjct: 127 GLRYIH---SMSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVTR 183
Query: 760 ILPYQTHVTTELVGTLGYIPPE-------YGQAWVATLRGDMYSFGVVMLELLTGKRPVD 812
I Q G ++ E + D+++ + ++ +
Sbjct: 184 ISSPQV-----EEGDSRFLANEVLQENYTHLPK------ADIFALALTVVCAAGAEPL-- 230
Query: 813 VLKPKMSRELVGWVLKMRSEGKQDQVFDPILRGKGFDEEMLQVLDVACMCVSQNPFKRPT 872
P+ + ++R +G+ ++ +E ++L + + +P +RP+
Sbjct: 231 ---PRNGDQ----WHEIR-QGRLPRIPQ------VLSQEFTELLK---VMIHPDPERRPS 273
Query: 873 VKEVVE 878
+V+
Sbjct: 274 AMALVK 279
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323 | Back alignment and structure |
|---|
Score = 111 bits (279), Expect = 7e-27
Identities = 64/300 (21%), Positives = 117/300 (39%), Gaps = 61/300 (20%)
Query: 613 NIIGCGGFGLVYKATLANG----TTLAIKKLSGDLGLMER--EFKAEVEALSTAQHKNLV 666
++G G FG V +A L +A+K L D+ EF E + H ++
Sbjct: 29 RMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVA 88
Query: 667 SLQGYCVHQG------FRLLIYSYMENGSLDYWL--HEKADGASQLDWLTRLKIARGTSC 718
L G + ++I +M++G L +L + L T ++ +C
Sbjct: 89 KLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIAC 148
Query: 719 GLAYMHQICEPHIVHRDIKSSNILLDDQFEAHLADFGLSRLILPYQTHVTTELVGTLGYI 778
G+ Y+ + +HRD+ + N +L + +ADFGLSR I Y G +
Sbjct: 149 GMEYLSSR---NFIHRDLAARNCMLAEDMTVCVADFGLSRKI--YSGDYYR--QGCASKL 201
Query: 779 P-----PE---YGQAWVATLRGDMYSFGVVMLELLT-GKRPVDVLKPKMSRELVGWVLKM 829
P E + T+ D+++FGV M E++T G+ P +
Sbjct: 202 PVKWLALESLADN---LYTVHSDVWAFGVTMWEIMTRGQTPY----AGIENA-------- 246
Query: 830 RSEGKQDQVFDPILRGKGFD------EEMLQVLDVACMCVSQNPFKRPTVKEVVEWLNNV 883
++++ ++ G EE+ ++ C S +P +RP+ + L N+
Sbjct: 247 -------EIYNYLIGGNRLKQPPECMEEVYDLM---YQCWSADPKQRPSFTCLRMELENI 296
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334 | Back alignment and structure |
|---|
Score = 111 bits (280), Expect = 7e-27
Identities = 72/314 (22%), Positives = 120/314 (38%), Gaps = 69/314 (21%)
Query: 607 DNFSQANIIGCGGFGLVYKATL--------ANGTTLAIKKLSGDLGLMER-EFKAEVEAL 657
D + +G G FG V A T+A+K L D + + +E+E +
Sbjct: 35 DKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMM 94
Query: 658 ST-AQHKNLVSLQGYCVHQGFRLLIYSYMENGSL------------DYWLHEKADGASQL 704
+HKN+++L G C G +I Y G+L +Y Q+
Sbjct: 95 KMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQM 154
Query: 705 DWLTRLKIARGTSCGLAYMHQICEPHIVHRDIKSSNILLDDQFEAHLADFGLSRLILPYQ 764
+ + + G+ Y+ +HRD+ + N+L+ + +ADFGL+R I
Sbjct: 155 TFKDLVSCTYQLARGMEYLASQ---KCIHRDLAARNVLVTENNVMKIADFGLARDI--NN 209
Query: 765 THVTTELVGTLGYIP-----PE---YGQAWVATLRGDMYSFGVVMLELLT-GKRPVDVLK 815
T G +P PE V T + D++SFGV+M E+ T G P
Sbjct: 210 IDYYK--KTTNGRLPVKWMAPEALFDR---VYTHQSDVWSFGVLMWEIFTLGGSPY---- 260
Query: 816 PKMSRELVGWVLKMRSEGKQDQVFDPILRG------KGFDEEMLQVLDVACMCVSQNPFK 869
P + E ++F + G E+ ++ C P +
Sbjct: 261 PGIPVE---------------ELFKLLKEGHRMDKPANCTNELYMMM---RDCWHAVPSQ 302
Query: 870 RPTVKEVVEWLNNV 883
RPT K++VE L+ +
Sbjct: 303 RPTFKQLVEDLDRI 316
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291 | Back alignment and structure |
|---|
Score = 110 bits (277), Expect = 7e-27
Identities = 49/213 (23%), Positives = 82/213 (38%), Gaps = 29/213 (13%)
Query: 614 IIGCGGFGLVYKATL----ANGTTLAIKKLSGDL---GLMEREFKAEVEALSTAQHKNLV 666
+G G FG+V + ++A+K L D+ +F EV A+ + H+NL+
Sbjct: 25 KLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLI 84
Query: 667 SLQGYCVHQGFRLLIYSYMENGSLDYWLHEKADGASQLDWLTRLKIARGTSCGLAYMHQI 726
L G + ++ GSL L + T + A + G+ Y+
Sbjct: 85 RLYGVVLTPPM-KMVTELAPLGSLLDRLRKHQG---HFLLGTLSRYAVQVAEGMGYLE-- 138
Query: 727 CEPHIVHRDIKSSNILLDDQFEAHLADFGLSRLILPYQTHVTTELVGTLGYIP-----PE 781
+HRD+ + N+LL + + DFGL R + H +P PE
Sbjct: 139 -SKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVM---QEHRKVPFAWCAPE 194
Query: 782 ---YGQAWVATLRGDMYSFGVVMLELLT-GKRP 810
+ D + FGV + E+ T G+ P
Sbjct: 195 SLKTRT---FSHASDTWMFGVTLWEMFTYGQEP 224
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 110 bits (277), Expect = 2e-26
Identities = 62/308 (20%), Positives = 108/308 (35%), Gaps = 68/308 (22%)
Query: 615 IGCGGFGLVYKAT-LANGTTLAIKKLSGDLGLMEREFKAEVEALST-AQHKNLVSLQGYC 672
+ GGF VY+A + +G A+K+L + R EV + + H N+V
Sbjct: 36 LAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQFCSAA 95
Query: 673 VHQGFRLLIYSYMENGSLDYWLHEKADGASQLDWLTR------------LKIARGTSCGL 720
+ G ++ L + +++L + LKI T +
Sbjct: 96 SIGK------EESDTGQAEFLLLTELCKGQLVEFLKKMESRGPLSCDTVLKIFYQTCRAV 149
Query: 721 AYMHQICEPHIVHRDIKSSNILLDDQFEAHLADFGLSRLILPYQTHVTTEL--------- 771
+MH+ +P I+HRD+K N+LL +Q L DFG + I Y + +
Sbjct: 150 QHMHR-QKPPIIHRDLKVENLLLSNQGTIKLCDFGSATTISHYPDYSWSAQRRALVEEEI 208
Query: 772 --VGTLGYIPPE---YGQAWVATLRGDMYSFGVVMLELLTGKRPVDVLKPKMSRELVGWV 826
T Y PE + + D+++ G ++ L + P +
Sbjct: 209 TRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFE-------------- 254
Query: 827 LKMRSEGKQDQVFDPILRGK-------GFDEEMLQVLDVACMCVSQNPFKRPTVKEVVEW 879
D I+ GK ++ + NP +R ++ EVV
Sbjct: 255 ---------DGAKLRIVNGKYSIPPHDTQYTVFHSLIR---AMLQVNPEERLSIAEVVHQ 302
Query: 880 LNNVGANR 887
L + A R
Sbjct: 303 LQEIAAAR 310
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396 | Back alignment and structure |
|---|
Score = 111 bits (279), Expect = 2e-26
Identities = 62/311 (19%), Positives = 108/311 (34%), Gaps = 46/311 (14%)
Query: 607 DNFSQANIIGCGGFGLVYKAT-LANGTTLAIK-----KLSGDLGLMEREFKAEVEALSTA 660
+ ++I+G G V++ G AIK + + RE E L
Sbjct: 9 HLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMRE----FEVLKKL 64
Query: 661 QHKNLVSLQGYCVHQGFR----LLIYSYMENGSLDYWLHEKADGASQLDWLTRLKIARGT 716
HKN+V L + + + +LI + GSL L E A L L + R
Sbjct: 65 NHKNIVKL--FAIEEETTTRHKVLIMEFCPCGSLYTVLEEP-SNAYGLPESEFLIVLRDV 121
Query: 717 SCGLAYMHQICEPHIVHRDIKSSNILLDDQFEAH----LADFGLSRLILPYQTHVTTELV 772
G+ ++ + IVHR+IK NI+ + L DFG +R L + L
Sbjct: 122 VGGMNHLREN---GIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAAR-ELEDDEQFVS-LY 176
Query: 773 GTLGYIPPEYGQAWVATLRG--------DMYSFGVVMLELLTGKRP-VDVLKPKMSRELV 823
GT Y+ P+ + V D++S GV TG P P+ ++E++
Sbjct: 177 GTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVM 236
Query: 824 GWVLKMRSEGKQDQVFDPILRGKGFDEEMLQVLDVACMCVSQ-----------NPFKRPT 872
++ + G V + +M ++ + K
Sbjct: 237 YKIITGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWG 296
Query: 873 VKEVVEWLNNV 883
+ +++
Sbjct: 297 FDQFFAETSDI 307
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370 | Back alignment and structure |
|---|
Score = 110 bits (278), Expect = 2e-26
Identities = 74/321 (23%), Positives = 122/321 (38%), Gaps = 69/321 (21%)
Query: 607 DNFSQANIIGCGGFGLVYKATL--------ANGTTLAIKKLSGDLGLMER-EFKAEVEAL 657
D + +G G FG V A T+A+K L D + + +E+E +
Sbjct: 81 DKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMM 140
Query: 658 ST-AQHKNLVSLQGYCVHQGFRLLIYSYMENGSL------------DYWLHEKADGASQL 704
+HKN+++L G C G +I Y G+L +Y Q+
Sbjct: 141 KMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQM 200
Query: 705 DWLTRLKIARGTSCGLAYMHQICEPHIVHRDIKSSNILLDDQFEAHLADFGLSRLILPYQ 764
+ + + G+ Y+ +HRD+ + N+L+ + +ADFGL+R I
Sbjct: 201 TFKDLVSCTYQLARGMEYLASQ---KCIHRDLAARNVLVTENNVMKIADFGLARDI--NN 255
Query: 765 THVTTELVGTLGYIP-----PE---YGQAWVATLRGDMYSFGVVMLELLT-GKRPVDVLK 815
T G +P PE V T + D++SFGV+M E+ T G P
Sbjct: 256 IDYYK--KTTNGRLPVKWMAPEALFDR---VYTHQSDVWSFGVLMWEIFTLGGSPY---- 306
Query: 816 PKMSRELVGWVLKMRSEGKQDQVFDPILRG------KGFDEEMLQVLDVACMCVSQNPFK 869
P + E ++F + G E+ ++ C P +
Sbjct: 307 PGIPVE---------------ELFKLLKEGHRMDKPANCTNELYMMM---RDCWHAVPSQ 348
Query: 870 RPTVKEVVEWLNNVGANRRNE 890
RPT K++VE L+ + NE
Sbjct: 349 RPTFKQLVEDLDRILTLTTNE 369
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345 | Back alignment and structure |
|---|
Score = 110 bits (276), Expect = 3e-26
Identities = 65/368 (17%), Positives = 98/368 (26%), Gaps = 118/368 (32%)
Query: 590 NTNEIKDLTIYELLKATDNFSQANIIGCGGFGLVYKAT-LANGTTLAIK-----KLSGDL 643
+ E++ Y L IG G +G+V A AIK K+
Sbjct: 20 SLLELQK--KYHLKG---------AIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQIN 68
Query: 644 GLMEREFKAEVEALSTAQHKNLVSLQGYCVHQGFRLLIYSYMENGSLDYWLHEKADGASQ 703
K EV + H N+ L + + L+ G L L+ D ++
Sbjct: 69 PKDVERIKTEVRLMKKLHHPNIARLYEVYEDEQYICLVMELCHGGHLLDKLNVFIDDSTG 128
Query: 704 LDWLTRLKIARGTSCGL--------------------------AYMHQICE-------PH 730
+ +K M QI
Sbjct: 129 KCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSALHYLHNQG 188
Query: 731 IVHRDIKSSNILLDDQFEAHL--ADFGLSRLIL---PYQTHVTTELVGTLGYIPPE---- 781
I HRDIK N L + DFGLS+ + + T GT ++ PE
Sbjct: 189 ICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNT 248
Query: 782 ----YGQAWVATLRGDMYSFGVVMLELLTGKRPVDVLKPKMSRELVGWVLKMRSEGKQDQ 837
YG D +S GV++ LL G P G D
Sbjct: 249 TNESYGPK------CDAWSAGVLLHLLLMGAVPFP--------------------GVNDA 282
Query: 838 -VFDPILRGK-GFDEE---------------MLQVLDVACMCVSQNPFKRPTVKEVVE-- 878
+L K F+ +L N +R ++
Sbjct: 283 DTISQVLNKKLCFENPNYNVLSPLARDLLSNLLNR----------NVDERFDAMRALQHP 332
Query: 879 WLNNVGAN 886
W++
Sbjct: 333 WISQFSDK 340
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413 | Back alignment and structure |
|---|
Score = 111 bits (278), Expect = 3e-26
Identities = 30/235 (12%), Positives = 60/235 (25%), Gaps = 41/235 (17%)
Query: 614 IIGCGGFGLVYKAT-LANGTTLAIKKLS-------GDLGLMERE---------------- 649
++G +AT G + + + M+ E
Sbjct: 85 VLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQA 144
Query: 650 -----FKAEVEALSTAQHKNLVSLQG----YCVHQGFRLLIYSYMENGSLDYWLHEKADG 700
F + + Q K ++ ++ V F L + L +
Sbjct: 145 KVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSST 204
Query: 701 ASQLDWLTRLKIARGTSCGLAYMHQICEPHIVHRDIKSSNILLDDQFEAHLADFGLSRLI 760
L RL++ LA +H +VH ++ +I+LD + L F
Sbjct: 205 HKSLVHHARLQLTLQVIRLLASLHHY---GLVHTYLRPVDIVLDQRGGVFLTGFEHLVRD 261
Query: 761 LPYQTHVTTELVGTLGYIPPE-----YGQAWVATLRGDMYSFGVVMLELLTGKRP 810
+ T D ++ G+ + + P
Sbjct: 262 GASAVSPIGRGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIWCADLP 316
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382 | Back alignment and structure |
|---|
Score = 110 bits (276), Expect = 5e-26
Identities = 74/317 (23%), Positives = 126/317 (39%), Gaps = 69/317 (21%)
Query: 615 IGCGGFGLVYKATL--------ANGTTLAIKKLSGDLGLMER-EFKAEVEALST-AQHKN 664
+G G FG V A T +A+K L D + + +E+E + +HKN
Sbjct: 77 LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 136
Query: 665 LVSLQGYCVHQGFRLLIYSYMENGSL------------DYWLHEKADGASQLDWLTRLKI 712
+++L G C G +I Y G+L +Y + + QL +
Sbjct: 137 IINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSC 196
Query: 713 ARGTSCGLAYMHQICEPHIVHRDIKSSNILLDDQFEAHLADFGLSRLILPYQTHVTTELV 772
A + G+ Y+ +HRD+ + N+L+ + +ADFGL+R I +
Sbjct: 197 AYQVARGMEYLASK---KCIHRDLAARNVLVTEDNVMKIADFGLARDI--HHIDYYK--K 249
Query: 773 GTLGYIP-----PE---YGQAWVATLRGDMYSFGVVMLELLT-GKRPVDVLKPKMSRELV 823
T G +P PE + T + D++SFGV++ E+ T G P P + E
Sbjct: 250 TTNGRLPVKWMAPEALFDR---IYTHQSDVWSFGVLLWEIFTLGGSPY----PGVPVE-- 300
Query: 824 GWVLKMRSEGKQDQVFDPILRG------KGFDEEMLQVLDVACMCVSQNPFKRPTVKEVV 877
++F + G E+ ++ C P +RPT K++V
Sbjct: 301 -------------ELFKLLKEGHRMDKPSNCTNELYMMM---RDCWHAVPSQRPTFKQLV 344
Query: 878 EWLNNVGANRRNENKGF 894
E L+ + A N+ G+
Sbjct: 345 EDLDRIVALTSNQEMGY 361
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494 | Back alignment and structure |
|---|
Score = 112 bits (281), Expect = 5e-26
Identities = 65/337 (19%), Positives = 115/337 (34%), Gaps = 94/337 (27%)
Query: 585 MLFPNNTNEIKDLTIYELLKATDNFSQANIIGCGGFGLVYKAT-LANGTTLAIKKLS-GD 642
M + + + +Y+ +K +G G +G V AIK +
Sbjct: 26 MFITSKKGHLSE--MYQRVK---------KLGSGAYGEVLLCRDKVTHVERAIKIIRKTS 74
Query: 643 LGLMERE-FKAEVEALSTAQHKNLVSLQGYCVHQGFRLLIYSYMENGSLDYWLHEK---- 697
+ EV L H N++ L + + L+ + G L + +
Sbjct: 75 VSTSSNSKLLEEVAVLKLLDHPNIMKLYDFFEDKRNYYLVMECYKGGELFDEIIHRMKFN 134
Query: 698 -ADGASQLDWLTRLKIARGTSCGLAYMHQICEPHIVHRDIKSSNILLDDQFEAH---LAD 753
D A I + G+ Y+H+ +IVHRD+K N+LL+ + + + D
Sbjct: 135 EVDAA---------VIIKQVLSGVTYLHKH---NIVHRDLKPENLLLESKEKDALIKIVD 182
Query: 754 FGLSRLILPYQTHVTTELVGTLGYIPPE-----YGQAWVATLRGDMYSFGVVMLELLTGK 808
FGLS + E +GT YI PE Y + D++S GV++ LL G
Sbjct: 183 FGLSAVFEN--QKKMKERLGTAYYIAPEVLRKKYDEK------CDVWSIGVILFILLAGY 234
Query: 809 RPVDVLKPKMSRELVGWVLKMRSEGKQDQVFDPILRGK-GFDEE---------------M 852
P ++ + +GK FD M
Sbjct: 235 PPFG-------------------GQTDQEILRKVEKGKYTFDSPEWKNVSEGAKDLIKQM 275
Query: 853 LQVLDVACMCVSQNPFKRPTVKEVVE--WLNNVGANR 887
LQ + +R + ++ +E W+ + + +
Sbjct: 276 LQF----------DSQRRISAQQALEHPWIKEMCSKK 302
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434 | Back alignment and structure |
|---|
Score = 111 bits (278), Expect = 5e-26
Identities = 65/316 (20%), Positives = 117/316 (37%), Gaps = 54/316 (17%)
Query: 592 NEIKDLTIYELLKATDNFSQANIIGCGGFGLVYKATLANGTTLAIKKLSGDLGLMEREFK 651
+ I ++ +E + I+G G G V G +A+K++ D
Sbjct: 1 SRIANIPNFEQ-SLKNLVVSEKILGYGSSGTVVFQGSFQGRPVAVKRMLID---FCDIAL 56
Query: 652 AEVEALS-TAQHKNLVSLQGYCVHQGFRLLIYSYME--NGSLDYWLHEK---ADGASQLD 705
E++ L+ + H N++ YC +Y +E N +L + K +
Sbjct: 57 MEIKLLTESDDHPNVIRY--YCSETT-DRFLYIALELCNLNLQDLVESKNVSDENLKLQK 113
Query: 706 WLTRLKIARGTSCGLAYMHQICEPHIVHRDIKSSNILLDDQFEAH-------------LA 752
+ + R + G+A++H + I+HRD+K NIL+ ++
Sbjct: 114 EYNPISLLRQIASGVAHLHSL---KIIHRDLKPQNILVSTSSRFTADQQTGAENLRILIS 170
Query: 753 DFGLSRLILPYQTHVTTEL---VGTLGYIPPEY--GQAWVATLRG-----DMYSFGVVML 802
DFGL + + Q+ T L GT G+ PE + T R D++S G V
Sbjct: 171 DFGLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFY 230
Query: 803 ELLT-GKRPVDVLKPKMSRELVGWVLKMRSEGKQDQVFDPILR-GKGFDEEMLQVLDVAC 860
+L+ GK P + S + G + + ++ +M+
Sbjct: 231 YILSKGKHPFGDKYSRESNIIRG---IFSLDEMKCLHDRSLIAEATDLISQMIDH----- 282
Query: 861 MCVSQNPFKRPTVKEV 876
+P KRPT +V
Sbjct: 283 -----DPLKRPTAMKV 293
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298 | Back alignment and structure |
|---|
Score = 108 bits (271), Expect = 6e-26
Identities = 77/346 (22%), Positives = 115/346 (33%), Gaps = 108/346 (31%)
Query: 588 PNNTNEIKDLTIYELLKATDNFSQANIIGCGGFGLVYKAT-LANGTTLAIKKLS------ 640
++T+ + YE + I+G G +V + A+K +
Sbjct: 9 SHSTHGFYE--NYEPKE---------ILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGS 57
Query: 641 ---GDLGLMEREFKAEVEALST-AQHKNLVSLQGYCVHQGFRLLIYSYMENGSL-DY--- 692
++ + EV+ L + H N++ L+ F L++ M+ G L DY
Sbjct: 58 FSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTE 117
Query: 693 --WLHEKADGASQLDWLTRLKIARGTSCGLAYMHQICEPHIVHRDIKSSNILLDDQFEAH 750
L EK KI R + +H++ +IVHRD+K NILLDD
Sbjct: 118 KVTLSEKE--TR--------KIMRALLEVICALHKL---NIVHRDLKPENILLDDDMNIK 164
Query: 751 LADFGLSRLILPYQTHVTTELVGTLGYIPPE------------YGQAWVATLRGDMYSFG 798
L DFG S + P E+ GT Y+ PE YG+ DM+S G
Sbjct: 165 LTDFGFSCQLDP--GEKLREVCGTPSYLAPEIIECSMNDNHPGYGKE------VDMWSTG 216
Query: 799 VVMLELLTGKRPVDVLKPKMSRELVGWVLKMRSEGKQDQVFDPILRGK-GFDEE------ 851
V+M LL G P KQ + I+ G F
Sbjct: 217 VIMYTLLAGSPPFW-------------------HRKQMLMLRMIMSGNYQFGSPEWDDYS 257
Query: 852 ---------MLQVLDVACMCVSQNPFKRPTVKEVVE--WLNNVGAN 886
L V P KR T +E + +
Sbjct: 258 DTVKDLVSRFLVV----------QPQKRYTAEEALAHPFFQQYVVE 293
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303 | Back alignment and structure |
|---|
Score = 107 bits (270), Expect = 8e-26
Identities = 79/293 (26%), Positives = 122/293 (41%), Gaps = 47/293 (16%)
Query: 607 DNFSQANIIGCGGFGLVYKAT-LANGTTLAIKKLSGDLGLMEREF---KAEVEALSTAQH 662
D++ +IG G +V A +AIK++ +L + E++A+S H
Sbjct: 15 DDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRI--NLEKCQTSMDELLKEIQAMSQCHH 72
Query: 663 KNLVSLQGYCVHQGFRLLIYSYMENGSL-DYWLHEKADGASQLDWLTRLKIA---RGTSC 718
N+VS V + L+ + GS+ D H A G + L IA R
Sbjct: 73 PNIVSYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLE 132
Query: 719 GLAYMHQICEPHIVHRDIKSSNILLDDQFEAHLADFG----LSRLILPYQTHVTTELVGT 774
GL Y+H+ +HRD+K+ NILL + +ADFG L+ + V VGT
Sbjct: 133 GLEYLHKN---GQIHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTFVGT 189
Query: 775 LGYIPPE-------YGQAWVATLRGDMYSFGVVMLELLTGKRPVDVLKPKMSRELVGWVL 827
++ PE Y + D++SFG+ +EL TG P P M VL
Sbjct: 190 PCWMAPEVMEQVRGYDF------KADIWSFGITAIELATGAAPYHKYPP-M------KVL 236
Query: 828 KMRSEGKQDQVFDPILRGKGFDEEMLQVL-----DVACMCVSQNPFKRPTVKE 875
+ + P L D+EML+ + +C+ ++P KRPT E
Sbjct: 237 MLTLQND-----PPSLETGVQDKEMLKKYGKSFRKMISLCLQKDPEKRPTAAE 284
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290 | Back alignment and structure |
|---|
Score = 106 bits (267), Expect = 1e-25
Identities = 63/279 (22%), Positives = 114/279 (40%), Gaps = 32/279 (11%)
Query: 607 DNFSQANIIGCGGFGLVYKAT-LANGTTLAIKKLSGDLGLMERE-FKAEVE-ALSTAQHK 663
D+ +G G +G+V K + +G +A+K++ + E++ +++ ++ T
Sbjct: 7 DDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCP 66
Query: 664 NLVSLQGYCVHQGFRLLIYSYMENGSLDYWLHEKADGASQL--DWLTRLKIARGTSCGLA 721
V+ G +G + M + SLD + + D + D L KIA L
Sbjct: 67 FTVTFYGALFREGDVWICMELM-DTSLDKFYKQVIDKGQTIPEDILG--KIAVSIVKALE 123
Query: 722 YMHQICEPHIVHRDIKSSNILLDDQFEAHLADFGLS-RLILPYQTHVTTELVGTLGYIPP 780
++H + ++HRD+K SN+L++ + + DFG+S L+ G Y+ P
Sbjct: 124 HLHS--KLSVIHRDVKPSNVLINALGQVKMCDFGISGYLV---DDVAKDIDAGCKPYMAP 178
Query: 781 E----YGQAWVATLRGDMYSFGVVMLELLTGKRPVDVLKPKMSRELVGWVLKMRSEGKQD 836
E +++ D++S G+ M+EL + P D LK E
Sbjct: 179 ERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGTPFQ------QLKQVVEEP-- 230
Query: 837 QVFDPILRGKGFDEEMLQVLDVACMCVSQNPFKRPTVKE 875
P L F E + C+ +N +RPT E
Sbjct: 231 ---SPQLPADKFSAEFVDFTSQ---CLKKNSKERPTYPE 263
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314 | Back alignment and structure |
|---|
Score = 107 bits (269), Expect = 2e-25
Identities = 78/324 (24%), Positives = 126/324 (38%), Gaps = 74/324 (22%)
Query: 607 DNFSQANIIGCGGFGLVYKATLANG------TTLAIKKLSGDLGLMER-EFKAEVEALST 659
N +G G FG V KAT + TT+A+K L + E + +E L
Sbjct: 23 KNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQ 82
Query: 660 AQHKNLVSLQGYCVHQGFRLLIYSYMENGSL-DY-------------------WLHEKAD 699
H +++ L G C G LLI Y + GSL +
Sbjct: 83 VNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHP 142
Query: 700 GASQLDWLTRLKIARGTSCGLAYMHQICEPHIVHRDIKSSNILLDDQFEAHLADFGLSRL 759
L + A S G+ Y+ ++ +VHRD+ + NIL+ + + ++DFGLSR
Sbjct: 143 DERALTMGDLISFAWQISQGMQYLAEM---KLVHRDLAARNILVAEGRKMKISDFGLSRD 199
Query: 760 ILPYQTHVTTELVGTLGYIP-----PE---YGQAWVATLRGDMYSFGVVMLELLT-GKRP 810
+ Y+ + G IP E + T + D++SFGV++ E++T G P
Sbjct: 200 V--YEEDSYV--KRSQGRIPVKWMAIESLFDH---IYTTQSDVWSFGVLLWEIVTLGGNP 252
Query: 811 VDVLKPKMSRELVGWVLKMRSEGKQDQVFDPILRG------KGFDEEMLQVLDVACMCVS 864
P + E ++F+ + G EEM +++ C
Sbjct: 253 Y----PGIPPE---------------RLFNLLKTGHRMERPDNCSEEMYRLM---LQCWK 290
Query: 865 QNPFKRPTVKEVVEWLNNVGANRR 888
Q P KRP ++ + L + RR
Sbjct: 291 QEPDKRPVFADISKDLEKMMVKRR 314
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313 | Back alignment and structure |
|---|
Score = 106 bits (268), Expect = 2e-25
Identities = 79/314 (25%), Positives = 118/314 (37%), Gaps = 70/314 (22%)
Query: 607 DNFSQANIIGCGGFGLVYKATLAN------GTTLAIKKLSGDLGLMER-EFKAEVEALST 659
+ S +G G FG V +AT T+A+K L L ER +E++ LS
Sbjct: 23 NRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSY 82
Query: 660 -AQHKNLVSLQGYCVHQGFRLLIYSYMENGSLDYWLHEK--------------ADGASQL 704
H N+V+L G C G L+I Y G L +L K D L
Sbjct: 83 LGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELAL 142
Query: 705 DWLTRLKIARGTSCGLAYMHQICEPHIVHRDIKSSNILLDDQFEAHLADFGLSRLILPYQ 764
D L + + G+A++ + +HRD+ + NILL + DFGL+R I
Sbjct: 143 DLEDLLSFSYQVAKGMAFLASK---NCIHRDLAARNILLTHGRITKICDFGLARDI--KN 197
Query: 765 THVTTELVGTLGYIP-----PE---YGQAWVATLRGDMYSFGVVMLELLT-GKRPVDVLK 815
V +P PE V T D++S+G+ + EL + G P
Sbjct: 198 DSNYV--VKGNARLPVKWMAPESIFNC---VYTFESDVWSYGIFLWELFSLGSSPY---- 248
Query: 816 PKMSRELVGWVLKMRSEGKQDQVFDPILRGKGFDEEMLQ-------VLDVACMCVSQNPF 868
P M + + I G ML + D+ C +P
Sbjct: 249 PGMP--------------VDSKFYKMIKEGF----RMLSPEHAPAEMYDIMKTCWDADPL 290
Query: 869 KRPTVKEVVEWLNN 882
KRPT K++V+ +
Sbjct: 291 KRPTFKQIVQLIEK 304
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 106 bits (267), Expect = 3e-25
Identities = 68/309 (22%), Positives = 122/309 (39%), Gaps = 45/309 (14%)
Query: 585 MLFPNNTNEIKDLTIYELLKATDNFSQANIIGCGGFGLVYKAT-LANGTTLAIK--KLSG 641
M + + ++ + L F ++G G +G VYK + G AIK ++G
Sbjct: 2 MASDSPARSLDEIDLSALRDPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTG 61
Query: 642 DLGLMEREFKAEVEALSTA-QHKNLVS-----LQGYCVHQGFRL-LIYSYMENGSLDYWL 694
D E E K E+ L H+N+ + ++ +L L+ + GS+ +
Sbjct: 62 DE---EEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLI 118
Query: 695 HEKADGASQLDWLTRLKIA---RGTSCGLAYMHQICEPHIVHRDIKSSNILLDDQFEAHL 751
L IA R GL+++H + ++HRDIK N+LL + E L
Sbjct: 119 KNTKGNT-----LKEEWIAYICREILRGLSHLH---QHKVIHRDIKGQNVLLTENAEVKL 170
Query: 752 ADFGLSRLILPYQTHVTTELVGTLGYIPPEYGQAWVATLRG-----DMYSFGVVMLELLT 806
DFG+S + T +GT ++ PE D++S G+ +E+
Sbjct: 171 VDFGVSAQLDRTVGRRNT-FIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAE 229
Query: 807 GKRPVDVLKPKMSRELVGWVLKMRSEGKQDQVFDPILRGKGFDEEMLQVLDVACMCVSQN 866
G P+ + P M L + P L+ K + ++ ++ C+ +N
Sbjct: 230 GAPPLCDMHP-M------RALFLIPRNPA-----PRLKSKKWSKKFQSFIES---CLVKN 274
Query: 867 PFKRPTVKE 875
+RP ++
Sbjct: 275 HSQRPATEQ 283
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 105 bits (264), Expect = 4e-25
Identities = 66/215 (30%), Positives = 94/215 (43%), Gaps = 28/215 (13%)
Query: 607 DNFSQANIIGCGGFGLVYKAT-LANGTTLAIKKLS----GDLGLMEREFKAEVEALSTAQ 661
++F +G G FG VY A + LA+K L G+ + + EVE S +
Sbjct: 9 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQ-LRREVEIQSHLR 67
Query: 662 HKNLVSLQGYCVHQGFRL-LIYSYMENGSLDYWLHEKADGASQLDWLTRLKIARGTSCGL 720
H N++ L GY H R+ LI Y G++ + + S+ D + L
Sbjct: 68 HPNILRLYGY-FHDATRVYLILEYAPLGTV----YRELQKLSKFDEQRTATYITELANAL 122
Query: 721 AYMHQICEPHIVHRDIKSSNILLDDQFEAHLADFGLSRLILPYQTHVTTELVGTLGYIPP 780
+Y H ++HRDIK N+LL E +ADFG S P L GTL Y+PP
Sbjct: 123 SYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWSVH-APSSRRTD--LCGTLDYLPP 176
Query: 781 EYGQAWVATLRG-----DMYSFGVVMLELLTGKRP 810
E + R D++S GV+ E L GK P
Sbjct: 177 E-----MIEGRMHDEKVDLWSLGVLCYEFLVGKPP 206
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335 | Back alignment and structure |
|---|
Score = 106 bits (267), Expect = 4e-25
Identities = 54/257 (21%), Positives = 92/257 (35%), Gaps = 53/257 (20%)
Query: 574 SPEADKDASLVMLFPNNTNEIKDLTIYELLKATDNFSQANIIGCGGFGLVYKAT-LANGT 632
+P A A P + + Y + +G GGF ++ +
Sbjct: 17 APGAPAAAPPAKEIPEVLVDPRSRRRYVRGR---------FLGKGGFAKCFEISDADTKE 67
Query: 633 TLAIKKLS----GDLGLMEREFKAEVEALSTAQHKNLVSLQGYCVHQGFRLLIYSYMENG 688
A K + E+ E+ + H+++V + + E+
Sbjct: 68 VFAGKIVPKSLLLKPHQREK-MSMEISIHRSLAHQHVVGF-------------HGFFEDN 113
Query: 689 SLDYWLHEKADGASQLDWLTRLK---------IARGTSCGLAYMHQICEPHIVHRDIKSS 739
+ + E S L+ R K R G Y+H+ ++HRD+K
Sbjct: 114 DFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHR---NRVIHRDLKLG 170
Query: 740 NILLDDQFEAHLADFGLSRLI-LPYQTHVTTELVGTLGYIPPEYGQAWVATLRG-----D 793
N+ L++ E + DFGL+ + + L GT YI PE V + +G D
Sbjct: 171 NLFLNEDLEVKIGDFGLATKVEYDGERKKV--LCGTPNYIAPE-----VLSKKGHSFEVD 223
Query: 794 MYSFGVVMLELLTGKRP 810
++S G +M LL GK P
Sbjct: 224 VWSIGCIMYTLLVGKPP 240
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419 | Back alignment and structure |
|---|
Score = 108 bits (271), Expect = 4e-25
Identities = 80/393 (20%), Positives = 127/393 (32%), Gaps = 123/393 (31%)
Query: 548 KRRIIPGGDPDKIELDTISSTSNFGVSPEADKDASLVMLFPNNTNEIKDLTIYELLKATD 607
KRR + +I L ++S F D S ++D Y + K
Sbjct: 96 KRRPLNNNS--EIAL-SLSRNKVFVFFDLTVDDQS------VYPKALRD--EYIMSK--- 141
Query: 608 NFSQANIIGCGGFGLVYKAT-LANGTTLAIK-----KLSGDLGL---MEREFKAEVEALS 658
+G G G V A +AI+ K + + E+E L
Sbjct: 142 ------TLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILK 195
Query: 659 TAQHKNLVSLQGYC----VHQGFRLLIYSYMENGSL-DY-----WLHEKADGASQLDWLT 708
H ++ ++ + + ++ ME G L D L E
Sbjct: 196 KLNHPCIIKIKNFFDAEDYY-----IVLELMEGGELFDKVVGNKRLKEAT--CK------ 242
Query: 709 RLKIARGTSCGLAYMHQICEPHIVHRDIKSSNILLDDQFEAH---LADFGLSRLILPYQT 765
+ Y+H+ I+HRD+K N+LL Q E + DFG S+++ T
Sbjct: 243 --LYFYQMLLAVQYLHEN---GIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGE--T 295
Query: 766 HVTTELVGTLGYIPPE---------YGQAWVATLRGDMYSFGVVMLELLTGKRPVDVLKP 816
+ L GT Y+ PE Y +A V D +S GV++ L+G P
Sbjct: 296 SLMRTLCGTPTYLAPEVLVSVGTAGYNRA-V-----DCWSLGVILFICLSGYPPFS---- 345
Query: 817 KMSRELVGWVLKMRSEGKQDQVFDPILRGK-GFDEE---------------MLQVLDVAC 860
Q + D I GK F E +L V
Sbjct: 346 --------------EHRTQVSLKDQITSGKYNFIPEVWAEVSEKALDLVKKLLVV----- 386
Query: 861 MCVSQNPFKRPTVKEVVE--WLNNVGANRRNEN 891
+P R T +E + WL + R+ ++
Sbjct: 387 -----DPKARFTTEEALRHPWLQDEDMKRKFQD 414
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484 | Back alignment and structure |
|---|
Score = 109 bits (273), Expect = 4e-25
Identities = 69/343 (20%), Positives = 120/343 (34%), Gaps = 95/343 (27%)
Query: 585 MLFPNNTNEIKDLTIYELLKATDNFSQANIIGCGGFGLVYKAT-LANGTTLAIK---KLS 640
M ++T D Y+ + ++G G FG V G A+K K
Sbjct: 15 MFVQHSTAIFSD--RYKGQR---------VLGKGSFGEVILCKDKITGQECAVKVISKRQ 63
Query: 641 GDLGLMEREFKAEVEALSTAQHKNLVSLQGYCVHQGFRLLIYSYMENGSLDYWLHEK--- 697
+ EV+ L H N++ L + +G+ L+ G L + +
Sbjct: 64 VKQKTDKESLLREVQLLKQLDHPNIMKLYEFFEDKGYFYLVGEVYTGGELFDEIISRKRF 123
Query: 698 --ADGASQLDWLTRLKIARGTSCGLAYMHQICEPHIVHRDIKSSNILLDDQFE-AHL--A 752
D A +I R G+ YMH+ IVHRD+K N+LL+ + + A++
Sbjct: 124 SEVDAA---------RIIRQVLSGITYMHKN---KIVHRDLKPENLLLESKSKDANIRII 171
Query: 753 DFGLSRLILPYQTHVTTELVGTLGYIPPE-----YGQAWVATLRGDMYSFGVVMLELLTG 807
DFGLS + + +GT YI PE Y + D++S GV++ LL+G
Sbjct: 172 DFGLSTHFEA--SKKMKDKIGTAYYIAPEVLHGTYDEK------CDVWSTGVILYILLSG 223
Query: 808 KRPVDVLKPKMSRELVGWVLKMRSEGKQDQVFDPILRGK-GFDEE--------------- 851
P + + + + +GK F+
Sbjct: 224 CPPFN-------------------GANEYDILKKVEKGKYTFELPQWKKVSESAKDLIRK 264
Query: 852 MLQVLDVACMCVSQNPFKRPTVKEVVE--WLNNVGANRRNENK 892
ML P R + ++ ++ W+ + + +
Sbjct: 265 MLTY----------VPSMRISARDALDHEWIQTYTKEQISVDV 297
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294 | Back alignment and structure |
|---|
Score = 105 bits (264), Expect = 4e-25
Identities = 61/328 (18%), Positives = 111/328 (33%), Gaps = 94/328 (28%)
Query: 588 PNNTNEIKDLTIYELLKATDNFSQANIIGCGGFGLVYKAT-LANGTTLAIKKLS----GD 642
P + + Y + +G GGF ++ + A K +
Sbjct: 5 PEVLVDPRSRRRYVRGR---------FLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLK 55
Query: 643 LGLMEREFKAEVEALSTAQHKNLVSLQGYCVHQGF--RLLIYSYME---NGSL-DYWLHE 696
E+ E+ + H+++V G+ F ++ +E SL +
Sbjct: 56 PHQREK-MSMEISIHRSLAHQHVVGFHGF-----FEDNDFVFVVLELCRRRSLLELHKRR 109
Query: 697 KADGASQLDWLTRL------KIARGTSCGLAYMHQICEPHIVHRDIKSSNILLDDQFEAH 750
K L R G Y+H+ ++HRD+K N+ L++ E
Sbjct: 110 K-----------ALTEPEARYYLRQIVLGCQYLHRN---RVIHRDLKLGNLFLNEDLEVK 155
Query: 751 LADFGLSRLI-LPYQTHVTTELVGTLGYIPPEYGQAWVATLRG-----DMYSFGVVMLEL 804
+ DFGL+ + + L GT YI PE V + +G D++S G +M L
Sbjct: 156 IGDFGLATKVEYDGERKKV--LCGTPNYIAPE-----VLSKKGHSFEVDVWSIGCIMYTL 208
Query: 805 LTGKRP-----VDVLKPKMSR---ELVGWVLKMRSEGKQDQVFDPILRGKGFDEEMLQVL 856
L GK P + ++ + + + + I + MLQ
Sbjct: 209 LVGKPPFETSCLKETYLRIKKNEYSIPKHI----NPVAASL----IQK-------MLQT- 252
Query: 857 DVACMCVSQNPFKRPTVKEVVE--WLNN 882
+P RPT+ E++ + +
Sbjct: 253 ---------DPTARPTINELLNDEFFTS 271
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333 | Back alignment and structure |
|---|
Score = 105 bits (265), Expect = 7e-25
Identities = 70/318 (22%), Positives = 122/318 (38%), Gaps = 66/318 (20%)
Query: 607 DNFSQANIIGCGGFGLVYKATL------ANGTTLAIKKLSGDLGLMER-EFKAEVEALST 659
+N +G G FG V +AT +A+K L E+ +E++ +S
Sbjct: 46 NNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSH 105
Query: 660 -AQHKNLVSLQGYCVHQGFRLLIYSYMENGSLDYWLHEK----------ADGASQLDWLT 708
QH+N+V+L G C H G L+I Y G L +L K A S
Sbjct: 106 LGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRD 165
Query: 709 RLKIARGTSCGLAYMHQICEPHIVHRDIKSSNILLDDQFEAHLADFGLSRLILPYQTHVT 768
L + + G+A++ + +HRD+ + N+LL + A + DFGL+R I
Sbjct: 166 LLHFSSQVAQGMAFLASK---NCIHRDVAARNVLLTNGHVAKIGDFGLARDI--MNDSNY 220
Query: 769 TELVGTLGYIP-----PE---YGQAWVATLRGDMYSFGVVMLELLT-GKRPVDVLKP-KM 818
V +P PE V T++ D++S+G+++ E+ + G P P +
Sbjct: 221 I--VKGNARLPVKWMAPESIFDC---VYTVQSDVWSYGILLWEIFSLGLNPY----PGIL 271
Query: 819 SRELVGWVLKMRSEGKQDQVFDPILRG------KGFDEEMLQVLDVACMCVSQNPFKRPT 872
+ + + G + + ++ C + P RPT
Sbjct: 272 VNS---------------KFYKLVKDGYQMAQPAFAPKNIYSIM---QACWALEPTHRPT 313
Query: 873 VKEVVEWLNNVGANRRNE 890
+++ +L R E
Sbjct: 314 FQQICSFLQEQAQEDRRE 331
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297 | Back alignment and structure |
|---|
Score = 104 bits (262), Expect = 8e-25
Identities = 66/282 (23%), Positives = 115/282 (40%), Gaps = 46/282 (16%)
Query: 606 TDNFSQANIIGCGGFGLVYKAT-LANGTTLAIKKLSGDLGLMEREFKAEVEALSTAQHKN 664
+++ IG G G VY A +A G +AI++++ + E+ + ++ N
Sbjct: 19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPN 78
Query: 665 LVSLQGYCVHQGFRLLIYSYMENGSLDYWLHEKADGASQLDWLTRLKIA---RGTSCGLA 721
+V+ + ++ Y+ GSL + E + +IA R L
Sbjct: 79 IVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETC--------MDEGQIAAVCRECLQALE 130
Query: 722 YMHQICEPHIVHRDIKSSNILLDDQFEAHLADFGLSRLILPYQTHVTTELVGTLGYIPPE 781
++H ++HRDIKS NILL L DFG I P Q+ +T +VGT ++ PE
Sbjct: 131 FLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRST-MVGTPYWMAPE 186
Query: 782 ------YGQAWVATLRGDMYSFGVVMLELLTGKRPVDVLKPKMSRELVGWVLKM-RSEGK 834
YG + D++S G++ +E++ G+ P P + L + + G
Sbjct: 187 VVTRKAYGP------KVDIWSLGIMAIEMIEGEPPYLNENP-LR------ALYLIATNGT 233
Query: 835 QDQVFDPILRGKG-FDEEMLQVLDVACMCVSQNPFKRPTVKE 875
P L+ L+ C+ + KR + KE
Sbjct: 234 ------PELQNPEKLSAIFRDFLNR---CLEMDVEKRGSAKE 266
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343 | Back alignment and structure |
|---|
Score = 105 bits (264), Expect = 1e-24
Identities = 73/318 (22%), Positives = 120/318 (37%), Gaps = 74/318 (23%)
Query: 607 DNFSQANIIGCGGFGLVYKATLANG------TTLAIKKLSGDLGLMER-EFKAEVEALST 659
+N IG G FG V++A T +A+K L + + +F+ E ++
Sbjct: 47 NNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAE 106
Query: 660 AQHKNLVSLQGYCVHQGFRLLIYSYMENGSLDYWL--------------------HEKAD 699
+ N+V L G C L++ YM G L+ +L +
Sbjct: 107 FDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSP 166
Query: 700 GASQLDWLTRLKIARGTSCGLAYMHQICEPHIVHRDIKSSNILLDDQFEAHLADFGLSRL 759
G L +L IAR + G+AY+ + VHRD+ + N L+ + +ADFGLSR
Sbjct: 167 GPPPLSCAEQLCIARQVAAGMAYLSER---KFVHRDLATRNCLVGENMVVKIADFGLSRN 223
Query: 760 ILPYQTHVTTELVGTLGYIP-----PE---YGQAWVATLRGDMYSFGVVMLELLT-GKRP 810
I Y IP PE Y T D++++GVV+ E+ + G +P
Sbjct: 224 I--YSADYYK--ADGNDAIPIRWMPPESIFYN---RYTTESDVWAYGVVLWEIFSYGLQP 276
Query: 811 VDVLKPKMSRELVGWVLKMRSEGKQDQVFDPILRG------KGFDEEMLQVLDVACMCVS 864
M+ E +V + G + E+ ++ +C S
Sbjct: 277 Y----YGMAHE---------------EVIYYVRDGNILACPENCPLELYNLM---RLCWS 314
Query: 865 QNPFKRPTVKEVVEWLNN 882
+ P RP+ + L
Sbjct: 315 KLPADRPSFCSIHRILQR 332
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278 | Back alignment and structure |
|---|
Score = 103 bits (260), Expect = 1e-24
Identities = 72/308 (23%), Positives = 132/308 (42%), Gaps = 61/308 (19%)
Query: 607 DNFSQANIIGCGGFGLVYKAT-LANGTTLAIKKLSGDL---GLMEREFKAEVEALSTAQH 662
++F N++G G F VY+A + G +AIK + M + + EV+ +H
Sbjct: 11 EDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKH 70
Query: 663 KNLVSLQGYCVHQGFRL-LIYSYMENGSLDYWLHEKADGASQLDWLTRLKIARGTSCGLA 721
+++ L Y + L+ NG ++ +L + S + R G+
Sbjct: 71 PSILELYNY-FEDSNYVYLVLEMCHNGEMNRYLKNRVKPFS--ENEAR-HFMHQIITGML 126
Query: 722 YMHQICEPHIVHRDIKSSNILLDDQFEAHLADFGLS-RLILPYQTHVTTELVGTLGYIPP 780
Y+H I+HRD+ SN+LL +ADFGL+ +L +P++ H T L GT YI P
Sbjct: 127 YLHSH---GILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPHEKHYT--LCGTPNYISP 181
Query: 781 EYGQAWVATLRG-----DMYSFGVVMLELLTGKRP-----VDVLKPKMSR---ELVGWVL 827
E +AT D++S G + LL G+ P V K+ E+ ++
Sbjct: 182 E-----IATRSAHGLESDVWSLGCMFYTLLIGRPPFDTDTVKNTLNKVVLADYEMPSFL- 235
Query: 828 KMRSEGKQDQVFDPILRGKGFDEEMLQVLDVACMCVSQNPFKRPTVKEVVE--WLNNVGA 885
S +D I + +L+ NP R ++ V++ +++ +
Sbjct: 236 ---SIEAKDL----IHQ-------LLRR----------NPADRLSLSSVLDHPFMSR-NS 270
Query: 886 NRRNENKG 893
+ +++++G
Sbjct: 271 STKSKDEG 278
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314 | Back alignment and structure |
|---|
Score = 104 bits (261), Expect = 2e-24
Identities = 65/281 (23%), Positives = 114/281 (40%), Gaps = 44/281 (15%)
Query: 606 TDNFSQANIIGCGGFGLVYKAT-LANGTTLAIKKLSGDLGLMEREFKAEVEALSTAQHKN 664
+ F +G G +G VYKA G +AIK++ + +E E+ + +
Sbjct: 28 EEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQV--PVESDLQEIIKEISIMQQCDSPH 85
Query: 665 LVSLQGYCVHQGFRLLIYSYMENGSLDYWLHEKADGASQLDWLTRLKIA---RGTSCGLA 721
+V G ++ Y GS+ + + LT +IA + T GL
Sbjct: 86 VVKYYGSYFKNTDLWIVMEYCGAGSVSDIIRLRNKT------LTEDEIATILQSTLKGLE 139
Query: 722 YMHQICEPHIVHRDIKSSNILLDDQFEAHLADFGLSRLILPYQTHVTTELVGTLGYIPPE 781
Y+H + +HRDIK+ NILL+ + A LADFG++ + T ++GT ++ PE
Sbjct: 140 YLHFM---RKIHRDIKAGNILLNTEGHAKLADFGVAGQLTDTMAKRNT-VIGTPFWMAPE 195
Query: 782 ------YGQAWVATLRGDMYSFGVVMLELLTGKRPVDVLKPKMSRELVGWVLKMRSEGKQ 835
Y D++S G+ +E+ GK P + P M R + + +
Sbjct: 196 VIQEIGYNC------VADIWSLGITAIEMAEGKPPYADIHP-M-RAI----FMIPTNPP- 242
Query: 836 DQVFDPILRGKG-FDEEMLQVLDVACMCVSQNPFKRPTVKE 875
P R + + + C+ ++P +R T +
Sbjct: 243 -----PTFRKPELWSDNFTDFVKQ---CLVKSPEQRATATQ 275
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316 | Back alignment and structure |
|---|
Score = 104 bits (261), Expect = 2e-24
Identities = 64/337 (18%), Positives = 120/337 (35%), Gaps = 77/337 (22%)
Query: 591 TNEIKDLTIYELLKATDNFSQANIIGCGGFGLVYKAT-LANGTTLAIKKLSGDLGLMERE 649
+ +D +Y+L + +++G G V L A+K + G +
Sbjct: 7 SGRFED--VYQLQE--------DVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSR 56
Query: 650 FKAEVEALSTAQ-HKNLVSLQGYCVHQGFRLLIYSYMENGSL-DYWLHEK-----ADGAS 702
EVE L Q H+N++ L + + L++ M GS+ + +H++ + +
Sbjct: 57 VFREVEMLYQCQGHRNVLELIEFFEEEDRFYLVFEKMRGGSILSH-IHKRRHFNELEAS- 114
Query: 703 QLDWLTRLKIARGTSCGLAYMHQICEPHIVHRDIKSSNILLDDQFEAH---LADFGLSRL 759
+ + + L ++H I HRD+K NIL + + + DF L
Sbjct: 115 --------VVVQDVASALDFLH---NKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSG 163
Query: 760 I------LPYQTHVTTELVGTLGYIPPEYGQAWVATLRG-----DMYSFGVVMLELLTGK 808
I P T G+ Y+ PE +A+ D++S GV++ LL+G
Sbjct: 164 IKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGY 223
Query: 809 RPVDVLKPKMSRELVGWVLKMRSEGKQDQVFDPILRGK-GFDEE---------------M 852
P GW Q+ +F+ I GK F ++ +
Sbjct: 224 PPFV----GRCGSDCGWDRGEACPACQNMLFESIQEGKYEFPDKDWAHISCAAKDLISKL 279
Query: 853 LQVLDVACMCVSQNPFKRPTVKEVVE--WLNNVGANR 887
L + +R + +V++ W+
Sbjct: 280 LVR----------DAKQRLSAAQVLQHPWVQGCAPEN 306
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303 | Back alignment and structure |
|---|
Score = 103 bits (259), Expect = 2e-24
Identities = 75/282 (26%), Positives = 118/282 (41%), Gaps = 47/282 (16%)
Query: 606 TDNFSQANIIGCGGFGLVYKAT-LANGTTLAIKKLSGDLGLMERE-FKAEVEALSTAQHK 663
+ F++ IG G FG V+K +AIK + + E E + E+ LS
Sbjct: 21 EELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSP 80
Query: 664 NLVSLQGYCVHQGFRL-LIYSYMENGSLDYWLHEKADGASQLDWLTRLKIA---RGTSCG 719
+ G + +L +I Y+ GS L L +IA R G
Sbjct: 81 YVTKYYG-SYLKDTKLWIIMEYLGGGSALDLLEPGP--------LDETQIATILREILKG 131
Query: 720 LAYMHQICEPHIVHRDIKSSNILLDDQFEAHLADFGLSRLILPYQTHVTTELVGTLGYIP 779
L Y+H +HRDIK++N+LL + E LADFG++ + Q T VGT ++
Sbjct: 132 LDYLHSE---KKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNT-FVGTPFWMA 187
Query: 780 PE------YGQAWVATLRGDMYSFGVVMLELLTGKRPVDVLKPKMSRELVGWVLKMRSEG 833
PE Y + D++S G+ +EL G+ P L P M VL + +
Sbjct: 188 PEVIKQSAYDS------KADIWSLGITAIELARGEPPHSELHP-M------KVLFLIPKN 234
Query: 834 KQDQVFDPILRGKGFDEEMLQVLDVACMCVSQNPFKRPTVKE 875
P L G + + + + ++ C+++ P RPT KE
Sbjct: 235 NP-----PTLEGN-YSKPLKEFVE---ACLNKEPSFRPTAKE 267
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321 | Back alignment and structure |
|---|
Score = 103 bits (260), Expect = 2e-24
Identities = 71/347 (20%), Positives = 112/347 (32%), Gaps = 104/347 (29%)
Query: 588 PNNTNEIKDLTIYELLKATDNFSQANIIGCGGFGLVYKAT-LANGTTLAIK-----KLSG 641
P +++D Y++ + +G G F +V K + G A K +
Sbjct: 4 PFKQQKVEDF--YDIGE---------ELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRA 52
Query: 642 DLGLMERE-FKAEVEALSTAQHKNLVSLQGYCVHQGFRLLIYSYMENGSL------DYWL 694
+ RE + EV L H N+++L ++ +LI + G L L
Sbjct: 53 SRRGVSREEIEREVSILRQVLHHNVITLHDVYENRTDVVLILELVSGGELFDFLAQKESL 112
Query: 695 HEKADGASQLDWLTRLKIARGTSCGLAYMHQICEPHIVHRDIKSSNILLDDQFEAH---- 750
E+ A+ + G+ Y+H I H D+K NI+L D+
Sbjct: 113 SEEE--AT--------SFIKQILDGVNYLHTK---KIAHFDLKPENIMLLDKNIPIPHIK 159
Query: 751 LADFGLSRLILPYQTHVTTELVGTLGYIPPE------YGQAWVATLRGDMYSFGVVMLEL 804
L DFGL+ I + GT ++ PE G DM+S GV+ L
Sbjct: 160 LIDFGLAHEIED--GVEFKNIFGTPEFVAPEIVNYEPLGLE------ADMWSIGVITYIL 211
Query: 805 LTGKRPVDVLKPKMSRELVGWVLKMRSEGKQDQ-VFDPILRGK-GFDEE----------- 851
L+G P G Q I FDEE
Sbjct: 212 LSGASPFL--------------------GDTKQETLANITSVSYDFDEEFFSHTSELAKD 251
Query: 852 ----MLQVLDVACMCVSQNPFKRPTVKEVVE--WLNNVGANRRNENK 892
+L KR T++E + W+ V + +
Sbjct: 252 FIRKLLVK----------ETRKRLTIQEALRHPWITPVDNQQAMVRR 288
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681 | Back alignment and structure |
|---|
Score = 108 bits (271), Expect = 2e-24
Identities = 52/206 (25%), Positives = 77/206 (37%), Gaps = 28/206 (13%)
Query: 615 IGCGGFGLVYKA--TLANGTTLAIKKL--SGDLGLMEREFKAEVEALSTAQHKNLVSLQG 670
I GG G +Y A NG + +K L SGD AE + L+ H ++V +
Sbjct: 88 IAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAM-AMAERQFLAEVVHPSIVQIFN 146
Query: 671 YCVHQGFRLLIYSY--ME--NG-SLDYWLHEKADGASQLDWLTRLKIARGTSCGLAYMHQ 725
+ H Y ME G SL +K L + L+Y+H
Sbjct: 147 FVEHTDRHGDPVGYIVMEYVGGQSLKRSKGQK------LPVAEAIAYLLEILPALSYLHS 200
Query: 726 ICEPHIVHRDIKSSNILLDDQFEAHLADFGLSRLILPYQTHVTTELVGTLGYIPPEYGQA 785
I +V+ D+K NI+L ++ + L D G I L GT G+ PE
Sbjct: 201 I---GLVYNDLKPENIMLTEE-QLKLIDLGAVSRI----NS-FGYLYGTPGFQAPE--IV 249
Query: 786 WV-ATLRGDMYSFGVVMLELLTGKRP 810
T+ D+Y+ G + L
Sbjct: 250 RTGPTVATDIYTVGRTLAALTLDLPT 275
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387 | Back alignment and structure |
|---|
Score = 105 bits (263), Expect = 2e-24
Identities = 71/355 (20%), Positives = 122/355 (34%), Gaps = 71/355 (20%)
Query: 566 SSTSNFGVSPEADKDASLVMLFPNNTNEIKDLTIYELLKA-----TDNFSQANIIGCGGF 620
+ G D + + +I + + ++ D + +G G F
Sbjct: 5 HHHHHHGSKVRGKYDGPKINDYDKFYEDIWKKYVPQPVEVKQGSVYDYYDILEELGSGAF 64
Query: 621 GLVYKAT-LANGTTLAIKKLSGDLGLMEREFKAEVEALSTAQHKNLVSLQGYCVHQGFRL 679
G+V++ A G K ++ L + K E+ ++ H L++L + +
Sbjct: 65 GVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMV 124
Query: 680 LIYSYMENGSL-------DYWLHEKADGASQLDWLTRLKIARGTSCGLAYMHQICEPHIV 732
LI ++ G L DY + E R GL +MH+ IV
Sbjct: 125 LILEFLSGGELFDRIAAEDYKMSEAE--VINY--------MRQACEGLKHMHEH---SIV 171
Query: 733 HRDIKSSNILLDDQFEAHL--ADFGLSRLILPYQTHVTTELVGTLGYIPPE------YGQ 784
H DIK NI+ + + + + DFGL+ + P + T + PE G
Sbjct: 172 HLDIKPENIMCETKKASSVKIIDFGLATKLNP--DEIVKVTTATAEFAAPEIVDREPVGF 229
Query: 785 AWVATLRGDMYSFGVVMLELLTGKRPVDVLKPKMSRELVGWVLKMRSEGKQDQ-VFDPIL 843
DM++ GV+ LL+G P G+ D +
Sbjct: 230 Y------TDMWAIGVLGYVLLSGLSPFA--------------------GEDDLETLQNVK 263
Query: 844 RGK-GFDEEMLQVL-----DVACMCVSQNPFKRPTVKEVVE--WLNNVGANRRNE 890
R FDE+ + D + + P KR TV + +E WL +N +
Sbjct: 264 RCDWEFDEDAFSSVSPEAKDFIKNLLQKEPRKRLTVHDALEHPWLKGDHSNLTSR 318
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486 | Back alignment and structure |
|---|
Score = 106 bits (267), Expect = 2e-24
Identities = 67/319 (21%), Positives = 106/319 (33%), Gaps = 91/319 (28%)
Query: 606 TDNFSQANIIGCGGFGLVYKAT-LANGTTLAIK-----KLSGDLGLMEREFKAEVEALST 659
+ ++ ++G G FG V K A+K EVE L
Sbjct: 21 AERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNK---DTSTILREVELLKK 77
Query: 660 AQHKNLVSLQGYCVHQGFRLLIYSYMENGSLDYWLHEK-----ADGASQLDWLTRLKIAR 714
H N++ L ++ G L + ++ D A +I +
Sbjct: 78 LDHPNIMKLFEILEDSSSFYIVGELYTGGELFDEIIKRKRFSEHDAA---------RIIK 128
Query: 715 GTSCGLAYMHQICEPHIVHRDIKSSNILLDDQFE-AHL--ADFGLSRLILPYQTHVTTEL 771
G+ YMH+ +IVHRD+K NILL+ + + + DFGLS +
Sbjct: 129 QVFSGITYMHKH---NIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQ--NTKMKDR 183
Query: 772 VGTLGYIPPE-----YGQAWVATLRGDMYSFGVVMLELLTGKRPVDVLKPKMSRELVGWV 826
+GT YI PE Y + D++S GV++ LL+G P
Sbjct: 184 IGTAYYIAPEVLRGTYDEK------CDVWSAGVILYILLSGTPPFY-------------- 223
Query: 827 LKMRSEGKQDQ-VFDPILRGK-GFDEE---------------MLQVLDVACMCVSQNPFK 869
GK + + + GK FD ML +P
Sbjct: 224 ------GKNEYDILKRVETGKYAFDLPQWRTISDDAKDLIRKMLTF----------HPSL 267
Query: 870 RPTVKEVVE--WLNNVGAN 886
R T + +E W+ +
Sbjct: 268 RITATQCLEHPWIQKYSSE 286
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365 | Back alignment and structure |
|---|
Score = 104 bits (261), Expect = 2e-24
Identities = 43/245 (17%), Positives = 76/245 (31%), Gaps = 28/245 (11%)
Query: 587 FPNNTNEIKDLTIYELLKATDNFSQANIIGCGGFGLVYKAT------LANGTTLAIKKLS 640
+ IK T ++L + +++G G F VY+AT N +K
Sbjct: 47 WQCKLPAIKPKTEFQL--GSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQK 104
Query: 641 GDLGLMEREFKAEVEALSTAQHKNLVSLQGYCVHQGFRLLIYSYMENGSL-DYWLHEKAD 699
+E L + + + Q +L+ G+L + K
Sbjct: 105 PANPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNT 164
Query: 700 GASQLDWLTRLKIARGTSCGLAYMHQICEPHIVHRDIKSSNILLDDQFEAH--------- 750
+ + A + +H I+H DIK N +L + F
Sbjct: 165 PEKVMPQGLVISFAMRMLYMIEQVHDC---EIIHGDIKPDNFILGNGFLEQDDEDDLSAG 221
Query: 751 --LADFGLSR-LILPYQTHVTTELVGTLGYIPPE--YGQAWVATLRGDMYSFGVVMLELL 805
L D G S + L + + T T G+ E + W + D + + +L
Sbjct: 222 LALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPW--NYQIDYFGVAATVYCML 279
Query: 806 TGKRP 810
G
Sbjct: 280 FGTYM 284
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316 | Back alignment and structure |
|---|
Score = 103 bits (259), Expect = 3e-24
Identities = 69/312 (22%), Positives = 116/312 (37%), Gaps = 67/312 (21%)
Query: 607 DNFSQANIIGCGGFGLVYKATLAN------GTTLAIKKLSGDLGLMER-EFKAEVEALST 659
D +G G FG V +A T+A+K L E +E++ L
Sbjct: 27 DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIH 86
Query: 660 -AQHKNLVSLQGYCVHQGF-RLLIYSYMENGSL------------DYWLHEKADGASQLD 705
H N+V+L G C G ++I + + G+L Y + + L
Sbjct: 87 IGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLT 146
Query: 706 WLTRLKIARGTSCGLAYMHQICEPHIVHRDIKSSNILLDDQFEAHLADFGLSRLILPYQT 765
+ + + G+ ++ +HRD+ + NILL ++ + DFGL+R I Y+
Sbjct: 147 LEHLICYSFQVAKGMEFLASR---KCIHRDLAARNILLSEKNVVKICDFGLARDI--YKD 201
Query: 766 HVTTELVGTLGYIP-----PE---YGQAWVATLRGDMYSFGVVMLELLT-GKRPVDVLKP 816
+P PE V T++ D++SFGV++ E+ + G P P
Sbjct: 202 PDYV--RKGDARLPLKWMAPETIFDR---VYTIQSDVWSFGVLLWEIFSLGASPY----P 252
Query: 817 KMSRELVGWVLKMRSEGKQDQVFDPILRG------KGFDEEMLQVLDVACMCVSQNPFKR 870
+ + ++ + G EM Q + C P +R
Sbjct: 253 GVKID--------------EEFCRRLKEGTRMRAPDYTTPEMYQTM---LDCWHGEPSQR 295
Query: 871 PTVKEVVEWLNN 882
PT E+VE L N
Sbjct: 296 PTFSELVEHLGN 307
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283 | Back alignment and structure |
|---|
Score = 102 bits (257), Expect = 3e-24
Identities = 75/331 (22%), Positives = 118/331 (35%), Gaps = 94/331 (28%)
Query: 606 TDNFSQANIIGCGGFGLVYKAT-LANGTTLAIK-----KLSGDLGLMERE-FKAEVEALS 658
D++ +G G F +V K G A K +LS + RE + EV L
Sbjct: 4 EDHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILR 63
Query: 659 TAQHKNLVSLQGYCVHQGFRLLIYSYMENGSL------DYWLHEKADGASQLDWLTRLKI 712
+H N+++L ++ +LI + G L L E A+Q + +I
Sbjct: 64 EIRHPNIITLHDIFENKTDVVLILELVSGGELFDFLAEKESLTEDE--ATQ---FLK-QI 117
Query: 713 ARGTSCGLAYMHQICEPHIVHRDIKSSNILLDDQFEAH----LADFGLSRLILPYQTHVT 768
G+ Y+H I H D+K NI+L D+ + L DFG++ I +
Sbjct: 118 LD----GVHYLHSK---RIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEA--GNEF 168
Query: 769 TELVGTLGYIPPE------YGQAWVATLRGDMYSFGVVMLELLTGKRPVDVLKPKMSREL 822
+ GT ++ PE G DM+S GV+ LL+G P
Sbjct: 169 KNIFGTPEFVAPEIVNYEPLGLE------ADMWSIGVITYILLSGASPFL---------- 212
Query: 823 VGWVLKMRSEGKQDQ-VFDPILRGK-GFDEE---------------MLQVLDVACMCVSQ 865
G+ Q I FDEE +L
Sbjct: 213 ----------GETKQETLTNISAVNYDFDEEYFSNTSELAKDFIRRLLVK---------- 252
Query: 866 NPFKRPTVKEVVE--WLNNVG-ANRRNENKG 893
+P +R T+ + +E W+ + N R E+ G
Sbjct: 253 DPKRRMTIAQSLEHSWIKAIRRRNVRGEDSG 283
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304 | Back alignment and structure |
|---|
Score = 103 bits (259), Expect = 3e-24
Identities = 65/332 (19%), Positives = 119/332 (35%), Gaps = 94/332 (28%)
Query: 591 TNEIKDLTIYELLKATDNFSQANIIGCGGFGLVYKAT-LANGTTLAIKKLSGDLGLMERE 649
T I+ + ++ ++G G F V+ G A+K + +
Sbjct: 4 TTNIRKT--FIFME---------VLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSS 52
Query: 650 FKAEVEALSTAQHKNLVSLQGYCVHQGFRLLIYSYMENGSLDYWLHEK-----ADGASQL 704
+ E+ L +H+N+V+L+ L+ + G L + E+ D +
Sbjct: 53 LENEIAVLKKIKHENIVTLEDIYESTTHYYLVMQLVSGGELFDRILERGVYTEKDAS--- 109
Query: 705 DWLTRLKIARGTSCGLAYMHQICEPHIVHRDIKSSNILLDDQFE-AHL--ADFGLSRLIL 761
+ + + Y+H+ IVHRD+K N+L E + + DFGLS++
Sbjct: 110 ------LVIQQVLSAVKYLHEN---GIVHRDLKPENLLYLTPEENSKIMITDFGLSKME- 159
Query: 762 PYQTHVTTELVGTLGYIPPE------YGQAWVATLRGDMYSFGVVMLELLTGKRPVDVLK 815
Q + + GT GY+ PE Y +A D +S GV+ LL G P
Sbjct: 160 --QNGIMSTACGTPGYVAPEVLAQKPYSKA------VDCWSIGVITYILLCGYPP----- 206
Query: 816 PKMSRELVGWVLKMRSEGKQDQVFDPILRGK-GFDEE---------------MLQVLDVA 859
E + ++F+ I G F+ +L+
Sbjct: 207 -------------FYEE-TESKLFEKIKEGYYEFESPFWDDISESAKDFICHLLEK---- 248
Query: 860 CMCVSQNPFKRPTVKEVVE--WLNNVGANRRN 889
+P +R T ++ + W++ A R+
Sbjct: 249 ------DPNERYTCEKALSHPWIDGNTALHRD 274
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504 | Back alignment and structure |
|---|
Score = 106 bits (266), Expect = 4e-24
Identities = 73/354 (20%), Positives = 118/354 (33%), Gaps = 107/354 (30%)
Query: 585 MLFPNNTNEIKDLTIYELLKATDNFSQANIIGCGGFGLVYKAT-LANGTTLAIK-----K 638
M +I + Y ++ +G G +G V + AIK +
Sbjct: 25 MYVRKKEGKIGE--SYFKVR---------KLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQ 73
Query: 639 LSGDLGLM--------EREFKAEVEALSTAQHKNLVSLQGYCVHQGFRLLIYSYMENGSL 690
E E+ L + H N++ L + + L+ + E G L
Sbjct: 74 FDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLFDVFEDKKYFYLVTEFYEGGEL 133
Query: 691 DYWLHEK-----ADGASQLDWLTRLKIARGTSCGLAYMHQICEPHIVHRDIKSSNILLDD 745
+ + D A I + G+ Y+H+ +IVHRDIK NILL++
Sbjct: 134 FEQIINRHKFDECDAA---------NIMKQILSGICYLHKH---NIVHRDIKPENILLEN 181
Query: 746 QFE-AHL--ADFGLSRLILPYQTHVTTELVGTLGYIPPE-----YGQAWVATLRGDMYSF 797
+ ++ DFGLS + + +GT YI PE Y + D++S
Sbjct: 182 KNSLLNIKIVDFGLSSFFSK--DYKLRDRLGTAYYIAPEVLKKKYNEK------CDVWSC 233
Query: 798 GVVMLELLTGKRPVDVLKPKMSRELVGWVLKMRSEGKQDQ-VFDPILRGK-GFDEE---- 851
GV+M LL G P G+ DQ + + +GK FD
Sbjct: 234 GVIMYILLCGYPPFG--------------------GQNDQDIIKKVEKGKYYFDFNDWKN 273
Query: 852 -----------MLQVLDVACMCVSQNPFKRPTVKEVVE--WLNNVGANRRNENK 892
ML + KR T +E + W+ N ++
Sbjct: 274 ISDEAKELIKLMLTY----------DYNKRCTAEEALNSRWIKKYANNINKSDQ 317
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327 | Back alignment and structure |
|---|
Score = 103 bits (258), Expect = 5e-24
Identities = 65/283 (22%), Positives = 115/283 (40%), Gaps = 36/283 (12%)
Query: 607 DNFSQANIIGCGGFGLVYKAT-LANGTTLAIKKLSGDLGLMERE-FKAEVE-ALSTAQHK 663
++ IG G +G V K +G +A+K++ + E++ +++ + ++
Sbjct: 22 EDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCP 81
Query: 664 NLVSLQGYCVHQGFRLLIYSYMENGSLDYWLHEKADGASQL---DWLTRLKIARGTSCGL 720
+V G +G + M + S D + + + L KI T L
Sbjct: 82 YIVQFYGALFREGDCWICMELM-STSFDKFYKYVYSVLDDVIPEEILG--KITLATVKAL 138
Query: 721 AYMHQICEPHIVHRDIKSSNILLDDQFEAHLADFGLS-RLILPYQTHVTTELVGTLGYIP 779
++ + I+HRDIK SNILLD L DFG+S +L+ + T G Y+
Sbjct: 139 NHLKE--NLKIIHRDIKPSNILLDRSGNIKLCDFGISGQLV---DSIAKTRDAGCRPYMA 193
Query: 780 PEYGQAWVA----TLRGDMYSFGVVMLELLTGKRPVDVLKPKMSRELVGWVLKMRSEGKQ 835
PE + +R D++S G+ + EL TG+ P V L +G
Sbjct: 194 PERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNS------VFDQLTQVVKGDP 247
Query: 836 DQVFDPILR---GKGFDEEMLQVLDVACMCVSQNPFKRPTVKE 875
P L + F + ++ +C++++ KRP KE
Sbjct: 248 -----PQLSNSEEREFSPSFINFVN---LCLTKDESKRPKYKE 282
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321 | Back alignment and structure |
|---|
Score = 102 bits (256), Expect = 6e-24
Identities = 60/281 (21%), Positives = 108/281 (38%), Gaps = 44/281 (15%)
Query: 606 TDNFSQANIIGCGGFGLVYKAT-LANGTTLAIKKLSGDLGLMEREFKAEVEALSTAQHKN 664
IG G G+V A +G +A+K + EV + QH N
Sbjct: 44 RLLLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHFN 103
Query: 665 LVSLQGYCVHQGFRLLIYSYMENGSLDYWLHEKADGASQLDWLTRLKIA---RGTSCGLA 721
+V + + ++ +++ G+L + + L +IA LA
Sbjct: 104 VVEMYKSYLVGEELWVLMEFLQGGALTDIVSQVR--------LNEEQIATVCEAVLQALA 155
Query: 722 YMHQICEPHIVHRDIKSSNILLDDQFEAHLADFGLSRLILPYQTHVTTELVGTLGYIPPE 781
Y+H ++HRDIKS +ILL L+DFG I + LVGT ++ PE
Sbjct: 156 YLHA---QGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRKS-LVGTPYWMAPE 211
Query: 782 ------YGQAWVATLRGDMYSFGVVMLELLTGKRPVDVLKPKMSRELVGWVLKMRSEGKQ 835
Y D++S G++++E++ G+ P P + + + ++R
Sbjct: 212 VISRSLYAT------EVDIWSLGIMVIEMVDGEPPYFSDSP-V-QAM----KRLRDSPP- 258
Query: 836 DQVFDPILRGKG-FDEEMLQVLDVACMCVSQNPFKRPTVKE 875
P L+ + L+ + ++P +R T +E
Sbjct: 259 -----PKLKNSHKVSPVLRDFLER---MLVRDPQERATAQE 291
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284 | Back alignment and structure |
|---|
Score = 101 bits (254), Expect = 7e-24
Identities = 68/341 (19%), Positives = 115/341 (33%), Gaps = 101/341 (29%)
Query: 591 TNEIKDLTIYELLKATDNFSQANIIGCGGFGLVYKAT-LANGTTLAIK-----KLSGDLG 644
+ + D Y++ + +G G F +V + G A K KLS
Sbjct: 1 STKFSD--NYDVKE---------ELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSAR-- 47
Query: 645 LMEREFKAEVEALSTAQHKNLVSLQGYCVHQGFRLLIYSYMENGSLDYWLHEK-----AD 699
++ + E QH N+V L + F L++ + G L + + AD
Sbjct: 48 -DFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEAD 106
Query: 700 GASQLDWLTRLKIARGTSCGLAYMHQICEPHIVHRDIKSSNILLDDQFEAH---LADFGL 756
+ + +AY H IVHR++K N+LL + + LADFGL
Sbjct: 107 AS---------HCIQQILESIAYCHSN---GIVHRNLKPENLLLASKAKGAAVKLADFGL 154
Query: 757 SRLILPYQTHVTTELVGTLGYIPPE------YGQAWVATLRGDMYSFGVVMLELLTGKRP 810
+ + + GT GY+ PE Y + D+++ GV++ LL G P
Sbjct: 155 AIEVND--SEAWHGFAGTPGYLSPEVLKKDPYSKP------VDIWACGVILYILLVGYPP 206
Query: 811 VDVLKPKMSRELVGWVLKMRSEGKQDQVFDPILRGK-GFDEE---------------MLQ 854
+ Q +++ I G + ML
Sbjct: 207 FW-------------------DEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKSLIDSMLT 247
Query: 855 VLDVACMCVSQNPFKRPTVKEVVE--WLNNVGANRRNENKG 893
V NP KR T + ++ W+ N ++
Sbjct: 248 V----------NPKKRITADQALKVPWICNRERVASAIHRQ 278
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285 | Back alignment and structure |
|---|
Score = 101 bits (254), Expect = 7e-24
Identities = 65/324 (20%), Positives = 103/324 (31%), Gaps = 88/324 (27%)
Query: 591 TNEIKDLTIYELLKATDNFSQANIIGCGGFGLVYKAT-LANGTTLAIK-----KLSGDLG 644
I D ++ + +G G FG V+ ++G IK + +
Sbjct: 17 QGTIDD--LFIFKR---------KLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPME 65
Query: 645 LMEREFKAEVEALSTAQHKNLVSLQGYCVHQGFRLLIYSYMENGSLDYWLHEKADGASQL 704
+E E +E L + H N++ + ++ E G L + L
Sbjct: 66 QIEAE----IEVLKSLDHPNIIKIFEVFEDYHNMYIVMETCEGGELLERIVSAQARGKAL 121
Query: 705 DWLTRLKIARGTSCGLAYMHQICEPHIVHRDIKSSNILLDDQFEAH---LADFGLSRLIL 761
++ + LAY H H+VH+D+K NIL D + DFGL+ L
Sbjct: 122 SEGYVAELMKQMMNALAYFHSQ---HVVHKDLKPENILFQDTSPHSPIKIIDFGLAELFK 178
Query: 762 PYQTHVTTELVGTLGYIPPE-----YGQAWVATLRGDMYSFGVVMLELLTGKRPVDVLKP 816
+T GT Y+ PE D++S GVVM LLTG P
Sbjct: 179 S--DEHSTNAAGTALYMAPEVFKRDVTFK------CDIWSAGVVMYFLLTGCLPFT---- 226
Query: 817 KMSRELVGWVLKMRSEGKQDQ-VFDPILRGK-GFDEE--------------MLQVLDVAC 860
G + V + + E ML
Sbjct: 227 ----------------GTSLEEVQQKATYKEPNYAVECRPLTPQAVDLLKQMLTK----- 265
Query: 861 MCVSQNPFKRPTVKEVVE--WLNN 882
+P +RP+ +V+ W
Sbjct: 266 -----DPERRPSAAQVLHHEWFKQ 284
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348 | Back alignment and structure |
|---|
Score = 102 bits (257), Expect = 8e-24
Identities = 77/310 (24%), Positives = 121/310 (39%), Gaps = 61/310 (19%)
Query: 588 PNNTNEIKDLTIYELLKATD---NFSQANIIGCGGFGLVYKAT-LANGTTLAIKKLSGDL 643
+KD + EL D FS IG G FG VY A + N +AIKK+
Sbjct: 32 GGRAGSLKDPDVAELFFKDDPEKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKM--SY 89
Query: 644 GLMERE-----FKAEVEALSTAQHKNLVSLQGYCVHQGFRLLIYSYMENGSLD-YWLHEK 697
+ EV L +H N + +G + + L+ Y + D +H+K
Sbjct: 90 SGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVMEYCLGSASDLLEVHKK 149
Query: 698 ADGASQLDWLTRLKIA---RGTSCGLAYMHQICEPHIVHRDIKSSNILLDDQFEAHLADF 754
L ++IA G GLAY+H +++HRD+K+ NILL + L DF
Sbjct: 150 P--------LQEVEIAAVTHGALQGLAYLHSH---NMIHRDVKAGNILLSEPGLVKLGDF 198
Query: 755 GLSRLILPYQTHVTTELVGTLGYIPPE---------YGQAWVATLRGDMYSFGVVMLELL 805
G + ++ P + VGT ++ PE Y + D++S G+ +EL
Sbjct: 199 GSASIMAPANS-----FVGTPYWMAPEVILAMDEGQYDG------KVDVWSLGITCIELA 247
Query: 806 TGKRPVDVLKPKMSRELVGWVLKMRSEGKQDQVFDPILRGKGFDEEMLQVLDVACMCVSQ 865
K P+ + M L + P L+ + E +D C+ +
Sbjct: 248 ERKPPLFNMNA-M-SAL----YHIAQNES------PALQSGHWSEYFRNFVDS---CLQK 292
Query: 866 NPFKRPTVKE 875
P RPT +
Sbjct: 293 IPQDRPTSEV 302
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389 | Back alignment and structure |
|---|
Score = 103 bits (259), Expect = 8e-24
Identities = 51/311 (16%), Positives = 93/311 (29%), Gaps = 67/311 (21%)
Query: 616 GCGGFGLVYKAT-LANGTTLAIKKLSGDLGLMEREF----KAEVEALSTAQHKNLVSLQG 670
G V A G + ++++ +L E + E+ H N+V +
Sbjct: 36 GFEDLMTVNLARYKPTGEYVTVRRI--NLEACSNEMVTFLQGELHVSKLFNHPNIVPYRA 93
Query: 671 YCVHQGFRLLIYSYMENGSLDYWLHEKADGASQLDWLTRLKIA---RGTSCGLAYMHQIC 727
+ ++ S+M GS + + L IA +G L Y+H +
Sbjct: 94 TFIADNELWVVTSFMAYGSAKDLICTHFMDG-----MNELAIAYILQGVLKALDYIHHM- 147
Query: 728 EPHIVHRDIKSSNILLDDQFEAHLADFGLSRLILPYQTHVTT------ELVGTLGYIPPE 781
VHR +K+S+IL+ + +L+ + ++ + V L ++ PE
Sbjct: 148 --GYVHRSVKASHILISVDGKVYLSGLRSNLSMISHGQRQRVVHDFPKYSVKVLPWLSPE 205
Query: 782 --------YGQAWVATLRGDMYSFGVVMLELLTGKRP--------VDVLKPKMSR-ELVG 824
Y + D+YS G+ EL G P + + K + L+
Sbjct: 206 VLQQNLQGYDA------KSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTVPCLLD 259
Query: 825 WVLKMRSEGKQDQVFDPILRGKGFDEEMLQVLDVAC--------------------MCVS 864
E G C+
Sbjct: 260 TSTIPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHFHHFVEQCLQ 319
Query: 865 QNPFKRPTVKE 875
+NP RP+
Sbjct: 320 RNPDARPSAST 330
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321 | Back alignment and structure |
|---|
Score = 102 bits (256), Expect = 8e-24
Identities = 56/309 (18%), Positives = 110/309 (35%), Gaps = 73/309 (23%)
Query: 606 TDNFSQANIIGCGGFGLVYKAT-LANGTTLA---IKKLSGDLGLMEREFKAEVEALSTAQ 661
+ + A +G G FG+V++ ++ T +K D L+++E + L+ A+
Sbjct: 4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQVLVKKE----ISILNIAR 59
Query: 662 HKNLVSLQGYCVHQGFRLLIYSYMENGSL-------DYWLHEKADGASQLDWLTRLKIAR 714
H+N++ L ++I+ ++ + + L+E+
Sbjct: 60 HRNILHLHESFESMEELVMIFEFISGLDIFERINTSAFELNERE--IV--------SYVH 109
Query: 715 GTSCGLAYMHQICEPHIVHRDIKSSNILLDDQFEAHL--ADFGLSRLILPYQTHVTTELV 772
L ++H +I H DI+ NI+ + + + +FG +R + P L
Sbjct: 110 QVCEALQFLHSH---NIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGD--NFRLLF 164
Query: 773 GTLGYIPPE------YGQAWVATLRGDMYSFGVVMLELLTGKRPVDVLKPKMSRELVGWV 826
Y PE A DM+S G ++ LL+G P
Sbjct: 165 TAPEYYAPEVHQHDVVSTA------TDMWSLGTLVYVLLSGINPFL-------------- 204
Query: 827 LKMRSEGKQDQ-VFDPILRGK-GFDEEMLQVL-----DVACMCVSQNPFKRPTVKEVVE- 878
+ +Q + + I+ + FDEE + + D + + R T E ++
Sbjct: 205 ------AETNQQIIENIMNAEYTFDEEAFKEISIEAMDFVDRLLVKERKSRMTASEALQH 258
Query: 879 -WLNNVGAN 886
WL
Sbjct: 259 PWLKQKIER 267
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349 | Back alignment and structure |
|---|
Score = 102 bits (256), Expect = 1e-23
Identities = 72/359 (20%), Positives = 121/359 (33%), Gaps = 94/359 (26%)
Query: 566 SSTSNFGVSPEADKDASLVMLFPNNTNEIKDLTIYELLKATDNFSQANIIGCGGFGLVYK 625
S+ +P + +N + + D +E+ +G G +VY+
Sbjct: 23 MSSVTASAAPGTASLVPDYWIDGSNRDALSDF--FEVES---------ELGRGATSIVYR 71
Query: 626 AT-LANGTTLAIKKLSGDLGLMEREFKAEVEALSTAQHKNLVSLQGYCVHQGFRLLIYSY 684
A+K L + ++ + E+ L H N++ L+ L+
Sbjct: 72 CKQKGTQKPYALKVLKKTVD--KKIVRTEIGVLLRLSHPNIIKLKEIFETPTEISLVLEL 129
Query: 685 MENGSLDYWLHEK-----ADGASQLDWLTRLKIARGTSCGLAYMHQICEPHIVHRDIKSS 739
+ G L + EK D A + +AY+H+ IVHRD+K
Sbjct: 130 VTGGELFDRIVEKGYYSERDAA---------DAVKQILEAVAYLHEN---GIVHRDLKPE 177
Query: 740 NILLDDQFE-AHL--ADFGLSRLILPYQTHVTTELVGTLGYIPPE------YGQAWVATL 790
N+L A L ADFGLS+++ + + GT GY PE YG V
Sbjct: 178 NLLYATPAPDAPLKIADFGLSKIVEH--QVLMKTVCGTPGYCAPEILRGCAYGPE-V--- 231
Query: 791 RGDMYSFGVVMLELLTGKRPVDVLKPKMSRELVGWVLKMRSEGKQDQVFDPILRGK-GFD 849
DM+S G++ LL G P E +F IL + F
Sbjct: 232 --DMWSVGIITYILLCGFEP------------------FYDERGDQFMFRRILNCEYYFI 271
Query: 850 EE---------------MLQVLDVACMCVSQNPFKRPTVKEVVE--WLNNVGANRRNEN 891
++ + +P KR T + ++ W+ AN + +
Sbjct: 272 SPWWDEVSLNAKDLVRKLIVL----------DPKKRLTTFQALQHPWVTGKAANFVHMD 320
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361 | Back alignment and structure |
|---|
Score = 102 bits (256), Expect = 1e-23
Identities = 69/329 (20%), Positives = 105/329 (31%), Gaps = 93/329 (28%)
Query: 606 TDNFSQANIIGCGGFGLVYKAT-LANGTTLAIK-----KLSGDLGLMERE-FKAEVEALS 658
D + +G G F +V K + G A K + + RE + EV L
Sbjct: 11 EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILR 70
Query: 659 TAQHKNLVSLQGYCVHQGFRLLIYSYMENGSL------DYWLHEKADGASQLDWLTRLKI 712
H N+++L ++ +LI + G L L E+ A+
Sbjct: 71 QVLHPNIITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEE--AT--------SF 120
Query: 713 ARGTSCGLAYMHQICEPHIVHRDIKSSNILLDDQFEAH----LADFGLSRLILPYQTHVT 768
+ G+ Y+H I H D+K NI+L D+ L DFGL+ I
Sbjct: 121 IKQILDGVNYLHTK---KIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIED--GVEF 175
Query: 769 TELVGTLGYIPPE------YGQAWVATLRGDMYSFGVVMLELLTGKRPVDVLKPKMSREL 822
+ GT ++ PE G DM+S GV+ LL+G P
Sbjct: 176 KNIFGTPEFVAPEIVNYEPLGLE------ADMWSIGVITYILLSGASPFL---------- 219
Query: 823 VGWVLKMRSEGKQDQ-VFDPILRGK-GFDEE---------------MLQVLDVACMCVSQ 865
G Q I FDEE +L
Sbjct: 220 ----------GDTKQETLANITAVSYDFDEEFFSQTSELAKDFIRKLLVK---------- 259
Query: 866 NPFKRPTVKEVVE--WLNNVGANRRNENK 892
KR T++E + W+ V + +
Sbjct: 260 ETRKRLTIQEALRHPWITPVDTQQAMVRR 288
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302 | Back alignment and structure |
|---|
Score = 101 bits (253), Expect = 1e-23
Identities = 55/220 (25%), Positives = 93/220 (42%), Gaps = 31/220 (14%)
Query: 606 TDNFSQANIIGCGGFGLVYKAT-LANGTTLAIKKLSGDLGLMEREFKAEVEALSTAQHKN 664
+ + +G G FG VYKA G A K + ++ E+E L+T H
Sbjct: 18 NEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPY 77
Query: 665 LVSLQGYCVHQGFRLLIYSYMENGSLDYWLHEKADGASQLDWLTRLKIA---RGTSCGLA 721
+V L G H G ++ + G++D + E G LT +I R L
Sbjct: 78 IVKLLGAYYHDGKLWIMIEFCPGGAVDAIMLELDRG------LTEPQIQVVCRQMLEALN 131
Query: 722 YMHQICEPHIVHRDIKSSNILLDDQFEAHLADFGLSRLILPYQTHVTTELVGTLGYIPPE 781
++H I+HRD+K+ N+L+ + + LADFG+S L + +GT ++ PE
Sbjct: 132 FLHSK---RIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTLQKRDS-FIGTPYWMAPE 187
Query: 782 -----------YGQAWVATLRGDMYSFGVVMLELLTGKRP 810
Y + D++S G+ ++E+ + P
Sbjct: 188 VVMCETMKDTPYDY------KADIWSLGITLIEMAQIEPP 221
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322 | Back alignment and structure |
|---|
Score = 101 bits (254), Expect = 1e-23
Identities = 70/335 (20%), Positives = 111/335 (33%), Gaps = 103/335 (30%)
Query: 606 TDNFSQANIIGCGGFGLVYKAT-LANGTTLAIK-----KLSGDLGL---MEREFKAEVEA 656
D + + +G G G V A +AIK K + + E+E
Sbjct: 9 RDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEI 68
Query: 657 LSTAQHKNLVSLQGY----CVHQGFRLLIYSYMENGSL-DY-----WLHEKADGASQLDW 706
L H ++ ++ + + ++ ME G L D L E
Sbjct: 69 LKKLNHPCIIKIKNFFDAEDYY-----IVLELMEGGELFDKVVGNKRLKEAT--CK---- 117
Query: 707 LTRLKIARGTSCGLAYMHQICEPHIVHRDIKSSNILLDDQFEAH---LADFGLSRLILPY 763
+ Y+H+ I+HRD+K N+LL Q E + DFG S+++
Sbjct: 118 ----LYFYQMLLAVQYLHEN---GIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGE- 169
Query: 764 QTHVTTELVGTLGYIPPE---------YGQAWVATLRGDMYSFGVVMLELLTGKRPVDVL 814
T + L GT Y+ PE Y +A V D +S GV++ L+G P
Sbjct: 170 -TSLMRTLCGTPTYLAPEVLVSVGTAGYNRA-V-----DCWSLGVILFICLSGYPPFS-- 220
Query: 815 KPKMSRELVGWVLKMRSEGKQDQVFDPILRGK-GFDEE---------------MLQVLDV 858
Q + D I GK F E +L V
Sbjct: 221 ----------------EHRTQVSLKDQITSGKYNFIPEVWAEVSEKALDLVKKLLVV--- 261
Query: 859 ACMCVSQNPFKRPTVKEVVE--WLNNVGANRRNEN 891
+P R T +E + WL + R+ ++
Sbjct: 262 -------DPKARFTTEEALRHPWLQDEDMKRKFQD 289
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287 | Back alignment and structure |
|---|
Score = 100 bits (252), Expect = 2e-23
Identities = 66/333 (19%), Positives = 105/333 (31%), Gaps = 100/333 (30%)
Query: 591 TNEIKDLTIYELLKATDNFSQANIIGCGGFGLVYKAT-LANGTTLAIK-----KLSGDLG 644
+ Y ++ ++G G FG V K A+K
Sbjct: 17 QGTFAE--RYNIVC---------MLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNK-- 63
Query: 645 LMEREFKAEVEALSTAQHKNLVSLQGYCVHQGFRLLIYSYMENGSLDYWLHEK-----AD 699
EVE L H N++ L ++ G L + ++ D
Sbjct: 64 -DTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIVGELYTGGELFDEIIKRKRFSEHD 122
Query: 700 GASQLDWLTRLKIARGTSCGLAYMHQICEPHIVHRDIKSSNILLDDQFEAH---LADFGL 756
A +I + G+ YMH+ +IVHRD+K NILL+ + + + DFGL
Sbjct: 123 AA---------RIIKQVFSGITYMHKH---NIVHRDLKPENILLESKEKDCDIKIIDFGL 170
Query: 757 SRLILPYQTHVTTELVGTLGYIPPE-----YGQAWVATLRGDMYSFGVVMLELLTGKRPV 811
S + +GT YI PE Y + D++S GV++ LL+G P
Sbjct: 171 STCFQQ--NTKMKDRIGTAYYIAPEVLRGTYDEK------CDVWSAGVILYILLSGTPPF 222
Query: 812 DVLKPKMSRELVGWVLKMRSEGKQDQVFDPILRGK-GFDEE---------------MLQV 855
+ + + GK FD ML
Sbjct: 223 Y-------------------GKNEYDILKRVETGKYAFDLPQWRTISDDAKDLIRKMLTF 263
Query: 856 LDVACMCVSQNPFKRPTVKEVVE--WLNNVGAN 886
+P R T + +E W+ +
Sbjct: 264 ----------HPSLRITATQCLEHPWIQKYSSE 286
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362 | Back alignment and structure |
|---|
Score = 102 bits (256), Expect = 2e-23
Identities = 72/357 (20%), Positives = 117/357 (32%), Gaps = 103/357 (28%)
Query: 569 SNFGVSPEADKDASLVMLFPNNTNEIKDLTIYELLKATDNFSQANIIGCGGFGLVYKAT- 627
+ + N + + D Y++ + +G G F +V +
Sbjct: 2 PHMASMTGGQQMGRGSEFMMNASTKFSD--NYDVKE---------ELGKGAFSVVRRCVH 50
Query: 628 LANGTTLAIK-----KLSG-DLGLMEREFKAEVEALSTAQHKNLVSLQGYCVHQGFRLLI 681
G A K KLS D +ERE QH N+V L + F L+
Sbjct: 51 KTTGLEFAAKIINTKKLSARDFQKLERE----ARICRKLQHPNIVRLHDSIQEESFHYLV 106
Query: 682 YSYMENGSLDYWLHEK-----ADGASQLDWLTRLKIARGTSCGLAYMHQICEPHIVHRDI 736
+ + G L + + AD + + +AY H IVHR++
Sbjct: 107 FDLVTGGELFEDIVAREFYSEADAS---------HCIQQILESIAYCHSN---GIVHRNL 154
Query: 737 KSSNILLDDQFEAH---LADFGLSRLILPYQTHVTTELVGTLGYIPPE------YGQAWV 787
K N+LL + + LADFGL+ + + GT GY+ PE Y +
Sbjct: 155 KPENLLLASKAKGAAVKLADFGLAIEVND--SEAWHGFAGTPGYLSPEVLKKDPYSKP-- 210
Query: 788 ATLRGDMYSFGVVMLELLTGKRPVDVLKPKMSRELVGWVLKMRSEGKQDQVFDPILRGK- 846
D+++ GV++ LL G P + Q +++ I G
Sbjct: 211 ----VDIWACGVILYILLVGYPPFW-------------------DEDQHRLYAQIKAGAY 247
Query: 847 GFDEE---------------MLQVLDVACMCVSQNPFKRPTVKEVVE--WLNNVGAN 886
+ ML V NP KR T + ++ W+ N
Sbjct: 248 DYPSPEWDTVTPEAKSLIDSMLTV----------NPKKRITADQALKVPWICNRERV 294
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365 | Back alignment and structure |
|---|
Score = 102 bits (256), Expect = 2e-23
Identities = 74/353 (20%), Positives = 115/353 (32%), Gaps = 107/353 (30%)
Query: 574 SPEADKDASLVMLFPNNTNEIKDLTIYELLKATDNFSQANIIGCGGFGLVYKAT-LANGT 632
+ E Y+ +IG G +V + A G
Sbjct: 72 LYFQSMGPEDELPDWAAAKEFYQ--KYDPKD---------VIGRGVSSVVRRCVHRATGH 120
Query: 633 TLAIK-----KLSG---DLGLMEREFKAEVEALST-AQHKNLVSLQGYCVHQGFRLLIYS 683
A+K L + + E L A H ++++L F L++
Sbjct: 121 EFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDSYESSSFMFLVFD 180
Query: 684 YMENGSL-DY-----WLHEKADGASQLDWLTRLKIARGTSCGLAYMHQICEPHIVHRDIK 737
M G L DY L EK I R ++++H +IVHRD+K
Sbjct: 181 LMRKGELFDYLTEKVALSEKE--TR--------SIMRSLLEAVSFLHAN---NIVHRDLK 227
Query: 738 SSNILLDDQFEAHLADFGLSRLILPYQTHVTTELVGTLGYIPPE------------YGQA 785
NILLDD + L+DFG S + P EL GT GY+ PE YG+
Sbjct: 228 PENILLDDNMQIRLSDFGFSCHLEP--GEKLRELCGTPGYLAPEILKCSMDETHPGYGKE 285
Query: 786 WVATLRGDMYSFGVVMLELLTGKRPVDVLKPKMSRELVGWVLKMRSEGKQDQVFDPILRG 845
D+++ GV++ LL G P +Q + I+ G
Sbjct: 286 ------VDLWACGVILFTLLAGSPPFW-------------------HRRQILMLRMIMEG 320
Query: 846 K-GFDEE---------------MLQVLDVACMCVSQNPFKRPTVKEVVE--WL 880
+ F +LQV +P R T ++ ++ +
Sbjct: 321 QYQFSSPEWDDRSSTVKDLISRLLQV----------DPEARLTAEQALQHPFF 363
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 100 bits (252), Expect = 3e-23
Identities = 66/341 (19%), Positives = 112/341 (32%), Gaps = 104/341 (30%)
Query: 588 PNNTNEIKDLTIYELLKATDNFSQANIIGCGGFGLVYKAT-LANGTTLAIK-----KLSG 641
+ D Y+ + +G G F +V K + G A K +
Sbjct: 3 VFRQENVDDY--YDTGE---------ELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKS 51
Query: 642 DLGLMERE-FKAEVEALSTAQHKNLVSLQGYCVHQGFRLLIYSYMENGSL------DYWL 694
+ RE + EV L QH N+++L ++ +LI + G L L
Sbjct: 52 SRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESL 111
Query: 695 HEKADGASQLDWLTRLKIARGTSCGLAYMHQICEPHIVHRDIKSSNILLDDQFEAH---- 750
E+ A+ + + G+ Y+H + I H D+K NI+L D+
Sbjct: 112 TEEE--AT--------EFLKQILNGVYYLHSL---QIAHFDLKPENIMLLDRNVPKPRIK 158
Query: 751 LADFGLSRLILPYQTHVTTELVGTLGYIPPE------YGQAWVATLRGDMYSFGVVMLEL 804
+ DFGL+ I + + GT ++ PE G DM+S GV+ L
Sbjct: 159 IIDFGLAHKIDF--GNEFKNIFGTPEFVAPEIVNYEPLGLE------ADMWSIGVITYIL 210
Query: 805 LTGKRPVDVLKPKMSRELVGWVLKMRSEGKQDQ-VFDPILRGK-GFDEE----------- 851
L+G P G Q + F++E
Sbjct: 211 LSGASPFL--------------------GDTKQETLANVSAVNYEFEDEYFSNTSALAKD 250
Query: 852 ----MLQVLDVACMCVSQNPFKRPTVKEVVE--WLNNVGAN 886
+L +P KR T+++ ++ W+
Sbjct: 251 FIRRLLVK----------DPKKRMTIQDSLQHPWIKPKDTQ 281
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573 | Back alignment and structure |
|---|
Score = 104 bits (260), Expect = 3e-23
Identities = 69/381 (18%), Positives = 119/381 (31%), Gaps = 88/381 (23%)
Query: 547 SKRRIIPGGDPDKIELDTISSTSNFGVSPEADKDASLVMLFPNNTNEIKDLTIYELLKAT 606
+ +IPG + + + +F +
Sbjct: 97 TAPVLIPGDERKRRRGYDVDEQGKIVRGKGTVSSNYDNYVFDIWKQYYPQPVEIKHDHVL 156
Query: 607 DNFSQANIIGCGGFGLVYKAT-LANGTTLAIKKLSGDLGLMEREFKAEVEALSTAQHKNL 665
D++ +G G FG+V++ T A G A K + + + E++ +S +H L
Sbjct: 157 DHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTL 216
Query: 666 VSLQGYCVHQGFRLLIYSYMENGSL-DYWLHEKADGASQLDWLTRLKIARGTSCGLAYMH 724
V+L ++IY +M G L + E + ++ + YM
Sbjct: 217 VNLHDAFEDDNEMVMIYEFMSGGELFEKVADEH-------NKMSEDEAVE-------YMR 262
Query: 725 QICEP-------HIVHRDIKSSNILLDDQFEAHL--ADFGLSRLILPYQTHVTTELVGTL 775
Q+C+ + VH D+K NI+ + L DFGL+ + P GT
Sbjct: 263 QVCKGLCHMHENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDP--KQSVKVTTGTA 320
Query: 776 GYIPPE------YGQAWVATLRGDMYSFGVVMLELLTGKRPVDVLKPKMSRELVGWVLKM 829
+ PE G DM+S GV+ LL+G P
Sbjct: 321 EFAAPEVAEGKPVGYY------TDMWSVGVLSYILLSGLSPFG----------------- 357
Query: 830 RSEGKQDQ-VFDPILRGK-GFDEE---------------MLQVLDVACMCVSQNPFKRPT 872
G+ D + D+ +L +P R T
Sbjct: 358 ---GENDDETLRNVKSCDWNMDDSAFSGISEDGKDFIRKLLLA----------DPNTRMT 404
Query: 873 VKEVVE--WLNNVGANRRNEN 891
+ + +E WL A R+
Sbjct: 405 IHQALEHPWLTPGNAPGRDSQ 425
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284 | Back alignment and structure |
|---|
Score = 99.2 bits (248), Expect = 5e-23
Identities = 55/223 (24%), Positives = 93/223 (41%), Gaps = 39/223 (17%)
Query: 600 YELLKATDNFSQANIIGCGGFGLVYKA-TLANGTTLAIKKLS----GDLGLMEREFKAEV 654
+++ + +G G FG VY A N +A+K L G+ + + E+
Sbjct: 16 FDIGR---------PLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQ-LRREI 65
Query: 655 EALSTAQHKNLVSLQGYCVHQGFRL-LIYSYMENGSLDYWLHEKADGASQLDWLTRLKIA 713
E S +H N++ + Y H R+ L+ + G L Y +K + + +
Sbjct: 66 EIQSHLRHPNILRMYNY-FHDRKRIYLMLEFAPRGEL-YKELQKHGRFD--EQRSATFME 121
Query: 714 RGTSCGLAYMHQICEPHIVHRDIKSSNILLDDQFEAHLADFGLSRLILPYQTHVTTELVG 773
+ L Y H+ ++HRDIK N+L+ + E +ADFG S + + G
Sbjct: 122 E-LADALHYCHER---KVIHRDIKPENLLMGYKGELKIADFGWSVHA---PSLRRRTMCG 174
Query: 774 TLGYIPPE------YGQAWVATLRGDMYSFGVVMLELLTGKRP 810
TL Y+PPE + + D++ GV+ E L G P
Sbjct: 175 TLDYLPPEMIEGKTHDEK------VDLWCAGVLCYEFLVGMPP 211
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318 | Back alignment and structure |
|---|
Score = 99.7 bits (249), Expect = 7e-23
Identities = 59/281 (20%), Positives = 108/281 (38%), Gaps = 37/281 (13%)
Query: 607 DNFSQANIIGCGGFGLVYKAT-LANGTTLAIKKLSGDLGLMEREFKA---EVEAL-STAQ 661
++ +G G G V+K G +A+K++ + E K +++ + +
Sbjct: 25 NDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQM--RRSGNKEENKRILMDLDVVLKSHD 82
Query: 662 HKNLVSLQGYCVHQGFRLLIYSYMENGSLDYWLHEKADGASQLDWLTRLKIARGTSCGLA 721
+V G + + M + + L K+ L
Sbjct: 83 CPYIVQCFGTFITNTDVFIAMELM-GTCAEKLKKRMQGPIPE-RILG--KMTVAIVKALY 138
Query: 722 YMHQICEPHIVHRDIKSSNILLDDQFEAHLADFGLS-RLILPYQTHVTTELVGTLGYIPP 780
Y+ + + ++HRD+K SNILLD++ + L DFG+S RL+ G Y+ P
Sbjct: 139 YLKE--KHGVIHRDVKPSNILLDERGQIKLCDFGISGRLV---DDKAKDRSAGCAAYMAP 193
Query: 781 EYGQAWVA-----TLRGDMYSFGVVMLELLTGKRPVDVLKPKMSRELVGWVLKMRSEGKQ 835
E +R D++S G+ ++EL TG+ P K VL + +
Sbjct: 194 ERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKTDFE------VLTKVLQEEP 247
Query: 836 DQVFDPILRGK-GFDEEMLQVLDVACMCVSQNPFKRPTVKE 875
P+L G GF + + C++++ KRP +
Sbjct: 248 -----PLLPGHMGFSGDFQSFVK---DCLTKDHRKRPKYNK 280
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344 | Back alignment and structure |
|---|
Score = 100 bits (250), Expect = 8e-23
Identities = 65/312 (20%), Positives = 116/312 (37%), Gaps = 73/312 (23%)
Query: 613 NIIGCGGFGLVYKATLANG------TTLAIKKLSGDLGLMER-EFKAEVEALST-AQHKN 664
++G G FG V AT +A+K L ER +E++ ++ H+N
Sbjct: 51 KVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHEN 110
Query: 665 LVSLQGYCVHQGFRLLIYSYMENGSLDYWL-------------------HEKADGASQLD 705
+V+L G C G LI+ Y G L +L E+ + + L
Sbjct: 111 IVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLT 170
Query: 706 WLTRLKIARGTSCGLAYMHQICEPHIVHRDIKSSNILLDDQFEAHLADFGLSRLILPYQT 765
+ L A + G+ ++ VHRD+ + N+L+ + DFGL+R I
Sbjct: 171 FEDLLCFAYQVAKGMEFLEFK---SCVHRDLAARNVLVTHGKVVKICDFGLARDI--MSD 225
Query: 766 HVTTELVGTLGYIP-----PE---YGQAWVATLRGDMYSFGVVMLELLT-GKRPVDVLKP 816
V +P PE G + T++ D++S+G+++ E+ + G P P
Sbjct: 226 SNYV--VRGNARLPVKWMAPESLFEG---IYTIKSDVWSYGILLWEIFSLGVNPY----P 276
Query: 817 KMSRELVGWVLKMRSEGKQDQVFDPILRG------KGFDEEMLQVLDVACMCVSQNPFKR 870
+ + + I G EE+ ++ C + + KR
Sbjct: 277 GIPVD--------------ANFYKLIQNGFKMDQPFYATEEIYIIM---QSCWAFDSRKR 319
Query: 871 PTVKEVVEWLNN 882
P+ + +L
Sbjct: 320 PSFPNLTSFLGC 331
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342 | Back alignment and structure |
|---|
Score = 100 bits (250), Expect = 8e-23
Identities = 60/331 (18%), Positives = 113/331 (34%), Gaps = 95/331 (28%)
Query: 590 NTNEIKDLTIYELLKATDNFSQANIIGCGGFGLVYKAT-LANGTTLAIKKLSGDLGLMER 648
N+ + D YE+ + IG G + + + A A+K + +R
Sbjct: 16 NSIQFTD--GYEVKE---------DIGVGSYSVCKRCIHKATNMEFAVKIIDKS----KR 60
Query: 649 EFKAEVEALST-AQHKNLVSLQGYCVHQGFRLLIYSYMENGSLDYWLHEK-----ADGAS 702
+ E+E L QH N+++L+ + ++ M+ G L + + + +
Sbjct: 61 DPTEEIEILLRYGQHPNIITLKDVYDDGKYVYVVTELMKGGELLDKILRQKFFSEREAS- 119
Query: 703 QLDWLTRLKIARGTSCGLAYMHQICEPHIVHRDIKSSNILLDDQFEAH----LADFGLSR 758
+ + + Y+H +VHRD+K SNIL D+ + DFG ++
Sbjct: 120 --------AVLFTITKTVEYLHAQ---GVVHRDLKPSNILYVDESGNPESIRICDFGFAK 168
Query: 759 LILPYQTHVTTELVGTLGYIPPE------YGQAWVATLRGDMYSFGVVMLELLTGKRPVD 812
+ + + T ++ PE Y A D++S GV++ +LTG P
Sbjct: 169 QLRA-ENGLLMTPCYTANFVAPEVLERQGYDAA-C-----DIWSLGVLLYTMLTGYTPFA 221
Query: 813 VLKPKMSRELVGWVLKMRSEGKQDQVFDPILRGK-GFDEE---------------MLQVL 856
+ +++ I GK ML V
Sbjct: 222 ----------------NGPDDTPEEILARIGSGKFSLSGGYWNSVSDTAKDLVSKMLHV- 264
Query: 857 DVACMCVSQNPFKRPTVKEVVE--WLNNVGA 885
+P +R T V+ W+ +
Sbjct: 265 ---------DPHQRLTAALVLRHPWIVHWDQ 286
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373 | Back alignment and structure |
|---|
Score = 100 bits (251), Expect = 8e-23
Identities = 69/307 (22%), Positives = 115/307 (37%), Gaps = 68/307 (22%)
Query: 608 NFSQANIIGCGGFGLVYKAT-LANGTTLAIKKLSGDLGLMERE-FKAEVEALSTAQHKNL 665
S+ I+G G FG V+K A G LA K + G+ ++E K E+ ++ H NL
Sbjct: 90 TVSKTEILGGGRFGQVHKCEETATGLKLAAKIIKTR-GMKDKEEVKNEISVMNQLDHANL 148
Query: 666 VSLQGYCVHQGFRLLIYSYMENGSL-------DYWLHEKADGASQLDWLTRLKIARGTSC 718
+ L + +L+ Y++ G L Y L E +
Sbjct: 149 IQLYDAFESKNDIVLVMEYVDGGELFDRIIDESYNLTELD--TI--------LFMKQICE 198
Query: 719 GLAYMHQICEPHIVHRDIKSSNILLDDQFEAHL--ADFGLSRLILPYQTHVTTELVGTLG 776
G+ +MHQ+ +I+H D+K NIL ++ + DFGL+R P GT
Sbjct: 199 GIRHMHQM---YILHLDLKPENILCVNRDAKQIKIIDFGLARRYKP--REKLKVNFGTPE 253
Query: 777 YIPPE------YGQAWVATLRGDMYSFGVVMLELLTGKRPVDVLKPKMSRELVGWVLKMR 830
++ PE DM+S GV+ LL+G P
Sbjct: 254 FLAPEVVNYDFVSFP------TDMWSVGVIAYMLLSGLSPFL------------------ 289
Query: 831 SEGKQDQ-VFDPILRGK-GFDEEMLQVL-----DVACMCVSQNPFKRPTVKEVVE--WLN 881
G D + IL + ++E Q + + + + R + E ++ WL+
Sbjct: 290 --GDNDAETLNNILACRWDLEDEEFQDISEEAKEFISKLLIKEKSWRISASEALKHPWLS 347
Query: 882 NVGANRR 888
+ + R
Sbjct: 348 DHKLHSR 354
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327 | Back alignment and structure |
|---|
Score = 99.3 bits (248), Expect = 9e-23
Identities = 68/343 (19%), Positives = 108/343 (31%), Gaps = 105/343 (30%)
Query: 586 LFPNNTNEIKDLTIYELLKATDNFSQANIIGCGGFGLVYKAT-LANGTTLAIK-----KL 639
L+ + + Y L +G G F +V + + G A K +
Sbjct: 18 LYFQSMENFNNF--YILTS--------KELGRGKFAVVRQCISKSTGQEYAAKFLKKRRR 67
Query: 640 SGDLGLMEREFKAEVEALSTAQH-KNLVSLQGYCVHQGFRLLIYSYMENGSLDYWLHEKA 698
D E E+ L A+ +++L + +LI Y G + +
Sbjct: 68 GQD---CRAEILHEIAVLELAKSCPRVINLHEVYENTSEIILILEYAAGGEIFSLCLPEL 124
Query: 699 DGASQLDWLTRLKIARGTSCGLAYMHQICEP----H---IVHRDIKSSNILLDDQFEAH- 750
++ + R + QI E H IVH D+K NILL +
Sbjct: 125 AEM-----VSENDVIR-------LIKQILEGVYYLHQNNIVHLDLKPQNILLSSIYPLGD 172
Query: 751 --LADFGLSRLILPYQTHVTTELVGTLGYIPPE------YGQAWVATLRGDMYSFGVVML 802
+ DFG+SR I E++GT Y+ PE A DM++ G++
Sbjct: 173 IKIVDFGMSRKIGHAC--ELREIMGTPEYLAPEILNYDPITTA------TDMWNIGIIAY 224
Query: 803 ELLTGKRPVDVLKPKMSRELVGWVLKMRSEGKQDQ-VFDPILRGK-GFDEE--------- 851
LLT P G+ +Q + I + + EE
Sbjct: 225 MLLTHTSPFV--------------------GEDNQETYLNISQVNVDYSEETFSSVSQLA 264
Query: 852 ------MLQVLDVACMCVSQNPFKRPTVKEVVE--WLNNVGAN 886
+L NP KRPT + + WL
Sbjct: 265 TDFIQSLLVK----------NPEKRPTAEICLSHSWLQQWDFE 297
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348 | Back alignment and structure |
|---|
Score = 99.4 bits (248), Expect = 1e-22
Identities = 58/339 (17%), Positives = 117/339 (34%), Gaps = 65/339 (19%)
Query: 586 LFPNNTNEIKDLTI--YELLKATDNFSQANIIGCGGFGLVYKATLANGTTLAIKKLS--- 640
++ N + KD I Y +++ + G F + + A+KK
Sbjct: 17 IYLNKYVKEKDKYINDYRIIR---------TLNQGKFNKIILCE-KDNKFYALKKYEKSL 66
Query: 641 --------------GDLGLMEREFKAEVEALSTAQHKNLVSLQGYCVHQGFRLLIYSYME 686
+ +FK E++ ++ +++ ++ +G + +IY YME
Sbjct: 67 LEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKNEYCLTCEGIITNYDEVYIIYEYME 126
Query: 687 NGSLDYWLHEKADGASQLDWLTRLKIAR----GTSCGLAYMHQICEPHIVHRDIKSSNIL 742
N S+ + +++ + +Y+H E +I HRD+K SNIL
Sbjct: 127 NDSILKFDEYFFVLDKNYTCFIPIQVIKCIIKSVLNSFSYIHN--EKNICHRDVKPSNIL 184
Query: 743 LDDQFEAHLADFGLSRLILPYQTHVTTELVGTLGYIPPE--YGQAWVATLRGDMYSFGVV 800
+D L+DFG S + GT ++PPE ++ + D++S G+
Sbjct: 185 MDKNGRVKLSDFGESEYM---VDKKIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGIC 241
Query: 801 MLELLTGKRP------VDVLKPKMSRELVGWVLKMRSEGKQDQVFDPILRGKGFDEE--- 851
+ + P + L + + + + L E
Sbjct: 242 LYVMFYNVVPFSLKISLVELFNNIRTKNIEYPLDRNHFLYPLTNKKSTCSNNFLSNEDID 301
Query: 852 ----MLQVLDVACMCVSQNPFKRPTVKEVVE--WLNNVG 884
L+ NP +R T ++ ++ WL +
Sbjct: 302 FLKLFLRK----------NPAERITSEDALKHEWLADTN 330
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351 | Back alignment and structure |
|---|
Score = 99.2 bits (248), Expect = 1e-22
Identities = 65/236 (27%), Positives = 97/236 (41%), Gaps = 60/236 (25%)
Query: 607 DNFSQANIIGCGGFGLVYKAT-LANGTTLAIKKLSGDLGLMERE-----FKA--EVEALS 658
+ + IG G FG V+KA G +A+KK+ LME E A E++ L
Sbjct: 17 SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKV-----LMENEKEGFPITALREIKILQ 71
Query: 659 TAQHKNLVSLQGYCV-----HQGFRLLIY-----------SYMENGSLDYWLHEKADGAS 702
+H+N+V+L C + + IY + N + + L E
Sbjct: 72 LLKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQ 131
Query: 703 QLDWLTRLKIARGTSCGLAYMHQICEPHIVHRDIKSSNILLDDQFEAHLADFGLSRLI-L 761
L L GL Y+H+ I+HRD+K++N+L+ LADFGL+R L
Sbjct: 132 ML-----LN-------GLYYIHRN---KILHRDMKAANVLITRDGVLKLADFGLARAFSL 176
Query: 762 PYQTHVT--TELVGTLGYIPPE-------YGQAWVATLRGDMYSFGVVMLELLTGK 808
+ T V TL Y PPE YG + D++ G +M E+ T
Sbjct: 177 AKNSQPNRYTNRVVTLWYRPPELLLGERDYGPP-I-----DLWGAGCIMAEMWTRS 226
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543 | Back alignment and structure |
|---|
Score = 101 bits (254), Expect = 1e-22
Identities = 58/252 (23%), Positives = 100/252 (39%), Gaps = 39/252 (15%)
Query: 607 DNFSQANIIGCGGFGLVYKATL-ANGTTLAIKKLSGDLGLMEREF---KAEVEALSTAQH 662
D F ++G GGFG V+ + A G A KKL+ + + E + L+
Sbjct: 185 DWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHS 244
Query: 663 KNLVSLQGYCVHQGFRL-LIYSYMENGSLDYWLHEKADGASQLD-WLTRLKIARGTSCGL 720
+ +VSL Y L L+ + M G + Y ++ + A+ GL
Sbjct: 245 RFIVSLA-YAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQ-IVSGL 302
Query: 721 AYMHQICEPHIVHRDIKSSNILLDDQFEAHLADFGLSRLILPYQTHVTTELVGTLGYIPP 780
++HQ +I++RD+K N+LLDD ++D GL+ + QT GT G++ P
Sbjct: 303 EHLHQR---NIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTKTKG-YAGTPGFMAP 358
Query: 781 E------YGQAWVATLRGDMYSFGVVMLELLTGKRPVDVLKPKMSRELVGWVLKMRSEGK 834
E Y + V D ++ GV + E++ + P K+
Sbjct: 359 ELLLGEEYDFS-V-----DYFALGVTLYEMIAARGPFRARGEKVEN-------------- 398
Query: 835 QDQVFDPILRGK 846
++ +L
Sbjct: 399 -KELKQRVLEQA 409
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317 | Back alignment and structure |
|---|
Score = 98.0 bits (245), Expect = 2e-22
Identities = 55/223 (24%), Positives = 101/223 (45%), Gaps = 34/223 (15%)
Query: 603 LKATDNFSQANIIGCGGFGLVYKAT-LANGTTLAIKKLSGDLGLMERE----FKA--EVE 655
+ ++ F Q +G G + VYK G +A+K++ ++ E A E+
Sbjct: 1 MSSSSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVK-----LDSEEGTPSTAIREIS 55
Query: 656 ALSTAQHKNLVSLQGYCVHQGFRLLIYSYMENGSLDYWLHEKADGASQLDWLTRL--KIA 713
+ +H+N+V L + L++ +M+N L ++ + G + L
Sbjct: 56 LMKELKHENIVRLYDVIHTENKLTLVFEFMDN-DLKKYMDSRTVGNTPRGLELNLVKYFQ 114
Query: 714 RGTSCGLAYMHQICEPHIVHRDIKSSNILLDDQFEAHLADFGLSRLI-LPYQTHVTTELV 772
GLA+ H+ I+HRD+K N+L++ + + L DFGL+R +P T + V
Sbjct: 115 WQLLQGLAFCHE---NKILHRDLKPQNLLINKRGQLKLGDFGLARAFGIPVNTF--SSEV 169
Query: 773 GTLGYIPPE-------YGQAWVATLRGDMYSFGVVMLELLTGK 808
TL Y P+ Y + + D++S G ++ E++TGK
Sbjct: 170 VTLWYRAPDVLMGSRTYSTS-I-----DIWSCGCILAEMITGK 206
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292 | Back alignment and structure |
|---|
Score = 97.2 bits (243), Expect = 3e-22
Identities = 53/220 (24%), Positives = 91/220 (41%), Gaps = 36/220 (16%)
Query: 607 DNFSQANIIGCGGFGLVYKAT-LANGTTLAIKKLSGDLGLMERE-----FKA--EVEALS 658
+ + IG G +G V+KA +A+K++ ++ + A E+ L
Sbjct: 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVR-----LDDDDEGVPSSALREICLLK 56
Query: 659 TAQHKNLVSLQGYCVHQGFRLLIYSYMENGSLDYWLHEKADGASQLDWLTRLKIARGTSC 718
+HKN+V L L++ + + L + LD
Sbjct: 57 ELKHKNIVRLHDVLHSDKKLTLVFEFCDQ-DLKKYFD---SCNGDLDPEIVKSFLFQLLK 112
Query: 719 GLAYMHQICEPHIVHRDIKSSNILLDDQFEAHLADFGLSRLI-LPYQTHVTTELVGTLGY 777
GL + H +++HRD+K N+L++ E LA+FGL+R +P + + + V TL Y
Sbjct: 113 GLGFCHS---RNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCY--SAEVVTLWY 167
Query: 778 IPPE-------YGQAWVATLRGDMYSFGVVMLELLTGKRP 810
PP+ Y + + DM+S G + EL RP
Sbjct: 168 RPPDVLFGAKLYSTS-I-----DMWSAGCIFAELANAGRP 201
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277 | Back alignment and structure |
|---|
Score = 96.5 bits (241), Expect = 3e-22
Identities = 67/330 (20%), Positives = 101/330 (30%), Gaps = 94/330 (28%)
Query: 590 NTNEIKDLTIYELLKATDNFSQANIIGCGGFGLVYKAT-LANGTTLAIKKLSGDLGLMER 648
+I Y L IG G +G V A A KK+
Sbjct: 3 TKGDINQ--YYTLEN---------TIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVD 51
Query: 649 EFKAEVEALSTAQHKNLVSLQGYCVHQGFRLLIYSYMENGSL-DY-----WLHEKADGAS 702
FK E+E + + H N++ L L+ G L + E A+
Sbjct: 52 RFKQEIEIMKSLDHPNIIRLYETFEDNTDIYLVMELCTGGELFERVVHKRVFRESD--AA 109
Query: 703 QLDWLTRLKIARGTSCGLAYMHQICEPHIVHRDIKSSNILLDDQFEAH---LADFGLSRL 759
+I + +AY H++ ++ HRD+K N L L DFGL+
Sbjct: 110 --------RIMKDVLSAVAYCHKL---NVAHRDLKPENFLFLTDSPDSPLKLIDFGLAAR 158
Query: 760 ILPYQTHVTTELVGTLGYIPPE-----YGQAWVATLRGDMYSFGVVMLELLTGKRPVDVL 814
P + VGT Y+ P+ YG D +S GV+M LL G P
Sbjct: 159 FKP--GKMMRTKVGTPYYVSPQVLEGLYGPE------CDEWSAGVMMYVLLCGYPPFS-- 208
Query: 815 KPKMSRELVGWVLKMRSEGKQDQVFDPILRGK-GFDEE---------------MLQVLDV 858
+V I G F E+ +L
Sbjct: 209 -----------------APTDSEVMLKIREGTFTFPEKDWLNVSPQAESLIRRLLTK--- 248
Query: 859 ACMCVSQNPFKRPTVKEVVE--WLNNVGAN 886
+P +R T + +E W ++
Sbjct: 249 -------SPKQRITSLQALEHEWFEKQLSS 271
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311 | Back alignment and structure |
|---|
Score = 97.2 bits (243), Expect = 4e-22
Identities = 61/218 (27%), Positives = 100/218 (45%), Gaps = 37/218 (16%)
Query: 607 DNFSQANIIGCGGFGLVYKATLANGTTLAIKKLSGDLGLMERE-----FKA--EVEALST 659
+ + + +G G +G+VYKA + G +A+K++ ++ E A E+ L
Sbjct: 21 EKYQKLEKVGEGTYGVVYKAKDSQGRIVALKRIR-----LDAEDEGIPSTAIREISLLKE 75
Query: 660 AQHKNLVSLQGYCVHQGFRLLIYSYMENGSLDYWLHEKADGASQLDWLTRLK-IARGTSC 718
H N+VSL + L++ +ME L L E G +K
Sbjct: 76 LHHPNIVSLIDVIHSERCLTLVFEFMEK-DLKKVLDENKTGLQDSQ----IKIYLYQLLR 130
Query: 719 GLAYMHQICEPHIVHRDIKSSNILLDDQFEAHLADFGLSRLI-LPYQTHVTTELVGTLGY 777
G+A+ HQ I+HRD+K N+L++ LADFGL+R +P +++ T V TL Y
Sbjct: 131 GVAHCHQ---HRILHRDLKPQNLLINSDGALKLADFGLARAFGIPVRSY--THEVVTLWY 185
Query: 778 IPPE-------YGQAWVATLRGDMYSFGVVMLELLTGK 808
P+ Y + V D++S G + E++TGK
Sbjct: 186 RAPDVLMGSKKYSTS-V-----DIWSIGCIFAEMITGK 217
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444 | Back alignment and structure |
|---|
Score = 98.1 bits (245), Expect = 1e-21
Identities = 64/332 (19%), Positives = 114/332 (34%), Gaps = 94/332 (28%)
Query: 590 NTNEIKDLTIYELLKATDNFSQANIIGCGGFGLVYKAT-LANGTTLAIKKLS-GDLGLME 647
+ Y+L + +G G F +V + + G A ++ L +
Sbjct: 5 TCTRFTE--EYQLFE---------ELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARD 53
Query: 648 RE-FKAEVEALSTAQHKNLVSLQGYCVHQGFRLLIYSYMENGSLDYWLHEK-----ADGA 701
+ + E +H N+V L +G LI+ + G L + + AD +
Sbjct: 54 HQKLEREARICRLLKHPNIVRLHDSISEEGHHYLIFDLVTGGELFEDIVAREYYSEADAS 113
Query: 702 SQLDWLTRLKIARGTSCGLAYMHQICEPHIVHRDIKSSNILLDDQFEAH---LADFGLSR 758
+ + + HQ+ +VHR++K N+LL + + LADFGL+
Sbjct: 114 ---------HCIQQILEAVLHCHQM---GVVHRNLKPENLLLASKLKGAAVKLADFGLAI 161
Query: 759 LILPYQTHVTTELVGTLGYIPPE------YGQAWVATLRGDMYSFGVVMLELLTGKRPVD 812
+ + GT GY+ PE YG+ D+++ GV++ LL G P
Sbjct: 162 EVEG-EQQAWFGFAGTPGYLSPEVLRKDPYGKP------VDLWACGVILYILLVGYPPFW 214
Query: 813 VLKPKMSRELVGWVLKMRSEGKQDQVFDPILRGK-GFDEE---------------MLQVL 856
+ Q +++ I G F ML +
Sbjct: 215 -------------------DEDQHRLYQQIKAGAYDFPSPEWDTVTPEAKDLINKMLTI- 254
Query: 857 DVACMCVSQNPFKRPTVKEVVE--WLNNVGAN 886
NP KR T E ++ W+++
Sbjct: 255 ---------NPSKRITAAEALKHPWISHRSTV 277
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437 | Back alignment and structure |
|---|
Score = 97.9 bits (244), Expect = 1e-21
Identities = 65/214 (30%), Positives = 89/214 (41%), Gaps = 17/214 (7%)
Query: 607 DNFSQANIIGCGGFGLVYKATL-ANGTTLAIKKLSGDLGLMERE---FKAEVEALSTAQH 662
++F +IG G FG V L A+K L+ L E F+ E + L
Sbjct: 74 EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDS 133
Query: 663 KNLVSLQGYCVHQGFRL-LIYSYMENGSLDYWLHEKADGASQLDWLTRLKIARGTSCGLA 721
K + +L Y L L+ Y G L L K + + R +A +
Sbjct: 134 KWITTLH-YAFQDDNNLYLVMDYYVGGDLLTLL-SKFEDRLPEEM-ARFYLAE-MVIAID 189
Query: 722 YMHQICEPHIVHRDIKSSNILLDDQFEAHLADFGLSRLILPYQTHVTTELVGTLGYIPPE 781
+HQ+ H VHRDIK NIL+D LADFG ++ T ++ VGT YI PE
Sbjct: 190 SVHQL---HYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQSSVAVGTPDYISPE 246
Query: 782 YGQAWVATLRG-----DMYSFGVVMLELLTGKRP 810
QA D +S GV M E+L G+ P
Sbjct: 247 ILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETP 280
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325 | Back alignment and structure |
|---|
Score = 95.8 bits (239), Expect = 1e-21
Identities = 65/331 (19%), Positives = 112/331 (33%), Gaps = 90/331 (27%)
Query: 591 TNEIKDLTIYELLKATDNFSQANIIGCGGFGLVYKAT-LANGTTLAIKKLS-GDLGLMER 648
+ Y+L + +G G F + K + A+K +S ++
Sbjct: 3 DSPFYQ--HYDL------DLKDKPLGEGSFSICRKCVHKKSNQAFAVKIISKRMEANTQK 54
Query: 649 EFKAEVEALSTAQ-HKNLVSLQGYCVHQGFRLLIYSYMENGSL-DYWLH-----EKADGA 701
E + AL + H N+V L Q L+ + G L + E A
Sbjct: 55 E----ITALKLCEGHPNIVKLHEVFHDQLHTFLVMELLNGGELFERIKKKKHFSETE--A 108
Query: 702 SQLDWLTRLKIARGTSCGLAYMHQICEPHIVHRDIKSSNILLDDQFEAH---LADFGLSR 758
S I R +++MH + +VHRD+K N+L D+ + + DFG +R
Sbjct: 109 SY--------IMRKLVSAVSHMHDV---GVVHRDLKPENLLFTDENDNLEIKIIDFGFAR 157
Query: 759 LILPYQTHVTTELVGTLGYIPPE------YGQAWVATLRGDMYSFGVVMLELLTGKRPVD 812
L P TL Y PE Y ++ D++S GV++ +L+G+ P
Sbjct: 158 LKPP-DNQPLKTPCFTLHYAAPELLNQNGYDES------CDLWSLGVILYTMLSGQVPFQ 210
Query: 813 VLKPKMSRELVGWVLKMRSEGKQDQVFDPILRGK-GFDEE---------------MLQVL 856
++ ++ I +G F+ E +L V
Sbjct: 211 SHDRSLTCT------------SAVEIMKKIKKGDFSFEGEAWKNVSQEAKDLIQGLLTV- 257
Query: 857 DVACMCVSQNPFKRPTVKEVVE--WLNNVGA 885
+P KR + + WL +
Sbjct: 258 ---------DPNKRLKMSGLRYNEWLQDGSQ 279
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329 | Back alignment and structure |
|---|
Score = 95.4 bits (238), Expect = 2e-21
Identities = 58/223 (26%), Positives = 89/223 (39%), Gaps = 42/223 (18%)
Query: 607 DNFSQANIIGCGGFGLVYKAT-LANGTTLAIKKLSGDLGLMERE-----FKA--EVEALS 658
D + + +G G +G VYKA T+AIK++ +E E A EV L
Sbjct: 34 DRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIR-----LEHEEEGVPGTAIREVSLLK 88
Query: 659 TAQHKNLVSLQGYCVHQGFRLLIYSYMENGSLDYWLHEKADGASQLDWLTRLKIARGTSC 718
QH+N++ L+ H LI+ Y E D L + D +
Sbjct: 89 ELQHRNIIELKSVIHHNHRLHLIFEYAE---ND--LKKYMDKNPDVSMRVIKSFLYQLIN 143
Query: 719 GLAYMHQICEPHIVHRDIKSSNILLDDQFEAH-----LADFGLSRLI-LPYQTHVTTELV 772
G+ + H +HRD+K N+LL + + DFGL+R +P + T +
Sbjct: 144 GVNFCHS---RRCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAFGIPIRQF--THEI 198
Query: 773 GTLGYIPPE-------YGQAWVATLRGDMYSFGVVMLELLTGK 808
TL Y PPE Y + V D++S + E+L
Sbjct: 199 ITLWYRPPEILLGSRHYSTS-V-----DIWSIACIWAEMLMKT 235
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308 | Back alignment and structure |
|---|
Score = 94.9 bits (237), Expect = 2e-21
Identities = 63/235 (26%), Positives = 89/235 (37%), Gaps = 54/235 (22%)
Query: 604 KATDNFSQANIIGCGGFGLVYKAT-LANGTTLAIKKL---SGDLGLME------REFKAE 653
AT + IG G +G VYKA +G +A+K + +G G RE
Sbjct: 6 MATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALL 65
Query: 654 VEALSTAQHKNLVSLQGYCVHQGFRL-----LIYSYMENGSLDYWLHEKADGASQLDWLT 708
L +H N+V L C L++ +++ D + LD
Sbjct: 66 RR-LEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQ-----------DLRTYLDKAP 113
Query: 709 RLKIARGTS--------CGLAYMHQICEPHIVHRDIKSSNILLDDQFEAHLADFGLSRLI 760
+ T GL ++H IVHRD+K NIL+ LADFGL+R
Sbjct: 114 PPGLPAETIKDLMRQFLRGLDFLHA---NCIVHRDLKPENILVTSGGTVKLADFGLAR-- 168
Query: 761 LPYQTHVT-TELVGTLGYIPPE------YGQAWVATLRGDMYSFGVVMLELLTGK 808
Y + T +V TL Y PE Y V DM+S G + E+ K
Sbjct: 169 -IYSYQMALTPVVVTLWYRAPEVLLQSTYATP-V-----DMWSVGCIFAEMFRRK 216
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 98.2 bits (245), Expect = 3e-21
Identities = 23/125 (18%), Positives = 42/125 (33%), Gaps = 13/125 (10%)
Query: 380 YNQLSNLPPA----------IYLANNSLSGNI-PVEIGQLKSLHVLDLSNNNFSGTIPDE 428
+ + +A NS N P +L++L LDLS P
Sbjct: 430 HTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTA 489
Query: 429 LSDLSNLEKLDLSGNHLVGEIPISLKGLHFLSSFSVAHNNLQGAVPS--GGQFDTFPSFS 486
+ LS+L+ L++S N+ K L+ L + N++ + + +
Sbjct: 490 FNSLSSLQVLNMSHNNFFSLDTFPYKCLNSLQVLDYSLNHIMTSKKQELQHFPSSLAFLN 549
Query: 487 FEGNP 491
N
Sbjct: 550 LTQND 554
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 96.6 bits (241), Expect = 7e-21
Identities = 23/106 (21%), Positives = 35/106 (33%), Gaps = 10/106 (9%)
Query: 380 YNQLSNLPPA----------IYLANNSLSGNIPVEIGQLKSLHVLDLSNNNFSGTIPDEL 429
+N L +L + L+ + L L L L+ N
Sbjct: 37 FNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQSLALGAF 96
Query: 430 SDLSNLEKLDLSGNHLVGEIPISLKGLHFLSSFSVAHNNLQGAVPS 475
S LS+L+KL +L + L L +VAHN +Q
Sbjct: 97 SGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQSFKLP 142
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 92.8 bits (231), Expect = 1e-19
Identities = 24/113 (21%), Positives = 33/113 (29%), Gaps = 7/113 (6%)
Query: 370 VMPSNATNQQYNQLSNLPPAI-------YLANNSLSGNIPVEIGQLKSLHVLDLSNNNFS 422
V+P+ +P + L+ N L L VLDLS
Sbjct: 6 VVPNITYQCMELNFYKIPDNLPFSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQ 65
Query: 423 GTIPDELSDLSNLEKLDLSGNHLVGEIPISLKGLHFLSSFSVAHNNLQGAVPS 475
LS+L L L+GN + + GL L NL
Sbjct: 66 TIEDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVAVETNLASLENF 118
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 91.2 bits (227), Expect = 4e-19
Identities = 23/140 (16%), Positives = 47/140 (33%), Gaps = 25/140 (17%)
Query: 379 QYNQLSNLPPAI---------YLANNSLSGNIPVEI-GQLKSLHVLDLSNNNFSGTIPDE 428
+N + + +++L + L++L LD+S+ +
Sbjct: 381 SFNGVITMSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGI 440
Query: 429 LSDLSNLEKLDLSGNHLVGEI-PISLKGLHFLSSFSVAHNNLQGAVP------------- 474
+ LS+LE L ++GN P L L+ ++ L+ P
Sbjct: 441 FNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLN 500
Query: 475 -SGGQFDTFPSFSFEGNPEL 493
S F + +F ++ L
Sbjct: 501 MSHNNFFSLDTFPYKCLNSL 520
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 83.9 bits (208), Expect = 8e-17
Identities = 25/113 (22%), Positives = 42/113 (37%), Gaps = 16/113 (14%)
Query: 379 QYNQLSNLPPA----------IYLANNSL-SGNIPVEIGQLKSLHVLDLSNNNFSGTIPD 427
L++L + +A+N + S +P L +L LDLS+N
Sbjct: 108 VETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCT 167
Query: 428 ELSDLSNLE----KLDLSGNHLVGEIPISLKGLHFLSSFSVAHNNLQGAVPSG 476
+L L + LDLS N + P + K + L ++ +N V
Sbjct: 168 DLRVLHQMPLLNLSLDLSLNPMNFIQPGAFKEIR-LHKLTLRNNFDSLNVMKT 219
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 77.4 bits (191), Expect = 8e-15
Identities = 26/107 (24%), Positives = 36/107 (33%), Gaps = 14/107 (13%)
Query: 390 IYLANNSLS--GNIPVEIGQLKSLHVLDLSNNNFSGTIPDELSDLSNLEKLDLSGNHLVG 447
+ L+ N LS G SL LDLS N T+ L LE LD ++L
Sbjct: 352 LDLSRNGLSFKGCCSQSDFGTTSLKYLDLSFNGVI-TMSSNFLGLEQLEHLDFQHSNLKQ 410
Query: 448 EIPIS-LKGLHFLSSFSVAHNNLQGAVPSGGQFDTFPSFSFEGNPEL 493
S L L ++H + + + F G L
Sbjct: 411 MSEFSVFLSLRNLIYLDISHTHTRV----------AFNGIFNGLSSL 447
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 61.2 bits (149), Expect = 1e-09
Identities = 23/103 (22%), Positives = 33/103 (32%), Gaps = 15/103 (14%)
Query: 379 QYNQLSNLPP--------AIYLANNSLSGNIPVEIGQLKSLHVLDLSNNNFSGTIPDELS 430
+ + + L N +LKSL L ++N
Sbjct: 290 VSVTIERVKDFSYNFGWQHLELVNCKFGQFPT---LKLKSLKRLTFTSNKGGNAFS--EV 344
Query: 431 DLSNLEKLDLSGNHL--VGEIPISLKGLHFLSSFSVAHNNLQG 471
DL +LE LDLS N L G S G L ++ N +
Sbjct: 345 DLPSLEFLDLSRNGLSFKGCCSQSDFGTTSLKYLDLSFNGVIT 387
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 60.8 bits (148), Expect = 1e-09
Identities = 22/96 (22%), Positives = 37/96 (38%), Gaps = 8/96 (8%)
Query: 381 NQLSNLPPAIYLANNSLSGNIPVEIGQLKSLHVLDLSNNNFSGTIPDE-LSDLSNLEKLD 439
+Q+ L ++ L+ N ++ I + LH L L NN S + + L+ LE
Sbjct: 173 HQMPLLNLSLDLSLNPMNF-IQPGAFKEIRLHKLTLRNNFDSLNVMKTCIQGLAGLEVHR 231
Query: 440 LSGNHLVGEIPI------SLKGLHFLSSFSVAHNNL 469
L E + +L+GL L+ L
Sbjct: 232 LVLGEFRNEGNLEKFDKSALEGLCNLTIEEFRLAYL 267
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 60.8 bits (148), Expect = 1e-09
Identities = 22/140 (15%), Positives = 43/140 (30%), Gaps = 36/140 (25%)
Query: 334 NLLSGEFPKELTALPALVSEAANDEVDRSYLELPVFVMPSNATNQQYNQLSNLPPAI--- 390
L P +L +L L + +N +L
Sbjct: 480 CQLEQLSPTAFNSLSSLQ-----------VLNM------------SHNNFFSLDTFPYKC 516
Query: 391 -------YLANNSLSGNIPVEIGQL-KSLHVLDLSNNNFSGTIPDE--LSDLSNLEKLDL 440
+ N + + E+ SL L+L+ N+F+ T + L + + +L +
Sbjct: 517 LNSLQVLDYSLNHIMTSKKQELQHFPSSLAFLNLTQNDFACTCEHQSFLQWIKDQRQLLV 576
Query: 441 SGNHLVGEIPISLKGLHFLS 460
+ P +G+ LS
Sbjct: 577 EVERMECATPSDKQGMPVLS 596
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 53.9 bits (130), Expect = 2e-07
Identities = 15/135 (11%), Positives = 35/135 (25%), Gaps = 15/135 (11%)
Query: 362 SYLELPVFVMPSNATNQQYNQLSNLPPAIYLANNSLSGNIPVEIGQLKSLHVLDLS---N 418
+ VM + ++ L + +L + L +L + +
Sbjct: 208 RNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKFDKSALEGLCNLTIEEFRLAYL 267
Query: 419 NNFSGTIPDELSDLSNLEKLDLSGNHLVGEIPISLKGLHFLSSFSVAHNNLQGAVPSGGQ 478
+ + I D + L+N+ L + S + +
Sbjct: 268 DYYLDDIIDLFNCLTNVSSFSLVSVTIERVKDFS--YNFGWQHLELVNCKFGQ------- 318
Query: 479 FDTFPSFSFEGNPEL 493
FP+ + L
Sbjct: 319 ---FPTLKLKSLKRL 330
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331 | Back alignment and structure |
|---|
Score = 95.0 bits (237), Expect = 3e-21
Identities = 58/218 (26%), Positives = 98/218 (44%), Gaps = 36/218 (16%)
Query: 607 DNFSQANIIGCGGFGLVYKAT-LANGTTLAIKKLSGDLGLMERE---FKA----EVEALS 658
+ + ++G G +G+V K G +AIKK L + K E++ L
Sbjct: 25 EKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKF-----LESDDDKMVKKIAMREIKLLK 79
Query: 659 TAQHKNLVSLQGYCVHQGFRLLIYSYMENGSLDYWLHEKADGASQLDWLTRLKIARGTSC 718
+H+NLV+L C + L++ ++++ LD L +G LD+ K
Sbjct: 80 QLRHENLVNLLEVCKKKKRWYLVFEFVDHTILDD-LELFPNG---LDYQVVQKYLFQIIN 135
Query: 719 GLAYMHQICEPHIVHRDIKSSNILLDDQFEAHLADFGLSRLI-LPYQTHVTTELVGTLGY 777
G+ + H +I+HRDIK NIL+ L DFG +R + P + + + V T Y
Sbjct: 136 GIGFCHSH---NIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVY--DDEVATRWY 190
Query: 778 IPPE-------YGQAWVATLRGDMYSFGVVMLELLTGK 808
PE YG+A V D+++ G ++ E+ G+
Sbjct: 191 RAPELLVGDVKYGKA-V-----DVWAIGCLVTEMFMGE 222
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576 | Back alignment and structure |
|---|
Score = 97.6 bits (243), Expect = 3e-21
Identities = 63/226 (27%), Positives = 95/226 (42%), Gaps = 25/226 (11%)
Query: 607 DNFSQANIIGCGGFGLVYKATL-ANGTTLAIKKLSGDLGLMEREF---KAEVEALSTAQH 662
+ F Q ++G GGFG V + A G A KKL + E + L
Sbjct: 184 NTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNS 243
Query: 663 KNLVSLQGYCVHQGFRL-LIYSYMENGSLDYWLHEKADGASQLDWLTRLKIARGTSCGLA 721
+ +VSL Y L L+ + M G L + ++ A CGL
Sbjct: 244 RFVVSLA-YAYETKDALCLVLTLMNGGDLKFHIYHMGQAGFPEAR-AVFYAAE-ICCGLE 300
Query: 722 YMHQICEPHIVHRDIKSSNILLDDQFEAHLADFGLSRLILPYQTHVTTELVGTLGYIPPE 781
+H+ IV+RD+K NILLDD ++D GL+ + QT VGT+GY+ PE
Sbjct: 301 DLHRE---RIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQT--IKGRVGTVGYMAPE 355
Query: 782 ------YGQAWVATLRGDMYSFGVVMLELLTGKRPVDVLKPKMSRE 821
Y + D ++ G ++ E++ G+ P K K+ RE
Sbjct: 356 VVKNERYTFS-P-----DWWALGCLLYEMIAGQSPFQQRKKKIKRE 395
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328 | Back alignment and structure |
|---|
Score = 94.7 bits (236), Expect = 3e-21
Identities = 74/316 (23%), Positives = 113/316 (35%), Gaps = 97/316 (30%)
Query: 600 YELLKATDNFSQANIIGCGGFGLVYKAT-LANGTTLAIKKL------SGDLGLMEREFKA 652
Y LLK IG G F V A + G +AIK + L + RE
Sbjct: 17 YRLLKT---------IGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFRE--- 64
Query: 653 EVEALSTAQHKNLVSLQGYCVHQGFRLLIYSYMENGSLDYWLHEKADGASQLDWLT---R 709
V + H N+V L + +E Y + E A G D+L R
Sbjct: 65 -VRIMKILNHPNIVKL-------------FEVIETEKTLYLIMEYASGGEVFDYLVAHGR 110
Query: 710 L------KIARGTSCGLAYMHQICEPHIVHRDIKSSNILLDDQFEAHLADFGLSRLILPY 763
+ R + Y HQ IVHRD+K+ N+LLD +ADFG S
Sbjct: 111 MKEKEARSKFRQIVSAVQYCHQK---RIVHRDLKAENLLLDADMNIKIADFGFSNEFTVG 167
Query: 764 QTHVTTELVGTLGYIPPEYGQAWVATLRGDMY--------SFGVVMLELLTGKRPVD--- 812
G Y PE +G Y S GV++ L++G P D
Sbjct: 168 GKLDAF--CGAPPYAAPE-------LFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQN 218
Query: 813 --VLKPKMSR---ELVGWVLKMRSEGKQDQVFDPILRGKGFDEEMLQVLDVACMCVSQNP 867
L+ ++ R + ++ S ++ +L+ L + NP
Sbjct: 219 LKELRERVLRGKYRIPFYM----STDCEN-----LLKR------FLVL----------NP 253
Query: 868 FKRPTVKEVVE--WLN 881
KR T++++++ W+N
Sbjct: 254 IKRGTLEQIMKDRWIN 269
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288 | Back alignment and structure |
|---|
Score = 93.3 bits (233), Expect = 5e-21
Identities = 55/220 (25%), Positives = 96/220 (43%), Gaps = 41/220 (18%)
Query: 607 DNFSQANIIGCGGFGLVYKATLANGTTLAIKKLSGDLGLMERE-----FKA--EVEALST 659
+ + IG G +G+VYKA G T A+KK+ +E+E E+ L
Sbjct: 2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIR-----LEKEDEGIPSTTIREISILKE 56
Query: 660 AQHKNLVSLQGYCVHQGFRLLIYSYMEN---GSLDYWLHEKADGASQLDWLTRLKIARGT 716
+H N+V L + +L++ +++ LD L+ +T
Sbjct: 57 LKHSNIVKLYDVIHTKKRLVLVFEHLDQDLKKLLD-------VCEGGLESVTAKSFLLQL 109
Query: 717 SCGLAYMHQICEPHIVHRDIKSSNILLDDQFEAHLADFGLSRLI-LPYQTHVTTELVGTL 775
G+AY H ++HRD+K N+L++ + E +ADFGL+R +P + + T + TL
Sbjct: 110 LNGIAYCHD---RRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKY--THEIVTL 164
Query: 776 GYIPPE-------YGQAWVATLRGDMYSFGVVMLELLTGK 808
Y P+ Y + D++S G + E++ G
Sbjct: 165 WYRAPDVLMGSKKYSTT-I-----DIWSVGCIFAEMVNGT 198
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326 | Back alignment and structure |
|---|
Score = 94.2 bits (235), Expect = 5e-21
Identities = 58/238 (24%), Positives = 93/238 (39%), Gaps = 62/238 (26%)
Query: 604 KATDNFSQANIIGCGGFGLVYKA--TLANGTTLAIKKLSGDLGLME-----------REF 650
+A + IG G +G V+KA G +A+K++ ++ RE
Sbjct: 8 RADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRV-----RVQTGEEGMPLSTIREV 62
Query: 651 KAEVEALSTAQHKNLVSL----QGYCVHQGFRL-LIYSYMENGSLDYWLHEKADGASQLD 705
L T +H N+V L + +L L++ +++ D + LD
Sbjct: 63 AVLRH-LETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQ-----------DLTTYLD 110
Query: 706 WLTRLKIARGTS--------CGLAYMHQICEPHIVHRDIKSSNILLDDQFEAHLADFGLS 757
+ + T GL ++H +VHRD+K NIL+ + LADFGL+
Sbjct: 111 KVPEPGVPTETIKDMMFQLLRGLDFLHS---HRVVHRDLKPQNILVTSSGQIKLADFGLA 167
Query: 758 RLILPYQTHVT-TELVGTLGYIPPE------YGQAWVATLRGDMYSFGVVMLELLTGK 808
R Y + T +V TL Y PE Y V D++S G + E+ K
Sbjct: 168 R---IYSFQMALTSVVVTLWYRAPEVLLQSSYATP-V-----DLWSVGCIFAEMFRRK 216
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324 | Back alignment and structure |
|---|
Score = 93.4 bits (233), Expect = 8e-21
Identities = 57/225 (25%), Positives = 98/225 (43%), Gaps = 51/225 (22%)
Query: 607 DNFSQANIIGCGGFGLVYKAT-LANGTTLAIKKLSGDLGLMERE----FKA--EVEALST 659
+ + + + +G G + VYK +A+K++ +E E A EV L
Sbjct: 2 ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIR-----LEHEEGAPCTAIREVSLLKD 56
Query: 660 AQHKNLVSLQGYCVHQGFRLLIY--------SYMENGSLDYWLHEKADGASQLDWLTRLK 711
+H N+V+L + L++ Y+++ +H QL L+
Sbjct: 57 LKHANIVTLHDIIHTEKSLTLVFEYLDKDLKQYLDDCGNIINMHNVKLFLFQL-----LR 111
Query: 712 IARGTSCGLAYMHQICEPHIVHRDIKSSNILLDDQFEAHLADFGLSRLI-LPYQTHVTTE 770
GLAY H+ ++HRD+K N+L++++ E LADFGL+R +P +T+
Sbjct: 112 -------GLAYCHR---QKVLHRDLKPQNLLINERGELKLADFGLARAKSIPTKTY--DN 159
Query: 771 LVGTLGYIPPE-------YGQAWVATLRGDMYSFGVVMLELLTGK 808
V TL Y PP+ Y + DM+ G + E+ TG+
Sbjct: 160 EVVTLWYRPPDILLGSTDYSTQ-I-----DMWGVGCIFYEMATGR 198
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384 | Back alignment and structure |
|---|
Score = 93.9 bits (234), Expect = 1e-20
Identities = 58/224 (25%), Positives = 87/224 (38%), Gaps = 42/224 (18%)
Query: 607 DNFSQANIIGCGGFGLVYKATL-ANGTTLAIKKLSGDLGLMEREF---KAEVEALSTAQH 662
D+F IG G FG V A+K ++ + E E++ + +H
Sbjct: 15 DHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEH 74
Query: 663 KNLVSLQGYCVHQGFRL-LIYSYMENGSLDYWL------HEKADGASQLDWLTRLKIARG 715
LV+L Y + ++ + G L Y L E+ +L I
Sbjct: 75 PFLVNLW-YSFQDEEDMFMVVDLLLGGDLRYHLQQNVHFKEET---------VKLFICE- 123
Query: 716 TSCGLAYMHQICEPHIVHRDIKSSNILLDDQFEAHLADFGLSRLILPYQTHVTTELVGTL 775
L Y+ I+HRD+K NILLD+ H+ DF ++ ++ T + GT
Sbjct: 124 LVMALDYLQNQ---RIIHRDMKPDNILLDEHGHVHITDFNIAAMLPRETQITT--MAGTK 178
Query: 776 GYIPPE---------YGQAWVATLRGDMYSFGVVMLELLTGKRP 810
Y+ PE Y A V D +S GV ELL G+RP
Sbjct: 179 PYMAPEMFSSRKGAGYSFA-V-----DWWSLGVTAYELLRGRRP 216
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 96.5 bits (240), Expect = 1e-20
Identities = 20/114 (17%), Positives = 38/114 (33%), Gaps = 15/114 (13%)
Query: 380 YNQLSNLPPAIY-----LANNSLSGNIPVEIGQLKSLHVLDLSNNNFSGTIPDELSDLSN 434
+ + A+ N + LK L ++L N +PD L DL
Sbjct: 457 NSPFTYDNIAVDWEDANSDYAKQYENEELSWSNLKDLTDVELYNCPNMTQLPDFLYDLPE 516
Query: 435 LEKLDLSGNHLVG---------EIPISLKGLHFLSSFSVAHNNLQGAVPSGGQF 479
L+ L+++ N + + + F + +NNL+ P+
Sbjct: 517 LQSLNIACNRGISAAQLKADWTRLADDEDTGPKIQIFYMGYNNLEE-FPASASL 569
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 88.0 bits (218), Expect = 6e-18
Identities = 18/137 (13%), Positives = 42/137 (30%), Gaps = 26/137 (18%)
Query: 380 YNQLSNLPPAI-----------YLANNSLSGNIPVEIGQLKSLHVLDL------SNNNFS 422
+N+L++L ++ N S P + L + N
Sbjct: 737 FNKLTSLSDDFRATTLPYLSNMDVSYNCFSS-FPTQPLNSSQLKAFGIRHQRDAEGNRIL 795
Query: 423 GTIPDELSDLSNLEKLDLSGNHLVGEIPISLKGLHFLSSFSVAHNNLQ----GAVPSGGQ 478
P ++ +L +L + N + ++ L L +A N +V +
Sbjct: 796 RQWPTGITTCPSLIQLQIGSNDI-RKVDEKL--TPQLYILDIADNPNISIDVTSVCPYIE 852
Query: 479 FDTFPSFSFEGNPELCG 495
+ ++ ++ G
Sbjct: 853 AGMY-VLLYDKTQDIRG 868
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 84.5 bits (209), Expect = 8e-17
Identities = 24/184 (13%), Positives = 59/184 (32%), Gaps = 28/184 (15%)
Query: 329 LFSQANLLSGEFPKELTALPALVSEAANDEVDRSYLELPVFVMPSNATNQQYNQLSNLPP 388
+ + + + K ++ + + + + + + + Q+ NL
Sbjct: 376 SEERKHRIRMHYKKMFLDYDQRLNLSDLLQDAINRNPEMKPIKKDSRISLKDTQIGNL-- 433
Query: 389 AIYLANNSLSGNIPVEIGQLKSLHVLDLSNNNFSG-------------------TIPDEL 429
N ++ I I +L L ++ +N+ F+
Sbjct: 434 -----TNRITF-ISKAIQRLTKLQIIYFANSPFTYDNIAVDWEDANSDYAKQYENEELSW 487
Query: 430 SDLSNLEKLDLSGNHLVGEIPISLKGLHFLSSFSVAHNNLQGAVPSGGQFDTFPSFSFEG 489
S+L +L ++L + ++P L L L S ++A N A + +
Sbjct: 488 SNLKDLTDVELYNCPNMTQLPDFLYDLPELQSLNIACNRGISAAQLKADWTRLAD-DEDT 546
Query: 490 NPEL 493
P++
Sbjct: 547 GPKI 550
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 83.4 bits (206), Expect = 2e-16
Identities = 18/130 (13%), Positives = 40/130 (30%), Gaps = 26/130 (20%)
Query: 379 QYNQLSNLPPA-----------IYLANNSLSGNIPVEIG------QLKSLHVLDLSNNNF 421
+N+L +P + + N + I + + + LS N
Sbjct: 627 SHNKLKYIPNIFNAKSVYVMGSVDFSYNKIGS-EGRNISCSMDDYKGINASTVTLSYNEI 685
Query: 422 SGTIPDELSDLSNLEKLDLSGNHL-------VGEIPISLKGLHFLSSFSVAHNNLQGAVP 474
+ + S + + LS N + + + K + L++ + N L +
Sbjct: 686 QKFPTELFATGSPISTIILSNNLMTSIPENSLKPKDGNYKNTYLLTTIDLRFNKLTS-LS 744
Query: 475 SGGQFDTFPS 484
+ T P
Sbjct: 745 DDFRATTLPY 754
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 81.1 bits (200), Expect = 8e-16
Identities = 31/168 (18%), Positives = 54/168 (32%), Gaps = 28/168 (16%)
Query: 334 NLLSGEFPKELTALPALVSE--AANDEVDRSYLELPVFVMPSNATNQQ--------YNQL 383
+ P L LP L S A N + + L+ + + YN L
Sbjct: 501 CPNMTQLPDFLYDLPELQSLNIACNRGISAAQLKADWTRLADDEDTGPKIQIFYMGYNNL 560
Query: 384 SNLPP-----------AIYLANNSLSGNIPVEIGQLKSLHVLDLSNNNFSGTIPDEL-SD 431
P + +N + ++ G L L L N IP++ +
Sbjct: 561 EEFPASASLQKMVKLGLLDCVHNKVR-HLE-AFGTNVKLTDLKLDYNQIE-EIPEDFCAF 617
Query: 432 LSNLEKLDLSGNHLVGEIP--ISLKGLHFLSSFSVAHNNLQGAVPSGG 477
+E L S N L IP + K ++ + S ++N + +
Sbjct: 618 TDQVEGLGFSHNKL-KYIPNIFNAKSVYVMGSVDFSYNKIGSEGRNIS 664
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 78.4 bits (193), Expect = 6e-15
Identities = 18/125 (14%), Positives = 39/125 (31%), Gaps = 19/125 (15%)
Query: 379 QYNQLSNLPPAI----------YLANNSLSGNIP--VEIGQLKSLHVLDLSNNNFSGTIP 426
YNQ+ +P ++N L IP + + +D S N
Sbjct: 603 DYNQIEEIPEDFCAFTDQVEGLGFSHNKLKY-IPNIFNAKSVYVMGSVDFSYNKIGSEGR 661
Query: 427 DELSDLS-----NLEKLDLSGNHLVGEIPISLKGLHFLSSFSVAHNNLQGAVPSGGQFDT 481
+ + N + LS N + +S+ +++N + ++P
Sbjct: 662 NISCSMDDYKGINASTVTLSYNEIQKFPTELFATGSPISTIILSNNLMT-SIPENSLKPK 720
Query: 482 FPSFS 486
++
Sbjct: 721 DGNYK 725
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 69.1 bits (169), Expect = 4e-12
Identities = 9/81 (11%), Positives = 23/81 (28%)
Query: 395 NSLSGNIPVEIGQLKSLHVLDLSNNNFSGTIPDELSDLSNLEKLDLSGNHLVGEIPISLK 454
+ V++ + L L+ G +PD + L+ L+ L + +
Sbjct: 309 DMWGDQPGVDLDNNGRVTGLSLAGFGAKGRVPDAIGQLTELKVLSFGTHSETVSGRLFGD 368
Query: 455 GLHFLSSFSVAHNNLQGAVPS 475
+ ++
Sbjct: 369 EELTPDMSEERKHRIRMHYKK 389
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 61.0 bits (148), Expect = 1e-09
Identities = 20/178 (11%), Positives = 44/178 (24%), Gaps = 35/178 (19%)
Query: 334 NLLSGEFPKELTALPALVS--------EAANDEVDRSYLELPVFVMPSNATNQQYNQLSN 385
G P + L L + L + + Y ++
Sbjct: 333 FGAKGRVPDAIGQLTELKVLSFGTHSETVSGRLFGDEELTPDMSEERKHRIRMHYKKMFL 392
Query: 386 LPPAI----YLANNSLSGN---IPVEIGQLKSLHVLDLSN-NNFSGTIPDELSDLSNLEK 437
L ++++ N P++ SL + N N I + L+ L+
Sbjct: 393 DYDQRLNLSDLLQDAINRNPEMKPIKKDSRISLKDTQIGNLTNRITFISKAIQRLTKLQI 452
Query: 438 LDLSGNHLVG-------------------EIPISLKGLHFLSSFSVAHNNLQGAVPSG 476
+ + + +S L L+ + + +P
Sbjct: 453 IYFANSPFTYDNIAVDWEDANSDYAKQYENEELSWSNLKDLTDVELYNCPNMTQLPDF 510
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 56.8 bits (137), Expect = 3e-08
Identities = 17/122 (13%), Positives = 40/122 (32%), Gaps = 1/122 (0%)
Query: 365 ELPVFVMPSNATNQQYNQLSNLPPAIYLANNSLSGNIPVEIGQLKSLHVLDLSNNNFSGT 424
+P+ + + + Y L + A+ N + + + + +
Sbjct: 256 NVPIQLKETAEYIKDYKALKAIWEALDGKNWRYYSGTINNTIHSLNWN-FNKELDMWGDQ 314
Query: 425 IPDELSDLSNLEKLDLSGNHLVGEIPISLKGLHFLSSFSVAHNNLQGAVPSGGQFDTFPS 484
+L + + L L+G G +P ++ L L S ++ + G + P
Sbjct: 315 PGVDLDNNGRVTGLSLAGFGAKGRVPDAIGQLTELKVLSFGTHSETVSGRLFGDEELTPD 374
Query: 485 FS 486
S
Sbjct: 375 MS 376
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 95.9 bits (239), Expect = 2e-20
Identities = 33/176 (18%), Positives = 53/176 (30%), Gaps = 26/176 (14%)
Query: 334 NLLSGEFPKELTALPAL----VSEAANDEVDRSYLELPVFVMPSNATNQQ-----YNQLS 384
+ P L ALP + V+ ++ + Q YN L
Sbjct: 259 CPNLTKLPTFLKALPEMQLINVACNRGISGEQLKDDWQALADAPVGEKIQIIYIGYNNLK 318
Query: 385 NLPP-----------AIYLANNSLSGNIPVEIGQLKSLHVLDLSNNNFSGTIPDELSDLS 433
P + N L G +P G L L+L+ N + +
Sbjct: 319 TFPVETSLQKMKKLGMLECLYNQLEGKLP-AFGSEIKLASLNLAYNQITEIPANFCGFTE 377
Query: 434 NLEKLDLSGNHLVGEIP--ISLKGLHFLSSFSVAHNNLQGAVPSGGQFDTFPSFSF 487
+E L + N L IP K + +S+ ++N + G FD F
Sbjct: 378 QVENLSFAHNKL-KYIPNIFDAKSVSVMSAIDFSYNEIGSV--DGKNFDPLDPTPF 430
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 95.1 bits (237), Expect = 2e-20
Identities = 24/131 (18%), Positives = 45/131 (34%), Gaps = 26/131 (19%)
Query: 379 QYNQLSNLPPA-----------IYLANNSLSG-------NIPVEIGQLKSLHVLDLSNNN 420
+N+L +P I + N + + + ++ ++LSNN
Sbjct: 385 AHNKLKYIPNIFDAKSVSVMSAIDFSYNEIGSVDGKNFDPLDPTPFKGINVSSINLSNNQ 444
Query: 421 FSGTIPDELSDLSNLEKLDLSGNHLVG-------EIPISLKGLHFLSSFSVAHNNLQGAV 473
S + S S L ++L GN L + + K + L+S + N L +
Sbjct: 445 ISKFPKELFSTGSPLSSINLMGNMLTEIPKNSLKDENENFKNTYLLTSIDLRFNKLTK-L 503
Query: 474 PSGGQFDTFPS 484
+ T P
Sbjct: 504 SDDFRATTLPY 514
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 92.0 bits (229), Expect = 3e-19
Identities = 18/114 (15%), Positives = 36/114 (31%), Gaps = 21/114 (18%)
Query: 380 YNQLSNLPPAI-----------YLANNSLSGNIPVEIGQLKSL------HVLDLSNNNFS 422
+N+L+ L L+ NS S P + +L + D N
Sbjct: 497 FNKLTKLSDDFRATTLPYLVGIDLSYNSFSK-FPTQPLNSSTLKGFGIRNQRDAQGNRTL 555
Query: 423 GTIPDELSDLSNLEKLDLSGNHLVGEIPISLKGLHFLSSFSVAHNNLQGAVPSG 476
P+ ++ +L +L + N + + + +S + N S
Sbjct: 556 REWPEGITLCPSLTQLQIGSNDIRK-VNEKI--TPNISVLDIKDNPNISIDLSY 606
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 91.3 bits (227), Expect = 4e-19
Identities = 16/131 (12%), Positives = 40/131 (30%), Gaps = 36/131 (27%)
Query: 377 NQQYNQLSNLPPAI---------YLANNSLSG-------------------NIPVEIGQL 408
Q N ++ + A+ Y+ N+ ++ L
Sbjct: 189 GQLSNNITFVSKAVMRLTKLRQFYMGNSPFVAENICEAWENENSEYAQQYKTEDLKWDNL 248
Query: 409 KSLHVLDLSNNNFSGTIPDELSDLSNLEKLDLSGNHLV--------GEIPISLKGLHFLS 460
K L +++ N +P L L ++ ++++ N + + +
Sbjct: 249 KDLTDVEVYNCPNLTKLPTFLKALPEMQLINVACNRGISGEQLKDDWQALADAPVGEKIQ 308
Query: 461 SFSVAHNNLQG 471
+ +NNL+
Sbjct: 309 IIYIGYNNLKT 319
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 86.6 bits (215), Expect = 1e-17
Identities = 16/106 (15%), Positives = 31/106 (29%), Gaps = 18/106 (16%)
Query: 380 YNQLSNLPPAI---------------YLANNSLSGNIPVEIGQLKSLHVLDLSNNNFSGT 424
YN S P N P I SL L + +N+
Sbjct: 522 YNSFSKFPTQPLNSSTLKGFGIRNQRDAQGNRTLREWPEGITLCPSLTQLQIGSNDIR-K 580
Query: 425 IPDELSDLSNLEKLDLSGNHLVGEIPISLKGLHFLSSFSVAHNNLQ 470
+ +++ N+ LD+ N + + + + ++ Q
Sbjct: 581 VNEKI--TPNISVLDIKDNPNISIDLSYVCPYIEAGMYMLFYDKTQ 624
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 77.8 bits (192), Expect = 6e-15
Identities = 27/159 (16%), Positives = 42/159 (26%), Gaps = 12/159 (7%)
Query: 347 LPALVSEAANDEVDRSYLELPVFVMPSNATNQQYNQLSNLPPA---IYLANNSLSGNIPV 403
+P +S A E + YL L N N P A + V
Sbjct: 18 VPIKLSRTA--EYIKDYLALKEIWDALNGKNWSQQGFGTQPGANWNFNKELDMWGAQPGV 75
Query: 404 EIGQLKSLHVLDLSNNNFSGTIPDELSDLSNLEKLDLSGNHLVG----EIPISLKGLHFL 459
+ + L L SG +PD + L+ LE L L + P +
Sbjct: 76 SLNSNGRVTGLSLEGFGASGRVPDAIGQLTELEVLALGSHGEKVNERLFGPKGISANMSD 135
Query: 460 SSFSVAHNNLQGAVPSGGQFDTFPS---FSFEGNPELCG 495
+ Q + F +P+
Sbjct: 136 EQKQKMRMHYQKTFVDYDPREDFSDLIKDCINSDPQQKS 174
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 68.1 bits (167), Expect = 8e-12
Identities = 19/109 (17%), Positives = 32/109 (29%), Gaps = 16/109 (14%)
Query: 379 QYNQLS-NLPPAI---------YLANNSLSGN----IPVEIGQLKSLHVLDLSNNNFSGT 424
+ S +P AI L ++ N P I S ++ T
Sbjct: 89 EGFGASGRVPDAIGQLTELEVLALGSHGEKVNERLFGPKGISANMSDEQKQKMRMHYQKT 148
Query: 425 IPDELS--DLSNLEKLDLSGNHLVGEIPISLKGLHFLSSFSVAHNNLQG 471
D D S+L K ++ + I S + + NN+
Sbjct: 149 FVDYDPREDFSDLIKDCINSDPQQKSIKKSSRITLKDTQIGQLSNNITF 197
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 58.1 bits (141), Expect = 8e-09
Identities = 17/122 (13%), Positives = 32/122 (26%), Gaps = 31/122 (25%)
Query: 334 NLLSGEFPKELTALPALVSEAANDEVDRSYLELPVFVMPSNATNQQYNQLS-NLPPAI-- 390
N S FP + L + N + Q N+ P I
Sbjct: 523 NSFSK-FPTQPLNSSTL-----------KGFGI------RNQRDAQGNRTLREWPEGITL 564
Query: 391 -------YLANNSLSGNIPVEIGQLKSLHVLDLSNNNFSGTIPDELSDLSNLEKLDLSGN 443
+ +N + + +I ++ VLD+ +N + L +
Sbjct: 565 CPSLTQLQIGSNDIRK-VNEKI--TPNISVLDIKDNPNISIDLSYVCPYIEAGMYMLFYD 621
Query: 444 HL 445
Sbjct: 622 KT 623
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412 | Back alignment and structure |
|---|
Score = 93.6 bits (233), Expect = 2e-20
Identities = 59/219 (26%), Positives = 82/219 (37%), Gaps = 25/219 (11%)
Query: 607 DNFSQANIIGCGGFGLVY----KATLANGTTLAIKKLSGDLGLMERE---FKAEVEALST 659
D+F +IG G F V K T G A+K ++ L E F+ E + L
Sbjct: 61 DDFEILKVIGRGAFSEVAVVKMKQT---GQVYAMKIMNKWDMLKRGEVSCFREERDVLVN 117
Query: 660 AQHKNLVSLQGYCVHQGFRL-LIYSYMENGSLDYWLHEKADGASQLDWLTRLKIARGTSC 718
+ + L + L L+ Y G L L K + R +A
Sbjct: 118 GDRRWITQLH-FAFQDENYLYLVMEYYVGGDLLTLL-SKFGERIPAEM-ARFYLAE-IVM 173
Query: 719 GLAYMHQICEPHIVHRDIKSSNILLDDQFEAHLADFGLSRLILPYQTHVTTELVGTLGYI 778
+ +H++ VHRDIK NILLD LADFG + T + VGT Y+
Sbjct: 174 AIDSVHRL---GYVHRDIKPDNILLDRCGHIRLADFGSCLKLRADGTVRSLVAVGTPDYL 230
Query: 779 PPEYGQAWVATLRGDMY-------SFGVVMLELLTGKRP 810
PE QA Y + GV E+ G+ P
Sbjct: 231 SPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTP 269
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346 | Back alignment and structure |
|---|
Score = 92.6 bits (231), Expect = 2e-20
Identities = 58/224 (25%), Positives = 95/224 (42%), Gaps = 45/224 (20%)
Query: 607 DNFSQANIIGCGGFGLVYKAT-LANGTTLAIKKLSGDLGLMEREFKA----------EVE 655
+ + + +G G F VYKA +AIKK+ + +A E++
Sbjct: 10 KRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKI-----KLGHRSEAKDGINRTALREIK 64
Query: 656 ALSTAQHKNLVSLQGYCVHQGFRLLIYSYMENGSLDYWLHEKADGASQLD---WLTRLKI 712
L H N++ L H+ L++ +ME L+ + + + + ++
Sbjct: 65 LLQELSHPNIIGLLDAFGHKSNISLVFDFMET-DLEVIIKDNSLVLTPSHIKAYMLMT-- 121
Query: 713 ARGTSCGLAYMHQICEPHIVHRDIKSSNILLDDQFEAHLADFGLSRLI-LPYQTHVTTEL 771
GL Y+HQ I+HRD+K +N+LLD+ LADFGL++ P + + T
Sbjct: 122 ----LQGLEYLHQH---WILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAY--THQ 172
Query: 772 VGTLGYIPPE-------YGQAWVATLRGDMYSFGVVMLELLTGK 808
V T Y PE YG V DM++ G ++ ELL
Sbjct: 173 VVTRWYRAPELLFGARMYGVG-V-----DMWAVGCILAELLLRV 210
|
| >3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695 | Back alignment and structure |
|---|
Score = 95.0 bits (236), Expect = 3e-20
Identities = 65/237 (27%), Positives = 93/237 (39%), Gaps = 44/237 (18%)
Query: 607 DNFSQANIIGCGGFGLVYKATL-ANGTTLAIKKLSGDLGLMEREF---KAE---VEALST 659
++FS IIG GGFG VY G A+K L M++ E + +ST
Sbjct: 189 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVST 248
Query: 660 AQHKNLVSLQGYCVHQGFRL-LIYSYMENGSLDYWLHEKADGASQLDWLTRLKIARGT-- 716
+V + Y H +L I M G L Y L + A
Sbjct: 249 GDCPFIVCMS-YAFHTPDKLSFILDLMNGGDLHYHLSQH----------GVFSEADMRFY 297
Query: 717 ----SCGLAYMHQICEPHIVHRDIKSSNILLDDQFEAHLADFGLSRLILPYQTHVTTELV 772
GL +MH +V+RD+K +NILLD+ ++D GL+ + H V
Sbjct: 298 AAEIILGLEHMHNR---FVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHA---SV 351
Query: 773 GTLGYIPPE-------YGQAWVATLRGDMYSFGVVMLELLTGKRPVDVLKPKMSREL 822
GT GY+ PE Y + D +S G ++ +LL G P K K E+
Sbjct: 352 GTHGYMAPEVLQKGVAYDSS------ADWFSLGCMLFKLLRGHSPFRQHKTKDKHEI 402
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336 | Back alignment and structure |
|---|
Score = 91.6 bits (228), Expect = 4e-20
Identities = 66/326 (20%), Positives = 111/326 (34%), Gaps = 83/326 (25%)
Query: 591 TNEIKDLTIYELLKATDNFSQANIIGCGGFGLVYKAT-LANGTTLAIKKLSGDLGLMERE 649
+ D Y+L K ++G G G V + G A+K L D +E
Sbjct: 23 KYAVTDD--YQLSK--------QVLGLGVNGKVLECFHRRTGQKCALKLLY-DSPKARQE 71
Query: 650 FKAEVEAL-STAQHKNLVSLQGYC----VHQGFRLLIYSYMENGSL--------DYWLHE 696
V+ + ++V + + L+I ME G L D E
Sbjct: 72 ----VDHHWQASGGPHIVCILDVYENMHHGKRCLLIIMECMEGGELFSRIQERGDQAFTE 127
Query: 697 KADGASQLDWLTRLKIARGTSCGLAYMHQICEPHIVHRDIKSSNILLDDQFEAH---LAD 753
+ A+ +I R + ++H +I HRD+K N+L + + L D
Sbjct: 128 RE--AA--------EIMRDIGTAIQFLHSH---NIAHRDVKPENLLYTSKEKDAVLKLTD 174
Query: 754 FGLSRLILPYQTHVTTELVGTLGYIPPE------YGQAWVATLRGDMYSFGVVMLELLTG 807
FG ++ + T Y+ PE Y ++ DM+S GV+M LL G
Sbjct: 175 FGFAKET---TQNALQTPCYTPYYVAPEVLGPEKYDKS------CDMWSLGVIMYILLCG 225
Query: 808 KRPVDVLKPKMSRELVGWVLKMRSEGKQDQVFDPILRGK-GFD-EEMLQVLDVACMCVSQ 865
P + + I G+ GF E +V + A +
Sbjct: 226 FPPFY---------------SNTGQAISPGMKRRIRLGQYGFPNPEWSEVSEDAKQLIRL 270
Query: 866 ----NPFKRPTVKEVVE--WLNNVGA 885
+P +R T+ + + W+N
Sbjct: 271 LLKTDPTERLTITQFMNHPWINQSMV 296
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 93.9 bits (234), Expect = 6e-20
Identities = 25/107 (23%), Positives = 40/107 (37%), Gaps = 10/107 (9%)
Query: 379 QYNQLSNLPPA----------IYLANNSLSGNIPVEIGQLKSLHVLDLSNNNFSGTIPDE 428
+NQL LP A + + N++S P +L L VL+L +N S
Sbjct: 33 THNQLRRLPAANFTRYSQLTSLDVGFNTISKLEPELCQKLPMLKVLNLQHNELSQLSDKT 92
Query: 429 LSDLSNLEKLDLSGNHLVGEIPISLKGLHFLSSFSVAHNNLQGAVPS 475
+ +NL +L L N + L + ++HN L
Sbjct: 93 FAFCTNLTELHLMSNSIQKIKNNPFVKQKNLITLDLSHNGLSSTKLG 139
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 93.5 bits (233), Expect = 9e-20
Identities = 35/162 (21%), Positives = 59/162 (36%), Gaps = 13/162 (8%)
Query: 334 NLLSGEFPKELTALPALVSEAANDEVDRSYLELPVFVMPSNATNQQYNQLSNLPPAIYLA 393
N + P A+ L + + ++L + + NL L+
Sbjct: 181 NQIKEFSPGCFHAIGRLF------GLFLNNVQLGPSLTEKLCLELANTSIRNL----SLS 230
Query: 394 NNSLSGNIPVEIGQLK--SLHVLDLSNNNFSGTIPDELSDLSNLEKLDLSGNHLVGEIPI 451
N+ LS LK +L +LDLS NN + D + L LE L N++
Sbjct: 231 NSQLSTTSNTTFLGLKWTNLTMLDLSYNNLNVVGNDSFAWLPQLEYFFLEYNNIQHLFSH 290
Query: 452 SLKGLHFLSSFSVAHNNLQGAVPSGGQFDTFPSFSFEGNPEL 493
SL GL + ++ + + ++ S FSF+ L
Sbjct: 291 SLHGLFNVRYLNLKRSFTKQSI-SLASLPKIDDFSFQWLKCL 331
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 88.9 bits (221), Expect = 2e-18
Identities = 22/121 (18%), Positives = 39/121 (32%), Gaps = 17/121 (14%)
Query: 380 YNQLSNLPPAI-------YLANNSLSGNIPVEIGQLKSLHVLDLSNNNFSGTIPDELSDL 432
+ +L+ +P + L +N L + L LD+ N S P+ L
Sbjct: 13 HLKLTQVPDDLPTNITVLNLTHNQLRRLPAANFTRYSQLTSLDVGFNTISKLEPELCQKL 72
Query: 433 SNLEKLDLSGNHLVGEIPISLKGLHFLSSFSVAHNNLQGAVPSGGQFDTFPSFSFEGNPE 492
L+ L+L N L + L+ + N++Q + F
Sbjct: 73 PMLKVLNLQHNELSQLSDKTFAFCTNLTELHLMSNSIQK----------IKNNPFVKQKN 122
Query: 493 L 493
L
Sbjct: 123 L 123
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 88.5 bits (220), Expect = 3e-18
Identities = 26/125 (20%), Positives = 39/125 (31%), Gaps = 18/125 (14%)
Query: 379 QYNQLSNLPPA----------IYLANNSLSGNIPVEIGQLKSLHVLDLSNNNFSGTIPDE 428
+N +S L P + L +N LS +L L L +N+ +
Sbjct: 57 GFNTISKLEPELCQKLPMLKVLNLQHNELSQLSDKTFAFCTNLTELHLMSNSIQKIKNNP 116
Query: 429 LSDLSNLEKLDLSGNHLVGEIPISLKGLHFLSSFSVAHNNLQGAVPSGGQFDTFPSFSFE 488
NL LDLS N L + L L +++N +Q
Sbjct: 117 FVKQKNLITLDLSHNGLSSTKLGTQVQLENLQELLLSNNKIQALKSE--------ELDIF 168
Query: 489 GNPEL 493
N L
Sbjct: 169 ANSSL 173
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 87.7 bits (218), Expect = 6e-18
Identities = 27/132 (20%), Positives = 45/132 (34%), Gaps = 20/132 (15%)
Query: 380 YNQLSNLPPA----------IYLANNSLS--------GNIPVEIGQLKSLHVLDLSNNNF 421
N ++N+ + L +N+L+ G + L LH+L+L +N F
Sbjct: 489 NNNIANINDDMLEGLEKLEILDLQHNNLARLWKHANPGGPIYFLKGLSHLHILNLESNGF 548
Query: 422 SGTIPDELSDLSNLEKLDLSGNHLVGEIPISLKGLHFLSSFSVAHNNLQGAVPS--GGQF 479
+ DL L+ +DL N+L L S ++ N + G F
Sbjct: 549 DEIPVEVFKDLFELKIIDLGLNNLNTLPASVFNNQVSLKSLNLQKNLITSVEKKVFGPAF 608
Query: 480 DTFPSFSFEGNP 491
NP
Sbjct: 609 RNLTELDMRFNP 620
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 84.3 bits (209), Expect = 7e-17
Identities = 32/113 (28%), Positives = 43/113 (38%), Gaps = 20/113 (17%)
Query: 379 QYNQLSNLPP----------AIYLANNSLSG--NIPVEIGQLKSLHVLDLSNNNFSGTIP 426
YN+ L + L +L + P L++L +LDLSNNN +
Sbjct: 438 SYNKYLQLTRNSFALVPSLQRLMLRRVALKNVDSSPSPFQPLRNLTILDLSNNNIANIND 497
Query: 427 DELSDLSNLEKLDLSGNHL--------VGEIPISLKGLHFLSSFSVAHNNLQG 471
D L L LE LDL N+L G LKGL L ++ N
Sbjct: 498 DMLEGLEKLEILDLQHNNLARLWKHANPGGPIYFLKGLSHLHILNLESNGFDE 550
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 79.7 bits (197), Expect = 2e-15
Identities = 22/107 (20%), Positives = 38/107 (35%), Gaps = 15/107 (14%)
Query: 380 YNQLSNLPPA----------IYLANNSLSGNIPVEIG--QLKSLHVLDLSNNNFSGTIPD 427
+N LS+ + L+NN + E+ SL L+LS+N P
Sbjct: 130 HNGLSSTKLGTQVQLENLQELLLSNNKIQALKSEELDIFANSSLKKLELSSNQIKEFSPG 189
Query: 428 ELSDLSNLEKLDLSGNHLVGEIPISLKGLHFLSSF---SVAHNNLQG 471
+ L L L+ L + L +S S++++ L
Sbjct: 190 CFHAIGRLFGLFLNNVQLGPSLTEKLCLELANTSIRNLSLSNSQLST 236
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 78.9 bits (195), Expect = 3e-15
Identities = 28/130 (21%), Positives = 46/130 (35%), Gaps = 25/130 (19%)
Query: 379 QYNQLSNLPPA----------IYLANNSLS-GNIPVEIGQ---LKSLHVLDLSNNNFSGT 424
+ N + + + L+N+ S + E LH+L+L+ N S
Sbjct: 337 EDNDIPGIKSNMFTGLINLKYLSLSNSFTSLRTLTNETFVSLAHSPLHILNLTKNKISKI 396
Query: 425 IPDELSDLSNLEKLDLSGNHLVGEIPIS-LKGLHFLSSFSVAHNNLQGAVPSGGQFDTFP 483
D S L +LE LDL N + E+ +GL + +++N
Sbjct: 397 ESDAFSWLGHLEVLDLGLNEIGQELTGQEWRGLENIFEIYLSYNKYLQ----------LT 446
Query: 484 SFSFEGNPEL 493
SF P L
Sbjct: 447 RNSFALVPSL 456
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 70.8 bits (174), Expect = 1e-12
Identities = 16/105 (15%), Positives = 29/105 (27%), Gaps = 11/105 (10%)
Query: 380 YNQLSNLPPAI----------YLANNSLSGNIPVEIGQLKSLHVLDLSNNNFSGTIPDEL 429
N +P + L N+L+ SL L+L N +
Sbjct: 545 SNGFDEIPVEVFKDLFELKIIDLGLNNLNTLPASVFNNQVSLKSLNLQKNLITSVEKKVF 604
Query: 430 SD-LSNLEKLDLSGNHLVGEIPISLKGLHFLSSFSVAHNNLQGAV 473
NL +LD+ N +++++ L
Sbjct: 605 GPAFRNLTELDMRFNPFDCTCESIAWFVNWINETHTNIPELSSHY 649
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 58.5 bits (142), Expect = 8e-09
Identities = 16/62 (25%), Positives = 27/62 (43%), Gaps = 3/62 (4%)
Query: 410 SLHVLDLSNNNFSGTIPDELSDLSNLEKLDLSGNHLVGEIPISLKGLHFLSSFSVAHNNL 469
S V D S+ + +PD+L +N+ L+L+ N L + L+S V N +
Sbjct: 5 SHEVADCSHLKLT-QVPDDL--PTNITVLNLTHNQLRRLPAANFTRYSQLTSLDVGFNTI 61
Query: 470 QG 471
Sbjct: 62 SK 63
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 46.5 bits (111), Expect = 3e-05
Identities = 18/97 (18%), Positives = 32/97 (32%), Gaps = 17/97 (17%)
Query: 380 YNQLSNLPPAI----------YLANNSLSGNIPVEIG-QLKSLHVLDLSNNNFSGTIPD- 427
N L+ LP ++ L N ++ G ++L LD+ N F T
Sbjct: 569 LNNLNTLPASVFNNQVSLKSLNLQKNLITSVEKKVFGPAFRNLTELDMRFNPFDCTCESI 628
Query: 428 ----ELSDLSNLEKLDLSGNHLVGEIPISLKGLHFLS 460
+ ++ +LS +H + P G
Sbjct: 629 AWFVNWINETHTNIPELS-SHYLCNTPPHYHGFPVRL 664
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 90.3 bits (225), Expect = 8e-20
Identities = 57/219 (26%), Positives = 92/219 (42%), Gaps = 38/219 (17%)
Query: 607 DNFSQANIIGCGGFGLVYKAT-LANGTTLAIKKLSGDLGLMEREFKA-------EVEALS 658
+ + + IG G +G+V+K G +AIKK L + E+ L
Sbjct: 3 EKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKF-----LESEDDPVIKKIALREIRMLK 57
Query: 659 TAQHKNLVSLQGYCVHQGFRL-LIYSYMENGSLDYWLHEKADGASQLDWLTRLKIARGTS 717
+H NLV+L + RL L++ Y ++ ++ + L G + I T
Sbjct: 58 QLKHPNLVNLLE-VFRRKRRLHLVFEYCDH-TVLHELDRYQRG---VPEHLVKSITWQTL 112
Query: 718 CGLAYMHQICEPHIVHRDIKSSNILLDDQFEAHLADFGLSRLI-LPYQTHVTTELVGTLG 776
+ + H+ + +HRD+K NIL+ L DFG +RL+ P + + V T
Sbjct: 113 QAVNFCHKH---NCIHRDVKPENILITKHSVIKLCDFGFARLLTGPSDYY--DDEVATRW 167
Query: 777 YIPPE-------YGQAWVATLRGDMYSFGVVMLELLTGK 808
Y PE YG V D+++ G V ELL+G
Sbjct: 168 YRSPELLVGDTQYGPP-V-----DVWAIGCVFAELLSGV 200
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335 | Back alignment and structure |
|---|
Score = 90.6 bits (225), Expect = 1e-19
Identities = 63/313 (20%), Positives = 108/313 (34%), Gaps = 90/313 (28%)
Query: 600 YELLKATDNFSQANIIGCGGFGLVYKAT-LANGTTLAIK-----KLSGDLGLMEREF--- 650
Y + +G G FG V+ A + +K K+ D + + +
Sbjct: 26 YSTMS---------PLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKV 76
Query: 651 KAEVEALSTAQHKNLVSLQGYCVHQGFRLLIYSYMENGSLDYWLHEKADGASQL-DWL-- 707
E+ LS +H N++ + EN + EK L ++
Sbjct: 77 TLEIAILSRVEHANIIKV-------------LDIFENQGFFQLVMEKHGSGLDLFAFIDR 123
Query: 708 -TRL------KIARGTSCGLAYMHQICEPHIVHRDIKSSNILLDDQFEAHLADFGLSRLI 760
RL I R + Y+ I+HRDIK NI++ + F L DFG + +
Sbjct: 124 HPRLDEPLASYIFRQLVSAVGYLRLK---DIIHRDIKDENIVIAEDFTIKLIDFGSAAYL 180
Query: 761 LPYQTHVTTELVGTLGYIPPEYGQAWVATLRG--------DMYSFGVVMLELLTGKRPVD 812
+ T GT+ Y PE L G +M+S GV + L+ + P
Sbjct: 181 ERGKLFYTF--CGTIEYCAPE-------VLMGNPYRGPELEMWSLGVTLYTLVFEENPFC 231
Query: 813 VLKPKMSRELV--GWVLKMRSEGKQDQVFDPILRGKGFDEEMLQVLDVACMCVSQNPFKR 870
L+ + + V S+ ++ G +LQ P +R
Sbjct: 232 ELEETVEAAIHPPYLV----SKELMS-----LVSG------LLQP----------VPERR 266
Query: 871 PTVKEVVE--WLN 881
T++++V W+
Sbjct: 267 TTLEKLVTDPWVT 279
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360 | Back alignment and structure |
|---|
Score = 90.8 bits (226), Expect = 1e-19
Identities = 52/229 (22%), Positives = 89/229 (38%), Gaps = 43/229 (18%)
Query: 604 KATDNFSQANIIGCGGFGLVYKATLA-NGTTLAIKKLSGDLGLMEREFKAEVEALSTAQH 662
K D F + G G FG V G ++AIKK+ D RE + ++ L+ H
Sbjct: 20 KEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPRFRNRELQ-IMQDLAVLHH 78
Query: 663 KNLVSLQGYCVHQGFR-------LLIYSYMENGSLDYWLHEKADGASQL-DWLTRL---- 710
N+V LQ Y G R ++ Y+ LH + +
Sbjct: 79 PNIVQLQSYFYTLGERDRRDIYLNVVMEYVP---DT--LHRCCRNYYRRQVAPPPILIKV 133
Query: 711 ---KIARGTSCGLAYMHQICEPHIVHRDIKSSNILLDDQ-FEAHLADFGLSRLILPYQTH 766
++ R + +H ++ HRDIK N+L+++ L DFG ++ + P + +
Sbjct: 134 FLFQLIRS----IGCLHLPS-VNVCHRDIKPHNVLVNEADGTLKLCDFGSAKKLSPSEPN 188
Query: 767 VTTELVGTLGYIPPE-------YGQAWVATLRGDMYSFGVVMLELLTGK 808
+ + Y PE Y A D++S G + E++ G+
Sbjct: 189 --VAYICSRYYRAPELIFGNQHYTTAV------DIWSVGCIFAEMMLGE 229
|
| >1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310 | Back alignment and structure |
|---|
Score = 88.8 bits (221), Expect = 3e-19
Identities = 55/216 (25%), Positives = 89/216 (41%), Gaps = 26/216 (12%)
Query: 607 DNFSQANIIGCGGFGLVYKATL-ANGTTLAIKKLSGDLGLMEREF---KAEVEALSTAQH 662
++F I+G G F V A A AIK L + E + E + +S H
Sbjct: 30 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 89
Query: 663 KNLVSLQGYCVHQGFRL-LIYSYMENGSLDYWLHEKADGASQLDWLTRLKIARGTSCGLA 721
V L + +L SY +NG L ++ + G+ TR A L
Sbjct: 90 PFFVKLY-FTFQDDEKLYFGLSYAKNGELLKYI--RKIGSFDET-CTRFYTAEIV-SALE 144
Query: 722 YMHQICEPHIVHRDIKSSNILLDDQFEAHLADFGLSRLILPYQTHVTTE-LVGTLGYIPP 780
Y+H I+HRD+K NILL++ + DFG ++++ P VGT Y+ P
Sbjct: 145 YLHGK---GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSP 201
Query: 781 E------YGQAWVATLRGDMYSFGVVMLELLTGKRP 810
E ++ D+++ G ++ +L+ G P
Sbjct: 202 ELLTEKSACKS------SDLWALGCIIYQLVAGLPP 231
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400 | Back alignment and structure |
|---|
Score = 89.8 bits (223), Expect = 3e-19
Identities = 61/313 (19%), Positives = 99/313 (31%), Gaps = 92/313 (29%)
Query: 614 IIGCGGFGLVYKAT-LANGTTLAIKKLSGDLGLMEREFKAEVEALSTAQ-HKNLVSLQGY 671
++G G G V + A+K L D R EVE A ++V +
Sbjct: 69 VLGLGINGKVLQIFNKRTQEKFALKMLQ-DCPKARR----EVELHWRASQCPHIVRIVDV 123
Query: 672 C----VHQGFRLLIYSYMENGSL--------DYWLHEKADGASQLDWLTRLKIARGTSCG 719
+ L++ ++ G L D E+ AS+ I +
Sbjct: 124 YENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTERE--ASE--------IMKSIGEA 173
Query: 720 LAYMHQICEPHIVHRDIKSSNILLDDQFEAH---LADFGLSRLILPYQTHVTTELVGTLG 776
+ Y+H I +I HRD+K N+L + L DFG ++ + + T T
Sbjct: 174 IQYLHSI---NIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTP--CYTPY 228
Query: 777 YIPPE------YGQAWVATLRGDMYSFGVVMLELLTGKRPVDVLKPKMSRELVGWVLKMR 830
Y+ PE Y ++ DM+S GV+M LL G P
Sbjct: 229 YVAPEVLGPEKYDKS------CDMWSLGVIMYILLCGYPPFYSNHGLAI----------- 271
Query: 831 SEGKQDQVFDPILRGK-GFDEE---------------MLQVLDVACMCVSQNPFKRPTVK 874
+ I G+ F +L+ P +R T+
Sbjct: 272 ----SPGMKTRIRMGQYEFPNPEWSEVSEEVKMLIRNLLKT----------EPTQRMTIT 317
Query: 875 EVVE--WLNNVGA 885
E + W+
Sbjct: 318 EFMNHPWIMQSTK 330
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394 | Back alignment and structure |
|---|
Score = 89.7 bits (223), Expect = 4e-19
Identities = 57/227 (25%), Positives = 97/227 (42%), Gaps = 50/227 (22%)
Query: 606 TDNFSQANIIGCGGFGLVYKATLANGTTLAIKKLSGDLGLMEREFKA-EVEALSTAQHKN 664
++ +IG G FG+V++A L +AIKK+ L ++ FK E++ + +H N
Sbjct: 39 EIAYTNCKVIGNGSFGVVFQAKLVESDEVAIKKV-----LQDKRFKNRELQIMRIVKHPN 93
Query: 665 LVSLQGYCVHQGFRL-------LIYSYMENGSLDYWLHEKADGASQL-DWLTRLKI---- 712
+V L+ + L+ Y+ ++ + ++L + L I
Sbjct: 94 VVDLK-AFFYSNGDKKDEVFLNLVLEYVP---ET--VYRASRHYAKLKQTMPMLLIKLYM 147
Query: 713 ---ARGTSCGLAYMHQICEPHIVHRDIKSSNILLD-DQFEAHLADFGLSRLILPYQTHVT 768
R LAY+H I I HRDIK N+LLD L DFG +++++ + +
Sbjct: 148 YQLLRS----LAYIHSI---GICHRDIKPQNLLLDPPSGVLKLIDFGSAKILIAGEPN-- 198
Query: 769 TELVGTLGYIPPE-------YGQAWVATLRGDMYSFGVVMLELLTGK 808
+ + Y PE Y D++S G VM EL+ G+
Sbjct: 199 VSYICSRYYRAPELIFGATNYTTNI------DIWSTGCVMAELMQGQ 239
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405 | Back alignment and structure |
|---|
Score = 89.5 bits (222), Expect = 4e-19
Identities = 56/217 (25%), Positives = 94/217 (43%), Gaps = 35/217 (16%)
Query: 615 IGCGGFGLVYKATLANGTT---LAIKKLSGDLGLMEREFKAEVEALSTAQHKNLVSLQGY 671
+G G +G VYKA +G A+K++ G G+ + E+ L +H N++SLQ
Sbjct: 29 VGRGTYGHVYKAKRKDGKDDKDYALKQIEGT-GISMSACR-EIALLRELKHPNVISLQKV 86
Query: 672 CVHQGFRL--LIYSYMEN---GSLDYWLHEKA-DGASQLDWLTRLKIARGTSCGLAYMHQ 725
+ R L++ Y E+ + + KA QL + G+ Y+H
Sbjct: 87 FLSHADRKVWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHA 146
Query: 726 ICEPHIVHRDIKSSNILLDDQFEAH----LADFGLSRLI---LPYQTHVTTELVGTLGYI 778
++HRD+K +NIL+ + +AD G +RL L + +V T Y
Sbjct: 147 N---WVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVV-TFWYR 202
Query: 779 PPE-------YGQAWVATLRGDMYSFGVVMLELLTGK 808
PE Y +A + D+++ G + ELLT +
Sbjct: 203 APELLLGARHYTKA-I-----DIWAIGCIFAELLTSE 233
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320 | Back alignment and structure |
|---|
Score = 87.8 bits (218), Expect = 6e-19
Identities = 70/354 (19%), Positives = 119/354 (33%), Gaps = 99/354 (27%)
Query: 564 TISSTSNFGVSPEADKDASLVMLFPNNTNEIKDLTIYELLKATDNFSQANIIGCGGFGLV 623
+ ++P D A+ + Y++ ++G GGFG V
Sbjct: 12 SGLVPRGSHMAPCNDLHATKLAPGKEKEPLESQ---YQVGP---------LLGSGGFGSV 59
Query: 624 YKAT-LANGTTLAIKKLS-------GDLGLMEREFKAEVEALSTAQHK--NLVSLQGYCV 673
Y +++ +AIK + G+L R EV L ++ L
Sbjct: 60 YSGIRVSDNLPVAIKHVEKDRISDWGELPNGTR-VPMEVVLLKKVSSGFSGVIRL----- 113
Query: 674 HQGFRLLIYSYMENGSLDYWLHEKADGASQL-DWLT---RL------KIARGTSCGLAYM 723
+ E + E+ + L D++T L + +
Sbjct: 114 --------LDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHC 165
Query: 724 HQICEPHIVHRDIKSSNILLD-DQFEAHLADFGLSRLILPYQTHVTTELVGTLGYIPPEY 782
H ++HRDIK NIL+D ++ E L DFG L T T GT Y PPE+
Sbjct: 166 HNC---GVLHRDIKDENILIDLNRGELKLIDFGSGA--LLKDTVYTD-FDGTRVYSPPEW 219
Query: 783 GQAWVATLRGDMY--------SFGVVMLELLTGKRPVDVLKPKMSRELVGWVLKMR---S 831
+R Y S G+++ +++ G P + E++ + R S
Sbjct: 220 -------IRYHRYHGRSAAVWSLGILLYDMVCGDIPFE-----HDEEIIRGQVFFRQRVS 267
Query: 832 EGKQDQVFDPILRGKGFDEEMLQVLDVACMCVSQNPFKRPTVKEVVE--WLNNV 883
Q ++R L + P RPT +E+ W+ +V
Sbjct: 268 SECQH-----LIRW------CLAL----------RPSDRPTFEEIQNHPWMQDV 300
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420 | Back alignment and structure |
|---|
Score = 88.2 bits (219), Expect = 2e-18
Identities = 59/225 (26%), Positives = 97/225 (43%), Gaps = 45/225 (20%)
Query: 606 TDNFSQANIIGCGGFGLVYKATL-ANGTTLAIKKLSGDLGLMEREFKA-EVEALSTAQHK 663
+++ +IG G FG+VY+A L +G +AIKK+ L ++ FK E++ + H
Sbjct: 53 EVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKV-----LQDKRFKNRELQIMRKLDHC 107
Query: 664 NLVSLQGYCVHQGFRL-------LIYSYMENGSLDYWLHEKADGASQLDWLTRLK----- 711
N+V L+ Y + L+ Y+ ++ + L + +K
Sbjct: 108 NIVRLR-YFFYSSGEKKDEVYLNLVLDYVPE-TVYRVARHYSRAKQTLP-VIYVKLYMYQ 164
Query: 712 IARGTSCGLAYMHQICEPHIVHRDIKSSNILLD-DQFEAHLADFGLSRLILPYQTHVTTE 770
+ R LAY+H I HRDIK N+LLD D L DFG ++ ++
Sbjct: 165 LFRS----LAYIHSF---GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVR--GEPNVS 215
Query: 771 LVGTLGYIPPE-------YGQAWVATLRGDMYSFGVVMLELLTGK 808
+ + Y PE Y + D++S G V+ ELL G+
Sbjct: 216 YICSRYYRAPELIFGATDYTSSI------DVWSAGCVLAELLLGQ 254
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371 | Back alignment and structure |
|---|
Score = 87.4 bits (217), Expect = 2e-18
Identities = 67/306 (21%), Positives = 112/306 (36%), Gaps = 50/306 (16%)
Query: 606 TDNFSQANIIGCGGFGLVYKAT-LANGTTLAIKKLS---GDLGLMEREFKAEVEALSTAQ 661
+ IG G G+V A +AIKKLS + +R ++ E+ +
Sbjct: 24 LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYR-ELVLMKCVN 82
Query: 662 HKNLVSLQGYCVHQGFRLL-----IYSYMENGSLDYWLHE--KADGASQLDWLTRLKIAR 714
HKN++ L V + L +Y ME +D L + + +LD +
Sbjct: 83 HKNIIGL--LNVFTPQKSLEEFQDVYIVME--LMDANLCQVIQ----MELDHERMSYLLY 134
Query: 715 GTSCGLAYMHQICEPHIVHRDIKSSNILLDDQFEAHLADFGLSRLILPYQTHVTTELVGT 774
CG+ ++H I+HRD+K SNI++ + DFGL+R + + T V T
Sbjct: 135 QMLCGIKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGT--SFMMTPYVVT 189
Query: 775 LGYIPPEYGQAWVATLRGDMYSFGVVMLELLTGK--------------------RPVDVL 814
Y PE D++S G +M E++ G P
Sbjct: 190 RYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEF 249
Query: 815 KPKMSRELVGWVLKMRSEGKQD--QVFDPILRGKGFDEEML---QVLDVACMCVSQNPFK 869
K+ + +V ++F +L + L Q D+ + + K
Sbjct: 250 MKKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASK 309
Query: 870 RPTVKE 875
R +V E
Sbjct: 310 RISVDE 315
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464 | Back alignment and structure |
|---|
Score = 88.0 bits (218), Expect = 2e-18
Identities = 68/350 (19%), Positives = 118/350 (33%), Gaps = 50/350 (14%)
Query: 564 TISSTSNFGVSPEADKDASLVMLFPNNTNEIKDLTIYELLKAT----DNFSQANIIGCGG 619
+ G + D + + E+ +T + IG G
Sbjct: 15 DVKIAFCQGFDKQVDVSYIAKHYNMSKSKVDNQFYSVEVGDSTFTVLKRYQNLKPIGSGA 74
Query: 620 FGLVYKAT-LANGTTLAIKKLS---GDLGLMEREFKAEVEALSTAQHKNLVSLQG-YCVH 674
G+V A +AIKKLS + +R ++ E+ + HKN++SL +
Sbjct: 75 QGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYR-ELVLMKCVNHKNIISLLNVFTPQ 133
Query: 675 QGFRLL--IYSYMENGSLDYWLHEKADGASQLDWLTRLKIARGTSCGLAYMHQICEPHIV 732
+ +Y ME + L + +LD + CG+ ++H I+
Sbjct: 134 KTLEEFQDVYLVMELMDAN--LCQVI--QMELDHERMSYLLYQMLCGIKHLHSA---GII 186
Query: 733 HRDIKSSNILLDDQFEAHLADFGLSRLILPYQTHVTTELVGTLGYIPPEYGQAWVATLRG 792
HRD+K SNI++ + DFGL+R + + T V T Y PE
Sbjct: 187 HRDLKPSNIVVKSDCTLKILDFGLARTAGT--SFMMTPYVVTRYYRAPEVILGMGYKENV 244
Query: 793 DMYSFGVVMLELLTGK--------------------RPVDVLKPKMSRELVGWVLKMRSE 832
D++S G +M E++ K P K+ + +V
Sbjct: 245 DIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNYVENRPKY 304
Query: 833 GKQDQVFDPILRGKGFDEEML-------QVLDVACMCVSQNPFKRPTVKE 875
F + F + Q D+ + +P KR +V +
Sbjct: 305 AGLT--FPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDD 352
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 87.8 bits (218), Expect = 4e-18
Identities = 23/115 (20%), Positives = 34/115 (29%), Gaps = 11/115 (9%)
Query: 380 YNQLSNLPPA----------IYLANNSLSGNIPVEIGQLKSLHVLDLSNNNFSGTIPDEL 429
+N L L + L+ + L L L L+ N P
Sbjct: 41 FNPLKILKSYSFSNFSELQWLDLSRCEIETIEDKAWHGLHHLSNLILTGNPIQSFSPGSF 100
Query: 430 SDLSNLEKLDLSGNHLVGEIPISLKGLHFLSSFSVAHNNLQGAVPSGGQFDTFPS 484
S L++LE L L + L L +VAHN + F +
Sbjct: 101 SGLTSLENLVAVETKLASLESFPIGQLITLKKLNVAHNFIHS-CKLPAYFSNLTN 154
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 87.0 bits (216), Expect = 8e-18
Identities = 25/127 (19%), Positives = 39/127 (30%), Gaps = 16/127 (12%)
Query: 379 QYNQLSNLPPAI----------YLANNSLSGNIPVEI-GQLKSLHVLDLSNNNFSGTIPD 427
Y I +A NS N + +L LDLS
Sbjct: 432 SYTNTKIDFDGIFLGLTSLNTLKMAGNSFKDNTLSNVFANTTNLTFLDLSKCQLEQISWG 491
Query: 428 ELSDLSNLEKLDLSGNHLVGEIPISLKGLHFLSSFSVAHNNLQGAVPSGGQFDTFPS--- 484
L L+ L++S N+L+ L+ LS+ + N ++ G S
Sbjct: 492 VFDTLHRLQLLNMSHNNLLFLDSSHYNQLYSLSTLDCSFNRIET--SKGILQHFPKSLAF 549
Query: 485 FSFEGNP 491
F+ N
Sbjct: 550 FNLTNNS 556
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 79.7 bits (197), Expect = 2e-15
Identities = 27/122 (22%), Positives = 34/122 (27%), Gaps = 17/122 (13%)
Query: 379 QYNQLSNLPPAI-------YLANNSLSGNIPVEIGQLKSLHVLDLSNNNFSGTIPDELSD 431
+LS +P I L+ N L L LDLS
Sbjct: 19 MDQKLSKVPDDIPSSTKNIDLSFNPLKILKSYSFSNFSELQWLDLSRCEIETIEDKAWHG 78
Query: 432 LSNLEKLDLSGNHLVGEIPISLKGLHFLSSFSVAHNNLQGAVPSGGQFDTFPSFSFEGNP 491
L +L L L+GN + P S GL L + L SF
Sbjct: 79 LHHLSNLILTGNPIQSFSPGSFSGLTSLENLVAVETKLAS----------LESFPIGQLI 128
Query: 492 EL 493
L
Sbjct: 129 TL 130
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 78.9 bits (195), Expect = 3e-15
Identities = 19/102 (18%), Positives = 36/102 (35%), Gaps = 11/102 (10%)
Query: 379 QYNQLSNLPPA-----------IYLANNSLSGNIPVEIGQLKSLHVLDLSNNNFSGTIPD 427
N + + + L+ L L L +L++S+NN
Sbjct: 456 AGNSFKDNTLSNVFANTTNLTFLDLSKCQLEQISWGVFDTLHRLQLLNMSHNNLLFLDSS 515
Query: 428 ELSDLSNLEKLDLSGNHLVGEIPISLKGLHFLSSFSVAHNNL 469
+ L +L LD S N + I L+ F++ +N++
Sbjct: 516 HYNQLYSLSTLDCSFNRIETSKGILQHFPKSLAFFNLTNNSV 557
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 75.8 bits (187), Expect = 3e-14
Identities = 17/126 (13%), Positives = 34/126 (26%), Gaps = 21/126 (16%)
Query: 379 QYNQLSNLPPAI---------YLANNSLSGNIPVE-IGQLKSLHVLDLSNNNFSGTIPDE 428
+N + +++L L+ L LD+S N
Sbjct: 384 SFNGAIIMSANFMGLEELQHLDFQHSTLKRVTEFSAFLSLEKLLYLDISYTNTKIDFDGI 443
Query: 429 LSDLSNLEKLDLSGNHLVGEIPIS-LKGLHFLSSFSVAHNNLQGAVPSGGQFDTFPSFSF 487
L++L L ++GN + L+ ++ L+ F
Sbjct: 444 FLGLTSLNTLKMAGNSFKDNTLSNVFANTTNLTFLDLSKCQLEQ----------ISWGVF 493
Query: 488 EGNPEL 493
+ L
Sbjct: 494 DTLHRL 499
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 68.5 bits (168), Expect = 5e-12
Identities = 20/113 (17%), Positives = 40/113 (35%), Gaps = 16/113 (14%)
Query: 379 QYNQLSNLPPA----------IYLANNSLSG-NIPVEIGQLKSLHVLDLSNNNFSGTIPD 427
+L++L + +A+N + +P L +L +DLS N +
Sbjct: 112 VETKLASLESFPIGQLITLKKLNVAHNFIHSCKLPAYFSNLTNLVHVDLSYNYIQTITVN 171
Query: 428 ELSDLSNL----EKLDLSGNHLVGEIPISLKGLHFLSSFSVAHNNLQGAVPSG 476
+L L LD+S N + + +G+ L ++ N +
Sbjct: 172 DLQFLRENPQVNLSLDMSLNPIDFIQDQAFQGIK-LHELTLRGNFNSSNIMKT 223
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 60.0 bits (146), Expect = 2e-09
Identities = 21/120 (17%), Positives = 37/120 (30%), Gaps = 24/120 (20%)
Query: 379 QYNQLSNLPPA--------------IYLANNSLSGNIPVEIGQLKSLHVLDLSNNNFSGT 424
YN + + + ++ N + I + Q LH L L N S
Sbjct: 161 SYNYIQTITVNDLQFLRENPQVNLSLDMSLNPID-FIQDQAFQGIKLHELTLRGNFNSSN 219
Query: 425 IPDE-LSDLSNLEKLDLSGNHLVGEIPIS------LKGLHFLS--SFSVAHNNLQGAVPS 475
I L +L+ L L E + ++GL ++ F + + N
Sbjct: 220 IMKTCLQNLAGLHVHRLILGEFKDERNLEIFEPSIMEGLCDVTIDEFRLTYTNDFSDDIV 279
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 59.7 bits (145), Expect = 3e-09
Identities = 22/101 (21%), Positives = 32/101 (31%), Gaps = 15/101 (14%)
Query: 380 YNQLSNLPPA--------IYLANNSLSGNIPVEIGQLKSLHVLDLSNNNFSGTIPDELSD 431
+ L + + L L L L L+ N G+I +
Sbjct: 294 GVSIKYLEDVPKHFKWQSLSIIRCQLKQ---FPTLDLPFLKSLTLTMNK--GSISFKKVA 348
Query: 432 LSNLEKLDLSGNHL--VGEIPISLKGLHFLSSFSVAHNNLQ 470
L +L LDLS N L G S G + L ++ N
Sbjct: 349 LPSLSYLDLSRNALSFSGCCSYSDLGTNSLRHLDLSFNGAI 389
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 57.0 bits (138), Expect = 2e-08
Identities = 16/116 (13%), Positives = 36/116 (31%), Gaps = 4/116 (3%)
Query: 358 EVDRSYLELPVFVMPSNATNQQYNQLSNLPPAIYLANNSLSGNIPVEIGQLKSLHV--LD 415
E+ +M + N + L + +L P + L + +
Sbjct: 208 ELTLRGNFNSSNIMKTCLQNLAGLHVHRLILGEFKDERNLEIFEPSIMEGLCDVTIDEFR 267
Query: 416 LSNNNFSGTIPDELSDLSNLEKLDLSGNHLVGEIPISLKGLHFLSSFSVAHNNLQG 471
L+ N + L+N+ + L+G + + + S S+ L+
Sbjct: 268 LTYTNDFSDDIVKFHCLANVSAMSLAGVSI--KYLEDVPKHFKWQSLSIIRCQLKQ 321
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 52.0 bits (125), Expect = 8e-07
Identities = 24/113 (21%), Positives = 38/113 (33%), Gaps = 16/113 (14%)
Query: 381 NQLSNLPPAIYLANNSLSGNIPVEIGQLKSLHVLDLSNNNFSGTIPDELSDLSNLEKLDL 440
+ L+N+ A+ LA S+ ++ + L + P DL L+ L L
Sbjct: 282 HCLANVS-AMSLAGVSI--KYLEDVPKHFKWQSLSIIRCQLK-QFPT--LDLPFLKSLTL 335
Query: 441 SGNHLVGEIPISLKGLHFLSSFSVAHNNLQGAVPSGGQFDTFPSFSFEGNPEL 493
+ N I L LS ++ N L S+S G L
Sbjct: 336 TMNKG--SISFKKVALPSLSYLDLSRNALSF-SGCC-------SYSDLGTNSL 378
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 42.7 bits (101), Expect = 5e-04
Identities = 15/95 (15%), Positives = 31/95 (32%), Gaps = 14/95 (14%)
Query: 379 QYNQLSNLPPAI----------YLANNSLSGNIPVEIGQLKSLHVLDLSNNNFSGTIPD- 427
+N L L + + N + + + KSL +L+NN+ + I +
Sbjct: 505 SHNNLLFLDSSHYNQLYSLSTLDCSFNRIETSKGILQHFPKSLAFFNLTNNSVA-CICEH 563
Query: 428 -ELSDLSNLEKLDLSG-NHLVGEIPISLKGLHFLS 460
+ +K L + P+ + L
Sbjct: 564 QKFLQWVKEQKQFLVNVEQMTCATPVEMNTSLVLD 598
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410 | Back alignment and structure |
|---|
Score = 85.9 bits (213), Expect = 8e-18
Identities = 55/228 (24%), Positives = 81/228 (35%), Gaps = 48/228 (21%)
Query: 607 DNFSQANIIGCGGFGLVY----KATLANGTTLAIKKLSGDLGLMERE---FKAEVEALST 659
+++ +IG G FG V K+T A+K LS + + F E + ++
Sbjct: 69 EDYEVVKVIGRGAFGEVQLVRHKST---RKVYAMKLLSKFEMIKRSDSAFFWEERDIMAF 125
Query: 660 AQHKNLVSLQGYCVHQGFRL-LIYSYMENGSLDYWLHEKADGASQLDWLTRLKIARG--- 715
A +V L Y L ++ YM G L + +
Sbjct: 126 ANSPWVVQLF-YAFQDDRYLYMVMEYMPGGDLVNLMSNY-----------DVPEKWARFY 173
Query: 716 ---TSCGLAYMHQICEPHIVHRDIKSSNILLDDQFEAHLADFGLSRLILPYQTHVTTELV 772
L +H + +HRD+K N+LLD LADFG + V
Sbjct: 174 TAEVVLALDAIHSM---GFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAV 230
Query: 773 GTLGYIPPE----------YGQAWVATLRGDMYSFGVVMLELLTGKRP 810
GT YI PE YG+ D +S GV + E+L G P
Sbjct: 231 GTPDYISPEVLKSQGGDGYYGRE-C-----DWWSVGVFLYEMLVGDTP 272
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312 | Back alignment and structure |
|---|
Score = 83.9 bits (208), Expect = 1e-17
Identities = 66/334 (19%), Positives = 109/334 (32%), Gaps = 106/334 (31%)
Query: 588 PNNTNEIKDLTIYELLKATDNFSQANIIGCGGFGLVYKAT-LANGTTLAIKKLS------ 640
P + Y L ++G GGFG V+ L + +AIK +
Sbjct: 21 PGGKDREAFEAEYRLGP---------LLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLG 71
Query: 641 ----GDLGLMEREFKAEVEALSTAQHKNLVSLQGYCVHQGFRLLIYSYMENGSLDYWLHE 696
D E + + H ++ L + E + E
Sbjct: 72 WSPLSDSVTCPLEVALLWKVGAGGGHPGVIRL-------------LDWFETQEGFMLVLE 118
Query: 697 KADGASQL-DWLT---RLK--IARGTSCGLAYMHQI------CEPH-IVHRDIKSSNILL 743
+ A L D++T L +R + Q+ C +VHRDIK NIL+
Sbjct: 119 RPLPAQDLFDYITEKGPLGEGPSR------CFFGQVVAAIQHCHSRGVVHRDIKDENILI 172
Query: 744 D-DQFEAHLADFGLSRLIL--PYQTHVTTELVGTLGYIPPEYGQAWVATLRGDMY----- 795
D + A L DFG L+ PY GT Y PPE+ + Y
Sbjct: 173 DLRRGCAKLIDFGSGALLHDEPYTD-----FDGTRVYSPPEW-------ISRHQYHALPA 220
Query: 796 ---SFGVVMLELLTGKRPVDVLKPKMSRELVGWVLKMR---SEGKQDQVFDPILRGKGFD 849
S G+++ +++ G P + +E++ L S ++R
Sbjct: 221 TVWSLGILLYDMVCGDIPFE-----RDQEILEAELHFPAHVSPDCCA-----LIRR---- 266
Query: 850 EEMLQVLDVACMCVSQNPFKRPTVKEVVE--WLN 881
L P RP+++E++ W+
Sbjct: 267 --CLAP----------KPSSRPSLEEILLDPWMQ 288
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362 | Back alignment and structure |
|---|
Score = 84.3 bits (209), Expect = 1e-17
Identities = 51/232 (21%), Positives = 78/232 (33%), Gaps = 47/232 (20%)
Query: 600 YELLKATDNFSQANIIGCGGFGLVYKATLANGTTLAIKKLS--GDLGLMEREFKAEVEA- 656
Y + + I G +G V + G +AIK++ G
Sbjct: 24 YTVQR---------FISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCK 74
Query: 657 --------LSTAQHKNLVSLQGYCVHQGFRLL--IYSYMENGSLDYWLHEKADGASQLDW 706
L+ H N++ L+ VH + +Y E + L + Q
Sbjct: 75 RVLREIRLLNHFHHPNILGLRDIFVHFEEPAMHKLYLVTE--LMRTDLAQVI--HDQRIV 130
Query: 707 LTRLKI---ARGTSCGLAYMHQICEPHIVHRDIKSSNILLDDQFEAHLADFGLSRLILPY 763
++ I GL +H E +VHRD+ NILL D + + DF L+R
Sbjct: 131 ISPQHIQYFMYHILLGLHVLH---EAGVVHRDLHPGNILLADNNDITICDFNLAREDTA- 186
Query: 764 QTHVTTELVGTLGYIPPE-------YGQAWVATLRGDMYSFGVVMLELLTGK 808
T V Y PE + + DM+S G VM E+ K
Sbjct: 187 -DANKTHYVTHRWYRAPELVMQFKGFTKLV------DMWSAGCVMAEMFNRK 231
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330 | Back alignment and structure |
|---|
Score = 83.5 bits (207), Expect = 2e-17
Identities = 48/231 (20%), Positives = 87/231 (37%), Gaps = 45/231 (19%)
Query: 600 YELLK----ATDNFSQANIIGCGGFGLVYKAT-LANGTTLAIKKLSGDLGLMEREFKAEV 654
YE D++ +G G + V++A + N + +K L +++ K E+
Sbjct: 25 YESHVVEWGNQDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPV---KKKKIKREI 81
Query: 655 EALST-AQHKNLVSLQGYCVH--QGFRL-LIYSYMENGSLDYWLHEKADGASQLDWLTRL 710
+ L N+++L V L++ ++ N D LT
Sbjct: 82 KILENLRGGPNIITLAD-IVKDPVSRTPALVFEHVNN----------TDFKQLYQTLTDY 130
Query: 711 KIA---RGTSCGLAYMHQICEPHIVHRDIKSSNILLD-DQFEAHLADFGLSRLILPYQTH 766
I L Y H I+HRD+K N+++D + + L D+GL+ P Q +
Sbjct: 131 DIRFYMYEILKALDYCHS---MGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEY 187
Query: 767 VTTELVGTLGYIPPE-------YGQAWVATLRGDMYSFGVVMLELLTGKRP 810
V + + PE Y + DM+S G ++ ++ K P
Sbjct: 188 --NVRVASRYFKGPELLVDYQMYDYSL------DMWSLGCMLASMIFRKEP 230
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276 | Back alignment and structure |
|---|
Score = 82.3 bits (204), Expect = 3e-17
Identities = 70/315 (22%), Positives = 117/315 (37%), Gaps = 94/315 (29%)
Query: 600 YELLKATDNFSQANIIGCGGFGLVYKAT-LANGTTLAIKKLS----GDLGLMEREFKAEV 654
Y L +G G FG V G +A+K L+ L ++ + K E+
Sbjct: 13 YVLGD---------TLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGK-IKREI 62
Query: 655 EALSTAQHKNLVSLQGYCVHQGFRLLIYSYMENGSLDYWLHEKADGASQLDWLT---RLK 711
+ L +H +++ L Y + + + + E G D++ R++
Sbjct: 63 QNLKLFRHPHIIKL-------------YQVISTPTDFFMVMEYVSGGELFDYICKHGRVE 109
Query: 712 I--ARGT----SCGLAYMHQICEPHIVHRDIKSSNILLDDQFEAHLADFGLSRLILPYQT 765
AR + Y H+ +VHRD+K N+LLD A +ADFGLS ++ +
Sbjct: 110 EMEARRLFQQILSAVDYCHRH---MVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEF 166
Query: 766 HVTT---------ELVGTLGYIPPEYGQAWVATLRGDMYSFGVVMLELLTGKRPVD---- 812
T+ E++ Y PE D++S GV++ LL G P D
Sbjct: 167 LRTSCGSPNYAAPEVISGRLYAGPE----------VDIWSCGVILYALLCGTLPFDDEHV 216
Query: 813 -VLKPKMSR---ELVGWVLKMRSEGKQDQVFDPILRGKGFDEEMLQVLDVACMCVSQNPF 868
L K+ + ++ + +L MLQV +P
Sbjct: 217 PTLFKKIRGGVFYIPEYL----NRSVAT-----LLMH------MLQV----------DPL 251
Query: 869 KRPTVKEVVE--WLN 881
KR T+K++ E W
Sbjct: 252 KRATIKDIREHEWFK 266
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383 | Back alignment and structure |
|---|
Score = 83.2 bits (206), Expect = 4e-17
Identities = 45/250 (18%), Positives = 83/250 (33%), Gaps = 63/250 (25%)
Query: 606 TDNFSQANIIGCGGFGLVYKAT-LANGTTLAIKKLSGDLGLMEREFKA-EVEALSTAQHK 663
+ +S +G G FG+V + + +G A+KK+ L + +K E++ + H
Sbjct: 6 SKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKV-----LQDPRYKNRELDIMKVLDHV 60
Query: 664 NLVSLQGYCVHQGFRLLIYSYMENGSLDYWLHEKADGASQLDWLTRL------------- 710
N++ L Y G + +
Sbjct: 61 NIIKLVDYFYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYV 120
Query: 711 -----KIARGTS-------------------CGLAYMHQICEPHIVHRDIKSSNILLD-D 745
K+ + + ++H + I HRDIK N+L++
Sbjct: 121 PDTLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIHSL---GICHRDIKPQNLLVNSK 177
Query: 746 QFEAHLADFGLSRLILPYQTHVTTELVGTLGYIPPE-------YGQAWVATLRGDMYSFG 798
L DFG ++ ++P + + + Y PE Y + D++S G
Sbjct: 178 DNTLKLCDFGSAKKLIPSEPS--VAYICSRFYRAPELMLGATEYTPSI------DLWSIG 229
Query: 799 VVMLELLTGK 808
V EL+ GK
Sbjct: 230 CVFGELILGK 239
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 82.7 bits (205), Expect = 4e-17
Identities = 28/112 (25%), Positives = 42/112 (37%), Gaps = 16/112 (14%)
Query: 380 YNQLSNLPPAI---------YLANNSLSGNIPVEIGQLKSLHVLDLSNNNFSGTIPDELS 430
+ LS L PAI L + N P G L L L + + T+P ++
Sbjct: 215 NSPLSALGPAIHHLPKLEELDLRGCTALRNYPPIFGGRAPLKRLILKDCSNLLTLPLDIH 274
Query: 431 DLSNLEKLDLSGNHLVGEIPISLKGLHFLSSFSVAHN-------NLQGAVPS 475
L+ LEKLDL G + +P + L V + + A P+
Sbjct: 275 RLTQLEKLDLRGCVNLSRLPSLIAQLPANCIILVPPHLQAQLDQHRPVARPA 326
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 76.9 bits (190), Expect = 3e-15
Identities = 25/109 (22%), Positives = 37/109 (33%), Gaps = 20/109 (18%)
Query: 380 YNQLSNLPPAI---------YLANNSLSGNIPVEIGQLKSLHVLDLSNNNFSGTIPDEL- 429
L LP + LA N L +P I L L L + +P+ L
Sbjct: 113 AAGLMELPDTMQQFAGLETLTLARNPLR-ALPASIASLNRLRELSIRACPELTELPEPLA 171
Query: 430 --------SDLSNLEKLDLSGNHLVGEIPISLKGLHFLSSFSVAHNNLQ 470
L NL+ L L + +P S+ L L S + ++ L
Sbjct: 172 STDASGEHQGLVNLQSLRLEWTGIR-SLPASIANLQNLKSLKIRNSPLS 219
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 64.2 bits (157), Expect = 5e-11
Identities = 17/104 (16%), Positives = 40/104 (38%), Gaps = 8/104 (7%)
Query: 373 SNATNQQYNQLSNLPPAIYLANNSLSGN----IPVEIGQLKS--LHVLDLSNNNFSGTIP 426
NA +++ + + +G + L+L + P
Sbjct: 39 YNADRNRWHSAWRQANSNNPQIETRTGRALKATADLLEDATQPGRVALELRSVPLP-QFP 97
Query: 427 DELSDLSNLEKLDLSGNHLVGEIPISLKGLHFLSSFSVAHNNLQ 470
D+ LS+L+ + + L+ E+P +++ L + ++A N L+
Sbjct: 98 DQAFRLSHLQHMTIDAAGLM-ELPDTMQQFAGLETLTLARNPLR 140
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 41.5 bits (98), Expect = 9e-04
Identities = 7/67 (10%), Positives = 12/67 (17%), Gaps = 4/67 (5%)
Query: 404 EIGQLKSLHVLDLSNNNFSGTIPDELSDLSNLEKLDLSGNHLVGEIPISLKGLHFLSSFS 463
L + D LS D + H + +
Sbjct: 7 HHHHSSGRENLYFQGSTALRPYHDVLSQWQRHYNADRNRWHSAWRQA----NSNNPQIET 62
Query: 464 VAHNNLQ 470
L+
Sbjct: 63 RTGRALK 69
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 84.7 bits (210), Expect = 5e-17
Identities = 24/117 (20%), Positives = 42/117 (35%), Gaps = 12/117 (10%)
Query: 379 QYNQLSNLPPA----------IYLANNSLSGNIPVEIGQLKSLHVLDLSNNNFSGTIPDE 428
Q + N+ + L LS +P + L +L L LS N F
Sbjct: 262 QKHYFFNISSNTFHCFSGLQELDLTATHLS-ELPSGLVGLSTLKKLVLSANKFENLCQIS 320
Query: 429 LSDLSNLEKLDLSGNHLVGEI-PISLKGLHFLSSFSVAHNNLQGAVPSGGQFDTFPS 484
S+ +L L + GN E+ L+ L L ++H++++ + Q
Sbjct: 321 ASNFPSLTHLSIKGNTKRLELGTGCLENLENLRELDLSHDDIETSDCCNLQLRNLSH 377
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 82.8 bits (205), Expect = 2e-16
Identities = 16/103 (15%), Positives = 26/103 (25%), Gaps = 10/103 (9%)
Query: 379 QYNQLSNLPPA----------IYLANNSLSGNIPVEIGQLKSLHVLDLSNNNFSGTIPDE 428
+N L + + L + L L L+ N
Sbjct: 41 SFNVLPTIQNTTFSRLINLTFLDLTRCQIYWIHEDTFQSQHRLDTLVLTANPLIFMAETA 100
Query: 429 LSDLSNLEKLDLSGNHLVGEIPISLKGLHFLSSFSVAHNNLQG 471
LS L+ L + I L L S + N++
Sbjct: 101 LSGPKALKHLFFIQTGISSIDFIPLHNQKTLESLYLGSNHISS 143
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 81.2 bits (201), Expect = 6e-16
Identities = 22/124 (17%), Positives = 40/124 (32%), Gaps = 12/124 (9%)
Query: 379 QYNQLSNLPPAI----------YLANNSLSGNIPVEIGQLKSLHVLDLSNNNFSGTIPDE 428
N L + + +S + + K+L L L +N+ S +
Sbjct: 89 TANPLIFMAETALSGPKALKHLFFIQTGISSIDFIPLHNQKTLESLYLGSNHISSIKLPK 148
Query: 429 LSDLSNLEKLDLSGNHLVGEIPISLKGLHFLS--SFSVAHNNLQGAVPSGGQFDTFPSFS 486
L+ LD N + + L + S ++ N++ G P F S +
Sbjct: 149 GFPTEKLKVLDFQNNAIHYLSKEDMSSLQQATNLSLNLNGNDIAGIEPGAFDSAVFQSLN 208
Query: 487 FEGN 490
F G
Sbjct: 209 FGGT 212
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 80.8 bits (200), Expect = 7e-16
Identities = 23/129 (17%), Positives = 40/129 (31%), Gaps = 19/129 (14%)
Query: 379 QYNQLSNLPPAI----------YLANNSLSGNIPVEIG---QLKSLHVLDLSNNNFSGTI 425
++ L + L N + L L +L LS + S
Sbjct: 433 SHSLLDISSEQLFDGLPALQHLNLQGNHFPKGNIQKTNSLQTLGRLEILVLSFCDLSSID 492
Query: 426 PDELSDLSNLEKLDLSGNHLVGEIPISLKGLHFLSSFSVAHNNLQGAVPSGGQFDTFPS- 484
+ L + +DLS N L +L L + ++A N++ +PS
Sbjct: 493 QHAFTSLKMMNHVDLSHNRLTSSSIEALSHLKGI-YLNLASNHISIILPS--LLPILSQQ 549
Query: 485 --FSFEGNP 491
+ NP
Sbjct: 550 RTINLRQNP 558
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 80.8 bits (200), Expect = 8e-16
Identities = 18/100 (18%), Positives = 31/100 (31%), Gaps = 7/100 (7%)
Query: 379 QYNQLSNLPPAI-------YLANNSLSGNIPVEIGQLKSLHVLDLSNNNFSGTIPDELSD 431
+ L+ +P + + N L +L +L LDL+ D
Sbjct: 20 ENLGLNEIPGTLPNSTECLEFSFNVLPTIQNTTFSRLINLTFLDLTRCQIYWIHEDTFQS 79
Query: 432 LSNLEKLDLSGNHLVGEIPISLKGLHFLSSFSVAHNNLQG 471
L+ L L+ N L+ +L G L +
Sbjct: 80 QHRLDTLVLTANPLIFMAETALSGPKALKHLFFIQTGISS 119
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 77.4 bits (191), Expect = 1e-14
Identities = 24/107 (22%), Positives = 36/107 (33%), Gaps = 14/107 (13%)
Query: 379 QYNQLSNLPPAI----------YLANNSLSGNIP-VEIGQLKSLHVLDLSNNNFSGTIPD 427
YN+ +L LA L L L VL+LS++ +
Sbjct: 384 SYNEPLSLKTEAFKECPQLELLDLAFTRLKVKDAQSPFQNLHLLKVLNLSHSLLDISSEQ 443
Query: 428 ELSDLSNLEKLDLSGNHLVGEIPI---SLKGLHFLSSFSVAHNNLQG 471
L L+ L+L GNH SL+ L L ++ +L
Sbjct: 444 LFDGLPALQHLNLQGNHFPKGNIQKTNSLQTLGRLEILVLSFCDLSS 490
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 77.0 bits (190), Expect = 1e-14
Identities = 17/103 (16%), Positives = 26/103 (25%), Gaps = 10/103 (9%)
Query: 379 QYNQLSNLPPA----------IYLANNSLSGNIPVEIGQLKSLHVLDLSNNNFSGTIPDE 428
Q+ + + L N L + K+L L S
Sbjct: 65 TRCQIYWIHEDTFQSQHRLDTLVLTANPLIFMAETALSGPKALKHLFFIQTGISSIDFIP 124
Query: 429 LSDLSNLEKLDLSGNHLVGEIPISLKGLHFLSSFSVAHNNLQG 471
L + LE L L NH+ L +N +
Sbjct: 125 LHNQKTLESLYLGSNHISSIKLPKGFPTEKLKVLDFQNNAIHY 167
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 71.6 bits (176), Expect = 6e-13
Identities = 23/106 (21%), Positives = 39/106 (36%), Gaps = 14/106 (13%)
Query: 379 QYNQLSNLPPAI-------------YLANNSLSGNIPVEIGQLKSLHVLDLSNNNFSGTI 425
Q N L+ LS LK ++ +DLS+N + +
Sbjct: 457 QGNHFPKGNIQKTNSLQTLGRLEILVLSFCDLSSIDQHAFTSLKMMNHVDLSHNRLTSSS 516
Query: 426 PDELSDLSNLEKLDLSGNHLVGEIPISLKGLHFLSSFSVAHNNLQG 471
+ LS L + L+L+ NH+ +P L L + ++ N L
Sbjct: 517 IEALSHLKGIY-LNLASNHISIILPSLLPILSQQRTINLRQNPLDC 561
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 70.4 bits (173), Expect = 1e-12
Identities = 24/107 (22%), Positives = 43/107 (40%), Gaps = 13/107 (12%)
Query: 390 IYLANNSL--SGNIPVEIGQLKSLHVLDLSNNNFSGTIPDELSDLSNLEKLDLSGNHLVG 447
+ L+++ + S +++ L L L+LS N + + LE LDL+ L
Sbjct: 355 LDLSHDDIETSDCCNLQLRNLSHLQSLNLSYNEPLSLKTEAFKECPQLELLDLAFTRLKV 414
Query: 448 EIPIS-LKGLHFLSSFSVAHNNLQGAVPSGGQFDTFPSFSFEGNPEL 493
+ S + LH L +++H+ L F+G P L
Sbjct: 415 KDAQSPFQNLHLLKVLNLSHSLLDI----------SSEQLFDGLPAL 451
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 70.0 bits (172), Expect = 2e-12
Identities = 24/124 (19%), Positives = 37/124 (29%), Gaps = 17/124 (13%)
Query: 372 PSNATNQQYNQLSNLPPAIYLANNSLSGNIPVEIGQLK--SLHVLDLSNNNFSGTIPDEL 429
N L + P L S+ ++L + F +
Sbjct: 219 FKGLKNSTIQSLWLG----TFEDMDDEDISPAVFEGLCEMSVESINLQKHYFFNISSNTF 274
Query: 430 SDLSNLEKLDLSGNHLVGEIPISLKGLHFLSSFSVAHNNLQGAVPSGGQFDTFPSFSFEG 489
S L++LDL+ HL E+P L GL L ++ N + S
Sbjct: 275 HCFSGLQELDLTATHL-SELPSGLVGLSTLKKLVLSANKFEN----------LCQISASN 323
Query: 490 NPEL 493
P L
Sbjct: 324 FPSL 327
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 65.4 bits (160), Expect = 5e-11
Identities = 26/173 (15%), Positives = 45/173 (26%), Gaps = 46/173 (26%)
Query: 334 NLLSGEFPKELTALPALVSEAANDEVDRSYLELPVFVMPSNATNQQYNQLSNLPPA---- 389
+S L L L L N +S++
Sbjct: 115 TGISSIDFIPLHNQKTLE-----------SLYL------------GSNHISSIKLPKGFP 151
Query: 390 ------IYLANNSLSGNIPVEIGQLKSLHVLDLS-NNNFSGTIPDELSDLSNLEKLDLSG 442
+ NN++ ++ L+ L L+ N N I D + + L+ G
Sbjct: 152 TEKLKVLDFQNNAIHYLSKEDMSSLQQATNLSLNLNGNDIAGIEPGAFDSAVFQSLNFGG 211
Query: 443 NHLVGEIPISLKGLHF--LSSFSVAHNNLQGAVPSGGQFDTFPSFSFEGNPEL 493
+ I LK L + + + FEG E+
Sbjct: 212 TQNLLVIFKGLKNSTIQSLWLGTFEDMDDE----------DISPAVFEGLCEM 254
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 48.5 bits (116), Expect = 7e-06
Identities = 14/99 (14%), Positives = 29/99 (29%), Gaps = 13/99 (13%)
Query: 380 YNQLSNLPPA---------IYLANNSLSGNIPVEIGQLKSLHVLDLSNNNFSGTIPDELS 430
+N+L++ + LA+N +S +P + L ++L N T
Sbjct: 509 HNRLTSSSIEALSHLKGIYLNLASNHISIILPSLLPILSQQRTINLRQNPLDCTC--SNI 566
Query: 431 DLSNLEKLDLSGNHLVGEIPISLKGLHFLSSFSVAHNNL 469
+ L + L ++ L
Sbjct: 567 YFLEW--YKENMQKLEDTEDTLCENPPLLRGVRLSDVTL 603
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 81.9 bits (202), Expect = 9e-17
Identities = 76/356 (21%), Positives = 122/356 (34%), Gaps = 105/356 (29%)
Query: 607 DNFSQANIIGCGGFGLVYKATL------ANGTTLAIKKLSGDLGLMER-EFKAEVEALST 659
D +G G FG V +A A T+A+K L E +E++ L
Sbjct: 22 DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIH 81
Query: 660 A-QHKNLVSLQGYCVHQGFRL-LIYSYMENGSLDYWLHEK-------------------- 697
H N+V+L G C G L +I + + G+L +L K
Sbjct: 82 IGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDY 141
Query: 698 -----ADGASQLDWLTRLKIARGTSCG---------------------------LAYMHQ 725
D +LD +T + + + + Y Q
Sbjct: 142 VGAIPVDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEEAPEDLYKDFLTLEHLICYSFQ 201
Query: 726 IC-------EPHIVHRDIKSSNILLDDQFEAHLADFGLSRLILPYQTHVTTELVGTLGYI 778
+ +HRD+ + NILL ++ + DFGL+R I +V +
Sbjct: 202 VAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYV----RKGDARL 257
Query: 779 P-----PEYGQAWVATLRGDMYSFGVVMLELLT-GKRPVDVLKPKMSRELVGWVLKMRSE 832
P PE V T++ D++SFGV++ E+ + G P P + +
Sbjct: 258 PLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPY----PGVKID----------- 302
Query: 833 GKQDQVFDPILRG------KGFDEEMLQVLDVACMCVSQNPFKRPTVKEVVEWLNN 882
++ + G EM Q + C P +RPT E+VE L N
Sbjct: 303 ---EEFCRRLKEGTRMRAPDYTTPEMYQTM---LDCWHGEPSQRPTFSELVEHLGN 352
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305 | Back alignment and structure |
|---|
Score = 80.8 bits (200), Expect = 1e-16
Identities = 65/313 (20%), Positives = 111/313 (35%), Gaps = 82/313 (26%)
Query: 600 YELLKATDNFSQANIIGCGGFGLVYKAT-LANGTTLAIKKLS----GDLGLMEREFKAEV 654
Y + ++G G +G V + A+K L + E K E+
Sbjct: 7 YLMGD---------LLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEI 57
Query: 655 EALSTAQHKNLVSLQGYCVHQGF-RLLIYSYME---NGS---LDYWLHEKADGASQLDWL 707
+ L +HKN++ L V + +Y ME G LD +
Sbjct: 58 QLLRRLRHKNVIQL--VDVLYNEEKQKMYMVMEYCVCGMQEMLDSVPEK----------- 104
Query: 708 TRLKI--ARG----TSCGLAYMHQICEPHIVHRDIKSSNILLDDQFEAHLADFGLSRLIL 761
R + A G GL Y+H IVH+DIK N+LL ++ G++ +
Sbjct: 105 -RFPVCQAHGYFCQLIDGLEYLHSQ---GIVHKDIKPGNLLLTTGGTLKISALGVAEALH 160
Query: 762 PYQTHVTTELV-GTLGYIPPE--YGQAWVATLRGDMYSFGVVMLELLTGKRPVD-----V 813
P+ T G+ + PPE G + + D++S GV + + TG P +
Sbjct: 161 PFAADDTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDNIYK 220
Query: 814 LKPKMSR---ELVGWVLKMRSEGKQDQVFDPILRGKGFDEEMLQVLDVACMCVSQNPFKR 870
L + + + G D +L+G ML+ P KR
Sbjct: 221 LFENIGKGSYAIPGDC----GPPLSD-----LLKG------MLEY----------EPAKR 255
Query: 871 PTVKEVVE--WLN 881
+++++ + W
Sbjct: 256 FSIRQIRQHSWFR 268
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 83.4 bits (205), Expect = 2e-16
Identities = 93/618 (15%), Positives = 192/618 (31%), Gaps = 153/618 (24%)
Query: 208 VVPDYQMLGYVEKIASDLS----DDPPRPLIMWNPRLISEDVGVGINVRNLRRYFLSTFT 263
++ ++ + + D P+ ++ + I + V R F
Sbjct: 21 ILSVFE-----DAFVDNFDCKDVQDMPKSIL--SKEEIDHIIMSKDAVSGTLRLF----- 68
Query: 264 PVYSMRPLPSGAVFRCYPGLWKVFYDDKDRPNRYLLAKELVSRPNADDLE-IIFGEVEGK 322
+++ V + F ++ R N L + + + ++ E +
Sbjct: 69 --WTLLSKQEEMV--------QKFVEEVLRINYKFLMSPIKTEQRQPSMMTRMYIEQRDR 118
Query: 323 SDEGPSLFSQANLLSGEFPKEL-TAL----PA---------------LVSEAANDEVDRS 362
+F++ N+ + +L AL PA + + +
Sbjct: 119 LYNDNQVFAKYNVSRLQPYLKLRQALLELRPAKNVLIDGVLGSGKTWVALDVCLSYKVQC 178
Query: 363 YLELPVF---VMPSNATNQQYNQLSNLPPAI---YLANNSLSGNIPVEIGQLKS-LHVLD 415
++ +F + N+ L L I + + + S NI + I +++ L L
Sbjct: 179 KMDFKIFWLNLKNCNSPETVLEMLQKLLYQIDPNWTSRSDHSSNIKLRIHSIQAELRRL- 237
Query: 416 LSNNNFSGT--IPDELSDLSNLEKLDLSGNHLVGEIPISLKGLHFLSSFSVAHNNLQGAV 473
L + + + + + +LS L+ + FLS+ + H +L
Sbjct: 238 LKSKPYENCLLVLLNVQNAKAWNAFNLSCKILLTTRFKQV--TDFLSAATTTHISLD--- 292
Query: 474 PSGGQFDTFPSFSFEGNPELCGSVVQRPCAISPGATHPTAPHKRTNTKLVIGLVLGICFG 533
+ + + L + P T P + +
Sbjct: 293 ------HHSMTLTPDEVKSLLLKYLDCRPQDLPREVLTTNP-------RRLSI-----IA 334
Query: 534 TGLIISMLALWILSKRRIIPGGDPDKIELDTISSTSNFGVSPEADKDA--SLVMLFPNNT 591
I LA W K + DK+ I S+ N + P + L + FP +
Sbjct: 335 E-SIRDGLATWDNWKHV-----NCDKLT-TIIESSLNV-LEPAEYRKMFDRLSV-FPPSA 385
Query: 592 N-EIKDLTIY-ELLKATDNFSQANIIGCGGFGLVYKATLANGTTLAIKKLSGDLGLMERE 649
+ L++ + +D N + LV K +T++I + L E
Sbjct: 386 HIPTILLSLIWFDVIKSDVMVVVN--KLHKYSLVEKQ--PKESTISIP----SIYL---E 434
Query: 650 FKAEVEALSTAQHKNLVS----LQGYCVHQGFRLL----IYSY-------MENGS----- 689
K ++E A H+++V + + YS+ +E+
Sbjct: 435 LKVKLENE-YALHRSIVDHYNIPKTFDSDDLIPPYLDQYFYSHIGHHLKNIEHPERMTLF 493
Query: 690 ----LDY-WLHEK--ADG------ASQLDWLTRLKIARGTSCGLAYMHQICEPH-IVHRD 735
LD+ +L +K D S L+ L +LK Y IC+ R
Sbjct: 494 RMVFLDFRFLEQKIRHDSTAWNASGSILNTLQQLKF---------YKPYICDNDPKYERL 544
Query: 736 IKSSNILLD--DQFEAHL 751
+ + +LD + E +L
Sbjct: 545 VNA---ILDFLPKIEENL 559
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 55.2 bits (132), Expect = 8e-08
Identities = 76/510 (14%), Positives = 147/510 (28%), Gaps = 132/510 (25%)
Query: 43 TNISSLKKAPWSSSRTYAKF-DKFQGDNLEETPNT----SPVETQEQAVQEEQQE----- 92
+ I + ++ P +R Y + D+ DN P QA+ E +
Sbjct: 96 SPIKTEQRQPSMMTRMYIEQRDRLYNDNQVFAKYNVSRLQPYLKLRQALLELRPAKNVLI 155
Query: 93 -GDDSCLPSDLEGAVRQSSQASSLF------VSAGGMRAIVELLIPQLQF---LDDEGAQ 142
G + + V S + ++ + +L + +D
Sbjct: 156 DGVLGSGKTWVALDVCLSYKVQCKMDFKIFWLNLKNCNSPETVLEMLQKLLYQIDPNWTS 215
Query: 143 AELWELSRLFVDTLIEETGSQRVKAIFPDAG-AAALL-------KYRWKDAAFGFS---- 190
L + ++ + LL W AF S
Sbjct: 216 ----RSDHSSNIKLRIHSIQAELRRLLKSKPYENCLLVLLNVQNAKAWN--AFNLSCKIL 269
Query: 191 ------SLSDRKPVEKEDEIIVMVVPD----YQMLGYVEKIASDLSDDPPRPLIMWNPRL 240
++D I + ++ + K D PR ++ NPR
Sbjct: 270 LTTRFKQVTDFLSAATTTHISLDHHSMTLTPDEVKSLLLKYLDCRPQDLPREVLTTNPRR 329
Query: 241 ISEDVGVGINVR-------NLRRYFLSTFTPVY--SMRPLPSGAVFRCYPGLWKVFYDDK 291
+S + ++R N + T + S+ L + + L VF
Sbjct: 330 LS---IIAESIRDGLATWDNWKHVNCDKLTTIIESSLNVLEPAEYRKMFDRL-SVFPPSA 385
Query: 292 DRPNRYL--LAKELVSRPNADDLEIIFGEVEGKSDEGPSLFSQANLLSGEFPKELTALPA 349
P L + +++ D+ ++ ++ S L+ + + ++P+
Sbjct: 386 HIPTILLSLIWFDVIK----SDVMVVVNKLHKYS-----------LVEKQPKESTISIPS 430
Query: 350 LVSEAANDEVDRSYLELPVFVMPSNATNQ----QYNQLSN------LPPAI------YLA 393
+ YLEL V + A ++ YN +PP + ++
Sbjct: 431 I------------YLELKVKLENEYALHRSIVDHYNIPKTFDSDDLIPPYLDQYFYSHIG 478
Query: 394 NNSLSGNIPVEIGQLKSLHVLDL-----------SNNNFSGTIPDELSDLSNLEKLDLSG 442
++ L E L + LD + N SG+I + L L + +
Sbjct: 479 HH-LKNIEHPERMTLFRMVFLDFRFLEQKIRHDSTAWNASGSILNTLQQLKFYKPY-ICD 536
Query: 443 NH-----LVGEIPISLKGLHFLSSFSVAHN 467
N LV I L FL + N
Sbjct: 537 NDPKYERLVNAI------LDFL--PKIEEN 558
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364 | Back alignment and structure |
|---|
Score = 80.4 bits (199), Expect = 3e-16
Identities = 52/239 (21%), Positives = 100/239 (41%), Gaps = 58/239 (24%)
Query: 598 TIYELLKATDNFSQANIIGCGGFGLVYKAT-LANGTTLAIKKLS--GDLGLMEREFKAEV 654
++++ ++ + IG G +G+V A N +AIKK+S +R + E+
Sbjct: 21 QVFDV---GPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLR-EI 76
Query: 655 EALSTAQHKNLVSLQGYCVHQGFRLL--IYSYMENGSLDYWLHEKADGASQLDWLTRLKI 712
+ L +H+N++ + + +Y + ++ L+ K+
Sbjct: 77 KILLRFRHENIIGINDIIRAPTIEQMKDVYIVQD--LMETDLY---------------KL 119
Query: 713 ARGTS--------------CGLAYMHQICEPHIVHRDIKSSNILLDDQFEAHLADFGLSR 758
+ GL Y+H +++HRD+K SN+LL+ + + DFGL+R
Sbjct: 120 LKTQHLSNDHICYFLYQILRGLKYIH---SANVLHRDLKPSNLLLNTTCDLKICDFGLAR 176
Query: 759 LILPYQTHVT--TELVGTLGYIPPE-------YGQAWVATLRGDMYSFGVVMLELLTGK 808
+ P H TE V T Y PE Y ++ D++S G ++ E+L+ +
Sbjct: 177 VADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSI------DIWSVGCILAEMLSNR 229
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 79.3 bits (196), Expect = 6e-16
Identities = 57/231 (24%), Positives = 90/231 (38%), Gaps = 60/231 (25%)
Query: 606 TDNFSQANIIGCGGFGLVYKAT-LANGTTLAIKKLS---GDLGLMEREFKAEVEALSTAQ 661
+ +G G +G V A +G +AIKKLS +R ++ E+ L Q
Sbjct: 23 PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYR-ELLLLKHMQ 81
Query: 662 HKNLVSL----QGYCVHQGFR--LLIYSYMENGSLDYWLHEKADGASQLDWLTRLKIARG 715
H+N++ L + F L+ +M+ D L ++ +
Sbjct: 82 HENVIGLLDVFTPASSLRNFYDFYLVMPFMQ-----------TD-------LQKIMGLKF 123
Query: 716 TS-----------CGLAYMHQICEPHIVHRDIKSSNILLDDQFEAHLADFGLSRLILPYQ 764
+ GL Y+H +VHRD+K N+ +++ E + DFGL+R
Sbjct: 124 SEEKIQYLVYQMLKGLKYIH---SAGVVHRDLKPGNLAVNEDCELKILDFGLARHADAEM 180
Query: 765 THVTTELVGTLGYIPPE-------YGQAWVATLRGDMYSFGVVMLELLTGK 808
T V T Y PE Y Q D++S G +M E+LTGK
Sbjct: 181 ----TGYVVTRWYRAPEVILSWMHYNQTV------DIWSVGCIMAEMLTGK 221
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 | Back alignment and structure |
|---|
Score = 78.5 bits (194), Expect = 7e-16
Identities = 20/103 (19%), Positives = 39/103 (37%), Gaps = 15/103 (14%)
Query: 379 QYNQLSNLPPA-----------IYLANNSLSGNIPVEIGQLKSLHVLDLSNNNFSGTIPD 427
+ N++ + A + L N + ++ ++ L LDLS+N + +
Sbjct: 152 KLNEIDTVNFAELAASSDTLEHLNLQYNFIY-DVKGQV-VFAKLKTLDLSSNKLA-FMGP 208
Query: 428 ELSDLSNLEKLDLSGNHLVGEIPISLKGLHFLSSFSVAHNNLQ 470
E + + + L N LV I +L+ L F + N
Sbjct: 209 EFQSAAGVTWISLRNNKLV-LIEKALRFSQNLEHFDLRGNGFH 250
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 | Back alignment and structure |
|---|
Score = 73.1 bits (180), Expect = 5e-14
Identities = 19/102 (18%), Positives = 37/102 (36%), Gaps = 14/102 (13%)
Query: 379 QYNQLSNLPPA----------IYLANNSLSG-NIPVEIGQLKSLHVLDLSNNNFSGTIPD 427
N+++ L + L N + N +L L+L N +
Sbjct: 128 ANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTLEHLNLQYNFIY-DVKG 186
Query: 428 ELSDLSNLEKLDLSGNHLVGEIPISLKGLHFLSSFSVAHNNL 469
++ + L+ LDLS N L + + ++ S+ +N L
Sbjct: 187 QVV-FAKLKTLDLSSNKLA-FMGPEFQSAAGVTWISLRNNKL 226
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 | Back alignment and structure |
|---|
Score = 68.1 bits (167), Expect = 2e-12
Identities = 18/97 (18%), Positives = 35/97 (36%), Gaps = 9/97 (9%)
Query: 380 YNQLSNLPP-----AIYLANNSLSGNIPVEIGQLKSLHVLDLSNNNFSGTIPDELSDLSN 434
N + L ++ ANN++S + GQ + L+NN + + S
Sbjct: 89 NNYVQELLVGPSIETLHAANNNIS-RVSCSRGQ--GKKNIYLANNKITMLRDLDEGCRSR 145
Query: 435 LEKLDLSGNHLVG-EIPISLKGLHFLSSFSVAHNNLQ 470
++ LDL N + L ++ +N +
Sbjct: 146 VQYLDLKLNEIDTVNFAELAASSDTLEHLNLQYNFIY 182
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 | Back alignment and structure |
|---|
Score = 65.8 bits (161), Expect = 1e-11
Identities = 23/81 (28%), Positives = 38/81 (46%), Gaps = 4/81 (4%)
Query: 391 YLANNSLSGNIPVEIGQ-LKSLHVLDLSNNNFSGTIPDELSDLSNLEKLDLSGNHLVGEI 449
+ ++SL + Q ++ LDLS N S +L+ + LE L+LS N L E
Sbjct: 16 KVTDSSLK-QALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLELLNLSSNVLY-ET 73
Query: 450 PISLKGLHFLSSFSVAHNNLQ 470
L+ L L + + +N +Q
Sbjct: 74 L-DLESLSTLRTLDLNNNYVQ 93
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 | Back alignment and structure |
|---|
Score = 65.0 bits (159), Expect = 2e-11
Identities = 15/100 (15%), Positives = 29/100 (29%), Gaps = 16/100 (16%)
Query: 379 QYNQLSNLPP--------AIYLANNSLSGNIPVEIGQLKSLHVLDLSNNNFSGTIPDELS 430
N L + L NN + E+ S+ L +NNN S +
Sbjct: 66 SSNVLYETLDLESLSTLRTLDLNNNYVQ-----ELLVGPSIETLHAANNNIS-RVSCSR- 118
Query: 431 DLSNLEKLDLSGNHLVGEIPISLKGLHFLSSFSVAHNNLQ 470
+ + L+ N + + + + N +
Sbjct: 119 -GQGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEID 157
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 | Back alignment and structure |
|---|
Score = 58.8 bits (143), Expect = 2e-09
Identities = 12/66 (18%), Positives = 25/66 (37%)
Query: 405 IGQLKSLHVLDLSNNNFSGTIPDELSDLSNLEKLDLSGNHLVGEIPISLKGLHFLSSFSV 464
+ +++++ + N+++LDLSGN L L L ++
Sbjct: 6 KQNGNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLELLNL 65
Query: 465 AHNNLQ 470
+ N L
Sbjct: 66 SSNVLY 71
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 | Back alignment and structure |
|---|
Score = 58.8 bits (143), Expect = 2e-09
Identities = 18/95 (18%), Positives = 31/95 (32%), Gaps = 11/95 (11%)
Query: 379 QYNQLSNLPPAI---------YLANNSLSGNIPVEIGQLKSLHVLDLSNNNFS-GTIPDE 428
N+L+ + P L NN L I + ++L DL N F GT+ D
Sbjct: 199 SSNKLAFMGPEFQSAAGVTWISLRNNKLV-LIEKALRFSQNLEHFDLRGNGFHCGTLRDF 257
Query: 429 LSDLSNLEKLDLSGNHLVGEIPISLKGLHFLSSFS 463
S ++ + + + L +
Sbjct: 258 FSKNQRVQTVAKQTVKKLTGQNEEECTVPTLGHYG 292
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 | Back alignment and structure |
|---|
Score = 41.5 bits (98), Expect = 8e-04
Identities = 5/69 (7%), Positives = 19/69 (27%), Gaps = 10/69 (14%)
Query: 425 IPDELSDLSNLEKLDLSGNHLVGEIPISLKGLHFLSSFSVAHNNLQGAVPSGGQFDTFPS 484
I + + + + ++ + L + + + ++ N L +
Sbjct: 2 IHEIKQNGNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLS----------QISA 51
Query: 485 FSFEGNPEL 493
+L
Sbjct: 52 ADLAPFTKL 60
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361 | Back alignment and structure |
|---|
Score = 79.3 bits (196), Expect = 7e-16
Identities = 63/326 (19%), Positives = 107/326 (32%), Gaps = 88/326 (26%)
Query: 588 PNNTNEIKDLTIYELLKATDNFSQANIIGCGGFGLVYKAT-LANGTTLAIKKLSGDLGLM 646
P + + D Y+ +K IG G FG+ +A+K + +
Sbjct: 10 PLDMPIMHDSDRYDFVK---------DIGSGNFGVARLMRDKLTKELVAVKYIERGA-AI 59
Query: 647 EREFKAEVEALSTAQHKNLVSLQGYCVHQGFRLLIYSYMENGSLDYWLHEKADGASQLDW 706
+ + E+ + +H N+V + + + E A G +
Sbjct: 60 DENVQREIINHRSLRHPNIVRF-------------KEVILTPTHLAIIMEYASGGELYER 106
Query: 707 LT---RLK--IARG----TSCGLAYMHQICEPHIVHRDIKSSNILLDDQFEAHL--ADFG 755
+ R AR G++Y H + I HRD+K N LLD L DFG
Sbjct: 107 ICNAGRFSEDEARFFFQQLLSGVSYCHSM---QICHRDLKLENTLLDGSPAPRLKICDFG 163
Query: 756 LSRLILPYQTHVTTELVGTLGYIPPEYGQAWVATLRGDMY--------SFGVVMLELLTG 807
S+ + + +T VGT YI PE L Y S GV + +L G
Sbjct: 164 YSKSSVLHSQPKST--VGTPAYIAPE-------VLLRQEYDGKIADVWSCGVTLYVMLVG 214
Query: 808 KRPV-DVLKPKMSRELVGWVLKMR---------SEGKQDQVFDPILRGKGFDEEMLQVLD 857
P D +P+ R+ + +L ++ S ++ +
Sbjct: 215 AYPFEDPEEPRDYRKTIQRILSVKYSIPDDIRISPECCH-----LISR------IFVA-- 261
Query: 858 VACMCVSQNPFKRPTVKEVVE--WLN 881
+P R ++ E+ W
Sbjct: 262 --------DPATRISIPEIKTHSWFL 279
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446 | Back alignment and structure |
|---|
Score = 79.8 bits (197), Expect = 1e-15
Identities = 66/266 (24%), Positives = 105/266 (39%), Gaps = 34/266 (12%)
Query: 556 DPDKIELDTISSTSNFGVSPEADKDASLVMLFPNNTNEIKDLTIYELLKATDNFSQANII 615
D ++ + SP + A + + + +E LK ++
Sbjct: 106 VADGLKKQAAAEMDFRSGSPSDNSGAEEMEVSLAKPKHRVTMNEFEYLK---------LL 156
Query: 616 GCGGFGLVYKATL-ANGTTLAIKKLSGDLGLMEREF---KAEVEALSTAQHKNLVSLQGY 671
G G FG V A G A+K L ++ + + E E L ++H L +L+ Y
Sbjct: 157 GKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALK-Y 215
Query: 672 CVHQGFRL-LIYSYMENGSLDYWLHEKADGASQLDWLTRLKIARGTSCGLAYMHQICEPH 730
RL + Y G L + L + D R A L Y+H E +
Sbjct: 216 SFQTHDRLCFVMEYANGGELFFHLSR--ERVFSED-RARFYGAE-IVSALDYLHS--EKN 269
Query: 731 IVHRDIKSSNILLDDQFEAHLADFGLSRLILPYQTHVTTELVGTLGYIPPE------YGQ 784
+V+RD+K N++LD + DFGL + + + T GT Y+ PE YG+
Sbjct: 270 VVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKT-FCGTPEYLAPEVLEDNDYGR 328
Query: 785 AWVATLRGDMYSFGVVMLELLTGKRP 810
A V D + GVVM E++ G+ P
Sbjct: 329 A-V-----DWWGLGVVMYEMMCGRLP 348
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320 | Back alignment and structure |
|---|
Score = 77.7 bits (192), Expect = 2e-15
Identities = 58/248 (23%), Positives = 98/248 (39%), Gaps = 77/248 (31%)
Query: 600 YELLKATDNFSQANIIGCGGFGLVYKAT-LANGTTLAIKKLS-GDLGLMEREFKAEVEAL 657
Y LK +GCGG GLV+ A +AIKK+ D ++ + E++ +
Sbjct: 13 YMDLK---------PLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHALR-EIKII 62
Query: 658 STAQHKNLVSL------------QGYCVHQGFR--LLIYSYME--------NGSLD---- 691
H N+V + ++ YME G L
Sbjct: 63 RRLDHDNIVKVFEILGPSGSQLTDDVGSLTELNSVYIVQEYMETDLANVLEQGPLLEEHA 122
Query: 692 -YWLHEKADGASQLDWLTRLKIARGTSCGLAYMHQICEPHIVHRDIKSSNILLDDQF-EA 749
+++ QL L GL Y+H +++HRD+K +N+ ++ +
Sbjct: 123 RLFMY-------QL-----L-------RGLKYIHS---ANVLHRDLKPANLFINTEDLVL 160
Query: 750 HLADFGLSRLILPYQTHVT--TELVGTLGYIPPE-------YGQAWVATLRGDMYSFGVV 800
+ DFGL+R++ P+ +H +E + T Y P Y +A DM++ G +
Sbjct: 161 KIGDFGLARIMDPHYSHKGHLSEGLVTKWYRSPRLLLSPNNYTKAI------DMWAAGCI 214
Query: 801 MLELLTGK 808
E+LTGK
Sbjct: 215 FAEMLTGK 222
|
| >3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325 | Back alignment and structure |
|---|
Score = 77.2 bits (191), Expect = 2e-15
Identities = 68/242 (28%), Positives = 107/242 (44%), Gaps = 40/242 (16%)
Query: 591 TNEIKDLTIYELLKAT------DNFSQANIIGCGGFG---LVYKATLANGTTL-AIKKLS 640
IK++ I +K F ++G G FG LV K + ++ L A+K L
Sbjct: 2 EGSIKEIAITHHVKEGHEKADPSQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLK 61
Query: 641 GDLGLMER---EFKAEVEALSTAQHKNLVSLQGYCVHQGFRL-LIYSYMENGSLDYWLHE 696
L R K E + L H +V L Y +L LI ++ G L L +
Sbjct: 62 KAT-LKVRDRVRTKMERDILVEVNHPFIVKLH-YAFQTEGKLYLILDFLRGGDLFTRLSK 119
Query: 697 KADGASQLDWLTRLKIARGTSCGLAYMHQICEPHIVHRDIKSSNILLDDQFEAH--LADF 754
+ + + +A + L ++H + I++RD+K NILLD+ E H L DF
Sbjct: 120 --EVMFTEED-VKFYLAE-LALALDHLHSL---GIIYRDLKPENILLDE--EGHIKLTDF 170
Query: 755 GLSRLILPYQTHVTTELVGTLGYIPPE------YGQAWVATLRGDMYSFGVVMLELLTGK 808
GLS+ + ++ + GT+ Y+ PE + Q+ D +SFGV+M E+LTG
Sbjct: 171 GLSKESIDHEKKAYS-FCGTVEYMAPEVVNRRGHTQS-A-----DWWSFGVLMFEMLTGT 223
Query: 809 RP 810
P
Sbjct: 224 LP 225
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476 | Back alignment and structure |
|---|
Score = 78.7 bits (194), Expect = 2e-15
Identities = 73/312 (23%), Positives = 118/312 (37%), Gaps = 88/312 (28%)
Query: 600 YELLKATDNFSQANIIGCGGFGLVYKAT-LANGTTLAIKKLS----GDLGLMEREFKAEV 654
Y L +G G FG V G +A+K L+ L ++ + + E+
Sbjct: 18 YILGD---------TLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGK-IRREI 67
Query: 655 EALSTAQHKNLVSLQGYCVHQGFRLLIYSYMENGSLDYWLHEKADGASQLDWLT---RLK 711
+ L +H +++ L Y + S + + E G D++ RL
Sbjct: 68 QNLKLFRHPHIIKL-------------YQVISTPSDIFMVMEYVSGGELFDYICKNGRLD 114
Query: 712 I--ARGT----SCGLAYMHQICEPHIVHRDIKSSNILLDDQFEAHLADFGLSRLILPYQT 765
+R G+ Y H+ +VHRD+K N+LLD A +ADFGLS ++ +
Sbjct: 115 EKESRRLFQQILSGVDYCHRH---MVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEF 171
Query: 766 HVTTELVGTLGYIPPE------YGQAWVATLRGDMYSFGVVMLELLTGKRPVD-----VL 814
T+ G+ Y PE Y V D++S GV++ LL G P D L
Sbjct: 172 LRTS--CGSPNYAAPEVISGRLYAGPEV-----DIWSSGVILYALLCGTLPFDDDHVPTL 224
Query: 815 KPKMSR---ELVGWVLKMRSEGKQDQVFDPILRGKGFDEEMLQVLDVACMCVSQNPFKRP 871
K+ ++ + +L+ MLQV +P KR
Sbjct: 225 FKKICDGIFYTPQYL----NPSVIS-----LLKH------MLQV----------DPMKRA 259
Query: 872 TVKEVVE--WLN 881
T+K++ E W
Sbjct: 260 TIKDIREHEWFK 271
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 76.5 bits (189), Expect = 3e-15
Identities = 53/249 (21%), Positives = 85/249 (34%), Gaps = 58/249 (23%)
Query: 600 YELLKATDNFSQANIIGCGGFGLVYKAT-LANGTTLAIKKLS------------------ 640
Y L IG G +G+V A + T A+K LS
Sbjct: 15 YTLKD---------EIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRG 65
Query: 641 ---------GDLGLMEREFKAEVEALSTAQHKNLVSLQGYCVHQGF-RLLIY---SYMEN 687
G +E+ E+ L H N+V L V +Y +
Sbjct: 66 TRPAPGGCIQPRGPIEQ-VYQEIAILKKLDHPNVVKL--VEVLDDPNEDHLYMVFELVNQ 122
Query: 688 GSL-DYWLHEKADGASQLDWLTRLKIARGTSCGLAYMHQICEPHIVHRDIKSSNILLDDQ 746
G + + + L + G+ Y+H I+HRDIK SN+L+ +
Sbjct: 123 GPVMEVPTLKP------LSEDQARFYFQDLIKGIEYLHYQ---KIIHRDIKPSNLLVGED 173
Query: 747 FEAHLADFGLSRLILPYQTHVTTELVGTLGYIPPEYGQAWVATLRG---DMYSFGVVMLE 803
+ADFG+S ++ VGT ++ PE G D+++ GV +
Sbjct: 174 GHIKIADFGVSNEFKGSDALLSN-TVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYC 232
Query: 804 LLTGKRPVD 812
+ G+ P
Sbjct: 233 FVFGQCPFM 241
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674 | Back alignment and structure |
|---|
Score = 78.9 bits (194), Expect = 4e-15
Identities = 54/222 (24%), Positives = 91/222 (40%), Gaps = 39/222 (17%)
Query: 607 DNFSQANIIGCGGFGLVYKATL-ANGTTLAIKKLSGDLGLMEREF---KAEVEALSTA-Q 661
+F+ ++G G FG V + A+K L D+ + + + E L+ +
Sbjct: 341 TDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGK 400
Query: 662 HKNLVSLQGYCVHQGFRL-LIYSYMENGSLDYWLHEKADGASQLDWLTRLKIARGT---- 716
L L C RL + Y+ G L Y + + R K
Sbjct: 401 PPFLTQLH-SCFQTMDRLYFVMEYVNGGDLMYHIQQV----------GRFKEPHAVFYAA 449
Query: 717 --SCGLAYMHQICEPHIVHRDIKSSNILLDDQFEAHLADFGLSRLILPYQTHVTTELVGT 774
+ GL ++ I++RD+K N++LD + +ADFG+ + + T GT
Sbjct: 450 EIAIGLFFLQ---SKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGVTTKT-FCGT 505
Query: 775 LGYIPPE------YGQAWVATLRGDMYSFGVVMLELLTGKRP 810
YI PE YG++ V D ++FGV++ E+L G+ P
Sbjct: 506 PDYIAPEIIAYQPYGKS-V-----DWWAFGVLLYEMLAGQAP 541
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276 | Back alignment and structure |
|---|
Score = 75.7 bits (187), Expect = 4e-15
Identities = 62/312 (19%), Positives = 113/312 (36%), Gaps = 84/312 (26%)
Query: 600 YELLKATDNFSQANIIGCGGFGLVYKAT-LANGTTLAIK-----KLSGDLGLMEREFKAE 653
++L++ +G G +G V A +A+K + +++ E
Sbjct: 9 WDLVQ---------TLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKK----E 55
Query: 654 VEALSTAQHKNLVSLQGYCVHQGFRLLIYSYMENGSLDYWLHEKADGASQLDWLT---RL 710
+ H+N+V Y + G++ Y E G D + +
Sbjct: 56 ICINKMLNHENVVKF-------------YGHRREGNIQYLFLEYCSGGELFDRIEPDIGM 102
Query: 711 K--IARG----TSCGLAYMHQICEPHIVHRDIKSSNILLDDQFEAHLADFGLSRLILPYQ 764
A+ G+ Y+H I I HRDIK N+LLD++ ++DFGL+ + ++
Sbjct: 103 PEPDAQRFFHQLMAGVVYLHGI---GITHRDIKPENLLLDERDNLKISDFGLATV---FR 156
Query: 765 THVTTEL----VGTLGYIPPE--YGQAWVATLRGDMYSFGVVMLELLTGKRPVDVLKPKM 818
+ L GTL Y+ PE + + A D++S G+V+ +L G+ P D
Sbjct: 157 YNNRERLLNKMCGTLPYVAPELLKRREFHAE-PVDVWSCGIVLTAMLAGELPWD-----Q 210
Query: 819 SRELVGWVLKMRSEGKQDQVFDPILRGKGFDEE-------MLQVLDVACMCVSQNPFKRP 871
+ + + + K D +L NP R
Sbjct: 211 PSDSCQEYSDWKEKKTY------LNPWKKIDSAPLALLHKILVE----------NPSARI 254
Query: 872 TVKEVVE--WLN 881
T+ ++ + W N
Sbjct: 255 TIPDIKKDRWYN 266
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336 | Back alignment and structure |
|---|
Score = 76.2 bits (188), Expect = 5e-15
Identities = 73/315 (23%), Positives = 119/315 (37%), Gaps = 95/315 (30%)
Query: 600 YELLKATDNFSQANIIGCGGFGLVYKAT-LANGTTLAIKKLS----GDLGLMEREFKAEV 654
Y + + +G G FG V AT +A+K +S + R + E+
Sbjct: 11 YIIRE---------TLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMR-VEREI 60
Query: 655 EALSTAQHKNLVSLQGYCVHQGFRLLIYSYME--NGSL-DYWLHEKADGASQLDWLTRLK 711
L +H +++ L Y V I +E G L DY + +K R+
Sbjct: 61 SYLKLLRHPHIIKL--YDVITT-PTDIVMVIEYAGGELFDYIVEKK-----------RMT 106
Query: 712 I--ARGT----SCGLAYMHQICEPHIVHRDIKSSNILLDDQFEAHLADFGLSRLILPYQT 765
R C + Y H+ IVHRD+K N+LLDD +ADFGLS ++
Sbjct: 107 EDEGRRFFQQIICAIEYCHRH---KIVHRDLKPENLLLDDNLNVKIADFGLSNIMTDGNF 163
Query: 766 HVTT---------ELVGTLGYIPPEYGQAWVATLRGDMYSFGVVMLELLTGKRPVD---- 812
T+ E++ Y PE D++S G+V+ +L G+ P D
Sbjct: 164 LKTSCGSPNYAAPEVINGKLYAGPE----------VDVWSCGIVLYVMLVGRLPFDDEFI 213
Query: 813 -VLKPKMSR---ELVGWVLKMRSEGKQDQVFDPILRGKGFDEEMLQVLDVACMCVSQNPF 868
L K++ + ++ S G Q ++R M+ +P
Sbjct: 214 PNLFKKVNSCVYVMPDFL----SPGAQS-----LIRR------MIVA----------DPM 248
Query: 869 KRPTVKEVVE--WLN 881
+R T++E+ W N
Sbjct: 249 QRITIQEIRRDPWFN 263
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 | Back alignment and structure |
|---|
Score = 77.0 bits (190), Expect = 5e-15
Identities = 27/125 (21%), Positives = 49/125 (39%), Gaps = 16/125 (12%)
Query: 380 YNQLSNLPPAI----------YLANNSLSGNIPVEIGQLKSLHVLDLSNNNFSGTIPDEL 429
YN+L + Y++NN L + + + +L VLDLS+N+ +
Sbjct: 257 YNELEKIMYHPFVKMQRLERLYISNNRLV-ALNLYGQPIPTLKVLDLSHNHLL-HVERNQ 314
Query: 430 SDLSNLEKLDLSGNHLVGEIPISLKGLHFLSSFSVAHNNLQGAVPSGGQFDTFPSFSFEG 489
LE L L N +V + +S H L + +++HN+ F + +
Sbjct: 315 PQFDRLENLYLDHNSIV-TLKLST--HHTLKNLTLSHNDWDC-NSLRALFRNVARPAVDD 370
Query: 490 NPELC 494
+ C
Sbjct: 371 ADQHC 375
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 | Back alignment and structure |
|---|
Score = 68.9 bits (169), Expect = 2e-12
Identities = 21/100 (21%), Positives = 42/100 (42%), Gaps = 12/100 (12%)
Query: 379 QYNQLSNLPPAI-------YLANNSLSGNIPVEIGQLKSLHVLDLSNNNFSGTIPDE-LS 430
+N ++ + + L +N+L+ + + L +DLS N I
Sbjct: 213 SHNSINVVRGPVNVELTILKLQHNNLT-DTAW-LLNYPGLVEVDLSYNELE-KIMYHPFV 269
Query: 431 DLSNLEKLDLSGNHLVGEIPISLKGLHFLSSFSVAHNNLQ 470
+ LE+L +S N LV + + + + L ++HN+L
Sbjct: 270 KMQRLERLYISNNRLV-ALNLYGQPIPTLKVLDLSHNHLL 308
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 | Back alignment and structure |
|---|
Score = 64.7 bits (158), Expect = 4e-11
Identities = 29/105 (27%), Positives = 45/105 (42%), Gaps = 19/105 (18%)
Query: 379 QYNQLSNLPPAI----------YLANNSLSGNIPVEI-GQLKSLHVLDLSNNNFSGTIPD 427
+N + LPP + L N LS ++P I L L +SNNN I D
Sbjct: 101 GFNAIRYLPPHVFQNVPLLTVLVLERNDLS-SLPRGIFHNTPKLTTLSMSNNNLE-RIED 158
Query: 428 E-LSDLSNLEKLDLSGNHLVGEIPIS-LKGLHFLSSFSVAHNNLQ 470
+ ++L+ L LS N L + +S + L +V++N L
Sbjct: 159 DTFQATTSLQNLQLSSNRLT-HVDLSLIPSLFHA---NVSYNLLS 199
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 | Back alignment and structure |
|---|
Score = 64.7 bits (158), Expect = 4e-11
Identities = 21/128 (16%), Positives = 43/128 (33%), Gaps = 26/128 (20%)
Query: 379 QYNQLSNLPPAI----------YLANNSLSGNIPVEI-GQLKSLHVLDLSNNNFSGTIPD 427
+ + + LP A+ L + + I ++ L + N +P
Sbjct: 53 KNSTMRKLPAALLDSFRQVELLNLNDLQIE-EIDTYAFAYAHTIQKLYMGFNAIR-YLPP 110
Query: 428 E-LSDLSNLEKLDLSGNHLVGEIPISL-KGLHFLSSFSVAHNNLQGAVPSGGQFDTFPSF 485
++ L L L N L +P + L++ S+++NNL+
Sbjct: 111 HVFQNVPLLTVLVLERNDLS-SLPRGIFHNTPKLTTLSMSNNNLE----------RIEDD 159
Query: 486 SFEGNPEL 493
+F+ L
Sbjct: 160 TFQATTSL 167
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 | Back alignment and structure |
|---|
Score = 63.9 bits (156), Expect = 7e-11
Identities = 20/117 (17%), Positives = 44/117 (37%), Gaps = 17/117 (14%)
Query: 379 QYNQLSNLPPAIY--LANNSLSGNIPVEIGQLKSLHVLDLSNNNFSGTIPDELSDLSNLE 436
N+L+++ ++ L + ++S N+ + ++ LD S+N+ + + + L
Sbjct: 173 SSNRLTHVDLSLIPSLFHANVSYNLLSTLAIPIAVEELDASHNSIN-VVRGPV--NVELT 229
Query: 437 KLDLSGNHLVGEIPISLKGLHFLSSFSVAHNNLQGAVPSGGQFDTFPSFSFEGNPEL 493
L L N+L + L L +++N L+ F L
Sbjct: 230 ILKLQHNNLT-DTA-WLLNYPGLVEVDLSYNELE----------KIMYHPFVKMQRL 274
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 | Back alignment and structure |
|---|
Score = 59.3 bits (144), Expect = 2e-09
Identities = 19/117 (16%), Positives = 36/117 (30%), Gaps = 19/117 (16%)
Query: 384 SNLPPAIYLANNSLSGN-----IPVEIGQLKSLHVLDLSNNNFSGTIPDE-LSDLSNLEK 437
SNL + + E L + ++ N+ +P L +E
Sbjct: 15 SNLQYDCVFYDVHIDMQTQDVYFGFEDITLNNQKIVTFKNSTMR-KLPAALLDSFRQVEL 73
Query: 438 LDLSGNHLVGEIP-ISLKGLHFLSSFSVAHNNLQGAVPSGGQFDTFPSFSFEGNPEL 493
L+L+ + EI + H + + N ++ P F+ P L
Sbjct: 74 LNLNDLQIE-EIDTYAFAYAHTIQKLYMGFNAIR----------YLPPHVFQNVPLL 119
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 | Back alignment and structure |
|---|
Score = 42.3 bits (100), Expect = 5e-04
Identities = 7/94 (7%), Positives = 28/94 (29%), Gaps = 12/94 (12%)
Query: 401 IPVEIGQLKSLHVLDLSNNNFSGTIPDELSDLSNLEKLDLSGNHLVGEIPIS-LKGLHFL 459
I + + + + E L+N + + + + ++P + L +
Sbjct: 13 IDSNLQYDCVFYDVHIDMQTQDVYFGFEDITLNNQKIVTFKNSTMR-KLPAALLDSFRQV 71
Query: 460 SSFSVAHNNLQGAVPSGGQFDTFPSFSFEGNPEL 493
++ ++ +++F +
Sbjct: 72 ELLNLNDLQIE----------EIDTYAFAYAHTI 95
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367 | Back alignment and structure |
|---|
Score = 76.2 bits (188), Expect = 8e-15
Identities = 55/218 (25%), Positives = 84/218 (38%), Gaps = 33/218 (15%)
Query: 606 TDNFSQANIIGCGGFGLVYKAT-LANGTTLAIKKLS---GDLGLMEREFKAEVEALSTAQ 661
+ +G G +G V A G +AIKKL +R ++ E+ L +
Sbjct: 24 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYR-ELRLLKHMR 82
Query: 662 HKNLVSL----QGYCVHQGFRLLIYSYMENGSLDYWLHEKADGASQLDWLTRLKIARGTS 717
H+N++ L F Y M + L K +L +
Sbjct: 83 HENVIGLLDVFTPDETLDDFTD-FYLVMP--FMGTDLG-KLMKHEKLGEDRIQFLVYQML 138
Query: 718 CGLAYMHQICEPHIVHRDIKSSNILLDDQFEAHLADFGLSRLILPYQTHVTTELVGTLGY 777
GL Y+H I+HRD+K N+ +++ E + DFGL+R T V T Y
Sbjct: 139 KGLRYIH---AAGIIHRDLKPGNLAVNEDCELKILDFGLARQADSEM----TGYVVTRWY 191
Query: 778 IPPE-------YGQAWVATLRGDMYSFGVVMLELLTGK 808
PE Y Q D++S G +M E++TGK
Sbjct: 192 RAPEVILNWMRYTQTV------DIWSVGCIMAEMITGK 223
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286 | Back alignment and structure |
|---|
Score = 74.8 bits (184), Expect = 1e-14
Identities = 22/207 (10%), Positives = 50/207 (24%), Gaps = 55/207 (26%)
Query: 615 IGCGGFGLVYKAT-LANGTTLAIKKLSGDLGL---MEREFKAEVEALSTAQHKNLVSLQG 670
G ++A A +A+ + L + +E + LS +
Sbjct: 39 HGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVAR--- 95
Query: 671 YCVHQGFRLLIYSYMENGSLDYWLHEKADGAS-------QLDWLTRLKIARGTSCGLAYM 723
+ + + + E G S + ++ + +
Sbjct: 96 ----------VLDVVHTRAGGLVVAEWIRGGSLQEVADTSPSPVGAIRAMQSLAAAADAA 145
Query: 724 HQICEPHIVHRDIKSSNILLDDQFEAHLADFGLSRLILPYQTHVTTELVGTLGYIPPEYG 783
H+ + S + + + LA +P
Sbjct: 146 HRA---GVALSIDHPSRVRVSIDGDVVLAYP---------------------ATMPD--- 178
Query: 784 QAWVATLRGDMYSFGVVMLELLTGKRP 810
A + D+ G + LL + P
Sbjct: 179 ----ANPQDDIRGIGASLYALLVNRWP 201
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337 | Back alignment and structure |
|---|
Score = 75.3 bits (186), Expect = 1e-14
Identities = 58/221 (26%), Positives = 88/221 (39%), Gaps = 38/221 (17%)
Query: 607 DNFSQANIIGCGGFGLVYKATL-ANGTTLAIKKLSGDLGLMEREF---KAEVEALSTAQH 662
++F ++G G FG V A G A+K L ++ + + E E L +H
Sbjct: 5 NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRH 64
Query: 663 KNLVSLQGYCVHQGFRL-LIYSYMENGSLDYWLHEKADGASQLDWLTRLKIARGT----- 716
L +L+ Y RL + Y G L + L + R
Sbjct: 65 PFLTALK-YAFQTHDRLCFVMEYANGGELFFHLSRE----------RVFTEERARFYGAE 113
Query: 717 -SCGLAYMHQICEPHIVHRDIKSSNILLDDQFEAHLADFGLSRLILPYQTHVTTELVGTL 775
L Y+H +V+RDIK N++LD + DFGL + + + T GT
Sbjct: 114 IVSALEYLH---SRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKT-FCGTP 169
Query: 776 GYIPPE------YGQAWVATLRGDMYSFGVVMLELLTGKRP 810
Y+ PE YG+A V D + GVVM E++ G+ P
Sbjct: 170 EYLAPEVLEDNDYGRA-V-----DWWGLGVVMYEMMCGRLP 204
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 75.3 bits (186), Expect = 1e-14
Identities = 24/99 (24%), Positives = 45/99 (45%), Gaps = 12/99 (12%)
Query: 380 YNQLSNLPP--------AIYLANNSLSGNIPVEIGQLKSLHVLDLSNNNFSGTIPDELSD 431
NQ+S++ + + +N +S +I + L L+ L L+NN + +
Sbjct: 252 TNQISDINAVKDLTKLKMLNVGSNQIS-DIS-VLNNLSQLNSLFLNNNQLGNEDMEVIGG 309
Query: 432 LSNLEKLDLSGNHLVGEIPISLKGLHFLSSFSVAHNNLQ 470
L+NL L LS NH+ P++ L + S A+ ++
Sbjct: 310 LTNLTTLFLSQNHITDIRPLA--SLSKMDSADFANQVIK 346
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 72.6 bits (179), Expect = 9e-14
Identities = 25/104 (24%), Positives = 48/104 (46%), Gaps = 12/104 (11%)
Query: 379 QYNQLSNLPP--------AIYLANNSLSGNIPVEIGQLKSLHVLDLSNNNFSGTIPDELS 430
N++++L P + + N +S +I + L L +L++ +N S L+
Sbjct: 229 GNNKITDLSPLANLSQLTWLEIGTNQIS-DIN-AVKDLTKLKMLNVGSNQISD--ISVLN 284
Query: 431 DLSNLEKLDLSGNHLVGEIPISLKGLHFLSSFSVAHNNLQGAVP 474
+LS L L L+ N L E + GL L++ ++ N++ P
Sbjct: 285 NLSQLNSLFLNNNQLGNEDMEVIGGLTNLTTLFLSQNHITDIRP 328
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 68.0 bits (167), Expect = 3e-12
Identities = 17/100 (17%), Positives = 39/100 (39%), Gaps = 14/100 (14%)
Query: 380 YNQLSNLPP--------AIYLANNSLSGNIPVEIGQLKSLHVLDLSNNNFSGTIPDELSD 431
+++ ++ P ++ L N + P + L SLH N + P +++
Sbjct: 164 ESKVKDVTPIANLTDLYSLSLNYNQIEDISP--LASLTSLHYFTAYVNQITDITP--VAN 219
Query: 432 LSNLEKLDLSGNHLVGEIPISLKGLHFLSSFSVAHNNLQG 471
++ L L + N + P++ L L+ + N +
Sbjct: 220 MTRLNSLKIGNNKITDLSPLA--NLSQLTWLEIGTNQISD 257
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 67.6 bits (166), Expect = 4e-12
Identities = 17/101 (16%), Positives = 35/101 (34%), Gaps = 15/101 (14%)
Query: 380 YNQLSNLPPAI---------YLANNSLSGNIPVEIGQLKSLHVLDLSNNNFSGTIPDELS 430
N + + + + + P I L L+ L L+ N P L+
Sbjct: 141 ANHNLSDLSPLSNMTGLNYLTVTESKVKDVTP--IANLTDLYSLSLNYNQIEDISP--LA 196
Query: 431 DLSNLEKLDLSGNHLVGEIPISLKGLHFLSSFSVAHNNLQG 471
L++L N + P++ + L+S + +N +
Sbjct: 197 SLTSLHYFTAYVNQITDITPVA--NMTRLNSLKIGNNKITD 235
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 67.2 bits (165), Expect = 5e-12
Identities = 20/100 (20%), Positives = 47/100 (47%), Gaps = 13/100 (13%)
Query: 380 YNQLSNLPP--------AIYLANNSLSGNIPVEIGQLKSLHVLDLSNNNFSGTIPDELSD 431
N+++++ +YL +++S P + L ++ L+L N+ + LS+
Sbjct: 97 TNKITDISALQNLTNLRELYLNEDNISDISP--LANLTKMYSLNLGANHNL-SDLSPLSN 153
Query: 432 LSNLEKLDLSGNHLVGEIPISLKGLHFLSSFSVAHNNLQG 471
++ L L ++ + + PI+ L L S S+ +N ++
Sbjct: 154 MTGLNYLTVTESKVKDVTPIA--NLTDLYSLSLNYNQIED 191
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 59.5 bits (145), Expect = 2e-09
Identities = 20/101 (19%), Positives = 41/101 (40%), Gaps = 14/101 (13%)
Query: 379 QYNQLSNLPP--------AIYLANNSLSGNIPVEIGQLKSLHVLDLSNNNFSGTIPDELS 430
Q ++++ + +A ++ +I I L +L L+L+ N + P LS
Sbjct: 30 QKASVTDVVTQEELESITKLVVAGEKVA-SIQ-GIEYLTNLEYLNLNGNQITDISP--LS 85
Query: 431 DLSNLEKLDLSGNHLVGEIPISLKGLHFLSSFSVAHNNLQG 471
+L L L + N + +L+ L L + +N+
Sbjct: 86 NLVKLTNLYIGTNKI--TDISALQNLTNLRELYLNEDNISD 124
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 59.1 bits (144), Expect = 2e-09
Identities = 21/89 (23%), Positives = 43/89 (48%), Gaps = 8/89 (8%)
Query: 383 LSNLPPAI--YLANNSLSGNIPVEIGQLKSLHVLDLSNNNFSGTIPDELSDLSNLEKLDL 440
++L I L S++ + +L+S+ L ++ + +I + L+NLE L+L
Sbjct: 18 DADLAEGIRAVLQKASVTDVVT--QEELESITKLVVAGEKVA-SIQG-IEYLTNLEYLNL 73
Query: 441 SGNHLVGEIPISLKGLHFLSSFSVAHNNL 469
+GN + P+S L L++ + N +
Sbjct: 74 NGNQITDISPLS--NLVKLTNLYIGTNKI 100
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323 | Back alignment and structure |
|---|
Score = 74.7 bits (184), Expect = 2e-14
Identities = 64/312 (20%), Positives = 115/312 (36%), Gaps = 84/312 (26%)
Query: 600 YELLKATDNFSQANIIGCGGFGLVYKAT-LANGTTLAIK-----KLSGDLGLMEREFKAE 653
++L++ +G G +G V A +A+K + +++E
Sbjct: 9 WDLVQ---------TLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKE---- 55
Query: 654 VEALSTAQHKNLVSLQGYCVHQGFRLLIYSYMENGSLDYWLHEKADGASQLDWLT---RL 710
+ H+N+V Y + G++ Y E G D + +
Sbjct: 56 ICINKMLNHENVVKF-------------YGHRREGNIQYLFLEYCSGGELFDRIEPDIGM 102
Query: 711 K--IARG----TSCGLAYMHQICEPHIVHRDIKSSNILLDDQFEAHLADFGLSRLILPYQ 764
A+ G+ Y+H I I HRDIK N+LLD++ ++DFGL+ + ++
Sbjct: 103 PEPDAQRFFHQLMAGVVYLHGI---GITHRDIKPENLLLDERDNLKISDFGLATV---FR 156
Query: 765 THVTTEL----VGTLGYIPPE--YGQAWVATLRGDMYSFGVVMLELLTGKRPVDVLKPKM 818
+ L GTL Y+ PE + + A D++S G+V+ +L G+ P D
Sbjct: 157 YNNRERLLNKMCGTLPYVAPELLKRREFHAE-PVDVWSCGIVLTAMLAGELPWDQPSDSC 215
Query: 819 SRELVGWVLKMRSEGKQDQVFDPILRGKGFDEE-------MLQVLDVACMCVSQNPFKRP 871
+E W + + + K D +L NP R
Sbjct: 216 -QEYSDWK--------EKKTYLN--PWKKIDSAPLALLHKILVE----------NPSARI 254
Query: 872 TVKEVVE--WLN 881
T+ ++ + W N
Sbjct: 255 TIPDIKKDRWYN 266
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345 | Back alignment and structure |
|---|
Score = 75.0 bits (185), Expect = 2e-14
Identities = 60/258 (23%), Positives = 101/258 (39%), Gaps = 49/258 (18%)
Query: 607 DNFSQANIIGCGGFGLVYKATL-ANGTTLAIKKLSGDLGLMEREF---KAEVEALSTA-Q 661
+F +IG G + V L A+K + +L + + + E A
Sbjct: 9 QDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASN 68
Query: 662 HKNLVSLQGYCVHQGFRL-LIYSYMENGSLDYWLHEKADGASQLDWLTRLKIARGT---- 716
H LV L C RL + Y+ G L + + + +L
Sbjct: 69 HPFLVGLH-SCFQTESRLFFVIEYVNGGDLMFHMQRQ----------RKLPEEHARFYSA 117
Query: 717 --SCGLAYMHQICEPHIVHRDIKSSNILLDDQFEAHLADFGLSRLILPYQTHVTTELVGT 774
S L Y+H+ I++RD+K N+LLD + L D+G+ + L T+ GT
Sbjct: 118 EISLALNYLHER---GIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGD-TTSTFCGT 173
Query: 775 LGYIPPE------YGQAWVATLRGDMYSFGVVMLELLTGKRPVDVLKPKMSRELVGWVLK 828
YI PE YG + V D ++ GV+M E++ G+ P D++ + +
Sbjct: 174 PNYIAPEILRGEDYGFS-V-----DWWALGVLMFEMMAGRSPFDIVGSSDNPD------- 220
Query: 829 MRSEGKQDQVFDPILRGK 846
+ +D +F IL +
Sbjct: 221 ---QNTEDYLFQVILEKQ 235
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355 | Back alignment and structure |
|---|
Score = 75.0 bits (185), Expect = 2e-14
Identities = 63/230 (27%), Positives = 98/230 (42%), Gaps = 48/230 (20%)
Query: 607 DNFSQANIIGCGGFG---LVYKATLANGTTL-AIKKLSGDLGLMEREF----KAEVEALS 658
+NF ++G G +G LV K + + L A+K L + + + + E + L
Sbjct: 54 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLE 113
Query: 659 TAQHKN-LVSLQGYCVHQGFRL-LIYSYMENGSLDYWLHEKADGASQLDWLTRLKIARGT 716
+ LV+L Y +L LI Y+ G L L ++ R
Sbjct: 114 HIRQSPFLVTLH-YAFQTETKLHLILDYINGGELFTHLSQR----------ERFTEHEVQ 162
Query: 717 ------SCGLAYMHQICEPHIVHRDIKSSNILLDDQFEAH--LADFGLSRLILPYQTHVT 768
L ++H++ I++RDIK NILLD H L DFGLS+ + +T
Sbjct: 163 IYVGEIVLALEHLHKL---GIIYRDIKLENILLDS--NGHVVLTDFGLSKEFVADETERA 217
Query: 769 TELVGTLGYIPPE--------YGQAWVATLRGDMYSFGVVMLELLTGKRP 810
+ GT+ Y+ P+ + +A V D +S GV+M ELLTG P
Sbjct: 218 YDFCGTIEYMAPDIVRGGDSGHDKA-V-----DWWSLGVLMYELLTGASP 261
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327 | Back alignment and structure |
|---|
Score = 74.5 bits (184), Expect = 2e-14
Identities = 62/228 (27%), Positives = 93/228 (40%), Gaps = 48/228 (21%)
Query: 607 DNFSQANIIGCGGFG---LVYKATL-ANGTTLAIKKLSGDLGLMEREF-----KAEVEAL 657
+ F ++G GG+G V K T G A+K L + ++ KAE L
Sbjct: 17 ECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAM-IVRNAKDTAHTKAERNIL 75
Query: 658 STAQHKNLVSLQGYCVHQGFRL-LIYSYMENGSLDYWLHEKADGASQLDWLTRLKIARGT 716
+H +V L Y G +L LI Y+ G L L +
Sbjct: 76 EEVKHPFIVDLI-YAFQTGGKLYLILEYLSGGELFMQLERE----------GIFMEDTAC 124
Query: 717 ------SCGLAYMHQICEPHIVHRDIKSSNILLDDQFEAH--LADFGLSRLILPYQTHVT 768
S L ++HQ I++RD+K NI+L+ + H L DFGL + + VT
Sbjct: 125 FYLAEISMALGHLHQK---GIIYRDLKPENIMLNH--QGHVKLTDFGLCKESIHD-GTVT 178
Query: 769 TELVGTLGYIPPE------YGQAWVATLRGDMYSFGVVMLELLTGKRP 810
GT+ Y+ PE + +A V D +S G +M ++LTG P
Sbjct: 179 HTFCGTIEYMAPEILMRSGHNRA-V-----DWWSLGALMYDMLTGAPP 220
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353 | Back alignment and structure |
|---|
Score = 74.6 bits (184), Expect = 2e-14
Identities = 49/244 (20%), Positives = 90/244 (36%), Gaps = 71/244 (29%)
Query: 600 YELLKATDNFSQANIIGCGGFGLVYKAT-LANGTTLAIKKLS--GDLGLMEREFKAEVEA 656
++L ++G G +G+V AT G +AIKK+ R + E++
Sbjct: 13 FQLKS---------LLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLR-EIKI 62
Query: 657 LSTAQHKNLVSLQGYCVHQGFRLL--IYSYMENGSLDYWLHEKADGASQLDWLTRLKIAR 714
L +H+N++++ F +Y E + LH ++
Sbjct: 63 LKHFKHENIITIFNIQRPDSFENFNEVYIIQE--LMQTDLH---------------RVIS 105
Query: 715 GTS--------------CGLAYMHQICEPHIVHRDIKSSNILLDDQFEAHLADFGLSRLI 760
+ +H +++HRD+K SN+L++ + + DFGL+R+I
Sbjct: 106 TQMLSDDHIQYFIYQTLRAVKVLH---GSNVIHRDLKPSNLLINSNCDLKVCDFGLARII 162
Query: 761 LPYQTHVT---------TELVGTLGYIPPE-------YGQAWVATLRGDMYSFGVVMLEL 804
+ E V T Y PE Y +A D++S G ++ EL
Sbjct: 163 DESAADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAM------DVWSCGCILAEL 216
Query: 805 LTGK 808
+
Sbjct: 217 FLRR 220
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396 | Back alignment and structure |
|---|
Score = 74.7 bits (184), Expect = 3e-14
Identities = 64/311 (20%), Positives = 115/311 (36%), Gaps = 60/311 (19%)
Query: 556 DPDKIELDTISSTSNFGVSPEADKDASLVMLFPNNTNEIKDLTI--YELLKATDNFSQAN 613
++ T + G ++ M + L + ++LL+
Sbjct: 8 HHHDYDIPTTENLYFQGAMGSGIEEEKEAMNTRESGKASSSLGLQDFDLLR--------- 58
Query: 614 IIGCGGFGLVYKATL-ANGTTLAIKKLSGDLGLMEREF---KAEVEALSTA-QHKNLVSL 668
+IG G + V L A++ + +L + + + E A H LV L
Sbjct: 59 VIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGL 118
Query: 669 QGYCVHQGFRL-LIYSYMENGSLDYWLHEKADGASQLDWLTRLKIARGT------SCGLA 721
C RL + Y+ G L + + + +L S L
Sbjct: 119 H-SCFQTESRLFFVIEYVNGGDLMFHMQRQ----------RKLPEEHARFYSAEISLALN 167
Query: 722 YMHQICEPHIVHRDIKSSNILLDDQFEAHLADFGLSRLILPYQTHVTTELVGTLGYIPPE 781
Y+H+ I++RD+K N+LLD + L D+G+ + L T+ GT YI PE
Sbjct: 168 YLHER---GIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGD-TTSTFCGTPNYIAPE 223
Query: 782 ------YGQAWVATLRGDMYSFGVVMLELLTGKRPVDVLKPKMSRELVGWVLKMRSEGKQ 835
YG + V D ++ GV+M E++ G+ P D++ + + + +
Sbjct: 224 ILRGEDYGFS-V-----DWWALGVLMFEMMAGRSPFDIVGSSDNPD----------QNTE 267
Query: 836 DQVFDPILRGK 846
D +F IL +
Sbjct: 268 DYLFQVILEKQ 278
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 75.1 bits (185), Expect = 4e-14
Identities = 24/116 (20%), Positives = 38/116 (32%), Gaps = 11/116 (9%)
Query: 379 QYNQLSNLPPA----------IYLANNSLSGNIPVEIGQLKSLHVLDLSNNNFSGTIPDE 428
+N L +L + L+ + L L L L+ N
Sbjct: 36 SFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQSLALGA 95
Query: 429 LSDLSNLEKLDLSGNHLVGEIPISLKGLHFLSSFSVAHNNLQGAVPSGGQFDTFPS 484
S LS+L+KL +L + L L +VAHN +Q + F +
Sbjct: 96 FSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQ-SFKLPEYFSNLTN 150
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 72.4 bits (178), Expect = 3e-13
Identities = 22/103 (21%), Positives = 35/103 (33%), Gaps = 11/103 (10%)
Query: 379 QYNQLSNLPPAI----------YLANNSLSGNIPVEI-GQLKSLHVLDLSNNNFSGTIPD 427
+ I +A NS N +I +L++L LDLS P
Sbjct: 429 SHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPT 488
Query: 428 ELSDLSNLEKLDLSGNHLVGEIPISLKGLHFLSSFSVAHNNLQ 470
+ LS+L+ L+++ N L L L + N
Sbjct: 489 AFNSLSSLQVLNMASNQLKSVPDGIFDRLTSLQKIWLHTNPWD 531
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 67.4 bits (165), Expect = 1e-11
Identities = 26/113 (23%), Positives = 34/113 (30%), Gaps = 13/113 (11%)
Query: 384 SNLPPAI---YLANNSLSGNIPVEIGQLKSLHVLDLSNNNFSGTIPDELSDLSNLEKLDL 440
NLP + L+ N L L VLDLS LS+L L L
Sbjct: 24 DNLPFSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLIL 83
Query: 441 SGNHLVGEIPISLKGLHFLSSFSVAHNNLQGAVPSGGQFDTFPSFSFEGNPEL 493
+GN + + GL L NL + +F L
Sbjct: 84 TGNPIQSLALGAFSGLSSLQKLVAVETNLA----------SLENFPIGHLKTL 126
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 65.5 bits (160), Expect = 5e-11
Identities = 20/126 (15%), Positives = 41/126 (32%), Gaps = 21/126 (16%)
Query: 379 QYNQLSNLPPAI---------YLANNSLSGNIPVEI-GQLKSLHVLDLSNNNFSGTIPDE 428
+N + + +++L + L++L LD+S+ +
Sbjct: 381 SFNGVITMSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGI 440
Query: 429 LSDLSNLEKLDLSGNHLVGEI-PISLKGLHFLSSFSVAHNNLQGAVPSGGQFDTFPSFSF 487
+ LS+LE L ++GN P L L+ ++ L+ +F
Sbjct: 441 FNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLE----------QLSPTAF 490
Query: 488 EGNPEL 493
L
Sbjct: 491 NSLSSL 496
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 63.6 bits (155), Expect = 2e-10
Identities = 25/113 (22%), Positives = 42/113 (37%), Gaps = 16/113 (14%)
Query: 379 QYNQLSNLPPA----------IYLANNSL-SGNIPVEIGQLKSLHVLDLSNNNFSGTIPD 427
L++L + +A+N + S +P L +L LDLS+N
Sbjct: 108 VETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCT 167
Query: 428 ELSDLSNLE----KLDLSGNHLVGEIPISLKGLHFLSSFSVAHNNLQGAVPSG 476
+L L + LDLS N + P + K + L ++ +N V
Sbjct: 168 DLRVLHQMPLLNLSLDLSLNPMNFIQPGAFKEIR-LHKLTLRNNFDSLNVMKT 219
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 54.0 bits (130), Expect = 2e-07
Identities = 25/113 (22%), Positives = 37/113 (32%), Gaps = 12/113 (10%)
Query: 379 QYNQLSNLPPAIY---LANNSLSGNIPVEI--GQLKSLHVLDLSNNNFSGTIPDELSDLS 433
+ + Y + L + +LKSL L ++N DL
Sbjct: 290 VSVTIERVKDFSYNFGWQHLELVNCKFGQFPTLKLKSLKRLTFTSNKGGNAFS--EVDLP 347
Query: 434 NLEKLDLSGNHL--VGEIPISLKGLHFLSSFSVAHNNLQGAVPSGGQFDTFPS 484
+LE LDLS N L G S G L ++ N + + S F
Sbjct: 348 SLEFLDLSRNGLSFKGCCSQSDFGTTSLKYLDLSFNGVI-TMSSN--FLGLEQ 397
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 50.9 bits (122), Expect = 2e-06
Identities = 20/94 (21%), Positives = 34/94 (36%), Gaps = 5/94 (5%)
Query: 381 NQLSNLPPAIYLANNSLSGNIPVEIGQLKSLHVLDLSNNNFSGTIPDE-LSDLSNLEKLD 439
+Q+ L ++ L+ N ++ I + LH L L NN S + + L+ LE
Sbjct: 173 HQMPLLNLSLDLSLNPMNF-IQPGAFKEIRLHKLTLRNNFDSLNVMKTCIQGLAGLEVHR 231
Query: 440 LSGNHLVGE---IPISLKGLHFLSSFSVAHNNLQ 470
L E L L + ++ L
Sbjct: 232 LVLGEFRNEGNLEKFDKSALEGLCNLTIEEFRLA 265
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 45.9 bits (109), Expect = 6e-05
Identities = 24/111 (21%), Positives = 38/111 (34%), Gaps = 19/111 (17%)
Query: 379 QYNQLSNLPP---------AIYLANNSLSGNIP-VEIGQLKSLHVLDL------SNNNFS 422
N ++ + P + L NN S N+ I L L V L + N
Sbjct: 185 SLNPMNFIQPGAFKEIRLHKLTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLE 244
Query: 423 GTIPDELSDLSNLEKLDLSGNHL---VGEIPISLKGLHFLSSFSVAHNNLQ 470
L L NL + +L + +I L +SSFS+ ++
Sbjct: 245 KFDKSALEGLCNLTIEEFRLAYLDYYLDDIIDLFNCLTNVSSFSLVSVTIE 295
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350 | Back alignment and structure |
|---|
Score = 73.5 bits (181), Expect = 5e-14
Identities = 49/215 (22%), Positives = 84/215 (39%), Gaps = 29/215 (13%)
Query: 607 DNFSQANIIGCGGFGLVYKATL-ANGTTLAIKKLSGDLGLMEREF---KAEVEALSTAQH 662
D F + +G G FG V +G A+K L + ++ E L
Sbjct: 41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 663 KNLVSLQGYCVHQGFRL-LIYSYMENGSLDYWLHEKADGASQLDWLTRLKIARGTSCGLA 721
LV L+ + L ++ Y+ G + + H + G R A+
Sbjct: 101 PFLVKLE-FSFKDNSNLYMVMEYVAGGEM--FSHLRRIGRFSEPH-ARFYAAQIV-LTFE 155
Query: 722 YMHQICEPHIVHRDIKSSNILLDDQFEAHLADFGLSRLILPYQTHVTTELVGTLGYIPPE 781
Y+H + +++RD+K N+L+D Q + DFG ++ + T L GT + PE
Sbjct: 156 YLHSL---DLIYRDLKPENLLIDQQGYIQVTDFGFAKRV----KGRTWTLCGTPEALAPE 208
Query: 782 ------YGQAWVATLRGDMYSFGVVMLELLTGKRP 810
Y +A D ++ GV++ E+ G P
Sbjct: 209 IILSKGYNKAV------DWWALGVLIYEMAAGYPP 237
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353 | Back alignment and structure |
|---|
Score = 73.4 bits (181), Expect = 6e-14
Identities = 54/222 (24%), Positives = 91/222 (40%), Gaps = 39/222 (17%)
Query: 607 DNFSQANIIGCGGFGLVYKATL-ANGTTLAIKKLSGDLGLMEREF---KAEVEALSTA-Q 661
+F+ ++G G FG V + A+K L D+ + + + E L+ +
Sbjct: 20 TDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGK 79
Query: 662 HKNLVSLQGYCVHQGFRL-LIYSYMENGSLDYWLHEKADGASQLDWLTRLKIARGT---- 716
L L C RL + Y+ G L Y + + R K
Sbjct: 80 PPFLTQLH-SCFQTMDRLYFVMEYVNGGDLMYHIQQV----------GRFKEPHAVFYAA 128
Query: 717 --SCGLAYMHQICEPHIVHRDIKSSNILLDDQFEAHLADFGLSRLILPYQTHVTTELVGT 774
+ GL ++ I++RD+K N++LD + +ADFG+ + + T GT
Sbjct: 129 EIAIGLFFLQSK---GIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWD-GVTTKTFCGT 184
Query: 775 LGYIPPE------YGQAWVATLRGDMYSFGVVMLELLTGKRP 810
YI PE YG++ V D ++FGV++ E+L G+ P
Sbjct: 185 PDYIAPEIIAYQPYGKS-V-----DWWAFGVLLYEMLAGQAP 220
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197 | Back alignment and structure |
|---|
Score = 70.4 bits (173), Expect = 6e-14
Identities = 20/98 (20%), Positives = 43/98 (43%), Gaps = 9/98 (9%)
Query: 380 YNQLSNLPP--------AIYLANNSLSGNIPVEIGQLKSLHVLDLSNNNFSGTIPDELSD 431
+N P + + ++ + + L SL +LD+S++ +I +++
Sbjct: 75 NIHATNYNPISGLSNLERLRIMGKDVTSDKIPNLSGLTSLTLLDISHSAHDDSILTKINT 134
Query: 432 LSNLEKLDLSGNHLVGEIPISLKGLHFLSSFSVAHNNL 469
L + +DLS N + +I LK L L S ++ + +
Sbjct: 135 LPKVNSIDLSYNGAITDIM-PLKTLPELKSLNIQFDGV 171
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197 | Back alignment and structure |
|---|
Score = 58.4 bits (142), Expect = 7e-10
Identities = 17/91 (18%), Positives = 38/91 (41%), Gaps = 4/91 (4%)
Query: 381 NQLSNLPPAIYLANNSLSGNIPVEIGQLKSLHVLDLSNNNFSGTIPDELSDLSNLEKLDL 440
+ L++L + +++++ +I +I L ++ +DLS N I L L L+ L++
Sbjct: 109 SGLTSLT-LLDISHSAHDDSILTKINTLPKVNSIDLSYNGAITDI-MPLKTLPELKSLNI 166
Query: 441 SGNHLVGEIPISLKGLHFLSSFSVAHNNLQG 471
+ + I L+ + G
Sbjct: 167 QFDGVHDYRGIE--DFPKLNQLYAFSQTIGG 195
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197 | Back alignment and structure |
|---|
Score = 56.5 bits (137), Expect = 4e-09
Identities = 25/104 (24%), Positives = 52/104 (50%), Gaps = 8/104 (7%)
Query: 373 SNATNQQYNQLSNLPPAIYLANNSLSGNIPVEIGQLKSLHVLDLSNNNFSGTIPDELSDL 432
+N T Q N L+ + LAN +++ ++ I ++ L ++N + + P +S L
Sbjct: 36 ANITEAQMNSLTYI----TLANINVT-DLT-GIEYAHNIKDLTINNIHATNYNP--ISGL 87
Query: 433 SNLEKLDLSGNHLVGEIPISLKGLHFLSSFSVAHNNLQGAVPSG 476
SNLE+L + G + + +L GL L+ ++H+ ++ +
Sbjct: 88 SNLERLRIMGKDVTSDKIPNLSGLTSLTLLDISHSAHDDSILTK 131
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197 | Back alignment and structure |
|---|
Score = 48.0 bits (115), Expect = 3e-06
Identities = 19/104 (18%), Positives = 34/104 (32%), Gaps = 6/104 (5%)
Query: 374 NATNQQYN-QLSNLPPAIYLANNSLSGNIPVEIGQLKSLHVLDLSNNNFSGTIPDELSDL 432
A+ N S + S + Q+ SL + L+N N + +
Sbjct: 9 KASQDNVNIPDSTFKAYLNGLLGQ-SSTANITEAQMNSLTYITLANINVTDLTG--IEYA 65
Query: 433 SNLEKLDLSGNHLVGEIPISLKGLHFLSSFSVAHNNLQGAVPSG 476
N++ L ++ H PIS GL L + ++
Sbjct: 66 HNIKDLTINNIHATNYNPIS--GLSNLERLRIMGKDVTSDKIPN 107
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367 | Back alignment and structure |
|---|
Score = 73.1 bits (180), Expect = 7e-14
Identities = 57/233 (24%), Positives = 90/233 (38%), Gaps = 63/233 (27%)
Query: 606 TDNFSQANIIGCGGFGLVYKAT-LANGTTLAIKKLSG---DLGLMEREFKAEVEALSTAQ 661
+ + + +G G +G V A G +A+KKLS + +R ++ E+ L +
Sbjct: 28 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMK 86
Query: 662 HKNLVSLQGYCVHQGFRLL-----IYSYMENGSLDYWLHEKADGASQLDWLTRLKIARGT 716
H+N++ L V R L +Y + L+ I +
Sbjct: 87 HENVIGL--LDVFTPARSLEEFNDVYLVTH--LMGADLN---------------NIVKCQ 127
Query: 717 S--------------CGLAYMHQICEPHIVHRDIKSSNILLDDQFEAHLADFGLSRLILP 762
GL Y+H I+HRD+K SN+ +++ E + DFGL+R
Sbjct: 128 KLTDDHVQFLIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLARHTAD 184
Query: 763 YQTHVTTELVGTLGYIPPE-------YGQAWVATLRGDMYSFGVVMLELLTGK 808
T V T Y PE Y Q D++S G +M ELLTG+
Sbjct: 185 EM----TGYVATRWYRAPEIMLNWMHYNQTV------DIWSVGCIMAELLTGR 227
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345 | Back alignment and structure |
|---|
Score = 73.0 bits (180), Expect = 7e-14
Identities = 62/224 (27%), Positives = 93/224 (41%), Gaps = 43/224 (19%)
Query: 607 DNFSQANIIGCGGFGLVYKATL-ANGTTLAIKKLSGDLGLMEREF---KAEVEALSTA-Q 661
++F ++G G FG V+ A AIK L D+ LM+ + E LS A +
Sbjct: 17 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWE 76
Query: 662 HKNLVSLQGYCVHQGFRL-LIYSYMENGSLDYWLHEKADGASQLDWLTRLKIARGT---- 716
H L + L + Y+ G L Y + + ++R T
Sbjct: 77 HPFLTHMF-CTFQTKENLFFVMEYLNGGDLMYHIQSC----------HKFDLSRATFYAA 125
Query: 717 --SCGLAYMHQICEPHIVHRDIKSSNILLDDQFEAH--LADFGLSRLILPYQTHVTTELV 772
GL ++H IV+RD+K NILLD + H +ADFG+ + + T
Sbjct: 126 EIILGLQFLH---SKGIVYRDLKLDNILLDK--DGHIKIADFGMCKENMLG-DAKTNTFC 179
Query: 773 GTLGYIPPE------YGQAWVATLRGDMYSFGVVMLELLTGKRP 810
GT YI PE Y + D +SFGV++ E+L G+ P
Sbjct: 180 GTPDYIAPEILLGQKYNHS------VDWWSFGVLLYEMLIGQSP 217
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299 | Back alignment and structure |
|---|
Score = 71.9 bits (177), Expect = 8e-14
Identities = 56/307 (18%), Positives = 93/307 (30%), Gaps = 101/307 (32%)
Query: 614 IIGCGGFGLVYKAT-LANGTTLAIKKLSGDLGLMEREFKAEVEAL-STAQHKNLVSLQGY 671
++G G G V + A+K L D RE VE +Q ++V +
Sbjct: 25 VLGLGINGKVLQIFNKRTQEKFALKMLQ-DCPKARRE----VELHWRASQCPHIVRIVDV 79
Query: 672 C----VHQGFRLLIYSYMENGSL--------DYWLHEKADGASQLDWLTRLKIARGTSCG 719
+ L++ ++ G L D E+ AS+ I +
Sbjct: 80 YENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTERE--ASE--------IMKSIGEA 129
Query: 720 LAYMHQICEPHIVHRDIKSSNILLDDQFEAH---LADFGLSRLILPYQTHVTTELVGTLG 776
+ Y+H I +I HRD+K N+L + L DFG ++ +
Sbjct: 130 IQYLHSI---NIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTGEK------------ 174
Query: 777 YIPPEYGQAWVATLRGDMYSFGVVMLELLTGKRPVDVLKPKMSRELVGWVLKMRSEGKQD 836
Y ++ DM+S GV+M LL G P
Sbjct: 175 -----YDKS------CDMWSLGVIMYILLCGYPPFY---------------SNHGLAISP 208
Query: 837 QVFDPILRGK-GFDEE---------------MLQVLDVACMCVSQNPFKRPTVKEVVE-- 878
+ I G+ F +L+ P +R T+ E +
Sbjct: 209 GMKTRIRMGQYEFPNPEWSEVSEEVKMLIRNLLKT----------EPTQRMTITEFMNHP 258
Query: 879 WLNNVGA 885
W+
Sbjct: 259 WIMQSTK 265
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388 | Back alignment and structure |
|---|
Score = 72.8 bits (179), Expect = 1e-13
Identities = 58/261 (22%), Positives = 95/261 (36%), Gaps = 95/261 (36%)
Query: 600 YELLKATDNFSQANIIGCGGFGLVYKAT-LANGTTLAIKKLSGDLGLMEREFKAEVEALS 658
YEL+K +G G +G+V+K+ G +A+KK+ F+ +A
Sbjct: 11 YELVK---------KLGKGAYGIVWKSIDRRTGEVVAVKKIF-------DAFQNSTDAQR 54
Query: 659 T----------AQHKNLVSLQGYCVHQGFRLLIYSYMENGSLDYWLHEKADGASQLDWLT 708
T + H+N+V+L R +Y + ++ LH
Sbjct: 55 TFREIMILTELSGHENIVNLLNVLRADNDRD-VYLVFD--YMETDLH------------- 98
Query: 709 RLKIARGTS--------------CGLAYMHQICEPHIVHRDIKSSNILLDDQFEAHLADF 754
+ R + Y+H ++HRD+K SNILL+ + +ADF
Sbjct: 99 --AVIRANILEPVHKQYVVYQLIKVIKYLH---SGGLLHRDMKPSNILLNAECHVKVADF 153
Query: 755 GLSRLILPYQTHVT--------------------TELVGTLGYIPPE-------YGQAWV 787
GLSR + + T+ V T Y PE Y + +
Sbjct: 154 GLSRSFVNIRRVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKG-I 212
Query: 788 ATLRGDMYSFGVVMLELLTGK 808
DM+S G ++ E+L GK
Sbjct: 213 -----DMWSLGCILGEILCGK 228
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 71.5 bits (176), Expect = 2e-13
Identities = 63/222 (28%), Positives = 91/222 (40%), Gaps = 39/222 (17%)
Query: 607 DNFSQANIIGCGGFGLVYKATL-ANGTTLAIKKLSGDLGLMEREF---KAEVEALSTA-Q 661
DNF ++G G FG V A + G A+K L D+ L + + E LS A
Sbjct: 23 DNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARN 82
Query: 662 HKNLVSLQGYCVHQGFRL-LIYSYMENGSLDYWLHEKADGASQLDWLTRLKIARG----- 715
H L L C RL + ++ G L + + + R AR
Sbjct: 83 HPFLTQLF-CCFQTPDRLFFVMEFVNGGDLMFHIQKS----------RRFDEARARFYAA 131
Query: 716 -TSCGLAYMHQICEPHIVHRDIKSSNILLDDQFEAHLADFGLSRLILPYQTHVTTELVGT 774
L ++H I++RD+K N+LLD + LADFG+ + + T GT
Sbjct: 132 EIISALMFLHDK---GIIYRDLKLDNVLLDHEGHCKLADFGMCKEGICNGV-TTATFCGT 187
Query: 775 LGYIPPE------YGQAWVATLRGDMYSFGVVMLELLTGKRP 810
YI PE YG A V D ++ GV++ E+L G P
Sbjct: 188 PDYIAPEILQEMLYGPA-V-----DWWAMGVLLYEMLCGHAP 223
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318 | Back alignment and structure |
|---|
Score = 70.6 bits (174), Expect = 3e-13
Identities = 56/221 (25%), Positives = 90/221 (40%), Gaps = 41/221 (18%)
Query: 607 DNFSQANIIGCGGFGLVYKATL-ANGTTLAIKKLSGDLGLMEREF---KAEVEALSTAQH 662
+F +G G FG V+ NG A+K L ++ + ++ E LS H
Sbjct: 6 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTH 65
Query: 663 KNLVSLQGYCVHQGFRL-LIYSYMENGSLDYWLHEKADGASQLDWLTRLKIARG------ 715
++ + ++ +I Y+E G L + L K+ R
Sbjct: 66 PFIIRMW-GTFQDAQQIFMIMDYIEGGEL-FSLLRKS---------QRFPNPVAKFYAAE 114
Query: 716 TSCGLAYMHQICEPHIVHRDIKSSNILLDDQFEAHLADFGLSRLILPYQTHVTTELVGTL 775
L Y+H I++RD+K NILLD + DFG ++ + VT L GT
Sbjct: 115 VCLALEYLHSK---DIIYRDLKPENILLDKNGHIKITDFGFAKYV----PDVTYTLCGTP 167
Query: 776 GYIPPE------YGQAWVATLRGDMYSFGVVMLELLTGKRP 810
YI PE Y ++ + D +SFG+++ E+L G P
Sbjct: 168 DYIAPEVVSTKPYNKS-I-----DWWSFGILIYEMLAGYTP 202
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373 | Back alignment and structure |
|---|
Score = 71.5 bits (176), Expect = 3e-13
Identities = 65/255 (25%), Positives = 98/255 (38%), Gaps = 48/255 (18%)
Query: 574 SPEADKDASLVMLFPNNTNEIKDLTIYELLKATDNFSQANIIGCGGFGLVYKATL-ANGT 632
+P S + ++N + + LK +IG G FG V A A
Sbjct: 14 NPAPPPAPSQQINLGPSSNPHAKPSDFHFLK---------VIGKGSFGKVLLARHKAEEV 64
Query: 633 TLAIKKLSGDLGLMEREF---KAEVEALSTA-QHKNLVSLQGYCVHQGFRL-LIYSYMEN 687
A+K L L ++E +E L +H LV L + +L + Y+
Sbjct: 65 FYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLH-FSFQTADKLYFVLDYING 123
Query: 688 GSLDYWLHEKADGASQLDWLTRLKIARGT------SCGLAYMHQICEPHIVHRDIKSSNI 741
G L Y L + R + L Y+H + +IV+RD+K NI
Sbjct: 124 GELFYHLQRE----------RCFLEPRARFYAAEIASALGYLHSL---NIVYRDLKPENI 170
Query: 742 LLDDQFEAHLADFGLSRLILPYQTHVTTELVGTLGYIPPE------YGQAWVATLRGDMY 795
LLD Q L DFGL + + + + T+ GT Y+ PE Y + V D +
Sbjct: 171 LLDSQGHIVLTDFGLCKENIEHNS-TTSTFCGTPEYLAPEVLHKQPYDRT-V-----DWW 223
Query: 796 SFGVVMLELLTGKRP 810
G V+ E+L G P
Sbjct: 224 CLGAVLYEMLYGLPP 238
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 71.8 bits (176), Expect = 3e-13
Identities = 19/103 (18%), Positives = 37/103 (35%), Gaps = 14/103 (13%)
Query: 379 QYNQLSNLPPA----------IYLANNSLSG-NIPVEIGQLKSLHVLDLSNNNFSGTIPD 427
N+++ L + L N + N +L L+L N +
Sbjct: 128 ANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTLEHLNLQYNFIY-DVKG 186
Query: 428 ELSDLSNLEKLDLSGNHLVGEIPISLKGLHFLSSFSVAHNNLQ 470
++ + L+ LDLS N L + + ++ S+ +N L
Sbjct: 187 QVV-FAKLKTLDLSSNKLA-FMGPEFQSAAGVTWISLRNNKLV 227
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 67.6 bits (165), Expect = 9e-12
Identities = 18/98 (18%), Positives = 35/98 (35%), Gaps = 9/98 (9%)
Query: 379 QYNQLSNLPP-----AIYLANNSLSGNIPVEIGQLKSLHVLDLSNNNFSGTIPDELSDLS 433
N + L ++ ANN++S + GQ + L+NN + + S
Sbjct: 88 NNNYVQELLVGPSIETLHAANNNIS-RVSCSRGQ--GKKNIYLANNKITMLRDLDEGCRS 144
Query: 434 NLEKLDLSGNHLVG-EIPISLKGLHFLSSFSVAHNNLQ 470
++ LDL N + L ++ +N +
Sbjct: 145 RVQYLDLKLNEIDTVNFAELAASSDTLEHLNLQYNFIY 182
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 66.8 bits (163), Expect = 1e-11
Identities = 24/91 (26%), Positives = 40/91 (43%), Gaps = 8/91 (8%)
Query: 381 NQLSNLPPAIYLANNSLSGNIPVEIGQ-LKSLHVLDLSNNNFSGTIPDELSDLSNLEKLD 439
N+ + ++SL + Q ++ LDLS N S +L+ + LE L+
Sbjct: 10 NRYKIE----KVTDSSLK-QALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLELLN 64
Query: 440 LSGNHLVGEIPISLKGLHFLSSFSVAHNNLQ 470
LS N L E L+ L L + + +N +Q
Sbjct: 65 LSSNVLY-ETL-DLESLSTLRTLDLNNNYVQ 93
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 64.5 bits (157), Expect = 7e-11
Identities = 15/100 (15%), Positives = 29/100 (29%), Gaps = 16/100 (16%)
Query: 379 QYNQLSNLPP--------AIYLANNSLSGNIPVEIGQLKSLHVLDLSNNNFSGTIPDELS 430
N L + L NN + E+ S+ L +NNN S +
Sbjct: 66 SSNVLYETLDLESLSTLRTLDLNNNYVQ-----ELLVGPSIETLHAANNNIS-RVSCSR- 118
Query: 431 DLSNLEKLDLSGNHLVGEIPISLKGLHFLSSFSVAHNNLQ 470
+ + L+ N + + + + N +
Sbjct: 119 -GQGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEID 157
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 60.6 bits (147), Expect = 1e-09
Identities = 19/93 (20%), Positives = 30/93 (32%), Gaps = 12/93 (12%)
Query: 379 QYNQLSNLPPAI---------YLANNSLSGNIPVEIGQLKSLHVLDLSNNNFS-GTIPDE 428
N+L+ + P L NN L I + ++L DL N F GT+ D
Sbjct: 199 SSNKLAFMGPEFQSAAGVTWISLRNNKLV-LIEKALRFSQNLEHFDLRGNGFHCGTLRDF 257
Query: 429 LSDLSNLEKLDLSGN-HLVGEIPISLKGLHFLS 460
S ++ + L G+
Sbjct: 258 FSKNQRVQTVAKQTVKKLTGQNEEECTVPTLGH 290
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 60.2 bits (146), Expect = 2e-09
Identities = 12/67 (17%), Positives = 25/67 (37%)
Query: 405 IGQLKSLHVLDLSNNNFSGTIPDELSDLSNLEKLDLSGNHLVGEIPISLKGLHFLSSFSV 464
+ +++++ + N+++LDLSGN L L L ++
Sbjct: 6 KQNGNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLELLNL 65
Query: 465 AHNNLQG 471
+ N L
Sbjct: 66 SSNVLYE 72
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 45.6 bits (108), Expect = 6e-05
Identities = 11/135 (8%), Positives = 28/135 (20%), Gaps = 1/135 (0%)
Query: 322 KSDEGPSLFSQANLLSGEFPKELTALPALVSEAANDEVDRSYLELPVFVMPSNATNQQYN 381
FS+ + + + L E Y +P+ ++
Sbjct: 250 HCGTLRDFFSKNQRVQTVAKQTVKKLTGQNEEECTVPTLGHYGAYCCEDLPAPFADRLIA 309
Query: 382 QLSNLPPAIYLANNSLSGNIPVEIGQLKSLHVLDLSNNNFSGTIPDELSDLSNLEKLDLS 441
+ + + E +D + I L+
Sbjct: 310 LKRKEHALLSGQGSETE-RLECERENQARQREIDALKEQYRTVIDQVTLRKQAKITLEQK 368
Query: 442 GNHLVGEIPISLKGL 456
L ++ +
Sbjct: 369 KKALDEQVSNGRRAH 383
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 70.8 bits (174), Expect = 7e-13
Identities = 30/100 (30%), Positives = 42/100 (42%), Gaps = 14/100 (14%)
Query: 380 YNQLSNLPP--------AIYLANNSLSGNIPVEIGQLKSLHVLDLSNNNFSGTIPDELSD 431
NQ+SN+ P + L N L P I LK+L L L NN S P +S
Sbjct: 274 ANQISNISPLAGLTALTNLELNENQLEDISP--ISNLKNLTYLTLYFNNISDISP--VSS 329
Query: 432 LSNLEKLDLSGNHLVGEIPISLKGLHFLSSFSVAHNNLQG 471
L+ L++L N + SL L ++ S HN +
Sbjct: 330 LTKLQRLFFYNNKV--SDVSSLANLTNINWLSAGHNQISD 367
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 70.0 bits (172), Expect = 1e-12
Identities = 28/100 (28%), Positives = 42/100 (42%), Gaps = 14/100 (14%)
Query: 380 YNQLSNLPP--------AIYLANNSLSGNIPVEIGQLKSLHVLDLSNNNFSGTIPDELSD 431
NQ+SNL P + L N +S P + L +L L+L+ N P +S+
Sbjct: 252 NNQISNLAPLSGLTKLTELKLGANQISNISP--LAGLTALTNLELNENQLEDISP--ISN 307
Query: 432 LSNLEKLDLSGNHLVGEIPISLKGLHFLSSFSVAHNNLQG 471
L NL L L N++ P+S L L +N +
Sbjct: 308 LKNLTYLTLYFNNISDISPVS--SLTKLQRLFFYNNKVSD 345
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 69.2 bits (170), Expect = 2e-12
Identities = 26/101 (25%), Positives = 44/101 (43%), Gaps = 14/101 (13%)
Query: 379 QYNQLSNLPP--------AIYLANNSLSGNIPVEIGQLKSLHVLDLSNNNFSGTIPDELS 430
N++S++ ++ NN +S P +G L +L L L+ N L+
Sbjct: 185 SSNKVSDISVLAKLTNLESLIATNNQISDITP--LGILTNLDELSLNGNQLKD--IGTLA 240
Query: 431 DLSNLEKLDLSGNHLVGEIPISLKGLHFLSSFSVAHNNLQG 471
L+NL LDL+ N + P+S GL L+ + N +
Sbjct: 241 SLTNLTDLDLANNQISNLAPLS--GLTKLTELKLGANQISN 279
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 65.8 bits (161), Expect = 3e-11
Identities = 21/101 (20%), Positives = 40/101 (39%), Gaps = 14/101 (13%)
Query: 379 QYNQLSNLPP--------AIYLANNSLSGNIPVEIGQLKSLHVLDLSNNNFSGTIPDELS 430
+ ++ I +NN L+ P + L L + ++NN + P L+
Sbjct: 54 DRLGIKSIDGVEYLNNLTQINFSNNQLTDITP--LKNLTKLVDILMNNNQIADITP--LA 109
Query: 431 DLSNLEKLDLSGNHLVGEIPISLKGLHFLSSFSVAHNNLQG 471
+L+NL L L N + P+ L L+ ++ N +
Sbjct: 110 NLTNLTGLTLFNNQITDIDPLK--NLTNLNRLELSSNTISD 148
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 62.7 bits (153), Expect = 3e-10
Identities = 16/100 (16%), Positives = 32/100 (32%), Gaps = 11/100 (11%)
Query: 377 NQQYNQLSNLPP-----AIYLANNSLSGNIPVEIGQLKSLHVLDLSNNNFSGTIPDELSD 431
+ NQ+ L +++ + L + L D +
Sbjct: 11 DTPINQIFTDTALAEKMKTVLGKTNVTDTVS--QTDLDQVTTLQADRLGI--KSIDGVEY 66
Query: 432 LSNLEKLDLSGNHLVGEIPISLKGLHFLSSFSVAHNNLQG 471
L+NL +++ S N L P+ L L + +N +
Sbjct: 67 LNNLTQINFSNNQLTDITPLK--NLTKLVDILMNNNQIAD 104
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 62.3 bits (152), Expect = 3e-10
Identities = 15/101 (14%), Positives = 39/101 (38%), Gaps = 14/101 (13%)
Query: 379 QYNQLSNLPP--------AIYLANNSLSGNIPVEIGQLKSLHVLDLSNNNFSGTIPDELS 430
+++ + + +I + L +L ++ SNN + P L
Sbjct: 32 GKTNVTDTVSQTDLDQVTTLQADRLGIK-SID-GVEYLNNLTQINFSNNQLTDITP--LK 87
Query: 431 DLSNLEKLDLSGNHLVGEIPISLKGLHFLSSFSVAHNNLQG 471
+L+ L + ++ N + P++ L L+ ++ +N +
Sbjct: 88 NLTKLVDILMNNNQIADITPLA--NLTNLTGLTLFNNQITD 126
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 60.0 bits (146), Expect = 2e-09
Identities = 25/100 (25%), Positives = 43/100 (43%), Gaps = 15/100 (15%)
Query: 380 YNQLSNLPP--------AIYLANNSLSGNIPVEIGQLKSLHVLDLSNNNFSGTIPDELSD 431
NQ++++ P + L++N++S + L SL L N T L++
Sbjct: 121 NNQITDIDPLKNLTNLNRLELSSNTISD--ISALSGLTSLQQLSFGNQV---TDLKPLAN 175
Query: 432 LSNLEKLDLSGNHLVGEIPISLKGLHFLSSFSVAHNNLQG 471
L+ LE+LD+S N + L L L S +N +
Sbjct: 176 LTTLERLDISSNKV--SDISVLAKLTNLESLIATNNQISD 213
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 54.6 bits (132), Expect = 1e-07
Identities = 12/100 (12%), Positives = 35/100 (35%), Gaps = 12/100 (12%)
Query: 379 QYNQLSNLPP--------AIYLANNSLSGNIPVEIGQLKSLHVLDLSNNNFSGTIPDELS 430
N++S++ + +N +S P + L + L L++ ++ + +
Sbjct: 339 YNNKVSDVSSLANLTNINWLSAGHNQISDLTP--LANLTRITQLGLNDQAWTNAPVNYKA 396
Query: 431 DLSNLEKLDLSGNHLVGEIPISLKGLHFLSSFSVAHNNLQ 470
++S + L+ P ++ + + N
Sbjct: 397 NVSIPNTVKNVTGALI--APATISDGGSYTEPDITWNLPS 434
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 | Back alignment and structure |
|---|
Score = 70.8 bits (174), Expect = 7e-13
Identities = 35/179 (19%), Positives = 59/179 (32%), Gaps = 41/179 (22%)
Query: 327 PSLFSQANLLSGEFPKELTALPALVS--------EAANDEVDRSYLELPVFVMPSNATNQ 378
++ L+ E P E + + E + E+ V + Q
Sbjct: 14 QEPLRHSSNLT-EMPVEAENVKSKTEYYNAWSEWERNAPPGNGEQREMAVSRLRDCLDRQ 72
Query: 379 ------QYNQLSNLPPAI------YLANNSLSGNIPVEIGQLKSLHVLDLSNNNFSGTIP 426
LS+LP + NSL+ +P LKSL V + + S P
Sbjct: 73 AHELELNNLGLSSLPELPPHLESLVASCNSLT-ELPELPQSLKSLLVDNNNLKALSDLPP 131
Query: 427 ---------------DELSDLSNLEKLDLSGNHLVGEIPISLKGLHFLSSFSVAHNNLQ 470
EL + S L+ +D+ N L ++P L F+ + +N L+
Sbjct: 132 LLEYLGVSNNQLEKLPELQNSSFLKIIDVDNNSLK-KLPDLPPSLEFI---AAGNNQLE 186
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 | Back alignment and structure |
|---|
Score = 70.8 bits (174), Expect = 8e-13
Identities = 28/95 (29%), Positives = 48/95 (50%), Gaps = 11/95 (11%)
Query: 379 QYNQLSNLPPAI---YLANNSLSGNIPVEIGQLKSLHVLDLSNNNFSGTIPDELSDLSNL 435
LS+LPP + ++NN L +P E+ L ++D+ NN+ +PD +L
Sbjct: 122 NLKALSDLPPLLEYLGVSNNQLE-KLP-ELQNSSFLKIIDVDNNSLK-KLPDLPP---SL 175
Query: 436 EKLDLSGNHLVGEIPISLKGLHFLSSFSVAHNNLQ 470
E + N L E+P L+ L FL++ +N+L+
Sbjct: 176 EFIAAGNNQLE-ELP-ELQNLPFLTAIYADNNSLK 208
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 | Back alignment and structure |
|---|
Score = 68.5 bits (168), Expect = 4e-12
Identities = 29/137 (21%), Positives = 47/137 (34%), Gaps = 34/137 (24%)
Query: 368 VFVMPSNATNQQ-------YNQLSNLPPAI---------YLANNSLSGNIPVEIGQL--- 408
+F+ P N +N + L+ +P Y A + N P G+
Sbjct: 1 MFINPRNVSNTFLQEPLRHSSNLTEMPVEAENVKSKTEYYNAWSEWERNAPPGNGEQREM 60
Query: 409 ----------KSLHVLDLSNNNFSGTIPDELSDLSNLEKLDLSGNHLVGEIPISLKGLHF 458
+ H L+L+N S ++P+ +LE L S N L E+P + L
Sbjct: 61 AVSRLRDCLDRQAHELELNNLGLS-SLPELPP---HLESLVASCNSLT-ELPELPQSLKS 115
Query: 459 LSSFSVAHNNLQGAVPS 475
L + L P
Sbjct: 116 LLVDNNNLKALSDLPPL 132
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 | Back alignment and structure |
|---|
Score = 67.3 bits (165), Expect = 8e-12
Identities = 27/103 (26%), Positives = 40/103 (38%), Gaps = 13/103 (12%)
Query: 379 QYNQLSNLPPAI------YLANNSLSGNIPVEIGQLKSLHVLDLSNNNFSGTIPDELSDL 432
N L LP NN L +P E+ L L + NN T+PD
Sbjct: 203 DNNSLKKLPDLPLSLESIVAGNNILE-ELP-ELQNLPFLTTIYADNNLLK-TLPDL---P 256
Query: 433 SNLEKLDLSGNHLVGEIPISLKGLHFLSSFSVAHNNLQGAVPS 475
+LE L++ N+L ++P + L FL + L P+
Sbjct: 257 PSLEALNVRDNYLT-DLPELPQSLTFLDVSENIFSGLSELPPN 298
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 | Back alignment and structure |
|---|
Score = 64.2 bits (157), Expect = 9e-11
Identities = 29/99 (29%), Positives = 36/99 (36%), Gaps = 18/99 (18%)
Query: 380 YNQLSNLPP--------AIYLANNSLSGNIPVEIGQLKSLHVLDLSNNNFSGTIPDELSD 431
NQL LP AIY NNSL +P L+S+ NN EL +
Sbjct: 182 NNQLEELPELQNLPFLTAIYADNNSLK-KLPDLPLSLESI---VAGNNIL--EELPELQN 235
Query: 432 LSNLEKLDLSGNHLVGEIPISLKGLHFLSSFSVAHNNLQ 470
L L + N L +P L L +V N L
Sbjct: 236 LPFLTTIYADNNLLK-TLPDLPPSLEAL---NVRDNYLT 270
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 | Back alignment and structure |
|---|
Score = 61.9 bits (151), Expect = 5e-10
Identities = 27/95 (28%), Positives = 43/95 (45%), Gaps = 15/95 (15%)
Query: 379 QYNQLSNLPPAI---YLANNSLSGNIPVEIGQLKSLHVLDLSNNNFSGTIPDELSDLSNL 435
++ LS LPP + ++N + ++ SL L++SNN +P L
Sbjct: 288 IFSGLSELPPNLYYLNASSNEIR-SLC---DLPPSLEELNVSNNKLI-ELPALPP---RL 339
Query: 436 EKLDLSGNHLVGEIPISLKGLHFLSSFSVAHNNLQ 470
E+L S NHL E+P + L L V +N L+
Sbjct: 340 ERLIASFNHLA-EVPELPQNLKQL---HVEYNPLR 370
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 | Back alignment and structure |
|---|
Score = 59.6 bits (145), Expect = 3e-09
Identities = 26/110 (23%), Positives = 41/110 (37%), Gaps = 24/110 (21%)
Query: 380 YNQLSNLPPAI------YLANNSLSGNIPVEIGQLKSLHVLDLSNNNFSGTIP------- 426
N L LP + +N L+ ++P L L V + + S P
Sbjct: 246 NNLLKTLPDLPPSLEALNVRDNYLT-DLPELPQSLTFLDVSENIFSGLSELPPNLYYLNA 304
Query: 427 -----DELSD-LSNLEKLDLSGNHLVGEIPISLKGLHFLSSFSVAHNNLQ 470
L D +LE+L++S N L+ E+P L L + N+L
Sbjct: 305 SSNEIRSLCDLPPSLEELNVSNNKLI-ELPALPPRLERL---IASFNHLA 350
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 | Back alignment and structure |
|---|
Score = 58.9 bits (143), Expect = 5e-09
Identities = 16/112 (14%), Positives = 34/112 (30%), Gaps = 27/112 (24%)
Query: 380 YNQLSNLPPAI------YLANNSLSGNIPVEIGQLKSLHV----------------LDLS 417
+N L+ +P ++ N L P ++ L + L +
Sbjct: 346 FNHLAEVPELPQNLKQLHVEYNPLR-EFPDIPESVEDLRMNSHLAEVPELPQNLKQLHVE 404
Query: 418 NNNFSGTIPDELSDLSNLEKLDLSGNHLVGEIPISLKGLHFLSSFSVAHNNL 469
N PD ++E L ++ +V + + L H++
Sbjct: 405 TNPLR-EFPDIPE---SVEDLRMNSERVVDPYEFAHETTDKLEDDVFEHHHH 452
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306 | Back alignment and structure |
|---|
Score = 69.3 bits (170), Expect = 7e-13
Identities = 27/132 (20%), Positives = 46/132 (34%), Gaps = 19/132 (14%)
Query: 379 QYNQLSNLPPAI----------YLANNSLSGNIPVEI-GQLKSLHVLDLSNNNFSGTIPD 427
+ I +A NS N +I +L++L LDLS +
Sbjct: 134 SHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLE-QLSP 192
Query: 428 E-LSDLSNLEKLDLSGNHLVGEIPISLKGLHFLSSFSVAHNNLQGAVPSGGQFDTFPS-- 484
+ LS+L+ L++S N+ K L+ L + N++ + FPS
Sbjct: 193 TAFNSLSSLQVLNMSHNNFFSLDTFPYKCLNSLQVLDYSLNHIM-TSKK-QELQHFPSSL 250
Query: 485 --FSFEGNPELC 494
+ N C
Sbjct: 251 AFLNLTQNDFAC 262
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306 | Back alignment and structure |
|---|
Score = 60.0 bits (146), Expect = 8e-10
Identities = 18/110 (16%), Positives = 40/110 (36%), Gaps = 14/110 (12%)
Query: 379 QYNQLSNLPPAI---------YLANNSLSGNIPVEI-GQLKSLHVLDLSNNNFSGTIPDE 428
+N + + +++L + L++L LD+S+ + +
Sbjct: 86 SFNGVITMSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTR-VAFNG 144
Query: 429 -LSDLSNLEKLDLSGNHLVGEI-PISLKGLHFLSSFSVAHNNLQGAVPSG 476
+ LS+LE L ++GN P L L+ ++ L+ +
Sbjct: 145 IFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLE-QLSPT 193
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306 | Back alignment and structure |
|---|
Score = 55.0 bits (133), Expect = 4e-08
Identities = 23/97 (23%), Positives = 34/97 (35%), Gaps = 8/97 (8%)
Query: 390 IYLANNSLSGNIPVEIGQLKSLHVLDLSNNNFSGTIPDELSDLSNLEKLDLSGNHL--VG 447
I + L+ ++P I S L+L +N L+ L KL LS N L G
Sbjct: 12 IRCNSKGLT-SVPTGI--PSSATRLELESNKLQSLPHGVFDKLTQLTKLSLSSNGLSFKG 68
Query: 448 EIPISLKGLHFLSSFSVAHNNLQGAVPSGGQFDTFPS 484
S G L ++ N + + S F
Sbjct: 69 CCSQSDFGTTSLKYLDLSFNGVI-TMSSN--FLGLEQ 102
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432 | Back alignment and structure |
|---|
Score = 70.2 bits (172), Expect = 1e-12
Identities = 54/287 (18%), Positives = 92/287 (32%), Gaps = 85/287 (29%)
Query: 573 VSPEADKDASLVMLFPNNTNEIKDLTIYELLKATDNFSQANIIGCGGFGLVYKAT-LANG 631
+ + L+ + Y + +IG G +G VY A
Sbjct: 1 MHHHHHHSSGRENLYFQGIKNVHVPDNYIIKH---------LIGRGSYGYVYLAYDKNTE 51
Query: 632 TTLAIKKLSG---DLGLMEREFKAEVEALSTAQHKNLVSLQGYCVHQGFRLL--IYSYME 686
+AIKK++ DL +R + E+ L+ + ++ L + +Y +E
Sbjct: 52 KNVAIKKVNRMFEDLIDCKRILR-EITILNRLKSDYIIRLYDLIIPDDLLKFDELYIVLE 110
Query: 687 NGSLDYWLHEKADGASQLDWLTRLKIARGTS---------------CGLAYMHQICEPHI 731
D L K+ + G ++H E I
Sbjct: 111 --IADSDLK---------------KLFKTPIFLTEEHIKTILYNLLLGENFIH---ESGI 150
Query: 732 VHRDIKSSNILLDDQFEAHLADFGLSRLILPYQTHVT---------------------TE 770
+HRD+K +N LL+ + DFGL+R I + T
Sbjct: 151 IHRDLKPANCLLNQDCSVKVCDFGLARTINSEKDTNIVNDLEENEEPGPHNKNLKKQLTS 210
Query: 771 LVGTLGYIPPE-------YGQAWVATLRGDMYSFGVVMLELLTGKRP 810
V T Y PE Y ++ + D++S G + ELL +
Sbjct: 211 HVVTRWYRAPELILLQENYTKS-I-----DIWSTGCIFAELLNMLQS 251
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352 | Back alignment and structure |
|---|
Score = 69.0 bits (169), Expect = 1e-12
Identities = 49/229 (21%), Positives = 83/229 (36%), Gaps = 44/229 (19%)
Query: 615 IGCGGFGLVYKAT---------LANGTTLAIK------KLSGDLGLMEREFKA-EVEALS 658
G++Y+A ++K +L + +R K +V
Sbjct: 50 QTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKDGRLFNEQNFFQRAAKPLQVNKWK 109
Query: 659 TAQHKNLV---SLQGYCVHQG-FRLLIYSYMENG-SLDYWLHEKADGASQLDWLTRLKIA 713
L+ + G+ VHQ +R L+ + G SL L + L++A
Sbjct: 110 KLYSTPLLAIPTCMGFGVHQDKYRFLVLPSL--GRSLQSALDVSPKHVLSER--SVLQVA 165
Query: 714 RGTSCGLAYMHQICEPHIVHRDIKSSNILL--DDQFEAHLADFGLSRLILPYQTHV---- 767
L ++H E VH ++ + NI + +DQ + LA +G + P HV
Sbjct: 166 CRLLDALEFLH---ENEYVHGNVTAENIFVDPEDQSQVTLAGYGFAFRYCPSGKHVAYVE 222
Query: 768 --TTELVGTLGYIPPE----YGQAWVATLRGDMYSFGVVMLELLTGKRP 810
+ G L +I + G + R D+ S G ML+ L G P
Sbjct: 223 GSRSPHEGDLEFISMDLHKGCGPSR----RSDLQSLGYCMLKWLYGFLP 267
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332 | Back alignment and structure |
|---|
Score = 68.5 bits (168), Expect = 2e-12
Identities = 25/100 (25%), Positives = 41/100 (41%), Gaps = 12/100 (12%)
Query: 380 YNQLSNLPPAI-------YLANNSLSGNIPVEI-GQLKSLHVLDLSNNNFSGTIPDE-LS 430
+L+ +P + +L +N + I +E + L+ L L +N I + LS
Sbjct: 181 EAKLTGIPKDLPETLNELHLDHNKIQ-AIELEDLLRYSKLYRLGLGHNQIR-MIENGSLS 238
Query: 431 DLSNLEKLDLSGNHLVGEIPISLKGLHFLSSFSVAHNNLQ 470
L L +L L N L +P L L L + NN+
Sbjct: 239 FLPTLRELHLDNNKLS-RVPAGLPDLKLLQVVYLHTNNIT 277
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332 | Back alignment and structure |
|---|
Score = 58.1 bits (141), Expect = 4e-09
Identities = 24/141 (17%), Positives = 43/141 (30%), Gaps = 33/141 (23%)
Query: 379 QYNQLSNLPPA----------IYLANNSLSGNIPVEIGQLKSLHVLDLSNNNFSGTIPDE 428
N++S + +Y++ N L IP SL L + +N +P
Sbjct: 86 VNNKISKIHEKAFSPLRKLQKLYISKNHLV-EIPP--NLPSSLVELRIHDNRIR-KVPKG 141
Query: 429 -LSDLSNLEKLDLSGNHLVGEIPIS---LKGLHFLSSFSVAHNNLQGAVPSGG------- 477
S L N+ +++ GN L GL L+ ++ L +P
Sbjct: 142 VFSGLRNMNCIEMGGNPL-ENSGFEPGAFDGLK-LNYLRISEAKLT-GIPKDLPETLNEL 198
Query: 478 -----QFDTFPSFSFEGNPEL 493
+ +L
Sbjct: 199 HLDHNKIQAIELEDLLRYSKL 219
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332 | Back alignment and structure |
|---|
Score = 55.0 bits (133), Expect = 4e-08
Identities = 35/123 (28%), Positives = 50/123 (40%), Gaps = 26/123 (21%)
Query: 381 NQLSNLPPAI-------YLANNSLSGNIPVE-IGQLKSLHVLDLSNNNFSGTIPDE-LSD 431
L +P I L NN +S + + L+ L+ L L NN S I ++ S
Sbjct: 43 LGLKAVPKEISPDTTLLDLQNNDIS-ELRKDDFKGLQHLYALVLVNNKIS-KIHEKAFSP 100
Query: 432 LSNLEKLDLSGNHLVGEIPISL-KGLHFLSSFSVAHNNLQGAVPSGGQFDTFPSFSFEGN 490
L L+KL +S NHLV EIP +L L L + N ++ P F G
Sbjct: 101 LRKLQKLYISKNHLV-EIPPNLPSSLVEL---RIHDNRIR----------KVPKGVFSGL 146
Query: 491 PEL 493
+
Sbjct: 147 RNM 149
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332 | Back alignment and structure |
|---|
Score = 53.1 bits (128), Expect = 2e-07
Identities = 18/108 (16%), Positives = 37/108 (34%), Gaps = 21/108 (19%)
Query: 379 QYNQLSNLPPA----------IYLANNSLSGNIPVEIGQLKSLHVLDLSNNNFSGTIPDE 428
+NQ+ + ++L NN LS +P + LK L V+ L NN + +
Sbjct: 225 GHNQIRMIENGSLSFLPTLRELHLDNNKLS-RVPAGLPDLKLLQVVYLHTNNIT-KVGVN 282
Query: 429 -------LSDLSNLEKLDLSGNHL-VGEIPISL-KGLHFLSSFSVAHN 467
+ + L N + E+ + + + + +
Sbjct: 283 DFCPVGFGVKRAYYNGISLFNNPVPYWEVQPATFRCVTDRLAIQFGNY 330
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597 | Back alignment and structure |
|---|
Score = 69.6 bits (170), Expect = 2e-12
Identities = 25/122 (20%), Positives = 47/122 (38%), Gaps = 14/122 (11%)
Query: 379 QYNQLSNLPP--------AIYLANNSLSGNIPVEI-GQLKSLHVLDLSNNNFSGTIPDEL 429
Q+N L++ + L+ N L I +++ L L +SNN +
Sbjct: 240 QHNNLTDTAWLLNYPGLVEVDLSYNELE-KIMYHPFVKMQRLERLYISNNRLV-ALNLYG 297
Query: 430 SDLSNLEKLDLSGNHLVGEIPISLKGLHFLSSFSVAHNNLQGAVPSGGQFDTFPSFSFEG 489
+ L+ LDLS NHL+ + + L + + HN++ + T + +
Sbjct: 298 QPIPTLKVLDLSHNHLL-HVERNQPQFDRLENLYLDHNSIV-TLKL-STHHTLKNLTLSH 354
Query: 490 NP 491
N
Sbjct: 355 ND 356
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597 | Back alignment and structure |
|---|
Score = 69.2 bits (169), Expect = 3e-12
Identities = 21/100 (21%), Positives = 42/100 (42%), Gaps = 12/100 (12%)
Query: 379 QYNQLSNLPPAI-------YLANNSLSGNIPVEIGQLKSLHVLDLSNNNFSGTIPDE-LS 430
+N ++ + + L +N+L+ + + L +DLS N I
Sbjct: 219 SHNSINVVRGPVNVELTILKLQHNNLT-DTAW-LLNYPGLVEVDLSYNELE-KIMYHPFV 275
Query: 431 DLSNLEKLDLSGNHLVGEIPISLKGLHFLSSFSVAHNNLQ 470
+ LE+L +S N LV + + + + L ++HN+L
Sbjct: 276 KMQRLERLYISNNRLV-ALNLYGQPIPTLKVLDLSHNHLL 314
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597 | Back alignment and structure |
|---|
Score = 65.3 bits (159), Expect = 5e-11
Identities = 29/105 (27%), Positives = 45/105 (42%), Gaps = 19/105 (18%)
Query: 379 QYNQLSNLPPAI----------YLANNSLSGNIPVEI-GQLKSLHVLDLSNNNFSGTIPD 427
+N + LPP + L N LS ++P I L L +SNNN I D
Sbjct: 107 GFNAIRYLPPHVFQNVPLLTVLVLERNDLS-SLPRGIFHNTPKLTTLSMSNNNLE-RIED 164
Query: 428 E-LSDLSNLEKLDLSGNHLVGEIPIS-LKGLHFLSSFSVAHNNLQ 470
+ ++L+ L LS N L + +S + L +V++N L
Sbjct: 165 DTFQATTSLQNLQLSSNRLT-HVDLSLIPSLFHA---NVSYNLLS 205
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597 | Back alignment and structure |
|---|
Score = 64.6 bits (157), Expect = 9e-11
Identities = 21/128 (16%), Positives = 44/128 (34%), Gaps = 26/128 (20%)
Query: 379 QYNQLSNLPPAI----------YLANNSLSGNIPVEI-GQLKSLHVLDLSNNNFSGTIPD 427
+ + + LP A+ L + + I ++ L + N +P
Sbjct: 59 KNSTMRKLPAALLDSFRQVELLNLNDLQIE-EIDTYAFAYAHTIQKLYMGFNAIR-YLPP 116
Query: 428 EL-SDLSNLEKLDLSGNHLVGEIPISL-KGLHFLSSFSVAHNNLQGAVPSGGQFDTFPSF 485
+ ++ L L L N L +P + L++ S+++NNL+
Sbjct: 117 HVFQNVPLLTVLVLERNDLS-SLPRGIFHNTPKLTTLSMSNNNLE----------RIEDD 165
Query: 486 SFEGNPEL 493
+F+ L
Sbjct: 166 TFQATTSL 173
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597 | Back alignment and structure |
|---|
Score = 63.4 bits (154), Expect = 2e-10
Identities = 20/117 (17%), Positives = 44/117 (37%), Gaps = 17/117 (14%)
Query: 379 QYNQLSNLPPAI--YLANNSLSGNIPVEIGQLKSLHVLDLSNNNFSGTIPDELSDLSNLE 436
N+L+++ ++ L + ++S N+ + ++ LD S+N+ + + + L
Sbjct: 179 SSNRLTHVDLSLIPSLFHANVSYNLLSTLAIPIAVEELDASHNSIN-VVRGPV--NVELT 235
Query: 437 KLDLSGNHLVGEIPISLKGLHFLSSFSVAHNNLQGAVPSGGQFDTFPSFSFEGNPEL 493
L L N+L + L L +++N L+ F L
Sbjct: 236 ILKLQHNNLT-DTA-WLLNYPGLVEVDLSYNELE----------KIMYHPFVKMQRL 280
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597 | Back alignment and structure |
|---|
Score = 60.3 bits (146), Expect = 2e-09
Identities = 19/117 (16%), Positives = 36/117 (30%), Gaps = 19/117 (16%)
Query: 384 SNLPPAIYLANNSLSGNIP-----VEIGQLKSLHVLDLSNNNFSGTIPDE-LSDLSNLEK 437
SNL + + E L + ++ N+ +P L +E
Sbjct: 21 SNLQYDCVFYDVHIDMQTQDVYFGFEDITLNNQKIVTFKNSTMR-KLPAALLDSFRQVEL 79
Query: 438 LDLSGNHLVGEIP-ISLKGLHFLSSFSVAHNNLQGAVPSGGQFDTFPSFSFEGNPEL 493
L+L+ + EI + H + + N ++ P F+ P L
Sbjct: 80 LNLNDLQIE-EIDTYAFAYAHTIQKLYMGFNAIR----------YLPPHVFQNVPLL 125
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597 | Back alignment and structure |
|---|
Score = 59.6 bits (144), Expect = 3e-09
Identities = 19/76 (25%), Positives = 28/76 (36%), Gaps = 13/76 (17%)
Query: 379 QYNQLSNLPPAI---------YLANNSLSGNIPVEIGQLKSLHVLDLSNNNFSGTIPDEL 429
N+L L L++N L ++ Q L L L +N+ T+ L
Sbjct: 286 SNNRLVALNLYGQPIPTLKVLDLSHNHLL-HVERNQPQFDRLENLYLDHNSIV-TLK--L 341
Query: 430 SDLSNLEKLDLSGNHL 445
S L+ L LS N
Sbjct: 342 STHHTLKNLTLSHNDW 357
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440 | Back alignment and structure |
|---|
Score = 69.0 bits (169), Expect = 2e-12
Identities = 32/130 (24%), Positives = 47/130 (36%), Gaps = 17/130 (13%)
Query: 378 QQYNQLSNLPPAI----------YLANNSLSGNIPVEIGQLKSLHVLDLSNNNFSGTIPD 427
+ +LS + LA +L IP + L L LDLS N+ S P
Sbjct: 168 GELKRLSYISEGAFEGLSNLRYLNLAMCNLR-EIP-NLTPLIKLDELDLSGNHLSAIRPG 225
Query: 428 ELSDLSNLEKLDLSGNHLVGEIPISLKGLHFLSSFSVAHNNLQGAVPSGGQFDTFPS--- 484
L +L+KL + + + + L L ++AHNNL +P F
Sbjct: 226 SFQGLMHLQKLWMIQSQIQVIERNAFDNLQSLVEINLAHNNLT-LLP-HDLFTPLHHLER 283
Query: 485 FSFEGNPELC 494
NP C
Sbjct: 284 IHLHHNPWNC 293
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440 | Back alignment and structure |
|---|
Score = 59.0 bits (143), Expect = 4e-09
Identities = 26/128 (20%), Positives = 45/128 (35%), Gaps = 25/128 (19%)
Query: 379 QYNQLSNLPPA----------IYLANNSLSGNIPVEI-GQLKSLHVLDLSNNNFSGTIPD 427
NQ+ + + L+ N + I + L +L+ L+L +N + TIP+
Sbjct: 72 HENQIQIIKVNSFKHLRHLEILQLSRNHIR-TIEIGAFNGLANLNTLELFDNRLT-TIPN 129
Query: 428 E-LSDLSNLEKLDLSGNHLVGEIPISL-KGLHFLSSFSVAHNNLQGAVPSGGQFDTFPSF 485
LS L++L L N + IP + L + +
Sbjct: 130 GAFVYLSKLKELWLRNNPIE-SIPSYAFNRIPSLRRLDLGELK---------RLSYISEG 179
Query: 486 SFEGNPEL 493
+FEG L
Sbjct: 180 AFEGLSNL 187
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440 | Back alignment and structure |
|---|
Score = 51.3 bits (123), Expect = 1e-06
Identities = 25/110 (22%), Positives = 42/110 (38%), Gaps = 13/110 (11%)
Query: 384 SNLPPAIYLANNSLSGNIPVEIGQLKSLHVLDLSNNNFSGTIPDELSDLSNLEKLDLSGN 443
SN + +L +P I + +L+L N + L +LE L LS N
Sbjct: 42 SNQFSKVICVRKNLR-EVPDGI--STNTRLLNLHENQIQIIKVNSFKHLRHLEILQLSRN 98
Query: 444 HLVGEIPISLKGLHFLSSFSVAHNNLQGAVPSGGQFDTFPSFSFEGNPEL 493
H+ + GL L++ + N L +P+G +F +L
Sbjct: 99 HIRTIEIGAFNGLANLNTLELFDNRLT-TIPNG---------AFVYLSKL 138
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364 | Back alignment and structure |
|---|
Score = 67.9 bits (166), Expect = 4e-12
Identities = 52/228 (22%), Positives = 83/228 (36%), Gaps = 42/228 (18%)
Query: 615 IGCGGFGLVYKAT------LANGTTLAIKKLSGDLGLMEREFK-----AEVEALSTAQHK 663
IG GGFG +Y A + + +K D G + E K A+ E +
Sbjct: 43 IGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRT 102
Query: 664 NLVSLQG-----YCVHQGFRLLIYSYME----NGSLDYWLHEKADGASQLDWLTRLKIAR 714
+ G Y +M L ++E + T L+++
Sbjct: 103 RKLKYLGVPKYWGSGLHDKNGKSYRFMIMDRFGSDLQK-IYEANAK--RFSRKTVLQLSL 159
Query: 715 GTSCGLAYMHQICEPHIVHRDIKSSNILLD--DQFEAHLADFGLSRLILPYQTHV----- 767
L Y+H E VH DIK+SN+LL+ + + +L D+GL+ P H
Sbjct: 160 RILDILEYIH---EHEYVHGDIKASNLLLNYKNPDQVYLVDYGLAYRYCPEGVHKAYAAD 216
Query: 768 -TTELVGTLGYIPPE----YGQAWVATLRGDMYSFGVVMLELLTGKRP 810
GT+ + + + RGD+ G M++ LTG P
Sbjct: 217 PKRCHDGTIEFTSIDAHNGVAPSR----RGDLEILGYCMIQWLTGHLP 260
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345 | Back alignment and structure |
|---|
Score = 67.4 bits (165), Expect = 4e-12
Identities = 52/226 (23%), Positives = 77/226 (34%), Gaps = 41/226 (18%)
Query: 615 IGCGGFGLVYKAT-LANGTTLAIKKL---SGDLGLMEREFKAEVEALSTAQHKNLVSLQG 670
IG GGFGL+Y A A + + G + E K + ++ +
Sbjct: 45 IGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFY-QRVAKKDCIKKWIERK 103
Query: 671 YCVHQGFRLLIYS-YMENGSLDYW----------LHEKADGASQLDWLTRLKIARGTSCG 719
+ G L S E Y L + + T L++
Sbjct: 104 QLDYLGIPLFYGSGLTEFKGRSYRFMVMERLGIDLQKISGQNGTFKKSTVLQLGIRMLDV 163
Query: 720 LAYMHQICEPHIVHRDIKSSNILLD--DQFEAHLADFGLSRLILPYQTHV------TTEL 771
L Y+H E VH DIK++N+LL + + +LAD+GLS P H
Sbjct: 164 LEYIH---ENEYVHGDIKAANLLLGYKNPDQVYLADYGLSYRYCPNGNHKQYQENPRKGH 220
Query: 772 VGTLGYIPPEYGQAWVATL-------RGDMYSFGVVMLELLTGKRP 810
GT+ + + R D+ G ML L GK P
Sbjct: 221 NGTIEFTS-------LDAHKGVALSRRSDVEILGYCMLRWLCGKLP 259
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452 | Back alignment and structure |
|---|
Score = 68.2 bits (167), Expect = 5e-12
Identities = 28/130 (21%), Positives = 50/130 (38%), Gaps = 17/130 (13%)
Query: 378 QQYNQLSNLPP----------AIYLANNSLSGNIPVEIGQLKSLHVLDLSNNNFSGTIPD 427
+ +L + + L ++ ++P + L L L++S N+F P
Sbjct: 179 GELKKLEYISEGAFEGLFNLKYLNLGMCNIK-DMP-NLTPLVGLEELEMSGNHFPEIRPG 236
Query: 428 ELSDLSNLEKLDLSGNHLVGEIPISLKGLHFLSSFSVAHNNLQGAVPSGGQFDTFPS--- 484
LS+L+KL + + + + GL L ++AHNNL ++P F
Sbjct: 237 SFHGLSSLKKLWVMNSQVSLIERNAFDGLASLVELNLAHNNLS-SLP-HDLFTPLRYLVE 294
Query: 485 FSFEGNPELC 494
NP C
Sbjct: 295 LHLHHNPWNC 304
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452 | Back alignment and structure |
|---|
Score = 57.4 bits (139), Expect = 1e-08
Identities = 27/128 (21%), Positives = 43/128 (33%), Gaps = 25/128 (19%)
Query: 379 QYNQLSNLPPA----------IYLANNSLSGNIPVEI-GQLKSLHVLDLSNNNFSGTIPD 427
N + + + L NS+ I V L SL+ L+L +N + IP
Sbjct: 83 MENNIQMIQADTFRHLHHLEVLQLGRNSIR-QIEVGAFNGLASLNTLELFDNWLT-VIPS 140
Query: 428 E-LSDLSNLEKLDLSGNHLVGEIPI-SLKGLHFLSSFSVAHNNLQGAVPSGGQFDTFPSF 485
LS L +L L N + IP + + L + + +
Sbjct: 141 GAFEYLSKLRELWLRNNPIE-SIPSYAFNRVPSLMRLDLGELK---------KLEYISEG 190
Query: 486 SFEGNPEL 493
+FEG L
Sbjct: 191 AFEGLFNL 198
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452 | Back alignment and structure |
|---|
Score = 50.9 bits (122), Expect = 1e-06
Identities = 29/111 (26%), Positives = 44/111 (39%), Gaps = 15/111 (13%)
Query: 384 SNLPPAIYLANNSLSGNIPVEIGQLKSLHVLDLSNNNFSGTIPDELSDLSNLEKLDLSGN 443
SN + LS +P I + L+L NN D L +LE L L N
Sbjct: 53 SNQFSKVVCTRRGLS-EVPQGI--PSNTRYLNLMENNIQMIQADTFRHLHHLEVLQLGRN 109
Query: 444 HLVGEIPI-SLKGLHFLSSFSVAHNNLQGAVPSGGQFDTFPSFSFEGNPEL 493
+ +I + + GL L++ + N L +PSG +FE +L
Sbjct: 110 SI-RQIEVGAFNGLASLNTLELFDNWLT-VIPSG---------AFEYLSKL 149
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330 | Back alignment and structure |
|---|
Score = 66.9 bits (164), Expect = 6e-12
Identities = 23/118 (19%), Positives = 45/118 (38%), Gaps = 14/118 (11%)
Query: 379 QYNQLSNLPPAI-------YLANNSLSGNIPVEI-GQLKSLHVLDLSNNNFSGTIPDELS 430
++ +P + +L N ++ + L +L L LS N+ S L+
Sbjct: 179 ADTNITTIPQGLPPSLTELHLDGNKIT-KVDAASLKGLNNLAKLGLSFNSISAVDNGSLA 237
Query: 431 DLSNLEKLDLSGNHLVGEIPISLKGLHFLSSFSVAHNNLQ----GAVPSGGQFDTFPS 484
+ +L +L L+ N LV ++P L ++ + +NN+ G S
Sbjct: 238 NTPHLRELHLNNNKLV-KVPGGLADHKYIQVVYLHNNNISAIGSNDFCPPGYNTKKAS 294
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330 | Back alignment and structure |
|---|
Score = 62.3 bits (152), Expect = 2e-10
Identities = 26/120 (21%), Positives = 46/120 (38%), Gaps = 24/120 (20%)
Query: 379 QYNQLSNLPPA----------IYLANNSLSGNIPVEIGQLKSLHVLDLSNNNFSGTIPDE 428
N++S + P +YL+ N L +P K+L L + N + +
Sbjct: 84 INNKISKISPGAFAPLVKLERLYLSKNQLK-ELPE--KMPKTLQELRVHENEIT-KVRKS 139
Query: 429 -LSDLSNLEKLDLSGNHLVGEIPIS---LKGLHFLSSFSVAHNNLQGAVPSGGQFDTFPS 484
+ L+ + ++L N L I +G+ LS +A N+ +P G PS
Sbjct: 140 VFNGLNQMIVVELGTNPL-KSSGIENGAFQGMKKLSYIRIADTNIT-TIPQG----LPPS 193
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330 | Back alignment and structure |
|---|
Score = 59.2 bits (144), Expect = 2e-09
Identities = 20/108 (18%), Positives = 42/108 (38%), Gaps = 21/108 (19%)
Query: 379 QYNQLSNLPPA----------IYLANNSLSGNIPVEIGQLKSLHVLDLSNNNFSGTIPDE 428
+N +S + ++L NN L +P + K + V+ L NNN S I
Sbjct: 224 SFNSISAVDNGSLANTPHLRELHLNNNKLV-KVPGGLADHKYIQVVYLHNNNIS-AIGSN 281
Query: 429 -------LSDLSNLEKLDLSGNHL-VGEI-PISLKGLHFLSSFSVAHN 467
+ ++ + L N + EI P + + ++ ++ + +
Sbjct: 282 DFCPPGYNTKKASYSGVSLFSNPVQYWEIQPSTFRCVYVRAAVQLGNY 329
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330 | Back alignment and structure |
|---|
Score = 59.2 bits (144), Expect = 2e-09
Identities = 28/129 (21%), Positives = 52/129 (40%), Gaps = 27/129 (20%)
Query: 379 QYNQLSNLPPA----------IYLANNSL-SGNIPVEI-GQLKSLHVLDLSNNNFSGTIP 426
N+++ + + + L N L S I +K L + +++ N + TIP
Sbjct: 129 HENEITKVRKSVFNGLNQMIVVELGTNPLKSSGIENGAFQGMKKLSYIRIADTNIT-TIP 187
Query: 427 DELSDLSNLEKLDLSGNHLVGEIP-ISLKGLHFLSSFSVAHNNLQGAVPSGGQFDTFPSF 485
L +L +L L GN + ++ SLKGL+ L+ ++ N++ +
Sbjct: 188 QGL--PPSLTELHLDGNKI-TKVDAASLKGLNNLAKLGLSFNSIS----------AVDNG 234
Query: 486 SFEGNPELC 494
S P L
Sbjct: 235 SLANTPHLR 243
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330 | Back alignment and structure |
|---|
Score = 54.6 bits (132), Expect = 6e-08
Identities = 19/96 (19%), Positives = 36/96 (37%), Gaps = 8/96 (8%)
Query: 389 AIYLANNSLSGNIPVEIGQLKSLHVLDLSNNNFSGTIPDELSDLSNLEKLDLSGNHLVGE 448
+ ++ L +P ++ +LDL NN + + +L NL L L N +
Sbjct: 35 VVQCSDLGLE-KVPKDLP--PDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKI 91
Query: 449 IPISLKGLHFLSSFSVAHNNLQGAVPSGGQFDTFPS 484
P + L L ++ N L+ +P +
Sbjct: 92 SPGAFAPLVKLERLYLSKNQLK-ELPEK----MPKT 122
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 68.7 bits (168), Expect = 6e-12
Identities = 21/119 (17%), Positives = 42/119 (35%), Gaps = 14/119 (11%)
Query: 379 QYNQLSNLPPA----------IYLANNSLSGNIPVEI-GQLKSLHVLDLSNNNFSGTIPD 427
+N + + + + L + I E L +L +LDL ++ PD
Sbjct: 32 SFNYIRTVTASSFPFLEQLQLLELGSQYTPLTIDKEAFRNLPNLRILDLGSSKIYFLHPD 91
Query: 428 ELSDLSNLEKLDLSGNHLVGEI--PISLKGLHFLSSFSVAHNNLQGAVPSGGQFDTFPS 484
L +L +L L L + + L L+ ++ N ++ ++ F S
Sbjct: 92 AFQGLFHLFELRLYFCGLSDAVLKDGYFRNLKALTRLDLSKNQIR-SLYLHPSFGKLNS 149
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 66.0 bits (161), Expect = 4e-11
Identities = 21/102 (20%), Positives = 35/102 (34%), Gaps = 10/102 (9%)
Query: 379 QYNQLSNLPPA----------IYLANNSLSGNIPVEIGQLKSLHVLDLSNNNFSGTIPDE 428
+ + +L + LA N ++ L +L VL+LS N
Sbjct: 274 SHGFVFSLNSRVFETLKDLKVLNLAYNKINKIADEAFYGLDNLQVLNLSYNLLGELYSSN 333
Query: 429 LSDLSNLEKLDLSGNHLVGEIPISLKGLHFLSSFSVAHNNLQ 470
L + +DL NH+ + K L L + + N L
Sbjct: 334 FYGLPKVAYIDLQKNHIAIIQDQTFKFLEKLQTLDLRDNALT 375
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 65.2 bits (159), Expect = 7e-11
Identities = 29/150 (19%), Positives = 48/150 (32%), Gaps = 25/150 (16%)
Query: 366 LPVFVMPSNATNQQY-----NQLSNLPP-----------AIYLANNSLSGNIPVEI---- 405
L + + Q N+ S+ ++L N L E+
Sbjct: 416 LDILYFLLRVPHLQILILNQNRFSSCSGDQTPSENPSLEQLFLGENMLQLAWETELCWDV 475
Query: 406 -GQLKSLHVLDLSNNNFSGTIPDELSDLSNLEKLDLSGNHLVGEIPISLKGLHFLSSFSV 464
L L VL L++N + P S L+ L L L+ N L + + L +
Sbjct: 476 FEGLSHLQVLYLNHNYLNSLPPGVFSHLTALRGLSLNSNRLT-VLSHNDL-PANLEILDI 533
Query: 465 AHNNLQGAVPSGGQFDTFPSFSFEGNPELC 494
+ N L P+ F + N +C
Sbjct: 534 SRNQLL--APNPDVFVSLSVLDITHNKFIC 561
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 64.4 bits (157), Expect = 1e-10
Identities = 19/105 (18%), Positives = 42/105 (40%), Gaps = 14/105 (13%)
Query: 379 QYNQLSNLPPA------------IYLANNSLSGNIPVEI-GQLKSLHVLDLSNNNFSGTI 425
++ + + + L++ + ++ + LK L VL+L+ N +
Sbjct: 248 GFHNIKDPDQNTFAGLARSSVRHLDLSHGFVF-SLNSRVFETLKDLKVLNLAYNKINKIA 306
Query: 426 PDELSDLSNLEKLDLSGNHLVGEIPISLKGLHFLSSFSVAHNNLQ 470
+ L NL+ L+LS N L + GL ++ + N++
Sbjct: 307 DEAFYGLDNLQVLNLSYNLLGELYSSNFYGLPKVAYIDLQKNHIA 351
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 63.7 bits (155), Expect = 2e-10
Identities = 29/122 (23%), Positives = 45/122 (36%), Gaps = 16/122 (13%)
Query: 379 QYNQLSNLPPA----------IYLANNSLSGNI--PVEIGQLKSLHVLDLSNNNFSG-TI 425
+++ L P + L LS + LK+L LDLS N +
Sbjct: 81 GSSKIYFLHPDAFQGLFHLFELRLYFCGLSDAVLKDGYFRNLKALTRLDLSKNQIRSLYL 140
Query: 426 PDELSDLSNLEKLDLSGNHLVGEIPISLKGLHF--LSSFSVAHNNLQGAVPSGGQFDTFP 483
L++L+ +D S N + L+ L LS FS+A N+L + S
Sbjct: 141 HPSFGKLNSLKSIDFSSNQIFLVCEHELEPLQGKTLSFFSLAANSLY-SRVSVDWGKCMN 199
Query: 484 SF 485
F
Sbjct: 200 PF 201
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 59.4 bits (144), Expect = 4e-09
Identities = 17/104 (16%), Positives = 32/104 (30%), Gaps = 15/104 (14%)
Query: 391 YLANNSLSGNIPVEIGQLKSLHVLDLSNNNFSGTIPDELSDLSNLEKLDLSGNHLVGEI- 449
+ +L+ +P L + L LS N L L+ L+L + I
Sbjct: 10 FYRFCNLT-QVP---QVLNTTERLLLSFNYIRTVTASSFPFLEQLQLLELGSQYTPLTID 65
Query: 450 PISLKGLHFLSSFSVAHNNLQGAVPSGGQFDTFPSFSFEGNPEL 493
+ + L L + + + +F+G L
Sbjct: 66 KEAFRNLPNLRILDLGSSKIY----------FLHPDAFQGLFHL 99
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 48.6 bits (116), Expect = 7e-06
Identities = 26/148 (17%), Positives = 43/148 (29%), Gaps = 44/148 (29%)
Query: 379 QYNQLSNLPPAI----------YLANNSLSGNIPVEIGQLKSLHVLDLSNNNFSGTIPDE 428
Q N ++ + L +N+L+ I + S+ + LS N T+P
Sbjct: 346 QKNHIAIIQDQTFKFLEKLQTLDLRDNALT-----TIHFIPSIPDIFLSGNKLV-TLPKI 399
Query: 429 ----------------------LSDLSNLEKLDLSGNHLVG-EIPISLKGLHFLSSFSVA 465
L + +L+ L L+ N + L +
Sbjct: 400 NLTANLIHLSENRLENLDILYFLLRVPHLQILILNQNRFSSCSGDQTPSENPSLEQLFLG 459
Query: 466 HNNLQGAVPSGGQFDTFPSFSFEGNPEL 493
N LQ A + FEG L
Sbjct: 460 ENMLQLAWET-----ELCWDVFEGLSHL 482
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 44.0 bits (104), Expect = 2e-04
Identities = 24/147 (16%), Positives = 44/147 (29%), Gaps = 42/147 (28%)
Query: 379 QYNQLSNLPP------------AIYLANNSLSGNIPVEIGQL------KSLHVLDLSNNN 420
NQ+ + LA NSL + V+ G+ L +LD+S N
Sbjct: 156 SSNQIFLVCEHELEPLQGKTLSFFSLAANSLYSRVSVDWGKCMNPFRNMVLEILDVSGNG 215
Query: 421 FSGTIPD------------ELSDLSNLEKLDLSGNHLVGEIPISLKGLHFLS--SFSVAH 466
++ I L ++ +++ + GL S ++H
Sbjct: 216 WTVDITGNFSNAISKSQAFSLILAHHIMGAGFGFHNIKDPDQNTFAGLARSSVRHLDLSH 275
Query: 467 NNLQGAVPSGGQFDTFPSFSFEGNPEL 493
+ + S FE +L
Sbjct: 276 GFVF----------SLNSRVFETLKDL 292
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622 | Back alignment and structure |
|---|
Score = 68.4 bits (167), Expect = 6e-12
Identities = 23/102 (22%), Positives = 42/102 (41%), Gaps = 17/102 (16%)
Query: 380 YNQLSNLPPAI-------YLANNSLSGNIPVEIGQLKSLHVLDLSNNNFSGTIPDELSDL 432
+ L+ LP + + +N+L+ ++P +L++L ++S N + ++P L
Sbjct: 49 ESGLTTLPDCLPAHITTLVIPDNNLT-SLPALPPELRTL---EVSGNQLT-SLPVLPPGL 103
Query: 433 SNLEKLDLSGNHLVGEIPISLKGLHF----LSSFSVAHNNLQ 470
L HL +P L L L+S V LQ
Sbjct: 104 LELSIFSNPLTHLP-ALPSGLCKLWIFGNQLTSLPVLPPGLQ 144
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622 | Back alignment and structure |
|---|
Score = 67.2 bits (164), Expect = 1e-11
Identities = 25/98 (25%), Positives = 39/98 (39%), Gaps = 18/98 (18%)
Query: 379 QYNQLSNLPPAI------YLANNSLSGNIPVEIGQLKSLHVLDLSNNNFSGTIPDELSDL 432
N L++LP ++ N L+ ++PV L L + + +
Sbjct: 69 PDNNLTSLPALPPELRTLEVSGNQLT-SLPVLPPGLLELSIFSNPLTHLP-------ALP 120
Query: 433 SNLEKLDLSGNHLVGEIPISLKGLHFLSSFSVAHNNLQ 470
S L KL + GN L +P+ GL L SV+ N L
Sbjct: 121 SGLCKLWIFGNQL-TSLPVLPPGLQEL---SVSDNQLA 154
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622 | Back alignment and structure |
|---|
Score = 67.2 bits (164), Expect = 1e-11
Identities = 20/86 (23%), Positives = 39/86 (45%), Gaps = 11/86 (12%)
Query: 380 YNQLSNLPPAI------YLANNSLSGNIPVEIGQLKSLHVLDLSNNNFSGTIPDELSDLS 433
N+L++LP ++ N L+ ++P+ L SL + N + +P+ L LS
Sbjct: 230 GNRLTSLPVLPSELKELMVSGNRLT-SLPMLPSGLLSL---SVYRNQLT-RLPESLIHLS 284
Query: 434 NLEKLDLSGNHLVGEIPISLKGLHFL 459
+ ++L GN L +L+ +
Sbjct: 285 SETTVNLEGNPLSERTLQALREITSA 310
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622 | Back alignment and structure |
|---|
Score = 65.3 bits (159), Expect = 5e-11
Identities = 33/144 (22%), Positives = 52/144 (36%), Gaps = 29/144 (20%)
Query: 334 NLLSGEFPKELTALPALVSEAANDEVDRSYLELPVFVMPSNAT--NQQYNQLSNLPPAI- 390
N L+ P L L LP PS NQL++LP
Sbjct: 91 NQLT-SLPVLPPGLLEL------SIFSNPLTHLPAL--PSGLCKLWIFGNQLTSLPVLPP 141
Query: 391 -----YLANNSLSGNIPVEIGQLKSLHVLDLSNNNFSGTIPDELSDLSNLEKLDLSGNHL 445
+++N L+ ++P +L L NN + ++P S L++L +S N L
Sbjct: 142 GLQELSVSDNQLA-SLPALPSELCKL---WAYNNQLT-SLPMLPS---GLQELSVSDNQL 193
Query: 446 VGEIPISLKGLHFLSSFSVAHNNL 469
+P L+ L +N L
Sbjct: 194 A-SLPTLPSELYKL---WAYNNRL 213
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622 | Back alignment and structure |
|---|
Score = 61.8 bits (150), Expect = 7e-10
Identities = 26/97 (26%), Positives = 44/97 (45%), Gaps = 18/97 (18%)
Query: 380 YNQLSNLPPAI------YLANNSLSGNIPVEIGQLKSLHVLDLSNNNFSGTIPDELSDLS 433
NQL++LP +++N L+ ++P +L L NN + ++P S
Sbjct: 170 NNQLTSLPMLPSGLQELSVSDNQLA-SLPTLPSELYK---LWAYNNRLT-SLPAL---PS 221
Query: 434 NLEKLDLSGNHLVGEIPISLKGLHFLSSFSVAHNNLQ 470
L++L +SGN L +P+ L L V+ N L
Sbjct: 222 GLKELIVSGNRL-TSLPVLPSELKEL---MVSGNRLT 254
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622 | Back alignment and structure |
|---|
Score = 52.6 bits (126), Expect = 4e-07
Identities = 12/72 (16%), Positives = 24/72 (33%), Gaps = 10/72 (13%)
Query: 380 YNQLSNLPPAI------YLANNSLSGNIPVEIGQLKSLHVLDLSNNNFSGTIPDELSDLS 433
N+L++LP + N L+ +P + L S ++L N S +
Sbjct: 250 GNRLTSLPMLPSGLLSLSVYRNQLT-RLPESLIHLSSETTVNLEGNPLS-ERTLQALR-- 305
Query: 434 NLEKLDLSGNHL 445
+ +
Sbjct: 306 EITSAPGYSGPI 317
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622 | Back alignment and structure |
|---|
Score = 48.4 bits (115), Expect = 1e-05
Identities = 15/63 (23%), Positives = 27/63 (42%), Gaps = 7/63 (11%)
Query: 408 LKSLHVLDLSNNNFSGTIPDELSDLSNLEKLDLSGNHLVGEIPISLKGLHFLSSFSVAHN 467
VL++ + + T+PD L +++ L + N+L +P L L V+ N
Sbjct: 39 NNGNAVLNVGESGLT-TLPDCL--PAHITTLVIPDNNLT-SLPALPPELRTL---EVSGN 91
Query: 468 NLQ 470
L
Sbjct: 92 QLT 94
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285 | Back alignment and structure |
|---|
Score = 66.2 bits (162), Expect = 7e-12
Identities = 30/129 (23%), Positives = 48/129 (37%), Gaps = 17/129 (13%)
Query: 380 YNQLSNLPPAI----------YLANNSLSGNIPVEI-GQLKSLHVLDLSNNNFSGTIPDE 428
L L P + YL +N+L +P + L +L L L N S
Sbjct: 114 RCGLQELGPGLFRGLAALQYLYLQDNALQ-ALPDDTFRDLGNLTHLFLHGNRISSVPERA 172
Query: 429 LSDLSNLEKLDLSGNHLVGEIPISLKGLHFLSSFSVAHNNLQGAVPSGGQFDTFPS---F 485
L +L++L L N + P + + L L + + NNL A+P+ +
Sbjct: 173 FRGLHSLDRLLLHQNRVAHVHPHAFRDLGRLMTLYLFANNLS-ALPT-EALAPLRALQYL 230
Query: 486 SFEGNPELC 494
NP +C
Sbjct: 231 RLNDNPWVC 239
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285 | Back alignment and structure |
|---|
Score = 56.2 bits (136), Expect = 1e-08
Identities = 27/124 (21%), Positives = 45/124 (36%), Gaps = 20/124 (16%)
Query: 379 QYNQLSNLPPAI-------YLANNSLSGNIPVEI-GQLKSLHVLDLSNNNFSGTIPDELS 430
L +P I +L N +S ++P ++L +L L +N + +
Sbjct: 19 PQQGLQAVPVGIPAASQRIFLHGNRIS-HVPAASFRACRNLTILWLHSNVLARIDAAAFT 77
Query: 431 DLSNLEKLDLSGNHLVGEIPIS-LKGLHFLSSFSVAHNNLQGAVPSGGQFDTFPSFSFEG 489
L+ LE+LDLS N + + + GL L + + LQ F G
Sbjct: 78 GLALLEQLDLSDNAQLRSVDPATFHGLGRLHTLHLDRCGLQ----------ELGPGLFRG 127
Query: 490 NPEL 493
L
Sbjct: 128 LAAL 131
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458 | Back alignment and structure |
|---|
Score = 67.5 bits (165), Expect = 8e-12
Identities = 61/306 (19%), Positives = 104/306 (33%), Gaps = 66/306 (21%)
Query: 547 SKRRIIPGGDPDKIELDTISSTSNFGVSPEADKDASLVMLFPNNTNEIKDLTIYELLKAT 606
S + T+S + G + + P ++ + YE+
Sbjct: 2 SSHEAAAAQQHNSGTQHTVSGSQQEGQQRKQHHSSKPTASMPRPHSDWQIPDRYEIRH-- 59
Query: 607 DNFSQANIIGCGGFGLVYKAT-LANGTTLAIKKLSG---DLGLMEREFKAEVEALSTAQH 662
+IG G +G V +A +AIKK+ DL +R + E+ L+ H
Sbjct: 60 -------LIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILR-EIAILNRLNH 111
Query: 663 KNLVSLQGYCVHQGFRLL--IYSYMENGSLDYWLHEKADGASQLDWLTRLKIARGTS--- 717
++V + + + +Y +E D K LT L I
Sbjct: 112 DHVVKVLDIVIPKDVEKFDELYVVLEIADSD--FK-KLFRTPVY--LTELHIKTLLYNLL 166
Query: 718 CGLAYMHQICEPHIVHRDIKSSNILLDDQFEAHLADFGLSRLILPYQTHVT--------- 768
G+ Y+H I+HRD+K +N L++ + DFGL+R + + +
Sbjct: 167 VGVKYVH---SAGILHRDLKPANCLVNQDCSVKVCDFGLARTVDYPENGNSQLPISPRED 223
Query: 769 -----------------TELVGTLGYIPPE-------YGQAWVATLRGDMYSFGVVMLEL 804
T V T Y PE Y +A + D++S G + EL
Sbjct: 224 DMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEA-I-----DVWSIGCIFAEL 277
Query: 805 LTGKRP 810
L +
Sbjct: 278 LNMIKE 283
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 66.3 bits (162), Expect = 2e-11
Identities = 20/125 (16%), Positives = 41/125 (32%), Gaps = 7/125 (5%)
Query: 363 YLELPVFVMPSNATNQQYNQLSNLPPAIYLANNSLSGNIPVEIGQLKSLHVLDLSNNNFS 422
+ S + + L ++ L ++ L+ + + + N+
Sbjct: 268 DFNPSESDVVSELGKVETVTIRRL----HIPQFYLFYDLSTVYSLLEKVKRITVENSKVF 323
Query: 423 GTIPDELSDLSNLEKLDLSGNHLVGEI---PISLKGLHFLSSFSVAHNNLQGAVPSGGQF 479
L +LE LDLS N +V E L + ++ N+L+ +G
Sbjct: 324 LVPCSFSQHLKSLEFLDLSENLMVEEYLKNSACKGAWPSLQTLVLSQNHLRSMQKTGEIL 383
Query: 480 DTFPS 484
T +
Sbjct: 384 LTLKN 388
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 65.1 bits (159), Expect = 6e-11
Identities = 24/114 (21%), Positives = 44/114 (38%), Gaps = 10/114 (8%)
Query: 379 QYNQLSNLPPAI-------YLANNSLSGNIPVEIGQLKSLHVLDLSNNNFSGTIPDE-LS 430
+ +++P + L+ N ++ ++ +L VL L ++ + TI +
Sbjct: 13 RSRSFTSIPSGLTAAMKSLDLSFNKITYIGHGDLRACANLQVLILKSSRIN-TIEGDAFY 71
Query: 431 DLSNLEKLDLSGNHLVGEIPISLKGLHFLSSFSVAHNNLQGAVPSGGQFDTFPS 484
L +LE LDLS NHL L L ++ N Q + F +
Sbjct: 72 SLGSLEHLDLSDNHLSSLSSSWFGPLSSLKYLNLMGNPYQ-TLGVTSLFPNLTN 124
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 62.4 bits (152), Expect = 3e-10
Identities = 15/105 (14%), Positives = 28/105 (26%), Gaps = 12/105 (11%)
Query: 379 QYNQLSNLPPA-----------IYLANNSLSGNIPVE-IGQLKSLHVLDLSNNNFSGTIP 426
N L + + N I L SL+ L++ +
Sbjct: 106 MGNPYQTLGVTSLFPNLTNLQTLRIGNVETFSEIRRIDFAGLTSLNELEIKALSLRNYQS 165
Query: 427 DELSDLSNLEKLDLSGNHLVGEIPISLKGLHFLSSFSVAHNNLQG 471
L + ++ L L + + I L + + NL
Sbjct: 166 QSLKSIRDIHHLTLHLSESAFLLEIFADILSSVRYLELRDTNLAR 210
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 61.7 bits (150), Expect = 7e-10
Identities = 29/160 (18%), Positives = 48/160 (30%), Gaps = 49/160 (30%)
Query: 380 YNQLSNLPPA-------------IYLANNSLSGNIPVEIG---QLKSLHVLDLSNNNFSG 423
N + + L+ N L ++ LK+L LD+S N F
Sbjct: 343 ENLMVEEYLKNSACKGAWPSLQTLVLSQNHLR-SMQKTGEILLTLKNLTSLDISRNTFH- 400
Query: 424 TIPDELSDLSNLEKLDLSGNHLV---GEIPISLK--------------GLHFLSSFSVAH 466
+PD + L+LS + IP +L+ L L ++
Sbjct: 401 PMPDSCQWPEKMRFLNLSSTGIRVVKTCIPQTLEVLDVSNNNLDSFSLFLPRLQELYISR 460
Query: 467 NNLQGAVPSGG-------------QFDTFPSFSFEGNPEL 493
N L+ +P Q + P F+ L
Sbjct: 461 NKLK-TLPDASLFPVLLVMKISRNQLKSVPDGIFDRLTSL 499
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 55.5 bits (134), Expect = 5e-08
Identities = 17/75 (22%), Positives = 31/75 (41%), Gaps = 10/75 (13%)
Query: 379 QYNQLSNLPP------AIYLANNSLSGNIPVEIGQLKSLHVLDLSNNNFSGTIPDE-LSD 431
N L + +Y++ N L +P + L V+ +S N ++PD
Sbjct: 439 SNNNLDSFSLFLPRLQELYISRNKLK-TLP-DASLFPVLLVMKISRNQLK-SVPDGIFDR 495
Query: 432 LSNLEKLDLSGNHLV 446
L++L+K+ L N
Sbjct: 496 LTSLQKIWLHTNPWD 510
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 53.2 bits (128), Expect = 3e-07
Identities = 13/100 (13%), Positives = 27/100 (27%), Gaps = 10/100 (10%)
Query: 380 YNQLSNLPPA----------IYLANNSLSGNIPVEIGQLKSLHVLDLSNNNFSGTIPDEL 429
S + + + SL + ++ +H L L + + +
Sbjct: 133 VETFSEIRRIDFAGLTSLNELEIKALSLRNYQSQSLKSIRDIHHLTLHLSESAFLLEIFA 192
Query: 430 SDLSNLEKLDLSGNHLVGEIPISLKGLHFLSSFSVAHNNL 469
LS++ L+L +L L S
Sbjct: 193 DILSSVRYLELRDTNLARFQFSPLPVDEVSSPMKKLAFRG 232
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 50.9 bits (122), Expect = 1e-06
Identities = 16/84 (19%), Positives = 31/84 (36%), Gaps = 13/84 (15%)
Query: 410 SLHVLDLSNNNFSGTIPDELSDLSNLEKLDLSGNHLVGEIPISLKGLHFLSSFSVAHNNL 469
+ V D + +F+ +IP L+ + ++ LDLS N + L+ L + + +
Sbjct: 6 ASGVCDGRSRSFT-SIPSGLT--AAMKSLDLSFNKITYIGHGDLRACANLQVLILKSSRI 62
Query: 470 QGAVPSGGQFDTFPSFSFEGNPEL 493
T +F L
Sbjct: 63 N----------TIEGDAFYSLGSL 76
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 43.2 bits (102), Expect = 4e-04
Identities = 16/133 (12%), Positives = 33/133 (24%), Gaps = 18/133 (13%)
Query: 379 QYNQLSNLPPA----------IYLANNSLSGNIPVEIGQLKSLHVLDLSNNNFSGTIPDE 428
+ L N + L + + + + L S+ L+L + N +
Sbjct: 156 KALSLRNYQSQSLKSIRDIHHLTLHLSESAFLLEIFADILSSVRYLELRDTNLARFQFSP 215
Query: 429 LSDLSNLEKLDLSGNHLV-------GEIPISLKGLHFLSSFSVAHNNLQG-AVPSGGQFD 480
L + E+ L+ + LS L G + + D
Sbjct: 216 LPVDEVSSPMKKLAFRGSVLTDESFNELLKLLRYILELSEVEFDDCTLNGLGDFNPSESD 275
Query: 481 TFPSFSFEGNPEL 493
+
Sbjct: 276 VVSELGKVETVTI 288
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477 | Back alignment and structure |
|---|
Score = 65.5 bits (160), Expect = 4e-11
Identities = 27/131 (20%), Positives = 51/131 (38%), Gaps = 18/131 (13%)
Query: 378 QQYNQLSNLPPAI---------YLANNSLSGNIPVE-IGQLKSLHVLDLSNNNFSGTIPD 427
+ L + P + + +L+ +P + L L L+LS N S
Sbjct: 208 SHWPYLDTMTPNCLYGLNLTSLSITHCNLT-AVPYLAVRHLVYLRFLNLSYNPISTIEGS 266
Query: 428 ELSDLSNLEKLDLSGNHLVGEIPI-SLKGLHFLSSFSVAHNNLQGAVPSGGQFDTFPS-- 484
L +L L+++ L G L + + +GL++L +V+ N L + F + +
Sbjct: 267 MLHELLRLQEIQLVGGQL-AVVEPYAFRGLNYLRVLNVSGNQLT-TLE-ESVFHSVGNLE 323
Query: 485 -FSFEGNPELC 494
+ NP C
Sbjct: 324 TLILDSNPLAC 334
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477 | Back alignment and structure |
|---|
Score = 64.4 bits (157), Expect = 8e-11
Identities = 28/141 (19%), Positives = 43/141 (30%), Gaps = 28/141 (19%)
Query: 379 QYNQLSNLPPA----------IYLANNSLSGNIPVEI-GQLKSLHVLDLSNNNFSGTIPD 427
N L + + L +L+ +IP E L L VL L + N +
Sbjct: 136 GDNDLVYISHRAFSGLNSLEQLTLEKCNLT-SIPTEALSHLHGLIVLRLRHLNINAIRDY 194
Query: 428 ELSDLSNLEKLDLSGNHLVGEIPISLKGLHFLSSFSVAHNNLQGAVPSGG---------- 477
L L+ L++S + + + L+S S+ H NL AVP
Sbjct: 195 SFKRLYRLKVLEISHWPYLDTMTPNCLYGLNLTSLSITHCNLT-AVPYLAVRHLVYLRFL 253
Query: 478 -----QFDTFPSFSFEGNPEL 493
T L
Sbjct: 254 NLSYNPISTIEGSMLHELLRL 274
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477 | Back alignment and structure |
|---|
Score = 62.0 bits (151), Expect = 4e-10
Identities = 27/128 (21%), Positives = 50/128 (39%), Gaps = 26/128 (20%)
Query: 379 QYNQLSNLPPAI----------YLANNSLSGNIPVEI-GQLKSLHVLDLSNNNFSGTIPD 427
+ N+L +P + ++ N + + + L +L L++ +N+ I
Sbjct: 88 RSNRLKLIPLGVFTGLSNLTKLDISENKIV-ILLDYMFQDLYNLKSLEVGDNDLV-YISH 145
Query: 428 E-LSDLSNLEKLDLSGNHLVGEIPI-SLKGLHFLSSFSVAHNNLQGAVPSGGQFDTFPSF 485
S L++LE+L L +L IP +L LH L + H N+ +
Sbjct: 146 RAFSGLNSLEQLTLEKCNLT-SIPTEALSHLHGLIVLRLRHLNIN----------AIRDY 194
Query: 486 SFEGNPEL 493
SF+ L
Sbjct: 195 SFKRLYRL 202
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477 | Back alignment and structure |
|---|
Score = 61.3 bits (149), Expect = 7e-10
Identities = 28/104 (26%), Positives = 42/104 (40%), Gaps = 14/104 (13%)
Query: 379 QYNQLSNLPPA----------IYLANNSLSGNIPVEI-GQLKSLHVLDLSNNNFSGTIPD 427
N++ L + L N +S + L +L L L +N IP
Sbjct: 40 GKNRIKTLNQDEFASFPHLEELELNENIVS-AVEPGAFNNLFNLRTLGLRSNRLK-LIPL 97
Query: 428 E-LSDLSNLEKLDLSGNHLVGEIPISLKGLHFLSSFSVAHNNLQ 470
+ LSNL KLD+S N +V + + L+ L S V N+L
Sbjct: 98 GVFTGLSNLTKLDISENKIVILLDYMFQDLYNLKSLEVGDNDLV 141
|
| >1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* Length = 567 | Back alignment and structure |
|---|
Score = 65.5 bits (159), Expect = 4e-11
Identities = 27/105 (25%), Positives = 45/105 (42%), Gaps = 9/105 (8%)
Query: 390 IYLANNSLSGNIPVEIGQLKSLHVLDLSNNNFSGTIPDELSDLSNLEKLDLSGNHLVGEI 449
++LA+ L+ + + QL + LDLS+N +P L+ L LE L S N L +
Sbjct: 446 LHLAHKDLT-VLC-HLEQLLLVTHLDLSHNRLR-ALPPALAALRCLEVLQASDNALE-NV 501
Query: 450 PISLKGLHFLSSFSVAHNNLQGAVPSGGQFDTFPS---FSFEGNP 491
+ L L + +N LQ + + P + +GN
Sbjct: 502 D-GVANLPRLQELLLCNNRLQQ-SAAIQPLVSCPRLVLLNLQGNS 544
|
| >1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* Length = 567 | Back alignment and structure |
|---|
Score = 60.5 bits (146), Expect = 1e-09
Identities = 22/79 (27%), Positives = 31/79 (39%), Gaps = 14/79 (17%)
Query: 379 QYNQLSNLPPAI---------YLANNSLSGNIPVEIGQLKSLHVLDLSNNNFSGTIPD-- 427
+N+L LPPA+ ++N+L N+ + L L L L NN
Sbjct: 471 SHNRLRALPPALAALRCLEVLQASDNALE-NVD-GVANLPRLQELLLCNNRLQ-QSAAIQ 527
Query: 428 ELSDLSNLEKLDLSGNHLV 446
L L L+L GN L
Sbjct: 528 PLVSCPRLVLLNLQGNSLC 546
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336 | Back alignment and structure |
|---|
Score = 63.4 bits (153), Expect = 9e-11
Identities = 36/198 (18%), Positives = 58/198 (29%), Gaps = 45/198 (22%)
Query: 603 LKATDNFSQANIIGCGGFGLVYKATLANGTTLAIKKL--------SGDLGLMEREFKAEV 654
T+ + IG G FG V++ A+ T +AIK + +G E E+
Sbjct: 16 CLPTEKLQRCEKIGEGVFGEVFQTI-ADHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEI 74
Query: 655 EAL---------STAQHKNLVSLQGYCVHQGF--RLLIYSYM----ENGSLD-------- 691
+ + + L QG LL+ ++ GS +
Sbjct: 75 IISKELSLLSGEVCNRTEGFIGLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKD 134
Query: 692 ---YWLHEKADGASQL--------DWLTRLKIARGTSCGLAYMHQICEPHIVHRDIKSSN 740
+ + E G L T I + LA HRD+ N
Sbjct: 135 DQLFIVLEFEFGGIDLEQMRTKLSSLATAKSILHQLTASLAVAEA--SLRFEHRDLHWGN 192
Query: 741 ILLDDQFEAHLADFGLSR 758
+LL L +
Sbjct: 193 VLLKKTSLKKLHYTLNGK 210
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296 | Back alignment and structure |
|---|
Score = 62.0 bits (151), Expect = 2e-10
Identities = 56/263 (21%), Positives = 97/263 (36%), Gaps = 44/263 (16%)
Query: 615 IGCGGFGLVYKAT-LANGTTLAIK--KLSGDLGLMEREFKAEVEALSTAQHKNLVSLQGY 671
IG G FG +Y T +A G +AIK + + E K + + + +++
Sbjct: 17 IGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQLHIESKI-YKMMQGGVG--IPTIRWC 73
Query: 672 CVHQGFRLLIYSYMENG-SLDYWLHEKADGASQLDWLTRLKIARGTSCGLAYMHQICEPH 730
+ +++ + G SL+ L + T L +A + Y+H +
Sbjct: 74 GAEGDYNVMVMELL--GPSLED-LFNFCSR--KFSLKTVLLLADQMISRIEYIHSK---N 125
Query: 731 IVHRDIKSSNILL---DDQFEAHLADFGLSRLILPYQTHV------TTELVGTLGYIPPE 781
+HRD+K N L+ ++ DFGL++ +TH L GT Y
Sbjct: 126 FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARY---- 181
Query: 782 YGQAWVATLRG-------DMYSFGVVMLELLTGKRPVDVLKPKMSRELVGWVLKMRSEGK 834
A + T G D+ S G V++ G P LK R+ + + K
Sbjct: 182 ---ASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEK----K 234
Query: 835 QDQVFDPILRGKGFDEEMLQVLD 857
+ + KG+ E L+
Sbjct: 235 MSTPIEVLC--KGYPSEFATYLN 255
|
| >3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} Length = 571 | Back alignment and structure |
|---|
Score = 63.5 bits (154), Expect = 2e-10
Identities = 22/106 (20%), Positives = 37/106 (34%), Gaps = 20/106 (18%)
Query: 377 NQQYNQLSNLPPAIY-----LANNSLSGN-------IPVEIGQLKSLHVLDLSNNNFSGT 424
N YN +S + +L G + E + L L+ N S +
Sbjct: 16 NSFYNTISGTYADYFSAWDKWEKQALPGENRNEAVSLLKEC-LINQFSELQLNRLNLS-S 73
Query: 425 IPDELSDLSNLEKLDLSGNHLVGEIPISLKGLHFLSSFSVAHNNLQ 470
+PD L + L+++ N L+ +P L +L N L
Sbjct: 74 LPDNL--PPQITVLEITQNALI-SLPELPASLEYL---DACDNRLS 113
|
| >3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} Length = 571 | Back alignment and structure |
|---|
Score = 59.6 bits (144), Expect = 3e-09
Identities = 22/100 (22%), Positives = 39/100 (39%), Gaps = 19/100 (19%)
Query: 379 QYNQLSNLPPAI--------YLANNSLSGNIPVEIGQLKSLHVLDLSNNNFSGTIPDELS 430
N+ +L L +LS ++P + + VL+++ N ++P+ +
Sbjct: 45 NRNEAVSLLKECLINQFSELQLNRLNLS-SLPDNLPP--QITVLEITQNALI-SLPELPA 100
Query: 431 DLSNLEKLDLSGNHLVGEIPISLKGLHFLSSFSVAHNNLQ 470
+LE LD N L +P L L V +N L
Sbjct: 101 ---SLEYLDACDNRLS-TLPELPASLKHL---DVDNNQLT 133
|
| >3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} Length = 571 | Back alignment and structure |
|---|
Score = 59.2 bits (143), Expect = 4e-09
Identities = 30/140 (21%), Positives = 47/140 (33%), Gaps = 35/140 (25%)
Query: 380 YNQLSNLPPAI------YLANNSLSGNIPVEIGQLKSLHV-----------------LDL 416
N+LS LP + NN L+ +P L+ ++ L +
Sbjct: 109 DNRLSTLPELPASLKHLDVDNNQLT-MLPELPALLEYINADNNQLTMLPELPTSLEVLSV 167
Query: 417 SNNNFSGTIPDELSDLSNLEKLDLSGNHLVGEIPISLKGLHFLSS----FSVAHNNLQGA 472
NN + +P+ +LE LD+S N L +P H F N +
Sbjct: 168 RNNQLT-FLPELPE---SLEALDVSTNLLE-SLPAVPVRNHHSEETEIFFRCRENRIT-H 221
Query: 473 VPSG-GQFDTFPSFSFEGNP 491
+P D + E NP
Sbjct: 222 IPENILSLDPTCTIILEDNP 241
|
| >3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} Length = 571 | Back alignment and structure |
|---|
Score = 54.2 bits (130), Expect = 1e-07
Identities = 18/109 (16%), Positives = 29/109 (26%), Gaps = 16/109 (14%)
Query: 380 YNQLSNLPPAI-------------YLANNSLSGNIPVEIGQLKSLHVLDLSNNNFSGTIP 426
N L +LP N ++ +IP I L + L +N S I
Sbjct: 189 TNLLESLPAVPVRNHHSEETEIFFRCRENRIT-HIPENILSLDPTCTIILEDNPLSSRIR 247
Query: 427 DELSDLSNLEKLDLSGNHLVGEIPISLKGLHFLSSFSVAHNNLQGAVPS 475
+ LS + D G + + + S
Sbjct: 248 ESLSQQTAQP--DYHGPRIYFSMSDGQQNTLHRPLADAVTAWFPENKQS 294
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347 | Back alignment and structure |
|---|
Score = 61.3 bits (148), Expect = 5e-10
Identities = 19/107 (17%), Positives = 33/107 (30%), Gaps = 11/107 (10%)
Query: 394 NNSLSGNIPVEIGQLKSLHVLDLSNNNFSGTIPDE-LSDLSNLEKLDLSGNHLVGEIPIS 452
+ + + ++L L + N + L L L L + + L P +
Sbjct: 16 TRDGALDSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDA 75
Query: 453 LKGLHFLSSFSVAHNNLQGAVPSGGQFDTFPSFS-----FEGNPELC 494
LS +++ N L+ T S GNP C
Sbjct: 76 FHFTPRLSRLNLSFNALESLSW-----KTVQGLSLQELVLSGNPLHC 117
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347 | Back alignment and structure |
|---|
Score = 49.4 bits (117), Expect = 3e-06
Identities = 20/97 (20%), Positives = 39/97 (40%), Gaps = 9/97 (9%)
Query: 381 NQLSNLPPA-----IYLANNSLSGNIPVE-IGQLKSLHVLDLSNNNFSGTIPDE-LSDLS 433
+ L +LP A +Y+ N ++ + + L L L + + + +
Sbjct: 22 DSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLR-FVAPDAFHFTP 80
Query: 434 NLEKLDLSGNHLVGEIPISLKGLHFLSSFSVAHNNLQ 470
L +L+LS N L +++GL L ++ N L
Sbjct: 81 RLSRLNLSFNALESLSWKTVQGLS-LQELVLSGNPLH 116
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455 | Back alignment and structure |
|---|
Score = 60.9 bits (148), Expect = 8e-10
Identities = 36/132 (27%), Positives = 53/132 (40%), Gaps = 21/132 (15%)
Query: 379 QYNQLSNLPPAI----------YLANNSLSGNIPVEI-GQLKSLHVLDLSNNNFSGTIPD 427
+++ L ++ LA N ++ I L L L+LS N +I
Sbjct: 283 SKSKIFALLKSVFSHFTDLEQLTLAQNEIN-KIDDNAFWGLTHLLKLNLSQNFLG-SIDS 340
Query: 428 EL-SDLSNLEKLDLSGNHLVGEIPI-SLKGLHFLSSFSVAHNNLQGAVPSGGQFDTFPSF 485
+ +L LE LDLS NH+ + S GL L ++ N L+ +VP G FD S
Sbjct: 341 RMFENLDKLEVLDLSYNHI-RALGDQSFLGLPNLKELALDTNQLK-SVPDGI-FDRLTSL 397
Query: 486 S---FEGNPELC 494
NP C
Sbjct: 398 QKIWLHTNPWDC 409
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455 | Back alignment and structure |
|---|
Score = 53.6 bits (129), Expect = 2e-07
Identities = 20/129 (15%), Positives = 34/129 (26%), Gaps = 13/129 (10%)
Query: 379 QYNQLSNLPPAI----------YLANNSL-SGNIPVEI-GQLKSLHVLDLSNNNFSGTIP 426
YNQ L L +L + L SL +L L +NN P
Sbjct: 87 DYNQFLQLETGAFNGLANLEVLTLTQCNLDGAVLSGNFFKPLTSLEMLVLRDNNIKKIQP 146
Query: 427 DELSD-LSNLEKLDLSGNHLVGEIPISLKGLHFLSSFSVAHNNLQGAVPSGGQFDTFPSF 485
+ LDL+ N + L + +++ +
Sbjct: 147 ASFFLNMRRFHVLDLTFNKVKSICEEDLLNFQGKHFTLLRLSSITLQDMNEYWLGWEKCG 206
Query: 486 SFEGNPELC 494
+ N +
Sbjct: 207 NPFKNTSIT 215
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455 | Back alignment and structure |
|---|
Score = 46.7 bits (111), Expect = 2e-05
Identities = 20/141 (14%), Positives = 39/141 (27%), Gaps = 56/141 (39%)
Query: 342 KELTALPALVSEAANDEVDRSYLELPVFVMPSNATNQQYNQLSNLPPA----------IY 391
+ L +P L + +Y++L N ++ L +
Sbjct: 20 RGLHQVPELPA-------HVNYVDL------------SLNSIAELNETSFSRLQDLQFLK 60
Query: 392 LANNSLSGNIPVEIGQ-------------------------LKSLHVLDLSNNNF-SGTI 425
+ + I + L +L VL L+ N +
Sbjct: 61 VEQQTPGLVIRNNTFRGLSSLIILKLDYNQFLQLETGAFNGLANLEVLTLTQCNLDGAVL 120
Query: 426 PDEL-SDLSNLEKLDLSGNHL 445
L++LE L L N++
Sbjct: 121 SGNFFKPLTSLEMLVLRDNNI 141
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455 | Back alignment and structure |
|---|
Score = 45.9 bits (109), Expect = 4e-05
Identities = 16/82 (19%), Positives = 32/82 (39%), Gaps = 9/82 (10%)
Query: 400 NIPVEIGQLKSLHVLDLSNNNFSGTIPDELSDLSNLEKLDLSGNHLVGEIPI-SLKGLHF 458
+P ++ +DLS N+ + S L +L+ L + I + +GL
Sbjct: 27 ELPA------HVNYVDLSLNSIAELNETSFSRLQDLQFLKVEQQTPGLVIRNNTFRGLSS 80
Query: 459 LSSFSVAHNNLQGAVPSGGQFD 480
L + +N + + G F+
Sbjct: 81 LIILKLDYNQFL-QLET-GAFN 100
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455 | Back alignment and structure |
|---|
Score = 42.8 bits (101), Expect = 5e-04
Identities = 20/135 (14%), Positives = 45/135 (33%), Gaps = 24/135 (17%)
Query: 379 QYNQLSNLPPA-----------IYLANNSLS----------GNIPVEIGQLKSLHVLDLS 417
+ N + + PA + L N + + +L S+ + D++
Sbjct: 137 RDNNIKKIQPASFFLNMRRFHVLDLTFNKVKSICEEDLLNFQGKHFTLLRLSSITLQDMN 196
Query: 418 NNNFSGTIPDELSDLSNLEKLDLSGNHL---VGEIPISLKGLHFLSSFSVAHNNLQGAVP 474
+++ LDLSGN + + + S ++++ G+
Sbjct: 197 EYWLGWEKCGNPFKNTSITTLDLSGNGFKESMAKRFFDAIAGTKIQSLILSNSYNMGSSF 256
Query: 475 SGGQFDTFPSFSFEG 489
F +F+F+G
Sbjct: 257 GHTNFKDPDNFTFKG 271
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298 | Back alignment and structure |
|---|
Score = 60.1 bits (146), Expect = 8e-10
Identities = 49/243 (20%), Positives = 85/243 (34%), Gaps = 52/243 (21%)
Query: 615 IGCGGFGLVYKAT-LANGTTLAIK--KLSGDLGLMEREFKAEVEALSTAQHKNLVSLQG- 670
IG G FG++++ T L N +AIK D + E++ +K L G
Sbjct: 18 IGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDAPQLRDEYRT---------YKLLAGCTGI 68
Query: 671 -----YCVHQGFRLLIYSYMENG-SLDYWLHEKADGASQLDWLTRLKIARGTSCGLAYMH 724
+ +L+ + G SL+ L + + T A+ + +H
Sbjct: 69 PNVYYFGQEGLHNVLVIDLL--GPSLED-LLDLCGR--KFSVKTVAMAAKQMLARVQSIH 123
Query: 725 QICEPHIVHRDIKSSNILLDDQFEA-----HLADFGLSRLILPYQTHV------TTELVG 773
+ +V+RDIK N L+ ++ DFG+ + T L G
Sbjct: 124 EK---SLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSG 180
Query: 774 TLGYIPPEYGQAWVATLRG-------DMYSFGVVMLELLTGKRPVDVLKPKMSRELVGWV 826
T Y + T G D+ + G V + L G P LK +++ +
Sbjct: 181 TARY-------MSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERI 233
Query: 827 LKM 829
+
Sbjct: 234 GEK 236
|
| >2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* Length = 239 | Back alignment and structure |
|---|
Score = 58.9 bits (143), Expect = 1e-09
Identities = 15/112 (13%), Positives = 32/112 (28%), Gaps = 15/112 (13%)
Query: 379 QYNQLSNLPPA----------IYLANNSLSGNIPVEI-GQLKSLHVLDLSNNNFSGTIPD 427
L +P IY++ + + L + +++ N I
Sbjct: 39 IETHLRTIPSHAFSNLPNISRIYVSIDVTLQQLESHSFYNLSKVTHIEIRNTRNLTYIDP 98
Query: 428 E-LSDLSNLEKLDLSGNHLVGEIP--ISLKGLHFLSSFSVAHNNLQGAVPSG 476
+ L +L L+ L + L P + + N ++P
Sbjct: 99 DALKELPLLKFLGIFNTGLK-MFPDLTKVYSTDIFFILEITDNPYMTSIPVN 149
|
| >2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* Length = 239 | Back alignment and structure |
|---|
Score = 46.2 bits (110), Expect = 2e-05
Identities = 16/103 (15%), Positives = 36/103 (34%), Gaps = 19/103 (18%)
Query: 378 QQYNQLSNLPPA-----------IYLANNSLSGNIPVEIGQLKSLHVLDLSNNNFSGTIP 426
++++P + L NN + ++ L + L+ N + I
Sbjct: 138 TDNPYMTSIPVNAFQGLCNETLTLKLYNNGFT-SVQGYAFNGTKLDAVYLNKNKYLTVID 196
Query: 427 DE-LSDL-SNLEKLDLSGNHLVGEIPI----SLKGLHFLSSFS 463
+ + S LD+S + +P LK L ++++
Sbjct: 197 KDAFGGVYSGPSLLDVSQTSVT-ALPSKGLEHLKELIARNTWT 238
|
| >2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* Length = 239 | Back alignment and structure |
|---|
Score = 43.5 bits (103), Expect = 1e-04
Identities = 14/86 (16%), Positives = 31/86 (36%), Gaps = 12/86 (13%)
Query: 410 SLHVLDLSNNNFSGTIP-DELSDLSNLEKLDLSGNHLVGEIPI-SLKGLHFLSSFSVAHN 467
S L L + TIP S+L N+ ++ +S + + ++ S L ++ + +
Sbjct: 32 STQTLKLIETHLR-TIPSHAFSNLPNISRIYVSIDVTLQQLESHSFYNLSKVTHIEIRNT 90
Query: 468 NLQGAVPSGGQFDTFPSFSFEGNPEL 493
+ + + P L
Sbjct: 91 RNLTYIDPD---------ALKELPLL 107
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483 | Back alignment and structure |
|---|
Score = 60.8 bits (147), Expect = 1e-09
Identities = 56/262 (21%), Positives = 95/262 (36%), Gaps = 42/262 (16%)
Query: 615 IGCGGFGLVYKAT-LANGTTLAIKKLSGDLGLMEREFKAEVEALSTAQHKNLV-SLQGYC 672
IG G FG +Y T + +AIK + + E + Q + +++ +
Sbjct: 15 IGSGSFGEIYLGTNIQTNEEVAIKLENVKTK--HPQLLYESKIYRILQGGTGIPNVRWFG 72
Query: 673 VHQGFRLLIYSYMENG-SLDYWLHEKADGASQLDWLTRLKIARGTSCGLAYMHQICEPHI 731
V + +L+ + G SL+ L +L T L +A + ++H
Sbjct: 73 VEGDYNVLVMDLL--GPSLED-LFNFCSR--KLSLKTVLMLADQMINRVEFVHSK---SF 124
Query: 732 VHRDIKSSNILL---DDQFEAHLADFGLSRLILPYQTHV------TTELVGTLGYIPPEY 782
+HRDIK N L+ + ++ DFGL++ TH L GT Y
Sbjct: 125 LHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARY----- 179
Query: 783 GQAWVATLRG-------DMYSFGVVMLELLTGKRPVDVLKPKMSRELVGWVLKMRSEGKQ 835
A V T G D+ S G V++ L G P LK ++ + + K
Sbjct: 180 --ASVNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEK----KV 233
Query: 836 DQVFDPILRGKGFDEEMLQVLD 857
+ + +G+ E
Sbjct: 234 ATSIEALC--RGYPTEFASYFH 253
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312 | Back alignment and structure |
|---|
Score = 59.1 bits (143), Expect = 2e-09
Identities = 20/134 (14%), Positives = 43/134 (32%), Gaps = 14/134 (10%)
Query: 359 VDRSYLELPVFVMPSNATNQQYNQLSNLPP-------AIYLANNSLSGNIPVEIGQLKSL 411
++ + +L + + + + + L+ L + +A ++ +L
Sbjct: 116 LEATGPDLNILNLRNVSWATRDAWLAELQQWLKPGLKVLSIAQAHSLNFSCEQVRVFPAL 175
Query: 412 HVLDLSNNNFSGTIPDELS----DLSNLEKLDLSGNH---LVGEIPISLKGLHFLSSFSV 464
LDLS+N G + L+ L L G L +
Sbjct: 176 STLDLSDNPELGERGLISALCPLKFPTLQVLALRNAGMETPSGVCSALAAARVQLQGLDL 235
Query: 465 AHNNLQGAVPSGGQ 478
+HN+L+ A +
Sbjct: 236 SHNSLRDAAGAPSC 249
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312 | Back alignment and structure |
|---|
Score = 58.8 bits (142), Expect = 2e-09
Identities = 32/140 (22%), Positives = 47/140 (33%), Gaps = 12/140 (8%)
Query: 334 NLLSGEFPKELTALPALVSEAANDEVDRSYLELPVFVMPSNATNQQYNQLSNLPPAIYLA 393
N GE P + + +E P V + A + QL L L+
Sbjct: 183 NPELGERGLISALCPLKFPTLQVLALRNAGMETPSGVCSALAAAR--VQLQGL----DLS 236
Query: 394 NNSLSGNIPVEIGQ-LKSLHVLDLSNNNFSGTIPDELSDLSNLEKLDLSGNHLVGEIPIS 452
+NSL L+ L+LS +P L + L LDLS N L P
Sbjct: 237 HNSLRDAAGAPSCDWPSQLNSLNLSFTGLK-QVPKGLP--AKLSVLDLSYNRL-DRNPSP 292
Query: 453 LKGLHFLSSFSVAHNNLQGA 472
L + + S+ N +
Sbjct: 293 D-ELPQVGNLSLKGNPFLDS 311
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312 | Back alignment and structure |
|---|
Score = 56.8 bits (137), Expect = 1e-08
Identities = 27/117 (23%), Positives = 41/117 (35%), Gaps = 14/117 (11%)
Query: 368 VFVMPSNATNQQYNQLSNLPPAIYLANNSLSGNIPVEI----GQLKSLHVLDLSNNNF-- 421
+ + LS L L++N G + + +L VL L N
Sbjct: 161 SLNFSCEQV-RVFPALSTL----DLSDNPELGERGLISALCPLKFPTLQVLALRNAGMET 215
Query: 422 -SGTIPDELSDLSNLEKLDLSGNHLVGEIP-ISLKGLHFLSSFSVAHNNLQGAVPSG 476
SG + L+ LDLS N L S L+S +++ L+ VP G
Sbjct: 216 PSGVCSALAAARVQLQGLDLSHNSLRDAAGAPSCDWPSQLNSLNLSFTGLK-QVPKG 271
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312 | Back alignment and structure |
|---|
Score = 56.8 bits (137), Expect = 1e-08
Identities = 19/141 (13%), Positives = 40/141 (28%), Gaps = 38/141 (26%)
Query: 364 LELPVFVMPSNATNQQYNQLSNLPPAIYLANNSLSGNIPVEIGQL--------------- 408
+P ++ + L L L N ++G P + +
Sbjct: 78 ARIPSRILFGALRVLGISGLQEL----TLENLEVTGTAPPPLLEATGPDLNILNLRNVSW 133
Query: 409 ---------------KSLHVLDLSNNNFSGTIPDELSDLSNLEKLDLSGNHLVGEIPIS- 452
L VL ++ + +++ L LDLS N +GE +
Sbjct: 134 ATRDAWLAELQQWLKPGLKVLSIAQAHSLNFSCEQVRVFPALSTLDLSDNPELGERGLIS 193
Query: 453 ---LKGLHFLSSFSVAHNNLQ 470
L ++ + ++
Sbjct: 194 ALCPLKFPTLQVLALRNAGME 214
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312 | Back alignment and structure |
|---|
Score = 44.9 bits (106), Expect = 7e-05
Identities = 14/94 (14%), Positives = 29/94 (30%), Gaps = 5/94 (5%)
Query: 383 LSNLPPAIYLANNSLSGNIPVEIGQLKSLHVLDLSNNNFSGTIPDELS---DLSNLEKLD 439
+L + + +I + SL L + I +S L++L
Sbjct: 42 GRSLEYLLKRVDTEADLGQFTDIIKSLSLKRLTVRAARIPSRILFGALRVLGISGLQELT 101
Query: 440 LSGNHLVGEIPISLKGLHF--LSSFSVAHNNLQG 471
L + G P L L+ ++ + +
Sbjct: 102 LENLEVTGTAPPPLLEATGPDLNILNLRNVSWAT 135
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457 | Back alignment and structure |
|---|
Score = 59.7 bits (145), Expect = 2e-09
Identities = 18/96 (18%), Positives = 32/96 (33%), Gaps = 11/96 (11%)
Query: 380 YNQLSNLPPA-----IYLANNSLSGNIPVEIGQLKSLHVLDLSNNNFSGTIPDELSDLSN 434
L + IY +++ L++LD + + LS
Sbjct: 263 QTDLLEIDLTHNTQLIYFQAEGCRKIKELDVTHNTQLYLLDCQAAGIT-ELD--LSQNPK 319
Query: 435 LEKLDLSGNHLVGEIPISLKGLHFLSSFSVAHNNLQ 470
L L L+ L E+ +S L S S + ++Q
Sbjct: 320 LVYLYLNNTELT-ELDVS--HNTKLKSLSCVNAHIQ 352
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457 | Back alignment and structure |
|---|
Score = 59.3 bits (144), Expect = 3e-09
Identities = 14/99 (14%), Positives = 39/99 (39%), Gaps = 17/99 (17%)
Query: 379 QYNQLSNLPP--------AIYLANNSLSGNIPVEIGQLKSLHVLDLSNNNFSGTIPDELS 430
+ ++++ + +N+++ +++ Q +L L +N + + ++
Sbjct: 50 HNSSITDMTGIEKLTGLTKLICTSNNITT---LDLSQNTNLTYLACDSNKLT-NLD--VT 103
Query: 431 DLSNLEKLDLSGNHLVGEIPISLKGLHFLSSFSVAHNNL 469
L+ L L+ N L + + L+ + A N L
Sbjct: 104 PLTKLTYLNCDTNKL---TKLDVSQNPLLTYLNCARNTL 139
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457 | Back alignment and structure |
|---|
Score = 57.8 bits (140), Expect = 9e-09
Identities = 19/100 (19%), Positives = 36/100 (36%), Gaps = 9/100 (9%)
Query: 373 SNATNQQYNQL---SNLPPAIYLANNSLSGNIPVEIGQLKSLHVLDLSNNNFSGTIPDEL 429
Q +N N + A + + QL +L LD N++ + +
Sbjct: 4 KAGQTQSFNDWFPDDNFASEV-AAAFEMQATDTISEEQLATLTSLDCHNSSITDM--TGI 60
Query: 430 SDLSNLEKLDLSGNHLVGEIPISLKGLHFLSSFSVAHNNL 469
L+ L KL + N++ + +S L+ + N L
Sbjct: 61 EKLTGLTKLICTSNNIT-TLDLS--QNTNLTYLACDSNKL 97
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457 | Back alignment and structure |
|---|
Score = 57.4 bits (139), Expect = 1e-08
Identities = 19/98 (19%), Positives = 34/98 (34%), Gaps = 16/98 (16%)
Query: 379 QYNQLSNLPPA-------IYLANNSLSGNIPVEIGQLKSLHVLDLSNNNFSGTIPDELSD 431
N ++ L + ++N L+ +++ L L D S N + + +S
Sbjct: 199 DTNNITKLDLNQNIQLTFLDCSSNKLTE---IDVTPLTQLTYFDCSVNPLT-ELD--VST 252
Query: 432 LSNLEKLDLSGNHLVGEIPISLKGLHFLSSFSVAHNNL 469
LS L L L+ EI ++ L F
Sbjct: 253 LSKLTTLHCIQTDLL-EIDLT--HNTQLIYFQAEGCRK 287
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457 | Back alignment and structure |
|---|
Score = 56.2 bits (136), Expect = 2e-08
Identities = 15/98 (15%), Positives = 34/98 (34%), Gaps = 15/98 (15%)
Query: 380 YNQLSNLPPA-------IYLANNSLSGNIPVEIGQLKSLHVLDLSNNNFSGTIPDELSDL 432
N L+ + + + N + + L LD S N + + +S
Sbjct: 136 RNTLTEIDVSHNTQLTELDCHLNKKITKLD--VTPQTQLTTLDCSFNKIT-ELD--VSQN 190
Query: 433 SNLEKLDLSGNHLVGEIPISLKGLHFLSSFSVAHNNLQ 470
L +L+ N++ ++ ++ L+ + N L
Sbjct: 191 KLLNRLNCDTNNIT-KLDLN--QNIQLTFLDCSSNKLT 225
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457 | Back alignment and structure |
|---|
Score = 55.8 bits (135), Expect = 4e-08
Identities = 18/98 (18%), Positives = 40/98 (40%), Gaps = 15/98 (15%)
Query: 379 QYNQLSNLPPA-------IYLANNSLSGNIPVEIGQLKSLHVLDLSNNNFSGTIPDELSD 431
N+L+NL + N L+ +++ Q L L+ + N + I +S
Sbjct: 93 DSNKLTNLDVTPLTKLTYLNCDTNKLT---KLDVSQNPLLTYLNCARNTLT-EID--VSH 146
Query: 432 LSNLEKLDLSGNHLVGEIPISLKGLHFLSSFSVAHNNL 469
+ L +LD N + ++ ++ L++ + N +
Sbjct: 147 NTQLTELDCHLNKKITKLDVT--PQTQLTTLDCSFNKI 182
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457 | Back alignment and structure |
|---|
Score = 48.1 bits (115), Expect = 1e-05
Identities = 19/130 (14%), Positives = 45/130 (34%), Gaps = 24/130 (18%)
Query: 380 YNQLSNLPPA-------IYLANNSLSGNIPVEIGQLKSLHVLDLSNNNFSGTIPDELSDL 432
+L+ L + + N + + +G++ +L+ + + L++
Sbjct: 327 NTELTELDVSHNTKLKSLSCVNAHIQ-DFS-SVGKIPALNNNFEAEGQTITMPKETLTNN 384
Query: 433 S-----NLEKLDLSGNHLVGEIPISLKGLHFLSSFSVAHNNLQGAVPS--------GGQF 479
S + + LD GN + I G++ ++ ++ NL P+ G
Sbjct: 385 SLTIAVSPDLLDQFGNPM--NIEPGDGGVYDQATNTITWENLSTDNPAVTYTFTSENGAI 442
Query: 480 DTFPSFSFEG 489
+ FE
Sbjct: 443 VGTVTTPFEA 452
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 59.1 bits (143), Expect = 4e-09
Identities = 26/113 (23%), Positives = 40/113 (35%), Gaps = 11/113 (9%)
Query: 379 QYNQLSNLPPAI-------YLANNSLSGNIPVEIGQLKSLHVLDLSNNNFSGTIPDELSD 431
N L ++P + ++ N +S +I L L +L +S+N
Sbjct: 8 SKNGLIHVPKDLSQKTTILNISQNYISELWTSDILSLSKLRILIISHNRIQYLDISVFKF 67
Query: 432 LSNLEKLDLSGNHLVGEIPISLKGLHFLSSFSVAHNNLQGAVPSGGQFDTFPS 484
LE LDLS N LV L L ++ N A+P +F
Sbjct: 68 NQELEYLDLSHNKLVKISCHPTVNLKHL---DLSFNAFD-ALPICKEFGNMSQ 116
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 55.3 bits (133), Expect = 6e-08
Identities = 24/129 (18%), Positives = 42/129 (32%), Gaps = 20/129 (15%)
Query: 364 LELPVFVMPSNAT--NQQYNQLSNLPPAI----------YLANNSLSGNIPVEIG---QL 408
+ + S + N L++ L N L + Q+
Sbjct: 315 VHMLCPSKISPFLHLDFSNNLLTDTVFENCGHLTELETLILQMNQLK-ELSKIAEMTTQM 373
Query: 409 KSLHVLDLSNNNFSGTIPDELSD-LSNLEKLDLSGNHLVGEIPISLKGLHFLSSFSVAHN 467
KSL LD+S N+ S +L L++S N L I L + + N
Sbjct: 374 KSLQQLDISQNSVSYDEKKGDCSWTKSLLSLNMSSNILTDTIFRCL--PPRIKVLDLHSN 431
Query: 468 NLQGAVPSG 476
++ ++P
Sbjct: 432 KIK-SIPKQ 439
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 51.8 bits (124), Expect = 8e-07
Identities = 21/119 (17%), Positives = 41/119 (34%), Gaps = 11/119 (9%)
Query: 379 QYNQLSNLPPA-------IYLANNSLSGNIPV--EIGQLKSLHVLDLSNNNFSGTIPDEL 429
+N+L + + L+ N+ +P+ E G + L L LS + + +
Sbjct: 77 SHNKLVKISCHPTVNLKHLDLSFNAFD-ALPICKEFGNMSQLKFLGLSTTHLEKSSVLPI 135
Query: 430 SDLSNLE-KLDLSGNHLVGEIPISLKGLHFLSSFSVAHNNLQGAVPSGGQFDTFPSFSF 487
+ L+ + L L + E P L+ + S V N + T +
Sbjct: 136 AHLNISKVLLVLGETYGEKEDPEGLQDFNTESLHIVFPTNKEFHFILDVSVKTVANLEL 194
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 48.7 bits (116), Expect = 7e-06
Identities = 17/78 (21%), Positives = 34/78 (43%), Gaps = 14/78 (17%)
Query: 379 QYNQLSNLPPA-----------IYLANNSLSGNIPVEIGQLKSLHVLDLSNNNFSGTIPD 427
N +S + +++N L+ I + + VLDL +N +IP
Sbjct: 382 SQNSVSYDEKKGDCSWTKSLLSLNMSSNILTDTIFRCL--PPRIKVLDLHSNKIK-SIPK 438
Query: 428 ELSDLSNLEKLDLSGNHL 445
++ L L++L+++ N L
Sbjct: 439 QVVKLEALQELNVASNQL 456
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 47.9 bits (114), Expect = 1e-05
Identities = 18/144 (12%), Positives = 39/144 (27%), Gaps = 2/144 (1%)
Query: 341 PKELTALPALVSEAANDEVDRSYLELPVFVMPSNATNQQYNQLSNLPPAIYLANNSLSGN 400
+ LV S ++L + + L L + ++
Sbjct: 234 WNSFIRILQLVWHTTVWYFSISNVKLQ-GQLDFRDFDYSGTSLKALS-IHQVVSDVFGFP 291
Query: 401 IPVEIGQLKSLHVLDLSNNNFSGTIPDELSDLSNLEKLDLSGNHLVGEIPISLKGLHFLS 460
++++ + + + S +S LD S N L + + L L
Sbjct: 292 QSYIYEIFSNMNIKNFTVSGTRMVHMLCPSKISPFLHLDFSNNLLTDTVFENCGHLTELE 351
Query: 461 SFSVAHNNLQGAVPSGGQFDTFPS 484
+ + N L+ S
Sbjct: 352 TLILQMNQLKELSKIAEMTTQMKS 375
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 47.6 bits (113), Expect = 1e-05
Identities = 17/74 (22%), Positives = 38/74 (51%), Gaps = 11/74 (14%)
Query: 379 QYNQLSNLPPA--------IYLANNSLSGNIPVEIGQLKSLHVLDLSNNNFSGTIPDE-L 429
N L++ + L +N + +IP ++ +L++L L++++N ++PD
Sbjct: 407 SSNILTDTIFRCLPPRIKVLDLHSNKIK-SIPKQVVKLEALQELNVASNQLK-SVPDGIF 464
Query: 430 SDLSNLEKLDLSGN 443
L++L+K+ L N
Sbjct: 465 DRLTSLQKIWLHTN 478
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330 | Back alignment and structure |
|---|
Score = 57.8 bits (140), Expect = 6e-09
Identities = 51/235 (21%), Positives = 84/235 (35%), Gaps = 52/235 (22%)
Query: 615 IGCGGFGLVYKAT-LANGTTLAIK--KLSGDLGLMEREFKAEVEALSTAQHKNLVSLQG- 670
IGCG FG + L +AIK + + E++ +K L S G
Sbjct: 17 IGCGNFGELRLGKNLYTNEYVAIKLEPMKSRAPQLHLEYRF---------YKQLGSGDGI 67
Query: 671 -----YCVHQGFRLLIYSYMENG-SLDYWLHEKADGASQLDWLTRLKIARGTSCGLAYMH 724
+ + ++ + G SL+ L + D T L IA + Y+H
Sbjct: 68 PQVYYFGPCGKYNAMVLELL--GPSLED-LFDLCDR--TFSLKTVLMIAIQLISRMEYVH 122
Query: 725 QICEPHIVHRDIKSSNILL-----DDQFEAHLADFGLSRLILPYQTHV------TTELVG 773
++++RD+K N L+ Q H+ DF L++ + +T L G
Sbjct: 123 SK---NLIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKEYIDPETKKHIPYREHKSLTG 179
Query: 774 TLGYIPPEYGQAWVATLRG-------DMYSFGVVMLELLTGKRPVDVLKPKMSRE 821
T Y + T G D+ + G + + L G P LK +E
Sbjct: 180 TARY-------MSINTHLGKEQSRRDDLEALGHMFMYFLRGSLPWQGLKADTLKE 227
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373 | Back alignment and structure |
|---|
Score = 58.2 bits (141), Expect = 6e-09
Identities = 48/227 (21%), Positives = 86/227 (37%), Gaps = 52/227 (22%)
Query: 614 IIGCGGFGLVYKAT-LANGTTLAIK-----KLSGDLGLMEREF-----KAEVEALSTAQH 662
+G G F V+ A + N T +A+K K+ + E + A+ +
Sbjct: 26 KLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAEDEIKLLQRVNDADNTKEDSMGA 85
Query: 663 KNLVSLQGYCVHQG---------FRLLIYSYMENGSLDYWLHEKADGASQLDWLTRLKIA 713
+++ L + H+G F +L +L + + L + +I+
Sbjct: 86 NHILKLLDHFNHKGPNGVHVVMVFEVL------GENLLALIKKYEHRGIPLI-YVK-QIS 137
Query: 714 RGTSCGLAYMHQICEPHIVHRDIKSSNILLDDQFEAH------LADFGLSRLILPYQTHV 767
+ GL YMH+ C I+H DIK N+L++ +AD G + +
Sbjct: 138 KQLLLGLDYMHRRC--GIIHTDIKPENVLMEIVDSPENLIQIKIADLGNAC----WYDEH 191
Query: 768 TTELVGTLGYIPPE------YGQAWVATLRGDMYSFGVVMLELLTGK 808
T + T Y PE +G D++S ++ EL+TG
Sbjct: 192 YTNSIQTREYRSPEVLLGAPWGCG------ADIWSTACLIFELITGD 232
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 57.4 bits (139), Expect = 8e-09
Identities = 25/111 (22%), Positives = 41/111 (36%), Gaps = 15/111 (13%)
Query: 379 QYNQLSNLPPA----------IYLANNSLSGNIPVEI-GQLKSLHVLDLSNNNFSGTIPD 427
N+++ + + + L +N ++ I + L SL LDLS N S +
Sbjct: 60 SNNRITYISNSDLQRCVNLQALVLTSNGIN-TIEEDSFSSLGSLEHLDLSYNYLS-NLSS 117
Query: 428 EL-SDLSNLEKLDLSGNHLVGEIPISL-KGLHFLSSFSVAHNNLQGAVPSG 476
LS+L L+L GN SL L L V + + +
Sbjct: 118 SWFKPLSSLTFLNLLGNPYKTLGETSLFSHLTKLQILRVGNMDTFTKIQRK 168
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 54.0 bits (130), Expect = 1e-07
Identities = 15/121 (12%), Positives = 36/121 (29%), Gaps = 17/121 (14%)
Query: 379 QYNQLSNLPPA-----------IYLANNSLSGNIPVEI-GQLKSLHVLDLSNNNFSGTIP 426
N L + + N I + L L L++ ++ +
Sbjct: 132 LGNPYKTLGETSLFSHLTKLQILRVGNMDTFTKIQRKDFAGLTFLEELEIDASDLQ-SYE 190
Query: 427 DE-LSDLSNLEKLDLSGNHLVGEIPISLKGLHFLSSFSVAHNNL---QGAVPSGGQFDTF 482
+ L + N+ L L + + I + + + +L + S G+ ++
Sbjct: 191 PKSLKSIQNVSHLILHMKQHILLLEIFVDVTSSVECLELRDTDLDTFHFSELSTGETNSL 250
Query: 483 P 483
Sbjct: 251 I 251
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 49.0 bits (117), Expect = 3e-06
Identities = 20/135 (14%), Positives = 37/135 (27%), Gaps = 26/135 (19%)
Query: 379 QYNQLSNLPPA----------IYLANNSLSGNIPVEI-GQLKSLHVLDLSNNNFSGT--- 424
+ L + P + L + S+ L+L + +
Sbjct: 182 DASDLQSYEPKSLKSIQNVSHLILHMKQHI-LLLEIFVDVTSSVECLELRDTDLDTFHFS 240
Query: 425 -----IPDELSDLSNLEKLDLSGNHLVGEIPISLKGLHFLSSFSVAHNNLQGAVPSGGQF 479
+ L + ++ L ++ L + L + N L+ VP G F
Sbjct: 241 ELSTGETNSLIKKFTFRNVKITDESLF-QVMKLLNQISGLLELEFSRNQLKS-VPD-GIF 297
Query: 480 DTFPS---FSFEGNP 491
D S NP
Sbjct: 298 DRLTSLQKIWLHTNP 312
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 47.4 bits (113), Expect = 1e-05
Identities = 16/80 (20%), Positives = 31/80 (38%), Gaps = 11/80 (13%)
Query: 376 TNQQYNQLSN-----LPPAIYLANNSLSGN----IPVEIGQLKSLHVLDLSNNNFSGTIP 426
+++LS L N ++ + + Q+ L L+ S N ++P
Sbjct: 235 DTFHFSELSTGETNSLIKKFTFRNVKITDESLFQVMKLLNQISGLLELEFSRNQLK-SVP 293
Query: 427 DE-LSDLSNLEKLDLSGNHL 445
D L++L+K+ L N
Sbjct: 294 DGIFDRLTSLQKIWLHTNPW 313
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 47.4 bits (113), Expect = 1e-05
Identities = 23/84 (27%), Positives = 39/84 (46%), Gaps = 6/84 (7%)
Query: 394 NNSLSGNIPVEIGQLKSLHVLDLSNNNFSGTIPDELSDLSNLEKLDLSGNHLVGEIPI-S 452
+ SL+ +IP + +++ LDLSNN + +L NL+ L L+ N + I S
Sbjct: 40 SGSLN-SIPSGL--TEAVKSLDLSNNRITYISNSDLQRCVNLQALVLTSNGIN-TIEEDS 95
Query: 453 LKGLHFLSSFSVAHNNLQGAVPSG 476
L L +++N L + S
Sbjct: 96 FSSLGSLEHLDLSYNYLS-NLSSS 118
|
| >2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Length = 276 | Back alignment and structure |
|---|
Score = 56.1 bits (136), Expect = 1e-08
Identities = 25/115 (21%), Positives = 41/115 (35%), Gaps = 17/115 (14%)
Query: 379 QYNQLSNLPPA----------IYLANNSLSGNIPVEI-GQLKSLHVLDLSNNNFSGTIPD 427
+N L +L + L+ + I L L L L+ N ++
Sbjct: 36 SFNPLRHLGSYSFFSFPELQVLDLSRCEIQ-TIEDGAYQSLSHLSTLILTGNPIQ-SLAL 93
Query: 428 EL-SDLSNLEKLDLSGNHLVGEIP-ISLKGLHFLSSFSVAHNNLQGAVPSGGQFD 480
S LS+L+KL +L + + L L +VAHN +Q + F
Sbjct: 94 GAFSGLSSLQKLVAVETNLA-SLENFPIGHLKTLKELNVAHNLIQ-SFKLPEYFS 146
|
| >2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Length = 276 | Back alignment and structure |
|---|
Score = 48.0 bits (115), Expect = 5e-06
Identities = 32/135 (23%), Positives = 50/135 (37%), Gaps = 29/135 (21%)
Query: 379 QYNQLSNLPPAI----------YLANNSLSGNIPVEIG---QLKSLHVLDLSNNNFSGTI 425
L++L +A+N + + + L +L LDLS+N +I
Sbjct: 108 VETNLASLENFPIGHLKTLKELNVAHNLIQ-SFKLP-EYFSNLTNLEHLDLSSNKIQ-SI 164
Query: 426 PDE-LSDLSNLE----KLDLSGNHLVGEIPI-SLKGLHFLSSFSVAHNNLQGAVPSGGQF 479
L L + LDLS N + I + K + L ++ N L+ +VP G F
Sbjct: 165 YCTDLRVLHQMPLLNLSLDLSLNPM-NFIQPGAFKEIR-LKELALDTNQLK-SVPDGI-F 220
Query: 480 DTFPSFSF---EGNP 491
D S NP
Sbjct: 221 DRLTSLQKIWLHTNP 235
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308 | Back alignment and structure |
|---|
Score = 55.5 bits (134), Expect = 3e-08
Identities = 21/98 (21%), Positives = 39/98 (39%), Gaps = 14/98 (14%)
Query: 380 YNQLSNLPP--------AIYLANNSLSGNIPVEIGQLKSLHVLDLSNNNFSGTIPDELSD 431
N L N+ + L + ++ P + L +L VL L N + P L+
Sbjct: 94 GNPLKNVSAIAGLQSIKTLDLTSTQITDVTP--LAGLSNLQVLYLDLNQITNISP--LAG 149
Query: 432 LSNLEKLDLSGNHLVGEIPISLKGLHFLSSFSVAHNNL 469
L+NL+ L + + ++ L L L++ N +
Sbjct: 150 LTNLQYLSIGNAQVS-DLT-PLANLSKLTTLKADDNKI 185
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308 | Back alignment and structure |
|---|
Score = 53.2 bits (128), Expect = 1e-07
Identities = 16/98 (16%), Positives = 39/98 (39%), Gaps = 14/98 (14%)
Query: 380 YNQLSNLPP--------AIYLANNSLSGNIPVEIGQLKSLHVLDLSNNNFSGTIPDELSD 431
++ + + L +N ++ ++ + L + L+LS N ++
Sbjct: 50 GTGVTTIEGVQYLNNLIGLELKDNQIT-DLA-PLKNLTKITELELSGNPL--KNVSAIAG 105
Query: 432 LSNLEKLDLSGNHLVGEIPISLKGLHFLSSFSVAHNNL 469
L +++ LDL+ + ++ L GL L + N +
Sbjct: 106 LQSIKTLDLTSTQI-TDVT-PLAGLSNLQVLYLDLNQI 141
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308 | Back alignment and structure |
|---|
Score = 52.8 bits (127), Expect = 2e-07
Identities = 20/89 (22%), Positives = 35/89 (39%), Gaps = 12/89 (13%)
Query: 379 QYNQLSNLPP--------AIYLANNSLSGNIPVEIGQLKSLHVLDLSNNNFSGTIPDELS 430
Q+S+L P + +N +S +I + L +L + L NN S P L+
Sbjct: 159 GNAQVSDLTPLANLSKLTTLKADDNKIS-DIS-PLASLPNLIEVHLKNNQISDVSP--LA 214
Query: 431 DLSNLEKLDLSGNHLVGEIPISLKGLHFL 459
+ SNL + L+ + + L
Sbjct: 215 NTSNLFIVTLTNQTITNQPVFYNNNLVVP 243
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308 | Back alignment and structure |
|---|
Score = 50.1 bits (120), Expect = 2e-06
Identities = 19/100 (19%), Positives = 36/100 (36%), Gaps = 11/100 (11%)
Query: 375 ATNQQYNQLSNLPP-----AIYLANNSLSGNIPVEIGQLKSLHVLDLSNNNFSGTIPDEL 429
N + P I ++++ V L + L + TI +
Sbjct: 4 TQPTAINVIFPDPALANAIKIAAGKSNVTD--TVTQADLDGITTLSAFGTGVT-TIE-GV 59
Query: 430 SDLSNLEKLDLSGNHLVGEIPISLKGLHFLSSFSVAHNNL 469
L+NL L+L N + ++ LK L ++ ++ N L
Sbjct: 60 QYLNNLIGLELKDNQIT-DLA-PLKNLTKITELELSGNPL 97
|
| >2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A Length = 149 | Back alignment and structure |
|---|
Score = 52.4 bits (126), Expect = 4e-08
Identities = 25/82 (30%), Positives = 37/82 (45%), Gaps = 9/82 (10%)
Query: 390 IYLANNSLS--GNIPVEIGQLKSLHVLDLSNNNFSGTIPDELSDLSNLEKLDLSGNHL-- 445
+ N L+ N+P +L L L+LS+N SG + NL L+LSGN +
Sbjct: 47 LSTINVGLTSIANLP----KLNKLKKLELSDNRVSGGLEVLAEKCPNLTHLNLSGNKIKD 102
Query: 446 VGEIPISLKGLHFLSSFSVAHN 467
+ I LK L L S + +
Sbjct: 103 LSTI-EPLKKLENLKSLDLFNC 123
|
| >2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A Length = 149 | Back alignment and structure |
|---|
Score = 49.3 bits (118), Expect = 4e-07
Identities = 20/95 (21%), Positives = 44/95 (46%), Gaps = 7/95 (7%)
Query: 377 NQQYNQLSNLPPAIYLANNSLS-GNIPVEIGQLKSLHVLDLSNNNFSGTIPDELSDLSNL 435
N+ + + L L N+ + G + + + L L N + +I + L L+ L
Sbjct: 13 NRTPSDVKEL----VLDNSRSNEGKLEGLTDEFEELEFLSTINVGLT-SIAN-LPKLNKL 66
Query: 436 EKLDLSGNHLVGEIPISLKGLHFLSSFSVAHNNLQ 470
+KL+LS N + G + + + L+ +++ N ++
Sbjct: 67 KKLELSDNRVSGGLEVLAEKCPNLTHLNLSGNKIK 101
|
| >2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Length = 361 | Back alignment and structure |
|---|
Score = 55.2 bits (133), Expect = 4e-08
Identities = 31/145 (21%), Positives = 49/145 (33%), Gaps = 37/145 (25%)
Query: 342 KELTALPALVSEAANDEVDRSYLELPVFVMPSNATNQQYNQLSNLPPAIYLANNSLSGNI 401
++L +P + + L+L +N LS L
Sbjct: 28 QQLPNVPQSLP------SYTALLDL------------SHNNLSRLRAEWTPTR------- 62
Query: 402 PVEIGQLKSLHVLDLSNNNFSGTIPDE-LSDLSNLEKLDLSGNHLVGEIPI-SLKGLHFL 459
L +LH L LS+N+ + I E + NL LDLS NHL + L L
Sbjct: 63 ------LTNLHSLLLSHNHLN-FISSEAFVPVPNLRYLDLSSNHLH-TLDEFLFSDLQAL 114
Query: 460 SSFSVAHNNLQGAVPSGGQFDTFPS 484
+ +N++ V F+
Sbjct: 115 EVLLLYNNHIV-VVDR-NAFEDMAQ 137
|
| >2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Length = 361 | Back alignment and structure |
|---|
Score = 54.1 bits (130), Expect = 1e-07
Identities = 27/106 (25%), Positives = 34/106 (32%), Gaps = 18/106 (16%)
Query: 379 QYNQLSNLPPAI----------YLANNSLSGNIPVEI-GQLKSLHVLDLSNNNFSGTIPD 427
N L L + L NN + + + L L LS N S P
Sbjct: 96 SSNHLHTLDEFLFSDLQALEVLLLYNNHIV-VVDRNAFEDMAQLQKLYLSQNQIS-RFPV 153
Query: 428 E----LSDLSNLEKLDLSGNHLVGEIPISLKGLHFLSSFSVA-HNN 468
E + L L LDLS N L L+ L + HNN
Sbjct: 154 ELIKDGNKLPKLMLLDLSSNKLKKLPLTDLQKLPAWVKNGLYLHNN 199
|
| >2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Length = 361 | Back alignment and structure |
|---|
Score = 42.5 bits (100), Expect = 4e-04
Identities = 22/83 (26%), Positives = 32/83 (38%), Gaps = 17/83 (20%)
Query: 379 QYNQLSNLPPA----------IYLANNSLSGNIPVEI----GQLKSLHVLDLSNNNFSGT 424
N + + +YL+ N +S PVE+ +L L +LDLS+N
Sbjct: 120 YNNHIVVVDRNAFEDMAQLQKLYLSQNQIS-RFPVELIKDGNKLPKLMLLDLSSNKLKKL 178
Query: 425 IPDELSDLSNLEK--LDLSGNHL 445
+L L K L L N L
Sbjct: 179 PLTDLQKLPAWVKNGLYLHNNPL 201
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562 | Back alignment and structure |
|---|
Score = 55.6 bits (134), Expect = 5e-08
Identities = 26/117 (22%), Positives = 45/117 (38%), Gaps = 20/117 (17%)
Query: 379 QYNQLSNLPPAI----------YLANNSLSGNIPVEIGQLKSLHVLDLSNNNFSGTIPD- 427
+N++ +L + +++N L NI + SL LDLS N+F +P
Sbjct: 84 SHNRIRSLDFHVFLFNQDLEYLDVSHNRLQ-NIS--CCPMASLRHLDLSFNDFD-VLPVC 139
Query: 428 -ELSDLSNLEKLDLSGNHLVGEIPISLKGLHFLSSFSVAHNNLQGAVPSGGQFDTFP 483
E +L+ L L LS + + LH +L GG+ ++
Sbjct: 140 KEFGNLTKLTFLGLSAAKFRQLDLLPVAHLHLSCILL----DLVSYHIKGGETESLQ 192
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562 | Back alignment and structure |
|---|
Score = 46.8 bits (111), Expect = 2e-05
Identities = 22/95 (23%), Positives = 43/95 (45%), Gaps = 19/95 (20%)
Query: 367 PVFVMPSNATN--QQYNQLSNLPPAI--------------YLANNSLSGNIPVEIGQLKS 410
V +M N ++ L++L L++N L+G++ +
Sbjct: 394 KVALMTKNMSSLETLDVSLNSLNSHAYDRTCAWAESILVLNLSSNMLTGSVFRCLPP--K 451
Query: 411 LHVLDLSNNNFSGTIPDELSDLSNLEKLDLSGNHL 445
+ VLDL NN +IP +++ L L++L+++ N L
Sbjct: 452 VKVLDLHNNRIM-SIPKDVTHLQALQELNVASNQL 485
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562 | Back alignment and structure |
|---|
Score = 46.8 bits (111), Expect = 3e-05
Identities = 17/86 (19%), Positives = 31/86 (36%), Gaps = 6/86 (6%)
Query: 380 YNQLSNLPPAIYLANNSLSGNIPVEIGQLKSLHVLDLSNNNFSGTIPDELSDLSNLEKLD 439
Y+ + + L+ + V S L+ + N F+ ++ S L L+ L
Sbjct: 325 YSVFAEMN-IKMLSISDTPFIHMVCPPSPSSFTFLNFTQNVFTDSVFQGCSTLKRLQTLI 383
Query: 440 LSGNHL-----VGEIPISLKGLHFLS 460
L N L V + ++ L L
Sbjct: 384 LQRNGLKNFFKVALMTKNMSSLETLD 409
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562 | Back alignment and structure |
|---|
Score = 42.9 bits (101), Expect = 4e-04
Identities = 12/101 (11%), Positives = 28/101 (27%), Gaps = 2/101 (1%)
Query: 391 YLANNSLSGNIPVEIGQLKSLHVLDLSNNNFSGTIPDELSD-LSNLEKLDLSGNHLVGEI 449
++ N + +++ LS ++ + I S+ L+ + N +
Sbjct: 311 HVKNQVFLFSKEALYSVFAEMNIKMLSISD-TPFIHMVCPPSPSSFTFLNFTQNVFTDSV 369
Query: 450 PISLKGLHFLSSFSVAHNNLQGAVPSGGQFDTFPSFSFEGN 490
L L + + N L+ S
Sbjct: 370 FQGCSTLKRLQTLILQRNGLKNFFKVALMTKNMSSLETLDV 410
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397 | Back alignment and structure |
|---|
Score = 53.4 bits (128), Expect = 2e-07
Identities = 49/257 (19%), Positives = 79/257 (30%), Gaps = 94/257 (36%)
Query: 711 KIARGTSCGLAYMHQICEPHIVHRDIKSSNILL--------------------------- 743
KI + GL Y+H C I+H DIK NILL
Sbjct: 150 KIIQQVLQGLDYLHTKC--RIIHTDIKPENILLSVNEQYIRRLAAEATEWQRSGAPPPSG 207
Query: 744 ----------------------DDQFEAHLADFGLSRLILPYQTHVTTELVGTLGYIPPE 781
++ + +AD G + + TE + T Y E
Sbjct: 208 SAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNAC----WVHKHFTEDIQTRQYRSLE 263
Query: 782 --YGQAWVATLRGDMYSFGVVMLELLTGKRP-------------------VDVLKPKMSR 820
G + D++S + EL TG +++L + R
Sbjct: 264 VLIGSGY--NTPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGK-VPR 320
Query: 821 ELV-GW-----------VLKMRSEGKQDQVFDPILRGKGFD-EEMLQVLDVACMCVSQNP 867
+L+ LK ++ K +F+ ++ + EE D + P
Sbjct: 321 KLIVAGKYSKEFFTKKGDLKHITKLKPWGLFEVLVEKYEWSQEEAAGFTDFLLPMLELIP 380
Query: 868 FKRPTVKEVV--EWLNN 882
KR T E + WLN+
Sbjct: 381 EKRATAAECLRHPWLNS 397
|
| >1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A Length = 290 | Back alignment and structure |
|---|
Score = 52.4 bits (126), Expect = 2e-07
Identities = 31/108 (28%), Positives = 51/108 (47%), Gaps = 14/108 (12%)
Query: 379 QYNQLSNLPP--------AIYLANNSLSGNIPVEIGQLKSLHVLDLSNNNFSGTIPDELS 430
+L+ L + L++N L ++P+ L +L VLD+S N + ++P
Sbjct: 63 DRAELTKLQVDGTLPVLGTLDLSHNQLQ-SLPLLGQTLPALTVLDVSFNRLT-SLPLGAL 120
Query: 431 D-LSNLEKLDLSGNHLVGEIPISL-KGLHFLSSFSVAHNNLQGAVPSG 476
L L++L L GN L +P L L S+A+NNL +P+G
Sbjct: 121 RGLGELQELYLKGNELK-TLPPGLLTPTPKLEKLSLANNNLT-ELPAG 166
|
| >1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A Length = 290 | Back alignment and structure |
|---|
Score = 47.4 bits (113), Expect = 8e-06
Identities = 24/79 (30%), Positives = 35/79 (44%), Gaps = 14/79 (17%)
Query: 379 QYNQLSNLPPAI----------YLANNSLSGNIPVEI-GQLKSLHVLDLSNNNFSGTIPD 427
+N+L++LP YL N L +P + L L L+NNN + +P
Sbjct: 108 SFNRLTSLPLGALRGLGELQELYLKGNELK-TLPPGLLTPTPKLEKLSLANNNLT-ELPA 165
Query: 428 EL-SDLSNLEKLDLSGNHL 445
L + L NL+ L L N L
Sbjct: 166 GLLNGLENLDTLLLQENSL 184
|
| >1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A Length = 290 | Back alignment and structure |
|---|
Score = 47.4 bits (113), Expect = 9e-06
Identities = 23/76 (30%), Positives = 33/76 (43%), Gaps = 13/76 (17%)
Query: 379 QYNQLSNLPPAI----------YLANNSLSGNIPVEI-GQLKSLHVLDLSNNNFSGTIPD 427
+ N+L LPP + LANN+L+ +P + L++L L L N+ TIP
Sbjct: 132 KGNELKTLPPGLLTPTPKLEKLSLANNNLT-ELPAGLLNGLENLDTLLLQENSLY-TIPK 189
Query: 428 ELSDLSNLEKLDLSGN 443
L L GN
Sbjct: 190 GFFGSHLLPFAFLHGN 205
|
| >1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A Length = 290 | Back alignment and structure |
|---|
Score = 41.6 bits (98), Expect = 8e-04
Identities = 23/100 (23%), Positives = 38/100 (38%), Gaps = 20/100 (20%)
Query: 379 QYNQLSNLPPAIYLANNSLSGNIPVEIGQLKSLHVLDLSNNNFSGTIPDELSDLSNLEKL 438
L+ LPP ++P +L LS N L + L +L
Sbjct: 18 DKRNLTALPP-----------DLPK------DTTILHLSENLLYTFSLATLMPYTRLTQL 60
Query: 439 DLSGNHLVGEIPISLKGLHFLSSFSVAHNNLQGAVPSGGQ 478
+L L ++ + L L + ++HN LQ ++P GQ
Sbjct: 61 NLDRAEL-TKLQVD-GTLPVLGTLDLSHNQLQ-SLPLLGQ 97
|
| >1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 Length = 176 | Back alignment and structure |
|---|
Score = 50.8 bits (122), Expect = 2e-07
Identities = 20/83 (24%), Positives = 34/83 (40%), Gaps = 9/83 (10%)
Query: 389 AIYLANNSLS--GNIPVEIGQLKSLHVLDLSNNNFSGTIPDELSDLSNLEKLDLSGNHL- 445
AI ++N + P L+ L L ++NN L +L +L L+ N L
Sbjct: 46 AIDFSDNEIRKLDGFP----LLRRLKTLLVNNNRICRIGEGLDQALPDLTELILTNNSLV 101
Query: 446 -VGEIPISLKGLHFLSSFSVAHN 467
+G++ L L L+ + N
Sbjct: 102 ELGDL-DPLASLKSLTYLCILRN 123
|
| >1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 Length = 176 | Back alignment and structure |
|---|
Score = 46.2 bits (110), Expect = 9e-06
Identities = 16/93 (17%), Positives = 30/93 (32%), Gaps = 4/93 (4%)
Query: 378 QQYNQLSNLPPAIYLANNSLSGNIPVEIGQLKSLHVLDLSNNNFSGTIPDELSDLSNLEK 437
QY + L + I L +D S+N + L L+
Sbjct: 13 AQYTNAVRDR-ELDLRGYKIP-VIENLGATLDQFDAIDFSDNEIR-KLDG-FPLLRRLKT 68
Query: 438 LDLSGNHLVGEIPISLKGLHFLSSFSVAHNNLQ 470
L ++ N + + L L+ + +N+L
Sbjct: 69 LLVNNNRICRIGEGLDQALPDLTELILTNNSLV 101
|
| >2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A Length = 168 | Back alignment and structure |
|---|
Score = 50.1 bits (120), Expect = 3e-07
Identities = 26/82 (31%), Positives = 36/82 (43%), Gaps = 9/82 (10%)
Query: 390 IYLANNSLS--GNIPVEIGQLKSLHVLDLSNNNFSGTIPDELSDLSNLEKLDLSGNHL-- 445
+ L N L N+P +L L L+LS N G + L NL L+LSGN L
Sbjct: 54 LSLINVGLISVSNLP----KLPKLKKLELSENRIFGGLDMLAEKLPNLTHLNLSGNKLKD 109
Query: 446 VGEIPISLKGLHFLSSFSVAHN 467
+ + LK L L S + +
Sbjct: 110 ISTL-EPLKKLECLKSLDLFNC 130
|
| >2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A Length = 168 | Back alignment and structure |
|---|
Score = 45.1 bits (107), Expect = 2e-05
Identities = 23/95 (24%), Positives = 42/95 (44%), Gaps = 7/95 (7%)
Query: 377 NQQYNQLSNLPPAIYLANNSLS-GNIPVEIGQLKSLHVLDLSNNNFSGTIPDELSDLSNL 435
N+ + L L N + G I + +L L L N ++ + L L L
Sbjct: 20 NRTPAAVREL----VLDNCKSNDGKIEGLTAEFVNLEFLSLINVGLI-SVSN-LPKLPKL 73
Query: 436 EKLDLSGNHLVGEIPISLKGLHFLSSFSVAHNNLQ 470
+KL+LS N + G + + + L L+ +++ N L+
Sbjct: 74 KKLELSENRIFGGLDMLAEKLPNLTHLNLSGNKLK 108
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605 | Back alignment and structure |
|---|
Score = 52.8 bits (126), Expect = 4e-07
Identities = 23/100 (23%), Positives = 39/100 (39%), Gaps = 14/100 (14%)
Query: 379 QYNQLSNLPP--------AIYLANNSLSGNIPVEIGQLKSLHVLDLSNNNFSGTIPDELS 430
+ + ++ ++L N L+ +I + LK+L L L N L
Sbjct: 51 NNSDIKSVQGIQYLPNVTKLFLNGNKLT-DIK-PLTNLKNLGWLFLDENKIKDLSS--LK 106
Query: 431 DLSNLEKLDLSGNHLVGEIPISLKGLHFLSSFSVAHNNLQ 470
DL L+ L L N + +I L L L S + +N +
Sbjct: 107 DLKKLKSLSLEHNGIS-DIN-GLVHLPQLESLYLGNNKIT 144
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605 | Back alignment and structure |
|---|
Score = 52.0 bits (124), Expect = 7e-07
Identities = 21/101 (20%), Positives = 40/101 (39%), Gaps = 16/101 (15%)
Query: 380 YNQLSNLPP--------AIYLANNSLSGNIPVEIGQLKSLHVLDLSNNNFSGTIPD--EL 429
N+++++ + L +N +S +I + L L L LS N+ I D L
Sbjct: 140 NNKITDITVLSRLTKLDTLSLEDNQIS-DIV-PLAGLTKLQNLYLSKNH----ISDLRAL 193
Query: 430 SDLSNLEKLDLSGNHLVGEIPISLKGLHFLSSFSVAHNNLQ 470
+ L NL+ L+L + + L ++ +L
Sbjct: 194 AGLKNLDVLELFSQECLNKPINHQSNLVVPNTVKNTDGSLV 234
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605 | Back alignment and structure |
|---|
Score = 52.0 bits (124), Expect = 7e-07
Identities = 20/103 (19%), Positives = 39/103 (37%), Gaps = 14/103 (13%)
Query: 375 ATNQQYNQLSNLPP--------AIYLANNSLSGNIPVEIGQLKSLHVLDLSNNNFSGTIP 426
T + + P L S++ + +L S+ + +N++ ++
Sbjct: 3 ETITVSTPIKQIFPDDAFAETIKDNLKKKSVTDAVTQN--ELNSIDQIIANNSDIK-SV- 58
Query: 427 DELSDLSNLEKLDLSGNHLVGEIPISLKGLHFLSSFSVAHNNL 469
+ L N+ KL L+GN L +I L L L + N +
Sbjct: 59 QGIQYLPNVTKLFLNGNKLT-DIK-PLTNLKNLGWLFLDENKI 99
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605 | Back alignment and structure |
|---|
Score = 46.6 bits (110), Expect = 3e-05
Identities = 20/84 (23%), Positives = 38/84 (45%), Gaps = 10/84 (11%)
Query: 377 NQQYNQLSNLPP--------AIYLANNSLSGNIPVEIGQLKSLHVLDLSNNNFSGTIPDE 428
+ + NQ+S++ P +YL+ N +S ++ + LK+L VL+L + +
Sbjct: 159 SLEDNQISDIVPLAGLTKLQNLYLSKNHIS-DLR-ALAGLKNLDVLELFSQECLNKPINH 216
Query: 429 LSDLSNLEKLDLSGNHLVGEIPIS 452
S+L + + LV IS
Sbjct: 217 QSNLVVPNTVKNTDGSLVTPEIIS 240
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291 | Back alignment and structure |
|---|
Score = 51.2 bits (123), Expect = 5e-07
Identities = 26/98 (26%), Positives = 44/98 (44%), Gaps = 14/98 (14%)
Query: 380 YNQLSNLPP--------AIYLANNSLSGNIPVEIGQLKSLHVLDLSNNNFSGTIPDELSD 431
N++ +L ++ L +N +S +I + L L L L NN T LS
Sbjct: 99 ENKVKDLSSLKDLKKLKSLSLEHNGIS-DING-LVHLPQLESLYLGNNKI--TDITVLSR 154
Query: 432 LSNLEKLDLSGNHLVGEIPISLKGLHFLSSFSVAHNNL 469
L+ L+ L L N + +I L GL L + ++ N++
Sbjct: 155 LTKLDTLSLEDNQIS-DIV-PLAGLTKLQNLYLSKNHI 190
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291 | Back alignment and structure |
|---|
Score = 50.4 bits (121), Expect = 1e-06
Identities = 23/100 (23%), Positives = 40/100 (40%), Gaps = 14/100 (14%)
Query: 379 QYNQLSNLPP--------AIYLANNSLSGNIPVEIGQLKSLHVLDLSNNNFSGTIPDELS 430
+ + ++ ++L N L+ +I + LK+L L L N + L
Sbjct: 54 NNSDIKSVQGIQYLPNVTKLFLNGNKLT-DIK-PLANLKNLGWLFLDENKVK-DL-SSLK 109
Query: 431 DLSNLEKLDLSGNHLVGEIPISLKGLHFLSSFSVAHNNLQ 470
DL L+ L L N + +I L L L S + +N +
Sbjct: 110 DLKKLKSLSLEHNGIS-DIN-GLVHLPQLESLYLGNNKIT 147
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291 | Back alignment and structure |
|---|
Score = 48.5 bits (116), Expect = 4e-06
Identities = 19/89 (21%), Positives = 36/89 (40%), Gaps = 8/89 (8%)
Query: 383 LSNLPPAI--YLANNSLSGNIPVEIGQLKSLHVLDLSNNNFSGTIPDELSDLSNLEKLDL 440
I L S++ + +L S+ + +N++ ++ + L N+ KL L
Sbjct: 20 DDAFAETIKDNLKKKSVTDAVTQN--ELNSIDQIIANNSDIK-SV-QGIQYLPNVTKLFL 75
Query: 441 SGNHLVGEIPISLKGLHFLSSFSVAHNNL 469
+GN L +I L L L + N +
Sbjct: 76 NGNKLT-DIK-PLANLKNLGWLFLDENKV 102
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291 | Back alignment and structure |
|---|
Score = 44.3 bits (105), Expect = 9e-05
Identities = 21/85 (24%), Positives = 38/85 (44%), Gaps = 10/85 (11%)
Query: 379 QYNQLSNLPP--------AIYLANNSLSGNIPVEIGQLKSLHVLDLSNNNFSGTIPDELS 430
+ NQ+S++ P +YL+ N +S ++ + LK+L VL+L + + S
Sbjct: 164 EDNQISDIVPLAGLTKLQNLYLSKNHIS-DLR-ALAGLKNLDVLELFSQECLNKPINHQS 221
Query: 431 DLSNLEKLDLSGNHLVGEIPISLKG 455
+L + + LV IS G
Sbjct: 222 NLVVPNTVKNTDGSLVTPEIISDDG 246
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382 | Back alignment and structure |
|---|
Score = 51.6 bits (124), Expect = 6e-07
Identities = 54/243 (22%), Positives = 90/243 (37%), Gaps = 46/243 (18%)
Query: 589 NNTNEIKDLTIYELLKATDNFSQANIIGCGGFGLVYKAT-LANGTTLAIK-----KLSGD 642
++ D + K D + ++IG G FG V KA +AIK K +
Sbjct: 36 GYDDDNYDYIVKNGEKWMDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNKKAFLN 95
Query: 643 LGLMEREFKAEVEALSTAQHKNLVSLQGYCVHQG-----FRLL---IYSYM-ENGSLDYW 693
+E + T +V L+ + + + F +L +Y +
Sbjct: 96 QAQIEVRLLELMNKHDTEMKYYIVHLKRHFMFRNHLCLVFEMLSYNLYDLLRNTNFRGVS 155
Query: 694 LHEKADGASQLDWLTRLKIARGTSCGLAYMHQICEPHIVHRDIKSSNILLDDQFEAH--L 751
L+ LTR K A+ L ++ E I+H D+K NILL + + +
Sbjct: 156 LN-----------LTR-KFAQQMCTALLFLATP-ELSIIHCDLKPENILLCNPKRSAIKI 202
Query: 752 ADFGLSRLILPYQTHVTTELVGTLGYIPPE------YGQAWVATLRGDMYSFGVVMLELL 805
DFG S + + + Y PE Y A DM+S G +++E+
Sbjct: 203 VDFGSSC----QLGQRIYQYIQSRFYRSPEVLLGMPYDLAI------DMWSLGCILVEMH 252
Query: 806 TGK 808
TG+
Sbjct: 253 TGE 255
|
| >1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} Length = 263 | Back alignment and structure |
|---|
Score = 50.4 bits (121), Expect = 9e-07
Identities = 26/100 (26%), Positives = 35/100 (35%), Gaps = 15/100 (15%)
Query: 379 QYNQLSNLPP--------AIYLANNSLSGNIPVEIGQLKSLHVLDLSNNNFSGTIPDELS 430
+NQ+S+L P + + N L + L L L NN T L
Sbjct: 71 SHNQISDLSPLKDLTKLEELSVNRNRLKN---LNGIPSACLSRLFLDNNELRDTDS--LI 125
Query: 431 DLSNLEKLDLSGNHLVGEIPISLKGLHFLSSFSVAHNNLQ 470
L NLE L + N L I L L L + N +
Sbjct: 126 HLKNLEILSIRNNKLK-SIV-MLGFLSKLEVLDLHGNEIT 163
|
| >1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} Length = 263 | Back alignment and structure |
|---|
Score = 48.5 bits (116), Expect = 4e-06
Identities = 22/88 (25%), Positives = 34/88 (38%), Gaps = 12/88 (13%)
Query: 380 YNQLSNLPP--------AIYLANNSLSGNIPVEIGQLKSLHVLDLSNNNFSGTIPDELSD 431
N+L + + + NN L +I +G L L VLDL N + L+
Sbjct: 115 NNELRDTDSLIHLKNLEILSIRNNKLK-SIV-MLGFLSKLEVLDLHGNEIT-NT-GGLTR 170
Query: 432 LSNLEKLDLSGNHLVGEIPISLKGLHFL 459
L + +DL+G V E L+
Sbjct: 171 LKKVNWIDLTGQKCVNEPVKYQPELYIT 198
|
| >1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} Length = 263 | Back alignment and structure |
|---|
Score = 43.1 bits (102), Expect = 2e-04
Identities = 8/78 (10%), Positives = 28/78 (35%), Gaps = 6/78 (7%)
Query: 392 LANNSLSGNIPVEIGQLKSLHVLDLSNNNFSGTIPDELSDLSNLEKLDLSGNHLVGEIPI 451
++ P L + +L + + + +LS ++ + +++ +
Sbjct: 4 QRPTPINQVFPDP--GLANAVKQNLGKQSVTDLVS--QKELSGVQNFNGDNSNIQ-SLA- 57
Query: 452 SLKGLHFLSSFSVAHNNL 469
++ L ++HN +
Sbjct: 58 GMQFFTNLKELHLSHNQI 75
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429 | Back alignment and structure |
|---|
Score = 50.1 bits (120), Expect = 2e-06
Identities = 53/218 (24%), Positives = 78/218 (35%), Gaps = 48/218 (22%)
Query: 614 IIGCGGFGLVYKAT-LANGTTLAIKKLSGDLGLMEREFKAEVEALST------AQHKNLV 666
+IG G FG V KA +A+K + + R+ E+ L N++
Sbjct: 104 VIGKGSFGQVVKAYDHKVHQHVALKMVR-NEKRFHRQAAEEIRILEHLRKQDKDNTMNVI 162
Query: 667 SLQGYCVHQG-----FRLL---IYSYMENGSLDYWLHEKADGASQLDWLTRLKIARGTSC 718
+ + F LL +Y ++ L R K A
Sbjct: 163 HMLENFTFRNHICMTFELLSMNLYELIKKNKFQG-FSLP---------LVR-KFAHSILQ 211
Query: 719 GLAYMHQICEPHIVHRDIKSSNILLDDQFEAH--LADFGLSRLILPYQTHVTTELVGTLG 776
L +H+ I+H D+K NILL Q + + DFG S V T + +
Sbjct: 212 CLDALHKN---RIIHCDLKPENILLKQQGRSGIKVIDFGSSCYE---HQRVYTYIQ-SRF 264
Query: 777 YIPPE------YGQAWVATLRGDMYSFGVVMLELLTGK 808
Y PE YG DM+S G ++ ELLTG
Sbjct: 265 YRAPEVILGARYGMPI------DMWSLGCILAELLTGY 296
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220 | Back alignment and structure |
|---|
Score = 48.5 bits (116), Expect = 2e-06
Identities = 34/144 (23%), Positives = 51/144 (35%), Gaps = 36/144 (25%)
Query: 342 KELTALPALVSEAANDEVDRSYLELPVFVMPSNATNQQYNQLSNLPPAIYLANNSLSGNI 401
K LT +P + + + L + N + +PP + S
Sbjct: 21 KGLTEIPTNLP------ETITEIRL------------EQNTIKVIPP------GAFSP-- 54
Query: 402 PVEIGQLKSLHVLDLSNNNFSGTIPDELSDLSNLEKLDLSGNHLVGEIPISL-KGLHFLS 460
K L +DLSNN S PD L +L L L GN + E+P SL +GL L
Sbjct: 55 ------YKKLRRIDLSNNQISELAPDAFQGLRSLNSLVLYGNKIT-ELPKSLFEGLFSLQ 107
Query: 461 SFSVAHNNLQGAVPSGGQFDTFPS 484
+ N + + F +
Sbjct: 108 LLLLNANKIN-CLRV-DAFQDLHN 129
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220 | Back alignment and structure |
|---|
Score = 46.2 bits (110), Expect = 1e-05
Identities = 22/79 (27%), Positives = 32/79 (40%), Gaps = 14/79 (17%)
Query: 379 QYNQLSNLPPAI----------YLANNSLSGNIPVEI-GQLKSLHVLDLSNNNFSGTIPD 427
NQ+S L P L N ++ +P + L SL +L L+ N + +
Sbjct: 64 SNNQISELAPDAFQGLRSLNSLVLYGNKIT-ELPKSLFEGLFSLQLLLLNANKIN-CLRV 121
Query: 428 EL-SDLSNLEKLDLSGNHL 445
+ DL NL L L N L
Sbjct: 122 DAFQDLHNLNLLSLYDNKL 140
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220 | Back alignment and structure |
|---|
Score = 45.0 bits (107), Expect = 4e-05
Identities = 18/77 (23%), Positives = 35/77 (45%), Gaps = 14/77 (18%)
Query: 379 QYNQLSNLPPAI----------YLANNSLSGNIPVEIGQ-LKSLHVLDLSNNNFSGTIPD 427
N+++ LP ++ L N ++ + V+ Q L +L++L L +N TI
Sbjct: 88 YGNKITELPKSLFEGLFSLQLLLLNANKIN-CLRVDAFQDLHNLNLLSLYDNKLQ-TIAK 145
Query: 428 E-LSDLSNLEKLDLSGN 443
S L ++ + L+ N
Sbjct: 146 GTFSPLRAIQTMHLAQN 162
|
| >1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A Length = 198 | Back alignment and structure |
|---|
Score = 47.8 bits (114), Expect = 3e-06
Identities = 17/102 (16%), Positives = 36/102 (35%), Gaps = 14/102 (13%)
Query: 373 SNATNQQYNQLSNLPPAIYLANNSLSGNIPVEIGQLKSLHVLDLSNNNFSGTIPDELSDL 432
+ + + ++ + + + LK+ L LS NN I LS +
Sbjct: 15 EERKSVVATEAEKV--ELHGMIPPIE-KMDATLSTLKACKHLALSTNNIE-KI-SSLSGM 69
Query: 433 SNLEKLDLSGNHLVGEIPISLKGLHFLSS----FSVAHNNLQ 470
NL L L N + ++ L ++ +++N +
Sbjct: 70 ENLRILSLGRNLIK-----KIENLDAVADTLEELWISYNQIA 106
|
| >1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A Length = 198 | Back alignment and structure |
|---|
Score = 45.1 bits (107), Expect = 3e-05
Identities = 21/79 (26%), Positives = 31/79 (39%), Gaps = 6/79 (7%)
Query: 391 YLANNSLSGNIPVEIGQLKSLHVLDLSNNNFSGTIPDELSDLSNLEKLDLSGNHL--VGE 448
L N + I +L L +S N + ++ + L NL L +S N + GE
Sbjct: 76 SLGRNLIK-KIENLDAVADTLEELWISYNQIA-SL-SGIEKLVNLRVLYMSNNKITNWGE 132
Query: 449 IPISLKGLHFLSSFSVAHN 467
I L L L +A N
Sbjct: 133 I-DKLAALDKLEDLLLAGN 150
|
| >1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A Length = 198 | Back alignment and structure |
|---|
Score = 43.1 bits (102), Expect = 1e-04
Identities = 24/86 (27%), Positives = 38/86 (44%), Gaps = 20/86 (23%)
Query: 379 QYNQ------LSNLPPAI---YLANN---SLSGNIPVEIGQLKSLHVLDLSNNNFSGTIP 426
N L + + +++ N SLSG I +L +L VL +SNN +
Sbjct: 78 GRNLIKKIENLDAVADTLEELWISYNQIASLSG-----IEKLVNLRVLYMSNNKIT-NWG 131
Query: 427 D--ELSDLSNLEKLDLSGNHLVGEIP 450
+ +L+ L LE L L+GN L +
Sbjct: 132 EIDKLAALDKLEDLLLAGNPLYNDYK 157
|
| >4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* Length = 350 | Back alignment and structure |
|---|
Score = 49.1 bits (117), Expect = 4e-06
Identities = 14/123 (11%), Positives = 31/123 (25%), Gaps = 19/123 (15%)
Query: 387 PPAIYLANNSLSGNIPVEIGQLKSLHVLDLSNNNFSGTIPDELSDLSNLEKLDLSGNHLV 446
+ ++ IP ++ ++ L S +LEK+++S N ++
Sbjct: 11 NRVFLCQESKVT-EIPSDL--PRNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVL 67
Query: 447 GEIPIS-LKGLHFLSSFSVAHNNLQGAVPSGG---------------QFDTFPSFSFEGN 490
I L L + N + P +
Sbjct: 68 EVIEADVFSNLPKLHEIRIEKANNLLYINPEAFQNLPNLQYLLISNTGIKHLPDVHKIHS 127
Query: 491 PEL 493
+
Sbjct: 128 LQK 130
|
| >4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* Length = 350 | Back alignment and structure |
|---|
Score = 45.2 bits (107), Expect = 6e-05
Identities = 19/117 (16%), Positives = 36/117 (30%), Gaps = 21/117 (17%)
Query: 381 NQLSNLPP-----------AIYLANNSLSGNIPVEI-GQLKSLHVLDLSNNNFSGTIPDE 428
+ + ++L N + I + + NNN D
Sbjct: 139 INIHTIERNSFVGLSFESVILWLNKNGIQ-EIHNSAFNGTQLDELNLSDNNNLEELPNDV 197
Query: 429 LSDLSNLEKLDLSGNHLVGEIPI-SLKGLHFLSSFSVAHNNLQGAVPSGGQFDTFPS 484
S LD+S + +P L+ L L + S NL+ +P+ + +
Sbjct: 198 FHGASGPVILDISRTRIH-SLPSYGLENLKKLRARS--TYNLK-KLPT---LEKLVA 247
|
| >4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* Length = 350 | Back alignment and structure |
|---|
Score = 44.8 bits (106), Expect = 8e-05
Identities = 17/106 (16%), Positives = 33/106 (31%), Gaps = 14/106 (13%)
Query: 378 QQYNQLSNLPPAI----------YLANNSLSGNIPVEIGQ-LKSLHVLDLSNNNFSGTIP 426
++ N L + P ++N + ++P +LD+ +N TI
Sbjct: 87 EKANNLLYINPEAFQNLPNLQYLLISNTGIK-HLPDVHKIHSLQKVLLDIQDNINIHTIE 145
Query: 427 DELSD--LSNLEKLDLSGNHLVGEIPISLKGLHFLSSFSVAHNNLQ 470
L L+ N + + G +NNL+
Sbjct: 146 RNSFVGLSFESVILWLNKNGIQEIHNSAFNGTQLDELNLSDNNNLE 191
|
| >2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} Length = 220 | Back alignment and structure |
|---|
Score = 47.7 bits (114), Expect = 4e-06
Identities = 24/112 (21%), Positives = 43/112 (38%), Gaps = 14/112 (12%)
Query: 379 QYNQLSNLPPAI-------YLANNSLSGNIPVEI-GQLKSLHVLDLSNNNFSGTIPDE-L 429
+L+ +P I L NN + I +L L ++ SNN + I +
Sbjct: 19 SNQKLNKIPEHIPQYTAELRLNNNEFTVLEATGIFKKLPQLRKINFSNNKIT-DIEEGAF 77
Query: 430 SDLSNLEKLDLSGNHLVGEIPISL-KGLHFLSSFSVAHNNLQGAVPSGGQFD 480
S + ++ L+ N L + + KGL L + + N + V + F
Sbjct: 78 EGASGVNEILLTSNRLE-NVQHKMFKGLESLKTLMLRSNRIT-CVGNDS-FI 126
|
| >2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} Length = 220 | Back alignment and structure |
|---|
Score = 43.9 bits (104), Expect = 9e-05
Identities = 16/79 (20%), Positives = 34/79 (43%), Gaps = 14/79 (17%)
Query: 379 QYNQLSNLPPAI----------YLANNSLSGNIPVEI-GQLKSLHVLDLSNNNFSGTIPD 427
N+++++ L +N L N+ ++ L+SL L L +N + + +
Sbjct: 65 SNNKITDIEEGAFEGASGVNEILLTSNRLE-NVQHKMFKGLESLKTLMLRSNRIT-CVGN 122
Query: 428 ELSD-LSNLEKLDLSGNHL 445
+ LS++ L L N +
Sbjct: 123 DSFIGLSSVRLLSLYDNQI 141
|
| >2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} Length = 220 | Back alignment and structure |
|---|
Score = 41.6 bits (98), Expect = 4e-04
Identities = 16/77 (20%), Positives = 31/77 (40%), Gaps = 14/77 (18%)
Query: 379 QYNQLSNLPPAI----------YLANNSLSGNIPVEI-GQLKSLHVLDLSNNNFSGTIPD 427
N+L N+ + L +N ++ + + L S+ +L L +N + T+
Sbjct: 89 TSNRLENVQHKMFKGLESLKTLMLRSNRIT-CVGNDSFIGLSSVRLLSLYDNQIT-TVAP 146
Query: 428 E-LSDLSNLEKLDLSGN 443
L +L L+L N
Sbjct: 147 GAFDTLHSLSTLNLLAN 163
|
| >2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} Length = 270 | Back alignment and structure |
|---|
Score = 46.1 bits (110), Expect = 2e-05
Identities = 33/129 (25%), Positives = 52/129 (40%), Gaps = 21/129 (16%)
Query: 379 QYNQLSNLPPAI----------YLANNSLSGNIPVEI-GQLKSLHVLDLSNNNFSGTIPD 427
N+L LP + L N L ++P + L L L L N ++P
Sbjct: 93 TDNKLQALPIGVFDQLVNLAELRLDRNQLK-SLPPRVFDSLTKLTYLSLGYNELQ-SLPK 150
Query: 428 ELSD-LSNLEKLDLSGNHLVGEIPISL-KGLHFLSSFSVAHNNLQGAVPSGGQFDTFPSF 485
+ D L++L++L L N L +P L L + + +N L+ VP G FD+
Sbjct: 151 GVFDKLTSLKELRLYNNQL-KRVPEGAFDKLTELKTLKLDNNQLK-RVP-EGAFDSLEKL 207
Query: 486 SF---EGNP 491
+ NP
Sbjct: 208 KMLQLQENP 216
|
| >2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} Length = 270 | Back alignment and structure |
|---|
Score = 42.7 bits (101), Expect = 3e-04
Identities = 31/114 (27%), Positives = 43/114 (37%), Gaps = 16/114 (14%)
Query: 368 VFVMPSNAT--NQQYNQLSNLPPAI----------YLANNSLSGNIPVEI-GQLKSLHVL 414
VF N NQL +LPP + L N L ++P + +L SL L
Sbjct: 104 VFDQLVNLAELRLDRNQLKSLPPRVFDSLTKLTYLSLGYNELQ-SLPKGVFDKLTSLKEL 162
Query: 415 DLSNNNFSGTIPDELSD-LSNLEKLDLSGNHLVGEIPISLKGLHFLSSFSVAHN 467
L NN +P+ D L+ L+ L L N L + L L + N
Sbjct: 163 RLYNNQLK-RVPEGAFDKLTELKTLKLDNNQLKRVPEGAFDSLEKLKMLQLQEN 215
|
| >2ra8_A Uncharacterized protein Q64V53_bacfr; WGR domain, LRR domain, leucine rich repeats, BFR43, structural genomics, PSI-2; 1.95A {Bacteroides fragilis} Length = 362 | Back alignment and structure |
|---|
Score = 45.7 bits (107), Expect = 4e-05
Identities = 9/66 (13%), Positives = 26/66 (39%), Gaps = 7/66 (10%)
Query: 390 IYLANNSLSGNIPVEIGQ---LKSLHVLDLSNNNFSGT----IPDELSDLSNLEKLDLSG 442
+ + + + + L L +D+S + + D + + +L+ +++
Sbjct: 257 LGIVDAEEQNVVVEMFLESDILPQLETMDISAGVLTDEGARLLLDHVDKIKHLKFINMKY 316
Query: 443 NHLVGE 448
N+L E
Sbjct: 317 NYLSDE 322
|
| >3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} Length = 229 | Back alignment and structure |
|---|
Score = 44.3 bits (105), Expect = 6e-05
Identities = 43/165 (26%), Positives = 69/165 (41%), Gaps = 38/165 (23%)
Query: 342 KELTALPALVSEAANDEVDRSYLELPVFVMPSNATNQQYNQLSNLPPAI----------Y 391
K ++PA + L L NQ++ L P + Y
Sbjct: 29 KRHASVPA------GIPTNAQILYL------------HDNQITKLEPGVFDSLINLKELY 70
Query: 392 LANNSLSGNIPVEI-GQLKSLHVLDLSNNNFSGTIPDELSD-LSNLEKLDLSGNHLVGEI 449
L +N L +PV + L L VLDL N + +P + D L +L++L + N L E+
Sbjct: 71 LGSNQLG-ALPVGVFDSLTQLTVLDLGTNQLT-VLPSAVFDRLVHLKELFMCCNKL-TEL 127
Query: 450 PISLKGLHFLSSFSVAHNNLQGAVPSGGQFDTFPSFS---FEGNP 491
P ++ L L+ ++ N L+ ++P G FD S + GNP
Sbjct: 128 PRGIERLTHLTHLALDQNQLK-SIPHGA-FDRLSSLTHAYLFGNP 170
|
| >3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A Length = 251 | Back alignment and structure |
|---|
Score = 44.3 bits (105), Expect = 9e-05
Identities = 47/181 (25%), Positives = 66/181 (36%), Gaps = 45/181 (24%)
Query: 342 KELTALPALVSEAANDEVDRSYLEL----------PVFVMPSNAT--NQQYNQLSNLPPA 389
K L ++P+ D L+L F + T N YNQL L
Sbjct: 24 KSLDSVPS------GIPADTEKLDLQSTGLATLSDATFRGLTKLTWLNLDYNQLQTLSAG 77
Query: 390 I----------YLANNSLSGNIPVEI-GQLKSLHVLDLSNNNFSGTIPDELSD-LSNLEK 437
+ LANN L+ ++P+ + L L L L N ++P + D L+ L++
Sbjct: 78 VFDDLTELGTLGLANNQLA-SLPLGVFDHLTQLDKLYLGGNQLK-SLPSGVFDRLTKLKE 135
Query: 438 LDLSGNHLVGEIPI----SLKGLHFLSSFSVAHNNLQGAVPSGGQFDTFPSFS---FEGN 490
L L+ N L IP L L LS N +VP G FD GN
Sbjct: 136 LRLNTNQL-QSIPAGAFDKLTNLQTLS----LSTNQLQSVPHGA-FDRLGKLQTITLFGN 189
Query: 491 P 491
Sbjct: 190 Q 190
|
| >1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7 Length = 192 | Back alignment and structure |
|---|
Score = 41.9 bits (99), Expect = 3e-04
Identities = 30/155 (19%), Positives = 53/155 (34%), Gaps = 40/155 (25%)
Query: 342 KELTALPALVSEAANDEVDRSYLELPVFVMPSNATNQQYNQLSNLPPAIYLANNSLSGNI 401
+ L +P + + + L L N+L +
Sbjct: 18 RGLKEIPR------DIPLHTTELLL------------NDNELGRISSDGLF--------- 50
Query: 402 PVEIGQLKSLHVLDLSNNNFSGTIPDELSD-LSNLEKLDLSGNHLVGEIPISL-KGLHFL 459
G+L L L+L N + I + S++++L L N + EI + GLH L
Sbjct: 51 ----GRLPHLVKLELKRNQLT-GIEPNAFEGASHIQELQLGENKI-KEISNKMFLGLHQL 104
Query: 460 SSFSVAHNNLQGAVPSGGQFDTFPSFS---FEGNP 491
+ ++ N + V G F+ S + NP
Sbjct: 105 KTLNLYDNQIS-CVMPGS-FEHLNSLTSLNLASNP 137
|
| >3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A Length = 272 | Back alignment and structure |
|---|
Score = 41.5 bits (98), Expect = 8e-04
Identities = 27/94 (28%), Positives = 44/94 (46%), Gaps = 16/94 (17%)
Query: 366 LPVFVMPSNAT--NQQYNQLSNLPPAI----------YLANNSLSGNIPVEI-GQLKSLH 412
+ +N T NQL +LP + L N L ++P + +L +L
Sbjct: 78 ISALKELTNLTYLILTGNQLQSLPNGVFDKLTNLKELVLVENQLQ-SLPDGVFDKLTNLT 136
Query: 413 VLDLSNNNFSGTIPDELSD-LSNLEKLDLSGNHL 445
L+L++N ++P + D L+NL +LDLS N L
Sbjct: 137 YLNLAHNQLQ-SLPKGVFDKLTNLTELDLSYNQL 169
|
Structure Templates Detected by HHsearch
Original result of HHsearch against PDB70 database
No hit with probability above 80.00
Homologous Structure Domains
Structure Domains Detected by RPS-BLAST
Original result of RPS-BLAST against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
E-value |
| 894 | ||||
| d1uwha_ | 276 | d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) | 7e-65 | |
| d1qpca_ | 272 | d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom | 2e-61 | |
| d1sm2a_ | 263 | d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu | 8e-60 | |
| d1vjya_ | 303 | d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human | 5e-59 | |
| d1k2pa_ | 258 | d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum | 6e-59 | |
| d1s9ja_ | 322 | d.144.1.7 (A:) Dual specificity mitogen-activated | 2e-58 | |
| d1fmka3 | 285 | d.144.1.7 (A:249-533) c-src tyrosine kinase {Human | 4e-58 | |
| d1jpaa_ | 299 | d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou | 3e-56 | |
| d1opja_ | 287 | d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou | 9e-56 | |
| d1lufa_ | 301 | d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n | 1e-55 | |
| d1r0pa_ | 311 | d.144.1.7 (A:) Hepatocyte growth factor receptor, | 2e-55 | |
| d1byga_ | 262 | d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) | 2e-55 | |
| d1t46a_ | 311 | d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens | 7e-55 | |
| d1u59a_ | 285 | d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum | 1e-54 | |
| d1u5ra_ | 309 | d.144.1.7 (A:) Serine/threonine protein kinase TAO | 2e-54 | |
| d2java1 | 269 | d.144.1.7 (A:3-271) Serine/threonine-protein kinas | 3e-54 | |
| d1xbba_ | 277 | d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human | 4e-54 | |
| d1mqba_ | 283 | d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum | 5e-54 | |
| d1fvra_ | 309 | d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [ | 2e-53 | |
| d2j4za1 | 263 | d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur | 6e-53 | |
| d1rjba_ | 325 | d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s | 7e-53 | |
| d1t4ha_ | 270 | d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa | 1e-52 | |
| d2jfla1 | 288 | d.144.1.7 (A:21-308) STE20-like serine/threonine-p | 4e-52 | |
| d1nvra_ | 271 | d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 { | 1e-51 | |
| d1yhwa1 | 293 | d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [ | 1e-50 | |
| d1mp8a_ | 273 | d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma | 2e-49 | |
| d1u46a_ | 273 | d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum | 2e-49 | |
| d1xkka_ | 317 | d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb- | 7e-49 | |
| d1koaa2 | 350 | d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C | 1e-48 | |
| d1uu3a_ | 288 | d.144.1.7 (A:) 3-phosphoinositide dependent protei | 7e-48 | |
| d1p4oa_ | 308 | d.144.1.7 (A:) Insulin-like growth factor 1 recept | 8e-47 | |
| d1ywna1 | 299 | d.144.1.7 (A:818-1166) Vascular endothelial growth | 1e-46 | |
| d1koba_ | 352 | d.144.1.7 (A:) Twitchin, kinase domain {California | 1e-46 | |
| d1fgka_ | 299 | d.144.1.7 (A:) Fibroblast growth factor receptor 1 | 2e-45 | |
| d1tkia_ | 321 | d.144.1.7 (A:) Titin, kinase domain {Human (Homo s | 7e-45 | |
| d1a06a_ | 307 | d.144.1.7 (A:) Calmodulin-dependent protein kinase | 1e-44 | |
| d1phka_ | 277 | d.144.1.7 (A:) gamma-subunit of glycogen phosphory | 2e-44 | |
| d1ckia_ | 299 | d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n | 1e-43 | |
| d1omwa3 | 364 | d.144.1.7 (A:186-549) G-protein coupled receptor k | 2e-43 | |
| d1o6ya_ | 277 | d.144.1.7 (A:) Mycobacterial protein kinase PknB, | 2e-43 | |
| d1xjda_ | 320 | d.144.1.7 (A:) Protein kinase C, theta type {Human | 8e-42 | |
| d1ob3a_ | 286 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod | 1e-41 | |
| d1blxa_ | 305 | d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H | 1e-41 | |
| d1gz8a_ | 298 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H | 2e-41 | |
| d1q5ka_ | 350 | d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs | 5e-41 | |
| d1pmea_ | 345 | d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien | 6e-41 | |
| d1csna_ | 293 | d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast | 1e-40 | |
| d1ua2a_ | 299 | d.144.1.7 (A:) Cell division protein kinase 7, CDK | 2e-40 | |
| d1fota_ | 316 | d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni | 7e-40 | |
| d1jksa_ | 293 | d.144.1.7 (A:) Death-associated protein kinase, Da | 2e-39 | |
| d1xwsa_ | 273 | d.144.1.7 (A:) Proto-oncogene serine/threonine-pro | 2e-39 | |
| d2ozaa1 | 335 | d.144.1.7 (A:51-385) MAP kinase activated protein | 5e-39 | |
| d3blha1 | 318 | d.144.1.7 (A:8-325) Cell division protein kinase 9 | 8e-37 | |
| d1unla_ | 292 | d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H | 2e-36 | |
| d1o6la_ | 337 | d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap | 7e-36 | |
| d1cm8a_ | 346 | d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s | 5e-34 | |
| d1rdqe_ | 350 | d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni | 1e-33 | |
| d3bqca1 | 328 | d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu | 4e-33 | |
| d1vzoa_ | 322 | d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5 | 8e-33 | |
| d2b1pa1 | 355 | d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3 | 7e-31 | |
| d2gfsa1 | 348 | d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa | 2e-29 | |
| d1q8ya_ | 362 | d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces | 5e-27 | |
| d1zara2 | 191 | d.144.1.9 (A:91-281) Rio2 serine protein kinase C- | 4e-20 | |
| d1ogqa_ | 313 | c.10.2.8 (A:) Polygalacturonase inhibiting protein | 2e-15 | |
| d1ogqa_ | 313 | c.10.2.8 (A:) Polygalacturonase inhibiting protein | 2e-15 | |
| d1ogqa_ | 313 | c.10.2.8 (A:) Polygalacturonase inhibiting protein | 1e-05 | |
| d1ogqa_ | 313 | c.10.2.8 (A:) Polygalacturonase inhibiting protein | 6e-04 | |
| d1ogqa_ | 313 | c.10.2.8 (A:) Polygalacturonase inhibiting protein | 0.002 | |
| d2omza2 | 384 | c.10.2.1 (A:33-416) Internalin A {Listeria monocyt | 1e-14 | |
| d2omza2 | 384 | c.10.2.1 (A:33-416) Internalin A {Listeria monocyt | 3e-10 | |
| d2omza2 | 384 | c.10.2.1 (A:33-416) Internalin A {Listeria monocyt | 9e-08 | |
| d2omza2 | 384 | c.10.2.1 (A:33-416) Internalin A {Listeria monocyt | 9e-07 | |
| d2omza2 | 384 | c.10.2.1 (A:33-416) Internalin A {Listeria monocyt | 1e-06 | |
| d1xkua_ | 305 | c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99 | 1e-09 | |
| d1xkua_ | 305 | c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99 | 2e-07 | |
| d1xkua_ | 305 | c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99 | 8e-06 | |
| d1xkua_ | 305 | c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99 | 1e-04 | |
| d1xkua_ | 305 | c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99 | 1e-04 | |
| d1jl5a_ | 353 | c.10.2.6 (A:) Leucine rich effector protein YopM { | 1e-09 | |
| d1jl5a_ | 353 | c.10.2.6 (A:) Leucine rich effector protein YopM { | 3e-06 | |
| d1jl5a_ | 353 | c.10.2.6 (A:) Leucine rich effector protein YopM { | 0.001 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 6e-09 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 2e-08 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 8e-07 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 1e-05 | |
| d1h6ua2 | 227 | c.10.2.1 (A:36-262) Internalin H {Listeria monocyt | 6e-08 | |
| d1h6ua2 | 227 | c.10.2.1 (A:36-262) Internalin H {Listeria monocyt | 7e-06 | |
| d1h6ua2 | 227 | c.10.2.1 (A:36-262) Internalin H {Listeria monocyt | 9e-05 | |
| d1h6ua2 | 227 | c.10.2.1 (A:36-262) Internalin H {Listeria monocyt | 2e-04 | |
| d1h6ua2 | 227 | c.10.2.1 (A:36-262) Internalin H {Listeria monocyt | 8e-04 | |
| d1ozna_ | 284 | c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 recept | 2e-07 | |
| d1ozna_ | 284 | c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 recept | 9e-06 | |
| d1ozna_ | 284 | c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 recept | 0.001 | |
| d1ozna_ | 284 | c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 recept | 0.004 | |
| d2ifga3 | 156 | c.10.2.7 (A:36-191) High affinity nerve growth fac | 2e-07 | |
| d2ca6a1 | 344 | c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal dom | 5e-07 | |
| d2ca6a1 | 344 | c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal dom | 2e-05 | |
| d2ca6a1 | 344 | c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal dom | 4e-05 | |
| d1p9ag_ | 266 | c.10.2.7 (G:) von Willebrand factor binding domain | 9e-07 | |
| d1p9ag_ | 266 | c.10.2.7 (G:) von Willebrand factor binding domain | 1e-06 | |
| d1p9ag_ | 266 | c.10.2.7 (G:) von Willebrand factor binding domain | 8e-06 | |
| d1p9ag_ | 266 | c.10.2.7 (G:) von Willebrand factor binding domain | 5e-04 | |
| d1p9ag_ | 266 | c.10.2.7 (G:) von Willebrand factor binding domain | 0.002 | |
| d2astb2 | 284 | c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p1 | 2e-06 | |
| d1dcea3 | 124 | c.10.2.2 (A:444-567) Rab geranylgeranyltransferase | 4e-06 | |
| d1dcea3 | 124 | c.10.2.2 (A:444-567) Rab geranylgeranyltransferase | 6e-06 | |
| d1dcea3 | 124 | c.10.2.2 (A:444-567) Rab geranylgeranyltransferase | 8e-04 | |
| d1h6ta2 | 210 | c.10.2.1 (A:31-240) Internalin B {Listeria monocyt | 4e-06 | |
| d1h6ta2 | 210 | c.10.2.1 (A:31-240) Internalin B {Listeria monocyt | 3e-05 | |
| d1a9na_ | 162 | c.10.2.4 (A:) Splicesomal U2A' protein {Human (Hom | 2e-05 | |
| d1xwdc1 | 242 | c.10.2.7 (C:18-259) Follicle-stimulating hormone r | 3e-05 | |
| d1xwdc1 | 242 | c.10.2.7 (C:18-259) Follicle-stimulating hormone r | 2e-04 | |
| d1xwdc1 | 242 | c.10.2.7 (C:18-259) Follicle-stimulating hormone r | 8e-04 | |
| d1xwdc1 | 242 | c.10.2.7 (C:18-259) Follicle-stimulating hormone r | 0.002 | |
| d2omxa2 | 199 | c.10.2.1 (A:37-235) Internalin B {Listeria monocyt | 8e-05 | |
| d2omxa2 | 199 | c.10.2.1 (A:37-235) Internalin B {Listeria monocyt | 0.001 | |
| d1koha1 | 162 | c.10.2.3 (A:201-362) mRNA export factor tap {Human | 5e-04 |
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 217 bits (553), Expect = 7e-65
Identities = 63/278 (22%), Positives = 120/278 (43%), Gaps = 22/278 (7%)
Query: 607 DNFSQANIIGCGGFGLVYKATLANGTTLAIKKLSGDLGLMEREFKAEVEALSTAQHKNLV 666
+ IG G FG VYK + + ++ + FK EV L +H N++
Sbjct: 8 GQITVGQRIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNIL 67
Query: 667 SLQGYCVHQGFRLLIYSYMENGSLDYWLHEKADGASQLDWLTRLKIARGTSCGLAYMHQI 726
GY ++ + E SL + LH ++ + + + IAR T+ G+ Y+H
Sbjct: 68 LFMGYS-TAPQLAIVTQWCEGSSLYHHLHII---ETKFEMIKLIDIARQTAQGMDYLHA- 122
Query: 727 CEPHIVHRDIKSSNILLDDQFEAHLADFGLSRLILPYQ-THVTTELVGTLGYIPPEY--- 782
I+HRD+KS+NI L + + DFGL+ + + +H +L G++ ++ PE
Sbjct: 123 --KSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRM 180
Query: 783 GQAWVATLRGDMYSFGVVMLELLTGKRPVDVLKPKMSRELVGWVLKMRSEGKQDQVFDPI 842
+ + D+Y+FG+V+ EL+TG+ P + + ++ M G +
Sbjct: 181 QDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRD------QIIFMVGRGYLSPDLSKV 234
Query: 843 LRGKGFDEEMLQVLDVACMCVSQNPFKRPTVKEVVEWL 880
+ M + C+ + +RP +++ +
Sbjct: 235 R--SNCPKAM---KRLMAECLKKKRDERPLFPQILASI 267
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Score = 207 bits (527), Expect = 2e-61
Identities = 70/276 (25%), Positives = 119/276 (43%), Gaps = 22/276 (7%)
Query: 607 DNFSQANIIGCGGFGLVYKATLANGTTLAIKKLSGDLGLMEREFKAEVEALSTAQHKNLV 666
+ +G G FG V+ T +A+K L + F AE + QH+ LV
Sbjct: 13 ETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQG-SMSPDAFLAEANLMKQLQHQRLV 71
Query: 667 SLQGYCVHQGFRLLIYSYMENGSLDYWLHEKADGASQLDWLTRLKIARGTSCGLAYMHQI 726
L + +I YMENGSL +L +L L +A + G+A++
Sbjct: 72 RLYAVVTQEPI-YIITEYMENGSLVDFLKTP--SGIKLTINKLLDMAAQIAEGMAFIE-- 126
Query: 727 CEPHIVHRDIKSSNILLDDQFEAHLADFGLSRLILPYQTHVTTELVGTLGYIPPEYGQAW 786
E + +HRD++++NIL+ D +ADFGL+RLI + + + PE
Sbjct: 127 -ERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYG 185
Query: 787 VATLRGDMYSFGVVMLELLTGKRPVDVLKPKMSRELVGWVLKMRSEGKQDQVFDPILRGK 846
T++ D++SFG+++ E++T R P M+ V++ G ++R
Sbjct: 186 TFTIKSDVWSFGILLTEIVTHGRIPY---PGMTNP---EVIQNLERGY------RMVRPD 233
Query: 847 GFDEEMLQVLDVACMCVSQNPFKRPTVKEVVEWLNN 882
EE+ + +C + P RPT + L +
Sbjct: 234 NCPEEL---YQLMRLCWKERPEDRPTFDYLRSVLED 266
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Score = 202 bits (515), Expect = 8e-60
Identities = 64/277 (23%), Positives = 114/277 (41%), Gaps = 22/277 (7%)
Query: 607 DNFSQANIIGCGGFGLVYKATLANGTTLAIKKLSGDLGLMEREFKAEVEALSTAQHKNLV 666
+ IG G FGLV+ N +AIK + + E +F E E + H LV
Sbjct: 5 SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREG-AMSEEDFIEEAEVMMKLSHPKLV 63
Query: 667 SLQGYCVHQGFRLLIYSYMENGSLDYWLHEKADGASQLDWLTRLKIARGTSCGLAYMHQI 726
L G C+ Q L++ +ME+G L +L + T L + G+AY+
Sbjct: 64 QLYGVCLEQAPICLVFEFMEHGCLSDYLRTQRG---LFAAETLLGMCLDVCEGMAYL--- 117
Query: 727 CEPHIVHRDIKSSNILLDDQFEAHLADFGLSRLILPYQTHVTTELVGTLGYIPPEYGQAW 786
E ++HRD+ + N L+ + ++DFG++R +L Q +T + + PE
Sbjct: 118 EEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFS 177
Query: 787 VATLRGDMYSFGVVMLELLTGKRPVDVLKPKMSRELVGWVLKMRSEGKQDQVFDPILRGK 846
+ + D++SFGV+M E+ + + + E+V + +++ P
Sbjct: 178 RYSSKSDVWSFGVLMWEVFSEGKIPYENRSNS--EVVEDISTGF------RLYKP----- 224
Query: 847 GFDEEMLQVLDVACMCVSQNPFKRPTVKEVVEWLNNV 883
V + C + P RP ++ L +
Sbjct: 225 --RLASTHVYQIMNHCWKERPEDRPAFSRLLRQLAEI 259
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Score = 201 bits (513), Expect = 5e-59
Identities = 65/292 (22%), Positives = 113/292 (38%), Gaps = 30/292 (10%)
Query: 615 IGCGGFGLVYKATLANGTTLAIKKLSGDLGLMEREFKAEVEALSTAQHKNLVSLQGYCVH 674
IG G FG V++ G +A+K S +AE+ +H+N++
Sbjct: 11 IGKGRFGEVWRGKW-RGEEVAVKIFSSR-EERSWFREAEIYQTVMLRHENILGFIAADNK 68
Query: 675 QGFRL----LIYSYMENGSLDYWLHEKADGASQLDWLTRLKIARGTSCGLAYMHQIC--- 727
L+ Y E+GSL +L+ + +K+A T+ GLA++H
Sbjct: 69 DNGTWTQLWLVSDYHEHGSLFDYLNRY-----TVTVEGMIKLALSTASGLAHLHMEIVGT 123
Query: 728 --EPHIVHRDIKSSNILLDDQFEAHLADFGLSRLILPYQTHV---TTELVGTLGYIPPEY 782
+P I HRD+KS NIL+ +AD GL+ + VGT Y+ PE
Sbjct: 124 QGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEV 183
Query: 783 GQAWV------ATLRGDMYSFGVVMLELLTGKRPVDVLK----PKMSRELVGWVLKMRSE 832
+ + R D+Y+ G+V E+ + + P ++ +
Sbjct: 184 LDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEEMRK 243
Query: 833 GKQDQVFDPILRGKGFDEEMLQVL-DVACMCVSQNPFKRPTVKEVVEWLNNV 883
+Q P + + E L+V+ + C N R T + + L+ +
Sbjct: 244 VVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQL 295
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 199 bits (508), Expect = 6e-59
Identities = 65/278 (23%), Positives = 117/278 (42%), Gaps = 24/278 (8%)
Query: 607 DNFSQANIIGCGGFGLVYKATLANGTTLAIKKLSGDLGLMEREFKAEVEALSTAQHKNLV 666
+ + +G G FG+V +AIK + + E EF E + + H+ LV
Sbjct: 4 KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEG-SMSEDEFIEEAKVMMNLSHEKLV 62
Query: 667 SLQGYCVHQGFRLLIYSYMENGSLDYWLHEKADGASQLDWLTRLKIARGTSCGLAYMHQI 726
L G C Q +I YM NG L +L E + L++ + + Y+
Sbjct: 63 QLYGVCTKQRPIFIITEYMANGCLLNYLREMR---HRFQTQQLLEMCKDVCEAMEYLES- 118
Query: 727 CEPHIVHRDIKSSNILLDDQFEAHLADFGLSRLILPYQTHVTTELVGTLGYIPPEYGQAW 786
+HRD+ + N L++DQ ++DFGLSR +L + + + + PPE
Sbjct: 119 --KQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLMYS 176
Query: 787 VATLRGDMYSFGVVMLELLT-GKRPVDVLKPKMSRELVGWVLKMRSEGKQDQVFDPILRG 845
+ + D+++FGV+M E+ + GK P + + E + L++ + P
Sbjct: 177 KFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLRL---------YRP---- 223
Query: 846 KGFDEEMLQVLDVACMCVSQNPFKRPTVKEVVEWLNNV 883
+V + C + +RPT K ++ + +V
Sbjct: 224 ---HLASEKVYTIMYSCWHEKADERPTFKILLSNILDV 258
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 201 bits (511), Expect = 2e-58
Identities = 64/310 (20%), Positives = 130/310 (41%), Gaps = 40/310 (12%)
Query: 605 ATDNFSQANIIGCGGFGLVYKAT-LANGTTLAIKKLSGDL-GLMEREFKAEVEALSTAQH 662
D+F + + +G G G+V+K + +G +A K + ++ + + E++ L
Sbjct: 4 KDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNS 63
Query: 663 KNLVSLQGYCVHQGFRLLIYSYMENGSLDYWLHEKADGASQLDWLTRLKIARGTSCGLAY 722
+V G G + +M+ GSLD L + ++ K++ GL Y
Sbjct: 64 PYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKA----GRIPEQILGKVSIAVIKGLTY 119
Query: 723 MHQICEPHIVHRDIKSSNILLDDQFEAHLADFGLSRLILPYQTHVTTELVGTLGYIPPEY 782
+ + I+HRD+K SNIL++ + E L DFG+S + + VGT Y+ PE
Sbjct: 120 LREKH--KIMHRDVKPSNILVNSRGEIKLCDFGVSGQL---IDSMANSFVGTRSYMSPER 174
Query: 783 GQAWVATLRGDMYSFGVVMLELLTGKRPVD---------VLKPKMSRELVGWVLKMRSEG 833
Q +++ D++S G+ ++E+ G+ P+ + ++ + + R+ G
Sbjct: 175 LQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPG 234
Query: 834 KQDQVFDPILRGKGFDEEML------------------QVLDVACMCVSQNPFKRPTVKE 875
+ + R E+L + D C+ +NP +R +K+
Sbjct: 235 RPLSSYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQ 294
Query: 876 VVE--WLNNV 883
++ ++
Sbjct: 295 LMVHAFIKRS 304
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 198 bits (505), Expect = 4e-58
Identities = 67/279 (24%), Positives = 117/279 (41%), Gaps = 28/279 (10%)
Query: 607 DNFSQANIIGCGGFGLVYKATLANGTTLAIKKLSGDLGLMEREFKAEVEALSTAQHKNLV 666
++ +G G FG V+ T T +AIK L + F E + + +H+ LV
Sbjct: 17 ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLV 75
Query: 667 SLQGYCVHQGFRLLIYSYMENGSLDYWLHEKADGASQLDWLTRLKIARGTSCGLAYMHQI 726
L + ++ YM GSL +L + L + +A + G+AY+ +
Sbjct: 76 QLYAVVSEEPI-YIVTEYMSKGSLLDFLKGE--TGKYLRLPQLVDMAAQIASGMAYVER- 131
Query: 727 CEPHIVHRDIKSSNILLDDQFEAHLADFGLSRLILPYQTHVTTELVGTLGYIPPEYGQAW 786
+ VHRD++++NIL+ + +ADFGL+RLI + + + PE
Sbjct: 132 --MNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYG 189
Query: 787 VATLRGDMYSFGVVMLELLTGKRPVDVLKPKMSRELVGWVLKMRSEGKQDQVFDPILRGK 846
T++ D++SFG+++ EL T R +V D + RG
Sbjct: 190 RFTIKSDVWSFGILLTELTTKGRVPY------------------PGMVNREVLDQVERGY 231
Query: 847 GF---DEEMLQVLDVACMCVSQNPFKRPTVKEVVEWLNN 882
E + D+ C C + P +RPT + + +L +
Sbjct: 232 RMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLED 270
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Score = 193 bits (492), Expect = 3e-56
Identities = 69/308 (22%), Positives = 124/308 (40%), Gaps = 47/308 (15%)
Query: 598 TIYELLKATDNFSQA---------NIIGCGGFGLVYKATLA----NGTTLAIKKLSGDLG 644
T + +A F++ +IG G FG V L +AIK L
Sbjct: 8 TFEDPNEAVREFAKEIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYT 67
Query: 645 L-MEREFKAEVEALSTAQHKNLVSLQGYCVHQGFRLLIYSYMENGSLDYWLHEKADGASQ 703
R+F +E + H N++ L+G ++I +MENGSLD +L + Q
Sbjct: 68 EKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMIITEFMENGSLDSFLRQND---GQ 124
Query: 704 LDWLTRLKIARGTSCGLAYMHQICEPHIVHRDIKSSNILLDDQFEAHLADFGLSRLILPY 763
+ + + RG + G+ Y+ + VHRD+ + NIL++ ++DFGLSR +
Sbjct: 125 FTVIQLVGMLRGIAAGMKYLAD---MNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDD 181
Query: 764 QTHVTTE----LVGTLGYIPPEYGQAWVATLRGDMYSFGVVMLELLT-GKRPVDVLKPKM 818
+ T + + PE Q T D++S+G+VM E+++ G+RP + +
Sbjct: 182 TSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMTNQ- 240
Query: 819 SRELVGWVLKMRSEGKQDQVFDPILRGKGFD---EEMLQVLDVACMCVSQNPFKRPTVKE 875
V + I + + + + C ++ RP +
Sbjct: 241 ------------------DVINAIEQDYRLPPPMDCPSALHQLMLDCWQKDRNHRPKFGQ 282
Query: 876 VVEWLNNV 883
+V L+ +
Sbjct: 283 IVNTLDKM 290
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Score = 192 bits (488), Expect = 9e-56
Identities = 59/278 (21%), Positives = 114/278 (41%), Gaps = 22/278 (7%)
Query: 607 DNFSQANIIGCGGFGLVYKATL-ANGTTLAIKKLSGDLGLMEREFKAEVEALSTAQHKNL 665
+ + + +G G +G VY+ T+A+K L D + EF E + +H NL
Sbjct: 17 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED-TMEVEEFLKEAAVMKEIKHPNL 75
Query: 666 VSLQGYCVHQGFRLLIYSYMENGSLDYWLHEKADGASQLDWLTRLKIARGTSCGLAYMHQ 725
V L G C + +I +M G+L +L E ++ + L +A S + Y+ +
Sbjct: 76 VQLLGVCTREPPFYIITEFMTYGNLLDYLREC--NRQEVSAVVLLYMATQISSAMEYLEK 133
Query: 726 ICEPHIVHRDIKSSNILLDDQFEAHLADFGLSRLILPYQTHVTTELVGTLGYIPPEYGQA 785
+ +HRD+ + N L+ + +ADFGLSRL+ + + PE
Sbjct: 134 ---KNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAY 190
Query: 786 WVATLRGDMYSFGVVMLELLTGKRPVDVLKPKMSRELVGWVLKMRSEGKQDQVFDPILRG 845
+++ D+++FGV++ E+ T + ++ + R
Sbjct: 191 NKFSIKSDVWAFGVLLWEIATYGMSPY---------------PGIDLSQVYELLEKDYRM 235
Query: 846 KGFDEEMLQVLDVACMCVSQNPFKRPTVKEVVEWLNNV 883
+ + +V ++ C NP RP+ E+ + +
Sbjct: 236 ERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETM 273
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 192 bits (488), Expect = 1e-55
Identities = 68/305 (22%), Positives = 117/305 (38%), Gaps = 52/305 (17%)
Query: 607 DNFSQANIIGCGGFGLVYKATLAN------GTTLAIKKLSGDLGL-MEREFKAEVEALST 659
+N IG G FG V++A T +A+K L + M+ +F+ E ++
Sbjct: 13 NNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAE 72
Query: 660 AQHKNLVSLQGYCVHQGFRLLIYSYMENGSLDYWLHEK--------------------AD 699
+ N+V L G C L++ YM G L+ +L +
Sbjct: 73 FDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSP 132
Query: 700 GASQLDWLTRLKIARGTSCGLAYMHQICEPHIVHRDIKSSNILLDDQFEAHLADFGLSRL 759
G L +L IAR + G+AY+ E VHRD+ + N L+ + +ADFGLSR
Sbjct: 133 GPPPLSCAEQLCIARQVAAGMAYLS---ERKFVHRDLATRNCLVGENMVVKIADFGLSRN 189
Query: 760 ILPYQ-THVTTELVGTLGYIPPEYGQAWVATLRGDMYSFGVVMLELLTGKRPVDVLKPKM 818
I + ++PPE T D++++GVV+ E+ +
Sbjct: 190 IYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQ-------- 241
Query: 819 SRELVGWVLKMRSEGKQDQVFDPILRGKGF---DEEMLQVLDVACMCVSQNPFKRPTVKE 875
++V + G + L++ ++ +C S+ P RP+
Sbjct: 242 ----------PYYGMAHEEVIYYVRDGNILACPENCPLELYNLMRLCWSKLPADRPSFCS 291
Query: 876 VVEWL 880
+ L
Sbjct: 292 IHRIL 296
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Score = 192 bits (488), Expect = 2e-55
Identities = 68/307 (22%), Positives = 126/307 (41%), Gaps = 33/307 (10%)
Query: 586 LFPNNTNEIKDLTIYELLKATDNFSQANIIGCGGFGLVYKATLAN----GTTLAIKKLSG 641
L P ++ + I +F+ +IG G FG VY TL + A+K L+
Sbjct: 9 LNPELVQAVQHVVI-GPSSLIVHFN--EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNR 65
Query: 642 DLGLME-REFKAEVEALSTAQHKNLVSLQGYCVH-QGFRLLIYSYMENGSLDYWLHEKAD 699
+ E +F E + H N++SL G C+ +G L++ YM++G L ++ +
Sbjct: 66 ITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNET- 124
Query: 700 GASQLDWLTRLKIARGTSCGLAYMHQICEPHIVHRDIKSSNILLDDQFEAHLADFGLSRL 759
+ + G+ ++ VHRD+ + N +LD++F +ADFGL+R
Sbjct: 125 --HNPTVKDLIGFGLQVAKGMKFLAS---KKFVHRDLAARNCMLDEKFTVKVADFGLARD 179
Query: 760 ILP---YQTHVTTELVGTLGYIPPEYGQAWVATLRGDMYSFGVVMLELLTGKRPVDVLKP 816
+ H T + ++ E Q T + D++SFGV++ EL+T P P
Sbjct: 180 MYDKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAP-----P 234
Query: 817 KMSRELVGWVLKMRSEGKQDQVFDPILRGKGFDEEMLQVLDVACMCVSQNPFKRPTVKEV 876
+ + +L+ + + + +V C RP+ E+
Sbjct: 235 YPDVNTFDITVYLLQG-------RRLLQPEYCPDPL---YEVMLKCWHPKAEMRPSFSEL 284
Query: 877 VEWLNNV 883
V ++ +
Sbjct: 285 VSRISAI 291
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 190 bits (483), Expect = 2e-55
Identities = 65/278 (23%), Positives = 112/278 (40%), Gaps = 28/278 (10%)
Query: 607 DNFSQANIIGCGGFGLVYKATLANGTTLAIKKLSGDLGLMEREFKAEVEALSTAQHKNLV 666
IG G FG V G +A+K + D + F AE ++ +H NLV
Sbjct: 7 KELKLLQTIGKGEFGDVMLGDY-RGNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLV 63
Query: 667 SLQGYCVHQGFRL-LIYSYMENGSLDYWLHEKADGASQLDWLTRLKIARGTSCGLAYMHQ 725
L G V + L ++ YM GSL +L + G S L LK + + Y+
Sbjct: 64 QLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSR--GRSVLGGDCLLKFSLDVCEAMEYLEG 121
Query: 726 ICEPHIVHRDIKSSNILLDDQFEAHLADFGLSRLILPYQTHVTTELVGTLGYIPPEYGQA 785
+ VHRD+ + N+L+ + A ++DFGL++ Q + + PE +
Sbjct: 122 ---NNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGK----LPVKWTAPEALRE 174
Query: 786 WVATLRGDMYSFGVVMLELLTGKRPVDVLKPKMSRELVGWVLKMRSEGKQDQVFDPILRG 845
+ + D++SFG+++ E+ + R P L V ++ K D
Sbjct: 175 KKFSTKSDVWSFGILLWEIYSFGRV-----PYPRIPLKDVVPRVEKGYKMDAP------- 222
Query: 846 KGFDEEMLQVLDVACMCVSQNPFKRPTVKEVVEWLNNV 883
G + +V C + RP+ ++ E L ++
Sbjct: 223 DGCPPAV---YEVMKNCWHLDAAMRPSFLQLREQLEHI 257
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 190 bits (483), Expect = 7e-55
Identities = 78/297 (26%), Positives = 120/297 (40%), Gaps = 40/297 (13%)
Query: 607 DNFSQANIIGCGGFGLVYKATLA------NGTTLAIKKLSGDLGLMERE-FKAEVEALST 659
+ S +G G FG V +AT T+A+K L L ERE +E++ LS
Sbjct: 23 NRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSY 82
Query: 660 -AQHKNLVSLQGYCVHQGFRLLIYSYMENGSLDYWLHEK--------------ADGASQL 704
H N+V+L G C G L+I Y G L +L K D L
Sbjct: 83 LGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELAL 142
Query: 705 DWLTRLKIARGTSCGLAYMHQICEPHIVHRDIKSSNILLDDQFEAHLADFGLSRLILPYQ 764
D L + + G+A++ + +HRD+ + NILL + DFGL+R I
Sbjct: 143 DLEDLLSFSYQVAKGMAFLA---SKNCIHRDLAARNILLTHGRITKICDFGLARDIKNDS 199
Query: 765 TH-VTTELVGTLGYIPPEYGQAWVATLRGDMYSFGVVMLELLTGKRPVDVLKPKMSRELV 823
+ V + ++ PE V T D++S+G+ + EL + +
Sbjct: 200 NYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPY-----PGMPVD 254
Query: 824 GWVLKMRSEGKQDQVFDPILRGKGFDEEMLQVLDVACMCVSQNPFKRPTVKEVVEWL 880
KM EG +L + EM D+ C +P KRPT K++V+ +
Sbjct: 255 SKFYKMIKEGF------RMLSPEHAPAEM---YDIMKTCWDADPLKRPTFKQIVQLI 302
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Score = 189 bits (480), Expect = 1e-54
Identities = 63/289 (21%), Positives = 118/289 (40%), Gaps = 31/289 (10%)
Query: 601 ELLKATDNFSQANI-IGCGGFGLVYKATLA---NGTTLAIKKLSGDLGLMERE-FKAEVE 655
+L DN A+I +GCG FG V + +AIK L + E E +
Sbjct: 2 KLFLKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQ 61
Query: 656 ALSTAQHKNLVSLQGYCVHQGFRLLIYSYMENGSLDYWLHEKADGASQLDWLTRLKIARG 715
+ + +V L G C + +L+ G L +L K + ++ ++
Sbjct: 62 IMHQLDNPYIVRLIGVCQAEAL-MLVMEMAGGGPLHKFLVGKRE---EIPVSNVAELLHQ 117
Query: 716 TSCGLAYMHQICEPHIVHRDIKSSNILLDDQFEAHLADFGLSRLILPYQTHVT--TELVG 773
S G+ Y+ + + VHRD+ + N+LL ++ A ++DFGLS+ + ++ T +
Sbjct: 118 VSMGMKYLEE---KNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKW 174
Query: 774 TLGYIPPEYGQAWVATLRGDMYSFGVVMLELLT-GKRPVDVLKPKMSRELVGWVLKMRSE 832
L + PE + R D++S+GV M E L+ G++P +K E++ ++ + +
Sbjct: 175 PLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGP---EVMAFIEQGK-- 229
Query: 833 GKQDQVFDPILRGKGFDEEMLQVLDVACMCVSQNPFKRPTVKEVVEWLN 881
+ E+ + C RP V + +
Sbjct: 230 --------RMECPPECPPEL---YALMSDCWIYKWEDRPDFLTVEQRMR 267
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 189 bits (481), Expect = 2e-54
Identities = 69/280 (24%), Positives = 114/280 (40%), Gaps = 34/280 (12%)
Query: 606 TDNFSQANIIGCGGFGLVYKAT-LANGTTLAIKKLSGDLGL---MEREFKAEVEALSTAQ 661
FS IG G FG VY A + N +AIKK+S ++ EV L +
Sbjct: 14 EKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLR 73
Query: 662 HKNLVSLQGYCVHQGFRLLIYSYMENGSLDYWLHEKADGASQLDWLTRLKIARGTSCGLA 721
H N + +G + + L+ Y + D K L + + G GLA
Sbjct: 74 HPNTIQYRGCYLREHTAWLVMEYCLGSASDLLEVHK----KPLQEVEIAAVTHGALQGLA 129
Query: 722 YMHQICEPHIVHRDIKSSNILLDDQFEAHLADFGLSRLILPYQTHVTTELVGTLGYIPPE 781
Y+H +++HRD+K+ NILL + L DFG + ++ P VGT ++ PE
Sbjct: 130 YLH---SHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAP-----ANSFVGTPYWMAPE 181
Query: 782 YGQAW---VATLRGDMYSFGVVMLELLTGKRPVDVLKPKMSRELVGWVLKMRSEGKQDQV 838
A + D++S G+ +EL K P+ + L ++ +
Sbjct: 182 VILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAM-------SALYHIAQNE---- 230
Query: 839 FDPILRGKGFDEEMLQVLDVACMCVSQNPFKRPTVKEVVE 878
P L+ + E +D C+ + P RPT + +++
Sbjct: 231 -SPALQSGHWSEYFRNFVD---SCLQKIPQDRPTSEVLLK 266
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 187 bits (476), Expect = 3e-54
Identities = 63/283 (22%), Positives = 115/283 (40%), Gaps = 26/283 (9%)
Query: 607 DNFSQANIIGCGGFGLVYKAT-LANGTTLAIKKLSGDL--GLMEREFKAEVEALSTAQHK 663
+++ IG G +G K ++G L K+L ++ +EV L +H
Sbjct: 4 EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHP 63
Query: 664 NLVSLQGYCVHQGFRLL--IYSYMENGSLDYWLHEKADGASQLDWLTRLKIARGTSCGLA 721
N+V + + L + Y E G L + + LD L++ + L
Sbjct: 64 NIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALK 123
Query: 722 YMHQ--ICEPHIVHRDIKSSNILLDDQFEAHLADFGLSRLILPYQTHVTTELVGTLGYIP 779
H+ ++HRD+K +N+ LD + L DFGL+R IL + T VGT Y+
Sbjct: 124 ECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLAR-ILNHDTSFAKAFVGTPYYMS 182
Query: 780 PEYGQAWVATLRGDMYSFGVVMLELLTGKRPVDVLKPKMSRELVGWVLKMRSEGKQDQVF 839
PE + D++S G ++ EL P K + EGK ++
Sbjct: 183 PEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKE-------LAGKIREGKFRRIP 235
Query: 840 DPILRGKGFDEEMLQVLDVACMCVSQNPFKRPTVKEVVE--WL 880
+ +E+ +++ ++ + RP+V+E++E +
Sbjct: 236 Y------RYSDELNEIIT---RMLNLKDYHRPSVEEILENPLI 269
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Score = 187 bits (475), Expect = 4e-54
Identities = 65/286 (22%), Positives = 120/286 (41%), Gaps = 32/286 (11%)
Query: 613 NIIGCGGFGLVYKATLAN---GTTLAIKKLSGDL--GLMEREFKAEVEALSTAQHKNLVS 667
+G G FG V K T+A+K L + ++ E AE + + +V
Sbjct: 13 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVR 72
Query: 668 LQGYCVHQGFRLLIYSYMENGSLDYWLHEKADGASQLDWLTRLKIARGTSCGLAYMHQIC 727
+ G C + + +L+ E G L+ +L + + +++ S G+ Y+ +
Sbjct: 73 MIGICEAESW-MLVMEMAELGPLNKYLQQN----RHVKDKNIIELVHQVSMGMKYLEE-- 125
Query: 728 EPHIVHRDIKSSNILLDDQFEAHLADFGLSRLILPYQTHVTTE--LVGTLGYIPPEYGQA 785
+ VHRD+ + N+LL Q A ++DFGLS+ + + + + + + PE
Sbjct: 126 -SNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINY 184
Query: 786 WVATLRGDMYSFGVVMLELLT-GKRPVDVLKPKMSRELVGWVLKMRSEGKQDQVFDPILR 844
+ + + D++SFGV+M E + G++P +K V M +G++
Sbjct: 185 YKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGS-------EVTAMLEKGERMGCPA---- 233
Query: 845 GKGFDEEMLQVLDVACMCVSQNPFKRPTVKEVVEWLNNVGANRRNE 890
G EM D+ +C + + RP V L N + NE
Sbjct: 234 --GCPREM---YDLMNLCWTYDVENRPGFAAVELRLRNYYYDVVNE 274
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 187 bits (475), Expect = 5e-54
Identities = 74/299 (24%), Positives = 123/299 (41%), Gaps = 39/299 (13%)
Query: 591 TNEIKDLTIYELLKATDNFSQANIIGCGGFGLVYKATLANGT-----TLAIKKLSGDLGL 645
T EI ++ +IG G FG VYK L + +AIK L
Sbjct: 1 TTEIH----------PSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTE 50
Query: 646 MER-EFKAEVEALSTAQHKNLVSLQGYCVHQGFRLLIYSYMENGSLDYWLHEKADGASQL 704
+R +F E + H N++ L+G ++I YMENG+LD +L EK +
Sbjct: 51 KQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMMIITEYMENGALDKFLREKD---GEF 107
Query: 705 DWLTRLKIARGTSCGLAYMHQICEPHIVHRDIKSSNILLDDQFEAHLADFGLSRLIL--P 762
L + + RG + G+ Y+ + VHRD+ + NIL++ ++DFGLSR++ P
Sbjct: 108 SVLQLVGMLRGIAAGMKYLA---NMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDP 164
Query: 763 YQTHVTTELVGTLGYIPPEYGQAWVATLRGDMYSFGVVMLELLTGKRPVDVLKPKMSREL 822
T+ T+ + + PE T D++SFG+VM E++T
Sbjct: 165 EATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPY---------- 214
Query: 823 VGWVLKMRSEGKQDQVFDPILRGKGFDEEMLQVLDVACMCVSQNPFKRPTVKEVVEWLN 881
S + + + R + + + C Q +RP ++V L+
Sbjct: 215 -----WELSNHEVMKAINDGFRLPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILD 268
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 186 bits (472), Expect = 2e-53
Identities = 70/300 (23%), Positives = 127/300 (42%), Gaps = 37/300 (12%)
Query: 607 DNFSQANIIGCGGFGLVYKATLANGTTL---AIKKLSGDLGL-MEREFKAEVEALST-AQ 661
++ ++IG G FG V KA + AIK++ R+F E+E L
Sbjct: 10 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGH 69
Query: 662 HKNLVSLQGYCVHQGFRLLIYSYMENGSLDYWLHEK------------ADGASQLDWLTR 709
H N+++L G C H+G+ L Y +G+L +L + AS L
Sbjct: 70 HPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQL 129
Query: 710 LKIARGTSCGLAYMHQICEPHIVHRDIKSSNILLDDQFEAHLADFGLSRLILPYQTHVTT 769
L A + G+ Y+ + +HRD+ + NIL+ + + A +ADFGLSR Y
Sbjct: 130 LHFAADVARGMDYL---SQKQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVKKTMG 186
Query: 770 ELVGTLGYIPPEYGQAWVATLRGDMYSFGVVMLELLTGKRPVDVLKPKMSRELVGWVLKM 829
+ ++ E V T D++S+GV++ E+++ P K+
Sbjct: 187 --RLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGT-----PYCGMTCAELYEKL 239
Query: 830 RSEGKQDQVFDPILRGKGFDEEMLQVLDVACMCVSQNPFKRPTVKEVVEWLNNVGANRRN 889
+ ++ + D+E+ D+ C + P++RP+ +++ LN + R+
Sbjct: 240 PQGYRLEKPLN-------CDDEV---YDLMRQCWREKPYERPSFAQILVSLNRMLEERKT 289
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 183 bits (465), Expect = 6e-53
Identities = 75/282 (26%), Positives = 118/282 (41%), Gaps = 37/282 (13%)
Query: 607 DNFSQANIIGCGGFGLVYKATL-ANGTTLAIKKLSGDLGL---MEREFKAEVEALSTAQH 662
++F +G G FG VY A + LA+K L +E + + EVE S +H
Sbjct: 6 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRH 65
Query: 663 KNLVSLQGYCVHQGFRLLIYSYMENGSLDYWLHEKADGASQLDWLTRLKIARGTSCGLAY 722
N++ L GY LI Y G++ L + S+ D + L+Y
Sbjct: 66 PNILRLYGYFHDATRVYLILEYAPLGTVYRELQKL----SKFDEQRTATYITELANALSY 121
Query: 723 MHQICEPHIVHRDIKSSNILLDDQFEAHLADFGLSRLILPYQTHVTTELVGTLGYIPPEY 782
H ++HRDIK N+LL E +ADFG S + T L GTL Y+PPE
Sbjct: 122 CH---SKRVIHRDIKPENLLLGSAGELKIADFGWSVHA---PSSRRTTLCGTLDYLPPEM 175
Query: 783 GQAWVATLRGDMYSFGVVMLELLTGKRPVDVLKPKMSRELVGWVLKMRSEGKQDQVFDPI 842
+ + + D++S GV+ E L GK P + + + + I
Sbjct: 176 IEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQ-------------------ETYKRI 216
Query: 843 LRGKGFDEEML--QVLDVACMCVSQNPFKRPTVKEVVE--WL 880
R + + + D+ + NP +RP ++EV+E W+
Sbjct: 217 SRVEFTFPDFVTEGARDLISRLLKHNPSQRPMLREVLEHPWI 258
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 185 bits (470), Expect = 7e-53
Identities = 63/303 (20%), Positives = 118/303 (38%), Gaps = 45/303 (14%)
Query: 607 DNFSQANIIGCGGFGLVYKATL------ANGTTLAIKKLSGDLGLMERE-FKAEVEALST 659
+N ++G G FG V AT +A+K L ERE +E++ ++
Sbjct: 37 ENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQ 96
Query: 660 -AQHKNLVSLQGYCVHQGFRLLIYSYMENGSLDYWLHEK-------------------AD 699
H+N+V+L G C G LI+ Y G L +L K +
Sbjct: 97 LGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEE 156
Query: 700 GASQLDWLTRLKIARGTSCGLAYMHQICEPHIVHRDIKSSNILLDDQFEAHLADFGLSRL 759
+ L + L A + G+ ++ VHRD+ + N+L+ + DFGL+R
Sbjct: 157 DLNVLTFEDLLCFAYQVAKGMEFLE---FKSCVHRDLAARNVLVTHGKVVKICDFGLARD 213
Query: 760 ILPYQTHVT-TELVGTLGYIPPEYGQAWVATLRGDMYSFGVVMLELLTGKRPVDVLKPKM 818
I+ +V + ++ PE + T++ D++S+G+++ E+ + P
Sbjct: 214 IMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVN-----PYP 268
Query: 819 SRELVGWVLKMRSEGKQDQVFDPILRGKGFDEEMLQVLDVACMCVSQNPFKRPTVKEVVE 878
+ K+ G + + EE+ + C + + KRP+ +
Sbjct: 269 GIPVDANFYKLIQNGF------KMDQPFYATEEI---YIIMQSCWAFDSRKRPSFPNLTS 319
Query: 879 WLN 881
+L
Sbjct: 320 FLG 322
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 182 bits (464), Expect = 1e-52
Identities = 61/278 (21%), Positives = 108/278 (38%), Gaps = 33/278 (11%)
Query: 613 NIIGCGGFGLVYKATL-ANGTTLAIKKLSGDLGLME--REFKAEVEALSTAQHKNLVSLQ 669
IG G F VYK +A +L + FK E E L QH N+V
Sbjct: 15 IEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFY 74
Query: 670 GYCV----HQGFRLLIYSYMENGSLDYWLHEKADGASQLDWLTRLKIARGTSCGLAYMHQ 725
+ +L+ M +G+L +L + R GL ++H
Sbjct: 75 DSWESTVKGKKCIVLVTELMTSGTLKTYLKRF----KVMKIKVLRSWCRQILKGLQFLHT 130
Query: 726 ICEPHIVHRDIKSSNILLDDQ-FEAHLADFGLSRLILPYQTHVTTELVGTLGYIPPEYGQ 784
P I+HRD+K NI + + D GL+ L + ++GT ++ PE +
Sbjct: 131 RT-PPIIHRDLKCDNIFITGPTGSVKIGDLGLATL---KRASFAKAVIGTPEFMAPEMYE 186
Query: 785 AWVATLRGDMYSFGVVMLELLTGKRPVDVLKPKMSRELVGWVLKMRSEGKQDQVFDPILR 844
D+Y+FG+ MLE+ T + P + + + ++ V D+V P ++
Sbjct: 187 E-KYDESVDVYAFGMCMLEMATSEYPYS--ECQNAAQIYRRVTSGVKPASFDKVAIPEVK 243
Query: 845 GKGFDEEMLQVLDVACMCVSQNPFKRPTVKEVVE--WL 880
++ C+ QN +R ++K+++ +
Sbjct: 244 ------------EIIEGCIRQNKDERYSIKDLLNHAFF 269
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Score = 182 bits (462), Expect = 4e-52
Identities = 60/288 (20%), Positives = 112/288 (38%), Gaps = 29/288 (10%)
Query: 603 LKATDNFSQANIIGCGGFGLVYKAT-LANGTTLAIKKLSGDLGLMEREFKAEVEALSTAQ 661
L D + +G G FG VYKA A K + ++ E++ L++
Sbjct: 8 LNPEDFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCD 67
Query: 662 HKNLVSLQGYCVHQGFRLLIYSYMENGSLDYWLHEKADGASQLDWLTRLKIARGTSCGLA 721
H N+V L ++ ++ + G++D + E L + + T L
Sbjct: 68 HPNIVKLLDAFYYENNLWILIEFCAGGAVDAVMLELE---RPLTESQIQVVCKQTLDALN 124
Query: 722 YMHQICEPHIVHRDIKSSNILLDDQFEAHLADFGLSRLILPYQTHVTTELVGTLGYIPPE 781
Y+H + I+HRD+K+ NIL + LADFG+S + +GT ++ PE
Sbjct: 125 YLH---DNKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDS-FIGTPYWMAPE 180
Query: 782 YGQAWVATLRG-----DMYSFGVVMLELLTGKRPVDVLKPKMSRELVGWVLKMRSEGKQD 836
+ R D++S G+ ++E+ + P L P VL ++ +
Sbjct: 181 VVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMR-------VLLKIAKSEPP 233
Query: 837 QVFDPILRGKGFDEEMLQVLDVACMCVSQNPFKRPTVKEVVE--WLNN 882
+ P + L C+ +N R T ++++ ++
Sbjct: 234 TLAQP----SRWSSNFKDFLK---KCLEKNVDARWTTSQLLQHPFVTV 274
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 179 bits (456), Expect = 1e-51
Identities = 60/281 (21%), Positives = 110/281 (39%), Gaps = 27/281 (9%)
Query: 607 DNFSQANIIGCGGFGLVYKAT-LANGTTLAIKKLSGDLGL-MEREFKAEVEALSTAQHKN 664
+++ +G G +G V A +A+K + + K E+ H+N
Sbjct: 5 EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHEN 64
Query: 665 LVSLQGYCVHQGFRLLIYSYMENGSLDYWLHEKADGASQLDWLTRLKIARGTSCGLAYMH 724
+V G+ + L Y G L + + + G+ Y+H
Sbjct: 65 VVKFYGHRREGNIQYLFLEYCSGGELFDRIEPD----IGMPEPDAQRFFHQLMAGVVYLH 120
Query: 725 QICEPHIVHRDIKSSNILLDDQFEAHLADFGLSRLILP-YQTHVTTELVGTLGYIPPEYG 783
I HRDIK N+LLD++ ++DFGL+ + + + ++ GTL Y+ PE
Sbjct: 121 ---GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELL 177
Query: 784 QAW-VATLRGDMYSFGVVMLELLTGKRPVDVLKPKMSRELVGWVLKMRSEGKQDQVFDPI 842
+ D++S G+V+ +L G+ P D + S+ K+ + +
Sbjct: 178 KRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSC---------QEYSDWKEKKTYLNP 228
Query: 843 LRGKGFDEEMLQVLDVACMCVSQNPFKRPTVKEVVE--WLN 881
K D L +L + +NP R T+ ++ + W N
Sbjct: 229 W--KKIDSAPLALLH---KILVENPSARITIPDIKKDRWYN 264
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 178 bits (452), Expect = 1e-50
Identities = 62/280 (22%), Positives = 116/280 (41%), Gaps = 26/280 (9%)
Query: 606 TDNFSQANIIGCGGFGLVYKAT-LANGTTLAIKKLSGDLGLMEREFKAEVEALSTAQHKN 664
+++ IG G G VY A +A G +AI++++ + E+ + ++ N
Sbjct: 19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPN 78
Query: 665 LVSLQGYCVHQGFRLLIYSYMENGSLDYWLHEKADGASQLDWLTRLKIARGTSCGLAYMH 724
+V+ + ++ Y+ GSL + E +D + R L ++H
Sbjct: 79 IVNYLDSYLVGDELWVVMEYLAGGSLTDVVTET-----CMDEGQIAAVCRECLQALEFLH 133
Query: 725 QICEPHIVHRDIKSSNILLDDQFEAHLADFGLSRLILPYQTHVTTELVGTLGYIPPEYGQ 784
++HRDIKS NILL L DFG I P Q+ +T VGT ++ PE
Sbjct: 134 SN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTM-VGTPYWMAPEVVT 189
Query: 785 AWVATLRGDMYSFGVVMLELLTGKRPVDVLKPKMSRELVGWVLKMRSEGKQDQVFDPILR 844
+ D++S G++ +E++ G+ P P L + + ++ +P
Sbjct: 190 RKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLR-------ALYLIATNGTPELQNP--- 239
Query: 845 GKGFDEEMLQVLDVACMCVSQNPFKRPTVKEVVE--WLNN 882
+ L+ C+ + KR + KE+++ +L
Sbjct: 240 -EKLSAIFRDFLN---RCLDMDVEKRGSAKELLQHQFLKI 275
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Score = 173 bits (440), Expect = 2e-49
Identities = 64/290 (22%), Positives = 110/290 (37%), Gaps = 31/290 (10%)
Query: 600 YELLKATDNFSQANIIGCGGFGLVYKATLAN----GTTLAIKKLSGDLGLMERE-FKAEV 654
YE+ + + IG G FG V++ + +AIK RE F E
Sbjct: 2 YEIQR--ERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEA 59
Query: 655 EALSTAQHKNLVSLQGYCVHQGFRLLIYSYMENGSLDYWLHEKADGASQLDWLTRLKIAR 714
+ H ++V L G + +I G L +L + LD + + A
Sbjct: 60 LTMRQFDHPHIVKLIGVI-TENPVWIIMELCTLGELRSFLQVRKYS---LDLASLILYAY 115
Query: 715 GTSCGLAYMHQICEPHIVHRDIKSSNILLDDQFEAHLADFGLSRLILPYQTHVTTELVGT 774
S LAY+ VHRDI + N+L+ L DFGLSR + + ++
Sbjct: 116 QLSTALAYLE---SKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLP 172
Query: 775 LGYIPPEYGQAWVATLRGDMYSFGVVMLELLT-GKRPVDVLKPKMSRELVGWVLKMRSEG 833
+ ++ PE T D++ FGV M E+L G +P +K +++G +
Sbjct: 173 IKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNN---DVIGRIENG---- 225
Query: 834 KQDQVFDPILRGKGFDEEMLQVLDVACMCVSQNPFKRPTVKEVVEWLNNV 883
+ + + + C + +P +RP E+ L+ +
Sbjct: 226 ------ERLPMPPNCPPTL---YSLMTKCWAYDPSRRPRFTELKAQLSTI 266
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 173 bits (440), Expect = 2e-49
Identities = 58/283 (20%), Positives = 109/283 (38%), Gaps = 30/283 (10%)
Query: 607 DNFSQANIIGCGGFGLVYKATL----ANGTTLAIKKLSGDLGL---MEREFKAEVEALST 659
+ +G G FG+V + ++A+K L D+ +F EV A+ +
Sbjct: 8 KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHS 67
Query: 660 AQHKNLVSLQGYCVHQGFRLLIYSYMENGSLDYWLHEKADGASQLDWLTRLKIARGTSCG 719
H+NL+ L G + ++ + GSL L + T + A + G
Sbjct: 68 LDHRNLIRLYGVVLTPPMKM-VTELAPLGSLLDRLRKHQ---GHFLLGTLSRYAVQVAEG 123
Query: 720 LAYMHQICEPHIVHRDIKSSNILLDDQFEAHLADFGLSRLILPYQTH--VTTELVGTLGY 777
+ Y+ +HRD+ + N+LL + + DFGL R + H + +
Sbjct: 124 MGYLE---SKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAW 180
Query: 778 IPPEYGQAWVATLRGDMYSFGVVMLELLTGKRPVDVLKPKMSRELVGWVLKMRSEGKQDQ 837
PE + + D + FGV + E+ T + P + + K+ EG+
Sbjct: 181 CAPESLKTRTFSHASDTWMFGVTLWEMFTYGQE-----PWIGLNGSQILHKIDKEGE--- 232
Query: 838 VFDPILRGKGFDEEMLQVLDVACMCVSQNPFKRPTVKEVVEWL 880
+ R + +++ +V C + P RPT + ++L
Sbjct: 233 ---RLPRPEDCPQDI---YNVMVQCWAHKPEDRPTFVALRDFL 269
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 173 bits (440), Expect = 7e-49
Identities = 59/288 (20%), Positives = 113/288 (39%), Gaps = 30/288 (10%)
Query: 601 ELLKATDNFSQANIIGCGGFGLVYKAT-LANGTTL----AIKKLS-GDLGLMEREFKAEV 654
+LK T+ F + ++G G FG VYK + G + AIK+L +E E
Sbjct: 4 RILKETE-FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEA 62
Query: 655 EALSTAQHKNLVSLQGYCVHQGFRLLIYSYMENGSLDYWLHEKADGASQLDWLTRLKIAR 714
+++ + ++ L G C+ +L I M G L ++ E D + L
Sbjct: 63 YVMASVDNPHVCRLLGICLTSTVQL-ITQLMPFGCLLDYVREHKD---NIGSQYLLNWCV 118
Query: 715 GTSCGLAYMHQICEPHIVHRDIKSSNILLDDQFEAHLADFGLSRLILPYQTHVTTE-LVG 773
+ G+ Y+ +VHRD+ + N+L+ + DFGL++L+ + E
Sbjct: 119 QIAKGMNYLED---RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKV 175
Query: 774 TLGYIPPEYGQAWVATLRGDMYSFGVVMLELLTGKRPVDVLKPKMSRELVGWVLKMRSEG 833
+ ++ E + T + D++S+GV + EL+T + + +L+
Sbjct: 176 PIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSK---PYDGIPASEISSILEKGERL 232
Query: 834 KQDQVFDPILRGKGFDEEMLQVLDVACMCVSQNPFKRPTVKEVVEWLN 881
Q + V + C + RP +E++ +
Sbjct: 233 PQPPICTI------------DVYMIMVKCWMIDADSRPKFRELIIEFS 268
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Score = 174 bits (442), Expect = 1e-48
Identities = 67/289 (23%), Positives = 114/289 (39%), Gaps = 26/289 (8%)
Query: 607 DNFSQANIIGCGGFGLVYKAT-LANGTTLAIKKLSGDLGLMEREFKAEVEALSTAQHKNL 665
D++ +G G FG+V++ T A G A K + + + E++ +S +H L
Sbjct: 26 DHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTL 85
Query: 666 VSLQGYCVHQGFRLLIYSYMENGSLDYWLHEKADGASQLDWLTRLKIARGTSCGLAYMHQ 725
V+L ++IY +M G L + ++ +++ ++ R GL +MH
Sbjct: 86 VNLHDAFEDDNEMVMIYEFMSGGELFEKVADE---HNKMSEDEAVEYMRQVCKGLCHMH- 141
Query: 726 ICEPHIVHRDIKSSNILLDDQFEAH--LADFGLSRLILPYQTHVTTELVGTLGYIPPEYG 783
E + VH D+K NI+ + L DFGL+ + P Q+ T GT + PE
Sbjct: 142 --ENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVT--TGTAEFAAPEVA 197
Query: 784 QAWVATLRGDMYSFGVVMLELLTGKRPVDVLKPKMSRELVGWVLKMRSEGKQDQVFDPIL 843
+ DM+S GV+ LL+G P + V K
Sbjct: 198 EGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNV----------KSCDWNMDDS 247
Query: 844 RGKGFDEEMLQVLDVACMCVSQNPFKRPTVKEVVE--WLNNVGANRRNE 890
G E+ + + +P R T+ + +E WL A R+
Sbjct: 248 AFSGISEDGKDFIR---KLLLADPNTRMTIHQALEHPWLTPGNAPGRDS 293
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 170 bits (431), Expect = 7e-48
Identities = 60/280 (21%), Positives = 104/280 (37%), Gaps = 33/280 (11%)
Query: 604 KATDNFSQANIIGCGGFGLVYKAT-LANGTTLAIKKLSGDLGLME---REFKAEVEALST 659
K ++F I+G G F V A LA AIK L + E E + +S
Sbjct: 5 KRPEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSR 64
Query: 660 AQHKNLVSLQGYCVHQGFRLLIYSYMENGSLDYWLHEKADGASQLDWLTRLKIARGTSCG 719
H V L SY +NG L ++ + D
Sbjct: 65 LDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKI----GSFDETCTRFYTA---EI 117
Query: 720 LAYMHQICEPHIVHRDIKSSNILLDDQFEAHLADFGLSRLILPY-QTHVTTELVGTLGYI 778
++ + + I+HRD+K NILL++ + DFG ++++ P + VGT Y+
Sbjct: 118 VSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYV 177
Query: 779 PPEYGQAWVATLRGDMYSFGVVMLELLTGKRPVDVLKPKMSRELVGWVLKMRSEGKQDQV 838
PE A D+++ G ++ +L+ G P G + +
Sbjct: 178 SPELLTEKSACKSSDLWALGCIIYQLVAGLPPFR-------------------AGNEYLI 218
Query: 839 FDPILRGKG-FDEEML-QVLDVACMCVSQNPFKRPTVKEV 876
F I++ + F E+ + D+ + + KR +E+
Sbjct: 219 FQKIIKLEYDFPEKFFPKARDLVEKLLVLDATKRLGCEEM 258
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 167 bits (424), Expect = 8e-47
Identities = 61/288 (21%), Positives = 109/288 (37%), Gaps = 32/288 (11%)
Query: 607 DNFSQANIIGCGGFGLVYKATL------ANGTTLAIKKLSGDLGLMER-EFKAEVEALST 659
+ + + +G G FG+VY+ T +AIK ++ + ER EF E +
Sbjct: 20 EKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKE 79
Query: 660 AQHKNLVSLQGYCVHQGFRLLIYSYMENGSLDYWLH------EKADGASQLDWLTRLKIA 713
++V L G L+I M G L +L + +++A
Sbjct: 80 FNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMA 139
Query: 714 RGTSCGLAYMHQICEPHIVHRDIKSSNILLDDQFEAHLADFGLSRLILPYQ-THVTTELV 772
+ G+ + VHRD+ + N ++ + F + DFG++R I + +
Sbjct: 140 GEIADGM---AYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGL 196
Query: 773 GTLGYIPPEYGQAWVATLRGDMYSFGVVMLELLTGKRPVDVLKPKMSRELVGWVLKMRSE 832
+ ++ PE + V T D++SFGVV+ E+ T VL+ E
Sbjct: 197 LPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNE------QVLRFVME 250
Query: 833 GKQDQVFDPILRGKGFDEEMLQVLDVACMCVSQNPFKRPTVKEVVEWL 880
G D + ++ MC NP RP+ E++ +
Sbjct: 251 GGLLDKPDNCPD---------MLFELMRMCWQYNPKMRPSFLEIISSI 289
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 166 bits (422), Expect = 1e-46
Identities = 69/299 (23%), Positives = 119/299 (39%), Gaps = 39/299 (13%)
Query: 607 DNFSQANIIGCGGFGLVYKAT------LANGTTLAIKKLS-GDLGLMEREFKAEVEALS- 658
D +G G FG V +A A T+A+K L G R +E++ L
Sbjct: 13 DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIH 72
Query: 659 TAQHKNLVSLQGYCVHQGFRLLI-YSYMENGSLDYWLHEK------------ADGASQLD 705
H N+V+L G C G L++ + + G+L +L K L
Sbjct: 73 IGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLT 132
Query: 706 WLTRLKIARGTSCGLAYMHQICEPHIVHRDIKSSNILLDDQFEAHLADFGLSRLILPYQT 765
+ + + G+ ++ +HRD+ + NILL ++ + DFGL+R I
Sbjct: 133 LEHLICYSFQVAKGMEFLA---SRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPD 189
Query: 766 HV-TTELVGTLGYIPPEYGQAWVATLRGDMYSFGVVMLELLTGKRPVDVLKPKMSRELVG 824
+V + L ++ PE V T++ D++SFGV++ E+ + P ++
Sbjct: 190 YVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGAS-----PYPGVKIDE 244
Query: 825 WVLKMRSEGKQDQVFDPILRGKGFDEEMLQVLDVACMCVSQNPFKRPTVKEVVEWLNNV 883
+ EG + + D ++ C P +RPT E+VE L N+
Sbjct: 245 EFCRRLKEGTRMRAPDYTTP---------EMYQTMLDCWHGEPSQRPTFSELVEHLGNL 294
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Score = 168 bits (426), Expect = 1e-46
Identities = 65/305 (21%), Positives = 116/305 (38%), Gaps = 38/305 (12%)
Query: 593 EIKDLTI---YELLKATDNFSQANIIGCGGFGLVYKAT-LANGTTLAIKKLSGDLGLMER 648
E+K ++ Y++L+ +G G FG+V++ A G K ++ L +
Sbjct: 21 EVKQGSVYDYYDILE---------ELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKY 71
Query: 649 EFKAEVEALSTAQHKNLVSLQGYCVHQGFRLLIYSYMENGSLDYWLHEKADGASQLDWLT 708
K E+ ++ H L++L + +LI ++ G L + + ++
Sbjct: 72 TVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEFLSGGELFDRIAAED---YKMSEAE 128
Query: 709 RLKIARGTSCGLAYMHQICEPHIVHRDIKSSNILLDDQFEAH--LADFGLSRLILPYQTH 766
+ R GL +MH E IVH DIK NI+ + + + + DFGL+ + P +
Sbjct: 129 VINYMRQACEGLKHMH---EHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIV 185
Query: 767 VTTELVGTLGYIPPEYGQAWVATLRGDMYSFGVVMLELLTGKRPVDVLKPKMSRELVGWV 826
T T + PE DM++ GV+ LL+G P + + V
Sbjct: 186 KVT--TATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNV--- 240
Query: 827 LKMRSEGKQDQVFDPILRGKGFDEEMLQVLDVACMCVSQNPFKRPTVKEVVE--WLNNVG 884
K+ E + + + P KR TV + +E WL
Sbjct: 241 -------KRCDWEFDEDAFSSVSPEAKDFIK---NLLQKEPRKRLTVHDALEHPWLKGDH 290
Query: 885 ANRRN 889
+N +
Sbjct: 291 SNLTS 295
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 163 bits (413), Expect = 2e-45
Identities = 69/300 (23%), Positives = 120/300 (40%), Gaps = 41/300 (13%)
Query: 607 DNFSQANIIGCGGFGLVYKATL--------ANGTTLAIKKLSGDLGLME-REFKAEVEAL 657
D +G G FG V A T +A+K L D + + +E+E +
Sbjct: 13 DRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMM 72
Query: 658 ST-AQHKNLVSLQGYCVHQGFRLLIYSYMENGSLDYWLHEK------------ADGASQL 704
+HKN+++L G C G +I Y G+L +L + + QL
Sbjct: 73 KMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQL 132
Query: 705 DWLTRLKIARGTSCGLAYMHQICEPHIVHRDIKSSNILLDDQFEAHLADFGLSRLILPYQ 764
+ A + G+ Y+ +HRD+ + N+L+ + +ADFGL+R I
Sbjct: 133 SSKDLVSCAYQVARGMEYLA---SKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHID 189
Query: 765 THVTTEL-VGTLGYIPPEYGQAWVATLRGDMYSFGVVMLELLTGKRPVDVLKPKMSRELV 823
+ T + ++ PE + T + D++SFGV++ E+ T P + E
Sbjct: 190 YYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPY---PGVPVE-- 244
Query: 824 GWVLKMRSEGKQDQVFDPILRGKGFDEEMLQVLDVACMCVSQNPFKRPTVKEVVEWLNNV 883
+ K+ EG R ++ + C P +RPT K++VE L+ +
Sbjct: 245 -ELFKLLKEGH---------RMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRI 294
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 162 bits (411), Expect = 7e-45
Identities = 56/292 (19%), Positives = 109/292 (37%), Gaps = 48/292 (16%)
Query: 600 YELLKATDNFSQANIIGCGGFGLVYKAT-LANGTTLAIKKLSGDLGLMEREFKAEVEALS 658
Y + + +G G FG+V++ ++ T K + G + K E+ L+
Sbjct: 7 YMIAE---------DLGRGEFGIVHRCVETSSKKTYMAKFVKVK-GTDQVLVKKEISILN 56
Query: 659 TAQHKNLVSLQGYCVHQGFRLLIYSYMENGSLDYWLHEKADGASQLDWLTRLKIARGTSC 718
A+H+N++ L ++I+ ++ + ++ A +L+ +
Sbjct: 57 IARHRNILHLHESFESMEELVMIFEFISGLDIFERINTSA---FELNEREIVSYVHQVCE 113
Query: 719 GLAYMHQICEPHIVHRDIKSSNILLDDQFEAH--LADFGLSRLILPYQTHVTTELVGTLG 776
L ++H +I H DI+ NI+ + + + +FG +R + P
Sbjct: 114 ALQFLH---SHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRLLF--TAPE 168
Query: 777 YIPPEYGQAWVATLRGDMYSFGVVMLELLTGKRPVDVLKPKMSRELVGWVLKMRSEGKQD 836
Y PE Q V + DM+S G ++ LL+G P
Sbjct: 169 YYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFL-------------------AETNQ 209
Query: 837 QVFDPILRGKG-FDEEML-----QVLDVACMCVSQNPFKRPTVKEVVE--WL 880
Q+ + I+ + FDEE + +D + + R T E ++ WL
Sbjct: 210 QIIENIMNAEYTFDEEAFKEISIEAMDFVDRLLVKERKSRMTASEALQHPWL 261
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 161 bits (408), Expect = 1e-44
Identities = 61/306 (19%), Positives = 109/306 (35%), Gaps = 34/306 (11%)
Query: 591 TNEIKDLTIYELLKATDNFSQANIIGCGGFGLVYKAT-LANGTTLAIKKLS-GDLGLMER 648
+I+D IY+ ++G G F V A +AIK ++ L E
Sbjct: 4 AEDIRD--IYDFRD---------VLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEG 52
Query: 649 EFKAEVEALSTAQHKNLVSLQGYCVHQGFRLLIYSYMENGSLDYWLHEKADGASQLDWLT 708
+ E+ L +H N+V+L G LI + G L + EK
Sbjct: 53 SMENEIAVLHKIKHPNIVALDDIYESGGHLYLIMQLVSGGELFDRIVEK----GFYTERD 108
Query: 709 RLKIARGTSCGLAYMHQICEPHIVHRDIKSSNILLDDQFEAHLADFGLSRLILPYQTHVT 768
++ + Y+H + H + LD+ + ++DFGLS++ P V
Sbjct: 109 ASRLIFQVLDAVKYLHDLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDP--GSVL 166
Query: 769 TELVGTLGYIPPEYGQAWVATLRGDMYSFGVVMLELLTGKRPVDVLKPKMSRELVGWVLK 828
+ GT GY+ PE + D +S GV+ LL G P E +
Sbjct: 167 STACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDAKLFEQI----- 221
Query: 829 MRSEGKQDQVFDPILRGKGFDEEMLQVLDVACMCVSQNPFKRPTVKEVVE--WLNNVGAN 886
+ + + + + ++P KR T ++ ++ W+ A
Sbjct: 222 -----LKAEYEFDSPYWDDISDSAKDFIR---HLMEKDPEKRFTCEQALQHPWIAGDTAL 273
Query: 887 RRNENK 892
+N ++
Sbjct: 274 DKNIHQ 279
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Score = 159 bits (404), Expect = 2e-44
Identities = 67/289 (23%), Positives = 106/289 (36%), Gaps = 39/289 (13%)
Query: 607 DNFSQANIIGCGGFGLVYKAT-LANGTTLAIKKLSGDLGL---------MEREFKAEVEA 656
+N+ I+G G +V + A+K + G + EV+
Sbjct: 3 ENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDI 62
Query: 657 LSTAQ-HKNLVSLQGYCVHQGFRLLIYSYMENGSLDYWLHEKADGASQLDWLTRLKIARG 715
L H N++ L+ F L++ M+ G L +L EK L KI R
Sbjct: 63 LRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEK----VTLSEKETRKIMRA 118
Query: 716 TSCGLAYMHQICEPHIVHRDIKSSNILLDDQFEAHLADFGLSRLILPYQTHVTTELVGTL 775
+ +H + +IVHRD+K NILLDD L DFG S + P E+ GT
Sbjct: 119 LLEVICALH---KLNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDP--GEKLREVCGTP 173
Query: 776 GYIPPEYGQAWVATLRG------DMYSFGVVMLELLTGKRPVDVLKPKMSRELVGWVLKM 829
Y+ PE + + DM+S GV+M LL G P K + ++
Sbjct: 174 SYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMI------ 227
Query: 830 RSEGKQDQVFDPILRGKGFDEEMLQVLDVACMCVSQNPFKRPTVKEVVE 878
+ + + ++ + P KR T +E +
Sbjct: 228 ----MSGNYQFGSPEWDDYSDTVKDLVS---RFLVVQPQKRYTAEEALA 269
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 158 bits (399), Expect = 1e-43
Identities = 59/291 (20%), Positives = 103/291 (35%), Gaps = 27/291 (9%)
Query: 603 LKATDNFSQANIIGCGGFGLVYKAT-LANGTTLAIKKLSGDLGLMEREFKAEVEALSTAQ 661
L+ + + IG G FG +Y T +A G +AIK + + E + Q
Sbjct: 3 LRVGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLEC--VKTKHPQLHIESKIYKMMQ 60
Query: 662 HKNLVSLQGYCVHQGFRLLIYSYMENGSLDYWLHEKADGASQLDWLTRLKIARGTSCGLA 721
+ +C +G ++ + SL+ + + + T L +A +
Sbjct: 61 GGVGIPTIRWCGAEGDYNVMVMELLGPSLEDLFNFCSR---KFSLKTVLLLADQMISRIE 117
Query: 722 YMHQICEPHIVHRDIKSSNIL---LDDQFEAHLADFGLSRLILPYQTHV------TTELV 772
Y+H + +HRD+K N L ++ DFGL++ +TH L
Sbjct: 118 YIHSK---NFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLT 174
Query: 773 GTLGYIPPEYGQAWVATLRGDMYSFGVVMLELLTGKRPVDVLKPKMSRELVGWVLKMRSE 832
GT Y + R D+ S G V++ G P LK R+ K
Sbjct: 175 GTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQ------KYERI 228
Query: 833 GKQDQVFDPILRGKGFDEEMLQVLDVACMCVSQNPFKRPTVKEVVEWLNNV 883
++ + KG+ E L+ C S +P + + N+
Sbjct: 229 SEKKMSTPIEVLCKGYPSEFATYLN---FCRSLRFDDKPDYSYLRQLFRNL 276
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Score = 159 bits (404), Expect = 2e-43
Identities = 69/275 (25%), Positives = 103/275 (37%), Gaps = 32/275 (11%)
Query: 607 DNFSQANIIGCGGFGLVYKAT-LANGTTLAIKKLSGDLGLME------REFKAEVEALST 659
++FS IIG GGFG VY G A+K L M+ + + +ST
Sbjct: 4 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVST 63
Query: 660 AQHKNLVSLQGYCVHQGFRLLIYSYMENGSLDYWLHEKADGASQLDWLTRLKIARGTSCG 719
+V + I M G L Y L + A G
Sbjct: 64 GDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQH----GVFSEADMRFYAAEIILG 119
Query: 720 LAYMHQICEPHIVHRDIKSSNILLDDQFEAHLADFGLSRLILPYQTHVTTELVGTLGYIP 779
L +MH +V+RD+K +NILLD+ ++D GL+ + H + GT GY+
Sbjct: 120 LEHMHN---RFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASV---GTHGYMA 173
Query: 780 PEYGQAWVA-TLRGDMYSFGVVMLELLTGKRPVDVLKPKMSRELVGWVLKMRSEGKQDQV 838
PE Q VA D +S G ++ +LL G P K K E+ L M E
Sbjct: 174 PEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVE------ 227
Query: 839 FDPILRGKGFDEEMLQVLDVACMCVSQNPFKRPTV 873
F E+ +L+ + ++ +R
Sbjct: 228 -----LPDSFSPELRSLLE---GLLQRDVNRRLGC 254
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Score = 156 bits (396), Expect = 2e-43
Identities = 63/289 (21%), Positives = 117/289 (40%), Gaps = 31/289 (10%)
Query: 606 TDNFSQANIIGCGGFGLVYKAT-LANGTTLAIKKLSGDLGL---MEREFKAEVEALSTAQ 661
+D + I+G GG V+ A L +A+K L DL F+ E + +
Sbjct: 6 SDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALN 65
Query: 662 HKNLVSLQGYCVHQ----GFRLLIYSYMENGSLDYWLHEKADGASQLDWLTRLKIARGTS 717
H +V++ + ++ Y++ +L +H + + +++
Sbjct: 66 HPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTE----GPMTPKRAIEVIADAC 121
Query: 718 CGLAYMHQICEPHIVHRDIKSSNILLDDQFEAHLADFGLSRLILPYQTHV--TTELVGTL 775
L + + I+HRD+K +NI++ + DFG++R I V T ++GT
Sbjct: 122 QALNFS---HQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTA 178
Query: 776 GYIPPEYGQAWVATLRGDMYSFGVVMLELLTGKRPVDVLKPKMSRELVGWVLKMRSEGKQ 835
Y+ PE + R D+YS G V+ E+LTG+ P P + ++
Sbjct: 179 QYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSP---VSVAYQHVR------- 228
Query: 836 DQVFDPILRGKGFDEEMLQVLDVACMCVSQNPFKRP-TVKEVVEWLNNV 883
+ P R +G ++ V+ +++NP R T E+ L V
Sbjct: 229 EDPIPPSARHEGLSADLDAVVL---KALAKNPENRYQTAAEMRADLVRV 274
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Score = 153 bits (388), Expect = 8e-42
Identities = 66/285 (23%), Positives = 104/285 (36%), Gaps = 33/285 (11%)
Query: 607 DNFSQANIIGCGGFGLVYKAT-LANGTTLAIKKLSGDLGLMERE---FKAEVEALSTA-Q 661
++F ++G G FG V+ A AIK L D+ LM+ + E LS A +
Sbjct: 2 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWE 61
Query: 662 HKNLVSLQGYCVHQGFRLLIYSYMENGSLDYWLHEKADGASQLDWLTRLKIARGTSCGLA 721
H L + + + Y+ G L Y + + D A GL
Sbjct: 62 HPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSC----HKFDLSRATFYAAEIILGLQ 117
Query: 722 YMHQICEPHIVHRDIKSSNILLDDQFEAHLADFGLSRLILPYQTHVTTELVGTLGYIPPE 781
++ IV+RD+K NILLD +ADFG+ + + T GT YI PE
Sbjct: 118 FL---HSKGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTNT-FCGTPDYIAPE 173
Query: 782 YGQAWVATLRGDMYSFGVVMLELLTGKRPVDVLKPKMSRELVGWVLKMRSEGKQDQVFDP 841
D +SFGV++ E+L G+ P + + E D
Sbjct: 174 ILLGQKYNHSVDWWSFGVLLYEMLIGQSP--------------FHGQDEEELFHSIRMDN 219
Query: 842 ILRGKGFDEEMLQVLDVACMCVSQNPFKRPTVKEVV---EWLNNV 883
+ ++E +L + P KR V+ + +
Sbjct: 220 PFYPRWLEKEAKDLLV---KLFVREPEKRLGVRGDIRQHPLFREI 261
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Score = 152 bits (384), Expect = 1e-41
Identities = 58/286 (20%), Positives = 113/286 (39%), Gaps = 21/286 (7%)
Query: 607 DNFSQANIIGCGGFGLVYKATLANGTTLAIKKLSGDL--GLMEREFKAEVEALSTAQHKN 664
+ + IG G +G+VYKA G T A+KK+ + + E+ L +H N
Sbjct: 2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSN 61
Query: 665 LVSLQGYCVHQGFRLLIYSYMENGSLDYWLHEKADGASQLDWLTRLKIARGTSCGLAYMH 724
+V L + +L++ +++ + L+ +T G+AY H
Sbjct: 62 IVKLYDVIHTKKRLVLVFEHLDQDLKKLLDVCE----GGLESVTAKSFLLQLLNGIAYCH 117
Query: 725 QICEPHIVHRDIKSSNILLDDQFEAHLADFGLSRLILPYQTHVTTELVGTLGYIPPEYGQ 784
+ ++HRD+K N+L++ + E +ADFGL+R T E+V P
Sbjct: 118 ---DRRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEIVTLWYRAPDVLMG 174
Query: 785 AWVATLRGDMYSFGVVMLELLTGKRPVD----------VLKPKMSRELVGW--VLKMRSE 832
+ + D++S G + E++ G + + + W V ++
Sbjct: 175 SKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKY 234
Query: 833 GKQDQVFDPILRGKGFDEEMLQVLDVACMCVSQNPFKRPTVKEVVE 878
V++P+ +D+ + +P +R T K+ +E
Sbjct: 235 DPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALE 280
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Score = 152 bits (385), Expect = 1e-41
Identities = 66/309 (21%), Positives = 105/309 (33%), Gaps = 28/309 (9%)
Query: 604 KATDNFSQANIIGCGGFGLVYKAT--LANGTTLAIKKLSGDLG--LMEREFKAEVE---A 656
+A + IG G +G V+KA G +A+K++ G M EV
Sbjct: 4 RADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRH 63
Query: 657 LSTAQHKNLVSLQGYCVHQGFRLLIYSY--MENGSLDYWLHEKADGASQLDWLTRLKIAR 714
L T +H N+V L C E+ D + + T +
Sbjct: 64 LETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMF 123
Query: 715 GTSCGLAYMHQICEPHIVHRDIKSSNILLDDQFEAHLADFGLSRLILPYQTHVTTELVGT 774
GL ++H +VHRD+K NIL+ + LADFGL+R+ + V T
Sbjct: 124 QLLRGLDFLH---SHRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALTSV--VVT 178
Query: 775 LGYIPPEYGQAWVATLRGDMYSFGVVMLELLTGKRPVD----------VLKPKMSRELVG 824
L Y PE D++S G + E+ K +L
Sbjct: 179 LWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEED 238
Query: 825 WVLKMRSEGKQDQVFDPILRGKGFDEEMLQVLDVACMCVSQNPFKRPTVKEVVE--WLNN 882
W + + K + D+ C++ NP KR + + + +
Sbjct: 239 WPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYFQD 298
Query: 883 VGANRRNEN 891
+ R EN
Sbjct: 299 L--ERCKEN 305
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 151 bits (382), Expect = 2e-41
Identities = 58/294 (19%), Positives = 102/294 (34%), Gaps = 23/294 (7%)
Query: 607 DNFSQANIIGCGGFGLVYKAT-LANGTTLAIKKLSGDLGL--MEREFKAEVEALSTAQHK 663
+NF + IG G +G+VYKA G +A+KK+ D + E+ L H
Sbjct: 2 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 61
Query: 664 NLVSLQGYCVHQGFRLLIYSYMENGSLDYWLHEKADGASQLDWLTRLKIARGTSCGLAYM 723
N+V L + L++ ++ + G + GLA+
Sbjct: 62 NIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTG---IPLPLIKSYLFQLLQGLAFC 118
Query: 724 HQICEPHIVHRDIKSSNILLDDQFEAHLADFGLSRLILPYQTHVTTELVGTLGYIPPEYG 783
++HRD+K N+L++ + LADFGL+R T E+V P
Sbjct: 119 ---HSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILL 175
Query: 784 QAWVATLRGDMYSFGVVMLELLTGKRP------VDVLKPKM------SRELVGWVLKMRS 831
+ D++S G + E++T + +D L + V M
Sbjct: 176 GCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPD 235
Query: 832 EGKQDQVFDPILRGKGFDEEMLQVLDVACMCVSQNPFKRPTVKEVVE--WLNNV 883
+ K + + +P KR + K + + +V
Sbjct: 236 YKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDV 289
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Score = 152 bits (384), Expect = 5e-41
Identities = 69/299 (23%), Positives = 116/299 (38%), Gaps = 31/299 (10%)
Query: 607 DNFSQANIIGCGGFGLVYKATL-ANGTTLAIKKLSGDLGLMEREFKAEVEALSTAQHKNL 665
+++ +IG G FG+VY+A L +G +AIKK+ D +R E++ + H N+
Sbjct: 20 VSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQD----KRFKNRELQIMRKLDHCNI 75
Query: 666 VSLQGYCVHQG------FRLLIYSYMENGSLDYWLHEKADGASQLDWLTRLKIARGTSCG 719
V L+ + G + L+ Y+ H + L +
Sbjct: 76 VRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQT-LPVIYVKLYMYQLFRS 134
Query: 720 LAYMHQICEPHIVHRDIKSSNILLD-DQFEAHLADFGLSRLILPYQTHVTTELVGTLGYI 778
LAY+H I HRDIK N+LLD D L DFG ++ ++ + +V+ +
Sbjct: 135 LAYIHS---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSY-ICSRYYRA 190
Query: 779 PPEYGQAWVATLRGDMYSFGVVMLELLTGKRP------VDVLK------PKMSRELVGWV 826
P A T D++S G V+ ELL G+ VD L +RE + +
Sbjct: 191 PELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREM 250
Query: 827 LKMRSEGKQDQVFDPILRGKGFDEEMLQVLDVACMCVSQNPFKRPTVKEVVE--WLNNV 883
+E K Q+ + + + + P R T E + + +
Sbjct: 251 NPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDEL 309
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 151 bits (383), Expect = 6e-41
Identities = 61/300 (20%), Positives = 120/300 (40%), Gaps = 26/300 (8%)
Query: 598 TIYELLKATDNFSQANIIGCGGFGLVYKAT-LANGTTLAIKKLS-GDLGLMEREFKAEVE 655
++++ ++ + IG G +G+V A N +AIKK+S + + E++
Sbjct: 2 QVFDV---GPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIK 58
Query: 656 ALSTAQHKNLVSLQGYCVHQGFRLLIYSYMENGSLDYWLHEKADGASQLDWLTRLKIARG 715
L +H+N++ + + Y+ + L++ L
Sbjct: 59 ILLRFRHENIIGINDIIRAPTIEQMKDVYLVTHLMGADLYKLLKT-QHLSNDHICYFLYQ 117
Query: 716 TSCGLAYMHQICEPHIVHRDIKSSNILLDDQFEAHLADFGLSRLILPYQTHVT--TELVG 773
GL Y+H +++HRD+K SN+LL+ + + DFGL+R+ P H TE V
Sbjct: 118 ILRGLKYIH---SANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVA 174
Query: 774 TLGYIPPEY-GQAWVATLRGDMYSFGVVMLELLTGKRPVDVLKPKMSRELVGWVLKMRSE 832
T Y PE + T D++S G ++ E+L+ + + +L S+
Sbjct: 175 TRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQ 234
Query: 833 GKQDQVF--------------DPILRGKGFDEEMLQVLDVACMCVSQNPFKRPTVKEVVE 878
+ + + + + F + LD+ ++ NP KR V++ +
Sbjct: 235 EDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALA 294
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 149 bits (377), Expect = 1e-40
Identities = 51/296 (17%), Positives = 95/296 (32%), Gaps = 38/296 (12%)
Query: 600 YELLKATDNFSQANIIGCGGFGLVYKAT-LANGTTLAIKKLSGDLGLMEREFKAEVEALS 658
Y++ + IG G FG++++ T L N +AIK + + E
Sbjct: 7 YKVGR---------RIGEGSFGVIFEGTNLLNNQQVAIKFEPRRS--DAPQLRDEYRTYK 55
Query: 659 TAQHKNLVSLQGYCVHQGFRLLIYSYMENGSLDYWLHEKADGASQLDWLTRLKIARGTSC 718
+ Y +G ++ + SL+ L + T A+
Sbjct: 56 LLAGCTGIPNVYYFGQEGLHNVLVIDLLGPSLEDLLDLCG---RKFSVKTVAMAAKQMLA 112
Query: 719 GLAYMHQICEPHIVHRDIKSSNILLDDQFEAH-----LADFGLSRLI------LPYQTHV 767
+ +H+ +V+RDIK N L+ + + DFG+ +
Sbjct: 113 RVQSIHE---KSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYRE 169
Query: 768 TTELVGTLGYIPPEYGQAWVATLRGDMYSFGVVMLELLTGKRPVDVLKPKMSRELVGWVL 827
L GT Y+ + R D+ + G V + L G P LK +++ +
Sbjct: 170 KKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIG 229
Query: 828 KMRSEGKQDQVFDPILRGKGFDEEMLQVLDVACMCVSQNPFKRPTVKEVVEWLNNV 883
+ + Q GF EE + + + P + + V
Sbjct: 230 EKK------QSTPLRELCAGFPEEFYKYMH---YARNLAFDATPDYDYLQGLFSKV 276
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Score = 148 bits (375), Expect = 2e-40
Identities = 68/290 (23%), Positives = 108/290 (37%), Gaps = 28/290 (9%)
Query: 613 NIIGCGGFGLVYKAT-LANGTTLAIKKL-----SGDLGLMEREFKAEVEALSTAQHKNLV 666
+ +G G F VYKA +AIKK+ S + R E++ L H N++
Sbjct: 4 DFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNII 63
Query: 667 SLQGYCVHQGFRLLIYSYMENGSLDYWLHEKADGASQLDWLTRLKIARGTSCGLAYMHQI 726
L H+ L++ +ME L T GL Y+H
Sbjct: 64 GLLDAFGHKSNISLVFDFMETDLEVIIKDNS----LVLTPSHIKAYMLMTLQGLEYLH-- 117
Query: 727 CEPHIVHRDIKSSNILLDDQFEAHLADFGLSRLILPYQTHVTTELVGTLGYIPPE-YGQA 785
+ I+HRD+K +N+LLD+ LADFGL++ T V T Y PE A
Sbjct: 118 -QHWILHRDLKPNNLLLDENGVLKLADFGLAK-SFGSPNRAYTHQVVTRWYRAPELLFGA 175
Query: 786 WVATLRGDMYSFGVVMLELLTGKRPVDVLKPKMSRELVGWVLKMRSEGKQDQV------- 838
+ + DM++ G ++ ELL + + L +E + +
Sbjct: 176 RMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDYV 235
Query: 839 ----FDPILRGKGFDEEMLQVLDVACMCVSQNPFKRPTVKEVVE--WLNN 882
F I F +LD+ NP R T + ++ + +N
Sbjct: 236 TFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMKYFSN 285
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 147 bits (373), Expect = 7e-40
Identities = 64/293 (21%), Positives = 107/293 (36%), Gaps = 49/293 (16%)
Query: 607 DNFSQANIIGCGGFGLVYKAT-LANGTTLAIKKLSGDLGL---MEREFKAEVEALSTAQH 662
+F +G G FG V+ NG A+K L ++ + E LS H
Sbjct: 4 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTH 63
Query: 663 KNLVSLQGYCVHQGFRLLIYSYMENGSLDYWLHEKADGASQLDWLTRLKIARGTSCGLAY 722
++ + G +I Y+E G L L + + A L Y
Sbjct: 64 PFIIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKS----QRFPNPVAKFYAAEVCLALEY 119
Query: 723 MHQICEPHIVHRDIKSSNILLDDQFEAHLADFGLSRLILPYQTHVTTELVGTLGYIPPEY 782
+H I++RD+K NILLD + DFG ++ + VT L GT YI PE
Sbjct: 120 LH---SKDIIYRDLKPENILLDKNGHIKITDFGFAKYV----PDVTYTLCGTPDYIAPEV 172
Query: 783 GQAWVATLRGDMYSFGVVMLELLTGKRPVDVLKPKMSRELVGWVLKMRSEGKQDQVFDPI 842
D +SFG+++ E+L G P + + ++ I
Sbjct: 173 VSTKPYNKSIDWWSFGILIYEMLAGYTPFY-------------------DSNTMKTYEKI 213
Query: 843 LRGK-----GFDEEMLQVLDVACMCVSQNPFKR-----PTVKEVVE--WLNNV 883
L + F+E++ +L ++++ +R ++V W V
Sbjct: 214 LNAELRFPPFFNEDVKDLLS---RLITRDLSQRLGNLQNGTEDVKNHPWFKEV 263
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Score = 146 bits (368), Expect = 2e-39
Identities = 65/297 (21%), Positives = 111/297 (37%), Gaps = 44/297 (14%)
Query: 609 FSQANI---------IGCGGFGLVYKAT-LANGTTLAIKKL------SGDLGLMEREFKA 652
F Q N+ +G G F +V K + G A K + S G+ + +
Sbjct: 3 FRQENVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIER 62
Query: 653 EVEALSTAQHKNLVSLQGYCVHQGFRLLIYSYMENGSLDYWLHEKADGASQLDWLTRLKI 712
EV L QH N+++L ++ +LI + G L +L EK L +
Sbjct: 63 EVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEK----ESLTEEEATEF 118
Query: 713 ARGTSCGLAYMHQICEPHIVHRDIKSSNILLDDQ----FEAHLADFGLSRLILPYQTHVT 768
+ L ++ + I H D+K NI+L D+ + DFGL+ I +
Sbjct: 119 LK---QILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKI--DFGNEF 173
Query: 769 TELVGTLGYIPPEYGQAWVATLRGDMYSFGVVMLELLTGKRPVDVLKPKMSRELVGWVLK 828
+ GT ++ PE L DM+S GV+ LL+G P + + V V
Sbjct: 174 KNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAV-- 231
Query: 829 MRSEGKQDQVFDPILRGKGFDEEMLQVLDVACMCVSQNPFKRPTVKEVVE--WLNNV 883
+ + F D + ++P KR T+++ ++ W+
Sbjct: 232 -----------NYEFEDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQHPWIKPK 277
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 145 bits (366), Expect = 2e-39
Identities = 58/297 (19%), Positives = 106/297 (35%), Gaps = 54/297 (18%)
Query: 600 YELLKATDNFSQANIIGCGGFGLVYKAT-LANGTTLAIKKLSGDLGLMERE------FKA 652
Y++ ++G GGFG VY +++ +AIK + D E
Sbjct: 6 YQVGP---------LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPM 56
Query: 653 EVEALSTAQ--HKNLVSLQGYCVHQGFRLLIYSYMENGSLDYWLHEKADGASQLDWLTRL 710
EV L ++ L + +LI E + + L
Sbjct: 57 EVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGA---LQEELAR 113
Query: 711 KIARGTSCGLAYMHQICEPHIVHRDIKSSNILLD-DQFEAHLADFGLSRLILPYQTHVTT 769
+ + ++HRDIK NIL+D ++ E L DFG L+ + V T
Sbjct: 114 SFFWQVLEAVRHC---HNCGVLHRDIKDENILIDLNRGELKLIDFGSGALL---KDTVYT 167
Query: 770 ELVGTLGYIPPEYGQAW-VATLRGDMYSFGVVMLELLTGKRPVDVLKPKMSRELVGWVLK 828
+ GT Y PPE+ + ++S G+++ +++ G P
Sbjct: 168 DFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPF----------------- 210
Query: 829 MRSEGKQDQVFDPILRGKGFDEEMLQVLDVACMCVSQNPFKRPTVKEVVE--WLNNV 883
E ++ + + + E ++ C++ P RPT +E+ W+ +V
Sbjct: 211 ---EHDEEIIRGQVFFRQRVSSECQHLIR---WCLALRPSDRPTFEEIQNHPWMQDV 261
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 146 bits (368), Expect = 5e-39
Identities = 58/279 (20%), Positives = 101/279 (36%), Gaps = 30/279 (10%)
Query: 614 IIGCGGFGLVYKAT-LANGTTLAIKKLSGDLGLMEREFKAEVEALSTAQHKNLVSLQGYC 672
++G G G V + A+K L D RE + A Q ++V +
Sbjct: 19 VLGLGINGKVLQIFNKRTQEKFALKMLQ-DCPKARREVELHWRAS---QCPHIVRIVDVY 74
Query: 673 ----VHQGFRLLIYSYMENGSLDYWLHEKADGASQLDWLTRLKIARGTSCGLAYMHQICE 728
+ L++ ++ G L + ++ G +I + + Y+H I
Sbjct: 75 ENLYAGRKCLLIVMECLDGGELFSRIQDR--GDQAFTEREASEIMKSIGEAIQYLHSI-- 130
Query: 729 PHIVHRDIKSSNILLDDQFE---AHLADFGLSRLILPYQTHVTTELVGTLGYIPPEYGQA 785
+I HRD+K N+L + L DFG ++ + + T T Y+ PE
Sbjct: 131 -NIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPC--YTPYYVAPEVLGP 187
Query: 786 WVATLRGDMYSFGVVMLELLTGKRPVDVLKPKMSRELVGWVLKMRSEGKQDQVFDPILRG 845
DM+S GV+M LL G P S + M++ + Q P
Sbjct: 188 EKYDKSCDMWSLGVIMYILLCGYPPFY------SNHGLAISPGMKTRIRMGQYEFPNPEW 241
Query: 846 KGFDEEMLQVLDVACMCVSQNPFKRPTVKEVVE--WLNN 882
EE+ ++ + P +R T+ E + W+
Sbjct: 242 SEVSEEVKMLIR---NLLKTEPTQRMTITEFMNHPWIMQ 277
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Score = 139 bits (350), Expect = 8e-37
Identities = 64/305 (20%), Positives = 113/305 (37%), Gaps = 43/305 (14%)
Query: 607 DNFSQANIIGCGGFGLVYKAT-LANGTTLAIKKL--SGDLGLMEREFKAEVEALSTAQHK 663
+ + IG G FG V+KA G +A+KK+ + E++ L +H+
Sbjct: 10 SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHE 69
Query: 664 NLVSLQGYC--------VHQGFRLLIYSYMENGSLDYWLHEKADGASQLDWLTRLKIARG 715
N+V+L C +G L++ + E+ + L T +I R
Sbjct: 70 NVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSN-------VLVKFTLSEIKRV 122
Query: 716 TSCGLAYMHQICEPHIVHRDIKSSNILLDDQFEAHLADFGLSRLILPYQT---HVTTELV 772
L ++ I I+HRD+K++N+L+ LADFGL+R + + T V
Sbjct: 123 MQMLLNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNRV 182
Query: 773 GTLGYIPPEYGQAWVA-TLRGDMYSFGVVMLELLTGKRPVDVLKPKMSRELVGWVL---- 827
TL Y PPE D++ G +M E+ T + + L+ +
Sbjct: 183 VTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSIT 242
Query: 828 --------------KMRSEGKQDQVFDPILRGKGFDEEMLQVLDVACMCVSQNPFKRPTV 873
K+ Q + L+ D L ++D + +P +R
Sbjct: 243 PEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLID---KLLVLDPAQRIDS 299
Query: 874 KEVVE 878
+ +
Sbjct: 300 DDALN 304
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Score = 137 bits (345), Expect = 2e-36
Identities = 57/301 (18%), Positives = 105/301 (34%), Gaps = 34/301 (11%)
Query: 600 YELLKATDNFSQANIIGCGGFGLVYKAT-LANGTTLAIKKLSGDLG--LMEREFKAEVEA 656
YE L+ IG G +G V+KA +A+K++ D + E+
Sbjct: 4 YEKLE---------KIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICL 54
Query: 657 LSTAQHKNLVSLQGYCVHQGFRLLIYSYMENGSLDYWLHEKADGASQLDWLTRLKIARGT 716
L +HKN+V L L++ + + Y+ L +
Sbjct: 55 LKELKHKNIVRLHDVLHSDKKLTLVFEFCDQDLKKYFDSCN-------GDLDPEIVKSFL 107
Query: 717 SCGLAYMHQICEPHIVHRDIKSSNILLDDQFEAHLADFGLSRLILPYQTHVTTELVGTLG 776
L + +++HRD+K N+L++ E LA+FGL+R + E+V
Sbjct: 108 FQLLKGLGFCHSRNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCYSAEVVTLWY 167
Query: 777 YIPPEYGQAWVATLRGDMYSFGVVMLELLTGKRP-------------VDVLKPKMSRELV 823
P A + + DM+S G + EL RP + L + E
Sbjct: 168 RPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQW 227
Query: 824 GWVLKMRSEGKQDQVFDPILRGKGFDEEMLQVLDVACMCVSQNPFKRPTVKEVVE--WLN 881
+ K+ + D+ + NP +R + +E ++ + +
Sbjct: 228 PSMTKLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHPYFS 287
Query: 882 N 882
+
Sbjct: 288 D 288
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 136 bits (344), Expect = 7e-36
Identities = 58/288 (20%), Positives = 106/288 (36%), Gaps = 36/288 (12%)
Query: 607 DNFSQANIIGCGGFGLVYKAT-LANGTTLAIKKLSGDLGLMERE---FKAEVEALSTAQH 662
++F ++G G FG V A G A+K L ++ + + E E L +H
Sbjct: 5 NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRH 64
Query: 663 KNLVSLQGYCVHQGFRLLIYSYMENGSLDYWLHEKADGASQLDWLTRLKIARGTSCGLAY 722
L +L+ + Y G L + L + T + + ++
Sbjct: 65 PFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRE-------RVFTEERARFYGAEIVSA 117
Query: 723 MHQICEPHIVHRDIKSSNILLDDQFEAHLADFGLSRLILPYQTHVTTELVGTLGYIPPEY 782
+ + +V+RDIK N++LD + DFGL + + GT Y+ PE
Sbjct: 118 LEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGAT-MKTFCGTPEYLAPEV 176
Query: 783 GQAWVATLRGDMYSFGVVMLELLTGKRPVDVLKPKMSRELVGWVLKMRSEGKQDQVFDPI 842
+ D + GVVM E++ G+ P + EL+ + + I
Sbjct: 177 LEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELI--------------LMEEI 222
Query: 843 LRGKGFDEEMLQVLDVACMCVSQNPFKRP-----TVKEVVE--WLNNV 883
+ E +L + ++P +R KEV+E + ++
Sbjct: 223 RFPRTLSPEAKSLLA---GLLKKDPKQRLGGGPSDAKEVMEHRFFLSI 267
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Score = 131 bits (331), Expect = 5e-34
Identities = 60/314 (19%), Positives = 108/314 (34%), Gaps = 36/314 (11%)
Query: 589 NNTNEIKDLTIYELLKATDNFSQANIIGCGGFGLVYKAT-LANGTTLAIKKLSGDL--GL 645
E++ +Y L+ +G G +G V A G +AIKKL L
Sbjct: 11 KTAWEVRA--VYRDLQ---------PVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSEL 59
Query: 646 MEREFKAEVEALSTAQHKNLVSLQGYCVHQGFRLLIYSYMENGSLDYWLHEKADGASQLD 705
+ E+ L +H+N++ L + K +L
Sbjct: 60 FAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFTDFYLVMPFMGTDLGKLMKHEKLG 119
Query: 706 WLTRLKIARGTSCGLAYMHQICEPHIVHRDIKSSNILLDDQFEAHLADFGLSRLILPYQT 765
+ GL Y+H I+HRD+K N+ +++ E + DFGL+R +
Sbjct: 120 EDRIQFLVYQMLKGLRYIH---AAGIIHRDLKPGNLAVNEDCELKILDFGLARQA---DS 173
Query: 766 HVTTELVGTLGYIPPEYGQAWVATLRGDMYSFGVVMLELLTGKRP----------VDVLK 815
+T +V P T D++S G +M E++TGK +++K
Sbjct: 174 EMTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMK 233
Query: 816 PKMSRELVGWVLKMRSEGKQDQVFDPILRGKGFDEEMLQV----LDVACMCVSQNPFKRP 871
+ E K P L K F + +++ + + +R
Sbjct: 234 VTGTPPAEFVQRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRV 293
Query: 872 TVKEVVE--WLNNV 883
T E + + ++
Sbjct: 294 TAGEALAHPYFESL 307
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Score = 130 bits (328), Expect = 1e-33
Identities = 42/208 (20%), Positives = 75/208 (36%), Gaps = 15/208 (7%)
Query: 607 DNFSQANIIGCGGFGLVYKAT-LANGTTLAIKKLSGDLGLMERE---FKAEVEALSTAQH 662
D F + +G G FG V +G A+K L + ++ E L
Sbjct: 41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 663 KNLVSLQGYCVHQGFRLLIYSYMENGSLDYWLHEKADGASQLDWLTRLKIARGTSCGLAY 722
LV L+ ++ Y+ G + L + A Y
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRI----GRFSEPHARFYAAQIVLTFEY 156
Query: 723 MHQICEPHIVHRDIKSSNILLDDQFEAHLADFGLSRLILPYQTHVTTELVGTLGYIPPEY 782
+H + +++RD+K N+L+D Q + DFG ++ + + GT + PE
Sbjct: 157 LHSL---DLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWTLC----GTPEALAPEI 209
Query: 783 GQAWVATLRGDMYSFGVVMLELLTGKRP 810
+ D ++ GV++ E+ G P
Sbjct: 210 ILSKGYNKAVDWWALGVLIYEMAAGYPP 237
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Score = 128 bits (323), Expect = 4e-33
Identities = 54/306 (17%), Positives = 110/306 (35%), Gaps = 44/306 (14%)
Query: 607 DNFSQANIIGCGGFGLVYKAT-LANGTTLAIKKLSGDLGLMEREFKAEVEALST-AQHKN 664
D++ +G G + V++A + N + +K L +++ K E++ L N
Sbjct: 35 DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPV---KKKKIKREIKILENLRGGPN 91
Query: 665 LVSLQGYCVHQGFRL--LIYSYMENGSLDYWLHEKADGASQLDWLTRLKIARGTSCGLAY 722
+++L R L++ ++ N L L Y
Sbjct: 92 IITLADIVKDPVSRTPALVFEHVNNTDFKQLYQ-------TLTDYDIRFYMYEILKALDY 144
Query: 723 MHQICEPHIVHRDIKSSNILLD-DQFEAHLADFGLSRLILPYQTHVTTELVGTLGYIPPE 781
H + I+HRD+K N+++D + + L D+GL+ P Q + V + + PE
Sbjct: 145 CHSMG---IMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEY--NVRVASRYFKGPE 199
Query: 782 YGQAWVA-TLRGDMYSFGVVMLELLTGKRP-----------VDVLKPKMSRELVGWVLKM 829
+ DM+S G ++ ++ K P V + K + +L ++ K
Sbjct: 200 LLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKY 259
Query: 830 RSEGKQD----------QVFDPILRGKGFDEEMLQVLDVACMCVSQNPFKRPTVKEVVE- 878
E + ++ + + + LD + + R T +E +E
Sbjct: 260 NIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEH 319
Query: 879 -WLNNV 883
+ V
Sbjct: 320 PYFYTV 325
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 127 bits (320), Expect = 8e-33
Identities = 65/277 (23%), Positives = 108/277 (38%), Gaps = 31/277 (11%)
Query: 607 DNFSQANIIGCGGFGLVYKATLA----NGTTLAIKKLSGDLGL----MEREFKAEVEALS 658
+NF ++G G +G V+ G A+K L + + E + L
Sbjct: 24 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLE 83
Query: 659 TAQHK-NLVSLQGYCVHQGFRLLIYSYMENGSLDYWLHEKADGASQLDWLTRLKIARGTS 717
+ LV+L + LI Y+ G L L ++ + T ++
Sbjct: 84 HIRQSPFLVTLHYAFQTETKLHLILDYINGGELFTHLSQR-------ERFTEHEVQIYVG 136
Query: 718 CGLAYMHQICEPHIVHRDIKSSNILLDDQFEAHLADFGLSRLILPYQTHVTTELVGTLGY 777
+ + + + I++RDIK NILLD L DFGLS+ + +T + GT+ Y
Sbjct: 137 EIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERAYDFCGTIEY 196
Query: 778 IPPE--YGQAWVATLRGDMYSFGVVMLELLTGKRPVDVLKPKMSRELVGWVLKMRSEGKQ 835
+ P+ G D +S GV+M ELLTG P V K S+ + ++SE
Sbjct: 197 MAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEI-SRRILKSEPPY 255
Query: 836 DQVFDPILRGKGFDEEMLQVLDVACMCVSQNPFKRPT 872
Q + + D+ + ++P KR
Sbjct: 256 PQEMSALAK------------DLIQRLLMKDPKKRLG 280
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Score = 122 bits (307), Expect = 7e-31
Identities = 65/319 (20%), Positives = 111/319 (34%), Gaps = 57/319 (17%)
Query: 600 YELLKATDNFSQANIIGCGGFGLVYKAT-LANGTTLAIKKLSGDL--GLMEREFKAEVEA 656
Y+ LK IG G G+V A +AIKKLS + E+
Sbjct: 19 YQNLK---------PIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVL 69
Query: 657 LSTAQHKNLVSLQGYCVHQGFR------LLIYSYMENGSLDYWLHEKADGASQLDWLTRL 710
+ HKN++SL Q L+ M+ E D
Sbjct: 70 MKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMEL-------DHERMS 122
Query: 711 KIARGTSCGLAYMHQICEPHIVHRDIKSSNILLDDQFEAHLADFGLSRLILPYQTHVTTE 770
+ CG+ ++H I+HRD+K SNI++ + DFGL+R + + T
Sbjct: 123 YLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLART--AGTSFMMTP 177
Query: 771 LVGTLGYIPPEYGQAWVATLRGDMYSFGVVMLELLTGKRP-------------VDVLKPK 817
V T Y PE D++S G +M E++ K ++ L
Sbjct: 178 YVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTP 237
Query: 818 MSRELVGWVLKMRSEGKQDQVFDPILRGKGFDEEML------------QVLDVACMCVSQ 865
+ +R+ + + + K F + + Q D+ +
Sbjct: 238 CPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVI 297
Query: 866 NPFKRPTVKEVVE--WLNN 882
+P KR +V + ++ ++N
Sbjct: 298 DPAKRISVDDALQHPYINV 316
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Score = 118 bits (295), Expect = 2e-29
Identities = 55/301 (18%), Positives = 110/301 (36%), Gaps = 36/301 (11%)
Query: 598 TIYELLKATDNFSQANIIGCGGFGLVYKAT-LANGTTLAIKKLSGDL--GLMEREFKAEV 654
TI+E+ + + + +G G +G V A G +A+KKLS + + E+
Sbjct: 12 TIWEV---PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYREL 68
Query: 655 EALSTAQHKNLVSLQGYCV-----HQGFRLLIYSYMENGSLDYWLHEKADGASQLDWLTR 709
L +H+N++ L + + + +++ L+ + + +L
Sbjct: 69 RLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQ-----KLTDDHV 123
Query: 710 LKIARGTSCGLAYMHQICEPHIVHRDIKSSNILLDDQFEAHLADFGLSRLILPYQTHVTT 769
+ GL Y+H I+HRD+K SN+ +++ E + DFGL+R +T
Sbjct: 124 QFLIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLAR---HTDDEMTG 177
Query: 770 ELVGTLGYIPPEYGQAWVATLRGDMYSFGVVMLELLTGKRP-----VDVLKPKMSRELVG 824
+ P D++S G +M ELLTG+ + R +
Sbjct: 178 YVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGT 237
Query: 825 WVLKMRSEGKQDQVFDPILRGKGFDEEML---------QVLDVACMCVSQNPFKRPTVKE 875
++ + + + I + +D+ + + KR T +
Sbjct: 238 PGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQ 297
Query: 876 V 876
Sbjct: 298 A 298
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 111 bits (278), Expect = 5e-27
Identities = 55/332 (16%), Positives = 104/332 (31%), Gaps = 60/332 (18%)
Query: 600 YELLKATDNFSQANIIGCGGFGLVYKAT-LANGTTLAIKKLSGDLGLMEREFKAEVEALS 658
Y L++ +G G F V+ A + N T +A+K + GD E + E++ L
Sbjct: 15 YILVR---------KLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEA-AEDEIKLLQ 64
Query: 659 TAQHKNLVSLQGYCVHQGFRLLIYSY------------MENGSLDYWLHEKADGASQLDW 706
+ + +LL + E + K +
Sbjct: 65 RVNDADNTKEDSMGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPL 124
Query: 707 LTRLKIARGTSCGLAYMHQICEPHIVHRDIKSSNILLD-DQFEAHLADFGLSRLILPYQT 765
+ +I++ GL YMH I+H DIK N+L++ +L ++ L
Sbjct: 125 IYVKQISKQLLLGLDYMH--RRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWY 182
Query: 766 HVTTELV-GTLGYIPPEYGQAWVATLRGDMYSFGVVMLELLTGKRPVDVLKPKMSRELVG 824
T Y PE D++S ++ EL+TG + + +
Sbjct: 183 DEHYTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDD 242
Query: 825 WVLKM------------RSEGKQDQVFDPILRGKGF-------------------DEEML 853
+ ++ R+ F+ + +E
Sbjct: 243 HIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAK 302
Query: 854 QVLDVACMCVSQNPFKRPTVKEVVE--WLNNV 883
++ D + +P KR +V WL +
Sbjct: 303 EISDFLSPMLQLDPRKRADAGGLVNHPWLKDT 334
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Score = 86.8 bits (214), Expect = 4e-20
Identities = 24/156 (15%), Positives = 49/156 (31%), Gaps = 21/156 (13%)
Query: 613 NIIGCGGFGLVYKATLANGTTLAIKKLSGDL----------GLMEREFKAEVEALSTAQH 662
++G G V+ +K + F + +
Sbjct: 6 KLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEF 65
Query: 663 KNLVSLQGYCVHQGFRLLIYSYMENGSLDYWLHEKADGASQLDWLTRLKIARGTSCGLAY 722
+ L LQG V + +Y++ N L + K +++ ++ +A
Sbjct: 66 RALQKLQGLAVPK-----VYAWEGNAVLMELIDAKELYRVRVEN--PDEVLDMILEEVAK 118
Query: 723 MHQICEPHIVHRDIKSSNILLDDQFEAHLADFGLSR 758
+ IVH D+ N+L+ + + DF S
Sbjct: 119 FYH---RGIVHGDLSQYNVLVSE-EGIWIIDFPQSV 150
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Score = 76.3 bits (186), Expect = 2e-15
Identities = 29/88 (32%), Positives = 38/88 (43%), Gaps = 24/88 (27%)
Query: 409 KSLHVLDLSNNNFSGTIPDELSDLSNLEKLDLSGNHLVGEIPISLKGLHFLSSFSVAHNN 468
K+L+ LDL NN GT+P L+ L L L++S N+L GEIP
Sbjct: 244 KNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIP------------------ 285
Query: 469 LQGAVPSGGQFDTFPSFSFEGNPELCGS 496
GG F ++ N LCGS
Sbjct: 286 ------QGGNLQRFDVSAYANNKCLCGS 307
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Score = 76.3 bits (186), Expect = 2e-15
Identities = 20/62 (32%), Positives = 31/62 (50%), Gaps = 1/62 (1%)
Query: 391 YLANNSLSGNIPVEIGQLKSLHVLDLSNNNFSGTIPDELSDLSNLEKLDLSGNHLVGEIP 450
L NN + G +P + QLK LH L++S NN G IP + +L + + N + P
Sbjct: 250 DLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIP-QGGNLQRFDVSAYANNKCLCGSP 308
Query: 451 IS 452
+
Sbjct: 309 LP 310
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Score = 45.9 bits (107), Expect = 1e-05
Identities = 14/60 (23%), Positives = 25/60 (41%), Gaps = 11/60 (18%)
Query: 377 NQQYNQLS-NLPPAI---------YLANNSLSGNIPVEIGQLKSLHVLDLSNNNFSGTIP 426
+ + N++ LP + ++ N+L G IP + G L+ V +NN P
Sbjct: 250 DLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIP-QGGNLQRFDVSAYANNKCLCGSP 308
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Score = 40.5 bits (93), Expect = 6e-04
Identities = 24/112 (21%), Positives = 45/112 (40%), Gaps = 3/112 (2%)
Query: 389 AIYLANNSLSGN--IPVEIGQLKSLHVLDLSNN-NFSGTIPDELSDLSNLEKLDLSGNHL 445
+ L+ +L IP + L L+ L + N G IP ++ L+ L L ++ ++
Sbjct: 54 NLDLSGLNLPKPYPIPSSLANLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNV 113
Query: 446 VGEIPISLKGLHFLSSFSVAHNNLQGAVPSGGQFDTFPSFSFEGNPELCGSV 497
G IP L + L + ++N L G +P + G++
Sbjct: 114 SGAIPDFLSQIKTLVTLDFSYNALSGTLPPSISSLPNLVGITFDGNRISGAI 165
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Score = 39.3 bits (90), Expect = 0.002
Identities = 22/66 (33%), Positives = 31/66 (46%), Gaps = 3/66 (4%)
Query: 406 GQLKSLHVLDLSNNNFSG--TIPDELSDLSNLEKLDLSGNH-LVGEIPISLKGLHFLSSF 462
Q ++ LDLS N IP L++L L L + G + LVG IP ++ L L
Sbjct: 47 TQTYRVNNLDLSGLNLPKPYPIPSSLANLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYL 106
Query: 463 SVAHNN 468
+ H N
Sbjct: 107 YITHTN 112
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Score = 74.3 bits (181), Expect = 1e-14
Identities = 17/78 (21%), Positives = 32/78 (41%), Gaps = 6/78 (7%)
Query: 390 IYLANNSLSGNIPVEIGQLKSLHVLDLSNNNFSGTIPDELSDLSNLEKLDLSGNHLVGEI 449
+ L N++S P + L L L +NN S L++L+N+ L N +
Sbjct: 312 LTLYFNNISDISP--VSSLTKLQRLFFANNKVSD--VSSLANLTNINWLSAGHNQISDLT 367
Query: 450 PISLKGLHFLSSFSVAHN 467
P++ L ++ +
Sbjct: 368 PLA--NLTRITQLGLNDQ 383
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Score = 60.8 bits (146), Expect = 3e-10
Identities = 21/68 (30%), Positives = 31/68 (45%), Gaps = 4/68 (5%)
Query: 407 QLKSLHVLDLSNNNFSGTIPDELSDLSNLEKLDLSGNHLVGEIPISLKGLHFLSSFSVAH 466
LK+L L L NN S P +S L+ L++L + N + SL L ++ S H
Sbjct: 305 NLKNLTYLTLYFNNISDISP--VSSLTKLQRLFFANNKVSD--VSSLANLTNINWLSAGH 360
Query: 467 NNLQGAVP 474
N + P
Sbjct: 361 NQISDLTP 368
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Score = 53.1 bits (126), Expect = 9e-08
Identities = 29/129 (22%), Positives = 45/129 (34%), Gaps = 32/129 (24%)
Query: 377 NQQYNQLSNLPPA--------IYLANNSLSGNIPVEIGQLKSLHVLDLSNNNFSGTIPDE 428
NQ+S++ P + L N L + L +L LDL+NN S P
Sbjct: 203 IATNNQISDITPLGILTNLDELSLNGNQLKD--IGTLASLTNLTDLDLANNQISNLAP-- 258
Query: 429 LSDLSNLEKLDLSGNHLVGEIPI--------------------SLKGLHFLSSFSVAHNN 468
LS L+ L +L L N + P+ + L L+ ++ NN
Sbjct: 259 LSGLTKLTELKLGANQISNISPLAGLTALTNLELNENQLEDISPISNLKNLTYLTLYFNN 318
Query: 469 LQGAVPSGG 477
+ P
Sbjct: 319 ISDISPVSS 327
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Score = 49.6 bits (117), Expect = 9e-07
Identities = 13/72 (18%), Positives = 25/72 (34%), Gaps = 5/72 (6%)
Query: 389 AIYLANNSLSGNIPVEIGQLKSLHVLDLSNNNFSGTIPDELSDLSNLEKLDLSGNHLVGE 448
L +++ + L + L D + L+NL +++ S N L
Sbjct: 26 KTVLGKTNVTDTVSQT--DLDQVTTLQADRLGIKSI--DGVEYLNNLTQINFSNNQLTDI 81
Query: 449 IPIS-LKGLHFL 459
P+ L L +
Sbjct: 82 TPLKNLTKLVDI 93
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Score = 49.2 bits (116), Expect = 1e-06
Identities = 24/85 (28%), Positives = 37/85 (43%), Gaps = 6/85 (7%)
Query: 390 IYLANNSLSGNIPVEIGQLKSLHVLDLSNNNFSGTIPDELSDLSNLEKLDLSGNHLVGEI 449
+ NN +S P+ I +L L L+ N L+ L+NL LDL+ N +
Sbjct: 202 LIATNNQISDITPLGIL--TNLDELSLNGNQLKD--IGTLASLTNLTDLDLANNQISNLA 257
Query: 450 PISLKGLHFLSSFSVAHNNLQGAVP 474
P+S GL L+ + N + P
Sbjct: 258 PLS--GLTKLTELKLGANQISNISP 280
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Score = 58.5 bits (140), Expect = 1e-09
Identities = 20/108 (18%), Positives = 38/108 (35%), Gaps = 3/108 (2%)
Query: 390 IYLANNSLSGNIPVEIGQLKSLHVLDLSNNNFSGTIPDELSDLSNLEKLDLSGNHLVGEI 449
+ ++ L +P ++ +LDL NN + + +L NL L L N +
Sbjct: 15 VQCSDLGLE-KVPKDLP--PDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKIS 71
Query: 450 PISLKGLHFLSSFSVAHNNLQGAVPSGGQFDTFPSFSFEGNPELCGSV 497
P + L L ++ N L+ + ++ SV
Sbjct: 72 PGAFAPLVKLERLYLSKNQLKELPEKMPKTLQELRVHENEITKVRKSV 119
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Score = 51.2 bits (121), Expect = 2e-07
Identities = 23/101 (22%), Positives = 39/101 (38%), Gaps = 3/101 (2%)
Query: 394 NNSLSGNIPVEIGQLKSLHVLDLSNNNFSGTIPDELSDLSNLEKLDLSGNHLVGEIPISL 453
SG +K L + +++ N + TIP L +L +L L GN + SL
Sbjct: 135 PLKSSGIENGAFQGMKKLSYIRIADTNIT-TIPQGL--PPSLTELHLDGNKITKVDAASL 191
Query: 454 KGLHFLSSFSVAHNNLQGAVPSGGQFDTFPSFSFEGNPELC 494
KGL+ L+ ++ N++ N +L
Sbjct: 192 KGLNNLAKLGLSFNSISAVDNGSLANTPHLRELHLNNNKLV 232
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Score = 46.2 bits (108), Expect = 8e-06
Identities = 24/132 (18%), Positives = 42/132 (31%), Gaps = 5/132 (3%)
Query: 362 SYLELPVFVMPSNATNQQYNQLSNLP--PAIYLANNSLSGNIPVEIGQLKSLHVLDLSNN 419
+ + + P ++ + + I +A+ +++ + G SL L L N
Sbjct: 125 QMIVVELGTNPLKSSGIENGAFQGMKKLSYIRIADTNIT---TIPQGLPPSLTELHLDGN 181
Query: 420 NFSGTIPDELSDLSNLEKLDLSGNHLVGEIPISLKGLHFLSSFSVAHNNLQGAVPSGGQF 479
+ L L+NL KL LS N + SL L + +N L
Sbjct: 182 KITKVDAASLKGLNNLAKLGLSFNSISAVDNGSLANTPHLRELHLNNNKLVKVPGGLADH 241
Query: 480 DTFPSFSFEGNP 491
N
Sbjct: 242 KYIQVVYLHNNN 253
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Score = 43.1 bits (100), Expect = 1e-04
Identities = 14/70 (20%), Positives = 29/70 (41%), Gaps = 8/70 (11%)
Query: 400 NIPVEIGQLKSLHVLDLSNNNFSG------TIPDELSDLSNLEKLDLSGNHL-VGEI-PI 451
+P + K + V+ L NNN S P + ++ + L N + EI P
Sbjct: 233 KVPGGLADHKYIQVVYLHNNNISAIGSNDFCPPGYNTKKASYSGVSLFSNPVQYWEIQPS 292
Query: 452 SLKGLHFLSS 461
+ + ++ ++
Sbjct: 293 TFRCVYVRAA 302
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Score = 42.7 bits (99), Expect = 1e-04
Identities = 20/127 (15%), Positives = 38/127 (29%), Gaps = 36/127 (28%)
Query: 380 YNQLSNLPPAI-------YLANNSLSGNIPVEIGQLKSLHVLDLSNNNFSGTI------- 425
++ +P + +L N ++ + L +L L LS N+ S
Sbjct: 159 DTNITTIPQGLPPSLTELHLDGNKITKVDAASLKGLNNLAKLGLSFNSISAVDNGSLANT 218
Query: 426 ----------------PDELSDLSNLEKLDLSGNHL------VGEIPISLKGLHFLSSFS 463
P L+D ++ + L N++ P S S
Sbjct: 219 PHLRELHLNNNKLVKVPGGLADHKYIQVVYLHNNNISAIGSNDFCPPGYNTKKASYSGVS 278
Query: 464 VAHNNLQ 470
+ N +Q
Sbjct: 279 LFSNPVQ 285
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Score = 58.7 bits (140), Expect = 1e-09
Identities = 25/85 (29%), Positives = 34/85 (40%), Gaps = 8/85 (9%)
Query: 387 PPAIYLANNSLSGNIPVEIGQLKSLHVLDLSNNNFSGTIPDELSDLSNLEKLDLSGNHLV 446
P N+ S I SL L++SNN +P LE+L S NHL
Sbjct: 262 LPPNLYYLNASSNEIRSLCDLPPSLEELNVSNNKLI-ELPAL---PPRLERLIASFNHL- 316
Query: 447 GEIPISLKGLHFLSSFSVAHNNLQG 471
E+P + L L V +N L+
Sbjct: 317 AEVPELPQNLKQL---HVEYNPLRE 338
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Score = 47.9 bits (112), Expect = 3e-06
Identities = 20/63 (31%), Positives = 31/63 (49%), Gaps = 8/63 (12%)
Query: 409 KSLHVLDLSNNNFSGTIPDELSDLSNLEKLDLSGNHLVGEIPISLKGLHFLSSFSVAHNN 468
+ H L+L+N S ++P+ +LE L S N L E+P + L S V +NN
Sbjct: 38 RQAHELELNNLGLS-SLPELPP---HLESLVASCNSLT-ELPELPQSLK---SLLVDNNN 89
Query: 469 LQG 471
L+
Sbjct: 90 LKA 92
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Score = 39.4 bits (90), Expect = 0.001
Identities = 17/67 (25%), Positives = 28/67 (41%), Gaps = 12/67 (17%)
Query: 381 NQLSNLPPAIYLANNSLSGNIPVEIGQLKSLHVLDLSNNNFSGTIPDELSDLSNLEKLDL 440
Q L L N LS ++P L+SL S N+ + +P+ +L+ L +
Sbjct: 38 RQAHEL----ELNNLGLS-SLPELPPHLESL---VASCNSLT-ELPEL---PQSLKSLLV 85
Query: 441 SGNHLVG 447
N+L
Sbjct: 86 DNNNLKA 92
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 56.9 bits (135), Expect = 6e-09
Identities = 16/87 (18%), Positives = 28/87 (32%), Gaps = 5/87 (5%)
Query: 390 IYLANNSLSGNIPVEI-GQLKSLHVLDLSNNNFSG----TIPDELSDLSNLEKLDLSGNH 444
+ + LS E+ L+ V+ L + + I L L +L+L N
Sbjct: 7 LDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLRSNE 66
Query: 445 LVGEIPISLKGLHFLSSFSVAHNNLQG 471
L + S + +LQ
Sbjct: 67 LGDVGVHCVLQGLQTPSCKIQKLSLQN 93
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 55.0 bits (130), Expect = 2e-08
Identities = 22/92 (23%), Positives = 34/92 (36%), Gaps = 13/92 (14%)
Query: 374 NATNQQYNQLSNLPPAIYLANNSLSGNIPVEIGQ----LKSLHVLDLSNNNFSGTIPDEL 429
Q + L L +LA+ +S + + SL LDLSNN +L
Sbjct: 362 QGLGQPGSVLRVL----WLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQL 417
Query: 430 SD-----LSNLEKLDLSGNHLVGEIPISLKGL 456
+ LE+L L + E+ L+ L
Sbjct: 418 VESVRQPGCLLEQLVLYDIYWSEEMEDRLQAL 449
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 50.0 bits (117), Expect = 8e-07
Identities = 12/68 (17%), Positives = 23/68 (33%), Gaps = 5/68 (7%)
Query: 410 SLHVLDLSNNNFSGT-IPDELSDLSNLEKLDLSGNHL----VGEIPISLKGLHFLSSFSV 464
+ LD+ S + L L + + L L +I +L+ L+ ++
Sbjct: 3 DIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNL 62
Query: 465 AHNNLQGA 472
N L
Sbjct: 63 RSNELGDV 70
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 46.5 bits (108), Expect = 1e-05
Identities = 15/76 (19%), Positives = 26/76 (34%), Gaps = 9/76 (11%)
Query: 409 KSLHVLDLSNNNFSGT----IPDELSDLSNLEKLDLSGNHLVGEIPISL-----KGLHFL 459
L VL L++ + S + + L +L +LDLS N L + L + L
Sbjct: 369 SVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVESVRQPGCLL 428
Query: 460 SSFSVAHNNLQGAVPS 475
+ +
Sbjct: 429 EQLVLYDIYWSEEMED 444
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Score = 52.0 bits (123), Expect = 6e-08
Identities = 15/48 (31%), Positives = 24/48 (50%), Gaps = 4/48 (8%)
Query: 394 NNSLSGNIPVEIGQLKSLHVLDLSNNNFSGTIPDELSDLSNLEKLDLS 441
+N +S P + L +L + L NN S P L++ SNL + L+
Sbjct: 182 DNKISDISP--LASLPNLIEVHLKNNQISDVSP--LANTSNLFIVTLT 225
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Score = 45.8 bits (107), Expect = 7e-06
Identities = 14/57 (24%), Positives = 24/57 (42%), Gaps = 3/57 (5%)
Query: 405 IGQLKSLHVLDLSNNNFSGTIPDELSDLSNLEKLDLSGNHLVGEIPIS-LKGLHFLS 460
+ L L L +N S P L+ L NL ++ L N + P++ L ++
Sbjct: 169 LANLSKLTTLKADDNKISDISP--LASLPNLIEVHLKNNQISDVSPLANTSNLFIVT 223
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Score = 42.3 bits (98), Expect = 9e-05
Identities = 9/57 (15%), Positives = 21/57 (36%), Gaps = 4/57 (7%)
Query: 389 AIYLANNSLSGNIPVEIGQLKSLHVLDLSNNNFSGTIPDELSDLSNLEKLDLSGNHL 445
I ++++ + L + L + + + L+NL L+L N +
Sbjct: 23 KIAAGKSNVTDTVTQA--DLDGITTLSAFGTGVTTI--EGVQYLNNLIGLELKDNQI 75
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Score = 41.6 bits (96), Expect = 2e-04
Identities = 9/55 (16%), Positives = 24/55 (43%), Gaps = 7/55 (12%)
Query: 407 QLKSLHVLDLSNNNFSGTIPDELSDLSNLEKLDLSGNHLVGEIPISLKGLHFLSS 461
L + + +N + T+ +DL + L G + +++G+ +L++
Sbjct: 17 ALANAIKIAAGKSNVTDTVT--QADLDGITTLSAFGTGVT-----TIEGVQYLNN 64
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Score = 39.6 bits (91), Expect = 8e-04
Identities = 11/51 (21%), Positives = 23/51 (45%), Gaps = 10/51 (19%)
Query: 376 TNQQYNQLSNLPP--------AIYLANNSLSGNIPVEIGQLKSLHVLDLSN 418
N++S++ P ++L NN +S P + +L ++ L+N
Sbjct: 178 LKADDNKISDISPLASLPNLIEVHLKNNQISDVSP--LANTSNLFIVTLTN 226
|
| >d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 51.3 bits (121), Expect = 2e-07
Identities = 19/78 (24%), Positives = 33/78 (42%), Gaps = 4/78 (5%)
Query: 394 NNSLSGNIPVEIGQLKSLHVLDLSNNNFSGTIPDELSDLSNLEKLDLSGNHLVGEIPISL 453
N+LS + L++L L L++N + + L+K S + + +P L
Sbjct: 210 ANNLSALPTEALAPLRALQYLRLNDNPWVCDC-RARPLWAWLQKFRGSSSEVPCSLPQRL 268
Query: 454 KGLHFLSSFSVAHNNLQG 471
G +A N+LQG
Sbjct: 269 AGRDLK---RLAANDLQG 283
|
| >d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 46.0 bits (107), Expect = 9e-06
Identities = 27/148 (18%), Positives = 42/148 (28%), Gaps = 38/148 (25%)
Query: 379 QYNQLSNLPPA----------IYLANNSLSGNIPVEIGQLKSLHVLDLSNNNFSGTIPDE 428
Q N L LP ++L N +S L SL L L N + P
Sbjct: 137 QDNALQALPDDTFRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVAHVHPHA 196
Query: 429 LSDLS------------------------NLEKLDLSGNHLVGEIPISLKGLHFLSSFSV 464
DL L+ L L+ N V + +L F
Sbjct: 197 FRDLGRLMTLYLFANNLSALPTEALAPLRALQYLRLNDNPWVCDCRA-RPLWAWLQKFRG 255
Query: 465 AHNNLQGAVPS---GGQFDTFPSFSFEG 489
+ + + ++P G + +G
Sbjct: 256 SSSEVPCSLPQRLAGRDLKRLAANDLQG 283
|
| >d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 39.4 bits (90), Expect = 0.001
Identities = 9/47 (19%), Positives = 12/47 (25%), Gaps = 3/47 (6%)
Query: 390 IYLANNSLSGNIPVEIGQLKSLHVLDLSNNNFSGTIPDELSDLSNLE 436
L +PV I + + L N S NL
Sbjct: 16 TSCPQQGLQ-AVPVGIP--AASQRIFLHGNRISHVPAASFRACRNLT 59
|
| >d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 37.9 bits (86), Expect = 0.004
Identities = 23/86 (26%), Positives = 32/86 (37%)
Query: 390 IYLANNSLSGNIPVEIGQLKSLHVLDLSNNNFSGTIPDELSDLSNLEKLDLSGNHLVGEI 449
++L L P L +L L L +N D DL NL L L GN +
Sbjct: 110 LHLDRCGLQELGPGLFRGLAALQYLYLQDNALQALPDDTFRDLGNLTHLFLHGNRISSVP 169
Query: 450 PISLKGLHFLSSFSVAHNNLQGAVPS 475
+ +GLH L + N + P
Sbjct: 170 ERAFRGLHSLDRLLLHQNRVAHVHPH 195
|
| >d2ifga3 c.10.2.7 (A:36-191) High affinity nerve growth factor receptor, N-terminal domain {Human (Homo sapiens) [TaxId: 9606]} Length = 156 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: High affinity nerve growth factor receptor, N-terminal domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 49.0 bits (115), Expect = 2e-07
Identities = 17/106 (16%), Positives = 33/106 (31%), Gaps = 2/106 (1%)
Query: 390 IYLANNSLSGNIPVEIGQLKSLHVLDLSNNNFSGTIPDEL-SDLSNLEKLDLSGNHLVGE 448
+ + + + ++L L + N + L L L + + L
Sbjct: 13 LRCTRDGAL-DSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFV 71
Query: 449 IPISLKGLHFLSSFSVAHNNLQGAVPSGGQFDTFPSFSFEGNPELC 494
P + LS +++ N L+ Q + GNP C
Sbjct: 72 APDAFHFTPRLSRLNLSFNALESLSWKTVQGLSLQELVLSGNPLHC 117
|
| >d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 344 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Rna1p (RanGAP1), N-terminal domain domain: Rna1p (RanGAP1), N-terminal domain species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 50.3 bits (118), Expect = 5e-07
Identities = 13/80 (16%), Positives = 25/80 (31%), Gaps = 13/80 (16%)
Query: 390 IYLANNSLSGNIPVEIGQ------LKSLHVLDLSNNNFSGTIPDELSD-----LSNLEKL 438
+ L + LS + L L L N L + +L L
Sbjct: 248 LGLNDCLLSARGAAAVVDAFSKLENIGLQTLRLQYNEIELDAVRTLKTVIDEKMPDLLFL 307
Query: 439 DLSGNHL--VGEIPISLKGL 456
+L+GN ++ ++ +
Sbjct: 308 ELNGNRFSEEDDVVDEIREV 327
|
| >d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 344 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Rna1p (RanGAP1), N-terminal domain domain: Rna1p (RanGAP1), N-terminal domain species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 45.3 bits (105), Expect = 2e-05
Identities = 12/92 (13%), Positives = 33/92 (35%), Gaps = 5/92 (5%)
Query: 407 QLKSLHVLDLSNNNFSGTIPDELSDLSNLEKLDLSGNHLVGE----IPISLKGLHFLSSF 462
+ KSL + ++ + ++ L + +++++ LSGN + E + ++ L
Sbjct: 6 EGKSLKLDAITTEDEK-SVFAVLLEDDSVKEIVLSGNTIGTEAARWLSENIASKKDLEIA 64
Query: 463 SVAHNNLQGAVPSGGQFDTFPSFSFEGNPELC 494
+ + + P+L
Sbjct: 65 EFSDIFTGRVKDEIPEALRLLLQALLKCPKLH 96
|
| >d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 344 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Rna1p (RanGAP1), N-terminal domain domain: Rna1p (RanGAP1), N-terminal domain species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 44.5 bits (103), Expect = 4e-05
Identities = 11/87 (12%), Positives = 28/87 (32%), Gaps = 8/87 (9%)
Query: 392 LANNSLSGN----IPVEIGQLKSLHVLDLSNNNFSG----TIPDELSDLSNLEKLDLSGN 443
L ++++ + + + S+ + LS N + + ++ +LE + S
Sbjct: 10 LKLDAITTEDEKSVFAVLLEDDSVKEIVLSGNTIGTEAARWLSENIASKKDLEIAEFSDI 69
Query: 444 HLVGEIPISLKGLHFLSSFSVAHNNLQ 470
+ L L + L
Sbjct: 70 FTGRVKDEIPEALRLLLQALLKCPKLH 96
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 266 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Score = 48.9 bits (115), Expect = 9e-07
Identities = 11/55 (20%), Positives = 21/55 (38%), Gaps = 3/55 (5%)
Query: 390 IYLANNSLSGNIPVEIGQLKSLHVLDLSNNNFSGTIPDELSDLSNLEKLDLSGNH 444
+ +L+ +P ++ K +L LS N L + L +L+L
Sbjct: 15 VNCDKRNLT-ALPPDLP--KDTTILHLSENLLYTFSLATLMPYTRLTQLNLDRAE 66
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 266 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Score = 48.6 bits (114), Expect = 1e-06
Identities = 15/50 (30%), Positives = 21/50 (42%), Gaps = 1/50 (2%)
Query: 394 NNSLSGNIPVEIGQLKSLHVLDLSNNNFSGTIPDELSDLSNLEKLDLSGN 443
NN+L+ + L++L L L N+ TIP L L GN
Sbjct: 157 NNNLTELPAGLLNGLENLDTLLLQENSLY-TIPKGFFGSHLLPFAFLHGN 205
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 266 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Score = 46.2 bits (108), Expect = 8e-06
Identities = 12/65 (18%), Positives = 25/65 (38%), Gaps = 3/65 (4%)
Query: 404 EIGQLKSLHVLDLSNNNFSGTIPDELSDLSNLEKLDLSGNHLVGEIPISLKGLHFLSSFS 463
E+ ++ S ++ N + +P +L + L LS N L +L L+ +
Sbjct: 5 EVSKVASHLEVNCDKRNLT-ALPPDLP--KDTTILHLSENLLYTFSLATLMPYTRLTQLN 61
Query: 464 VAHNN 468
+
Sbjct: 62 LDRAE 66
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 266 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Score = 40.5 bits (93), Expect = 5e-04
Identities = 17/54 (31%), Positives = 22/54 (40%), Gaps = 1/54 (1%)
Query: 417 SNNNFSGTIPDELSDLSNLEKLDLSGNHLVGEIPISLKGLHFLSSFSVAHNNLQ 470
+NNN + L+ L NL+ L L N L IP G H L + N
Sbjct: 156 ANNNLTELPAGLLNGLENLDTLLLQENSLY-TIPKGFFGSHLLPFAFLHGNPWL 208
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 266 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Score = 38.9 bits (89), Expect = 0.002
Identities = 10/50 (20%), Positives = 16/50 (32%), Gaps = 7/50 (14%)
Query: 379 QYNQLSNLPPAI-------YLANNSLSGNIPVEIGQLKSLHVLDLSNNNF 421
L+ LPP + +L+ N L + L L+L
Sbjct: 18 DKRNLTALPPDLPKDTTILHLSENLLYTFSLATLMPYTRLTQLNLDRAEL 67
|
| >d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Cyclin A/CDK2-associated p19, Skp2 domain: Cyclin A/CDK2-associated p19, Skp2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 48.2 bits (113), Expect = 2e-06
Identities = 20/87 (22%), Positives = 33/87 (37%), Gaps = 2/87 (2%)
Query: 383 LSNLPPAIYLANNSLSGNIPVEIGQLKSLHVLDLSNNNFSG-TIPDELSDLSNLEKLDLS 441
LS A + + + E + +DLSN+ T+ LS S L+ L L
Sbjct: 21 LSQGVIAFRCPRSFMDQPLA-EHFSPFRVQHMDLSNSVIEVSTLHGILSQCSKLQNLSLE 79
Query: 442 GNHLVGEIPISLKGLHFLSSFSVAHNN 468
G L I +L L +++ +
Sbjct: 80 GLRLSDPIVNTLAKNSNLVRLNLSGCS 106
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 44.7 bits (105), Expect = 4e-06
Identities = 24/114 (21%), Positives = 34/114 (29%), Gaps = 32/114 (28%)
Query: 379 QYNQLSNLPP--------AIYLANNSLSGNIPVEIGQLKSLHV----------------- 413
+ L+ L + L++N L P + L+ L V
Sbjct: 6 AHKDLTVLCHLEQLLLVTHLDLSHNRLRALPP-ALAALRCLEVLQASDNALENVDGVANL 64
Query: 414 -----LDLSNNNFSGT-IPDELSDLSNLEKLDLSGNHLVGEIPISLKGLHFLSS 461
L L NN + L L L+L GN L E I + L S
Sbjct: 65 PRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQEEGIQERLAEMLPS 118
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 44.3 bits (104), Expect = 6e-06
Identities = 17/56 (30%), Positives = 24/56 (42%), Gaps = 3/56 (5%)
Query: 413 VLDLSNNNFSGTIPDELSDLSNLEKLDLSGNHLVGEIPISLKGLHFLSSFSVAHNN 468
VL L++ + T+ L L + LDLS N L P +L L L + N
Sbjct: 2 VLHLAHKDL--TVLCHLEQLLLVTHLDLSHNRLRALPP-ALAALRCLEVLQASDNA 54
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 38.2 bits (88), Expect = 8e-04
Identities = 10/53 (18%), Positives = 21/53 (39%), Gaps = 4/53 (7%)
Query: 390 IYLANNSLSGNIPVE-IGQLKSLHVLDLSNNNFS---GTIPDELSDLSNLEKL 438
+ L NN L + ++ + L +L+L N+ G L ++ +
Sbjct: 70 LLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQEEGIQERLAEMLPSVSSI 122
|
| >d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 210 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Score = 46.5 bits (109), Expect = 4e-06
Identities = 15/69 (21%), Positives = 26/69 (37%), Gaps = 2/69 (2%)
Query: 384 SNLPPAIYLANNSLSGNIPVEIGQLKSLHVLDLSNNNFSGTIPDELSDLSNLEKLDLSGN 443
I S V +L S+ + +N++ + L N+ KL L+GN
Sbjct: 21 DAFAETIKDNLKKKSVTDAVTQNELNSIDQIIANNSDIKSVQG--IQYLPNVTKLFLNGN 78
Query: 444 HLVGEIPIS 452
L P++
Sbjct: 79 KLTDIKPLA 87
|
| >d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 210 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Score = 43.8 bits (102), Expect = 3e-05
Identities = 13/39 (33%), Positives = 18/39 (46%), Gaps = 2/39 (5%)
Query: 404 EIGQLKSLHVLDLSNNNFSGTIPDELSDLSNLEKLDLSG 442
+ L L L LS N+ S L+ L NL+ L+L
Sbjct: 173 PLAGLTKLQNLYLSKNHISD--LRALAGLKNLDVLELFS 209
|
| >d1a9na_ c.10.2.4 (A:) Splicesomal U2A' protein {Human (Homo sapiens) [TaxId: 9606]} Length = 162 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: U2A'-like domain: Splicesomal U2A' protein species: Human (Homo sapiens) [TaxId: 9606]
Score = 43.8 bits (102), Expect = 2e-05
Identities = 17/100 (17%), Positives = 29/100 (29%), Gaps = 6/100 (6%)
Query: 397 LSGNIPVEIGQ---LKSLHVLDLSNNNFSGTIPDELSDLSNLEKLDLSGNHLVGEIPISL 453
L+ + + Q LDL I + + L + +D S N +
Sbjct: 3 LTAELIEQAAQYTNAVRDRELDLRGYKIP-VIENLGATLDQFDAIDFSDNEIRKLDGFP- 60
Query: 454 KGLHFLSSFSVAHNNLQGAVPSGGQFDTFPSFSFEGNPEL 493
L L + V +N + Q + N L
Sbjct: 61 -LLRRLKTLLVNNNRICRIGEGLDQALPDLTELILTNNSL 99
|
| >d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 242 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Follicle-stimulating hormone receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 44.5 bits (103), Expect = 3e-05
Identities = 10/57 (17%), Positives = 21/57 (36%), Gaps = 5/57 (8%)
Query: 399 GNIPVEI-GQLKSLHVLDLSNNNFSGTIPDELSDLSNLEKLDLSGNHLVGEIPISLK 454
+P ++ +LD+S L +L L +L ++P +L+
Sbjct: 190 EELPNDVFHGASGPVILDISRTRIHSLPSYGLENLKKLRARST--YNL-KKLP-TLE 242
|
| >d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 242 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Follicle-stimulating hormone receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 41.4 bits (95), Expect = 2e-04
Identities = 14/60 (23%), Positives = 20/60 (33%), Gaps = 2/60 (3%)
Query: 411 LHVLDLSNNNFSGTIPDELSDLSNLEKLDLSGNHLVGEIPISLKGLHFLSSFSVAHNNLQ 470
+ NNN D S LD+S + L+ L L + S NL+
Sbjct: 179 DELNLSDNNNLEELPNDVFHGASGPVILDISRTRIHSLPSYGLENLKKLRARST--YNLK 236
|
| >d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 242 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Follicle-stimulating hormone receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 39.9 bits (91), Expect = 8e-04
Identities = 11/59 (18%), Positives = 19/59 (32%), Gaps = 3/59 (5%)
Query: 410 SLHVLDLSNNNFSGTIPDELSDLSNLEKLDLSGNHLVGEIPISLKGLHFLSSFSVAHNN 468
S V + + IP +L N +L L + G L ++ N+
Sbjct: 9 SNRVFLCQESKVT-EIPSDLP--RNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQND 64
|
| >d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 242 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Follicle-stimulating hormone receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 38.7 bits (88), Expect = 0.002
Identities = 10/60 (16%), Positives = 23/60 (38%), Gaps = 3/60 (5%)
Query: 390 IYLANNSLSGNIPVEIGQLKSLHVLDLSNNNFSGTIPDELSDLSNLEKLDLSGNHLVGEI 449
+ ++ IP ++ ++ L S +LEK+++S N ++ I
Sbjct: 13 FLCQESKVT-EIPSDL--PRNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVI 69
|
| >d2omxa2 c.10.2.1 (A:37-235) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 199 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Score = 42.3 bits (98), Expect = 8e-05
Identities = 15/45 (33%), Positives = 24/45 (53%), Gaps = 4/45 (8%)
Query: 394 NNSLSGNIPVEIGQLKSLHVLDLSNNNFSGTIPDELSDLSNLEKL 438
+N ++ P + L +L LD+S+N S L+ L+NLE L
Sbjct: 159 SNQVTDLKP--LANLTTLERLDISSNKVSD--ISVLAKLTNLESL 199
|
| >d2omxa2 c.10.2.1 (A:37-235) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 199 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Score = 39.3 bits (90), Expect = 0.001
Identities = 12/69 (17%), Positives = 22/69 (31%), Gaps = 2/69 (2%)
Query: 384 SNLPPAIYLANNSLSGNIPVEIGQLKSLHVLDLSNNNFSGTIPDELSDLSNLEKLDLSGN 443
+ L + + V L + L D + L+NL +++ S N
Sbjct: 15 TALAEKMKTVLGKTNVTDTVSQTDLDQVTTLQADRLGIKSI--DGVEYLNNLTQINFSNN 72
Query: 444 HLVGEIPIS 452
L P+
Sbjct: 73 QLTDITPLK 81
|
| >d1koha1 c.10.2.3 (A:201-362) mRNA export factor tap {Human (Homo sapiens) [TaxId: 9606]} Length = 162 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: mRNA export factor tap domain: mRNA export factor tap species: Human (Homo sapiens) [TaxId: 9606]
Score = 39.4 bits (91), Expect = 5e-04
Identities = 19/83 (22%), Positives = 33/83 (39%), Gaps = 2/83 (2%)
Query: 395 NSLSGNIPVEIGQLKSLHVLDLSNNNFSGT--IPDELSDLSNLEKLDLSGNHLVGEIPIS 452
+S++ + + + L L+LSNN + + NL+ L+LSGN L E +
Sbjct: 51 SSMAATLRIIEENIPELLSLNLSNNRLYRLDDMSSIVQKAPNLKILNLSGNELKSERELD 110
Query: 453 LKGLHFLSSFSVAHNNLQGAVPS 475
L + N+L
Sbjct: 111 KIKGLKLEELWLDGNSLSDTFRD 133
|
Homologous Domains Detected by HHsearch
Original result of HHsearch against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 894 | |||
| d1sm2a_ | 263 | Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie | 100.0 | |
| d1yhwa1 | 293 | pak1 {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1jpaa_ | 299 | ephb2 receptor tyrosine kinase {Mouse (Mus musculu | 100.0 | |
| d1uwha_ | 276 | B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1s9ja_ | 322 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| d1qpca_ | 272 | Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax | 100.0 | |
| d1opja_ | 287 | Abelsone tyrosine kinase (abl) {Mouse (Mus musculu | 100.0 | |
| d1koaa2 | 350 | Twitchin, kinase domain {Caenorhabditis elegans, p | 100.0 | |
| d1k2pa_ | 258 | Bruton's tyrosine kinase (Btk) {Human (Homo sapien | 100.0 | |
| d1koba_ | 352 | Twitchin, kinase domain {California sea hare (Aply | 100.0 | |
| d2j4za1 | 263 | Aurora-related kinase 1 (aurora-2) {Human (Homo sa | 100.0 | |
| d1rjba_ | 325 | Fl cytokine receptor {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1u59a_ | 285 | Tyrosine-protein kinase ZAP-70 {Human (Homo sapien | 100.0 | |
| d1nvra_ | 271 | Cell cycle checkpoint kinase chk1 {Human (Homo sap | 100.0 | |
| d2jfla1 | 288 | STE20-like serine/threonine-protein kinase, SLK {H | 100.0 | |
| d1mqba_ | 283 | epha2 receptor tyrosine kinase {Human (Homo sapien | 100.0 | |
| d2java1 | 269 | Serine/threonine-protein kinase Nek2 {Human (Homo | 100.0 | |
| d1xbba_ | 277 | Tyrosine-protein kinase SYK {Human (Homo sapiens) | 100.0 | |
| d1u5ra_ | 309 | Serine/threonine protein kinase TAO2 {Rat (Rattus | 100.0 | |
| d1fmka3 | 285 | c-src tyrosine kinase {Human (Homo sapiens) [TaxId | 100.0 | |
| d1a06a_ | 307 | Calmodulin-dependent protein kinase {Rat (Rattus n | 100.0 | |
| d1lufa_ | 301 | Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1o6la_ | 337 | Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9 | 100.0 | |
| d1t4ha_ | 270 | Protein kinase wnk1 {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1jksa_ | 293 | Death-associated protein kinase, Dap {Human (Homo | 100.0 | |
| d1uu3a_ | 288 | 3-phosphoinositide dependent protein kinase-1 Pdk1 | 100.0 | |
| d1xkka_ | 317 | EGF receptor tyrosine kinase, Erbb-1 {Human (Homo | 100.0 | |
| d1omwa3 | 364 | G-protein coupled receptor kinase 2 {Cow (Bos taur | 100.0 | |
| d1mp8a_ | 273 | Focal adhesion kinase 1 (fak) {Human (Homo sapiens | 100.0 | |
| d1fota_ | 316 | cAMP-dependent PK, catalytic subunit {Baker's yeas | 100.0 | |
| d1rdqe_ | 350 | cAMP-dependent PK, catalytic subunit {Mouse (Mus m | 100.0 | |
| d1r0pa_ | 311 | Hepatocyte growth factor receptor, c-MET {Human (H | 100.0 | |
| d1byga_ | 262 | Carboxyl-terminal src kinase (csk) {Human (Homo sa | 100.0 | |
| d1fvra_ | 309 | Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1ywna1 | 299 | Vascular endothelial growth factor receptor 2 (kdr | 100.0 | |
| d1tkia_ | 321 | Titin, kinase domain {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1t46a_ | 311 | c-KIT receptor {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d2ozaa1 | 335 | MAP kinase activated protein kinase 2, mapkap2 {Hu | 100.0 | |
| d1vjya_ | 303 | Type I TGF-beta receptor R4 {Human (Homo sapiens) | 100.0 | |
| d1u46a_ | 273 | Activated CDC42 kinase 1, ACK1 {Human (Homo sapien | 100.0 | |
| d1o6ya_ | 277 | Mycobacterial protein kinase PknB, catalytic domai | 100.0 | |
| d1fgka_ | 299 | Fibroblast growth factor receptor 1 {Human (Homo s | 100.0 | |
| d1phka_ | 277 | gamma-subunit of glycogen phosphorylase kinase (Ph | 100.0 | |
| d1p4oa_ | 308 | Insulin-like growth factor 1 receptor {Human (Homo | 100.0 | |
| d1xjda_ | 320 | Protein kinase C, theta type {Human (Homo sapiens) | 100.0 | |
| d1gz8a_ | 298 | Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T | 100.0 | |
| d1ua2a_ | 299 | Cell division protein kinase 7, CDK7 {Human (Homo | 100.0 | |
| d1blxa_ | 305 | Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T | 100.0 | |
| d1ob3a_ | 286 | Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) | 100.0 | |
| d1q5ka_ | 350 | Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho | 100.0 | |
| d1cm8a_ | 346 | MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1pmea_ | 345 | MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606 | 100.0 | |
| d1xwsa_ | 273 | Proto-oncogene serine/threonine-protein kinase Pim | 100.0 | |
| d3blha1 | 318 | Cell division protein kinase 9, CDK9 {Human (Homo | 100.0 | |
| d1ckia_ | 299 | Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1vzoa_ | 322 | Ribosomal protein S6 kinase alpha 5, Msk1 {Human ( | 100.0 | |
| d1csna_ | 293 | Casein kinase-1, CK1 {Fission yeast (Schizosacchar | 100.0 | |
| d3bqca1 | 328 | Protein kinase CK2, alpha subunit {Rattus norvegic | 100.0 | |
| d1unla_ | 292 | Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T | 100.0 | |
| d2b1pa1 | 355 | c-jun N-terminal kinase (jnk3s) {Human (Homo sapie | 100.0 | |
| d2gfsa1 | 348 | MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1q8ya_ | 362 | Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T | 100.0 | |
| d1p9ag_ | 266 | von Willebrand factor binding domain of glycoprote | 99.9 | |
| d1zara2 | 191 | Rio2 serine protein kinase C-terminal domain {Arch | 99.9 | |
| d1ogqa_ | 313 | Polygalacturonase inhibiting protein PGIP {Kidney | 99.87 | |
| d1ozna_ | 284 | Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Huma | 99.86 | |
| d1xkua_ | 305 | Decorin {Cow (Bos taurus) [TaxId: 9913]} | 99.79 | |
| d1p9ag_ | 266 | von Willebrand factor binding domain of glycoprote | 99.78 | |
| d1w8aa_ | 192 | Slit {Fruit fly (Drosophila melanogaster) [TaxId: | 99.75 | |
| d1ogqa_ | 313 | Polygalacturonase inhibiting protein PGIP {Kidney | 99.74 | |
| d1ozna_ | 284 | Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Huma | 99.73 | |
| d1w8aa_ | 192 | Slit {Fruit fly (Drosophila melanogaster) [TaxId: | 99.7 | |
| d1xkua_ | 305 | Decorin {Cow (Bos taurus) [TaxId: 9913]} | 99.69 | |
| d2omza2 | 384 | Internalin A {Listeria monocytogenes [TaxId: 1639] | 99.66 | |
| d2omxa2 | 199 | Internalin B {Listeria monocytogenes [TaxId: 1639] | 99.58 | |
| d1h6ta2 | 210 | Internalin B {Listeria monocytogenes [TaxId: 1639] | 99.58 | |
| d2omxa2 | 199 | Internalin B {Listeria monocytogenes [TaxId: 1639] | 99.57 | |
| d2ifga3 | 156 | High affinity nerve growth factor receptor, N-term | 99.56 | |
| d1h6ta2 | 210 | Internalin B {Listeria monocytogenes [TaxId: 1639] | 99.55 | |
| d2omza2 | 384 | Internalin A {Listeria monocytogenes [TaxId: 1639] | 99.53 | |
| d1h6ua2 | 227 | Internalin H {Listeria monocytogenes [TaxId: 1639] | 99.52 | |
| d1dcea3 | 124 | Rab geranylgeranyltransferase alpha-subunit, C-ter | 99.48 | |
| d1a9na_ | 162 | Splicesomal U2A' protein {Human (Homo sapiens) [Ta | 99.46 | |
| d1dcea3 | 124 | Rab geranylgeranyltransferase alpha-subunit, C-ter | 99.46 | |
| d1a9na_ | 162 | Splicesomal U2A' protein {Human (Homo sapiens) [Ta | 99.42 | |
| d1h6ua2 | 227 | Internalin H {Listeria monocytogenes [TaxId: 1639] | 99.39 | |
| d1m9la_ | 198 | Outer arm dynein light chain 1 {Green algae (Chlam | 99.32 | |
| d2ifga3 | 156 | High affinity nerve growth factor receptor, N-term | 99.31 | |
| d1xwdc1 | 242 | Follicle-stimulating hormone receptor {Human (Homo | 99.28 | |
| d1xwdc1 | 242 | Follicle-stimulating hormone receptor {Human (Homo | 99.22 | |
| d1m9la_ | 198 | Outer arm dynein light chain 1 {Green algae (Chlam | 99.16 | |
| d1jl5a_ | 353 | Leucine rich effector protein YopM {Yersinia pesti | 99.01 | |
| d1jl5a_ | 353 | Leucine rich effector protein YopM {Yersinia pesti | 99.0 | |
| d1j7la_ | 263 | Type IIIa 3',5"-aminoglycoside phosphotransferase | 98.76 | |
| d2astb2 | 284 | Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sa | 98.52 | |
| d2ca6a1 | 344 | Rna1p (RanGAP1), N-terminal domain {Fission yeast | 98.49 | |
| d2astb2 | 284 | Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sa | 98.48 | |
| d1koha1 | 162 | mRNA export factor tap {Human (Homo sapiens) [TaxI | 98.41 | |
| d1nd4a_ | 255 | Aminoglycoside 3'-phosphotransferase IIa (Kanamyci | 98.27 | |
| d2ca6a1 | 344 | Rna1p (RanGAP1), N-terminal domain {Fission yeast | 98.25 | |
| d1z7xw1 | 460 | Ribonuclease inhibitor {Human (Homo sapiens) [TaxI | 98.2 | |
| d1koha1 | 162 | mRNA export factor tap {Human (Homo sapiens) [TaxI | 98.12 | |
| d1z7xw1 | 460 | Ribonuclease inhibitor {Human (Homo sapiens) [TaxI | 98.03 | |
| d2pula1 | 392 | Methylthioribose kinase MtnK {Bacillus subtilis [T | 97.96 | |
| d1zyla1 | 325 | RdoA {Escherichia coli [TaxId: 562]} | 97.69 | |
| d1nw1a_ | 395 | Choline kinase {Caenorhabditis elegans [TaxId: 623 | 97.26 | |
| d2ppqa1 | 316 | Homoserine kinase ThrB {Agrobacterium tumefaciens | 97.21 | |
| d1pgva_ | 167 | Tropomodulin C-terminal domain {nematode (Caenorha | 96.83 | |
| d1pgva_ | 167 | Tropomodulin C-terminal domain {nematode (Caenorha | 96.45 | |
| d1io0a_ | 166 | Tropomodulin C-terminal domain {Chicken (Gallus ga | 94.92 | |
| d1io0a_ | 166 | Tropomodulin C-terminal domain {Chicken (Gallus ga | 91.23 |
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=364.46 Aligned_cols=257 Identities=26% Similarity=0.428 Sum_probs=211.3
Q ss_pred CCCCCCCCEEEECCCEEEEEEEECCCCEEEEEEECCCCHHHHHHHHHHHHHHHHCCCCCEEEECCEEEECCEEEEEEEEC
Q ss_conf 05987654471028389999998489848999974851265999999999999459982455322431046388999844
Q 002673 606 TDNFSQANIIGCGGFGLVYKATLANGTTLAIKKLSGDLGLMEREFKAEVEALSTAQHKNLVSLQGYCVHQGFRLLIYSYM 685 (894)
Q Consensus 606 ~~~~~~~~~LG~G~fg~Vy~a~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~lV~E~~ 685 (894)
.++|+..+.||+|+||.||+|.+.++..||||++.... ...+++.+|+.+++.++|||||+++|+|.+.+..++||||+
T Consensus 4 p~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~-~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~lv~E~~ 82 (263)
T d1sm2a_ 4 PSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGA-MSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFM 82 (263)
T ss_dssp CSCEEEEEEEECCSSCCEEEEEETTTEEEEEEECCSSS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECC
T ss_pred HHHCEEEEEEEECCCEEEEEEEECCCCEEEEEEECCCC-CCHHHHHHHHHHHHHCCCCCCCCCCCEECCCCCEEEEEEEC
T ss_conf 69958888982088829999998899999999987886-76899999999999668997565352431599337999836
Q ss_pred CCCCHHHHHHHHCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCEEEEECCCCCCCCCCCC
Q ss_conf 69998899844148988757999999999999999998850699836418999985778998599997345332378887
Q 002673 686 ENGSLDYWLHEKADGASQLDWLTRLKIARGTSCGLAYMHQICEPHIVHRDIKSSNILLDDQFEAHLADFGLSRLILPYQT 765 (894)
Q Consensus 686 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~Ia~aL~yLHs~~~~~ivH~DLkp~NILl~~~~~vkL~DFGla~~~~~~~~ 765 (894)
++|+|.+++.... ..+++..+..++.||+.||.|||+ ++|+||||||+|||++.++.+||+|||+++.......
T Consensus 83 ~~g~L~~~l~~~~---~~~~~~~~~~i~~qia~gl~~lH~---~~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~ 156 (263)
T d1sm2a_ 83 EHGCLSDYLRTQR---GLFAAETLLGMCLDVCEGMAYLEE---ACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQY 156 (263)
T ss_dssp TTCBHHHHHHTTT---TCCCHHHHHHHHHHHHHHHHHHHH---TTCCCTTCSGGGEEECGGGCEEECSCC----------
T ss_pred CCCCHHHHHHCCC---CCCCHHHHHHHHHHHHHHHHHHHC---CCEEECCCCHHHEEECCCCCEEECCCCHHEECCCCCC
T ss_conf 9991899752013---478899999999999998776531---6431044315326666887768655321002368873
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHCC-CCCCCCCCCCHHHHHHHHHHHHHHCCCCCCCCCCCCC
Q ss_conf 431124556786682243676778621189999999999919-9999988930125699999988414987754452003
Q 002673 766 HVTTELVGTLGYIPPEYGQAWVATLRGDMYSFGVVMLELLTG-KRPVDVLKPKMSRELVGWVLKMRSEGKQDQVFDPILR 844 (894)
Q Consensus 766 ~~~~~~~gt~~y~APE~~~~~~~s~ksDVwSlGvil~elltG-~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~ 844 (894)
.......||..|+|||++.+..++.++||||||+++|||+|+ ++||..... ......+.. +... ..+
T Consensus 157 ~~~~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvil~el~t~~~~~~~~~~~---~~~~~~i~~----~~~~--~~p--- 224 (263)
T d1sm2a_ 157 TSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSN---SEVVEDIST----GFRL--YKP--- 224 (263)
T ss_dssp --------CTTSCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSCCH---HHHHHHHHH----TCCC--CCC---
T ss_pred EEECCEECCCCCCCHHHHCCCCCCCHHHHCCHHHHHHHHHHCCCCCCCCCCH---HHHHHHHHH----CCCC--CCC---
T ss_conf 3504300176667857860799984033210599999998789888778999---999999980----6888--995---
Q ss_pred CCCCHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHHCCC
Q ss_conf 99996999999999987111599999999999999982001
Q 002673 845 GKGFDEEMLQVLDVACMCVSQNPFKRPTVKEVVEWLNNVGA 885 (894)
Q Consensus 845 ~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~eil~~L~~i~~ 885 (894)
...+ .++.+++.+||+.||++||||+++++.|+++..
T Consensus 225 -~~~~---~~l~~li~~cl~~~p~~Rps~~~il~~L~~i~e 261 (263)
T d1sm2a_ 225 -RLAS---THVYQIMNHCWKERPEDRPAFSRLLRQLAEIAE 261 (263)
T ss_dssp -TTSC---HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred -CCCC---HHHHHHHHHHCCCCHHHCCCHHHHHHHHHHHHH
T ss_conf -4367---999999999765797689199999999999985
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=357.70 Aligned_cols=255 Identities=24% Similarity=0.341 Sum_probs=209.9
Q ss_pred CCCCCCCEEEECCCEEEEEEEE-CCCCEEEEEEECCCCHHHHHHHHHHHHHHHHCCCCCEEEECCEEEECCEEEEEEEEC
Q ss_conf 5987654471028389999998-489848999974851265999999999999459982455322431046388999844
Q 002673 607 DNFSQANIIGCGGFGLVYKATL-ANGTTLAIKKLSGDLGLMEREFKAEVEALSTAQHKNLVSLQGYCVHQGFRLLIYSYM 685 (894)
Q Consensus 607 ~~~~~~~~LG~G~fg~Vy~a~~-~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~lV~E~~ 685 (894)
++|+..+.||+|+||.||+|.. .+|+.||+|++........+.+.+|+.+++.++|||||++++++.+.+..++||||+
T Consensus 20 ~~Y~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmEy~ 99 (293)
T d1yhwa1 20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYL 99 (293)
T ss_dssp TTBCSCEECCCSSSCEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred CCCEEEEEEECCCCCEEEEEEECCCCCEEEEEEEECCCCHHHHHHHHHHHHHHHCCCCCEEEEEEEEEECCEEEEEEEEC
T ss_conf 05388789812858299999998999899999984301727999999999998679998805857798899989999703
Q ss_pred CCCCHHHHHHHHCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCEEEEECCCCCCCCCCCC
Q ss_conf 69998899844148988757999999999999999998850699836418999985778998599997345332378887
Q 002673 686 ENGSLDYWLHEKADGASQLDWLTRLKIARGTSCGLAYMHQICEPHIVHRDIKSSNILLDDQFEAHLADFGLSRLILPYQT 765 (894)
Q Consensus 686 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~Ia~aL~yLHs~~~~~ivH~DLkp~NILl~~~~~vkL~DFGla~~~~~~~~ 765 (894)
++|+|.+++... .++...+..++.||+.||.|||+ ++|+||||||+|||++.++.+||+|||+++......
T Consensus 100 ~gg~L~~~~~~~-----~l~~~~~~~i~~qi~~aL~yLH~---~~iiHrDiKp~NILl~~~~~vkl~DFG~a~~~~~~~- 170 (293)
T d1yhwa1 100 AGGSLTDVVTET-----CMDEGQIAAVCRECLQALEFLHS---NQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQ- 170 (293)
T ss_dssp TTCBHHHHHHHS-----CCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTCCEEECCCTTCEECCSTT-
T ss_pred CCCCHHHHHHCC-----CCCHHHHHHHHHHHHHHHHHHHH---CCCCCCCCCHHHEEECCCCCEEECCCHHHEEECCCC-
T ss_conf 798089886415-----99999999999999999999998---797226776888688789968642515641321366-
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHCCCCCCCCCCCCHHHHHHHHHHHHHHCCCCCCCCCCCCCC
Q ss_conf 43112455678668224367677862118999999999991999999889301256999999884149877544520039
Q 002673 766 HVTTELVGTLGYIPPEYGQAWVATLRGDMYSFGVVMLELLTGKRPVDVLKPKMSRELVGWVLKMRSEGKQDQVFDPILRG 845 (894)
Q Consensus 766 ~~~~~~~gt~~y~APE~~~~~~~s~ksDVwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~ 845 (894)
......+||+.|+|||++.+..++.++||||+||++|+|++|+.||....... .... ............
T Consensus 171 ~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~---~~~~---~~~~~~~~~~~~----- 239 (293)
T d1yhwa1 171 SKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLR---ALYL---IATNGTPELQNP----- 239 (293)
T ss_dssp CCBCCCCSCGGGCCHHHHSSSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHH---HHHH---HHHHCSCCCSSG-----
T ss_pred CCCCCCCCCCCCCCHHHHCCCCCCCHHCEEHHHHHHHHHHHCCCCCCCCCHHH---HHHH---HHHCCCCCCCCC-----
T ss_conf 64444444777368266447998801203137299999804889989979999---9999---985799988885-----
Q ss_pred CCCHHHHHHHHHHHHHHCCCCCCCCCCHHHHHH--HHHHCC
Q ss_conf 999699999999998711159999999999999--998200
Q 002673 846 KGFDEEMLQVLDVACMCVSQNPFKRPTVKEVVE--WLNNVG 884 (894)
Q Consensus 846 ~~~~~~~~~l~~li~~Cl~~dP~~RPs~~eil~--~L~~i~ 884 (894)
......+.+++.+||+.||.+|||+.|+++ |++..+
T Consensus 240 ---~~~s~~~~~li~~~L~~dP~~R~s~~eil~Hp~~~~~~ 277 (293)
T d1yhwa1 240 ---EKLSAIFRDFLNRCLDMDVEKRGSAKELLQHQFLKIAK 277 (293)
T ss_dssp ---GGSCHHHHHHHHHHTCSSTTTSCCHHHHTTCGGGGGCC
T ss_pred ---CCCCHHHHHHHHHHCCCCHHHCCCHHHHHCCHHHCCCC
T ss_conf ---53799999999998669966890999996499657788
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=0 Score=358.30 Aligned_cols=260 Identities=25% Similarity=0.405 Sum_probs=209.0
Q ss_pred CCCCCCCCEEEECCCEEEEEEEECC-C---CEEEEEEECCCC-HHHHHHHHHHHHHHHHCCCCCEEEECCEEEECCEEEE
Q ss_conf 0598765447102838999999848-9---848999974851-2659999999999994599824553224310463889
Q 002673 606 TDNFSQANIIGCGGFGLVYKATLAN-G---TTLAIKKLSGDL-GLMEREFKAEVEALSTAQHKNLVSLQGYCVHQGFRLL 680 (894)
Q Consensus 606 ~~~~~~~~~LG~G~fg~Vy~a~~~~-~---~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~l 680 (894)
.++|+..+.||+|+||.||+|.+.. + ..||||++.... ....+.|.+|+.+++.++|||||+++|++.+.+..++
T Consensus 25 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~~~~i 104 (299)
T d1jpaa_ 25 ISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMI 104 (299)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEECC---CCEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEE
T ss_pred HHHCEEEEEEEECCCEEEEEEEEECCCCEEEEEEEEEECCCCCHHHHHHHHHHHHHHHHCCCCCCCCEEEEEEECCEEEE
T ss_conf 00427856980278829999999579978899999997844598999999999999985799888618999962887799
Q ss_pred EEEECCCCCHHHHHHHHCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCEEEEECCCCCCC
Q ss_conf 99844699988998441489887579999999999999999988506998364189999857789985999973453323
Q 002673 681 IYSYMENGSLDYWLHEKADGASQLDWLTRLKIARGTSCGLAYMHQICEPHIVHRDIKSSNILLDDQFEAHLADFGLSRLI 760 (894)
Q Consensus 681 V~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~Ia~aL~yLHs~~~~~ivH~DLkp~NILl~~~~~vkL~DFGla~~~ 760 (894)
||||+++|+|.+++.... ..+++..+..++.||+.||.|||+ ++++||||||+|||++.++.+||+|||+++..
T Consensus 105 v~Ey~~~g~L~~~~~~~~---~~l~~~~~~~i~~qia~gl~yLH~---~~iiHrDlKp~NILl~~~~~~Kl~DFGla~~~ 178 (299)
T d1jpaa_ 105 ITEFMENGSLDSFLRQND---GQFTVIQLVGMLRGIAAGMKYLAD---MNYVHRDLAARNILVNSNLVCKVSDFGLSRFL 178 (299)
T ss_dssp EEECCTTEEHHHHHHTTT---TCSCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECTTCCEEECCC------
T ss_pred EEEECCCCCCEEEECCCC---CCCCHHHHHHHHHHHHHHHHHHHH---CCCCCCCCCCCEEEECCCCCEEECCCCCCEEC
T ss_conf 997227985300210456---799999999999999998898852---79835761504489889991998884431575
Q ss_pred CCCCCCC----CCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHC-CCCCCCCCCCCHHHHHHHHHHHHHHCCCC
Q ss_conf 7888743----112455678668224367677862118999999999991-99999988930125699999988414987
Q 002673 761 LPYQTHV----TTELVGTLGYIPPEYGQAWVATLRGDMYSFGVVMLELLT-GKRPVDVLKPKMSRELVGWVLKMRSEGKQ 835 (894)
Q Consensus 761 ~~~~~~~----~~~~~gt~~y~APE~~~~~~~s~ksDVwSlGvil~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~ 835 (894)
....... .....||+.|+|||++.+..++.++|||||||++|||+| |+.||...... +....+. .....
T Consensus 179 ~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~sDvwS~Gvvl~el~t~g~~Pf~~~~~~---~~~~~i~---~~~~~ 252 (299)
T d1jpaa_ 179 EDDTSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMTNQ---DVINAIE---QDYRL 252 (299)
T ss_dssp -----------------CGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHH---HHHHHHH---TTCCC
T ss_pred CCCCCCCEEEECCCCCCCCCCCCHHHHHCCCCCCCCCCCCCHHHHHHHHHCCCCCCCCCCHH---HHHHHHH---CCCCC
T ss_conf 67777653650256668830038788836997861214453578999986799999999999---9999997---37889
Q ss_pred CCCCCCCCCCCCCHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHHCCCCC
Q ss_conf 7544520039999699999999998711159999999999999998200134
Q 002673 836 DQVFDPILRGKGFDEEMLQVLDVACMCVSQNPFKRPTVKEVVEWLNNVGANR 887 (894)
Q Consensus 836 ~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~eil~~L~~i~~~~ 887 (894)
. . ..+....+.+++.+||+.||++||||.++++.|+.+....
T Consensus 253 ~-~---------~~~~~~~l~~li~~cl~~~P~~RPs~~ei~~~L~~~l~~p 294 (299)
T d1jpaa_ 253 P-P---------PMDCPSALHQLMLDCWQKDRNHRPKFGQIVNTLDKMIRNP 294 (299)
T ss_dssp C-C---------CTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHSG
T ss_pred C-C---------CCCCHHHHHHHHHHHCCCCHHHCCCHHHHHHHHHHHHCCH
T ss_conf 9-9---------7422699999999975879768929999999999984186
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=358.16 Aligned_cols=261 Identities=25% Similarity=0.437 Sum_probs=206.3
Q ss_pred CCCCCCCCEEEECCCEEEEEEEECCCCEEEEEEECCCC--HHHHHHHHHHHHHHHHCCCCCEEEECCEEEECCEEEEEEE
Q ss_conf 05987654471028389999998489848999974851--2659999999999994599824553224310463889998
Q 002673 606 TDNFSQANIIGCGGFGLVYKATLANGTTLAIKKLSGDL--GLMEREFKAEVEALSTAQHKNLVSLQGYCVHQGFRLLIYS 683 (894)
Q Consensus 606 ~~~~~~~~~LG~G~fg~Vy~a~~~~~~~vavK~~~~~~--~~~~~~~~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~lV~E 683 (894)
.++|++.+.||+|+||.||+|+++ ..||||++.... ....+.|.+|+.++++++|||||+++|++.+ +..++|||
T Consensus 7 ~~~~~~~~~lG~G~fg~Vy~~~~~--~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~-~~~~lv~E 83 (276)
T d1uwha_ 7 DGQITVGQRIGSGSFGTVYKGKWH--GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTA-PQLAIVTQ 83 (276)
T ss_dssp TTCCCCCSEEEECSSCEEEEEESS--SEEEEEECCCSSCCTTHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSCEEEEE
T ss_pred CCCEEEEEEEEECCCCEEEEEEEC--CEEEEEEEECCCCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEEEC-CEEEEEEE
T ss_conf 451899889830788589999999--989999997346998999999999999984799878645679715-58999996
Q ss_pred ECCCCCHHHHHHHHCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCEEEEECCCCCCCCCC
Q ss_conf 44699988998441489887579999999999999999988506998364189999857789985999973453323788
Q 002673 684 YMENGSLDYWLHEKADGASQLDWLTRLKIARGTSCGLAYMHQICEPHIVHRDIKSSNILLDDQFEAHLADFGLSRLILPY 763 (894)
Q Consensus 684 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~Ia~aL~yLHs~~~~~ivH~DLkp~NILl~~~~~vkL~DFGla~~~~~~ 763 (894)
|+++|+|.+++.... ..+++..+..++.||+.||.|||+ ++|+||||||+|||++.++.+||+|||+++.....
T Consensus 84 y~~~g~L~~~l~~~~---~~~~~~~~~~i~~qi~~gl~yLH~---~~ivHrDlKp~NiLl~~~~~~Kl~DFGla~~~~~~ 157 (276)
T d1uwha_ 84 WCEGSSLYHHLHIIE---TKFEMIKLIDIARQTAQGMDYLHA---KSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRW 157 (276)
T ss_dssp CCCEEEHHHHHHTSC---CCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEEETTSSEEECCCCCSCC----
T ss_pred CCCCCCHHHHHHHCC---CCCCHHHHHHHHHHHHHHHHHHHC---CCEECCCCCHHHEEECCCCCEEECCCCCEEECCCC
T ss_conf 589988899985235---789999999999999999888750---99951614789979818997887500221333556
Q ss_pred CC-CCCCCCCCCCCCCCCCCCCC---CCCCCCCCHHHHHHHHHHHHCCCCCCCCCCCCHHHHHHHHHHHHHHCCCCCCCC
Q ss_conf 87-43112455678668224367---677862118999999999991999999889301256999999884149877544
Q 002673 764 QT-HVTTELVGTLGYIPPEYGQA---WVATLRGDMYSFGVVMLELLTGKRPVDVLKPKMSRELVGWVLKMRSEGKQDQVF 839 (894)
Q Consensus 764 ~~-~~~~~~~gt~~y~APE~~~~---~~~s~ksDVwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 839 (894)
.. .......||+.|+|||++.+ ..++.++|||||||++|||+||+.||........ ...... .+......
T Consensus 158 ~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~sDiwS~Gv~l~el~tg~~Pf~~~~~~~~--~~~~~~----~~~~~p~~ 231 (276)
T d1uwha_ 158 SGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQ--IIFMVG----RGYLSPDL 231 (276)
T ss_dssp --------CCCCGGGCCHHHHTTCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHH--HHHHHH----HTSCCCCG
T ss_pred CCCCCCCCCCCCCCCCCHHHHHCCCCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCCHHHH--HHHHHH----CCCCCCCC
T ss_conf 776312566557431799999505689999531516359999999978899899896999--999996----58889860
Q ss_pred CCCCCCCCCHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHHCCCC
Q ss_conf 52003999969999999999871115999999999999999820013
Q 002673 840 DPILRGKGFDEEMLQVLDVACMCVSQNPFKRPTVKEVVEWLNNVGAN 886 (894)
Q Consensus 840 d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~eil~~L~~i~~~ 886 (894)
. .. .... ...+.+++.+||+.||.+|||++++++.|+.+...
T Consensus 232 ~-~~-~~~~---~~~l~~li~~cl~~dp~~RPt~~~il~~Le~l~~~ 273 (276)
T d1uwha_ 232 S-KV-RSNC---PKAMKRLMAECLKKKRDERPLFPQILASIELLARS 273 (276)
T ss_dssp G-GS-CTTC---CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHT
T ss_pred H-HC-CCCC---HHHHHHHHHHHCCCCHHHCCCHHHHHHHHHHHHHC
T ss_conf 0-03-6555---49999999997588976892999999999999970
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=363.80 Aligned_cols=270 Identities=25% Similarity=0.404 Sum_probs=211.8
Q ss_pred HCCCCCCCCEEEECCCEEEEEEEE-CCCCEEEEEEECCCC-HHHHHHHHHHHHHHHHCCCCCEEEECCEEEECCEEEEEE
Q ss_conf 405987654471028389999998-489848999974851-265999999999999459982455322431046388999
Q 002673 605 ATDNFSQANIIGCGGFGLVYKATL-ANGTTLAIKKLSGDL-GLMEREFKAEVEALSTAQHKNLVSLQGYCVHQGFRLLIY 682 (894)
Q Consensus 605 ~~~~~~~~~~LG~G~fg~Vy~a~~-~~~~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~lV~ 682 (894)
..++|++.+.||+|+||.||+|.. .+++.||+|++.... ......+.+|+.+++.++|||||++++++.+....++||
T Consensus 4 ~~d~y~~~~~iG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~iVm 83 (322)
T d1s9ja_ 4 KDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICM 83 (322)
T ss_dssp CGGGEEEEEEEECCSSCCEEEEEETTTTEEEEEEEEECCCCTTHHHHHHHHGGGGGGCCCTTBCCEEEEEECSSEEEEEE
T ss_pred CCCCCEEEEEEECCCCEEEEEEEECCCCCEEEEEEECHHHCHHHHHHHHHHHHHHHHCCCCCCCCEEEEEEECCEEEEEE
T ss_conf 75688897897127780999999989996999999875409789999999999998679999994999999899999999
Q ss_pred EECCCCCHHHHHHHHCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCEEEEECCCCCCCCC
Q ss_conf 84469998899844148988757999999999999999998850699836418999985778998599997345332378
Q 002673 683 SYMENGSLDYWLHEKADGASQLDWLTRLKIARGTSCGLAYMHQICEPHIVHRDIKSSNILLDDQFEAHLADFGLSRLILP 762 (894)
Q Consensus 683 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~Ia~aL~yLHs~~~~~ivH~DLkp~NILl~~~~~vkL~DFGla~~~~~ 762 (894)
||+++|+|.+++... ..+++..+..++.|++.||.|||+. ++|+||||||+|||++.++.+||+|||+|+....
T Consensus 84 Ey~~gg~L~~~l~~~----~~l~~~~~~~~~~qil~aL~yLH~~--~~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~ 157 (322)
T d1s9ja_ 84 EHMDGGSLDQVLKKA----GRIPEQILGKVSIAVIKGLTYLREK--HKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLID 157 (322)
T ss_dssp ECCTTEEHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHHH--HCCCCSCCSGGGEEECTTCCEEECCCCCCHHHHH
T ss_pred ECCCCCCHHHHHHHC----CCCCHHHHHHHHHHHHHHHHHHHHH--CCEECCCCCHHHEEECCCCCEEEEECCCCCCCCC
T ss_conf 767998689987424----9999999999999999999999985--9997144577994687899899954877625678
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHCCCCCCCCCCCCHHHHHHHH-HHHHHHCC--------
Q ss_conf 887431124556786682243676778621189999999999919999998893012569999-99884149--------
Q 002673 763 YQTHVTTELVGTLGYIPPEYGQAWVATLRGDMYSFGVVMLELLTGKRPVDVLKPKMSRELVGW-VLKMRSEG-------- 833 (894)
Q Consensus 763 ~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwSlGvil~elltG~~Pf~~~~~~~~~~~~~~-~~~~~~~~-------- 833 (894)
......+||+.|+|||++.+..|+.++||||+||++|||++|+.||.............. ........
T Consensus 158 ---~~~~~~~GT~~Y~APEvl~~~~y~~~~DiWSlGvil~ell~G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (322)
T d1s9ja_ 158 ---SMANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPG 234 (322)
T ss_dssp ---HTC---CCSSCCCCHHHHHCSCCCTTHHHHHHHHHHHHHHHSSCCSSCCCTTHHHHHC-------------------
T ss_pred ---CCCCCCCCCCCCCCCHHHCCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHHCCCCCCCCCCCCCCC
T ss_conf ---86211137714119468758998948889989999999998889989988789999998875177545774212333
Q ss_pred ------CCC-----C---C-------CCCCCCCCCCHHHHHHHHHHHHHHCCCCCCCCCCHHHHHH--HHHHCCCC
Q ss_conf ------877-----5---4-------4520039999699999999998711159999999999999--99820013
Q 002673 834 ------KQD-----Q---V-------FDPILRGKGFDEEMLQVLDVACMCVSQNPFKRPTVKEVVE--WLNNVGAN 886 (894)
Q Consensus 834 ------~~~-----~---~-------~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~eil~--~L~~i~~~ 886 (894)
... . . ..+.+... ....++.+++.+||+.||.+|||++|+++ |+++....
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~s~~~~dli~~~L~~dP~~R~ta~e~L~Hpf~~~~~~~ 307 (322)
T d1s9ja_ 235 RPLSSYGMDSRPPMAIFELLDYIVNEPPPKLPSG---VFSLEFQDFVNKCLIKNPAERADLKQLMVHAFIKRSDAE 307 (322)
T ss_dssp -----------CCCCHHHHHHHHHTSCCCCCCBT---TBCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHHHHHS
T ss_pred CCCCCCCCCCCCCHHHHHHHHHHHCCCCCCCCCC---CCCHHHHHHHHHHCCCCHHHCCCHHHHHHCHHHCCCCCC
T ss_conf 2211112223541347788766502687667644---489999999999868994679089999609864769823
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=357.26 Aligned_cols=257 Identities=25% Similarity=0.370 Sum_probs=207.2
Q ss_pred CCCCCCCCEEEECCCEEEEEEEECCCCEEEEEEECCCCHHHHHHHHHHHHHHHHCCCCCEEEECCEEEECCEEEEEEEEC
Q ss_conf 05987654471028389999998489848999974851265999999999999459982455322431046388999844
Q 002673 606 TDNFSQANIIGCGGFGLVYKATLANGTTLAIKKLSGDLGLMEREFKAEVEALSTAQHKNLVSLQGYCVHQGFRLLIYSYM 685 (894)
Q Consensus 606 ~~~~~~~~~LG~G~fg~Vy~a~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~lV~E~~ 685 (894)
.++|++.+.||+|+||.||+|.++++..||||++.... ...+.|.+|+.+++.++|||||+++|++.+ +..++||||+
T Consensus 12 ~~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~~~~~~-~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~-~~~~iv~Ey~ 89 (272)
T d1qpca_ 12 RETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGS-MSPDAFLAEANLMKQLQHQRLVRLYAVVTQ-EPIYIITEYM 89 (272)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEEECC
T ss_pred HHHEEEEEEEECCCCCEEEEEEECCCCEEEEEEECCCC-CCHHHHHHHHHHHHHCCCCCEEEEEEEECC-CCEEEEEEEC
T ss_conf 89938867981079828999999999999999986476-888999999999986799988578731045-9769999957
Q ss_pred CCCCHHHHHHHHCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCEEEEECCCCCCCCCCCC
Q ss_conf 69998899844148988757999999999999999998850699836418999985778998599997345332378887
Q 002673 686 ENGSLDYWLHEKADGASQLDWLTRLKIARGTSCGLAYMHQICEPHIVHRDIKSSNILLDDQFEAHLADFGLSRLILPYQT 765 (894)
Q Consensus 686 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~Ia~aL~yLHs~~~~~ivH~DLkp~NILl~~~~~vkL~DFGla~~~~~~~~ 765 (894)
++|+|.+++.... ...+++..++.++.||+.||.|||+ ++|+||||||+|||++.++.+||+|||+++.......
T Consensus 90 ~~g~L~~~~~~~~--~~~l~~~~~~~i~~qi~~gl~~lH~---~~ivHrDiKp~NIll~~~~~~Kl~DFGla~~~~~~~~ 164 (272)
T d1qpca_ 90 ENGSLVDFLKTPS--GIKLTINKLLDMAAQIAEGMAFIEE---RNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEY 164 (272)
T ss_dssp TTCBHHHHTTSHH--HHTCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECTTSCEEECCCTTCEECSSSCE
T ss_pred CCCCHHHHHHHCC--CCCCCHHHHHHHHHHHHHHHHHHHH---CCCCCCCCCHHHEEEECCCCEEECCCCCEEECCCCCC
T ss_conf 8982888875147--8988788999999999999999974---8954675642251562024404234101477358864
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHCCCCCCCCCCCCHHHHHHHHHHHHHHCCCCCCCCCCCCCC
Q ss_conf 43112455678668224367677862118999999999991999999889301256999999884149877544520039
Q 002673 766 HVTTELVGTLGYIPPEYGQAWVATLRGDMYSFGVVMLELLTGKRPVDVLKPKMSRELVGWVLKMRSEGKQDQVFDPILRG 845 (894)
Q Consensus 766 ~~~~~~~gt~~y~APE~~~~~~~s~ksDVwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~ 845 (894)
.......|+..|+|||++.+..++.++|||||||++|||+||..|+..... .......+. .+..... .
T Consensus 165 ~~~~~~~gt~~y~APE~~~~~~~~~~sDvwS~Gvvl~ellt~~~~~~~~~~--~~~~~~~i~----~~~~~~~------p 232 (272)
T d1qpca_ 165 TAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMT--NPEVIQNLE----RGYRMVR------P 232 (272)
T ss_dssp ECCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCC--HHHHHHHHH----TTCCCCC------C
T ss_pred CCCCCCCCCCCCCCHHHHHCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCCC--HHHHHHHHH----HCCCCCC------C
T ss_conf 420356774444582898379998245645257999999968988888889--999999997----0688889------6
Q ss_pred CCCHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHHCC
Q ss_conf 999699999999998711159999999999999998200
Q 002673 846 KGFDEEMLQVLDVACMCVSQNPFKRPTVKEVVEWLNNVG 884 (894)
Q Consensus 846 ~~~~~~~~~l~~li~~Cl~~dP~~RPs~~eil~~L~~i~ 884 (894)
...+ ..+.+++.+||+.||++||||+++++.|+.+-
T Consensus 233 ~~~~---~~l~~li~~cl~~~P~~Rpt~~ei~~~L~~~f 268 (272)
T d1qpca_ 233 DNCP---EELYQLMRLCWKERPEDRPTFDYLRSVLEDFF 268 (272)
T ss_dssp TTCC---HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred CCCH---HHHHHHHHHHCCCCHHHCCCHHHHHHHHHHHH
T ss_conf 5571---99999999975889768939999999861132
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=0 Score=359.46 Aligned_cols=261 Identities=23% Similarity=0.347 Sum_probs=212.0
Q ss_pred HCCCCCCCCEEEECCCEEEEEEEEC-CCCEEEEEEECCCCHHHHHHHHHHHHHHHHCCCCCEEEECCEEEECCEEEEEEE
Q ss_conf 4059876544710283899999984-898489999748512659999999999994599824553224310463889998
Q 002673 605 ATDNFSQANIIGCGGFGLVYKATLA-NGTTLAIKKLSGDLGLMEREFKAEVEALSTAQHKNLVSLQGYCVHQGFRLLIYS 683 (894)
Q Consensus 605 ~~~~~~~~~~LG~G~fg~Vy~a~~~-~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~lV~E 683 (894)
..++|+..+.||+|+||.||+|.+. ++..||||++..+. ...+++.+|+.+++.++|||||+++|+|.+.+..++|||
T Consensus 15 ~~~~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~-~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~iv~E 93 (287)
T d1opja_ 15 ERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITE 93 (287)
T ss_dssp CGGGEEEEEETTTTTTSSEEEEEEGGGTEEEEEEECCTTC-SCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEE
T ss_pred CHHHEEEEEEEEECCCEEEEEEEECCCCEEEEEEEECCCC-CHHHHHHHHHHHHHHCCCCCEECCCCCEEECCEEEEEEE
T ss_conf 5799398659820888089999999999699999977761-039999999999986799988267752745785478763
Q ss_pred ECCCCCHHHHHHHHCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCEEEEECCCCCCCCCC
Q ss_conf 44699988998441489887579999999999999999988506998364189999857789985999973453323788
Q 002673 684 YMENGSLDYWLHEKADGASQLDWLTRLKIARGTSCGLAYMHQICEPHIVHRDIKSSNILLDDQFEAHLADFGLSRLILPY 763 (894)
Q Consensus 684 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~Ia~aL~yLHs~~~~~ivH~DLkp~NILl~~~~~vkL~DFGla~~~~~~ 763 (894)
|+++|+|.+++.... ...+++..+..++.||+.||.|||+ ++|+||||||+|||++.++.+||+|||+++.....
T Consensus 94 ~~~~g~l~~~l~~~~--~~~~~~~~~~~i~~qi~~gL~yLH~---~~iiHrDlKp~NILl~~~~~~Kl~DFG~a~~~~~~ 168 (287)
T d1opja_ 94 FMTYGNLLDYLRECN--RQEVSAVVLLYMATQISSAMEYLEK---KNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGD 168 (287)
T ss_dssp CCTTCBHHHHHHHSC--TTTSCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEECGGGCEEECCCCCTTTCCSS
T ss_pred CCCCCCHHHHHHHCC--CCCHHHHHHHHHHHHHHHHHHHHHH---CCCCCCCCCCCEEEECCCCCEEECCCCCEEECCCC
T ss_conf 146760677753035--5415799999999999997888987---89305760457689989992898324454653788
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHCCCCCCCCCCCCHHHHHHHHHHHHHHCCCCCCCCCCCC
Q ss_conf 87431124556786682243676778621189999999999919999998893012569999998841498775445200
Q 002673 764 QTHVTTELVGTLGYIPPEYGQAWVATLRGDMYSFGVVMLELLTGKRPVDVLKPKMSRELVGWVLKMRSEGKQDQVFDPIL 843 (894)
Q Consensus 764 ~~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l 843 (894)
.........|+..|+|||++.+..++.++||||||+++|||++|..|+..... .......+ ..+.....
T Consensus 169 ~~~~~~~~~g~~~y~aPE~~~~~~~~~k~DiwS~Gv~l~ell~~~~p~~~~~~--~~~~~~~i----~~~~~~~~----- 237 (287)
T d1opja_ 169 TYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGID--LSQVYELL----EKDYRMER----- 237 (287)
T ss_dssp SSEEETTEEECGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCSSTTCC--HHHHHHHH----HTTCCCCC-----
T ss_pred CCEEECCCCCCCCCCCHHHHCCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCCH--HHHHHHHH----HCCCCCCC-----
T ss_conf 72210355665466692787279998104302178999999867998877425--99999998----55888888-----
Q ss_pred CCCCCHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHHCCCC
Q ss_conf 3999969999999999871115999999999999999820013
Q 002673 844 RGKGFDEEMLQVLDVACMCVSQNPFKRPTVKEVVEWLNNVGAN 886 (894)
Q Consensus 844 ~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~eil~~L~~i~~~ 886 (894)
. ...+ ..+.+++.+||+.||.+|||+.+++++|+.+...
T Consensus 238 ~-~~~~---~~l~~li~~cl~~dP~~Rps~~ei~~~L~~~~~~ 276 (287)
T d1opja_ 238 P-EGCP---EKVYELMRACWQWNPSDRPSFAEIHQAFETMFQE 276 (287)
T ss_dssp C-TTCC---HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTSS
T ss_pred C-CCCH---HHHHHHHHHHCCCCHHHCCCHHHHHHHHHHHHHH
T ss_conf 7-4330---9999999997577976893999999999999875
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Probab=100.00 E-value=0 Score=355.82 Aligned_cols=257 Identities=25% Similarity=0.353 Sum_probs=210.1
Q ss_pred CCCCCCCEEEECCCEEEEEEEE-CCCCEEEEEEECCCCHHHHHHHHHHHHHHHHCCCCCEEEECCEEEECCEEEEEEEEC
Q ss_conf 5987654471028389999998-489848999974851265999999999999459982455322431046388999844
Q 002673 607 DNFSQANIIGCGGFGLVYKATL-ANGTTLAIKKLSGDLGLMEREFKAEVEALSTAQHKNLVSLQGYCVHQGFRLLIYSYM 685 (894)
Q Consensus 607 ~~~~~~~~LG~G~fg~Vy~a~~-~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~lV~E~~ 685 (894)
++|++.+.||+|+||.||+|.. .+|..||+|++........+.+.+|+.+++.++|||||++++++.+.+..++||||+
T Consensus 26 ~~Y~i~~~lG~G~fg~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmE~~ 105 (350)
T d1koaa2 26 DHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFM 105 (350)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECCCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEEETTEEEEEECCC
T ss_pred CCEEEEEEEECCCCEEEEEEEECCCCCEEEEEEECCCCHHHHHHHHHHHHHHHHCCCCCCCCEEEEEEECCEEEEEEECC
T ss_conf 57589889840768199999988999899999984524316999999999998679979992999999899999999857
Q ss_pred CCCCHHHHHHHHCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECC--CCCEEEEECCCCCCCCCC
Q ss_conf 699988998441489887579999999999999999988506998364189999857789--985999973453323788
Q 002673 686 ENGSLDYWLHEKADGASQLDWLTRLKIARGTSCGLAYMHQICEPHIVHRDIKSSNILLDD--QFEAHLADFGLSRLILPY 763 (894)
Q Consensus 686 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~Ia~aL~yLHs~~~~~ivH~DLkp~NILl~~--~~~vkL~DFGla~~~~~~ 763 (894)
++|+|.+++... ...+++..+..++.||+.||.|||+ ++++||||||+|||++. ++.+||+|||+++.....
T Consensus 106 ~gg~L~~~l~~~---~~~l~e~~~~~i~~qi~~aL~ylH~---~~iiHrDiKp~NIll~~~~~~~vkL~DFG~a~~~~~~ 179 (350)
T d1koaa2 106 SGGELFEKVADE---HNKMSEDEAVEYMRQVCKGLCHMHE---NNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPK 179 (350)
T ss_dssp CSCBHHHHHTCT---TSCBCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEESSTTSCCEEECCCTTCEECCTT
T ss_pred CCCCHHHHHHHH---CCCCCHHHHHHHHHHHHHHHHHHHH---CCCEEEEECHHHEEECCCCCCEEEEEECCHHEECCCC
T ss_conf 998899999762---3789999999999999999999975---6976000154673641688986999545210442565
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHCCCCCCCCCCCCHHHHHHHHHHHHHHCCCCCCCCCCCC
Q ss_conf 87431124556786682243676778621189999999999919999998893012569999998841498775445200
Q 002673 764 QTHVTTELVGTLGYIPPEYGQAWVATLRGDMYSFGVVMLELLTGKRPVDVLKPKMSRELVGWVLKMRSEGKQDQVFDPIL 843 (894)
Q Consensus 764 ~~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l 843 (894)
.......||+.|+|||++.+..++.++||||+||++|+|++|+.||...... +....+.. .........
T Consensus 180 --~~~~~~~gT~~Y~aPEv~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~---~~~~~i~~--~~~~~~~~~---- 248 (350)
T d1koaa2 180 --QSVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDD---ETLRNVKS--CDWNMDDSA---- 248 (350)
T ss_dssp --SCEEEECSCTTTCCHHHHHTCCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHH---HHHHHHHH--TCCCSCCGG----
T ss_pred --CCCCEECCCCCCCCHHHHCCCCCCHHHHHHHHHHHHHHHHHCCCCCCCCCHH---HHHHHHHH--CCCCCCCCC----
T ss_conf --4320006862421889975899872676554659999998598998997999---99999984--788989422----
Q ss_pred CCCCCHHHHHHHHHHHHHHCCCCCCCCCCHHHHHH--HHHHCC
Q ss_conf 39999699999999998711159999999999999--998200
Q 002673 844 RGKGFDEEMLQVLDVACMCVSQNPFKRPTVKEVVE--WLNNVG 884 (894)
Q Consensus 844 ~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~eil~--~L~~i~ 884 (894)
.......+.+++.+||+.||++|||+.|+++ |+....
T Consensus 249 ----~~~~s~~~~~li~~~L~~dP~~R~t~~eil~hp~~~~~~ 287 (350)
T d1koaa2 249 ----FSGISEDGKDFIRKLLLADPNTRMTIHQALEHPWLTPGN 287 (350)
T ss_dssp ----GGGCCHHHHHHHHHHCCSSGGGSCCHHHHHHSTTTSCTT
T ss_pred ----CCCCCHHHHHHHHHHCCCCHHHCCCHHHHHCCCCCCCCC
T ss_conf ----358999999999997568966790899986291328898
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=354.83 Aligned_cols=255 Identities=25% Similarity=0.423 Sum_probs=213.0
Q ss_pred CCCCCCCCEEEECCCEEEEEEEECCCCEEEEEEECCCCHHHHHHHHHHHHHHHHCCCCCEEEECCEEEECCEEEEEEEEC
Q ss_conf 05987654471028389999998489848999974851265999999999999459982455322431046388999844
Q 002673 606 TDNFSQANIIGCGGFGLVYKATLANGTTLAIKKLSGDLGLMEREFKAEVEALSTAQHKNLVSLQGYCVHQGFRLLIYSYM 685 (894)
Q Consensus 606 ~~~~~~~~~LG~G~fg~Vy~a~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~lV~E~~ 685 (894)
.++|+..+.||+|+||.||+|+++++..||||++.... ...+++.+|+.+++.++||||++++|+|.+++..++|+||+
T Consensus 3 ~~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~l~~~~-~~~~~~~~Ev~~~~~l~HpnIv~~~g~~~~~~~~~iv~Ey~ 81 (258)
T d1k2pa_ 3 PKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGS-MSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYM 81 (258)
T ss_dssp CCCCCCCCCCCEETTEEEEEEEETTTEEEEEEEEESSS-SCHHHHHHHHHHHHTCCCTTBCCEEEEECCSSSEEEEEECC
T ss_pred HHHCEEEEEEECCCCEEEEEEEECCCCEEEEEEECCCC-CCHHHHHHHHHHHHHCCCCCEEEEEEEEEECCCEEEEEECC
T ss_conf 69979968982078839999998899899999987475-77899999999999668986015889985078169999704
Q ss_pred CCCCHHHHHHHHCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCEEEEECCCCCCCCCCCC
Q ss_conf 69998899844148988757999999999999999998850699836418999985778998599997345332378887
Q 002673 686 ENGSLDYWLHEKADGASQLDWLTRLKIARGTSCGLAYMHQICEPHIVHRDIKSSNILLDDQFEAHLADFGLSRLILPYQT 765 (894)
Q Consensus 686 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~Ia~aL~yLHs~~~~~ivH~DLkp~NILl~~~~~vkL~DFGla~~~~~~~~ 765 (894)
++|+|..++.... ..+++..+..++.|++.||.|||+ ++|+||||||+|||++.++.+||+|||+++.......
T Consensus 82 ~~g~l~~~~~~~~---~~~~~~~~~~i~~qi~~gl~~LH~---~~iiH~dlk~~Nill~~~~~~kl~DfG~a~~~~~~~~ 155 (258)
T d1k2pa_ 82 ANGCLLNYLREMR---HRFQTQQLLEMCKDVCEAMEYLES---KQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEY 155 (258)
T ss_dssp TTEEHHHHHHSGG---GCCCHHHHHHHHHHHHHHHHHHHH---TTBCCSCCSGGGEEECTTCCEEECCCSSCCBCSSSSC
T ss_pred CCCCHHHHHHCCC---CCCCHHHHHHHHHHHHHHHHHHHH---CCCCCCCCCCEEEEECCCCCEEECCCHHHEECCCCCC
T ss_conf 8993888641024---677689999999999999998754---6843466541358876998479886144202357872
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHC-CCCCCCCCCCCHHHHHHHHHHHHHHCCCCCCCCCCCCC
Q ss_conf 43112455678668224367677862118999999999991-99999988930125699999988414987754452003
Q 002673 766 HVTTELVGTLGYIPPEYGQAWVATLRGDMYSFGVVMLELLT-GKRPVDVLKPKMSRELVGWVLKMRSEGKQDQVFDPILR 844 (894)
Q Consensus 766 ~~~~~~~gt~~y~APE~~~~~~~s~ksDVwSlGvil~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~ 844 (894)
.......||..|+|||++.+..++.++||||||+++|||+| |+.||........ ...+ ..+.. ...+
T Consensus 156 ~~~~~~~~t~~y~aPE~~~~~~~~~ksDiwS~G~~l~el~t~g~~Pf~~~~~~~~---~~~i----~~~~~--~~~p--- 223 (258)
T d1k2pa_ 156 TSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSET---AEHI----AQGLR--LYRP--- 223 (258)
T ss_dssp CCCCCSCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCHHHH---HHHH----HTTCC--CCCC---
T ss_pred EEECCCCCCCCCCCCHHHCCCCCCCCEEECCCCHHHHHHHHCCCCCCCCCCHHHH---HHHH----HHCCC--CCCC---
T ss_conf 2524657887757807863799885210336432467397559999889999999---9999----80797--8996---
Q ss_pred CCCCHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHHC
Q ss_conf 999969999999999871115999999999999999820
Q 002673 845 GKGFDEEMLQVLDVACMCVSQNPFKRPTVKEVVEWLNNV 883 (894)
Q Consensus 845 ~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~eil~~L~~i 883 (894)
...+ ..+.+++.+||+.||++|||++++++.|.++
T Consensus 224 -~~~~---~~l~~li~~cl~~dP~~RPt~~eil~~L~di 258 (258)
T d1k2pa_ 224 -HLAS---EKVYTIMYSCWHEKADERPTFKILLSNILDV 258 (258)
T ss_dssp -TTCC---HHHHHHHHHTTCSSGGGSCCHHHHHHHHHCC
T ss_pred -CCCC---HHHHHHHHHHCCCCHHHCCCHHHHHHHHHCC
T ss_conf -5465---9999999997668976893999999874188
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Probab=100.00 E-value=0 Score=354.06 Aligned_cols=256 Identities=24% Similarity=0.340 Sum_probs=210.1
Q ss_pred CCCCCCCEEEECCCEEEEEEEE-CCCCEEEEEEECCCCHHHHHHHHHHHHHHHHCCCCCEEEECCEEEECCEEEEEEEEC
Q ss_conf 5987654471028389999998-489848999974851265999999999999459982455322431046388999844
Q 002673 607 DNFSQANIIGCGGFGLVYKATL-ANGTTLAIKKLSGDLGLMEREFKAEVEALSTAQHKNLVSLQGYCVHQGFRLLIYSYM 685 (894)
Q Consensus 607 ~~~~~~~~LG~G~fg~Vy~a~~-~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~lV~E~~ 685 (894)
++|++.+.||+|+||.||+|.. .++..||+|++..........+.+|+.+++.++|||||++++++.+++..++||||+
T Consensus 29 d~Y~i~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivmE~~ 108 (352)
T d1koba_ 29 DYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEFL 108 (352)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEECC
T ss_pred CCEEEEEEEECCCCEEEEEEEECCCCCEEEEEEECCCCHHHHHHHHHHHHHHHHCCCCCCCCEEEEEEECCEEEEEEECC
T ss_conf 03599899931778299999998999799999988726467999999999998679979891999999899999999828
Q ss_pred CCCCHHHHHHHHCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEEC--CCCCEEEEECCCCCCCCCC
Q ss_conf 69998899844148988757999999999999999998850699836418999985778--9985999973453323788
Q 002673 686 ENGSLDYWLHEKADGASQLDWLTRLKIARGTSCGLAYMHQICEPHIVHRDIKSSNILLD--DQFEAHLADFGLSRLILPY 763 (894)
Q Consensus 686 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~Ia~aL~yLHs~~~~~ivH~DLkp~NILl~--~~~~vkL~DFGla~~~~~~ 763 (894)
++|+|.+++... ...+++..+..++.||+.||.|||+ ++|+||||||+|||++ .++.+||+|||++......
T Consensus 109 ~gg~L~~~~~~~---~~~l~e~~~~~i~~qi~~aL~ylH~---~~iiHRDiKp~NILl~~~~~~~vkL~DFGla~~~~~~ 182 (352)
T d1koba_ 109 SGGELFDRIAAE---DYKMSEAEVINYMRQACEGLKHMHE---HSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPD 182 (352)
T ss_dssp CCCBHHHHTTCT---TCCBCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEESSTTCCCEEECCCTTCEECCTT
T ss_pred CCCHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHHH---CCEEECCCCCCCCCCCCCCCCEEEEEECCCCEECCCC
T ss_conf 998088889863---8998999999999999999999997---7926513144553113467884899525630343788
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHCCCCCCCCCCCCHHHHHHHHHHHHHHCCCCCCCCCCCC
Q ss_conf 87431124556786682243676778621189999999999919999998893012569999998841498775445200
Q 002673 764 QTHVTTELVGTLGYIPPEYGQAWVATLRGDMYSFGVVMLELLTGKRPVDVLKPKMSRELVGWVLKMRSEGKQDQVFDPIL 843 (894)
Q Consensus 764 ~~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l 843 (894)
.......|++.|+|||++.+..++.++||||+||++|+|++|+.||....... ....+. ... .. +.
T Consensus 183 --~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~---~~~~i~---~~~-~~--~~--- 248 (352)
T d1koba_ 183 --EIVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLE---TLQNVK---RCD-WE--FD--- 248 (352)
T ss_dssp --SCEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHH---HHHHHH---HCC-CC--CC---
T ss_pred --CCEEECCCCCCCCCHHHHCCCCCCCCCCHHHHHHHHHHHHHCCCCCCCCCHHH---HHHHHH---HCC-CC--CC---
T ss_conf --72010047645348999747998976333898999999996889989979999---999998---478-89--89---
Q ss_pred CCCCCHHHHHHHHHHHHHHCCCCCCCCCCHHHHHH--HHHHC
Q ss_conf 39999699999999998711159999999999999--99820
Q 002673 844 RGKGFDEEMLQVLDVACMCVSQNPFKRPTVKEVVE--WLNNV 883 (894)
Q Consensus 844 ~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~eil~--~L~~i 883 (894)
..........+.+|+.+||+.||.+|||+.|+++ |+++.
T Consensus 249 -~~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~Hp~~~~~ 289 (352)
T d1koba_ 249 -EDAFSSVSPEAKDFIKNLLQKEPRKRLTVHDALEHPWLKGD 289 (352)
T ss_dssp -SSTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHTSTTTSSC
T ss_pred -CCCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHCCHHHCCC
T ss_conf -30024799999999999756996689189999609734888
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=352.23 Aligned_cols=249 Identities=30% Similarity=0.429 Sum_probs=206.5
Q ss_pred CCCCCCCEEEECCCEEEEEEEEC-CCCEEEEEEECCCC---HHHHHHHHHHHHHHHHCCCCCEEEECCEEEECCEEEEEE
Q ss_conf 59876544710283899999984-89848999974851---265999999999999459982455322431046388999
Q 002673 607 DNFSQANIIGCGGFGLVYKATLA-NGTTLAIKKLSGDL---GLMEREFKAEVEALSTAQHKNLVSLQGYCVHQGFRLLIY 682 (894)
Q Consensus 607 ~~~~~~~~LG~G~fg~Vy~a~~~-~~~~vavK~~~~~~---~~~~~~~~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~lV~ 682 (894)
++|++.+.||+|+||.||+|... +++.||+|++.... ......+.+|+.+++.++|||||++++++.+++..++||
T Consensus 6 ~dy~i~~~iG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~ivm 85 (263)
T d2j4za1 6 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLIL 85 (263)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred HHEEEEEEEECCCCCEEEEEEECCCCCEEEEEEECHHHCCCHHHHHHHHHHHHHHHHCCCCCCCEEEEEEEECCEEEEEE
T ss_conf 37699889851778589999998999499999981688567689999999999998568888885999999899989998
Q ss_pred EECCCCCHHHHHHHHCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCEEEEECCCCCCCCC
Q ss_conf 84469998899844148988757999999999999999998850699836418999985778998599997345332378
Q 002673 683 SYMENGSLDYWLHEKADGASQLDWLTRLKIARGTSCGLAYMHQICEPHIVHRDIKSSNILLDDQFEAHLADFGLSRLILP 762 (894)
Q Consensus 683 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~Ia~aL~yLHs~~~~~ivH~DLkp~NILl~~~~~vkL~DFGla~~~~~ 762 (894)
||+++|+|.+++... ..+++..+..++.||+.||.|||+ ++|+||||||+|||++.++.+||+|||+++....
T Consensus 86 Ey~~~g~L~~~l~~~----~~l~e~~~~~i~~qi~~al~~lH~---~~ivHrDiKp~Nill~~~~~~kl~DFG~a~~~~~ 158 (263)
T d2j4za1 86 EYAPLGTVYRELQKL----SKFDEQRTATYITELANALSYCHS---KRVIHRDIKPENLLLGSAGELKIADFGWSVHAPS 158 (263)
T ss_dssp ECCTTCBHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTSCEEECCCCSCSCCCC
T ss_pred EECCCCCHHHHHHHC----CCCCHHHHHHHHHHHHHHHHHHHH---CCEEEEEECCCCCEECCCCCEEECCCCEEEECCC
T ss_conf 504798589887504----899999999999999999999998---8946522023441466899871155563354488
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHCCCCCCCCCCCCHHHHHHHHHHHHHHCCCCCCCCCCC
Q ss_conf 88743112455678668224367677862118999999999991999999889301256999999884149877544520
Q 002673 763 YQTHVTTELVGTLGYIPPEYGQAWVATLRGDMYSFGVVMLELLTGKRPVDVLKPKMSRELVGWVLKMRSEGKQDQVFDPI 842 (894)
Q Consensus 763 ~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 842 (894)
.......||+.|+|||++.+..++.++|||||||++|||++|+.||....... ..... . ..... ++
T Consensus 159 ---~~~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~---~~~~i---~-~~~~~--~p-- 224 (263)
T d2j4za1 159 ---SRRTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQE---TYKRI---S-RVEFT--FP-- 224 (263)
T ss_dssp ---CCCEETTEEGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHH---HHHHH---H-TTCCC--CC--
T ss_pred ---CCCCCCCCCCCCCCHHHHCCCCCCCHHHHHHHHHHHHHHHCCCCCCCCCCHHH---HHHHH---H-CCCCC--CC--
T ss_conf ---85235578876349999758998931440467599999832999988899999---99999---7-18999--98--
Q ss_pred CCCCCCHHHHHHHHHHHHHHCCCCCCCCCCHHHHHH--HHHH
Q ss_conf 039999699999999998711159999999999999--9982
Q 002673 843 LRGKGFDEEMLQVLDVACMCVSQNPFKRPTVKEVVE--WLNN 882 (894)
Q Consensus 843 l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~eil~--~L~~ 882 (894)
...+ .++.+++.+||+.||.+|||++|+++ |+.+
T Consensus 225 ---~~~s---~~~~~li~~~L~~dp~~R~t~~eil~hp~~~~ 260 (263)
T d2j4za1 225 ---DFVT---EGARDLISRLLKHNPSQRPMLREVLEHPWITA 260 (263)
T ss_dssp ---TTSC---HHHHHHHHHHTCSSGGGSCCHHHHHTCHHHHH
T ss_pred ---CCCC---HHHHHHHHHHCCCCHHHCCCHHHHHCCCCCCC
T ss_conf ---6689---99999999976479768909999971907078
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=353.81 Aligned_cols=259 Identities=22% Similarity=0.377 Sum_probs=207.4
Q ss_pred CCCCCCCCEEEECCCEEEEEEEECC-C-----CEEEEEEECCCCH-HHHHHHHHHHHHHHHC-CCCCEEEECCEEEECCE
Q ss_conf 0598765447102838999999848-9-----8489999748512-6599999999999945-99824553224310463
Q 002673 606 TDNFSQANIIGCGGFGLVYKATLAN-G-----TTLAIKKLSGDLG-LMEREFKAEVEALSTA-QHKNLVSLQGYCVHQGF 677 (894)
Q Consensus 606 ~~~~~~~~~LG~G~fg~Vy~a~~~~-~-----~~vavK~~~~~~~-~~~~~~~~Ei~~l~~l-~Hpniv~l~g~~~~~~~ 677 (894)
.++|++.+.||+|+||.||+|++.. + ..||+|.+..... .....+.+|+.++.++ +|||||++++++.+.+.
T Consensus 36 ~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~ 115 (325)
T d1rjba_ 36 RENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLSGP 115 (325)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred HHHEEEEEEEEECCCEEEEEEEECCCCCCCCEEEEEEEEECCCCCHHHHHHHHHHHHHHHHHCCCCCEEEEEEEEEECCE
T ss_conf 89939701983078819999998578855420499999966335878999999999999971589968687788862995
Q ss_pred EEEEEEECCCCCHHHHHHHHCC-------------------CCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCC
Q ss_conf 8899984469998899844148-------------------988757999999999999999998850699836418999
Q 002673 678 RLLIYSYMENGSLDYWLHEKAD-------------------GASQLDWLTRLKIARGTSCGLAYMHQICEPHIVHRDIKS 738 (894)
Q Consensus 678 ~~lV~E~~~~gsL~~~l~~~~~-------------------~~~~l~~~~~~~i~~~Ia~aL~yLHs~~~~~ivH~DLkp 738 (894)
.++||||+++|+|.++++.... ....+++..++.++.||+.||.|||+ ++|+||||||
T Consensus 116 ~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH~---~~IiHRDlKp 192 (325)
T d1rjba_ 116 IYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEF---KSCVHRDLAA 192 (325)
T ss_dssp CEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHH---TTEEETTCSG
T ss_pred EEEEEECCCCCCHHHHHHHCCCCCCCHHHHHCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHH---CCEEECCCCH
T ss_conf 8999972799959999986257775102210000122200125778999999999999999999973---9905052703
Q ss_pred CCEEECCCCCEEEEECCCCCCCCCCCCC-CCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHC-CCCCCCCCCC
Q ss_conf 9857789985999973453323788874-3112455678668224367677862118999999999991-9999998893
Q 002673 739 SNILLDDQFEAHLADFGLSRLILPYQTH-VTTELVGTLGYIPPEYGQAWVATLRGDMYSFGVVMLELLT-GKRPVDVLKP 816 (894)
Q Consensus 739 ~NILl~~~~~vkL~DFGla~~~~~~~~~-~~~~~~gt~~y~APE~~~~~~~s~ksDVwSlGvil~ellt-G~~Pf~~~~~ 816 (894)
+|||++.++.+||+|||+++........ ......||+.|+|||++.+..++.++|||||||++|||+| |+.||.....
T Consensus 193 ~Nill~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwS~Gvil~emlt~g~~Pf~~~~~ 272 (325)
T d1rjba_ 193 RNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIPV 272 (325)
T ss_dssp GGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCC
T ss_pred HCCCCCCCCEEEEEECCCCCCCCCCCCEEEECCCCCCCCCCCHHHHCCCCCCCCEECCCHHHHHHHHHHCCCCCCCCCCH
T ss_conf 21443459828985142222045778615623435787657838872799996330300039999998389999999898
Q ss_pred CHHHHHHHHHHHHHHCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHH
Q ss_conf 012569999998841498775445200399996999999999987111599999999999999982
Q 002673 817 KMSRELVGWVLKMRSEGKQDQVFDPILRGKGFDEEMLQVLDVACMCVSQNPFKRPTVKEVVEWLNN 882 (894)
Q Consensus 817 ~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~eil~~L~~ 882 (894)
... ....+ ..+..... ....+ ..+.+|+.+||+.||++|||+++|++.|..
T Consensus 273 ~~~--~~~~~----~~~~~~~~------p~~~~---~~l~~li~~cl~~dP~~RPt~~ei~~~L~~ 323 (325)
T d1rjba_ 273 DAN--FYKLI----QNGFKMDQ------PFYAT---EEIYIIMQSCWAFDSRKRPSFPNLTSFLGC 323 (325)
T ss_dssp SHH--HHHHH----HTTCCCCC------CTTCC---HHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred HHH--HHHHH----HCCCCCCC------CCCCC---HHHHHHHHHHCCCCHHHCCCHHHHHHHHHC
T ss_conf 999--99998----56998998------87678---999999999758896689399999999748
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=349.94 Aligned_cols=257 Identities=23% Similarity=0.360 Sum_probs=205.0
Q ss_pred CCCCCCC-EEEECCCEEEEEEEEC---CCCEEEEEEECCCC-HHHHHHHHHHHHHHHHCCCCCEEEECCEEEECCEEEEE
Q ss_conf 5987654-4710283899999984---89848999974851-26599999999999945998245532243104638899
Q 002673 607 DNFSQAN-IIGCGGFGLVYKATLA---NGTTLAIKKLSGDL-GLMEREFKAEVEALSTAQHKNLVSLQGYCVHQGFRLLI 681 (894)
Q Consensus 607 ~~~~~~~-~LG~G~fg~Vy~a~~~---~~~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~lV 681 (894)
++|...+ .||+|+||.||+|.++ ++..||||++.... ....+.|.+|+.+++.++|||||+++|++.+ +..++|
T Consensus 8 ~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~-~~~~lv 86 (285)
T d1u59a_ 8 DNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALMLV 86 (285)
T ss_dssp GGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEEEE
T ss_pred CCEEECCCEEECCCCEEEEEEEEECCCCCEEEEEEEECHHCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEECC-CEEEEE
T ss_conf 4718878487306080999999960897689999998820397899999999999986799888068656036-807999
Q ss_pred EEECCCCCHHHHHHHHCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCEEEEECCCCCCCC
Q ss_conf 98446999889984414898875799999999999999999885069983641899998577899859999734533237
Q 002673 682 YSYMENGSLDYWLHEKADGASQLDWLTRLKIARGTSCGLAYMHQICEPHIVHRDIKSSNILLDDQFEAHLADFGLSRLIL 761 (894)
Q Consensus 682 ~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~Ia~aL~yLHs~~~~~ivH~DLkp~NILl~~~~~vkL~DFGla~~~~ 761 (894)
|||+++|+|.+++.... ..+++..+..++.|++.||.|||+ ++|+||||||+|||++.++.+||+|||+++...
T Consensus 87 mE~~~~g~L~~~l~~~~---~~l~~~~~~~i~~qi~~gL~ylH~---~~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~ 160 (285)
T d1u59a_ 87 MEMAGGGPLHKFLVGKR---EEIPVSNVAELLHQVSMGMKYLEE---KNFVHRDLAARNVLLVNRHYAKISDFGLSKALG 160 (285)
T ss_dssp EECCTTEEHHHHHTTCT---TTSCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEEEETTEEEECCCTTCEECT
T ss_pred EEECCCCCHHHHHHCCC---CCCCHHHHHHHHHHHHHHHHHHHH---CCEECCCCCHHHEEECCCCCEEECCCHHHHCCC
T ss_conf 98078996899752125---699999999999999998789986---881057676466045468854203313421155
Q ss_pred CCCCC--CCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHC-CCCCCCCCCCCHHHHHHHHHHHHHHCCCCCCC
Q ss_conf 88874--3112455678668224367677862118999999999991-99999988930125699999988414987754
Q 002673 762 PYQTH--VTTELVGTLGYIPPEYGQAWVATLRGDMYSFGVVMLELLT-GKRPVDVLKPKMSRELVGWVLKMRSEGKQDQV 838 (894)
Q Consensus 762 ~~~~~--~~~~~~gt~~y~APE~~~~~~~s~ksDVwSlGvil~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 838 (894)
..... ......||+.|+|||++.+..++.++|||||||++|||+| |+.||....... ....+ ..+.....
T Consensus 161 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gv~l~E~lt~G~~Pf~~~~~~~---~~~~i----~~~~~~~~ 233 (285)
T d1u59a_ 161 ADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPE---VMAFI----EQGKRMEC 233 (285)
T ss_dssp TCSCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHH---HHHHH----HTTCCCCC
T ss_pred CCCCCCCCCCCCCCCCCCCCHHHHHCCCCCCCCHHHCCHHHHHHHHHCCCCCCCCCCHHH---HHHHH----HCCCCCCC
T ss_conf 434321135621137433586887279999541232201789999938999999979999---99999----81899999
Q ss_pred CCCCCCCCCCHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHHCCCC
Q ss_conf 452003999969999999999871115999999999999999820013
Q 002673 839 FDPILRGKGFDEEMLQVLDVACMCVSQNPFKRPTVKEVVEWLNNVGAN 886 (894)
Q Consensus 839 ~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~eil~~L~~i~~~ 886 (894)
. ...+ ..+.+++.+||+.+|++||||.+|++.|+.+-..
T Consensus 234 p------~~~~---~~l~~li~~cl~~~p~~RPs~~~i~~~L~~~~~~ 272 (285)
T d1u59a_ 234 P------PECP---PELYALMSDCWIYKWEDRPDFLTVEQRMRACYYS 272 (285)
T ss_dssp C------TTCC---HHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred C------CCCC---HHHHHHHHHHCCCCHHHCCCHHHHHHHHHHHHHH
T ss_conf 9------7678---9999999997577976890999999999999998
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=353.84 Aligned_cols=256 Identities=22% Similarity=0.352 Sum_probs=205.9
Q ss_pred CCCCCCCCEEEECCCEEEEEEEE-CCCCEEEEEEECCCCH-HHHHHHHHHHHHHHHCCCCCEEEECCEEEECCEEEEEEE
Q ss_conf 05987654471028389999998-4898489999748512-659999999999994599824553224310463889998
Q 002673 606 TDNFSQANIIGCGGFGLVYKATL-ANGTTLAIKKLSGDLG-LMEREFKAEVEALSTAQHKNLVSLQGYCVHQGFRLLIYS 683 (894)
Q Consensus 606 ~~~~~~~~~LG~G~fg~Vy~a~~-~~~~~vavK~~~~~~~-~~~~~~~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~lV~E 683 (894)
.++|++.+.||+|+||.||+|.. .+++.||+|++..... ...+.+.+|+.+++.++|||||++++++.+++..++|||
T Consensus 4 ~~dy~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~~~~~~~~~~~~~ivmE 83 (271)
T d1nvra_ 4 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLE 83 (271)
T ss_dssp TTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred CCCEEEEEEEECCCCEEEEEEEECCCCCEEEEEEEEHHHCCHHHHHHHHHHHHHHHCCCCCEEEEEEEECCCCEEEEEEE
T ss_conf 74608998972174809999999999979999998456641279999999999985799888469654046743679886
Q ss_pred ECCCCCHHHHHHHHCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCEEEEECCCCCCCCCC
Q ss_conf 44699988998441489887579999999999999999988506998364189999857789985999973453323788
Q 002673 684 YMENGSLDYWLHEKADGASQLDWLTRLKIARGTSCGLAYMHQICEPHIVHRDIKSSNILLDDQFEAHLADFGLSRLILPY 763 (894)
Q Consensus 684 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~Ia~aL~yLHs~~~~~ivH~DLkp~NILl~~~~~vkL~DFGla~~~~~~ 763 (894)
|+++|+|.+++... ..+++..+..++.|++.||.|||+ ++|+||||||+|||++.++.+||+|||+++.....
T Consensus 84 y~~gg~L~~~l~~~----~~l~e~~~~~i~~qi~~al~ylH~---~~IiHrDiKp~NILl~~~~~~KL~DFG~a~~~~~~ 156 (271)
T d1nvra_ 84 YCSGGELFDRIEPD----IGMPEPDAQRFFHQLMAGVVYLHG---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYN 156 (271)
T ss_dssp CCTTEEGGGGSBTT----TBCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGGGEEECTTCCEEECCCTTCEECEET
T ss_pred CCCCCCHHHHHHCC----CCCCHHHHHHHHHHHHHHHHHHHH---CCCCCCCCCHHHEEECCCCCEEECCCHHHEEECCC
T ss_conf 45898089997537----999999999999999999999997---59835754689978878998798323142240468
Q ss_pred CC-CCCCCCCCCCCCCCCCCCCCCCC-CCCCCHHHHHHHHHHHHCCCCCCCCCCCCHHHHHHHHHHHHHHCCCCCCCCCC
Q ss_conf 87-43112455678668224367677-86211899999999999199999988930125699999988414987754452
Q 002673 764 QT-HVTTELVGTLGYIPPEYGQAWVA-TLRGDMYSFGVVMLELLTGKRPVDVLKPKMSRELVGWVLKMRSEGKQDQVFDP 841 (894)
Q Consensus 764 ~~-~~~~~~~gt~~y~APE~~~~~~~-s~ksDVwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 841 (894)
.. ......+||+.|+|||++.+..+ +.++||||+||++|||++|+.||........ ..... .........
T Consensus 157 ~~~~~~~~~~GT~~Y~APE~~~~~~~~~~~~DiwSlGvilyeml~G~~pf~~~~~~~~-~~~~~----~~~~~~~~~--- 228 (271)
T d1nvra_ 157 NRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQ-EYSDW----KEKKTYLNP--- 228 (271)
T ss_dssp TEECCBCCCCSCGGGSCTHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSSTTSH-HHHHH----HTTCTTSTT---
T ss_pred CCCCCCCCEEECCCCCCHHHHCCCCCCCCCEEEEHHHHHHHHHHHCCCCCCCCCHHHH-HHHHH----HCCCCCCCC---
T ss_conf 8653111325574742872861899999710161737999999829978888985999-99998----638887886---
Q ss_pred CCCCCCCHHHHHHHHHHHHHHCCCCCCCCCCHHHHHH--HHHH
Q ss_conf 0039999699999999998711159999999999999--9982
Q 002673 842 ILRGKGFDEEMLQVLDVACMCVSQNPFKRPTVKEVVE--WLNN 882 (894)
Q Consensus 842 ~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~eil~--~L~~ 882 (894)
.......+.+++.+||+.||++|||++|+++ |+++
T Consensus 229 ------~~~~s~~~~~li~~~L~~dP~~R~t~~eil~hpwf~~ 265 (271)
T d1nvra_ 229 ------WKKIDSAPLALLHKILVENPSARITIPDIKKDRWYNK 265 (271)
T ss_dssp ------GGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTCTTTTC
T ss_pred ------CCCCCHHHHHHHHHHCCCCHHHCCCHHHHHCCHHHCC
T ss_conf ------4469999999999976799668909999961984585
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=352.87 Aligned_cols=254 Identities=22% Similarity=0.315 Sum_probs=206.4
Q ss_pred CCCCCCCEEEECCCEEEEEEEE-CCCCEEEEEEECCCCHHHHHHHHHHHHHHHHCCCCCEEEECCEEEECCEEEEEEEEC
Q ss_conf 5987654471028389999998-489848999974851265999999999999459982455322431046388999844
Q 002673 607 DNFSQANIIGCGGFGLVYKATL-ANGTTLAIKKLSGDLGLMEREFKAEVEALSTAQHKNLVSLQGYCVHQGFRLLIYSYM 685 (894)
Q Consensus 607 ~~~~~~~~LG~G~fg~Vy~a~~-~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~lV~E~~ 685 (894)
+.|++.+.||+|+||.||+|.. .++..||+|++........+.+.+|+.+++.++|||||++++++.+.+..++||||+
T Consensus 12 d~Y~i~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lvmEy~ 91 (288)
T d2jfla1 12 DFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFC 91 (288)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECSSSGGGGGTHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred CCEEEEEEEEECCCCEEEEEEECCCCEEEEEEEECCCCHHHHHHHHHHHHHHHHCCCCCCCEEEEEEEECCEEEEEEECC
T ss_conf 37598479930778199999999999399999987289999999999999998679999884988980099589999627
Q ss_pred CCCCHHHHHHHHCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCEEEEECCCCCCCCCCCC
Q ss_conf 69998899844148988757999999999999999998850699836418999985778998599997345332378887
Q 002673 686 ENGSLDYWLHEKADGASQLDWLTRLKIARGTSCGLAYMHQICEPHIVHRDIKSSNILLDDQFEAHLADFGLSRLILPYQT 765 (894)
Q Consensus 686 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~Ia~aL~yLHs~~~~~ivH~DLkp~NILl~~~~~vkL~DFGla~~~~~~~~ 765 (894)
++|+|.+++.... ..+++..+..++.||+.||.|||+ ++|+||||||+|||++.++.+||+|||+++..... .
T Consensus 92 ~~g~L~~~~~~~~---~~l~e~~~~~i~~qi~~gL~ylH~---~~ivHrDiKp~NIll~~~~~~Kl~DFG~a~~~~~~-~ 164 (288)
T d2jfla1 92 AGGAVDAVMLELE---RPLTESQIQVVCKQTLDALNYLHD---NKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRT-I 164 (288)
T ss_dssp TTEEHHHHHHHHT---SCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTSCEEECCCTTCEECHHH-H
T ss_pred CCCCHHHHHHHCC---CCCCHHHHHHHHHHHHHHHHHHHH---CCEEEEECCHHHEEECCCCCEEEEECHHHHCCCCC-C
T ss_conf 9981889998628---999999999999999999999998---89887140700314878999899716123035778-6
Q ss_pred CCCCCCCCCCCCCCCCCCC-----CCCCCCCCCHHHHHHHHHHHHCCCCCCCCCCCCHHHHHHHHHHHHHHCCCCCCCCC
Q ss_conf 4311245567866822436-----76778621189999999999919999998893012569999998841498775445
Q 002673 766 HVTTELVGTLGYIPPEYGQ-----AWVATLRGDMYSFGVVMLELLTGKRPVDVLKPKMSRELVGWVLKMRSEGKQDQVFD 840 (894)
Q Consensus 766 ~~~~~~~gt~~y~APE~~~-----~~~~s~ksDVwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 840 (894)
.......||+.|+|||++. ...|+.++|||||||++|||++|+.||........ ..... ... ......
T Consensus 165 ~~~~~~~Gt~~y~APE~l~~~~~~~~~y~~k~DiwSlGvilyemltg~~Pf~~~~~~~~---~~~i~---~~~-~~~~~~ 237 (288)
T d2jfla1 165 QRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRV---LLKIA---KSE-PPTLAQ 237 (288)
T ss_dssp HHHTCCCSCCTTCCHHHHTTCSTTTSSTTTHHHHHHHHHHHHHHHHSSCTTTTSCGGGH---HHHHH---HSC-CCCCSS
T ss_pred CCCCCCCCCCCCCCHHHHHHCCCCCCCCCHHHHHHHHHHHHHHHHHCCCCCCCCCHHHH---HHHHH---CCC-CCCCCC
T ss_conf 41001025626479999832025788888066578789999998208899999899999---99997---079-987776
Q ss_pred CCCCCCCCHHHHHHHHHHHHHHCCCCCCCCCCHHHHHH--HHH
Q ss_conf 20039999699999999998711159999999999999--998
Q 002673 841 PILRGKGFDEEMLQVLDVACMCVSQNPFKRPTVKEVVE--WLN 881 (894)
Q Consensus 841 ~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~eil~--~L~ 881 (894)
+ ......+.+++.+||+.||.+|||+.|+++ |++
T Consensus 238 ~-------~~~s~~~~~li~~~L~~dp~~R~t~~ell~hp~~~ 273 (288)
T d2jfla1 238 P-------SRWSSNFKDFLKKCLEKNVDARWTTSQLLQHPFVT 273 (288)
T ss_dssp G-------GGSCHHHHHHHHHHSCSSTTTSCCHHHHTTSGGGC
T ss_pred C-------CCCCHHHHHHHHHHCCCCHHHCCCHHHHHCCCCCC
T ss_conf 5-------66999999999997669966891999996292318
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=346.86 Aligned_cols=260 Identities=26% Similarity=0.406 Sum_probs=206.6
Q ss_pred CCCCCCCCEEEECCCEEEEEEEECCC-----CEEEEEEECCCCH-HHHHHHHHHHHHHHHCCCCCEEEECCEEEECCEEE
Q ss_conf 05987654471028389999998489-----8489999748512-65999999999999459982455322431046388
Q 002673 606 TDNFSQANIIGCGGFGLVYKATLANG-----TTLAIKKLSGDLG-LMEREFKAEVEALSTAQHKNLVSLQGYCVHQGFRL 679 (894)
Q Consensus 606 ~~~~~~~~~LG~G~fg~Vy~a~~~~~-----~~vavK~~~~~~~-~~~~~~~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~ 679 (894)
++.|+..++||+|+||.||+|.++.. ..||||++..... .....|.+|+.+++.++|||||+++|++.+....+
T Consensus 6 ~~~~~~~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~~~g~~~~~~~~~ 85 (283)
T d1mqba_ 6 PSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMM 85 (283)
T ss_dssp TTTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEE
T ss_pred HHHEEEEEEEEECCCEEEEEEEEECCCCEEEEEEEEEEECCCCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEEECCCCEE
T ss_conf 89968615981177909999999689987879999999884459689999999999998568987832367783388038
Q ss_pred EEEEECCCCCHHHHHHHHCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCEEEEECCCCCC
Q ss_conf 99984469998899844148988757999999999999999998850699836418999985778998599997345332
Q 002673 680 LIYSYMENGSLDYWLHEKADGASQLDWLTRLKIARGTSCGLAYMHQICEPHIVHRDIKSSNILLDDQFEAHLADFGLSRL 759 (894)
Q Consensus 680 lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~Ia~aL~yLHs~~~~~ivH~DLkp~NILl~~~~~vkL~DFGla~~ 759 (894)
+|+||+.+|++.+++.... ..+++..+..++.|++.||.|||+ ++|+||||||+|||++.++.+||+|||+++.
T Consensus 86 ~v~e~~~~~~l~~~~~~~~---~~~~~~~~~~i~~~i~~gl~~lH~---~~iiHrDlKp~NILl~~~~~~Kl~DFGla~~ 159 (283)
T d1mqba_ 86 IITEYMENGALDKFLREKD---GEFSVLQLVGMLRGIAAGMKYLAN---MNYVHRDLAARNILVNSNLVCKVSDFGLSRV 159 (283)
T ss_dssp EEEECCTTEEHHHHHHHTT---TCSCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECTTCCEEECCCCC---
T ss_pred EEEEECCCCCCHHHHHCCC---CCCCHHHHHHHHHHHHHHHHHCCC---CCCCCCCCCCCEEEECCCCEEEECCCCHHHC
T ss_conf 9997213574022210234---542089999999999985412121---2342576564427888998499845510300
Q ss_pred CCCCCC--CCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHCCCCCCCCCCCCHHHHHHHHHHHHHHCCCCCC
Q ss_conf 378887--431124556786682243676778621189999999999919999998893012569999998841498775
Q 002673 760 ILPYQT--HVTTELVGTLGYIPPEYGQAWVATLRGDMYSFGVVMLELLTGKRPVDVLKPKMSRELVGWVLKMRSEGKQDQ 837 (894)
Q Consensus 760 ~~~~~~--~~~~~~~gt~~y~APE~~~~~~~s~ksDVwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 837 (894)
...... .......||..|+|||++.+..++.++||||||+++|||++|..|+...... ......+ ..+....
T Consensus 160 ~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~sDI~S~Gvil~el~t~~~~~~~~~~~--~~~~~~i----~~~~~~~ 233 (283)
T d1mqba_ 160 LEDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSN--HEVMKAI----NDGFRLP 233 (283)
T ss_dssp --------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCH--HHHHHHH----HTTCCCC
T ss_pred CCCCCCCCEEECCCCCCCCCCCHHHHCCCCCCCCCCCCCCHHHHHHHHHCCCCCCCCCCH--HHHHHHH----HCCCCCC
T ss_conf 357876526742677773434888870499997355634489899999679886556899--9999998----6357899
Q ss_pred CCCCCCCCCCCHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHHCCCC
Q ss_conf 4452003999969999999999871115999999999999999820013
Q 002673 838 VFDPILRGKGFDEEMLQVLDVACMCVSQNPFKRPTVKEVVEWLNNVGAN 886 (894)
Q Consensus 838 ~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~eil~~L~~i~~~ 886 (894)
.. ... ...+.+++.+||+.+|++||||.+|++.|+.+...
T Consensus 234 ~~------~~~---~~~l~~li~~cl~~~p~~RPt~~eil~~L~~l~~~ 273 (283)
T d1mqba_ 234 TP------MDC---PSAIYQLMMQCWQQERARRPKFADIVSILDKLIRA 273 (283)
T ss_dssp CC------TTC---BHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHS
T ss_pred CC------HHH---HHHHHHHHHHHCCCCHHHCCCHHHHHHHHHHHHHC
T ss_conf 85------045---79999999997767976893999999999998669
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=353.41 Aligned_cols=256 Identities=24% Similarity=0.389 Sum_probs=206.5
Q ss_pred CCCCCCCCEEEECCCEEEEEEEE-CCCCEEEEEEECCCC--HHHHHHHHHHHHHHHHCCCCCEEEECCEEEE--CCEEEE
Q ss_conf 05987654471028389999998-489848999974851--2659999999999994599824553224310--463889
Q 002673 606 TDNFSQANIIGCGGFGLVYKATL-ANGTTLAIKKLSGDL--GLMEREFKAEVEALSTAQHKNLVSLQGYCVH--QGFRLL 680 (894)
Q Consensus 606 ~~~~~~~~~LG~G~fg~Vy~a~~-~~~~~vavK~~~~~~--~~~~~~~~~Ei~~l~~l~Hpniv~l~g~~~~--~~~~~l 680 (894)
.++|++.+.||+|+||.||+|+. .+|+.||+|.+.... ....+.+.+|+.+++.++|||||++++++.+ .+..++
T Consensus 3 ~edy~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~i 82 (269)
T d2java1 3 AEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYI 82 (269)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCTTSCHHHHHHHHHHHHHTTSCCCTTBCCEEEEEEC----CEEE
T ss_pred CHHCEEEEEEECCCCEEEEEEEECCCCCEEEEEEECHHHCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEEEECCCCEEEE
T ss_conf 33379967983088919999999999979999998746579799999999999999778999824899999178998999
Q ss_pred EEEECCCCCHHHHHHHHCCCCCCCCHHHHHHHHHHHHHHHHHHHHCC--CCCEEECCCCCCCEEECCCCCEEEEECCCCC
Q ss_conf 99844699988998441489887579999999999999999988506--9983641899998577899859999734533
Q 002673 681 IYSYMENGSLDYWLHEKADGASQLDWLTRLKIARGTSCGLAYMHQIC--EPHIVHRDIKSSNILLDDQFEAHLADFGLSR 758 (894)
Q Consensus 681 V~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~Ia~aL~yLHs~~--~~~ivH~DLkp~NILl~~~~~vkL~DFGla~ 758 (894)
||||+++|+|.+++.........+++..++.++.|++.||.|||+.. ..+|+||||||+|||++.++.+||+|||+++
T Consensus 83 vmEy~~~g~L~~~i~~~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~~~~~vkl~DFG~a~ 162 (269)
T d2java1 83 VMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLAR 162 (269)
T ss_dssp EEECCTTEEHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEECTTSCEEECCHHHHH
T ss_pred EEECCCCCCHHHHHHHCCCCCCCCCHHHHHHHHHHHHHHHHHHHHHCCCCCCEEECCCCHHHCCCCCCCCEEEEECCCEE
T ss_conf 99568999389999851545789999999999999999999999716778878858676542574788857980010003
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHCCCCCCCCCCCCHHHHHHHHHHHHHHCCCCCCC
Q ss_conf 23788874311245567866822436767786211899999999999199999988930125699999988414987754
Q 002673 759 LILPYQTHVTTELVGTLGYIPPEYGQAWVATLRGDMYSFGVVMLELLTGKRPVDVLKPKMSRELVGWVLKMRSEGKQDQV 838 (894)
Q Consensus 759 ~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 838 (894)
...... .......||+.|+|||++.+..++.++|||||||++|||++|+.||...... +....+ ..+....+
T Consensus 163 ~~~~~~-~~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyel~tg~~Pf~~~~~~---~~~~~i----~~~~~~~~ 234 (269)
T d2java1 163 ILNHDT-SFAKAFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQK---ELAGKI----REGKFRRI 234 (269)
T ss_dssp HC------------CCCSCCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHH---HHHHHH----HHTCCCCC
T ss_pred ECCCCC-CCCCCCCCCCCCCCHHHHCCCCCCHHHHHHHHCHHHHHHHHCCCCCCCCCHH---HHHHHH----HCCCCCCC
T ss_conf 224577-7556677882327999983999993898875278999980188998998999---999999----71899889
Q ss_pred CCCCCCCCCCHHHHHHHHHHHHHHCCCCCCCCCCHHHHHH
Q ss_conf 4520039999699999999998711159999999999999
Q 002673 839 FDPILRGKGFDEEMLQVLDVACMCVSQNPFKRPTVKEVVE 878 (894)
Q Consensus 839 ~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~eil~ 878 (894)
. ...+ .++.+++.+||+.||.+|||+.|+++
T Consensus 235 ~------~~~s---~~l~~li~~~L~~dp~~Rps~~ell~ 265 (269)
T d2java1 235 P------YRYS---DELNEIITRMLNLKDYHRPSVEEILE 265 (269)
T ss_dssp C------TTSC---HHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred C------CCCC---HHHHHHHHHHCCCCHHHCCCHHHHHH
T ss_conf 7------4359---99999999976799557918999972
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=344.03 Aligned_cols=248 Identities=24% Similarity=0.398 Sum_probs=199.8
Q ss_pred CEEEECCCEEEEEEEECC---CCEEEEEEECCCC--HHHHHHHHHHHHHHHHCCCCCEEEECCEEEECCEEEEEEEECCC
Q ss_conf 447102838999999848---9848999974851--26599999999999945998245532243104638899984469
Q 002673 613 NIIGCGGFGLVYKATLAN---GTTLAIKKLSGDL--GLMEREFKAEVEALSTAQHKNLVSLQGYCVHQGFRLLIYSYMEN 687 (894)
Q Consensus 613 ~~LG~G~fg~Vy~a~~~~---~~~vavK~~~~~~--~~~~~~~~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~lV~E~~~~ 687 (894)
+.||+|+||.||+|.+++ +..||||++.... ....+.+.+|+.++++++|||||+++|+|.+ +..++||||+++
T Consensus 13 k~iG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~g~~~~-~~~~lvmE~~~~ 91 (277)
T d1xbba_ 13 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWMLVMEMAEL 91 (277)
T ss_dssp EEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEEES-SSEEEEEECCTT
T ss_pred CCCCCCCCEEEEEEEECCCCCCEEEEEEEECHHHCCHHHHHHHHHHHHHHHHCCCCCCCEEEEEECC-CCEEEEEECCCC
T ss_conf 7834587829999998169738599999988010898999999999999986799898527777505-977999974788
Q ss_pred CCHHHHHHHHCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCEEEEECCCCCCCCCCCCC-
Q ss_conf 9988998441489887579999999999999999988506998364189999857789985999973453323788874-
Q 002673 688 GSLDYWLHEKADGASQLDWLTRLKIARGTSCGLAYMHQICEPHIVHRDIKSSNILLDDQFEAHLADFGLSRLILPYQTH- 766 (894)
Q Consensus 688 gsL~~~l~~~~~~~~~l~~~~~~~i~~~Ia~aL~yLHs~~~~~ivH~DLkp~NILl~~~~~vkL~DFGla~~~~~~~~~- 766 (894)
|+|.+++... ..+++..+..++.||+.||.|||+ ++|+||||||+|||++.++.+||+|||+++........
T Consensus 92 g~L~~~l~~~----~~l~~~~~~~i~~qi~~gl~ylH~---~~iiHrDlKp~Nill~~~~~~kl~DFGla~~~~~~~~~~ 164 (277)
T d1xbba_ 92 GPLNKYLQQN----RHVKDKNIIELVHQVSMGMKYLEE---SNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYY 164 (277)
T ss_dssp EEHHHHHHHC----TTCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEEEETTEEEECCCTTCEECCTTCSEE
T ss_pred CCHHHHHHHC----CCCCHHHHHHHHHHHHHHHHHHHH---CCCCCCCCCCHHHCCCCCCCCCCCCHHHHHHCCCCCCCC
T ss_conf 9689997522----578999999999999999766874---795567776113102356751234134533134323443
Q ss_pred -CCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHC-CCCCCCCCCCCHHHHHHHHHHHHHHCCCCCCCCCCCCC
Q ss_conf -3112455678668224367677862118999999999991-99999988930125699999988414987754452003
Q 002673 767 -VTTELVGTLGYIPPEYGQAWVATLRGDMYSFGVVMLELLT-GKRPVDVLKPKMSRELVGWVLKMRSEGKQDQVFDPILR 844 (894)
Q Consensus 767 -~~~~~~gt~~y~APE~~~~~~~s~ksDVwSlGvil~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~ 844 (894)
......||+.|+|||++.+..++.++||||||+++|||++ |+.||....... ....+ ..+..... .
T Consensus 165 ~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gv~l~ellt~g~~Pf~~~~~~~---~~~~i----~~~~~~~~-----p 232 (277)
T d1xbba_ 165 KAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSE---VTAML----EKGERMGC-----P 232 (277)
T ss_dssp EC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHHH---HHHHH----HTTCCCCC-----C
T ss_pred CCCCCCCCCCEECCCHHHCCCCCCCHHHHCCCHHHHHHHHHCCCCCCCCCCHHH---HHHHH----HCCCCCCC-----C
T ss_conf 224456778420391665379998434430340313289658999999989999---99999----82899999-----8
Q ss_pred CCCCHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHHCC
Q ss_conf 9999699999999998711159999999999999998200
Q 002673 845 GKGFDEEMLQVLDVACMCVSQNPFKRPTVKEVVEWLNNVG 884 (894)
Q Consensus 845 ~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~eil~~L~~i~ 884 (894)
..++ ..+.+++.+||+.||++|||+.+|++.|+..-
T Consensus 233 -~~~~---~~~~~li~~cl~~dp~~RPs~~~i~~~L~~~~ 268 (277)
T d1xbba_ 233 -AGCP---REMYDLMNLCWTYDVENRPGFAAVELRLRNYY 268 (277)
T ss_dssp -TTCC---HHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHH
T ss_pred -CCCC---HHHHHHHHHHCCCCHHHCCCHHHHHHHHHCHH
T ss_conf -6567---99999999975889768909899999852887
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=0 Score=346.55 Aligned_cols=249 Identities=26% Similarity=0.372 Sum_probs=200.8
Q ss_pred CCCCCCCEEEECCCEEEEEEEE-CCCCEEEEEEECCCC---HHHHHHHHHHHHHHHHCCCCCEEEECCEEEECCEEEEEE
Q ss_conf 5987654471028389999998-489848999974851---265999999999999459982455322431046388999
Q 002673 607 DNFSQANIIGCGGFGLVYKATL-ANGTTLAIKKLSGDL---GLMEREFKAEVEALSTAQHKNLVSLQGYCVHQGFRLLIY 682 (894)
Q Consensus 607 ~~~~~~~~LG~G~fg~Vy~a~~-~~~~~vavK~~~~~~---~~~~~~~~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~lV~ 682 (894)
+.|+..+.||+|+||.||+|.. .++..||||++.... ....+.+.+|+.+++.++|||||++++++.+.+..++||
T Consensus 15 ~~y~~l~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~iv~ 94 (309)
T d1u5ra_ 15 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVM 94 (309)
T ss_dssp HHEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEECCSSCHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred HHCEEEEEEECCCCEEEEEEEECCCCCEEEEEEECHHHCCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEEEECCEEEEEE
T ss_conf 85676279701888099999998999399999984444358899999999999999778999823899999899889999
Q ss_pred EECCCCCHHHHHHHHCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCEEEEECCCCCCCCC
Q ss_conf 84469998899844148988757999999999999999998850699836418999985778998599997345332378
Q 002673 683 SYMENGSLDYWLHEKADGASQLDWLTRLKIARGTSCGLAYMHQICEPHIVHRDIKSSNILLDDQFEAHLADFGLSRLILP 762 (894)
Q Consensus 683 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~Ia~aL~yLHs~~~~~ivH~DLkp~NILl~~~~~vkL~DFGla~~~~~ 762 (894)
||+++|+|..++... ..+++..+..++.||+.||.|||+ ++|+||||||+|||++.++.+||+|||++.....
T Consensus 95 E~~~~g~l~~~~~~~----~~l~e~~~~~i~~qi~~aL~yLH~---~~iiHrDiKp~NILl~~~~~~Kl~DFG~a~~~~~ 167 (309)
T d1u5ra_ 95 EYCLGSASDLLEVHK----KPLQEVEIAAVTHGALQGLAYLHS---HNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAP 167 (309)
T ss_dssp ECCSEEHHHHHHHHT----SCCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCSGGGEEEETTTEEEECCCTTCBSSSS
T ss_pred EECCCCCHHHHHHHC----CCCCHHHHHHHHHHHHHHHHHHHH---CCEECCCCCCCEEEECCCCCEEEEECCCCCCCCC
T ss_conf 806999457899737----999999999999999999999986---8976667884217987999789844365334677
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCC---CCCCCCCCHHHHHHHHHHHHCCCCCCCCCCCCHHHHHHHHHHHHHHCCCCCCCC
Q ss_conf 88743112455678668224367---677862118999999999991999999889301256999999884149877544
Q 002673 763 YQTHVTTELVGTLGYIPPEYGQA---WVATLRGDMYSFGVVMLELLTGKRPVDVLKPKMSRELVGWVLKMRSEGKQDQVF 839 (894)
Q Consensus 763 ~~~~~~~~~~gt~~y~APE~~~~---~~~s~ksDVwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 839 (894)
.....||+.|+|||++.+ ..|+.++|||||||++|||++|+.||...... .... ...... .....
T Consensus 168 -----~~~~~GT~~Y~APE~~~~~~~~~y~~~~DiwSlGvilyel~~g~~Pf~~~~~~---~~~~---~i~~~~-~~~~~ 235 (309)
T d1u5ra_ 168 -----ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAM---SALY---HIAQNE-SPALQ 235 (309)
T ss_dssp -----BCCCCSCGGGCCHHHHTTTTSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHH---HHHH---HHHHSC-CCCCS
T ss_pred -----CCCCCCCCCCCCHHHHHCCCCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCCHH---HHHH---HHHHCC-CCCCC
T ss_conf -----87313476636889983467888672145455899999998788999997999---9999---998289-99888
Q ss_pred CCCCCCCCCHHHHHHHHHHHHHHCCCCCCCCCCHHHHHH--HHHH
Q ss_conf 520039999699999999998711159999999999999--9982
Q 002673 840 DPILRGKGFDEEMLQVLDVACMCVSQNPFKRPTVKEVVE--WLNN 882 (894)
Q Consensus 840 d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~eil~--~L~~ 882 (894)
....+ ..+.+++.+||+.||.+|||+.++++ |+.+
T Consensus 236 -----~~~~s---~~~~~li~~~L~~dP~~Rpt~~ell~Hp~~~~ 272 (309)
T d1u5ra_ 236 -----SGHWS---EYFRNFVDSCLQKIPQDRPTSEVLLKHRFVLR 272 (309)
T ss_dssp -----CTTSC---HHHHHHHHHHTCSSGGGSCCHHHHTTCHHHHS
T ss_pred -----CCCCC---HHHHHHHHHHCCCCHHHCCCHHHHHHCHHHCC
T ss_conf -----78889---99999999977379657918999971997537
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=346.27 Aligned_cols=259 Identities=25% Similarity=0.384 Sum_probs=209.6
Q ss_pred CCCCCCCCEEEECCCEEEEEEEECCCCEEEEEEECCCCHHHHHHHHHHHHHHHHCCCCCEEEECCEEEECCEEEEEEEEC
Q ss_conf 05987654471028389999998489848999974851265999999999999459982455322431046388999844
Q 002673 606 TDNFSQANIIGCGGFGLVYKATLANGTTLAIKKLSGDLGLMEREFKAEVEALSTAQHKNLVSLQGYCVHQGFRLLIYSYM 685 (894)
Q Consensus 606 ~~~~~~~~~LG~G~fg~Vy~a~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~lV~E~~ 685 (894)
.++|++.+.||+|+||.||+|.++++..||||++.... ...+.|.+|+.+++.++|||||+++|++.+ +..++||||+
T Consensus 16 ~~~~~i~~~iG~G~fg~Vy~~~~~~~~~vAiK~l~~~~-~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~-~~~~lv~Ey~ 93 (285)
T d1fmka3 16 RESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYM 93 (285)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEECCC
T ss_pred HHHEEEEEEEEECCCEEEEEEEECCCCEEEEEEECCCC-CCHHHHHHHHHHHHHCCCCCEEEEEEEEEC-CCEEEEEEEC
T ss_conf 79979846993079809999999999999999988044-888999999999986666788689999823-9759999944
Q ss_pred CCCCHHHHHHHHCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCEEEEECCCCCCCCCCCC
Q ss_conf 69998899844148988757999999999999999998850699836418999985778998599997345332378887
Q 002673 686 ENGSLDYWLHEKADGASQLDWLTRLKIARGTSCGLAYMHQICEPHIVHRDIKSSNILLDDQFEAHLADFGLSRLILPYQT 765 (894)
Q Consensus 686 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~Ia~aL~yLHs~~~~~ivH~DLkp~NILl~~~~~vkL~DFGla~~~~~~~~ 765 (894)
++|+|..++..... ..++|..++.++.||+.||.|||+ ++++||||||+|||++.++.+||+|||+++.......
T Consensus 94 ~~g~l~~~~~~~~~--~~l~~~~~~~i~~~i~~gl~~LH~---~~ivH~DlKp~NIll~~~~~~kl~DfGla~~~~~~~~ 168 (285)
T d1fmka3 94 SKGSLLDFLKGETG--KYLRLPQLVDMAAQIASGMAYVER---MNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEY 168 (285)
T ss_dssp TTCBHHHHHSHHHH--TTCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEECGGGCEEECCCCTTC-------
T ss_pred CCCCHHHHHHHCCC--CCCHHHHHHHHHHHHHHHHHHHHH---HHEECCCCCCEEEEECCCCCEEECCCCHHHHCCCCCC
T ss_conf 79943542000035--530599999999999999998754---1143353123079998999299844255542568873
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHCCCCCCCCCCCCHHHHHHHHHHHHHHCCCCCCCCCCCCCC
Q ss_conf 43112455678668224367677862118999999999991999999889301256999999884149877544520039
Q 002673 766 HVTTELVGTLGYIPPEYGQAWVATLRGDMYSFGVVMLELLTGKRPVDVLKPKMSRELVGWVLKMRSEGKQDQVFDPILRG 845 (894)
Q Consensus 766 ~~~~~~~gt~~y~APE~~~~~~~s~ksDVwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~ 845 (894)
.......|++.|+|||++....++.++||||||+++|||++|..|+..... ..+....+.. +..... .
T Consensus 169 ~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~S~Giil~el~t~~~p~~~~~~--~~~~~~~i~~----~~~~~~-~----- 236 (285)
T d1fmka3 169 TARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMV--NREVLDQVER----GYRMPC-P----- 236 (285)
T ss_dssp -------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCC--HHHHHHHHHT----TCCCCC-C-----
T ss_pred EEECCCCCCCCCCCHHHHHCCCCCCHHHHHCCHHHHHHHHHCCCCCCCCCC--HHHHHHHHHH----CCCCCC-C-----
T ss_conf 352454556654580898379989177413235899999868999998888--9999999982----689999-8-----
Q ss_pred CCCHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHHCCCC
Q ss_conf 99969999999999871115999999999999999820013
Q 002673 846 KGFDEEMLQVLDVACMCVSQNPFKRPTVKEVVEWLNNVGAN 886 (894)
Q Consensus 846 ~~~~~~~~~l~~li~~Cl~~dP~~RPs~~eil~~L~~i~~~ 886 (894)
...+ ..+.+++.+||+.||++||||++|+++|+..-..
T Consensus 237 ~~~~---~~l~~li~~cl~~dP~~Rps~~~i~~~L~~~~~~ 274 (285)
T d1fmka3 237 PECP---ESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTS 274 (285)
T ss_dssp TTSC---HHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTSC
T ss_pred CCCC---HHHHHHHHHHCCCCHHHCCCHHHHHHHHHHHHCC
T ss_conf 3237---9999999997566975891999999987666238
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=0 Score=349.82 Aligned_cols=255 Identities=25% Similarity=0.341 Sum_probs=206.4
Q ss_pred CCCCCCCCEEEECCCEEEEEEEEC-CCCEEEEEEECCCCH-HHHHHHHHHHHHHHHCCCCCEEEECCEEEECCEEEEEEE
Q ss_conf 059876544710283899999984-898489999748512-659999999999994599824553224310463889998
Q 002673 606 TDNFSQANIIGCGGFGLVYKATLA-NGTTLAIKKLSGDLG-LMEREFKAEVEALSTAQHKNLVSLQGYCVHQGFRLLIYS 683 (894)
Q Consensus 606 ~~~~~~~~~LG~G~fg~Vy~a~~~-~~~~vavK~~~~~~~-~~~~~~~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~lV~E 683 (894)
.+.|++.+.||+|+||.||+|... +++.||+|++..... .....+.+|+.+++.++|||||++++++.+++..++|||
T Consensus 8 ~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lvmE 87 (307)
T d1a06a_ 8 RDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIVALDDIYESGGHLYLIMQ 87 (307)
T ss_dssp GGTEEEEEESBSGGGGGEEEEEETTTCCEEEEEEEEC----------CHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred CCCEEEEEEEEECCCEEEEEEEECCCCCEEEEEEECHHHHHHHHHHHHHHHHHHHHCCCCCCCCEEEEEEECCEEEEEEE
T ss_conf 66669988994065839999999999989999998157731289999999999986799899919899998998889885
Q ss_pred ECCCCCHHHHHHHHCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEEC---CCCCEEEEECCCCCCC
Q ss_conf 4469998899844148988757999999999999999998850699836418999985778---9985999973453323
Q 002673 684 YMENGSLDYWLHEKADGASQLDWLTRLKIARGTSCGLAYMHQICEPHIVHRDIKSSNILLD---DQFEAHLADFGLSRLI 760 (894)
Q Consensus 684 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~Ia~aL~yLHs~~~~~ivH~DLkp~NILl~---~~~~vkL~DFGla~~~ 760 (894)
|+++|+|.+++... ..+++..+..++.||+.||.|||+ ++|+||||||+|||++ .++.+||+|||+++..
T Consensus 88 ~~~gg~L~~~l~~~----~~l~e~~~~~~~~qi~~al~ylH~---~~iiHrDiKp~Nil~~~~~~~~~vkl~DFG~a~~~ 160 (307)
T d1a06a_ 88 LVSGGELFDRIVEK----GFYTERDASRLIFQVLDAVKYLHD---LGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKME 160 (307)
T ss_dssp CCCSCBHHHHHHTC----SCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEESSSSTTCCEEECCC------
T ss_pred CCCCCCHHHHHHCC----CCCCHHHHHHHHHHHHHHHHHHHH---CEEEEEEECCCCEEECCCCCCCEEEEECCCEEEEC
T ss_conf 26898488865303----678878999999999999875241---30556870463001104688824998315435872
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHCCCCCCCCCCCCHHHHHHHHHHHHHHCCCCCCCCC
Q ss_conf 78887431124556786682243676778621189999999999919999998893012569999998841498775445
Q 002673 761 LPYQTHVTTELVGTLGYIPPEYGQAWVATLRGDMYSFGVVMLELLTGKRPVDVLKPKMSRELVGWVLKMRSEGKQDQVFD 840 (894)
Q Consensus 761 ~~~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 840 (894)
... ......+||+.|+|||++.+..++.++||||+||++|+|++|+.||...... ....... ... .. ++
T Consensus 161 ~~~--~~~~~~~GT~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~---~~~~~i~---~~~-~~--~~ 229 (307)
T d1a06a_ 161 DPG--SVLSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDA---KLFEQIL---KAE-YE--FD 229 (307)
T ss_dssp --------------CTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH---HHHHHHH---TTC-CC--CC
T ss_pred CCC--CEEEEEEECCCCCCCHHHCCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCCHH---HHHHHHH---CCC-CC--CC
T ss_conf 589--7044003284225918873799980787345159999998597999998999---9999986---168-77--78
Q ss_pred CCCCCCCCHHHHHHHHHHHHHHCCCCCCCCCCHHHHHH--HHHH
Q ss_conf 20039999699999999998711159999999999999--9982
Q 002673 841 PILRGKGFDEEMLQVLDVACMCVSQNPFKRPTVKEVVE--WLNN 882 (894)
Q Consensus 841 ~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~eil~--~L~~ 882 (894)
. .........+.+++.+||+.||++|||+.|+++ |+.+
T Consensus 230 ~----~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~hp~~~~ 269 (307)
T d1a06a_ 230 S----PYWDDISDSAKDFIRHLMEKDPEKRFTCEQALQHPWIAG 269 (307)
T ss_dssp T----TTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHHHSTTTTS
T ss_pred C----CCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHCCHHHCC
T ss_conf 7----666678999999999976089757918999862984479
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=0 Score=345.28 Aligned_cols=262 Identities=26% Similarity=0.426 Sum_probs=211.9
Q ss_pred HHCCCCCCCCEEEECCCEEEEEEEEC------CCCEEEEEEECCCCHH-HHHHHHHHHHHHHHCCCCCEEEECCEEEECC
Q ss_conf 74059876544710283899999984------8984899997485126-5999999999999459982455322431046
Q 002673 604 KATDNFSQANIIGCGGFGLVYKATLA------NGTTLAIKKLSGDLGL-MEREFKAEVEALSTAQHKNLVSLQGYCVHQG 676 (894)
Q Consensus 604 ~~~~~~~~~~~LG~G~fg~Vy~a~~~------~~~~vavK~~~~~~~~-~~~~~~~Ei~~l~~l~Hpniv~l~g~~~~~~ 676 (894)
...++|+..+.||+|+||.||+|++. ++..||||++...... ..+.+.+|+.+++.++|||+++++++|.+..
T Consensus 10 ~p~~~~~~~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~ 89 (301)
T d1lufa_ 10 YPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCAVGK 89 (301)
T ss_dssp CCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSS
T ss_pred CCHHHCEEEEEEEECCCEEEEEEEECCCCCCCCCEEEEEEEECHHCCHHHHHHHHHHHHHHHHCCCCCCCCCEEEECCCC
T ss_conf 89889388679820788399999988876577882999999882108579999999999999668997655246660598
Q ss_pred EEEEEEEECCCCCHHHHHHHHC--------------------CCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCC
Q ss_conf 3889998446999889984414--------------------89887579999999999999999988506998364189
Q 002673 677 FRLLIYSYMENGSLDYWLHEKA--------------------DGASQLDWLTRLKIARGTSCGLAYMHQICEPHIVHRDI 736 (894)
Q Consensus 677 ~~~lV~E~~~~gsL~~~l~~~~--------------------~~~~~l~~~~~~~i~~~Ia~aL~yLHs~~~~~ivH~DL 736 (894)
..++++||+++|+|.+++.... .....+++..+..++.|++.||.|||+ ++++||||
T Consensus 90 ~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH~---~~ivHrDl 166 (301)
T d1lufa_ 90 PMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSE---RKFVHRDL 166 (301)
T ss_dssp SCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCC
T ss_pred CEEEEEEECCCCCHHHHHHHCCCCCCCCCCCCCCCHHHHCCCCCCCCCCHHHHHHHHHHHHHHHHHCCC---CCEEEEEE
T ss_conf 038999815899299999852755421000011100121034678898999999999999998554135---78685488
Q ss_pred CCCCEEECCCCCEEEEECCCCCCCCCCCC-CCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHCCC-CCCCCC
Q ss_conf 99985778998599997345332378887-4311245567866822436767786211899999999999199-999988
Q 002673 737 KSSNILLDDQFEAHLADFGLSRLILPYQT-HVTTELVGTLGYIPPEYGQAWVATLRGDMYSFGVVMLELLTGK-RPVDVL 814 (894)
Q Consensus 737 kp~NILl~~~~~vkL~DFGla~~~~~~~~-~~~~~~~gt~~y~APE~~~~~~~s~ksDVwSlGvil~elltG~-~Pf~~~ 814 (894)
||+|||++.++.+||+|||+++....... .......|+..|+|||++.+..++.++|||||||++|||++|. +||...
T Consensus 167 Kp~NILld~~~~~Kl~DFGls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~t~ksDVwS~Gvvl~ell~~~~~p~~~~ 246 (301)
T d1lufa_ 167 ATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYGM 246 (301)
T ss_dssp SGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTS
T ss_pred CCCCEEECCCCCEEECCCHHHEECCCCCCCCCCCCCCCCCCCCCHHHHCCCCCCHHHHHCCCHHHHHHHHCCCCCCCCCC
T ss_conf 40116898999289833144211367764111577776767679899726889805630252362999980689999998
Q ss_pred CCCHHHHHHHHHHHHHHCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHHCC
Q ss_conf 9301256999999884149877544520039999699999999998711159999999999999998200
Q 002673 815 KPKMSRELVGWVLKMRSEGKQDQVFDPILRGKGFDEEMLQVLDVACMCVSQNPFKRPTVKEVVEWLNNVG 884 (894)
Q Consensus 815 ~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~eil~~L~~i~ 884 (894)
.... ....+ ..+...... ... +.++.+++.+||+.+|++||||.+|+++|+++.
T Consensus 247 ~~~e---~~~~v----~~~~~~~~p------~~~---~~~~~~li~~cl~~~P~~RPt~~ev~~~L~~i~ 300 (301)
T d1lufa_ 247 AHEE---VIYYV----RDGNILACP------ENC---PLELYNLMRLCWSKLPADRPSFCSIHRILQRMC 300 (301)
T ss_dssp CHHH---HHHHH----HTTCCCCCC------TTC---CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTT
T ss_pred CHHH---HHHHH----HCCCCCCCC------CCC---HHHHHHHHHHHCCCCHHHCCCHHHHHHHHHHHC
T ss_conf 9999---99999----739978887------325---299999999974889657939999999999842
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=340.92 Aligned_cols=252 Identities=22% Similarity=0.301 Sum_probs=207.1
Q ss_pred CCCCCCCEEEECCCEEEEEEEE-CCCCEEEEEEECCCC---HHHHHHHHHHHHHHHHCCCCCEEEECCEEEECCEEEEEE
Q ss_conf 5987654471028389999998-489848999974851---265999999999999459982455322431046388999
Q 002673 607 DNFSQANIIGCGGFGLVYKATL-ANGTTLAIKKLSGDL---GLMEREFKAEVEALSTAQHKNLVSLQGYCVHQGFRLLIY 682 (894)
Q Consensus 607 ~~~~~~~~LG~G~fg~Vy~a~~-~~~~~vavK~~~~~~---~~~~~~~~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~lV~ 682 (894)
++|++.+.||+|+||.||+|+. .+++.||+|++.... ....+.+.+|+.+|+.++||||+++++++.+....++||
T Consensus 5 ~dy~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~iv~ 84 (337)
T d1o6la_ 5 NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVM 84 (337)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEEE
T ss_pred HHCEEEEEEECCCCEEEEEEEECCCCCEEEEEEECHHHCCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEECCCCCCCCCE
T ss_conf 74289889831768499999998999899999981565449799999999999998679998877876403564211100
Q ss_pred EECCCCCHHHHHHHHCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCEEEEECCCCCCCCC
Q ss_conf 84469998899844148988757999999999999999998850699836418999985778998599997345332378
Q 002673 683 SYMENGSLDYWLHEKADGASQLDWLTRLKIARGTSCGLAYMHQICEPHIVHRDIKSSNILLDDQFEAHLADFGLSRLILP 762 (894)
Q Consensus 683 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~Ia~aL~yLHs~~~~~ivH~DLkp~NILl~~~~~vkL~DFGla~~~~~ 762 (894)
||+++|+|..++... ..++...+..++.|++.||.|||+ ++|+||||||+|||++.++.+||+|||+++....
T Consensus 85 ey~~gg~L~~~~~~~----~~~~e~~~~~~~~qil~al~ylH~---~~iiHRDlKP~NILl~~~g~vkl~DFG~a~~~~~ 157 (337)
T d1o6la_ 85 EYANGGELFFHLSRE----RVFTEERARFYGAEIVSALEYLHS---RDVVYRDIKLENLMLDKDGHIKITDFGLCKEGIS 157 (337)
T ss_dssp ECCTTCBHHHHHHHH----SCCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCCGGGEEECTTSCEEECCCTTCBCSCC
T ss_pred ECCCCCCHHHHHHCC----CCCCHHHHHHHHHHHHHHHHHHHH---CCCCCCCCCHHHEEECCCCCEEEEECCCCCCCCC
T ss_conf 035798605555325----677599999999999652113431---5962246477784765899888820565200356
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHCCCCCCCCCCCCHHHHHHHHHHHHHHCCCCCCCCCCC
Q ss_conf 88743112455678668224367677862118999999999991999999889301256999999884149877544520
Q 002673 763 YQTHVTTELVGTLGYIPPEYGQAWVATLRGDMYSFGVVMLELLTGKRPVDVLKPKMSRELVGWVLKMRSEGKQDQVFDPI 842 (894)
Q Consensus 763 ~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 842 (894)
.. ......+||+.|+|||++.+..|+.++||||+||++|||++|+.||....... ... .... .... +.
T Consensus 158 ~~-~~~~~~~GT~~Y~aPE~~~~~~y~~~~DiwSlGvilyeml~G~~pf~~~~~~~---~~~---~i~~-~~~~--~p-- 225 (337)
T d1o6la_ 158 DG-ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHER---LFE---LILM-EEIR--FP-- 225 (337)
T ss_dssp TT-CCBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHH---HHH---HHHH-CCCC--CC--
T ss_pred CC-CCCCCCEECHHHHHHHHCCCCCCCHHHCCCCHHHHHHHHHHCCCCCCCCCHHH---HHH---HHHC-CCCC--CC--
T ss_conf 78-62055100889966665048988833310223067889987899999969999---999---9852-8998--98--
Q ss_pred CCCCCCHHHHHHHHHHHHHHCCCCCCCCCC-----HHHHHH--HHHHC
Q ss_conf 039999699999999998711159999999-----999999--99820
Q 002673 843 LRGKGFDEEMLQVLDVACMCVSQNPFKRPT-----VKEVVE--WLNNV 883 (894)
Q Consensus 843 l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs-----~~eil~--~L~~i 883 (894)
... ..++.+|+.+||+.||.+||+ ++++++ |+.++
T Consensus 226 ---~~~---s~~~~dli~~~L~~dP~~R~~~~~~~~~eil~Hp~f~~i 267 (337)
T d1o6la_ 226 ---RTL---SPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEHRFFLSI 267 (337)
T ss_dssp ---TTS---CHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTSGGGTTC
T ss_pred ---CCC---CHHHHHHHHHHCCCCCHHHCCCCCCCHHHHHCCCCCCCC
T ss_conf ---668---999999998666389344225652349999729150369
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=341.53 Aligned_cols=246 Identities=25% Similarity=0.377 Sum_probs=194.2
Q ss_pred CCCCEEEECCCEEEEEEEEC-CCCEEEEEEECCCC--HHHHHHHHHHHHHHHHCCCCCEEEECCEEEE----CCEEEEEE
Q ss_conf 76544710283899999984-89848999974851--2659999999999994599824553224310----46388999
Q 002673 610 SQANIIGCGGFGLVYKATLA-NGTTLAIKKLSGDL--GLMEREFKAEVEALSTAQHKNLVSLQGYCVH----QGFRLLIY 682 (894)
Q Consensus 610 ~~~~~LG~G~fg~Vy~a~~~-~~~~vavK~~~~~~--~~~~~~~~~Ei~~l~~l~Hpniv~l~g~~~~----~~~~~lV~ 682 (894)
+..+.||+|+||.||+|.+. ++..||+|++.... ....+.+.+|+++++.++|||||++++++.+ +...++||
T Consensus 12 ~~~~~iG~G~fg~Vy~~~~~~~~~~va~K~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~~~ivm 91 (270)
T d1t4ha_ 12 KFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVT 91 (270)
T ss_dssp EEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEEEE
T ss_pred EEEEEEECCCCCEEEEEEECCCCEEEEEEEECHHHCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEEEECCCCCCEEEEEE
T ss_conf 85169700828499999999999599999985122798999999999999985799985069999840334588899999
Q ss_pred EECCCCCHHHHHHHHCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEEC-CCCCEEEEECCCCCCCC
Q ss_conf 84469998899844148988757999999999999999998850699836418999985778-99859999734533237
Q 002673 683 SYMENGSLDYWLHEKADGASQLDWLTRLKIARGTSCGLAYMHQICEPHIVHRDIKSSNILLD-DQFEAHLADFGLSRLIL 761 (894)
Q Consensus 683 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~Ia~aL~yLHs~~~~~ivH~DLkp~NILl~-~~~~vkL~DFGla~~~~ 761 (894)
||+++|+|.+++... ..+++..+..++.||+.||.|||+. ..+|+||||||+|||++ +++.+||+|||+++...
T Consensus 92 E~~~~g~L~~~l~~~----~~~~~~~~~~~~~qi~~gl~yLH~~-~~~IiHrDiKp~NILl~~~~~~~Kl~DFGla~~~~ 166 (270)
T d1t4ha_ 92 ELMTSGTLKTYLKRF----KVMKIKVLRSWCRQILKGLQFLHTR-TPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKR 166 (270)
T ss_dssp ECCCSCBHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHTS-SSCCCCSCCCGGGEEESSTTSCEEECCTTGGGGCC
T ss_pred ECCCCCCHHHHHHCC----CCCCHHHHHHHHHHHHHHHHHHHHC-CCCEEECCCCHHHCEEECCCCCEEEEECCCCEECC
T ss_conf 578989489997513----5546999999999999999999978-99799687674351166799988980057654236
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHCCCCCCCCCCCCHHHHHHHHHHHHHHCCCCCCCCCC
Q ss_conf 88874311245567866822436767786211899999999999199999988930125699999988414987754452
Q 002673 762 PYQTHVTTELVGTLGYIPPEYGQAWVATLRGDMYSFGVVMLELLTGKRPVDVLKPKMSRELVGWVLKMRSEGKQDQVFDP 841 (894)
Q Consensus 762 ~~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 841 (894)
. ......+||+.|+|||++.+ .++.++|||||||++|||++|+.||...... ..... .. ..+.....++.
T Consensus 167 ~---~~~~~~~GT~~Y~aPE~~~~-~~~~~~DIwSlGvilyel~~g~~Pf~~~~~~--~~~~~---~i-~~~~~~~~~~~ 236 (270)
T d1t4ha_ 167 A---SFAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNA--AQIYR---RV-TSGVKPASFDK 236 (270)
T ss_dssp T---TSBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSH--HHHHH---HH-TTTCCCGGGGG
T ss_pred C---CCCCCCCCCCCCCCHHHHCC-CCCCCCCHHHHHHHHHHHHHCCCCCCCCCCH--HHHHH---HH-HCCCCCCCCCC
T ss_conf 8---76677553813008988478-9998671100799999998788999876559--99999---99-73899865675
Q ss_pred CCCCCCCHHHHHHHHHHHHHHCCCCCCCCCCHHHHHH
Q ss_conf 0039999699999999998711159999999999999
Q 002673 842 ILRGKGFDEEMLQVLDVACMCVSQNPFKRPTVKEVVE 878 (894)
Q Consensus 842 ~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~eil~ 878 (894)
.. ..++.+++.+||+.||++|||++|+++
T Consensus 237 -----~~---~~~~~~li~~~l~~dp~~R~s~~ell~ 265 (270)
T d1t4ha_ 237 -----VA---IPEVKEIIEGCIRQNKDERYSIKDLLN 265 (270)
T ss_dssp -----CC---CHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred -----CC---CHHHHHHHHHHCCCCHHHCCCHHHHHC
T ss_conf -----57---899999999976379758929999967
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=340.90 Aligned_cols=256 Identities=25% Similarity=0.342 Sum_probs=207.2
Q ss_pred CCCCCCCCEEEECCCEEEEEEEE-CCCCEEEEEEECCCC------HHHHHHHHHHHHHHHHCCCCCEEEECCEEEECCEE
Q ss_conf 05987654471028389999998-489848999974851------26599999999999945998245532243104638
Q 002673 606 TDNFSQANIIGCGGFGLVYKATL-ANGTTLAIKKLSGDL------GLMEREFKAEVEALSTAQHKNLVSLQGYCVHQGFR 678 (894)
Q Consensus 606 ~~~~~~~~~LG~G~fg~Vy~a~~-~~~~~vavK~~~~~~------~~~~~~~~~Ei~~l~~l~Hpniv~l~g~~~~~~~~ 678 (894)
.++|++.+.||+|+||.||+|.. .+|+.||+|++.... ....+.+.+|+.+++.++|||||++++++.+....
T Consensus 9 ~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~ 88 (293)
T d1jksa_ 9 DDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDV 88 (293)
T ss_dssp GGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred CCCEEEEEEEECCCCEEEEEEEECCCCCEEEEEEEEHHHCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCEEEEEEECCEE
T ss_conf 56779827981178959999999999989999998756632134068999999999999867998999388999979989
Q ss_pred EEEEEECCCCCHHHHHHHHCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCC----CEEEEEC
Q ss_conf 899984469998899844148988757999999999999999998850699836418999985778998----5999973
Q 002673 679 LLIYSYMENGSLDYWLHEKADGASQLDWLTRLKIARGTSCGLAYMHQICEPHIVHRDIKSSNILLDDQF----EAHLADF 754 (894)
Q Consensus 679 ~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~Ia~aL~yLHs~~~~~ivH~DLkp~NILl~~~~----~vkL~DF 754 (894)
++||||+++|+|.+++... ..+++..+..++.|++.||.|||+ ++|+||||||+|||++.++ .+|++||
T Consensus 89 ~iv~E~~~gg~L~~~i~~~----~~l~~~~~~~~~~qi~~al~yLH~---~~ivHrDiKp~Nill~~~~~~~~~vkl~Df 161 (293)
T d1jksa_ 89 ILILELVAGGELFDFLAEK----ESLTEEEATEFLKQILNGVYYLHS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDF 161 (293)
T ss_dssp EEEEECCCSCBHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEESCSSSSSCCEEECCC
T ss_pred EEEEECCCCCCCCCHHCCC----CCCCHHHHHHHHHHHHHHHHHHHH---CCEEECCCCCCEEEEECCCCCCCCEEECCH
T ss_conf 9999867786431001035----642155789999999999876662---542211333012798258986664696433
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHCCCCCCCCCCCCHHHHHHHHHHHHHHCCC
Q ss_conf 45332378887431124556786682243676778621189999999999919999998893012569999998841498
Q 002673 755 GLSRLILPYQTHVTTELVGTLGYIPPEYGQAWVATLRGDMYSFGVVMLELLTGKRPVDVLKPKMSRELVGWVLKMRSEGK 834 (894)
Q Consensus 755 Gla~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~ 834 (894)
|++....... ......|++.|+|||++.+..++.++||||+||++|||++|+.||....... ...... ...
T Consensus 162 G~a~~~~~~~--~~~~~~~t~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~---~~~~i~----~~~ 232 (293)
T d1jksa_ 162 GLAHKIDFGN--EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQE---TLANVS----AVN 232 (293)
T ss_dssp TTCEECTTSC--BCSCCCCCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH---HHHHHH----TTC
T ss_pred HHHHHCCCCC--CCCCCCCCCCCCCHHHHCCCCCCCCCCCHHHHHHHHHHHCCCCCCCCCCHHH---HHHHHH----HCC
T ss_conf 4421057776--3122477774309999818999976652214099999970889988999999---999998----168
Q ss_pred CCCCCCCCCCCCCCHHHHHHHHHHHHHHCCCCCCCCCCHHHHHH--HHHHC
Q ss_conf 77544520039999699999999998711159999999999999--99820
Q 002673 835 QDQVFDPILRGKGFDEEMLQVLDVACMCVSQNPFKRPTVKEVVE--WLNNV 883 (894)
Q Consensus 835 ~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~eil~--~L~~i 883 (894)
.. +.+... ......+.+++.+||+.||.+|||++++++ |++..
T Consensus 233 ~~--~~~~~~----~~~s~~~~~li~~~L~~dP~~R~s~~eil~hp~~~~~ 277 (293)
T d1jksa_ 233 YE--FEDEYF----SNTSALAKDFIRRLLVKDPKKRMTIQDSLQHPWIKPK 277 (293)
T ss_dssp CC--CCHHHH----TTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSTTTCC-
T ss_pred CC--CCCHHC----CCCCHHHHHHHHHHCCCCHHHCCCHHHHHCCCCCCCC
T ss_conf 88--870104----7889999999999863896689199999619041888
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=346.65 Aligned_cols=248 Identities=24% Similarity=0.331 Sum_probs=204.1
Q ss_pred CCCCCCCEEEECCCEEEEEEEE-CCCCEEEEEEECCCC---HHHHHHHHHHHHHHHHCCCCCEEEECCEEEECCEEEEEE
Q ss_conf 5987654471028389999998-489848999974851---265999999999999459982455322431046388999
Q 002673 607 DNFSQANIIGCGGFGLVYKATL-ANGTTLAIKKLSGDL---GLMEREFKAEVEALSTAQHKNLVSLQGYCVHQGFRLLIY 682 (894)
Q Consensus 607 ~~~~~~~~LG~G~fg~Vy~a~~-~~~~~vavK~~~~~~---~~~~~~~~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~lV~ 682 (894)
++|++.+.||+|+||.||+|.. .+++.||||++.... ....+.+.+|+.+++.++||||+++++++.+++..++||
T Consensus 8 ~dy~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~ivm 87 (288)
T d1uu3a_ 8 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGL 87 (288)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCSTTBCCEEEEEECSSEEEEEE
T ss_pred CCCEEEEEEEECCCEEEEEEEECCCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEEEECCEEEEEE
T ss_conf 87789889850879099999998999799999986577557778999999999998768888617999999899889999
Q ss_pred EECCCCCHHHHHHHHCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCEEEEECCCCCCCCC
Q ss_conf 84469998899844148988757999999999999999998850699836418999985778998599997345332378
Q 002673 683 SYMENGSLDYWLHEKADGASQLDWLTRLKIARGTSCGLAYMHQICEPHIVHRDIKSSNILLDDQFEAHLADFGLSRLILP 762 (894)
Q Consensus 683 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~Ia~aL~yLHs~~~~~ivH~DLkp~NILl~~~~~vkL~DFGla~~~~~ 762 (894)
||+++|+|.+++... ..+++..+..++.|++.||.|||+ ++|+||||||+|||+++++.+||+|||+++.+..
T Consensus 88 Ey~~gg~L~~~~~~~----~~l~e~~~~~~~~qi~~al~ylH~---~~iiHrDiKp~NIll~~~~~vkl~DFG~a~~~~~ 160 (288)
T d1uu3a_ 88 SYAKNGELLKYIRKI----GSFDETCTRFYTAEIVSALEYLHG---KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSP 160 (288)
T ss_dssp CCCTTEEHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECTTSCEEECCCTTCEECC-
T ss_pred ECCCCCCHHHHHHCC----CCCCHHHHHHHHHHHHHHHHHHCC---CCEECCCCCCCCCCCCCCCEEEECCCCCCEECCC
T ss_conf 704898777765315----999999999999999999976216---5088476774123668885388603210242256
Q ss_pred CC-CCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHCCCCCCCCCCCCHHHHHHHHHHHHHHCCCCCCCCCC
Q ss_conf 88-74311245567866822436767786211899999999999199999988930125699999988414987754452
Q 002673 763 YQ-THVTTELVGTLGYIPPEYGQAWVATLRGDMYSFGVVMLELLTGKRPVDVLKPKMSRELVGWVLKMRSEGKQDQVFDP 841 (894)
Q Consensus 763 ~~-~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 841 (894)
.. .......+||+.|+|||++.+..++.++||||+||++|||++|+.||...... .... .+. ..... ++
T Consensus 161 ~~~~~~~~~~~GT~~Y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~---~~~~---~i~-~~~~~--~p- 230 (288)
T d1uu3a_ 161 ESKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEY---LIFQ---KII-KLEYD--FP- 230 (288)
T ss_dssp ---------CCCCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHH---HHHH---HHH-TTCCC--CC-
T ss_pred CCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCEEHHHHHHHHHHHCCCCCCCCCHH---HHHH---HHH-CCCCC--CC-
T ss_conf 77643335556775525844002689896662304569999980388998995999---9999---997-18999--98-
Q ss_pred CCCCCCCHHHHHHHHHHHHHHCCCCCCCCCCHHHHHH
Q ss_conf 0039999699999999998711159999999999999
Q 002673 842 ILRGKGFDEEMLQVLDVACMCVSQNPFKRPTVKEVVE 878 (894)
Q Consensus 842 ~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~eil~ 878 (894)
... ...+.+|+.+||+.||.+|||++|+++
T Consensus 231 ----~~~---s~~~~~li~~~L~~dP~~R~t~~e~~~ 260 (288)
T d1uu3a_ 231 ----EKF---FPKARDLVEKLLVLDATKRLGCEEMEG 260 (288)
T ss_dssp ----TTC---CHHHHHHHHTTSCSSGGGSTTSGGGTC
T ss_pred ----CCC---CHHHHHHHHHHCCCCHHHCCCHHHHCC
T ss_conf ----547---999999999985579768919789737
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=342.36 Aligned_cols=255 Identities=22% Similarity=0.369 Sum_probs=205.6
Q ss_pred CCCCCCCEEEECCCEEEEEEEEC-CCC----EEEEEEECCCC-HHHHHHHHHHHHHHHHCCCCCEEEECCEEEECCEEEE
Q ss_conf 59876544710283899999984-898----48999974851-2659999999999994599824553224310463889
Q 002673 607 DNFSQANIIGCGGFGLVYKATLA-NGT----TLAIKKLSGDL-GLMEREFKAEVEALSTAQHKNLVSLQGYCVHQGFRLL 680 (894)
Q Consensus 607 ~~~~~~~~LG~G~fg~Vy~a~~~-~~~----~vavK~~~~~~-~~~~~~~~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~l 680 (894)
++|+..+.||+|+||.||+|.+. +++ +||+|++.... ....+++.+|+.+++.++|||||+++|+|.+. ..++
T Consensus 9 ~dy~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~-~~~~ 87 (317)
T d1xkka_ 9 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQL 87 (317)
T ss_dssp TTEEEEEEEEECSSEEEEEEEECC----CCEEEEEEEECC----CTHHHHHHHHHHHHHCCCTTBCCEEEEEESS-SEEE
T ss_pred HHCEEEEEEECCCCEEEEEEEECCCCCEEEEEEEEEEECCCCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEEECC-CEEE
T ss_conf 999783198208992999999958998898999999965134979999999999999867998881589999619-8369
Q ss_pred EEEECCCCCHHHHHHHHCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCEEEEECCCCCCC
Q ss_conf 99844699988998441489887579999999999999999988506998364189999857789985999973453323
Q 002673 681 IYSYMENGSLDYWLHEKADGASQLDWLTRLKIARGTSCGLAYMHQICEPHIVHRDIKSSNILLDDQFEAHLADFGLSRLI 760 (894)
Q Consensus 681 V~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~Ia~aL~yLHs~~~~~ivH~DLkp~NILl~~~~~vkL~DFGla~~~ 760 (894)
++||+.+|+|.+++.... ..+++..++.++.||+.||.|||+ ++|+||||||+|||++.++.+||+|||+++..
T Consensus 88 v~e~~~~~~l~~~~~~~~---~~~~~~~~~~i~~qi~~gl~yLH~---~~iiHrDlKp~NIll~~~~~~kl~DFGla~~~ 161 (317)
T d1xkka_ 88 ITQLMPFGCLLDYVREHK---DNIGSQYLLNWCVQIAKGMNYLED---RRLVHRDLAARNVLVKTPQHVKITDFGLAKLL 161 (317)
T ss_dssp EEECCTTCBHHHHHHHTS---SSCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEEEETTEEEECCCSHHHHT
T ss_pred EEEECCCCCCCCCCCCCC---CCCCHHHHHHHHHHHHHHHHHHHH---CCCCCCCCHHHCCEECCCCCEEEECCCCCEEC
T ss_conf 998426874010111334---579999999999999999999987---69504762120311679987586025522233
Q ss_pred CCCCCC-CCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHC-CCCCCCCCCCCHHHHHHHHHHHHHHCCCCCCC
Q ss_conf 788874-3112455678668224367677862118999999999991-99999988930125699999988414987754
Q 002673 761 LPYQTH-VTTELVGTLGYIPPEYGQAWVATLRGDMYSFGVVMLELLT-GKRPVDVLKPKMSRELVGWVLKMRSEGKQDQV 838 (894)
Q Consensus 761 ~~~~~~-~~~~~~gt~~y~APE~~~~~~~s~ksDVwSlGvil~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 838 (894)
...... ......||..|+|||++.++.++.++||||||+++|||+| |..||........... +.. ..... .
T Consensus 162 ~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDvwS~Gvil~el~t~g~~p~~~~~~~~~~~~---i~~---~~~~~-~ 234 (317)
T d1xkka_ 162 GAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSI---LEK---GERLP-Q 234 (317)
T ss_dssp TTTCC--------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCGGGHHHH---HHH---TCCCC-C
T ss_pred CCCCCCCCCCCCCCCCCCCCHHHHHCCCCCHHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHH---HHC---CCCCC-C
T ss_conf 5444532236510586446708874699983565440799999999779999999998999999---975---99899-9
Q ss_pred CCCCCCCCCCHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHHCC
Q ss_conf 4520039999699999999998711159999999999999998200
Q 002673 839 FDPILRGKGFDEEMLQVLDVACMCVSQNPFKRPTVKEVVEWLNNVG 884 (894)
Q Consensus 839 ~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~eil~~L~~i~ 884 (894)
+ . .....+.+++.+||+.||.+|||+.++++.|+.+.
T Consensus 235 -p-----~---~~~~~~~~li~~cl~~dP~~RPs~~eil~~l~~~~ 271 (317)
T d1xkka_ 235 -P-----P---ICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMA 271 (317)
T ss_dssp -C-----T---TBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred -C-----C---CCCHHHHHHHHHHCCCCHHHCCCHHHHHHHHHHHH
T ss_conf -8-----5---56899999999847899346919999999999987
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Probab=100.00 E-value=0 Score=340.25 Aligned_cols=253 Identities=26% Similarity=0.312 Sum_probs=199.9
Q ss_pred CCCCCCCEEEECCCEEEEEEEE-CCCCEEEEEEECCCCH---HHHHHHHH---HHHHHHHCCCCCEEEECCEEEECCEEE
Q ss_conf 5987654471028389999998-4898489999748512---65999999---999999459982455322431046388
Q 002673 607 DNFSQANIIGCGGFGLVYKATL-ANGTTLAIKKLSGDLG---LMEREFKA---EVEALSTAQHKNLVSLQGYCVHQGFRL 679 (894)
Q Consensus 607 ~~~~~~~~LG~G~fg~Vy~a~~-~~~~~vavK~~~~~~~---~~~~~~~~---Ei~~l~~l~Hpniv~l~g~~~~~~~~~ 679 (894)
++|++.+.||+|+||.||+|+. .+|..||+|++..... .....+.+ ++.+++.++|||||++++++.+.+..+
T Consensus 4 ddy~i~~~lG~G~fg~Vy~~~~~~t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~~hpnIv~l~~~~~~~~~~~ 83 (364)
T d1omwa3 4 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLS 83 (364)
T ss_dssp TTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEEE
T ss_pred HHCEEEEEEECCCCEEEEEEEECCCCCEEEEEEECHHHCCHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEEEEEECCEEE
T ss_conf 76851018842889099999999999799999984587542667999999999999985089985889999999899889
Q ss_pred EEEEECCCCCHHHHHHHHCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCEEEEECCCCCC
Q ss_conf 99984469998899844148988757999999999999999998850699836418999985778998599997345332
Q 002673 680 LIYSYMENGSLDYWLHEKADGASQLDWLTRLKIARGTSCGLAYMHQICEPHIVHRDIKSSNILLDDQFEAHLADFGLSRL 759 (894)
Q Consensus 680 lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~Ia~aL~yLHs~~~~~ivH~DLkp~NILl~~~~~vkL~DFGla~~ 759 (894)
+||||+++|+|.+++... ..+++..+..++.||+.||.|||+ ++++||||||+|||++.++.+||+|||+++.
T Consensus 84 ivmE~~~gg~L~~~l~~~----~~~~e~~~~~~~~qi~~aL~ylH~---~~iiHrDlKP~NILl~~~g~iKl~DFGla~~ 156 (364)
T d1omwa3 84 FILDLMNGGDLHYHLSQH----GVFSEADMRFYAAEIILGLEHMHN---RFVVYRDLKPANILLDEHGHVRISDLGLACD 156 (364)
T ss_dssp EEECCCCSCBHHHHHHHH----CSCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECSSSCEEECCCTTCEE
T ss_pred EEEEECCCCCHHHHHHHC----CCCCHHHHHHHHHHHHHHHHHHHH---CCCCCEEECCCEEEECCCCCEEEEEECEEEE
T ss_conf 999914898389998732----553278999999999999999997---7962204442216785889679822010233
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCC-CCCCCCCCHHHHHHHHHHHHCCCCCCCCCCCCHHHHHHHHHHHHHHCCCCCCC
Q ss_conf 37888743112455678668224367-67786211899999999999199999988930125699999988414987754
Q 002673 760 ILPYQTHVTTELVGTLGYIPPEYGQA-WVATLRGDMYSFGVVMLELLTGKRPVDVLKPKMSRELVGWVLKMRSEGKQDQV 838 (894)
Q Consensus 760 ~~~~~~~~~~~~~gt~~y~APE~~~~-~~~s~ksDVwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 838 (894)
.... ......||+.|+|||++.. ..++.++||||+||++|||++|+.||............ .. ..... ..
T Consensus 157 ~~~~---~~~~~~GT~~y~APE~~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~~---~~-~~~~~-~~- 227 (364)
T d1omwa3 157 FSKK---KPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEID---RM-TLTMA-VE- 227 (364)
T ss_dssp CSSS---CCCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCSSCSSCSSCHHHHH---HH-SSSCC-CC-
T ss_pred CCCC---CCCCCCCCCCCCHHHHHHCCCCCCCCCCHHHHHHHHHHHHHCCCCCCCCCHHHHHHHH---HH-CCCCC-CC-
T ss_conf 3788---6433113455421687603899984410467789999998599988889989999999---86-04688-87-
Q ss_pred CCCCCCCCCCHHHHHHHHHHHHHHCCCCCCCCCC-----HHHHHH--HHHHC
Q ss_conf 4520039999699999999998711159999999-----999999--99820
Q 002673 839 FDPILRGKGFDEEMLQVLDVACMCVSQNPFKRPT-----VKEVVE--WLNNV 883 (894)
Q Consensus 839 ~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs-----~~eil~--~L~~i 883 (894)
+. ... ...+.+++.+||+.||.+||| ++++++ |++++
T Consensus 228 ~~-----~~~---s~~~~~li~~~L~~dP~~R~t~~~~~a~eil~Hp~f~~i 271 (364)
T d1omwa3 228 LP-----DSF---SPELRSLLEGLLQRDVNRRLGCLGRGAQEVKESPFFRSL 271 (364)
T ss_dssp CC-----SSS---CHHHHHHHHHHTCSSTTTSTTTSSSTHHHHHTSGGGTTC
T ss_pred CC-----CCC---CHHHHHHHHHHCCCCHHHHCCCCCCCHHHHHCCCCCCCC
T ss_conf 88-----778---999999999985669888088743579999749102378
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=341.27 Aligned_cols=258 Identities=24% Similarity=0.336 Sum_probs=209.4
Q ss_pred CCCCCCCCEEEECCCEEEEEEEECC----CCEEEEEEECCCC-HHHHHHHHHHHHHHHHCCCCCEEEECCEEEECCEEEE
Q ss_conf 0598765447102838999999848----9848999974851-2659999999999994599824553224310463889
Q 002673 606 TDNFSQANIIGCGGFGLVYKATLAN----GTTLAIKKLSGDL-GLMEREFKAEVEALSTAQHKNLVSLQGYCVHQGFRLL 680 (894)
Q Consensus 606 ~~~~~~~~~LG~G~fg~Vy~a~~~~----~~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~l 680 (894)
.++|++.+.||+|+||.||+|.+.. +..||||++.... ......+.+|+.+++.++|||||+++|++. ++..++
T Consensus 6 ~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-~~~~~i 84 (273)
T d1mp8a_ 6 RERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPVWI 84 (273)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-SSSCEE
T ss_pred HHHEEEEEEEEECCCCEEEEEEEECCCCEEEEEEEEEECCCCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEEE-CCEEEE
T ss_conf 8996987799307882999999936996449999999365668799999999999998689999856988995-374799
Q ss_pred EEEECCCCCHHHHHHHHCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCEEEEECCCCCCC
Q ss_conf 99844699988998441489887579999999999999999988506998364189999857789985999973453323
Q 002673 681 IYSYMENGSLDYWLHEKADGASQLDWLTRLKIARGTSCGLAYMHQICEPHIVHRDIKSSNILLDDQFEAHLADFGLSRLI 760 (894)
Q Consensus 681 V~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~Ia~aL~yLHs~~~~~ivH~DLkp~NILl~~~~~vkL~DFGla~~~ 760 (894)
||||+++|+|.+++.... ..+++..++.++.||+.||.|||+ ++++||||||+||+++.++.+||+|||+++..
T Consensus 85 v~E~~~~g~l~~~~~~~~---~~l~~~~~~~~~~qi~~gl~ylH~---~~iiHrDlKp~NIll~~~~~~Kl~DfG~a~~~ 158 (273)
T d1mp8a_ 85 IMELCTLGELRSFLQVRK---YSLDLASLILYAYQLSTALAYLES---KRFVHRDIAARNVLVSSNDCVKLGDFGLSRYM 158 (273)
T ss_dssp EEECCTTEEHHHHHHHTT---TTSCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEEEETTEEEECC-------
T ss_pred EEEECCCCCHHHHHHCCC---CCCCHHHHHHHHHHHHHHHHHHCC---CCEECCCCCHHHEEECCCCCEEECCCHHHEEC
T ss_conf 998406980776542247---899999999999999877523022---67441410265532067896787650342133
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHC-CCCCCCCCCCCHHHHHHHHHHHHHHCCCCCCCC
Q ss_conf 7888743112455678668224367677862118999999999991-999999889301256999999884149877544
Q 002673 761 LPYQTHVTTELVGTLGYIPPEYGQAWVATLRGDMYSFGVVMLELLT-GKRPVDVLKPKMSRELVGWVLKMRSEGKQDQVF 839 (894)
Q Consensus 761 ~~~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwSlGvil~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 839 (894)
............||+.|+|||++.+..++.++|||||||++|||++ |..||........ ...+. .+.....
T Consensus 159 ~~~~~~~~~~~~gt~~y~apE~l~~~~~~~~~DiwSlGvil~e~lt~g~~P~~~~~~~~~---~~~i~----~~~~~~~- 230 (273)
T d1mp8a_ 159 EDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDV---IGRIE----NGERLPM- 230 (273)
T ss_dssp ------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGH---HHHHH----TTCCCCC-
T ss_pred CCCCCEECCCEECCCCCCHHHHHCCCCCCCCCCCCCCHHHHHHHHHCCCCCCCCCCHHHH---HHHHH----CCCCCCC-
T ss_conf 677623305400583103266751699887452444247899998269999888999999---99998----1899989-
Q ss_pred CCCCCCCCCHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHHCCCC
Q ss_conf 52003999969999999999871115999999999999999820013
Q 002673 840 DPILRGKGFDEEMLQVLDVACMCVSQNPFKRPTVKEVVEWLNNVGAN 886 (894)
Q Consensus 840 d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~eil~~L~~i~~~ 886 (894)
. ...+ ..+.+++.+||+.||++|||+.+|++.|+.+..+
T Consensus 231 ~-----~~~~---~~~~~li~~cl~~dp~~Rps~~ei~~~L~~i~~~ 269 (273)
T d1mp8a_ 231 P-----PNCP---PTLYSLMTKCWAYDPSRRPRFTELKAQLSTILEE 269 (273)
T ss_dssp C-----TTCC---HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred C-----CCCC---HHHHHHHHHHCCCCHHHCCCHHHHHHHHHHHHHH
T ss_conf 8-----7779---9999999997687976892999999999999778
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=0 Score=339.59 Aligned_cols=249 Identities=26% Similarity=0.369 Sum_probs=205.2
Q ss_pred CCCCCCCEEEECCCEEEEEEEE-CCCCEEEEEEECCCC---HHHHHHHHHHHHHHHHCCCCCEEEECCEEEECCEEEEEE
Q ss_conf 5987654471028389999998-489848999974851---265999999999999459982455322431046388999
Q 002673 607 DNFSQANIIGCGGFGLVYKATL-ANGTTLAIKKLSGDL---GLMEREFKAEVEALSTAQHKNLVSLQGYCVHQGFRLLIY 682 (894)
Q Consensus 607 ~~~~~~~~LG~G~fg~Vy~a~~-~~~~~vavK~~~~~~---~~~~~~~~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~lV~ 682 (894)
++|++.+.||+|+||.||+|+. .+|..||+|++.... ....+.+.+|+.+++.++|||||++++++.+.+..++||
T Consensus 4 ~dy~i~~~lG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivm 83 (316)
T d1fota_ 4 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMIM 83 (316)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEEE
T ss_pred HHEEEEEEEECCCCCEEEEEEECCCCCEEEEEEECHHHCCCHHHHHHHHHHHHHHHHCCCCCHHHEEEEEEECCEEEEEE
T ss_conf 47088889720768089999998999799999984577548899999999999998636967533035685288005676
Q ss_pred EECCCCCHHHHHHHHCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCEEEEECCCCCCCCC
Q ss_conf 84469998899844148988757999999999999999998850699836418999985778998599997345332378
Q 002673 683 SYMENGSLDYWLHEKADGASQLDWLTRLKIARGTSCGLAYMHQICEPHIVHRDIKSSNILLDDQFEAHLADFGLSRLILP 762 (894)
Q Consensus 683 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~Ia~aL~yLHs~~~~~ivH~DLkp~NILl~~~~~vkL~DFGla~~~~~ 762 (894)
||+++|+|..++... ..++......++.||+.||.|||+ ++|+||||||+|||++.++.+||+|||+++....
T Consensus 84 E~~~gg~l~~~~~~~----~~~~~~~~~~~~~qi~~al~~lH~---~~iiHrDiKp~NILl~~~g~vkL~DFG~a~~~~~ 156 (316)
T d1fota_ 84 DYIEGGELFSLLRKS----QRFPNPVAKFYAAEVCLALEYLHS---KDIIYRDLKPENILLDKNGHIKITDFGFAKYVPD 156 (316)
T ss_dssp CCCCSCBHHHHHHHT----SSCCHHHHHHHHHHHHHHHHHHHT---TTEECCCCCGGGEEECTTSCEEECCCSSCEECSS
T ss_pred EECCCCCCCCCCCCC----CCCCCCHHHHHHHHHHHHHHHHCC---CCEECCCCCCHHEEECCCCCEEEECCCCCEEECC
T ss_conf 503786322343222----211100799999999876554124---7677055681050386899889831752167124
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHCCCCCCCCCCCCHHHHHHHHHHHHHHCCCCCCCCCCC
Q ss_conf 88743112455678668224367677862118999999999991999999889301256999999884149877544520
Q 002673 763 YQTHVTTELVGTLGYIPPEYGQAWVATLRGDMYSFGVVMLELLTGKRPVDVLKPKMSRELVGWVLKMRSEGKQDQVFDPI 842 (894)
Q Consensus 763 ~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 842 (894)
.....+||+.|+|||++.+..++.++||||+||++|+|++|+.||....... ... ..... ... +.+
T Consensus 157 ----~~~~~~Gt~~Y~APE~l~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~---~~~---~i~~~-~~~--~p~- 222 (316)
T d1fota_ 157 ----VTYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMK---TYE---KILNA-ELR--FPP- 222 (316)
T ss_dssp ----CBCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHH---HHH---HHHHC-CCC--CCT-
T ss_pred ----CCCCCCCCCCCCCHHHHCCCCCCCHHHCCCCCHHHHHHHHCCCCCCCCCHHH---HHH---HHHCC-CCC--CCC-
T ss_conf ----5643457634359999838999804304653336899975989999969999---999---99708-988--997-
Q ss_pred CCCCCCHHHHHHHHHHHHHHCCCCCCCCC-----CHHHHHH--HHHHC
Q ss_conf 03999969999999999871115999999-----9999999--99820
Q 002673 843 LRGKGFDEEMLQVLDVACMCVSQNPFKRP-----TVKEVVE--WLNNV 883 (894)
Q Consensus 843 l~~~~~~~~~~~l~~li~~Cl~~dP~~RP-----s~~eil~--~L~~i 883 (894)
.. ...+.+++.+||..||.+|+ |++++++ |++++
T Consensus 223 ----~~---s~~~~~li~~~L~~dp~~R~~~~r~t~~~il~Hp~f~~i 263 (316)
T d1fota_ 223 ----FF---NEDVKDLLSRLITRDLSQRLGNLQNGTEDVKNHPWFKEV 263 (316)
T ss_dssp ----TS---CHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHTSGGGSSC
T ss_pred ----CC---CHHHHHHHHHHHHHCHHHCCCCCHHHHHHHHCCCCCCCC
T ss_conf ----78---999999999995449976664310219999819351467
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=0 Score=340.31 Aligned_cols=249 Identities=22% Similarity=0.296 Sum_probs=205.3
Q ss_pred CCCCCCCEEEECCCEEEEEEEE-CCCCEEEEEEECCCC---HHHHHHHHHHHHHHHHCCCCCEEEECCEEEECCEEEEEE
Q ss_conf 5987654471028389999998-489848999974851---265999999999999459982455322431046388999
Q 002673 607 DNFSQANIIGCGGFGLVYKATL-ANGTTLAIKKLSGDL---GLMEREFKAEVEALSTAQHKNLVSLQGYCVHQGFRLLIY 682 (894)
Q Consensus 607 ~~~~~~~~LG~G~fg~Vy~a~~-~~~~~vavK~~~~~~---~~~~~~~~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~lV~ 682 (894)
++|++.+.||+|+||.||+|.. .+|+.||+|++.... ....+.+.+|+.+++.++|||||++++++.+....++|+
T Consensus 41 d~y~i~~~lG~G~fg~Vy~a~~~~~g~~~AvK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~v~ 120 (350)
T d1rdqe_ 41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVM 120 (350)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred CCEEEEEEEECCCCCEEEEEEECCCCCEEEEEEECHHHCCCHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCCCCCCCCC
T ss_conf 37089889611768089999998999899999982677458899999999999999748772740344443222223222
Q ss_pred EECCCCCHHHHHHHHCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCEEEEECCCCCCCCC
Q ss_conf 84469998899844148988757999999999999999998850699836418999985778998599997345332378
Q 002673 683 SYMENGSLDYWLHEKADGASQLDWLTRLKIARGTSCGLAYMHQICEPHIVHRDIKSSNILLDDQFEAHLADFGLSRLILP 762 (894)
Q Consensus 683 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~Ia~aL~yLHs~~~~~ivH~DLkp~NILl~~~~~vkL~DFGla~~~~~ 762 (894)
||+.+|+|..++... ..+++..+..++.||+.||.|||+ ++|+||||||+|||++.++.+||+|||+++....
T Consensus 121 e~~~~g~l~~~l~~~----~~l~e~~~~~i~~qi~~aL~yLH~---~~iiHRDIKP~NILl~~~g~ikL~DFG~a~~~~~ 193 (350)
T d1rdqe_ 121 EYVAGGEMFSHLRRI----GRFSEPHARFYAAQIVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG 193 (350)
T ss_dssp ECCTTCBHHHHHHHH----CCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTSCEEECCCTTCEECSS
T ss_pred CCCCCCCHHHHHHHC----CCCCHHHHHHHHHHHHHHHHHHHH---CCEECCCCCHHHCCCCCCCCEEEEECEEEEECCC
T ss_conf 233466226667515----898999999999999998999985---9986176799993607789788610103332256
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHCCCCCCCCCCCCHHHHHHHHHHHHHHCCCCCCCCCCC
Q ss_conf 88743112455678668224367677862118999999999991999999889301256999999884149877544520
Q 002673 763 YQTHVTTELVGTLGYIPPEYGQAWVATLRGDMYSFGVVMLELLTGKRPVDVLKPKMSRELVGWVLKMRSEGKQDQVFDPI 842 (894)
Q Consensus 763 ~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 842 (894)
......||+.|+|||++.+..++.++|||||||++|||++|+.||...... .... .+.. .... +.
T Consensus 194 ----~~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~---~~~~---~i~~-~~~~--~p-- 258 (350)
T d1rdqe_ 194 ----RTWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPI---QIYE---KIVS-GKVR--FP-- 258 (350)
T ss_dssp ----CBCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH---HHHH---HHHH-CCCC--CC--
T ss_pred ----CCCCCCCCCCCCCHHHHCCCCCCCCCCCCCHHHHHHHHHHCCCCCCCCCHH---HHHH---HHHC-CCCC--CC--
T ss_conf ----664336763567889971799885331145007899997588998995999---9999---9861-7988--97--
Q ss_pred CCCCCCHHHHHHHHHHHHHHCCCCCCCCC-----CHHHHHH--HHHHC
Q ss_conf 03999969999999999871115999999-----9999999--99820
Q 002673 843 LRGKGFDEEMLQVLDVACMCVSQNPFKRP-----TVKEVVE--WLNNV 883 (894)
Q Consensus 843 l~~~~~~~~~~~l~~li~~Cl~~dP~~RP-----s~~eil~--~L~~i 883 (894)
... ...+.+++.+||+.||.+|+ |++++++ |+.++
T Consensus 259 ---~~~---s~~~~~li~~~L~~dP~kR~~~~r~t~~ell~Hp~f~~~ 300 (350)
T d1rdqe_ 259 ---SHF---SSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNHKWFATT 300 (350)
T ss_dssp ---TTC---CHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHTSGGGTTC
T ss_pred ---CCC---CHHHHHHHHHHHHHCHHHCCCCCCCCHHHHHCCCCCCCC
T ss_conf ---668---999999999983409986065534549999719051589
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=333.49 Aligned_cols=255 Identities=25% Similarity=0.386 Sum_probs=202.4
Q ss_pred CCEEEECCCEEEEEEEECCC----CEEEEEEECCCC-HHHHHHHHHHHHHHHHCCCCCEEEECCEEEE-CCEEEEEEEEC
Q ss_conf 54471028389999998489----848999974851-2659999999999994599824553224310-46388999844
Q 002673 612 ANIIGCGGFGLVYKATLANG----TTLAIKKLSGDL-GLMEREFKAEVEALSTAQHKNLVSLQGYCVH-QGFRLLIYSYM 685 (894)
Q Consensus 612 ~~~LG~G~fg~Vy~a~~~~~----~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l~Hpniv~l~g~~~~-~~~~~lV~E~~ 685 (894)
.++||+|+||+||+|.+.++ ..||||++.... ....+.|.+|++++++++||||++++|++.+ ++..++||||+
T Consensus 32 ~~~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~E~~ 111 (311)
T d1r0pa_ 32 NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYM 111 (311)
T ss_dssp EEEEEEETTEEEEEEEECC----CEEEEEEEECCCCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEETTTEEEEEEECC
T ss_pred CEEEEECCCEEEEEEEEECCCCEEEEEEEEEECCCCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEEEECCCCEEEEEEEE
T ss_conf 66981368809999999779987999999998843697899999999999986789998678678980699438999874
Q ss_pred CCCCHHHHHHHHCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCEEEEECCCCCCCCCCCC
Q ss_conf 69998899844148988757999999999999999998850699836418999985778998599997345332378887
Q 002673 686 ENGSLDYWLHEKADGASQLDWLTRLKIARGTSCGLAYMHQICEPHIVHRDIKSSNILLDDQFEAHLADFGLSRLILPYQT 765 (894)
Q Consensus 686 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~Ia~aL~yLHs~~~~~ivH~DLkp~NILl~~~~~vkL~DFGla~~~~~~~~ 765 (894)
++|+|.+++.... ..+++..++.++.|++.||.|||+ ++|+||||||+|||+++++.+||+|||+++.......
T Consensus 112 ~~g~l~~~~~~~~---~~~~~~~~~~i~~qia~gL~~lH~---~~iiHrDLK~~NILl~~~~~~kL~DFG~~~~~~~~~~ 185 (311)
T d1r0pa_ 112 KHGDLRNFIRNET---HNPTVKDLIGFGLQVAKGMKFLAS---KKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEF 185 (311)
T ss_dssp TTCBHHHHHHCTT---CCCBHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEECTTCCEEECSSGGGCCTTTTTC
T ss_pred ECCCHHHHHCCCC---CCCHHHHHHHHHHHHHHHHHHHCC---CCCCCCCCCHHHEEECCCCCEEEECCCCHHHCCCCCC
T ss_conf 0674144210134---540489999999998876520033---6762577668757677999889910652322556655
Q ss_pred C---CCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHCCCCCCCCCCCCHHHHHHHHHHHHHHCCCCCCCCCCC
Q ss_conf 4---3112455678668224367677862118999999999991999999889301256999999884149877544520
Q 002673 766 H---VTTELVGTLGYIPPEYGQAWVATLRGDMYSFGVVMLELLTGKRPVDVLKPKMSRELVGWVLKMRSEGKQDQVFDPI 842 (894)
Q Consensus 766 ~---~~~~~~gt~~y~APE~~~~~~~s~ksDVwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 842 (894)
. ......||..|+|||++....++.++||||||+++|||++|+.||...... .+....+. .+.... .+
T Consensus 186 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~SfGivl~El~t~~~p~~~~~~~--~~~~~~i~----~g~~~~--~p- 256 (311)
T d1r0pa_ 186 DSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNT--FDITVYLL----QGRRLL--QP- 256 (311)
T ss_dssp CCTTCTTCSSCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCC--------CHHHHH----TTCCCC--CC-
T ss_pred CCCEECCCCCCCCCCCCHHHHHCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCCCH--HHHHHHHH----CCCCCC--CC-
T ss_conf 5310025655564556768874379997457466199999999789999888999--99999998----089889--96-
Q ss_pred CCCCCCHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHHCCCCC
Q ss_conf 039999699999999998711159999999999999998200134
Q 002673 843 LRGKGFDEEMLQVLDVACMCVSQNPFKRPTVKEVVEWLNNVGANR 887 (894)
Q Consensus 843 l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~eil~~L~~i~~~~ 887 (894)
...+ ..+.+++.+||+.||.+||||.||++.|+++....
T Consensus 257 ---~~~~---~~l~~li~~cl~~dP~~RPs~~ei~~~L~~i~~~~ 295 (311)
T d1r0pa_ 257 ---EYCP---DPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTF 295 (311)
T ss_dssp ---TTCC---HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTC
T ss_pred ---CCCC---HHHHHHHHHHCCCCHHHCCCHHHHHHHHHHHHHHH
T ss_conf ---4475---99999999976889768939999999999999752
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=340.36 Aligned_cols=252 Identities=25% Similarity=0.389 Sum_probs=206.7
Q ss_pred CCCCCCCEEEECCCEEEEEEEECCCCEEEEEEECCCCHHHHHHHHHHHHHHHHCCCCCEEEECCEEEE-CCEEEEEEEEC
Q ss_conf 59876544710283899999984898489999748512659999999999994599824553224310-46388999844
Q 002673 607 DNFSQANIIGCGGFGLVYKATLANGTTLAIKKLSGDLGLMEREFKAEVEALSTAQHKNLVSLQGYCVH-QGFRLLIYSYM 685 (894)
Q Consensus 607 ~~~~~~~~LG~G~fg~Vy~a~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~Hpniv~l~g~~~~-~~~~~lV~E~~ 685 (894)
++|+..+.||+|+||.||+|.+ ++..||||+++.+. ..+.+.+|++++++++||||++++|+|.+ .+..++|+||+
T Consensus 7 ~~~~~~~~lG~G~fg~Vy~~~~-~~~~vAvK~i~~~~--~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~ey~ 83 (262)
T d1byga_ 7 KELKLLQTIGKGEFGDVMLGDY-RGNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYM 83 (262)
T ss_dssp GGEEEEEEEEECSSCEEEEEEE-TTEEEEEEECCCCC----HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEECCC
T ss_pred HHEEEEEEEECCCCEEEEEEEE-CCEEEEEEEECCHH--HHHHHHHHHHHHHHCCCCCEEEEEEEEEECCCCEEEEEECC
T ss_conf 9948857982079808999999-99099999988577--79999999999986789898549878872389289999636
Q ss_pred CCCCHHHHHHHHCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCEEEEECCCCCCCCCCCC
Q ss_conf 69998899844148988757999999999999999998850699836418999985778998599997345332378887
Q 002673 686 ENGSLDYWLHEKADGASQLDWLTRLKIARGTSCGLAYMHQICEPHIVHRDIKSSNILLDDQFEAHLADFGLSRLILPYQT 765 (894)
Q Consensus 686 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~Ia~aL~yLHs~~~~~ivH~DLkp~NILl~~~~~vkL~DFGla~~~~~~~~ 765 (894)
++|+|.+++.... ...+++..++.++.||+.||.|||+ ++++||||||+|||++.++.+|++|||+++....
T Consensus 84 ~~g~L~~~l~~~~--~~~l~~~~~~~i~~~i~~al~ylH~---~~ivH~dlkp~Nil~~~~~~~kl~dfg~s~~~~~--- 155 (262)
T d1byga_ 84 AKGSLVDYLRSRG--RSVLGGDCLLKFSLDVCEAMEYLEG---NNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASS--- 155 (262)
T ss_dssp TTEEHHHHHHHHH--HHHCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEECTTSCEEECCCCC---------
T ss_pred CCCCHHHHHHHCC--CCCCCHHHHHHHHHHHHHHCCCCCC---CCEECCCCCHHHHEECCCCCEEECCCCCCEECCC---
T ss_conf 9998999987457--8888999999999999852321133---7655366656760146899776324560034478---
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHC-CCCCCCCCCCCHHHHHHHHHHHHHHCCCCCCCCCCCCC
Q ss_conf 43112455678668224367677862118999999999991-99999988930125699999988414987754452003
Q 002673 766 HVTTELVGTLGYIPPEYGQAWVATLRGDMYSFGVVMLELLT-GKRPVDVLKPKMSRELVGWVLKMRSEGKQDQVFDPILR 844 (894)
Q Consensus 766 ~~~~~~~gt~~y~APE~~~~~~~s~ksDVwSlGvil~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~ 844 (894)
......++..|+|||++.+..++.++||||||+++|||+| |+.||....... ....+ ..+....+.
T Consensus 156 -~~~~~~~~~~y~aPE~l~~~~~t~~sDIwSfG~il~el~t~~~~p~~~~~~~~---~~~~i----~~~~~~~~~----- 222 (262)
T d1byga_ 156 -TQDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKD---VVPRV----EKGYKMDAP----- 222 (262)
T ss_dssp -------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGG---HHHHH----TTTCCCCCC-----
T ss_pred -CCCCCCCCCCCCCHHHHHCCCCCHHHHHHHHHHHHHHHHHCCCCCCCCCCHHH---HHHHH----HCCCCCCCC-----
T ss_conf -77655666467781787279888588777579999999978999999999999---99999----808999997-----
Q ss_pred CCCCHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHHCCCC
Q ss_conf 999969999999999871115999999999999999820013
Q 002673 845 GKGFDEEMLQVLDVACMCVSQNPFKRPTVKEVVEWLNNVGAN 886 (894)
Q Consensus 845 ~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~eil~~L~~i~~~ 886 (894)
... ...+.+++.+||+.||.+||||.+++++|++++..
T Consensus 223 -~~~---~~~~~~li~~cl~~dP~~Rps~~~l~~~L~~i~~~ 260 (262)
T d1byga_ 223 -DGC---PPAVYEVMKNCWHLDAAMRPSFLQLREQLEHIKTH 260 (262)
T ss_dssp -TTC---CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred -CCC---CHHHHHHHHHHCCCCHHHCCCHHHHHHHHHHHHHC
T ss_conf -657---99999999997566976893999999999999867
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=336.97 Aligned_cols=261 Identities=28% Similarity=0.425 Sum_probs=207.4
Q ss_pred CCCCCCCCEEEECCCEEEEEEEEC-CCC--EEEEEEECCCC-HHHHHHHHHHHHHHHHC-CCCCEEEECCEEEECCEEEE
Q ss_conf 059876544710283899999984-898--48999974851-26599999999999945-99824553224310463889
Q 002673 606 TDNFSQANIIGCGGFGLVYKATLA-NGT--TLAIKKLSGDL-GLMEREFKAEVEALSTA-QHKNLVSLQGYCVHQGFRLL 680 (894)
Q Consensus 606 ~~~~~~~~~LG~G~fg~Vy~a~~~-~~~--~vavK~~~~~~-~~~~~~~~~Ei~~l~~l-~Hpniv~l~g~~~~~~~~~l 680 (894)
.++|+..+.||+|+||.||+|.+. ++. .||||++.... ....+.+.+|+++++.+ +|||||+++|++.+.+..++
T Consensus 9 ~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~i 88 (309)
T d1fvra_ 9 WNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYL 88 (309)
T ss_dssp GGGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEE
T ss_pred HHHCEEEEEEEECCCCEEEEEEECCCCEEEEEEEEEECCCCCHHHHHHHHHHHHHHHHCCCCCCEEEEEEEEECCCEEEE
T ss_conf 79968877982078828999999899969999999978233857999999999999862289988367888841873699
Q ss_pred EEEECCCCCHHHHHHHHC------------CCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCC
Q ss_conf 998446999889984414------------89887579999999999999999988506998364189999857789985
Q 002673 681 IYSYMENGSLDYWLHEKA------------DGASQLDWLTRLKIARGTSCGLAYMHQICEPHIVHRDIKSSNILLDDQFE 748 (894)
Q Consensus 681 V~E~~~~gsL~~~l~~~~------------~~~~~l~~~~~~~i~~~Ia~aL~yLHs~~~~~ivH~DLkp~NILl~~~~~ 748 (894)
|+||+++|+|.++++... .....+++..+..++.||+.||.|||+ ++++||||||+|||++.++.
T Consensus 89 V~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH~---~~iiHrDlkp~NIL~~~~~~ 165 (309)
T d1fvra_ 89 AIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQ---KQFIHRDLAARNILVGENYV 165 (309)
T ss_dssp EECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECGGGC
T ss_pred EEEECCCCCHHHHHHHCCCCCCCHHHHCCCCCCCCCCHHHHHHHHHHHHHHHHHHHC---CCCCCCCCCCCEEEECCCCC
T ss_conf 998028986999986403555551231012345789999999999999999876630---89545550520489868876
Q ss_pred EEEEECCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHCCC-CCCCCCCCCHHHHHHHHHH
Q ss_conf 999973453323788874311245567866822436767786211899999999999199-9999889301256999999
Q 002673 749 AHLADFGLSRLILPYQTHVTTELVGTLGYIPPEYGQAWVATLRGDMYSFGVVMLELLTGK-RPVDVLKPKMSRELVGWVL 827 (894)
Q Consensus 749 vkL~DFGla~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwSlGvil~elltG~-~Pf~~~~~~~~~~~~~~~~ 827 (894)
+||+|||+++..... .......||..|+|||.+.+..++.++||||||+++|||++|. .||...... .....+
T Consensus 166 ~kl~DfG~a~~~~~~--~~~~~~~gt~~y~aPE~l~~~~~~~~sDvwSfGvil~ell~~~~~p~~~~~~~---~~~~~i- 239 (309)
T d1fvra_ 166 AKIADFGLSRGQEVY--VKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCA---ELYEKL- 239 (309)
T ss_dssp EEECCTTCEESSCEE--CCC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCHH---HHHHHG-
T ss_pred EEECCCCCCCCCCCC--CCCCCEECCCCCCCHHHHCCCCCCCCCEEEHHHHHHHHHHHCCCCCCCCCCHH---HHHHHH-
T ss_conf 387434432244422--34553013775555387526999962215313889999983689999999999---999999-
Q ss_pred HHHHCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHHCCCCC
Q ss_conf 884149877544520039999699999999998711159999999999999998200134
Q 002673 828 KMRSEGKQDQVFDPILRGKGFDEEMLQVLDVACMCVSQNPFKRPTVKEVVEWLNNVGANR 887 (894)
Q Consensus 828 ~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~eil~~L~~i~~~~ 887 (894)
..+..... .......+.+++.+||+.||++||||++|++.|+++....
T Consensus 240 ---~~~~~~~~---------~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~L~~i~~~~ 287 (309)
T d1fvra_ 240 ---PQGYRLEK---------PLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEER 287 (309)
T ss_dssp ---GGTCCCCC---------CTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHSS
T ss_pred ---HHCCCCCC---------CCCCCHHHHHHHHHHCCCCHHHCCCHHHHHHHHHHHHHCC
T ss_conf ---82688888---------7667899999999976789668949999999999998618
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=335.36 Aligned_cols=263 Identities=25% Similarity=0.362 Sum_probs=205.6
Q ss_pred HHCCCCCCCCEEEECCCEEEEEEEECC------CCEEEEEEECCCC-HHHHHHHHHHHHHHHHC-CCCCEEEECCEEEEC
Q ss_conf 740598765447102838999999848------9848999974851-26599999999999945-998245532243104
Q 002673 604 KATDNFSQANIIGCGGFGLVYKATLAN------GTTLAIKKLSGDL-GLMEREFKAEVEALSTA-QHKNLVSLQGYCVHQ 675 (894)
Q Consensus 604 ~~~~~~~~~~~LG~G~fg~Vy~a~~~~------~~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l-~Hpniv~l~g~~~~~ 675 (894)
...++|++.+.||+|+||.||+|.+.. ++.||||++.... ....+.+..|...+.++ +|+||+.+++++.+.
T Consensus 10 i~~~~y~~~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~ 89 (299)
T d1ywna1 10 FPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKP 89 (299)
T ss_dssp CCGGGEEEEEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC----CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECST
T ss_pred CCHHHEEEEEEEEECCCEEEEEEEECCCCCCCCCEEEEEEEECCCCCCHHHHHHHHHHHHHHHHCCCCEEEEEEEEECCC
T ss_conf 16799798449841678399999986777555783999999860017178999999999988614998499741154047
Q ss_pred -CEEEEEEEECCCCCHHHHHHHHCC------------CCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEE
Q ss_conf -638899984469998899844148------------9887579999999999999999988506998364189999857
Q 002673 676 -GFRLLIYSYMENGSLDYWLHEKAD------------GASQLDWLTRLKIARGTSCGLAYMHQICEPHIVHRDIKSSNIL 742 (894)
Q Consensus 676 -~~~~lV~E~~~~gsL~~~l~~~~~------------~~~~l~~~~~~~i~~~Ia~aL~yLHs~~~~~ivH~DLkp~NIL 742 (894)
...++||||+++|+|.++++.... ....+++..+..++.||+.||.|||+ ++|+||||||+|||
T Consensus 90 ~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~---~~ivHrDlKp~NIL 166 (299)
T d1ywna1 90 GGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLAS---RKCIHRDLAARNIL 166 (299)
T ss_dssp TSCCEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEE
T ss_pred CCEEEEEEEECCCCCHHHHHHHCCCCCCCCCCCHHHHHCCCCCHHHHHHHHHHHHHHHHHHHH---CCCCCCCCCCCCEE
T ss_conf 975799998458992999998536666653222023321468999999999999999998873---79717867731065
Q ss_pred ECCCCCEEEEECCCCCCCCCCCCC-CCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHCC-CCCCCCCCCCHHH
Q ss_conf 789985999973453323788874-31124556786682243676778621189999999999919-9999988930125
Q 002673 743 LDDQFEAHLADFGLSRLILPYQTH-VTTELVGTLGYIPPEYGQAWVATLRGDMYSFGVVMLELLTG-KRPVDVLKPKMSR 820 (894)
Q Consensus 743 l~~~~~vkL~DFGla~~~~~~~~~-~~~~~~gt~~y~APE~~~~~~~s~ksDVwSlGvil~elltG-~~Pf~~~~~~~~~ 820 (894)
++.++.+||+|||+++........ ......||+.|+|||++.+..++.++|||||||++|||++| ..||.......
T Consensus 167 l~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gvil~ellt~~~~p~~~~~~~~-- 244 (299)
T d1ywna1 167 LSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDE-- 244 (299)
T ss_dssp ECGGGCEEECC------CCSCTTSCCTTSCCCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCCSH--
T ss_pred ECCCCCEEECCCCCHHHCCCCCCCCCCCCEEECCCCCCHHHHHCCCCCCCCCEEEHHHHHHHHHHCCCCCCCCCCHHH--
T ss_conf 779982898457520011356652224751667210203686468899663221367899999868899998999899--
Q ss_pred HHHHHHHHHHHCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHHCC
Q ss_conf 6999999884149877544520039999699999999998711159999999999999998200
Q 002673 821 ELVGWVLKMRSEGKQDQVFDPILRGKGFDEEMLQVLDVACMCVSQNPFKRPTVKEVVEWLNNVG 884 (894)
Q Consensus 821 ~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~eil~~L~~i~ 884 (894)
...... ..+...... ... ...+.+++.+||+.||++|||+.++++.|+++.
T Consensus 245 ~~~~~~----~~~~~~~~~------~~~---~~~l~~li~~cl~~dP~~Rpt~~eil~~L~~il 295 (299)
T d1ywna1 245 EFCRRL----KEGTRMRAP------DYT---TPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLL 295 (299)
T ss_dssp HHHHHH----HHTCCCCCC------TTC---CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred HHHHHH----HCCCCCCCC------CCC---CHHHHHHHHHHCCCCHHHCCCHHHHHHHHHHHH
T ss_conf 999999----638988888------657---899999999976779667919999999997998
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=333.39 Aligned_cols=256 Identities=21% Similarity=0.299 Sum_probs=206.5
Q ss_pred CCCCCCCCEEEECCCEEEEEEEEC-CCCEEEEEEECCCCHHHHHHHHHHHHHHHHCCCCCEEEECCEEEECCEEEEEEEE
Q ss_conf 059876544710283899999984-8984899997485126599999999999945998245532243104638899984
Q 002673 606 TDNFSQANIIGCGGFGLVYKATLA-NGTTLAIKKLSGDLGLMEREFKAEVEALSTAQHKNLVSLQGYCVHQGFRLLIYSY 684 (894)
Q Consensus 606 ~~~~~~~~~LG~G~fg~Vy~a~~~-~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~lV~E~ 684 (894)
.++|++.+.||+|+||.||+|... +++.||+|.+.... .....+.+|+.+|+.++|||||++++++.+.+..|+||||
T Consensus 4 ~~rY~i~~~lG~G~fg~Vy~~~~~~~~~~~AiK~i~~~~-~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~lvmE~ 82 (321)
T d1tkia_ 4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKG-TDQVLVKKEISILNIARHRNILHLHESFESMEELVMIFEF 82 (321)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCT-HHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEECC
T ss_pred CCCEEEEEEEECCCCEEEEEEEECCCCCEEEEEEECCCC-CCHHHHHHHHHHHHHCCCCCCCEEEEEEEECCEEEEEEEC
T ss_conf 010588789831778399999998999699999975786-6599999999999857997989098999889988999953
Q ss_pred CCCCCHHHHHHHHCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCC--CCEEEEECCCCCCCCC
Q ss_conf 46999889984414898875799999999999999999885069983641899998577899--8599997345332378
Q 002673 685 MENGSLDYWLHEKADGASQLDWLTRLKIARGTSCGLAYMHQICEPHIVHRDIKSSNILLDDQ--FEAHLADFGLSRLILP 762 (894)
Q Consensus 685 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~Ia~aL~yLHs~~~~~ivH~DLkp~NILl~~~--~~vkL~DFGla~~~~~ 762 (894)
+++|+|.+++.... ..+++..+..++.||+.||.|||+ ++|+||||||+|||++.+ ..+||+|||+++....
T Consensus 83 ~~gg~L~~~i~~~~---~~l~e~~~~~i~~qi~~al~yLH~---~~iiHrDlKp~NIll~~~~~~~ikl~DFG~~~~~~~ 156 (321)
T d1tkia_ 83 ISGLDIFERINTSA---FELNEREIVSYVHQVCEALQFLHS---HNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKP 156 (321)
T ss_dssp CCCCBHHHHHTSSS---CCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEESSSSCCCEEECCCTTCEECCT
T ss_pred CCCCCHHHHHHHCC---CCCCHHHHHHHHHHHHHHHHHHHH---CCCCCCCCCCCCEEECCCCCEEEEECCCCHHHCCCC
T ss_conf 89980889987538---999999999999999999999987---699751355444344378851899764411100346
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHCCCCCCCCCCCCHHHHHHHHHHHHHHCCCCCCCCCCC
Q ss_conf 88743112455678668224367677862118999999999991999999889301256999999884149877544520
Q 002673 763 YQTHVTTELVGTLGYIPPEYGQAWVATLRGDMYSFGVVMLELLTGKRPVDVLKPKMSRELVGWVLKMRSEGKQDQVFDPI 842 (894)
Q Consensus 763 ~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 842 (894)
. .......+++.|+|||...+..++.++||||+||++|+|++|+.||...... +....+.. .... ++..
T Consensus 157 ~--~~~~~~~~t~~y~ape~~~~~~~~~~~DiWSlGvily~ll~G~~Pf~~~~~~---~~~~~i~~--~~~~----~~~~ 225 (321)
T d1tkia_ 157 G--DNFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQ---QIIENIMN--AEYT----FDEE 225 (321)
T ss_dssp T--CEEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHH---HHHHHHHH--TCCC----CCHH
T ss_pred C--CCCCCCCCCCCCCCCHHCCCCCCCCHHHCCCHHHHHHHHHHCCCCCCCCCHH---HHHHHHHH--CCCC----CCHH
T ss_conf 7--7532122332223402104877784011302799999998289999998999---99999983--8999----8802
Q ss_pred CCCCCCHHHHHHHHHHHHHHCCCCCCCCCCHHHHHH--HHHHC
Q ss_conf 039999699999999998711159999999999999--99820
Q 002673 843 LRGKGFDEEMLQVLDVACMCVSQNPFKRPTVKEVVE--WLNNV 883 (894)
Q Consensus 843 l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~eil~--~L~~i 883 (894)
.. .. ....+.+++.+|+..||.+|||++|+++ |+.+-
T Consensus 226 ~~-~~---~s~~~~~li~~~L~~dp~~R~s~~eil~hp~~~~~ 264 (321)
T d1tkia_ 226 AF-KE---ISIEAMDFVDRLLVKERKSRMTASEALQHPWLKQK 264 (321)
T ss_dssp HH-TT---SCHHHHHHHHTTSCSSGGGSCCHHHHHHSHHHHSC
T ss_pred HC-CC---CCHHHHHHHHHHCCCCHHHCCCHHHHHCCHHHCCC
T ss_conf 23-67---89999999999866996689099999639965667
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=335.40 Aligned_cols=264 Identities=27% Similarity=0.399 Sum_probs=210.1
Q ss_pred HCCCCCCCCEEEECCCEEEEEEEEC------CCCEEEEEEECCCC-HHHHHHHHHHHHHHHHC-CCCCEEEECCEEEECC
Q ss_conf 4059876544710283899999984------89848999974851-26599999999999945-9982455322431046
Q 002673 605 ATDNFSQANIIGCGGFGLVYKATLA------NGTTLAIKKLSGDL-GLMEREFKAEVEALSTA-QHKNLVSLQGYCVHQG 676 (894)
Q Consensus 605 ~~~~~~~~~~LG~G~fg~Vy~a~~~------~~~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l-~Hpniv~l~g~~~~~~ 676 (894)
..++|+..+.||+|+||.||+|.+. ++..||||++.... ......+.+|+.+++.+ +|||||+++|+|.+..
T Consensus 21 ~~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~~~~~l~~HpnIv~~~g~~~~~~ 100 (311)
T d1t46a_ 21 PRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGG 100 (311)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred CHHHEEEEEEEEECCCEEEEEEEEECCCCCCCCEEEEEEEECCCCCHHHHHHHHHHHHHHHHCCCCCCEEEEEEEEEECC
T ss_conf 78996985498206882999999806644778869999998742487799999999999876269998878998983199
Q ss_pred EEEEEEEECCCCCHHHHHHHHCC--------------CCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEE
Q ss_conf 38899984469998899844148--------------9887579999999999999999988506998364189999857
Q 002673 677 FRLLIYSYMENGSLDYWLHEKAD--------------GASQLDWLTRLKIARGTSCGLAYMHQICEPHIVHRDIKSSNIL 742 (894)
Q Consensus 677 ~~~lV~E~~~~gsL~~~l~~~~~--------------~~~~l~~~~~~~i~~~Ia~aL~yLHs~~~~~ivH~DLkp~NIL 742 (894)
..++||||+++|+|.++++.... ....+++..+..++.||+.|+.|||+ ++++||||||+||+
T Consensus 101 ~~~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH~---~~ivHrDLKp~NIl 177 (311)
T d1t46a_ 101 PTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLAS---KNCIHRDLAARNIL 177 (311)
T ss_dssp SCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEE
T ss_pred EEEEEEECCCCCCHHHHHHHCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHH---CCEEECCCCCCCCC
T ss_conf 789999737998799999853566544444533222334588999999999999999998875---79266624102100
Q ss_pred ECCCCCEEEEECCCCCCCCCCCC-CCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHC-CCCCCCCCCCCHHH
Q ss_conf 78998599997345332378887-43112455678668224367677862118999999999991-99999988930125
Q 002673 743 LDDQFEAHLADFGLSRLILPYQT-HVTTELVGTLGYIPPEYGQAWVATLRGDMYSFGVVMLELLT-GKRPVDVLKPKMSR 820 (894)
Q Consensus 743 l~~~~~vkL~DFGla~~~~~~~~-~~~~~~~gt~~y~APE~~~~~~~s~ksDVwSlGvil~ellt-G~~Pf~~~~~~~~~ 820 (894)
++.++.+|++|||.++....... .......||+.|+|||++.+..++.++||||||+++|||+| |.+||........
T Consensus 178 ~~~~~~~ki~DfG~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DIwS~G~~l~ellt~g~p~~~~~~~~~~- 256 (311)
T d1t46a_ 178 LTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSK- 256 (311)
T ss_dssp EETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSSHH-
T ss_pred CCCCCCCCCCCCCHHEECCCCCCCEEEEECCCCHHHCCHHHHCCCCCCCCCCCCCHHHHHHHHHHCCCCCCCCCCHHHH-
T ss_conf 0025752102340102336788615862013596876778861799997400102589999998589988778998999-
Q ss_pred HHHHHHHHHHHCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHHCCCC
Q ss_conf 699999988414987754452003999969999999999871115999999999999999820013
Q 002673 821 ELVGWVLKMRSEGKQDQVFDPILRGKGFDEEMLQVLDVACMCVSQNPFKRPTVKEVVEWLNNVGAN 886 (894)
Q Consensus 821 ~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~eil~~L~~i~~~ 886 (894)
+...+. .+..... . ... ...+.+|+.+||+.||.+||||.+++++|+++...
T Consensus 257 -~~~~i~----~~~~~~~-~-----~~~---~~~l~~Li~~cl~~dP~~RPs~~~il~~L~~~i~~ 308 (311)
T d1t46a_ 257 -FYKMIK----EGFRMLS-P-----EHA---PAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQISE 308 (311)
T ss_dssp -HHHHHH----HTCCCCC-C-----TTS---CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred -HHHHHH----CCCCCCC-C-----CCC---CHHHHHHHHHHCCCCHHHCCCHHHHHHHHHHHHCC
T ss_conf -999986----6898898-5-----436---59999999997577965792999999999876534
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=335.08 Aligned_cols=256 Identities=21% Similarity=0.272 Sum_probs=199.2
Q ss_pred CCCCCC-CEEEECCCEEEEEEEE-CCCCEEEEEEECCCCHHHHHHHHHHHHHHHH-CCCCCEEEECCEEEE----CCEEE
Q ss_conf 598765-4471028389999998-4898489999748512659999999999994-599824553224310----46388
Q 002673 607 DNFSQA-NIIGCGGFGLVYKATL-ANGTTLAIKKLSGDLGLMEREFKAEVEALST-AQHKNLVSLQGYCVH----QGFRL 679 (894)
Q Consensus 607 ~~~~~~-~~LG~G~fg~Vy~a~~-~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~-l~Hpniv~l~g~~~~----~~~~~ 679 (894)
++|.+. +.||+|+||.||+|.. .+++.||||++... ..+.+|+.++.+ .+|||||++++++.+ +...|
T Consensus 11 ~~y~i~~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~-----~~~~~E~~~~~~~~~hpnIv~l~~~~~~~~~~~~~~~ 85 (335)
T d2ozaa1 11 DDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-----PKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLL 85 (335)
T ss_dssp GTEEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECS-----HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEE
T ss_pred CCEEEEEEEEEECCCEEEEEEEECCCCCEEEEEEECCC-----HHHHHHHHHHHHHCCCCCCCEEEEEEEECCCCCCEEE
T ss_conf 48798107965454869999998899989999998974-----7799999999986699997829899950346897899
Q ss_pred EEEEECCCCCHHHHHHHHCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECC---CCCEEEEECCC
Q ss_conf 999844699988998441489887579999999999999999988506998364189999857789---98599997345
Q 002673 680 LIYSYMENGSLDYWLHEKADGASQLDWLTRLKIARGTSCGLAYMHQICEPHIVHRDIKSSNILLDD---QFEAHLADFGL 756 (894)
Q Consensus 680 lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~Ia~aL~yLHs~~~~~ivH~DLkp~NILl~~---~~~vkL~DFGl 756 (894)
+|||||++|+|.+++.... ...+++..+..++.||+.||.|||+ ++|+||||||+|||++. .+.+||+|||+
T Consensus 86 ivmEy~~gg~L~~~i~~~~--~~~l~e~~~~~i~~qi~~al~ylH~---~~iiHRDiKp~NIll~~~~~~~~~Kl~DFG~ 160 (335)
T d2ozaa1 86 IVMECLDGGELFSRIQDRG--DQAFTEREASEIMKSIGEAIQYLHS---INIAHRDVKPENLLYTSKRPNAILKLTDFGF 160 (335)
T ss_dssp EEEECCCSEEHHHHHHSCS--CCCEEHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEESCSSTTCCEEECCCTT
T ss_pred EEEECCCCCCHHHHHHHCC--CCCCCHHHHHHHHHHHHHHHHHHHH---CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCE
T ss_conf 9997789984999998627--8775799999999999999999997---6986444100220113555566311354551
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHCCCCCCCCCCCCHHHHHHHHHHHHHHCCCCC
Q ss_conf 33237888743112455678668224367677862118999999999991999999889301256999999884149877
Q 002673 757 SRLILPYQTHVTTELVGTLGYIPPEYGQAWVATLRGDMYSFGVVMLELLTGKRPVDVLKPKMSRELVGWVLKMRSEGKQD 836 (894)
Q Consensus 757 a~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~ 836 (894)
++...... ......||+.|+|||++.+..|+.++||||+||++|+|+||+.||........... ...........
T Consensus 161 a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~y~~~~DiwSlGvily~lltg~~Pf~~~~~~~~~~~---~~~~i~~~~~~ 235 (335)
T d2ozaa1 161 AKETTSHN--SLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPG---MKTRIRMGQYE 235 (335)
T ss_dssp CEECCCCC--CCCCCSCCCSSCCCCCCCGGGGSHHHHHHHHHHHHHHHTTSSCSCEETTCC-----------CCCSCSSS
T ss_pred EEECCCCC--CCCCCCCCCCCCCCHHHCCCCCCHHHHHHHHCHHHHHHHHCCCCCCCCCHHHHHHH---HHHHHHCCCCC
T ss_conf 23336888--64322677563792777489888888887645167788658899889887788999---99998538888
Q ss_pred CCCCCCCCCCCCHHHHHHHHHHHHHHCCCCCCCCCCHHHHHH--HHHHC
Q ss_conf 544520039999699999999998711159999999999999--99820
Q 002673 837 QVFDPILRGKGFDEEMLQVLDVACMCVSQNPFKRPTVKEVVE--WLNNV 883 (894)
Q Consensus 837 ~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~eil~--~L~~i 883 (894)
+...........+.+|+.+||+.||++|||+.|+++ |+.+-
T Consensus 236 ------~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~hp~~~~~ 278 (335)
T d2ozaa1 236 ------FPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQS 278 (335)
T ss_dssp ------CCTTHHHHSCHHHHHHHHHHSCSSTTTSCCHHHHHHSHHHHTT
T ss_pred ------CCCCCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHCCHHHHCC
T ss_conf ------8985434699999999999756996579099999709876178
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=337.99 Aligned_cols=270 Identities=24% Similarity=0.274 Sum_probs=201.8
Q ss_pred CCCCCCCEEEECCCEEEEEEEECCCCEEEEEEECCCCHHHHHHHHHHHHHHHHCCCCCEEEECCEEEECC----EEEEEE
Q ss_conf 5987654471028389999998489848999974851265999999999999459982455322431046----388999
Q 002673 607 DNFSQANIIGCGGFGLVYKATLANGTTLAIKKLSGDLGLMEREFKAEVEALSTAQHKNLVSLQGYCVHQG----FRLLIY 682 (894)
Q Consensus 607 ~~~~~~~~LG~G~fg~Vy~a~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~Hpniv~l~g~~~~~~----~~~lV~ 682 (894)
++|...+.||+|+||.||+|++ +|..||||++..... .......|+..+..++||||++++++|.+.+ ..++||
T Consensus 3 ~~~~l~~~iG~G~fg~Vy~~~~-~g~~vAvK~~~~~~~-~~~~~e~ei~~~~~~~HpnIv~~~~~~~~~~~~~~~~~lv~ 80 (303)
T d1vjya_ 3 RTIVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSSREE-RSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVS 80 (303)
T ss_dssp GGEEEEEEEECCSSSEEEEEEE-TTEEEEEEEECGGGH-HHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEE
T ss_pred CEEEEEEEEEECCCEEEEEEEE-CCEEEEEEEECCCCH-HHHHHHHHHHHHHHCCCCCCCCEEEEEEECCCCCEEEEEEE
T ss_conf 6899988982078819999999-998999999872004-67999999999962799868326889983798604899999
Q ss_pred EECCCCCHHHHHHHHCCCCCCCCHHHHHHHHHHHHHHHHHHHHC-----CCCCEEECCCCCCCEEECCCCCEEEEECCCC
Q ss_conf 84469998899844148988757999999999999999998850-----6998364189999857789985999973453
Q 002673 683 SYMENGSLDYWLHEKADGASQLDWLTRLKIARGTSCGLAYMHQI-----CEPHIVHRDIKSSNILLDDQFEAHLADFGLS 757 (894)
Q Consensus 683 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~Ia~aL~yLHs~-----~~~~ivH~DLkp~NILl~~~~~vkL~DFGla 757 (894)
||+++|+|.++++.. .++|..++.++.+++.||.|+|+. ..++|+||||||+|||++.++.+||+|||++
T Consensus 81 Ey~~~g~L~~~l~~~-----~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~~~~~~Kl~DFGl~ 155 (303)
T d1vjya_ 81 DYHEHGSLFDYLNRY-----TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLA 155 (303)
T ss_dssp ECCTTCBHHHHHHHC-----CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEECTTSCEEECCCTTC
T ss_pred ECCCCCCHHHHHHCC-----CCCHHHHHHHHHHHHHHHHHHHHHHHHHCCCCCEECCCCCCCCEEECCCCCEEEEECCCC
T ss_conf 646698989998658-----999899999999999999998876652046898661531731357868877688763866
Q ss_pred CCCCCCCCC---CCCCCCCCCCCCCCCCCCCCC------CCCCCCHHHHHHHHHHHHCCCCCCCCCCCCHH--------H
Q ss_conf 323788874---311245567866822436767------78621189999999999919999998893012--------5
Q 002673 758 RLILPYQTH---VTTELVGTLGYIPPEYGQAWV------ATLRGDMYSFGVVMLELLTGKRPVDVLKPKMS--------R 820 (894)
Q Consensus 758 ~~~~~~~~~---~~~~~~gt~~y~APE~~~~~~------~s~ksDVwSlGvil~elltG~~Pf~~~~~~~~--------~ 820 (894)
+........ ......||+.|+|||++.+.. ++.++|||||||++|||+||..||........ .
T Consensus 156 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~Gvvl~el~tg~~~~~~~~~~~~~~~~~~~~~ 235 (303)
T d1vjya_ 156 VRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSD 235 (303)
T ss_dssp EEEETTTTEECC----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCSS
T ss_pred CCCCCCCCCEECCCCCEECCCCCCCHHHCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHCCCCCCCCCCCCCCHHHCCCCC
T ss_conf 23467776200135525035476782210565454677767501220159999999628998876631124101225564
Q ss_pred HHHHHHHHHHHCCCCCCCCCCCCCC-CCCHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHHCCCCC
Q ss_conf 6999999884149877544520039-999699999999998711159999999999999998200134
Q 002673 821 ELVGWVLKMRSEGKQDQVFDPILRG-KGFDEEMLQVLDVACMCVSQNPFKRPTVKEVVEWLNNVGANR 887 (894)
Q Consensus 821 ~~~~~~~~~~~~~~~~~~~d~~l~~-~~~~~~~~~l~~li~~Cl~~dP~~RPs~~eil~~L~~i~~~~ 887 (894)
............... ++.+.. ....+....+.+++.+||+.||.+|||+.||++.|+++..+.
T Consensus 236 ~~~~~~~~~~~~~~~----~p~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ei~~~L~~i~~~~ 299 (303)
T d1vjya_ 236 PSVEEMRKVVCEQKL----RPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQQE 299 (303)
T ss_dssp CCHHHHHHHHTTSCC----CCCCCGGGGGCHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred CHHHHHHHHHHCCCC----CCCCCCCCCCHHHHHHHHHHHHHHCCCCHHHCCCHHHHHHHHHHHHHHC
T ss_conf 309999998750246----8887765577689999999999976069858959999999999888865
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=334.92 Aligned_cols=256 Identities=23% Similarity=0.360 Sum_probs=204.6
Q ss_pred CCCCCCCCEEEECCCEEEEEEEECC--C--CEEEEEEECCCC---HHHHHHHHHHHHHHHHCCCCCEEEECCEEEECCEE
Q ss_conf 0598765447102838999999848--9--848999974851---26599999999999945998245532243104638
Q 002673 606 TDNFSQANIIGCGGFGLVYKATLAN--G--TTLAIKKLSGDL---GLMEREFKAEVEALSTAQHKNLVSLQGYCVHQGFR 678 (894)
Q Consensus 606 ~~~~~~~~~LG~G~fg~Vy~a~~~~--~--~~vavK~~~~~~---~~~~~~~~~Ei~~l~~l~Hpniv~l~g~~~~~~~~ 678 (894)
.++|++.+.||+|+||.||+|.+.. + ..||||++.... ....+.|.+|+.+++.++||||++++|++.+ ...
T Consensus 7 ~~d~~~~~~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~~~g~~~~-~~~ 85 (273)
T d1u46a_ 7 EKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLT-PPM 85 (273)
T ss_dssp GGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSC
T ss_pred HHHEEEEEEEECCCCEEEEEEEEECCCCCEEEEEEEEECHHHCCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEEEE-CCH
T ss_conf 4891997898038883999999988999079999999983555798999999999999986899998789877740-100
Q ss_pred EEEEEECCCCCHHHHHHHHCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCEEEEECCCCC
Q ss_conf 89998446999889984414898875799999999999999999885069983641899998577899859999734533
Q 002673 679 LLIYSYMENGSLDYWLHEKADGASQLDWLTRLKIARGTSCGLAYMHQICEPHIVHRDIKSSNILLDDQFEAHLADFGLSR 758 (894)
Q Consensus 679 ~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~Ia~aL~yLHs~~~~~ivH~DLkp~NILl~~~~~vkL~DFGla~ 758 (894)
++|+||+++|++.+++.... ..+++..+..++.||+.||.|||+ ++|+||||||+||+++.++.+||+|||+++
T Consensus 86 ~lv~e~~~~~~l~~~~~~~~---~~l~~~~~~~~~~qi~~gl~ylH~---~~iiHrDikp~NIll~~~~~vkl~DfGl~~ 159 (273)
T d1u46a_ 86 KMVTELAPLGSLLDRLRKHQ---GHFLLGTLSRYAVQVAEGMGYLES---KRFIHRDLAARNLLLATRDLVKIGDFGLMR 159 (273)
T ss_dssp EEEEECCTTCBHHHHHHHHG---GGSCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGGGEEEEETTEEEECCCTTCE
T ss_pred HEEEEEECCCCHHHHHHCCC---CCCCHHHHHHHHHHHHHHHHHHHH---CCEEEEEECHHHHCCCCCCCEEECCCHHHH
T ss_conf 11465423861254442126---899999999999999999987521---787520566888156556543325611555
Q ss_pred CCCCCCCC--CCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHC-CCCCCCCCCCCHHHHHHHHHHHHHHCCCC
Q ss_conf 23788874--3112455678668224367677862118999999999991-99999988930125699999988414987
Q 002673 759 LILPYQTH--VTTELVGTLGYIPPEYGQAWVATLRGDMYSFGVVMLELLT-GKRPVDVLKPKMSRELVGWVLKMRSEGKQ 835 (894)
Q Consensus 759 ~~~~~~~~--~~~~~~gt~~y~APE~~~~~~~s~ksDVwSlGvil~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~ 835 (894)
........ ......|+..|+|||++.+..++.++||||||+++|||+| |+.||....... .... +...+..
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~S~Gvil~emlt~G~~Pf~~~~~~~---~~~~---i~~~~~~ 233 (273)
T d1u46a_ 160 ALPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQ---ILHK---IDKEGER 233 (273)
T ss_dssp ECCC-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHHH---HHHH---HHTSCCC
T ss_pred HCCCCCCCCEECCCCCCCCCCCCHHHHHCCCCCCCHHHHHHHHHHHHHHHCCCCCCCCCCHHH---HHHH---HHHCCCC
T ss_conf 303588752654763257310799998379999421566148999999968999999969999---9999---9847999
Q ss_pred CCCCCCCCCCCCCHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHHC
Q ss_conf 754452003999969999999999871115999999999999999820
Q 002673 836 DQVFDPILRGKGFDEEMLQVLDVACMCVSQNPFKRPTVKEVVEWLNNV 883 (894)
Q Consensus 836 ~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~eil~~L~~i 883 (894)
.... ... ...+.+++.+||+.||++||||.+|++.|.+.
T Consensus 234 ~~~~------~~~---~~~l~~li~~cl~~dp~~RPt~~ei~~~L~~~ 272 (273)
T d1u46a_ 234 LPRP------EDC---PQDIYNVMVQCWAHKPEDRPTFVALRDFLLEA 272 (273)
T ss_dssp CCCC------TTC---CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred CCCC------CCC---CHHHHHHHHHHCCCCHHHCCCHHHHHHHHHHC
T ss_conf 9985------445---39999999997688966792999999999964
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Probab=100.00 E-value=0 Score=331.92 Aligned_cols=259 Identities=25% Similarity=0.382 Sum_probs=207.9
Q ss_pred CCCCCCCCEEEECCCEEEEEEEE-CCCCEEEEEEECCCC---HHHHHHHHHHHHHHHHCCCCCEEEECCEEEECC----E
Q ss_conf 05987654471028389999998-489848999974851---265999999999999459982455322431046----3
Q 002673 606 TDNFSQANIIGCGGFGLVYKATL-ANGTTLAIKKLSGDL---GLMEREFKAEVEALSTAQHKNLVSLQGYCVHQG----F 677 (894)
Q Consensus 606 ~~~~~~~~~LG~G~fg~Vy~a~~-~~~~~vavK~~~~~~---~~~~~~~~~Ei~~l~~l~Hpniv~l~g~~~~~~----~ 677 (894)
.++|++.+.||+|+||.||+|.. .+++.||+|++.... ......+.+|+.+++.++||||+++++++.... .
T Consensus 6 ~drY~i~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~~l~~~~hpniv~~~~~~~~~~~~~~~ 85 (277)
T d1o6ya_ 6 SDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPL 85 (277)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTTTCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEECSSSEE
T ss_pred CCEEEEEEEEEECCCEEEEEEEECCCCCEEEEEEECHHHCCCHHHHHHHHHHHHHHHHCCCCCCCCCCCEEEECCCCCCE
T ss_conf 62069868996089929999999999989999998556646989999999999999856999887311435432688766
Q ss_pred EEEEEEECCCCCHHHHHHHHCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCEEEEECCCC
Q ss_conf 88999844699988998441489887579999999999999999988506998364189999857789985999973453
Q 002673 678 RLLIYSYMENGSLDYWLHEKADGASQLDWLTRLKIARGTSCGLAYMHQICEPHIVHRDIKSSNILLDDQFEAHLADFGLS 757 (894)
Q Consensus 678 ~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~Ia~aL~yLHs~~~~~ivH~DLkp~NILl~~~~~vkL~DFGla 757 (894)
.|+||||+++|+|..++... ..+++..+..++.||+.||.|||+ ++++||||||+|||++.++..+++|||.+
T Consensus 86 ~~lvmE~~~g~~L~~~~~~~----~~l~~~~~~~i~~qi~~al~~lH~---~~iiHrDiKP~NIll~~~~~~~l~d~~~~ 158 (277)
T d1o6ya_ 86 PYIVMEYVDGVTLRDIVHTE----GPMTPKRAIEVIADACQALNFSHQ---NGIIHRDVKPANIMISATNAVKVMDFGIA 158 (277)
T ss_dssp EEEEEECCCEEEHHHHHHHH----CSCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEEETTSCEEECCCTTC
T ss_pred EEEEEECCCCCEEHHHHCCC----CCCCHHHHHHHHHHHHHHHHHHHH---CCCCCCCCCCCCCCCCCCCCCEEEHHHHH
T ss_conf 99999778898710112035----899999999999999999999985---79527634675566575432010034443
Q ss_pred CCCCCCCC--CCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHCCCCCCCCCCCCHHHHHHHHHHHHHHCCCC
Q ss_conf 32378887--4311245567866822436767786211899999999999199999988930125699999988414987
Q 002673 758 RLILPYQT--HVTTELVGTLGYIPPEYGQAWVATLRGDMYSFGVVMLELLTGKRPVDVLKPKMSRELVGWVLKMRSEGKQ 835 (894)
Q Consensus 758 ~~~~~~~~--~~~~~~~gt~~y~APE~~~~~~~s~ksDVwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~ 835 (894)
........ .......||+.|+|||++.+..++.++||||+||++|||+||+.||....... . ..........
T Consensus 159 ~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~---~---~~~~~~~~~~ 232 (277)
T d1o6ya_ 159 RAIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVS---V---AYQHVREDPI 232 (277)
T ss_dssp EECC----------------TTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHH---H---HHHHHHCCCC
T ss_pred HHHCCCCCCCCCCCCCCCCCCCCCHHHHCCCCCCCCEECCCCHHHHHHHHHCCCCCCCCCHHH---H---HHHHHHCCCC
T ss_conf 221235443333464257624369999839999966320265289999976979989969999---9---9999846999
Q ss_pred CCCCCCCCCCCCCHHHHHHHHHHHHHHCCCCCCCCC-CHHHHHHHHHHCC
Q ss_conf 754452003999969999999999871115999999-9999999998200
Q 002673 836 DQVFDPILRGKGFDEEMLQVLDVACMCVSQNPFKRP-TVKEVVEWLNNVG 884 (894)
Q Consensus 836 ~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RP-s~~eil~~L~~i~ 884 (894)
. +.......+ ..+.+++.+||+.||.+|| |++++++.|.+++
T Consensus 233 ~----~~~~~~~~s---~~l~~li~~~L~~dp~~R~~sa~~l~~~l~r~~ 275 (277)
T d1o6ya_ 233 P----PSARHEGLS---ADLDAVVLKALAKNPENRYQTAAEMRADLVRVH 275 (277)
T ss_dssp C----GGGTSSSCC---HHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHHH
T ss_pred C----CCHHCCCCC---HHHHHHHHHHCCCCHHHCHHHHHHHHHHHHHHH
T ss_conf 9----710034789---999999999866797677739999999999975
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=331.97 Aligned_cols=261 Identities=27% Similarity=0.400 Sum_probs=210.5
Q ss_pred CCCCCCCCEEEECCCEEEEEEEECC--------CCEEEEEEECCCCHH-HHHHHHHHHHHHHHC-CCCCEEEECCEEEEC
Q ss_conf 0598765447102838999999848--------984899997485126-599999999999945-998245532243104
Q 002673 606 TDNFSQANIIGCGGFGLVYKATLAN--------GTTLAIKKLSGDLGL-MEREFKAEVEALSTA-QHKNLVSLQGYCVHQ 675 (894)
Q Consensus 606 ~~~~~~~~~LG~G~fg~Vy~a~~~~--------~~~vavK~~~~~~~~-~~~~~~~Ei~~l~~l-~Hpniv~l~g~~~~~ 675 (894)
.++|.+.+.||+|+||.||+|+... +..||||++..+... ...++.+|...+..+ +|||||+++++|.++
T Consensus 12 ~~~~~l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~e~~~l~~~~~HpnIv~~~~~~~~~ 91 (299)
T d1fgka_ 12 RDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQD 91 (299)
T ss_dssp GGGEEEEEECC-----CEEEEEEECC----CCCEEEEEEECCCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred HHHEEEEEEEEECCCCEEEEEEECCCCCCCCCCCEEEEEEEECCCCCHHHHHHHHHHHHHHHHHCCCCEEEECCCCCCCC
T ss_conf 89969700985167828999998578755566754999999881128688999999999999813999697346522018
Q ss_pred CEEEEEEEECCCCCHHHHHHHHCC------------CCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEE
Q ss_conf 638899984469998899844148------------98875799999999999999999885069983641899998577
Q 002673 676 GFRLLIYSYMENGSLDYWLHEKAD------------GASQLDWLTRLKIARGTSCGLAYMHQICEPHIVHRDIKSSNILL 743 (894)
Q Consensus 676 ~~~~lV~E~~~~gsL~~~l~~~~~------------~~~~l~~~~~~~i~~~Ia~aL~yLHs~~~~~ivH~DLkp~NILl 743 (894)
+..++||||+++|+|.+++..... ....+++..++.++.||+.||.|||+ ++++||||||+|||+
T Consensus 92 ~~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH~---~~ivHrDiKp~NiLl 168 (299)
T d1fgka_ 92 GPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLAS---KKCIHRDLAARNVLV 168 (299)
T ss_dssp SSCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEE
T ss_pred CEEEEEEECCCCCCHHHHHHHHCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHH---CCEEEEEECCCCEEE
T ss_conf 86899997369990999998606776432223345743467999999999999999987663---797863022102245
Q ss_pred CCCCCEEEEECCCCCCCCCCCC-CCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHC-CCCCCCCCCCCHHHH
Q ss_conf 8998599997345332378887-43112455678668224367677862118999999999991-999999889301256
Q 002673 744 DDQFEAHLADFGLSRLILPYQT-HVTTELVGTLGYIPPEYGQAWVATLRGDMYSFGVVMLELLT-GKRPVDVLKPKMSRE 821 (894)
Q Consensus 744 ~~~~~vkL~DFGla~~~~~~~~-~~~~~~~gt~~y~APE~~~~~~~s~ksDVwSlGvil~ellt-G~~Pf~~~~~~~~~~ 821 (894)
+.++.+||+|||+++....... .......+++.|+|||++.++.|+.++||||||+++|||++ |..||...... .
T Consensus 169 ~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~y~~k~DiwS~Gvvl~ell~~g~~p~~~~~~~---~ 245 (299)
T d1fgka_ 169 TEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVE---E 245 (299)
T ss_dssp CTTCCEEECSTTCCCCGGGCCTTCCCTTSCCGGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHH---H
T ss_pred CCCCCEEECCCHHHCCCCCCCCCCCCCCCCCCHHHHHHHHHCCCCCCCHHHHHHHHHHHHHHCCCCCCCCCCCCHH---H
T ss_conf 4789767622111011355555431466788846632667517988825554775888887401798989999999---9
Q ss_pred HHHHHHHHHHCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHHCCC
Q ss_conf 9999998841498775445200399996999999999987111599999999999999982001
Q 002673 822 LVGWVLKMRSEGKQDQVFDPILRGKGFDEEMLQVLDVACMCVSQNPFKRPTVKEVVEWLNNVGA 885 (894)
Q Consensus 822 ~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~eil~~L~~i~~ 885 (894)
....+ ..+..... + ...+ ..+.+++.+||+.||++|||+.+|++.|+++.+
T Consensus 246 ~~~~i----~~~~~~~~-p-----~~~~---~~l~~li~~cl~~dP~~Rps~~eil~~L~~i~a 296 (299)
T d1fgka_ 246 LFKLL----KEGHRMDK-P-----SNCT---NELYMMMRDCWHAVPSQRPTFKQLVEDLDRIVA 296 (299)
T ss_dssp HHHHH----HTTCCCCC-C-----SSCC---HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred HHHHH----HCCCCCCC-C-----CCCH---HHHHHHHHHHCCCCHHHCCCHHHHHHHHHHHHH
T ss_conf 99999----72888898-7-----4352---999999999766797679399999999988860
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Probab=100.00 E-value=0 Score=330.46 Aligned_cols=254 Identities=28% Similarity=0.394 Sum_probs=204.5
Q ss_pred CCCCCCCEEEECCCEEEEEEEE-CCCCEEEEEEECCCCH---------HHHHHHHHHHHHHHHCC-CCCEEEECCEEEEC
Q ss_conf 5987654471028389999998-4898489999748512---------65999999999999459-98245532243104
Q 002673 607 DNFSQANIIGCGGFGLVYKATL-ANGTTLAIKKLSGDLG---------LMEREFKAEVEALSTAQ-HKNLVSLQGYCVHQ 675 (894)
Q Consensus 607 ~~~~~~~~LG~G~fg~Vy~a~~-~~~~~vavK~~~~~~~---------~~~~~~~~Ei~~l~~l~-Hpniv~l~g~~~~~ 675 (894)
++|++.+.||+|+||.||+|+. .+++.||||++..... .....+.+|+.++++++ ||||+++++++.++
T Consensus 3 ~~y~~~~~iG~G~~g~V~~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~ 82 (277)
T d1phka_ 3 ENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYETN 82 (277)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEECS
T ss_pred CCCEECEEEECCCCEEEEEEEECCCCCEEEEEEEECCCCCCHHHHHHHHHHHHHHHHHHHHHHHCCCCCEEEEEEECCCC
T ss_conf 63888528841768499999999999899999996244641147888999999999999999850799747997621467
Q ss_pred CEEEEEEEECCCCCHHHHHHHHCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCEEEEECC
Q ss_conf 63889998446999889984414898875799999999999999999885069983641899998577899859999734
Q 002673 676 GFRLLIYSYMENGSLDYWLHEKADGASQLDWLTRLKIARGTSCGLAYMHQICEPHIVHRDIKSSNILLDDQFEAHLADFG 755 (894)
Q Consensus 676 ~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~Ia~aL~yLHs~~~~~ivH~DLkp~NILl~~~~~vkL~DFG 755 (894)
+..|+||||+++|+|.+++... ..+++..+..++.||+.||.|||+ ++++||||||+|||++.++.+||+|||
T Consensus 83 ~~~~ivmE~~~~g~L~~~l~~~----~~l~e~~~~~~~~qi~~al~~lH~---~~ivHrDlkp~Nill~~~~~~kl~DFG 155 (277)
T d1phka_ 83 TFFFLVFDLMKKGELFDYLTEK----VTLSEKETRKIMRALLEVICALHK---LNIVHRDLKPENILLDDDMNIKLTDFG 155 (277)
T ss_dssp SEEEEEEECCTTCBHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECTTCCEEECCCT
T ss_pred CCEEEEEECCCCCHHHHHHHHC----CCCCHHHHHHHHHHHHHHHHHHHH---CCCCCCCCCCCEEEECCCCCEEECCCH
T ss_conf 6059999768986689999865----999999999999999999999987---599432346254898689983871240
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCCCCC------CCCCCCCCHHHHHHHHHHHHCCCCCCCCCCCCHHHHHHHHHHHH
Q ss_conf 533237888743112455678668224367------67786211899999999999199999988930125699999988
Q 002673 756 LSRLILPYQTHVTTELVGTLGYIPPEYGQA------WVATLRGDMYSFGVVMLELLTGKRPVDVLKPKMSRELVGWVLKM 829 (894)
Q Consensus 756 la~~~~~~~~~~~~~~~gt~~y~APE~~~~------~~~s~ksDVwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~ 829 (894)
+++...... ......||..|+|||++.+ ..++.++||||+||++|+|++|+.||....... ....+.
T Consensus 156 ~a~~~~~~~--~~~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilyeml~g~~Pf~~~~~~~---~~~~i~-- 228 (277)
T d1phka_ 156 FSCQLDPGE--KLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQML---MLRMIM-- 228 (277)
T ss_dssp TCEECCTTC--CBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH---HHHHHH--
T ss_pred HEEECCCCC--CEEEEECCCCCCCHHHHHCCCCCCCCCCCCHHEECCCCHHHHHHCCCCCCCCCCCHHH---HHHHHH--
T ss_conf 316726887--2134524678889888605344567889923318565602310322888988999999---999998--
Q ss_pred HHCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHCCCCCCCCCCHHHHHH--HHHH
Q ss_conf 4149877544520039999699999999998711159999999999999--9982
Q 002673 830 RSEGKQDQVFDPILRGKGFDEEMLQVLDVACMCVSQNPFKRPTVKEVVE--WLNN 882 (894)
Q Consensus 830 ~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~eil~--~L~~ 882 (894)
.+... .. .........++.+++.+||+.||.+|||++|+++ ||++
T Consensus 229 --~~~~~-~~-----~~~~~~~s~~~~~li~~~L~~~p~~R~s~~eil~h~~~~~ 275 (277)
T d1phka_ 229 --SGNYQ-FG-----SPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALAHPFFQQ 275 (277)
T ss_dssp --HTCCC-CC-----TTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTTSGGGCT
T ss_pred --HCCCC-CC-----CCCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHCCHHHHH
T ss_conf --18988-89-----8543468999999999976589668919999973978797
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=332.52 Aligned_cols=262 Identities=24% Similarity=0.351 Sum_probs=209.4
Q ss_pred HCCCCCCCCEEEECCCEEEEEEEEC------CCCEEEEEEECCCC-HHHHHHHHHHHHHHHHCCCCCEEEECCEEEECCE
Q ss_conf 4059876544710283899999984------89848999974851-2659999999999994599824553224310463
Q 002673 605 ATDNFSQANIIGCGGFGLVYKATLA------NGTTLAIKKLSGDL-GLMEREFKAEVEALSTAQHKNLVSLQGYCVHQGF 677 (894)
Q Consensus 605 ~~~~~~~~~~LG~G~fg~Vy~a~~~------~~~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l~Hpniv~l~g~~~~~~~ 677 (894)
..++|+..+.||+|+||.||+|.+. ++..||||++.... ......+.+|+.+++.++||||++++|++.....
T Consensus 18 ~~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~ 97 (308)
T d1p4oa_ 18 AREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQP 97 (308)
T ss_dssp CGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEECSSSS
T ss_pred CHHHEEEEEEEEECCCEEEEEEEECCCCCCCCCCEEEEEEECCCCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEEECCCC
T ss_conf 68991883598207881899999878644778968999998701286899999999999997699988412547842881
Q ss_pred EEEEEEECCCCCHHHHHHHHC------CCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCEEE
Q ss_conf 889998446999889984414------89887579999999999999999988506998364189999857789985999
Q 002673 678 RLLIYSYMENGSLDYWLHEKA------DGASQLDWLTRLKIARGTSCGLAYMHQICEPHIVHRDIKSSNILLDDQFEAHL 751 (894)
Q Consensus 678 ~~lV~E~~~~gsL~~~l~~~~------~~~~~l~~~~~~~i~~~Ia~aL~yLHs~~~~~ivH~DLkp~NILl~~~~~vkL 751 (894)
.++|+||+++|+|.+++.... .....+++..+..++.|++.||.|||+ ++|+||||||+|||++.++.+||
T Consensus 98 ~~lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~---~~ivHrDlk~~NiLld~~~~~Kl 174 (308)
T d1p4oa_ 98 TLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNA---NKFVHRDLAARNCMVAEDFTVKI 174 (308)
T ss_dssp CEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHH---TTCBCSCCSGGGEEECTTCCEEE
T ss_pred EEEEEEECCCCCHHHHHHHCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHH---CCEEECEECCCCEEECCCCEEEE
T ss_conf 067776048998899987503321134446887999999999999999998764---79654328677540359964999
Q ss_pred EECCCCCCCCCCCCC-CCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHCC-CCCCCCCCCCHHHHHHHHHHHH
Q ss_conf 973453323788874-31124556786682243676778621189999999999919-9999988930125699999988
Q 002673 752 ADFGLSRLILPYQTH-VTTELVGTLGYIPPEYGQAWVATLRGDMYSFGVVMLELLTG-KRPVDVLKPKMSRELVGWVLKM 829 (894)
Q Consensus 752 ~DFGla~~~~~~~~~-~~~~~~gt~~y~APE~~~~~~~s~ksDVwSlGvil~elltG-~~Pf~~~~~~~~~~~~~~~~~~ 829 (894)
+|||+++........ ......|++.|+|||.+.+..++.++||||||+++|||+|| ..||........ ...+
T Consensus 175 ~DFGla~~~~~~~~~~~~~~~~~t~~y~aPe~l~~~~~~~~~Dv~S~G~il~El~t~~~~p~~~~~~~~~---~~~i--- 248 (308)
T d1p4oa_ 175 GDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQV---LRFV--- 248 (308)
T ss_dssp CCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCHHHH---HHHH---
T ss_pred EECCCCEECCCCCCEEECCCEECCCCCCCHHHHCCCCCCCCCCCCCHHHHHHHHHHCCCCCCCCCCHHHH---HHHH---
T ss_conf 4245420235776303134023163237888873699883334443789999999689999999899999---9999---
Q ss_pred HHCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHHCCC
Q ss_conf 41498775445200399996999999999987111599999999999999982001
Q 002673 830 RSEGKQDQVFDPILRGKGFDEEMLQVLDVACMCVSQNPFKRPTVKEVVEWLNNVGA 885 (894)
Q Consensus 830 ~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~eil~~L~~i~~ 885 (894)
. .+...... ...+ ..+.+++.+||+.+|++||||.+|++.|++...
T Consensus 249 ~-~~~~~~~p------~~~~---~~l~~li~~cl~~~P~~RPs~~~il~~L~~~~~ 294 (308)
T d1p4oa_ 249 M-EGGLLDKP------DNCP---DMLFELMRMCWQYNPKMRPSFLEIISSIKEEME 294 (308)
T ss_dssp H-TTCCCCCC------TTCC---HHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGSC
T ss_pred H-HCCCCCCC------CCCH---HHHHHHHHHHCCCCHHHCCCHHHHHHHHHHHCC
T ss_conf 8-08888886------3353---999999999757796589399999999787617
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=334.21 Aligned_cols=252 Identities=25% Similarity=0.347 Sum_probs=202.3
Q ss_pred CCCCCCCEEEECCCEEEEEEEE-CCCCEEEEEEECCCC---HHHHHHHHHHHHHHH-HCCCCCEEEECCEEEECCEEEEE
Q ss_conf 5987654471028389999998-489848999974851---265999999999999-45998245532243104638899
Q 002673 607 DNFSQANIIGCGGFGLVYKATL-ANGTTLAIKKLSGDL---GLMEREFKAEVEALS-TAQHKNLVSLQGYCVHQGFRLLI 681 (894)
Q Consensus 607 ~~~~~~~~LG~G~fg~Vy~a~~-~~~~~vavK~~~~~~---~~~~~~~~~Ei~~l~-~l~Hpniv~l~g~~~~~~~~~lV 681 (894)
++|.+.+.||+|+||.||+|.. .+++.||||++.... ......+..|..++. .++|||||++++++.+++..|+|
T Consensus 2 ddy~i~~~iG~G~fg~Vy~~~~~~t~~~vAvK~i~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~~~~~~~yiv 81 (320)
T d1xjda_ 2 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFFV 81 (320)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEE
T ss_pred CCEEEEEEEECCCCCEEEEEEECCCCCEEEEEEECHHHCCCHHHHHHHHHHHHHHHHHCCCCCEEEEEEEECCCCCEEEE
T ss_conf 97188658940878289999999999899999980555338489999999999999847999687898897049831677
Q ss_pred EEECCCCCHHHHHHHHCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCEEEEECCCCCCCC
Q ss_conf 98446999889984414898875799999999999999999885069983641899998577899859999734533237
Q 002673 682 YSYMENGSLDYWLHEKADGASQLDWLTRLKIARGTSCGLAYMHQICEPHIVHRDIKSSNILLDDQFEAHLADFGLSRLIL 761 (894)
Q Consensus 682 ~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~Ia~aL~yLHs~~~~~ivH~DLkp~NILl~~~~~vkL~DFGla~~~~ 761 (894)
|||+++|+|.+++... ..++...+..++.||+.||.|||+ ++++||||||+|||++.++.+||+|||+++...
T Consensus 82 mEy~~~g~L~~~i~~~----~~~~e~~~~~~~~qi~~al~ylH~---~~iiHrDikp~NiL~~~~~~~kl~DFG~a~~~~ 154 (320)
T d1xjda_ 82 MEYLNGGDLMYHIQSC----HKFDLSRATFYAAEIILGLQFLHS---KGIVYRDLKLDNILLDKDGHIKIADFGMCKENM 154 (320)
T ss_dssp EECCTTCBHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCCGGGEEECTTSCEEECCCTTCBCCC
T ss_pred EEECCCCCHHHHHHCC----CCCCHHHHHHHHHHHHHHHHHHHH---CCEEECCCCCCCEEECCCCCEECCCCCHHHHCC
T ss_conf 7503798089986404----789999999999999999999986---893403476540444489963015553023235
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHCCCCCCCCCCCCHHHHHHHHHHHHHHCCCCCCCCCC
Q ss_conf 88874311245567866822436767786211899999999999199999988930125699999988414987754452
Q 002673 762 PYQTHVTTELVGTLGYIPPEYGQAWVATLRGDMYSFGVVMLELLTGKRPVDVLKPKMSRELVGWVLKMRSEGKQDQVFDP 841 (894)
Q Consensus 762 ~~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 841 (894)
... .......||+.|+|||++.+..++.++||||+||++|+|++|+.||...... ....... .+... +.
T Consensus 155 ~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~PF~~~~~~---~~~~~i~----~~~~~--~p- 223 (320)
T d1xjda_ 155 LGD-AKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEE---ELFHSIR----MDNPF--YP- 223 (320)
T ss_dssp CTT-CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH---HHHHHHH----HCCCC--CC-
T ss_pred CCC-CCCCCCCCCCCCCCHHHHCCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCCHH---HHHHHHH----CCCCC--CC-
T ss_conf 665-3345457877768999982799883232011227898987388999998999---9999997----18998--97-
Q ss_pred CCCCCCCHHHHHHHHHHHHHHCCCCCCCCCCHH-HHHH--HHHHC
Q ss_conf 003999969999999999871115999999999-9999--99820
Q 002673 842 ILRGKGFDEEMLQVLDVACMCVSQNPFKRPTVK-EVVE--WLNNV 883 (894)
Q Consensus 842 ~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~-eil~--~L~~i 883 (894)
... ...+.+|+.+||+.||.+|||+. ++++ |++++
T Consensus 224 ----~~~---s~~~~dli~~~L~~dP~~R~s~~~~l~~hpff~~~ 261 (320)
T d1xjda_ 224 ----RWL---EKEAKDLLVKLFVREPEKRLGVRGDIRQHPLFREI 261 (320)
T ss_dssp ----TTS---CHHHHHHHHHHSCSSGGGSBTTBSCGGGSGGGTTC
T ss_pred ----CCC---CHHHHHHHHHHCCCCCCCCCCHHHHHHHCCHHCCC
T ss_conf ----567---99999999996544898783889999809013158
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=329.65 Aligned_cols=270 Identities=23% Similarity=0.287 Sum_probs=204.5
Q ss_pred CCCCCCCEEEECCCEEEEEEEE-CCCCEEEEEEECCCCHH--HHHHHHHHHHHHHHCCCCCEEEECCEEEECCEEEEEEE
Q ss_conf 5987654471028389999998-48984899997485126--59999999999994599824553224310463889998
Q 002673 607 DNFSQANIIGCGGFGLVYKATL-ANGTTLAIKKLSGDLGL--MEREFKAEVEALSTAQHKNLVSLQGYCVHQGFRLLIYS 683 (894)
Q Consensus 607 ~~~~~~~~LG~G~fg~Vy~a~~-~~~~~vavK~~~~~~~~--~~~~~~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~lV~E 683 (894)
++|++.+.||+|+||.||+|.. .+++.||+|++...... ....+.+|+.+++.++|||||++++++.+.+..++|+|
T Consensus 2 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~Hp~Iv~~~~~~~~~~~~~iv~e 81 (298)
T d1gz8a_ 2 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFE 81 (298)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEC-------CCHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred CCCEECCEEECCCCEEEEEEEECCCCCEEEEEEEEHHHCCHHHHHHHHHHHHHHHHCCCCCEEEECCCCCCCCCEEEEEE
T ss_conf 99776517723768099999999999799999980222575899999999999986799838874453322432037886
Q ss_pred ECCCCCHHHHHHHHCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCEEEEECCCCCCCCCC
Q ss_conf 44699988998441489887579999999999999999988506998364189999857789985999973453323788
Q 002673 684 YMENGSLDYWLHEKADGASQLDWLTRLKIARGTSCGLAYMHQICEPHIVHRDIKSSNILLDDQFEAHLADFGLSRLILPY 763 (894)
Q Consensus 684 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~Ia~aL~yLHs~~~~~ivH~DLkp~NILl~~~~~vkL~DFGla~~~~~~ 763 (894)
|+.++ +..++... ....+++..+..++.|++.||.|||+ ++|+||||||+|||++.++.+||+|||.++.....
T Consensus 82 ~~~~~-~~~~~~~~--~~~~l~e~~~~~~~~qil~~L~yLH~---~~IiHrDiKpeNIl~~~~~~~kl~DFG~a~~~~~~ 155 (298)
T d1gz8a_ 82 FLHQD-LKKFMDAS--ALTGIPLPLIKSYLFQLLQGLAFCHS---HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVP 155 (298)
T ss_dssp CCSEE-HHHHHHHT--TTTCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECTTSCEEECSTTHHHHHCCC
T ss_pred ECCCC-HHHHHHHH--CCCCCCHHHHHHHHHHHHHHHHHHHC---CCEECCCCCCHHEEECCCCCCEECCCCCCEECCCC
T ss_conf 23774-45554420--25688889999999999999998652---88992135711401134676210357861343688
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCC-CCCCCCHHHHHHHHHHHHCCCCCCCCCCCCHHHHHHHHHHHHHH--CCCCCCCCC
Q ss_conf 874311245567866822436767-78621189999999999919999998893012569999998841--498775445
Q 002673 764 QTHVTTELVGTLGYIPPEYGQAWV-ATLRGDMYSFGVVMLELLTGKRPVDVLKPKMSRELVGWVLKMRS--EGKQDQVFD 840 (894)
Q Consensus 764 ~~~~~~~~~gt~~y~APE~~~~~~-~s~ksDVwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~~--~~~~~~~~d 840 (894)
. .......|++.|+|||+..... ++.++||||+||++|+|++|+.||........ .......... .........
T Consensus 156 ~-~~~~~~~gt~~y~apE~~~~~~~~~~~~DiwSlGvily~m~~G~~Pf~~~~~~~~--~~~i~~~~~~~~~~~~~~~~~ 232 (298)
T d1gz8a_ 156 V-RTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQ--LFRIFRTLGTPDEVVWPGVTS 232 (298)
T ss_dssp S-BCTTCCBCCCTTCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH--HHHHHHHHCCCCTTTSTTGGG
T ss_pred C-CCCEEECCCCEEEEHHHHCCCCCCCCCCCCCCCCHHHHHHHHCCCCCCCCCHHHH--HHHHHHHCCCCCHHHCCCCCC
T ss_conf 6-4100103652154112213665777422103333134279668799898899999--999998328983331444222
Q ss_pred -----CCC---CCCC----CHHHHHHHHHHHHHHCCCCCCCCCCHHHHHH--HHHHCCC
Q ss_conf -----200---3999----9699999999998711159999999999999--9982001
Q 002673 841 -----PIL---RGKG----FDEEMLQVLDVACMCVSQNPFKRPTVKEVVE--WLNNVGA 885 (894)
Q Consensus 841 -----~~l---~~~~----~~~~~~~l~~li~~Cl~~dP~~RPs~~eil~--~L~~i~~ 885 (894)
... .... .......+.+++.+||+.||.+|||++|+++ |++++..
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~t~~ell~H~ff~~~~~ 291 (298)
T d1gz8a_ 233 MPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTK 291 (298)
T ss_dssp STTCCTTSCCCCCCCHHHHSTTCCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGTTCCC
T ss_pred CCCCCCCCCCCCCCCHHHHCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHCCHHHCCCCC
T ss_conf 42124345432222044416678999999999976399557918999967870146999
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=329.13 Aligned_cols=263 Identities=25% Similarity=0.266 Sum_probs=199.4
Q ss_pred CCCEEEECCCEEEEEEEE-CCCCEEEEEEECCCCHHH-----HHHHHHHHHHHHHCCCCCEEEECCEEEECCEEEEEEEE
Q ss_conf 654471028389999998-489848999974851265-----99999999999945998245532243104638899984
Q 002673 611 QANIIGCGGFGLVYKATL-ANGTTLAIKKLSGDLGLM-----EREFKAEVEALSTAQHKNLVSLQGYCVHQGFRLLIYSY 684 (894)
Q Consensus 611 ~~~~LG~G~fg~Vy~a~~-~~~~~vavK~~~~~~~~~-----~~~~~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~lV~E~ 684 (894)
..++||+|+||.||+|.. .+++.||||++....... .+.+.+|+.+++.++|||||++++++.+++..++||||
T Consensus 2 ~l~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~~~~~~~~~ivmE~ 81 (299)
T d1ua2a_ 2 KLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNISLVFDF 81 (299)
T ss_dssp EEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCCEEEEEC
T ss_pred CCEEECCCCCEEEEEEEECCCCCEEEEEEEEHHHHHHHHHHHHHHHHHHHHHHHHCCCCCEEEEEEEECCCCCEEEHHHH
T ss_conf 56385127282999999999996999999842021245679999999999999867999986898542258740220455
Q ss_pred CCCCCHHHHHHHHCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCEEEEECCCCCCCCCCC
Q ss_conf 46999889984414898875799999999999999999885069983641899998577899859999734533237888
Q 002673 685 MENGSLDYWLHEKADGASQLDWLTRLKIARGTSCGLAYMHQICEPHIVHRDIKSSNILLDDQFEAHLADFGLSRLILPYQ 764 (894)
Q Consensus 685 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~Ia~aL~yLHs~~~~~ivH~DLkp~NILl~~~~~vkL~DFGla~~~~~~~ 764 (894)
+.++++..+... ...+++..+..++.||+.||.|||+ ++++||||||+|||++.++.+||+|||+++......
T Consensus 82 ~~~~~~~~~~~~----~~~l~~~~~~~~~~qil~aL~~lH~---~~iiHrDiKp~NIli~~~~~~KL~DFG~a~~~~~~~ 154 (299)
T d1ua2a_ 82 METDLEVIIKDN----SLVLTPSHIKAYMLMTLQGLEYLHQ---HWILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPN 154 (299)
T ss_dssp CSEEHHHHHTTC----CSSCCSSHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTCCEEECCCGGGSTTTSCC
T ss_pred HCCHHHHHHHHC----CCCCCHHHHHHHHHHHHHHHHHHHC---CCEECCCCCCCEEEECCCCCCCCCCCCCCCCCCCCC
T ss_conf 345077655412----6677899999999999999988631---635503577625885377841146576100057875
Q ss_pred CCCCCCCCCCCCCCCCCCCCCC-CCCCCCCHHHHHHHHHHHHCCCCCCCCCCCCHHHHHHHHHHHHHHCCCCCCCCCC--
Q ss_conf 7431124556786682243676-7786211899999999999199999988930125699999988414987754452--
Q 002673 765 THVTTELVGTLGYIPPEYGQAW-VATLRGDMYSFGVVMLELLTGKRPVDVLKPKMSRELVGWVLKMRSEGKQDQVFDP-- 841 (894)
Q Consensus 765 ~~~~~~~~gt~~y~APE~~~~~-~~s~ksDVwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~-- 841 (894)
......+||+.|+|||++... .++.++||||+||++|||++|+.||...... +..................+.
T Consensus 155 -~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~---~~l~~i~~~~~~~~~~~~~~~~~ 230 (299)
T d1ua2a_ 155 -RAYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDL---DQLTRIFETLGTPTEEQWPDMCS 230 (299)
T ss_dssp -CCCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHH---HHHHHHHHHHCCCCTTTSSSTTS
T ss_pred -CCCCCEECCHHHCCHHHHCCCCCCCHHHHHHHCCHHHHHHHHCCCCCCCCCHH---HHHHHHHHHCCCCCHHHCCCHHC
T ss_conf -54330204733363999726778880564363042899998596999999999---99999998518997254521000
Q ss_pred --------CCCCCC----CHHHHHHHHHHHHHHCCCCCCCCCCHHHHHH--HHHHCC
Q ss_conf --------003999----9699999999998711159999999999999--998200
Q 002673 842 --------ILRGKG----FDEEMLQVLDVACMCVSQNPFKRPTVKEVVE--WLNNVG 884 (894)
Q Consensus 842 --------~l~~~~----~~~~~~~l~~li~~Cl~~dP~~RPs~~eil~--~L~~i~ 884 (894)
...... .+.....+.+|+.+||+.||++|||++|+++ ||++..
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~dP~~R~sa~e~L~Hp~f~~~p 287 (299)
T d1ua2a_ 231 LPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMKYFSNRP 287 (299)
T ss_dssp STTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTSGGGTSSS
T ss_pred CCHHHHHCCCCCCCHHHHCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHCCHHHCCCC
T ss_conf 213443034789886785656899999999997638945690899996799657899
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=328.21 Aligned_cols=275 Identities=23% Similarity=0.269 Sum_probs=200.7
Q ss_pred CCCCCCCCEEEECCCEEEEEEEE-CC-CCEEEEEEECCCCHH--HHHHHHHHHHHHHHC---CCCCEEEECCEEEE----
Q ss_conf 05987654471028389999998-48-984899997485126--599999999999945---99824553224310----
Q 002673 606 TDNFSQANIIGCGGFGLVYKATL-AN-GTTLAIKKLSGDLGL--MEREFKAEVEALSTA---QHKNLVSLQGYCVH---- 674 (894)
Q Consensus 606 ~~~~~~~~~LG~G~fg~Vy~a~~-~~-~~~vavK~~~~~~~~--~~~~~~~Ei~~l~~l---~Hpniv~l~g~~~~---- 674 (894)
.++|++.+.||+|+||.||+|.. .+ ++.||||++...... ....+.+|+.+++.+ +||||+++++++..
T Consensus 6 ~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~~~~~ 85 (305)
T d1blxa_ 6 DQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTD 85 (305)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEECS
T ss_pred CCCEEEEEEEECCCCEEEEEEEEECCCCEEEEEEEEEHHHCCCHHHHHHHHHHHHHHHHHHCCCCCCCEEEEEECCCCCC
T ss_conf 58979888992155869999999888998999999802324516799999999999987425898802366322146666
Q ss_pred -CCEEEEEEEECCCCCHHHHHHHHCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCEEEEE
Q ss_conf -4638899984469998899844148988757999999999999999998850699836418999985778998599997
Q 002673 675 -QGFRLLIYSYMENGSLDYWLHEKADGASQLDWLTRLKIARGTSCGLAYMHQICEPHIVHRDIKSSNILLDDQFEAHLAD 753 (894)
Q Consensus 675 -~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~Ia~aL~yLHs~~~~~ivH~DLkp~NILl~~~~~vkL~D 753 (894)
....++++||++++.+....... ...+++..+..++.|++.||.|||+ ++|+||||||+|||++.++.+||+|
T Consensus 86 ~~~~~~~~~e~~~~~~~~~~~~~~---~~~~~~~~~~~~~~qi~~aL~yLH~---~~ivHrDiKp~NILi~~~~~~kl~d 159 (305)
T d1blxa_ 86 RETKLTLVFEHVDQDLTTYLDKVP---EPGVPTETIKDMMFQLLRGLDFLHS---HRVVHRDLKPQNILVTSSGQIKLAD 159 (305)
T ss_dssp SEEEEEEEEECCSCBHHHHHHHSC---TTCSCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTCCEEECS
T ss_pred CCCEEEEEEEECCCCCHHHHHHCC---CCCCCHHHHHHHHHHHHHHHHHHHH---CCEEECCCCCCEEEECCCCCEEECC
T ss_conf 674699999740587144444303---7899989999999999999999975---8898357986278985899754210
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHCCCCCCCCCCCCHHHHHHHHHHHHHHCC
Q ss_conf 34533237888743112455678668224367677862118999999999991999999889301256999999884149
Q 002673 754 FGLSRLILPYQTHVTTELVGTLGYIPPEYGQAWVATLRGDMYSFGVVMLELLTGKRPVDVLKPKMSRELVGWVLKMRSEG 833 (894)
Q Consensus 754 FGla~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~ 833 (894)
||++..... ........||+.|+|||++.+..|+.++||||+||++|||++|+.||...........+..........
T Consensus 160 fg~~~~~~~--~~~~~~~~gT~~Y~APE~~~~~~y~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~ 237 (305)
T d1blxa_ 160 FGLARIYSF--QMALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEE 237 (305)
T ss_dssp CCSCCCCCG--GGGGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCGG
T ss_pred HHHHHHHCC--CCCCCCCCCCHHHCCCCHHCCCCCCHHEHHHCHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHHCCCCHH
T ss_conf 001011002--345777654851148310017988811100032899999987879989989899999999840799611
Q ss_pred CCC-CCC--CCCC-------CCCCCHHHHHHHHHHHHHHCCCCCCCCCCHHHHHH--HHHHCCCCCC
Q ss_conf 877-544--5200-------39999699999999998711159999999999999--9982001344
Q 002673 834 KQD-QVF--DPIL-------RGKGFDEEMLQVLDVACMCVSQNPFKRPTVKEVVE--WLNNVGANRR 888 (894)
Q Consensus 834 ~~~-~~~--d~~l-------~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~eil~--~L~~i~~~~~ 888 (894)
... ... .... ...........+.+|+.+||+.||++|||++|+++ ||+++...+.
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~sa~e~L~Hpff~~i~~~ke 304 (305)
T d1blxa_ 238 DWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYFQDLERCKE 304 (305)
T ss_dssp GSCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGTTCCCCCC
T ss_pred CCCCCCCCHHHHHCCCCCCCHHHCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHCCHHHCCCHHHCC
T ss_conf 0532111103330223456454404458999999999987489667918999966963407521078
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Probab=100.00 E-value=0 Score=325.63 Aligned_cols=267 Identities=22% Similarity=0.286 Sum_probs=204.0
Q ss_pred CCCCCCCEEEECCCEEEEEEEECCCCEEEEEEECCCCHH--HHHHHHHHHHHHHHCCCCCEEEECCEEEECCEEEEEEEE
Q ss_conf 598765447102838999999848984899997485126--599999999999945998245532243104638899984
Q 002673 607 DNFSQANIIGCGGFGLVYKATLANGTTLAIKKLSGDLGL--MEREFKAEVEALSTAQHKNLVSLQGYCVHQGFRLLIYSY 684 (894)
Q Consensus 607 ~~~~~~~~LG~G~fg~Vy~a~~~~~~~vavK~~~~~~~~--~~~~~~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~lV~E~ 684 (894)
++|+..+.||+|+||.||+|.+++++.||||++...... ..+.+.+|+.+++.++||||+++++++.+.+..++++|+
T Consensus 2 ~~Y~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~i~~e~ 81 (286)
T d1ob3a_ 2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEH 81 (286)
T ss_dssp CSEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred CCCEECCEEECCCCCEEEEEEECCCCEEEEEEEEHHHCCHHHHHHHHHHHHHHHHCCCCCEEEEEEECCCCCCEEEEEEE
T ss_conf 99634318722778189999968999999999812326858999999999999867998687660120467731589974
Q ss_pred CCCCCHHHHHHHHCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCEEEEECCCCCCCCCCC
Q ss_conf 46999889984414898875799999999999999999885069983641899998577899859999734533237888
Q 002673 685 MENGSLDYWLHEKADGASQLDWLTRLKIARGTSCGLAYMHQICEPHIVHRDIKSSNILLDDQFEAHLADFGLSRLILPYQ 764 (894)
Q Consensus 685 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~Ia~aL~yLHs~~~~~ivH~DLkp~NILl~~~~~vkL~DFGla~~~~~~~ 764 (894)
+.++.+..+.... ..++...+..++.||+.||.|||+ .+|+||||||+|||++.++.+|++|||.+.......
T Consensus 82 ~~~~~~~~~~~~~----~~l~~~~~~~i~~qi~~~L~~LH~---~~IvHrDiKp~NIll~~~~~~kl~DfG~a~~~~~~~ 154 (286)
T d1ob3a_ 82 LDQDLKKLLDVCE----GGLESVTAKSFLLQLLNGIAYCHD---RRVLHRDLKPQNLLINREGELKIADFGLARAFGIPV 154 (286)
T ss_dssp CSEEHHHHHHTST----TCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC--
T ss_pred EHHHHHHHHHHHC----CCCCHHHHHHHHHHHHHHHHHHCC---CCEEECCCCCCEEEECCCCCEEECCCCCCEECCCCC
T ss_conf 0045678998604----775144568999999999998605---748826787750568689978732366430114676
Q ss_pred CCCCCCCCCCCCCCCCCCCCCC-CCCCCCCHHHHHHHHHHHHCCCCCCCCCCCCHHHHHHHHHHHHHHCCCCCCC-----
Q ss_conf 7431124556786682243676-7786211899999999999199999988930125699999988414987754-----
Q 002673 765 THVTTELVGTLGYIPPEYGQAW-VATLRGDMYSFGVVMLELLTGKRPVDVLKPKMSRELVGWVLKMRSEGKQDQV----- 838 (894)
Q Consensus 765 ~~~~~~~~gt~~y~APE~~~~~-~~s~ksDVwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~----- 838 (894)
.......+++.|+|||.+.+. .++.++||||+||++|||++|+.||...........+...............
T Consensus 155 -~~~~~~~~~~~y~~pE~~~~~~~~~~~~DiwslGv~l~el~~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 233 (286)
T d1ob3a_ 155 -RKYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPK 233 (286)
T ss_dssp --------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTT
T ss_pred -CCCCEECCCCHHHHHHHHHCCCCCCCCEEEHHCCCHHHHHHHCCCCCCCCCHHHHHHHHHHHHCCCCHHHCCCHHHHHH
T ss_conf -5410102431101378871788888410021117589999779799898898999999998638997110421233322
Q ss_pred ----C---CCCCCCCCCHHHHHHHHHHHHHHCCCCCCCCCCHHHHHH--HHH
Q ss_conf ----4---520039999699999999998711159999999999999--998
Q 002673 839 ----F---DPILRGKGFDEEMLQVLDVACMCVSQNPFKRPTVKEVVE--WLN 881 (894)
Q Consensus 839 ----~---d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~eil~--~L~ 881 (894)
. .+.............+.+++.+||+.||++|||++|+++ |++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~s~~ell~Hp~f~ 285 (286)
T d1ob3a_ 234 YDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEHAYFK 285 (286)
T ss_dssp CCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGG
T ss_pred CCCCCCCCCCCCHHHHCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHCCCCCC
T ss_conf 1433333567646665125899999999998668966890999985692207
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=322.75 Aligned_cols=268 Identities=23% Similarity=0.238 Sum_probs=196.7
Q ss_pred CCCCCCEEEECCCEEEEEEEE-CCCCEEEEEEECCCCHHHHHHHHHHHHHHHHCCCCCEEEECCEEEEC------CEEEE
Q ss_conf 987654471028389999998-48984899997485126599999999999945998245532243104------63889
Q 002673 608 NFSQANIIGCGGFGLVYKATL-ANGTTLAIKKLSGDLGLMEREFKAEVEALSTAQHKNLVSLQGYCVHQ------GFRLL 680 (894)
Q Consensus 608 ~~~~~~~LG~G~fg~Vy~a~~-~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~Hpniv~l~g~~~~~------~~~~l 680 (894)
+|+..++||+|+||+||+|++ .+++.||||++..... ...+|+.+++.++||||+++++++... ...++
T Consensus 21 ~Y~~~k~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~----~~~~Ei~il~~l~h~niv~~~~~~~~~~~~~~~~~~~l 96 (350)
T d1q5ka_ 21 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR----FKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNL 96 (350)
T ss_dssp EEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSS----SCCHHHHHHHHCCCTTBCCEEEEEEEC--CCSCCEEEE
T ss_pred CCEEEEEEEECCCEEEEEEEECCCCCEEEEEEECCCCH----HHHHHHHHHHHCCCCCCCCEEEEEEECCCCCCCEEEEE
T ss_conf 76751698217683999999999997999999881606----89999999986689898738789974476577318999
Q ss_pred EEEECCCCCHHHHHHHHCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCC-CEEEEECCCCCC
Q ss_conf 9984469998899844148988757999999999999999998850699836418999985778998-599997345332
Q 002673 681 IYSYMENGSLDYWLHEKADGASQLDWLTRLKIARGTSCGLAYMHQICEPHIVHRDIKSSNILLDDQF-EAHLADFGLSRL 759 (894)
Q Consensus 681 V~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~Ia~aL~yLHs~~~~~ivH~DLkp~NILl~~~~-~vkL~DFGla~~ 759 (894)
||||++++. ...+.........+++..+..++.||+.||.|||+ ++|+||||||+|||++.++ .+||+|||+++.
T Consensus 97 v~Ey~~~~~-~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~yLH~---~~IiHrDiKp~NILl~~~~~~~kl~DFG~a~~ 172 (350)
T d1q5ka_ 97 VLDYVPETV-YRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHS---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQ 172 (350)
T ss_dssp EEECCSEEH-HHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHT---TTEECCCCCGGGEEECTTTCCEEECCCTTCEE
T ss_pred EEECCCCCC-HHHHHHHHHCCCCCCHHHHHHHHHHHHHHHHHHHH---CCCCCCCCCCCEEEEECCCCCEEEECCCCHHH
T ss_conf 984168860-78888631036899999999999999999999986---68764578860378735897116733660544
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCC-CCCCCCCCHHHHHHHHHHHHCCCCCCCCCCCCHHHHHHHH---------HHHH
Q ss_conf 37888743112455678668224367-6778621189999999999919999998893012569999---------9988
Q 002673 760 ILPYQTHVTTELVGTLGYIPPEYGQA-WVATLRGDMYSFGVVMLELLTGKRPVDVLKPKMSRELVGW---------VLKM 829 (894)
Q Consensus 760 ~~~~~~~~~~~~~gt~~y~APE~~~~-~~~s~ksDVwSlGvil~elltG~~Pf~~~~~~~~~~~~~~---------~~~~ 829 (894)
..... ......|+..|+|||.+.+ ..++.++||||+||++|||++|+.||...........+.. ....
T Consensus 173 ~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~DIwSlG~il~el~~g~~pf~~~~~~~~l~~i~~~~g~~~~~~~~~~ 250 (350)
T d1q5ka_ 173 LVRGE--PNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREM 250 (350)
T ss_dssp CCTTS--CCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHH
T ss_pred CCCCC--CCCCCCCCCCCCCHHHHHCCCCCCCCEEECCCCEEEEEHHHCCCCCCCCCHHHHHHHHHHHHCCCHHHHHHHH
T ss_conf 04776--5320025555568277640468882100024652778550287998987999999999997489817765430
Q ss_pred HH---CCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHCCCCCCCCCCHHHHHH--HHHHCCC
Q ss_conf 41---49877544520039999699999999998711159999999999999--9982001
Q 002673 830 RS---EGKQDQVFDPILRGKGFDEEMLQVLDVACMCVSQNPFKRPTVKEVVE--WLNNVGA 885 (894)
Q Consensus 830 ~~---~~~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~eil~--~L~~i~~ 885 (894)
.. ......................++.+|+.+||+.||.+|||+.|+++ |+++++.
T Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~f~~~~~ 311 (350)
T d1q5ka_ 251 NPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDELRD 311 (350)
T ss_dssp CC---CCCCCCCCCCCGGGTSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGGGGGC
T ss_pred CCCHHHCCCCCCCCCCHHHHCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHCCHHHCCCCC
T ss_conf 6210110355445674444315689999999999976589557929999966984524667
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=316.83 Aligned_cols=266 Identities=21% Similarity=0.269 Sum_probs=202.4
Q ss_pred CCCCCCCCEEEECCCEEEEEEEE-CCCCEEEEEEECCCC--HHHHHHHHHHHHHHHHCCCCCEEEECCEEEECC------
Q ss_conf 05987654471028389999998-489848999974851--265999999999999459982455322431046------
Q 002673 606 TDNFSQANIIGCGGFGLVYKATL-ANGTTLAIKKLSGDL--GLMEREFKAEVEALSTAQHKNLVSLQGYCVHQG------ 676 (894)
Q Consensus 606 ~~~~~~~~~LG~G~fg~Vy~a~~-~~~~~vavK~~~~~~--~~~~~~~~~Ei~~l~~l~Hpniv~l~g~~~~~~------ 676 (894)
.++|++.+.||+|+||.||+|.. .+++.||||++.... ....+.+.+|+.+|+.++|||||++++++...+
T Consensus 17 ~~~Y~~i~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~hpniv~l~~~~~~~~~~~~~~ 96 (346)
T d1cm8a_ 17 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFT 96 (346)
T ss_dssp BSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCC
T ss_pred CCCEEEEEEEECCCCEEEEEEEECCCCCEEEEEEECHHHCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEECCCCCCCCCC
T ss_conf 77189988980177819999999999989999998522259699999999999998668987547999863576555541
Q ss_pred EEEEEEEECCCCCHHHHHHHHCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCEEEEECCC
Q ss_conf 38899984469998899844148988757999999999999999998850699836418999985778998599997345
Q 002673 677 FRLLIYSYMENGSLDYWLHEKADGASQLDWLTRLKIARGTSCGLAYMHQICEPHIVHRDIKSSNILLDDQFEAHLADFGL 756 (894)
Q Consensus 677 ~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~Ia~aL~yLHs~~~~~ivH~DLkp~NILl~~~~~vkL~DFGl 756 (894)
..++||||+ +++|..+.+. ..+++..+..++.|++.||.|||+ ++|+||||||+|||++.++.+|++|||+
T Consensus 97 ~~~lv~e~~-~~~l~~~~~~-----~~l~~~~~~~~~~qi~~aL~~LH~---~~IiHrDiKp~NIL~~~~~~~kl~Dfg~ 167 (346)
T d1cm8a_ 97 DFYLVMPFM-GTDLGKLMKH-----EKLGEDRIQFLVYQMLKGLRYIHA---AGIIHRDLKPGNLAVNEDCELKILDFGL 167 (346)
T ss_dssp CCEEEEECC-SEEHHHHHHH-----CCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECTTCCEEECCCTT
T ss_pred EEEEEEECC-CCCHHHHHHH-----CCCCHHHHHHHHHHHHHHHHHHHH---CCCCCCCCCCCHHHCCCCCCCCCCCCCC
T ss_conf 599998405-5218999874-----022699999999999999999873---7876456685111121001221134310
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCCCCC-CCCCCCCHHHHHHHHHHHHCCCCCCCCCCCCHHHHHHHHHHHH-----H
Q ss_conf 332378887431124556786682243676-7786211899999999999199999988930125699999988-----4
Q 002673 757 SRLILPYQTHVTTELVGTLGYIPPEYGQAW-VATLRGDMYSFGVVMLELLTGKRPVDVLKPKMSRELVGWVLKM-----R 830 (894)
Q Consensus 757 a~~~~~~~~~~~~~~~gt~~y~APE~~~~~-~~s~ksDVwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~-----~ 830 (894)
++.... ......|++.|+|||++.+. .++.++||||+||++|+|++|+.||.................. .
T Consensus 168 a~~~~~----~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 243 (346)
T d1cm8a_ 168 ARQADS----EMTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFV 243 (346)
T ss_dssp CEECCS----SCCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHH
T ss_pred EECCCC----CCCCCCCCCCCCCHHHHCCCCCCCCCCHHHCCHHHHHHHHHCCCCCCCCCHHHHHHHHHHCCCCCCHHHH
T ss_conf 220687----6310245533358899817878996501030038999999786998889768999999850378848888
Q ss_pred HCCC----------CCCCCCCCCCCCCCHHHHHHHHHHHHHHCCCCCCCCCCHHHHHH--HHHHCCC
Q ss_conf 1498----------77544520039999699999999998711159999999999999--9982001
Q 002673 831 SEGK----------QDQVFDPILRGKGFDEEMLQVLDVACMCVSQNPFKRPTVKEVVE--WLNNVGA 885 (894)
Q Consensus 831 ~~~~----------~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~eil~--~L~~i~~ 885 (894)
.... ........+. .........+.+|+.+||+.||.+|||++|+++ ||+++..
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~s~~~~dli~~mL~~dP~~R~ta~eiL~Hp~f~~~~~ 309 (346)
T d1cm8a_ 244 QRLQSDEAKNYMKGLPELEKKDFA-SILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESLHD 309 (346)
T ss_dssp HTCSCHHHHHHHHHSCCCCCCCGG-GTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTTC-
T ss_pred HHHCCHHHHHHHCCCCCCCCCCHH-HHCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHCCHHHCCCCC
T ss_conf 653000344331157866655667-755689999999999977299557929999963962375877
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=317.49 Aligned_cols=268 Identities=23% Similarity=0.272 Sum_probs=201.6
Q ss_pred CCCCCCCCEEEECCCEEEEEEEE-CCCCEEEEEEECCCC-HHHHHHHHHHHHHHHHCCCCCEEEECCEEEECC----EEE
Q ss_conf 05987654471028389999998-489848999974851-265999999999999459982455322431046----388
Q 002673 606 TDNFSQANIIGCGGFGLVYKATL-ANGTTLAIKKLSGDL-GLMEREFKAEVEALSTAQHKNLVSLQGYCVHQG----FRL 679 (894)
Q Consensus 606 ~~~~~~~~~LG~G~fg~Vy~a~~-~~~~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l~Hpniv~l~g~~~~~~----~~~ 679 (894)
.++|++.+.||+|+||.||+|.. .+++.||||++.... ....+.+.+|+.+|+.++|||++++++++.... ..+
T Consensus 7 ~~rY~~~~~LG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~hp~iv~~~~~~~~~~~~~~~~~ 86 (345)
T d1pmea_ 7 GPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDV 86 (345)
T ss_dssp CTTEEEEEECC---CCCEEEEEETTTCSEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCE
T ss_pred CCCEEEEEEEEECCCEEEEEEEECCCCCEEEEEEEEHHCCHHHHHHHHHHHHHHHHCCCCCCCCEEEEEEECCCCCCCEE
T ss_conf 89859978994064809999999999949999998031095899999999999997689898858889950564554149
Q ss_pred EEEEECCCCCHHHHHHHHCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCEEEEECCCCCC
Q ss_conf 99984469998899844148988757999999999999999998850699836418999985778998599997345332
Q 002673 680 LIYSYMENGSLDYWLHEKADGASQLDWLTRLKIARGTSCGLAYMHQICEPHIVHRDIKSSNILLDDQFEAHLADFGLSRL 759 (894)
Q Consensus 680 lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~Ia~aL~yLHs~~~~~ivH~DLkp~NILl~~~~~vkL~DFGla~~ 759 (894)
++++++.+|+|.+++... .+++..+..++.|++.||.|||+ ++|+||||||+|||++.++.+||+|||++..
T Consensus 87 ~l~~~~~~g~L~~~l~~~-----~l~~~~i~~i~~qil~al~yLH~---~~iiHRDIKp~NILl~~~~~~kl~DfG~a~~ 158 (345)
T d1pmea_ 87 YLVTHLMGADLYKLLKTQ-----HLSNDHICYFLYQILRGLKYIHS---ANVLHRDLKPSNLLLNTTCDLKICDFGLARV 158 (345)
T ss_dssp EEEEECCCEEHHHHHHHC-----CCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECTTCCEEECCCTTCEE
T ss_pred EEEEEECCCCHHHHHHCC-----CCCHHHHHHHHHHHHHHHHHHHH---CCCCCCCCCCCEEEECCCCCEEECCCCCEEE
T ss_conf 999962598656644058-----99999999999999999999997---8986777876437887999778754570565
Q ss_pred CCCCCC--CCCCCCCCCCCCCCCCCCCC-CCCCCCCCHHHHHHHHHHHHCCCCCCCCCCCCHHHHHHHHHHHHHHCCCCC
Q ss_conf 378887--43112455678668224367-677862118999999999991999999889301256999999884149877
Q 002673 760 ILPYQT--HVTTELVGTLGYIPPEYGQA-WVATLRGDMYSFGVVMLELLTGKRPVDVLKPKMSRELVGWVLKMRSEGKQD 836 (894)
Q Consensus 760 ~~~~~~--~~~~~~~gt~~y~APE~~~~-~~~s~ksDVwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~ 836 (894)
...... ......+|++.|+|||++.. ..++.++||||+|+++|+|++|+.||................ ......
T Consensus 159 ~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~eml~g~~pf~~~~~~~~~~~~~~~~---~~~~~~ 235 (345)
T d1pmea_ 159 ADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGIL---GSPSQE 235 (345)
T ss_dssp CCGGGCBCCTTCCCCSCGGGCCGGGTTTBCSCSTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHH---CSCCHH
T ss_pred CCCCCCCCEEECCCCCCCEECHHHHHHCCCCCCCHHHHHCCCCEEHHHHHCCCCCCCCCHHHHHHHHHHHC---CCCCHH
T ss_conf 04777641010110265200038786047888741010046701337766979978888899999876520---699756
Q ss_pred CC-------------CCCCCCCC----CCHHHHHHHHHHHHHHCCCCCCCCCCHHHHHH--HHHHCC
Q ss_conf 54-------------45200399----99699999999998711159999999999999--998200
Q 002673 837 QV-------------FDPILRGK----GFDEEMLQVLDVACMCVSQNPFKRPTVKEVVE--WLNNVG 884 (894)
Q Consensus 837 ~~-------------~d~~l~~~----~~~~~~~~l~~li~~Cl~~dP~~RPs~~eil~--~L~~i~ 884 (894)
.. ..+..... .......++.+++.+||+.||.+|||++++++ ||+...
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~ta~e~L~hpf~~~~~ 302 (345)
T d1pmea_ 236 DLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYY 302 (345)
T ss_dssp HHHTCCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGTTTC
T ss_pred HHHHHHHHHHHCCCCCCCCCCCCCHHHHCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHCCHHHCCCC
T ss_conf 6423433222202446775577877783789999999999997648956790899986198655588
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=323.22 Aligned_cols=245 Identities=24% Similarity=0.379 Sum_probs=197.2
Q ss_pred CCCCCCCEEEECCCEEEEEEEE-CCCCEEEEEEECCCCHH------HHHHHHHHHHHHHHCC--CCCEEEECCEEEECCE
Q ss_conf 5987654471028389999998-48984899997485126------5999999999999459--9824553224310463
Q 002673 607 DNFSQANIIGCGGFGLVYKATL-ANGTTLAIKKLSGDLGL------MEREFKAEVEALSTAQ--HKNLVSLQGYCVHQGF 677 (894)
Q Consensus 607 ~~~~~~~~LG~G~fg~Vy~a~~-~~~~~vavK~~~~~~~~------~~~~~~~Ei~~l~~l~--Hpniv~l~g~~~~~~~ 677 (894)
++|++.+.||+|+||.||+|+. .++..||||++...... ....+.+|+.+++.++ |||||++++++.+.+.
T Consensus 4 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~~~~~~~~ 83 (273)
T d1xwsa_ 4 SQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDS 83 (273)
T ss_dssp TTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECSSE
T ss_pred CEEEEEEEEEECCCEEEEEEEECCCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCEEEEEEEECCE
T ss_conf 83799679840878399999999999799999985688443345567999999999999743589881279999830996
Q ss_pred EEEEEEECCC-CCHHHHHHHHCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECC-CCCEEEEECC
Q ss_conf 8899984469-9988998441489887579999999999999999988506998364189999857789-9859999734
Q 002673 678 RLLIYSYMEN-GSLDYWLHEKADGASQLDWLTRLKIARGTSCGLAYMHQICEPHIVHRDIKSSNILLDD-QFEAHLADFG 755 (894)
Q Consensus 678 ~~lV~E~~~~-gsL~~~l~~~~~~~~~l~~~~~~~i~~~Ia~aL~yLHs~~~~~ivH~DLkp~NILl~~-~~~vkL~DFG 755 (894)
.++|+||+.+ +++.+++... ..+++..+..++.|++.||.|||+ ++|+||||||+|||++. ++.+||+|||
T Consensus 84 ~~lv~e~~~~~~~l~~~~~~~----~~l~e~~~~~~~~qi~~al~~lH~---~~iiHrDiKp~NIll~~~~~~vkl~DFG 156 (273)
T d1xwsa_ 84 FVLILERPEPVQDLFDFITER----GALQEELARSFFWQVLEAVRHCHN---CGVLHRDIKDENILIDLNRGELKLIDFG 156 (273)
T ss_dssp EEEEEECCSSEEEHHHHHHHH----CSCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEEETTTTEEEECCCT
T ss_pred EEEEEEECCCCCHHHHHHHCC----CCCCHHHHHHHHHHHHHHHHHHHH---CCCCCCCCCCCCEEEECCCCEEEECCCC
T ss_conf 899998336862289998615----899999999999999999999987---7975566761114774478848977546
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCC-CCCCCHHHHHHHHHHHHCCCCCCCCCCCCHHHHHHHHHHHHHHCCC
Q ss_conf 533237888743112455678668224367677-8621189999999999919999998893012569999998841498
Q 002673 756 LSRLILPYQTHVTTELVGTLGYIPPEYGQAWVA-TLRGDMYSFGVVMLELLTGKRPVDVLKPKMSRELVGWVLKMRSEGK 834 (894)
Q Consensus 756 la~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~-s~ksDVwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~ 834 (894)
+++.... .......||+.|+|||++.+..+ +.++||||+||++|||++|+.||.... ... .....
T Consensus 157 ~a~~~~~---~~~~~~~GT~~y~aPE~~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~-----~i~------~~~~~ 222 (273)
T d1xwsa_ 157 SGALLKD---TVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE-----EII------RGQVF 222 (273)
T ss_dssp TCEECCS---SCBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH-----HHH------HCCCC
T ss_pred CCEECCC---CCCCCCCCCCCCCCHHHHCCCCCCCCCCCCCCCEEEEHHHHHCCCCCCCCH-----HHH------HCCCC
T ss_conf 5353244---455665658774799998489978865332554034536756889988736-----776------15447
Q ss_pred CCCCCCCCCCCCCCHHHHHHHHHHHHHHCCCCCCCCCCHHHHHH--HHHHCC
Q ss_conf 77544520039999699999999998711159999999999999--998200
Q 002673 835 QDQVFDPILRGKGFDEEMLQVLDVACMCVSQNPFKRPTVKEVVE--WLNNVG 884 (894)
Q Consensus 835 ~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~eil~--~L~~i~ 884 (894)
+. ...+ .++.+++.+||+.||++|||++|+++ |++++.
T Consensus 223 ----~~-----~~~s---~~~~~li~~~L~~dp~~R~s~~eil~hp~~~~~~ 262 (273)
T d1xwsa_ 223 ----FR-----QRVS---SECQHLIRWCLALRPSDRPTFEEIQNHPWMQDVL 262 (273)
T ss_dssp ----CS-----SCCC---HHHHHHHHHHTCSSGGGSCCHHHHHTSGGGSSCC
T ss_pred ----CC-----CCCC---HHHHHHHHHHCCCCHHHCCCHHHHHCCHHHCCCC
T ss_conf ----78-----7799---9999999997608975893999985398667887
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=315.23 Aligned_cols=270 Identities=22% Similarity=0.275 Sum_probs=200.9
Q ss_pred CCCCCCCCEEEECCCEEEEEEEE-CCCCEEEEEEECCCC--HHHHHHHHHHHHHHHHCCCCCEEEECCEEEE--------
Q ss_conf 05987654471028389999998-489848999974851--2659999999999994599824553224310--------
Q 002673 606 TDNFSQANIIGCGGFGLVYKATL-ANGTTLAIKKLSGDL--GLMEREFKAEVEALSTAQHKNLVSLQGYCVH-------- 674 (894)
Q Consensus 606 ~~~~~~~~~LG~G~fg~Vy~a~~-~~~~~vavK~~~~~~--~~~~~~~~~Ei~~l~~l~Hpniv~l~g~~~~-------- 674 (894)
.++|++.+.||+|+||.||+|+. .+++.||||++.... ......+.+|+.+|+.++|||++++++++..
T Consensus 9 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~nii~~~~~~~~~~~~~~~~ 88 (318)
T d3blha1 9 VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRC 88 (318)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEC----CTTSSCHHHHHHHHHHHHCCCTTBCCEEEEEEC--------
T ss_pred CCCEEEEEEEECCCCEEEEEEEECCCCCEEEEEEEEHHHCCHHHHHHHHHHHHHHHHHCCCCCCCEEEEEECCCCCCCCC
T ss_conf 27988999972274829999999899979999998422246378999999999999835999660676540246544445
Q ss_pred CCEEEEEEEECCCCCHHHHHHHHCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCEEEEEC
Q ss_conf 46388999844699988998441489887579999999999999999988506998364189999857789985999973
Q 002673 675 QGFRLLIYSYMENGSLDYWLHEKADGASQLDWLTRLKIARGTSCGLAYMHQICEPHIVHRDIKSSNILLDDQFEAHLADF 754 (894)
Q Consensus 675 ~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~Ia~aL~yLHs~~~~~ivH~DLkp~NILl~~~~~vkL~DF 754 (894)
.+..++|+||+.++.+...... ...++......++.|++.||.|||+ ++|+||||||+|||++.++.+|++||
T Consensus 89 ~~~~~iv~e~~~~~~~~~~~~~----~~~~~~~~~~~i~~qil~~l~~lH~---~~ivHrDlKp~NILl~~~~~~kl~df 161 (318)
T d3blha1 89 KGSIYLVFDFCEHDLAGLLSNV----LVKFTLSEIKRVMQMLLNGLYYIHR---NKILHRDMKAANVLITRDGVLKLADF 161 (318)
T ss_dssp --CEEEEEECCCEEHHHHHTCT----TCCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECTTSCEEECCC
T ss_pred CCEEEEEEECCCCCCCCHHHHC----CCCCCCHHHHHHHHHHHHHHHHHCC---CCEEECCCCCHHEEECCCCCEEEEEC
T ss_conf 7638999853578741012220----3443308999999999999988522---99885676722203668996876313
Q ss_pred CCCCCCCCCCC---CCCCCCCCCCCCCCCCCCCCC-CCCCCCCHHHHHHHHHHHHCCCCCCCCCCCCHHHHHHHHHHHHH
Q ss_conf 45332378887---431124556786682243676-77862118999999999991999999889301256999999884
Q 002673 755 GLSRLILPYQT---HVTTELVGTLGYIPPEYGQAW-VATLRGDMYSFGVVMLELLTGKRPVDVLKPKMSRELVGWVLKMR 830 (894)
Q Consensus 755 Gla~~~~~~~~---~~~~~~~gt~~y~APE~~~~~-~~s~ksDVwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~ 830 (894)
|+++....... .......||+.|+|||++.+. .++.++||||+||++|||++|+.||...........+.......
T Consensus 162 g~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~~~~k~DiwSlGvil~el~~g~~pf~~~~~~~~~~~i~~~~~~~ 241 (318)
T d3blha1 162 GLARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSI 241 (318)
T ss_dssp TTCEECCC-----CCCCCSCCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCC
T ss_pred CEEEECCCCCCCCCCCCCCEECCHHHHHHHHHCCCCCCCCHHHCCCCCCEEEEHHHCCCCCCCCCHHHHHHHHHHHCCCC
T ss_conf 50022355444321135660249787428997079998917870067864661744879989989999999999841899
Q ss_pred HCCCCCCCCCCCC---------CCCCCHHH------HHHHHHHHHHHCCCCCCCCCCHHHHHH--HHHH
Q ss_conf 1498775445200---------39999699------999999998711159999999999999--9982
Q 002673 831 SEGKQDQVFDPIL---------RGKGFDEE------MLQVLDVACMCVSQNPFKRPTVKEVVE--WLNN 882 (894)
Q Consensus 831 ~~~~~~~~~d~~l---------~~~~~~~~------~~~l~~li~~Cl~~dP~~RPs~~eil~--~L~~ 882 (894)
............. ......+. ...+.+|+.+||+.||++|||++|+++ |++.
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~sa~elL~Hpff~~ 310 (318)
T d3blha1 242 TPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNHDFFWS 310 (318)
T ss_dssp CTTTSTTCCCC-------CCSSCCBCHHHHHHHHHCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGSS
T ss_pred CHHHCCCCCHHHHHHHHCCCCCCCCCCHHHHCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHCCHHHCC
T ss_conf 825534432034443320133445550334044459989999999987389658909999974950156
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=0 Score=308.25 Aligned_cols=261 Identities=20% Similarity=0.268 Sum_probs=198.1
Q ss_pred CCCCCCCEEEECCCEEEEEEEE-CCCCEEEEEEECCCCHHHHHHHHHHHHHHHHCCCCCEEEE-CCEEEECCEEEEEEEE
Q ss_conf 5987654471028389999998-4898489999748512659999999999994599824553-2243104638899984
Q 002673 607 DNFSQANIIGCGGFGLVYKATL-ANGTTLAIKKLSGDLGLMEREFKAEVEALSTAQHKNLVSL-QGYCVHQGFRLLIYSY 684 (894)
Q Consensus 607 ~~~~~~~~LG~G~fg~Vy~a~~-~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~Hpniv~l-~g~~~~~~~~~lV~E~ 684 (894)
++|++.+.||+|+||.||+|.+ .+++.||||.+.... ...++..|+++++.++|+|++.. .++..+....++|+||
T Consensus 7 ~rY~l~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~--~~~~~~~E~~i~~~l~~~~~i~~~~~~~~~~~~~~ivme~ 84 (299)
T d1ckia_ 7 NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKT--KHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMEL 84 (299)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEESCT--TSCCHHHHHHHHHHSTTSTTCCCEEEEEEETTEEEEEEEC
T ss_pred CEEEEEEEEEECCCCEEEEEEECCCCCEEEEEEECHHC--CCHHHHHHHHHHHHCCCCCCCCEEEEEEECCCEEEEEEEE
T ss_conf 88999689850788099999998899899999972100--5888999999999703899601799999519877899987
Q ss_pred CCCCCHHHHHHHHCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECC---CCCEEEEECCCCCCCC
Q ss_conf 4699988998441489887579999999999999999988506998364189999857789---9859999734533237
Q 002673 685 MENGSLDYWLHEKADGASQLDWLTRLKIARGTSCGLAYMHQICEPHIVHRDIKSSNILLDD---QFEAHLADFGLSRLIL 761 (894)
Q Consensus 685 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~Ia~aL~yLHs~~~~~ivH~DLkp~NILl~~---~~~vkL~DFGla~~~~ 761 (894)
+ +|++...+.... ..+++..+..++.|++.||.|||+ ++|+||||||+|||++. +..+|++|||+++...
T Consensus 85 ~-~~~l~~~~~~~~---~~~~~~~~~~~~~qi~~~l~~lH~---~~iiHrDiKp~NIl~~~~~~~~~vkl~DFG~a~~~~ 157 (299)
T d1ckia_ 85 L-GPSLEDLFNFCS---RKFSLKTVLLLADQMISRIEYIHS---KNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYR 157 (299)
T ss_dssp C-CCBHHHHHHHTT---TCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGGGEEECCGGGTTCEEECCCSSCEECB
T ss_pred C-CCCHHHHHHHCC---CCCCHHHHHHHHHHHHHHHHHHHH---CCEEECCCCHHHCCCCCCCCCCEEEEECCCCCEECC
T ss_conf 3-871333244306---887689999999999999999997---994426678766064335777615650467513425
Q ss_pred CCCCC------CCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHCCCCCCCCCCCCHHHHHHHHHHHHHHCCCC
Q ss_conf 88874------311245567866822436767786211899999999999199999988930125699999988414987
Q 002673 762 PYQTH------VTTELVGTLGYIPPEYGQAWVATLRGDMYSFGVVMLELLTGKRPVDVLKPKMSRELVGWVLKMRSEGKQ 835 (894)
Q Consensus 762 ~~~~~------~~~~~~gt~~y~APE~~~~~~~s~ksDVwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~ 835 (894)
..... ......||+.|+|||...+..++.++||||||+++|||++|+.||........................
T Consensus 158 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (299)
T d1ckia_ 158 DARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPI 237 (299)
T ss_dssp CTTTCCBCCCCBCCSCCCCSSSCCHHHHTTBCCCHHHHHHHHHHHHHHHHHSSCTTCCCC-------HHHHHHHHHHSCH
T ss_pred CCCCCCCEECCCCCCCCCCCCCCCHHHHHCCCCCCHHHEEECCHHHHHHHHCCCCCCCCCHHHHHHHHHHHHCCCCCCCH
T ss_conf 54455410001357767873532999991899898321886177899998498766553057799999985235678983
Q ss_pred CCCCCCCCCCCCCHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHHCCC
Q ss_conf 75445200399996999999999987111599999999999999982001
Q 002673 836 DQVFDPILRGKGFDEEMLQVLDVACMCVSQNPFKRPTVKEVVEWLNNVGA 885 (894)
Q Consensus 836 ~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~eil~~L~~i~~ 885 (894)
... . ...+ .++.+++..||+.+|++||++.++.+.|+.+..
T Consensus 238 ~~~-----~-~~~p---~~~~~li~~cl~~~p~~RP~~~~i~~~l~~~~~ 278 (299)
T d1ckia_ 238 EVL-----C-KGYP---SEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFH 278 (299)
T ss_dssp HHH-----T-TTSC---HHHHHHHHHHHHSCTTCCCCHHHHHHHHHHHHH
T ss_pred HHH-----C-CCCC---HHHHHHHHHHCCCCHHHCCCHHHHHHHHHHHHH
T ss_conf 575-----3-4788---999999999843995579199999999999999
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=313.50 Aligned_cols=258 Identities=25% Similarity=0.333 Sum_probs=204.8
Q ss_pred CCCCCCCEEEECCCEEEEEEEEC----CCCEEEEEEECCCC----HHHHHHHHHHHHHHHHCCC-CCEEEECCEEEECCE
Q ss_conf 59876544710283899999984----89848999974851----2659999999999994599-824553224310463
Q 002673 607 DNFSQANIIGCGGFGLVYKATLA----NGTTLAIKKLSGDL----GLMEREFKAEVEALSTAQH-KNLVSLQGYCVHQGF 677 (894)
Q Consensus 607 ~~~~~~~~LG~G~fg~Vy~a~~~----~~~~vavK~~~~~~----~~~~~~~~~Ei~~l~~l~H-pniv~l~g~~~~~~~ 677 (894)
++|++.+.||+|+||.||+|... +|+.||+|.+.... ....+.+.+|+.++++++| |||+++++++.+...
T Consensus 24 ~~y~~~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~~~~~~~~~~ 103 (322)
T d1vzoa_ 24 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETK 103 (322)
T ss_dssp GGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETTE
T ss_pred HCEEEEEEEECCCCEEEEEEEECCCCCCCCEEEEEEEEHHHHCCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEEECCCCC
T ss_conf 02599989832878399999987658879489999983677210168999999999999864679839996200024873
Q ss_pred EEEEEEECCCCCHHHHHHHHCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCEEEEECCCC
Q ss_conf 88999844699988998441489887579999999999999999988506998364189999857789985999973453
Q 002673 678 RLLIYSYMENGSLDYWLHEKADGASQLDWLTRLKIARGTSCGLAYMHQICEPHIVHRDIKSSNILLDDQFEAHLADFGLS 757 (894)
Q Consensus 678 ~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~Ia~aL~yLHs~~~~~ivH~DLkp~NILl~~~~~vkL~DFGla 757 (894)
.++++||+.+|+|.+++.... .++......++.|++.|+.|+|+ ++++||||||+|||++.++.+||+|||++
T Consensus 104 ~~~v~e~~~~~~L~~~i~~~~----~~~e~~~~~~~~Qi~~al~~lH~---~~ivHrDiKp~Nill~~~~~vkL~DFG~a 176 (322)
T d1vzoa_ 104 LHLILDYINGGELFTHLSQRE----RFTEHEVQIYVGEIVLALEHLHK---LGIIYRDIKLENILLDSNGHVVLTDFGLS 176 (322)
T ss_dssp EEEEECCCCSCBHHHHHHHHS----CCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTSCEEESCSSEE
T ss_pred EEEEEECCCCCHHHHHHHHCC----CCCHHHHHHHHHHHHHHHHHHHC---CCEEECCCCCCCEEECCCCCEEEEECCCH
T ss_conf 001231234117999987304----54378888889999999988514---99896547732012469998887413202
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCCCC--CCCCCCCHHHHHHHHHHHHCCCCCCCCCCCCHHHHHHHHHHHHHHCCCC
Q ss_conf 32378887431124556786682243676--7786211899999999999199999988930125699999988414987
Q 002673 758 RLILPYQTHVTTELVGTLGYIPPEYGQAW--VATLRGDMYSFGVVMLELLTGKRPVDVLKPKMSRELVGWVLKMRSEGKQ 835 (894)
Q Consensus 758 ~~~~~~~~~~~~~~~gt~~y~APE~~~~~--~~s~ksDVwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~ 835 (894)
+.+............|++.|++||.+.+. .++.++||||+||++|+|++|+.||...........+. ...... ..
T Consensus 177 ~~~~~~~~~~~~~~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG~iLyelltG~~PF~~~~~~~~~~~i~--~~~~~~-~~ 253 (322)
T d1vzoa_ 177 KEFVADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEIS--RRILKS-EP 253 (322)
T ss_dssp EECCGGGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHHH--HHHHHC-CC
T ss_pred HHHCCCCCCCCCCCCCCCCCCHHHHHHCCCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHH--HHCCCC-CC
T ss_conf 220344443221222333331068760577688713251777799999976899988887777999999--833568-99
Q ss_pred CCCCCCCCCCCCCHHHHHHHHHHHHHHCCCCCCCCC-----CHHHHHH--HHHHCC
Q ss_conf 754452003999969999999999871115999999-----9999999--998200
Q 002673 836 DQVFDPILRGKGFDEEMLQVLDVACMCVSQNPFKRP-----TVKEVVE--WLNNVG 884 (894)
Q Consensus 836 ~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RP-----s~~eil~--~L~~i~ 884 (894)
. ........+.+++.+||+.||.+|| |++|+++ |++++.
T Consensus 254 ~----------~~~~~s~~~~~li~~~l~~dP~~R~s~~~~t~~eil~Hpff~~i~ 299 (322)
T d1vzoa_ 254 P----------YPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHLFFQKIN 299 (322)
T ss_dssp C----------CCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTSGGGTTCC
T ss_pred C----------CCCCCCHHHHHHHHHHCCCCHHHCCCCCCCCHHHHHCCHHHCCCC
T ss_conf 8----------865479999999999744589881999745099997497234899
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=100.00 E-value=0 Score=306.54 Aligned_cols=261 Identities=18% Similarity=0.210 Sum_probs=204.8
Q ss_pred CCCCCCCEEEECCCEEEEEEEE-CCCCEEEEEEECCCCHHHHHHHHHHHHHHHHCCC-CCEEEECCEEEECCEEEEEEEE
Q ss_conf 5987654471028389999998-4898489999748512659999999999994599-8245532243104638899984
Q 002673 607 DNFSQANIIGCGGFGLVYKATL-ANGTTLAIKKLSGDLGLMEREFKAEVEALSTAQH-KNLVSLQGYCVHQGFRLLIYSY 684 (894)
Q Consensus 607 ~~~~~~~~LG~G~fg~Vy~a~~-~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~H-pniv~l~g~~~~~~~~~lV~E~ 684 (894)
++|++.+.||+|+||.||+|++ .+++.||+|.+.... ....+.+|++.+..++| +|++.+++++.+....++||||
T Consensus 5 ~~Y~i~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~--~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~~vme~ 82 (293)
T d1csna_ 5 VHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRS--DAPQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVIDL 82 (293)
T ss_dssp TTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCT--TSCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEEEC
T ss_pred CCEEEEEEEECCCCEEEEEEEECCCCCEEEEEEECCCC--CCHHHHHHHHHHHHHCCCCCCCEEEEEEECCCCCEEEEEE
T ss_conf 80699799841788299999998899799999975025--8299999999999964899987799996018811799996
Q ss_pred CCCCCHHHHHHHHCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECC-----CCCEEEEECCCCCC
Q ss_conf 4699988998441489887579999999999999999988506998364189999857789-----98599997345332
Q 002673 685 MENGSLDYWLHEKADGASQLDWLTRLKIARGTSCGLAYMHQICEPHIVHRDIKSSNILLDD-----QFEAHLADFGLSRL 759 (894)
Q Consensus 685 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~Ia~aL~yLHs~~~~~ivH~DLkp~NILl~~-----~~~vkL~DFGla~~ 759 (894)
+ +++|.+++.... ..++......++.|++.||.|||+ ++|+||||||+|||++. ++.+||+|||+++.
T Consensus 83 ~-~~~l~~~~~~~~---~~~~~~~~~~i~~q~~~~l~~lH~---~giiHrDiKp~Nili~~~~~~~~~~vkl~DFG~a~~ 155 (293)
T d1csna_ 83 L-GPSLEDLLDLCG---RKFSVKTVAMAAKQMLARVQSIHE---KSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKF 155 (293)
T ss_dssp C-CCBHHHHHHHTT---TCCCHHHHHHHHHHHHHHHHHHHT---TTEECCCCCGGGEEECCSSSTTTTCEEECCCTTCEE
T ss_pred C-CCCHHHHHHHHC---CCHHHHHHHHHHHHHHHHHHHHHH---CCCEECCCCCCCEEECCCCCCCCCCEEECCCCEEEE
T ss_conf 4-888799997520---311068999999999999999997---796626677131523475434479568723660577
Q ss_pred CCCCCCC------CCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHCCCCCCCCCCCCHHHHHHHHHHHHHHCC
Q ss_conf 3788874------3112455678668224367677862118999999999991999999889301256999999884149
Q 002673 760 ILPYQTH------VTTELVGTLGYIPPEYGQAWVATLRGDMYSFGVVMLELLTGKRPVDVLKPKMSRELVGWVLKMRSEG 833 (894)
Q Consensus 760 ~~~~~~~------~~~~~~gt~~y~APE~~~~~~~s~ksDVwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~ 833 (894)
....... ......||+.|+|||++.+..++.++||||||+++|||++|+.||......................
T Consensus 156 ~~~~~~~~~~~~~~~~~~~GT~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~i~~~~~~~ 235 (293)
T d1csna_ 156 YRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQST 235 (293)
T ss_dssp SBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHHHHS
T ss_pred CCCCCCCCCEEECCCCCEEECHHHCCHHHHCCCCCCHHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHHHHCCCCC
T ss_conf 14676654111024676277510267989648888869998983199999986987678853021999999997056799
Q ss_pred CCCCCCCCCCCCCCCHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHHCCC
Q ss_conf 8775445200399996999999999987111599999999999999982001
Q 002673 834 KQDQVFDPILRGKGFDEEMLQVLDVACMCVSQNPFKRPTVKEVVEWLNNVGA 885 (894)
Q Consensus 834 ~~~~~~d~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~eil~~L~~i~~ 885 (894)
...++ . ...+ .++.+++..|+..+|++||+++.+.+.|+++..
T Consensus 236 ~~~~l-----~-~~~p---~~l~~ii~~~~~~~~~~rP~y~~l~~~l~~~~~ 278 (293)
T d1csna_ 236 PLREL-----C-AGFP---EEFYKYMHYARNLAFDATPDYDYLQGLFSKVLE 278 (293)
T ss_dssp CHHHH-----T-TTSC---HHHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHH
T ss_pred CHHHH-----C-CCCC---HHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHHH
T ss_conf 95896-----5-7998---999999999843993008599999999999999
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Probab=100.00 E-value=0 Score=309.74 Aligned_cols=263 Identities=19% Similarity=0.266 Sum_probs=198.6
Q ss_pred CCCCCCCEEEECCCEEEEEEEE-CCCCEEEEEEECCCCHHHHHHHHHHHHHHHHCC-CCCEEEECCEEEE--CCEEEEEE
Q ss_conf 5987654471028389999998-489848999974851265999999999999459-9824553224310--46388999
Q 002673 607 DNFSQANIIGCGGFGLVYKATL-ANGTTLAIKKLSGDLGLMEREFKAEVEALSTAQ-HKNLVSLQGYCVH--QGFRLLIY 682 (894)
Q Consensus 607 ~~~~~~~~LG~G~fg~Vy~a~~-~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~-Hpniv~l~g~~~~--~~~~~lV~ 682 (894)
++|++.+.||+|+||.||+|+. .+++.||+|++... ..+.+.+|+.+|+.++ ||||+++++++.. ....++||
T Consensus 35 d~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~---~~~~~~~Ei~il~~l~~hpnIv~~~~~~~~~~~~~~~~v~ 111 (328)
T d3bqca1 35 DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPV---KKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVF 111 (328)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSS---CHHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCSEEEEE
T ss_pred CCEEEEEEEECCCCEEEEEEEECCCCCEEEEEEECHH---HHHHHHHHHHHHHHCCCCCCCCEEEEEEEECCCCCEEEEE
T ss_conf 6718978983174819999998899979999998889---9999999999998515799876799999816877126888
Q ss_pred EECCCCCHHHHHHHHCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCC-CEEEEECCCCCCCC
Q ss_conf 84469998899844148988757999999999999999998850699836418999985778998-59999734533237
Q 002673 683 SYMENGSLDYWLHEKADGASQLDWLTRLKIARGTSCGLAYMHQICEPHIVHRDIKSSNILLDDQF-EAHLADFGLSRLIL 761 (894)
Q Consensus 683 E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~Ia~aL~yLHs~~~~~ivH~DLkp~NILl~~~~-~vkL~DFGla~~~~ 761 (894)
||+++|+|..+. ..++...+..++.||+.||.|||+ ++|+||||||+|||++.++ .+||+|||+++...
T Consensus 112 e~~~~~~L~~~~-------~~l~e~~i~~i~~qil~aL~~LH~---~gIvHrDiKp~NILi~~~~~~vkl~DFG~a~~~~ 181 (328)
T d3bqca1 112 EHVNNTDFKQLY-------QTLTDYDIRFYMYEILKALDYCHS---MGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYH 181 (328)
T ss_dssp ECCCSCBGGGTT-------TSCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEEETTTTEEEECCGGGCEECC
T ss_pred EECCCCCHHHHH-------CCCCHHHHHHHHHHHHHHHHHHHH---CCCCCCCCCCCCEEECCCCCEEEECCCCCCEECC
T ss_conf 631798589974-------689999999999999999988764---3344345644123774899836641565426646
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCC-CCCCCCCHHHHHHHHHHHHCCCCCCCCCCCCHHHH--HHHHH-----HHHHHCC
Q ss_conf 8887431124556786682243676-77862118999999999991999999889301256--99999-----9884149
Q 002673 762 PYQTHVTTELVGTLGYIPPEYGQAW-VATLRGDMYSFGVVMLELLTGKRPVDVLKPKMSRE--LVGWV-----LKMRSEG 833 (894)
Q Consensus 762 ~~~~~~~~~~~gt~~y~APE~~~~~-~~s~ksDVwSlGvil~elltG~~Pf~~~~~~~~~~--~~~~~-----~~~~~~~ 833 (894)
... ......+|..|+|||.+.+. .++.++||||+|+++|+|++|+.||.......... ..... .......
T Consensus 182 ~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~~l~e~~~g~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~~~~ 259 (328)
T d3bqca1 182 PGQ--EYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKY 259 (328)
T ss_dssp TTC--CCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHT
T ss_pred CCC--CCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHCCCCCCCCCCCHHHHHHHHHHHHHCCCHHHHHHHHC
T ss_conf 887--444322486424761026888888452323354555876048899988760189999999987884155555422
Q ss_pred --CCCCCCC------------CCCCCCCCHHHHHHHHHHHHHHCCCCCCCCCCHHHHHH--HHHHCC
Q ss_conf --8775445------------20039999699999999998711159999999999999--998200
Q 002673 834 --KQDQVFD------------PILRGKGFDEEMLQVLDVACMCVSQNPFKRPTVKEVVE--WLNNVG 884 (894)
Q Consensus 834 --~~~~~~d------------~~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~eil~--~L~~i~ 884 (894)
.....+. .............++.+|+.+||+.||.+|||++|+++ |++.+.
T Consensus 260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~e~L~Hp~F~~v~ 326 (328)
T d3bqca1 260 NIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYFYTVV 326 (328)
T ss_dssp TCCCCGGGGGTCCCCCCCCGGGGCCTTTGGGCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTSC
T ss_pred CCCCCCCCCHHCCCCCCCCHHHCCCCCCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHCCCCCCCCC
T ss_conf 5444743000003334331121155211244899999999998669956890899996493558879
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=305.96 Aligned_cols=268 Identities=22% Similarity=0.271 Sum_probs=205.5
Q ss_pred CCCCCCCEEEECCCEEEEEEEE-CCCCEEEEEEECCCC--HHHHHHHHHHHHHHHHCCCCCEEEECCEEEECCEEEEEEE
Q ss_conf 5987654471028389999998-489848999974851--2659999999999994599824553224310463889998
Q 002673 607 DNFSQANIIGCGGFGLVYKATL-ANGTTLAIKKLSGDL--GLMEREFKAEVEALSTAQHKNLVSLQGYCVHQGFRLLIYS 683 (894)
Q Consensus 607 ~~~~~~~~LG~G~fg~Vy~a~~-~~~~~vavK~~~~~~--~~~~~~~~~Ei~~l~~l~Hpniv~l~g~~~~~~~~~lV~E 683 (894)
++|++.+.||+|+||.||+|++ .+++.||||++.... ......+.+|+.+++.++||||+++++++.+....+++++
T Consensus 2 ~ry~~i~~LG~G~fg~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~iv~~ 81 (292)
T d1unla_ 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFE 81 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred CCCEEEEEEECCCCEEEEEEEECCCCCEEEEEEEEHHHCCHHHHHHHHHHHHHHHHCCCCCEEEECCCCCCCCCEEEEEE
T ss_conf 99786269712868199999999999699999980321786899999999999985675788821354444431158863
Q ss_pred ECCCCCHHHHHHHHCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCEEEEECCCCCCCCCC
Q ss_conf 44699988998441489887579999999999999999988506998364189999857789985999973453323788
Q 002673 684 YMENGSLDYWLHEKADGASQLDWLTRLKIARGTSCGLAYMHQICEPHIVHRDIKSSNILLDDQFEAHLADFGLSRLILPY 763 (894)
Q Consensus 684 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~Ia~aL~yLHs~~~~~ivH~DLkp~NILl~~~~~vkL~DFGla~~~~~~ 763 (894)
++.++++..++... ..+++..+..++.|++.||.|||+ ++|+||||||+|||++.++.+||+|||.++.....
T Consensus 82 ~~~~~~l~~~~~~~----~~~~~~~~~~~~~q~~~aL~~lH~---~~IvHrDiKP~NIli~~~~~~kl~DFG~a~~~~~~ 154 (292)
T d1unla_ 82 FCDQDLKKYFDSCN----GDLDPEIVKSFLFQLLKGLGFCHS---RNVLHRDLKPQNLLINRNGELKLANFGLARAFGIP 154 (292)
T ss_dssp CCSEEHHHHHHHTT----TCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTCCEEECCCTTCEECCSC
T ss_pred ECCCCCCCCCCCCC----CCCCHHHHHHHHHHHHHHHHHHHC---CCEEEECCCCCCCCCCCCCCEEEEECCHHHCCCCC
T ss_conf 02332221121235----654036789999999999877433---99860014676121133782665204601104688
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCC-CCCCCCHHHHHHHHHHHHCCCCCCCCCCCCHHHHHHHHHHHHHHCCCCCCC----
Q ss_conf 874311245567866822436767-786211899999999999199999988930125699999988414987754----
Q 002673 764 QTHVTTELVGTLGYIPPEYGQAWV-ATLRGDMYSFGVVMLELLTGKRPVDVLKPKMSRELVGWVLKMRSEGKQDQV---- 838 (894)
Q Consensus 764 ~~~~~~~~~gt~~y~APE~~~~~~-~s~ksDVwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~---- 838 (894)
. .......++..|+|||++.... ++.++||||+||++|||++|+.||..... ..+.................
T Consensus 155 ~-~~~~~~~~~~~~~~pe~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~ 231 (292)
T d1unla_ 155 V-RCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGND--VDDQLKRIFRLLGTPTEEQWPSMT 231 (292)
T ss_dssp C-SCCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSS--HHHHHHHHHHHHCCCCTTTCTTGG
T ss_pred C-CCCEEECCCCCHHHHHHHCCCCCCCCHHHCCCCCHHHHHHHHCCCCCCCCCC--HHHHHHHHHHHCCCCCHHHHHHHH
T ss_conf 7-5100103443101466750698888044402654188998518999988999--999999998611899735513443
Q ss_pred --CC----C-----CCCCCCCHHHHHHHHHHHHHHCCCCCCCCCCHHHHHH--HHHHCC
Q ss_conf --45----2-----0039999699999999998711159999999999999--998200
Q 002673 839 --FD----P-----ILRGKGFDEEMLQVLDVACMCVSQNPFKRPTVKEVVE--WLNNVG 884 (894)
Q Consensus 839 --~d----~-----~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~eil~--~L~~i~ 884 (894)
.+ + .............+.+|+.+|++.||.+|||++|+++ ||+++.
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~sa~e~L~Hp~f~~~~ 290 (292)
T d1unla_ 232 KLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHPYFSDFC 290 (292)
T ss_dssp GSTTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHTTSGGGSSCS
T ss_pred HCCCCCCCCCCCCCCHHHHCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHCCHHHCCCC
T ss_conf 22211334445443104330656899999999998649966890999996495340798
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=308.68 Aligned_cols=265 Identities=24% Similarity=0.247 Sum_probs=201.6
Q ss_pred CCCCCCCEEEECCCEEEEEEEEC-CCCEEEEEEECCCC--HHHHHHHHHHHHHHHHCCCCCEEEECCEEEE------CCE
Q ss_conf 59876544710283899999984-89848999974851--2659999999999994599824553224310------463
Q 002673 607 DNFSQANIIGCGGFGLVYKATLA-NGTTLAIKKLSGDL--GLMEREFKAEVEALSTAQHKNLVSLQGYCVH------QGF 677 (894)
Q Consensus 607 ~~~~~~~~LG~G~fg~Vy~a~~~-~~~~vavK~~~~~~--~~~~~~~~~Ei~~l~~l~Hpniv~l~g~~~~------~~~ 677 (894)
++|++.+.||+|+||+||+|.+. ++..||||++.... ......+.+|+.+++.++||||+++++++.. ...
T Consensus 17 ~~Y~i~~~LG~G~fg~V~~~~d~~t~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~f~~~~~~~~~~~ 96 (355)
T d2b1pa1 17 KRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQD 96 (355)
T ss_dssp TTEEEEEECSCC--CEEEEEEETTTTEEEEEEEEESTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCCE
T ss_pred CCEEEEEEEECCCCEEEEEEEECCCCCEEEEEEECHHHCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEEECCCCCCCCCE
T ss_conf 77599889621758599999999999899999988233697999999999999986489876489989702564345762
Q ss_pred EEEEEEECCCCCHHHHHHHHCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCEEEEECCCC
Q ss_conf 88999844699988998441489887579999999999999999988506998364189999857789985999973453
Q 002673 678 RLLIYSYMENGSLDYWLHEKADGASQLDWLTRLKIARGTSCGLAYMHQICEPHIVHRDIKSSNILLDDQFEAHLADFGLS 757 (894)
Q Consensus 678 ~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~Ia~aL~yLHs~~~~~ivH~DLkp~NILl~~~~~vkL~DFGla 757 (894)
.|+|+||+.++ +...+. ..+++..+..++.|++.||.|||+ ++|+||||||+|||++.++.+|++|||++
T Consensus 97 ~~iv~Ey~~~~-l~~~~~------~~~~~~~i~~~~~qil~gl~~LH~---~giiHrDlKP~Nil~~~~~~~kl~df~~~ 166 (355)
T d2b1pa1 97 VYLVMELMDAN-LCQVIQ------MELDHERMSYLLYQMLCGIKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDFGLA 166 (355)
T ss_dssp EEEEEECCSEE-HHHHHT------SCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECTTCCEEECCCCC-
T ss_pred EEEEEECCCHH-HHHHHH------CCCCHHHHHHHHHHHHHHHHHHHH---CCCCCCCCCCCCCCCCCCCCEEEECHHHH
T ss_conf 69998414467-787650------389999999999999999988652---21124567763211365443132010232
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHCCCCCCCCCCCCHHHHHHHHH-----------
Q ss_conf 323788874311245567866822436767786211899999999999199999988930125699999-----------
Q 002673 758 RLILPYQTHVTTELVGTLGYIPPEYGQAWVATLRGDMYSFGVVMLELLTGKRPVDVLKPKMSRELVGWV----------- 826 (894)
Q Consensus 758 ~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~----------- 826 (894)
+.... ........+|+.|+|||++.+..++.++||||+||++|+|++|+.||...........+...
T Consensus 167 ~~~~~--~~~~~~~~~t~~y~aPE~l~~~~~~~~~DiwSlG~~l~ell~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~ 244 (355)
T d2b1pa1 167 RTAGT--SFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKK 244 (355)
T ss_dssp ----------------CCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHTT
T ss_pred HCCCC--CCCCCCCCCCCCCCCHHHHCCCCCCCCCCCCCCCCHHHHHHHCCCCCCCCCHHHHHHHHHHHCCCCCHHHHHH
T ss_conf 11466--6553322146555581331477778774333566257898659899888977889999997205898799987
Q ss_pred -----HHHHHCC-CCC-----CCCCCCCCCCC---CHHHHHHHHHHHHHHCCCCCCCCCCHHHHHH--HHHHC
Q ss_conf -----9884149-877-----54452003999---9699999999998711159999999999999--99820
Q 002673 827 -----LKMRSEG-KQD-----QVFDPILRGKG---FDEEMLQVLDVACMCVSQNPFKRPTVKEVVE--WLNNV 883 (894)
Q Consensus 827 -----~~~~~~~-~~~-----~~~d~~l~~~~---~~~~~~~l~~li~~Cl~~dP~~RPs~~eil~--~L~~i 883 (894)
....... ... ..+........ .......+.+|+.+|++.||++|||++|+++ ||+..
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~ta~elL~Hpw~~~~ 317 (355)
T d2b1pa1 245 LQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPYINVW 317 (355)
T ss_dssp SCHHHHHHHHTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTSTTTGGG
T ss_pred HHHHHHHHHHCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHCCCCCCCC
T ss_conf 6566777764175435666421264333543210133379999999999876994579089999669420878
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=311.04 Aligned_cols=264 Identities=22% Similarity=0.297 Sum_probs=202.0
Q ss_pred CCCCCCCCEEEECCCEEEEEEEE-CCCCEEEEEEECCCC--HHHHHHHHHHHHHHHHCCCCCEEEECCEEEEC-----CE
Q ss_conf 05987654471028389999998-489848999974851--26599999999999945998245532243104-----63
Q 002673 606 TDNFSQANIIGCGGFGLVYKATL-ANGTTLAIKKLSGDL--GLMEREFKAEVEALSTAQHKNLVSLQGYCVHQ-----GF 677 (894)
Q Consensus 606 ~~~~~~~~~LG~G~fg~Vy~a~~-~~~~~vavK~~~~~~--~~~~~~~~~Ei~~l~~l~Hpniv~l~g~~~~~-----~~ 677 (894)
+++|++.+.||+|+||.||+|+. .+++.||||++.... ....+.+.+|+.+++.++|||+|++++++... ..
T Consensus 17 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~h~~iv~~~~~~~~~~~~~~~~ 96 (348)
T d2gfsa1 17 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFN 96 (348)
T ss_dssp ETTEEEEEECGGGTTSSEEEEEETTTTEEEEEEECSCTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSTTTCC
T ss_pred CCCEEEEEEEECCCCEEEEEEEECCCCCEEEEEEECCHHCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEEEECCCCCCCC
T ss_conf 98718888983178839999999999979999998820028689999999999998668987425999996346456686
Q ss_pred EEEEEEECCCCCHHHHHHHHCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCEEEEECCCC
Q ss_conf 88999844699988998441489887579999999999999999988506998364189999857789985999973453
Q 002673 678 RLLIYSYMENGSLDYWLHEKADGASQLDWLTRLKIARGTSCGLAYMHQICEPHIVHRDIKSSNILLDDQFEAHLADFGLS 757 (894)
Q Consensus 678 ~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~Ia~aL~yLHs~~~~~ivH~DLkp~NILl~~~~~vkL~DFGla 757 (894)
.+++++|+.+|+|.+++.. ..+++..+..++.||+.||.|||+ ++|+||||||+|||++.++.+|++|||.+
T Consensus 97 ~~~i~~~~~gg~L~~~~~~-----~~l~e~~~~~i~~qil~aL~~LH~---~giiHrDiKp~NILi~~~~~~kl~dfg~a 168 (348)
T d2gfsa1 97 DVYLVTHLMGADLNNIVKC-----QKLTDDHVQFLIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLA 168 (348)
T ss_dssp CCEEEEECCSEEHHHHHTT-----CCCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTCCEEECCC---
T ss_pred EEEEEEEECCCCHHHHCCC-----CCCCHHHHHHHHHHHHHHHHHHHH---CCCCCCCCCCCCCCCCCCCCCCCCCCCHH
T ss_conf 4999996258862320022-----453099999999999999999973---88765166776334554322001321000
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCCCC-CCCCCCCHHHHHHHHHHHHCCCCCCCCCCCCHHHHHHHHHHHHHHCCCCC
Q ss_conf 32378887431124556786682243676-77862118999999999991999999889301256999999884149877
Q 002673 758 RLILPYQTHVTTELVGTLGYIPPEYGQAW-VATLRGDMYSFGVVMLELLTGKRPVDVLKPKMSRELVGWVLKMRSEGKQD 836 (894)
Q Consensus 758 ~~~~~~~~~~~~~~~gt~~y~APE~~~~~-~~s~ksDVwSlGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~ 836 (894)
.... .......|+..|+|||+..+. .++.++||||+||++|+|++|+.||...........+ ........ .
T Consensus 169 ~~~~----~~~~~~~g~~~y~apE~~~~~~~~~~~~DiwSlGv~l~~ll~g~~pF~~~~~~~~~~~i---~~~~~~~~-~ 240 (348)
T d2gfsa1 169 RHTD----DEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLI---LRLVGTPG-A 240 (348)
T ss_dssp -CCT----GGGSSSCHHHHTSCHHHHTTCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHH---HHHHCCCC-H
T ss_pred CCCC----CCCCCCCCCCCCCCCHHHCCCCCCCCCCCHHHHHHHHHHHHHCCCCCCCCCHHHHHHHH---HHHCCCCC-H
T ss_conf 1257----54444345435558355337756785512432058999997688997889889999999---97307997-5
Q ss_pred CCC------------C--CCCCCCC----CHHHHHHHHHHHHHHCCCCCCCCCCHHHHHH--HHHHCCC
Q ss_conf 544------------5--2003999----9699999999998711159999999999999--9982001
Q 002673 837 QVF------------D--PILRGKG----FDEEMLQVLDVACMCVSQNPFKRPTVKEVVE--WLNNVGA 885 (894)
Q Consensus 837 ~~~------------d--~~l~~~~----~~~~~~~l~~li~~Cl~~dP~~RPs~~eil~--~L~~i~~ 885 (894)
... . ....... .......+.+|+.+||+.||.+|||++|+++ |++++..
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~elL~Hp~f~~~~~ 309 (348)
T d2gfsa1 241 ELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHD 309 (348)
T ss_dssp HHHTTCCCHHHHHHHTTSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTTCC
T ss_pred HHHHHCCCHHHHHHHHHCCCCCCCCHHHHCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHCCHHHCCCCC
T ss_conf 773200102445444303557875556626789999999999977588345938999855995487999
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=9.2e-44 Score=276.84 Aligned_cols=270 Identities=20% Similarity=0.229 Sum_probs=195.3
Q ss_pred CCCCCCCEEEECCCEEEEEEEE-CCCCEEEEEEECCCCHHHHHHHHHHHHHHHHCC-----------CCCEEEECCEEEE
Q ss_conf 5987654471028389999998-489848999974851265999999999999459-----------9824553224310
Q 002673 607 DNFSQANIIGCGGFGLVYKATL-ANGTTLAIKKLSGDLGLMEREFKAEVEALSTAQ-----------HKNLVSLQGYCVH 674 (894)
Q Consensus 607 ~~~~~~~~LG~G~fg~Vy~a~~-~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~-----------Hpniv~l~g~~~~ 674 (894)
.+|++.+.||+|+||.||+|+. .+++.||||++..+. ...+.+.+|+.+++.++ |+||+++++++..
T Consensus 13 ~rY~i~~~LG~G~fg~Vy~~~~~~~g~~vAvKvi~~~~-~~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~iv~~~~~~~~ 91 (362)
T d1q8ya_ 13 ARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDK-VYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNH 91 (362)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCH-HHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEEE
T ss_pred CCEEEEEEEEECCCEEEEEEEECCCCCEEEEEEEECCC-CCHHHHHHHHHHHHHHCCHHHHHHHHCCCCCEEEEEEEEEE
T ss_conf 85799899750778189999999999799999983431-33689999999999840145555542276764789987631
Q ss_pred C--CEEEEEEEECCCCCHHHHHHHHCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCC-----
Q ss_conf 4--638899984469998899844148988757999999999999999998850699836418999985778998-----
Q 002673 675 Q--GFRLLIYSYMENGSLDYWLHEKADGASQLDWLTRLKIARGTSCGLAYMHQICEPHIVHRDIKSSNILLDDQF----- 747 (894)
Q Consensus 675 ~--~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~Ia~aL~yLHs~~~~~ivH~DLkp~NILl~~~~----- 747 (894)
. ...+++++++..+......... .....+++..+..++.|++.||.|||+ ..+|+||||||+|||++.++
T Consensus 92 ~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~i~~i~~qil~al~~lh~--~~~IvHrDlKp~NIll~~~~~~~~~ 168 (362)
T d1q8ya_ 92 KGPNGVHVVMVFEVLGENLLALIKK-YEHRGIPLIYVKQISKQLLLGLDYMHR--RCGIIHTDIKPENVLMEIVDSPENL 168 (362)
T ss_dssp EETTEEEEEEEECCCCEEHHHHHHH-TTTSCCCHHHHHHHHHHHHHHHHHHHH--TTCEECSCCSGGGEEEEEEETTTTE
T ss_pred CCCCCEEEEEEECCCCCCCCCCCCC-CCCCCCCHHHHHHHHHHHHHHHHHHHH--HCCCCCCCCCHHHEEEECCCCCCCC
T ss_conf 2565202343200035420000012-234678689999999999999888764--0586465677057056305765644
Q ss_pred -CEEEEECCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHCCCCCCCCCCCCHHHH----H
Q ss_conf -59999734533237888743112455678668224367677862118999999999991999999889301256----9
Q 002673 748 -EAHLADFGLSRLILPYQTHVTTELVGTLGYIPPEYGQAWVATLRGDMYSFGVVMLELLTGKRPVDVLKPKMSRE----L 822 (894)
Q Consensus 748 -~vkL~DFGla~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwSlGvil~elltG~~Pf~~~~~~~~~~----~ 822 (894)
.++++|||.+.... .......|++.|+|||+..+..++.++||||+|+++++|++|+.||.......... .
T Consensus 169 ~~~kl~dfg~s~~~~----~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~pF~~~~~~~~~~~~~~~ 244 (362)
T d1q8ya_ 169 IQIKIADLGNACWYD----EHYTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHI 244 (362)
T ss_dssp EEEEECCCTTCEETT----BCCCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------CHHHHH
T ss_pred CEEEEEECCCCCCCC----CCCCCCCCCCCCCCHHHCCCCCCCCCCCCCCHHHHHHHHHHCCCCCCCCCCCCCCCHHHHH
T ss_conf 305675314421234----4542236652105713214667776432012378999998788998987554321026899
Q ss_pred HHHHHHHHH-------C----------CCCCCCCCC----------CCCCCCCHHHHHHHHHHHHHHCCCCCCCCCCHHH
Q ss_conf 999998841-------4----------987754452----------0039999699999999998711159999999999
Q 002673 823 VGWVLKMRS-------E----------GKQDQVFDP----------ILRGKGFDEEMLQVLDVACMCVSQNPFKRPTVKE 875 (894)
Q Consensus 823 ~~~~~~~~~-------~----------~~~~~~~d~----------~l~~~~~~~~~~~l~~li~~Cl~~dP~~RPs~~e 875 (894)
......... . ......... .............+.+|+.+|++.||.+|||++|
T Consensus 245 ~~~~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~Rpta~e 324 (362)
T d1q8ya_ 245 AQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRADAGG 324 (362)
T ss_dssp HHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCBCHHH
T ss_pred HHHHHHHCCCCHHHHHCCCCCCCCCCCCHHHHCCCCCCCCCHHHHCCCCCCCCCCCCHHHHHHHHHHCCCCHHHCCCHHH
T ss_conf 99999837998788624532200013201220243235776444210001567435899999999987799457908999
Q ss_pred HHH--HHHHCC
Q ss_conf 999--998200
Q 002673 876 VVE--WLNNVG 884 (894)
Q Consensus 876 il~--~L~~i~ 884 (894)
+++ |+++..
T Consensus 325 ~L~Hp~f~~~~ 335 (362)
T d1q8ya_ 325 LVNHPWLKDTL 335 (362)
T ss_dssp HHTCGGGTTCT
T ss_pred HHCCCCCCCCC
T ss_conf 96693407898
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.90 E-value=3.3e-23 Score=153.64 Aligned_cols=172 Identities=22% Similarity=0.150 Sum_probs=129.9
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCCHHCCCCCCCCCCCCCCCCCCCCCCCCCCCC----------CCCCCCCEEECCC
Q ss_conf 886421235544564240025844320100136311123586610147887745566----------8789999188127
Q 002673 325 EGPSLFSQANLLSGEFPKELTALPALVSEAANDEVDRSYLELPVFVMPSNATNQQYN----------QLSNLPPAIYLAN 394 (894)
Q Consensus 325 ~L~~L~l~~N~l~~~~p~~l~~l~~L~~L~l~~n~~~~~~~~~~~~~~~~~~~l~~~----------~l~~Lp~~L~L~~ 394 (894)
+++.|++..|.|.++.+..|.++++|+.|+|++|.+..++.. ........+.+..| .+..| +.|++++
T Consensus 32 ~l~~L~Ls~N~i~~l~~~~f~~l~~L~~L~L~~N~l~~l~~~-~~l~~L~~L~Ls~N~l~~~~~~~~~l~~L-~~L~l~~ 109 (266)
T d1p9ag_ 32 DTTILHLSENLLYTFSLATLMPYTRLTQLNLDRAELTKLQVD-GTLPVLGTLDLSHNQLQSLPLLGQTLPAL-TVLDVSF 109 (266)
T ss_dssp TCCEEECTTSCCSEEEGGGGTTCTTCCEEECTTSCCCEEECC-SCCTTCCEEECCSSCCSSCCCCTTTCTTC-CEEECCS
T ss_pred CCCEEECCCCCCCCCCHHHHHCCCCCCCCCCCCCCCCCCCCC-CCCCCCCCCCCCCCCCCCCCCCCCCCCCC-CCCCCCC
T ss_conf 889898849928985977863456552213566544443111-11223211111222221111121222222-2222222
Q ss_pred CCCCCCCCHHHCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCC
Q ss_conf 86876786311178787687564773888799000399999989657981467579764477765532333665679878
Q 002673 395 NSLSGNIPVEIGQLKSLHVLDLSNNNFSGTIPDELSDLSNLEKLDLSGNHLVGEIPISLKGLHFLSSFSVAHNNLQGAVP 474 (894)
Q Consensus 395 N~l~~~~p~~l~~L~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~ls~N~l~~~~~ 474 (894)
|.+....+..+..+.+++.|++++|.++...+..+..+++|+.|++++|+|++..+..|..+++|+.|+|++|+|+.+++
T Consensus 110 ~~~~~~~~~~~~~l~~l~~L~l~~n~l~~l~~~~~~~l~~l~~l~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~L~~lp~ 189 (266)
T d1p9ag_ 110 NRLTSLPLGALRGLGELQELYLKGNELKTLPPGLLTPTPKLEKLSLANNNLTELPAGLLNGLENLDTLLLQENSLYTIPK 189 (266)
T ss_dssp SCCCCCCSSTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTSCCSCCCTTTTTTCTTCCEEECCSSCCCCCCT
T ss_pred CCCCEEECCCCCCCCCCCCCCCCCCCCCEECCCCCCCCCCCHHCCCCCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCH
T ss_conf 31101100112222111122124342102212333221110000000156522372001342124234301397855686
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCC
Q ss_conf 999788888655689988888755
Q 002673 475 SGGQFDTFPSFSFEGNPELCGSVV 498 (894)
Q Consensus 475 ~~~~l~~L~~l~l~~N~~~c~~~~ 498 (894)
....+.+|+.+++.+|||.|+|..
T Consensus 190 ~~~~~~~L~~L~L~~Np~~CdC~~ 213 (266)
T d1p9ag_ 190 GFFGSHLLPFAFLHGNPWLCNCEI 213 (266)
T ss_dssp TTTTTCCCSEEECCSCCBCCSGGG
T ss_pred HHCCCCCCCEEEECCCCCCCCCCH
T ss_conf 677788899998369998788643
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Probab=99.90 E-value=8.9e-24 Score=157.03 Aligned_cols=170 Identities=15% Similarity=0.056 Sum_probs=118.5
Q ss_pred CCCCEEEECCCEEEEEEEECCCCEEEEEEECCCCH------------------HHHHHHHHHHHHHHHCCCCCEEEECCE
Q ss_conf 76544710283899999984898489999748512------------------659999999999994599824553224
Q 002673 610 SQANIIGCGGFGLVYKATLANGTTLAIKKLSGDLG------------------LMEREFKAEVEALSTAQHKNLVSLQGY 671 (894)
Q Consensus 610 ~~~~~LG~G~fg~Vy~a~~~~~~~vavK~~~~~~~------------------~~~~~~~~Ei~~l~~l~Hpniv~l~g~ 671 (894)
.+++.||+|+||.||+|...+|+.||||+++.... ........|...+..+.|.+++..+++
T Consensus 3 ~vg~~IG~G~~g~Vy~a~~~~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~v~~~~~~ 82 (191)
T d1zara2 3 AIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPKVYAW 82 (191)
T ss_dssp EEEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSSSCCEEEE
T ss_pred HHCCEEEECCCEEEEEEECCCCCEEEEEEEECCCCHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHCCCCCCCEEEEE
T ss_conf 22778024856599999979999999999860443466655656300088899999977899999998169991449986
Q ss_pred EEECCEEEEEEEECCCCCHHHHHHHHCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCEEE
Q ss_conf 31046388999844699988998441489887579999999999999999988506998364189999857789985999
Q 002673 672 CVHQGFRLLIYSYMENGSLDYWLHEKADGASQLDWLTRLKIARGTSCGLAYMHQICEPHIVHRDIKSSNILLDDQFEAHL 751 (894)
Q Consensus 672 ~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~Ia~aL~yLHs~~~~~ivH~DLkp~NILl~~~~~vkL 751 (894)
.. .+++|||++++.+. .++......++.|++.++.|||+ ++++||||||+|||++++ .++|
T Consensus 83 ~~----~~lvme~~~~~~~~-----------~l~~~~~~~i~~ql~~~l~~lH~---~giiHrDiKP~NILv~~~-~~~l 143 (191)
T d1zara2 83 EG----NAVLMELIDAKELY-----------RVRVENPDEVLDMILEEVAKFYH---RGIVHGDLSQYNVLVSEE-GIWI 143 (191)
T ss_dssp ET----TEEEEECCCCEEGG-----------GCCCSCHHHHHHHHHHHHHHHHH---TTEECSCCSTTSEEEETT-EEEE
T ss_pred CC----CEEEEEEECCCCCC-----------CHHHHHHHHHHHHHHHHHHHHHH---CCEEECCCCHHHEEEECC-CEEE
T ss_conf 28----88999950456542-----------00157899999999999999826---888983689036114289-8999
Q ss_pred EECCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHH
Q ss_conf 973453323788874311245567866822436767786211899999999
Q 002673 752 ADFGLSRLILPYQTHVTTELVGTLGYIPPEYGQAWVATLRGDMYSFGVVML 802 (894)
Q Consensus 752 ~DFGla~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~s~ksDVwSlGvil~ 802 (894)
+|||.+........... ...... ...+ ...+.|+.++|+||..--+.
T Consensus 144 iDFG~a~~~~~~~~~~~--l~rd~~-~~~~-~f~r~y~~~~d~~s~~~~~~ 190 (191)
T d1zara2 144 IDFPQSVEVGEEGWREI--LERDVR-NIIT-YFSRTYRTEKDINSAIDRIL 190 (191)
T ss_dssp CCCTTCEETTSTTHHHH--HHHHHH-HHHH-HHHHHHCCCCCHHHHHHHHH
T ss_pred EECCCCCCCCCCCCHHH--HHHHHH-HHHH-HHCCCCCCCCCHHHHHHHHH
T ss_conf 87788430899870999--987799-9999-97578998446899999874
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Probab=99.87 E-value=1.2e-23 Score=156.29 Aligned_cols=203 Identities=26% Similarity=0.358 Sum_probs=160.5
Q ss_pred EECEEECCCCCHHHHHHHHHHC-------CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHCCCCCCCCCCCCC-CCC
Q ss_conf 2111102899832499997201-------59999886421235544564240025844320100136311123586-610
Q 002673 298 LLAKELVSRPNADDLEIIFGEV-------EGKSDEGPSLFSQANLLSGEFPKELTALPALVSEAANDEVDRSYLEL-PVF 369 (894)
Q Consensus 298 ~~i~~~~~~p~l~~Ldl~~n~~-------~~~l~~L~~L~l~~N~l~~~~p~~l~~l~~L~~L~l~~n~~~~~~~~-~~~ 369 (894)
.++..+..++.|+.|++..|+. ...+..+..+++..|.+...+|..+.++++|+.+++++|.+....+. ...
T Consensus 92 ~iP~~i~~L~~L~~L~Ls~N~l~~~~~~~~~~~~~L~~l~l~~N~~~~~~p~~l~~l~~L~~l~l~~n~l~~~ip~~~~~ 171 (313)
T d1ogqa_ 92 PIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQIKTLVTLDFSYNALSGTLPPSISSLPNLVGITFDGNRISGAIPDSYGS 171 (313)
T ss_dssp CCCGGGGGCTTCSEEEEEEECCEEECCGGGGGCTTCCEEECCSSEEESCCCGGGGGCTTCCEEECCSSCCEEECCGGGGC
T ss_pred CCCCCCCCCCCCCHHHHCCCCCCCCCCCCCCCHHHHCCCCCCCCCCCCCCCHHHCCCCCCCEEECCCCCCCCCCCCCCCC
T ss_conf 02431145420011020356434433222220111001111224555568512206740000002355335620312144
Q ss_pred CCCC-CCCCCCCCCCCCCC---------CEEECCCCCCCCCCCHHHCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCEEE
Q ss_conf 1478-87745566878999---------9188127868767863111787876875647738887990003999999896
Q 002673 370 VMPS-NATNQQYNQLSNLP---------PAIYLANNSLSGNIPVEIGQLKSLHVLDLSNNNFSGTIPDELSDLSNLEKLD 439 (894)
Q Consensus 370 ~~~~-~~~~l~~~~l~~Lp---------~~L~L~~N~l~~~~p~~l~~L~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~ 439 (894)
.... ..+....|+++... ..+++.++.+.+.+|..+..+++|+.|++++|.+++.+| .+..+++|+.|+
T Consensus 172 l~~l~~~l~~~~n~l~~~~~~~~~~l~~~~l~l~~~~~~~~~~~~~~~~~~l~~l~~~~~~l~~~~~-~~~~~~~L~~L~ 250 (313)
T d1ogqa_ 172 FSKLFTSMTISRNRLTGKIPPTFANLNLAFVDLSRNMLEGDASVLFGSDKNTQKIHLAKNSLAFDLG-KVGLSKNLNGLD 250 (313)
T ss_dssp CCTTCCEEECCSSEEEEECCGGGGGCCCSEEECCSSEEEECCGGGCCTTSCCSEEECCSSEECCBGG-GCCCCTTCCEEE
T ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCC-CCCCCCCCCCCC
T ss_conf 3112323102246435332433222222233333343322222222222221112222222222222-222455444444
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCC
Q ss_conf 579814675797644777655323336656798789997888886556899888887556777
Q 002673 440 LSGNHLVGEIPISLKGLHFLSSFSVAHNNLQGAVPSGGQFDTFPSFSFEGNPELCGSVVQRPC 502 (894)
Q Consensus 440 Ls~N~l~g~~p~~~~~l~~L~~L~ls~N~l~~~~~~~~~l~~L~~l~l~~N~~~c~~~~~~~c 502 (894)
|++|+|+|.+|..|.++++|+.|+|++|+|+|.+|..+.+.+|+.+++.+|+.+||.++. +|
T Consensus 251 Ls~N~l~g~iP~~l~~L~~L~~L~Ls~N~l~g~iP~~~~L~~L~~l~l~~N~~l~g~plp-~c 312 (313)
T d1ogqa_ 251 LRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIPQGGNLQRFDVSAYANNKCLCGSPLP-AC 312 (313)
T ss_dssp CCSSCCEECCCGGGGGCTTCCEEECCSSEEEEECCCSTTGGGSCGGGTCSSSEEESTTSS-CC
T ss_pred CCCCEECCCCCHHHHCCCCCCEEECCCCCCCCCCCCCCCCCCCCHHHHCCCCCCCCCCCC-CC
T ss_conf 765706660876884799999897958835166898666799897886889500198988-98
|
| >d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.86 E-value=1.3e-21 Score=144.14 Aligned_cols=183 Identities=19% Similarity=0.148 Sum_probs=131.8
Q ss_pred ECCCCCHHHHHHHHHHC-------CCCCCCCCCCC-CCCCCCCCCCCCCCCCCCCCCHHCCCCCCCCCCCCCCCCCCCCC
Q ss_conf 02899832499997201-------59999886421-23554456424002584432010013631112358661014788
Q 002673 303 LVSRPNADDLEIIFGEV-------EGKSDEGPSLF-SQANLLSGEFPKELTALPALVSEAANDEVDRSYLELPVFVMPSN 374 (894)
Q Consensus 303 ~~~~p~l~~Ldl~~n~~-------~~~l~~L~~L~-l~~N~l~~~~p~~l~~l~~L~~L~l~~n~~~~~~~~~~~~~~~~ 374 (894)
|..+++++.+++..++. ......+..+. ...+.+..+.|..|.++++|++|+++.|........
T Consensus 52 f~~l~~L~~L~ls~n~l~~i~~~~~~~~~~~~~l~~~~~~~~~~l~~~~~~~l~~L~~L~l~~n~~~~~~~~-------- 123 (284)
T d1ozna_ 52 FRACRNLTILWLHSNVLARIDAAAFTGLALLEQLDLSDNAQLRSVDPATFHGLGRLHTLHLDRCGLQELGPG-------- 123 (284)
T ss_dssp TTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSCTTCCCCCTTTTTTCTTCCEEECTTSCCCCCCTT--------
T ss_pred HHCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHCCCCCCCEEECCCCCCCCCCCC--------
T ss_conf 641421300001344543321112122222222222210223544620101010277875688544320135--------
Q ss_pred CCCCCCCCCCCCCCEEECCCCCCCCCCCHHHCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCCCCC
Q ss_conf 77455668789999188127868767863111787876875647738887990003999999896579814675797644
Q 002673 375 ATNQQYNQLSNLPPAIYLANNSLSGNIPVEIGQLKSLHVLDLSNNNFSGTIPDELSDLSNLEKLDLSGNHLVGEIPISLK 454 (894)
Q Consensus 375 ~~~l~~~~l~~Lp~~L~L~~N~l~~~~p~~l~~L~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~ 454 (894)
.+.....| ..+++.+|+|++..+..|..+++|+.|++++|++++..+..|.++++|+.+++++|++++..|..|.
T Consensus 124 ----~~~~~~~L-~~l~l~~N~l~~i~~~~f~~~~~L~~L~l~~N~l~~l~~~~f~~l~~L~~l~l~~N~l~~i~~~~f~ 198 (284)
T d1ozna_ 124 ----LFRGLAAL-QYLYLQDNALQALPDDTFRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVAHVHPHAFR 198 (284)
T ss_dssp ----TTTTCTTC-CEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTT
T ss_pred ----CCCHHCCC-CHHHHCCCCCCCCCHHHHCCCCCHHHCCCCCCCCCCCCHHHHCCCCCCCHHHHHHCCCCCCCHHHHH
T ss_conf ----33200012-1102001431445805740434050223141765662566654656341314211434662816766
Q ss_pred CCCCCCCCCCCCCCCCCCCCCC-CCCCCCCCCCCCCCCCCCCCCC
Q ss_conf 7776553233366567987899-9788888655689988888755
Q 002673 455 GLHFLSSFSVAHNNLQGAVPSG-GQFDTFPSFSFEGNPELCGSVV 498 (894)
Q Consensus 455 ~l~~L~~L~ls~N~l~~~~~~~-~~l~~L~~l~l~~N~~~c~~~~ 498 (894)
.+++|+.|++++|++.+.++.. ..+.+|+.+++.+|||.|+|..
T Consensus 199 ~l~~L~~L~l~~N~i~~~~~~~~~~~~~L~~L~l~~N~l~C~C~~ 243 (284)
T d1ozna_ 199 DLGRLMTLYLFANNLSALPTEALAPLRALQYLRLNDNPWVCDCRA 243 (284)
T ss_dssp TCTTCCEEECCSSCCSCCCHHHHTTCTTCCEEECCSSCEECSGGG
T ss_pred HHHHCCCCCCCCCCCCCCCCCCCCCCCCCCEEEECCCCCCCCCCC
T ss_conf 532000233333522100000235546568898119988787564
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Probab=99.79 E-value=7.3e-19 Score=127.57 Aligned_cols=108 Identities=21% Similarity=0.295 Sum_probs=78.4
Q ss_pred CEEECCCCCCCCCCCHHHCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCCCCCCCC
Q ss_conf 91881278687678631117878768756477388879900039999998965798146757976447776553233366
Q 002673 388 PAIYLANNSLSGNIPVEIGQLKSLHVLDLSNNNFSGTIPDELSDLSNLEKLDLSGNHLVGEIPISLKGLHFLSSFSVAHN 467 (894)
Q Consensus 388 ~~L~L~~N~l~~~~p~~l~~L~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~ls~N 467 (894)
+.|++.+|.+++..+..|.+++.++.|++++|.+++..+..+.++++|++|+|++|.|+ .+|..|..+++|+.|++++|
T Consensus 174 ~~L~l~~n~~~~~~~~~~~~~~~l~~L~~s~n~l~~~~~~~~~~l~~L~~L~L~~N~L~-~lp~~l~~l~~L~~L~Ls~N 252 (305)
T d1xkua_ 174 TELHLDGNKITKVDAASLKGLNNLAKLGLSFNSISAVDNGSLANTPHLRELHLNNNKLV-KVPGGLADHKYIQVVYLHNN 252 (305)
T ss_dssp SEEECTTSCCCEECTGGGTTCTTCCEEECCSSCCCEECTTTGGGSTTCCEEECCSSCCS-SCCTTTTTCSSCCEEECCSS
T ss_pred CEEECCCCCCCCCCHHHHHCCCCCCCCCCCCCCCCCCCCCCCCCCCCCEEEECCCCCCC-CCCCCCCCCCCCCEEECCCC
T ss_conf 78989788677888267641341330154455332223454334433224302554002-46311033467898989898
Q ss_pred CCCCCCCCC-------CCCCCCCCCCCCCCCCCCCC
Q ss_conf 567987899-------97888886556899888887
Q 002673 468 NLQGAVPSG-------GQFDTFPSFSFEGNPELCGS 496 (894)
Q Consensus 468 ~l~~~~~~~-------~~l~~L~~l~l~~N~~~c~~ 496 (894)
+|+...... ..+.+|+.+++.+|||.+..
T Consensus 253 ~i~~i~~~~f~~~~~~~~~~~L~~L~L~~N~~~~~~ 288 (305)
T d1xkua_ 253 NISAIGSNDFCPPGYNTKKASYSGVSLFSNPVQYWE 288 (305)
T ss_dssp CCCCCCTTSSSCSSCCTTSCCCSEEECCSSSSCGGG
T ss_pred CCCCCCHHHCCCCCHHCCCCCCCEEECCCCCCCCCC
T ss_conf 657638100267210021588897889899576676
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.78 E-value=1.3e-18 Score=126.12 Aligned_cols=147 Identities=23% Similarity=0.192 Sum_probs=92.3
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHCCCCCCCCCCCCCCCCCCCCCCCCCCC-----------CCCCCCCCE
Q ss_conf 999988642123554456424002584432010013631112358661014788774556-----------687899991
Q 002673 321 GKSDEGPSLFSQANLLSGEFPKELTALPALVSEAANDEVDRSYLELPVFVMPSNATNQQY-----------NQLSNLPPA 389 (894)
Q Consensus 321 ~~l~~L~~L~l~~N~l~~~~p~~l~~l~~L~~L~l~~n~~~~~~~~~~~~~~~~~~~l~~-----------~~l~~Lp~~ 389 (894)
..+++|+.|++..|.++. +| .++.+++|+.|++++|.+...............+.+.. ..+..+ ..
T Consensus 52 ~~l~~L~~L~L~~N~l~~-l~-~~~~l~~L~~L~Ls~N~l~~~~~~~~~l~~L~~L~l~~~~~~~~~~~~~~~l~~l-~~ 128 (266)
T d1p9ag_ 52 MPYTRLTQLNLDRAELTK-LQ-VDGTLPVLGTLDLSHNQLQSLPLLGQTLPALTVLDVSFNRLTSLPLGALRGLGEL-QE 128 (266)
T ss_dssp TTCTTCCEEECTTSCCCE-EE-CCSCCTTCCEEECCSSCCSSCCCCTTTCTTCCEEECCSSCCCCCCSSTTTTCTTC-CE
T ss_pred HCCCCCCCCCCCCCCCCC-CC-CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCC-CC
T ss_conf 345655221356654444-31-1111223211111222221111121222222222222231101100112222111-12
Q ss_pred EECCCCCCCCCCCHHHCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCCCCCCCCCC
Q ss_conf 88127868767863111787876875647738887990003999999896579814675797644777655323336656
Q 002673 390 IYLANNSLSGNIPVEIGQLKSLHVLDLSNNNFSGTIPDELSDLSNLEKLDLSGNHLVGEIPISLKGLHFLSSFSVAHNNL 469 (894)
Q Consensus 390 L~L~~N~l~~~~p~~l~~L~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~ls~N~l 469 (894)
|++.+|.++...+..+..+++|+.|++++|+|++..+..|..+++|+.|+|++|+|+ .+|..+..+++|+.|+|++|.+
T Consensus 129 L~l~~n~l~~l~~~~~~~l~~l~~l~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~L~-~lp~~~~~~~~L~~L~L~~Np~ 207 (266)
T d1p9ag_ 129 LYLKGNELKTLPPGLLTPTPKLEKLSLANNNLTELPAGLLNGLENLDTLLLQENSLY-TIPKGFFGSHLLPFAFLHGNPW 207 (266)
T ss_dssp EECTTSCCCCCCTTTTTTCTTCCEEECTTSCCSCCCTTTTTTCTTCCEEECCSSCCC-CCCTTTTTTCCCSEEECCSCCB
T ss_pred CCCCCCCCCEECCCCCCCCCCCHHCCCCCCCCCCCCCCCCCCCCCCCEEECCCCCCC-CCCHHHCCCCCCCEEEECCCCC
T ss_conf 212434210221233322111000000015652237200134212423430139785-5686677788899998369998
Q ss_pred CC
Q ss_conf 79
Q 002673 470 QG 471 (894)
Q Consensus 470 ~~ 471 (894)
..
T Consensus 208 ~C 209 (266)
T d1p9ag_ 208 LC 209 (266)
T ss_dssp CC
T ss_pred CC
T ss_conf 78
|
| >d1w8aa_ c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanogaster) [TaxId: 7227]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Slit species: Fruit fly (Drosophila melanogaster) [TaxId: 7227]
Probab=99.75 E-value=5.6e-18 Score=122.28 Aligned_cols=111 Identities=23% Similarity=0.404 Sum_probs=92.6
Q ss_pred CEEECCCCCCCCCC-CHHHCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCCCCCCC
Q ss_conf 91881278687678-63111787876875647738887990003999999896579814675797644777655323336
Q 002673 388 PAIYLANNSLSGNI-PVEIGQLKSLHVLDLSNNNFSGTIPDELSDLSNLEKLDLSGNHLVGEIPISLKGLHFLSSFSVAH 466 (894)
Q Consensus 388 ~~L~L~~N~l~~~~-p~~l~~L~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~ls~ 466 (894)
+.|+|++|+|++.+ +..|.++++|+.|+|++|.+....+..|..+++|+.|+|++|+|++..|..|.++++|+.|+|++
T Consensus 32 ~~L~Ls~N~i~~~~~~~~f~~l~~L~~L~L~~N~i~~~~~~~~~~~~~L~~L~Ls~N~l~~l~~~~F~~l~~L~~L~L~~ 111 (192)
T d1w8aa_ 32 TELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGIEPNAFEGASHIQELQLGENKIKEISNKMFLGLHQLKTLNLYD 111 (192)
T ss_dssp SEEECCSCCCCSBCCSCSGGGCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSCCCCEECSSSSTTCTTCCEEECCS
T ss_pred CEEEECCCCCCCCCCCCCCCCCCEEEEEECCCCCCCCCCCCCCCCCCCCCEEEECCCCCCCCCHHHHHCCCCCCCCCCCC
T ss_conf 88984898775530200257876272130136322121212221122221010035534434979980797465524577
Q ss_pred CCCCCCCCCC-CCCCCCCCCCCCCCCCCCCCCC
Q ss_conf 6567987899-9788888655689988888755
Q 002673 467 NNLQGAVPSG-GQFDTFPSFSFEGNPELCGSVV 498 (894)
Q Consensus 467 N~l~~~~~~~-~~l~~L~~l~l~~N~~~c~~~~ 498 (894)
|+|++.++.. ..+++|+.+++.+|++.|+|..
T Consensus 112 N~l~~i~~~~f~~l~~L~~l~L~~N~~~~~~~~ 144 (192)
T d1w8aa_ 112 NQISCVMPGSFEHLNSLTSLNLASNPFNCNCHL 144 (192)
T ss_dssp SCCCEECTTSSTTCTTCCEEECTTCCBCCSGGG
T ss_pred CCCCCCCHHHHCCCCCCCCCCCCCCCCCCCCCH
T ss_conf 453535977856875334200036443435302
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Probab=99.74 E-value=1.4e-18 Score=125.97 Aligned_cols=76 Identities=22% Similarity=0.281 Sum_probs=33.8
Q ss_pred EECCCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCC-CCCCCCCCCCCCCCC
Q ss_conf 75647738887990003999999896579814675797644777655323336656798789-997888886556899
Q 002673 414 LDLSNNNFSGTIPDELSDLSNLEKLDLSGNHLVGEIPISLKGLHFLSSFSVAHNNLQGAVPS-GGQFDTFPSFSFEGN 490 (894)
Q Consensus 414 L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~ls~N~l~~~~~~-~~~l~~L~~l~l~~N 490 (894)
+++++|.+.+.+|..+..+++|+.+++++|.+.+.+| .+..++.|+.|++++|+|+|.+|. +..+++|+.+++++|
T Consensus 202 l~l~~~~~~~~~~~~~~~~~~l~~l~~~~~~l~~~~~-~~~~~~~L~~L~Ls~N~l~g~iP~~l~~L~~L~~L~Ls~N 278 (313)
T d1ogqa_ 202 VDLSRNMLEGDASVLFGSDKNTQKIHLAKNSLAFDLG-KVGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFN 278 (313)
T ss_dssp EECCSSEEEECCGGGCCTTSCCSEEECCSSEECCBGG-GCCCCTTCCEEECCSSCCEECCCGGGGGCTTCCEEECCSS
T ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCC-CCCCCCCCCCCCCCCCEECCCCCHHHHCCCCCCEEECCCC
T ss_conf 3333343322222222222221112222222222222-2224554444447657066608768847999998979588
|
| >d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.73 E-value=2.8e-17 Score=118.10 Aligned_cols=168 Identities=19% Similarity=0.182 Sum_probs=136.0
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCCHHCCCCCCCCCCCCCCCCC----------CCCCCC---CCCCCCCCCCCCEEE
Q ss_conf 8864212355445642400258443201001363111235866101----------478877---455668789999188
Q 002673 325 EGPSLFSQANLLSGEFPKELTALPALVSEAANDEVDRSYLELPVFV----------MPSNAT---NQQYNQLSNLPPAIY 391 (894)
Q Consensus 325 ~L~~L~l~~N~l~~~~p~~l~~l~~L~~L~l~~n~~~~~~~~~~~~----------~~~~~~---~l~~~~l~~Lp~~L~ 391 (894)
.++.|+++.|+|..+.+..|.++++|++|++++|.+.......+.. ..+.+. +..+..+++| +.|+
T Consensus 33 ~~~~L~Ls~N~i~~i~~~~f~~l~~L~~L~ls~n~l~~i~~~~~~~~~~~~~l~~~~~~~~~~l~~~~~~~l~~L-~~L~ 111 (284)
T d1ozna_ 33 ASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALLEQLDLSDNAQLRSVDPATFHGLGRL-HTLH 111 (284)
T ss_dssp TCSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSCTTCCCCCTTTTTTCTTC-CEEE
T ss_pred CCCEEECCCCCCCCCCHHHHHCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHCCCCCC-CEEE
T ss_conf 988897748817987977864142130000134454332111212222222222221022354462010101027-7875
Q ss_pred CCCCCCCCCCCHHHCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCC
Q ss_conf 12786876786311178787687564773888799000399999989657981467579764477765532333665679
Q 002673 392 LANNSLSGNIPVEIGQLKSLHVLDLSNNNFSGTIPDELSDLSNLEKLDLSGNHLVGEIPISLKGLHFLSSFSVAHNNLQG 471 (894)
Q Consensus 392 L~~N~l~~~~p~~l~~L~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~ls~N~l~~ 471 (894)
+++|.+....+..+..+.+|+.+++++|+|++..+..|..+++|+.|++++|+|++..+..|.++++|+.+++++|++.+
T Consensus 112 l~~n~~~~~~~~~~~~~~~L~~l~l~~N~l~~i~~~~f~~~~~L~~L~l~~N~l~~l~~~~f~~l~~L~~l~l~~N~l~~ 191 (284)
T d1ozna_ 112 LDRCGLQELGPGLFRGLAALQYLYLQDNALQALPDDTFRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVAH 191 (284)
T ss_dssp CTTSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCE
T ss_pred CCCCCCCCCCCCCCCHHCCCCHHHHCCCCCCCCCHHHHCCCCCHHHCCCCCCCCCCCCHHHHCCCCCCCHHHHHHCCCCC
T ss_conf 68854432013533200012110200143144580574043405022314176566256665465634131421143466
Q ss_pred CCCCC-CCCCCCCCCCCCCCCCC
Q ss_conf 87899-97888886556899888
Q 002673 472 AVPSG-GQFDTFPSFSFEGNPEL 493 (894)
Q Consensus 472 ~~~~~-~~l~~L~~l~l~~N~~~ 493 (894)
..|.. ..+++++.+++.+|...
T Consensus 192 i~~~~f~~l~~L~~L~l~~N~i~ 214 (284)
T d1ozna_ 192 VHPHAFRDLGRLMTLYLFANNLS 214 (284)
T ss_dssp ECTTTTTTCTTCCEEECCSSCCS
T ss_pred CCHHHHHHHHHCCCCCCCCCCCC
T ss_conf 28167665320002333335221
|
| >d1w8aa_ c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanogaster) [TaxId: 7227]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Slit species: Fruit fly (Drosophila melanogaster) [TaxId: 7227]
Probab=99.70 E-value=2.8e-17 Score=118.04 Aligned_cols=157 Identities=18% Similarity=0.173 Sum_probs=96.0
Q ss_pred CCCCCCCCCCCCCCCC-CCCCCCCCCCCHHCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCH
Q ss_conf 8864212355445642-400258443201001363111235866101478877455668789999188127868767863
Q 002673 325 EGPSLFSQANLLSGEF-PKELTALPALVSEAANDEVDRSYLELPVFVMPSNATNQQYNQLSNLPPAIYLANNSLSGNIPV 403 (894)
Q Consensus 325 ~L~~L~l~~N~l~~~~-p~~l~~l~~L~~L~l~~n~~~~~~~~~~~~~~~~~~~l~~~~l~~Lp~~L~L~~N~l~~~~p~ 403 (894)
+++.|++..|.|.+.+ +..|.++++|+.|++.+|.+...... .+..+..| +.|+|++|+|+...|.
T Consensus 30 ~l~~L~Ls~N~i~~~~~~~~f~~l~~L~~L~L~~N~i~~~~~~------------~~~~~~~L-~~L~Ls~N~l~~l~~~ 96 (192)
T d1w8aa_ 30 HTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGIEPN------------AFEGASHI-QELQLGENKIKEISNK 96 (192)
T ss_dssp TCSEEECCSCCCCSBCCSCSGGGCTTCCEEECCSSCCCCBCTT------------TTTTCTTC-CEEECCSCCCCEECSS
T ss_pred CCCEEEECCCCCCCCCCCCCCCCCCEEEEEECCCCCCCCCCCC------------CCCCCCCC-CEEEECCCCCCCCCHH
T ss_conf 8788984898775530200257876272130136322121212------------22112222-1010035534434979
Q ss_pred HHCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCC
Q ss_conf 11178787687564773888799000399999989657981467579764477765532333665679878999788888
Q 002673 404 EIGQLKSLHVLDLSNNNFSGTIPDELSDLSNLEKLDLSGNHLVGEIPISLKGLHFLSSFSVAHNNLQGAVPSGGQFDTFP 483 (894)
Q Consensus 404 ~l~~L~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~ls~N~l~~~~~~~~~l~~L~ 483 (894)
.|.++++|++|+|++|+|++..+..|..+++|++|+|++|.+....+. ..-...+..+.+..|.+....|. .+..++
T Consensus 97 ~F~~l~~L~~L~L~~N~l~~i~~~~f~~l~~L~~l~L~~N~~~~~~~~-~~~~~~l~~~~l~~~~~~c~~p~--~l~~~~ 173 (192)
T d1w8aa_ 97 MFLGLHQLKTLNLYDNQISCVMPGSFEHLNSLTSLNLASNPFNCNCHL-AWFAEWLRKKSLNGGAARCGAPS--KVRDVQ 173 (192)
T ss_dssp SSTTCTTCCEEECCSSCCCEECTTSSTTCTTCCEEECTTCCBCCSGGG-HHHHHHHHHHCCSGGGCBBCSST--TTTTSB
T ss_pred HHHCCCCCCCCCCCCCCCCCCCHHHHCCCCCCCCCCCCCCCCCCCCCH-HHHHHHHHHHCCCCCCEEECCCH--HHCCCE
T ss_conf 980797465524577453535977856875334200036443435302-77764235403568982768984--336988
Q ss_pred CCCCCCCCCCCCCC
Q ss_conf 65568998888875
Q 002673 484 SFSFEGNPELCGSV 497 (894)
Q Consensus 484 ~l~l~~N~~~c~~~ 497 (894)
.+++..|...|.+.
T Consensus 174 l~~L~~n~l~C~~~ 187 (192)
T d1w8aa_ 174 IKDLPHSEFKCSSE 187 (192)
T ss_dssp GGGSCTTTCCCCCC
T ss_pred EEECCHHHCCCCCC
T ss_conf 61448755758998
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Probab=99.69 E-value=2.1e-16 Score=112.81 Aligned_cols=182 Identities=19% Similarity=0.175 Sum_probs=124.4
Q ss_pred CCHHHHHHHHHHC-------CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHCCCCCCCCCCCCCCCCC---------
Q ss_conf 9832499997201-------599998864212355445642400258443201001363111235866101---------
Q 002673 307 PNADDLEIIFGEV-------EGKSDEGPSLFSQANLLSGEFPKELTALPALVSEAANDEVDRSYLELPVFV--------- 370 (894)
Q Consensus 307 p~l~~Ldl~~n~~-------~~~l~~L~~L~l~~N~l~~~~p~~l~~l~~L~~L~l~~n~~~~~~~~~~~~--------- 370 (894)
++++.|++..|+. +..+++++.+++..|.+..+.|..|.++++|+.|++.+|.+..++......
T Consensus 31 ~~l~~L~Ls~N~i~~l~~~~f~~l~~L~~L~l~~n~~~~i~~~~f~~l~~L~~L~l~~n~l~~l~~~~~~~l~~L~~~~n 110 (305)
T d1xkua_ 31 PDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKLERLYLSKNQLKELPEKMPKTLQELRVHEN 110 (305)
T ss_dssp TTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSSCCSBCCSSCCTTCCEEECCSS
T ss_pred CCCCEEECCCCCCCCCCHHHHHCCCCCCCCCCCCCCCCCCCHHHHHCCCCCCEECCCCCCCCCCCCCHHHHHHHHHCCCC
T ss_conf 99798978499189869657604656523112344344523566527985578315687567676400111323210246
Q ss_pred ------------C---------CC-----CCCCCCCCCCCCCCCEEECCCCCCCCCCCHHHCCCCCCCEEECCCCCCCCC
Q ss_conf ------------4---------78-----877455668789999188127868767863111787876875647738887
Q 002673 371 ------------M---------PS-----NATNQQYNQLSNLPPAIYLANNSLSGNIPVEIGQLKSLHVLDLSNNNFSGT 424 (894)
Q Consensus 371 ------------~---------~~-----~~~~l~~~~l~~Lp~~L~L~~N~l~~~~p~~l~~L~~L~~L~Ls~N~l~g~ 424 (894)
. .+ ......+..++.| ..+++.+|+++ .+|..+ +++|+.|++++|.+++.
T Consensus 111 ~l~~l~~~~~~~~~~~~~l~~~~n~~~~~~~~~~~~~~l~~L-~~l~l~~n~l~-~l~~~~--~~~L~~L~l~~n~~~~~ 186 (305)
T d1xkua_ 111 EITKVRKSVFNGLNQMIVVELGTNPLKSSGIENGAFQGMKKL-SYIRIADTNIT-TIPQGL--PPSLTELHLDGNKITKV 186 (305)
T ss_dssp CCCBBCHHHHTTCTTCCEEECCSSCCCGGGBCTTGGGGCTTC-CEEECCSSCCC-SCCSSC--CTTCSEEECTTSCCCEE
T ss_pred CHHHHHHHHHHCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCC-CCCCCCCCCCC-CCCCCC--CCCCCEEECCCCCCCCC
T ss_conf 102344445401331100001233333467776422345656-71203467745-167101--77667898978867788
Q ss_pred CCCCCCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCC
Q ss_conf 99000399999989657981467579764477765532333665679878999788888655689988
Q 002673 425 IPDELSDLSNLEKLDLSGNHLVGEIPISLKGLHFLSSFSVAHNNLQGAVPSGGQFDTFPSFSFEGNPE 492 (894)
Q Consensus 425 ~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~ls~N~l~~~~~~~~~l~~L~~l~l~~N~~ 492 (894)
.+..|.+++.++.|++++|.+++..+..+..+++|+.|+|++|+|+..++....+++|+.+++++|..
T Consensus 187 ~~~~~~~~~~l~~L~~s~n~l~~~~~~~~~~l~~L~~L~L~~N~L~~lp~~l~~l~~L~~L~Ls~N~i 254 (305)
T d1xkua_ 187 DAASLKGLNNLAKLGLSFNSISAVDNGSLANTPHLRELHLNNNKLVKVPGGLADHKYIQVVYLHNNNI 254 (305)
T ss_dssp CTGGGTTCTTCCEEECCSSCCCEECTTTGGGSTTCCEEECCSSCCSSCCTTTTTCSSCCEEECCSSCC
T ss_pred CHHHHHCCCCCCCCCCCCCCCCCCCCCCCCCCCCCEEEECCCCCCCCCCCCCCCCCCCCEEECCCCCC
T ss_conf 82676413413301544553322234543344332243025540024631103346789898989865
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Probab=99.66 E-value=9.3e-17 Score=114.96 Aligned_cols=178 Identities=23% Similarity=0.283 Sum_probs=117.7
Q ss_pred ECCCCCHHHHHHHHHHC-----CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHCCCCCCCCCCCCCCCCCCCCCCCC
Q ss_conf 02899832499997201-----5999988642123554456424002584432010013631112358661014788774
Q 002673 303 LVSRPNADDLEIIFGEV-----EGKSDEGPSLFSQANLLSGEFPKELTALPALVSEAANDEVDRSYLELPVFVMPSNATN 377 (894)
Q Consensus 303 ~~~~p~l~~Ldl~~n~~-----~~~l~~L~~L~l~~N~l~~~~p~~l~~l~~L~~L~l~~n~~~~~~~~~~~~~~~~~~~ 377 (894)
+...+.+..+++..+.. ....++++.+.+..|.+.. + ..+..+++|+.|.+.+|.+....+.. .......+.
T Consensus 193 ~~~l~~~~~l~l~~n~i~~~~~~~~~~~L~~L~l~~n~l~~-~-~~l~~l~~L~~L~l~~n~l~~~~~~~-~~~~L~~L~ 269 (384)
T d2omza2 193 LAKLTNLESLIATNNQISDITPLGILTNLDELSLNGNQLKD-I-GTLASLTNLTDLDLANNQISNLAPLS-GLTKLTELK 269 (384)
T ss_dssp GGGCTTCSEEECCSSCCCCCGGGGGCTTCCEEECCSSCCCC-C-GGGGGCTTCSEEECCSSCCCCCGGGT-TCTTCSEEE
T ss_pred CCCCCCCCEEECCCCCCCCCCCCCCCCCCCEEECCCCCCCC-C-CHHHCCCCCCHHCCCCCCCCCCCCCC-CCCCCCEEE
T ss_conf 02235323330357744787864445778788887777789-6-13432565341004467447877535-546687754
Q ss_pred CCCCCCCCCC--------CEEECCCCCCCCCCCHHHCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCC
Q ss_conf 5566878999--------91881278687678631117878768756477388879900039999998965798146757
Q 002673 378 QQYNQLSNLP--------PAIYLANNSLSGNIPVEIGQLKSLHVLDLSNNNFSGTIPDELSDLSNLEKLDLSGNHLVGEI 449 (894)
Q Consensus 378 l~~~~l~~Lp--------~~L~L~~N~l~~~~p~~l~~L~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~g~~ 449 (894)
+..+.++.++ ..+.+..|++++ + ..+..+.+++.|++++|++++ ++ .+..+++|+.|++++|+|+ .+
T Consensus 270 l~~~~l~~~~~~~~~~~l~~l~~~~n~l~~-~-~~~~~~~~l~~L~ls~n~l~~-l~-~l~~l~~L~~L~L~~n~l~-~l 344 (384)
T d2omza2 270 LGANQISNISPLAGLTALTNLELNENQLED-I-SPISNLKNLTYLTLYFNNISD-IS-PVSSLTKLQRLFFANNKVS-DV 344 (384)
T ss_dssp CCSSCCCCCGGGTTCTTCSEEECCSSCCSC-C-GGGGGCTTCSEEECCSSCCSC-CG-GGGGCTTCCEEECCSSCCC-CC
T ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCCCCC-C-CCCCHHCCCCEEECCCCCCCC-CC-CCCCCCCCCEEECCCCCCC-CC
T ss_conf 567445787732356522223323233333-2-210000246767777887789-84-5366898898989899899-97
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCC
Q ss_conf 97644777655323336656798789997888886556899
Q 002673 450 PISLKGLHFLSSFSVAHNNLQGAVPSGGQFDTFPSFSFEGN 490 (894)
Q Consensus 450 p~~~~~l~~L~~L~ls~N~l~~~~~~~~~l~~L~~l~l~~N 490 (894)
+ .+.++++|+.|++++|+|++.+| ...+++|+.+++++|
T Consensus 345 ~-~l~~l~~L~~L~l~~N~l~~l~~-l~~l~~L~~L~L~~N 383 (384)
T d2omza2 345 S-SLANLTNINWLSAGHNQISDLTP-LANLTRITQLGLNDQ 383 (384)
T ss_dssp G-GGGGCTTCCEEECCSSCCCBCGG-GTTCTTCSEEECCCE
T ss_pred H-HHCCCCCCCEEECCCCCCCCCHH-HCCCCCCCEEECCCC
T ss_conf 4-67089999989897995899800-003999999639789
|
| >d2omxa2 c.10.2.1 (A:37-235) Internalin B {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Probab=99.58 E-value=8.7e-15 Score=103.15 Aligned_cols=145 Identities=23% Similarity=0.335 Sum_probs=94.8
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCC
Q ss_conf 99886421235544564240025844320100136311123586610147887745566878999918812786876786
Q 002673 323 SDEGPSLFSQANLLSGEFPKELTALPALVSEAANDEVDRSYLELPVFVMPSNATNQQYNQLSNLPPAIYLANNSLSGNIP 402 (894)
Q Consensus 323 l~~L~~L~l~~N~l~~~~p~~l~~l~~L~~L~l~~n~~~~~~~~~~~~~~~~~~~l~~~~l~~Lp~~L~L~~N~l~~~~p 402 (894)
+++++.|++..|.+.. + +.++.+++|++|++++|.+....+ +.++.+| +.|++++|.+. .++
T Consensus 39 l~~l~~L~l~~~~i~~-l-~~l~~l~nL~~L~Ls~N~l~~~~~--------------l~~l~~L-~~L~l~~n~~~-~~~ 100 (199)
T d2omxa2 39 LDQVTTLQADRLGIKS-I-DGVEYLNNLTQINFSNNQLTDITP--------------LKNLTKL-VDILMNNNQIA-DIT 100 (199)
T ss_dssp HTTCCEEECTTSCCCC-C-TTGGGCTTCCEEECCSSCCCCCGG--------------GTTCTTC-CEEECCSSCCC-CCG
T ss_pred HCCCCEEECCCCCCCC-C-CCCCCCCCCCCCCCCCCCCCCCCC--------------CCCCCCC-CCCCCCCCCCC-CCC
T ss_conf 4687899899999977-5-202137886757545655667640--------------1677522-31111222222-221
Q ss_pred HHHCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCC
Q ss_conf 31117878768756477388879900039999998965798146757976447776553233366567987899978888
Q 002673 403 VEIGQLKSLHVLDLSNNNFSGTIPDELSDLSNLEKLDLSGNHLVGEIPISLKGLHFLSSFSVAHNNLQGAVPSGGQFDTF 482 (894)
Q Consensus 403 ~~l~~L~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~ls~N~l~~~~~~~~~l~~L 482 (894)
.+.++++|+.|++++|.+.. ++ .+..+++|+.|++++|++. .++ .+..+++|+.|++++|++++.. ....+++|
T Consensus 101 -~l~~l~~L~~L~l~~~~~~~-~~-~~~~l~~L~~L~l~~n~l~-~~~-~l~~~~~L~~L~l~~n~l~~l~-~l~~l~~L 174 (199)
T d2omxa2 101 -PLANLTNLTGLTLFNNQITD-ID-PLKNLTNLNRLELSSNTIS-DIS-ALSGLTSLQQLNFSSNQVTDLK-PLANLTTL 174 (199)
T ss_dssp -GGTTCTTCSEEECCSSCCCC-CG-GGTTCTTCSEEECCSSCCC-CCG-GGTTCTTCSEEECCSSCCCCCG-GGTTCTTC
T ss_pred -CCCCCCCCCCCCCCCCCCCC-CC-CCCHHHHHHHHHHHHHHHC-CCC-CCCCCCCCCCCCCCCCCCCCCC-CCCCCCCC
T ss_conf -11112232221112222223-21-0001223677643111100-234-3332111111223455556770-11679989
Q ss_pred CCCCCCCCC
Q ss_conf 865568998
Q 002673 483 PSFSFEGNP 491 (894)
Q Consensus 483 ~~l~l~~N~ 491 (894)
+.+++++|+
T Consensus 175 ~~L~ls~N~ 183 (199)
T d2omxa2 175 ERLDISSNK 183 (199)
T ss_dssp CEEECCSSC
T ss_pred CEEECCCCC
T ss_conf 999787997
|
| >d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Probab=99.58 E-value=7e-15 Score=103.72 Aligned_cols=145 Identities=22% Similarity=0.315 Sum_probs=88.8
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCCCHHCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCH
Q ss_conf 98864212355445642400258443201001363111235866101478877455668789999188127868767863
Q 002673 324 DEGPSLFSQANLLSGEFPKELTALPALVSEAANDEVDRSYLELPVFVMPSNATNQQYNQLSNLPPAIYLANNSLSGNIPV 403 (894)
Q Consensus 324 ~~L~~L~l~~N~l~~~~p~~l~~l~~L~~L~l~~n~~~~~~~~~~~~~~~~~~~l~~~~l~~Lp~~L~L~~N~l~~~~p~ 403 (894)
.+++.+.+..|.+.. ++ .+..+++|++|++++|.+...... ..+++| +.|++++|+|+ .+|
T Consensus 46 ~~L~~L~l~~~~i~~-l~-~l~~l~~L~~L~L~~n~i~~l~~~--------------~~l~~L-~~L~l~~n~i~-~l~- 106 (210)
T d1h6ta2 46 NSIDQIIANNSDIKS-VQ-GIQYLPNVTKLFLNGNKLTDIKPL--------------ANLKNL-GWLFLDENKVK-DLS- 106 (210)
T ss_dssp HTCCEEECTTSCCCC-CT-TGGGCTTCCEEECCSSCCCCCGGG--------------TTCTTC-CEEECCSSCCC-CGG-
T ss_pred CCCCEEECCCCCCCC-CH-HHHHCCCCCEEECCCCCCCCCCCC--------------CCCCCC-CCCCCCCCCCC-CCC-
T ss_conf 484589782798887-44-476489989876989602586011--------------358621-20143333321-222-
Q ss_pred HHCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCC
Q ss_conf 11178787687564773888799000399999989657981467579764477765532333665679878999788888
Q 002673 404 EIGQLKSLHVLDLSNNNFSGTIPDELSDLSNLEKLDLSGNHLVGEIPISLKGLHFLSSFSVAHNNLQGAVPSGGQFDTFP 483 (894)
Q Consensus 404 ~l~~L~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~ls~N~l~~~~~~~~~l~~L~ 483 (894)
.+.++++|+.|++++|.+. .++ .+..+++|+.+++++|.++ ..+ .+..+++|+.+++++|++++.. ....+++|+
T Consensus 107 ~l~~l~~L~~L~l~~~~~~-~~~-~l~~l~~l~~l~~~~n~l~-~~~-~~~~l~~L~~l~l~~n~l~~i~-~l~~l~~L~ 181 (210)
T d1h6ta2 107 SLKDLKKLKSLSLEHNGIS-DIN-GLVHLPQLESLYLGNNKIT-DIT-VLSRLTKLDTLSLEDNQISDIV-PLAGLTKLQ 181 (210)
T ss_dssp GGTTCTTCCEEECTTSCCC-CCG-GGGGCTTCCEEECCSSCCC-CCG-GGGGCTTCSEEECCSSCCCCCG-GGTTCTTCC
T ss_pred CCCCCCCCCCCCCCCCCCC-CCC-CCCCCCCCCCCCCCCCCCC-CCC-CCCCCCCCCCCCCCCCCCCCCC-CCCCCCCCC
T ss_conf 1212221112234565322-112-2011111222112223334-543-1000133210013464302564-536789899
Q ss_pred CCCCCCCCC
Q ss_conf 655689988
Q 002673 484 SFSFEGNPE 492 (894)
Q Consensus 484 ~l~l~~N~~ 492 (894)
.+++++|..
T Consensus 182 ~L~Ls~N~i 190 (210)
T d1h6ta2 182 NLYLSKNHI 190 (210)
T ss_dssp EEECCSSCC
T ss_pred EEECCCCCC
T ss_conf 998979989
|
| >d2omxa2 c.10.2.1 (A:37-235) Internalin B {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Probab=99.57 E-value=1.4e-14 Score=101.84 Aligned_cols=141 Identities=25% Similarity=0.354 Sum_probs=112.2
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCEEECCCCCCCCC
Q ss_conf 99998864212355445642400258443201001363111235866101478877455668789999188127868767
Q 002673 321 GKSDEGPSLFSQANLLSGEFPKELTALPALVSEAANDEVDRSYLELPVFVMPSNATNQQYNQLSNLPPAIYLANNSLSGN 400 (894)
Q Consensus 321 ~~l~~L~~L~l~~N~l~~~~p~~l~~l~~L~~L~l~~n~~~~~~~~~~~~~~~~~~~l~~~~l~~Lp~~L~L~~N~l~~~ 400 (894)
+.+++++.|++..|.+.+..| +.++++|++|+++.|.+..... +..+..| +.|++++|.+..
T Consensus 59 ~~l~nL~~L~Ls~N~l~~~~~--l~~l~~L~~L~l~~n~~~~~~~--------------l~~l~~L-~~L~l~~~~~~~- 120 (199)
T d2omxa2 59 EYLNNLTQINFSNNQLTDITP--LKNLTKLVDILMNNNQIADITP--------------LANLTNL-TGLTLFNNQITD- 120 (199)
T ss_dssp GGCTTCCEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCCCCGG--------------GTTCTTC-SEEECCSSCCCC-
T ss_pred CCCCCCCCCCCCCCCCCCCCC--CCCCCCCCCCCCCCCCCCCCCC--------------CCCCCCC-CCCCCCCCCCCC-
T ss_conf 137886757545655667640--1677522311112222222211--------------1112232-221112222223-
Q ss_pred CCHHHCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCC
Q ss_conf 86311178787687564773888799000399999989657981467579764477765532333665679878999788
Q 002673 401 IPVEIGQLKSLHVLDLSNNNFSGTIPDELSDLSNLEKLDLSGNHLVGEIPISLKGLHFLSSFSVAHNNLQGAVPSGGQFD 480 (894)
Q Consensus 401 ~p~~l~~L~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~ls~N~l~~~~~~~~~l~ 480 (894)
++ .+..+++|+.|++++|++. .++ .+..+++|+.|++++|.++ .++ .+.++++|+.|++++|+++.. +....++
T Consensus 121 ~~-~~~~l~~L~~L~l~~n~l~-~~~-~l~~~~~L~~L~l~~n~l~-~l~-~l~~l~~L~~L~ls~N~i~~i-~~l~~L~ 194 (199)
T d2omxa2 121 ID-PLKNLTNLNRLELSSNTIS-DIS-ALSGLTSLQQLNFSSNQVT-DLK-PLANLTTLERLDISSNKVSDI-SVLAKLT 194 (199)
T ss_dssp CG-GGTTCTTCSEEECCSSCCC-CCG-GGTTCTTCSEEECCSSCCC-CCG-GGTTCTTCCEEECCSSCCCCC-GGGGGCT
T ss_pred CC-CCCHHHHHHHHHHHHHHHC-CCC-CCCCCCCCCCCCCCCCCCC-CCC-CCCCCCCCCEEECCCCCCCCC-CCCCCCC
T ss_conf 21-0001223677643111100-234-3332111111223455556-770-116799899997879979988-1012789
Q ss_pred CCCCC
Q ss_conf 88865
Q 002673 481 TFPSF 485 (894)
Q Consensus 481 ~L~~l 485 (894)
+|+.|
T Consensus 195 ~L~~L 199 (199)
T d2omxa2 195 NLESL 199 (199)
T ss_dssp TCSEE
T ss_pred CCCCC
T ss_conf 98949
|
| >d2ifga3 c.10.2.7 (A:36-191) High affinity nerve growth factor receptor, N-terminal domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: High affinity nerve growth factor receptor, N-terminal domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.56 E-value=9.5e-15 Score=102.91 Aligned_cols=110 Identities=16% Similarity=0.164 Sum_probs=94.2
Q ss_pred CEEECCCCCCCCCCCHHHCCCCCCCEEECCCC-CCCCCCCCCCCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCCCCCCC
Q ss_conf 91881278687678631117878768756477-38887990003999999896579814675797644777655323336
Q 002673 388 PAIYLANNSLSGNIPVEIGQLKSLHVLDLSNN-NFSGTIPDELSDLSNLEKLDLSGNHLVGEIPISLKGLHFLSSFSVAH 466 (894)
Q Consensus 388 ~~L~L~~N~l~~~~p~~l~~L~~L~~L~Ls~N-~l~g~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~ls~ 466 (894)
..+...++++. ..|..+..+++|+.|++++| .|+..-+..|.++++|+.|+|++|+|+...|..|..+++|+.|+|++
T Consensus 11 ~~l~c~~~~~~-~~p~~l~~l~~l~~L~l~~n~~l~~i~~~~f~~l~~L~~L~Ls~N~l~~i~~~~f~~l~~L~~L~Ls~ 89 (156)
T d2ifga3 11 SGLRCTRDGAL-DSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRLSRLNLSF 89 (156)
T ss_dssp SCEECCSSCCC-TTTTTSCSCSCCSEEECCSCSSCCEECGGGSCSCCCCSEEECCSSCCCEECTTGGGSCSCCCEEECCS
T ss_pred CEEEECCCCCC-CCCCCCCCCCCCCEEECCCCCCCCCCCCHHHCCCCCCCCCEEECCCCCCCCCCCCCCCCCCCCEECCC
T ss_conf 96985289976-58600257656574316898664436921225666667216202124774201112455433332267
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCC
Q ss_conf 65679878999788888655689988888755
Q 002673 467 NNLQGAVPSGGQFDTFPSFSFEGNPELCGSVV 498 (894)
Q Consensus 467 N~l~~~~~~~~~l~~L~~l~l~~N~~~c~~~~ 498 (894)
|+|+..++.......+..+++.+|||.|+|..
T Consensus 90 N~l~~l~~~~~~~~~l~~L~L~~Np~~C~C~~ 121 (156)
T d2ifga3 90 NALESLSWKTVQGLSLQELVLSGNPLHCSCAL 121 (156)
T ss_dssp SCCSCCCSTTTCSCCCCEEECCSSCCCCCGGG
T ss_pred CCCCCCCHHHHCCCCCCCCCCCCCCCCCCCHH
T ss_conf 87851574563353212433579863388117
|
| >d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Probab=99.55 E-value=2.5e-14 Score=100.39 Aligned_cols=144 Identities=23% Similarity=0.315 Sum_probs=112.7
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCEEECCCCCCCCC
Q ss_conf 99998864212355445642400258443201001363111235866101478877455668789999188127868767
Q 002673 321 GKSDEGPSLFSQANLLSGEFPKELTALPALVSEAANDEVDRSYLELPVFVMPSNATNQQYNQLSNLPPAIYLANNSLSGN 400 (894)
Q Consensus 321 ~~l~~L~~L~l~~N~l~~~~p~~l~~l~~L~~L~l~~n~~~~~~~~~~~~~~~~~~~l~~~~l~~Lp~~L~L~~N~l~~~ 400 (894)
+.+++++.|++..|.+.+ ++ .++.+++|+.|++.+|.+..... +..++.| +.|++.+|.+. .
T Consensus 65 ~~l~~L~~L~L~~n~i~~-l~-~~~~l~~L~~L~l~~n~i~~l~~--------------l~~l~~L-~~L~l~~~~~~-~ 126 (210)
T d1h6ta2 65 QYLPNVTKLFLNGNKLTD-IK-PLANLKNLGWLFLDENKVKDLSS--------------LKDLKKL-KSLSLEHNGIS-D 126 (210)
T ss_dssp GGCTTCCEEECCSSCCCC-CG-GGTTCTTCCEEECCSSCCCCGGG--------------GTTCTTC-CEEECTTSCCC-C
T ss_pred HHCCCCCEEECCCCCCCC-CC-CCCCCCCCCCCCCCCCCCCCCCC--------------CCCCCCC-CCCCCCCCCCC-C
T ss_conf 648998987698960258-60-11358621201433333212221--------------2122211-12234565322-1
Q ss_pred CCHHHCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCC
Q ss_conf 86311178787687564773888799000399999989657981467579764477765532333665679878999788
Q 002673 401 IPVEIGQLKSLHVLDLSNNNFSGTIPDELSDLSNLEKLDLSGNHLVGEIPISLKGLHFLSSFSVAHNNLQGAVPSGGQFD 480 (894)
Q Consensus 401 ~p~~l~~L~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~ls~N~l~~~~~~~~~l~ 480 (894)
++ .+..+++|+.+++++|.+++ . ..+..+++|+.+++++|+++ .++ .+.++++|+.|++++|+++. ++....++
T Consensus 127 ~~-~l~~l~~l~~l~~~~n~l~~-~-~~~~~l~~L~~l~l~~n~l~-~i~-~l~~l~~L~~L~Ls~N~i~~-l~~l~~l~ 200 (210)
T d1h6ta2 127 IN-GLVHLPQLESLYLGNNKITD-I-TVLSRLTKLDTLSLEDNQIS-DIV-PLAGLTKLQNLYLSKNHISD-LRALAGLK 200 (210)
T ss_dssp CG-GGGGCTTCCEEECCSSCCCC-C-GGGGGCTTCSEEECCSSCCC-CCG-GGTTCTTCCEEECCSSCCCB-CGGGTTCT
T ss_pred CC-CCCCCCCCCCCCCCCCCCCC-C-CCCCCCCCCCCCCCCCCCCC-CCC-CCCCCCCCCEEECCCCCCCC-CHHHCCCC
T ss_conf 12-20111112221122233345-4-31000133210013464302-564-53678989999897998998-72116999
Q ss_pred CCCCCCCC
Q ss_conf 88865568
Q 002673 481 TFPSFSFE 488 (894)
Q Consensus 481 ~L~~l~l~ 488 (894)
+|+.+++.
T Consensus 201 ~L~~L~Ls 208 (210)
T d1h6ta2 201 NLDVLELF 208 (210)
T ss_dssp TCSEEEEE
T ss_pred CCCEEECC
T ss_conf 98999711
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Probab=99.53 E-value=1e-14 Score=102.70 Aligned_cols=157 Identities=24% Similarity=0.253 Sum_probs=58.2
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHCCCCCCCCCCCCCCCCCCCCCCCCCCCCCC---------CCCCCEEECC
Q ss_conf 9988642123554456424002584432010013631112358661014788774556687---------8999918812
Q 002673 323 SDEGPSLFSQANLLSGEFPKELTALPALVSEAANDEVDRSYLELPVFVMPSNATNQQYNQL---------SNLPPAIYLA 393 (894)
Q Consensus 323 l~~L~~L~l~~N~l~~~~p~~l~~l~~L~~L~l~~n~~~~~~~~~~~~~~~~~~~l~~~~l---------~~Lp~~L~L~ 393 (894)
++++..+.+..|.+.+..| +...++|+.|++++|.+...... ........+.+..+.+ .+| +.|+++
T Consensus 196 l~~~~~l~l~~n~i~~~~~--~~~~~~L~~L~l~~n~l~~~~~l-~~l~~L~~L~l~~n~l~~~~~~~~~~~L-~~L~l~ 271 (384)
T d2omza2 196 LTNLESLIATNNQISDITP--LGILTNLDELSLNGNQLKDIGTL-ASLTNLTDLDLANNQISNLAPLSGLTKL-TELKLG 271 (384)
T ss_dssp CTTCSEEECCSSCCCCCGG--GGGCTTCCEEECCSSCCCCCGGG-GGCTTCSEEECCSSCCCCCGGGTTCTTC-SEEECC
T ss_pred CCCCCEEECCCCCCCCCCC--CCCCCCCCEEECCCCCCCCCCHH-HCCCCCCHHCCCCCCCCCCCCCCCCCCC-CEEECC
T ss_conf 3532333035774478786--44457787888877777896134-3256534100446744787753554668-775456
Q ss_pred CCCCCCCCCHHHCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCC
Q ss_conf 78687678631117878768756477388879900039999998965798146757976447776553233366567987
Q 002673 394 NNSLSGNIPVEIGQLKSLHVLDLSNNNFSGTIPDELSDLSNLEKLDLSGNHLVGEIPISLKGLHFLSSFSVAHNNLQGAV 473 (894)
Q Consensus 394 ~N~l~~~~p~~l~~L~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~ls~N~l~~~~ 473 (894)
+|++++. + .+.++..++.+.+..|++++ + ..+..+++++.|++++|++++ ++ .+..+++|+.|++++|+|++.
T Consensus 272 ~~~l~~~-~-~~~~~~~l~~l~~~~n~l~~-~-~~~~~~~~l~~L~ls~n~l~~-l~-~l~~l~~L~~L~L~~n~l~~l- 344 (384)
T d2omza2 272 ANQISNI-S-PLAGLTALTNLELNENQLED-I-SPISNLKNLTYLTLYFNNISD-IS-PVSSLTKLQRLFFANNKVSDV- 344 (384)
T ss_dssp SSCCCCC-G-GGTTCTTCSEEECCSSCCSC-C-GGGGGCTTCSEEECCSSCCSC-CG-GGGGCTTCCEEECCSSCCCCC-
T ss_pred CCCCCCC-C-CCCCCCCCCCCCCCCCCCCC-C-CCCCHHCCCCEEECCCCCCCC-CC-CCCCCCCCCEEECCCCCCCCC-
T ss_conf 7445787-7-32356522223323233333-2-210000246767777887789-84-536689889898989989997-
Q ss_pred CCCCCCCCCCCCCCCCC
Q ss_conf 89997888886556899
Q 002673 474 PSGGQFDTFPSFSFEGN 490 (894)
Q Consensus 474 ~~~~~l~~L~~l~l~~N 490 (894)
+....+++|+.+++++|
T Consensus 345 ~~l~~l~~L~~L~l~~N 361 (384)
T d2omza2 345 SSLANLTNINWLSAGHN 361 (384)
T ss_dssp GGGGGCTTCCEEECCSS
T ss_pred HHHCCCCCCCEEECCCC
T ss_conf 46708999998989799
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Probab=99.52 E-value=1.9e-14 Score=101.17 Aligned_cols=94 Identities=20% Similarity=0.324 Sum_probs=60.8
Q ss_pred CEEECCCCCCCCCCCHHHCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCCCCCCCC
Q ss_conf 91881278687678631117878768756477388879900039999998965798146757976447776553233366
Q 002673 388 PAIYLANNSLSGNIPVEIGQLKSLHVLDLSNNNFSGTIPDELSDLSNLEKLDLSGNHLVGEIPISLKGLHFLSSFSVAHN 467 (894)
Q Consensus 388 ~~L~L~~N~l~~~~p~~l~~L~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~ls~N 467 (894)
..+.++++.+... ..+.++++|+.|++++|.+.. .+ .+.++++|+.|+|++|.++ .++ .+..+++|+.|++++|
T Consensus 132 ~~l~~~~~~~~~~--~~~~~~~~L~~L~l~~n~~~~-~~-~l~~l~~L~~L~Ls~n~l~-~l~-~l~~l~~L~~L~Ls~N 205 (227)
T d1h6ua2 132 QVLYLDLNQITNI--SPLAGLTNLQYLSIGNAQVSD-LT-PLANLSKLTTLKADDNKIS-DIS-PLASLPNLIEVHLKNN 205 (227)
T ss_dssp CEEECCSSCCCCC--GGGGGCTTCCEEECCSSCCCC-CG-GGTTCTTCCEEECCSSCCC-CCG-GGGGCTTCCEEECTTS
T ss_pred HHHHCHHHHHCHH--HHHCCCCCCCCCCCCCCCCCC-CH-HHCCCCCCEECCCCCCCCC-CCH-HHCCCCCCCEEECCCC
T ss_conf 2220000000000--000102111002333333331-00-1056463356445888417-785-3447999998979599
Q ss_pred CCCCCCCCCCCCCCCCCCCCC
Q ss_conf 567987899978888865568
Q 002673 468 NLQGAVPSGGQFDTFPSFSFE 488 (894)
Q Consensus 468 ~l~~~~~~~~~l~~L~~l~l~ 488 (894)
++++.+ ....+++|+.+++.
T Consensus 206 ~lt~i~-~l~~l~~L~~L~ls 225 (227)
T d1h6ua2 206 QISDVS-PLANTSNLFIVTLT 225 (227)
T ss_dssp CCCBCG-GGTTCTTCCEEEEE
T ss_pred CCCCCC-CCCCCCCCCEEEEE
T ss_conf 689980-20369998989712
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=99.48 E-value=8.3e-14 Score=97.27 Aligned_cols=99 Identities=26% Similarity=0.342 Sum_probs=58.8
Q ss_pred EEECCCCCCCCCCCHHHCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCCCCCCCCC
Q ss_conf 18812786876786311178787687564773888799000399999989657981467579764477765532333665
Q 002673 389 AIYLANNSLSGNIPVEIGQLKSLHVLDLSNNNFSGTIPDELSDLSNLEKLDLSGNHLVGEIPISLKGLHFLSSFSVAHNN 468 (894)
Q Consensus 389 ~L~L~~N~l~~~~p~~l~~L~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~ls~N~ 468 (894)
.|+|++|+|+ .++ .+..+++|++|++++|+|+ .+|..|..+++|+.|++++|.|+ .+| .+..+++|+.|++++|+
T Consensus 2 ~L~Ls~n~l~-~l~-~l~~l~~L~~L~ls~N~l~-~lp~~~~~l~~L~~L~l~~N~i~-~l~-~~~~l~~L~~L~l~~N~ 76 (124)
T d1dcea3 2 VLHLAHKDLT-VLC-HLEQLLLVTHLDLSHNRLR-ALPPALAALRCLEVLQASDNALE-NVD-GVANLPRLQELLLCNNR 76 (124)
T ss_dssp EEECTTSCCS-SCC-CGGGGTTCCEEECCSSCCC-CCCGGGGGCTTCCEEECCSSCCC-CCG-GGTTCSSCCEEECCSSC
T ss_pred EEECCCCCCC-CCC-CCCCCCCCCEEECCCCCCC-CCHHHHHHHHCCCCCCCCCCCCC-CCC-CCCCCCCCCEEECCCCC
T ss_conf 8986899898-871-0105898898979787168-65215655431354532432112-357-41233555768888986
Q ss_pred CCCCCC--CCCCCCCCCCCCCCCCCC
Q ss_conf 679878--999788888655689988
Q 002673 469 LQGAVP--SGGQFDTFPSFSFEGNPE 492 (894)
Q Consensus 469 l~~~~~--~~~~l~~L~~l~l~~N~~ 492 (894)
++..+. ....+++|+.+++.+|+.
T Consensus 77 i~~~~~~~~l~~~~~L~~L~l~~N~i 102 (124)
T d1dcea3 77 LQQSAAIQPLVSCPRLVLLNLQGNSL 102 (124)
T ss_dssp CCSSSTTGGGGGCTTCCEEECTTSGG
T ss_pred CCCCCCCHHHCCCCCCCEEECCCCCC
T ss_conf 58888825653799999998979968
|
| >d1a9na_ c.10.2.4 (A:) Splicesomal U2A' protein {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: U2A'-like domain: Splicesomal U2A' protein species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.46 E-value=7.7e-14 Score=97.46 Aligned_cols=101 Identities=17% Similarity=0.201 Sum_probs=65.7
Q ss_pred CEEECCCCCCCCCCCHHHCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCCC-CCCCCCCCCCCCCC
Q ss_conf 91881278687678631117878768756477388879900039999998965798146757976-44777655323336
Q 002673 388 PAIYLANNSLSGNIPVEIGQLKSLHVLDLSNNNFSGTIPDELSDLSNLEKLDLSGNHLVGEIPIS-LKGLHFLSSFSVAH 466 (894)
Q Consensus 388 ~~L~L~~N~l~~~~p~~l~~L~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~-~~~l~~L~~L~ls~ 466 (894)
++|+|++|+|+ .++..+..+++|+.|+|++|+|+ .++ .|..+++|+.|++++|.++ .+|.. +..+++|+.|++++
T Consensus 21 r~L~L~~n~I~-~i~~~~~~l~~L~~L~Ls~N~i~-~l~-~~~~l~~L~~L~ls~N~i~-~l~~~~~~~l~~L~~L~L~~ 96 (162)
T d1a9na_ 21 RELDLRGYKIP-VIENLGATLDQFDAIDFSDNEIR-KLD-GFPLLRRLKTLLVNNNRIC-RIGEGLDQALPDLTELILTN 96 (162)
T ss_dssp EEEECTTSCCC-SCCCGGGGTTCCSEEECCSSCCC-EEC-CCCCCSSCCEEECCSSCCC-EECSCHHHHCTTCCEEECCS
T ss_pred CEEECCCCCCC-CCCCCCCCCCCCCEEECCCCCCC-CCC-CCCCCCCHHHHHCCCCCCC-CCCCCCCCCCCCCCCCEECC
T ss_conf 48978899788-65762004145998989799787-647-7445761306431021345-77763223345344342030
Q ss_pred CCCCCCCC--CCCCCCCCCCCCCCCCCC
Q ss_conf 65679878--999788888655689988
Q 002673 467 NNLQGAVP--SGGQFDTFPSFSFEGNPE 492 (894)
Q Consensus 467 N~l~~~~~--~~~~l~~L~~l~l~~N~~ 492 (894)
|+++.... ....+++|+.+++.+||.
T Consensus 97 N~i~~~~~l~~l~~l~~L~~L~l~~N~i 124 (162)
T d1a9na_ 97 NSLVELGDLDPLASLKSLTYLCILRNPV 124 (162)
T ss_dssp CCCCCGGGGGGGGGCTTCCEEECCSSGG
T ss_pred CCCCCCCCCCCCCCCCCCCHHHCCCCCC
T ss_conf 0016654211001365320664079963
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=99.46 E-value=1.4e-13 Score=95.87 Aligned_cols=82 Identities=24% Similarity=0.351 Sum_probs=70.9
Q ss_pred CEEECCCCCCCCCCCHHHCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCC--CCCCCCCCCCCCCCC
Q ss_conf 918812786876786311178787687564773888799000399999989657981467579--764477765532333
Q 002673 388 PAIYLANNSLSGNIPVEIGQLKSLHVLDLSNNNFSGTIPDELSDLSNLEKLDLSGNHLVGEIP--ISLKGLHFLSSFSVA 465 (894)
Q Consensus 388 ~~L~L~~N~l~~~~p~~l~~L~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~g~~p--~~~~~l~~L~~L~ls 465 (894)
+.|++++|+|+ .+|+.+..+++|+.|++++|+|+ .+| .+..+++|+.|++++|+|+ .+| ..+..+++|+.++++
T Consensus 23 ~~L~ls~N~l~-~lp~~~~~l~~L~~L~l~~N~i~-~l~-~~~~l~~L~~L~l~~N~i~-~~~~~~~l~~~~~L~~L~l~ 98 (124)
T d1dcea3 23 THLDLSHNRLR-ALPPALAALRCLEVLQASDNALE-NVD-GVANLPRLQELLLCNNRLQ-QSAAIQPLVSCPRLVLLNLQ 98 (124)
T ss_dssp CEEECCSSCCC-CCCGGGGGCTTCCEEECCSSCCC-CCG-GGTTCSSCCEEECCSSCCC-SSSTTGGGGGCTTCCEEECT
T ss_pred CEEECCCCCCC-CCHHHHHHHHCCCCCCCCCCCCC-CCC-CCCCCCCCCEEECCCCCCC-CCCCCHHHCCCCCCCEEECC
T ss_conf 98979787168-65215655431354532432112-357-4123355576888898658-88882565379999999897
Q ss_pred CCCCCCCC
Q ss_conf 66567987
Q 002673 466 HNNLQGAV 473 (894)
Q Consensus 466 ~N~l~~~~ 473 (894)
+|.++...
T Consensus 99 ~N~i~~~~ 106 (124)
T d1dcea3 99 GNSLCQEE 106 (124)
T ss_dssp TSGGGGSS
T ss_pred CCCCCCCC
T ss_conf 99688682
|
| >d1a9na_ c.10.2.4 (A:) Splicesomal U2A' protein {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: U2A'-like domain: Splicesomal U2A' protein species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.42 E-value=8.7e-14 Score=97.16 Aligned_cols=126 Identities=18% Similarity=0.122 Sum_probs=67.9
Q ss_pred CCCCCCCCHHCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCHHHCCCCCCCEEECCCCCCCC
Q ss_conf 25844320100136311123586610147887745566878999918812786876786311178787687564773888
Q 002673 344 LTALPALVSEAANDEVDRSYLELPVFVMPSNATNQQYNQLSNLPPAIYLANNSLSGNIPVEIGQLKSLHVLDLSNNNFSG 423 (894)
Q Consensus 344 l~~l~~L~~L~l~~n~~~~~~~~~~~~~~~~~~~l~~~~l~~Lp~~L~L~~N~l~~~~p~~l~~L~~L~~L~Ls~N~l~g 423 (894)
+.+..+|+.|+|.+|.+..++.. +..+..| +.|+|++|+|+ .++ .|..+++|+.|++++|+++.
T Consensus 14 ~~n~~~lr~L~L~~n~I~~i~~~-------------~~~l~~L-~~L~Ls~N~i~-~l~-~~~~l~~L~~L~ls~N~i~~ 77 (162)
T d1a9na_ 14 YTNAVRDRELDLRGYKIPVIENL-------------GATLDQF-DAIDFSDNEIR-KLD-GFPLLRRLKTLLVNNNRICR 77 (162)
T ss_dssp EECTTSCEEEECTTSCCCSCCCG-------------GGGTTCC-SEEECCSSCCC-EEC-CCCCCSSCCEEECCSSCCCE
T ss_pred CCCCCCCCEEECCCCCCCCCCCC-------------CCCCCCC-CEEECCCCCCC-CCC-CCCCCCCHHHHHCCCCCCCC
T ss_conf 16857484897889978865762-------------0041459-98989799787-647-74457613064310213457
Q ss_pred CCCCCCCCCCCCCEEECCCCCCCCCCC--CCCCCCCCCCCCCCCCCCCCCCCC----CCCCCCCCCCCC
Q ss_conf 799000399999989657981467579--764477765532333665679878----999788888655
Q 002673 424 TIPDELSDLSNLEKLDLSGNHLVGEIP--ISLKGLHFLSSFSVAHNNLQGAVP----SGGQFDTFPSFS 486 (894)
Q Consensus 424 ~~p~~~~~l~~L~~L~Ls~N~l~g~~p--~~~~~l~~L~~L~ls~N~l~~~~~----~~~~l~~L~~l~ 486 (894)
..+..+..+++|+.|++++|.|+ .++ ..+..+++|+.+++++|.++..+. ....+++|+.++
T Consensus 78 l~~~~~~~l~~L~~L~L~~N~i~-~~~~l~~l~~l~~L~~L~l~~N~i~~~~~~r~~~i~~lp~L~~LD 145 (162)
T d1a9na_ 78 IGEGLDQALPDLTELILTNNSLV-ELGDLDPLASLKSLTYLCILRNPVTNKKHYRLYVIYKVPQVRVLD 145 (162)
T ss_dssp ECSCHHHHCTTCCEEECCSCCCC-CGGGGGGGGGCTTCCEEECCSSGGGGSTTHHHHHHHHCTTCSEET
T ss_pred CCCCCCCCCCCCCCCEECCCCCC-CCCCCCCCCCCCCCCHHHCCCCCCCCCCCHHHHHHHHCCCCCEEC
T ss_conf 77632233453443420300016-654211001365320664079963456106999998789958337
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Probab=99.39 E-value=2.1e-12 Score=88.87 Aligned_cols=156 Identities=15% Similarity=0.215 Sum_probs=95.1
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCCHHCCCCCCCCCCCCCCCCCCCCCCCCCC---------CCCCCCCCCEEECCCC
Q ss_conf 8864212355445642400258443201001363111235866101478877455---------6687899991881278
Q 002673 325 EGPSLFSQANLLSGEFPKELTALPALVSEAANDEVDRSYLELPVFVMPSNATNQQ---------YNQLSNLPPAIYLANN 395 (894)
Q Consensus 325 ~L~~L~l~~N~l~~~~p~~l~~l~~L~~L~l~~n~~~~~~~~~~~~~~~~~~~l~---------~~~l~~Lp~~L~L~~N 395 (894)
+++.|.+..|.+.. + +.+..+++|+.|++++|.+....+... ......+... +..++.| +.+.++++
T Consensus 42 ~L~~L~l~~~~i~~-l-~~l~~l~~L~~L~ls~n~i~~~~~l~~-l~~l~~l~~~~n~~~~i~~l~~l~~L-~~l~l~~~ 117 (227)
T d1h6ua2 42 GITTLSAFGTGVTT-I-EGVQYLNNLIGLELKDNQITDLAPLKN-LTKITELELSGNPLKNVSAIAGLQSI-KTLDLTST 117 (227)
T ss_dssp TCCEEECTTSCCCC-C-TTGGGCTTCCEEECCSSCCCCCGGGTT-CCSCCEEECCSCCCSCCGGGTTCTTC-CEEECTTS
T ss_pred CCCEEECCCCCCCC-C-HHHHCCCCCCEEECCCCEEECCCCCCC-CCCCCCCCCCCCCCCCCCCCCCCCCC-CCCCCCCC
T ss_conf 86899777999976-6-457448888376357853202543112-33432012111222222222222222-12212224
Q ss_pred CCCCCCCHHHCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCC
Q ss_conf 68767863111787876875647738887990003999999896579814675797644777655323336656798789
Q 002673 396 SLSGNIPVEIGQLKSLHVLDLSNNNFSGTIPDELSDLSNLEKLDLSGNHLVGEIPISLKGLHFLSSFSVAHNNLQGAVPS 475 (894)
Q Consensus 396 ~l~~~~p~~l~~L~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~ls~N~l~~~~~~ 475 (894)
.+.+. ..+...+.+..+.++++.+... ..+..+++|+.|++++|.+. ..+ .+.++++|+.|++++|++++. +.
T Consensus 118 ~~~~~--~~~~~~~~~~~l~~~~~~~~~~--~~~~~~~~L~~L~l~~n~~~-~~~-~l~~l~~L~~L~Ls~n~l~~l-~~ 190 (227)
T d1h6ua2 118 QITDV--TPLAGLSNLQVLYLDLNQITNI--SPLAGLTNLQYLSIGNAQVS-DLT-PLANLSKLTTLKADDNKISDI-SP 190 (227)
T ss_dssp CCCCC--GGGTTCTTCCEEECCSSCCCCC--GGGGGCTTCCEEECCSSCCC-CCG-GGTTCTTCCEEECCSSCCCCC-GG
T ss_pred CCCCC--CHHCCCCCHHHHHCHHHHHCHH--HHHCCCCCCCCCCCCCCCCC-CCH-HHCCCCCCEECCCCCCCCCCC-HH
T ss_conf 43311--0000023012220000000000--00010211100233333333-100-105646335644588841778-53
Q ss_pred CCCCCCCCCCCCCCCC
Q ss_conf 9978888865568998
Q 002673 476 GGQFDTFPSFSFEGNP 491 (894)
Q Consensus 476 ~~~l~~L~~l~l~~N~ 491 (894)
...+++|+.+++++|.
T Consensus 191 l~~l~~L~~L~Ls~N~ 206 (227)
T d1h6ua2 191 LASLPNLIEVHLKNNQ 206 (227)
T ss_dssp GGGCTTCCEEECTTSC
T ss_pred HCCCCCCCEEECCCCC
T ss_conf 4479999989795996
|
| >d1m9la_ c.10.3.1 (A:) Outer arm dynein light chain 1 {Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: Outer arm dynein light chain 1 family: Outer arm dynein light chain 1 domain: Outer arm dynein light chain 1 species: Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]
Probab=99.32 E-value=9.5e-15 Score=102.92 Aligned_cols=99 Identities=20% Similarity=0.321 Sum_probs=46.0
Q ss_pred CEEECCCCCCCCCCCHHHCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCCCCCCCC
Q ss_conf 91881278687678631117878768756477388879900039999998965798146757976447776553233366
Q 002673 388 PAIYLANNSLSGNIPVEIGQLKSLHVLDLSNNNFSGTIPDELSDLSNLEKLDLSGNHLVGEIPISLKGLHFLSSFSVAHN 467 (894)
Q Consensus 388 ~~L~L~~N~l~~~~p~~l~~L~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~ls~N 467 (894)
+.|+|++|+|+ .++ .+.+|++|+.|+|++|+|+ .+|..+..+++|+.|++++|.|+ .++ .+..+++|+.|++++|
T Consensus 51 ~~L~Ls~n~I~-~i~-~l~~l~~L~~L~Ls~N~i~-~i~~~~~~~~~L~~L~l~~N~i~-~l~-~~~~l~~L~~L~L~~N 125 (198)
T d1m9la_ 51 KHLALSTNNIE-KIS-SLSGMENLRILSLGRNLIK-KIENLDAVADTLEELWISYNQIA-SLS-GIEKLVNLRVLYMSNN 125 (198)
T ss_dssp CEEECSEEEES-CCC-CHHHHTTCCEEECCEEEEC-SCSSHHHHHHHCCEEECSEEECC-CHH-HHHHHHHSSEEEESEE
T ss_pred CEEECCCCCCC-CCC-CCCCCCCCCCHHHCCCCCC-CCCCCCCCCCCCCCCCCCCCCCC-CCC-CCCCCCCCCCCCCCCC
T ss_conf 15199446899-864-4247825357341353432-10000332212333333332222-222-2222223411123410
Q ss_pred CCCCCCC--CCCCCCCCCCCCCCCCC
Q ss_conf 5679878--99978888865568998
Q 002673 468 NLQGAVP--SGGQFDTFPSFSFEGNP 491 (894)
Q Consensus 468 ~l~~~~~--~~~~l~~L~~l~l~~N~ 491 (894)
+++.... ....+++|+.+++.+||
T Consensus 126 ~i~~~~~~~~l~~l~~L~~L~L~~N~ 151 (198)
T d1m9la_ 126 KITNWGEIDKLAALDKLEDLLLAGNP 151 (198)
T ss_dssp ECCCHHHHHHHTTTTTCSEEEECSSH
T ss_pred HHCCCCCCCCCCCCCCCCEEECCCCC
T ss_conf 21255422123677763023427984
|
| >d2ifga3 c.10.2.7 (A:36-191) High affinity nerve growth factor receptor, N-terminal domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: High affinity nerve growth factor receptor, N-terminal domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.31 E-value=7e-12 Score=85.71 Aligned_cols=87 Identities=22% Similarity=0.231 Sum_probs=68.5
Q ss_pred CCCCCCEEECCCC-CCCCCCCHHHCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCC
Q ss_conf 7899991881278-687678631117878768756477388879900039999998965798146757976447776553
Q 002673 383 LSNLPPAIYLANN-SLSGNIPVEIGQLKSLHVLDLSNNNFSGTIPDELSDLSNLEKLDLSGNHLVGEIPISLKGLHFLSS 461 (894)
Q Consensus 383 l~~Lp~~L~L~~N-~l~~~~p~~l~~L~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~ 461 (894)
++++ .+|++.+| .|+...+..|.++++|+.|+|++|+|+...+..|..+++|+.|+|++|+|+ .+|........|+.
T Consensus 30 l~~l-~~L~l~~n~~l~~i~~~~f~~l~~L~~L~Ls~N~l~~i~~~~f~~l~~L~~L~Ls~N~l~-~l~~~~~~~~~l~~ 107 (156)
T d2ifga3 30 AENL-TELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRLSRLNLSFNALE-SLSWKTVQGLSLQE 107 (156)
T ss_dssp CSCC-SEEECCSCSSCCEECGGGSCSCCCCSEEECCSSCCCEECTTGGGSCSCCCEEECCSSCCS-CCCSTTTCSCCCCE
T ss_pred CCCC-CEEECCCCCCCCCCCCHHHCCCCCCCCCEEECCCCCCCCCCCCCCCCCCCCEECCCCCCC-CCCHHHHCCCCCCC
T ss_conf 6565-743168986644369212256666672162021247742011124554333322678785-15745633532124
Q ss_pred CCCCCCCCCC
Q ss_conf 2333665679
Q 002673 462 FSVAHNNLQG 471 (894)
Q Consensus 462 L~ls~N~l~~ 471 (894)
|+|++|.+..
T Consensus 108 L~L~~Np~~C 117 (156)
T d2ifga3 108 LVLSGNPLHC 117 (156)
T ss_dssp EECCSSCCCC
T ss_pred CCCCCCCCCC
T ss_conf 3357986338
|
| >d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Follicle-stimulating hormone receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.28 E-value=1.2e-12 Score=90.22 Aligned_cols=38 Identities=8% Similarity=-0.138 Sum_probs=18.7
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCCHHCCCCCCCCC
Q ss_conf 88642123554456424002584432010013631112
Q 002673 325 EGPSLFSQANLLSGEFPKELTALPALVSEAANDEVDRS 362 (894)
Q Consensus 325 ~L~~L~l~~N~l~~~~p~~l~~l~~L~~L~l~~n~~~~ 362 (894)
+++.|++..|.+..+.+..|.++++|++|++++|.+..
T Consensus 30 ~l~~L~Ls~n~i~~l~~~~f~~l~~L~~L~ls~n~~~~ 67 (242)
T d1xwdc1 30 NAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLE 67 (242)
T ss_dssp CCSEEEEESCCCCEECTTTTTTCTTCCEEEEESCTTCC
T ss_pred CCCEEECCCCCCCCCCHHHHHCCCHHHHHHHCCCCCCC
T ss_conf 88999876991896496686146432321102211242
|
| >d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Follicle-stimulating hormone receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.22 E-value=3.9e-11 Score=81.25 Aligned_cols=172 Identities=15% Similarity=0.109 Sum_probs=89.7
Q ss_pred EECCCCCHHHHHHHHHHCC--------CCCCCCCCCCCC-CCCCCCCCCCCCCCCCCCCHHCCCCCCCCCCCCCCCCCCC
Q ss_conf 1028998324999972015--------999988642123-5544564240025844320100136311123586610147
Q 002673 302 ELVSRPNADDLEIIFGEVE--------GKSDEGPSLFSQ-ANLLSGEFPKELTALPALVSEAANDEVDRSYLELPVFVMP 372 (894)
Q Consensus 302 ~~~~~p~l~~Ldl~~n~~~--------~~l~~L~~L~l~-~N~l~~~~p~~l~~l~~L~~L~l~~n~~~~~~~~~~~~~~ 372 (894)
.|...++++.|++..|... ..++++..+... .|.+....+..|.++++|+.+++.+|.+.......
T Consensus 48 ~f~~l~~L~~L~ls~n~~~~~i~~~~f~~l~~l~~l~~~~~n~l~~~~~~~~~~l~~L~~l~l~~~~l~~~~~~~----- 122 (242)
T d1xwdc1 48 AFSGFGDLEKIEISQNDVLEVIEADVFSNLPKLHEIRIEKANNLLYINPEAFQNLPNLQYLLISNTGIKHLPDVH----- 122 (242)
T ss_dssp TTTTCTTCCEEEEESCTTCCEECSSSEESCTTCCEEEEECCTTCCEECTTSEECCTTCCEEEEESCCCCSCCCCT-----
T ss_pred HHHCCCHHHHHHHCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHCCCCCCC-----
T ss_conf 861464323211022112420100112222222221111123432222221222222222234211112554333-----
Q ss_pred CCCCCCCCCCCCCCCCEEECCCCCCCCCCCHHHCCCC-CCCEEECCCCCCCCCCCCCCCCCCCCCEE-ECCCCCCCCCCC
Q ss_conf 8877455668789999188127868767863111787-87687564773888799000399999989-657981467579
Q 002673 373 SNATNQQYNQLSNLPPAIYLANNSLSGNIPVEIGQLK-SLHVLDLSNNNFSGTIPDELSDLSNLEKL-DLSGNHLVGEIP 450 (894)
Q Consensus 373 ~~~~~l~~~~l~~Lp~~L~L~~N~l~~~~p~~l~~L~-~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L-~Ls~N~l~g~~p 450 (894)
....+..+ ..+...++.+....+..|.++. .++.|++++|+++ .++....+..++..+ ++++|+++ .+|
T Consensus 123 ------~~~~l~~l-~~~~~~n~~l~~i~~~~~~~~~~~l~~L~l~~n~l~-~i~~~~~~~~~l~~~~~l~~n~l~-~l~ 193 (242)
T d1xwdc1 123 ------KIHSLQKV-LLDIQDNINIHTIERNSFVGLSFESVILWLNKNGIQ-EIHNCAFNGTQLDELNLSDNNNLE-ELP 193 (242)
T ss_dssp ------TTCBSSCE-EEEEESCTTCCEECTTSSTTSBSSCEEEECCSSCCC-EECTTTTTTCCEEEEECTTCTTCC-CCC
T ss_pred ------CCCCCCCC-CCCCCCCCCCCCCCCCCCCCCCCCCEEEECCCCCCC-CCCCCCCCCHHHHCCCCCCCCCCC-CCC
T ss_conf ------22211112-222222121112222222222331001220012333-322222220111012123543246-424
Q ss_pred -CCCCCCCCCCCCCCCCCCCCCCCCCC-CCCCCCCCCCC
Q ss_conf -76447776553233366567987899-97888886556
Q 002673 451 -ISLKGLHFLSSFSVAHNNLQGAVPSG-GQFDTFPSFSF 487 (894)
Q Consensus 451 -~~~~~l~~L~~L~ls~N~l~~~~~~~-~~l~~L~~l~l 487 (894)
..|.++++|+.|++++|+|+..++.. ..+..|+.+++
T Consensus 194 ~~~f~~l~~L~~L~Ls~N~l~~l~~~~~~~l~~L~~l~~ 232 (242)
T d1xwdc1 194 NDVFHGASGPVILDISRTRIHSLPSYGLENLKKLRARST 232 (242)
T ss_dssp TTTTTTSCCCSEEECTTSCCCCCCSSSCTTCCEEESSSE
T ss_pred HHHHCCCCCCCEEECCCCCCCCCCHHHHCCCCCCCCCCC
T ss_conf 788668999998989799289459779737713414767
|
| >d1m9la_ c.10.3.1 (A:) Outer arm dynein light chain 1 {Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: Outer arm dynein light chain 1 family: Outer arm dynein light chain 1 domain: Outer arm dynein light chain 1 species: Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]
Probab=99.16 E-value=7.2e-14 Score=97.63 Aligned_cols=117 Identities=22% Similarity=0.207 Sum_probs=79.2
Q ss_pred CCCCCCCCCCCCHHCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCHHHCCCCCCCEEECCCC
Q ss_conf 24002584432010013631112358661014788774556687899991881278687678631117878768756477
Q 002673 340 FPKELTALPALVSEAANDEVDRSYLELPVFVMPSNATNQQYNQLSNLPPAIYLANNSLSGNIPVEIGQLKSLHVLDLSNN 419 (894)
Q Consensus 340 ~p~~l~~l~~L~~L~l~~n~~~~~~~~~~~~~~~~~~~l~~~~l~~Lp~~L~L~~N~l~~~~p~~l~~L~~L~~L~Ls~N 419 (894)
+|..+..|++|++|++++|.+..+..+ ..+++| +.|+|++|+|+ .+|..+..+++|+.|++++|
T Consensus 40 l~~sl~~L~~L~~L~Ls~n~I~~i~~l--------------~~l~~L-~~L~Ls~N~i~-~i~~~~~~~~~L~~L~l~~N 103 (198)
T d1m9la_ 40 MDATLSTLKACKHLALSTNNIEKISSL--------------SGMENL-RILSLGRNLIK-KIENLDAVADTLEELWISYN 103 (198)
T ss_dssp CHHHHHHTTTCCEEECSEEEESCCCCH--------------HHHTTC-CEEECCEEEEC-SCSSHHHHHHHCCEEECSEE
T ss_pred HHHHHHCCCCCCEEECCCCCCCCCCCC--------------CCCCCC-CCHHHCCCCCC-CCCCCCCCCCCCCCCCCCCC
T ss_conf 246776260461519944689986442--------------478253-57341353432-10000332212333333332
Q ss_pred CCCCCCCCCCCCCCCCCEEECCCCCCCCCCC--CCCCCCCCCCCCCCCCCCCCCCCCC
Q ss_conf 3888799000399999989657981467579--7644777655323336656798789
Q 002673 420 NFSGTIPDELSDLSNLEKLDLSGNHLVGEIP--ISLKGLHFLSSFSVAHNNLQGAVPS 475 (894)
Q Consensus 420 ~l~g~~p~~~~~l~~L~~L~Ls~N~l~g~~p--~~~~~l~~L~~L~ls~N~l~~~~~~ 475 (894)
+|+ .++ .+..+++|+.|++++|+|+ .++ ..+..+++|+.|++++|.+....+.
T Consensus 104 ~i~-~l~-~~~~l~~L~~L~L~~N~i~-~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~ 158 (198)
T d1m9la_ 104 QIA-SLS-GIEKLVNLRVLYMSNNKIT-NWGEIDKLAALDKLEDLLLAGNPLYNDYKE 158 (198)
T ss_dssp ECC-CHH-HHHHHHHSSEEEESEEECC-CHHHHHHHTTTTTCSEEEECSSHHHHHHCT
T ss_pred CCC-CCC-CCCCCCCCCCCCCCCCHHC-CCCCCCCCCCCCCCCEEECCCCCCCCCCCC
T ss_conf 222-222-2222223411123410212-554221236777630234279843467632
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Probab=99.01 E-value=6.1e-09 Score=68.12 Aligned_cols=135 Identities=24% Similarity=0.289 Sum_probs=78.4
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCCHHCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCHH
Q ss_conf 88642123554456424002584432010013631112358661014788774556687899991881278687678631
Q 002673 325 EGPSLFSQANLLSGEFPKELTALPALVSEAANDEVDRSYLELPVFVMPSNATNQQYNQLSNLPPAIYLANNSLSGNIPVE 404 (894)
Q Consensus 325 ~L~~L~l~~N~l~~~~p~~l~~l~~L~~L~l~~n~~~~~~~~~~~~~~~~~~~l~~~~l~~Lp~~L~L~~N~l~~~~p~~ 404 (894)
+++.|++..+.+++ +|+. +++|++|++++|.+..++.. +.+| +.|++.+|+++ .++.
T Consensus 39 ~l~~LdLs~~~L~~-lp~~---~~~L~~L~Ls~N~l~~lp~~----------------~~~L-~~L~l~~n~l~-~l~~- 95 (353)
T d1jl5a_ 39 QAHELELNNLGLSS-LPEL---PPHLESLVASCNSLTELPEL----------------PQSL-KSLLVDNNNLK-ALSD- 95 (353)
T ss_dssp TCSEEECTTSCCSC-CCSC---CTTCSEEECCSSCCSSCCCC----------------CTTC-CEEECCSSCCS-CCCS-
T ss_pred CCCEEEECCCCCCC-CCCC---CCCCCEEECCCCCCCCCCCC----------------HHHH-HHHHHHHCCCC-HHHH-
T ss_conf 99899937999887-8898---78988898999979633620----------------3320-33266551432-0321-
Q ss_pred HCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCC
Q ss_conf 11787876875647738887990003999999896579814675797644777655323336656798789997888886
Q 002673 405 IGQLKSLHVLDLSNNNFSGTIPDELSDLSNLEKLDLSGNHLVGEIPISLKGLHFLSSFSVAHNNLQGAVPSGGQFDTFPS 484 (894)
Q Consensus 405 l~~L~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~ls~N~l~~~~~~~~~l~~L~~ 484 (894)
+ .+.|++|++++|.+. .+|. ++.+++|+.|++++|.+. ..+... ..+..+.+..+... .......+..++.
T Consensus 96 l--p~~L~~L~L~~n~l~-~lp~-~~~l~~L~~L~l~~~~~~-~~~~~~---~~l~~l~~~~~~~~-~~~~l~~l~~l~~ 166 (353)
T d1jl5a_ 96 L--PPLLEYLGVSNNQLE-KLPE-LQNSSFLKIIDVDNNSLK-KLPDLP---PSLEFIAAGNNQLE-ELPELQNLPFLTA 166 (353)
T ss_dssp C--CTTCCEEECCSSCCS-SCCC-CTTCTTCCEEECCSSCCS-CCCCCC---TTCCEEECCSSCCS-SCCCCTTCTTCCE
T ss_pred H--CCCCCCCCCCCCCCC-CCCC-HHHHCCCEEECCCCCCCC-CCCCCC---CCCCCHHHCCCCCC-CCCCCCCCCCCEE
T ss_conf 0--221111133455432-2210-011013123113565100-132233---33210000122222-3332000122200
Q ss_pred CCCCCCC
Q ss_conf 5568998
Q 002673 485 FSFEGNP 491 (894)
Q Consensus 485 l~l~~N~ 491 (894)
+.+.+|.
T Consensus 167 L~l~~n~ 173 (353)
T d1jl5a_ 167 IYADNNS 173 (353)
T ss_dssp EECCSSC
T ss_pred CCCCCCC
T ss_conf 1112334
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Probab=99.00 E-value=1.6e-09 Score=71.62 Aligned_cols=33 Identities=27% Similarity=0.522 Sum_probs=13.8
Q ss_pred CEEECCCCCCCCCCCHHHCCCCCCCEEECCCCCCC
Q ss_conf 91881278687678631117878768756477388
Q 002673 388 PAIYLANNSLSGNIPVEIGQLKSLHVLDLSNNNFS 422 (894)
Q Consensus 388 ~~L~L~~N~l~~~~p~~l~~L~~L~~L~Ls~N~l~ 422 (894)
+.|++++|.|. .+| .++.+++|+.|++++|.+.
T Consensus 101 ~~L~L~~n~l~-~lp-~~~~l~~L~~L~l~~~~~~ 133 (353)
T d1jl5a_ 101 EYLGVSNNQLE-KLP-ELQNSSFLKIIDVDNNSLK 133 (353)
T ss_dssp CEEECCSSCCS-SCC-CCTTCTTCCEEECCSSCCS
T ss_pred CCCCCCCCCCC-CCC-CHHHHCCCEEECCCCCCCC
T ss_conf 11133455432-221-0011013123113565100
|
| >d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Type IIIa 3',5"-aminoglycoside phosphotransferase species: Enterococcus faecalis [TaxId: 1351]
Probab=98.76 E-value=4.5e-08 Score=62.90 Aligned_cols=149 Identities=18% Similarity=0.136 Sum_probs=94.0
Q ss_pred HHHHHCCCCCCCCEEEECCCEEEEEEEECCCCEEEEEEECCCCHHHHHHHHHHHHHHHHCC-CCCEEEECCEEEECCEEE
Q ss_conf 9997405987654471028389999998489848999974851265999999999999459-982455322431046388
Q 002673 601 ELLKATDNFSQANIIGCGGFGLVYKATLANGTTLAIKKLSGDLGLMEREFKAEVEALSTAQ-HKNLVSLQGYCVHQGFRL 679 (894)
Q Consensus 601 ~~~~~~~~~~~~~~LG~G~fg~Vy~a~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~-Hpniv~l~g~~~~~~~~~ 679 (894)
++.+..+.|+..+..+.++...||+... ++..+++|+...........+.+|...+..+. +-.+.+++.+..+.+..+
T Consensus 8 ~l~~~~~~~~~~~~~~G~s~~~v~rv~~-~~~~~vlk~~~~~~~~~~~~~~~E~~~l~~l~~~vpvP~vl~~~~~~~~~~ 86 (263)
T d1j7la_ 8 ELKKLIEKYRCVKDTEGMSPAKVYKLVG-ENENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSN 86 (263)
T ss_dssp HHHHHHTTSEEEECSCCCSSSEEEEEEC-SSCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEE
T ss_pred HHHHHHHCEEEEECCCCCCCCCEEEEEE-CCCEEEEEECCCCCCCCHHHHHHHHHHHHHHHCCCCCCCEEEEEECCCCEE
T ss_conf 9997513527997678998771899990-898699998488765325569999999998760699872899975089649
Q ss_pred EEEEECCCCCHHHHHHHHCCCCCCCCHHHHHHHHHHHHHHHHHHHHCC--------------------------------
Q ss_conf 999844699988998441489887579999999999999999988506--------------------------------
Q 002673 680 LIYSYMENGSLDYWLHEKADGASQLDWLTRLKIARGTSCGLAYMHQIC-------------------------------- 727 (894)
Q Consensus 680 lV~E~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~Ia~aL~yLHs~~-------------------------------- 727 (894)
+||+++++..+....... . ....++.+++..+..||+..
T Consensus 87 lv~~~l~G~~~~~~~~~~------~---~~~~~~~~l~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 157 (263)
T d1j7la_ 87 LLMSEADGVLCSEEYEDE------Q---SPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCEN 157 (263)
T ss_dssp EEEECCSSEEHHHHTTTC------S---CHHHHHHHHHHHHHHHHTSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCCGGG
T ss_pred EEEEECCCCCCCCCCCCC------C---CHHHHHHHHHHHHHHHHCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHHHC
T ss_conf 999860433435433440------2---6999999899999998556842143576446565557789987765555430
Q ss_pred ------------------------CCCEEECCCCCCCEEECCCCCEEEEECCCCCC
Q ss_conf ------------------------99836418999985778998599997345332
Q 002673 728 ------------------------EPHIVHRDIKSSNILLDDQFEAHLADFGLSRL 759 (894)
Q Consensus 728 ------------------------~~~ivH~DLkp~NILl~~~~~vkL~DFGla~~ 759 (894)
...++|+|+.+.||+++++..+-|+||+.+..
T Consensus 158 ~~~~~~~~~~~~~~~~l~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDwe~a~~ 213 (263)
T d1j7la_ 158 WEEDTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSGR 213 (263)
T ss_dssp GSTTCSCSSHHHHHHHHHHSCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCEE
T ss_pred CCCCCCCHHHHHHHHHHHHCCCCCCCEEEEEECCCCCEEECCCCEEEEEECHHCCC
T ss_conf 33232005799999999844986781789860047642364996599960231441
|
| >d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Cyclin A/CDK2-associated p19, Skp2 domain: Cyclin A/CDK2-associated p19, Skp2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=98.52 E-value=7.9e-09 Score=67.42 Aligned_cols=160 Identities=18% Similarity=0.192 Sum_probs=88.4
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCEEECCCC-CCC
Q ss_conf 5999988642123554456424002584432010013631112358661014788774556687899991881278-687
Q 002673 320 EGKSDEGPSLFSQANLLSGEFPKELTALPALVSEAANDEVDRSYLELPVFVMPSNATNQQYNQLSNLPPAIYLANN-SLS 398 (894)
Q Consensus 320 ~~~l~~L~~L~l~~N~l~~~~p~~l~~l~~L~~L~l~~n~~~~~~~~~~~~~~~~~~~l~~~~l~~Lp~~L~L~~N-~l~ 398 (894)
....++++.|.+.++.+....+..+..+++|+.|++.++...+-..+. .-...+.+| +.|+++++ +++
T Consensus 67 ~~~c~~L~~L~L~~~~l~~~~~~~l~~~~~L~~L~Ls~c~~itd~~l~----------~l~~~~~~L-~~L~ls~c~~~~ 135 (284)
T d2astb2 67 LSQCSKLQNLSLEGLRLSDPIVNTLAKNSNLVRLNLSGCSGFSEFALQ----------TLLSSCSRL-DELNLSWCFDFT 135 (284)
T ss_dssp HTTBCCCSEEECTTCBCCHHHHHHHTTCTTCSEEECTTCBSCCHHHHH----------HHHHHCTTC-CEEECCCCTTCC
T ss_pred HHHCCCCCCCCCCCCCCCCHHHHHHHCCCCCCCCCCCCCCCCCCCCCC----------HHHHHHHHC-CCCCCCCCCCCC
T ss_conf 974877651452346798678999851899757151001341235540----------365788743-565224533233
Q ss_pred CC-CCHHHCC-CCCCCEEECCCC--CCCCC-CCCCCCCCCCCCEEECCCC-CCCCCCCCCCCCCCCCCCCCCCCC-CCCC
Q ss_conf 67-8631117-878768756477--38887-9900039999998965798-146757976447776553233366-5679
Q 002673 399 GN-IPVEIGQ-LKSLHVLDLSNN--NFSGT-IPDELSDLSNLEKLDLSGN-HLVGEIPISLKGLHFLSSFSVAHN-NLQG 471 (894)
Q Consensus 399 ~~-~p~~l~~-L~~L~~L~Ls~N--~l~g~-~p~~~~~l~~L~~L~Ls~N-~l~g~~p~~~~~l~~L~~L~ls~N-~l~~ 471 (894)
.. +...+.. .++|+.|++++. .++.. +..-+.++++|+.|++++| .++......+..+++|+.|+++++ +++.
T Consensus 136 ~~~~~~~~~~~~~~L~~L~l~~~~~~i~~~~l~~l~~~~~~L~~L~L~~~~~itd~~~~~l~~~~~L~~L~L~~C~~i~~ 215 (284)
T d2astb2 136 EKHVQVAVAHVSETITQLNLSGYRKNLQKSDLSTLVRRCPNLVHLDLSDSVMLKNDCFQEFFQLNYLQHLSLSRCYDIIP 215 (284)
T ss_dssp HHHHHHHHHHSCTTCCEEECCSCGGGSCHHHHHHHHHHCTTCSEEECTTCTTCCGGGGGGGGGCTTCCEEECTTCTTCCG
T ss_pred CCCCHHHHCCCCCCCCHHHHCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHCCCCCCCEEECCCCCCCCH
T ss_conf 32200010001111101221355424444434342323222123553223477830333321357687798999997873
Q ss_pred CC-CCCCCCCCCCCCCCCCC
Q ss_conf 87-89997888886556899
Q 002673 472 AV-PSGGQFDTFPSFSFEGN 490 (894)
Q Consensus 472 ~~-~~~~~l~~L~~l~l~~N 490 (894)
.. .....+++|+.+++.++
T Consensus 216 ~~l~~L~~~~~L~~L~l~~~ 235 (284)
T d2astb2 216 ETLLELGEIPTLKTLQVFGI 235 (284)
T ss_dssp GGGGGGGGCTTCCEEECTTS
T ss_pred HHHHHHHCCCCCCEEEEECC
T ss_conf 78999726999898964488
|
| >d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Rna1p (RanGAP1), N-terminal domain domain: Rna1p (RanGAP1), N-terminal domain species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=98.49 E-value=2.9e-09 Score=70.02 Aligned_cols=37 Identities=8% Similarity=-0.064 Sum_probs=14.8
Q ss_pred CCCCCCCCCCCCCCCCC----CCCCCCCCCCCCHHCCCCCC
Q ss_conf 99886421235544564----24002584432010013631
Q 002673 323 SDEGPSLFSQANLLSGE----FPKELTALPALVSEAANDEV 359 (894)
Q Consensus 323 l~~L~~L~l~~N~l~~~----~p~~l~~l~~L~~L~l~~n~ 359 (894)
.+++..|++..|.+... +...+...++|+.|.+++|.
T Consensus 92 ~~~L~~L~L~~n~i~~~~~~~l~~~l~~~~~L~~L~l~~n~ 132 (344)
T d2ca6a1 92 CPKLHTVRLSDNAFGPTAQEPLIDFLSKHTPLEHLYLHNNG 132 (344)
T ss_dssp CTTCCEEECCSCCCCTTTHHHHHHHHHHCTTCCEEECCSSC
T ss_pred CCCCCCCCCCCCCCCCCCCCCHHHHHCCCCCCHHEECCCCC
T ss_conf 77756330000134554333101110023432100000246
|
| >d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Cyclin A/CDK2-associated p19, Skp2 domain: Cyclin A/CDK2-associated p19, Skp2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=98.48 E-value=4.4e-08 Score=62.97 Aligned_cols=61 Identities=25% Similarity=0.281 Sum_probs=24.8
Q ss_pred CCCCCCEEECCCC-CCCCCCCCCCCCCCCCCEEECCC-CCCCCCCCCCCCCCCCCCCCCCCCC
Q ss_conf 7878768756477-38887990003999999896579-8146757976447776553233366
Q 002673 407 QLKSLHVLDLSNN-NFSGTIPDELSDLSNLEKLDLSG-NHLVGEIPISLKGLHFLSSFSVAHN 467 (894)
Q Consensus 407 ~L~~L~~L~Ls~N-~l~g~~p~~~~~l~~L~~L~Ls~-N~l~g~~p~~~~~l~~L~~L~ls~N 467 (894)
++++|+.|++++| .+++.....+.++++|++|++++ +.++......+.++++|+.|+++++
T Consensus 173 ~~~~L~~L~L~~~~~itd~~~~~l~~~~~L~~L~L~~C~~i~~~~l~~L~~~~~L~~L~l~~~ 235 (284)
T d2astb2 173 RCPNLVHLDLSDSVMLKNDCFQEFFQLNYLQHLSLSRCYDIIPETLLELGEIPTLKTLQVFGI 235 (284)
T ss_dssp HCTTCSEEECTTCTTCCGGGGGGGGGCTTCCEEECTTCTTCCGGGGGGGGGCTTCCEEECTTS
T ss_pred CCCCCCCCCCCCCCCCCCHHHHHHCCCCCCCEEECCCCCCCCHHHHHHHHCCCCCCEEEEECC
T ss_conf 322212355322347783033332135768779899999787378999726999898964488
|
| >d1koha1 c.10.2.3 (A:201-362) mRNA export factor tap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: mRNA export factor tap domain: mRNA export factor tap species: Human (Homo sapiens) [TaxId: 9606]
Probab=98.41 E-value=4.5e-09 Score=68.88 Aligned_cols=73 Identities=23% Similarity=0.196 Sum_probs=38.5
Q ss_pred CCCHHHCCCCCCCEEECCCCCCCCCC--CCCCCCCCCCCEEECCCCCCCCCCCC-CCCCCCCCCCCCCCCCCCCCCC
Q ss_conf 78631117878768756477388879--90003999999896579814675797-6447776553233366567987
Q 002673 400 NIPVEIGQLKSLHVLDLSNNNFSGTI--PDELSDLSNLEKLDLSGNHLVGEIPI-SLKGLHFLSSFSVAHNNLQGAV 473 (894)
Q Consensus 400 ~~p~~l~~L~~L~~L~Ls~N~l~g~~--p~~~~~l~~L~~L~Ls~N~l~g~~p~-~~~~l~~L~~L~ls~N~l~~~~ 473 (894)
.++..+..+++|++|+|++|+|+..- +..+..+++|+.|+|++|.|+ .++. .+.....|+.+++++|.++...
T Consensus 56 ~l~~~~~~~~~L~~L~Ls~N~i~~l~~~~~~~~~l~~L~~L~Ls~N~i~-~l~~l~~l~~~~L~~L~L~~Npl~~~~ 131 (162)
T d1koha1 56 TLRIIEENIPELLSLNLSNNRLYRLDDMSSIVQKAPNLKILNLSGNELK-SERELDKIKGLKLEELWLDGNSLSDTF 131 (162)
T ss_dssp HHHHHHHHCTTCCCCCCCSSCCCCCSGGGTHHHHSTTCCCCCCTTSCCC-CGGGHHHHTTCCCSSCCCTTSTTSSSS
T ss_pred HHHHHHHHCCCCCEEECCCCCCCCCCHHHHHHHHCCCCCCCCCCCCCCC-CCHHHHHHHCCCCCEEECCCCCCCCCC
T ss_conf 6078897487878863777666677315889865885610004357213-423442220331042664899767676
|
| >d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]
Probab=98.27 E-value=2.6e-06 Score=52.31 Aligned_cols=143 Identities=15% Similarity=0.091 Sum_probs=80.1
Q ss_pred EEEECCC-EEEEEEEECCCCEEEEEEECCCCHHHHHHHHHHHHHHHHCCC--CCEEEECCEEEECCEEEEEEEECCCCCH
Q ss_conf 4710283-899999984898489999748512659999999999994599--8245532243104638899984469998
Q 002673 614 IIGCGGF-GLVYKATLANGTTLAIKKLSGDLGLMEREFKAEVEALSTAQH--KNLVSLQGYCVHQGFRLLIYSYMENGSL 690 (894)
Q Consensus 614 ~LG~G~f-g~Vy~a~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~H--pniv~l~g~~~~~~~~~lV~E~~~~gsL 690 (894)
.+..|.. +.||+....++..+++|...... ...+..|...++.+.. -.+.++++++.+.+..++|+++++|.++
T Consensus 17 ~~~~G~s~~~v~r~~~~~~~~~vlK~~~~~~---~~~l~~E~~~l~~L~~~gvpvP~v~~~~~~~~~~~~v~~~i~G~~~ 93 (255)
T d1nd4a_ 17 QQTIGCSDAAVFRLSAQGRPVLFVKTDLSGA---LNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVPGQDL 93 (255)
T ss_dssp ECSCTTSSCEEEEEECTTSCCEEEEEECSCT---TSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCSSEET
T ss_pred ECCCCCCCCEEEEEEECCCCEEEEEECCCCC---HHHHHHHHHHHHHHHHCCCCCCCEEEECCCCCCEEEEEEEEECCCC
T ss_conf 7678654775899993898789999589667---7689999999999986599988613222456615999874413554
Q ss_pred HH--------------HH---HHHCCCCC--CCCHHHHHHHH--------------------HHHHHHHHHHHHC----C
Q ss_conf 89--------------98---44148988--75799999999--------------------9999999998850----6
Q 002673 691 DY--------------WL---HEKADGAS--QLDWLTRLKIA--------------------RGTSCGLAYMHQI----C 727 (894)
Q Consensus 691 ~~--------------~l---~~~~~~~~--~l~~~~~~~i~--------------------~~Ia~aL~yLHs~----~ 727 (894)
.. .+ |....... ...+.....-. ......+..+... .
T Consensus 94 ~~~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~ 173 (255)
T d1nd4a_ 94 LSSHLAPAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLAPAELFARLKARMPDGE 173 (255)
T ss_dssp TTSCCCHHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCCHHHHHHHHHHTCCSSC
T ss_pred CCCCCCHHHHHHHHHHHHHHHCCCCHHHCCCCCCCHHHHHHHHHHHHHHHHCCCCCCCHHHHHHHHHHHHHHHHHCCCCC
T ss_conf 32212689999999999998736885448875541246889999998754110113401121379999999987187657
Q ss_pred CCCEEECCCCCCCEEECCCCCEEEEECCCCCC
Q ss_conf 99836418999985778998599997345332
Q 002673 728 EPHIVHRDIKSSNILLDDQFEAHLADFGLSRL 759 (894)
Q Consensus 728 ~~~ivH~DLkp~NILl~~~~~vkL~DFGla~~ 759 (894)
...++|+|+.+.|||++.+..+-|+||+.+..
T Consensus 174 ~~~liHgD~~~~Nvl~~~~~~~~iID~~~~~~ 205 (255)
T d1nd4a_ 174 DLVVTHGDACLPNIMVENGRFSGFIDCGRLGV 205 (255)
T ss_dssp CEEEECSSCCGGGEEEETTEEEEECCCTTCEE
T ss_pred CCEEEECCCCCCCEEEECCCEEEEEECHHCCC
T ss_conf 95678678887635773796589998533265
|
| >d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Rna1p (RanGAP1), N-terminal domain domain: Rna1p (RanGAP1), N-terminal domain species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=98.25 E-value=3.5e-08 Score=63.54 Aligned_cols=14 Identities=36% Similarity=0.442 Sum_probs=4.7
Q ss_pred CCCCCEEECCCCCC
Q ss_conf 99999896579814
Q 002673 432 LSNLEKLDLSGNHL 445 (894)
Q Consensus 432 l~~L~~L~Ls~N~l 445 (894)
+++|+.|+|++|.|
T Consensus 242 ~~~L~~L~Ls~n~i 255 (344)
T d2ca6a1 242 WPNLRELGLNDCLL 255 (344)
T ss_dssp CTTCCEEECTTCCC
T ss_pred CCCCHHHHHHCCCC
T ss_conf 22111103004756
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Probab=98.20 E-value=3.3e-08 Score=63.67 Aligned_cols=83 Identities=22% Similarity=0.336 Sum_probs=33.2
Q ss_pred CEEECCCCCCCC----CCCHHHCCCCCCCEEECCCCCCCCC----CCCCCC-CCCCCCEEECCCCCCCCC----CCCCCC
Q ss_conf 918812786876----7863111787876875647738887----990003-999999896579814675----797644
Q 002673 388 PAIYLANNSLSG----NIPVEIGQLKSLHVLDLSNNNFSGT----IPDELS-DLSNLEKLDLSGNHLVGE----IPISLK 454 (894)
Q Consensus 388 ~~L~L~~N~l~~----~~p~~l~~L~~L~~L~Ls~N~l~g~----~p~~~~-~l~~L~~L~Ls~N~l~g~----~p~~~~ 454 (894)
+.|+|.+|.|+. .+...+..+++|+.|+|++|.|+.. +...+. ...+|+.|+|++|.++.. ++..+.
T Consensus 30 ~~L~L~~~~i~~~~~~~l~~~L~~~~~L~~LdLs~N~i~~~~~~~l~~~l~~~~~~L~~L~L~~n~it~~~~~~l~~~l~ 109 (460)
T d1z7xw1 30 QVVRLDDCGLTEARCKDISSALRVNPALAELNLRSNELGDVGVHCVLQGLQTPSCKIQKLSLQNCCLTGAGCGVLSSTLR 109 (460)
T ss_dssp SEEEEESSCCCHHHHHHHHHHHHTCTTCCEEECTTCCCHHHHHHHHHHTTCSTTCCCCEEECTTSCCBGGGHHHHHHHTT
T ss_pred CEEEECCCCCCHHHHHHHHHHHHCCCCCCEEECCCCCCCHHHHHHHHHHHHCCCCCCCEEECCCCCCCCCCCCCCCCHHH
T ss_conf 99982899998899999999985399988897959859728999999998437887788778887754322101211000
Q ss_pred CCCCCCCCCCCCCCCC
Q ss_conf 7776553233366567
Q 002673 455 GLHFLSSFSVAHNNLQ 470 (894)
Q Consensus 455 ~l~~L~~L~ls~N~l~ 470 (894)
.+++|+.|++++|.+.
T Consensus 110 ~~~~L~~L~L~~N~i~ 125 (460)
T d1z7xw1 110 TLPTLQELHLSDNLLG 125 (460)
T ss_dssp SCTTCCEEECCSSBCH
T ss_pred CCCCCCCCCCCCCCCH
T ss_conf 0343200244433202
|
| >d1koha1 c.10.2.3 (A:201-362) mRNA export factor tap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: mRNA export factor tap domain: mRNA export factor tap species: Human (Homo sapiens) [TaxId: 9606]
Probab=98.12 E-value=5e-07 Score=56.63 Aligned_cols=81 Identities=22% Similarity=0.212 Sum_probs=53.6
Q ss_pred CCCCCCCEEECCCCCCCCCC--CHHHCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCCC-------
Q ss_conf 87899991881278687678--631117878768756477388879900039999998965798146757976-------
Q 002673 382 QLSNLPPAIYLANNSLSGNI--PVEIGQLKSLHVLDLSNNNFSGTIPDELSDLSNLEKLDLSGNHLVGEIPIS------- 452 (894)
Q Consensus 382 ~l~~Lp~~L~L~~N~l~~~~--p~~l~~L~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~------- 452 (894)
.+..| +.|+|++|+|+..- +..+..+++|+.|+|++|.|+..-+..+....+|+.|++++|.+.......
T Consensus 63 ~~~~L-~~L~Ls~N~i~~l~~~~~~~~~l~~L~~L~Ls~N~i~~l~~l~~l~~~~L~~L~L~~Npl~~~~~~~~~y~~~i 141 (162)
T d1koha1 63 NIPEL-LSLNLSNNRLYRLDDMSSIVQKAPNLKILNLSGNELKSERELDKIKGLKLEELWLDGNSLSDTFRDQSTYISAI 141 (162)
T ss_dssp HCTTC-CCCCCCSSCCCCCSGGGTHHHHSTTCCCCCCTTSCCCCGGGHHHHTTCCCSSCCCTTSTTSSSSSSHHHHHHHH
T ss_pred HCCCC-CEEECCCCCCCCCCHHHHHHHHCCCCCCCCCCCCCCCCCHHHHHHHCCCCCEEECCCCCCCCCCCCCHHHHHHH
T ss_conf 48787-88637776666773158898658856100043572134234422203310426648997676766615699999
Q ss_pred CCCCCCCCCCC
Q ss_conf 44777655323
Q 002673 453 LKGLHFLSSFS 463 (894)
Q Consensus 453 ~~~l~~L~~L~ 463 (894)
+..+++|+.||
T Consensus 142 ~~~~P~L~~LD 152 (162)
T d1koha1 142 RERFPKLLRLD 152 (162)
T ss_dssp HTTSTTCCEET
T ss_pred HHHCCCCCEEC
T ss_conf 99889978799
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Probab=98.03 E-value=1.3e-07 Score=60.14 Aligned_cols=113 Identities=21% Similarity=0.155 Sum_probs=45.6
Q ss_pred CCCCCCCCCCCCCCCC-CCCCCCCCCCCHHCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCEEECCCCCCCCC---
Q ss_conf 8864212355445642-400258443201001363111235866101478877455668789999188127868767---
Q 002673 325 EGPSLFSQANLLSGEF-PKELTALPALVSEAANDEVDRSYLELPVFVMPSNATNQQYNQLSNLPPAIYLANNSLSGN--- 400 (894)
Q Consensus 325 ~L~~L~l~~N~l~~~~-p~~l~~l~~L~~L~l~~n~~~~~~~~~~~~~~~~~~~l~~~~l~~Lp~~L~L~~N~l~~~--- 400 (894)
+++.|+++.|+++... ..-+..+++|+.|.|.+|.++...- ..+...+...++| +.|+|++|+|+..
T Consensus 3 ~l~~ld~~~~~i~~~~~~~l~~~l~~l~~L~L~~~~i~~~~~--------~~l~~~L~~~~~L-~~LdLs~N~i~~~~~~ 73 (460)
T d1z7xw1 3 DIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARC--------KDISSALRVNPAL-AELNLRSNELGDVGVH 73 (460)
T ss_dssp EEEEEEEESCCCCHHHHHHHHHHHTTCSEEEEESSCCCHHHH--------HHHHHHHHTCTTC-CEEECTTCCCHHHHHH
T ss_pred CCCEEEEECCCCCHHHHHHHHHHCCCCCEEEECCCCCCHHHH--------HHHHHHHHCCCCC-CEEECCCCCCCHHHHH
T ss_conf 877798208958868999999767799999828999988999--------9999998539998-8897959859728999
Q ss_pred -CCHHHCC-CCCCCEEECCCCCCCCC----CCCCCCCCCCCCEEECCCCCCC
Q ss_conf -8631117-87876875647738887----9900039999998965798146
Q 002673 401 -IPVEIGQ-LKSLHVLDLSNNNFSGT----IPDELSDLSNLEKLDLSGNHLV 446 (894)
Q Consensus 401 -~p~~l~~-L~~L~~L~Ls~N~l~g~----~p~~~~~l~~L~~L~Ls~N~l~ 446 (894)
+...+.. ..+|+.|+|++|+++.. ++..+..+++|+.|++++|.+.
T Consensus 74 ~l~~~l~~~~~~L~~L~L~~n~it~~~~~~l~~~l~~~~~L~~L~L~~N~i~ 125 (460)
T d1z7xw1 74 CVLQGLQTPSCKIQKLSLQNCCLTGAGCGVLSSTLRTLPTLQELHLSDNLLG 125 (460)
T ss_dssp HHHHTTCSTTCCCCEEECTTSCCBGGGHHHHHHHTTSCTTCCEEECCSSBCH
T ss_pred HHHHHHHCCCCCCCEEECCCCCCCCCCCCCCCCHHHCCCCCCCCCCCCCCCH
T ss_conf 9999984378877887788877543221012110000343200244433202
|
| >d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Methylthioribose kinase MtnK species: Bacillus subtilis [TaxId: 1423]
Probab=97.96 E-value=4.2e-05 Score=45.07 Aligned_cols=76 Identities=16% Similarity=0.111 Sum_probs=46.7
Q ss_pred CCEEEECCCEEEEEEEEC-CCCEEEEEEECCCC-------HHHHHHHHHHHHHHHHCC-C-C-CEEEECCEEEECCEEEE
Q ss_conf 544710283899999984-89848999974851-------265999999999999459-9-8-24553224310463889
Q 002673 612 ANIIGCGGFGLVYKATLA-NGTTLAIKKLSGDL-------GLMEREFKAEVEALSTAQ-H-K-NLVSLQGYCVHQGFRLL 680 (894)
Q Consensus 612 ~~~LG~G~fg~Vy~a~~~-~~~~vavK~~~~~~-------~~~~~~~~~Ei~~l~~l~-H-p-niv~l~g~~~~~~~~~l 680 (894)
.+.||.|....||++... ++..+++|.-.... .........|...++.+. + | .+.+++.+ +....++
T Consensus 31 ~~eig~G~~N~vfrV~~~~~~~svivKqa~p~~r~~g~~~~~~~~R~~~E~~~L~~~~~~~p~~vP~v~~~--d~~~~~l 108 (392)
T d2pula1 31 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAVT 108 (392)
T ss_dssp EEECCSSSSEEEEEEEC----CEEEEEEECCGGGC--CCCCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTEE
T ss_pred EEEECCCCEEEEEEEEECCCCEEEEEECCCCHHCCCCCCCCCCHHHHHHHHHHHHHHHHHCCCCCCEEEEE--CCCCCEE
T ss_conf 99807985276899995799848999617713034677788877899999999998650579885528998--5988779
Q ss_pred EEEECCCCC
Q ss_conf 998446999
Q 002673 681 IYSYMENGS 689 (894)
Q Consensus 681 V~E~~~~gs 689 (894)
|||++++..
T Consensus 109 vmE~L~~~~ 117 (392)
T d2pula1 109 VMEDLSHLK 117 (392)
T ss_dssp EECCCTTSE
T ss_pred EEECCCCCC
T ss_conf 871357765
|
| >d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: RdoA species: Escherichia coli [TaxId: 562]
Probab=97.69 E-value=0.00026 Score=40.34 Aligned_cols=138 Identities=16% Similarity=0.176 Sum_probs=76.3
Q ss_pred CCEEEEEEEECCCCEEEEEEECCCCHHHHHHHHHHHHHHHHCCCCCE-----EEECC--EEEECCEEEEEEEECCCCCH-
Q ss_conf 83899999984898489999748512659999999999994599824-----55322--43104638899984469998-
Q 002673 619 GFGLVYKATLANGTTLAIKKLSGDLGLMEREFKAEVEALSTAQHKNL-----VSLQG--YCVHQGFRLLIYSYMENGSL- 690 (894)
Q Consensus 619 ~fg~Vy~a~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~Hpni-----v~l~g--~~~~~~~~~lV~E~~~~gsL- 690 (894)
.--.||++...+|..+++|...... ....++..|...+..+....+ +..-+ .....+..+.++++++|..+
T Consensus 34 ~EN~vy~v~~~dg~~~VlK~~rp~~-~s~~~i~~E~~~l~~L~~~gipv~~p~~~~g~~~~~~~~~~~~l~~~~~G~~~~ 112 (325)
T d1zyla1 34 YENRVYQFQDEDRRRFVVKFYRPER-WTADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSVGGRQFE 112 (325)
T ss_dssp SSSEEEEECCTTCCCEEEEEECTTT-SCHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECCCCEECC
T ss_pred CCCEEEEEECCCCCEEEEEEECCCC-CCHHHHHHHHHHHHHHHHCCCCCCCCEECCCCEEEEEEEEEEEEEEECCCCCCC
T ss_conf 1202699983899979999847877-889999999999999985599878752068980566534799998652776889
Q ss_pred ----HH---------HHHHHC-----CCCCCCCHH-------------------HHHHHHHHHHHHHHHHHH----CCCC
Q ss_conf ----89---------984414-----898875799-------------------999999999999999885----0699
Q 002673 691 ----DY---------WLHEKA-----DGASQLDWL-------------------TRLKIARGTSCGLAYMHQ----ICEP 729 (894)
Q Consensus 691 ----~~---------~l~~~~-----~~~~~l~~~-------------------~~~~i~~~Ia~aL~yLHs----~~~~ 729 (894)
.. .+|... .....+++. .+..+...+...+..+.. ....
T Consensus 113 ~~~~~~~~~lG~~LA~lH~~~~~~~~~~r~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~~~~~~~p~ 192 (325)
T d1zyla1 113 ADNIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPSGLKAAFLKATDELIAAVTAHWREDFTV 192 (325)
T ss_dssp SSCHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCTTTHHHHHHHHHHHHHHHHHHCCSCSCC
T ss_pred CCCHHHHHHHHHHHHHHHHHCCCCCCCCCCCCCHHHHHHHHHHHHHHCCCCCHHHHHHHHHHHHHHHHHHHHHCCCCCCC
T ss_conf 99999999989999998863035786556778978876656899987476998898999999999999999845456871
Q ss_pred CEEECCCCCCCEEECCCCCEEEEECCCCCC
Q ss_conf 836418999985778998599997345332
Q 002673 730 HIVHRDIKSSNILLDDQFEAHLADFGLSRL 759 (894)
Q Consensus 730 ~ivH~DLkp~NILl~~~~~vkL~DFGla~~ 759 (894)
+++|+|+.+.|||++++ ..++||+-++.
T Consensus 193 ~liHgDlh~~NvL~~~~--~~~IDFdd~~~ 220 (325)
T d1zyla1 193 LRLHGDCHAGNILWRDG--PMFVDLDDARN 220 (325)
T ss_dssp EECCSSCSGGGEEESSS--EEECCCTTCCE
T ss_pred EEECCCCCCCCEEEECC--CEEEECHHCCC
T ss_conf 20247888042878389--35886520146
|
| >d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Choline kinase domain: Choline kinase species: Caenorhabditis elegans [TaxId: 6239]
Probab=97.26 E-value=0.0005 Score=38.66 Aligned_cols=72 Identities=14% Similarity=0.149 Sum_probs=45.1
Q ss_pred CCEEEECCCEEEEEEEECCC--------CEEEEEEECCCCHHHHHHHHHHHHHHHHCCCCCE-EEECCEEEECCEEEEEE
Q ss_conf 54471028389999998489--------8489999748512659999999999994599824-55322431046388999
Q 002673 612 ANIIGCGGFGLVYKATLANG--------TTLAIKKLSGDLGLMEREFKAEVEALSTAQHKNL-VSLQGYCVHQGFRLLIY 682 (894)
Q Consensus 612 ~~~LG~G~fg~Vy~a~~~~~--------~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~Hpni-v~l~g~~~~~~~~~lV~ 682 (894)
.+.|+.|-.-.+|++...++ ..|.++.... .. ......+|..+++.+.-.++ .++++++.+ .+|+
T Consensus 47 v~~l~GGltN~~y~v~~~~~~~~~~~~~~~vllRi~g~-~~-~~idr~~E~~i~~~ls~~gl~Pkll~~~~~----g~I~ 120 (395)
T d1nw1a_ 47 ISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFN-PE-TESHLVAESVIFTLLSERHLGPKLYGIFSG----GRLE 120 (395)
T ss_dssp EEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECS-CC-CHHHHHHHHHHHHHHHHTTSSSCEEEEETT----EEEE
T ss_pred EEECCCCCCCCEEEEEECCCCCCCCCCCCCEEEEECCC-CC-HHHHHHHHHHHHHHHHHCCCCCEEEEECCC----CEEE
T ss_conf 99917853343489996887754457898179996599-61-165899999999999757999808998189----5699
Q ss_pred EECCCCC
Q ss_conf 8446999
Q 002673 683 SYMENGS 689 (894)
Q Consensus 683 E~~~~gs 689 (894)
||+++..
T Consensus 121 efi~g~~ 127 (395)
T d1nw1a_ 121 EYIPSRP 127 (395)
T ss_dssp CCCCEEE
T ss_pred EEECCCC
T ss_conf 9734554
|
| >d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Homoserine kinase ThrB species: Agrobacterium tumefaciens [TaxId: 358]
Probab=97.21 E-value=0.0042 Score=33.10 Aligned_cols=160 Identities=14% Similarity=0.072 Sum_probs=80.9
Q ss_pred CCHHHHHHHCCCCCCCCEE-----EECCCEEEEEEEECCCCEEEEEEECCCCHHHHHHHHHHHHHHHHCC-----CCCEE
Q ss_conf 6989999740598765447-----1028389999998489848999974851265999999999999459-----98245
Q 002673 597 LTIYELLKATDNFSQANII-----GCGGFGLVYKATLANGTTLAIKKLSGDLGLMEREFKAEVEALSTAQ-----HKNLV 666 (894)
Q Consensus 597 ~~~~~~~~~~~~~~~~~~L-----G~G~fg~Vy~a~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~-----Hpniv 666 (894)
++..++.....+|..++.. ..|.--+.|+....++ .+++|++.... ...++..++..+..+. .|..+
T Consensus 3 ls~~el~~~l~~Y~lg~~~~~~~i~~G~~N~ny~v~t~~g-~yVLri~~~~~--~~~~l~~~~~~l~~L~~~g~pvp~pi 79 (316)
T d2ppqa1 3 ITEDELRNFLTQYDVGSLTSYKGIAEGVENSNFLLHTTKD-PLILTLYEKRV--EKNDLPFFLGLMQHLAAKGLSCPLPL 79 (316)
T ss_dssp CCHHHHHHHHTTBCCCCEEEEEEECC---EEEEEEEESSC-CEEEEEECC-----CCHHHHHHHHHHHHHHTTCCCCCBC
T ss_pred CCHHHHHHHHHHCCCCCCEEEECCCCCCCCCEEEEEECCC-CEEEEECCCCC--CHHHHHHHHHHHHHHHHCCCCCCCCC
T ss_conf 8999999999867999856852378885267389997897-28999807899--98899999999875430255545564
Q ss_pred EEC-C--EEEECCEEEEEEEECCCCCH--------------HHHHHHHCCC-------CCCCCHH---------------
Q ss_conf 532-2--43104638899984469998--------------8998441489-------8875799---------------
Q 002673 667 SLQ-G--YCVHQGFRLLIYSYMENGSL--------------DYWLHEKADG-------ASQLDWL--------------- 707 (894)
Q Consensus 667 ~l~-g--~~~~~~~~~lV~E~~~~gsL--------------~~~l~~~~~~-------~~~l~~~--------------- 707 (894)
... | +.........++.+..+... ...++..... .....+.
T Consensus 80 ~~~~g~~~~~~~~~~~~~~~~~~g~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 159 (316)
T d2ppqa1 80 PRKDGELLGELSGRPAALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVE 159 (316)
T ss_dssp CBTTCCSCEEETTEEEEEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTS
T ss_pred EECCCCCCEEEECCCCEEEEECCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCHHHCCHHHHHHHHHHHHCC
T ss_conf 10489762134125502453114655333204678888899876454443202453101110120024567777653114
Q ss_pred -HHHHHHHHHHHHHHHHHH-CCCCCEEECCCCCCCEEECCCCCEEEEECCCCCC
Q ss_conf -999999999999999885-0699836418999985778998599997345332
Q 002673 708 -TRLKIARGTSCGLAYMHQ-ICEPHIVHRDIKSSNILLDDQFEAHLADFGLSRL 759 (894)
Q Consensus 708 -~~~~i~~~Ia~aL~yLHs-~~~~~ivH~DLkp~NILl~~~~~vkL~DFGla~~ 759 (894)
.....+..+...+...+. ....+++|+|+.+.||+++.+...-|.||+.+..
T Consensus 160 ~~~~~~l~~~~~~~~~~~~~~L~~giIHgDl~~dNvl~~~~~v~gvIDF~~~~~ 213 (316)
T d2ppqa1 160 KGLREEIRPEIDYLAAHWPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFACN 213 (316)
T ss_dssp TTHHHHHHHHHHHHHHHCCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCEE
T ss_pred HHHHHHHHHHHHHHHCCCCCCCCCCCCCCCCCHHHHHCCCCCCEEEECCCCCCC
T ss_conf 127999999987642048554545033378636564020454126742221236
|
| >d1pgva_ c.10.1.1 (A:) Tropomodulin C-terminal domain {nematode (Caenorhabditis elegans) [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Tropomodulin C-terminal domain species: nematode (Caenorhabditis elegans) [TaxId: 6239]
Probab=96.83 E-value=0.00026 Score=40.31 Aligned_cols=40 Identities=13% Similarity=0.135 Sum_probs=16.1
Q ss_pred CCCCCCEEECCCCCCCCC----CCCCCCCCCCCCEEECCCCCCC
Q ss_conf 787876875647738887----9900039999998965798146
Q 002673 407 QLKSLHVLDLSNNNFSGT----IPDELSDLSNLEKLDLSGNHLV 446 (894)
Q Consensus 407 ~L~~L~~L~Ls~N~l~g~----~p~~~~~l~~L~~L~Ls~N~l~ 446 (894)
..+.|+.|+|++|.|+.. +-..+...++|+.|++++|.+.
T Consensus 70 ~n~~L~~L~L~~n~i~~~g~~~l~~aL~~n~sL~~L~l~~n~~~ 113 (167)
T d1pgva_ 70 TSPSLRVLNVESNFLTPELLARLLRSTLVTQSIVEFKADNQRQS 113 (167)
T ss_dssp HCSSCCEEECCSSBCCHHHHHHHHHHTTTTCCCSEEECCCCSSC
T ss_pred HCCCCCCEEEEHHHCCHHHHHHHHHHHHHCCCCCEEECCCCCCC
T ss_conf 02343300330102145999999999984893898778877688
|
| >d1pgva_ c.10.1.1 (A:) Tropomodulin C-terminal domain {nematode (Caenorhabditis elegans) [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Tropomodulin C-terminal domain species: nematode (Caenorhabditis elegans) [TaxId: 6239]
Probab=96.45 E-value=0.00069 Score=37.81 Aligned_cols=83 Identities=16% Similarity=0.193 Sum_probs=47.2
Q ss_pred CEEECCCC-CCCCC----CCHHHCCCCCCCEEECCCCCCCCC----CCCCCCCCCCCCEEECCCCCCCCC----CCCCCC
Q ss_conf 91881278-68767----863111787876875647738887----990003999999896579814675----797644
Q 002673 388 PAIYLANN-SLSGN----IPVEIGQLKSLHVLDLSNNNFSGT----IPDELSDLSNLEKLDLSGNHLVGE----IPISLK 454 (894)
Q Consensus 388 ~~L~L~~N-~l~~~----~p~~l~~L~~L~~L~Ls~N~l~g~----~p~~~~~l~~L~~L~Ls~N~l~g~----~p~~~~ 454 (894)
++|+|+++ .++.. +-..+...+.|+.|+|++|.+... +...+...+.|+.|+|++|.|... +-..+.
T Consensus 18 ~~L~L~~~~~i~~~~~~~l~~~L~~n~~L~~L~Ls~n~l~~~~~~~la~~L~~n~~L~~L~L~~n~i~~~g~~~l~~aL~ 97 (167)
T d1pgva_ 18 KEVNINNMKRVSKERIRSLIEAACNSKHIEKFSLANTAISDSEARGLIELIETSPSLRVLNVESNFLTPELLARLLRSTL 97 (167)
T ss_dssp CEEECTTCCSSCHHHHHHHHHHHTTCSCCCEEECTTSCCBHHHHTTHHHHHHHCSSCCEEECCSSBCCHHHHHHHHHHTT
T ss_pred CEEEECCCCCCCHHHHHHHHHHHHHCCCCCEEECCCCCCCHHHHHHHHHHHHHCCCCCCEEEEHHHCCHHHHHHHHHHHH
T ss_conf 19782799998989999999997637764540120156215679887531000234330033010214599999999998
Q ss_pred CCCCCCCCCCCCCCCC
Q ss_conf 7776553233366567
Q 002673 455 GLHFLSSFSVAHNNLQ 470 (894)
Q Consensus 455 ~l~~L~~L~ls~N~l~ 470 (894)
..+.|+.|++++|.+.
T Consensus 98 ~n~sL~~L~l~~n~~~ 113 (167)
T d1pgva_ 98 VTQSIVEFKADNQRQS 113 (167)
T ss_dssp TTCCCSEEECCCCSSC
T ss_pred HCCCCCEEECCCCCCC
T ss_conf 4893898778877688
|
| >d1io0a_ c.10.1.1 (A:) Tropomodulin C-terminal domain {Chicken (Gallus gallus) [TaxId: 9031]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Tropomodulin C-terminal domain species: Chicken (Gallus gallus) [TaxId: 9031]
Probab=94.92 E-value=0.0021 Score=34.85 Aligned_cols=35 Identities=11% Similarity=0.167 Sum_probs=13.7
Q ss_pred CEEECCCCCCCCCCCH----HHCCCCCCCEEECCCCCCC
Q ss_conf 9188127868767863----1117878768756477388
Q 002673 388 PAIYLANNSLSGNIPV----EIGQLKSLHVLDLSNNNFS 422 (894)
Q Consensus 388 ~~L~L~~N~l~~~~p~----~l~~L~~L~~L~Ls~N~l~ 422 (894)
+.|+|++|.++...-. .+...+.++.|++++|.+.
T Consensus 49 ~~L~Ls~n~l~~~~~~~L~~~l~~~~~l~~l~l~~~~~~ 87 (166)
T d1io0a_ 49 KKFSIVGTRSNDPVAFALAEMLKVNNTLKSLNVESNFIS 87 (166)
T ss_dssp CEEECTTSCCCHHHHHHHHHHHHHCSSCCEEECCSSCCC
T ss_pred CEEECCCCCCCHHHHHHHHHHHHHCCCCHHHHHCCCCCC
T ss_conf 743015896117789999987752122101210254322
|
| >d1io0a_ c.10.1.1 (A:) Tropomodulin C-terminal domain {Chicken (Gallus gallus) [TaxId: 9031]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Tropomodulin C-terminal domain species: Chicken (Gallus gallus) [TaxId: 9031]
Probab=91.23 E-value=0.035 Score=27.60 Aligned_cols=65 Identities=12% Similarity=0.184 Sum_probs=29.9
Q ss_pred HCCCCCCCEEECCCCCCCCC----CCCCCCCCCCCCEEECCCCCCCCC----CCCCCCCCCCCCCCC--CCCCCC
Q ss_conf 11787876875647738887----990003999999896579814675----797644777655323--336656
Q 002673 405 IGQLKSLHVLDLSNNNFSGT----IPDELSDLSNLEKLDLSGNHLVGE----IPISLKGLHFLSSFS--VAHNNL 469 (894)
Q Consensus 405 l~~L~~L~~L~Ls~N~l~g~----~p~~~~~l~~L~~L~Ls~N~l~g~----~p~~~~~l~~L~~L~--ls~N~l 469 (894)
+...++|+.|+|++|.++.. +-..+...++|+.+++++|.+... +-..+...+.|+.++ ++.|.+
T Consensus 42 l~~n~~L~~L~Ls~n~l~~~~~~~L~~~l~~~~~l~~l~l~~~~~~~~g~~~l~~~l~~~~~L~~l~L~l~~n~i 116 (166)
T d1io0a_ 42 LKTNTYVKKFSIVGTRSNDPVAFALAEMLKVNNTLKSLNVESNFISGSGILALVEALQSNTSLIELRIDNQSQPL 116 (166)
T ss_dssp HTTCCSCCEEECTTSCCCHHHHHHHHHHHHHCSSCCEEECCSSCCCHHHHHHHHHGGGGCSSCCEEECCCCSSCC
T ss_pred HHCCCCCCEEECCCCCCCHHHHHHHHHHHHHCCCCHHHHHCCCCCCCHHHHHHHHHHHHCCCCCEEEECCCCCCC
T ss_conf 841982574301589611778999998775212210121025432201478899999848652477321677867
|